{"meta":{"query_hash":"a541b9b1b08a","filters":{"topic":"Lymphoma Diagnosis and Treatment"},"cohort_total":3251,"direct_labels_cover":5,"predictions_cover":3251,"exported":3251,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a541b9b1b08a","api":"https://metacan.xera.ac/api/v1/cohort?topic=Lymphoma+Diagnosis+and+Treatment"},"results":[{"id":"W1049067418","doi":"10.1007/s00277-015-2467-z","title":"Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia; American Society of Hematology","keywords":"Medicine; Refractory (planetary science); Internal medicine; CHOP; Diffuse large B-cell lymphoma; Lymphoma; Hematology; Surgery; Gastroenterology","score_opus":0.03958313229841773,"score_gpt":0.3005493670425425,"score_spread":0.2609662347441247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1049067418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470145,0.0020158198,0.0000031628044,0.0003894688,0.00006680499,0.00037295403,0.000092255344,0.000018491686,0.0023395917],"genre_scores_gemma":[0.99850214,0.0001233554,0.00024215908,0.00075925316,0.000014335591,0.000076921155,0.00008392537,0.00002214044,0.00017576035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870694,0.000047618472,0.00045187224,0.0002416257,0.00026214076,0.0002898353],"domain_scores_gemma":[0.9988031,0.000084920975,0.00024271227,0.00044781304,0.0002214241,0.00020005467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006363088,0.00021180713,0.0008163699,0.00011447131,0.000014762986,0.0000023631123,0.000060285634,0.00011419719,0.00003660715],"category_scores_gemma":[0.000027166589,0.00013183767,0.00014339923,0.00008150035,0.00008825848,0.00005813001,0.0000416394,0.00002570477,0.000029782348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017719789,0.0267432,0.96809834,0.00016269245,0.00023433809,0.00019638576,0.00034437352,1.0024045e-7,0.000012885232,0.00012900613,0.0009661967,0.0013405194],"study_design_scores_gemma":[0.033698756,0.0046082595,0.93857557,0.00007564503,0.00022563775,0.00003083337,0.00007240649,0.0000012069947,0.015340992,0.000037616315,0.0071922736,0.00014083523],"about_ca_topic_score_codex":0.00007760352,"about_ca_topic_score_gemma":0.00001559785,"teacher_disagreement_score":0.031926777,"about_ca_system_score_codex":0.00006707918,"about_ca_system_score_gemma":0.0001421172,"threshold_uncertainty_score":0.53761846},"labels":[],"label_agreement":null},{"id":"W1076230489","doi":"10.1038/bmt.2015.177","title":"A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma","year":2015,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service","keywords":"Medicine; Hematopoietic cell; Confidence interval; Internal medicine; Retrospective cohort study; Transplantation; Young adult; Refractory (planetary science); Oncology; Salvage therapy; Multivariate analysis; Hematopoietic stem cell transplantation; Lymphoma; Surgery; Chemotherapy; Haematopoiesis; Stem cell","score_opus":0.010465260722938489,"score_gpt":0.2301423396169149,"score_spread":0.21967707889397642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1076230489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679935,0.00021292284,0.0010863149,0.00017417382,0.000053681095,0.0012526059,0.00009330099,0.00011336272,0.00021425984],"genre_scores_gemma":[0.99716043,0.00039080277,0.0015972245,0.000081304315,0.00002114212,0.00019329025,0.00049866876,0.000030169416,0.000026947228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985288,0.000055708857,0.00034782296,0.00039691877,0.00038459478,0.00028615474],"domain_scores_gemma":[0.9994862,0.000032551878,0.00009836777,0.00013125809,0.00006723564,0.00018436028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014553961,0.00025855668,0.00036656662,0.00018369663,0.000057174322,0.000029170566,0.000038401202,0.000112513844,0.0000013521018],"category_scores_gemma":[0.000016453298,0.00020298542,0.00004408818,0.00015441391,0.000047083304,0.00020062689,0.000004154625,0.00007121517,0.000004331262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002745167,0.0006021677,0.98692924,0.00036211708,0.00007488025,0.00041615212,0.0035820638,0.0003464531,0.000078648205,0.00003387158,0.00000428809,0.004824978],"study_design_scores_gemma":[0.023225883,0.00053795084,0.96143514,0.0011015031,0.00059393863,0.0017457718,0.0001655508,0.010572129,0.00038567418,0.000032968335,3.359309e-7,0.00020318115],"about_ca_topic_score_codex":0.0005707287,"about_ca_topic_score_gemma":0.0008033676,"teacher_disagreement_score":0.025494099,"about_ca_system_score_codex":0.0001382444,"about_ca_system_score_gemma":0.00014164529,"threshold_uncertainty_score":0.8277505},"labels":[],"label_agreement":null},{"id":"W110982080","doi":"10.1182/blood.v122.21.768.768","title":"Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Regimen; Transplantation; Busulfan; Surgery; International Prognostic Index; Hematopoietic stem cell transplantation; Etoposide; Autologous stem-cell transplantation; Oncology; Single Center; Cyclophosphamide; Gastroenterology; Chemotherapy","score_opus":0.017542218795791722,"score_gpt":0.2864364714355683,"score_spread":0.26889425263977657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W110982080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995133,0.0004340859,0.000075205004,0.00004717982,0.00002043919,0.004110155,0.000060564587,0.000043005355,0.00007641028],"genre_scores_gemma":[0.9967202,0.00012318027,0.0021512064,0.000021540023,0.000010664925,0.00075793976,0.000108027416,0.000025607906,0.000081628335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843633,0.00006615896,0.00061884604,0.0004247409,0.00022012339,0.00023379964],"domain_scores_gemma":[0.9988649,0.00017628449,0.00040666087,0.00026532798,0.00017419235,0.000112662114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066045446,0.00024855405,0.0006686238,0.000119941345,0.000033807057,0.000009476389,0.000060066093,0.00004889994,0.000007606837],"category_scores_gemma":[0.000013075704,0.00018673608,0.000072991555,0.00023979413,0.00009645111,0.00006271878,0.000016519341,0.000043641416,0.0000013128441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012063766,0.13039395,0.78946376,0.0014933357,0.0018222933,0.004264486,0.04131235,0.00017185912,0.0053145555,0.0000020697648,0.0001344984,0.013563096],"study_design_scores_gemma":[0.194619,0.0057484116,0.7297948,0.00024055119,0.0017168574,0.0006951732,0.00091159024,0.00085950573,0.0651801,0.0000010671213,0.000024262652,0.00020867641],"about_ca_topic_score_codex":0.00062676,"about_ca_topic_score_gemma":0.000137763,"teacher_disagreement_score":0.18255523,"about_ca_system_score_codex":0.000063178195,"about_ca_system_score_gemma":0.00017412618,"threshold_uncertainty_score":0.76148766},"labels":[],"label_agreement":null},{"id":"W1143070445","doi":"10.14694/edbook_am.2015.35.e458","title":"Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Gene expression profiling; Immunophenotyping; Immunohistochemistry; Tissue microarray; Malignancy; Computational biology; Pathology; Cancer research; Gene expression; Biology; Gene; Medicine; Immunology; Genetics; Flow cytometry","score_opus":0.2117505345741191,"score_gpt":0.5167497764654623,"score_spread":0.3049992418913432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1143070445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051863777,0.97503555,0.000009411331,0.015608172,0.0007579519,0.0025751612,0.00032037054,0.000011168848,0.005163604],"genre_scores_gemma":[0.0005678128,0.9783442,0.001796267,0.006485008,0.001013778,0.0013830322,0.00034305203,0.00005027831,0.010016567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528915,0.00065808604,0.002638377,0.00057883706,0.00044528887,0.00039026415],"domain_scores_gemma":[0.95523417,0.03961119,0.0036326756,0.00082282664,0.00048108018,0.00021805527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034531364,0.00040552585,0.0039747413,0.000043488577,0.00010339097,0.0000069799084,0.00052556995,0.00052028155,0.00011858966],"category_scores_gemma":[0.0012666583,0.00021209878,0.0025848527,0.000313926,0.001636308,0.000034818833,0.00012718396,0.00048778605,0.00008663982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011260305,0.032416437,0.008531258,0.0015277535,0.0007611256,0.000001826178,0.0003402586,1.4575086e-7,2.2617584e-8,0.0002920932,0.44351685,0.51249963],"study_design_scores_gemma":[0.009291499,0.0013492623,0.0051058116,0.00076519063,0.0028901147,0.000009738283,0.0019419016,0.0000087202725,2.7276818e-7,0.000088466964,0.97837144,0.0001775934],"about_ca_topic_score_codex":0.00018071347,"about_ca_topic_score_gemma":0.000015431227,"teacher_disagreement_score":0.5348546,"about_ca_system_score_codex":0.0007707034,"about_ca_system_score_gemma":0.013504606,"threshold_uncertainty_score":0.9920879},"labels":[],"label_agreement":null},{"id":"W1193538218","doi":"10.1182/blood.v122.21.3044.3044","title":"A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Etoposide; Internal medicine; CHOP; Gastroenterology; Cyclophosphamide; Epirubicin; Prednisone; Peripheral T-cell lymphoma; Chemotherapy; Surgery; Oncology; Immunology; T cell","score_opus":0.009784853628099706,"score_gpt":0.2432115664098138,"score_spread":0.23342671278171412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1193538218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888212,0.001163182,0.0000064030355,0.0002668907,0.00008732701,0.00900386,0.0003188471,0.000049058883,0.00028325184],"genre_scores_gemma":[0.99581444,0.0001446213,0.0018522817,0.00015800216,0.00018385497,0.0011608396,0.0002684184,0.00006645722,0.00035108867],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99768156,0.00009835541,0.0007162906,0.0006560293,0.0004878102,0.0003599785],"domain_scores_gemma":[0.9977951,0.00047123551,0.0006288106,0.0005998022,0.00031989327,0.00018515617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014936173,0.00042572507,0.0006753117,0.000043474738,0.00025073567,0.00005786086,0.00015380516,0.00008628135,0.000035761903],"category_scores_gemma":[0.00006634436,0.00022821434,0.000086641536,0.00009568018,0.00010829452,0.00013028244,0.00008928985,0.00008319182,0.0000031241193],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45581403,0.25079843,0.2607716,0.00008402999,0.0018921824,0.0001333044,0.010125086,0.000019318102,0.000785677,0.0000022594488,0.00075554097,0.018818518],"study_design_scores_gemma":[0.6783352,0.20091224,0.104638405,0.00016850981,0.001110927,0.00001274428,0.0007817312,0.00018098624,0.013465555,0.00001023922,0.00013328758,0.00025017076],"about_ca_topic_score_codex":0.004849246,"about_ca_topic_score_gemma":0.00009763433,"teacher_disagreement_score":0.22252116,"about_ca_system_score_codex":0.00005383057,"about_ca_system_score_gemma":0.00016915772,"threshold_uncertainty_score":0.93063104},"labels":[],"label_agreement":null},{"id":"W130495402","doi":"10.1200/jco.2005.23.16_suppl.6595","title":"Evaluation of three prognostic indexes in follicular lymphoma","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Internal medicine; Follicular lymphoma; Erythrocyte sedimentation rate; Concordance; Stage (stratigraphy); Lymphoma; Gastroenterology; Oncology; Surgery; Rituximab","score_opus":0.1932692705109697,"score_gpt":0.48550509627348576,"score_spread":0.29223582576251605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W130495402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902868,0.0020506755,0.000017318935,0.0049981903,0.0003039178,0.0003074467,7.7055097e-7,0.0000027104213,0.00203213],"genre_scores_gemma":[0.99645406,0.00031703128,0.0021328044,0.0005121587,0.00055289007,0.000011692302,0.0000011319543,0.0000068999084,0.000011346221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653745,0.00041287657,0.0020072137,0.00011650222,0.0007890267,0.00013691078],"domain_scores_gemma":[0.99633473,0.0014002726,0.0011871228,0.00013591457,0.00078368984,0.00015824698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073349746,0.0000878475,0.0010165875,0.00014157091,0.000010400431,0.0000028061713,0.000080298756,0.00025139525,0.00012023532],"category_scores_gemma":[0.006150623,0.000057566725,0.00034986122,0.00013042035,0.00008653655,0.00007966669,0.000022194014,0.00015687007,0.000015360718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004155864,0.003978859,0.5046979,0.0000061714363,0.00021467375,0.00011965631,0.00002975606,0.00008277819,0.00001623117,0.00006869619,0.00024073856,0.49012893],"study_design_scores_gemma":[0.023739992,0.0062114117,0.9600922,0.00015792313,0.0012761042,0.00020416612,0.000022790373,0.0010800145,0.00024039371,0.000858129,0.0060717133,0.000045146073],"about_ca_topic_score_codex":0.00002590968,"about_ca_topic_score_gemma":0.00029251646,"teacher_disagreement_score":0.49008378,"about_ca_system_score_codex":0.0004838627,"about_ca_system_score_gemma":0.0026769745,"threshold_uncertainty_score":0.73633146},"labels":[],"label_agreement":null},{"id":"W131577531","doi":"10.4049/jimmunol.182.supp.38.5","title":"Selective ablation of the YxxM motif of IL-7R alpha suppresses lymphomagenesis but maintains lymphocyte development (38.5)","year":2009,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Lymphocyte; Biology; Transgene; Cytokine; Cancer research; Immunology; Haematopoiesis; Progenitor cell; Cell biology; Stem cell; Genetics; Gene","score_opus":0.01062949612367809,"score_gpt":0.24012300099137168,"score_spread":0.2294935048676936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W131577531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929572,0.0045520472,0.00011049638,0.0014315156,0.00018271476,0.00023892111,0.0000063690845,0.0000061784763,0.0005145787],"genre_scores_gemma":[0.99732226,0.001802105,0.00050159974,0.00017243622,0.000049062684,0.0000033955284,0.0000022923452,0.00001091659,0.00013590437],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984391,0.0002329877,0.00070538797,0.000094924006,0.0003036236,0.00022401832],"domain_scores_gemma":[0.9981247,0.00027006664,0.0008073789,0.0003141323,0.00044308614,0.000040599647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043603484,0.00016497006,0.0004979199,0.00014265638,0.000109486355,0.0000047285193,0.00027990495,0.000096320764,0.000049494716],"category_scores_gemma":[0.00015464632,0.00008478666,0.00018185674,0.00024182751,0.00018524722,0.000069621194,0.0000581228,0.0000974955,0.000005069829],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007462106,0.004349892,0.07323813,0.000118356416,0.0059838053,0.00011113972,0.012448971,0.0007218376,0.7085211,0.0013595676,0.00093647256,0.18474862],"study_design_scores_gemma":[0.0024609964,0.0007241368,0.53402144,0.00011372517,0.0002357689,0.0005456801,0.00044074934,0.000011505753,0.46079952,0.00018545426,0.00041561454,0.000045414035],"about_ca_topic_score_codex":0.000101412305,"about_ca_topic_score_gemma":0.0000113121805,"teacher_disagreement_score":0.4607833,"about_ca_system_score_codex":0.00046965625,"about_ca_system_score_gemma":0.0008518319,"threshold_uncertainty_score":0.34574997},"labels":[],"label_agreement":null},{"id":"W13543319","doi":"10.1155/2007/768149","title":"Primary Duodenal Mucosa-Associated Lymphoid Tissue (Malt) Lymphoma – a Rare Presentation of Gastric Outlet Obstruction","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"MALT lymphoma; Mucosa-associated lymphoid tissue; Lymphatic system; Medicine; Lymphoma; Stomach; Pathology; Gastric lymphoma; Small intestine; Gastroenterology; Internal medicine","score_opus":0.010373876289917093,"score_gpt":0.24082502926311705,"score_spread":0.23045115297319996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W13543319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969896,0.00035914322,0.0004175121,0.0007916267,0.00064568454,0.00021889442,0.00005074682,0.000007504728,0.00051927986],"genre_scores_gemma":[0.99802786,0.00004106416,0.0008636254,0.00062316295,0.00023443563,0.0000037607967,0.00008199443,0.000022072958,0.00010200869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980571,0.00010695669,0.00080844684,0.00017881664,0.00028569569,0.00056293566],"domain_scores_gemma":[0.99788445,0.00007045521,0.00068870146,0.00017346877,0.000429605,0.0007533444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000397446,0.00019162506,0.00059665064,0.0007205577,0.00007564364,0.000014631037,0.00013392071,0.00014305621,0.000150497],"category_scores_gemma":[0.00015380658,0.00017333851,0.00019288146,0.0002201297,0.00014805603,0.00012733026,0.000013659867,0.00010671121,0.0000073347223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012592888,0.0002686949,0.980089,0.00003697267,0.0003985064,0.0017749196,0.00023454038,0.000019259147,0.0017162124,0.000025956624,0.0025675166,0.011609152],"study_design_scores_gemma":[0.008505317,0.0035970837,0.9743811,0.00012225047,0.0003153525,0.00944384,0.00019112971,0.000008798913,0.0021781675,0.000034656496,0.0011560507,0.000066271576],"about_ca_topic_score_codex":0.0024520732,"about_ca_topic_score_gemma":0.011104044,"teacher_disagreement_score":0.011542881,"about_ca_system_score_codex":0.0014330246,"about_ca_system_score_gemma":0.0009890173,"threshold_uncertainty_score":0.7068539},"labels":[],"label_agreement":null},{"id":"W1440956116","doi":"10.1182/blood.v122.21.371.371","title":"A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Diffuse large B-cell lymphoma; Rituximab; International Prognostic Index; Prednisone; Vincristine; Placebo; Surrogate endpoint; Phases of clinical research; Oncology; Cyclophosphamide; Lymphoma; Surgery; Clinical trial; Chemotherapy; Pathology","score_opus":0.007121130264520015,"score_gpt":0.23569982298567893,"score_spread":0.2285786927211589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1440956116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298054,0.00009743372,8.115189e-7,0.000066525194,0.00006999871,0.0066160103,0.00005127817,0.000028568558,0.00008882452],"genre_scores_gemma":[0.9981964,0.000009326747,0.00009535366,0.00008300208,0.000041991632,0.0013537963,0.000029578308,0.000033064287,0.00015746079],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981691,0.00027953403,0.00042261512,0.0003680294,0.00042266332,0.0003380106],"domain_scores_gemma":[0.99871904,0.00028212738,0.0001585635,0.0006301433,0.00004993534,0.0001602233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021535018,0.00026503086,0.000558183,0.00014907376,0.000092057424,0.000025446838,0.00011033205,0.000055165063,0.000021148144],"category_scores_gemma":[0.000053734766,0.0001424213,0.00012323036,0.00026425652,0.000016012964,0.00007936871,0.00006548073,0.00004328281,0.000023685154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10224705,0.4366467,0.45126122,0.000010612339,0.00063053553,0.00013832463,0.0047937557,9.347149e-7,0.00016007407,0.0000012275311,0.000042681033,0.004066893],"study_design_scores_gemma":[0.5123239,0.031139756,0.4534957,0.000037439044,0.00074128,7.585077e-7,0.0003542578,0.000001001899,0.0017715391,0.0000012000013,0.000052000574,0.000081128455],"about_ca_topic_score_codex":0.001965461,"about_ca_topic_score_gemma":0.00014986061,"teacher_disagreement_score":0.4100769,"about_ca_system_score_codex":0.00022455274,"about_ca_system_score_gemma":0.00014394458,"threshold_uncertainty_score":0.58077717},"labels":[],"label_agreement":null},{"id":"W14419551","doi":"10.1182/blood.v122.21.1804.1804","title":"The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; CHOP; Gemcitabine; Oncology; Chemotherapy regimen; Anaplastic large-cell lymphoma; Population; Lymphoma; Chemotherapy; Gastroenterology","score_opus":0.025607020485965522,"score_gpt":0.22883328315955528,"score_spread":0.20322626267358976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W14419551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232006,0.005355841,0.000001316477,0.00059601775,0.000021282254,0.00061773026,0.0000071576837,0.0000052992323,0.0010753103],"genre_scores_gemma":[0.9954043,0.0029384033,0.0009977367,0.00033248254,0.000025040836,0.00009748752,0.000005511517,0.000010893409,0.00018813535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991857,0.0000781444,0.00025093427,0.00013086553,0.00020255503,0.00015181203],"domain_scores_gemma":[0.9989456,0.0005308347,0.000099880664,0.00033015365,0.00005635472,0.00003720832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015018944,0.00011457744,0.0002418428,0.000030178793,0.000041560656,0.000023864535,0.000081379534,0.00004736895,0.000037182825],"category_scores_gemma":[0.000039461833,0.000053345724,0.000066804074,0.00012124485,0.00011838377,0.00006959004,0.000024629438,0.000044351393,0.0000025582542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015684581,0.0040567773,0.9289181,0.00006684817,0.00019623728,0.000022192717,0.0015463929,0.0000020549342,0.018716514,0.00025048523,0.0011758936,0.044891655],"study_design_scores_gemma":[0.009470174,0.0005294819,0.9704884,0.000044329252,0.00007491196,0.00003626823,0.0001702804,0.000028959743,0.016793208,0.00006536343,0.0022380978,0.00006048731],"about_ca_topic_score_codex":0.0008650238,"about_ca_topic_score_gemma":0.00003643787,"teacher_disagreement_score":0.044831168,"about_ca_system_score_codex":0.000019429703,"about_ca_system_score_gemma":0.00006065759,"threshold_uncertainty_score":0.21753755},"labels":[],"label_agreement":null},{"id":"W1453424702","doi":"10.1182/blood.v124.21.1681.1681","title":"CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; RHOA; Biology; Lymphoma; Mutation; T-cell lymphoma; T cell; Molecular biology; Genetics; Immunology; Gene; Signal transduction; Immune system","score_opus":0.007615652848479673,"score_gpt":0.2514435641624953,"score_spread":0.24382791131401563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1453424702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934165,0.00080851896,0.0000058282953,0.00031644155,0.00002331736,0.0001858663,0.0000015458855,0.000025540225,0.005216454],"genre_scores_gemma":[0.99795645,0.00006257796,0.0015227256,0.00011691986,0.00004390571,0.00007283264,0.000013809189,0.000009110879,0.00020168557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995305,0.000022107608,0.00009908392,0.00014764287,0.000087117085,0.00011355224],"domain_scores_gemma":[0.9997484,0.000030141433,0.00002259528,0.00010994549,0.000015793632,0.00007313934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049728253,0.000074586795,0.00012319376,0.000043795397,0.000037083188,0.000013483514,0.000017516195,0.000037636197,0.000029707093],"category_scores_gemma":[0.000018341381,0.000055942586,0.000026188129,0.00006963448,0.00002412847,0.000028113409,0.000014898007,0.000017710632,0.000014259465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017614899,0.0020460924,0.9618015,0.00003558136,0.00001849282,0.000060961484,0.00024887337,8.909861e-7,0.002679637,0.000082125,0.000054996446,0.032953218],"study_design_scores_gemma":[0.009871355,0.0003300445,0.96098727,0.000071821065,0.00013391602,0.00006252507,0.00004500662,0.0001309502,0.027153429,0.00005202005,0.0010883318,0.0000733377],"about_ca_topic_score_codex":0.000039987597,"about_ca_topic_score_gemma":0.000016152815,"teacher_disagreement_score":0.032879878,"about_ca_system_score_codex":0.000025670988,"about_ca_system_score_gemma":0.000031193853,"threshold_uncertainty_score":0.22812724},"labels":[],"label_agreement":null},{"id":"W1467009401","doi":"10.1212/wnl.84.14_supplement.p7.274","title":"Efficacy of Teriflunomide in Early-Stage MS: Reanalysis of the TOPIC Study Using 2010 McDonald Diagnostic Criteria (P7.274)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Teriflunomide; Miller; Stage (stratigraphy); Medicine; Family medicine; Psychiatry; Multiple sclerosis","score_opus":0.04919179832201942,"score_gpt":0.3193339702247425,"score_spread":0.2701421719027231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1467009401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799836,0.00013492642,0.000001467893,0.0009037295,0.00025813864,0.000513847,0.0000073188344,0.000007738599,0.00017448465],"genre_scores_gemma":[0.99943984,0.000014853283,0.000039918632,0.00036589507,0.000053919735,0.000022526621,0.0000027857614,0.000012361627,0.000047932994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987141,0.00023959,0.0004256865,0.00024607455,0.00019603304,0.00017854384],"domain_scores_gemma":[0.9987113,0.00044875822,0.00016571398,0.00052979053,0.000074565636,0.00006988479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019463281,0.00012760585,0.00047792384,0.0001321527,0.000018432662,0.00000455204,0.00013335726,0.00007518311,0.00005913505],"category_scores_gemma":[0.0006309114,0.00008582804,0.000114657305,0.00023523276,0.000098827986,0.000029458279,0.000107376734,0.00010780625,0.000004932078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045437546,0.0015685656,0.9954005,0.000013564614,0.000093874696,0.00018742456,0.0006959005,0.00007655266,0.0011222253,0.000019310568,0.00007060867,0.00029710852],"study_design_scores_gemma":[0.0048239883,0.0018018266,0.9910176,0.000020375453,0.000350277,0.000019796182,0.000032911365,0.00013770338,0.0014702926,0.000019495194,0.00025481658,0.00005091079],"about_ca_topic_score_codex":0.005150753,"about_ca_topic_score_gemma":0.0005882086,"teacher_disagreement_score":0.004562544,"about_ca_system_score_codex":0.00003935908,"about_ca_system_score_gemma":0.00008859197,"threshold_uncertainty_score":0.7786432},"labels":[],"label_agreement":null},{"id":"W1471456583","doi":"10.1016/j.prp.2015.08.007","title":"Amyloid deposition in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: A clinicopathologic study of 5 cases","year":2015,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"MALT lymphoma; Pathology; Marginal zone; Medicine; Lymphoma; Lymphatic system; Amyloid (mycology); Mucosa-associated lymphoid tissue; Marginal zone B-cell lymphoma; Perforation; B cell; Immunology; Antibody","score_opus":0.18848141389612977,"score_gpt":0.4568425177482149,"score_spread":0.2683611038520851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1471456583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939115,0.00238769,0.000009916478,0.0007593215,0.000072660405,0.00092492264,0.000030312183,0.000016829463,0.001886815],"genre_scores_gemma":[0.9980308,0.00080538314,0.0007524715,0.000071995346,0.000036171015,0.00013889716,0.00003626469,0.000014814866,0.000113222995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955653,0.002389875,0.000564862,0.00042938642,0.0006279867,0.00042261742],"domain_scores_gemma":[0.99498814,0.0034525627,0.00026287,0.00033649607,0.00073280063,0.00022714051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046946546,0.00016332726,0.0005908904,0.0003673772,0.0000772162,0.000015452222,0.00009879256,0.00019203326,0.000025889465],"category_scores_gemma":[0.0073140557,0.00012276976,0.00003867994,0.0005294384,0.00034126217,0.00019782747,0.00012234763,0.00019372361,0.000013548796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015500127,0.041149765,0.8481719,0.00013157075,0.00019811855,0.04575297,0.005200369,0.000002218636,0.010940977,0.0001200802,0.00027942596,0.03255248],"study_design_scores_gemma":[0.03467422,0.046673354,0.86972415,0.0001821047,0.00037662016,0.019650603,0.01799544,0.000043820015,0.009855884,0.00023771796,0.00037319717,0.00021290507],"about_ca_topic_score_codex":0.002514907,"about_ca_topic_score_gemma":0.00063413795,"teacher_disagreement_score":0.032339577,"about_ca_system_score_codex":0.0002328746,"about_ca_system_score_gemma":0.00040369594,"threshold_uncertainty_score":0.87561363},"labels":[],"label_agreement":null},{"id":"W1488831052","doi":"10.1002/cyto.b.21251","title":"Novel lymphocyte screening tube using dried monoclonal antibody reagents","year":2015,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"CD20; Bone marrow; Medicine; Antibody; CD5; Chemistry; Pathology; Immunology","score_opus":0.3074094827735038,"score_gpt":0.46838573601296496,"score_spread":0.1609762532394612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488831052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806821,0.0016131236,0.010660715,0.00034803085,0.0019171408,0.0007260865,0.000120031225,0.0003207842,0.003611995],"genre_scores_gemma":[0.9634411,0.00028672628,0.030891994,0.0021356186,0.0020924008,0.000034298166,0.00033353534,0.00012474996,0.0006595987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99375975,0.0002264997,0.00197776,0.0013554263,0.0015742483,0.0011062869],"domain_scores_gemma":[0.9944476,0.0011071179,0.0005370814,0.0012961571,0.00054381986,0.0020682425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025058752,0.000670324,0.0017081412,0.0010118086,0.00024459264,0.00014445168,0.0004183039,0.00066440745,0.00027975306],"category_scores_gemma":[0.003437976,0.000589113,0.00086237735,0.0030389694,0.00040879406,0.0003563531,0.00046864065,0.00056825,0.00064697425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012209701,0.003516884,0.9735877,0.000065009335,0.0010069577,0.0007006484,0.000041311036,0.000035867182,0.0025353392,0.00005940393,0.0031836259,0.014046267],"study_design_scores_gemma":[0.03434862,0.002087619,0.90122026,0.00066287303,0.0014127409,0.0012415039,0.0002870519,0.0052623185,0.007592986,0.000046315952,0.044706255,0.0011314758],"about_ca_topic_score_codex":0.00017432816,"about_ca_topic_score_gemma":0.00000292788,"teacher_disagreement_score":0.072367474,"about_ca_system_score_codex":0.0008446777,"about_ca_system_score_gemma":0.0009214872,"threshold_uncertainty_score":0.999656},"labels":[],"label_agreement":null},{"id":"W1492155712","doi":"10.1002/9781444300857.ch45","title":"Management of Patients with Peripheral T‐Cell Lymphoma","year":2008,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Lymphoma; CHOP; Transplantation; Oncology; Autologous stem-cell transplantation; Internal medicine; Peripheral; Not Otherwise Specified; T-cell lymphoma; Refractory (planetary science); T cell; Immunology; Immune system; Biology","score_opus":0.005513829780421174,"score_gpt":0.20531294449253268,"score_spread":0.1997991147121115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492155712","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0131973205,0.0007424055,0.000008253236,0.00001940597,0.00006509599,0.0006936617,0.000032242628,0.00007055696,0.9851711],"genre_scores_gemma":[0.05221531,0.001036323,0.003728781,0.00009895147,0.00004211136,0.00005522922,0.00019979956,0.00023105841,0.9423924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914265,0.000006184087,0.00014102932,0.0002400941,0.00031895775,0.00015107397],"domain_scores_gemma":[0.99943656,0.0000037212594,0.00011110416,0.00034159143,0.000028314415,0.00007871831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000006944396,0.00022830201,0.00037724013,0.00008713878,0.000012362192,0.0000029246628,0.00005126922,0.000097920674,0.0042633303],"category_scores_gemma":[2.4338843e-7,0.00013805961,0.00008674739,0.00007018413,0.000046403795,0.0000081523685,0.00002754702,0.00001617394,0.00009835398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002333021,0.0075688623,0.22405651,0.00081661803,0.0014626834,0.00061322906,0.00004642172,2.3843074e-7,2.1353176e-7,0.00018118034,0.7347835,0.03023726],"study_design_scores_gemma":[0.015969358,0.00065563945,0.2982756,0.00056943577,0.0004524063,0.000005887388,0.000027449392,8.1794843e-7,0.0001069261,8.1423406e-7,0.68373704,0.00019865097],"about_ca_topic_score_codex":0.00019943315,"about_ca_topic_score_gemma":0.000011500433,"teacher_disagreement_score":0.074219055,"about_ca_system_score_codex":0.000117954434,"about_ca_system_score_gemma":0.000039992465,"threshold_uncertainty_score":0.9966469},"labels":[],"label_agreement":null},{"id":"W1493119983","doi":"10.1002/pbc.24851","title":"Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma","year":2013,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Oncology; Hodgkin lymphoma; Chemotherapy; Risk stratification; Regimen; Refractory (planetary science); Hematopoietic stem cell transplantation; Internal medicine; Radiation therapy; Transplantation","score_opus":0.05349176858192455,"score_gpt":0.3342105659369809,"score_spread":0.28071879735505634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493119983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046204127,0.94998974,3.949984e-7,0.00004595111,0.00044532793,0.0027191122,0.00014859904,0.000053183157,0.00039356117],"genre_scores_gemma":[0.008417777,0.9865167,0.00018729677,0.000026462516,0.0015049936,0.0025804394,0.0002595306,0.00008222117,0.00042458432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678606,0.00010466878,0.0014000008,0.00083913497,0.00039061118,0.00047951078],"domain_scores_gemma":[0.9975031,0.00021507691,0.0010115991,0.0008021089,0.00022464468,0.00024348855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015688538,0.0007411318,0.0029722326,0.00075299764,0.00004549397,0.000024400968,0.00018630389,0.00052957505,0.00028264738],"category_scores_gemma":[0.000048525406,0.0005273368,0.00076570327,0.0012595714,0.000041016905,0.00006231491,0.00005481146,0.00016795448,0.00014034503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046309535,0.0037945155,0.084450044,0.017135104,0.0006826054,0.00009506874,0.00015152252,0.0000016627181,4.7482402e-7,0.000032443295,0.0015179518,0.8920923],"study_design_scores_gemma":[0.036938313,0.0070241676,0.13593979,0.010781543,0.17920586,0.00049278396,0.00012260121,0.0000295266,0.00014102466,0.000093168375,0.62587124,0.003359979],"about_ca_topic_score_codex":0.0036276544,"about_ca_topic_score_gemma":0.00013976288,"teacher_disagreement_score":0.8887323,"about_ca_system_score_codex":0.0014106939,"about_ca_system_score_gemma":0.0027028432,"threshold_uncertainty_score":0.99971783},"labels":[],"label_agreement":null},{"id":"W1495226064","doi":"10.4049/jimmunol.192.supp.203.14","title":"Control of B lymphoma through regulation of TRAF protein degradation during nutrient stress (TUM7P.932)","year":2014,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Raji cell; Cancer research; Lymphoma; Signal transduction; Biology; Medicine; Cell biology; Immunology","score_opus":0.008768588906964253,"score_gpt":0.23004324661626038,"score_spread":0.22127465770929614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495226064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516714,0.0014734085,0.0017864072,0.0010300013,0.000093346105,0.00029439983,0.0000037947505,0.0000043562704,0.0001471773],"genre_scores_gemma":[0.99929714,0.00019664408,0.0003601449,0.000022816346,0.00006173213,0.0000057832217,0.0000029384967,0.000008354863,0.000044423417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883986,0.00020416589,0.00057427376,0.000059507216,0.0002028364,0.00011937391],"domain_scores_gemma":[0.9985075,0.00014759086,0.0008485165,0.0002215569,0.00025353863,0.000021316353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032687632,0.000094179166,0.00040370188,0.00008049338,0.00004324857,0.000002571812,0.00010283014,0.000070239505,0.000027961578],"category_scores_gemma":[0.000111879875,0.000055333807,0.00011447081,0.00008687691,0.00012138551,0.00007969981,0.000015359798,0.000060439655,0.000001835649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005399384,0.0018002505,0.014014671,0.00015526895,0.0011673998,0.00001111704,0.001394753,0.0001637868,0.94895244,0.007863062,0.00003450884,0.01904336],"study_design_scores_gemma":[0.010290659,0.0014896909,0.34449852,0.00034379485,0.00029668928,0.00031560985,0.00024524378,0.00005790765,0.6416424,0.0006360878,0.00014272769,0.000040679686],"about_ca_topic_score_codex":0.00007465169,"about_ca_topic_score_gemma":0.0000037989257,"teacher_disagreement_score":0.33048382,"about_ca_system_score_codex":0.000110142326,"about_ca_system_score_gemma":0.000073891686,"threshold_uncertainty_score":0.22564471},"labels":[],"label_agreement":null},{"id":"W149751534","doi":"10.1182/blood.v122.21.1809.1809","title":"Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Anaplastic large-cell lymphoma; Oncology; Population; Phases of clinical research; Antibody-drug conjugate; Refractory (planetary science); CD30; Lymphoma; Surgery; Clinical trial; Immunology; Antibody","score_opus":0.011728922263416437,"score_gpt":0.24269242626078552,"score_spread":0.2309635039973691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W149751534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977923,0.00007848407,0.0000024117815,0.000009769935,0.00011304003,0.0015800998,0.00022464285,0.000043873526,0.00015535705],"genre_scores_gemma":[0.999332,0.0000073890733,0.00012851394,0.000015760634,0.000057250058,0.000094739604,0.0003005575,0.000041207033,0.000022546785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794954,0.00011420183,0.0005983559,0.0005095225,0.0005004155,0.0003279931],"domain_scores_gemma":[0.99850494,0.0002471433,0.00028818563,0.000634421,0.00014451017,0.00018083052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014735824,0.00025735094,0.000595114,0.00014496589,0.00005053797,0.000023824734,0.00011943773,0.00009077024,0.000054403245],"category_scores_gemma":[0.000089886475,0.00017203673,0.000045744673,0.00023208349,0.000022389948,0.00015208338,0.00004774845,0.00007837012,0.000048227117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049138097,0.14142808,0.8505549,0.00006067159,0.00023992555,0.00018127813,0.0013250917,0.0000019677425,0.00013520647,0.0000016003613,0.00004925778,0.0011082387],"study_design_scores_gemma":[0.27544987,0.013687498,0.70829344,0.00035219692,0.0003853167,0.0000025889267,0.0012104308,0.00005973186,0.0004067046,0.000001401633,0.0000073245005,0.00014351324],"about_ca_topic_score_codex":0.003383907,"about_ca_topic_score_gemma":0.0021508147,"teacher_disagreement_score":0.27053604,"about_ca_system_score_codex":0.00013581413,"about_ca_system_score_gemma":0.00015610932,"threshold_uncertainty_score":0.7015454},"labels":[],"label_agreement":null},{"id":"W1503750180","doi":"10.1002/cncr.25117","title":"Long‐term outcomes for patients with limited stage follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymph node; Follicular lymphoma; Internal medicine; Lymphoma; Follicular phase; Radiation therapy; B symptoms; Lymph; Survival rate; Gastroenterology; Surgery; Pathology","score_opus":0.016077075595430666,"score_gpt":0.2879694780512765,"score_spread":0.27189240245584584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503750180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774706,0.00014216149,0.000019304853,0.00047474308,0.00033460732,0.00081509387,0.00010918756,0.000041312996,0.00031652628],"genre_scores_gemma":[0.9957639,0.000029073131,0.00039828147,0.00087135256,0.000094975185,0.0005957085,0.00011105499,0.000028056515,0.0021076077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929357,0.000003866878,0.00011412538,0.00021460472,0.00016595202,0.00020786237],"domain_scores_gemma":[0.99935824,0.000041651783,0.000056964353,0.0002813013,0.00012948542,0.00013234897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022392382,0.0001445715,0.0002347417,0.000038074762,0.00005515266,0.000017257431,0.000047888378,0.000062743755,0.00022408422],"category_scores_gemma":[0.000023213966,0.000087097724,0.000095031406,0.00006272915,0.000034651566,0.00004822701,0.000013458303,0.00002935531,0.000014423646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018444279,0.00065306824,0.9691963,0.00004443987,0.00023314274,0.000020540541,0.000050831986,4.7074838e-7,0.000059657832,0.00008724228,0.00077239296,0.028697472],"study_design_scores_gemma":[0.011786116,0.00033068674,0.96720916,0.00004701294,0.00021310116,0.0000014218011,0.000004394391,0.00000735932,0.0016212297,0.000003854727,0.018662654,0.00011299987],"about_ca_topic_score_codex":0.00006936252,"about_ca_topic_score_gemma":0.00017015236,"teacher_disagreement_score":0.028584471,"about_ca_system_score_codex":0.00012752194,"about_ca_system_score_gemma":0.00010958626,"threshold_uncertainty_score":0.3551742},"labels":[],"label_agreement":null},{"id":"W150572272","doi":"10.1200/jco.2009.27.15_suppl.8524","title":"Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; University of Alberta; Saint John Regional Hospital; University of Ottawa; Dalhousie University","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Anaplastic large-cell lymphoma; Clinical endpoint; Peripheral T-cell lymphoma; Gastroenterology; Interim analysis; Phases of clinical research; Surgery; Progressive disease; Mycosis fungoides; Lymphoma; Oncology; Chemotherapy; Clinical trial; Multiple myeloma; T cell; Immunology; Immune system","score_opus":0.20177150045491404,"score_gpt":0.4937980521055584,"score_spread":0.29202655165064434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W150572272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627057,0.00014644802,0.000008405219,0.034117434,0.0008616456,0.00063973357,0.000005517482,0.0000030332715,0.0015121257],"genre_scores_gemma":[0.99585754,0.00021984016,0.00028024026,0.0024946947,0.0009633374,0.000019178577,0.0000013611227,0.000006883101,0.00015692973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99702895,0.00020395106,0.0021467563,0.00016984822,0.00027280636,0.00017770349],"domain_scores_gemma":[0.9890846,0.008108763,0.0022112934,0.00024094895,0.00019728337,0.00015709297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034157038,0.00012597244,0.0014812934,0.00009270179,0.000053540753,0.000004185326,0.000104696286,0.00023866078,0.000030211344],"category_scores_gemma":[0.008020493,0.00006624627,0.00077775837,0.0000962963,0.000099898105,0.000049034526,0.000019287228,0.00022210783,0.0000018289686],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.545044,0.16203322,0.0077611217,0.00002694286,0.00035584622,0.012752068,0.00009760612,0.000006905759,0.00014901716,0.0002338989,0.026697265,0.2448421],"study_design_scores_gemma":[0.5983787,0.24127963,0.057550985,0.00017636034,0.0006304291,0.0017615188,0.000038638937,0.000035674766,0.0042553716,0.0004367657,0.09536657,0.00008933113],"about_ca_topic_score_codex":0.00003898152,"about_ca_topic_score_gemma":0.000057541398,"teacher_disagreement_score":0.24475276,"about_ca_system_score_codex":0.00026301816,"about_ca_system_score_gemma":0.0014764213,"threshold_uncertainty_score":0.9601859},"labels":[],"label_agreement":null},{"id":"W1505869554","doi":"10.1002/ajh.24169","title":"Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: A <scp>D</scp>anish–<scp>C</scp>anadian study of 443 patients with diffuse‐large <scp>B</scp>‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Danish; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Lymphoma","score_opus":0.011077441676237773,"score_gpt":0.23967480393728618,"score_spread":0.2285973622610484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505869554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953583,0.0024043913,0.000024285042,0.00021360625,0.00020705306,0.0010888887,0.00010447747,0.00002321075,0.00057578017],"genre_scores_gemma":[0.9983208,0.00029795905,0.00028016345,0.00075688434,0.00007119453,0.000076601274,0.000040902207,0.00006398628,0.00009147114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578273,0.0005176296,0.001388562,0.0005748462,0.0009189687,0.0008172329],"domain_scores_gemma":[0.9957651,0.0013748887,0.0012972499,0.00049875374,0.0003738157,0.00069019943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007733214,0.0005651269,0.0018082873,0.00050630356,0.00017197474,0.00006730649,0.0003221104,0.00005924125,0.0000034288096],"category_scores_gemma":[0.00054150086,0.00037452887,0.00015631672,0.00053917227,0.0005334589,0.0002743744,0.00010941401,0.0003858272,0.000006561364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008841018,0.017605416,0.9650039,0.0000876998,0.00055014144,0.0018132501,0.0076040523,0.0000014902265,0.00001794493,0.000060679253,0.0065601394,0.0006068677],"study_design_scores_gemma":[0.08442642,0.019255247,0.8066097,0.00022295602,0.0010970546,0.0066892765,0.075943604,0.0000777759,0.00034094692,0.0000779542,0.00515509,0.000103977225],"about_ca_topic_score_codex":0.0010409285,"about_ca_topic_score_gemma":0.0005402987,"teacher_disagreement_score":0.1583942,"about_ca_system_score_codex":0.00029375637,"about_ca_system_score_gemma":0.0003400325,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W1506670234","doi":"10.1212/wnl.84.14_supplement.p7.246","title":"Durable Effect of Alemtuzumab on MRI Activity in Treatment-Naive Active Relapsing-Remitting Multiple Sclerosis Patients: 4-Year Follow-up of CARE-MS I (P7.246)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Alemtuzumab; Multiple sclerosis; Relapsing remitting; Medicine; Pediatrics; Internal medicine; Psychiatry","score_opus":0.0227014373891247,"score_gpt":0.25448077513146655,"score_spread":0.23177933774234186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506670234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965149,0.00009346312,9.473547e-7,0.00020549787,0.00040074787,0.00095758255,0.000052069267,0.000026965616,0.0017478092],"genre_scores_gemma":[0.9995534,0.000074689335,0.000038313156,0.00008807303,0.000034233697,0.000116694006,0.0000432765,0.000031561387,0.00001980106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828476,0.0003448579,0.0003189075,0.00045466205,0.0002620253,0.0003348093],"domain_scores_gemma":[0.99819535,0.0008432275,0.00027578938,0.00039450263,0.00015690019,0.00013424184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117059,0.00027326358,0.0008311942,0.00019925248,0.00003815599,0.0000038008416,0.00007612423,0.0001993317,0.000014152098],"category_scores_gemma":[0.0005044826,0.0002080257,0.0001939327,0.00020315728,0.00009805332,0.000078692974,0.00004963002,0.00015148256,0.000017962091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01961667,0.0016789623,0.96219677,0.00006252926,0.00018572161,0.000046029258,0.0015829196,0.00012576222,0.002679575,0.0000107687465,0.000116978335,0.011697313],"study_design_scores_gemma":[0.041926775,0.04285412,0.70090246,0.00015093137,0.00025179636,0.000005709225,0.000065298365,0.00010550284,0.21346875,0.0000051935035,0.00014586755,0.00011762003],"about_ca_topic_score_codex":0.0030525548,"about_ca_topic_score_gemma":0.00040788268,"teacher_disagreement_score":0.26129434,"about_ca_system_score_codex":0.00043923047,"about_ca_system_score_gemma":0.00011761466,"threshold_uncertainty_score":0.8483042},"labels":[],"label_agreement":null},{"id":"W1509594523","doi":"10.1002/hon.2165","title":"Use of non‐steroidal anti‐inflammatory drugs and risk of non‐Hodgkin lymphoma: a systematic review and meta‐analysis","year":2014,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health; Winnipeg Regional Health Authority","funders":"ExxonMobil Research and Engineering Company","keywords":"Medicine; Internal medicine; Odds ratio; Follicular lymphoma; Lymphoma; Epidemiology; Confidence interval; Meta-analysis; Oncology; Aspirin; Chronic lymphocytic leukemia; Relative risk; Leukemia","score_opus":0.060194367901718906,"score_gpt":0.35641511288956,"score_spread":0.2962207449878411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509594523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022873632,0.9934491,0.000027874346,0.000092633716,0.000030698437,0.003840973,0.00010606198,0.000024367262,0.00014092981],"genre_scores_gemma":[0.003658242,0.99385357,0.0010888434,0.00024450466,0.000014777044,0.0009807501,0.000057094214,0.00003387045,0.00006834994],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99427176,0.0014482394,0.0027649263,0.00079591054,0.00034553136,0.00037365488],"domain_scores_gemma":[0.99185616,0.0036632936,0.0030620175,0.0009149027,0.0001994728,0.0003041571],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012183061,0.00076636364,0.026192414,0.00040510835,0.000055391505,0.0000146102675,0.0001877227,0.00088098424,0.0001021106],"category_scores_gemma":[0.00067233894,0.00040278665,0.0027660714,0.0005322049,0.00046345897,0.00005169186,0.00025275344,0.00021064274,0.00002204334],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017322502,0.00074254395,0.000858744,0.85194194,0.13809451,0.000260894,0.00003933963,1.17564525e-7,2.2457287e-7,0.00012621317,0.00013503445,0.007783086],"study_design_scores_gemma":[0.0010985673,0.00079856446,0.0004635251,0.04402433,0.9344133,0.0013006834,0.000012826855,0.000018675806,0.000004627309,0.000008215974,0.017551277,0.00030537948],"about_ca_topic_score_codex":0.000073129886,"about_ca_topic_score_gemma":0.000015467169,"teacher_disagreement_score":0.80791765,"about_ca_system_score_codex":0.00014421756,"about_ca_system_score_gemma":0.0002689379,"threshold_uncertainty_score":0.9998424},"labels":[],"label_agreement":null},{"id":"W1511554067","doi":"10.5772/29295","title":"Appendiceal MALT Lymphoma in Childhood - Presentation and Evolution","year":2012,"lang":"en","type":"book-chapter","venue":"InTech eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Presentation (obstetrics); Medicine; Radiology","score_opus":0.014923931408132345,"score_gpt":0.2516768102852875,"score_spread":0.23675287887715515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511554067","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06310594,0.005543686,0.000043379274,0.00019834298,0.00027421632,0.0016193261,0.0000493182,0.000120231016,0.92904556],"genre_scores_gemma":[0.9254219,0.00017246717,0.000114659866,0.0001207435,0.0002466932,0.00008191221,0.00010469744,0.00004970803,0.07368721],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881256,0.00001222634,0.0003270182,0.00033843727,0.00026416173,0.00024562853],"domain_scores_gemma":[0.99935573,0.000043274365,0.00014369682,0.00026798103,0.00004265867,0.0001466353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090702575,0.000298771,0.0004009385,0.00028521623,0.000040467865,0.00001919574,0.000052900363,0.0003516632,0.0001359343],"category_scores_gemma":[0.000011382795,0.00026192566,0.00010444896,0.000010748142,0.00008925306,0.000045083318,0.000072315735,0.00014361102,0.00015519522],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042766452,0.00080887787,0.046471454,0.0003978242,0.00075932685,0.0007985165,0.0013584484,6.847838e-8,0.0011925317,0.07617837,0.0005962064,0.8710107],"study_design_scores_gemma":[0.01614708,0.0013375913,0.79838943,0.0042803767,0.001556748,0.0025866777,0.00017401739,0.0000116134215,0.01561047,0.031218536,0.12748098,0.0012064916],"about_ca_topic_score_codex":0.0002496894,"about_ca_topic_score_gemma":0.00009183555,"teacher_disagreement_score":0.8698042,"about_ca_system_score_codex":0.0005638502,"about_ca_system_score_gemma":0.00013505711,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W1516737592","doi":"10.1054/bjoc.2000.1203","title":"True","year":2000,"lang":"fr","type":"review","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine","score_opus":0.02665370392028779,"score_gpt":0.34200776626536206,"score_spread":0.31535406234507424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516737592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010206512,0.98640454,0.000001341386,0.00044104934,0.003926387,0.00038287352,0.00024507951,0.0000060386556,0.0075720414],"genre_scores_gemma":[0.00043948815,0.9840116,0.00012736117,0.00045202128,0.0073495377,0.000051196646,0.000017739141,0.00006783981,0.007483231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969207,0.00018558909,0.001478084,0.0002567748,0.0006510202,0.0005078485],"domain_scores_gemma":[0.9977825,0.00017068278,0.0010269339,0.00019393023,0.00029433484,0.0005315848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032384042,0.00039197496,0.0025009434,0.0001383936,0.00009711878,0.0001270234,0.000247903,0.00033997424,0.025929937],"category_scores_gemma":[0.000077305944,0.00036552627,0.0014546629,0.00024471624,0.0001240162,0.00014349645,0.000023959756,0.00062251254,0.00043814743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043848882,0.0005889746,0.00067593105,0.0043756664,0.0018483162,0.017483158,0.000024596635,0.0000057321517,1.837159e-7,0.000019535382,0.035529632,0.9394044],"study_design_scores_gemma":[0.0025031816,0.00033372443,0.004069352,0.17433181,0.005938037,0.02898926,0.000009079075,7.389994e-7,0.000006892313,0.000020862986,0.7835675,0.00022954798],"about_ca_topic_score_codex":0.0011768697,"about_ca_topic_score_gemma":0.00028968762,"teacher_disagreement_score":0.9391749,"about_ca_system_score_codex":0.001566367,"about_ca_system_score_gemma":0.0025697006,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W1517487782","doi":"10.14740/wjon900w","title":"Primary Hepatic Non-Hodgkin’s Lymphoma: An Enigma Beyond the Liver, a Case Report","year":2015,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Porta hepatis; Fibrous capsule of Glisson; Bile duct; Jaundice; Pathology; Intrahepatic bile ducts; Common bile duct; Internal medicine","score_opus":0.03406470192877635,"score_gpt":0.32372565424993266,"score_spread":0.2896609523211563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517487782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706143,0.0034838999,0.000030364505,0.005873523,0.0010355227,0.00029916345,0.0000025213456,0.000012938905,0.01864777],"genre_scores_gemma":[0.99162596,0.0002342337,0.00295828,0.0031680095,0.00079123885,0.000019641115,0.000007420164,0.000021072932,0.0011741557],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982386,0.00020212072,0.0007315327,0.00017904656,0.0003829334,0.00026573657],"domain_scores_gemma":[0.99775,0.0003049616,0.00067263335,0.0003930062,0.00040264535,0.00047676882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012103177,0.00017577068,0.0006421487,0.00021140915,0.00010099761,0.000022068134,0.00014074672,0.0000884726,0.000080137026],"category_scores_gemma":[0.00015567035,0.00010169138,0.00020189387,0.00021992327,0.00013400147,0.00014180673,0.00006194632,0.0001729328,0.000029478193],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007688649,0.002858921,0.03258467,0.000020077192,0.00036392588,0.7508225,0.0017132463,0.0000073936712,0.000052713658,0.00010903349,0.038844533,0.17185411],"study_design_scores_gemma":[0.009499766,0.0050728414,0.06715269,0.000051561612,0.0007775709,0.7507578,0.00038854964,0.00008218561,0.00016101528,0.00024944165,0.16569406,0.00011252868],"about_ca_topic_score_codex":0.0003814809,"about_ca_topic_score_gemma":0.0009272719,"teacher_disagreement_score":0.17174158,"about_ca_system_score_codex":0.0013931488,"about_ca_system_score_gemma":0.0019656832,"threshold_uncertainty_score":0.4146854},"labels":[],"label_agreement":null},{"id":"W151761936","doi":"10.1007/978-3-642-57054-4_14","title":"Primary Gastric Lymphoma: Brief Overview of the Recent Princess Margaret Hospital Experience","year":2000,"lang":"en","type":"review","venue":"Recent results in cancer research/Recent Results in Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Gastric lymphoma; Stomach; Gastrectomy; Disease; Stage (stratigraphy); MALT lymphoma; Chemotherapy; Internal medicine; Radiation therapy; Surgery; Survival rate; Gastroenterology; Oncology; Cancer","score_opus":0.23717016941554467,"score_gpt":0.4911101282959061,"score_spread":0.25393995888036147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W151761936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030303732,0.950559,1.4832948e-7,0.010450443,0.0015111574,0.014452438,0.0034720814,0.00007998609,0.016444378],"genre_scores_gemma":[0.00073636265,0.98323834,0.000079688296,0.00019044553,0.0008813913,0.011393114,0.00090415886,0.00031612066,0.002260357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9668692,0.0064273127,0.0058562243,0.0047731805,0.010833975,0.005240141],"domain_scores_gemma":[0.9853086,0.0036958302,0.0015035986,0.005132982,0.0031006378,0.001258338],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0122445645,0.0018812986,0.0053715934,0.00362687,0.00068435434,0.0003601419,0.0044309185,0.0015169618,0.0013817971],"category_scores_gemma":[0.0042783124,0.0012983617,0.0010404224,0.019562075,0.0026383265,0.00044211882,0.0030192612,0.0053107585,0.000104108214],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0056617986,0.0061896704,0.0013809744,0.013559226,0.00043922703,0.0006630407,0.0012197971,0.000039370923,0.0000038524,0.00006743108,0.029491553,0.94128406],"study_design_scores_gemma":[0.014039219,0.0011015566,0.007994156,0.08564635,0.00020891053,0.00006988463,0.00025782856,0.000010089618,0.00032314064,0.000060434133,0.8893037,0.0009847574],"about_ca_topic_score_codex":0.02367579,"about_ca_topic_score_gemma":0.0070385938,"teacher_disagreement_score":0.9402993,"about_ca_system_score_codex":0.03695483,"about_ca_system_score_gemma":0.024655478,"threshold_uncertainty_score":0.9997793},"labels":[],"label_agreement":null},{"id":"W1517888833","doi":"10.1038/modpathol.2012.184","title":"Non-Hodgkin lymphoma: the clinician's perspective—a view from the receiving end","year":2013,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Disease; Natural history; Intensive care medicine; Intervention (counseling); Stage (stratigraphy); Perspective (graphical); Pathology; Internal medicine; Computer science; Psychiatry; Biology; Artificial intelligence","score_opus":0.06474203285072698,"score_gpt":0.35954813406556374,"score_spread":0.29480610121483675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517888833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058804743,0.98912525,0.00006772861,0.0023847797,0.00082038384,0.0025408904,0.00012565404,0.000070424445,0.004276821],"genre_scores_gemma":[0.0018563442,0.9921945,0.00024008114,0.0020038588,0.0011333475,0.0014989333,0.00017946442,0.00012246276,0.00077102793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643147,0.0007203466,0.0008640797,0.0010658812,0.00032962897,0.000588599],"domain_scores_gemma":[0.99542034,0.0018772479,0.00056041765,0.0018579154,0.0001462884,0.00013777072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060902274,0.0007478954,0.0026634568,0.000079894206,0.00030392274,0.00007435749,0.000623848,0.000663348,0.00045689367],"category_scores_gemma":[0.00025891847,0.0003314802,0.0010865567,0.00020988352,0.00035424548,0.00005050886,0.00032762278,0.000474972,0.0015200194],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009578595,0.0003611517,0.00026653145,0.00043483992,0.0006052611,0.0005375789,0.00091990025,1.586276e-7,5.1157997e-7,0.00022828428,0.0030368995,0.9935993],"study_design_scores_gemma":[0.0013429372,0.00021941107,0.0044170124,0.0047314907,0.00428033,0.00094264426,0.00018839841,0.000034213757,0.0000013634309,0.0012231063,0.98226476,0.00035431905],"about_ca_topic_score_codex":0.0009605732,"about_ca_topic_score_gemma":0.00013019644,"teacher_disagreement_score":0.993245,"about_ca_system_score_codex":0.00070587546,"about_ca_system_score_gemma":0.00061575667,"threshold_uncertainty_score":0.99991375},"labels":[],"label_agreement":null},{"id":"W1517954749","doi":"10.1038/leu.2010.117","title":"Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Cancer Research Institute","keywords":"Mantle cell lymphoma; Apoptosis; Cancer research; Tumor necrosis factor alpha; NF-κB; Lymphoma; Signal transduction; NFKB1; Medicine; Immunology; Cell biology; Biology; Transcription factor; Genetics; Gene","score_opus":0.00678752369883891,"score_gpt":0.2298998000547284,"score_spread":0.22311227635588948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517954749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097973,0.00037615479,0.00000791017,0.0005697467,0.00021404664,0.00065584446,0.000014179346,0.00006163388,0.007120766],"genre_scores_gemma":[0.99814785,0.000033458582,0.0003310401,0.0006845607,0.00019896816,0.00023405516,0.00003423839,0.000037283964,0.00029854395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985674,0.00007746257,0.00029547283,0.00039186917,0.0002607149,0.000407055],"domain_scores_gemma":[0.9989765,0.00043425683,0.00012452112,0.00029184355,0.000045786706,0.00012706501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029573592,0.00025625806,0.00033466186,0.000090687376,0.00017010864,0.00006866069,0.00013087294,0.00018464541,0.00008970482],"category_scores_gemma":[0.000074672476,0.00016891977,0.00011738044,0.00029345075,0.00008419445,0.00011171572,0.000078516474,0.00023827222,0.00014504865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012078936,0.0005810055,0.05041712,0.00010573974,0.000120051525,0.00009725796,0.0016981709,0.000015053512,0.8831716,0.00018816104,0.0028991483,0.060585875],"study_design_scores_gemma":[0.004409762,0.00017372885,0.024134511,0.00015113736,0.00009836295,0.00002513465,0.00036402917,0.00012836207,0.9689485,0.000112457026,0.0012636194,0.00019039301],"about_ca_topic_score_codex":0.0014837937,"about_ca_topic_score_gemma":0.00007569675,"teacher_disagreement_score":0.08577688,"about_ca_system_score_codex":0.00059921923,"about_ca_system_score_gemma":0.00020257148,"threshold_uncertainty_score":0.6888348},"labels":[],"label_agreement":null},{"id":"W1523246414","doi":"10.1002/9781444300857.ch41","title":"Diffuse Large B‐Cell Lymphoma","year":2008,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Chemotherapy; Oncology; CHOP; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Radiation therapy; Disease; Surgery","score_opus":0.010338859394568524,"score_gpt":0.23904212493135174,"score_spread":0.22870326553678322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523246414","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008367121,0.004703584,0.000009727207,0.00015337711,0.00020462122,0.0004091672,0.00005850161,0.00035146397,0.99327284],"genre_scores_gemma":[0.008629839,0.0048518092,0.0005603028,0.0012659156,0.00039596483,0.00005706462,0.00017685421,0.0004091022,0.9836531],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990127,0.000010772386,0.00014063637,0.0003215961,0.00023217387,0.00028213882],"domain_scores_gemma":[0.9992257,0.0000175307,0.00007250012,0.0004901672,0.00001396178,0.00018018082],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000015243207,0.00028824923,0.00045644166,0.00014857629,0.00002835891,0.000007851745,0.00006141611,0.00028123794,0.010417136],"category_scores_gemma":[0.000005310415,0.00019506007,0.00019310748,0.00007010296,0.000027652359,0.000008161111,0.000039088274,0.00003422492,0.00437494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011933152,0.009060886,0.0041327383,0.00006995987,0.0001505506,0.00083148264,0.000021353817,1.1625616e-9,0.000002436325,0.00020325521,0.9826837,0.0028316856],"study_design_scores_gemma":[0.019637601,0.0001188966,0.0033515869,0.00013346903,0.00017447653,0.000115210925,0.000010583714,0.0000019710033,0.00029209483,0.0000023358898,0.9759721,0.00018963132],"about_ca_topic_score_codex":0.00042771114,"about_ca_topic_score_gemma":0.00008183424,"teacher_disagreement_score":0.019625667,"about_ca_system_score_codex":0.00012885063,"about_ca_system_score_gemma":0.000121796125,"threshold_uncertainty_score":0.9964003},"labels":[],"label_agreement":null},{"id":"W1529386050","doi":"10.1002/cncr.29372","title":"Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced‐stage follicular lymphoma: A cost‐effectiveness analysis","year":2015,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Asymptomatic; Follicular lymphoma; Quality-adjusted life year; Internal medicine; Oncology; Life expectancy; Cost effectiveness; Lymphoma; Population","score_opus":0.05132671987027703,"score_gpt":0.3404673985013477,"score_spread":0.2891406786310707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1529386050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97879565,0.0067017567,0.01180356,0.00032612498,0.00023200458,0.0018077601,0.00006725564,0.00006509585,0.00020080122],"genre_scores_gemma":[0.9910437,0.00046475584,0.0043675937,0.00010483186,0.00014907485,0.003423252,0.00016980799,0.000033318873,0.00024365672],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99885654,0.000051171854,0.00019690552,0.00043152005,0.00021415522,0.00024970365],"domain_scores_gemma":[0.9991565,0.00009064693,0.00009645898,0.00028611926,0.0001632788,0.00020701451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001959863,0.00022179545,0.0006105954,0.00010574554,0.00007075053,0.00002814099,0.0000468314,0.000104838415,0.000017966455],"category_scores_gemma":[0.000041316143,0.00017056821,0.00018869642,0.00036819236,0.00004834173,0.00012015843,0.000017749167,0.0000344512,0.0000030297028],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023809312,0.008102229,0.23832504,0.0010127487,0.021634432,0.00008121137,0.0029915927,0.010309398,0.0016583569,0.00063037965,0.0015646579,0.6898806],"study_design_scores_gemma":[0.44056103,0.004671675,0.30900288,0.00044077262,0.019635804,0.000050643557,0.0024382067,0.1253245,0.03278477,0.00031966955,0.06316536,0.0016047182],"about_ca_topic_score_codex":0.0004514825,"about_ca_topic_score_gemma":0.000048452173,"teacher_disagreement_score":0.68827593,"about_ca_system_score_codex":0.00096952723,"about_ca_system_score_gemma":0.00016352015,"threshold_uncertainty_score":0.69555694},"labels":[],"label_agreement":null},{"id":"W1536129374","doi":"10.1002/0471463736.tnmp43.pub2","title":"Non‐Hodgkin Lymphomas","year":2006,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Disease; Hodgkin lymphoma; Lymphoma; Pathological; Immune system; Immunology; Medicine; Biology; Pathology","score_opus":0.011596174054342788,"score_gpt":0.2771597021296492,"score_spread":0.2655635280753064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536129374","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083896465,0.002516459,0.000004880039,0.0006611375,0.00031440973,0.0005543053,0.0027062267,0.00033127167,0.99207234],"genre_scores_gemma":[0.0016589422,0.00039621073,0.0028031906,0.00083291036,0.0020038146,0.00006319324,0.009525157,0.0005119085,0.9822047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881697,0.000009877623,0.00023309288,0.00038077743,0.0002745204,0.00028473523],"domain_scores_gemma":[0.99912196,0.000023764658,0.00014097306,0.0005477721,0.00002649375,0.00013905887],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000025365933,0.0003592452,0.0006164689,0.00021166963,0.000020886086,0.000011391852,0.00008795901,0.00033195937,0.011056846],"category_scores_gemma":[0.000012098724,0.0002727121,0.00020051966,0.00012952088,0.00004969049,0.00000915673,0.00004018858,0.000087464956,0.0011027863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019751584,0.0015246765,0.0038665205,0.000097484866,0.00021338083,0.00052703836,0.000006413859,1.0558718e-7,0.0000096353915,0.000046402976,0.9797853,0.013903244],"study_design_scores_gemma":[0.003276406,0.00018920178,0.024315897,0.0006375051,0.0003526089,0.00007701788,0.0000046419614,0.000015462148,0.00008888239,0.00001481055,0.97079206,0.00023553206],"about_ca_topic_score_codex":0.0012458033,"about_ca_topic_score_gemma":0.00064577244,"teacher_disagreement_score":0.020449376,"about_ca_system_score_codex":0.0001992274,"about_ca_system_score_gemma":0.00019157396,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W1536282106","doi":"10.1007/978-3-642-12780-9_25","title":"What Will We Learn from Genomics and Proteomics in Hodgkin Lymphoma?","year":2010,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genomics; Computational biology; Identification (biology); Proteome; Genome; Proteomics; Lymphoma; Bioinformatics; Biology; Gene; Immunology; Genetics","score_opus":0.016651932470238065,"score_gpt":0.23388646370143043,"score_spread":0.21723453123119235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536282106","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55796874,0.030093063,0.00003166967,0.010770269,0.0018454163,0.005190747,0.00021069768,0.00021985896,0.39366955],"genre_scores_gemma":[0.033189736,0.14196923,0.01684039,0.0028509481,0.0012724659,0.00022811544,0.00075542467,0.00035818398,0.80253553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850804,0.0000089297955,0.00039309665,0.0006173098,0.00021780076,0.00025484242],"domain_scores_gemma":[0.998975,0.00009763009,0.00014745866,0.0005233056,0.000046131594,0.00021050945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000801187,0.0004624405,0.0007646612,0.00017187459,0.00004218637,0.00011378897,0.00008979069,0.0007623054,0.0008914898],"category_scores_gemma":[0.000012782734,0.00036551137,0.00014290484,0.000016596281,0.00012289004,0.00016856314,0.00012666536,0.00026126445,0.00019765946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011258128,0.001448804,0.016261172,0.00039529047,0.0017716099,0.0034555886,0.0022396522,0.000001496514,0.003954827,0.05549843,0.0026267618,0.91122055],"study_design_scores_gemma":[0.011085556,0.00052172196,0.010529567,0.0017723578,0.00061370037,0.00021483267,0.00015173829,0.00004922004,0.005304022,0.025115415,0.94375277,0.0008890841],"about_ca_topic_score_codex":0.00054158777,"about_ca_topic_score_gemma":0.0010187904,"teacher_disagreement_score":0.94112605,"about_ca_system_score_codex":0.00041921422,"about_ca_system_score_gemma":0.00026063513,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W1549128215","doi":"10.1002/9781444300857.ch46","title":"Selected Management Issues of Patients with Hodgkin Lymphoma","year":2008,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lymphoma; Stage (stratigraphy); Hodgkin lymphoma; Medicine; Inclusion (mineral); Oncology; Internal medicine; Psychology; Biology","score_opus":0.005975893824373261,"score_gpt":0.2237256266539756,"score_spread":0.21774973282960233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549128215","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01095684,0.0011505899,0.000008083895,0.000067332796,0.00006098366,0.0011179105,0.000045725617,0.00017480069,0.9864177],"genre_scores_gemma":[0.02308667,0.001972609,0.004900866,0.00014022242,0.00006979579,0.000080491176,0.0004820915,0.00028938276,0.96897787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989796,0.000012556894,0.00017064362,0.0002789705,0.00038329043,0.00017493877],"domain_scores_gemma":[0.99933994,0.000008059912,0.00013457466,0.0003636025,0.00007823264,0.000075576456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000010370348,0.00026078027,0.0004895899,0.00021802926,0.000013957836,0.0000036953618,0.000059429134,0.00012169392,0.0031511043],"category_scores_gemma":[0.000002600069,0.00015917784,0.00006191105,0.00021163597,0.000048305243,0.000009388613,0.000028149147,0.000019099713,0.00013697366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001271122,0.0022085023,0.17406254,0.00022651328,0.0013944788,0.0001393747,0.00002526422,5.2164246e-8,2.3430343e-7,0.00013912588,0.8059021,0.015774703],"study_design_scores_gemma":[0.006429395,0.000540891,0.45237538,0.00042085763,0.0003601089,0.0000049263163,0.000008278983,4.4454094e-7,0.00018018519,0.0000010772067,0.539534,0.00014448703],"about_ca_topic_score_codex":0.0005370552,"about_ca_topic_score_gemma":0.00005562302,"teacher_disagreement_score":0.27831286,"about_ca_system_score_codex":0.00010158649,"about_ca_system_score_gemma":0.000049719485,"threshold_uncertainty_score":0.9977602},"labels":[],"label_agreement":null},{"id":"W1551703232","doi":"10.1182/blood.v122.21.626.626","title":"A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Genome-wide association study; SNP; Population stratification; Meta-analysis; Nodular sclerosis; Imputation (statistics); Genetic association; Expression quantitative trait loci; Oncology; Biology; Single-nucleotide polymorphism; Genetics; Case-control study; Linkage disequilibrium; Population; Heritability; Medicine; Internal medicine; Genotype; Lymphoma; Gene; Hodgkin lymphoma; Missing data","score_opus":0.0625893641432492,"score_gpt":0.2937914286735529,"score_spread":0.2312020645303037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551703232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928026,0.0017844163,0.000019061663,0.00088866096,0.000023150042,0.0007434141,0.000081676735,0.000046510424,0.0036105015],"genre_scores_gemma":[0.9957338,0.000039686303,0.0018614371,0.00063110614,0.000035167468,0.0002753417,0.000056468736,0.000019808354,0.0013472049],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9980835,0.00006736916,0.00059274764,0.00049286353,0.00046097586,0.00030255085],"domain_scores_gemma":[0.998073,0.0002112137,0.00023155723,0.0009913369,0.0002637733,0.00022910879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002918316,0.00025972733,0.0016048816,0.0002488997,0.00004358784,0.000025050142,0.00012765908,0.00011645747,0.003864824],"category_scores_gemma":[0.00014701985,0.00017436962,0.0016701639,0.0007671828,0.00008527589,0.000078330784,0.00006680833,0.000039660757,0.000294533],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007014807,0.02122166,0.40723476,0.0001365357,0.5478832,0.000085827356,0.0004881574,0.0000074289615,0.018879255,0.0007877969,0.001291194,0.0019140494],"study_design_scores_gemma":[0.0047672093,0.00042568013,0.5411299,0.000008877538,0.4371754,0.00003532312,0.000066549044,0.000034748984,0.015825704,0.00015348652,0.00022825444,0.0001488788],"about_ca_topic_score_codex":0.003729861,"about_ca_topic_score_gemma":0.00013598804,"teacher_disagreement_score":0.13389514,"about_ca_system_score_codex":0.00007570362,"about_ca_system_score_gemma":0.00011378356,"threshold_uncertainty_score":0.99704576},"labels":[],"label_agreement":null},{"id":"W1552466093","doi":"10.1212/wnl.84.14_supplement.p7.249","title":"Durable Effect of Alemtuzumab on MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Who Relapsed on Prior Therapy: 4-Year Follow-up of CARE-MS II (P7.249)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital; McGill University; University of British Columbia","funders":"","keywords":"Alemtuzumab; Medicine; Relapsing remitting; Multiple sclerosis; Internal medicine; Psychiatry","score_opus":0.016493919364014186,"score_gpt":0.2361152477536156,"score_spread":0.2196213283896014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1552466093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973063,0.00011915892,2.8151408e-7,0.0005046269,0.00032033498,0.001046994,0.000015107095,0.000031266376,0.0006559289],"genre_scores_gemma":[0.9992585,0.000051127536,0.000058385463,0.00043264678,0.000018110652,0.00006806624,0.000026769987,0.000043593696,0.000042784704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982337,0.00022890158,0.00040263083,0.00042509666,0.00039645913,0.0003132147],"domain_scores_gemma":[0.9984181,0.0005799194,0.00025924327,0.0004949789,0.0001381105,0.00010967644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001928872,0.00026741074,0.00087106985,0.0002017606,0.00005474611,0.0000041396647,0.00010343133,0.00017580719,0.000012178833],"category_scores_gemma":[0.00036875557,0.00017314026,0.00013597446,0.00018216528,0.000079569036,0.00004223426,0.00004611433,0.00019541182,0.000010388127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022424065,0.0010547341,0.9709437,0.000042569183,0.0001270589,0.00002052516,0.00083181326,0.000108449094,0.00022064167,0.000016138047,0.00012701147,0.0040833335],"study_design_scores_gemma":[0.060028397,0.05967958,0.86653334,0.00022658985,0.00008719531,0.000001955329,0.000015865477,0.000025482661,0.013113747,0.000002645543,0.0001784953,0.00010668716],"about_ca_topic_score_codex":0.0003904738,"about_ca_topic_score_gemma":0.000103239116,"teacher_disagreement_score":0.1044103,"about_ca_system_score_codex":0.00012112152,"about_ca_system_score_gemma":0.000075878466,"threshold_uncertainty_score":0.7060455},"labels":[],"label_agreement":null},{"id":"W1554065380","doi":"10.4081/hmr.v3i3.587","title":"Advanced Hodgkin’s lymphoma: doxorubicin, bleomycin, vinblastine, dacarbazine and beyond","year":2009,"lang":"en","type":"article","venue":"Hematology Meeting Reports (formerly Haematologica Reports)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Vinblastine; Bleomycin; Internal medicine; Oncology; Nuclear medicine; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.008444083112896697,"score_gpt":0.2554773388233663,"score_spread":0.24703325571046963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554065380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9347111,0.0071851877,0.000045891582,0.004701888,0.00062538043,0.001546908,0.0000035937653,0.0007348437,0.05044523],"genre_scores_gemma":[0.98708576,0.00054348906,0.008615018,0.002609938,0.00010610222,0.0002598553,0.00012951445,0.000069810114,0.0005805001],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99266493,0.000108885026,0.0029788467,0.0020514694,0.0008189141,0.0013769419],"domain_scores_gemma":[0.9943144,0.00038068008,0.002305229,0.0016390239,0.00062680757,0.0007338899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010876443,0.0010092568,0.0027489683,0.0004294248,0.0005397471,0.0000868006,0.00013434653,0.0007006517,0.00018400932],"category_scores_gemma":[0.0021205298,0.00076138927,0.00045909273,0.0005833092,0.00043479927,0.0003198242,0.00016299658,0.0003220498,0.000030262392],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058619335,0.0026735058,0.64124364,0.00044939594,0.00058304623,0.3012058,0.0004148373,0.000014375322,0.0044125225,0.003800494,0.009415065,0.035201117],"study_design_scores_gemma":[0.003491206,0.0024154955,0.2071815,0.0007674144,0.00093661714,0.7346634,0.00045371088,0.00006774429,0.03036756,0.0048241187,0.013789238,0.0010419608],"about_ca_topic_score_codex":0.00006933148,"about_ca_topic_score_gemma":0.00002315479,"teacher_disagreement_score":0.43406212,"about_ca_system_score_codex":0.00023596766,"about_ca_system_score_gemma":0.00039540892,"threshold_uncertainty_score":0.9994837},"labels":[],"label_agreement":null},{"id":"W1572981676","doi":"10.1097/pas.0000000000000473","title":"Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling","year":2015,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Pathology; Medicine; Hematopathology; Reed–Sternberg cell; Hodgkin lymphoma; Biology; Gene; Cytogenetics","score_opus":0.01943223541755064,"score_gpt":0.26859990916871096,"score_spread":0.24916767375116033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572981676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962583,0.0021254427,0.00024492174,0.0008143938,0.00012303761,0.00014189856,0.00003279943,0.000009247529,0.00024993005],"genre_scores_gemma":[0.99742013,0.00047046324,0.0015359254,0.0001750177,0.00023707088,0.000009594306,0.000044251614,0.000016844871,0.000090694346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997921,0.00031733236,0.00075983815,0.00018659492,0.0005405992,0.00027464394],"domain_scores_gemma":[0.9975219,0.00038897022,0.0012679325,0.00024690246,0.00029212792,0.00028218434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011139873,0.00016328845,0.00068917143,0.00009820413,0.0000619999,0.0000067536635,0.00017818688,0.00004990805,0.000030185043],"category_scores_gemma":[0.00012524569,0.00009412981,0.00018291885,0.00019330815,0.00045697694,0.00006309314,0.00010817108,0.00012186863,0.000025634914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052352366,0.0040726303,0.15835854,0.000044282187,0.00008958132,0.003050708,0.0009271553,0.000015197368,0.8116412,0.000018149502,0.0037580344,0.0127892485],"study_design_scores_gemma":[0.02168273,0.005984592,0.1249788,0.000117235446,0.0005251129,0.021612363,0.0012153221,0.00009421507,0.8209482,0.000094371535,0.0024921212,0.00025492982],"about_ca_topic_score_codex":0.000003936481,"about_ca_topic_score_gemma":2.3907336e-7,"teacher_disagreement_score":0.03337974,"about_ca_system_score_codex":0.00022995827,"about_ca_system_score_gemma":0.00018719812,"threshold_uncertainty_score":0.38385025},"labels":[],"label_agreement":null},{"id":"W1572992859","doi":"10.1111/j.1600-0609.2005.00461.x","title":"Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Randomized controlled trial; Lymph node; Oncology; Radiology; Internal medicine","score_opus":0.08705444835431066,"score_gpt":0.333600224076648,"score_spread":0.24654577572233738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572992859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16309445,0.83130765,0.003109559,0.0016249893,0.000036324782,0.0007976384,0.000013671143,0.000004593614,0.000011143421],"genre_scores_gemma":[0.3208695,0.67830396,0.00048638487,0.00027733578,0.000020149531,0.000004026667,0.000022180022,0.000014083226,0.0000023824734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978385,0.00088579074,0.0008625739,0.00015398429,0.0001482095,0.00011096989],"domain_scores_gemma":[0.9982097,0.00046020545,0.001005173,0.00014503876,0.00010017095,0.00007969329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345206,0.00020260995,0.0010770163,0.0003110754,0.000039467068,0.000025391319,0.000080484184,0.000056970657,0.000004067357],"category_scores_gemma":[0.00010803096,0.00012913335,0.00009756658,0.00016265461,0.000068653564,0.00015456742,0.000010343099,0.00012326032,3.9950814e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017699225,0.00017254634,0.0013123029,0.00019262485,0.000175187,0.00012982753,0.0027233069,0.0000075995863,0.000023595625,0.00000855148,0.0007081016,0.9943694],"study_design_scores_gemma":[0.050432824,0.0065576946,0.39018357,0.019383306,0.0030798656,0.06416274,0.0009460003,0.003458886,0.0015633187,0.00011587958,0.45888165,0.0012342582],"about_ca_topic_score_codex":0.000024357616,"about_ca_topic_score_gemma":0.0000024247258,"teacher_disagreement_score":0.9931351,"about_ca_system_score_codex":0.00006251548,"about_ca_system_score_gemma":0.0001475115,"threshold_uncertainty_score":0.52659047},"labels":[],"label_agreement":null},{"id":"W1578343902","doi":"10.1002/0471463736.tnmp43","title":"Non‐ <scp>H</scp> odgkin's Malignant Lymphoma","year":2003,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphoma; Disease; Pathological; Immunology; Immune system; Medicine; Biology; Internal medicine","score_opus":0.014513320995915228,"score_gpt":0.26598104369795506,"score_spread":0.2514677227020398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578343902","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058343792,0.0066847624,0.000009416827,0.00036765885,0.0008033549,0.0011129458,0.0027173604,0.00039010888,0.98208],"genre_scores_gemma":[0.0010044553,0.0023917728,0.002761432,0.002089959,0.0012275191,0.00013035373,0.0040533883,0.00075627235,0.98558486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997909,0.000029227964,0.0003764121,0.0006632093,0.00045813064,0.0005640151],"domain_scores_gemma":[0.99833983,0.000096069176,0.00026444872,0.00089240586,0.000058316247,0.00034890504],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000065514236,0.000620125,0.0009893739,0.0003140664,0.000043973887,0.00002448144,0.00016013125,0.0005353224,0.007880955],"category_scores_gemma":[0.000100776684,0.00046617058,0.0003246041,0.00023485211,0.00008329111,0.000019043306,0.00006165166,0.000113865855,0.002673476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007720937,0.0024209106,0.0024183604,0.00017954769,0.0005240693,0.0012352193,0.00003967839,1.2715519e-7,0.000023689863,0.000097823795,0.98272294,0.010329901],"study_design_scores_gemma":[0.004700528,0.00034524102,0.008215154,0.0010700043,0.00059435295,0.00023344153,0.00005428982,0.0000108135655,0.00039360966,0.000018856039,0.9842014,0.0001623588],"about_ca_topic_score_codex":0.00030397222,"about_ca_topic_score_gemma":0.00011972142,"teacher_disagreement_score":0.010167542,"about_ca_system_score_codex":0.00028142802,"about_ca_system_score_gemma":0.0003780234,"threshold_uncertainty_score":0.999779},"labels":[],"label_agreement":null},{"id":"W1582036651","doi":"10.1111/j.1600-0609.2005.00464.x","title":"Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; ABVD; Disease; Radiation therapy; Randomized controlled trial; Lymphoma; Chemotherapy; Stage (stratigraphy); Oncology; Intensive care medicine; Internal medicine; Surgery; Vincristine; Cyclophosphamide","score_opus":0.1503753029679155,"score_gpt":0.3515405477591824,"score_spread":0.20116524479126693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582036651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035025973,0.96287274,0.00008529881,0.00056859903,0.000115913914,0.0012604481,0.00003423835,0.000006226565,0.000030584433],"genre_scores_gemma":[0.014196826,0.9834906,0.0014428254,0.00052092155,0.000101716774,0.000013796829,0.000011073065,0.00009608413,0.00012615033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728787,0.00056224776,0.0013185027,0.00025055886,0.00030845407,0.0002723556],"domain_scores_gemma":[0.9956264,0.001469546,0.0020068835,0.00047698367,0.00031851296,0.00010166377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060630956,0.00038074524,0.0024454608,0.0002589885,0.000042799384,0.000023120725,0.00030208766,0.00008745249,0.00006389644],"category_scores_gemma":[0.00026951145,0.00018540063,0.0005191741,0.0002070951,0.000121354205,0.00011804151,0.00004601,0.0001888989,0.000010902116],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010749367,0.0009244895,0.017449683,0.0037503506,0.0016508446,0.0021082328,0.00036319473,0.000005247592,1.2903318e-7,0.000018375436,0.0016389698,0.9710156],"study_design_scores_gemma":[0.010490531,0.0022018233,0.029896682,0.036127437,0.0020637717,0.0019038933,0.000029486191,0.000007013842,0.000009483538,5.3895343e-7,0.9170643,0.00020500505],"about_ca_topic_score_codex":0.0000110892925,"about_ca_topic_score_gemma":0.000005616164,"teacher_disagreement_score":0.97081053,"about_ca_system_score_codex":0.00024796574,"about_ca_system_score_gemma":0.0004905321,"threshold_uncertainty_score":0.7560418},"labels":[],"label_agreement":null},{"id":"W1587476434","doi":"10.1002/cncr.29103","title":"Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Ottawa; University of Manitoba; BC Cancer Agency; Interior Health; University of Alberta; Saint John Regional Hospital; Canadian Cancer Society; University of New Brunswick; Dalhousie University","funders":"Canadian Cancer Society; Alberta Cancer Foundation; Celgene","keywords":"Medicine; Lenalidomide; Internal medicine; Lymphoma; Refractory (planetary science); Clinical endpoint; Gastroenterology; Phases of clinical research; Surgery; Peripheral T-cell lymphoma; Mycosis fungoides; Toxicity; Clinical trial; Multiple myeloma; T cell; Immunology","score_opus":0.05764999082719615,"score_gpt":0.39215781001711225,"score_spread":0.3345078191899161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1587476434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795985,0.00016198296,0.00018092793,0.00013269312,0.0002271047,0.00090261124,0.000040571907,0.000006685501,0.00038758386],"genre_scores_gemma":[0.99794877,0.00010327795,0.0009568612,0.00017137486,0.00024851013,0.0002571347,0.00003596009,0.000015160331,0.0002629594],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990182,0.000023412824,0.00048856006,0.00019003252,0.0001702963,0.00010949895],"domain_scores_gemma":[0.9989629,0.00015832306,0.00036320635,0.00025726264,0.00018638946,0.00007191537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017788223,0.00009511525,0.00044742384,0.000028652601,0.0000141349765,0.0000022183624,0.000037359565,0.000054140655,0.000044950673],"category_scores_gemma":[0.00007783947,0.00006096084,0.00016720322,0.0000464563,0.00006467625,0.000020680951,0.0000057994985,0.000016054571,8.479379e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2841475,0.021069258,0.3768585,0.00018370182,0.00052158895,0.00002551254,0.00011432437,0.0000039256356,0.0001736563,0.00007350018,0.005250384,0.31157815],"study_design_scores_gemma":[0.86540395,0.017319003,0.0614323,0.00018533162,0.00048449027,0.0000050237713,0.000007587561,0.000079495796,0.016004393,0.000040650873,0.03892677,0.000110986],"about_ca_topic_score_codex":0.00008130175,"about_ca_topic_score_gemma":0.0000064597752,"teacher_disagreement_score":0.58125645,"about_ca_system_score_codex":0.000062086256,"about_ca_system_score_gemma":0.00025639878,"threshold_uncertainty_score":0.2485911},"labels":[],"label_agreement":null},{"id":"W1592515282","doi":"10.1182/blood-2015-01-622084","title":"Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; Hôpital Notre-Dame; Saskatchewan Cancer Agency; CancerCare Manitoba; Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Eli Lilly Canada; Cancer Research Institute","keywords":"Medicine; Transplantation; Stem cell; Chemotherapy; Chemotherapy regimen; Autologous stem-cell transplantation; Oncology; Internal medicine; Lymphoma; Surgery; Biology","score_opus":0.019692023321322076,"score_gpt":0.25990329448557936,"score_spread":0.24021127116425728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592515282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969685,0.0013780633,0.00027636034,0.00017769498,0.000027266706,0.0006225918,0.00016713295,0.00003102184,0.0003513891],"genre_scores_gemma":[0.99836934,0.0005615783,0.0005441628,0.00012858145,0.00002014008,0.00011453188,0.00019620363,0.00001526339,0.00005022868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914056,0.000022474705,0.0002646827,0.00021670025,0.00018320895,0.00017238548],"domain_scores_gemma":[0.99947435,0.00007557186,0.000084441555,0.00015571475,0.00006970512,0.00014020315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012876412,0.00014429454,0.00047162178,0.00017889545,0.000025778165,0.000008446237,0.00003812582,0.00008809004,0.000008353468],"category_scores_gemma":[0.0000029277228,0.00011214107,0.00017877144,0.00025726028,0.00003419661,0.000038948136,0.0000024190483,0.000017142635,0.0000013401062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047725416,0.017413104,0.74484575,0.0017726901,0.012683407,0.00029942885,0.025840005,0.00004073399,0.01507335,0.00026519902,0.00045473504,0.17653903],"study_design_scores_gemma":[0.04359676,0.00137224,0.71305627,0.00005357073,0.01284363,0.000059535563,0.00040626616,0.0002535421,0.22787867,0.00002276552,0.00029674722,0.00016002197],"about_ca_topic_score_codex":0.000078124576,"about_ca_topic_score_gemma":0.000055640525,"teacher_disagreement_score":0.21280533,"about_ca_system_score_codex":0.000053301163,"about_ca_system_score_gemma":0.00011262629,"threshold_uncertainty_score":0.457298},"labels":[],"label_agreement":null},{"id":"W1592826781","doi":"10.1002/cncy.21535","title":"Multiplex sequencing for <i>EZH2</i>, <i>CD79B</i>, and <i>MYD88</i> mutations using archival cytospin preparations from B‐cell non‐Hodgkin lymphoma aspirates previously tested for <i>MYC</i> rearrangement and <i>IGH/BCL2</i> translocation","year":2015,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Chromosomal translocation; Sanger sequencing; Fluorescence in situ hybridization; Lymphoma; Gene rearrangement; Molecular biology; Multiplex; Multiplex ligation-dependent probe amplification; Multiplex polymerase chain reaction; Cancer research; Mutation; Biology; Medicine; Gene; Polymerase chain reaction; Genetics; Pathology; Chromosome; Exon","score_opus":0.08855667975440545,"score_gpt":0.34057229765728886,"score_spread":0.2520156179028834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592826781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97100407,0.0063545094,0.016189827,0.000912687,0.00029433586,0.0039479905,0.00094651256,0.000102656384,0.00024739024],"genre_scores_gemma":[0.9604168,0.000719588,0.0330424,0.0015671586,0.00034516535,0.0031240762,0.0006319863,0.00007416208,0.00007867191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977244,0.000098245066,0.00061851373,0.000835838,0.00019392784,0.0005290483],"domain_scores_gemma":[0.99826545,0.00039249548,0.000263843,0.00037727933,0.0003398287,0.00036110973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003189211,0.0004002826,0.0006902175,0.0001355573,0.0002975311,0.000073568255,0.0000957858,0.00016601922,0.000004287172],"category_scores_gemma":[0.00012271586,0.0003743314,0.00013493645,0.00017814714,0.0002240155,0.00020792648,0.000045011944,0.00007533695,0.000002340744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021903121,0.001298239,0.08259673,0.0007577238,0.00041560858,0.0001352596,0.013713338,0.0019734076,0.83558476,0.00032234844,0.0027143399,0.058297962],"study_design_scores_gemma":[0.11075446,0.009265152,0.05800769,0.0017357566,0.006944218,0.0015330567,0.0042038024,0.06304637,0.70602566,0.0045137093,0.03129223,0.002677893],"about_ca_topic_score_codex":0.0008874299,"about_ca_topic_score_gemma":0.0005295586,"teacher_disagreement_score":0.12955907,"about_ca_system_score_codex":0.0004997777,"about_ca_system_score_gemma":0.000816404,"threshold_uncertainty_score":0.99987084},"labels":[],"label_agreement":null},{"id":"W1593650811","doi":"10.1111/j.1365-2796.2012.02549.x","title":"Letter to the Editor: response to letter from Dr. Eroglu and Dr. Unal","year":2012,"lang":"en","type":"letter","venue":"Journal of Internal Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Stage (stratigraphy); Autologous stem-cell transplantation; Surgery; Clinical trial; Refractory (planetary science); Disease; Randomized controlled trial; Transplantation; Internal medicine; Radiation therapy; Oncology","score_opus":0.018716449782642284,"score_gpt":0.29149722941855716,"score_spread":0.27278077963591485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593650811","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05353131,0.002679975,0.00016269785,0.92634255,0.016485158,0.00045226878,0.000052750147,0.0000136008,0.00027970126],"genre_scores_gemma":[0.011257219,0.000075966665,0.0002520421,0.70745105,0.27712333,0.0000224631,0.000015352334,0.00006489347,0.0037376657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568266,0.00034891977,0.0012504036,0.00040318727,0.0017082994,0.0006065133],"domain_scores_gemma":[0.9961271,0.0014519714,0.0006948007,0.00062492443,0.00040296992,0.00069818157],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012673856,0.0006055936,0.001379192,0.0005890038,0.000082873725,0.00006672122,0.0005195785,0.00048052066,0.00095804944],"category_scores_gemma":[0.0008195337,0.00030064047,0.00034879113,0.00016726599,0.00017252027,0.000120496574,0.00019424717,0.0023047223,0.00028652264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043222476,0.000111840374,0.004423573,0.0000406194,0.0010105146,0.005531477,0.0011271781,4.4711246e-7,0.0012462842,6.8202e-7,0.9797177,0.0024674674],"study_design_scores_gemma":[0.0037715093,0.0037323467,0.021953825,0.0038682588,0.0012562692,0.0020623072,0.00005049239,0.0000011933877,0.0005504537,0.000015507978,0.96248513,0.00025268085],"about_ca_topic_score_codex":0.00037125783,"about_ca_topic_score_gemma":0.000016283608,"teacher_disagreement_score":0.26063818,"about_ca_system_score_codex":0.0005709086,"about_ca_system_score_gemma":0.00013919827,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W1596002476","doi":"10.1001/archopht.118.2.284","title":"Treatment of Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma With Intralesional Injection of Interferon Alfa-2b","year":2000,"lang":"en","type":"article","venue":"Archives of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lymphoma; Lymphatic system; Mucosa-associated lymphoid tissue; Interferon alfa; Pathology; Alpha interferon; Interferon; MALT lymphoma; Immunology","score_opus":0.015777718978554442,"score_gpt":0.27347576290282755,"score_spread":0.2576980439242731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596002476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865738,0.00034416092,0.000006444176,0.00012541702,0.000053179916,0.0003959508,0.00007691511,0.000013799946,0.0124103315],"genre_scores_gemma":[0.99795914,0.00014890796,0.00062777346,0.000009347795,0.000029582305,0.00004456381,0.00014705777,0.000020777687,0.0010128581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872285,0.000113882044,0.00045619748,0.00029011717,0.00018074282,0.00023618051],"domain_scores_gemma":[0.99901265,0.0003184205,0.00023719204,0.0002809427,0.000055571672,0.00009525175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003453055,0.00022614363,0.00073884963,0.00017154343,0.00003075474,0.0000017973185,0.00007953678,0.00009148226,0.0007644943],"category_scores_gemma":[0.0000176199,0.00015960263,0.00015365795,0.00011191637,0.00042164067,0.00003919607,0.00002122587,0.000025370047,0.000008237589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018429039,0.018713096,0.70345193,0.00020562713,0.0025169263,0.0014545228,0.002740876,0.00012549855,0.04434866,0.0005382149,0.00005461095,0.20742102],"study_design_scores_gemma":[0.0138338255,0.04308059,0.7300989,0.00030328022,0.00035698013,0.012792116,0.00012205065,0.00009958196,0.19858392,0.0004559874,0.00011540724,0.00015732896],"about_ca_topic_score_codex":0.00086664414,"about_ca_topic_score_gemma":0.0000069510857,"teacher_disagreement_score":0.2072637,"about_ca_system_score_codex":0.00014099461,"about_ca_system_score_gemma":0.0002025752,"threshold_uncertainty_score":0.8370676},"labels":[],"label_agreement":null},{"id":"W1600734675","doi":"10.1002/cncr.26687","title":"Limited‐stage diffuse large B‐cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Diffuse large B-cell lymphoma; Internal medicine; Stage (stratigraphy); Oncology; Rituximab; Chemotherapy; Lymphoma; B symptoms; Surgery","score_opus":0.021868775753216947,"score_gpt":0.2707823273846517,"score_spread":0.24891355163143475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600734675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93615025,0.062254988,0.00002452517,0.00016071693,0.00007162298,0.00065919524,0.000051874486,0.0000814247,0.00054538605],"genre_scores_gemma":[0.97377425,0.023329152,0.00006986086,0.00083922583,0.0001539418,0.0002690346,0.000068776164,0.00003930749,0.0014564503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911034,0.00004697627,0.00016372658,0.00021548019,0.0001416846,0.00032179922],"domain_scores_gemma":[0.999349,0.000046922665,0.000100704696,0.00023841213,0.00006583196,0.00019914348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007251794,0.00021274798,0.00033450875,0.000066742374,0.00007235634,0.000024847373,0.00003167329,0.0000846387,0.0002054594],"category_scores_gemma":[0.0000034618529,0.000133621,0.000045767516,0.00015364126,0.00004268898,0.000112929956,0.000006630536,0.000031959746,0.000015023846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006376278,0.002769277,0.9660127,0.00011938343,0.00036016834,0.000033102282,0.0008584248,8.0272997e-7,0.0064853136,0.00009441155,0.00091031054,0.021718448],"study_design_scores_gemma":[0.07870809,0.0007759471,0.8142104,0.00052129396,0.00033091597,0.0002029783,0.0002469583,0.00021402432,0.0404866,7.2412564e-7,0.063912876,0.00038918326],"about_ca_topic_score_codex":0.00017289758,"about_ca_topic_score_gemma":0.000008848872,"teacher_disagreement_score":0.15180233,"about_ca_system_score_codex":0.00034273334,"about_ca_system_score_gemma":0.00008120331,"threshold_uncertainty_score":0.5448906},"labels":[],"label_agreement":null},{"id":"W1600734883","doi":"10.1155/2007/362360","title":"A Definitive Diagnosis of Primary Hodgkin Lymphoma on Endoscopic Biopsy Material Utilizing in-Depth Immunohistochemical Analysis","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Pathognomonic; Biopsy; Endoscopy; Esophagus; Immunohistochemistry; Lymphoma; Endoscope; Laparotomy; Thoracotomy; Radiology; Pathology; Surgery; Disease","score_opus":0.017153999714103356,"score_gpt":0.25560474547705897,"score_spread":0.2384507457629556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600734883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973459,0.00024381312,0.000030448673,0.0003869741,0.0002899028,0.00013993212,0.00005248771,0.000003177615,0.001507363],"genre_scores_gemma":[0.998327,0.000056199056,0.0007410235,0.00071916246,0.00009213856,0.000010248816,0.00003305177,0.000015822423,0.000005354394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982048,0.00008767728,0.00078897213,0.00019823022,0.00018455101,0.00053575804],"domain_scores_gemma":[0.9986315,0.00014395194,0.00038380016,0.00020220388,0.00013654656,0.0005019912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000352099,0.00019353289,0.0009382933,0.0014612424,0.000034975757,0.000009988518,0.00014057478,0.00012384338,0.00015984353],"category_scores_gemma":[0.00009946159,0.00017009107,0.00033146425,0.00033381875,0.00019564551,0.00004596982,0.000015955648,0.0001276663,0.000003883128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022009627,0.00037567248,0.98927003,0.000023000783,0.00089678756,0.0031982274,0.00023524993,0.0000041568974,0.0011679932,0.00010106524,0.00012320747,0.0024036271],"study_design_scores_gemma":[0.0051795556,0.0031059266,0.98302984,0.00019581294,0.00076160504,0.0007273451,0.0001457527,0.000001551525,0.006630499,0.000023701736,0.0001403421,0.000058065143],"about_ca_topic_score_codex":0.004713647,"about_ca_topic_score_gemma":0.014213007,"teacher_disagreement_score":0.00949936,"about_ca_system_score_codex":0.0012245381,"about_ca_system_score_gemma":0.00052947813,"threshold_uncertainty_score":0.79311913},"labels":[],"label_agreement":null},{"id":"W1608828635","doi":"10.1002/pbc.25698","title":"Anaplastic Large Cell Lymphoma in Central America: A Report From the Central American Association of Pediatric Hematology Oncology (AHOPCA)","year":2015,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Vincristine; Hematology; Anaplastic large-cell lymphoma; Regimen; Retrospective cohort study; Oncology; Prednisone; Lymphoma; Anaplastic lymphoma kinase; Salvage therapy; Chemotherapy; Cyclophosphamide","score_opus":0.013201376362562387,"score_gpt":0.2769869622804383,"score_spread":0.2637855859178759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608828635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867297,0.008865149,0.000017050304,0.0021324402,0.0008737668,0.0005074297,0.00021597165,0.000044400473,0.0006141355],"genre_scores_gemma":[0.99078786,0.0059641744,0.00028854975,0.0005621222,0.0019459786,0.00018495157,0.00012328294,0.000032524313,0.00011055382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969877,0.00021206852,0.0007904307,0.0005206814,0.000579579,0.0009095443],"domain_scores_gemma":[0.99725837,0.00071724434,0.0010647083,0.00039538983,0.00019897215,0.00036533695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002263999,0.00028838584,0.0009210699,0.00016937008,0.000051983225,0.000013336395,0.00017216078,0.00018042861,0.00009282294],"category_scores_gemma":[0.0004584169,0.00021542089,0.00019398691,0.00108034,0.00006506693,0.00006726627,0.00008768844,0.00017402932,0.000024888612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027005302,0.0038595411,0.97376645,0.000043226966,0.0001920341,0.0007788542,0.00092210073,0.000022349865,0.0000064255964,0.000013985388,0.018626079,0.0014989312],"study_design_scores_gemma":[0.01431768,0.0007339861,0.9729891,0.0000117926165,0.002785699,0.000070390735,0.00047845286,0.00006741592,0.00017671037,0.000024274499,0.008133385,0.00021111511],"about_ca_topic_score_codex":0.012597044,"about_ca_topic_score_gemma":0.002584123,"teacher_disagreement_score":0.014047627,"about_ca_system_score_codex":0.001302992,"about_ca_system_score_gemma":0.002159551,"threshold_uncertainty_score":0.99397814},"labels":[],"label_agreement":null},{"id":"W161731825","doi":"10.1007/978-1-59745-478-0_7","title":"Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma","year":2009,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Transplantation; Medicine; Lymphoma; Natural history; Stem cell; Oncology; Myeloid leukemia; Immunology; Non-Hodgkin's lymphoma; Internal medicine; Biology","score_opus":0.048625859623647974,"score_gpt":0.2709212515842313,"score_spread":0.22229539196058334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W161731825","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009599997,0.0051806765,0.00013685385,0.000029423663,0.00020852634,0.0030720436,0.00033385333,0.00012712186,0.9899515],"genre_scores_gemma":[0.063756935,0.0028704111,0.00056793104,0.0005496714,0.0005442704,0.0005676248,0.0007469469,0.00017826229,0.9302179],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800664,0.000016123458,0.0005214873,0.00070039683,0.00037662635,0.00037871645],"domain_scores_gemma":[0.9986728,0.000117765536,0.00032463946,0.0005308688,0.00015876477,0.00019514929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008455891,0.00062689866,0.0008307812,0.0001668918,0.00015908034,0.00004680934,0.0001534177,0.00047079605,0.00005765816],"category_scores_gemma":[9.757149e-7,0.0005513146,0.0004898786,0.000004385133,0.00007991056,0.000038004586,0.00002278585,0.000106115185,0.000038649265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094590394,0.00027038713,0.000008430012,0.001184847,0.0010096097,0.0006456448,0.001802248,0.0000056347317,0.00012279529,0.04703354,0.004489497,0.94248146],"study_design_scores_gemma":[0.014946858,0.0025363036,0.0025288665,0.0017473596,0.005432145,0.0001252119,0.000026945469,0.000052785686,0.026018796,0.0035657485,0.94180286,0.0012161074],"about_ca_topic_score_codex":0.000066370674,"about_ca_topic_score_gemma":0.00004490222,"teacher_disagreement_score":0.94126534,"about_ca_system_score_codex":0.00033158032,"about_ca_system_score_gemma":0.00016073027,"threshold_uncertainty_score":0.9996938},"labels":[],"label_agreement":null},{"id":"W1641986442","doi":"10.1007/s11912-015-0472-y","title":"Consolidative Radiation in DLBCL: Evidence-Based Recommendations","year":2015,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Modality (human–computer interaction); Lymphoma; Medical physics; Intensive care medicine; Oncology; Internal medicine; Artificial intelligence","score_opus":0.42244736941420413,"score_gpt":0.5428566322432403,"score_spread":0.12040926282903619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1641986442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041149033,0.9924918,0.000007452481,0.0009300355,0.0026542353,0.002467662,0.000029303563,0.0000553154,0.0013230777],"genre_scores_gemma":[0.00016897252,0.9952984,0.00016720638,0.000097265096,0.00028473506,0.0017314736,0.0021151088,0.000032838558,0.000103993996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996866,0.0004917332,0.0013913997,0.0006685928,0.00027363506,0.00030863762],"domain_scores_gemma":[0.9968501,0.0007750448,0.0013073082,0.0005669681,0.0002368546,0.00026377873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000995103,0.00040795107,0.0023062609,0.00048152427,0.00004860189,0.000018358454,0.00007051631,0.0004131519,0.00017838695],"category_scores_gemma":[0.00096839364,0.00031301446,0.0004004496,0.00045573284,0.00010447058,0.00010792629,0.00005106012,0.00041624822,0.00012484059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000009978912,0.0019993938,0.004278546,0.002341383,0.00012372463,0.0013928049,0.000056534504,3.9790956e-7,1.26132695e-8,0.000021632943,0.031861987,0.9579136],"study_design_scores_gemma":[0.0011669531,0.00043292667,0.0004948294,0.028193906,0.0019113555,0.0010203326,0.000011756925,0.00000491402,0.0000013019239,0.000037755653,0.96653414,0.00018980363],"about_ca_topic_score_codex":0.000024396755,"about_ca_topic_score_gemma":0.000014829694,"teacher_disagreement_score":0.9577238,"about_ca_system_score_codex":0.004119948,"about_ca_system_score_gemma":0.008141454,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W164266583","doi":"10.1016/j.hoc.2013.10.001","title":"Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma","year":2013,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Hospital; Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Disease; Stage (stratigraphy); Lymphoma; Dilemma; Intensive care medicine; Non-Hodgkin's lymphoma; Affect (linguistics); Multidisciplinary approach; Multidisciplinary team; Internal medicine; Psychology; Nursing","score_opus":0.0653382762121664,"score_gpt":0.3578242546071609,"score_spread":0.29248597839499446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W164266583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19754894,0.79706264,0.00002610799,0.000042964686,0.00018470618,0.0041111177,0.0008825793,0.000036807105,0.00010417088],"genre_scores_gemma":[0.0072371443,0.98309344,0.007277843,0.00020921673,0.000051399413,0.0011017025,0.0008859216,0.000105796295,0.00003751515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597025,0.00031425362,0.0019778344,0.0008809494,0.00027414062,0.0005825652],"domain_scores_gemma":[0.9904073,0.0037683584,0.004134273,0.0008282418,0.00058940967,0.00027243554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027163987,0.00076053286,0.0064153443,0.0003544455,0.000108541324,0.0000076097,0.00025971569,0.00077214354,0.000028137485],"category_scores_gemma":[0.00048266537,0.00050411973,0.0006647619,0.00039959923,0.0006123708,0.00006273196,0.00012479747,0.00028383738,0.000016304586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034242545,0.0020642302,0.36586934,0.003662051,0.0013523648,0.000014889784,0.0000439856,0.000002357637,3.7131154e-9,0.000022298247,0.00031313705,0.6263129],"study_design_scores_gemma":[0.015980426,0.018793026,0.12865375,0.004982416,0.005524256,0.0001240815,0.00006571748,0.000027666025,0.0000027329133,0.000014381475,0.8251997,0.00063180266],"about_ca_topic_score_codex":0.00018164751,"about_ca_topic_score_gemma":0.000057950245,"teacher_disagreement_score":0.8248866,"about_ca_system_score_codex":0.00016617616,"about_ca_system_score_gemma":0.0011147199,"threshold_uncertainty_score":0.999741},"labels":[],"label_agreement":null},{"id":"W1651525714","doi":"10.1177/229255031302100209","title":"Implant-associated anaplastic large cell lymphoma of the breast: Insight into a poorly understood disease","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Plastic Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Breast implant; Seroma; Implant; T-cell lymphoma; Disease; Lymphoma; Surgery; Pathology; Complication","score_opus":0.009161720700461158,"score_gpt":0.191144261459942,"score_spread":0.18198254075948087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1651525714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593747,0.0010190968,0.00001560453,0.00089243683,0.0015708086,0.00016803568,0.0002089344,0.0000060495,0.00018159204],"genre_scores_gemma":[0.9993596,0.000028987344,0.0000087753315,0.0003514605,0.000115722905,0.00000773961,0.000022869384,0.00002628551,0.000078548976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982572,0.0001049043,0.00062649336,0.00015535002,0.0003671051,0.00048894936],"domain_scores_gemma":[0.99565715,0.0017642829,0.00048641444,0.00023856017,0.00035125331,0.0015023178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019892842,0.00021950561,0.0005558517,0.00043230198,0.00015840193,0.000044927812,0.000149311,0.00009379772,0.00039059026],"category_scores_gemma":[0.0012071932,0.00014320594,0.0004978959,0.00038378354,0.000115973686,0.00013845215,0.000018132492,0.000112113805,0.000042201806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014890193,0.0008395484,0.96139264,0.000107835185,0.0004905022,0.0018817006,0.00040274803,0.000018676135,0.000087013475,0.00007072746,0.03306989,0.0014898204],"study_design_scores_gemma":[0.00302998,0.0001552021,0.9929582,0.00068331254,0.0005425453,0.0007565185,0.00019777345,0.00009845957,0.00010502006,0.00009963814,0.0012290895,0.00014425408],"about_ca_topic_score_codex":0.0065145525,"about_ca_topic_score_gemma":0.008810942,"teacher_disagreement_score":0.0318408,"about_ca_system_score_codex":0.0007615301,"about_ca_system_score_gemma":0.005635833,"threshold_uncertainty_score":0.99977255},"labels":[],"label_agreement":null},{"id":"W1652309814","doi":"10.1158/1538-7445.am2015-846","title":"Abstract 846: Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in a pooled analysis of three prospective cohorts of Chinese men and women in Shanghai and Singapore","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Quartile; Odds ratio; Internal medicine; Lymphoma; Prospective cohort study; Population; Logistic regression; Incidence (geometry); Immunology; Confidence interval; Demography; Environmental health","score_opus":0.044997440399100634,"score_gpt":0.3566884812036524,"score_spread":0.31169104080455173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1652309814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691546,0.001792039,4.6765408e-7,0.000061718994,0.0000048376037,0.0006891802,0.00023239899,0.000002557641,0.0003013558],"genre_scores_gemma":[0.9994205,0.00035840634,0.00002562637,0.0000026925889,0.0000059258473,0.00013537708,0.000010382872,0.000012585392,0.0000284555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.000085378764,0.00036332413,0.00029015288,0.00053842,0.0002897773],"domain_scores_gemma":[0.9985981,0.0002722191,0.00028283402,0.00020248044,0.00048930093,0.00015505737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432852,0.00013155189,0.0009510478,0.00061663234,0.000020799776,0.000007748853,0.000054727137,0.00008538258,0.00002034669],"category_scores_gemma":[0.00036624123,0.000091618356,0.000034700075,0.0013018466,0.00032489863,0.00007230554,0.0000841837,0.00009678339,5.063192e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011977272,0.00074012385,0.9844702,0.00020327192,0.001829517,0.000044028093,0.006916291,0.00004436202,0.0017705373,0.0000029061248,0.000014211602,0.0027668546],"study_design_scores_gemma":[0.008715824,0.00079057436,0.98287356,0.00059145596,0.00029798647,0.0000014268909,0.0018091392,0.0005419169,0.004060432,0.00024663363,3.9983163e-7,0.0000706462],"about_ca_topic_score_codex":0.015295181,"about_ca_topic_score_gemma":0.01696087,"teacher_disagreement_score":0.0075180973,"about_ca_system_score_codex":0.00059619313,"about_ca_system_score_gemma":0.0004415041,"threshold_uncertainty_score":0.9912621},"labels":[],"label_agreement":null},{"id":"W1703926337","doi":"10.4021/jocmr397w","title":"Font Size: Ninety-seven Years Old Hispanic Male With Mantle Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mantle cell lymphoma; Lymphoma; Geriatrics; Health care; Internal medicine; Intensive care medicine; Psychiatry","score_opus":0.08858603845813061,"score_gpt":0.4578730825275026,"score_spread":0.36928704406937196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1703926337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641341,0.0008492432,0.0000075554085,0.016981883,0.000731597,0.000384654,0.0000027712567,0.000012278118,0.01689591],"genre_scores_gemma":[0.98260534,0.0022725547,0.0020087801,0.0007144051,0.0033705356,0.000013197963,0.0000028309005,0.000041790394,0.008970541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950954,0.000311495,0.0014668407,0.00033813497,0.0021997215,0.0005884592],"domain_scores_gemma":[0.9923477,0.004435389,0.0004896179,0.0006109678,0.0010341911,0.0010821318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006140804,0.00020603869,0.0011406199,0.00027887573,0.000084512954,0.00002353435,0.00036352576,0.0002627478,0.0020223937],"category_scores_gemma":[0.0033628535,0.00011532477,0.00029485387,0.00044462478,0.00065742503,0.00010036048,0.00010044076,0.0014083136,0.00017273483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053730435,0.0077203675,0.5464092,0.00022421182,0.0006945305,0.013042886,0.00040928347,0.000001394463,0.0041167685,0.00034003452,0.16287343,0.25879487],"study_design_scores_gemma":[0.029857181,0.017805336,0.7278865,0.0008075167,0.0003496038,0.0030029719,0.00038421445,0.000036357786,0.001311193,0.00020031037,0.21820207,0.000156738],"about_ca_topic_score_codex":0.00015863929,"about_ca_topic_score_gemma":0.00004658306,"teacher_disagreement_score":0.25863814,"about_ca_system_score_codex":0.0001365294,"about_ca_system_score_gemma":0.001108242,"threshold_uncertainty_score":0.99888986},"labels":[],"label_agreement":null},{"id":"W1717399098","doi":"10.1002/cncy.21262","title":"<scp><i>EZH2</i></scp> and <scp><i>CD79B</i></scp> mutational status over time in B‐cell non‐Hodgkin lymphomas detected by high‐throughput sequencing using minimal samples","year":2013,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Multiplex; Sanger sequencing; Medicine; Cancer research; B cell; Mutation; Pathology; Gene; Biology; Immunology; Antibody; Bioinformatics; Genetics","score_opus":0.015528553285070934,"score_gpt":0.25766695362178965,"score_spread":0.2421384003367187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1717399098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918277,0.0053831693,0.000115012146,0.00013349237,0.00029962583,0.000915924,0.00028761133,0.000096707445,0.0009407453],"genre_scores_gemma":[0.9911852,0.0006245784,0.00511774,0.0014028581,0.00025700402,0.00045684873,0.0002200758,0.00009449376,0.0006411866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966363,0.00018515902,0.000686187,0.0009800805,0.00037779647,0.0011345304],"domain_scores_gemma":[0.9977665,0.0008993655,0.00032493682,0.00040016268,0.00020472816,0.00040428352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002013247,0.00054924865,0.00090177497,0.00029234006,0.000175523,0.0000793632,0.0001391425,0.00038274485,0.00021222931],"category_scores_gemma":[0.000303122,0.00051233754,0.000125331,0.00040651692,0.00035327402,0.0003012639,0.00014811216,0.00023982405,0.000114673436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033929406,0.00043645356,0.5318966,0.00016392101,0.00011890392,0.0009981953,0.0024300201,0.00014530179,0.45236924,0.00006889949,0.008493805,0.0028447353],"study_design_scores_gemma":[0.0104579935,0.00070359383,0.86442316,0.0002151363,0.0003342292,0.0008148856,0.0007135168,0.0017423404,0.11638531,0.00041243277,0.0036036947,0.00019372912],"about_ca_topic_score_codex":0.0056309174,"about_ca_topic_score_gemma":0.00020250343,"teacher_disagreement_score":0.33598393,"about_ca_system_score_codex":0.0015126994,"about_ca_system_score_gemma":0.0008798317,"threshold_uncertainty_score":0.99973285},"labels":[],"label_agreement":null},{"id":"W172066064","doi":"10.1182/blood.v122.21.5093.5093","title":"Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Diffuse large B-cell lymphoma; Burkitt's lymphoma; Internal medicine; Regimen; Oncology","score_opus":0.006194568633169314,"score_gpt":0.20625558912471148,"score_spread":0.20006102049154217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172066064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98235554,0.014644125,0.0000010345142,0.00016298739,0.000039160645,0.0022772325,0.00028976882,0.00002785433,0.0002022807],"genre_scores_gemma":[0.9946809,0.0037442234,0.00024943874,0.00046077438,0.000044179502,0.00035566036,0.00017386445,0.0000577919,0.00023315768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793136,0.00009473588,0.00044823857,0.0006611743,0.00035728054,0.0005072032],"domain_scores_gemma":[0.9985847,0.00016916083,0.00029961407,0.0004789376,0.0002206037,0.00024697845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001027386,0.0005077673,0.0009427608,0.00010729147,0.00011804764,0.00011912589,0.00014299227,0.000167373,0.0000041938742],"category_scores_gemma":[0.000047998376,0.00027698957,0.00008983681,0.00025465625,0.00023352532,0.00025855078,0.00016095597,0.000060554707,8.082512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781091,0.021856867,0.965347,0.0031522573,0.00020103471,0.00003037931,0.0012352093,8.181069e-9,0.0005076224,0.000011898296,0.00020877608,0.0068708514],"study_design_scores_gemma":[0.15099674,0.0022184402,0.83108336,0.006410517,0.0005650016,0.000053537005,0.00013969683,0.0000069719263,0.0076606357,0.0000100644065,0.00054032414,0.00031469998],"about_ca_topic_score_codex":0.00024604073,"about_ca_topic_score_gemma":0.000047240097,"teacher_disagreement_score":0.15041862,"about_ca_system_score_codex":0.000108168824,"about_ca_system_score_gemma":0.00009436229,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W1724875595","doi":"10.3109/10428194.2015.1086919","title":"Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma","year":2015,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Internal medicine; Chemotherapy; Lymphoma; Multivariate analysis; Univariate analysis; Oncology; Gastroenterology; Disease; Vincristine; Cyclophosphamide","score_opus":0.02645099087539054,"score_gpt":0.3144176601644274,"score_spread":0.28796666928903686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1724875595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965194,0.00016291701,0.000017861048,0.0003434,0.00017842068,0.0014239763,0.00031105094,0.000074959644,0.0009680095],"genre_scores_gemma":[0.9971789,0.00020352476,0.0007596481,0.0009791057,0.000120434685,0.00024171927,0.00030735534,0.00010435153,0.00010494079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505705,0.00029687714,0.0016776983,0.0010913808,0.0011688706,0.0007081362],"domain_scores_gemma":[0.9958222,0.0010619039,0.0007064103,0.0009388317,0.0005281166,0.0009425697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041647087,0.0008467068,0.0022289741,0.000520636,0.00006968332,0.000049123475,0.00030009233,0.00051177293,0.00009021547],"category_scores_gemma":[0.0004910512,0.0005904935,0.0005822395,0.00069377077,0.00035645918,0.000279609,0.00014340683,0.000100015655,0.00008653981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503872,0.005137275,0.85145634,0.000027482747,0.00087772997,0.00008989792,0.0008809833,0.000058679663,0.00004938592,0.00007417091,0.0013741647,0.13147001],"study_design_scores_gemma":[0.07209689,0.009435912,0.9137143,0.0006095557,0.0002945279,0.00001630778,0.00011705488,0.00042746705,0.0021196336,0.00009374601,0.0005402273,0.00053438527],"about_ca_topic_score_codex":0.0040136417,"about_ca_topic_score_gemma":0.000104946186,"teacher_disagreement_score":0.13093562,"about_ca_system_score_codex":0.008713103,"about_ca_system_score_gemma":0.0032864937,"threshold_uncertainty_score":0.99965465},"labels":[],"label_agreement":null},{"id":"W1740754789","doi":"10.1002/cncy.20098","title":"Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations","year":2010,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Subtyping; Medicine; Pathology; Chromosomal translocation; Immunophenotyping; Lymphoma; Gene rearrangement; Follicular lymphoma; Cytology; Biology; Immunology; Gene; Antigen","score_opus":0.022480596413686514,"score_gpt":0.3020537568230414,"score_spread":0.2795731604093549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740754789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982818,0.00010948921,0.000031330168,0.000645583,0.000217142,0.0003613401,0.000024974512,0.000016759775,0.00031162682],"genre_scores_gemma":[0.9977968,0.0001893666,0.0013461114,0.0003045727,0.000043142958,0.00019532649,0.000052585434,0.000009416295,0.00006267477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992075,0.000041935393,0.00027506318,0.0002300402,0.000078866986,0.00016660155],"domain_scores_gemma":[0.9995169,0.000048926908,0.00007738759,0.0002373386,0.00007167473,0.00004775598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008187319,0.00009301631,0.00025908786,0.00015830672,0.0000148074105,0.000005070096,0.000045083634,0.00009599585,0.00007069196],"category_scores_gemma":[0.00016879721,0.0000848799,0.00003374686,0.00025844664,0.000081702296,0.00009465959,0.00002239837,0.00011482553,0.0000064494584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007341795,0.00031202775,0.7217394,0.000016893384,0.000004599777,0.00015596056,0.00031297485,0.00006377101,0.27467528,0.00043879778,0.00021926056,0.0019876075],"study_design_scores_gemma":[0.0014400887,0.000109988796,0.86816055,0.0000495488,0.000019726089,0.000043273725,0.000013769718,0.00015680245,0.12918708,0.000036199654,0.0007216076,0.000061386636],"about_ca_topic_score_codex":0.00043176996,"about_ca_topic_score_gemma":0.0052116183,"teacher_disagreement_score":0.14642112,"about_ca_system_score_codex":0.000117107076,"about_ca_system_score_gemma":0.00020064163,"threshold_uncertainty_score":0.3461302},"labels":[],"label_agreement":null},{"id":"W1751016438","doi":"10.1007/s00277-015-2478-9","title":"Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; H. Lundbeck A/S; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Internal medicine; Mantle cell lymphoma; Neutropenia; Tolerability; Gastroenterology; Rituximab; Nausea; Adverse effect; Progressive disease; Salvage therapy; Phases of clinical research; Surgery; Febrile neutropenia; Lymphoma; Chemotherapy","score_opus":0.047856919404286505,"score_gpt":0.32922497514834703,"score_spread":0.28136805574406054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1751016438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634314,0.0009806614,9.92014e-7,0.001101432,0.000039094095,0.0007530625,0.000016792239,0.000016910062,0.00074789923],"genre_scores_gemma":[0.99960166,0.00006161081,0.000115241855,0.00011307075,0.0000073233646,0.000029699508,0.000022038774,0.000015843265,0.000033482695],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848634,0.00008874783,0.0006121488,0.00033014728,0.00023044889,0.0002521489],"domain_scores_gemma":[0.99887526,0.00023037707,0.0002069191,0.0003661266,0.00015842692,0.00016287844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028538832,0.00019882749,0.0010831696,0.00017529205,0.000038438677,0.0000027376154,0.000080118545,0.00010622114,0.000019778427],"category_scores_gemma":[0.00010782831,0.00014722139,0.000052352207,0.00018917338,0.00016981011,0.000044005756,0.00010873385,0.000069093796,0.000003276376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020290628,0.36522633,0.5977226,0.0005260694,0.0003712944,0.000993893,0.0068876105,0.0000070184888,0.00037811426,0.0006949039,0.0017956236,0.005105958],"study_design_scores_gemma":[0.5030619,0.14153786,0.28205198,0.00048712746,0.0004572058,0.00057836255,0.004057001,0.00010417844,0.06626119,0.00023375198,0.0007556962,0.00041377457],"about_ca_topic_score_codex":0.00032616634,"about_ca_topic_score_gemma":0.000116870986,"teacher_disagreement_score":0.48277125,"about_ca_system_score_codex":0.000028417058,"about_ca_system_score_gemma":0.00014773027,"threshold_uncertainty_score":0.6003514},"labels":[],"label_agreement":null},{"id":"W1764703361","doi":"10.1182/blood.v124.21.629.629","title":"Brentuximab Vedotin Monotherapy in DLBCL Patients with Undetectable CD30: Preliminary Results from a Phase 2 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; CD30; Internal medicine; Oncology; Rituximab; Diffuse large B-cell lymphoma; Chemotherapy regimen; Lymphoma; Chemotherapy","score_opus":0.008682233837594403,"score_gpt":0.24453516561794775,"score_spread":0.23585293178035335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1764703361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767953,0.00014983237,0.00000821373,0.00011760199,0.00004669905,0.0011082502,0.000081745784,0.000051854408,0.0007562475],"genre_scores_gemma":[0.99895436,0.0000137828565,0.00040998074,0.00013862299,0.00006808404,0.00014254548,0.00017220445,0.000030176217,0.00007024429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866915,0.00007453037,0.00029770957,0.00042664417,0.0002856181,0.00024635743],"domain_scores_gemma":[0.9991414,0.00013620913,0.00009804171,0.00046653827,0.000046811747,0.00011098417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010973315,0.00019815858,0.0003498612,0.000086353575,0.000047020105,0.000022817481,0.000076276476,0.000053682983,0.000037168087],"category_scores_gemma":[0.000048316582,0.00013998973,0.000044637094,0.00015700584,0.000021317996,0.00006007446,0.000027333474,0.00007734463,0.00003479152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009445738,0.10973359,0.8592574,0.000009430874,0.00033237063,0.00013124666,0.0013538556,0.0000054136876,0.000059129845,0.0000026128043,0.0001311062,0.019538086],"study_design_scores_gemma":[0.2743812,0.017417224,0.70457834,0.00012507288,0.00030315222,0.0000026741916,0.00015359705,0.00008538692,0.0024364314,0.000017223185,0.00035932584,0.00014037032],"about_ca_topic_score_codex":0.0010312499,"about_ca_topic_score_gemma":0.00013397452,"teacher_disagreement_score":0.26493543,"about_ca_system_score_codex":0.000066276356,"about_ca_system_score_gemma":0.000052465606,"threshold_uncertainty_score":0.5708615},"labels":[],"label_agreement":null},{"id":"W176944500","doi":"10.1007/978-1-4419-8459-3_4","title":"Design of Early-Phase Trials","year":2011,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clinical trial; Medicine; Intensive care medicine; Accrual; Phase (matter); Medical physics; Oncology; Internal medicine; Business","score_opus":0.20858870159482804,"score_gpt":0.3520199153679167,"score_spread":0.14343121377308868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W176944500","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018607917,0.001620303,0.00093573605,0.000070167735,0.0001393504,0.001232724,0.0000356819,0.00004218915,0.9957378],"genre_scores_gemma":[0.026084067,0.0013578665,0.0027422172,0.00017534534,0.00018015514,0.00004364341,0.000050647777,0.000055864184,0.96931016],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884987,0.000024888239,0.0005841612,0.00022112225,0.00020727982,0.00011265273],"domain_scores_gemma":[0.99884236,0.00025129676,0.0003102565,0.00038619552,0.00009200613,0.00011791422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033705836,0.0002416233,0.0011833808,0.000116629635,0.000012488571,0.0000044209146,0.000052206076,0.00025700926,0.011202694],"category_scores_gemma":[0.000048923288,0.00015090902,0.00034015262,0.000008553421,0.000048153626,0.000016328699,0.000021792728,0.000059318725,0.0004973947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058385218,0.0036992605,0.00040032668,0.00037538356,0.0075959763,0.0014986036,0.0004868414,4.3282196e-7,0.00061283197,0.520931,0.08441264,0.3741482],"study_design_scores_gemma":[0.10530182,0.037232593,0.0014634428,0.004583138,0.023763895,0.00030935532,0.000018789697,0.000013899799,0.09244976,0.08355608,0.6492592,0.0020479972],"about_ca_topic_score_codex":0.000084425206,"about_ca_topic_score_gemma":9.050237e-7,"teacher_disagreement_score":0.5648466,"about_ca_system_score_codex":0.000058707872,"about_ca_system_score_gemma":0.00016885014,"threshold_uncertainty_score":0.9897012},"labels":[],"label_agreement":null},{"id":"W1793743052","doi":"10.1007/s10552-015-0610-8","title":"Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base","year":2015,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; National Comprehensive Cancer Network; American Cancer Society","keywords":"Medicine; Cancer registry; Internal medicine; International Prognostic Index; Proportional hazards model; Prognostic variable; Diffuse large B-cell lymphoma; Oncology; Population; Cohort; Cancer; Lymphoma","score_opus":0.1849196632955814,"score_gpt":0.43465217923353133,"score_spread":0.24973251593794993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1793743052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852843,0.004391499,0.0000802225,0.0027539579,0.00036247936,0.0016044553,0.0020702402,0.000015628433,0.00019306588],"genre_scores_gemma":[0.99461514,0.0003467612,0.00007523808,0.0026306657,0.0005757263,0.0013679678,0.00032362546,0.000015210412,0.00004968948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984183,0.00011935247,0.00049133954,0.00031943936,0.00043752595,0.00021409607],"domain_scores_gemma":[0.9980167,0.0009604536,0.00025924086,0.00033204473,0.0003220598,0.000109501496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009729325,0.00013405368,0.00039090126,0.000063933054,0.000036377827,0.000021779764,0.00021975476,0.000079442616,0.000029387755],"category_scores_gemma":[0.00091372203,0.00008474178,0.000084849584,0.00013372695,0.00005533502,0.00013942228,0.00003695152,0.000050149316,0.000005155546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008183474,0.006105022,0.9717422,0.000103768994,0.00023471234,0.000016615453,0.00038863395,0.00002162567,0.000056592562,0.00017396404,0.013927039,0.0064114756],"study_design_scores_gemma":[0.17475083,0.00082748465,0.7567554,0.00034840326,0.0016751667,0.000009146003,0.00042474683,0.006221017,0.0018929233,0.00016779838,0.05666482,0.00026222176],"about_ca_topic_score_codex":0.0005479878,"about_ca_topic_score_gemma":0.0005451656,"teacher_disagreement_score":0.21498677,"about_ca_system_score_codex":0.00019854936,"about_ca_system_score_gemma":0.0012870486,"threshold_uncertainty_score":0.34556696},"labels":[],"label_agreement":null},{"id":"W1794399453","doi":"10.1111/j.1600-0609.2005.00463.x","title":"How to define intermediate stage in Hodgkin's lymphoma?","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Medicine; Internal medicine; Multivariate analysis; Population; Oncology; Lymphoma; Prospective cohort study; Proportional hazards model; Biology","score_opus":0.019069780225030735,"score_gpt":0.26287488639337947,"score_spread":0.24380510616834875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1794399453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97696316,0.0009248461,0.00018716419,0.017519576,0.00023743202,0.00012835259,0.0000030769017,0.000012869601,0.004023509],"genre_scores_gemma":[0.9937011,0.00012534017,0.0033225077,0.0018646795,0.00025065872,0.0000020962095,0.0000021573078,0.000028670122,0.00070279354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861467,0.00024272004,0.0005248629,0.0001589916,0.00018010437,0.00027863486],"domain_scores_gemma":[0.99910027,0.00007884423,0.0002552528,0.00020611827,0.00009557477,0.0002639709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045996736,0.00015881337,0.0005820779,0.00035846568,0.000020919366,0.000026350328,0.00015588096,0.000028013525,0.000085063024],"category_scores_gemma":[0.00022599203,0.000115150804,0.00013505104,0.00014421382,0.000048632857,0.000099397046,0.00006876389,0.00010492223,0.00023389523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019383525,0.0033676832,0.25475046,0.00016541914,0.0005500876,0.25789812,0.0038777695,0.00009998518,0.001847333,0.0024568138,0.026216473,0.44683152],"study_design_scores_gemma":[0.016031737,0.0030029176,0.589809,0.0005243222,0.000150554,0.034326676,0.00039659985,0.000028658518,0.00649452,0.000024995696,0.34895235,0.00025771002],"about_ca_topic_score_codex":0.000003084919,"about_ca_topic_score_gemma":0.000023144004,"teacher_disagreement_score":0.44657382,"about_ca_system_score_codex":0.00020067526,"about_ca_system_score_gemma":0.00011737672,"threshold_uncertainty_score":0.46957135},"labels":[],"label_agreement":null},{"id":"W1796636701","doi":"10.1136/jclinpath-2014-202705","title":"Getting controls under control: the time is now for immunohistochemistry","year":2015,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Immunohistochemistry; CLARITY; Test (biology); Pathology; Control (management); Medicine; Computer science; Biology; Artificial intelligence","score_opus":0.12631764226172207,"score_gpt":0.4889015793162599,"score_spread":0.36258393705453784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1796636701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013932525,0.9922658,0.000109431916,0.00474072,0.0009820289,0.00096972176,0.00008214728,0.000008783067,0.0007020363],"genre_scores_gemma":[0.00019068635,0.9909819,0.00050672307,0.0040550446,0.002656883,0.00007855849,0.000025900092,0.000051243733,0.0014530647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537885,0.00048943376,0.0032029988,0.00029251093,0.00032158286,0.00031459559],"domain_scores_gemma":[0.98998415,0.005125417,0.003450964,0.00050440885,0.0006649009,0.00027014982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044336417,0.00036020752,0.0052586044,0.00006416461,0.00006503816,0.000021400207,0.00032656034,0.0008140933,0.000090194284],"category_scores_gemma":[0.00249795,0.00017577314,0.0031119876,0.00006453464,0.0002580402,0.000029782354,0.000048095226,0.00088003534,0.00012591694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063995714,0.00091141526,0.00013392657,0.0015390464,0.002869013,0.0008810207,0.000017738692,3.9663146e-7,0.0000096107,0.00004687344,0.07722351,0.9157275],"study_design_scores_gemma":[0.010159368,0.0016367837,0.00015676147,0.0030841131,0.009250524,0.0045720786,0.0000079408,0.0000066832536,0.0000010157534,0.00034517367,0.97062695,0.00015260765],"about_ca_topic_score_codex":5.147362e-7,"about_ca_topic_score_gemma":9.533361e-8,"teacher_disagreement_score":0.9155749,"about_ca_system_score_codex":0.00022313916,"about_ca_system_score_gemma":0.0016487953,"threshold_uncertainty_score":0.71678203},"labels":[],"label_agreement":null},{"id":"W1801682147","doi":"10.1073/pnas.1514944112","title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","year":2015,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Dr. Mildred Scheel Stiftung für Krebsforschung; Deutsche Krebshilfe; National Cancer Institute; National Institute for Health and Care Research","keywords":"breakpoint cluster region; Antigen; B cell; B-cell receptor; Cancer research; Lymphoma; Biology; Epitope; Cell culture; Immunology; Antibody; Receptor; Genetics","score_opus":0.07241743131140992,"score_gpt":0.32751801413550824,"score_spread":0.2551005828240983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1801682147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812231,0.00030163923,8.092601e-8,0.0016795628,0.000039338312,0.0002560718,0.000027621236,0.00001344823,0.016459158],"genre_scores_gemma":[0.99814653,0.000085453365,0.0011806755,0.00013569975,0.000064169064,0.000011952784,7.0430735e-7,0.000005046372,0.0003697578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766207,0.00001159589,0.00039439584,0.00022695557,0.0015515141,0.00015346595],"domain_scores_gemma":[0.9989046,0.00008926525,0.00047835588,0.000013309251,0.00043176615,0.00008274294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015155812,0.00011028483,0.00025187235,0.00011217062,0.00012107324,0.000011809175,0.0003830137,0.000068862544,0.000022645498],"category_scores_gemma":[0.00015709121,0.000068918496,0.00010077653,0.00040702557,0.0004266317,0.00017756705,0.00012072971,0.00005231161,0.000004035741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034909837,0.0011866133,0.054033343,0.0001466488,0.00007460212,2.1260043e-8,0.00072412763,0.0000033654017,0.90461755,0.009384085,0.029468643,0.00032611322],"study_design_scores_gemma":[0.0013833191,0.00031780565,0.028754741,0.0000942272,0.000056669887,0.000001849677,0.0005102934,0.000034272885,0.9651432,0.0014868755,0.0021488024,0.00006792564],"about_ca_topic_score_codex":0.000024904466,"about_ca_topic_score_gemma":4.511471e-8,"teacher_disagreement_score":0.06052569,"about_ca_system_score_codex":0.00012363796,"about_ca_system_score_gemma":0.00010328904,"threshold_uncertainty_score":0.28104147},"labels":[],"label_agreement":null},{"id":"W1831380443","doi":"10.3747/co.2007.132","title":"Phase II Testing of Sunitinib: The National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Queen's University; Cancer Care Ontario; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Sunitinib; Clinical trial; Bevacizumab; Vascular endothelial growth factor; Oncology; Angiogenesis; Internal medicine; PDGFRA; Tyrosine-kinase inhibitor; Cancer research; Cancer; Chemotherapy; VEGF receptors; Stromal cell; GiST","score_opus":0.6175286996166528,"score_gpt":0.6092700241267817,"score_spread":0.008258675489871137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831380443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885066,0.0019834724,0.000021361988,0.001351794,0.0037063605,0.0019068626,0.00020261615,0.000019023902,0.00230192],"genre_scores_gemma":[0.99704176,0.00024849843,0.0005787755,0.00027730074,0.0014154097,0.0002909246,0.00011028945,0.000010662376,0.0000263774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958087,0.0007541335,0.0023771876,0.00025428904,0.0005011286,0.00030453096],"domain_scores_gemma":[0.989708,0.007713576,0.0015274995,0.0001669145,0.00069514447,0.00018886395],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012090985,0.00017124113,0.0014460704,0.000102674654,0.000115952585,0.0000049231385,0.00013336261,0.00015665316,0.00011537892],"category_scores_gemma":[0.019686738,0.00010270461,0.00022389149,0.00034621684,0.00030997064,0.000040627565,0.00006944174,0.00023165782,9.0710273e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010576806,0.012297452,0.060622845,0.00007620318,0.00044816977,0.000028566927,0.00014635995,0.0000027156673,0.0001314438,0.000993713,0.011462829,0.912732],"study_design_scores_gemma":[0.04342874,0.008932797,0.09502322,0.00041220366,0.0010775225,0.000040043826,0.00017135598,0.00007632953,0.0023787033,0.00017629728,0.8481133,0.00016947875],"about_ca_topic_score_codex":0.018155506,"about_ca_topic_score_gemma":0.08040064,"teacher_disagreement_score":0.91256255,"about_ca_system_score_codex":0.0005917163,"about_ca_system_score_gemma":0.0057805884,"threshold_uncertainty_score":0.9998557},"labels":[],"label_agreement":null},{"id":"W1834032251","doi":"10.1002/cam4.543","title":"Outcomes of both abbreviated hyper‐<scp>CVAD</scp> induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10‐year single‐centre experience with literature review","year":2015,"lang":"en","type":"review","venue":"Cancer Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Taibah University; Saudi Arabian Cultural Bureau","keywords":"Mantle cell lymphoma; Medicine; Hematopoietic cell; Rituximab; Lymphoma; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Induction chemotherapy; Surgery; Chemotherapy; Oncology; Haematopoiesis; Stem cell","score_opus":0.027029820218836757,"score_gpt":0.3135609958313095,"score_spread":0.2865311756124727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834032251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024529232,0.9932531,0.000026943017,0.0005324383,0.00024270636,0.0028354905,0.00032452485,0.000041951153,0.00028993658],"genre_scores_gemma":[0.000847979,0.9929266,0.0002293953,0.00045639428,0.00013245358,0.0007762355,0.0019763105,0.00007353157,0.0025810841],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977246,0.000085474654,0.0007963854,0.0006097947,0.00047683716,0.00030689634],"domain_scores_gemma":[0.9981727,0.00021605346,0.0007225098,0.00033633973,0.0003120331,0.00024036688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019929196,0.00059540867,0.0027151129,0.00013460827,0.000054825083,0.000013059532,0.00011461707,0.00030082485,0.0001140871],"category_scores_gemma":[0.000046013203,0.0003563382,0.0002724213,0.00038411608,0.00019042003,0.000078040626,0.000010744704,0.00011369404,0.0000039645533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003266134,0.0029099828,0.0036246437,0.4434431,0.0014350206,0.00021928296,0.0046744947,1.8168348e-7,0.00017298559,0.000036297402,0.1617163,0.38144112],"study_design_scores_gemma":[0.016218409,0.0011683609,0.00040801128,0.14034785,0.006636931,0.00035033046,0.0001975571,0.0000013264934,0.00036429582,0.000005342367,0.83407795,0.00022363805],"about_ca_topic_score_codex":0.00002865854,"about_ca_topic_score_gemma":0.000003959766,"teacher_disagreement_score":0.6723617,"about_ca_system_score_codex":0.00034858374,"about_ca_system_score_gemma":0.00042217286,"threshold_uncertainty_score":0.99988884},"labels":[],"label_agreement":null},{"id":"W1836083640","doi":"10.1182/blood-2015-06-649905","title":"Cell of origin of transformed follicular lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Cancer research; Biology; Immunology","score_opus":0.02427362276669239,"score_gpt":0.2581502085533498,"score_spread":0.2338765857866574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836083640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850522,0.001632302,0.000009106142,0.00009646191,0.000039194685,0.00020456998,0.000012461876,0.00001314775,0.012940523],"genre_scores_gemma":[0.9989047,0.00007990614,0.00073964515,0.00003477828,0.000027575286,0.00001638379,0.000012574407,0.000008991208,0.00017545368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937874,0.000010915529,0.00019392786,0.00009900341,0.00020971935,0.0001076945],"domain_scores_gemma":[0.9995419,0.000020619407,0.00005581665,0.00018695749,0.000078201665,0.000116503266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006618965,0.00007988802,0.00026445987,0.00004377238,0.0000065190275,0.0000014788691,0.000039887775,0.00004681249,0.000023961331],"category_scores_gemma":[0.000013135175,0.000057900117,0.00011086458,0.000099198805,0.00002905276,0.000021087044,0.000006389436,0.000010971169,0.000014853657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005076346,0.030831465,0.9094436,0.0007324211,0.0010942088,0.00046425444,0.0024785316,0.000005636212,0.03452625,0.0017256085,0.003808831,0.014381532],"study_design_scores_gemma":[0.029311009,0.0011003511,0.06221422,0.00008292135,0.00077982096,0.000047854828,0.00014165817,0.000006554027,0.8994309,0.00008380769,0.0067240424,0.00007688212],"about_ca_topic_score_codex":0.00014351607,"about_ca_topic_score_gemma":0.000003583518,"teacher_disagreement_score":0.86490464,"about_ca_system_score_codex":0.000027589356,"about_ca_system_score_gemma":0.00019075694,"threshold_uncertainty_score":0.23610982},"labels":[],"label_agreement":null},{"id":"W1840432652","doi":"10.1155/2012/480160","title":"Increasing Incidence Rates, Distribution and Histological Characteristics of Primary Gastrointestinal Non-Hodgkin Lymphoma in a North American Population","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Lymphoma; Population; Follicular lymphoma; Esophagus; Stomach; Gastroenterology; Pathology; Marginal zone B-cell lymphoma; Internal medicine; Mantle cell lymphoma; Marginal zone; B cell; Immunology; Antibody","score_opus":0.011496525500497708,"score_gpt":0.23500868439726327,"score_spread":0.22351215889676557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1840432652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991745,0.00011013457,0.00016998597,0.000319042,0.00007779445,0.00009778823,0.000039352683,0.000001823735,0.000009620199],"genre_scores_gemma":[0.9979718,0.000025769981,0.0015623184,0.00024638732,0.00008538046,0.000002909408,0.00009755491,0.0000069356306,9.617694e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988025,0.00012804345,0.00049580523,0.00010030094,0.00009975186,0.0003736335],"domain_scores_gemma":[0.9987341,0.00006801737,0.00047578083,0.00008502824,0.00011330523,0.00052375754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002897218,0.00012485051,0.0005351372,0.00020147751,0.000034485707,0.000007031034,0.000055785116,0.000028971119,0.0000075496378],"category_scores_gemma":[0.0002682788,0.00010431494,0.000057419067,0.00012078759,0.00020618789,0.000104336774,0.000014530252,0.00010305119,6.695452e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091508625,0.00015020662,0.99161386,0.000021064096,0.000021974698,0.00037914637,0.0000637299,0.0000011189652,0.00009052547,0.000009352445,0.000037691796,0.006696265],"study_design_scores_gemma":[0.0015437925,0.0022478567,0.98424643,0.00012791551,0.00007541489,0.011609947,0.000029173021,0.00002364388,0.000009049699,0.0000021617657,0.000044183034,0.000040425595],"about_ca_topic_score_codex":0.010116133,"about_ca_topic_score_gemma":0.019865157,"teacher_disagreement_score":0.011230801,"about_ca_system_score_codex":0.000826554,"about_ca_system_score_gemma":0.00026680648,"threshold_uncertainty_score":0.99801975},"labels":[],"label_agreement":null},{"id":"W1843690058","doi":"10.1002/pbc.24983","title":"ACR appropriateness Criteria® pediatric Hodgkin lymphoma","year":2014,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Appropriate Use Criteria; Expert opinion; Hodgkin lymphoma; Guideline; Appropriateness criteria; Medical literature; Delphi method; Lymphoma; Multidisciplinary approach; Medical physics; MEDLINE; Intensive care medicine; Radiology; Pathology; Internal medicine","score_opus":0.04184763080693982,"score_gpt":0.3596962113668628,"score_spread":0.317848580559923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1843690058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020235872,0.99139374,0.000007667397,0.00009914773,0.0024866674,0.0022069267,0.0003470512,0.00027773986,0.0011574613],"genre_scores_gemma":[0.0005198411,0.9744211,0.0003018075,0.00028395586,0.01949282,0.0033319667,0.000403164,0.0002953505,0.0009499933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453366,0.00027415477,0.0015440834,0.0015859548,0.0009277306,0.0011344146],"domain_scores_gemma":[0.99626744,0.0003920986,0.0010606548,0.0013424538,0.00026029124,0.0006770906],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00043064033,0.0014045038,0.004679986,0.0007794891,0.00019444038,0.00013503963,0.0005387308,0.0009969433,0.0008886588],"category_scores_gemma":[0.0001358009,0.0010284849,0.0016206731,0.001549122,0.000058391655,0.00011198548,0.00026771415,0.0003592495,0.00081243913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037598777,0.0018137201,0.007760344,0.07457228,0.0010461035,0.00055232947,0.000051963405,3.272182e-7,7.223114e-8,0.00004300074,0.014616515,0.89950573],"study_design_scores_gemma":[0.0046686917,0.00035602244,0.0017103098,0.002279074,0.062312383,0.00045032898,0.0000040615296,0.0000023357816,0.000002600515,0.00001594012,0.9271304,0.0010678454],"about_ca_topic_score_codex":0.00041981132,"about_ca_topic_score_gemma":0.000014786464,"teacher_disagreement_score":0.9125139,"about_ca_system_score_codex":0.0005761298,"about_ca_system_score_gemma":0.0026726425,"threshold_uncertainty_score":0.99996555},"labels":[],"label_agreement":null},{"id":"W1850402196","doi":"10.1002/cncr.28747","title":"Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"Pediatric Oncology Group of Ontario; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Mammography; Magnetic resonance imaging; Biopsy; Radiology; Breast MRI; Cancer; Stage (stratigraphy); Radiation therapy; Lymph node; Oncology; Internal medicine","score_opus":0.00670236539737386,"score_gpt":0.23047337221558944,"score_spread":0.22377100681821557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1850402196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98360586,0.014562505,0.00038335673,0.00022345234,0.00023058185,0.000284453,0.000038634036,0.000056647965,0.000614504],"genre_scores_gemma":[0.99738574,0.0012033774,0.00022044964,0.00012407993,0.00051874673,0.000257239,0.000004546847,0.00003840392,0.00024741917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987961,0.000041969353,0.0002235325,0.00034206058,0.00030017877,0.00029617985],"domain_scores_gemma":[0.9992252,0.00005232638,0.00014921694,0.00026371953,0.00015683277,0.00015272468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012029209,0.00019633466,0.00030655242,0.0001234508,0.00008798847,0.000017669723,0.00006745868,0.000050237548,0.00015570172],"category_scores_gemma":[0.000014235882,0.00015022967,0.00007279822,0.0003759736,0.00009375228,0.00010550683,0.00002497777,0.000053101056,0.0000036961042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016318524,0.00005824092,0.6760011,0.000052436342,0.000018765071,0.000013416925,0.00009026311,0.000040347044,0.000107623906,0.0000059394597,0.000109343564,0.32333934],"study_design_scores_gemma":[0.0034177904,0.00014167979,0.9910888,0.00023411082,0.00035025435,0.0000852535,0.000057244386,0.0014245936,0.002227145,0.0000044495973,0.00079913763,0.0001695387],"about_ca_topic_score_codex":0.020397544,"about_ca_topic_score_gemma":0.0046304152,"teacher_disagreement_score":0.3231698,"about_ca_system_score_codex":0.0003100832,"about_ca_system_score_gemma":0.00014572013,"threshold_uncertainty_score":0.9861257},"labels":[],"label_agreement":null},{"id":"W1854833437","doi":"10.1186/s13104-015-1277-7","title":"Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease","year":2015,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Royal Jubilee Hospital","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Cancer research; Fusion gene; ALK inhibitor; Crizotinib; Lymphoma; NPM1; Medicine; Oncology; Biology; Internal medicine; Lung cancer; Gene; Genetics","score_opus":0.061205910471373894,"score_gpt":0.3345261388058409,"score_spread":0.273320228334467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854833437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793535,0.0009990823,0.00004883141,0.00015406593,0.000024198342,0.00070181757,0.000021965885,0.000017511233,0.00009717623],"genre_scores_gemma":[0.99938756,0.00010557023,0.0002631222,0.000026824762,0.00005228163,0.00010459259,0.00002027439,0.000021303476,0.000018489476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982244,0.00018352205,0.00021070967,0.00031658213,0.00072450726,0.00034032005],"domain_scores_gemma":[0.9986764,0.0002757331,0.000050654933,0.0002784836,0.00023979477,0.00047894084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040679323,0.00013695305,0.00023134751,0.0002671542,0.000067419656,0.000029253983,0.000046756664,0.000056360866,0.000009131625],"category_scores_gemma":[0.0002390494,0.00009329352,0.000034020937,0.0003412215,0.00010190587,0.000103384016,0.000041946405,0.000067290996,0.000004424157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029283168,0.013466695,0.8518407,0.00058950373,0.00004305316,0.00060856756,0.0029348151,0.000027080723,0.03380677,0.000058884747,0.00010278346,0.06723798],"study_design_scores_gemma":[0.024090687,0.009930851,0.85178775,0.00038939685,0.000036762456,0.000013417588,0.0010562857,0.0025249736,0.10939955,0.000073247735,0.00053623813,0.00016087214],"about_ca_topic_score_codex":0.0005527493,"about_ca_topic_score_gemma":0.0018235832,"teacher_disagreement_score":0.07559278,"about_ca_system_score_codex":0.00026849343,"about_ca_system_score_gemma":0.00040949258,"threshold_uncertainty_score":0.38043994},"labels":[],"label_agreement":null},{"id":"W1856082554","doi":"10.1017/cbo9780511781926.014","title":"Molecular pathology of lymphoma","year":2010,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunophenotyping; Lymphoma; Pathology; Medicine; Biopsy; Molecular pathology; Flow cytometry; Biology; Immunology","score_opus":0.013475772303179433,"score_gpt":0.20385337261717462,"score_spread":0.1903776003139952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856082554","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02212373,0.0003206291,0.000024111534,0.00003453297,0.0001647382,0.00044640966,0.00021463922,0.00005819451,0.976613],"genre_scores_gemma":[0.04161529,0.00018160963,0.00026190892,0.00012115263,0.00006066648,0.0000013059581,0.00010210368,0.000047610403,0.95760834],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893993,0.000017424165,0.00019397993,0.00041235695,0.00023063438,0.00020567323],"domain_scores_gemma":[0.9986764,0.00004173568,0.00022360851,0.0006848208,0.00018552189,0.0001878835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000042525895,0.0003199352,0.00064396166,0.00017579945,0.00005336113,0.000005736234,0.00017877655,0.0005910189,0.000012165087],"category_scores_gemma":[0.000008708737,0.00032880506,0.0003719592,0.000005344039,0.00032376824,0.00001861561,0.00019291027,0.00018615733,0.000016340964],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029181354,0.0001434584,0.00006051627,0.00019521445,0.0005955553,0.01197588,0.000031847714,1.8559712e-7,0.004797188,0.9713158,0.0037273306,0.0068651843],"study_design_scores_gemma":[0.003499703,0.00030012347,0.00079472625,0.0002401725,0.0013129548,0.00034508956,0.000008658017,0.0000029442876,0.042681348,0.000010676328,0.9505121,0.0002914829],"about_ca_topic_score_codex":0.00008480064,"about_ca_topic_score_gemma":0.000001093956,"teacher_disagreement_score":0.97130513,"about_ca_system_score_codex":0.00017665456,"about_ca_system_score_gemma":0.00021566993,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W1859347718","doi":"10.3324/haematol.2015.126656","title":"Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Kreftforeningen","keywords":"Lymphocytosis; Bone marrow; Monoclonal; Lymphoma; Pathology; Diffuse large B-cell lymphoma; Medicine; Monoclonal antibody; Immunology; Antibody","score_opus":0.018170999321482813,"score_gpt":0.23208852591256693,"score_spread":0.21391752659108412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859347718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8712737,0.006596628,0.000002262872,0.08504054,0.00030288106,0.0026312682,0.0008633464,0.00079794286,0.032491423],"genre_scores_gemma":[0.7463533,0.00057713897,0.0005326536,0.22941925,0.0003441028,0.0011258961,0.013204518,0.00030826664,0.008134864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936526,0.0004879024,0.0011807949,0.0015115133,0.0016185076,0.0015486975],"domain_scores_gemma":[0.995777,0.0008239919,0.0013783828,0.0011301757,0.0003685994,0.00052184484],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00039183247,0.0014407997,0.0031534643,0.00042410963,0.00029529608,0.00012756887,0.0006209856,0.0028919235,0.00030004967],"category_scores_gemma":[0.000108602784,0.0009721526,0.00065082614,0.0006031916,0.00034204702,0.00012352009,0.0003469439,0.0010157054,0.0009187658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006676223,0.019379202,0.045315564,0.0007242029,0.0015603222,0.026357038,0.00032689353,5.166371e-7,0.00002446009,0.00003136342,0.9053036,0.0003092317],"study_design_scores_gemma":[0.20432426,0.008679971,0.103982426,0.004517444,0.011887515,0.007232531,0.0001750152,0.00014811095,0.008776724,0.0008233835,0.6445019,0.004950712],"about_ca_topic_score_codex":0.000111648194,"about_ca_topic_score_gemma":0.000025025429,"teacher_disagreement_score":0.26080167,"about_ca_system_score_codex":0.002317366,"about_ca_system_score_gemma":0.0014957645,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W1866077720","doi":"10.1002/ijc.28049","title":"Hodgkin's lymphoma mortality in the Americas, 1997–2008: Achievements and persistent inadequacies","year":2013,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Latin Americans; Demography; Mortality rate; Medicine; Population; Geography; Environmental health; Political science","score_opus":0.026691307714580607,"score_gpt":0.33685464741699106,"score_spread":0.31016333970241045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1866077720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836988,0.003096612,0.0000061965775,0.012176564,0.00030298776,0.00012548684,0.000010371309,0.0000021012486,0.00058091845],"genre_scores_gemma":[0.99544144,0.0018073536,0.0000936446,0.0023433035,0.00021898904,0.00003205781,0.0000034690183,0.0000046094915,0.000055141387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998995,0.000032201446,0.000266565,0.00008021956,0.0005266845,0.00009932598],"domain_scores_gemma":[0.9994308,0.00005258625,0.00017907706,0.00007320669,0.0002051534,0.000059176327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013005217,0.00008253898,0.00015888366,0.00008852828,0.000022289829,0.000053314856,0.00013800625,0.00002285031,0.00019216647],"category_scores_gemma":[0.000026816899,0.000047271726,0.000106703745,0.000058267247,0.00006158638,0.00014130776,0.000026877611,0.000056605957,0.0000063401535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008921223,0.00045291413,0.89567727,0.0000071540335,0.0007785995,0.00019131711,0.00078244956,0.0000129868795,0.0001247398,0.00011880967,0.0032696659,0.09849488],"study_design_scores_gemma":[0.0025211568,0.00020344391,0.981584,0.000121894016,0.00011301834,0.0002423691,0.0006248809,0.0000508148,0.00019183925,0.00013752763,0.014162034,0.000047008045],"about_ca_topic_score_codex":0.001517321,"about_ca_topic_score_gemma":0.000084626474,"teacher_disagreement_score":0.098447874,"about_ca_system_score_codex":0.00029838432,"about_ca_system_score_gemma":0.00009433839,"threshold_uncertainty_score":0.22937456},"labels":[],"label_agreement":null},{"id":"W187322289","doi":"","title":"Upper gastrointestinal and intra-abdominal hemorrhage secondary to diffuse large B-cell gastric lymphoma.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lymphoma; Gastric lymphoma; Spleen; Stomach; Pathology; Internal medicine; Radiology; Gastroenterology","score_opus":0.012616069066710995,"score_gpt":0.2057709393251913,"score_spread":0.1931548702584803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W187322289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904104,0.0006548824,0.00013223999,0.00086627394,0.0000817376,0.0009612306,0.0000458174,0.000073691364,0.006773716],"genre_scores_gemma":[0.9904103,0.000066512424,0.0038846054,0.0018855705,0.00018972311,0.0009497301,0.000025524854,0.000032607215,0.0025553978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829257,0.000031592663,0.0002644536,0.00043101705,0.00025918236,0.00072117004],"domain_scores_gemma":[0.9987914,0.00007057923,0.000059659214,0.00030109624,0.000055219978,0.00072203355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013811684,0.00026025137,0.0003883517,0.00017433753,0.00014452288,0.000027606418,0.000078238016,0.000047399124,0.000101230544],"category_scores_gemma":[0.0000985332,0.00021138591,0.00010914526,0.00021014376,0.00006640886,0.000085772874,0.00009615123,0.000086002925,0.000094923445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073612964,0.007117193,0.7555036,0.000148103,0.00006542101,0.005620181,0.00029338172,3.6877702e-7,0.0001498316,0.000076860306,0.012796257,0.21749267],"study_design_scores_gemma":[0.016786015,0.00028641117,0.96641946,0.000027762679,0.000113014,0.009617106,0.00006101114,0.00004653486,0.0017162263,0.000007312487,0.004740888,0.00017824488],"about_ca_topic_score_codex":0.00004091317,"about_ca_topic_score_gemma":0.00000617108,"teacher_disagreement_score":0.21731442,"about_ca_system_score_codex":0.00021981625,"about_ca_system_score_gemma":0.000104137005,"threshold_uncertainty_score":0.8620067},"labels":[],"label_agreement":null},{"id":"W1874071964","doi":"10.1111/bjh.13634","title":"Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network; American Cancer Society","keywords":"Medicine; Internal medicine; Univariate; International Prognostic Index; Oncology; Multivariate analysis; Univariate analysis; Framingham Risk Score; Risk stratification; Stage (stratigraphy); Proportional hazards model; Prognostic model; Prognostic variable; Multivariate statistics; Overall survival; Lymphoma; Disease; Rituximab; Machine learning","score_opus":0.07048132621520345,"score_gpt":0.32302799265549303,"score_spread":0.25254666644028956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874071964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976207,0.0056914003,0.00007431842,0.002638046,0.00030756296,0.0013480557,0.000020617454,0.000004510771,0.00015344494],"genre_scores_gemma":[0.99863416,0.00009913108,0.0006290041,0.00033491306,0.00009413786,0.00017075255,0.000012570304,0.000015038,0.000010319836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797773,0.00025190588,0.0005954482,0.00017380647,0.0007998942,0.00020119917],"domain_scores_gemma":[0.9977689,0.00044940115,0.00045867715,0.00014806703,0.0010919016,0.00008306241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015289973,0.00012833686,0.0004541232,0.00010579824,0.0000539618,0.000039335413,0.00022279579,0.000084262174,0.000011778097],"category_scores_gemma":[0.0031331072,0.000084467225,0.00012791657,0.00012601276,0.00013819465,0.0001269523,0.000054237513,0.000111481226,8.997989e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007151871,0.0019376527,0.6493475,0.0001715369,0.00048237765,0.0027742607,0.0028485502,0.00021956392,0.00014162337,0.00060247234,0.0033629378,0.33739638],"study_design_scores_gemma":[0.02465597,0.0011764318,0.81284803,0.0021743993,0.0012199332,0.13374725,0.0008691691,0.0044475202,0.0006307697,0.017767092,0.0003078967,0.0001555302],"about_ca_topic_score_codex":0.000037736518,"about_ca_topic_score_gemma":0.00024301503,"teacher_disagreement_score":0.33724084,"about_ca_system_score_codex":0.00020717138,"about_ca_system_score_gemma":0.0009526302,"threshold_uncertainty_score":0.37508485},"labels":[],"label_agreement":null},{"id":"W1875651711","doi":"10.5489/cuaj.1191","title":"Mantle cell lymphoma of the prostate","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Geology; Prostate; Lymphoma; Cancer research; Medicine; Geochemistry; Internal medicine; Cancer","score_opus":0.006029864745402953,"score_gpt":0.1881222558911157,"score_spread":0.18209239114571274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875651711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96355474,0.00015979249,7.80582e-7,0.027355857,0.00016825595,0.00022139982,0.000011824801,0.0000054078746,0.008521968],"genre_scores_gemma":[0.99451965,0.000043143067,0.000058662994,0.0033747698,0.00009284745,0.000013250244,0.0000028316445,0.0000048111647,0.0018900456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999176,0.000065967266,0.00020344937,0.00007974104,0.00022085858,0.0002539579],"domain_scores_gemma":[0.99913824,0.00005927629,0.00019275698,0.000091588015,0.00018825023,0.0003298923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015183119,0.00007083449,0.00014548929,0.000045431858,0.00013273547,0.00003496635,0.00007684086,0.00009699957,0.0007950665],"category_scores_gemma":[0.000148584,0.000038589296,0.00012544838,0.0001100181,0.000022063907,0.00004484881,0.000011038778,0.00009368456,0.000144815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053227864,0.000120890305,0.96594703,0.0000026500106,0.00004171934,0.000016672855,0.00006094385,0.0000030384244,0.000115175346,0.000077972414,0.029012157,0.0045964103],"study_design_scores_gemma":[0.0013446126,0.0001338146,0.9659988,0.000007506271,0.00004564909,0.000073012976,0.000035146633,0.000026158423,0.00055400986,0.00047990782,0.03126127,0.00004008555],"about_ca_topic_score_codex":0.0024976963,"about_ca_topic_score_gemma":0.00019502989,"teacher_disagreement_score":0.030964926,"about_ca_system_score_codex":0.00077748974,"about_ca_system_score_gemma":0.0003982443,"threshold_uncertainty_score":0.87054205},"labels":[],"label_agreement":null},{"id":"W1875763950","doi":"10.1111/j.1600-0609.2005.00458.x","title":"Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Disease; Medicine; Quality of life (healthcare); Foundation (evidence); Developing country; Gerontology; Intensive care medicine; Pediatrics; Environmental health; Family medicine; Pathology; Economic growth; Political science; Nursing","score_opus":0.042623741761769154,"score_gpt":0.32552792253056484,"score_spread":0.2829041807687957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875763950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953599,0.0016289847,0.00028317588,0.0017215819,0.00029605484,0.00017140787,0.000012563145,0.000005097664,0.00052124565],"genre_scores_gemma":[0.9989704,0.000244623,0.0003486907,0.00014922142,0.00019148838,0.0000012280067,0.00003490931,0.000016500204,0.000042959597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972857,0.00067413674,0.0013386008,0.00021160241,0.00035409688,0.00013586311],"domain_scores_gemma":[0.99745095,0.00042563915,0.0013776654,0.0003193442,0.0002870815,0.00013934233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016870641,0.00014376789,0.0005807424,0.00012917937,0.00003682858,0.000015597552,0.00015016164,0.000033838583,0.000054671116],"category_scores_gemma":[0.0021318947,0.000099357574,0.00012114172,0.00012607411,0.00013131744,0.000103534294,0.00006811722,0.00016469174,0.0000043718946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012150664,0.0006052405,0.9791163,0.00006895246,0.00034125408,0.0030249024,0.000521655,0.000081935934,0.00029489194,0.000063343294,0.00024096761,0.014425468],"study_design_scores_gemma":[0.0022952273,0.000111963556,0.99518055,0.0004851464,0.00016078452,0.0006444367,0.00009818983,0.000046269703,0.00067356543,0.00001965969,0.00021002813,0.00007420495],"about_ca_topic_score_codex":0.00025588955,"about_ca_topic_score_gemma":0.00018496852,"teacher_disagreement_score":0.0160642,"about_ca_system_score_codex":0.00012790949,"about_ca_system_score_gemma":0.0002450871,"threshold_uncertainty_score":0.4051684},"labels":[],"label_agreement":null},{"id":"W1875927722","doi":"10.1158/1078-0432.ccr-15-1848","title":"Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American College of Radiology Imaging Network","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Genotyping; Oncology; Single-nucleotide polymorphism; Lymphoma; Genotype; SNP; Randomized controlled trial; Biology; Gene","score_opus":0.22202483359602618,"score_gpt":0.49515386741850004,"score_spread":0.2731290338224739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875927722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96624476,0.0037909104,0.0000024983742,0.027659763,0.000318089,0.0011470322,0.0000743875,0.00004015707,0.00072241377],"genre_scores_gemma":[0.9938456,0.0012777736,0.00034783717,0.0013864577,0.00063328486,0.00071836496,0.000014844656,0.000041988427,0.001733853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995293,0.0012080794,0.0006967913,0.0008251966,0.0012329166,0.0007440141],"domain_scores_gemma":[0.9955109,0.0019305968,0.000056680834,0.00069873524,0.0004054049,0.001397732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077193696,0.0002125653,0.00068665895,0.00033724678,0.00008947983,0.00007541241,0.0002229211,0.00026542935,0.00032150396],"category_scores_gemma":[0.005095774,0.00016384169,0.00014294739,0.00070223596,0.00036509408,0.000083702354,0.0003289828,0.0003390817,0.00052545534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066094935,0.00525642,0.57351446,0.00006390418,0.00020820803,0.0014474264,0.00077172247,0.000002644191,0.00057311496,0.00017191753,0.09818973,0.2537055],"study_design_scores_gemma":[0.041213144,0.0063363924,0.69641334,0.00058750296,0.000060988325,0.000037035938,0.00027220958,0.0000813965,0.0030705654,0.00015031216,0.2515069,0.000270239],"about_ca_topic_score_codex":0.0015567996,"about_ca_topic_score_gemma":0.00023820497,"teacher_disagreement_score":0.25343525,"about_ca_system_score_codex":0.0010727581,"about_ca_system_score_gemma":0.0016533977,"threshold_uncertainty_score":0.67538404},"labels":[],"label_agreement":null},{"id":"W1895050506","doi":"10.1111/bjh.13586","title":"Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.07000858373368732,"score_gpt":0.3261071172833843,"score_spread":0.256098533549697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895050506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741087,0.020941773,0.00010227575,0.0027827756,0.00044516014,0.0005557006,0.00008913092,0.000007875578,0.000966624],"genre_scores_gemma":[0.9893536,0.008920044,0.0007598271,0.000573933,0.0001821354,0.000039762377,0.00009230264,0.00002576663,0.000052620697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970034,0.00032528737,0.0015688014,0.00026959577,0.0006204614,0.00021246295],"domain_scores_gemma":[0.9965002,0.0003537016,0.0016118127,0.0003469092,0.001069827,0.00011758356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088276,0.0001956902,0.0010028877,0.00020793454,0.000033006476,0.000028666203,0.0004058154,0.00013384645,0.00004838211],"category_scores_gemma":[0.001321326,0.00015651561,0.00022374163,0.0003583422,0.00019330965,0.00016670252,0.00007742051,0.0001117363,0.000021984917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014431166,0.004415741,0.64823866,0.0015690572,0.0009862437,0.019802848,0.002719189,0.000004972232,0.0018017899,0.00038919016,0.038948387,0.2796808],"study_design_scores_gemma":[0.010961354,0.0007821608,0.8966789,0.016626025,0.0005500511,0.061827965,0.0015388,0.000572828,0.0019626117,0.00008227919,0.008208598,0.00020839254],"about_ca_topic_score_codex":0.0011033933,"about_ca_topic_score_gemma":0.00020814386,"teacher_disagreement_score":0.2794724,"about_ca_system_score_codex":0.00029479392,"about_ca_system_score_gemma":0.0012226325,"threshold_uncertainty_score":0.63825214},"labels":[],"label_agreement":null},{"id":"W1901626940","doi":"10.1111/j.1542-4758.2011.00612.x","title":"Renal involvement of mantle cell lymphoma leading to end stage renal disease","year":2011,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; End stage renal disease; Renal biopsy; Hemodialysis; Mantle cell lymphoma; Chemotherapy; Lymphoma; Tumor lysis syndrome; Gastroenterology; Creatinine; Surgery; Internal medicine; Kidney","score_opus":0.03381912585763598,"score_gpt":0.27207973159441623,"score_spread":0.23826060573678026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1901626940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972068,0.00009283579,0.00062531844,0.0003568813,0.0002510729,0.00025432132,0.00014352745,0.000027892396,0.026180135],"genre_scores_gemma":[0.9906974,0.000037148773,0.0033502888,0.0005120692,0.00016205035,0.000080930826,0.000181787,0.00001710778,0.00496125],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985179,0.00002431363,0.00037218304,0.00032396617,0.0005682174,0.0001934237],"domain_scores_gemma":[0.9990718,0.00004007474,0.00013556918,0.0003052803,0.00015806884,0.0002892419],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001357155,0.00016241186,0.00027462127,0.00027419865,0.000039916824,0.000015786367,0.00016387102,0.000038622504,0.003207734],"category_scores_gemma":[0.000043125823,0.000139461,0.00023745491,0.00014173085,0.000043041353,0.00007862331,0.00010395276,0.000030893723,0.00020742163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036368018,0.013682038,0.8579934,0.00019953371,0.0026363744,0.001240279,0.004660004,0.00021019277,0.0409281,0.009998381,0.015917828,0.048897047],"study_design_scores_gemma":[0.0085027935,0.00046145997,0.45862672,0.00025099108,0.0007702751,0.000012246893,0.00020481403,0.00087403273,0.49481913,0.00030450372,0.03479428,0.00037875804],"about_ca_topic_score_codex":0.0002150363,"about_ca_topic_score_gemma":0.000031138177,"teacher_disagreement_score":0.45389104,"about_ca_system_score_codex":0.00033062673,"about_ca_system_score_gemma":0.00013224306,"threshold_uncertainty_score":0.9977035},"labels":[],"label_agreement":null},{"id":"W190208491","doi":"10.1182/blood.v122.21.1788.1788","title":"Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Rituximab; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Total body irradiation; Oncology; Chemotherapy regimen; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.006118569060031915,"score_gpt":0.19070869772260665,"score_spread":0.18459012866257474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W190208491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973846,0.00017117891,0.0000033998824,0.000027354537,0.000013965286,0.0013938706,0.000106573614,0.00004064931,0.000858379],"genre_scores_gemma":[0.99842614,0.000038099013,0.00014997955,0.000049952756,0.0000053642116,0.00026194708,0.0002989628,0.00003512661,0.00073445454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871176,0.000026152382,0.00037888496,0.00029518423,0.0003371808,0.00025083928],"domain_scores_gemma":[0.99936235,0.000038374346,0.00013840455,0.00022031723,0.00011268138,0.00012785994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035016554,0.00015942138,0.00047523994,0.000045249813,0.000038833015,0.00006042844,0.00006172762,0.0000851524,0.00015827145],"category_scores_gemma":[9.919629e-7,0.00015660586,0.00005876696,0.00022345736,0.00004455832,0.00010668797,0.000007298739,0.000043574317,0.000017702812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022089218,0.0055455803,0.9925429,0.00026230665,0.00014417457,0.00016035348,0.0002090853,7.029202e-7,0.00013640565,0.0000012099713,0.00029914582,0.00047723606],"study_design_scores_gemma":[0.06806275,0.0012339067,0.92162514,0.0003394441,0.0006506609,0.00005189392,0.000119179655,0.0000023239854,0.007719415,0.0000016003233,0.000020784497,0.00017287808],"about_ca_topic_score_codex":0.020979337,"about_ca_topic_score_gemma":0.008720138,"teacher_disagreement_score":0.07091774,"about_ca_system_score_codex":0.00007888381,"about_ca_system_score_gemma":0.000054007014,"threshold_uncertainty_score":0.98554003},"labels":[],"label_agreement":null},{"id":"W1912345398","doi":"10.5489/cuaj.1153","title":"Malignant lymphoma of the testis: a study of 12 cases","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; International Prognostic Index; Stage (stratigraphy); Surgery; Lymphoma; Orchiectomy; Retrospective cohort study; Proportional hazards model; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.017926795870709163,"score_gpt":0.22696911088215568,"score_spread":0.20904231501144652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912345398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932687,0.0001357061,3.3147825e-7,0.00535943,0.0001164979,0.00036173014,0.0000139293625,0.000004135745,0.0007394901],"genre_scores_gemma":[0.99883115,0.000015457694,0.000026006799,0.00085013337,0.00007007398,0.00002091698,0.0000012211153,0.0000045706743,0.00018048157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891657,0.00013060428,0.00033478928,0.00009250896,0.00030711864,0.00021839081],"domain_scores_gemma":[0.9987821,0.00020876767,0.00033439358,0.00012264911,0.00026623334,0.00028588687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020364372,0.00008295154,0.0002467738,0.00007125908,0.00011097466,0.000019228772,0.0000931411,0.00008508254,0.00042376493],"category_scores_gemma":[0.00078337017,0.0000445365,0.00011275452,0.00013678145,0.000025826732,0.000039213006,0.000015077324,0.000076727636,0.0000149410735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009398714,0.00057864503,0.99123585,0.0000023103846,0.00014581146,0.000079394325,0.00017697552,0.00000594172,0.000051644784,0.000038904407,0.004097935,0.0035771802],"study_design_scores_gemma":[0.001800828,0.0010813827,0.99487495,0.000018716695,0.0001428734,0.00030374626,0.0003642874,0.000016102225,0.00009566187,0.00013404441,0.0011261506,0.000041244537],"about_ca_topic_score_codex":0.018265272,"about_ca_topic_score_gemma":0.002884531,"teacher_disagreement_score":0.015380742,"about_ca_system_score_codex":0.00061855355,"about_ca_system_score_gemma":0.00041160575,"threshold_uncertainty_score":0.9882722},"labels":[],"label_agreement":null},{"id":"W191538678","doi":"","title":"Oncodiagnosis panel: 2004 lymphoma","year":2006,"lang":"en","type":"article","venue":"Radiographics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Medical physics; Internal medicine","score_opus":0.017998244394056204,"score_gpt":0.24433411037505762,"score_spread":0.22633586598100142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W191538678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720064,0.00556774,0.000046254827,0.0021351918,0.00026800402,0.0004191684,0.00003083664,0.00026605662,0.019260397],"genre_scores_gemma":[0.9958469,0.0013029724,0.0009784268,0.0007822016,0.0003813025,0.000105264655,0.000104864215,0.000034664514,0.00046338263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998626,0.00002550515,0.00027390482,0.00032395488,0.0003889792,0.00036166917],"domain_scores_gemma":[0.9991416,0.000107687796,0.000070044574,0.00041914065,0.000088703615,0.00017286606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101206744,0.00022147343,0.00033723266,0.0003111774,0.000114877475,0.0000355491,0.00008019448,0.00016406094,0.00008404067],"category_scores_gemma":[0.000019166106,0.00018224353,0.0003638312,0.00073893374,0.00011001634,0.00006240932,0.000018553494,0.00006144842,0.000089927766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037792655,0.0018012038,0.9219614,0.000033832115,0.00018186156,0.00037157058,0.00003191182,0.00000965281,0.00008518171,0.005658563,0.0553577,0.014469303],"study_design_scores_gemma":[0.0039052938,0.0002834832,0.8535597,0.00007276766,0.00033007236,0.00024909907,0.000021892212,0.000048683592,0.002215741,0.00048001466,0.13863085,0.00020243418],"about_ca_topic_score_codex":0.0011239871,"about_ca_topic_score_gemma":0.00008539443,"teacher_disagreement_score":0.08327315,"about_ca_system_score_codex":0.00016072067,"about_ca_system_score_gemma":0.00010375465,"threshold_uncertainty_score":0.7431676},"labels":[],"label_agreement":null},{"id":"W1918773895","doi":"","title":"Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Nuclear medicine; Predictive value; Biopsy; Positron emission tomography; Radiology; Internal medicine","score_opus":0.06420501774522011,"score_gpt":0.3096128782041539,"score_spread":0.24540786045893379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918773895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920215,0.0014810205,0.000027827648,0.00032773928,0.00011300659,0.005369105,0.00003542059,0.000013191353,0.0006112051],"genre_scores_gemma":[0.99058235,0.00002682354,0.0015632462,0.00009493373,0.00002717667,0.007565323,0.000053850927,0.000016897524,0.00006943014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885756,0.000076293574,0.00025054745,0.00023530734,0.00029423824,0.00028605948],"domain_scores_gemma":[0.9992559,0.00013443468,0.00008356046,0.000218148,0.0001232049,0.00018474563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039425708,0.00013064069,0.00024736093,0.0001097141,0.00003168343,0.000009553883,0.000030246054,0.000018962455,0.000023481054],"category_scores_gemma":[0.00078806386,0.00010297423,0.00010985378,0.00015013754,0.000027459546,0.000045567172,0.000009259689,0.000021279962,0.0000022252996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002878187,0.002860694,0.9644458,0.00014459132,0.00020656969,0.00012457135,0.00008549083,0.00030524813,0.00001648184,0.00238027,0.000089265,0.029053178],"study_design_scores_gemma":[0.0068170186,0.00011271755,0.9880985,0.00006738373,0.0009589675,0.000026438283,0.00003994015,0.0016888542,0.0011606656,0.00063885516,0.00029879235,0.00009188896],"about_ca_topic_score_codex":0.000057750683,"about_ca_topic_score_gemma":0.000007745339,"teacher_disagreement_score":0.028961288,"about_ca_system_score_codex":0.00050842384,"about_ca_system_score_gemma":0.00026874975,"threshold_uncertainty_score":0.41991672},"labels":[],"label_agreement":null},{"id":"W1931677646","doi":"","title":"The Prevalence and Importance of Variant Patterns in Nodular Lymphocyte Predominant Hodgkin Lymphoma lymphocyte predominant Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pathological; Lymphoma; Pathology; Hodgkin lymphoma; Medicine; Clinical significance; Lymphocyte; Internal medicine","score_opus":0.01664888296048354,"score_gpt":0.30230900743508776,"score_spread":0.2856601244746042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1931677646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817735,0.014385014,0.00012124607,0.0019654934,0.000491231,0.00055301137,0.000028724828,0.000010089664,0.00067166594],"genre_scores_gemma":[0.9844122,0.013496529,0.0009026327,0.00042032226,0.00041398464,0.000035978832,0.000003343021,0.00004025506,0.00027477476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953003,0.0004401217,0.0020945389,0.00042085806,0.0007760414,0.00096813],"domain_scores_gemma":[0.9955856,0.0014035088,0.0013584708,0.00061689573,0.00035735936,0.00067812187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024681166,0.00045021207,0.001633639,0.0003323687,0.00013123035,0.000038825317,0.00038793008,0.00036578896,0.00016289603],"category_scores_gemma":[0.00077488815,0.0002732173,0.0004565387,0.00040405802,0.00051905133,0.00027633534,0.0002120513,0.00016710408,0.000016327635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059517818,0.005596405,0.86466056,0.00042478472,0.0009856578,0.0042005074,0.000849624,0.000015221336,0.0005633605,0.0023766777,0.00070018164,0.113675244],"study_design_scores_gemma":[0.024419477,0.0043471158,0.93362534,0.00076188694,0.0016221332,0.011320039,0.0003314082,0.0019382046,0.003565676,0.00019449806,0.017547602,0.00032664067],"about_ca_topic_score_codex":0.00017133703,"about_ca_topic_score_gemma":0.00009368847,"teacher_disagreement_score":0.1133486,"about_ca_system_score_codex":0.0026019253,"about_ca_system_score_gemma":0.0016876117,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W1933195564","doi":"10.3109/10428194.2015.1055480","title":"Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy; Lymphoma; Gastroenterology; Multivariate analysis; CHOP; Oncology; Surgery","score_opus":0.011959820987386145,"score_gpt":0.2533390327014776,"score_spread":0.24137921171409146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933195564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457437,0.0004112164,0.000033489032,0.00006506647,0.00013351881,0.0012520974,0.0013546394,0.00006682272,0.002108796],"genre_scores_gemma":[0.9977141,0.0002919763,0.00048956583,0.0003220787,0.000103523256,0.00016885855,0.0006772147,0.000119671175,0.00011300106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958722,0.00019485883,0.0011427696,0.00087638554,0.0012320001,0.0006817822],"domain_scores_gemma":[0.99591196,0.0006394146,0.0009062752,0.00096026616,0.00081289565,0.0007691792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026652013,0.00081916654,0.0017982599,0.00045287868,0.000092709575,0.000033449556,0.00029300697,0.00038373683,0.00010430819],"category_scores_gemma":[0.00017849971,0.0006062622,0.00043638304,0.00076312956,0.00024952734,0.00028783982,0.00013714333,0.000056813526,0.000048331265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011640224,0.017319655,0.913803,0.00015567969,0.0012341196,0.00007166056,0.0041758916,0.000062637664,0.0011696244,0.00014725492,0.0016675777,0.048552673],"study_design_scores_gemma":[0.11643529,0.005742162,0.83280325,0.000533544,0.00044726834,0.000009999255,0.00026632496,0.0003509747,0.042187564,0.00007120832,0.00063565397,0.00051678595],"about_ca_topic_score_codex":0.0035404474,"about_ca_topic_score_gemma":0.0000565617,"teacher_disagreement_score":0.10479507,"about_ca_system_score_codex":0.005627714,"about_ca_system_score_gemma":0.003086279,"threshold_uncertainty_score":0.99963886},"labels":[],"label_agreement":null},{"id":"W1950572657","doi":"10.1002/ijc.29637","title":"Soluble levels of <scp>CD</scp>27 and <scp>CD</scp>30 are associated with risk of non‐<scp>H</scp>odgkin lymphoma in three <scp>C</scp>hinese prospective cohorts","year":2015,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"Quartile; Lymphoma; Prospective cohort study; Immunology; Internal medicine; Medicine; Odds ratio; Confidence interval","score_opus":0.019271698708943016,"score_gpt":0.2875748932292921,"score_spread":0.26830319452034906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950572657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864448,0.006917282,0.00011534029,0.00023219637,0.0012496226,0.0008369395,0.0005067524,0.000033351927,0.0036637725],"genre_scores_gemma":[0.99528134,0.0015422934,0.00038682777,0.00023559608,0.0006283079,0.00011415492,0.000033846587,0.000100362966,0.001677294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942733,0.00017797462,0.0016168071,0.0006441645,0.0025844194,0.00070331496],"domain_scores_gemma":[0.9896053,0.002262434,0.0032761223,0.00040420308,0.003864923,0.0005869841],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011563946,0.0006709505,0.0016842817,0.0007886406,0.000089342495,0.000119718236,0.00057784904,0.0003632764,0.00003341368],"category_scores_gemma":[0.004953138,0.00051208533,0.00041540366,0.00064102357,0.00035140474,0.0006258977,0.0002223159,0.0004757859,0.000015150564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098930184,0.0021216709,0.96869475,0.0000752192,0.004968926,0.001030038,0.0035711734,0.00081489095,0.0006999305,0.00011108411,0.01561795,0.0021954111],"study_design_scores_gemma":[0.019776935,0.0013304747,0.95537174,0.0021699397,0.0010364589,0.00028081817,0.001956384,0.0004485617,0.012747893,0.0015581851,0.0032555866,0.00006703009],"about_ca_topic_score_codex":0.0017584793,"about_ca_topic_score_gemma":0.0032797644,"teacher_disagreement_score":0.019678004,"about_ca_system_score_codex":0.002332513,"about_ca_system_score_gemma":0.0017093719,"threshold_uncertainty_score":0.9997331},"labels":[],"label_agreement":null},{"id":"W1952004741","doi":"10.5858/2001-125-0332-plgbcl","title":"Primary Low-Grade B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type Arising in the Urinary Bladder","year":2001,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Immunophenotyping; Pathology; Urinary bladder; Immunohistochemistry; Medicine; Immunoglobulin heavy chain; Immunoglobulin light chain; MALT lymphoma; Context (archaeology); Antibody; Biology; Internal medicine; Immunology; Antigen","score_opus":0.01325325441962185,"score_gpt":0.2703122377388107,"score_spread":0.25705898331918886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952004741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811848,0.008051071,0.000010937359,0.0017314361,0.00019286171,0.00047016607,0.000029654493,0.000030136736,0.008298981],"genre_scores_gemma":[0.9952115,0.0021381637,0.0003822624,0.0018194207,0.00012434843,0.000029101879,0.00013974289,0.000030078721,0.00012542715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977072,0.00045543167,0.0006983911,0.0003778182,0.00037361364,0.00038756483],"domain_scores_gemma":[0.997974,0.00083284196,0.00035600024,0.00060668716,0.00011303438,0.00011748673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050873373,0.0002821099,0.00085958774,0.00033640707,0.000061592946,0.0000025475103,0.00024637417,0.00014923252,0.00006801321],"category_scores_gemma":[0.00028843703,0.00018549738,0.000083420215,0.00074374327,0.00085927994,0.000055078082,0.000072120114,0.00014231027,0.000010553685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525017,0.013124918,0.6889994,0.0003607104,0.00031843662,0.012800549,0.0114826355,0.0000071315912,0.2551973,0.00039412203,0.0019428451,0.014219448],"study_design_scores_gemma":[0.014503422,0.0034175063,0.9580658,0.00058138417,0.00041047175,0.0008086405,0.0012427276,0.000020630416,0.017984344,0.00029768585,0.0024915189,0.00017585618],"about_ca_topic_score_codex":0.00012091371,"about_ca_topic_score_gemma":0.000024951216,"teacher_disagreement_score":0.2690664,"about_ca_system_score_codex":0.00010363607,"about_ca_system_score_gemma":0.00043603167,"threshold_uncertainty_score":0.7564364},"labels":[],"label_agreement":null},{"id":"W1955256573","doi":"10.1038/leu.2015.237","title":"Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Oncology; Medicine; Germinal center; Immunophenotyping; International Prognostic Index; Cancer research; B cell; Immunology; Antibody","score_opus":0.03606321623262632,"score_gpt":0.30399122009957463,"score_spread":0.2679280038669483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955256573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373466,0.0011448597,0.0000490791,0.0029511808,0.0002609727,0.00079852215,0.00028927712,0.000040827814,0.00073061936],"genre_scores_gemma":[0.9947897,0.00015969909,0.0018021128,0.0010555615,0.0004065072,0.00031462786,0.001138104,0.000017677068,0.00031597735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843204,0.000070791386,0.00048084033,0.0005237439,0.0002247081,0.0002678542],"domain_scores_gemma":[0.99825966,0.000932005,0.00014523558,0.00037166488,0.0000761645,0.00021528418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030604925,0.00024571543,0.00052870106,0.000030227518,0.00006714651,0.00005090493,0.000115609895,0.00019463553,0.000011861008],"category_scores_gemma":[0.00067462557,0.00012953911,0.00017587705,0.000058559453,0.00015436784,0.000044342432,0.000106727406,0.00008194327,0.000013558269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007429558,0.0065470217,0.9719019,0.000009232985,0.000188283,0.0019062236,0.00016008744,4.25176e-7,0.000049330327,0.00016425886,0.013845855,0.004484427],"study_design_scores_gemma":[0.06210827,0.00054561626,0.8937962,0.000059238922,0.00022430535,0.00036644403,0.00011744231,0.00019308602,0.00014515272,0.00027067453,0.042031456,0.00014211683],"about_ca_topic_score_codex":0.0005665634,"about_ca_topic_score_gemma":0.00046399285,"teacher_disagreement_score":0.0781057,"about_ca_system_score_codex":0.0009477629,"about_ca_system_score_gemma":0.0005311344,"threshold_uncertainty_score":0.52824515},"labels":[],"label_agreement":null},{"id":"W1955391915","doi":"10.1200/jco.2000.18.12.2435","title":"Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and Adolescence","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Thyroid; Population; Confidence interval; Internal medicine; Relative risk; Cancer; Esophagus; Breast cancer; Absolute risk reduction; Pediatrics; Gastroenterology","score_opus":0.0386597129460435,"score_gpt":0.3908485813166965,"score_spread":0.352188868370653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955391915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960138,0.0015818205,9.3869136e-7,0.0011284185,0.00027901575,0.00021427406,0.000008401245,0.0000032453192,0.0007700805],"genre_scores_gemma":[0.99306774,0.0055890344,0.00011297258,0.0008507246,0.00026476427,0.0000061760984,0.0000020716257,0.000009928826,0.00009659819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759144,0.0002453885,0.0015599283,0.00018551748,0.0002268246,0.00019093289],"domain_scores_gemma":[0.99725014,0.0012128826,0.00074002397,0.00015804553,0.00009689059,0.00054202345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008982786,0.00012776183,0.0011672303,0.00009587113,0.000016938722,0.000005129411,0.00009549626,0.00017843359,0.00071541546],"category_scores_gemma":[0.00069505995,0.000090386675,0.00027549636,0.00010487659,0.0002834343,0.00009723153,0.000021252876,0.0003550101,0.000004504942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001418482,0.00267836,0.81931293,0.000041375257,0.00013048702,0.0024776065,0.00010850105,0.00001075888,0.0000022567326,0.0000050205003,0.00019086158,0.17362335],"study_design_scores_gemma":[0.0122421635,0.003476274,0.98278904,0.0004895075,0.00025527875,0.00007311541,0.000025447516,0.000012284698,0.000026002836,0.000039727667,0.00049690716,0.00007423408],"about_ca_topic_score_codex":0.00021794955,"about_ca_topic_score_gemma":0.0023430123,"teacher_disagreement_score":0.17354912,"about_ca_system_score_codex":0.00020232245,"about_ca_system_score_gemma":0.0012654396,"threshold_uncertainty_score":0.7833297},"labels":[],"label_agreement":null},{"id":"W1961840580","doi":"10.1089/jayao.2015.0038","title":"Management of Adolescent Low-Risk Classical Hodgkin Lymphoma: Which Chemotherapy Backbone Gives the Best Chance of Omitting Radiotherapy Safely","year":2015,"lang":"en","type":"review","venue":"Journal of Adolescent and Young Adult Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; ABVD; Radiation therapy; Hodgkin lymphoma; Cure rate; Chemotherapy; Randomized controlled trial; Lymphoma; Clinical trial; Hodgkin's lymphoma; Oncology; Intensive care medicine; Internal medicine; Surgery; Cyclophosphamide","score_opus":0.030822888499560934,"score_gpt":0.3427184378516955,"score_spread":0.31189554935213454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1961840580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017681554,0.9782113,0.00006274082,0.001476972,0.0008538126,0.0013801666,0.000035239227,0.000009654128,0.00028855918],"genre_scores_gemma":[0.022106338,0.9754492,0.0010501882,0.00019826324,0.00091649505,0.000028514305,0.000012136586,0.00007353043,0.00016530548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562144,0.00054824876,0.002167008,0.0004355701,0.00076465704,0.00046306473],"domain_scores_gemma":[0.9941694,0.00021099468,0.0038794305,0.0004907107,0.0008820608,0.0003673998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012073517,0.00065030897,0.003957074,0.00030772263,0.00009730143,0.000024049414,0.00039251897,0.00050757383,0.000019569547],"category_scores_gemma":[0.000074083444,0.00037314877,0.0008929993,0.00041835467,0.0003426029,0.000072681076,0.00010385278,0.0005805075,0.0000047260232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012633806,0.004497149,0.008439056,0.012532685,0.0028368514,0.00031989362,0.00051820645,0.0000013698188,0.00001085773,0.00008778518,0.0018082726,0.9676845],"study_design_scores_gemma":[0.030863712,0.0076380535,0.024933727,0.11383144,0.010629121,0.0034197955,0.0015580915,0.000049258168,0.00014608675,0.000030636947,0.806195,0.0007050302],"about_ca_topic_score_codex":0.000031830918,"about_ca_topic_score_gemma":0.000019554895,"teacher_disagreement_score":0.96697944,"about_ca_system_score_codex":0.0011469689,"about_ca_system_score_gemma":0.0010747515,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W1963543962","doi":"10.1016/j.leukres.2009.02.015","title":"Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature","year":2009,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Survivin; Medicine; Lymphoma; Angiogenesis; Vascular endothelial growth factor; Diffuse large B-cell lymphoma; Internal medicine; Beta-2 microglobulin; Gastroenterology; Proportional hazards model; Pathology; VEGF receptors; Cancer","score_opus":0.032765040611274596,"score_gpt":0.3325268069805384,"score_spread":0.29976176636926377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963543962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22691926,0.7699023,7.404025e-8,0.000029188055,0.000017926044,0.0028476897,0.00020704973,0.000008352249,0.000068150075],"genre_scores_gemma":[0.102893285,0.8964964,0.000027984479,0.000036111232,0.000041528543,0.00018285656,0.0001162001,0.000048659578,0.00015696137],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99645907,0.00062920805,0.00082878256,0.00064409577,0.0008357137,0.000603126],"domain_scores_gemma":[0.9973158,0.0009573668,0.00039514605,0.0008569262,0.00026002576,0.00021473723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074213766,0.0005198102,0.0022324182,0.00043739862,0.00009110186,0.000035677254,0.00028313277,0.00033832222,0.000009924743],"category_scores_gemma":[0.00033649165,0.00027535207,0.00041274377,0.0011068402,0.0003730918,0.00008394091,0.00022559051,0.00029956637,0.0000023535245],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027373212,0.004353364,0.04414583,0.6379754,0.00094551133,0.0021392882,0.0010770371,2.5200538e-7,0.00008622933,0.00023454188,0.0011430598,0.30762574],"study_design_scores_gemma":[0.017155461,0.0020178377,0.08013736,0.76260674,0.0035772016,0.0011217273,0.00014616309,0.0000052244886,0.0021167297,0.000021408317,0.13017043,0.0009237005],"about_ca_topic_score_codex":0.00017143652,"about_ca_topic_score_gemma":0.000053532847,"teacher_disagreement_score":0.30670205,"about_ca_system_score_codex":0.0010268094,"about_ca_system_score_gemma":0.0025003816,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W1963631227","doi":"10.1097/cad.0b013e3282f46aec","title":"A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Hôpital Saint-François d'Assise","funders":"","keywords":"Gemcitabine; Medicine; Regimen; Internal medicine; Vinorelbine; Oxaliplatin; Refractory (planetary science); Gastroenterology; Chemotherapy; Adverse effect; Oncology; Surgery; Cancer; Colorectal cancer","score_opus":0.02533042115458789,"score_gpt":0.29155552318333233,"score_spread":0.26622510202874444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963631227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729484,0.0003247276,3.5551656e-7,0.00012917831,0.0001977317,0.0010775763,0.000013048384,0.000037188733,0.0009253263],"genre_scores_gemma":[0.99804384,0.00051397394,0.0000949457,0.00034566797,0.0000668128,0.00023201779,0.000017873592,0.00003805326,0.00064683927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981671,0.00007910929,0.00053448166,0.00043560105,0.0004372557,0.00034647546],"domain_scores_gemma":[0.9989445,0.00011533011,0.00023968054,0.00043828273,0.00014713364,0.000115039424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011474165,0.00024771036,0.0006285788,0.0002006772,0.00007667195,0.000006715387,0.000112710586,0.000086082626,0.000119799035],"category_scores_gemma":[0.000056292585,0.00018221403,0.00009910416,0.00029806656,0.00006447515,0.00011648862,0.00006978633,0.0000817106,0.000022990458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016843398,0.010304583,0.9632279,0.000047906236,0.0002456059,0.00026608404,0.011456745,0.0000062358895,0.00012266201,0.0000028451036,0.0006332496,0.012001801],"study_design_scores_gemma":[0.043835547,0.0022541801,0.9479571,0.00029946782,0.0001402093,0.000004431767,0.0022540854,0.00006106261,0.0019485259,9.853097e-7,0.0010620032,0.00018240856],"about_ca_topic_score_codex":0.0033937858,"about_ca_topic_score_gemma":0.0002498882,"teacher_disagreement_score":0.04215121,"about_ca_system_score_codex":0.00044653055,"about_ca_system_score_gemma":0.00021780799,"threshold_uncertainty_score":0.74304724},"labels":[],"label_agreement":null},{"id":"W1963879883","doi":"10.1111/j.1365-2141.2008.07353.x","title":"Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Rituximab; Lymphoma; Medicine; Cancer research; Oligonucleotide; Hodgkin lymphoma; Monoclonal; Internal medicine; Oncology; Monoclonal antibody; Immunology; Chemistry; Antibody; Biochemistry; Gene","score_opus":0.010358930872147341,"score_gpt":0.24942293107160227,"score_spread":0.23906400019945492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963879883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820524,0.0005554779,0.0000051497077,0.000101408914,0.00010037116,0.0009362015,0.000010037631,0.000005821339,0.00008028178],"genre_scores_gemma":[0.99903303,0.00029596497,0.0005333322,0.00005759015,0.000011600124,0.000018977473,0.000014607711,0.000024833413,0.000010031599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979574,0.00016614154,0.0008984605,0.00024712668,0.00043341576,0.00029745031],"domain_scores_gemma":[0.998635,0.0000705742,0.00062121433,0.00016572817,0.00037668005,0.00013078933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017122399,0.00020111814,0.0010799665,0.00044480475,0.00006881155,0.00001041216,0.000096665986,0.00007895569,0.000017852159],"category_scores_gemma":[0.000042288426,0.00017066656,0.000074847114,0.0003127015,0.00012865357,0.0001747191,0.000041362367,0.00015797946,0.0000031619284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004694717,0.16179223,0.75163525,0.00007854052,0.00017129394,0.065303564,0.0019374938,0.000005167148,0.000017791745,0.000002354558,0.00018928555,0.014172289],"study_design_scores_gemma":[0.24585794,0.019839173,0.7164579,0.0009800914,0.00017375323,0.015467747,0.00055401167,0.000052717987,0.00045505498,0.0000027109475,0.000027558075,0.00013136091],"about_ca_topic_score_codex":0.0005813617,"about_ca_topic_score_gemma":0.00078258425,"teacher_disagreement_score":0.24116322,"about_ca_system_score_codex":0.0002073098,"about_ca_system_score_gemma":0.00023021136,"threshold_uncertainty_score":0.6959581},"labels":[],"label_agreement":null},{"id":"W1963923599","doi":"10.1038/bmt.2013.72","title":"Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?","year":2013,"lang":"en","type":"review","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Lymphoma; Transplantation; Diffuse large B-cell lymphoma; Oncology; Hematopoietic cell; Hematopoietic stem cell transplantation; Regimen; Refractory (planetary science); Aggressive lymphoma; Surgery; Haematopoiesis; Stem cell","score_opus":0.023275655417855194,"score_gpt":0.26687831897776865,"score_spread":0.24360266355991345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963923599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004868707,0.9860317,0.0014484111,0.00021732326,0.00019358899,0.005077519,0.0014972818,0.000113439564,0.0005519994],"genre_scores_gemma":[0.00692016,0.9792902,0.001717421,0.00012274292,0.00014289193,0.002193048,0.007427915,0.00014729115,0.0020383361],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740994,0.000140541,0.00067630893,0.00083053374,0.00037861313,0.0005640624],"domain_scores_gemma":[0.9984726,0.00035084048,0.0004039831,0.00038522203,0.00009706741,0.00029029086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002071333,0.0007968063,0.0018926804,0.0003049322,0.00018071721,0.00012562139,0.00011288843,0.0005506812,0.000048991857],"category_scores_gemma":[0.0000059379236,0.00063553674,0.00062942755,0.00014317292,0.00005166803,0.00019187685,0.000010035386,0.00011777175,0.000062126914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000466433,0.0058788634,0.00049176835,0.38494268,0.0006520395,0.000834611,0.0026113892,3.3488516e-7,0.00022914364,0.00038861574,0.0042085536,0.59929556],"study_design_scores_gemma":[0.06032965,0.0011580265,0.0013083795,0.021623282,0.036269605,0.0028596844,0.00015523912,0.000040158964,0.0024450112,0.00016703928,0.8716528,0.001991148],"about_ca_topic_score_codex":0.000044328695,"about_ca_topic_score_gemma":0.000038572547,"teacher_disagreement_score":0.8674442,"about_ca_system_score_codex":0.0002012078,"about_ca_system_score_gemma":0.00023976403,"threshold_uncertainty_score":0.9996096},"labels":[],"label_agreement":null},{"id":"W1964225651","doi":"10.1182/blood-2010-08-304048","title":"Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Chromosomal translocation; Follicular lymphoma; Peripheral blood; Follicular phase; Lymphoma; Immunology; Medicine; Biology; Pathology; Internal medicine; Genetics; Gene","score_opus":0.028706695071479292,"score_gpt":0.2685993858829945,"score_spread":0.23989269081151518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964225651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86734056,0.0009932127,0.00003343602,0.12856974,0.0003178981,0.0018761733,0.00019748705,0.000116722826,0.00055478717],"genre_scores_gemma":[0.8442836,0.00012827372,0.003152093,0.1478476,0.0019094895,0.00124292,0.00084214215,0.00017326143,0.00042063964],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734277,0.00006240739,0.0007285724,0.00067530206,0.00070973596,0.0004812442],"domain_scores_gemma":[0.9981439,0.00020783891,0.0003131078,0.0008592477,0.00030143154,0.0001744812],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00016409245,0.0004939749,0.0009978736,0.00029272464,0.00008686895,0.000033440534,0.00019751544,0.0014118125,0.00033487863],"category_scores_gemma":[0.00019253253,0.00042878924,0.0004454403,0.0003753653,0.00004686882,0.00005305642,0.00003799037,0.0005014809,0.00009140352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016861716,0.014077888,0.19614567,0.0041930247,0.008767561,0.00885056,0.002972482,0.000011454437,0.050674725,0.000060935614,0.4604223,0.25365478],"study_design_scores_gemma":[0.019484295,0.00089216145,0.16476668,0.0025838304,0.005368224,0.00047606538,0.000019404579,0.000012160882,0.41026825,0.000050904473,0.39513505,0.000943001],"about_ca_topic_score_codex":0.0003720126,"about_ca_topic_score_gemma":0.00002294229,"teacher_disagreement_score":0.3595935,"about_ca_system_score_codex":0.00020760624,"about_ca_system_score_gemma":0.00051490415,"threshold_uncertainty_score":0.99988455},"labels":[],"label_agreement":null},{"id":"W1964390441","doi":"10.1016/j.bbmt.2007.12.095","title":"86: Long-Term Follow-Up of Autologous Stem Cell Transplant (ASCT) in Patients with Mantle Cell Lymphoma (MCL)","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Melphalan; Internal medicine; Rituximab; CHOP; Surgery; Chemotherapy regimen; Autologous stem-cell transplantation; Median follow-up; Salvage therapy; Oncology; Regimen; Progressive disease; Chemotherapy; Lymphoma","score_opus":0.008150151015690277,"score_gpt":0.20149001497931918,"score_spread":0.1933398639636289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964390441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979053,0.0010671883,0.000031917327,0.000022336111,0.00006766405,0.0004231002,0.00017673109,0.00001571328,0.00029002063],"genre_scores_gemma":[0.9969947,0.002279541,0.00014348375,0.000026385836,0.000007251878,0.000023025681,0.00045648115,0.000012271356,0.00005688445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990424,0.000050553375,0.00034128618,0.00025737018,0.00011583312,0.00019256667],"domain_scores_gemma":[0.99956864,0.000065317145,0.00013728821,0.00012416652,0.000046741283,0.000057845275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051672137,0.00017676133,0.00043356273,0.00013278938,0.00003747336,0.0000015007055,0.00004771414,0.0001487842,0.000011219086],"category_scores_gemma":[5.5387005e-7,0.00013027547,0.00006705596,0.000086170294,0.00014046523,0.00004494882,0.0000036091044,0.000037412738,0.0000015903253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021033285,0.0021001499,0.97516435,0.0006837,0.00011707451,0.00016808145,0.0012505972,0.0000011176231,0.014827517,0.000018245606,0.000003422759,0.0035624132],"study_design_scores_gemma":[0.026178844,0.0018117838,0.78782016,0.00017040649,0.0005601943,0.000105765044,0.00002521739,0.0000019605332,0.1832132,0.0000031976895,0.0000036196536,0.00010564692],"about_ca_topic_score_codex":0.00015564318,"about_ca_topic_score_gemma":0.000081341735,"teacher_disagreement_score":0.1873442,"about_ca_system_score_codex":0.000015333088,"about_ca_system_score_gemma":0.00006882756,"threshold_uncertainty_score":0.5312479},"labels":[],"label_agreement":null},{"id":"W1964495651","doi":"10.1046/j.1365-2141.2003.04086.x","title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health; Deutsche Krebshilfe","keywords":"BCL6; Biology; Follicular lymphoma; Fluorescence in situ hybridization; Karyotype; Lymphoma; Cytogenetics; Gene rearrangement; Immunohistochemistry; Pathology; Follicular phase; Molecular biology; Cancer research; Chromosome; Genetics; Immunology; B cell; Germinal center; Antibody; Gene; Medicine","score_opus":0.01638694824535327,"score_gpt":0.2833452304685933,"score_spread":0.26695828222324003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964495651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97985816,0.018007023,0.0002520099,0.00090795284,0.00032477485,0.00019674012,0.000008642127,0.000008048923,0.00043667655],"genre_scores_gemma":[0.9983186,0.0009998139,0.00024316984,0.00023766622,0.00006192348,0.000011276988,0.000005576073,0.00001546489,0.000106467436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998414,0.00023915622,0.00071073644,0.00014335045,0.0002979802,0.00019480713],"domain_scores_gemma":[0.9985555,0.00017696289,0.00056653435,0.00022287155,0.00032753605,0.00015059856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057879643,0.000110313864,0.00049568835,0.00008802745,0.00009988423,0.00003446261,0.00012520474,0.00005483321,0.0001245885],"category_scores_gemma":[0.00062296103,0.0000861503,0.00026514783,0.00014374939,0.00013836444,0.00009323,0.000017974917,0.000075326476,0.000014938816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075411214,0.005786722,0.6804787,0.0006338427,0.0023882801,0.15643682,0.00072633266,0.00011987839,0.0027986881,0.041469708,0.018807875,0.089599065],"study_design_scores_gemma":[0.013392104,0.00033751602,0.58028793,0.0012486626,0.0019081844,0.3496697,0.00035823334,0.000080911144,0.03290688,0.0073053194,0.012231624,0.00027293625],"about_ca_topic_score_codex":0.000067902736,"about_ca_topic_score_gemma":0.000025443122,"teacher_disagreement_score":0.19323286,"about_ca_system_score_codex":0.00009096072,"about_ca_system_score_gemma":0.0003292851,"threshold_uncertainty_score":0.35131073},"labels":[],"label_agreement":null},{"id":"W1964627033","doi":"10.1586/14737140.6.11.1609","title":"Primary gastrointestinal tract lymphoma: diagnosis and management of common neoplasms","year":2006,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Gastrointestinal tract; Lymphoma; Lymph; Pathology; Disease; Internal medicine","score_opus":0.040822187876616976,"score_gpt":0.3698390312929727,"score_spread":0.32901684341635573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964627033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012835812,0.9950501,0.000004716163,0.00022861149,0.00009046198,0.002719312,0.000059309565,0.000023965114,0.00169522],"genre_scores_gemma":[0.000024545798,0.99490786,0.002966185,0.00063061254,0.00011973231,0.0010206467,0.00019832552,0.00006684066,0.00006527747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972256,0.0001322709,0.0013272975,0.000513099,0.0005001112,0.00030166222],"domain_scores_gemma":[0.9979849,0.00026235584,0.00083705934,0.0007023135,0.00008779438,0.00012557917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002454805,0.0006163398,0.0042341338,0.00012128732,0.0000367436,0.000010435368,0.00019731182,0.00009501499,0.00013978696],"category_scores_gemma":[0.000007974182,0.00039812698,0.0009418519,0.0003038328,0.00019742154,0.00004871379,0.000065968175,0.000086141816,0.0000070112956],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025512387,0.0021010367,0.0012250554,0.17945269,0.0004264972,0.00014874262,0.000009450406,6.8859767e-9,3.6446323e-7,0.00006690299,0.0040626875,0.81248105],"study_design_scores_gemma":[0.0012741652,0.0005242509,0.003484122,0.34274787,0.0011151613,0.0003710247,0.000002898329,1.4211957e-7,0.000019342006,0.000002796827,0.6502689,0.00018929728],"about_ca_topic_score_codex":0.00016623807,"about_ca_topic_score_gemma":0.000001436831,"teacher_disagreement_score":0.81229174,"about_ca_system_score_codex":0.00024767607,"about_ca_system_score_gemma":0.00022004695,"threshold_uncertainty_score":0.99984705},"labels":[],"label_agreement":null},{"id":"W1964744337","doi":"10.1200/jco.2008.16.0283","title":"Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Terry Fox Foundation; Genome Canada","keywords":"Medicine; Lymphoma; Follicular lymphoma; Hodgkin lymphoma; Internal medicine; Population; Incidence (geometry); Stage (stratigraphy); Multivariate analysis; Biopsy; Cancer; Survival analysis; Oncology","score_opus":0.11739105286033585,"score_gpt":0.46615780440928595,"score_spread":0.3487667515489501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964744337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758,0.00021819955,0.00018066418,0.0014422187,0.00015929832,0.00011047309,0.000006836597,0.0000022947602,0.00030002758],"genre_scores_gemma":[0.99561137,0.00046841605,0.0032036286,0.00060350285,0.000081110345,0.000002047357,0.0000051139023,0.000005825368,0.000018985596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965712,0.00014116715,0.0026887655,0.00012375636,0.0003589287,0.000116213036],"domain_scores_gemma":[0.9948675,0.0026496188,0.0017468433,0.00015368128,0.00035806,0.00022431664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001168141,0.00010241277,0.0022382198,0.0003284356,0.000024595058,0.0000012703448,0.00007875487,0.00022115097,0.00006633888],"category_scores_gemma":[0.0013226258,0.00006740551,0.00081139145,0.0003518992,0.00019267526,0.00005977182,0.00001093359,0.00011390527,8.5517934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014234364,0.002103592,0.95778877,0.000030817027,0.0015032344,0.00029242842,0.00007585186,0.00009864779,0.000037757898,0.00002521946,0.00005406484,0.036566194],"study_design_scores_gemma":[0.010053408,0.0056129512,0.979196,0.000053259486,0.0036429171,0.00010327673,0.00002468542,0.0006843554,0.0002651537,0.000028321676,0.00028581102,0.000049833707],"about_ca_topic_score_codex":0.00031894055,"about_ca_topic_score_gemma":0.00014146804,"teacher_disagreement_score":0.03651636,"about_ca_system_score_codex":0.00012253047,"about_ca_system_score_gemma":0.0008185685,"threshold_uncertainty_score":0.27487168},"labels":[],"label_agreement":null},{"id":"W1964837213","doi":"10.1182/blood-2006-06-031948","title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lymphoma; Internal medicine; Odds ratio; Medicine; Non-Hodgkin's lymphoma; Epidemiology; First-degree relatives; Oncology; Relative risk; Leukemia; Family history; Confidence interval","score_opus":0.015563212331046359,"score_gpt":0.24558472384319488,"score_spread":0.23002151151214853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964837213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782401,0.02020204,0.000025108358,0.00024183476,0.00008684336,0.00027522657,0.0005215777,0.000012351391,0.00039491913],"genre_scores_gemma":[0.99805117,0.0009110909,0.00040256832,0.00025606633,0.000047587553,0.00004740722,0.00009248712,0.000014469471,0.00017717908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.00017646517,0.0008997671,0.00034994038,0.00022676316,0.00019617759],"domain_scores_gemma":[0.9958404,0.002717643,0.00077359803,0.00039518598,0.00019841289,0.00007480906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003746195,0.00022799744,0.0012444602,0.00020497484,0.000029487583,0.000005080882,0.00013144506,0.000117284246,0.00008641215],"category_scores_gemma":[0.0005281505,0.00015525454,0.00031603657,0.00014689885,0.0005565932,0.000040744948,0.00007697819,0.00002257362,0.000001411359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034790547,0.0017049373,0.97806686,0.00004879581,0.0063407556,0.00008054414,0.00037780774,0.000006284762,0.009532213,0.0003566732,0.0015244804,0.0016127347],"study_design_scores_gemma":[0.010671292,0.000423638,0.9650091,0.0001592349,0.014062907,0.000121271354,0.0002960653,0.00042056394,0.008044463,0.00011764801,0.0005566514,0.00011718596],"about_ca_topic_score_codex":0.024144102,"about_ca_topic_score_gemma":0.0010213214,"teacher_disagreement_score":0.02312278,"about_ca_system_score_codex":0.00014040947,"about_ca_system_score_gemma":0.0002068273,"threshold_uncertainty_score":0.9823542},"labels":[],"label_agreement":null},{"id":"W1964891782","doi":"10.1016/s0360-3016(02)03302-3","title":"Localized extranodal marginal zone B-cell lymphoma: clinical outcome with radiation therapy","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Mucosa-associated lymphoid tissue; MALT lymphoma; Marginal zone B-cell lymphoma; Larynx; Biopsy; Stage (stratigraphy); Internal medicine; Gastroenterology; Surgery; Marginal zone; B cell","score_opus":0.04495077109830758,"score_gpt":0.3567502038040136,"score_spread":0.31179943270570604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964891782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97622055,0.003273972,0.008748584,0.006675827,0.0024788307,0.00044533206,0.000044621942,0.000061977626,0.0020503222],"genre_scores_gemma":[0.98458886,0.005790925,0.0038444893,0.002552187,0.0028274392,0.00002322275,0.00008960628,0.000040201227,0.00024305836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972682,0.0003180119,0.0012947065,0.00033379724,0.0004845165,0.00030074688],"domain_scores_gemma":[0.99691176,0.0005826964,0.0013498041,0.00022270034,0.00067721057,0.00025584304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060970424,0.00030476204,0.0008151691,0.00018526295,0.00008557773,0.00004051543,0.00030841626,0.00032346108,0.0003820474],"category_scores_gemma":[0.00012169456,0.00022137022,0.00044539096,0.00018816422,0.00024794263,0.00028244144,0.000029098132,0.00031277793,0.00013171231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012549318,0.0039710253,0.5989255,0.000004600314,0.0007343999,0.00021528432,0.00014338181,0.000065276865,0.0001505555,0.0010617657,0.0018746856,0.39159864],"study_design_scores_gemma":[0.13946316,0.0109319035,0.49554846,0.00008888227,0.00063774484,0.0016467426,0.00008592153,0.0051177647,0.0026736732,0.0009927074,0.34226444,0.00054860715],"about_ca_topic_score_codex":0.000023400366,"about_ca_topic_score_gemma":0.000002676969,"teacher_disagreement_score":0.39105004,"about_ca_system_score_codex":0.0009796654,"about_ca_system_score_gemma":0.00038997887,"threshold_uncertainty_score":0.9027216},"labels":[],"label_agreement":null},{"id":"W1964918642","doi":"10.1186/1748-717x-2-13","title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk","year":2007,"lang":"en","type":"article","venue":"Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Nuclear medicine; Lung cancer; Internal medicine; Oncology","score_opus":0.028648584798518083,"score_gpt":0.40059020369831777,"score_spread":0.3719416188997997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964918642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932015,0.004261722,0.00020827701,0.0006263972,0.0005711385,0.00057803345,0.000020983272,0.000012036516,0.0005198916],"genre_scores_gemma":[0.9964572,0.0014155632,0.0015594413,0.00011557682,0.00024445102,0.00010059397,0.000033292356,0.000010102979,0.00006374652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99924713,0.000037009242,0.0002986252,0.0001733616,0.00007579777,0.00016808517],"domain_scores_gemma":[0.99921054,0.0003854045,0.00019618774,0.000095950636,0.000043673248,0.0000682226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024441592,0.00009153357,0.00033157333,0.0001533809,0.000039437356,0.0000039241017,0.000024917586,0.00016232612,0.00013212583],"category_scores_gemma":[0.00004792053,0.000085629836,0.00003665331,0.000112449045,0.000036689762,0.00005574842,0.000006489781,0.0000450007,0.0000013776789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039379424,0.0007929324,0.35236973,0.000046052723,0.0001265356,0.000008846908,0.0014791191,0.000034662775,0.00322039,0.00019791209,0.0020158412,0.63577],"study_design_scores_gemma":[0.03104771,0.004711216,0.79734606,0.000024049843,0.00014742561,0.000016481321,0.0005626568,0.00088404864,0.07724516,0.00003121356,0.08787343,0.00011055998],"about_ca_topic_score_codex":0.00082844205,"about_ca_topic_score_gemma":0.002379859,"teacher_disagreement_score":0.63565946,"about_ca_system_score_codex":0.0006729284,"about_ca_system_score_gemma":0.00016315153,"threshold_uncertainty_score":0.34918836},"labels":[],"label_agreement":null},{"id":"W1965317558","doi":"10.1016/s0165-4608(02)00843-9","title":"Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis","year":2003,"lang":"en","type":"article","venue":"Cancer Genetics and Cytogenetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Fluorescence in situ hybridization; Biology; Follicular lymphoma; Lymphoma; Karyotype; Cytogenetics; Comparative genomic hybridization; Pathology; Interphase; Gene rearrangement; Immunology; Chromosome; Genetics; Medicine; Gene","score_opus":0.038806260139456976,"score_gpt":0.3170879960897829,"score_spread":0.2782817359503259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965317558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96827024,0.03069283,0.0001237615,0.00016217474,0.000082533574,0.0005437752,0.000020990543,0.000013200447,0.000090498004],"genre_scores_gemma":[0.95132136,0.045167096,0.002926367,0.00030547648,0.000037219626,0.00018357324,0.000019603034,0.000028195625,0.000011112092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982332,0.00008694015,0.00047604417,0.00058553636,0.0002002948,0.00041799166],"domain_scores_gemma":[0.99919033,0.00012541437,0.00010426195,0.0002610827,0.000093036346,0.00022588347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009213542,0.00030486885,0.00055906887,0.00045438652,0.000080722704,0.000057227455,0.00006709417,0.000117196374,0.000025051704],"category_scores_gemma":[0.00004890677,0.00030278065,0.00008460596,0.0007937316,0.00013094558,0.0000331095,0.00008323607,0.00007682697,0.0000014782802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006938365,0.00041133477,0.95978403,0.00008343743,0.00023219716,0.00013545413,0.00057271216,0.001622989,0.007904048,0.000049783324,0.000011209882,0.029123412],"study_design_scores_gemma":[0.004235856,0.00029313916,0.8856968,0.00018200454,0.0006770162,0.000033582404,0.00024437575,0.004820922,0.10259823,0.00005837708,0.00085820124,0.00030145454],"about_ca_topic_score_codex":0.00021636697,"about_ca_topic_score_gemma":0.0013364395,"teacher_disagreement_score":0.09469418,"about_ca_system_score_codex":0.00036081366,"about_ca_system_score_gemma":0.00015269851,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W1965512384","doi":"10.1111/j.1365-2141.2009.07721.x","title":"Highly increased familial risks for specific lymphoma subtypes","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Socialstyrelsen; National Institutes of Health; McMaster University; World Health Organization","keywords":"Lymphoma; Follicular lymphoma; Etiology; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Population; First-degree relatives; Family history","score_opus":0.027035196651240004,"score_gpt":0.28873266542329595,"score_spread":0.26169746877205596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965512384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869529,0.009646518,0.00017619944,0.0017075692,0.00039227933,0.0002765928,0.000023940547,0.00002036407,0.0008036619],"genre_scores_gemma":[0.99405956,0.0016126899,0.0029771023,0.00084637385,0.00039900898,0.0000083818495,0.000016901453,0.000014975931,0.00006502642],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998688,0.000058492984,0.0005845188,0.00017406647,0.00020492545,0.00028999435],"domain_scores_gemma":[0.99890363,0.00017243814,0.0002983119,0.00013525698,0.00028144813,0.00020894187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002181962,0.00014017639,0.0007721082,0.00012929097,0.000090768524,0.000035125184,0.0001105396,0.0001374367,0.00006105777],"category_scores_gemma":[0.00016158212,0.00013278103,0.0003118011,0.00008776605,0.00007117944,0.00008328584,0.000010395945,0.00007871776,0.000019690653],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039538494,0.005451893,0.044388626,0.00013484182,0.00076758006,0.19818993,0.00019157474,0.0000042733604,0.0018856155,0.0056151124,0.1164459,0.6229708],"study_design_scores_gemma":[0.017594708,0.0024489665,0.50242794,0.00043434172,0.0003597405,0.42852882,0.00007114725,0.000014220473,0.0073005073,0.0022496828,0.038384996,0.00018494896],"about_ca_topic_score_codex":0.00011606685,"about_ca_topic_score_gemma":0.00002148606,"teacher_disagreement_score":0.62278587,"about_ca_system_score_codex":0.00015392063,"about_ca_system_score_gemma":0.00027582794,"threshold_uncertainty_score":0.5414653},"labels":[],"label_agreement":null},{"id":"W1965807814","doi":"10.1038/leu.2015.57","title":"IL10 receptor is a novel therapeutic target in DLBCLs","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Germinal center; Interleukin 10; Cancer research; STAT3; Cytokine; B cell; Immunology; Signal transduction; Antibody; Cell biology","score_opus":0.0441758864175798,"score_gpt":0.290553981244657,"score_spread":0.24637809482707718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965807814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165214,0.0012925705,0.00004256788,0.003849074,0.00024382299,0.00034440268,0.00001664299,0.00005551509,0.012503253],"genre_scores_gemma":[0.99016553,0.000048060785,0.0020133946,0.0054264655,0.00013907613,0.000066970126,0.000028134464,0.000019125639,0.002093262],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917805,0.000013589787,0.00016912833,0.00021181468,0.00020540415,0.00022199198],"domain_scores_gemma":[0.9994644,0.00003275019,0.000036152185,0.00025153742,0.000045321154,0.00016982363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001097744,0.0001268477,0.00023099054,0.00006531858,0.00001614867,0.000012942131,0.000058148464,0.000089196474,0.00026972307],"category_scores_gemma":[0.000031378317,0.000094860334,0.0000628298,0.00016095229,0.000026237949,0.000047995014,0.000022941538,0.000082053164,0.00058981933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052171864,0.0019701167,0.84005165,0.00006882853,0.0003032407,0.00018534133,0.0050584376,0.000026969228,0.007209782,0.0025118738,0.11307471,0.029017337],"study_design_scores_gemma":[0.025454834,0.0008337147,0.35261807,0.00023224275,0.00012822943,0.00008358013,0.0004930771,0.00087874586,0.029528357,0.0010268887,0.58833414,0.00038813523],"about_ca_topic_score_codex":0.0004052768,"about_ca_topic_score_gemma":0.000017452021,"teacher_disagreement_score":0.48743358,"about_ca_system_score_codex":0.0012383508,"about_ca_system_score_gemma":0.00046047388,"threshold_uncertainty_score":0.75811315},"labels":[],"label_agreement":null},{"id":"W1965861190","doi":"10.3816/clm.2006.s.003","title":"Treatment of Diffuse Large B-Cell Lymphoma: A Risk-Based Approach","year":2006,"lang":"en","type":"review","venue":"Clinical Lymphoma & Myeloma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Rituximab; Medicine; Diffuse large B-cell lymphoma; Context (archaeology); Oncology; Prednisone; Lymphoma; Vincristine; Internal medicine; CHOP; Cyclophosphamide; Clinical trial; Intensive care medicine; Chemotherapy; Biology","score_opus":0.06659608710929593,"score_gpt":0.373539151332449,"score_spread":0.3069430642231531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965861190","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007285988,0.97865546,0.00006229872,0.000032010663,0.0006054322,0.0038003088,0.0014992406,0.00026494043,0.007794349],"genre_scores_gemma":[0.006988157,0.98229915,0.0025072882,0.00012764355,0.0010945606,0.0013623389,0.0033255178,0.00032438562,0.0019709382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902066,0.0010326155,0.004373487,0.0021685867,0.0009449215,0.0012738112],"domain_scores_gemma":[0.99054986,0.0026369889,0.0028076319,0.0028404733,0.00024954922,0.0009154714],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006422851,0.0019098136,0.009312323,0.00050564104,0.00022866062,0.00006767876,0.00055761135,0.0018746424,0.00007401837],"category_scores_gemma":[0.0003025901,0.0012847857,0.0070508616,0.00085225474,0.0004954501,0.000069720074,0.00017050756,0.00019449565,0.0005612267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002740469,0.13896988,0.0074913613,0.0076997713,0.001427938,0.0007893301,0.000018224917,2.8024138e-7,5.4810595e-8,0.00009372751,0.002341434,0.840894],"study_design_scores_gemma":[0.07153158,0.0038097713,0.016152287,0.0034049193,0.015251763,0.00030903704,0.0000127236135,0.00012756283,0.000012973651,0.000014226111,0.8884491,0.000924069],"about_ca_topic_score_codex":0.0003474243,"about_ca_topic_score_gemma":0.000012937336,"teacher_disagreement_score":0.8861076,"about_ca_system_score_codex":0.001991736,"about_ca_system_score_gemma":0.0032173048,"threshold_uncertainty_score":0.9994211},"labels":[],"label_agreement":null},{"id":"W1967021411","doi":"10.1007/s11886-013-0417-8","title":"Screening for and Management of Elevated Lp(a)","year":2013,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Medicine; Internal medicine; Intensive care medicine","score_opus":0.1298919830030253,"score_gpt":0.4018830581065653,"score_spread":0.27199107510354004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967021411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018982755,0.9949717,0.00021693931,0.000008731371,0.00072726636,0.0033799603,0.000028852313,0.00003067005,0.0004460707],"genre_scores_gemma":[0.00015519075,0.9961851,0.00087930326,0.000004391588,0.00017348515,0.001728911,0.00069743604,0.000032851964,0.00014332798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982055,0.000052576263,0.00081956637,0.0005419663,0.00012641097,0.00025399352],"domain_scores_gemma":[0.9985623,0.00009652223,0.00061762356,0.0005154769,0.00009428143,0.00011380535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023632437,0.0003394648,0.0026092196,0.00013036063,0.000035509733,0.000006662549,0.000040379684,0.00021489228,0.000009722586],"category_scores_gemma":[0.00002854227,0.0002333979,0.00071321795,0.000092036695,0.00008435092,0.000018206028,0.000096920594,0.00009768525,0.000003620872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055706223,0.00005407757,0.0023158486,0.031852745,0.002416885,0.0005781648,0.000003005242,1.4560455e-7,1.06981076e-7,0.00008233394,0.0035547114,0.9591364],"study_design_scores_gemma":[0.0005339526,0.0001344521,0.001279433,0.0151963495,0.007986114,0.0031891607,0.0000035657333,8.1604935e-7,0.0000019510742,0.000035859113,0.971468,0.00017034804],"about_ca_topic_score_codex":0.000003507985,"about_ca_topic_score_gemma":6.113252e-8,"teacher_disagreement_score":0.96791327,"about_ca_system_score_codex":0.00007115783,"about_ca_system_score_gemma":0.00008048338,"threshold_uncertainty_score":0.95176905},"labels":[],"label_agreement":null},{"id":"W1967334603","doi":"10.5858/arpa.2014-0543-cp","title":"Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program","year":2015,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Minimal residual disease; Medicine; Leukemia; Chronic lymphocytic leukemia; Flow cytometry; Myeloid leukemia; Multiple myeloma; Oncology; Lymphoma; Context (archaeology); Immunology; Internal medicine; Pathology; Biology","score_opus":0.13004071106158105,"score_gpt":0.36010906846870194,"score_spread":0.2300683574071209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967334603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743134,0.0003713229,0.000053483003,0.00011463062,0.000069441914,0.0011062833,0.0007502018,0.000012022725,0.00009129044],"genre_scores_gemma":[0.9966754,0.0000252946,0.003064271,0.000026244677,0.00001314317,0.00013612585,0.000043880573,0.000013681463,0.0000019847032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99525386,0.0018824172,0.0016436523,0.00040425317,0.0004949303,0.00032087637],"domain_scores_gemma":[0.9943717,0.0029840334,0.0012705929,0.0006857182,0.0005331332,0.00015479706],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045887902,0.00021801206,0.0012684015,0.00045193243,0.000016180773,6.0125654e-7,0.00017824586,0.00007713012,0.0000035081296],"category_scores_gemma":[0.021958057,0.00014521285,0.00006337251,0.0019820551,0.0026360876,0.00004087061,0.00007508998,0.00013836529,1.246442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035328916,0.00490284,0.93444574,0.00046432807,0.00005981672,0.0009979104,0.002529631,0.000012008922,0.0477861,0.000015581045,0.000008563972,0.00524458],"study_design_scores_gemma":[0.0047587086,0.005071599,0.9657286,0.00056043605,0.00021304605,0.000053596264,0.0016387372,0.0005408822,0.021274356,0.00007251,0.0000011546681,0.00008636507],"about_ca_topic_score_codex":0.0011116613,"about_ca_topic_score_gemma":0.00051895104,"teacher_disagreement_score":0.03128286,"about_ca_system_score_codex":0.000055524146,"about_ca_system_score_gemma":0.0011354309,"threshold_uncertainty_score":0.9862804},"labels":[],"label_agreement":null},{"id":"W1967767575","doi":"10.1002/gcc.10069","title":"Uncovering novel inter‐ and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique","year":2002,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Biology; Karyotype; Breakpoint; Genetics; Chromosome; Chromosome 22; Chromosome 21; Molecular biology; Gene","score_opus":0.03129544006781052,"score_gpt":0.28748344710341717,"score_spread":0.2561880070356066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967767575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656255,0.011776487,0.0002040787,0.00031514146,0.00010903095,0.00074621255,0.00008937664,0.00004891577,0.0001481935],"genre_scores_gemma":[0.9942462,0.0031115639,0.0015585802,0.00028201265,0.00014786301,0.00049304595,0.000030434187,0.00003922137,0.00009109489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985709,0.000026907694,0.00035490983,0.00051722437,0.00016980075,0.00036023805],"domain_scores_gemma":[0.99939334,0.00003672288,0.00010912563,0.00021126754,0.000079222955,0.00017033772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008047285,0.00030521653,0.00045309306,0.00016543057,0.00016909171,0.00007944509,0.00006042621,0.00015191015,0.00013843467],"category_scores_gemma":[0.000015374271,0.00026551928,0.000045210454,0.00043852726,0.00012857241,0.00034057596,0.00008198743,0.00008529134,0.000001562686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069157904,0.0017445246,0.1273913,0.00025926952,0.00033977293,0.00018924942,0.0028581268,0.00017074302,0.7781698,0.00016911623,0.0001717391,0.08846721],"study_design_scores_gemma":[0.034040116,0.003042066,0.11044327,0.0037337875,0.0008893716,0.0027,0.002686302,0.055513907,0.75161785,0.00014055091,0.032366887,0.0028258713],"about_ca_topic_score_codex":0.0008092092,"about_ca_topic_score_gemma":0.00015498277,"teacher_disagreement_score":0.08564134,"about_ca_system_score_codex":0.00051548675,"about_ca_system_score_gemma":0.00007292982,"threshold_uncertainty_score":0.9999797},"labels":[],"label_agreement":null},{"id":"W1968117566","doi":"10.1182/blood-2007-02-072082","title":"Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Diffuse large B-cell lymphoma; Biology; Lymphoma; Cancer research; DNA; Genetics; Molecular biology; Immunology","score_opus":0.015433812543418864,"score_gpt":0.25343110858945483,"score_spread":0.23799729604603598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968117566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786377,0.000102929625,0.000036015674,0.000113156086,0.000030130364,0.00092584343,0.0003333383,0.000016231405,0.000578604],"genre_scores_gemma":[0.9991997,0.000011088481,0.00026641297,0.00003277175,0.000021260134,0.00012285428,0.0002978368,0.000020803589,0.000027304379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868447,0.00008907798,0.00040598155,0.00019754624,0.00033172814,0.0002912201],"domain_scores_gemma":[0.9983859,0.0009647935,0.00025255795,0.00019144788,0.00012880022,0.00007652075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006255236,0.00014823588,0.00038770464,0.000172807,0.000049209164,0.0000066467783,0.000093481074,0.00010932053,0.000009203705],"category_scores_gemma":[0.00040227943,0.00009543374,0.00008230938,0.00047610953,0.00003525546,0.000045098233,0.0000140618495,0.000050536542,6.845526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044721473,0.05585267,0.9300486,0.00010252623,0.00011347211,0.000059261296,0.0018145656,0.0000016565493,0.01123389,0.00006187979,0.00007330812,0.00019099234],"study_design_scores_gemma":[0.07595515,0.00053583836,0.7505268,0.00067331345,0.00033511908,0.000005500571,0.0026902154,0.000029815365,0.16912773,0.00001135384,0.000024453037,0.00008470685],"about_ca_topic_score_codex":0.000105603525,"about_ca_topic_score_gemma":0.0023847963,"teacher_disagreement_score":0.17952177,"about_ca_system_score_codex":0.00008984561,"about_ca_system_score_gemma":0.00015087785,"threshold_uncertainty_score":0.3891675},"labels":[],"label_agreement":null},{"id":"W1968797324","doi":"10.1111/cas.12392","title":"Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Japan Society for the Promotion of Science","keywords":"Follicular lymphoma; MALT lymphoma; Lymphoma; Pathology; Biology; Pathogenesis; BCL10; Cancer research; Medicine","score_opus":0.012039072201028518,"score_gpt":0.2674853476507857,"score_spread":0.2554462754497572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968797324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934898,0.0029002065,0.0026287702,0.00023126484,0.000099237186,0.00019232008,0.0000025230527,0.000039081646,0.0004168056],"genre_scores_gemma":[0.9941496,0.00023669504,0.004703683,0.0006050187,0.00010315493,0.00012867192,0.000008328242,0.000009714626,0.000055123193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826604,0.000030956668,0.00016224022,0.0006010895,0.0006563018,0.000283351],"domain_scores_gemma":[0.9987193,0.000039716142,0.00009369191,0.00052846014,0.0003196604,0.00029919724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009021251,0.00017849781,0.00036632037,0.0002695679,0.0003178181,0.000052700936,0.00019138155,0.00004100816,0.000036267927],"category_scores_gemma":[0.000018358014,0.00010841338,0.00011352852,0.0017065023,0.0003541314,0.00016429575,0.00007895272,0.00002440926,0.0000163312],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001655484,0.00055937003,0.4324491,0.000050965573,0.0005191609,0.00020785037,0.0014381421,0.0016424734,0.51915544,0.00040442948,0.00019441286,0.04321312],"study_design_scores_gemma":[0.001947552,0.00028074768,0.58407134,0.00008596588,0.00074803113,0.000015201084,0.000064051404,0.0022581525,0.40791774,0.000035166704,0.0024006406,0.00017544407],"about_ca_topic_score_codex":0.0003761572,"about_ca_topic_score_gemma":0.0000837297,"teacher_disagreement_score":0.15162222,"about_ca_system_score_codex":0.00038826163,"about_ca_system_score_gemma":0.00038059466,"threshold_uncertainty_score":0.44209692},"labels":[],"label_agreement":null},{"id":"W1969056568","doi":"10.1038/leu.2015.2","title":"Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma","year":2014,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Hematology; Internal medicine; Immunology","score_opus":0.011221830440637548,"score_gpt":0.2583113693289272,"score_spread":0.24708953888828963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969056568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94921285,0.00017519479,0.000027251406,0.047435094,0.00017011473,0.0020749085,0.000496055,0.0001337071,0.00027482325],"genre_scores_gemma":[0.7554208,0.00016217875,0.00081956765,0.24057049,0.0007050455,0.00085741124,0.0005537285,0.00017972273,0.0007310579],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99616855,0.00025350018,0.00072807586,0.00110528,0.0008921365,0.0008524357],"domain_scores_gemma":[0.99626964,0.0012448321,0.0005667676,0.00097528525,0.0003900014,0.00055348536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004229866,0.00085058506,0.0017576772,0.0005453015,0.00015881745,0.000081330545,0.00029032488,0.0008597819,0.0001072606],"category_scores_gemma":[0.0008591419,0.00064098986,0.00023944181,0.0007504515,0.0001240138,0.000067923946,0.00016969204,0.0004916793,0.00013294084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042771062,0.00020779626,0.48266506,0.00029652653,0.0016792507,0.0007624909,0.00037381751,0.000016773145,0.0001540379,0.0000029388332,0.5012634,0.012150206],"study_design_scores_gemma":[0.016948866,0.0024038225,0.8505595,0.0040029828,0.0030161315,0.00006925684,0.00002933081,0.00011964516,0.015473974,0.000017227532,0.10646633,0.00089295895],"about_ca_topic_score_codex":0.008116794,"about_ca_topic_score_gemma":0.00052777183,"teacher_disagreement_score":0.39479706,"about_ca_system_score_codex":0.002633629,"about_ca_system_score_gemma":0.0009789333,"threshold_uncertainty_score":0.99960417},"labels":[],"label_agreement":null},{"id":"W1969261714","doi":"10.1111/j.1365-2141.2009.07674.x","title":"Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; Internal medicine; Transplantation; Cohort; Gastroenterology; Relative risk; Immunology; Graft-versus-host disease; Lymphoma; Hematopoietic stem cell transplantation; Confidence interval","score_opus":0.0077869163399606,"score_gpt":0.21783098194565167,"score_spread":0.21004406560569108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969261714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995047,0.003692033,0.000013431593,0.00057589734,0.00017598453,0.00033732614,0.000046060555,0.000010286155,0.0001019837],"genre_scores_gemma":[0.9955766,0.0036691767,0.000306819,0.000294798,0.000035808418,0.000009449397,0.000044248154,0.000020520927,0.000042539967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984908,0.00013942602,0.00052717136,0.00026061997,0.00027475925,0.00030719765],"domain_scores_gemma":[0.99909663,0.00009234497,0.00029062724,0.00010354115,0.00015515741,0.00026167484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094309486,0.00021491495,0.0007513569,0.00012161133,0.00008062822,0.000047872214,0.00008461185,0.00011844998,0.000015456277],"category_scores_gemma":[0.0000068582185,0.00019080461,0.000109227265,0.0000996359,0.00008588711,0.0001716407,0.000010322723,0.00013314362,0.0000021988312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068092723,0.0061636283,0.8028646,0.00019539021,0.0003939773,0.15742029,0.00070275686,0.0000063386037,0.0001787189,0.000011189946,0.000119574725,0.025134258],"study_design_scores_gemma":[0.06842689,0.002155243,0.8973685,0.00067927217,0.0015026535,0.028092794,0.00013915199,0.000015382002,0.001375595,0.000017185243,0.000025936408,0.00020141195],"about_ca_topic_score_codex":0.00005487419,"about_ca_topic_score_gemma":0.00015366983,"teacher_disagreement_score":0.12932749,"about_ca_system_score_codex":0.00010670462,"about_ca_system_score_gemma":0.00018322069,"threshold_uncertainty_score":0.7780786},"labels":[],"label_agreement":null},{"id":"W1969267175","doi":"10.1182/blood-2005-04-1565","title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":456,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Follicular lymphoma; Internal medicine; Gastroenterology; CD68; Lymphoma; Vincristine; Rituximab; Prednisone; Chemotherapy; Cyclophosphamide; Oncology; Immunohistochemistry","score_opus":0.03216766737090314,"score_gpt":0.2545637908689651,"score_spread":0.22239612349806193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969267175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996854,0.0014180795,0.0000071420004,0.00012920158,0.000079236284,0.0006547627,0.0005081397,0.000045159653,0.00030427144],"genre_scores_gemma":[0.998873,0.0001874803,0.0002173795,0.00013107582,0.000035584046,0.00007690178,0.00030003034,0.000036158937,0.00014240402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971458,0.00016759428,0.00082547235,0.0005552114,0.0008642283,0.00044173293],"domain_scores_gemma":[0.99826634,0.00016625995,0.00042960513,0.00067386124,0.00019329734,0.00027062942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004512601,0.00034257502,0.0012618481,0.0006042096,0.00004377951,0.00001731427,0.00020418382,0.0002545027,0.0002541402],"category_scores_gemma":[0.00012677991,0.00028700917,0.00063473574,0.0009303023,0.00010002796,0.00012649411,0.000080905294,0.000041567084,0.0000059480494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035906263,0.016287582,0.95579314,0.00004379789,0.010725864,0.00022043704,0.0009121864,0.000024836023,0.008163022,0.000014015034,0.000025394691,0.007430641],"study_design_scores_gemma":[0.031490833,0.00045987047,0.84975266,0.00009894903,0.0056172456,0.000010293211,0.0005096168,0.0019138793,0.10986941,0.0000019391089,0.00008119495,0.00019409727],"about_ca_topic_score_codex":0.0032739697,"about_ca_topic_score_gemma":0.0038027822,"teacher_disagreement_score":0.10604049,"about_ca_system_score_codex":0.00042359982,"about_ca_system_score_gemma":0.00018460823,"threshold_uncertainty_score":0.9999582},"labels":[],"label_agreement":null},{"id":"W1969392166","doi":"10.1080/10428190290017114","title":"ALK-positive Anaplastic Large T-cell Lymphoma Preceded by Epstein-Barr Virus Infection Complicated by Development of an Aorto-esophageal Fistula","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lymphoma; Epstein–Barr virus; Fistula; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Virus; Chemotherapy; Pathology; Immunology; Internal medicine; Radiology; Lung cancer","score_opus":0.009485274140353299,"score_gpt":0.23115687166377036,"score_spread":0.22167159752341706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969392166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865221,0.0044344636,0.0002851201,0.000083515704,0.0003151738,0.0015177974,0.00069640717,0.0004206172,0.0057248184],"genre_scores_gemma":[0.99161965,0.0012406464,0.000984781,0.0009526421,0.00016502151,0.00043944083,0.0022630799,0.00020884264,0.0021258795],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99326247,0.00029832608,0.0018017957,0.0018732385,0.001168118,0.0015960677],"domain_scores_gemma":[0.99600327,0.00037678296,0.0008203963,0.0011525949,0.00035835724,0.0012885978],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003813415,0.0014044552,0.0018041799,0.000452189,0.0008636442,0.00018263036,0.0004189616,0.0008552325,0.0003014398],"category_scores_gemma":[0.00007868473,0.0013220763,0.00040476755,0.000928033,0.00042298832,0.00053340883,0.00026797884,0.00014818709,0.0002417474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004625608,0.03209772,0.05447117,0.0015628263,0.0032087578,0.0015286849,0.0077012377,0.00006178819,0.109650984,0.00040138635,0.07654181,0.708148],"study_design_scores_gemma":[0.10749603,0.003935106,0.2858205,0.00074765,0.0014574152,0.0016339879,0.00039754107,0.016844913,0.5147538,0.000056716162,0.06437477,0.0024815444],"about_ca_topic_score_codex":0.0031482677,"about_ca_topic_score_gemma":0.00033129656,"teacher_disagreement_score":0.7056665,"about_ca_system_score_codex":0.009708332,"about_ca_system_score_gemma":0.0015875272,"threshold_uncertainty_score":0.9998706},"labels":[],"label_agreement":null},{"id":"W1969461242","doi":"10.1080/10428190801993470","title":"Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group","year":2008,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; DHAP; Chemotherapy; Oncology; Internal medicine; Lymphoma; Hodgkin lymphoma; Salvage therapy; Biology","score_opus":0.018076305265650464,"score_gpt":0.27221272113167416,"score_spread":0.2541364158660237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969461242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802954,0.0028033382,0.000091094895,0.0010157712,0.00048047327,0.006156188,0.00028094312,0.00021407702,0.0009285604],"genre_scores_gemma":[0.9824636,0.005307114,0.0009967682,0.0032291287,0.0011406189,0.005187008,0.00056456064,0.00021783862,0.00089336146],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938071,0.00019820635,0.001279304,0.0017582187,0.0010154599,0.00194176],"domain_scores_gemma":[0.99673796,0.0005440846,0.00051337807,0.0013328838,0.00016462538,0.0007070955],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00033923754,0.0014651911,0.0020478514,0.000406407,0.0012136252,0.00014552091,0.00051333633,0.0005542202,0.00006977784],"category_scores_gemma":[0.0000488971,0.0009421615,0.0007192966,0.00097444194,0.0006104306,0.00039245494,0.00009719128,0.00012232164,0.000020561492],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.23045643,0.03700059,0.068539836,0.00038261144,0.0024863158,0.0057637333,0.018512065,0.00006598773,0.00055824383,0.0005930377,0.011355517,0.62428564],"study_design_scores_gemma":[0.6982388,0.018499756,0.22545874,0.00032342892,0.0009673715,0.0020415538,0.0006115387,0.0019950853,0.0016774593,0.00004847835,0.049051743,0.0010860811],"about_ca_topic_score_codex":0.007955142,"about_ca_topic_score_gemma":0.0020492924,"teacher_disagreement_score":0.6231996,"about_ca_system_score_codex":0.014891688,"about_ca_system_score_gemma":0.005758763,"threshold_uncertainty_score":0.9998777},"labels":[],"label_agreement":null},{"id":"W1970016523","doi":"10.1002/cncr.25053","title":"A population‐based study of follow‐up care for Hodgkin lymphoma survivors","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Radiation therapy; Cancer registry; Population; Hodgkin lymphoma; Lymphoma; Internal medicine; Pediatrics","score_opus":0.022659661843198717,"score_gpt":0.32258232231515754,"score_spread":0.2999226604719588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970016523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974429,0.00032816996,0.000007242252,0.00013171507,0.0007539796,0.001041924,0.00007997009,0.000024527399,0.00018955031],"genre_scores_gemma":[0.9985206,0.0000043650593,0.0002217858,0.00012257253,0.00013096229,0.0006959718,0.00007288398,0.00001899955,0.00021187092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935156,0.000011528545,0.00016420237,0.00018609739,0.00015673893,0.00012985863],"domain_scores_gemma":[0.9993695,0.00006142655,0.00006988279,0.00026978957,0.00015774881,0.00007163175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004240018,0.00010441738,0.00026571957,0.000058582795,0.000052596348,0.0000061710693,0.000046898575,0.00005456165,0.00014545646],"category_scores_gemma":[0.00003672851,0.00008042804,0.00010015198,0.00010230189,0.000010614364,0.000022656683,0.000009875418,0.00002246194,0.0000025980573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020343911,0.0006469633,0.9638489,0.00008410246,0.00009951907,0.000004800712,0.0009839681,0.000011418562,0.00032319548,0.000047308582,0.00029957507,0.033446826],"study_design_scores_gemma":[0.0131182065,0.0005844903,0.97591954,0.00004625351,0.00027946668,8.0598244e-7,0.00077063555,0.00005544815,0.0044096876,0.000011355538,0.0047160094,0.00008808502],"about_ca_topic_score_codex":0.0064838785,"about_ca_topic_score_gemma":0.019043032,"teacher_disagreement_score":0.03335874,"about_ca_system_score_codex":0.00014517645,"about_ca_system_score_gemma":0.00016008726,"threshold_uncertainty_score":0.9988569},"labels":[],"label_agreement":null},{"id":"W1970778176","doi":"10.1038/sj.leu.2403470","title":"Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma","year":2004,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Centrosome; Lymphoma; Pathology; Cancer research; Biology; Medicine; Cell; Genetics; Cell cycle; Lung cancer","score_opus":0.00785674257229205,"score_gpt":0.22358401517627852,"score_spread":0.21572727260398647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970778176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4146948,0.010262629,0.00004409082,0.4477941,0.003099032,0.004275195,0.0022998753,0.00056924176,0.11696103],"genre_scores_gemma":[0.39148748,0.0005591551,0.00020162777,0.5869167,0.0030361656,0.00028183137,0.003612373,0.00016154186,0.013743118],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997009,0.00008030598,0.00055199454,0.00071464386,0.0005976414,0.0010464567],"domain_scores_gemma":[0.9987336,0.000252349,0.00020158841,0.00057192845,0.00007895363,0.00016159356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008458014,0.0006505046,0.0009964404,0.0003577073,0.00008404056,0.00006572732,0.0001851039,0.0009915377,0.0002470526],"category_scores_gemma":[0.00003376711,0.0005605942,0.0003366341,0.00024883798,0.00009402952,0.00010434778,0.00009535988,0.00067204784,0.00069512136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002925986,0.001361021,0.013895274,0.0011648072,0.00041229874,0.046174712,0.0009793412,0.000029160601,0.000016280605,0.0003249439,0.93422765,0.0011218924],"study_design_scores_gemma":[0.04233347,0.0009540507,0.06480555,0.0024247207,0.0007846087,0.00068679044,0.00014930932,0.000052243035,0.0020664125,0.0003212959,0.88439965,0.0010218777],"about_ca_topic_score_codex":0.0014021,"about_ca_topic_score_gemma":0.00012329489,"teacher_disagreement_score":0.1391226,"about_ca_system_score_codex":0.0087885335,"about_ca_system_score_gemma":0.0017205541,"threshold_uncertainty_score":0.9996846},"labels":[],"label_agreement":null},{"id":"W1970810546","doi":"10.3109/10428194.2011.594925","title":"Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; International Prognostic Index; Oncology; Autologous stem-cell transplantation; Refractory (planetary science); Confidence interval; Lymphoma; Chemotherapy; Surgery","score_opus":0.015737094584909357,"score_gpt":0.24472084131699387,"score_spread":0.22898374673208452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970810546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863373,0.005869914,0.00040162285,0.00009026931,0.0012030428,0.0032464284,0.0011036292,0.00029698497,0.0014507931],"genre_scores_gemma":[0.9911023,0.0052385577,0.001047925,0.00022344984,0.0002734012,0.0007969389,0.0006273584,0.00027862028,0.0004114742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922752,0.0004282946,0.0020525001,0.0021220136,0.0014187853,0.0017032068],"domain_scores_gemma":[0.9944022,0.0010360683,0.0012356375,0.001606725,0.0006077335,0.0011116179],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000899258,0.001694648,0.0026388746,0.0006652511,0.00069981185,0.0001845989,0.0008369531,0.00116148,0.000109733526],"category_scores_gemma":[0.00029181025,0.0013317752,0.0015203973,0.00075686077,0.00048399597,0.00071347115,0.00035649326,0.00017205597,0.000019060846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.031006549,0.011192337,0.5591725,0.0016271438,0.010004132,0.008956383,0.008401171,0.00009194352,0.0050551267,0.00064880087,0.0012037811,0.3626401],"study_design_scores_gemma":[0.14297296,0.006163849,0.81620514,0.0017719034,0.003780231,0.0022804167,0.0012561405,0.004141693,0.018155662,0.00042514462,0.0011193032,0.0017275313],"about_ca_topic_score_codex":0.0044523333,"about_ca_topic_score_gemma":0.00022697994,"teacher_disagreement_score":0.3609126,"about_ca_system_score_codex":0.009398334,"about_ca_system_score_gemma":0.0061504156,"threshold_uncertainty_score":0.99958},"labels":[],"label_agreement":null},{"id":"W1970857271","doi":"10.1016/j.beha.2004.08.019","title":"What is remission in follicular lymphoma and what is its relevance?","year":2005,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Follicular lymphoma; Medicine; Clinical significance; Chemotherapy; Oncology; Natural history; Lymphoma; Internal medicine; Complete remission; Disease","score_opus":0.26054859318658974,"score_gpt":0.5690522045388872,"score_spread":0.3085036113522974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970857271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010635201,0.9610868,5.528435e-7,0.033252433,0.00068486546,0.003058856,0.000011112349,0.000038150993,0.0008036738],"genre_scores_gemma":[0.00008144223,0.9930081,0.0006327964,0.0026938056,0.00050752534,0.0007138857,0.0000756356,0.0001228943,0.0021639452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98766166,0.0045024897,0.0028020814,0.0021566984,0.0015185225,0.0013585322],"domain_scores_gemma":[0.9693712,0.026157118,0.0009025283,0.00169605,0.00082501787,0.0010481059],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007283739,0.0007688629,0.005193313,0.00066006155,0.00023409953,0.00064315303,0.0005046217,0.0022415025,0.0004522293],"category_scores_gemma":[0.016780365,0.000561149,0.00085948285,0.0010111906,0.00065667747,0.0027763783,0.0008279557,0.0020785949,0.0025863317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003670806,0.0052384944,0.00018361528,0.0062277406,0.00054373755,0.013472244,0.0001913234,9.314522e-9,7.8629554e-8,0.0002791675,0.0059291096,0.9675674],"study_design_scores_gemma":[0.003717874,0.0015817101,0.00003645136,0.05372256,0.0015881888,0.011113037,0.00076931407,0.000014711812,0.0000058349287,0.0000914038,0.92696375,0.00039516835],"about_ca_topic_score_codex":0.00012531852,"about_ca_topic_score_gemma":0.000047858823,"teacher_disagreement_score":0.9671722,"about_ca_system_score_codex":0.00096806465,"about_ca_system_score_gemma":0.003489722,"threshold_uncertainty_score":0.999684},"labels":[],"label_agreement":null},{"id":"W1970983568","doi":"10.1186/1476-4598-7-12","title":"Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency","funders":"","keywords":"Lymphoma; Biology; Cancer research; Hodgkin lymphoma; Pathology; Oncology; Immunology; Medicine","score_opus":0.012552871389347414,"score_gpt":0.2632453695817811,"score_spread":0.25069249819243367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970983568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876459,0.007829059,0.00047181902,0.00030461614,0.000064751424,0.0010181477,0.0001903052,0.000029398996,0.0024459756],"genre_scores_gemma":[0.996218,0.0006360324,0.0016904126,0.0004956509,0.000041721356,0.00047130743,0.00003991141,0.000034343513,0.00037260912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984548,0.000034125635,0.00030565177,0.00047494413,0.0004171905,0.0003132578],"domain_scores_gemma":[0.99896556,0.00003320825,0.0002973002,0.00034269528,0.00014845912,0.00021275335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049524675,0.00029953293,0.0005167521,0.00008911024,0.00010985862,0.00001138153,0.000081579135,0.00015290504,0.00009527285],"category_scores_gemma":[0.000060749113,0.00024105005,0.00013701736,0.00018455935,0.00037735075,0.000079230864,0.00009080913,0.000054607404,0.0000058239825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088588084,0.0019794046,0.021810591,0.00019320518,0.0005662802,0.0016837467,0.0006783592,0.000014134988,0.9468045,0.0005243626,0.005867864,0.018991666],"study_design_scores_gemma":[0.016709803,0.0005864819,0.027304165,0.0019387341,0.00018802356,0.00051820633,0.00006195885,0.00020411352,0.94709456,0.000028209797,0.0050411047,0.00032462995],"about_ca_topic_score_codex":0.0012777604,"about_ca_topic_score_gemma":0.0000109102975,"teacher_disagreement_score":0.018667035,"about_ca_system_score_codex":0.00034573936,"about_ca_system_score_gemma":0.0005949804,"threshold_uncertainty_score":0.9829736},"labels":[],"label_agreement":null},{"id":"W1971286493","doi":"10.4021/wjon681w","title":"Indolent Breast Lymphomas: A Case Series and Review of Literature","year":2013,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Radiology; Chemotherapy; Radiation therapy; Oncology; Internal medicine","score_opus":0.0103237501818608,"score_gpt":0.2874881443227061,"score_spread":0.27716439414084526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971286493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7102726,0.25443667,0.0000013225904,0.029447682,0.00027983155,0.00045243785,0.000015088476,0.0000061767087,0.005088181],"genre_scores_gemma":[0.9381551,0.057475153,0.0013122765,0.0024044933,0.00017735088,0.000014607227,0.0000028152126,0.000008401045,0.0004497884],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99912006,0.00007641376,0.0004773922,0.000081938044,0.00012591168,0.000118316726],"domain_scores_gemma":[0.9988905,0.00009074732,0.00037769854,0.00011385325,0.00036397934,0.00016317648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019715137,0.0001053825,0.00059287477,0.00015176315,0.00002428725,0.0000097965985,0.00003720447,0.000050632396,0.00038379582],"category_scores_gemma":[0.000048137194,0.00006511539,0.00011796217,0.00017932367,0.000076614044,0.00012309143,0.000028298613,0.00010531492,0.0000061635674],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007364346,0.0023758635,0.089448474,0.0052971644,0.0008588181,0.050515473,0.0011918163,2.947819e-7,0.00049281697,0.0010861182,0.06943237,0.77856433],"study_design_scores_gemma":[0.0056208833,0.003274044,0.078971125,0.015549461,0.0005708762,0.7745063,0.00017124892,0.000001351909,0.0003003407,0.00016584923,0.12077231,0.000096218406],"about_ca_topic_score_codex":0.000027093081,"about_ca_topic_score_gemma":0.000029703984,"teacher_disagreement_score":0.77846813,"about_ca_system_score_codex":0.00017661178,"about_ca_system_score_gemma":0.00023501978,"threshold_uncertainty_score":0.42022952},"labels":[],"label_agreement":null},{"id":"W1971635088","doi":"10.1053/clon.2000.9174","title":"Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease","year":2000,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; ABVD; Radiation therapy; Dacarbazine; Internal medicine; Vinblastine; Bleomycin; Surgery; Disease; Cohort; B symptoms; Chemotherapy; Vincristine","score_opus":0.05088077981269245,"score_gpt":0.4110029143906137,"score_spread":0.36012213457792125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971635088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555705,0.020216398,0.0011515105,0.005819676,0.0005428027,0.0068203444,0.009773553,0.00008668877,0.000018499466],"genre_scores_gemma":[0.7156627,0.26409903,0.013649556,0.0020958032,0.001477382,0.0013460305,0.00061224354,0.00012033579,0.00093687535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99473816,0.0007722533,0.0021646374,0.001404409,0.00027930978,0.00064120314],"domain_scores_gemma":[0.9838519,0.012173174,0.0011190758,0.00093291723,0.0002620224,0.0016608957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024939429,0.0005207517,0.0021758717,0.00010604789,0.0003611947,0.000034534623,0.00020769172,0.00047819677,0.00012542056],"category_scores_gemma":[0.0030643481,0.0003901806,0.0009785197,0.00012980339,0.00094019034,0.00012415284,0.000039041694,0.0003041171,0.0000022096344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19609725,0.008464277,0.41625723,0.00014227869,0.0018066113,0.00006636007,0.00008105883,0.000017909946,0.000006174023,0.00026651897,0.01228963,0.3645047],"study_design_scores_gemma":[0.112989716,0.01952478,0.7143591,0.00009378338,0.00176239,0.0000018735102,0.000018711693,0.002003192,0.000014955736,0.0010788221,0.14782287,0.0003297981],"about_ca_topic_score_codex":0.00012587325,"about_ca_topic_score_gemma":0.000039223065,"teacher_disagreement_score":0.3641749,"about_ca_system_score_codex":0.00016599268,"about_ca_system_score_gemma":0.00084616564,"threshold_uncertainty_score":0.999855},"labels":[],"label_agreement":null},{"id":"W1971899950","doi":"10.1038/bmt.2008.220","title":"Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results","year":2008,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; Health Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Cumulative incidence; Internal medicine; Lymphoma; Incidence (geometry); Surgery; Transplantation","score_opus":0.026001911643459226,"score_gpt":0.2643229587773552,"score_spread":0.23832104713389596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971899950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957741,0.0017390898,0.0004083288,0.00042942364,0.000076120115,0.0011292931,0.00016343861,0.000086681684,0.00019350751],"genre_scores_gemma":[0.99115294,0.0055894824,0.0016691396,0.0000972144,0.000023774035,0.000052065057,0.001238092,0.00003339463,0.00014389002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986238,0.00004703695,0.00048871135,0.00040175245,0.00017598446,0.00026271935],"domain_scores_gemma":[0.9993682,0.00015425286,0.00010796442,0.00013751273,0.00006369345,0.0001683949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014153383,0.00024230935,0.00037581698,0.0001559916,0.00025870852,0.000020929192,0.000026660508,0.00019271814,0.000005118813],"category_scores_gemma":[0.000010457541,0.00021306083,0.00009370001,0.00015230163,0.000116613184,0.00015226768,0.0000036054605,0.000052884352,0.0000024947906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023056583,0.0013015801,0.77871495,0.0016137315,0.0011765229,0.003130872,0.008194567,0.0001008894,0.15655546,0.00020417284,0.00009175894,0.025858898],"study_design_scores_gemma":[0.038653873,0.00063475454,0.92974687,0.0005296285,0.0011722209,0.005140989,0.000021857728,0.0009312046,0.0228383,0.00003813128,0.000029065084,0.00026312654],"about_ca_topic_score_codex":0.00015533305,"about_ca_topic_score_gemma":0.00007026919,"teacher_disagreement_score":0.15103188,"about_ca_system_score_codex":0.000112805224,"about_ca_system_score_gemma":0.00008406041,"threshold_uncertainty_score":0.8688369},"labels":[],"label_agreement":null},{"id":"W1972151064","doi":"10.1182/blood-2009-08-234351","title":"Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Interim; Positron emission tomography; Nuclear medicine; Diffuse large B-cell lymphoma; Rituximab; Medical physics; Lymphoma; Concordance; Vincristine; Prednisone; Clinical trial; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.02720674554937162,"score_gpt":0.3272892630740647,"score_spread":0.30008251752469306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972151064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541724,0.00087643915,0.000002654386,0.0006277417,0.00011529117,0.0014906959,0.000003928756,0.000023206616,0.0014428059],"genre_scores_gemma":[0.99908376,0.00005915813,0.000030138472,0.0006052001,0.00008442738,0.00007254591,0.000023860006,0.000017450677,0.000023458195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977674,0.00051084993,0.0004270863,0.0003703824,0.00068938825,0.00023490898],"domain_scores_gemma":[0.9990465,0.00004076654,0.00016366731,0.00044594862,0.00016865079,0.00013448433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006047923,0.0002149879,0.0004552461,0.00016637403,0.00008193937,0.00001045925,0.00016149358,0.000114820126,0.000053138872],"category_scores_gemma":[0.000047595247,0.00012769306,0.00008959718,0.00028871096,0.00005595479,0.00008849351,0.00006358501,0.000089912166,0.000003461509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010080043,0.37339735,0.52709806,0.000019974952,0.00029598788,0.00014911087,0.03710601,0.00000321249,0.032989018,0.00006522908,0.00022953044,0.02763849],"study_design_scores_gemma":[0.16673961,0.020086735,0.7900438,0.00034650238,0.00096770487,0.000046864883,0.0119988695,0.0007633627,0.008625889,0.000031140327,0.00018000556,0.00016955119],"about_ca_topic_score_codex":0.00043506673,"about_ca_topic_score_gemma":0.00041624976,"teacher_disagreement_score":0.3533106,"about_ca_system_score_codex":0.00028029914,"about_ca_system_score_gemma":0.00014104514,"threshold_uncertainty_score":0.5207172},"labels":[],"label_agreement":null},{"id":"W1972168709","doi":"10.1182/blood-2002-01-0099","title":"The role of cytokines in classical Hodgkin lymphoma","year":2002,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":508,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Cytokine; Chemokine; Immune system; Biology; Immunology; Tumor necrosis factor alpha; Cancer research; Lymphoma; T cell; Cell biology","score_opus":0.02666551994444972,"score_gpt":0.2915230698729212,"score_spread":0.2648575499284715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972168709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005327842,0.99195826,3.204543e-8,0.00006767978,0.00005975159,0.0005942652,0.000022478323,0.000016903432,0.006747838],"genre_scores_gemma":[0.0013541601,0.9977258,0.000040528175,0.00001421881,0.00017791506,0.00024802444,0.00002744185,0.00003232409,0.00037957297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986405,0.00008421725,0.00053504953,0.0002590718,0.00024009477,0.00024109031],"domain_scores_gemma":[0.9988698,0.00035152683,0.00020036777,0.0004718049,0.00002881886,0.00007769111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009994322,0.00027546348,0.0013275604,0.000099032804,0.000034946715,0.000014069154,0.00014976638,0.00022282194,0.000033454737],"category_scores_gemma":[0.000072384806,0.00014184054,0.00047477358,0.00024480862,0.00007252401,0.000013287275,0.000056131772,0.00008443073,0.000085980275],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054275915,0.0022406874,0.0011004863,0.0012745095,0.00032483504,0.00014282297,0.000015642216,6.1140493e-9,3.2454878e-7,0.00045022267,0.00023801855,0.994207],"study_design_scores_gemma":[0.0024689403,0.00017902211,0.0010598628,0.00642325,0.0020944052,0.00023876705,0.000009779646,0.0000012384742,0.00004557049,0.000038574442,0.98732346,0.00011710106],"about_ca_topic_score_codex":0.000034723398,"about_ca_topic_score_gemma":0.000019452473,"teacher_disagreement_score":0.9940899,"about_ca_system_score_codex":0.000102129605,"about_ca_system_score_gemma":0.00019350648,"threshold_uncertainty_score":0.5784089},"labels":[],"label_agreement":null},{"id":"W1972179222","doi":"10.1097/01.pas.0000149689.75462.ff","title":"TRAF1 Expression and c-Rel Activation Are Useful Adjuncts in Distinguishing Classical Hodgkin Lymphoma From a Subset of Morphologically or Immunophenotypically Similar Lymphomas","year":2005,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lymphoma; Hodgkin lymphoma; Classical Hodgkin lymphoma; Medicine; Pathology","score_opus":0.020478956207584623,"score_gpt":0.26866842124281226,"score_spread":0.24818946503522765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972179222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300194,0.0005570267,0.00007327785,0.00599921,0.000060017668,0.00017572669,0.000020469022,0.000018809536,0.00009353115],"genre_scores_gemma":[0.99523294,0.00055454887,0.003239131,0.0007036978,0.0002126681,0.0000105913405,0.0000080804675,0.000025268511,0.000013087035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974729,0.0005649057,0.0009409989,0.00029780832,0.00039473042,0.00032864683],"domain_scores_gemma":[0.99657637,0.0016479343,0.0011214503,0.00029496118,0.00015852308,0.0002007422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005759039,0.00025785502,0.0011770661,0.00014492733,0.00007148677,0.000018998919,0.00021882524,0.00013288844,0.000057385336],"category_scores_gemma":[0.00058753876,0.00013467524,0.0001952641,0.00029108312,0.0007155272,0.00011447767,0.0001023724,0.00026510222,0.000003871316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04001171,0.005816081,0.46521705,0.000040129482,0.00032197667,0.015247454,0.0023927006,0.00017791461,0.05604678,0.00023117624,0.00044506998,0.41405195],"study_design_scores_gemma":[0.008750392,0.0027846312,0.9792628,0.00040633886,0.0001348795,0.002921202,0.000636658,0.000100003475,0.0033959658,0.00026274635,0.0011894826,0.00015484479],"about_ca_topic_score_codex":0.00005278077,"about_ca_topic_score_gemma":0.000014571117,"teacher_disagreement_score":0.51404583,"about_ca_system_score_codex":0.00021685955,"about_ca_system_score_gemma":0.00015802581,"threshold_uncertainty_score":0.5491897},"labels":[],"label_agreement":null},{"id":"W1972230289","doi":"10.1097/iop.0b013e3181cff63d","title":"Orbital Lymphoma Presenting With Choroidal Detachments","year":2010,"lang":"en","type":"article","venue":"Ophthalmic Plastic and Reconstructive Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Optic nerve; Radiology; Pathology; Effusion; Radiography; Marginal zone; Immunohistochemistry; Ophthalmology; B cell; Surgery","score_opus":0.011019153305955433,"score_gpt":0.23488834049598203,"score_spread":0.2238691871900266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972230289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921508,0.000110037625,0.000010303519,0.000042234904,0.0008375717,0.0002172389,0.000031352345,0.000041467225,0.0065590395],"genre_scores_gemma":[0.9984734,0.000022831302,0.0009867484,0.000017606339,0.00017713892,0.000042673255,0.00003052318,0.000022861577,0.00022618793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987648,0.000024458239,0.00025878692,0.00040420837,0.00020913105,0.00033862455],"domain_scores_gemma":[0.99847704,0.0008924163,0.0001241329,0.00017807863,0.0000742076,0.00025410842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001097652,0.000239843,0.00044771997,0.00014358043,0.00015319379,0.000043695265,0.000035521804,0.00010998848,0.00017726673],"category_scores_gemma":[0.00017631499,0.00016413194,0.00010012943,0.00012347431,0.00032578982,0.00014339222,0.000039694994,0.00012546402,0.000028804405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022504141,0.00024202117,0.9792505,0.000041768548,0.00028402155,0.0014376362,0.00004964467,2.8467036e-7,0.0010060306,0.00009427972,0.00009025762,0.01727855],"study_design_scores_gemma":[0.0017744547,0.00010967499,0.96015704,0.0001145695,0.00017659034,0.034390017,0.0001688434,0.00007492517,0.002571605,0.00007873001,0.00016806024,0.00021548998],"about_ca_topic_score_codex":0.000048194503,"about_ca_topic_score_gemma":0.000005332896,"teacher_disagreement_score":0.03295238,"about_ca_system_score_codex":0.000046113146,"about_ca_system_score_gemma":0.00022198114,"threshold_uncertainty_score":0.6693106},"labels":[],"label_agreement":null},{"id":"W1972342014","doi":"10.1182/blood-2013-12-541078","title":"Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Stage (stratigraphy); Lymphoma; Medicine; Vinblastine; Chemotherapy; Hodgkin lymphoma; Oncology; Internal medicine; Pathology; Vincristine; Cyclophosphamide; Biology","score_opus":0.013906570616635564,"score_gpt":0.2567452202686415,"score_spread":0.24283864965200594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972342014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939147,0.00076277903,0.0011468078,0.00089759607,0.00012665734,0.0010069651,0.000098045246,0.00036786814,0.0016785745],"genre_scores_gemma":[0.9883345,0.00007309847,0.008254556,0.0007783771,0.00020549913,0.000426347,0.000261002,0.000112660215,0.0015539865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955266,0.00023357314,0.0009821035,0.0012595367,0.0009928741,0.0010053045],"domain_scores_gemma":[0.9966985,0.0003152677,0.00043974753,0.0016455827,0.00021325627,0.00068762136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042045352,0.0008117564,0.002112905,0.0004613321,0.00024182192,0.00011065824,0.00034563435,0.00027457176,0.00023011466],"category_scores_gemma":[0.00012566149,0.0005793755,0.00078197557,0.0012367873,0.00024808574,0.00016430061,0.00015731069,0.000088208515,0.00025026264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002244681,0.01391509,0.94198465,0.00026018644,0.0076403646,0.0018045558,0.00046517086,0.00033414896,0.0013076768,0.0006788477,0.00038005668,0.028984545],"study_design_scores_gemma":[0.09789158,0.0021554164,0.8281367,0.00024644428,0.0140353255,0.0004313693,0.00031070376,0.0055891867,0.024267608,0.00003376318,0.025852798,0.0010491161],"about_ca_topic_score_codex":0.00036853945,"about_ca_topic_score_gemma":0.00023827895,"teacher_disagreement_score":0.11384799,"about_ca_system_score_codex":0.00069328083,"about_ca_system_score_gemma":0.0003642116,"threshold_uncertainty_score":0.9996658},"labels":[],"label_agreement":null},{"id":"W1972729963","doi":"10.1007/s11912-002-0071-6","title":"Pediatric non-hodgkin’s lymphoma: Clinical and biologic prognostic factors and risk allocation","year":2002,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Oncology; Anaplastic lymphoma kinase; Internal medicine; Stage (stratigraphy); Disease; Chemotherapy; Non-Hodgkin's lymphoma; CD30","score_opus":0.14998719979615785,"score_gpt":0.4384578945387222,"score_spread":0.28847069474256437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972729963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.104862005,0.8904743,0.000002717811,0.00002172059,0.002131081,0.0021899242,0.000023924476,0.00006977244,0.00022453077],"genre_scores_gemma":[0.013295532,0.9848571,0.000094520045,0.000012938166,0.0007534505,0.0004848195,0.00041555968,0.000042673357,0.000043411703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960457,0.00038773386,0.0017745694,0.0011866447,0.0002055985,0.0003997653],"domain_scores_gemma":[0.99600285,0.0011547928,0.0017857573,0.0005188561,0.000112370726,0.00042538103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000711586,0.0006601112,0.0030597602,0.00027493385,0.00013774679,0.000028709235,0.00006471915,0.0009187482,0.000035113884],"category_scores_gemma":[0.0010646478,0.0004081453,0.0004944492,0.00024536374,0.0002932104,0.000047538015,0.00016022375,0.00039501762,0.000031635696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025881113,0.0010624648,0.47682163,0.0021003445,0.00019288753,0.00058158743,0.00001786898,4.1183457e-9,1.8388359e-9,0.000001837266,0.00093105,0.5182878],"study_design_scores_gemma":[0.00090780534,0.0010355964,0.34425136,0.0012942863,0.009836525,0.0029697067,0.0000057289444,0.0000021692836,5.5315382e-8,0.000016907303,0.63945085,0.00022898597],"about_ca_topic_score_codex":0.00002236429,"about_ca_topic_score_gemma":0.000005652763,"teacher_disagreement_score":0.6385198,"about_ca_system_score_codex":0.00034961532,"about_ca_system_score_gemma":0.0008331923,"threshold_uncertainty_score":0.99983704},"labels":[],"label_agreement":null},{"id":"W1973610900","doi":"10.1002/ajh.10393","title":"Case of acute lymphoblastic leukemia presenting with t(14;18)/<i>BCL2</i>, t(8;14)/cMYC, and t(1;2)/<i>FCGR2B</i>","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chromosomal translocation; BCL6; Cancer research; Lymphoma; Lymphoblastic lymphoma; Phenotype; Follicular lymphoma; Biology; Molecular biology; T cell; Antibody; Immunology; Gene; B cell; Genetics; Immune system; Germinal center","score_opus":0.009367562735246984,"score_gpt":0.2615077763345461,"score_spread":0.2521402135992991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973610900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657506,0.0010484809,0.0002003947,0.00031588876,0.00009532351,0.00015895256,0.0000062844615,0.0000105074005,0.0015891124],"genre_scores_gemma":[0.99318546,0.0003263387,0.0060344194,0.00031996166,0.000032776094,0.0000076792185,0.000001360411,0.000028433205,0.00006356582],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983898,0.00013458055,0.0006570961,0.00022636502,0.00023653667,0.00035561953],"domain_scores_gemma":[0.9979041,0.00038384405,0.0008916946,0.00025225186,0.00027630635,0.00029178354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019948238,0.00023685023,0.0011142938,0.00019947898,0.0000702077,0.000012025342,0.00007510302,0.00005841717,0.00006003815],"category_scores_gemma":[0.000132619,0.00016005537,0.00014352493,0.0002717286,0.0005844534,0.00008836605,0.000029061168,0.00015720988,0.0000042212973],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017722913,0.0013234449,0.82449746,0.00031087332,0.004956991,0.1449109,0.0015027869,0.00004372139,0.001680359,0.004397906,0.0036615194,0.010941741],"study_design_scores_gemma":[0.009182118,0.0055748895,0.010930855,0.00033232625,0.0024105622,0.94194126,0.0013522705,0.000057417397,0.026239457,0.00019505681,0.0015134469,0.00027034708],"about_ca_topic_score_codex":0.000099644785,"about_ca_topic_score_gemma":0.000012777255,"teacher_disagreement_score":0.8135666,"about_ca_system_score_codex":0.00013364143,"about_ca_system_score_gemma":0.00048292507,"threshold_uncertainty_score":0.65268683},"labels":[],"label_agreement":null},{"id":"W1973773204","doi":"10.1016/j.beha.2011.02.006","title":"Transformation of follicular lymphoma","year":2011,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Pathogenesis; Lymphoma; Medicine; Transformation (genetics); Natural history; Pathology; Immunology; Biology; Internal medicine; Genetics","score_opus":0.39168052905457135,"score_gpt":0.5762903486837176,"score_spread":0.1846098196291463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973773204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020470512,0.9651823,0.000017985034,0.0007926431,0.00029475047,0.0027299381,0.000031282794,0.0000366968,0.030709704],"genre_scores_gemma":[0.0003145099,0.9970513,0.0010838024,0.000102686165,0.00018324838,0.00063645706,0.00016734828,0.000070688,0.000389983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904561,0.0041635768,0.0028924465,0.0007970011,0.00092684425,0.00076401624],"domain_scores_gemma":[0.98347247,0.012561177,0.0010374509,0.0012770091,0.0011350083,0.0005168968],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006460964,0.0004513025,0.00471965,0.00054966955,0.00012823389,0.00002743149,0.00044611676,0.0014117884,0.0003152542],"category_scores_gemma":[0.011579704,0.00031459087,0.0015233869,0.00073810184,0.0008215751,0.00029596678,0.00020454086,0.001029853,0.002293652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034485897,0.009294365,0.00008449895,0.014810559,0.0014863932,0.0023631046,0.0001123966,4.698065e-9,2.7541699e-8,0.01549706,0.0012115992,0.9547951],"study_design_scores_gemma":[0.002446153,0.0033742122,0.00002554061,0.009688548,0.00478709,0.007286858,0.00013129368,0.0000020189852,0.000004670198,0.00014604638,0.97189873,0.00020881229],"about_ca_topic_score_codex":0.00037954442,"about_ca_topic_score_gemma":0.000018517248,"teacher_disagreement_score":0.97068715,"about_ca_system_score_codex":0.0003433749,"about_ca_system_score_gemma":0.0043374086,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W1973838311","doi":"10.1016/s1359-6349(03)90008-5","title":"Role of radiation therapy in localised non-Hodgkin's lymphomas","year":2003,"lang":"en","type":"article","venue":"European Journal of Cancer Supplements","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Disease; Follicular lymphoma; Medical physics; Oncology; Radiology; Internal medicine","score_opus":0.01200055884370317,"score_gpt":0.2827546296577005,"score_spread":0.2707540708139973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973838311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884899,0.0050808717,0.000028909859,0.00022692893,0.00020219319,0.00022185298,0.000016468033,0.0000028109457,0.005730068],"genre_scores_gemma":[0.9953748,0.0038429901,0.0003392159,0.00025905267,0.00010175268,0.000005105501,0.0000075533835,0.000022348911,0.000047163347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986462,0.00019083903,0.0005658654,0.000104939245,0.00032471053,0.00016741795],"domain_scores_gemma":[0.999254,0.000023285673,0.0003689297,0.00013836162,0.000108423475,0.000107030035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045533464,0.00011947333,0.00029308914,0.00016106847,0.000019125215,0.000010060661,0.00008378459,0.000014382681,0.00079957105],"category_scores_gemma":[0.000022299755,0.00009022876,0.00011460173,0.00015891122,0.000021453803,0.00008491103,0.000009241535,0.000058814403,0.0000075957264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042420923,0.00068311975,0.7807099,0.000014922497,0.0002561029,0.0002110702,0.00070596184,0.000053232794,0.003948756,0.00005075348,0.0026962361,0.2102457],"study_design_scores_gemma":[0.022547193,0.0013900435,0.74697334,0.00020275735,0.000077652374,0.000040866125,0.00018329112,0.000015240006,0.11157639,0.00003060055,0.11686961,0.0000930062],"about_ca_topic_score_codex":0.00007492528,"about_ca_topic_score_gemma":0.000013313576,"teacher_disagreement_score":0.2101527,"about_ca_system_score_codex":0.00022994935,"about_ca_system_score_gemma":0.00021272372,"threshold_uncertainty_score":0.8754743},"labels":[],"label_agreement":null},{"id":"W1973897018","doi":"10.1309/ajcpmmlq67yomgew","title":"Automated Analysis of Multidimensional Flow Cytometry Data Improves Diagnostic Accuracy Between Mantle Cell Lymphoma and Small Lymphocytic Lymphoma","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research","keywords":"Mantle cell lymphoma; Flow cytometry; Lymphoma; Cytometry; Fluorescence in situ hybridization; Computer science; Pathology; Medicine; Biology; Immunology","score_opus":0.0866818042701752,"score_gpt":0.37417511404966114,"score_spread":0.28749330977948595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973897018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975843,0.0012255806,0.0002523761,0.0001367332,0.00024794386,0.00019937572,0.00019368232,0.00004028414,0.00011971471],"genre_scores_gemma":[0.9711866,0.0014226091,0.026547778,0.0005069304,0.0001743216,0.0000049954024,0.00011244026,0.00003323699,0.000011105373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955819,0.00055542524,0.002438761,0.0006079976,0.00039767954,0.00041818756],"domain_scores_gemma":[0.98714733,0.008482965,0.002411726,0.0009836446,0.00038604558,0.0005883157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012968064,0.00033776002,0.0027156721,0.00070214557,0.00005991797,0.0000106636135,0.00044743557,0.00020262733,0.000054010125],"category_scores_gemma":[0.004651433,0.0002473367,0.0005801577,0.0009602245,0.0010394397,0.00014671148,0.0003788083,0.00014556089,0.00001637945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077533576,0.0023514638,0.7342062,0.00003380906,0.0029705837,0.0020099834,0.00024258057,0.0000058218657,0.0002491066,0.000005709006,0.00012913054,0.25702026],"study_design_scores_gemma":[0.010029264,0.0045367074,0.9697157,0.00009330478,0.009373865,0.00069376844,0.0002791574,0.0041577024,0.0007537802,0.000019297579,0.00013702142,0.00021040942],"about_ca_topic_score_codex":0.00033989368,"about_ca_topic_score_gemma":0.000019796007,"teacher_disagreement_score":0.25680986,"about_ca_system_score_codex":0.0001608041,"about_ca_system_score_gemma":0.00082788675,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W1973979329","doi":"10.1016/j.clml.2014.07.015","title":"A Canadian Evidence-Based Guideline for the First-Line Treatment of Follicular Lymphoma: Joint Consensus of the Lymphoma Canada Scientific Advisory Board","year":2014,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Calgary; McGill University; University of Toronto; Dalhousie University; BC Cancer Agency; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Guideline; Follicular lymphoma; Medicine; Lymphoma; Family medicine; Disease; Executive summary; Intensive care medicine; Front line; Internal medicine; Political science; Pathology","score_opus":0.10358129079999641,"score_gpt":0.35496664619442087,"score_spread":0.25138535539442447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973979329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011836782,0.9691123,0.000026691203,0.005704411,0.003496351,0.0080108335,0.0015797314,0.000060202983,0.00017273746],"genre_scores_gemma":[0.069137335,0.92088896,0.0008033979,0.003055017,0.0014342839,0.002409284,0.0007155454,0.00034578246,0.001210415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876653,0.0007736765,0.0065903952,0.0019613942,0.0015579454,0.0014512831],"domain_scores_gemma":[0.97992575,0.00920817,0.003600045,0.004700962,0.0013323659,0.0012327161],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0025499763,0.001670018,0.0070007998,0.0004314508,0.00089316524,0.00010993867,0.0014125576,0.0011399,0.00009908345],"category_scores_gemma":[0.0038575497,0.000893511,0.0058535584,0.0012790287,0.0016811283,0.000055406912,0.00023446744,0.0001518062,0.000034809415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00031322511,0.0009844113,0.0010356781,0.004966446,0.0022016922,0.0002253741,0.000023902167,0.000044702512,7.7398266e-7,0.000119254175,0.040146075,0.9499385],"study_design_scores_gemma":[0.01169449,0.0015594611,0.021816071,0.018090706,0.010802427,0.00022841581,0.000027057902,0.0010666118,0.00016575532,0.00002866712,0.9337709,0.0007494161],"about_ca_topic_score_codex":0.7477101,"about_ca_topic_score_gemma":0.7807855,"teacher_disagreement_score":0.94918907,"about_ca_system_score_codex":0.020723531,"about_ca_system_score_gemma":0.107809246,"threshold_uncertainty_score":0.99960464},"labels":[],"label_agreement":null},{"id":"W1974251353","doi":"10.1016/j.bbmt.2008.05.021","title":"Second Autologous Stem Cell Transplantation for Relapsed Lymphoma after a Prior Autologous Transplant","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Lymphoma; Internal medicine; Confidence interval; Transplantation; Single Center; Surgery; Autologous stem-cell transplantation; Gastroenterology","score_opus":0.011114813398856949,"score_gpt":0.2264137020942178,"score_spread":0.21529888869536085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974251353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432725,0.002363317,0.0007113992,0.00016605842,0.00014851846,0.00096553925,0.0008818118,0.000075445554,0.0003606612],"genre_scores_gemma":[0.99146396,0.0052311616,0.0018874687,0.00016542053,0.000041375093,0.0003031403,0.00072852947,0.000023422475,0.00015553259],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859565,0.00007158613,0.00048489054,0.0004338352,0.00010483473,0.0003092179],"domain_scores_gemma":[0.9992891,0.00021749068,0.00014899015,0.00015092196,0.00007013394,0.00012336714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011137122,0.00027032229,0.0005381086,0.00015822251,0.0001343677,0.0000049730725,0.000055905923,0.0003138926,0.000038851882],"category_scores_gemma":[0.0000020063494,0.00022367177,0.00017684081,0.00008162064,0.00019922155,0.00007966628,0.0000026174223,0.000055739623,0.000003740375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022049544,0.0036613757,0.40704417,0.008105807,0.0014595571,0.0030006242,0.01763888,0.000007108424,0.4606889,0.0010987268,0.00014727136,0.07509806],"study_design_scores_gemma":[0.021591697,0.0030046995,0.65403146,0.00020741171,0.0026815948,0.005042494,0.0000611772,0.00004977695,0.312536,0.00009310049,0.00038085523,0.00031973037],"about_ca_topic_score_codex":0.000041513136,"about_ca_topic_score_gemma":0.00007706453,"teacher_disagreement_score":0.2469873,"about_ca_system_score_codex":0.0000210541,"about_ca_system_score_gemma":0.00013259012,"threshold_uncertainty_score":0.912107},"labels":[],"label_agreement":null},{"id":"W1974312523","doi":"10.1016/j.bbmt.2007.11.013","title":"Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma","year":2008,"lang":"en","type":"review","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemoimmunotherapy; Salvage therapy; Oncology; Chemotherapy; Internal medicine; Lymphoma; Refractory (planetary science); Regimen; Transplantation; Chemotherapy regimen; Aggressive lymphoma; Diffuse large B-cell lymphoma; Hematopoietic stem cell transplantation; Rituximab","score_opus":0.025420576980258063,"score_gpt":0.2936905210275606,"score_spread":0.26826994404730253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974312523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019362515,0.97791904,0.0000319793,0.000019716017,0.00014728842,0.0013090296,0.00095518096,0.00003109964,0.00022417858],"genre_scores_gemma":[0.023250336,0.97259045,0.00031041438,0.00007320305,0.00010633119,0.0002932823,0.0032370968,0.00003644579,0.00010242643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987583,0.000086276006,0.00046782455,0.00038022138,0.000072465904,0.00023489598],"domain_scores_gemma":[0.999086,0.00031744016,0.0002794116,0.00018799181,0.00004184069,0.00008728896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077701945,0.0003402798,0.0012590466,0.00015054437,0.000078359626,0.000004013836,0.00006200662,0.00047931983,0.000009783861],"category_scores_gemma":[0.000006307602,0.00023548258,0.00042115408,0.000065397675,0.0000885407,0.000031348078,0.0000052446876,0.00006193318,0.0000038947373],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046063165,0.007961628,0.00094359904,0.018827582,0.0010931769,0.0001087141,0.00029674007,4.103991e-9,0.00055906095,0.0002432582,0.00031904265,0.96918654],"study_design_scores_gemma":[0.039758395,0.002514872,0.00065806624,0.0029421854,0.005065314,0.0005673433,0.000010471848,3.939956e-7,0.0013645797,0.00002744681,0.9467662,0.00032476126],"about_ca_topic_score_codex":0.000019703797,"about_ca_topic_score_gemma":0.0000052675687,"teacher_disagreement_score":0.9688618,"about_ca_system_score_codex":0.000022139291,"about_ca_system_score_gemma":0.00018453899,"threshold_uncertainty_score":0.9602701},"labels":[],"label_agreement":null},{"id":"W1974587089","doi":"10.1002/(sici)1097-0142(20000215)88:4<894::aid-cncr21>3.0.co;2-o","title":"Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Bone marrow; Pathology; Lymphoma; Biopsy; Stage (stratigraphy)","score_opus":0.0049433467705201715,"score_gpt":0.23542665978308913,"score_spread":0.23048331301256897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974587089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952427,0.0012927632,0.000010943606,0.00018529741,0.00006118426,0.00025883003,0.0001546086,0.00001993891,0.002773737],"genre_scores_gemma":[0.997103,0.00028541422,0.00038512945,0.00046190125,0.00005105791,0.00008087406,0.000078528865,0.000023391167,0.0015307054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916863,0.00000855277,0.00015960103,0.00020324651,0.00026059078,0.00019936176],"domain_scores_gemma":[0.9995289,0.000018478662,0.000055027056,0.00021936308,0.000068717265,0.00010955775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000029090734,0.00013287886,0.0002726394,0.000054837754,0.000031680775,0.0000072338016,0.0000398526,0.000042616135,0.0021450291],"category_scores_gemma":[0.000003845913,0.00009351124,0.00005036883,0.00020497951,0.000045075343,0.000052872616,0.000009431372,0.000024915937,0.000032348828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034800725,0.0006025473,0.706479,0.00005216865,0.00012763287,0.000021822898,0.000114201954,0.000011773538,0.00016167264,0.0000011552734,0.011300643,0.28077936],"study_design_scores_gemma":[0.0099442955,0.00041715748,0.95392823,0.00025958827,0.00016689546,0.0000024591707,0.000020251287,0.00009924391,0.012220195,0.0000024593928,0.0227988,0.00014043385],"about_ca_topic_score_codex":0.00023078686,"about_ca_topic_score_gemma":0.000008032644,"teacher_disagreement_score":0.28063893,"about_ca_system_score_codex":0.00027221118,"about_ca_system_score_gemma":0.00010383675,"threshold_uncertainty_score":0.99876714},"labels":[],"label_agreement":null},{"id":"W1974617054","doi":"10.1016/j.humpath.2006.10.017","title":"Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Calgary Laboratory Services","funders":"","keywords":"Marginal zone; Mantle cell lymphoma; Lymphoma; CD5; Cyclin D1; Pathology; CD43; Immunohistochemistry; Lymph node; Mantle zone; B cell; Large cell; Biology; Medicine; Cell; CD20; Antibody; Cell cycle; Cancer; Internal medicine; Immunology; Adenocarcinoma","score_opus":0.017197094183516805,"score_gpt":0.26989413480432395,"score_spread":0.25269704062080717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974617054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802981,0.0018247741,0.0005134759,0.00017493695,0.0002475435,0.00062298373,0.000055883793,0.00007341054,0.016188895],"genre_scores_gemma":[0.9928034,0.00027298316,0.003898614,0.0004948349,0.00018029103,0.00004714921,0.00012524665,0.000056186942,0.002121322],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969314,0.00018902597,0.0007968047,0.00088487956,0.0003674787,0.00083041925],"domain_scores_gemma":[0.9981097,0.0004280173,0.00035857045,0.0005804512,0.000166629,0.00035662053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075790717,0.0004622503,0.00095845794,0.00036418354,0.00023368868,0.000026401745,0.00018463742,0.00047533555,0.00018934741],"category_scores_gemma":[0.0000406975,0.00038532258,0.00022854797,0.0002501249,0.00045524255,0.0000730621,0.0002371484,0.0001401964,0.00011776412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046155,0.05199255,0.22005366,0.0009689344,0.0003057921,0.19831829,0.0044917148,0.000014212258,0.49220678,0.00463453,0.005845168,0.016552864],"study_design_scores_gemma":[0.061304282,0.005685355,0.62372047,0.00021279816,0.0008445482,0.01138684,0.0009992684,0.00010150582,0.2918889,0.00044320873,0.0026284892,0.00078434806],"about_ca_topic_score_codex":0.00029431525,"about_ca_topic_score_gemma":0.00008914243,"teacher_disagreement_score":0.40366682,"about_ca_system_score_codex":0.00023975097,"about_ca_system_score_gemma":0.00012520756,"threshold_uncertainty_score":0.99985987},"labels":[],"label_agreement":null},{"id":"W1974738398","doi":"10.3816/clm.2005.n.030","title":"A Randomized Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin as Salvage Chemotherapy Followed by Posttransplantation Rituximab Maintenance Therapy Versus Observation for Treatment of Aggressive B-Cell and T-Cell Non-Hodgkin's Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Salvage therapy; Etoposide; Internal medicine; Oncology; Vincristine; Gemcitabine; Cytarabine; Carboplatin; Febrile neutropenia; Surgery; Chemotherapy; Rituximab; Neutropenia; Cyclophosphamide; Cisplatin; Lymphoma","score_opus":0.045795418080093964,"score_gpt":0.36480908885507635,"score_spread":0.3190136707749824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974738398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725843,0.005663087,0.00025600867,0.0003467474,0.00023926499,0.005814325,0.0001885713,0.00004275375,0.00019079013],"genre_scores_gemma":[0.97391915,0.017696496,0.006919248,0.00020257557,0.000113635455,0.0006735006,0.00024268204,0.00007873736,0.00015399084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959782,0.000354808,0.0017549082,0.0010077138,0.00044240963,0.00046196365],"domain_scores_gemma":[0.9905121,0.006696046,0.0016313929,0.00051796343,0.00030035854,0.000342178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087389944,0.00066921365,0.0025698668,0.00017216214,0.00015109021,0.00004360023,0.00012179869,0.00035184153,0.000020257607],"category_scores_gemma":[0.0004842803,0.0005121028,0.00042187155,0.00026282488,0.00046410988,0.00020919711,0.000030740477,0.000056075824,0.0000022448307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63311845,0.030899199,0.018706135,0.00016159695,0.0014819037,0.00006063108,0.0022472877,0.000002720473,0.0062188455,0.00003846294,0.00020897757,0.30685577],"study_design_scores_gemma":[0.8992887,0.030609258,0.03963176,0.00018439208,0.0018506233,0.000024536397,0.0006165365,0.0028055855,0.024226306,0.000026760867,0.00032616168,0.0004093448],"about_ca_topic_score_codex":0.0005857235,"about_ca_topic_score_gemma":0.00007320231,"teacher_disagreement_score":0.30644643,"about_ca_system_score_codex":0.00021309206,"about_ca_system_score_gemma":0.00023545648,"threshold_uncertainty_score":0.99973303},"labels":[],"label_agreement":null},{"id":"W1974941133","doi":"10.3109/07357907.2013.820319","title":"The Use of Salivary Protein Secretions as an<i>In Vivo</i>Model to Study Mantel Cell Lymphoma Progression and Treatment","year":2013,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Theoretical Astrophysics","keywords":"In vivo; Saliva; Salivary Proteins; Chemotherapy; Lymphoma; Medicine; Salivary gland; Oncology; Internal medicine; Cancer research; Pathology; Immunology; Biology","score_opus":0.06818538827177109,"score_gpt":0.31944437943282394,"score_spread":0.2512589911610529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974941133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944237,0.0002906363,0.0000070436263,0.0014814468,0.000027310367,0.0036569068,0.000012744355,0.000021818281,0.00007837858],"genre_scores_gemma":[0.993642,0.00011690211,0.0016920025,0.0002693971,0.000027261538,0.0038550373,0.000013555185,0.000015550895,0.00036833528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991025,0.00006925158,0.00023787956,0.00025245413,0.00019010488,0.0001478503],"domain_scores_gemma":[0.9993236,0.00004313994,0.00008682312,0.00026871785,0.00009144746,0.00018627636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006793186,0.00013975153,0.00017128147,0.00006390386,0.00010675336,0.000044885495,0.00003890297,0.000044300014,0.000022564313],"category_scores_gemma":[0.000023770493,0.00008471452,0.000026053835,0.00014892388,0.00007221659,0.00017554585,0.000024424862,0.00002186371,0.000007339653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003762208,0.005041679,0.74889255,0.000085740394,0.00013786895,0.000026995558,0.009926631,0.00049158884,0.078352876,0.0005795096,0.0010088136,0.15507953],"study_design_scores_gemma":[0.008347512,0.0042153075,0.67933416,0.00051879225,0.0002200419,0.000008385728,0.00092705316,0.014177206,0.29017726,0.0009972397,0.00084191066,0.00023515424],"about_ca_topic_score_codex":0.0029679318,"about_ca_topic_score_gemma":0.00034960223,"teacher_disagreement_score":0.21182439,"about_ca_system_score_codex":0.00030003313,"about_ca_system_score_gemma":0.00021115801,"threshold_uncertainty_score":0.4486645},"labels":[],"label_agreement":null},{"id":"W1975003408","doi":"10.1002/path.1981","title":"A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma","year":2006,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Follicular lymphoma; Marginal zone; Lymphoma; Phenotype; Biology; Follicular phase; Pathology; Cancer research; Medicine; Immunology; Genetics; Gene; B cell; Antibody","score_opus":0.012051194654928762,"score_gpt":0.23893845063369426,"score_spread":0.2268872559787655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975003408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479866,0.0019055594,0.00057343347,0.001460805,0.0000646381,0.00026943212,0.000026298309,0.000009370166,0.00089177926],"genre_scores_gemma":[0.9973674,0.000117866184,0.0016129083,0.00037941523,0.000112453774,0.000013124214,0.000020667509,0.000029792238,0.00034636806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811554,0.0002695824,0.0006321661,0.00018399513,0.00043824088,0.0003604754],"domain_scores_gemma":[0.998511,0.0001909844,0.0005708752,0.00029581983,0.00032612568,0.00010519742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005072485,0.00024499997,0.0007339783,0.00022956496,0.00008159319,0.000010905191,0.00015583076,0.00015073834,0.00025807598],"category_scores_gemma":[0.00003598949,0.00013875045,0.0001255165,0.0003971541,0.00029369732,0.000069509,0.000032882934,0.00014779315,0.000011260751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020603746,0.013868886,0.87806517,0.0001385795,0.002325582,0.031819347,0.0030209494,0.0007683714,0.0188673,0.0012487295,0.005170607,0.02410276],"study_design_scores_gemma":[0.019048082,0.0038929903,0.95862526,0.00027243714,0.0009358752,0.012848552,0.00022160826,0.00007260442,0.0032295003,0.00018582992,0.00051246345,0.00015481647],"about_ca_topic_score_codex":0.00015162936,"about_ca_topic_score_gemma":0.00042770733,"teacher_disagreement_score":0.080560096,"about_ca_system_score_codex":0.00031755373,"about_ca_system_score_gemma":0.0006171358,"threshold_uncertainty_score":0.5658079},"labels":[],"label_agreement":null},{"id":"W1975712049","doi":"10.1016/j.ejca.2004.02.006","title":"Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease","year":2004,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Lymphoma; Asymptomatic; Immunophenotyping; Rituximab; Marginal zone B-cell lymphoma; Biopsy; Lung; Bone marrow; Mucosa-associated lymphoid tissue; Internal medicine; MALT lymphoma; Pathology; Marginal zone; B cell; Antigen; Antibody; Immunology","score_opus":0.031006899039304696,"score_gpt":0.3474808403479048,"score_spread":0.31647394130860007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975712049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922877,0.004849906,0.000010531689,0.00088213716,0.0005176022,0.00030116455,0.000021685568,0.000014574165,0.0011146739],"genre_scores_gemma":[0.99793065,0.00071650825,0.000089167144,0.00038803928,0.0005682723,0.0000047513545,0.0000030700746,0.00003873362,0.00026080533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774015,0.00034256387,0.0009941917,0.00018709342,0.0005403859,0.00019564302],"domain_scores_gemma":[0.9981188,0.0000619876,0.000738241,0.00025094528,0.00038842962,0.00044158252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006130401,0.00017489669,0.0005936058,0.00009850555,0.000050755894,0.000016963282,0.00015498477,0.00002321274,0.00011046206],"category_scores_gemma":[0.00028969123,0.00012444885,0.00023818013,0.00019827245,0.000065652544,0.00007627202,0.000048334467,0.00008653294,0.000022434726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022733808,0.017331889,0.8344523,0.000040155104,0.0014882535,0.0099327965,0.0013794646,0.00019821785,0.0001206955,0.00001787446,0.0034703754,0.12929465],"study_design_scores_gemma":[0.041100226,0.00450931,0.94404805,0.0005617032,0.0010650578,0.0001094006,0.00025946676,0.000001795777,0.00028978358,0.00001248742,0.007930635,0.000112103444],"about_ca_topic_score_codex":0.000112922986,"about_ca_topic_score_gemma":0.000038773473,"teacher_disagreement_score":0.12918253,"about_ca_system_score_codex":0.0004423153,"about_ca_system_score_gemma":0.00085413485,"threshold_uncertainty_score":0.50748765},"labels":[],"label_agreement":null},{"id":"W1975846828","doi":"10.1016/j.semradonc.2007.02.009","title":"Pediatric Hodgkin Lymphoma: Maximizing Efficacy and Minimizing Toxicity","year":2007,"lang":"en","type":"review","venue":"Seminars in Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Disease; Lymphoma; Oncology; Internal medicine; Stage (stratigraphy); Toxicity; Clinical trial; Pediatrics","score_opus":0.05884376718186866,"score_gpt":0.40053036537637954,"score_spread":0.34168659819451086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975846828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005940828,0.98927444,0.0000070463907,0.000105033396,0.0005395923,0.001430738,0.000018394629,0.000059415026,0.0026245168],"genre_scores_gemma":[0.0006087734,0.995912,0.0020134319,0.00022604589,0.0006438327,0.00020463331,0.00019837917,0.00006233606,0.00013054158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716675,0.00026190432,0.0010557716,0.00071710104,0.00025730502,0.0005411431],"domain_scores_gemma":[0.9968876,0.0018744281,0.0005873551,0.00035709448,0.000042808402,0.00025067304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007642287,0.00051349186,0.0022975572,0.0010392632,0.00008964879,0.000024525838,0.00012513639,0.0009799036,0.00004802586],"category_scores_gemma":[0.00037943295,0.00044936847,0.0002725699,0.00074894936,0.000081689046,0.000066615976,0.00010055884,0.00028168323,0.000060099996],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040929026,0.0009223561,0.0026685602,0.002838327,0.0001041192,0.0008558946,0.00020561948,7.792581e-7,2.4518252e-7,0.000060738214,0.0011142188,0.9911882],"study_design_scores_gemma":[0.005033369,0.00072643434,0.006468176,0.003190313,0.0017334318,0.00092093146,0.000043623088,0.000012412243,0.0000047055073,0.000010934917,0.981497,0.00035865972],"about_ca_topic_score_codex":0.000033775137,"about_ca_topic_score_gemma":0.00001571676,"teacher_disagreement_score":0.9908295,"about_ca_system_score_codex":0.0027929128,"about_ca_system_score_gemma":0.000985058,"threshold_uncertainty_score":0.9997958},"labels":[],"label_agreement":null},{"id":"W1975927623","doi":"10.1007/s12185-010-0608-7","title":"Targeted treatment and new agents in follicular lymphoma","year":2010,"lang":"en","type":"review","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Follicular lymphoma; Lenalidomide; Bendamustine; Medicine; Rituximab; Chemotherapy; Lymphoma; Bortezomib; Hematology; Oncology; Cancer research; Pharmacology; Internal medicine; Immunology; Multiple myeloma","score_opus":0.06392537263640298,"score_gpt":0.38410035173294454,"score_spread":0.3201749790965416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975927623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005067034,0.99271166,0.0000051765314,0.0007308042,0.0009610356,0.00027936912,0.00001163549,0.000005105098,0.00022819592],"genre_scores_gemma":[0.0014779754,0.9971784,0.00062098453,0.000129445,0.00030969628,0.000017609153,0.00004452778,0.00002350911,0.00019789937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844867,0.000059583843,0.0008829574,0.00019733948,0.00024893324,0.00016252145],"domain_scores_gemma":[0.9987247,0.00015952309,0.00064519566,0.00014031453,0.00013103631,0.00019926117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009352096,0.00028401043,0.0017157522,0.00054436247,0.000012332695,0.000022266537,0.00017056038,0.00030682402,0.00012968708],"category_scores_gemma":[0.00009257975,0.00018094214,0.0004909081,0.00007577622,0.000039533712,0.000051277413,0.000044089757,0.00014341729,0.000029799769],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006073163,0.00074279,0.0031580892,0.00025574554,0.0014762407,0.0077056456,0.000049945676,1.00114256e-7,6.474619e-7,0.00068356976,0.0008934112,0.9849731],"study_design_scores_gemma":[0.0047440436,0.0003927856,0.0009964841,0.0041942014,0.00086366304,0.03965005,0.000005815558,0.0000017424571,0.000028511115,0.00013540132,0.94887716,0.00011016443],"about_ca_topic_score_codex":0.000082585146,"about_ca_topic_score_gemma":0.000032909622,"teacher_disagreement_score":0.9848629,"about_ca_system_score_codex":0.0005467049,"about_ca_system_score_gemma":0.000867003,"threshold_uncertainty_score":0.7378606},"labels":[],"label_agreement":null},{"id":"W1975979823","doi":"10.3109/10428194.2013.783211","title":"High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Rituximab; Etoposide; Internal medicine; Salvage therapy; International Prognostic Index; Regimen; Gastroenterology; Cyclophosphamide; Refractory (planetary science); Surgery; Chemotherapy; Induction chemotherapy; Progression-free survival; Oncology; Lymphoma","score_opus":0.008772769486172028,"score_gpt":0.24535839739229398,"score_spread":0.23658562790612195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975979823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98351616,0.009112012,0.000061431965,0.000910942,0.0004264278,0.0044635744,0.00031628672,0.00033643423,0.000856756],"genre_scores_gemma":[0.9765485,0.010505484,0.0029032696,0.0049954606,0.00045869057,0.0025109756,0.0007088961,0.00033316785,0.0010355334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934649,0.00022415572,0.0014463977,0.0021888118,0.0009117488,0.0017639967],"domain_scores_gemma":[0.99375033,0.0015245219,0.0010311074,0.0013258453,0.0008696964,0.0014985189],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003981635,0.0018520883,0.0022911725,0.0005322822,0.00081838475,0.00043641898,0.0004291384,0.000934337,0.00018880512],"category_scores_gemma":[0.00020628946,0.0013620647,0.00048386373,0.0006219411,0.0009576859,0.0008708505,0.00018825647,0.00020710652,0.00010836772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028913772,0.0027869628,0.13484257,0.0011316703,0.0038990828,0.0076649715,0.006277368,0.000048244354,0.016179735,0.0017609858,0.015613759,0.78088087],"study_design_scores_gemma":[0.13206461,0.004854204,0.8041553,0.002104947,0.00127529,0.0051664296,0.001513879,0.0016411074,0.03748245,0.0007864671,0.0068552312,0.0021001163],"about_ca_topic_score_codex":0.014002888,"about_ca_topic_score_gemma":0.00020526144,"teacher_disagreement_score":0.77878076,"about_ca_system_score_codex":0.0046612625,"about_ca_system_score_gemma":0.0033440734,"threshold_uncertainty_score":0.9994224},"labels":[],"label_agreement":null},{"id":"W1976058252","doi":"10.1186/ar3998","title":"Nonlymphoma hematological malignancies in systemic lupus erythematosus","year":2012,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université Laval; Toronto Western Hospital; McGill University Health Centre","funders":"Canadian Arthritis Network; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society; Lupus Research Alliance","keywords":"Medicine; Rheumatology; Internal medicine; Hematology; Dermatology; Oncology","score_opus":0.06309912581167211,"score_gpt":0.34635442974207403,"score_spread":0.28325530393040194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976058252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9181325,0.076483786,0.0000034278069,0.0009793967,0.00018458498,0.000959596,0.0000073953247,0.00007054995,0.003178759],"genre_scores_gemma":[0.9662612,0.032015823,0.00022731694,0.00023568483,0.00017401668,0.0006233779,0.000014779268,0.000030563035,0.00041724957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704313,0.0003221971,0.00037931424,0.00033694165,0.00079437456,0.0011240237],"domain_scores_gemma":[0.9985802,0.0003778404,0.000041720243,0.00047398586,0.00015495387,0.00037127125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011155045,0.00020929874,0.000528667,0.00028085447,0.00014797966,0.000051800773,0.00014586518,0.00015459258,0.0003847223],"category_scores_gemma":[0.0001242645,0.00015118663,0.00013983696,0.00048780272,0.00022113077,0.00018187269,0.00007317398,0.00021344835,0.0006469273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039359907,0.0022473305,0.90536785,0.000058917405,0.0000762907,0.0012513025,0.0014300687,2.8402394e-7,0.0040114215,0.0061105974,0.003872065,0.07518028],"study_design_scores_gemma":[0.052168984,0.0043735933,0.70564634,0.0046165837,0.000022481623,0.083353095,0.005632359,0.000060047776,0.05610337,0.002189806,0.08480684,0.0010265165],"about_ca_topic_score_codex":0.00019094997,"about_ca_topic_score_gemma":0.000045711375,"teacher_disagreement_score":0.19972152,"about_ca_system_score_codex":0.00033722294,"about_ca_system_score_gemma":0.00016060087,"threshold_uncertainty_score":0.8315157},"labels":[],"label_agreement":null},{"id":"W1976204719","doi":"10.5489/cuaj.1452","title":"A unique case of kidney’s collecting system MALT lymphoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; MALT lymphoma; Kidney; Ureter; Lymphoma; Pathology; Gastrointestinal tract; Mucosa-associated lymphoid tissue; Lesion; Lymphatic system; Immunohistochemistry; Radiology; Urology; Internal medicine","score_opus":0.010665649562726736,"score_gpt":0.22734688736522668,"score_spread":0.21668123780249995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976204719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730603,0.00007828786,0.00006396858,0.011888911,0.00027319798,0.00019199148,0.00003190051,0.000028485048,0.014382952],"genre_scores_gemma":[0.9955808,0.000010648895,0.00031263105,0.0034998488,0.00026522885,0.000010783187,0.00000789139,0.0000090563835,0.0003030971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987245,0.00023039801,0.00036780693,0.00013763341,0.00019542858,0.00034422002],"domain_scores_gemma":[0.99771166,0.00023119614,0.00032974678,0.000100121666,0.00029326574,0.001334004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076762703,0.00011189596,0.00032719268,0.00016687893,0.00026503013,0.00004057423,0.000053333348,0.00020045326,0.0001439184],"category_scores_gemma":[0.0021168445,0.00008561181,0.00014452169,0.00021183967,0.00001751865,0.000038230915,0.0000087275375,0.00012822372,0.000023102019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049631177,0.00014538736,0.9593612,0.000035149485,0.0002652373,0.0038615565,0.00015735399,0.00001578972,0.000043613814,0.0035729236,0.023972454,0.008519686],"study_design_scores_gemma":[0.01085738,0.002077105,0.76739377,0.00026626792,0.0006651804,0.066978596,0.0007899432,0.0030530894,0.0005798456,0.00047131637,0.14648204,0.0003854528],"about_ca_topic_score_codex":0.0055080266,"about_ca_topic_score_gemma":0.0008486674,"teacher_disagreement_score":0.19196743,"about_ca_system_score_codex":0.0029183219,"about_ca_system_score_gemma":0.0011777601,"threshold_uncertainty_score":0.8326525},"labels":[],"label_agreement":null},{"id":"W1976299049","doi":"10.1002/ajh.1102","title":"Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project","year":2001,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; U.S. Department of Health and Human Services","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Anaplastic lymphoma kinase; Medicine; Large-cell lymphoma; Null cell; Stage (stratigraphy); International Prognostic Index; Peripheral T-cell lymphoma; Internal medicine; Pathology; Non-Hodgkin's lymphoma; Not Otherwise Specified; Bone marrow; Oncology; Diffuse large B-cell lymphoma; T cell; Immunology; Biology","score_opus":0.03797715189213066,"score_gpt":0.32788348335132883,"score_spread":0.2899063314591982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976299049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006869871,0.98976135,0.00010527754,0.00045637065,0.00065005233,0.001083483,0.00023099745,0.000029213616,0.00081340136],"genre_scores_gemma":[0.06499922,0.93325084,0.00042529425,0.00023908961,0.0005589967,0.00010354792,0.00023807316,0.000085516374,0.00009939687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950986,0.0007352189,0.002418767,0.000594588,0.00054822717,0.0006045915],"domain_scores_gemma":[0.9908439,0.0026672606,0.0049769995,0.00095202983,0.0003170007,0.00024280208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005888985,0.00069106446,0.004579581,0.0004151425,0.00014875861,0.00004653395,0.00056949165,0.00031652732,0.000019481173],"category_scores_gemma":[0.00039141582,0.000377818,0.0011310445,0.0009278043,0.0003397334,0.00007116616,0.00008573725,0.00028016968,0.00016645687],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006211743,0.0020931405,0.00068815186,0.0015713273,0.0016709055,0.003239521,0.00034778306,2.644357e-7,7.0116863e-7,0.000094587245,0.012423489,0.97724897],"study_design_scores_gemma":[0.010979051,0.0024058267,0.00082593533,0.017409446,0.0071151583,0.055786967,0.001457274,0.000022885866,0.0000060003727,0.00001082621,0.90358317,0.0003974491],"about_ca_topic_score_codex":0.0003225056,"about_ca_topic_score_gemma":0.000023317218,"teacher_disagreement_score":0.9768515,"about_ca_system_score_codex":0.0009116279,"about_ca_system_score_gemma":0.0026212838,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W1976312922","doi":"10.2353/jmoldx.2006.050050","title":"Association of Clinical Status of Follicular Lymphoma Patients after Autologous Stem Cell Transplant and Quantitative Assessment of Lymphoma in Blood and Bone Marrow as Measured by SYBR Green I Polymerase Chain Reaction","year":2006,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"World Health Organization","keywords":"Minimal residual disease; Follicular lymphoma; Bone marrow; Medicine; Transplantation; Oncology; Stem cell; Internal medicine; Lymphoma; Hematology; Pathology; Gastroenterology; Biology","score_opus":0.008938636229539092,"score_gpt":0.271213103962537,"score_spread":0.2622744677329979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976312922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900281,0.009059803,0.000102620914,0.00014097121,0.00008591552,0.00035816527,0.00018221102,0.0000030729323,0.00003913858],"genre_scores_gemma":[0.9932478,0.0057119043,0.0008898995,0.000052688592,0.000016596627,0.000011071952,0.000039363124,0.000020476344,0.000010190852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970006,0.0003378047,0.0014711905,0.00020060816,0.00075454306,0.00023528107],"domain_scores_gemma":[0.9969027,0.00073913555,0.0016144176,0.00014230389,0.00043291043,0.00016851608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006458014,0.00020283787,0.0009572726,0.00021570022,0.000017338181,0.000007830688,0.000043508997,0.00020592836,0.0000023110197],"category_scores_gemma":[0.00025538218,0.0001728188,0.00020474392,0.00015378515,0.00007563094,0.00007383774,0.000019201238,0.00008908404,1.6011577e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007611046,0.0066101286,0.9665811,0.00022225785,0.0005372277,0.0007951166,0.00022037621,0.000009832753,0.01660096,0.00004925038,0.000060685827,0.007551976],"study_design_scores_gemma":[0.01667675,0.0032789637,0.899158,0.00053345494,0.0016166826,0.000053012147,0.00008891096,0.00007053112,0.0783218,0.00004365959,0.000039794908,0.00011845575],"about_ca_topic_score_codex":0.0010351047,"about_ca_topic_score_gemma":0.00006351012,"teacher_disagreement_score":0.0674231,"about_ca_system_score_codex":0.00021332533,"about_ca_system_score_gemma":0.00029688928,"threshold_uncertainty_score":0.7047346},"labels":[],"label_agreement":null},{"id":"W1976800786","doi":"10.1097/brs.0b013e318186b2db","title":"Natural Killer/T-Cell Nasal-Type Lymphoma","year":2008,"lang":"en","type":"review","venue":"Spine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Medicine; Lymphoma; Nasal cavity; Histopathology; Natural killer T cell; T-cell lymphoma; Biopsy; Natural killer cell; Surgery; Large cell; Pathology; T cell; Cytotoxic T cell; Internal medicine; Immunology; Immune system; Cancer","score_opus":0.032851236115884266,"score_gpt":0.3229385422278765,"score_spread":0.29008730611199224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976800786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073023955,0.98682636,2.9579638e-7,0.00010059215,0.0020362542,0.0009612345,0.00000970003,0.00012368712,0.009868841],"genre_scores_gemma":[0.00011802161,0.9778842,0.0004241006,0.0002635406,0.00074524974,0.00010221626,0.0008054094,0.000101375044,0.019555895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805987,0.00004435906,0.0005530391,0.00056142826,0.00035959933,0.00042170304],"domain_scores_gemma":[0.99869496,0.00004401204,0.00023595298,0.0007070064,0.00008172536,0.0002363314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000041342,0.0006279056,0.0021615047,0.00019594339,0.000086431864,0.000018735205,0.0001647073,0.00033915273,0.00026176107],"category_scores_gemma":[0.00004605661,0.000409538,0.0008503147,0.00043492988,0.00006860094,0.000035308065,0.00009045293,0.00016978924,0.0019343139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012005721,0.0006831118,0.000023765087,0.005121088,0.00036193637,0.0012917407,0.000012853271,2.3228354e-8,4.607547e-7,0.000058578742,0.04177746,0.95065695],"study_design_scores_gemma":[0.0022774825,0.0004023818,0.00033122918,0.0068936683,0.00114537,0.0016892417,0.000001928542,0.000001270867,0.000009100876,0.0000024079052,0.986888,0.00035795054],"about_ca_topic_score_codex":0.00004492991,"about_ca_topic_score_gemma":0.0000025853,"teacher_disagreement_score":0.950299,"about_ca_system_score_codex":0.00054999767,"about_ca_system_score_gemma":0.00079457375,"threshold_uncertainty_score":0.99983567},"labels":[],"label_agreement":null},{"id":"W1977128682","doi":"10.1016/s0360-3016(03)01141-6","title":"Primary spinal epidural lymphoma: outcome and prognostic factors in patients treated with radiotherapy: a multicenter rare cancer network (RCN) study","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Stage (stratigraphy); Biopsy; Laminectomy; Surgery; Chemotherapy; Radiology; Bone marrow; Spinal cord; Internal medicine","score_opus":0.019113831486069502,"score_gpt":0.32088298261228454,"score_spread":0.30176915112621505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977128682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970477,0.0009444146,0.000089817004,0.00044192866,0.0006417858,0.000729892,0.000024361249,0.000016660402,0.0000634106],"genre_scores_gemma":[0.9977485,0.0003471096,0.00077233225,0.00058820116,0.00039408426,0.00004906916,0.000058097645,0.000027273683,0.000015321484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982263,0.00027427534,0.0006967371,0.00026252188,0.00027481897,0.0002653328],"domain_scores_gemma":[0.9984201,0.00023201668,0.0006930054,0.00010700573,0.0004097413,0.00013809146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023810969,0.00026144876,0.0006412793,0.0001440379,0.000058037753,0.0000253791,0.00012501501,0.00012927546,0.000032931035],"category_scores_gemma":[0.00011686057,0.00017920196,0.000113600945,0.00016731262,0.00010074489,0.00019927777,0.000021732936,0.00017293508,0.0000019913693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016298959,0.0038647468,0.96079886,0.000008736337,0.0010299326,0.00011605858,0.00037097489,0.00016207075,0.000020230418,0.00014353727,0.00008227555,0.031772695],"study_design_scores_gemma":[0.032788992,0.004916347,0.9603173,0.000116020994,0.00025677218,0.000050837818,0.00008347385,0.000112500005,0.000054918404,0.000048852497,0.0011029037,0.0001510736],"about_ca_topic_score_codex":0.00007824264,"about_ca_topic_score_gemma":0.000033016582,"teacher_disagreement_score":0.031621624,"about_ca_system_score_codex":0.0017109807,"about_ca_system_score_gemma":0.00041177002,"threshold_uncertainty_score":0.7307644},"labels":[],"label_agreement":null},{"id":"W1977273659","doi":"10.1111/bjh.12222","title":"The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and <scp>S</scp>tanford <scp>V</scp> in older <scp>H</scp>odgkin lymphoma patients: a comprehensive analysis from the <scp>N</scp>orth <scp>A</scp>merican intergroup trial <scp>E</scp>2496","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Dacarbazine; Vinblastine; Medicine; Internal medicine; ABVD; Bleomycin; Vincristine; Tolerability; Gastroenterology; Hodgkin's lymphoma; Chemotherapy; Etoposide; Oncology; Surgery; Adverse effect; Cyclophosphamide","score_opus":0.009635228307854288,"score_gpt":0.23920548102576533,"score_spread":0.22957025271791104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977273659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617776,0.02431978,0.0002252938,0.0004869139,0.001630572,0.0045220195,0.0006473375,0.00015511687,0.0018352034],"genre_scores_gemma":[0.9855498,0.008525563,0.0010065386,0.0017154373,0.0010275841,0.0005536128,0.0004984759,0.00029613302,0.00082684634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98305947,0.0025225144,0.006308113,0.0025325,0.002501196,0.0030761894],"domain_scores_gemma":[0.9400064,0.047426064,0.0054879817,0.0021201416,0.0031693322,0.0017901062],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019869942,0.0022318906,0.0072595053,0.0014297178,0.001034722,0.0009138227,0.0019260648,0.001321539,0.000047204434],"category_scores_gemma":[0.03409843,0.0017458135,0.0019047135,0.0030045197,0.0025226,0.00109022,0.0012502475,0.0019351259,0.00007232117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041201906,0.011463362,0.7463935,0.00066364964,0.013551963,0.007803468,0.013451128,0.00020447472,0.00062888616,0.00025432027,0.18480764,0.020365559],"study_design_scores_gemma":[0.07577506,0.0044958047,0.83212316,0.0018808506,0.005866844,0.010003991,0.019307703,0.0007282962,0.001519788,0.00061341946,0.047506534,0.00017857342],"about_ca_topic_score_codex":0.0052812747,"about_ca_topic_score_gemma":0.0029357483,"teacher_disagreement_score":0.13730112,"about_ca_system_score_codex":0.0008038369,"about_ca_system_score_gemma":0.0010780025,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W1977342543","doi":"10.1038/nm.3435","title":"Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Ibrutinib; Mantle cell lymphoma; Bruton's tyrosine kinase; Cancer research; Chronic lymphocytic leukemia; Signal transduction; B-cell receptor; breakpoint cluster region; Biology; IκBα; NF-κB; B cell; PI3K/AKT/mTOR pathway; Lymphoma; Leukemia; Cell biology; Tyrosine kinase; Immunology; Receptor; Genetics; Antibody","score_opus":0.016556943815620187,"score_gpt":0.30227423824929217,"score_spread":0.285717294433672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977342543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97008604,0.020696204,0.000023842436,0.003947715,0.00046257104,0.0020838631,0.000021591202,0.00009630406,0.0025818986],"genre_scores_gemma":[0.99322945,0.0012861008,0.001193209,0.0013001469,0.00062543433,0.00065407704,0.00018170426,0.000028128605,0.001501767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998627,0.000029282946,0.0003080803,0.00044356394,0.00022797147,0.000364122],"domain_scores_gemma":[0.999118,0.00021473791,0.000098507,0.0001944137,0.00014290427,0.00023145544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110812005,0.00031374927,0.00054725236,0.00011783176,0.00013347059,0.000040099574,0.000070699556,0.00027307885,0.0003720662],"category_scores_gemma":[0.000040454328,0.00017947447,0.00009942966,0.000105912615,0.00015318101,0.00010827687,0.0000302234,0.00011263598,0.00004008875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009035307,0.003211093,0.02601599,0.0006879728,0.0012190101,0.00041057254,0.0015800124,0.0000049059718,0.8759621,0.0023746486,0.031594615,0.05603558],"study_design_scores_gemma":[0.056691967,0.0072821705,0.17482588,0.00030251816,0.0028291708,0.0003061777,0.0045615584,0.0010155754,0.7186313,0.002534599,0.030399606,0.00061946723],"about_ca_topic_score_codex":0.00015446258,"about_ca_topic_score_gemma":0.0000097199,"teacher_disagreement_score":0.15733077,"about_ca_system_score_codex":0.00026353524,"about_ca_system_score_gemma":0.00013469807,"threshold_uncertainty_score":0.73187566},"labels":[],"label_agreement":null},{"id":"W1977794231","doi":"10.1054/ebog.2002.0036","title":"Chemotherapy combined with radiotherapy for cervical cancer improves survival and reduces local and distant recurrence","year":2002,"lang":"en","type":"article","venue":"Evidence-based obstetrics and gynecology/Evidence-based obstetrics & gynecology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Cervical cancer; Chemotherapy; Oncology; Cancer; Internal medicine; Radiology","score_opus":0.049226430857068,"score_gpt":0.2924587864684965,"score_spread":0.24323235561142847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977794231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6867644,0.28340754,0.0023517983,0.020789184,0.0024395604,0.0039359266,0.00009139904,0.00017570576,0.000044468263],"genre_scores_gemma":[0.8901678,0.10067666,0.0037206619,0.003601995,0.00013863613,0.0013542813,0.00003152115,0.00011668134,0.00019176179],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99356776,0.00053484645,0.0012688548,0.002224487,0.00087249925,0.001531549],"domain_scores_gemma":[0.8898277,0.10679484,0.0007149272,0.0008414403,0.0008698931,0.0009511657],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001155808,0.001155166,0.0021001843,0.0010540329,0.00072008616,0.0002948106,0.00044879824,0.000899197,0.0003078035],"category_scores_gemma":[0.026783815,0.00090388255,0.00029469657,0.0021424994,0.0018535741,0.00070464803,0.00013076485,0.0006574429,0.000007019813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003371245,0.0024419904,0.32232007,0.0015616314,0.00073427666,0.0006076932,0.00048610976,0.00015424182,0.001228586,0.00084607454,0.0014841172,0.6647639],"study_design_scores_gemma":[0.086753115,0.08611025,0.61710495,0.009111698,0.0045623877,0.00022032915,0.002047405,0.1357559,0.013735296,0.00069383055,0.038600802,0.005304053],"about_ca_topic_score_codex":0.00020628012,"about_ca_topic_score_gemma":0.00014712576,"teacher_disagreement_score":0.6594599,"about_ca_system_score_codex":0.001594908,"about_ca_system_score_gemma":0.0011550827,"threshold_uncertainty_score":0.9993412},"labels":[],"label_agreement":null},{"id":"W1977878174","doi":"10.1016/j.semcancer.2013.11.004","title":"The microenvironment in T-cell lymphomas: Emerging themes","year":2013,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Swiss Cancer Research Foundation; Institut National Du Cancer; Institute of Cancer Research; Fondation pour la Recherche Médicale","keywords":"Tumor microenvironment; Stroma; Lymphoma; Angioimmunoblastic T-cell lymphoma; Biology; Cancer research; Cell of origin; Pathology; Cell; T cell; Immunology; Medicine; Tumor cells; Immune system; Genetics; Immunohistochemistry","score_opus":0.032958600802972436,"score_gpt":0.3543223377900849,"score_spread":0.32136373698711246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977878174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008943145,0.9952211,1.3093027e-7,0.00040884357,0.00045043862,0.0012903262,0.000034823348,0.000011236523,0.0016888164],"genre_scores_gemma":[0.00032640356,0.9951984,0.00007860652,0.00015559529,0.00013868319,0.0026805527,0.00008324232,0.000041649622,0.0012968307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803627,0.00016720219,0.0006352306,0.00053589675,0.000092050555,0.00053332903],"domain_scores_gemma":[0.99881446,0.0003588577,0.00024868475,0.00049843534,0.00000959722,0.00006998969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018562711,0.00042189105,0.0013383032,0.00016574428,0.00005703938,0.000012306194,0.00024380836,0.00035214503,0.0002595494],"category_scores_gemma":[0.000018470799,0.00023060862,0.00026662316,0.00019670141,0.00018871373,0.000015674355,0.0001476883,0.00022694477,0.00010987757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000097489155,0.00023810194,0.0054723155,0.0012768176,0.00009680391,0.000058479927,0.00009377053,3.1502137e-7,0.0000082961005,0.000040637526,0.0018947821,0.9908099],"study_design_scores_gemma":[0.00091316435,0.00013758634,0.00024233124,0.009020421,0.00024795556,0.00004388822,0.000097995,0.0000017263683,0.00005556964,0.000053551536,0.98897916,0.00020664027],"about_ca_topic_score_codex":0.00072527805,"about_ca_topic_score_gemma":0.00018846273,"teacher_disagreement_score":0.99060327,"about_ca_system_score_codex":0.001752623,"about_ca_system_score_gemma":0.00032695063,"threshold_uncertainty_score":0.94039464},"labels":[],"label_agreement":null},{"id":"W1977886211","doi":"10.1111/j.1365-2141.2004.05194.x","title":"Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Cumulative incidence; Follicular lymphoma; Lymphoma; Total body irradiation; Internal medicine; Surgery; Transplantation; Incidence (geometry); Bone marrow; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.005038763484335681,"score_gpt":0.21835521181074105,"score_spread":0.21331644832640537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977886211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248314,0.0063707014,0.00025811774,0.0003074957,0.00016383672,0.00028600116,0.000096184165,0.00000839687,0.000026098895],"genre_scores_gemma":[0.9976299,0.0011210195,0.0009699198,0.00012611004,0.0000322068,0.000021115691,0.000068220346,0.000022772492,0.00000875331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985954,0.000056172066,0.00054309913,0.0001737591,0.00040649212,0.00022506171],"domain_scores_gemma":[0.9989245,0.00003827266,0.00033721927,0.00018500682,0.00028823628,0.00022678376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083356856,0.00015418866,0.00067006354,0.000105675645,0.000035916066,0.000011645983,0.00009522142,0.000072957344,0.000052463274],"category_scores_gemma":[0.00004161016,0.00013265814,0.00020312016,0.00009334559,0.00010948805,0.00013474481,0.0000149465595,0.00005618439,0.0000028594736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045101834,0.0022709628,0.820621,0.00033450665,0.00040415733,0.15990646,0.000090202666,0.000034832672,0.000058997917,0.000055650908,0.000023300328,0.01168973],"study_design_scores_gemma":[0.02459226,0.00087360764,0.93233955,0.0011362712,0.0006815287,0.038958214,0.0000103523125,2.8724708e-7,0.0011190011,0.00014884607,0.000025086736,0.00011496593],"about_ca_topic_score_codex":0.000028823926,"about_ca_topic_score_gemma":0.0001729186,"teacher_disagreement_score":0.12094825,"about_ca_system_score_codex":0.00013339224,"about_ca_system_score_gemma":0.00027883658,"threshold_uncertainty_score":0.5409642},"labels":[],"label_agreement":null},{"id":"W1977911898","doi":"10.1080/10428190290026259","title":"The Role of Interleukin 13 in Classical Hodgkin Lymphoma","year":2002,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Autocrine signalling; Lymphoma; Cancer research; Cytokine; STAT protein; Biology; Interleukin 9; Immune system; Immunology; Interleukin; Reed–Sternberg cell; Cell culture; Signal transduction; STAT3; Cell biology; Hodgkin lymphoma","score_opus":0.01843052369170105,"score_gpt":0.2748539430926376,"score_spread":0.25642341940093655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977911898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02980521,0.9547249,0.000002110973,0.00011362194,0.00062849105,0.0025038773,0.00016101179,0.0002085035,0.011852287],"genre_scores_gemma":[0.03728555,0.9575989,0.00017456237,0.0002279725,0.0006253357,0.0012088229,0.00028258516,0.00036128866,0.0022349635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899603,0.00070056925,0.00358964,0.002251096,0.0014355791,0.0020628255],"domain_scores_gemma":[0.9925738,0.0021544609,0.0015822479,0.0024916541,0.00023325726,0.0009645755],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00082269224,0.0023800074,0.006252119,0.0010337698,0.00050163275,0.00030670088,0.0012368663,0.0020823993,0.00012158037],"category_scores_gemma":[0.00034075344,0.0016152603,0.0021588383,0.0016930577,0.0012055074,0.00028780525,0.00076118606,0.00039595022,0.00033720437],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033291298,0.0009827394,0.0010205562,0.003935674,0.0010730979,0.0010585262,0.00037367584,0.0000011987989,0.0000067625106,0.0019810654,0.0023542258,0.9868796],"study_design_scores_gemma":[0.015281121,0.00064888445,0.005526684,0.01588034,0.002719829,0.0038570985,0.0003556739,0.00063431775,0.00015474197,0.00036418444,0.9531462,0.0014308926],"about_ca_topic_score_codex":0.002176804,"about_ca_topic_score_gemma":0.00038144094,"teacher_disagreement_score":0.98544866,"about_ca_system_score_codex":0.020534938,"about_ca_system_score_gemma":0.0074296747,"threshold_uncertainty_score":0.9992131},"labels":[],"label_agreement":null},{"id":"W1978272320","doi":"10.1016/j.bbmt.2014.07.015","title":"Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma","year":2014,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Hôpital Maisonneuve-Rosemont; Hôpital de l'Enfant-Jésus; Hamilton Health Sciences; Queen Elizabeth II Health Sciences Centre; Baker Hughes (Canada); Ottawa Hospital; Health Sciences Centre; Alberta Cancer Foundation; Sunnybrook Health Science Centre; London Health Sciences Centre; Vancouver Hospital and Health Sciences Centre; Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Transplantation; Internal medicine; Lymphoma; Aggressive lymphoma; Autologous stem-cell transplantation; Rituximab; Surgery; Oncology; Cohort; Progression-free survival; Gastroenterology; Chemotherapy","score_opus":0.006669453766291562,"score_gpt":0.2083856955674406,"score_spread":0.20171624180114905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978272320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963039,0.0004698625,0.0017287562,0.00012763237,0.00004854232,0.0007774249,0.00043924962,0.00002425444,0.000080379454],"genre_scores_gemma":[0.9951512,0.0016406595,0.001588868,0.00010804816,0.000013128672,0.00010148208,0.0013732339,0.000013160378,0.0000102043705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991536,0.000046197667,0.0002575109,0.00028524315,0.000086521686,0.00017088639],"domain_scores_gemma":[0.9994921,0.00018843087,0.00009713467,0.0000878644,0.000053023658,0.00008143624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000735397,0.00018460104,0.00039501328,0.00007364792,0.00006891604,0.000006762838,0.000029987088,0.00014385396,0.0000037823443],"category_scores_gemma":[0.0000017259875,0.00012752094,0.00006073811,0.000036555608,0.000080991296,0.000055675442,0.0000016208004,0.000022941933,4.6614485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017816506,0.00075256795,0.9236876,0.0006794923,0.00040495617,0.000008120094,0.0011071053,0.0000026052526,0.019372242,0.00018743113,0.0000022550548,0.052014004],"study_design_scores_gemma":[0.024166819,0.0024341228,0.8844949,0.00010670163,0.0021444187,0.000021695278,0.00004349925,0.000024042514,0.08626422,0.00007340262,0.000073643554,0.00015255601],"about_ca_topic_score_codex":0.00014148917,"about_ca_topic_score_gemma":0.000076255696,"teacher_disagreement_score":0.06689198,"about_ca_system_score_codex":0.000009737062,"about_ca_system_score_gemma":0.00003399868,"threshold_uncertainty_score":0.52001524},"labels":[],"label_agreement":null},{"id":"W1978618037","doi":"10.1007/s00277-013-1991-y","title":"Survival of patients with transformed lymphoma in the rituximab era","year":2014,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Medicine; Vincristine; Internal medicine; CHOP; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Cyclophosphamide; Prednisone; Chemotherapy; Oncology; Hematology; Gastroenterology","score_opus":0.023990251094445778,"score_gpt":0.2864974165225775,"score_spread":0.2625071654281317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978618037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316704,0.00017110797,0.0000123141945,0.0033679602,0.000027404914,0.000249044,0.0000095212845,0.0000049164123,0.0029906672],"genre_scores_gemma":[0.99912286,0.00004362726,0.00007519858,0.0006921917,0.0000070016845,0.000025151285,0.000024094335,0.00000645313,0.0000034305506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918526,0.00007639983,0.0002669406,0.00011692475,0.00018653568,0.00016796362],"domain_scores_gemma":[0.9993584,0.00022034202,0.00008991242,0.00021872207,0.00008078938,0.00003180351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014595222,0.000093556,0.0004795193,0.00006874947,0.000014055736,0.0000014757338,0.00007716454,0.000056108944,0.00002044827],"category_scores_gemma":[0.000043761454,0.000049886774,0.00006877,0.00011039039,0.000102726655,0.000025551344,0.000006886386,0.000027400274,0.0000045790366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006503744,0.0043627108,0.972287,0.00015034,0.00011362342,0.000021728767,0.0005863904,5.2921024e-7,0.000012511385,0.0123268915,0.00038722114,0.009100684],"study_design_scores_gemma":[0.00969957,0.001280976,0.9768378,0.000085734995,0.000048735572,0.00003387678,0.00008465716,0.000008119639,0.010662887,0.0003276508,0.0008748132,0.000055145418],"about_ca_topic_score_codex":0.000086081796,"about_ca_topic_score_gemma":0.00007775117,"teacher_disagreement_score":0.01199924,"about_ca_system_score_codex":0.000004453718,"about_ca_system_score_gemma":0.000046386347,"threshold_uncertainty_score":0.20343237},"labels":[],"label_agreement":null},{"id":"W1979416682","doi":"10.1067/mhn.2001.114308","title":"Nasopharyngeal Burkitt's lymphoma Causing Acute Airway Obstruction","year":2001,"lang":"en","type":"article","venue":"Otolaryngology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Otorhinolaryngology; Medicine; Sobol sequence; Library science; Surgery; Computer science; Mathematics","score_opus":0.013882048288762851,"score_gpt":0.26740038557812046,"score_spread":0.25351833728935763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979416682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836075,0.00095620425,0.00007727798,0.0018166094,0.0006498185,0.00037071225,0.0000070365745,0.00015856272,0.012356278],"genre_scores_gemma":[0.9950788,0.0005759981,0.00090557354,0.0013281986,0.00040094613,0.000080657155,0.00009634577,0.00003398842,0.0014994995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863315,0.00005046503,0.0002722134,0.000416412,0.00018720797,0.00044054975],"domain_scores_gemma":[0.9991959,0.00005412195,0.0000886285,0.0003831114,0.00007436683,0.00020391429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007052808,0.00023218367,0.00042656058,0.00015171156,0.00015135303,0.000020676896,0.00006208809,0.00020835786,0.00053771306],"category_scores_gemma":[0.000025151203,0.00019847532,0.00015682449,0.00023636445,0.00010330704,0.00013010076,0.00005601772,0.00008027439,0.00032903207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016105243,0.0017526185,0.8203285,0.000067334135,0.0013861089,0.02100123,0.00035512238,0.000006977821,0.013172098,0.0029352377,0.007943732,0.12944056],"study_design_scores_gemma":[0.007815426,0.0008510146,0.8842283,0.000056562112,0.00062426704,0.022650078,0.00003514058,0.00022417249,0.012656945,0.00025267035,0.07032063,0.00028481602],"about_ca_topic_score_codex":0.00023532461,"about_ca_topic_score_gemma":0.00002950937,"teacher_disagreement_score":0.12915574,"about_ca_system_score_codex":0.00031134253,"about_ca_system_score_gemma":0.00011309578,"threshold_uncertainty_score":0.80935884},"labels":[],"label_agreement":null},{"id":"W1979590202","doi":"10.3816/clml.2010.n.079","title":"Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Refractory (planetary science); Gastroenterology; Salvage therapy; Chronic lymphocytic leukemia; Follicular lymphoma; Chemotherapy; Surgery; Lymphoma; Oncology; Leukemia","score_opus":0.013917964573779846,"score_gpt":0.29288665793761726,"score_spread":0.2789686933638374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979590202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356645,0.000100060744,0.0000074689083,0.00043728878,0.00053062337,0.0025257433,0.00016371901,0.00022599325,0.0024426593],"genre_scores_gemma":[0.99065757,0.00007938107,0.005597504,0.0007757843,0.0005670502,0.00047453973,0.0006570337,0.00017511683,0.0010159976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99359375,0.00033939874,0.0017482452,0.0019002054,0.0011561903,0.001262199],"domain_scores_gemma":[0.9949422,0.0008058863,0.0006736338,0.0019773599,0.00060304574,0.0009979137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012213682,0.00092021574,0.0017613651,0.0003756055,0.00034775023,0.00015002741,0.00054016494,0.000645887,0.00067249173],"category_scores_gemma":[0.00077946717,0.00062459125,0.00025941365,0.0008487663,0.0007144764,0.0008023783,0.00021564828,0.0005259713,0.00027798416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020723693,0.0086154435,0.60080284,0.00008106384,0.00020065268,0.00043298345,0.00015283927,0.000004046958,0.00014289291,0.000037878974,0.0005621338,0.36824355],"study_design_scores_gemma":[0.0540026,0.009004774,0.9225539,0.0004899871,0.00030414795,0.00012166408,0.0001238899,0.00013704642,0.0029401353,0.000017134427,0.009533,0.00077171077],"about_ca_topic_score_codex":0.0008485492,"about_ca_topic_score_gemma":0.0009527349,"teacher_disagreement_score":0.36747184,"about_ca_system_score_codex":0.0015253568,"about_ca_system_score_gemma":0.003941066,"threshold_uncertainty_score":0.99962056},"labels":[],"label_agreement":null},{"id":"W1979816280","doi":"10.1038/nature08638","title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","year":2010,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1645,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"U.S. Public Health Service; National Institutes of Health; Howard Hughes Medical Institute","keywords":"breakpoint cluster region; B-cell receptor; Lymphoma; B cell; Biology; Diffuse large B-cell lymphoma; Cancer research; PAX5; Receptor; Antibody; Immunology; Genetics","score_opus":0.004481336229919334,"score_gpt":0.24480415916368511,"score_spread":0.24032282293376578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979816280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851246,0.0029199275,0.000002356252,0.0010243047,0.0005353902,0.00041310186,0.000045401368,0.000059106776,0.006487943],"genre_scores_gemma":[0.9966669,0.00017791032,0.00031731877,0.0008411976,0.0005814335,0.0000625415,0.00010407978,0.000034629593,0.0012140069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875104,0.000022625223,0.00017683765,0.0003649684,0.0002808302,0.00040369306],"domain_scores_gemma":[0.99929965,0.00010079024,0.00007153573,0.0002957223,0.000064541455,0.00016775465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009385201,0.00022476599,0.00029794866,0.00012008018,0.00006580332,0.000021972191,0.00011532603,0.0011630753,0.00038756555],"category_scores_gemma":[0.000040544546,0.00017344674,0.00013719541,0.00021312817,0.000027282484,0.000079430596,0.000046460624,0.0012139886,0.00027181415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086034084,0.06655945,0.08877922,0.000496852,0.0002840834,0.0012633814,0.0021698854,0.0000037919144,0.7371773,0.0017759759,0.024183774,0.07644596],"study_design_scores_gemma":[0.07457161,0.00047978506,0.06643728,0.00017138051,0.00014964103,0.000034209035,0.00017264513,0.00020350555,0.68905485,0.00006408759,0.16825335,0.000407673],"about_ca_topic_score_codex":0.00004265962,"about_ca_topic_score_gemma":0.00021158464,"teacher_disagreement_score":0.14406957,"about_ca_system_score_codex":0.000399433,"about_ca_system_score_gemma":0.00025585113,"threshold_uncertainty_score":0.8970702},"labels":[],"label_agreement":null},{"id":"W1979981121","doi":"10.1016/j.semradonc.2007.02.006","title":"Low-Grade Non-Hodgkin Lymphomas","year":2007,"lang":"en","type":"review","venue":"Seminars in Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; MALT lymphoma; Radiation therapy; Follicular lymphoma; Stage (stratigraphy); Mucosa-associated lymphoid tissue; Helicobacter pylori; Marginal zone; Gastroenterology; Chemotherapy; Internal medicine; Lymphatic system; Oncology; Pathology; B cell; Immunology","score_opus":0.04428351610655796,"score_gpt":0.4148824023522947,"score_spread":0.3705988862457367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979981121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001880092,0.98213166,0.000007877208,0.00018870567,0.0010078901,0.0016899836,0.000029079885,0.0000535074,0.014703287],"genre_scores_gemma":[0.00016088839,0.9956347,0.000790232,0.0004633835,0.00056685356,0.0005456351,0.0006913662,0.00007513258,0.0010718344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997187,0.00019870533,0.0010957773,0.0006510748,0.00030236194,0.0005650631],"domain_scores_gemma":[0.99773276,0.00091597025,0.0005391104,0.0005231677,0.00004695673,0.00024202124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006038155,0.00052505103,0.0025596793,0.00088361866,0.00005518811,0.000014645296,0.00017906999,0.0012129421,0.00025998655],"category_scores_gemma":[0.00015579183,0.00043933702,0.0005283021,0.00074558734,0.00010133884,0.00005185107,0.00006197151,0.00035879697,0.0004937937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030470088,0.0013223289,0.0008186563,0.0029174713,0.00018006552,0.0015746176,0.00015169533,0.0000011185014,3.0404104e-7,0.00014085737,0.009185918,0.9836765],"study_design_scores_gemma":[0.0030326725,0.0007863401,0.00093816285,0.009340385,0.00088528247,0.0008291624,0.000031483945,0.0000147053215,0.000019029276,0.000023485882,0.9837783,0.00032097803],"about_ca_topic_score_codex":0.00006369293,"about_ca_topic_score_gemma":0.000040498013,"teacher_disagreement_score":0.9833555,"about_ca_system_score_codex":0.0056357374,"about_ca_system_score_gemma":0.0018314811,"threshold_uncertainty_score":0.99980587},"labels":[],"label_agreement":null},{"id":"W1979982928","doi":"10.1016/j.ajhg.2012.01.010","title":"Use of a Multiethnic Approach to Identify Rheumatoid- Arthritis-Susceptibility Loci, 1p36 and 17q12","year":2012,"lang":"en","type":"review","venue":"The American Journal of Human Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Genome-wide association study; Locus (genetics); Single-nucleotide polymorphism; Allele; Genetics; Biology; Bonferroni correction; Genetic association; Gene; Genotype; Statistics","score_opus":0.11918097710468356,"score_gpt":0.3807508136963977,"score_spread":0.2615698365917141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979982928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17643493,0.8227466,0.000032016324,0.000025130817,0.0000689744,0.0006268845,0.000025318845,0.00000549034,0.000034661956],"genre_scores_gemma":[0.09340876,0.9034378,0.0027925156,0.00007364377,0.00017345499,0.000019365803,0.00001267244,0.000052948973,0.000028850602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725,0.00038084973,0.0012984318,0.00025364035,0.000489273,0.00032778297],"domain_scores_gemma":[0.9965017,0.000264968,0.001889251,0.00073308364,0.00023260608,0.00037842628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067892915,0.00040132925,0.0026898417,0.00021347225,0.000087623885,0.00004274933,0.00028797777,0.000083613,0.00001969496],"category_scores_gemma":[0.00006629265,0.00023694312,0.0006514131,0.00028363898,0.0005922132,0.00004641146,0.00016187709,0.0003469071,0.000009312588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004257301,0.00078434846,0.0029426978,0.0013490567,0.0008471372,0.0000169717,0.00067346304,0.0000029123164,0.000019844038,0.000013514956,0.00044821316,0.99285924],"study_design_scores_gemma":[0.0042638956,0.010760104,0.12074438,0.02891911,0.0123783,0.008622625,0.0014675268,0.000009945393,0.00010285046,0.000098503035,0.8112407,0.001392089],"about_ca_topic_score_codex":0.00006402686,"about_ca_topic_score_gemma":0.00001101766,"teacher_disagreement_score":0.9914672,"about_ca_system_score_codex":0.00018060571,"about_ca_system_score_gemma":0.00022010074,"threshold_uncertainty_score":0.966226},"labels":[],"label_agreement":null},{"id":"W1979988208","doi":"10.4021/jocmr2010.02.258w","title":"B-Cell Lymphoma of the Thoracic Spine Presenting with Spinal Cord Pressure Syndrome","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Weakness; Lymphoma; Spinal cord; Prednisone; Surgery; Back pain; Pathology","score_opus":0.1431996460776826,"score_gpt":0.5142762148245381,"score_spread":0.3710765687468555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979988208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97774786,0.0019456152,0.000009076354,0.014638459,0.00066240976,0.0005154319,0.0000020132802,0.000006493601,0.004472623],"genre_scores_gemma":[0.995424,0.00045914605,0.0008845848,0.00014334868,0.0013738514,0.000008514351,9.0681925e-7,0.000026043723,0.001679657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944393,0.0005094469,0.0016920072,0.00026935845,0.0026439545,0.00044593657],"domain_scores_gemma":[0.9945383,0.0014631147,0.00096847606,0.00071978115,0.00175234,0.0005579921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072134035,0.00018559277,0.0011391167,0.00025378948,0.00012725116,0.000016489144,0.00052583584,0.00020552891,0.00023973809],"category_scores_gemma":[0.0051478157,0.000080217964,0.0003454,0.0006450129,0.0012396382,0.00009721809,0.00017607564,0.0014690931,0.000009674982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066817473,0.0054088165,0.89702815,0.0007799391,0.0007601519,0.0022056943,0.000084728104,0.0000017611063,0.0024514382,0.000219355,0.009250031,0.07512818],"study_design_scores_gemma":[0.010775501,0.02001412,0.94120324,0.001790046,0.0006139371,0.0033828167,0.00017364923,0.00004893042,0.0037113116,0.00015029732,0.01805678,0.000079401434],"about_ca_topic_score_codex":0.00007167398,"about_ca_topic_score_gemma":0.000010546022,"teacher_disagreement_score":0.07504878,"about_ca_system_score_codex":0.00003519517,"about_ca_system_score_gemma":0.0010571324,"threshold_uncertainty_score":0.6382561},"labels":[],"label_agreement":null},{"id":"W1981053556","doi":"10.1097/pap.0b013e3182862724","title":"Next-generation Sequencing Discoveries in Lymphoma","year":2013,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"DNA sequencing; Computational biology; Genome; Lymphoma; Biology; Human genome; Cancer genome sequencing; Genetics; Gene; Immunology","score_opus":0.08964017555852204,"score_gpt":0.3619920681011002,"score_spread":0.27235189254257813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981053556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009293764,0.9877847,0.0000114613185,0.000034076522,0.00048499752,0.0009785881,0.00002053209,0.000027403541,0.0013644827],"genre_scores_gemma":[0.0049055503,0.9928041,0.00065267086,0.00014774663,0.00015033716,0.0008829275,0.0002994929,0.00004021714,0.00011694506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979057,0.00020201388,0.0007609986,0.00061351416,0.00012526901,0.0003925285],"domain_scores_gemma":[0.99909115,0.00014646261,0.00026817358,0.00040322283,0.000022210806,0.000068787456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016151437,0.00041361537,0.001857078,0.00044722715,0.000030599596,0.000023162682,0.00012941184,0.00034914364,0.000058357855],"category_scores_gemma":[0.00009685945,0.0003111739,0.0002109639,0.00033599447,0.00013057965,0.00037585865,0.00006770529,0.00016224418,0.00012820766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053550984,0.0001304026,0.0013817514,0.0018030744,0.000022541582,0.0016479476,0.00008238046,0.0000038358107,0.00000766305,0.0009781644,0.000036760386,0.9939001],"study_design_scores_gemma":[0.0019122666,0.00016321185,0.0004094817,0.007166797,0.00026911494,0.0015115686,0.000109570836,0.00010802447,0.000037884045,0.00041805036,0.98746645,0.00042758777],"about_ca_topic_score_codex":0.00012785914,"about_ca_topic_score_gemma":0.0004911,"teacher_disagreement_score":0.9934725,"about_ca_system_score_codex":0.001811076,"about_ca_system_score_gemma":0.0005415791,"threshold_uncertainty_score":0.999934},"labels":[],"label_agreement":null},{"id":"W1981484881","doi":"10.1080/10428190601078605","title":"HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen","year":2007,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"American Cancer Society","keywords":"Regimen; Medicine; Internal medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Proportional hazards model; Lymphoma; Human leukocyte antigen; Chemotherapy; Chemotherapy regimen; Oncology; Rituximab; Gastroenterology; Antigen; Immunology","score_opus":0.006734132314767544,"score_gpt":0.2154206246546265,"score_spread":0.20868649233985895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981484881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98327345,0.00066031836,0.000017010425,0.0004286612,0.00020000382,0.0036580993,0.00017215032,0.00034305532,0.01124727],"genre_scores_gemma":[0.9926893,0.00041511323,0.00018845587,0.0024761888,0.00026513846,0.0004843996,0.00040958365,0.0002699185,0.0028019147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926325,0.0002794854,0.0012471235,0.0017204471,0.001656468,0.0024639587],"domain_scores_gemma":[0.99584526,0.0006063216,0.00056464935,0.0016532098,0.00027842255,0.0010521389],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000869651,0.0014412128,0.0014806603,0.0005837405,0.00056141167,0.0002083499,0.00048174255,0.00070112385,0.00010669108],"category_scores_gemma":[0.00010825183,0.0009437771,0.00033335562,0.0012491622,0.0004310472,0.0003225305,0.00019080921,0.00021051714,0.0001258097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02035698,0.02096747,0.83483154,0.00032401778,0.00090315397,0.0021568267,0.0021656347,0.000010396738,0.0007239652,0.0013996642,0.0032406803,0.11291969],"study_design_scores_gemma":[0.17936824,0.0025333718,0.78519386,0.00064989855,0.0002657841,0.00008134247,0.0004958244,0.000357142,0.015447498,0.000052039668,0.014631568,0.000923404],"about_ca_topic_score_codex":0.00265528,"about_ca_topic_score_gemma":0.000378236,"teacher_disagreement_score":0.15901126,"about_ca_system_score_codex":0.013021815,"about_ca_system_score_gemma":0.0023791823,"threshold_uncertainty_score":0.99983376},"labels":[],"label_agreement":null},{"id":"W1981811866","doi":"10.1182/blood-2008-08-174037","title":"Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Gene knockdown; Oncogene; Molecular biology; Cell culture; Gene; Cell cycle","score_opus":0.004190354572752902,"score_gpt":0.21986978035813312,"score_spread":0.2156794257853802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981811866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564457,0.0032210646,0.00000361084,0.00040826976,0.00003931478,0.00039254388,0.000047659134,0.000009330283,0.00023361559],"genre_scores_gemma":[0.9987173,0.00092803134,0.00013965702,0.0000817064,0.000026854685,0.0000139428785,0.000041109393,0.000008542798,0.000042819694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906594,0.00002132093,0.00038251284,0.00019529261,0.00020512028,0.00012979275],"domain_scores_gemma":[0.99957687,0.000033175354,0.00011446582,0.00014886298,0.00004059517,0.0000860111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107274835,0.000114827446,0.000327166,0.00012803722,0.000016502167,0.0000068181844,0.000035727615,0.00005851102,0.000015305965],"category_scores_gemma":[0.000017659735,0.00009563282,0.000047189493,0.00012419884,0.000050539813,0.000060887658,0.000009942949,0.000037024314,0.0000013238896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002287873,0.0030563995,0.022911131,0.00021162808,0.0000724481,0.00009554672,0.00032138388,0.000001054517,0.9670979,0.000061785446,0.000053861804,0.0058880677],"study_design_scores_gemma":[0.006904451,0.00044433394,0.33572635,0.00007386558,0.00027807956,0.00003462404,0.00002512571,0.000008213493,0.65638137,0.000047896505,0.00002277479,0.00005293699],"about_ca_topic_score_codex":0.000082408216,"about_ca_topic_score_gemma":0.000011543492,"teacher_disagreement_score":0.31281522,"about_ca_system_score_codex":0.000033968314,"about_ca_system_score_gemma":0.00006816808,"threshold_uncertainty_score":0.38997933},"labels":[],"label_agreement":null},{"id":"W1982060371","doi":"10.1111/j.1365-2141.2005.05387.x","title":"Incidence and spectrum of non‐Hodgkin lymphoma in Chinese migrants to British Columbia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Incidence (geometry); Medicine; Lymphoma; Demography; Standardized rate; Follicular lymphoma; Non-Hodgkin's lymphoma; Population; Internal medicine; Pediatrics; Epidemiology; Environmental health","score_opus":0.005149361932843713,"score_gpt":0.25333741115138453,"score_spread":0.24818804921854082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982060371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222463,0.0058975117,0.000016203128,0.0012685388,0.00011050075,0.00023532227,0.00001584123,0.000005605115,0.0002258507],"genre_scores_gemma":[0.9955867,0.0014784766,0.0021940926,0.0005236431,0.000091275644,0.000008579682,0.000001937707,0.000015336736,0.00009995201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847275,0.00005896768,0.0007607596,0.00019341573,0.00023694054,0.00027717947],"domain_scores_gemma":[0.9991629,0.00010702056,0.00026715588,0.00011673266,0.00011812706,0.00022803234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026854072,0.000103473474,0.0009292765,0.0001317576,0.00004156377,0.000062864965,0.00011505979,0.00010461261,0.00015025656],"category_scores_gemma":[0.00025621854,0.00014197682,0.00011259819,0.00022735471,0.00010384147,0.00013250452,0.000057043202,0.0000991453,0.000007766686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010932844,0.0008787643,0.8039289,0.000076382334,0.00008069195,0.069076836,0.00021244503,0.000004707049,0.0001592143,0.0000042704137,0.003958647,0.12150978],"study_design_scores_gemma":[0.0042060018,0.00040315444,0.664445,0.0010649144,0.000041840958,0.32893693,0.000037584883,0.00001863004,0.00027206843,0.000118017204,0.00038114184,0.000074731775],"about_ca_topic_score_codex":0.020396894,"about_ca_topic_score_gemma":0.14898604,"teacher_disagreement_score":0.2598601,"about_ca_system_score_codex":0.00013822386,"about_ca_system_score_gemma":0.00021375918,"threshold_uncertainty_score":0.98612636},"labels":[],"label_agreement":null},{"id":"W1982308436","doi":"10.1111/j.1365-2141.2012.09177.x","title":"Impact of rituximab on treatment outcomes of patients with diffuse large b‐cell lymphoma: a population‐based analysis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; St. Michael's Hospital; Princess Margaret Cancer Centre; Niagara Health System","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Rituximab; Medicine; CHOP; Diffuse large B-cell lymphoma; Vincristine; Internal medicine; Population; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; Oncology; Chemotherapy; Surgery; Gastroenterology; Confidence interval","score_opus":0.009586511896449226,"score_gpt":0.2774775081604935,"score_spread":0.2678909962640443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982308436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985851,0.0008453201,0.00003798076,0.000045572877,0.000052482224,0.00020742712,0.00016111581,0.0000050312574,0.000059992224],"genre_scores_gemma":[0.99919534,0.00005703324,0.0005573354,0.00004382935,0.000016494254,0.000007172405,0.000089835885,0.000015859112,0.000017083199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849975,0.00009295555,0.0006732242,0.00011744223,0.00033848544,0.00027812985],"domain_scores_gemma":[0.99836105,0.00016421772,0.00081591203,0.00020560021,0.00025810074,0.00019510055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010596935,0.00018443783,0.0015427691,0.00039191064,0.000037198435,0.0000066444795,0.00006323004,0.000083420346,0.00010865557],"category_scores_gemma":[0.00005762088,0.00011986083,0.00072518503,0.00026723844,0.000040381914,0.00008758453,0.00001116395,0.000040616516,0.000003168211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030682,0.06150962,0.93166935,0.000035751404,0.00319556,0.000878757,0.00009289104,0.00001618858,0.0000019786457,0.000020045514,0.000057764617,0.0019190124],"study_design_scores_gemma":[0.050741874,0.0028287696,0.94136953,0.00010957622,0.0034032767,0.0010938541,0.000018791701,0.000014826481,0.00031576367,0.0000049184187,0.0000151403565,0.0000836657],"about_ca_topic_score_codex":0.0007579408,"about_ca_topic_score_gemma":0.00009681949,"teacher_disagreement_score":0.05868085,"about_ca_system_score_codex":0.0004054269,"about_ca_system_score_gemma":0.00016608904,"threshold_uncertainty_score":0.4887783},"labels":[],"label_agreement":null},{"id":"W1982408296","doi":"10.1016/j.bbmt.2007.04.009","title":"A 15-Year Analysis of Early and Late Autologous Hematopoietic Stem Cell Transplant in Relapsed, Aggressive, Transformed, and Nontransformed Follicular Lymphoma","year":2007,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Melphalan; Etoposide; Follicular lymphoma; Internal medicine; Chemotherapy; Autologous stem-cell transplantation; Oncology; Carmustine; Cyclophosphamide; Surgery; Lymphoma; Aggressive lymphoma; Rituximab","score_opus":0.006404923857906044,"score_gpt":0.22839032173045878,"score_spread":0.22198539787255275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982408296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941588,0.0047553116,0.00022600792,0.00007951279,0.000021639446,0.00043280047,0.00015388124,0.000013944938,0.00015807475],"genre_scores_gemma":[0.98873854,0.010811518,0.00026641553,0.000026839352,0.0000048658308,0.000017594488,0.00011591961,0.000009558926,0.0000087521275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998811,0.000048286784,0.0004989446,0.00029775142,0.00010410039,0.00023990693],"domain_scores_gemma":[0.9994283,0.00018030572,0.00015272204,0.00009476764,0.000032630873,0.0001113171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023237616,0.00019084867,0.0006762525,0.000412296,0.000037508355,0.0000041522017,0.000032664742,0.00022435946,0.000005329351],"category_scores_gemma":[0.0000017251648,0.00015152113,0.000111925896,0.00026838583,0.00019848342,0.000044022057,0.000002412099,0.000051349514,2.0086237e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032990365,0.000726183,0.8231585,0.0012948385,0.0016102138,0.0005803505,0.008685906,0.0000037693717,0.14404602,0.00048645868,3.4855003e-7,0.016108401],"study_design_scores_gemma":[0.016359543,0.0013550826,0.8496518,0.00032626014,0.0074084504,0.0002734433,0.0002522624,0.000051360003,0.124076,0.000071482355,0.0000057790226,0.00016851116],"about_ca_topic_score_codex":0.0003565787,"about_ca_topic_score_gemma":0.000609423,"teacher_disagreement_score":0.026493348,"about_ca_system_score_codex":0.000010754655,"about_ca_system_score_gemma":0.000037891194,"threshold_uncertainty_score":0.61788523},"labels":[],"label_agreement":null},{"id":"W1983084203","doi":"10.1182/blood-2010-09-310342","title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Lymphoma; Internal medicine; International Prognostic Index; Anthracycline; Not Otherwise Specified; B symptoms; Stage (stratigraphy); T-cell lymphoma; Multivariate analysis; Oncology; Chemotherapy; Disease; Survival analysis; Gastroenterology; Cancer; Diffuse large B-cell lymphoma; T cell; Immunology; Breast cancer; Immune system","score_opus":0.04157237539381178,"score_gpt":0.2569832007150762,"score_spread":0.2154108253212644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983084203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949072,0.0010588908,0.0000066500365,0.00027261986,0.0004235076,0.00063737127,0.00015840628,0.000069417554,0.048301134],"genre_scores_gemma":[0.99303406,0.00020059438,0.0021723206,0.0005790586,0.0005637767,0.0001493264,0.0001224139,0.00005774071,0.0031207025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785745,0.0000619811,0.0006065071,0.0005511022,0.0005856825,0.00033729634],"domain_scores_gemma":[0.9984116,0.00014316173,0.00034138758,0.0008141621,0.00016032971,0.00012933693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016443146,0.00034664813,0.0004766325,0.0000693034,0.00009863408,0.000045044464,0.0003314961,0.00013157254,0.0011478447],"category_scores_gemma":[0.000068970854,0.00022863327,0.00035152535,0.00015183043,0.00014935617,0.00010086983,0.00011694974,0.00005642678,0.000050723494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033624205,0.058786474,0.84609663,0.00013572695,0.0022233513,0.024165753,0.0129907215,0.0000012964236,0.022613954,0.00027026463,0.01274733,0.016606096],"study_design_scores_gemma":[0.04885441,0.0014538434,0.4792354,0.00019902179,0.0014042176,0.004528923,0.0023860482,0.00005695318,0.42274082,0.00006287587,0.038485978,0.0005915052],"about_ca_topic_score_codex":0.008273018,"about_ca_topic_score_gemma":0.00030514947,"teacher_disagreement_score":0.40012687,"about_ca_system_score_codex":0.0002237492,"about_ca_system_score_gemma":0.00052773114,"threshold_uncertainty_score":0.9997652},"labels":[],"label_agreement":null},{"id":"W1983100070","doi":"10.1016/s0145-2126(06)80002-0","title":"Principles of maintenance therapy","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Maintenance therapy; Medicine; Rituximab; Asymptomatic; Follicular lymphoma; Disease; Randomized controlled trial; Internal medicine; Oncology; Intensive care medicine; Lymphoma; Surgery; Chemotherapy","score_opus":0.3289401216310138,"score_gpt":0.481570942499759,"score_spread":0.1526308208687452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983100070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121136596,0.94807005,7.487e-7,0.000060097926,0.000047322934,0.0014753153,0.000038265305,0.0000238653,0.050163224],"genre_scores_gemma":[0.000089033085,0.9795498,0.00020023069,0.0000151283975,0.00022052239,0.00049850164,0.00014921636,0.00005624538,0.019221285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724764,0.0002440897,0.0006053438,0.00044922868,0.0009084671,0.0005452472],"domain_scores_gemma":[0.99799895,0.0005630988,0.000170771,0.00082979293,0.00030259258,0.00013479448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008055643,0.00028442236,0.0016141164,0.00037426985,0.00006645798,0.000021230775,0.0002731672,0.0003153802,0.00011847274],"category_scores_gemma":[0.0001364051,0.00016938076,0.000550714,0.00061511673,0.00023417588,0.000021730038,0.00012392603,0.00051087554,0.0002225008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032768683,0.00029612897,0.00017014844,0.010181981,0.00024229097,0.00026783487,0.000012895934,2.4345803e-7,7.9799764e-7,0.002542065,0.008248355,0.9780045],"study_design_scores_gemma":[0.0012510498,0.00031351918,0.00038561106,0.014610435,0.00011722151,0.00008066752,0.0000051414213,0.000002912752,0.000045740435,0.000024992525,0.983044,0.00011868133],"about_ca_topic_score_codex":0.0006625936,"about_ca_topic_score_gemma":0.000015251047,"teacher_disagreement_score":0.9778858,"about_ca_system_score_codex":0.0024972535,"about_ca_system_score_gemma":0.0034699992,"threshold_uncertainty_score":0.69071466},"labels":[],"label_agreement":null},{"id":"W1984310422","doi":"10.1093/jnci/dju207","title":"Risk of Premature Menopause After Treatment for Hodgkin’s Lymphoma","year":2014,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Premature Menopause; Menopause; Medicine; Lymphoma; Cohort; Premature ovarian failure; Non-Hodgkin's lymphoma; Internal medicine; Pediatrics; Oncology","score_opus":0.027080968121646926,"score_gpt":0.32085088970587267,"score_spread":0.29376992158422577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984310422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920369,0.0015798638,0.000094971896,0.0031689531,0.0014648018,0.0004632985,0.0003072983,0.000005261553,0.00087865617],"genre_scores_gemma":[0.9958417,0.0004541412,0.0014928008,0.0006188008,0.00102464,0.0001002408,0.000005122256,0.000010587738,0.00045200175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882865,0.00003643869,0.00037229116,0.00010254293,0.00054715545,0.000112900634],"domain_scores_gemma":[0.9984991,0.000115171904,0.00052052946,0.0001223333,0.00066345825,0.00007941476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002447484,0.000130407,0.00031314333,0.00008467605,0.000072491006,0.000011502797,0.00009992674,0.000062926956,0.000035457513],"category_scores_gemma":[0.00022280897,0.00006711304,0.00030127625,0.00009771008,0.000062740495,0.00011727099,0.000017374363,0.000046976733,0.000001817908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019304333,0.008830406,0.6157986,0.00070511294,0.0133946305,0.00007629656,0.0026756001,0.0091608185,0.0066964533,0.011993761,0.06623606,0.24512793],"study_design_scores_gemma":[0.015460405,0.001532846,0.61287755,0.0005257532,0.0017543349,0.00023935904,0.000012817244,0.00020178896,0.028269408,0.0019452333,0.33704343,0.00013707887],"about_ca_topic_score_codex":0.00007736694,"about_ca_topic_score_gemma":0.000107160966,"teacher_disagreement_score":0.2708074,"about_ca_system_score_codex":0.0009711217,"about_ca_system_score_gemma":0.0006272792,"threshold_uncertainty_score":0.27367902},"labels":[],"label_agreement":null},{"id":"W1984666457","doi":"10.3109/10428190109058004","title":"Prolonged Molecular and Clinical Remission after Treatment of a Patient with Follicular Lymphoma with Rituximab","year":2001,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"IC Design Education Center","keywords":"Rituximab; Medicine; Follicular lymphoma; Complete remission; Lymphoma; Refractory (planetary science); Internal medicine; Oncology; CD20; Follicular phase; Monoclonal; Clinical trial; Radiation therapy; Gastroenterology; Monoclonal antibody; Antibody; Chemotherapy; Immunology","score_opus":0.007920645523747646,"score_gpt":0.24652712978806582,"score_spread":0.23860648426431819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984666457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876871,0.008196678,0.000052219963,0.00032020867,0.00009482984,0.0018663551,0.000034282228,0.000168836,0.0015794917],"genre_scores_gemma":[0.9911689,0.0040689916,0.0026893546,0.0007365836,0.00013835785,0.00060583703,0.00009320854,0.00015351354,0.00034522446],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99501896,0.00021404689,0.0012041837,0.0016102431,0.00095113914,0.001001416],"domain_scores_gemma":[0.9966748,0.0002404413,0.0005273394,0.0012175208,0.000289353,0.0010505696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021194543,0.0011248383,0.0019235007,0.00031031301,0.00025339675,0.000104810686,0.00014859748,0.00056703197,0.000050230014],"category_scores_gemma":[0.00004534788,0.0007232154,0.00040571974,0.00059441733,0.0007206587,0.00025180585,0.0001313148,0.000070868584,0.000020129792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017443402,0.005269557,0.40643457,0.00023651683,0.0017801813,0.016329158,0.0010213354,0.000011795634,0.00053686346,0.00016348677,0.00012480654,0.55064833],"study_design_scores_gemma":[0.15266763,0.023889853,0.74151,0.0017398205,0.0037014533,0.020148875,0.0007202821,0.0011587631,0.021015346,0.000107986896,0.031801645,0.0015383711],"about_ca_topic_score_codex":0.0013475439,"about_ca_topic_score_gemma":0.00011925689,"teacher_disagreement_score":0.54910994,"about_ca_system_score_codex":0.004287149,"about_ca_system_score_gemma":0.0025480406,"threshold_uncertainty_score":0.9995352},"labels":[],"label_agreement":null},{"id":"W1984740505","doi":"10.1053/sonc.2002.30143","title":"Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma","year":2002,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Autologous stem-cell transplantation; Transplantation; Surgery; Cyclophosphamide; Internal medicine; Vincristine; Chemoimmunotherapy; Oncology; Debulking; Chemotherapy; Lymphoma; Cancer; Ovarian cancer","score_opus":0.016037350853888393,"score_gpt":0.26521463581250715,"score_spread":0.24917728495861877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984740505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810701,0.014820286,0.000052405227,0.00076476234,0.00017451205,0.000977578,0.000014836646,0.00004023731,0.002085295],"genre_scores_gemma":[0.9775504,0.016175559,0.004307318,0.00059909426,0.00003587459,0.00035681628,0.000032463628,0.000034729343,0.0009077864],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989245,0.000060440503,0.0002495651,0.0003362309,0.000116975134,0.0003122966],"domain_scores_gemma":[0.99930745,0.0003282149,0.000090548565,0.00018356262,0.000023544313,0.00006669013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001343633,0.00020540076,0.00049500895,0.000121190045,0.00008167397,0.000012090898,0.00006113691,0.00018481907,0.000046065143],"category_scores_gemma":[0.0000018262625,0.00015625615,0.00008126329,0.00011067055,0.000065159395,0.000058341564,0.0000065217214,0.00005602278,0.000012387828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033510874,0.007060202,0.032415193,0.00014049666,0.0001662639,0.0019796125,0.0046890792,0.0000066247135,0.0053798165,0.00009967645,0.0009099825,0.94380194],"study_design_scores_gemma":[0.44044825,0.04273662,0.30373058,0.00088064617,0.00088976015,0.0026774488,0.0025951182,0.0013091615,0.12758216,0.0004821308,0.07536379,0.0013043276],"about_ca_topic_score_codex":0.0000975894,"about_ca_topic_score_gemma":0.000043350476,"teacher_disagreement_score":0.9424976,"about_ca_system_score_codex":0.0002921015,"about_ca_system_score_gemma":0.00006905984,"threshold_uncertainty_score":0.63719404},"labels":[],"label_agreement":null},{"id":"W1984763467","doi":"10.1016/s0046-8177(03)00286-7","title":"Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma","year":2003,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Pathology; CD5; Bone marrow; Lymphoma; Mantle cell lymphoma; Immunohistochemistry; CD20; Mantle zone; Cyclin D1; Medicine; Biology; B cell; Antibody; Immunology; Germinal center; Internal medicine; Cancer","score_opus":0.010085250330301408,"score_gpt":0.23676228797793075,"score_spread":0.22667703764762934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984763467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838248,0.00044781293,0.000008941616,0.00034111188,0.00011829269,0.0003588273,0.000012423396,0.000015985837,0.014871817],"genre_scores_gemma":[0.9978616,0.000022529768,0.00017059591,0.00025711226,0.000028015598,0.000054739117,0.000029920187,0.000012771541,0.0015627178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991842,0.000091835806,0.00024037223,0.00018711502,0.00012740117,0.00016907434],"domain_scores_gemma":[0.9994683,0.000022641712,0.00011606112,0.00030500966,0.00003988296,0.000048054942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103035985,0.00011570629,0.00022289857,0.000037115205,0.00007176874,0.0000053502595,0.000050841503,0.00009065757,0.0001966541],"category_scores_gemma":[0.000027140064,0.000076331904,0.00008363405,0.000069664886,0.00011244949,0.000022107755,0.00001836969,0.000039891023,0.000028252303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074231444,0.004139316,0.22050348,0.00013684508,0.000058549773,0.00034627217,0.0008807667,0.0000010377399,0.733392,0.009570847,0.027537944,0.0033587036],"study_design_scores_gemma":[0.0061239013,0.00087294483,0.2112533,0.000036499925,0.00015436497,0.00058512,0.00008442966,0.0000036322003,0.7681833,0.00056277047,0.01200964,0.00013013356],"about_ca_topic_score_codex":0.000018112627,"about_ca_topic_score_gemma":0.000014993871,"teacher_disagreement_score":0.034791254,"about_ca_system_score_codex":0.00008083349,"about_ca_system_score_gemma":0.00006264799,"threshold_uncertainty_score":0.31127247},"labels":[],"label_agreement":null},{"id":"W1984796340","doi":"10.1038/sj.bmt.1704040","title":"Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?","year":2003,"lang":"en","type":"review","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Transplantation; Stem cell; Autotransplantation; Surgery; Oncology; Disease; Leukemia; Autologous stem-cell transplantation; Internal medicine","score_opus":0.034101140297277927,"score_gpt":0.3243815145936209,"score_spread":0.290280374296343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984796340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024714827,0.99335724,0.00047457058,0.00029900257,0.0004428127,0.0037292894,0.00061875,0.00008620177,0.00074499886],"genre_scores_gemma":[0.00026959396,0.9881031,0.00214654,0.00046781346,0.00022750719,0.0023448642,0.005783742,0.00013704436,0.00051979074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973606,0.000079158395,0.0008483968,0.0007521885,0.0004238087,0.0005358902],"domain_scores_gemma":[0.99823445,0.00029075838,0.000685035,0.00042347377,0.00013174964,0.00023456082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017999568,0.00077265594,0.0020203064,0.00036844306,0.00019417248,0.000056128087,0.00012032242,0.0005183591,0.00007303528],"category_scores_gemma":[0.000024122677,0.0005994135,0.0010630821,0.00028712265,0.00006516909,0.00012707216,0.000008962743,0.0001295267,0.000041128034],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019895246,0.00045325374,0.00009699991,0.04654163,0.0007238798,0.0010195627,0.00035374943,0.0000012828532,0.000004755477,0.00005250546,0.004324326,0.9462291],"study_design_scores_gemma":[0.0057966667,0.00045068207,0.00015058805,0.03919264,0.0108004045,0.0023488633,0.00004698948,0.000021687993,0.000089590685,0.000023469116,0.94046223,0.00061616243],"about_ca_topic_score_codex":0.000059883423,"about_ca_topic_score_gemma":0.00003325361,"teacher_disagreement_score":0.94561297,"about_ca_system_score_codex":0.0004315748,"about_ca_system_score_gemma":0.0004959235,"threshold_uncertainty_score":0.9996457},"labels":[],"label_agreement":null},{"id":"W1984965357","doi":"10.1182/blood-2008-02-140616","title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia","keywords":"Comparative genomic hybridization; Follicular lymphoma; Biology; Genome; Oncology; Internal medicine; Survival analysis; Multivariate analysis; Proportional hazards model; Computational biology; Gene dosage; Lymphoma; Genetics; Gene; Medicine; Immunology","score_opus":0.01849612188139503,"score_gpt":0.2535839149867676,"score_spread":0.23508779310537253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984965357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484664,0.0010858381,0.00028337774,0.00012677311,0.00004195315,0.0011808143,0.00007842225,0.000057503014,0.0022986806],"genre_scores_gemma":[0.99371576,0.00038450398,0.0050642635,0.00013143547,0.00008199752,0.00017450542,0.0003028243,0.000025903288,0.000118777396],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837935,0.00007013307,0.00051825814,0.0003896515,0.00033888733,0.00030370383],"domain_scores_gemma":[0.9989503,0.00017444084,0.00023619508,0.00027951124,0.000191133,0.00016843445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115858966,0.00023976315,0.0006189752,0.000044349046,0.00010885078,0.0000131521565,0.0000947185,0.00007451482,0.000058015234],"category_scores_gemma":[0.00008398026,0.00019183982,0.000138806,0.0001827852,0.00014297558,0.00006196656,0.000021874477,0.000042294538,0.00008540817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008513896,0.002767397,0.7674217,0.00006936096,0.00041112836,0.00013494029,0.00029844797,0.0000047555563,0.22832452,0.000067344045,0.0003710092,0.000044245055],"study_design_scores_gemma":[0.0045740493,0.0003246399,0.43345004,0.00007944967,0.00035284093,0.00011835483,0.00006295217,0.000007455101,0.5604708,0.000030506593,0.00037956078,0.00014936099],"about_ca_topic_score_codex":0.00002796063,"about_ca_topic_score_gemma":8.8786385e-7,"teacher_disagreement_score":0.33397168,"about_ca_system_score_codex":0.000100604644,"about_ca_system_score_gemma":0.0002218729,"threshold_uncertainty_score":0.78230006},"labels":[],"label_agreement":null},{"id":"W1985344321","doi":"10.1371/journal.pone.0074619","title":"Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Institute of Infection and Immunity; Royal Jubilee Hospital; University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Lymphoma; Single-nucleotide polymorphism; Linkage disequilibrium; Biology; Mantle cell lymphoma; Genetics; Genetic association; SNP; Population; Oncology; Internal medicine; Genome-wide association study; Immunology; Genotype; Medicine; Gene","score_opus":0.027497460432830294,"score_gpt":0.22658628244355855,"score_spread":0.19908882201072825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985344321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957946,0.0012411675,0.000002987139,0.0005651381,0.000010072215,0.00037017046,0.000012471642,0.000016688251,0.0019867152],"genre_scores_gemma":[0.99777406,0.0005376289,0.0007634197,0.00014544459,0.000031497617,0.00008593374,0.000038463633,0.000014137609,0.00060938956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989899,0.000022414435,0.00028232206,0.0002517574,0.00026147894,0.00019217689],"domain_scores_gemma":[0.9993331,0.00008454205,0.000078097124,0.0003205586,0.000063385094,0.00012035925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007859977,0.00013329931,0.0006263683,0.00038553143,0.000020470605,0.000013729784,0.0000486046,0.00007111973,0.0005869802],"category_scores_gemma":[0.000015556376,0.00010818855,0.00008583907,0.0005788633,0.000057137386,0.000059008053,0.000034659377,0.000031166226,0.00007571864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047958234,0.0048350957,0.95996153,0.000040409817,0.0021499295,0.000041361913,0.00055904797,0.0000010596103,0.019865267,0.00010671131,0.00013312066,0.012258489],"study_design_scores_gemma":[0.0024056244,0.00021426586,0.9472194,0.000110421126,0.0013479264,0.0000024163198,0.000066734035,0.00074345624,0.047722824,0.00004141832,0.000031069834,0.000094475676],"about_ca_topic_score_codex":0.0012205306,"about_ca_topic_score_gemma":0.000060604634,"teacher_disagreement_score":0.027857557,"about_ca_system_score_codex":0.00013658275,"about_ca_system_score_gemma":0.000039069906,"threshold_uncertainty_score":0.64270216},"labels":[],"label_agreement":null},{"id":"W1985518662","doi":"10.1159/000334265","title":"SNP Analysis of Minimally Evolved t(14;18)(q32;q21)-Positive Follicular Lymphomas Reveals a Common Copy-Neutral Loss of Heterozygosity Pattern","year":2011,"lang":"en","type":"article","venue":"Cytogenetic and Genome Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; University of British Columbia; Provincial Health Services Authority; Terry Fox Foundation","keywords":"Loss of heterozygosity; Biology; Follicular lymphoma; Karyotype; SNP array; SNP; Ploidy; Cytogenetics; Chromosomal translocation; Lymphoma; Pathology; Genetics; Chromosome; Single-nucleotide polymorphism; Allele; Gene; Genotype; Immunology","score_opus":0.12022635693906936,"score_gpt":0.3644435242013968,"score_spread":0.24421716726232745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985518662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333376,0.0042033657,0.00006745528,0.000083156505,0.00002143605,0.0007628597,0.0002113032,0.000010758419,0.0013059035],"genre_scores_gemma":[0.9978697,0.0012027875,0.0005043872,0.000050934344,0.00003530618,0.00007401906,0.00010554186,0.000025083591,0.00013225667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730796,0.00033470226,0.0005950833,0.00054180395,0.00065404444,0.0005664035],"domain_scores_gemma":[0.9980398,0.00023710479,0.00016632715,0.00067388284,0.00051177177,0.00037113592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007381765,0.0002510199,0.0010449439,0.00062528776,0.00012573389,0.00001719132,0.00022051355,0.00015000012,0.0003469196],"category_scores_gemma":[0.000037149628,0.00020561182,0.00038103375,0.0009260964,0.0005519226,0.00003640242,0.0002246505,0.0001221166,0.000015519037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006118615,0.0013592105,0.95612496,0.00023609551,0.0034375489,0.00031177388,0.0016609977,0.000007012471,0.033835042,0.00005037282,0.000041710482,0.0023234014],"study_design_scores_gemma":[0.002506865,0.0015805122,0.92406464,0.00012135137,0.0016389438,0.00003398181,0.00018213336,0.000069002315,0.06953093,0.00007850451,0.000036831214,0.00015629503],"about_ca_topic_score_codex":0.0016710418,"about_ca_topic_score_gemma":0.0001514626,"teacher_disagreement_score":0.035695888,"about_ca_system_score_codex":0.00017629862,"about_ca_system_score_gemma":0.00014981207,"threshold_uncertainty_score":0.8384607},"labels":[],"label_agreement":null},{"id":"W1985934326","doi":"10.1016/s0360-3016(03)00765-x","title":"Impact of chest wall and lung invasion on outcome of stage I–II Hodgkin's lymphoma after combined modality therapy","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; ABVD; Internal medicine; Stage (stratigraphy); Lymphoma; Lung; Chemotherapy; Radiation therapy; Survival rate; Gastroenterology; Radiology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.030150734379532137,"score_gpt":0.3547396245274305,"score_spread":0.3245888901478984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985934326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971966,0.0005948783,0.00018254852,0.00095053774,0.00044092783,0.0002475931,0.00007814778,0.000008568331,0.0003001552],"genre_scores_gemma":[0.9976465,0.0010624715,0.00060633663,0.00042445603,0.00016601496,0.000011273335,0.000036733312,0.000017161747,0.000029025097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836564,0.00021666956,0.0008006485,0.00018372106,0.00027621494,0.00015710558],"domain_scores_gemma":[0.99767834,0.0003738543,0.0011203107,0.0001690868,0.00053930574,0.00011910204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045900635,0.00020393431,0.0006451675,0.00016276226,0.000036958147,0.000008649926,0.00013902524,0.0001852669,0.000097827244],"category_scores_gemma":[0.00020944884,0.00014481047,0.00033680137,0.00010156835,0.00015561051,0.00013984789,0.000031735028,0.00013244976,0.0000023151067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019378084,0.002672663,0.95217764,0.00001360764,0.0011120054,0.000034924946,0.00033864312,0.00010847947,0.0025276167,0.0046776673,0.00008896257,0.03431],"study_design_scores_gemma":[0.016268753,0.0060142833,0.9637259,0.00006557538,0.000117527554,0.000065740096,0.000021918948,0.00027735927,0.010384038,0.0020031787,0.000944108,0.00011158483],"about_ca_topic_score_codex":0.00008063577,"about_ca_topic_score_gemma":0.0000028969512,"teacher_disagreement_score":0.03419841,"about_ca_system_score_codex":0.0008588184,"about_ca_system_score_gemma":0.00041915168,"threshold_uncertainty_score":0.59051996},"labels":[],"label_agreement":null},{"id":"W1986060736","doi":"10.1111/bjh.12880","title":"Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medical diagnosis; Medicine; Referral; Lymphoma; Follicular lymphoma; Biopsy; Pediatrics; Internal medicine; Radiology; Family medicine","score_opus":0.009490982908465806,"score_gpt":0.278075712845727,"score_spread":0.26858472993726124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986060736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839378,0.015167709,0.0000024473557,0.00046581688,0.00012942014,0.00017182996,0.000021826125,0.0000064444516,0.000096734344],"genre_scores_gemma":[0.99240583,0.00697124,0.00012932462,0.00039126276,0.00006228914,0.0000034765637,0.000013585203,0.000016500588,0.000006465206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861336,0.00023445353,0.0005773326,0.00017718354,0.00018583465,0.0002118382],"domain_scores_gemma":[0.9986283,0.0002638647,0.00047295395,0.0001468273,0.00021579709,0.00027222058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019414721,0.00014585417,0.00077342615,0.00011061144,0.00006269624,0.000011596013,0.00006992251,0.00014657776,0.00008376746],"category_scores_gemma":[0.00026212723,0.00011530102,0.0001729854,0.0000648554,0.00008269055,0.000099642304,0.000043816402,0.00010702142,0.0000069188945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006583187,0.00064551085,0.43169326,0.00018868338,0.00017245431,0.008761803,0.00071568484,0.000009092821,0.00011680624,0.00013064766,0.0039687566,0.552939],"study_design_scores_gemma":[0.011995547,0.010131549,0.78265566,0.0045932443,0.00057412067,0.16102836,0.0005086926,0.000038186994,0.021325078,0.00021354633,0.006685369,0.00025065063],"about_ca_topic_score_codex":0.00011909015,"about_ca_topic_score_gemma":0.00002253258,"teacher_disagreement_score":0.5526883,"about_ca_system_score_codex":0.0002300953,"about_ca_system_score_gemma":0.00008818813,"threshold_uncertainty_score":0.4701839},"labels":[],"label_agreement":null},{"id":"W1986331658","doi":"10.1007/s100240010139","title":"Morphological and Phenotypic Features in Pediatric Large Cell Lymphoma and Their Correlation with ALK Expression and the t(2;5)(p23;q35) Translocation","year":2001,"lang":"en","type":"article","venue":"Pediatric and Developmental Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Anaplastic lymphoma kinase; Phenotype; Chromosomal translocation; Anaplastic large-cell lymphoma; CD30; Lymphoma; Immunophenotyping; Biology; Immunohistochemistry; Fusion gene; Pathology; Large-cell lymphoma; Population; Gene; Cancer research; Molecular biology; Medicine; Genetics; Immunology; Flow cytometry","score_opus":0.006285691288332623,"score_gpt":0.20351694405782453,"score_spread":0.1972312527694919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986331658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812813,0.017061038,0.00020894357,0.00039483389,0.0000387685,0.00045865393,0.0000058077203,0.000021328999,0.00052932906],"genre_scores_gemma":[0.97308475,0.025433218,0.0009100573,0.00030610434,0.000080855185,0.000074693635,0.00003642836,0.000010899627,0.00006302439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899465,0.00008860731,0.00021866724,0.0003734684,0.000094507435,0.0002301206],"domain_scores_gemma":[0.99949425,0.00023273192,0.00007525481,0.00007480849,0.000020206167,0.00010275858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022735981,0.00020571679,0.00030345964,0.00013027387,0.00016341206,0.000022372755,0.00002807895,0.00015251752,0.000009571379],"category_scores_gemma":[0.000023431623,0.0001102049,0.000017177674,0.00017786214,0.00013124073,0.00008096702,0.000056557907,0.00009275634,0.0000024217698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073037663,0.00033721354,0.9824447,0.000043869757,0.000006837387,0.00020390181,0.0023408404,5.927553e-7,0.00008036324,0.00008427433,0.00008454923,0.013642492],"study_design_scores_gemma":[0.017466038,0.00022199175,0.9786678,0.000010971884,0.00009325881,0.0021752114,0.0007673274,0.00005795524,0.00010599624,0.00020083011,0.00009244571,0.00014014968],"about_ca_topic_score_codex":0.000024042834,"about_ca_topic_score_gemma":0.00003570812,"teacher_disagreement_score":0.016735664,"about_ca_system_score_codex":0.00003801694,"about_ca_system_score_gemma":0.00005530244,"threshold_uncertainty_score":0.4494025},"labels":[],"label_agreement":null},{"id":"W1986832357","doi":"10.1016/s0360-3016(02)03574-5","title":"Combined modality therapy for clinical stage I and II primary mediastinal large B-cell lymphoma treated at the Princess Margaret hospital","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); B symptoms; Internal medicine; Lymphoma; International Prognostic Index; Radiation therapy; CHOP; Chemotherapy; Gastroenterology; Surgery; Vincristine; Diffuse large B-cell lymphoma; Cyclophosphamide","score_opus":0.03602019849888926,"score_gpt":0.34777841418081595,"score_spread":0.3117582156819267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986832357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98463994,0.0017386941,0.00043655335,0.010596248,0.0012089973,0.00059961673,0.00022748118,0.000025065572,0.0005274061],"genre_scores_gemma":[0.9889104,0.006530989,0.00059707934,0.0020669573,0.0012670304,0.000050628278,0.00021598687,0.000023866958,0.00033708772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811333,0.00024479686,0.000823347,0.00028276097,0.000285524,0.00025026177],"domain_scores_gemma":[0.9970793,0.0010277218,0.0010132685,0.00017712737,0.0005395689,0.00016301121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073642033,0.0002240127,0.0005652906,0.00006315369,0.0001996878,0.0000253589,0.00025796515,0.0002252924,0.00012166613],"category_scores_gemma":[0.000174123,0.0001453456,0.00031887405,0.00008008547,0.00026858415,0.00015140302,0.000110000874,0.00017970962,0.000009982715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014267684,0.00736286,0.8404398,0.000009556497,0.00081600493,0.000053972515,0.00040098745,0.0000059762197,0.00014387518,0.0016202424,0.004109532,0.14361043],"study_design_scores_gemma":[0.06792749,0.00934466,0.83540285,0.00003721313,0.0002560145,0.00011513446,0.00006541974,0.001990058,0.0014235345,0.0010923049,0.08212599,0.00021932194],"about_ca_topic_score_codex":0.000011926326,"about_ca_topic_score_gemma":0.0000035316161,"teacher_disagreement_score":0.1433911,"about_ca_system_score_codex":0.00079189165,"about_ca_system_score_gemma":0.00022804609,"threshold_uncertainty_score":0.5927022},"labels":[],"label_agreement":null},{"id":"W1986861934","doi":"10.1002/cncr.25295","title":"Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dacarbazine; ABVD; Vinblastine; Bleomycin; Hodgkin's lymphoma; Regimen; Chemotherapy; Urology; Gastroenterology; Nuclear medicine; Internal medicine; Lymphoma; Surgery; Vincristine; Cyclophosphamide","score_opus":0.012778211441625038,"score_gpt":0.2827712902365161,"score_spread":0.26999307879489104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986861934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973084,0.0010196595,5.756154e-7,0.00038615998,0.0003206663,0.00033027318,0.0000708114,0.000013857652,0.00054960256],"genre_scores_gemma":[0.99901706,0.00037870966,0.00021148183,0.000056990102,0.00008027062,0.00011823012,0.000018428676,0.000017432616,0.00010138423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990919,0.000019514477,0.00031242598,0.00022591157,0.0001790966,0.00017115493],"domain_scores_gemma":[0.99929476,0.00009641281,0.0001492525,0.00023928043,0.00012727217,0.0000930398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007673704,0.0001507835,0.0003703583,0.00013727816,0.000014707096,0.0000071346362,0.000045933055,0.000096662196,0.00019501707],"category_scores_gemma":[0.00007810006,0.0001230505,0.00005293401,0.00018084382,0.00009317257,0.00007346281,0.00002811946,0.00007246342,0.0000025593542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004394331,0.00045212253,0.76343614,0.00017387516,0.00013404075,0.000033136585,0.0006474783,0.000009395919,0.22380887,0.00023349703,0.00019783407,0.00647929],"study_design_scores_gemma":[0.011150268,0.0006507269,0.8927763,0.00015532762,0.00011791223,0.0000025600707,0.00006343398,0.000063878484,0.094575725,0.000018102604,0.00033086815,0.000094905765],"about_ca_topic_score_codex":0.0014912271,"about_ca_topic_score_gemma":0.001090271,"teacher_disagreement_score":0.12934016,"about_ca_system_score_codex":0.00010023085,"about_ca_system_score_gemma":0.0001550214,"threshold_uncertainty_score":0.5017854},"labels":[],"label_agreement":null},{"id":"W1986973952","doi":"10.1097/pas.0b013e3182049a9c","title":"Molecular Characteristics of Mantle Cell Lymphoma Presenting With Clonal Plasma Cell Component","year":2011,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Immunophenotyping; Mantle cell lymphoma; Lymphoma; Population; Biology; Pathology; Plasma cell; Germinal center; Molecular biology; B cell; Antibody; Immunology; Flow cytometry; Medicine","score_opus":0.014249936769420315,"score_gpt":0.23011893966733835,"score_spread":0.21586900289791802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986973952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964325,0.00017082671,0.000051184143,0.00031157548,0.000065320244,0.000107078595,0.000008518024,0.0000056845347,0.0028473476],"genre_scores_gemma":[0.9980191,0.00024015922,0.0014925747,0.00012331361,0.00006721621,0.0000036086901,0.000003226716,0.00001798299,0.000032813754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865556,0.00018639206,0.00049231824,0.00013351775,0.00028990436,0.00024230761],"domain_scores_gemma":[0.9983635,0.00018453898,0.0009191878,0.00022476225,0.00015711054,0.00015089908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025525762,0.00015454076,0.00068887963,0.00008105833,0.00003846752,0.0000045645265,0.0001616096,0.000032787713,0.00006132213],"category_scores_gemma":[0.000008904368,0.000082579245,0.00018865895,0.00012872978,0.00055380195,0.000025456331,0.00005725586,0.00012393719,0.000010815691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015890706,0.014225992,0.7612289,0.00018357694,0.0008964521,0.11104395,0.0043553305,0.00003159319,0.049424537,0.0006485477,0.00025495962,0.041815445],"study_design_scores_gemma":[0.009737571,0.0075666998,0.8279445,0.0001001887,0.0007389739,0.021876527,0.0007720764,0.00007209077,0.12933046,0.00006592751,0.0015862526,0.00020871157],"about_ca_topic_score_codex":0.000029005005,"about_ca_topic_score_gemma":2.0472058e-7,"teacher_disagreement_score":0.08916742,"about_ca_system_score_codex":0.00004672872,"about_ca_system_score_gemma":0.00010231284,"threshold_uncertainty_score":0.3367484},"labels":[],"label_agreement":null},{"id":"W1987130154","doi":"10.1038/leu.2009.100","title":"Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation","keywords":"Apoptosis; Cancer research; Biology; Mantle cell lymphoma; Tumor necrosis factor alpha; STAT1; Signal transduction; Lymphoma; Molecular biology; Cell biology; Immunology; Biochemistry","score_opus":0.01327014297712055,"score_gpt":0.258905328367161,"score_spread":0.24563518539004048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987130154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823334,0.00037765424,0.000087829845,0.00048451507,0.00020357942,0.0006590935,0.000012254346,0.00009951266,0.01574216],"genre_scores_gemma":[0.99635935,0.00017927308,0.0008897371,0.0015528764,0.00009973639,0.00011608585,0.000028782597,0.000029140212,0.0007449926],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823374,0.00007262866,0.00034467765,0.00051997445,0.00036071625,0.00046827138],"domain_scores_gemma":[0.9992318,0.00010248063,0.000107028216,0.000373815,0.00004473489,0.00014010406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000140491,0.00032059374,0.0005001719,0.00015005769,0.00006486879,0.00004397861,0.0001394071,0.00018587848,0.000109799425],"category_scores_gemma":[0.000028648525,0.00026029104,0.00015330635,0.0002537604,0.000028220855,0.0001626411,0.00005407517,0.0001365929,0.00025089385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00423801,0.02239801,0.043418415,0.00091924216,0.0011926239,0.0070248903,0.031526063,0.00010578152,0.3570916,0.027367406,0.011518826,0.49319914],"study_design_scores_gemma":[0.015100151,0.0018155326,0.11939916,0.00034797878,0.00017007867,0.00009847373,0.0004742933,0.00007178526,0.85639423,0.004628371,0.0011281129,0.00037180405],"about_ca_topic_score_codex":0.0011088327,"about_ca_topic_score_gemma":0.00006107127,"teacher_disagreement_score":0.49930266,"about_ca_system_score_codex":0.0035466966,"about_ca_system_score_gemma":0.00042837084,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W1987220531","doi":"10.1111/cyt.12119","title":"Cytomorphological and clinicopathological spectrum of pulmonary marginal zone lymphoma: the utility of immunophenotyping, <scp>PCR</scp> and <scp>FISH</scp> studies","year":2013,"lang":"en","type":"article","venue":"Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Medicine; Fish <Actinopterygii>; Pathology; Immunology; Biology; Antigen; Fishery","score_opus":0.033309168369824706,"score_gpt":0.2835391930139726,"score_spread":0.2502300246441479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987220531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077375,0.015464475,0.00003298072,0.00086389453,0.00025226275,0.00084820704,0.000044703585,0.000057099845,0.0016626326],"genre_scores_gemma":[0.9938244,0.00419772,0.00068925996,0.0006353098,0.0001381272,0.00017058093,0.000024365374,0.000024079582,0.00029613113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704975,0.00045335904,0.00087989646,0.0007412559,0.00027447465,0.0006012822],"domain_scores_gemma":[0.9962379,0.0022398443,0.00044689092,0.0006749464,0.00021607497,0.00018435382],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00090202654,0.00042198726,0.0014100127,0.0001212522,0.0001972517,0.000019534866,0.00021942446,0.0003647753,0.00005363961],"category_scores_gemma":[0.0014918894,0.0002531189,0.000197292,0.00021962645,0.00277686,0.000094824216,0.0005500981,0.0002483371,0.00003330722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009364372,0.0019511103,0.972437,0.00022217905,0.0001454199,0.0015722887,0.001053883,2.9844585e-7,0.0058491006,0.00097490376,0.0019134454,0.013786679],"study_design_scores_gemma":[0.0027989883,0.0017289569,0.9798507,0.00008696866,0.00033994296,0.0051111574,0.002376297,0.000080603444,0.0043798457,0.0018007233,0.0013887538,0.000057024066],"about_ca_topic_score_codex":0.00008021027,"about_ca_topic_score_gemma":0.0000073909905,"teacher_disagreement_score":0.013729655,"about_ca_system_score_codex":0.0000625606,"about_ca_system_score_gemma":0.00008964899,"threshold_uncertainty_score":0.99999213},"labels":[],"label_agreement":null},{"id":"W1987552614","doi":"10.1038/sj.ki.5000341","title":"Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: Report of 21 cases and review of the literature","year":2006,"lang":"en","type":"review","venue":"Kidney International","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Hospitalier Universitaire de Nantes","keywords":"Medicine; Lymphoma; Nephrotic syndrome; Retrospective cohort study; Glomerulopathy; Internal medicine; Pathophysiology; Regimen; Cohort; Pathology; Nodular sclerosis; Gastroenterology; Glomerulonephritis; Hodgkin lymphoma; Kidney","score_opus":0.03913863093153001,"score_gpt":0.32924113934372884,"score_spread":0.2901025084121988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987552614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006225242,0.9939232,1.2589041e-7,0.002654609,0.000409046,0.0009355397,0.0007536499,0.000007730256,0.0006935581],"genre_scores_gemma":[0.001110269,0.9958626,0.00014475132,0.0006646492,0.00025141682,0.00018511868,0.0008903041,0.000022238331,0.0008686568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828774,0.00007038526,0.00074264884,0.00033730015,0.0004403096,0.00012159029],"domain_scores_gemma":[0.9984944,0.00020947632,0.00064483006,0.00033147042,0.00017835118,0.00014150112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001498364,0.00029140335,0.0013139929,0.0001219642,0.000025100391,0.000018007844,0.00012781474,0.00018108671,0.0000655373],"category_scores_gemma":[0.0006650973,0.00016520449,0.00040917742,0.00017530328,0.00016096245,0.000055443816,0.00014138724,0.00009861803,0.0000019329989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003274234,0.0014367524,0.006301856,0.26823395,0.00224531,0.010539197,0.00008552499,2.492169e-9,9.735162e-7,0.0010163708,0.102022946,0.6080844],"study_design_scores_gemma":[0.00056657364,0.00010466675,0.008017386,0.20358972,0.0015992286,0.041377496,0.0000011817414,5.41233e-7,0.000002054383,0.0000068102995,0.7446383,0.00009602654],"about_ca_topic_score_codex":0.000050833412,"about_ca_topic_score_gemma":0.0000020066689,"teacher_disagreement_score":0.6426154,"about_ca_system_score_codex":0.00015233966,"about_ca_system_score_gemma":0.00042072174,"threshold_uncertainty_score":0.67368436},"labels":[],"label_agreement":null},{"id":"W1987879827","doi":"10.1111/j.1524-4733.2010.00737.x","title":"Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CHOP; Rituximab; Medicine; Diffuse large B-cell lymphoma; Vincristine; Population; Cost effectiveness; Internal medicine; Oncology; Cohort; Lymphoma; Cyclophosphamide; Chemotherapy; Environmental health","score_opus":0.036195372987913865,"score_gpt":0.29702635170920827,"score_spread":0.2608309787212944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987879827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931206,0.00007755879,0.000005880559,0.0011591648,0.000115746276,0.0047607757,0.0007508058,0.0000039411448,0.000005518157],"genre_scores_gemma":[0.9970096,0.000052308544,0.00032060337,0.0005029175,0.000019592642,0.0016548049,0.0004129314,0.000016238759,0.000011040451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857575,0.0001346864,0.00056468515,0.00024652513,0.0002303107,0.00024804755],"domain_scores_gemma":[0.9988187,0.0006724002,0.00015710108,0.00021127654,0.000065126245,0.00007540582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510319,0.00010181417,0.00049212447,0.00009477903,0.000034889843,0.0000073636425,0.00005899261,0.000073453346,0.000020095948],"category_scores_gemma":[0.00014688916,0.00011291449,0.000057722355,0.0004076611,0.0000136974195,0.000028433067,0.000007981145,0.000052743333,1.5014979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002569423,0.012396617,0.9825778,0.00036544105,0.000009729386,0.000009158946,0.000093131865,0.0008010595,0.00002394927,0.000025281794,0.000046358306,0.0033945497],"study_design_scores_gemma":[0.05401586,0.0003753312,0.9401411,0.00091904245,0.00000738309,0.000002160221,0.00001744717,0.0037957213,0.00032309772,0.000085653875,0.00024551895,0.00007169946],"about_ca_topic_score_codex":0.98491395,"about_ca_topic_score_gemma":0.9962586,"teacher_disagreement_score":0.05375892,"about_ca_system_score_codex":0.0029108014,"about_ca_system_score_gemma":0.001866483,"threshold_uncertainty_score":0.7611644},"labels":[],"label_agreement":null},{"id":"W1988055831","doi":"10.1016/j.transci.2013.07.014","title":"Epidemiology of Non-Hodgkin Lymphoma","year":2013,"lang":"en","type":"review","venue":"Transfusion and Apheresis Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Epidemiology; Hodgkin lymphoma; Incidence (geometry); Lymphoma; Medicine; Demography; Immunology; Pathology","score_opus":0.08228679774115465,"score_gpt":0.3879282853649029,"score_spread":0.30564148762374826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988055831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050243726,0.99104875,0.000025502615,0.000088745015,0.00012276083,0.0009629409,0.000015579899,0.000019876865,0.0026914817],"genre_scores_gemma":[0.0016162121,0.99640214,0.001356879,0.00010457385,0.000037329362,0.00011049477,0.000007868666,0.000016628746,0.0003478666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799097,0.000090935704,0.00065641006,0.0006262547,0.00027368616,0.0003617559],"domain_scores_gemma":[0.99855405,0.00041941938,0.00021375404,0.00042352412,0.00008332602,0.00030592535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005997081,0.00031758583,0.0019489661,0.00023654876,0.00013536857,0.0000066493785,0.00021433842,0.00020786104,0.00039292974],"category_scores_gemma":[0.000110232984,0.00018735371,0.00036210203,0.00061266386,0.00082304823,0.000073719326,0.000056095992,0.000073069205,0.00006776253],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000072578223,0.0002045656,0.0012096625,0.0035989592,0.000037974274,0.000010072465,0.000035587353,2.8388921e-8,0.000022119719,0.0002659139,0.00020616417,0.9944017],"study_design_scores_gemma":[0.0027203553,0.0009837068,0.035621077,0.023661051,0.0020970118,0.0004315032,0.00007852816,0.000058559173,0.00031360524,0.00010860396,0.9333243,0.0006017236],"about_ca_topic_score_codex":0.00040865652,"about_ca_topic_score_gemma":0.000011313627,"teacher_disagreement_score":0.9938,"about_ca_system_score_codex":0.0000888435,"about_ca_system_score_gemma":0.00057040044,"threshold_uncertainty_score":0.76400626},"labels":[],"label_agreement":null},{"id":"W1988166471","doi":"10.3109/10428190109097680","title":"Liposomal Daunorubicin (Daunoxome) in Combination with Cyclophosphamide, Vincristine and Prednisolone (COP-X) as Salvage Therapy in Poor-Prognosis Non-Hodgkins Lymphoma","year":2001,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Mucositis; Regimen; Gastroenterology; Vincristine; Cyclophosphamide; Surgery; Salvage therapy; Prednisolone; Lymphoma; Febrile neutropenia; CHOP; Chemotherapy","score_opus":0.008608960792715007,"score_gpt":0.2378536185548517,"score_spread":0.2292446577621367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988166471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860797,0.0049728397,0.000023654884,0.00077666016,0.00023801829,0.0024437662,0.00003981845,0.0002843737,0.0051411837],"genre_scores_gemma":[0.9831968,0.011706379,0.0006861578,0.0020683855,0.00021542003,0.00085957895,0.00025690946,0.0002369602,0.0007734411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933854,0.0003458073,0.0015606299,0.0019258644,0.0010673905,0.0017149438],"domain_scores_gemma":[0.99682444,0.0006058718,0.0005180185,0.0009825544,0.00023502168,0.00083409826],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007336577,0.0014684486,0.0019942643,0.0011030982,0.0005042968,0.0002754333,0.00041559283,0.0008328965,0.00008172191],"category_scores_gemma":[0.00015520885,0.0012523168,0.0002516809,0.0019054706,0.0006303669,0.0007214876,0.00028570555,0.00027366553,0.00007213968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006189623,0.0032196085,0.67534816,0.00025358825,0.0003593912,0.0049817725,0.0019486762,0.00003641999,0.0030594063,0.0006825161,0.0003480148,0.3035728],"study_design_scores_gemma":[0.09027924,0.0038022734,0.88221276,0.0011866383,0.00024839336,0.004043229,0.0008133627,0.0021440303,0.010390467,0.00037932547,0.003301967,0.0011983473],"about_ca_topic_score_codex":0.02740654,"about_ca_topic_score_gemma":0.0018198319,"teacher_disagreement_score":0.30237445,"about_ca_system_score_codex":0.008996447,"about_ca_system_score_gemma":0.0026451445,"threshold_uncertainty_score":0.9998065},"labels":[],"label_agreement":null},{"id":"W1988930419","doi":"10.1016/j.ijrobp.2014.05.633","title":"Identification of Gene Expression Signatures to Predict the Response of Low-Grade Lymphomas to Very Low Dose Radiation Therapy","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Microarray; Gene expression; Complete response; Radiation therapy; Lymphoma; Gene expression profiling; Mantle cell lymphoma; Nuclear medicine; Pathology; Oncology; Cancer research; Internal medicine; Gene; Chemotherapy; Biology","score_opus":0.013893902686252681,"score_gpt":0.3141815001699313,"score_spread":0.3002875974836786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988930419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866981,0.00059602817,0.005685613,0.0049748775,0.0013887624,0.00052393397,0.00007357844,0.000017024411,0.000042085376],"genre_scores_gemma":[0.99604255,0.00049803033,0.00104785,0.0011521807,0.0011054234,0.000042410953,0.00006404195,0.00002254462,0.000024962694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752784,0.00055213226,0.0010200918,0.00023755152,0.00048929465,0.0001730686],"domain_scores_gemma":[0.99632627,0.0010106319,0.0013595222,0.00030078,0.0008554933,0.00014732161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012740808,0.00019370136,0.00047710634,0.00028965267,0.00006518681,0.000019944004,0.0004043747,0.00020412904,0.000026740634],"category_scores_gemma":[0.00095455087,0.00013415264,0.0002559132,0.00025256374,0.00011064312,0.00016840696,0.000045309167,0.00015349963,0.0000143368425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066444897,0.0016458633,0.102311306,0.00001477051,0.0005587967,0.000011484512,0.0016589459,0.004907334,0.7511975,0.0012960169,0.0022827925,0.12747066],"study_design_scores_gemma":[0.0068740114,0.002351619,0.37281412,0.00012999863,0.0000883529,0.00004478835,0.00006285602,0.0009687386,0.61135757,0.0009303608,0.0042636,0.00011397463],"about_ca_topic_score_codex":0.000013396754,"about_ca_topic_score_gemma":9.963811e-7,"teacher_disagreement_score":0.27050284,"about_ca_system_score_codex":0.00061619515,"about_ca_system_score_gemma":0.00045496758,"threshold_uncertainty_score":0.5470586},"labels":[],"label_agreement":null},{"id":"W1989311050","doi":"10.1155/2011/439456","title":"Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies","year":2011,"lang":"en","type":"article","venue":"Advances in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Disease; Neoplasm; Gene expression profiling; Epidemiology; Classical Hodgkin lymphoma; Gene; Cancer research; Immunology; Pathology; Gene expression; Biology; Genetics","score_opus":0.014861006991288459,"score_gpt":0.301663234628154,"score_spread":0.2868022276368655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989311050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85032636,0.14619182,0.000041925392,0.00018542763,0.00016280255,0.00049797463,0.000014245025,0.000013675019,0.0025657467],"genre_scores_gemma":[0.8871141,0.11237008,0.00014828214,0.00015943171,0.000018386221,0.00016965719,0.000009666776,0.000009307404,0.0000010521813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986941,0.00020308583,0.0003654676,0.00031559184,0.00011497949,0.00030672792],"domain_scores_gemma":[0.9985658,0.0009449763,0.0001491572,0.0002563557,0.00004097576,0.00004274641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016203252,0.00021144557,0.00054468657,0.00014086155,0.000029950228,0.0000042775723,0.000117014715,0.000117210206,0.000049951475],"category_scores_gemma":[0.000118506345,0.00011841764,0.00006240263,0.00017566385,0.00033852342,0.00015648012,0.000030173536,0.0000882154,0.000003643758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001266304,0.0018549687,0.77762043,0.00009050265,0.000060176695,0.0006704388,0.0013707511,0.00009847553,0.000024978215,0.01829798,0.000007383347,0.19863762],"study_design_scores_gemma":[0.004432326,0.0038397647,0.96595544,0.00020134305,0.000089394314,0.00089309725,0.002117611,0.00006017319,0.0014367402,0.019126924,0.0016973463,0.00014982474],"about_ca_topic_score_codex":0.000048703823,"about_ca_topic_score_gemma":0.0001530332,"teacher_disagreement_score":0.1984878,"about_ca_system_score_codex":0.00006452663,"about_ca_system_score_gemma":0.00008529758,"threshold_uncertainty_score":0.48289314},"labels":[],"label_agreement":null},{"id":"W1989512507","doi":"10.1016/j.anndiagpath.2014.02.008","title":"Livin, a novel marker in lymphoma type distinction","year":2014,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Isfahan University of Medical Sciences","keywords":"Lymphoma; Receiver operating characteristic; Glyceraldehyde 3-phosphate dehydrogenase; Diffuse large B-cell lymphoma; Pathology; Immunohistochemistry; Biomarker; Likelihood ratios in diagnostic testing; Medicine; Tissue microarray; Oncology; Internal medicine; Biology; Gene expression; Gene; Genetics","score_opus":0.041891375035923537,"score_gpt":0.31349944202571317,"score_spread":0.2716080669897896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989512507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155277,0.00064450694,0.00015105275,0.0021191451,0.00025093873,0.00023123951,0.000012291903,0.00002538677,0.0050126566],"genre_scores_gemma":[0.9971464,0.0006208803,0.00035774423,0.0015785309,0.00008766064,0.000055918175,0.00003692274,0.000015373886,0.00010052416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989225,0.000078035075,0.00032555748,0.0002686872,0.00013271807,0.00027247157],"domain_scores_gemma":[0.99769264,0.001660049,0.00010925832,0.00030156158,0.00013735806,0.00009913618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188677,0.00014516847,0.00040042188,0.0001431244,0.000021629043,0.000004245156,0.000060895276,0.00012506626,0.00012013242],"category_scores_gemma":[0.005424084,0.000121542325,0.00008440184,0.00020260966,0.00009371196,0.000038072518,0.000043146734,0.00004484737,0.00009827727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022713012,0.003066761,0.8971626,0.00007603492,0.000055795186,0.00034913275,0.00016033117,0.000008046671,0.001010545,0.0022721165,0.0023707896,0.0932407],"study_design_scores_gemma":[0.002355231,0.0010601833,0.9880002,0.00019004595,0.000058547717,0.00020569065,0.00002019317,0.00010135795,0.002668934,0.0004102252,0.00482746,0.00010192876],"about_ca_topic_score_codex":0.000112576774,"about_ca_topic_score_gemma":0.00004606601,"teacher_disagreement_score":0.09313878,"about_ca_system_score_codex":0.000029202141,"about_ca_system_score_gemma":0.00006431178,"threshold_uncertainty_score":0.6493527},"labels":[],"label_agreement":null},{"id":"W1989577949","doi":"10.1080/10428190290033332","title":"Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Internal medicine; Vincristine; Chemotherapy; Regimen; Lymphoma; Etoposide; Procarbazine; Prednisone; Combination chemotherapy; Gastroenterology; Neutropenia; Surgery; Oncology; Cyclophosphamide","score_opus":0.01424569885269534,"score_gpt":0.24476227634504188,"score_spread":0.23051657749234655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989577949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98844993,0.0026879814,0.000019011743,0.00025932153,0.000275488,0.0037010447,0.00031331056,0.00033013648,0.003963768],"genre_scores_gemma":[0.9927006,0.0008560134,0.00085702125,0.0003698764,0.00027766256,0.00088542176,0.00024901793,0.00022948641,0.0035749173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9932507,0.00016919822,0.0015637263,0.0019944294,0.0015372512,0.0014846824],"domain_scores_gemma":[0.99531144,0.0003279448,0.00084916496,0.0019441795,0.00047011976,0.0010971532],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00019853102,0.0016373331,0.0024145832,0.0006532971,0.00076892524,0.00014782233,0.0004254625,0.00043267536,0.00022315375],"category_scores_gemma":[0.00006098451,0.0012127772,0.00056713197,0.0010541036,0.00053346733,0.0004914221,0.00023931052,0.00007692198,0.0000699018],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005979247,0.07067837,0.16578862,0.00023604576,0.003146777,0.0015566413,0.0099901585,0.00001605068,0.00044512836,0.0002801982,0.0028686821,0.7390141],"study_design_scores_gemma":[0.41797823,0.069713615,0.45822087,0.00061589584,0.0037799764,0.0013745389,0.0021730599,0.0021859044,0.005238346,0.000036096557,0.036726095,0.0019573553],"about_ca_topic_score_codex":0.003614209,"about_ca_topic_score_gemma":0.00015506301,"teacher_disagreement_score":0.73705673,"about_ca_system_score_codex":0.010600097,"about_ca_system_score_gemma":0.0016663596,"threshold_uncertainty_score":0.9996374},"labels":[],"label_agreement":null},{"id":"W1989625297","doi":"10.1038/onc.2014.44","title":"High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Oncogene","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Biology; Chromatin immunoprecipitation; Mantle cell lymphoma; Immunoprecipitation; Computational biology; Chromatin; High resolution; Cancer research; Lymphoma; Mantle (geology); Genetics; Gene; Gene expression; Immunology; Remote sensing; Paleontology","score_opus":0.014820298856687035,"score_gpt":0.24480302730738693,"score_spread":0.2299827284506999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989625297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624205,0.0010932889,0.0009168439,0.0001841368,0.00012544401,0.00090203044,0.00003238245,0.000038898834,0.00046490095],"genre_scores_gemma":[0.978557,0.00007117029,0.020489795,0.00008112088,0.00012773843,0.00028475453,0.00019985998,0.000029292494,0.00015930098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988876,0.000036393423,0.00031848738,0.00030927928,0.00015626755,0.00029198467],"domain_scores_gemma":[0.9993362,0.00020665629,0.00013912232,0.00017264226,0.00005721823,0.00008816364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033452286,0.00017193083,0.00031253495,0.00013593899,0.000105238396,0.000027158821,0.000043916974,0.000096704134,0.000011144539],"category_scores_gemma":[0.00014937087,0.00015248361,0.000056475157,0.00012166511,0.000024447629,0.00009094455,0.000029443234,0.000030943247,0.000023819057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013352263,0.00069665763,0.031812847,0.00024423536,0.000051734343,0.000010608543,0.00065847026,0.00007664328,0.93859076,0.00044664936,0.000116168965,0.027161686],"study_design_scores_gemma":[0.023914205,0.0017080277,0.47316474,0.0009289966,0.00036635651,0.00009260198,0.00044092903,0.014339789,0.4825888,0.0009045969,0.0010785032,0.00047245805],"about_ca_topic_score_codex":0.00035233755,"about_ca_topic_score_gemma":0.00005976146,"teacher_disagreement_score":0.456002,"about_ca_system_score_codex":0.0005094887,"about_ca_system_score_gemma":0.000085803564,"threshold_uncertainty_score":0.62181014},"labels":[],"label_agreement":null},{"id":"W1989963052","doi":"10.3109/10428194.2011.555892","title":"Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Neutropenia; Internal medicine; Refractory (planetary science); Pharmacodynamics; Diffuse large B-cell lymphoma; Oncology; Phases of clinical research; Toxicity; Clinical trial; Febrile neutropenia; Lymphoma; Gastroenterology; Pharmacokinetics; Cancer; Biology","score_opus":0.09485852275559409,"score_gpt":0.3912644948390851,"score_spread":0.296405972083491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989963052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915329,0.0018940237,0.0000065301087,0.00007490869,0.0011998998,0.0038462302,0.00016262867,0.00015106535,0.0011318022],"genre_scores_gemma":[0.99314976,0.003264458,0.00028395248,0.0014503337,0.00039925016,0.0004353594,0.000062831496,0.0001660415,0.0007880313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874762,0.003350563,0.005046345,0.0018953276,0.0009576459,0.0012738936],"domain_scores_gemma":[0.9922655,0.003015169,0.001757605,0.0017254506,0.00022151825,0.0010147204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00577353,0.0011795971,0.0035545868,0.0004688139,0.0005386136,0.000071528724,0.0006559158,0.0009540461,0.00015663456],"category_scores_gemma":[0.0015726639,0.000757657,0.0009769175,0.00080606784,0.0009357801,0.00032025395,0.0008966893,0.00038137176,0.000026536205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02896218,0.16162759,0.5090455,0.00039421546,0.0013710842,0.0023507662,0.007037765,4.6841654e-7,0.00061668066,0.00014362525,0.0011689906,0.28728113],"study_design_scores_gemma":[0.4162365,0.008183586,0.5623866,0.00047008958,0.0019976334,0.0002656871,0.0028760573,0.0022463952,0.0007258358,0.00003540907,0.0039107143,0.0006655552],"about_ca_topic_score_codex":0.0024923976,"about_ca_topic_score_gemma":0.0008747874,"teacher_disagreement_score":0.3872743,"about_ca_system_score_codex":0.0025111835,"about_ca_system_score_gemma":0.002778672,"threshold_uncertainty_score":0.99948746},"labels":[],"label_agreement":null},{"id":"W1990358661","doi":"10.1159/000225266","title":"Continuous Treatment of Non-Hodgkin’s Malignant Lymphoma with Prednimustine (Leo 1031)","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Lymphoma; Gastroenterology; Internal medicine; Malignant lymphoma; Chemotherapy; Surgery","score_opus":0.013470239338953194,"score_gpt":0.29480008155983295,"score_spread":0.28132984222087976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990358661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96477306,0.00066192873,0.00002438812,0.0025059623,0.000099520425,0.00074360723,0.000014367648,0.000048804384,0.031128349],"genre_scores_gemma":[0.9945581,0.0003212896,0.0026772425,0.00052169233,0.00013433558,0.00010595211,0.00004402277,0.000016938653,0.0016204588],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987999,0.000037455244,0.0003264233,0.00032953318,0.00017133451,0.00033536274],"domain_scores_gemma":[0.99908155,0.00009217079,0.00017550636,0.00036686365,0.00011314748,0.0001707703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059401733,0.00023887662,0.0008062246,0.000094801384,0.00004178862,0.00000564653,0.00005882377,0.0001436336,0.00015946396],"category_scores_gemma":[0.000012441105,0.00014639036,0.00012592548,0.00013614865,0.00009242782,0.00002882267,0.000010736806,0.000022407643,0.000049434802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033537294,0.02256122,0.119546026,0.000039675382,0.0006568763,0.0040308894,0.0010044118,0.000010718075,0.0071220603,0.0006489068,0.0027586531,0.83826685],"study_design_scores_gemma":[0.030275602,0.09920696,0.7472797,0.00014504559,0.00093662244,0.0014633875,0.00020349468,0.00007144839,0.03825564,0.000050002905,0.08189031,0.00022179223],"about_ca_topic_score_codex":0.00031441337,"about_ca_topic_score_gemma":0.0000643373,"teacher_disagreement_score":0.83804506,"about_ca_system_score_codex":0.0006758637,"about_ca_system_score_gemma":0.00045264573,"threshold_uncertainty_score":0.5969625},"labels":[],"label_agreement":null},{"id":"W1990370347","doi":"10.3109/10428194.2014.963075","title":"Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Prednisone; Vincristine; Internal medicine; CHOP; Cyclophosphamide; Lymphoma; Chemoimmunotherapy; Gastroenterology; Ofatumumab; Oncology; Chemotherapy; Surgery","score_opus":0.0035991984274510364,"score_gpt":0.2022721831625936,"score_spread":0.19867298473514255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990370347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939457,0.00069003046,0.00010821119,0.00013832045,0.00013604865,0.001236453,0.000032323736,0.0001471682,0.0035657496],"genre_scores_gemma":[0.9951173,0.0005391879,0.0024779132,0.0008882918,0.0001223354,0.0002836715,0.00012631438,0.00018804103,0.00025691383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99491894,0.00016717597,0.0011712163,0.0013713695,0.0011921976,0.0011791135],"domain_scores_gemma":[0.99670565,0.0004299814,0.0006622084,0.0013101915,0.0003936929,0.0004982666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045374833,0.0010663498,0.0018961519,0.00057262176,0.00027150614,0.0001230355,0.0004258466,0.0004722575,0.000057853023],"category_scores_gemma":[0.00009565069,0.0008093962,0.00022489205,0.0010706154,0.00060110056,0.0005254436,0.00016763314,0.00012382652,0.000040155774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036819833,0.0017283999,0.681426,0.00029296434,0.00033319762,0.0002318784,0.0009219383,0.000034402317,0.0005039761,0.000192405,0.00013018891,0.31052268],"study_design_scores_gemma":[0.094211176,0.0032209854,0.8879123,0.0019941467,0.0003025312,0.00044738594,0.00019125296,0.0011424688,0.007985738,0.00007262798,0.0016404011,0.0008790181],"about_ca_topic_score_codex":0.004308831,"about_ca_topic_score_gemma":0.00033716066,"teacher_disagreement_score":0.30964366,"about_ca_system_score_codex":0.0061990763,"about_ca_system_score_gemma":0.0024643564,"threshold_uncertainty_score":0.99943566},"labels":[],"label_agreement":null},{"id":"W1990481171","doi":"10.1097/lgt.0b013e318187a7ee","title":"Hodgkin Lymphoma Presenting as a Vulvar Mass in a Patient With Crohn Disease","year":2009,"lang":"en","type":"review","venue":"Journal of Lower Genital Tract Disease","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Labia majora; Vulva; Lymphoma; Dacarbazine; ABVD; Labia minora; Perineum; Bleomycin; Dermatology; Follicular lymphoma; Pathology; Chemotherapy; Internal medicine; Surgery; Vincristine; Cyclophosphamide","score_opus":0.022269907923944867,"score_gpt":0.3069487758171661,"score_spread":0.2846788678932213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990481171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12517959,0.87239623,0.0000025471027,0.00015275704,0.00022906836,0.0013756647,0.00012874822,0.000019825442,0.0005155878],"genre_scores_gemma":[0.18087839,0.81776094,0.00021050942,0.00022111039,0.0004497391,0.00010134802,0.00007304017,0.00010461193,0.0002003057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958818,0.00020650336,0.0015718054,0.00051396823,0.0012264788,0.0005994366],"domain_scores_gemma":[0.9956384,0.00022403292,0.0013053983,0.00057521695,0.00024522588,0.0020117403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002001859,0.00080031506,0.0022629115,0.0006541465,0.000071991846,0.00014268912,0.00025860468,0.00016747067,0.00015066998],"category_scores_gemma":[0.00031814352,0.0005048115,0.0017016039,0.00048573047,0.00007024438,0.00032567227,0.00004673394,0.00037825826,0.00007238828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025902737,0.00936958,0.0029258588,0.003970513,0.0006061766,0.40929174,0.00006865905,0.000005818346,1.5665432e-7,0.000006787848,0.00027898065,0.5708854],"study_design_scores_gemma":[0.0149123445,0.0055599143,0.19910519,0.08372442,0.02805177,0.014806188,0.00016239946,0.000019862775,0.0000024966705,0.00020073549,0.65170354,0.0017511577],"about_ca_topic_score_codex":0.000014056449,"about_ca_topic_score_gemma":0.0000014466084,"teacher_disagreement_score":0.6514245,"about_ca_system_score_codex":0.0009278109,"about_ca_system_score_gemma":0.0035299931,"threshold_uncertainty_score":0.99974036},"labels":[],"label_agreement":null},{"id":"W1991182114","doi":"10.1002/pbc.22552","title":"Successful treatment of multiply relapsed lymphoma with rituximab as a single agent","year":2010,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Oncology; Internal medicine","score_opus":0.011821744829459267,"score_gpt":0.25994658646907276,"score_spread":0.24812484163961349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991182114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081486,0.0053593,0.0000014668013,0.0005643529,0.00037832002,0.00073589646,0.000061993414,0.00007878555,0.002005042],"genre_scores_gemma":[0.9940555,0.0028469288,0.0009166991,0.00015780183,0.0008235938,0.0005026795,0.00002902002,0.00004797386,0.0006198083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983373,0.00002152435,0.0003571847,0.0004673953,0.00043073046,0.0003858637],"domain_scores_gemma":[0.99869734,0.00010479915,0.00022621053,0.00051220745,0.00017454695,0.00028488488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048225033,0.00032693587,0.000600309,0.00015820864,0.00007874028,0.000021647427,0.00009342498,0.00013558794,0.000500558],"category_scores_gemma":[0.000027976263,0.00021778255,0.0001925948,0.00037103202,0.000078596524,0.00007419462,0.000024218165,0.000062086896,0.000067595574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079094,0.019878892,0.9471001,0.0001563827,0.0006636825,0.00049340416,0.00058594934,0.0000044133944,0.001958274,0.000058311292,0.00038059542,0.027929079],"study_design_scores_gemma":[0.13475706,0.012795644,0.6748814,0.00013815389,0.011312763,0.00053451787,0.00018157603,0.000036595433,0.14126353,0.00003810197,0.02331809,0.00074254564],"about_ca_topic_score_codex":0.0042967177,"about_ca_topic_score_gemma":0.00085165066,"teacher_disagreement_score":0.27221864,"about_ca_system_score_codex":0.00020779016,"about_ca_system_score_gemma":0.0006101019,"threshold_uncertainty_score":0.88809144},"labels":[],"label_agreement":null},{"id":"W1991185912","doi":"10.1378/chest.11-2609","title":"The Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue","year":2012,"lang":"en","type":"letter","venue":"CHEST Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; MALT lymphoma; Pathology; Mucosa-associated lymphoid tissue; Lymphoma; Marginal zone; Biopsy; Atelectasis; Lymphatic system; Submucosa; Population; B cell; Lung; Internal medicine; Immunology; Antibody","score_opus":0.020616254559052766,"score_gpt":0.2563225771479242,"score_spread":0.23570632258887145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991185912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5673076,0.07627789,0.000052627038,0.34288707,0.0038010008,0.0015723933,0.00050505804,0.00007631778,0.00752007],"genre_scores_gemma":[0.92366797,0.018749326,0.0007432128,0.040613294,0.008312683,0.00020443712,0.00042276675,0.0002619511,0.007024359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961378,0.00023824362,0.0012239745,0.0003221141,0.001210955,0.0008669247],"domain_scores_gemma":[0.99611187,0.0008740272,0.0015979263,0.0006240946,0.00049332826,0.000298735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006860658,0.0005858397,0.0013280603,0.00023235308,0.00026455027,0.000064184715,0.00045863772,0.00085973664,0.0005184792],"category_scores_gemma":[0.00016595704,0.0003742305,0.0007396676,0.0002673355,0.00034467704,0.00010618911,0.00008555537,0.00072715234,0.000065614484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022508802,0.0035999536,0.11272678,0.0007226308,0.0015931152,0.0019193686,0.00033692535,4.8182477e-7,0.0005181158,0.000010690614,0.84211016,0.036236703],"study_design_scores_gemma":[0.01060577,0.0008496177,0.085403256,0.0009776079,0.0023269823,0.0025614444,0.00007107474,0.0000026997964,0.03559961,0.000035330646,0.86120033,0.0003662568],"about_ca_topic_score_codex":0.00016383333,"about_ca_topic_score_gemma":0.000010965288,"teacher_disagreement_score":0.35636038,"about_ca_system_score_codex":0.00094654487,"about_ca_system_score_gemma":0.0008183626,"threshold_uncertainty_score":0.99987096},"labels":[],"label_agreement":null},{"id":"W1991331507","doi":"10.1007/s11912-000-0093-x","title":"Mucosa-associated lymphoid tissue lymphomas","year":2000,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; MALT lymphoma; Lymphoma; Pathology; Lymphatic system; Mucosa-associated lymphoid tissue; Malignancy","score_opus":0.10775065125840738,"score_gpt":0.44347771101920924,"score_spread":0.33572705976080186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991331507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015353356,0.96995527,6.4783995e-7,0.00007957701,0.0040776078,0.002459871,0.000065250235,0.00028716525,0.022921057],"genre_scores_gemma":[0.00011248201,0.99180216,0.000053577773,0.000103775616,0.0007533695,0.0011988224,0.0031185038,0.00013575623,0.0027215478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477303,0.00033063916,0.0021273522,0.0013595822,0.00056255405,0.0008468693],"domain_scores_gemma":[0.9960564,0.000312706,0.0016612709,0.0012302127,0.00016189874,0.0005775302],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00047015696,0.0010352465,0.0051749446,0.0004068128,0.0001683947,0.000038716604,0.00017480896,0.0012211094,0.0016899331],"category_scores_gemma":[0.0002612384,0.00077782595,0.0013086195,0.0005588538,0.00018133209,0.00006395464,0.0001331923,0.0004264608,0.000919734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000011138709,0.004091068,0.0012474905,0.0036726177,0.0009534269,0.016498903,0.00003611322,6.027084e-8,6.584375e-8,0.000014707582,0.032606702,0.9408677],"study_design_scores_gemma":[0.0015216514,0.0006593303,0.00023812568,0.012768502,0.008283415,0.032306626,0.000003289362,5.628475e-7,0.0000035664048,0.000042394564,0.94369835,0.0004741752],"about_ca_topic_score_codex":0.00004390276,"about_ca_topic_score_gemma":0.000012136683,"teacher_disagreement_score":0.9403935,"about_ca_system_score_codex":0.005172339,"about_ca_system_score_gemma":0.00582396,"threshold_uncertainty_score":0.99985814},"labels":[],"label_agreement":null},{"id":"W1991361673","doi":"10.1182/blood-2009-07-235598","title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"FOXP3; International Prognostic Index; Follicular lymphoma; Internal medicine; Tissue microarray; Follicular phase; Medicine; CD8; Lymphoma; Oncology; Survival analysis; Pathology; Gastroenterology; Immunohistochemistry; Diffuse large B-cell lymphoma; Immunology; Immune system","score_opus":0.009620876395095606,"score_gpt":0.22815448081537282,"score_spread":0.21853360442027722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981213,0.0006829162,0.000026959913,0.00037312138,0.000028701535,0.00037613546,0.00003896824,0.0000073589094,0.000344502],"genre_scores_gemma":[0.99971664,0.00011986052,0.0000401777,0.00007007037,0.000014351501,0.000011907943,0.000016729804,0.000003931932,0.0000063467864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.000052227955,0.0002478145,0.00012331385,0.00019445173,0.00012159417],"domain_scores_gemma":[0.999642,0.000054713928,0.00008068539,0.00013787906,0.000034304165,0.00005038311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010713734,0.00009593586,0.00022829839,0.00005036057,0.00002802621,0.0000055596597,0.00004777754,0.000052647836,0.0000042176],"category_scores_gemma":[0.0000054980064,0.000058694313,0.000060735016,0.000059474216,0.000046654844,0.000038901067,0.000007041207,0.000029509916,5.00776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061284506,0.006993599,0.5567984,0.0001458197,0.00039922967,0.00013668509,0.01728526,0.000010095949,0.018429874,0.00032352828,0.000014249085,0.3988504],"study_design_scores_gemma":[0.007073104,0.0013396867,0.85442775,0.000063663734,0.00016327285,0.000037979808,0.0002622952,0.0000823956,0.13637227,0.00010770139,0.000017978124,0.000051912968],"about_ca_topic_score_codex":0.00026796662,"about_ca_topic_score_gemma":0.000097555734,"teacher_disagreement_score":0.3987985,"about_ca_system_score_codex":0.000035895115,"about_ca_system_score_gemma":0.000031945285,"threshold_uncertainty_score":0.23934846},"labels":[],"label_agreement":null},{"id":"W1991386396","doi":"10.3399/bjgp15x684661","title":"Assessing risk and improving survival in lymphoma","year":2015,"lang":"en","type":"letter","venue":"British Journal of General Practice","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Lymphoma; Intensive care medicine; Data science; Computer science; Pathology","score_opus":0.029883964635644966,"score_gpt":0.31250972705410074,"score_spread":0.2826257624184558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991386396","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6039928,0.06254617,0.000085436455,0.3217717,0.0024939068,0.00052879984,0.000066324144,0.000027250499,0.008487599],"genre_scores_gemma":[0.22769389,0.04494221,0.046067584,0.63961416,0.038068794,0.000032078064,0.00022188133,0.00037346114,0.0029859666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971159,0.0006343113,0.00077881885,0.00030069155,0.0008211865,0.00034905548],"domain_scores_gemma":[0.9969216,0.0006624517,0.0014103875,0.00017060203,0.00063708785,0.00019789925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018274604,0.00025917822,0.000825573,0.00021292,0.00008976747,0.00058676186,0.00011094831,0.00045246098,0.000020034502],"category_scores_gemma":[0.0028538546,0.0002588831,0.00016649408,0.00014009388,0.000059692233,0.0011231133,0.00007246376,0.001343599,0.0000055542296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014092111,0.0003839299,0.006083005,0.000111908776,0.00033127933,0.110633515,0.00005390722,0.0000040431833,0.000029477627,0.0000013131745,0.46800393,0.41422278],"study_design_scores_gemma":[0.009094369,0.0005667343,0.06663865,0.0013485664,0.0017607943,0.14441939,0.00025145212,0.00006386132,0.000040928775,0.000061027156,0.7754097,0.0003445284],"about_ca_topic_score_codex":0.0051803743,"about_ca_topic_score_gemma":0.000077091936,"teacher_disagreement_score":0.41387823,"about_ca_system_score_codex":0.0006278805,"about_ca_system_score_gemma":0.0010000473,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W1991404956","doi":"10.1007/s00280-010-1342-9","title":"Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; CD22; Chemotherapy; CHOP; Cancer research; Medicine; Monoclonal antibody; Antibody; Internal medicine; Immunology","score_opus":0.017626628089461523,"score_gpt":0.3344375505906821,"score_spread":0.31681092250122056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991404956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366724,0.0009605626,0.00023442588,0.0021880544,0.00025535596,0.0023739473,0.00010414691,0.000081450955,0.00013480162],"genre_scores_gemma":[0.99073505,0.005086237,0.0012064453,0.002221798,0.00020273906,0.00024028734,0.00007970523,0.00012693302,0.000100815785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973229,0.00011875654,0.0006823275,0.000851692,0.00042147472,0.00060284405],"domain_scores_gemma":[0.9976062,0.00027150186,0.0008134986,0.00054120476,0.0004986918,0.0002689108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027411006,0.0006787116,0.0017432516,0.00021317386,0.00014641916,0.000022851005,0.00023620421,0.00027906595,0.0013991689],"category_scores_gemma":[0.000005431643,0.0004315304,0.00014734457,0.00057288865,0.0010273379,0.00018183613,0.000023124836,0.00053423777,0.0000021121587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04719944,0.003857173,0.11283406,0.00037917294,0.0021486972,0.000063043015,0.0013412612,0.000017980958,0.821379,0.000013640061,0.00057491567,0.010191602],"study_design_scores_gemma":[0.059913427,0.0045729047,0.25443324,0.000255125,0.00034316635,0.0001398958,0.00008264979,0.00065448676,0.6769153,0.000007965986,0.0022822276,0.00039965584],"about_ca_topic_score_codex":0.0006348733,"about_ca_topic_score_gemma":0.0001331677,"teacher_disagreement_score":0.14446376,"about_ca_system_score_codex":0.00018446178,"about_ca_system_score_gemma":0.0007330073,"threshold_uncertainty_score":0.9998137},"labels":[],"label_agreement":null},{"id":"W1991589385","doi":"10.3109/10428194.2013.853298","title":"The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoplasmacytic Lymphoma; Follicular lymphoma; Lymphoma; Internal medicine; Stage (stratigraphy); Retrospective cohort study; Gastroenterology; Pathology; Oncology; Waldenstrom macroglobulinemia","score_opus":0.011555288649860556,"score_gpt":0.2503653937384022,"score_spread":0.23881010508854167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991589385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843016,0.0035393285,0.0000012986329,0.00030241394,0.0007795068,0.008551109,0.00006529099,0.000057515696,0.0024018928],"genre_scores_gemma":[0.99611974,0.0012821303,0.00010081798,0.00039854078,0.00016583067,0.0011385743,0.000013784749,0.00009394355,0.0006866342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99267864,0.0008148551,0.0023068597,0.0014700595,0.0019983272,0.00073127536],"domain_scores_gemma":[0.9952821,0.0007125272,0.0013823078,0.0017840969,0.000491125,0.00034784726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014407446,0.0009380931,0.0018170864,0.000272396,0.00072455686,0.00020134303,0.0010337933,0.0003485189,0.000023318127],"category_scores_gemma":[0.00018341928,0.00052274944,0.00051423034,0.00075955334,0.0012762047,0.00031325885,0.0019079244,0.00020307205,0.0000027840854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014583786,0.011472411,0.76383436,0.00022148057,0.0029341828,0.00010348703,0.005295561,0.0000013822431,0.00014703473,0.00030749655,0.0014297295,0.21279448],"study_design_scores_gemma":[0.059289623,0.0041863867,0.9144285,0.00040507535,0.0017079742,0.0004157499,0.01755203,0.00010667082,0.00051506865,0.00015748163,0.000802969,0.0004324851],"about_ca_topic_score_codex":0.004624951,"about_ca_topic_score_gemma":0.0009133109,"teacher_disagreement_score":0.212362,"about_ca_system_score_codex":0.0031871465,"about_ca_system_score_gemma":0.0013849848,"threshold_uncertainty_score":0.9997224},"labels":[],"label_agreement":null},{"id":"W1993022805","doi":"10.1016/j.mpdhp.2014.10.003","title":"Personalized lymphoma diagnosis and treatment: recent advances","year":2014,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Lymphoma; Medicine; Computational biology; Cancer research; Biology; Immunology","score_opus":0.015984205299316285,"score_gpt":0.26520124436524695,"score_spread":0.24921703906593065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993022805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.929766,0.052004762,0.00009794006,0.004412847,0.00053569366,0.00077169185,0.00003442483,0.00016661918,0.012210034],"genre_scores_gemma":[0.91170007,0.083190665,0.0009527367,0.0019325418,0.0002336926,0.0011496085,0.00009311107,0.000039934017,0.00070766645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983791,0.00014719607,0.00030434094,0.0005897719,0.00016989709,0.00040965903],"domain_scores_gemma":[0.9974632,0.0016693643,0.00010671313,0.00038378258,0.000079442456,0.00029748408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001357913,0.00032326585,0.0006506422,0.00013753658,0.00016835185,0.000017276609,0.000063291234,0.00014040282,0.00041519655],"category_scores_gemma":[0.0014157712,0.00025196624,0.00012514052,0.00013537375,0.00033917985,0.00007221443,0.000037331123,0.000042503307,0.00018873626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009364039,0.0010815985,0.39707717,0.000028059925,0.000030908235,0.00055449986,0.00046888253,7.185049e-7,0.000036737136,0.0026382392,0.0010076038,0.59698194],"study_design_scores_gemma":[0.005839949,0.0017674017,0.33044493,0.00006445527,0.0003429813,0.0006741744,0.000056633107,0.000019513202,0.00045057072,0.0002837697,0.6598637,0.00019190683],"about_ca_topic_score_codex":0.00005759758,"about_ca_topic_score_gemma":0.00004847831,"teacher_disagreement_score":0.6588561,"about_ca_system_score_codex":0.00034468778,"about_ca_system_score_gemma":0.00008186678,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W1993095416","doi":"10.1111/j.1440-1843.2003.00520.x","title":"Pancoast's syndrome in a patient with B‐cell lymphoma diagnosed and confirmed with immunoglobulin gene rearrangement","year":2004,"lang":"en","type":"article","venue":"Respirology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Lymphoma; Medicine; Gene rearrangement; Antibody; Pathology; Diffuse large B-cell lymphoma; Immunoglobulin gene; Immunoglobulin heavy chain; Gene; Immunology; Biology","score_opus":0.006109737267048943,"score_gpt":0.20835127364947387,"score_spread":0.20224153638242492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993095416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420863,0.0020931624,0.000012904154,0.0016747881,0.000032932952,0.00091125874,0.000008976883,0.000036566256,0.0010207765],"genre_scores_gemma":[0.99710214,0.00038704637,0.0009758258,0.0010564972,0.00001654567,0.0003617242,0.000025297453,0.000028331868,0.000046577057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986159,0.000052397576,0.00027118134,0.00043798372,0.0002150988,0.00040743776],"domain_scores_gemma":[0.9992769,0.00007358815,0.00009894157,0.000344341,0.00004471613,0.00016153736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008001565,0.00024477032,0.0004854983,0.00014805538,0.000048302114,0.000013285431,0.000051974475,0.000112788526,0.00004209508],"category_scores_gemma":[0.0000124586595,0.00016064155,0.00003563833,0.00018004309,0.0001525288,0.00003762784,0.00004329739,0.00006659802,0.000028338969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01406066,0.012823261,0.7786417,0.0002799433,0.0008663059,0.13361491,0.0029080757,0.0004924438,0.0074096574,0.0004886636,0.00023543363,0.048178934],"study_design_scores_gemma":[0.04456525,0.013499524,0.92557025,0.00020528193,0.00016895706,0.005236599,0.00016574885,0.0000042368406,0.006464171,0.000061999934,0.0038254492,0.00023252393],"about_ca_topic_score_codex":0.0010459096,"about_ca_topic_score_gemma":0.0006510221,"teacher_disagreement_score":0.14692855,"about_ca_system_score_codex":0.00027451594,"about_ca_system_score_gemma":0.00020171527,"threshold_uncertainty_score":0.6550772},"labels":[],"label_agreement":null},{"id":"W1993100979","doi":"10.1016/s0360-3016(00)80271-0","title":"Mucosa-associated lymphoid tissue (MALT) lymphomas: treatment results for localized disease","year":2000,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucosa-associated lymphoid tissue; Lymphatic system; MALT lymphoma; Pathology; Disease","score_opus":0.02259455648754209,"score_gpt":0.34176601055245637,"score_spread":0.31917145406491426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993100979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782319,0.0020560392,0.0011450541,0.01133032,0.0022343143,0.0011105969,0.0011831477,0.000105421284,0.0026031951],"genre_scores_gemma":[0.9894487,0.0030296561,0.0016764892,0.0016368045,0.0021220006,0.00010932765,0.0011099915,0.000040411003,0.0008265751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775004,0.00019233707,0.0010410233,0.0003542221,0.0003226578,0.00033969834],"domain_scores_gemma":[0.9971319,0.00066307274,0.00090964016,0.0002253525,0.0007105371,0.00035949575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036500132,0.00031556722,0.000720269,0.00014487773,0.00011751739,0.00003756362,0.00025431745,0.00023929375,0.00023742497],"category_scores_gemma":[0.00043278845,0.00024760416,0.0004793731,0.00015099355,0.00013553644,0.0001940987,0.000021212107,0.00009951231,0.00008799456],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009417046,0.00611581,0.16355227,0.0000104409,0.0027871856,0.00033879167,0.0004575241,0.0006952807,0.00046504405,0.003049767,0.007517436,0.8055934],"study_design_scores_gemma":[0.116376966,0.010025831,0.08437149,0.00020879545,0.0015962222,0.00046441285,0.00006317471,0.004621174,0.0076309065,0.009132983,0.76499903,0.00050899846],"about_ca_topic_score_codex":0.000070805174,"about_ca_topic_score_gemma":0.000009729233,"teacher_disagreement_score":0.8050844,"about_ca_system_score_codex":0.0039589372,"about_ca_system_score_gemma":0.0013807195,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W1993863834","doi":"10.1532/ijh97.04133","title":"Molecular Signatures of Lymphoma","year":2004,"lang":"en","type":"review","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Disease; Hematology; Gene expression profiling; Biology; Molecular pathology; Computational biology; Gene; Bioinformatics; Gene expression; Pathology; Medicine; Immunology; Genetics","score_opus":0.021613915618712315,"score_gpt":0.35635743284221455,"score_spread":0.33474351722350226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993863834","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050218054,0.9975355,0.00004188471,0.00029927996,0.00082582055,0.00015969719,0.000018830093,0.000004717267,0.0006120784],"genre_scores_gemma":[0.012076474,0.98690754,0.00068871473,0.00010371036,0.00014152032,0.000008035055,0.000028792918,0.000023993396,0.000021244898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812603,0.00005583855,0.0010607156,0.00013701858,0.0004974307,0.00012295373],"domain_scores_gemma":[0.99773467,0.00017038608,0.0013120055,0.00015350389,0.0005381,0.00009134374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104929495,0.00022727028,0.0018316715,0.00048900995,0.000007872112,0.000008386218,0.00032818833,0.00027426644,0.00009765029],"category_scores_gemma":[0.0001420125,0.00015040311,0.0010313803,0.00008275067,0.00007436583,0.000034657725,0.000055544344,0.00014359159,0.000019648427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012070044,0.0015279813,0.00013704383,0.005882499,0.006907054,0.01960606,0.000039400482,0.0000074642726,0.0000068487534,0.025204921,0.0007882824,0.9397718],"study_design_scores_gemma":[0.0036241564,0.0006155597,0.00007115804,0.042631943,0.0026397093,0.06282373,0.000010430363,6.679901e-7,0.0008335345,0.000969673,0.88560957,0.00016989141],"about_ca_topic_score_codex":0.000008621768,"about_ca_topic_score_gemma":4.9144813e-7,"teacher_disagreement_score":0.93960184,"about_ca_system_score_codex":0.00038075272,"about_ca_system_score_gemma":0.0011699692,"threshold_uncertainty_score":0.6133261},"labels":[],"label_agreement":null},{"id":"W1994149481","doi":"10.1097/jto.0b013e3182519d4d","title":"Characterization of Lymphomas Developing in Immunodeficient Mice Implanted With Primary Human Non–Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Medicine; Pathology; Immunohistochemistry; In situ hybridization; Lung cancer; Lung; Cancer research; Biology; Internal medicine; Gene; Gene expression","score_opus":0.018185451420730765,"score_gpt":0.3533658169457758,"score_spread":0.33518036552504504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994149481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963893,0.00155988,0.00017184344,0.00043118012,0.000288524,0.00026544364,0.0000060887874,0.000004320005,0.0008833811],"genre_scores_gemma":[0.9969395,0.00040706588,0.0020820578,0.00030273033,0.00013155722,0.000017627235,0.000023174636,0.000015798894,0.00008049903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987751,0.00008461963,0.00059783907,0.000098460885,0.00018270442,0.00026123077],"domain_scores_gemma":[0.998747,0.00006230914,0.0007920736,0.00010473878,0.00020433131,0.00008956609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039745113,0.00013611904,0.000579307,0.00025632678,0.000038172133,0.0000056039976,0.00008050996,0.0001103692,0.00003421863],"category_scores_gemma":[0.000008314006,0.000094427414,0.000072271076,0.00020013686,0.000034197088,0.00012117809,0.00003295029,0.00012225057,0.0000018241199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012546412,0.0016768962,0.58015513,0.0003837951,0.0001750802,0.00020985499,0.0016116597,0.00000919062,0.39851028,0.00001634799,0.00003898561,0.01595811],"study_design_scores_gemma":[0.0025705632,0.0007584197,0.86278564,0.000756335,0.00039906587,0.0008464512,0.0001631919,0.000016982793,0.13058853,0.0000013689506,0.0010175969,0.00009584919],"about_ca_topic_score_codex":0.000093263785,"about_ca_topic_score_gemma":0.000031582906,"teacher_disagreement_score":0.2826305,"about_ca_system_score_codex":0.0014988381,"about_ca_system_score_gemma":0.00083009404,"threshold_uncertainty_score":0.39194095},"labels":[],"label_agreement":null},{"id":"W1994292673","doi":"10.1053/jpsu.2000.6945","title":"The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma","year":2000,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pathological; Biopsy; Perioperative; Surgery; Cardiorespiratory fitness; Radiology; Internal medicine","score_opus":0.01890979879307761,"score_gpt":0.25030054981176675,"score_spread":0.23139075101868914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994292673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883757,0.009280733,4.5170592e-7,0.0011364766,0.0006190964,0.00030986927,0.000009607857,0.000005315121,0.00026271376],"genre_scores_gemma":[0.96137154,0.03709573,0.000018796498,0.00011269741,0.0012247374,0.000047964964,0.0000017944454,0.00001638729,0.0001103537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978817,0.00017500762,0.0009194408,0.00012455462,0.0006522214,0.0002470936],"domain_scores_gemma":[0.9862923,0.012218083,0.0008326634,0.00032441766,0.00017787797,0.00015463792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000505521,0.00020280771,0.0006509166,0.00016504852,0.00008814098,0.000014181594,0.00012179576,0.00006497344,0.0001612827],"category_scores_gemma":[0.0008594387,0.00008805074,0.0006323585,0.00031447643,0.000095311654,0.0000495692,0.000013156275,0.000067171495,0.000013839541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010790187,0.0031937435,0.7015083,0.00010925494,0.00060071284,0.0005758187,0.00026075164,0.000005143269,0.000076685144,0.000017252161,0.017333996,0.27523932],"study_design_scores_gemma":[0.0042302725,0.00441822,0.958665,0.00035075372,0.0022724262,0.0003820913,0.00009402827,0.0000063803523,0.025021689,0.00004577988,0.0043805907,0.0001327822],"about_ca_topic_score_codex":0.0000383838,"about_ca_topic_score_gemma":0.0000022752356,"teacher_disagreement_score":0.27510652,"about_ca_system_score_codex":0.00019727378,"about_ca_system_score_gemma":0.0003887433,"threshold_uncertainty_score":0.35906053},"labels":[],"label_agreement":null},{"id":"W1994372389","doi":"10.1097/pas.0000000000000188","title":"Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-cell Lymphomas","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Comprehensive Cancer Network; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Medical diagnosis; Medicine; Lymphoma; Peripheral T-cell lymphoma; H&E stain; Pathology; Immunohistochemistry; Gene rearrangement; Not Otherwise Specified; Oncology; Gene; Immunology; T cell; Biology","score_opus":0.00834235410707016,"score_gpt":0.24447141695387264,"score_spread":0.2361290628468025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994372389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916306,0.003852056,0.0029586866,0.00085752766,0.000048317157,0.00026490155,0.000004565985,0.0000055190567,0.00037783204],"genre_scores_gemma":[0.9866912,0.0010430033,0.011718585,0.00039193427,0.000092464295,0.000027961212,0.0000034130585,0.000019624553,0.000011823892],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868137,0.00026377893,0.0004815756,0.0001644134,0.00016972696,0.00023911452],"domain_scores_gemma":[0.9970849,0.0017977892,0.0005922915,0.00025100043,0.00013943312,0.00013457963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038181347,0.00016432181,0.00076492946,0.000071305876,0.000052368574,0.000009016989,0.0001396427,0.00004176187,0.0000139667345],"category_scores_gemma":[0.0003591328,0.00009479184,0.00023531083,0.00012747842,0.00056535134,0.00002293876,0.00004565427,0.000099800054,0.0000012236186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015601167,0.00819886,0.29468057,0.00070354197,0.0016601862,0.00510998,0.0030085992,0.0013685289,0.07192477,0.0077930978,0.00057144376,0.58937925],"study_design_scores_gemma":[0.04469023,0.034379203,0.8519529,0.0002716503,0.0030122206,0.039070867,0.0011995279,0.0021116761,0.013137329,0.0042428775,0.0052240654,0.0007074578],"about_ca_topic_score_codex":0.000019793571,"about_ca_topic_score_gemma":1.6826004e-7,"teacher_disagreement_score":0.5886718,"about_ca_system_score_codex":0.000045453027,"about_ca_system_score_gemma":0.000084837884,"threshold_uncertainty_score":0.3865499},"labels":[],"label_agreement":null},{"id":"W1994567562","doi":"10.1016/j.ijrobp.2011.03.050","title":"Localized Orbital Mucosa-Associated Lymphoma Tissue Lymphoma Managed With Primary Radiation Therapy: Efficacy and Toxicity","year":2011,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Surgery; Stage (stratigraphy); Internal medicine; Gastroenterology","score_opus":0.021445347866326164,"score_gpt":0.2928225944347297,"score_spread":0.2713772465684035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994567562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934861,0.0013803734,0.0011271613,0.0009655434,0.00075274584,0.00045461484,0.000041829608,0.00006308534,0.0017285545],"genre_scores_gemma":[0.9939743,0.0018089501,0.0019029147,0.0013238651,0.0006791535,0.000025210418,0.00019501783,0.000039653394,0.000050918265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980101,0.00027252824,0.0007367235,0.0003225427,0.0003776028,0.00028048427],"domain_scores_gemma":[0.99752676,0.00037313288,0.0011440238,0.00017930429,0.0005663506,0.00021044772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004455164,0.00030617946,0.00070069736,0.00020244617,0.000109206,0.00003707817,0.00023985648,0.00028492665,0.00008761901],"category_scores_gemma":[0.00017634493,0.00023220447,0.00015817168,0.00020366156,0.00023378641,0.00033006773,0.000052809537,0.00014129007,0.000021794755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031313119,0.00387249,0.3054585,0.000008294494,0.0021695292,0.00037738483,0.00094979536,0.000014779323,0.0018386606,0.0019004057,0.00056729093,0.6797116],"study_design_scores_gemma":[0.05104864,0.0056383247,0.914262,0.00009492681,0.00040316838,0.00082910474,0.00006146536,0.00028659176,0.01559027,0.001782094,0.009698271,0.00030512793],"about_ca_topic_score_codex":0.00009621336,"about_ca_topic_score_gemma":0.0000075223597,"teacher_disagreement_score":0.67940646,"about_ca_system_score_codex":0.0015119696,"about_ca_system_score_gemma":0.0005546798,"threshold_uncertainty_score":0.9469024},"labels":[],"label_agreement":null},{"id":"W1994842101","doi":"10.1002/pbc.21821","title":"Primary mediastinal B‐cell lymphoma in the pediatric patient: Can a rational approach to therapy be based on adult studies?","year":2008,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Positron emission tomography; Radiation therapy; Adverse effect; Rituximab; Oncology; Chemotherapy; Mediastinal mass; Blood cancer; Internal medicine; Cancer; Radiology","score_opus":0.05929624626061409,"score_gpt":0.3190382606248893,"score_spread":0.25974201436427524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994842101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00838492,0.9842753,0.0000010739393,0.0005554942,0.00045791993,0.0041831774,0.00037747616,0.000051663043,0.0017129736],"genre_scores_gemma":[0.0020482293,0.97754353,0.00035158725,0.006239892,0.0038940012,0.009177756,0.00056768535,0.000110484696,0.000066818255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507505,0.00037181124,0.0011121298,0.0011274472,0.0015912794,0.0007223077],"domain_scores_gemma":[0.99696946,0.0010494479,0.0006044888,0.0007640841,0.00029845466,0.00031406342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023306183,0.0009905422,0.002196321,0.0007921581,0.0002030693,0.000037999784,0.00041260896,0.00033050939,0.000034131586],"category_scores_gemma":[0.00013874157,0.0005863081,0.00073171215,0.0020552627,0.000056614645,0.000044776323,0.00007499378,0.00038965483,0.000028084929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044221024,0.027130513,0.034947895,0.0235313,0.00093194493,0.0010326949,0.003910635,0.00008661727,4.636148e-8,0.00004143891,0.058559794,0.8493849],"study_design_scores_gemma":[0.03520239,0.005266381,0.018489456,0.003768906,0.018890385,0.00075004844,0.0002899504,0.000034377408,0.000004336538,0.000007509169,0.91465807,0.0026381707],"about_ca_topic_score_codex":0.00025521262,"about_ca_topic_score_gemma":0.000032501644,"teacher_disagreement_score":0.8560983,"about_ca_system_score_codex":0.0010278957,"about_ca_system_score_gemma":0.004230607,"threshold_uncertainty_score":0.9996588},"labels":[],"label_agreement":null},{"id":"W1995048156","doi":"10.1038/sj.bjc.6601052","title":"Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Vetenskapsrådet","keywords":"Medicine; Radiological weapon; Retrospective cohort study; Disease; Surgery; Radiology; Pediatrics; Internal medicine","score_opus":0.009867171702763702,"score_gpt":0.26549342799210357,"score_spread":0.2556262562893399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995048156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983625,0.014795744,0.000008714819,0.00034812413,0.00021765912,0.0003134936,0.00015459044,0.0000026722876,0.0005340312],"genre_scores_gemma":[0.99775547,0.0015846671,0.00013022682,0.00016439961,0.000054042663,0.000021656422,0.000006906405,0.000018490544,0.00026417107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987576,0.000075024196,0.00040287338,0.00012474583,0.00047396764,0.00016579704],"domain_scores_gemma":[0.9988664,0.00007171712,0.00044434014,0.00014772876,0.00030330036,0.00016653903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106744636,0.00013906241,0.00046565337,0.0000469386,0.00006649241,0.000017489725,0.00006722651,0.000018676195,0.00016790633],"category_scores_gemma":[0.000080295,0.00008649471,0.00034321818,0.0001610542,0.00007135717,0.00011403867,0.0000083812865,0.000060963866,6.4523283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006787065,0.0011635701,0.9509798,0.00003305506,0.0014616455,0.00042774327,0.00048096207,0.00002608638,0.000012623695,0.000066926856,0.00081953884,0.043849308],"study_design_scores_gemma":[0.01932396,0.0013461284,0.9639941,0.0016911302,0.0017421584,0.00009547356,0.00017627924,0.0000047205253,0.0058212755,0.0000728677,0.0056243255,0.00010761438],"about_ca_topic_score_codex":0.0008982287,"about_ca_topic_score_gemma":0.0001451485,"teacher_disagreement_score":0.04374169,"about_ca_system_score_codex":0.00027015322,"about_ca_system_score_gemma":0.00049480534,"threshold_uncertainty_score":0.3527152},"labels":[],"label_agreement":null},{"id":"W1995158011","doi":"10.1002/ajh.10109","title":"Cytogenetic findings in reactive lymphoid hyperplasia: Significance of non‐clonal t(3;14) and t(3;22)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoid hyperplasia; clone (Java method); Chromosomal translocation; Pathology; Karyotype; Cytogenetics; Population; Immunology; Biology; Medicine; Chromosome; Genetics","score_opus":0.010786895183906534,"score_gpt":0.25618099078977613,"score_spread":0.2453940956058696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995158011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961496,0.0016805094,0.000018211987,0.0011989257,0.000057617533,0.0001249007,0.000003872819,0.0000029419664,0.00076340564],"genre_scores_gemma":[0.9970411,0.00073973584,0.0019145905,0.00022494263,0.000031098767,0.00000855838,6.8305644e-7,0.000012635358,0.000026634276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988373,0.000057965968,0.0005257593,0.00016668001,0.00019140966,0.00022087469],"domain_scores_gemma":[0.9988992,0.00028920945,0.00042953625,0.0001323461,0.000109419285,0.00014026782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118034666,0.00014415107,0.00089905574,0.00024396564,0.000020545129,0.0000038875864,0.000076694494,0.0000510777,0.00008806503],"category_scores_gemma":[0.00009308299,0.00011248292,0.000100214456,0.00023934233,0.00040013186,0.000048675764,0.00002123516,0.00011840403,0.000007379379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035241127,0.00075843604,0.9724825,0.00003834066,0.0002042773,0.0013188368,0.00070143817,0.000004528406,0.0059252833,0.00016357651,0.0005207625,0.017529577],"study_design_scores_gemma":[0.0114133265,0.00840699,0.81328183,0.00058429583,0.00043354338,0.07903896,0.002080167,0.00023816821,0.082940504,0.00018545843,0.0010976725,0.00029910594],"about_ca_topic_score_codex":0.00008039219,"about_ca_topic_score_gemma":0.0000071970185,"teacher_disagreement_score":0.15920073,"about_ca_system_score_codex":0.000116115574,"about_ca_system_score_gemma":0.00009193778,"threshold_uncertainty_score":0.45869204},"labels":[],"label_agreement":null},{"id":"W1995314727","doi":"10.1056/nejmoa055759","title":"Molecular Diagnosis of Burkitt's Lymphoma","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":903,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Burkitt's lymphoma; Medicine; Gene expression profiling; Diffuse large B-cell lymphoma; Pathology; BCL10; Cancer research; Gene expression; Gene; Biology; Genetics","score_opus":0.009913088923979619,"score_gpt":0.252875592312471,"score_spread":0.24296250338849135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995314727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748797,0.0066281497,0.00012548089,0.013342057,0.00033036267,0.00012917683,0.0000029662342,0.000009052362,0.004553055],"genre_scores_gemma":[0.99539554,0.00092353695,0.0005571204,0.00068896846,0.002229848,0.000003317886,0.000008717688,0.00001695366,0.00017602318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983285,0.000048525846,0.00070555636,0.0001169588,0.00061745115,0.00018297274],"domain_scores_gemma":[0.9986514,0.00022082949,0.00042028868,0.00019732356,0.00025424114,0.00025591056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035306838,0.00016700805,0.0006882428,0.00022888235,0.000021782014,0.000004416758,0.00009403403,0.00006611896,0.00023753916],"category_scores_gemma":[0.0001995427,0.00010088261,0.00017046805,0.00020332412,0.000100806035,0.00005205533,0.000014989698,0.00007690406,0.0000037116106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011316764,0.0015640712,0.4752093,0.00011999263,0.00056767004,0.004606028,0.000354153,0.000082834486,0.0073891515,0.002091923,0.0632757,0.44360748],"study_design_scores_gemma":[0.20305271,0.0066680517,0.49403718,0.0018476013,0.0018114515,0.0050543547,0.00012650026,0.000021503787,0.09818413,0.0020661778,0.1869261,0.00020422903],"about_ca_topic_score_codex":0.0006659238,"about_ca_topic_score_gemma":0.00002124009,"teacher_disagreement_score":0.44340327,"about_ca_system_score_codex":0.00009953541,"about_ca_system_score_gemma":0.00020647654,"threshold_uncertainty_score":0.41138732},"labels":[],"label_agreement":null},{"id":"W1995513757","doi":"10.1080/10428190500051844","title":"Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; University of California, San Francisco; University of Nebraska Medical Center","keywords":"Concordance; Immunohistochemistry; Medicine; Pathology; Tissue microarray; Stain; Lymphoma; Staining; Internal medicine","score_opus":0.0056392378217780745,"score_gpt":0.246330318001575,"score_spread":0.24069108017979693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995513757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884759,0.0063724695,0.00010912293,0.00017816375,0.00013293809,0.0007394161,0.000061295854,0.00011724251,0.0038134616],"genre_scores_gemma":[0.9951012,0.0013060665,0.0016429564,0.0004684449,0.00017117962,0.00016398705,0.0002691039,0.000094811374,0.00078222575],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635834,0.0001212446,0.0011866317,0.0010016505,0.0005199758,0.00081218703],"domain_scores_gemma":[0.99795085,0.00028184112,0.00049486523,0.00071237737,0.00016961606,0.00039044957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042897405,0.00070121035,0.0010827128,0.00042858964,0.00020865207,0.000102549304,0.00021419777,0.00050380954,0.000047881917],"category_scores_gemma":[0.000115316274,0.00067728467,0.00018870298,0.00045462593,0.00027242515,0.00044243678,0.00020344126,0.00009390403,0.000030385689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025969832,0.007288861,0.0520468,0.0013763062,0.00037337377,0.00046282215,0.0101335645,0.00004982547,0.26757717,0.0005337386,0.0008338974,0.65672666],"study_design_scores_gemma":[0.12919144,0.0006707621,0.15555854,0.0011422206,0.00056463864,0.0011469225,0.0021425418,0.0070585944,0.6920059,0.00013800233,0.009230686,0.0011497996],"about_ca_topic_score_codex":0.0009261516,"about_ca_topic_score_gemma":0.000037025962,"teacher_disagreement_score":0.6555768,"about_ca_system_score_codex":0.0069250325,"about_ca_system_score_gemma":0.0015098777,"threshold_uncertainty_score":0.9995678},"labels":[],"label_agreement":null},{"id":"W1995834660","doi":"10.1002/cncy.20156","title":"Cytomorphologic findings of B‐cell lymphomas with concurrent <i>IGH/BCL2</i> and <i>MYC</i> rearrangements (dual‐translocation lymphomas)","year":2011,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Chromosomal translocation; Immunophenotyping; Pathology; Fluorescence in situ hybridization; Gene rearrangement; Population; Medicine; Basophilic; Biology; Immunology; Flow cytometry; Genetics; Chromosome; Gene","score_opus":0.031192805870579553,"score_gpt":0.25010484215001616,"score_spread":0.21891203627943662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995834660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863428,0.0056460705,0.000088364315,0.00023281746,0.00025281563,0.00063847477,0.00007754493,0.000062012296,0.0066590887],"genre_scores_gemma":[0.9946292,0.0031173732,0.0008869137,0.00078096817,0.000066170316,0.00023702729,0.000051556646,0.000034872264,0.00019592611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983573,0.000071505696,0.00040133778,0.00055492966,0.00022812247,0.0003868197],"domain_scores_gemma":[0.9990378,0.000045516645,0.00020069722,0.00037258514,0.00016104082,0.00018235881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016078184,0.0003086716,0.0006300924,0.00013304803,0.00007244979,0.000008369897,0.00009735737,0.00016436973,0.0003077921],"category_scores_gemma":[0.000009631325,0.00023193014,0.00008305147,0.00021114133,0.00040400244,0.00008579739,0.00005327603,0.00007869908,0.000026704085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010350707,0.0016330373,0.9333225,0.00033069885,0.00017913371,0.0015459753,0.0023678883,0.0000010377161,0.03961937,0.001226115,0.0010705756,0.017668596],"study_design_scores_gemma":[0.018381547,0.0029269555,0.5888195,0.000365941,0.00081060035,0.0021994796,0.00026399083,0.000012556088,0.38221532,0.00015231418,0.003429916,0.00042189445],"about_ca_topic_score_codex":0.00028087752,"about_ca_topic_score_gemma":0.000041841588,"teacher_disagreement_score":0.34450302,"about_ca_system_score_codex":0.00021371621,"about_ca_system_score_gemma":0.0002331667,"threshold_uncertainty_score":0.9457837},"labels":[],"label_agreement":null},{"id":"W1995981720","doi":"10.1016/j.ijrobp.2005.09.030","title":"Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin’s lymphoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Progressive disease; Lymphoma; Mantle cell lymphoma; Follicular lymphoma; Internal medicine; Stage (stratigraphy); Complete response; Gastroenterology; Oncology","score_opus":0.015764227015917166,"score_gpt":0.3310105092523486,"score_spread":0.3152462822364314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995981720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221873,0.00087507855,0.0013100028,0.0032350516,0.0011415815,0.00024102707,0.00003751168,0.000018668814,0.0009223394],"genre_scores_gemma":[0.99344,0.00077993236,0.0035161779,0.00091002905,0.0011775248,0.000014582821,0.000067528796,0.000027983066,0.000066264445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804574,0.00010833619,0.0011325119,0.00020320194,0.000311185,0.00019902017],"domain_scores_gemma":[0.99779737,0.0003215692,0.0011065739,0.00015060416,0.0005495928,0.00007429703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037747328,0.00020643177,0.0006695347,0.00029598252,0.000031497257,0.000013932056,0.00022402042,0.0002266298,0.00011465513],"category_scores_gemma":[0.0000751552,0.00017065761,0.00029757002,0.00021812806,0.00012592277,0.00017491804,0.000018203527,0.00016306585,0.000010457818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011495493,0.0022946459,0.8698183,0.000008260166,0.00052569015,0.00009281412,0.00012894542,0.0004562218,0.015180078,0.00251047,0.0007611846,0.10707384],"study_design_scores_gemma":[0.023566896,0.0014636742,0.92970043,0.000074136384,0.000100575955,0.00022941649,0.000051726867,0.0012944881,0.015447452,0.0026044445,0.02529734,0.00016939157],"about_ca_topic_score_codex":0.0003393688,"about_ca_topic_score_gemma":0.000023895154,"teacher_disagreement_score":0.10690445,"about_ca_system_score_codex":0.0018435278,"about_ca_system_score_gemma":0.00047879457,"threshold_uncertainty_score":0.6959216},"labels":[],"label_agreement":null},{"id":"W1996193488","doi":"10.3109/10428190009113384","title":"18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT","year":2000,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Lymphoma; Radiology; Stage (stratigraphy); Positron emission tomography; Interim; Internal medicine; Nuclear medicine; Aggressive lymphoma; PET-CT; Rituximab","score_opus":0.010701937970799547,"score_gpt":0.2634812659616695,"score_spread":0.25277932799086994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996193488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998714,0.004958959,0.0000040905716,0.00032967518,0.0001334219,0.0027012879,0.00007777196,0.00014703287,0.011660634],"genre_scores_gemma":[0.990751,0.004757013,0.00046779812,0.0010473864,0.00026800076,0.0013924227,0.00023017656,0.00014613055,0.00094003807],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941466,0.0002892473,0.0014097755,0.0015073409,0.0012657694,0.0013812556],"domain_scores_gemma":[0.99596745,0.00073209545,0.0010062004,0.0015193501,0.00013191385,0.00064302015],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003231318,0.0013030232,0.0020549784,0.0005352303,0.00040433015,0.0001784195,0.00055678585,0.0002912176,0.00048730124],"category_scores_gemma":[0.0000837936,0.00081810344,0.00048466396,0.001159489,0.00076301413,0.00029291314,0.00006485619,0.00010900747,0.00026981867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039580134,0.0071428916,0.35398516,0.00027063722,0.0010289567,0.012725811,0.006587241,0.00007771091,0.0001513504,0.00025949514,0.0018221495,0.6119906],"study_design_scores_gemma":[0.064671926,0.0088398075,0.86342263,0.0012912722,0.0015625106,0.0127845835,0.0018950725,0.0012574223,0.009524881,0.00014985776,0.033518977,0.0010810707],"about_ca_topic_score_codex":0.006452158,"about_ca_topic_score_gemma":0.00024958432,"teacher_disagreement_score":0.6109095,"about_ca_system_score_codex":0.007501016,"about_ca_system_score_gemma":0.0045373887,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W1996289772","doi":"10.1111/bjh.13372","title":"Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hodgkin lymphoma; Radiation therapy; Clinical trial; Lymphoma; Intensive care medicine; Oncology; Pediatrics; Internal medicine","score_opus":0.045654852384713486,"score_gpt":0.3155238752040581,"score_spread":0.2698690228193446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996289772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103923574,0.89495754,0.000001981789,0.000024874664,0.00010674847,0.0008962026,0.00003322614,0.0000020464997,0.00005381895],"genre_scores_gemma":[0.05236366,0.94733745,0.00014574578,0.000012336358,0.000050311784,0.000041790478,0.000026532736,0.00002009543,0.0000020832051],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9974431,0.0005108178,0.0012084866,0.00024374404,0.0003430502,0.0002508366],"domain_scores_gemma":[0.99857706,0.0000624552,0.0009972715,0.00020956888,0.000054305918,0.00009931621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093479204,0.0002594922,0.0024624541,0.00031889402,0.000020547184,0.000022222732,0.00025832056,0.00017771276,0.0000039268443],"category_scores_gemma":[0.000034542125,0.00018304405,0.000307859,0.00024197203,0.00011815614,0.000043797114,0.0000949203,0.00032799994,0.0000033650288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028366601,0.001755115,0.03618501,0.009585867,0.00044491034,0.013056507,0.00007448398,2.95817e-7,5.472078e-10,0.000048861788,0.0003625273,0.938458],"study_design_scores_gemma":[0.010250563,0.00033118945,0.33174697,0.18260029,0.0034720248,0.42865193,0.00014241386,0.0000023624443,3.227567e-7,0.0001659298,0.04237184,0.00026416584],"about_ca_topic_score_codex":0.00009897865,"about_ca_topic_score_gemma":0.000034552824,"teacher_disagreement_score":0.93819386,"about_ca_system_score_codex":0.00022219669,"about_ca_system_score_gemma":0.0002884037,"threshold_uncertainty_score":0.74643195},"labels":[],"label_agreement":null},{"id":"W1996671618","doi":"10.1111/j.1365-2141.2009.07942.x","title":"Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R‐CHOP)","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Fidelity Foundation","keywords":"International Prognostic Index; Vincristine; Lymphoma; CHOP; Medicine; Internal medicine; Univariate analysis; Diffuse large B-cell lymphoma; Autocrine signalling; Cyclophosphamide; Chemotherapy; Oncology; Rituximab; Vascular endothelial growth factor; Cancer research; Pathology; VEGF receptors; Receptor; Multivariate analysis","score_opus":0.004486132184889379,"score_gpt":0.22257870626120538,"score_spread":0.218092574076316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996671618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97974217,0.018470801,0.000035399706,0.00025656982,0.00011542923,0.00036657974,0.0000509722,0.00005091892,0.0009111308],"genre_scores_gemma":[0.9958898,0.0025802716,0.0005174822,0.00042147486,0.00006870041,0.000020268719,0.00007749482,0.000056864523,0.0003676413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972364,0.00017644111,0.0009937878,0.00042138222,0.0004947627,0.00067726924],"domain_scores_gemma":[0.9982846,0.00012555855,0.0006765735,0.00035061024,0.0002525048,0.0003101959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021494406,0.00041821055,0.0012900794,0.00018641459,0.00012393274,0.00006155622,0.00027467075,0.00037501723,0.00009349144],"category_scores_gemma":[0.000052159965,0.00037563735,0.0002586128,0.00022663352,0.00010222676,0.00017965888,0.000034146226,0.00021982809,0.0000088209235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096748555,0.063027814,0.046205528,0.0003259427,0.0004249839,0.14134379,0.0005968273,0.0000031475806,0.70432186,0.000007259044,0.0116221,0.02244588],"study_design_scores_gemma":[0.16112891,0.0026286342,0.13447146,0.0017150389,0.0002495935,0.09055218,0.00017921606,0.00003634312,0.60740733,0.000034232373,0.00110793,0.0004891179],"about_ca_topic_score_codex":0.00021916935,"about_ca_topic_score_gemma":0.000012983088,"teacher_disagreement_score":0.15145406,"about_ca_system_score_codex":0.0006225643,"about_ca_system_score_gemma":0.00043756576,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W1996918021","doi":"10.1007/s00259-003-1157-6","title":"Therapy of non-Hodgkin's lymphoma","year":2003,"lang":"en","type":"review","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Medicine; Follicular lymphoma; Chemotherapy; Radiation therapy; Working Formulation; Radioimmunotherapy; Stage (stratigraphy); Non-Hodgkin's lymphoma; Oncology; Pathology; Internal medicine; Immunology; Biology","score_opus":0.03347218143483415,"score_gpt":0.31928980589477424,"score_spread":0.2858176244599401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996918021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038546292,0.9860764,0.000036981495,0.000729851,0.00022168782,0.00025799373,0.0000022701,0.000007939598,0.012281379],"genre_scores_gemma":[0.001690142,0.9943142,0.0009205846,0.0026653996,0.00025085616,7.90837e-7,0.00000639275,0.00013282847,0.000018794402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766827,0.00039030434,0.001063659,0.00023926854,0.00041844096,0.0002200363],"domain_scores_gemma":[0.9980981,0.00006606504,0.0010270926,0.00033271208,0.00019448862,0.00028157997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079097087,0.0003942802,0.001960525,0.00041473765,0.000044094584,0.000017618124,0.00016900396,0.000040141094,0.00007514354],"category_scores_gemma":[0.00009059531,0.00024197863,0.0005571927,0.00020262922,0.00019678706,0.000051269184,0.000049446062,0.00020988827,0.000013379113],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035118825,0.0001833639,0.000026379988,0.0013536145,0.00060929346,0.0075513953,0.00023530584,3.2834482e-8,0.000118566444,0.000029198784,0.010592235,0.9792655],"study_design_scores_gemma":[0.004423109,0.0010853402,0.00014456864,0.021476531,0.0016048981,0.006669397,0.00012958577,0.0000015172997,0.000015303003,0.0000031392403,0.96428275,0.00016383878],"about_ca_topic_score_codex":0.000004102188,"about_ca_topic_score_gemma":1.3445056e-8,"teacher_disagreement_score":0.97910166,"about_ca_system_score_codex":0.00007074859,"about_ca_system_score_gemma":0.00017010974,"threshold_uncertainty_score":0.98676026},"labels":[],"label_agreement":null},{"id":"W1997733493","doi":"10.1074/jbc.m706067200","title":"Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Università degli Studi di Perugia; Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Padova; National Cancer Institute; Fondazione Cariplo; European Commission","keywords":"Autophosphorylation; Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Tyrosine kinase; Protein kinase domain; Receptor tyrosine kinase; Chemistry; Cyclin-dependent kinase 9; Biology; Kinase; Molecular biology; Cancer research; Mitogen-activated protein kinase kinase; Cell biology; Mutant; Biochemistry; Signal transduction; Protein kinase A; Lymphoma","score_opus":0.010495869490229869,"score_gpt":0.22750292666697958,"score_spread":0.2170070571767497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997733493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877906,0.00009558193,0.00067053875,0.00019150735,0.00006011784,0.00008776948,0.000017278537,0.0000021057808,0.00009603875],"genre_scores_gemma":[0.99969286,0.000026092112,0.00015078465,0.000060447743,0.00004336063,9.950435e-7,0.000008107341,0.0000042188644,0.000013137022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904794,0.000025304676,0.00047620907,0.000076661854,0.00027814414,0.00009572999],"domain_scores_gemma":[0.99866503,0.000098808705,0.00092710083,0.00015272392,0.000110036926,0.00004629731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025430878,0.00008886902,0.00027039103,0.000016045387,0.000023479974,0.00000228862,0.0001214783,0.00011006365,0.000021970493],"category_scores_gemma":[0.00024561211,0.00004116077,0.00020814962,0.00012331163,0.00009096838,0.000028913271,0.00004332098,0.00006783989,2.2530836e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001992809,0.00044966134,0.009516953,0.00007400697,0.0000849322,0.000017804921,0.00003472376,0.000004814823,0.988213,0.00017151647,0.0000015356261,0.0012317769],"study_design_scores_gemma":[0.00088486995,0.00017156675,0.26773533,0.00019905904,0.0000703535,0.00007029778,0.000054855394,0.000009141019,0.73053044,0.0002296488,0.00001703821,0.000027387901],"about_ca_topic_score_codex":0.000004224067,"about_ca_topic_score_gemma":1.3513923e-7,"teacher_disagreement_score":0.25821838,"about_ca_system_score_codex":0.00014294006,"about_ca_system_score_gemma":0.000095577176,"threshold_uncertainty_score":0.16784874},"labels":[],"label_agreement":null},{"id":"W1997765594","doi":"10.1016/s0002-9440(10)63284-1","title":"BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma","year":2004,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; U.S. Department of Health and Human Services","keywords":"BCL6; Germinal center; Diffuse large B-cell lymphoma; Fluorescence in situ hybridization; Biology; Lymphoma; Chromosomal translocation; Cancer research; Pathology; Immunohistochemistry; B cell; In situ hybridization; Molecular biology; Gene; Gene expression; Immunology; Medicine; Antibody; Genetics","score_opus":0.0074728700212155046,"score_gpt":0.24347405739057434,"score_spread":0.23600118736935885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997765594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437594,0.00075414835,0.00090896693,0.0031700016,0.0002215119,0.00020071551,0.000022005699,0.00001545946,0.0003312671],"genre_scores_gemma":[0.99323106,0.0003422984,0.0021830627,0.003990981,0.00014631469,0.000020488911,0.000013562326,0.000028455668,0.00004379343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984446,0.0001976766,0.0005712138,0.00020572536,0.00025417857,0.00032658302],"domain_scores_gemma":[0.9986004,0.000096476964,0.00065672275,0.00028803258,0.00016984838,0.00018851973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034940647,0.00022368124,0.000544619,0.0001454389,0.000100158846,0.00001715819,0.00017269835,0.000049457416,0.00001659038],"category_scores_gemma":[0.00003023254,0.00013389949,0.00024558537,0.00023947778,0.00031530377,0.00007116514,0.000021611155,0.00016523109,0.0000246029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00841823,0.14851403,0.54380476,0.00034128682,0.0010344826,0.09993888,0.04050013,0.00030251424,0.05586455,0.0067458237,0.0031029037,0.09143241],"study_design_scores_gemma":[0.20622216,0.026815347,0.4762463,0.0008202966,0.0023167178,0.17619209,0.015432092,0.00014718171,0.0808831,0.0015187494,0.012193795,0.0012121727],"about_ca_topic_score_codex":0.00008286706,"about_ca_topic_score_gemma":0.000038298607,"teacher_disagreement_score":0.19780393,"about_ca_system_score_codex":0.00020129881,"about_ca_system_score_gemma":0.00040512037,"threshold_uncertainty_score":0.5460263},"labels":[],"label_agreement":null},{"id":"W1998094040","doi":"10.1016/j.cancergencyto.2005.12.003","title":"Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma","year":2006,"lang":"en","type":"article","venue":"Cancer Genetics and Cytogenetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital; Calgary Laboratory Services","funders":"Calgary Laboratory Services","keywords":"Biology; Lymphoma; Ring chromosome; Chromosome; Genetics; Molecular biology; Karyotype; Immunology; Gene","score_opus":0.014568934011631807,"score_gpt":0.2572347546951268,"score_spread":0.242665820683495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998094040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765364,0.022815641,0.000037128706,0.000044111548,0.00003396774,0.00027278016,0.000045316174,0.0000054709135,0.00020917237],"genre_scores_gemma":[0.9812882,0.017056612,0.0014463628,0.00001567291,0.00007428013,0.000053255342,0.000011278549,0.000016674088,0.00003765334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911356,0.000014665989,0.00033287506,0.00022661529,0.00014649815,0.00016579361],"domain_scores_gemma":[0.99941677,0.00002828273,0.00017239302,0.00021223509,0.00010506589,0.0000652399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046260608,0.00014008659,0.00027459225,0.00010479506,0.000025178719,0.000007315311,0.000042737054,0.00006535458,0.0000075828675],"category_scores_gemma":[0.000002185581,0.000114644055,0.000037426405,0.00025746285,0.000086791,0.000012018573,0.00002252692,0.000023695435,4.4396444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042183183,0.00045501225,0.9851032,0.00031825167,0.000023327104,0.00018139,0.00014217352,0.0005855801,0.007936246,0.00006981759,0.00001705963,0.0051257527],"study_design_scores_gemma":[0.0045596883,0.00062281906,0.7337857,0.00010649878,0.00040913926,0.00033091498,0.000102044156,0.0006955986,0.2589214,0.00009019632,0.00019849701,0.00017751976],"about_ca_topic_score_codex":0.0009075777,"about_ca_topic_score_gemma":0.0008632561,"teacher_disagreement_score":0.25131753,"about_ca_system_score_codex":0.0000789278,"about_ca_system_score_gemma":0.00022583586,"threshold_uncertainty_score":0.4675049},"labels":[],"label_agreement":null},{"id":"W1998276281","doi":"10.1097/iop.0b013e31821cc4bb","title":"Primary, Unilateral Ocular Adnexal Lymphoma: Disease Progression and Long-Term Survival","year":2011,"lang":"en","type":"article","venue":"Ophthalmic Plastic and Reconstructive Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Marginal zone; Follicular lymphoma; Mantle cell lymphoma; Mucosa-associated lymphoid tissue; MALT lymphoma; Retrospective cohort study; Biopsy; Diffuse large B-cell lymphoma; Pathology; Large cell; Marginal zone B-cell lymphoma; Disease; Internal medicine; B cell; Cancer; Adenocarcinoma; Immunology; Antibody","score_opus":0.026725185686575736,"score_gpt":0.25010822722589166,"score_spread":0.22338304153931593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998276281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512374,0.0016692012,0.000014955401,0.000027860062,0.000782982,0.00031154556,0.00005252835,0.00004321819,0.0019739356],"genre_scores_gemma":[0.9988315,0.0005062236,0.0002680822,0.000027446793,0.00010228754,0.000044965793,0.000087955086,0.000025547639,0.0001059792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985808,0.0000717434,0.00030205975,0.00050034,0.00020494855,0.00034007698],"domain_scores_gemma":[0.99867886,0.00043679596,0.00012205527,0.00018836159,0.00006276267,0.00051117875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012350506,0.00029764092,0.00055341213,0.00015161335,0.00014442996,0.000030242827,0.00003537277,0.000107961445,0.00012746447],"category_scores_gemma":[0.000090193396,0.000216192,0.00013020122,0.0000940707,0.00045393806,0.00015740514,0.00007995448,0.000069827125,0.000011933812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008616305,0.00042137166,0.93341625,0.00019331678,0.00021677549,0.0035053429,0.00008067487,2.8912678e-8,0.00006718361,0.00011318695,0.00001933494,0.061104916],"study_design_scores_gemma":[0.0019224718,0.00013970914,0.99185693,0.0005865275,0.00030657838,0.0045147804,0.000039460032,0.000014930377,0.00021681047,0.0001378723,0.000021982576,0.00024196529],"about_ca_topic_score_codex":0.000017631499,"about_ca_topic_score_gemma":0.0000010090478,"teacher_disagreement_score":0.06086295,"about_ca_system_score_codex":0.00009692754,"about_ca_system_score_gemma":0.00025995358,"threshold_uncertainty_score":0.8816054},"labels":[],"label_agreement":null},{"id":"W1998352493","doi":"10.1182/blood-2013-05-500595","title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Biology; Genome; Genetics; Copy number analysis; Lymphoma; Computational biology; Comparative genomic hybridization; Copy-number variation; Gene; Immunology","score_opus":0.022727876396799122,"score_gpt":0.2684191870169629,"score_spread":0.24569131062016375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998352493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952132,0.0009398197,0.000010175043,0.00022396559,0.00002300237,0.00055940734,0.0000132701825,0.000024801933,0.0029923336],"genre_scores_gemma":[0.9987089,0.00028052964,0.00040839918,0.00019208378,0.000035072724,0.00014906735,0.000099563644,0.000014815042,0.000111578636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989404,0.000042770997,0.0004510984,0.00016133375,0.00018379613,0.00022060037],"domain_scores_gemma":[0.9994476,0.00005904509,0.00009588358,0.00022990482,0.0000774574,0.000090142814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010121865,0.00015236171,0.00038880453,0.00011450203,0.000029099605,0.000016699429,0.00006265588,0.00007840203,0.0002579505],"category_scores_gemma":[0.000018350396,0.0001219399,0.0001511924,0.00016988858,0.00004159311,0.00016323195,0.000014898901,0.00002980722,0.00013401931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003670848,0.0014467285,0.9874179,0.00016811298,0.00036739232,0.000042541687,0.0012416922,0.00001622389,0.008294161,0.0001356154,0.00008718048,0.00074573886],"study_design_scores_gemma":[0.0077725467,0.00013650357,0.92293876,0.00007991157,0.00036431674,0.000029155273,0.0004705722,0.000025216194,0.067664385,0.00014319667,0.00026250657,0.00011293504],"about_ca_topic_score_codex":0.0017207349,"about_ca_topic_score_gemma":0.00008215101,"teacher_disagreement_score":0.06447915,"about_ca_system_score_codex":0.00010965829,"about_ca_system_score_gemma":0.000092226685,"threshold_uncertainty_score":0.49725646},"labels":[],"label_agreement":null},{"id":"W1998481715","doi":"10.1111/cas.12442","title":"Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis","year":2014,"lang":"en","type":"article","venue":"Cancer Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation","keywords":"Lymphoma; CDKN2A; Mantle cell lymphoma; Follicular lymphoma; Genetic heterogeneity; Somatic evolution in cancer; Biology; Comparative genomic hybridization; Cell of origin; Chronic lymphocytic leukemia; Aggressive lymphoma; Cancer research; Leukemia; Pathology; Immunology; Cancer; Medicine; Gene; Phenotype; Genetics; Genome","score_opus":0.015043030651057108,"score_gpt":0.2735225468366568,"score_spread":0.25847951618559967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998481715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971788,0.00071666046,0.00005059119,0.00048208598,0.00012909273,0.00019590289,0.000008600298,0.000023381359,0.001214871],"genre_scores_gemma":[0.9984334,0.00009066612,0.00088479475,0.00037339074,0.000039333052,0.000103981736,0.0000014746786,0.000006067425,0.000066906105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989258,0.000009331475,0.00013207996,0.00029130687,0.00040396128,0.00023750261],"domain_scores_gemma":[0.99936384,0.00003364005,0.000083750536,0.00018420318,0.00019471596,0.00013983343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016610746,0.000103942526,0.00019991439,0.00006231207,0.00009899131,0.000018881887,0.00013315107,0.000023967386,0.00003461841],"category_scores_gemma":[0.000037132308,0.00006469119,0.00004363547,0.000390362,0.00063395675,0.00010711308,0.000039971277,0.000022902985,0.000008684359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053783875,0.00017212455,0.9701856,0.000035303827,0.00002416501,0.000005468725,0.00009371833,0.000019165955,0.014230491,0.00083038467,0.00012496952,0.014224826],"study_design_scores_gemma":[0.0010000137,0.00047941192,0.54911727,0.00018337497,0.00006277296,0.000052801457,0.000018801167,0.00035210882,0.44785476,0.000018137669,0.0007846613,0.00007592562],"about_ca_topic_score_codex":0.00021041896,"about_ca_topic_score_gemma":0.000041236777,"teacher_disagreement_score":0.43362427,"about_ca_system_score_codex":0.0001650158,"about_ca_system_score_gemma":0.0004915394,"threshold_uncertainty_score":0.263803},"labels":[],"label_agreement":null},{"id":"W1998892163","doi":"10.1038/sj.bjc.6601388","title":"Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Yale University; State of Connecticut Department of Public Health","keywords":"Medicine; Follicular lymphoma; Lymphoma; Internal medicine; Population; Hodgkin lymphoma; Non-Hodgkin's lymphoma; Epidemiology; Risk factor; Etiology; Oncology; Environmental health","score_opus":0.005941546187466647,"score_gpt":0.24532152094221069,"score_spread":0.23937997475474404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998892163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739513,0.024757937,0.0000099949975,0.000047794434,0.00018189331,0.0000873463,0.00001701054,0.0000035511891,0.00094318396],"genre_scores_gemma":[0.9775654,0.021915816,0.00015629405,0.000104956256,0.000114015194,0.00001176001,5.1259514e-7,0.000015082644,0.00011615886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901813,0.000046277994,0.00035196796,0.000109624794,0.000284547,0.00018945581],"domain_scores_gemma":[0.99914294,0.000055246655,0.0003744688,0.000079634156,0.00017902975,0.00016865911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032663305,0.00009467692,0.00038573763,0.000069318114,0.00005234825,0.000029605342,0.000042510896,0.000060357594,0.00020276196],"category_scores_gemma":[0.00010111374,0.00008817737,0.00009837449,0.00009797946,0.00008036503,0.00010270999,0.000010970715,0.00008469995,3.2888659e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067187546,0.00013749888,0.77251774,0.000031968928,0.00064538734,0.000545148,0.00022030053,0.0000064208243,0.00005219448,0.0000068814015,0.0006755917,0.22509366],"study_design_scores_gemma":[0.0050604874,0.00029434825,0.9815379,0.0009267964,0.00045490434,0.0013733786,0.0001668216,0.000006209127,0.005131906,0.00006947841,0.0048962072,0.00008156227],"about_ca_topic_score_codex":0.00097454566,"about_ca_topic_score_gemma":0.00020925495,"teacher_disagreement_score":0.22501211,"about_ca_system_score_codex":0.00024009089,"about_ca_system_score_gemma":0.00019544712,"threshold_uncertainty_score":0.35957685},"labels":[],"label_agreement":null},{"id":"W1999897515","doi":"10.1080/10428190802108870","title":"Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma","year":2008,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Medicine; Salvage therapy; Autologous stem-cell transplantation; Chemotherapy; Lymphoma; Refractory (planetary science); Internal medicine; Oncology; Transplantation; Diffuse large B-cell lymphoma; Surgery; Biology","score_opus":0.012832555256231951,"score_gpt":0.2258245512521214,"score_spread":0.21299199599588944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999897515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579633,0.0060898024,0.0005641873,0.00021322064,0.00041272433,0.0031755748,0.00096145255,0.0006971013,0.0020896113],"genre_scores_gemma":[0.9781298,0.009421814,0.0028944085,0.0032521137,0.00045053748,0.0010180817,0.0012252153,0.0004417675,0.0031662637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99170184,0.00031172056,0.001774737,0.0024759518,0.0013619928,0.002373742],"domain_scores_gemma":[0.994274,0.0011882907,0.0012296704,0.0014243475,0.00042291865,0.0014607745],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00053556496,0.0020404877,0.0028323778,0.0006427223,0.0014405656,0.0002285224,0.00053898623,0.0011679691,0.000062875304],"category_scores_gemma":[0.000039052768,0.0016145657,0.00057587144,0.000788453,0.0006971943,0.0007261739,0.00018856175,0.00019526697,0.000063576634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12539966,0.0988891,0.2882883,0.018525045,0.0032494874,0.038597286,0.034605008,0.000037973023,0.02513131,0.00043054653,0.02420163,0.34264466],"study_design_scores_gemma":[0.36929435,0.0034507925,0.56087196,0.00087557046,0.0015439463,0.0074290363,0.0017279878,0.0020821437,0.022958742,0.000019784613,0.027667895,0.002077774],"about_ca_topic_score_codex":0.0005103246,"about_ca_topic_score_gemma":0.0002230625,"teacher_disagreement_score":0.3405669,"about_ca_system_score_codex":0.007700336,"about_ca_system_score_gemma":0.0059701046,"threshold_uncertainty_score":0.99985945},"labels":[],"label_agreement":null},{"id":"W2000255540","doi":"10.5430/jhm.v3n1p7","title":"L428 cell morphophenotypic changes induced by CD99 overexpression via NF-κB inactivation","year":2013,"lang":"en","type":"article","venue":"Journal of Hematological Malignancies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Transfection; Chemistry; Cell culture; Cell biology; Flow cytometry; Apoptosis; Cell cycle; Viability assay; Molecular biology; Biology; Biochemistry; Genetics","score_opus":0.017789899933660508,"score_gpt":0.24304452154336628,"score_spread":0.22525462160970577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000255540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354917,0.0016861296,0.0001355327,0.0033670752,0.00012105923,0.00030534377,0.0000028038048,0.000024407724,0.0008085016],"genre_scores_gemma":[0.99772376,0.0001827927,0.001010963,0.0007908419,0.00009672187,0.00003804764,0.0000064351116,0.000013178731,0.00013725259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986136,0.00005985767,0.00046529257,0.00017318664,0.00042002826,0.00026806424],"domain_scores_gemma":[0.99870884,0.00017309586,0.0004915181,0.00015686316,0.0002659432,0.00020376313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011916017,0.0002080499,0.0005804384,0.00010321237,0.00007514334,0.000039017807,0.00010911155,0.00018982001,0.00054159673],"category_scores_gemma":[0.00013345537,0.00011873868,0.0001469978,0.0001347853,0.000046734338,0.0002090694,0.000050496645,0.00018030289,0.00008033697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013704775,0.0011797744,0.0154494485,0.00012130404,0.00005887911,0.00012428661,0.00015581907,7.956804e-7,0.9651568,0.000306121,0.014887308,0.0024224375],"study_design_scores_gemma":[0.0023848284,0.0017120695,0.062351175,0.000508557,0.00008891817,0.00068305555,0.00034830504,0.000024169507,0.9291084,0.0016236749,0.0009966155,0.00017027045],"about_ca_topic_score_codex":0.000041071096,"about_ca_topic_score_gemma":4.8320356e-7,"teacher_disagreement_score":0.046901725,"about_ca_system_score_codex":0.00014572864,"about_ca_system_score_gemma":0.000051758292,"threshold_uncertainty_score":0.5930104},"labels":[],"label_agreement":null},{"id":"W2000738457","doi":"10.3129/i06-071","title":"Characterization of lymphoproliferative lesions of the conjunctiva: immunohistochemical and molecular genetic studies","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lymphoma; Pathology; Immunophenotyping; MALT lymphoma; Medicine; Lymphoid hyperplasia; Lymphoproliferative disorders; Chemotherapy; Immunohistochemistry; Gene rearrangement; Conjunctiva; Mucosa-associated lymphoid tissue; Internal medicine; Biology; Immunology; Antigen; Gene","score_opus":0.016292609939412686,"score_gpt":0.26580159592615776,"score_spread":0.2495089859867451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000738457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949326,0.0036898153,0.0000046742357,0.00064326014,0.000118617354,0.00012141966,0.00001399501,3.7860926e-7,0.0004752419],"genre_scores_gemma":[0.99971646,0.000022365433,0.00011999256,0.000032940956,0.000030185567,0.00000352206,0.0000028942345,0.000005639186,0.000065979635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994095,0.000047787336,0.00030526318,0.00006488143,0.00007400841,0.000098568744],"domain_scores_gemma":[0.9992608,0.000040926647,0.00024240368,0.00010010251,0.00026744744,0.000088317924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051680843,0.000073551084,0.00030591863,0.00008916946,0.00003900623,0.0000020862387,0.000049326714,0.000052841006,0.000035354093],"category_scores_gemma":[0.00008098145,0.00004735461,0.00007579634,0.00007959303,0.0002969995,0.000017301729,0.000010345044,0.000044838464,2.5924965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008587045,0.0001330092,0.54626334,0.000056281497,0.0004105842,0.0034622028,0.00040727048,0.000008430096,0.4480152,0.0007881122,0.000107710635,0.00026195025],"study_design_scores_gemma":[0.0010910997,0.00040431926,0.8165169,0.00012018659,0.00016994918,0.033753064,0.00008297501,0.0000026853406,0.14747608,0.0003021112,0.00004047817,0.000040171784],"about_ca_topic_score_codex":0.00080568675,"about_ca_topic_score_gemma":0.000015401953,"teacher_disagreement_score":0.30053914,"about_ca_system_score_codex":0.00013428224,"about_ca_system_score_gemma":0.00060054054,"threshold_uncertainty_score":0.19310649},"labels":[],"label_agreement":null},{"id":"W2001171502","doi":"10.1002/gcc.10232","title":"Non‐muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma","year":2003,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Anaplastic lymphoma kinase; Molecular biology; Fusion protein; Fusion gene; Biology; Anaplastic large-cell lymphoma; Complementary DNA; Fluorescence in situ hybridization; Tyrosine; Gene; Chemistry; Biochemistry; Lymphoma; Recombinant DNA; Chromosome","score_opus":0.012855338806305263,"score_gpt":0.2627055680012933,"score_spread":0.24985022919498803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001171502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775866,0.01885254,0.000026520056,0.0011115966,0.0002565104,0.0005470964,0.000036198973,0.000028505583,0.001554384],"genre_scores_gemma":[0.99040174,0.003846723,0.0002770599,0.0019676632,0.00020445044,0.00026218235,0.000016878406,0.000035530058,0.0029877457],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853843,0.000027022346,0.0002511702,0.00045606552,0.00020592246,0.00052139914],"domain_scores_gemma":[0.9991999,0.000038559363,0.00004909886,0.00026964443,0.00003089965,0.00041184263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008288584,0.00026017084,0.00042234632,0.000111999274,0.0000793047,0.00003473177,0.000055082706,0.00009782938,0.00048729533],"category_scores_gemma":[0.000011658342,0.00020910031,0.000082921455,0.0003190054,0.000024086401,0.00005340846,0.000035842164,0.000039500883,0.000054562646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084695173,0.0065010693,0.4934562,0.00063782,0.00038186714,0.0011131013,0.005502666,0.00022703712,0.016911915,0.0008743266,0.043545593,0.43000144],"study_design_scores_gemma":[0.025478577,0.0010184414,0.31780338,0.0003796115,0.00019155028,0.000048300008,0.0005320763,0.00016696952,0.06595143,0.00005719519,0.587833,0.0005395139],"about_ca_topic_score_codex":0.000788143,"about_ca_topic_score_gemma":0.0013722441,"teacher_disagreement_score":0.5442874,"about_ca_system_score_codex":0.00027662062,"about_ca_system_score_gemma":0.0003907702,"threshold_uncertainty_score":0.8526863},"labels":[],"label_agreement":null},{"id":"W2001175105","doi":"10.1002/ijc.27438","title":"Self‐reported history of infections and the risk of non‐Hodgkin lymphoma: An InterLymph pooled analysis","year":2012,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; University of California, San Francisco; National Cancer Institute; National Institutes of Health; Bundesamt für Strahlenschutz; Cancerfonden; Fondation de France; National Health and Medical Research Council; European Commission; Canadian Institutes of Health Research; Compagnia di San Paolo","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Internal medicine; Oncology","score_opus":0.011349317934335357,"score_gpt":0.3050157837360925,"score_spread":0.29366646580175715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001175105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99021786,0.007322156,0.00027150218,0.00036696106,0.00083303114,0.000084260326,0.000018618479,0.0000037138088,0.00088187977],"genre_scores_gemma":[0.9969834,0.0021999807,0.00028447874,0.000117942705,0.00027899837,0.00001085662,0.0000040140712,0.0000068309837,0.00011351549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879503,0.00007331247,0.0005611105,0.000070964415,0.0004150555,0.000084516105],"domain_scores_gemma":[0.9979184,0.00014379188,0.001003272,0.00013059605,0.00070613157,0.00009776732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042880955,0.00009069315,0.00038070476,0.00032476554,0.000015141284,0.00000624623,0.000099717,0.00003987293,0.00020321466],"category_scores_gemma":[0.00008914817,0.000054138913,0.00031375428,0.00012960877,0.00011930965,0.00017412596,0.000024030913,0.000052864263,6.813025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006920616,0.0014178926,0.9468083,0.00001267069,0.026050756,0.000017682425,0.0023894885,0.0000841122,0.00033414978,0.00022923452,0.00041219193,0.021551482],"study_design_scores_gemma":[0.008230594,0.00024197406,0.97130316,0.00008044561,0.012702985,0.00021225268,0.00014295998,0.0007764888,0.0013988507,0.00005426775,0.004799703,0.000056290253],"about_ca_topic_score_codex":0.0016344474,"about_ca_topic_score_gemma":0.0001565239,"teacher_disagreement_score":0.02449491,"about_ca_system_score_codex":0.0007918406,"about_ca_system_score_gemma":0.00033438156,"threshold_uncertainty_score":0.24708064},"labels":[],"label_agreement":null},{"id":"W2001550610","doi":"10.1002/jso.21269","title":"The role of surgical intervention in the management of duodenal lymphoma","year":2009,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Perforation; Chemotherapy; Lymphoma; Surgery; Stage (stratigraphy); Retrospective cohort study; Demographics; Cancer; Internal medicine","score_opus":0.013845138125873301,"score_gpt":0.3160717912309845,"score_spread":0.3022266531051112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001550610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631703,0.004851835,0.0000028256704,0.009377833,0.000120258956,0.00018368456,0.0000012184664,0.000002017143,0.022290021],"genre_scores_gemma":[0.9936673,0.0059620584,0.00012735033,0.00006128549,0.00010281561,0.0000046507603,0.0000012281691,0.0000031933878,0.0000701386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828976,0.00022889658,0.00084793405,0.00008086562,0.00038822103,0.0001643359],"domain_scores_gemma":[0.9987361,0.0004627928,0.00048405305,0.00014035734,0.000112698486,0.00006402859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011780722,0.000090946996,0.0004699396,0.00008450751,0.000030396404,0.0000065159784,0.00017285674,0.00008528431,0.00005882447],"category_scores_gemma":[0.0000084081585,0.00004117796,0.00037801513,0.0001708086,0.000103987266,0.00003871529,0.00002781494,0.000111181515,0.0000030737874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039950926,0.0071456884,0.01458773,0.000032821292,0.00041102912,0.0077838493,0.00025176807,0.000015191239,0.000052447547,0.021042172,0.00052956166,0.94415265],"study_design_scores_gemma":[0.021959662,0.008384281,0.37106732,0.00043227815,0.00043255626,0.0066590146,0.001606672,0.000059222573,0.0011661506,0.0032055986,0.5849515,0.00007572952],"about_ca_topic_score_codex":0.000015689808,"about_ca_topic_score_gemma":0.000005702591,"teacher_disagreement_score":0.9440769,"about_ca_system_score_codex":0.00019635419,"about_ca_system_score_gemma":0.00007023183,"threshold_uncertainty_score":0.16791885},"labels":[],"label_agreement":null},{"id":"W2001663034","doi":"10.1182/blood-2013-02-483727","title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Simon Fraser University; Jewish General Hospital; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Canada's Michael Smith Genome Sciences Centre","keywords":"Biology; Diffuse large B-cell lymphoma; Exome sequencing; Exome; Genetics; Point mutation; Gene; Copy-number variation; Mutation; Computational biology; Genome; Cancer research","score_opus":0.014695954641379422,"score_gpt":0.24690667997788573,"score_spread":0.2322107253365063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001663034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988275,0.0006294442,0.000017594168,0.00004829882,0.000015026915,0.00016936778,0.000092199116,0.000012974505,0.00018757227],"genre_scores_gemma":[0.9981326,0.000011385178,0.001514086,0.00009266901,0.000031018397,0.000010952912,0.00014645449,0.000009136189,0.000051712435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928284,0.000016376405,0.0001973629,0.0001751514,0.00016926958,0.00015897494],"domain_scores_gemma":[0.999546,0.000042671592,0.00008739245,0.00014793845,0.000078516525,0.000097503216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003746242,0.00010692155,0.0002899054,0.00016814709,0.000055970653,0.000019747902,0.000029114228,0.000042524058,0.0001082376],"category_scores_gemma":[0.000012605789,0.00008262396,0.00010411024,0.00025173245,0.000031495463,0.00007454545,0.000028368122,0.0000178926,0.000007161741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001690127,0.0030499294,0.8646342,0.00009595074,0.0031412672,0.00011819434,0.0011302567,0.00006388021,0.12672623,0.00015210565,0.000007372604,0.0008636788],"study_design_scores_gemma":[0.014759961,0.000091804446,0.9649082,0.000019460062,0.004614896,0.000067665496,0.00025824178,0.006019977,0.009088308,0.000049234888,0.000021222402,0.00010107181],"about_ca_topic_score_codex":0.00040486857,"about_ca_topic_score_gemma":0.000014191544,"teacher_disagreement_score":0.11763791,"about_ca_system_score_codex":0.00007457554,"about_ca_system_score_gemma":0.00007072663,"threshold_uncertainty_score":0.33693072},"labels":[],"label_agreement":null},{"id":"W2001727131","doi":"10.1038/modpathol.3880211","title":"Anaplastic Large Cell Lymphomas Presented as Bone Lesions: A Clinicopathologic Study of Six Cases and Review of the Literature","year":2000,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; CD30; Pathology; Lymphoma; Bone pain; Large cell; Internal medicine","score_opus":0.04387488692084849,"score_gpt":0.3549298185859914,"score_spread":0.31105493166514286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001727131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041198257,0.9546315,5.310496e-7,0.000057592613,0.00011959666,0.003347744,0.00036898602,0.000021894008,0.00025389806],"genre_scores_gemma":[0.03536592,0.96326244,0.000032396747,0.00027853742,0.000044976416,0.0004005797,0.00016041068,0.00004655284,0.0004081771],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961309,0.0011232517,0.0013509128,0.0007480379,0.00031313507,0.0003338061],"domain_scores_gemma":[0.99677056,0.00088285014,0.00089414255,0.0012016019,0.00013872435,0.00011211679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042823594,0.0005494395,0.0036510278,0.00019438141,0.00008035487,0.000008527557,0.00021652796,0.00045833175,0.00007629557],"category_scores_gemma":[0.0006360491,0.00029288526,0.0006292543,0.0004324932,0.0001700651,0.000027972621,0.00026835274,0.0003061369,0.000015523188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024312332,0.01894038,0.004521385,0.22238745,0.00044369328,0.018261684,0.0011224644,4.184772e-7,0.0000027731303,0.00003808788,0.0009935151,0.73304504],"study_design_scores_gemma":[0.014848493,0.013702779,0.005550811,0.4769682,0.02533694,0.036409922,0.0001903025,0.000011789003,0.000014318843,0.00013484331,0.4259434,0.0008881983],"about_ca_topic_score_codex":0.000018632216,"about_ca_topic_score_gemma":0.000018275367,"teacher_disagreement_score":0.7321568,"about_ca_system_score_codex":0.0000780089,"about_ca_system_score_gemma":0.0003726689,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2001744336","doi":"10.1016/j.ijrobp.2012.04.007","title":"Role of Salvage Radiation Therapy for Patients With Relapsed or Refractory Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant","year":2012,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Surgery; Refractory (planetary science); Radiation therapy; Progression-free survival; Confidence interval; Autologous stem-cell transplantation; Chemotherapy; Internal medicine","score_opus":0.013195079415946763,"score_gpt":0.28263809620879726,"score_spread":0.2694430167928505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001744336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949644,0.0014636788,0.0011695583,0.00038767233,0.00093507575,0.0006487133,0.00020222263,0.000025560657,0.0002031022],"genre_scores_gemma":[0.9953474,0.0014994182,0.0014583517,0.00039633442,0.00088074506,0.00005511528,0.0002840362,0.000036980793,0.000041633633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982213,0.00018544821,0.0007790615,0.00020108085,0.00033153978,0.00028161594],"domain_scores_gemma":[0.99687696,0.0006728642,0.0014611409,0.00016084805,0.00066779146,0.00016041461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003502993,0.00024514107,0.00064237136,0.00018578224,0.00006260919,0.000012977159,0.00021216243,0.00026392177,0.000043353648],"category_scores_gemma":[0.000046747373,0.00016455038,0.00024740794,0.00012415368,0.000100865,0.00033729902,0.0000139329795,0.00013744234,0.0000075592957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049381885,0.003305966,0.62957865,0.000012902,0.00076234643,0.0000079800275,0.0011896511,0.00003404371,0.0013286555,0.00064816675,0.00034286422,0.3578506],"study_design_scores_gemma":[0.04002759,0.010187728,0.90154433,0.000101131176,0.0003818592,0.000061579965,0.00013582328,0.00034398693,0.018056782,0.0003198317,0.028605709,0.0002336534],"about_ca_topic_score_codex":0.00001503052,"about_ca_topic_score_gemma":0.0000022706802,"teacher_disagreement_score":0.35761693,"about_ca_system_score_codex":0.0008766123,"about_ca_system_score_gemma":0.00056752923,"threshold_uncertainty_score":0.671017},"labels":[],"label_agreement":null},{"id":"W2002534044","doi":"10.1002/hon.743","title":"Radiation therapy for localized low-grade non-Hodgkin's lymphomas","year":2005,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Medicine; MALT lymphoma; Radiation therapy; Follicular lymphoma; Helicobacter pylori; Marginal zone; Gastric lymphoma; Mucosa-associated lymphoid tissue; Stage (stratigraphy); Non-Hodgkin's lymphoma; Gastroenterology; Disease; Internal medicine; Pathology; Oncology; B cell; Immunology; Biology; Antibody","score_opus":0.08553989961677713,"score_gpt":0.42155492979817444,"score_spread":0.33601503018139733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002534044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011039689,0.9908996,0.00012682733,0.0009797504,0.0004405929,0.0049044797,0.000046892084,0.00015281541,0.0023386031],"genre_scores_gemma":[0.00029841694,0.98909867,0.0027347319,0.0015472148,0.0006792368,0.0045362194,0.0007112319,0.000076308876,0.00031799581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967795,0.00025873145,0.0011662381,0.00087072933,0.0002526442,0.0006721448],"domain_scores_gemma":[0.99669164,0.0017148367,0.00063370203,0.0005283505,0.00009241959,0.00033902295],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000299667,0.00072688056,0.0051061613,0.00020507303,0.0001197545,0.000022499331,0.00022649033,0.001735443,0.00054245105],"category_scores_gemma":[0.00019425261,0.0004336388,0.0015440027,0.00027091365,0.00017675929,0.00003890874,0.00006113255,0.00024856676,0.00040896854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021960484,0.003060925,0.000089415524,0.0029801496,0.00057378015,0.00045136397,0.000019679674,2.0428345e-7,2.8899362e-7,0.0018155595,0.010059547,0.98072946],"study_design_scores_gemma":[0.00974141,0.0026539096,0.0000917799,0.0018664214,0.0014210459,0.0018815001,0.000005854874,0.00002727802,0.00001769158,0.0001453359,0.98175555,0.00039222513],"about_ca_topic_score_codex":0.000010562206,"about_ca_topic_score_gemma":0.0000033383974,"teacher_disagreement_score":0.98033726,"about_ca_system_score_codex":0.0013770374,"about_ca_system_score_gemma":0.0011260158,"threshold_uncertainty_score":0.99981153},"labels":[],"label_agreement":null},{"id":"W2002818377","doi":"10.1016/j.jacr.2008.06.016","title":"ACR Appropriateness Criteria® on Hodgkin's Lymphoma—Favorable Prognosis Stage I and II","year":2008,"lang":"en","type":"review","venue":"Journal of the American College of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Lymphoma; Regimen; Oncology; Stage (stratigraphy); Randomized controlled trial; Clinical trial; Internal medicine","score_opus":0.0333093447193824,"score_gpt":0.3223295945157505,"score_spread":0.2890202497963681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002818377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066941276,0.93017644,0.0000020710825,0.0008363311,0.00055085524,0.0009327375,0.00026800376,0.000009365856,0.00028292817],"genre_scores_gemma":[0.009048913,0.988866,0.0007947429,0.0002753262,0.00035130337,0.0000542208,0.00000638965,0.00005701579,0.0005461247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712336,0.00060924166,0.0011795027,0.00034293017,0.0003831137,0.00036185523],"domain_scores_gemma":[0.9953624,0.0005018396,0.003175098,0.0005396676,0.00021072448,0.00021025061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034653285,0.00050024,0.0046284585,0.00038105485,0.00018256059,0.000007716694,0.00042999384,0.00019627107,0.00002568235],"category_scores_gemma":[0.00022601917,0.00026137763,0.0010650987,0.00056878047,0.00080979656,0.00004705006,0.00018104866,0.00026968744,0.000002846623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001151309,0.0028845577,0.0021281135,0.00449401,0.004720482,0.003176604,0.0001593645,0.0000034586383,0.00001848622,0.00030855986,0.03663574,0.9443193],"study_design_scores_gemma":[0.0027224885,0.0070275194,0.0022232628,0.0060634376,0.0022966696,0.03791155,0.000109929286,0.0000034735551,0.000053899064,0.000019966043,0.94130296,0.00026483648],"about_ca_topic_score_codex":0.000049216065,"about_ca_topic_score_gemma":0.0000017676367,"teacher_disagreement_score":0.9440545,"about_ca_system_score_codex":0.00048733287,"about_ca_system_score_gemma":0.0013059885,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W2002858168","doi":"10.1053/j.seminoncol.2003.12.002","title":"Integrating Monoclonal Antibodies into the Management of Mantle Cell Lymphoma","year":2004,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Autologous stem-cell transplantation; Oncology; Internal medicine; Transplantation; Chemotherapy; Clinical trial; Surgery; Maintenance therapy; Lymphoma","score_opus":0.011499077761637565,"score_gpt":0.3028536267254322,"score_spread":0.29135454896379465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002858168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560026,0.0029489521,0.000018610739,0.0019748777,0.00015386217,0.00031103397,0.0000017103723,0.000013291062,0.038575068],"genre_scores_gemma":[0.9792343,0.0024851926,0.017465448,0.00030098812,0.00003193964,0.000069716785,0.000009638605,0.0000100622965,0.00039270814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991654,0.00003153713,0.0002800049,0.00019090992,0.00013631309,0.00019581424],"domain_scores_gemma":[0.99950606,0.00010869079,0.00009539151,0.00022136889,0.00002997338,0.000038499093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018901844,0.00012255613,0.00028769934,0.00007938625,0.000050056788,0.0000041556664,0.000108502376,0.00008091245,0.00002962928],"category_scores_gemma":[0.000010448339,0.00007768345,0.000074892334,0.00015531752,0.00014017399,0.00002369894,0.0000999055,0.000059372054,0.0000248362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005032173,0.006759181,0.17616618,0.0004670734,0.00041380903,0.0035231528,0.015380705,0.00012492991,0.0029099812,0.020969927,0.0015481787,0.7712337],"study_design_scores_gemma":[0.04134235,0.006895991,0.6010589,0.0040228353,0.0009474838,0.00076392054,0.045374077,0.0002147281,0.22255982,0.015911961,0.060276553,0.0006314057],"about_ca_topic_score_codex":0.00040231185,"about_ca_topic_score_gemma":0.00014068464,"teacher_disagreement_score":0.7706023,"about_ca_system_score_codex":0.0006404192,"about_ca_system_score_gemma":0.00012103468,"threshold_uncertainty_score":0.3167839},"labels":[],"label_agreement":null},{"id":"W2003773799","doi":"10.1182/blood-2010-01-263806","title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; CDKN2A; Mantle cell lymphoma; Gene expression profiling; Loss of heterozygosity; Gene dosage; Comparative genomic hybridization; Copy number analysis; Cancer research; Copy-number variation; Gene; Genetics; Locus (genetics); Gene expression; Lymphoma; Genome","score_opus":0.005399649423686771,"score_gpt":0.2228407628115854,"score_spread":0.21744111338789865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003773799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988746,0.00036475508,0.000046250632,0.000032507385,0.000047189023,0.00019526595,0.000115196926,0.000014944514,0.00030926036],"genre_scores_gemma":[0.99700946,0.00011235923,0.002296487,0.000022074264,0.000019838306,0.00003599157,0.00035642873,0.000010716896,0.00013666389],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922216,0.000026532318,0.00022609445,0.00023731164,0.00014611786,0.00014179063],"domain_scores_gemma":[0.99955386,0.00004532256,0.00008791943,0.00021082383,0.00003742604,0.000064654734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082517865,0.00011924857,0.00032326076,0.00011620687,0.000026295149,0.0000148458685,0.00003514618,0.00009917117,0.00004355691],"category_scores_gemma":[0.000019532152,0.00008570246,0.00006893266,0.00031078604,0.000036347952,0.00007764065,0.000030343996,0.00005174061,0.0000043304035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059420425,0.0022439293,0.5165747,0.000021247954,0.00014731154,0.000026532787,0.000055099754,0.0000020794741,0.48018053,0.000034646004,0.000059041824,0.0005954732],"study_design_scores_gemma":[0.005549141,0.00007223351,0.18699895,0.000042511547,0.00069740345,0.0000075775056,0.00004768041,0.00015593531,0.8062938,0.000011350552,0.00005347673,0.0000699817],"about_ca_topic_score_codex":0.00078915904,"about_ca_topic_score_gemma":0.00010582283,"teacher_disagreement_score":0.32957572,"about_ca_system_score_codex":0.000030554333,"about_ca_system_score_gemma":0.000058492613,"threshold_uncertainty_score":0.3494845},"labels":[],"label_agreement":null},{"id":"W2003775647","doi":"10.1159/000087284","title":"Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma","year":2005,"lang":"en","type":"article","venue":"Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Vincristine; Epirubicin; Regimen; Clinical endpoint; CHOP; Neutropenia; International Prognostic Index; Surgery; Febrile neutropenia; Cyclophosphamide; Lymphoma; Toxicity; Chemotherapy; Randomized controlled trial","score_opus":0.007833934636717148,"score_gpt":0.272210120108722,"score_spread":0.2643761854720048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003775647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829433,0.00016262,0.000008977767,0.00047126363,0.00007429713,0.004847711,0.000002471825,0.000045558045,0.011443825],"genre_scores_gemma":[0.9961614,0.000025596488,0.0011749477,0.0003013102,0.00008557112,0.0018952303,0.000020479689,0.00003465139,0.00030079947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813145,0.0001932887,0.00040077715,0.00053688086,0.0003344901,0.00040311372],"domain_scores_gemma":[0.99864763,0.0002779288,0.00039564716,0.00034062797,0.00018443211,0.00015370449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025611106,0.00030762522,0.0014029867,0.0001807424,0.00008058376,0.000018483264,0.000097638804,0.000109401124,0.000049100032],"category_scores_gemma":[0.000051111816,0.0001842736,0.000074724754,0.00024141347,0.00016962485,0.00010510253,0.00005341669,0.00011921551,0.00004078442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12109277,0.013809044,0.83961326,0.000012605055,0.0007696198,0.0007448685,0.00439453,0.000030739255,0.000002470438,0.000025760704,0.00025742306,0.01924692],"study_design_scores_gemma":[0.45784187,0.009504309,0.53069377,0.00015796632,0.00037860367,0.00005555148,0.0005698121,0.000076089476,0.000062852625,0.000007022759,0.00050761516,0.00014454218],"about_ca_topic_score_codex":0.0006132724,"about_ca_topic_score_gemma":0.0028368856,"teacher_disagreement_score":0.3367491,"about_ca_system_score_codex":0.0015969732,"about_ca_system_score_gemma":0.00038869865,"threshold_uncertainty_score":0.7514459},"labels":[],"label_agreement":null},{"id":"W2004729151","doi":"10.5430/jhm.v2n3p55","title":"Role of endoscopic ultrasonography with and without fine needle aspiration cytology in the diagnosis and staging of lymphoma","year":2012,"lang":"en","type":"article","venue":"Journal of Hematological Malignancies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Endoscopic ultrasound; Radiology; Fine-needle aspiration; Lymphoma; Endoscopic ultrasonography; Cytology; Endoscopy; Biopsy; Pathology","score_opus":0.02136834303294098,"score_gpt":0.2626540646117381,"score_spread":0.24128572157879713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004729151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714757,0.012078002,0.000016049355,0.00045051775,0.000014677689,0.00016296835,0.0000023342802,0.0000025143368,0.00012534573],"genre_scores_gemma":[0.99807465,0.0005818384,0.0012062805,0.000095836105,0.000017744169,0.000018372102,6.985887e-7,0.0000038486924,7.2874246e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913645,0.00007016752,0.00038711165,0.00007218708,0.00017965396,0.00015445077],"domain_scores_gemma":[0.9991385,0.00031587025,0.0003302811,0.00007816033,0.00007621693,0.000061025567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026345233,0.00010547597,0.0005108413,0.0001231402,0.000024204468,0.000007251464,0.00004634842,0.00005687173,0.000008693357],"category_scores_gemma":[0.00010805132,0.000049719853,0.000053913813,0.00014511017,0.00018918948,0.000108892535,0.000015528838,0.00005124516,1.3373736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013637773,0.0006913097,0.9908837,0.00011547234,0.00006708843,0.000022520504,0.0012699515,7.802336e-7,0.002253647,0.0025819112,0.000010674914,0.0019665614],"study_design_scores_gemma":[0.0021706652,0.0017474167,0.9628396,0.00035393078,0.00015267132,0.0011528742,0.0020991676,0.00000334061,0.02912994,0.00024707004,0.000060105544,0.000043210846],"about_ca_topic_score_codex":0.000025211408,"about_ca_topic_score_gemma":0.0000072298903,"teacher_disagreement_score":0.028044097,"about_ca_system_score_codex":0.000013032106,"about_ca_system_score_gemma":0.000027784534,"threshold_uncertainty_score":0.20275167},"labels":[],"label_agreement":null},{"id":"W2005034045","doi":"10.1002/gcc.1103","title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","year":2001,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Follicular lymphoma; Immunophenotyping; Lymphoma; Biology; Histopathology; Pathology; Gene duplication; Cytogenetics; Karyotype; Follicular phase; Chromosomal translocation; Chromosome; Immunology; Medicine; Genetics; Gene; Flow cytometry","score_opus":0.016915244098908055,"score_gpt":0.27614876733200683,"score_spread":0.2592335232330988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005034045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452694,0.024374748,0.000005139836,0.00017927053,0.000031901178,0.00020634366,0.00012881168,0.000008472251,0.00053837],"genre_scores_gemma":[0.99081093,0.008526547,0.00011965296,0.00011239487,0.000049034046,0.00011271791,0.00007753002,0.000011662297,0.00017955371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908906,0.000019224619,0.0002882589,0.00024734202,0.00018479777,0.00017133214],"domain_scores_gemma":[0.99944127,0.00004496478,0.00011389546,0.00022754434,0.00008919875,0.00008313438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003827103,0.00015223258,0.0005680619,0.00023500275,0.00003806541,0.000008924594,0.00003880879,0.00005519022,0.0008149095],"category_scores_gemma":[0.000004530655,0.00010874771,0.00012912734,0.00069487083,0.00009111079,0.00006749619,0.000021847154,0.000022484495,6.5728324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021199546,0.00058528973,0.91588444,0.00011686106,0.002019929,0.00042932318,0.00035287254,0.00035438934,0.0023887872,0.000058681082,0.000070951486,0.077526495],"study_design_scores_gemma":[0.0044662585,0.0006101239,0.9631504,0.00021084165,0.0023358515,0.00019429876,0.0002662617,0.0004343585,0.024880987,0.000006180552,0.0032898013,0.00015468313],"about_ca_topic_score_codex":0.0021339385,"about_ca_topic_score_gemma":0.0026047174,"teacher_disagreement_score":0.07737181,"about_ca_system_score_codex":0.00009538143,"about_ca_system_score_gemma":0.00021545973,"threshold_uncertainty_score":0.8922688},"labels":[],"label_agreement":null},{"id":"W2005037741","doi":"10.1097/00001622-200409000-00004","title":"Emerging prognostic factors in diffuse large B cell lymphoma","year":2004,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Immunophenotyping; International Prognostic Index; Oncology; Confusion; Internal medicine; Bioinformatics; Pathology; Immunology; Biology; Flow cytometry","score_opus":0.09202435898323355,"score_gpt":0.4265505245424696,"score_spread":0.3345261655592361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005037741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015273056,0.98886776,0.0000034427,0.00006843788,0.0066898433,0.0023392278,0.00007058053,0.000051865612,0.00038155017],"genre_scores_gemma":[0.001922762,0.99527717,0.00003561487,0.000013241444,0.00035564776,0.0010153941,0.0012854685,0.00006551807,0.000029163519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968167,0.00027232105,0.001166797,0.00075592095,0.00025855988,0.0007296872],"domain_scores_gemma":[0.9983589,0.00053421804,0.00043460666,0.00041255448,0.00003786261,0.00022188186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022633602,0.0006357245,0.0026013958,0.00081870117,0.00004556623,0.000015766413,0.00020276294,0.0005781745,0.000076979864],"category_scores_gemma":[0.00015696236,0.00048119613,0.000492388,0.0006273486,0.000057513593,0.000051708586,0.00016224632,0.00041255812,0.00017540158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017639577,0.030913483,0.027051263,0.035552308,0.000060077175,0.00013096388,0.00035780686,3.753136e-7,1.9084254e-8,0.00026917696,0.0006461319,0.90500075],"study_design_scores_gemma":[0.016869916,0.00045756725,0.0051580253,0.04434378,0.00029891572,0.0000602131,0.00006025666,0.000003467286,5.152816e-7,0.000024018309,0.93237627,0.0003470426],"about_ca_topic_score_codex":0.00005951058,"about_ca_topic_score_gemma":0.00002600297,"teacher_disagreement_score":0.93173015,"about_ca_system_score_codex":0.0043994267,"about_ca_system_score_gemma":0.0021585466,"threshold_uncertainty_score":0.99976397},"labels":[],"label_agreement":null},{"id":"W2005689613","doi":"10.1002/gcc.20187","title":"Amplification of <i>IGH/MYC</i> fusion in clinically aggressive <i>IGH/BCL2</i>‐positive germinal center B‐cell lymphomas","year":2005,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Germinal center; Biology; BCL6; Gene duplication; Fluorescence in situ hybridization; Cancer research; Oncogene; Fusion gene; Molecular biology; Gene rearrangement; Recombination-activating gene; B cell; Locus (genetics); Genetics; Gene; Cell cycle; Recombination; Chromosome; Antibody","score_opus":0.011913851530547855,"score_gpt":0.28974849559182725,"score_spread":0.2778346440612794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005689613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193694,0.024500767,0.000007688499,0.000970035,0.00012595921,0.0004128059,0.00012977397,0.000017352906,0.0018986592],"genre_scores_gemma":[0.9621175,0.035545655,0.00045553,0.0009899718,0.000312894,0.0001373627,0.00008448376,0.000020951245,0.00033565823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985465,0.000039287068,0.0004962394,0.0004111734,0.0002387703,0.00026803685],"domain_scores_gemma":[0.9991016,0.00007531791,0.0003213575,0.0002444456,0.00011400796,0.00014329096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086856184,0.0002141538,0.00043782024,0.000082037965,0.000058040834,0.00001603938,0.00006938516,0.00012582791,0.00021792854],"category_scores_gemma":[0.000009018174,0.0001655126,0.00012080726,0.0001458616,0.00010589391,0.00008921872,0.00005891375,0.00006413836,0.000016674467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007371749,0.0022618296,0.5430635,0.00022677341,0.00012802317,0.0001629131,0.0012348174,0.000025476658,0.02761475,0.00013541375,0.0013917321,0.42301756],"study_design_scores_gemma":[0.016102975,0.0011130553,0.74097073,0.0013736663,0.00037622705,0.00022163083,0.00036337355,0.0002394178,0.2014494,0.000067029614,0.037244588,0.00047788006],"about_ca_topic_score_codex":0.00020837813,"about_ca_topic_score_gemma":0.000088668916,"teacher_disagreement_score":0.42253968,"about_ca_system_score_codex":0.00022460941,"about_ca_system_score_gemma":0.00018020961,"threshold_uncertainty_score":0.67494076},"labels":[],"label_agreement":null},{"id":"W2006214678","doi":"10.1016/j.ijrobp.2009.07.164","title":"Hodgkin-Lymphoma with Relapsed or Progressive Disease after Autologous Stem Cell Transplantation: Efficacy of Salvage Radiation Therapy","year":2009,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Salvage therapy; Nodular sclerosis; Radiation therapy; Autologous stem-cell transplantation; Chemotherapy; Transplantation; Surgery; Hematopoietic stem cell transplantation; Lymphoma; Internal medicine; Oncology; Hodgkin lymphoma","score_opus":0.014276164893003315,"score_gpt":0.3061380575651312,"score_spread":0.29186189267212787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006214678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157745,0.0028112007,0.0012297855,0.0028225055,0.00062714337,0.0005737393,0.00009048583,0.00004028659,0.000227411],"genre_scores_gemma":[0.993551,0.0027287349,0.0014500878,0.0011691469,0.0008267407,0.000038328773,0.00016346625,0.00002466315,0.000047844896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811393,0.0002092238,0.00077665574,0.00027329152,0.0004039862,0.00022290874],"domain_scores_gemma":[0.99727714,0.00042524008,0.0012871235,0.00018868872,0.00061712525,0.00020465699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020879137,0.0002678981,0.00057023787,0.00019257238,0.000055907567,0.000024700837,0.00022175019,0.00018717501,0.000080413825],"category_scores_gemma":[0.000040926072,0.00017967178,0.00025978847,0.00019920962,0.00015128577,0.00026038426,0.000009991842,0.00016464136,0.000011603639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020705394,0.0038153382,0.2666174,0.000022145206,0.00077617407,0.0013687259,0.0011202245,0.00028746313,0.00067167234,0.0008689345,0.0002830147,0.70346355],"study_design_scores_gemma":[0.03374269,0.008521122,0.94139147,0.0001816496,0.00051084504,0.0005235426,0.000049896364,0.00024618188,0.010196179,0.00056399807,0.0038499378,0.00022251454],"about_ca_topic_score_codex":0.000005054655,"about_ca_topic_score_gemma":0.0000010411226,"teacher_disagreement_score":0.703241,"about_ca_system_score_codex":0.0005993074,"about_ca_system_score_gemma":0.0010288963,"threshold_uncertainty_score":0.7326803},"labels":[],"label_agreement":null},{"id":"W2006857073","doi":"10.1111/j.1365-2141.2008.07094.x","title":"Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"IWK Health Centre","keywords":"Medicine; Stage (stratigraphy); Hodgkin lymphoma; Bone marrow; Lymphoma; Pediatrics; Internal medicine","score_opus":0.04361698736652288,"score_gpt":0.3087089068437661,"score_spread":0.26509191947724325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006857073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831787,0.0094011845,0.000004067116,0.004247296,0.00015086656,0.00035880922,0.00000802644,0.0000021006251,0.002648957],"genre_scores_gemma":[0.99890596,0.00052138366,0.00006576686,0.00031311056,0.00014872896,0.000022359058,0.00000735092,0.0000076203173,0.000007720261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997957,0.0006921259,0.00047994574,0.000104635146,0.00058063754,0.00018569047],"domain_scores_gemma":[0.99841666,0.00025618757,0.00033341703,0.00011781166,0.00080303155,0.000072893425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972036,0.000086571374,0.00037575772,0.00025378037,0.00014667341,0.0000142337585,0.00011458145,0.0000926852,0.00006896974],"category_scores_gemma":[0.00089373306,0.00005981103,0.00011496629,0.00030368773,0.00016106095,0.000078444,0.0000112168955,0.00013054162,0.0000039295733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000556263,0.005141379,0.38866428,0.00010319546,0.0008689802,0.2269893,0.033256304,0.00014968168,0.000045939625,0.008425973,0.015456914,0.3203418],"study_design_scores_gemma":[0.0052110073,0.00027357525,0.73691076,0.000079923564,0.00028622587,0.25446802,0.0018470446,0.00009822153,0.00011631101,0.00055059855,0.00011069811,0.000047624675],"about_ca_topic_score_codex":0.053088143,"about_ca_topic_score_gemma":0.11420512,"teacher_disagreement_score":0.34824646,"about_ca_system_score_codex":0.0008228143,"about_ca_system_score_gemma":0.0017875376,"threshold_uncertainty_score":0.95321745},"labels":[],"label_agreement":null},{"id":"W2007027997","doi":"10.3324/haematol.13326","title":"Gene expression signatures in follicular lymphoma: are they ready for the clinic?","year":2008,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Follicular lymphoma; SNP array; Gene expression profiling; Single-nucleotide polymorphism; Biology; Computational biology; SNP; Genetics; Gene expression; Gene; Genome; Lymphoma; Genotype; Immunology","score_opus":0.03799693587896399,"score_gpt":0.3181259929605036,"score_spread":0.2801290570815396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007027997","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033623107,0.08098301,0.000036957485,0.0027124484,0.86916035,0.008713261,0.0011243088,0.0004192503,0.0032272835],"genre_scores_gemma":[0.22110942,0.049095098,0.0033532127,0.0011922262,0.7091938,0.008373877,0.0031039042,0.00027764586,0.004300819],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718577,0.00013497239,0.0006762894,0.00079756987,0.0007029,0.0005024808],"domain_scores_gemma":[0.99433297,0.0038575658,0.00051634264,0.00093972695,0.00022751454,0.00012589709],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032851592,0.0005432576,0.001469073,0.00011551706,0.00025622072,0.00003435783,0.0003628899,0.0016760055,0.00008086514],"category_scores_gemma":[0.0016685043,0.0002701069,0.00051971193,0.000107879765,0.000109612614,0.000035390898,0.00012980553,0.00034795352,0.000073310955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007587074,0.0010659682,0.0012663447,0.00017771467,0.00020976092,0.0023469967,0.00011310656,0.00000529953,0.000019544625,0.000022175116,0.9931793,0.0008350345],"study_design_scores_gemma":[0.007691014,0.00056310254,0.004083296,0.0009150139,0.00047166643,0.00011726808,0.00010635345,0.000014493627,0.0022942093,0.00017912888,0.9832,0.00036443578],"about_ca_topic_score_codex":0.00016302991,"about_ca_topic_score_gemma":0.0000786473,"teacher_disagreement_score":0.18748632,"about_ca_system_score_codex":0.00026231646,"about_ca_system_score_gemma":0.0003622417,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2007050465","doi":"10.1111/bjh.12763","title":"<scp>MYC</scp> and <scp>BCL</scp>2 protein expression predicts survival in patients with diffuse large <scp>B</scp>‐cell lymphoma treated with rituximab","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Rituximab; Lymphoma; Medicine; Internal medicine; CHOP; Oncology; Cyclophosphamide; Prednisone; Survival analysis; Cancer research; Immunology; Chemotherapy","score_opus":0.00490902539138982,"score_gpt":0.19707676294554458,"score_spread":0.19216773755415475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007050465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993879,0.0028383797,0.00011021464,0.00005949499,0.00014937483,0.0012353184,0.0000757016,0.00006739267,0.0015850981],"genre_scores_gemma":[0.9973816,0.0004272217,0.0009941729,0.0001903077,0.00013120624,0.00010834067,0.00009659273,0.00011459701,0.0005559213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956473,0.00051549834,0.0011164716,0.0007019855,0.00094249606,0.0010762513],"domain_scores_gemma":[0.99628884,0.0010151893,0.0010148322,0.00043148862,0.0005370949,0.00071257626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053918146,0.00060402905,0.0019776567,0.00043173198,0.00023591022,0.00013988513,0.0002795298,0.0004325435,0.000008442936],"category_scores_gemma":[0.0011744797,0.0004718475,0.00017352401,0.0003810667,0.00029465902,0.0004002553,0.00014410459,0.00042632164,0.000020402265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022696359,0.017484758,0.950627,0.00041463098,0.0003578266,0.022264881,0.00076084933,0.0000035141754,0.00024500678,0.00006259439,0.004852148,0.002699824],"study_design_scores_gemma":[0.12812594,0.0056067705,0.81668645,0.004024759,0.00052169454,0.027866943,0.0007680867,0.00007237169,0.010021501,0.00008640985,0.0061052097,0.00011384105],"about_ca_topic_score_codex":0.00021793549,"about_ca_topic_score_gemma":0.00022373298,"teacher_disagreement_score":0.13394053,"about_ca_system_score_codex":0.00023978106,"about_ca_system_score_gemma":0.00033922473,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W2007195406","doi":"10.1002/pbc.24279","title":"Response‐dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Etoposide; Chemotherapy; Vincristine; Internal medicine; Lymphoma; Bleomycin; Dexrazoxane; Chemoimmunotherapy; Progressive disease; Hodgkin's lymphoma; Oncology; Randomized controlled trial; Gastroenterology; Cancer; Anthracycline; Cyclophosphamide; Breast cancer","score_opus":0.00807263097122936,"score_gpt":0.26315706956516044,"score_spread":0.2550844385939311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007195406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96905625,0.028342614,2.0766656e-7,0.0007917737,0.00018292485,0.0011758895,0.00038928792,0.000016897944,0.000044155207],"genre_scores_gemma":[0.9715964,0.02717957,0.00010793287,0.00013080283,0.0005917042,0.0002519121,0.00007601502,0.000025791845,0.00003986421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779475,0.00033564089,0.0006119948,0.000543093,0.00028449754,0.00043001512],"domain_scores_gemma":[0.99852824,0.0003665206,0.00039970948,0.00047099966,0.00003245012,0.00020207267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070459914,0.00029446874,0.000603869,0.00018287722,0.000054883752,0.000012723938,0.0000805199,0.00018423896,0.000019913385],"category_scores_gemma":[0.00017477981,0.00019426522,0.00008655286,0.00029990947,0.00008084054,0.00007893663,0.00007372462,0.00012376555,0.0000025171241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041580703,0.0039955843,0.966425,0.000009438625,0.0002793788,0.00016402313,0.0010954477,0.000001398881,0.000063627136,0.0000015241804,0.00033458215,0.023471914],"study_design_scores_gemma":[0.027394444,0.00090323173,0.96889347,0.00009701369,0.0014179768,0.00032592868,0.000051866682,0.0000017036757,0.0004909478,0.0000072138005,0.00024700406,0.00016917298],"about_ca_topic_score_codex":0.03306231,"about_ca_topic_score_gemma":0.0018619988,"teacher_disagreement_score":0.03120031,"about_ca_system_score_codex":0.00046005982,"about_ca_system_score_gemma":0.00031077207,"threshold_uncertainty_score":0.97337663},"labels":[],"label_agreement":null},{"id":"W2007505304","doi":"10.1007/s11899-014-0213-6","title":"Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Vinblastine; Oncology; Internal medicine; Hodgkin's lymphoma; Regimen; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.03486173526679406,"score_gpt":0.2923363232740295,"score_spread":0.25747458800723544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007505304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289984,0.0011761647,0.0000120212535,0.0011900647,0.00013198455,0.0010971113,0.000008758903,0.00009595973,0.0033881064],"genre_scores_gemma":[0.9982179,0.00032527532,0.00009313742,0.0003669881,0.00003147387,0.00037426694,0.0005171256,0.000021589289,0.000052262683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976724,0.00014788774,0.0006385483,0.0005620522,0.0005335477,0.00044560162],"domain_scores_gemma":[0.9983744,0.00021870053,0.00035164296,0.0007172462,0.00021027494,0.00012770882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036126678,0.00035366093,0.0006076245,0.00013262565,0.000103084356,0.000041889,0.00010739855,0.000105350424,0.00007247883],"category_scores_gemma":[0.00023598775,0.00017579155,0.00009180204,0.0005212029,0.00007614406,0.00007519158,0.000041845076,0.00016882227,0.000011688238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049684426,0.0020393091,0.9900486,0.00016849532,0.000046477944,0.0006543185,0.00031828583,0.000004335351,0.000003721285,0.00053256616,0.0042026737,0.001931528],"study_design_scores_gemma":[0.0032441434,0.0012062605,0.969393,0.0012008572,0.0003341622,0.0016035541,0.00021026282,0.000065429704,0.002056725,0.0007435111,0.019549618,0.00039248465],"about_ca_topic_score_codex":0.00013981714,"about_ca_topic_score_gemma":0.00012490498,"teacher_disagreement_score":0.020655612,"about_ca_system_score_codex":0.00009580651,"about_ca_system_score_gemma":0.00007805063,"threshold_uncertainty_score":0.71685714},"labels":[],"label_agreement":null},{"id":"W2007660268","doi":"10.1182/blood-2011-05-349662","title":"Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Children’s Oncology Group; National Institutes of Health; University of Nebraska Medical Center","keywords":"Lymphoma; Germinal center; Gene expression profiling; Diffuse large B-cell lymphoma; Cancer research; Biology; B cell; Gene rearrangement; Medicine; Oncology; Pathology; Immunology; Gene; Gene expression; Genetics; Antibody","score_opus":0.010796418517869978,"score_gpt":0.24668723805357745,"score_spread":0.23589081953570748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007660268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903374,0.005120996,0.00009072407,0.00012745442,0.00016853266,0.0005122732,0.000041223528,0.000062669285,0.0035387445],"genre_scores_gemma":[0.9960404,0.00022545381,0.002393765,0.00012488088,0.0007454953,0.00010907691,0.00012812132,0.000036446057,0.0001963832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989096,0.000024847643,0.00023366365,0.0002840308,0.00018297642,0.00036486215],"domain_scores_gemma":[0.9993012,0.000050430095,0.00008989725,0.0002982981,0.000055723383,0.00020442875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007035375,0.00020416811,0.0002787619,0.000061486935,0.000121828954,0.000033917095,0.000055210843,0.00012987596,0.000032824595],"category_scores_gemma":[0.00002372168,0.0001696541,0.00010494251,0.0001611154,0.000028873068,0.000109420755,0.000065245404,0.0000873736,0.00010294723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015785605,0.0014928445,0.99356884,0.00013893966,0.00018302878,0.000068772715,0.00037138083,3.2798252e-7,0.0032197929,0.00036199627,0.00024789185,0.0003304021],"study_design_scores_gemma":[0.007111493,0.00014713491,0.91965055,0.000025647487,0.002754939,0.000105459396,0.00014456894,0.0000030919007,0.06948496,0.00006650038,0.0002930013,0.00021265584],"about_ca_topic_score_codex":0.00007306221,"about_ca_topic_score_gemma":0.0000012565225,"teacher_disagreement_score":0.07391829,"about_ca_system_score_codex":0.00006001756,"about_ca_system_score_gemma":0.00005704191,"threshold_uncertainty_score":0.6918294},"labels":[],"label_agreement":null},{"id":"W2007794249","doi":"10.1046/j.1365-2141.2000.02098.x","title":"Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Internal medicine; Etoposide; Autologous stem-cell transplantation; Transplantation; Melphalan; Large cell; Oncology; Lymphoma; Chemotherapy; Gastroenterology; Chemotherapy regimen; Surgery; Cancer; Adenocarcinoma","score_opus":0.010019238523221258,"score_gpt":0.2515401976893634,"score_spread":0.24152095916614216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007794249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392605,0.00260742,0.00017787142,0.00015695122,0.00026163372,0.0008349317,0.00022932811,0.000013586707,0.0017922325],"genre_scores_gemma":[0.9971673,0.0012263148,0.0009760346,0.00006098396,0.00010264055,0.000040790615,0.000030843767,0.00001789597,0.00037720994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99828374,0.00009537051,0.0009388068,0.0001999181,0.0002108421,0.00027129866],"domain_scores_gemma":[0.9986683,0.0003598424,0.000501769,0.00010503783,0.00024549698,0.000119545526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026866928,0.00013884706,0.0008607314,0.000114784845,0.00006749712,0.000014455027,0.00008485121,0.00015303429,0.00008300034],"category_scores_gemma":[0.00004375134,0.00013090324,0.0002831372,0.00010390924,0.000065720706,0.00007896278,0.0000048632664,0.00009503058,0.00000834779],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61481816,0.023473972,0.0074212444,0.0027014986,0.0014298718,0.1516171,0.0050872094,0.00012654121,0.0005652902,0.00061461213,0.0141471075,0.17799743],"study_design_scores_gemma":[0.6301929,0.018939996,0.0325743,0.0011685175,0.001916931,0.27719778,0.00046516416,0.00012807296,0.033755038,0.0004750131,0.00288856,0.0002977695],"about_ca_topic_score_codex":0.000044600292,"about_ca_topic_score_gemma":0.00006413498,"teacher_disagreement_score":0.17769966,"about_ca_system_score_codex":0.000120372344,"about_ca_system_score_gemma":0.00038596374,"threshold_uncertainty_score":0.53380793},"labels":[],"label_agreement":null},{"id":"W2007928660","doi":"10.1038/sj.leu.2403464","title":"Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a ‘small-cell variant’ of ALCL","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; CD43; Lymphoma; Cancer research; Cell culture; Biology; Immunophenotyping; CD8; Large cell; Cell; CD5; Anaplastic lymphoma kinase; Antigen; Pathology; Immunology; CD20; Medicine; Cancer; Genetics; Adenocarcinoma","score_opus":0.017347393300795187,"score_gpt":0.23909509657034667,"score_spread":0.22174770326955148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007928660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874069,0.0016141284,0.0022064028,0.0001582009,0.00021284413,0.0007566162,0.00043016844,0.000051928313,0.007162821],"genre_scores_gemma":[0.98847514,0.00033864134,0.009706016,0.00040470067,0.00013557544,0.00007087094,0.00026468973,0.0000534442,0.0005509468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977867,0.00002638947,0.00071357936,0.0005271326,0.000458786,0.0004874304],"domain_scores_gemma":[0.9982233,0.00022573749,0.0003779803,0.00071679265,0.00016678024,0.00028939242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014706339,0.000368259,0.00077188946,0.00017115017,0.00005058666,0.00001490565,0.00021069283,0.0002234424,0.00016580318],"category_scores_gemma":[0.00005168385,0.00030949156,0.00027137308,0.00034889727,0.00006859689,0.0000757001,0.00012513026,0.00010681237,0.000077888944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00811295,0.23528413,0.09458467,0.005648292,0.002689126,0.0057137655,0.010232742,0.014477866,0.58726406,0.0042161057,0.01228816,0.019488104],"study_design_scores_gemma":[0.13602644,0.0025429232,0.029001717,0.00091048505,0.0014757813,0.00005987516,0.00034799342,0.0019882643,0.8222291,0.00020645406,0.0046830317,0.0005279691],"about_ca_topic_score_codex":0.003823068,"about_ca_topic_score_gemma":0.00019601673,"teacher_disagreement_score":0.23496498,"about_ca_system_score_codex":0.0012444648,"about_ca_system_score_gemma":0.0012080141,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W2008247420","doi":"10.1002/pbc.21543","title":"Non‐anaplastic peripheral t‐cell lymphoma in childhood and adolescence: A Children's Oncology Group study","year":2008,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; CD30; Peripheral T-cell lymphoma; Anaplastic lymphoma kinase; Internal medicine; T-cell lymphoma; Not Otherwise Specified; Large cell; Pathology; Stage (stratigraphy); Oncology; Cancer; T cell; Immunology; Adenocarcinoma","score_opus":0.0077170506306853065,"score_gpt":0.2471445376400583,"score_spread":0.239427487009373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008247420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876252,0.010334657,0.0000011342202,0.00016477906,0.00020815496,0.0011968286,0.000018726874,0.000047965616,0.00040259023],"genre_scores_gemma":[0.9891995,0.008794469,0.00013246632,0.00036012265,0.0009301321,0.00044610546,0.000013964713,0.000036559664,0.000086658634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981499,0.00005192578,0.00038698554,0.0006099099,0.0003237768,0.00047752747],"domain_scores_gemma":[0.99922985,0.000066899585,0.00012415639,0.00026571937,0.00004514393,0.00026825498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009043325,0.00031969414,0.0006078901,0.00021179164,0.00013500894,0.000014730389,0.00010059813,0.00013978378,0.000094878706],"category_scores_gemma":[0.000019043719,0.00026647895,0.00009322615,0.00047679179,0.000069390306,0.00008045791,0.00007828594,0.00015542246,0.00001827205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017505798,0.015622326,0.97607344,0.000054519078,0.00013528719,0.0008445902,0.0018338511,0.0000063930556,0.000010932435,0.0000016147061,0.00038018505,0.0048617935],"study_design_scores_gemma":[0.030638289,0.0033090836,0.9639205,0.00003471408,0.0011167397,0.0004231898,0.00017042855,0.000018284627,0.000048215803,0.0000028608056,0.00007066157,0.00024707438],"about_ca_topic_score_codex":0.002022174,"about_ca_topic_score_gemma":0.00063569006,"teacher_disagreement_score":0.03046323,"about_ca_system_score_codex":0.000289324,"about_ca_system_score_gemma":0.0005506393,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W2008401471","doi":"10.1158/1078-0432.ccr-13-2175","title":"Inactivation of the <i>CDKN2A</i> Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Health Research Board; King Fahad Medical City; University Health Network; Leukemia and Lymphoma Society of Canada","keywords":"CDKN2A; Follicular lymphoma; DNA methylation; Lymphoma; Methylation; CDKN2B; Biopsy; p14arf; Cancer research; CpG site; Oncology; Medicine; Mantle cell lymphoma; Pathology; Biology; Internal medicine; Cancer; Tumor suppressor gene; Carcinogenesis; Gene; Genetics; Gene expression","score_opus":0.15638008130249578,"score_gpt":0.47314775636562323,"score_spread":0.3167676750631274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008401471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913303,0.00051199936,0.000007669271,0.006845726,0.00009570819,0.0010259653,0.00006366505,0.000014885506,0.00010405669],"genre_scores_gemma":[0.99657387,0.00095699984,0.000059443428,0.0015219683,0.000104246385,0.00048687906,0.0000486509,0.000027605736,0.00022036984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956672,0.0015000396,0.0010758687,0.0005211482,0.0008836649,0.000352077],"domain_scores_gemma":[0.9938162,0.0048366715,0.00034225764,0.0004566539,0.00034824671,0.00019998504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040942547,0.00016983646,0.00073862623,0.00008795045,0.00014848595,0.000023576997,0.00015700547,0.00024392584,0.000088315384],"category_scores_gemma":[0.0034670783,0.00009541345,0.00016766513,0.0005588476,0.00044839177,0.00008197209,0.00018329996,0.00032967163,0.0000061175647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017245987,0.0015481948,0.97179264,0.00004665241,0.00015134223,0.000011846097,0.00004988107,0.000002796481,0.00042006574,0.000017792396,0.005063555,0.019170618],"study_design_scores_gemma":[0.009923156,0.0015725303,0.95492357,0.00030886967,0.0001410979,0.0000037676643,0.000021277478,0.0004921019,0.028072273,0.0000641622,0.0043677166,0.00010946306],"about_ca_topic_score_codex":0.0017619808,"about_ca_topic_score_gemma":0.0018245287,"teacher_disagreement_score":0.027652208,"about_ca_system_score_codex":0.00066370366,"about_ca_system_score_gemma":0.00022559703,"threshold_uncertainty_score":0.4150667},"labels":[],"label_agreement":null},{"id":"W2008411546","doi":"10.1111/j.1365-2141.2012.09176.x","title":"<scp><i>MYD88</i></scp> somatic mutations in <scp>MALT</scp> lymphomas","year":2012,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse","keywords":"MALT lymphoma; Mucosa-associated lymphoid tissue; Macroglobulinemia; Cancer research; Lymphoma; Waldenstrom macroglobulinemia; Germline mutation; B cell; Biology; Marginal zone; Chromosomal translocation; Mutation; Immunology; Gene; Genetics; Antibody; Multiple myeloma","score_opus":0.01721686155693252,"score_gpt":0.257928519284201,"score_spread":0.2407116577272685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008411546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8558575,0.060746904,0.000045013243,0.07074915,0.0026524684,0.0010772139,0.00014924127,0.00008278126,0.008639718],"genre_scores_gemma":[0.5948832,0.011563747,0.0056910953,0.36635715,0.010401099,0.00047696248,0.0012799959,0.0006314864,0.008715282],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9946813,0.0004778287,0.0021350565,0.0005026675,0.00089252496,0.00131065],"domain_scores_gemma":[0.9941281,0.0028413495,0.001708666,0.00047853572,0.00040549485,0.00043784673],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005666564,0.0006443686,0.0028552383,0.0009293336,0.00015913113,0.00013670273,0.00045401245,0.0014485987,0.00015532099],"category_scores_gemma":[0.001845646,0.0006599498,0.0008081637,0.0003666954,0.00030956152,0.00031683437,0.000115360686,0.0018142211,0.0003963646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037113412,0.0008528945,0.02146626,0.0006618396,0.0007060837,0.2789344,0.00054906245,0.000002674479,0.000012714224,0.00005835637,0.6942148,0.0025371956],"study_design_scores_gemma":[0.005505711,0.0003299847,0.02763659,0.002528229,0.0012191,0.55407035,0.0003870926,0.000007969827,0.0002929325,0.0007929275,0.40713385,0.000095263604],"about_ca_topic_score_codex":0.000246987,"about_ca_topic_score_gemma":0.00014605529,"teacher_disagreement_score":0.29560798,"about_ca_system_score_codex":0.00075056317,"about_ca_system_score_gemma":0.0012571561,"threshold_uncertainty_score":0.9998477},"labels":[],"label_agreement":null},{"id":"W2008441553","doi":"10.1074/jbc.m502952200","title":"Evidence for a Triplex DNA Conformation at the bcl-2 Major Breakpoint Region of the t(14;18) Translocation","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"DNA; Chromosomal translocation; Breakpoint; DNA supercoil; Chemistry; Molecular biology; Biology; Biophysics; Biochemistry; DNA replication; Gene","score_opus":0.09675994271069469,"score_gpt":0.31701471883991517,"score_spread":0.22025477612922048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008441553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805205,0.0030994748,0.00013886021,0.015546926,0.00004245707,0.00026987368,0.0000056730028,0.0000043375007,0.0003718833],"genre_scores_gemma":[0.9977774,0.0011746912,0.00013834577,0.00041995582,0.0002205281,0.000016845019,0.0000057158377,0.0000028255145,0.00024370312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917555,0.000025305577,0.00045714356,0.000074128446,0.00017160598,0.00009626044],"domain_scores_gemma":[0.9988971,0.00026445522,0.00045735028,0.00015065016,0.0001786854,0.000051762043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031323318,0.00008467622,0.00020921398,0.000008600798,0.00006540715,0.000005721906,0.00011572591,0.00010280351,0.00010261811],"category_scores_gemma":[0.0003399154,0.000033220356,0.00027269963,0.00006117886,0.000091633905,0.000055770513,0.000016365098,0.00008248024,0.0000018015367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040842486,0.0010127416,0.015074233,0.00034818373,0.00031529527,0.000013616212,0.0005082129,0.000045994282,0.8386753,0.000055673016,0.02093329,0.1189332],"study_design_scores_gemma":[0.0031840708,0.0003662639,0.046744987,0.0005116595,0.00016288937,0.00092701387,0.000115449046,0.00009591806,0.93848085,0.00008473098,0.009267557,0.000058609312],"about_ca_topic_score_codex":0.0000023897696,"about_ca_topic_score_gemma":0.0000012533272,"teacher_disagreement_score":0.118874595,"about_ca_system_score_codex":0.00019615328,"about_ca_system_score_gemma":0.00007638516,"threshold_uncertainty_score":0.13546869},"labels":[],"label_agreement":null},{"id":"W2008699564","doi":"10.1182/blood-2011-07-370122","title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation","keywords":"Mantle cell lymphoma; microRNA; Biology; Gene expression profiling; Chronic lymphocytic leukemia; Cyclin D1; Cancer research; Stromal cell; Lymphoma; Leukemia; Gene; Gene expression; Genetics; Cell cycle; Immunology","score_opus":0.012841834515012971,"score_gpt":0.22725667454484264,"score_spread":0.21441484002982966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008699564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915295,0.002494033,0.000011322891,0.00014838003,0.00004085862,0.0008524757,0.0000295185,0.000051230672,0.0048426613],"genre_scores_gemma":[0.9944434,0.00005322665,0.004601993,0.00009889984,0.00014283312,0.0002324594,0.000059866932,0.00003927623,0.00032804516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987138,0.00003147365,0.0002976066,0.00024413965,0.00029127652,0.00042169605],"domain_scores_gemma":[0.9991452,0.0000915098,0.00016800876,0.00028174435,0.000080831196,0.00023269278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514545,0.00021183288,0.00040847206,0.000072196526,0.000056687157,0.000011645516,0.00007708982,0.0000687333,0.000057850943],"category_scores_gemma":[0.000033910233,0.00014281712,0.00011422007,0.0001801738,0.000054877724,0.00007985857,0.00004198247,0.00003657952,0.00005737787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012078765,0.0089602405,0.97827744,0.000343705,0.0002550937,0.00008176588,0.00021371186,8.968155e-8,0.011069844,0.00004360371,0.000065734275,0.00056798384],"study_design_scores_gemma":[0.0069581456,0.00056092086,0.70727056,0.00013790275,0.00081925606,0.000090999994,0.00007785912,0.0000011322749,0.28355193,0.000005828876,0.0003973772,0.00012808936],"about_ca_topic_score_codex":0.00007049829,"about_ca_topic_score_gemma":0.000005522471,"teacher_disagreement_score":0.2724821,"about_ca_system_score_codex":0.00006836219,"about_ca_system_score_gemma":0.00008176261,"threshold_uncertainty_score":0.5823913},"labels":[],"label_agreement":null},{"id":"W2009925410","doi":"10.1038/modpathol.3800677","title":"Immunoglobulin V somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome","year":2006,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"","keywords":"Somatic hypermutation; Biology; Mantle cell lymphoma; Genotype; Lymphoma; Molecular biology; Germline mutation; Immunoglobulin heavy chain; Antibody; Mutation; B cell; Genetics; Gene; Immunology","score_opus":0.016598249851778886,"score_gpt":0.27848500497402795,"score_spread":0.26188675512224907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009925410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612,0.00068412675,0.00057417183,0.00058816123,0.0001384811,0.00040796737,0.00000872959,0.000067862726,0.0014105113],"genre_scores_gemma":[0.9964268,0.000025508147,0.0021256062,0.0006676436,0.00005880581,0.00006829193,0.0001782141,0.000033939312,0.0004151462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984019,0.000114794566,0.00062231335,0.00039301376,0.00014840106,0.00031959784],"domain_scores_gemma":[0.99930066,0.00013433292,0.00014221724,0.00031429896,0.00005104721,0.000057422894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018094963,0.00020734545,0.0005155209,0.00011327333,0.00004394587,0.000012746821,0.00006422776,0.00020923588,0.000046674246],"category_scores_gemma":[0.000019648312,0.00015129734,0.000092530165,0.0001198846,0.00010091081,0.00004912794,0.000030784784,0.0001044442,0.00033424623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025129344,0.0020202964,0.9846586,0.00003473881,0.00003126837,0.0038048795,0.00017909423,0.00017782833,0.0009691585,0.000029646199,0.00007279202,0.0077703856],"study_design_scores_gemma":[0.012344129,0.00055522256,0.97994095,0.000036653906,0.00018277203,0.00065892737,0.000028537861,0.0039792014,0.0011112565,0.0009392449,0.000058229165,0.00016487522],"about_ca_topic_score_codex":0.00018624839,"about_ca_topic_score_gemma":0.00009440424,"teacher_disagreement_score":0.012092836,"about_ca_system_score_codex":0.00015786632,"about_ca_system_score_gemma":0.00007517599,"threshold_uncertainty_score":0.6169727},"labels":[],"label_agreement":null},{"id":"W2009962689","doi":"10.1016/j.humpath.2014.06.005","title":"BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Manitoba","funders":"National Cancer Institute; University of Nebraska Medical Center","keywords":"clone (Java method); Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Biology; Lymphoma; Immunohistochemistry; Chromosomal translocation; Epitope; Gene duplication; Antibody; Monoclonal; Context (archaeology); Monoclonal antibody; Immunophenotyping; Immunoglobulin heavy chain; Cancer research; Molecular biology; Pathology; Immunology; Gene; Medicine; Flow cytometry; Genetics","score_opus":0.01787920913736699,"score_gpt":0.2483347191986855,"score_spread":0.2304555100613185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009962689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977246,0.0009859565,0.0003491847,0.000046169134,0.000033760927,0.0006497493,0.000024234501,0.000033165266,0.00015318579],"genre_scores_gemma":[0.9985362,0.000092414586,0.0009252341,0.00005129971,0.000025253901,0.00014951598,0.00006354496,0.000024780862,0.00013175113],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986916,0.00016030653,0.00033564548,0.00039507973,0.00014298865,0.00027438678],"domain_scores_gemma":[0.9992878,0.00006733907,0.00020442293,0.00031454602,0.000044548076,0.00008135195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001130189,0.0002161478,0.00047282845,0.000145312,0.00011745338,0.000008159439,0.000056052213,0.000123769,0.000026974236],"category_scores_gemma":[0.000029309753,0.00014650311,0.00004506309,0.000055352753,0.000107727144,0.000039396942,0.00008502578,0.000058488764,0.0000064630913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017189486,0.0023197776,0.15429854,0.00012636624,0.0000195712,0.00012730675,0.00084046123,0.0000012878473,0.83983946,0.00015350328,0.0000067759297,0.0020950811],"study_design_scores_gemma":[0.0123358155,0.0005524707,0.5754346,0.00017747356,0.000044471224,0.000054221902,0.000018230163,0.000046927875,0.4110795,0.00012608683,0.000030336094,0.000099839264],"about_ca_topic_score_codex":0.000030416097,"about_ca_topic_score_gemma":0.00006001535,"teacher_disagreement_score":0.42875996,"about_ca_system_score_codex":0.000119669116,"about_ca_system_score_gemma":0.0000133226085,"threshold_uncertainty_score":0.5974223},"labels":[],"label_agreement":null},{"id":"W2010308729","doi":"10.1155/2012/164934","title":"Diagnosis of B-Cell Non-Hodgkin Lymphomas with Small-/Intermediate-Sized Cells in Cytopathology","year":2012,"lang":"en","type":"article","venue":"Pathology Research International","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Follicular lymphoma; Cytopathology; Pathology; Mantle cell lymphoma; Chronic lymphocytic leukemia; Lymphoplasmacytic Lymphoma; Context (archaeology); Lymphoid hyperplasia; Marginal zone; Immunophenotyping; Confusion; Cytology; B cell; Leukemia; Waldenstrom macroglobulinemia; Immunology; Flow cytometry; Biology","score_opus":0.05227572942849894,"score_gpt":0.34898708805283757,"score_spread":0.2967113586243386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010308729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865242,0.00031477114,0.00004250288,0.0008219604,0.0004761204,0.0005344939,0.000053484422,0.00001816624,0.011214281],"genre_scores_gemma":[0.9948045,0.0007228068,0.0026161133,0.00017437978,0.00023464921,0.00068916584,0.00007341046,0.000028758523,0.00065619254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760765,0.00031148703,0.0004296452,0.00038527086,0.0005502791,0.0007156443],"domain_scores_gemma":[0.9982531,0.00069219817,0.00011988779,0.000348045,0.0003537486,0.00023302452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013194034,0.00019389967,0.00046106154,0.00071321015,0.00004438256,0.000012185428,0.00027885992,0.00018606815,0.00057584763],"category_scores_gemma":[0.00024767654,0.00014803611,0.0001053964,0.00030159875,0.00044028534,0.00010139227,0.00021127825,0.00030147462,0.00020957566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086593983,0.003917694,0.9681167,0.00006423996,0.000072388866,0.001597636,0.00087626773,0.0000031745242,0.019076077,0.00033539557,0.00074910274,0.0043253894],"study_design_scores_gemma":[0.008733732,0.001003787,0.8052804,0.00015070534,0.000036709225,0.00051366613,0.00024081222,0.00004994059,0.18172938,0.00006767303,0.0020581682,0.00013505024],"about_ca_topic_score_codex":0.00013494302,"about_ca_topic_score_gemma":0.00007869687,"teacher_disagreement_score":0.16283631,"about_ca_system_score_codex":0.00037888982,"about_ca_system_score_gemma":0.0002568807,"threshold_uncertainty_score":0.6305128},"labels":[],"label_agreement":null},{"id":"W2010656118","doi":"10.1016/j.joms.2002.09.002","title":"Hodgkin’s lymphoma: a case report involving the mandible","year":2003,"lang":"en","type":"review","venue":"Journal of Oral and Maxillofacial Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD15; CD30; Medicine; Lymphoma; Reed–Sternberg cell; Pathology; CD20; Lymphocyte; Population; CD3; Epstein–Barr virus; Hodgkin's lymphoma; Immunohistochemistry; Hodgkin lymphoma; Virus; Immunology; Antigen; CD8; Biology; CD34; Genetics","score_opus":0.09516810112496095,"score_gpt":0.3445380428589332,"score_spread":0.24936994173397226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010656118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044323704,0.99349487,0.0000016475515,0.00016850547,0.001130967,0.00034580484,0.000016038128,0.000009977688,0.00039981486],"genre_scores_gemma":[0.0001972141,0.9987262,0.00009433621,0.00018218365,0.00015879369,0.000023508514,0.00001699017,0.000036971138,0.0005638107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975814,0.00011147137,0.0013454809,0.0002449599,0.00040080174,0.00031584495],"domain_scores_gemma":[0.997794,0.0001490477,0.0013151135,0.00027686937,0.0001752009,0.0002897937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011270369,0.00041076978,0.0024538133,0.0002932094,0.00020473578,0.00009277229,0.00006735083,0.00024679807,0.00008128093],"category_scores_gemma":[0.00024341569,0.00020184407,0.0013789716,0.00029097177,0.000100875135,0.00012362382,0.000053676347,0.00021347973,0.000010601281],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023214041,0.00018865381,0.0010783928,0.0012207062,0.0005058223,0.3119248,0.000015152981,1.7419119e-8,5.134174e-8,0.00003327041,0.0016589388,0.683351],"study_design_scores_gemma":[0.00030713636,0.0000631908,0.00011359844,0.0018748974,0.0017713634,0.43394765,0.000018317136,1.1268847e-7,5.3583943e-7,0.00002040537,0.5617676,0.00011519328],"about_ca_topic_score_codex":0.00023464246,"about_ca_topic_score_gemma":0.000007861364,"teacher_disagreement_score":0.6832358,"about_ca_system_score_codex":0.00026836482,"about_ca_system_score_gemma":0.001027848,"threshold_uncertainty_score":0.8230962},"labels":[],"label_agreement":null},{"id":"W2010658726","doi":"10.1016/j.clml.2013.03.004","title":"Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell/Histiocyte-Rich Large B-Cell Lymphoma?","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Histiocyte; Radiology; Pathology","score_opus":0.014538373546597984,"score_gpt":0.2669038417416777,"score_spread":0.2523654681950797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010658726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97198504,0.004138135,0.0005689201,0.0012691682,0.0047340323,0.0020893728,0.00047685456,0.00084013265,0.013898321],"genre_scores_gemma":[0.977414,0.0008595835,0.004083256,0.0052666334,0.0038163615,0.00092344015,0.0015536307,0.00036926992,0.0057138125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9879473,0.0006382502,0.0036231163,0.0033747423,0.0018882934,0.002528315],"domain_scores_gemma":[0.9900052,0.0026461831,0.0013356301,0.0029387167,0.0010225812,0.0020516925],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.001225688,0.0018325115,0.0028225959,0.00042165292,0.0010051429,0.00055507984,0.0010326861,0.0010664259,0.003438047],"category_scores_gemma":[0.0013702044,0.0013014248,0.0018343304,0.00088576024,0.00087667396,0.0006650074,0.00092735805,0.0003077617,0.007858887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014758265,0.01078206,0.296185,0.00021601008,0.0007031279,0.002608725,0.0002307088,0.000010343076,0.0016089804,0.00032380325,0.05044381,0.6354116],"study_design_scores_gemma":[0.05983892,0.0005426516,0.83446413,0.00044862562,0.0011731158,0.0002853096,0.00040621415,0.0049965493,0.0091159865,0.00078617176,0.0863646,0.0015777175],"about_ca_topic_score_codex":0.0040677227,"about_ca_topic_score_gemma":0.00008139633,"teacher_disagreement_score":0.6338339,"about_ca_system_score_codex":0.008206922,"about_ca_system_score_gemma":0.0043862374,"threshold_uncertainty_score":0.999442},"labels":[],"label_agreement":null},{"id":"W2010787685","doi":"10.1259/bjr/27372198","title":"An audit of imaging test utilization for the management of lymphoma in an oncology hospital: implications for resource planning?","year":2006,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Radiology; Radiography; Audit; Referral; Asymptomatic; Lymphoma; Medical physics; Medical imaging; Nuclear medicine; Surgery; Internal medicine","score_opus":0.022606511689181923,"score_gpt":0.3282011259616807,"score_spread":0.3055946142724988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010787685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98616946,0.0061160247,0.004453288,0.0021127309,0.00009849105,0.00075314345,0.00008061097,0.0000063251687,0.00020994921],"genre_scores_gemma":[0.9947639,0.0003947016,0.004411545,0.00011333682,0.00014400236,0.000080651575,0.00006676008,0.0000129613245,0.000012101243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909675,0.00004407676,0.00052257336,0.00012359605,0.000059920807,0.00015307053],"domain_scores_gemma":[0.99877423,0.00039655506,0.00044556466,0.00013940445,0.00020135083,0.000042893564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034850105,0.000071119386,0.00033086346,0.00009839897,0.000054136184,0.0000075691146,0.0001287959,0.000054550466,0.0000033599513],"category_scores_gemma":[0.000052747608,0.00006128248,0.00009598955,0.00009055945,0.00010081913,0.00006534332,0.000010521283,0.00003147992,6.338713e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003494406,0.0033352156,0.6751976,0.00011516976,0.00019504061,0.00018116964,0.00019335415,0.0006354598,0.0007390506,0.002044341,0.012340204,0.30467397],"study_design_scores_gemma":[0.0060197194,0.0024814473,0.9789065,0.00020636381,0.0002548449,0.004070439,0.00043307958,0.00049901597,0.0003408232,0.0008678951,0.0058672205,0.000052644253],"about_ca_topic_score_codex":0.00008677124,"about_ca_topic_score_gemma":0.00003730117,"teacher_disagreement_score":0.30462134,"about_ca_system_score_codex":0.00015210692,"about_ca_system_score_gemma":0.00008521523,"threshold_uncertainty_score":0.2499027},"labels":[],"label_agreement":null},{"id":"W2011228017","doi":"10.1182/blood-2013-10-535443","title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Biology; Follicular lymphoma; Phenotype; Gene rearrangement; Cancer research; B-cell lymphoma; Fluorescence in situ hybridization; Gene; Genetics; Immunology","score_opus":0.014839297019957709,"score_gpt":0.23602139221244203,"score_spread":0.22118209519248433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011228017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928158,0.002822404,0.000005198256,0.00020619165,0.00015374113,0.0006394288,0.000012602213,0.00007440703,0.003270251],"genre_scores_gemma":[0.9976509,0.00036472254,0.0008109079,0.0004188894,0.00023956221,0.00023596267,0.00013022518,0.000034863308,0.000113939655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983578,0.000045137087,0.00034774072,0.00041224298,0.0003279859,0.00050914026],"domain_scores_gemma":[0.9991742,0.0000666592,0.00014126406,0.00033928733,0.00005244989,0.00022615299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031080836,0.00023876339,0.00041662922,0.0001441088,0.00006812565,0.000031599116,0.00010904146,0.00009747991,0.000026361124],"category_scores_gemma":[0.00007115724,0.00019881169,0.000110884765,0.00016263158,0.00002194393,0.000051741303,0.00009668457,0.0000794961,0.00008050906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011810804,0.014507646,0.9615725,0.00022751429,0.000090240734,0.00024527934,0.00030993955,1.3780517e-7,0.0014466306,0.000045840065,0.0002718642,0.02116428],"study_design_scores_gemma":[0.03797961,0.00066676177,0.94958663,0.00044235584,0.00030030988,0.000049701262,0.00007766557,0.000050928185,0.0067106467,0.00002884632,0.003910688,0.00019584094],"about_ca_topic_score_codex":0.000052256742,"about_ca_topic_score_gemma":0.00007205328,"teacher_disagreement_score":0.037861504,"about_ca_system_score_codex":0.0002694791,"about_ca_system_score_gemma":0.0001236621,"threshold_uncertainty_score":0.8107305},"labels":[],"label_agreement":null},{"id":"W2011306323","doi":"10.1016/j.transci.2013.05.029","title":"Relapsed and refractory aggressive NHL: Time for a change","year":2013,"lang":"en","type":"review","venue":"Transfusion and Apheresis Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Salvage therapy; Lymphoma; Disease; Chemotherapy; Autologous stem-cell transplantation; Standard of care; Internal medicine; Transplantation; Aggressive lymphoma; Intensive care medicine; Rituximab; Biology","score_opus":0.07898060678497817,"score_gpt":0.35510350605013236,"score_spread":0.2761228992651542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011306323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025314465,0.9936818,0.000002607519,0.0002118136,0.00008773926,0.00264772,0.000048732145,0.00003632125,0.000751841],"genre_scores_gemma":[0.00016873411,0.9973551,0.0004441232,0.00015053865,0.00008682344,0.0007576844,0.000019107814,0.000024509938,0.0009933991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984386,0.000033080454,0.00027882712,0.00065351604,0.0002888714,0.0003070988],"domain_scores_gemma":[0.9989501,0.00020390806,0.00017800825,0.00026598704,0.000080137914,0.00032183732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022269347,0.00031196765,0.00097448844,0.00017429583,0.00028299942,0.00007409046,0.000114127615,0.00017463295,0.00024171533],"category_scores_gemma":[0.00006402403,0.00018959034,0.00018567932,0.0003014992,0.00040897884,0.00015551802,0.000039604594,0.00009796411,0.000047589012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001640601,0.00012679756,0.000016104,0.0031547877,0.000029468343,0.000015707199,0.0001419647,7.7944784e-10,0.00006934747,0.000051881783,0.00062394224,0.9957536],"study_design_scores_gemma":[0.0016072432,0.00057864096,0.0005293322,0.01350003,0.0009802709,0.00014603768,0.000031720945,0.00001737566,0.00003887656,0.000022259659,0.98226064,0.0002875753],"about_ca_topic_score_codex":0.0000843052,"about_ca_topic_score_gemma":0.000007681325,"teacher_disagreement_score":0.995466,"about_ca_system_score_codex":0.00007774944,"about_ca_system_score_gemma":0.00023104531,"threshold_uncertainty_score":0.77312696},"labels":[],"label_agreement":null},{"id":"W2011629215","doi":"10.3109/10428190009087023","title":"A Comparison of Elderly Patients with Aggressive Histology Lymphoma who Were Entered or Not Entered on to a Randomized Phase II Trial","year":2000,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Randomized controlled trial; Medicine; Internal medicine; Randomization; Surgery","score_opus":0.01806251221639087,"score_gpt":0.3000154975304829,"score_spread":0.281952985314092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011629215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892115,0.00080130476,0.000022694121,0.00041491934,0.00049328065,0.0055892733,0.00031605875,0.0002229264,0.0029280277],"genre_scores_gemma":[0.9910898,0.00040877733,0.00054225104,0.00230289,0.0003015063,0.0012618093,0.0004570279,0.00017698435,0.0034589157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99249476,0.0005305723,0.0023431568,0.0018424368,0.0014020769,0.0013870173],"domain_scores_gemma":[0.9946231,0.0010169767,0.0013555442,0.0014567104,0.00038918728,0.0011584745],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000395426,0.0014723501,0.0047312276,0.0006970773,0.0005777506,0.00011654708,0.0005290267,0.0007004594,0.0008796859],"category_scores_gemma":[0.00038187837,0.0010162079,0.0008208101,0.0006909255,0.00079548743,0.00027210743,0.00019982042,0.00014032905,0.00013260257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62836754,0.008446223,0.0024419625,0.00014345147,0.0011523734,0.0005989427,0.002370615,0.000017301873,0.000097265576,0.00013238001,0.0039324327,0.35229954],"study_design_scores_gemma":[0.9099479,0.038470875,0.021278081,0.0017049911,0.0017018286,0.00040632614,0.00026926995,0.00085190684,0.005944847,0.000026062526,0.018343808,0.0010541222],"about_ca_topic_score_codex":0.0012941938,"about_ca_topic_score_gemma":0.00013881612,"teacher_disagreement_score":0.3512454,"about_ca_system_score_codex":0.00670095,"about_ca_system_score_gemma":0.0030428665,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W2012098025","doi":"10.3109/10428194.2010.546015","title":"A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172)","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Alberta Cancer Foundation; University Health Network; Queen Elizabeth II Health Sciences Centre; Juravinski Hospital","funders":"National Cancer Institute","keywords":"Gemcitabine; Bortezomib; Mantle cell lymphoma; Medicine; Internal medicine; Oncology; Adverse effect; Chemotherapy; Refractory (planetary science); Phases of clinical research; Lymphoma; Multiple myeloma","score_opus":0.07482145748558373,"score_gpt":0.33985409406348344,"score_spread":0.2650326365778997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012098025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074095,0.003886436,0.0000042610973,0.00016198315,0.00070559786,0.0018306371,0.00047530993,0.000036146306,0.0021587],"genre_scores_gemma":[0.9963504,0.00136068,0.00029578173,0.0008445946,0.00034040253,0.00034976043,0.00011332205,0.00006645341,0.0002785814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367315,0.000615981,0.0028064908,0.0011135611,0.0011155411,0.000675291],"domain_scores_gemma":[0.99591684,0.0013448305,0.0012113615,0.00073039386,0.0003007128,0.00049583724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021215987,0.0007134531,0.0022890335,0.00025089242,0.00031243605,0.00003345714,0.0003958075,0.00041936256,0.00012806128],"category_scores_gemma":[0.0005944296,0.0005089969,0.00031131518,0.00058345357,0.0005210735,0.0002205011,0.00032980563,0.00013195384,0.0000025850218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015231115,0.028285516,0.581189,0.00039199716,0.0030329206,0.0013714087,0.0111953635,0.000025102592,0.0021359876,0.0010901979,0.012058553,0.34399286],"study_design_scores_gemma":[0.17922735,0.0039493167,0.80179405,0.00043958382,0.0011404909,0.00011133193,0.0019769662,0.0008691282,0.0041893553,0.00027317883,0.005492006,0.00053722603],"about_ca_topic_score_codex":0.6153727,"about_ca_topic_score_gemma":0.22532701,"teacher_disagreement_score":0.39004567,"about_ca_system_score_codex":0.0044094697,"about_ca_system_score_gemma":0.010826242,"threshold_uncertainty_score":0.9997362},"labels":[],"label_agreement":null},{"id":"W2012284254","doi":"10.1038/bmt.2009.241","title":"Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantation","year":2009,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Canadian Blood Services; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Autologous stem-cell transplantation; Transplantation; Oncology; Internal medicine; Lymphoma; Monoclonal; Immunology; Stem cell; Log-rank test; Somatic evolution in cancer; Gastroenterology; Monoclonal antibody; Confidence interval; Survival analysis; Antibody; Cancer; Biology","score_opus":0.006896191897896627,"score_gpt":0.23184951363066347,"score_spread":0.22495332173276686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012284254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982262,0.00008306092,0.0001808815,0.000250256,0.00012791606,0.0006365141,0.00024734178,0.00008152077,0.0001663123],"genre_scores_gemma":[0.99717075,0.0002035295,0.000816718,0.00011348848,0.00003559782,0.000035606474,0.0015873001,0.000024795072,0.000012215654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982946,0.0001153108,0.000366161,0.0004667777,0.0004403278,0.00031682436],"domain_scores_gemma":[0.9993319,0.00021263667,0.000092755974,0.00015477807,0.00003714197,0.00017081601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009726833,0.0003270588,0.00044933826,0.00020131932,0.00008021548,0.00003495614,0.000040606676,0.00017363986,0.00001374271],"category_scores_gemma":[0.000006906169,0.0002442502,0.000114289614,0.00022703022,0.00003219949,0.00016851106,0.0000019001969,0.000108662425,0.0000076032206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019911204,0.002846248,0.9157153,0.00009556715,0.00027112322,0.003457494,0.0018680805,0.00021969031,0.01530023,0.000058066056,0.000038176688,0.040218845],"study_design_scores_gemma":[0.022888098,0.0020073017,0.963878,0.0003402635,0.00052702444,0.000040955096,0.000021028847,0.00032699027,0.009640241,0.0000757546,0.0000051262086,0.00024923286],"about_ca_topic_score_codex":0.00047704845,"about_ca_topic_score_gemma":0.0003664612,"teacher_disagreement_score":0.048162706,"about_ca_system_score_codex":0.0002444348,"about_ca_system_score_gemma":0.00009249072,"threshold_uncertainty_score":0.9960235},"labels":[],"label_agreement":null},{"id":"W2012308231","doi":"10.1054/bjoc.2001.1822","title":"A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Follicular lymphoma; Medicine; Randomized controlled trial; Maintenance therapy; Chlorambucil; Follicular phase; Internal medicine; Lymphoma; Interferon alfa; Gastroenterology; Alpha interferon; Chemotherapy; Interferon; Surgery; Immunology; Cyclophosphamide","score_opus":0.008052774753800444,"score_gpt":0.28113286387969433,"score_spread":0.2730800891258939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012308231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851199,0.011470791,0.0000044678163,0.0005209024,0.00012975918,0.0023793275,0.00000388355,0.000001991888,0.00036901495],"genre_scores_gemma":[0.9932191,0.005814128,0.000025981743,0.0004958154,0.00012946864,0.0002689869,8.5674355e-7,0.000011873471,0.00003379809],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854726,0.00020693436,0.0005738412,0.00010662459,0.00041498814,0.00015035132],"domain_scores_gemma":[0.9990336,0.000165389,0.00027700033,0.00007923725,0.000354183,0.00009063872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006560361,0.00011386928,0.0010616166,0.000073813084,0.000028092581,0.000030266818,0.00006502504,0.00003569338,0.000083173705],"category_scores_gemma":[0.00019382044,0.000061183586,0.00020569927,0.00010153446,0.00007446182,0.00006334644,0.000012384411,0.000059361595,5.940698e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8195851,0.0006082727,0.013076316,0.0000025860213,0.0005933145,0.0001705559,0.00016660789,0.000008382261,0.000016167018,0.000010282431,0.000041977986,0.16572048],"study_design_scores_gemma":[0.92066026,0.0033921255,0.0734407,0.0008727382,0.0003003274,0.0002680761,0.000060262522,0.000018648929,0.00027938938,0.00010561135,0.000540026,0.000061810686],"about_ca_topic_score_codex":0.0009750024,"about_ca_topic_score_gemma":0.00022375131,"teacher_disagreement_score":0.16565867,"about_ca_system_score_codex":0.00013042559,"about_ca_system_score_gemma":0.00022302165,"threshold_uncertainty_score":0.24949943},"labels":[],"label_agreement":null},{"id":"W2013140316","doi":"10.1369/0022155411417309","title":"Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas","year":2011,"lang":"en","type":"article","venue":"Journal of Histochemistry & Cytochemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"BCL6; Comparative genomic hybridization; NODAL; Biology; Lymphoma; Diffuse large B-cell lymphoma; Chromosome; Phenotype; Copy-number variation; Karyotype; Pathology; Genetics; Genome; Cancer research; B cell; Gene; Antibody; Medicine; Immunology; Germinal center","score_opus":0.02117940212775364,"score_gpt":0.22941535331685134,"score_spread":0.2082359511890977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013140316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863037,0.0075571304,0.000067203815,0.000105324616,0.0000542807,0.00013857885,0.000036873367,0.000024846619,0.005712104],"genre_scores_gemma":[0.9966429,0.00040168755,0.001675626,0.00007896478,0.00040893117,0.000011994489,0.00001625777,0.000032377102,0.0007312547],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981103,0.000019534815,0.0006828352,0.00038205137,0.0004039743,0.00040133615],"domain_scores_gemma":[0.9983118,0.000091452144,0.000491287,0.00032819284,0.00017693218,0.0006003111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017138268,0.000387616,0.0007599135,0.00006298525,0.00014297005,0.00003350911,0.000181234,0.0002732315,0.00021527719],"category_scores_gemma":[0.00005961047,0.00031515033,0.00020827846,0.000088420165,0.0002492927,0.00010516082,0.00009482577,0.00031141753,0.000004310639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080933125,0.0036135511,0.65848863,0.0009546342,0.00048786608,0.0008167803,0.0011885423,3.225315e-8,0.32913294,0.000023052375,0.00085786544,0.0036267303],"study_design_scores_gemma":[0.019634865,0.00056581065,0.38581586,0.00040957314,0.0013023491,0.0025536008,0.0005443722,0.000007701492,0.5872687,0.00027737522,0.0011118646,0.00050793536],"about_ca_topic_score_codex":0.000014902671,"about_ca_topic_score_gemma":5.619046e-7,"teacher_disagreement_score":0.2726728,"about_ca_system_score_codex":0.0002455846,"about_ca_system_score_gemma":0.00026414546,"threshold_uncertainty_score":0.9999301},"labels":[],"label_agreement":null},{"id":"W2013404890","doi":"10.1259/bjr.20140360","title":"Impact of<sup>18</sup>F-FDG PET/CT on the staging and management of follicular lymphoma","year":2014,"lang":"en","type":"review","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Positron emission tomography; Lymphoma; Radiation therapy; Stage (stratigraphy); Radiology; Nuclear medicine; Internal medicine","score_opus":0.02839675414657091,"score_gpt":0.3214366135531398,"score_spread":0.2930398594065689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013404890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09474843,0.9038411,0.000007554257,0.00006662305,0.00009642166,0.00059248327,0.000051620074,0.000004378954,0.00059141306],"genre_scores_gemma":[0.04546972,0.95398265,0.00019031775,0.000051412295,0.0001714453,0.000023312332,0.00002009442,0.00003773489,0.00005333764],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99755996,0.0004384199,0.0011462428,0.00025479725,0.00030291243,0.0002976703],"domain_scores_gemma":[0.9976261,0.0005049582,0.0012469903,0.00033455447,0.00012493093,0.00016245845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007970658,0.0003397044,0.0029120229,0.00022238109,0.000059045033,0.000022058624,0.0002430043,0.000058249698,0.000106618565],"category_scores_gemma":[0.00009611914,0.00021229238,0.0013312115,0.00014884282,0.00018979952,0.000033943914,0.00006900706,0.0002013739,0.00000438685],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006282102,0.0004465371,0.0016845412,0.005473271,0.006157243,0.018890671,0.0000152201355,0.000013198764,2.1540966e-7,0.00028873977,0.008415344,0.9585522],"study_design_scores_gemma":[0.005637707,0.0031484761,0.023646696,0.06268848,0.0072047994,0.59320986,0.00005674593,0.000018156185,0.000003130486,0.0000695265,0.30401686,0.0002995198],"about_ca_topic_score_codex":0.00010936467,"about_ca_topic_score_gemma":0.0000010268184,"teacher_disagreement_score":0.95825267,"about_ca_system_score_codex":0.000329915,"about_ca_system_score_gemma":0.00024392355,"threshold_uncertainty_score":0.86570317},"labels":[],"label_agreement":null},{"id":"W2013464763","doi":"10.3747/co.v18i2.735","title":"Rare Synchronous Primary Large B-cell Gastric Lymphoma and Huge Retroperitoneal Liposarcoma with Inguinal Hernia in Chronic Hepatitis B Patient","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Inguinal hernia; Radiology; Malignancy; Gastrectomy; Lymphoma; Inguinal canal; Hernia; Pathology; Internal medicine; Cancer","score_opus":0.029571759024292963,"score_gpt":0.28138530419075636,"score_spread":0.25181354516646337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013464763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027265,0.015195467,0.000014067156,0.00006979874,0.0003204058,0.00067440135,0.000035735757,0.000046771256,0.0033707258],"genre_scores_gemma":[0.99645656,0.0022333772,0.00063129805,0.00014159609,0.0001592105,0.0002171365,0.00010681534,0.00003110283,0.000022901631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982902,0.00011306936,0.00036694607,0.00047613357,0.00021300394,0.00054067944],"domain_scores_gemma":[0.99920887,0.00004770857,0.00015267475,0.00027862206,0.000077610166,0.00023450197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091213326,0.00028063878,0.00056641805,0.00018391997,0.000080400365,0.0000114782615,0.00008365501,0.00013474931,0.00014831669],"category_scores_gemma":[0.000014624031,0.00021393377,0.00006327767,0.00020317029,0.00012801339,0.000071967486,0.000126768,0.00016152361,0.000043400007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005188082,0.005964589,0.7840772,0.00021726183,0.00004268009,0.0016854625,0.00096124376,2.1119054e-7,0.00006893826,0.000039248545,0.00037697298,0.20604737],"study_design_scores_gemma":[0.01644065,0.012474612,0.9403453,0.00031372023,0.00015594675,0.0008835976,0.0000822937,0.00009000722,0.00050544535,0.00000835745,0.028471058,0.0002290416],"about_ca_topic_score_codex":0.00046870176,"about_ca_topic_score_gemma":0.0010355854,"teacher_disagreement_score":0.20581833,"about_ca_system_score_codex":0.0027666441,"about_ca_system_score_gemma":0.00090484053,"threshold_uncertainty_score":0.8723966},"labels":[],"label_agreement":null},{"id":"W2013510245","doi":"10.1016/j.bbmt.2006.12.152","title":"148: Salvage and disease control of aggressive histology non-Hodgkin’s lymphoma by allogeneic stem cell transplantation","year":2007,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Transplantation; Internal medicine; Cyclophosphamide; Lymphoma; Autologous stem-cell transplantation; Rituximab; Surgery; Aggressive lymphoma; Ibritumomab tiuxetan; Gastroenterology; Salvage therapy; Non-Hodgkin's lymphoma; Alemtuzumab; Biopsy; Oncology; Chemotherapy; Radioimmunotherapy; Immunology","score_opus":0.005072792528464511,"score_gpt":0.22365871392508327,"score_spread":0.21858592139661875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013510245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869485,0.009696019,0.0020376658,0.00018519549,0.000070922215,0.00040722828,0.00049841555,0.000013894611,0.00014218256],"genre_scores_gemma":[0.9902895,0.008767325,0.00022419158,0.0001612466,0.000019870968,0.000023422597,0.00047982368,0.000010738477,0.000023871886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990365,0.000058122998,0.00036737305,0.0002685751,0.00008201262,0.0001874549],"domain_scores_gemma":[0.99915355,0.00020175392,0.0003228827,0.00009573219,0.000053075608,0.00017299177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013940292,0.00016786277,0.00039216792,0.00011363553,0.000044688655,0.0000022771737,0.00003436718,0.00015499757,0.0000075716675],"category_scores_gemma":[0.0000051700836,0.00013940583,0.00006645439,0.00004987149,0.00021165829,0.00004026613,0.0000027261458,0.00003111451,6.172112e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033279746,0.00065259944,0.43770912,0.0010283425,0.00026382843,0.00028948826,0.0007598776,7.514752e-7,0.53593796,0.00023414682,0.000033205673,0.019762702],"study_design_scores_gemma":[0.020158261,0.001511875,0.6252429,0.00019776942,0.003216828,0.00031280806,0.00009230484,0.000014857577,0.3489072,0.000085062675,0.00008226166,0.00017786113],"about_ca_topic_score_codex":0.00010342091,"about_ca_topic_score_gemma":0.00003480104,"teacher_disagreement_score":0.18753378,"about_ca_system_score_codex":0.000013931811,"about_ca_system_score_gemma":0.0000627631,"threshold_uncertainty_score":0.5684805},"labels":[],"label_agreement":null},{"id":"W2014255239","doi":"10.1007/s11899-009-0030-5","title":"Update on the World Health Organization classification of peripheral T-cell lymphomas","year":2009,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoproliferative disorders; Hematology; Medicine; Phenotype; Pathology; Not Otherwise Specified; Oncology; Peripheral T-cell lymphoma; Internal medicine; T cell; Immunology; Biology; Gene; Genetics; Immune system","score_opus":0.07503516850817778,"score_gpt":0.35915129264967016,"score_spread":0.2841161241414924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014255239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026256128,0.99271125,0.000014444382,0.00083110906,0.0006467903,0.0025524623,0.000017343558,0.00010566097,0.00285839],"genre_scores_gemma":[0.009789083,0.98807436,0.000087565684,0.00017736638,0.00010123032,0.00023553002,0.0010855293,0.00005174712,0.00039758874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611807,0.0002515693,0.0019304341,0.0007883079,0.00052212016,0.0003894875],"domain_scores_gemma":[0.9952505,0.00015519848,0.0029725062,0.0012408657,0.00021120317,0.0001696922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000410666,0.00060992857,0.0024614045,0.00023928605,0.00015510798,0.00003336428,0.00016206832,0.00020110226,0.00037076065],"category_scores_gemma":[0.00017315945,0.00033544996,0.00053419464,0.0009565551,0.000078918674,0.000038776067,0.00005078131,0.00022222323,0.00006313045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008972374,0.0030132036,0.0038487636,0.022423837,0.00015868606,0.00053548464,0.00004872501,3.0290119e-7,7.4268627e-7,0.014095834,0.026956728,0.9289087],"study_design_scores_gemma":[0.00038302183,0.00021410127,0.00088204106,0.030165065,0.00081753737,0.0019892722,0.000010483558,0.0000019006229,0.00009650151,0.0002648614,0.9648575,0.00031767073],"about_ca_topic_score_codex":0.0000054951447,"about_ca_topic_score_gemma":0.0000028031063,"teacher_disagreement_score":0.93790084,"about_ca_system_score_codex":0.0006900836,"about_ca_system_score_gemma":0.001195289,"threshold_uncertainty_score":0.99990976},"labels":[],"label_agreement":null},{"id":"W2014488544","doi":"10.1080/10428190290016890","title":"Cytogenetic Analysis in Mantle Cell Lymphoma: A Review of 214 Cases","year":2002,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Mantle cell lymphoma; Lymphoma; Mantle (geology); Cancer research; Ibrutinib; Medicine; Pathology; Internal medicine; Geology; Leukemia; Chronic lymphocytic leukemia; Geochemistry","score_opus":0.030705201939201874,"score_gpt":0.29829572606515825,"score_spread":0.26759052412595635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014488544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011747343,0.97691536,0.000004478912,0.00004812541,0.0002699821,0.0030884857,0.00047395576,0.00016275558,0.007289499],"genre_scores_gemma":[0.009685474,0.9838109,0.0004240999,0.0008450103,0.00028439844,0.001086488,0.001197342,0.0003145172,0.0023517513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98938054,0.0006530516,0.004127579,0.002649933,0.0014660405,0.0017228558],"domain_scores_gemma":[0.9926405,0.0011942978,0.0020666653,0.0027651978,0.00030794536,0.001025386],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00073542463,0.0025300316,0.01104892,0.002472298,0.0002341282,0.000116575575,0.00084152207,0.0015552945,0.0005668185],"category_scores_gemma":[0.00026068537,0.002069914,0.0038800854,0.0051586493,0.00051182293,0.00021870816,0.0005145783,0.00020110796,0.00027080925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009692195,0.0017695565,0.0013485196,0.13169779,0.00304853,0.0049884915,0.00011939425,0.0000028620614,0.000002050181,0.00006347195,0.0041258424,0.8527366],"study_design_scores_gemma":[0.016568508,0.00069524575,0.0048132883,0.118470855,0.042491544,0.005621288,0.00007006655,0.00020127055,0.00010299015,0.000015382786,0.8089725,0.001977071],"about_ca_topic_score_codex":0.0027629316,"about_ca_topic_score_gemma":0.00019904166,"teacher_disagreement_score":0.8507595,"about_ca_system_score_codex":0.016019426,"about_ca_system_score_gemma":0.007038617,"threshold_uncertainty_score":0.9997409},"labels":[],"label_agreement":null},{"id":"W2014504782","doi":"10.1093/annonc/mdt482","title":"The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Diffuse large B-cell lymphoma; Chemotherapy; Surgery; Retrospective cohort study; Gastroenterology; Adverse effect; Anthracycline; Lymphoma; Chemotherapy regimen; Cancer","score_opus":0.014917543905354658,"score_gpt":0.3113641136041908,"score_spread":0.29644656969883615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014504782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583834,0.001335373,5.216549e-7,0.0009899717,0.000058434212,0.0013462866,0.000011251756,0.0000028430127,0.00041699756],"genre_scores_gemma":[0.998202,0.0009722763,0.0002233116,0.0004275185,0.000008580942,0.000100637706,0.0000055249466,0.0000068233844,0.000053297732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987827,0.00022390576,0.0004633892,0.00016038155,0.00018631794,0.00018329722],"domain_scores_gemma":[0.99814105,0.0010140651,0.00038305315,0.0002608861,0.0001527799,0.00004813716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002196146,0.00011863133,0.0005181842,0.00003992278,0.000024958576,0.0000026976204,0.000092671966,0.000117214215,0.000005046125],"category_scores_gemma":[0.0002984091,0.000050366652,0.00009633264,0.00007769,0.00037737357,0.000030195648,0.00013407628,0.00006404913,6.4397636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011502499,0.02056057,0.95067984,0.00030455564,0.00016940564,0.000038462338,0.00032983004,2.5882656e-7,0.000057849407,0.0001462217,0.0010884999,0.025474261],"study_design_scores_gemma":[0.018456979,0.005818515,0.9705527,0.00026382567,0.000146768,0.0000047762405,0.00012744169,0.0000027388446,0.003763633,0.00008078738,0.00073993363,0.000041940137],"about_ca_topic_score_codex":0.000062905245,"about_ca_topic_score_gemma":0.000060587325,"teacher_disagreement_score":0.02543232,"about_ca_system_score_codex":0.000013091307,"about_ca_system_score_gemma":0.000036894267,"threshold_uncertainty_score":0.20538925},"labels":[],"label_agreement":null},{"id":"W2014768746","doi":"10.1007/s00330-004-2432-z","title":"Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children","year":2004,"lang":"en","type":"article","venue":"European Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neuroradiology; Radiology; Bone marrow; Whole body imaging; Lymphoma; Biopsy; Scintigraphy; Stage (stratigraphy); Nuclear medicine; Bone scintigraphy; Magnetic resonance imaging; Pathology","score_opus":0.011317666665179318,"score_gpt":0.27053606277901265,"score_spread":0.25921839611383335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014768746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954421,0.00034930703,0.0005396507,0.00085418613,0.000106458,0.0005351071,0.000016010265,0.00007237871,0.0020848175],"genre_scores_gemma":[0.9971193,0.000025061008,0.0012532998,0.001051432,0.00029380023,0.00006846972,0.00009598704,0.00004282014,0.00004983406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988032,0.00008860347,0.0002417337,0.00040356812,0.000090232184,0.0003726903],"domain_scores_gemma":[0.9994676,0.000051788713,0.00006869421,0.00026372867,0.00003383886,0.000114328315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014359222,0.00018859976,0.0002890664,0.00012558138,0.00007974492,0.000018031056,0.00010640711,0.000023644352,0.000014540097],"category_scores_gemma":[0.00004681113,0.0001432581,0.000055952274,0.00011357664,0.00015259872,0.000081702114,0.000041615243,0.000055042536,0.000047028087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044998474,0.0005604908,0.9770449,0.000013270916,0.00009154092,0.0017615749,0.0020119762,0.00012696665,0.0014664525,0.0007629306,0.00022600596,0.015483913],"study_design_scores_gemma":[0.016908038,0.00064332824,0.9757224,0.000114819944,0.000049995146,0.0019239334,0.00023107954,0.000033622462,0.002448512,0.000035495643,0.0017052988,0.00018347905],"about_ca_topic_score_codex":0.000083210485,"about_ca_topic_score_gemma":0.0000050870253,"teacher_disagreement_score":0.016458053,"about_ca_system_score_codex":0.00023204669,"about_ca_system_score_gemma":0.00010506458,"threshold_uncertainty_score":0.5841896},"labels":[],"label_agreement":null},{"id":"W2015410907","doi":"10.1038/ng.3105","title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma","year":2014,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; World Health Organization; National Human Genome Research Institute; National Center for Advancing Translational Sciences; Purdue University","keywords":"Genome-wide association study; Biology; Diffuse large B-cell lymphoma; Single-nucleotide polymorphism; Genetics; Genetic association; Genotyping; Lymphoma; Genetic predisposition; Genotype; Gene; Immunology","score_opus":0.019576049258113758,"score_gpt":0.31674865271119484,"score_spread":0.2971726034530811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015410907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04079682,0.9514739,0.000029302337,0.000044004075,0.00086434965,0.006029048,0.00056429213,0.00008229466,0.00011600327],"genre_scores_gemma":[0.07863515,0.91496336,0.0003519429,0.00025217,0.0008861585,0.0007158908,0.0020496312,0.00012763299,0.0020180773],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966046,0.00023656004,0.00090601825,0.00094739604,0.00068513624,0.0006202546],"domain_scores_gemma":[0.99597514,0.0015094422,0.00076581433,0.0011028991,0.00042965866,0.00021701973],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007659925,0.0006931224,0.002350089,0.0001730594,0.00019180342,0.00009874677,0.00028965683,0.0015261405,0.00002578355],"category_scores_gemma":[0.0012190879,0.00053054595,0.001050887,0.00024467518,0.000022948087,0.000026804926,0.00015828203,0.00039367337,0.00010793793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001144078,0.045268513,0.5796605,0.0414414,0.0035586497,0.00009055074,0.00065846555,7.939905e-7,0.0000027288404,0.000004652287,0.022848077,0.30635127],"study_design_scores_gemma":[0.011875137,0.0005688703,0.06648834,0.0006132414,0.0061292956,0.0000029153164,0.000061888895,0.000006859546,0.00002481092,0.000014159495,0.91379666,0.00041778988],"about_ca_topic_score_codex":0.000011186996,"about_ca_topic_score_gemma":0.00023599173,"teacher_disagreement_score":0.8909486,"about_ca_system_score_codex":0.0019456164,"about_ca_system_score_gemma":0.0003863751,"threshold_uncertainty_score":0.9997701},"labels":[],"label_agreement":null},{"id":"W2016307324","doi":"10.1155/2012/735392","title":"HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era","year":2011,"lang":"en","type":"article","venue":"Advances in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Human immunodeficiency virus (HIV); Oncology; Internal medicine; Virology","score_opus":0.029946467811718187,"score_gpt":0.3035487556377703,"score_spread":0.2736022878260521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016307324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919995,0.0050888434,0.000027003945,0.0008757056,0.00006131652,0.0006682438,0.0000048852935,0.000023432722,0.0012510525],"genre_scores_gemma":[0.99553525,0.0016019661,0.0014506276,0.0012174797,0.000013750929,0.00013156999,0.000007886001,0.000020546604,0.00002092662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868214,0.00009573231,0.000410361,0.00034130906,0.00015871272,0.00031177298],"domain_scores_gemma":[0.9988233,0.0004799204,0.00021855546,0.00028407614,0.00014713114,0.00004704716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016876996,0.00022369558,0.00088018517,0.00011803347,0.00004539183,0.000004982743,0.0001281074,0.00010761072,0.000022659327],"category_scores_gemma":[0.00021851511,0.00012735878,0.000036558737,0.00032629614,0.0002872822,0.00012982625,0.000039800878,0.00010797654,0.0000040571013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023556324,0.0027071068,0.97908133,0.00010603023,0.00009460077,0.0005090226,0.0066794953,0.0000020249436,0.000034173965,0.0019902973,0.00004573652,0.0063945763],"study_design_scores_gemma":[0.083981715,0.0029570097,0.8868488,0.002109041,0.00019001542,0.002479005,0.0055166935,0.00028754168,0.012663906,0.0010899242,0.0014398064,0.00043650874],"about_ca_topic_score_codex":0.00017248845,"about_ca_topic_score_gemma":0.0006059914,"teacher_disagreement_score":0.092232466,"about_ca_system_score_codex":0.00009646271,"about_ca_system_score_gemma":0.00008591097,"threshold_uncertainty_score":0.51935405},"labels":[],"label_agreement":null},{"id":"W2016487786","doi":"10.1038/leu.2011.266","title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Follicular lymphoma; Lymphoma; Biology; Cancer research; Gene; Hematology; Immunology; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.016547806026892365,"score_gpt":0.2576666314970746,"score_spread":0.2411188254701822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016487786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372517,0.0003291109,0.0000063972766,0.06074977,0.00011893629,0.0010905669,0.000053279615,0.000041533902,0.00035872473],"genre_scores_gemma":[0.89575493,0.00035849158,0.0006827316,0.10092492,0.00036467853,0.00041193626,0.0005567561,0.000084207866,0.0008613377],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99820167,0.00012501595,0.00050354825,0.0005402048,0.0002025919,0.0004269874],"domain_scores_gemma":[0.99888796,0.0001299907,0.00020260472,0.00053069205,0.00008391099,0.0001648736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013885925,0.00042234105,0.0007692049,0.00041597665,0.000047054476,0.000026000782,0.00010232208,0.0006781492,0.00004766032],"category_scores_gemma":[0.000059834023,0.0003164601,0.00021612244,0.0003176371,0.000049825485,0.000050046565,0.000044964854,0.00028760804,0.00004514211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009217446,0.0010409905,0.18330905,0.00051488687,0.0016648853,0.017071871,0.0016247787,0.00018828349,0.0015603363,0.00034447593,0.7812186,0.010540143],"study_design_scores_gemma":[0.016071841,0.0036399115,0.89035416,0.0029677679,0.0013276144,0.001290036,0.000018390492,0.00013793836,0.04333058,0.00073580735,0.039234914,0.00089106074],"about_ca_topic_score_codex":0.0029307024,"about_ca_topic_score_gemma":0.000042744614,"teacher_disagreement_score":0.74198365,"about_ca_system_score_codex":0.0023167846,"about_ca_system_score_gemma":0.0005861089,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2016548691","doi":"10.1182/blood.v97.12.3902","title":"MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"MCL1; Lymphoma; Transgene; Carcinogenesis; Biology; Cancer research; Follicular lymphoma; Genetically modified mouse; Cancer; Immunology; Gene; Genetics; Downregulation and upregulation","score_opus":0.010035937456847643,"score_gpt":0.22788017044847092,"score_spread":0.21784423299162328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016548691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914423,0.0027558848,0.0000040612767,0.0003766347,0.00007092167,0.00033862976,0.000012175553,0.000039882525,0.004959482],"genre_scores_gemma":[0.99807703,0.00057542196,0.0004762165,0.00013274432,0.000052012234,0.000026689986,0.000014999276,0.000018051403,0.000626856],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987743,0.000037555776,0.00038622675,0.00028296397,0.00027137564,0.00024759438],"domain_scores_gemma":[0.9992001,0.00009913959,0.00017848084,0.00034848248,0.00006663869,0.000107145584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008132731,0.00018235896,0.00047608785,0.00011100085,0.000028941195,0.0000038556473,0.000121764475,0.00010685137,0.00027200207],"category_scores_gemma":[0.000032772525,0.00014717849,0.00017453363,0.00025095366,0.00008658481,0.000042256186,0.000023613038,0.00003803202,0.000077233475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012119528,0.03291239,0.7921804,0.0006627082,0.0007598512,0.002585572,0.0009714475,0.0000039440833,0.16399774,0.0018983668,0.0003148069,0.0025008232],"study_design_scores_gemma":[0.015151463,0.001791251,0.3784858,0.00017473818,0.0010137614,0.0008673107,0.000074499876,0.000005089574,0.60160303,0.00027356204,0.00041104507,0.0001484533],"about_ca_topic_score_codex":0.0014823503,"about_ca_topic_score_gemma":0.0001210809,"teacher_disagreement_score":0.4376053,"about_ca_system_score_codex":0.00008080601,"about_ca_system_score_gemma":0.00018451145,"threshold_uncertainty_score":0.60017645},"labels":[],"label_agreement":null},{"id":"W2016783244","doi":"10.1182/blood-2013-11-536359","title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":540,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; China Scholarship Council; Center for Clinical and Translational Research; University of Nebraska Medical Center; Lymphoma Research Foundation","keywords":"Lymphoma; Gene expression; Peripheral T-cell lymphoma; Biology; Gene expression profiling; Cancer research; Medicine; Gene; Pathology; Immunology; T cell; Genetics; Immune system","score_opus":0.011833157775561378,"score_gpt":0.22987988305863277,"score_spread":0.2180467252830714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016783244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959567,0.0030134022,0.000019377338,0.00013301152,0.00003670892,0.00028819355,0.0000036305264,0.000030936542,0.0005179977],"genre_scores_gemma":[0.9970676,0.00025547436,0.002180965,0.00021854643,0.00012193227,0.00006583029,0.00003613515,0.000011723305,0.000041803887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991601,0.000057378584,0.00017214991,0.0002878674,0.00010924313,0.00021324883],"domain_scores_gemma":[0.9995778,0.00009322363,0.000036045592,0.00015009129,0.000024657087,0.000118191005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092769784,0.0001489999,0.00023767904,0.000046591435,0.000040340594,0.000017266202,0.000040489755,0.00012551682,0.000036333022],"category_scores_gemma":[0.00007455101,0.000095329895,0.00004602126,0.000065425906,0.000040266383,0.00002646148,0.00004290147,0.00004451887,0.00001146356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103778584,0.0034410504,0.9064849,0.000029039742,0.000021002108,0.000194851,0.00010274503,0.0000028732156,0.081403874,0.000020025735,0.000057211502,0.008138667],"study_design_scores_gemma":[0.014821384,0.00086233753,0.76526934,0.000099331504,0.000088741726,0.00008823538,0.000024177933,0.00018930902,0.21788076,0.000064010885,0.00047139768,0.00014094428],"about_ca_topic_score_codex":0.000021889815,"about_ca_topic_score_gemma":0.000005971361,"teacher_disagreement_score":0.14121552,"about_ca_system_score_codex":0.000025324125,"about_ca_system_score_gemma":0.000022901855,"threshold_uncertainty_score":0.38874403},"labels":[],"label_agreement":null},{"id":"W2017007462","doi":"10.1038/modpathol.3880425","title":"An Immunophenotypic and Molecular Study of Primary Large B-Cell Lymphoma of Bone","year":2001,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Lymphoma; Germinal center; Pathology; CD30; Biology; Immunophenotyping; Gene rearrangement; Primary bone; B cell; Large cell; Cancer research; Antibody; Medicine; Gene; Molecular biology; Immunology; Cancer; Genetics; Adenocarcinoma; Flow cytometry","score_opus":0.009929034926959207,"score_gpt":0.24860397659356967,"score_spread":0.23867494166661046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017007462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947147,0.0035054798,0.0002688564,0.000043376607,0.00003012096,0.00037604955,0.0000103648135,0.000017538325,0.0010335268],"genre_scores_gemma":[0.99910486,0.0001527763,0.0004255948,0.00018745738,0.000010191746,0.000031063835,0.00002320011,0.000017877082,0.000046968304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999043,0.000086129236,0.00028585308,0.000264551,0.0001362592,0.00018423209],"domain_scores_gemma":[0.9992908,0.000023969724,0.00010999095,0.00045055026,0.000059467806,0.00006522333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013386272,0.00012738766,0.00049281894,0.0000933017,0.000026202219,0.000002404977,0.000048476788,0.00008227336,0.000014982205],"category_scores_gemma":[0.0000081246,0.000106781015,0.000048124766,0.000072261275,0.000056951303,0.00003122593,0.000055448152,0.000030440935,0.0000029806706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082951837,0.046820108,0.611888,0.00014036126,0.00015641809,0.004461722,0.0044751423,0.0000111676045,0.29037046,0.00020421474,0.00001662225,0.04062624],"study_design_scores_gemma":[0.025177587,0.004987648,0.95159024,0.000024004674,0.00031855816,0.0004978023,0.00042775235,0.00026980872,0.016153479,0.0003663092,0.00006631583,0.00012049566],"about_ca_topic_score_codex":0.00006974615,"about_ca_topic_score_gemma":0.000012063469,"teacher_disagreement_score":0.33970222,"about_ca_system_score_codex":0.000041039744,"about_ca_system_score_gemma":0.000044084896,"threshold_uncertainty_score":0.43544033},"labels":[],"label_agreement":null},{"id":"W2017049223","doi":"10.3747/co.v16i4.443","title":"Primary Non-Hodgkin Lymphoma of Liver","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Primary (astronomy); Pathology; Cancer research","score_opus":0.06472953108512793,"score_gpt":0.3770567463351225,"score_spread":0.31232721524999457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017049223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96759343,0.005544714,0.000042658972,0.0009799008,0.0005045354,0.00036478433,0.000007501459,0.00003323233,0.02492926],"genre_scores_gemma":[0.9971955,0.0012603097,0.0006059813,0.00055045035,0.00019068111,0.000023216006,0.000043127635,0.0000068044515,0.00012396782],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991712,0.000031358595,0.0002502794,0.00020053005,0.00014555868,0.00020108737],"domain_scores_gemma":[0.99940485,0.00007256559,0.00010330709,0.00022435677,0.00007990702,0.00011503194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008284525,0.00012346782,0.00041788904,0.00008499652,0.00002440416,0.000002650725,0.00006551426,0.000092062284,0.00013070335],"category_scores_gemma":[0.000023941937,0.000095742056,0.00012685085,0.00010708276,0.00006278258,0.00003113806,0.000027157384,0.000046652105,0.00010134827],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019842773,0.0050295484,0.048662845,0.000065166205,0.00004834867,0.00014484797,0.00020650694,3.3363278e-7,0.00082213787,0.00048257044,0.0144064715,0.9299328],"study_design_scores_gemma":[0.0050021145,0.0023790526,0.8289141,0.00009162195,0.00015949071,0.000102331454,0.000013104818,0.000040643918,0.0026807403,0.00009775074,0.16043982,0.00007925065],"about_ca_topic_score_codex":0.000013862181,"about_ca_topic_score_gemma":0.000002861427,"teacher_disagreement_score":0.92985356,"about_ca_system_score_codex":0.0004186849,"about_ca_system_score_gemma":0.00028563009,"threshold_uncertainty_score":0.3904248},"labels":[],"label_agreement":null},{"id":"W2017518118","doi":"10.1002/cncr.24714","title":"Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Bendamustine; Internal medicine; Neutropenia; Rituximab; Gastroenterology; Regimen; Nausea; Adverse effect; Febrile neutropenia; Surgery; Chemotherapy; Lymphoma","score_opus":0.005720106909151717,"score_gpt":0.25057562994167654,"score_spread":0.2448555230325248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017518118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475044,0.0017270102,0.0000028567406,0.0005501806,0.0001114235,0.0011601837,0.000032269203,0.000026788188,0.0016388702],"genre_scores_gemma":[0.9958012,0.00046166775,0.00006879483,0.0030975728,0.00010999591,0.0002566832,0.000032290853,0.00002254733,0.00014925428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885184,0.00002463102,0.00018244167,0.0003570435,0.00028627735,0.00029777669],"domain_scores_gemma":[0.9993709,0.000036151498,0.0000871633,0.00027042825,0.000104724495,0.0001306431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044255692,0.00024184784,0.00038688965,0.000103753664,0.00004069745,0.000014827302,0.00006218458,0.00008413878,0.0002578222],"category_scores_gemma":[0.00000544285,0.00016088871,0.00008720538,0.00020692495,0.00003307659,0.00007324399,0.000010916445,0.00007125031,0.000044170574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001310134,0.0046866494,0.6015276,0.000017313727,0.00008015451,0.000045979592,0.00062923535,0.000006204766,0.00008267094,0.0000022941695,0.001529683,0.39008215],"study_design_scores_gemma":[0.04274689,0.003825222,0.9355536,0.00023204436,0.000066151144,0.0000014173767,0.000017845288,0.000018819826,0.012039774,0.00000765472,0.0053171413,0.00017342273],"about_ca_topic_score_codex":0.0003244068,"about_ca_topic_score_gemma":0.000026297406,"teacher_disagreement_score":0.3899087,"about_ca_system_score_codex":0.0007059215,"about_ca_system_score_gemma":0.00014319245,"threshold_uncertainty_score":0.65608513},"labels":[],"label_agreement":null},{"id":"W2017608397","doi":"10.1111/j.1365-2141.2008.07042.x","title":"Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; T-cell lymphoma; Medicine; Internal medicine; Pathology; Angioimmunoblastic T-cell lymphoma; Not Otherwise Specified; Karyotype; Cytogenetics; Oncology; T cell; Biology; Immunology; Chromosome; Genetics","score_opus":0.02616071682398868,"score_gpt":0.2891621206018354,"score_spread":0.2630014037778467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017608397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854119,0.012908152,0.000021647162,0.00038558073,0.00020482102,0.00009604033,0.0000036527588,0.0000056199565,0.00096262427],"genre_scores_gemma":[0.9909522,0.0074302754,0.001021864,0.00026531456,0.00008571729,0.0000037244529,0.000002834624,0.000009342828,0.00022875739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879384,0.000112110385,0.00068417215,0.000113585455,0.00012464498,0.00017162344],"domain_scores_gemma":[0.9993303,0.00017432815,0.00018447077,0.00007239148,0.000095073156,0.00014347964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016808104,0.00008395825,0.0005545841,0.00009005091,0.000068603236,0.000011411367,0.000045587985,0.00011063745,0.0000749056],"category_scores_gemma":[0.00010178305,0.0000833866,0.00012882573,0.00006529495,0.00022271229,0.00006953171,0.000022280357,0.00011170541,0.000007028987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007401232,0.0009572273,0.88881534,0.000022732533,0.000062043386,0.100864775,0.00024663887,0.0000034082332,0.0000037883208,0.0000714611,0.0011389196,0.0077396617],"study_design_scores_gemma":[0.0052168425,0.00028681193,0.5700423,0.00010857647,0.000056765715,0.42325714,0.000115647454,0.00002661925,0.000045937322,0.000055726152,0.0007432929,0.000044358876],"about_ca_topic_score_codex":0.00015917908,"about_ca_topic_score_gemma":0.00012972312,"teacher_disagreement_score":0.32239234,"about_ca_system_score_codex":0.00007715534,"about_ca_system_score_gemma":0.00031879867,"threshold_uncertainty_score":0.34004068},"labels":[],"label_agreement":null},{"id":"W2017707395","doi":"10.1177/1066896907302372","title":"Multiple Lymphomatous Diverticulosis and Comorbid Chronic Lymphocytic Leukemia: Novel Manifestations of Ileocolic Mantle Cell Lymphoma","year":2007,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Medicine; Chronic lymphocytic leukemia; Diverticulosis; Sigmoid colon; Lymphoma; Pathology; Gastroenterology; Leukemia; Internal medicine; Rectum","score_opus":0.012948843607274935,"score_gpt":0.27547666060333764,"score_spread":0.2625278169960627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017707395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995999,0.001252721,0.00042299824,0.00033391087,0.0004589226,0.00016107946,0.000040019902,0.00001254095,0.0013188159],"genre_scores_gemma":[0.9971171,0.0012348144,0.0011130321,0.00016136181,0.00025105922,0.0000064131573,0.000016880605,0.000016152444,0.00008316726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982884,0.000035745477,0.00077088503,0.0001867512,0.00047634702,0.00024186574],"domain_scores_gemma":[0.9981788,0.00056276534,0.0004475835,0.00013102884,0.0004778584,0.00020196647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032333325,0.00017067834,0.000448369,0.00031207202,0.000045282693,0.0000151219365,0.00016635918,0.00013797943,0.00007570387],"category_scores_gemma":[0.00007582549,0.00013432797,0.00021606404,0.000104782295,0.00020133663,0.00010223685,0.000093190196,0.00007821522,0.00001573794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053122733,0.0065169,0.7163953,0.0003159868,0.0018284076,0.1394638,0.0014617264,0.0006984578,0.06518656,0.003283471,0.0010081613,0.058528937],"study_design_scores_gemma":[0.045883667,0.0013799294,0.8177096,0.0002828164,0.00038146434,0.09335235,0.00024208936,0.001096076,0.03434966,0.00014071276,0.0049539763,0.00022763824],"about_ca_topic_score_codex":0.00016037312,"about_ca_topic_score_gemma":0.000029036197,"teacher_disagreement_score":0.1013143,"about_ca_system_score_codex":0.0025404433,"about_ca_system_score_gemma":0.0007314061,"threshold_uncertainty_score":0.6643171},"labels":[],"label_agreement":null},{"id":"W2017712465","doi":"10.1182/blood-2014-10-567461","title":"The biology and management of systemic anaplastic large cell lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Vincristine; Brentuximab vedotin; CD30; Medicine; Internal medicine; Oncology; Lymphoma; Cancer research; Transplantation; Cyclophosphamide; Chemotherapy","score_opus":0.026585593898832968,"score_gpt":0.3112655085809483,"score_spread":0.28467991468211534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017712465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007073914,0.99580646,0.0000011086784,0.000009393203,0.00013338668,0.0009778116,0.00007466759,0.000015684653,0.0022740725],"genre_scores_gemma":[0.0034484246,0.995774,0.00004395291,0.0000075770713,0.000059823,0.00021783142,0.00007526001,0.000023058159,0.00035011512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989324,0.00007803507,0.00038993373,0.00025602663,0.00012224799,0.00022130928],"domain_scores_gemma":[0.99907863,0.00014691155,0.00023759861,0.00039747162,0.000041194646,0.00009819645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019985196,0.00024093858,0.0010921234,0.00005998654,0.00004828782,0.000010070463,0.00010243668,0.00014432002,0.000003622496],"category_scores_gemma":[0.000008149104,0.00012206112,0.00017771815,0.00010803049,0.00004823575,0.000007055442,0.00011339017,0.000035127643,0.000044315464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015376983,0.0023752546,0.0004757797,0.05641181,0.0022117496,0.00028882176,0.000027255091,5.0928297e-9,1.6393463e-7,0.0028597543,0.0007345584,0.93459946],"study_design_scores_gemma":[0.006768492,0.00040044673,0.00010081903,0.014135079,0.0096291555,0.00044209193,0.000045826095,3.614649e-7,0.0000031689162,0.000014103141,0.9683467,0.00011373091],"about_ca_topic_score_codex":0.000007748929,"about_ca_topic_score_gemma":0.0000020337588,"teacher_disagreement_score":0.96761215,"about_ca_system_score_codex":0.00007614208,"about_ca_system_score_gemma":0.00014490001,"threshold_uncertainty_score":0.49775082},"labels":[],"label_agreement":null},{"id":"W2018133817","doi":"10.1007/s00280-010-1442-6","title":"Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Cancer research; Apoptosis; Biology; CHOP; Cell growth; Growth inhibition; Lymphoma; Immunology; Biochemistry","score_opus":0.009250837476188,"score_gpt":0.2699156145872909,"score_spread":0.2606647771111029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018133817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899449,0.003314857,0.000006765789,0.004065798,0.00051426835,0.0010735409,0.00014938536,0.00006890804,0.0008615744],"genre_scores_gemma":[0.98506016,0.0031033258,0.00037587815,0.009176986,0.00053348107,0.00058941485,0.000017099997,0.00006394636,0.0010796862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983287,0.00003914438,0.00027547215,0.0006654414,0.0001712119,0.0005200569],"domain_scores_gemma":[0.99903095,0.00007139285,0.0001406005,0.0002834317,0.00009181168,0.0003818016],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013522431,0.00036628207,0.0005154849,0.00010676017,0.00018193971,0.000031583848,0.00011011069,0.00029427488,0.0012264907],"category_scores_gemma":[0.0000043676837,0.0003073248,0.00010634432,0.000144413,0.00018600158,0.00010662138,0.00006115724,0.00020241254,0.000010132307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007895248,0.0057404744,0.015606177,0.0003510749,0.00026863493,0.000016811344,0.0010427982,8.642529e-8,0.9574952,0.000095673975,0.0143865375,0.0042070127],"study_design_scores_gemma":[0.05403436,0.00031906096,0.014268279,0.0000357028,0.00029714778,0.000028201039,0.000042916872,0.00010454016,0.89241326,0.00005746331,0.03810905,0.00029004933],"about_ca_topic_score_codex":0.00020906812,"about_ca_topic_score_gemma":0.000014853895,"teacher_disagreement_score":0.06508196,"about_ca_system_score_codex":0.00009720737,"about_ca_system_score_gemma":0.00018270747,"threshold_uncertainty_score":0.9999379},"labels":[],"label_agreement":null},{"id":"W2018366887","doi":"10.1188/08.cjon.437-442","title":"Second Cancers in Survivors of Hodgkin Lymphoma: Risks and Recommendations","year":2008,"lang":"en","type":"review","venue":"Clinical journal of oncology nursing","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Oncology; Radiation therapy; Internal medicine; Cancer; Radiation oncology; Population; Environmental health","score_opus":0.2392535736494435,"score_gpt":0.5265268912591797,"score_spread":0.28727331760973623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018366887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01128398,0.98432285,0.0000043812984,0.0008114724,0.001534261,0.00033843244,0.000021426578,0.000003412316,0.0016797652],"genre_scores_gemma":[0.0027041992,0.99539477,0.0013363435,0.00013840897,0.00034687566,0.000007986886,0.000014694217,0.000024549341,0.000032171985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959632,0.0007270873,0.0026784467,0.0002460762,0.00016086744,0.00022431837],"domain_scores_gemma":[0.99409574,0.0030927553,0.0022075044,0.00018699093,0.00015796178,0.0002590665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001002529,0.00025481012,0.0036764129,0.0003938648,0.000044568777,0.0000054854904,0.000120780714,0.0006248521,0.00007964992],"category_scores_gemma":[0.0004619467,0.00018612093,0.000738808,0.0002429108,0.00048352955,0.000058014797,0.000025759422,0.00054334337,0.0000029775229],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115381175,0.0017086916,0.006735108,0.00056878245,0.0004806606,0.00058468187,0.0001310133,2.909431e-7,3.5090387e-8,0.000013557743,0.004213751,0.98544806],"study_design_scores_gemma":[0.005972892,0.0027973216,0.016997665,0.029301625,0.0018741009,0.005283148,0.00012243551,0.0000024056742,7.8891736e-7,0.00005343458,0.9374546,0.00013958056],"about_ca_topic_score_codex":0.00005309342,"about_ca_topic_score_gemma":0.000110292596,"teacher_disagreement_score":0.98530847,"about_ca_system_score_codex":0.0018116,"about_ca_system_score_gemma":0.0040857987,"threshold_uncertainty_score":0.75897914},"labels":[],"label_agreement":null},{"id":"W2018478795","doi":"10.1002/pbc.24425","title":"Children's Oncology Group's 2013 blueprint for research: Radiation oncology","year":2012,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Radiation oncology; Blueprint; Pediatric oncology; Radiation therapy; Clinical Oncology; Clinical trial; Medical physics; Oncology; Cancer; Hodgkin lymphoma; Specialty; Internal medicine; Blood cancer; Lymphoma; Family medicine","score_opus":0.1959949297024808,"score_gpt":0.48435800725527955,"score_spread":0.2883630775527988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018478795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004172494,0.99028844,0.0000047734893,0.0008629137,0.0015263403,0.005582514,0.00034740774,0.00007982783,0.0008905332],"genre_scores_gemma":[0.00034014447,0.96793634,0.0005653536,0.0001713592,0.018097676,0.011553345,0.00086121843,0.00012828746,0.000346275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595493,0.00047406892,0.0009504761,0.0009133248,0.0005409931,0.0011662001],"domain_scores_gemma":[0.99635935,0.0014423863,0.0006597133,0.00067480654,0.0002883852,0.00057536096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012959692,0.0005866918,0.0026240696,0.0007041575,0.00021000777,0.00002929313,0.00029401018,0.0011044614,0.0004395651],"category_scores_gemma":[0.00015380206,0.00044240858,0.0008646576,0.0007088776,0.00010370667,0.000083905456,0.00018524246,0.0007531239,0.00039055152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005338069,0.0025493365,0.005191353,0.0070562707,0.0012069969,0.000033913708,0.00008256136,2.6529037e-7,7.155124e-8,0.00019741092,0.025193831,0.9584346],"study_design_scores_gemma":[0.0041741594,0.0016190943,0.0027630671,0.00066814263,0.024392445,0.00019038616,0.0000071726818,7.533139e-7,0.0000015066718,0.000029304449,0.96579146,0.00036251495],"about_ca_topic_score_codex":0.0012264076,"about_ca_topic_score_gemma":0.00017649209,"teacher_disagreement_score":0.95807207,"about_ca_system_score_codex":0.0024972777,"about_ca_system_score_gemma":0.003474432,"threshold_uncertainty_score":0.99980277},"labels":[],"label_agreement":null},{"id":"W2018866177","doi":"10.1097/01.pgp.0000070845.25718.4c","title":"Sarcomatoid Variant of B-Cell Lymphoma of the Uterine Cervix","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Parametrium; Cervix; Lymphoma; Pathology; Biopsy; Cancer; Internal medicine","score_opus":0.014259516284980797,"score_gpt":0.27871712566579127,"score_spread":0.2644576093808105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018866177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915903,0.0003122437,0.00012824775,0.0013899193,0.00090860785,0.00010208127,0.000014968627,0.0000032151454,0.005550388],"genre_scores_gemma":[0.99681914,0.00020401661,0.0022371768,0.0005639064,0.000055476696,0.0000035690844,0.0000015441386,0.000005711464,0.00010947436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860275,0.00016540941,0.00065611134,0.000105751395,0.00034747281,0.00012252967],"domain_scores_gemma":[0.99833864,0.00035135343,0.000631644,0.00015347713,0.0004593445,0.000065549146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032611217,0.00010340906,0.0004014277,0.00009522296,0.00001783734,0.0000040916884,0.00027397714,0.00010444341,0.0005678896],"category_scores_gemma":[0.00062411034,0.00005550711,0.00029449465,0.000079564685,0.00015596146,0.00003407918,0.00007717869,0.000082677354,0.000006627915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013707944,0.022851277,0.7528891,0.00009392549,0.0012419283,0.015450067,0.0004396666,0.000086798325,0.1328683,0.046949513,0.0016909768,0.024067672],"study_design_scores_gemma":[0.008204605,0.0017557103,0.8843813,0.00006220816,0.000112199596,0.010000827,0.00005994013,0.000012208389,0.084631585,0.003297508,0.0074113635,0.00007055328],"about_ca_topic_score_codex":0.0000059134295,"about_ca_topic_score_gemma":0.0000021872074,"teacher_disagreement_score":0.13149221,"about_ca_system_score_codex":0.00012600361,"about_ca_system_score_gemma":0.00016760165,"threshold_uncertainty_score":0.6217993},"labels":[],"label_agreement":null},{"id":"W2019122063","doi":"10.1097/ppo.0b013e3181a282d8","title":"Clinical Manifestations and Natural History of Hodgkin’s Lymphoma","year":2009,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Medicine; Natural history; Hodgkin lymphoma; Biopsy; Presentation (obstetrics); Lymph node; Intensive care medicine; Radiology; Pathology; Internal medicine","score_opus":0.09541127806918819,"score_gpt":0.4176371840993635,"score_spread":0.3222259060301753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019122063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002877744,0.99717224,0.0000011520909,0.00034337625,0.0010861844,0.0002839726,0.000014709617,0.0000073550855,0.0008032187],"genre_scores_gemma":[0.00029550696,0.996761,0.000118666336,0.00035498233,0.0008633381,0.000025379293,0.0000104183955,0.000019945737,0.0015507543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985444,0.00018295701,0.00071875646,0.00017198372,0.00022314729,0.00015876825],"domain_scores_gemma":[0.9986169,0.0002488469,0.000641252,0.00025191423,0.00009793646,0.00014315822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004003464,0.00021374047,0.0011463577,0.00008468208,0.000061839106,0.000012702831,0.00014075584,0.00012168727,0.00012676993],"category_scores_gemma":[0.000050117455,0.00010745883,0.00053826376,0.0000593463,0.00015311281,0.000033816315,0.000027594617,0.0003125655,0.0000073150786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019231386,0.00013467879,0.00029612737,0.00076098467,0.0005001203,0.00017992088,0.00006749601,4.7758853e-8,3.8369244e-8,0.000059551334,0.021298666,0.97668314],"study_design_scores_gemma":[0.001170315,0.00018102817,0.01103208,0.007170091,0.0038637999,0.0045391833,0.000010911427,0.0000014675818,9.851413e-8,0.000056955225,0.9718771,0.00009697615],"about_ca_topic_score_codex":0.000036018282,"about_ca_topic_score_gemma":0.000009870202,"teacher_disagreement_score":0.97658616,"about_ca_system_score_codex":0.0014957224,"about_ca_system_score_gemma":0.0021788273,"threshold_uncertainty_score":0.43820438},"labels":[],"label_agreement":null},{"id":"W2019424002","doi":"10.1007/s12308-011-0106-8","title":"Nodular lymphocyte-predominant Hodgkin lymphoma of the tonsil: a case study using immunohistochemistry and FISH analysis and review of the literature","year":2011,"lang":"en","type":"article","venue":"Journal of Hematopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Tonsil; Pathology; Lymphoma; CD15; CD30; Immunohistochemistry; CD20; Fluorescence in situ hybridization; Differential diagnosis; Medicine; Gene rearrangement; Palatine tonsil; Lymph node; Lymphocyte; Biology; CD34; Immunology","score_opus":0.017285672465884798,"score_gpt":0.2942266060671282,"score_spread":0.2769409336012434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019424002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9377088,0.06174771,0.000003786317,0.0001440982,0.00006709025,0.00027841813,0.000011049702,0.000001367844,0.000037684735],"genre_scores_gemma":[0.99547416,0.003756378,0.00048546292,0.00023839189,0.000019030502,0.0000047314393,4.1849177e-7,0.0000082995175,0.0000131509405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864095,0.00020176092,0.0006946765,0.00014763199,0.00020014637,0.00011480977],"domain_scores_gemma":[0.9982431,0.00006844294,0.0008807003,0.0004745247,0.00027258944,0.00006063139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052753725,0.000150498,0.0008823908,0.00009977901,0.000070158756,0.0000058739306,0.00011748856,0.00008088798,0.000019048533],"category_scores_gemma":[0.00017360254,0.00007291357,0.0003385295,0.00038817554,0.00019166917,0.000039638417,0.00012957568,0.00008537182,5.605422e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003689817,0.0025374917,0.9366976,0.0034161718,0.0019540703,0.02060665,0.009690545,6.794537e-7,0.020703223,0.000025017427,0.00011142149,0.0038881688],"study_design_scores_gemma":[0.006739177,0.0008756965,0.45825315,0.009503538,0.013616935,0.4448135,0.0026419936,0.000023198194,0.063278295,0.000046968915,0.000047489124,0.00016007821],"about_ca_topic_score_codex":0.0001049303,"about_ca_topic_score_gemma":0.000008384538,"teacher_disagreement_score":0.47844443,"about_ca_system_score_codex":0.0001046319,"about_ca_system_score_gemma":0.00018047949,"threshold_uncertainty_score":0.2973329},"labels":[],"label_agreement":null},{"id":"W2019465092","doi":"10.1158/1538-7445.am10-3890","title":"Abstract 3890: Induction of cell cycle arrest and apoptosis in mantle cell lymphoma by AZD5438, a novel cyclin-dependent kinase inhibitor","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cyclin-dependent kinase; Cell cycle; Cyclin-dependent kinase 1; Mantle cell lymphoma; Cell cycle checkpoint; Cyclin B; Cyclin B1; Cyclin D1; Cancer research; Cyclin A; Cell growth; Cyclin D; Kinase; Biology; Chemistry; Molecular biology; Cell biology; Apoptosis; Biochemistry; Immunology; Lymphoma","score_opus":0.032264068446668334,"score_gpt":0.339952562499045,"score_spread":0.30768849405237664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019465092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995553,0.0008815324,8.9314585e-7,0.0006104304,0.00031234144,0.00058827514,0.00009940784,0.000014245373,0.001939882],"genre_scores_gemma":[0.9979778,0.0009409262,0.000107200765,0.00003922937,0.00021733524,0.00026261475,0.000025040463,0.000030842646,0.0003989975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981752,0.000033798016,0.00031272147,0.00043858928,0.0006040272,0.00043564648],"domain_scores_gemma":[0.99901265,0.00014037454,0.00007981376,0.0003542623,0.00015898155,0.00025394664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004667545,0.00016315097,0.00029021173,0.00025944677,0.00008349481,0.000035806082,0.00010833356,0.00018217356,0.00019907478],"category_scores_gemma":[0.000052413216,0.00013921983,0.000056533492,0.00029581337,0.0001819744,0.00010486513,0.00009510166,0.00034085347,0.000035564874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025754195,0.0029702995,0.03198444,0.00026518668,0.000021062307,0.000029193106,0.00026154032,0.0000026238713,0.95207757,0.000015164768,0.0017017059,0.010413699],"study_design_scores_gemma":[0.0063061826,0.00020025174,0.12892412,0.00013595876,0.000021203949,0.0000046887694,0.00027686547,0.00001513178,0.8625677,0.00002356967,0.0014120511,0.00011224997],"about_ca_topic_score_codex":0.007738354,"about_ca_topic_score_gemma":0.00070435076,"teacher_disagreement_score":0.096939676,"about_ca_system_score_codex":0.0003434842,"about_ca_system_score_gemma":0.00034618448,"threshold_uncertainty_score":0.9988692},"labels":[],"label_agreement":null},{"id":"W2019596026","doi":"10.1002/ijc.23003","title":"Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium","year":2007,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Danmarks Grundforskningsfond; Medical Research Council; National Institutes of Health; Fondation de France; Bundesamt für Strahlenschutz; Cancerfonden; National Cancer Institute; National Research Foundation; Cancer Council NSW; National Health and Medical Research Council; European Commission; Health Research Board; Compagnia di San Paolo","keywords":"Medicine; Odds ratio; Confidence interval; Confounding; Epidemiology; Demography; Logistic regression; Pooled analysis; Environmental health; Internal medicine","score_opus":0.00877400037424055,"score_gpt":0.29836579074912145,"score_spread":0.2895917903748809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019596026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901614,0.006916205,0.0005577601,0.0015582033,0.00042035448,0.00007092602,0.00011586176,0.0000028209047,0.00019646544],"genre_scores_gemma":[0.99670905,0.0020228897,0.0002665363,0.0004036336,0.000518619,0.0000037343802,0.000009177373,0.000007716632,0.000058672802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986369,0.000036497728,0.00050041254,0.000120424585,0.00059533014,0.00011041047],"domain_scores_gemma":[0.99827236,0.00035650635,0.00059622247,0.00009439724,0.000581959,0.00009855895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036460164,0.00011436394,0.00034364135,0.00019841007,0.000028575409,0.000026632359,0.0001470625,0.0000522002,0.00030633737],"category_scores_gemma":[0.00008311256,0.000067746485,0.00032163097,0.0001500766,0.000095155694,0.000076089316,0.000032045846,0.00007471215,0.0000015776524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011857947,0.00025369742,0.88776314,0.0000029073485,0.014841414,0.00017376608,0.0010311553,0.000015473763,0.0007404563,0.00002552076,0.00032453486,0.09364212],"study_design_scores_gemma":[0.00550417,0.00023064134,0.98211396,0.00014788665,0.0051724296,0.00009380225,0.00051551394,0.00020932831,0.004575095,0.000052351275,0.0013251947,0.00005964383],"about_ca_topic_score_codex":0.0025433716,"about_ca_topic_score_gemma":0.0009654134,"teacher_disagreement_score":0.094350785,"about_ca_system_score_codex":0.00027703523,"about_ca_system_score_gemma":0.0001896928,"threshold_uncertainty_score":0.3844834},"labels":[],"label_agreement":null},{"id":"W2019726944","doi":"10.3109/10428190903297531","title":"Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV","year":2009,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; University of Arizona; American Cancer Society","keywords":"Methylation; CIITA; CpG site; Transactivation; Lymphoma; Promoter; Diffuse large B-cell lymphoma; DNA methylation; Biology; Cancer research; Major histocompatibility complex; CD74; Immunology; MHC class II; Gene; Genetics; Gene expression","score_opus":0.01056275874558213,"score_gpt":0.2278023158749936,"score_spread":0.21723955712941148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019726944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807972,0.0014573532,0.00015071256,0.010735411,0.00031526395,0.004363445,0.00068278523,0.00030060616,0.0011972253],"genre_scores_gemma":[0.9586177,0.00067971443,0.0014160142,0.03392092,0.0005382735,0.0008558661,0.0019073104,0.00032075887,0.0017434743],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98994124,0.0006427672,0.0025591585,0.003071092,0.0018397329,0.0019460304],"domain_scores_gemma":[0.99416554,0.00078384,0.0017331503,0.002046461,0.00036328755,0.0009077377],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007003268,0.0024312467,0.0040612575,0.0010846154,0.00093427865,0.00015289593,0.00059942226,0.002759452,0.00011927019],"category_scores_gemma":[0.00008298952,0.0017845088,0.00070275785,0.0007903287,0.00087763293,0.00059756526,0.0003492369,0.0006810527,0.000008728057],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0694099,0.0759514,0.052415915,0.018647177,0.0057026288,0.020647312,0.022802766,0.00008911798,0.119507834,0.00050672895,0.18462993,0.4296893],"study_design_scores_gemma":[0.39598507,0.006260111,0.30745035,0.006108445,0.0039275982,0.0014891952,0.0006027998,0.009238502,0.077475384,0.00032901543,0.18674487,0.0043886765],"about_ca_topic_score_codex":0.0038558962,"about_ca_topic_score_gemma":0.0004082906,"teacher_disagreement_score":0.42530063,"about_ca_system_score_codex":0.014115454,"about_ca_system_score_gemma":0.0041633914,"threshold_uncertainty_score":0.9988425},"labels":[],"label_agreement":null},{"id":"W2019962803","doi":"10.1038/bmt.2013.226","title":"Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!","year":2014,"lang":"en","type":"review","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bendamustine; Oncology; Internal medicine; Transplantation; Brentuximab vedotin; Hematopoietic stem cell transplantation; Panobinostat; Surgery; Follicular lymphoma; Lymphoma; Rituximab; Histone deacetylase; Hodgkin lymphoma","score_opus":0.017736768054656543,"score_gpt":0.28659586630802836,"score_spread":0.26885909825337184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019962803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003599347,0.99026346,0.000652633,0.00048868335,0.00066413445,0.0022535534,0.0005608991,0.00024202319,0.0012752807],"genre_scores_gemma":[0.059526496,0.93239343,0.000909642,0.00086598034,0.00028573797,0.0033008263,0.0018784503,0.00019928282,0.0006401353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956481,0.00031556157,0.0013937441,0.0011608922,0.0007260258,0.0007557071],"domain_scores_gemma":[0.9981568,0.00028372256,0.0005232712,0.00063379057,0.00008671738,0.00031570115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030235172,0.0010876742,0.0025315254,0.00049992494,0.00013684064,0.00015257095,0.00016782635,0.00067678373,0.00040129523],"category_scores_gemma":[0.000004763778,0.0009106534,0.0010373811,0.00035445744,0.00011236919,0.00019093859,0.000016532447,0.00028678466,0.00028148718],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014500311,0.00058426213,0.0008069649,0.14180325,0.00077629683,0.009329381,0.0023793054,0.000005797935,0.000017667262,0.000058024416,0.00015890278,0.8426301],"study_design_scores_gemma":[0.013078013,0.0006354595,0.009455537,0.11368029,0.053616162,0.011301963,0.000048204325,0.0000835464,0.000543547,0.000088083776,0.7948446,0.0026245494],"about_ca_topic_score_codex":0.000247996,"about_ca_topic_score_gemma":0.0001978329,"teacher_disagreement_score":0.8400056,"about_ca_system_score_codex":0.000634543,"about_ca_system_score_gemma":0.00049048953,"threshold_uncertainty_score":0.9993344},"labels":[],"label_agreement":null},{"id":"W2020055542","doi":"10.1182/blood-2010-05-231548","title":"Peripheral T-cell lymphoma","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Vorinostat; Lymphoma; Medicine; Peripheral T-cell lymphoma; Brentuximab vedotin; Clinical trial; Histone deacetylase; Oncology; Bioinformatics; Internal medicine; Immunology; T cell; Biology; Histone; Hodgkin lymphoma; Gene","score_opus":0.043225392328565856,"score_gpt":0.29482984095524317,"score_spread":0.2516044486266773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020055542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011297475,0.94273525,2.7429283e-7,0.000005739353,0.00016632288,0.0006783985,0.000027816024,0.0000751071,0.05619814],"genre_scores_gemma":[0.000071212206,0.99450326,0.000311391,0.00006842547,0.00034218153,0.0002983706,0.00015167639,0.000074206364,0.004179302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875027,0.00004196607,0.00036705434,0.00040285676,0.00014712689,0.00029075105],"domain_scores_gemma":[0.999009,0.000035705732,0.00015985682,0.00056277233,0.00003150946,0.00020111623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047759244,0.00042177102,0.0015441461,0.00008700325,0.000043055592,0.000019172945,0.00012296588,0.00029293261,0.00052556145],"category_scores_gemma":[0.00000991089,0.00027878713,0.000787488,0.0001232973,0.00003256859,0.000021648604,0.00005530086,0.000072870884,0.0010421523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004036673,0.0054653883,0.00015214174,0.008510209,0.00059266045,0.0005646522,0.000031651045,4.376078e-10,9.038265e-8,0.00009339086,0.0011102995,0.9834755],"study_design_scores_gemma":[0.004711084,0.00029384327,0.00009647859,0.0055235815,0.008871305,0.000798237,0.0000030170131,3.2363367e-8,0.000020239922,0.000005069562,0.9794336,0.00024353537],"about_ca_topic_score_codex":0.000045918205,"about_ca_topic_score_gemma":0.0000017370043,"teacher_disagreement_score":0.98323196,"about_ca_system_score_codex":0.00013902309,"about_ca_system_score_gemma":0.0004770506,"threshold_uncertainty_score":0.99996644},"labels":[],"label_agreement":null},{"id":"W2020521632","doi":"10.1182/blood-2011-07-365932","title":"Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"ABVD; Lymphoma; Medicine; Stage (stratigraphy); Dacarbazine; Bleomycin; Classical Hodgkin lymphoma; Vinblastine; Hodgkin lymphoma; Brentuximab vedotin; Oncology; Internal medicine; Cancer research; Pathology; Chemotherapy; Cyclophosphamide; Biology; Vincristine","score_opus":0.029673667552053813,"score_gpt":0.2598252865507503,"score_spread":0.23015161899869652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020521632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678356,0.0006333331,0.00021013404,0.00048792036,0.00024645135,0.0018079113,0.00013648292,0.00034889948,0.009345311],"genre_scores_gemma":[0.98195714,0.00008404205,0.011588436,0.0014911322,0.00034113525,0.0006372233,0.00006652386,0.00019111965,0.0036432396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538755,0.00012985991,0.000979996,0.0013781432,0.00087391934,0.0012505385],"domain_scores_gemma":[0.99682695,0.00017399287,0.0003553498,0.0014744458,0.00023925691,0.00093001744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003325987,0.00091975916,0.0013059224,0.00036181696,0.00026830874,0.00019189315,0.00038429615,0.00037203336,0.00020298193],"category_scores_gemma":[0.00019579328,0.00065855804,0.000434624,0.00058802776,0.0001778808,0.00038790627,0.0002318195,0.00010881177,0.0003930825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004728027,0.021576473,0.7628783,0.00036837126,0.0019877278,0.011926808,0.0033351015,0.0000062835197,0.010327578,0.0013427039,0.00047692427,0.1810457],"study_design_scores_gemma":[0.07191088,0.0092764,0.68344474,0.00073120295,0.0030279832,0.0012720965,0.0006744702,0.00022712293,0.21505623,0.000031468164,0.012972163,0.001375234],"about_ca_topic_score_codex":0.0008844881,"about_ca_topic_score_gemma":0.00014833655,"teacher_disagreement_score":0.20472865,"about_ca_system_score_codex":0.0008093897,"about_ca_system_score_gemma":0.00058384024,"threshold_uncertainty_score":0.9995866},"labels":[],"label_agreement":null},{"id":"W2020657349","doi":"10.1038/modpathol.3880144","title":"Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma","year":2000,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Mantle cell lymphoma; Mantle (geology); Pathology; Medicine; Geology; Lymphoma; Geochemistry","score_opus":0.011584102513866127,"score_gpt":0.25106694292858955,"score_spread":0.23948284041472342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020657349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734456,0.00047041805,0.0006776868,0.000063474115,0.00012820243,0.0003486536,0.00004405892,0.00005933006,0.010863586],"genre_scores_gemma":[0.99555004,0.00014481782,0.0006766405,0.00017204188,0.00010350708,0.000058904854,0.00013425562,0.000040385064,0.00311939],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984664,0.000101621496,0.0003624854,0.00046653574,0.00023493796,0.00036802783],"domain_scores_gemma":[0.99911755,0.00010678677,0.000109221,0.00044336947,0.0000619337,0.00016113331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008256015,0.0002315502,0.0004254311,0.000119876335,0.00006410024,0.000010981966,0.00010939293,0.00019768062,0.0005401476],"category_scores_gemma":[0.000012783949,0.00020001868,0.000107711516,0.00010727505,0.0001253392,0.00008488427,0.0000346552,0.00007033689,0.0004009985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052559893,0.036308564,0.24158877,0.0020185623,0.0004990743,0.016778775,0.016116016,0.014706627,0.23292567,0.0005974422,0.005763261,0.42744124],"study_design_scores_gemma":[0.03150439,0.006574041,0.5164829,0.00015275228,0.0014163697,0.0015238328,0.0005000047,0.06741999,0.37038806,0.0019097057,0.0013398285,0.0007881467],"about_ca_topic_score_codex":0.00010278413,"about_ca_topic_score_gemma":0.00003342463,"teacher_disagreement_score":0.4266531,"about_ca_system_score_codex":0.00021184658,"about_ca_system_score_gemma":0.00017334934,"threshold_uncertainty_score":0.8156525},"labels":[],"label_agreement":null},{"id":"W2020789296","doi":"10.1182/blood-2014-05-577189","title":"Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Context (archaeology); Lymphoma; Medicine; Ibrutinib; Cancer research; Internal medicine; Biology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.1056111912434274,"score_gpt":0.39516675257100214,"score_spread":0.28955556132757476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020789296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.111018136,0.88763916,9.354917e-7,0.000033169334,0.00008816643,0.0008429079,0.00006055397,0.000012984669,0.0003039754],"genre_scores_gemma":[0.15111373,0.8481392,0.00014271411,0.0002994765,0.00010074618,0.00010765744,0.00006174094,0.000019711686,0.000015012437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974511,0.00047621765,0.0012409118,0.00041816643,0.00015569375,0.0002578866],"domain_scores_gemma":[0.997907,0.00093228754,0.00046875016,0.0005692647,0.000025795536,0.00009694772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010032762,0.00033729227,0.0028109371,0.00008020472,0.000035147674,0.000014348923,0.0001803053,0.00037136578,0.0000049749597],"category_scores_gemma":[0.00020514536,0.00016403706,0.0007115356,0.000106694584,0.000110452296,0.000014101443,0.000113346476,0.0001508205,0.00002126224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028654269,0.04205003,0.32611755,0.012210916,0.00070940296,0.00034779764,0.00009559177,6.1467422e-9,2.147293e-7,0.00020742977,0.00009607309,0.61813635],"study_design_scores_gemma":[0.07196796,0.0012643338,0.023159381,0.006363182,0.008479162,0.00042319624,0.000095105526,0.0000033600586,0.000020596242,0.000007079179,0.8877751,0.00044153898],"about_ca_topic_score_codex":0.00003287754,"about_ca_topic_score_gemma":0.000017704157,"teacher_disagreement_score":0.88767904,"about_ca_system_score_codex":0.000023020628,"about_ca_system_score_gemma":0.00010157874,"threshold_uncertainty_score":0.66892374},"labels":[],"label_agreement":null},{"id":"W2020840915","doi":"10.1182/blood-2006-01-028647","title":"NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; School of Medicine, Stanford University; National IT Industry Promotion Agency","keywords":"Anaplastic lymphoma kinase; Molecular biology; Anaplastic large-cell lymphoma; Biology; Nucleophosmin; Fusion protein; Cancer research; Cell biology; Chemistry; Biochemistry; Lymphoma; Recombinant DNA; Medicine","score_opus":0.007402039493538433,"score_gpt":0.22751881432940524,"score_spread":0.2201167748358668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020840915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225855,0.0018118711,0.000003691467,0.0003205218,0.0000624697,0.00064909144,0.000009776085,0.000041294337,0.00484275],"genre_scores_gemma":[0.9986472,0.00010825645,0.000202523,0.00013963945,0.00007692333,0.00007336477,0.00001351601,0.000025423687,0.00071312924],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998721,0.000024830688,0.0002706542,0.00029913126,0.00023000377,0.0004543551],"domain_scores_gemma":[0.9993232,0.0001728379,0.00007583728,0.0002551199,0.000027830421,0.000145204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037649774,0.00020091643,0.000261092,0.00012753742,0.00012282131,0.000036713693,0.000078400386,0.00010504771,0.000044920384],"category_scores_gemma":[0.00006529357,0.00012948016,0.00006472404,0.00028173174,0.000054200562,0.00005253998,0.00005898863,0.000078532306,0.000058694724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005910593,0.01744781,0.8984746,0.0002623231,0.00040476056,0.0030645123,0.0018024127,6.4882227e-7,0.049687512,0.0012673121,0.00049883244,0.026498254],"study_design_scores_gemma":[0.036099363,0.00091401074,0.35631853,0.00035203045,0.0003567138,0.00019154225,0.0006356655,0.000034770215,0.60170335,0.00009451308,0.0030261765,0.000273294],"about_ca_topic_score_codex":0.00009196314,"about_ca_topic_score_gemma":0.00014557502,"teacher_disagreement_score":0.55201584,"about_ca_system_score_codex":0.00009329097,"about_ca_system_score_gemma":0.000076197626,"threshold_uncertainty_score":0.52800477},"labels":[],"label_agreement":null},{"id":"W2021130630","doi":"10.1182/blood-2012-06-436725","title":"Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Medicine; Internal medicine; Regimen; Transplantation; Oncology; Lymphoma; Progression-free survival; Diffuse large B-cell lymphoma; Rituximab; Overall survival","score_opus":0.02898630427423769,"score_gpt":0.28469700642362356,"score_spread":0.25571070214938585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021130630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514997,0.0005019697,0.00051192427,0.00036921125,0.0002480569,0.0015556382,0.0005408357,0.00008537965,0.0010370025],"genre_scores_gemma":[0.99267864,0.00006264002,0.003509731,0.00063661963,0.00034638323,0.0006488784,0.0005390642,0.000040413954,0.0015376087],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988609,0.000015430156,0.00022376099,0.00025101923,0.00012843728,0.0005204788],"domain_scores_gemma":[0.999045,0.0002793412,0.00009691415,0.0002168025,0.00014056316,0.00022138315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013913764,0.0001995165,0.00037486537,0.00006223565,0.00017663624,0.000016147767,0.00004985278,0.00010465895,0.000038783353],"category_scores_gemma":[0.000088099114,0.00014600319,0.00017571369,0.00006986439,0.00003772705,0.000116944335,0.00001644091,0.000029672807,0.00002797422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020795168,0.42126384,0.29265666,0.0036546206,0.010641113,0.0007098076,0.025280943,0.0000013300704,0.11558192,0.018116845,0.08275246,0.008545301],"study_design_scores_gemma":[0.24567533,0.002358472,0.0775826,0.00045737126,0.004353925,0.00042339647,0.00086284796,0.000063375526,0.64585775,0.00016265879,0.021656161,0.00054611353],"about_ca_topic_score_codex":0.000011701399,"about_ca_topic_score_gemma":0.000006277865,"teacher_disagreement_score":0.5302758,"about_ca_system_score_codex":0.00008385078,"about_ca_system_score_gemma":0.00009232168,"threshold_uncertainty_score":0.5953837},"labels":[],"label_agreement":null},{"id":"W2021372460","doi":"10.3129/i10-031","title":"Ocular adnexal lymphoma mimicking glaucoma: a case presentation","year":2010,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Presentation (obstetrics); Medicine; Glaucoma; Ophthalmology; Lymphoma; Dermatology; Optometry; Pathology; Radiology","score_opus":0.026292497485047885,"score_gpt":0.28307152509225514,"score_spread":0.2567790276072073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021372460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8184708,0.0020756216,0.0000037916636,0.17039432,0.0025639413,0.00035756925,0.00008119022,0.000005440625,0.006047371],"genre_scores_gemma":[0.9421734,0.000009840652,0.00069608056,0.050447945,0.004850793,0.000020450972,0.00017609322,0.00008724424,0.0015381381],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978279,0.0001945866,0.00070150464,0.0003211015,0.00028930278,0.0006656429],"domain_scores_gemma":[0.99749315,0.00022669567,0.0006076085,0.00043489353,0.00042962236,0.00080800755],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026584422,0.00038719637,0.0008966916,0.0008231991,0.00016689666,0.00006792861,0.00022635226,0.0018232134,0.0018138705],"category_scores_gemma":[0.00025508058,0.00033482307,0.0004707555,0.0001595719,0.00021645719,0.000098727505,0.000018475315,0.0016166738,0.00005538394],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024682975,0.000045321543,0.041313168,0.00006866058,0.0003911547,0.70560217,0.00010953607,2.8091964e-7,0.000010819319,0.0000077731465,0.25156218,0.00086428015],"study_design_scores_gemma":[0.002050243,0.0005407813,0.015167841,0.00015764794,0.00061201985,0.7868361,0.000040089497,0.0000056901795,0.00011034058,0.00008180809,0.19420056,0.00019687822],"about_ca_topic_score_codex":0.018986557,"about_ca_topic_score_gemma":0.0006942992,"teacher_disagreement_score":0.12370265,"about_ca_system_score_codex":0.0008156759,"about_ca_system_score_gemma":0.0042242636,"threshold_uncertainty_score":0.99991035},"labels":[],"label_agreement":null},{"id":"W2021406325","doi":"10.1038/sj.bmt.1703790","title":"Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma","year":2003,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Busulfan; Cyclophosphamide; Regimen; Internal medicine; Univariate analysis; Surgery; Fludarabine; Gastroenterology; Chemotherapy; Transplantation; Lymphoma; Multivariate analysis","score_opus":0.005008890386667659,"score_gpt":0.2233290234796564,"score_spread":0.21832013309298876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021406325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610746,0.0004335601,0.00023620836,0.00014062096,0.000038038925,0.001980653,0.00011339672,0.000030028694,0.00092001125],"genre_scores_gemma":[0.9945107,0.00132767,0.0027765823,0.00016165432,0.00001286576,0.0004548422,0.00060802716,0.000033988952,0.00011364865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985994,0.00006200536,0.00032591814,0.0004890682,0.000241108,0.000282471],"domain_scores_gemma":[0.9993952,0.00012279183,0.00011395948,0.00014377102,0.000081193044,0.00014311173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014937254,0.00028266612,0.0003709067,0.0001500371,0.0001008723,0.000032325694,0.000027034122,0.000119443524,0.000010641521],"category_scores_gemma":[0.000012810444,0.00023564958,0.000046782665,0.00015886461,0.00006534012,0.00019116436,0.0000022903414,0.000041795232,0.0000022623965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087881675,0.001190942,0.974618,0.0008176461,0.00029904538,0.00031522405,0.004250443,0.000022541628,0.0031821914,0.0006544831,0.000029411562,0.005831861],"study_design_scores_gemma":[0.036726914,0.002086073,0.9325124,0.0003726808,0.0010420711,0.00030675813,0.00011416137,0.000024855892,0.026251374,0.00019288981,0.00008696852,0.00028282747],"about_ca_topic_score_codex":0.00018465483,"about_ca_topic_score_gemma":0.0003044859,"teacher_disagreement_score":0.042105615,"about_ca_system_score_codex":0.00007539369,"about_ca_system_score_gemma":0.000108492575,"threshold_uncertainty_score":0.9609511},"labels":[],"label_agreement":null},{"id":"W2021864751","doi":"10.1182/blood-2013-01-479865","title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"FOXO1; Diffuse large B-cell lymphoma; Cancer research; Mutation; Lymphoma; Biology; Genetics; Oncology; Medicine; Internal medicine; Gene; Transcription factor","score_opus":0.008405575303897819,"score_gpt":0.2402173492603096,"score_spread":0.23181177395641178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021864751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953932,0.00033574336,0.0000059478925,0.00016001725,0.000013202224,0.00022097449,0.000024056082,0.000015130941,0.0038317142],"genre_scores_gemma":[0.99912006,0.000048386326,0.00025819393,0.00011769541,0.00001157782,0.000096925294,0.000078752004,0.000007190307,0.00026120283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993712,0.000016417434,0.00020351866,0.00013772033,0.00012437432,0.00014681178],"domain_scores_gemma":[0.9995371,0.00006315229,0.000054379103,0.00022595323,0.00004862491,0.0000707663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037930884,0.000077940815,0.00027631986,0.00026618488,0.000017480308,0.000007283037,0.000036656733,0.00004129444,0.00022184379],"category_scores_gemma":[0.000022543221,0.000060995055,0.00014257229,0.0005542741,0.000015701778,0.00003840774,0.000017376118,0.000015394133,0.00008068172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054118573,0.043434482,0.9530577,0.000020488029,0.00081767654,0.000045685956,0.0003627692,0.0000019406825,0.0006890138,0.00014550715,0.00011467745,0.0013046305],"study_design_scores_gemma":[0.027596088,0.00010197429,0.9594738,0.000016786913,0.002889102,0.000003273175,0.00014194266,0.00033098547,0.009210991,0.000029162693,0.00014940595,0.000056478155],"about_ca_topic_score_codex":0.00066495733,"about_ca_topic_score_gemma":0.00016134833,"teacher_disagreement_score":0.04333251,"about_ca_system_score_codex":0.000032925946,"about_ca_system_score_gemma":0.000041731793,"threshold_uncertainty_score":0.24873061},"labels":[],"label_agreement":null},{"id":"W2022013393","doi":"10.1182/blood-2008-01-129783","title":"Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Gundersen Medical Foundation; University of Nebraska Medical Center; Centre International de Recherche sur le Cancer; World Health Organization; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Diffuse large B-cell lymphoma; Missense mutation; International Prognostic Index; Mutation; Cancer research; Lymphoma; Germinal center; Biology; Gene mutation; Gene; Internal medicine; Oncology; Medicine; B cell; Genetics; Antibody","score_opus":0.04009594736173656,"score_gpt":0.34755304597596004,"score_spread":0.3074570986142235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022013393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980292,0.00011260454,0.0000013278378,0.00007056738,0.0001738881,0.0009020053,0.00029139032,0.00003005879,0.00038900075],"genre_scores_gemma":[0.9984812,0.00005310124,0.00084744097,0.000054492593,0.000121584526,0.00011953278,0.00021534206,0.000014872534,0.000092436785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984755,0.000113760114,0.000629637,0.00029322164,0.0003221677,0.00016574343],"domain_scores_gemma":[0.999164,0.000110298795,0.0001623711,0.0002636142,0.00018290215,0.000116839605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001462092,0.00014699901,0.00039351374,0.00011719928,0.000059329395,0.00000852598,0.00010931641,0.00006971171,0.00003586607],"category_scores_gemma":[0.0001234405,0.000112731,0.0000842362,0.00020329538,0.00007717944,0.00011964296,0.000049213486,0.00005736452,0.000008707823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012238492,0.07186805,0.9253802,0.000009092743,0.00022814597,0.00046404233,0.0016111702,0.0000015640326,0.00006921752,0.00004063036,0.000021698897,0.00018382762],"study_design_scores_gemma":[0.07964521,0.0014019103,0.915136,0.000013024819,0.00023669204,0.000051298866,0.0009279869,0.00011021314,0.0023557602,0.000008552775,0.000027799686,0.000085583655],"about_ca_topic_score_codex":0.00008037814,"about_ca_topic_score_gemma":0.000081328544,"teacher_disagreement_score":0.07952282,"about_ca_system_score_codex":0.000065523636,"about_ca_system_score_gemma":0.00022755994,"threshold_uncertainty_score":0.45970368},"labels":[],"label_agreement":null},{"id":"W2022033193","doi":"10.1259/bjr.73.872.11026871","title":"Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease.","year":2000,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Lumpectomy; Radiation therapy; Breast cancer; Mastectomy; Disease; Stage (stratigraphy); Incidence (geometry); Surgery; Cancer; Oncology; Internal medicine","score_opus":0.01285533688020863,"score_gpt":0.26913824612637044,"score_spread":0.2562829092461618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022033193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487848,0.047587972,0.00007235831,0.0019739848,0.00016854909,0.00067770446,0.0007194989,0.000006636408,0.000008468995],"genre_scores_gemma":[0.93141806,0.066461325,0.00016643069,0.0008810528,0.0004907369,0.00025962858,0.000053263262,0.000017803553,0.00025170218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991926,0.000074178504,0.00031772428,0.00014962514,0.0000826867,0.00018318369],"domain_scores_gemma":[0.9990702,0.00037207434,0.00019795162,0.000060637714,0.00014764302,0.00015143922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021646934,0.000103168924,0.00039383126,0.00006428171,0.000063993044,0.000030324149,0.00002876307,0.0000666389,0.00025165558],"category_scores_gemma":[0.000051062736,0.00009460075,0.00017223512,0.00004256194,0.000062743224,0.00013489454,0.000002378443,0.00004984291,7.800478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034888904,0.00016988583,0.49498296,0.00004289957,0.00027849703,0.00020214925,0.00008781517,0.0000057420816,0.000011810407,0.000008098242,0.013284529,0.4874367],"study_design_scores_gemma":[0.005766294,0.0004873036,0.97058296,0.00016627717,0.00016691256,0.0038051899,0.000009147363,0.00004717279,0.000056743826,0.00009260252,0.018730465,0.00008890655],"about_ca_topic_score_codex":0.00015995023,"about_ca_topic_score_gemma":0.000018287798,"teacher_disagreement_score":0.4873478,"about_ca_system_score_codex":0.00011310064,"about_ca_system_score_gemma":0.0002050027,"threshold_uncertainty_score":0.38577068},"labels":[],"label_agreement":null},{"id":"W2022249597","doi":"10.1007/s00277-006-0149-6","title":"Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa; St. Paul's Hospital","funders":"","keywords":"Follicular lymphoma; Hematology; Lymphoma; Medicine; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Internal medicine; Haematopoiesis; Oncology; Hematopoietic cell; Autologous stem-cell transplantation; Follicular phase; Biology","score_opus":0.014911367398650708,"score_gpt":0.2537675452173268,"score_spread":0.2388561778186761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022249597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963148,0.0008123619,0.0002948753,0.00067945593,0.00007206542,0.001004924,0.000057519846,0.000042689953,0.0007213045],"genre_scores_gemma":[0.9982785,0.00005412491,0.00079137716,0.0002593644,0.000012634128,0.00020243054,0.00030644995,0.00002442751,0.0000706869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987184,0.000035819845,0.00044396776,0.00028779806,0.00020782692,0.00030618414],"domain_scores_gemma":[0.99908835,0.00015058389,0.00023886951,0.00025101224,0.00019760907,0.00007358648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005419914,0.00019694511,0.0005740529,0.0001055589,0.000056520996,0.000005024374,0.000057753638,0.00014521701,0.000009816567],"category_scores_gemma":[0.0000051831644,0.00014273153,0.00016694861,0.000098223514,0.000068675865,0.000043191343,0.000007911208,0.000025579639,0.000010515416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029569913,0.011750944,0.95340645,0.002296506,0.00042850434,0.00038426794,0.0008743346,0.00004617656,0.0002083546,0.015326741,0.0049093105,0.0074114394],"study_design_scores_gemma":[0.027386054,0.007699806,0.6404184,0.00042867914,0.0008130154,0.00038876652,0.00015368836,0.000074158736,0.3194243,0.0009595871,0.0018208898,0.00043263525],"about_ca_topic_score_codex":0.00006432333,"about_ca_topic_score_gemma":0.000010191585,"teacher_disagreement_score":0.31921592,"about_ca_system_score_codex":0.000020822568,"about_ca_system_score_gemma":0.00006918706,"threshold_uncertainty_score":0.5820423},"labels":[],"label_agreement":null},{"id":"W2022331869","doi":"10.1016/s1083-8791(03)80074-5","title":"73 The ottawa 10-year experience in allogeneic stem cell transplantation for follicular lymphoma","year":2003,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Follicular lymphoma; Transplantation; Follicular phase; Stem cell; Lymphoma; Oncology; Internal medicine; Genetics; Biology","score_opus":0.014818859710558513,"score_gpt":0.2513551781423425,"score_spread":0.23653631843178397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022331869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669546,0.0016244809,0.00032542675,0.00012396497,0.00005700705,0.0005750046,0.00006768364,0.000010901656,0.0005200617],"genre_scores_gemma":[0.9958696,0.0028844802,0.0007303732,0.00008406055,0.000013616811,0.00019052549,0.0001559396,0.000008163936,0.00006327124],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923277,0.00007818235,0.00025043642,0.00021748712,0.00006374796,0.00015738809],"domain_scores_gemma":[0.9996156,0.00014243824,0.000070447946,0.00009852216,0.000032068016,0.000040916213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015657829,0.00012055043,0.00020607478,0.000062267005,0.000056287165,0.00000468016,0.000039164315,0.0001061511,0.00001645281],"category_scores_gemma":[0.0000040107266,0.000082311046,0.00006884509,0.00007669624,0.00007726506,0.000038592883,0.0000011879192,0.00001976388,0.0000013737636],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012999898,0.0011689067,0.49968064,0.0010443967,0.00023332285,0.00008728276,0.0064391624,0.000013976892,0.4698198,0.007258742,0.000043372336,0.012910382],"study_design_scores_gemma":[0.015170409,0.0010406717,0.1848617,0.00011317418,0.0008867622,0.00022918086,0.00061308354,0.000013357368,0.79510176,0.0002020222,0.0015933558,0.00017449206],"about_ca_topic_score_codex":0.000056936435,"about_ca_topic_score_gemma":0.000071674796,"teacher_disagreement_score":0.32528198,"about_ca_system_score_codex":0.000011515467,"about_ca_system_score_gemma":0.000044116012,"threshold_uncertainty_score":0.3356547},"labels":[],"label_agreement":null},{"id":"W2022335609","doi":"10.4021/jocmr2009.12.1284","title":"A Primary Testicular Diffuse Large B-cell Lymphoma Belonging to the Germinal Center B-cell-like Group","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Pathology; Spermatic cord; Germinal center; Rituximab; Seminoma; B-cell lymphoma; Rete testis; CD20; B cell; Chemotherapy; Epididymis; Internal medicine; Antibody; Immunology","score_opus":0.0698584640260051,"score_gpt":0.4444178761701387,"score_spread":0.37455941214413363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022335609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538405,0.001083557,0.0000919249,0.038059406,0.0014859232,0.00067005365,0.0000066787284,0.000015116017,0.004746824],"genre_scores_gemma":[0.9867072,0.0009763098,0.0013680486,0.0047695534,0.0050771646,0.00002932426,0.000009273681,0.00004432648,0.0010187691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936405,0.0005756231,0.0018374708,0.00040734242,0.0026669467,0.00087215746],"domain_scores_gemma":[0.9910754,0.00517879,0.00043607363,0.000796799,0.0010721749,0.0014407487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011916168,0.00026431703,0.0011161746,0.00043159578,0.00027245152,0.000047565623,0.00058994297,0.00023822387,0.00025638784],"category_scores_gemma":[0.0050935233,0.00013002986,0.0004816022,0.0006128786,0.00043837592,0.00010410187,0.00029988994,0.0017700866,0.00017940004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032629436,0.05779355,0.6138993,0.00038322873,0.0004327066,0.009545866,0.00079632085,6.07055e-7,0.0057423245,0.00027539307,0.1792029,0.12866485],"study_design_scores_gemma":[0.06204768,0.008450157,0.5815848,0.00090774684,0.0003748322,0.0017639439,0.00035009452,0.00010465145,0.00056661386,0.000101341684,0.3435685,0.00017961809],"about_ca_topic_score_codex":0.00005835957,"about_ca_topic_score_gemma":0.000031025134,"teacher_disagreement_score":0.16436562,"about_ca_system_score_codex":0.00017599169,"about_ca_system_score_gemma":0.00070146675,"threshold_uncertainty_score":0.7690244},"labels":[],"label_agreement":null},{"id":"W2022946612","doi":"10.1007/s11899-014-0214-5","title":"Chemotherapy Only in Early Stage Hodgkin Lymphoma: More Relapses but the Same Survival – What to Do?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Medicine; Lymphoma; Stage (stratigraphy); Hodgkin's lymphoma; Chemotherapy; Radiation therapy; Hodgkin lymphoma; Internal medicine; Dacarbazine; Randomized controlled trial; Survival rate; Positron emission tomography; Oncology; Surgery; Radiology; Vincristine; Cyclophosphamide","score_opus":0.024286227314749415,"score_gpt":0.3011997911824983,"score_spread":0.2769135638677489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022946612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838459,0.008438315,0.00005533407,0.0034956248,0.0015832379,0.0014117219,0.0000064678175,0.00012252436,0.0010408643],"genre_scores_gemma":[0.9959638,0.0020048327,0.00018209722,0.00079231727,0.00013884922,0.00024047955,0.00003370401,0.00004222819,0.00060167565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967336,0.00015433735,0.00094237743,0.0008815321,0.0006421818,0.00064599345],"domain_scores_gemma":[0.9977357,0.00021853858,0.00041426666,0.0012328019,0.00012599409,0.0002727443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070992566,0.0004678371,0.0009441758,0.00016108039,0.00012394754,0.0001566663,0.00019561712,0.00016753464,0.00014031454],"category_scores_gemma":[0.0003402293,0.0002851472,0.00026297214,0.0004158383,0.00010603711,0.00019497515,0.00011800012,0.00014244548,0.00007452319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011520835,0.0016152853,0.909737,0.00020027952,0.00007548851,0.002608219,0.0012652605,0.0000041990743,0.000045017387,0.003066776,0.0016833196,0.07958399],"study_design_scores_gemma":[0.0036890714,0.0005382037,0.9401551,0.0021827673,0.000118365606,0.0029250225,0.0012929295,0.000018790033,0.0048546637,0.0015396331,0.042098366,0.0005870974],"about_ca_topic_score_codex":0.00023859374,"about_ca_topic_score_gemma":0.000050842078,"teacher_disagreement_score":0.07899689,"about_ca_system_score_codex":0.00023977367,"about_ca_system_score_gemma":0.00023554801,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W2023053101","doi":"10.1053/crad.2000.0449","title":"Low Grade Gastric MALT Lymphoma:Radiographic Findings","year":2000,"lang":"en","type":"article","venue":"Clinical Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital","funders":"","keywords":"Medicine; MALT lymphoma; Lymphoma; Stomach; Helicobacter pylori; Gastric lymphoma; Mucosa-associated lymphoid tissue; Radiography; Lymphatic system; Gastroenterology; Radiology; Pathology; Internal medicine","score_opus":0.0323167742173704,"score_gpt":0.33631644663870813,"score_spread":0.30399967242133774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023053101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098283,0.0012632317,0.000007760649,0.00267342,0.00046522706,0.00036379104,0.000009377431,0.00012706553,0.0041072927],"genre_scores_gemma":[0.98819286,0.0051746196,0.0005225901,0.0040616393,0.00061796216,0.00006851652,0.00007201529,0.000028058417,0.0012617442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977133,0.00019148413,0.00076417654,0.0006133722,0.00016026018,0.00055739743],"domain_scores_gemma":[0.9981049,0.0007950801,0.00007726851,0.00052654214,0.0000349333,0.00046131393],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003967395,0.00024877198,0.00082817895,0.00016012027,0.00009305732,0.000012665803,0.00016402581,0.00038382708,0.0021215237],"category_scores_gemma":[0.00024095805,0.00018990181,0.00056069205,0.00039365148,0.00043796646,0.00004135604,0.000024997806,0.00017437241,0.0011251153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003554793,0.0022277103,0.7802262,0.000017027449,0.0002997143,0.0007698994,0.000022846414,0.0000030990918,0.00003163449,0.00045925903,0.020404939,0.19518222],"study_design_scores_gemma":[0.008053272,0.002023427,0.9366138,0.000050586546,0.00025933897,0.0017957159,0.000008296015,0.00008609997,0.0001040775,0.0003668264,0.05046114,0.00017740921],"about_ca_topic_score_codex":0.000028438828,"about_ca_topic_score_gemma":0.000003855828,"teacher_disagreement_score":0.1950048,"about_ca_system_score_codex":0.00010184505,"about_ca_system_score_gemma":0.00013448323,"threshold_uncertainty_score":0.9996526},"labels":[],"label_agreement":null},{"id":"W2023285691","doi":"10.1371/journal.pone.0065156","title":"Early Stage W.H.O. Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Follicular lymphoma; Stage (stratigraphy); Radiation therapy; International Prognostic Index; Internal medicine; Retrospective cohort study; Lymphoma; Population; Gastroenterology; Progression-free survival; Cancer; Surgery; Chemotherapy; Rituximab","score_opus":0.024767316880463432,"score_gpt":0.21726420357040518,"score_spread":0.19249688668994175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023285691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957614,0.0014145226,0.0000015653379,0.0012947682,0.000005551098,0.0010179821,0.000008631155,0.000087699766,0.00040786562],"genre_scores_gemma":[0.9953777,0.0015574615,0.0005604722,0.00034476077,0.00005643729,0.00030360735,0.000057945883,0.00002863248,0.0017129502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911183,0.000023377297,0.0001360877,0.00024153532,0.00028614985,0.00020104625],"domain_scores_gemma":[0.99943644,0.000030077672,0.00005939118,0.0002401175,0.00007135762,0.00016260448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028041484,0.00016696195,0.0003076227,0.000067995265,0.000101300415,0.00003803101,0.000030467922,0.00006385756,0.00015629476],"category_scores_gemma":[0.000008283182,0.00010999058,0.00003601792,0.00012827262,0.00004151179,0.00013028625,0.000013345565,0.000028767747,0.0000634206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021988702,0.009066884,0.9476385,0.000046349276,0.0016972154,0.000103587,0.0005728733,3.171658e-7,0.019960096,0.00008627205,0.0001959312,0.0204121],"study_design_scores_gemma":[0.010574958,0.0021365525,0.87259644,0.000102253856,0.00026439197,0.000009856885,0.00002341212,0.00009342367,0.1137307,0.000016638289,0.0003244169,0.00012697373],"about_ca_topic_score_codex":0.0014535311,"about_ca_topic_score_gemma":0.0000086978125,"teacher_disagreement_score":0.0937706,"about_ca_system_score_codex":0.000095349315,"about_ca_system_score_gemma":0.00003203229,"threshold_uncertainty_score":0.44852856},"labels":[],"label_agreement":null},{"id":"W2023428359","doi":"10.1016/j.clml.2014.12.015","title":"Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Roche","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Plerixafor; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Autologous stem-cell transplantation; Vincristine; Chemoimmunotherapy; Etoposide; Progression-free survival; Cyclophosphamide; Gastroenterology; Chemotherapy","score_opus":0.02383174685501354,"score_gpt":0.28165116699961157,"score_spread":0.257819420144598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023428359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955068,0.00039329694,0.00019457663,0.00011007812,0.000089323745,0.002006561,0.00023993409,0.0001183908,0.0013410171],"genre_scores_gemma":[0.9971073,0.00013720033,0.001062056,0.00026713195,0.000045599896,0.0002259189,0.00064490427,0.00013484673,0.0003750211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99539393,0.00019479734,0.0013385549,0.0011388408,0.0012570707,0.0006768161],"domain_scores_gemma":[0.99657595,0.00037112398,0.000768945,0.00078896765,0.00057222706,0.0009227698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036767422,0.0008260036,0.0018474236,0.00015511317,0.00013138901,0.000066696404,0.00021985099,0.00030585006,0.000026082347],"category_scores_gemma":[0.00001909741,0.00048476248,0.00016410746,0.0004921015,0.00063420343,0.00026379726,0.000051669034,0.00016311987,0.000033769855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014668599,0.0039858,0.94939256,0.00046395394,0.00076422456,0.00060830096,0.00053757906,0.000006128263,0.000027770397,0.000022796308,0.00088072056,0.02864156],"study_design_scores_gemma":[0.12537977,0.013520992,0.8533948,0.0009687151,0.002163129,0.00018434576,0.00034740943,0.00007120559,0.002758391,0.0000033249785,0.0005888753,0.0006190458],"about_ca_topic_score_codex":0.00033983993,"about_ca_topic_score_gemma":0.00008387698,"teacher_disagreement_score":0.11071117,"about_ca_system_score_codex":0.00093958474,"about_ca_system_score_gemma":0.0009423646,"threshold_uncertainty_score":0.9997604},"labels":[],"label_agreement":null},{"id":"W2023505313","doi":"10.1016/j.ijrobp.2008.06.422","title":"Extra Nodal Marginal Zone Lymphoma of MALT Type: Radiotherapy is Potentially Curative for Localized Disease","year":2008,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Thyroid; Gastroenterology; Stage (stratigraphy); MALT lymphoma; Internal medicine; Stomach; Surgery","score_opus":0.02655772059497044,"score_gpt":0.3373899315596678,"score_spread":0.3108322109646974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023505313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92178345,0.0030815282,0.06360378,0.008312643,0.0021165602,0.00058249827,0.00028407446,0.000025811332,0.00020964222],"genre_scores_gemma":[0.97973555,0.003388336,0.01299386,0.0019125752,0.0015746185,0.00002606953,0.00016403125,0.00003052925,0.00017444447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983628,0.00011599343,0.00075283373,0.00022702293,0.0003314803,0.00020988916],"domain_scores_gemma":[0.9970564,0.00031776627,0.0010053583,0.00014973118,0.0012683508,0.00020236195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021320552,0.00021423007,0.00060451863,0.00015413856,0.00007832496,0.000010772362,0.0002327605,0.00015952809,0.0001841534],"category_scores_gemma":[0.00014750168,0.00017502766,0.0004141747,0.00013495232,0.000259996,0.00019022587,0.000024213969,0.000109699664,0.000011405223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015509683,0.0053235064,0.6034255,0.000040398845,0.0041955933,0.0005337433,0.0012104984,0.00044161122,0.006561454,0.012555941,0.012763264,0.33743882],"study_design_scores_gemma":[0.10149036,0.012496665,0.5095043,0.00030803608,0.0013270632,0.002230397,0.00016008253,0.010187357,0.0207263,0.007758866,0.33310103,0.0007095317],"about_ca_topic_score_codex":0.000022415097,"about_ca_topic_score_gemma":0.0000011221381,"teacher_disagreement_score":0.3367293,"about_ca_system_score_codex":0.0008231535,"about_ca_system_score_gemma":0.0013945902,"threshold_uncertainty_score":0.7137421},"labels":[],"label_agreement":null},{"id":"W2023887842","doi":"10.1016/j.ijrobp.2012.07.1657","title":"A Single Institution Experience of Extranodal Natural Killer/T-cell Lymphoma of Nasal Type","year":2012,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Natural killer T cell; Pathology; Immunology; T cell","score_opus":0.024176598210445006,"score_gpt":0.32319545028693963,"score_spread":0.29901885207649465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023887842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111116,0.002046969,0.000680269,0.00037018713,0.0045542507,0.00013403535,0.000013952082,0.000011450881,0.0010777544],"genre_scores_gemma":[0.99594575,0.0003972918,0.0022784504,0.00021808989,0.0010599088,0.0000052062546,0.000042753163,0.000012032634,0.000040527564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862105,0.000091986214,0.00068726303,0.00012199952,0.00029281952,0.00018489937],"domain_scores_gemma":[0.9979353,0.00019892372,0.00096702593,0.00011705073,0.0006711195,0.00011060406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002252554,0.00014848768,0.00043033046,0.00013849107,0.000031869276,0.0000060050083,0.00019079806,0.00015667905,0.000056957393],"category_scores_gemma":[0.00018110924,0.00011950672,0.00020935271,0.0001556651,0.00022933968,0.00031182088,0.000037921498,0.00011299182,0.000012371153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011930652,0.005823613,0.78002137,0.00002279734,0.0005552112,0.000028120954,0.0022893234,0.0000731004,0.07221804,0.01059604,0.00054309354,0.12663624],"study_design_scores_gemma":[0.029819174,0.0055897506,0.523757,0.0002606127,0.00048232253,0.0009489183,0.0005492828,0.00073256285,0.38781035,0.0013395763,0.048328176,0.0003823136],"about_ca_topic_score_codex":0.00003125838,"about_ca_topic_score_gemma":0.0000014378754,"teacher_disagreement_score":0.31559232,"about_ca_system_score_codex":0.0006723762,"about_ca_system_score_gemma":0.00046459466,"threshold_uncertainty_score":0.48733428},"labels":[],"label_agreement":null},{"id":"W2024291886","doi":"10.1038/sj.bmt.1702541","title":"Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation","year":2000,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Melphalan; Autologous stem-cell transplantation; Etoposide; Internal medicine; Transplantation; Surgery; Oncology; Cyclophosphamide; Radiation therapy; Salvage therapy; Chemotherapy","score_opus":0.010594089658352995,"score_gpt":0.24029274420585015,"score_spread":0.22969865454749716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024291886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915319,0.0013656738,0.00034028044,0.0022430744,0.00010833604,0.0035228427,0.0005923708,0.00013748366,0.00015802676],"genre_scores_gemma":[0.98665,0.007034326,0.002573677,0.0010630228,0.000068898655,0.00071800227,0.0012072946,0.00007110446,0.0006136681],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979114,0.00006270139,0.00046852778,0.00075255183,0.00036866576,0.00043613662],"domain_scores_gemma":[0.9987472,0.0002008953,0.0001295498,0.0002713218,0.00017659224,0.00047439075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001434308,0.00046568585,0.0005892796,0.00017462007,0.00024388882,0.00008461506,0.00006253075,0.00014467102,0.00007789997],"category_scores_gemma":[0.0000024699984,0.00036469233,0.00008975088,0.00020274906,0.00008981794,0.00023884619,0.000004414479,0.000104071136,0.00001529619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31765932,0.002786113,0.14401622,0.0047837603,0.001033208,0.0066674496,0.02068746,0.00076989474,0.026589625,0.0015771963,0.0008687825,0.47256097],"study_design_scores_gemma":[0.048427463,0.0025307937,0.9175032,0.0004934324,0.0014578196,0.0004848495,0.00021052276,0.00014060322,0.027656043,0.00012938373,0.0004332485,0.0005326377],"about_ca_topic_score_codex":0.00081149105,"about_ca_topic_score_gemma":0.00028737588,"teacher_disagreement_score":0.773487,"about_ca_system_score_codex":0.0000928798,"about_ca_system_score_gemma":0.00013480033,"threshold_uncertainty_score":0.9998805},"labels":[],"label_agreement":null},{"id":"W2024595809","doi":"10.1016/j.ygyno.2004.01.011","title":"Primary extranodal marginal zone B-cell lymphoma of MALT type of the endometrium","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pathology; MALT lymphoma; Endometrium; Lymphoma; Medicine; Mucosa-associated lymphoid tissue; Marginal zone; Lymphatic system; B cell; Internal medicine; Immunology; Antibody","score_opus":0.022911765660753956,"score_gpt":0.2820026087674815,"score_spread":0.25909084310672753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024595809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579987,0.0012836029,0.000020000523,0.0016104843,0.00061292265,0.0005674638,0.000015540223,0.000022515052,0.037868805],"genre_scores_gemma":[0.99498284,0.00031372963,0.002992489,0.00084014586,0.00005982851,0.00004001104,0.000014519163,0.000012196414,0.00074424926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866307,0.00009875992,0.00044313387,0.0002507471,0.00023976168,0.00030453902],"domain_scores_gemma":[0.99854356,0.00052515784,0.00030162543,0.00038022536,0.00015991999,0.0000895081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024315236,0.00016795611,0.00065659895,0.00012782484,0.00004950445,0.0000022091663,0.00019046203,0.0002427843,0.000425003],"category_scores_gemma":[0.00022494237,0.0001029128,0.00020540859,0.00046662102,0.00030333668,0.000027346156,0.0001126249,0.00008500073,0.00005129528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037294147,0.047976114,0.6876317,0.0008721123,0.0008334544,0.0015511939,0.00072480075,0.0002045361,0.098974586,0.0074654017,0.0040430175,0.14599366],"study_design_scores_gemma":[0.02093524,0.007272938,0.9019608,0.000035839912,0.0003485481,0.00028085086,0.00010009532,0.000002279255,0.05061842,0.00032252874,0.01801197,0.000110519875],"about_ca_topic_score_codex":0.00011571074,"about_ca_topic_score_gemma":0.00003365413,"teacher_disagreement_score":0.21432906,"about_ca_system_score_codex":0.0008578138,"about_ca_system_score_gemma":0.001190128,"threshold_uncertainty_score":0.46534848},"labels":[],"label_agreement":null},{"id":"W2025438336","doi":"10.4021//jmc.v3i4.633","title":"Probable Bexarotene Hepatotoxicity Associated With Transient Serum Antimitochondrial Antibodies","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bexarotene; Medicine; Pathology; Primary biliary cirrhosis; Antibody; Liver biopsy; Gastroenterology; Cirrhosis; Internal medicine; Lymphoma; Biopsy; Immunology","score_opus":0.030722816250912253,"score_gpt":0.2923016013439598,"score_spread":0.26157878509304755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025438336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928171,0.0016169044,0.00006017739,0.004463854,0.00046547395,0.00022828938,0.000012915742,0.000018945795,0.00031630934],"genre_scores_gemma":[0.9975071,0.00046828645,0.00044478234,0.0006342668,0.0008559159,0.0000058987475,0.0000067739943,0.000015533624,0.000061465296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973207,0.0000863635,0.00047092026,0.000106662046,0.0016311632,0.00038420744],"domain_scores_gemma":[0.9983783,0.00027575454,0.0002755836,0.00011781731,0.00021486798,0.0007377069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006334745,0.00017169536,0.00057936384,0.00009485927,0.00007957355,0.000019478393,0.00009167608,0.00016002858,0.0004076899],"category_scores_gemma":[0.00097140647,0.00009486247,0.0001934192,0.00015591958,0.000120772704,0.00018190549,0.000020502373,0.00025592578,0.000007827436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001396909,0.006351888,0.9639899,0.0000915324,0.0010016916,0.008110745,0.00042223342,0.0000048199854,0.00034895606,0.000091712725,0.013104571,0.0050850366],"study_design_scores_gemma":[0.018583326,0.0073606903,0.9247507,0.002728806,0.0014638987,0.019198943,0.00031727616,0.00006156397,0.017962275,0.000018723738,0.007255985,0.00029780634],"about_ca_topic_score_codex":0.00003546623,"about_ca_topic_score_gemma":0.000034583492,"teacher_disagreement_score":0.039239198,"about_ca_system_score_codex":0.00017601899,"about_ca_system_score_gemma":0.00040795392,"threshold_uncertainty_score":0.44639185},"labels":[],"label_agreement":null},{"id":"W2025822036","doi":"10.1097/01.pas.0000213334.40358.0e","title":"Expression of TRAF1 and Nuclear c-Rel Distinguishes Primary Mediastinal Large Cell Lymphoma From Other Types of Diffuse Large B-cell Lymphoma","year":2006,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Immunohistochemistry; Pathology; Cancer research; Biology; BCL10; B cell; Medicine; Immunology; Antibody","score_opus":0.006358811031634059,"score_gpt":0.2224163459182974,"score_spread":0.21605753488666335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025822036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510103,0.0026122201,0.000026559877,0.00032795683,0.000082887076,0.000101862606,0.00010382201,0.000013605712,0.0016300806],"genre_scores_gemma":[0.99800646,0.00051830657,0.0009130431,0.00022922692,0.00024106589,0.0000024280034,0.000009296945,0.00003734063,0.000042818017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817866,0.0002860078,0.0006891379,0.00020274596,0.00034211678,0.00030131006],"domain_scores_gemma":[0.9977614,0.00066677376,0.001043163,0.00025917267,0.00012502105,0.00014445854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036588337,0.0002117489,0.0009825578,0.00009421485,0.00006505375,0.0000074691193,0.00017212465,0.00007342329,0.000060905546],"category_scores_gemma":[0.00004328361,0.00012171385,0.00023659413,0.00013952739,0.00058224786,0.000042664833,0.00009590199,0.000095912634,0.000005884883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020376485,0.10678463,0.58397496,0.00042566238,0.0005415482,0.014866145,0.007381174,0.000012624772,0.18531749,0.0010047234,0.0044648247,0.07484972],"study_design_scores_gemma":[0.058190823,0.0041555357,0.89785886,0.00040139622,0.00076065765,0.002345507,0.0014734431,0.000052280535,0.022035237,0.00034144038,0.012083164,0.0003016346],"about_ca_topic_score_codex":0.00016031894,"about_ca_topic_score_gemma":0.0000036584918,"teacher_disagreement_score":0.3138839,"about_ca_system_score_codex":0.00005860942,"about_ca_system_score_gemma":0.00008197438,"threshold_uncertainty_score":0.49633467},"labels":[],"label_agreement":null},{"id":"W2026003958","doi":"10.1182/blood-2013-08-523845","title":"Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Mantle cell lymphoma; Vincristine; Bortezomib; Rituximab; Internal medicine; Autologous stem-cell transplantation; Progression-free survival; Surgery; Chemoimmunotherapy; Cyclophosphamide; Oncology; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.01799034897380513,"score_gpt":0.29848352782711657,"score_spread":0.28049317885331143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026003958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949594,0.000097995755,0.00010785835,0.000052125048,0.000055963937,0.0035193919,0.00003839548,0.000053100684,0.0011157312],"genre_scores_gemma":[0.9980499,0.000008907638,0.00052786595,0.00010285586,0.000088118104,0.000729459,0.000068300564,0.000043191103,0.00038139356],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983051,0.0001788464,0.00038228402,0.0005426716,0.00024669792,0.000344422],"domain_scores_gemma":[0.9986737,0.00014891638,0.00019565853,0.0005202135,0.00027873943,0.00018280419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020725015,0.0002970498,0.0008190151,0.000091427275,0.00010785349,0.000019301759,0.00012548645,0.00007404338,0.000020852971],"category_scores_gemma":[0.000029424207,0.00019495441,0.00006410722,0.00017211692,0.0000709877,0.00008059896,0.000041660154,0.000046946483,0.00001952767],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004954995,0.7656544,0.2020648,0.00007613637,0.0012568331,0.0006109237,0.006093005,0.0000043976147,0.00068104715,0.00007388362,0.00014334137,0.018386245],"study_design_scores_gemma":[0.62226766,0.30510873,0.042883005,0.00009637492,0.0033518514,0.000105465835,0.014228538,0.00044115706,0.010256853,0.000011005511,0.0009269083,0.00032245647],"about_ca_topic_score_codex":0.0005351997,"about_ca_topic_score_gemma":0.0011085306,"teacher_disagreement_score":0.61731267,"about_ca_system_score_codex":0.00010549558,"about_ca_system_score_gemma":0.00014056332,"threshold_uncertainty_score":0.795001},"labels":[],"label_agreement":null},{"id":"W2026171879","doi":"10.1038/modpathol.3800409","title":"Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma","year":2005,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"University of Alberta","keywords":"Mantle cell lymphoma; Immunohistochemistry; International Prognostic Index; Mantle zone; Lymphoma; Tissue microarray; Medicine; Pathology; Internal medicine; Clinical significance; Univariate analysis; Stage (stratigraphy); Oncology; Biology; Cancer research; Germinal center; Diffuse large B-cell lymphoma; Multivariate analysis; Antibody; Immunology; B cell","score_opus":0.006463149020435679,"score_gpt":0.21456663470746837,"score_spread":0.20810348568703269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026171879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879396,0.00020417885,0.00008885181,0.00007291575,0.000050538267,0.00026961925,0.000010502516,0.000016506201,0.00049291836],"genre_scores_gemma":[0.99948376,0.000015539053,0.00027825468,0.00007953391,0.00002315122,0.000040507963,0.000019884152,0.00001742938,0.000041950483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990379,0.000041440104,0.00028289072,0.00026788894,0.00015300947,0.00021682183],"domain_scores_gemma":[0.99958044,0.000035805642,0.00008590302,0.0002171381,0.000041505056,0.000039198476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009030934,0.00012449968,0.00030499435,0.00013118828,0.000015809424,0.0000022739218,0.000045250563,0.00012530577,0.000015472766],"category_scores_gemma":[0.000015152958,0.000103325416,0.00004027718,0.000103961946,0.0000482704,0.000044841272,0.000031710555,0.00006719788,0.000010061563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056191324,0.002048489,0.9725212,0.000027357484,0.000012131737,0.00006881875,0.0011686004,0.000028164708,0.009379482,0.0000011774878,0.000004460237,0.014178209],"study_design_scores_gemma":[0.011169532,0.00051007647,0.9301152,0.000052689396,0.00003073444,0.000020417481,0.000034233934,0.00097478594,0.0569668,0.000016877153,0.000028642888,0.00007998628],"about_ca_topic_score_codex":0.00014502673,"about_ca_topic_score_gemma":0.00015835781,"teacher_disagreement_score":0.047587316,"about_ca_system_score_codex":0.0003254388,"about_ca_system_score_gemma":0.000040842082,"threshold_uncertainty_score":0.4213488},"labels":[],"label_agreement":null},{"id":"W2026214119","doi":"10.1038/sj.leu.2404856","title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation; U.S. Department of Health and Human Services","keywords":"BCL6; Diffuse large B-cell lymphoma; Biology; Lymphoma; Chromosomal translocation; Cancer research; Germinal center; B cell; Molecular biology; Gene; Genetics; Immunology; Antibody","score_opus":0.01082582329923507,"score_gpt":0.23512892316808737,"score_spread":0.2243030998688523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026214119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710655,0.00035305906,0.0015609395,0.00009897138,0.000048420636,0.00022771962,0.0000992836,0.000008747862,0.00049631594],"genre_scores_gemma":[0.99959755,0.000052694093,0.000054099466,0.00011072054,0.000026128231,0.000023884519,0.00008240661,0.000008723935,0.00004378238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991891,0.000027294616,0.00029035355,0.0001831869,0.00014279243,0.00016727386],"domain_scores_gemma":[0.99943507,0.0001806497,0.00010144328,0.0001527874,0.000053162952,0.000076910306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088426044,0.00013929718,0.00028982176,0.000094457726,0.000027010661,0.0000053037543,0.00003223859,0.00005871388,0.000032127715],"category_scores_gemma":[0.000022510309,0.000093037605,0.00007209581,0.00007786489,0.00008476664,0.000031393025,0.000030392328,0.000039002978,0.0000012394958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021222094,0.0034653184,0.95795333,0.00011298224,0.000093950934,0.00011374888,0.00082493905,0.0000033003937,0.032170452,0.0028403492,0.000024701181,0.002184706],"study_design_scores_gemma":[0.009021899,0.00019767789,0.78825736,0.00009739162,0.000045908284,0.00002088397,0.0003688669,0.000099292025,0.20159014,0.00019292193,0.000041182717,0.000066452805],"about_ca_topic_score_codex":0.000403214,"about_ca_topic_score_gemma":0.00027680153,"teacher_disagreement_score":0.16969594,"about_ca_system_score_codex":0.0002966521,"about_ca_system_score_gemma":0.00010205807,"threshold_uncertainty_score":0.37939635},"labels":[],"label_agreement":null},{"id":"W2026487055","doi":"10.1016/j.transci.2007.04.005","title":"The role of hematopoietic stem cell transplantation in advanced Hodgkin Lymphoma","year":2007,"lang":"en","type":"review","venue":"Transfusion and Apheresis Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Lymphoma; Hematopoietic stem cell transplantation; Medicine; Transplantation; Stem cell; Haematopoiesis; Hodgkin lymphoma; Hematopoietic cell; Cancer research; Oncology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.021311354776419458,"score_gpt":0.3072051083556846,"score_spread":0.28589375357926516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026487055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042911433,0.9530549,0.000009024636,0.000019982364,0.00005611809,0.0008125012,0.0000114909035,0.00001319038,0.0031113438],"genre_scores_gemma":[0.05000691,0.94971496,0.000098798795,0.000013259407,0.000008359125,0.000051876217,0.0000042128286,0.000013041685,0.00008859704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827504,0.000052333384,0.0005152704,0.0004079496,0.00045875888,0.00029062683],"domain_scores_gemma":[0.9991438,0.00028435705,0.00013322767,0.000265663,0.00004293529,0.00013004373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004959828,0.0002365034,0.00072438404,0.00018999315,0.00017695261,0.000027868993,0.0001808764,0.00011166422,0.000018213052],"category_scores_gemma":[0.000004107097,0.00013350722,0.00017783466,0.0008108346,0.000330515,0.00006867317,0.000013574557,0.00007182957,0.00000604766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004911231,0.00019400296,0.0001960112,0.0028485854,0.000007209699,0.00002468043,0.0003530389,2.2462696e-7,0.0001635808,0.00023973003,0.0000015179967,0.9959223],"study_design_scores_gemma":[0.008836013,0.0010461649,0.012961175,0.04374318,0.00199827,0.0005995693,0.0033278053,0.00005023316,0.026697723,0.0001931505,0.89955896,0.0009877768],"about_ca_topic_score_codex":0.000087209795,"about_ca_topic_score_gemma":0.00011324876,"teacher_disagreement_score":0.9949345,"about_ca_system_score_codex":0.00010195791,"about_ca_system_score_gemma":0.0003512907,"threshold_uncertainty_score":0.5444266},"labels":[],"label_agreement":null},{"id":"W2026508121","doi":"10.1111/j.1365-2125.2009.03494.x","title":"Development of a drug–disease simulation model for rituximab in follicular non‐Hodgkin's lymphoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Vincristine; CHOP; Cyclophosphamide; Confidence interval; Chemotherapy","score_opus":0.06277340527213665,"score_gpt":0.43320657698803455,"score_spread":0.3704331717158979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026508121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929735,0.0012567735,0.0037056482,0.0010930188,0.00034513284,0.0005479495,0.00001284924,0.0000062635713,0.000058850153],"genre_scores_gemma":[0.98098975,0.00048262306,0.015979996,0.0021270642,0.00033311217,0.000020426596,0.0000112364705,0.000011873186,0.000043899552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99736136,0.00009391784,0.0018426536,0.00020162911,0.0002618415,0.00023861202],"domain_scores_gemma":[0.9980718,0.00046603946,0.0006313195,0.00007597038,0.0004097152,0.00034514832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010404958,0.00012732507,0.0008797252,0.00012391737,0.000042918018,0.000009214038,0.00010919979,0.00010791235,0.00003392551],"category_scores_gemma":[0.00039838094,0.00012781251,0.00038398273,0.000112152324,0.000054538297,0.00009853734,0.000019278632,0.00012824162,0.0000028580325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009245854,0.028607812,0.016645577,0.00014888532,0.0005883772,0.0033399172,0.00027088242,0.021569299,0.0006248323,0.000025116475,0.008390268,0.9105432],"study_design_scores_gemma":[0.11447423,0.0010541879,0.57707936,0.0006524468,0.0009540833,0.00029400154,0.000029470173,0.2973663,0.0013040126,0.00075080135,0.005812166,0.00022897964],"about_ca_topic_score_codex":0.000004529375,"about_ca_topic_score_gemma":0.000007756018,"teacher_disagreement_score":0.9103142,"about_ca_system_score_codex":0.00014211211,"about_ca_system_score_gemma":0.0010942619,"threshold_uncertainty_score":0.5212043},"labels":[],"label_agreement":null},{"id":"W2026534042","doi":"10.1111/his.12624","title":"Computerized image analysis of the Ki‐67 proliferation index in mantle cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Helse Sør-Øst RHF; Norges Forskningsråd; Kreftforeningen","keywords":"Mantle cell lymphoma; Proliferation index; Lymphoma; Proliferative index; Pathology; Index (typography); Mantle (geology); Geology; Immunohistochemistry; Medicine; Computer science; Paleontology; World Wide Web","score_opus":0.005730258730849002,"score_gpt":0.22628088091513668,"score_spread":0.22055062218428767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026534042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557745,0.000086763146,0.000605159,0.00048091795,0.00013359037,0.00021187731,0.00000494908,0.000013510169,0.0028857978],"genre_scores_gemma":[0.99858713,0.0000113564265,0.0005647759,0.00047961474,0.000027631037,0.000035351277,0.00002559167,0.0000071727504,0.0002614003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921614,0.000103267914,0.00024945836,0.00019467794,0.000108671054,0.00012777744],"domain_scores_gemma":[0.9994202,0.00004552148,0.00011567084,0.00034232694,0.000043726206,0.000032528853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015555279,0.00009228965,0.0003762374,0.00020888248,0.00003192493,0.0000038793996,0.000071968665,0.00007258816,0.00004327179],"category_scores_gemma":[0.000027934158,0.00006239494,0.0001361715,0.00032852904,0.00008419933,0.000020978254,0.000040282433,0.00003260996,0.0000151315935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102416256,0.0009847212,0.97548735,0.00003409363,0.000027407941,0.00006428391,0.0004713711,0.000036493802,0.019366032,0.00041888832,0.00028066497,0.0027262503],"study_design_scores_gemma":[0.003230171,0.000117731004,0.9852118,0.000011461147,0.0003976654,0.000027116987,0.000010140969,0.004982565,0.004554627,0.000041452065,0.0013632077,0.000052100077],"about_ca_topic_score_codex":0.00009695299,"about_ca_topic_score_gemma":0.00010535227,"teacher_disagreement_score":0.014811404,"about_ca_system_score_codex":0.00015147726,"about_ca_system_score_gemma":0.000048357637,"threshold_uncertainty_score":0.25443918},"labels":[],"label_agreement":null},{"id":"W2026548922","doi":"10.3324/haematol.2011.040402","title":"Genomic profiles of MALT lymphomas: variability across anatomical sites","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Biology; Chromosome; Comparative genomic hybridization; MALT lymphoma; Chromosomal translocation; Genetics; Pathology; Evolutionary biology; Gene; Medicine","score_opus":0.05047863974647793,"score_gpt":0.2929303381884109,"score_spread":0.24245169844193298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026548922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989351,0.00029095422,0.000014334849,0.00012317361,0.000050775237,0.00045341667,0.000040243795,0.000085058986,0.009591042],"genre_scores_gemma":[0.9947828,0.000051423474,0.00483042,0.00014607988,0.000019438134,0.000089690795,0.000023218512,0.000011559999,0.00004539222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987425,0.000071541166,0.00038660318,0.00034731635,0.00014555197,0.00030649244],"domain_scores_gemma":[0.9990591,0.00013535278,0.00013472405,0.0004554813,0.00008275147,0.00013260212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023004896,0.00017591617,0.000594972,0.00003268237,0.000062091334,0.000004713372,0.00011964557,0.00015484376,0.0010781985],"category_scores_gemma":[0.00016776247,0.00011558949,0.00017111823,0.00011048074,0.00023633767,0.000037740294,0.00010807285,0.000052679115,0.00013582948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028934103,0.001543887,0.98511076,0.00014594551,0.000117107564,0.000275568,0.0005658718,7.774389e-8,0.0013794014,0.009063702,0.00028329185,0.0012250695],"study_design_scores_gemma":[0.0014861994,0.00036000894,0.9282975,0.000042394124,0.00009727847,0.00042498444,0.0001586199,0.000031746524,0.06688721,0.0018395509,0.00025799926,0.00011650492],"about_ca_topic_score_codex":0.00010065021,"about_ca_topic_score_gemma":0.000007345572,"teacher_disagreement_score":0.06550781,"about_ca_system_score_codex":0.00009423296,"about_ca_system_score_gemma":0.00008069123,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W2027091982","doi":"10.3109/10428194.2011.594193","title":"Is there a role for consolidative radiation therapy for aggressive B-cell lymphoma in the rituximab era?","year":2011,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Rituximab; Lymphoma; Medicine; Radiation therapy; Aggressive lymphoma; Oncology; Chemotherapy; Radioimmunotherapy; Internal medicine; Immunology; Monoclonal antibody; Antibody","score_opus":0.01890653494419384,"score_gpt":0.26031343238437393,"score_spread":0.2414068974401801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027091982","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7772925,0.07809823,0.0001666425,0.10245182,0.0017297779,0.022817938,0.004362013,0.0005154759,0.012565622],"genre_scores_gemma":[0.43609592,0.015681908,0.0012756186,0.518288,0.004847301,0.014242976,0.0049094255,0.0006695055,0.003989295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922803,0.0004432381,0.0016619996,0.002454907,0.0010905822,0.0020689652],"domain_scores_gemma":[0.9930777,0.0023835758,0.001748599,0.0018904883,0.000527891,0.00037177434],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007031662,0.002114908,0.0027191374,0.000719449,0.0007642137,0.00040886883,0.0010289974,0.0027558315,0.00012791506],"category_scores_gemma":[0.00019331614,0.0015239514,0.001418868,0.0006273908,0.00059649657,0.0003911399,0.00016010502,0.00044022594,0.00010978865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003644777,0.0023559325,0.0027181723,0.0010768485,0.0013676158,0.0015133198,0.007713294,0.0000014903749,0.00008177215,0.0003714313,0.7075318,0.27162355],"study_design_scores_gemma":[0.133078,0.0025190506,0.025455479,0.0010039663,0.0014258241,0.001479845,0.0009448339,0.0009685016,0.007142043,0.002376277,0.8218192,0.0017870156],"about_ca_topic_score_codex":0.002261479,"about_ca_topic_score_gemma":0.00005746241,"teacher_disagreement_score":0.41583622,"about_ca_system_score_codex":0.009130464,"about_ca_system_score_gemma":0.0069472077,"threshold_uncertainty_score":0.9991592},"labels":[],"label_agreement":null},{"id":"W2027092056","doi":"10.5732/cjc.012.10198","title":"Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases","year":2013,"lang":"en","type":"article","venue":"Chinese Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Bone marrow; Germinal center; Stage (stratigraphy); B symptoms; Gastroenterology; Oncology; B cell; Immunology; Biology","score_opus":0.01926320514715917,"score_gpt":0.33747069208428015,"score_spread":0.318207486937121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027092056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947304,0.003931397,0.0000052436853,0.00028251193,0.0005525636,0.00024051098,0.00003807763,0.0000050713006,0.0002142044],"genre_scores_gemma":[0.9896856,0.00898237,0.00017371628,0.000099233686,0.0007193512,0.000009568886,0.000016672286,0.000022853861,0.0002906545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793196,0.000051739135,0.0013209757,0.00017946969,0.00034728894,0.00016854571],"domain_scores_gemma":[0.996808,0.0002293699,0.0016669919,0.00028179018,0.00078992336,0.0002239033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028935066,0.00021098935,0.0008270227,0.00015928903,0.000029754445,0.0000140971615,0.00008470283,0.00011377498,0.000109800916],"category_scores_gemma":[0.000348647,0.00012126807,0.00026491986,0.0002284791,0.000067483095,0.00013885715,0.00004343949,0.00011370295,0.000005722379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035763293,0.009825957,0.98417777,0.00030979046,0.0001238093,0.00052790914,0.00012262244,9.4041006e-8,0.00096035947,0.0000018964233,0.0009151987,0.0026769552],"study_design_scores_gemma":[0.01390182,0.0006701767,0.98291785,0.000094548544,0.00049921154,0.0010165409,0.000024106817,0.00007561054,0.00018366169,0.000016083535,0.00050331553,0.00009708249],"about_ca_topic_score_codex":0.00008526387,"about_ca_topic_score_gemma":0.000010282634,"teacher_disagreement_score":0.013544188,"about_ca_system_score_codex":0.00009245878,"about_ca_system_score_gemma":0.0003501405,"threshold_uncertainty_score":0.49451685},"labels":[],"label_agreement":null},{"id":"W2027450972","doi":"10.1002/cyto.b.20362","title":"2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia","year":2007,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Standardization; Immunophenotyping; Lymphoma; Consensus conference; Pathology; Intensive care medicine; Medical physics; Flow cytometry; Immunology; Internal medicine; Computer science","score_opus":0.07494909770492787,"score_gpt":0.38956171434020775,"score_spread":0.3146126166352799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027450972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96318096,0.0013381195,0.0010991374,0.0009209659,0.0028098337,0.000695029,0.00022024877,0.00020278196,0.02953291],"genre_scores_gemma":[0.9903621,0.0006080703,0.0060105524,0.001159087,0.0007794706,0.000027128941,0.00015324532,0.00007432144,0.00082598784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99385995,0.00017465046,0.0025895033,0.0010314337,0.001459815,0.00088466937],"domain_scores_gemma":[0.9916349,0.004887689,0.00085447135,0.0011667332,0.00072207185,0.00073414674],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003012597,0.0005906455,0.0016707124,0.0026726248,0.00014902398,0.000065299675,0.0005054938,0.0006107088,0.0010345214],"category_scores_gemma":[0.004242204,0.00050710246,0.0008342421,0.0042213895,0.0005630481,0.000102967315,0.0002442467,0.0006546278,0.0007501556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002898199,0.0054822364,0.89334273,0.00017791301,0.0014436968,0.0007922503,0.000056523786,0.000009337548,0.0017043754,0.0014229482,0.005429733,0.08724005],"study_design_scores_gemma":[0.016476227,0.0030626953,0.9019023,0.0010301465,0.00061051775,0.0006226679,0.00034015355,0.0005243388,0.05437206,0.00024211708,0.019933755,0.0008830297],"about_ca_topic_score_codex":0.00003958849,"about_ca_topic_score_gemma":0.0000045639777,"teacher_disagreement_score":0.08635702,"about_ca_system_score_codex":0.00049319735,"about_ca_system_score_gemma":0.00040992178,"threshold_uncertainty_score":0.99987864},"labels":[],"label_agreement":null},{"id":"W2027529437","doi":"10.1016/j.dld.2013.05.008","title":"Primary intestinal B-cell lymphoma: A prospective multicentre clinical study of 91 cases","year":2013,"lang":"en","type":"article","venue":"Digestive and Liver Disease","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Prospective cohort study; Gastroenterology; Oncology","score_opus":0.022645607915575468,"score_gpt":0.28560438296451696,"score_spread":0.2629587750489415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027529437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521035,0.0018521607,0.0000012710693,0.000072714516,0.000041428797,0.0018385473,0.000032334952,0.000029969286,0.00092121225],"genre_scores_gemma":[0.99891746,0.00018201933,0.00010032724,0.00020365846,0.00006980172,0.00021409492,0.00002577728,0.000014029917,0.00027280868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988412,0.00008164783,0.00029538685,0.00039264397,0.0002043342,0.00018478552],"domain_scores_gemma":[0.9985495,0.00040838966,0.00011369552,0.0002194532,0.00024022508,0.00046871774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056354314,0.00019104253,0.00036956384,0.000052186722,0.00006583153,0.000019961113,0.000045815166,0.00003521999,0.00007560545],"category_scores_gemma":[0.00020231369,0.0001375736,0.00009482121,0.000096262236,0.00015412903,0.000114275375,0.00008719497,0.000052516083,0.000053669264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009322026,0.028093487,0.95431256,0.0001076748,0.00017150446,0.0014327411,0.0008755522,3.1621488e-7,0.000010768474,0.000016754579,0.00046837726,0.01357804],"study_design_scores_gemma":[0.013376885,0.0024041098,0.98122495,0.00013236201,0.00086595194,0.000026475305,0.0016335333,0.00007288777,0.00006209857,0.000011713267,0.00005765391,0.00013139044],"about_ca_topic_score_codex":0.0009865352,"about_ca_topic_score_gemma":0.000015020279,"teacher_disagreement_score":0.026912356,"about_ca_system_score_codex":0.0000883085,"about_ca_system_score_gemma":0.00018527564,"threshold_uncertainty_score":0.5610089},"labels":[],"label_agreement":null},{"id":"W2028043880","doi":"10.1586/erp.12.57","title":"Cost–effectiveness of rituximab in follicular lymphoma","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Oncology; Lymphoma; Life expectancy; Cost effectiveness; Internal medicine; Follicular phase; Quality-adjusted life year; Refractory (planetary science); Intensive care medicine; Population; Risk analysis (engineering)","score_opus":0.13706052877003747,"score_gpt":0.5745074355120686,"score_spread":0.4374469067420311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028043880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020202267,0.99013746,0.0000014078146,0.00014565574,0.0003550359,0.0075923745,0.00012208981,0.000014902782,0.0014290744],"genre_scores_gemma":[0.00032129118,0.99533993,0.00023132206,0.0002568713,0.00015301025,0.0032072898,0.00027677274,0.0001166305,0.00009686862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933979,0.0019955684,0.0022904892,0.0007467134,0.00068136636,0.0008879743],"domain_scores_gemma":[0.99468267,0.0027212459,0.00067588803,0.0011860165,0.00033533448,0.0003988751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005853023,0.00072150514,0.0079960255,0.0009029294,0.000049327256,0.00001623445,0.0006538882,0.00031692983,0.0006463721],"category_scores_gemma":[0.00031006496,0.0005171079,0.0021360922,0.00070939795,0.00023897648,0.00015241565,0.00041932942,0.0004384673,0.00031596716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048089936,0.0028729555,0.0010029094,0.26839975,0.0009649682,0.000060590093,0.000038219336,5.304712e-8,0.0000027469391,0.00015460528,0.000722064,0.72573304],"study_design_scores_gemma":[0.0053084185,0.000115450384,0.0004963778,0.15610275,0.00093652075,0.00006672839,0.000010579985,0.0000024168444,0.0002146963,0.0000062107883,0.83643264,0.00030721087],"about_ca_topic_score_codex":0.00037741038,"about_ca_topic_score_gemma":0.000004389147,"teacher_disagreement_score":0.8357106,"about_ca_system_score_codex":0.0023369405,"about_ca_system_score_gemma":0.00143991,"threshold_uncertainty_score":0.999728},"labels":[],"label_agreement":null},{"id":"W2028214577","doi":"10.1182/blood-2012-05-430389","title":"A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Rituximab; Tissue microarray; Immunohistochemistry; Vincristine; Survival analysis; Gene expression profiling; Pathology; Hematology; Cyclophosphamide; Chemotherapy; Biology; Gene expression","score_opus":0.00818017686283699,"score_gpt":0.2167461740695784,"score_spread":0.20856599720674143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028214577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958121,0.00035700147,0.00005318458,0.000044457833,0.00006563488,0.00062098296,0.000050025817,0.000060466427,0.0029361164],"genre_scores_gemma":[0.9984337,0.000008257827,0.0007664923,0.0001673087,0.00006710731,0.00011547302,0.00022375045,0.000028031896,0.00018984104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987376,0.000026774453,0.00019728455,0.0002739254,0.00030142395,0.00046300044],"domain_scores_gemma":[0.9991792,0.0000767602,0.00007792429,0.00037340837,0.000038582577,0.00025413558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000810195,0.00024012788,0.00030458302,0.00006272056,0.000041568288,0.0000099809695,0.00007839682,0.00011872168,0.000024177278],"category_scores_gemma":[0.000057171987,0.00016220895,0.0000676393,0.00012931821,0.000021929587,0.00004693565,0.000030817373,0.00006344928,0.000031704596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044502123,0.06293323,0.93569124,0.000054108757,0.000054049735,0.000026424947,0.00007723672,0.000009350476,0.00019756256,0.000019692878,0.000095662894,0.00039643797],"study_design_scores_gemma":[0.11187889,0.0011596315,0.8814911,0.00020035067,0.00032255406,0.0000025130932,0.000014620128,0.00056928664,0.0041046035,0.000005457753,0.000051652987,0.00019930254],"about_ca_topic_score_codex":0.000029978291,"about_ca_topic_score_gemma":0.0000020615655,"teacher_disagreement_score":0.11143387,"about_ca_system_score_codex":0.00015655682,"about_ca_system_score_gemma":0.00021490757,"threshold_uncertainty_score":0.6614689},"labels":[],"label_agreement":null},{"id":"W2028261606","doi":"10.1007/s40265-013-0092-5","title":"The Optimal Management of Follicular Lymphoma: An Evolving Field","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"Pharmacyclics; Genentech; Celgene; Teva Pharmaceutical Industries; American Society of Hematology","keywords":"Medicine; Follicular lymphoma; Rituximab; Chemoimmunotherapy; Radioimmunotherapy; Bendamustine; Oncology; Tolerability; Internal medicine; Lymphoma; Vincristine; Cyclophosphamide; Immunology; Chemotherapy; Adverse effect","score_opus":0.02607585979887412,"score_gpt":0.32327577265854934,"score_spread":0.29719991285967523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028261606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002007599,0.98945445,0.0000052629885,0.00009716835,0.00017991231,0.0012800253,0.0000070881592,0.000028815386,0.008746538],"genre_scores_gemma":[0.00026629254,0.99621934,0.0008784439,0.000056392902,0.00011242815,0.0005447862,0.00007178171,0.000037209124,0.0018132998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998585,0.00006107702,0.00046358086,0.00031232467,0.00031504364,0.00026300916],"domain_scores_gemma":[0.9985904,0.00019459358,0.00023062919,0.00079962687,0.00006617571,0.00011853907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001683827,0.00030691733,0.0009988975,0.000060500963,0.000101011996,0.000049039045,0.00022987164,0.0001538544,0.000124594],"category_scores_gemma":[0.000013181688,0.00016209499,0.00055116083,0.00014120499,0.00003742278,0.00005388742,0.00011742409,0.00006311468,0.00015092778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042272472,0.00027818675,0.000011458171,0.0051175603,0.0009220085,0.00008644799,0.00004945355,1.102469e-7,2.6061224e-8,0.0008118318,0.003849542,0.98886913],"study_design_scores_gemma":[0.00077403954,0.00017743671,0.00007988996,0.008162773,0.0027136675,0.00003697607,0.00013974239,0.000013894938,0.000010440239,0.00001164072,0.9877285,0.0001510308],"about_ca_topic_score_codex":0.0001047867,"about_ca_topic_score_gemma":9.1018234e-7,"teacher_disagreement_score":0.9887181,"about_ca_system_score_codex":0.0001934317,"about_ca_system_score_gemma":0.000107511805,"threshold_uncertainty_score":0.6610042},"labels":[],"label_agreement":null},{"id":"W2028313456","doi":"10.1111/j.1365-2141.2006.06080.x","title":"Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma*","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Stem cell; Haematopoiesis; Internal medicine; Chemoradiotherapy; Oncology; Hematology; Chemotherapy; Hematopoietic stem cell transplantation; Disease; Gastroenterology; Biology","score_opus":0.006630559670720683,"score_gpt":0.2195492214605781,"score_spread":0.2129186617898574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028313456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722733,0.024209276,0.000075272575,0.0004453089,0.00019674128,0.0002484549,0.000014885198,0.000015572929,0.0025212248],"genre_scores_gemma":[0.9868671,0.011803404,0.0006338885,0.0003919691,0.00008970649,0.000009072405,0.000028691311,0.000025614585,0.00015055729],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99818766,0.000097708435,0.0009241277,0.00017115369,0.00037884832,0.00024050551],"domain_scores_gemma":[0.9986743,0.000117488955,0.00061995804,0.00014362053,0.00032861292,0.00011604071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017206758,0.00016729845,0.0009312721,0.00016605621,0.00005242126,0.00001851033,0.00011480832,0.0001486699,0.000088460365],"category_scores_gemma":[0.000007472883,0.00015662902,0.00029011111,0.00013557052,0.0001262628,0.00010724194,0.000007888881,0.000092323135,0.00001802633],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031080463,0.011907773,0.19650874,0.002566716,0.000935668,0.5371978,0.0012812988,0.000039791394,0.0076375296,0.003834834,0.013038802,0.22194296],"study_design_scores_gemma":[0.016049996,0.001060457,0.25417486,0.0011117973,0.00033419183,0.6577309,0.0001539517,0.0000049882324,0.06704409,0.00092854904,0.0012273652,0.00017888559],"about_ca_topic_score_codex":0.00052261725,"about_ca_topic_score_gemma":0.000028565784,"teacher_disagreement_score":0.22176407,"about_ca_system_score_codex":0.00012418565,"about_ca_system_score_gemma":0.00041063564,"threshold_uncertainty_score":0.6387146},"labels":[],"label_agreement":null},{"id":"W2029046535","doi":"10.1155/2015/581470","title":"Kaposi’s Sarcoma Presenting as Acute Small Bowel Obstruction Diagnosed on Multidetector Computed Tomography with Histopathological Correlation","year":2015,"lang":"en","type":"article","venue":"Case Reports in Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sarcoma; Multidetector computed tomography; Computed tomography; Perforation; Radiology; Quadrant (abdomen); Pathology","score_opus":0.02789834588633486,"score_gpt":0.27169663842982517,"score_spread":0.2437982925434903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029046535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695474,0.00042502952,0.0001396438,0.00015682426,0.0006721829,0.00078947324,0.0000034677516,0.00012086299,0.0007377777],"genre_scores_gemma":[0.996926,0.000019911278,0.002411133,0.00016238887,0.00013215716,0.00015718596,0.000105082334,0.000021318996,0.000064818945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982789,0.00016532817,0.00050705665,0.00057396793,0.00016771331,0.00030701593],"domain_scores_gemma":[0.9986984,0.00023512194,0.00030501027,0.00041994368,0.00011792774,0.00022360444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026934707,0.00023528699,0.00047425667,0.00025871932,0.000071306895,0.0000125691495,0.000028396198,0.00023239473,0.000013220869],"category_scores_gemma":[0.00030864257,0.00017067474,0.00010219144,0.00022368871,0.0001546881,0.000048973332,0.00003158277,0.00021174575,0.000007651825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036704712,0.00036762492,0.54068226,0.000009556392,0.00007433532,0.45497486,0.00026332316,0.0003291537,0.000119051954,0.00004644942,0.00014654188,0.0026198048],"study_design_scores_gemma":[0.0035781586,0.0017247808,0.5177257,0.000066120585,0.00017361814,0.47450957,0.00009016046,0.0009140918,0.0005660168,0.000096866905,0.00040025625,0.00015467229],"about_ca_topic_score_codex":0.0002877195,"about_ca_topic_score_gemma":0.000069181726,"teacher_disagreement_score":0.022956578,"about_ca_system_score_codex":0.00041992724,"about_ca_system_score_gemma":0.00010830753,"threshold_uncertainty_score":0.6959914},"labels":[],"label_agreement":null},{"id":"W2029073097","doi":"10.1016/j.semcancer.2015.02.001","title":"Cell-secreted signals shape lymphoma identity","year":2015,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Ministero della Salute","keywords":"Tumor microenvironment; Autocrine signalling; Paracrine signalling; Biology; Lymphoma; Cell signaling; Cell biology; Secretion; Immune system; Cancer cell; Signal transduction; Cancer; Cancer research; Immunology; Cell culture; Genetics; Receptor; Biochemistry","score_opus":0.07919624698069105,"score_gpt":0.417635424327694,"score_spread":0.33843917734700296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029073097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096560386,0.9939401,9.0120193e-7,0.00010021357,0.0008295433,0.0011796199,0.0002878095,0.000049190403,0.0026469817],"genre_scores_gemma":[0.00045967568,0.99623454,0.00010496116,0.00024134504,0.00037276986,0.0011065941,0.0007224919,0.00006310731,0.0006945094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973885,0.00026169687,0.0007766042,0.00080110034,0.00021072703,0.00056138507],"domain_scores_gemma":[0.99845386,0.00024835864,0.00038806384,0.0005555395,0.000109638575,0.00024455696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042665337,0.0005801499,0.0028252148,0.00034937126,0.000038032766,0.000017985476,0.00030627052,0.0009795206,0.0008105767],"category_scores_gemma":[0.00006908072,0.0004239834,0.0004760585,0.00055242545,0.00017013925,0.0000552816,0.00018746394,0.0002240298,0.00024681768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031628886,0.00036479675,0.002445171,0.004239819,0.00024305776,0.0003160441,0.000048306516,1.5741746e-7,0.0000035094465,0.00005013455,0.01142191,0.98083544],"study_design_scores_gemma":[0.0017622707,0.0004511012,0.00019890662,0.015127862,0.0012508559,0.00013928952,0.000018452887,0.000005435554,0.000019575222,0.00015291972,0.98050296,0.0003703615],"about_ca_topic_score_codex":0.00085393107,"about_ca_topic_score_gemma":0.000108944856,"teacher_disagreement_score":0.9804651,"about_ca_system_score_codex":0.002336082,"about_ca_system_score_gemma":0.0017791345,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W2029325184","doi":"10.1002/hon.930","title":"Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program","year":2009,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Epidemiology; Incidence (geometry); Lymphoma; Chronic lymphocytic leukemia; Cohort; Multiple myeloma; Internal medicine; Surveillance, Epidemiology, and End Results; Oncology; Cancer; Demography; Leukemia; Cancer registry","score_opus":0.09203680189599868,"score_gpt":0.44985943269434053,"score_spread":0.35782263079834187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029325184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8137352,0.0007729262,0.000010813843,0.17870688,0.00014363547,0.0053682644,0.00002283661,0.000063991436,0.0011754588],"genre_scores_gemma":[0.9693423,0.00013259472,0.0016109686,0.027173366,0.00005227571,0.0015750987,0.00003875399,0.0000068068434,0.00006783278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967832,0.0010263704,0.0008471515,0.0005323464,0.00016139317,0.00064951694],"domain_scores_gemma":[0.9937445,0.0053546727,0.0002248802,0.00042418943,0.00006579049,0.00018596029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002441444,0.00025234005,0.0014724126,0.00006983185,0.00019315815,0.000014285995,0.00021105775,0.00016191068,0.000010295379],"category_scores_gemma":[0.0022003138,0.000107610795,0.00012608095,0.00022809848,0.00018433819,0.000017918397,0.000050906234,0.0001302609,0.00001828771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013694428,0.007173019,0.9271225,0.000019949433,0.00007494946,0.00025845377,0.002081151,0.0000065575923,0.0000014217547,0.008471863,0.011281189,0.04213951],"study_design_scores_gemma":[0.007415847,0.01515152,0.92055935,0.000021498567,0.00003681022,0.00084317,0.0022072627,0.000037289166,0.0000042623906,0.0009058878,0.052711993,0.00010508826],"about_ca_topic_score_codex":0.00024171919,"about_ca_topic_score_gemma":0.0012814427,"teacher_disagreement_score":0.15560712,"about_ca_system_score_codex":0.0002153503,"about_ca_system_score_gemma":0.00019133162,"threshold_uncertainty_score":0.4388241},"labels":[],"label_agreement":null},{"id":"W2029653604","doi":"10.1182/blood-2013-07-512830","title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Gastrointestinal tract; Lymphoma; Disease; Medicine; Lymphoproliferative disease; Lymphoproliferative disorders; Immunology; Pathology; Internal medicine","score_opus":0.008360033305339735,"score_gpt":0.214086726527523,"score_spread":0.20572669322218326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029653604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956944,0.00025339916,0.0000030365593,0.0008998983,0.000025514313,0.00050935196,0.000011704085,0.0000133096055,0.002589407],"genre_scores_gemma":[0.99893737,0.000010501977,0.0002989803,0.00026174713,0.00005385302,0.00010267363,0.0000047793365,0.000008231438,0.00032183703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939394,0.000023762637,0.00014371357,0.00012656045,0.00017956844,0.00013246803],"domain_scores_gemma":[0.99943423,0.000039188475,0.00006743417,0.000245331,0.00007056985,0.00014321954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025517726,0.00009699831,0.0001384396,0.000019187975,0.000034548993,0.00000917623,0.000057648,0.000013282284,0.00016799274],"category_scores_gemma":[0.00004401277,0.000052405227,0.000118584336,0.00006108338,0.00004757411,0.00003140287,0.000028641005,0.0000359923,0.0000716302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026129595,0.005219835,0.991161,0.00003804313,0.0000196701,0.000041204734,0.00009033769,0.0000013567769,0.0024574082,0.000057193396,0.000452843,0.0004349988],"study_design_scores_gemma":[0.004715858,0.00026597778,0.95146656,0.00015438964,0.00024574762,0.00011643847,0.00004325723,0.000019850724,0.04282752,0.000050800627,0.00004909089,0.000044533917],"about_ca_topic_score_codex":0.00006348006,"about_ca_topic_score_gemma":0.0000012814866,"teacher_disagreement_score":0.040370114,"about_ca_system_score_codex":0.000029858507,"about_ca_system_score_gemma":0.00015312764,"threshold_uncertainty_score":0.21370232},"labels":[],"label_agreement":null},{"id":"W2029779613","doi":"10.1158/1538-7445.am2014-5071","title":"Abstract 5071: A genome-wide association study suggests evidence of variants at 6p21.32 associated with marginal zone lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Biology; Single-nucleotide polymorphism; Genetic association; Linkage disequilibrium; Odds ratio; Genotyping; Genetics; Oncology; Internal medicine; Medicine; Genotype; Gene","score_opus":0.07008695964899038,"score_gpt":0.37841343394587834,"score_spread":0.308326474296888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029779613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952365,0.0010293908,0.0000038128612,0.0013368521,0.00006432664,0.0011485664,0.000027096981,0.00003361321,0.0011198332],"genre_scores_gemma":[0.9966985,0.0004081984,0.000023854898,0.00010366762,0.00012477791,0.00042474415,0.000024794455,0.000035625624,0.0021558346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627465,0.00036730262,0.00035624704,0.00049183035,0.0018599334,0.0006500113],"domain_scores_gemma":[0.9957973,0.0022600438,0.00024693098,0.00048452071,0.0009584395,0.00025277946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002544516,0.0001961709,0.000515439,0.00021127531,0.00020365072,0.000045129666,0.00019261266,0.00012555801,0.0004882257],"category_scores_gemma":[0.00201571,0.00014815049,0.0000775402,0.0006255045,0.00009702429,0.00013338414,0.00012023466,0.00017694334,0.00010220761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011273137,0.002127883,0.9878287,0.00010983593,0.00063311553,0.00015813831,0.00059618516,0.000014179447,0.0024681287,0.000007748594,0.0015604066,0.0033683751],"study_design_scores_gemma":[0.006633398,0.002156325,0.987187,0.0008670582,0.00016657026,0.0000034212735,0.00015196714,0.000020001364,0.0021093069,0.0000126416435,0.00055695756,0.00013532984],"about_ca_topic_score_codex":0.0032950903,"about_ca_topic_score_gemma":0.002606214,"teacher_disagreement_score":0.0055060848,"about_ca_system_score_codex":0.0052220123,"about_ca_system_score_gemma":0.0007412326,"threshold_uncertainty_score":0.9985968},"labels":[],"label_agreement":null},{"id":"W2030105242","doi":"10.1073/pnas.0804295105","title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","year":2008,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":985,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Diffuse large B-cell lymphoma; Biology; Cancer research; Germinal center; Gene expression profiling; Amplicon; Lymphoma; Gene knockdown; Genetics; B cell; Gene; Gene expression; Immunology; Polymerase chain reaction","score_opus":0.024560286973597165,"score_gpt":0.26022171043562375,"score_spread":0.2356614234620266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030105242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935624,0.0010155416,7.4530215e-7,0.0006309924,0.000008729069,0.00018527581,0.000048316484,0.000007765812,0.0045402395],"genre_scores_gemma":[0.998979,0.00017197049,0.00054968795,0.0001844559,0.000020726997,0.000013311155,6.0198283e-7,0.000004910374,0.00007537072],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982839,0.0000043460786,0.00030730525,0.00020975496,0.001042672,0.00015197469],"domain_scores_gemma":[0.9993124,0.00006797694,0.00034006292,0.000012808823,0.00021060626,0.000056136094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619129,0.000103543694,0.00021864429,0.00009052089,0.00011974676,0.000004984368,0.00030220154,0.000065111446,0.000009284764],"category_scores_gemma":[0.00019021658,0.00006366299,0.000116413416,0.00039619347,0.00056739757,0.00009406839,0.00008370725,0.000041044375,0.0000017030766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068893365,0.0052374247,0.528385,0.00021317894,0.00006506614,4.978191e-7,0.00041239767,0.000004762215,0.4524725,0.010110528,0.002421819,0.000607967],"study_design_scores_gemma":[0.0018774519,0.00011974984,0.416823,0.00005820644,0.000037641927,0.00002312625,0.00004953676,0.00014474483,0.5788089,0.0018640159,0.00014373513,0.000049861446],"about_ca_topic_score_codex":0.000012018013,"about_ca_topic_score_gemma":2.8292357e-8,"teacher_disagreement_score":0.12633643,"about_ca_system_score_codex":0.000047156394,"about_ca_system_score_gemma":0.00006975145,"threshold_uncertainty_score":0.25961015},"labels":[],"label_agreement":null},{"id":"W2030256476","doi":"10.1186/1471-2350-10-117","title":"Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"BMC Medical Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; National Cancer Institute; BC Cancer Foundation; Michael Smith Health Research BC","keywords":"Rad50; Lymphoma; DNA repair; Biology; Genetics; Single-nucleotide polymorphism; Gene; Chromosomal translocation; Population; dbSNP; Cancer research; Medicine; Genotype; Immunology","score_opus":0.016852515479804247,"score_gpt":0.2848330792956911,"score_spread":0.26798056381588686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030256476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917644,0.0031599018,0.0009538203,0.003090116,0.000082445185,0.00070002244,0.000003882624,0.000016263293,0.00022913836],"genre_scores_gemma":[0.98595434,0.0020166766,0.008386991,0.0033115249,0.00024258251,0.000041039515,0.000006453961,0.000010224506,0.00003014162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982639,0.00013526187,0.0003532248,0.00039896622,0.00056957576,0.0002790858],"domain_scores_gemma":[0.99882704,0.00033530334,0.00004348863,0.00038354317,0.000041255367,0.00036934347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005006901,0.00018403922,0.00029395928,0.000073193696,0.00006403606,0.000036151665,0.00011337161,0.00016077691,0.00005612144],"category_scores_gemma":[0.00032267135,0.00012005641,0.00004401233,0.00019681081,0.000092618655,0.000016314294,0.00005347374,0.000059633876,0.000012617418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014387365,0.0009288592,0.6477069,0.0000829841,0.000027539736,0.00013204098,0.0014312053,0.000016589658,0.0012764287,0.000120611694,0.00066868943,0.34746423],"study_design_scores_gemma":[0.0034713987,0.000821151,0.9914526,0.00007250079,0.00009352015,0.00018225273,0.00009486162,0.0019906973,0.0003840387,0.00032441257,0.0009894747,0.00012314325],"about_ca_topic_score_codex":0.000092764436,"about_ca_topic_score_gemma":0.0003460862,"teacher_disagreement_score":0.3473411,"about_ca_system_score_codex":0.00007317928,"about_ca_system_score_gemma":0.0002510524,"threshold_uncertainty_score":0.48957583},"labels":[],"label_agreement":null},{"id":"W2030265874","doi":"10.1016/j.ijrobp.2014.12.009","title":"Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radiation oncology; Hodgkin lymphoma; Stage (stratigraphy); Medicine; Lymphoma; Radiation therapy; Oncology; Internal medicine; Medical physics; Biology","score_opus":0.04723241598107786,"score_gpt":0.3653147915424645,"score_spread":0.31808237556138663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030265874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98035413,0.0014346386,0.005601436,0.0042991317,0.006624204,0.0006979739,0.00012863186,0.000037180813,0.0008226915],"genre_scores_gemma":[0.9917658,0.0010409608,0.002595579,0.0015050608,0.0026477173,0.000115143914,0.00020126492,0.000038752365,0.000089749665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972551,0.00028368447,0.0011680946,0.00034754808,0.00064149103,0.0003041073],"domain_scores_gemma":[0.9953946,0.0006823119,0.002254603,0.00026681533,0.0011972247,0.00020447043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088898366,0.00029943185,0.00065468776,0.00025992875,0.00011292092,0.000047404614,0.0007134914,0.00036093956,0.000035769983],"category_scores_gemma":[0.00071528007,0.00022631373,0.00045271296,0.00023803939,0.00022346288,0.00047918592,0.00009752021,0.0001624301,0.000010412379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018937348,0.0016178219,0.5416719,0.0000060568345,0.0008843603,0.00002900913,0.0034048916,0.0005900403,0.002000693,0.0058196313,0.0021965099,0.43988538],"study_design_scores_gemma":[0.054509994,0.005495107,0.57051826,0.00012657979,0.0002642422,0.00038677274,0.0010509045,0.0051981756,0.026703151,0.0051629622,0.33017996,0.00040391664],"about_ca_topic_score_codex":0.00012995489,"about_ca_topic_score_gemma":0.0000056609065,"teacher_disagreement_score":0.43948144,"about_ca_system_score_codex":0.0030957034,"about_ca_system_score_gemma":0.001463017,"threshold_uncertainty_score":0.92288065},"labels":[],"label_agreement":null},{"id":"W2030317437","doi":"10.1053/clon.2002.0118","title":"Positron Emission Tomography in the Management of Lymphomas","year":2002,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Positron emission tomography; Lymphoma; Functional imaging; Molecular imaging; Pet imaging; Preclinical imaging; Fluorodeoxyglucose; Pathology; Nuclear medicine; Radiology; In vivo","score_opus":0.09246476359120659,"score_gpt":0.407799149894335,"score_spread":0.31533438630312843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030317437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9030872,0.0012393402,0.000002955756,0.0069500078,0.00019561549,0.00039830492,0.0000012168663,0.000012211165,0.08811312],"genre_scores_gemma":[0.9952617,0.0015597321,0.0009627265,0.0017758593,0.00007429639,0.000045388595,0.00000465987,0.000005076967,0.00031052344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988378,0.00015782723,0.00051977125,0.00018925345,0.00014334156,0.00015198589],"domain_scores_gemma":[0.9990606,0.00045315892,0.00010899618,0.00028237686,0.000021143784,0.00007372937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046520814,0.00008052158,0.00036802108,0.00005354308,0.00002069306,0.0000023352065,0.0001036775,0.00013732252,0.0002054531],"category_scores_gemma":[0.000029101366,0.000045281216,0.00020161035,0.00018927426,0.000111841924,0.000014146075,0.000039979266,0.000088606255,0.00004616161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002166286,0.007893058,0.59742707,0.000047630503,0.00020089558,0.000787495,0.0001591871,3.1998536e-7,0.000014948949,0.0019883225,0.00999052,0.3812739],"study_design_scores_gemma":[0.0062681003,0.0025573976,0.9282636,0.00009300114,0.00023392079,0.000039260096,0.00014501002,0.000043633518,0.000082383434,0.00027990591,0.06194742,0.000046354],"about_ca_topic_score_codex":0.000017037866,"about_ca_topic_score_gemma":0.0000040099917,"teacher_disagreement_score":0.38122755,"about_ca_system_score_codex":0.00008041493,"about_ca_system_score_gemma":0.000020389458,"threshold_uncertainty_score":0.22495674},"labels":[],"label_agreement":null},{"id":"W2030638302","doi":"10.1200/jco.2014.56.5853","title":"Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American Society of Hematology","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Clinical endpoint; Oncology; Clinical trial; Surgery; Lymphoma","score_opus":0.13237633855893713,"score_gpt":0.48663721217821676,"score_spread":0.3542608736192796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030638302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88168526,0.00020180842,0.0011735066,0.015117564,0.0035023696,0.09401982,0.00002414969,0.00006492639,0.004210573],"genre_scores_gemma":[0.88070846,0.00016382763,0.03096908,0.0056869546,0.01330647,0.067025855,0.000026329986,0.00011702016,0.0019960192],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933183,0.0012585077,0.0037479103,0.00057684944,0.00051724294,0.00058115355],"domain_scores_gemma":[0.98977566,0.005293443,0.002754607,0.0004672229,0.0008880318,0.0008210508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003335176,0.00045280467,0.004116193,0.00017097266,0.0001508464,0.000037340218,0.0002771767,0.0006981745,0.00029067785],"category_scores_gemma":[0.005226147,0.0002526791,0.0014506062,0.000163401,0.00031343737,0.0001634391,0.00008607254,0.00033771916,0.00010332868],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4336282,0.059049677,0.0016388134,0.00009276584,0.0023394441,0.0030011665,0.0001734766,0.00001610575,0.000049834638,0.00051328575,0.004180598,0.49531662],"study_design_scores_gemma":[0.4022153,0.20692235,0.0015585761,0.00014499758,0.0009629446,0.0005592345,0.00014738743,0.0005621138,0.00026442987,0.00017108792,0.3863359,0.00015566063],"about_ca_topic_score_codex":0.000043727105,"about_ca_topic_score_gemma":0.00015074915,"teacher_disagreement_score":0.49516097,"about_ca_system_score_codex":0.0015591482,"about_ca_system_score_gemma":0.0055615343,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2030794949","doi":"10.1158/1538-7445.am2014-5072","title":"Abstract 5072: Meta-analysis of genome-wide association studies identifies novel susceptibility loci for follicular lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Genome-wide association study; Expression quantitative trait loci; Follicular lymphoma; Single-nucleotide polymorphism; Biology; Genetic association; Imputation (statistics); Genetics; Human leukocyte antigen; 1000 Genomes Project; Lymphoma; Gene; Immunology; Genotype","score_opus":0.21861907413139953,"score_gpt":0.44950131877676913,"score_spread":0.2308822446453696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030794949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843325,0.010127133,0.0001080299,0.003964076,0.00005961545,0.0009350706,0.00022014233,0.000019570585,0.00023384222],"genre_scores_gemma":[0.99613374,0.0007613695,0.00015814765,0.0002002524,0.0000969213,0.0009979057,0.00009724341,0.000018097893,0.0015363413],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99747145,0.00012047289,0.00046997966,0.00047368807,0.0010301583,0.00043422575],"domain_scores_gemma":[0.9941497,0.003159425,0.00021028289,0.00055950606,0.001799721,0.000121394456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003300427,0.0001631897,0.0012481019,0.00036482123,0.00017099752,0.000038880553,0.00014047396,0.000102176404,0.00032305208],"category_scores_gemma":[0.0031960679,0.00011594131,0.0011733326,0.0007724914,0.0001305223,0.00007796238,0.00007654435,0.00007276943,0.000014697907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039195808,0.0019533068,0.4089877,0.00094977714,0.5540777,0.000008563252,0.0013062672,0.00049313914,0.017114837,0.0003840016,0.011841223,0.0024915226],"study_design_scores_gemma":[0.0025368235,0.00023841171,0.8664469,0.000016939952,0.09338373,2.3116351e-7,0.0004804849,0.00009710467,0.029005889,0.00031484867,0.007338386,0.00014023905],"about_ca_topic_score_codex":0.0013794242,"about_ca_topic_score_gemma":0.0015923185,"teacher_disagreement_score":0.46069396,"about_ca_system_score_codex":0.0016927834,"about_ca_system_score_gemma":0.00021610541,"threshold_uncertainty_score":0.47279492},"labels":[],"label_agreement":null},{"id":"W2030867589","doi":"10.1182/blood-2014-10-603738","title":"STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Anaplastic lymphoma kinase; Cancer research; STAT1; Anaplastic large-cell lymphoma; Tyrosine kinase; Biology; STAT3; Phosphorylation; Molecular biology; Lymphoma; Signal transduction; Lung cancer; Cell biology; Medicine; Immunology; Oncology","score_opus":0.009253198289338556,"score_gpt":0.23017511801146578,"score_spread":0.22092191972212724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030867589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835837,0.012704153,0.000004779972,0.0011601939,0.00007344113,0.00062644266,0.00022680493,0.00005245394,0.0015680654],"genre_scores_gemma":[0.9973402,0.0003211909,0.00007358035,0.00086592324,0.000039283404,0.00006150627,0.00020629846,0.000035271732,0.0010567295],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843234,0.00007692194,0.0003121631,0.00042130516,0.00031818546,0.0004391145],"domain_scores_gemma":[0.99897707,0.00013608063,0.00009873095,0.00035017284,0.00011980826,0.00031814788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001927455,0.00028802606,0.0003929239,0.00008230229,0.000088159024,0.000043947734,0.00008979074,0.000138073,0.00005658544],"category_scores_gemma":[0.000053896907,0.00019259781,0.0000753595,0.0003721966,0.00009185476,0.000072279465,0.000079729856,0.000086178574,0.000077162535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008071023,0.1164196,0.5538306,0.00037315514,0.0043950747,0.009996957,0.025311919,0.0000244026,0.05950838,0.00044919847,0.17517918,0.046440493],"study_design_scores_gemma":[0.17593755,0.0043608793,0.2248272,0.0004002928,0.0022617057,0.00065640523,0.0011587744,0.00082753855,0.56390244,0.00013690027,0.024769934,0.0007603773],"about_ca_topic_score_codex":0.00066007534,"about_ca_topic_score_gemma":0.00009237411,"teacher_disagreement_score":0.50439405,"about_ca_system_score_codex":0.00025108477,"about_ca_system_score_gemma":0.0002971446,"threshold_uncertainty_score":0.7853911},"labels":[],"label_agreement":null},{"id":"W2030869855","doi":"10.1016/j.bbmt.2008.11.011","title":"Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma","year":2009,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; Otsuka Pharmaceutical; Astellas Pharma; Therakos; Kiadis Pharma; Association of Medical Microbiology and Infectious Disease Canada; American Society for Blood and Marrow Transplantation; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; CellGenix; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; U.S. Navy; Centers for Disease Control and Prevention; Celgene; Osiris Therapeutics; Pfizer; Baxter International; Amgen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; Bayer HealthCare; U.S. Public Health Service; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Refractory (planetary science); Transplantation; Hematopoietic stem cell transplantation; Salvage therapy; Lymphoma; Cumulative incidence; Regimen; Incidence (geometry); Surgery; Oncology; Gastroenterology; Chemotherapy","score_opus":0.011923673205851248,"score_gpt":0.2393056938962956,"score_spread":0.22738202069044436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030869855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957641,0.0025053853,0.0002714481,0.00047764683,0.00008085816,0.0005856062,0.00010934031,0.000041377298,0.00016426522],"genre_scores_gemma":[0.98988205,0.00851104,0.0008120434,0.00018632479,0.000026357571,0.000030182344,0.0004980667,0.00001048184,0.000043438034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990592,0.000047732643,0.00032471973,0.0003211923,0.0000662284,0.00018093202],"domain_scores_gemma":[0.99947166,0.00012530491,0.0001284579,0.00010713789,0.00007203172,0.00009540358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012565359,0.00018200542,0.00037883245,0.00010410984,0.00007853049,0.0000064126275,0.000030031233,0.00022416595,0.00000367719],"category_scores_gemma":[0.00000323986,0.00015111895,0.00007866219,0.0000619869,0.00008366296,0.000057618083,0.000001934851,0.000041043113,8.447641e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037288724,0.00090039975,0.027545746,0.00091972086,0.00025724323,0.000081195605,0.0018054281,0.0000013702477,0.9319511,0.0006657856,0.000039763792,0.03210337],"study_design_scores_gemma":[0.01693818,0.003939787,0.33900958,0.00027785444,0.0028486731,0.00088548573,0.00013932983,0.000022676722,0.63513684,0.0004617845,0.00010058759,0.00023920472],"about_ca_topic_score_codex":0.000035213914,"about_ca_topic_score_gemma":0.000010326502,"teacher_disagreement_score":0.31146383,"about_ca_system_score_codex":0.0000160812,"about_ca_system_score_gemma":0.000047020414,"threshold_uncertainty_score":0.61624515},"labels":[],"label_agreement":null},{"id":"W2031185392","doi":"10.1097/00001813-200211002-00004","title":"Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkinʼs lymphoma","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Watchful waiting; Rituximab; Chemotherapy; Autologous stem-cell transplantation; Lymphoma; Oncology; Aggressive lymphoma; Non-Hodgkin's lymphoma; Disease; Internal medicine; Clinical trial; Surgery; Intensive care medicine; Cancer","score_opus":0.07813416068665378,"score_gpt":0.3619001896838279,"score_spread":0.2837660289971741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031185392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025294744,0.9886997,0.0000116445735,0.001359663,0.00019862755,0.0056976257,0.0006277902,0.000017928009,0.00085755443],"genre_scores_gemma":[0.0022440895,0.98855525,0.00023575875,0.00031702942,0.00013475883,0.0068909205,0.00009490042,0.0000565547,0.0014707404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821234,0.00008612999,0.00053428515,0.00052635133,0.0002940745,0.00034682572],"domain_scores_gemma":[0.997489,0.0009192613,0.0007384885,0.00065798016,0.00010365454,0.00009164885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014553797,0.0005749176,0.0014482113,0.00009626942,0.0002753781,0.000039907958,0.00019874795,0.00013635341,0.0000925549],"category_scores_gemma":[0.00001005408,0.00025347777,0.0006469331,0.00021976049,0.00024385675,0.000032318778,0.00009353371,0.00007770297,0.000024880734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006350499,0.0008592931,0.00005179738,0.0029327718,0.0056571416,0.00007025359,0.00052613864,0.0000065881773,1.0180247e-7,0.0010363612,0.0027817718,0.98601425],"study_design_scores_gemma":[0.0052480255,0.00093753205,0.0009504561,0.026555391,0.010714503,0.000052856118,0.0005064697,0.00015612137,0.00011671836,0.000010339838,0.95442116,0.00033044117],"about_ca_topic_score_codex":0.00019558214,"about_ca_topic_score_gemma":0.000006564529,"teacher_disagreement_score":0.98568386,"about_ca_system_score_codex":0.00054700975,"about_ca_system_score_gemma":0.0001951002,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2031245658","doi":"10.2353/ajpath.2009.080521","title":"Proteome-Wide Identification of Novel Binding Partners to the Oncogenic Fusion Gene Protein, NPM-ALK, using Tandem Affinity Purification and Mass Spectrometry","year":2009,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of California, Irvine; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Alberta Cancer Foundation","keywords":"Tandem affinity purification; Anaplastic lymphoma kinase; Nucleophosmin; Fusion protein; Carcinogenesis; Biology; Fusion gene; Proteome; Molecular biology; Anaplastic large-cell lymphoma; Gene; Cancer research; Biochemistry; Lymphoma; Affinity chromatography; Enzyme","score_opus":0.028770018399762072,"score_gpt":0.3144124556590679,"score_spread":0.2856424372593058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031245658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829979,0.0002386136,0.012720932,0.0033896966,0.000055834473,0.0005560422,0.000005547522,0.000006328521,0.000029104243],"genre_scores_gemma":[0.971353,0.00011345006,0.02815728,0.0002349622,0.00010340857,0.000011956663,0.0000034402565,0.000009290326,0.000013187916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869746,0.00011742334,0.0005703659,0.00018223375,0.00025072155,0.00018178517],"domain_scores_gemma":[0.998453,0.00006637924,0.00094555464,0.00022284855,0.00019259955,0.00011960018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072145846,0.00012188663,0.00039487742,0.00027502974,0.000087833105,0.000015344163,0.00009860486,0.00004361498,0.00000546661],"category_scores_gemma":[0.0002719203,0.00008193564,0.00009409946,0.00047968616,0.0001342811,0.000067382505,0.000017943086,0.00012590244,0.0000023703972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015452644,0.00033304185,0.021394597,0.000006748223,0.000049836992,0.0000786663,0.000349857,0.000038308805,0.96277964,0.000042844673,0.000012444844,0.014759508],"study_design_scores_gemma":[0.0019108603,0.0038109215,0.46147022,0.00012475296,0.00030416012,0.001956082,0.00079102477,0.00014518943,0.52914137,0.000114467715,0.000103961094,0.00012701683],"about_ca_topic_score_codex":0.000010261825,"about_ca_topic_score_gemma":0.0000010699023,"teacher_disagreement_score":0.44007564,"about_ca_system_score_codex":0.00019355956,"about_ca_system_score_gemma":0.00013375141,"threshold_uncertainty_score":0.33412385},"labels":[],"label_agreement":null},{"id":"W2031322795","doi":"10.1182/blood-2011-03-345272","title":"Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Germinal center; International Prognostic Index; Stromal cell; Biology; Cancer research; Tumor microenvironment; Lymphoma; Immune system; Oncology; Medicine; B cell; Immunology; Antibody","score_opus":0.0340174480951962,"score_gpt":0.23094980375719243,"score_spread":0.19693235566199624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031322795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982725,0.00034973066,0.0000045892293,0.000033864035,0.000026131296,0.00022956902,0.000022132024,0.0000064882242,0.0010549993],"genre_scores_gemma":[0.9994873,0.0000904808,0.0003011893,0.000047625872,0.000014705881,0.000029461316,0.000005629497,0.000008934644,0.000014693325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939364,0.000051304414,0.00018210233,0.00013684761,0.00013332748,0.00010274815],"domain_scores_gemma":[0.9995979,0.00007747895,0.0000932995,0.00018908447,0.000009529961,0.00003269799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001356321,0.00008246239,0.00016317908,0.00004531558,0.00002589632,0.0000016400851,0.000030450263,0.000028971957,0.000027666447],"category_scores_gemma":[0.000017543236,0.000050300816,0.000038259426,0.000042542506,0.00002735935,0.00001178815,0.000025167297,0.000021974047,0.0000013491529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020389272,0.026566114,0.823525,0.000082623716,0.000020898155,0.000028590304,0.0005397259,4.265046e-7,0.14843927,0.000017609646,0.000016163918,0.00055965106],"study_design_scores_gemma":[0.013033431,0.0003578718,0.4103401,0.00013765939,0.00006587376,0.0000033193426,0.000131278,0.000030607684,0.57583094,0.0000037285906,0.000042247044,0.000022921402],"about_ca_topic_score_codex":0.00007668135,"about_ca_topic_score_gemma":0.000006500917,"teacher_disagreement_score":0.42739168,"about_ca_system_score_codex":0.0000244673,"about_ca_system_score_gemma":0.00001558265,"threshold_uncertainty_score":0.20512077},"labels":[],"label_agreement":null},{"id":"W2031530131","doi":"10.1182/blood-2013-01-478834","title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Ubiquitin ligase; Biology; DNA ligase; Lymphoma; Genetics; Ubiquitin-Protein Ligases; Cancer research; Ubiquitin; Gene; Immunology","score_opus":0.008018948697593554,"score_gpt":0.22821397900998117,"score_spread":0.2201950303123876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031530131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352784,0.0023282622,2.6196793e-7,0.0023204545,0.00009912895,0.0005732455,0.000011092001,0.00004304984,0.011096637],"genre_scores_gemma":[0.99673617,0.00060297473,0.00008444554,0.0006916747,0.000079241625,0.00023476471,0.000023374318,0.000020487421,0.0015268914],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989378,0.000036048583,0.00025463352,0.00024350922,0.00019316672,0.0003348729],"domain_scores_gemma":[0.99927676,0.000111018904,0.000064549,0.00035335522,0.00005763608,0.00013668885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000089605695,0.00015884318,0.00020379672,0.000054480017,0.00008593484,0.000052282532,0.00009840934,0.00006819268,0.0002935787],"category_scores_gemma":[0.0000306712,0.00009871009,0.000089274115,0.00016962171,0.000042858195,0.000052012758,0.000046126635,0.00005235766,0.001213672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029980316,0.040202565,0.4839807,0.00032796524,0.0007345916,0.002434673,0.004354241,0.0000013277241,0.010963225,0.00060430414,0.12608632,0.3300103],"study_design_scores_gemma":[0.028314888,0.00062868046,0.4112143,0.00022812073,0.00032809205,0.00015294547,0.00049558067,0.000103699844,0.5335317,0.0003541425,0.024368986,0.00027883987],"about_ca_topic_score_codex":0.0006039728,"about_ca_topic_score_gemma":0.00004048854,"teacher_disagreement_score":0.5225685,"about_ca_system_score_codex":0.000074053314,"about_ca_system_score_gemma":0.000088866575,"threshold_uncertainty_score":0.999564},"labels":[],"label_agreement":null},{"id":"W2031731997","doi":"10.1155/2012/123253","title":"NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases","year":2012,"lang":"en","type":"article","venue":"Journal of Signal Transduction","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates; Alberta Innovates - Health Solutions; University of Alberta; Alberta Cancer Foundation","keywords":"Anaplastic lymphoma kinase; Cancer research; Chromosomal translocation; Fusion protein; Tyrosine kinase; Fusion gene; Kinase; Anaplastic large-cell lymphoma; Signal transduction; Receptor Protein-Tyrosine Kinases; Receptor tyrosine kinase; Lymphoma; Medicine; Biology; Gene; Lung cancer; Immunology; Cell biology; Genetics; Oncology","score_opus":0.045737098967157795,"score_gpt":0.3002504053257018,"score_spread":0.254513306358544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031731997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393994,0.0040482357,0.00019014957,0.0007851561,0.0002697912,0.00043194875,0.000004993246,0.0000040874197,0.00032570193],"genre_scores_gemma":[0.99836326,0.00062483334,0.0004216907,0.000057130674,0.0004609678,0.000012477722,0.000002361046,0.000010835518,0.000046434023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987573,0.00006044756,0.00054567517,0.000065323664,0.0004329995,0.00013825219],"domain_scores_gemma":[0.9990695,0.00005921012,0.00040233397,0.000114210205,0.00026475627,0.00008999002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041596463,0.000108777145,0.000340618,0.00010908223,0.000039191942,0.00000378318,0.00005630556,0.00006007406,0.00026437963],"category_scores_gemma":[0.000016765509,0.00005944634,0.00029378338,0.00018197687,0.00007548683,0.00016827954,0.00000535286,0.00011045153,0.000003146531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002491102,0.0034087247,0.042918842,0.00028851052,0.0005462377,0.000017899181,0.0014498985,0.00006578783,0.90616924,0.0001915386,0.0007301117,0.04172213],"study_design_scores_gemma":[0.003698577,0.0023133978,0.29999837,0.0005286321,0.0010137003,0.0006753242,0.00047076345,0.000012283823,0.6872715,0.000083624305,0.0038608469,0.00007301023],"about_ca_topic_score_codex":0.000036474776,"about_ca_topic_score_gemma":0.0000012748856,"teacher_disagreement_score":0.25707954,"about_ca_system_score_codex":0.00008190411,"about_ca_system_score_gemma":0.00010564828,"threshold_uncertainty_score":0.28947714},"labels":[],"label_agreement":null},{"id":"W2032698211","doi":"10.1002/gcc.20606","title":"Prognostic significance of secondary cytogenetic alterations in follicular lymphomas","year":2008,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Karyotype; Chromosomal translocation; Follicular lymphoma; Biology; Pathology; Histology; Lymphoma; Cytogenetics; Chromosome; Epigenetics; Malignant transformation; Cancer research; Immunology; Genetics; Medicine; Gene","score_opus":0.020102437111287806,"score_gpt":0.26237567618573887,"score_spread":0.24227323907445106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032698211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94171757,0.05703014,0.0000055814576,0.00023104355,0.000056992514,0.00040047284,0.00004314341,0.000011555581,0.0005035162],"genre_scores_gemma":[0.9833201,0.015518341,0.00027469484,0.00017397033,0.00007820121,0.00036480578,0.00002224452,0.0000122259125,0.00023537118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924695,0.000017057577,0.00021287342,0.00022646123,0.00013062429,0.00016600669],"domain_scores_gemma":[0.9996339,0.000031894866,0.00005326689,0.00015524792,0.000044799264,0.00008090688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026158448,0.00012310321,0.00027813824,0.0000620105,0.000057278536,0.000005493219,0.000032410568,0.000046653244,0.00021657828],"category_scores_gemma":[0.000006203952,0.000098957724,0.000060105525,0.00015353372,0.00009067974,0.000038146332,0.000019119414,0.000028335311,0.0000035891862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046478486,0.00035353831,0.94324505,0.00016796078,0.00011237434,0.00021255086,0.00048440156,0.000058234345,0.012844428,0.000108907625,0.00022774642,0.04213835],"study_design_scores_gemma":[0.0028294902,0.00026053193,0.91619986,0.00017154803,0.00010618493,0.00017899172,0.00007037,0.00009025233,0.07484979,0.000050315917,0.0050595305,0.00013311034],"about_ca_topic_score_codex":0.00034192027,"about_ca_topic_score_gemma":0.00009550118,"teacher_disagreement_score":0.062005363,"about_ca_system_score_codex":0.000087232525,"about_ca_system_score_gemma":0.00032345977,"threshold_uncertainty_score":0.40353787},"labels":[],"label_agreement":null},{"id":"W2033070843","doi":"10.1038/leu.2010.302","title":"The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Groupement des Entreprises Françaises dans la lutte contre le Cancer; Ligue Contre le Cancer","keywords":"Isotype; breakpoint cluster region; Biology; Germinal center; Immunoglobulin D; Lymphoma; Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Cancer research; Antibody; B cell; Gene expression profiling; Immunology; Molecular biology; Gene; Monoclonal antibody; Gene expression; Genetics; Chromosome","score_opus":0.011765748620751363,"score_gpt":0.2329931367322983,"score_spread":0.22122738811154694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033070843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833203,0.00856229,0.000004529294,0.000686697,0.00011583067,0.0006093912,0.000008416566,0.000009818266,0.0016709759],"genre_scores_gemma":[0.9973882,0.0011681546,0.00005546528,0.00063144515,0.00002210565,0.00011296054,0.0000018225082,0.00001649183,0.0006033457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992602,0.000044628367,0.00017981483,0.00015946142,0.0001360065,0.0002199227],"domain_scores_gemma":[0.9990322,0.00034817855,0.0000819936,0.00044165007,0.00005197211,0.000044031734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002148463,0.000122069956,0.00018119221,0.0000200967,0.00011900031,0.000011434929,0.00014681749,0.000061772174,0.000008039098],"category_scores_gemma":[0.00011533644,0.000050348066,0.00010657964,0.00010845514,0.00012133543,0.000022403374,0.00007199425,0.000046098885,0.000011165905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006168906,0.01683743,0.6990485,0.0010446559,0.0025291492,0.00066915987,0.03257875,0.000010522656,0.014262431,0.09762436,0.009617545,0.11960855],"study_design_scores_gemma":[0.06276986,0.0011039537,0.6244838,0.00040953196,0.00091617584,0.00010120577,0.002380401,0.000966487,0.25558886,0.006943904,0.043998204,0.00033760726],"about_ca_topic_score_codex":0.00049871014,"about_ca_topic_score_gemma":0.00026632615,"teacher_disagreement_score":0.24132644,"about_ca_system_score_codex":0.00017081847,"about_ca_system_score_gemma":0.00018932312,"threshold_uncertainty_score":0.20531346},"labels":[],"label_agreement":null},{"id":"W2033492820","doi":"10.1016/j.cxom.2014.10.004","title":"Hematopoietic Neck Lesions","year":2014,"lang":"en","type":"review","venue":"Atlas of the Oral and Maxillofacial Surgery Clinics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Lymphoma; Lymph; Head and neck; Cervical lymph nodes; Hodgkin lymphoma; Neck mass; Pathology; Radiology; Internal medicine; Cancer; Surgery; Metastasis","score_opus":0.06945040021235213,"score_gpt":0.35127377810905325,"score_spread":0.2818233778967011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033492820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030328133,0.99440485,5.850247e-7,0.00034179632,0.0009456823,0.0006336863,0.000050873296,0.00002753434,0.0005621578],"genre_scores_gemma":[0.0004204845,0.99812335,0.000050197785,0.00022316848,0.00006708797,0.00004694654,0.000060329323,0.00003814213,0.00097030797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980229,0.00009219628,0.0009945697,0.00035163222,0.00027106277,0.0002676132],"domain_scores_gemma":[0.99823236,0.00035258912,0.0005875257,0.0005880763,0.00006270048,0.00017672846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036819823,0.0003832551,0.0028139406,0.00008138946,0.000120704644,0.00001852598,0.00014774252,0.0003610971,0.00006077763],"category_scores_gemma":[0.00038539726,0.00019853712,0.0017440454,0.0002241512,0.00019032258,0.000027775764,0.00021480347,0.00020225956,0.00007440867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014332092,0.0002347065,0.004048832,0.0051637436,0.00026004406,0.000020461826,0.000008958311,3.9812054e-8,3.0427255e-8,0.00032912559,0.0016340635,0.98828566],"study_design_scores_gemma":[0.00026849075,0.000078325014,0.0010719039,0.006791097,0.0022788208,0.00011776098,0.0000034711024,8.2299624e-7,0.0000021599812,0.00018257718,0.9890106,0.00019397601],"about_ca_topic_score_codex":0.00010635014,"about_ca_topic_score_gemma":0.000005131899,"teacher_disagreement_score":0.9880917,"about_ca_system_score_codex":0.00004685083,"about_ca_system_score_gemma":0.00036564167,"threshold_uncertainty_score":0.8096109},"labels":[],"label_agreement":null},{"id":"W2033495545","doi":"10.1016/j.leukres.2009.08.030","title":"Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Dasatinib; Proto-oncogene tyrosine-protein kinase Src; Src family kinase; Cancer research; Kinase; Phosphorylation; Imatinib; Lymphoma; Biology; Medicine; Internal medicine; Cell biology","score_opus":0.0668813852658236,"score_gpt":0.3853924470342055,"score_spread":0.3185110617683819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033495545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869745,0.0007975933,0.00008672427,0.0014266967,0.000020045723,0.0007836225,0.000013789885,0.000024759685,0.009872301],"genre_scores_gemma":[0.9984218,0.00032817316,0.000069860784,0.00038881073,0.000036593345,0.000131298,0.000054795244,0.000014179042,0.00055447826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982371,0.0001285042,0.00031775792,0.00030035566,0.0005729775,0.00044333452],"domain_scores_gemma":[0.9988905,0.00017315887,0.000048744303,0.0005242423,0.0002245309,0.00013882997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294967,0.000115456896,0.00023947212,0.00034381993,0.00007835339,0.000019669924,0.00014533194,0.00013475597,0.000043548647],"category_scores_gemma":[0.00005042078,0.00009339001,0.00007528992,0.00069408247,0.000054226002,0.0000600054,0.00004872399,0.00014386188,0.000060469843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008154206,0.06104986,0.6643628,0.0002807905,0.00012095317,0.0002165535,0.002050093,0.000042520718,0.103391945,0.025765138,0.003236296,0.13866763],"study_design_scores_gemma":[0.01981887,0.00053757825,0.9386604,0.00006683298,0.00002395366,0.000012611909,0.000220551,0.0005758988,0.037297737,0.0012844531,0.0014144664,0.00008663564],"about_ca_topic_score_codex":0.00034805207,"about_ca_topic_score_gemma":0.00006758475,"teacher_disagreement_score":0.2742976,"about_ca_system_score_codex":0.001869948,"about_ca_system_score_gemma":0.00068776857,"threshold_uncertainty_score":0.4889849},"labels":[],"label_agreement":null},{"id":"W2033870096","doi":"10.1200/jco.2010.30.8353","title":"Reply to U. Dührsen et al","year":2010,"lang":"de","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.1106455328833646,"score_gpt":0.5054863553609301,"score_spread":0.3948408224775655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033870096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52373105,0.0021510832,0.000013083142,0.44366804,0.02250297,0.00026209722,0.000010078839,0.000008422791,0.0076531665],"genre_scores_gemma":[0.60381365,0.0050881957,0.00719315,0.37525627,0.007834399,0.0000067601936,0.0000039497318,0.0000333001,0.0007703082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938769,0.00068608276,0.0040055225,0.0003613379,0.00063241547,0.00043778602],"domain_scores_gemma":[0.9884594,0.0062486064,0.0023970052,0.0005224246,0.0007230064,0.0016495397],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008156539,0.0002567591,0.002409557,0.0001737472,0.000054263965,0.000029812929,0.0003179362,0.0005954862,0.0009945927],"category_scores_gemma":[0.01587406,0.00017237764,0.0010819031,0.00016631032,0.0002313982,0.0001076464,0.00014426082,0.0022487524,0.0018051274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030499657,0.0070825256,0.14408061,0.000009544661,0.0014937685,0.0049774614,0.00016740005,0.0000028628094,0.00013707388,0.00070880976,0.5860318,0.2522582],"study_design_scores_gemma":[0.009206194,0.020372458,0.28354248,0.000111657966,0.0011027423,0.00030533937,0.000042449225,0.000009570666,0.00009744472,0.00014864211,0.68495435,0.00010667959],"about_ca_topic_score_codex":0.000102840524,"about_ca_topic_score_gemma":0.000095542535,"teacher_disagreement_score":0.25215152,"about_ca_system_score_codex":0.00020842254,"about_ca_system_score_gemma":0.004630847,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W2033888902","doi":"10.1186/1471-230x-14-127","title":"Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease","year":2014,"lang":"en","type":"article","venue":"BMC Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Lymphomatoid granulomatosis; Azathioprine; Thiopurine methyltransferase; Crohn's disease; Lymphoma; Malignancy; Internal medicine; Inflammatory bowel disease; Gastroenterology; Lymphoproliferative disorders; Rituximab; Maintenance therapy; Disease; Pathology; Dermatology; Chemotherapy","score_opus":0.012936313012180416,"score_gpt":0.23146286605616417,"score_spread":0.21852655304398375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033888902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783033,0.00009655663,0.00017775397,0.0010616159,0.000060396393,0.00042432905,0.000010011563,0.00008647186,0.0002525342],"genre_scores_gemma":[0.99626255,0.000074410375,0.00034647912,0.0028899147,0.000043797325,0.00020901312,0.00007786098,0.000031065756,0.00006491762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985088,0.00017495707,0.00027386018,0.0003734488,0.00019437316,0.00047455146],"domain_scores_gemma":[0.999135,0.00009109407,0.00010444701,0.00036358283,0.000053909906,0.00025193344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016015126,0.00023616612,0.0004715584,0.00014864649,0.00004388861,0.000014389188,0.00009094885,0.00006874548,0.00007280098],"category_scores_gemma":[0.00008445267,0.00016738047,0.00011118179,0.00012668985,0.00010031366,0.00004493703,0.000033661636,0.00006782364,0.000033202286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031342017,0.001713968,0.9932326,0.00001771439,0.00010122887,0.00026786287,0.00004327911,0.000017011393,0.00004852808,0.00013562785,0.00019240963,0.0010955874],"study_design_scores_gemma":[0.018379485,0.0016227195,0.9788398,0.00010803293,0.00006606422,0.00007423804,0.000009292918,0.00036748618,0.00010700447,0.000051223396,0.00029217094,0.00008245179],"about_ca_topic_score_codex":0.00008464595,"about_ca_topic_score_gemma":0.00048692682,"teacher_disagreement_score":0.015245284,"about_ca_system_score_codex":0.00016112012,"about_ca_system_score_gemma":0.00006774581,"threshold_uncertainty_score":0.6825577},"labels":[],"label_agreement":null},{"id":"W2034075944","doi":"10.1016/j.blre.2012.04.001","title":"Treatment of newly diagnosed advanced stage Hodgkin lymphoma","year":2012,"lang":"en","type":"review","venue":"Blood Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Oncology; Autologous stem-cell transplantation; Interim; Internal medicine; Dacarbazine; Clinical trial; Interim analysis; Transplantation; Lymphoma; Chemotherapy; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.09205674892183442,"score_gpt":0.36548863548980337,"score_spread":0.27343188656796896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034075944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001099775,0.98986477,0.0000021530775,0.000018437733,0.00034326888,0.006942301,0.000200169,0.00005947189,0.0024594578],"genre_scores_gemma":[0.000024158286,0.9909093,0.0016842321,0.000050380313,0.00033775173,0.0033781994,0.0005797792,0.0001271758,0.0029090522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960048,0.00036809305,0.001932025,0.0007270436,0.0003560512,0.0006119714],"domain_scores_gemma":[0.996071,0.00034980333,0.0014523828,0.0016128843,0.00006763155,0.000446292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023186854,0.0011196096,0.0075955847,0.00023078731,0.000058118425,0.000017477929,0.00020970474,0.0003916316,0.00052953744],"category_scores_gemma":[0.000122030506,0.00064199243,0.002811721,0.00044874297,0.000063852676,0.000077242934,0.000061875755,0.000075673,0.000976222],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001565623,0.0062824795,0.00011857803,0.0318969,0.0011867455,0.0003031977,0.00007022087,2.1572728e-8,8.5267914e-7,0.00012280351,0.00036254633,0.95964],"study_design_scores_gemma":[0.0069746496,0.0015076307,0.00009193796,0.02345594,0.025818639,0.00029034563,0.0000064396545,9.2114256e-8,0.0000275577,0.0000018830433,0.9413845,0.00044041063],"about_ca_topic_score_codex":0.000061051745,"about_ca_topic_score_gemma":0.000010266819,"teacher_disagreement_score":0.9591996,"about_ca_system_score_codex":0.00053662603,"about_ca_system_score_gemma":0.0005284554,"threshold_uncertainty_score":0.99980164},"labels":[],"label_agreement":null},{"id":"W2034156891","doi":"10.1182/blood-2011-04-345777","title":"Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Cytotoxic T cell; Follicular lymphoma; Pathology; Granzyme B; CD8; CTL*; Lymph; Biology; Immunophenotyping; Cancer research; Lymphoma; Medicine; Immunology; Immune system; Flow cytometry; In vitro","score_opus":0.01257205450176963,"score_gpt":0.2355240481751352,"score_spread":0.22295199367336557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034156891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961282,0.0024677883,0.000038782277,0.000033606415,0.000044373533,0.0009549147,0.000014865263,0.000039695035,0.00027775537],"genre_scores_gemma":[0.99944246,0.000049126535,0.00018492622,0.000034395103,0.000028997552,0.00019539199,0.00003223331,0.00001547753,0.000017020202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893254,0.00005032894,0.00031639225,0.0002981725,0.00019478524,0.00020779483],"domain_scores_gemma":[0.9994355,0.000052054387,0.00008408689,0.0002502586,0.00007843507,0.000099678924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014725924,0.00016549951,0.0003272969,0.000086745575,0.000048838596,0.00001038514,0.00004592654,0.00004123571,0.000026180158],"category_scores_gemma":[0.00009645814,0.0001344607,0.000047213667,0.00024452998,0.00005808792,0.00006671524,0.000046101515,0.000023549226,0.000009897956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009509874,0.011164459,0.98455846,0.00005542916,0.00020288963,0.000309849,0.00062221015,3.2353412e-7,0.00039255855,0.0003521591,0.000021737967,0.0022248193],"study_design_scores_gemma":[0.01775534,0.001033402,0.96519375,0.00012764712,0.00088832213,0.00015376353,0.0004671326,0.000018947872,0.013999542,0.00018096514,0.00006833993,0.000112847214],"about_ca_topic_score_codex":0.0006188955,"about_ca_topic_score_gemma":0.000026609307,"teacher_disagreement_score":0.019364716,"about_ca_system_score_codex":0.00008855666,"about_ca_system_score_gemma":0.000112031696,"threshold_uncertainty_score":0.5483148},"labels":[],"label_agreement":null},{"id":"W2034174018","doi":"10.1007/s00259-004-1604-z","title":"18F-FDG PET in children with lymphomas","year":2004,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Positron emission tomography; Nuclear medicine; Lymphoma; Radiology; Internal medicine","score_opus":0.006391153753171287,"score_gpt":0.2235045582695621,"score_spread":0.2171134045163908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034174018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487056,0.002280818,0.000064354994,0.014536447,0.00003756783,0.0001145246,5.207195e-7,0.000012906155,0.008082309],"genre_scores_gemma":[0.99046624,0.0003921864,0.0020066216,0.0069588884,0.00012481202,2.8111165e-7,0.0000025067923,0.000043754113,0.0000047217095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899375,0.00007231003,0.00032171208,0.00015381089,0.00027708782,0.00018132433],"domain_scores_gemma":[0.9994105,0.000009865901,0.00015327208,0.00014413077,0.00007211889,0.00021010678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033080875,0.00015248035,0.00031009215,0.00022110432,0.000039232196,0.000018234947,0.00007314695,0.000005423553,0.00002873646],"category_scores_gemma":[0.00005035174,0.00009734813,0.00005710104,0.0001347877,0.00012772887,0.00008193491,0.000031464355,0.00014123437,0.000009929645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009552876,0.001414117,0.6901686,0.00009006628,0.0010445307,0.19778332,0.004733158,0.000085883,0.023136843,0.0017440985,0.006731935,0.07211215],"study_design_scores_gemma":[0.03344111,0.002432988,0.8745577,0.002077085,0.000534674,0.06988998,0.001104361,0.000016142772,0.0006713931,0.000068640125,0.014977828,0.0002281468],"about_ca_topic_score_codex":0.00003457978,"about_ca_topic_score_gemma":5.810931e-7,"teacher_disagreement_score":0.18438904,"about_ca_system_score_codex":0.00008355775,"about_ca_system_score_gemma":0.000061616505,"threshold_uncertainty_score":0.39697415},"labels":[],"label_agreement":null},{"id":"W2034400622","doi":"10.1056/nejmoa0905680","title":"Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Lymphoma; Oncology; Hodgkin lymphoma; Disease; Internal medicine; Classical Hodgkin lymphoma","score_opus":0.011961149293354123,"score_gpt":0.2660067477339572,"score_spread":0.2540455984406031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034400622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859823,0.0016611719,0.0000058241435,0.009701917,0.0009469814,0.00011191822,0.000002079443,0.00001061428,0.0015772117],"genre_scores_gemma":[0.9965096,0.00057602476,0.0002475634,0.0005377857,0.0018363319,0.0000015284268,0.0000043698674,0.000016448834,0.00027036495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985992,0.000074651776,0.0005049647,0.00014531384,0.00044462178,0.00023130432],"domain_scores_gemma":[0.9986998,0.00035527223,0.0002763456,0.00013821789,0.00012932827,0.00040105678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008399863,0.00017576058,0.0006616262,0.00024274945,0.000035265028,0.0000122149395,0.00007580769,0.00008242149,0.00019340945],"category_scores_gemma":[0.0007138252,0.00010640797,0.00006266117,0.00019167969,0.00012656525,0.00007019567,0.000020672238,0.00027312947,0.0000037721995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007364578,0.0005429914,0.67427534,0.000027599473,0.00018592115,0.004738629,0.00067062106,9.805104e-7,0.00606269,0.00025466082,0.0032042635,0.30929983],"study_design_scores_gemma":[0.112905286,0.0017862984,0.8664008,0.0003936489,0.00022488035,0.0030228796,0.00013581802,0.000024603512,0.0007363805,0.00039345375,0.013885126,0.00009084498],"about_ca_topic_score_codex":0.00034138653,"about_ca_topic_score_gemma":0.00049832003,"teacher_disagreement_score":0.309209,"about_ca_system_score_codex":0.000093617055,"about_ca_system_score_gemma":0.00024298788,"threshold_uncertainty_score":0.4339191},"labels":[],"label_agreement":null},{"id":"W2034429440","doi":"10.1038/sj.onc.1208467","title":"Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein","year":2005,"lang":"en","type":"article","venue":"Oncogene","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"Canadian Institutes of Health Research; Fondation de France; Ligue Contre le Cancer","keywords":"Carcinogenesis; Biology; Genome instability; Lymphoma; Phenotype; Molecular biology; Cancer research; Chromosome instability; Mutant; Gene; Genetics; DNA; DNA damage; Immunology; Chromosome","score_opus":0.020962116148879564,"score_gpt":0.25692387177568243,"score_spread":0.23596175562680288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034429440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981865,0.00065058924,0.00012184473,0.00017582763,0.000008407569,0.00054083084,0.00014858939,0.000017081229,0.00015028696],"genre_scores_gemma":[0.99167293,0.000066317065,0.007892253,0.000071285336,0.00004074512,0.000116172385,0.000043718002,0.000019473466,0.00007710917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987739,0.000024104746,0.0004976095,0.00028515595,0.00022750339,0.00019176293],"domain_scores_gemma":[0.9993467,0.000039410083,0.00017278624,0.00024614905,0.000095253534,0.0000997274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017791463,0.00016210761,0.00044808624,0.00012887096,0.00005271421,0.00000542948,0.000052983694,0.000079200705,0.000033025906],"category_scores_gemma":[0.000036124173,0.0001448368,0.00008250748,0.000098760815,0.00010378759,0.00007989299,0.00006716271,0.00003288305,0.0000013063514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027539587,0.0017060154,0.020783158,0.00014221529,0.00006948446,0.000010749533,0.00047563607,0.0027716649,0.9640342,0.00010996173,0.000008291071,0.009613212],"study_design_scores_gemma":[0.0063377507,0.00025990175,0.028496236,0.00018511087,0.000077318815,0.00001594076,0.00009272191,0.0220154,0.94217247,0.00014995002,0.00006691827,0.00013028992],"about_ca_topic_score_codex":0.00027627818,"about_ca_topic_score_gemma":0.00009608484,"teacher_disagreement_score":0.021861752,"about_ca_system_score_codex":0.00039342584,"about_ca_system_score_gemma":0.00036142694,"threshold_uncertainty_score":0.5906273},"labels":[],"label_agreement":null},{"id":"W2034992259","doi":"10.1182/blood-2008-02-136374","title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Medicine; Prednisone; Oncology; Rituximab; CHOP; Cyclophosphamide; Anthracycline; Lymphoma; Chemotherapy; Cancer","score_opus":0.01674366896439497,"score_gpt":0.2244839283498904,"score_spread":0.20774025938549542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034992259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752575,0.0002190674,0.000015386346,0.00006504917,0.000021463797,0.0006888605,0.000104755636,0.00009680198,0.0012628691],"genre_scores_gemma":[0.99784577,0.000061386425,0.0006578402,0.0005082233,0.000025580237,0.00019260612,0.00021267695,0.000047294474,0.00044865004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836326,0.000030337946,0.0003524159,0.00041158407,0.00039150426,0.00045089],"domain_scores_gemma":[0.99909425,0.00004771099,0.00009792155,0.0004406907,0.00008005123,0.00023935428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045420224,0.00029838108,0.000459683,0.0001530767,0.00008316349,0.000009694717,0.000083900915,0.00011912394,0.000014190556],"category_scores_gemma":[0.000023388297,0.00021024798,0.000104960105,0.0002022805,0.000043206048,0.000056772973,0.000025033067,0.00005634292,0.00006338072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003325069,0.08784653,0.91006136,0.00003347385,0.00008009042,0.0010796444,0.00014177807,0.000078973055,0.00007710223,0.0000035082685,0.000091291666,0.00017376196],"study_design_scores_gemma":[0.2045406,0.0009335032,0.77196157,0.00006820032,0.000324109,0.000027023592,0.000006597821,0.0030774183,0.018777408,0.0000014980053,0.00007268808,0.00020937898],"about_ca_topic_score_codex":0.00010815084,"about_ca_topic_score_gemma":0.00004198628,"teacher_disagreement_score":0.20420809,"about_ca_system_score_codex":0.00015627356,"about_ca_system_score_gemma":0.00019529795,"threshold_uncertainty_score":0.8573664},"labels":[],"label_agreement":null},{"id":"W2035135228","doi":"10.1016/j.ophtha.2004.07.025","title":"Mantle cell lymphoma in the ocular adnexal region","year":2004,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Mantle cell lymphoma; Lymphoma; Adnexal Diseases; Pathology; Surgery","score_opus":0.024724760905406665,"score_gpt":0.27692019104505805,"score_spread":0.2521954301396514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035135228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95307094,0.0006619224,0.0000042847805,0.0030454919,0.00010896436,0.00026466433,0.0000011027205,0.000012153179,0.042830452],"genre_scores_gemma":[0.9985037,0.000044001536,0.00017770813,0.0006608321,0.00007347455,0.00006942,0.000016393407,0.000011006473,0.00044348504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923545,0.000054318123,0.00014385847,0.00021332932,0.00011952919,0.00023349228],"domain_scores_gemma":[0.9995205,0.00005125383,0.000036432415,0.00032607457,0.000016681848,0.000049086626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090557165,0.00011383396,0.00019026476,0.000062044346,0.00004309961,0.0000074251598,0.000097264296,0.000103031365,0.0000831031],"category_scores_gemma":[0.000015329842,0.00007150994,0.00008017045,0.00013311708,0.000059228303,0.00002539667,0.000024377237,0.00004991228,0.00023454153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048261235,0.010611378,0.8144604,0.000109838875,0.00011401579,0.15160286,0.0019835185,0.00005821405,0.00080749247,0.010518791,0.002548184,0.0067026713],"study_design_scores_gemma":[0.010377781,0.0010917409,0.93727463,0.000048733218,0.000075701,0.039973557,0.00028159874,0.000005521493,0.0041847066,0.0022786413,0.004277222,0.0001301467],"about_ca_topic_score_codex":0.00044468237,"about_ca_topic_score_gemma":0.000004085366,"teacher_disagreement_score":0.12281423,"about_ca_system_score_codex":0.00016044539,"about_ca_system_score_gemma":0.00008666812,"threshold_uncertainty_score":0.30146348},"labels":[],"label_agreement":null},{"id":"W2035589413","doi":"10.1016/j.jim.2004.06.003","title":"Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening","year":2004,"lang":"en","type":"article","venue":"Journal of Immunological Methods","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Flow cytometry; Lymphoma; Monoclonal antibody; Rituximab; Apoptosis; Cell cycle; High-content screening; Cancer research; Computational biology; Cell; Chemistry; Biology; Antibody; Immunology; Biochemistry","score_opus":0.12742954405269485,"score_gpt":0.3945535339193077,"score_spread":0.26712398986661284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035589413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85605735,0.0048151514,0.13815585,0.00050566945,0.00025211892,0.00018497118,0.0000050050203,0.000007499676,0.000016388518],"genre_scores_gemma":[0.77883416,0.00075285416,0.22032279,0.000030698633,0.00004240609,0.000003130579,7.679759e-7,0.000008151125,0.00000505303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778676,0.0004944892,0.00086875085,0.00016835818,0.00047805102,0.00020360634],"domain_scores_gemma":[0.9967951,0.00082361983,0.0015348264,0.00033457525,0.00045028547,0.00006156284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002073495,0.00017676236,0.0009149553,0.00031697948,0.00010058998,0.000023817178,0.00024245447,0.00013784299,0.000016058371],"category_scores_gemma":[0.0009916426,0.00009617021,0.00040918853,0.00068802893,0.00025214738,0.00018268908,0.00008167404,0.00020075301,0.0000010125964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052511133,0.0021905352,0.0064210747,0.00003328692,0.00050379976,0.000037313395,0.00008217533,0.00019338293,0.6943378,0.00009919698,0.0000015015198,0.29557484],"study_design_scores_gemma":[0.0030880168,0.0006092216,0.44609138,0.0001921195,0.0002528932,0.0002436322,0.000103246726,0.00012646169,0.5490421,0.00018447003,0.000014695888,0.00005177821],"about_ca_topic_score_codex":0.00012717105,"about_ca_topic_score_gemma":4.0566445e-7,"teacher_disagreement_score":0.4396703,"about_ca_system_score_codex":0.0003165735,"about_ca_system_score_gemma":0.00012347414,"threshold_uncertainty_score":0.39217073},"labels":[],"label_agreement":null},{"id":"W2035684502","doi":"10.1038/bmt.2010.294","title":"High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma","year":2011,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Melphalan; Internal medicine; Chemotherapy; Confidence interval; Surgery; Cohort; Lymphoma; Refractory (planetary science)","score_opus":0.009316358435786204,"score_gpt":0.20649828264243703,"score_spread":0.19718192420665082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035684502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824226,0.00009860853,0.00006389571,0.00016219771,0.00004243485,0.0005086105,0.000025212074,0.00004286194,0.0008139306],"genre_scores_gemma":[0.9968976,0.00034777305,0.0021857144,0.00022005627,0.000015333375,0.000065707885,0.00018701778,0.000021699747,0.0000591385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991892,0.000024058309,0.00018888792,0.00024258788,0.00018084611,0.00017443497],"domain_scores_gemma":[0.99967504,0.00002356352,0.000055788023,0.0001281158,0.00003450833,0.00008296219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054554377,0.00016123195,0.00022718025,0.00011005379,0.000034667723,0.000011608613,0.000024652814,0.00006756902,0.00006998923],"category_scores_gemma":[0.0000018867629,0.00012130507,0.000029049294,0.00011259691,0.00003724454,0.00011443528,0.000002163911,0.00003055096,0.000010224117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034346692,0.0013197697,0.893342,0.00013053612,0.000077861136,0.0003055477,0.0023523413,7.0368344e-7,0.00034121293,0.00025516102,0.00003554935,0.0984046],"study_design_scores_gemma":[0.022806713,0.0011430645,0.9711848,0.00016043268,0.00013549373,0.000050177867,0.000029228613,0.000013108053,0.0041965293,0.000078530225,0.00006702657,0.00013492435],"about_ca_topic_score_codex":0.0008004404,"about_ca_topic_score_gemma":0.000233334,"teacher_disagreement_score":0.09826968,"about_ca_system_score_codex":0.00007071159,"about_ca_system_score_gemma":0.000042687607,"threshold_uncertainty_score":0.49466774},"labels":[],"label_agreement":null},{"id":"W2035691212","doi":"10.1002/pbc.23050","title":"The use of ultrasound in endemic Burkitt lymphoma in Cameroon","year":2011,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Lymphoma; Incidence (geometry); Disease; Abdominal ultrasound; Burkitt's lymphoma; Demographics; Retrospective cohort study; Pediatrics; Internal medicine","score_opus":0.052151219054071205,"score_gpt":0.26638966417640675,"score_spread":0.21423844512233553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035691212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847662,0.014013301,4.572513e-7,0.00010490294,0.00017758604,0.000343995,0.000018691406,0.000014671204,0.00056019286],"genre_scores_gemma":[0.9722053,0.026949905,0.0001283236,0.0001612996,0.0001877374,0.00020623724,0.000004326776,0.00001746368,0.00013944774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881214,0.00004424832,0.00038073602,0.00023732067,0.00021380458,0.00031172493],"domain_scores_gemma":[0.9990243,0.00041679665,0.00012866127,0.00030159723,0.00004757092,0.00008112032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013317444,0.00015118938,0.00029165868,0.00014563568,0.000030272198,0.000008691552,0.000094943665,0.00008638987,0.00010369479],"category_scores_gemma":[0.00013049772,0.000100934856,0.00008048741,0.0004617888,0.00004375384,0.00007393198,0.000027469829,0.000076359414,0.000010645044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013104767,0.00091541954,0.9871446,0.00004499277,0.000060906805,0.00007412302,0.00067651767,0.0000036147605,0.000073124545,0.00009856371,0.00080529664,0.009971794],"study_design_scores_gemma":[0.0045696334,0.00016241953,0.9896442,0.000049316044,0.000394551,0.000026337999,0.00007599253,0.000006757691,0.0021990763,0.000052765175,0.002712552,0.00010638086],"about_ca_topic_score_codex":0.016295282,"about_ca_topic_score_gemma":0.0024540033,"teacher_disagreement_score":0.013841279,"about_ca_system_score_codex":0.00016829453,"about_ca_system_score_gemma":0.00029533828,"threshold_uncertainty_score":0.9902553},"labels":[],"label_agreement":null},{"id":"W2036430660","doi":"10.1155/2014/247286","title":"Coexisting Mantle Cell Lymphoma and Prostate Adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Case Reports in Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Electricity Association; Ottawa Hospital","funders":"","keywords":"Medicine; Mantle cell lymphoma; Prostate; Pathology; Lymphoma; CD5; CD20; Adenocarcinoma; Internal medicine","score_opus":0.01768831848566816,"score_gpt":0.274955344247842,"score_spread":0.25726702576217386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036430660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767229,0.003850125,0.000020211679,0.0009472315,0.00022077246,0.0004422289,0.0000011452559,0.00004766224,0.0177477],"genre_scores_gemma":[0.9976012,0.0001744449,0.0004646738,0.0005710125,0.0002453151,0.000052022875,0.000023571685,0.000024975412,0.0008427636],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9984632,0.000040964253,0.0005469536,0.00043375892,0.00023225088,0.0002828332],"domain_scores_gemma":[0.9989254,0.00015599144,0.00018801373,0.00041591033,0.00006317735,0.0002515455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060731894,0.0001988972,0.0004927195,0.00014734188,0.00007433511,0.000009543767,0.000016150118,0.00007569352,0.000058408026],"category_scores_gemma":[0.0003544298,0.00014085392,0.000035156158,0.00015846465,0.0001629589,0.00004057022,0.000042251555,0.00007145798,0.000006498443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004734865,0.00030412726,0.577926,0.0002659436,0.000023246908,0.38302597,0.00078204117,9.389775e-7,0.00026257968,0.00009380395,0.0015876072,0.035680417],"study_design_scores_gemma":[0.010884798,0.0012342271,0.45298514,0.0010564143,0.0003529806,0.5120298,0.0009739859,0.0005564007,0.0027422411,0.00035425054,0.016544908,0.00028481166],"about_ca_topic_score_codex":0.0005287117,"about_ca_topic_score_gemma":0.000037524376,"teacher_disagreement_score":0.12900387,"about_ca_system_score_codex":0.00013794049,"about_ca_system_score_gemma":0.00006426468,"threshold_uncertainty_score":0.5743856},"labels":[],"label_agreement":null},{"id":"W2036772491","doi":"10.1097/rlu.0b013e3181db4d33","title":"Primary Mediastinal Large B-Cell Lymphoma (Thymic Lymphoma) Imaged With F-18 FDG PET-CT","year":2010,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Lymphoma; Mediastinum; Pathology; Pancreas; Population; Diffuse large B-cell lymphoma; Radiology; Internal medicine","score_opus":0.02305974017743515,"score_gpt":0.31294395194111824,"score_spread":0.28988421176368306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036772491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94014,0.00040910012,0.000011540559,0.008245769,0.0013576903,0.00072667346,0.000024306742,0.00030984182,0.048775084],"genre_scores_gemma":[0.97928876,0.0005259473,0.0027063473,0.013528518,0.002189436,0.00003777986,0.00017519988,0.00015949897,0.00138854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563473,0.00016442011,0.001239732,0.0010488008,0.0010349255,0.0008774079],"domain_scores_gemma":[0.99576604,0.0010619132,0.00039924504,0.0012689881,0.0002542278,0.0012496114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013425945,0.00058958493,0.0014939681,0.00018029074,0.00026309292,0.00003225188,0.00037968878,0.00013881597,0.004137005],"category_scores_gemma":[0.0009960819,0.00037573042,0.0003567232,0.00037242498,0.0012083848,0.00013892092,0.00018745687,0.0005276498,0.0013622118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00735812,0.041823853,0.35118714,0.0007548201,0.0012112192,0.03876241,0.0005835565,2.7137867e-7,0.007079417,0.0014147403,0.3268773,0.22294715],"study_design_scores_gemma":[0.07623501,0.0048368024,0.6532027,0.00050486333,0.0010625852,0.00436886,0.0003193366,0.00012664584,0.0002571593,0.000059139504,0.25855482,0.00047209646],"about_ca_topic_score_codex":0.000094554554,"about_ca_topic_score_gemma":0.000034927893,"teacher_disagreement_score":0.30201554,"about_ca_system_score_codex":0.0001911988,"about_ca_system_score_gemma":0.0004964912,"threshold_uncertainty_score":0.99986947},"labels":[],"label_agreement":null},{"id":"W2036879929","doi":"10.1097/mop.0b013e3282f424b0","title":"The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence","year":2008,"lang":"en","type":"review","venue":"Current Opinion in Pediatrics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Chemotherapy; Internal medicine; CD20; Leukemia; Oncology; Clinical trial; Salvage therapy","score_opus":0.11149184626989707,"score_gpt":0.37223789803064433,"score_spread":0.2607460517607473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036879929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017385793,0.99349153,0.0000011250002,0.000055649027,0.0031007892,0.0029646,0.00009463841,0.00002236883,0.0000954442],"genre_scores_gemma":[0.000051075418,0.99807805,0.0000916071,0.000011998682,0.0010524415,0.00035293147,0.000251393,0.0000627349,0.000047791124],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941161,0.0004419469,0.0030156667,0.0007818282,0.0010520929,0.000592323],"domain_scores_gemma":[0.9927524,0.0036847277,0.0019552761,0.0011673734,0.00024831027,0.00019190994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086930685,0.0007139482,0.0035919566,0.00083857676,0.00006803527,0.0000144554415,0.0006183024,0.0004002539,0.000035176345],"category_scores_gemma":[0.0015841181,0.00047705535,0.0009963968,0.0032970011,0.0001281504,0.00010329051,0.00025133067,0.0005258364,0.00015870178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003107734,0.005695131,0.00875495,0.47644114,0.000032091153,0.000020821939,0.00003268725,6.521402e-7,5.040869e-9,0.000052497027,0.06119634,0.4477426],"study_design_scores_gemma":[0.0074445144,0.00024449656,0.0016075711,0.17447227,0.0014644489,0.00005885983,0.0000036054314,0.0000031708578,6.589497e-7,0.000006004999,0.8143153,0.00037908036],"about_ca_topic_score_codex":0.00011691523,"about_ca_topic_score_gemma":0.0000017213702,"teacher_disagreement_score":0.753119,"about_ca_system_score_codex":0.0015304128,"about_ca_system_score_gemma":0.004697607,"threshold_uncertainty_score":0.99976814},"labels":[],"label_agreement":null},{"id":"W2037620714","doi":"10.1016/s0936-6555(02)00417-x","title":"Evolution of Treatment for Hodgkin's Disease: a Population-based Study of Radiation Therapy Use and Outcome","year":2003,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Incidence (geometry); Cohort; Radiation therapy; Population; Cancer registry; Internal medicine; Surgery; Chemotherapy; Cancer; Pediatrics","score_opus":0.17837978919877695,"score_gpt":0.4687110863374081,"score_spread":0.29033129713863115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037620714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976752,0.0003727033,0.000058169382,0.0002417259,0.00014278639,0.00146291,0.000022088632,0.0000083944105,0.000016062724],"genre_scores_gemma":[0.9989972,0.00010447697,0.0004902588,0.00011170979,0.000038704722,0.00018254077,0.00003878173,0.000007394781,0.000028938086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988454,0.00020670507,0.0006026924,0.0001890246,0.00007199175,0.00008421007],"domain_scores_gemma":[0.99771625,0.0016551428,0.00025846215,0.00018393486,0.00007985221,0.000106373634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002541256,0.00008595547,0.000517978,0.000052716696,0.000024994668,0.0000021060505,0.000015937096,0.00008662007,0.000016546917],"category_scores_gemma":[0.00076697976,0.00005893517,0.00013861193,0.00005647357,0.000036122976,0.00002570193,0.0000031081804,0.000022286644,6.318396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043118,0.010399308,0.95581627,0.000013712429,0.00015020304,0.000004369849,0.000037159665,0.000030108622,0.0000064340024,0.0004492378,0.00002330033,0.031765573],"study_design_scores_gemma":[0.02457206,0.01985352,0.9528901,0.000008735334,0.00038164246,5.411292e-7,0.00003850956,0.00018426015,0.000035970847,0.000097252065,0.0018961509,0.000041232302],"about_ca_topic_score_codex":0.0002490905,"about_ca_topic_score_gemma":0.00006663619,"teacher_disagreement_score":0.03172434,"about_ca_system_score_codex":0.00037746766,"about_ca_system_score_gemma":0.0002988949,"threshold_uncertainty_score":0.24033064},"labels":[],"label_agreement":null},{"id":"W2037676917","doi":"10.1097/mph.0b013e3182273b57","title":"MLL Duplication in a Pediatric Patient With B-Cell Lymphoblastic Lymphoma","year":2011,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Lymphoblastic lymphoma; Gene duplication; Lymphoma; Medicine; Lineage (genetic); Cancer research; Gene rearrangement; Myeloid; Pathology; Immunology; Gene; T cell; Biology; Genetics","score_opus":0.019489822667204195,"score_gpt":0.25950416212989363,"score_spread":0.24001433946268944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037676917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876176,0.0036874784,0.000118849515,0.0005015361,0.00036420018,0.00044642395,0.000002405268,0.000023750868,0.0072377156],"genre_scores_gemma":[0.9917716,0.002708111,0.004555625,0.00036506986,0.0004579654,0.000067674686,0.000003998332,0.000033020922,0.000036947684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973223,0.00018096126,0.0012849037,0.00033747609,0.00037184925,0.0005025121],"domain_scores_gemma":[0.9971914,0.00043021573,0.0013158193,0.00029902742,0.00038205538,0.000381451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038392824,0.00030424297,0.0010686748,0.0009222147,0.00005262876,0.000007709876,0.00018550882,0.0003798487,0.00010614075],"category_scores_gemma":[0.00016125407,0.00021259446,0.00020035883,0.00074754213,0.00007648361,0.00014147651,0.000058324145,0.00021861233,0.00010142713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018488711,0.01028276,0.9568363,0.0002071378,0.00011269771,0.015463047,0.001988357,0.0000077270415,0.000031487707,0.00032380968,0.0028423879,0.010055416],"study_design_scores_gemma":[0.040168118,0.02528915,0.8776537,0.00007387624,0.0033957167,0.043368466,0.00096201233,0.0000749268,0.0021763146,0.00044910947,0.005801852,0.00058671914],"about_ca_topic_score_codex":0.000051549006,"about_ca_topic_score_gemma":0.000035085588,"teacher_disagreement_score":0.079182565,"about_ca_system_score_codex":0.0009931149,"about_ca_system_score_gemma":0.0020057417,"threshold_uncertainty_score":0.866935},"labels":[],"label_agreement":null},{"id":"W2037796411","doi":"10.1056/nejmoa0802885","title":"Stromal Gene Signatures in Large-B-Cell Lymphomas","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1818,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Allos Therapeutics; National Cancer Institute; National Institutes of Health; Genentech; Celgene; Biogen; Amgen","keywords":"Vincristine; Medicine; Rituximab; CHOP; Prednisone; Lymphoma; Cyclophosphamide; Doxorubicin; Chemotherapy; Diffuse large B-cell lymphoma; Cancer research; B cell; Oncology; Stromal cell; Internal medicine; Immunology; Antibody","score_opus":0.01635634650571655,"score_gpt":0.2560204910338821,"score_spread":0.23966414452816553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037796411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892106,0.011939653,0.000058414287,0.0041055754,0.00041112097,0.0001303043,0.0000026912478,0.000010194533,0.0044210055],"genre_scores_gemma":[0.99213976,0.00218516,0.0009040578,0.0008933025,0.002905336,0.0000015626508,0.000007383001,0.000016538224,0.0009468771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839854,0.000058875004,0.0005648865,0.00014070733,0.0005607453,0.00027624948],"domain_scores_gemma":[0.99892384,0.00016916037,0.0002312292,0.00016163914,0.00012004304,0.00039406953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041108008,0.00018017675,0.0006209668,0.00028829975,0.00004491219,0.0000033962697,0.00009527517,0.00009075756,0.0004442104],"category_scores_gemma":[0.0001593173,0.000108090535,0.00010870629,0.00019708493,0.00006474204,0.0000687205,0.000017071625,0.00023164727,0.0000080997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033499715,0.0032970097,0.833666,0.00007762887,0.0003144703,0.035761088,0.0036989527,0.00013056354,0.011656413,0.00024963336,0.0700939,0.03770433],"study_design_scores_gemma":[0.33486038,0.0049780854,0.5819152,0.0005178191,0.000307128,0.009767991,0.00020099069,0.00005901263,0.009179392,0.00015151247,0.057894018,0.00016846896],"about_ca_topic_score_codex":0.00012712617,"about_ca_topic_score_gemma":0.000030267449,"teacher_disagreement_score":0.3315104,"about_ca_system_score_codex":0.00016155213,"about_ca_system_score_gemma":0.00039427262,"threshold_uncertainty_score":0.48637924},"labels":[],"label_agreement":null},{"id":"W2037994583","doi":"10.1182/blood-2014-08-595801","title":"Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Pharmaceuticals International; National Cancer Institute; Celgene; Sanofi; Pfizer","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Refractory (planetary science); Hodgkin lymphoma; Lymphoma; Phases of clinical research; Chemotherapy; Biology","score_opus":0.01928113197485227,"score_gpt":0.297972365067819,"score_spread":0.27869123309296673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037994583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708295,0.00021512125,6.301418e-7,0.00014187847,0.000063348576,0.0007016107,0.0000069201596,0.000029954716,0.0017575696],"genre_scores_gemma":[0.99926496,0.00003979175,0.00016477473,0.000059638565,0.000042821288,0.00012174273,0.000013822434,0.000023241966,0.0002692198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845153,0.0001414678,0.00051385903,0.0003448095,0.00027527218,0.00027303677],"domain_scores_gemma":[0.9990339,0.00021022432,0.00013085835,0.00045044726,0.000038144895,0.00013642556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027141735,0.00018229929,0.00052580016,0.0002348771,0.000033325676,0.00000788694,0.00008946018,0.000092447255,0.00011179219],"category_scores_gemma":[0.00035384393,0.00013237145,0.00006610523,0.00037713637,0.000027982636,0.00004323746,0.00004580109,0.00008610979,0.000017390323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002103406,0.235492,0.7202937,0.00011245009,0.00019288248,0.0014891705,0.0026329237,0.0000054918555,0.009846725,0.00003951943,0.00043852613,0.027353201],"study_design_scores_gemma":[0.19930278,0.009180764,0.7790502,0.0005421412,0.00029322095,0.000097109216,0.0011219098,0.00013856243,0.009223568,0.000022038794,0.0008364372,0.00019127592],"about_ca_topic_score_codex":0.00083917606,"about_ca_topic_score_gemma":0.00048073928,"teacher_disagreement_score":0.22631125,"about_ca_system_score_codex":0.00013252461,"about_ca_system_score_gemma":0.00019031673,"threshold_uncertainty_score":0.5397951},"labels":[],"label_agreement":null},{"id":"W2038308917","doi":"10.1002/cncr.25377","title":"Interim report of a phase 2 clinical trial of lenalidomide for T‐cell non‐Hodgkin lymphoma","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of Manitoba; University of Ottawa; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Neutropenia; Interim analysis; Clinical endpoint; Rash; Febrile neutropenia; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Surgery; Clinical trial; Chemotherapy; Multiple myeloma","score_opus":0.08300553938195884,"score_gpt":0.460166474150189,"score_spread":0.3771609347682302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038308917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953968,0.00017765725,0.00007429111,0.00034819864,0.0015452153,0.0009158944,0.000050008817,0.000009224949,0.001482725],"genre_scores_gemma":[0.9969293,0.00011567972,0.0010747532,0.0001581362,0.0006908331,0.0003416132,0.000026224925,0.00001649282,0.0006469894],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987434,0.000015042942,0.000739213,0.0002265102,0.00014042085,0.00013537682],"domain_scores_gemma":[0.99876106,0.00018574669,0.00038938693,0.00038411567,0.00017057231,0.000109117995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033835456,0.00010782976,0.0005494519,0.000042689557,0.000013959394,0.000003361113,0.00006446187,0.000111948175,0.0002058397],"category_scores_gemma":[0.00025339183,0.00007900063,0.00034449037,0.000057183206,0.00010903435,0.000024546365,0.000022518552,0.000046544836,0.0000032591138],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.210867,0.027604092,0.05753933,0.0006873156,0.0011185255,0.0005629514,0.00045377694,0.0000010247763,0.13510163,0.00020514392,0.046851207,0.519008],"study_design_scores_gemma":[0.44128403,0.006051747,0.009688553,0.0001816406,0.00071207195,0.00007198811,0.000035881705,0.00009366818,0.4646433,0.00005662515,0.077049576,0.0001309116],"about_ca_topic_score_codex":0.00019883514,"about_ca_topic_score_gemma":0.00004029519,"teacher_disagreement_score":0.5188771,"about_ca_system_score_codex":0.000053054086,"about_ca_system_score_gemma":0.00051517243,"threshold_uncertainty_score":0.3221552},"labels":[],"label_agreement":null},{"id":"W2038880599","doi":"10.1111/j.1365-2141.2005.05755.x","title":"Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Lymphoma; Medicine; Stem cell; Refractory (planetary science); Transplantation; Hematopoietic stem cell transplantation; Histology; Haematopoiesis; Non-Hodgkin's lymphoma; Aggressive lymphoma; Oncology; Hematology; Hodgkin lymphoma; Internal medicine; Pathology; Cancer research; Biology; Rituximab","score_opus":0.010519418045095994,"score_gpt":0.2520527148463884,"score_spread":0.24153329680129243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038880599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96635425,0.030507931,0.0005737829,0.0015766532,0.00028719113,0.00040806519,0.000023977625,0.0000144187725,0.00025374716],"genre_scores_gemma":[0.9875548,0.007538231,0.0038001735,0.0006399786,0.00013693038,0.000043981287,0.00002140543,0.000030352667,0.0002341348],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9983921,0.0001048645,0.00076142413,0.0002507827,0.0001767417,0.00031408563],"domain_scores_gemma":[0.9983321,0.00030800657,0.00078738685,0.00013156608,0.00023332084,0.00020765811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002295416,0.00018737323,0.00091462454,0.00017898002,0.00011433058,0.000021997677,0.00009680712,0.00023895243,0.000045826837],"category_scores_gemma":[0.00005124572,0.00018417387,0.00021205228,0.00006177922,0.00015733122,0.00012881237,0.000013984064,0.00011662893,0.000011151537],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031238422,0.004208424,0.026858086,0.0019981777,0.001124921,0.22612682,0.0030416057,0.00003169876,0.004900881,0.0006361621,0.020930655,0.70701873],"study_design_scores_gemma":[0.021412777,0.001835172,0.0451713,0.0009709816,0.0011731309,0.9022434,0.00022552647,0.00005624089,0.01326232,0.00024070409,0.013148354,0.00026012913],"about_ca_topic_score_codex":0.00003107085,"about_ca_topic_score_gemma":0.00008194389,"teacher_disagreement_score":0.7067586,"about_ca_system_score_codex":0.0002113563,"about_ca_system_score_gemma":0.00031611155,"threshold_uncertainty_score":0.75103927},"labels":[],"label_agreement":null},{"id":"W2039237147","doi":"10.1038/nm.2407","title":"Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma","year":2011,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"Lymphoma; Radiation therapy; Etiology; Locus (genetics); Cancer research; Medicine; Oncology; Gene; Biology; Bioinformatics; Internal medicine; Genetics","score_opus":0.031556540576575726,"score_gpt":0.2809859275511437,"score_spread":0.24942938697456798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039237147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761021,0.0065648495,9.561592e-7,0.0040755393,0.00033075627,0.00071665074,0.00001509301,0.000021319545,0.012172727],"genre_scores_gemma":[0.9909751,0.0005044048,0.00009317154,0.00752734,0.000270303,0.00021515586,0.00003057396,0.000021561027,0.00036240797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984426,0.0001268816,0.00040771445,0.0003590458,0.0003270428,0.00033673676],"domain_scores_gemma":[0.9988248,0.0001960849,0.0001604948,0.00061382365,0.00011235433,0.00009247032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044532717,0.00025752175,0.00059060496,0.00016535025,0.00004048015,0.0000024891267,0.0001999414,0.00039667203,0.0021439064],"category_scores_gemma":[0.000099468634,0.00012686665,0.00010130944,0.0003073428,0.00019336265,0.000039447274,0.000049828835,0.00021717201,0.000036575406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006812238,0.0039047273,0.75099695,0.00033326412,0.00091536884,0.0029573848,0.027249906,6.2598595e-8,0.10227488,0.0034543478,0.02675316,0.07434769],"study_design_scores_gemma":[0.007581391,0.0014861589,0.9430558,0.00018895374,0.00010807232,0.0003878351,0.00024671495,0.0000011904697,0.032609195,0.00030785523,0.013916976,0.00010985057],"about_ca_topic_score_codex":0.00021251355,"about_ca_topic_score_gemma":0.00018430392,"teacher_disagreement_score":0.19205883,"about_ca_system_score_codex":0.00012537095,"about_ca_system_score_gemma":0.000081639984,"threshold_uncertainty_score":0.99876827},"labels":[],"label_agreement":null},{"id":"W2039431106","doi":"10.1080/10428190400015022","title":"Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?","year":2004,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Mantle cell lymphoma; Medicine; Transplantation; Lymphoma; Stem cell; Population; Autologous stem-cell transplantation; Internal medicine; Surgery; Oncology; Biology","score_opus":0.01109129190567764,"score_gpt":0.23112762485023536,"score_spread":0.2200363329445577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039431106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584485,0.0030264542,0.00066782045,0.0008824121,0.0005334796,0.0022388925,0.00040492037,0.00030486324,0.006096278],"genre_scores_gemma":[0.9826513,0.0028931375,0.003570756,0.0048598363,0.00055369537,0.0010052845,0.00071400014,0.00025315286,0.0034988376],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99434096,0.00011549139,0.0012901154,0.0018065207,0.000850591,0.0015963003],"domain_scores_gemma":[0.9967434,0.00047442084,0.00047189932,0.0011334526,0.00025782167,0.0009190056],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00036071107,0.0012827317,0.0014285739,0.00043810363,0.0006556951,0.00025527494,0.00045762662,0.0008112957,0.00010425977],"category_scores_gemma":[0.000019562538,0.0010184,0.0007880144,0.00049134,0.00032545783,0.0004945225,0.00013326785,0.00009694647,0.00026184836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013489458,0.012537492,0.106736094,0.01245919,0.0031634334,0.00932313,0.016372947,0.00078903325,0.07548682,0.0042332676,0.019609233,0.7257999],"study_design_scores_gemma":[0.17333992,0.0027116975,0.1830551,0.0013011607,0.003702885,0.0032979983,0.002394688,0.00096995337,0.5732422,0.0017482938,0.05132019,0.002915934],"about_ca_topic_score_codex":0.0015248469,"about_ca_topic_score_gemma":0.00029337837,"teacher_disagreement_score":0.72288394,"about_ca_system_score_codex":0.00940539,"about_ca_system_score_gemma":0.003565626,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W2039455697","doi":"10.1097/mnm.0b013e328334fc14","title":"False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma","year":2010,"lang":"en","type":"article","venue":"Nuclear Medicine Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lymphoma; Nuclear medicine; Hodgkin lymphoma; Burkitt's lymphoma; Radiology; Internal medicine","score_opus":0.040708825888237814,"score_gpt":0.32624410083646477,"score_spread":0.28553527494822695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039455697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811094,0.001586207,4.1852257e-7,0.007297441,0.00014148859,0.0006795357,0.000011299419,0.000052180767,0.009122053],"genre_scores_gemma":[0.99476206,0.0021069958,0.0019718255,0.00074005494,0.00009520227,0.000116891424,0.0000927218,0.000041628064,0.000072629584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998441,0.000109140485,0.00049319834,0.0003062257,0.00035174933,0.00029872745],"domain_scores_gemma":[0.99759036,0.00047123118,0.0001559144,0.00137428,0.00024821327,0.0001600093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030738924,0.00024555274,0.00054245436,0.00038826672,0.00016610803,0.0000107151955,0.00035263324,0.000028226177,0.00013758341],"category_scores_gemma":[0.00038669966,0.00017500277,0.000055012028,0.00058139116,0.0004957866,0.00010575815,0.00019908589,0.0003320801,0.00007557357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024261666,0.0036216895,0.97075486,0.00006581257,0.00013930837,0.00040731207,0.0026431684,0.0000010759637,0.000040462062,0.0018284514,0.0034606704,0.01679457],"study_design_scores_gemma":[0.010943194,0.0005883871,0.9783071,0.0003719131,0.0002689854,0.0001331972,0.0016679376,0.00007145419,0.00000860469,0.00007478863,0.007403609,0.00016083056],"about_ca_topic_score_codex":0.00046206938,"about_ca_topic_score_gemma":0.0014428272,"teacher_disagreement_score":0.016633738,"about_ca_system_score_codex":0.00028096142,"about_ca_system_score_gemma":0.000114375485,"threshold_uncertainty_score":0.71364063},"labels":[],"label_agreement":null},{"id":"W2039488033","doi":"10.1186/1476-4598-7-2","title":"Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research; Korea Institute of Machinery and Materials; Lymphoma Research Foundation","keywords":"Anaplastic large-cell lymphoma; Comparative genomic hybridization; Biology; Lymphoma; Cell culture; Cancer research; Genetics; Chromosome; Karyotype; Molecular biology; Gene; Immunology","score_opus":0.03140122116698504,"score_gpt":0.27909316065782336,"score_spread":0.24769193949083831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039488033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821545,0.0070494046,0.0036092047,0.00010559823,0.000052680833,0.0007085818,0.00013443008,0.000026843933,0.00009781026],"genre_scores_gemma":[0.99587494,0.00086490257,0.0027057335,0.00018821144,0.00005065731,0.00012437443,0.00013488243,0.000033204586,0.000023085579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984912,0.000073252486,0.00041890945,0.00046348185,0.00023116956,0.00032194218],"domain_scores_gemma":[0.9991654,0.00009842958,0.00022307725,0.00022741027,0.00014500125,0.00014063732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011116811,0.00026553575,0.0005008299,0.00021582855,0.0001294844,0.000014526041,0.000047462006,0.000097028234,0.0000045361794],"category_scores_gemma":[0.000038805483,0.00025290824,0.00007665891,0.00029954064,0.00012275766,0.0000777906,0.000032628534,0.000047650316,0.0000016292045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004921891,0.0021397816,0.16670077,0.0004717783,0.000069157424,0.00033105045,0.0006850503,0.0020790352,0.82670176,0.00008207069,0.00007708865,0.00017027903],"study_design_scores_gemma":[0.013496107,0.0003592292,0.17084427,0.00043514837,0.00017025897,0.0000650018,0.00012144886,0.012172756,0.80201,0.000008209866,0.00008470169,0.0002328463],"about_ca_topic_score_codex":0.00029575863,"about_ca_topic_score_gemma":0.00021125664,"teacher_disagreement_score":0.024691738,"about_ca_system_score_codex":0.00039930508,"about_ca_system_score_gemma":0.00050565397,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W2039888190","doi":"10.1056/nejmoa1408648","title":"Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":750,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Leukaemia and Lymphoma Research; Cancer Research UK; National Institute for Health and Care Research; Teenage Cancer Trust","keywords":"ABVD; Vinblastine; Dacarbazine; Bleomycin; Medicine; Positron emission tomography; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Radiation therapy; Hodgkin's lymphoma; Chemotherapy; Oncology; Doxorubicin; Nuclear medicine; Internal medicine; Radiology; Vincristine; Cyclophosphamide","score_opus":0.05951511092452814,"score_gpt":0.32697309889752446,"score_spread":0.2674579879729963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039888190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017894,0.002075097,0.000055258668,0.004930137,0.00080437015,0.0006131185,0.00002678567,0.000012182489,0.0013040807],"genre_scores_gemma":[0.9939747,0.0010052262,0.0014542898,0.00014787553,0.0026808295,0.0000063891944,0.000016332848,0.000018875104,0.00069549354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978248,0.00009669592,0.0010670496,0.00013423967,0.00069854414,0.00017867402],"domain_scores_gemma":[0.9971845,0.0004988299,0.00093907857,0.00024174721,0.00073745527,0.0003983752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013950855,0.00017213429,0.0009902137,0.00023633901,0.000016686517,0.0000035689427,0.00011364719,0.00006287603,0.00003094635],"category_scores_gemma":[0.0014024724,0.00009683935,0.00019638453,0.00018236942,0.000085456755,0.000056147343,0.000011063431,0.000072257986,7.9596157e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6102227,0.0024309764,0.0096264295,0.00008846901,0.0010834871,0.00051039335,0.004293341,0.000009104723,0.0023182482,0.00010676878,0.04450162,0.32480845],"study_design_scores_gemma":[0.8693152,0.038497243,0.021248287,0.00054987246,0.00038540934,0.00042925216,0.00026140155,0.000026499234,0.007981619,0.0002063126,0.06102073,0.00007818184],"about_ca_topic_score_codex":0.0006169825,"about_ca_topic_score_gemma":0.000021466181,"teacher_disagreement_score":0.32473028,"about_ca_system_score_codex":0.00009705749,"about_ca_system_score_gemma":0.00067618705,"threshold_uncertainty_score":0.3948994},"labels":[],"label_agreement":null},{"id":"W2040996294","doi":"10.1016/j.ijrobp.2012.07.1639","title":"Pattern of Failure in Patients With Stage I-II Hodgkin Lymphoma Treated With CMT: Implications of Partial Nodal Region Coverage and the Need for Adjacent Uninvolved Nodal Region Coverage","year":2012,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; ABVD; NODAL; Stage (stratigraphy); Radiation therapy; Lymphoma; Internal medicine; Nuclear medicine; Gastroenterology; Surgery; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.01578572017107233,"score_gpt":0.27596816453911766,"score_spread":0.26018244436804533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040996294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768157,0.00013707718,0.008343919,0.002704845,0.0001712286,0.0007664503,0.0001369592,0.000008608104,0.000049347742],"genre_scores_gemma":[0.99840385,0.00024528184,0.0003408813,0.00035894036,0.00029525254,0.00005715999,0.00026099852,0.0000223325,0.000015299971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851674,0.00017981314,0.0006653783,0.00017967111,0.00024139692,0.00021703052],"domain_scores_gemma":[0.99717313,0.00043401518,0.0014099748,0.00017945502,0.0007001948,0.00010322322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026187705,0.00020583037,0.0005746017,0.00014469198,0.00006903261,0.000010695015,0.00015625404,0.00014889246,0.0000064262886],"category_scores_gemma":[0.000076745404,0.00012558093,0.00013885833,0.00015526703,0.00026952513,0.00024177055,0.000041616255,0.000120709454,5.653159e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058740894,0.002075658,0.95686793,0.000017918706,0.0006719306,0.000007180036,0.0008047068,0.00018621598,0.00012091767,0.0030469475,0.00015945431,0.03016707],"study_design_scores_gemma":[0.05428191,0.0036511477,0.93733966,0.00013402726,0.00032542,0.000072216455,0.00011136933,0.0003672229,0.0014233977,0.00033019984,0.0018337413,0.00012967087],"about_ca_topic_score_codex":0.00012354353,"about_ca_topic_score_gemma":0.000033264183,"teacher_disagreement_score":0.04840782,"about_ca_system_score_codex":0.00055885414,"about_ca_system_score_gemma":0.0002835878,"threshold_uncertainty_score":0.51210415},"labels":[],"label_agreement":null},{"id":"W2041503963","doi":"10.1016/j.ijrobp.2011.06.040","title":"Active Breath Control to Reduce Normal Tissue Dose in Patients Receiving Mediastinal Radiotherapy for Hodgkin Lymphoma","year":2011,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mediastinum; Radiation therapy; Chemoradiotherapy; Lung; Hodgkin lymphoma; Lung cancer; Nuclear medicine; Lymphoma; Breathing; Radiology; Internal medicine; Anesthesia","score_opus":0.021960112279133533,"score_gpt":0.3287943977939445,"score_spread":0.30683428551481096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041503963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908216,0.00017805707,0.0057620825,0.0016136232,0.0019071293,0.0007724214,0.0001276373,0.00001923432,0.0005376648],"genre_scores_gemma":[0.9879746,0.00018520221,0.008649162,0.0014304578,0.0015347736,0.00008705042,0.000082191495,0.000029266415,0.000027295751],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983412,0.00015409896,0.00070769346,0.00025696884,0.00025471384,0.00028530997],"domain_scores_gemma":[0.9977282,0.00046261694,0.00072265597,0.00012561244,0.00076152687,0.00019934823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037956116,0.00021984536,0.00056464697,0.00025980463,0.000049147446,0.000014939278,0.00026271972,0.00018991713,0.00009663367],"category_scores_gemma":[0.0003605197,0.00018710912,0.00018452617,0.0001432841,0.000076220414,0.0002470358,0.000026605698,0.00014280893,0.000016782842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004872953,0.001875136,0.45702404,0.0000038226844,0.00054871815,0.000041358522,0.0014044999,0.00005150278,0.0011380294,0.000552637,0.00050638366,0.53198093],"study_design_scores_gemma":[0.039720427,0.0065254103,0.9317241,0.000094995405,0.00014812488,0.0001229884,0.00006642738,0.00028517624,0.010889298,0.0007512439,0.009485422,0.00018642511],"about_ca_topic_score_codex":0.000068100315,"about_ca_topic_score_gemma":0.000010625663,"teacher_disagreement_score":0.5317945,"about_ca_system_score_codex":0.0018492767,"about_ca_system_score_gemma":0.00052519696,"threshold_uncertainty_score":0.76300883},"labels":[],"label_agreement":null},{"id":"W2041587180","doi":"10.1159/000070661","title":"Serum Soluble CD27, but Not Thymidine Kinase, Is an Independent Prognostic Factor for Outcome in Indolent Non-Hodgkin&amp;rsquo;s Lymphoma","year":2003,"lang":"en","type":"article","venue":"Tumor Biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Oncology; Proportional hazards model; Beta-2 microglobulin; Survival analysis; Immunology","score_opus":0.060586746255306724,"score_gpt":0.33024892676515827,"score_spread":0.2696621805098515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041587180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954302,0.00030023395,0.00006634609,0.0008213701,0.00065658404,0.0020203155,0.00031768743,0.00007638024,0.00031090618],"genre_scores_gemma":[0.9949369,0.00003800487,0.0009460574,0.0024515674,0.00013574185,0.00071156933,0.00019088185,0.000055823617,0.0005334469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973284,0.00012293972,0.0006918764,0.0007923364,0.0002025753,0.0008618912],"domain_scores_gemma":[0.99852985,0.00023214055,0.00019913587,0.000595205,0.000120685014,0.00032300403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031067088,0.00044278358,0.000867249,0.0002685038,0.00010339666,0.00002729919,0.000183421,0.0002385713,0.00038203236],"category_scores_gemma":[0.0002921418,0.0003402579,0.00021187398,0.00020698537,0.00010488402,0.00008083197,0.00007485852,0.00012517627,0.0001679423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037848725,0.0021748904,0.98354775,0.00010739051,0.000116581934,0.00016972865,0.00035035217,0.0000020141276,0.006607254,0.00066690455,0.00018048934,0.005698189],"study_design_scores_gemma":[0.012200591,0.0024001393,0.9190686,0.00007696929,0.00012724516,0.00021259543,0.00014314227,0.000052763808,0.057196684,0.0002341538,0.007895258,0.00039186646],"about_ca_topic_score_codex":0.00044626388,"about_ca_topic_score_gemma":0.0003164437,"teacher_disagreement_score":0.06447913,"about_ca_system_score_codex":0.00047257234,"about_ca_system_score_gemma":0.00030004658,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W2041794160","doi":"10.1155/2011/945752","title":"Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission after Eradication of Helicobacter Pylori Infection","year":2011,"lang":"en","type":"article","venue":"Case Reports in Gastrointestinal Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"MALT lymphoma; Helicobacter pylori; Medicine; Lymphoma; Lacrimal gland; Lymphatic system; Pathology; Mucosa-associated lymphoid tissue; Radiation therapy; Stomach; Gastroenterology; Chemotherapy; Internal medicine","score_opus":0.01958109088471906,"score_gpt":0.2654018894663582,"score_spread":0.2458207985816391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041794160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710447,0.00018784813,0.00007034325,0.00037874683,0.0001924491,0.0006202175,0.000005342872,0.00003348613,0.0014071184],"genre_scores_gemma":[0.9988158,0.00002544754,0.0006962457,0.00008508628,0.00011003346,0.00006685787,0.00003266565,0.00002425085,0.00014363819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774426,0.00012968195,0.0010691757,0.00034752532,0.000422924,0.00028640666],"domain_scores_gemma":[0.9978945,0.00013517115,0.0008139667,0.0005702098,0.0004140094,0.00017213865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006713444,0.00024709053,0.0005657555,0.00022053797,0.000051495026,0.000002734527,0.0000422295,0.00008533746,0.00020323326],"category_scores_gemma":[0.0019800384,0.0001525778,0.00011546266,0.00044741225,0.0002686351,0.00007183077,0.000058668084,0.000113539725,0.0000012389089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006164007,0.0011014547,0.9550778,0.00017999105,0.00004729651,0.031249672,0.0007412488,9.291732e-7,0.006318646,0.000023391858,0.00016641755,0.004476738],"study_design_scores_gemma":[0.0032862045,0.0014831292,0.7947756,0.0031078681,0.0002808738,0.17737292,0.00021119065,0.00004037252,0.019155726,0.00008753116,0.0001061783,0.000092414775],"about_ca_topic_score_codex":0.00358812,"about_ca_topic_score_gemma":0.00016640758,"teacher_disagreement_score":0.1603022,"about_ca_system_score_codex":0.00053698715,"about_ca_system_score_gemma":0.0002795459,"threshold_uncertainty_score":0.62219423},"labels":[],"label_agreement":null},{"id":"W2042396314","doi":"10.4161/mabs.1.1.7472","title":"Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society; William K. Warren Foundation","keywords":"Bortezomib; Mantle cell lymphoma; Rituximab; Proteasome inhibitor; Cancer research; Medicine; Apoptosis; Protein kinase B; Proteasome; Lymphoma; Pharmacology; Internal medicine; Chemistry; Multiple myeloma; Biochemistry","score_opus":0.017791913357777203,"score_gpt":0.2454242294326189,"score_spread":0.2276323160748417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042396314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613625,0.0005094923,0.0000075873586,0.0011047539,0.000053819076,0.0009313603,0.00001586323,0.000041483472,0.0011993987],"genre_scores_gemma":[0.99870694,0.00026491747,0.0005754225,0.00016536006,0.00002520041,0.00008810054,0.000042349613,0.000013445549,0.00011827119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991092,0.000030599524,0.000145214,0.00033332192,0.00014654515,0.00023508513],"domain_scores_gemma":[0.9995329,0.00005458279,0.000036027686,0.0001783944,0.00002412791,0.00017396327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008392207,0.0001930807,0.00033227977,0.00011716433,0.00006238285,0.000033831522,0.000025623805,0.00006840619,0.000006250898],"category_scores_gemma":[0.000019782687,0.00015233009,0.00003936142,0.00010658763,0.000011272025,0.00005532322,0.000022319922,0.000021695523,0.000017699253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063891127,0.018730111,0.54340595,0.00012138107,0.000081985454,0.00035625114,0.0019315807,0.0000021092453,0.012730025,0.001190389,0.00023735322,0.42057392],"study_design_scores_gemma":[0.031222919,0.0027627253,0.9033009,0.00009798117,0.00008696637,0.000020572123,0.00010178062,0.00033933684,0.060831815,0.00015170616,0.0009187418,0.00016459906],"about_ca_topic_score_codex":0.00027170085,"about_ca_topic_score_gemma":0.000080629296,"teacher_disagreement_score":0.42040932,"about_ca_system_score_codex":0.00030616802,"about_ca_system_score_gemma":0.00003541179,"threshold_uncertainty_score":0.62118405},"labels":[],"label_agreement":null},{"id":"W2042604203","doi":"10.1177/1066896913491318","title":"A Rare Case of Anaplastic Variant of Diffuse Large B-Cell Lymphoma Presenting as a Lung Primary","year":2013,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Pathology; Large cell; Lung; Lymphoma; Diffuse large B-cell lymphoma; Primary (astronomy); Internal medicine; Adenocarcinoma; Cancer","score_opus":0.008840833355390591,"score_gpt":0.2717984022642064,"score_spread":0.2629575689088158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042604203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955662,0.0006772369,0.000082442326,0.00069190987,0.0003494112,0.00014576397,0.000032626238,0.0000048049715,0.0024495986],"genre_scores_gemma":[0.99872696,0.00023421034,0.0005801861,0.00012580374,0.00017101945,0.000007860591,0.00001269843,0.000011184499,0.0001300924],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99843556,0.00009697666,0.00076706376,0.00013678537,0.0003886436,0.00017497918],"domain_scores_gemma":[0.9979392,0.0004771526,0.0006173575,0.00012237891,0.0007018796,0.00014197541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021858221,0.0001237258,0.00048933085,0.00023437853,0.00001960466,0.000011349531,0.00014445475,0.0000961597,0.0004250282],"category_scores_gemma":[0.00015245102,0.000087645516,0.00026799273,0.00007765486,0.0000828712,0.00011613401,0.00010418443,0.00009368744,0.000014909594],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002235853,0.02828463,0.2031333,0.00026573878,0.0012580764,0.74021024,0.0012177612,0.000022625942,0.0077411756,0.0029672598,0.0016565119,0.011006842],"study_design_scores_gemma":[0.083773755,0.0024797737,0.26443014,0.0006818271,0.0006678422,0.63317,0.00048595603,0.0011272987,0.009659205,0.00087861705,0.002378773,0.00026682368],"about_ca_topic_score_codex":0.00007681892,"about_ca_topic_score_gemma":0.0000022876247,"teacher_disagreement_score":0.10704024,"about_ca_system_score_codex":0.00012578609,"about_ca_system_score_gemma":0.0001624899,"threshold_uncertainty_score":0.46537608},"labels":[],"label_agreement":null},{"id":"W2042790564","doi":"10.1182/blood-2014-07-537480","title":"Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Lymphoma; Intensive care medicine; Malignancy; Risk assessment; Disease; Hodgkin lymphoma; Oncology; Internal medicine; Computer science","score_opus":0.04405258293351854,"score_gpt":0.35222294588632413,"score_spread":0.3081703629528056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042790564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011448468,0.9844537,0.0000027789856,0.00014290302,0.00012527601,0.0024505688,0.00008441485,0.000025358311,0.011570198],"genre_scores_gemma":[0.0012847614,0.99570787,0.0012335654,0.000063882595,0.00014894088,0.0011902328,0.0001806843,0.000044379594,0.00014570208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972621,0.00038552156,0.0008022653,0.00047507187,0.0007416481,0.00033337137],"domain_scores_gemma":[0.9980854,0.00033404576,0.00044898357,0.0009355846,0.000057387602,0.00013861171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007022199,0.00045707697,0.00190394,0.00017115907,0.000036164703,0.00003098397,0.00033482633,0.00024348393,0.00003268373],"category_scores_gemma":[0.000024667394,0.00024851866,0.00060440955,0.00044130377,0.000066847584,0.000029560882,0.00013226047,0.0002100153,0.00006698435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009374189,0.008512838,0.0020255854,0.0063355095,0.0017645424,0.0022281548,0.00006923956,1.3684648e-7,1.0489375e-8,0.0008526444,0.0020592967,0.97614264],"study_design_scores_gemma":[0.011606126,0.0005467163,0.02052815,0.011804528,0.015729576,0.00015448412,0.000117636795,0.0000016322334,9.1087657e-7,0.00006635614,0.9392115,0.0002323868],"about_ca_topic_score_codex":0.00010756113,"about_ca_topic_score_gemma":0.000016108237,"teacher_disagreement_score":0.9759103,"about_ca_system_score_codex":0.0003579768,"about_ca_system_score_gemma":0.00054456055,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W2042913617","doi":"10.1007/s00277-013-1856-4","title":"Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)","year":2013,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Stage (stratigraphy); Nasal cavity; Internal medicine; Paranasal sinuses; Oncology; Hematology; Radiation therapy; Pathology; Surgery; Biology","score_opus":0.04692309188358019,"score_gpt":0.30938030324569665,"score_spread":0.26245721136211647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042913617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985842,0.00019488492,0.0000014444468,0.00027078658,0.00007581121,0.00067859306,0.000059307713,0.0000066536104,0.00012829427],"genre_scores_gemma":[0.99922675,0.00034293107,0.000021315796,0.0002253455,0.000008126277,0.000029019917,0.00003223681,0.000008556267,0.000105699146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989657,0.00009478374,0.00044382096,0.00019994925,0.0001233778,0.0001724013],"domain_scores_gemma":[0.99912,0.000120935496,0.00030671622,0.00025431596,0.00013126856,0.0000667694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009031121,0.00012346725,0.00055127824,0.000049179354,0.0000319783,0.0000041843837,0.00006672182,0.000116847616,0.00004632332],"category_scores_gemma":[0.00009247953,0.000074182964,0.0000841225,0.00007179422,0.00012472055,0.00004831356,0.00011097527,0.000032377775,0.000005279595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016640766,0.0064518824,0.99026096,0.0000873261,0.0000861862,0.000004367863,0.0004937666,6.023077e-9,0.0009653431,0.00026922024,0.00013119074,0.001083338],"study_design_scores_gemma":[0.012691967,0.0018704333,0.9693084,0.00006244965,0.00004952829,0.0000044058265,0.00016445923,0.0000055405994,0.015581252,0.000037385915,0.00016778566,0.000056417477],"about_ca_topic_score_codex":0.00011189076,"about_ca_topic_score_gemma":0.000008796053,"teacher_disagreement_score":0.02095259,"about_ca_system_score_codex":0.000003546241,"about_ca_system_score_gemma":0.000023207436,"threshold_uncertainty_score":0.30250937},"labels":[],"label_agreement":null},{"id":"W2043104308","doi":"10.1038/modpathol.3880214","title":"Small Lymphocytic Lymphoma with Perifollicular, Marginal Zone, or Interfollicular Distribution","year":2000,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pathology; Hematopathology; Marginal zone; Medicine; Lymphoma; Biology; Immunology; B cell","score_opus":0.017722231804236106,"score_gpt":0.2323764019740509,"score_spread":0.2146541701698148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043104308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101126,0.0007184851,0.0057293586,0.0004955585,0.00006314353,0.0004705915,0.00005710211,0.00013102489,0.0013234628],"genre_scores_gemma":[0.99369514,0.00026144623,0.0015474461,0.0006246715,0.00009351722,0.00022565704,0.00039606806,0.000041524843,0.0031145469],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983131,0.000083915074,0.0002854726,0.0005984558,0.0002176442,0.0005013862],"domain_scores_gemma":[0.9990533,0.000036868358,0.00006499485,0.00055690424,0.0000761693,0.00021178999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010345914,0.00032716585,0.0005204404,0.000061821476,0.00012438337,0.000030094163,0.00010977042,0.00019149893,0.000867556],"category_scores_gemma":[0.000015327361,0.0002092989,0.00014751329,0.00017578022,0.0001526479,0.00005778024,0.000033322078,0.0000656244,0.00036149813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016309222,0.0043251794,0.119468495,0.0002223991,0.00092449586,0.062266786,0.0017420885,0.0007664615,0.0019050678,0.0004840574,0.0010299425,0.79055583],"study_design_scores_gemma":[0.05910945,0.012955774,0.7361069,0.0006560627,0.0021897666,0.07335876,0.0002125652,0.027266389,0.013522039,0.00025425028,0.07289132,0.0014767704],"about_ca_topic_score_codex":0.00013793395,"about_ca_topic_score_gemma":0.00008890307,"teacher_disagreement_score":0.789079,"about_ca_system_score_codex":0.00083658175,"about_ca_system_score_gemma":0.00035552497,"threshold_uncertainty_score":0.949913},"labels":[],"label_agreement":null},{"id":"W2043622833","doi":"10.1182/blood-2014-05-578963","title":"Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Transplantation; BCL6; Retrospective cohort study; Autologous stem-cell transplantation; Regimen; Leukocytosis; Oncology; Surgery; Immunology; B cell","score_opus":0.011427774036542587,"score_gpt":0.26646992987857604,"score_spread":0.25504215584203344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043622833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860823,0.000038729748,0.000009253872,0.000058847672,0.000017625254,0.0002576061,0.0000127485655,0.000012056805,0.0009849037],"genre_scores_gemma":[0.99969846,0.00006930498,0.00006436532,0.000016225738,0.000015245905,0.000024216288,0.000024403977,0.0000076192014,0.000080159305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932164,0.000033136002,0.00018512839,0.00020395806,0.00014674601,0.000109397275],"domain_scores_gemma":[0.99961454,0.00004571073,0.000093743656,0.00015669502,0.00003473965,0.000054551736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083380335,0.00011407901,0.00035637012,0.00024176456,0.000017931101,0.000007956558,0.000020240597,0.00005923682,0.000009713451],"category_scores_gemma":[0.000003569072,0.00007923047,0.00014084863,0.00022745944,0.000017319782,0.000047692414,0.0000046514265,0.00002860773,0.0000031652783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004019311,0.0028246327,0.9930818,0.000033014898,0.0008556633,0.000015410928,0.00089207623,0.000015445752,0.00047847518,0.00004043029,0.000002867696,0.0013582493],"study_design_scores_gemma":[0.023877544,0.0008555186,0.958932,0.000039445385,0.0020250576,0.000006236394,0.00005411042,0.00007231206,0.01406738,0.000006216302,0.0000013680789,0.000062832776],"about_ca_topic_score_codex":0.0006962503,"about_ca_topic_score_gemma":0.00009306048,"teacher_disagreement_score":0.034149826,"about_ca_system_score_codex":0.000136088,"about_ca_system_score_gemma":0.000019820636,"threshold_uncertainty_score":0.32309246},"labels":[],"label_agreement":null},{"id":"W2043640405","doi":"10.1182/blood.v97.1.250","title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Ontario Institute for Cancer Research; University of Toronto; BC Cancer Agency","funders":"","keywords":"Reed–Sternberg cell; Lymphoma; Autocrine signalling; Histiocyte; Pathology; In situ hybridization; Anaplastic large-cell lymphoma; CD30; Lymphocyte; Interleukin 2; Biology; Cancer research; Medicine; Receptor; Hodgkin lymphoma; Immunology; Cytokine; Internal medicine; Gene expression; Gene","score_opus":0.009382057275340796,"score_gpt":0.22156422464930117,"score_spread":0.21218216737396037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043640405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930318,0.004112638,0.00001485924,0.0006180427,0.00015866368,0.00051738566,0.0001550235,0.00006605087,0.0013255415],"genre_scores_gemma":[0.9955713,0.0020830347,0.00062774355,0.0003556915,0.00012408527,0.000089095614,0.00006336382,0.000052683474,0.0010330094],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811006,0.00008711681,0.00052598043,0.00059319043,0.00030094926,0.000382696],"domain_scores_gemma":[0.9987061,0.00015021174,0.0002720662,0.00048949727,0.00008856876,0.00029352456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015033633,0.00037446656,0.00068561645,0.00015057865,0.000059415823,0.000057389723,0.00014003964,0.00018969,0.00020263334],"category_scores_gemma":[0.000050888375,0.00031102414,0.00012284327,0.00016065498,0.00016987137,0.00013056071,0.00013744892,0.00008762081,0.000031824304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096084236,0.0065553547,0.5961653,0.0004529519,0.0010460173,0.0006954485,0.0019907872,4.8736166e-7,0.3241438,0.000060589653,0.02397539,0.04395305],"study_design_scores_gemma":[0.031645007,0.0024579228,0.12347456,0.001571222,0.0008429794,0.00046799093,0.00095576607,0.000029477309,0.8117212,0.0000957038,0.026151879,0.0005862849],"about_ca_topic_score_codex":0.000784077,"about_ca_topic_score_gemma":0.00015609762,"teacher_disagreement_score":0.4875774,"about_ca_system_score_codex":0.000095584415,"about_ca_system_score_gemma":0.000051809442,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2043995760","doi":"10.1111/bjh.12714","title":"Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the <scp>IELSG</scp> 14 study)","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Radiation therapy; Stage (stratigraphy); Oncology; Pathology","score_opus":0.012666216875482599,"score_gpt":0.27175735920211574,"score_spread":0.25909114232663316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043995760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489367,0.0013900098,0.000017455222,0.00023608621,0.0007255212,0.0022136394,0.0000067561377,0.000011420212,0.0005054268],"genre_scores_gemma":[0.9988709,0.00027872104,0.000331992,0.00014479281,0.0001506093,0.00010113338,0.000002504989,0.000027086333,0.000092271264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958587,0.00083091616,0.0015810151,0.00042965516,0.001025272,0.0002743962],"domain_scores_gemma":[0.9971744,0.0007038297,0.0011379408,0.00039636358,0.00045066013,0.00013681251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017319103,0.00025591106,0.0014340499,0.00016576725,0.0001558273,0.000042822016,0.00044248975,0.00011974131,0.000009403047],"category_scores_gemma":[0.00060890475,0.00017053635,0.0003335107,0.0002315044,0.00034866855,0.000096024596,0.0003913086,0.00022593176,0.0000016332883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030964048,0.047563974,0.8839264,0.0000659849,0.0030046315,0.0064783935,0.002011927,0.0000011252614,0.000009063927,0.00011483986,0.0012881025,0.0552259],"study_design_scores_gemma":[0.032167215,0.0068860454,0.9247859,0.00029101537,0.001568499,0.025255201,0.008520368,0.000014460806,0.000037100715,0.00006140275,0.00035327577,0.000059481164],"about_ca_topic_score_codex":0.0003094659,"about_ca_topic_score_gemma":0.0005659744,"teacher_disagreement_score":0.05516642,"about_ca_system_score_codex":0.00020687009,"about_ca_system_score_gemma":0.00011378011,"threshold_uncertainty_score":0.69542706},"labels":[],"label_agreement":null},{"id":"W2044224841","doi":"10.1002/cncy.20075","title":"Classifying B‐cell non‐Hodgkin lymphoma by using MIB‐1 proliferative index in fine‐needle aspirates","year":2010,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Proliferation index; Pathology; Immunophenotyping; Non-Hodgkin's lymphoma; Immunocytochemistry; Cytology; Immunohistochemistry; Aggressive lymphoma; Cytopathology; Flow cytometry; Rituximab; Immunology","score_opus":0.0191697854141618,"score_gpt":0.30513896038982646,"score_spread":0.28596917497566465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044224841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948757,0.0012146853,0.000060830924,0.0006790489,0.0005465203,0.00055702013,0.00003779245,0.0000408444,0.0019875527],"genre_scores_gemma":[0.9971544,0.00007132244,0.0006249234,0.0011167355,0.000255521,0.0003582902,0.000029181821,0.000039419596,0.0003501788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984259,0.000061434424,0.00035696762,0.0005135731,0.00015451388,0.00048762723],"domain_scores_gemma":[0.9992116,0.00007117084,0.00014009945,0.00032412616,0.00009587761,0.00015714385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001517851,0.00028306898,0.00053958804,0.00017452188,0.000090221474,0.000025374819,0.00010768096,0.0002922287,0.00020395574],"category_scores_gemma":[0.000048742706,0.00023890815,0.0000875392,0.0002608795,0.00016148736,0.00009665845,0.000064996246,0.00023504587,0.000035074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013549776,0.00058578624,0.78159183,0.000048755155,0.000021570133,0.0005542438,0.00060490886,0.000021811864,0.20237517,0.000030860447,0.0007857448,0.013243783],"study_design_scores_gemma":[0.012610288,0.0006564537,0.64724445,0.00018405404,0.00016222066,0.0005309512,0.00026749092,0.0025602952,0.32933033,0.000107411375,0.005852673,0.0004934211],"about_ca_topic_score_codex":0.0005924664,"about_ca_topic_score_gemma":0.00062658574,"teacher_disagreement_score":0.13434744,"about_ca_system_score_codex":0.0003940379,"about_ca_system_score_gemma":0.00047442195,"threshold_uncertainty_score":0.9742392},"labels":[],"label_agreement":null},{"id":"W2044240154","doi":"10.3324/haematol.2015.124008","title":"Tumor-associated macrophages in diffuse large B-cell lymphoma","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia; Ligue Genevoise Contre le Cancer; Michael Smith Health Research BC","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Internal medicine; Disease; Oncology; Pathology; Biology","score_opus":0.024532070276834118,"score_gpt":0.26239133987691127,"score_spread":0.23785926960007714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044240154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7212471,0.0064432886,8.7843824e-7,0.24701943,0.0005484882,0.0015520084,0.0003724383,0.00041542083,0.022400972],"genre_scores_gemma":[0.5911464,0.00027544374,0.00011713576,0.40127283,0.0003720533,0.00035797752,0.0012977844,0.00009014347,0.0050702197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967571,0.00022294186,0.00062753283,0.00078546396,0.0006428069,0.00096418156],"domain_scores_gemma":[0.9983474,0.00024635092,0.0003622949,0.00071765075,0.00014087572,0.00018542852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024021445,0.00064379076,0.0017502555,0.00027216328,0.00007508894,0.000050941668,0.00026154297,0.0011330857,0.0002789704],"category_scores_gemma":[0.0002508529,0.0004565949,0.00033486707,0.0003107473,0.00008844446,0.00004405452,0.00017364856,0.000588537,0.0011240824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005884586,0.009745623,0.016659912,0.0002520269,0.00012461466,0.105672784,0.00009578342,3.3849187e-8,0.0000029104158,0.000022541744,0.86714005,0.00022485064],"study_design_scores_gemma":[0.05021192,0.00072401203,0.027002547,0.00073000917,0.0005090636,0.0017547752,0.00007554112,0.000022073205,0.0005306593,0.0003286044,0.9173633,0.000747532],"about_ca_topic_score_codex":0.00017783293,"about_ca_topic_score_gemma":0.000046012345,"teacher_disagreement_score":0.15425342,"about_ca_system_score_codex":0.00084323995,"about_ca_system_score_gemma":0.00032200382,"threshold_uncertainty_score":0.9997886},"labels":[],"label_agreement":null},{"id":"W2044344068","doi":"10.14740/jh186w","title":"Enteropathy Type II Associated T-Cell Non-Hodgkin Lymphoma: A Case Report","year":2015,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Enteropathy; Hodgkin lymphoma; Immunology; Pathology; Disease","score_opus":0.025898800969449933,"score_gpt":0.29538305335985515,"score_spread":0.26948425239040524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044344068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929493,0.001585808,0.000021915288,0.0011526677,0.00084063684,0.00011946226,0.0000019026124,0.0000135682385,0.0033147212],"genre_scores_gemma":[0.99834216,0.00004105395,0.0005713431,0.00034310727,0.000120995406,0.000003593867,0.0000067375963,0.00001762657,0.00055338343],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986066,0.00006501321,0.0006947648,0.00014290145,0.00025932133,0.00023138766],"domain_scores_gemma":[0.99813294,0.00007122305,0.0006947333,0.00021782627,0.0005613338,0.00032192023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047145472,0.00014787017,0.00068560295,0.00014971077,0.000054505756,0.000009432191,0.00006423678,0.0001452995,0.00005738081],"category_scores_gemma":[0.00043464985,0.00010472778,0.00017678704,0.00014400457,0.000040616233,0.00006469032,0.000052508218,0.00009619209,0.000048405807],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003798036,0.0029459188,0.15077408,0.000023038992,0.00030541528,0.7992795,0.00045665927,0.0000018687701,0.00014446843,0.000034311033,0.04501013,0.0006447727],"study_design_scores_gemma":[0.011077721,0.0036091628,0.00567412,0.0001063151,0.00041710332,0.9669954,0.00033947825,0.000056024044,0.005445607,0.0000947253,0.006083884,0.000100423094],"about_ca_topic_score_codex":0.00006828121,"about_ca_topic_score_gemma":0.00001735944,"teacher_disagreement_score":0.1677159,"about_ca_system_score_codex":0.00033459798,"about_ca_system_score_gemma":0.00056301383,"threshold_uncertainty_score":0.42706746},"labels":[],"label_agreement":null},{"id":"W2044479160","doi":"10.1111/bjh.12878","title":"Guidelines for the first line management of classical Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Hematology; Medicine; Hodgkin lymphoma; Internal medicine; Lymphoma; Oncology; Medical physics","score_opus":0.04588011173821988,"score_gpt":0.3272710597969642,"score_spread":0.2813909480587443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044479160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049603,0.017772388,0.012540555,0.061775893,0.00095320033,0.0007525933,0.00001997496,0.000018769191,0.0012063519],"genre_scores_gemma":[0.98697305,0.002837905,0.008171688,0.0014424805,0.0003028153,0.000030914045,0.0000038462335,0.000016429438,0.00022090245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987207,0.00003314403,0.0007427274,0.00011521987,0.00020739643,0.00018082981],"domain_scores_gemma":[0.9985224,0.00035672,0.0003679095,0.00016324851,0.0005108125,0.00007892528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004289786,0.00010133873,0.0005980365,0.00005418553,0.00007734827,0.000014735872,0.00015002249,0.000073206735,0.00003539764],"category_scores_gemma":[0.00026894672,0.000069776484,0.00027800942,0.00006842986,0.00011249509,0.000031322445,0.000042117044,0.000047967897,0.000004787624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004822715,0.0014912293,0.0069958935,0.00055777177,0.0014983439,0.009978862,0.000052787265,0.000044228862,0.0000140946095,0.010217275,0.13301256,0.8356547],"study_design_scores_gemma":[0.023246419,0.0021996512,0.111869924,0.0027914606,0.002037211,0.26973623,0.00020648475,0.0013576739,0.002109859,0.0026337085,0.5816014,0.0002099783],"about_ca_topic_score_codex":0.000027827644,"about_ca_topic_score_gemma":0.000044866993,"teacher_disagreement_score":0.8354447,"about_ca_system_score_codex":0.000050796854,"about_ca_system_score_gemma":0.00006530297,"threshold_uncertainty_score":0.28454024},"labels":[],"label_agreement":null},{"id":"W2044496270","doi":"10.1097/00004728-200411000-00009","title":"Primary Mediastinal Lymphoma","year":2004,"lang":"en","type":"article","venue":"Journal of Computer Assisted Tomography","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Lymphoma; Primary (astronomy); Radiology; Pathology","score_opus":0.011663294717002623,"score_gpt":0.23945098545588991,"score_spread":0.2277876907388873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044496270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874026,0.0017940688,0.0056072506,0.0020982816,0.00091274246,0.00015920606,0.0000039446836,0.000043059215,0.001978808],"genre_scores_gemma":[0.94723284,0.000107075335,0.050409302,0.001359657,0.0008518837,0.0000036732267,0.000007377417,0.00001744174,0.000010740668],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984153,0.000034207314,0.00057865545,0.00015539156,0.00058260834,0.0002338595],"domain_scores_gemma":[0.99872303,0.00007459424,0.00036737468,0.0002048014,0.00030140765,0.0003287813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017391438,0.00019410263,0.0005189423,0.0005159923,0.000058804224,0.0000436413,0.00013558228,0.00008136778,0.000024675965],"category_scores_gemma":[0.000009587668,0.00013732567,0.0006509759,0.00045931386,0.000076208446,0.00013919573,0.000036245954,0.00011274693,0.000012576702],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011682201,0.008923608,0.2833055,0.00020707201,0.0027959335,0.009367995,0.00070810807,0.00014477594,0.000974101,0.00053702964,0.009049586,0.68281806],"study_design_scores_gemma":[0.011131971,0.001921699,0.96912694,0.0004939875,0.00038512904,0.008109202,0.000013708845,0.000010721364,0.0010060653,0.00023601012,0.0074327276,0.00013181452],"about_ca_topic_score_codex":0.0000069647244,"about_ca_topic_score_gemma":8.6435483e-7,"teacher_disagreement_score":0.6858215,"about_ca_system_score_codex":0.00022856498,"about_ca_system_score_gemma":0.0003323387,"threshold_uncertainty_score":0.5599978},"labels":[],"label_agreement":null},{"id":"W2045070821","doi":"10.1309/ajcpjx4bjv9nlqhy","title":"The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Julius-Maximilians-Universität Würzburg; Universitetet i Oslo; Universitat de Barcelona; University of Nebraska Medical Center","keywords":"Diffuse large B-cell lymphoma; Stromal cell; Rituximab; International Prognostic Index; Tumor microenvironment; Vincristine; Cancer research; Lymphoma; Medicine; Oncology; Internal medicine; Pathology; Cyclophosphamide; Chemotherapy; Cancer","score_opus":0.01078148819345586,"score_gpt":0.2894020644441536,"score_spread":0.27862057625069775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045070821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793535,0.000046091278,0.00005872848,0.0007102049,0.00028524853,0.0004668627,0.000046382906,0.0000101658525,0.00044097984],"genre_scores_gemma":[0.99675304,0.00007838564,0.0023648634,0.00042825312,0.00020486691,0.000027654327,0.000018240378,0.000037337802,0.0000873475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974752,0.00032355494,0.0010335309,0.00030670196,0.00036886465,0.0004921313],"domain_scores_gemma":[0.99613917,0.0017545174,0.0010240377,0.00038035781,0.0003616853,0.00034022375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010710215,0.00024274173,0.0011113784,0.0000889626,0.000087721346,0.000019030475,0.00019431907,0.00011865523,0.000013974955],"category_scores_gemma":[0.00034038528,0.000118186246,0.00023378656,0.00017643672,0.00067345344,0.000063589156,0.000037244896,0.0003792879,0.0000061772153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014293262,0.021833334,0.9383093,0.000008900861,0.00012559767,0.0005877029,0.00004565137,4.3378446e-7,0.000016545266,0.000014423038,0.00015537451,0.024609433],"study_design_scores_gemma":[0.10886626,0.022560237,0.8654136,0.000037701488,0.00029697764,0.00011755326,0.0001259065,0.00002005888,0.00006760771,0.0000113821725,0.0023669682,0.00011574218],"about_ca_topic_score_codex":0.000025314037,"about_ca_topic_score_gemma":0.00011555114,"teacher_disagreement_score":0.09457299,"about_ca_system_score_codex":0.000051459116,"about_ca_system_score_gemma":0.00035279992,"threshold_uncertainty_score":0.4819495},"labels":[],"label_agreement":null},{"id":"W2045378618","doi":"10.1182/blood-2007-10-119974","title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":624,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Lymphoma; Immunology; Hodgkin lymphoma; Oncology; Internal medicine","score_opus":0.0065473991619259715,"score_gpt":0.2263341170731123,"score_spread":0.2197867179111863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045378618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996012,0.0024630183,0.000037625934,0.00024763003,0.000044259796,0.00030739966,0.000023270646,0.000030931682,0.0008338696],"genre_scores_gemma":[0.99753535,0.0017685436,0.0003246761,0.00008762526,0.000020755007,0.00004922825,0.000018448376,0.000015278876,0.00018010494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989161,0.000072713454,0.0003646591,0.0002600839,0.00021209,0.00017436598],"domain_scores_gemma":[0.998998,0.00016263704,0.00023194721,0.0004686661,0.000057570574,0.00008120587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016920682,0.00017830117,0.0004983523,0.00014601927,0.00013207652,0.000010700825,0.000091413676,0.00006919276,0.000039351766],"category_scores_gemma":[0.000084485524,0.000107206695,0.0002468904,0.00046825194,0.0002615175,0.000037131947,0.000048600752,0.0000456995,0.000010688939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012608223,0.0017678624,0.98411757,0.000020672342,0.007545515,0.000057970774,0.0017274152,0.000011112763,0.00027908987,0.000057366582,0.000054105963,0.00423521],"study_design_scores_gemma":[0.008457598,0.00043148262,0.9736021,0.00003900586,0.012186746,0.00010797018,0.00037831205,0.0006003533,0.003952484,0.00003576493,0.00009898691,0.00010920821],"about_ca_topic_score_codex":0.0022280924,"about_ca_topic_score_gemma":0.00033909339,"teacher_disagreement_score":0.010515509,"about_ca_system_score_codex":0.000030926924,"about_ca_system_score_gemma":0.00012604984,"threshold_uncertainty_score":0.4371762},"labels":[],"label_agreement":null},{"id":"W2045593945","doi":"10.1097/pas.0b013e31817d7470","title":"Follicular Lymphoma of the Thyroid Gland","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Wellcome Trust; Abbott Laboratories","keywords":"Pathology; Thyroid; Lymphoma; Follicular lymphoma; Follicular phase; Medicine; Thyroiditis; Thyroid lymphoma; Mucosa-associated lymphoid tissue; Lymphatic system; Germinal center; Immunohistochemistry; MALT lymphoma; B cell; Internal medicine; Immunology; Antibody","score_opus":0.013121741463644698,"score_gpt":0.2511812449600062,"score_spread":0.2380595034963615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045593945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169147,0.001398254,0.000008898701,0.005779704,0.00011140064,0.00008906876,0.000003156909,0.0000040132622,0.0009140315],"genre_scores_gemma":[0.9974692,0.0014966591,0.00014963595,0.0006398547,0.00014947019,0.0000026431296,4.6532105e-7,0.0000087901335,0.00008326945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987842,0.00027045616,0.00039013912,0.00009122121,0.0002895105,0.00017448093],"domain_scores_gemma":[0.9986627,0.00027773512,0.00054926315,0.00029676166,0.00011858007,0.00009493119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030977177,0.00010859557,0.0005756767,0.00004671186,0.000084766674,0.0000022203233,0.00019403858,0.000029250688,0.00003157906],"category_scores_gemma":[0.00004866489,0.000043520507,0.00038100264,0.00023839889,0.0010099075,0.000020308495,0.000051795494,0.00010216449,0.000008126781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035225062,0.0023827697,0.89145607,0.000015972373,0.0007851239,0.026352243,0.0015683699,0.000051595114,0.0053124186,0.0010016896,0.0033534146,0.06419781],"study_design_scores_gemma":[0.0048728767,0.0025723092,0.89198697,0.00004399685,0.00024025353,0.08585741,0.0001877068,0.0000053314798,0.0031226284,0.00019015126,0.010852107,0.00006828136],"about_ca_topic_score_codex":0.000030075818,"about_ca_topic_score_gemma":7.099296e-7,"teacher_disagreement_score":0.064129524,"about_ca_system_score_codex":0.000051918727,"about_ca_system_score_gemma":0.00013435181,"threshold_uncertainty_score":0.37210461},"labels":[],"label_agreement":null},{"id":"W2045794442","doi":"10.1038/sj.leu.2403921","title":"ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas","year":2005,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Center for Long-Term Cybersecurity, University of California Berkeley; Deutsche Krebshilfe","keywords":"Lymphoma; Clathrin; Anaplastic lymphoma kinase; Fusion gene; Cancer research; Medicine; Pathology; Virology; Biology; Internal medicine; Genetics; Gene","score_opus":0.006942954419659957,"score_gpt":0.21738802117515313,"score_spread":0.21044506675549318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045794442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64983547,0.0039526303,0.000055171728,0.3202402,0.000568395,0.003228663,0.0006134408,0.00020004644,0.021305988],"genre_scores_gemma":[0.6307418,0.0017192606,0.0006460911,0.34285635,0.00969595,0.0004154227,0.0011344674,0.00030065258,0.012490049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572974,0.00012497736,0.00072505267,0.001071663,0.0012418095,0.001106734],"domain_scores_gemma":[0.9972365,0.00031306947,0.0005206392,0.001468498,0.00016474511,0.00029652967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019021216,0.0009487187,0.0012544144,0.00041440196,0.00023855499,0.000064312946,0.0004998267,0.0008776884,0.00022394369],"category_scores_gemma":[0.000027618655,0.00057539216,0.00047914844,0.0006866731,0.000101402096,0.00009048351,0.0002892596,0.00057852356,0.0005610283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006399114,0.0035337277,0.0124942735,0.00039185173,0.00057918084,0.0050380314,0.0014119816,0.000011293973,0.000047153677,0.00008593563,0.9680081,0.007758545],"study_design_scores_gemma":[0.041238364,0.0023632618,0.056595247,0.00058509514,0.0031439979,0.0006635884,0.00010239835,0.00007167808,0.005493615,0.000026957436,0.8886342,0.0010815753],"about_ca_topic_score_codex":0.0011514486,"about_ca_topic_score_gemma":0.00021025266,"teacher_disagreement_score":0.079373896,"about_ca_system_score_codex":0.0033439288,"about_ca_system_score_gemma":0.0014595236,"threshold_uncertainty_score":0.99966973},"labels":[],"label_agreement":null},{"id":"W2045970616","doi":"10.1182/blood.v97.11.3552","title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pathology; Lymphoma; Immunocytochemistry; Splenic marginal zone lymphoma; Biology; BCL10; Chromosome abnormality; Medicine; Spleen; Immunology; Splenectomy; Chromosome; Karyotype; Gene","score_opus":0.00931315153146382,"score_gpt":0.22351798256583733,"score_spread":0.21420483103437352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045970616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772869,0.002511241,0.0000014907156,0.0002947682,0.00003878676,0.00026752191,0.000006266284,0.00008135747,0.019511689],"genre_scores_gemma":[0.99718285,0.0007893058,0.00034211975,0.00044041712,0.00010166566,0.00010625219,0.000022547994,0.000024887162,0.0009899681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893516,0.000021257492,0.00020870905,0.00025465226,0.00023438469,0.00034581436],"domain_scores_gemma":[0.99942815,0.000059986458,0.00004693402,0.00030033372,0.000039610764,0.00012495452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000649829,0.00018916695,0.00030817545,0.00011892608,0.000045892626,0.000023045932,0.00006368065,0.00006725626,0.00016414955],"category_scores_gemma":[0.000017084489,0.00013260407,0.00006982589,0.00023468636,0.00005563238,0.000078992285,0.0000252785,0.000027813092,0.00011073099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027571747,0.0032203023,0.9821463,0.000040337385,0.00019202428,0.0038334017,0.00035948076,0.0000031335992,0.0000860502,0.00044367503,0.00012478119,0.009274799],"study_design_scores_gemma":[0.033255044,0.0010451161,0.9395159,0.0002663131,0.0003494707,0.004056939,0.00037849348,0.000017054514,0.011907164,0.000064153435,0.00889902,0.00024534625],"about_ca_topic_score_codex":0.00085580884,"about_ca_topic_score_gemma":0.0003098091,"teacher_disagreement_score":0.04263041,"about_ca_system_score_codex":0.00018701963,"about_ca_system_score_gemma":0.00021131244,"threshold_uncertainty_score":0.54074365},"labels":[],"label_agreement":null},{"id":"W2045989969","doi":"10.1007/s11899-008-0030-x","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hematology; Oncology; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Bioinformatics; T cell; Immunology; Biology; Immune system","score_opus":0.07527003511942738,"score_gpt":0.3469950288066572,"score_spread":0.27172499368722985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045989969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066823646,0.9909198,0.000008903094,0.000029595813,0.0013182389,0.0023852212,0.000020305944,0.00016248642,0.0044871755],"genre_scores_gemma":[0.0017160298,0.9954708,0.00035074545,0.00003332605,0.00015477484,0.0013132944,0.00038678088,0.000089534755,0.00048470264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995171,0.00010286322,0.002125674,0.0013041733,0.00054542936,0.00075086864],"domain_scores_gemma":[0.9970626,0.00013247099,0.0012710278,0.001182094,0.00009564712,0.00025612343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016917812,0.0010840766,0.0043877997,0.00036661845,0.00010417302,0.0000372095,0.00017628325,0.00055465987,0.00029294225],"category_scores_gemma":[0.00008896111,0.0007205428,0.0013485604,0.00053235184,0.00014423806,0.00007449892,0.00013324808,0.00035556758,0.000077612596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015153144,0.00644659,0.019601887,0.035480317,0.00030991322,0.03544865,0.00020925124,2.1765418e-7,0.0000013583941,0.00034347715,0.0039537456,0.8981894],"study_design_scores_gemma":[0.0012176222,0.000117982876,0.00037270237,0.030470472,0.00056296174,0.064896375,0.000014437179,9.309357e-7,0.000016127364,0.00007054565,0.901632,0.0006278414],"about_ca_topic_score_codex":0.00003629225,"about_ca_topic_score_gemma":0.000004828343,"teacher_disagreement_score":0.89767826,"about_ca_system_score_codex":0.00077804166,"about_ca_system_score_gemma":0.0012380356,"threshold_uncertainty_score":0.9995246},"labels":[],"label_agreement":null},{"id":"W2046150302","doi":"10.1016/j.leukres.2005.08.016","title":"Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Cyclin D1; Mantle cell lymphoma; Cyclin; Cell culture; Chromosomal translocation; Biology; Molecular biology; Messenger RNA; Lymphoma; Cell; Cell cycle; Gene; Genetics; Immunology","score_opus":0.051532910390858944,"score_gpt":0.3407128781114639,"score_spread":0.28917996772060495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046150302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97453165,0.0025547391,0.000007452037,0.0010201051,0.000052922434,0.0004863308,0.000011916034,0.000045006786,0.021289904],"genre_scores_gemma":[0.9892074,0.00037971366,0.0016526636,0.00015244457,0.00042941552,0.0000740702,0.000027633518,0.000048902402,0.008027771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973747,0.0001579824,0.0004013627,0.00053362426,0.0008274893,0.0007048293],"domain_scores_gemma":[0.9983348,0.00042634265,0.000106247375,0.0005442229,0.0002821844,0.00030617378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007941396,0.00025016812,0.00048498358,0.00035767315,0.0003301463,0.00008872604,0.00019948225,0.0002145793,0.00011707689],"category_scores_gemma":[0.00009745749,0.00019833112,0.0001287476,0.000314151,0.00020625243,0.0001241492,0.00023576169,0.00027814152,0.00005387811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001717146,0.0065196543,0.38397375,0.0029781484,0.0006001565,0.0057577244,0.007534792,0.0001219356,0.2567266,0.007079185,0.067010954,0.25998],"study_design_scores_gemma":[0.024595277,0.0020428628,0.56923485,0.00076568325,0.0002638781,0.0004114541,0.0016855969,0.0016010588,0.37557474,0.00029309452,0.0230119,0.0005195884],"about_ca_topic_score_codex":0.0020199318,"about_ca_topic_score_gemma":0.0004870135,"teacher_disagreement_score":0.2594604,"about_ca_system_score_codex":0.0011701646,"about_ca_system_score_gemma":0.00063220604,"threshold_uncertainty_score":0.8087709},"labels":[],"label_agreement":null},{"id":"W2046562935","doi":"10.3109/10428190009148399","title":"Clinical Significance of the t(14;18) And<i>BCL2</i>Overexpression in Follicular Large Cell Lymphoma","year":2000,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Follicular lymphoma; Lymphoma; Anthracycline; Trisomy; Medicine; Oncology; Internal medicine; Chemotherapy; Diffuse large B-cell lymphoma; Cancer research; Biology; Cancer; Breast cancer","score_opus":0.01216047175015825,"score_gpt":0.263319022229649,"score_spread":0.2511585504794907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046562935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98035425,0.0052162143,0.000007460381,0.00026179937,0.00026042687,0.0013653112,0.00010193133,0.000114272414,0.012318306],"genre_scores_gemma":[0.9893399,0.00498753,0.00045124447,0.0018567775,0.00026667284,0.00021837778,0.000054062886,0.000111618865,0.002713814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942793,0.00043855494,0.0017035146,0.0014710096,0.0009409815,0.0011666344],"domain_scores_gemma":[0.9966333,0.0005885426,0.00050191104,0.0014810729,0.00013967317,0.0006554988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007814211,0.0008888667,0.0015943163,0.00022103777,0.00037496907,0.0000916827,0.0004963285,0.00081528886,0.00032942044],"category_scores_gemma":[0.0001321988,0.0006376975,0.0006278284,0.000794795,0.00063157146,0.0003041737,0.00033658996,0.00017788842,0.000072643015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028891796,0.005731442,0.45298254,0.0008505502,0.0003882696,0.00088078616,0.0012849305,0.000044653567,0.005309684,0.00092362374,0.008110375,0.52060395],"study_design_scores_gemma":[0.072861955,0.00056358095,0.83865464,0.0016836909,0.00042004907,0.0006089419,0.00033693903,0.0020645123,0.024407128,0.00037055952,0.05718976,0.0008382718],"about_ca_topic_score_codex":0.00179542,"about_ca_topic_score_gemma":0.00007964709,"teacher_disagreement_score":0.5197657,"about_ca_system_score_codex":0.0030328499,"about_ca_system_score_gemma":0.0025044596,"threshold_uncertainty_score":0.99960744},"labels":[],"label_agreement":null},{"id":"W2046635524","doi":"10.1182/blood-2008-12-193037","title":"The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Germinal center; Biology; Psychological repression; Transcription factor; B cell; Cancer research; Repressor; Gene; Molecular biology; Genetics; Gene expression","score_opus":0.008876522422026474,"score_gpt":0.24955896153853388,"score_spread":0.2406824391165074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046635524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934574,0.0047130114,1.7395053e-7,0.00093004457,0.000018202061,0.0004812816,0.0000063839534,0.000014224845,0.00037932026],"genre_scores_gemma":[0.9984941,0.0006118154,0.0005682841,0.00019403506,0.000021037515,0.000036990314,0.0000168388,0.000004699969,0.000052192034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994037,0.000020658546,0.00017112843,0.00015443265,0.00013162478,0.000118436124],"domain_scores_gemma":[0.99972516,0.000053329517,0.000037219987,0.00013272802,0.000019634781,0.000031915315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007119992,0.00008141805,0.00016124627,0.000047249625,0.000027043692,0.000008769353,0.000031995165,0.00006414819,0.0000032626542],"category_scores_gemma":[0.000010651927,0.000049082628,0.000041773696,0.00010058809,0.000034458753,0.000025952007,0.000007681503,0.00004577263,5.442937e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043084563,0.011056049,0.65444684,0.000065580934,0.000068547146,0.00010341774,0.00073479395,0.000005397205,0.12503283,0.00007653861,0.0002604893,0.20771869],"study_design_scores_gemma":[0.008108714,0.00025403217,0.8706704,0.0001517851,0.00004995117,0.000021652244,0.00003005867,0.000028168512,0.1200546,0.00006889523,0.0005198598,0.00004188385],"about_ca_topic_score_codex":0.00010756866,"about_ca_topic_score_gemma":0.00007391954,"teacher_disagreement_score":0.21622357,"about_ca_system_score_codex":0.000022873612,"about_ca_system_score_gemma":0.00003855893,"threshold_uncertainty_score":0.20015316},"labels":[],"label_agreement":null},{"id":"W2046809689","doi":"10.1016/s0167-4781(00)00239-6","title":"Presence of new alternative exons in human and mouse Fli-1 genes","year":2000,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Exon; Biology; Gene; Exon trapping; Molecular biology; Genetics; Translation (biology); Messenger RNA; Alternative splicing","score_opus":0.012934156468468079,"score_gpt":0.271380819450796,"score_spread":0.25844666298232793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046809689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982013,0.0006862012,0.0000012223868,0.0004395822,0.000032731758,0.0003364377,0.0000841459,0.00002048053,0.00019791328],"genre_scores_gemma":[0.99645156,0.0018539028,0.00095937116,0.00012882435,0.0001509953,0.000011749132,0.00008117752,0.0000200681,0.00034232615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885345,0.000046901907,0.00025385697,0.00043260123,0.00020263965,0.00021055045],"domain_scores_gemma":[0.9993499,0.00003777438,0.00010279485,0.0003055519,0.000025475707,0.0001784913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029117693,0.0002485964,0.0003798024,0.00009216678,0.000077762204,0.000026333899,0.00009201225,0.000112549395,0.00009309627],"category_scores_gemma":[0.000008086529,0.00017589536,0.00006166944,0.00010990766,0.00011867663,0.00011379152,0.00008140034,0.00010035032,0.0000011356761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022294508,0.00016462583,0.00063089293,0.000044013115,0.000051110837,0.000012347713,0.001314383,0.00000437755,0.9905625,0.000032022825,0.0005271651,0.0064336383],"study_design_scores_gemma":[0.0019740176,0.0003073172,0.07175523,0.00018768843,0.00006307092,0.00001791048,0.000050883322,0.000032238135,0.92485076,0.00040680938,0.00019787916,0.00015618892],"about_ca_topic_score_codex":0.0003666807,"about_ca_topic_score_gemma":0.000015280857,"teacher_disagreement_score":0.07112434,"about_ca_system_score_codex":0.000023199624,"about_ca_system_score_gemma":0.00004918255,"threshold_uncertainty_score":0.7172805},"labels":[],"label_agreement":null},{"id":"W2047071244","doi":"10.1016/j.ijrobp.2009.03.070","title":"Comparison of Favorable Early-Stage Hodgkin's Lymphoma Treatments: A Single-Institution Review","year":2009,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dacarbazine; Vinblastine; Stage (stratigraphy); Bleomycin; Radiation therapy; Chemotherapy; ABVD; Internal medicine; Hodgkin lymphoma; Oncology; Hodgkin's lymphoma; Lymphoma; Vincristine; Cyclophosphamide","score_opus":0.07911483046178627,"score_gpt":0.4257564907452539,"score_spread":0.34664166028346766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047071244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011815053,0.993467,0.00055735133,0.000546336,0.0016428207,0.0010174665,0.0002164984,0.000036558708,0.0013345131],"genre_scores_gemma":[0.00896895,0.9869109,0.0014429222,0.00046645713,0.0013068783,0.000053070962,0.0006807182,0.000045049288,0.0001250971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958386,0.00046157098,0.0024379566,0.0004083645,0.00054135994,0.0003121502],"domain_scores_gemma":[0.9928857,0.0004193174,0.005165174,0.00035507474,0.00096777244,0.00020693886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005052242,0.0005761767,0.0037441223,0.0003579401,0.000072472234,0.000029911876,0.00049317523,0.0005746906,0.00007777949],"category_scores_gemma":[0.00033090726,0.0004324057,0.0014236956,0.00035706616,0.00017324813,0.00026916,0.00006404044,0.00035965352,0.00007173397],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011204901,0.004199655,0.0092454245,0.0015045613,0.003028811,0.00013877137,0.00006944004,0.000012111907,0.0000073756005,0.0019122252,0.0016681525,0.97810143],"study_design_scores_gemma":[0.0056887893,0.0041614366,0.0012979505,0.022010028,0.005301288,0.00050166773,0.00001386902,0.000027049004,0.00012379754,0.00029701745,0.96027315,0.00030393986],"about_ca_topic_score_codex":0.000041561805,"about_ca_topic_score_gemma":0.0000024225458,"teacher_disagreement_score":0.9777975,"about_ca_system_score_codex":0.0038853113,"about_ca_system_score_gemma":0.0020720544,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W2047181533","doi":"10.1016/j.ccr.2010.11.013","title":"Cooperative Epigenetic Modulation by Cancer Amplicon Genes","year":2010,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Demethylase; Biology; Histone; Epigenetics; Chromatin; Epigenome; Cancer research; Histone H3; Amplicon; Gene; PRC2; Molecular biology; Genetics; DNA methylation; Gene expression","score_opus":0.012350934676404086,"score_gpt":0.28682563868852096,"score_spread":0.2744747040121169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047181533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828543,0.012471159,0.000030111667,0.0007043217,0.00049842685,0.00034057477,0.000059158378,0.000028422324,0.0030135445],"genre_scores_gemma":[0.99171716,0.0039634053,0.00009481478,0.0006152079,0.00027655484,0.00039823796,0.00004972076,0.000018455985,0.0028664249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937636,0.000009382509,0.000115744006,0.00022907562,0.000109016124,0.00016044197],"domain_scores_gemma":[0.99954945,0.00001833149,0.000044479377,0.00018468047,0.00008930285,0.00011375929],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000021960954,0.00012098306,0.00016087087,0.000014226117,0.000059070637,0.000015749827,0.00003730926,0.00006971459,0.0019215387],"category_scores_gemma":[0.000003205358,0.000093720606,0.000043501666,0.000058855683,0.000035750447,0.000042105185,0.000012020829,0.000059080197,0.00004531176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056255558,0.00041638012,0.22311218,0.000054004104,0.00009827594,0.000009670707,0.0003556693,0.00018067472,0.6402693,0.00009727678,0.0150826005,0.12026774],"study_design_scores_gemma":[0.0021978219,0.00013316178,0.13633983,0.00003352198,0.00014065122,0.0000027710994,0.00003467319,0.00057236553,0.76721704,0.000019442094,0.09313947,0.00016925244],"about_ca_topic_score_codex":0.0030882962,"about_ca_topic_score_gemma":0.0012628228,"teacher_disagreement_score":0.12694778,"about_ca_system_score_codex":0.00018284925,"about_ca_system_score_gemma":0.00014716694,"threshold_uncertainty_score":0.99899083},"labels":[],"label_agreement":null},{"id":"W2047750426","doi":"10.1046/j.1365-2141.2003.04502.x","title":"Multicolour fluorescence <i>in situ</i> hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Comparative genomic hybridization; Fluorescence in situ hybridization; Biology; Gene duplication; Karyotype; Breakpoint; Follicular lymphoma; Chromosome; Cytogenetics; Genetics; Molecular biology; Gene; Chromosomal rearrangement; Gene dosage; Lymphoma; Gene expression; Immunology","score_opus":0.028809754963868794,"score_gpt":0.3193472609882517,"score_spread":0.29053750602438294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047750426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945286,0.0030442248,0.0019740923,0.0001320075,0.00005960541,0.00019307017,0.000024951769,0.0000032399676,0.000040195802],"genre_scores_gemma":[0.9880209,0.0016612393,0.01014978,0.0000855205,0.000011970299,0.00000230503,0.000053729364,0.000008635509,0.0000059387585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831855,0.0002567282,0.0008339813,0.00025389198,0.00020384019,0.00013300455],"domain_scores_gemma":[0.9986378,0.00030611732,0.00054302765,0.00018915541,0.00020086115,0.00012305622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055415113,0.000107473,0.0008857916,0.00020135164,0.000043098462,0.00001790929,0.00006628625,0.00010650197,0.000009519755],"category_scores_gemma":[0.00053554977,0.000091255446,0.000077013174,0.00024634987,0.00013381743,0.00016247485,0.000043414064,0.000087925764,3.338946e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002520405,0.0007294207,0.98036283,0.000028253331,0.00066072174,0.0113292225,0.000065717424,0.000044527595,0.0005965108,0.0000327992,0.00009414443,0.005803804],"study_design_scores_gemma":[0.0077031963,0.00042675118,0.93906814,0.00043812455,0.0024345666,0.043964393,0.00009606376,0.0015909726,0.004141776,0.000014316349,0.0000312058,0.00009048844],"about_ca_topic_score_codex":0.00006095925,"about_ca_topic_score_gemma":0.00015817078,"teacher_disagreement_score":0.041294694,"about_ca_system_score_codex":0.000049572212,"about_ca_system_score_gemma":0.00011854937,"threshold_uncertainty_score":0.3721289},"labels":[],"label_agreement":null},{"id":"W2047794551","doi":"10.1002/ebch.171","title":"Summary of ‘Therapeutic interventions for Burkitt's lymphoma in children’","year":2007,"lang":"en","type":"article","venue":"Evidence-Based Child Health A Cochrane Review Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Systematic review; Cochrane collaboration; Psychological intervention; Alternative medicine; Family medicine; MEDLINE; Nursing; Pathology; Cochrane Library","score_opus":0.06378672787994405,"score_gpt":0.40969296810431316,"score_spread":0.3459062402243691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047794551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016697837,0.94243664,0.0018942745,0.036008924,0.00018908628,0.002649909,0.00001907214,0.000022170798,0.000082085644],"genre_scores_gemma":[0.37643787,0.6079585,0.0014633054,0.013631711,0.0003170511,0.00009841447,0.000038538074,0.000030588355,0.000023991912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961696,0.00024967236,0.0020428558,0.00032156424,0.00057173386,0.0006445248],"domain_scores_gemma":[0.99711835,0.0006887236,0.00096002774,0.00041411823,0.00030036934,0.00051841757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004751387,0.00028975832,0.0014001842,0.00044521136,0.00021543357,0.000018337372,0.00019857439,0.00008716987,0.00015096934],"category_scores_gemma":[0.00059162953,0.00022179681,0.0011171366,0.0005585365,0.00007842124,0.00016271646,0.000019610863,0.00025426477,0.000010344718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083131023,0.0032255352,0.24965051,0.038105957,0.0003356476,0.00008684707,0.00006746696,0.00001225017,0.000011783305,0.00031324147,0.0051015513,0.7022579],"study_design_scores_gemma":[0.007853361,0.0024248492,0.5719054,0.40973026,0.00049040385,0.0015858096,0.000016682805,0.000022350754,0.00022240222,0.000071016,0.0054848213,0.00019264837],"about_ca_topic_score_codex":0.000113754475,"about_ca_topic_score_gemma":0.00006966815,"teacher_disagreement_score":0.7020652,"about_ca_system_score_codex":0.0008368389,"about_ca_system_score_gemma":0.0013339561,"threshold_uncertainty_score":0.90446115},"labels":[],"label_agreement":null},{"id":"W2047861432","doi":"10.1182/blood-2012-02-414441","title":"TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Fusion gene; Follicular lymphoma; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Biology; Cancer research; Gene; Oncology; B cell; Immunology; Medicine; Genetics; Antibody","score_opus":0.017386372069822437,"score_gpt":0.2560405399172242,"score_spread":0.23865416784740176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047861432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904383,0.00322193,0.000016710934,0.00022443,0.00031595663,0.00045587085,0.000015682173,0.00003909391,0.006666476],"genre_scores_gemma":[0.9964311,0.0003700412,0.0021612109,0.00029301582,0.00027676247,0.0001230181,0.000054287135,0.000028070777,0.00026247496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.000020057962,0.00028082632,0.0002665199,0.00026129704,0.000468759],"domain_scores_gemma":[0.9992383,0.00004730838,0.00007323602,0.00034736397,0.000034412187,0.00025936615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016615354,0.00020944164,0.0003160417,0.00012794085,0.000045637727,0.000012884536,0.000072062685,0.0001122677,0.00010177728],"category_scores_gemma":[0.000025144942,0.00016512471,0.000121652956,0.00021039974,0.000021456857,0.00007855122,0.000073122916,0.000056005178,0.00029483458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023058684,0.05996751,0.8143149,0.0001397486,0.00015030486,0.00022042416,0.0012598996,0.0000010499263,0.07416499,0.000121222234,0.0016545806,0.04777478],"study_design_scores_gemma":[0.026149053,0.00052519765,0.8200236,0.000169527,0.0002981342,0.0001764858,0.00006722937,0.00003569426,0.1450252,0.0000064229926,0.007313384,0.0002100751],"about_ca_topic_score_codex":0.00020074312,"about_ca_topic_score_gemma":0.00002240412,"teacher_disagreement_score":0.07086021,"about_ca_system_score_codex":0.0001665407,"about_ca_system_score_gemma":0.00009404157,"threshold_uncertainty_score":0.67335904},"labels":[],"label_agreement":null},{"id":"W2047867934","doi":"10.1182/blood-2011-05-326538","title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"STAT protein; Biology; Lymphoma; Cancer research; Crosstalk; Transcription factor; Janus kinase; Germinal center; Tumor microenvironment; Epigenome; Pathogenesis; Immune system; stat; Gene expression profiling; Signal transduction; Gene; B cell; Cell biology; Gene expression; Immunology; STAT3; Genetics; Antibody; DNA methylation","score_opus":0.02589214070933102,"score_gpt":0.2648918936415143,"score_spread":0.23899975293218326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047867934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007666785,0.9895564,0.000002692591,0.000009514739,0.00012523611,0.000839082,0.00012905773,0.000027994065,0.008543389],"genre_scores_gemma":[0.00024803996,0.9984435,0.0003055726,0.0000562931,0.000121959514,0.00031603887,0.00017540975,0.00006858355,0.00026463083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982123,0.00012699123,0.000607347,0.0003625012,0.00032724024,0.00036363443],"domain_scores_gemma":[0.99832696,0.00023163168,0.00041685198,0.00077792857,0.000085618856,0.00016099059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023722649,0.00040874103,0.0015663072,0.00008481277,0.00007698376,0.00001129584,0.00024400471,0.00024040428,0.00003976601],"category_scores_gemma":[0.00005016145,0.00022345198,0.00088977476,0.00018815098,0.00006933116,0.000014484384,0.00013236712,0.00007274154,0.0001082952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001443737,0.0076425667,0.00017731625,0.010753836,0.000916596,0.00069947593,0.00002848353,1.1118693e-9,0.000009829147,0.0004373999,0.00021316294,0.9791069],"study_design_scores_gemma":[0.005732966,0.0003062865,0.0008632073,0.004823632,0.012116811,0.00040987416,0.000006816804,5.2055963e-8,0.00033285082,0.000009813847,0.9751902,0.0002074939],"about_ca_topic_score_codex":0.000015935704,"about_ca_topic_score_gemma":0.0000017938632,"teacher_disagreement_score":0.9788994,"about_ca_system_score_codex":0.00009179474,"about_ca_system_score_gemma":0.0007847055,"threshold_uncertainty_score":0.9112107},"labels":[],"label_agreement":null},{"id":"W2048790475","doi":"10.3109/10428194.2014.985673","title":"Structural genomic alterations in primary mediastinal large B-cell lymphoma","year":2014,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Lymphoma; CIITA; Cancer research; Somatic cell; Biology; Breakpoint; Chromothripsis; Pathogenesis; Computational biology; Genetics; Gene; Genome instability; Immunology; DNA; Chromosomal translocation; DNA damage","score_opus":0.01713303286461503,"score_gpt":0.2728314617455311,"score_spread":0.25569842888091604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048790475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14118701,0.84640145,0.000017556058,0.000057486766,0.0009892745,0.0028251868,0.00045283418,0.00033283612,0.007736339],"genre_scores_gemma":[0.03542165,0.95333326,0.0008731274,0.0012738499,0.0016215353,0.0013176417,0.0036833645,0.0005038983,0.0019716658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.989466,0.0006254973,0.003253956,0.0029042219,0.0012735262,0.002476787],"domain_scores_gemma":[0.99385756,0.0010559487,0.0013766795,0.0021040486,0.00020991973,0.0013958289],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007821462,0.0028230294,0.006907969,0.0014384359,0.0006764618,0.00041253382,0.0008937966,0.0019831427,0.00019170204],"category_scores_gemma":[0.00015263089,0.0023554873,0.0017616944,0.0012255635,0.00046910107,0.00042830672,0.0007452288,0.00039216265,0.00063047867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003211683,0.0011041983,0.0011354683,0.015337619,0.00064096943,0.0020501975,0.00043861518,0.000005004283,0.000014065485,0.00062035397,0.0023010757,0.97603124],"study_design_scores_gemma":[0.052935798,0.0006006367,0.03313953,0.012915854,0.0042779148,0.007510304,0.0001130665,0.0010252212,0.00003976175,0.00010301689,0.88467395,0.0026649623],"about_ca_topic_score_codex":0.0011593885,"about_ca_topic_score_gemma":0.00019355727,"teacher_disagreement_score":0.9733663,"about_ca_system_score_codex":0.032946408,"about_ca_system_score_gemma":0.015111659,"threshold_uncertainty_score":0.9993125},"labels":[],"label_agreement":null},{"id":"W2049005290","doi":"10.1111/j.1365-2141.2005.05954.x","title":"Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; Cancer Research UK","keywords":"Immunohistochemistry; Follicular lymphoma; Lymphoma; Medicine; Pathology; High-power field; Internal medicine","score_opus":0.004807008348192153,"score_gpt":0.22816037746805634,"score_spread":0.2233533691198642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049005290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870215,0.011955122,0.000020608953,0.0005864144,0.000050664454,0.0001805305,0.000005696468,0.0000028428142,0.00017658641],"genre_scores_gemma":[0.9991506,0.00026380032,0.00044474518,0.00007288145,0.000020641373,0.00000698497,0.0000040700565,0.000007366923,0.000028924149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.00007870617,0.0006131882,0.00012074055,0.00020059354,0.00016205951],"domain_scores_gemma":[0.99931216,0.00006762614,0.00031669636,0.00014368861,0.000111734196,0.000048099282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016785643,0.00009184539,0.0008032249,0.0002110748,0.000035891237,0.000011196059,0.00009110552,0.0000938671,0.000026138368],"category_scores_gemma":[0.00009519314,0.00007095785,0.00029979105,0.00041047035,0.00016716575,0.00003925851,0.000036976453,0.0000812635,6.0219463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017599633,0.002558315,0.951268,0.00014439058,0.0021789055,0.023636844,0.0001359704,0.0000424427,0.009059402,0.0010513498,0.0007641533,0.008984237],"study_design_scores_gemma":[0.0037605711,0.00011444282,0.90410805,0.00038693438,0.0016586265,0.07775119,0.000036039724,0.00006924453,0.011596722,0.00024343825,0.00020584177,0.00006888659],"about_ca_topic_score_codex":0.0010328795,"about_ca_topic_score_gemma":0.00024003471,"teacher_disagreement_score":0.05411434,"about_ca_system_score_codex":0.000113640155,"about_ca_system_score_gemma":0.00014106576,"threshold_uncertainty_score":0.28935772},"labels":[],"label_agreement":null},{"id":"W2049096914","doi":"10.1016/j.ijrobp.2010.07.1291","title":"A Prospective Study of FDG-PET Imaging in Assessment of Response to Therapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplant","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Autologous stem-cell transplantation; Refractory (planetary science); Lymphoma; Progressive disease; Chemotherapy; Internal medicine; Oncology; Nuclear medicine; Radiology; Surgery","score_opus":0.00852896230046179,"score_gpt":0.3062001080630655,"score_spread":0.29767114576260373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049096914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820536,0.000041537096,0.00015623786,0.0004478513,0.0002889786,0.0007805317,0.000024030538,0.0000067200403,0.000048774873],"genre_scores_gemma":[0.99804413,0.00016038334,0.0014596893,0.00019888491,0.00006877057,0.00003243109,0.00000981007,0.000020627256,0.0000052847236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984032,0.00023988739,0.00069710513,0.00023052422,0.00027716358,0.00015212015],"domain_scores_gemma":[0.9979264,0.0006824567,0.0008126091,0.00013583241,0.00036992526,0.00007277554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056715537,0.00017930157,0.0005653955,0.0003357609,0.000023194174,0.0000091374695,0.00015027619,0.00008434208,0.000009598595],"category_scores_gemma":[0.000038958973,0.00012623925,0.00006159462,0.00018213889,0.00008327546,0.00014239553,0.000019527228,0.00021454017,3.574267e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014464536,0.0071434537,0.9053278,0.00000842335,0.00026923153,0.0001597651,0.0039654747,0.00009109879,0.0066713137,0.00005192897,0.0000076075385,0.061839364],"study_design_scores_gemma":[0.049076147,0.013348516,0.93387115,0.000120893885,0.000045968063,0.000050261297,0.0004748411,0.00022940955,0.0025622111,0.0000723848,0.000047555615,0.00010064759],"about_ca_topic_score_codex":0.000070622686,"about_ca_topic_score_gemma":0.00010075617,"teacher_disagreement_score":0.061738715,"about_ca_system_score_codex":0.00073964224,"about_ca_system_score_gemma":0.00081698596,"threshold_uncertainty_score":0.5147887},"labels":[],"label_agreement":null},{"id":"W2049141040","doi":"10.3324/haematol.2013.100818","title":"R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Medicine; CHOP; Rituximab; Internal medicine; Vincristine; Gastroenterology; Hazard ratio; Diffuse large B-cell lymphoma; Bevacizumab; Lymphoma; Surgery; Confidence interval; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.014153833998881038,"score_gpt":0.25063564342900474,"score_spread":0.2364818094301237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049141040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594426,0.000046728008,0.000018304074,0.00018077427,0.000028924604,0.0025518695,0.000014953037,0.00014004322,0.0010741461],"genre_scores_gemma":[0.9977048,0.0000101660935,0.00065031956,0.00039193066,0.0000107032765,0.00043628845,0.000056107052,0.000044480817,0.0006952139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756837,0.0001873816,0.0004401175,0.0006571714,0.0005090343,0.0006379419],"domain_scores_gemma":[0.99861825,0.00018484824,0.0002041875,0.0006719085,0.00009938126,0.0002214321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017928696,0.00048069766,0.0012438894,0.00015299166,0.00012911478,0.00004147306,0.0001545593,0.00012334908,0.00010765515],"category_scores_gemma":[0.00009085879,0.00022232057,0.00007578472,0.00032889287,0.00007694383,0.00008507935,0.000078066136,0.00009709049,0.00009404263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004994751,0.047562283,0.9441427,0.00007920355,0.00018607438,0.0012523571,0.0006142702,8.5723104e-7,3.5911813e-7,0.00006226416,0.00014726938,0.0009576376],"study_design_scores_gemma":[0.14270648,0.009391142,0.8462236,0.00018006428,0.00038165433,0.00011953592,0.00034783274,0.000038862483,0.00005082033,0.000008269524,0.00026788795,0.00028385286],"about_ca_topic_score_codex":0.00019045279,"about_ca_topic_score_gemma":0.0011215704,"teacher_disagreement_score":0.13771173,"about_ca_system_score_codex":0.00023343426,"about_ca_system_score_gemma":0.00012634991,"threshold_uncertainty_score":0.90659696},"labels":[],"label_agreement":null},{"id":"W2049281518","doi":"10.3109/10428194.2014.961013","title":"A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lymphoma; Stage (stratigraphy); Medicine; Multivariate analysis; Lymphocyte; Internal medicine; Pathology; Disease; Scoring system; Hodgkin lymphoma; Overall survival; Oncology; Multivariate statistics; Proportional hazards model; Biology; Computer science","score_opus":0.00739729284019881,"score_gpt":0.2310635807097419,"score_spread":0.2236662878695431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049281518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884318,0.0013171767,0.0009834688,0.0004505329,0.0009889634,0.0026882193,0.00008553795,0.00058993575,0.004464337],"genre_scores_gemma":[0.9917764,0.00062575267,0.0019802991,0.0024402943,0.00077496143,0.0013442569,0.00015816225,0.00029057785,0.00060927565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9905665,0.00046562977,0.0022051143,0.0027861516,0.0015047732,0.0024718319],"domain_scores_gemma":[0.9944272,0.0005749472,0.0005765444,0.0023035414,0.00026089567,0.0018568409],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013331926,0.0017490209,0.00261031,0.0011523238,0.0005636576,0.0004635169,0.0007435936,0.00082015235,0.00009191342],"category_scores_gemma":[0.0002488382,0.0015529189,0.0006174864,0.0012573487,0.00022056841,0.00047170703,0.00072413177,0.00014490474,0.0005165551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054956186,0.0019954692,0.09729479,0.0026873262,0.0011909588,0.010139633,0.0038616892,0.0009491998,0.0051731556,0.014082921,0.0015829739,0.85554624],"study_design_scores_gemma":[0.10701346,0.0023572503,0.77570695,0.0064458037,0.0012559629,0.0102545805,0.0019674972,0.024481941,0.023869341,0.00029071164,0.043030124,0.0033263708],"about_ca_topic_score_codex":0.010487816,"about_ca_topic_score_gemma":0.0004503296,"teacher_disagreement_score":0.8522199,"about_ca_system_score_codex":0.032984857,"about_ca_system_score_gemma":0.0034323535,"threshold_uncertainty_score":0.99952555},"labels":[],"label_agreement":null},{"id":"W2049794466","doi":"10.1182/blood-2005-12-4898","title":"Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Melphalan; Vincristine; CHOP; International Prognostic Index; Autologous stem-cell transplantation; Surgery; Aggressive lymphoma; Gastroenterology; Cyclophosphamide; Transplantation; Chemotherapy; Lymphoma; Oncology; Rituximab","score_opus":0.005191703411979636,"score_gpt":0.21289705561844569,"score_spread":0.20770535220646605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049794466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947894,0.0021966174,0.00017025515,0.0005934565,0.00005969784,0.0015746943,0.00013915742,0.00008713418,0.00038957337],"genre_scores_gemma":[0.99575025,0.00045042066,0.0018429459,0.00023829305,0.00008844968,0.0007198819,0.0003816017,0.000051194827,0.00047698503],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874645,0.000013567292,0.0002537019,0.00043756838,0.00021883442,0.00032987713],"domain_scores_gemma":[0.9993556,0.00007956549,0.00020439016,0.0001712253,0.00006780376,0.00012140672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056950666,0.0002855505,0.00042640086,0.000064358945,0.00012452253,0.00004218126,0.00005928953,0.00013408902,0.000012017456],"category_scores_gemma":[8.566914e-7,0.00020797401,0.00009504668,0.000099286386,0.000057223,0.00007676683,0.0000069009398,0.00003246204,0.0000052926794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015985092,0.030122744,0.7236993,0.0016528537,0.0026706306,0.0021234213,0.002536536,0.00002913961,0.0864823,0.0002409021,0.02146698,0.1129901],"study_design_scores_gemma":[0.09561872,0.002541598,0.25123227,0.00021083452,0.0016152693,0.00021780963,0.00008523051,0.00003030498,0.6474345,0.000019931256,0.0006999334,0.00029361644],"about_ca_topic_score_codex":0.0008635758,"about_ca_topic_score_gemma":0.000088727415,"teacher_disagreement_score":0.5609522,"about_ca_system_score_codex":0.00007212744,"about_ca_system_score_gemma":0.00008474007,"threshold_uncertainty_score":0.8480934},"labels":[],"label_agreement":null},{"id":"W2050115670","doi":"10.1016/s0140-6736(16)32407-2","title":"Non-Hodgkin lymphoma","year":2017,"lang":"en","type":"review","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Non-Hodgkin's lymphoma; Oncology; Immunology; Internal medicine","score_opus":0.16752787640500771,"score_gpt":0.4133069042580451,"score_spread":0.2457790278530374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050115670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013784301,0.9537025,3.9041936e-7,0.0008109305,0.00031787387,0.0007701311,0.000057624457,0.000044947898,0.04428181],"genre_scores_gemma":[0.00006451831,0.9923191,0.00006506577,0.00038881216,0.0028010514,0.0002797326,0.00011098848,0.00004233345,0.0039283945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893147,0.000042853742,0.00026012326,0.0002672918,0.00019227376,0.0003059788],"domain_scores_gemma":[0.9975679,0.00010754208,0.0002719751,0.0019464438,0.000023073702,0.00008308864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022129813,0.0003126704,0.002560053,0.000040312825,0.00015420179,0.00007050265,0.00049052894,0.00016864388,0.00010259147],"category_scores_gemma":[0.00004840563,0.00014268047,0.00051319256,0.000053465665,0.00007712172,0.000021487616,0.00011110819,0.00010752967,0.001526062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010959711,0.00009186152,0.00009644385,0.0035683974,0.0003772507,0.00015869866,0.000017040737,4.408027e-9,9.774808e-9,0.000138923,0.07457384,0.92096657],"study_design_scores_gemma":[0.0015401648,0.00007420237,0.0013660152,0.012014033,0.0019826577,0.00029313593,0.0000015672738,6.5505327e-7,8.62376e-7,0.000031249703,0.9825534,0.00014206098],"about_ca_topic_score_codex":0.00006179411,"about_ca_topic_score_gemma":0.0000054092684,"teacher_disagreement_score":0.9208245,"about_ca_system_score_codex":0.00018747934,"about_ca_system_score_gemma":0.00031020783,"threshold_uncertainty_score":0.99925137},"labels":[],"label_agreement":null},{"id":"W2050171635","doi":"10.1016/j.bbmt.2008.04.007","title":"Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Busulfan; Cyclophosphamide; Follicular lymphoma; Total body irradiation; Transplantation; Surgery; Internal medicine; Chemotherapy; Gastroenterology; Oncology; Lymphoma","score_opus":0.015108548071462903,"score_gpt":0.2264044126001427,"score_spread":0.21129586452867982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050171635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950098,0.0011355362,0.0022163414,0.0001200365,0.000054463857,0.00068191154,0.00025664756,0.000028769406,0.0004965418],"genre_scores_gemma":[0.99102443,0.005833533,0.0020183688,0.00007082509,0.000033574484,0.00010298024,0.0007760953,0.000015755184,0.00012440422],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991007,0.000052404648,0.00024766504,0.0002951774,0.00010384243,0.00020021552],"domain_scores_gemma":[0.99948955,0.00013201943,0.00011323015,0.00009621601,0.00008931717,0.00007967823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087087225,0.00018594036,0.00036362256,0.00008201296,0.000111619105,0.000003906303,0.000034536264,0.00013317654,0.000006806057],"category_scores_gemma":[0.0000011587103,0.00013873985,0.00008687764,0.00006510329,0.0001134397,0.00007179915,0.0000019210074,0.000025908414,0.0000011481384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008532197,0.0017086193,0.52796847,0.0020273835,0.0013371885,0.00043400674,0.003981676,0.000050073144,0.442147,0.0022222274,0.000038507642,0.009552672],"study_design_scores_gemma":[0.02947517,0.004500558,0.37482247,0.00017844929,0.0027836792,0.000993934,0.00015288725,0.000034576537,0.58633983,0.00013443951,0.00028083887,0.00030313633],"about_ca_topic_score_codex":0.00012395911,"about_ca_topic_score_gemma":0.0000584884,"teacher_disagreement_score":0.15314598,"about_ca_system_score_codex":0.000016187736,"about_ca_system_score_gemma":0.00010840505,"threshold_uncertainty_score":0.56576467},"labels":[],"label_agreement":null},{"id":"W2050208729","doi":"10.1016/s0008-4182(05)80060-2","title":"Immunohistochemical profile of lymphoid lesions of the orbit","year":2005,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pathology; Lymphoid hyperplasia; Lymphoma; Immunoglobulin light chain; Immunohistochemistry; CD5; CD20; Medicine; Polyclonal antibodies; Immunophenotyping; Histopathology; H&E stain; Hyperplasia; Monoclonal; Antibody; Monoclonal antibody; Antigen; Immunology","score_opus":0.019549870331531116,"score_gpt":0.27386374028508625,"score_spread":0.25431386995355515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050208729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97969645,0.0021929163,6.036763e-7,0.0016248765,0.00019659194,0.000116464136,0.000022571627,6.49517e-7,0.016148899],"genre_scores_gemma":[0.99861693,0.000007289654,0.0005182972,0.000050682134,0.0000838711,0.0000032473306,0.0000021969272,0.000008518371,0.0007089633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917424,0.000038842925,0.00041722905,0.0000710866,0.00011845668,0.00018014497],"domain_scores_gemma":[0.9989627,0.000063113446,0.00028241178,0.00022194005,0.00020531019,0.00026455376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011085933,0.00008368353,0.00033758112,0.00012482962,0.00004217453,0.0000019481554,0.00016646214,0.00009143155,0.0014848398],"category_scores_gemma":[0.00014732618,0.000053376763,0.00020442279,0.00012455169,0.00023247754,0.000026921458,0.000013397129,0.000096908654,0.000007814748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002493019,0.0008176625,0.9399954,0.00009276707,0.00057230156,0.006911226,0.0007481488,0.00003336899,0.03281476,0.0015040867,0.01160402,0.0046569407],"study_design_scores_gemma":[0.0032388142,0.0010434634,0.5452959,0.00030786236,0.00029292793,0.3142307,0.00013958101,0.000011034625,0.1307896,0.00014486264,0.0043958807,0.000109375556],"about_ca_topic_score_codex":0.0018053633,"about_ca_topic_score_gemma":0.00005040964,"teacher_disagreement_score":0.3946995,"about_ca_system_score_codex":0.00033274753,"about_ca_system_score_gemma":0.0021064272,"threshold_uncertainty_score":0.9994279},"labels":[],"label_agreement":null},{"id":"W2050231360","doi":"10.1182/blood-2009-01-198580","title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Chromosomal translocation; Germinal center; Follicular lymphoma; Molecular biology; Gene; Gene duplication; Gene expression; Comparative genomic hybridization; Gene expression profiling; Immunohistochemistry; Locus (genetics); Genetics; B cell; Lymphoma; Chromosome; Antibody; Immunology","score_opus":0.010507382009862256,"score_gpt":0.23894196257930342,"score_spread":0.22843458056944116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050231360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954291,0.0033026624,0.0001140003,0.000505508,0.0000068842332,0.0004946678,0.000003913713,0.000020869704,0.00012238405],"genre_scores_gemma":[0.99321735,0.0005610136,0.005881873,0.00013953407,0.000034283938,0.00009481945,0.000026435679,0.0000090099575,0.000035672405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940705,0.000020020967,0.00012632333,0.00021825568,0.00011304681,0.000115286435],"domain_scores_gemma":[0.99972576,0.000010289756,0.000026341355,0.00013406915,0.000022740564,0.00008081499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022748929,0.00011551662,0.00016918406,0.000058160324,0.000052094212,0.000022857,0.000015485746,0.000045753484,0.000008044794],"category_scores_gemma":[0.000004944562,0.00007715084,0.000015704705,0.00006638156,0.000024763178,0.000048321202,0.000004543729,0.000024488432,0.0000010135275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087663815,0.0015179972,0.8928765,0.000029947032,0.00004796376,0.00009431054,0.000555477,0.000005023219,0.09630003,0.000047863334,0.00002280718,0.0084144],"study_design_scores_gemma":[0.008357245,0.00040959177,0.7451414,0.0001632094,0.00014467216,0.00022008205,0.000017516879,0.000074239804,0.24532434,0.000047289035,0.000024754849,0.00007566268],"about_ca_topic_score_codex":0.0000179817,"about_ca_topic_score_gemma":0.000012122129,"teacher_disagreement_score":0.14902432,"about_ca_system_score_codex":0.00001753859,"about_ca_system_score_gemma":0.00003356988,"threshold_uncertainty_score":0.314612},"labels":[],"label_agreement":null},{"id":"W2050729712","doi":"10.3109/01676830.2013.842257","title":"Comparison of American Joint Committee on Cancer TNM-based Staging System (7th edition) and Ann Arbor Classification for Predicting Outcome in Ocular Adnexal Lymphoma","year":2013,"lang":"en","type":"article","venue":"Orbit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Staging system; Oncology; Internal medicine; Gynecology; Cancer; Medical physics; General surgery","score_opus":0.055680590780580866,"score_gpt":0.3388270457000503,"score_spread":0.28314645491946944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050729712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962676,0.00016664143,0.0002647384,0.001775816,0.00013135563,0.001010483,0.00005663034,0.00004573051,0.00028098075],"genre_scores_gemma":[0.9980702,0.000008726061,0.00072647526,0.00024537565,0.000108403314,0.0007339311,0.00006881064,0.000020943007,0.000017157297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998814,0.000041770523,0.00045824095,0.0002555241,0.00022493742,0.00020553544],"domain_scores_gemma":[0.9991222,0.00015283523,0.00028844242,0.00022666295,0.00010909377,0.00010076503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013978075,0.00015166731,0.00050163106,0.00013513012,0.00006458318,0.000021531985,0.00004066936,0.00004700398,0.000016534892],"category_scores_gemma":[0.00004963499,0.00012305078,0.00007004335,0.00013616227,0.000076675686,0.00006200591,0.000012725175,0.00005066488,0.0000062397858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007839847,0.00053426897,0.98290294,0.00038750615,0.000056923353,0.000004308008,0.00016458755,0.00007240523,0.00062775315,0.00024836525,0.00060523354,0.014317317],"study_design_scores_gemma":[0.0037314673,0.00049309834,0.9391849,0.000667761,0.00010954678,0.0000018619202,0.0011768114,0.049009815,0.005241871,0.0000049337086,0.0002753987,0.00010255978],"about_ca_topic_score_codex":0.0022199808,"about_ca_topic_score_gemma":0.000060736747,"teacher_disagreement_score":0.04893741,"about_ca_system_score_codex":0.0005271592,"about_ca_system_score_gemma":0.00008315558,"threshold_uncertainty_score":0.50178653},"labels":[],"label_agreement":null},{"id":"W2051249005","doi":"10.1159/000132232","title":"Phenotypic heterogeneity in three cases of lymphoid malignancy with chromosomal translocations in 14q11","year":2008,"lang":"en","type":"article","venue":"Cytogenetics and Cell Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Chromosomal translocation; Biology; Phenotype; Genetics; Gene; Lineage (genetic); Cancer research","score_opus":0.029953103749590128,"score_gpt":0.24233481231669401,"score_spread":0.2123817085671039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051249005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856127,0.013397918,0.000052457584,0.000043852324,0.000024519812,0.0004111169,0.000025844858,0.000007618941,0.00042400483],"genre_scores_gemma":[0.99060047,0.0067177205,0.0024939459,0.000055221913,0.000025188776,0.000047228372,0.00001927427,0.000023622988,0.000017321712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989092,0.000022191134,0.0003442995,0.0002937164,0.00018027767,0.00025034355],"domain_scores_gemma":[0.9994109,0.00004215026,0.00006711829,0.00030091303,0.000059695507,0.00011917414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000404501,0.00019348838,0.00033867973,0.00011816991,0.000044866818,0.0000054246148,0.000063315296,0.00009210219,0.000016649477],"category_scores_gemma":[0.0000042395795,0.00016330302,0.000049902672,0.00024181108,0.00015595336,0.00001323346,0.000024754587,0.000048370697,0.0000025186853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008734957,0.0009876278,0.9870736,0.0000945229,0.000027641996,0.00038003174,0.00033713732,0.00026834672,0.008171055,0.00003885412,0.0000041617773,0.0025296565],"study_design_scores_gemma":[0.0037629076,0.00082302844,0.7550547,0.0000895895,0.0000808771,0.00041919717,0.00004547555,0.00017970135,0.23928465,0.000039226168,0.00007829589,0.00014236297],"about_ca_topic_score_codex":0.00016700174,"about_ca_topic_score_gemma":0.0014281943,"teacher_disagreement_score":0.23201893,"about_ca_system_score_codex":0.000059225487,"about_ca_system_score_gemma":0.00021242262,"threshold_uncertainty_score":0.6659304},"labels":[],"label_agreement":null},{"id":"W2051274722","doi":"10.1038/modpathol.2011.116","title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","year":2011,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Krebshilfe; National Cancer Institute; National Institutes of Health; Michael Smith Health Research BC; Canadian Institutes of Health Research; Cancer Research Society; Alexander von Humboldt-Stiftung","keywords":"Lymphoma; Immunophenotyping; Pathology; Hematopathology; Medicine; Non-Hodgkin's lymphoma; Cytogenetics; Biology; Immunology; Chromosome; Antigen; Genetics","score_opus":0.03444242583592626,"score_gpt":0.27459761025996976,"score_spread":0.2401551844240435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051274722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897944,0.0006694008,0.0035391522,0.00027693543,0.00014798947,0.00029205278,0.0000119833,0.000067504254,0.0052006077],"genre_scores_gemma":[0.9934619,0.00009172707,0.005386781,0.00031157324,0.00006246394,0.000078632525,0.000041690477,0.000019879679,0.0005453378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990384,0.00006574706,0.00027434947,0.0003296017,0.00008736838,0.00020453538],"domain_scores_gemma":[0.99932164,0.000072020506,0.00007739229,0.00034029398,0.00006457649,0.00012406468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009592987,0.00014627461,0.00031106512,0.000059470847,0.00013255651,0.0000072687235,0.000041842002,0.0001466646,0.00010658598],"category_scores_gemma":[0.000026377335,0.000105033236,0.00006180477,0.00007276684,0.0002586218,0.000042948475,0.00003658535,0.00007618085,0.000083750776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033185567,0.0023852265,0.95588803,0.0000106059915,0.00023412246,0.0010242494,0.0017130646,0.0000029649884,0.00021515704,0.0034933821,0.00013875107,0.034562603],"study_design_scores_gemma":[0.0050356733,0.0012769337,0.98997545,0.00002264078,0.0003707838,0.0014663266,0.000051975134,0.00067609834,0.00011343668,0.0006961873,0.00020022324,0.00011426345],"about_ca_topic_score_codex":0.00007574968,"about_ca_topic_score_gemma":0.00012613146,"teacher_disagreement_score":0.03444834,"about_ca_system_score_codex":0.000046595207,"about_ca_system_score_gemma":0.000109527384,"threshold_uncertainty_score":0.4283131},"labels":[],"label_agreement":null},{"id":"W2051578380","doi":"10.1016/j.humpath.2007.05.026","title":"T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?","year":2007,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Bone marrow; Lymphoma; Pathology; CD20; CD5; Medicine; Follicular lymphoma; Rituximab; Biopsy; B cell; Antibody; Immunology","score_opus":0.01538806783348146,"score_gpt":0.27558775545592035,"score_spread":0.2601996876224389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051578380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96340036,0.03338929,0.00006400063,0.00016291265,0.000109046814,0.0012706472,0.000017526896,0.000040313767,0.0015458838],"genre_scores_gemma":[0.9963673,0.0006007508,0.0008955273,0.00096173544,0.00008524982,0.00035216458,0.000059086135,0.00006161232,0.0006165853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997998,0.00009293111,0.00060581986,0.0005154293,0.00019914802,0.00058867317],"domain_scores_gemma":[0.9987951,0.00026372005,0.00020322303,0.00052528374,0.0000939662,0.00011871609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005646548,0.00033091177,0.0007753021,0.00030171545,0.00006183588,0.000010420239,0.000114568255,0.00026342194,0.00016932534],"category_scores_gemma":[0.000016543598,0.00026458612,0.00034215403,0.00018061204,0.00017510206,0.000040525745,0.000038090104,0.000061613944,0.000036722606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093425065,0.043180577,0.70192033,0.00046460127,0.00029631736,0.006874153,0.002268782,0.0000018261798,0.1245672,0.00061271735,0.0006241687,0.10984681],"study_design_scores_gemma":[0.09321989,0.0025713681,0.7844466,0.00012721242,0.00022700125,0.00048984285,0.00013086262,0.000017120898,0.10938875,0.00057093543,0.008435673,0.0003747497],"about_ca_topic_score_codex":0.000044341967,"about_ca_topic_score_gemma":0.000038736453,"teacher_disagreement_score":0.10947206,"about_ca_system_score_codex":0.00019814855,"about_ca_system_score_gemma":0.000086947686,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W2051898741","doi":"10.3814/2010/581923","title":"Fatal Mimicry: Oral Melanoma versus Mantle Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"SRX Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mantle cell lymphoma; Medicine; Melanoma; Immunohistochemistry; Differential diagnosis; Biopsy; Pathology; Lymphoma; Mantle zone; Mantle (geology); Hyperplasia; Dermatology; Cancer research; B cell; Biology; Antibody; Immunology","score_opus":0.018866640394012563,"score_gpt":0.27988414608867734,"score_spread":0.26101750569466475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051898741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934078,0.0006856261,0.000007316013,0.0051035597,0.002308242,0.000343729,0.00002001549,0.000111819936,0.05734172],"genre_scores_gemma":[0.9942997,0.00010758238,0.0008354967,0.00091462006,0.0009909091,0.00003950038,0.00020368805,0.000037086043,0.002571402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847466,0.000021672355,0.00029402866,0.00038728135,0.00041593457,0.00040645318],"domain_scores_gemma":[0.9987369,0.00014009081,0.00008507033,0.0005745384,0.000081834354,0.00038151903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001725204,0.0002708958,0.00048006536,0.00012868973,0.00009069868,0.000010396278,0.00013294935,0.00015217169,0.0018171093],"category_scores_gemma":[0.000115680385,0.00018304394,0.00010805609,0.00018670029,0.00022777564,0.00006029656,0.000056816112,0.00014500663,0.0006773581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005369153,0.007021181,0.14207143,0.00044445004,0.001057719,0.00901187,0.0021211766,7.143212e-7,0.15128368,0.0068120565,0.3841833,0.29062328],"study_design_scores_gemma":[0.09496518,0.005131525,0.32503057,0.00023397831,0.0012829949,0.00073588267,0.0007215425,0.00011244487,0.086422086,0.0001790745,0.48461142,0.0005733079],"about_ca_topic_score_codex":0.0004978679,"about_ca_topic_score_gemma":0.00014813666,"teacher_disagreement_score":0.29004997,"about_ca_system_score_codex":0.00010826037,"about_ca_system_score_gemma":0.00011919107,"threshold_uncertainty_score":0.9990954},"labels":[],"label_agreement":null},{"id":"W2052126847","doi":"10.1038/leu.2008.129","title":"Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Texas MD Anderson Cancer Center; Alberta Cancer Foundation","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Autocrine signalling; Cancer research; Biology; Cell culture; Molecular biology; Lymphoma; Chemistry; Immunology; Medicine; Pathology","score_opus":0.01204600280183415,"score_gpt":0.2481504776560066,"score_spread":0.23610447485417244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052126847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782056,0.00033777702,0.00015062696,0.00013838823,0.00014231472,0.0006976278,0.0001530058,0.000043972213,0.00051574886],"genre_scores_gemma":[0.99800766,0.00020457142,0.00088693644,0.00020272302,0.000081454535,0.000074448,0.0001238355,0.000022496455,0.00039588465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984503,0.000053807187,0.00044021817,0.00037506476,0.00031962077,0.00036099934],"domain_scores_gemma":[0.9990858,0.00016827733,0.00012646314,0.0002894209,0.000092901224,0.00023717064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013332095,0.00022378347,0.00050811836,0.00015729557,0.00008675154,0.000007750349,0.00006519991,0.0001054652,0.00015469354],"category_scores_gemma":[0.0001184556,0.0001828553,0.00007638264,0.0002453099,0.000039924595,0.00008473439,0.00007553988,0.00007136026,0.000046359655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043666135,0.004877254,0.80339926,0.0004575796,0.00012173569,0.0011510941,0.0025864756,0.001014699,0.1510907,0.00022576819,0.022277312,0.008431495],"study_design_scores_gemma":[0.02286248,0.0009511732,0.77163386,0.00033111274,0.00007731105,0.00006170254,0.000054820004,0.0025684508,0.19293994,0.000024762045,0.008273772,0.00022063075],"about_ca_topic_score_codex":0.00045925486,"about_ca_topic_score_gemma":0.000063139116,"teacher_disagreement_score":0.041849237,"about_ca_system_score_codex":0.0009251061,"about_ca_system_score_gemma":0.00026941407,"threshold_uncertainty_score":0.7456623},"labels":[],"label_agreement":null},{"id":"W2052327827","doi":"10.3919/jjsa.64.936","title":"A CASE OF MALT LYMPHOMA OF THE RECTUM WITH SYNCHRONOUS RECTAL CANCER AND SYSTEMIC SPREAD OF RECURRENT BILATERAL BREAST CANCER","year":2003,"lang":"en","type":"article","venue":"Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Medicine; Rectum; Cancer; Internal medicine; Lymphoma; Oncology; Gastroenterology; Tamoxifen; Breast cancer","score_opus":0.00840465996159108,"score_gpt":0.24813021282671674,"score_spread":0.23972555286512565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052327827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458784,0.0031912357,0.0000010697847,0.0006617316,0.00041297698,0.00040032345,0.00019789886,0.0000068852437,0.0005400427],"genre_scores_gemma":[0.9977946,0.001736743,0.000075991746,0.00003478934,0.00013543283,0.00002769945,0.0000030404121,0.000024863537,0.0001668015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733746,0.0002858514,0.0010973786,0.00023881103,0.00072274,0.00031777332],"domain_scores_gemma":[0.9961563,0.00041290556,0.0020843178,0.00024036341,0.0008955063,0.00021061537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061884744,0.00026660183,0.0010714977,0.00015346083,0.00007246478,0.000016510268,0.00011030532,0.00015538906,0.00014061002],"category_scores_gemma":[0.0001374802,0.0001560003,0.00034101398,0.0004052795,0.00012133968,0.0001211898,0.000034920915,0.00018497882,0.0000010075277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009848642,0.0010494811,0.9780819,0.00031853485,0.0011052192,0.0004182736,0.0006192519,0.000047169036,0.00047145883,0.00012850415,0.00023494908,0.016540425],"study_design_scores_gemma":[0.012491372,0.0011232952,0.9409405,0.0029738054,0.0014335263,0.030200988,0.00039659668,0.00003649593,0.009601005,0.000022537584,0.00052895606,0.00025094426],"about_ca_topic_score_codex":0.0010322662,"about_ca_topic_score_gemma":0.0004357939,"teacher_disagreement_score":0.037141394,"about_ca_system_score_codex":0.0013500192,"about_ca_system_score_gemma":0.00082095497,"threshold_uncertainty_score":0.6361507},"labels":[],"label_agreement":null},{"id":"W2052404621","doi":"10.1158/1078-0432.tcmusa10-pr5","title":"Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Univariate; Oncology; Medicine; Lymphoma; Stromal cell; Survival analysis; Internal medicine; Cancer research; Biology; Machine learning; Computer science; Multivariate statistics","score_opus":0.09799676627710484,"score_gpt":0.4264810766183701,"score_spread":0.32848431034126524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052404621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997772,0.0002520831,0.000002395682,0.0007600001,0.00011874754,0.00052818534,0.000074042044,0.000004888749,0.0004876818],"genre_scores_gemma":[0.999111,0.00038806352,0.00012044666,0.00007367135,0.0001113271,0.0001387919,0.000009594003,0.000013144436,0.000033935878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821204,0.0002405233,0.0005070979,0.00028616143,0.00051989144,0.00023430811],"domain_scores_gemma":[0.9974332,0.0018903248,0.00012251678,0.00036224542,0.000076990626,0.00011471409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002251567,0.00010089377,0.00030125908,0.000083597464,0.000059528174,0.000009209659,0.00010278907,0.00007608821,0.00019337755],"category_scores_gemma":[0.00043812935,0.000057216934,0.000084753236,0.00011225869,0.00028468572,0.000024649315,0.00008376399,0.0003380155,0.0000033246713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081645016,0.010289982,0.857956,0.00011615711,0.000013324191,0.000022454955,0.0000929314,0.0000023841865,0.11813712,0.000047056565,0.00018341556,0.012322754],"study_design_scores_gemma":[0.014123804,0.00057879585,0.80740845,0.00034259626,0.000015918175,7.928055e-7,0.00016313962,0.0006576354,0.17605095,0.000021714608,0.0005970304,0.000039148123],"about_ca_topic_score_codex":0.0005871242,"about_ca_topic_score_gemma":0.0003206761,"teacher_disagreement_score":0.057913832,"about_ca_system_score_codex":0.00009064288,"about_ca_system_score_gemma":0.00020302064,"threshold_uncertainty_score":0.23332389},"labels":[],"label_agreement":null},{"id":"W2052567922","doi":"10.1054/cdip.2002.0116","title":"Genogenic immunohistochemistry: a new era in diagnostic immunohistochemistry","year":2002,"lang":"en","type":"article","venue":"Current Diagnostic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunohistochemistry; Pathology; Breast cancer; Trastuzumab; Biology; Cancer; Medicine; Cancer research; Internal medicine","score_opus":0.024882990669521234,"score_gpt":0.2953602193689943,"score_spread":0.2704772286994731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052567922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8683111,0.1253906,0.00006679286,0.0010165281,0.0009390913,0.0008686301,0.000046576377,0.00014113518,0.00321951],"genre_scores_gemma":[0.9857441,0.011513469,0.0004165271,0.0003208745,0.00040989817,0.00062009017,0.00023998009,0.00005948118,0.0006755359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969624,0.00007835139,0.0008602113,0.0008837596,0.0003371298,0.0008781337],"domain_scores_gemma":[0.9961351,0.0021089488,0.00022393915,0.0009964252,0.00008483313,0.00045075454],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001574964,0.0005434255,0.0008473607,0.00019496962,0.00010758069,0.000027914297,0.00029496325,0.0002977957,0.0016190474],"category_scores_gemma":[0.0064769424,0.00052924565,0.00031217685,0.00041129865,0.00023423956,0.000075724565,0.00014962287,0.0005632143,0.0010404259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023173704,0.01177413,0.53901786,0.00077283627,0.0003588116,0.017270496,0.0022907108,0.000033779248,0.058555014,0.00056822866,0.09605013,0.27307627],"study_design_scores_gemma":[0.0327786,0.001539988,0.8693863,0.0030908342,0.0016902812,0.008247815,0.0001795496,0.00034045882,0.029009635,0.0012778391,0.0499751,0.0024836136],"about_ca_topic_score_codex":0.0000764349,"about_ca_topic_score_gemma":0.0000033490667,"teacher_disagreement_score":0.33036843,"about_ca_system_score_codex":0.000870388,"about_ca_system_score_gemma":0.00026701903,"threshold_uncertainty_score":0.9997374},"labels":[],"label_agreement":null},{"id":"W2052924000","doi":"10.1007/s11899-007-0022-2","title":"Is BEACOPP better than ABVD?","year":2007,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vincristine; Oncology; Vinblastine; Prednisone; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.14328563488198798,"score_gpt":0.41713827398589703,"score_spread":0.27385263910390906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052924000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021559637,0.9906241,0.00003115482,0.00010785048,0.0023749112,0.0025990424,0.000039034167,0.00023961447,0.0037686576],"genre_scores_gemma":[0.00029848237,0.9960502,0.0003649493,0.00023779181,0.00043160128,0.0006996829,0.00071530545,0.00010059003,0.0011014374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426156,0.00008732635,0.0023719282,0.0015710392,0.0007831602,0.0009249736],"domain_scores_gemma":[0.99581605,0.00017193536,0.0016712402,0.0017500406,0.00016213758,0.0004285979],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004336018,0.0011801542,0.0045307563,0.00040701657,0.0001269442,0.000075261894,0.00019298228,0.0007623023,0.0005542011],"category_scores_gemma":[0.00011399546,0.000763792,0.0020347224,0.0004871582,0.00012337258,0.000099101824,0.00019161339,0.0005084653,0.00047489704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053842614,0.0011435401,0.013516734,0.03857718,0.0005092877,0.025561797,0.000029959416,2.4324318e-9,6.750819e-8,0.0003316156,0.031598564,0.8887259],"study_design_scores_gemma":[0.00037838108,0.00011291668,0.00021579297,0.05484532,0.0031852634,0.03046706,0.0000034204777,1.1146088e-7,0.000044353594,0.00037577318,0.90974593,0.0006256891],"about_ca_topic_score_codex":0.000011238511,"about_ca_topic_score_gemma":0.0000012783167,"teacher_disagreement_score":0.8881002,"about_ca_system_score_codex":0.00042715474,"about_ca_system_score_gemma":0.0005947284,"threshold_uncertainty_score":0.9994813},"labels":[],"label_agreement":null},{"id":"W2053209597","doi":"10.1111/j.1365-3156.2004.01348.x","title":"Socioeconomic constraints to effective management of Burkitt's lymphoma in south‐eastern Nigeria","year":2005,"lang":"en","type":"article","venue":"Tropical Medicine & International Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socioeconomic status; Medicine; Developing country; Pediatrics; Disease; Quarter (Canadian coin); Family medicine; Distress; Health care; Environmental health; Population; Economic growth; Internal medicine","score_opus":0.014787007289277487,"score_gpt":0.33309634394691745,"score_spread":0.31830933665763994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053209597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94567674,0.00017265402,0.00025671726,0.048062142,0.00034542367,0.0009181161,0.000019772651,0.000024182113,0.0045242463],"genre_scores_gemma":[0.9914916,0.00009349869,0.0012230311,0.0063703707,0.00040211753,0.0001293256,0.000030264344,0.0000138191035,0.0002459538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984022,0.00004865201,0.0006133543,0.00032130248,0.00033693097,0.0002775702],"domain_scores_gemma":[0.9992242,0.00009792558,0.0001399979,0.000181236,0.00006299293,0.00029365506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014938257,0.00016944655,0.0005100974,0.00021063293,0.000023982171,0.0000043710606,0.00012288877,0.000050905583,0.00068081595],"category_scores_gemma":[0.00002838629,0.00013370399,0.00007916073,0.000080566824,0.00014128575,0.000038598784,0.00005303842,0.00006786306,0.00020997705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005623791,0.0008329635,0.52841127,0.00014626601,0.00026962737,0.00007595595,0.0019526207,0.000017320623,0.00001733867,0.00531898,0.001018418,0.46137685],"study_design_scores_gemma":[0.009606486,0.0011227528,0.98262787,0.0007995288,0.000027286742,0.000029805682,0.0005689527,0.00015333513,0.00011218708,0.00009145844,0.004774243,0.00008607024],"about_ca_topic_score_codex":0.0001569681,"about_ca_topic_score_gemma":0.00009503618,"teacher_disagreement_score":0.46129078,"about_ca_system_score_codex":0.0012707628,"about_ca_system_score_gemma":0.000101814745,"threshold_uncertainty_score":0.7454457},"labels":[],"label_agreement":null},{"id":"W2053328285","doi":"10.1080/10428190600572582","title":"Yttrium 90 ibritumomab tiuxetan in lymphoma","year":2006,"lang":"pl","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; Health Sciences Centre","funders":"European Commission; Government of Ontario; GlaxoSmithKline","keywords":"Ibritumomab tiuxetan; Medicine; Rituximab; Radioimmunotherapy; Refractory (planetary science); Follicular lymphoma; Lymphoma; Oncology; Non-Hodgkin's lymphoma; Internal medicine; CD20; Nuclear medicine; Monoclonal antibody; Immunology; Antibody","score_opus":0.01923111208947437,"score_gpt":0.27481083829889047,"score_spread":0.2555797262094161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053328285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1797979,0.78249174,0.000012682571,0.00031056415,0.0032608833,0.0058910544,0.0010939366,0.0007356636,0.026405582],"genre_scores_gemma":[0.17543054,0.7996742,0.00050901674,0.0015249036,0.003678403,0.002331166,0.00409849,0.0012149719,0.011538277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97312826,0.0016913859,0.007885642,0.0072429357,0.0035738219,0.0064779413],"domain_scores_gemma":[0.9853369,0.0024538287,0.0033515103,0.005078854,0.0006351106,0.0031438253],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018613734,0.00729812,0.013629449,0.0034404653,0.0013331186,0.0012870202,0.0024703487,0.005838771,0.00068142253],"category_scores_gemma":[0.0005317319,0.006714251,0.003981544,0.004750543,0.0018689254,0.0011958461,0.0016909412,0.00084585865,0.0035246392],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001037464,0.004067933,0.011359351,0.016433995,0.00239566,0.017924972,0.0006177783,0.00002878965,0.000038182312,0.0018097939,0.023503609,0.92078245],"study_design_scores_gemma":[0.06498131,0.0012132539,0.10138984,0.028873803,0.007919634,0.010718908,0.00037272766,0.0011570347,0.0003317583,0.0003019162,0.7769426,0.0057971985],"about_ca_topic_score_codex":0.02513539,"about_ca_topic_score_gemma":0.0015133435,"teacher_disagreement_score":0.9149853,"about_ca_system_score_codex":0.08052968,"about_ca_system_score_gemma":0.031375386,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W2053472493","doi":"10.1016/j.oooo.2014.05.046","title":"Characterization of diffuse large B-cell lymphomas of the oral cavity","year":2014,"lang":"en","type":"article","venue":"Oral Surgery Oral Medicine Oral Pathology and Oral Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Germinal center; Diffuse large B-cell lymphoma; Lymphoma; Oral cavity; B cell; Medicine; Pathology; Cancer research; Immunology; Antibody","score_opus":0.01756013141508705,"score_gpt":0.2543235878690855,"score_spread":0.23676345645399843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053472493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937616,0.0006402552,0.00012289861,0.0034235737,0.0011421174,0.0005130656,0.000078521676,0.000053781125,0.00026420548],"genre_scores_gemma":[0.9960493,0.0004947306,0.00024005205,0.0023099915,0.00018809843,0.000040459432,0.00031657354,0.00004020198,0.0003205875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961669,0.0011247708,0.0010432651,0.0006399423,0.00031623358,0.0007089191],"domain_scores_gemma":[0.9976644,0.00053536287,0.00064442464,0.0006649051,0.00020562968,0.00028526667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015763518,0.0004911046,0.0022223291,0.00027254137,0.00017346453,0.0000058523283,0.00020121878,0.0005156415,0.00023708603],"category_scores_gemma":[0.000652039,0.00029620592,0.00031449864,0.00046806483,0.0014327333,0.00013312156,0.00017074321,0.00027612151,0.0000141738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011143184,0.0019323834,0.91964227,0.00020455249,0.00012299935,0.00024945606,0.00027937116,6.3220574e-7,0.050789315,0.0011819754,0.0019641467,0.022518575],"study_design_scores_gemma":[0.011095091,0.0019053128,0.9614852,0.00019440819,0.00063337106,0.0010969075,0.00007288161,0.00014153615,0.013068523,0.0004572459,0.0095303925,0.00031914513],"about_ca_topic_score_codex":0.00040883894,"about_ca_topic_score_gemma":0.0001479838,"teacher_disagreement_score":0.04184291,"about_ca_system_score_codex":0.00008498704,"about_ca_system_score_gemma":0.00014914859,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W2054534658","doi":"10.1002/ajh.23205","title":"The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Medicine; Peripheral T-cell lymphoma; T-cell lymphoma; Internal medicine; Anaplastic lymphoma kinase; Not Otherwise Specified; Natural killer cell; Gastroenterology; Pathology; T cell; Immunology; Biology; Immune system; Cytotoxic T cell; Pleural effusion","score_opus":0.012272677754966764,"score_gpt":0.2720979502373004,"score_spread":0.2598252724823336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054534658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864208,0.011451991,0.0000033302097,0.00062422064,0.00051787094,0.0007314978,0.000011123874,0.00000612984,0.00023304592],"genre_scores_gemma":[0.99837375,0.0005724627,0.00057144824,0.0001890768,0.0001276478,0.00006416277,0.000004698825,0.000027053366,0.00006969783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747705,0.00037847308,0.001003737,0.0002434534,0.0004904925,0.00040680522],"domain_scores_gemma":[0.9964559,0.0016632042,0.0012148451,0.00032303488,0.00021784358,0.0001251853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038256086,0.00028953838,0.00096078473,0.00012667516,0.00009805207,0.000027919808,0.0003872816,0.00005532797,0.00003138167],"category_scores_gemma":[0.00018906951,0.00015752175,0.00018157835,0.00029114934,0.0006086548,0.00014062227,0.000120455494,0.00014093339,0.0000015525098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017077776,0.0053366455,0.9753547,0.00003734676,0.000333617,0.00045740913,0.008491655,0.0000061536025,0.0013117794,0.000037463185,0.00037288317,0.0065525994],"study_design_scores_gemma":[0.021205878,0.00651712,0.8881476,0.00024867544,0.0006098234,0.0058591547,0.06477763,0.00017710627,0.010758551,0.000030074829,0.0013518756,0.00031653262],"about_ca_topic_score_codex":0.0026102674,"about_ca_topic_score_gemma":0.00026865554,"teacher_disagreement_score":0.087207094,"about_ca_system_score_codex":0.000276697,"about_ca_system_score_gemma":0.00053154724,"threshold_uncertainty_score":0.642355},"labels":[],"label_agreement":null},{"id":"W2054830906","doi":"10.1182/blood-2008-08-174953","title":"Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK","keywords":"Follicular lymphoma; Transformation (genetics); Medicine; Uniparental disomy; Lymphoma; Survival analysis; Oncology; Biology; Internal medicine; Genetics; Gene","score_opus":0.011204330696069529,"score_gpt":0.2225724274465951,"score_spread":0.2113680967505256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054830906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980757,0.00079733675,0.000007474047,0.0001668085,0.000012101467,0.00035484563,0.00020273101,0.000015072573,0.00036789532],"genre_scores_gemma":[0.9983732,0.0013758678,0.00006243848,0.000014339731,0.000008421777,0.000022298223,0.000119609016,0.000009136638,0.00001468017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991068,0.000052576666,0.0003019141,0.00013845625,0.00027156537,0.00012868455],"domain_scores_gemma":[0.9992379,0.000100294375,0.00033465776,0.00017639076,0.000076443626,0.000074311254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007657248,0.0001338396,0.0004539036,0.00006341307,0.000040311883,0.0000030800873,0.000037156926,0.00007083976,0.000009614533],"category_scores_gemma":[0.000039419825,0.000097340475,0.0001184939,0.00013651626,0.00006945303,0.0000677371,0.000009740662,0.000012092151,2.826327e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022009375,0.004822975,0.9917163,0.00005950032,0.00081192405,0.000018573091,0.00059229514,0.0000050465806,0.0005136198,0.00029170085,0.00004364186,0.0009042813],"study_design_scores_gemma":[0.016414516,0.0012197386,0.9243068,0.0004389478,0.0016983063,0.0000133303865,0.00019154727,0.000018284534,0.055545244,0.000048598937,0.000022856753,0.000081822414],"about_ca_topic_score_codex":0.00027806655,"about_ca_topic_score_gemma":0.00019750377,"teacher_disagreement_score":0.067409545,"about_ca_system_score_codex":0.000062449806,"about_ca_system_score_gemma":0.000038102524,"threshold_uncertainty_score":0.39694294},"labels":[],"label_agreement":null},{"id":"W2054884450","doi":"10.1016/j.bbmt.2008.09.008","title":"Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood &amp; Marrow Transplant Research (CIBMTR)","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Health Resources and Services Administration; U.S. Department of Health and Human Services","keywords":"Medicine; Lymphoma; Internal medicine; Transplantation; Multivariate analysis; Confidence interval; Single Center; Hematopoietic stem cell transplantation; Follicular lymphoma; Hematopoietic cell; Surgery; Haematopoiesis; Stem cell","score_opus":0.025169612890225047,"score_gpt":0.2931788418190854,"score_spread":0.2680092289288603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054884450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977642,0.00021293618,0.00007067628,0.0003446203,0.000125435,0.0007612328,0.0005738843,0.000011855555,0.00013510285],"genre_scores_gemma":[0.993634,0.003777474,0.00067667227,0.00012516207,0.00002859103,0.00011225174,0.0016142167,0.000013801783,0.000017828495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833375,0.00013685277,0.0006770753,0.0004097792,0.00020298902,0.00023955709],"domain_scores_gemma":[0.99848694,0.0008357599,0.00021288516,0.00017094296,0.00023153007,0.000061936014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025090796,0.00018885345,0.00042933229,0.00019978573,0.00009725208,0.0000045990973,0.00009601555,0.00020062279,0.0000044961207],"category_scores_gemma":[0.000085742526,0.00014099435,0.00008053954,0.00009116042,0.00032492544,0.000060130336,0.000007751106,0.000098386474,8.0390834e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020007752,0.0012828977,0.9728221,0.0005346296,0.00017868375,0.00046611516,0.0038861572,0.0000110444535,0.018164607,0.00013583103,0.000018665405,0.00049846666],"study_design_scores_gemma":[0.016851908,0.0010927679,0.956397,0.0004321902,0.00047940502,0.0006024843,0.00005685931,0.000010777859,0.023744592,0.00016426471,0.00004082853,0.00012690306],"about_ca_topic_score_codex":0.00075055554,"about_ca_topic_score_gemma":0.0007815734,"teacher_disagreement_score":0.016425109,"about_ca_system_score_codex":0.000028980738,"about_ca_system_score_gemma":0.00008076727,"threshold_uncertainty_score":0.57495826},"labels":[],"label_agreement":null},{"id":"W2055244688","doi":"10.1053/j.seminhematol.2013.09.004","title":"Newly Identified Mechanisms in B-Cell Non-Hodgkin Lymphomas Uncovered by Next-Generation Sequencing","year":2013,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Germinal center; Lymphoma; Biology; Disease; B cell; Molecular genetics; Gene; Molecular pathology; Computational biology; Cancer research; Genetics; Immunology; Medicine; Pathology; Antibody","score_opus":0.06928221153326854,"score_gpt":0.3162576214512335,"score_spread":0.24697540991796496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055244688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062028076,0.9890443,0.000057806552,0.00006936776,0.00073380634,0.0025274009,0.000032624375,0.000044326538,0.0012875606],"genre_scores_gemma":[0.0033872155,0.98978645,0.0027180663,0.00018103633,0.00008363943,0.001556963,0.0011380747,0.000109394685,0.0010391847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961378,0.00029299463,0.0015023326,0.0010314677,0.00032566756,0.00070975744],"domain_scores_gemma":[0.9980648,0.00036927618,0.0005726933,0.00074935256,0.000059620543,0.00018426447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038533757,0.00075897283,0.003338727,0.0006395478,0.000056290894,0.00006293922,0.0002670631,0.0011101259,0.00024908484],"category_scores_gemma":[0.00011343552,0.00064458733,0.00040544645,0.0005953853,0.000067055276,0.00015450036,0.00013728392,0.00035363954,0.0004099762],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040333845,0.0016958728,0.0006536607,0.022789415,0.00031417483,0.0043010563,0.00054410595,0.0000062934273,0.0014806432,0.0017241676,0.035302468,0.9311478],"study_design_scores_gemma":[0.0284168,0.002297387,0.0000371063,0.16666515,0.0051602027,0.014283731,0.0012909308,0.0020668611,0.027433664,0.005368559,0.7421466,0.0048329853],"about_ca_topic_score_codex":0.0010878555,"about_ca_topic_score_gemma":0.00029133086,"teacher_disagreement_score":0.92631483,"about_ca_system_score_codex":0.0023357186,"about_ca_system_score_gemma":0.00093190843,"threshold_uncertainty_score":0.9996005},"labels":[],"label_agreement":null},{"id":"W2055264579","doi":"10.1182/blood-2007-01-070300","title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Medicine; Proportional hazards model; Lymphoma; Bone marrow; Concordance; Lactate dehydrogenase; B symptoms; Oncology; Gastroenterology; Biology","score_opus":0.025528312612662724,"score_gpt":0.29390138224688483,"score_spread":0.26837306963422214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055264579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629885,0.00022822815,0.00003846651,0.00087471865,0.0006041545,0.0012323214,0.00010587886,0.00003028735,0.0005871243],"genre_scores_gemma":[0.997745,0.00008281299,0.00018050882,0.0012835718,0.0001779044,0.00010651746,0.00004105509,0.000029129349,0.00035350173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996763,0.00007489971,0.0013097934,0.00044812038,0.000945617,0.0004585574],"domain_scores_gemma":[0.9984502,0.000330529,0.00039422626,0.00049096113,0.0001079692,0.0002260967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010200429,0.0002662631,0.0005706442,0.0001562207,0.00004889235,0.000022572283,0.00029497166,0.0001195186,0.00003506736],"category_scores_gemma":[0.00035176674,0.000168842,0.0003063603,0.00018954188,0.000115765775,0.000060997674,0.00035513737,0.00018332918,0.000018225846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046246644,0.06085584,0.9342614,0.00007812214,0.000238909,0.0010025394,0.00016952246,3.7778977e-7,0.001726887,0.00020078341,0.00009076767,0.0009123959],"study_design_scores_gemma":[0.078490146,0.00055275497,0.89427364,0.00025561987,0.00034128776,0.00010880715,0.00030390464,0.00009224104,0.024963075,0.000024501356,0.0004463569,0.00014766806],"about_ca_topic_score_codex":0.0003784992,"about_ca_topic_score_gemma":0.0010064419,"teacher_disagreement_score":0.07802768,"about_ca_system_score_codex":0.00024231499,"about_ca_system_score_gemma":0.00029218386,"threshold_uncertainty_score":0.6885177},"labels":[],"label_agreement":null},{"id":"W2055511462","doi":"10.1097/mph.0b013e3181acd82b","title":"Anaplastic Large Cell Lymphoma of the Ovary in a Pediatric Patient","year":2009,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Ovary; Chemotherapy; Disease; Oncology; Pathology; Internal medicine","score_opus":0.010335422446503388,"score_gpt":0.271957808795942,"score_spread":0.26162238634943863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055511462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665863,0.0078788195,0.000018461658,0.0022861492,0.0007114578,0.00033647098,0.000006344144,0.000008793885,0.0020948944],"genre_scores_gemma":[0.9955147,0.0024406742,0.0007061693,0.00078822573,0.00050179526,0.000008700653,0.0000018619045,0.00001329337,0.000024575556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723434,0.0002665493,0.0014130949,0.00021675782,0.0004046951,0.00046456023],"domain_scores_gemma":[0.99728465,0.00061662856,0.0013571788,0.00028099812,0.00024517818,0.00021538268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048622527,0.00023199391,0.0010921215,0.00061240105,0.000053636017,0.0000047197395,0.00023209263,0.00035144883,0.0000445301],"category_scores_gemma":[0.00035078253,0.00014472436,0.00038216592,0.00082773366,0.000049761362,0.00007602822,0.000072431285,0.0002929579,0.000016905276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091255765,0.01595381,0.95547765,0.00017735641,0.00007614142,0.004137609,0.00094475975,0.000018607168,0.00005540488,0.00052812573,0.013853975,0.007863973],"study_design_scores_gemma":[0.028544908,0.012192811,0.9415784,0.000053014748,0.0016574165,0.006908598,0.00041409812,0.000054014767,0.0013690541,0.0005883713,0.0064014248,0.00023789007],"about_ca_topic_score_codex":0.000007325088,"about_ca_topic_score_gemma":0.000015093366,"teacher_disagreement_score":0.027632352,"about_ca_system_score_codex":0.00053921755,"about_ca_system_score_gemma":0.001619874,"threshold_uncertainty_score":0.59016883},"labels":[],"label_agreement":null},{"id":"W2055699311","doi":"10.1080/10428190903015628","title":"pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation","year":2009,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Etoposide; Vincristine; Oncology; Diffuse large B-cell lymphoma; Internal medicine; Autologous stem-cell transplantation; International Prognostic Index; Transplantation; Cyclophosphamide; Lymphoma; Chemotherapy; Melphalan; Cancer research","score_opus":0.008825021794675286,"score_gpt":0.2302343601438441,"score_spread":0.22140933834916882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055699311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905228,0.004003557,0.0001809767,0.0004972329,0.00011184366,0.0030213783,0.00043191397,0.00045784857,0.00077245454],"genre_scores_gemma":[0.98779196,0.004838973,0.0024484873,0.0019845509,0.00014101197,0.0006725367,0.0005176664,0.00013419705,0.0014706512],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952913,0.00012262864,0.0010567586,0.0016764516,0.0006053903,0.0012474855],"domain_scores_gemma":[0.9974715,0.0004261055,0.0004718557,0.0006399324,0.00019801986,0.00079256255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002770992,0.0012387416,0.0015801489,0.00042890108,0.00064809894,0.00023676129,0.00022026185,0.0007290505,0.000009751906],"category_scores_gemma":[0.000015181472,0.00093218166,0.00025833724,0.0004394484,0.0002802793,0.000436477,0.00006468029,0.00009520695,0.0000057610696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018683922,0.013940894,0.25196788,0.0033557878,0.0007646245,0.0018614056,0.0040158937,0.00000870635,0.03325577,0.00060014875,0.0020839728,0.669461],"study_design_scores_gemma":[0.19832546,0.0038987051,0.6714968,0.0007599484,0.0015929725,0.0011235699,0.0005666215,0.0018400712,0.1163115,0.00007507649,0.0029286093,0.0010806347],"about_ca_topic_score_codex":0.000607665,"about_ca_topic_score_gemma":0.000040495775,"teacher_disagreement_score":0.6683804,"about_ca_system_score_codex":0.0025460497,"about_ca_system_score_gemma":0.0011051112,"threshold_uncertainty_score":0.9993129},"labels":[],"label_agreement":null},{"id":"W2055815343","doi":"10.1007/s12308-013-0177-9","title":"CD20-positive T-cell lymphoma involving bone marrow: report of four cases","year":2013,"lang":"en","type":"article","venue":"Journal of Hematopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Hematology; Bone marrow; Lymphoma; Medicine; Internal medicine; CD20; Oncology; Pathology","score_opus":0.016978288091192225,"score_gpt":0.25779191301091325,"score_spread":0.24081362491972103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055815343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242055,0.003612355,0.000034046938,0.0011122952,0.00024913825,0.00022569318,0.000003825422,0.000009422031,0.0023326448],"genre_scores_gemma":[0.99532545,0.0002809101,0.0034289847,0.00033831538,0.00015086889,0.00001313619,0.0000040475734,0.00002010364,0.00043819682],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982541,0.00008238105,0.00096650375,0.00016711191,0.00029048746,0.00023940625],"domain_scores_gemma":[0.99771357,0.0002518082,0.0010249031,0.0002699935,0.00055833673,0.0001813897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000356342,0.00017105264,0.00081217807,0.00022265951,0.000042049793,0.000011645913,0.0000759962,0.0001214637,0.00017325912],"category_scores_gemma":[0.00031968148,0.0001221017,0.00028520447,0.000110060246,0.000097537275,0.00014039065,0.00005009167,0.00009373084,0.000040590705],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033026218,0.004064689,0.49127725,0.00035363284,0.00026235843,0.38172916,0.0008150265,0.0000030048307,0.10426994,0.00039567988,0.009549232,0.0069497647],"study_design_scores_gemma":[0.004969821,0.0017362171,0.3035769,0.00042325543,0.00034501698,0.6059889,0.00042164722,0.000010580534,0.08154726,0.00041835284,0.0004395203,0.00012253849],"about_ca_topic_score_codex":0.000093424394,"about_ca_topic_score_gemma":0.0000055235623,"teacher_disagreement_score":0.22425975,"about_ca_system_score_codex":0.00015761939,"about_ca_system_score_gemma":0.00024302141,"threshold_uncertainty_score":0.49791628},"labels":[],"label_agreement":null},{"id":"W2056641238","doi":"10.1182/blood-2012-10-460063","title":"MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":679,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; Cancer research; Gene expression; Gene; Genetics; Immunology","score_opus":0.0068453526359068375,"score_gpt":0.22946402255005457,"score_spread":0.22261866991414775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056641238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940375,0.0016778787,0.0000274383,0.00074366044,0.00013425066,0.0028766138,0.00034553462,0.000053880165,0.00010321354],"genre_scores_gemma":[0.9972544,0.00018796943,0.0013440972,0.000102059,0.00008944783,0.0006919459,0.00021645566,0.000028041442,0.000085632484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806803,0.00016242398,0.00060035684,0.00041464227,0.00047267188,0.00028184103],"domain_scores_gemma":[0.99778646,0.0005421713,0.0005579333,0.0005798787,0.00039354502,0.0001399948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002763383,0.00027450017,0.0005166254,0.00006277388,0.00013664509,0.000068001864,0.00024536272,0.00018018471,0.000054332228],"category_scores_gemma":[0.00042537382,0.00014217991,0.000121900135,0.00016479891,0.0001379455,0.00009578681,0.00021860073,0.00013587305,0.000009389967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037843717,0.02340232,0.31983504,0.000036327765,0.00029120405,0.000045798097,0.00019956104,6.048053e-7,0.6538397,0.000016380995,0.00076328166,0.0011913227],"study_design_scores_gemma":[0.028926408,0.00031753138,0.27514133,0.0002925795,0.00030044964,0.000010565962,0.00020796111,0.0000278216,0.6939664,0.00004772293,0.0006563097,0.00010493525],"about_ca_topic_score_codex":0.0017837905,"about_ca_topic_score_gemma":0.00006714857,"teacher_disagreement_score":0.044693716,"about_ca_system_score_codex":0.000037477505,"about_ca_system_score_gemma":0.00016935598,"threshold_uncertainty_score":0.5797928},"labels":[],"label_agreement":null},{"id":"W2056742573","doi":"10.1016/j.annpat.2012.07.021","title":"Pièges et nouveautés en hématopathologie. Cas no 7. Lymphome de Hodgkin à prédominance lymphocytaire nodulaire","year":2012,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dominance (genetics); Biology; Genetics","score_opus":0.027868187239260326,"score_gpt":0.335036562373548,"score_spread":0.3071683751342877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056742573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81286496,0.16467758,0.00051615183,0.009170701,0.0034989861,0.0008352274,0.00020473702,0.0003734808,0.007858193],"genre_scores_gemma":[0.92872375,0.04585998,0.010339073,0.005100838,0.0019338267,0.0004108887,0.000116901654,0.00014066322,0.007374098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99322927,0.0012890622,0.00083723664,0.0009651951,0.0005188512,0.0031603589],"domain_scores_gemma":[0.9960118,0.0011585441,0.00039554865,0.0012619084,0.00024868886,0.00092354557],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002650759,0.0009957424,0.0012806241,0.00022509982,0.00031816817,0.00011031812,0.00056303473,0.0011017252,0.00042076947],"category_scores_gemma":[0.0020910741,0.00088968466,0.00061098405,0.00038138646,0.0006718029,0.00060603087,0.0004677297,0.0004580014,0.00592369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033427807,0.003286596,0.7745362,0.00067781506,0.00022413066,0.013744984,0.005456668,0.000080898026,0.0027470416,0.0025630323,0.019640114,0.17670828],"study_design_scores_gemma":[0.0049137706,0.0011649915,0.89441466,0.0014942855,0.00072062114,0.010984832,0.0014997588,0.00027079857,0.015555644,0.000380931,0.06762668,0.00097305054],"about_ca_topic_score_codex":0.0004758841,"about_ca_topic_score_gemma":0.000056754903,"teacher_disagreement_score":0.17573522,"about_ca_system_score_codex":0.0046554185,"about_ca_system_score_gemma":0.002586765,"threshold_uncertainty_score":0.9993554},"labels":[],"label_agreement":null},{"id":"W2056756183","doi":"10.1097/00000441-200602000-00013","title":"Orbital Lymphomas: A Clinicopathologic Study of a Rare Disease","year":2006,"lang":"en","type":"article","venue":"The American Journal of the Medical Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Radiation therapy; Internal medicine; Chemotherapy; Localized disease; Disease; Gastroenterology; Cancer","score_opus":0.026093641349997726,"score_gpt":0.32369821241289437,"score_spread":0.2976045710628966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056756183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862595,0.0006506402,0.0000040823297,0.012390281,0.00018338126,0.00017627944,0.0000018939539,0.000004956229,0.00032897416],"genre_scores_gemma":[0.99906427,0.00004402041,0.00006987178,0.00057216897,0.00020687662,0.000004779854,1.0812164e-7,0.0000033705155,0.00003454322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973926,0.00032235868,0.0005184772,0.00012552958,0.0014563593,0.0001846619],"domain_scores_gemma":[0.9983325,0.00042893726,0.0007258284,0.0002399898,0.0000658037,0.0002069367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015752518,0.00009787356,0.0004064758,0.00005311744,0.00017119314,0.000016280532,0.0006472795,0.000012480377,0.0000745343],"category_scores_gemma":[0.00069598324,0.000033327775,0.0002144104,0.0005970676,0.0020524184,0.000043241213,0.00011861847,0.00011229482,0.0000033893368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003362208,0.0031521649,0.9739067,0.0000057840325,0.00005624449,0.00082302134,0.00033889755,0.000033417433,0.000021221644,0.00010996123,0.0005914063,0.020624977],"study_design_scores_gemma":[0.0018075694,0.0047679334,0.9881007,0.00014252252,0.00026022206,0.0009546856,0.0028867484,0.00006457948,0.000050000166,0.0007969355,0.00012022172,0.00004786802],"about_ca_topic_score_codex":0.0003407299,"about_ca_topic_score_gemma":0.000015861726,"teacher_disagreement_score":0.020577108,"about_ca_system_score_codex":0.00005303624,"about_ca_system_score_gemma":0.0005657551,"threshold_uncertainty_score":0.7562221},"labels":[],"label_agreement":null},{"id":"W2057239580","doi":"10.1182/blood-2009-05-220095","title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":667,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Diffuse large B-cell lymphoma; Hazard ratio; Vincristine; Internal medicine; Rituximab; Oncology; Medicine; Population; Cyclophosphamide; Lymphoma; CHOP; Chemotherapy; Confidence interval; Cancer research","score_opus":0.007187967582575832,"score_gpt":0.20952294597654375,"score_spread":0.2023349783939679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057239580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969672,0.00020342227,6.2406014e-7,0.00035384577,0.0000109360635,0.0013168202,0.000070730595,0.00011424873,0.00096218835],"genre_scores_gemma":[0.9978239,0.00010885394,0.00019892052,0.0010038833,0.000027863336,0.00020796062,0.00026858633,0.000049826518,0.00031018455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824697,0.000047935333,0.00027117532,0.0004701707,0.00045445721,0.00050930143],"domain_scores_gemma":[0.99918026,0.000026841975,0.00020085054,0.00026461235,0.00014322606,0.00018420348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000699271,0.00034606527,0.00050844526,0.00014734559,0.000073524134,0.00003380978,0.00008360087,0.00012561947,0.00002558116],"category_scores_gemma":[0.000021369215,0.00022747948,0.0000772325,0.00048692385,0.000024619583,0.00008003745,0.00001239361,0.00005958597,0.000017782999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007168523,0.12883608,0.86663574,0.000016082256,0.00039965753,0.0005307788,0.00021267628,1.14959704e-7,0.00027952623,0.0000011463416,0.00021096448,0.0021603773],"study_design_scores_gemma":[0.18828078,0.0033064974,0.7838655,0.00035772377,0.00045675196,0.000012076359,0.000036272308,0.000007840178,0.023355184,0.0000015951695,0.0001050978,0.00021468278],"about_ca_topic_score_codex":0.00008179563,"about_ca_topic_score_gemma":0.00010705624,"teacher_disagreement_score":0.18756393,"about_ca_system_score_codex":0.00024393084,"about_ca_system_score_gemma":0.00006904811,"threshold_uncertainty_score":0.9276344},"labels":[],"label_agreement":null},{"id":"W2057281986","doi":"10.14740/jh194w","title":"Prognostic Utility of Transforming Growth Factor Beta-1 in Diffuse Large Cell Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; BETA (programming language); Transforming growth factor beta; Transforming growth factor; Hodgkin lymphoma; Cancer research; Pathology; Internal medicine","score_opus":0.026928639968953134,"score_gpt":0.28295168461057346,"score_spread":0.25602304464162035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057281986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964342,0.0015095512,0.00016872825,0.0006375014,0.00017441703,0.00026891695,0.000012705137,0.0000057589727,0.0007882104],"genre_scores_gemma":[0.9991563,0.00009794067,0.00058477564,0.0000850309,0.000037665526,0.0000077321165,0.00000325428,0.000013586993,0.0000136998215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983881,0.000073460455,0.0008207992,0.00013567183,0.00028983885,0.00029209317],"domain_scores_gemma":[0.9987894,0.000206613,0.00037412177,0.00014933637,0.00024350632,0.00023698476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032895277,0.00016072548,0.0009033048,0.00023235484,0.000016842507,0.0000048680477,0.00010286624,0.00013671666,0.000032922155],"category_scores_gemma":[0.00016848899,0.000111029614,0.00020837177,0.00015207204,0.000054506298,0.00010354161,0.000021443182,0.00010946088,0.000007485285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048365016,0.009712014,0.984021,0.00028339057,0.00011548865,0.0014191522,0.001401814,1.4979871e-7,0.00028973207,0.0002433346,0.00048505657,0.0015452228],"study_design_scores_gemma":[0.057804994,0.0026737666,0.8232223,0.00049243326,0.00042195307,0.0041522426,0.00086325954,0.00015303397,0.10856076,0.0005339492,0.00093307294,0.00018825624],"about_ca_topic_score_codex":0.00004610125,"about_ca_topic_score_gemma":0.000034455836,"teacher_disagreement_score":0.16079871,"about_ca_system_score_codex":0.00011373306,"about_ca_system_score_gemma":0.00040481534,"threshold_uncertainty_score":0.45276564},"labels":[],"label_agreement":null},{"id":"W2057629675","doi":"10.1046/j.1365-2141.2003.04541.x","title":"A selective history of the therapy of Hodgkin's disease","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vinblastine; Disease; Oncology; Bleomycin; Radiation therapy; Chemotherapy; Combination chemotherapy; Internal medicine; Intensive care medicine; Vincristine; Cyclophosphamide","score_opus":0.015480755791139101,"score_gpt":0.23823477701964668,"score_spread":0.22275402122850757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057629675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533531,0.044129044,0.000010748204,0.0003533003,0.0003032755,0.00014228806,0.00000473365,0.0000021209737,0.0017013947],"genre_scores_gemma":[0.997403,0.0019605728,0.00018383256,0.00024459453,0.000018976116,0.0000045806605,3.9938624e-7,0.000008266798,0.0001757736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990967,0.00016117087,0.000379498,0.00007366653,0.00018104713,0.000107938984],"domain_scores_gemma":[0.9990016,0.00009250492,0.00043438908,0.00012108075,0.00026258422,0.000087803666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014810113,0.000068530906,0.00047713896,0.000054397653,0.000017449138,0.0000016404653,0.00007608264,0.000044874956,0.000117348616],"category_scores_gemma":[0.00026233165,0.000049648675,0.0002471901,0.00007120905,0.00017415089,0.000030754276,0.000008664614,0.00009383087,8.932126e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001865552,0.008056396,0.82206315,0.00037696198,0.0022025073,0.035680953,0.0018766772,0.000011988723,0.0026782323,0.008494674,0.08178694,0.034905963],"study_design_scores_gemma":[0.010934529,0.0011401718,0.7817154,0.0011121683,0.00039340972,0.14585589,0.00014452962,0.0000032957873,0.019960558,0.0020131744,0.036595065,0.00013183762],"about_ca_topic_score_codex":0.000055464596,"about_ca_topic_score_gemma":0.000011189606,"teacher_disagreement_score":0.11017494,"about_ca_system_score_codex":0.00020450389,"about_ca_system_score_gemma":0.0010282823,"threshold_uncertainty_score":0.20246142},"labels":[],"label_agreement":null},{"id":"W2057862856","doi":"10.1182/blood-2010-05-285320","title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"DNA methylation; Biology; Epigenetics; Diffuse large B-cell lymphoma; Gene expression profiling; Methylation; CpG site; Promoter; Gene; Cancer research; Genetics; Gene expression; Computational biology","score_opus":0.005171165776245504,"score_gpt":0.22737425126074026,"score_spread":0.22220308548449474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057862856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497616,0.0015955116,0.000016607572,0.0001597604,0.00008828881,0.00021502622,0.000022667316,0.00003836729,0.0028876157],"genre_scores_gemma":[0.99836856,0.000051777413,0.001156371,0.00016041112,0.0000565939,0.000022122125,0.000059806876,0.000019148774,0.00010523287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992388,0.000019678555,0.0001780791,0.00018589682,0.0002064968,0.00017107312],"domain_scores_gemma":[0.9993827,0.00006106485,0.00008209361,0.00030898213,0.00007387309,0.000091284775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008513105,0.00012860395,0.00023117173,0.00007334978,0.000030797575,0.000007948342,0.00005644732,0.00012338733,0.000066569184],"category_scores_gemma":[0.0000649065,0.000098090044,0.000118958225,0.000110218774,0.000026709577,0.000030431343,0.000027596374,0.000056454683,0.000024928224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007138831,0.026811656,0.065253496,0.00008431244,0.00021597196,0.00017439123,0.0001269904,4.0511043e-7,0.9004768,0.0035740775,0.00024528604,0.0029652345],"study_design_scores_gemma":[0.021816112,0.0002290908,0.13967231,0.000019368397,0.00045951494,0.0000174549,0.000010894179,0.00001188972,0.83595484,0.000155539,0.001568532,0.000084437524],"about_ca_topic_score_codex":0.000035146928,"about_ca_topic_score_gemma":0.000022148313,"teacher_disagreement_score":0.07441882,"about_ca_system_score_codex":0.000011472917,"about_ca_system_score_gemma":0.000059337777,"threshold_uncertainty_score":0.3999996},"labels":[],"label_agreement":null},{"id":"W2058203674","doi":"10.1038/bmt.2011.97","title":"Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents","year":2011,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Medicine; Melphalan; Mucositis; Refractory (planetary science); Surgery; Lymphoma; Regimen; Internal medicine; Chemotherapy; Single Center; Autologous stem-cell transplantation; Oncology","score_opus":0.013866586661695648,"score_gpt":0.22289156759155282,"score_spread":0.20902498092985716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058203674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973175,0.0009952438,0.0000964438,0.0001361003,0.00007670025,0.0010468066,0.00017130387,0.000048015125,0.00011187329],"genre_scores_gemma":[0.9967547,0.0011779921,0.0009854384,0.00015494846,0.00002441912,0.00011383509,0.0006898224,0.000029718842,0.00006914278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890435,0.000047256905,0.00029585452,0.00036276897,0.00016031288,0.00022946513],"domain_scores_gemma":[0.99957484,0.000039148676,0.00008798718,0.00013764824,0.000023889676,0.00013648241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010677352,0.00020667946,0.00030932415,0.00012299875,0.000059192225,0.000017718412,0.00003167674,0.00011988113,0.000012081812],"category_scores_gemma":[0.000010121498,0.0001843541,0.000054532284,0.000074710886,0.00004237077,0.00011586258,0.0000063710854,0.000040544084,0.0000033159608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003947954,0.002346292,0.89875615,0.00034397683,0.00014996142,0.00016117928,0.0018699042,2.1759044e-7,0.03378212,0.00008412195,0.00057861186,0.057979517],"study_design_scores_gemma":[0.022875896,0.0008116534,0.9607457,0.00034007197,0.00038172078,0.00015177134,0.000028475222,0.000025368583,0.014290675,0.000052420608,0.00011354934,0.00018268563],"about_ca_topic_score_codex":0.00066577503,"about_ca_topic_score_gemma":0.00012356087,"teacher_disagreement_score":0.061989572,"about_ca_system_score_codex":0.00012212948,"about_ca_system_score_gemma":0.00003425805,"threshold_uncertainty_score":0.7517742},"labels":[],"label_agreement":null},{"id":"W2058577331","doi":"10.4021/jocmr2009.07.1251","title":"Lymphoma of the Base of the Tongue: An Incidental Finding on the Preoperative Workup for a Spine Surgery","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Tongue; Lymphoma; Cervical spine; Radiology; Cervical spondylosis; Surgery; Pathology","score_opus":0.34909853260496543,"score_gpt":0.5427345535270144,"score_spread":0.19363602092204896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058577331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9318186,0.00056434626,0.0000053657136,0.065808415,0.00042536546,0.0008019265,0.000006124618,0.0000019974113,0.0005678592],"genre_scores_gemma":[0.99668825,0.0004193434,0.000074666415,0.0013523696,0.0012116419,0.000013740421,0.0000015664858,0.0000114929335,0.00022693878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99488026,0.001185526,0.0016635226,0.00018225894,0.001790513,0.00029794793],"domain_scores_gemma":[0.98599577,0.011330482,0.0008098805,0.00059618574,0.0010237992,0.00024387597],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01222886,0.0001415406,0.00093103206,0.00016152258,0.00018351561,0.000010722125,0.0004570955,0.000114202165,0.000099434576],"category_scores_gemma":[0.023656784,0.000047713478,0.0006569713,0.00057904335,0.0007338715,0.00006802468,0.00008018783,0.0005316403,0.0000012864098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006040646,0.007434616,0.7697633,0.00014680845,0.0007205808,0.00018193363,0.001411827,0.000014420029,0.0016655306,0.0024517628,0.049431678,0.16073689],"study_design_scores_gemma":[0.0055214227,0.007838416,0.9687957,0.0032457332,0.00019689815,0.00011264811,0.0010068755,0.00010285341,0.011777342,0.00061162945,0.0007424235,0.000048047656],"about_ca_topic_score_codex":0.000044447534,"about_ca_topic_score_gemma":0.000017397553,"teacher_disagreement_score":0.1990324,"about_ca_system_score_codex":0.00015114884,"about_ca_system_score_gemma":0.0010412629,"threshold_uncertainty_score":0.98456734},"labels":[],"label_agreement":null},{"id":"W2058912410","doi":"10.1016/j.ijrobp.2009.07.1095","title":"Is 30 Gy Enough to Assure In-Field Local Control after 3–4 Cycles of Chemotherapy in Patients with Stage I–II Aggressive Non-Hodgkin's Lymphoma?","year":2009,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Vincristine; Stage (stratigraphy); International Prognostic Index; Regimen; Cyclophosphamide; Radiation therapy; Prednisone; Context (archaeology); Internal medicine; Chemotherapy; Surgery; CHOP; Rituximab; Aggressive lymphoma; Lymphoma; Chemotherapy regimen","score_opus":0.006158318050878631,"score_gpt":0.29339531866644347,"score_spread":0.28723700061556484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058912410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898144,0.0002343699,0.0015545174,0.007450794,0.0003054128,0.00038670993,0.00006456309,0.0000065625613,0.00018267086],"genre_scores_gemma":[0.99142075,0.0001765021,0.0007923571,0.0072145616,0.00032055986,0.000020135352,0.000025287269,0.000015565332,0.0000142898825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984663,0.00008880177,0.0006778548,0.00022127171,0.00032636264,0.00021942199],"domain_scores_gemma":[0.99810356,0.00023025225,0.000886167,0.00013771688,0.0005318275,0.0001105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019390791,0.00020621692,0.0006183929,0.00024465806,0.000022377983,0.000009932963,0.00019257943,0.00020677042,0.00009418331],"category_scores_gemma":[0.00009062648,0.00015700914,0.00014246846,0.00016634748,0.000070220674,0.00015866246,0.000021674994,0.00016771941,0.000010512019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003901376,0.0026678168,0.76749486,0.0000042168904,0.0003399702,0.00012934676,0.00087519374,0.00039946497,0.00011163011,0.00027873565,0.00027282492,0.22352459],"study_design_scores_gemma":[0.03142056,0.007791808,0.95301485,0.00021130705,0.000064897635,0.000018501614,0.000056157896,0.0002529612,0.0034082728,0.0004645194,0.0031602709,0.00013590208],"about_ca_topic_score_codex":0.000058271547,"about_ca_topic_score_gemma":0.000016457467,"teacher_disagreement_score":0.22338867,"about_ca_system_score_codex":0.0008647811,"about_ca_system_score_gemma":0.00037984963,"threshold_uncertainty_score":0.6402647},"labels":[],"label_agreement":null},{"id":"W2058924049","doi":"10.1016/j.jaapos.2013.04.005","title":"Primary conjunctival anaplastic large cell lymphoma in a child","year":2013,"lang":"en","type":"article","venue":"Journal of American Association for Pediatric Ophthalmology and Strabismus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Lymphoma; Lymphoid hyperplasia; Medicine; Conjunctiva; Anaplastic large-cell lymphoma; Pathology; Biopsy; Large cell; Hyperplasia; Pseudolymphoma; Internal medicine; Cancer; Adenocarcinoma","score_opus":0.0055140052203769135,"score_gpt":0.23894152566979565,"score_spread":0.23342752044941872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058924049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404275,0.0006580765,0.000013149501,0.0014566719,0.00022814426,0.0003364557,0.000023947685,0.0000059488284,0.0032348637],"genre_scores_gemma":[0.99820244,0.00037435166,0.00046119202,0.000260611,0.00032696733,0.000028657645,0.000012822607,0.000012118988,0.00032082936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998742,0.000073965435,0.0005025071,0.00015850362,0.00021587532,0.00030714597],"domain_scores_gemma":[0.99818045,0.00050944387,0.000873414,0.00007063246,0.00020944918,0.00015659555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031883526,0.00014547298,0.00057164533,0.00027187777,0.00006964085,0.000018645589,0.00005225496,0.000114479655,0.000049805156],"category_scores_gemma":[0.00021685693,0.00011716793,0.00015870838,0.0002484952,0.00003646842,0.00012090194,0.000015527881,0.00013155588,0.000008764521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030081236,0.0018479764,0.9928942,0.00005354272,0.00011466346,0.00021852857,0.00010610392,0.0000027995495,0.000014623093,0.000040349096,0.0019998765,0.0024065254],"study_design_scores_gemma":[0.0105535425,0.003124172,0.983853,0.000011180937,0.00027236296,0.0013013574,0.00022203907,0.000021039172,0.00001952872,0.00012464804,0.00039522487,0.00010192777],"about_ca_topic_score_codex":0.000043972315,"about_ca_topic_score_gemma":0.0000012219303,"teacher_disagreement_score":0.01025273,"about_ca_system_score_codex":0.00045203735,"about_ca_system_score_gemma":0.00020213664,"threshold_uncertainty_score":0.47779697},"labels":[],"label_agreement":null},{"id":"W2059028235","doi":"10.1046/j.1365-2141.2003.04082.x","title":"Complete remission of tumour with interleukin 2 therapy in a patient with non‐Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T‐cell bone marrow lymphocytosis","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Bone marrow; Lymphoma; Lymphocytosis; Pathology","score_opus":0.009166110864208193,"score_gpt":0.2111154780458491,"score_spread":0.20194936718164092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059028235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935995,0.004835842,0.00004663755,0.00047016804,0.000069435504,0.0005323648,0.00009302495,0.00001417948,0.000338888],"genre_scores_gemma":[0.99663305,0.0009800742,0.0017107929,0.00045888408,0.000016368129,0.000033342076,0.000063626416,0.00006610652,0.0000377307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969289,0.00033586737,0.0010994911,0.00038945494,0.00068261195,0.00056368223],"domain_scores_gemma":[0.9977143,0.00019220663,0.0010759371,0.00021939246,0.0004815962,0.00031658745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033835924,0.00040749204,0.0017192422,0.00035834324,0.00008699569,0.000030249534,0.00014296372,0.00019673858,0.0001103994],"category_scores_gemma":[0.000049047037,0.00029116936,0.00020640054,0.00037751716,0.00024037992,0.00011914738,0.000015870199,0.00021158847,0.000002106114],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02209809,0.010441438,0.34820208,0.00029873784,0.0017412108,0.549883,0.0016915356,0.00007414257,0.052771155,0.000045966983,0.00058579934,0.012166842],"study_design_scores_gemma":[0.04902805,0.015203626,0.19575024,0.006636464,0.00050033006,0.6641863,0.0005064045,0.000025820176,0.06742276,0.000019407344,0.00028047338,0.00044012448],"about_ca_topic_score_codex":0.0006395673,"about_ca_topic_score_gemma":0.0011741059,"teacher_disagreement_score":0.15245184,"about_ca_system_score_codex":0.0005464117,"about_ca_system_score_gemma":0.0011706799,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W2059078891","doi":"10.1097/pap.0b013e3182169948","title":"MYC and Aggressive B-cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Follicular lymphoma; Cancer research; Aggressive lymphoma; Gene rearrangement; B cell; Medicine; Lymphoblastic lymphoma; Oncogene; Leukemia; Pathology; Biology; Cell cycle; Gene; Immunology; Cancer; T cell; Internal medicine; Genetics; Antibody","score_opus":0.024512183655248546,"score_gpt":0.341723045082337,"score_spread":0.31721086142708843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059078891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049637863,0.98507863,0.0000024092985,0.000010248262,0.00033727987,0.00067765324,0.000036692883,0.000033893648,0.013326796],"genre_scores_gemma":[0.00055491115,0.9978992,0.0006523777,0.00014563017,0.0000694523,0.000311448,0.00008107567,0.000045746976,0.00024020705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820065,0.00014264951,0.0005289304,0.00067016797,0.00008052194,0.0003770502],"domain_scores_gemma":[0.99870896,0.00019444221,0.0005054888,0.0004348224,0.000025100218,0.0001311884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000114940325,0.00044687843,0.0020379955,0.0003260579,0.00003451012,0.000006140767,0.0001314169,0.0004042897,0.00006705216],"category_scores_gemma":[0.00006555332,0.000325442,0.00022945362,0.0001836274,0.0002361019,0.00008303123,0.00011441444,0.00020927463,0.00013325241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001626917,0.00028719066,0.0011313634,0.0038294583,0.000041249008,0.0072873184,0.00006564807,1.7485135e-8,1.1633462e-7,0.0011861733,0.000065808716,0.9860894],"study_design_scores_gemma":[0.0020840303,0.00021155199,0.00020761245,0.0062191654,0.00066665484,0.005656636,0.000020499117,0.0000010234395,0.0000059704275,0.0006059195,0.9840422,0.00027871627],"about_ca_topic_score_codex":0.00001597335,"about_ca_topic_score_gemma":0.000020566746,"teacher_disagreement_score":0.9858107,"about_ca_system_score_codex":0.000289011,"about_ca_system_score_gemma":0.00025312853,"threshold_uncertainty_score":0.9999198},"labels":[],"label_agreement":null},{"id":"W2059294763","doi":"10.1001/archotol.132.7.797","title":"Progressive Transformation of Germinal Centers","year":2006,"lang":"en","type":"article","venue":"Archives of Otolaryngology - Head and Neck Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Transformation (genetics); Germinal center; Biology; Genetics","score_opus":0.01222090257966528,"score_gpt":0.254540275841256,"score_spread":0.2423193732615907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059294763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949529,0.0013525881,0.000013890201,0.00043694713,0.00004395414,0.00023316943,0.000018359147,0.0000126409,0.002935553],"genre_scores_gemma":[0.99916387,0.00024729568,0.00034920205,0.00005514902,0.000028128145,0.00002432285,0.000101255966,0.000006609451,0.000024149347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924344,0.00004003508,0.00033552136,0.00013229504,0.00008366355,0.0001650594],"domain_scores_gemma":[0.9993684,0.00032599852,0.0001258755,0.00010657324,0.000018139921,0.000055004275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051604056,0.00010248246,0.00040785313,0.00016208705,0.000032250595,0.000002065178,0.00002322924,0.000045968292,0.00001935662],"category_scores_gemma":[0.000012595935,0.00008025035,0.00014633485,0.00005607635,0.00023831218,0.000059141792,0.000011678032,0.000043487544,0.0000014039471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052563637,0.00071434805,0.98149246,0.0003493606,0.000083976905,0.00018471954,0.0003164104,5.2999576e-7,0.004192851,0.0008605142,0.000107959764,0.011171235],"study_design_scores_gemma":[0.0012457535,0.0003006246,0.9791301,0.0003338077,0.000073729796,0.00039471692,0.000019339046,0.000043495467,0.017791916,0.00027300607,0.00033486815,0.000058664114],"about_ca_topic_score_codex":0.00013222588,"about_ca_topic_score_gemma":0.000007424426,"teacher_disagreement_score":0.013599065,"about_ca_system_score_codex":0.0000058349574,"about_ca_system_score_gemma":0.000055490946,"threshold_uncertainty_score":0.32725143},"labels":[],"label_agreement":null},{"id":"W2059334385","doi":"10.1182/asheducation-2008.1.280","title":"Prognosis and Primary Therapy in Peripheral T-Cell Lymphomas","year":2008,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral; Oncology; Lymphoma; Internal medicine; Cancer research; Immunology","score_opus":0.020454309139030805,"score_gpt":0.24426603371333347,"score_spread":0.22381172457430265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059334385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811764,0.008994424,0.0000012035412,0.0010260333,0.000042703665,0.00032866094,0.0000010062629,0.000035608056,0.008394004],"genre_scores_gemma":[0.9941215,0.0036772895,0.0006928388,0.0010645698,0.000021365337,0.0001435237,0.000010385867,0.000013171528,0.0002553776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992862,0.000029286071,0.00016947713,0.00022445324,0.000081730584,0.00020890163],"domain_scores_gemma":[0.999686,0.000049315404,0.000032916643,0.00013434922,0.000019159606,0.000078261335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003402812,0.00012118901,0.00035297775,0.00006822921,0.000043388347,0.0000032799646,0.000027926739,0.000093315524,0.000099628385],"category_scores_gemma":[0.0000067372907,0.00009169752,0.000045265202,0.00008481073,0.00010278367,0.000030596908,0.00002051101,0.000041824078,0.000022063437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000126165,0.0010745917,0.99074805,0.000046614157,0.000026800733,0.0012840052,0.00042974792,8.761824e-8,0.000431089,0.00039152018,0.0011681768,0.0042731287],"study_design_scores_gemma":[0.0087117925,0.000566613,0.9657498,0.00003485891,0.000016074453,0.005058391,0.000044042223,0.000016591284,0.014172227,0.00007642278,0.005438437,0.000114753566],"about_ca_topic_score_codex":0.00007088561,"about_ca_topic_score_gemma":0.0000105268155,"teacher_disagreement_score":0.024998277,"about_ca_system_score_codex":0.00008329381,"about_ca_system_score_gemma":0.000102396,"threshold_uncertainty_score":0.37393165},"labels":[],"label_agreement":null},{"id":"W2059410730","doi":"10.1073/pnas.0510441103","title":"Mutation and genomic deletion status of <i>ataxia telangiectasia mutated</i> ( <i>ATM</i> ) and <i>p53</i> confer specific gene expression profiles in mantle cell lymphoma","year":2006,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; University of Southern California; V Foundation for Cancer Research; Lymphoma Research Foundation","keywords":"Biology; Gene; Genetics; Allele; Mantle cell lymphoma; Ataxia-telangiectasia; Phenotype; Mutation; Cancer research; Cyclin D1; Point mutation; Molecular biology; Cell cycle; Lymphoma; DNA damage; DNA; Immunology","score_opus":0.018199048258742304,"score_gpt":0.25505738837106556,"score_spread":0.23685834011232326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059410730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509287,0.0020663529,7.1865463e-7,0.00031970098,0.000008811451,0.0003435788,0.00004285509,0.0000062734425,0.0021188543],"genre_scores_gemma":[0.9972242,0.00056461804,0.0020546182,0.0000618791,0.00002982478,0.000017941982,0.0000038523012,0.0000051605457,0.000037892605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987338,0.0000070529836,0.00034311836,0.00023875832,0.00052052474,0.00015674156],"domain_scores_gemma":[0.9994192,0.00006711013,0.00033228885,0.000009884153,0.00013296831,0.0000385217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031417323,0.000103814375,0.0001984077,0.00016238383,0.000071618146,0.00001477,0.000092849106,0.00007128731,0.0000051599613],"category_scores_gemma":[0.000031878095,0.00006921057,0.000034510787,0.00028760813,0.00040391798,0.00019906764,0.00005743932,0.00004294547,4.8955496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067332185,0.00024524823,0.15436466,0.00012980432,0.000006044497,1.955304e-7,0.0001724931,0.000017304468,0.84235084,0.0014632703,0.00042404694,0.000758764],"study_design_scores_gemma":[0.0011108951,0.000065841195,0.4060042,0.00010190016,0.00001469749,0.000027292012,0.000109634355,0.000115825955,0.5906869,0.0015857689,0.0001351699,0.000041884967],"about_ca_topic_score_codex":0.00008309203,"about_ca_topic_score_gemma":3.6951027e-7,"teacher_disagreement_score":0.25166395,"about_ca_system_score_codex":0.00008229773,"about_ca_system_score_gemma":0.000046852263,"threshold_uncertainty_score":0.2822325},"labels":[],"label_agreement":null},{"id":"W2059472490","doi":"10.1503/cmaj.070628","title":"Superior vena cava syndrome and telangiectasia in a man with lymphoma","year":2007,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Supine position; Surgery; Telangiectasia","score_opus":0.00405108817964968,"score_gpt":0.21690239710211953,"score_spread":0.21285130892246984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059472490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858479,0.00046863602,0.000004024614,0.011491303,0.00011268047,0.00012219194,0.0000065650825,0.00000886199,0.0019378389],"genre_scores_gemma":[0.995363,0.000099021905,0.000115507406,0.004027026,0.0002033241,0.0000050469425,0.0000067365377,0.00001232658,0.00016799835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984428,0.000034903045,0.00025919764,0.00013063372,0.00069059833,0.0004418399],"domain_scores_gemma":[0.9981279,0.000098757104,0.00006972295,0.0000651536,0.00008564588,0.0015528494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081188336,0.00010507056,0.00023527832,0.00023597392,0.00009975885,0.000039127328,0.000047831978,0.00020328842,0.0005537466],"category_scores_gemma":[0.00026413277,0.00007873692,0.00003919356,0.00018541614,0.00003217846,0.00006107668,0.000006061281,0.00021022609,0.000041081683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029029496,0.00008063706,0.92789084,0.000007308831,0.00009748474,0.02470365,0.00026776225,1.1137659e-7,0.0000026582131,0.00004814173,0.0024291726,0.04444323],"study_design_scores_gemma":[0.004030401,0.00024130438,0.9451141,0.00017715724,0.000041645544,0.016219506,0.00035191883,0.000011684143,0.000014446184,0.000012501357,0.033700563,0.00008479258],"about_ca_topic_score_codex":0.00604921,"about_ca_topic_score_gemma":0.07328386,"teacher_disagreement_score":0.06723464,"about_ca_system_score_codex":0.002156507,"about_ca_system_score_gemma":0.0017467825,"threshold_uncertainty_score":0.9436263},"labels":[],"label_agreement":null},{"id":"W2059989231","doi":"10.1007/s11605-011-1572-0","title":"Primary Colorectal Lymphoma—Clinical Outcomes in a Population-Based Series","year":2011,"lang":"en","type":"article","venue":"Journal of Gastrointestinal Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Rectum; Internal medicine; Lymphoma; Colorectal cancer; Population; Gastroenterology; Surgery; Oncology; Cancer","score_opus":0.046413600217412386,"score_gpt":0.28877450224571943,"score_spread":0.24236090202830704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059989231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868083,0.00006410428,0.00003334505,0.0004814692,0.00025896134,0.000114684284,0.000004946497,0.000016762377,0.00034487553],"genre_scores_gemma":[0.98773056,0.000015652811,0.011695102,0.0003536684,0.00013201976,0.0000061077512,0.000011424436,0.000017641043,0.000037816222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979393,0.00010926324,0.0011863791,0.0001506716,0.00035109476,0.00026331877],"domain_scores_gemma":[0.997844,0.0009988272,0.00058726006,0.00013349674,0.00019568596,0.00024073668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075534725,0.00018307225,0.00088660215,0.00031232415,0.00003122231,0.000013534875,0.00006770552,0.000047053625,0.00011909323],"category_scores_gemma":[0.0011159908,0.00013021375,0.0005820853,0.00017095805,0.000067268586,0.00017639942,0.000020455906,0.00013695666,0.000011349483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025456357,0.0024572073,0.9854466,0.000029856094,0.00006871121,0.004709213,0.000021142823,0.000002360794,0.00003733676,0.000012808115,0.00040041556,0.0042687324],"study_design_scores_gemma":[0.0024203938,0.0012893163,0.98708355,0.00063366594,0.000096025775,0.008152349,0.000027460217,0.000009154305,0.0001012306,0.000048847385,0.000046970454,0.00009102105],"about_ca_topic_score_codex":0.00017515275,"about_ca_topic_score_gemma":0.00003642483,"teacher_disagreement_score":0.011661757,"about_ca_system_score_codex":0.00030930294,"about_ca_system_score_gemma":0.0006649421,"threshold_uncertainty_score":0.53099626},"labels":[],"label_agreement":null},{"id":"W2060145608","doi":"10.1038/sj.thj.6200441","title":"Molecular heterogeneity of diffuse large B-cell lymphoma","year":2004,"lang":"en","type":"review","venue":"The Hematology Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine","score_opus":0.02882496758912056,"score_gpt":0.32832860431236005,"score_spread":0.2995036367232395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060145608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010532972,0.9880407,0.000036307945,0.00015750903,0.00030341995,0.00049017987,0.000025161426,0.000017530832,0.00039626053],"genre_scores_gemma":[0.01171072,0.98778003,0.00014306694,0.0001263527,0.00008208057,0.000043833825,0.00002323692,0.000054268276,0.00003641239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977944,0.00028695646,0.0009134188,0.00025410406,0.00030767513,0.00044344674],"domain_scores_gemma":[0.99796206,0.00021614802,0.0008664573,0.00065005163,0.00009271095,0.00021258126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000334408,0.00043627515,0.0024978989,0.00016628734,0.00014118309,0.000017052675,0.0003259419,0.00037926508,0.00005867043],"category_scores_gemma":[0.00005884189,0.00022362005,0.0013657635,0.00016585563,0.00014370144,0.00002353146,0.00011886781,0.00031996123,0.00012404157],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022037751,0.051494088,0.0014737769,0.06193865,0.010846987,0.030078592,0.0004459139,0.00000156867,0.000010722799,0.0148625225,0.0026466644,0.8259801],"study_design_scores_gemma":[0.02376624,0.000576266,0.00010019004,0.027607538,0.011588588,0.16564994,0.000033734195,0.0000015914811,0.001430683,0.00039844014,0.7683898,0.0004569451],"about_ca_topic_score_codex":0.000005706183,"about_ca_topic_score_gemma":0.000001448813,"teacher_disagreement_score":0.8255232,"about_ca_system_score_codex":0.00030749806,"about_ca_system_score_gemma":0.0008995824,"threshold_uncertainty_score":0.9118961},"labels":[],"label_agreement":null},{"id":"W2060594675","doi":"10.1002/cncr.21587","title":"Similar response rates and superior early progression‐free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma","year":2005,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Blood Services; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Carmustine; Melphalan; Gemcitabine; Salvage therapy; Cytarabine; Autologous stem-cell transplantation; Internal medicine; Hematopoietic stem cell transplantation; Surgery; Chemotherapy; Dexamethasone; Oncology; Transplantation; Urology","score_opus":0.028639028277932858,"score_gpt":0.31112831821002407,"score_spread":0.2824892899320912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060594675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019785,0.01408793,0.000112454305,0.0019283876,0.00007358586,0.003180874,0.00030204983,0.00009317057,0.000023714008],"genre_scores_gemma":[0.98177207,0.006445523,0.009640502,0.00049042236,0.000117489406,0.0012417668,0.00004950611,0.00008857563,0.00015417268],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99785644,0.00020357549,0.0003791656,0.0007457847,0.00036484317,0.00045019662],"domain_scores_gemma":[0.9981289,0.0007894803,0.0001700515,0.0003672395,0.00018536935,0.00035897776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035316736,0.0005070775,0.00075075624,0.0001633967,0.0002192203,0.000101795245,0.00009968335,0.00014176102,0.000025784517],"category_scores_gemma":[0.000022671844,0.00030002327,0.000048934842,0.0002291786,0.00018127906,0.00019099978,0.000022184095,0.00010407171,7.782964e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16288565,0.0008677788,0.30199182,0.0003684613,0.0004200654,0.00029293622,0.008010314,0.000023437766,0.014861547,0.000010888753,0.0003737361,0.50989336],"study_design_scores_gemma":[0.03395537,0.010112829,0.91812485,0.0006137734,0.00028764873,0.00015288101,0.00039748175,0.0001699578,0.03143096,0.0000022635156,0.0042809136,0.0004710518],"about_ca_topic_score_codex":0.00018946898,"about_ca_topic_score_gemma":0.00086752145,"teacher_disagreement_score":0.61613303,"about_ca_system_score_codex":0.00020392875,"about_ca_system_score_gemma":0.0003716082,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W2060670573","doi":"10.1111/j.1365-2141.2007.06924.x","title":"Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Generalitat de Catalunya","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Comparative genomic hybridization; Biology; Chromosomal translocation; Cancer research; Fluorescence in situ hybridization; Lymphoma; Molecular biology; Gene; Chromosome; Genetics; Pathology; Medicine; Immunology","score_opus":0.010674375375968518,"score_gpt":0.2332291182757592,"score_spread":0.2225547428997907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060670573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248905,0.01619316,0.00012752354,0.00014690576,0.00015165396,0.0004577333,0.00003580222,0.000008875602,0.0003893035],"genre_scores_gemma":[0.9949216,0.0037048282,0.0010293451,0.0001403631,0.0000658811,0.000031763077,0.0000097677785,0.000021587635,0.00007486371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982494,0.00020322221,0.0007930487,0.00023661395,0.00018547024,0.00033220486],"domain_scores_gemma":[0.9988324,0.00030372088,0.0003936255,0.00010690343,0.0001697177,0.00019360155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012881642,0.00018342272,0.00091311784,0.00021204709,0.00014170667,0.000021231006,0.00007194783,0.0001241442,0.000027887216],"category_scores_gemma":[0.00012497265,0.00017309719,0.000117834796,0.00011210088,0.00009649357,0.00007470625,0.00004236065,0.00017482882,0.000009169828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000366089,0.0024852154,0.78405035,0.00042689388,0.00045077474,0.20210536,0.0023401119,0.000036208927,0.0049340515,0.00037600298,0.0008424032,0.0015865747],"study_design_scores_gemma":[0.0073940214,0.00054603204,0.55170745,0.0009558051,0.00018787672,0.43533564,0.000342283,0.00011190356,0.0031421117,0.00014201074,0.000014153004,0.00012069658],"about_ca_topic_score_codex":0.00008858528,"about_ca_topic_score_gemma":0.00016984061,"teacher_disagreement_score":0.23323028,"about_ca_system_score_codex":0.00033869885,"about_ca_system_score_gemma":0.0002908534,"threshold_uncertainty_score":0.7058698},"labels":[],"label_agreement":null},{"id":"W2061337936","doi":"10.1200/jco.2013.54.2456","title":"Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Takeda Oncology","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Neutropenia; Vincristine; CHOP; Anaplastic large-cell lymphoma; Febrile neutropenia; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Surgery; Cyclophosphamide; Lymphoma; Chemotherapy; CD30","score_opus":0.060078820617117196,"score_gpt":0.4065655712450807,"score_spread":0.3464867506279635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061337936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964136,0.0002364648,0.000012341109,0.0012164522,0.0001750409,0.0007673593,0.000027997905,0.0000032808846,0.0011474842],"genre_scores_gemma":[0.99828076,0.00017891472,0.000798608,0.00031135514,0.00031168532,0.000019672347,0.000016145466,0.000015327414,0.00006754078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949279,0.000991939,0.0030031046,0.00024706783,0.0005937149,0.00023629495],"domain_scores_gemma":[0.99443686,0.0023545867,0.0021920172,0.00039740436,0.00042063525,0.00019850578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019864736,0.00022472348,0.002051708,0.00012574709,0.000027299795,0.000005683609,0.00019184907,0.0001753654,0.000047229958],"category_scores_gemma":[0.0008500417,0.00010626571,0.00043323755,0.0001382,0.0001869626,0.000060913895,0.000026794165,0.000195407,0.0000039368297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035321098,0.1891557,0.64633083,0.000020992962,0.00056072185,0.0003062407,0.0026872223,0.00012722365,0.000005263117,0.000006719026,0.0003775522,0.12510042],"study_design_scores_gemma":[0.23514998,0.23048395,0.52565926,0.000086589396,0.00090150686,0.000027872436,0.0010134168,0.00038236452,0.00008326435,0.000015641013,0.006122345,0.000073832896],"about_ca_topic_score_codex":0.00020662302,"about_ca_topic_score_gemma":0.0001336435,"teacher_disagreement_score":0.19982888,"about_ca_system_score_codex":0.00034258876,"about_ca_system_score_gemma":0.0008326747,"threshold_uncertainty_score":0.433339},"labels":[],"label_agreement":null},{"id":"W2061918976","doi":"10.1182/blood-2006-11-051672","title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Epidemiology; Medicine; Working Formulation; Pathology; Etiology; Oncology; Non-Hodgkin's lymphoma","score_opus":0.14767376877730368,"score_gpt":0.3773571086854142,"score_spread":0.22968333990811055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061918976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999876,0.0012221911,0.0008119713,0.005248476,0.00048773593,0.0010795407,0.00005628123,0.000019832429,0.0010752338],"genre_scores_gemma":[0.99533695,0.00015942981,0.003223179,0.0007129244,0.0002691218,0.00012583358,0.000090952104,0.00001656262,0.000065036926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997325,0.0006212694,0.00095139525,0.0004116023,0.0002784036,0.00041232124],"domain_scores_gemma":[0.98714143,0.011294363,0.0005566711,0.00063168764,0.00030648505,0.000069363814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051214686,0.0001587056,0.00053965085,0.00009476172,0.0001312211,0.00000514487,0.00045859267,0.00022262646,0.00002880272],"category_scores_gemma":[0.005032457,0.000081996106,0.0002861881,0.00021869213,0.00063925504,0.000025510662,0.00014074905,0.00009554188,0.0000062004005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058840733,0.001553133,0.93170595,0.000022085222,0.00029257056,0.000012194715,0.00027203225,0.0000013115613,0.027670944,0.014422345,0.0006313398,0.022827685],"study_design_scores_gemma":[0.006643882,0.0005470345,0.94673526,0.00017808858,0.00022858586,0.00013863292,0.00048315624,0.0001730991,0.037863426,0.004870737,0.0020646714,0.00007339564],"about_ca_topic_score_codex":0.0004249816,"about_ca_topic_score_gemma":0.00018045037,"teacher_disagreement_score":0.02275429,"about_ca_system_score_codex":0.00019325338,"about_ca_system_score_gemma":0.00019761363,"threshold_uncertainty_score":0.60246843},"labels":[],"label_agreement":null},{"id":"W2062205146","doi":"10.4021//jmc.v4i1.345","title":"Primary Hepatic Lymphoma: A Diagnosis to Remember","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Liver biopsy; Jaundice; Liver function; Lymphoma; Liver function tests; Biopsy; Hepatic function; Radiology; Internal medicine; Gastroenterology","score_opus":0.03267632500026138,"score_gpt":0.3188295173991295,"score_spread":0.28615319239886816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062205146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755455,0.0072424826,0.000022971895,0.015058223,0.0005988783,0.00015090725,0.0000034658078,0.000012530399,0.0013650449],"genre_scores_gemma":[0.9882711,0.0013567918,0.0009283692,0.007793694,0.0014958784,0.00002816105,0.0000027757296,0.000016379216,0.00010682531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974206,0.0000631211,0.00052924245,0.00009543872,0.001568849,0.00032274355],"domain_scores_gemma":[0.9974224,0.00067291915,0.0001686194,0.00016999169,0.00013479822,0.0014312927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076474407,0.00014156218,0.00049216894,0.00014252737,0.000042506963,0.000014617008,0.00011454913,0.00011518826,0.001441527],"category_scores_gemma":[0.0022059751,0.00008794692,0.00023280615,0.00017415531,0.0000457747,0.00012681632,0.00006431073,0.00010609099,0.00013103684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029025626,0.004333049,0.6959403,0.00011301819,0.0002612399,0.0075257034,0.00030524575,3.005184e-7,0.000027453834,0.0001080088,0.11423,0.1768654],"study_design_scores_gemma":[0.00545118,0.0016799633,0.73946816,0.0010488312,0.00065620575,0.021400023,0.00013725802,0.0000038398553,0.0020622627,0.000017784569,0.22792497,0.0001495162],"about_ca_topic_score_codex":0.00006320686,"about_ca_topic_score_gemma":0.000007719702,"teacher_disagreement_score":0.17671588,"about_ca_system_score_codex":0.00035888838,"about_ca_system_score_gemma":0.00039356036,"threshold_uncertainty_score":0.9994713},"labels":[],"label_agreement":null},{"id":"W2062299904","doi":"10.1007/s11899-011-0100-3","title":"Update: Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Hematology; Peripheral T-cell lymphoma; Oncology; Internal medicine; Disease; T-cell lymphoma; Peripheral; T cell; Pathology; Immunology; Immune system","score_opus":0.07608571854870042,"score_gpt":0.3457742507995178,"score_spread":0.26968853225081735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062299904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009275743,0.97629285,0.000008626071,0.000015730842,0.002580801,0.002452415,0.000029295672,0.000315916,0.018211603],"genre_scores_gemma":[0.00059948105,0.99533725,0.00030404457,0.00004482912,0.00024342065,0.00129809,0.00090516324,0.00011981102,0.0011478981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994744,0.00014644723,0.002215964,0.001562693,0.00046555194,0.0008653309],"domain_scores_gemma":[0.9956842,0.000066189976,0.0017895317,0.0018054881,0.00015494683,0.0004996114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026493537,0.0012684856,0.004700146,0.0002628756,0.00014240634,0.000056448323,0.0002366135,0.0006741556,0.0021782727],"category_scores_gemma":[0.00008434121,0.0008322091,0.0018907423,0.00039928462,0.00013870854,0.00008526207,0.0002335022,0.00036328944,0.00066151866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011411324,0.0027497069,0.003479491,0.053045157,0.00036423147,0.020453459,0.000038024693,1.1479527e-8,9.6887e-8,0.0014845663,0.016278625,0.9020952],"study_design_scores_gemma":[0.00061499764,0.0001433238,0.000040776777,0.0257851,0.0034333328,0.035320584,0.0000049307946,2.6468845e-7,0.00002704867,0.00031866264,0.93358976,0.0007212259],"about_ca_topic_score_codex":0.000014856072,"about_ca_topic_score_gemma":0.0000010217565,"teacher_disagreement_score":0.91731113,"about_ca_system_score_codex":0.00058689754,"about_ca_system_score_gemma":0.0012379063,"threshold_uncertainty_score":0.9994129},"labels":[],"label_agreement":null},{"id":"W2062625525","doi":"10.1111/j.1365-2559.2007.02580.x","title":"Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence <i>in situ</i> hybridization (FISH) study","year":2007,"lang":"en","type":"article","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trisomy; MALT lymphoma; Pathology; Fluorescence in situ hybridization; Biology; Thyroid; Aneuploidy; Lymphoma; Medicine; Chromosome; Genetics; Gene","score_opus":0.014657940585167284,"score_gpt":0.24705019099949974,"score_spread":0.23239225041433245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062625525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700886,0.0012710233,0.00005567493,0.00027704187,0.00015770529,0.00068491325,0.000024086881,0.000035461624,0.00048525774],"genre_scores_gemma":[0.9988473,0.00031840845,0.00016190947,0.0003228565,0.00005003894,0.00008480966,0.000057065008,0.00002075231,0.0001368633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860066,0.00013499541,0.00039412087,0.00042696827,0.00012074601,0.00032249908],"domain_scores_gemma":[0.99933225,0.00016961338,0.000074764095,0.0002881184,0.00002797042,0.00010729293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021035282,0.00021857265,0.0004396289,0.00022559769,0.00005821965,0.000009817977,0.00007018292,0.00009376773,0.000035369412],"category_scores_gemma":[0.000051932057,0.00015434442,0.000038732753,0.00014521253,0.00010629176,0.000042126354,0.00006633034,0.000087001405,0.000009364513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002037058,0.0019826014,0.9702039,0.000018691462,0.0000063895077,0.0013927106,0.0057928767,0.0000012367714,0.01329756,0.00006687986,0.000058054935,0.0069754375],"study_design_scores_gemma":[0.0043287547,0.0005676456,0.9821577,0.000075328186,0.000053482625,0.00018539824,0.0014371264,0.000013184399,0.0106525,0.00009903472,0.00028942214,0.00014040736],"about_ca_topic_score_codex":0.00058538845,"about_ca_topic_score_gemma":0.0056017493,"teacher_disagreement_score":0.01195386,"about_ca_system_score_codex":0.00040801064,"about_ca_system_score_gemma":0.00006572127,"threshold_uncertainty_score":0.6293983},"labels":[],"label_agreement":null},{"id":"W2063207072","doi":"10.3109/10428194.2012.742522","title":"Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; Cancer research; Cytokine; Immunohistochemistry; Interleukin 9; Interleukin; Receptor; Biopsy; Pathology; Biology; Medicine; Immunology; Internal medicine","score_opus":0.008604430355567336,"score_gpt":0.23427686687463076,"score_spread":0.22567243651906344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063207072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900369,0.006322302,0.000024110017,0.00025492697,0.0004202802,0.0015900681,0.00026886328,0.00017972304,0.0009028442],"genre_scores_gemma":[0.99458545,0.0012285692,0.0005372538,0.0013742254,0.00027424356,0.0005045226,0.00037858696,0.00019393189,0.0009232188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941463,0.00026304717,0.0013453558,0.0012967272,0.0012993668,0.0016492336],"domain_scores_gemma":[0.99528885,0.00045019155,0.0011374723,0.0012724709,0.00029150856,0.0015594924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044673507,0.0012136891,0.00184061,0.00060046953,0.0002819738,0.00009917483,0.0004073321,0.0006336886,0.0002144439],"category_scores_gemma":[0.00022678162,0.0009319441,0.0005275769,0.0009097323,0.0006070035,0.0006507976,0.00032078245,0.00013575194,0.0000800305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010089124,0.00946301,0.7653259,0.0012541896,0.0018632489,0.0051255035,0.012722555,0.00007643226,0.034099158,0.0005163867,0.014678772,0.14478573],"study_design_scores_gemma":[0.04772152,0.0008834932,0.7252565,0.00472586,0.0010268529,0.0005472401,0.0013742298,0.0009458505,0.20597728,0.000064120104,0.0101139285,0.001363152],"about_ca_topic_score_codex":0.001198948,"about_ca_topic_score_gemma":0.000040862407,"teacher_disagreement_score":0.17187811,"about_ca_system_score_codex":0.010437863,"about_ca_system_score_gemma":0.0029549147,"threshold_uncertainty_score":0.9993131},"labels":[],"label_agreement":null},{"id":"W2063397227","doi":"10.1016/j.jpedsurg.2006.01.018","title":"Assessment of residual posttreatment masses in Hodgkin's disease and the need for biopsy in children","year":2006,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Biopsy; Radiology; Gallium 67 scan; Nuclear medicine; Computed tomographic; Computed tomography","score_opus":0.012271495166778851,"score_gpt":0.2743869928510295,"score_spread":0.2621154976842507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063397227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136496,0.006322637,0.0000058398728,0.0016935184,0.00010231866,0.00042835975,0.00002874109,0.0000024814033,0.000051117982],"genre_scores_gemma":[0.99643815,0.0021251608,0.00050436717,0.00004855703,0.00080906996,0.000031778665,0.000017779621,0.000010247062,0.000014922645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866897,0.00008727167,0.0006832122,0.000112211164,0.0002801322,0.0001681945],"domain_scores_gemma":[0.9979936,0.0013094741,0.0004165748,0.000115933275,0.0000812013,0.00008320403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077291194,0.00012459628,0.00052982004,0.00046201542,0.00002211896,0.0000139658005,0.000038736074,0.0000393718,0.000009265767],"category_scores_gemma":[0.00016517607,0.0000708151,0.0002118241,0.00025815502,0.000041510015,0.00006414656,0.000017232738,0.000067885456,1.8532471e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007143827,0.001155622,0.99476975,0.000039928633,0.0001006097,0.00024098794,0.000017665592,0.000026722591,0.000009951807,0.00011968515,0.0020482298,0.00075643696],"study_design_scores_gemma":[0.008121478,0.00013566499,0.99059427,0.000052563373,0.0005936331,0.000088957895,0.00004103477,0.000014412846,0.00003681731,0.00024111256,0.000020285432,0.00005979244],"about_ca_topic_score_codex":0.0003160666,"about_ca_topic_score_gemma":0.00000889628,"teacher_disagreement_score":0.0074070953,"about_ca_system_score_codex":0.00015510416,"about_ca_system_score_gemma":0.0004497995,"threshold_uncertainty_score":0.2887756},"labels":[],"label_agreement":null},{"id":"W2063691874","doi":"10.1182/blood-2013-09-524108","title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":953,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Rituximab; International Prognostic Index; Diffuse large B-cell lymphoma; Medicine; Internal medicine; Lymphoma; Oncology","score_opus":0.0047602183113819715,"score_gpt":0.222502393562567,"score_spread":0.21774217525118506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063691874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967666,0.000045590303,0.000029248806,0.00027793893,0.00004683879,0.001960547,0.000057866,0.00003724509,0.0007781098],"genre_scores_gemma":[0.9971492,0.000011433733,0.00029368926,0.0004660735,0.00006916648,0.001472165,0.00044445216,0.000024024477,0.00006973897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989384,0.00003364592,0.00019941309,0.00027731727,0.0002768979,0.000274339],"domain_scores_gemma":[0.9992958,0.00011017101,0.0000758344,0.00027842587,0.00015418134,0.00008560363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055627374,0.00017749827,0.00021344157,0.000081121776,0.00005902942,0.000059423342,0.00014302497,0.000064211315,0.000062627565],"category_scores_gemma":[0.000036471076,0.000099895755,0.00005671456,0.00011991067,0.000024800787,0.00013712254,0.000017016957,0.000042483614,0.000043616015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020279567,0.10893485,0.8869172,0.000021822752,0.00011559437,0.000020848835,0.00041072385,2.2868574e-7,0.00008884571,0.000032874585,0.00015407577,0.0031001908],"study_design_scores_gemma":[0.12780161,0.0014734721,0.86701494,0.00006369475,0.00018327952,0.0000076628485,0.00008586376,0.00015965886,0.0028773407,0.000026125097,0.00019125249,0.00011510225],"about_ca_topic_score_codex":0.00013537533,"about_ca_topic_score_gemma":0.00007130669,"teacher_disagreement_score":0.12759882,"about_ca_system_score_codex":0.000066955035,"about_ca_system_score_gemma":0.000051414296,"threshold_uncertainty_score":0.4073631},"labels":[],"label_agreement":null},{"id":"W2063882823","doi":"10.1182/blood-2010-01-264275","title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Biology; Genome; Marginal zone; Gene expression profiling; Lymphoma; Immunology; Computational biology; Cancer research; Genetics; Gene; Gene expression; B cell; Antibody","score_opus":0.05815297952425725,"score_gpt":0.33543914595410745,"score_spread":0.2772861664298502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063882823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975059,0.00016501822,0.0000070216606,0.00057220546,0.00014483878,0.000524043,0.0000274753,0.00004103968,0.0010124615],"genre_scores_gemma":[0.9983632,0.0000752576,0.0008891593,0.00013176037,0.0002279056,0.00004334514,0.000041052288,0.00002956209,0.00019875081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985532,0.00006937223,0.0004472713,0.0003208825,0.00033707128,0.00027219698],"domain_scores_gemma":[0.9983374,0.00043133207,0.00017502018,0.0007541359,0.000106227606,0.00019590219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046586528,0.00020917824,0.00043021294,0.00007530329,0.000121308476,0.000035034704,0.00015458716,0.00010337464,0.00025492074],"category_scores_gemma":[0.00010348855,0.000101240876,0.00021381724,0.00014270702,0.0001899423,0.00006179521,0.000037110196,0.00019797959,0.00007402802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044169676,0.0040584425,0.98757035,0.000018879218,0.00030020167,0.00015528382,0.000086445085,0.0000012161837,0.005936843,0.0007092324,0.0000655009,0.0006559376],"study_design_scores_gemma":[0.0048308927,0.0016825441,0.9634771,0.000048195467,0.00035927325,0.00010319663,0.00012234392,0.000003838541,0.028847447,0.000043740638,0.0003662695,0.00011518146],"about_ca_topic_score_codex":0.00004915673,"about_ca_topic_score_gemma":0.000061678176,"teacher_disagreement_score":0.024093244,"about_ca_system_score_codex":0.00003358463,"about_ca_system_score_gemma":0.00018794814,"threshold_uncertainty_score":0.41284832},"labels":[],"label_agreement":null},{"id":"W2064378168","doi":"10.1016/j.bbmt.2015.02.005","title":"Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Allos Therapeutics; National Center for Advancing Translational Sciences; Actinium Pharmaceuticals; European Hematology Association; U.S. Public Health Service; Office of Naval Research; Health Resources and Services Administration; National Institute of Allergy and Infectious Diseases; Amgen","keywords":"Medicine; Etoposide; Regimen; Carmustine; Internal medicine; Total body irradiation; Busulfan; Transplantation; Cyclophosphamide; Melphalan; Oncology; Surgery; Hazard ratio; Gastroenterology; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.012633301246335294,"score_gpt":0.2576713998864688,"score_spread":0.2450380986401335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064378168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985748,0.00014152798,0.00023429515,0.00006921118,0.000025866553,0.00063719414,0.00020415205,0.00001859662,0.000094346455],"genre_scores_gemma":[0.997242,0.00036449448,0.0012747356,0.000032813405,0.000007695101,0.000057301335,0.0010002094,0.000013249133,0.0000075107982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993315,0.000036263555,0.00020703583,0.00019092073,0.000101900376,0.00013240942],"domain_scores_gemma":[0.9993512,0.00021042765,0.00017412059,0.00008819747,0.00010828678,0.000067777335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058154743,0.00015799858,0.00034465658,0.00009431631,0.000040163963,0.000003968067,0.000025421792,0.00008322675,0.0000032431878],"category_scores_gemma":[0.0000040198465,0.00009390255,0.00005731228,0.000053414642,0.00008967351,0.000055326742,9.796412e-7,0.000019799181,3.2806713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008173204,0.0015562832,0.9832228,0.00036579047,0.0005767256,0.000016390271,0.0011327046,0.000045155324,0.002919965,0.00041317887,0.000006846655,0.0015710028],"study_design_scores_gemma":[0.044532124,0.016785739,0.90486974,0.00022431443,0.0008415429,0.000047972742,0.00006720647,0.0000045408883,0.03237038,0.00014153477,0.0000012450811,0.00011367777],"about_ca_topic_score_codex":0.0001292008,"about_ca_topic_score_gemma":0.000023601679,"teacher_disagreement_score":0.07835303,"about_ca_system_score_codex":0.000023849456,"about_ca_system_score_gemma":0.00013276355,"threshold_uncertainty_score":0.38292348},"labels":[],"label_agreement":null},{"id":"W2064417789","doi":"10.1016/j.jchromb.2008.10.036","title":"Quantitative proteomic analysis of follicular lymphoma cells in response to rituximab☆","year":2008,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Theoretical Astrophysics","keywords":"Rituximab; Follicular lymphoma; Chemistry; CD20; Lymphoma; Monoclonal antibody; Cell adhesion; Follicular phase; Cancer research; Antibody; Cell; Immunology; Biochemistry; Biology; Medicine; Internal medicine","score_opus":0.016741964467246497,"score_gpt":0.2807801967362169,"score_spread":0.2640382322689704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064417789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981739,0.0008417029,0.000085172025,0.00038538766,0.00005610478,0.00033751954,0.000016713915,0.000006578839,0.000096906406],"genre_scores_gemma":[0.9923656,0.00026802387,0.0071741594,0.00013239312,0.000017678574,0.000015632095,0.0000020679636,0.000012695401,0.0000117567715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981928,0.000156749,0.0007908212,0.0001604331,0.0004988427,0.00020034681],"domain_scores_gemma":[0.9986471,0.00018826975,0.00044983206,0.00024374203,0.0002618276,0.00020923208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049589766,0.00016455396,0.0010134191,0.0026818227,0.00003605268,0.0000074745153,0.00011153638,0.00007084775,0.000038973627],"category_scores_gemma":[0.0000944633,0.00012294571,0.00091465603,0.0026948433,0.0000845073,0.00009181409,0.00001868136,0.000060473158,0.00000806301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009725258,0.0057490133,0.7483433,0.00006237335,0.0064756647,0.003959508,0.0026657209,0.0002815121,0.2209912,0.00007844222,0.001086037,0.0005819769],"study_design_scores_gemma":[0.007361315,0.002202365,0.891571,0.0002345427,0.0013164575,0.0002837566,0.00018159527,0.00007202845,0.0963997,0.00001798751,0.00025592733,0.00010335786],"about_ca_topic_score_codex":0.00009924362,"about_ca_topic_score_gemma":0.000013317503,"teacher_disagreement_score":0.14322767,"about_ca_system_score_codex":0.00014191796,"about_ca_system_score_gemma":0.00025076966,"threshold_uncertainty_score":0.5013581},"labels":[],"label_agreement":null},{"id":"W2064731149","doi":"10.1038/bmt.2008.382","title":"Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma","year":2008,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Alberta; Western University; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Genentech","keywords":"Medicine; Rituximab; Hypogammaglobulinemia; Follicular lymphoma; Internal medicine; Regimen; Lymphoma; Gastroenterology; Surgery; Prospective cohort study; Confidence interval; Maintenance therapy; Minimal residual disease; Chemotherapy; Immunology; Leukemia; Antibody","score_opus":0.008222293131319027,"score_gpt":0.21905335992118596,"score_spread":0.21083106678986693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064731149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961288,0.0010894081,0.00026957915,0.0012456176,0.00002311456,0.0008539941,0.00001487111,0.00006917011,0.00030547433],"genre_scores_gemma":[0.9962057,0.0015227797,0.0016215745,0.00018019692,0.0000121106605,0.00012815026,0.00016765845,0.000028160735,0.00013365348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987049,0.000050728955,0.0002981342,0.00041498183,0.00025138285,0.0002798457],"domain_scores_gemma":[0.99944645,0.000053947275,0.00008416301,0.00019134009,0.000050570776,0.0001735449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108945635,0.00023971296,0.0004201652,0.00013935103,0.00012601295,0.000018614055,0.000033587752,0.00010931141,0.000008713021],"category_scores_gemma":[0.000016981543,0.00018854011,0.000047446418,0.00019691422,0.00010946204,0.00009016608,0.000009078502,0.00008028349,0.0000025849208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031788526,0.0009223673,0.9558581,0.00045697682,0.000104290084,0.0191358,0.0010192256,0.00001760556,0.013847244,0.00017643192,0.00003354413,0.005249561],"study_design_scores_gemma":[0.03394846,0.00052631117,0.94921297,0.00083136297,0.00030724652,0.0047636884,0.000028576473,0.0005558874,0.00954415,0.000029938663,0.000027552465,0.00022386009],"about_ca_topic_score_codex":0.00006907208,"about_ca_topic_score_gemma":0.0000665445,"teacher_disagreement_score":0.030769605,"about_ca_system_score_codex":0.00010988296,"about_ca_system_score_gemma":0.000107558444,"threshold_uncertainty_score":0.76884425},"labels":[],"label_agreement":null},{"id":"W2064865448","doi":"10.1182/blood-2008-08-174839","title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cancer Research UK","keywords":"Follicular lymphoma; Somatic hypermutation; Biology; Germinal center; Lymphoma; clone (Java method); Somatic evolution in cancer; Immunoglobulin heavy chain; Transplantation; Progenitor cell; Cell of origin; Lymph node; B cell; Immunology; Pathology; Antibody; Genetics; Stem cell; Gene; Medicine; Internal medicine","score_opus":0.007387720383040668,"score_gpt":0.22400863516151445,"score_spread":0.21662091477847378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064865448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603345,0.01602592,0.0005476889,0.00091594225,0.00023262082,0.002516273,0.0032277894,0.00018065312,0.00031964484],"genre_scores_gemma":[0.9952097,0.0007299813,0.00041880467,0.0005822775,0.00023926905,0.0003524894,0.0022328869,0.00006313118,0.00017148902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609053,0.00028286377,0.0009798992,0.0008054921,0.0010858076,0.00075543125],"domain_scores_gemma":[0.99775547,0.00020395084,0.00039825487,0.0010042957,0.0001804583,0.00045758818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002610968,0.0006638056,0.0009564969,0.00012948929,0.00036168177,0.000071478586,0.00038057438,0.00036538029,0.00006908771],"category_scores_gemma":[0.000051162613,0.00046127048,0.0005613281,0.0005949003,0.00006015194,0.00027963816,0.00007754822,0.000064135085,0.00013374712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470588,0.2619146,0.25177708,0.00030444542,0.0031239162,0.0004893684,0.00576808,0.00001627664,0.3509168,0.00024352898,0.074894615,0.044080693],"study_design_scores_gemma":[0.105493374,0.002413838,0.25925502,0.00035277664,0.0037025497,0.000036046997,0.00063554686,0.0004169836,0.60466737,0.000095697564,0.02214304,0.0007877654],"about_ca_topic_score_codex":0.00500996,"about_ca_topic_score_gemma":0.00016488631,"teacher_disagreement_score":0.25950077,"about_ca_system_score_codex":0.0010123525,"about_ca_system_score_gemma":0.00027775124,"threshold_uncertainty_score":0.9997839},"labels":[],"label_agreement":null},{"id":"W2065778093","doi":"10.1038/bmt.2010.225","title":"Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment","year":2010,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"Health Research Board","keywords":"Medicine; Follicular lymphoma; Lymphoma; Internal medicine; Radioimmunotherapy; Oncology; Chemotherapy; Toxicity; Surgery; Immunology; Antibody","score_opus":0.016689453876754395,"score_gpt":0.2717177983341917,"score_spread":0.2550283444574373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065778093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977056,0.0002484084,0.00022684733,0.00018548762,0.00010363048,0.0010447504,0.00021300682,0.000026226871,0.00024603962],"genre_scores_gemma":[0.9958319,0.0003637875,0.0023304527,0.000030491703,0.000040520306,0.00054725277,0.00076301844,0.000013981992,0.00007860308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992449,0.000019595225,0.00022647284,0.00022530937,0.00014623233,0.0001374433],"domain_scores_gemma":[0.999531,0.00011326728,0.00010899825,0.00011766518,0.000065290566,0.00006380161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039150556,0.00014854281,0.000254221,0.000050283135,0.00008871106,0.000013294257,0.000022654018,0.000060559967,0.000011593564],"category_scores_gemma":[0.000010172678,0.0001152498,0.000098799545,0.000050462604,0.000051723724,0.00008058754,0.0000030667675,0.000020415982,0.0000013946745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025671108,0.0055424646,0.6115727,0.00080985954,0.00096072647,0.000026296872,0.012420738,0.000041930813,0.2570249,0.0028820427,0.00014233317,0.10600886],"study_design_scores_gemma":[0.026160594,0.0019974047,0.73911124,0.00019959081,0.0011876943,0.000011904486,0.00024160798,0.0003331678,0.22921774,0.00009150444,0.001234869,0.00021267848],"about_ca_topic_score_codex":0.0002580272,"about_ca_topic_score_gemma":0.00013289406,"teacher_disagreement_score":0.12753855,"about_ca_system_score_codex":0.000058188198,"about_ca_system_score_gemma":0.00004288739,"threshold_uncertainty_score":0.46997505},"labels":[],"label_agreement":null},{"id":"W2066022953","doi":"10.3109/10428194.2013.848982","title":"Isolated bone marrow Hodgkin lymphoma in a human immunodeficiency virus-negative patient: a second case","year":2013,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Bone marrow; Human immunodeficiency virus (HIV); Cancer; Immunodeficiency; Pathology; Oncology; Cancer research; Internal medicine; Virology; Immunology; Immune system","score_opus":0.020159616710042506,"score_gpt":0.27953799006091146,"score_spread":0.25937837335086894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066022953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31077886,0.6786094,0.000004087478,0.000024118528,0.00047267645,0.004590624,0.0005477268,0.00035344515,0.0046191276],"genre_scores_gemma":[0.13045579,0.85993147,0.00042337883,0.0006956793,0.0003663021,0.0036806965,0.0011312013,0.0006497044,0.0026657556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865345,0.0009328117,0.004513187,0.0037510924,0.0013519115,0.0029164967],"domain_scores_gemma":[0.9920221,0.0010654082,0.002240959,0.0028215954,0.00041081492,0.0014391401],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006731708,0.0037988941,0.008266656,0.0022673102,0.0010418502,0.00061729155,0.0007947277,0.0028490818,0.0011129273],"category_scores_gemma":[0.00023819013,0.0031825583,0.0021428047,0.002629905,0.00092930207,0.0007968931,0.00092897506,0.0005601093,0.000774428],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00032067564,0.0018949363,0.0001583873,0.008483381,0.0013232024,0.042767316,0.0016498825,0.0000015149282,0.00008353022,0.0003108672,0.0026234756,0.94038284],"study_design_scores_gemma":[0.042039637,0.0029769463,0.0017835202,0.025841018,0.005227478,0.12691234,0.0010148707,0.0007164127,0.0004108727,0.00029123176,0.7880134,0.0047722515],"about_ca_topic_score_codex":0.014988345,"about_ca_topic_score_gemma":0.001008455,"teacher_disagreement_score":0.9356106,"about_ca_system_score_codex":0.032223906,"about_ca_system_score_gemma":0.009215559,"threshold_uncertainty_score":0.9998002},"labels":[],"label_agreement":null},{"id":"W2066267439","doi":"10.1136/jmg.2009.071910","title":"Oesophageal squamous cell carcinoma in a young adult with IL-12R<i>β</i>1 deficiency","year":2010,"lang":"en","type":"letter","venue":"Journal of Medical Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Howard Hughes Medical Institute","keywords":"Basal cell; Medicine; Internal medicine; Oncology; Pathology; Cancer research; Biology","score_opus":0.008736619331962632,"score_gpt":0.24236109722670185,"score_spread":0.23362447789473922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066267439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7447895,0.005241767,0.000030066509,0.24704115,0.001018868,0.00033762577,0.000023469614,0.000009487996,0.0015080757],"genre_scores_gemma":[0.8364493,0.0010621749,0.0013733389,0.15600309,0.0047348877,0.000013582811,0.00003320008,0.00007488844,0.00025548998],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9943751,0.00010504793,0.001110873,0.00035333494,0.0034454279,0.000610216],"domain_scores_gemma":[0.99761975,0.0002499795,0.0006712198,0.00044680768,0.00044468616,0.000567538],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004587634,0.00045670618,0.0010557979,0.00037823137,0.000045591016,0.000043075343,0.0005044383,0.0021254197,0.00032947896],"category_scores_gemma":[0.000241809,0.00028619365,0.00031229877,0.00024427913,0.0002176574,0.000031890944,0.00008104791,0.005377481,0.00002760426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002497349,0.0020207032,0.32880968,0.0007213369,0.000085934145,0.11591467,0.00051618053,0.0000075867465,0.000049127615,0.0000054200123,0.5456509,0.005968718],"study_design_scores_gemma":[0.06723521,0.022288335,0.49643546,0.0030966573,0.004792072,0.06729495,0.00040583586,0.00060294283,0.005012846,0.00013243331,0.33084998,0.0018533017],"about_ca_topic_score_codex":0.00018043844,"about_ca_topic_score_gemma":0.00019574889,"teacher_disagreement_score":0.21480095,"about_ca_system_score_codex":0.0002853659,"about_ca_system_score_gemma":0.0019578878,"threshold_uncertainty_score":0.999959},"labels":[],"label_agreement":null},{"id":"W2067288748","doi":"10.1155/2012/907025","title":"Unanswered Questions in HIV Hematology","year":2012,"lang":"en","type":"article","venue":"Advances in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; St. Paul's Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Cart; Lymphoma; Hematology; Incidence (geometry); Internal medicine; Chemotherapy; Epidemiology; Human immunodeficiency virus (HIV); Anemia; Natural history; Antiretroviral therapy; Non-Hodgkin's lymphoma; Pediatrics; Immunology; Intensive care medicine; Oncology; Viral load","score_opus":0.013133767798326207,"score_gpt":0.3224976033324421,"score_spread":0.3093638355341159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067288748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90867287,0.0729039,0.00015018006,0.0031245607,0.00059238105,0.00049700466,0.000005416331,0.00007324138,0.013980443],"genre_scores_gemma":[0.9949704,0.0016876841,0.0026018845,0.0003534911,0.0000358843,0.00023958791,0.000019077721,0.00001265519,0.00007938248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987961,0.00006939208,0.0003612805,0.00022180192,0.00007758685,0.00047382814],"domain_scores_gemma":[0.99928826,0.00026685707,0.000065850785,0.00025225797,0.000020641924,0.000106111984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105873776,0.000145691,0.0005223994,0.00020746549,0.00002340374,0.0000020275802,0.000060830975,0.00013622803,0.00013012331],"category_scores_gemma":[0.0001452736,0.00012253769,0.000050022227,0.00024340775,0.000108595945,0.00019453313,0.000033630746,0.00011359217,0.0001886238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004260669,0.000769997,0.8159087,0.000055739947,0.000010341349,0.00023688689,0.00016909017,0.0000071468658,0.0000107146825,0.18065591,0.00012229937,0.00201059],"study_design_scores_gemma":[0.009731371,0.00033350632,0.8786236,0.0006692499,0.00009338659,0.007806575,0.0005622505,0.00011666549,0.007978332,0.012952513,0.08066687,0.00046569743],"about_ca_topic_score_codex":0.000047776306,"about_ca_topic_score_gemma":0.0003413862,"teacher_disagreement_score":0.16770339,"about_ca_system_score_codex":0.00013472809,"about_ca_system_score_gemma":0.000046493216,"threshold_uncertainty_score":0.4996942},"labels":[],"label_agreement":null},{"id":"W2067305498","doi":"10.3109/10428194.2011.654339","title":"High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Dentistry, University of Alberta","keywords":"Medicine; International Prognostic Index; Follicular lymphoma; Hazard ratio; Internal medicine; Lymphoma; Beta-2 microglobulin; Oncology; Proportional hazards model; Lactate dehydrogenase; Chronic lymphocytic leukemia; Rituximab; Stage (stratigraphy); Gastroenterology; Immunology; Leukemia; Confidence interval; Biology","score_opus":0.015060401493968709,"score_gpt":0.23096356657214256,"score_spread":0.21590316507817386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067305498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992188,0.0025876448,0.00007129171,0.0003850066,0.0007038119,0.0019494605,0.00043101926,0.00037709935,0.0013067053],"genre_scores_gemma":[0.9914892,0.00043025703,0.0022329488,0.0022858856,0.0006183676,0.00044977508,0.0009288034,0.00027421542,0.0012905868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992271,0.00028967555,0.0017027339,0.0016237722,0.0016017156,0.00251107],"domain_scores_gemma":[0.99532,0.0003908788,0.0005646329,0.0016551316,0.00035705688,0.0017122502],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00092860917,0.0015966023,0.0021455886,0.0007481611,0.00047591628,0.00017615593,0.0004469515,0.0007988127,0.0002247343],"category_scores_gemma":[0.00023989526,0.0012428486,0.00041887106,0.0013401929,0.00038300955,0.0010612122,0.00036419794,0.00017889815,0.00023773575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021993641,0.0034340126,0.9012339,0.0003431925,0.0005278339,0.0006490142,0.00041670314,0.00007604356,0.00010079678,0.0009105962,0.0016405779,0.08846794],"study_design_scores_gemma":[0.08022164,0.001018645,0.9021219,0.0006493081,0.0008214202,0.00041338516,0.0001974952,0.00069029845,0.003237039,0.00006588228,0.009286089,0.0012768728],"about_ca_topic_score_codex":0.004475087,"about_ca_topic_score_gemma":0.00020302641,"teacher_disagreement_score":0.08719107,"about_ca_system_score_codex":0.013033524,"about_ca_system_score_gemma":0.00242605,"threshold_uncertainty_score":0.9996782},"labels":[],"label_agreement":null},{"id":"W2067578715","doi":"10.1182/blood-2008-09-177469","title":"Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"CD20; Diffuse large B-cell lymphoma; Lymphoma; CHOP; Rituximab; Immunohistochemistry; International Prognostic Index; Pathology; Vincristine; Immunophenotyping; Medicine; Biology; Cancer research; Antigen; Internal medicine; Immunology; Cyclophosphamide; Chemotherapy","score_opus":0.018510790643641098,"score_gpt":0.24336470975438856,"score_spread":0.22485391911074748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067578715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622935,0.00026063508,0.0000024577566,0.00012896575,0.00007163843,0.00032420256,0.00005427251,0.00014719543,0.0027812785],"genre_scores_gemma":[0.99793535,0.000119477554,0.00025251711,0.00034000224,0.00010754758,0.00006499914,0.00015803064,0.00004398303,0.0009780762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857694,0.000066013796,0.00021263518,0.0003730789,0.0003976416,0.0003737129],"domain_scores_gemma":[0.9990083,0.000061180894,0.0001084572,0.00044365713,0.00009828325,0.00028010437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008197359,0.00023723498,0.00040401574,0.00006286761,0.00019103487,0.000018107276,0.000080568105,0.00013509762,0.00009647753],"category_scores_gemma":[0.000047323447,0.00016404397,0.00009469708,0.00016991062,0.000043960463,0.00010628461,0.000041630967,0.00005641208,0.00005663171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045144014,0.13084525,0.8358791,0.000035325644,0.0004116216,0.0026652876,0.0020059552,1.3625049e-7,0.025322398,0.000020983087,0.0019232824,0.0004392653],"study_design_scores_gemma":[0.097517475,0.0014291278,0.6399099,0.00015846973,0.00044745638,0.0001663064,0.00011400018,0.000012361241,0.2591213,0.000004757318,0.00086607004,0.0002527629],"about_ca_topic_score_codex":0.0000786616,"about_ca_topic_score_gemma":0.000023240633,"teacher_disagreement_score":0.23379889,"about_ca_system_score_codex":0.00009172579,"about_ca_system_score_gemma":0.00019438993,"threshold_uncertainty_score":0.66895187},"labels":[],"label_agreement":null},{"id":"W2067637255","doi":"10.1182/blood-2007-09-111948","title":"Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":354,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Autocrine signalling; STAT3; Cancer research; Signal transduction; Biology; STAT protein; Diffuse large B-cell lymphoma; Germinal center; Transcription factor; Janus kinase; stat; PIM1; B cell; Lymphoma; Cell biology; Phosphorylation; Cell culture; Immunology; Genetics; Gene","score_opus":0.01675344155575692,"score_gpt":0.23422661037823644,"score_spread":0.21747316882247952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067637255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776274,0.0014413518,0.000037017053,0.00007155854,0.000014185793,0.00030513632,0.000055733915,0.00000909412,0.00030319576],"genre_scores_gemma":[0.99944043,0.00029428344,0.00013727271,0.00007551027,0.00002072772,0.0000055196115,0.0000055207747,0.000014325782,0.0000064005258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992584,0.000036891935,0.00023887635,0.00016477845,0.00014437694,0.00015665132],"domain_scores_gemma":[0.999622,0.00012696792,0.00006518137,0.00009636457,0.000041121544,0.000048401766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114022856,0.00012451899,0.000271265,0.000040135452,0.00004574296,0.0000074204163,0.000031210322,0.00007342155,0.000034378318],"category_scores_gemma":[0.000008116596,0.000079212994,0.00005128285,0.00009715077,0.00008078809,0.00007786353,0.0000082635515,0.000045508852,5.5857294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005154879,0.011387527,0.047924478,0.00017981196,0.00017893064,0.000047598016,0.026743487,5.060761e-7,0.9098493,0.00093230867,0.0000047811195,0.0022357858],"study_design_scores_gemma":[0.02492078,0.00061710406,0.15239717,0.00012998235,0.00020477106,0.000016431875,0.0024297563,0.000013012905,0.8189981,0.000031889896,0.00015545372,0.00008557941],"about_ca_topic_score_codex":0.00013692588,"about_ca_topic_score_gemma":0.000038277834,"teacher_disagreement_score":0.10447269,"about_ca_system_score_codex":0.000020543433,"about_ca_system_score_gemma":0.000036251273,"threshold_uncertainty_score":0.3230212},"labels":[],"label_agreement":null},{"id":"W2067682130","doi":"10.1007/s00259-003-1169-2","title":"Limitations of PET for imaging lymphoma","year":2003,"lang":"en","type":"review","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Positron emission tomography; Fluorodeoxyglucose; Biopsy; Radiology; Pathology","score_opus":0.0829613649777335,"score_gpt":0.3203069748519841,"score_spread":0.23734560987425063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067682130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000665164,0.9897614,0.00025574127,0.0018804882,0.00022048398,0.00036845185,0.000008643153,0.00000985218,0.007428436],"genre_scores_gemma":[0.001380421,0.99162704,0.004428783,0.0021688393,0.0002188544,0.0000025086456,0.000020774633,0.00013007753,0.000022679651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794215,0.0002694198,0.0010471304,0.00022809752,0.0002949739,0.00021819977],"domain_scores_gemma":[0.99800396,0.00023058441,0.00096118456,0.0002521038,0.00030962445,0.000242553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007513084,0.0003258956,0.0015019473,0.00043544755,0.000067199704,0.000021661883,0.0001317821,0.000016566722,0.000017113178],"category_scores_gemma":[0.00047928924,0.00022364467,0.00056875346,0.00016124919,0.0001687114,0.00006561684,0.000041595027,0.00013956163,0.00000542647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023255649,0.00014488483,0.000018359333,0.00258336,0.00043200387,0.0041334145,0.00022399942,9.627922e-8,0.000053581913,0.00023598145,0.015566771,0.9765843],"study_design_scores_gemma":[0.0034730732,0.00043374376,0.00004475805,0.018117575,0.00479226,0.009687818,0.0003450828,0.000010161096,0.0000041789885,0.000013231268,0.9629248,0.00015333302],"about_ca_topic_score_codex":0.000001894499,"about_ca_topic_score_gemma":3.4473693e-8,"teacher_disagreement_score":0.97643095,"about_ca_system_score_codex":0.00008273199,"about_ca_system_score_gemma":0.00017784427,"threshold_uncertainty_score":0.9119965},"labels":[],"label_agreement":null},{"id":"W2067685415","doi":"10.3324/haematol.2008.001024","title":"CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Rituximab; CD20; Epitope; CHOP; Lymphoma; Diffuse large B-cell lymphoma; Medicine; B cell; Immunophenotyping; Cancer research; Antigen; Immunology; Pathology; Antibody","score_opus":0.0215030188867451,"score_gpt":0.2558321422840284,"score_spread":0.2343291233972833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067685415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869326,0.002189097,0.000006531228,0.0097804135,0.000029086059,0.0006726226,0.000069976006,0.000052578995,0.00026714316],"genre_scores_gemma":[0.99756366,0.0005429934,0.0003379339,0.0013374931,0.00002044029,0.000097149925,0.00002568722,0.000012515825,0.000062129104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856764,0.00010474939,0.00040801405,0.00035867476,0.0002300959,0.0003307973],"domain_scores_gemma":[0.99882376,0.0002957922,0.00026046688,0.0004106196,0.000088717585,0.000120621386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013815648,0.00023577761,0.0006754508,0.00011265335,0.00014884559,0.000032516138,0.00011696844,0.0001424765,0.000044061264],"category_scores_gemma":[0.00024043849,0.00012749742,0.00010901864,0.00026228582,0.00010818203,0.000071168215,0.000057393656,0.00012370071,0.000019556855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038775502,0.025620224,0.94871503,0.0004505367,0.00016163116,0.007910205,0.0040899795,0.0000055022933,0.0019079256,0.0047841226,0.0041424516,0.0018246068],"study_design_scores_gemma":[0.022980213,0.00040481836,0.9585598,0.00060610916,0.0002687012,0.0005497225,0.0050056074,0.00019046973,0.009469562,0.00058060646,0.001120518,0.00026387267],"about_ca_topic_score_codex":0.000063011685,"about_ca_topic_score_gemma":0.00023562707,"teacher_disagreement_score":0.025215406,"about_ca_system_score_codex":0.000081762235,"about_ca_system_score_gemma":0.000062888226,"threshold_uncertainty_score":0.5199194},"labels":[],"label_agreement":null},{"id":"W2067781784","doi":"10.1016/s0242-6498(04)93922-3","title":"Lymphome anaplasique à grandes cellules (LAGC) chez des patients aux antécédents de carcinome : à propos de 2 cas incluant une tumeur de collision","year":2004,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine","score_opus":0.03476842428607773,"score_gpt":0.3045141502305148,"score_spread":0.2697457259444371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067781784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96960384,0.025122171,0.0003978975,0.0023475005,0.0005538776,0.0011169615,0.00023434336,0.00016761776,0.0004557813],"genre_scores_gemma":[0.97327924,0.02006678,0.00410804,0.0010674262,0.00032444837,0.0002619726,0.00020412299,0.00010059478,0.00058737467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951402,0.00055139145,0.000746792,0.0008433502,0.0005265164,0.002191758],"domain_scores_gemma":[0.9975237,0.0002956237,0.00029980013,0.0006245714,0.00035904834,0.0008972501],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009831548,0.00074867316,0.00087978976,0.00028033202,0.0005762754,0.00013113914,0.00043677405,0.0006703507,0.00006969957],"category_scores_gemma":[0.0007756368,0.0006499925,0.00039359636,0.00057101675,0.0008773805,0.00026189873,0.00031197572,0.00033520177,0.00029496997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004955614,0.0052739047,0.9311149,0.00072489533,0.00022639373,0.015185933,0.011368782,0.0008290823,0.004689939,0.00043023445,0.0004666618,0.029193679],"study_design_scores_gemma":[0.008858708,0.002497362,0.90134054,0.001570255,0.00069375697,0.001403602,0.0012688774,0.0002043472,0.076570205,0.004109943,0.00090004667,0.0005823355],"about_ca_topic_score_codex":0.006856675,"about_ca_topic_score_gemma":0.0014238257,"teacher_disagreement_score":0.07188027,"about_ca_system_score_codex":0.0075927894,"about_ca_system_score_gemma":0.0031085317,"threshold_uncertainty_score":0.99975675},"labels":[],"label_agreement":null},{"id":"W2067915257","doi":"10.1182/blood-2013-10-535278","title":"Treatment of NLPHL","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Hodgkin lymphoma; Intensive care medicine; Lymphoma; Internal medicine; Pathology","score_opus":0.019768587025680035,"score_gpt":0.2479634362136167,"score_spread":0.22819484918793664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067915257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22309373,0.0074146055,5.3878546e-7,0.73176134,0.00038884563,0.0018538925,0.00017354586,0.00010268505,0.03521082],"genre_scores_gemma":[0.19192769,0.0062664063,0.0024751334,0.69102734,0.015022317,0.0022007104,0.0036834117,0.0003117791,0.087085195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904,0.000019891295,0.00024740348,0.00025364535,0.0002293878,0.0002096925],"domain_scores_gemma":[0.9991961,0.0000780613,0.00012879934,0.00048537433,0.000055417895,0.00005626091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000009444716,0.00025105945,0.0006779402,0.00008082168,0.000015618016,0.000008453489,0.000047098805,0.0003648598,0.0005291099],"category_scores_gemma":[0.000007463404,0.00016041855,0.00030199112,0.00004655649,0.00003479669,0.000013004229,0.0000117473155,0.00009044633,0.00041912743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008812197,0.0039938996,0.020308565,0.00022070632,0.0016675405,0.0026469398,0.00007587478,1.6920486e-8,0.0000696622,0.000015107595,0.9648443,0.0061485777],"study_design_scores_gemma":[0.008193401,0.0021876679,0.012363851,0.00013728399,0.002712919,0.00027154956,0.000004108387,4.39111e-7,0.010521065,0.00002026454,0.9634444,0.00014303258],"about_ca_topic_score_codex":0.0003087125,"about_ca_topic_score_gemma":0.0000011812286,"teacher_disagreement_score":0.051874377,"about_ca_system_score_codex":0.00009639383,"about_ca_system_score_gemma":0.00010604455,"threshold_uncertainty_score":0.6541679},"labels":[],"label_agreement":null},{"id":"W2068181649","doi":"10.1016/s1476-5586(03)80013-1","title":"DTI-015 Produces Cures in T9 Gliosarcoma","year":2003,"lang":"en","type":"article","venue":"Neoplasia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University","keywords":"Gliosarcoma; Medicine; Glioblastoma; Cancer research","score_opus":0.012061042487428543,"score_gpt":0.26633295568913135,"score_spread":0.2542719132017028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068181649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95950264,0.0015110624,9.2353787e-7,0.0014242283,0.0001663869,0.00031054538,0.000002341639,0.00004226339,0.03703961],"genre_scores_gemma":[0.99807525,0.000095907526,0.0005311968,0.000328737,0.00006596637,0.000067951645,0.000008283877,0.0000139095,0.0008128297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913234,0.00003608478,0.00016608425,0.0002545674,0.00017837885,0.00023253633],"domain_scores_gemma":[0.99954486,0.00004439153,0.000031912892,0.00025472726,0.000028328426,0.000095781215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009367256,0.00012912018,0.00021816936,0.000098745215,0.000031785505,0.000015558768,0.000041384592,0.000060548373,0.00019995544],"category_scores_gemma":[0.00011510122,0.00009745364,0.00005506655,0.00020926108,0.00002745818,0.000048557402,0.000010957859,0.00006843524,0.00022133718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006147786,0.0010830517,0.97289604,0.000041491963,0.000048920778,0.00059707166,0.0004131236,0.0000030426777,0.00061854825,0.0036803908,0.010415479,0.01014137],"study_design_scores_gemma":[0.0044656284,0.00037900382,0.81591004,0.00012054066,0.000062366285,0.00035751527,0.00015051178,0.0000107056485,0.046312843,0.00040872782,0.13166407,0.00015807601],"about_ca_topic_score_codex":0.00009445673,"about_ca_topic_score_gemma":0.00014261012,"teacher_disagreement_score":0.15698601,"about_ca_system_score_codex":0.00011316268,"about_ca_system_score_gemma":0.0001237262,"threshold_uncertainty_score":0.3974044},"labels":[],"label_agreement":null},{"id":"W2068331840","doi":"10.1111/bjh.12244","title":"Modern management of lymphocyte predominant <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD15; CD30; Lymphoma; CD20; Medicine; Lymphocyte; Pathological; Stage (stratigraphy); Hodgkin lymphoma; Pathology; Immunology; Biology; CD34","score_opus":0.03051863911245825,"score_gpt":0.30376686698209776,"score_spread":0.27324822786963954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068331840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062792487,0.9892507,0.00008842981,0.000025618205,0.00058045686,0.0012952015,0.000052068757,0.000019616129,0.0024086183],"genre_scores_gemma":[0.0009130968,0.9948492,0.002435219,0.000051064217,0.0001587392,0.00016119669,0.00004598759,0.00010315557,0.0012823372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953965,0.00033465854,0.0025673027,0.00046480793,0.00063147146,0.0006052786],"domain_scores_gemma":[0.9954973,0.00052180426,0.0027053936,0.0005148194,0.000398461,0.0003622289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049317966,0.0005929604,0.005947391,0.00045368914,0.00007264821,0.00005661973,0.00049080147,0.000562419,0.00013692606],"category_scores_gemma":[0.00016248088,0.00049953244,0.0016697581,0.00027102264,0.00021693687,0.00011696178,0.00021623197,0.00023164706,0.00015377297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013221709,0.0011225787,0.00003025079,0.021961793,0.003251131,0.11766483,0.00004856388,5.8127677e-7,2.2962784e-7,0.00023680624,0.00916649,0.84650356],"study_design_scores_gemma":[0.003928658,0.0002837402,0.000106886386,0.05344594,0.005287422,0.41023362,0.000053475316,0.000006665211,0.00002468387,0.0001511351,0.52636784,0.00010990752],"about_ca_topic_score_codex":0.000089431946,"about_ca_topic_score_gemma":0.0000054762518,"teacher_disagreement_score":0.84639364,"about_ca_system_score_codex":0.000769099,"about_ca_system_score_gemma":0.0011516822,"threshold_uncertainty_score":0.9997456},"labels":[],"label_agreement":null},{"id":"W2068410289","doi":"10.1002/cncr.20587","title":"Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma","year":2004,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Gemcitabine; Neutropenia; Internal medicine; Gastroenterology; Regimen; Chemotherapy; Dexamethasone; Lymphoma; Transplantation; Refractory (planetary science); Cisplatin; Surgery","score_opus":0.009573822624196053,"score_gpt":0.25848173564667315,"score_spread":0.24890791302247708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068410289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939563,0.0043125753,0.000008322831,0.0002947026,0.00019929338,0.0005372876,0.000025005244,0.000017469532,0.0006489932],"genre_scores_gemma":[0.99739003,0.00080224144,0.00082069746,0.00043425788,0.000052714593,0.00024076647,0.00003123404,0.000025291381,0.00020278354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989372,0.000023033257,0.00021548202,0.0003678672,0.00018213752,0.00027431652],"domain_scores_gemma":[0.9993015,0.000065059874,0.00018530824,0.00021827358,0.00008279663,0.0001470547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039912342,0.00020567991,0.00037333346,0.000112731395,0.0000407323,0.000008364406,0.000046412402,0.00010099094,0.0001522389],"category_scores_gemma":[0.000042818065,0.00013317648,0.000031809028,0.00016723732,0.00009463062,0.00006525724,0.000028719473,0.000074333424,0.000013964428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022637085,0.0015950059,0.8493266,0.0000964894,0.000069809954,0.0004103923,0.00063122046,0.000015614974,0.000042814474,0.000020936086,0.00080459425,0.1447228],"study_design_scores_gemma":[0.02618706,0.0018792364,0.9671486,0.0005692623,0.00012050681,0.000018285182,0.00004102375,0.000007773665,0.0007769758,0.000018015406,0.0030564459,0.0001768095],"about_ca_topic_score_codex":0.00066698715,"about_ca_topic_score_gemma":0.0006512677,"teacher_disagreement_score":0.144546,"about_ca_system_score_codex":0.0010919857,"about_ca_system_score_gemma":0.00039995776,"threshold_uncertainty_score":0.54307795},"labels":[],"label_agreement":null},{"id":"W2068631879","doi":"10.1532/ijh97.07028","title":"Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy","year":2007,"lang":"en","type":"article","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut national de la recherche scientifique; Johns Hopkins University","keywords":"CD20; Lymphoma; Cancer research; Rituximab; Trichostatin A; Follicular lymphoma; B cell; Medicine; Biology; Immunology; Antibody; Histone deacetylase; Histone; Gene","score_opus":0.008600545770794105,"score_gpt":0.24882331716322112,"score_spread":0.240222771392427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068631879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958172,0.0006589372,0.0021872686,0.00035560175,0.000107797794,0.0003417218,0.0000103505,0.000009568281,0.00051159],"genre_scores_gemma":[0.9878512,0.00003681043,0.011812202,0.00012733435,0.00006727778,0.000013181582,0.00003440967,0.000022199902,0.000035370544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980812,0.000042923042,0.00097604643,0.00021610445,0.00049233093,0.0001913881],"domain_scores_gemma":[0.9980943,0.00016826909,0.0008905968,0.00016360787,0.0005826235,0.00010055361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020683985,0.00018294544,0.00055033446,0.0004298475,0.000017855176,0.000014201784,0.00013809864,0.00013451706,0.00007060026],"category_scores_gemma":[0.00005783645,0.00013167622,0.00011445137,0.00014791443,0.000050931205,0.000115838055,0.00002531546,0.00009607755,0.0000026109412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019212388,0.015372372,0.36274227,0.000060012266,0.00043004376,0.0027204866,0.0027133995,0.00016862825,0.58007175,0.00013934026,0.000073546136,0.016295766],"study_design_scores_gemma":[0.030355033,0.0018550331,0.10883249,0.00091705786,0.000056216268,0.00066929584,0.00026694284,0.00019192656,0.8564925,0.00009971125,0.0001591933,0.0001045574],"about_ca_topic_score_codex":0.0003118022,"about_ca_topic_score_gemma":0.00006361145,"teacher_disagreement_score":0.2764208,"about_ca_system_score_codex":0.00035306436,"about_ca_system_score_gemma":0.00024557245,"threshold_uncertainty_score":0.53696},"labels":[],"label_agreement":null},{"id":"W2068693591","doi":"10.1182/blood-2012-04-421057","title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Hospital; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Tissue microarray; Medicine; CD68; Internal medicine; Oncology; CD163; Immunohistochemistry; Proportional hazards model; Cohort; Pathology; Biology; Macrophage","score_opus":0.019099619487802047,"score_gpt":0.27656627245462784,"score_spread":0.2574666529668258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068693591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531084,0.00088625157,0.0000014866118,0.00033092548,0.0006879414,0.002163856,0.000090641406,0.00008522773,0.00044279936],"genre_scores_gemma":[0.99841106,0.000020441486,0.00003469214,0.0003558817,0.00030798576,0.00057821,0.000051628802,0.000033602533,0.00020651743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979932,0.00033179246,0.0005047584,0.0003163435,0.00040399784,0.0004499277],"domain_scores_gemma":[0.99829197,0.0008833227,0.00020449351,0.00041785403,0.000043734362,0.0001586288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036741226,0.00030828814,0.000694106,0.000080636484,0.00009640963,0.000042464824,0.00015685082,0.000102996964,0.00011826981],"category_scores_gemma":[0.0005647999,0.00017966129,0.0001983712,0.0002503726,0.00007094938,0.00012973853,0.00013128718,0.00014846971,0.00010362563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020403313,0.03167978,0.9590448,0.000003133718,0.0012204053,0.00023415721,0.003978279,1.8787962e-7,0.000022750059,0.000016803513,0.0003423822,0.0014169652],"study_design_scores_gemma":[0.17906433,0.0018067373,0.816088,0.0000852532,0.0010434759,0.000010318096,0.0014169003,0.000009802695,0.00022620446,0.000018035056,0.000095343756,0.00013559066],"about_ca_topic_score_codex":0.0014309804,"about_ca_topic_score_gemma":0.00050838344,"teacher_disagreement_score":0.177024,"about_ca_system_score_codex":0.00031102847,"about_ca_system_score_gemma":0.00012293068,"threshold_uncertainty_score":0.73263747},"labels":[],"label_agreement":null},{"id":"W2068710304","doi":"10.1097/00004347-200404000-00017","title":"Precursor B-cell Lymphoblastic Lymphoma of the Ovaries: An Immunohistochemical Study and Review of the Literature","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Lymphoblastic lymphoma; Lymphoma; Medicine; Ovary; Pathology; Immunohistochemistry; Internal medicine; Immunology","score_opus":0.00933430748730712,"score_gpt":0.2804334068139001,"score_spread":0.271099099326593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068710304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665935,0.009885937,0.000007507734,0.0023329388,0.00049742725,0.00034968692,0.00001597241,0.0000028685379,0.0002483139],"genre_scores_gemma":[0.99651814,0.0019400776,0.00027636654,0.0011557577,0.000065403176,0.00001131824,0.000002456161,0.00000554461,0.000024947032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985419,0.00018296576,0.00062909693,0.00014130436,0.000401788,0.000102934406],"domain_scores_gemma":[0.9982739,0.00028258478,0.0006043005,0.00021809468,0.00056188426,0.000059233313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032275802,0.00012458954,0.00043387723,0.000050244034,0.000034433997,0.000008564265,0.00039033743,0.00010360055,0.000054091117],"category_scores_gemma":[0.001008722,0.000055530083,0.00023122877,0.00011989404,0.0002831154,0.000053392025,0.00015350687,0.00013052492,0.0000010597892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006690521,0.084967114,0.74690133,0.0023320136,0.0029418822,0.0069579408,0.009778268,0.000098883094,0.08842205,0.006201815,0.0017497622,0.04295841],"study_design_scores_gemma":[0.008062366,0.0034923726,0.9722476,0.0026368436,0.00038510546,0.0039443593,0.0001494321,0.0000022757233,0.007147861,0.0015473224,0.0003082827,0.000076199285],"about_ca_topic_score_codex":0.000006158023,"about_ca_topic_score_gemma":0.0000025525553,"teacher_disagreement_score":0.22534624,"about_ca_system_score_codex":0.00024905626,"about_ca_system_score_gemma":0.00025400898,"threshold_uncertainty_score":0.22644511},"labels":[],"label_agreement":null},{"id":"W2068794772","doi":"10.3109/10428194.2010.500046","title":"Prognostic biomarkers in malignant lymphomas","year":2010,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Tumor microenvironment; Follicular lymphoma; Disease; Translational research; Chemokine; Medicine; Cancer research; Biology; Bioinformatics; Computational biology; Immunology; Pathology; Immune system; Tumor cells","score_opus":0.022238817785007865,"score_gpt":0.2893704191402985,"score_spread":0.2671316013552906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068794772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030907586,0.95349294,0.0000036360568,0.00009271821,0.0012412518,0.0047623045,0.00019845946,0.00049712125,0.008804011],"genre_scores_gemma":[0.008555663,0.98362815,0.0008514405,0.0005875276,0.0007776581,0.002466193,0.0011682343,0.0005721247,0.0013929893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889001,0.00046932368,0.0032289226,0.0034202533,0.0013761292,0.0026052247],"domain_scores_gemma":[0.99304414,0.0012462527,0.0012792599,0.0025513014,0.00022473371,0.0016543003],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008851986,0.0031762943,0.007173788,0.001985887,0.0004570466,0.0004143448,0.00093330693,0.003461533,0.00022779056],"category_scores_gemma":[0.0004381817,0.00252548,0.0020328283,0.0021608083,0.00085806334,0.00040084953,0.00066714536,0.0005819461,0.0006848402],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002512107,0.000980831,0.0046663536,0.010613453,0.0015468481,0.0052806307,0.00019219094,6.5005213e-7,0.000009030572,0.00082004076,0.0018084026,0.97383034],"study_design_scores_gemma":[0.0186505,0.00059713627,0.017605841,0.027992873,0.0056450097,0.013151982,0.000104283434,0.0001367136,0.000055546647,0.00015071947,0.9134595,0.0024498939],"about_ca_topic_score_codex":0.0021678256,"about_ca_topic_score_gemma":0.00031646685,"teacher_disagreement_score":0.9713805,"about_ca_system_score_codex":0.02117475,"about_ca_system_score_gemma":0.018057995,"threshold_uncertainty_score":0.99809647},"labels":[],"label_agreement":null},{"id":"W2069248127","doi":"10.1016/j.jacr.2014.07.038","title":"ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma","year":2014,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sequela; Appropriate Use Criteria; Physical examination; ABVD; Intensive care medicine; Radiology; Surgery; Chemotherapy; Internal medicine","score_opus":0.012406968893124119,"score_gpt":0.26964225294622457,"score_spread":0.2572352840531005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069248127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953422,0.00036571734,0.00010827491,0.00272073,0.0007709378,0.00016271674,0.00003147919,0.0000042301294,0.0004937345],"genre_scores_gemma":[0.9968444,0.00018516627,0.0020838317,0.00045195193,0.00023258531,0.000004888209,9.761692e-7,0.000016597674,0.00017957244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837595,0.00034031286,0.00068526587,0.00013216228,0.0002598605,0.00020647196],"domain_scores_gemma":[0.9973866,0.00032611232,0.0014961305,0.00039828673,0.00028255087,0.00011034812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004962395,0.000156344,0.0012109437,0.0001522717,0.0000414263,0.0000023529285,0.00031614365,0.000058267175,0.000034788958],"category_scores_gemma":[0.0003657536,0.00008831318,0.00045184034,0.00031854576,0.0005144485,0.00003656221,0.000067394314,0.00007233781,0.000002054281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016879233,0.00436138,0.61887574,0.00041627794,0.005376828,0.00075740844,0.0012095317,0.000112419126,0.15330201,0.006485429,0.08427325,0.10795049],"study_design_scores_gemma":[0.019041644,0.009691928,0.8903078,0.00034811912,0.0011672765,0.012687138,0.0008270676,0.00023101515,0.050029278,0.0010631613,0.014371732,0.00023385776],"about_ca_topic_score_codex":0.00008362433,"about_ca_topic_score_gemma":0.0000058273135,"teacher_disagreement_score":0.27143204,"about_ca_system_score_codex":0.00013329863,"about_ca_system_score_gemma":0.0002838179,"threshold_uncertainty_score":0.3601307},"labels":[],"label_agreement":null},{"id":"W2069485773","doi":"10.1038/sj.bjc.6602654","title":"Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; Manitoba Health; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute; Centre International de Recherche sur le Cancer","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Oncology; Pathology","score_opus":0.008630476264784581,"score_gpt":0.26716797460924036,"score_spread":0.2585374983444558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069485773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605593,0.033363346,0.0000045882844,0.00026056566,0.0003013185,0.00016137538,0.00009708546,0.0000070941196,0.00524532],"genre_scores_gemma":[0.9876622,0.009173639,0.0005360244,0.0008422897,0.0008174697,0.000019761581,0.000004957423,0.000025602427,0.0009180846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985802,0.000024145998,0.00057752826,0.00014974234,0.00042403472,0.00024433908],"domain_scores_gemma":[0.99883145,0.00006959228,0.0004665131,0.0001296644,0.00027122424,0.0002315746],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014170793,0.00014400037,0.00056910666,0.00010221141,0.000052772473,0.000030405967,0.00010275244,0.00007872917,0.0017940652],"category_scores_gemma":[0.0000287068,0.00013972301,0.0002552693,0.0001287339,0.000115850555,0.00023541445,0.000022322212,0.000094888564,0.0000035539701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031468313,0.00045090765,0.17035231,0.00013380086,0.00055376167,0.0037848859,0.00014744716,0.00010062444,0.0005770788,0.0000027668693,0.029566888,0.7940149],"study_design_scores_gemma":[0.0067006443,0.00046969278,0.9060334,0.0016904864,0.0003486298,0.006838266,0.00006259372,0.000017525483,0.012418984,0.0000053796402,0.06527751,0.00013688425],"about_ca_topic_score_codex":0.0037611383,"about_ca_topic_score_gemma":0.0050983513,"teacher_disagreement_score":0.79387796,"about_ca_system_score_codex":0.001184573,"about_ca_system_score_gemma":0.0009128822,"threshold_uncertainty_score":0.99911845},"labels":[],"label_agreement":null},{"id":"W2069993664","doi":"10.1053/j.seminhematol.2015.01.002","title":"Emerging Biological Insights and Novel Treatment Strategies in Primary Mediastinal Large B-Cell Lymphoma","year":2015,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Cancer research; Janus kinase; Computational biology; Biology; Pathology; Immunology","score_opus":0.05155560579263405,"score_gpt":0.34031380600222405,"score_spread":0.28875820020959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069993664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02708014,0.9683952,0.000003458573,0.000044434964,0.00018396419,0.0011469125,0.000037561495,0.000037946458,0.0030703912],"genre_scores_gemma":[0.006816919,0.99122995,0.00064670783,0.000051552044,0.00006711885,0.00063307094,0.0004419498,0.000042048305,0.00007070027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997269,0.0001784345,0.0009358532,0.00081404945,0.00019329613,0.0006094153],"domain_scores_gemma":[0.9985688,0.00052242324,0.00028408744,0.00037290493,0.000037578815,0.00021421684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023690668,0.00068753574,0.003548125,0.00054932444,0.00003919899,0.00001837889,0.00012879624,0.0007522134,0.000020683123],"category_scores_gemma":[0.000055584245,0.0004451434,0.00022643294,0.00035872005,0.0001677776,0.00006092311,0.0001634296,0.00018498098,0.000029743005],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013653234,0.010227216,0.007908661,0.009707433,0.00022404909,0.0092466995,0.0010589551,2.502635e-7,0.0000024589522,0.004175103,0.00023254156,0.9570801],"study_design_scores_gemma":[0.016865315,0.0017345876,0.0013432163,0.019353574,0.00077251956,0.0077083334,0.00089850865,0.000014982721,0.00001618536,0.00032438178,0.9503024,0.0006659735],"about_ca_topic_score_codex":0.00006980836,"about_ca_topic_score_gemma":0.00009361563,"teacher_disagreement_score":0.9564141,"about_ca_system_score_codex":0.0012115837,"about_ca_system_score_gemma":0.0011233371,"threshold_uncertainty_score":0.9998},"labels":[],"label_agreement":null},{"id":"W2070095096","doi":"10.1016/j.ctrv.2015.02.001","title":"Primary and secondary bone lymphomas","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Pathological; Disease; Radiation therapy; Pathology; Radiology","score_opus":0.11476396420634723,"score_gpt":0.3917319352950804,"score_spread":0.27696797108873317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070095096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007396355,0.97723943,2.6387755e-7,0.00009360124,0.0003126222,0.004871309,0.00024182853,0.00006913987,0.017164383],"genre_scores_gemma":[3.9349604e-7,0.98491836,0.00032296544,0.00038391893,0.0005190721,0.0065369476,0.0010441408,0.000099570505,0.006174631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971569,0.00018977109,0.0010603843,0.0009125745,0.00025201848,0.000428349],"domain_scores_gemma":[0.99781704,0.00007752357,0.0005795474,0.00090293953,0.000059066995,0.00056387717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022797337,0.001061796,0.0064320806,0.00017152667,0.00008101548,0.000048040052,0.00009136725,0.00032099636,0.000473106],"category_scores_gemma":[0.000013488346,0.00059190544,0.0011137207,0.00026186966,0.000096313495,0.000078355304,0.000082689556,0.00013359166,0.00048281864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013869034,0.00049408054,0.00011459153,0.026310692,0.0008493391,0.000328468,0.000038778195,3.5773777e-9,4.166992e-8,0.00003418973,0.018436981,0.953379],"study_design_scores_gemma":[0.002966266,0.0005793899,0.000066003166,0.029980894,0.012983981,0.00078447646,0.00000273308,1.114746e-7,8.8447547e-7,0.000008763896,0.95220244,0.00042408056],"about_ca_topic_score_codex":0.00015052961,"about_ca_topic_score_gemma":0.000019740846,"teacher_disagreement_score":0.9529549,"about_ca_system_score_codex":0.0048272433,"about_ca_system_score_gemma":0.0025285073,"threshold_uncertainty_score":0.9996532},"labels":[],"label_agreement":null},{"id":"W2070285748","doi":"10.1182/blood-2012-05-427989","title":"PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; José Carreras Leukämie-Stiftung; Bundesministerium für Bildung und Forschung","keywords":"Lymphoma; Genotyping; Odds ratio; Biology; Immunology; B cell; Allele; Oncology; Single-nucleotide polymorphism; Genotype; Genetics; Internal medicine; Gene; Medicine; Antibody","score_opus":0.01033931200351582,"score_gpt":0.24070536401281206,"score_spread":0.23036605200929625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070285748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954674,0.0025086144,0.000008924442,0.000286136,0.00012310134,0.00035152485,0.0003546981,0.000023529505,0.00087602844],"genre_scores_gemma":[0.99772495,0.0006046725,0.0010396228,0.0003041508,0.00018933191,0.000036950372,0.000037460817,0.000016679349,0.000046165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881357,0.000069611895,0.00038046393,0.00025321485,0.0002114965,0.0002716208],"domain_scores_gemma":[0.9985435,0.00045927882,0.00022685499,0.0005287472,0.000073339754,0.00016826572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026785437,0.00017610523,0.00031908596,0.000033487147,0.000073467716,0.000017361539,0.000103299055,0.000089751586,0.000020422684],"category_scores_gemma":[0.00031890947,0.00010701916,0.00007576747,0.000105639,0.00013057173,0.00010188029,0.00008816788,0.000046203455,0.000037185557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032349926,0.0025040307,0.97909427,0.000015946272,0.0006896824,0.00004343883,0.0024415455,7.679553e-7,0.004750575,0.000043777018,0.00035332725,0.009739134],"study_design_scores_gemma":[0.015179663,0.00024587856,0.9359749,0.00012691373,0.0010318045,0.000089880654,0.00011334872,0.000018023013,0.046497446,0.000029172657,0.00059165445,0.00010129532],"about_ca_topic_score_codex":0.0025090347,"about_ca_topic_score_gemma":0.000022724438,"teacher_disagreement_score":0.043119356,"about_ca_system_score_codex":0.000035271656,"about_ca_system_score_gemma":0.000087547494,"threshold_uncertainty_score":0.43641147},"labels":[],"label_agreement":null},{"id":"W2070685379","doi":"10.3109/10428194.2013.862242","title":"Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Vincristine; Rituximab; Diffuse large B-cell lymphoma; Positron emission tomography; Oncology; Internal medicine; Prednisone; Interim analysis; Lymphoma; Interim; Cyclophosphamide; Chemotherapy; Clinical trial; Nuclear medicine","score_opus":0.024409207622668537,"score_gpt":0.31240700740628746,"score_spread":0.28799779978361895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070685379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836819,0.0023185962,0.000045835728,0.00046532595,0.00063074555,0.010840737,0.00051155896,0.0003649332,0.0011403488],"genre_scores_gemma":[0.98724043,0.0008213967,0.003010654,0.0007904862,0.00065664406,0.005329331,0.0007416467,0.00023263863,0.001176748],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922398,0.00032462683,0.002398305,0.002096916,0.0012656986,0.001674657],"domain_scores_gemma":[0.99470854,0.00075304374,0.0013497863,0.0012352483,0.0009739791,0.0009794115],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00097461906,0.0014383525,0.0022160918,0.00068891764,0.00090149004,0.00024971366,0.0005265111,0.00081798155,0.0000832185],"category_scores_gemma":[0.00042976553,0.0011312183,0.0011192177,0.00094512553,0.00038468483,0.00062724884,0.00039182074,0.0001282969,0.000027262675],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23680389,0.0655155,0.005416514,0.00082883815,0.0020084323,0.00018207332,0.004729111,0.0000031319594,0.10427444,0.0004256974,0.015990406,0.563822],"study_design_scores_gemma":[0.7095359,0.02690673,0.032945648,0.0007673409,0.0009368227,0.00022366375,0.00056228694,0.003614837,0.22051436,0.00043172468,0.0025218572,0.0010388475],"about_ca_topic_score_codex":0.0034939402,"about_ca_topic_score_gemma":0.00002366277,"teacher_disagreement_score":0.5627831,"about_ca_system_score_codex":0.0057292134,"about_ca_system_score_gemma":0.0033960713,"threshold_uncertainty_score":0.9998366},"labels":[],"label_agreement":null},{"id":"W2070857960","doi":"10.1002/cyto.b.20365","title":"2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications","year":2007,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Flow cytometry; Consensus conference; Intensive care medicine; Diagnostic test; Pathology; Medical physics; Immunology; Internal medicine; Pediatrics","score_opus":0.05627296788117551,"score_gpt":0.39592253188623805,"score_spread":0.3396495640050625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070857960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95718974,0.0010773641,0.0026870617,0.015913164,0.0020403513,0.0008526421,0.0006289191,0.00017575604,0.019435031],"genre_scores_gemma":[0.99055773,0.0008566381,0.0024941731,0.0042496272,0.0004944637,0.00007565915,0.00066932995,0.000047489157,0.000554869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933095,0.0003622454,0.002754784,0.0008539636,0.002053285,0.00066622894],"domain_scores_gemma":[0.9790327,0.017229417,0.0009470517,0.001474149,0.0005645764,0.00075212197],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057952474,0.00045385995,0.001490002,0.005223662,0.0003084652,0.00005827001,0.0007413722,0.00062190153,0.0051549072],"category_scores_gemma":[0.013083524,0.0003184546,0.0012770745,0.015890747,0.0007062051,0.00007419496,0.0002573259,0.0008215667,0.0005045485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006203718,0.00649029,0.905089,0.000032922075,0.010725411,0.0001886492,0.00008484705,0.000013486363,0.00005574697,0.003045908,0.020010553,0.053642817],"study_design_scores_gemma":[0.004929062,0.000774577,0.94940346,0.00023183624,0.003898414,0.00013617062,0.0004198527,0.0009488082,0.0018504355,0.00012261375,0.036878716,0.00040604145],"about_ca_topic_score_codex":0.00006216977,"about_ca_topic_score_gemma":0.000031607866,"teacher_disagreement_score":0.053236775,"about_ca_system_score_codex":0.00046257884,"about_ca_system_score_gemma":0.00051744556,"threshold_uncertainty_score":0.99992675},"labels":[],"label_agreement":null},{"id":"W2071134744","doi":"10.3324/haematol.2011.047670","title":"Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Salvage therapy; Chemotherapy; Medicine; Gemcitabine; Oncology; Internal medicine; Lymphoma; Refractory (planetary science); Cisplatin; Transplantation; Surgery; Materials science","score_opus":0.02961090295293868,"score_gpt":0.2552838877525562,"score_spread":0.22567298479961756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071134744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032176,0.00028633713,0.0010480818,0.0013951332,0.0001101815,0.0028084882,0.00023013623,0.00027319923,0.00352668],"genre_scores_gemma":[0.9795793,0.00016528991,0.014229581,0.004527847,0.00009049047,0.00072011555,0.00025065825,0.00010726589,0.0003294257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997295,0.000039507082,0.00066713215,0.0008349763,0.0003876236,0.0007757532],"domain_scores_gemma":[0.9982712,0.00023851548,0.000265546,0.00065590703,0.00019414931,0.00037462733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020549753,0.00059867406,0.0011877166,0.00017974373,0.0002589087,0.00004027379,0.00024341546,0.00025651566,0.0009669896],"category_scores_gemma":[0.00004349667,0.00039805434,0.00026373737,0.00028570992,0.00009303496,0.00010931269,0.000028784683,0.00009215449,0.00006404957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09951002,0.016118186,0.7821785,0.0015370831,0.0031163385,0.0025362489,0.015764207,0.000012655933,0.0016242306,0.0041332296,0.011356133,0.06211313],"study_design_scores_gemma":[0.06957195,0.024111763,0.76046336,0.0012812178,0.00057889527,0.0002923199,0.00030625134,0.00009663109,0.1051405,0.000634841,0.036112864,0.0014094342],"about_ca_topic_score_codex":0.00010207199,"about_ca_topic_score_gemma":0.0002803991,"teacher_disagreement_score":0.103516266,"about_ca_system_score_codex":0.00019696042,"about_ca_system_score_gemma":0.0001088072,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W2071296119","doi":"10.1080/10428190801895345","title":"Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"BCL6; Cancer research; Psychological repression; Biology; Lymphoma; Diffuse large B-cell lymphoma; Repressor; Histone deacetylase; Gene; Genetics; B cell; Transcription factor; Histone; Immunology; Germinal center; Gene expression; Antibody","score_opus":0.02476285182321983,"score_gpt":0.2853888692776675,"score_spread":0.26062601745444763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071296119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018047135,0.972186,0.00003893226,0.000063462074,0.0010203096,0.004876827,0.0007620364,0.00022928331,0.0027759993],"genre_scores_gemma":[0.024737703,0.9670379,0.0006367661,0.0008784925,0.00085977884,0.0016006851,0.0007273887,0.0004983865,0.0030228975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914914,0.00044266845,0.002776507,0.0020999634,0.0012429109,0.0019465876],"domain_scores_gemma":[0.99298906,0.0014338519,0.0020856054,0.002342042,0.00038585963,0.0007635941],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00051918783,0.0023361337,0.0058184736,0.00053474907,0.001008763,0.00012797621,0.0011044851,0.0017720985,0.000057144603],"category_scores_gemma":[0.00022259646,0.0015313114,0.003815566,0.0011811274,0.0006607471,0.00020785691,0.0006631422,0.00026400652,0.000075363896],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033501585,0.0035836792,0.00068669126,0.017528333,0.001958244,0.00023921397,0.0005075648,0.0000017916892,0.00004803843,0.00088370347,0.008460701,0.965767],"study_design_scores_gemma":[0.043413945,0.0005906924,0.0013217693,0.0083884485,0.006104424,0.002749731,0.00014654727,0.00018823407,0.0009775108,0.00010098942,0.93455774,0.0014599499],"about_ca_topic_score_codex":0.00046868972,"about_ca_topic_score_gemma":0.000023177257,"teacher_disagreement_score":0.96430707,"about_ca_system_score_codex":0.012470882,"about_ca_system_score_gemma":0.013531202,"threshold_uncertainty_score":0.9995238},"labels":[],"label_agreement":null},{"id":"W2071582678","doi":"10.1182/blood-2009-12-257345","title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Biology; Comparative genomic hybridization; Cancer research; ABCC1; Gene silencing; Gene dosage; Chromosome; Genetics; Gene; Gene expression; ATP-binding cassette transporter","score_opus":0.015229363559561237,"score_gpt":0.2854469116598305,"score_spread":0.27021754810026927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071582678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658567,0.00012370192,0.000037034824,0.0003484551,0.00020376589,0.00050902733,0.000116183335,0.00003655041,0.0020396262],"genre_scores_gemma":[0.99644226,0.0000815511,0.0014931872,0.00007727101,0.00006139781,0.00014073605,0.0001327135,0.000017214676,0.0015536976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987311,0.000023422896,0.00039737066,0.0003374226,0.0002901832,0.00022052639],"domain_scores_gemma":[0.9988576,0.00014344741,0.00016416663,0.0005231368,0.00012037309,0.00019123068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007756126,0.00021475984,0.0006056849,0.00020797728,0.00006526361,0.000028627708,0.000082391845,0.000065486245,0.00040881365],"category_scores_gemma":[0.00002511172,0.00014166147,0.00024262985,0.00055801205,0.000054502052,0.00004848911,0.000027830929,0.0000644813,0.00014699873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008629154,0.002647983,0.99041194,0.000017703309,0.003266036,0.000055379005,0.0005053245,0.00003932118,0.0023990183,0.00004405198,0.000069869,0.00045708608],"study_design_scores_gemma":[0.0034084802,0.00067297847,0.95517874,0.000033597793,0.008988915,0.000014467163,0.00009272319,0.000014306499,0.029404491,0.0000064829323,0.0020379934,0.00014681555],"about_ca_topic_score_codex":0.00037399985,"about_ca_topic_score_gemma":0.0019012144,"teacher_disagreement_score":0.03523319,"about_ca_system_score_codex":0.00007008905,"about_ca_system_score_gemma":0.00006293534,"threshold_uncertainty_score":0.5776787},"labels":[],"label_agreement":null},{"id":"W2071995956","doi":"10.1016/j.critrevonc.2010.07.007","title":"Peripheral T-cell lymphoma – Not otherwise specified","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; CD5; International Prognostic Index; CD8; Not Otherwise Specified; Medicine; Pathology; Lymph node; B symptoms; Bone marrow; Cytotoxic T cell; Generalized lymphadenopathy; T cell; Biology; Immunology; Diffuse large B-cell lymphoma; Immune system","score_opus":0.0986027842196142,"score_gpt":0.43288626105203254,"score_spread":0.3342834768324183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071995956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038659928,0.95753664,0.000012676252,0.001497559,0.0016383943,0.0033829669,0.00003715363,0.00008548563,0.03577049],"genre_scores_gemma":[0.000105663945,0.9894032,0.0035968185,0.0023924983,0.0005766406,0.0027707568,0.00013071255,0.0001522931,0.00087143935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927229,0.0012242359,0.002948834,0.0014967519,0.0003201959,0.0012870505],"domain_scores_gemma":[0.99382097,0.0032849147,0.0005388285,0.0015346141,0.00013585135,0.00068484887],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010787268,0.0012271164,0.010917283,0.0004191805,0.00010837398,0.000036140304,0.0005800984,0.0028523523,0.0020476454],"category_scores_gemma":[0.0030086234,0.00086363894,0.0018331537,0.0005535887,0.0009200052,0.00006920716,0.00025517287,0.0012636652,0.0035540997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007159432,0.004142976,0.00006981566,0.020242061,0.00007862611,0.0043293606,0.000044870645,2.3992732e-9,0.0000013330163,0.021978913,0.0056549716,0.9433855],"study_design_scores_gemma":[0.0033645495,0.0007403184,0.000026410968,0.017727682,0.0019089445,0.0069085313,0.000015793337,0.0000018416162,0.000019094561,0.00019724468,0.96845305,0.00063655624],"about_ca_topic_score_codex":0.000016141252,"about_ca_topic_score_gemma":0.00008338322,"teacher_disagreement_score":0.96279806,"about_ca_system_score_codex":0.0016261148,"about_ca_system_score_gemma":0.0017717038,"threshold_uncertainty_score":0.9993814},"labels":[],"label_agreement":null},{"id":"W2072037526","doi":"10.1016/j.critrevonc.2012.02.005","title":"Anaplastic large cell lymphoma, ALK-positive","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; CD30; Medicine; Lymphoma; CHOP; Internal medicine; Oncology; International Prognostic Index; Large cell; Chemotherapy; Autologous stem-cell transplantation; Vincristine; Pathology; Cancer research; Cyclophosphamide; Diffuse large B-cell lymphoma; Cancer; Adenocarcinoma","score_opus":0.0786741343386865,"score_gpt":0.42814028940004256,"score_spread":0.34946615506135603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072037526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000074684754,0.96812326,0.00005459175,0.0005224791,0.0012638372,0.0032200355,0.000106305626,0.00006526389,0.026636774],"genre_scores_gemma":[0.00045897078,0.9927591,0.0013363045,0.0014947031,0.00040225632,0.0027066348,0.00039525307,0.00011808016,0.0003287011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922154,0.0017940131,0.0026665332,0.0012355717,0.00029401644,0.0017944569],"domain_scores_gemma":[0.9910871,0.0063729254,0.00053213374,0.0010385411,0.00014487209,0.0008244592],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001277102,0.0011837181,0.0105069205,0.0005158386,0.00012679191,0.000020995194,0.00040513615,0.0020451015,0.000901501],"category_scores_gemma":[0.0027705152,0.00083847996,0.0015138029,0.00064384344,0.00053467706,0.00009897523,0.00035147657,0.000788432,0.0062984615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000460339,0.009321378,0.00023982678,0.03520036,0.00017954728,0.003738858,0.000062306084,1.9538946e-9,6.451448e-8,0.035573646,0.0061065517,0.9095314],"study_design_scores_gemma":[0.003478855,0.001032053,0.00005303802,0.033860974,0.0059802462,0.006173156,0.000020478219,0.0000018021784,0.0000041658477,0.00016041649,0.9486441,0.0005907027],"about_ca_topic_score_codex":0.000011269871,"about_ca_topic_score_gemma":0.000042490312,"teacher_disagreement_score":0.94253755,"about_ca_system_score_codex":0.002108809,"about_ca_system_score_gemma":0.0013409368,"threshold_uncertainty_score":0.9994066},"labels":[],"label_agreement":null},{"id":"W2072108067","doi":"10.1097/rlu.0b013e3181a34552","title":"Spectrum of FDG PET/CT Findings in Burkitt Lymphoma","year":2009,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lymphoma; Positron emission tomography; Radiology; Nuclear medicine; Burkitt's lymphoma; Pelvis; Abdomen; Retrospective cohort study; Pathology","score_opus":0.0338965500803921,"score_gpt":0.3546723202807815,"score_spread":0.3207757702003894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072108067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511065,0.00045087532,7.5280184e-7,0.033354547,0.0002801771,0.00030241263,0.00000239515,0.000054872766,0.014447474],"genre_scores_gemma":[0.9915064,0.0009050989,0.00026381158,0.006633625,0.00037844433,0.000002731733,0.000013161747,0.000023463383,0.00027325796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775755,0.00006525992,0.0010587819,0.00040738113,0.0003810319,0.00032996343],"domain_scores_gemma":[0.9986362,0.00038092106,0.00014800367,0.00047998925,0.000043856613,0.00031107262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006472331,0.00020775126,0.0009936084,0.0001695848,0.000031723604,0.000004328656,0.00014424547,0.000040311712,0.0009814823],"category_scores_gemma":[0.00083068095,0.0001453226,0.00021687621,0.00033198946,0.00031445496,0.000045556524,0.000036628073,0.00016876367,0.00018808826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019895826,0.009823107,0.7626593,0.00014869809,0.0002869623,0.014677006,0.00046383557,0.0000015250307,0.0007712805,0.010589773,0.06678775,0.13180117],"study_design_scores_gemma":[0.014201016,0.004772083,0.9504591,0.00071560516,0.00017601838,0.00057679095,0.00015440905,0.000099584315,0.00017865536,0.0008248728,0.027712636,0.0001292262],"about_ca_topic_score_codex":0.00011526133,"about_ca_topic_score_gemma":0.000010202868,"teacher_disagreement_score":0.1877998,"about_ca_system_score_codex":0.00013246533,"about_ca_system_score_gemma":0.00007610232,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W2072351874","doi":"10.1182/blood-2006-08-038257","title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1484,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Medicine; CHOP; Oncology; Lymphoma; Progression-free survival; Chemotherapy","score_opus":0.005419418758643413,"score_gpt":0.21613464835556098,"score_spread":0.21071522959691757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072351874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958372,0.00017205988,0.00003431138,0.0009828304,0.000045583824,0.0018759415,0.0006307796,0.000034532968,0.00038673342],"genre_scores_gemma":[0.9983429,0.000021211992,0.00015807038,0.00028765158,0.00011008551,0.0004675754,0.00017839778,0.000036521593,0.00039762942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985465,0.000030601288,0.00033648856,0.00025905826,0.0005473513,0.00027999817],"domain_scores_gemma":[0.9988038,0.00024289064,0.00022510298,0.00037215813,0.00029185734,0.0000641852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008734888,0.00022535406,0.00030103666,0.00004708639,0.00014164344,0.000047318194,0.00015406522,0.000056307137,0.00001785756],"category_scores_gemma":[0.00003290474,0.00009299769,0.0001159779,0.0001232819,0.000091093614,0.000051403407,0.00003355066,0.00004398543,0.0000031154818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014957441,0.010029045,0.98649514,0.00005479325,0.00051803736,0.000014686706,0.00009783753,2.2156414e-7,0.000006183735,0.00004346119,0.0007307156,0.0005141198],"study_design_scores_gemma":[0.086941056,0.001713722,0.90428656,0.00015872446,0.0008694925,0.000007117479,0.000030607167,0.000027949112,0.0011753389,0.000015249479,0.004665524,0.00010866554],"about_ca_topic_score_codex":0.00006890323,"about_ca_topic_score_gemma":0.00005014957,"teacher_disagreement_score":0.085445315,"about_ca_system_score_codex":0.00008189346,"about_ca_system_score_gemma":0.00007796001,"threshold_uncertainty_score":0.37923357},"labels":[],"label_agreement":null},{"id":"W2072666920","doi":"10.1111/j.1440-1673.2007.01701.x","title":"Hodgkin’s disease of the oesophagus: A literature review","year":2007,"lang":"en","type":"review","venue":"Australasian Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Hospital; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Disease; Gastrointestinal tract; Dermatology; Pathology; Internal medicine","score_opus":0.04342687006723153,"score_gpt":0.37138660320342587,"score_spread":0.3279597331361943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072666920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008903066,0.99562836,4.0552504e-7,0.00081338856,0.0003991413,0.0020942646,0.00021302351,0.000026004083,0.00081651926],"genre_scores_gemma":[0.00009514254,0.9965545,0.00007525146,0.00086382235,0.00034797334,0.0002162596,0.0003639393,0.000044154458,0.0014389687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997767,0.00028085717,0.00084232725,0.00049840147,0.00020988812,0.00040156356],"domain_scores_gemma":[0.9978105,0.00018178108,0.0004997906,0.0011426717,0.00007181154,0.00029346973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021329639,0.00051920407,0.0027244142,0.00014569677,0.000043485114,0.0000075655685,0.000320915,0.00046470252,0.00017908863],"category_scores_gemma":[0.00016401087,0.00025972427,0.001598867,0.0005738117,0.0002251734,0.0000244108,0.00007046439,0.00044810155,0.00007242798],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022965038,0.0003341907,0.0012234226,0.14654443,0.000838906,0.0018297782,0.000021952541,2.2221279e-8,5.0583168e-8,0.00082225114,0.035198454,0.8131636],"study_design_scores_gemma":[0.0003930457,0.00010330354,0.0045611835,0.17438315,0.0051200977,0.0026537497,0.000001010629,2.8538038e-8,5.7356175e-7,0.000017319471,0.81262285,0.0001436728],"about_ca_topic_score_codex":0.0000034069576,"about_ca_topic_score_gemma":0.0000010954941,"teacher_disagreement_score":0.81301993,"about_ca_system_score_codex":0.00022328184,"about_ca_system_score_gemma":0.00054975343,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W2072820018","doi":"10.14740/wjon736w","title":"Isolated Recurrence of Diffuse Large B-Cell Lymphoma in Sciatic Nerve","year":2014,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sciatic nerve; Lymphoma; Diffuse large B-cell lymphoma; Surgery; Pathology; Internal medicine","score_opus":0.013654529176654055,"score_gpt":0.29159475471930957,"score_spread":0.2779402255426555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072820018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092764,0.0011588259,0.000058904647,0.0015201885,0.00035931478,0.00012368693,0.0000024197323,0.000004326242,0.005844722],"genre_scores_gemma":[0.9982111,0.00023254956,0.00075068546,0.00040471304,0.00010637536,0.0000038142298,0.0000019784275,0.000009465031,0.00027935996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998613,0.00016998786,0.0006803589,0.00011249113,0.00019026658,0.00023387867],"domain_scores_gemma":[0.99858713,0.00036680073,0.0005946928,0.00015608862,0.00015551639,0.00013974967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889336,0.00011405078,0.00065439066,0.00039139262,0.000021881977,0.0000045925594,0.000110648274,0.00007500433,0.00007719088],"category_scores_gemma":[0.00016653458,0.000083481915,0.00014219273,0.00034748172,0.000051206724,0.00005495333,0.00003326862,0.00012337002,0.00001765202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017631417,0.04249561,0.7174914,0.00017155654,0.00023411412,0.0017425861,0.0010837206,0.000010516724,0.0020632735,0.0013143467,0.006061865,0.2255679],"study_design_scores_gemma":[0.119720876,0.011520602,0.74995595,0.0010303113,0.00054451404,0.0011377874,0.00017579284,0.0012781419,0.004443594,0.0007251885,0.109221995,0.00024523164],"about_ca_topic_score_codex":0.000035894365,"about_ca_topic_score_gemma":0.00023456491,"teacher_disagreement_score":0.22532268,"about_ca_system_score_codex":0.00040552317,"about_ca_system_score_gemma":0.0003242444,"threshold_uncertainty_score":0.34042937},"labels":[],"label_agreement":null},{"id":"W2072876252","doi":"10.1038/sj.leu.2403702","title":"Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Biology; B cell; Intracellular; Cell; Pathology; BCL10; Cell signaling; Cancer research; Immunology; Signal transduction; Cell biology; Medicine; Antibody; Genetics","score_opus":0.009223210128632177,"score_gpt":0.2203856454429748,"score_spread":0.21116243531434262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072876252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471194,0.00080856023,0.000049289436,0.00024096658,0.00005559124,0.0005481967,0.000009910515,0.000046190402,0.0035293372],"genre_scores_gemma":[0.99784446,0.000101077145,0.00096807635,0.00032268936,0.00011896596,0.00010753124,0.00009793305,0.00002685727,0.0004124252],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849206,0.000056856265,0.00044668745,0.00029446938,0.00039087926,0.0003190536],"domain_scores_gemma":[0.99925005,0.000078984776,0.00018573784,0.0002936869,0.000055571334,0.00013595923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015942084,0.00020245559,0.0004287728,0.00012529905,0.000030647752,0.000008513295,0.000100558,0.0001699662,0.00013588308],"category_scores_gemma":[0.000042049327,0.00016503346,0.00010788804,0.00017434434,0.000048064863,0.000085440035,0.00006245988,0.00010188751,0.00006733317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000497276,0.0058892774,0.4588615,0.00042885842,0.000088042696,0.00078758853,0.0018613234,0.00012773467,0.2724782,0.000011016777,0.002830933,0.25613827],"study_design_scores_gemma":[0.011069591,0.00029507422,0.4122215,0.0005156482,0.000057119483,0.000020773266,0.00005083703,0.00047521672,0.5740025,0.0000073778174,0.001141377,0.00014300729],"about_ca_topic_score_codex":0.0004884588,"about_ca_topic_score_gemma":0.00008276741,"teacher_disagreement_score":0.30152428,"about_ca_system_score_codex":0.0025755842,"about_ca_system_score_gemma":0.00050856493,"threshold_uncertainty_score":0.6735063},"labels":[],"label_agreement":null},{"id":"W2073376803","doi":"10.1016/j.hoc.2007.06.014","title":"New Strategies for the Treatment of Early Stages of Hodgkin's Lymphoma","year":2007,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Chemotherapy; Stage (stratigraphy); Medicine; Balance (ability); Intensive care medicine; Radiation therapy; Cure rate; Oncology; Internal medicine; Biology; Physical therapy","score_opus":0.09615635814690017,"score_gpt":0.42976516302183165,"score_spread":0.3336088048749315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073376803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004130519,0.99100953,0.00040401716,0.00013585763,0.0004442724,0.0030758877,0.00035618956,0.000029091978,0.00041461363],"genre_scores_gemma":[0.0021167628,0.9902801,0.0064980127,0.00008246351,0.0001381413,0.0004280564,0.00022142314,0.000065650835,0.00016937751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586403,0.00018783772,0.0025663096,0.00058937544,0.00027560495,0.0005168238],"domain_scores_gemma":[0.98648345,0.008478588,0.0034333675,0.0010563954,0.00034684222,0.00020135034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024932128,0.00066544756,0.0068567027,0.0003241299,0.00006425302,0.0000050152385,0.00038817353,0.00070324476,0.00005544105],"category_scores_gemma":[0.00016508072,0.00039072946,0.001983928,0.00046139502,0.0009940559,0.000038485974,0.00006536798,0.00013101948,0.00001551357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050840486,0.003413887,0.01854355,0.0053722584,0.0039639105,0.000118618016,0.00026808117,0.0000014623818,4.5625974e-8,0.00077515683,0.0010141948,0.9660204],"study_design_scores_gemma":[0.004694143,0.020134673,0.0041830693,0.0015586662,0.009687691,0.00021367263,0.00022241492,0.0000018605718,0.000010159663,0.00010314734,0.95894533,0.00024518522],"about_ca_topic_score_codex":0.00044336767,"about_ca_topic_score_gemma":0.0001933982,"teacher_disagreement_score":0.96577525,"about_ca_system_score_codex":0.00027448847,"about_ca_system_score_gemma":0.0050425897,"threshold_uncertainty_score":0.99985445},"labels":[],"label_agreement":null},{"id":"W2073523783","doi":"10.1080/10428190210173","title":"Diffuse Large B-cell Lymphoma: A Clinicopathologic Analysis of 444 Cases Classified According to the Updated Kiel Classification","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lymphoma; Medicine; Anaplastic large-cell lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Retrospective cohort study; Stage (stratigraphy); Overall survival; Subtyping; Large cell; Pathology; Gastroenterology; Cancer; Adenocarcinoma; Biology","score_opus":0.039268709251652406,"score_gpt":0.2788327295271943,"score_spread":0.23956402027554188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073523783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874051,0.003145645,0.00012071083,0.0009408429,0.00039603445,0.0013259447,0.0003132219,0.00030578795,0.006046679],"genre_scores_gemma":[0.9907342,0.0023064779,0.00047432454,0.0034873176,0.00027702432,0.00042913225,0.0004818558,0.00011834909,0.0016913164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99371946,0.00038500334,0.0018199661,0.0017021707,0.0010228403,0.0013505386],"domain_scores_gemma":[0.9948106,0.0009951298,0.00088154007,0.0021135348,0.00037255947,0.00082664884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007595996,0.0010442438,0.0020885868,0.0011290396,0.000720317,0.00021557085,0.0006688663,0.00070109504,0.00021680968],"category_scores_gemma":[0.0003462649,0.0007503422,0.0010242878,0.0034828007,0.0003660741,0.00031390684,0.00040536025,0.00013999295,0.0002773214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030009628,0.029650643,0.47769836,0.0004979946,0.0066386224,0.0037009004,0.006357049,0.0001848464,0.010831891,0.0039409366,0.035156887,0.42234093],"study_design_scores_gemma":[0.051807053,0.001125194,0.863433,0.0002105022,0.008280741,0.0008947371,0.0037398783,0.034292765,0.0049878363,0.00003475999,0.0300942,0.001099305],"about_ca_topic_score_codex":0.0009054961,"about_ca_topic_score_gemma":0.00018883396,"teacher_disagreement_score":0.4212416,"about_ca_system_score_codex":0.005328424,"about_ca_system_score_gemma":0.000971933,"threshold_uncertainty_score":0.99949473},"labels":[],"label_agreement":null},{"id":"W2073562475","doi":"10.1002/pon.1404","title":"The impact of follicular (FL) and other indolent non‐Hodgkin's lymphomas (NHL) on work productivity–a preliminary analysis","year":2008,"lang":"en","type":"article","venue":"Psycho-Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Lymphoma; Internal medicine; Sick leave; Work productivity; Hodgkin lymphoma; Hematology; Follicular lymphoma; Productivity; Non-Hodgkin's lymphoma; Cancer; Physical therapy","score_opus":0.02695732670355088,"score_gpt":0.3424197512546001,"score_spread":0.3154624245510492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073562475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989764,0.0020113837,0.00001584972,0.0018727713,0.00016028863,0.00074948615,0.000011445505,0.00002577748,0.0053890357],"genre_scores_gemma":[0.99812293,0.0007411683,0.00021353178,0.00024521194,0.00018091574,0.00019855374,0.000009793152,0.0000257885,0.0002621115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835193,0.00017402937,0.00036629886,0.00048429295,0.0002663822,0.00035706995],"domain_scores_gemma":[0.998379,0.00039816403,0.00024639763,0.00070881366,0.00008467328,0.00018295489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003123918,0.00026506535,0.00073333987,0.00022485372,0.0001986879,0.000008779152,0.00011515753,0.00017781454,0.00006657196],"category_scores_gemma":[0.000071739705,0.00015053092,0.0004455811,0.0006985364,0.00028499996,0.00003412565,0.00004539196,0.00011636819,0.000026406917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040138117,0.004303175,0.9347688,0.000016208038,0.004610841,0.00024410733,0.0042545353,0.00010722713,0.00041243213,0.0000547844,0.0037093477,0.04350472],"study_design_scores_gemma":[0.004722893,0.0066049844,0.9770825,0.00004516332,0.0011482621,0.00024922783,0.00025171778,0.000055975157,0.002000469,0.000050522394,0.0076404274,0.00014787618],"about_ca_topic_score_codex":0.0005912622,"about_ca_topic_score_gemma":0.000044013632,"teacher_disagreement_score":0.043356843,"about_ca_system_score_codex":0.00056890724,"about_ca_system_score_gemma":0.00029112806,"threshold_uncertainty_score":0.61384726},"labels":[],"label_agreement":null},{"id":"W2073588844","doi":"10.1002/hon.935","title":"Vav‐1 expression correlates with NFκB activation and CD40‐mediated cell death in diffuse large B‐cell lymphoma cell lines","year":2010,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"Germinal center; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; CD40; B cell; Biology; Gene expression profiling; Cell; Cell culture; Gene expression; Immunology; Antibody; Gene; Cytotoxic T cell; In vitro; Genetics","score_opus":0.013925940525976614,"score_gpt":0.2678761809839723,"score_spread":0.2539502404579957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073588844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917353,0.00026820856,0.00004234242,0.0006682891,0.00013174379,0.00054928806,0.000007150186,0.00009509339,0.0065026334],"genre_scores_gemma":[0.99640656,0.00022254983,0.0021661539,0.00070736767,0.00005876927,0.00013523657,0.000088969246,0.000024028932,0.00019035907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984133,0.0001275831,0.00037415038,0.0004840787,0.00017303276,0.00042782963],"domain_scores_gemma":[0.99840796,0.0008313989,0.00019749823,0.00024926057,0.00006584527,0.00024805396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016811576,0.0002821496,0.0006597199,0.00011976823,0.00009085018,0.000016171649,0.00008243069,0.0005313401,0.00012684459],"category_scores_gemma":[0.00011166977,0.00016834607,0.00006111809,0.00015642485,0.00010786833,0.000077281235,0.00009672613,0.00026684406,0.000085798885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009099177,0.028853247,0.89328665,0.00015263101,0.000017464994,0.0020096123,0.00039945042,9.22028e-7,0.07232915,0.00031030006,0.00070392946,0.0010267119],"study_design_scores_gemma":[0.06708867,0.0030438004,0.5843744,0.00017043465,0.00015244549,0.0007071778,0.00035541173,0.00053017994,0.33457348,0.00021476996,0.008368769,0.0004204123],"about_ca_topic_score_codex":0.000035406356,"about_ca_topic_score_gemma":0.00006182064,"teacher_disagreement_score":0.30891222,"about_ca_system_score_codex":0.00011307865,"about_ca_system_score_gemma":0.00011814129,"threshold_uncertainty_score":0.68649536},"labels":[],"label_agreement":null},{"id":"W2074047902","doi":"10.1182/asheducation-2014.1.144","title":"The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling","year":2014,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Tumor microenvironment; Oncology; BCL6; CD163; Bleomycin; Immunohistochemistry; Lymphoma; Cancer research; Pathology; Internal medicine; Biology; Chemotherapy; Immunology; Cancer; Antibody; Phenotype; Gene; Vincristine; B cell","score_opus":0.02576251505755687,"score_gpt":0.2971332092750211,"score_spread":0.27137069421746424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074047902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008761543,0.99725926,0.0002151495,0.0005671261,0.000150027,0.0007711048,0.000019064582,0.00004290133,0.00009921644],"genre_scores_gemma":[0.002919427,0.9946185,0.0011428338,0.00032463268,0.0001304924,0.0005563627,0.00008586343,0.000073520045,0.00014836455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786186,0.00024071835,0.0006359912,0.00061733444,0.00019423454,0.000449884],"domain_scores_gemma":[0.9981976,0.0006362774,0.00026473438,0.0006722554,0.00001754179,0.00021156536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015632978,0.00049684674,0.0020584867,0.00008619935,0.00023940254,0.0000341614,0.00015872152,0.00031014578,0.000037590296],"category_scores_gemma":[0.000069538706,0.000267204,0.00039515438,0.00006239767,0.00023131246,0.000013029645,0.00013031205,0.00014409942,0.00014689448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008017577,0.0006689306,0.00023936205,0.011395465,0.00044347826,0.0015603595,0.000022318973,0.000004188107,0.000015819907,0.0008557576,0.0023896797,0.9823245],"study_design_scores_gemma":[0.002023406,0.00016229667,0.000014461037,0.006529777,0.0013945934,0.0038385298,0.000008617007,0.0009187708,0.00035294713,0.000051146602,0.984415,0.00029047934],"about_ca_topic_score_codex":0.0000050438625,"about_ca_topic_score_gemma":0.0000019343029,"teacher_disagreement_score":0.98203397,"about_ca_system_score_codex":0.00017584853,"about_ca_system_score_gemma":0.00020682298,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W2074214385","doi":"10.1016/j.bbmt.2012.04.010","title":"Tandem Transplantation for Follicular Lymphoma: The Best of Both Worlds?","year":2012,"lang":"en","type":"letter","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Oncology; Transplantation; Internal medicine; Hematopoietic stem cell transplantation","score_opus":0.016275851345430015,"score_gpt":0.2535653762400942,"score_spread":0.23728952489466415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074214385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.886724,0.021896098,0.0011405156,0.08279418,0.0006755093,0.0032853142,0.0026523012,0.00004747477,0.00078458624],"genre_scores_gemma":[0.96944654,0.012636476,0.0006503531,0.011572462,0.0005903798,0.00022634072,0.004712229,0.000029824729,0.00013538478],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988398,0.00008187039,0.00043458783,0.00026531282,0.00013367907,0.00024475562],"domain_scores_gemma":[0.99905026,0.0003703715,0.00028591426,0.00017458684,0.00007703679,0.00004182365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017131682,0.0002551046,0.0005693118,0.00012011744,0.00007120534,0.00000497302,0.000073311334,0.000535079,0.0000127612875],"category_scores_gemma":[0.0000060803422,0.00016541552,0.0002277689,0.000070616356,0.00019015545,0.000043026117,0.0000032262303,0.00010475375,0.0000012036885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065747513,0.0064171315,0.5193255,0.045868345,0.017269129,0.00088253466,0.009282331,0.0000051131474,0.21457702,0.005851801,0.06294995,0.11099642],"study_design_scores_gemma":[0.0788036,0.009406476,0.19246915,0.0049750465,0.10751313,0.0038560035,0.00034787573,0.000028539924,0.3474434,0.0017345729,0.25154278,0.0018794136],"about_ca_topic_score_codex":0.00016242528,"about_ca_topic_score_gemma":0.000037715647,"teacher_disagreement_score":0.32685634,"about_ca_system_score_codex":0.0000147435085,"about_ca_system_score_gemma":0.000078727666,"threshold_uncertainty_score":0.67454493},"labels":[],"label_agreement":null},{"id":"W2074565879","doi":"10.1158/1538-7445.am2013-2637","title":"Abstract 2637: Examining the function of the serine protease, Granzyme B, in ALK-positive, anaplastic large cell lymphoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Cancer research; Granzyme; Anaplastic large-cell lymphoma; Granzyme B; Cytotoxic T cell; Biology; Lymphoma; Medicine; Immunology; Pathology; T cell; Perforin; Lung cancer; Genetics; Immune system; In vitro","score_opus":0.04677557367154738,"score_gpt":0.3309162721922856,"score_spread":0.2841406985207382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074565879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081224,0.0011862407,0.000002223573,0.0013357309,0.00010240154,0.0016339326,0.000023993229,0.000010316743,0.0048929434],"genre_scores_gemma":[0.997277,0.00020663174,0.0000075566786,0.00012948015,0.00009998011,0.0012332074,0.000009000405,0.000018316177,0.0010187972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839896,0.00013808464,0.00021902815,0.00024717278,0.00057218835,0.00042458423],"domain_scores_gemma":[0.9989262,0.00029410585,0.00006168981,0.0003887663,0.00023637644,0.00009286473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984735,0.00011860821,0.00018928782,0.00010745869,0.00016326073,0.000031233612,0.00015921803,0.00006101813,0.0005723685],"category_scores_gemma":[0.0000863265,0.000060665876,0.000059157574,0.0005376176,0.00014279349,0.000084414816,0.00010872911,0.00019223939,0.00007643354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016197559,0.0056257523,0.7902577,0.0009251666,0.0003142401,0.00013784065,0.0018680099,0.0000912242,0.09161544,0.00055503024,0.017666198,0.08932362],"study_design_scores_gemma":[0.0041428055,0.00033900645,0.95513326,0.00032050643,0.000025194568,0.000004208386,0.00034624914,0.00006938844,0.037101757,0.000059298305,0.002399272,0.0000590584],"about_ca_topic_score_codex":0.004074993,"about_ca_topic_score_gemma":0.0005495018,"teacher_disagreement_score":0.16487554,"about_ca_system_score_codex":0.00038769146,"about_ca_system_score_gemma":0.0003584344,"threshold_uncertainty_score":0.6267034},"labels":[],"label_agreement":null},{"id":"W2074678620","doi":"10.1182/blood-2012-02-408542","title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Institute of Cancer Research; Fondation pour la Recherche Médicale","keywords":"Angioimmunoblastic T-cell lymphoma; Lymphoma; Peripheral T-cell lymphoma; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Not Otherwise Specified; T cell; Gastroenterology; Oncology; Cancer research; Immunology; Immune system","score_opus":0.01871058031353838,"score_gpt":0.2828336209555949,"score_spread":0.2641230406420565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074678620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365413,0.0035433264,0.0000021262413,0.00019054707,0.00022818123,0.00036316607,0.000009184864,0.000030444187,0.001978865],"genre_scores_gemma":[0.99679863,0.0003437605,0.0021475006,0.00022127971,0.00006749977,0.000071712355,0.00003758748,0.000017440947,0.00029459316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990361,0.000059417685,0.00024119043,0.00023106593,0.00015085313,0.00028141926],"domain_scores_gemma":[0.99932927,0.00013788401,0.00007026024,0.00018903427,0.000024630752,0.00024894264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012911548,0.0001613183,0.00027397697,0.000058800088,0.000048106165,0.000011912634,0.0000319349,0.000094648014,0.00002967898],"category_scores_gemma":[0.0000330564,0.00011192709,0.00007491191,0.00010918351,0.00010008667,0.00008418214,0.000022995791,0.000113703405,0.00002259517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020358106,0.0048575457,0.9872574,0.000025607791,0.00013362133,0.00014817688,0.0007137806,0.0000031325314,0.000020376161,0.00004037963,0.00023763215,0.006358766],"study_design_scores_gemma":[0.01714163,0.00086317543,0.9788474,0.00011348574,0.0006028719,0.00033974278,0.0003536308,0.000018793971,0.00043163967,0.000011064911,0.0011314014,0.00014515957],"about_ca_topic_score_codex":0.000087375396,"about_ca_topic_score_gemma":0.00005802362,"teacher_disagreement_score":0.01693805,"about_ca_system_score_codex":0.00006290609,"about_ca_system_score_gemma":0.00008281811,"threshold_uncertainty_score":0.45642543},"labels":[],"label_agreement":null},{"id":"W2075104136","doi":"10.1007/s11912-008-0062-3","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Lymphoma; Peripheral T-cell lymphoma; Targeted therapy; Internal medicine; Bioinformatics; T cell; Immunology; Cancer; Immune system","score_opus":0.1148281629155169,"score_gpt":0.4089567738251841,"score_spread":0.2941286109096672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075104136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054663373,0.98736817,0.0000026024443,0.00006188487,0.0025619776,0.001651992,0.000013197166,0.00007433275,0.007719195],"genre_scores_gemma":[0.00030645163,0.9968459,0.00023972112,0.0000586759,0.00044891716,0.00097049476,0.00039879864,0.00007401871,0.00065704633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673444,0.00011748275,0.0014319137,0.00088235526,0.00031693754,0.0005168729],"domain_scores_gemma":[0.997895,0.00016531962,0.0009034173,0.00073038787,0.00008063548,0.00022525975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018482143,0.0006774192,0.003317209,0.00032409743,0.00007400623,0.000014796556,0.000106362866,0.00061143097,0.00019201802],"category_scores_gemma":[0.000059206694,0.0004805,0.0009165944,0.0003244595,0.00016979774,0.000047537458,0.00009708984,0.00041325827,0.00006285089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010366136,0.0056549376,0.006065972,0.003835396,0.0002242547,0.011331696,0.00021080878,1.5694881e-7,5.9454806e-7,0.0000129081545,0.0043823253,0.9682706],"study_design_scores_gemma":[0.0018300187,0.00037335273,0.0014263137,0.006065829,0.0007862903,0.033201754,0.000014988162,6.8455023e-7,0.0000016110881,0.000008702033,0.95599234,0.0002981101],"about_ca_topic_score_codex":0.00004672891,"about_ca_topic_score_gemma":0.000018398758,"teacher_disagreement_score":0.96797246,"about_ca_system_score_codex":0.0025819768,"about_ca_system_score_gemma":0.0036348475,"threshold_uncertainty_score":0.9997647},"labels":[],"label_agreement":null},{"id":"W2075141373","doi":"10.1200/jco.2008.17.1561","title":"Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Vincristine; Rituximab; Internal medicine; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; International Prognostic Index; Gastroenterology; Chemotherapy; Surgery; Oncology; Confidence interval","score_opus":0.029554109536050983,"score_gpt":0.41137157549942155,"score_spread":0.3818174659633706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075141373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854863,0.0020053268,0.0000097930115,0.009085357,0.0006833783,0.0021711036,0.000014900897,0.00000783067,0.000535995],"genre_scores_gemma":[0.996227,0.0011559008,0.0015534492,0.00067022734,0.00022025214,0.00008305166,0.0000016797441,0.000012556697,0.00007583008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993223,0.0013518631,0.0041232402,0.0003527523,0.00063272734,0.00031643143],"domain_scores_gemma":[0.9928412,0.0031062164,0.0028557428,0.0004812429,0.00044128657,0.00027433076],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007480532,0.00025154397,0.00330803,0.00011086033,0.000042122603,0.000010133099,0.00027077648,0.00025522537,0.0000109629245],"category_scores_gemma":[0.010928425,0.00012670553,0.00053835916,0.00021988936,0.00039648102,0.000110004505,0.0001441849,0.0004126062,0.0000011489254],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58080494,0.04590476,0.09241938,0.000021251766,0.00033180756,0.001613904,0.00046217168,0.0000033039653,0.000012804668,0.000021280674,0.00036885255,0.27803555],"study_design_scores_gemma":[0.5212825,0.013617939,0.4631668,0.000349992,0.00039526555,0.000117926575,0.00012983344,0.000034427456,0.00007257643,0.00023853044,0.0005266153,0.00006762038],"about_ca_topic_score_codex":0.000049915714,"about_ca_topic_score_gemma":0.00012391685,"teacher_disagreement_score":0.37074742,"about_ca_system_score_codex":0.00022384923,"about_ca_system_score_gemma":0.0009507101,"threshold_uncertainty_score":0.99740297},"labels":[],"label_agreement":null},{"id":"W2075274617","doi":"10.1038/leu.2013.224","title":"Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Cancer research; Biology; CHOP; Internal medicine; Lymphoma; Oncology; Medicine","score_opus":0.01151518917437346,"score_gpt":0.2321673165111979,"score_spread":0.22065212733682443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075274617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631256,0.00027009597,9.310822e-7,0.00015266554,0.0000657883,0.0022142734,0.000035075445,0.000037285306,0.00091132807],"genre_scores_gemma":[0.9978069,0.000034754306,0.000048964368,0.0001659218,0.00002974897,0.00057545933,0.000014890548,0.00002768016,0.0012956546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983397,0.00009336586,0.0004764609,0.00038755816,0.0003511621,0.00035176508],"domain_scores_gemma":[0.99897856,0.000098558885,0.00019178225,0.00048162803,0.000095728705,0.00015373183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000817904,0.00022973631,0.00039237537,0.00007847771,0.00006001906,0.000015862852,0.00012379218,0.0001526113,0.00005229657],"category_scores_gemma":[0.00023343753,0.00012430786,0.000093246206,0.00015181748,0.000044259123,0.00013467288,0.00017269213,0.00008249998,0.000040815685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018863313,0.0027647056,0.9738869,0.0001865683,0.000023419627,0.000030585452,0.00028959377,4.4927026e-7,0.019503174,0.00003440004,0.00035584104,0.0027357202],"study_design_scores_gemma":[0.03333341,0.00021518201,0.7250006,0.0006175021,0.0000496584,0.0000052527053,0.0000240463,0.00015580995,0.24027328,0.000044561682,0.00017315755,0.00010751768],"about_ca_topic_score_codex":0.00022447684,"about_ca_topic_score_gemma":0.000009889773,"teacher_disagreement_score":0.24888629,"about_ca_system_score_codex":0.0007052655,"about_ca_system_score_gemma":0.000110745415,"threshold_uncertainty_score":0.5069127},"labels":[],"label_agreement":null},{"id":"W2075365709","doi":"10.1111/bjh.12688","title":"Genome‐wide <scp>DNA</scp> profiling identifies clonal heterogeneity in marginal zone lymphomas","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Oncosuisse","keywords":"Biology; Genome; Somatic evolution in cancer; SNP array; Genetics; Cancer; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.01687744581327626,"score_gpt":0.25179646801281375,"score_spread":0.23491902219953747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93374836,0.023544824,0.000030117857,0.0403214,0.0010686378,0.0006678116,0.00006888539,0.00002869304,0.0005212855],"genre_scores_gemma":[0.71750224,0.011507642,0.0051888474,0.2513606,0.0074227713,0.00039517926,0.0012390637,0.0004304013,0.0049532535],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99528027,0.00038177578,0.0018779767,0.0006103488,0.0008550399,0.0009945916],"domain_scores_gemma":[0.99682325,0.0006847915,0.0013141636,0.00038178003,0.0005215026,0.0002745131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005165021,0.00057046366,0.002589933,0.00069170404,0.00012366696,0.00019506554,0.00043649445,0.0011599421,0.00021037781],"category_scores_gemma":[0.0005057342,0.00057938794,0.0007460149,0.00022180082,0.00029930368,0.00025011224,0.00016375737,0.0016203395,0.00017332517],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038921815,0.00058712286,0.07542245,0.0008092861,0.00097387936,0.56854326,0.00008061861,0.000003394877,0.00018298312,0.000014235292,0.35223088,0.0011129972],"study_design_scores_gemma":[0.0056263935,0.00042274466,0.16804126,0.0020156023,0.00062209886,0.6699031,0.000087976376,0.000006065776,0.0026182472,0.00026814197,0.15016595,0.00022241239],"about_ca_topic_score_codex":0.00034849774,"about_ca_topic_score_gemma":0.0001599768,"teacher_disagreement_score":0.2162461,"about_ca_system_score_codex":0.0007628076,"about_ca_system_score_gemma":0.0009656625,"threshold_uncertainty_score":0.99966574},"labels":[],"label_agreement":null},{"id":"W2075382803","doi":"10.1097/01.lab.0000028824.03032.ab","title":"A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors","year":2002,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Monoclonal antibody; Lymphatic system; Pathology; Antibody; Primary (astronomy); Monoclonal; Biology; Medicine; Immunology","score_opus":0.021921691450873918,"score_gpt":0.25089977593317087,"score_spread":0.22897808448229695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075382803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976619,0.00062432914,0.0002559219,0.00048799982,0.00009212934,0.0006327931,0.000015138473,0.000035795565,0.00019403177],"genre_scores_gemma":[0.9954246,0.000061250845,0.0036297648,0.0005365446,0.00008794379,0.00008005686,0.00009089427,0.000016676879,0.00007221213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990731,0.000040519823,0.00033898943,0.00021082815,0.00019669996,0.00013988573],"domain_scores_gemma":[0.99935466,0.00007626327,0.00015445652,0.00016953822,0.000114428876,0.00013065903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012761178,0.0001252415,0.0002480401,0.0001685113,0.000036763882,0.00001008277,0.000036276455,0.000086274216,0.000030430861],"category_scores_gemma":[0.00012676792,0.000115040755,0.00004993179,0.0004433268,0.00004520691,0.00017717859,0.000010543312,0.000037115973,0.000014754953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016003408,0.00036710702,0.39211723,0.00041703743,0.000049284743,0.000020902877,0.00079256593,0.00003798475,0.58530545,0.00039403647,0.0011331895,0.019205164],"study_design_scores_gemma":[0.0040137493,0.00043746794,0.5920091,0.00036210887,0.000076842516,0.0000090618405,0.000044068765,0.001748997,0.40014496,0.00052046,0.0005171091,0.000116057],"about_ca_topic_score_codex":0.0001116918,"about_ca_topic_score_gemma":0.000030057383,"teacher_disagreement_score":0.19989188,"about_ca_system_score_codex":0.00031190788,"about_ca_system_score_gemma":0.0002368839,"threshold_uncertainty_score":0.46912256},"labels":[],"label_agreement":null},{"id":"W2075864830","doi":"10.1111/bjh.13085","title":"<scp>CD</scp>30 expression in <i>de novo</i> diffuse large B‐cell lymphoma: a population‐based study from British Columbia","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Tissue microarray; Lymphoma; CHOP; Rituximab; Medicine; International Prognostic Index; Immunohistochemistry; Population; Internal medicine; Germinal center; Cancer research; Oncology; Cyclophosphamide; Pathology; Immunology; Antibody; B cell; Chemotherapy","score_opus":0.007589520789091803,"score_gpt":0.2362843618387992,"score_spread":0.2286948410497074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075864830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624085,0.0024356938,0.00012345072,0.00009626835,0.00028250884,0.00044082408,0.00006341638,0.000031859963,0.00028509737],"genre_scores_gemma":[0.99741757,0.0001450586,0.001190629,0.0007614293,0.00016872321,0.00004430195,0.00005319615,0.00004457505,0.00017454519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972552,0.00044668588,0.0009881,0.00036447417,0.00043460593,0.00051091117],"domain_scores_gemma":[0.9981548,0.0005579972,0.0005244529,0.00027100724,0.0001763599,0.0003153815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005110098,0.00018072689,0.0011471782,0.00012615614,0.00015763886,0.00021767756,0.00020392881,0.00022014558,0.00017859487],"category_scores_gemma":[0.0006254937,0.0002526144,0.00022863859,0.00017997969,0.000038412596,0.00014252312,0.000071430455,0.00021284384,0.000021339614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034631026,0.019929782,0.89029706,0.0000520623,0.0000733255,0.07314353,0.00021341302,0.000004731364,0.00013108188,0.0000020634518,0.012579564,0.003538738],"study_design_scores_gemma":[0.051848207,0.0006249421,0.912077,0.00093983137,0.00023461644,0.030624678,0.00031368763,0.000070965936,0.00027987553,0.00019736153,0.0026880093,0.0001007994],"about_ca_topic_score_codex":0.0158536,"about_ca_topic_score_gemma":0.034193918,"teacher_disagreement_score":0.051813573,"about_ca_system_score_codex":0.00034276012,"about_ca_system_score_gemma":0.00026288573,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W2076100327","doi":"10.1182/blood-2008-09-179630","title":"FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.","year":2009,"lang":"en","type":"preprint","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Autoimmune lymphoproliferative syndrome; Hypergammaglobulinemia; CD8; Immunology; Apoptosis; Cytotoxic T cell; Autoimmunity; Fas receptor; T cell; Lymphoproliferative disorders; In vitro; Biology; Molecular biology; Antigen; Immune system; Antibody; Programmed cell death; Genetics","score_opus":0.016695197226416613,"score_gpt":0.21659517534146175,"score_spread":0.19989997811504515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076100327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845534,0.0024147613,0.000023208291,0.00069411786,0.00038534286,0.0051588933,0.0007062629,0.00012761215,0.0059363893],"genre_scores_gemma":[0.9911272,0.0008507062,0.0002684453,0.00015693466,0.000047813344,0.0026753405,0.00038569878,0.00007943033,0.0044084643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961853,0.00016417356,0.0010260738,0.0010121388,0.0008823884,0.00072994136],"domain_scores_gemma":[0.99610376,0.00028252392,0.0016130393,0.0008609497,0.00080054963,0.00033919106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000629741,0.00078785204,0.0021932882,0.00036534463,0.00011938848,0.00005918934,0.00021703728,0.000610723,0.0001247728],"category_scores_gemma":[0.00012784086,0.0006112681,0.00034214018,0.00046974348,0.00040977672,0.00015634579,0.00026631524,0.0003855325,0.0000092381715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051405307,0.02166256,0.7902043,0.0058608963,0.056034036,0.0039227614,0.0038854133,0.0027681706,0.0003878547,0.0008836184,0.022914166,0.040070947],"study_design_scores_gemma":[0.016366338,0.0011360073,0.9644234,0.0016407315,0.0025295126,0.00009024086,0.0003022362,0.00007682795,0.012386831,0.00022004473,0.00028841358,0.00053940446],"about_ca_topic_score_codex":0.00071153895,"about_ca_topic_score_gemma":0.000055026172,"teacher_disagreement_score":0.17421915,"about_ca_system_score_codex":0.0010333051,"about_ca_system_score_gemma":0.00049026887,"threshold_uncertainty_score":0.99963385},"labels":[],"label_agreement":null},{"id":"W2076240151","doi":"10.1200/jco.2012.42.3582","title":"Tale of Two Lymphomas: Peripheral T-Cell Lymphoma After Allogeneic Stem-Cell Transplantation for Marginal Zone Lymphoma","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Niagara Health System","funders":"","keywords":"Medicine; Lymphoma; Transplantation; Marginal zone; Stem cell; Peripheral T-cell lymphoma; Pathology; Cancer research; B cell; T cell; Immunology; Immune system; Internal medicine; Biology; Antibody","score_opus":0.05298566938386337,"score_gpt":0.3877025316011677,"score_spread":0.33471686221730435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076240151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894787,0.005005243,0.0008314427,0.0007276824,0.0016163969,0.0005018363,0.000047013637,0.000011652973,0.0023108441],"genre_scores_gemma":[0.9850381,0.0017824896,0.009495021,0.0012156211,0.0015556783,0.000064485364,0.00001963353,0.000043090575,0.00078585563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956354,0.00035485218,0.0027166307,0.0002643545,0.0004930048,0.00053577224],"domain_scores_gemma":[0.9951908,0.0015517807,0.0018751748,0.00026745468,0.00045670848,0.00065807253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019601495,0.00030174872,0.0018497539,0.0001649,0.000053180614,0.000011363166,0.00018184156,0.0004434479,0.00022252424],"category_scores_gemma":[0.00008664311,0.00021944878,0.001181331,0.00013355291,0.00021787336,0.00025174726,0.00003019309,0.00012182582,0.000025727995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024812331,0.02946136,0.55001616,0.00047889122,0.0008013741,0.00090687594,0.0006846349,0.000019031406,0.0022258032,0.00014548576,0.0016174659,0.38883057],"study_design_scores_gemma":[0.10954743,0.017077398,0.7984562,0.0002012113,0.0029437938,0.0022340338,0.00028618154,0.00007833772,0.014389616,0.000072454546,0.05440518,0.0003081686],"about_ca_topic_score_codex":0.000038601695,"about_ca_topic_score_gemma":0.000022785129,"teacher_disagreement_score":0.3885224,"about_ca_system_score_codex":0.0005516308,"about_ca_system_score_gemma":0.0016137736,"threshold_uncertainty_score":0.89488614},"labels":[],"label_agreement":null},{"id":"W2076304345","doi":"10.1200/jco.2012.45.3050","title":"MicroRNA Signature Obtained From the Comparison of Aggressive With Indolent Non-Hodgkin Lymphomas: Potential Prognostic Value in Mantle-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Terry Fox Foundation; Princess Margaret Hospital Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; European Hematology Association; University of Toronto; University Health Network; Wallace H. Coulter Foundation","keywords":"Mantle cell lymphoma; Medicine; Lymphoma; Hodgkin lymphoma; Aggressive lymphoma; microRNA; Value (mathematics); Signature (topology); Oncology; Pathology; Cancer research; Internal medicine; Rituximab; Gene; Biology; Statistics","score_opus":0.03552455754692488,"score_gpt":0.3681375681061373,"score_spread":0.33261301055921244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076304345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936653,0.0028653357,0.00005786627,0.0056896317,0.0006211819,0.00081700936,0.000010701827,0.000006047887,0.0005656899],"genre_scores_gemma":[0.994242,0.00044826145,0.003182762,0.0013859593,0.00063901616,0.000026291249,0.000012501129,0.00002540597,0.0000377868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560034,0.0005992242,0.0025905361,0.00029312202,0.0005764637,0.0003403024],"domain_scores_gemma":[0.98996127,0.00399095,0.0048591197,0.0003176279,0.0005510591,0.00031996655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009126217,0.00027132314,0.0020413434,0.0001191877,0.000047648835,0.000020635704,0.000336096,0.0005231467,0.00014257917],"category_scores_gemma":[0.0012465599,0.00013702165,0.00048384565,0.00020885191,0.00032192084,0.00010521372,0.00009306861,0.0005597088,0.000033881428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005488811,0.016255634,0.88476574,0.000041631425,0.00084836554,0.0024069876,0.00072328583,0.00019409542,0.0011266808,0.000020753405,0.006055421,0.08207257],"study_design_scores_gemma":[0.040482447,0.013248451,0.9383126,0.0008167256,0.0009048341,0.00030470363,0.0008323773,0.0008347423,0.0028424386,0.00017979507,0.0011005714,0.0001403482],"about_ca_topic_score_codex":0.0005780887,"about_ca_topic_score_gemma":0.00007681641,"teacher_disagreement_score":0.081932224,"about_ca_system_score_codex":0.0003296201,"about_ca_system_score_gemma":0.0019000483,"threshold_uncertainty_score":0.5587581},"labels":[],"label_agreement":null},{"id":"W2076657168","doi":"10.1159/000326095","title":"Diagnosis of Lymphoma by Image-Guided Needle Biopsies","year":2005,"lang":"en","type":"article","venue":"Acta Cytologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Biopsy; Lymphoma; Fine-needle aspiration; Radiology; Subtyping; Grading (engineering); Pathology","score_opus":0.02164122349295079,"score_gpt":0.2799963162416219,"score_spread":0.25835509274867113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076657168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763001,0.0016727549,0.000002234335,0.009060699,0.000051089664,0.0002732374,0.000050724568,0.000093493516,0.01249564],"genre_scores_gemma":[0.9942496,0.0011762695,0.0025747418,0.0011633357,0.00007803109,0.00015547957,0.000059245453,0.000015673952,0.00052763586],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882203,0.000032571916,0.00034288125,0.00028790662,0.00021795553,0.00029665415],"domain_scores_gemma":[0.99906135,0.00020166038,0.00013388954,0.00037511677,0.00009046161,0.00013755234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008125773,0.00020303875,0.00046544513,0.00007467658,0.00006492811,0.000015828187,0.00012786954,0.00013077416,0.0008507414],"category_scores_gemma":[0.0001113617,0.00013943242,0.00016975994,0.0001822065,0.00015252175,0.00010188639,0.00006664319,0.000037576832,0.00015253831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020136192,0.0054502306,0.4246381,0.00008774021,0.00043177698,0.00017038331,0.00039102172,0.0000010888507,0.036014996,0.0003675024,0.45693246,0.075313345],"study_design_scores_gemma":[0.0046280706,0.00067145214,0.37410176,0.000077424076,0.00027248324,0.00019898213,0.0002573963,0.000027292072,0.44713444,0.00004923176,0.17234008,0.00024140038],"about_ca_topic_score_codex":0.00017163211,"about_ca_topic_score_gemma":0.000005926056,"teacher_disagreement_score":0.41111943,"about_ca_system_score_codex":0.00018156432,"about_ca_system_score_gemma":0.000079494646,"threshold_uncertainty_score":0.9315022},"labels":[],"label_agreement":null},{"id":"W2077075388","doi":"10.1053/beha.2002.0223","title":"Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma","year":2002,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Transplantation; Mantle cell lymphoma; Stem cell; Lymphoblastic lymphoma; Non-Hodgkin's lymphoma; Disease; Immunology; Population; Oncology; Internal medicine; T cell; Biology","score_opus":0.302159131816992,"score_gpt":0.5402749328025299,"score_spread":0.23811580098553792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077075388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035883096,0.98251957,0.00012407845,0.0020949517,0.000747782,0.0073963604,0.00016342703,0.0000772696,0.0065177144],"genre_scores_gemma":[0.0004427909,0.98832554,0.0027849835,0.00035275865,0.0006266144,0.0036147917,0.0005120516,0.00019822978,0.0031422353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98874414,0.0037710485,0.0029154,0.0018291511,0.0012197446,0.0015204902],"domain_scores_gemma":[0.9579901,0.037501324,0.0010738634,0.001492515,0.0010745875,0.0008675781],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0055558886,0.0008212185,0.005278436,0.00061401713,0.00038597593,0.00012547913,0.00066678756,0.0020116454,0.000215016],"category_scores_gemma":[0.0028503737,0.0006250344,0.001885391,0.000727223,0.00070039456,0.00025813156,0.00019730198,0.001279941,0.003362951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006332534,0.009821291,0.00010914791,0.032519527,0.0010317015,0.009402496,0.000093713075,8.1948095e-8,1.5206932e-7,0.00038069955,0.008643804,0.93736416],"study_design_scores_gemma":[0.0057899533,0.005850043,0.000029959247,0.007914787,0.008845093,0.012031892,0.00013536312,0.000023628976,0.000009467874,0.000044397682,0.9588566,0.00046880316],"about_ca_topic_score_codex":0.00009782157,"about_ca_topic_score_gemma":0.000026631136,"teacher_disagreement_score":0.95021284,"about_ca_system_score_codex":0.00073053344,"about_ca_system_score_gemma":0.0035219097,"threshold_uncertainty_score":0.9996201},"labels":[],"label_agreement":null},{"id":"W2077349663","doi":"10.1002/pbc.24258","title":"Impact of low‐dose involved‐field radiation therapy on pediatric patients with lymphocyte‐predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Chemotherapy; Radiation therapy; Lymphoma; Hodgkin lymphoma; Internal medicine; Blood cancer; Oncology; Cancer","score_opus":0.007855660212955492,"score_gpt":0.2612938931026239,"score_spread":0.25343823288966844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077349663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861246,0.011469663,0.0000047206727,0.00019022389,0.00016353994,0.0017063137,0.00016631083,0.00006395827,0.00011066959],"genre_scores_gemma":[0.9829954,0.0132823475,0.00011637836,0.00058567896,0.0020710297,0.0004953019,0.00034990642,0.00008542375,0.000018540417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743754,0.00014301618,0.0005662082,0.0005701419,0.0006646046,0.0006185068],"domain_scores_gemma":[0.99742603,0.0005061666,0.00081042846,0.00074889,0.00020412164,0.00030434263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023007771,0.00053410657,0.0007930145,0.00019921195,0.00012758923,0.000023605262,0.00017598511,0.00024442482,0.00026618032],"category_scores_gemma":[0.000052752024,0.00026951273,0.00027107866,0.00078175636,0.00006547836,0.0001648249,0.000029030403,0.0001301514,0.000011988554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005725366,0.008184639,0.92787915,0.000022747432,0.0012828121,0.00005396114,0.0005402729,0.000009946257,0.000013110249,0.0000023143393,0.0011400835,0.05514559],"study_design_scores_gemma":[0.03989727,0.0070463116,0.9491731,0.00004713553,0.0022623264,0.00003714229,0.0000145735075,0.0000054221423,0.0010638804,0.0000020708073,0.00013972548,0.00031106872],"about_ca_topic_score_codex":0.009620824,"about_ca_topic_score_gemma":0.00011214119,"teacher_disagreement_score":0.054834522,"about_ca_system_score_codex":0.00078448374,"about_ca_system_score_gemma":0.0009939207,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W2077522084","doi":"10.1038/leu.2011.378","title":"BCL2 mutations in diffuse large B-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Diffuse large B-cell lymphoma; Somatic hypermutation; Biology; Lymphoma; Cancer research; Germinal center; Mantle cell lymphoma; Germline mutation; Follicular lymphoma; Large-cell lymphoma; Mutation; B cell; Gene; Genetics; Immunology; Antibody","score_opus":0.020950733346727597,"score_gpt":0.24746990090036908,"score_spread":0.2265191675536415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077522084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412614,0.00023339533,0.000013771146,0.0000835838,0.00007968102,0.00020797028,0.000010247913,0.000050684903,0.05805926],"genre_scores_gemma":[0.9967903,0.00005515438,0.0007036681,0.000599551,0.000040762323,0.00008466878,0.000039824095,0.000016649328,0.0016694524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.000016963415,0.00017288262,0.00019036527,0.00011632294,0.0002428429],"domain_scores_gemma":[0.99954396,0.00003371844,0.000036307672,0.00025103247,0.000022819419,0.00011215584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005071525,0.00011375025,0.00017551363,0.0000906281,0.000037739104,0.000007219791,0.000052185216,0.00007292064,0.00022711202],"category_scores_gemma":[0.00001956957,0.00009238227,0.00007038364,0.00014918839,0.000023172128,0.000052220228,0.000026139298,0.00004020448,0.0005339895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021358611,0.027045226,0.9309439,0.0001006148,0.000105281,0.0024017547,0.006844246,0.0000010908495,0.00057281967,0.005271111,0.0055371146,0.020963231],"study_design_scores_gemma":[0.03881298,0.00018083163,0.9398225,0.000060793787,0.00009517492,0.00004699766,0.00027438058,0.00016924988,0.011962101,0.00035907605,0.008072882,0.00014306269],"about_ca_topic_score_codex":0.00066759036,"about_ca_topic_score_gemma":0.00014701368,"teacher_disagreement_score":0.05638981,"about_ca_system_score_codex":0.00066235365,"about_ca_system_score_gemma":0.00020618527,"threshold_uncertainty_score":0.68635327},"labels":[],"label_agreement":null},{"id":"W2077594293","doi":"10.1038/modpathol.3880041","title":"Sinusoidal CD30-Positive Large B-Cell Lymphoma: A Morphologic Mimic of Anaplastic Large Cell Lymphoma","year":2000,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"CD30; Anaplastic large-cell lymphoma; Pathology; Lymphoma; Large cell; Anaplastic lymphoma kinase; Large-cell lymphoma; Lymph node; Immunophenotyping; Medicine; CD20; Null cell; Biology; Antigen; Immunology; Internal medicine; Adenocarcinoma; Cancer; Cell culture","score_opus":0.007816032517773616,"score_gpt":0.22899194487293226,"score_spread":0.22117591235515865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077594293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288894,0.0023354308,0.0005435932,0.0002254067,0.00015386922,0.0006189654,0.00054734905,0.00011918739,0.0125672845],"genre_scores_gemma":[0.9944965,0.0002994507,0.0007352072,0.001304766,0.00010068862,0.00012046153,0.0002961585,0.00006942654,0.0025772871],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969171,0.00021732734,0.0006223562,0.00088921067,0.00034157475,0.0010123748],"domain_scores_gemma":[0.99844915,0.00020244368,0.0002165769,0.0007298494,0.00012848439,0.000273485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023082197,0.0005055642,0.0009944908,0.00022082764,0.00016210826,0.000016169191,0.0002165228,0.00044194056,0.0008082098],"category_scores_gemma":[0.000033170505,0.0004270675,0.0003599228,0.00025168437,0.00018965508,0.00008380956,0.00011551347,0.00010468713,0.00077644835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013191467,0.30577043,0.2738688,0.0015255155,0.0013311076,0.103904195,0.017058196,0.0003414869,0.10626458,0.001615613,0.013435514,0.1616931],"study_design_scores_gemma":[0.22184533,0.011897104,0.58144724,0.00039449203,0.0021792266,0.008493227,0.0006821621,0.012271884,0.14984897,0.0014804818,0.0075678714,0.0018919889],"about_ca_topic_score_codex":0.000073628325,"about_ca_topic_score_gemma":0.000043927907,"teacher_disagreement_score":0.30757844,"about_ca_system_score_codex":0.00033963996,"about_ca_system_score_gemma":0.00024122544,"threshold_uncertainty_score":0.9998181},"labels":[],"label_agreement":null},{"id":"W2077797108","doi":"10.1378/chest.129.3.791","title":"Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue With Initial Presentation in the Pleura","year":2006,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Marginal zone; Presentation (obstetrics); MALT lymphoma; Lymphoma; Mucosa-associated lymphoid tissue; Pathology; Lymphatic system; Lung; B cell; Radiology; Internal medicine; Immunology","score_opus":0.015127618018646578,"score_gpt":0.27653043433152125,"score_spread":0.26140281631287465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077797108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488974,0.00048708078,0.00013435708,0.0011572009,0.000079937265,0.00025876003,0.00001094538,0.000011279071,0.0029706913],"genre_scores_gemma":[0.9988046,0.00005927145,0.00044267342,0.00012837454,0.000320665,0.000022155788,0.0000547871,0.000016754588,0.00015068817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859387,0.00010636789,0.00039077472,0.00013987164,0.00051134935,0.0002577591],"domain_scores_gemma":[0.99930924,0.0001194931,0.00023314191,0.00014155458,0.00012509347,0.00007146028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029207353,0.00015776687,0.000285254,0.00012507073,0.0000928384,0.000048748432,0.000105200794,0.00007315122,0.00009804369],"category_scores_gemma":[0.000031642096,0.00009357176,0.00007610403,0.00027197928,0.000090894624,0.00012270118,0.00001027995,0.00009584931,0.000008681543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013910856,0.005457424,0.9512355,0.00009276209,0.00024300849,0.004027849,0.0015315992,0.00007000065,0.0047302423,0.00037629332,0.0027381843,0.028106088],"study_design_scores_gemma":[0.01317764,0.0007696558,0.9642293,0.00017150438,0.00018576343,0.004235017,0.00040105256,0.000049608105,0.015019267,0.00010338147,0.0015561882,0.00010164135],"about_ca_topic_score_codex":0.00058485434,"about_ca_topic_score_gemma":0.0002340132,"teacher_disagreement_score":0.028004445,"about_ca_system_score_codex":0.0003104492,"about_ca_system_score_gemma":0.00028581612,"threshold_uncertainty_score":0.38157457},"labels":[],"label_agreement":null},{"id":"W2078147862","doi":"10.1080/10428190701344881","title":"CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Rituximab; Diffuse large B-cell lymphoma; CHOP; Medicine; Internal medicine; Lymphoma; Oncology; Chemotherapy; Progression-free survival; Retrospective cohort study","score_opus":0.008076986968633092,"score_gpt":0.24277807292535974,"score_spread":0.23470108595672665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078147862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866968,0.008188946,0.000028787501,0.00016227349,0.00024798597,0.0018238326,0.000055955294,0.00018008989,0.002615328],"genre_scores_gemma":[0.9923734,0.0044769524,0.00037028347,0.0015450304,0.00021002023,0.0002736487,0.000068363195,0.00013072265,0.00055157684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942679,0.0002189362,0.0015657872,0.0012316899,0.0011573964,0.0015582934],"domain_scores_gemma":[0.9958245,0.0012025279,0.00065235,0.0014511253,0.00024338636,0.0006260923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010569382,0.0010256816,0.0013590263,0.0005621939,0.00041083398,0.00007827247,0.0005889962,0.0006424543,0.00004707049],"category_scores_gemma":[0.00024071198,0.00069950876,0.00048030925,0.0010994653,0.0005310064,0.00048441935,0.00033006136,0.00015902694,0.00006505897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047480455,0.014933243,0.77258104,0.00061989424,0.00038063264,0.0021718615,0.0051737553,0.00007549023,0.027603047,0.00087691593,0.0013721378,0.16946396],"study_design_scores_gemma":[0.098621815,0.00053641153,0.8370598,0.00079925876,0.0001900295,0.0004807497,0.0010550261,0.00037770878,0.04829753,0.00013586467,0.011788658,0.0006571634],"about_ca_topic_score_codex":0.0016591955,"about_ca_topic_score_gemma":0.00020872951,"teacher_disagreement_score":0.1688068,"about_ca_system_score_codex":0.005151262,"about_ca_system_score_gemma":0.0023889816,"threshold_uncertainty_score":0.99954563},"labels":[],"label_agreement":null},{"id":"W2078254962","doi":"10.1080/10428190290021632","title":"A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma","year":2002,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Vinorelbine; Etoposide; Oncology; Population; Internal medicine; Clinical trial; Lymphoma; Aggressive lymphoma; Vincristine; Inclusion and exclusion criteria; Rituximab; Chemotherapy; Pathology; Alternative medicine; Cyclophosphamide","score_opus":0.028927631738162974,"score_gpt":0.2899046831440661,"score_spread":0.2609770514059031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078254962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006404272,0.98249114,0.000004812579,0.00006891366,0.0007438618,0.005456779,0.001028608,0.00019406708,0.0036075716],"genre_scores_gemma":[0.0026940333,0.98910606,0.0008576564,0.00047127358,0.00050883496,0.0015662627,0.0019893714,0.00044272386,0.0023638012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890803,0.00057899073,0.0044331364,0.0026376399,0.0016412477,0.001628683],"domain_scores_gemma":[0.9888741,0.0010398681,0.0051572123,0.0031213358,0.00077478914,0.0010327378],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00040242542,0.0032394547,0.011405225,0.0012035825,0.00030361186,0.00013414094,0.00077797734,0.0021355683,0.00021100558],"category_scores_gemma":[0.000374489,0.0023720448,0.004291019,0.0021943753,0.0007620767,0.0003171785,0.0003672256,0.00018305834,0.00014455181],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00032244777,0.003636439,0.00009555558,0.13897276,0.0031053717,0.004390969,0.00069794006,6.888451e-7,0.000030848183,0.00006212564,0.003592539,0.8450923],"study_design_scores_gemma":[0.021377422,0.0027655978,0.0006283157,0.33195227,0.010430412,0.0065569747,0.00005197216,0.00005865324,0.00054508983,0.000011505476,0.6242668,0.0013550065],"about_ca_topic_score_codex":0.0006088303,"about_ca_topic_score_gemma":0.000013235866,"teacher_disagreement_score":0.8437373,"about_ca_system_score_codex":0.021573387,"about_ca_system_score_gemma":0.006504773,"threshold_uncertainty_score":0.9991599},"labels":[],"label_agreement":null},{"id":"W2078678877","doi":"10.1074/jbc.m407171200","title":"Human Pax-5 C-terminal Isoforms Possess Distinct Transactivation Properties and Are Differentially Modulated in Normal and Malignant B Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Transactivation; Gene isoform; Transcription factor; Exon; Alternative splicing; Biology; DNA-binding domain; Molecular biology; RNA splicing; Cell biology; Gene; Genetics","score_opus":0.029429266622813904,"score_gpt":0.24132720073922556,"score_spread":0.21189793411641167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078678877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992559,0.0003053477,0.000021574388,0.00027074377,0.000015432524,0.00008185036,0.0000047879466,0.000005509785,0.000038878163],"genre_scores_gemma":[0.9996747,0.00013139425,0.00006838641,0.000031761807,0.000058757687,0.0000035183095,0.000005443376,0.000004237787,0.000021810802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99930716,0.000010149379,0.00031466788,0.00012603693,0.00010864595,0.0001333651],"domain_scores_gemma":[0.9996169,0.0000116410965,0.00016718038,0.00005132878,0.000048093032,0.0001048174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007281817,0.00012443365,0.000298366,0.000022075155,0.000044355373,0.00002202097,0.00003610262,0.000118594915,0.000024290308],"category_scores_gemma":[0.000015954662,0.000064321575,0.000056822322,0.000036115358,0.00009071422,0.000056519068,0.000014719677,0.00012693269,2.0780784e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034131925,0.0007311593,0.16959332,0.00014569922,0.000049099737,0.0005502913,0.000101075624,0.000008724306,0.82679,0.0000016816489,0.0000018360778,0.0016858034],"study_design_scores_gemma":[0.002384924,0.00038779376,0.5721886,0.00030880442,0.000033845332,0.00054377015,0.00008283305,0.0000076000597,0.42393637,0.000060062684,0.000003240751,0.0000621595],"about_ca_topic_score_codex":0.000017376613,"about_ca_topic_score_gemma":0.0000027549083,"teacher_disagreement_score":0.4028536,"about_ca_system_score_codex":0.0000831441,"about_ca_system_score_gemma":0.00003404209,"threshold_uncertainty_score":0.26229578},"labels":[],"label_agreement":null},{"id":"W2078926052","doi":"10.1016/j.bbmt.2007.12.108","title":"99: Predictors of Outcome of Mantle Cell Lymphoma in Patients with Progressive Disease following Autologous Stem Cell Transplantation (ASCT)","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Mantle cell lymphoma; Internal medicine; Oncology; Rituximab; Proportional hazards model; Transplantation; Progression-free survival; Surgery; Lymphoma; Chemotherapy","score_opus":0.0075772231312956125,"score_gpt":0.21504001044862078,"score_spread":0.20746278731732518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078926052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998095,0.00089719525,0.000023336734,0.000015245413,0.000055015913,0.00055828906,0.00025318854,0.000012353543,0.00009039328],"genre_scores_gemma":[0.9984931,0.0007037435,0.00026907946,0.000010804982,0.000006546365,0.000032492408,0.0004634778,0.000010199418,0.00001056433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990316,0.00005506854,0.00042251233,0.00021092642,0.0001386676,0.00014121269],"domain_scores_gemma":[0.9994834,0.000069980306,0.00022372394,0.00009888489,0.000051387953,0.0000726342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005302866,0.0001476921,0.000406385,0.00014040648,0.000028551736,9.812627e-7,0.000038070033,0.00009518278,0.0000035191765],"category_scores_gemma":[0.0000017519448,0.000109624605,0.00008194288,0.00009423891,0.0001271473,0.00005960728,0.000003032523,0.00002820249,2.937945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020357016,0.0018739633,0.9882423,0.0012823583,0.00013173257,0.0001766133,0.0011967692,0.0000057010698,0.00420832,0.000015226836,0.0000011476558,0.00083013467],"study_design_scores_gemma":[0.015696723,0.0014158329,0.8983338,0.00022996942,0.0011176144,0.00001926232,0.000050230778,0.000004915227,0.08303956,0.0000050812523,0.0000011076735,0.00008591264],"about_ca_topic_score_codex":0.0000814709,"about_ca_topic_score_gemma":0.000013668422,"teacher_disagreement_score":0.08990854,"about_ca_system_score_codex":0.000012921925,"about_ca_system_score_gemma":0.00006352782,"threshold_uncertainty_score":0.44703618},"labels":[],"label_agreement":null},{"id":"W2079013883","doi":"10.1182/blood-2004-06-2125","title":"Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Anaplastic large-cell lymphoma; Protein kinase B; Anaplastic lymphoma kinase; Cancer research; Cell cycle; Lymphoma; PI3K/AKT/mTOR pathway; Kinase; Cell cycle checkpoint; Chemistry; Biology; Signal transduction; Medicine; Apoptosis; Pathology; Immunology; Cell biology; Biochemistry","score_opus":0.010442712795126296,"score_gpt":0.22817432091634735,"score_spread":0.21773160812122105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079013883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643177,0.0012308909,0.000002947321,0.0000623795,0.000033461332,0.000236381,0.00006936687,0.000020762696,0.0019120455],"genre_scores_gemma":[0.99945116,0.000085785854,0.00023073776,0.000096328455,0.000045254426,0.000027464837,0.000032996606,0.000013896253,0.000016384482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991578,0.000022456223,0.00023403356,0.00021966464,0.00016061025,0.00020543487],"domain_scores_gemma":[0.9995545,0.00007446042,0.00008198995,0.00014747588,0.00003011935,0.00011141225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007058416,0.00014047622,0.00026384537,0.00012516488,0.000036212412,0.000011277773,0.000027874841,0.00008200888,0.00001842744],"category_scores_gemma":[0.000034563804,0.00011930015,0.00004486115,0.00015706403,0.000040046292,0.00007295039,0.000037496888,0.00003516573,0.000016491384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003223674,0.08194723,0.8185832,0.0009294849,0.00016220206,0.0018180414,0.0015898091,0.000025169391,0.091890365,0.00066403975,0.00009862966,0.0019694667],"study_design_scores_gemma":[0.031220667,0.00057819847,0.50579554,0.00028126602,0.00017656485,0.00003417838,0.00020686034,0.0000026421055,0.46132565,0.00025752274,0.000016444703,0.000104502324],"about_ca_topic_score_codex":0.0008644957,"about_ca_topic_score_gemma":0.00024819584,"teacher_disagreement_score":0.36943528,"about_ca_system_score_codex":0.00007076377,"about_ca_system_score_gemma":0.00012610904,"threshold_uncertainty_score":0.48649192},"labels":[],"label_agreement":null},{"id":"W2079335457","doi":"10.1080/10428190902756578","title":"Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Medicine; Internal medicine; Etoposide; Transplantation; Melphalan; Chemotherapy; Oncology; Lymphoma; Cumulative incidence; Cancer; Total body irradiation; Population; Hematopoietic stem cell transplantation; Surgery; Cyclophosphamide","score_opus":0.006591239452566481,"score_gpt":0.24115905153030998,"score_spread":0.2345678120777435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079335457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890981,0.005344154,0.0007519713,0.00014655867,0.00037811036,0.0027995207,0.00075664575,0.00019720144,0.000527764],"genre_scores_gemma":[0.9897116,0.0040619113,0.0025939995,0.0010954506,0.0002688739,0.0012353647,0.00035686762,0.0001200836,0.00055588235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99566615,0.00008960748,0.0009885277,0.001526915,0.00049674144,0.0012320329],"domain_scores_gemma":[0.996588,0.0009642381,0.00075942563,0.0006757212,0.00024899142,0.0007636494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029298896,0.0010730571,0.0014132964,0.00035376466,0.0006359656,0.00019773885,0.00024630193,0.0006900925,0.000048124686],"category_scores_gemma":[0.00012790672,0.00091768766,0.0004954483,0.00032580405,0.00033843424,0.00042812963,0.000056068322,0.000086478976,0.000012363815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016454836,0.0014827467,0.22497743,0.004267514,0.001530822,0.002419625,0.018464724,0.00017153416,0.0057228482,0.00069007557,0.006219597,0.71759826],"study_design_scores_gemma":[0.047482856,0.0027308501,0.8782822,0.00084140856,0.0022146264,0.0018657309,0.0009448188,0.0038566994,0.05576242,0.0010859106,0.0035931352,0.0013393539],"about_ca_topic_score_codex":0.0014960513,"about_ca_topic_score_gemma":0.00031946247,"teacher_disagreement_score":0.7162589,"about_ca_system_score_codex":0.0063212863,"about_ca_system_score_gemma":0.0028171623,"threshold_uncertainty_score":0.99932736},"labels":[],"label_agreement":null},{"id":"W2079462672","doi":"10.1111/bjh.13451","title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Multivariate analysis; Stage (stratigraphy); Internal medicine; International Prognostic Index; Young adult; Retrospective cohort study; Lymphoma; Surgery; B symptoms; Pediatrics; Rituximab","score_opus":0.027510097228572006,"score_gpt":0.3125271388128811,"score_spread":0.28501704158430907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079462672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562657,0.003426857,0.000005048483,0.00035353025,0.000279534,0.00016973543,0.000010211525,0.0000042520564,0.00012427321],"genre_scores_gemma":[0.997077,0.0020632953,0.0006907622,0.000060952283,0.00005330752,0.00000633197,0.0000034346085,0.000010907936,0.000034017183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840486,0.00011127815,0.000999161,0.00013714092,0.00017948334,0.00016809971],"domain_scores_gemma":[0.9988786,0.00013973717,0.0004345888,0.00011099796,0.00020423466,0.0002318206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030350988,0.00011752451,0.0012491127,0.00010693465,0.000014480687,0.000012608793,0.00005300733,0.00012506917,0.0000066623006],"category_scores_gemma":[0.0003319381,0.00009680769,0.00018801936,0.000058608424,0.00010923363,0.000061899125,0.000024315057,0.00006123221,0.0000031413438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000324718,0.0015545615,0.8981791,0.000025850451,0.00027028145,0.045105323,0.00025909333,7.34055e-8,0.0000018690621,0.000055580673,0.00008756675,0.054135967],"study_design_scores_gemma":[0.014893763,0.0018876315,0.87429243,0.00039042335,0.00020519459,0.10776291,0.0001210666,0.000005367699,0.00006936505,0.00006122554,0.0002496719,0.000060974744],"about_ca_topic_score_codex":0.0007221069,"about_ca_topic_score_gemma":0.00018309052,"teacher_disagreement_score":0.06265759,"about_ca_system_score_codex":0.00013380578,"about_ca_system_score_gemma":0.0002622363,"threshold_uncertainty_score":0.3947703},"labels":[],"label_agreement":null},{"id":"W2080660025","doi":"10.1016/j.ejca.2013.05.024","title":"The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Canada Research Chairs; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Interquartile range; Internal medicine; Biopsy; CD163; Proportional hazards model; Tissue microarray; Oncology; CD30; CD68; Univariate analysis; Cohort; Confidence interval; Reed–Sternberg cell; Lymphoma; Pathology; Hodgkin lymphoma; Immunohistochemistry; Multivariate analysis; Macrophage; Biology","score_opus":0.008944217694203236,"score_gpt":0.2581965383795944,"score_spread":0.24925232068539116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080660025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830015,0.015387981,8.85448e-7,0.00055962784,0.00014268835,0.00022024916,0.000008958205,0.000004462264,0.00067367556],"genre_scores_gemma":[0.99478585,0.0047027525,0.000039821167,0.00006101945,0.00016170133,0.000005351749,6.889685e-7,0.000024236884,0.00021860673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986683,0.00025870622,0.00049748376,0.00010003919,0.00026132233,0.00021414118],"domain_scores_gemma":[0.9988152,0.00021582589,0.00048591805,0.000110270135,0.00022653099,0.00014628329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004915463,0.00013801527,0.00030977718,0.000106121064,0.00004023093,0.00004240103,0.00010330532,0.00001921841,0.00007274886],"category_scores_gemma":[0.00014539633,0.00007294745,0.00015484172,0.00018660058,0.000064859785,0.00008209961,0.000038089067,0.00008783382,0.00001540573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015955738,0.00036789355,0.8936975,0.000023453109,0.00033365336,0.00063161727,0.0003673769,0.00003928616,0.0047875266,0.0000023795044,0.0040445486,0.09554522],"study_design_scores_gemma":[0.0042749066,0.0010709073,0.9916526,0.00026402745,0.00016402095,0.00008165016,0.000059635684,0.000031166026,0.0020453476,0.00001060654,0.00027814048,0.00006697613],"about_ca_topic_score_codex":0.00027330747,"about_ca_topic_score_gemma":0.000025559117,"teacher_disagreement_score":0.09795512,"about_ca_system_score_codex":0.00024959768,"about_ca_system_score_gemma":0.00017095666,"threshold_uncertainty_score":0.29747108},"labels":[],"label_agreement":null},{"id":"W2080724300","doi":"10.1182/blood-2014-08-545152","title":"Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thorax (insect anatomy); Radiology; Stage (stratigraphy); Biopsy; Mediastinum; Supraclavicular lymph nodes; Mediastinal mass; Lymphoma; Radiation therapy; Axilla; Pathology; Metastasis; Internal medicine; Anatomy; Cancer","score_opus":0.09113541500845695,"score_gpt":0.3409795814210709,"score_spread":0.24984416641261392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080724300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009572092,0.98616385,1.07955294e-7,0.00011771082,0.000051632596,0.0037898791,0.0000887888,0.0000060100983,0.00020992187],"genre_scores_gemma":[0.007215499,0.99186134,0.00003223517,0.00007693402,0.00006356887,0.0006489862,0.000047429963,0.000027021186,0.000026962221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974522,0.00062062783,0.0009299785,0.00025584633,0.00057957595,0.00016174889],"domain_scores_gemma":[0.9972192,0.00047720972,0.0010327203,0.0010574104,0.00016519258,0.00004824649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057717477,0.00033950678,0.0020564068,0.00011462534,0.000017886541,0.000005312913,0.00028313804,0.0001510636,0.000032574666],"category_scores_gemma":[0.0001433541,0.00014386959,0.0009363818,0.0005370736,0.00006617622,0.00003249731,0.000014151531,0.00004487578,0.0000043789155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035890538,0.0049952143,0.005948655,0.015332432,0.00043487345,0.0000088183,0.00019701583,9.211413e-8,0.0000015633489,0.000029480138,0.000053375814,0.9729626],"study_design_scores_gemma":[0.009304132,0.004197154,0.009081736,0.19891304,0.005989815,0.000012519374,0.0000216337,8.448065e-7,0.0023589672,0.000013471457,0.7699368,0.00016988681],"about_ca_topic_score_codex":0.00050377427,"about_ca_topic_score_gemma":0.000011163639,"teacher_disagreement_score":0.9727927,"about_ca_system_score_codex":0.00023301452,"about_ca_system_score_gemma":0.0012337421,"threshold_uncertainty_score":0.5866832},"labels":[],"label_agreement":null},{"id":"W2080925567","doi":"10.3109/10428190109057962","title":"Fludarabine in Alkylator-Resistant Follicular Non-Hodgkin's Lymphoma","year":2001,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Fludarabine; Medicine; Chemotherapy; Transplantation; Follicular lymphoma; Salvage therapy; Oncology; Internal medicine; Surgery; Lymphoma; Cyclophosphamide","score_opus":0.009063964940791711,"score_gpt":0.24025947942153852,"score_spread":0.23119551448074682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080925567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742824,0.006750056,0.000056321132,0.0008134749,0.00058105687,0.0016417705,0.000060949547,0.00042261838,0.01539139],"genre_scores_gemma":[0.98797697,0.0041122246,0.001036761,0.0026001385,0.0006388371,0.00061136653,0.00026458743,0.00025919062,0.0024999187],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99213856,0.0002039195,0.0018108753,0.0022389984,0.0013913721,0.0022162735],"domain_scores_gemma":[0.9956152,0.00037990802,0.0004814207,0.0018710287,0.00027036865,0.0013820803],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00066317635,0.0016098856,0.0022651504,0.00095885247,0.00053889194,0.0002877117,0.00058389636,0.0009997081,0.00026855746],"category_scores_gemma":[0.00017236901,0.0014269168,0.00075993704,0.0017788057,0.0005087008,0.00059960264,0.00039337945,0.0001746998,0.00042108743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007345272,0.0040429165,0.30531463,0.00066103437,0.0014555324,0.027816776,0.0017610282,0.00013292799,0.015541235,0.0034069235,0.010030354,0.62249136],"study_design_scores_gemma":[0.06502645,0.0011066082,0.79573524,0.0009762964,0.00067584787,0.0049499837,0.00054597744,0.0039535854,0.010086822,0.0005184654,0.114737555,0.0016871596],"about_ca_topic_score_codex":0.0065644626,"about_ca_topic_score_gemma":0.0005128073,"teacher_disagreement_score":0.6208042,"about_ca_system_score_codex":0.016156746,"about_ca_system_score_gemma":0.004234705,"threshold_uncertainty_score":0.9996649},"labels":[],"label_agreement":null},{"id":"W2081019225","doi":"10.1093/jnci/djv106","title":"Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12","year":2015,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; CancerCare Manitoba; McMaster University; Juravinski Hospital; Princess Margaret Cancer Centre; Kingston General Hospital; Queen Elizabeth II Health Sciences Centre; University of Toronto; Dalhousie University","funders":"","keywords":"Gemcitabine; Dexamethasone; Cisplatin; Medicine; Cytarabine; Refractory (planetary science); Internal medicine; Chemotherapy; Oncology; Histology; Biology","score_opus":0.14612185061816677,"score_gpt":0.39299308880020156,"score_spread":0.2468712381820348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081019225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876122,0.0029175673,0.0007867144,0.0035038881,0.0026987628,0.0010150787,0.00064792216,0.000020550795,0.00079732115],"genre_scores_gemma":[0.9919746,0.00032179843,0.0050573023,0.0010617962,0.0006490499,0.00013983402,0.000076574564,0.00003206531,0.00068697124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582046,0.00023676039,0.0015028602,0.00041683752,0.001632592,0.00039051316],"domain_scores_gemma":[0.9923119,0.0010471725,0.002891732,0.00042331222,0.0029685905,0.00035732225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016443791,0.00038304098,0.0014157558,0.0007181737,0.00019189625,0.00002723366,0.00048024318,0.00027935332,0.0001865382],"category_scores_gemma":[0.005375952,0.0002397595,0.0009041424,0.0012079182,0.00041824055,0.000419073,0.00009541332,0.00029417657,0.0000054389807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07620821,0.009814277,0.5768684,0.00071629055,0.03269174,0.00065923407,0.0045583127,0.031094704,0.006493654,0.0031173355,0.13965702,0.11812078],"study_design_scores_gemma":[0.044393484,0.002880931,0.79851073,0.000877265,0.013702435,0.0009441869,0.0002114589,0.010548592,0.007467911,0.0010869993,0.11871133,0.00066465256],"about_ca_topic_score_codex":0.00059708214,"about_ca_topic_score_gemma":0.0010091359,"teacher_disagreement_score":0.22164232,"about_ca_system_score_codex":0.003131518,"about_ca_system_score_gemma":0.00440231,"threshold_uncertainty_score":0.97771084},"labels":[],"label_agreement":null},{"id":"W2081222723","doi":"10.1046/j.1365-2141.2001.02705.x","title":"Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Surgery; Melphalan; Follicular lymphoma; Internal medicine; Etoposide; Lymphoma; Total body irradiation; Progressive disease; Chemotherapy; B symptoms; Transplantation; Gastroenterology; Salvage therapy; Cyclophosphamide","score_opus":0.016168254243755266,"score_gpt":0.2685698339200709,"score_spread":0.2524015796763156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081222723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865239,0.005179749,0.003935785,0.0023196172,0.00035863966,0.00047720253,0.000023062259,0.000024757179,0.0011572707],"genre_scores_gemma":[0.99142593,0.0031364004,0.00419878,0.0008322705,0.000121953744,0.000046376183,0.000019941986,0.000022808143,0.00019554047],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983799,0.000047606845,0.0007265366,0.00020362451,0.00023783544,0.00040451853],"domain_scores_gemma":[0.99895155,0.0001660996,0.00025722565,0.00012228449,0.00025205515,0.00025076643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024275194,0.00017548415,0.0009941426,0.00012419527,0.00011112638,0.000024128898,0.00014298692,0.00021208856,0.00015180247],"category_scores_gemma":[0.00010037329,0.00015486979,0.00050270115,0.00010448978,0.00010510883,0.000095944364,0.000007317394,0.00009312988,0.000013229993],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002840632,0.0042488836,0.043240406,0.0004095919,0.0015672377,0.62519187,0.00038585532,0.000013791551,0.0010278655,0.00088149915,0.013805178,0.30638722],"study_design_scores_gemma":[0.017058171,0.0015365408,0.08045715,0.00055691856,0.0006605773,0.84620947,0.000044847577,0.000042424996,0.0021157342,0.0006206849,0.050519347,0.00017813643],"about_ca_topic_score_codex":0.000051739702,"about_ca_topic_score_gemma":0.000060377493,"teacher_disagreement_score":0.3062091,"about_ca_system_score_codex":0.00018229279,"about_ca_system_score_gemma":0.0003415054,"threshold_uncertainty_score":0.63154066},"labels":[],"label_agreement":null},{"id":"W2081440424","doi":"10.1182/blood-2010-11-318048","title":"Leukemic transformation of anaplastic large-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Transformation (genetics); Medicine; Cancer research; Internal medicine; Biology; Genetics","score_opus":0.016355442677598087,"score_gpt":0.21831896625209174,"score_spread":0.20196352357449365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081440424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96897244,0.00033565916,0.00006300106,0.000017057606,0.000040908853,0.00016688,0.000014621016,0.00002710123,0.030362302],"genre_scores_gemma":[0.99929553,0.000088374705,0.00039404165,0.000055893528,0.000020082836,0.000018588873,0.000022436969,0.000008359402,0.00009668024],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948215,0.000009129163,0.00017324822,0.000091719594,0.00011325197,0.00013049481],"domain_scores_gemma":[0.9996985,0.000017911838,0.000047823014,0.00013911359,0.000033330056,0.0000633231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041642248,0.00007896517,0.0001568596,0.000054912693,0.000020810709,0.0000020204131,0.000032783766,0.00004596828,0.00013259046],"category_scores_gemma":[0.000007072343,0.00006129207,0.00007377869,0.00007553029,0.000015483938,0.0000471163,0.000006018633,0.000014997769,0.00007475636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016872007,0.12226528,0.7605897,0.0019181615,0.0015884067,0.0006580867,0.023059698,0.0000018410072,0.029414168,0.011692957,0.0016253048,0.045499183],"study_design_scores_gemma":[0.037624504,0.0013498546,0.43292454,0.00010197396,0.00080728595,0.00010108318,0.00022784203,0.000048720885,0.52579814,0.00009226312,0.0008129096,0.000110896006],"about_ca_topic_score_codex":0.000056706307,"about_ca_topic_score_gemma":0.000008424841,"teacher_disagreement_score":0.49638397,"about_ca_system_score_codex":0.00003149325,"about_ca_system_score_gemma":0.0000712703,"threshold_uncertainty_score":0.2499418},"labels":[],"label_agreement":null},{"id":"W2081446512","doi":"10.1038/bcj.2014.71","title":"Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Takeda Pharmaceuticals International; Takeda Oncology; Weill Cornell Medical College","keywords":"Medicine; Ixazomib; Follicular lymphoma; Nausea; Internal medicine; Neutropenia; Tolerability; Adverse effect; Pharmacodynamics; Gastroenterology; Lymphoma; Proteasome inhibitor; Pharmacokinetics; Pharmacology; Multiple myeloma; Toxicity; Carfilzomib","score_opus":0.014046845654841822,"score_gpt":0.27365247284934247,"score_spread":0.25960562719450064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081446512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865896,0.00014003355,0.000004007082,0.00012861274,0.00013678096,0.0008264788,0.000010725105,0.000013400284,0.000081013226],"genre_scores_gemma":[0.999091,0.000017676497,0.00025906638,0.00011545791,0.00032314315,0.00012574717,0.000026857117,0.000024181589,0.000016832413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982742,0.00014433313,0.00048055916,0.00023856842,0.00066008884,0.00020224557],"domain_scores_gemma":[0.9988695,0.000035030447,0.00036752893,0.00020715376,0.00026137542,0.00025943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025349957,0.00018010283,0.00034206014,0.00019479204,0.00009195303,0.000028415272,0.00007290313,0.00006828802,0.000061572304],"category_scores_gemma":[0.00005101791,0.00012844523,0.0000464325,0.00020835378,0.000050558352,0.00030417385,0.000015843205,0.00013664394,0.0000023174011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012608975,0.036151942,0.9324747,0.000024748413,0.0002008756,0.000025237629,0.00086583395,0.000058565518,0.00027066818,0.00001724776,0.00007341853,0.028575864],"study_design_scores_gemma":[0.10328675,0.014472968,0.8798629,0.0003211006,0.00029411592,0.000024967392,0.00011983292,0.000079770616,0.0012385447,0.000048301623,0.00012722788,0.00012349327],"about_ca_topic_score_codex":0.0002102274,"about_ca_topic_score_gemma":0.00014007014,"teacher_disagreement_score":0.10202586,"about_ca_system_score_codex":0.00028441494,"about_ca_system_score_gemma":0.0004819145,"threshold_uncertainty_score":0.52378446},"labels":[],"label_agreement":null},{"id":"W2081859509","doi":"10.1002/cncr.23911","title":"Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non‐Hodgkin lymphoma (NHL) multicenter outcomes database","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Hodgkin lymphoma; Comorbidity; Lymphoma; Cancer; Reliability (semiconductor); Internal medicine; Oncology; Multicenter study; Database; Randomized controlled trial","score_opus":0.09488356434292948,"score_gpt":0.36509909004659535,"score_spread":0.27021552570366586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081859509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427515,0.0020429883,0.000011004832,0.0017919353,0.00024665333,0.0009792468,0.00048016617,0.000014331277,0.00015854943],"genre_scores_gemma":[0.99282676,0.0040988275,0.0005339632,0.0016524249,0.00014087364,0.0004321055,0.0002510455,0.000011914111,0.000052070936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985875,0.00009625093,0.00030855133,0.0003970387,0.00039741507,0.0002132484],"domain_scores_gemma":[0.99884975,0.00028653705,0.00013798413,0.00041389762,0.00024619163,0.0000656628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022897728,0.0001668516,0.00035026917,0.000049249542,0.00013612406,0.000011021162,0.0001514369,0.000052742856,0.00008315681],"category_scores_gemma":[0.00008722579,0.00010875439,0.000045580568,0.00025536318,0.00019290406,0.0001572313,0.00012938459,0.00007936734,0.0000019013816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019147465,0.00070948456,0.9566972,0.00010335786,0.00010395929,0.000020878566,0.0004914337,0.00007597125,0.00006122366,0.00000887471,0.03989625,0.0016398948],"study_design_scores_gemma":[0.004658398,0.000059954484,0.98223984,0.00019667414,0.0001111075,0.000011439659,0.00008267325,0.0027501602,0.00030526382,0.0000082969345,0.0094756745,0.00010048584],"about_ca_topic_score_codex":0.008487164,"about_ca_topic_score_gemma":0.001747959,"teacher_disagreement_score":0.030420577,"about_ca_system_score_codex":0.00040939453,"about_ca_system_score_gemma":0.00040978452,"threshold_uncertainty_score":0.9981154},"labels":[],"label_agreement":null},{"id":"W2082063532","doi":"10.6000/1929-2279.2014.03.02.2","title":"Case Report: Coexistence of Non-Keratinizing Squamous Cell Carcinoma and Follicular Lymphoma in Nasopharynx","year":2014,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Basal cell; Lymphoma; Pathology; Biopsy; Follicular phase; Follicular lymphoma; Carcinoma; Radiology; Internal medicine; Radiation therapy","score_opus":0.040257726424400744,"score_gpt":0.36654166430446394,"score_spread":0.3262839378800632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082063532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901835,0.00795347,0.0000048651154,0.00079861825,0.000077394565,0.00024374404,0.0000062277227,0.0000025617069,0.00072964915],"genre_scores_gemma":[0.99848545,0.00053620804,0.0006044492,0.00007077362,0.00017725251,0.000023015049,0.000002603087,0.000016713579,0.00008352508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797213,0.000148915,0.0006601032,0.00020545685,0.00069539505,0.00031801203],"domain_scores_gemma":[0.9981711,0.00037727036,0.00032635484,0.00025509048,0.000612763,0.00025743071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015313815,0.0001308064,0.0005007985,0.00033444836,0.0000802681,0.000037331378,0.00009779659,0.000066940054,0.000041062412],"category_scores_gemma":[0.0003516908,0.000094198156,0.00010281449,0.00029823367,0.00014440337,0.00014065315,0.00007114668,0.00018412435,0.0000018444754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080481346,0.0010570202,0.76101434,0.0005642671,0.000098479635,0.19945464,0.0011224814,0.000039194736,0.018567355,0.00006657635,0.0019205126,0.015290334],"study_design_scores_gemma":[0.022122512,0.004491117,0.4600521,0.0009717203,0.00025493142,0.105071485,0.0012895819,0.0016484645,0.39953175,0.00021476072,0.004057242,0.0002943437],"about_ca_topic_score_codex":0.0021363732,"about_ca_topic_score_gemma":0.00020343991,"teacher_disagreement_score":0.38096437,"about_ca_system_score_codex":0.00028670937,"about_ca_system_score_gemma":0.0004975204,"threshold_uncertainty_score":0.38412893},"labels":[],"label_agreement":null},{"id":"W2082831337","doi":"10.1067/j.cpradiol.2008.07.001","title":"Radiological Manifestations of Skeletal Lymphoma","year":2009,"lang":"en","type":"review","venue":"Current Problems in Diagnostic Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Lymphoma; Magnetic resonance imaging; Radiological weapon; Radiology; Pathology; Radiography; Disease; Mycosis fungoides","score_opus":0.06897112825171645,"score_gpt":0.3675362431918536,"score_spread":0.29856511494013716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082831337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008121795,0.99450463,0.000033529945,0.00006295814,0.0007839819,0.002828597,0.00010860149,0.000059471342,0.00080602616],"genre_scores_gemma":[0.0023948585,0.9945295,0.00027278904,0.000032608157,0.00028349875,0.0012278715,0.0011846791,0.000044204022,0.000029989538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958002,0.00046142962,0.0019730942,0.00086605444,0.00023918,0.00066002115],"domain_scores_gemma":[0.993302,0.004980703,0.0007380013,0.0006728408,0.00008200319,0.00022449277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038556533,0.00071771437,0.0038831593,0.000598152,0.00004554823,0.0000111860145,0.00033391616,0.0006507938,0.000109495995],"category_scores_gemma":[0.0024616017,0.00051211426,0.00084680127,0.0005171601,0.00034809578,0.00004901464,0.000087083965,0.00038812563,0.00011843831],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005946587,0.0023654776,0.0030992064,0.009698,0.00022527775,0.0007734736,0.000052136293,0.000010603419,9.1818414e-8,0.0015045508,0.0019016147,0.9803636],"study_design_scores_gemma":[0.0027891954,0.0012454467,0.014585247,0.028614642,0.0020595684,0.00608233,0.0000061026967,0.000007814611,3.8578733e-7,0.00084482087,0.94327974,0.00048471024],"about_ca_topic_score_codex":0.000016952032,"about_ca_topic_score_gemma":0.000005883422,"teacher_disagreement_score":0.9798789,"about_ca_system_score_codex":0.0006379543,"about_ca_system_score_gemma":0.00073445216,"threshold_uncertainty_score":0.99973303},"labels":[],"label_agreement":null},{"id":"W2082968048","doi":"10.1053/j.seminhematol.2015.01.012","title":"Summary and Future Directions","year":2015,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Clinical trial; Disease; Medicine; Precision medicine; Intensive care medicine; Medical physics; Bioinformatics; Computational biology; Internal medicine; Biology; Pathology","score_opus":0.03294181224422383,"score_gpt":0.3480487230918615,"score_spread":0.3151069108476377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082968048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038174865,0.99179983,4.9753368e-8,0.00031118552,0.00047137882,0.00059237395,0.000020068372,0.000035115445,0.0067317956],"genre_scores_gemma":[0.000002486052,0.99832326,0.0002581129,0.00005222281,0.00021632967,0.0003194672,0.0001511788,0.000029301891,0.00064766133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886644,0.00008692096,0.0003675557,0.0003597754,0.0000940004,0.0002253256],"domain_scores_gemma":[0.9992394,0.0001777942,0.000110415785,0.0003069563,0.000028843324,0.0001366009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012481358,0.00028102938,0.0019586585,0.00024959515,0.000027858025,0.0000059226886,0.000053526845,0.0004951636,0.00004069547],"category_scores_gemma":[0.000035140194,0.0002004287,0.00015975031,0.00023648654,0.0000775795,0.000018544331,0.00006723171,0.00021642559,0.0000491124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006058768,0.00019545903,0.0014022845,0.005813843,0.000110925735,0.0010469555,0.000069119036,1.218629e-9,2.8839156e-9,0.0009123282,0.015903065,0.97453994],"study_design_scores_gemma":[0.00046141687,0.00010859889,0.00004454362,0.011735638,0.0007644088,0.00901226,0.000047905298,2.6355852e-7,3.0665484e-7,0.00008683409,0.9775983,0.0001395057],"about_ca_topic_score_codex":0.000021608925,"about_ca_topic_score_gemma":0.000022160255,"teacher_disagreement_score":0.97440046,"about_ca_system_score_codex":0.00022869051,"about_ca_system_score_gemma":0.0002767442,"threshold_uncertainty_score":0.8173245},"labels":[],"label_agreement":null},{"id":"W2083786422","doi":"10.1038/sj.bmt.1705080","title":"Stem cell transplantation for mantle cell lymphoma: if, when and how?","year":2005,"lang":"en","type":"review","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Mantle cell lymphoma; Lymphoma; Transplantation; Oncology; Surgery; Internal medicine; Chemotherapy; Disease","score_opus":0.02838120961560778,"score_gpt":0.2739583413141862,"score_spread":0.24557713169857845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083786422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010056731,0.99116516,0.0008938072,0.00023417194,0.00019920841,0.0033805822,0.0014133814,0.0001082678,0.0015997256],"genre_scores_gemma":[0.0041580433,0.9837668,0.002121635,0.00008358508,0.0002472407,0.00094745005,0.005543018,0.00011921455,0.0030130162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978226,0.00010334271,0.000591283,0.0007250147,0.00034408737,0.00041370196],"domain_scores_gemma":[0.99876523,0.0003034516,0.000350915,0.000294131,0.00007038274,0.00021586343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019104299,0.00065878546,0.0014997987,0.0002866981,0.00014492343,0.00008975465,0.00008840077,0.0004572362,0.00003094802],"category_scores_gemma":[0.0000012037996,0.00054596126,0.000530987,0.0001282027,0.0000446969,0.00017859429,0.0000057561297,0.000104142026,0.000046473073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027021463,0.0005399361,0.000048710117,0.0752389,0.000152962,0.0002803606,0.0006508215,6.504442e-7,0.000024515482,0.00005912337,0.0008919457,0.92184186],"study_design_scores_gemma":[0.013860106,0.00057366467,0.00047560126,0.008995363,0.017378498,0.0014951996,0.000080733924,0.000030045345,0.0008968077,0.00002092881,0.9553699,0.0008231477],"about_ca_topic_score_codex":0.000030011135,"about_ca_topic_score_gemma":0.000032921173,"teacher_disagreement_score":0.95447797,"about_ca_system_score_codex":0.0002685126,"about_ca_system_score_gemma":0.00026291268,"threshold_uncertainty_score":0.9996992},"labels":[],"label_agreement":null},{"id":"W2084369992","doi":"10.1016/j.gynor.2012.11.001","title":"Nodular lymphocyte predominant Hodgkin's lymphoma of the cervix: A case report of a rare entity","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Presentation (obstetrics); Cervix; Stage (stratigraphy); Lymphoma; Pathology; Immunohistochemistry; Hodgkin lymphoma; Radiology; Internal medicine; Cancer","score_opus":0.020216790360968732,"score_gpt":0.29514495145206787,"score_spread":0.27492816109109913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084369992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989205,0.0023563537,0.000008710696,0.00037689952,0.0015913154,0.0015041687,0.000030087313,0.000051921284,0.004875525],"genre_scores_gemma":[0.99765337,0.00010793469,0.0010756985,0.0002459953,0.00012722943,0.0002846853,0.000025159576,0.00002740669,0.00045254757],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99654233,0.00032568426,0.0015501736,0.0005509914,0.00039903764,0.00063179707],"domain_scores_gemma":[0.9952078,0.0005576885,0.0019808589,0.0015552738,0.00037954494,0.0003188719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015380518,0.0003543331,0.0012362935,0.00013909242,0.00021973946,0.000006534547,0.00008214118,0.0004884358,0.0005274178],"category_scores_gemma":[0.0017049855,0.00022066779,0.0005848872,0.00037948895,0.00045482506,0.00011429546,0.0003285781,0.00011044667,0.00000975238],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010575802,0.003477882,0.2816072,0.00013382685,0.00034831886,0.70011383,0.00035914866,0.0000036982267,0.00029648232,0.00005089296,0.0009291538,0.012573783],"study_design_scores_gemma":[0.0027936508,0.000869959,0.13777441,0.000060779592,0.0011797764,0.8256958,0.00043486102,0.000011459189,0.016026976,0.00005524949,0.014934601,0.00016244574],"about_ca_topic_score_codex":0.0017050679,"about_ca_topic_score_gemma":0.00038200495,"teacher_disagreement_score":0.1438328,"about_ca_system_score_codex":0.0014927558,"about_ca_system_score_gemma":0.0015753092,"threshold_uncertainty_score":0.89985716},"labels":[],"label_agreement":null},{"id":"W2084446054","doi":"10.1200/jco.2011.41.0910","title":"International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Dacarbazine; Hodgkin's lymphoma; Internal medicine; Vinblastine; Stage (stratigraphy); Regimen; Surgery; Population; Oncology; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.1556374997009582,"score_gpt":0.46611874311032825,"score_spread":0.31048124340937006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084446054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830583,0.0007563795,0.000033391483,0.008982114,0.0015390471,0.00030916714,0.0000046705964,0.0000041280755,0.005312854],"genre_scores_gemma":[0.9948867,0.0005340343,0.0012639954,0.0022210807,0.0010018286,0.000022642487,0.0000047428002,0.000008515581,0.00005643767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970056,0.00047291818,0.0016905755,0.00015224685,0.00039302482,0.0002856729],"domain_scores_gemma":[0.99636626,0.0023192838,0.0007757711,0.00019151943,0.00014358154,0.00020358548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034888524,0.00012715712,0.00083675963,0.00012574402,0.000018084207,0.000009375085,0.0002245724,0.00020892723,0.00010089224],"category_scores_gemma":[0.002555742,0.000072308874,0.00029093365,0.00012557652,0.00009863232,0.00020596197,0.000053352676,0.00045657536,0.000014674035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013469286,0.0071418444,0.70006716,0.000008918457,0.00007783377,0.0005030863,0.0003344962,0.000010266265,0.000005645074,0.000112215756,0.00042423946,0.2899674],"study_design_scores_gemma":[0.013690826,0.0020960665,0.9516404,0.00010502894,0.00008794381,0.00033233906,0.00019779641,0.00032557035,0.000013490138,0.0004144552,0.031037979,0.000058087593],"about_ca_topic_score_codex":0.000041367435,"about_ca_topic_score_gemma":0.000097703654,"teacher_disagreement_score":0.2899093,"about_ca_system_score_codex":0.00036180275,"about_ca_system_score_gemma":0.0007139167,"threshold_uncertainty_score":0.30596465},"labels":[],"label_agreement":null},{"id":"W2084661091","doi":"10.1182/blood-2006-06-028522","title":"AKTion on mantle cell lymphoma","year":2006,"lang":"als","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blastoid; Mantle cell lymphoma; Cancer research; Lymphoma; Protein kinase B; Medicine; Signal transduction; Biology; Cell biology; Immunology","score_opus":0.007577001102124336,"score_gpt":0.2174372150310166,"score_spread":0.20986021392889226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084661091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86618674,0.004872697,0.000002805967,0.00059455266,0.00042653922,0.0004020203,0.00005725464,0.00006982361,0.12738758],"genre_scores_gemma":[0.9867508,0.0005149225,0.00010469089,0.00040582445,0.001112579,0.000055385666,0.00012685651,0.00004145196,0.010887513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983514,0.000054895136,0.00034107995,0.00043825546,0.0003781757,0.00043617084],"domain_scores_gemma":[0.9990988,0.00010680537,0.0001306009,0.000471023,0.000050477614,0.00014230298],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009870175,0.0003005556,0.0003609044,0.00010385663,0.000122032056,0.00004863955,0.000083519866,0.00017888704,0.000452039],"category_scores_gemma":[0.0000135673945,0.0002503556,0.0001961106,0.00015502579,0.000041535557,0.000042934364,0.000030687974,0.00005009329,0.004694539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070766645,0.25492463,0.50253075,0.0010840693,0.0014185017,0.00744829,0.00056464435,0.000045553526,0.017917968,0.015752902,0.13110137,0.06650367],"study_design_scores_gemma":[0.03714814,0.0018184691,0.53140026,0.00047283378,0.0018030751,0.00009298318,0.00007651345,0.000032261374,0.39845678,0.00024868982,0.028076671,0.00037329618],"about_ca_topic_score_codex":0.00077430287,"about_ca_topic_score_gemma":0.000022569047,"teacher_disagreement_score":0.38053882,"about_ca_system_score_codex":0.00017943286,"about_ca_system_score_gemma":0.00011546886,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2084846449","doi":"10.1007/s12308-012-0141-0","title":"Laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma associated with bronchial MALT lymphoma: a case series and review of the literature","year":2012,"lang":"en","type":"article","venue":"Journal of Hematopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Medicine; MALT lymphoma; Vincristine; Lymphoma; Debulking; Rituximab; Mucosa-associated lymphoid tissue; Larynx; Internal medicine; Radiology; Surgery; Cyclophosphamide; Chemotherapy; Cancer","score_opus":0.00857127592468803,"score_gpt":0.25330986285618107,"score_spread":0.24473858693149303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084846449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90797484,0.08909344,0.0000014535239,0.0018397209,0.00033806177,0.0004047604,0.000062239356,0.000016264974,0.00026919015],"genre_scores_gemma":[0.9904645,0.007428937,0.00026007512,0.001313661,0.00021462141,0.000019652802,0.000023289665,0.000036741545,0.00023852615],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.997525,0.0004493483,0.00089343055,0.00020455473,0.00045150565,0.00047618814],"domain_scores_gemma":[0.99736625,0.00023870381,0.0012563126,0.0003356426,0.00052053825,0.0002825638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009725615,0.00033625754,0.0012952861,0.00013402884,0.0001508192,0.000023099814,0.00013491142,0.00026549996,0.000048234968],"category_scores_gemma":[0.00082599814,0.00018653629,0.0002561803,0.0004200893,0.00022711311,0.00028893197,0.000096318036,0.00014428937,0.0000031536233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011483062,0.0060089207,0.9218753,0.0033865324,0.0012733513,0.04543669,0.0028518722,4.3430933e-7,0.0013375304,0.00079467386,0.006180152,0.009706257],"study_design_scores_gemma":[0.01061891,0.002243634,0.2895616,0.012629916,0.0017459219,0.67558515,0.00026338967,0.00000190195,0.004770298,0.000058607617,0.0022841136,0.00023659658],"about_ca_topic_score_codex":0.00002354399,"about_ca_topic_score_gemma":0.000042352054,"teacher_disagreement_score":0.63231367,"about_ca_system_score_codex":0.00047118252,"about_ca_system_score_gemma":0.0004476311,"threshold_uncertainty_score":0.76067287},"labels":[],"label_agreement":null},{"id":"W2085276059","doi":"10.1111/bjh.12343","title":"<scp>B</scp>‐cell lymphoma, unclassifiable, with features intermediate between diffuse large <scp>B</scp>‐cell lymphoma and burkitt lymphoma: study of 39 cases","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"BCL6; Lymphoma; Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Immunohistochemistry; Fluorescence in situ hybridization; Pathology; Stage (stratigraphy); B-cell lymphoma; Internal medicine; Oncology; B cell; Gastroenterology; Immunology; Biology; Gene; Antibody; Chromosome","score_opus":0.010707840875849922,"score_gpt":0.2343592752815923,"score_spread":0.2236514344057424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085276059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97909594,0.017032426,0.0000215575,0.0001261235,0.0003688533,0.001280653,0.00012488554,0.00006268353,0.0018868804],"genre_scores_gemma":[0.9946997,0.0022101952,0.00045609812,0.0003726368,0.00030014984,0.00011385287,0.000049757884,0.00013349649,0.0016640911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948747,0.00042701242,0.0017516712,0.0007845625,0.0009625584,0.0011994719],"domain_scores_gemma":[0.9932388,0.0027186144,0.0016779682,0.000614845,0.0008262998,0.0009234596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004739237,0.0007724576,0.0028654127,0.0006122615,0.0003048194,0.00022309345,0.0004992434,0.00047868097,0.00003429087],"category_scores_gemma":[0.00083794777,0.00064495276,0.00037398734,0.00046750103,0.0004885881,0.00048498804,0.00032084994,0.00026610526,0.00004597712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018866293,0.04422823,0.71987563,0.0009915882,0.0024491833,0.14343035,0.0043192003,0.0000033692313,0.0002730055,0.00006561539,0.064993285,0.019181892],"study_design_scores_gemma":[0.07550513,0.0061775544,0.7145088,0.001113072,0.0019879404,0.17857783,0.011849265,0.000017887722,0.0048113638,0.00013704455,0.0051061907,0.00020796334],"about_ca_topic_score_codex":0.0018548981,"about_ca_topic_score_gemma":0.00045389193,"teacher_disagreement_score":0.075316474,"about_ca_system_score_codex":0.0003706935,"about_ca_system_score_gemma":0.00075384695,"threshold_uncertainty_score":0.9996002},"labels":[],"label_agreement":null},{"id":"W2085346499","doi":"10.1182/blood-2013-11-531327","title":"Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"National Cancer Institute; Teva Pharmaceutical Industries","keywords":"Bendamustine; Rituximab; Medicine; CHOP; Internal medicine; Oncology; Lymphoma","score_opus":0.033397176635848715,"score_gpt":0.30563597359123723,"score_spread":0.2722387969553885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085346499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926395,0.00047938267,0.000004994025,0.00076937745,0.00016736062,0.0054416475,0.000024866533,0.000022363698,0.00045051565],"genre_scores_gemma":[0.9976661,0.00055114174,0.00012732869,0.00005485913,0.0002457296,0.00089956546,0.00001690924,0.000023953842,0.00041438572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775386,0.00031572732,0.00094835163,0.00032362132,0.00040757496,0.00025084426],"domain_scores_gemma":[0.99745315,0.0014439776,0.0003145689,0.00060671836,0.0000887529,0.00009280299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192997,0.0002845795,0.0016443798,0.00013629286,0.000052355655,0.0000100203515,0.00012009518,0.000081792896,0.00022825437],"category_scores_gemma":[0.00050703296,0.00011933853,0.00032503944,0.00024513778,0.00011425985,0.000027290856,0.000040375468,0.00005719174,0.000010439496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85929006,0.10820132,0.01858292,0.00008890235,0.0014459377,0.00014485886,0.0022227382,0.000008490075,0.000030146548,0.00005420492,0.00007018659,0.009860264],"study_design_scores_gemma":[0.9631204,0.014369595,0.012025389,0.00017015066,0.002640802,0.000027813814,0.0001941792,0.000060495862,0.0063558538,0.000022034668,0.0008985866,0.000114687726],"about_ca_topic_score_codex":0.0011672506,"about_ca_topic_score_gemma":0.0012162814,"teacher_disagreement_score":0.103830375,"about_ca_system_score_codex":0.00008311031,"about_ca_system_score_gemma":0.0001721062,"threshold_uncertainty_score":0.4866484},"labels":[],"label_agreement":null},{"id":"W2085770931","doi":"10.1097/00005176-200105000-00021","title":"Primary Non-Hodgkin Lymphoma of the Extrahepatic Biliary Tract and Gallbladder in a Child","year":2001,"lang":"en","type":"article","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Jaundice; Lymphoma; Biliary tract; Bile duct; Cholestasis; Malignancy; Gallbladder; Gastroenterology; Common bile duct; Abdominal pain; Pathology; Internal medicine","score_opus":0.006351252448815201,"score_gpt":0.2208184103809018,"score_spread":0.2144671579320866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085770931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946807,0.0027459876,0.0000185457,0.0021873207,0.00009823133,0.00021225179,0.000003520585,0.0000019028172,0.000051545696],"genre_scores_gemma":[0.9866445,0.012508251,0.00022636664,0.0003411707,0.00025914368,0.000008313723,0.0000022456102,0.000005633364,0.000004361797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911946,0.00007832689,0.0004157061,0.00010346027,0.00013650134,0.00014657395],"domain_scores_gemma":[0.9994514,0.00006663073,0.00027602242,0.00008055518,0.00005163095,0.000073752286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021105651,0.000100707985,0.00032526738,0.00021643177,0.000034185312,0.000004760063,0.000042753818,0.00007765897,0.000010333291],"category_scores_gemma":[0.000024910325,0.000064548636,0.00009761924,0.000115648625,0.0000646456,0.000087863686,0.000020749023,0.00011169487,2.745109e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013549626,0.002304939,0.9934285,0.00012696382,0.000042005307,0.00023443319,0.000081226215,6.2858635e-7,0.00013240732,0.000002000734,0.00037306244,0.0019188651],"study_design_scores_gemma":[0.010674926,0.0021373236,0.98062235,0.00013178862,0.0003253276,0.005834465,0.00004343084,0.000019727444,0.000052718802,0.00007890335,0.000050233808,0.000028788972],"about_ca_topic_score_codex":0.000012281899,"about_ca_topic_score_gemma":0.000011587867,"teacher_disagreement_score":0.012806139,"about_ca_system_score_codex":0.000052655396,"about_ca_system_score_gemma":0.000034984238,"threshold_uncertainty_score":0.2632217},"labels":[],"label_agreement":null},{"id":"W2086036138","doi":"10.1002/ajh.10466","title":"Hepatosplenic γδ T‐cell lymphoma in a 10‐year‐old boy successfully treated with hematopoietic stem cell transplantation","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lymphoma; Hematopoietic stem cell transplantation; Medicine; Transplantation; Chemotherapy; Stem cell; T-cell lymphoma; Haematopoiesis; Oncology; Internal medicine; Biology","score_opus":0.006172396217719142,"score_gpt":0.22689735442727116,"score_spread":0.220724958209552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694514,0.000748639,0.000115297946,0.0012107026,0.00003589172,0.00023775437,0.0000055733453,0.000020723815,0.0006802474],"genre_scores_gemma":[0.9979804,0.00050293887,0.0010222328,0.00029200077,0.000024953153,0.000021061502,0.000009548043,0.000033636832,0.00011321306],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827933,0.000096896954,0.0006832923,0.00025518276,0.00030611776,0.00037917637],"domain_scores_gemma":[0.9987075,0.00010716532,0.00059395604,0.00022728833,0.00013720339,0.00022693117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012342923,0.00026235954,0.0009950706,0.00032088923,0.000040485706,0.00001623717,0.00012867835,0.000076747325,0.000053172913],"category_scores_gemma":[0.0000045213005,0.0001850065,0.0001660508,0.00045795704,0.00016332512,0.00010815823,0.000009894508,0.00012446292,0.000048388738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050160284,0.0056037474,0.9550382,0.00043541775,0.000335586,0.022717053,0.0030972655,0.00015919801,0.0010311019,0.00063130795,0.00021928277,0.0057158195],"study_design_scores_gemma":[0.12201221,0.032608997,0.3501148,0.0026074129,0.0025612176,0.11782027,0.013980471,0.000047589427,0.35625815,0.00031714846,0.0004920197,0.0011797221],"about_ca_topic_score_codex":0.00043092686,"about_ca_topic_score_gemma":0.0000720862,"teacher_disagreement_score":0.6049234,"about_ca_system_score_codex":0.00029577533,"about_ca_system_score_gemma":0.00040913862,"threshold_uncertainty_score":0.75443465},"labels":[],"label_agreement":null},{"id":"W2086108274","doi":"10.1179/102453308x343527","title":"Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy","year":2008,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"Haematology Society of Australia and New Zealand; University Health Network","keywords":"Salvage therapy; Chemotherapy; Medicine; Anthracycline; Chemotherapy regimen; Oncology; Refractory (planetary science); Internal medicine; Regimen; Lymphoma; Transplantation; Surgery; Cancer; Biology","score_opus":0.022510725490434612,"score_gpt":0.2838328409385954,"score_spread":0.2613221154481608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086108274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26775575,0.7290907,0.00003068128,0.000045163677,0.00011835522,0.0022125049,0.00032142003,0.00006389653,0.00036153445],"genre_scores_gemma":[0.22002806,0.77745026,0.00034766208,0.00021512447,0.000027390914,0.0002544509,0.0015122546,0.00011102816,0.00005376298],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964218,0.00022345666,0.0013680283,0.00083745026,0.00051122456,0.0006380482],"domain_scores_gemma":[0.99770856,0.00043446006,0.0008046234,0.00072681275,0.00012614958,0.00019938464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015017536,0.0007926547,0.0035017438,0.0004141509,0.00007063264,0.000007834987,0.00020472406,0.00071414904,0.00032835387],"category_scores_gemma":[0.000017009801,0.0005767186,0.0007350385,0.000361654,0.00021540656,0.000046234123,0.000018894583,0.00027292751,0.000035115616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005191686,0.1512345,0.5729999,0.053887486,0.0021826783,0.0025655236,0.00084218686,8.2574786e-7,0.000005587526,0.00060319615,0.0012945608,0.20919186],"study_design_scores_gemma":[0.32852408,0.002496118,0.06311892,0.032768793,0.0017557105,0.0009632959,0.000044086304,0.00010136312,0.0013275316,0.00003431927,0.5670943,0.0017714876],"about_ca_topic_score_codex":0.00006903021,"about_ca_topic_score_gemma":0.000047749283,"teacher_disagreement_score":0.5657997,"about_ca_system_score_codex":0.00031225,"about_ca_system_score_gemma":0.0011053954,"threshold_uncertainty_score":0.9996684},"labels":[],"label_agreement":null},{"id":"W2086488319","doi":"10.1097/00000478-200003000-00016","title":"Hepatosplenic T-Cell Lymphoma of αβ Lineage in a 16-Year-Old Boy Presenting With Hemolytic Anemia and Thrombocytopenia","year":2000,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CD5; Lymphoma; Immunophenotyping; Gene rearrangement; Pathology; Bone marrow; T-cell lymphoma; Medicine; Terminal deoxynucleotidyl transferase; Peripheral T-cell lymphoma; CD3; CD8; T cell; Immunology; Biology; Antigen; Immunohistochemistry; Immune system","score_opus":0.008826116456811159,"score_gpt":0.24856128586494264,"score_spread":0.23973516940813147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086488319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964372,0.0007706166,0.0000019053188,0.0011491692,0.000017320182,0.00015511885,0.0000033916674,0.000005690911,0.0014595957],"genre_scores_gemma":[0.99743694,0.0016239786,0.0004106872,0.00022642575,0.00006991745,0.000004568479,0.0000014501022,0.000016689068,0.00020936245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985873,0.00021675712,0.0005129808,0.0001770886,0.00023533968,0.00027050535],"domain_scores_gemma":[0.99882984,0.00031382215,0.00042186736,0.00023450589,0.000064652784,0.00013530199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004125033,0.00016117381,0.0008850133,0.00009582659,0.000034985573,0.00000947561,0.00012590404,0.00004210606,0.00011625505],"category_scores_gemma":[0.000019527719,0.00008720466,0.00011686948,0.00028389698,0.0004927478,0.000050990446,0.000038464732,0.00016201587,0.000007504432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045458237,0.0017662034,0.9450927,0.000058222373,0.0001258345,0.013300055,0.00085913064,0.00003303082,0.00087415933,0.000059292324,0.00016382559,0.033121742],"study_design_scores_gemma":[0.02180735,0.006999324,0.9299242,0.0002680362,0.00044130808,0.03287719,0.0010480027,0.00010836564,0.005260496,0.000098903816,0.00093947316,0.00022734747],"about_ca_topic_score_codex":0.00014075066,"about_ca_topic_score_gemma":0.000007818722,"teacher_disagreement_score":0.032894395,"about_ca_system_score_codex":0.00008034707,"about_ca_system_score_gemma":0.0001079207,"threshold_uncertainty_score":0.35561028},"labels":[],"label_agreement":null},{"id":"W2087612171","doi":"10.1593/tlo.10172","title":"Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Cancer Society Research Institute; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Signal transduction; Mantle cell lymphoma; Cell growth; Cancer research; Transcription factor; Biology; Western blot; Cell; Cell culture; Interleukin 9; Interleukin; Cell biology; Molecular biology; Lymphoma; Gene; Cytokine; Immunology; Genetics","score_opus":0.03522521691656925,"score_gpt":0.27247219769798203,"score_spread":0.2372469807814128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087612171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90813756,0.00040379493,0.00013783785,0.0007107371,0.00010349721,0.00036960124,0.000010161239,0.00003401509,0.090092786],"genre_scores_gemma":[0.9931524,0.000025883031,0.0059936587,0.00033771852,0.00006499028,0.000071356495,0.000053796815,0.000017772038,0.0002824182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989841,0.00007027201,0.00031879768,0.00025001567,0.00014853998,0.00022828368],"domain_scores_gemma":[0.99951214,0.00017951935,0.000066498345,0.00009446272,0.000054538337,0.00009284267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016129181,0.00014481721,0.00029054622,0.00014786383,0.000031704927,0.000004255071,0.00006815915,0.00013619596,0.000995512],"category_scores_gemma":[0.0000072991475,0.00012349882,0.00009713661,0.00012828599,0.000053594835,0.00006420921,0.000010161527,0.000066712884,0.0001716783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023879632,0.024645142,0.86991394,0.00039883947,0.0002112081,0.0025253303,0.01375081,0.000019867168,0.02366232,0.008894772,0.000905796,0.05268399],"study_design_scores_gemma":[0.02411356,0.002550549,0.6889702,0.00011564436,0.0002526111,0.00015040637,0.0002674562,0.00044414768,0.27283025,0.0049033305,0.005043283,0.00035855224],"about_ca_topic_score_codex":0.00020451962,"about_ca_topic_score_gemma":0.00006919738,"teacher_disagreement_score":0.24916793,"about_ca_system_score_codex":0.00019723951,"about_ca_system_score_gemma":0.00028923067,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W2087888521","doi":"10.1016/j.jclinepi.2012.03.008","title":"Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Epidemiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Data extraction; Medicine; Randomized controlled trial; Systematic review; Grading (engineering); Citation; MEDLINE; Evidence-based medicine; Rituximab; Medical physics; Alternative medicine; Lymphoma; Computer science; Library science; Pathology","score_opus":0.5681861577016148,"score_gpt":0.5815530398219163,"score_spread":0.01336688212030146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087888521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025981293,0.98628026,0.0075712805,0.0016618731,0.00069555844,0.0037188123,0.00002713844,0.0000055570454,0.000013563616],"genre_scores_gemma":[0.0003721808,0.9882629,0.007465198,0.002250939,0.001038101,0.00051342795,0.0000190824,0.00003157107,0.00004661726],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9700301,0.016322164,0.012276667,0.0005196635,0.0003330817,0.00051827467],"domain_scores_gemma":[0.76530284,0.21025081,0.022063281,0.0011154327,0.00083579426,0.00043186842],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07392393,0.0005099268,0.03095388,0.003307292,0.00007398873,0.000007233733,0.0005536455,0.00092200097,0.000027039778],"category_scores_gemma":[0.14681761,0.00023974171,0.0073071024,0.011406542,0.00040918402,0.000081631224,0.00016857096,0.00045308584,0.00000898735],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009310728,0.00056465075,0.02174552,0.4975055,0.0132238,0.0000047897984,0.000003853619,0.0000011868659,7.606876e-9,0.000509621,0.002811176,0.4635368],"study_design_scores_gemma":[0.0023378928,0.001464226,0.022991681,0.34468928,0.38085434,0.0009050165,0.0000052913056,0.000045915993,1.06968315e-7,0.00042581317,0.24603194,0.00024850963],"about_ca_topic_score_codex":0.00002525464,"about_ca_topic_score_gemma":0.0000067697642,"teacher_disagreement_score":0.4632883,"about_ca_system_score_codex":0.00015113354,"about_ca_system_score_gemma":0.0005589866,"threshold_uncertainty_score":0.98343265},"labels":[],"label_agreement":null},{"id":"W2088035066","doi":"10.1111/j.1349-7006.2009.01128.x","title":"Translocation t(11;18)(q21;q21) in gastric B‐cell lymphomas","year":2009,"lang":"en","type":"article","venue":"Cancer Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Office of Research and Development; Fondazione Italiana per la Ricerca sul Cancro; U.S. Department of Veterans Affairs","keywords":"Lymphoma; Chromosomal translocation; Pathology; MALT lymphoma; Lymphatic system; Mucosa-associated lymphoid tissue; Biology; B cell; Gastric mucosa; Fluorescence in situ hybridization; Molecular biology; Stomach; Medicine; Immunology; Antibody; Gene","score_opus":0.021378817854705974,"score_gpt":0.3105950068779898,"score_spread":0.28921618902328383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088035066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435485,0.0030967335,0.00008974903,0.0026712478,0.0001932041,0.00029400748,0.000002933811,0.000036057136,0.009261217],"genre_scores_gemma":[0.99734735,0.00069191004,0.0004897967,0.001067538,0.000063723266,0.000047244146,0.0000023245661,0.0000044379926,0.0002856873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99877423,0.0000095918895,0.00017206499,0.00036187962,0.00035477147,0.000327468],"domain_scores_gemma":[0.99945384,0.000016444861,0.00004388694,0.0002512068,0.00007012791,0.00016447584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001750961,0.00011084391,0.00016326338,0.00019590453,0.00008389416,0.000032320557,0.00015306383,0.00003389489,0.00011395899],"category_scores_gemma":[0.000019431896,0.00008909818,0.000040525036,0.0012261792,0.00013345461,0.00019035151,0.000009252998,0.000036597143,0.000028998267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008753411,0.0014352702,0.4112299,0.0000398895,0.000006583893,0.00014643653,0.0014057051,0.00025933277,0.046576887,0.0011609881,0.002034858,0.53561664],"study_design_scores_gemma":[0.0028849095,0.00025365577,0.91480243,0.00013575616,0.000023995493,0.000029587725,0.00006694593,0.0007847394,0.078739256,0.00012464292,0.0020303745,0.0001237285],"about_ca_topic_score_codex":0.00035388896,"about_ca_topic_score_gemma":0.00008470428,"teacher_disagreement_score":0.5354929,"about_ca_system_score_codex":0.0007564217,"about_ca_system_score_gemma":0.00081144884,"threshold_uncertainty_score":0.36333185},"labels":[],"label_agreement":null},{"id":"W2088182134","doi":"10.1016/j.ajhg.2014.09.004","title":"Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region","year":2014,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Cancer Research UK; World Health Organization","keywords":"Follicular lymphoma; Human leukocyte antigen; Genetics; Biology; Genome-wide association study; Lymphoma; Genetic association; Genome; Single-nucleotide polymorphism; Gene; Immunology; Genotype; Antigen","score_opus":0.0182272396420241,"score_gpt":0.2867709222454471,"score_spread":0.268543682603423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088182134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953589,0.0004310829,0.00029686702,0.003036425,0.00010552422,0.0006926726,0.0000027563208,0.000009718387,0.0000660449],"genre_scores_gemma":[0.99802595,0.00014150872,0.00013645843,0.00085477025,0.0004429226,0.00002538546,0.0000043631167,0.000023205395,0.00034541008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817604,0.00037995633,0.00054041675,0.00016987891,0.0004896503,0.00024406739],"domain_scores_gemma":[0.99700195,0.0007796348,0.0011606448,0.00051619904,0.00044861477,0.00009297831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013047354,0.00017014907,0.0004984261,0.00006110098,0.00033027533,0.000068041,0.0002802944,0.000027109385,0.000006647078],"category_scores_gemma":[0.00037838484,0.00008993598,0.0003222884,0.00013455718,0.00018724731,0.000032694796,0.0000532148,0.000089235786,0.0000062418044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002882455,0.0010798934,0.97823787,0.000014691518,0.0011060106,0.000027521915,0.005179502,0.00012490294,0.00072059553,0.000023010578,0.0030515476,0.010146225],"study_design_scores_gemma":[0.002719752,0.005095533,0.9816919,0.000021503854,0.0011148094,0.000036205623,0.00574971,0.000033145006,0.00096015964,0.0008583825,0.0016182128,0.000100660895],"about_ca_topic_score_codex":0.00008392098,"about_ca_topic_score_gemma":0.00009193332,"teacher_disagreement_score":0.010045564,"about_ca_system_score_codex":0.00046986013,"about_ca_system_score_gemma":0.000083219515,"threshold_uncertainty_score":0.3667483},"labels":[],"label_agreement":null},{"id":"W2088431383","doi":"10.1182/blood-2015-01-623777","title":"A roadmap for discovery and translation in lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Allos Therapeutics; Leonard M. Miller School of Medicine; Weill Cornell Medical College; Pharmacyclics; Genentech; Five Prime Therapeutics; National Institutes of Health; Helsinn; BC Cancer Agency; Bristol-Myers Squibb; University of Miami; Celgene; Teva Pharmaceutical Industries; Kite Pharma; Gilead Sciences; Sanofi; University of Washington; GlaxoSmithKline; Takeda Oncology; Amgen","keywords":"Chronic lymphocytic leukemia; Immunophenotyping; Lymphoma; Hodgkin lymphoma; Medicine; Leukemia; Pathology; Biology; Immunology; Flow cytometry","score_opus":0.04222863533692403,"score_gpt":0.28163556231727804,"score_spread":0.239406926980354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088431383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961417,0.001756051,0.00004020398,0.00064944813,0.000027351376,0.00031458947,0.0000075325806,0.000010958726,0.0010522205],"genre_scores_gemma":[0.9986647,0.00003877942,0.00094729656,0.00009751093,0.00004682251,0.000082545754,0.000019654837,0.0000058197397,0.00009690595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996771,0.0000058773367,0.000078328296,0.00010004206,0.0000598547,0.00007877711],"domain_scores_gemma":[0.9998165,0.000036366288,0.000012910493,0.00006409721,0.000012666729,0.000057471698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005381676,0.000050162304,0.00010465168,0.000032634984,0.000008975005,0.000011689816,0.000009728576,0.000028750323,0.0000010412995],"category_scores_gemma":[0.000022337168,0.00003823149,0.000024385858,0.00003773678,0.000009422713,0.000065008935,0.0000035936391,0.0000066351836,0.0000023220762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042723326,0.0041490872,0.8787122,0.00008882656,0.000128098,0.00009900791,0.0016524427,0.0000018220929,0.00060403,0.0010419631,0.00047199964,0.1126233],"study_design_scores_gemma":[0.07479754,0.0011334697,0.90160364,0.00013177806,0.00039168497,0.00012641601,0.00029774816,0.00020994255,0.012911511,0.0011148001,0.0071332757,0.00014817539],"about_ca_topic_score_codex":0.0000620431,"about_ca_topic_score_gemma":0.00004556715,"teacher_disagreement_score":0.11247512,"about_ca_system_score_codex":0.00002543599,"about_ca_system_score_gemma":0.00005674222,"threshold_uncertainty_score":0.15590349},"labels":[],"label_agreement":null},{"id":"W2088900228","doi":"10.1002/ajh.20359","title":"Anaplastic large‐cell lymphoma presenting as acute leukemia","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphoma; Leukemia; Anaplastic large-cell lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.005965687940182669,"score_gpt":0.27116655238889104,"score_spread":0.2652008644487084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088900228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300975,0.0010062075,0.00011332831,0.0023717682,0.00013375022,0.00008732192,0.0000027210613,0.000016888573,0.0032582502],"genre_scores_gemma":[0.9944789,0.00026170624,0.0034870442,0.0012594011,0.00020845578,0.000004985926,0.0000030506085,0.000021034712,0.0002754604],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99860525,0.00006298909,0.0005299914,0.00016501453,0.0002504389,0.00038633554],"domain_scores_gemma":[0.99859846,0.00021818971,0.00059041794,0.00019481174,0.00013841911,0.00025970815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012370711,0.0001688341,0.0007400382,0.00018308354,0.00006404855,0.0000130204435,0.00012166328,0.00004966049,0.00015709926],"category_scores_gemma":[0.00007802562,0.00012502799,0.00022237503,0.00019139714,0.00014612841,0.00009145159,0.0000435958,0.00010621891,0.00018677129],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032488217,0.009384124,0.6711595,0.00016206963,0.004632693,0.0335149,0.0034781022,0.000089899215,0.0020080158,0.0055155144,0.04132598,0.22548041],"study_design_scores_gemma":[0.071728684,0.022751082,0.19841251,0.0007379328,0.0055628894,0.36445156,0.0066300114,0.001682858,0.12323716,0.00059984135,0.20299238,0.0012131071],"about_ca_topic_score_codex":0.000030457535,"about_ca_topic_score_gemma":0.0000065994427,"teacher_disagreement_score":0.47274697,"about_ca_system_score_codex":0.00029357555,"about_ca_system_score_gemma":0.00043885683,"threshold_uncertainty_score":0.5098493},"labels":[],"label_agreement":null},{"id":"W2088941610","doi":"10.1080/10428190802023715","title":"Targeting the follicular lymphoma microenvironment – Ready for prime-time?","year":2008,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Follicular lymphoma; Prime time; Lymphoma; Medicine; Prime (order theory); Cancer research; Oncology; Follicular phase; Internal medicine; Computer science","score_opus":0.02287477505465715,"score_gpt":0.27518199615586886,"score_spread":0.25230722110121173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088941610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005905099,0.98274785,0.00005527996,0.00019672637,0.000714431,0.007679807,0.0005754544,0.00043867776,0.001686667],"genre_scores_gemma":[0.00064823765,0.9808669,0.0016150316,0.0013274676,0.0016554984,0.0042907894,0.0032488406,0.00068371627,0.0056635137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98950356,0.00051807624,0.00294407,0.0031071203,0.0014295294,0.0024976553],"domain_scores_gemma":[0.9924082,0.0016817794,0.0017368903,0.0027899027,0.00023138961,0.0011518165],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00072040316,0.0031474405,0.0062905685,0.00056674704,0.0017106908,0.00035186583,0.0011470189,0.0019696082,0.00011621925],"category_scores_gemma":[0.00027655135,0.0021219628,0.0029890744,0.0008311624,0.000962625,0.000302029,0.0007108839,0.00026690867,0.00084725063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003105284,0.0008303621,0.00009096099,0.005240575,0.0028516287,0.001114128,0.0003013945,0.000005737033,0.000043641605,0.00023311628,0.03876007,0.95021784],"study_design_scores_gemma":[0.017681409,0.00074340636,0.0006769807,0.007230982,0.0069038314,0.009735879,0.00010407879,0.00047510152,0.00026886162,0.00004721509,0.9540961,0.0020361575],"about_ca_topic_score_codex":0.00072958716,"about_ca_topic_score_gemma":0.000007803848,"teacher_disagreement_score":0.9481817,"about_ca_system_score_codex":0.024048176,"about_ca_system_score_gemma":0.009111144,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W2089121900","doi":"10.1016/s0002-9440(10)64248-4","title":"The Nucleophosmin-Anaplastic Lymphoma Kinase Fusion Protein Induces c-Myc Expression in Pediatric Anaplastic Large Cell Lymphomas","year":2002,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; Huntsman Cancer Foundation; University of Utah; University of Arizona Cancer Center","keywords":"Nucleophosmin; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; Lymphoma; Medicine; Pathology","score_opus":0.009633588759923524,"score_gpt":0.2355942269617414,"score_spread":0.2259606382018179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089121900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947125,0.0033861126,0.000033805285,0.0006739597,0.0002897057,0.00029851787,0.000007637922,0.000015681211,0.0005821356],"genre_scores_gemma":[0.9965537,0.0019867285,0.00072278164,0.0002582789,0.00028919874,0.000034518434,0.0000026162506,0.00003341738,0.00011872184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755204,0.00033998425,0.00078943145,0.0003080651,0.0004353306,0.00057515764],"domain_scores_gemma":[0.997869,0.00051335135,0.00085652765,0.00033360926,0.00014162571,0.0002858519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004048947,0.0002870391,0.00067580584,0.0004079694,0.00019311723,0.000030334306,0.00023923426,0.00010427932,0.00011776024],"category_scores_gemma":[0.00032023832,0.00017674794,0.00020529969,0.0006125664,0.00022354127,0.00010443084,0.000090597845,0.00020669795,0.000083776606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006084853,0.021536035,0.43234897,0.00020662924,0.00021428333,0.07173997,0.005943731,0.00006756877,0.0693711,0.0004473719,0.006110673,0.38592884],"study_design_scores_gemma":[0.036426418,0.028634831,0.8862415,0.0005926073,0.0007796808,0.009177414,0.004202317,0.00036594758,0.025321351,0.0002621955,0.007186088,0.0008096821],"about_ca_topic_score_codex":0.00001789284,"about_ca_topic_score_gemma":0.000021085261,"teacher_disagreement_score":0.4538925,"about_ca_system_score_codex":0.00030204735,"about_ca_system_score_gemma":0.00016796935,"threshold_uncertainty_score":0.7207572},"labels":[],"label_agreement":null},{"id":"W2089158135","doi":"10.1182/blood-2010-09-288373","title":"How I treat relapsed and refractory Hodgkin lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Comprehensive Cancer Network; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Salvage therapy; Context (archaeology); Radiation therapy; Oncology; Refractory (planetary science); Chemotherapy; Lymphoma; Internal medicine; Chemotherapy regimen; Regimen; Disease; Clinical trial; Transplantation; Autologous stem-cell transplantation; Surgery","score_opus":0.025612686941002293,"score_gpt":0.22196040425727537,"score_spread":0.19634771731627307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089158135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746346,0.002167053,0.0000018286387,0.00035475596,0.000049904116,0.00018283342,0.0000059126924,0.000066629145,0.022536518],"genre_scores_gemma":[0.9959309,0.00045313773,0.00087249454,0.00019416543,0.00008023259,0.000039273415,0.000010212064,0.00001844868,0.0024011005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993701,0.00001892185,0.000093768365,0.00022870282,0.00011690539,0.00017157465],"domain_scores_gemma":[0.99947685,0.000031991538,0.00004105402,0.0002698097,0.000026208247,0.00015408544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039140697,0.00013474817,0.00020754196,0.00005314347,0.00004608764,0.000018623135,0.00003317637,0.00008093175,0.00006593393],"category_scores_gemma":[0.00003136582,0.00009732711,0.00006145535,0.00005767165,0.00004781745,0.00006681674,0.000023661472,0.000026496813,0.000034619068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003322158,0.010814486,0.80943173,0.00010502959,0.00063076016,0.0022598724,0.0016818877,3.6212615e-9,0.0046170074,0.001562165,0.0030882768,0.16547655],"study_design_scores_gemma":[0.018467821,0.0013659268,0.90063715,0.000071068665,0.0007942949,0.0004525655,0.00014601913,0.0000012031293,0.065252624,0.00013401094,0.012515215,0.00016212817],"about_ca_topic_score_codex":0.00010930335,"about_ca_topic_score_gemma":0.000009296254,"teacher_disagreement_score":0.16531442,"about_ca_system_score_codex":0.000035260546,"about_ca_system_score_gemma":0.00004194372,"threshold_uncertainty_score":0.39688843},"labels":[],"label_agreement":null},{"id":"W2089198341","doi":"10.1007/s00256-006-0087-3","title":"Anaplastic large cell lymphoma presenting as an epiphyseal lytic lesion—a case report with clinico-pathologic correlation","year":2006,"lang":"en","type":"article","venue":"Skeletal Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Lesion; Biopsy; Presentation (obstetrics); Large-cell lymphoma; Lytic cycle; Pathology; Orthopedic surgery; Osteomyelitis; Radiology; Surgery","score_opus":0.015263329330651264,"score_gpt":0.29371224372721627,"score_spread":0.278448914396565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089198341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138427,0.00032704897,0.00035842482,0.00012464928,0.00027083937,0.0005156242,0.0000145631675,0.00012591883,0.006878636],"genre_scores_gemma":[0.99669003,0.00001784774,0.00078135036,0.00015946006,0.00040316864,0.0000697631,0.00051073416,0.00003481548,0.0013328289],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978862,0.0001783681,0.00054089224,0.0006544435,0.00019990685,0.000540202],"domain_scores_gemma":[0.9986249,0.00030247026,0.00030148937,0.00048732082,0.00009595681,0.00018787161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030185832,0.00027828396,0.0005240604,0.0001312075,0.00021084264,0.000020371514,0.00006751161,0.0002406646,0.00008881279],"category_scores_gemma":[0.00014353714,0.00020105873,0.00014160204,0.00018378733,0.00015873229,0.000119996956,0.00004169721,0.00011984919,0.00014607345],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037777398,0.003445129,0.4369189,0.00006407038,0.00008159098,0.5541377,0.00012492976,0.0001645402,0.00020493746,0.0015019537,0.0006307194,0.0023476959],"study_design_scores_gemma":[0.01158237,0.004439357,0.45139936,0.000038830123,0.0004947067,0.5263874,0.0002382085,0.002963965,0.00047488918,0.0005510829,0.0011009377,0.00032887657],"about_ca_topic_score_codex":0.00032836496,"about_ca_topic_score_gemma":0.0001411963,"teacher_disagreement_score":0.027750328,"about_ca_system_score_codex":0.00018427652,"about_ca_system_score_gemma":0.0002188946,"threshold_uncertainty_score":0.8198938},"labels":[],"label_agreement":null},{"id":"W2089743461","doi":"10.1182/blood-2014-04-566778","title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Gene expression profiling; microRNA; Lymphoma; Biology; Cancer research; Medicine; Computational biology; Gene expression; Immunology; Genetics; Gene","score_opus":0.009375312588064186,"score_gpt":0.24673417560656252,"score_spread":0.23735886301849835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089743461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623686,0.0008320038,0.00013892046,0.00027328354,0.000043048192,0.0009846257,0.000019535491,0.000027410464,0.0014443275],"genre_scores_gemma":[0.99217755,0.00007767404,0.007116122,0.00013359876,0.00003251021,0.0003737374,0.000058171587,0.000014039532,0.000016605914],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991165,0.000037758095,0.00018459605,0.0003272417,0.00013286265,0.00020105427],"domain_scores_gemma":[0.9994942,0.00006368154,0.00013987168,0.00015286342,0.000049873513,0.0000995305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052633,0.00014244163,0.00020050147,0.000047663983,0.000044120523,0.00002258145,0.000042223004,0.00009371256,0.0000022044096],"category_scores_gemma":[0.000097589254,0.00011688339,0.000066509405,0.0001050331,0.00003120523,0.000045305736,0.00002544946,0.000019160232,0.0000031367588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033659444,0.0028759872,0.90724456,0.00023230893,0.00006960084,0.00006817488,0.00006030846,0.0000020603554,0.0731387,0.00031417562,0.00022119768,0.015436305],"study_design_scores_gemma":[0.029126897,0.0006749071,0.35745275,0.00051369396,0.0003595068,0.000060544084,0.00016486674,0.000412975,0.6103353,0.00020554732,0.0005028186,0.0001902247],"about_ca_topic_score_codex":0.000023805145,"about_ca_topic_score_gemma":0.000004130549,"teacher_disagreement_score":0.5497919,"about_ca_system_score_codex":0.00011270194,"about_ca_system_score_gemma":0.000067542176,"threshold_uncertainty_score":0.47663665},"labels":[],"label_agreement":null},{"id":"W2089892267","doi":"10.1002/ijc.11356","title":"History of antibiotic use and risk of non‐Hodgkin's lymphoma (NHL)","year":2003,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; York University","keywords":"Medicine; Odds ratio; Internal medicine; Population; Antibiotics; Lymphoma; Confounding; Respiratory tract infections; Respiratory system; Environmental health","score_opus":0.017089349500895138,"score_gpt":0.29003856504408204,"score_spread":0.2729492155431869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089892267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903279,0.0075999103,0.000043719367,0.00015160949,0.000873712,0.000050509432,0.000020712856,0.0000013625727,0.00093054667],"genre_scores_gemma":[0.9918832,0.0069234497,0.0006838546,0.00010935394,0.00009227989,8.3314285e-7,8.288134e-7,0.0000072866164,0.0002989232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991302,0.00002681925,0.0003456975,0.00006841306,0.00036637287,0.0000625049],"domain_scores_gemma":[0.9986707,0.00009338048,0.0005276851,0.00007238598,0.0005703901,0.00006544473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012606617,0.00007303622,0.00024656768,0.00014127309,0.0000058126057,0.0000050611366,0.00006130025,0.000034281267,0.00013504592],"category_scores_gemma":[0.00013732834,0.000054159882,0.00011672668,0.000030833507,0.00007398625,0.00010749353,0.000010770561,0.000038794344,8.5877815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035178373,0.0004700283,0.96461624,0.00002568606,0.0014491794,0.00012374266,0.0002655099,0.000025151225,0.0031320804,0.00030089976,0.00258761,0.0266521],"study_design_scores_gemma":[0.0052150744,0.00032938272,0.9425589,0.00042543886,0.00045564887,0.00024825434,0.000034556804,0.00003447325,0.026243769,0.000060372793,0.024342444,0.000051692212],"about_ca_topic_score_codex":0.00043845963,"about_ca_topic_score_gemma":0.000024781428,"teacher_disagreement_score":0.026600407,"about_ca_system_score_codex":0.0005923006,"about_ca_system_score_gemma":0.00045093746,"threshold_uncertainty_score":0.22085759},"labels":[],"label_agreement":null},{"id":"W2090031499","doi":"10.5489/cuaj.1533","title":"Mucosa-associated lymphoid tissue lymphoma arising from the kidney","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lymphoma; Lymphatic system; MALT lymphoma; Pathology; Mucosa-associated lymphoid tissue; Medicine; Kidney; B cell; Internal medicine; Immunology; Antibody","score_opus":0.009455813919629148,"score_gpt":0.21910545218377558,"score_spread":0.20964963826414643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090031499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88151664,0.00034132245,0.00005848209,0.11048077,0.0007554395,0.00022924617,0.000116801275,0.000057117286,0.006444165],"genre_scores_gemma":[0.95677465,0.000076489545,0.00012468241,0.041440926,0.0009818324,0.00001200759,0.00013121284,0.000017616034,0.00044057358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783045,0.00039358475,0.00040172355,0.00025549196,0.0004941793,0.000624558],"domain_scores_gemma":[0.99721605,0.0006918853,0.00034905397,0.00020330664,0.0002471845,0.0012925086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008699312,0.0002053192,0.00037468434,0.00008171965,0.00065435603,0.00021996914,0.0001870541,0.0003370495,0.00085691595],"category_scores_gemma":[0.0041839764,0.00012996135,0.00019129325,0.00022501174,0.00003967761,0.00008307018,0.000021550526,0.00024127249,0.00028890072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001969123,0.0001402168,0.889492,7.1339326e-7,0.00028402888,0.00009080815,0.0001254711,0.0000051770826,0.00006106798,0.00024786612,0.08570715,0.023825848],"study_design_scores_gemma":[0.0024212082,0.00019356205,0.69310874,0.000022686792,0.00018804078,0.00012630806,0.000029249246,0.00015878832,0.000088418936,0.0010912895,0.30246037,0.000111347],"about_ca_topic_score_codex":0.010340405,"about_ca_topic_score_gemma":0.0020935987,"teacher_disagreement_score":0.21675321,"about_ca_system_score_codex":0.0035750864,"about_ca_system_score_gemma":0.0009578771,"threshold_uncertainty_score":0.9962498},"labels":[],"label_agreement":null},{"id":"W2090169411","doi":"10.1016/j.bbaexp.2006.05.003","title":"Characterization of the MCT-1 pseudogene: Identification and implication of its location in a highly amplified region of chromosome 20","year":2006,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Pseudogene; Amplicon; Biology; Gene; Genetics; Chromosome; Oncogene; Genome; Lymphoma; Comparative genomic hybridization; Molecular biology; Cancer research; Polymerase chain reaction; Cell cycle","score_opus":0.008293509497678262,"score_gpt":0.22898651136158574,"score_spread":0.22069300186390747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090169411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983567,0.00021820079,0.00002633911,0.00064945576,0.000049828956,0.0005784331,0.00009993787,0.000008850727,0.000012234089],"genre_scores_gemma":[0.99874943,0.0005264526,0.00009992046,0.000021825106,0.00006265165,0.000025540287,0.0004810216,0.000013439401,0.000019731824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988865,0.000061804465,0.000461734,0.00029136002,0.00019586789,0.00010271772],"domain_scores_gemma":[0.9988808,0.000025107924,0.0005705768,0.00034413033,0.00014543161,0.000033955344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052344043,0.00015687337,0.00028951027,0.00011241852,0.000046213154,0.000010853742,0.00007550599,0.00013561947,0.0000018096837],"category_scores_gemma":[0.000015212773,0.00010735238,0.000052745065,0.00030409894,0.000087572356,0.00011816443,0.00005107687,0.000054804255,1.7579433e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001582519,0.00018629561,0.0011962148,0.00023902468,0.000018710081,3.135722e-7,0.00024036456,0.0000031731647,0.99699515,0.00018600648,0.000029241146,0.00074725965],"study_design_scores_gemma":[0.00058519584,0.00007059349,0.41796836,0.0001872704,0.00005349412,0.000007779762,0.000009290023,0.0000337634,0.5809106,0.00011582782,0.0000067324836,0.00005106611],"about_ca_topic_score_codex":0.000056977824,"about_ca_topic_score_gemma":0.0000045232127,"teacher_disagreement_score":0.41677213,"about_ca_system_score_codex":0.000031484564,"about_ca_system_score_gemma":0.000052369105,"threshold_uncertainty_score":0.4377703},"labels":[],"label_agreement":null},{"id":"W2090544453","doi":"10.1002/hon.890","title":"Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long‐term toxicities","year":2009,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Stage (stratigraphy); Disease; Hodgkin lymphoma; Chemotherapy; Oncology; Modality (human–computer interaction); Intensive care medicine; Internal medicine","score_opus":0.09884274014293155,"score_gpt":0.3997563416836778,"score_spread":0.30091360154074626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090544453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005509829,0.98603505,0.00013611058,0.000832809,0.0003826326,0.0051160585,0.0000880038,0.0002802539,0.001619237],"genre_scores_gemma":[0.0009823911,0.9895456,0.0023958096,0.0026112592,0.00045516284,0.002011988,0.00089703465,0.00008255178,0.0010182066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960616,0.00034193305,0.0013506269,0.0010687275,0.00025308153,0.0009239976],"domain_scores_gemma":[0.9945506,0.0035207325,0.00067544426,0.0007449833,0.0000891986,0.00041904455],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00021445144,0.00108534,0.0063726143,0.0002912041,0.00017962007,0.00004971334,0.00026507693,0.0016817063,0.00019198406],"category_scores_gemma":[0.00029106022,0.00065784185,0.0018438306,0.00026461025,0.00012804472,0.000043657645,0.000059060145,0.00021042948,0.000054297074],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044475286,0.006189518,0.00064846757,0.0038656553,0.0013787543,0.0028998163,0.00008401387,4.0623027e-7,0.0000021211943,0.0005066705,0.0021595692,0.9818202],"study_design_scores_gemma":[0.0126491925,0.013916964,0.00069783814,0.004841729,0.002314438,0.00076156325,0.00003377069,0.000012330545,0.000087007094,0.000019037947,0.96405196,0.0006141817],"about_ca_topic_score_codex":0.000017352926,"about_ca_topic_score_gemma":0.000034542398,"teacher_disagreement_score":0.98120606,"about_ca_system_score_codex":0.0032575647,"about_ca_system_score_gemma":0.001028571,"threshold_uncertainty_score":0.9996143},"labels":[],"label_agreement":null},{"id":"W2090670937","doi":"10.1002/gcc.10142","title":"Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes","year":2002,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Loss of heterozygosity; Fluorescence in situ hybridization; Splenic marginal zone lymphoma; Lymphoma; Chromosomal translocation; Chromosome 7 (human); Pathology; Chromosome; Cytogenetics; Genetics; Immunology; Spleen; Gene; Allele; Medicine; Splenectomy","score_opus":0.022689922229038803,"score_gpt":0.2349222936634172,"score_spread":0.2122323714343784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090670937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622072,0.035248335,0.0000016675098,0.0012251835,0.000065605826,0.0003679977,0.000015398224,0.000019359844,0.0008492716],"genre_scores_gemma":[0.97592896,0.022962142,0.000036854137,0.0005141123,0.000120156816,0.00021058513,0.0000072150783,0.000020848196,0.00019913804],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99897647,0.000025219391,0.00022246389,0.00028439576,0.00023895779,0.00025247017],"domain_scores_gemma":[0.99946237,0.00007177631,0.000099419296,0.00025089568,0.000043122607,0.000072443305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057044337,0.00019712691,0.0003344246,0.000089511785,0.000073705356,0.000017382037,0.00006155261,0.00006289939,0.00056529033],"category_scores_gemma":[0.000005905888,0.00011230762,0.00006629369,0.0002550101,0.000105399406,0.000047442914,0.000026295162,0.00003393193,0.000011762446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023334162,0.0013016227,0.3956004,0.0003307846,0.0003882695,0.00030139543,0.0013719728,0.00011977666,0.0030749182,0.0005751629,0.00038147863,0.59632087],"study_design_scores_gemma":[0.012948933,0.0019449451,0.89042026,0.002237162,0.00027282778,0.00052457495,0.0006883381,0.0014087668,0.07792578,0.00007074148,0.011071955,0.0004857406],"about_ca_topic_score_codex":0.00041463526,"about_ca_topic_score_gemma":0.00018244017,"teacher_disagreement_score":0.59583515,"about_ca_system_score_codex":0.00031741554,"about_ca_system_score_gemma":0.000068110116,"threshold_uncertainty_score":0.6189532},"labels":[],"label_agreement":null},{"id":"W2090941758","doi":"10.3816/clm.2005.n.028","title":"ABVD, the Stanford V Regimen, and BEACOPP for Hodgkin's Lymphoma: What Should an Oncologist Do?","year":2005,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Vincristine; Regimen; Vinblastine; Dacarbazine; Bleomycin; Prednisone; Etoposide; Internal medicine; Oncology; Hodgkin's lymphoma; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.2624196302931387,"score_gpt":0.49752479171567293,"score_spread":0.23510516142253424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090941758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006815971,0.9891603,0.000017074844,0.0022037916,0.0015191075,0.0049444637,0.00026482766,0.00017239893,0.0010364121],"genre_scores_gemma":[0.0002742703,0.98669356,0.0012586953,0.0040698475,0.002979121,0.0018368617,0.000732544,0.0001981349,0.0019569374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935453,0.00054545543,0.002547664,0.0017820376,0.00062181795,0.00095774257],"domain_scores_gemma":[0.99037117,0.005310973,0.0011195547,0.0020944537,0.00025160267,0.0008522492],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021179114,0.0012013345,0.0046910034,0.0001686707,0.00042459794,0.00068220287,0.00069251045,0.0016709272,0.00007057711],"category_scores_gemma":[0.0008531851,0.0006761185,0.0020682584,0.0003350437,0.00096424593,0.00054675166,0.00033618175,0.00027380456,0.00011531453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031139728,0.0028486347,0.00018609472,0.002117384,0.0009969174,0.00021101239,0.000043323045,5.7857033e-8,1.9473358e-8,0.0012544441,0.016001865,0.97602886],"study_design_scores_gemma":[0.010141828,0.003189292,0.0017704669,0.007640158,0.0067007905,0.00070173776,0.00016785816,0.000011071689,8.724381e-7,0.00014960456,0.96883845,0.00068785145],"about_ca_topic_score_codex":0.00004293895,"about_ca_topic_score_gemma":0.000068892965,"teacher_disagreement_score":0.975341,"about_ca_system_score_codex":0.0012570691,"about_ca_system_score_gemma":0.002094342,"threshold_uncertainty_score":0.9996251},"labels":[],"label_agreement":null},{"id":"W2091254943","doi":"10.14740/jmc.v5i4.1718","title":"Composite Mantle Cell Lymphoma and “Gray Zone” Lymphoma in Two Different Anatomical Locations","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mantle cell lymphoma; Lymphoma; Medicine; Pathology; Lymph node; Population; Mantle zone; Immunohistochemistry; B cell; Antibody; Immunology","score_opus":0.01319925263918878,"score_gpt":0.2924956344226743,"score_spread":0.2792963817834855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091254943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921774,0.0020209514,0.00020206092,0.0049838945,0.0001812356,0.0001051411,0.0000040238897,0.000009263945,0.00031597717],"genre_scores_gemma":[0.99760765,0.0007911245,0.00026213913,0.0009750447,0.00029687758,0.000006167298,0.000006836359,0.00001364894,0.000040532537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810517,0.00011465672,0.0005611863,0.00016134686,0.000832943,0.00022470143],"domain_scores_gemma":[0.9983416,0.00062875246,0.00018597435,0.00015500226,0.000076902645,0.0006117609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003742464,0.00016704497,0.00052997057,0.00019771532,0.00005224349,0.000028652257,0.000112616566,0.00009603081,0.0001327735],"category_scores_gemma":[0.00025974697,0.00010680774,0.00012792138,0.00010739704,0.00013431405,0.00005836916,0.00005608209,0.0001041226,0.000012886199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006286868,0.008869207,0.65159124,0.00017659628,0.00016591566,0.008134843,0.00027454813,0.0000046307828,0.00043635318,0.0010323756,0.004519535,0.32416606],"study_design_scores_gemma":[0.02776215,0.001043457,0.9447169,0.00070106366,0.0002920043,0.0106420405,0.00019027882,0.0017112981,0.0049570426,0.00013427658,0.007676391,0.00017310368],"about_ca_topic_score_codex":0.00023584552,"about_ca_topic_score_gemma":0.00017041557,"teacher_disagreement_score":0.32399294,"about_ca_system_score_codex":0.00022755073,"about_ca_system_score_gemma":0.00019944059,"threshold_uncertainty_score":0.43554932},"labels":[],"label_agreement":null},{"id":"W2091374687","doi":"10.1007/s12105-012-0380-5","title":"Hodgkin Lymphoma of the Oral Mucosa","year":2012,"lang":"en","type":"article","venue":"Head and Neck Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lymphoma; Medicine; Oral mucosa; Differential diagnosis; Oral and maxillofacial surgery; Hodgkin lymphoma; Lesion; Pathology; Dermatology; Otorhinolaryngology; Surgery","score_opus":0.023998318187900467,"score_gpt":0.28616753824360486,"score_spread":0.26216922005570437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091374687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324554,0.0020612483,0.000001694161,0.0008881772,0.0001633508,0.00013083973,0.0000064565074,0.000011050496,0.0034916676],"genre_scores_gemma":[0.9984872,0.00013787475,0.00026404278,0.00082019664,0.00007386255,0.000015326272,0.000003751801,0.0000061876626,0.0001915832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949896,0.00004583303,0.000112826754,0.000094950505,0.00006402517,0.00018340036],"domain_scores_gemma":[0.9996522,0.000035546826,0.000037866535,0.00018270517,0.000016921525,0.00007477068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000822652,0.00007518122,0.00020176652,0.00002260762,0.00004031784,0.0000017594695,0.000027114878,0.00006688852,0.000043821143],"category_scores_gemma":[0.000024447865,0.000041475203,0.000056940753,0.00005448929,0.00009358665,0.000023168288,0.000041422958,0.000023992114,0.000018703813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004664805,0.000518252,0.9616527,0.00002018477,0.000020048697,0.00003688281,0.00029759007,2.2506791e-8,0.0017116695,0.0023161578,0.00071823515,0.03266159],"study_design_scores_gemma":[0.0022279609,0.0002541334,0.97685885,0.00003016619,0.00006536982,0.0007753719,0.000040633793,0.0000024434416,0.008057766,0.000061507686,0.011586132,0.000039680137],"about_ca_topic_score_codex":0.00003813004,"about_ca_topic_score_gemma":0.000011495071,"teacher_disagreement_score":0.03262191,"about_ca_system_score_codex":0.000020459338,"about_ca_system_score_gemma":0.000025677466,"threshold_uncertainty_score":0.16913097},"labels":[],"label_agreement":null},{"id":"W2092204393","doi":"10.1016/j.semradonc.2009.09.006","title":"Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects","year":2009,"lang":"en","type":"review","venue":"Seminars in Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Epidemiology; Hodgkin lymphoma; Disease; Schema (genetic algorithms); Lymphoma; Young adult; Broad spectrum; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.05450573930746089,"score_gpt":0.41424222962303914,"score_spread":0.35973649031557825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092204393","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006188248,0.9878744,0.0000014882299,0.0020381908,0.00046871873,0.0022568228,0.000020210933,0.00004542127,0.0011065326],"genre_scores_gemma":[0.0007978488,0.995053,0.00022142428,0.0023658026,0.00034897774,0.0005758117,0.00021845804,0.00004247955,0.00037622068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964539,0.0013169842,0.0008543378,0.0006406045,0.00012632612,0.00060789305],"domain_scores_gemma":[0.9937554,0.0050185355,0.00055774336,0.000522583,0.000016614584,0.00012912026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015309838,0.00051289867,0.0028006532,0.00018955482,0.00013404046,0.000018086967,0.00018698494,0.00089307793,0.000022383198],"category_scores_gemma":[0.00051478884,0.0003072928,0.00036914402,0.0003615608,0.00027622026,0.00003987158,0.00007001677,0.00032377176,0.00005758899],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053329084,0.00043027184,0.00239453,0.00079828873,0.00022465592,0.00089011947,0.00038936434,9.780057e-7,1.6810912e-7,0.00022419765,0.0025104447,0.99208367],"study_design_scores_gemma":[0.0032825118,0.0015011159,0.058466654,0.003208815,0.0004212499,0.0007697606,0.00001591515,0.000011523779,0.000002634705,0.0004908706,0.9315983,0.00023063653],"about_ca_topic_score_codex":0.00011498188,"about_ca_topic_score_gemma":0.000075840195,"teacher_disagreement_score":0.991853,"about_ca_system_score_codex":0.0015052082,"about_ca_system_score_gemma":0.00043241103,"threshold_uncertainty_score":0.9999379},"labels":[],"label_agreement":null},{"id":"W2092232503","doi":"10.1371/journal.pgen.1000640","title":"A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis","year":2009,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; Phenotype; Cancer research; Carcinogenesis; Lineage (genetic); E2F; Lymphoma; Gene; Genetics; Cell cycle; Immunology","score_opus":0.03440013852981412,"score_gpt":0.2796236730022402,"score_spread":0.24522353447242612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092232503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792814,0.00052862224,0.000003556111,0.00035338232,0.000024537698,0.00048729707,0.000010502689,0.000013116775,0.0006508165],"genre_scores_gemma":[0.998688,0.000105504565,0.00071507815,0.0002888768,0.00005563247,0.00007955857,0.000006197465,0.000012968489,0.00004819223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993302,0.000018533234,0.00019006342,0.00013936798,0.00014168028,0.00018015532],"domain_scores_gemma":[0.9994914,0.0001306018,0.000067509565,0.00022539972,0.000043973974,0.000041131603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051186635,0.000110781366,0.00023012997,0.00005819101,0.00003735429,0.000010225094,0.00006875273,0.000051480456,0.0000058886417],"category_scores_gemma":[0.000038599923,0.00007541071,0.00007989771,0.00008444795,0.000019854495,0.00001860124,0.00001597875,0.000022393755,0.0000020263722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003238024,0.0030941167,0.32593703,0.00012164978,0.0002462608,0.000020954452,0.0032519253,0.00004485104,0.35220036,0.00010722757,0.0001482102,0.31450358],"study_design_scores_gemma":[0.0023138113,0.0007071693,0.36841986,0.0000657255,0.00015697572,0.000003631749,0.00022057218,0.00142538,0.6263666,0.00011172799,0.00013686415,0.00007168576],"about_ca_topic_score_codex":0.000005981668,"about_ca_topic_score_gemma":0.000017319102,"teacher_disagreement_score":0.3144319,"about_ca_system_score_codex":0.000070625065,"about_ca_system_score_gemma":0.00007295899,"threshold_uncertainty_score":0.30751595},"labels":[],"label_agreement":null},{"id":"W2092467128","doi":"10.1080/10428190601043278","title":"What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?","year":2006,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Rituximab; Diffuse large B-cell lymphoma; Salvage therapy; Lymphoma; Medicine; Internal medicine; Ibrutinib; Oncology; Cancer research; Leukemia; Chronic lymphocytic leukemia; Chemotherapy","score_opus":0.005676256751926217,"score_gpt":0.213364026246244,"score_spread":0.2076877694943178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092467128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612464,0.016871402,0.000008007144,0.011952396,0.0006219285,0.005673136,0.001688247,0.00017700695,0.0017615105],"genre_scores_gemma":[0.8811459,0.005650148,0.0005428907,0.09568945,0.0015967861,0.0033546058,0.0063400934,0.0006788486,0.0050012534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919515,0.000244505,0.0018331289,0.0022848865,0.0014977774,0.002188156],"domain_scores_gemma":[0.994609,0.0010989736,0.0011866287,0.0022799617,0.00042897373,0.00039643477],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002927154,0.0022463966,0.0032038444,0.00072380516,0.00048015357,0.00039048327,0.00069167657,0.0020131567,0.000049569873],"category_scores_gemma":[0.00003153573,0.0014627123,0.001109052,0.00072407234,0.00055532926,0.00056011666,0.00026236178,0.00027491583,0.00006535568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006478026,0.0625572,0.15732828,0.0033804434,0.0038012832,0.0031607582,0.0050744307,0.000008417105,0.000102942686,0.00035012368,0.3634177,0.39434037],"study_design_scores_gemma":[0.26916,0.0026763745,0.08177685,0.0017304447,0.002550496,0.00018914265,0.0005861761,0.0005153935,0.0036971034,0.00035799594,0.6351425,0.0016175343],"about_ca_topic_score_codex":0.0046651685,"about_ca_topic_score_gemma":0.00033724392,"teacher_disagreement_score":0.39272285,"about_ca_system_score_codex":0.01657285,"about_ca_system_score_gemma":0.004281976,"threshold_uncertainty_score":0.9992824},"labels":[],"label_agreement":null},{"id":"W2092503047","doi":"10.1172/jci63186","title":"Pathogenesis of follicular lymphoma","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Canadian Institutes of Health Research; Ligue Genevoise Contre le Cancer; Terry Fox Foundation","keywords":"Follicular lymphoma; Biology; Germinal center; Cancer research; Neoplastic transformation; Immune system; Lymphoma; Stromal cell; Immunology; Tumor microenvironment; Crosstalk; Malignant transformation; B cell; Gene; Genetics; Antibody; Carcinogenesis","score_opus":0.22437060783493384,"score_gpt":0.4434498753022194,"score_spread":0.21907926746728557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092503047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067595905,0.9917711,0.000010099888,0.00016048948,0.0007674919,0.00034211617,0.000012471177,0.0000060270854,0.00017062588],"genre_scores_gemma":[0.0014877133,0.9942309,0.002519008,0.00013146507,0.0014743402,0.000011616279,0.00003956559,0.000033288474,0.00007208047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949211,0.00043315874,0.00375518,0.00016797039,0.00055784016,0.00016476662],"domain_scores_gemma":[0.9933436,0.0009251305,0.004499791,0.00032380244,0.00040105253,0.00050664233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018701447,0.00027006448,0.0034434733,0.00020527821,0.000022066255,0.000010311528,0.00013613414,0.00053233415,0.00005356368],"category_scores_gemma":[0.001155449,0.00016448449,0.002351478,0.00025279622,0.00015047016,0.00010863444,0.000032854183,0.00019656563,0.00003855006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025485146,0.00083965994,0.009011557,0.0043796217,0.000947556,0.00008461891,0.000012521816,1.3699288e-7,0.0000015117091,0.00012850531,0.0005487775,0.98402005],"study_design_scores_gemma":[0.0020287102,0.0009559385,0.023425853,0.018744742,0.015088618,0.00062418706,0.0000046003674,0.0000017212499,0.0000367687,0.00015510392,0.9387823,0.0001515029],"about_ca_topic_score_codex":0.000005332789,"about_ca_topic_score_gemma":4.5470972e-7,"teacher_disagreement_score":0.98386854,"about_ca_system_score_codex":0.00014449151,"about_ca_system_score_gemma":0.0013669805,"threshold_uncertainty_score":0.6707483},"labels":[],"label_agreement":null},{"id":"W2092568922","doi":"10.1080/10428190902912478","title":"Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone<i>versus</i>chemotherapy + involved field radiotherapy","year":2009,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Stage (stratigraphy); Internal medicine; Radiation therapy; Induction chemotherapy; Lymphoma; Anthracycline; Clinical trial; Gastroenterology; Incidence (geometry); Oncology; Radiology; Cancer","score_opus":0.014246067083915251,"score_gpt":0.2543617198471192,"score_spread":0.24011565276320396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092568922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848682,0.0036776953,0.00025214357,0.00063004263,0.000614136,0.0034269488,0.00011714176,0.00040185958,0.0060118036],"genre_scores_gemma":[0.9836308,0.006995981,0.0021918924,0.0042854524,0.00071352924,0.00024659288,0.00022932675,0.00018194514,0.0015244941],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9927428,0.0003100088,0.0022358163,0.0017448519,0.0012773088,0.0016892232],"domain_scores_gemma":[0.9947169,0.0010962178,0.0011667174,0.0017803678,0.00026866412,0.0009711486],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00083728676,0.0014667496,0.0029356095,0.00067308446,0.00043999992,0.00023161841,0.00063488464,0.00088912813,0.00011842334],"category_scores_gemma":[0.0001865588,0.0012798049,0.0011139654,0.0010597893,0.00028186903,0.00044015338,0.000103855404,0.00022118689,0.000026470228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8211003,0.01216235,0.010461036,0.00030466504,0.0016256057,0.00062235346,0.004181681,0.000022390495,0.00963794,0.0005378551,0.007815876,0.13152798],"study_design_scores_gemma":[0.88100207,0.0075271106,0.050393306,0.00034566858,0.00054124906,0.00011748023,0.0003849824,0.0025318959,0.040859804,0.00007738432,0.015089606,0.0011294694],"about_ca_topic_score_codex":0.0020305887,"about_ca_topic_score_gemma":0.00007459455,"teacher_disagreement_score":0.13039851,"about_ca_system_score_codex":0.0055098496,"about_ca_system_score_gemma":0.0026288105,"threshold_uncertainty_score":0.9998082},"labels":[],"label_agreement":null},{"id":"W2092939241","doi":"10.1016/j.ijrobp.2015.01.009","title":"Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Medical physics; Radiation treatment planning; Oncology; Modalities; Radiation oncology; Hodgkin lymphoma; Internal medicine; Radiology","score_opus":0.05420683265528694,"score_gpt":0.3699091900337361,"score_spread":0.3157023573784492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092939241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8885587,0.012076362,0.022337526,0.06539054,0.009013783,0.0011525056,0.0003384727,0.0000830377,0.0010490635],"genre_scores_gemma":[0.9655937,0.008822249,0.0063970215,0.010417549,0.00785295,0.0001147731,0.00070089375,0.000043465137,0.00005738882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997528,0.00023493716,0.0011039353,0.0003824519,0.0004838831,0.0002667655],"domain_scores_gemma":[0.9951878,0.001704558,0.0012435612,0.0002230643,0.0014115588,0.00022942158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009640225,0.00030900017,0.00059187796,0.00016202623,0.00012200164,0.00008931499,0.0004837338,0.0003927032,0.000054904518],"category_scores_gemma":[0.0010852219,0.00022414423,0.00031544958,0.00011864869,0.00014433854,0.00044086316,0.00007333844,0.00018113876,0.000012940691],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023977049,0.0008648823,0.17024222,0.0000024138492,0.0011263122,0.000028560566,0.0009853446,0.00015780481,0.0009376825,0.00429092,0.014138039,0.8048281],"study_design_scores_gemma":[0.07101077,0.006287096,0.13356318,0.000093953415,0.0005165323,0.00057327276,0.00044282214,0.027252894,0.0046326765,0.05337079,0.7017866,0.00046946167],"about_ca_topic_score_codex":0.00018894531,"about_ca_topic_score_gemma":0.000022879456,"teacher_disagreement_score":0.80435866,"about_ca_system_score_codex":0.0018095882,"about_ca_system_score_gemma":0.0012161481,"threshold_uncertainty_score":0.91403365},"labels":[],"label_agreement":null},{"id":"W2093055119","doi":"10.1002/cncr.23880","title":"Phase 2 trial of rituximab plus hyper‐CVAD alternating with rituximab plus methotrexate‐cytarabine for relapsed or refractory aggressive mantle cell lymphoma","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Mantle cell lymphoma; Cytarabine; Rituximab; Internal medicine; Neutropenia; Vincristine; Regimen; Gastroenterology; Cyclophosphamide; Febrile neutropenia; Surgery; Phases of clinical research; Chemotherapy; Lymphoma","score_opus":0.054899795439898876,"score_gpt":0.34559334347226545,"score_spread":0.2906935480323666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093055119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958707,0.0057055517,0.00018833781,0.00028513296,0.00055632985,0.0019977014,0.00024748212,0.00006788597,0.0013644841],"genre_scores_gemma":[0.9867392,0.0024310118,0.0050385995,0.00032683474,0.00069758866,0.00118682,0.00009760022,0.00008929811,0.003393007],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99787545,0.00006325076,0.0005659322,0.0005687727,0.00046763758,0.0004589324],"domain_scores_gemma":[0.99791574,0.0003562867,0.00069546106,0.0005033434,0.00030409437,0.0002250679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014836395,0.0003775133,0.0011725009,0.00013875059,0.00017365022,0.000013585211,0.00015483773,0.00014827336,0.00024293624],"category_scores_gemma":[0.00015874757,0.00024969544,0.00024153588,0.00021698965,0.00017673054,0.00013200332,0.000041346764,0.0001001922,0.000020277872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69743216,0.045006067,0.0011924612,0.0014417912,0.0021217242,0.0055480045,0.004208624,0.00017317393,0.010411923,0.00007885076,0.017262654,0.21512254],"study_design_scores_gemma":[0.8560067,0.0098867575,0.0002833205,0.0007396481,0.000936281,0.00026054264,0.00018164633,0.0010989573,0.11111334,0.000013002031,0.019099372,0.00038042472],"about_ca_topic_score_codex":0.00073385244,"about_ca_topic_score_gemma":0.0000696362,"teacher_disagreement_score":0.21474211,"about_ca_system_score_codex":0.0011211324,"about_ca_system_score_gemma":0.001510511,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2094502152","doi":"10.1182/blood-2006-11-059469","title":"Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Rituximab; Maintenance therapy; Chemotherapy regimen; Corticosteroid; Chemotherapy; Internal medicine; Oncology; Surgery; Lymphoma","score_opus":0.020805593284187976,"score_gpt":0.2641695825640168,"score_spread":0.24336398927982883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094502152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945045,0.00042445297,0.0000037814298,0.0032911988,0.000012539061,0.00076415774,0.000004142606,0.000019955953,0.00097523397],"genre_scores_gemma":[0.9911117,0.00076288544,0.00025978958,0.0077360827,0.000012002081,0.000034984434,0.00003294837,0.000015865775,0.00003372274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898565,0.00014306935,0.00026963837,0.00016433756,0.00018970945,0.00024760122],"domain_scores_gemma":[0.9992594,0.00028050246,0.00010510222,0.00023416658,0.000068879825,0.000051963503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006435865,0.00016024815,0.00025765089,0.000087645014,0.00013479876,0.00003387717,0.00007765349,0.000070709684,0.00004432724],"category_scores_gemma":[0.000034929937,0.0000928972,0.00002225456,0.00024788527,0.000053346015,0.00005004635,0.000018652812,0.00021298049,0.0000018574907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005606689,0.01188522,0.8321028,0.000045407567,0.00015509824,0.000676392,0.035143994,6.958447e-7,0.003114974,0.00005830898,0.00011344035,0.11109704],"study_design_scores_gemma":[0.08267623,0.0036244325,0.88620025,0.00039848304,0.00004560266,0.00023868892,0.0049418,0.00009393741,0.02110229,0.000031862546,0.0005000753,0.00014635205],"about_ca_topic_score_codex":0.0039404826,"about_ca_topic_score_gemma":0.0035082141,"teacher_disagreement_score":0.110950686,"about_ca_system_score_codex":0.00010244691,"about_ca_system_score_gemma":0.000078496974,"threshold_uncertainty_score":0.5956857},"labels":[],"label_agreement":null},{"id":"W2094859089","doi":"10.1182/blood-2012-05-423236","title":"Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Hematologist; Medicine; Radiation therapy; Hodgkin lymphoma; Radiation oncologist; Stage (stratigraphy); Lymphoma; Clinical trial; Protocol (science); Counterpoint; Oncology; Medical physics; Internal medicine; Pathology; Disease; Psychology; Alternative medicine; Biology","score_opus":0.019638987593020973,"score_gpt":0.2778677943432261,"score_spread":0.25822880675020515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094859089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006334789,0.99045306,4.284508e-7,0.000050890743,0.00007545101,0.0013258215,0.000057080655,0.000021691507,0.001680766],"genre_scores_gemma":[0.01867941,0.9804052,0.000029648467,0.00006514281,0.00024805608,0.00026329025,0.000069017966,0.000043314547,0.00019689494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873585,0.00014999717,0.00043431605,0.00023910619,0.00022972932,0.00021100423],"domain_scores_gemma":[0.99880946,0.00022293939,0.00037357592,0.00046689637,0.000032911405,0.00009421222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943709,0.0003154518,0.0013104578,0.000095016025,0.000048219612,0.000024345743,0.00010012528,0.00018077347,0.00006625207],"category_scores_gemma":[0.000022714186,0.00016086781,0.0004307607,0.00012006206,0.000092260896,0.000054051354,0.000041487147,0.00006898003,0.000041526822],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047408575,0.0008760778,0.0026828244,0.001131364,0.00095233665,0.00001004129,0.00023434348,2.1227031e-9,4.7928995e-7,0.00092410215,0.000019250323,0.99312174],"study_design_scores_gemma":[0.012367999,0.00024100333,0.0055173077,0.0021263605,0.004439628,0.000183044,0.000026449166,6.88931e-7,0.0001659662,0.000049160208,0.9747188,0.00016358467],"about_ca_topic_score_codex":0.00026657368,"about_ca_topic_score_gemma":0.0000035196424,"teacher_disagreement_score":0.9929582,"about_ca_system_score_codex":0.000058931815,"about_ca_system_score_gemma":0.00013780725,"threshold_uncertainty_score":0.6559999},"labels":[],"label_agreement":null},{"id":"W2095623863","doi":"10.1002/gcc.20495","title":"Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Lymphoma; Primary (astronomy); Medicine; Cancer research; Internal medicine; Physics; Astronomy","score_opus":0.013996508835722683,"score_gpt":0.2713122385188923,"score_spread":0.2573157296831696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095623863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95695484,0.041116163,0.00001565923,0.00020552978,0.00013113316,0.00017256846,0.000059731665,0.000010154323,0.0013342439],"genre_scores_gemma":[0.9870795,0.012081307,0.00032813507,0.00025734107,0.00009327997,0.00005176711,0.000032079966,0.0000061430983,0.000070454815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991962,0.000007972076,0.00023098907,0.00019108715,0.0001668487,0.00020694367],"domain_scores_gemma":[0.9996111,0.000046814148,0.000065275875,0.00012390132,0.000045408815,0.000107515145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008501323,0.000112294234,0.00023878308,0.00007849924,0.000027912398,0.0000046053765,0.000036979225,0.000049535498,0.00013089324],"category_scores_gemma":[0.000004286366,0.000088368375,0.000050041363,0.00014731036,0.00007486991,0.00003267346,0.00002717542,0.000026029176,0.0000035251257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007848997,0.0006875266,0.6079624,0.00022295749,0.000033768276,0.000110455396,0.00026421738,0.000004849604,0.0070998385,0.000057776568,0.00036639263,0.38311133],"study_design_scores_gemma":[0.0036732273,0.00020569036,0.94207096,0.00021179786,0.00007940823,0.00005397493,0.00011586193,0.0000115946805,0.044458035,0.000019196556,0.00898929,0.000110936875],"about_ca_topic_score_codex":0.0003918215,"about_ca_topic_score_gemma":0.00017076479,"teacher_disagreement_score":0.38300037,"about_ca_system_score_codex":0.00019958624,"about_ca_system_score_gemma":0.00020039882,"threshold_uncertainty_score":0.36035576},"labels":[],"label_agreement":null},{"id":"W2095774866","doi":"10.1182/asheducation-2005.1.239","title":"Evolving Approaches to Primary Treatment of Hodgkin Lymphoma","year":2005,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Vinblastine; Bleomycin; Stage (stratigraphy); Lymphoma; Chemotherapy; Oncology; Internal medicine; Radiation therapy; Autologous stem-cell transplantation; Disease; Surgery; Cyclophosphamide; Vincristine","score_opus":0.08461832890207267,"score_gpt":0.2745400556001945,"score_spread":0.18992172669812185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095774866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97433376,0.003759247,0.00005970393,0.004318551,0.000056316945,0.00048521967,0.000005337962,0.000049383383,0.01693245],"genre_scores_gemma":[0.98801416,0.00008637945,0.010748136,0.00043384472,0.0000785032,0.00015649367,0.000020796704,0.000015769498,0.00044593474],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99912053,0.00002467791,0.00025977776,0.00024867416,0.00011281528,0.00023353637],"domain_scores_gemma":[0.9993767,0.000087388515,0.000061173385,0.00031328708,0.000025859903,0.00013554854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037448033,0.00015198394,0.00053801667,0.0001101226,0.00002929368,0.0000037794614,0.000042885058,0.00008367159,0.0001384875],"category_scores_gemma":[0.000017807768,0.0001113068,0.00011864751,0.00010373378,0.000041579355,0.000029499406,0.000025173957,0.000011066976,0.00018088105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004376214,0.009765268,0.4594303,0.00024040075,0.00065815914,0.0003969512,0.0022325192,0.000018356825,0.0009800757,0.019488594,0.0053198365,0.50103194],"study_design_scores_gemma":[0.014245774,0.003997337,0.703309,0.00019618853,0.00055225077,0.0030685824,0.00026848257,0.00032138597,0.20033015,0.00017932664,0.073158205,0.0003732834],"about_ca_topic_score_codex":0.000046344016,"about_ca_topic_score_gemma":0.00002149876,"teacher_disagreement_score":0.50065863,"about_ca_system_score_codex":0.0003631202,"about_ca_system_score_gemma":0.0001060609,"threshold_uncertainty_score":0.45389596},"labels":[],"label_agreement":null},{"id":"W2095891194","doi":"10.1093/annonc/mdq418","title":"Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Roche","keywords":"Rituximab; Medicine; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; International Prognostic Index; Chemotherapy; Oncology; Surgery; Gastroenterology","score_opus":0.037411170413930356,"score_gpt":0.33787127636633907,"score_spread":0.3004601059524087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095891194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878707,0.000034762088,0.0000034546395,0.0028382186,0.00028738513,0.0016110009,0.000041393367,0.000023896395,0.0072891833],"genre_scores_gemma":[0.9968753,0.00008077255,0.0007379634,0.0011523793,0.00023490479,0.00015237073,0.000033389417,0.00003083772,0.00070208247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982591,0.00011745181,0.00052057864,0.00035708718,0.0005055399,0.0002402012],"domain_scores_gemma":[0.9982547,0.00025576973,0.0005401392,0.00049007905,0.00035195675,0.00010731644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038834426,0.00024355228,0.00076710817,0.000107138796,0.000050439852,0.000008913683,0.00025533093,0.00013945288,0.00011416784],"category_scores_gemma":[0.000050975163,0.0001140831,0.0001159049,0.0002140793,0.0003276204,0.00006358328,0.000047441372,0.0001337517,0.000004560705],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55304563,0.06254861,0.2820769,0.000042984928,0.0014090277,0.0002731215,0.0015828386,0.0000010859586,0.0025774138,0.000025654417,0.0022842716,0.09413248],"study_design_scores_gemma":[0.50530934,0.054819703,0.41562325,0.000093526156,0.0003329,0.00024251579,0.0003015557,0.000019442437,0.009112107,0.0000070305846,0.013975556,0.00016303427],"about_ca_topic_score_codex":0.0004789832,"about_ca_topic_score_gemma":0.0008677324,"teacher_disagreement_score":0.13354637,"about_ca_system_score_codex":0.00007728506,"about_ca_system_score_gemma":0.0006184458,"threshold_uncertainty_score":0.46521738},"labels":[],"label_agreement":null},{"id":"W2096556609","doi":"10.1182/asheducation-2006.1.295","title":"Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma","year":2006,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Context (archaeology); Medicine; Follicular lymphoma; Clinical trial; Lymphoma; Oncology; Rituximab; Hodgkin lymphoma; Internal medicine; Intensive care medicine; Biology","score_opus":0.06121503127060528,"score_gpt":0.3390622691520642,"score_spread":0.27784723788145893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096556609","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035542507,0.96243274,0.0000054496168,0.00001581119,0.00015001309,0.0014714275,0.000050059225,0.000029564273,0.0003024548],"genre_scores_gemma":[0.008832687,0.9891977,0.0008548828,0.000018569448,0.000034829918,0.00035038678,0.00048435567,0.000063625004,0.00016298145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793047,0.0001014524,0.0009540274,0.00045292222,0.00017037861,0.0003907285],"domain_scores_gemma":[0.9982369,0.0007648045,0.000397865,0.00045264114,0.000048171056,0.000099622426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006259553,0.00046611967,0.0034879139,0.00041940607,0.000017276474,0.000008544405,0.00010376101,0.000553277,0.00005821608],"category_scores_gemma":[0.00014921595,0.00032184465,0.0005194136,0.00031726423,0.00010635481,0.00003709594,0.000069868096,0.00010847431,0.000065725675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058783,0.0057615363,0.2985935,0.06131134,0.0010581517,0.005747616,0.00012770179,0.0000038957673,3.4009906e-7,0.0016436817,0.0053689107,0.62032455],"study_design_scores_gemma":[0.0027669815,0.00054785894,0.02724539,0.025199067,0.0026991207,0.002717373,0.000014345826,0.00001309532,0.00005775996,0.0000082937495,0.9382709,0.0004597703],"about_ca_topic_score_codex":0.00039175854,"about_ca_topic_score_gemma":0.00004750719,"teacher_disagreement_score":0.93290204,"about_ca_system_score_codex":0.0002459514,"about_ca_system_score_gemma":0.00042517504,"threshold_uncertainty_score":0.99992335},"labels":[],"label_agreement":null},{"id":"W2096617875","doi":"10.1016/s0360-3016(01)01549-8","title":"Stage I and II malt lymphoma: results of treatment with radiotherapy","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; MALT lymphoma; Stomach; Radiation therapy; Lymphoma; Stage (stratigraphy); Larynx; Gastroenterology; Rectum; Biopsy; Mucosa-associated lymphoid tissue; Chemotherapy; Internal medicine; Surgery","score_opus":0.019872480840720155,"score_gpt":0.3228061793408418,"score_spread":0.3029336985001217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096617875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921669,0.0015894186,0.00076332386,0.0036655162,0.0004269937,0.00022343731,0.000089730405,0.000015937514,0.0010587771],"genre_scores_gemma":[0.9862044,0.008948045,0.0032048037,0.00045568324,0.0007989121,0.000011612054,0.000068260575,0.000018349567,0.00028993256],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987665,0.00008748818,0.00059583015,0.0001942613,0.00019631958,0.00015962163],"domain_scores_gemma":[0.9981746,0.00024361565,0.00088762736,0.00013970968,0.00042944937,0.00012499155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020798222,0.00018605858,0.00051230163,0.00011323664,0.000057501293,0.000011419735,0.000117387266,0.00012966011,0.000041402236],"category_scores_gemma":[0.000046097342,0.00012530733,0.00014062299,0.00010912606,0.00016724842,0.00013937084,0.0000217014,0.00007219675,0.0000027269216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042044767,0.0023759627,0.55689436,0.0000055075543,0.0017940276,0.00023724599,0.00076735165,0.00016512396,0.001806641,0.002939958,0.0004042038,0.42840514],"study_design_scores_gemma":[0.12265264,0.04970465,0.35536194,0.00020688321,0.00068867503,0.0030603786,0.00028933445,0.0016955606,0.012473186,0.001356734,0.45212442,0.00038561216],"about_ca_topic_score_codex":0.0000998812,"about_ca_topic_score_gemma":0.000011532098,"teacher_disagreement_score":0.4517202,"about_ca_system_score_codex":0.0013138669,"about_ca_system_score_gemma":0.0005875244,"threshold_uncertainty_score":0.5109885},"labels":[],"label_agreement":null},{"id":"W2096764404","doi":"10.1093/annonc/mdq626","title":"An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Lymphoma; Aggressive lymphoma; Oncology; Internal medicine; Multiple myeloma; Rituximab","score_opus":0.17223423508747657,"score_gpt":0.42186340011588325,"score_spread":0.24962916502840668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096764404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886269,0.00017171474,0.000047564237,0.00068496796,0.0008510967,0.0009578976,0.000111682944,0.000016166952,0.008532036],"genre_scores_gemma":[0.9951552,0.0004791241,0.002576718,0.00074720994,0.0002980969,0.00020148125,0.00010672358,0.000023568766,0.0004118621],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984919,0.00008126237,0.0006657912,0.0002989002,0.00021811604,0.00024404099],"domain_scores_gemma":[0.9977791,0.00029303876,0.000936819,0.00035281046,0.00047331103,0.00016495895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032530396,0.00017841655,0.0006626317,0.00017769323,0.000048659615,0.0000033850731,0.00018792688,0.00020150292,0.0003623164],"category_scores_gemma":[0.00030303805,0.00013145093,0.00027035223,0.00007163384,0.00013914576,0.00012027863,0.000050419283,0.00004133928,0.0000073224755],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41119823,0.11884099,0.000772447,0.000103924256,0.0009780686,0.00056305726,0.0028574532,0.0000013197572,0.03162555,0.00025887223,0.012600824,0.42019928],"study_design_scores_gemma":[0.3575714,0.23499104,0.0025678682,0.00016223213,0.0003789019,0.00006362687,0.0002732817,0.00005707345,0.3319942,0.00017918178,0.07158569,0.00017551082],"about_ca_topic_score_codex":0.00013599418,"about_ca_topic_score_gemma":0.000024814186,"teacher_disagreement_score":0.42002377,"about_ca_system_score_codex":0.0001468328,"about_ca_system_score_gemma":0.0005403058,"threshold_uncertainty_score":0.5360413},"labels":[],"label_agreement":null},{"id":"W2096822640","doi":"10.1158/1078-0432.ccr-07-4946","title":"Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL; Wellcome Trust","keywords":"BCL6; Chromosomal translocation; Fluorescence in situ hybridization; Lymphoma; Biology; MALT lymphoma; Germinal center; Immunoglobulin heavy chain; Immunophenotyping; Pathology; Mucosa-associated lymphoid tissue; Diffuse large B-cell lymphoma; Gene rearrangement; BCL10; Cancer research; B cell; Immunology; Antibody; Medicine; Genetics; Antigen; Gene; Chromosome","score_opus":0.14671510116045278,"score_gpt":0.42349920412208497,"score_spread":0.2767841029616322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096822640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97492546,0.010485202,0.000034509503,0.0124359075,0.0002695599,0.0010404249,0.000073862204,0.000039639628,0.00069543364],"genre_scores_gemma":[0.9816597,0.014949402,0.00012426495,0.0008942088,0.00074913655,0.0006624588,0.0000468383,0.000038840182,0.00087514485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959253,0.0007739148,0.0008176792,0.0005919217,0.0009940026,0.00089718914],"domain_scores_gemma":[0.9970708,0.0014829158,0.0000731522,0.00079927215,0.00024603453,0.00032784537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027041999,0.0002120998,0.00051575806,0.00020204968,0.00060339365,0.000029760447,0.0003681826,0.00020143506,0.00020548051],"category_scores_gemma":[0.00041558009,0.00014014106,0.00025839076,0.0010049135,0.0005255779,0.00006353677,0.00020596635,0.0006153166,0.00010386152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011282387,0.02074332,0.93920803,0.00006984818,0.00016725935,0.00062033156,0.00095634966,0.000008872142,0.00027631357,0.00010042338,0.009015708,0.02770528],"study_design_scores_gemma":[0.03516481,0.0011912932,0.9443355,0.0002091047,0.000073908166,0.000043685573,0.00023948384,0.0006344071,0.0019810349,0.00007420558,0.015851887,0.00020068184],"about_ca_topic_score_codex":0.0023859846,"about_ca_topic_score_gemma":0.00089198066,"teacher_disagreement_score":0.034036573,"about_ca_system_score_codex":0.00062219275,"about_ca_system_score_gemma":0.0012259604,"threshold_uncertainty_score":0.5714786},"labels":[],"label_agreement":null},{"id":"W2097324482","doi":"10.3109/10428194.2011.624227","title":"Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Melphalan; Etoposide; Internal medicine; Autologous stem-cell transplantation; Cyclophosphamide; Oncology; Progression-free survival; Gastroenterology; Transplantation; Carmustine; Refractory (planetary science); Stem cell; Salvage therapy; Chemotherapy; Urology; Surgery","score_opus":0.014815767357193631,"score_gpt":0.2296442179792584,"score_spread":0.21482845062206476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097324482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289096,0.009418841,0.00015657672,0.00027679882,0.00077585934,0.00373036,0.0004413231,0.0005499904,0.0017593144],"genre_scores_gemma":[0.980702,0.009592884,0.0026704867,0.0020852478,0.00024088749,0.0013673977,0.0009972265,0.00036475275,0.0019791103],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.993036,0.0002291518,0.0015780884,0.0023826135,0.0010169776,0.0017572201],"domain_scores_gemma":[0.99521834,0.00071323,0.0009642663,0.0013016124,0.000614679,0.0011879036],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00047964332,0.0018312592,0.0022840002,0.0005022527,0.00083521527,0.0002398708,0.0004706533,0.001142072,0.000094436284],"category_scores_gemma":[0.000026720982,0.0014597832,0.00047554888,0.00065801997,0.0006893788,0.00075271004,0.0001269134,0.00020353241,0.000055580986],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.115463994,0.00570311,0.0817881,0.002043683,0.004060471,0.0081368545,0.017991677,0.000031247586,0.028355582,0.0036127581,0.01887602,0.7139365],"study_design_scores_gemma":[0.23224474,0.0074402564,0.6057937,0.00080062496,0.002356655,0.003469155,0.0018401723,0.0004327918,0.1345825,0.00040856667,0.0082978215,0.002332972],"about_ca_topic_score_codex":0.010601348,"about_ca_topic_score_gemma":0.00031218427,"teacher_disagreement_score":0.7116035,"about_ca_system_score_codex":0.0046832142,"about_ca_system_score_gemma":0.0027633812,"threshold_uncertainty_score":0.99944323},"labels":[],"label_agreement":null},{"id":"W2097367878","doi":"10.3324/haematol.2012.072090","title":"Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant","year":2013,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre Léon Bérard; Centre hospitalier universitaire Sainte-Justine; Institut Gustave-Roussy","keywords":"Medicine; Lymphoma; Oncology; Internal medicine; Salvage therapy; Autologous stem-cell transplantation; Transplantation; Refractory (planetary science); Clinical trial; Brentuximab vedotin; Hodgkin lymphoma; Classical Hodgkin lymphoma; Chemotherapy","score_opus":0.10536846001959649,"score_gpt":0.3775607193242865,"score_spread":0.27219225930469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097367878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012471358,0.9677778,0.000030120967,0.0014676823,0.0005432681,0.01686502,0.00048875296,0.00014190265,0.00021410683],"genre_scores_gemma":[0.003481208,0.980536,0.0009737504,0.0005765632,0.00025290163,0.012554863,0.000778926,0.000083271545,0.0007625444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966069,0.00023620322,0.0013158057,0.00081754214,0.0004801302,0.00054341234],"domain_scores_gemma":[0.9951097,0.002218885,0.0009464843,0.0005545129,0.0009900996,0.00018036568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004771361,0.000693629,0.002857058,0.00012101877,0.0003445491,0.00009192074,0.00023191675,0.0006974637,0.000015693866],"category_scores_gemma":[0.0016211948,0.00034036988,0.00081248564,0.00015669737,0.000062550636,0.00007195909,0.000060279224,0.0000909946,0.00004408647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020107228,0.0040493426,0.003123883,0.0053129364,0.0013652749,0.000039743038,0.00015559446,2.3185374e-8,7.7594066e-8,0.00035624654,0.06969885,0.915697],"study_design_scores_gemma":[0.012056761,0.0027161397,0.0032238136,0.0035982335,0.006870681,0.00011156434,0.00011242286,0.000020600566,0.0000035194405,0.00009046025,0.97077763,0.00041819204],"about_ca_topic_score_codex":0.0000689336,"about_ca_topic_score_gemma":0.000026069598,"teacher_disagreement_score":0.9152788,"about_ca_system_score_codex":0.0006583108,"about_ca_system_score_gemma":0.00031065725,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W2097426308","doi":"10.1016/j.bbmt.2015.05.010","title":"The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen","year":2015,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"St. Baldrick's Foundation; Terumo BCT; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Health Resources and Services Administration; Medac; Swedish Orphan Biovitrum; GlaxoSmithKline; Kiadis Pharma; Miltenyi Biotec; Otsuka America; Incyte; Therakos; Genentech; Seattle Genetics; Chimerix; U.S. Department of Defense; Medical College of Wisconsin; National Institute of Allergy and Infectious Diseases; Blue Cross and Blue Shield Association; Takeda Oncology; University of Minnesota; Sigma-Tau Pharmaceuticals; StemCyte; Tarix Pharmaceuticals; Sanofi; University of Utah; HistoGenetics; WellPoint; Teva Pharmaceutical Industries; Health Research; National Marrow Donor Program; Roswell Park Cancer Institute; Fred Hutchinson Cancer Research Center; U.S. Navy; Celgene; Osiris Therapeutics; Merck; Leukemia and Lymphoma Society; Be The Match Foundation; Allos Therapeutics; U.S. Public Health Service; Actinium Pharmaceuticals; Ariad Pharmaceuticals; Otsuka America Pharmaceutical; Amgen; Onyx Pharmaceuticals","keywords":"Medicine; Lymphoma; Internal medicine; Transplantation; Follicular lymphoma; Regimen; Hematopoietic stem cell transplantation; Incidence (geometry); Oncology; Graft-versus-host disease; Gastroenterology; Mantle cell lymphoma; Immunology","score_opus":0.015268559452819323,"score_gpt":0.23817945641678137,"score_spread":0.22291089696396205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097426308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656856,0.0003041917,6.4617063e-7,0.0024402693,0.00004384202,0.00042342936,0.000056648,0.0000028109707,0.00015958173],"genre_scores_gemma":[0.9995103,0.0002951333,0.0000023181901,0.00011549004,0.000006449467,0.000022713784,0.00003779336,0.000003383938,0.000006443235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992798,0.00027234326,0.00015892638,0.00011125832,0.00009102232,0.000086643704],"domain_scores_gemma":[0.9987301,0.0008302488,0.00016807557,0.00016572289,0.00007214929,0.000033651893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034475818,0.000094244766,0.00017829648,0.000019595773,0.00010548332,0.0000039559895,0.000064795466,0.000040011073,0.0000022758152],"category_scores_gemma":[0.000121112695,0.000027224385,0.000053301555,0.000063187006,0.00063158333,0.000017186348,0.000009463896,0.000053702308,2.2714626e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029967831,0.00046747195,0.95833343,0.000020883755,0.00034042445,0.0000072758594,0.00092498126,0.000007264166,0.00039821066,0.009092722,0.00007310531,0.0003663727],"study_design_scores_gemma":[0.011536011,0.0016106943,0.983618,0.00010014533,0.00041927787,0.0000054875377,0.00016858563,0.000015219968,0.002116856,0.00036998937,0.000005350846,0.000034371697],"about_ca_topic_score_codex":0.00027122523,"about_ca_topic_score_gemma":0.00008113459,"teacher_disagreement_score":0.025284553,"about_ca_system_score_codex":0.000020828433,"about_ca_system_score_gemma":0.00006616762,"threshold_uncertainty_score":0.2327095},"labels":[],"label_agreement":null},{"id":"W2098205907","doi":"10.3109/10428194.2013.824077","title":"Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Cancer Institute","keywords":"STAT3; microRNA; STAT protein; Cancer research; Lymphoma; Carcinogenesis; Diffuse large B-cell lymphoma; Biology; Transfection; Medicine; Signal transduction; Immunology; Cell culture; Gene; Cell biology; Genetics","score_opus":0.003196871236730002,"score_gpt":0.178234416654029,"score_spread":0.175037545417299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098205907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996335,0.0017471197,0.000008565517,0.000033326,0.000105588384,0.0013069307,0.0002704938,0.00005908653,0.00013383526],"genre_scores_gemma":[0.99811697,0.0008961678,0.00017675583,0.00012019266,0.0000283562,0.0000921818,0.0003813451,0.00010019904,0.000087802335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675846,0.00016908367,0.001030436,0.0008953789,0.0005770781,0.0005695793],"domain_scores_gemma":[0.99769753,0.00024469316,0.00062094786,0.0005615497,0.00030670615,0.000568546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116516785,0.00070401,0.0012888438,0.00040030974,0.00011143251,0.000038670554,0.0001419056,0.00057472964,0.00008910029],"category_scores_gemma":[0.000027325295,0.0005556034,0.00016418031,0.0005263385,0.00036704028,0.00048332036,0.000082917446,0.00011625845,0.0000043102114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074646906,0.011473349,0.5624079,0.0011261625,0.00031440024,0.00007407638,0.0019978075,0.00001047964,0.39505777,0.000024801038,0.00011172558,0.019936858],"study_design_scores_gemma":[0.09420364,0.00097031216,0.63941056,0.00095233915,0.00041850744,0.00001403333,0.00017371963,0.00023912788,0.26313192,0.0000646892,0.00005589987,0.000365247],"about_ca_topic_score_codex":0.004568544,"about_ca_topic_score_gemma":0.000031508745,"teacher_disagreement_score":0.13192585,"about_ca_system_score_codex":0.0013158872,"about_ca_system_score_gemma":0.0010278376,"threshold_uncertainty_score":0.9996895},"labels":[],"label_agreement":null},{"id":"W2098594842","doi":"10.6000/1927-7229.2012.01.02.6","title":"The Prevalence and Importance of Variant Patterns in Nodular Lymphocyte Predominant Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pathological; Lymphoma; Pathology; Hodgkin lymphoma; Clinical significance; Medicine; Lymphocyte; Internal medicine","score_opus":0.017525931626494632,"score_gpt":0.31179046228069524,"score_spread":0.2942645306542006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098594842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909861,0.0057779886,0.00004059561,0.0023494798,0.00016012818,0.00014541096,0.0000043589393,0.0000017999503,0.00053413946],"genre_scores_gemma":[0.9943202,0.0047873096,0.0003560528,0.0002581052,0.00016511271,0.000005029378,4.3648316e-7,0.000007797461,0.00009991687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984254,0.0001237059,0.00076881,0.00011205533,0.000263809,0.00030619517],"domain_scores_gemma":[0.99840236,0.0006060165,0.00044371228,0.00018643469,0.00012369257,0.00023776386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010420677,0.00011979852,0.00057533546,0.00009777194,0.00003338417,0.000007793027,0.00010419831,0.00010888593,0.00006767815],"category_scores_gemma":[0.00032076027,0.00006520308,0.00014030283,0.00012269492,0.0001628499,0.000089063,0.0000519266,0.00009037217,0.00000320655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008168781,0.0014765919,0.97266954,0.0000929038,0.00021949086,0.0009666316,0.00021140253,0.000001807545,0.0001087732,0.0016288575,0.00023792496,0.021569174],"study_design_scores_gemma":[0.005654846,0.0018643503,0.9799887,0.00018982375,0.0005096901,0.00332086,0.0001021761,0.00037943787,0.0006221991,0.00010866546,0.0071940143,0.000065216394],"about_ca_topic_score_codex":0.000032659456,"about_ca_topic_score_gemma":0.00002753784,"teacher_disagreement_score":0.021503957,"about_ca_system_score_codex":0.00053835,"about_ca_system_score_gemma":0.00038944403,"threshold_uncertainty_score":0.26589045},"labels":[],"label_agreement":null},{"id":"W2098675401","doi":"10.1093/annonc/mdr173","title":"VII. The role of the microenvironment in lymphoid cancers","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cyclin D1; Lymphoma; Cancer research; Follicular lymphoma; Mantle cell lymphoma; Cancer cell; Medicine; Cyclin; Cell cycle; Cancer; Biology; Cell biology; Immunology; Internal medicine","score_opus":0.0543061739795201,"score_gpt":0.31094950381304787,"score_spread":0.2566433298335278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098675401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629423,0.0020114058,1.2989302e-7,0.0029930146,0.00006500707,0.00022195044,0.0000067844953,0.000001895562,0.031757537],"genre_scores_gemma":[0.99718565,0.0010670805,0.000044384313,0.001549838,0.000016624512,0.00003817569,9.0225825e-7,0.000004602827,0.000092721595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994487,0.000054119646,0.00019226098,0.00009018879,0.00008510534,0.00012962948],"domain_scores_gemma":[0.9995403,0.00005514548,0.00011682284,0.00024035314,0.000019877518,0.000027453441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001249338,0.000061688486,0.00020379946,0.000024419105,0.000016777893,4.5543135e-7,0.00010405322,0.00005005805,0.00017936963],"category_scores_gemma":[0.000015706479,0.000030746447,0.00008645457,0.00006003571,0.00017056025,0.0000110537285,0.000048942835,0.000034901746,0.000008651782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030985475,0.0015311105,0.8595318,0.000015028548,0.00017402411,0.000020875055,0.0029760497,0.000007392545,0.0073195864,0.00095762237,0.0017805509,0.12537606],"study_design_scores_gemma":[0.0011812054,0.0008893284,0.70873636,0.000031558724,0.000045310182,0.000023888275,0.00045897244,0.0000054024276,0.23840013,0.00038048727,0.04981889,0.000028475664],"about_ca_topic_score_codex":0.0023451846,"about_ca_topic_score_gemma":0.00031465126,"teacher_disagreement_score":0.23108055,"about_ca_system_score_codex":0.00012903707,"about_ca_system_score_gemma":0.00018311467,"threshold_uncertainty_score":0.3545233},"labels":[],"label_agreement":null},{"id":"W2099126154","doi":"10.1056/nejmoa1111961","title":"ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McGill University; Western University; University of Alberta; BC Cancer Agency; University of Toronto; Queen's University","funders":"National Cancer Institute","keywords":"Medicine; ABVD; Chemotherapy; Radiation therapy; Lymphoma; Stage (stratigraphy); Hodgkin lymphoma; Dacarbazine; Bleomycin; Vinblastine; Oncology; Internal medicine; Surgery; Vincristine; Cyclophosphamide","score_opus":0.05688542617800288,"score_gpt":0.29120505766439303,"score_spread":0.23431963148639015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099126154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842444,0.0053829816,0.00009214603,0.005607589,0.00093901233,0.00022874231,0.0000026563841,0.000016187812,0.0034862976],"genre_scores_gemma":[0.993739,0.0024814613,0.000646378,0.0011649431,0.0016608859,0.000004585082,0.000012736958,0.000021435591,0.0002685615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99842584,0.00008896466,0.0005895592,0.00015731508,0.00049780397,0.00024053163],"domain_scores_gemma":[0.9986006,0.00034259955,0.00033447915,0.00022643233,0.00014339812,0.00035251112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005624737,0.00020338861,0.0005997621,0.0004042622,0.00003112979,0.0000082161905,0.00011268978,0.000089163266,0.0004552608],"category_scores_gemma":[0.00028486497,0.00012521552,0.00011262625,0.00027660714,0.00006249745,0.00011654332,0.000007218638,0.0001343113,0.000010155395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014248959,0.0012643161,0.22311386,0.000023304774,0.00034094296,0.0031134803,0.0023134823,0.000019101071,0.0004886696,0.00016477915,0.004659588,0.7502495],"study_design_scores_gemma":[0.38963163,0.010057859,0.55117506,0.00042966608,0.00021409834,0.0002919847,0.0002095634,0.00007479819,0.004814232,0.000080963466,0.042881973,0.0001381904],"about_ca_topic_score_codex":0.00074015243,"about_ca_topic_score_gemma":0.00008561866,"teacher_disagreement_score":0.75011134,"about_ca_system_score_codex":0.00022302751,"about_ca_system_score_gemma":0.0004379134,"threshold_uncertainty_score":0.51061404},"labels":[],"label_agreement":null},{"id":"W2099298424","doi":"10.1093/jnci/dji344","title":"A Putative Exonic Splicing Polymorphism in the BCL6 Gene and the Risk of Non-Hodgkin Lymphoma","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"BCL6; Odds ratio; Lymphoma; Genotype; Single-nucleotide polymorphism; Biology; SNP; Population; Oncology; Chronic lymphocytic leukemia; Cancer research; Internal medicine; Genetics; Immunology; Medicine; Leukemia; Gene; B cell; Antibody","score_opus":0.023436437779957266,"score_gpt":0.31688374806668695,"score_spread":0.2934473102867297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099298424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97777456,0.0038430847,0.00003527952,0.016854985,0.000304476,0.00030824172,0.00003486229,0.0000015665478,0.00084293965],"genre_scores_gemma":[0.99498135,0.0016075032,0.00045355028,0.0021822716,0.00067425496,0.000029634313,0.0000011529636,0.000006279207,0.00006398663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985356,0.0001122739,0.0004299853,0.00009315961,0.00071097433,0.000118017655],"domain_scores_gemma":[0.998758,0.00030117668,0.0005355176,0.0001074696,0.00025887488,0.000038963066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093719154,0.000113593975,0.00027158813,0.00010239007,0.00013623675,0.00001886643,0.00020233619,0.00003985979,0.000013418383],"category_scores_gemma":[0.00022603077,0.000046418114,0.0001795075,0.00024879293,0.00024659428,0.00015346837,0.000039816747,0.0001493527,0.0000015565113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010143828,0.00433069,0.44026336,0.00019184095,0.0066622524,0.00031652773,0.041109327,0.06074541,0.0074758627,0.028650079,0.015334829,0.384776],"study_design_scores_gemma":[0.016591212,0.00015768145,0.9639885,0.00030923603,0.0005453374,0.00093777373,0.00020589314,0.0016157232,0.007428788,0.0014781134,0.0066517023,0.00009005413],"about_ca_topic_score_codex":0.00079546124,"about_ca_topic_score_gemma":0.00035614724,"teacher_disagreement_score":0.52372515,"about_ca_system_score_codex":0.00056729733,"about_ca_system_score_gemma":0.0006718821,"threshold_uncertainty_score":0.18928757},"labels":[],"label_agreement":null},{"id":"W2099626767","doi":"10.1007/s00277-014-2288-5","title":"Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Gilead Sciences","keywords":"Medicine; Autologous stem-cell transplantation; Rituximab; Internal medicine; Follicular lymphoma; Transplantation; Oncology; Lymphoma; Gastroenterology; Surgery","score_opus":0.06008705568568157,"score_gpt":0.3245621606122814,"score_spread":0.2644751049265998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099626767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976864,0.00031532565,0.000012942597,0.0005359735,0.000030073877,0.0007586671,0.000015040077,0.000049335074,0.0005962515],"genre_scores_gemma":[0.9982295,0.000072307244,0.0011751497,0.00021885068,0.000009815006,0.00007851443,0.00014881491,0.000025708589,0.00004135379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812883,0.00024131946,0.00069728395,0.00037852876,0.0002787831,0.000275247],"domain_scores_gemma":[0.9985319,0.00022657978,0.0004324074,0.00032118257,0.0002643269,0.00022362881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025298216,0.00022168136,0.0008873492,0.00012607023,0.000039652616,0.0000051454895,0.00007289771,0.00024351144,0.0000065622994],"category_scores_gemma":[0.00005728553,0.00012787283,0.00007126204,0.00026472512,0.00013614882,0.00009042201,0.000013769369,0.00010372757,0.000008350562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012764986,0.0061781295,0.9721868,0.00015075333,0.00016135986,0.001728242,0.00032301195,0.0000055180717,0.000014751426,0.00007032318,0.0002469161,0.006169214],"study_design_scores_gemma":[0.04674909,0.0126476865,0.9280194,0.00060707005,0.00029886002,0.00035997728,0.00021998718,0.00006247928,0.0106869675,0.000027594302,0.00010745751,0.0002134072],"about_ca_topic_score_codex":0.00009517642,"about_ca_topic_score_gemma":0.00008258016,"teacher_disagreement_score":0.04416737,"about_ca_system_score_codex":0.00004102291,"about_ca_system_score_gemma":0.00046929024,"threshold_uncertainty_score":0.5214502},"labels":[],"label_agreement":null},{"id":"W2100008973","doi":"10.1002/cncr.25226","title":"Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gastroenterology; Thyroid; Stomach; Stage (stratigraphy); Radiation therapy; Mucosa-associated lymphoid tissue; MALT lymphoma; Internal medicine; Survival rate; Surgery","score_opus":0.015705734048429416,"score_gpt":0.30954200099815066,"score_spread":0.29383626694972126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100008973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947916,0.0019475932,0.000020737853,0.00073650136,0.00025736002,0.00072935666,0.000039964027,0.00012820764,0.0013486273],"genre_scores_gemma":[0.9957552,0.00043035575,0.00022583085,0.00094858493,0.00016230342,0.00037348748,0.0000849571,0.000067420966,0.0019518862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839,0.00003878931,0.0003607194,0.00044411322,0.00029724944,0.0004691039],"domain_scores_gemma":[0.99908406,0.000059307855,0.00011710696,0.00040508853,0.000087334935,0.00024712438],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010365958,0.00033443086,0.00065513956,0.00014285502,0.000060023187,0.000032930417,0.00010919077,0.00021829527,0.0016558924],"category_scores_gemma":[0.000021778624,0.00023341592,0.00010182363,0.00037077628,0.000123415,0.00008423406,0.0000124274,0.00013329307,0.000030034085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006928511,0.00091044937,0.9549674,0.000031945237,0.0002858355,0.0007690448,0.00017582241,0.0000055939586,0.008084724,0.00006436154,0.00022750115,0.03378449],"study_design_scores_gemma":[0.028918615,0.0004100236,0.94242,0.00017243695,0.00020500629,0.00017042708,0.000011980176,0.000106737636,0.020757183,0.00000482722,0.0065217037,0.0003010832],"about_ca_topic_score_codex":0.0020667717,"about_ca_topic_score_gemma":0.0032701243,"teacher_disagreement_score":0.03348341,"about_ca_system_score_codex":0.0011432145,"about_ca_system_score_gemma":0.00040011082,"threshold_uncertainty_score":0.99925673},"labels":[],"label_agreement":null},{"id":"W2100197564","doi":"10.3324/haematol.2009.007203","title":"Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft; Michael Smith Health Research BC; Lymphoma Research Foundation","keywords":"CHOP; BCL6; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Medicine; Vincristine; Cancer research; Outcome (game theory); Rituximab; Oncology; Gastroenterology; B cell; Chemotherapy; Immunology; Mathematics; Cyclophosphamide; Antibody","score_opus":0.0197562111914154,"score_gpt":0.2564587346492451,"score_spread":0.23670252345782972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100197564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603534,0.00010843751,0.000016589935,0.00062045973,0.000011363822,0.0010082404,0.000035450088,0.0000851176,0.0020790068],"genre_scores_gemma":[0.99829555,0.000038806964,0.00059731264,0.00041933055,0.000012016551,0.00008069518,0.000117048265,0.000016014721,0.00042320887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986439,0.000042157597,0.00032575757,0.00038050555,0.00025841073,0.00034931028],"domain_scores_gemma":[0.9992299,0.00009861844,0.00012423747,0.0003099791,0.00006128525,0.0001759807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006268527,0.000266164,0.0006145284,0.00012786813,0.00010715625,0.000025575211,0.000056499048,0.000112399815,0.00006711558],"category_scores_gemma":[0.000028924322,0.0001354593,0.0000400475,0.00027452293,0.000051040395,0.00007531565,0.00002381687,0.00006658275,0.000034443965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009253996,0.006977381,0.98857576,0.000027483295,0.00006548579,0.0004705695,0.00014942532,4.5879526e-7,0.0000012595567,0.00008499103,0.00018507314,0.0025366903],"study_design_scores_gemma":[0.046801604,0.002765118,0.94908553,0.00014136375,0.00025612273,0.000038465263,0.000067671936,0.000012331744,0.000055023298,0.000010903702,0.00058547256,0.00018040874],"about_ca_topic_score_codex":0.00005675882,"about_ca_topic_score_gemma":0.00005130133,"teacher_disagreement_score":0.045876205,"about_ca_system_score_codex":0.00013525251,"about_ca_system_score_gemma":0.000036648922,"threshold_uncertainty_score":0.55238694},"labels":[],"label_agreement":null},{"id":"W2100198173","doi":"10.3109/10428194.2012.710907","title":"Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anthracycline; Chemotherapy; Stage (stratigraphy); Lymphoma; Internal medicine; Radiation therapy; Gastroenterology; Surgery; Diffuse large B-cell lymphoma; Induction chemotherapy; Oncology; Cancer; Breast cancer","score_opus":0.004290189130809547,"score_gpt":0.22056401710279658,"score_spread":0.21627382797198702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100198173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919984,0.005511275,0.000016996992,0.000033509397,0.00011228398,0.0011242386,0.000064643595,0.00006774176,0.0010709107],"genre_scores_gemma":[0.9963552,0.0013316098,0.0012012626,0.00037472325,0.00013213379,0.00017681102,0.00007705662,0.00016423292,0.00018701592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954139,0.00016672666,0.0013922994,0.0008693281,0.0008288008,0.0013289413],"domain_scores_gemma":[0.997473,0.0002577395,0.00065691036,0.00091586745,0.00014807886,0.00054841436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005159767,0.0008538362,0.0016641305,0.0006979583,0.00010217983,0.00003880309,0.00026593916,0.0005285689,0.00007907796],"category_scores_gemma":[0.00004536067,0.0006901125,0.000278117,0.00077314314,0.00023771884,0.0005836547,0.00013568204,0.00011989121,0.0000065760805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007846705,0.0088933585,0.90453094,0.00031890385,0.00017848705,0.00010180587,0.004842003,0.000010375071,0.0027211981,0.000085011394,0.000017540515,0.07045367],"study_design_scores_gemma":[0.13967933,0.0010578185,0.82709366,0.0010436521,0.00012104292,0.00003630229,0.0006217573,0.00094412203,0.02734063,0.000015997723,0.001466574,0.00057913724],"about_ca_topic_score_codex":0.0030716558,"about_ca_topic_score_gemma":0.0001295067,"teacher_disagreement_score":0.13183263,"about_ca_system_score_codex":0.005291068,"about_ca_system_score_gemma":0.0010468133,"threshold_uncertainty_score":0.999555},"labels":[],"label_agreement":null},{"id":"W2100367991","doi":"10.1200/jco.2003.11.141","title":"Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; International Prognostic Index; Radiation therapy; Chemotherapy; Anthracycline; Stage (stratigraphy); Lymphoma; Internal medicine; Surgery; Retrospective cohort study; Diffuse large B-cell lymphoma; Cancer; Breast cancer","score_opus":0.10533880825817948,"score_gpt":0.3874672162959088,"score_spread":0.2821284080377293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100367991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970652,0.00047344118,0.000003477628,0.0012804432,0.00045150297,0.0004558104,0.000044192726,0.0000017726844,0.0002241651],"genre_scores_gemma":[0.99908227,0.0002802383,0.00004111783,0.00045405075,0.000059663416,0.000009130527,0.000004100519,0.000010442045,0.000058971946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960257,0.0008116939,0.0023389668,0.00017268897,0.0004725219,0.00017845858],"domain_scores_gemma":[0.992127,0.0061294455,0.0013049067,0.00018730715,0.00014733459,0.000103975486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029178231,0.00014398804,0.0011250084,0.000107164626,0.000019574814,0.0000067582996,0.00028422425,0.00016469129,0.00005383792],"category_scores_gemma":[0.002575416,0.000070786606,0.00023477098,0.00015850352,0.00011842406,0.00006306038,0.00011721272,0.00020882842,9.0051066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051034364,0.0322343,0.9465383,0.000022639422,0.00016499255,0.00018968117,0.00036555086,9.1574077e-7,0.000022699744,0.0000047034355,0.00024781545,0.019698007],"study_design_scores_gemma":[0.030577708,0.0049198004,0.96337354,0.0000948428,0.00015096816,0.00008925051,0.00029230694,0.000046148176,0.000030380557,0.000009193139,0.00036091727,0.000054955868],"about_ca_topic_score_codex":0.0006761654,"about_ca_topic_score_gemma":0.0017912801,"teacher_disagreement_score":0.030067364,"about_ca_system_score_codex":0.0002657151,"about_ca_system_score_gemma":0.00023014423,"threshold_uncertainty_score":0.30831993},"labels":[],"label_agreement":null},{"id":"W2100532497","doi":"10.1016/j.humpath.2007.08.002","title":"A B-cell lymphoma–associated chromosomal translocation in a progressive transformation of germinal center","year":2008,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"BCL6; Germinal center; Mantle zone; Pathology; Follicular hyperplasia; Histiocyte; Lymph node; Lymphoma; Chromosomal translocation; Population; Biology; B cell; Medicine; Immunology; Gene; Genetics; Antibody","score_opus":0.022986455599602895,"score_gpt":0.27518189673542776,"score_spread":0.25219544113582487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100532497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969131,0.00039531622,0.00001124903,0.00013967551,0.000030366537,0.00044981838,0.000015357406,0.00002493289,0.0020202054],"genre_scores_gemma":[0.99937224,0.000074747026,0.0000779621,0.00008636805,0.000020673175,0.0001183512,0.00018831035,0.000010436599,0.000050887247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991042,0.00006814398,0.00034361667,0.00016570189,0.00012969918,0.00018860701],"domain_scores_gemma":[0.99964327,0.00001659101,0.00011549559,0.00011936438,0.000060892075,0.000044387423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007396405,0.00011317757,0.00029959506,0.0001415834,0.00005147186,0.0000018003493,0.00003776762,0.00011888234,0.00006364409],"category_scores_gemma":[0.00000752936,0.00009906295,0.000085456006,0.00011865313,0.00011052824,0.000060335726,0.0000047408084,0.000042440333,0.000013410728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071520725,0.029795026,0.8534724,0.00035758162,0.00013185125,0.008169108,0.042705838,0.000006432123,0.044267405,0.0009810199,0.0003841827,0.019013928],"study_design_scores_gemma":[0.019053541,0.001060505,0.9496297,0.00013930688,0.00005438851,0.0011791891,0.0001267886,0.00005329388,0.028486779,0.000048348735,0.00006945501,0.000098656565],"about_ca_topic_score_codex":0.000031105803,"about_ca_topic_score_gemma":0.000031286803,"teacher_disagreement_score":0.09615733,"about_ca_system_score_codex":0.00014656382,"about_ca_system_score_gemma":0.000081969265,"threshold_uncertainty_score":0.403967},"labels":[],"label_agreement":null},{"id":"W2100660242","doi":"10.3109/10428194.2012.711828","title":"Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Blastoid; Mantle cell lymphoma; Stage (stratigraphy); Internal medicine; Univariate analysis; Chemoradiotherapy; Radiation therapy; Lymphoma; Surgery; Oncology; Gastroenterology; Multivariate analysis","score_opus":0.013008611068373449,"score_gpt":0.24576594878896707,"score_spread":0.23275733772059362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100660242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634958,0.009838583,0.000012587955,0.0012579005,0.0012193386,0.0019349128,0.00022135198,0.00042616564,0.021593345],"genre_scores_gemma":[0.95868665,0.0034202,0.0003752286,0.0022961714,0.00070670596,0.00082486024,0.00039046502,0.000229696,0.033070028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993652,0.00023712227,0.0011815822,0.0014700621,0.0011824124,0.0022768471],"domain_scores_gemma":[0.99509054,0.0007222752,0.00057952775,0.0020431143,0.00016601082,0.0013985133],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00044519364,0.0016070544,0.0016912972,0.000306452,0.0011712549,0.0002587983,0.0005420597,0.0006905728,0.00044689974],"category_scores_gemma":[0.00008374054,0.0010216472,0.00090591284,0.0006007822,0.00066230434,0.00059412536,0.0006286972,0.00010641258,0.00096985034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008451599,0.005640209,0.8124231,0.00030964252,0.001347191,0.0010424528,0.0033360391,0.000014960616,0.00054438406,0.0016231986,0.013564421,0.15930925],"study_design_scores_gemma":[0.033543672,0.0010440705,0.6880203,0.00012971733,0.0011140226,0.0009118131,0.00092988135,0.00026220764,0.016753525,0.00003478019,0.256172,0.0010840576],"about_ca_topic_score_codex":0.0033049134,"about_ca_topic_score_gemma":0.00018647972,"teacher_disagreement_score":0.24260756,"about_ca_system_score_codex":0.02296672,"about_ca_system_score_gemma":0.0021268213,"threshold_uncertainty_score":0.999808},"labels":[],"label_agreement":null},{"id":"W2101109518","doi":"10.3109/10428194.2011.555888","title":"High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Provincia autonoma di Bolzano - Alto Adige","keywords":"Medicine; Lymphoma; Radiation therapy; Internal medicine; Modalities; Chemotherapy; Survival rate; Thyroid; Oncology; Diffuse large B-cell lymphoma; Surgery; Gastroenterology","score_opus":0.008709439332276173,"score_gpt":0.21736576793321233,"score_spread":0.20865632860093616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101109518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940607,0.00042396583,0.000013586219,0.000026485903,0.00028755088,0.0043914793,0.00040463926,0.00015127032,0.00024033718],"genre_scores_gemma":[0.99716276,0.0005572122,0.00027941263,0.00019366185,0.0000860829,0.00076769234,0.00042588497,0.0001950459,0.00033225166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934046,0.00081203756,0.0015512678,0.001964987,0.0011329466,0.0011341402],"domain_scores_gemma":[0.99631023,0.00047012835,0.00083644706,0.0012758621,0.00030896187,0.0007983546],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010489483,0.0015178908,0.0020742142,0.0007451208,0.00038314087,0.00022547193,0.00043151752,0.00034574297,0.00003041834],"category_scores_gemma":[0.000047707978,0.0011089554,0.00018331973,0.00045293235,0.0005491669,0.0009269897,0.00044663835,0.00010092236,0.0000046206037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07855922,0.05932483,0.81429964,0.00016742964,0.0016622826,0.0016978129,0.0098059205,0.0000018398837,0.00025107464,0.000065014916,0.0000065889267,0.034158316],"study_design_scores_gemma":[0.2708822,0.037779298,0.68352145,0.000226625,0.0010822098,0.00011880237,0.004145825,0.000091517446,0.0013349116,0.000015697799,0.000016039601,0.0007854194],"about_ca_topic_score_codex":0.009764229,"about_ca_topic_score_gemma":0.002119545,"teacher_disagreement_score":0.19232297,"about_ca_system_score_codex":0.0066881655,"about_ca_system_score_gemma":0.0015259354,"threshold_uncertainty_score":0.999757},"labels":[],"label_agreement":null},{"id":"W2101611242","doi":"10.1016/j.tripleo.2009.08.010","title":"Mantle cell lymphoma of the oral cavity: case series and comprehensive review of the literature","year":2009,"lang":"en","type":"review","venue":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Oral cavity; Lymphoma; Population; Presentation (obstetrics); Pathology; Dermatology; Radiology; Dentistry","score_opus":0.047759829537825434,"score_gpt":0.31951657145257495,"score_spread":0.2717567419147495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101611242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054997426,0.9366549,8.863663e-7,0.004656566,0.0014801945,0.0017639243,0.00023301893,0.000041070794,0.00017199283],"genre_scores_gemma":[0.018950531,0.97620004,0.00024430474,0.0035647026,0.00018051022,0.00012857048,0.0003014904,0.00006489231,0.00036496177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917511,0.0036792674,0.002109634,0.0011711874,0.0003280861,0.0009607345],"domain_scores_gemma":[0.9949824,0.0014210506,0.0016373578,0.0012728608,0.00035107596,0.00033521894],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012375974,0.0012731542,0.009316392,0.00036987758,0.00031379325,0.00001039336,0.0004017775,0.0015216848,0.000114927534],"category_scores_gemma":[0.00075205247,0.0006291059,0.0012974717,0.00090073585,0.004515801,0.0001334287,0.0004054563,0.0008958979,0.0000058722167],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056790747,0.0006542041,0.026209038,0.050080046,0.00097530085,0.020732805,0.00024558007,1.2554453e-7,0.00002394505,0.0004916734,0.02241246,0.8776069],"study_design_scores_gemma":[0.0036878793,0.00229865,0.013656817,0.042235736,0.008656417,0.34783497,0.00010604736,0.0000012354448,0.00003282182,0.0003064783,0.58051676,0.0006661876],"about_ca_topic_score_codex":0.00045763885,"about_ca_topic_score_gemma":0.00030819816,"teacher_disagreement_score":0.8769407,"about_ca_system_score_codex":0.0001474884,"about_ca_system_score_gemma":0.00051603053,"threshold_uncertainty_score":0.9997746},"labels":[],"label_agreement":null},{"id":"W2101740016","doi":"10.3109/10428194.2014.909039","title":"A single institution experience of extranodal natural killer/T cell lymphoma of nasal type","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; CHOP; Vincristine; Prednisone; Internal medicine; Lymphoma; Cyclophosphamide; Gastroenterology; Nasal cavity; Radiation therapy; Stage (stratigraphy); Chemotherapy; International Prognostic Index; B symptoms; Surgery; Oncology","score_opus":0.010408843332424539,"score_gpt":0.2336162705908109,"score_spread":0.22320742725838635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101740016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843151,0.003506922,0.00009397002,0.00007743917,0.0011887561,0.0006230093,0.000021260592,0.00015557473,0.0100179985],"genre_scores_gemma":[0.9958289,0.0005685803,0.0016277054,0.00046147135,0.00027099033,0.00007669592,0.000101297606,0.00008636005,0.0009779526],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957612,0.00015145288,0.0012694591,0.0010267146,0.0009342967,0.0008568702],"domain_scores_gemma":[0.99714625,0.00032370345,0.0006300157,0.0010212512,0.00036784672,0.00051093794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002947816,0.0007854341,0.0014218559,0.00039754598,0.000247345,0.000058918904,0.00037864488,0.0005031727,0.00007082957],"category_scores_gemma":[0.00020314484,0.000674663,0.00042792337,0.00080653676,0.00087166723,0.00038686962,0.00020950339,0.00008080451,0.00004188013],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006397238,0.006395471,0.097188,0.0020465157,0.00078477885,0.00055185903,0.007772066,0.00009915986,0.19990027,0.01063458,0.002727758,0.6655023],"study_design_scores_gemma":[0.059209675,0.0033570128,0.43298465,0.001119771,0.00075985026,0.0016181493,0.0010477023,0.005525375,0.4568088,0.0003060357,0.035932586,0.0013303688],"about_ca_topic_score_codex":0.0019212458,"about_ca_topic_score_gemma":0.000050472274,"teacher_disagreement_score":0.66417193,"about_ca_system_score_codex":0.003773706,"about_ca_system_score_gemma":0.0023950182,"threshold_uncertainty_score":0.9995704},"labels":[],"label_agreement":null},{"id":"W2101868054","doi":"10.1081/cnv-100103843","title":"Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"National Cancer Institute","keywords":"Vincristine; Medicine; Procarbazine; Etoposide; Dacarbazine; Prednisone; ABVD; Internal medicine; Vinblastine; Regimen; Cyclophosphamide; Surgery; Gastroenterology; Cohort; Chemotherapy; Oncology; Urology","score_opus":0.025525111102034332,"score_gpt":0.30861721996975455,"score_spread":0.28309210886772024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101868054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803874,0.010167559,0.00039385096,0.006433749,0.00029411848,0.0014664738,0.00019027079,0.000120470235,0.0005461284],"genre_scores_gemma":[0.98492885,0.0032781472,0.003092216,0.0030394893,0.00031725617,0.0014292572,0.00033303513,0.000046869216,0.003534883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986454,0.00002441422,0.00030459638,0.00048162616,0.00023208534,0.00031182836],"domain_scores_gemma":[0.9988126,0.000091743685,0.00014214253,0.00029765497,0.00016215802,0.0004937031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009614251,0.0002461912,0.00030515512,0.00007152997,0.00016813859,0.000042209853,0.000057587764,0.000081506594,0.000070246155],"category_scores_gemma":[0.0001724955,0.00021376077,0.00008224139,0.00019730357,0.00013255086,0.00019415682,0.000029329021,0.00007077291,0.000009509956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008967139,0.00018468029,0.93473625,0.0004711867,0.00013902353,0.00009376138,0.000270817,0.00031668908,0.0055331257,0.0026281986,0.0122108795,0.04251865],"study_design_scores_gemma":[0.006740797,0.0003478787,0.865709,0.00057647424,0.00048353578,0.000020226367,0.00008132681,0.0015326445,0.021581829,0.0016836156,0.10088148,0.0003611908],"about_ca_topic_score_codex":0.0004932831,"about_ca_topic_score_gemma":0.00012769391,"teacher_disagreement_score":0.088670604,"about_ca_system_score_codex":0.00037672598,"about_ca_system_score_gemma":0.000308072,"threshold_uncertainty_score":0.8716911},"labels":[],"label_agreement":null},{"id":"W2101924574","doi":"10.4021/jmc.v4i9.1432","title":"Hypercalcemia and Peripheral T-Cell Lymphoma-Type Lymphoproliferative Disorder Associated With Methotrexate in a Rheumatoid Arthritis Patient","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Discontinuation; Lymphoma; Lymph node biopsy; Peripheral T-cell lymphoma; Internal medicine; Lymphoproliferative disorders; Gastroenterology; Arthritis; Immunology; T cell; Immune system","score_opus":0.011636464896867817,"score_gpt":0.2532364171212439,"score_spread":0.24159995222437608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101924574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873928,0.009403242,0.000008314486,0.0025652978,0.0000978396,0.0002666694,0.000003997401,0.000010021656,0.0002518428],"genre_scores_gemma":[0.9915267,0.0070773265,0.00035114997,0.0009060891,0.000049950842,0.000025384354,0.000006770075,0.00001978726,0.00003680604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783075,0.00016248193,0.00058091804,0.00017850116,0.00097148574,0.0002758672],"domain_scores_gemma":[0.99836427,0.00046130217,0.00026307988,0.00010452304,0.0002959511,0.0005108529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030390226,0.00020618184,0.00064264314,0.000121190154,0.00005515091,0.000045119436,0.00006533413,0.0001585964,0.0007267309],"category_scores_gemma":[0.001050039,0.00012267541,0.000088002285,0.00019586628,0.0001441245,0.00015817488,0.000037745947,0.00016053506,0.00000773129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010244875,0.0056364313,0.6734567,0.000048290945,0.00041875607,0.01460618,0.0019427575,0.00001234851,0.00010204286,0.000028931896,0.0033728867,0.29935014],"study_design_scores_gemma":[0.075379156,0.014959382,0.86089647,0.0052380646,0.00022483227,0.031067949,0.0043577426,0.0013937891,0.0017122193,0.0001606973,0.0040212856,0.0005884059],"about_ca_topic_score_codex":0.0005597749,"about_ca_topic_score_gemma":0.00016690181,"teacher_disagreement_score":0.29876173,"about_ca_system_score_codex":0.00030268315,"about_ca_system_score_gemma":0.00058746675,"threshold_uncertainty_score":0.7957194},"labels":[],"label_agreement":null},{"id":"W2102184347","doi":"10.1200/jco.2008.16.4061","title":"Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Genentech; National Comprehensive Cancer Network; Biogen; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; American Society of Hematology","keywords":"Medicine; Concordance; Lymphoma; Medical diagnosis; Cancer; Follicular lymphoma; Etiology; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Internal medicine; Pathology","score_opus":0.2634506086962319,"score_gpt":0.5057099807041731,"score_spread":0.24225937200794118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102184347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703693,0.00051073625,0.000020233818,0.0016216158,0.00023999742,0.00026546296,0.0000042594265,0.0000016783805,0.00029905874],"genre_scores_gemma":[0.9944272,0.0003729331,0.0030142798,0.0017398355,0.00040440253,0.000020773117,0.0000031155616,0.000009874429,0.0000075714993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819714,0.00016987069,0.0011172998,0.00011427228,0.00025946856,0.00014195168],"domain_scores_gemma":[0.99549115,0.0028022334,0.0010023223,0.000059436363,0.00056816544,0.00007669329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060435745,0.00008796079,0.0009919483,0.00005195401,0.00003966697,0.0000018350901,0.000069630485,0.00014623112,0.000009380313],"category_scores_gemma":[0.00032643156,0.000046901554,0.00013013673,0.00007657403,0.00020828343,0.000036491387,0.000018523511,0.00016083832,6.49405e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043019215,0.0031090917,0.96590143,0.000016417007,0.00016573732,0.000109087516,0.00023538299,0.00017922194,0.0000016773998,0.000063178435,0.0070664356,0.01885042],"study_design_scores_gemma":[0.020639021,0.013701369,0.9519121,0.000099367244,0.00015558384,0.00019406601,0.00006484497,0.00014517864,0.000006793966,0.00007554933,0.012964343,0.00004179987],"about_ca_topic_score_codex":0.00001820447,"about_ca_topic_score_gemma":0.000047669724,"teacher_disagreement_score":0.01880862,"about_ca_system_score_codex":0.00011753006,"about_ca_system_score_gemma":0.00060682197,"threshold_uncertainty_score":0.19125898},"labels":[],"label_agreement":null},{"id":"W2102338972","doi":"","title":"[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Cytarabine; Etoposide; Vincristine; Vindesine; Anaplastic large-cell lymphoma; Internal medicine; Gastroenterology; Lymphoma; Regimen; Cyclophosphamide; Surgery; Mitoxantrone; Chemotherapy","score_opus":0.012273360993093894,"score_gpt":0.23907819924544724,"score_spread":0.22680483825235334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102338972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94111395,0.00003903015,0.00000133824,0.0002212752,0.000018279752,0.056657135,0.0000075298894,0.000029097384,0.0019123367],"genre_scores_gemma":[0.95292765,0.000011024719,0.000028162523,0.0002728126,0.00004770786,0.04660132,0.000011779823,0.00001225756,0.00008730798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988207,0.00003141432,0.00028795243,0.00030592555,0.00022698508,0.00032698852],"domain_scores_gemma":[0.99941,0.000034546443,0.00009253126,0.0002541743,0.00002340717,0.00018534978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009694598,0.00018019439,0.0003276789,0.00016551933,0.000022956341,0.000013175325,0.00006390806,0.000078526995,0.000004032668],"category_scores_gemma":[0.000060922834,0.00013900809,0.00006646296,0.00017521843,0.000031966047,0.00003826459,0.000019102948,0.000050169165,0.000006215383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028059576,0.010996776,0.5530758,0.00008940228,0.000053726355,0.00005146006,0.0000736618,0.000021100153,0.00003631259,0.00013961711,0.000434995,0.4322212],"study_design_scores_gemma":[0.032420546,0.000555737,0.96255475,0.00013283704,0.0000547255,0.000019325049,0.0000033434728,0.00003305238,0.0040006423,0.000028124447,0.00008600118,0.0001109371],"about_ca_topic_score_codex":0.00007300355,"about_ca_topic_score_gemma":0.0000067078804,"teacher_disagreement_score":0.43211025,"about_ca_system_score_codex":0.00017925396,"about_ca_system_score_gemma":0.000042419444,"threshold_uncertainty_score":0.56685853},"labels":[],"label_agreement":null},{"id":"W2102586314","doi":"10.1016/j.humpath.2010.10.011","title":"Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma","year":2011,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Kingston General Hospital; Vancouver General Hospital; Queen's University","funders":"Health Research Board","keywords":"Follicular lymphoma; Follicular phase; Biology; Differential (mechanical device); Lymphoma; Cell biology; Cell cycle; Expression (computer science); Computational biology; Cell; Immunology; Genetics; Computer science","score_opus":0.026547200224909154,"score_gpt":0.25186950674067243,"score_spread":0.2253223065157633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102586314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939817,0.0003287993,0.000060569295,0.000008842352,0.00007396722,0.00035331864,0.000014432028,0.0000303706,0.0051479824],"genre_scores_gemma":[0.99862283,0.000020049076,0.0010121185,0.00001573068,0.000044283865,0.00008501116,0.00003474457,0.000020581181,0.00014465826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989713,0.00007159231,0.00035656054,0.00025583373,0.00016127851,0.0001834449],"domain_scores_gemma":[0.99915695,0.000025659518,0.00022998049,0.00044163645,0.000074270865,0.000071475275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004945909,0.00016015477,0.00045502814,0.000094586256,0.000053996064,0.0000018528899,0.00008540839,0.00013096858,0.00033304503],"category_scores_gemma":[0.000015680807,0.00011776251,0.00016521377,0.000052464777,0.00019968192,0.000034653818,0.00007763985,0.00003119651,0.000007449785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027113777,0.00461693,0.24389513,0.0003612561,0.00006170552,0.0004589282,0.0011288712,2.956115e-7,0.7428968,0.0044173696,0.00023590872,0.0016556776],"study_design_scores_gemma":[0.0021040514,0.0005476774,0.5118609,0.00008198045,0.00010952048,0.0000405193,0.000038774902,0.0000019811885,0.48437357,0.0007538663,0.000027174301,0.000059962873],"about_ca_topic_score_codex":0.00007264401,"about_ca_topic_score_gemma":0.000014524127,"teacher_disagreement_score":0.26796582,"about_ca_system_score_codex":0.000033934404,"about_ca_system_score_gemma":0.000044044777,"threshold_uncertainty_score":0.48022157},"labels":[],"label_agreement":null},{"id":"W2103541791","doi":"10.1002/ajh.24082","title":"Gray zone lymphoma with features intermediate between classical<scp>H</scp>odgkin lymphoma and diffuse large<scp>B</scp>‐cell lymphoma:<scp>C</scp>haracteristics, outcomes, and prognostication among a large multicenter cohort","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Internal medicine; Rituximab; CHOP; Gastroenterology; Hazard ratio; Dacarbazine; Oncology; Lymphoma; Prednisone; Cyclophosphamide; Diffuse large B-cell lymphoma; B symptoms; Surgery; Chemotherapy; Confidence interval","score_opus":0.008092142052280111,"score_gpt":0.24796022870251758,"score_spread":0.23986808665023746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103541791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946191,0.0022677318,0.00063541764,0.0004995347,0.00034576707,0.0009997992,0.00014595698,0.00009262133,0.00039409014],"genre_scores_gemma":[0.9948434,0.0008536376,0.0021248613,0.0009984002,0.0003035583,0.00011882312,0.00018078343,0.00014371457,0.00043281727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948439,0.00045843146,0.0014969836,0.00091683,0.00093476137,0.0013490937],"domain_scores_gemma":[0.9909929,0.0038801194,0.002152301,0.0006778615,0.00068354135,0.0016132446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000739645,0.0009297663,0.0027529646,0.0005860889,0.00022587275,0.0001761284,0.0003847879,0.000355231,0.000003299261],"category_scores_gemma":[0.0030569527,0.000659662,0.00030303566,0.0004477491,0.0013092136,0.00037776923,0.0003006747,0.00031744284,0.000034474047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012906751,0.005421891,0.9757278,0.00014715434,0.0014361459,0.002165,0.0026356138,2.6634342e-7,0.00005757053,0.00015898845,0.006358864,0.0057616523],"study_design_scores_gemma":[0.033219475,0.003228954,0.93629354,0.00040985705,0.0020271663,0.00393076,0.005183771,0.00009512685,0.0016752782,0.00006025671,0.013727409,0.00014839166],"about_ca_topic_score_codex":0.00013423117,"about_ca_topic_score_gemma":0.00008266106,"teacher_disagreement_score":0.03943423,"about_ca_system_score_codex":0.00047235648,"about_ca_system_score_gemma":0.0005225204,"threshold_uncertainty_score":0.99958545},"labels":[],"label_agreement":null},{"id":"W2103610103","doi":"10.1182/asheducation-2011.1.323","title":"Late Effects in the Era of Modern Therapy for Hodgkin Lymphoma","year":2011,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Toxicity; Oncology; Internal medicine; Cumulative incidence; Clinical trial; Incidence (geometry); Disease; Surgery; Cohort","score_opus":0.05332880508712512,"score_gpt":0.3434117805923853,"score_spread":0.2900829755052602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103610103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013348901,0.9949412,0.000024638728,0.00009019792,0.00012969063,0.0029223599,0.000017257249,0.00001525194,0.000524566],"genre_scores_gemma":[0.0024355883,0.9946996,0.0003025285,0.00025801084,0.000042096934,0.0021060107,0.000079473415,0.000040110855,0.00003656028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998668,0.00019296863,0.00048241642,0.00030095226,0.00008796382,0.00026768324],"domain_scores_gemma":[0.99816906,0.0009879583,0.00026124853,0.00050886336,0.000032859247,0.000039986335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019224884,0.00031101424,0.0022558647,0.00010645395,0.000022822163,0.0000036791769,0.00017649167,0.00034955735,0.000021487658],"category_scores_gemma":[0.000046665242,0.00015809962,0.00052597385,0.00012638343,0.00006620932,0.000012697358,0.00002336621,0.000093874725,0.00002715499],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005908415,0.00084104453,0.00029883446,0.012330424,0.00033598632,0.00015357263,0.00027421652,1.5283621e-8,1.2516179e-7,0.007486134,0.00044438738,0.97777617],"study_design_scores_gemma":[0.0061527467,0.0009958348,0.00081870763,0.012079395,0.0011845115,0.0013899511,0.000005945632,0.000008629221,0.00006262006,0.0029844139,0.9740933,0.00022390338],"about_ca_topic_score_codex":0.000041003572,"about_ca_topic_score_gemma":0.000012010589,"teacher_disagreement_score":0.9775523,"about_ca_system_score_codex":0.00006233642,"about_ca_system_score_gemma":0.00023435825,"threshold_uncertainty_score":0.6447115},"labels":[],"label_agreement":null},{"id":"W2103651203","doi":"10.1182/blood-2012-06-439570","title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Defense Advanced Research Projects Agency; Canadian Institutes of Health Research; Pennsylvania State University; National Science Foundation","keywords":"Reed–Sternberg cell; CD68; Gene expression profiling; Biology; In situ hybridization; Gene signature; Lymphoma; Cancer research; Phenotype; Immunohistochemistry; Gene expression; Pathology; Comparative genomic hybridization; Internal medicine; Gene; Oncology; Immunology; Medicine; Hodgkin lymphoma; Genetics","score_opus":0.02070070896423385,"score_gpt":0.26157096943076646,"score_spread":0.24087026046653262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103651203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971749,0.0013309965,0.000011227728,0.00009072825,0.00011954271,0.0007399758,0.000026382102,0.000051532552,0.0004546979],"genre_scores_gemma":[0.99276984,0.000092375645,0.006459857,0.000037829508,0.000112545524,0.00014941946,0.0000733894,0.0000408186,0.00026391432],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838847,0.00007102223,0.00048460826,0.0003384437,0.0002636168,0.0004538235],"domain_scores_gemma":[0.9990125,0.0001225168,0.00017842789,0.0004136814,0.000050034905,0.00022286986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010545094,0.00030918172,0.00061169674,0.00014692335,0.00003969107,0.000011390773,0.00007241097,0.00015831314,0.000044587134],"category_scores_gemma":[0.000019993653,0.00019445956,0.00013001275,0.00020701159,0.0000614874,0.00008567434,0.00004221931,0.00006031848,0.000039527324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033458855,0.008428746,0.72663456,0.000048176666,0.00015289363,0.00015873734,0.00037672787,0.0000027092237,0.26225278,0.0000162526,0.000021348205,0.0015724746],"study_design_scores_gemma":[0.012393648,0.00088153046,0.34864968,0.00020121936,0.00035597023,0.00011768769,0.00008167625,0.000009525681,0.63710916,0.0000018367497,0.00006748408,0.00013054152],"about_ca_topic_score_codex":0.0001166065,"about_ca_topic_score_gemma":0.00002099216,"teacher_disagreement_score":0.37798488,"about_ca_system_score_codex":0.00022270164,"about_ca_system_score_gemma":0.00009452243,"threshold_uncertainty_score":0.79298306},"labels":[],"label_agreement":null},{"id":"W2103956236","doi":"10.3960/jslrt.52.91","title":"Germinal Center B-Cell-Like versus Non-Germinal Center B-Cell-Like as Important Prognostic Factor for Localized Nodal DLBCL","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical and Experimental Hematopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Saitama Medical University","keywords":"Germinal center; Univariate analysis; Medicine; Lymphoma; Internal medicine; Single Center; NODAL; Immunohistochemistry; Oncology; Diffuse large B-cell lymphoma; Multivariate analysis; Pathology; B cell; Immunology; Antibody","score_opus":0.04589997382105805,"score_gpt":0.39395416903683406,"score_spread":0.348054195215776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103956236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151665,0.0034975056,0.0000415536,0.0003481712,0.0031121017,0.00063074514,0.000049999027,0.000016380129,0.00078691513],"genre_scores_gemma":[0.99503964,0.00028333318,0.0020869598,0.0011413068,0.001020919,0.00006100526,0.000027392683,0.000045735338,0.00029369604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963843,0.00013280477,0.0019639547,0.00039568092,0.000412033,0.0007111989],"domain_scores_gemma":[0.997252,0.0005578885,0.0008583805,0.00025165128,0.00014575587,0.0009343338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006113531,0.00041581184,0.0013960524,0.000118322474,0.00012390986,0.000032426975,0.00014544894,0.0003350003,0.00027493289],"category_scores_gemma":[0.00011701177,0.00028611987,0.0008049988,0.00006470965,0.00032034153,0.00021310507,0.00012737235,0.0003622902,0.00006157823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01576794,0.027543517,0.9440565,0.00022924104,0.0002526408,0.0025754652,0.0008739831,1.3058691e-7,0.0036506332,0.00008275237,0.002988507,0.001978676],"study_design_scores_gemma":[0.32053468,0.05834636,0.3210793,0.0010556008,0.0023949533,0.054681018,0.004244754,0.0002335152,0.13991983,0.00010787706,0.09566323,0.0017388569],"about_ca_topic_score_codex":0.0000063585126,"about_ca_topic_score_gemma":9.513154e-7,"teacher_disagreement_score":0.6229772,"about_ca_system_score_codex":0.00009706734,"about_ca_system_score_gemma":0.00019033923,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2104277004","doi":"10.1007/s00428-004-1129-7","title":"CD10 expression in diffuse large B-cell lymphomas does not influence survival","year":2004,"lang":"en","type":"review","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vindesine; Vincristine; Diffuse large B-cell lymphoma; Cyclophosphamide; Lymphoma; International Prognostic Index; Prednisone; Internal medicine; Medicine; Immunohistochemistry; Oncology; Pathology; Chemotherapy","score_opus":0.04012967627677751,"score_gpt":0.3841470468649245,"score_spread":0.344017370588147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104277004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04520868,0.944542,0.000057138146,0.00030181458,0.0010038653,0.0034276468,0.0006499479,0.0004347178,0.0043742186],"genre_scores_gemma":[0.09019496,0.9033067,0.0019550927,0.0009101699,0.00055580365,0.000778757,0.0016190676,0.00022328958,0.00045612265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98943186,0.0015675778,0.0027419513,0.0028392118,0.0011945644,0.002224864],"domain_scores_gemma":[0.99167645,0.0031797506,0.0013855331,0.0027313228,0.00015771849,0.0008692017],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0016764741,0.0022596405,0.0064680646,0.001011052,0.00035645286,0.000089084686,0.001437208,0.0016669544,0.00010807399],"category_scores_gemma":[0.0016344113,0.0013011466,0.0016848813,0.0010527206,0.0011464976,0.00025982168,0.0012547066,0.002303095,0.00048599663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024759795,0.0667918,0.011557703,0.068690896,0.0035916488,0.028335886,0.002993665,0.000074973366,0.0040438226,0.0073619,0.0015892116,0.8024925],"study_design_scores_gemma":[0.062660255,0.003710258,0.014639065,0.07274974,0.0091272695,0.0002741736,0.00083545625,0.000052000596,0.00470301,0.0037459729,0.8229421,0.004560738],"about_ca_topic_score_codex":0.00032159482,"about_ca_topic_score_gemma":0.000071736045,"teacher_disagreement_score":0.82135284,"about_ca_system_score_codex":0.0008031485,"about_ca_system_score_gemma":0.0024466356,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W2104621581","doi":"10.1186/1748-717x-9-94","title":"Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma","year":2014,"lang":"en","type":"article","venue":"Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Ventricle; Radiology; Nuclear medicine; Lymphoma; Internal medicine","score_opus":0.011340492567839722,"score_gpt":0.29486373736569116,"score_spread":0.28352324479785146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104621581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780393,0.00021796033,0.017108364,0.00056277623,0.0003036445,0.0035316998,0.000068547364,0.000050473674,0.00011720904],"genre_scores_gemma":[0.9910577,0.00014912734,0.006126532,0.00044630922,0.00017413891,0.0013333163,0.0006519242,0.000031277174,0.000029707175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882865,0.00006997376,0.00037449514,0.00030353418,0.00018308159,0.00024028485],"domain_scores_gemma":[0.9982579,0.00058979704,0.00039927813,0.00020366891,0.00045195408,0.000097411656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030683327,0.00018275241,0.00052093534,0.000355246,0.00007917496,0.00000806657,0.00006347707,0.00018217877,0.000015444348],"category_scores_gemma":[0.00032651937,0.0001397195,0.0001127581,0.00027902744,0.0000533621,0.00008534986,0.000010327777,0.00003536651,0.0000026912753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031478994,0.0016076548,0.6551102,0.00006830268,0.00021076587,0.0000018993298,0.00028449946,0.000016989565,0.0016325815,0.00013632873,0.0006845272,0.3370984],"study_design_scores_gemma":[0.024099732,0.010873777,0.9152735,0.000038497194,0.00019388036,0.000020500815,0.00002124222,0.00093453034,0.037025232,0.00007741301,0.0112978,0.00014388472],"about_ca_topic_score_codex":0.00004375161,"about_ca_topic_score_gemma":0.000009255871,"teacher_disagreement_score":0.3369545,"about_ca_system_score_codex":0.0005294603,"about_ca_system_score_gemma":0.00018586367,"threshold_uncertainty_score":0.5697596},"labels":[],"label_agreement":null},{"id":"W2105261559","doi":"10.1093/intimm/dxu046","title":"Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface","year":2014,"lang":"en","type":"article","venue":"International Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Arthritis Research Centre of Canada; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CD20; Rituximab; Chemistry; Cell; Medicine; Immunology; Antibody; Biochemistry","score_opus":0.008346045337499414,"score_gpt":0.2424990008508643,"score_spread":0.23415295551336487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105261559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459226,0.00008439571,0.00009563149,0.0045150104,0.000107044856,0.00017915771,0.000014177914,0.0000057265147,0.010406623],"genre_scores_gemma":[0.9986564,0.000042822066,0.000083017876,0.0002816405,0.000029794179,0.000025502883,0.00002714986,0.0000073829083,0.00084630516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992591,0.00008231633,0.00015859432,0.00012175129,0.00027630822,0.00010191669],"domain_scores_gemma":[0.9989557,0.00045192463,0.00023265152,0.00018691702,0.000161087,0.000011680348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012277842,0.00009203011,0.00018001559,0.000019737694,0.000029496492,0.000005514842,0.00014316654,0.000043101296,0.00005238758],"category_scores_gemma":[0.000043683136,0.000046275523,0.00006404444,0.000039329105,0.00004418002,0.000017088887,0.00003194244,0.00008106328,0.00003507075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005204038,0.0055565173,0.031208264,0.000014962437,0.00077524246,0.0000031386883,0.00063738716,0.000036754747,0.9463587,0.011315509,0.0021231181,0.0014500427],"study_design_scores_gemma":[0.0026017914,0.0010666229,0.02773867,0.00003119301,0.000077587625,0.0000023799046,0.000074418625,0.00031669592,0.9665319,0.00014123974,0.0013727371,0.000044795197],"about_ca_topic_score_codex":0.00017212801,"about_ca_topic_score_gemma":0.0000058926867,"teacher_disagreement_score":0.020173209,"about_ca_system_score_codex":0.00015487618,"about_ca_system_score_gemma":0.00003373554,"threshold_uncertainty_score":0.1887061},"labels":[],"label_agreement":null},{"id":"W2105446438","doi":"10.1634/theoncologist.2013-0249","title":"Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphoma; Internal medicine; Radiation therapy; Confidence interval; Diffuse large B-cell lymphoma; Chemotherapy; Gastroenterology; International Prognostic Index; Surgery","score_opus":0.016547005499426972,"score_gpt":0.288071779150658,"score_spread":0.27152477365123107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105446438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407697,0.00007135316,0.0000020125049,0.0006483857,0.00011156205,0.0011307191,0.000051645166,0.000010650954,0.0038966914],"genre_scores_gemma":[0.9983332,0.00012599175,0.0001931851,0.00022029477,0.0000348218,0.00007263545,0.000018958139,0.000011130381,0.0009897427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987165,0.0002318112,0.00037718684,0.00019493341,0.00035183234,0.000127781],"domain_scores_gemma":[0.99863684,0.00023996431,0.0004186509,0.0005361802,0.00012687493,0.000041490995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052359357,0.00013156819,0.00034267805,0.00003211088,0.00008412332,0.0000115909825,0.00027152486,0.000053030188,0.000010312631],"category_scores_gemma":[0.00009009116,0.0000522391,0.000084982246,0.00011748742,0.0004784639,0.000050935472,0.00022588173,0.00006445269,8.574644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009569748,0.025957216,0.9616462,0.00005617509,0.0003511032,0.000005887521,0.00044484652,0.0000010748894,0.0000062724757,0.00083669764,0.00046418075,0.009273388],"study_design_scores_gemma":[0.017767478,0.00368607,0.9713962,0.00006077521,0.00046472868,0.0000032434261,0.0007621249,0.000020228794,0.00046601726,0.000021615057,0.0052979644,0.000053553347],"about_ca_topic_score_codex":0.00011286124,"about_ca_topic_score_gemma":0.0002504637,"teacher_disagreement_score":0.022271147,"about_ca_system_score_codex":0.00004225726,"about_ca_system_score_gemma":0.000030268606,"threshold_uncertainty_score":0.21302487},"labels":[],"label_agreement":null},{"id":"W2105786909","doi":"10.1038/ncomms6751","title":"A genome-wide association study of marginal zone lymphoma shows association to the HLA region","year":2015,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Center for Chronic Disease Prevention and Health Promotion; National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; Karolinska Institutet; Yale University; BC Cancer Agency; Cancer Council NSW; Medical Research Council; Institut National Du Cancer; University of Texas MD Anderson Cancer Center; Centers for Disease Control and Prevention; National Institutes of Health; Health Research Board; H. Lundbeck A/S; Dansk Kræftforsknings Fond; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; National Health and Medical Research Council; José Carreras Leukämie-Stiftung; University of Pittsburgh; Stockholms Läns Landsting; Canadian Institutes of Health Research; Bundesamt für Strahlenschutz; MedStar Health Research Institute; Cancerfonden; World Health Organization; University of Southern California; Division of Cancer Prevention, National Cancer Institute; University of Sydney; U.S. Department of Health and Human Services; University of California, San Francisco; Michael Smith Health Research BC; Fondation de France; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; National Institute on Aging; University at Buffalo; European Commission; Compagnia di San Paolo; U.S. Public Health Service; Associazione Italiana per la Ricerca sul Cancro; National Cancer Institute; Lundbeckfonden; State of Connecticut Department of Public Health; American Cancer Society; Ohio State University; Wake Forest University; National Human Genome Research Institute; Cancer Council Victoria; Brigham and Women's Hospital; Fondation ARC pour la Recherche sur le Cancer; Memorial Sloan-Kettering Cancer Center","keywords":"Genome-wide association study; Lymphoma; Human leukocyte antigen; Genetic association; Biology; Marginal zone; Marginal zone B-cell lymphoma; Genetics; Immunology; B cell; Genotype; Gene; Single-nucleotide polymorphism; Antigen","score_opus":0.036408566672685876,"score_gpt":0.3097156953413877,"score_spread":0.2733071286687018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105786909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92619336,0.0024932786,0.000025982543,0.06477238,0.00017628213,0.001414839,0.000021348942,0.00005685601,0.004845667],"genre_scores_gemma":[0.9952641,0.00018663242,0.0005890116,0.0016170306,0.000086728156,0.00026086,0.00010721806,0.000015179309,0.0018732322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842435,0.00031234062,0.00031050693,0.00017101664,0.0005956842,0.00018609839],"domain_scores_gemma":[0.99647266,0.0008248019,0.00034372884,0.0015090355,0.0007260653,0.00012370471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079359347,0.00012602602,0.0002653398,0.00010811215,0.00019275268,0.000030667783,0.00044805216,0.00022347427,0.000006257316],"category_scores_gemma":[0.0017452636,0.00009137863,0.00008502775,0.0004999689,0.000014686448,0.000068866975,0.00021443199,0.00025463421,0.000051086492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007002939,0.0027595502,0.9552444,0.000003852965,0.00032348078,0.000003391672,0.0029917504,0.000012711259,0.000025179486,0.00028091797,0.03676728,0.0015174549],"study_design_scores_gemma":[0.0026464644,0.00039066144,0.8504858,0.000021184724,0.0003260285,0.000003956702,0.0014784667,0.00003558028,0.00004607192,0.000026200823,0.14446501,0.00007459514],"about_ca_topic_score_codex":0.00026579495,"about_ca_topic_score_gemma":0.0024770133,"teacher_disagreement_score":0.10769773,"about_ca_system_score_codex":0.0023262654,"about_ca_system_score_gemma":0.00019337812,"threshold_uncertainty_score":0.60831034},"labels":[],"label_agreement":null},{"id":"W2105864650","doi":"10.1200/jco.2010.32.4079","title":"Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Fondation contre le Cancer; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Cohort; Hodgkin lymphoma; Breast cancer; Lymphoma; Oncology; Internal medicine; Radiation therapy; Cancer","score_opus":0.08516803699037885,"score_gpt":0.4012294280667831,"score_spread":0.31606139107640424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105864650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985701,0.00035669582,0.000029870962,0.00027777962,0.00022116027,0.00048134706,0.000024214478,0.0000016235936,0.000037235004],"genre_scores_gemma":[0.9973184,0.00084325566,0.0015051768,0.00018496042,0.000056144298,0.000054011503,8.5148866e-7,0.00000670235,0.000030524086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844563,0.0000904723,0.0011041794,0.000118136006,0.00014492344,0.0000966679],"domain_scores_gemma":[0.99797934,0.00038454932,0.001196186,0.00007710839,0.000230272,0.00013251427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010487151,0.00009568965,0.0013683712,0.00009583082,0.00000955826,0.00000110065,0.000035156907,0.00010544764,0.000019720113],"category_scores_gemma":[0.00031415568,0.000056325232,0.00006440844,0.00003257957,0.00022056242,0.00005874703,0.000015614078,0.00007158679,9.526357e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008104614,0.0071505923,0.90911496,0.00004765316,0.00076045096,0.000054537526,0.0012865424,3.6494194e-7,0.000012667032,0.000014474065,0.000025787389,0.07342735],"study_design_scores_gemma":[0.030255416,0.007389418,0.96092886,0.00007978704,0.0005713035,0.000115315925,0.00022937593,0.00003372748,0.0000072814537,0.000008730722,0.00033326473,0.00004754594],"about_ca_topic_score_codex":0.0002449563,"about_ca_topic_score_gemma":0.00012736041,"teacher_disagreement_score":0.07337981,"about_ca_system_score_codex":0.0005921381,"about_ca_system_score_gemma":0.0014523631,"threshold_uncertainty_score":0.25764298},"labels":[],"label_agreement":null},{"id":"W2106168795","doi":"10.1016/j.bbmt.2009.12.142","title":"The Impact Of Prior Exposure To Rituximab On Autologous Stem Cell Transplantation In Patients With Follicular And Transformed Lymphoma","year":2010,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Rituximab; Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Lymphoma; Internal medicine; CD20; Oncology; Transplantation; Chemotherapy; Retrospective cohort study; Gastroenterology; Surgery","score_opus":0.004083530348598413,"score_gpt":0.22107916086729534,"score_spread":0.21699563051869694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106168795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878424,0.00022185403,0.000015208921,0.00009214797,0.00002965315,0.0006584754,0.00012828918,0.000008006539,0.00006210331],"genre_scores_gemma":[0.9989047,0.00073683757,0.00017481111,0.00001754959,0.000006167616,0.0000371959,0.00011170535,0.000007559809,0.0000034736763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932355,0.000038758462,0.00023323113,0.00018051197,0.000083245395,0.00014072741],"domain_scores_gemma":[0.9996094,0.000118346405,0.000072227376,0.000092387476,0.000042862222,0.00006474409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009121611,0.00013459325,0.00027038058,0.00009111946,0.000048945625,0.0000043552463,0.000031706113,0.00011289635,0.0000020607315],"category_scores_gemma":[0.0000019785218,0.00007526707,0.000047633366,0.00007371543,0.00008955575,0.00003481923,0.0000012940968,0.000045647495,3.264994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054127458,0.0012773011,0.88486046,0.00025526976,0.00016073645,0.000019832712,0.0017148985,0.0000044326866,0.047198076,0.000118621174,0.0000012463237,0.058976397],"study_design_scores_gemma":[0.017579246,0.0053812917,0.8963552,0.00009207536,0.00033763013,0.000035794346,0.000036049638,0.0000030313774,0.08008785,0.00001585611,0.0000031845284,0.0000728068],"about_ca_topic_score_codex":0.00016271719,"about_ca_topic_score_gemma":0.00024247426,"teacher_disagreement_score":0.05890359,"about_ca_system_score_codex":0.000009420395,"about_ca_system_score_gemma":0.000051574796,"threshold_uncertainty_score":0.30693018},"labels":[],"label_agreement":null},{"id":"W2106198555","doi":"10.1158/1535-7163.mct-05-0146","title":"Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Lymphoma; Biology; Diffuse large B-cell lymphoma; Immune system; Tumor microenvironment; Immunology","score_opus":0.015815451971037616,"score_gpt":0.2625357891127456,"score_spread":0.246720337141708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106198555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659762,0.030084834,0.00015104002,0.000854395,0.00019102986,0.0010896645,0.0001363623,0.00008951342,0.0014269907],"genre_scores_gemma":[0.99240637,0.0011190877,0.000924581,0.0037576132,0.00018918588,0.00037756105,0.000054923454,0.00011628447,0.001054388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975742,0.00010034494,0.00048048366,0.00068507803,0.00047507987,0.00068479683],"domain_scores_gemma":[0.99905795,0.000043715256,0.00013851137,0.0004777251,0.00008180657,0.00020027797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014884496,0.0005050211,0.0005738303,0.00014617336,0.00013720721,0.00011367467,0.00017469011,0.00017475715,0.00013180175],"category_scores_gemma":[0.0000056299855,0.0004276122,0.0002189835,0.0002561058,0.00012129892,0.00011788212,0.000050961815,0.00013287168,0.000019362906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003288844,0.030113796,0.06582866,0.0010080641,0.00071694236,0.0019556405,0.0060326084,0.00007949699,0.7967112,0.0005457713,0.00030586685,0.093413085],"study_design_scores_gemma":[0.051406264,0.00032694047,0.04787453,0.00019883618,0.00052713754,0.000044878616,0.0005332744,0.0025587773,0.869771,0.000047294612,0.02601769,0.00069335126],"about_ca_topic_score_codex":0.00021451933,"about_ca_topic_score_gemma":0.00041315766,"teacher_disagreement_score":0.09271973,"about_ca_system_score_codex":0.00062194525,"about_ca_system_score_gemma":0.0002467542,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2106968573","doi":"10.1016/j.clbc.2012.07.006","title":"Treatment and Outcomes of Primary Breast Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Medicine; Breast cancer; Lymphoma; Stage (stratigraphy); Internal medicine; Univariate analysis; Chemotherapy; Surgery; Radiation therapy; Population; Aggressive lymphoma; Oncology; Cancer; Multivariate analysis; Rituximab","score_opus":0.04203916915508224,"score_gpt":0.36359237589206034,"score_spread":0.32155320673697807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106968573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913415,0.0021840374,0.000001254636,0.003922497,0.00035621194,0.00028249048,0.00024349395,0.00003068293,0.0016378417],"genre_scores_gemma":[0.9966001,0.0012837832,0.00017429556,0.0009609574,0.00042123123,0.00008965054,0.000019647325,0.000019293277,0.00043105247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987964,0.000044535824,0.0004723663,0.0002446957,0.00015431498,0.00028767227],"domain_scores_gemma":[0.99881524,0.00027861798,0.00013408599,0.00030378584,0.00006595034,0.00040233147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001325331,0.00019547515,0.0007363049,0.000036541795,0.000034044977,0.000006345801,0.00004060809,0.00011454757,0.00027965705],"category_scores_gemma":[0.00001852395,0.000119766984,0.0002519148,0.00007093108,0.0001847883,0.00008171733,0.00004651106,0.000034335837,0.000036451933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002409588,0.002395798,0.6583265,0.000025415502,0.0003680176,0.000007149116,0.00003401462,4.4240718e-8,0.000016116492,0.00014337669,0.00022329696,0.33821929],"study_design_scores_gemma":[0.0076857833,0.0002759199,0.98568976,0.000066632674,0.00057175354,0.00051120104,0.000020481893,0.0000028673337,0.00008829879,0.000009651669,0.004969286,0.00010836604],"about_ca_topic_score_codex":0.0004171056,"about_ca_topic_score_gemma":0.000009417059,"teacher_disagreement_score":0.33811092,"about_ca_system_score_codex":0.00030878145,"about_ca_system_score_gemma":0.00019472763,"threshold_uncertainty_score":0.4883956},"labels":[],"label_agreement":null},{"id":"W2107093204","doi":"10.1093/jncimonographs/lgu013","title":"Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"review","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":334,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Non-Hodgkin's lymphoma; Oncology; Pathology","score_opus":0.03891576270641639,"score_gpt":0.33489039068419324,"score_spread":0.29597462797777685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107093204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07746812,0.9105512,0.000057305853,0.000110274545,0.0015270334,0.0065850755,0.00023643032,0.0004161688,0.003048433],"genre_scores_gemma":[0.063937426,0.9284388,0.00037387456,0.0005943707,0.00095581106,0.0038866655,0.0010486897,0.0003187404,0.00044562714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99201703,0.00091183954,0.002227074,0.0022164215,0.000981033,0.001646627],"domain_scores_gemma":[0.99345136,0.0009744794,0.0016057389,0.0031186258,0.00030536018,0.0005444208],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013558705,0.0022527443,0.0053815125,0.0011401362,0.0005681377,0.0003280677,0.0013999343,0.0015660998,0.000094798284],"category_scores_gemma":[0.0002068482,0.001308477,0.0042326567,0.0018896632,0.0008440634,0.00021143135,0.00051207363,0.0004213704,0.0006686394],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001842793,0.0016153775,0.02981507,0.006360666,0.0030470851,0.00041315978,0.0003552209,7.13911e-7,0.0000014484806,0.00006141509,0.011490579,0.946655],"study_design_scores_gemma":[0.0046686972,0.0020005403,0.049305845,0.012002797,0.0062372754,0.00081361475,0.00014878198,0.00008197729,0.00007968674,0.0000559347,0.923025,0.0015798473],"about_ca_topic_score_codex":0.0015569191,"about_ca_topic_score_gemma":0.00039808569,"teacher_disagreement_score":0.94507515,"about_ca_system_score_codex":0.0011634766,"about_ca_system_score_gemma":0.001325918,"threshold_uncertainty_score":0.99973005},"labels":[],"label_agreement":null},{"id":"W2107886618","doi":"10.1002/hon.2048","title":"Successful treatment of non‐Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy","year":2013,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Thrombocytopenic purpura; Immune system; Chemotherapy; Radiation therapy; Immunology; Antibody; clone (Java method); Oncology; Internal medicine; Biology","score_opus":0.022743525150738575,"score_gpt":0.3064587636854287,"score_spread":0.2837152385346901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107886618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881282,0.0011885758,0.00005609021,0.004325492,0.00008307535,0.0012114636,0.0000043707496,0.0000741931,0.004928582],"genre_scores_gemma":[0.9946887,0.00078397465,0.0027059098,0.00095054973,0.000035818684,0.0005280031,0.0000389176,0.000020246149,0.00024790602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983523,0.00012493001,0.00053016364,0.00037714932,0.00020455441,0.0004108848],"domain_scores_gemma":[0.99833226,0.00067363295,0.00028550683,0.00037069406,0.00015149832,0.00018640226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000078653255,0.00030258435,0.001666303,0.00007686154,0.00006894839,0.000014344116,0.000117281976,0.0004015377,0.0018797592],"category_scores_gemma":[0.00006394623,0.00016604595,0.0002166281,0.00021289338,0.0001881867,0.00006530402,0.000029421075,0.000057190373,0.000094857496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013941836,0.016985256,0.903945,0.00006126908,0.0016513882,0.0013220415,0.00051401637,0.0000024200003,0.0077673043,0.00084578624,0.0022460895,0.063265204],"study_design_scores_gemma":[0.028347377,0.04009485,0.84359515,0.00013178989,0.00041216516,0.00053378806,0.000337535,0.00021850452,0.08061916,0.00019522526,0.0052062953,0.00030814574],"about_ca_topic_score_codex":0.0011511315,"about_ca_topic_score_gemma":0.00012551888,"teacher_disagreement_score":0.07285185,"about_ca_system_score_codex":0.00069964724,"about_ca_system_score_gemma":0.00025383334,"threshold_uncertainty_score":0.9990327},"labels":[],"label_agreement":null},{"id":"W2108233576","doi":"10.1111/bjh.13320","title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Surrey Memorial Hospital; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Medicine; Splenic marginal zone lymphoma; Splenectomy; Rituximab; Chemoimmunotherapy; Internal medicine; Gastroenterology; Hazard ratio; Chemotherapy; Lymphoma; Surgery; Confidence interval; Spleen","score_opus":0.014724133313153866,"score_gpt":0.25854078237018446,"score_spread":0.2438166490570306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108233576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662286,0.0026672995,0.000003120018,0.0001290311,0.00012743991,0.00021418514,0.00005784507,0.0000066376106,0.00017158934],"genre_scores_gemma":[0.9989767,0.0004153679,0.00025721983,0.000100602694,0.000013483087,0.000012316108,0.00005109089,0.00001585084,0.00015737428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764436,0.00017641002,0.0012381631,0.00021673806,0.0004001182,0.00032419528],"domain_scores_gemma":[0.99855757,0.00012604178,0.00053136685,0.00015243846,0.00040917148,0.0002233876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003593188,0.00012200484,0.0018969111,0.00052128395,0.000021606991,0.000047960322,0.00013190892,0.00015698787,0.00017535263],"category_scores_gemma":[0.00034104887,0.0001714965,0.0003347716,0.0008565812,0.00011022863,0.00012583238,0.000042533127,0.000115650364,0.000004715091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013611763,0.0038124998,0.9162403,0.00003242036,0.0010045297,0.06104972,0.00008914797,0.000010360556,0.0000016121273,0.0000033511303,0.0012574692,0.016362522],"study_design_scores_gemma":[0.019641753,0.00060523296,0.95025027,0.00044138083,0.0010923975,0.027470905,0.00014276252,0.000043688382,0.000021533016,0.00003570209,0.0001391226,0.00011523217],"about_ca_topic_score_codex":0.062434103,"about_ca_topic_score_gemma":0.2563383,"teacher_disagreement_score":0.1939042,"about_ca_system_score_codex":0.00047327747,"about_ca_system_score_gemma":0.0003030217,"threshold_uncertainty_score":0.9438092},"labels":[],"label_agreement":null},{"id":"W2108597878","doi":"10.1200/jco.2005.01.9083","title":"High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Transplantation; Incidence (geometry); Hematopoietic stem cell transplantation; Lymphoma; Radiation therapy; Surgery; Risk factor; Oncology; Gastroenterology","score_opus":0.035314203487995625,"score_gpt":0.3382631690742938,"score_spread":0.3029489655862982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108597878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930573,0.0029505873,0.00030120558,0.0012132757,0.0005891512,0.0014065561,0.00041836663,0.0000144931955,0.000049076],"genre_scores_gemma":[0.9885502,0.009049725,0.0015827105,0.0003568338,0.00012492639,0.000084975996,0.00014028621,0.000035103265,0.00007527877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951595,0.0008102997,0.0026652706,0.00037529785,0.00068595965,0.0003036474],"domain_scores_gemma":[0.9895565,0.0058986964,0.0035061184,0.00023715157,0.0005579642,0.00024357378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013960171,0.00036984542,0.0020057252,0.000140883,0.00014051642,0.00001803556,0.00020083397,0.00041522708,0.00012222164],"category_scores_gemma":[0.00003187018,0.00020173953,0.0006665924,0.0001128783,0.00048842555,0.00016481197,0.000010056547,0.00029550283,0.0000024381416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29800323,0.04947589,0.46856952,0.0006441952,0.004824236,0.00015475607,0.0034341002,0.00014668271,0.002169265,0.0004025047,0.0014225189,0.1707531],"study_design_scores_gemma":[0.2810098,0.0503134,0.6282729,0.00021326635,0.0020372234,0.0002497609,0.0005161575,0.0002069682,0.034544285,0.00015032054,0.0021531412,0.00033279636],"about_ca_topic_score_codex":0.00007762897,"about_ca_topic_score_gemma":0.00009417055,"teacher_disagreement_score":0.1704203,"about_ca_system_score_codex":0.00012949685,"about_ca_system_score_gemma":0.0007806439,"threshold_uncertainty_score":0.8226699},"labels":[],"label_agreement":null},{"id":"W2108969608","doi":"10.1182/asheducation-2011.1.317","title":"Positron Emission Tomography in the Management of Hodgkin Lymphoma","year":2011,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Positron emission tomography; Medicine; Lymphoma; Medical physics; Radiology; Hodgkin lymphoma; Nuclear medicine; Pathology","score_opus":0.04479901574241945,"score_gpt":0.3337582922261264,"score_spread":0.28895927648370695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108969608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003262211,0.98691887,0.000002441059,0.000056535762,0.00009640697,0.001179551,0.00000623083,0.00001551257,0.011398236],"genre_scores_gemma":[0.001268104,0.9976266,0.0004354881,0.00006862217,0.000017296787,0.00041341598,0.00007015549,0.000022958939,0.000077367586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985611,0.00016048092,0.0005712472,0.00031500775,0.0001448429,0.0002473312],"domain_scores_gemma":[0.99896693,0.000106394684,0.0002608848,0.00059447903,0.000018552495,0.000052735908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001718757,0.00029258124,0.0016307934,0.00027489863,0.000022984295,0.000003553708,0.0002082209,0.00026554434,0.00007141019],"category_scores_gemma":[0.0000038410185,0.00015478919,0.0004970675,0.00034996987,0.0000642302,0.000012251439,0.00007346718,0.000077444245,0.000046777666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026458169,0.0011836946,0.0013928969,0.025123842,0.00063321984,0.0010945795,0.00011247794,1.5990885e-9,4.074049e-8,0.01983417,0.0012229395,0.9493757],"study_design_scores_gemma":[0.0013685359,0.00025187884,0.0022474662,0.022901576,0.0027602783,0.002162482,0.00006162065,1.5839613e-7,0.000018254239,0.00022858103,0.96784705,0.00015214075],"about_ca_topic_score_codex":0.000043836222,"about_ca_topic_score_gemma":0.000002932597,"teacher_disagreement_score":0.9666241,"about_ca_system_score_codex":0.000074170355,"about_ca_system_score_gemma":0.00006855638,"threshold_uncertainty_score":0.631212},"labels":[],"label_agreement":null},{"id":"W2109283397","doi":"10.1093/annonc/mds340","title":"Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case–control studies","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of California, San Francisco; Blood Cancer UK; Associazione Italiana per la Ricerca sul Cancro; Ministry of Education, Culture, Sports, Science and Technology; Leukaemia and Lymphoma Research","keywords":"Medicine; Odds ratio; Internal medicine; Hormone therapy; Confidence interval; Menopause; Oncology; Lymphoma; Non-Hodgkin's lymphoma; Hormone replacement therapy (female-to-male); Breast cancer; Cancer","score_opus":0.07709461144010266,"score_gpt":0.3936857988991771,"score_spread":0.31659118745907444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109283397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94936943,0.04726334,0.000009549757,0.0020408004,0.000074970965,0.00032364213,0.00005058561,0.000010773553,0.00085692573],"genre_scores_gemma":[0.9912539,0.0069015943,0.00024187514,0.0014097955,0.000072778814,0.00006426042,0.000011669589,0.000012335075,0.000031804073],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987383,0.0001224453,0.00047570508,0.00019910462,0.00014897088,0.00031549373],"domain_scores_gemma":[0.99848396,0.00051700324,0.00028793258,0.00026466616,0.00028870875,0.00015775819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046253603,0.00018933896,0.0012751677,0.00037522125,0.00003858425,0.0000030853112,0.00004987389,0.00012412194,0.000033699114],"category_scores_gemma":[0.0000873508,0.00013301152,0.00020830869,0.00035915416,0.0002066683,0.000078722565,0.000042156837,0.000029882913,0.0000033310794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037484665,0.008995875,0.34015635,0.0000727608,0.06348195,0.0013940714,0.0065988703,0.000006717079,0.00756585,0.0004017568,0.0022858195,0.5652915],"study_design_scores_gemma":[0.013538508,0.014442884,0.95519626,0.000030320458,0.008882697,0.00073691184,0.0012949604,0.00019662299,0.0039445227,0.000043126838,0.0015450397,0.00014817079],"about_ca_topic_score_codex":0.00037072942,"about_ca_topic_score_gemma":0.0000511374,"teacher_disagreement_score":0.6150399,"about_ca_system_score_codex":0.000078156605,"about_ca_system_score_gemma":0.00009513667,"threshold_uncertainty_score":0.54240525},"labels":[],"label_agreement":null},{"id":"W2109363414","doi":"10.1111/j.1365-2141.2009.07859.x","title":"Multiple isoforms of <i>PAX5</i> are expressed in both lymphomas and normal B‐cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Atlantic Cancer Research Institute; Dr. Georges-L.-Dumont University Hospital Centre; Université de Moncton; Fisheries and Oceans Canada","funders":"Canadian Institutes of Health Research","keywords":"Gene isoform; PAX5; B cell; Biology; Alternative splicing; Gene expression; Molecular biology; RNA splicing; Transcription factor; Gene; Lymphoma; Antibody; RNA; Genetics; Immunology","score_opus":0.007966033997693042,"score_gpt":0.22840499862092944,"score_spread":0.2204389646232364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109363414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158704,0.0071084886,0.00001802774,0.00069151906,0.00009333578,0.00014067847,0.000014409519,0.0000057915786,0.00034069575],"genre_scores_gemma":[0.996014,0.002450283,0.001003105,0.0004459234,0.000038555667,0.0000027712463,0.0000026612815,0.000008681933,0.000033991797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880296,0.000043385386,0.0006213854,0.00012890814,0.00017369118,0.00022969977],"domain_scores_gemma":[0.99916154,0.00010671731,0.000394306,0.00010197178,0.000100091755,0.00013536318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015932141,0.000114472154,0.0007830236,0.00013859897,0.000029785971,0.000013932221,0.00007458504,0.00010939895,0.000033956596],"category_scores_gemma":[0.000096370044,0.000094068295,0.00011543927,0.00008996934,0.00008252108,0.00012225965,0.000020597412,0.000107100794,0.000002097824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011510486,0.0036949534,0.6911224,0.00033015962,0.00024999387,0.15673442,0.00070321537,0.00002530451,0.0091479905,0.00020374029,0.0068553616,0.12978137],"study_design_scores_gemma":[0.015391258,0.0009907028,0.7513172,0.0013981134,0.000115576186,0.1907217,0.00029331018,0.000045262623,0.03802481,0.0003576222,0.0012065523,0.00013791396],"about_ca_topic_score_codex":0.00012706376,"about_ca_topic_score_gemma":0.00010386781,"teacher_disagreement_score":0.12964346,"about_ca_system_score_codex":0.0000606682,"about_ca_system_score_gemma":0.00012417391,"threshold_uncertainty_score":0.38359937},"labels":[],"label_agreement":null},{"id":"W2109391427","doi":"10.1093/aje/kwh234","title":"Antidepressant Medication Use and Non-Hodgkin's Lymphoma Risk: No Association","year":2004,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Odds ratio; Lymphoma; Internal medicine; Antidepressant; Population; Tricyclic antidepressant; Logistic regression; Non-Hodgkin's lymphoma; Cancer; Oncology; Environmental health","score_opus":0.019524678690598537,"score_gpt":0.30650934304342753,"score_spread":0.286984664352829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109391427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087906,0.0006559556,0.0015131116,0.0064541255,0.00023662296,0.00010821677,0.0000073303713,0.000009605605,0.00013594824],"genre_scores_gemma":[0.9773417,0.007311041,0.012757432,0.0022526586,0.00028821736,0.00000565635,0.000007862504,0.000011933226,0.00002349287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982442,0.0003947274,0.0007256468,0.0001880468,0.00017302317,0.0002743534],"domain_scores_gemma":[0.994953,0.0024517511,0.001862757,0.00018151743,0.00028734226,0.00026367663],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0018629163,0.00013731868,0.00083787605,0.00013078726,0.00006135338,0.0000073449273,0.000062975814,0.00008347607,0.000017919518],"category_scores_gemma":[0.008982472,0.00009530496,0.00015155545,0.00011745452,0.00020607098,0.00013856943,0.000023190578,0.0001316307,0.000022353615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019500912,0.00023886916,0.95700455,0.000005188783,0.00036494652,0.00007054741,0.00010436303,0.00004042459,0.00009312376,0.00013409926,0.0017610472,0.039987843],"study_design_scores_gemma":[0.003625144,0.0021034991,0.98762643,0.00010340344,0.00035797895,0.0005135494,0.000061659084,0.00005336689,0.00016706855,0.0005467417,0.00476222,0.00007892978],"about_ca_topic_score_codex":0.0013275426,"about_ca_topic_score_gemma":0.000014379233,"teacher_disagreement_score":0.039908916,"about_ca_system_score_codex":0.0005111633,"about_ca_system_score_gemma":0.00018997226,"threshold_uncertainty_score":0.99936527},"labels":[],"label_agreement":null},{"id":"W2109658051","doi":"10.1093/jnci/djr450","title":"Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis","year":2011,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Autologous stem-cell transplantation; Follicular lymphoma; Transplantation; Clinical trial; Adverse effect; Randomized controlled trial; Meta-analysis; Surgery; Confidence interval; Lymphoma","score_opus":0.14056570236552943,"score_gpt":0.37188435136547027,"score_spread":0.23131864899994084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109658051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024739446,0.9975538,0.000008060464,0.00031050347,0.00018791528,0.0015217989,0.00016285531,0.000004016702,0.00022626959],"genre_scores_gemma":[0.00072437286,0.9977214,0.00008699553,0.00066769944,0.000062189705,0.00038635035,0.000018624367,0.000015333895,0.00031707945],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971191,0.00029237292,0.0015301051,0.00021771157,0.0007048457,0.00013582195],"domain_scores_gemma":[0.9973239,0.00013201514,0.0018638326,0.00019382189,0.0003925357,0.00009395358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000775987,0.00033769212,0.0051335245,0.00045276457,0.00005803362,0.000021354428,0.00023941405,0.00015183439,0.000049032347],"category_scores_gemma":[0.00004576546,0.00015881669,0.0029480387,0.00079698104,0.000049566577,0.00014138968,0.00002329259,0.00017124288,0.0000049157015],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019138542,0.00032946543,0.00002945385,0.83322346,0.15967871,0.00022448509,0.00010265772,0.000028117183,5.6748345e-8,0.00026910342,0.00033776052,0.0057576085],"study_design_scores_gemma":[0.000688832,0.000038909282,0.00016133125,0.049289398,0.90780324,0.0014025347,0.0000021495691,0.0000016746685,0.0000022681102,0.000017397986,0.040454857,0.00013739681],"about_ca_topic_score_codex":0.000085278625,"about_ca_topic_score_gemma":0.000098034354,"teacher_disagreement_score":0.78393406,"about_ca_system_score_codex":0.0009974793,"about_ca_system_score_gemma":0.0012321281,"threshold_uncertainty_score":0.6476357},"labels":[],"label_agreement":null},{"id":"W2109763190","doi":"10.1093/aje/kwp383","title":"Tumor Necrosis Factor (TNF) and Lymphotoxin-  (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium","year":2010,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Cancer Council NSW; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Simon Fraser University; Dublin City University; José Carreras Leukämie-Stiftung; School of Medicine, University of California, San Francisco; University of Southern California; Purdue University; University of Sydney; Compagnia di San Paolo; European Commission; National Health and Medical Research Council; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Michael Smith Health Research BC; University of California, San Francisco; Bundesamt für Strahlenschutz; Barbara Ann Karmanos Cancer Institute; Deutsches Krebsforschungszentrum; Università degli Studi di Cagliari; Health Research Board; School of Medicine, Wayne State University; Yale University; Wayne State University; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona","keywords":"Odds ratio; Lymphotoxin alpha; Medicine; Immunology; Internal medicine; Haplotype; Lymphoma; Oncology; Tumor necrosis factor alpha; Gastroenterology; Lymphotoxin; Biology; Allele; Genetics","score_opus":0.016068492905008943,"score_gpt":0.2999633763887836,"score_spread":0.2838948834837747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109763190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609774,0.00086966157,0.000061999024,0.002421286,0.00019434476,0.000197553,0.000030659827,0.0000043183677,0.00012240547],"genre_scores_gemma":[0.9928786,0.0016732271,0.0030872398,0.0022129745,0.00010656762,0.000013918517,0.0000022491945,0.000016556718,0.000008669305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975158,0.0006420917,0.0010782607,0.00025991467,0.00014413771,0.00035981485],"domain_scores_gemma":[0.9937404,0.004140366,0.0014428815,0.00031887105,0.00010646522,0.0002510241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017533165,0.00023637341,0.0013572568,0.00024205228,0.000052529977,0.000008440947,0.00017476798,0.000081945494,0.0000579581],"category_scores_gemma":[0.0021521999,0.00013575329,0.00019675418,0.00020364202,0.0013554674,0.000070402595,0.00005267392,0.00022190211,0.0000023710431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004319657,0.00030542145,0.8758694,0.000011048466,0.00023436679,0.00013503848,0.00068922574,6.212473e-7,0.0030742085,0.00015536566,0.00023588823,0.11885745],"study_design_scores_gemma":[0.003855596,0.0029162148,0.9855534,0.00009107244,0.00026363993,0.0038838745,0.0007018095,0.000104736915,0.0014731701,0.00033991964,0.00070163555,0.00011491734],"about_ca_topic_score_codex":0.0035240897,"about_ca_topic_score_gemma":0.0001718234,"teacher_disagreement_score":0.11874253,"about_ca_system_score_codex":0.00007265922,"about_ca_system_score_gemma":0.00019548202,"threshold_uncertainty_score":0.5535858},"labels":[],"label_agreement":null},{"id":"W2110105488","doi":"10.1093/hmg/ddh195","title":"Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes","year":2004,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Genome British Columbia; Genome Canada; Lymphoma Research Foundation","keywords":"Comparative genomic hybridization; Biology; Mantle cell lymphoma; Genome; Genetics; Copy number analysis; Copy-number variation; Gene expression profiling; Gene duplication; Microarray; Gene dosage; Computational biology; Lymphoma; Gene; Gene expression","score_opus":0.022822319877659723,"score_gpt":0.26478665580737215,"score_spread":0.24196433592971242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110105488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834907,0.008863298,0.0035737343,0.00008230627,0.00003368273,0.000569283,0.00004161719,0.000036939775,0.0033084052],"genre_scores_gemma":[0.97025126,0.00028272378,0.02867242,0.00035051885,0.00004261734,0.000036399233,0.00015775615,0.000055696197,0.00015060337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986095,0.000020056726,0.00035647576,0.00036105642,0.00033130037,0.00032163362],"domain_scores_gemma":[0.9989772,0.000008603251,0.00012778427,0.00055497524,0.00016915731,0.00016227733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034800323,0.00025400042,0.0003982338,0.00010999999,0.00008833235,0.000017935716,0.00013206557,0.00010470738,0.000017604054],"category_scores_gemma":[0.0000025729148,0.00023952164,0.00019933109,0.00011052651,0.000102266466,0.000018353014,0.000064154374,0.000052296273,0.00005408324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002205733,0.0010449591,0.0015488747,0.00016943844,0.0001367879,0.00020256206,0.00040081327,0.018039105,0.97731566,0.0006773324,0.000012322748,0.00043009693],"study_design_scores_gemma":[0.0069564357,0.00060938596,0.023955937,0.00006763389,0.00033683525,0.000045823297,0.0001575597,0.00044111893,0.96411705,0.0018834636,0.0011321703,0.00029660895],"about_ca_topic_score_codex":0.000018494902,"about_ca_topic_score_gemma":0.0000018740836,"teacher_disagreement_score":0.025098685,"about_ca_system_score_codex":0.0001858004,"about_ca_system_score_gemma":0.00018858428,"threshold_uncertainty_score":0.9767409},"labels":[],"label_agreement":null},{"id":"W2110636137","doi":"10.1093/annonc/mdn195","title":"Radiotherapy in non-Hodgkin lymphomas","year":2008,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Radiation therapy; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine","score_opus":0.1490769391752207,"score_gpt":0.464937773801715,"score_spread":0.31586083462649434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110636137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021289407,0.98424375,9.426254e-7,0.0008678624,0.0001961027,0.00091870624,0.00002049448,0.000015111708,0.013524145],"genre_scores_gemma":[0.0001238215,0.9976407,0.00038722108,0.0008823313,0.00021872576,0.0002502919,0.000084192536,0.000046978123,0.00036568398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980715,0.0001643121,0.00084690365,0.00037998907,0.00017754501,0.00035977527],"domain_scores_gemma":[0.9985295,0.000384674,0.0004343195,0.00043765223,0.00007833892,0.0001355008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017339474,0.00036612965,0.0035560504,0.00042318544,0.000020481553,0.0000028237828,0.00015250836,0.00061745296,0.00017895106],"category_scores_gemma":[0.000048935402,0.00026615142,0.00076011557,0.0003376378,0.00012864808,0.000026220314,0.000035651632,0.00015680109,0.000077860495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055171673,0.0017124127,0.0003486699,0.0021591221,0.00050955475,0.0014341451,0.00008702837,1.681027e-7,2.62974e-7,0.00009540692,0.01859096,0.9750071],"study_design_scores_gemma":[0.0026811946,0.0027709426,0.0009843153,0.004701475,0.00021938892,0.0011677925,0.000004922104,0.000001217867,0.000010173327,0.000020881998,0.9872624,0.00017527076],"about_ca_topic_score_codex":0.00019325681,"about_ca_topic_score_gemma":0.000023460238,"teacher_disagreement_score":0.9748318,"about_ca_system_score_codex":0.00042001097,"about_ca_system_score_gemma":0.0014950079,"threshold_uncertainty_score":0.9999791},"labels":[],"label_agreement":null},{"id":"W2110859080","doi":"10.1634/theoncologist.2012-0228","title":"The Case for Chemotherapy Alone for Limited-Stage Hodgkin's Lymphoma","year":2012,"lang":"en","type":"article","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Chemotherapy; Stage (stratigraphy); Oncology; Disease; Radiation therapy; Internal medicine","score_opus":0.052371290433459845,"score_gpt":0.3465056750231264,"score_spread":0.29413438458966656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110859080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455801,0.003891815,0.00049489905,0.040701646,0.00075959164,0.004245403,0.00013251131,0.00012040249,0.0040735793],"genre_scores_gemma":[0.98768723,0.00038302373,0.001343102,0.0032105306,0.00076522696,0.0016752452,0.000029886842,0.000027529017,0.0048782052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901974,0.000042928496,0.00020342751,0.0001628814,0.000097528005,0.00047347],"domain_scores_gemma":[0.99777496,0.001430638,0.00011898251,0.0004780855,0.0000766172,0.000120691235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067331083,0.00016969723,0.00026864506,0.000018709625,0.00057206897,0.000038788443,0.00013213484,0.00009218223,0.000022853415],"category_scores_gemma":[0.00019854371,0.000076251075,0.00021038952,0.000077271514,0.00018317265,0.00004393159,0.00003116278,0.000034966855,0.000027436541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032607159,0.003447182,0.0126077635,0.00009973048,0.00079086935,0.00028775967,0.0011002279,0.0000035691264,0.00039372183,0.016807638,0.16527295,0.7959279],"study_design_scores_gemma":[0.010464717,0.0014709467,0.016010007,0.000015691043,0.00033823657,0.00091475225,0.0009454235,0.00019610755,0.005345615,0.0002659189,0.9638876,0.00014503933],"about_ca_topic_score_codex":0.00018348338,"about_ca_topic_score_gemma":0.00013566256,"teacher_disagreement_score":0.7986146,"about_ca_system_score_codex":0.00034796906,"about_ca_system_score_gemma":0.000098694036,"threshold_uncertainty_score":0.43999496},"labels":[],"label_agreement":null},{"id":"W2111128439","doi":"10.3109/10428194.2013.816700","title":"Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Vincristine; Gastroenterology; Bevacizumab; Neutropenia; Regimen; CHOP; Prednisone; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.00647058112068715,"score_gpt":0.23524904892706575,"score_spread":0.2287784678063786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111128439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920238,0.0015286847,0.000027793512,0.00015272264,0.00028914202,0.0054059234,0.000037238926,0.00010998638,0.0004246867],"genre_scores_gemma":[0.9936095,0.0004089673,0.0017433105,0.0006814257,0.00009531141,0.0014621214,0.00040547855,0.00012274325,0.0014711267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960437,0.00022245945,0.000893763,0.0014222057,0.0005234122,0.0008944564],"domain_scores_gemma":[0.9976847,0.00044115345,0.00036465627,0.0005193687,0.0003715063,0.0006185851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022712092,0.00092724065,0.0013477912,0.0002608271,0.00042660622,0.00025658487,0.00017841735,0.0003998841,0.00005322376],"category_scores_gemma":[0.00006397692,0.0006600992,0.00008546508,0.000367801,0.00041052277,0.00078075373,0.00019693315,0.00014850966,0.000010699999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0116460975,0.01083236,0.7800323,0.00043272617,0.0003629741,0.00038338854,0.0077070594,0.000019096124,0.0004029745,0.00013090784,0.0007720635,0.18727809],"study_design_scores_gemma":[0.16515748,0.02417139,0.79143345,0.00021982394,0.00048144287,0.0002462717,0.004141957,0.0109531265,0.00073038886,0.00006901677,0.0015442792,0.00085138524],"about_ca_topic_score_codex":0.005102743,"about_ca_topic_score_gemma":0.0015681837,"teacher_disagreement_score":0.1864267,"about_ca_system_score_codex":0.005039828,"about_ca_system_score_gemma":0.001359726,"threshold_uncertainty_score":0.99958503},"labels":[],"label_agreement":null},{"id":"W2111203514","doi":"10.1093/jncimonographs/lgu006","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Follicular Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Medicine; Family history; Odds ratio; Lymphoma; Hay fever; Internal medicine; Follicular lymphoma; Risk factor; Confidence interval; Atopy; Asthma","score_opus":0.02153529836997574,"score_gpt":0.26326963230742495,"score_spread":0.2417343339374492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111203514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898541,0.005372298,0.00063593005,0.0003701882,0.0010327501,0.0012955475,0.00005796218,0.00012980669,0.0012514082],"genre_scores_gemma":[0.99540824,0.00070219144,0.0008643643,0.0013944365,0.00036176294,0.0006844774,0.0001822571,0.00006485142,0.00033739532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739826,0.00016277024,0.0005352663,0.0006634409,0.00074672047,0.00049357105],"domain_scores_gemma":[0.997857,0.0007110142,0.0002982364,0.00060950435,0.00016715101,0.0003571294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006611207,0.0004616678,0.0006263184,0.00032124002,0.00022285516,0.000031350846,0.0002621073,0.00029659425,0.000060979288],"category_scores_gemma":[0.0005093633,0.00029306757,0.0005155249,0.00017748182,0.00040901915,0.00012105025,0.00008059059,0.0000834283,0.000016507314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059732434,0.0014827553,0.767329,0.000118876895,0.0008206726,0.00004073448,0.0023106316,9.256063e-7,0.00005373324,0.0011300307,0.15474571,0.071369626],"study_design_scores_gemma":[0.0063183745,0.00081014517,0.63399166,0.00008158321,0.00046036788,0.00005060649,0.00021079622,0.001490571,0.000094837655,0.000072517316,0.35615546,0.00026309103],"about_ca_topic_score_codex":0.0028553882,"about_ca_topic_score_gemma":0.00015068852,"teacher_disagreement_score":0.20140974,"about_ca_system_score_codex":0.0013267777,"about_ca_system_score_gemma":0.00096559623,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W2111500154","doi":"10.1084/jem.20031074","title":"Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma","year":2003,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Pathology; Gene expression profiling; Cancer research; Biology; B cell; Medicine; Gene; Immunology; Gene expression; Antibody; Genetics","score_opus":0.01464565170772613,"score_gpt":0.28286176159878756,"score_spread":0.2682161098910614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111500154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97161734,0.02171748,0.000067575675,0.00072799035,0.0007003494,0.0007681458,0.000022575272,0.000020664951,0.0043578614],"genre_scores_gemma":[0.99551505,0.0020834547,0.00083807454,0.001070922,0.00012267921,0.00004782186,0.000016966467,0.00007825682,0.0002267533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99420005,0.00055284763,0.0026383763,0.00038033415,0.0016131893,0.00061522605],"domain_scores_gemma":[0.99526775,0.0011197552,0.0017163346,0.0007892423,0.00046431954,0.00064260757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020561104,0.00054450735,0.0018068262,0.0004368787,0.0001272604,0.000014102206,0.0005270763,0.00021003859,0.00034134698],"category_scores_gemma":[0.0006022076,0.00034241023,0.0005163912,0.0006990786,0.00048976555,0.00016653602,0.00016924887,0.00013733098,0.000025071808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066362177,0.07487344,0.07144474,0.000580303,0.0013863713,0.0021993387,0.014733333,0.000022428878,0.8137569,0.0005276878,0.008104649,0.0057346136],"study_design_scores_gemma":[0.06579069,0.009910859,0.031630956,0.0013972239,0.0012306205,0.00097417855,0.0057773124,0.000014782798,0.88184106,0.00010590593,0.0010324505,0.00029396996],"about_ca_topic_score_codex":0.00016853043,"about_ca_topic_score_gemma":0.0000032863384,"teacher_disagreement_score":0.06808418,"about_ca_system_score_codex":0.00060461153,"about_ca_system_score_gemma":0.0005191726,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2111827890","doi":"10.1056/nejmoa1301077","title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":341,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Calgary; Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Autologous stem-cell transplantation; Transplantation; Rituximab; Internal medicine; Vincristine; Induction chemotherapy; Prednisone; Surgery; International Prognostic Index; CHOP; Cyclophosphamide; Chemotherapy; Lymphoma; Oncology; Gastroenterology; Confidence interval","score_opus":0.013743852271562669,"score_gpt":0.28909332990883585,"score_spread":0.2753494776372732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111827890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762121,0.001170457,0.0020824848,0.017391058,0.0006508428,0.0006151444,0.000004390259,0.000014296793,0.0018592688],"genre_scores_gemma":[0.993421,0.0012143406,0.0016310448,0.0011441606,0.0021350924,0.000023239621,0.000045020173,0.000014994483,0.00037108883],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988454,0.00003592485,0.0004916717,0.00012276166,0.00032436594,0.00017988845],"domain_scores_gemma":[0.99827904,0.0003853323,0.0005360073,0.00011033682,0.0003873117,0.00030196906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002523986,0.00015103989,0.0004730393,0.00017234846,0.000054164706,0.000012756941,0.00006298498,0.00007943772,0.00036464256],"category_scores_gemma":[0.00032286625,0.00009037432,0.000100429286,0.00008693628,0.00006544928,0.00012970761,0.0000038143633,0.00006502755,0.000028896879],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020283943,0.00030542866,0.011251021,0.00012666773,0.00039555546,0.0009477509,0.0022627672,0.0000140049015,0.0042346166,0.00030870494,0.033856258,0.9442688],"study_design_scores_gemma":[0.4465377,0.020282436,0.4105667,0.0031418744,0.0028916663,0.033629034,0.0007531947,0.00048719294,0.025817456,0.0051406627,0.050410468,0.00034162126],"about_ca_topic_score_codex":0.00027320103,"about_ca_topic_score_gemma":0.000009702155,"teacher_disagreement_score":0.9439272,"about_ca_system_score_codex":0.00010001205,"about_ca_system_score_gemma":0.00028742573,"threshold_uncertainty_score":0.39925802},"labels":[],"label_agreement":null},{"id":"W2112387181","doi":"10.1200/jco.2003.06.085","title":"Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; MALT lymphoma; Lymphoma; Mucosa-associated lymphoid tissue; Gastroenterology; Stage (stratigraphy); Internal medicine; Radiation therapy; Thyroid; Lymphatic system; Stomach; Thyroid lymphoma; Chemotherapy; Surgery; Pathology; Thyroiditis","score_opus":0.1762809649238636,"score_gpt":0.462614739162051,"score_spread":0.2863337742381874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112387181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803526,0.0019857648,0.00010037858,0.005216419,0.0012851135,0.00057260186,0.0000055602204,0.000038231727,0.0027606813],"genre_scores_gemma":[0.98728704,0.0054436126,0.0014889431,0.00450947,0.00062419963,0.000019602183,0.000017634644,0.0000464233,0.0005630723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99159676,0.002089568,0.0047524287,0.0004205386,0.0006873538,0.00045332927],"domain_scores_gemma":[0.9904928,0.0042418274,0.0033260083,0.0003922879,0.00068954204,0.00085748837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005549156,0.00035910803,0.0031620765,0.00017167188,0.00011523837,0.000034471534,0.00017942683,0.00094686454,0.00048171417],"category_scores_gemma":[0.004852239,0.0002129069,0.0009689184,0.00031331135,0.00039675483,0.00012508155,0.000020946914,0.00046621848,0.00010854577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056286636,0.013419276,0.72158426,0.0000063101993,0.0015791513,0.0017858449,0.000053902375,0.0000063970156,0.000015086366,0.0000703303,0.00299014,0.25286064],"study_design_scores_gemma":[0.08074074,0.029000146,0.58059037,0.000062942694,0.00079755724,0.0008199306,0.000046283938,0.000034398166,0.00041076582,0.00006256311,0.30726314,0.00017116741],"about_ca_topic_score_codex":0.00007902507,"about_ca_topic_score_gemma":0.00003834432,"teacher_disagreement_score":0.304273,"about_ca_system_score_codex":0.00091923715,"about_ca_system_score_gemma":0.003427018,"threshold_uncertainty_score":0.8682092},"labels":[],"label_agreement":null},{"id":"W2112529529","doi":"10.3109/10428194.2013.790968","title":"Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Confidence interval; International Prognostic Index; Retrospective cohort study; Lymphoma; Comorbidity; Cohort; Performance status; Population; Overall survival","score_opus":0.007458380733081112,"score_gpt":0.24030235645578002,"score_spread":0.2328439757226989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112529529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958536,0.00047556285,0.000007515943,0.000028390643,0.00015190497,0.002992385,0.00010721823,0.00012947724,0.00025396392],"genre_scores_gemma":[0.99793994,0.0000444675,0.0002839879,0.0005151508,0.00004457303,0.00037717904,0.00046261676,0.00012774658,0.0002043524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954593,0.00020271198,0.0011671204,0.001215815,0.0010842638,0.00087076705],"domain_scores_gemma":[0.99713063,0.00035605382,0.0007038033,0.000829737,0.0002926213,0.00068712374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020065525,0.0009841516,0.0017318182,0.00041247156,0.00043322777,0.00019791999,0.00017745234,0.00039450979,0.00005555256],"category_scores_gemma":[0.00007852278,0.0007263804,0.00018670649,0.00039587045,0.000240149,0.0007259542,0.00023850048,0.000089555746,0.000012109424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071128993,0.01540805,0.96413976,0.0002715481,0.00038740842,0.000036176054,0.0013099889,0.0000027938147,0.000029228113,0.000022580653,0.00036727378,0.01731393],"study_design_scores_gemma":[0.15225148,0.0018990805,0.8418542,0.00022219389,0.0008387395,0.000007490945,0.0005478524,0.0013729447,0.0002326818,0.00001557989,0.00010870375,0.00064902834],"about_ca_topic_score_codex":0.0087092975,"about_ca_topic_score_gemma":0.0004018551,"teacher_disagreement_score":0.15154019,"about_ca_system_score_codex":0.0026691693,"about_ca_system_score_gemma":0.0004894114,"threshold_uncertainty_score":0.99951875},"labels":[],"label_agreement":null},{"id":"W2112543414","doi":"10.1016/j.celrep.2015.10.008","title":"Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression","year":2015,"lang":"en","type":"article","venue":"Cell Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"CIITA; Biology; MHC class II; Lymphoma; Major histocompatibility complex; Phenotype; Cancer research; Missense mutation; MHC class I; Genetics; Immune system; Gene; Immunology","score_opus":0.01678642179457296,"score_gpt":0.22880180655101803,"score_spread":0.21201538475644507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112543414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241793,0.0012045233,0.000003996356,0.00027486926,0.00013519454,0.000563607,0.000016335382,0.0000343162,0.0053492216],"genre_scores_gemma":[0.9984568,0.000060217313,0.00018461872,0.00025734399,0.000051096464,0.00013659081,0.0002589953,0.000029118235,0.0005652727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982697,0.00006679528,0.0005073631,0.00047498939,0.0003465615,0.00033461224],"domain_scores_gemma":[0.99877584,0.00007203433,0.00043181638,0.00034432617,0.00009682968,0.00027913958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031784715,0.00022611176,0.00045430762,0.00014517846,0.00007651889,0.000028135702,0.000038218812,0.00013274609,0.00001915866],"category_scores_gemma":[0.00011699344,0.00017350457,0.000042584357,0.00015892513,0.00003915546,0.000096821226,0.00009392558,0.000094456635,0.0000035571022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116706906,0.0037748895,0.9781746,0.00005469033,0.000016595663,0.011655772,0.0011746066,0.000018489844,0.00274467,0.0000012920339,0.0021073644,0.00016030349],"study_design_scores_gemma":[0.009604466,0.00033890322,0.9773965,0.000609275,0.00007517922,0.00026435684,0.00062621984,0.00007657418,0.009929679,0.000027263508,0.0008592401,0.00019235096],"about_ca_topic_score_codex":0.00010210291,"about_ca_topic_score_gemma":0.0005218575,"teacher_disagreement_score":0.011391415,"about_ca_system_score_codex":0.00088731723,"about_ca_system_score_gemma":0.00042031778,"threshold_uncertainty_score":0.7075311},"labels":[],"label_agreement":null},{"id":"W2112626326","doi":"10.3109/10428194.2013.858154","title":"The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma","year":2013,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prednisone; Vincristine; Cyclophosphamide; Medicine; Doxorubicin; Peripheral; Lymphoma; Peripheral T-cell lymphoma; Chemotherapy; Oncology; Internal medicine; Immunology; T cell; Immune system","score_opus":0.008534077756637998,"score_gpt":0.21878022310359987,"score_spread":0.21024614534696187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112626326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8613048,0.06650622,0.00009799657,0.055645987,0.00074059796,0.0113919815,0.00067344186,0.00034975825,0.0032891978],"genre_scores_gemma":[0.6977758,0.09439697,0.0068421396,0.11202104,0.0080626765,0.020226123,0.002552038,0.001616928,0.056506313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928784,0.0002974873,0.0017375511,0.0018765235,0.0012478568,0.0019621842],"domain_scores_gemma":[0.9922416,0.003121721,0.0012915778,0.0021890868,0.0006085097,0.0005474636],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00044498127,0.0022360096,0.0026463193,0.0002500195,0.0019448664,0.00052760897,0.00069149426,0.0015167098,0.000043993492],"category_scores_gemma":[0.00005750586,0.0011542997,0.00080550555,0.00050203846,0.001785031,0.00024231315,0.00021851965,0.00030950838,0.000025093199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049263095,0.002343208,0.006173768,0.002792211,0.0047269696,0.0011239428,0.002760507,0.000026700454,0.00049193425,0.0003358352,0.39228436,0.58201426],"study_design_scores_gemma":[0.06288914,0.0071727494,0.03182644,0.0008724555,0.0045351177,0.0024317785,0.00075201766,0.0011673338,0.0055929166,0.00029779645,0.881019,0.001443254],"about_ca_topic_score_codex":0.009291051,"about_ca_topic_score_gemma":0.00024043389,"teacher_disagreement_score":0.580571,"about_ca_system_score_codex":0.010062141,"about_ca_system_score_gemma":0.0046090507,"threshold_uncertainty_score":0.9997795},"labels":[],"label_agreement":null},{"id":"W2112910931","doi":"10.1093/clinchem/47.2.195","title":"Quantitative Real-Time Reverse Transcription-PCR Assay for Cyclin D1 Expression: Utility in the Diagnosis of Mantle Cell Lymphoma","year":2001,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cyclin D1; Mantle cell lymphoma; Real-time polymerase chain reaction; Cancer research; Biology; Molecular biology; Reverse transcription polymerase chain reaction; Lymph node; Cyclin; Cyclin D; Lymphoma; Gene; Gene expression; Cell cycle; Immunology; Genetics","score_opus":0.0747773388173723,"score_gpt":0.37065268623412484,"score_spread":0.29587534741675253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112910931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948103,0.00033852065,0.00001784146,0.0014250717,0.00009076846,0.00053836603,0.000092002025,0.000023418716,0.007992998],"genre_scores_gemma":[0.99532205,0.0015754072,0.0011651765,0.00029359016,0.00013330308,0.00032074755,0.000115294235,0.000016476175,0.0010579792],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981278,0.00013831191,0.0008253612,0.00042225927,0.00024622743,0.00024004752],"domain_scores_gemma":[0.9961498,0.0028725192,0.00020684327,0.0005366554,0.00010033033,0.00013385112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010392637,0.00018647707,0.0005515872,0.000016648346,0.000052404095,0.00000946444,0.00017493445,0.00025034818,0.00047874957],"category_scores_gemma":[0.00061843183,0.0001252924,0.00043140713,0.0001467063,0.00018442642,0.000046304544,0.000023823643,0.00011238668,0.000030258057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031565607,0.018933142,0.8887471,0.0007325721,0.00014836623,0.00027887663,0.0006244654,0.0000015288786,0.026028244,0.00003611024,0.052450217,0.008862838],"study_design_scores_gemma":[0.030386128,0.0013120478,0.4464565,0.0010998289,0.00077887136,0.00005148092,0.0022849503,0.0005837196,0.47613505,0.0007071209,0.03969216,0.0005121527],"about_ca_topic_score_codex":0.000060778133,"about_ca_topic_score_gemma":0.000005199624,"teacher_disagreement_score":0.4501068,"about_ca_system_score_codex":0.000068893874,"about_ca_system_score_gemma":0.00011667466,"threshold_uncertainty_score":0.5241972},"labels":[],"label_agreement":null},{"id":"W2113346537","doi":"10.1186/1471-2407-14-586","title":"Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Health Sciences Centre; Niagara Health System; Mount Sinai Hospital; Princess Margaret Cancer Centre; McGill University; Institute for Clinical Evaluative Sciences; Toronto General Hospital; University of Toronto; Cancer Care Ontario; Toronto Public Health; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; Surgical oncology; Lymphoma; Oncology; Population; Internal medicine; Environmental health","score_opus":0.015400232756047086,"score_gpt":0.3032765442604331,"score_spread":0.28787631150438603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113346537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714464,0.00018361749,0.00082473445,0.000023390452,0.00006919084,0.0011422329,0.00029571503,0.000019307028,0.00029716745],"genre_scores_gemma":[0.99793917,0.000030904816,0.00043242713,0.000105511266,0.00004101326,0.00089654274,0.0004432183,0.000017350523,0.0000938466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991039,0.00007581881,0.00020669028,0.00026450405,0.0001688769,0.00018022492],"domain_scores_gemma":[0.99887985,0.000514834,0.00012818344,0.00022321881,0.00015361389,0.00010028797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015985138,0.00013789312,0.00047555222,0.00018670075,0.000054747386,0.0000109815155,0.000032336553,0.000046032223,0.000025501462],"category_scores_gemma":[0.000054603493,0.00011003153,0.00017519099,0.00031211338,0.000020310023,0.00003424525,0.000013952788,0.0000146330085,0.0000014510748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083528913,0.005508591,0.9851646,0.00031503997,0.000230202,4.812429e-7,0.000018231676,0.000028626868,0.000022192706,0.00021592264,0.00007710413,0.0075837276],"study_design_scores_gemma":[0.059276666,0.00020538659,0.93220645,0.00013713923,0.0014566303,7.919843e-8,0.0000048617358,0.0043229065,0.0014805765,0.0000141215905,0.0007925733,0.00010258205],"about_ca_topic_score_codex":0.0049935696,"about_ca_topic_score_gemma":0.006994149,"teacher_disagreement_score":0.05844138,"about_ca_system_score_codex":0.0005136846,"about_ca_system_score_gemma":0.00009026456,"threshold_uncertainty_score":0.7548817},"labels":[],"label_agreement":null},{"id":"W2113560147","doi":"10.1093/rheumatology/kel396","title":"Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories","year":2006,"lang":"en","type":"review","venue":"Lara D. Veeken","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Arthritis Society; McGill University; Canadian Arthritis Network; McGill University Health Centre; Pfizer","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Dermatology; Internal medicine","score_opus":0.04101673631723452,"score_gpt":0.3319574391590103,"score_spread":0.2909407028417758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113560147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094977416,0.90255255,0.0000023913217,0.000025305166,0.00026262866,0.0016979041,0.00011859993,0.000017172402,0.0003460128],"genre_scores_gemma":[0.081668235,0.91727275,0.00009423037,0.000045236495,0.00015203416,0.00028111032,0.00012283633,0.00005408834,0.00030949764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729955,0.0001473511,0.0011668524,0.0005013945,0.0005567486,0.00032809796],"domain_scores_gemma":[0.99714714,0.0005966989,0.0010537817,0.000948079,0.00013410006,0.00012022655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016847573,0.00067081983,0.0047891983,0.00013641179,0.00006941163,0.00003502975,0.000265692,0.00034295063,0.000015466327],"category_scores_gemma":[0.000089954054,0.0003186388,0.0017973055,0.00038043025,0.00021192325,0.000063148225,0.00023002879,0.00012037475,0.000007637295],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007361098,0.002128082,0.036142588,0.12272128,0.04002575,0.00062663143,0.00021767837,9.401293e-7,0.00084276916,0.00004327016,0.0018328213,0.7953446],"study_design_scores_gemma":[0.0076863905,0.0016068304,0.19463593,0.026899653,0.28245094,0.0005180367,0.000020109494,0.0000072810367,0.015790313,0.000026083475,0.4693144,0.0010440437],"about_ca_topic_score_codex":0.00034126025,"about_ca_topic_score_gemma":0.000025648682,"teacher_disagreement_score":0.79430056,"about_ca_system_score_codex":0.000120742145,"about_ca_system_score_gemma":0.00026700372,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2113822020","doi":"10.1093/annonc/mdh132","title":"Hodgkin’s lymphoma in Chinese migrants to British Columbia:a 25-year survey","year":2004,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Population; Lymphoma; Demography; Cancer registry; Nodular sclerosis; Hodgkin lymphoma; Pediatrics; Internal medicine; Environmental health","score_opus":0.05037512773404305,"score_gpt":0.36194546206197237,"score_spread":0.3115703343279293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113822020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915306,0.00041989738,0.0000016375327,0.0030116912,0.00016172977,0.000441371,0.00009112982,0.000021126063,0.0043208147],"genre_scores_gemma":[0.99528724,0.00048428524,0.00041764666,0.0032923785,0.00005990229,0.00006695302,0.000053032647,0.000018571938,0.00031996885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866134,0.00010163599,0.00039131934,0.0003024515,0.00018942452,0.0003538258],"domain_scores_gemma":[0.99909145,0.00016442609,0.00009091569,0.00025235108,0.00018684624,0.00021402966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042773312,0.00011505283,0.00063700025,0.00009918854,0.000032249223,0.000021285769,0.000107039974,0.00016355983,0.00017999063],"category_scores_gemma":[0.0003937423,0.00014091741,0.00011348107,0.00038939295,0.00006899675,0.000047103873,0.000056781082,0.000048684717,0.000102427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021504126,0.0031983154,0.9062887,0.000021501848,0.000084398205,0.0009411107,0.00019342202,0.000008918445,0.000060211198,0.000014111869,0.0127177425,0.076256566],"study_design_scores_gemma":[0.008919685,0.0031545984,0.9781812,0.0001352241,0.00001792248,0.00017436565,0.000035773504,7.9769154e-7,0.0002249475,0.0002898014,0.008752207,0.00011352022],"about_ca_topic_score_codex":0.22188042,"about_ca_topic_score_gemma":0.45485052,"teacher_disagreement_score":0.2329701,"about_ca_system_score_codex":0.00019525661,"about_ca_system_score_gemma":0.00042180065,"threshold_uncertainty_score":0.7833011},"labels":[],"label_agreement":null},{"id":"W2113950318","doi":"10.1111/bjh.13493","title":"A phase <scp>II</scp> trial of <scp>RCHOP</scp> followed by radioimmunotherapy for early stage (stages I/<scp>II</scp>) diffuse large B‐cell non‐Hodgkin lymphoma: <scp>ECOG</scp>3402","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pharmacyclics; Genentech; ECOG-ACRIN Cancer Research Group; Roche; American College of Radiology Imaging Network; Spectrum Pharmaceuticals; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Radioimmunotherapy; Medicine; Diffuse large B-cell lymphoma; Rituximab; Chemoimmunotherapy; Internal medicine; Phases of clinical research; Lymphoma; Nuclear medicine; Clinical trial; Immunology","score_opus":0.019109684220618747,"score_gpt":0.2890661712795868,"score_spread":0.269956487058968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113950318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95129293,0.03861298,0.0008067782,0.00026305678,0.0024469742,0.0033846973,0.0015198622,0.00015040314,0.001522329],"genre_scores_gemma":[0.97313803,0.008922633,0.002566486,0.0010590487,0.0010511685,0.00052437437,0.0003615887,0.0004212033,0.011955444],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98966885,0.0008254601,0.003821282,0.0013283263,0.001785117,0.0025709982],"domain_scores_gemma":[0.9866834,0.0053879847,0.0036079218,0.0011968026,0.0014511435,0.0016727238],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026712099,0.0013703301,0.0050213686,0.00095192506,0.00071686355,0.00031220884,0.0012066803,0.0012445978,0.000019510413],"category_scores_gemma":[0.00677033,0.0013643844,0.0020938583,0.0007999142,0.0006083658,0.0008200918,0.0003727892,0.0008668744,0.00006383607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003519906,0.099974014,0.014086407,0.0010943922,0.006468135,0.04577371,0.013773711,0.000012209106,0.01599582,0.00039146407,0.7879365,0.010973722],"study_design_scores_gemma":[0.5351607,0.024705356,0.0023124067,0.0010496753,0.0019759762,0.027325774,0.004240017,0.0001046406,0.0931066,0.00038589677,0.30943346,0.0001994597],"about_ca_topic_score_codex":0.0005391206,"about_ca_topic_score_gemma":0.00013986991,"teacher_disagreement_score":0.5316408,"about_ca_system_score_codex":0.00084172824,"about_ca_system_score_gemma":0.0020788063,"threshold_uncertainty_score":0.99990475},"labels":[],"label_agreement":null},{"id":"W2113961586","doi":"10.1182/asheducation-2009.1.497","title":"Standard therapy of advanced Hodgkin lymphoma","year":2009,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"ABVD; Medicine; Oncology; Salvage therapy; Dacarbazine; Internal medicine; Autologous stem-cell transplantation; Vinblastine; Chemotherapy; Radiation therapy; Clinical trial; Regimen; Randomized controlled trial; Surgery; Vincristine; Cyclophosphamide","score_opus":0.04297548223703827,"score_gpt":0.3677090469334678,"score_spread":0.3247335646964295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113961586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029090882,0.9954243,0.0000041089875,0.00009612234,0.00014585438,0.000997344,0.000038600563,0.000049278315,0.002953525],"genre_scores_gemma":[0.00025078421,0.998263,0.00084433134,0.00014189092,0.000048284288,0.00016941334,0.00011411992,0.000040327148,0.00012786398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983634,0.000094673545,0.0006785556,0.00037954547,0.00019757746,0.0002862951],"domain_scores_gemma":[0.99863416,0.00019865182,0.00040978412,0.00057181105,0.00007814942,0.00010744324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008252011,0.0003925708,0.0037526388,0.00018226613,0.000025607027,0.0000038785824,0.00011611517,0.00038983414,0.00018382893],"category_scores_gemma":[0.000039523155,0.0002561102,0.0006511235,0.00019649201,0.00008174495,0.000017857568,0.000024955798,0.00007202923,0.00008148014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093008,0.00045324984,0.00008452262,0.0037768418,0.00039374258,0.0003870419,0.000017512846,1.7135624e-8,2.119773e-7,0.00275499,0.0013476566,0.9906912],"study_design_scores_gemma":[0.003189022,0.0010118992,0.00010696396,0.0084052,0.00050482946,0.0021277205,0.0000055519085,8.1248224e-8,0.00013195284,0.0001100492,0.98423284,0.00017387798],"about_ca_topic_score_codex":0.0000059961694,"about_ca_topic_score_gemma":0.00000183763,"teacher_disagreement_score":0.9905173,"about_ca_system_score_codex":0.0001879655,"about_ca_system_score_gemma":0.00057533773,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2114150166","doi":"10.1309/j7y74d9dxeaj9yuy","title":"The Reliability of Lymphoma Diagnosis in Small Tissue Samples Is Heavily Influenced by Lymphoma Subtype","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; University of Ottawa; University of Toronto; Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; Mantle cell lymphoma; Medicine; Subtyping; Pathology; Medical diagnosis; Lymphoblastic lymphoma; Immunology; T cell","score_opus":0.033414686977876376,"score_gpt":0.3748406567823233,"score_spread":0.34142596980444695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114150166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924676,0.0015686882,0.00007518105,0.0050933636,0.00034082556,0.00022746985,0.000019235378,0.000008514849,0.00019911179],"genre_scores_gemma":[0.99094325,0.003724465,0.0024862387,0.0026323178,0.00015423028,0.000012272807,0.0000032915577,0.000020060494,0.000023842687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99566406,0.0005272378,0.0027015288,0.00033354267,0.00031925365,0.0004543994],"domain_scores_gemma":[0.98987806,0.0070995037,0.0017181324,0.00053430157,0.00042364956,0.0003463346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004062965,0.0002219587,0.0014480713,0.0001284946,0.000061861254,0.000009994215,0.00030623816,0.00017554978,0.000032189695],"category_scores_gemma":[0.004245649,0.00013732431,0.00040742985,0.00043315368,0.0015521721,0.000056061363,0.000071359435,0.00020301032,0.000012364788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012634743,0.0014504874,0.6006412,0.0000075603893,0.000059602742,0.0004204333,0.00014606783,0.0000011737148,0.00012897236,0.000031697124,0.0006392668,0.39521006],"study_design_scores_gemma":[0.005170406,0.007054081,0.9653136,0.0001000954,0.0001485041,0.00044247697,0.0004015783,0.000002119441,0.0044770665,0.00041702774,0.016355412,0.00011762705],"about_ca_topic_score_codex":0.000720766,"about_ca_topic_score_gemma":0.00016859722,"teacher_disagreement_score":0.39509243,"about_ca_system_score_codex":0.00017490574,"about_ca_system_score_gemma":0.00045267201,"threshold_uncertainty_score":0.5719043},"labels":[],"label_agreement":null},{"id":"W2114319427","doi":"10.3816/clm.2006.n.030","title":"Late Clinically Silent Perforation of Intestinal Non-Hodgkin's Lymphoma","year":2006,"lang":"en","type":"article","venue":"Clinical Lymphoma & Myeloma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Positron emission tomography; Medicine; Perforation; Lymphoma; Chemotherapy; Radiology; Abscess; Nuclear medicine; Pathology; Surgery","score_opus":0.02568037654029906,"score_gpt":0.32988548373048077,"score_spread":0.3042051071901817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114319427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510855,0.0003393269,0.00017661508,0.0010564787,0.0007279639,0.0007776921,0.000029900364,0.00016010039,0.011623349],"genre_scores_gemma":[0.9904782,0.0001855142,0.005546205,0.0009736433,0.0011857408,0.000100145226,0.00020701678,0.00007190952,0.0012516158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99449265,0.00021295102,0.0029861536,0.00095142575,0.0007258739,0.0006309634],"domain_scores_gemma":[0.99572325,0.0014039279,0.00087404903,0.0010163086,0.0005336478,0.0004488381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011906308,0.0005098689,0.0014091674,0.00017208669,0.00014849378,0.000051660805,0.0003038506,0.0004869941,0.00023776312],"category_scores_gemma":[0.0008684817,0.00041398962,0.0009586938,0.00042988846,0.0005549441,0.00016574842,0.00018599752,0.00013552266,0.00051588827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001395506,0.0057491497,0.6815372,0.00009117973,0.00020491135,0.00038775045,0.000037669044,0.0000124339285,0.0005094931,0.0006739907,0.0048818113,0.30451888],"study_design_scores_gemma":[0.013603717,0.00394737,0.96957344,0.00041699628,0.000491553,0.0002523048,0.000040251463,0.0016437613,0.0032555982,0.0007066485,0.0056921546,0.00037617848],"about_ca_topic_score_codex":0.00034406834,"about_ca_topic_score_gemma":0.000026214368,"teacher_disagreement_score":0.3041427,"about_ca_system_score_codex":0.00034492853,"about_ca_system_score_gemma":0.00081959995,"threshold_uncertainty_score":0.9998312},"labels":[],"label_agreement":null},{"id":"W2114541062","doi":"10.3109/10428194.2013.770151","title":"Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1–2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database","year":2013,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Santé et de Services Sociaux de Chicoutimi","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Positron emission tomography; Follicular lymphoma; Stage (stratigraphy); Lymphoma; Nuclear medicine; Radiation therapy; Radiology; Internal medicine","score_opus":0.043497121389043866,"score_gpt":0.33806455552479425,"score_spread":0.2945674341357504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114541062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916913,0.0029456394,0.000026829559,0.00015681928,0.00017675577,0.0030961633,0.0017517677,0.000043952336,0.0001107904],"genre_scores_gemma":[0.9944527,0.0023644657,0.0003753274,0.0007311017,0.00025540593,0.0009683778,0.0007037637,0.00010773395,0.000041111845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99472487,0.00033614508,0.00162656,0.0010737189,0.0011506238,0.0010880741],"domain_scores_gemma":[0.99552125,0.0017505783,0.00095572614,0.0007147351,0.0005972556,0.0004604371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003671517,0.0011266761,0.0019901355,0.00064798293,0.00028385612,0.00012167123,0.0003445034,0.0004509564,0.000053148393],"category_scores_gemma":[0.00008660433,0.0007576303,0.00076003064,0.0006770142,0.0002786687,0.0005928847,0.00018416604,0.00007932712,0.0000023955956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077303783,0.0068617254,0.7319412,0.0017361136,0.004009841,0.0004472186,0.0027734095,0.0018654584,0.023972748,0.0011675723,0.002358994,0.21513532],"study_design_scores_gemma":[0.043325223,0.0032035038,0.8806025,0.0014034456,0.00080532266,0.00022219443,0.0005525225,0.006938633,0.06177036,0.00016886389,0.0003644588,0.0006430205],"about_ca_topic_score_codex":0.017922066,"about_ca_topic_score_gemma":0.00017815708,"teacher_disagreement_score":0.2144923,"about_ca_system_score_codex":0.003884637,"about_ca_system_score_gemma":0.0025994505,"threshold_uncertainty_score":0.99993926},"labels":[],"label_agreement":null},{"id":"W2114829023","doi":"10.18433/j39p45","title":"Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Internal medicine; Surrogate endpoint; Lymphoma; Oncology; Drug; Disease; Retrospective cohort study; Pharmacology","score_opus":0.1498334501926799,"score_gpt":0.45429706995100677,"score_spread":0.30446361975832686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114829023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465084,0.0014065356,0.00006874933,0.000676377,0.0008918872,0.00039652636,0.0000032828177,0.000012015423,0.0018937571],"genre_scores_gemma":[0.98937285,0.0043421476,0.005007534,0.0006226102,0.00061659125,0.000010829557,3.7953015e-7,0.000008633568,0.000018432127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742204,0.0002714892,0.001039772,0.0003120577,0.00056745944,0.00038718394],"domain_scores_gemma":[0.9985357,0.0003025843,0.0004159779,0.000070114205,0.00011671202,0.0005589379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003222118,0.00018720789,0.00052210037,0.00024467247,0.00013715372,0.000041868214,0.00017028606,0.00006057653,0.00057325367],"category_scores_gemma":[0.0002753312,0.00012232525,0.00024155951,0.00043241557,0.0004234287,0.0003631897,0.000060918122,0.000324826,0.000016276494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02012682,0.0032609422,0.7547119,0.000017888095,0.00012566464,0.00030563242,0.00028566486,0.0000031518437,0.00036658457,0.00006635814,0.0004967618,0.22023262],"study_design_scores_gemma":[0.20018846,0.0054456443,0.70823264,0.000103708975,0.0007816561,0.00085618405,0.00017656574,0.00709317,0.024281032,0.0005525295,0.05200861,0.00027981616],"about_ca_topic_score_codex":0.0001261076,"about_ca_topic_score_gemma":0.0000066043417,"teacher_disagreement_score":0.21995279,"about_ca_system_score_codex":0.00015371495,"about_ca_system_score_gemma":0.00037655467,"threshold_uncertainty_score":0.62767255},"labels":[],"label_agreement":null},{"id":"W2115362683","doi":"10.1093/jnci/dji290","title":"Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Breast cancer; Medicine; Cumulative incidence; Population; Absolute risk reduction; Relative risk; Cumulative dose; Cancer; Cohort; Incidence (geometry); Internal medicine; Standardized mortality ratio; Confidence interval; Oncology; Environmental health","score_opus":0.039307057783653135,"score_gpt":0.3475019722692566,"score_spread":0.3081949144856035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115362683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98285466,0.0011581536,0.00015392306,0.010263582,0.0015493744,0.00090747356,0.0026033085,0.00001364244,0.00049590395],"genre_scores_gemma":[0.99157023,0.00065815693,0.001110832,0.0013354179,0.0033217254,0.000551627,0.00001534996,0.000022905524,0.001413745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847186,0.000024785133,0.00047772855,0.00016662285,0.0005944995,0.00026450487],"domain_scores_gemma":[0.9976814,0.00013247285,0.00062957266,0.00009547356,0.0013159915,0.00014508625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003575664,0.00018220814,0.00035527014,0.00012611637,0.00025259415,0.000031004533,0.00016327134,0.000077968885,0.00009136307],"category_scores_gemma":[0.0001557989,0.0001108345,0.00035545908,0.00018718855,0.0000780159,0.00031165057,0.000022441307,0.00008007505,0.0000026494602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018625716,0.00379303,0.2533944,0.00030102584,0.010989435,0.000031571766,0.0042352458,0.056561977,0.0017457253,0.0044887397,0.20256156,0.44327158],"study_design_scores_gemma":[0.02168707,0.00035691538,0.6795079,0.00038902866,0.00087918097,0.00042365506,0.00004862795,0.003420331,0.0034402537,0.0009815113,0.28863397,0.00023156019],"about_ca_topic_score_codex":0.00038360697,"about_ca_topic_score_gemma":0.0005034117,"teacher_disagreement_score":0.44304,"about_ca_system_score_codex":0.00437807,"about_ca_system_score_gemma":0.001304924,"threshold_uncertainty_score":0.99944395},"labels":[],"label_agreement":null},{"id":"W2115445516","doi":"10.1200/jco.2005.03.9644","title":"Radiotherapy and Hodgkin's Lymphoma","year":2005,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine","score_opus":0.10138300798777258,"score_gpt":0.45435868406205865,"score_spread":0.35297567607428604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115445516","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041069422,0.009522276,0.000012036836,0.9432829,0.001963745,0.00021289139,0.000006624157,0.000010552844,0.0039195763],"genre_scores_gemma":[0.006959075,0.024735773,0.0069348314,0.9210724,0.038099762,0.0000065654417,0.0000117375475,0.00004834429,0.0021315175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601483,0.000418491,0.0025022805,0.00028493762,0.0004783402,0.00030111836],"domain_scores_gemma":[0.99351615,0.0031899572,0.0024021936,0.0002734782,0.00027517026,0.00034303038],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014302311,0.00028851203,0.0031074288,0.0001893971,0.000032390995,0.000018576104,0.00015608728,0.0021585284,0.00034196425],"category_scores_gemma":[0.00078581105,0.00018202423,0.0009635797,0.000064373715,0.00027435325,0.000064517655,0.00003555754,0.0014924142,0.000027770348],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005931802,0.0008342427,0.008908344,0.000025802667,0.0010140724,0.009928978,0.000015677557,1.5045765e-7,0.0000011583882,0.0000082668,0.5700928,0.40857735],"study_design_scores_gemma":[0.016354695,0.012086867,0.0930255,0.00016727622,0.0010567943,0.0055800946,0.0000052254827,0.0000063817633,0.000005590997,0.0000894504,0.871491,0.00013111807],"about_ca_topic_score_codex":0.000014634959,"about_ca_topic_score_gemma":0.000004582989,"teacher_disagreement_score":0.40844622,"about_ca_system_score_codex":0.0005920657,"about_ca_system_score_gemma":0.0022813266,"threshold_uncertainty_score":0.99913687},"labels":[],"label_agreement":null},{"id":"W2116382435","doi":"10.1038/nature09671","title":"Oncogenically active MYD88 mutations in human lymphoma","year":2010,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1509,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Cancer research; Diffuse large B-cell lymphoma; Biology; Lymphoma; Mutation; Mutant; Ibrutinib; Gene; Genetics; Leukemia; Immunology; Chronic lymphocytic leukemia","score_opus":0.007723989715644191,"score_gpt":0.3081169940131739,"score_spread":0.3003930042975297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116382435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97883856,0.0001356126,4.2057863e-7,0.0026388546,0.00018936725,0.00022970558,0.000015209536,0.000035916684,0.017916324],"genre_scores_gemma":[0.9973901,0.000008024729,0.0005174588,0.0013363786,0.00015040427,0.00004779827,0.000081906604,0.000011770489,0.00045614326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993673,0.000011657019,0.00011923285,0.0001896061,0.00016611937,0.00014607914],"domain_scores_gemma":[0.9995356,0.000061953164,0.000033039858,0.00021035079,0.000065067994,0.00009396092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045975732,0.000097371536,0.00015650813,0.00008090517,0.000054005108,0.000011151038,0.000057474594,0.00072475034,0.00021043509],"category_scores_gemma":[0.00009693311,0.000074768635,0.00007705162,0.00015633003,0.000037840455,0.00004564672,0.000018616474,0.0006744213,0.000053149644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004410536,0.008411017,0.46756533,0.00006396111,0.00049046124,0.0023385796,0.002022581,0.0000027662004,0.16946626,0.035759155,0.014866973,0.29857185],"study_design_scores_gemma":[0.0039242064,0.00012556382,0.9449226,0.0000290875,0.00006407209,0.0000764453,0.00005298254,0.000008153305,0.029913742,0.0006346145,0.02016205,0.00008643067],"about_ca_topic_score_codex":0.000071445735,"about_ca_topic_score_gemma":0.0006115373,"teacher_disagreement_score":0.47735733,"about_ca_system_score_codex":0.0001227155,"about_ca_system_score_gemma":0.00012211628,"threshold_uncertainty_score":0.5589938},"labels":[],"label_agreement":null},{"id":"W2116438695","doi":"10.5581/1516-8484.20120013","title":"T-Cell Lymphomas in South America and Europe","year":2011,"lang":"en","type":"article","venue":"Revista Brasileira de Hematologia e Hemoterapia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Allos Therapeutics; Associazione Angela Serra per la Ricerca sul Cancro; Fondazione Cassa di Risparmio di Modena","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Immunology; Biology; Medicine; Cancer research","score_opus":0.026172814983075856,"score_gpt":0.24836382875044608,"score_spread":0.22219101376737022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116438695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848393,0.004154976,0.000094112016,0.000053269636,0.00003361999,0.00046425362,0.000007374146,0.00011420867,0.010238854],"genre_scores_gemma":[0.99262893,0.00035885707,0.0056088166,0.0010669066,0.000022980503,0.000037709768,0.000014191629,0.00003927291,0.00022233144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835294,0.000098907745,0.00043009335,0.00049997773,0.00015785961,0.00046019666],"domain_scores_gemma":[0.99898815,0.0000815342,0.00014349082,0.00046959947,0.000053407246,0.00026380862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011024861,0.00031035213,0.0006736907,0.00017085827,0.00005673082,0.000045119086,0.0001141955,0.00013321932,0.0002903995],"category_scores_gemma":[0.00008767958,0.00024834432,0.00010798836,0.00036074666,0.00013676254,0.00007479093,0.00008325642,0.0001333709,0.00020977398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013580866,0.0006637604,0.99102396,0.0003571549,0.00004409233,0.0015484585,0.001519295,6.3823734e-8,0.00032586575,0.0016301285,0.0007755302,0.001975875],"study_design_scores_gemma":[0.0033882733,0.0003519128,0.9889537,0.0003480436,0.00011074173,0.0010966425,0.0001975572,0.00007620629,0.003399248,0.000038035076,0.0017485525,0.00029107125],"about_ca_topic_score_codex":0.00007701969,"about_ca_topic_score_gemma":0.0000015486645,"teacher_disagreement_score":0.010016523,"about_ca_system_score_codex":0.000118198885,"about_ca_system_score_gemma":0.00013338833,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W2117120512","doi":"10.1093/annonc/mdg414","title":"Limited-stage mantle-cell lymphoma","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Mantle cell lymphoma; Stage (stratigraphy); Lymphoma; Cancer research; Oncology; Internal medicine; Paleontology; Geology","score_opus":0.08338842833118928,"score_gpt":0.36283467821477877,"score_spread":0.27944624988358946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117120512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69537526,0.0012185901,0.0000050148537,0.0021703152,0.00012451322,0.0001703398,0.00000948598,0.000020506666,0.30090597],"genre_scores_gemma":[0.9886152,0.0011058322,0.0006338516,0.0035806992,0.000039510105,0.000027647146,0.0000136906065,0.000014193427,0.0059693693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907184,0.0000713258,0.00026222612,0.00019767601,0.00013219361,0.00026472192],"domain_scores_gemma":[0.9991855,0.00015546977,0.00012173947,0.0002734917,0.00012201953,0.00014179117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017712786,0.00012353061,0.0003921887,0.00009268342,0.00003137905,0.0000034397078,0.00005486311,0.00013880288,0.00050391635],"category_scores_gemma":[0.00008702964,0.000098769815,0.0001454058,0.00012222913,0.00007531563,0.00003145868,0.00001925497,0.000034968085,0.00020822098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011001998,0.035340082,0.26693892,0.00041594417,0.0009277513,0.0038471743,0.0009937835,0.000012404547,0.00718427,0.050825894,0.21744357,0.41496998],"study_design_scores_gemma":[0.0060397573,0.0038086819,0.047121074,0.000024839792,0.000080583326,0.000115754774,0.00012525335,0.0000069659027,0.104073904,0.00018836255,0.8383177,0.00009714414],"about_ca_topic_score_codex":0.000051287057,"about_ca_topic_score_gemma":0.000009476719,"teacher_disagreement_score":0.6208741,"about_ca_system_score_codex":0.000060899667,"about_ca_system_score_gemma":0.000271343,"threshold_uncertainty_score":0.5517531},"labels":[],"label_agreement":null},{"id":"W2117200606","doi":"10.1002/pbc.24423","title":"Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma","year":2012,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Oncology; Internal medicine; Hodgkin lymphoma; Gemcitabine; Radiation therapy; Chemotherapy; Lymphoma; Clinical trial","score_opus":0.2109878846014605,"score_gpt":0.4608212988251221,"score_spread":0.24983341422366162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117200606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008473551,0.9907484,0.0000035583992,0.00042789598,0.0012294876,0.0054353033,0.0005087141,0.00010651471,0.0006927744],"genre_scores_gemma":[0.00045380223,0.96912736,0.0006736767,0.00014497699,0.016389282,0.0119109675,0.0005450625,0.00019140447,0.0005634819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953049,0.00035203266,0.0009871619,0.0011191418,0.0007513501,0.0014854108],"domain_scores_gemma":[0.99630135,0.0011306938,0.00055007363,0.0009778871,0.00031538738,0.00072460814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011376014,0.00078170956,0.0029296626,0.0007179903,0.00024147237,0.000050052724,0.00042366167,0.0009343247,0.00045654728],"category_scores_gemma":[0.00012434744,0.00057103176,0.0012159911,0.0008671656,0.00012809574,0.000083866325,0.00030546833,0.00047965613,0.000510613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050881135,0.0030510416,0.0056644385,0.011472861,0.0015242174,0.000057778576,0.000054223998,9.09229e-8,5.2134308e-8,0.00018537464,0.023486068,0.954453],"study_design_scores_gemma":[0.0048209396,0.00095822715,0.0039864792,0.0015930705,0.026686648,0.00029104567,0.0000065363015,3.778829e-7,0.000002056942,0.00003120091,0.9611232,0.00050016254],"about_ca_topic_score_codex":0.0016717215,"about_ca_topic_score_gemma":0.00014586495,"teacher_disagreement_score":0.9539528,"about_ca_system_score_codex":0.0015469114,"about_ca_system_score_gemma":0.0027414565,"threshold_uncertainty_score":0.99967414},"labels":[],"label_agreement":null},{"id":"W2117327517","doi":"10.1158/1078-0432.ccr-07-1720","title":"Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; International Prognostic Index; Oncology; Medicine; Gene expression profiling; Follicular phase; Internal medicine; Gene; Bioinformatics; Gene expression; Biology; Diffuse large B-cell lymphoma; Genetics","score_opus":0.3324872493807791,"score_gpt":0.5375851220581682,"score_spread":0.2050978726773891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117327517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949063,0.0022612752,0.000007826139,0.0012288338,0.00022442732,0.0006058487,0.000025226667,0.000031785665,0.00070844224],"genre_scores_gemma":[0.9968222,0.0015360729,0.00023308696,0.00041228585,0.00034918095,0.00019235103,0.000016508286,0.000030787265,0.00040757033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969798,0.0003875457,0.0007543994,0.0005531033,0.0007434678,0.00058168673],"domain_scores_gemma":[0.99784154,0.0011164601,0.000086861735,0.00037749545,0.00023954203,0.00033810103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001447413,0.00015483708,0.00053905934,0.00016347475,0.00017204038,0.000018721657,0.00014415882,0.00017332274,0.0001919412],"category_scores_gemma":[0.0010990072,0.000122035635,0.00021440558,0.00046857636,0.00030937965,0.00009773427,0.00016451617,0.0004138619,0.000054879565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050082477,0.0012869905,0.9801317,0.000025670055,0.00012909636,0.0009905975,0.0001786006,0.000009402444,0.00032180533,0.0000040116142,0.0020257619,0.014395579],"study_design_scores_gemma":[0.00904887,0.00069446326,0.9785145,0.00027291957,0.000051476913,0.00009749726,0.0002037728,0.0019171179,0.0042523635,0.00002305792,0.004767348,0.00015662938],"about_ca_topic_score_codex":0.0052684415,"about_ca_topic_score_gemma":0.00013182031,"teacher_disagreement_score":0.014238949,"about_ca_system_score_codex":0.0012875709,"about_ca_system_score_gemma":0.00063589844,"threshold_uncertainty_score":0.7964343},"labels":[],"label_agreement":null},{"id":"W2117613554","doi":"10.1002/path.4522","title":"Recurrent genomic rearrangements in primary testicular lymphoma","year":2015,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Terry Fox Research Institute; Canadian Institutes of Health Research; Dr. Mildred Scheel Stiftung für Krebsforschung; Killam Trusts; Michael Smith Health Research BC","keywords":"CIITA; Biology; Gene rearrangement; Comparative genomic hybridization; Lymphoma; Malignancy; Diffuse large B-cell lymphoma; Fluorescence in situ hybridization; MHC class II; Chromosomal rearrangement; Cancer research; Breakpoint; Pathology; Genetics; Immune system; Major histocompatibility complex; Chromosome; Medicine; Gene; Immunology; Karyotype","score_opus":0.035782868216441645,"score_gpt":0.2833541948941516,"score_spread":0.24757132667770995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117613554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207705,0.004526844,0.000019206589,0.0014233026,0.00030396768,0.00013995038,0.0000014766329,0.0000038881053,0.0015043307],"genre_scores_gemma":[0.9979548,0.0005236742,0.00068411743,0.0006335806,0.0001350474,0.0000036837482,0.000002393021,0.000008504244,0.00005420014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910605,0.00016548422,0.00032576072,0.00006623483,0.00018611821,0.00015033658],"domain_scores_gemma":[0.9993623,0.000074810516,0.000186013,0.00016968678,0.00010042759,0.00010675551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008324365,0.000084669926,0.00027790788,0.00010132737,0.000016735905,0.0000038080816,0.0000976321,0.000044352477,0.000014964581],"category_scores_gemma":[0.00012482448,0.00004688104,0.000060543516,0.00008204652,0.000054220396,0.000031041043,0.00004120066,0.00007555728,0.000043772885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003671868,0.0043170815,0.75411046,0.00006511367,0.00034106165,0.024660042,0.005276665,0.00009416004,0.017666047,0.00015047641,0.013229668,0.17641738],"study_design_scores_gemma":[0.008182811,0.001661574,0.9742779,0.00009337657,0.00023149728,0.010927057,0.00019754093,0.000013379488,0.00045595923,0.00040025415,0.003502607,0.00005603192],"about_ca_topic_score_codex":0.00001274752,"about_ca_topic_score_gemma":0.0000040741934,"teacher_disagreement_score":0.22016747,"about_ca_system_score_codex":0.00042630162,"about_ca_system_score_gemma":0.00022125835,"threshold_uncertainty_score":0.19117533},"labels":[],"label_agreement":null},{"id":"W2117677108","doi":"10.1002/1096-9896(2000)9999:9999<::aid-path733>3.0.co;2-u","title":"Significantly differentbcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas","year":2000,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Gastric lymphoma; Lymphoma; Stomach; Pathology; Biology; Chromosomal translocation; Immunohistochemistry; Phenotype; Cancer research; Medicine; Internal medicine; Gene; Genetics","score_opus":0.009318471791157296,"score_gpt":0.22622134243433553,"score_spread":0.21690287064317823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117677108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960593,0.0023479245,0.00005337183,0.0006107053,0.00009040223,0.0002792406,0.000007239233,0.0000073681754,0.0005444409],"genre_scores_gemma":[0.9951184,0.0031941151,0.00108982,0.00020367443,0.00014253485,0.000010712748,0.000005714732,0.000016794944,0.00021823958],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986127,0.00024181517,0.0004809078,0.00015203623,0.00023525248,0.00027726957],"domain_scores_gemma":[0.9992129,0.00019993936,0.0002226998,0.00019401869,0.00003764143,0.00013280546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003395289,0.00018415066,0.0004865452,0.00021187584,0.000060597355,0.0000102827835,0.00012294672,0.00010188892,0.0001629378],"category_scores_gemma":[0.000014715201,0.00010005571,0.00008360057,0.00017085312,0.000107498505,0.00006501758,0.000029025832,0.00019759688,0.000013874577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026752304,0.004912509,0.3518177,0.0001501749,0.000078521734,0.007605887,0.0016882002,0.000050272105,0.56475246,0.00001576445,0.0013925709,0.06486072],"study_design_scores_gemma":[0.00984709,0.0016248995,0.95744735,0.00017339163,0.00021314387,0.007931433,0.00016041553,0.000018804854,0.022253882,0.00013534175,0.00009811869,0.00009611487],"about_ca_topic_score_codex":0.000020446998,"about_ca_topic_score_gemma":0.0000021044361,"teacher_disagreement_score":0.6056297,"about_ca_system_score_codex":0.00013445674,"about_ca_system_score_gemma":0.0001154847,"threshold_uncertainty_score":0.40801534},"labels":[],"label_agreement":null},{"id":"W2118028844","doi":"10.1038/nature11378","title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","year":2012,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":915,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Lymphoma; Cancer research; Biology; Oncogene; Cell cycle; Cancer; Genetics; Immunology","score_opus":0.010808729487585485,"score_gpt":0.2404201434775254,"score_spread":0.22961141398993992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118028844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9033561,0.09539083,0.000003629055,0.00065432413,0.0002909939,0.000121361365,0.000057691806,0.000020160642,0.0001049291],"genre_scores_gemma":[0.9964432,0.0004277463,0.0006004366,0.0018414926,0.00047275226,0.000010826316,0.00010431372,0.000013917252,0.000085287196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994373,0.000014539432,0.000080426275,0.00017009514,0.00012883784,0.00016882918],"domain_scores_gemma":[0.99962664,0.00005578992,0.000029458859,0.00011561574,0.000028043547,0.00014443438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035332374,0.00013004067,0.00016006321,0.000029356379,0.00007667169,0.000015991604,0.000017064534,0.0004078118,0.00011117631],"category_scores_gemma":[0.000009944914,0.00009002578,0.00003755651,0.000037025802,0.000036545254,0.000047855443,0.000026664695,0.00013384485,0.000007460905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015315242,0.00010695458,0.88137335,0.000015195162,0.00025972145,0.000019378962,0.00036439492,2.67922e-7,0.006769486,0.0007485623,0.0007281977,0.10946133],"study_design_scores_gemma":[0.0018950321,0.000046346617,0.9803698,0.0000091753645,0.00019334382,0.00011576031,0.000047323905,0.000037480204,0.0024913144,0.00029865763,0.014403113,0.00009262927],"about_ca_topic_score_codex":0.000026603662,"about_ca_topic_score_gemma":0.000004233106,"teacher_disagreement_score":0.1093687,"about_ca_system_score_codex":0.00010853039,"about_ca_system_score_gemma":0.000030739648,"threshold_uncertainty_score":0.36711448},"labels":[],"label_agreement":null},{"id":"W2118097985","doi":"10.1093/annonc/mdq615","title":"Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Surrogate endpoint; Internal medicine; Clinical endpoint; Aggressive lymphoma; Randomized controlled trial; Confidence interval; Progression-free survival; Proportional hazards model; Oncology; Clinical trial; Log-rank test; Lymphoma; Overall survival; Rituximab","score_opus":0.1132801754187347,"score_gpt":0.41383054635094546,"score_spread":0.30055037093221076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118097985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660534,0.0004575274,0.00011062068,0.0009286867,0.00020873213,0.001349638,0.0001466629,0.000003905389,0.00018891142],"genre_scores_gemma":[0.9983732,0.0010123528,0.00036150543,0.00008940647,0.00002708442,0.000039575814,0.000044479475,0.0000122519095,0.000040126808],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9927697,0.0036086622,0.0028050346,0.00032521435,0.00030438596,0.00018697802],"domain_scores_gemma":[0.99074745,0.004840187,0.0035980484,0.00025741156,0.0004220602,0.00013486312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01357927,0.0001762724,0.0025425178,0.00035954418,0.000018130722,0.0000029010578,0.00007992181,0.00022417362,0.00014022423],"category_scores_gemma":[0.0062302365,0.0001421813,0.0003245858,0.00012348895,0.00046411197,0.00006494172,0.00009494175,0.00006380681,0.0000060822254],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75103074,0.008834481,0.087379575,0.00030361433,0.0019281447,0.00018061916,0.004063789,0.000023551695,0.033108916,0.0004939659,0.0005078486,0.11214474],"study_design_scores_gemma":[0.16945806,0.0037961812,0.79561,0.0003786823,0.00044918648,0.000029004988,0.0000952661,0.0005277563,0.028958514,0.0005457931,0.0000532197,0.00009832597],"about_ca_topic_score_codex":0.00035938845,"about_ca_topic_score_gemma":0.00002553668,"teacher_disagreement_score":0.70823044,"about_ca_system_score_codex":0.00004260313,"about_ca_system_score_gemma":0.0002704865,"threshold_uncertainty_score":0.7458625},"labels":[],"label_agreement":null},{"id":"W2118192033","doi":"10.1093/annonc/mdm471","title":"Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Anthracycline; Oncology; Mastectomy; Lymphoma; Radiation therapy; Chemotherapy regimen; Chemotherapy; Surgery; Breast cancer; Cancer","score_opus":0.028926218165787256,"score_gpt":0.3264011218535761,"score_spread":0.29747490368778884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118192033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958563,0.0004590876,0.0000030388458,0.0010504305,0.00018150755,0.0014001473,0.00009372692,0.000009613455,0.00094616896],"genre_scores_gemma":[0.9992931,0.00005714271,0.000015034589,0.00044599012,0.000024414085,0.000041904314,0.000014329855,0.00001507622,0.00009304461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982616,0.00014891684,0.0006113207,0.00024518694,0.0004835003,0.00024953234],"domain_scores_gemma":[0.99806356,0.00090948725,0.0004053334,0.00035577634,0.00018657332,0.0000792651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070446555,0.00020114874,0.00064491254,0.00009114459,0.00006207996,0.0000058773794,0.000271266,0.000083410334,0.00002064292],"category_scores_gemma":[0.00010944725,0.000099245204,0.00017442733,0.00014447693,0.00019777544,0.000047799927,0.00019869853,0.000044535434,9.0270265e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047882035,0.093844585,0.8837232,0.0000291964,0.0007606477,0.000040374016,0.0027457182,4.5580315e-8,0.00063558505,0.000047980317,0.00046879795,0.017225077],"study_design_scores_gemma":[0.023730239,0.0049594063,0.9634459,0.000022410437,0.0003498742,0.000054659387,0.0041223606,0.0000020191899,0.0025221247,0.000016193206,0.00070195145,0.00007288578],"about_ca_topic_score_codex":0.000529953,"about_ca_topic_score_gemma":0.0003062268,"teacher_disagreement_score":0.08888518,"about_ca_system_score_codex":0.0000866109,"about_ca_system_score_gemma":0.00014839169,"threshold_uncertainty_score":0.40471017},"labels":[],"label_agreement":null},{"id":"W2118316308","doi":"10.1016/j.jcjo.2014.04.008","title":"Extranodal natural killer/T-cell lymphoma masquerading as conjunctivitis","year":2014,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemosis; Dermatology; Lymphoma; Surgery; Pathology","score_opus":0.01798426439682472,"score_gpt":0.25217513791597956,"score_spread":0.23419087351915485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118316308","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38339183,0.009946864,0.0000050572044,0.45080486,0.012185311,0.00056853716,0.000045207133,0.000014669213,0.14303765],"genre_scores_gemma":[0.85117227,0.000024220551,0.00021104897,0.12709644,0.0043709446,0.000012964254,0.00012005256,0.0001000509,0.016892022],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99719834,0.00023129582,0.0007821491,0.00043164933,0.00040166592,0.00095487834],"domain_scores_gemma":[0.9972905,0.0003450092,0.0006462255,0.00044872414,0.0002942893,0.00097525824],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002480271,0.00056726474,0.0014427841,0.00089581084,0.00016140509,0.0000739221,0.00035757213,0.0011226884,0.003950007],"category_scores_gemma":[0.00014475491,0.00047927935,0.00067082606,0.00016364234,0.00028173285,0.00009316093,0.00001732081,0.0012050098,0.00024485265],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004757466,0.00005421504,0.0070560444,0.00009350745,0.0003543804,0.45496866,0.000059440623,6.7925197e-7,0.000013408396,0.00003571627,0.53669643,0.0006199332],"study_design_scores_gemma":[0.0035238315,0.0011995594,0.006790085,0.0002575161,0.00037925525,0.55404514,0.000014609675,0.000003066019,0.00011164224,0.00013623094,0.43326548,0.00027359696],"about_ca_topic_score_codex":0.005897067,"about_ca_topic_score_gemma":0.00004906275,"teacher_disagreement_score":0.4677804,"about_ca_system_score_codex":0.0014569997,"about_ca_system_score_gemma":0.004702769,"threshold_uncertainty_score":0.9997659},"labels":[],"label_agreement":null},{"id":"W2118477722","doi":"10.3816/clm.2009.n.038","title":"Biomarkers and Prognosis in Malignant Lymphomas","year":2009,"lang":"en","type":"article","venue":"Clinical Lymphoma & Myeloma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Boehringer Ingelheim","keywords":"Hematology; Lymphoma; Medicine; Internal medicine; Follicular lymphoma; Oncology; Hodgkin lymphoma; Mantle cell lymphoma; Pathology","score_opus":0.032543491852764624,"score_gpt":0.33770214878561705,"score_spread":0.30515865693285243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118477722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354435,0.0023347216,0.0000024704868,0.0054577426,0.0002327188,0.0007958399,0.000008289968,0.00014066006,0.00748322],"genre_scores_gemma":[0.99378234,0.000993103,0.0015767738,0.0030620822,0.00020782779,0.00008263886,0.000031108466,0.00003089003,0.00023320716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968392,0.0001480478,0.0011364998,0.00088891695,0.00036268926,0.0006246216],"domain_scores_gemma":[0.9982285,0.00043406425,0.00017964219,0.00049653975,0.00008149755,0.00057974015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006443822,0.00039110193,0.00092553947,0.00022139774,0.0000927494,0.00006102616,0.00014626015,0.0003477122,0.00008485679],"category_scores_gemma":[0.00037323087,0.00030658854,0.00033190037,0.0004576032,0.00026481602,0.00013278799,0.00007924238,0.00008476995,0.00013280673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004287619,0.0019675589,0.5607663,0.00001717298,0.00010917259,0.0011501136,0.000041713727,6.857977e-8,0.00009287207,0.0007752168,0.0012942267,0.43335685],"study_design_scores_gemma":[0.01204841,0.0019509739,0.9765552,0.0003350424,0.00018512846,0.0007359787,0.00006860287,0.00013088496,0.0010780635,0.0007346635,0.0058568595,0.00032017886],"about_ca_topic_score_codex":0.000076991775,"about_ca_topic_score_gemma":0.000019154315,"teacher_disagreement_score":0.43303668,"about_ca_system_score_codex":0.00029532373,"about_ca_system_score_gemma":0.00029467634,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W2118515024","doi":"10.1093/annonc/mdm287","title":"Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; University of Toronto; University of British Columbia; Queen's University","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Vinblastine; Internal medicine; Hazard ratio; Radiation therapy; Randomized controlled trial; Bleomycin; Confidence interval; Oncology; Progression-free survival; Cancer; Hodgkin's lymphoma; Lymphoma; Surgery; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.054794425521469195,"score_gpt":0.38218034545652624,"score_spread":0.32738591993505706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118515024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607867,0.00018152618,0.000032909116,0.0006871502,0.0000558609,0.0027586576,0.000055168035,0.000009294996,0.00014076968],"genre_scores_gemma":[0.9980302,0.00005606667,0.001308161,0.00025401532,0.000026753112,0.00023007933,0.000047762616,0.000010896887,0.000036091198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878263,0.00008371295,0.00054191926,0.0001965391,0.00017160854,0.0002235616],"domain_scores_gemma":[0.9972865,0.0018556594,0.0003876201,0.00013489931,0.00020966363,0.0001256862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006625582,0.0001350921,0.0010440581,0.00016455965,0.00002020347,0.00000365994,0.000035976096,0.000078006036,0.0000031159736],"category_scores_gemma":[0.0011619858,0.00008239948,0.00011378171,0.000089180314,0.000071636125,0.000051211922,0.000027877615,0.000024427245,1.909995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39802712,0.003930982,0.5167851,0.00008834828,0.00010069066,0.00004013468,0.00008384411,3.474296e-7,0.0000075965645,0.000033767275,0.000012925494,0.080889165],"study_design_scores_gemma":[0.4904299,0.0065933038,0.5020691,0.00018486315,0.000111839334,8.0211424e-7,0.000020672622,0.000013981761,0.00040826874,0.000022471682,0.000099518504,0.0000452406],"about_ca_topic_score_codex":0.00011718822,"about_ca_topic_score_gemma":0.000054536882,"teacher_disagreement_score":0.0924028,"about_ca_system_score_codex":0.00003844385,"about_ca_system_score_gemma":0.00014312645,"threshold_uncertainty_score":0.3360153},"labels":[],"label_agreement":null},{"id":"W2118875599","doi":"10.1200/jco.2007.15.1001","title":"Involved-Nodal Radiation Therapy As a Component of Combination Therapy for Limited-Stage Hodgkin's Lymphoma: A Question of Field Size","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Dacarbazine; Stage (stratigraphy); ABVD; Vinblastine; Vincristine; Chemotherapy; Bleomycin; Hodgkin's lymphoma; Surgery; Nuclear medicine; Cyclophosphamide","score_opus":0.11147853037135746,"score_gpt":0.43829897388396843,"score_spread":0.32682044351261097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118875599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902348,0.0014243526,0.0001681319,0.0066641145,0.000605189,0.0005496535,0.0000060392545,0.000007283393,0.0003404315],"genre_scores_gemma":[0.9811456,0.014722399,0.0017561507,0.0019139849,0.00032667065,0.000019747558,0.000010704627,0.000012605119,0.000092122325],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971284,0.000346893,0.0018905341,0.00014219192,0.0003559232,0.00013605267],"domain_scores_gemma":[0.9914532,0.005201575,0.00233534,0.00016205256,0.00069785677,0.00014999922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015250702,0.00013107603,0.0012088593,0.000121178295,0.000040059964,0.00000291843,0.00009700111,0.0003392786,0.000049666585],"category_scores_gemma":[0.0024027615,0.000091157744,0.00060061016,0.000110493565,0.00011756652,0.00009341348,0.000012312348,0.000118300566,0.0000017938507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026269637,0.022856247,0.42878744,0.00005132705,0.0009808354,0.00016647791,0.00043937485,0.000015056396,0.002278092,0.0018475202,0.003181302,0.5131267],"study_design_scores_gemma":[0.053526968,0.06189958,0.846203,0.0001045165,0.00014667884,0.00012316968,0.00007123249,0.00018725632,0.01576325,0.0006433227,0.021248976,0.00008204371],"about_ca_topic_score_codex":0.00012165618,"about_ca_topic_score_gemma":0.0000072742923,"teacher_disagreement_score":0.51304466,"about_ca_system_score_codex":0.000182971,"about_ca_system_score_gemma":0.0011117805,"threshold_uncertainty_score":0.3717305},"labels":[],"label_agreement":null},{"id":"W2119410505","doi":"10.1158/0008-5472.can-10-2460","title":"Acquired <i>TNFRSF14</i> Mutations in Follicular Lymphoma Are Associated with Worse Prognosis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Nonsynonymous substitution; Follicular lymphoma; Biology; Hazard ratio; Loss of heterozygosity; Exon; Genetics; Oncology; Gene; Cancer research; Confidence interval; Allele; Lymphoma; Internal medicine; Medicine; Immunology; Genome","score_opus":0.051380995128582206,"score_gpt":0.3698850732634636,"score_spread":0.3185040781348814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119410505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928449,0.0004687662,7.4343865e-7,0.004172392,0.00007921488,0.0010725908,0.000041331772,0.00005365528,0.0012664271],"genre_scores_gemma":[0.99609584,0.00012043771,0.00009174686,0.00019252351,0.00010126489,0.0025149407,0.0000736069,0.00003533421,0.0007743192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797124,0.000105344996,0.00019862062,0.000399052,0.00074571656,0.000580057],"domain_scores_gemma":[0.9986742,0.00022417396,0.00005959489,0.0003450316,0.00044735402,0.0002496163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046639616,0.00015266452,0.00029518869,0.00027708983,0.00016683998,0.000057885773,0.00012745039,0.00013630558,0.00029923482],"category_scores_gemma":[0.0003185611,0.00011141562,0.00006816273,0.0011739428,0.00022713248,0.000091874404,0.000050742772,0.00018659519,0.00005760384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022894077,0.001834333,0.9762033,0.00004020667,0.00020681658,0.00083843764,0.00044407116,0.000007848547,0.005811787,0.00014444126,0.0031807912,0.011059005],"study_design_scores_gemma":[0.0069499738,0.0002974203,0.9607984,0.0005300357,0.000074767355,0.00001911646,0.00032842066,0.00005456718,0.025820434,0.0000770268,0.0048983567,0.00015149903],"about_ca_topic_score_codex":0.0012669015,"about_ca_topic_score_gemma":0.0071335123,"teacher_disagreement_score":0.020008648,"about_ca_system_score_codex":0.00063517503,"about_ca_system_score_gemma":0.0007323188,"threshold_uncertainty_score":0.4543397},"labels":[],"label_agreement":null},{"id":"W2119607854","doi":"10.1200/jco.2011.35.4449","title":"Meta-Analysis of the Association Between Cigarette Smoking and Incidence of Hodgkin's Lymphoma","year":2011,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Incidence (geometry); Observational study; Meta-analysis; Hodgkin lymphoma; Publication bias; Confidence interval; Lymphoma; Gastroenterology","score_opus":0.41229916660991,"score_gpt":0.5045479278318453,"score_spread":0.09224876122193532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119607854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012262853,0.9859432,0.0000045143306,0.00053380994,0.0003468932,0.0002956884,0.00004788661,0.0000020099485,0.00056313525],"genre_scores_gemma":[0.052363142,0.9467552,0.00022174299,0.0002436088,0.00028984854,0.00000839176,0.0000058577166,0.00001463664,0.00009762001],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922673,0.0015657281,0.0051249755,0.00022803484,0.0006482699,0.00016567927],"domain_scores_gemma":[0.9717254,0.010744024,0.016336406,0.00038318115,0.00063041743,0.00018058183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071482365,0.00024950405,0.013525327,0.0003284374,0.000028276654,0.000005325127,0.0003014874,0.0009771525,0.00010556738],"category_scores_gemma":[0.0044741887,0.00011770725,0.008573688,0.0005495668,0.00017349873,0.000053952852,0.00014462465,0.0005080058,9.2845045e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033715645,0.00044564466,0.12620732,0.0003899789,0.3660826,0.00003273806,0.000028411901,1.4850339e-7,1.5625687e-8,0.000040712228,0.0001569927,0.5065817],"study_design_scores_gemma":[0.00087285496,0.0010513561,0.22241777,0.0004960784,0.572962,0.000030088493,0.0000037935126,3.680149e-7,0.0000014541364,0.000034702465,0.20207858,0.00005095388],"about_ca_topic_score_codex":0.00007453633,"about_ca_topic_score_gemma":0.000029225592,"teacher_disagreement_score":0.50653076,"about_ca_system_score_codex":0.00047435827,"about_ca_system_score_gemma":0.0019828137,"threshold_uncertainty_score":0.9245643},"labels":[],"label_agreement":null},{"id":"W2119661337","doi":"10.1158/1078-0432.ccr-07-1254","title":"Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global<i>CD20</i>Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CD20; Rituximab; Lymphoma; Medicine; Cancer research; Transfection; Immunology; Chemistry; Gene; Biochemistry","score_opus":0.14338762689709106,"score_gpt":0.40205136518796136,"score_spread":0.2586637382908703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119661337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236805,0.008832386,0.000004166317,0.0067594224,0.000032835178,0.0012962817,0.00031219746,0.000014083982,0.00038059356],"genre_scores_gemma":[0.9953881,0.0013974899,0.0002393291,0.0002517212,0.00006384657,0.00024114695,0.000052221083,0.000016060138,0.002350077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706703,0.00034349176,0.00062171294,0.00052595075,0.0010841271,0.0003577055],"domain_scores_gemma":[0.99860156,0.00032016885,0.00013097805,0.0002860297,0.00048592768,0.00017532753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011872945,0.00017798865,0.0004429662,0.00007357197,0.00024000164,0.000019047622,0.00009648706,0.00017569771,0.00014901061],"category_scores_gemma":[0.00013029303,0.000115199815,0.00008118288,0.00048846874,0.0010792281,0.000087711,0.00005729022,0.00014773087,0.0000036029123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010531087,0.004498494,0.95042676,0.0003098292,0.00045258645,0.00014772319,0.0007866511,0.000010139399,0.023877116,0.00049242645,0.0055692126,0.0028979878],"study_design_scores_gemma":[0.0145439645,0.00065216125,0.9706545,0.00052382355,0.00006218139,0.000017265458,0.00002328674,0.00006300021,0.011764775,0.0003505726,0.0012298569,0.00011462138],"about_ca_topic_score_codex":0.00053208956,"about_ca_topic_score_gemma":0.0015214127,"teacher_disagreement_score":0.020227745,"about_ca_system_score_codex":0.00062856113,"about_ca_system_score_gemma":0.0006574762,"threshold_uncertainty_score":0.4697712},"labels":[],"label_agreement":null},{"id":"W2119667587","doi":"10.1111/j.1365-2559.2005.02068.x","title":"Aggressive B‐cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology","year":2005,"lang":"en","type":"review","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Terminology; Medical diagnosis; Variety (cybernetics); Panel discussion; Medicine; Psychology; Pathology; Family medicine; Computer science; Linguistics","score_opus":0.04104258926581771,"score_gpt":0.3126845605772443,"score_spread":0.2716419713114266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119667587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000107787884,0.9781683,0.0000036417118,0.0024833917,0.00058144075,0.003144218,0.000102732796,0.000017358283,0.015391135],"genre_scores_gemma":[0.0015712769,0.99348956,0.00011851234,0.0023195592,0.00021276671,0.000621578,0.000043272954,0.00007281809,0.0015506742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949547,0.0027677913,0.0011340145,0.00045895786,0.0003540563,0.0003304762],"domain_scores_gemma":[0.9920983,0.0021814501,0.004093417,0.0013594793,0.00022382868,0.0000435708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021362829,0.00042584856,0.0021581277,0.000089517045,0.00017986965,0.000004891972,0.0005822118,0.0003030626,0.00004472354],"category_scores_gemma":[0.0024501183,0.00018258943,0.0015637615,0.0003091578,0.00023334997,0.0000115738485,0.00016274095,0.00029229003,0.000029158797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005916723,0.00210971,0.0029620223,0.058960952,0.00016270702,0.0002966951,0.0006061004,0.0000091596885,0.00002423688,0.0016238837,0.03820687,0.8949785],"study_design_scores_gemma":[0.0010445692,0.00017941346,0.0019399086,0.071448326,0.004793004,0.00032960175,0.00001558346,0.000003599687,0.000026101623,0.000018920466,0.9200295,0.00017147642],"about_ca_topic_score_codex":0.0000046239475,"about_ca_topic_score_gemma":0.000007894354,"teacher_disagreement_score":0.89480704,"about_ca_system_score_codex":0.0008360098,"about_ca_system_score_gemma":0.0005515341,"threshold_uncertainty_score":0.7445781},"labels":[],"label_agreement":null},{"id":"W2119761437","doi":"10.1093/jncimonographs/lgu005","title":"Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"review","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Hodgkin lymphoma; Epidemiology; Lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.08290826798318492,"score_gpt":0.350934207181764,"score_spread":0.2680259391985791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119761437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011178202,0.99284,0.00028608282,0.00031311746,0.00086513715,0.0034644888,0.00017105749,0.000046682842,0.00089562865],"genre_scores_gemma":[0.002354899,0.9932898,0.0017911019,0.000491412,0.00024673948,0.0010475877,0.0002644357,0.00006302059,0.0004509814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967761,0.00054235477,0.0012910278,0.0006867033,0.00033314925,0.00037065794],"domain_scores_gemma":[0.996137,0.0017602321,0.0010578207,0.0007331943,0.00018169182,0.00013003702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008850625,0.00057770964,0.0024040332,0.00044323102,0.00010721249,0.000027922973,0.00041595902,0.0004334061,0.000043552198],"category_scores_gemma":[0.00050945766,0.00033957724,0.0010330079,0.0003893955,0.00040595012,0.000062631916,0.00018883361,0.00008926126,0.000026137022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013837646,0.0006852559,0.013010539,0.0034548002,0.0020004562,0.000026201715,0.00013670846,0.0000014269257,0.0000022694,0.0009509059,0.016881684,0.9627114],"study_design_scores_gemma":[0.0030270177,0.000469738,0.009657331,0.0064404923,0.002164188,0.0006707392,0.00003266394,0.0001972588,0.0000309088,0.00021740954,0.97673255,0.00035971752],"about_ca_topic_score_codex":0.0001858196,"about_ca_topic_score_gemma":0.000014793094,"teacher_disagreement_score":0.9623517,"about_ca_system_score_codex":0.00029442646,"about_ca_system_score_gemma":0.0010218164,"threshold_uncertainty_score":0.99990565},"labels":[],"label_agreement":null},{"id":"W2119909547","doi":"10.1200/jco.2006.05.6879","title":"Survival and Late Effects in Children With Hodgkin's Lymphoma Treated With MOPP/ABV and Low-Dose, Extended-Field Irradiation","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; SickKids Foundation; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Procarbazine; Vinblastine; Vincristine; Bleomycin; Internal medicine; Radiation therapy; Lymphoma; Prednisone; Cumulative incidence; Chemotherapy; ABVD; Oncology; Surgery; Gastroenterology; Cyclophosphamide; Cohort","score_opus":0.018974925201696698,"score_gpt":0.3447616431269368,"score_spread":0.3257867179252401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119909547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635214,0.0006383408,0.000012804273,0.0016203204,0.00008589055,0.00030923882,0.0000014492553,0.000008298483,0.0009715095],"genre_scores_gemma":[0.99780226,0.00053382263,0.0007791544,0.00050090457,0.00029662665,0.000008073335,0.0000052794994,0.0000148114705,0.00005904548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.00023452446,0.00081951683,0.00021530686,0.00022519269,0.00019718226],"domain_scores_gemma":[0.9974624,0.0014825757,0.00061645015,0.000110107365,0.00010671055,0.00022175442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006673879,0.00016571075,0.0010468498,0.00012831078,0.000030902524,0.00001537278,0.000041366773,0.00024647682,0.0000073696606],"category_scores_gemma":[0.00025005557,0.00009426402,0.0000808689,0.00012811125,0.0001238856,0.00010093003,0.00001774581,0.00020671565,0.0000016207312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037081896,0.0020117408,0.87192005,0.0000156107,0.00031355178,0.0014846013,0.000014420555,0.000011364127,0.000014425832,0.00009042003,0.00008477834,0.12033084],"study_design_scores_gemma":[0.036471725,0.02112338,0.9398717,0.00017220632,0.00046649892,0.0013059662,0.000012368284,0.0000728962,0.000097715565,0.0001231363,0.00018619461,0.000096193995],"about_ca_topic_score_codex":0.00039553115,"about_ca_topic_score_gemma":0.00036617156,"teacher_disagreement_score":0.120234646,"about_ca_system_score_codex":0.000119133554,"about_ca_system_score_gemma":0.00039211655,"threshold_uncertainty_score":0.3843975},"labels":[],"label_agreement":null},{"id":"W2119915366","doi":"10.3109/10428190009148856","title":"The Use of Archival Bone Marrow Specimens in Detecting B-Cell Non-Hodgkin's Lymphomas Using Polymerase Chain Reaction Methods","year":2000,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Lymphoma; Bone marrow; Pathology; Polymerase chain reaction; Biopsy; Non-Hodgkin's lymphoma; Monoclonal; Medicine; Biology; Molecular biology; Monoclonal antibody; Antibody; Gene; Immunology","score_opus":0.026970797353493493,"score_gpt":0.2842633691387643,"score_spread":0.2572925717852708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119915366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913132,0.0028014435,0.00013248688,0.00017586631,0.00036848828,0.0011467178,0.000037566817,0.00013808884,0.0038861153],"genre_scores_gemma":[0.98023504,0.0029127882,0.013716966,0.00057039445,0.00036551125,0.00014757106,0.000052856976,0.00017330736,0.0018255812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941182,0.0005975882,0.0017063232,0.0013072309,0.00081852445,0.0014521204],"domain_scores_gemma":[0.9956144,0.0016364222,0.000632389,0.0013583385,0.0001377468,0.0006207223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010562907,0.0009994141,0.0014907776,0.0005669976,0.0007170316,0.00021760832,0.00031469588,0.00046341642,0.00008376155],"category_scores_gemma":[0.0002061338,0.0007948668,0.00054739113,0.0010811135,0.0005649564,0.0005101436,0.00019448566,0.0002176114,0.000034295164],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028251202,0.00085821614,0.012271836,0.00021152291,0.0003026524,0.0010006768,0.0011488667,0.00030653208,0.1158933,0.00018612396,0.00028254764,0.8647126],"study_design_scores_gemma":[0.06247854,0.0015518495,0.4704781,0.0015729017,0.0013852057,0.006607569,0.0012029884,0.0858609,0.32423875,0.00042187856,0.042047422,0.0021539323],"about_ca_topic_score_codex":0.011422258,"about_ca_topic_score_gemma":0.00022487433,"teacher_disagreement_score":0.86255866,"about_ca_system_score_codex":0.008169762,"about_ca_system_score_gemma":0.0025905932,"threshold_uncertainty_score":0.9994502},"labels":[],"label_agreement":null},{"id":"W2120309731","doi":"10.3109/10428194.2014.970548","title":"Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Lymphoma; Cell culture; Medicine; Malignancy; Disease; Cancer research; Biology; Pathology; Genetics","score_opus":0.007498928054494789,"score_gpt":0.2181362960515551,"score_spread":0.21063736799706032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120309731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926142,0.0006919033,0.00002703067,0.0001460131,0.00015894265,0.00072181894,0.0000137943725,0.000069215,0.005557092],"genre_scores_gemma":[0.99442065,0.0016254024,0.0010827237,0.0011986987,0.00014124592,0.00014615506,0.00019830724,0.000059303864,0.0011274865],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971974,0.00019668254,0.0007468383,0.0007446457,0.00054110383,0.00057332404],"domain_scores_gemma":[0.99841154,0.00017373974,0.0004891011,0.000531754,0.00014750853,0.00024634958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004000953,0.0005525588,0.0008714584,0.00030388162,0.000294334,0.000097403245,0.00020685043,0.0002462548,0.000015051851],"category_scores_gemma":[0.000039959905,0.00040289888,0.000121867866,0.00096301804,0.00027327,0.00017318907,0.00010976988,0.000069687434,0.000028475892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032347317,0.00382438,0.18710057,0.0014708892,0.00035070235,0.00041539693,0.02214977,0.0000116176725,0.13330844,0.0010352685,0.0032266036,0.6438716],"study_design_scores_gemma":[0.017808972,0.0009547638,0.83787954,0.00022994325,0.0002448995,0.0004579158,0.0011796838,0.0014441909,0.08161751,0.00004927832,0.05761581,0.0005174771],"about_ca_topic_score_codex":0.0009406087,"about_ca_topic_score_gemma":0.000095317744,"teacher_disagreement_score":0.65077895,"about_ca_system_score_codex":0.0026170257,"about_ca_system_score_gemma":0.0013936332,"threshold_uncertainty_score":0.9998423},"labels":[],"label_agreement":null},{"id":"W2120615563","doi":"10.1007/s00432-006-0188-3","title":"Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic–pathologic–clinical correlations","year":2007,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Trisomy; Lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma; Internal medicine; Hematology; Cytogenetics; Chemotherapy; Aneuploidy; Medicine; Gastroenterology; Working Formulation; Pathology; Chromosome; Biology; Genetics","score_opus":0.17056183380717926,"score_gpt":0.5409794011989751,"score_spread":0.3704175673917959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120615563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898412,0.0026145745,0.0005026608,0.005242207,0.0003799335,0.000320629,0.0000109907205,0.000005639999,0.001082118],"genre_scores_gemma":[0.98266333,0.01416163,0.0012290456,0.0005276163,0.0011675104,0.00001475946,0.000003400729,0.0000132013865,0.00021948347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706227,0.00032587445,0.0012480115,0.00031210977,0.00060618174,0.00044557807],"domain_scores_gemma":[0.99480456,0.0029772948,0.00043031687,0.00016670552,0.00084124535,0.00077986805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054551084,0.00014031252,0.00075609435,0.00019826074,0.00014935539,0.000023820194,0.000098796816,0.00036672098,0.00012980044],"category_scores_gemma":[0.000612716,0.000086721215,0.00016431414,0.00019495623,0.0008430575,0.00007678302,0.00009099249,0.0006776539,0.0000072368052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052184234,0.0019275018,0.7926267,0.000015166318,0.00028594988,0.0018657483,0.0000325641,0.0000011659948,0.000024972016,0.00011258708,0.0018532377,0.19603601],"study_design_scores_gemma":[0.013762039,0.03112076,0.94112676,0.00017464701,0.00024729423,0.0014011378,0.00019903638,0.000031952444,0.00005170474,0.00032409927,0.011478194,0.00008237703],"about_ca_topic_score_codex":0.00017815737,"about_ca_topic_score_gemma":0.0009128408,"teacher_disagreement_score":0.19595364,"about_ca_system_score_codex":0.00045997932,"about_ca_system_score_gemma":0.0016017419,"threshold_uncertainty_score":0.35363886},"labels":[],"label_agreement":null},{"id":"W2120703089","doi":"10.1093/annonc/mdh069","title":"Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis","year":2004,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Autologous stem-cell transplantation; Chemotherapy; Oncology; Lymphoma; Stage (stratigraphy); Transplantation; Internal medicine","score_opus":0.030222630829341558,"score_gpt":0.32999387399501345,"score_spread":0.2997712431656719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120703089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787091,0.0009137175,0.002024047,0.016348196,0.00007796217,0.0014637972,0.00026941887,0.00005994529,0.00013381697],"genre_scores_gemma":[0.97785836,0.0022187917,0.004965593,0.013946297,0.000032033826,0.0003629758,0.00016470149,0.000045055596,0.00040621287],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831665,0.0000464965,0.0005349255,0.000514921,0.0002067578,0.00038024053],"domain_scores_gemma":[0.9984663,0.00032990516,0.0002463407,0.00025239366,0.0004913773,0.00021366814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017610846,0.0002926128,0.001139754,0.0002889542,0.0000647579,0.000013906701,0.00009459211,0.00021818429,0.0001031035],"category_scores_gemma":[0.000017247386,0.00025921772,0.00040121193,0.00031985657,0.00012208939,0.00008177606,0.000014492175,0.000049737297,0.000010946335],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068244204,0.04498556,0.050755937,0.0034592275,0.01371929,0.002628817,0.057280283,0.0016319315,0.05992352,0.0018120464,0.011956514,0.6836027],"study_design_scores_gemma":[0.29009193,0.020982418,0.2032828,0.00022249651,0.0028097194,0.00017102937,0.0044773924,0.00053851545,0.45380306,0.00080325606,0.021997675,0.0008196955],"about_ca_topic_score_codex":0.00032001242,"about_ca_topic_score_gemma":0.000104237784,"teacher_disagreement_score":0.68278295,"about_ca_system_score_codex":0.00023706432,"about_ca_system_score_gemma":0.0004110085,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W2120711586","doi":"10.1016/s1470-2045(14)70005-1","title":"Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Follicular lymphoma; Clinical endpoint; Internal medicine; International Prognostic Index; Vincristine; Regimen; Prednisone; Cyclophosphamide; Population; Lymphoma; Oncology; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy","score_opus":0.025716597926266682,"score_gpt":0.35121340322397865,"score_spread":0.32549680529771197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120711586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966029,0.00046031756,0.0000429115,0.0006687423,0.000038041828,0.0009465871,0.000038213544,0.0000109488155,0.0011913702],"genre_scores_gemma":[0.9988902,0.00053822855,0.00015499072,0.000230883,0.00004691976,0.00006503441,0.000017673716,0.00000864762,0.000047409634],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856496,0.00041682448,0.00045129814,0.00020201213,0.00016522035,0.00019966178],"domain_scores_gemma":[0.9985726,0.00070934097,0.0002244334,0.0003774209,0.000058819765,0.000057424048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085725123,0.00013304861,0.0014593778,0.00016991375,0.000025926704,0.0000030419644,0.00010507546,0.000057134195,0.00006992476],"category_scores_gemma":[0.00009768567,0.00008379804,0.00013424509,0.00040381151,0.00013097972,0.000012232936,0.000053340358,0.00005129539,0.0000015233769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15153833,0.0568159,0.5843416,0.0003221491,0.013448017,0.0020286266,0.0072056977,0.0005179915,0.006185865,0.00103362,0.00026540644,0.1762968],"study_design_scores_gemma":[0.6829539,0.0082918005,0.27904138,0.00003844142,0.009897011,0.00010536201,0.0006754579,0.0075536007,0.0031375524,0.000038772545,0.008110094,0.0001566422],"about_ca_topic_score_codex":0.00034148825,"about_ca_topic_score_gemma":0.00021356189,"teacher_disagreement_score":0.5314156,"about_ca_system_score_codex":0.000116365416,"about_ca_system_score_gemma":0.00006440347,"threshold_uncertainty_score":0.3417185},"labels":[],"label_agreement":null},{"id":"W2121142323","doi":"10.3109/10428194.2015.1010079","title":"Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials","year":2015,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Clinical trial; Biology","score_opus":0.03231703514413337,"score_gpt":0.31077920280161025,"score_spread":0.2784621676574769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121142323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96399283,0.0046697087,0.00004070404,0.014460747,0.0025684012,0.0067590047,0.003001204,0.00037233508,0.0041350853],"genre_scores_gemma":[0.66179866,0.00268741,0.001880941,0.31250522,0.0057536643,0.002027378,0.0062953862,0.0009798801,0.0060714968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98292226,0.0019816016,0.00529041,0.0034791867,0.0036467277,0.0026798362],"domain_scores_gemma":[0.98644084,0.0021511894,0.0029455773,0.0031714132,0.0013589023,0.0039320765],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0038124705,0.0028943373,0.0076427027,0.0010888575,0.00047051665,0.00028056838,0.001068186,0.0034201352,0.00026484902],"category_scores_gemma":[0.0020675906,0.0021565913,0.0019278079,0.0010029431,0.0006331447,0.0003463615,0.0008020251,0.0006495144,0.0002686134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008970414,0.007025703,0.071405105,0.0012933766,0.0027714353,0.00206731,0.0010076176,0.000002733369,0.000014959095,0.00004929442,0.7922036,0.11318842],"study_design_scores_gemma":[0.18816221,0.005839722,0.08392619,0.0016474071,0.004081746,0.00017189028,0.00026285404,0.00011040823,0.00045910987,0.000050610226,0.71327376,0.002014113],"about_ca_topic_score_codex":0.0012641299,"about_ca_topic_score_gemma":0.00011325055,"teacher_disagreement_score":0.30219418,"about_ca_system_score_codex":0.020851562,"about_ca_system_score_gemma":0.01925212,"threshold_uncertainty_score":0.9983788},"labels":[],"label_agreement":null},{"id":"W2121907519","doi":"10.1016/j.jaci.2010.09.016","title":"Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency","year":2010,"lang":"en","type":"letter","venue":"Journal of Allergy and Clinical Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Feature (linguistics); Diffuse large B-cell lymphoma; Lymphoma; Medicine; Cancer research; Pathology","score_opus":0.01677387037179141,"score_gpt":0.30534198265353957,"score_spread":0.28856811228174817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121907519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7725306,0.014979386,0.000003569802,0.20770939,0.001861579,0.0001651777,0.000013097646,0.000011168319,0.0027260033],"genre_scores_gemma":[0.47728315,0.12244782,0.0010166112,0.3745125,0.008675897,0.000017481956,0.00015921736,0.00018400984,0.015703315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969049,0.00025320353,0.001518336,0.00035058893,0.0005110761,0.00046190605],"domain_scores_gemma":[0.996114,0.0010924863,0.0017473584,0.00047500245,0.00040733,0.00016382665],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00059341156,0.00035348203,0.0015353978,0.00020996691,0.00008905705,0.00002284614,0.00036803022,0.0038305789,0.0003204422],"category_scores_gemma":[0.0008042863,0.00024043338,0.0008668561,0.00010001522,0.0003599446,0.00007190121,0.00022407637,0.0034373766,0.000027583894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022829906,0.035696123,0.0419727,0.0003865733,0.0117689865,0.022278953,0.0003015274,1.376855e-7,0.0004362627,0.000381687,0.85547966,0.02901438],"study_design_scores_gemma":[0.029385218,0.0036029317,0.0746767,0.00045661023,0.00095221127,0.004373058,0.000072667346,0.0000049537566,0.00041525756,0.00023445708,0.8855686,0.0002573379],"about_ca_topic_score_codex":0.00003969147,"about_ca_topic_score_gemma":0.000025337591,"teacher_disagreement_score":0.29524747,"about_ca_system_score_codex":0.000047554924,"about_ca_system_score_gemma":0.0006252271,"threshold_uncertainty_score":0.99886173},"labels":[],"label_agreement":null},{"id":"W2121968091","doi":"10.1158/1078-0432.ccr-14-3253","title":"The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Follicular lymphoma; Lymphoma; Cancer; Medicine; CD163; International agency; Oncology; Pathology; Internal medicine; Immunology; Biology; Macrophage","score_opus":0.14753129388764258,"score_gpt":0.5131827052500217,"score_spread":0.36565141136237916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121968091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720457,0.018012373,2.5071262e-7,0.004471236,0.00019591718,0.0050381464,0.00007566771,0.000011265615,0.00014941728],"genre_scores_gemma":[0.9929609,0.003917083,0.0000027243245,0.00010873755,0.0003496215,0.002396078,0.0000062027557,0.00002442541,0.00023422744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99318457,0.0035180594,0.00077880063,0.0005173415,0.0014711838,0.0005300473],"domain_scores_gemma":[0.9862505,0.011844878,0.00025757067,0.00065042946,0.0007726531,0.00022395141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008683898,0.00021377778,0.0006718054,0.000056307133,0.00034580173,0.00012246003,0.00037496226,0.000116746916,0.000037025766],"category_scores_gemma":[0.0050126947,0.00008569019,0.00023976654,0.00065661187,0.0005370928,0.00006412576,0.0003304918,0.00029202588,0.00001435373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030692592,0.004923912,0.9354058,0.0000056624162,0.0015538407,0.00012847091,0.006070724,0.000006314348,0.0000029569148,0.00001449308,0.0018012755,0.04701733],"study_design_scores_gemma":[0.030362029,0.0029875862,0.96019655,0.00012765377,0.00046060164,0.00000156197,0.00523788,0.00013450522,0.000025423513,0.0002665619,0.00011535161,0.000084315616],"about_ca_topic_score_codex":0.13027488,"about_ca_topic_score_gemma":0.014465101,"teacher_disagreement_score":0.11580978,"about_ca_system_score_codex":0.001920211,"about_ca_system_score_gemma":0.0018549265,"threshold_uncertainty_score":0.8755167},"labels":[],"label_agreement":null},{"id":"W2122019520","doi":"10.1016/s1470-2045(05)70434-4","title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","year":2005,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Odds ratio; Single-nucleotide polymorphism; Follicular lymphoma; Genotype; Allele; Medicine; Immunology; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Biology; Genetics; Gene","score_opus":0.018200695965837014,"score_gpt":0.29873375294802484,"score_spread":0.28053305698218783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122019520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989653,0.0016823438,0.00004024343,0.0070293704,0.00008334687,0.0003154649,0.000017581398,0.000009301516,0.001169329],"genre_scores_gemma":[0.994991,0.0021618449,0.0015085685,0.00091578637,0.0003145756,0.00005698039,0.0000064798646,0.000007015976,0.000037716618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991438,0.00016443637,0.00028657017,0.0001824219,0.00007980673,0.00014297321],"domain_scores_gemma":[0.99882966,0.00059872726,0.00019977048,0.00030905197,0.000028405266,0.00003439764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043971214,0.00009201042,0.00038468794,0.000025467118,0.000038329224,0.0000073028114,0.00006327995,0.00007950108,0.000026448353],"category_scores_gemma":[0.00012728272,0.000048455866,0.000027330965,0.00006195908,0.00015123132,0.000021028993,0.000054664644,0.000055246455,0.0000054275756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037461202,0.00029973482,0.8576423,0.000009428415,0.0001766979,0.00015087289,0.002494636,0.000006788199,0.00041135895,0.00010878549,0.00095668365,0.1373681],"study_design_scores_gemma":[0.0064538484,0.0002961607,0.9827149,0.00003356187,0.00025911542,0.00041654846,0.00013427618,0.00064168125,0.0002180336,0.00037831944,0.00840786,0.000045699755],"about_ca_topic_score_codex":0.0029782795,"about_ca_topic_score_gemma":0.0017065433,"teacher_disagreement_score":0.1373224,"about_ca_system_score_codex":0.0001372133,"about_ca_system_score_gemma":0.00011288419,"threshold_uncertainty_score":0.45022875},"labels":[],"label_agreement":null},{"id":"W2123164802","doi":"10.1371/journal.pgen.1001378","title":"GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Burnaby Hospital; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; Cancer Council NSW; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; AFA Försäkring; Michael Smith Health Research BC; Genome Institute of Singapore; National Cancer Institute; Sundhed og Sygdom, Det Frie Forskningsråd; Cancerfonden; National Institutes of Health; Vetenskapsrådet; Yale University","keywords":"Biology; Follicular lymphoma; Allele; Genome-wide association study; Genetics; Diffuse large B-cell lymphoma; Lymphoma; Genetic heterogeneity; Phenotype; Single-nucleotide polymorphism; Genotype; Gene; Immunology","score_opus":0.027678270282105996,"score_gpt":0.23719668959465673,"score_spread":0.20951841931255072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123164802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189055,0.006155702,0.00001197302,0.000043462645,0.0000443426,0.0011237449,0.00016771453,0.000065979824,0.00049652014],"genre_scores_gemma":[0.9940426,0.0013004036,0.0039432226,0.0002377911,0.00005699359,0.00011555621,0.000081166945,0.00007989444,0.00014242377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997312,0.00011952972,0.00060364377,0.00079324184,0.0005563112,0.00061527966],"domain_scores_gemma":[0.997726,0.00007871238,0.00026887245,0.0011985373,0.00023650915,0.0004913224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013519937,0.0004800456,0.00080136245,0.000105272,0.00012861405,0.000021268494,0.00019207541,0.00022267729,0.00013467998],"category_scores_gemma":[0.00003614996,0.0003729391,0.00019565065,0.00018990932,0.00020182398,0.000044916353,0.00026046456,0.00004272052,0.000046451212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049901096,0.015433944,0.96183103,0.00046077388,0.00050714746,0.00030842534,0.0009252729,0.0000014375274,0.018165676,0.000009581073,0.00017895427,0.0016787244],"study_design_scores_gemma":[0.018427717,0.0014920792,0.7007994,0.00012808894,0.00078543136,0.00013608037,0.00004762011,0.00020354634,0.2773275,0.000039578426,0.00030125197,0.0003117015],"about_ca_topic_score_codex":0.00008751645,"about_ca_topic_score_gemma":0.000365464,"teacher_disagreement_score":0.26103166,"about_ca_system_score_codex":0.00027986453,"about_ca_system_score_gemma":0.00014056354,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W2123235255","doi":"10.1200/jco.2010.33.6594","title":"Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Rituximab; Vincristine; Surgery; Prednisone; Gastroenterology; Cyclophosphamide; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.21672619874835625,"score_gpt":0.5308915157766564,"score_spread":0.31416531702830014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123235255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899135,0.0013262887,0.00007087968,0.003609055,0.0012784676,0.003247917,0.00022728923,0.0000045405977,0.00032201805],"genre_scores_gemma":[0.9920358,0.0007034161,0.0012834514,0.0047747097,0.0006030459,0.0003334466,0.000008618435,0.000017230639,0.00024024902],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99390525,0.0011639445,0.0037914407,0.0003468582,0.00052042585,0.00027207087],"domain_scores_gemma":[0.9888744,0.006880722,0.0026202584,0.00018795293,0.0008866674,0.00055004086],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009952803,0.00022767346,0.0027514761,0.00007191095,0.00012584738,0.0000063411217,0.00017534682,0.00024161699,0.00010484066],"category_scores_gemma":[0.012457592,0.0001249287,0.0006170977,0.00015556498,0.00019458521,0.00010051157,0.000074444884,0.00022769152,6.9205527e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057566267,0.03978397,0.10935776,0.000057071633,0.008231993,0.0004822526,0.000996581,0.000009053361,0.00010076388,0.0001775068,0.083633244,0.69960356],"study_design_scores_gemma":[0.20193596,0.1452504,0.32487065,0.00023880492,0.0044310065,0.00010646868,0.00041004116,0.00008100716,0.0006255951,0.00014268045,0.3216707,0.00023666245],"about_ca_topic_score_codex":0.014562649,"about_ca_topic_score_gemma":0.037755232,"teacher_disagreement_score":0.69936687,"about_ca_system_score_codex":0.00061571825,"about_ca_system_score_gemma":0.004919022,"threshold_uncertainty_score":0.9958609},"labels":[],"label_agreement":null},{"id":"W2123411437","doi":"10.1186/1746-1596-7-107","title":"Histological and immunohistochemical features of the spleen in persistent polyclonal B-cell lymphocytosis closely mimic splenic B-cell lymphoma","year":2012,"lang":"en","type":"review","venue":"Diagnostic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"","keywords":"Lymphocytosis; Pathology; Immunohistochemistry; Lymphoma; Spleen; Polyclonal antibodies; Medicine; Biology; Antibody; Immunology","score_opus":0.02927449661996363,"score_gpt":0.28008858398985,"score_spread":0.25081408736988636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123411437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09004783,0.90643495,4.4052356e-7,0.00017006714,0.0004741119,0.0014138165,0.00017740559,0.000026127913,0.0012552732],"genre_scores_gemma":[0.15959376,0.8388292,0.00020001012,0.00024981584,0.00012586573,0.0004979377,0.00020377593,0.00006244716,0.0002371916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962731,0.0004998881,0.0012164545,0.00085988303,0.00037421976,0.000776469],"domain_scores_gemma":[0.9954894,0.0025595955,0.00072239543,0.000908455,0.000059339443,0.00026080868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032181898,0.0008063176,0.002982363,0.00028471273,0.00009284405,0.000012010049,0.00043629552,0.0010538556,0.000071857394],"category_scores_gemma":[0.00060476444,0.0005051961,0.0013626905,0.00032744062,0.0006750436,0.000033723758,0.0004338584,0.00039851532,0.000057512556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003418536,0.016854415,0.036951195,0.021787692,0.0008549889,0.0035381278,0.0008879261,4.007979e-7,0.00031596675,0.0005050519,0.0033262845,0.9146361],"study_design_scores_gemma":[0.025288597,0.0026689095,0.1670947,0.016048582,0.02918741,0.025823634,0.00016902636,0.000003395323,0.000824675,0.00007897482,0.7306616,0.0021505104],"about_ca_topic_score_codex":0.0001793058,"about_ca_topic_score_gemma":0.000010974754,"teacher_disagreement_score":0.9124856,"about_ca_system_score_codex":0.0013926479,"about_ca_system_score_gemma":0.0007670095,"threshold_uncertainty_score":0.99973994},"labels":[],"label_agreement":null},{"id":"W2123957608","doi":"10.1200/jco.2012.43.4589","title":"Gene Expression–Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC; Terry Fox Foundation; Canadian Institutes of Health Research; Cancer Research Society; American Society of Hematology; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Internal medicine; Oncology; Dacarbazine; Hazard ratio; Proportional hazards model; Population; Bleomycin; Cohort; ABVD; Vinblastine; Chemotherapy; Confidence interval; Vincristine","score_opus":0.16696197063148124,"score_gpt":0.4494040615140494,"score_spread":0.2824420908825681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123957608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297684,0.0008237717,0.0016610989,0.002065068,0.0015280432,0.00031599577,0.000018161305,0.000021923095,0.0005891094],"genre_scores_gemma":[0.93911695,0.00030500634,0.057478875,0.0019052648,0.0010300282,0.000015067491,0.00001032979,0.000033139295,0.00010531534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950206,0.00055494194,0.0028091713,0.00028345597,0.0006660293,0.00066578],"domain_scores_gemma":[0.9946907,0.002185993,0.0016609062,0.000329165,0.00025752635,0.0008757118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002670078,0.00030599211,0.0020463057,0.00023025699,0.00006464393,0.000014923244,0.00019687976,0.0006447927,0.00006932218],"category_scores_gemma":[0.0018002011,0.00021015486,0.00069038157,0.00015841624,0.00020137081,0.0004209487,0.000103427614,0.0004934327,0.0000114328495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024571072,0.03274012,0.8247592,0.00012929727,0.00064630416,0.0025461775,0.00042847876,0.034521244,0.012331564,0.0007563044,0.0018005854,0.06476964],"study_design_scores_gemma":[0.09858061,0.010263338,0.7433166,0.00072069635,0.0009219882,0.0005097599,0.00022340976,0.10782713,0.024636596,0.00038905276,0.012032417,0.0005784439],"about_ca_topic_score_codex":0.000012508137,"about_ca_topic_score_gemma":0.00002092854,"teacher_disagreement_score":0.08144265,"about_ca_system_score_codex":0.00071622984,"about_ca_system_score_gemma":0.0023662443,"threshold_uncertainty_score":0.85698664},"labels":[],"label_agreement":null},{"id":"W2124219582","doi":"10.1016/j.bbmt.2011.11.012","title":"Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation","year":2012,"lang":"en","type":"review","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Hematopoietic cell; Lymphoma; Oncology; Hematopoietic stem cell transplantation; Transplantation; Follicular phase; Haematopoiesis; Immunology; Internal medicine; Cancer research; Stem cell","score_opus":0.026445402097081377,"score_gpt":0.2734654768296464,"score_spread":0.24702007473256501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124219582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07886406,0.9195307,0.000046799163,0.00002307347,0.000100408026,0.0009110819,0.0004187229,0.000024754145,0.00008039845],"genre_scores_gemma":[0.27157342,0.7245725,0.00023200225,0.000009829438,0.000039084727,0.00009553771,0.0034397887,0.00001894826,0.000018930861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987183,0.0001274426,0.00048551304,0.00033994406,0.00011319483,0.00021556983],"domain_scores_gemma":[0.9992214,0.0002525182,0.00025575212,0.000112640955,0.000037041107,0.00012066375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011683475,0.00036119978,0.0010575592,0.00015178663,0.00006848865,0.000009439172,0.0000416047,0.00037915632,0.00002934935],"category_scores_gemma":[0.000003055958,0.00025469536,0.00023326054,0.000078640514,0.00014649292,0.000057394824,0.000005080687,0.00006559214,0.000002918126],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031548584,0.0035317275,0.124970876,0.22733349,0.0041994904,0.00023431743,0.002354586,4.9806353e-8,0.001453742,0.0037019826,0.000024255198,0.63188],"study_design_scores_gemma":[0.052946586,0.00620139,0.16969043,0.051983833,0.29946384,0.015538792,0.00038767786,0.00000290596,0.010716846,0.00081114244,0.38878718,0.0034693675],"about_ca_topic_score_codex":0.00003981136,"about_ca_topic_score_gemma":0.0000065120144,"teacher_disagreement_score":0.62841064,"about_ca_system_score_codex":0.000016417416,"about_ca_system_score_gemma":0.00011058804,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2125354192","doi":"10.1093/annonc/mds177","title":"Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Lymphoma; Adverse effect; Confidence interval; Population; Oncology; Progression-free survival; Gastroenterology; Surgery; Chemotherapy","score_opus":0.11021171750183127,"score_gpt":0.39544526286376036,"score_spread":0.2852335453619291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125354192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990346,0.0029432068,0.00018813112,0.003953994,0.00049022894,0.00071887486,0.000032919583,0.000040604806,0.0012860277],"genre_scores_gemma":[0.9961567,0.0008949519,0.0010946633,0.00065032736,0.0006067607,0.00023034833,0.00009867508,0.000040094386,0.00022745729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848604,0.000077012584,0.00041296714,0.00027592957,0.00026275354,0.00048530864],"domain_scores_gemma":[0.9985726,0.00023641596,0.00027924182,0.00037281972,0.00036611667,0.00017280766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003959887,0.0002466657,0.0009000104,0.00016405215,0.0001044777,0.0000091853735,0.00009896355,0.000169614,0.00011019712],"category_scores_gemma":[0.00008694514,0.0001756972,0.0003207266,0.00023535102,0.000117837946,0.00015208761,0.000026691143,0.00005338314,0.00003147881],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03824132,0.045456596,0.34730536,0.00096311845,0.015517987,0.00040081335,0.004478758,0.00018081516,0.01684876,0.005562801,0.02377852,0.50126517],"study_design_scores_gemma":[0.14207977,0.03056088,0.29759225,0.00042740436,0.0020910685,0.00047510993,0.0015337638,0.000105487896,0.15440692,0.0005872511,0.3692554,0.00088467315],"about_ca_topic_score_codex":0.0004240797,"about_ca_topic_score_gemma":0.00009402904,"teacher_disagreement_score":0.5003805,"about_ca_system_score_codex":0.00014875554,"about_ca_system_score_gemma":0.00024195788,"threshold_uncertainty_score":0.71647245},"labels":[],"label_agreement":null},{"id":"W2125523937","doi":"10.3324/haematol.2011.056531","title":"A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; University of Alberta","funders":"","keywords":"International Prognostic Index; Medicine; Epoch (astronomy); Rituximab; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Etoposide; Cancer; Germinal center; Single Center; Prednisone; Oncology; Cyclophosphamide; B cell; Chemotherapy; Immunology","score_opus":0.03265571834827629,"score_gpt":0.280381009607812,"score_spread":0.24772529125953568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125523937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981018,0.00094525225,0.000021437269,0.00001891639,0.000011058665,0.00063459703,0.00007055458,0.0000223341,0.00017408592],"genre_scores_gemma":[0.999238,0.000121606594,0.00032607387,0.00008540571,0.0000011006787,0.00013397493,0.000049138675,0.000015974338,0.000028692482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985706,0.00007489574,0.00049198396,0.00039372485,0.00021063641,0.00025812205],"domain_scores_gemma":[0.9991513,0.00004216972,0.00025237765,0.00038014908,0.00007409037,0.000099933204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008655569,0.00023997435,0.0012080562,0.0002564801,0.000025733747,0.0000057517163,0.00008676606,0.00010139275,0.000056803296],"category_scores_gemma":[0.000017582954,0.00014855199,0.000106174986,0.0005782241,0.00008226948,0.00003605361,0.000065310145,0.00004612184,0.000002340474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063843455,0.070458755,0.92462474,0.00008906149,0.0013377438,0.0010735898,0.0012900343,6.8314256e-7,0.00023585102,0.00006154179,0.000017752343,0.00017182926],"study_design_scores_gemma":[0.086407416,0.0013801964,0.9037953,0.000071571994,0.0027092665,0.000028997154,0.00076420157,0.00029090693,0.004380634,0.0000029112946,0.000011924315,0.00015669793],"about_ca_topic_score_codex":0.006135767,"about_ca_topic_score_gemma":0.0027118078,"teacher_disagreement_score":0.085768975,"about_ca_system_score_codex":0.00012284194,"about_ca_system_score_gemma":0.00003304482,"threshold_uncertainty_score":0.9275485},"labels":[],"label_agreement":null},{"id":"W2125933401","doi":"10.1093/annonc/mds054","title":"Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Medicine; Mantle cell lymphoma; Transplantation; Rituximab; Internal medicine; Surgery; Autologous stem-cell transplantation; Regimen; Lymphoma; Oncology","score_opus":0.06548935314046735,"score_gpt":0.35033610711244606,"score_spread":0.28484675397197873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125933401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940237,0.00108458,0.000113196016,0.00045987038,0.00040936397,0.00051101914,0.000049298407,0.000025138212,0.0033238356],"genre_scores_gemma":[0.9965585,0.00067468383,0.0008048644,0.0012511798,0.000120106146,0.0001731392,0.000104834915,0.0000173487,0.00029534748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989296,0.000052185085,0.00032787453,0.00021396764,0.00012501187,0.00035131595],"domain_scores_gemma":[0.9990227,0.0002171702,0.0002117975,0.00017959779,0.00020501312,0.00016368342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017315701,0.00014564215,0.00037752552,0.000075832635,0.00007607921,0.000004394997,0.00005916325,0.00015142623,0.000053262444],"category_scores_gemma":[0.000012548588,0.0001253988,0.00015872873,0.00005361698,0.00008095767,0.00013559927,0.000014512606,0.000040646624,0.000034703506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009810237,0.03984267,0.34154466,0.0017689328,0.00066953554,0.0004573961,0.04202846,0.000024626255,0.41399547,0.00052583666,0.029754795,0.11957739],"study_design_scores_gemma":[0.008978084,0.0024527162,0.20442405,0.00007109848,0.00024643575,0.000095901996,0.0013802841,0.000030034587,0.7589718,0.000011050312,0.023188729,0.00014980535],"about_ca_topic_score_codex":0.00005030157,"about_ca_topic_score_gemma":0.0000051390307,"teacher_disagreement_score":0.34497634,"about_ca_system_score_codex":0.00011023046,"about_ca_system_score_gemma":0.000108257576,"threshold_uncertainty_score":0.5113615},"labels":[],"label_agreement":null},{"id":"W2126593792","doi":"10.3390/cancers5020714","title":"Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin’s Lymphoma","year":2013,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke","funders":"","keywords":"Genome instability; Oncogene; Cancer research; Biology; Lymphoma; Germinal center; Telomere; Gene expression profiling; Shelterin; BCL6; Chromosome instability; Gene; Gene expression; Transcription factor; Genetics; Cell cycle; Immunology; B cell; DNA damage; DNA; DNA-binding protein","score_opus":0.015177210463428894,"score_gpt":0.25149886959254036,"score_spread":0.23632165912911146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126593792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871447,0.0017828315,0.00001784624,0.001526591,0.00041545025,0.0006336231,0.0000035819003,0.000056806002,0.008418572],"genre_scores_gemma":[0.996727,0.0002682002,0.00019035055,0.0013155914,0.0002141171,0.00022303963,0.000009090268,0.000028026976,0.0010246214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894685,0.000034187422,0.00021313036,0.00029263212,0.00019049733,0.00032270583],"domain_scores_gemma":[0.99906915,0.00013030763,0.00008841291,0.00049355626,0.00006329442,0.00015529132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010928016,0.0001707887,0.00023168752,0.00004159891,0.00019409017,0.000061434555,0.00011404703,0.00007208422,0.00051835255],"category_scores_gemma":[0.00005409157,0.00010892116,0.00012176721,0.000078985846,0.000122037236,0.00012988862,0.000053387448,0.000071748305,0.00020069361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077073935,0.0001801974,0.4954352,0.000071100396,0.00044958986,0.00005338296,0.00375,0.00012483029,0.008437487,0.00031906893,0.013479953,0.4776221],"study_design_scores_gemma":[0.0028980526,0.00024898633,0.93599784,0.0001709974,0.00019833357,0.000051436196,0.0009772772,0.0007615951,0.0024218427,0.00028078744,0.055778284,0.0002145582],"about_ca_topic_score_codex":0.0024109602,"about_ca_topic_score_gemma":0.00020220288,"teacher_disagreement_score":0.47740754,"about_ca_system_score_codex":0.004460606,"about_ca_system_score_gemma":0.0006435541,"threshold_uncertainty_score":0.9993611},"labels":[],"label_agreement":null},{"id":"W2127018518","doi":"10.1016/s1470-2045(15)70128-2","title":"Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital","funders":"Genentech","keywords":"Medicine; Internal medicine; Tolerability; Brentuximab vedotin; Rituximab; Antibody-drug conjugate; Oncology; Refractory (planetary science); Lymphoma; Phases of clinical research; Adverse effect; Clinical trial; Antibody; Immunology; Monoclonal antibody; Hodgkin lymphoma","score_opus":0.036975464534527845,"score_gpt":0.3523724593174217,"score_spread":0.3153969947828939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127018518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938109,0.0018750799,0.0000025361637,0.0016190562,0.00022138742,0.0013298314,0.00002562057,0.000024115328,0.0010914777],"genre_scores_gemma":[0.9979154,0.0011603396,0.000039709375,0.0004450865,0.0001710409,0.00004784182,0.000006502718,0.000024918918,0.00018914985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792105,0.00061772857,0.00041307067,0.00040169826,0.0002463688,0.00040008454],"domain_scores_gemma":[0.9981904,0.0006199568,0.00031995325,0.0006588202,0.000066774395,0.00014407618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010013905,0.00026721915,0.0011129692,0.00008201844,0.00011210947,0.000014104774,0.00020369173,0.00014967898,0.000012225467],"category_scores_gemma":[0.00015539714,0.00013891111,0.00006391523,0.0002638344,0.00037805273,0.00006471055,0.00024092433,0.00021219351,0.000007607597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0642446,0.027305808,0.72249913,0.000882865,0.0013195704,0.0028492322,0.025759263,0.00016437485,0.047808174,0.00020367885,0.003711288,0.10325201],"study_design_scores_gemma":[0.21685308,0.011379373,0.7484221,0.0002789526,0.0006866841,0.0005267663,0.0017624678,0.0026750304,0.008842267,0.00006128293,0.008213401,0.00029859316],"about_ca_topic_score_codex":0.0018174658,"about_ca_topic_score_gemma":0.0011764263,"teacher_disagreement_score":0.1526085,"about_ca_system_score_codex":0.0027388078,"about_ca_system_score_gemma":0.0027556177,"threshold_uncertainty_score":0.7161887},"labels":[],"label_agreement":null},{"id":"W2127197865","doi":"10.1182/asheducation-2001.1.178","title":"Hodgkin's Lymphoma: Basing the Treatment on the Evidence","year":2001,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Hodgkin lymphoma; Lymphoma; Clinical trial; Stage (stratigraphy); Disease; Intensive care medicine; Surgery; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.16203369313422852,"score_gpt":0.38846288015882324,"score_spread":0.22642918702459472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127197865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020677526,0.9891634,0.0000021067617,0.0041910475,0.00034270235,0.0019559676,0.000008820046,0.000059302733,0.0040698536],"genre_scores_gemma":[0.00046194962,0.9957979,0.00003141664,0.0009826733,0.00025535398,0.001372905,0.0000263927,0.000053994023,0.0010174172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977983,0.0004166692,0.0005243982,0.0005538668,0.00025482662,0.0004519258],"domain_scores_gemma":[0.99453163,0.0037283509,0.0003074163,0.001285819,0.000041081934,0.000105723586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021819364,0.0005860695,0.0020113885,0.00009882168,0.0002634415,0.00003581449,0.0002634535,0.0003143522,0.00032318285],"category_scores_gemma":[0.00018614833,0.0002124227,0.0008548181,0.0003138714,0.00018720573,0.000021224474,0.000051755796,0.00013242081,0.0012466096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022491535,0.00078976474,0.00011977918,0.0012110566,0.00065160304,0.0011597273,0.00007429004,4.9036622e-8,1.446081e-8,0.0075970683,0.0054980335,0.9828761],"study_design_scores_gemma":[0.0006324801,0.00064955873,0.00006421494,0.015918333,0.00244749,0.0067476803,0.000030518062,0.0000017138335,0.000011164321,0.00005452065,0.9732745,0.00016781413],"about_ca_topic_score_codex":0.000087967914,"about_ca_topic_score_gemma":0.000022413868,"teacher_disagreement_score":0.98270833,"about_ca_system_score_codex":0.0008252553,"about_ca_system_score_gemma":0.0004909801,"threshold_uncertainty_score":0.99953103},"labels":[],"label_agreement":null},{"id":"W2127379731","doi":"10.1093/jnci/djj017","title":"Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients","year":2006,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Medicine; Lymphoma; Confidence interval; Internal medicine; Hodgkin lymphoma; Poisson regression; Myeloid leukemia; Leukemia; Population; Cancer; Chemotherapy; Oncology","score_opus":0.0216134116331989,"score_gpt":0.30736356705921575,"score_spread":0.28575015542601684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127379731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997091,0.00019593115,0.000009431595,0.000419192,0.0014595278,0.0003783822,0.000047423226,0.000006732346,0.00039240756],"genre_scores_gemma":[0.998689,0.000008966884,0.00027417028,0.00039124864,0.00046914825,0.000026438103,0.000023118699,0.000012532347,0.000105390565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997664,0.00004268815,0.00064848387,0.00013178831,0.0013783998,0.00013465986],"domain_scores_gemma":[0.998508,0.00006441358,0.00065393717,0.0001204427,0.0005913684,0.00006188575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018744842,0.00015063386,0.0003535629,0.00018443407,0.00014200926,0.000018488434,0.00016784787,0.000055199744,0.000018000974],"category_scores_gemma":[0.00009606122,0.00009559251,0.00032576537,0.0003168931,0.000024266032,0.00020715543,0.000029065102,0.00008118983,0.0000015558621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045029042,0.001951016,0.98283434,0.000016562335,0.0006306153,0.000035364814,0.00008057226,0.009604069,0.0001792019,0.00011664274,0.0018574942,0.0022438557],"study_design_scores_gemma":[0.013937315,0.0004684435,0.98144567,0.00021882645,0.0006543869,0.000016556722,0.000014985957,0.000121366334,0.0015717553,0.00014447932,0.0013178494,0.000088382476],"about_ca_topic_score_codex":0.0014127336,"about_ca_topic_score_gemma":0.0005393821,"teacher_disagreement_score":0.013487025,"about_ca_system_score_codex":0.0025446287,"about_ca_system_score_gemma":0.0012414042,"threshold_uncertainty_score":0.66541153},"labels":[],"label_agreement":null},{"id":"W2127590261","doi":"10.1093/annonc/mdt389","title":"An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Juravinski Hospital; Queen's University","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Internal medicine; Hazard ratio; Vinblastine; Radiation therapy; Bleomycin; Confidence interval; Chemotherapy regimen; Progression-free survival; Oncology; Gastroenterology; Surgery; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.1481142623853248,"score_gpt":0.3927858500323817,"score_spread":0.2446715876470569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127590261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961235,0.0003487109,0.0000127029,0.0014104951,0.00004509419,0.0013961197,0.0005270246,0.000014425739,0.000121960504],"genre_scores_gemma":[0.99614394,0.00015889658,0.001678301,0.00071778795,0.000017027627,0.00011746426,0.0011399816,0.000016495695,0.000010105932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986789,0.000095608775,0.000442569,0.00031654112,0.00023245162,0.00023392857],"domain_scores_gemma":[0.998248,0.00024103747,0.00038873934,0.0005510887,0.00042903336,0.0001421206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001605671,0.00016695022,0.0007248124,0.00008624383,0.00004383415,0.0000124323,0.00016027616,0.00013125391,0.000024856847],"category_scores_gemma":[0.000050948816,0.00011639622,0.000045848446,0.00008816438,0.00015330048,0.00022422556,0.00007429685,0.000033571312,0.0000015467082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017383741,0.012010564,0.67416096,0.000046601686,0.00040215347,0.0000025804002,0.0006536597,0.0000016604605,0.000098289536,0.00011699408,0.0026724536,0.3080957],"study_design_scores_gemma":[0.01655714,0.044414733,0.93016595,0.000036200945,0.00010081909,0.0000017577765,0.00026808924,0.00027857584,0.0055214274,0.00010996003,0.0024365177,0.000108860295],"about_ca_topic_score_codex":0.0005518261,"about_ca_topic_score_gemma":0.000050909537,"teacher_disagreement_score":0.30798683,"about_ca_system_score_codex":0.00002379698,"about_ca_system_score_gemma":0.00013014009,"threshold_uncertainty_score":0.47465},"labels":[],"label_agreement":null},{"id":"W2127762891","doi":"10.1007/s00277-015-2543-4","title":"Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Follicular lymphoma; Hematology; Non-Hodgkin's lymphoma; Gastroenterology","score_opus":0.15940831922656118,"score_gpt":0.3890267915782633,"score_spread":0.22961847235170213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127762891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9258749,0.026715735,0.00001617013,0.041956842,0.00024655633,0.00117614,0.00009670771,0.0000152186785,0.0039017214],"genre_scores_gemma":[0.983913,0.008687507,0.0001944888,0.0066473535,0.00008699328,0.00025015016,0.00018281837,0.000015680222,0.00002197468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980474,0.00019256539,0.0007519165,0.00030698712,0.0004662582,0.00023483856],"domain_scores_gemma":[0.9979159,0.0005937749,0.00046025566,0.0006513706,0.00031924015,0.000059438855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006940349,0.00020679888,0.0006888971,0.00011404755,0.000034144614,0.000011039683,0.0004285047,0.00011768618,0.00004266167],"category_scores_gemma":[0.00062051334,0.00011415143,0.00019830452,0.0002929005,0.00019035232,0.000076548095,0.0000839187,0.000051918527,0.000036224985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014119027,0.007702207,0.5124828,0.0019413963,0.0012863812,0.0011545172,0.0066234646,0.0000021590083,0.0006855125,0.01439532,0.3302715,0.12204278],"study_design_scores_gemma":[0.011466669,0.0019186847,0.8484411,0.009548966,0.0005711607,0.0031388698,0.005701743,0.0006398095,0.025898807,0.0012357141,0.0909888,0.000449663],"about_ca_topic_score_codex":0.002199972,"about_ca_topic_score_gemma":0.00018420914,"teacher_disagreement_score":0.33595827,"about_ca_system_score_codex":0.000054397555,"about_ca_system_score_gemma":0.00048389545,"threshold_uncertainty_score":0.465496},"labels":[],"label_agreement":null},{"id":"W2128062075","doi":"10.1503/cmaj.090955","title":"Yellow swelling around the eyes: periocular lymphoma","year":2010,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lymphocytosis; Chronic lymphocytic leukemia; Medicine; Swelling; Lymphoma; Stage (stratigraphy); Leukemia; Dermatology; Surgery; Pathology; Internal medicine; Biology","score_opus":0.005921606821856256,"score_gpt":0.23118960160494248,"score_spread":0.22526799478308623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128062075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91317236,0.00037742057,0.000020354028,0.07738712,0.0015117733,0.00014600401,0.000006776139,0.000015772675,0.0073624486],"genre_scores_gemma":[0.98042256,0.0002483386,0.00013117485,0.015160087,0.0031449937,0.0000119308215,0.000008828888,0.0000160693,0.0008560307],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978397,0.00007027324,0.0003087452,0.00014143404,0.0011930399,0.00044680008],"domain_scores_gemma":[0.9976143,0.000197034,0.00013712478,0.00016923515,0.0002550565,0.0016272023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011935553,0.00012419061,0.00020400707,0.00009205728,0.0004991795,0.00015608814,0.00016816128,0.00032113455,0.0033437577],"category_scores_gemma":[0.001221972,0.00007889479,0.00017717858,0.00016135619,0.000064996304,0.00007137852,0.000009826754,0.00061287516,0.00037311425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014208488,0.00020328474,0.7091678,0.000009271214,0.00051847176,0.0027585002,0.0007084194,0.0000027203573,0.00007420681,0.0011971593,0.09507156,0.19027439],"study_design_scores_gemma":[0.0016542171,0.00005547286,0.18977948,0.000048928225,0.00009722125,0.00174805,0.000460454,0.00036908957,0.00009146959,0.00013604286,0.80546105,0.0000985313],"about_ca_topic_score_codex":0.0029589434,"about_ca_topic_score_gemma":0.024274511,"teacher_disagreement_score":0.7103895,"about_ca_system_score_codex":0.0009786317,"about_ca_system_score_gemma":0.0030822302,"threshold_uncertainty_score":0.9975673},"labels":[],"label_agreement":null},{"id":"W2128139858","doi":"10.1016/j.ijrobp.2010.07.1287","title":"Treatment and Outcomes in Patients with Indolent and Aggressive Primary Breast Lymphoma","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Lymphoma; Stage (stratigraphy); Aggressive lymphoma; Radiation therapy; Surgery; Oncology; Gastroenterology; Rituximab","score_opus":0.007141648213767089,"score_gpt":0.27988733640365715,"score_spread":0.27274568818989003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128139858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689686,0.00018480296,0.000022950691,0.0019209927,0.00050721056,0.00023955423,0.00006153519,0.0000086234995,0.0001574872],"genre_scores_gemma":[0.99768203,0.00042603962,0.0010325899,0.00044832306,0.00029941398,0.000016286283,0.0000698066,0.000013075581,0.000012408074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909765,0.00005469373,0.00036906096,0.00017889736,0.00016178067,0.00013793175],"domain_scores_gemma":[0.9986471,0.00021021433,0.0006382198,0.00008962371,0.0002918311,0.00012299392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093155766,0.00017378527,0.00043396352,0.00013617086,0.00003518868,0.000019737077,0.00007661987,0.00013023973,0.000012711095],"category_scores_gemma":[0.00005357651,0.00011160088,0.00006799509,0.000052622494,0.00014808806,0.00015739829,0.00003428286,0.00012439382,0.0000029426171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051119574,0.0014336157,0.69163865,0.0000024865203,0.0003683831,0.00006826507,0.00020139434,0.0000022603604,0.00007277886,0.0006510081,0.000013275908,0.30503666],"study_design_scores_gemma":[0.025559701,0.00225459,0.96964806,0.000041566083,0.000117269214,0.0005444662,0.000023341654,0.000034835968,0.00017668311,0.0003892836,0.0011172509,0.00009296886],"about_ca_topic_score_codex":0.000029795045,"about_ca_topic_score_gemma":0.000015444635,"teacher_disagreement_score":0.3049437,"about_ca_system_score_codex":0.000623132,"about_ca_system_score_gemma":0.00030814114,"threshold_uncertainty_score":0.45509517},"labels":[],"label_agreement":null},{"id":"W2128294765","doi":"10.1182/asheducation-2008.1.326","title":"Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant","year":2008,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Oncology; Transplantation; Disease; Autologous stem-cell transplantation; Natural history; Internal medicine; Stem cell; Clinical trial; Radiation therapy; Chemotherapy; Human leukocyte antigen; Surgery; Immunology; Antigen","score_opus":0.012952329267670861,"score_gpt":0.2314538708349497,"score_spread":0.21850154156727883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128294765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906281,0.0028074172,0.000025422938,0.00030130445,0.00009206909,0.00033696927,0.0000074519976,0.000032771313,0.005768492],"genre_scores_gemma":[0.9974687,0.0009793796,0.00068223255,0.00014186562,0.0000064589385,0.00016175219,0.000009628929,0.000014389652,0.0005355662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989486,0.000042265285,0.00036086334,0.00025682844,0.00012986852,0.00026162164],"domain_scores_gemma":[0.99950725,0.000049920738,0.00006748626,0.00028536652,0.000017301014,0.00007269173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051741023,0.00014908171,0.00050008047,0.00012891997,0.000019751933,0.000001042262,0.000057425084,0.00012303655,0.00009408434],"category_scores_gemma":[7.047736e-7,0.00011979214,0.000098075725,0.00012856253,0.00008739516,0.000020496356,0.00002386338,0.0000381314,0.00009857122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093550875,0.0030056452,0.9088606,0.00085325463,0.00020130699,0.070220366,0.001829052,0.0000040913196,0.00006590857,0.0043956256,0.00065036915,0.008978236],"study_design_scores_gemma":[0.008837306,0.00038618216,0.95923334,0.0003585304,0.00016757991,0.006947337,0.00020851675,0.000035684978,0.02222979,0.00007194613,0.001360196,0.00016358188],"about_ca_topic_score_codex":0.000050230334,"about_ca_topic_score_gemma":0.000016218533,"teacher_disagreement_score":0.06327303,"about_ca_system_score_codex":0.00008536959,"about_ca_system_score_gemma":0.000045211782,"threshold_uncertainty_score":0.48849815},"labels":[],"label_agreement":null},{"id":"W2128427533","doi":"10.1016/j.bbmt.2005.11.352","title":"A 15-year review of autologous stem cell transplant of advanced relapsed follicular lymphoma at the Ottawa hospital","year":2006,"lang":"en","type":"review","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Stem cell; Follicular phase; Oncology; Lymphoma; Internal medicine; Genetics","score_opus":0.009265481446107155,"score_gpt":0.2524311501049228,"score_spread":0.24316566865881564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128427533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03923254,0.9575049,0.0000063755315,0.00006940433,0.00010469154,0.0015848763,0.0011137862,0.000014958896,0.0003684658],"genre_scores_gemma":[0.04601667,0.95165175,0.00016280179,0.00002800051,0.000020889827,0.00014082293,0.0018741017,0.00002423559,0.00008072312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979388,0.00022699255,0.0010895834,0.0003779351,0.00016454484,0.00020214356],"domain_scores_gemma":[0.9984007,0.00028876777,0.00085843424,0.00031439654,0.00008047419,0.00005723136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023479624,0.00036982805,0.002119734,0.00010387605,0.00004323548,0.0000015139623,0.00011675378,0.00035240958,0.000019530424],"category_scores_gemma":[0.0000047598214,0.00021919199,0.0006177942,0.00015537383,0.0002373559,0.000023653562,0.000010019643,0.000072885916,0.0000023927641],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021693711,0.0015093255,0.0026335008,0.4415756,0.0016775916,0.000169777,0.00028718056,3.6157277e-7,0.001273207,0.00032703724,0.00027327726,0.5500562],"study_design_scores_gemma":[0.029258111,0.009150009,0.007237398,0.38932654,0.11636269,0.0025595203,0.00008876603,0.0000013094731,0.03593204,0.000048031296,0.40863094,0.0014046386],"about_ca_topic_score_codex":0.000078797406,"about_ca_topic_score_gemma":0.000019022424,"teacher_disagreement_score":0.5486516,"about_ca_system_score_codex":0.000030362015,"about_ca_system_score_gemma":0.00017653864,"threshold_uncertainty_score":0.893839},"labels":[],"label_agreement":null},{"id":"W2128614795","doi":"10.1067/moe.2001.116062","title":"Characteristics of oral and paraoral malignant lymphoma: A population-based review of 361 cases","year":2001,"lang":"en","type":"review","venue":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Tonsil; Population; Grading (engineering); Pathology","score_opus":0.07775917974372422,"score_gpt":0.35088656162490506,"score_spread":0.27312738188118085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128614795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057840727,0.9372363,0.00001605185,0.0015145241,0.0010975071,0.0016327704,0.000499204,0.00008628528,0.00007664221],"genre_scores_gemma":[0.04502353,0.94851905,0.00082732586,0.0017579454,0.00017729652,0.000285631,0.0031863716,0.00010958849,0.00011324105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907343,0.0023853208,0.0036684528,0.0015289774,0.00040750622,0.0012754716],"domain_scores_gemma":[0.99298996,0.0026446946,0.002428874,0.000964237,0.000353027,0.0006192077],"candidate_categories":["metaepi_narrow","metaepi_broad","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0021680235,0.0015360181,0.014698549,0.0010004552,0.0001777408,0.000007335943,0.00028511405,0.0016808154,0.00044021168],"category_scores_gemma":[0.002249908,0.001057468,0.0011579735,0.00082359643,0.0027838915,0.00013216102,0.00018302933,0.0005576825,0.000014786844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006753523,0.0006509529,0.24049059,0.032699566,0.0007322386,0.008974323,0.000023372384,9.030284e-8,0.0000035124872,0.00034226905,0.0032712775,0.71213645],"study_design_scores_gemma":[0.009049571,0.007589505,0.2134024,0.07676371,0.021939777,0.08704792,0.000050074927,0.000020625805,0.000010423969,0.0002486364,0.58197397,0.0019033961],"about_ca_topic_score_codex":0.0026148714,"about_ca_topic_score_gemma":0.0003201702,"teacher_disagreement_score":0.7102331,"about_ca_system_score_codex":0.000245545,"about_ca_system_score_gemma":0.0007422428,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W2128936398","doi":"10.1200/jco.2007.12.5070","title":"Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Bendamustine; Internal medicine; Rituximab; Neutropenia; Nausea; Gastroenterology; Phases of clinical research; Adverse effect; Refractory (planetary science); Surgery; Vomiting; Lymphoma; Chemotherapy","score_opus":0.08933246323390666,"score_gpt":0.40151559454303215,"score_spread":0.3121831313091255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128936398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706805,0.00026044893,0.0000098118935,0.0010567326,0.0005204145,0.00084759993,0.000055943245,0.000007811705,0.00017321562],"genre_scores_gemma":[0.99730617,0.00044700064,0.0011989543,0.0006405076,0.0003212836,0.000013483832,0.000031101677,0.000020880645,0.000020620146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957442,0.000298401,0.0027216778,0.000368088,0.0005704901,0.0002970867],"domain_scores_gemma":[0.9961628,0.0014507902,0.001314537,0.0002304178,0.0003245826,0.00051690417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009393158,0.00025570276,0.0018244988,0.00018983036,0.00008660833,0.000007298855,0.00011050559,0.0002451236,0.000029766617],"category_scores_gemma":[0.00097156706,0.00015931985,0.00022750978,0.00013048976,0.00020471434,0.0001541031,0.000054313576,0.00039761982,0.0000046492455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055523623,0.20823726,0.54527706,0.000007578504,0.00052193546,0.0032774683,0.0019217194,0.0000021680924,0.000010939331,1.7152246e-7,0.00028277285,0.1849373],"study_design_scores_gemma":[0.29662055,0.09871376,0.60058933,0.000146516,0.0004154307,0.000046506062,0.0002105079,0.000023522696,0.000037140155,0.0000014811995,0.0031062327,0.00008903116],"about_ca_topic_score_codex":0.00022346567,"about_ca_topic_score_gemma":0.000265283,"teacher_disagreement_score":0.24109693,"about_ca_system_score_codex":0.00047420457,"about_ca_system_score_gemma":0.0008107997,"threshold_uncertainty_score":0.64968747},"labels":[],"label_agreement":null},{"id":"W2129272684","doi":"10.1158/1078-0432.ccr-11-0267","title":"BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Internal medicine; Oncology; CHOP; Lymphoma; Medicine; Germinal center; Survival analysis; Cohort; Cyclophosphamide; B cell; Immunology; Chemotherapy; Antibody","score_opus":0.18120615402389872,"score_gpt":0.4198209906312234,"score_spread":0.2386148366073247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129272684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891072,0.0032853698,0.0000013335336,0.00038116143,0.00017447614,0.0011006638,0.00008219963,0.000048562415,0.005819042],"genre_scores_gemma":[0.98464054,0.011935832,0.0000930565,0.00051267195,0.00022683885,0.0004354006,0.00003596056,0.000061503895,0.0020582224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996147,0.00052320486,0.0006129975,0.0008789068,0.00086290424,0.00097499165],"domain_scores_gemma":[0.997793,0.00056804024,0.00009563933,0.00063504174,0.0002719229,0.00063635857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013936913,0.0003121884,0.0007603606,0.00022073908,0.00014241556,0.00004765645,0.00021981905,0.00026760742,0.00040338817],"category_scores_gemma":[0.000055669967,0.00020535412,0.00014613324,0.00043332097,0.0004927563,0.00011003643,0.00016312557,0.0004659057,0.00008883904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008117849,0.053912535,0.9116398,0.00009067284,0.00012451934,0.0011169397,0.00043703595,2.216289e-8,0.000032296386,0.00001736054,0.0017060464,0.022804914],"study_design_scores_gemma":[0.15959056,0.003476397,0.8208601,0.00021688464,0.000055464687,0.000022405524,0.00016772775,0.000053848802,0.00085387676,0.000015721555,0.014482486,0.00020450687],"about_ca_topic_score_codex":0.002559373,"about_ca_topic_score_gemma":0.0009735265,"teacher_disagreement_score":0.15147272,"about_ca_system_score_codex":0.00031813307,"about_ca_system_score_gemma":0.0005634741,"threshold_uncertainty_score":0.8374098},"labels":[],"label_agreement":null},{"id":"W2129277265","doi":"10.1200/jco.2012.42.2444","title":"Phase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Immunochemotherapy Followed by Yttrium-90–Ibritumomab Tiuxetan in Untreated Mantle-Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Genentech; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; IC Design Education Center; Biogen","keywords":"Medicine; Vincristine; Mantle cell lymphoma; Rituximab; Cyclophosphamide; Ibritumomab tiuxetan; Radioimmunotherapy; Internal medicine; Oncology; Phases of clinical research; Doxorubicin; Prednisone; Lymphoma; Chemotherapy; Monoclonal antibody; Immunology; Antibody","score_opus":0.05367725134889992,"score_gpt":0.41884830891929253,"score_spread":0.3651710575703926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129277265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880233,0.007312927,0.000015128021,0.0007731248,0.00081481284,0.0021393655,0.000023178498,0.000019365672,0.00087883737],"genre_scores_gemma":[0.99648476,0.0016064567,0.0005210638,0.00054888695,0.00036795813,0.00007108664,0.000019415076,0.000054833443,0.00032552643],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921996,0.0015762756,0.0044183303,0.0005339434,0.00062933785,0.000642539],"domain_scores_gemma":[0.99334586,0.0023351794,0.0026900207,0.0004442684,0.00052753737,0.00065716077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030443124,0.0005219617,0.004632468,0.00030638845,0.00012967021,0.000018082952,0.00028385554,0.00054425414,0.000100458405],"category_scores_gemma":[0.00073190854,0.00037751562,0.00037810527,0.000436511,0.00032055058,0.00026979623,0.00020428082,0.00060715835,0.000012491744],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034680184,0.43846577,0.4600355,0.00003329797,0.0017329701,0.0022270493,0.0038800086,0.0000021691415,0.0012144226,0.000007755325,0.0022146462,0.055506222],"study_design_scores_gemma":[0.44707233,0.30000418,0.23725517,0.00011790822,0.0017583442,0.00051427307,0.006223032,0.00009031249,0.0009096486,0.000009079518,0.0057591777,0.00028656697],"about_ca_topic_score_codex":0.00082761334,"about_ca_topic_score_gemma":0.00036389494,"teacher_disagreement_score":0.41239214,"about_ca_system_score_codex":0.0009789569,"about_ca_system_score_gemma":0.0013123372,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W2129822063","doi":"10.1093/annonc/mds150","title":"Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Fonds De La Recherche Scientifique - FNRS","keywords":"BCL6; Immunophenotyping; Germinal center; Subtyping; Medicine; Pathology; Lymphoma; Stage (stratigraphy); Follicular lymphoma; International Prognostic Index; Biopsy; Diffuse large B-cell lymphoma; B cell; Internal medicine; Biology; Immunology; Antibody; Flow cytometry","score_opus":0.11285357637503934,"score_gpt":0.3977432483262386,"score_spread":0.28488967195119924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129822063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856018,0.0031573505,0.0000043436507,0.0008751469,0.00028649234,0.000622042,0.000038232287,0.000032361462,0.009382272],"genre_scores_gemma":[0.9981978,0.00031652133,0.00022172948,0.00067584036,0.00017470097,0.000082658764,0.000021501912,0.000021790354,0.00028747684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809986,0.00023605548,0.0006148258,0.0002789463,0.0002434044,0.0005269069],"domain_scores_gemma":[0.99821347,0.00050031074,0.0004144724,0.00048092796,0.00016611019,0.00022468026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008224324,0.00022367512,0.000934023,0.00013186783,0.000075728276,0.000005656677,0.00014196376,0.00020797011,0.00007638299],"category_scores_gemma":[0.00028375324,0.00016141096,0.00026264242,0.00015693199,0.00015092024,0.00007186774,0.00015558641,0.00009391096,0.00004673422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058591604,0.11712931,0.8482062,0.00009702625,0.00023800062,0.0003299157,0.0024819854,2.0164815e-7,0.0003275675,0.00020793034,0.0034444113,0.026951509],"study_design_scores_gemma":[0.023961533,0.010094554,0.9403894,0.000056528013,0.00037526773,0.00011166936,0.0010998595,0.0000032936466,0.005840665,0.000043553977,0.01788778,0.00013590486],"about_ca_topic_score_codex":0.00014016964,"about_ca_topic_score_gemma":0.00006878376,"teacher_disagreement_score":0.10703476,"about_ca_system_score_codex":0.00007800016,"about_ca_system_score_gemma":0.00018670499,"threshold_uncertainty_score":0.6582148},"labels":[],"label_agreement":null},{"id":"W2130159340","doi":"10.1093/annonc/mds433","title":"Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Medicine; Rituximab; Internal medicine; Lymphoma; Oncology; Radiation therapy; Stage (stratigraphy); Population; Gastroenterology; Multivariate analysis","score_opus":0.04268085807683187,"score_gpt":0.3507610932435733,"score_spread":0.30808023516674143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130159340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299103,0.002162815,0.00005910319,0.0018304635,0.000034643814,0.00063901494,0.00001928283,0.000015898817,0.0022477594],"genre_scores_gemma":[0.99656945,0.0012296757,0.00074834336,0.001207789,0.000035328892,0.00010712502,0.000026297801,0.000016145865,0.000059825667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987627,0.0000930935,0.0004338106,0.00016052996,0.00021990274,0.0003299072],"domain_scores_gemma":[0.9989573,0.0001416654,0.00030848334,0.00023467827,0.0001788184,0.00017909902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002419275,0.00016817672,0.00062004075,0.00028273588,0.000020416814,0.000002748446,0.000077770004,0.00014557189,0.00005098387],"category_scores_gemma":[0.0000525982,0.00012152362,0.00010172865,0.00040901618,0.00008153667,0.00016351407,0.0000111239115,0.000023739136,0.000008381061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037147407,0.005761043,0.5748312,0.00013319796,0.0004533465,0.00032009397,0.006419982,0.0000839353,0.005089361,0.0007723219,0.0004771717,0.4019436],"study_design_scores_gemma":[0.010442519,0.007970419,0.8150132,0.00033937412,0.000090618036,0.0001753846,0.00035276066,0.0000681807,0.15163635,0.000008489792,0.013762693,0.00014007288],"about_ca_topic_score_codex":0.0006509572,"about_ca_topic_score_gemma":0.000107612526,"teacher_disagreement_score":0.40180352,"about_ca_system_score_codex":0.00022113588,"about_ca_system_score_gemma":0.00021767263,"threshold_uncertainty_score":0.49555895},"labels":[],"label_agreement":null},{"id":"W2130178296","doi":"10.6000/1927-7229.2014.03.04.2","title":"Angioimmunoblastic T-Cell Lymphoma: Clinical Aspects and Recent Advances in Biology and Therapy","year":2014,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Lymphoma; Disease; Epigenetics; Medicine; Immunology; Biology; Cancer research; Pathology; T cell; Gene; Immune system; Genetics","score_opus":0.02705607495028739,"score_gpt":0.3883883897520342,"score_spread":0.3613323148017468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130178296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602589,0.028721435,0.00006203879,0.004833393,0.00022890394,0.00009742238,6.2938665e-7,0.0000039504284,0.0057933237],"genre_scores_gemma":[0.9025001,0.09576204,0.000573122,0.0009269961,0.00020885216,0.000001658327,8.2242053e-7,0.0000064174974,0.00002002048],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986516,0.00021734023,0.0006621828,0.00017464839,0.00009641799,0.0001978099],"domain_scores_gemma":[0.9981672,0.0011665619,0.00024275323,0.00009501123,0.000105294355,0.00022314244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072153244,0.00011901241,0.0007701844,0.00015390602,0.000022962837,0.000008126768,0.000049322545,0.00017043063,0.000039558665],"category_scores_gemma":[0.00041565378,0.00007484241,0.00010206279,0.00011082762,0.00025094004,0.000058801532,0.00003029439,0.00014680253,0.0000048732118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011830907,0.0027348609,0.33089885,0.000013830145,0.00012361819,0.00031587394,0.00003668143,0.0000015675907,0.000097384414,0.0025225377,0.0002495622,0.66182214],"study_design_scores_gemma":[0.025500061,0.018829742,0.6401037,0.00007124256,0.0002417901,0.0010951447,0.00006030721,0.0005423288,0.000143571,0.0036678344,0.30962986,0.0001144121],"about_ca_topic_score_codex":0.0000052668033,"about_ca_topic_score_gemma":0.000011663656,"teacher_disagreement_score":0.66170776,"about_ca_system_score_codex":0.00014509769,"about_ca_system_score_gemma":0.00020750175,"threshold_uncertainty_score":0.3051985},"labels":[],"label_agreement":null},{"id":"W2130198817","doi":"10.3109/10428194.2012.697560","title":"Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; St. Paul's Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Lymphoma; Medicine; Incidence (geometry); Human immunodeficiency virus (HIV); Hodgkin lymphoma; Oncology; Toxicity; Internal medicine; Immunology; Virology","score_opus":0.00703833338773078,"score_gpt":0.22090101145416002,"score_spread":0.21386267806642925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130198817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937666,0.0023442549,0.0000052923874,0.000029958459,0.00017959767,0.0013333343,0.00015740427,0.0001471194,0.0020364395],"genre_scores_gemma":[0.9981267,0.00048309084,0.00023534827,0.00032882876,0.00009169922,0.00020542419,0.00021066642,0.00010875958,0.00020949259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99510264,0.00022809945,0.001211184,0.0010168654,0.0010854112,0.0013557692],"domain_scores_gemma":[0.99721515,0.00033183588,0.00067727384,0.000846507,0.0002667908,0.00066245644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058692676,0.0009172634,0.0014890637,0.0004985584,0.00038581507,0.00008061089,0.0003114468,0.0005734247,0.000056382145],"category_scores_gemma":[0.00013842071,0.00075138285,0.0002002203,0.000999974,0.0006854012,0.0007257426,0.00022362248,0.00012199873,0.000014440422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011157906,0.00278926,0.9653797,0.00021716749,0.00032865186,0.00007328265,0.0018701813,0.000012557561,0.0016518509,0.0004436368,0.00020473852,0.025913142],"study_design_scores_gemma":[0.035038903,0.0013065336,0.9545579,0.0007315525,0.0004133389,0.00014517823,0.0003356289,0.00013105814,0.0060224673,0.00006945036,0.0004724577,0.00077554246],"about_ca_topic_score_codex":0.004695102,"about_ca_topic_score_gemma":0.00032466292,"teacher_disagreement_score":0.03392311,"about_ca_system_score_codex":0.007673319,"about_ca_system_score_gemma":0.0015388161,"threshold_uncertainty_score":0.9994937},"labels":[],"label_agreement":null},{"id":"W2130491242","doi":"10.1182/blood-2003-07-2365","title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Arizona","keywords":"Immunosurveillance; International Prognostic Index; Human leukocyte antigen; Biology; MHC class I; Diffuse large B-cell lymphoma; CD8; Lymphoma; Immunology; Major histocompatibility complex; Gene expression profiling; CIITA; Cancer research; Internal medicine; Oncology; Antigen; MHC class II; Immune system; Medicine; Gene expression; Gene; Genetics","score_opus":0.008935299649229515,"score_gpt":0.23012964310653877,"score_spread":0.22119434345730926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130491242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929566,0.002279515,0.000003604489,0.00005137594,0.000028200582,0.0044435146,0.00019543292,0.000023025757,0.000018776744],"genre_scores_gemma":[0.9990464,0.000033697408,0.00040871944,0.00006228007,0.000008050023,0.00035901755,0.00002857716,0.000044073633,0.000009177113],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980237,0.00019437842,0.000550231,0.0005479024,0.0003854497,0.0002983687],"domain_scores_gemma":[0.998958,0.00014711755,0.00025624686,0.00041803514,0.000097311546,0.00012332476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022033502,0.00032291407,0.00063954707,0.000101801714,0.000093421346,0.000023464552,0.00009446446,0.00009944758,0.0000018564593],"category_scores_gemma":[0.00018227992,0.00020864641,0.0000703421,0.0002486051,0.00008024569,0.0000509914,0.00019765394,0.000054187294,3.3778818e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009461803,0.017128203,0.85863656,0.0001317032,0.00026814025,0.00023000961,0.007216523,8.701287e-7,0.11511767,0.000010226693,0.0000017493809,0.00031216245],"study_design_scores_gemma":[0.074026465,0.0018083848,0.43151876,0.00073271553,0.00021911327,0.00001830849,0.0015094463,0.000015237902,0.48994932,0.000021422587,0.000008227804,0.00017261974],"about_ca_topic_score_codex":0.0028200105,"about_ca_topic_score_gemma":0.00014057655,"teacher_disagreement_score":0.42711782,"about_ca_system_score_codex":0.00012692952,"about_ca_system_score_gemma":0.000287484,"threshold_uncertainty_score":0.8508354},"labels":[],"label_agreement":null},{"id":"W2130965960","doi":"10.1016/j.clml.2011.06.012","title":"A Prospective Phase II Study of RICE Re-Induction, Then High-Dose Fludarabine and Busulfan, Followed by Autologous or Allogeneic Blood Stem Cell Transplantation for Indolent B-Cell Lymphoma. ClinicalTrials.gov ID: NCT00144092","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Alberta Health Services; University of Saskatchewan; University of Calgary","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Fludarabine; Mantle cell lymphoma; Busulfan; Surgery; Transplantation; Internal medicine; Etoposide; Rituximab; Carboplatin; Induction chemotherapy; Ifosfamide; Autologous stem-cell transplantation; Oncology; Chemotherapy; Lymphoma; Hematopoietic stem cell transplantation; Cyclophosphamide; Cisplatin","score_opus":0.050369952640332456,"score_gpt":0.32793063732195543,"score_spread":0.277560684681623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130965960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901344,0.0011845345,0.000060530798,0.00014540546,0.0008682421,0.0065197265,0.0004400717,0.00021858282,0.00042851054],"genre_scores_gemma":[0.99375933,0.0015132315,0.0014552226,0.00036821864,0.00042532617,0.0013288505,0.00028328685,0.00014038499,0.0007261313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9924341,0.000670005,0.003458447,0.001885828,0.0007191828,0.0008324452],"domain_scores_gemma":[0.9940164,0.0020270536,0.0015400337,0.0011853565,0.00050582597,0.0007252931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017118629,0.00089207664,0.0025216064,0.00023958212,0.00044019168,0.00004313012,0.00041936635,0.00081542565,0.00006611664],"category_scores_gemma":[0.00034957912,0.00066490436,0.0006088059,0.00052625773,0.00042740235,0.0002365178,0.00016850256,0.00021285319,0.000025312966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11802463,0.18643416,0.090158544,0.0014322328,0.0046591274,0.0019052797,0.012276485,0.000003639469,0.012693951,0.00012674244,0.0052999756,0.56698525],"study_design_scores_gemma":[0.22725429,0.059027974,0.65275306,0.0001969297,0.006182963,0.00023009258,0.0015276815,0.000044241428,0.05132367,0.00012720612,0.0006161436,0.00071573077],"about_ca_topic_score_codex":0.0008181789,"about_ca_topic_score_gemma":0.00008239281,"teacher_disagreement_score":0.5662695,"about_ca_system_score_codex":0.0007079562,"about_ca_system_score_gemma":0.0014938116,"threshold_uncertainty_score":0.9995802},"labels":[],"label_agreement":null},{"id":"W2131122962","doi":"10.1182/asheducation-2005.1.267","title":"Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types)","year":2005,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Medicine; Oncology; Anaplastic lymphoma kinase; Disease; Internal medicine; Clinical trial; Gene expression profiling; T cell; Immunology; Biology; Gene; Gene expression; Immune system","score_opus":0.012780713742576005,"score_gpt":0.25615420286612134,"score_spread":0.24337348912354534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131122962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370161,0.009266494,0.00001526608,0.0039518047,0.00013170435,0.00026768827,0.0000042443758,0.000080621154,0.049266074],"genre_scores_gemma":[0.994282,0.0006093513,0.0014155498,0.0010051298,0.00017318412,0.000043769352,0.000017178942,0.000019904715,0.0024339363],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908066,0.00002754358,0.00020881378,0.00030258627,0.00010904912,0.00027135367],"domain_scores_gemma":[0.9993872,0.000058515972,0.00010102318,0.00024684786,0.000046312296,0.00016010852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035637262,0.00016921712,0.0003952594,0.00006225771,0.00006753332,0.000012674221,0.00004475188,0.00013138383,0.0008674044],"category_scores_gemma":[0.000023332492,0.00013184261,0.00006827865,0.00007013755,0.00010552103,0.000039648665,0.000038342594,0.00005904978,0.00031488325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003255554,0.007662206,0.47808173,0.0006303464,0.0011292282,0.010542176,0.0057775355,0.000025146517,0.0048825266,0.2182737,0.12488933,0.1448505],"study_design_scores_gemma":[0.041350253,0.0017031898,0.32452038,0.00036114923,0.00072070304,0.019960666,0.00083282264,0.00084566115,0.1328291,0.0014157934,0.4743547,0.0011055752],"about_ca_topic_score_codex":0.000019445002,"about_ca_topic_score_gemma":0.000026733182,"teacher_disagreement_score":0.3494654,"about_ca_system_score_codex":0.00011352669,"about_ca_system_score_gemma":0.00007149631,"threshold_uncertainty_score":0.949747},"labels":[],"label_agreement":null},{"id":"W2131395115","doi":"10.3109/10428194.2011.643404","title":"Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; Etoposide; Salvage therapy; Oncology; CHOP; DHAP; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Chemotherapy; Gemcitabine; Surgery; Cyclophosphamide; Lymphoma; Chemistry","score_opus":0.012257883743986255,"score_gpt":0.21361873074930124,"score_spread":0.20136084700531498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131395115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447573,0.0086785555,0.000016432012,0.00009055485,0.00025988187,0.001527045,0.00015955849,0.00033488547,0.0044573736],"genre_scores_gemma":[0.9894861,0.006763267,0.00043615757,0.0015968366,0.000078294885,0.00024751908,0.00016324663,0.00019950008,0.0010290758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99467134,0.0002132131,0.0012174336,0.0017189885,0.00066081353,0.001518202],"domain_scores_gemma":[0.9969871,0.00061791367,0.00042826965,0.00091596023,0.00008338756,0.0009673655],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003780659,0.0013859294,0.0019852314,0.0005566293,0.00038033837,0.00014000123,0.0003038535,0.0008620459,0.00004319062],"category_scores_gemma":[0.00002418007,0.0011021056,0.0003183273,0.00041403263,0.00048456335,0.00045474243,0.00021273189,0.00018000745,0.00002737594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012873565,0.0071837,0.8878057,0.000995968,0.0003224494,0.002489261,0.010242562,2.567706e-7,0.0013029962,0.00018897909,0.00028200727,0.087898746],"study_design_scores_gemma":[0.08732257,0.0010138477,0.8978844,0.0003648661,0.00058281346,0.0008344682,0.0010572551,0.0002252555,0.007121382,0.00007215264,0.0024615314,0.0010594331],"about_ca_topic_score_codex":0.0019183047,"about_ca_topic_score_gemma":0.00014014747,"teacher_disagreement_score":0.08683932,"about_ca_system_score_codex":0.004535478,"about_ca_system_score_gemma":0.0017167851,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W2131526357","doi":"10.1016/j.currproblcancer.2006.04.001","title":"Hodgkin’s Lymphoma","year":2006,"lang":"en","type":"review","venue":"Current Problems in Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gynecology","score_opus":0.13656168527186863,"score_gpt":0.429721453183676,"score_spread":0.29315976791180737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131526357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012721072,0.9932231,0.0000027455867,0.00004867798,0.0015669767,0.0021006768,0.0001341886,0.00006642013,0.002844533],"genre_scores_gemma":[0.000026106476,0.99349684,0.000037996637,0.000031364478,0.00063480716,0.0045407456,0.0004468976,0.000081232916,0.0007040037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975343,0.00006463701,0.0008468287,0.00070462766,0.00034757773,0.00050206477],"domain_scores_gemma":[0.9988721,0.0000740398,0.0003351494,0.0005215143,0.000055918845,0.00014127538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013085749,0.0005994004,0.0020828038,0.00032618156,0.00003800384,0.000036334066,0.0001753847,0.00029081092,0.0002328891],"category_scores_gemma":[0.0000130786275,0.00042342587,0.0006022121,0.00048605102,0.000060428683,0.000054230994,0.000086202876,0.00023156962,0.00019137502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002500104,0.0010367734,0.0017913363,0.027457753,0.00012884176,0.00003937769,0.000016888971,0.000002462468,1.2484695e-8,0.00007694628,0.014041818,0.9554053],"study_design_scores_gemma":[0.0016384379,0.00006606462,0.0006368062,0.0759862,0.0011940586,0.000044360142,7.203711e-7,0.0000023501866,5.237852e-7,0.00004623515,0.92003256,0.00035168356],"about_ca_topic_score_codex":0.0004505632,"about_ca_topic_score_gemma":0.00015851906,"teacher_disagreement_score":0.9550536,"about_ca_system_score_codex":0.0025721905,"about_ca_system_score_gemma":0.001270258,"threshold_uncertainty_score":0.9998218},"labels":[],"label_agreement":null},{"id":"W2131611002","doi":"10.1158/0008-5472.can-07-5817","title":"Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Cancer research; Transcription factor; Biology; Repressor; Lymphoma; Psychological repression; Diffuse large B-cell lymphoma; Suppressor; Gene; B cell; Gene expression; Immunology; Genetics; Germinal center","score_opus":0.135465683375778,"score_gpt":0.40252433179571423,"score_spread":0.2670586484199362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131611002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934849,0.0030936198,0.0001348549,0.00087022624,0.00021393501,0.0009980152,0.0002091714,0.000051061663,0.0009441967],"genre_scores_gemma":[0.9929852,0.0018009386,0.0002210986,0.00014218717,0.0004966694,0.0008424293,0.00009888984,0.000035266316,0.0033773028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982603,0.00006504009,0.00018882252,0.00033787615,0.0005243872,0.0006235306],"domain_scores_gemma":[0.9991584,0.00010470108,0.000028233868,0.00020871821,0.00027581205,0.00022412304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024049096,0.00012898627,0.00022435296,0.00013133792,0.00038443008,0.000022621347,0.00008660224,0.0000924157,0.00047581285],"category_scores_gemma":[0.000055701497,0.00010306758,0.00015898344,0.00019346333,0.00008761096,0.00008097102,0.000026472095,0.00012318535,0.00006433072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022627905,0.010878071,0.10631707,0.000905445,0.00034902836,0.0005523051,0.005150182,0.0000040357345,0.7784211,0.00082097814,0.08401868,0.010320292],"study_design_scores_gemma":[0.044037033,0.000952935,0.033698216,0.00015281141,0.00008839709,0.00003977156,0.00034224195,0.00023364322,0.67383826,0.00008626295,0.24624562,0.00028480357],"about_ca_topic_score_codex":0.00038516452,"about_ca_topic_score_gemma":0.000035347453,"teacher_disagreement_score":0.16222695,"about_ca_system_score_codex":0.00071841973,"about_ca_system_score_gemma":0.0004921047,"threshold_uncertainty_score":0.5209817},"labels":[],"label_agreement":null},{"id":"W2132268020","doi":"10.1038/bmt.2008.41","title":"The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant","year":2008,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Haematology Society of Australia and New Zealand","keywords":"Medicine; Apheresis; Lymphoma; Lymphocyte; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Hematology; Transplantation; Refractory (planetary science); Hematopoietic cell; Salvage therapy; Chemotherapy; Haematopoiesis; Immunology; Stem cell; Platelet","score_opus":0.014783576718686868,"score_gpt":0.21727180773164476,"score_spread":0.20248823101295788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132268020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969939,0.0003496532,0.000421122,0.0003316828,0.000046023462,0.0008891578,0.00006691221,0.000085235435,0.00081633875],"genre_scores_gemma":[0.99801946,0.00052188424,0.00048238778,0.000088539426,0.000027595079,0.00012926687,0.0005452489,0.000045305664,0.00014034203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980471,0.00009273877,0.00045387275,0.0003919272,0.0005893434,0.00042500006],"domain_scores_gemma":[0.9985519,0.00076905865,0.00016502116,0.00030050456,0.00007465439,0.00013883183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015534667,0.00031223215,0.00039167152,0.00014360885,0.00041104775,0.00003173636,0.00008433735,0.00012619015,0.000006487446],"category_scores_gemma":[0.0000072769512,0.00019525153,0.00007308377,0.0003170187,0.00014697888,0.00015937473,0.0000042022484,0.00009923255,0.000027709084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002445693,0.00041076876,0.99317396,0.00023766048,0.000079159894,0.0008753952,0.0018002844,0.000090068876,0.00000929962,0.00019135643,0.000024147383,0.0006622229],"study_design_scores_gemma":[0.020607967,0.0008328992,0.9761255,0.0005170587,0.0004495028,0.0005664637,0.00007137936,0.000027241531,0.00044232982,0.000046648976,0.0000578545,0.00025514804],"about_ca_topic_score_codex":0.00023789646,"about_ca_topic_score_gemma":0.0006422852,"teacher_disagreement_score":0.018162273,"about_ca_system_score_codex":0.00046503253,"about_ca_system_score_gemma":0.00044286656,"threshold_uncertainty_score":0.7962126},"labels":[],"label_agreement":null},{"id":"W2132432381","doi":"10.1002/ajh.24223","title":"Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Statistic; Oncology; Population; Anthracycline; Framingham Risk Score; Disease; Lymphoma; Cancer; Clinical trial; Statistics; Mathematics; Breast cancer","score_opus":0.009678997285731131,"score_gpt":0.24355383513251344,"score_spread":0.2338748378467823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132432381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977776,0.0006609619,0.00024694327,0.00046026366,0.0002592063,0.00036527307,0.00009115089,0.00001040071,0.00012824048],"genre_scores_gemma":[0.99821454,0.00009171278,0.0013285144,0.00014874786,0.000056545246,0.000030530544,0.000028536002,0.000024971385,0.00007588216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985204,0.00013595504,0.0004830246,0.00018334515,0.0003673795,0.00030993554],"domain_scores_gemma":[0.99834675,0.00019594702,0.0006873692,0.00022127546,0.00027616514,0.0002724767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026976917,0.00017288388,0.00077370956,0.00016253369,0.000045527006,0.0000057924794,0.0001027327,0.000052219813,0.000013861278],"category_scores_gemma":[0.00018829493,0.00011596993,0.00015136947,0.00014990884,0.00014002017,0.00007030771,0.000038627535,0.00007260426,0.0000059117456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006496529,0.006275752,0.9807684,0.00001963089,0.00022858806,0.00014234628,0.0006966708,0.000003990522,0.000002251851,0.000075998534,0.002642819,0.00264703],"study_design_scores_gemma":[0.17879196,0.013733959,0.7982037,0.00013892513,0.00060107687,0.0006230198,0.0017619664,0.00014799896,0.00029242074,0.00013570212,0.005388602,0.00018069331],"about_ca_topic_score_codex":0.000102222766,"about_ca_topic_score_gemma":0.00008365384,"teacher_disagreement_score":0.18256472,"about_ca_system_score_codex":0.00044936698,"about_ca_system_score_gemma":0.00022302233,"threshold_uncertainty_score":0.47291166},"labels":[],"label_agreement":null},{"id":"W2132608570","doi":"10.1182/blood-2011-01-330795","title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Germinal center; Chromosomal translocation; IRF4; Lymphoma; Biology; B cell; Burkitt's lymphoma; Genetics; Immunology; Cancer research; Medicine; Transcription factor; Antibody; Gene","score_opus":0.012856211195775841,"score_gpt":0.23724400742345017,"score_spread":0.22438779622767432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132608570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971037,0.00054427097,0.000016595961,0.000018572639,0.000055779466,0.0005295606,0.000026071126,0.00003787962,0.0016675815],"genre_scores_gemma":[0.9981771,0.00011307366,0.0015170375,0.000013347546,0.00004961996,0.00003804542,0.000031774165,0.000022801125,0.00003718337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990442,0.000034263394,0.00027581496,0.00028119946,0.00014978061,0.00021474685],"domain_scores_gemma":[0.9994027,0.000050031238,0.00016075067,0.00021730154,0.00006370849,0.000105483974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008460622,0.00016452903,0.00027957134,0.00008208194,0.000094423856,0.000012231335,0.000060135913,0.00007170085,0.000023159524],"category_scores_gemma":[0.000037810467,0.00014191729,0.00009470083,0.000117226155,0.000055148455,0.0000828771,0.000029305951,0.000043836073,0.000005219597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024501735,0.007124485,0.94358826,0.0001755584,0.0002719293,0.000053659736,0.0054913233,3.7920433e-8,0.02391812,0.00001976425,0.000009094181,0.01910276],"study_design_scores_gemma":[0.013143344,0.00036642863,0.7088276,0.0002864251,0.00034458167,0.00031265168,0.00026494617,0.0000079962165,0.27635187,0.000005271099,0.0000015366622,0.00008733853],"about_ca_topic_score_codex":0.0008580442,"about_ca_topic_score_gemma":0.000059945924,"teacher_disagreement_score":0.25243375,"about_ca_system_score_codex":0.00002592823,"about_ca_system_score_gemma":0.00006462287,"threshold_uncertainty_score":0.5787219},"labels":[],"label_agreement":null},{"id":"W2132696402","doi":"10.1200/jco.2009.23.3239","title":"Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; ABVD; Lymphoma; Cancer; Randomized controlled trial; Internal medicine; Regimen; Hodgkin lymphoma; Vinblastine; Oncology; Family medicine; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.2911474729327905,"score_gpt":0.5579397610728143,"score_spread":0.2667922881400238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132696402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987472,0.0015360874,0.000004740444,0.008382525,0.00042207938,0.001512356,0.0000072255507,0.0000029577523,0.00066004257],"genre_scores_gemma":[0.9962768,0.0022875722,0.0004171206,0.0006540352,0.00025252084,0.000060407903,0.0000035664184,0.000007846698,0.000040115345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99344546,0.002304877,0.0026451717,0.00022387622,0.0011316724,0.00024891773],"domain_scores_gemma":[0.9886627,0.008276565,0.001821838,0.00028305582,0.00082604116,0.00012978552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006606835,0.00018375566,0.0022870451,0.0003237605,0.00009405941,0.000013761505,0.00026639333,0.00020178975,0.0000090218],"category_scores_gemma":[0.0024611435,0.00008342241,0.0004467072,0.00059970294,0.00067027204,0.00013029059,0.00003916311,0.00021936612,4.7292264e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23895417,0.07247418,0.28948477,0.000028644386,0.0017346082,0.0003384695,0.004238902,0.00018293504,0.000066456705,0.0038071107,0.0009405924,0.38774917],"study_design_scores_gemma":[0.36333048,0.02043949,0.5966539,0.00015894738,0.0004713873,0.000044703873,0.001072779,0.000113867776,0.00009614197,0.00047986666,0.017082071,0.000056364646],"about_ca_topic_score_codex":0.0007629968,"about_ca_topic_score_gemma":0.00069217966,"teacher_disagreement_score":0.38769278,"about_ca_system_score_codex":0.0008239669,"about_ca_system_score_gemma":0.0017132265,"threshold_uncertainty_score":0.34018672},"labels":[],"label_agreement":null},{"id":"W2133005406","doi":"10.3324/haematol.2009.019943","title":"Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Salvage therapy; Refractory (planetary science); Chemotherapy; Transplantation; Internal medicine; Surgery; Lymphoma; Oncology; Cohort","score_opus":0.0058981634693385555,"score_gpt":0.22754268173314432,"score_spread":0.22164451826380577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133005406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943797,0.00004659309,0.0000030287608,0.0043221912,0.00008798462,0.0009098131,0.000051697894,0.00007550582,0.00012348106],"genre_scores_gemma":[0.9965776,0.000041484833,0.0006642833,0.0024294988,0.000009568048,0.00011534671,0.000035528108,0.000027517292,0.00009915598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985854,0.00008390057,0.0002821518,0.00043276467,0.00028484117,0.0003309127],"domain_scores_gemma":[0.9988622,0.00031760047,0.00007907308,0.00043308214,0.000063367,0.0002446986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012725388,0.00030619127,0.000678817,0.00015637751,0.000068585774,0.000022665381,0.000090512614,0.00017604048,0.00009742907],"category_scores_gemma":[0.00012183921,0.00017033539,0.0000702962,0.000096476666,0.000081772,0.000048650432,0.000031071435,0.00012306978,0.00002477727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104086725,0.002417034,0.98076785,0.000031232794,0.00008905185,0.0007286133,0.0004992643,1.03811466e-7,0.0020343,0.00005923158,0.000086555185,0.002878103],"study_design_scores_gemma":[0.012427477,0.0026115824,0.9801887,0.00011193993,0.00006054632,0.0000816248,0.00005112024,0.0000016867076,0.0033873038,0.000016021699,0.00085019384,0.0002117863],"about_ca_topic_score_codex":0.000063036474,"about_ca_topic_score_gemma":0.00011686394,"teacher_disagreement_score":0.0026663167,"about_ca_system_score_codex":0.0000809744,"about_ca_system_score_gemma":0.00004906626,"threshold_uncertainty_score":0.69460756},"labels":[],"label_agreement":null},{"id":"W2133201432","doi":"10.1200/jco.2006.09.2403","title":"Revised Response Criteria for Malignant Lymphoma","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4448,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Medical physics; Harmonization; Lymphoma; Positron emission tomography; Clinical trial; Oncology; Internal medicine; Nuclear medicine","score_opus":0.18308287476718046,"score_gpt":0.5290861835862772,"score_spread":0.3460033088190968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133201432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98074424,0.00070967025,0.0005589846,0.014046807,0.0016625896,0.00033789387,0.0000048138054,0.000009040019,0.0019259634],"genre_scores_gemma":[0.9757976,0.0003553906,0.01582222,0.0057994677,0.0017052786,0.00000663612,0.0000019762283,0.000015900674,0.00049551367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964332,0.0004222936,0.0024627782,0.00016236477,0.00024638505,0.00027296314],"domain_scores_gemma":[0.9879258,0.009604478,0.0012486276,0.00019474776,0.00053566013,0.000490648],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0142215565,0.00012113604,0.0013223087,0.00012398041,0.00004633707,0.0000083711175,0.0001044544,0.00032457913,0.00012492384],"category_scores_gemma":[0.010908005,0.00007619528,0.0007779118,0.00008556961,0.00011523405,0.000056240016,0.000024255929,0.00015787159,0.000024365807],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15471116,0.007330968,0.062456753,0.000053865988,0.00070268154,0.0057048164,0.00010105541,3.56788e-7,0.0017998168,0.00058298575,0.047714245,0.7188413],"study_design_scores_gemma":[0.020865763,0.019820334,0.54039854,0.00012002501,0.00038981508,0.000917596,0.000055563192,0.000009048169,0.0010533353,0.0002555153,0.41605607,0.000058419402],"about_ca_topic_score_codex":0.0000042664738,"about_ca_topic_score_gemma":0.000004433834,"teacher_disagreement_score":0.7187829,"about_ca_system_score_codex":0.00032093455,"about_ca_system_score_gemma":0.0015219192,"threshold_uncertainty_score":0.9974235},"labels":[],"label_agreement":null},{"id":"W2133345449","doi":"10.1200/jco.2013.53.9593","title":"Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Eli Lilly Canada; Eli Lilly and Company","keywords":"Medicine; Gemcitabine; DHAP; Autologous stem-cell transplantation; Internal medicine; Oncology; Cytarabine; Transplantation; Aggressive lymphoma; Population; Chemotherapy; Gastroenterology; Rituximab; Urology; Surgery; Lymphoma","score_opus":0.0665883136468229,"score_gpt":0.4124516741035159,"score_spread":0.345863360456693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133345449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990829,0.0042232256,0.0012368333,0.0014958765,0.0005928399,0.0010448919,0.00002066789,0.000014788418,0.0005418573],"genre_scores_gemma":[0.9718104,0.0059422385,0.021403724,0.0003993904,0.00027977134,0.000041695985,0.00001786586,0.000036391717,0.000068550384],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949983,0.0009838927,0.002916151,0.00041723717,0.0003727284,0.0003117217],"domain_scores_gemma":[0.9735608,0.021079415,0.004323524,0.00021791113,0.0003922624,0.00042607987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004153774,0.0003474593,0.0038399273,0.00021204283,0.00009229172,0.00001933519,0.00010606711,0.0006836354,0.000018845041],"category_scores_gemma":[0.0028971296,0.00023983137,0.00045573726,0.00010102121,0.00065327383,0.00015318212,0.000027643056,0.00042501063,8.927599e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3628067,0.0021950174,0.1089663,0.00039567304,0.0011189705,0.00011578966,0.0013883263,0.000011332941,0.00039779628,0.0003423328,0.00038023025,0.5218815],"study_design_scores_gemma":[0.6267493,0.029969309,0.33197138,0.0004195906,0.0031441476,0.00043088454,0.00033572217,0.0033258542,0.0010450553,0.0004729854,0.0018992415,0.00023656366],"about_ca_topic_score_codex":0.000047254067,"about_ca_topic_score_gemma":0.000085580614,"teacher_disagreement_score":0.52164495,"about_ca_system_score_codex":0.00013145922,"about_ca_system_score_gemma":0.0005035444,"threshold_uncertainty_score":0.9780039},"labels":[],"label_agreement":null},{"id":"W2133654917","doi":"10.1186/1756-8722-6-46","title":"A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)","year":2013,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Internal medicine; Sorafenib; Rash; Diffuse large B-cell lymphoma; Hematology; Lymphoma; Oncology; Progression-free survival; Neutropenia; Overall survival; Gastroenterology; Chemotherapy; Hepatocellular carcinoma","score_opus":0.028262361654969093,"score_gpt":0.35753368450433876,"score_spread":0.32927132284936966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133654917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937851,0.0011340032,0.000019175119,0.00093821663,0.00073691475,0.0026508362,0.0000086220425,0.000019064379,0.00070806],"genre_scores_gemma":[0.9985264,0.0001498512,0.0003644864,0.00035666642,0.0001475147,0.00031951984,0.000011029834,0.00004117775,0.00008334717],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9942902,0.0016768365,0.002265452,0.00055194285,0.00051171565,0.00070388615],"domain_scores_gemma":[0.995889,0.00066827977,0.0015942603,0.0005185479,0.0008716604,0.00045822334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012032755,0.00047838347,0.0030361214,0.00073044794,0.00015462845,0.000015501279,0.0003732643,0.0004279757,0.00027167305],"category_scores_gemma":[0.0002151616,0.00034548985,0.00024617102,0.00038332705,0.00020227132,0.00029317537,0.00025522723,0.00049119326,0.0000516801],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041500195,0.66074115,0.28246543,0.000047300207,0.0008495133,0.007352568,0.020575494,0.0000026062887,0.00073050236,0.00011270604,0.0009908584,0.021981884],"study_design_scores_gemma":[0.3637734,0.48692653,0.077981114,0.00013130959,0.0013530809,0.0050696996,0.059641898,0.0001977814,0.00092451024,0.000088688066,0.003556651,0.00035532293],"about_ca_topic_score_codex":0.00037595525,"about_ca_topic_score_gemma":0.004004176,"teacher_disagreement_score":0.3596234,"about_ca_system_score_codex":0.001206622,"about_ca_system_score_gemma":0.0013287166,"threshold_uncertainty_score":0.9998997},"labels":[],"label_agreement":null},{"id":"W2133950343","doi":"10.1093/annonc/13.s1.92","title":"Current clinical trials for advanced Hodgkin's lymphoma in North America: history, design and rationale","year":2002,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Clinical trial; Current (fluid); Medical physics; Oncology; Intensive care medicine; Internal medicine","score_opus":0.6356551969923488,"score_gpt":0.551617626287587,"score_spread":0.08403757070476181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133950343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018544454,0.9945708,0.0001059293,0.00040133353,0.0006012122,0.0038466153,0.00008163276,0.000011742823,0.00019526975],"genre_scores_gemma":[0.000043517826,0.99467146,0.0025549144,0.00040693404,0.00028031148,0.0016423375,0.00026439776,0.000029790226,0.00010636085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567527,0.0013064184,0.0020799772,0.0005082929,0.00015298105,0.00027703497],"domain_scores_gemma":[0.99156964,0.00634189,0.0014513563,0.0002810339,0.0001808465,0.00017523965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017779814,0.00033069754,0.005023722,0.00024915955,0.000021212221,0.000003258102,0.0001028344,0.00033257937,0.00008097312],"category_scores_gemma":[0.0022499457,0.00024191217,0.0008512019,0.00013825211,0.00018674279,0.000038028516,0.000037719434,0.000118711694,0.00001850137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029130734,0.0024485362,0.00017025348,0.0023004704,0.0003482297,0.000044852964,0.00004028051,0.0000010470276,3.1008252e-8,0.0000442501,0.030595897,0.96371484],"study_design_scores_gemma":[0.006030824,0.006048079,0.00046361837,0.0018165426,0.0011508219,0.000034534198,0.0000050367285,0.000016807518,5.0806113e-7,0.00003271822,0.9842298,0.00017071121],"about_ca_topic_score_codex":0.000008930283,"about_ca_topic_score_gemma":0.000017256176,"teacher_disagreement_score":0.96354413,"about_ca_system_score_codex":0.00047263535,"about_ca_system_score_gemma":0.0015351279,"threshold_uncertainty_score":0.98648924},"labels":[],"label_agreement":null},{"id":"W2134644214","doi":"10.1016/j.blre.2007.03.001","title":"Peripheral T-cell Lymphomas","year":2007,"lang":"en","type":"review","venue":"Blood Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; Anaplastic large-cell lymphoma; Medicine; Oncology; Disease; Anaplastic lymphoma kinase; Internal medicine; T cell; Immunology; Immune system","score_opus":0.10649983031624694,"score_gpt":0.38410115996686817,"score_spread":0.27760132965062123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134644214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002336099,0.9424711,0.000002004813,0.000015434587,0.0003282919,0.0034061326,0.000020182157,0.00007504454,0.05367949],"genre_scores_gemma":[7.1901803e-7,0.98808295,0.0014036541,0.0004030555,0.0007853641,0.0007165336,0.00029881936,0.00011006516,0.008198865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678046,0.0001869756,0.0014432645,0.00072579196,0.0003286779,0.00053485815],"domain_scores_gemma":[0.99775696,0.00010330172,0.000599039,0.0011149583,0.000048581827,0.0003771787],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00052617845,0.0008520987,0.0050160955,0.00018292032,0.000077383454,0.00003930123,0.00022181452,0.00046687832,0.0010992456],"category_scores_gemma":[0.00006391648,0.0005055458,0.002480847,0.00043534455,0.000053367094,0.000036096466,0.000082470324,0.0002425708,0.0027390544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028974218,0.0012504379,0.000037842437,0.04789647,0.00030052598,0.0005296512,0.000016090187,1.6439158e-9,1.6073683e-7,0.000039992312,0.0073165316,0.94260937],"study_design_scores_gemma":[0.0015948886,0.00024308654,0.000007511981,0.03723178,0.012666889,0.0012223813,0.000002123053,5.7292173e-8,0.000006108152,0.0000013092609,0.9466132,0.00041066075],"about_ca_topic_score_codex":0.000018157532,"about_ca_topic_score_gemma":0.0000028503582,"teacher_disagreement_score":0.94219875,"about_ca_system_score_codex":0.00034922935,"about_ca_system_score_gemma":0.00051894516,"threshold_uncertainty_score":0.9998139},"labels":[],"label_agreement":null},{"id":"W2135067956","doi":"10.3324/haematol.2009.021766","title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Fundação para a Ciência e a Tecnologia; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Follicular lymphoma; Follicular phase; Lymphoma; Medicine; Internal medicine; CD34; Pathology; Angiogenesis; Microvessel; Prognostic variable; Survival analysis; Oncology; Multivariate analysis; Biology","score_opus":0.010060671104852398,"score_gpt":0.23402911254233863,"score_spread":0.22396844143748623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135067956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966612,0.00019332445,0.00016294689,0.00020626129,0.00006698213,0.00037493318,0.000008490838,0.000027130904,0.0022987556],"genre_scores_gemma":[0.9986005,0.0006624675,0.00061493524,0.000025412539,0.000010738298,0.000034633493,0.00003784505,0.0000053209064,0.000008159148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931,0.000043278586,0.00023443314,0.00014244077,0.00015719567,0.00011263768],"domain_scores_gemma":[0.99961144,0.000058569356,0.00007895027,0.00015175843,0.000042801712,0.00005649655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000171118,0.0000941417,0.00029860917,0.00006703047,0.000030301977,0.0000081676,0.000027819597,0.00012231321,0.000032569566],"category_scores_gemma":[0.000101022684,0.000065890476,0.000065291904,0.00009013431,0.000045059962,0.0000777195,0.000011234585,0.000048874463,0.000004410802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011514647,0.0006103471,0.96950746,0.000117832824,0.000107900014,0.00008881736,0.000511744,0.0000066298335,0.00095636427,0.01897329,0.00002105064,0.0089834],"study_design_scores_gemma":[0.0045407047,0.00017051851,0.98534316,0.000049156206,0.00014268338,0.00013943035,0.000046573983,0.0007774841,0.007486699,0.00077680557,0.00046290067,0.00006390325],"about_ca_topic_score_codex":0.00024343398,"about_ca_topic_score_gemma":0.00014202554,"teacher_disagreement_score":0.018196486,"about_ca_system_score_codex":0.000015750453,"about_ca_system_score_gemma":0.000030909927,"threshold_uncertainty_score":0.26869357},"labels":[],"label_agreement":null},{"id":"W2135321054","doi":"10.1200/jco.2007.13.5376","title":"Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Medicine; International Prognostic Index; Follicular lymphoma; Prednisone; Vincristine; Internal medicine; Subgroup analysis; Rituximab; Cyclophosphamide; Gastroenterology; Univariate analysis; Lymphoma; Surgery; Oncology; Confidence interval; Chemotherapy; Multivariate analysis","score_opus":0.037635128536769286,"score_gpt":0.3714512317465326,"score_spread":0.3338161032097633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135321054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790674,0.00053018547,0.000009524658,0.00016286141,0.000089829795,0.0011316204,0.0000054146726,0.000009216287,0.00015463123],"genre_scores_gemma":[0.9975442,0.0003846545,0.0017524115,0.00017510273,0.000056270605,0.000023207142,0.0000107793,0.000021952597,0.000031403193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963441,0.00039140732,0.0022326638,0.00026905938,0.0005065888,0.00025619668],"domain_scores_gemma":[0.9960768,0.0008469189,0.0018537015,0.00026016237,0.00058838393,0.00037399592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069293706,0.00024155296,0.0025068359,0.00014449039,0.00006249376,0.000003924237,0.00010139198,0.00015894232,0.000013805086],"category_scores_gemma":[0.0004454304,0.00013973686,0.0001286611,0.000281021,0.00025753718,0.00011364966,0.00003915035,0.00026498846,0.0000010784693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0676992,0.08403176,0.8187889,0.000026284577,0.00091754925,0.0028850257,0.00062396924,0.000044429107,0.0000070446463,0.0000018156667,0.000106417654,0.02486763],"study_design_scores_gemma":[0.26901844,0.111968294,0.6173728,0.00019574974,0.00061115186,0.00024282452,0.00023152826,0.00001926232,0.000046318924,0.0000029659568,0.00020757415,0.00008306626],"about_ca_topic_score_codex":0.00032572565,"about_ca_topic_score_gemma":0.00028200593,"teacher_disagreement_score":0.20141606,"about_ca_system_score_codex":0.00023335303,"about_ca_system_score_gemma":0.0008077032,"threshold_uncertainty_score":0.56983036},"labels":[],"label_agreement":null},{"id":"W2135334174","doi":"10.1016/j.bbmt.2012.10.024","title":"Controversies in BMT for Lymphoma","year":2012,"lang":"en","type":"review","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Multiple myeloma; Disease; Intensive care medicine; Lymphoma; Psychological intervention; Internal medicine","score_opus":0.041012997897363006,"score_gpt":0.32260216877074765,"score_spread":0.28158917087338464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135334174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030777238,0.9953741,0.000010240347,0.000043996177,0.00009647591,0.0008782423,0.00034523057,0.0000068493405,0.00016717581],"genre_scores_gemma":[0.028121104,0.97034657,0.00025557124,0.000036908754,0.000062361876,0.00019878044,0.0009438669,0.000010640182,0.000024179657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992916,0.000041100433,0.0003089055,0.00017460177,0.00003234796,0.000151423],"domain_scores_gemma":[0.9992259,0.0005015061,0.00013458687,0.00007358856,0.000019248915,0.000045181998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095560914,0.00017096421,0.00095118146,0.00012903311,0.00001741585,0.000002067378,0.000026530679,0.00025517112,0.000006560294],"category_scores_gemma":[0.000013277937,0.00012199703,0.00017326677,0.00004404918,0.000060165243,0.000018616713,0.0000030676038,0.000025062624,0.0000013906688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015457724,0.00040432092,0.0036344903,0.024818001,0.00050683646,0.000013191889,0.00010278409,6.039726e-9,0.00007768588,0.0011905712,0.000018974028,0.96907854],"study_design_scores_gemma":[0.014864683,0.0011394873,0.0028041115,0.008613896,0.022852486,0.0004914236,0.00002472323,5.4014805e-7,0.00045497046,0.000101381236,0.9483588,0.00029355023],"about_ca_topic_score_codex":0.000046582634,"about_ca_topic_score_gemma":0.000026208552,"teacher_disagreement_score":0.968785,"about_ca_system_score_codex":0.000018577597,"about_ca_system_score_gemma":0.00008113513,"threshold_uncertainty_score":0.49748945},"labels":[],"label_agreement":null},{"id":"W2135471715","doi":"10.1111/j.1365-2141.2010.08331.x","title":"Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Prednisone; Vincristine; Population; CHOP; Rituximab; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.011323437320668489,"score_gpt":0.26909237899233773,"score_spread":0.25776894167166925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135471715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842095,0.00016812116,0.0000034795066,0.00003352569,0.00006652069,0.0012642678,0.000021484902,0.0000056526274,0.00001600326],"genre_scores_gemma":[0.99969876,0.0000108116155,0.000089512214,0.00003545797,0.000014819883,0.00007192794,0.000051472343,0.000023422803,0.000003808271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976089,0.00036989638,0.0009913127,0.00026114273,0.0004709987,0.00029773178],"domain_scores_gemma":[0.9986218,0.00020804662,0.0006879056,0.00018213851,0.00020701818,0.00009309469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285461,0.00020425324,0.000953469,0.0004450706,0.000029449677,0.000045293218,0.00016788323,0.00015349673,0.000029487494],"category_scores_gemma":[0.000076121716,0.00015231286,0.00007288083,0.0002924293,0.00019237166,0.00018973536,0.000030604984,0.00031469157,0.0000010913627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010130821,0.031145737,0.93596506,0.000076723496,0.0001379002,0.026567992,0.0040986342,0.0000052607215,0.000021219552,0.0000068590043,0.00001994322,0.0009416089],"study_design_scores_gemma":[0.04296666,0.0067027225,0.94252217,0.0010129453,0.00020091583,0.0047192164,0.0015373873,0.000037867296,0.00015550842,0.000012699125,0.0000025230047,0.00012936599],"about_ca_topic_score_codex":0.0011290722,"about_ca_topic_score_gemma":0.023967313,"teacher_disagreement_score":0.04195358,"about_ca_system_score_codex":0.000069479116,"about_ca_system_score_gemma":0.00020581813,"threshold_uncertainty_score":0.9938427},"labels":[],"label_agreement":null},{"id":"W2135742799","doi":"10.1002/cncr.21586","title":"Biomarkers of potential prognostic significance in diffuse large B‐cell lymphoma","year":2005,"lang":"en","type":"review","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Disease; Lymphoma; Diffuse large B-cell lymphoma; Cancer; Bioinformatics; Oncology; Gene expression profiling; Computational biology; Internal medicine; Gene expression; Gene; Biology","score_opus":0.028782808929395793,"score_gpt":0.33037290040108475,"score_spread":0.30159009147168897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135742799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014333825,0.9953688,0.0000032480107,0.00004922631,0.0002975683,0.0017122817,0.00029288232,0.000026200727,0.00081642956],"genre_scores_gemma":[0.0092221005,0.98835844,0.000102625556,0.00006801636,0.00028209918,0.0011777832,0.00014801149,0.00006599322,0.00057494314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803525,0.000074276104,0.0006794472,0.0005046355,0.00028374555,0.00042266498],"domain_scores_gemma":[0.99888206,0.000105640924,0.0003700365,0.0004280473,0.00005884918,0.0001553888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010541591,0.00042656818,0.001750298,0.0002389409,0.000024495259,0.000011283578,0.00014837408,0.00028510467,0.00022938424],"category_scores_gemma":[0.000031127474,0.00031438566,0.00052562763,0.00040212274,0.00007026293,0.000036497833,0.000052274612,0.00009219009,0.00006198901],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040854367,0.0060846284,0.0015276276,0.012284655,0.0003702467,0.00030361966,0.00003478784,3.2871205e-7,0.0000023773737,0.0000114918,0.0015294235,0.97780997],"study_design_scores_gemma":[0.0105619505,0.00011706216,0.0023601253,0.01802595,0.0024667024,0.00003170306,0.00001227752,0.000008994843,0.00003823703,0.0000018500431,0.9660788,0.00029635688],"about_ca_topic_score_codex":0.00018259643,"about_ca_topic_score_gemma":0.00006274783,"teacher_disagreement_score":0.9775136,"about_ca_system_score_codex":0.0009774287,"about_ca_system_score_gemma":0.0011774511,"threshold_uncertainty_score":0.9999308},"labels":[],"label_agreement":null},{"id":"W2136007869","doi":"10.1200/jco.2005.04.5823","title":"Hodgkin's Lymphoma in Adolescents","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Young adult; Hodgkin lymphoma; Cancer; Pediatrics; Malignancy; Internal medicine; Population; Disease; Stage (stratigraphy); Lymphoma; Hazard ratio; Confidence interval","score_opus":0.07967849297874934,"score_gpt":0.44699982434358665,"score_spread":0.3673213313648373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136007869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541415,0.0007121647,0.0000105944055,0.004470989,0.0008523855,0.000107701766,7.081874e-7,0.0000051668476,0.008426158],"genre_scores_gemma":[0.9954016,0.00027007752,0.001006919,0.001978557,0.001167694,0.000002415854,0.0000010365477,0.000008716174,0.000162992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973507,0.0001933707,0.0018792122,0.000126008,0.00026030256,0.00019041965],"domain_scores_gemma":[0.9982438,0.00043382795,0.00084640965,0.00012482035,0.00015519808,0.00019596203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012484333,0.00009753507,0.0010712519,0.00012484894,0.000013406442,0.000005160005,0.0000849569,0.00026840193,0.000049265524],"category_scores_gemma":[0.00068038097,0.000064656735,0.00040230682,0.00011304778,0.00008333606,0.000056702058,0.000025147567,0.000214974,0.00004891379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001211933,0.007488244,0.7857616,0.000011179506,0.000055246488,0.0032656344,0.0000070102665,0.000004823559,0.000015309608,0.00014496177,0.004557796,0.19747627],"study_design_scores_gemma":[0.021034377,0.0046407315,0.92017174,0.0002149682,0.0001311297,0.0005052438,0.000015728294,0.000015945017,0.000076130884,0.00043146472,0.052712183,0.00005034904],"about_ca_topic_score_codex":0.00012852166,"about_ca_topic_score_gemma":0.00012077617,"teacher_disagreement_score":0.19742592,"about_ca_system_score_codex":0.00033666653,"about_ca_system_score_gemma":0.0009856842,"threshold_uncertainty_score":0.26366252},"labels":[],"label_agreement":null},{"id":"W2136038764","doi":"10.1002/path.1986","title":"Prognostic significance of PU.1 in follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"International Prognostic Index; Follicular lymphoma; Medicine; Lymphoma; Germinal center; Internal medicine; Immunohistochemistry; Malignancy; Pathological; Oncology; CD20; Pathology; Diffuse large B-cell lymphoma; Immunology; B cell; Antibody","score_opus":0.011159157677379487,"score_gpt":0.2522099009864713,"score_spread":0.2410507433090918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136038764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532145,0.002660042,0.00007592241,0.0010243421,0.00008183014,0.00017125085,0.0000018377688,0.0000026645957,0.00066065165],"genre_scores_gemma":[0.9991128,0.00014982083,0.00045737362,0.00012456397,0.000090262794,0.0000052853497,0.0000010229462,0.0000066066755,0.000052284035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913245,0.00012858163,0.0003991043,0.000056712106,0.00015052319,0.00013264628],"domain_scores_gemma":[0.9992669,0.00019623843,0.00027742356,0.0001389071,0.00009036073,0.000030126737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042989975,0.00007469251,0.000311623,0.00009244859,0.000015195351,0.0000019024196,0.00008221984,0.000048276303,0.000017825301],"category_scores_gemma":[0.00008212157,0.000041017483,0.000089299894,0.00012523304,0.00009031576,0.000023780132,0.000014048833,0.000053200096,0.0000060100474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055009284,0.0022643283,0.9301337,0.00005205917,0.00009132736,0.0074860766,0.00045528894,0.00018689579,0.0467722,0.0009997984,0.00080449774,0.010203714],"study_design_scores_gemma":[0.0033832022,0.0008852379,0.9701881,0.000097999415,0.00021216786,0.00451201,0.000090535395,0.000014438826,0.019022936,0.0010960536,0.00045728352,0.000040063995],"about_ca_topic_score_codex":0.0000758392,"about_ca_topic_score_gemma":0.000024073748,"teacher_disagreement_score":0.04005435,"about_ca_system_score_codex":0.00007129352,"about_ca_system_score_gemma":0.000106628104,"threshold_uncertainty_score":0.16726445},"labels":[],"label_agreement":null},{"id":"W2136121072","doi":"10.1634/theoncologist.2013-0343","title":"Effect of Place of Residence and Treatment on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma in British Columbia","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Residence; Rural area; Confidence interval; Hazard ratio; Diffuse large B-cell lymphoma; Cancer registry; Demography; Cancer; Lymphoma; Internal medicine; Pathology","score_opus":0.006921278772214086,"score_gpt":0.24701985129497664,"score_spread":0.24009857252276257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136121072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983286,0.00006034771,1.7502741e-7,0.00009021408,0.000030582723,0.00072702277,0.000027695127,0.0000070643055,0.00072829565],"genre_scores_gemma":[0.9995048,0.00006699903,0.00001833543,0.000042231975,0.0000058162664,0.000067646884,0.000009568674,0.000008817949,0.00027580117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902266,0.00024386612,0.00021310548,0.0001786058,0.00018000127,0.0001617716],"domain_scores_gemma":[0.9985477,0.0010376435,0.00011690965,0.00023611303,0.00002161213,0.000040051887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003533274,0.000101811325,0.0005428338,0.000029501129,0.000027313523,0.000012091713,0.00005791881,0.000051963387,0.00000720055],"category_scores_gemma":[0.00013138838,0.00007035921,0.000038310012,0.00008687208,0.00012866703,0.000018647735,0.00003021195,0.000028637329,0.0000017700706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091442064,0.0096120825,0.97557145,0.000046170364,0.000028081495,0.000036230147,0.00010260801,0.0000021141407,0.000005283741,0.000008159672,0.00004522548,0.013628187],"study_design_scores_gemma":[0.05821368,0.014507005,0.92635155,0.0002012995,0.00007286193,0.0000017721067,0.000034466648,0.000013884055,0.0004985019,0.000004560212,0.00004484462,0.00005559177],"about_ca_topic_score_codex":0.029659165,"about_ca_topic_score_gemma":0.11364881,"teacher_disagreement_score":0.08398964,"about_ca_system_score_codex":0.00029236524,"about_ca_system_score_gemma":0.000043702326,"threshold_uncertainty_score":0.9768024},"labels":[],"label_agreement":null},{"id":"W2136268782","doi":"10.1200/jco.2014.60.2383","title":"Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Tissue microarray; Diffuse large B-cell lymphoma; Germinal center; Medicine; Vincristine; International Prognostic Index; Immunohistochemistry; Lymphoma; Pathology; Cancer research; Rituximab; Oncology; Internal medicine; Cyclophosphamide; B cell; Immunology; Chemotherapy; Antibody","score_opus":0.07129790435913139,"score_gpt":0.39625720036363743,"score_spread":0.324959296004506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136268782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659026,0.001305664,0.00013718216,0.00037940062,0.00043024262,0.00042590912,0.000049811082,0.000007810421,0.0006737111],"genre_scores_gemma":[0.99378484,0.00036857408,0.0052083726,0.00016178213,0.00018978523,0.000017373965,0.000019010593,0.00002051731,0.00022974507],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958205,0.00025720813,0.0028903692,0.00022951321,0.00047864267,0.00032371545],"domain_scores_gemma":[0.9942956,0.0020735743,0.0024684647,0.0002558796,0.00042885076,0.00047760457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012570482,0.00021646936,0.001842479,0.00015222137,0.000013459534,0.000009826428,0.00021060141,0.00037128924,0.000015022794],"category_scores_gemma":[0.0017738134,0.00014593294,0.00032671823,0.00017619609,0.00018104342,0.00019755783,0.00008106222,0.00020398364,0.000011153872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012190247,0.112067625,0.7448246,0.00028586254,0.00021729118,0.0021831903,0.00073731586,0.000021374255,0.07863972,0.000016988522,0.008585016,0.040230777],"study_design_scores_gemma":[0.16717823,0.035870552,0.08895388,0.0004982932,0.00060117955,0.00023906888,0.00050954527,0.00026299866,0.6822872,0.00015713809,0.023116667,0.00032520134],"about_ca_topic_score_codex":0.000018466897,"about_ca_topic_score_gemma":0.000009523355,"teacher_disagreement_score":0.65587074,"about_ca_system_score_codex":0.00019658277,"about_ca_system_score_gemma":0.0014626385,"threshold_uncertainty_score":0.59509724},"labels":[],"label_agreement":null},{"id":"W2136385642","doi":"10.1517/14712598.2012.657622","title":"Obinutuzumab for the treatment of lymphoproliferative disorders","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Antibody-dependent cell-mediated cytotoxicity; CD20; Clinical trial; Lymphoma; Oncology; Monoclonal antibody; Immunology; Monoclonal antibody therapy; Internal medicine; Antibody","score_opus":0.28090023864748026,"score_gpt":0.44167147150498937,"score_spread":0.1607712328575091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136385642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027329826,0.99407923,0.000016623999,0.00039240226,0.0007326926,0.004383258,0.00009602461,0.00003850581,0.00023396013],"genre_scores_gemma":[0.00029476863,0.9922414,0.00012476198,0.0003265515,0.0009098382,0.0055914433,0.00042869025,0.00003493287,0.000047634352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848497,0.0001544764,0.0004708662,0.00041947112,0.00015354271,0.00031664464],"domain_scores_gemma":[0.99783945,0.0012661774,0.00025686048,0.00048630213,0.000040224095,0.000111002664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097148724,0.00054340804,0.0016913858,0.000061881045,0.00012491576,0.000011032526,0.00014371135,0.00037557626,0.00019583397],"category_scores_gemma":[0.000018241617,0.00019437136,0.0013593143,0.000118971555,0.00015290151,0.000014652208,0.000011965986,0.00005396312,0.00003208983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044033412,0.0023526691,0.000035867117,0.000057592362,0.0009977716,5.784509e-7,0.00020549976,1.09586324e-7,8.3199694e-7,0.0008714508,0.00044890837,0.9945884],"study_design_scores_gemma":[0.0032069387,0.010031813,0.000101408725,0.0007286714,0.000025741752,0.000010549215,0.000032604956,0.0000016896671,0.000055091852,0.00003730388,0.98556733,0.00020082868],"about_ca_topic_score_codex":0.000027703549,"about_ca_topic_score_gemma":4.954013e-7,"teacher_disagreement_score":0.99438757,"about_ca_system_score_codex":0.000700042,"about_ca_system_score_gemma":0.00018117219,"threshold_uncertainty_score":0.7926234},"labels":[],"label_agreement":null},{"id":"W2136443348","doi":"10.1158/0008-5472.can-07-0080","title":"Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; Pretargeting; CD20; Lymphoma; Raji cell; Medicine; Cancer research; Biodistribution; Antigen; Ibritumomab tiuxetan; CD22; Antibody; Immunology; Monoclonal antibody; Chemistry","score_opus":0.13587631984553242,"score_gpt":0.46846264311062596,"score_spread":0.3325863232650935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136443348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97230136,0.024452941,0.00004435754,0.00027146935,0.000058294623,0.0010056875,0.000017991484,0.0000055139435,0.0018423825],"genre_scores_gemma":[0.99692535,0.0019272713,0.0005476409,0.000025290177,0.00009420715,0.0001850695,0.0000121905105,0.000016475358,0.00026647828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834526,0.00008383534,0.00025061125,0.00018123646,0.00087795814,0.00026109032],"domain_scores_gemma":[0.9982195,0.0003448246,0.00007448682,0.00018080197,0.0011075294,0.00007287231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004698478,0.000073362775,0.00022034267,0.00016066546,0.000061881154,0.000006121604,0.00004967827,0.000057034405,0.00014571921],"category_scores_gemma":[0.00018787285,0.000058349022,0.00005953214,0.00020637675,0.00012429153,0.000032602962,0.000019762472,0.00004905104,0.0000012962441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013460818,0.0009226813,0.05082442,0.00052825967,0.00028863022,0.0000055902237,0.0013485798,0.000014019777,0.6585395,0.0003859918,0.0030784179,0.28271788],"study_design_scores_gemma":[0.012115597,0.0006860111,0.052670572,0.00018847134,0.00013414209,0.000002945929,0.0003948009,0.00035634075,0.92795235,0.00027761894,0.0051584626,0.00006269994],"about_ca_topic_score_codex":0.00058375526,"about_ca_topic_score_gemma":0.000023656035,"teacher_disagreement_score":0.28265518,"about_ca_system_score_codex":0.00045551782,"about_ca_system_score_gemma":0.0005658998,"threshold_uncertainty_score":0.23794042},"labels":[],"label_agreement":null},{"id":"W2136761623","doi":"10.1002/cncr.23081","title":"Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Aeronautics and Space Administration; U.S. Department of Energy","keywords":"Medicine; Breast cancer; Radiation therapy; Lung cancer; Mantle cell lymphoma; Lymphoma; Oncology; Internal medicine; Cancer; Incidence (geometry); Nuclear medicine","score_opus":0.05894403257315865,"score_gpt":0.3745382832710063,"score_spread":0.31559425069784763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136761623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94975936,0.047275644,0.0000784015,0.00035234366,0.00029684757,0.00090160733,0.00042078237,0.000027602558,0.000887381],"genre_scores_gemma":[0.99501216,0.0015179876,0.000578071,0.0012058475,0.00023115354,0.0011257216,0.00008125005,0.00002703196,0.00022075983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991415,0.000011250512,0.00028032213,0.00021125865,0.00015257276,0.00020310418],"domain_scores_gemma":[0.9993152,0.00015678244,0.00015605747,0.00016837253,0.000107608954,0.0000959902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016345103,0.00015206306,0.0003373474,0.00008335913,0.00003344545,0.0000099505305,0.000043819648,0.00009417009,0.000951096],"category_scores_gemma":[0.000018394408,0.00011471723,0.00012494424,0.000100795325,0.000052782903,0.000068580586,0.0000092467935,0.000022542357,0.0000033686933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017403574,0.00028070153,0.64878976,0.00009189001,0.00040199878,0.000014295649,0.00055115187,0.0000016945614,0.0010768141,0.000036866964,0.0057882606,0.3412262],"study_design_scores_gemma":[0.011902271,0.00023958649,0.7908291,0.00012068677,0.00009679159,0.0000025426193,0.000032813845,0.00002247947,0.1273574,0.00008837193,0.069200665,0.00010729753],"about_ca_topic_score_codex":0.0008302264,"about_ca_topic_score_gemma":0.000165814,"teacher_disagreement_score":0.3411189,"about_ca_system_score_codex":0.00026120592,"about_ca_system_score_gemma":0.00033355906,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W2137344646","doi":"10.3109/10428194.2014.982638","title":"Tumor suppressors in follicular lymphoma","year":2014,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Epigenetics; Somatic cell; Follicular lymphoma; Cancer research; Suppressor; DNA methylation; Lymphoma; Chromosomal translocation; Gene silencing; Gene; Genetics; Immunology; Gene expression","score_opus":0.01861678396511938,"score_gpt":0.2871781545044321,"score_spread":0.2685613705393127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137344646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046577416,0.9412538,0.000009572558,0.00008550312,0.0009620763,0.003652122,0.00022196637,0.00052169943,0.0067158765],"genre_scores_gemma":[0.014276989,0.97676754,0.0005297552,0.0012342245,0.0011164269,0.002212622,0.0012045598,0.00066706864,0.0019907975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98761183,0.000768069,0.0035941072,0.0036272574,0.0016304022,0.002768313],"domain_scores_gemma":[0.9923676,0.0011918036,0.0014824449,0.003022762,0.00022997032,0.0017053843],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009806046,0.0034713934,0.009643789,0.0017956618,0.0004905087,0.00042988043,0.0011200835,0.0022787617,0.00021833122],"category_scores_gemma":[0.00037068425,0.00284197,0.0027504317,0.001891225,0.0006753158,0.000420778,0.0007712733,0.00037535053,0.00097017066],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00028273131,0.00097841,0.00087528856,0.016644608,0.0012562107,0.0062855184,0.00022377711,0.0000044858634,0.0000034132897,0.0010350881,0.004506223,0.96790427],"study_design_scores_gemma":[0.026823694,0.00054159854,0.0073151984,0.024813304,0.004857394,0.009760769,0.00009414966,0.00037398352,0.000088233675,0.00014626238,0.9226219,0.0025635213],"about_ca_topic_score_codex":0.002904284,"about_ca_topic_score_gemma":0.0001631848,"teacher_disagreement_score":0.96534073,"about_ca_system_score_codex":0.027352344,"about_ca_system_score_gemma":0.011443577,"threshold_uncertainty_score":0.9998077},"labels":[],"label_agreement":null},{"id":"W2137372268","doi":"10.3109/10428194.2010.500051","title":"The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma","year":2010,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Peter MacCallum Cancer Centre; National Cancer Research Institute","keywords":"Medicine; Positron emission tomography; Lymphoma; Interim; Hodgkin lymphoma; Medical physics; Grading (engineering); Oncology; Nuclear medicine; Internal medicine","score_opus":0.01110885524102844,"score_gpt":0.30170028290951584,"score_spread":0.2905914276684874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137372268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43056294,0.565497,0.0000023494304,0.00013776218,0.00030651817,0.0026883385,0.00007190387,0.00006636776,0.00066685217],"genre_scores_gemma":[0.14554,0.8510033,0.0008645597,0.00015413936,0.0001813121,0.0016244955,0.0001635448,0.0002297636,0.00023890691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99096864,0.0011555498,0.002983224,0.0020855942,0.0012055939,0.001601402],"domain_scores_gemma":[0.9931711,0.0027965517,0.0013330082,0.0017068735,0.00018463,0.00080785766],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0025231827,0.001919715,0.0047511505,0.0016526716,0.000460224,0.00027097762,0.00073233206,0.0020276112,0.000013608033],"category_scores_gemma":[0.000309941,0.0013243022,0.0011013334,0.001987101,0.0008612555,0.0002837392,0.00062805094,0.0005375197,0.000011244837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016091804,0.0010745391,0.018465798,0.005070368,0.00046612232,0.0009472571,0.00046682404,9.482213e-7,0.00015864708,0.00043341256,0.0002823157,0.9710246],"study_design_scores_gemma":[0.029498084,0.0014979424,0.47188547,0.03220084,0.0025541699,0.0026006,0.00038695888,0.0006389866,0.00053300353,0.00021776171,0.45618957,0.0017966053],"about_ca_topic_score_codex":0.002962007,"about_ca_topic_score_gemma":0.000291697,"teacher_disagreement_score":0.96922797,"about_ca_system_score_codex":0.011938574,"about_ca_system_score_gemma":0.011332776,"threshold_uncertainty_score":0.99935466},"labels":[],"label_agreement":null},{"id":"W2137460829","doi":"10.1111/bjh.13310","title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Histiocyte; Lymphoma; Comparative genomic hybridization; Pathology; Biology; Locus (genetics); Medicine; Gene; Genetics; Chromosome","score_opus":0.027286588475523964,"score_gpt":0.26722657711876363,"score_spread":0.23993998864323968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137460829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647492,0.031757418,0.0010746347,0.00030872415,0.0003299411,0.00047919113,0.0001377206,0.000030569943,0.0011325544],"genre_scores_gemma":[0.99329036,0.0022946324,0.0033172795,0.00034668966,0.0002931604,0.000023784622,0.00007952512,0.00004855348,0.0003060052],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99691063,0.00038053817,0.0012318068,0.00042517087,0.00047435818,0.0005775163],"domain_scores_gemma":[0.9973264,0.0002600819,0.00093562214,0.00026693562,0.0006471368,0.000563849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007438213,0.00036855787,0.0017596725,0.00026796243,0.00021825137,0.00011324128,0.00020138112,0.00024195794,0.000037806014],"category_scores_gemma":[0.0001387269,0.00037096383,0.00021492198,0.00019291465,0.00023367166,0.00024730258,0.00009642164,0.00011774188,0.000042375137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003935308,0.015020949,0.65008277,0.0021782634,0.0030130986,0.1896683,0.011476111,0.0001484002,0.008341904,0.00080134545,0.08244452,0.032889012],"study_design_scores_gemma":[0.112181805,0.0031523122,0.34581015,0.0017816689,0.0028113017,0.3759948,0.003149492,0.00024664614,0.11928005,0.0012177278,0.033159822,0.0012142339],"about_ca_topic_score_codex":0.00015268153,"about_ca_topic_score_gemma":0.000035352165,"teacher_disagreement_score":0.30427265,"about_ca_system_score_codex":0.0010100269,"about_ca_system_score_gemma":0.0011531113,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2137781261","doi":"10.1182/asheducation-2004.1.203","title":"Low-Grade Lymphoma","year":2004,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; University of Chicago","keywords":"Rituximab; Follicular lymphoma; Lymphoma; Medicine; Transplantation; Clinical trial; Oncology; Internal medicine; Bioinformatics; Biology","score_opus":0.0432592770647726,"score_gpt":0.34853438864946007,"score_spread":0.30527511158468745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137781261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022160177,0.9953016,0.0000034420016,0.00016474267,0.0003372569,0.00084566575,0.000016839916,0.00011053571,0.0031977643],"genre_scores_gemma":[0.000094474424,0.9981194,0.00027374228,0.00018893443,0.0001202382,0.00041549368,0.00023693404,0.00006636732,0.00048438253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832237,0.000058865484,0.000560172,0.00049519236,0.00016013412,0.00040328884],"domain_scores_gemma":[0.99879575,0.00015068224,0.00022145492,0.00060353254,0.0000297316,0.00019884478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004735805,0.00046264936,0.0030051295,0.00019297072,0.000046902114,0.000010075442,0.00012076936,0.0005911255,0.0002653161],"category_scores_gemma":[0.000040235813,0.00031433068,0.00077499705,0.00019892593,0.0000909051,0.0000168821,0.00006354167,0.000104015526,0.0024647447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005524131,0.001222719,0.000054335334,0.04730027,0.0006036389,0.004155416,0.000017976465,1.5629611e-8,1.9565189e-8,0.014378606,0.002275574,0.9299859],"study_design_scores_gemma":[0.0017092731,0.00014007614,0.00002480406,0.029455809,0.002042783,0.018579906,0.000003547565,1.1757224e-7,0.00002010823,0.00014247345,0.9476548,0.0002263479],"about_ca_topic_score_codex":0.00002440677,"about_ca_topic_score_gemma":0.0000035451367,"teacher_disagreement_score":0.9453792,"about_ca_system_score_codex":0.00054170983,"about_ca_system_score_gemma":0.0010095445,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W2137811814","doi":"10.1158/1055-9965.1665.13.10","title":"Dietary Factors and Risk of Non-Hodgkin Lymphoma by Histologic Subtype: A Case-Control Analysis","year":2004,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Cancer Care Ontario","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Odds ratio; Logistic regression; Population; Follicular lymphoma; Hodgkin lymphoma; Pathology; Gastroenterology; Oncology; Environmental health","score_opus":0.028159531806976057,"score_gpt":0.3290995845242137,"score_spread":0.3009400527172376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137811814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651844,0.03119042,0.0018090038,0.00086291943,0.00016753994,0.000532992,0.00017638433,0.00003356362,0.000042788866],"genre_scores_gemma":[0.99243754,0.0056375046,0.0012826193,0.0001960355,0.000030510806,0.00014853118,0.00018432636,0.000014277575,0.00006865861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787045,0.0004734595,0.00067370204,0.00055016595,0.000089722875,0.00034249108],"domain_scores_gemma":[0.9981347,0.0006553422,0.00062107045,0.00033481486,0.00006789622,0.00018617882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008573184,0.00027932355,0.001131283,0.00030307026,0.000110500456,0.0000029905357,0.000061390645,0.00028058825,0.00009749077],"category_scores_gemma":[0.00033879653,0.00020346012,0.00053168845,0.00043271034,0.00029034298,0.00006910253,0.000027450067,0.00007048325,0.0000034842221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043412353,0.000385751,0.9548343,0.00004828148,0.009879656,0.00011712582,0.00007778916,0.00005574706,0.00043193597,0.00001807477,0.00095482473,0.0327624],"study_design_scores_gemma":[0.0055962675,0.0006387114,0.9798565,0.00007798478,0.011511815,0.000118403346,0.0000764363,0.00033528,0.0007940018,0.0006477045,0.00018119079,0.00016568443],"about_ca_topic_score_codex":0.011127534,"about_ca_topic_score_gemma":0.00131087,"teacher_disagreement_score":0.03259672,"about_ca_system_score_codex":0.0005322138,"about_ca_system_score_gemma":0.00012958421,"threshold_uncertainty_score":0.9954575},"labels":[],"label_agreement":null},{"id":"W2137905169","doi":"10.1182/asheducation-2011.1.515","title":"Therapies for Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Vincristine; Medicine; CHOP; Anaplastic large-cell lymphoma; Oncology; Lymphoma; Internal medicine; Prednisone; Brentuximab vedotin; Regimen; Cyclophosphamide; Doxorubicin; Chemotherapy; CD30","score_opus":0.07664482397366434,"score_gpt":0.34735053588227327,"score_spread":0.2707057119086089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137905169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015814583,0.9888248,0.00001773942,0.00005767091,0.00034249507,0.0015524537,0.000033054304,0.00007430686,0.009081679],"genre_scores_gemma":[0.000074625736,0.9938384,0.0013671132,0.00017148461,0.00014272,0.001741497,0.0001956516,0.00008033965,0.0023881118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860835,0.000056236804,0.00046280224,0.00043421672,0.00006933303,0.000369046],"domain_scores_gemma":[0.9989347,0.00019968426,0.00022695684,0.00046576452,0.000053320502,0.00011957375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006377134,0.00043103646,0.0025273438,0.00011223654,0.000060917657,0.000009503121,0.000118589254,0.00047064063,0.0005757481],"category_scores_gemma":[0.000019249814,0.00027863373,0.00087138003,0.000076293436,0.00008132981,0.000017813669,0.000037093025,0.00007671127,0.0002685178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039142098,0.00085433165,0.00021526344,0.028269567,0.00084229984,0.0001915092,0.00016631481,1.6338955e-9,1.05985066e-7,0.020202853,0.008539087,0.94067955],"study_design_scores_gemma":[0.0017093787,0.00035854036,0.000009282903,0.0025768802,0.0020517006,0.002215585,0.000018154045,3.917445e-7,0.000016043254,0.0002048993,0.99061364,0.00022550934],"about_ca_topic_score_codex":0.00001728293,"about_ca_topic_score_gemma":0.000004293085,"teacher_disagreement_score":0.98207456,"about_ca_system_score_codex":0.00016915167,"about_ca_system_score_gemma":0.00041004666,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W2138498648","doi":"10.1093/annonc/mdm440","title":"Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin’s lymphoma","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mammography; Ductal carcinoma; Breast cancer; Lymphoma; Magnetic resonance imaging; Radiation therapy; Hodgkin lymphoma; Radiology; Cancer; Gynecology; Internal medicine","score_opus":0.04571391059470557,"score_gpt":0.35542855668697315,"score_spread":0.30971464609226756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138498648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167967,0.00048266668,0.0030755962,0.0013280729,0.00006556521,0.0014999278,0.00006544922,0.00004095678,0.0017620936],"genre_scores_gemma":[0.9891203,0.00014595251,0.008691642,0.00093823246,0.00012201937,0.0006453612,0.0001701183,0.000028450766,0.00013791966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873936,0.000025749667,0.00037461158,0.00023972336,0.00014002132,0.00048051594],"domain_scores_gemma":[0.9985533,0.00060310477,0.00024079553,0.00018827549,0.00023252152,0.00018202624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005946358,0.00016662448,0.00053472153,0.00029669117,0.000076713186,0.000007713378,0.0000581998,0.00014322292,0.000021934882],"category_scores_gemma":[0.000083204184,0.00012747114,0.00017836104,0.00023550162,0.00007890215,0.00006838,0.000008340916,0.000023093095,0.0000016831239],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005804174,0.0015811502,0.21304217,0.00018345423,0.0010537595,0.000053879157,0.0008911408,0.000008330989,0.00035069275,0.00095535483,0.004409876,0.771666],"study_design_scores_gemma":[0.030772025,0.031351857,0.7835172,0.00015456509,0.00054851314,0.00019362418,0.0010041319,0.000321174,0.02724483,0.00046370996,0.1241286,0.0002998018],"about_ca_topic_score_codex":0.000111046575,"about_ca_topic_score_gemma":0.00007386813,"teacher_disagreement_score":0.77136624,"about_ca_system_score_codex":0.00014551739,"about_ca_system_score_gemma":0.00014422154,"threshold_uncertainty_score":0.5198122},"labels":[],"label_agreement":null},{"id":"W2138537095","doi":"10.1002/gcc.10314","title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","year":2003,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Deutsche Krebshilfe; Cancerfonden","keywords":"Biology; Identification (biology); Genetics; Somatic evolution in cancer; Cancer research; Follicular lymphoma; Follicular phase; Computational biology; Evolutionary biology; Lymphoma; Cancer; Immunology","score_opus":0.012389221681426407,"score_gpt":0.24614182820645208,"score_spread":0.23375260652502566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138537095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162855,0.08331869,0.000013401072,0.000036387908,0.00004970437,0.00018948848,0.000026387426,0.000003864046,0.00007654745],"genre_scores_gemma":[0.9881661,0.011612832,0.00006969401,0.000017961349,0.000020993188,0.00006569149,0.000009981619,0.000007362545,0.000029385636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999313,0.00002425986,0.00024996835,0.00018097715,0.00012486713,0.000106930915],"domain_scores_gemma":[0.99967116,0.000016189206,0.00009558881,0.00012358165,0.00004610218,0.00004736802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007777456,0.00009071893,0.00022971378,0.00006737479,0.000022505928,0.00000425951,0.000018742252,0.000053344684,0.000036104168],"category_scores_gemma":[0.000007901015,0.000075059375,0.000041049712,0.00012736655,0.000064375374,0.00003207595,0.000011318292,0.000014868461,5.746911e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039421942,0.00020181642,0.8708505,0.00021078679,0.00006625431,0.000007908275,0.0001888588,0.000017653107,0.109786585,0.0038454377,0.000009219631,0.014775573],"study_design_scores_gemma":[0.0019069894,0.00012275206,0.82933074,0.00009477386,0.000097464654,0.00002880986,0.000103256665,0.00006431951,0.16746534,0.000536599,0.0001866698,0.00006225906],"about_ca_topic_score_codex":0.00018013614,"about_ca_topic_score_gemma":0.00005032638,"teacher_disagreement_score":0.071880564,"about_ca_system_score_codex":0.000097839606,"about_ca_system_score_gemma":0.00010583077,"threshold_uncertainty_score":0.30608326},"labels":[],"label_agreement":null},{"id":"W2138573874","doi":"10.3109/10428194.2014.939967","title":"Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Mantle cell lymphoma; Follicular lymphoma; Hodgkin lymphoma; Medicine; Classical Hodgkin lymphoma; Oncology; Internal medicine","score_opus":0.015628852843106826,"score_gpt":0.27578041283930294,"score_spread":0.2601515599961961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138573874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98790675,0.00048822552,0.0010444833,0.004677608,0.0004380183,0.001625996,0.000025630467,0.00016103308,0.0036322277],"genre_scores_gemma":[0.99325764,0.00044486107,0.001536208,0.0031005389,0.00038455828,0.00030524144,0.0002924322,0.00012776857,0.000550757],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99533945,0.000330083,0.0014970355,0.0011695143,0.0007761641,0.0008877387],"domain_scores_gemma":[0.9964955,0.00054220256,0.0007548508,0.0013096381,0.0003417905,0.0005560607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010989336,0.0006771368,0.0011756233,0.0008112123,0.0004411356,0.00015469275,0.0004486586,0.0003255443,0.000040090305],"category_scores_gemma":[0.00041303807,0.00053729705,0.00019443044,0.0026761852,0.00021162974,0.00031305174,0.00019758091,0.00009370731,0.00012766162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052944536,0.00074176124,0.27030984,0.0003254154,0.00016706267,0.000023586053,0.0019316771,0.00010928429,0.011190322,0.008645486,0.005057105,0.70096904],"study_design_scores_gemma":[0.011976594,0.00049630436,0.9470407,0.0006098255,0.00014850458,0.00017495424,0.0011676071,0.013345414,0.0071683945,0.00015129549,0.017229263,0.00049114286],"about_ca_topic_score_codex":0.0027757387,"about_ca_topic_score_gemma":0.0009278324,"teacher_disagreement_score":0.7004779,"about_ca_system_score_codex":0.010058571,"about_ca_system_score_gemma":0.003222384,"threshold_uncertainty_score":0.9997079},"labels":[],"label_agreement":null},{"id":"W2139055966","doi":"10.1586/17474086.2013.841538","title":"Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Tolerability; Clinical trial; Oncology; Pharmacokinetics; Refractory (planetary science); Pharmacology; Internal medicine; Lymphoma; Rituximab; Adverse effect","score_opus":0.11394806879692908,"score_gpt":0.4874092623334129,"score_spread":0.3734611935364838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139055966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050995608,0.9791405,0.000010895833,0.0038659566,0.00055844866,0.016192405,0.000078277,0.000013279438,0.00008919688],"genre_scores_gemma":[0.000007731706,0.9853189,0.0033117395,0.0060562347,0.0002704525,0.004557476,0.00034094256,0.00006463286,0.000071887654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921234,0.0010369761,0.0052749785,0.00071909226,0.00041920447,0.00042630726],"domain_scores_gemma":[0.9916357,0.0042842706,0.0026079621,0.0010606572,0.0002516307,0.0001598077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002555492,0.0007662982,0.011025778,0.00016954252,0.000034852936,0.0000065279123,0.00045037415,0.00043206092,0.0003010143],"category_scores_gemma":[0.0032070763,0.0003548979,0.001900218,0.00027836516,0.00022931844,0.000034134344,0.00016861354,0.00026294915,0.000017689617],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042081237,0.0013990669,0.000055692723,0.39981073,0.00051531213,0.00006042319,0.00003026635,8.6692226e-10,3.8159964e-8,0.00004664253,0.04058098,0.55708003],"study_design_scores_gemma":[0.021279374,0.0014435495,0.000019970008,0.3735369,0.0035599524,0.0005157904,0.000011880659,0.000002087129,0.0000030099905,0.000002615637,0.5994407,0.00018414878],"about_ca_topic_score_codex":0.00003221218,"about_ca_topic_score_gemma":0.0000054350357,"teacher_disagreement_score":0.5588597,"about_ca_system_score_codex":0.00010321896,"about_ca_system_score_gemma":0.00075848337,"threshold_uncertainty_score":0.9998903},"labels":[],"label_agreement":null},{"id":"W2139176812","doi":"10.1200/jco.2009.26.1693","title":"Prognostic Factors in Follicular Lymphoma","year":2010,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Chemoimmunotherapy; Medicine; Follicular lymphoma; Rituximab; Lymphoma; Oncology; Internal medicine; International Prognostic Index; Stage (stratigraphy); Obinutuzumab","score_opus":0.21296917113921873,"score_gpt":0.5163045012523486,"score_spread":0.30333533011312985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139176812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017339224,0.9776844,0.0000012263374,0.00039484812,0.0024987108,0.0007122019,0.000006248884,0.000007809823,0.001355352],"genre_scores_gemma":[0.0018931681,0.9956005,0.00065932353,0.00026970953,0.0013697856,0.000027313705,0.000017690201,0.00004117476,0.000121335106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321765,0.00065193715,0.005071524,0.0003063912,0.0004273461,0.00032517267],"domain_scores_gemma":[0.9882696,0.0066524865,0.003930474,0.0003313204,0.00023187844,0.00058420707],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002354499,0.00039127792,0.008438457,0.00036202665,0.00002145285,0.000012631749,0.00026374904,0.0019874766,0.00011642834],"category_scores_gemma":[0.0074920957,0.00021164404,0.003097414,0.00025190425,0.00015248048,0.00005771355,0.00006845832,0.0014050378,0.00007478422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010774439,0.004897271,0.042277306,0.001032717,0.000719345,0.0060421512,0.000012117091,4.7699782e-8,3.128508e-8,0.000042480628,0.00071594847,0.94415283],"study_design_scores_gemma":[0.0057171914,0.005611473,0.05691527,0.007167256,0.0048240325,0.0016864173,0.000008331694,5.27673e-7,3.6237356e-7,0.000038867587,0.9178803,0.0001499785],"about_ca_topic_score_codex":0.000019825999,"about_ca_topic_score_gemma":0.000039887393,"teacher_disagreement_score":0.94400287,"about_ca_system_score_codex":0.00059934135,"about_ca_system_score_gemma":0.007633004,"threshold_uncertainty_score":0.99930817},"labels":[],"label_agreement":null},{"id":"W2139526378","doi":"10.1002/pbc.25187","title":"Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the children's oncology group","year":2014,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Regimen; Vinblastine; Neutropenia; Internal medicine; Gastroenterology; Febrile neutropenia; Prednisone; Surgery; Randomized controlled trial; Chemotherapy; Oncology; Cyclophosphamide","score_opus":0.006459814301567227,"score_gpt":0.26185916454755237,"score_spread":0.25539935024598515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139526378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931305,0.0026683866,0.000047640704,0.00014368995,0.0001956038,0.0030777187,0.00052614155,0.000026206919,0.00018410943],"genre_scores_gemma":[0.9958048,0.0025398834,0.0002500529,0.00006162287,0.0005588151,0.00044631527,0.00027641602,0.000033084172,0.000029029196],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717575,0.00028102787,0.001061506,0.000639488,0.0004548595,0.00038734617],"domain_scores_gemma":[0.9969214,0.0010724086,0.0011589268,0.00056509586,0.00011561934,0.00016655402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006774422,0.00034404974,0.001473151,0.00016613807,0.00005604414,0.000010456612,0.00014535898,0.0001528919,0.00001437171],"category_scores_gemma":[0.000498555,0.00021366304,0.0001753835,0.00042306806,0.00015576326,0.00007166764,0.00008122516,0.00013648295,6.5739874e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90270966,0.009934371,0.08327565,0.000070860006,0.0007158886,0.00007530361,0.00038581502,0.000040666582,0.00003498447,0.000014600264,0.00017914249,0.0025630607],"study_design_scores_gemma":[0.88646334,0.00480067,0.10405664,0.00016975621,0.0037414648,0.000025080446,0.00003338607,0.00014025735,0.00032652522,0.0000052154446,0.000051707786,0.00018594907],"about_ca_topic_score_codex":0.0050037256,"about_ca_topic_score_gemma":0.0006652962,"teacher_disagreement_score":0.020780992,"about_ca_system_score_codex":0.00012108439,"about_ca_system_score_gemma":0.0004398117,"threshold_uncertainty_score":0.8712926},"labels":[],"label_agreement":null},{"id":"W2139582914","doi":"10.1200/jco.2003.09.057","title":"Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mantle cell lymphoma; Nausea; Toxicity; Gastroenterology; Vomiting; Internal medicine; Progressive disease; Lymphoma; Phases of clinical research; Surgery; Chemotherapy","score_opus":0.28585878921707086,"score_gpt":0.5286928873413912,"score_spread":0.24283409812432033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139582914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293506,0.00026654065,0.000001123797,0.0021927147,0.0021460252,0.0007603496,0.00007533957,0.000001665634,0.001621167],"genre_scores_gemma":[0.9979268,0.00053390086,0.00024837677,0.0006040915,0.0003054607,0.000015526273,0.0000030964818,0.000010428808,0.00035235117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98736453,0.0027743562,0.008555513,0.00024603403,0.0008556305,0.00020390787],"domain_scores_gemma":[0.9832163,0.008801968,0.0066062524,0.00025409448,0.0008774404,0.0002439699],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013244783,0.00017501043,0.0031637808,0.0001393632,0.000041380063,0.0000019267577,0.0002214777,0.0003276524,0.000084328254],"category_scores_gemma":[0.03243627,0.00009036017,0.00058891607,0.00038995387,0.00026592574,0.00006200932,0.000056678415,0.00035789784,3.8568308e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13002938,0.26181722,0.49300897,0.00013919824,0.0039500985,0.0017182364,0.0006593691,0.0002589271,0.00043870346,0.00025820325,0.042368166,0.06535355],"study_design_scores_gemma":[0.42739287,0.066512205,0.4605074,0.00047768737,0.0016916649,0.00011030355,0.00042720896,0.00006896562,0.001656658,0.00007944084,0.040943637,0.00013196588],"about_ca_topic_score_codex":0.026277944,"about_ca_topic_score_gemma":0.1787989,"teacher_disagreement_score":0.29736352,"about_ca_system_score_codex":0.0006062127,"about_ca_system_score_gemma":0.017195089,"threshold_uncertainty_score":0.9883765},"labels":[],"label_agreement":null},{"id":"W2139637702","doi":"10.1016/j.jval.2013.03.690","title":"Cost-Effectiveness Of Bendamustine+Rituximab Versus Fludarabine+Rituximab In The Treatment Of Relapsed Indolent Non-Hodgkin's And Mantle Cell Lymphomas In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Bendamustine; Mantle cell lymphoma; Internal medicine; Oncology; Adverse effect; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.045726813580193156,"score_gpt":0.29543919753835685,"score_spread":0.2497123839581637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139637702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924126,0.003001611,0.0000014668024,0.0007344021,0.00018481306,0.0032452247,0.000044130633,0.00000460968,0.00037113405],"genre_scores_gemma":[0.9971083,0.0019674876,0.00018770435,0.00009109072,0.00001906191,0.00056700583,0.000033856526,0.00001862284,0.0000068909767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997786,0.00041695076,0.0006924311,0.00034319184,0.00033971365,0.00042173633],"domain_scores_gemma":[0.99820554,0.0010309129,0.00020476551,0.0003759371,0.00005314884,0.00012971794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957769,0.0002428211,0.00087028916,0.00022300809,0.000031263546,0.0000068641466,0.000095626616,0.00007435939,0.000024913565],"category_scores_gemma":[0.000040996303,0.00016883243,0.00006184945,0.00039755422,0.000058399844,0.000051495444,0.000023139059,0.000094103416,0.0000036851814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026742227,0.019192003,0.9203485,0.0025343467,0.00008825441,0.00035522887,0.0050082393,0.0012138535,0.00018665976,0.00023333913,0.00017084244,0.04799451],"study_design_scores_gemma":[0.0735214,0.0030670068,0.91514015,0.00076626235,0.00003768357,0.000017121492,0.0014094891,0.0018191658,0.003804937,0.000043416672,0.00024110006,0.00013227692],"about_ca_topic_score_codex":0.9543812,"about_ca_topic_score_gemma":0.3492801,"teacher_disagreement_score":0.6051011,"about_ca_system_score_codex":0.0032981557,"about_ca_system_score_gemma":0.0021034821,"threshold_uncertainty_score":0.86245626},"labels":[],"label_agreement":null},{"id":"W2139789114","doi":"10.1111/bjh.13389","title":"Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"U.S. Public Health Service; ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network","keywords":"Medicine; Vincristine; Internal medicine; Positron emission tomography; Confidence interval; Rituximab; Lymphoma; Nuclear medicine; Prednisone; Etoposide; PET-CT; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.08657996483546601,"score_gpt":0.39282087888565004,"score_spread":0.30624091405018405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139789114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857164,0.004960472,0.000041576543,0.0038469974,0.0005928464,0.001609199,0.00005687668,0.000026101217,0.0002942933],"genre_scores_gemma":[0.99704874,0.0004188736,0.0007935206,0.0007593999,0.0002617512,0.00041939088,0.000012010952,0.00007148847,0.00021482192],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99573916,0.0011193358,0.00086963194,0.0004724556,0.0010655267,0.0007338929],"domain_scores_gemma":[0.99534166,0.0013506484,0.0006960936,0.00038463456,0.0016503241,0.0005766605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029348177,0.00029605205,0.0012473362,0.00061672414,0.00026074657,0.00011600037,0.00033688213,0.00014254906,0.000100439],"category_scores_gemma":[0.0014105834,0.00026243823,0.00030156958,0.00038897368,0.00022609449,0.00014361551,0.00005719466,0.00040290487,0.000019818772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08611124,0.015892914,0.2299553,0.000107023356,0.001953629,0.5217435,0.0027983522,0.00012819833,0.00047888115,0.00015233841,0.09087623,0.049802415],"study_design_scores_gemma":[0.13152882,0.061992403,0.5899019,0.004369862,0.000542831,0.1814815,0.004109634,0.00050665304,0.0052806586,0.00060758274,0.018950425,0.00072772586],"about_ca_topic_score_codex":0.0013993317,"about_ca_topic_score_gemma":0.00035686322,"teacher_disagreement_score":0.3599466,"about_ca_system_score_codex":0.00083514664,"about_ca_system_score_gemma":0.00206832,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2139836848","doi":"10.1200/jco.2014.55.5714","title":"Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lenalidomide; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Vincristine; Oncology; Lymphoma; CHOP; Gastroenterology; Cyclophosphamide; Prednisone; Chemotherapy; Multiple myeloma","score_opus":0.0370089595624113,"score_gpt":0.41043221897205295,"score_spread":0.37342325940964166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139836848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967331,0.00012594838,0.00004959996,0.0005507959,0.00031954682,0.001171011,0.00002005505,0.000009423986,0.0010204798],"genre_scores_gemma":[0.9979539,0.00017812001,0.00078269455,0.00056750193,0.00033651994,0.000037091257,0.000007596619,0.000038245707,0.00009831155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485767,0.000882915,0.0027921395,0.00037340104,0.00058387953,0.0005099785],"domain_scores_gemma":[0.9901493,0.005867294,0.0024946402,0.00036962784,0.00051714276,0.0006019828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021700964,0.00038765176,0.0029951446,0.00028900895,0.00006562872,0.000015461546,0.00024089121,0.00028742198,0.000078685815],"category_scores_gemma":[0.0023137892,0.00022581988,0.0007873523,0.00030991802,0.00020378685,0.00017272588,0.000117485426,0.0005040945,0.000013922097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028617315,0.3116232,0.6359593,0.000038964,0.0006322577,0.0024166554,0.0008672249,0.000009874993,0.000078926,0.0000059384656,0.0006622619,0.019088075],"study_design_scores_gemma":[0.32713178,0.16102602,0.5097007,0.0001689926,0.00076347863,0.000073922834,0.00029752622,0.0001979282,0.00011410961,0.000025825513,0.0003772075,0.00012250122],"about_ca_topic_score_codex":0.00023623688,"about_ca_topic_score_gemma":0.0002458697,"teacher_disagreement_score":0.29851446,"about_ca_system_score_codex":0.0005134011,"about_ca_system_score_gemma":0.0019215958,"threshold_uncertainty_score":0.9208667},"labels":[],"label_agreement":null},{"id":"W2139891818","doi":"10.1200/jco.2011.38.0402","title":"Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":990,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Neutropenia; Antibody-drug conjugate; Phases of clinical research; Refractory (planetary science); Oncology; CD30; Adverse effect; Lymphoma; Gastroenterology; Chemotherapy; Immunology; Antibody; Monoclonal antibody","score_opus":0.05924066866749524,"score_gpt":0.41006241614011024,"score_spread":0.350821747472615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139891818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971379,0.0005109746,0.000004516281,0.00018845529,0.00100257,0.0006911681,0.000027150243,0.0000073936017,0.0004298814],"genre_scores_gemma":[0.99875647,0.00013315381,0.00034993954,0.00020628865,0.00036667794,0.000013015241,0.00000985361,0.000023724284,0.00014087895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99438477,0.0007306376,0.0035979068,0.00024496255,0.0006275878,0.00041416753],"domain_scores_gemma":[0.9929075,0.0027028867,0.0031453818,0.0003277029,0.00042622755,0.00049025624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031918501,0.00022700508,0.0021299236,0.00024783175,0.00004543801,0.0000043003715,0.00015453361,0.00030489435,0.00004138225],"category_scores_gemma":[0.0028118868,0.00012684174,0.00027053713,0.00026170842,0.00009434174,0.00016913434,0.00007828018,0.00038957753,0.000013932532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08750263,0.26959702,0.6161203,0.00005500649,0.0004323373,0.00069923874,0.00062389625,0.0000024122594,0.000007249552,0.0000026690773,0.001331133,0.023626119],"study_design_scores_gemma":[0.29137155,0.1708482,0.53301424,0.000354415,0.00071040366,0.00008739443,0.0004292887,0.000011269102,0.00001855691,9.616061e-7,0.0030699698,0.000083739484],"about_ca_topic_score_codex":0.00003538698,"about_ca_topic_score_gemma":0.00008038376,"teacher_disagreement_score":0.20386894,"about_ca_system_score_codex":0.000583372,"about_ca_system_score_gemma":0.0015837235,"threshold_uncertainty_score":0.5172456},"labels":[],"label_agreement":null},{"id":"W2140104756","doi":"10.1093/annonc/mdg496","title":"Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Gemcitabine; Neutropenia; Regimen; Internal medicine; Salvage therapy; Dexamethasone; Phases of clinical research; Chemotherapy; Surgery; Transplantation; Progressive disease; Gastroenterology; Chemotherapy regimen; Cisplatin; Refractory (planetary science); Oncology","score_opus":0.23709605487564997,"score_gpt":0.5114015104831595,"score_spread":0.2743054556075095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140104756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041325,0.0013956681,0.0000015805934,0.0062257424,0.00015830548,0.001161982,0.00023843066,0.000004269444,0.00040075913],"genre_scores_gemma":[0.99420244,0.0014922738,0.0001191539,0.003621707,0.000071534814,0.00021824152,0.000024405586,0.000012854651,0.000237412],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99733675,0.0009154553,0.00086061907,0.0003366064,0.00034580307,0.00020476966],"domain_scores_gemma":[0.9973944,0.0014116692,0.0005688228,0.00021329947,0.00021049494,0.0002013336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026035982,0.00016853328,0.0009478609,0.00007845311,0.000069944894,0.0000036562865,0.000083545936,0.000117568554,0.00023334865],"category_scores_gemma":[0.0017289027,0.00010333825,0.00008298116,0.00019532778,0.00019268591,0.000082558305,0.000021598122,0.0001407666,1.7375379e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056801222,0.077214904,0.18385763,0.00010325877,0.0037570037,0.00040075646,0.0052440944,0.000009851365,0.002827942,0.00034139855,0.14769164,0.5217503],"study_design_scores_gemma":[0.13244118,0.056892555,0.6371329,0.00020064984,0.0006920316,0.00003021356,0.0015812455,0.00011392982,0.007931527,0.00034183118,0.16225588,0.00038607893],"about_ca_topic_score_codex":0.024825506,"about_ca_topic_score_gemma":0.078016736,"teacher_disagreement_score":0.5213642,"about_ca_system_score_codex":0.00023924663,"about_ca_system_score_gemma":0.0029748604,"threshold_uncertainty_score":0.9816683},"labels":[],"label_agreement":null},{"id":"W2140485109","doi":"10.1200/jco.2010.30.0368","title":"Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Concordance; Medicine; Tissue microarray; Diffuse large B-cell lymphoma; Rituximab; Microarray; Lymphoma; CHOP; Vincristine; Oncology; International Prognostic Index; Internal medicine; Hazard ratio; Immunohistochemistry; Algorithm; Cyclophosphamide; Chemotherapy; Biology; Confidence interval; Computer science; Gene; Gene expression; Genetics","score_opus":0.035121574967914466,"score_gpt":0.41735122554648185,"score_spread":0.3822296505785674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140485109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824876,0.00015919605,0.00018632111,0.00020578137,0.000253183,0.00040200932,0.000013066176,0.0000053582894,0.00052635185],"genre_scores_gemma":[0.95133066,0.00006154031,0.048283737,0.00010918908,0.00013344837,0.000013522298,0.0000092287555,0.00002051076,0.00003817499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976696,0.00022911318,0.0014235609,0.00021207113,0.00022081319,0.00024486764],"domain_scores_gemma":[0.9948338,0.0030520882,0.0012593402,0.00017911944,0.00041793223,0.00025769195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018049298,0.00016938103,0.0015608275,0.00010485631,0.000029076904,0.000005514094,0.00009216863,0.00032194355,0.0000124346725],"category_scores_gemma":[0.0007860864,0.00009652405,0.00018437074,0.00010711755,0.00018354609,0.000068670466,0.00003247373,0.00036959923,5.3535086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014624187,0.043580975,0.9126264,0.000056628585,0.00019349626,0.000071926945,0.000070648544,1.9486166e-7,0.000644183,0.000019517447,0.000046459238,0.028065369],"study_design_scores_gemma":[0.21863566,0.021486387,0.7536017,0.000091065696,0.00061097683,0.000043330438,0.000050143324,0.00008536479,0.0022978156,0.000017445414,0.0029873054,0.00009281065],"about_ca_topic_score_codex":0.000041126874,"about_ca_topic_score_gemma":0.00003612886,"teacher_disagreement_score":0.20401148,"about_ca_system_score_codex":0.00012660398,"about_ca_system_score_gemma":0.0006967043,"threshold_uncertainty_score":0.39361364},"labels":[],"label_agreement":null},{"id":"W2140652862","doi":"10.1080/10428190310001593120","title":"The Spectrum of Lymphoma with 8q24 Aberrations: A Clinical, Pathological and Cytogenetic Study of 87 Consecutive Cases","year":2003,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Croucher Foundation","keywords":"Lymphoma; Mantle cell lymphoma; Follicular lymphoma; Medicine; Chromosomal translocation; Pathology; Burkitt's lymphoma; Internal medicine; Gastroenterology; Oncology; Biology","score_opus":0.027477785139627432,"score_gpt":0.2930685879245135,"score_spread":0.26559080278488606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140652862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976356,0.0055913352,0.000015150507,0.00013925266,0.00017472029,0.0017628528,0.000050240338,0.00007389074,0.0024290269],"genre_scores_gemma":[0.9948758,0.0035042,0.00049311,0.00033878098,0.000080441416,0.00028415208,0.000019718958,0.000067768015,0.0003360298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99521744,0.0006202214,0.0015832579,0.0011013284,0.0007345673,0.000743201],"domain_scores_gemma":[0.99528104,0.0020856787,0.0007521283,0.0010968781,0.0002897689,0.00049448886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007867556,0.00073085766,0.0015484481,0.00020279949,0.0005676362,0.00009634126,0.00024085684,0.000377962,0.000026106269],"category_scores_gemma":[0.0005433973,0.00045226046,0.00026466936,0.00048745266,0.0016616018,0.00013383961,0.00015969572,0.00008740146,0.0000075466082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044133137,0.006908549,0.86853665,0.00025801707,0.0020995224,0.0033041688,0.002982085,0.000021317106,0.0004657394,0.00892959,0.0010086781,0.10107236],"study_design_scores_gemma":[0.0469272,0.011776215,0.91331106,0.0003448889,0.001531372,0.007112158,0.008497972,0.00018756962,0.005333037,0.00047256387,0.0038924143,0.00061351806],"about_ca_topic_score_codex":0.0011542862,"about_ca_topic_score_gemma":0.00047472533,"teacher_disagreement_score":0.100458845,"about_ca_system_score_codex":0.0013591667,"about_ca_system_score_gemma":0.0031316616,"threshold_uncertainty_score":0.99979293},"labels":[],"label_agreement":null},{"id":"W2141117259","doi":"10.1093/annonc/mds606","title":"Patients’ and physicians’ roles in detecting recurrent Hodgkin lymphoma following complete remission","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Medicine; Asymptomatic; Internal medicine; Complete remission; Lymphoma; Anxiety; Pediatrics; Gastroenterology; Chemotherapy; Psychiatry","score_opus":0.07420821571337413,"score_gpt":0.3646897573913303,"score_spread":0.29048154167795615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141117259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994328,0.002183343,0.0000022865067,0.00096162444,0.0001925261,0.00020848177,0.0000041627386,0.000011553621,0.002107982],"genre_scores_gemma":[0.9985943,0.00028075278,0.00036097306,0.0006349696,0.000074115254,0.000021216716,0.000014254048,0.000010002599,0.000009406936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990716,0.000083852276,0.00027382365,0.00015418301,0.0001264955,0.00029003693],"domain_scores_gemma":[0.9994193,0.00018343618,0.00013646977,0.00011040076,0.000049277336,0.000101125384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024784394,0.000112663234,0.00039567347,0.00009522023,0.000039907205,0.0000031405632,0.000033740893,0.000084512016,0.000007821394],"category_scores_gemma":[0.00012797475,0.000093191156,0.000092883936,0.00010352512,0.000033149223,0.000078493584,0.000049739323,0.000044596956,0.000005242801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112233574,0.0011485348,0.45209584,0.000019957788,0.00004104188,0.000011072867,0.00063359604,2.2508848e-7,0.00087802374,0.00003107011,0.00027053608,0.5447579],"study_design_scores_gemma":[0.004275111,0.0019760053,0.96358985,0.00027682103,0.000059185848,0.000009772314,0.00025674506,0.000031658634,0.010643306,0.000063940744,0.01872285,0.00009474415],"about_ca_topic_score_codex":0.0000779806,"about_ca_topic_score_gemma":0.000027256645,"teacher_disagreement_score":0.54466313,"about_ca_system_score_codex":0.000088790985,"about_ca_system_score_gemma":0.000038783975,"threshold_uncertainty_score":0.38002253},"labels":[],"label_agreement":null},{"id":"W2141117691","doi":"10.3109/10428190903308064","title":"Early detection of patients with poor risk diffuse large B-cell lymphoma","year":2009,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; Vincristine; International Prognostic Index; Prednisone; Internal medicine; Lymphoma; Oncology; Context (archaeology); CHOP; Cyclophosphamide; Clinical trial; Chemotherapy; Biology","score_opus":0.008167993805071017,"score_gpt":0.23357155439725139,"score_spread":0.22540356059218036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141117691","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40263766,0.592062,0.000028273233,0.0000071198324,0.0003132234,0.0026130595,0.0007673736,0.00026982307,0.0013014612],"genre_scores_gemma":[0.22719775,0.76933557,0.0003144057,0.00021543344,0.00037737607,0.000488862,0.0009917803,0.00037788,0.00070095586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908232,0.00050633174,0.0025665194,0.0024835414,0.0017104632,0.0019099422],"domain_scores_gemma":[0.9928283,0.0006107003,0.0026664122,0.0021407318,0.0005252473,0.0012285997],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00046519953,0.0026943448,0.006176568,0.0011389708,0.00063066394,0.0002229862,0.0006716889,0.0019549914,0.000047838235],"category_scores_gemma":[0.00013854224,0.0019823946,0.0017786949,0.0014980562,0.00044173145,0.0004507227,0.0003391611,0.00031537592,0.00020647823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011500565,0.00795536,0.0048928345,0.007429005,0.0014519156,0.00046728924,0.0002465148,5.205908e-7,0.000004669147,0.00006501057,0.00040371966,0.9759331],"study_design_scores_gemma":[0.1267318,0.0035941382,0.15182361,0.012094611,0.014327837,0.0006820957,0.000078830926,0.00008429545,0.0003994897,0.000045043682,0.68763715,0.0025011317],"about_ca_topic_score_codex":0.0017889369,"about_ca_topic_score_gemma":0.000088917055,"teacher_disagreement_score":0.97343194,"about_ca_system_score_codex":0.013796209,"about_ca_system_score_gemma":0.0059028035,"threshold_uncertainty_score":0.9997328},"labels":[],"label_agreement":null},{"id":"W2141226562","doi":"10.1093/annonc/mdq574","title":"Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Anthracycline; Internal medicine; Follicular lymphoma; International Prognostic Index; Grading (engineering); Chemotherapy; Lymphoma; Oncology; Population; Retrospective cohort study; Survival analysis; Cancer; Gastroenterology; Surgery; Rituximab; Breast cancer","score_opus":0.05823165632258045,"score_gpt":0.3776472863348455,"score_spread":0.3194156300122651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141226562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837996,0.0012138585,0.000018124301,0.013497504,0.000060639806,0.0005110135,0.000014895395,0.000023219036,0.0008611725],"genre_scores_gemma":[0.9927851,0.0012754468,0.0019420087,0.0037492402,0.00006722139,0.00007311681,0.000017069928,0.00002486575,0.00006590873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988272,0.000059052752,0.00031738775,0.00032966278,0.00017295242,0.000293729],"domain_scores_gemma":[0.99889576,0.000284273,0.00017666147,0.00030254456,0.0001407739,0.00019999118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033236833,0.00022648026,0.00068276573,0.00012199935,0.000084081425,0.000015579193,0.00006495368,0.00020048511,0.00005136376],"category_scores_gemma":[0.000069296,0.00014789263,0.00008760633,0.00009229314,0.00035091717,0.0000671809,0.000030541953,0.000098746335,0.000003821596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010675619,0.002289593,0.83910245,0.000077898156,0.0003381062,0.0004703262,0.00024787852,0.0000024485987,0.0053031137,0.00017183345,0.000937783,0.14999104],"study_design_scores_gemma":[0.023133641,0.01173265,0.81057495,0.000106642576,0.00020254623,0.00032939258,0.00016766875,0.00046549764,0.0658225,0.00019839332,0.08697257,0.00029355672],"about_ca_topic_score_codex":0.00042756647,"about_ca_topic_score_gemma":0.00027305583,"teacher_disagreement_score":0.14969747,"about_ca_system_score_codex":0.00001905582,"about_ca_system_score_gemma":0.00017100638,"threshold_uncertainty_score":0.6030886},"labels":[],"label_agreement":null},{"id":"W2141351597","doi":"10.1148/rg.275065151","title":"Primary Gastrointestinal Lymphoma: Spectrum of Imaging Findings with Pathologic Correlation","year":2007,"lang":"en","type":"review","venue":"Radiographics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Lymphoma; Gastrointestinal tract; Esophagus; Radiology; Rectum; Perforation; Immunosuppression; Gastric lymphoma; Stomach; Pathology; Gastroenterology; Internal medicine","score_opus":0.028317480228731085,"score_gpt":0.2954333839611666,"score_spread":0.2671159037324355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141351597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065037207,0.9951357,0.0008212188,0.000035409903,0.00010198203,0.0009464443,0.00004059345,0.00008852346,0.0021797223],"genre_scores_gemma":[0.001255486,0.9922614,0.0056239273,0.00006348949,0.0001216757,0.000050859766,0.0005044748,0.00006957864,0.000049126036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978806,0.000059383725,0.0006841239,0.0004957744,0.00046122647,0.0004189155],"domain_scores_gemma":[0.9984847,0.00029783515,0.0004968182,0.00046932788,0.000086754575,0.00016456378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033322896,0.0005208099,0.0017953335,0.0010029793,0.00007290385,0.000019992322,0.00012689405,0.00016334593,0.000017081737],"category_scores_gemma":[0.000034738638,0.0003483619,0.0007778358,0.001242596,0.00025412685,0.000058314326,0.000038433496,0.00023163985,0.000010520259],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000949017,0.0009871516,0.197663,0.011751902,0.00038983187,0.0042071315,0.000029782319,9.665677e-7,4.7116256e-7,0.0006575342,0.00035749344,0.78385985],"study_design_scores_gemma":[0.008069378,0.0031309482,0.15604313,0.118182115,0.016039068,0.09254721,0.000048840724,0.00005224465,0.000008566273,0.00011707753,0.60441595,0.0013454488],"about_ca_topic_score_codex":0.000029174833,"about_ca_topic_score_gemma":0.00000329675,"teacher_disagreement_score":0.7825144,"about_ca_system_score_codex":0.0003833458,"about_ca_system_score_gemma":0.00043481844,"threshold_uncertainty_score":0.9998968},"labels":[],"label_agreement":null},{"id":"W2141593354","doi":"10.1093/annonc/mdg201","title":"Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as ‘in vivo purge’ and consolidative immunotherapy following autologous stem cell transplantation","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Genentech; IC Design Education Center","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Follicular lymphoma; Lymphoma; Oncology; Autologous stem-cell transplantation; Transplantation; Purge; In vivo; Internal medicine; Cancer research; Biology","score_opus":0.02221958073040302,"score_gpt":0.3093099517854315,"score_spread":0.2870903710550285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141593354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629825,0.0005017499,0.000004635711,0.00004896087,0.000024184146,0.0013257419,0.000023420265,0.000011360622,0.0017617091],"genre_scores_gemma":[0.99893004,0.000503416,0.0001417073,0.00016873897,0.000002699392,0.0001092222,0.00001588917,0.000021154043,0.00010712323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872524,0.0002077179,0.0003669134,0.00027542823,0.00020191906,0.00022279228],"domain_scores_gemma":[0.9992328,0.00017754835,0.00024008015,0.00015125192,0.00012957018,0.00006873364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011694738,0.00020428676,0.00070501416,0.00015139407,0.000036466667,0.000004238196,0.000044563454,0.000070718655,0.000060337687],"category_scores_gemma":[0.0000033651995,0.00012971435,0.000053262727,0.0002115867,0.00006821672,0.000058553185,0.0000054437614,0.00003841954,0.0000016735006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01531894,0.042011146,0.91248626,0.00020111415,0.0011273039,0.002437385,0.0059818276,0.000030028583,0.002797269,0.000012248256,0.000056547346,0.017539911],"study_design_scores_gemma":[0.14575647,0.05142935,0.46336967,0.00015322621,0.00087592565,0.00008252162,0.0024550874,0.000012622396,0.33481857,0.0000054883635,0.0008086018,0.00023247059],"about_ca_topic_score_codex":0.00030833454,"about_ca_topic_score_gemma":0.00008355789,"teacher_disagreement_score":0.44911662,"about_ca_system_score_codex":0.00005482386,"about_ca_system_score_gemma":0.00018267511,"threshold_uncertainty_score":0.52895975},"labels":[],"label_agreement":null},{"id":"W2141628791","doi":"10.1200/jco.2005.05.011","title":"Molecular Pathogenesis of Mucosa-Associated Lymphoid Tissue Lymphoma","year":2005,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"MALT lymphoma; Chromosomal translocation; Pathogenesis; Mucosa-associated lymphoid tissue; Biology; Lymphoma; BCL10; Marginal zone; Helicobacter pylori; Immunology; Lymphatic system; Pathology; Cytogenetics; Cancer research; B cell; Genetics; Gene; Medicine; Chromosome; Antibody","score_opus":0.15851001432194722,"score_gpt":0.505749278314124,"score_spread":0.34723926399217675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141628791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051518697,0.99033415,0.0000074934305,0.00051878684,0.0012446298,0.00056674186,0.00005092633,0.000013067366,0.002112338],"genre_scores_gemma":[0.0028424086,0.99346346,0.0014094455,0.0006904423,0.0012415969,0.00002428198,0.00004269589,0.00007491058,0.00021075836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98989224,0.0013650638,0.00719032,0.00039635712,0.00075472635,0.00040126752],"domain_scores_gemma":[0.98522425,0.0036309154,0.009211985,0.000498836,0.0007672684,0.0006667202],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031120544,0.00052662106,0.01127343,0.0003607599,0.000032244414,0.000009279601,0.0003926213,0.0019432771,0.00021553086],"category_scores_gemma":[0.004635971,0.00034075708,0.004155633,0.00037712947,0.00021832701,0.000058523263,0.00011451614,0.00045283054,0.00008335061],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025189028,0.0083868,0.0007488434,0.0011347961,0.0039092517,0.005109969,0.00001100408,8.378402e-7,0.000003187575,0.00004886204,0.0020370798,0.9783575],"study_design_scores_gemma":[0.009517544,0.008979602,0.003935522,0.006682551,0.015002165,0.0030017,0.0000073419683,0.0000016417459,0.000021116544,0.000021258555,0.9525977,0.00023185542],"about_ca_topic_score_codex":0.000025201865,"about_ca_topic_score_gemma":0.000010933488,"teacher_disagreement_score":0.97812563,"about_ca_system_score_codex":0.0014383207,"about_ca_system_score_gemma":0.009550673,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W2141843344","doi":"10.1002/gcc.22184","title":"Amplification of 2p as a genomic marker for transformation in lymphoma","year":2014,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Emil och Wera Cornells Stiftelse; Stockholms Läns Landsting; Karolinska Institutet; Cancerfonden","keywords":"CDKN2A; Follicular lymphoma; Cancer research; Transformation (genetics); Biology; Lymphoma; Gene duplication; Malignant transformation; Gene; Diffuse large B-cell lymphoma; Comparative genomic hybridization; Genetics; Genome; Immunology","score_opus":0.01342764627115118,"score_gpt":0.27685709100836436,"score_spread":0.2634294447372132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141843344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933583,0.0049277716,0.00012199877,0.0006152094,0.00005418092,0.0003908423,0.00002130219,0.000007108691,0.0005032819],"genre_scores_gemma":[0.9946806,0.0043890174,0.00022944664,0.0001830798,0.0000618636,0.00032505268,0.000034571916,0.000008010319,0.000088402194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995518,0.000008777228,0.00016075076,0.000119694014,0.00006188016,0.0000971177],"domain_scores_gemma":[0.99976987,0.000025894466,0.000047264744,0.00008956865,0.000030228026,0.000037191385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063388296,0.00007135258,0.00016768953,0.000045230776,0.000022364355,0.0000060786706,0.000019438547,0.000040066614,0.000049968105],"category_scores_gemma":[0.0000041844255,0.000056239463,0.000043496966,0.000050469494,0.00002037841,0.00003859817,0.000004197303,0.0000073403544,0.0000025767738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023620369,0.00018139892,0.09142999,0.00033069833,0.000062352236,6.3348386e-7,0.000670802,0.000015902082,0.022843866,0.0016915995,0.00008515733,0.8824514],"study_design_scores_gemma":[0.005548027,0.0002900807,0.91044146,0.00012668116,0.00010167746,0.0000138378955,0.00012513126,0.0009667568,0.04414885,0.00035409795,0.037786536,0.000096892836],"about_ca_topic_score_codex":0.00025434955,"about_ca_topic_score_gemma":0.000063972635,"teacher_disagreement_score":0.8823545,"about_ca_system_score_codex":0.000088421824,"about_ca_system_score_gemma":0.000057075315,"threshold_uncertainty_score":0.22933787},"labels":[],"label_agreement":null},{"id":"W2142220672","doi":"10.1002/hon.2266","title":"Non‐Hodgkin lymphoma in Romania: a single‐centre experience","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Internal medicine","score_opus":0.06943261231885393,"score_gpt":0.3354643070766122,"score_spread":0.26603169475775823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142220672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94935966,0.00045370442,0.0000137649495,0.0038801287,0.00018893213,0.0003899709,0.0000013190039,0.000074018426,0.0456385],"genre_scores_gemma":[0.99605227,0.000022421602,0.0018048564,0.0016824685,0.000055074648,0.00013591588,0.000010515809,0.000011048098,0.00022544955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845004,0.00008054148,0.0003948759,0.00041546448,0.00021610994,0.00044294627],"domain_scores_gemma":[0.99903464,0.00018075305,0.00008903204,0.00025734212,0.000071158065,0.0003670903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013437057,0.0001989765,0.00072977116,0.00008517747,0.000029126992,0.000010939896,0.00010868977,0.00031288114,0.00021245606],"category_scores_gemma":[0.00027139988,0.00013661239,0.000096591146,0.00023389353,0.00015903084,0.00005236951,0.000101831356,0.000081055674,0.00040240554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009859959,0.013455395,0.9141741,0.000043116517,0.00006560051,0.023554794,0.0037658026,0.0000022410206,0.000770908,0.008740263,0.0095258355,0.024915995],"study_design_scores_gemma":[0.04318297,0.010051747,0.6351006,0.0003096215,0.0001926126,0.010305814,0.007086362,0.00047742785,0.013083869,0.0023013935,0.27711743,0.00079015625],"about_ca_topic_score_codex":0.0000737645,"about_ca_topic_score_gemma":0.00011498999,"teacher_disagreement_score":0.27907348,"about_ca_system_score_codex":0.0008590516,"about_ca_system_score_gemma":0.0002382214,"threshold_uncertainty_score":0.55708915},"labels":[],"label_agreement":null},{"id":"W2142330668","doi":"10.3109/10428194.2014.894190","title":"Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine<sup>131</sup>-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; University of Calgary; GlaxoSmithKline (Canada); Centre Hospitalier de l’Université de Montréal","funders":"GlaxoSmithKline","keywords":"Medicine; Internal medicine; Rituximab; Radioimmunotherapy; Oncology; Adverse effect; Lymphoma; Gastroenterology; Immunology; Antibody; Monoclonal antibody","score_opus":0.021871265829693374,"score_gpt":0.27748041892764,"score_spread":0.25560915309794663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142330668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987295,0.0025691683,0.000010032005,0.0003773905,0.00009456123,0.008340781,0.00018133326,0.00008068833,0.001051099],"genre_scores_gemma":[0.996236,0.00031376633,0.0003883581,0.0002816142,0.00019010917,0.0022880204,0.00011654207,0.00011730494,0.000068279114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928804,0.00088581076,0.002007863,0.0016576922,0.0012716696,0.0012965612],"domain_scores_gemma":[0.99464613,0.0013163668,0.00089540717,0.0016873339,0.0004904793,0.00096430193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023489797,0.0011157322,0.0026448735,0.00061813963,0.00063298794,0.00020679351,0.0006949277,0.0006072345,0.000008168383],"category_scores_gemma":[0.00084216014,0.00081303803,0.000310635,0.0007777698,0.00071104587,0.0003488146,0.00040152125,0.00016395263,0.0000024753137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006832574,0.0051469887,0.9311923,0.0014169286,0.00081289525,0.00015872213,0.01095917,0.000024030518,0.00038922636,0.0011007907,0.00030250242,0.041663922],"study_design_scores_gemma":[0.12324824,0.0051141293,0.85995036,0.00070193195,0.00073261204,0.00022213644,0.0039537866,0.0024054858,0.002472057,0.00025783855,0.00023732144,0.0007041055],"about_ca_topic_score_codex":0.13249084,"about_ca_topic_score_gemma":0.083957635,"teacher_disagreement_score":0.11641567,"about_ca_system_score_codex":0.0036915245,"about_ca_system_score_gemma":0.0038701312,"threshold_uncertainty_score":0.999432},"labels":[],"label_agreement":null},{"id":"W2142453326","doi":"10.1093/annonc/mdt218","title":"Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)","year":2013,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Canadian Science Centre for Human and Animal Health; Lunenfeld-Tanenbaum Research Institute; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Odds ratio; Internal medicine; Confidence interval; Epidemiology; Etiology; Lymphoma; Confounding; Nodular sclerosis; Case-control study; Oncology; Hodgkin lymphoma","score_opus":0.11935347982163717,"score_gpt":0.3995361259983531,"score_spread":0.2801826461767159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142453326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1569152,0.8395714,0.000005728986,0.0015488414,0.00022963656,0.0006652103,0.00055768323,0.000014498693,0.00049179775],"genre_scores_gemma":[0.0728744,0.9252001,0.00011519131,0.0010149284,0.00017075373,0.00017579422,0.00033754244,0.000031636544,0.00007962494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596035,0.0010518418,0.0016442692,0.00071716495,0.00024640758,0.00037998604],"domain_scores_gemma":[0.98985344,0.0067177922,0.0022893946,0.00056168047,0.00038160718,0.00019609883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012752657,0.00050166267,0.0045285197,0.00043163725,0.00006790346,0.000014414448,0.00034785617,0.00069687114,0.00025634977],"category_scores_gemma":[0.0015630849,0.0003057721,0.0009624524,0.00034942434,0.00042518743,0.00006299494,0.00029156887,0.00013532276,0.000010466197],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111646055,0.00043739114,0.058454167,0.0005224957,0.03799386,0.00005743825,0.00016559445,4.3212492e-7,9.882888e-7,0.0003129352,0.0018874118,0.90005565],"study_design_scores_gemma":[0.004286275,0.0016784936,0.18549514,0.003298096,0.067070976,0.00030122325,0.00013663687,0.00016572236,0.00005612202,0.00036570826,0.7367576,0.00038802292],"about_ca_topic_score_codex":0.0027227893,"about_ca_topic_score_gemma":0.000248036,"teacher_disagreement_score":0.8996676,"about_ca_system_score_codex":0.00018492115,"about_ca_system_score_gemma":0.0005636489,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W2142478330","doi":"10.1182/asheducation-2006.1.253","title":"The Management of Patients with Limited-Stage Classical Hodgkin Lymphoma","year":2006,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"ABVD; Medicine; Disease; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Intensive care medicine; Radiation therapy; Bleomycin; Chemotherapy; Oncology; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.024866043607404437,"score_gpt":0.3001854743876312,"score_spread":0.2753194307802268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142478330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047609746,0.99056137,0.0000062622416,0.00009270554,0.00012986855,0.0014551025,0.00005169227,0.00003380998,0.0071930913],"genre_scores_gemma":[0.00036574272,0.9962553,0.0003544124,0.000037109145,0.000028902028,0.00043573193,0.0003840583,0.000050469574,0.0020882813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822605,0.00009282734,0.0006375481,0.00038657166,0.00030672183,0.00035027554],"domain_scores_gemma":[0.99845463,0.000267522,0.00043646165,0.00068504945,0.0000709022,0.00008544461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000714084,0.00038584936,0.0018041735,0.000097447955,0.00007766121,0.000010946808,0.0001656816,0.00025446084,0.00003082434],"category_scores_gemma":[0.0000068051686,0.00018314707,0.00035754422,0.00021810688,0.00019480177,0.000013565711,0.00010131524,0.000083431565,0.00008284536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007593466,0.0016116808,0.0040857615,0.016726466,0.0017321637,0.00065093074,0.0000054335037,4.8292723e-8,7.8376267e-10,0.023962107,0.005305273,0.9458442],"study_design_scores_gemma":[0.002440155,0.0003342516,0.005405105,0.00614361,0.0028500205,0.0001253418,0.000007853125,6.9809624e-7,0.0000011817584,0.00001352602,0.9825219,0.00015636209],"about_ca_topic_score_codex":0.000010281251,"about_ca_topic_score_gemma":0.000009714525,"teacher_disagreement_score":0.9772166,"about_ca_system_score_codex":0.0001933197,"about_ca_system_score_gemma":0.00013891584,"threshold_uncertainty_score":0.7468521},"labels":[],"label_agreement":null},{"id":"W2142535539","doi":"10.1016/j.leukres.2008.10.013","title":"Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"CHOP; Lymphoma; CD20; Rituximab; Diffuse large B-cell lymphoma; Oncology; Cancer research; Internal medicine; Immunology; Medicine; Mutation; Biology; Gene; Gastroenterology; Genetics","score_opus":0.04413447653465624,"score_gpt":0.3095650200788036,"score_spread":0.26543054354414736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142535539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423766,0.000057799,0.000001053371,0.004106561,0.000029854158,0.0011027311,0.00007527826,0.000012237285,0.00037684568],"genre_scores_gemma":[0.9943556,0.000040553798,0.00003769865,0.0013780546,0.000023977937,0.00018697132,0.00001852626,0.000027776403,0.003930848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970828,0.0005854525,0.00025538474,0.0002966284,0.0012843795,0.0004953248],"domain_scores_gemma":[0.9978484,0.001011642,0.00008373726,0.0005744502,0.00034438996,0.0001373829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008698949,0.00014640282,0.00024691503,0.00020691604,0.00026703216,0.000015737023,0.00023944858,0.00010602377,0.000047788235],"category_scores_gemma":[0.00079108565,0.000068150606,0.000072440605,0.0011465506,0.00015144228,0.000045379373,0.00014916711,0.00017460035,0.000050347026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045133963,0.023157282,0.8506388,0.000081066006,0.00034142344,0.0025232914,0.028556513,0.000020360007,0.013046308,0.00004503423,0.03233825,0.0041177305],"study_design_scores_gemma":[0.030909846,0.001021476,0.90975505,0.000111035835,0.000025089494,0.000021481826,0.00022836034,0.00011880375,0.05682728,0.000004762888,0.0008961984,0.00008058886],"about_ca_topic_score_codex":0.0012518534,"about_ca_topic_score_gemma":0.00037994428,"teacher_disagreement_score":0.059116296,"about_ca_system_score_codex":0.0023760484,"about_ca_system_score_gemma":0.0013847327,"threshold_uncertainty_score":0.62132835},"labels":[],"label_agreement":null},{"id":"W2142599682","doi":"10.1046/j.1365-2141.2003.04203.x","title":"Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Lymphoma; Univariate analysis; Internal medicine; Melphalan; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Gastroenterology; Large-cell lymphoma; Aggressive lymphoma; Survival analysis; Chemotherapy; Surgery; Oncology; Rituximab; Multivariate analysis","score_opus":0.020477174359010752,"score_gpt":0.2595813583051911,"score_spread":0.23910418394618033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142599682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990267,0.0060836817,0.0013259267,0.00034478668,0.00046171815,0.0003895929,0.00002702225,0.000022548764,0.0010777301],"genre_scores_gemma":[0.98878145,0.00045120515,0.009615234,0.0006124566,0.000048935806,0.000029508103,0.000005678146,0.000027161625,0.00042834767],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982461,0.00015805966,0.0007356188,0.00028309313,0.00016544698,0.0004117071],"domain_scores_gemma":[0.99885553,0.00025710964,0.00028542962,0.00013455265,0.00016137694,0.00030600425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044381368,0.00019721632,0.0010219712,0.000104738065,0.00013427569,0.000042155887,0.00009577161,0.00024116671,0.000051312654],"category_scores_gemma":[0.00010052504,0.00017493071,0.00018647581,0.00009354414,0.00006498207,0.000085170366,0.00001767407,0.00015188206,0.00000756856],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034424602,0.008266003,0.61200005,0.001388063,0.0005159344,0.30857584,0.0016767548,0.00004736071,0.007627052,0.0029700964,0.006834152,0.046656244],"study_design_scores_gemma":[0.02993106,0.005951093,0.073005706,0.00055220706,0.00096149044,0.8531897,0.0011783496,0.000040980234,0.006751284,0.00043218757,0.027468331,0.0005375982],"about_ca_topic_score_codex":0.000023717783,"about_ca_topic_score_gemma":0.000005749342,"teacher_disagreement_score":0.5446139,"about_ca_system_score_codex":0.00018561327,"about_ca_system_score_gemma":0.00027222486,"threshold_uncertainty_score":0.7133467},"labels":[],"label_agreement":null},{"id":"W2142814377","doi":"10.1182/blood-2011-04-345256","title":"Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Rituximab; International Prognostic Index; Medicine; BCL6; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Biomarker; Pathology; Immunology; B cell; Antibody; Biology","score_opus":0.02218879087789223,"score_gpt":0.2473049939326845,"score_spread":0.2251162030547923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142814377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197197,0.0035381077,0.0000038349585,0.00007737683,0.00012123044,0.002066048,0.000101681515,0.000055744094,0.0020640297],"genre_scores_gemma":[0.9988016,0.000067940724,0.00026880918,0.000122057136,0.000034719564,0.0005679226,0.00004753442,0.000040821214,0.00004861063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773496,0.00016447097,0.00067947916,0.0005621136,0.00039326286,0.00046570128],"domain_scores_gemma":[0.99818283,0.0004744229,0.00024251435,0.000866337,0.0000827834,0.0001511238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002888155,0.00034075696,0.0005993144,0.000108125714,0.00007401832,0.000014898001,0.0002859874,0.00013650516,0.00010925946],"category_scores_gemma":[0.00017764406,0.0002290937,0.00020929701,0.00040840465,0.00021538604,0.000050004684,0.0001325067,0.00005573149,0.00003901154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007224275,0.14697237,0.83394647,0.000035137116,0.0009837585,0.00059593155,0.0021808117,6.232254e-9,0.0131003745,0.000018565797,0.00029651285,0.0011476498],"study_design_scores_gemma":[0.082078144,0.000580698,0.8692805,0.00013886634,0.0012322423,0.000029684405,0.0013581741,0.000014795649,0.044873636,0.000031161657,0.00016280837,0.00021929131],"about_ca_topic_score_codex":0.002862183,"about_ca_topic_score_gemma":0.00009656525,"teacher_disagreement_score":0.14639167,"about_ca_system_score_codex":0.00015004835,"about_ca_system_score_gemma":0.00026334438,"threshold_uncertainty_score":0.934217},"labels":[],"label_agreement":null},{"id":"W2143068734","doi":"10.1136/gut.2008.163279","title":"Hepatosplenic T cell lymphoma in inflammatory bowel disease: Table 1","year":2008,"lang":"en","type":"article","venue":"Gut","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Inflammatory bowel disease; Medicine; Lymphoma; Inflammatory Bowel Diseases; Gastroenterology; T-cell lymphoma; Disease; Internal medicine; Pathology","score_opus":0.011699734665955315,"score_gpt":0.2242253098891568,"score_spread":0.21252557522320148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143068734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890512,0.0031718877,0.0000010623882,0.00031316906,0.00009416663,0.00026981925,0.000010776381,0.00005863189,0.0070292526],"genre_scores_gemma":[0.9947439,0.0007936931,0.000081360624,0.00043636467,0.0000881829,0.00010624171,0.00003574103,0.000019313611,0.003695226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990773,0.000018323195,0.00019650807,0.00023055317,0.00020594777,0.0002713287],"domain_scores_gemma":[0.99934536,0.000030569394,0.0000389909,0.00032771484,0.000026343318,0.00023102552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045192235,0.00013724003,0.00018309652,0.00007876664,0.00006018767,0.000007983477,0.000057588284,0.000052322703,0.00013154627],"category_scores_gemma":[0.000020040181,0.00011546928,0.00008053299,0.00011498894,0.000044931996,0.00006728868,0.00003505515,0.000034494424,0.00056187867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010231747,0.0010463817,0.986489,0.000063198466,0.000018663904,0.0023983433,0.00013745291,0.000007756021,0.00015544132,0.00012999652,0.008554092,0.00089734123],"study_design_scores_gemma":[0.0053192084,0.00006570215,0.9713446,0.00006638308,0.000040262996,0.000053462838,0.000017672457,0.00013594385,0.0013628496,0.000038913782,0.021438831,0.000116171905],"about_ca_topic_score_codex":0.00017402058,"about_ca_topic_score_gemma":0.000015500611,"teacher_disagreement_score":0.015144418,"about_ca_system_score_codex":0.00024966654,"about_ca_system_score_gemma":0.00034185496,"threshold_uncertainty_score":0.72220016},"labels":[],"label_agreement":null},{"id":"W2143483266","doi":"10.1634/theoncologist.11-5-488","title":"Primary Mediastinal Large B-Cell Lymphoma","year":2006,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.051360434164611356,"score_gpt":0.350298974765783,"score_spread":0.29893854060117164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143483266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027532282,0.8802553,0.0000034893826,0.00025511865,0.00036300468,0.0012462818,0.00012413936,0.000101167905,0.11762398],"genre_scores_gemma":[0.0000647275,0.9875488,0.00020182361,0.00062567875,0.00095187896,0.00053766504,0.0009014849,0.000062951854,0.009104954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782234,0.00020291211,0.00061563007,0.00045417293,0.0003869401,0.0005179828],"domain_scores_gemma":[0.9979427,0.0006623587,0.0004330945,0.00077004224,0.000050460658,0.00014133344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004294306,0.00053054764,0.0020680204,0.00008895083,0.00018015607,0.00003526672,0.0003402487,0.00038505957,0.00014831053],"category_scores_gemma":[0.000054888656,0.00025934246,0.00080561533,0.00024997926,0.00021878898,0.000022472801,0.00019878427,0.00020955855,0.0011830527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002161828,0.0037485333,0.000063731706,0.0054764366,0.00017369307,0.00086411205,0.0000121278745,3.389251e-8,6.2990665e-8,0.00016306528,0.071579814,0.91789675],"study_design_scores_gemma":[0.00370566,0.00042535202,0.00084646733,0.0027837143,0.003925146,0.00061902095,0.0000085599795,6.3880833e-7,0.0000012300842,0.00001497687,0.98742837,0.00024088149],"about_ca_topic_score_codex":0.00012810239,"about_ca_topic_score_gemma":0.000032260115,"teacher_disagreement_score":0.9176559,"about_ca_system_score_codex":0.0016023683,"about_ca_system_score_gemma":0.0013916912,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W2143511968","doi":"10.1002/mpo.10326","title":"Epigenetic changes in the DAP‐kinase CpG island in pediatric lymphoma","year":2003,"lang":"en","type":"article","venue":"Medical and Pediatric Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources","keywords":"Lymphoma; Anaplastic lymphoma kinase; Cancer research; Medicine; Anaplastic large-cell lymphoma; Large-cell lymphoma; DNA methylation; CpG site; Lymphoblastic lymphoma; BCL10; Pathology; T cell; Immunology; Biology; Gene expression; Gene","score_opus":0.015940408341146933,"score_gpt":0.2895448854141576,"score_spread":0.2736044770730107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143511968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97281253,0.011982387,0.0000056356857,0.008708997,0.00028462493,0.00041527118,0.000004956384,0.000013381453,0.005772197],"genre_scores_gemma":[0.96844834,0.027483884,0.00006304589,0.002817964,0.0008093172,0.0002501335,0.000012084227,0.000011015952,0.000104213235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980769,0.00036134303,0.0003524153,0.00035069897,0.00041582435,0.00044279583],"domain_scores_gemma":[0.99854594,0.0008995255,0.000071075134,0.00019802438,0.000021757754,0.0002636478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093384745,0.0001901998,0.00045064616,0.00028288437,0.000055001987,0.000010513537,0.000116299256,0.00031399925,0.00052495085],"category_scores_gemma":[0.0005645147,0.000114339215,0.000049939266,0.0006145731,0.000090021786,0.00002049369,0.000038868428,0.00018952534,0.00004032806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061033094,0.0016662685,0.94603825,0.00009198299,0.000008507648,0.0032430356,0.0005334197,3.58111e-7,6.0021733e-7,0.00036406892,0.0025282183,0.045464262],"study_design_scores_gemma":[0.009358819,0.001355593,0.9335903,0.000012563653,0.00021355585,0.00062377925,0.00020547505,0.000029721718,0.000011418424,0.00044627735,0.054003563,0.00014894051],"about_ca_topic_score_codex":0.00021683438,"about_ca_topic_score_gemma":0.0025010388,"teacher_disagreement_score":0.051475346,"about_ca_system_score_codex":0.00014246177,"about_ca_system_score_gemma":0.0005737831,"threshold_uncertainty_score":0.57478434},"labels":[],"label_agreement":null},{"id":"W2143651540","doi":"10.3109/10428194.2015.1034699","title":"Isolated<i>MYC</i>cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome","year":2015,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"BCL6; Fluorescence in situ hybridization; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Medicine; Oncology; Cancer research; Biology; B cell; Immunology; Gene; Genetics","score_opus":0.03735700249744781,"score_gpt":0.3056437599755823,"score_spread":0.26828675747813446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143651540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98586416,0.0038404278,0.000050742274,0.00023440534,0.0012084725,0.0015923638,0.00029322668,0.0005687669,0.006347438],"genre_scores_gemma":[0.9882354,0.002187357,0.0008143931,0.004419772,0.00088610925,0.0003955864,0.00043526528,0.00027960126,0.0023464735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9897353,0.0007227092,0.0031594057,0.0024078316,0.0015898728,0.002384888],"domain_scores_gemma":[0.9931419,0.00060037384,0.0007436429,0.0022639234,0.00039261547,0.0028575344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019046128,0.0016630996,0.0026514903,0.0007793865,0.00041287375,0.00028163788,0.00078621507,0.0014190731,0.00009830979],"category_scores_gemma":[0.00035231787,0.0014670162,0.0008311193,0.0009463904,0.0006997913,0.0009547318,0.00062703167,0.00028851134,0.0004724349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005412781,0.015598422,0.8838878,0.00042653,0.00049201516,0.005688156,0.0032852532,0.00003605256,0.00013689614,0.00089586823,0.0036926246,0.08044757],"study_design_scores_gemma":[0.24932165,0.0036815687,0.68494064,0.00049127155,0.0010663973,0.0028338751,0.003166629,0.009256204,0.001354394,0.0002429524,0.041697573,0.0019468437],"about_ca_topic_score_codex":0.0031520268,"about_ca_topic_score_gemma":0.00043975664,"teacher_disagreement_score":0.24390887,"about_ca_system_score_codex":0.01092163,"about_ca_system_score_gemma":0.00620082,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W2144147029","doi":"10.1182/asheducation-2008.1.334","title":"Challenging Problems: Coincident Pregnancy, HIV Infection, and Older Age","year":2008,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Vinblastine; Pregnancy; Chemotherapy; Disease; Radiation therapy; Intensive care medicine; Internal medicine; Surgery; Pediatrics; Oncology","score_opus":0.02705185886864993,"score_gpt":0.26066497450288756,"score_spread":0.23361311563423762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144147029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865612,0.007962667,0.00012839789,0.0012360157,0.0000867862,0.0004080808,9.736167e-7,0.00009287384,0.003523039],"genre_scores_gemma":[0.995897,0.0029946314,0.00019960987,0.00017898207,0.000026484655,0.00013788164,0.000010648777,0.000012590045,0.0005421927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993373,0.0000185786,0.00016679414,0.00021005856,0.00008023895,0.00018702533],"domain_scores_gemma":[0.9996389,0.000040239745,0.000044486198,0.0001565498,0.000031688516,0.000088124674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025738713,0.00011069602,0.0002849929,0.000067073655,0.00009879834,0.000003733748,0.000016186394,0.000079083664,0.00007686706],"category_scores_gemma":[0.000020268448,0.000087668304,0.000042856485,0.000054454318,0.00007868408,0.00003457888,0.000030242663,0.00005069423,0.00007495566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008870604,0.0004583556,0.9873025,0.00025784795,0.00009827748,0.0026417982,0.001260117,0.0000017142328,0.000035773264,0.0046972414,0.0023033118,0.0009341961],"study_design_scores_gemma":[0.0039418144,0.00023618089,0.9643113,0.0007704261,0.000102812315,0.022009583,0.000046533118,0.000056745906,0.0019349431,0.0002485736,0.006188675,0.00015239645],"about_ca_topic_score_codex":0.0000692653,"about_ca_topic_score_gemma":0.000035494522,"teacher_disagreement_score":0.02299118,"about_ca_system_score_codex":0.000044973418,"about_ca_system_score_gemma":0.00003256924,"threshold_uncertainty_score":0.35750097},"labels":[],"label_agreement":null},{"id":"W2144451670","doi":"10.1084/jem.20062041","title":"Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma","year":2007,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Immunoglobulin class switching; Diffuse large B-cell lymphoma; Germinal center; Cytidine deaminase; Biology; Somatic hypermutation; Chromosomal translocation; B cell; Lymphoma; Immunoglobulin heavy chain; Cancer research; Molecular biology; Genetics; Antibody; Gene; Immunology","score_opus":0.013130661799067732,"score_gpt":0.28227257260739463,"score_spread":0.2691419108083269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144451670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119015,0.012829009,0.000095837015,0.0033915373,0.00035453573,0.00041574982,0.0000022418724,0.000012141535,0.0017087893],"genre_scores_gemma":[0.9974303,0.0014403628,0.00013558759,0.00062139926,0.00014041904,0.0000119633805,0.000011488221,0.000024150495,0.0001842794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820393,0.00009103359,0.0007703739,0.00015208291,0.00046965043,0.0003129091],"domain_scores_gemma":[0.9988388,0.0002801879,0.00033502688,0.00022789775,0.00011100777,0.00020706982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010502391,0.00022616301,0.00047365157,0.0002519684,0.00012002547,0.000009255392,0.00012999447,0.00009470527,0.00010916648],"category_scores_gemma":[0.000029085442,0.00013212602,0.00007719905,0.00031787512,0.000111839174,0.00012817257,0.000026725742,0.00018349028,0.000006151185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025452364,0.014788324,0.007850515,0.000046311765,0.00012883994,0.00027636907,0.013268192,0.0000013228474,0.95466864,0.00007997445,0.0012458722,0.0051003927],"study_design_scores_gemma":[0.067986995,0.0030298717,0.11304346,0.00051618635,0.00029584407,0.0007851116,0.014688756,0.000068664485,0.79756933,0.000050446815,0.0017968165,0.00016851678],"about_ca_topic_score_codex":0.0002451809,"about_ca_topic_score_gemma":0.000028835622,"teacher_disagreement_score":0.15709932,"about_ca_system_score_codex":0.00048069292,"about_ca_system_score_gemma":0.0000897194,"threshold_uncertainty_score":0.5387943},"labels":[],"label_agreement":null},{"id":"W2144716232","doi":"10.3324/haematol.2013.095257","title":"The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Flow cytometry; Pathology; Medicine; Biomarker; Immunophenotyping; Tumor microenvironment; Tissue microarray; Cytometry; Immunohistochemistry; Oncology; Biology; Immunology; Immune system","score_opus":0.012448043695978454,"score_gpt":0.2525029391425586,"score_spread":0.24005489544658015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144716232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963623,0.00084026565,0.000010816199,0.0013599147,0.00006582414,0.0011265439,0.000023488843,0.000012042111,0.00019876724],"genre_scores_gemma":[0.9994394,0.000054053082,0.000070549504,0.00015113661,0.000007418667,0.00022923392,0.000024462339,0.000008600755,0.000015139996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976183,0.0005578655,0.0007940011,0.0003820514,0.0004300487,0.00021770688],"domain_scores_gemma":[0.9968653,0.0012233313,0.00044537883,0.0013642545,0.00005787443,0.00004390396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077455415,0.00020539088,0.0007649129,0.000052174135,0.00015130734,0.000013413688,0.00034386473,0.00007728744,0.00006458953],"category_scores_gemma":[0.0005587104,0.00008439259,0.00044739686,0.00055004563,0.00047127513,0.000019286374,0.00018930538,0.000045047163,0.0000055796972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035497267,0.00331689,0.98869336,0.000013291579,0.0010759147,0.000020713462,0.00043585812,0.000021151482,0.004173036,0.0001223466,0.00022169475,0.0015507867],"study_design_scores_gemma":[0.0029167773,0.00014683188,0.96814734,0.000045205234,0.0021559598,0.000014936971,0.0005389747,0.00046355178,0.024796385,0.00012052696,0.000571009,0.0000825286],"about_ca_topic_score_codex":0.0012957795,"about_ca_topic_score_gemma":0.00006774396,"teacher_disagreement_score":0.020623349,"about_ca_system_score_codex":0.00024692257,"about_ca_system_score_gemma":0.00005883296,"threshold_uncertainty_score":0.344143},"labels":[],"label_agreement":null},{"id":"W2144718749","doi":"10.1136/jcp.2008.057257","title":"Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Takeda Oncology; Genentech; National Institute for Health and Care Research","keywords":"Concordance; Immunohistochemistry; Tissue microarray; Pathology; Lymphoma; Diffuse large B-cell lymphoma; Medicine; Oncology; Biomarker; Internal medicine; Biology","score_opus":0.05222152559700138,"score_gpt":0.39128765675756455,"score_spread":0.33906613116056317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144718749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374366,0.0016840941,0.0003184724,0.00087315554,0.0005261421,0.0025631709,0.000094648094,0.000016005206,0.00018067715],"genre_scores_gemma":[0.99582535,0.000777947,0.001866285,0.0006323133,0.0004531933,0.00022399654,0.00008335084,0.000037521902,0.00010004447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933791,0.0010180294,0.004197561,0.00054947997,0.0004662955,0.00038952642],"domain_scores_gemma":[0.9884694,0.0078077856,0.0021568744,0.0007249595,0.00056858355,0.0002723501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035428316,0.00029962882,0.0016428522,0.00015291806,0.000115003946,0.000013923464,0.00037695948,0.00061137514,0.000053968473],"category_scores_gemma":[0.0044009974,0.00020216874,0.00075151864,0.00028881532,0.00055561325,0.000098157165,0.000104976374,0.00038165384,0.000026096171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053515616,0.06792679,0.9039577,0.000030754436,0.00048197617,0.0008890939,0.00034121648,2.9047263e-7,0.0032129774,0.000010891636,0.002147524,0.01564923],"study_design_scores_gemma":[0.0695672,0.00411348,0.91732913,0.00011359852,0.0010075775,0.00076664914,0.00026817317,0.000019028932,0.0014664833,0.00013495059,0.0050464994,0.00016719614],"about_ca_topic_score_codex":0.00006185315,"about_ca_topic_score_gemma":0.000009954062,"teacher_disagreement_score":0.064215645,"about_ca_system_score_codex":0.00016461707,"about_ca_system_score_gemma":0.00076405454,"threshold_uncertainty_score":0.82442015},"labels":[],"label_agreement":null},{"id":"W2145001558","doi":"10.3109/10428194.2012.719615","title":"Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Etoposide; Lymphoma; Diffuse large B-cell lymphoma; Cytarabine; Chemotherapy; Autologous stem-cell transplantation; Gastroenterology; Peripheral T-cell lymphoma; Cohort; Oncology; Salvage therapy; Immunology; T cell","score_opus":0.010972065217812627,"score_gpt":0.2393099212090804,"score_spread":0.22833785599126777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145001558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035156,0.0049259136,0.00002009661,0.00017979847,0.0003396926,0.0021292893,0.0004413992,0.0002262317,0.0013860405],"genre_scores_gemma":[0.9932863,0.0010081247,0.0014218257,0.0011942026,0.00021480831,0.00037284597,0.00030323767,0.00025426847,0.0019443599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993319,0.00042153677,0.001537538,0.0016516126,0.0011255231,0.0019448265],"domain_scores_gemma":[0.9946027,0.00073315995,0.0007089389,0.0014679426,0.00030536312,0.002181915],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00050166703,0.001658534,0.0023691435,0.0006018742,0.00058514177,0.00018314783,0.00030112857,0.0006747831,0.00005643567],"category_scores_gemma":[0.00011737876,0.0012820207,0.0003746831,0.0005344754,0.00049996655,0.0006786263,0.0004102886,0.00009219875,0.0000491381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025630932,0.021350741,0.8978194,0.00055342796,0.00065765553,0.00040585207,0.0053951424,0.000004356416,0.002303507,0.0001943715,0.00083450205,0.04485014],"study_design_scores_gemma":[0.19059621,0.0034444246,0.77164894,0.000240725,0.00093874737,0.00037948918,0.00065035647,0.00026959283,0.004770527,0.000012059456,0.025917664,0.0011312827],"about_ca_topic_score_codex":0.0017554231,"about_ca_topic_score_gemma":0.000079478836,"teacher_disagreement_score":0.16496527,"about_ca_system_score_codex":0.010695535,"about_ca_system_score_gemma":0.0016830488,"threshold_uncertainty_score":0.99961615},"labels":[],"label_agreement":null},{"id":"W2145255912","doi":"10.1016/j.ijrobp.2009.02.061","title":"Quantification of Local Tumor Response to Fractionated Radiation Therapy for Non-Hodgkin Lymphoma Using Weekly 18F-FDG PET/CT Imaging","year":2009,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nuclear medicine; Positron emission tomography; Radiation therapy; Deoxyglucose; Lymphoma; Standardized uptake value; Radiology; Pathology; Internal medicine","score_opus":0.025228486236541493,"score_gpt":0.3614702537783623,"score_spread":0.3362417675418208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145255912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250277,0.0003792493,0.06512223,0.007427461,0.0012935104,0.00059027673,0.000074962954,0.000027347107,0.0000572143],"genre_scores_gemma":[0.9901748,0.000246865,0.0066094943,0.0018857626,0.00087295467,0.000026007703,0.00014507402,0.000024503595,0.000014596087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99789625,0.00023095099,0.0009941657,0.00029397054,0.00034824605,0.00023639933],"domain_scores_gemma":[0.9962012,0.0007291549,0.0014071591,0.00018931372,0.0013208531,0.00015231948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008901959,0.0002338249,0.000550755,0.0004047915,0.00010210333,0.00003165452,0.00023736093,0.000043380096,0.000028113038],"category_scores_gemma":[0.00039072573,0.00020921524,0.000317185,0.00026827943,0.00009649623,0.00032833996,0.000017305352,0.00013091107,0.000012338767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110601345,0.0027212081,0.09871322,0.000009273757,0.00072604604,0.00022286933,0.0002664988,0.0042883437,0.09775465,0.002268902,0.0015414774,0.7804274],"study_design_scores_gemma":[0.03397855,0.0068337335,0.70318455,0.000233133,0.0003948212,0.0031295484,0.00033399026,0.054924082,0.15158205,0.004237356,0.040694006,0.00047420748],"about_ca_topic_score_codex":0.00004743756,"about_ca_topic_score_gemma":0.000001384281,"teacher_disagreement_score":0.7799532,"about_ca_system_score_codex":0.0018544494,"about_ca_system_score_gemma":0.0010370399,"threshold_uncertainty_score":0.853155},"labels":[],"label_agreement":null},{"id":"W2145304413","doi":"10.1200/jco.2005.09.137","title":"Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":989,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; International Prognostic Index; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Prednisone; CHOP; Population; Cyclophosphamide; Lymphoma; Gastroenterology; Oncology; Surgery; Chemotherapy","score_opus":0.04227816456457361,"score_gpt":0.3824355696899724,"score_spread":0.34015740512539877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145304413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991711,0.0005832715,0.000025130315,0.0063381996,0.00058096007,0.00037507524,0.000010409748,0.000006846654,0.00036907743],"genre_scores_gemma":[0.9926847,0.0015692906,0.0033438383,0.0011061616,0.0008824282,0.000009096997,0.0000055400783,0.00001814962,0.00038079973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490464,0.00032456702,0.00394853,0.00020948488,0.0003516822,0.00026107987],"domain_scores_gemma":[0.99574536,0.0011140881,0.002159519,0.00026001726,0.00047622502,0.00024480806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00222366,0.00012312084,0.0023938287,0.00009560715,0.000023740935,0.000017088558,0.00016048174,0.0003865047,0.00030982276],"category_scores_gemma":[0.001804552,0.00012290696,0.0005880951,0.00016615033,0.00018939351,0.000115874005,0.00004495206,0.0003204963,0.000008702478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045747403,0.13870041,0.58617836,0.00009498622,0.0004222497,0.00032031653,0.00012929432,0.0000033427427,0.00052684185,0.000039214523,0.0055613923,0.26344886],"study_design_scores_gemma":[0.20721722,0.013385055,0.75928354,0.00008078486,0.00022583731,0.00020870838,0.00008532662,0.00031825138,0.00028166,0.00009412729,0.018729296,0.00009022317],"about_ca_topic_score_codex":0.0009784792,"about_ca_topic_score_gemma":0.004751514,"teacher_disagreement_score":0.26335865,"about_ca_system_score_codex":0.00042997947,"about_ca_system_score_gemma":0.00091239496,"threshold_uncertainty_score":0.5012},"labels":[],"label_agreement":null},{"id":"W2145378763","doi":"10.5858/2000-124-0770-ctaglo","title":"Coexisting Thymic and Gastric Lymphomas of Mucosa-Associated Lymphoid Tissues in a Patient With Sjögren Syndrome","year":2000,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Pathology; CD5; Lymphoma; MALT lymphoma; Lymphatic system; Immunohistochemistry; Monoclonal; Immunoglobulin heavy chain; Gastric mucosa; Lamina propria; Pathogenesis; Immunoglobulin light chain; J chain; Antibody; Immunology; Medicine; Monoclonal antibody; Stomach; Gastroenterology; Epithelium","score_opus":0.007758900700625699,"score_gpt":0.23829772259127172,"score_spread":0.230538821890646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145378763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162245,0.00507213,0.0000024108415,0.00030939427,0.000032994692,0.00038967663,0.000066154695,0.00002885526,0.0024759595],"genre_scores_gemma":[0.99778366,0.0010024762,0.000795496,0.00022323665,0.000018547582,0.00003957002,0.000062957646,0.000023808501,0.000050261253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982768,0.00019912802,0.0005876182,0.00037005713,0.00025358488,0.00031275247],"domain_scores_gemma":[0.99880165,0.00039949012,0.00027150282,0.00030268996,0.00007300871,0.00015167403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019073422,0.0002486547,0.00091813586,0.0003431923,0.00004026228,0.0000018101775,0.00008049729,0.00008480511,0.00013184625],"category_scores_gemma":[0.00017186912,0.00017424265,0.000038993177,0.0004839199,0.0008547019,0.000045092078,0.00003361361,0.000092881965,0.0000031075422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010363427,0.0013638906,0.9269827,0.00019875845,0.0002511208,0.010118346,0.006556137,0.000009678827,0.010347629,0.00013559313,0.00005931278,0.042940494],"study_design_scores_gemma":[0.01167912,0.006402994,0.97237605,0.001718894,0.00031167205,0.003301844,0.00077451626,0.000048647318,0.0028772675,0.00012588906,0.00022254903,0.00016058014],"about_ca_topic_score_codex":0.0002471061,"about_ca_topic_score_gemma":0.000069783826,"teacher_disagreement_score":0.045393325,"about_ca_system_score_codex":0.000074629475,"about_ca_system_score_gemma":0.00022931019,"threshold_uncertainty_score":0.7105409},"labels":[],"label_agreement":null},{"id":"W2145448213","doi":"10.1002/gcc.20780","title":"High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genes","year":2010,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of British Columbia; Provincial Health Services Authority","keywords":"Loss of heterozygosity; CDKN2A; Biology; Comparative genomic hybridization; SNP array; Copy number analysis; Genetics; Follicular lymphoma; FHIT; Carcinogenesis; Chromosomal translocation; Gene dosage; Genome; Somatic cell; Copy-number variation; Gene; Cancer research; Single-nucleotide polymorphism; Tumor suppressor gene; Lymphoma; Genotype; Gene expression; Allele","score_opus":0.01830622849796035,"score_gpt":0.275795318791569,"score_spread":0.2574890902936086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145448213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97666633,0.022328615,0.000024021854,0.00014215182,0.00012588323,0.00028282686,0.00039738033,0.000009174669,0.000023640194],"genre_scores_gemma":[0.9899184,0.008022206,0.0017038122,0.000030403302,0.000071329065,0.00006148452,0.000151945,0.000011052509,0.000029359742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886847,0.000040491694,0.00040893667,0.0002792391,0.00022103857,0.00018180853],"domain_scores_gemma":[0.9990973,0.00006175023,0.0003031304,0.00027958557,0.00015176609,0.00010649374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009355063,0.00018913917,0.00074180623,0.00012767571,0.000076663266,0.000015307662,0.000052671734,0.00008304308,0.0002752515],"category_scores_gemma":[0.0000062520694,0.00014802135,0.00018950459,0.00027473882,0.00018900103,0.00008239619,0.00004590897,0.000030400697,4.6319218e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005854718,0.00049717276,0.8752059,0.00032021292,0.0014300515,0.000005172231,0.00032935617,0.00009473725,0.11538996,0.0001930191,0.00005085494,0.0064250324],"study_design_scores_gemma":[0.0015098976,0.0001948099,0.5937382,0.000123841,0.002186993,0.000016734517,0.00005796757,0.00032432436,0.4014104,0.000103177015,0.0002006103,0.00013304337],"about_ca_topic_score_codex":0.0007361285,"about_ca_topic_score_gemma":0.00033502138,"teacher_disagreement_score":0.28602043,"about_ca_system_score_codex":0.000053622778,"about_ca_system_score_gemma":0.000060050465,"threshold_uncertainty_score":0.60361356},"labels":[],"label_agreement":null},{"id":"W2145453495","doi":"10.1016/s1470-2045(11)70235-2","title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":811,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Rituximab; CHOP; Diffuse large B-cell lymphoma; Open label; Internal medicine; Oncology; Lymphoma; Chemotherapy; Clinical trial","score_opus":0.046055733105281375,"score_gpt":0.3159028828759636,"score_spread":0.2698471497706822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145453495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907629,0.000014785448,0.0000027879266,0.00025538582,0.0002259202,0.005212453,0.00006258204,0.000016888482,0.0034462933],"genre_scores_gemma":[0.9977812,0.00004337305,0.00085165794,0.0003170328,0.00010723504,0.000681837,0.000029405257,0.000035616787,0.00015262506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99790716,0.00045479392,0.0005654558,0.00036986254,0.0003923417,0.0003103589],"domain_scores_gemma":[0.9983307,0.00020667685,0.00056282105,0.0006882984,0.0001496831,0.00006178943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008306747,0.00023735345,0.0010443203,0.00007057602,0.00006801935,0.000015588786,0.00067489105,0.000098232355,0.00004335795],"category_scores_gemma":[0.000043469157,0.00010048069,0.000042558186,0.00022420178,0.00015492659,0.00010293396,0.0001511203,0.00011437491,0.0000025235374],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48262542,0.13484728,0.3756017,0.000012821149,0.0003676744,0.000017178745,0.0049421173,1.7672616e-7,0.000020935078,0.00003625464,0.000065298016,0.0014631377],"study_design_scores_gemma":[0.64991856,0.017947316,0.3305367,0.00006307852,0.0002092111,0.000007821829,0.00070759,0.000024985513,0.00026706012,0.0000096767335,0.00022600814,0.00008201209],"about_ca_topic_score_codex":0.0018191708,"about_ca_topic_score_gemma":0.006389767,"teacher_disagreement_score":0.16729312,"about_ca_system_score_codex":0.0002325536,"about_ca_system_score_gemma":0.00021953728,"threshold_uncertainty_score":0.40974835},"labels":[],"label_agreement":null},{"id":"W2146701863","doi":"10.1016/s1470-2045(13)70501-1","title":"Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; ABVD; Medicine; Dacarbazine; Internal medicine; Vinblastine; Oncology; Bleomycin; Phases of clinical research; Lymphoma; Surgery; Chemotherapy; CD30; Vincristine; Cyclophosphamide","score_opus":0.05715420935216558,"score_gpt":0.35931487641307147,"score_spread":0.3021606670609059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146701863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843252,0.000038389222,0.000071700895,0.004405242,0.00016123184,0.01005733,0.000043667915,0.00007878109,0.0008184957],"genre_scores_gemma":[0.9900072,0.000024920135,0.002380936,0.001796026,0.00021144046,0.004879539,0.00020651783,0.000049769485,0.0004436318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981671,0.00021339493,0.000350334,0.0004670107,0.0002886041,0.00051358785],"domain_scores_gemma":[0.99788606,0.0007448471,0.0002903842,0.00063226174,0.00029298736,0.00015343336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028480854,0.0003155717,0.0009736783,0.00006355608,0.00022771324,0.00011483247,0.00033953058,0.000099586825,0.00011879276],"category_scores_gemma":[0.00009739404,0.00014701375,0.00003470117,0.00024602877,0.00012619208,0.00024271762,0.00011873073,0.00008407543,0.0000673415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08871958,0.1468432,0.5346357,0.00010378656,0.0016477568,0.00032922407,0.0027340858,0.000010270064,0.000052545256,0.00040973895,0.02769823,0.1968159],"study_design_scores_gemma":[0.37447622,0.079413705,0.53960586,0.00007753942,0.00060086866,0.000025592066,0.00037419144,0.00020787025,0.00004974413,0.0000622772,0.0049087796,0.00019736167],"about_ca_topic_score_codex":0.00056953245,"about_ca_topic_score_gemma":0.00061635626,"teacher_disagreement_score":0.28575665,"about_ca_system_score_codex":0.0004236396,"about_ca_system_score_gemma":0.0003970371,"threshold_uncertainty_score":0.5995047},"labels":[],"label_agreement":null},{"id":"W2147463460","doi":"10.1309/ajcpgr8bg4jdvowr","title":"B Cells With High Side Scatter Parameter by Flow Cytometry Correlate With Inferior Survival in Diffuse Large B-Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; McGill University; BC Cancer Agency","funders":"National Institute of Biomedical Imaging and Bioengineering; BC Cancer Agency; Natural Sciences and Engineering Research Council of Canada; Terry Fox Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation; National Institutes of Health; Michael Smith Health Research BC","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Rituximab; Lymphoma; Medicine; Proportional hazards model; Biomarker; Oncology; Flow cytometry; Internal medicine; Multivariate analysis; Survival analysis; Pathology; Immunology; Biology","score_opus":0.015572961952369393,"score_gpt":0.30716468960760845,"score_spread":0.29159172765523905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147463460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726,0.00028677323,0.00056469673,0.0009300961,0.00049049465,0.00018953304,0.000026033973,0.000012634325,0.00023973559],"genre_scores_gemma":[0.9889741,0.0003014973,0.0067793704,0.003495986,0.0002808016,0.000012507002,0.000011443819,0.000048537146,0.000095757045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996762,0.0005740153,0.0012728747,0.00031091392,0.0004035127,0.0006766834],"domain_scores_gemma":[0.99607736,0.0017216036,0.0010645278,0.00038123512,0.00014779893,0.0006075021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011622097,0.00031216524,0.0016841779,0.000210629,0.00003539352,0.00001526387,0.00015413127,0.00015971476,0.000060819388],"category_scores_gemma":[0.00020913134,0.00018267933,0.00025080962,0.00037350217,0.00061319326,0.00015339575,0.000054362306,0.00045089104,0.00007569943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029270602,0.016771775,0.95161116,0.000012232785,0.00021841892,0.002512845,0.00017339225,0.00000437832,0.00018646232,0.0000046061937,0.0004899979,0.02508766],"study_design_scores_gemma":[0.042326365,0.010598468,0.94229597,0.00011656395,0.00044843758,0.0015266498,0.00024475297,0.000018270723,0.0006489718,0.000006183916,0.0015299235,0.00023946646],"about_ca_topic_score_codex":0.000057971803,"about_ca_topic_score_gemma":0.000017216289,"teacher_disagreement_score":0.039399303,"about_ca_system_score_codex":0.00011250576,"about_ca_system_score_gemma":0.00021356014,"threshold_uncertainty_score":0.7449447},"labels":[],"label_agreement":null},{"id":"W2147758514","doi":"10.3324/haematol.2009.010264","title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Lymphoma; BCL10; Biology; Cyclin D2; Pathology; Medicine; Cell; Cell cycle; Immunology; Genetics","score_opus":0.025375690484738173,"score_gpt":0.2710360779570358,"score_spread":0.24566038747229765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147758514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860298,0.0026335027,0.000036832895,0.0055954712,0.00015617855,0.0007939684,0.000021490814,0.00006468784,0.004668078],"genre_scores_gemma":[0.9951396,0.0010241028,0.0012370641,0.0011892015,0.00006663938,0.00009462278,0.000015856893,0.000010169971,0.001222724],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989875,0.000035827397,0.00023180021,0.00034011935,0.0001627862,0.00024196021],"domain_scores_gemma":[0.9991141,0.00030889217,0.0001146222,0.0003170132,0.000060870425,0.00008448202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087742395,0.00018474937,0.00036278716,0.0000412461,0.00023590599,0.000051902174,0.00009087946,0.00010570851,0.00011394878],"category_scores_gemma":[0.0000444199,0.00009652131,0.00011564971,0.00008046292,0.000100895,0.000056383826,0.000037793594,0.000038858234,0.000093616174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037646957,0.007997562,0.055399127,0.00056363153,0.00034081432,0.0019592287,0.008570842,0.0000017318656,0.05063878,0.018631699,0.78542763,0.066704266],"study_design_scores_gemma":[0.006113937,0.00095169205,0.23543581,0.00019808524,0.00016662868,0.0002937433,0.0010445677,0.000033972767,0.71621865,0.01027024,0.029024348,0.00024830794],"about_ca_topic_score_codex":0.000013482983,"about_ca_topic_score_gemma":0.0000032897349,"teacher_disagreement_score":0.75640327,"about_ca_system_score_codex":0.00003898825,"about_ca_system_score_gemma":0.000024102828,"threshold_uncertainty_score":0.3936025},"labels":[],"label_agreement":null},{"id":"W2147881986","doi":"10.1186/1756-8722-5-67","title":"Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial","year":2012,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Takeda Oncology; European Society for Medical Oncology; National Comprehensive Cancer Network","keywords":"Rituximab; Medicine; Bortezomib; Internal medicine; Follicular lymphoma; International Prognostic Index; Hazard ratio; Lymphoma; Clinical endpoint; Oncology; Surgery; Randomized controlled trial; Confidence interval; Multiple myeloma","score_opus":0.015188422910360717,"score_gpt":0.31005445830081385,"score_spread":0.29486603539045314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147881986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917402,0.0028053566,0.00032019085,0.0007062798,0.0015370832,0.0024917952,0.000107807,0.000031277847,0.00025997043],"genre_scores_gemma":[0.99330425,0.00062873005,0.005039078,0.00027565495,0.00029903807,0.0001967021,0.00016024784,0.00006912028,0.000027191149],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99154353,0.0020998395,0.0034921616,0.00064980774,0.0010529857,0.0011616907],"domain_scores_gemma":[0.9886702,0.004714754,0.0041396734,0.0007155295,0.001121646,0.0006382202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029513964,0.00078345713,0.01076938,0.002136573,0.00016657852,0.000022581919,0.00031685602,0.0008635553,0.00024319132],"category_scores_gemma":[0.0022367463,0.00050951116,0.0018342945,0.0015918404,0.0008626358,0.00044026444,0.00012720595,0.0006659273,0.000046041725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83320093,0.0945292,0.04310078,0.00006998133,0.020696929,0.003558871,0.00093121885,0.000017680197,0.0000082843635,0.0009451435,0.00045058725,0.0024904031],"study_design_scores_gemma":[0.9188962,0.017444078,0.022860778,0.00019376852,0.037269242,0.0010612827,0.0004649872,0.00018853672,0.0006252129,0.000050715822,0.0005328034,0.0004124114],"about_ca_topic_score_codex":0.00085860153,"about_ca_topic_score_gemma":0.0005771228,"teacher_disagreement_score":0.08569527,"about_ca_system_score_codex":0.0019894731,"about_ca_system_score_gemma":0.0015510153,"threshold_uncertainty_score":0.99973565},"labels":[],"label_agreement":null},{"id":"W2148248846","doi":"10.1016/j.transci.2013.05.028","title":"Allogeneic stem cell transplantation for diffuse large B cell lymphoma: Defining the role of allografts","year":2013,"lang":"en","type":"review","venue":"Transfusion and Apheresis Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Lymphoma; Stem cell; Transplantation; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Surgery; Biology","score_opus":0.02026914115759237,"score_gpt":0.28058802126140864,"score_spread":0.26031888010381626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148248846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030946054,0.9655296,0.000061441715,0.000030367788,0.00007681067,0.0019277326,0.00015635723,0.000024607354,0.0012469887],"genre_scores_gemma":[0.05928436,0.9396464,0.0003876947,0.000049925435,0.000019132262,0.00035873664,0.000040679926,0.000026717076,0.00018631274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980817,0.00006733051,0.0004881781,0.0005559493,0.0004110158,0.00039583488],"domain_scores_gemma":[0.99886245,0.00032283025,0.00020611142,0.00033744398,0.000088315464,0.00018283268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038707515,0.00034296582,0.000889799,0.00014511259,0.00035764324,0.000055242544,0.000266353,0.00016158818,0.000039909966],"category_scores_gemma":[0.0000044191856,0.00018680657,0.00039539815,0.00042100146,0.00024565455,0.000088723595,0.000025113159,0.000065595195,0.0000132027735],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029834486,0.0013491705,0.00019666238,0.006010404,0.000032037362,0.0000052320156,0.00049033307,1.3489071e-7,0.00063457084,0.00035594797,0.000036951824,0.99085873],"study_design_scores_gemma":[0.01591651,0.00094289833,0.0019998206,0.008265659,0.006158905,0.00013958564,0.001289665,0.000117268326,0.018991066,0.00007035725,0.9452987,0.00080957665],"about_ca_topic_score_codex":0.000107737156,"about_ca_topic_score_gemma":0.00003932047,"teacher_disagreement_score":0.9900491,"about_ca_system_score_codex":0.000059766928,"about_ca_system_score_gemma":0.00036634784,"threshold_uncertainty_score":0.7617751},"labels":[],"label_agreement":null},{"id":"W2148801868","doi":"10.1038/ncomms4856","title":"A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus","year":2014,"lang":"en","type":"review","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Chronic Disease Prevention and Health Promotion; National Cancer Institute; U.S. Army; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Centers for Disease Control and Prevention; H. Lundbeck A/S; Dansk Kræftforsknings Fond; José Carreras Leukämie-Stiftung; Fondation de France; Bundesamt für Strahlenschutz; Medical Research and Materiel Command; Plan Danmark; American Cancer Society; Kay Kendall Leukaemia Fund; Compagnia di San Paolo; European Commission; Ministerstvo Zdravotnictví Ceské Republiky; Cancerfonden; Lundbeckfonden; U.S. Department of Defense; World Health Organization; Blood Cancer UK; Institut National Du Cancer; National Institutes of Health; American Lebanese Syrian Associated Charities; Health Research Board; U.S. Department of Health and Human Services","keywords":"Locus (genetics); Lymphoma; Hodgkin lymphoma; Genetics; Computational biology; Medicine; Biology; Gene; Immunology","score_opus":0.17264632316920564,"score_gpt":0.43088337614765687,"score_spread":0.25823705297845123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148801868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023264976,0.9913498,0.000015277936,0.0011510474,0.00005883495,0.0017056253,0.0008879534,0.00006778016,0.00474041],"genre_scores_gemma":[0.018517027,0.972192,0.004109054,0.00049994764,0.000043670312,0.00089886336,0.0028791996,0.00006289344,0.000797379],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960126,0.000748205,0.0016021878,0.0007172438,0.0006017783,0.0003179355],"domain_scores_gemma":[0.9855818,0.0025853633,0.0013373629,0.009653278,0.0006013769,0.00024081377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010786293,0.0006798448,0.008007573,0.0008549597,0.00018260883,0.000036551515,0.001576968,0.0012551191,0.00036072143],"category_scores_gemma":[0.0008073799,0.00045193054,0.007914454,0.0025939473,0.00029876636,0.000048628444,0.00061849447,0.0007745353,0.00011251119],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020600964,0.005728177,0.0003827431,0.0053037503,0.7103953,0.0000099915405,0.00012976388,0.0000010498472,0.0000038130468,0.0128624225,0.004049644,0.26111275],"study_design_scores_gemma":[0.00035827552,0.00006531838,0.00035772228,0.0004267482,0.46618998,0.000028399081,0.000005791449,0.0000064199617,0.0000014244685,0.000027477565,0.5323517,0.00018078457],"about_ca_topic_score_codex":0.0004257248,"about_ca_topic_score_gemma":0.0009455958,"teacher_disagreement_score":0.528302,"about_ca_system_score_codex":0.0005632296,"about_ca_system_score_gemma":0.00068876497,"threshold_uncertainty_score":0.99979323},"labels":[],"label_agreement":null},{"id":"W2148983898","doi":"10.4021//jmc.v2i1.87","title":"A Case of Mucosa-Associated Lymphoid Tissue Lymphoma (MALToma) That Developed From Lungs and Stomach","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pathology; Lymphoma; MALT lymphoma; Bronchiectasis; Lymphatic system; Stomach; Lung; Differential diagnosis; Pleural effusion; Mucosa-associated lymphoid tissue; Radiology; Gastroenterology; Internal medicine","score_opus":0.06769790500666006,"score_gpt":0.31468455046671107,"score_spread":0.246986645460051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148983898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935161,0.0049102018,0.000020750833,0.00074637315,0.00023930747,0.00014932887,0.000045978984,0.000016162365,0.00035580574],"genre_scores_gemma":[0.9969779,0.0010511423,0.0011857862,0.0005418264,0.00015863434,0.000005703872,0.000010492328,0.000021531067,0.00004695878],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99769706,0.00012079902,0.0007100449,0.00019179596,0.0010270132,0.0002532815],"domain_scores_gemma":[0.99762976,0.0006247086,0.00057158223,0.00018092843,0.00025677995,0.00073624455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006016748,0.000213451,0.0007898687,0.00016422295,0.00006607426,0.000014574257,0.00013311405,0.00024635246,0.0010378709],"category_scores_gemma":[0.0014773855,0.00014339853,0.00015289431,0.00015696023,0.00018354763,0.00011492474,0.00008195632,0.00011699097,0.0000070100887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011734052,0.004006168,0.39717844,0.000106757856,0.0014522164,0.42326236,0.0027286424,4.05244e-8,0.00029028198,0.0000903801,0.0062196124,0.1634917],"study_design_scores_gemma":[0.02519327,0.0035904131,0.569743,0.0014603927,0.0018856194,0.35334817,0.0018213376,0.00007564368,0.03973844,0.00017439538,0.0026514386,0.00031791243],"about_ca_topic_score_codex":0.0035786657,"about_ca_topic_score_gemma":0.00029424415,"teacher_disagreement_score":0.17256455,"about_ca_system_score_codex":0.00023102085,"about_ca_system_score_gemma":0.00081308663,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W2149138933","doi":"10.25011/cim.v35i6.19207","title":"Precision of Histological Bone Marrow Staging in Follicular Lymphoma and Diffuse Large B-cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Trephine; Bone marrow; Follicular lymphoma; Lymphoma; Histology; Biopsy; Pathology; Immunophenotyping; Diffuse large B-cell lymphoma; Gold standard (test); Kappa; Radiology; Internal medicine; Immunology","score_opus":0.08941772451939874,"score_gpt":0.3291037842165667,"score_spread":0.239686059697168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149138933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97949314,0.013896188,0.000019384916,0.005105108,0.00019949688,0.00040558042,0.00000990016,0.000021827529,0.0008493726],"genre_scores_gemma":[0.99509466,0.0018285997,0.00080516346,0.0017481765,0.00022031923,0.000031240943,0.000032174834,0.000015778623,0.00022388423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776113,0.0002264427,0.00091727934,0.00040983412,0.00030336602,0.00038194522],"domain_scores_gemma":[0.998169,0.00057482335,0.00023842904,0.0002543799,0.000073523486,0.0006898439],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0011154424,0.0002572411,0.0010552589,0.00012770249,0.00005886529,0.000004381932,0.000055769804,0.00019246385,0.00004749466],"category_scores_gemma":[0.0015098202,0.00015659751,0.00009291606,0.0002101888,0.0031695473,0.00012957558,0.00012813618,0.000108364846,0.0000063229145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018523113,0.0056600925,0.9655397,0.00012846745,0.00005395935,0.0001026687,0.0008064699,2.1603578e-8,0.00086435466,0.00253525,0.0010649551,0.02305882],"study_design_scores_gemma":[0.03731605,0.0014960507,0.9492938,0.00063479925,0.00022963397,0.000054539192,0.00037615348,0.000101161786,0.0017034269,0.0020217146,0.006619784,0.00015287544],"about_ca_topic_score_codex":0.00011218032,"about_ca_topic_score_gemma":0.000010914618,"teacher_disagreement_score":0.03713082,"about_ca_system_score_codex":0.000072674426,"about_ca_system_score_gemma":0.000067033725,"threshold_uncertainty_score":0.99954325},"labels":[],"label_agreement":null},{"id":"W2149306989","doi":"10.1093/annonc/mdl426","title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; American Society of Hematology","keywords":"Medicine; Lymphoblastic lymphoma; Hematopoietic stem cell transplantation; Lymphoma; Chemotherapy; Transplantation; Internal medicine; Surgery; Regimen; Chemotherapy regimen; Stem cell; Oncology; Immunology; T cell","score_opus":0.02289958350213624,"score_gpt":0.2851067968960264,"score_spread":0.2622072133938902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149306989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862257,0.0009780021,0.00007746142,0.0017122165,0.000036511923,0.0012279035,0.000077786346,0.000028118222,0.009636288],"genre_scores_gemma":[0.9959789,0.0010263094,0.0010194991,0.00086610747,0.000026592055,0.0002881715,0.00019938916,0.000030955063,0.00056410383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985026,0.000055426935,0.0005035287,0.00036121593,0.00022489535,0.0003523352],"domain_scores_gemma":[0.99873,0.00049799314,0.00027564578,0.00024243696,0.0001766848,0.00007722354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018236064,0.00023928788,0.00069564674,0.0001608437,0.000040288953,0.0000077029545,0.00007603627,0.00013579418,0.0000062401355],"category_scores_gemma":[0.000003649622,0.00015249872,0.000097325545,0.000182325,0.00008849744,0.00007475722,0.0000059873873,0.000034147866,0.0000064797678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18299155,0.056741014,0.57288265,0.00465898,0.000728876,0.0027588212,0.0073398966,0.0013543646,0.004284745,0.0006753965,0.009567865,0.15601581],"study_design_scores_gemma":[0.16038978,0.037718084,0.68398756,0.00074416597,0.00029177527,0.00028242744,0.00062008505,0.000077543526,0.11008229,0.00015293248,0.005218946,0.00043442077],"about_ca_topic_score_codex":0.00061177905,"about_ca_topic_score_gemma":0.00040851813,"teacher_disagreement_score":0.15558138,"about_ca_system_score_codex":0.00014608131,"about_ca_system_score_gemma":0.0005532175,"threshold_uncertainty_score":0.62187177},"labels":[],"label_agreement":null},{"id":"W2149734297","doi":"10.5489/cuaj.1645","title":"Primary renal MALToma: A rare differential diagnosis for a recurrent renal mass after primary ablative therapy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Differential diagnosis; Renal mass; Kidney; Lymphoma; Ablative case; Cryoablation; Lymphatic system; Percutaneous; Pathology; Radiology; Radiation therapy; Nephrectomy; Internal medicine; Ablation","score_opus":0.011712462127367871,"score_gpt":0.22514364952947435,"score_spread":0.21343118740210648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149734297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96828866,0.0013793434,0.0006302098,0.025641317,0.0006337103,0.001041651,0.00028056325,0.000050220006,0.0020543486],"genre_scores_gemma":[0.9867573,0.0005237379,0.0009623472,0.00905233,0.0014770762,0.0006045704,0.00022269327,0.00002849806,0.00037147495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758524,0.0002880278,0.0005062619,0.00037754944,0.00051228737,0.0007306404],"domain_scores_gemma":[0.99762845,0.0005405522,0.0003682844,0.00016338674,0.00034494436,0.0009543879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052272406,0.0002936568,0.00057340314,0.00020680107,0.00032995857,0.00014021991,0.00012991542,0.00033582022,0.00091790623],"category_scores_gemma":[0.00041379512,0.00021022485,0.00044089337,0.00015258677,0.00004377939,0.00011839023,0.000018167897,0.0004062057,0.000034409943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018321859,0.0005660219,0.8883425,0.000020556652,0.00071902334,0.00017811327,0.00018882279,0.0000058390397,0.0001482755,0.00017520059,0.035862986,0.0719605],"study_design_scores_gemma":[0.0058717206,0.0021377432,0.86349607,0.000059718175,0.0002012739,0.000081768434,0.000007609418,0.00007910862,0.000101785685,0.00092084997,0.12682731,0.0002150397],"about_ca_topic_score_codex":0.00013435548,"about_ca_topic_score_gemma":0.00023113764,"teacher_disagreement_score":0.09096433,"about_ca_system_score_codex":0.0030112662,"about_ca_system_score_gemma":0.0005979881,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2149993033","doi":"10.1016/j.transci.2004.10.001","title":"Lymphoma––the immune system in disarray Theme for the 11th Congress of the South African Lymphoma Study Group meeting","year":2005,"lang":"en","type":"editorial","venue":"Transfusion and Apheresis Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Theme (computing); Quarter (Canadian coin); Scope (computer science); Political science; Medicine; Family medicine; History; Archaeology","score_opus":0.012461650665052414,"score_gpt":0.26008296298572764,"score_spread":0.24762131232067522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149993033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7934977,0.008874416,0.000025350775,0.0012528056,0.18644446,0.008162854,0.00031906558,0.00007513776,0.001348202],"genre_scores_gemma":[0.9755136,0.0006501522,0.000031106516,0.000026200274,0.023095818,0.00043086955,0.000005097907,0.00003303107,0.00021414908],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99626046,0.00019269955,0.0007166463,0.0007408301,0.0015864453,0.0005029008],"domain_scores_gemma":[0.99690485,0.0014590012,0.00036140168,0.00094539026,0.00021324192,0.000116144576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002198786,0.00041006194,0.0007409549,0.00011279638,0.0010356032,0.0001354824,0.0009785068,0.00019043981,0.000011965102],"category_scores_gemma":[0.0003199624,0.00016825147,0.0003001968,0.0008713341,0.0010683505,0.00008324788,0.0001522865,0.00014114444,0.000001502378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009333721,0.025357326,0.111844584,0.0054086284,0.0027399296,0.00019093967,0.16108148,0.00021647326,0.0132939285,0.0036393427,0.10673157,0.56016207],"study_design_scores_gemma":[0.061107647,0.0030567297,0.5161062,0.010046014,0.0046681897,0.00006474329,0.20428085,0.0021911385,0.010205255,0.000032799548,0.18651596,0.0017244873],"about_ca_topic_score_codex":0.0027397845,"about_ca_topic_score_gemma":0.0018306636,"teacher_disagreement_score":0.5584376,"about_ca_system_score_codex":0.00035886333,"about_ca_system_score_gemma":0.00060550834,"threshold_uncertainty_score":0.7965127},"labels":[],"label_agreement":null},{"id":"W2150981643","doi":"10.1093/annonc/mdp238","title":"Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Follicular phase; Internal medicine; Radiation therapy; Stage (stratigraphy); Oncology; Marginal zone B-cell lymphoma; Marginal zone; Pathology; Gastroenterology; B cell; Immunology; Antibody","score_opus":0.05293562114077078,"score_gpt":0.37530783533212936,"score_spread":0.3223722141913586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150981643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715127,0.0016627432,0.0000015751276,0.008950427,0.00017884038,0.0016067836,0.000044856264,0.000012771845,0.0003907416],"genre_scores_gemma":[0.99788845,0.00025822964,0.000034584642,0.0015752842,0.000064425854,0.0000480833,0.000017381826,0.000011802683,0.00010173274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979593,0.00032674032,0.0006791284,0.00036848843,0.0004434626,0.00022286549],"domain_scores_gemma":[0.9983771,0.00066193135,0.00033086934,0.00036542307,0.0001472356,0.00011745452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075932936,0.00023244797,0.00075367955,0.00006404894,0.00009213179,0.00001747486,0.00023706978,0.00012877156,0.000012887904],"category_scores_gemma":[0.00016046592,0.00011634822,0.00018321603,0.00013360643,0.00027093757,0.00005714402,0.00014930556,0.00008743165,6.9455433e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070230325,0.017832873,0.8426887,0.000013185554,0.0006990096,0.0001011225,0.00062899163,1.0475365e-7,0.00006602728,0.00006352729,0.0018303533,0.1353738],"study_design_scores_gemma":[0.011859211,0.010286291,0.973311,0.00003325194,0.0005167087,0.00041789512,0.0010819025,0.0000036645336,0.00007584987,0.000038495604,0.0022817717,0.00009394256],"about_ca_topic_score_codex":0.0003126774,"about_ca_topic_score_gemma":0.000106735424,"teacher_disagreement_score":0.13527986,"about_ca_system_score_codex":0.00007120106,"about_ca_system_score_gemma":0.00014481012,"threshold_uncertainty_score":0.47445428},"labels":[],"label_agreement":null},{"id":"W2151638388","doi":"10.1200/jco.2006.09.4490","title":"Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology; Genentech","keywords":"Tissue microarray; Immunohistochemistry; Medicine; Concordance; Lymphoma; Biomarker; Pathology; Diffuse large B-cell lymphoma; Oncology; CD20; Follicular lymphoma; Internal medicine; Biology","score_opus":0.05768192276787162,"score_gpt":0.43886856693056936,"score_spread":0.38118664416269776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151638388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160534,0.0018129253,0.00070989184,0.0014413754,0.000730179,0.0031167835,0.000039798837,0.00001304804,0.0005306631],"genre_scores_gemma":[0.99483573,0.00034049834,0.0027481753,0.0010648966,0.0006476149,0.00016723975,0.000048972546,0.000034219534,0.00011264043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921595,0.0007962921,0.00558059,0.0004958096,0.00051854644,0.00044924725],"domain_scores_gemma":[0.97727543,0.018012408,0.003091934,0.0005839339,0.0006567223,0.00037954617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009112061,0.00028815473,0.001982887,0.00016303675,0.00007933076,0.000017874365,0.00039681498,0.0006243238,0.000060289116],"category_scores_gemma":[0.0052163624,0.00018853912,0.0007964844,0.00030688447,0.0003734727,0.000095899035,0.000117331634,0.00031915112,0.000024132372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015647117,0.107266955,0.73761123,0.00003609994,0.000921881,0.00030395272,0.0002340681,2.7799965e-7,0.0014534466,0.000028107075,0.0022520234,0.13424483],"study_design_scores_gemma":[0.10836441,0.009905345,0.8406499,0.00012170533,0.0015445784,0.00011978219,0.00062113605,0.000021361615,0.0022902219,0.00016490341,0.036035497,0.00016118836],"about_ca_topic_score_codex":0.00016685887,"about_ca_topic_score_gemma":0.00005712818,"teacher_disagreement_score":0.13408363,"about_ca_system_score_codex":0.0004892108,"about_ca_system_score_gemma":0.0016642933,"threshold_uncertainty_score":0.76884025},"labels":[],"label_agreement":null},{"id":"W2151694080","doi":"10.1200/jco.2012.44.0693","title":"Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Stem cell; Lymphoma; Transplantation; Oncology; Internal medicine; Biology","score_opus":0.037860650969018014,"score_gpt":0.33635820775871983,"score_spread":0.2984975567897018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151694080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104786,0.001167877,0.00005977627,0.0062792045,0.0002806102,0.0007278649,0.000021267158,0.0000029264259,0.0004126389],"genre_scores_gemma":[0.99563795,0.0020668234,0.0013719792,0.00071055704,0.000092640425,0.000035590056,0.0000068336994,0.000010532131,0.00006709826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978924,0.00014439876,0.0014188269,0.00016295836,0.00018229873,0.00019910916],"domain_scores_gemma":[0.9978273,0.0008072731,0.0006820043,0.00011821494,0.00017297112,0.0003922649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010074378,0.00012507774,0.00089826196,0.00007558702,0.00007246464,0.000008628103,0.000071230104,0.00032136554,0.000014994929],"category_scores_gemma":[0.00007482842,0.000070281814,0.00035147747,0.000053934113,0.00017784882,0.00006142693,0.0000036830772,0.00012393577,4.435628e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018643778,0.003160474,0.7202569,0.00048018765,0.0015489818,0.00466174,0.0007450181,0.0000034587233,0.003142981,0.00028325428,0.0006357986,0.2632168],"study_design_scores_gemma":[0.02008822,0.0063106315,0.9493055,0.00012374809,0.002807963,0.013250853,0.00006526283,0.000025959933,0.0020109296,0.00019542886,0.005730455,0.00008508143],"about_ca_topic_score_codex":0.0050184918,"about_ca_topic_score_gemma":0.021471754,"teacher_disagreement_score":0.2631317,"about_ca_system_score_codex":0.000085966734,"about_ca_system_score_gemma":0.0013489292,"threshold_uncertainty_score":0.99638385},"labels":[],"label_agreement":null},{"id":"W2151883851","doi":"10.1200/jco.2010.33.3419","title":"Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genentech; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Medicine; International Prognostic Index; Internal medicine; Rituximab; Bone marrow; Vincristine; Diffuse large B-cell lymphoma; Cyclophosphamide; Lymphoma; Oncology; Prednisone; Gastroenterology; Chemotherapy","score_opus":0.11400188818165757,"score_gpt":0.4166145084204617,"score_spread":0.30261262023880414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151883851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973756,0.00031705556,0.0000063348366,0.00039260593,0.00014166889,0.0003049228,0.0000139079975,0.0000048759484,0.0014429955],"genre_scores_gemma":[0.99767476,0.0007923775,0.0007582566,0.00055944914,0.000091153495,0.000008800194,0.0000030660624,0.000019017398,0.00009311395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667895,0.00025279474,0.002246317,0.0002243223,0.00030399716,0.00029360093],"domain_scores_gemma":[0.99667424,0.0008771409,0.0015973913,0.00023844773,0.0001696676,0.0004430867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012248768,0.00022598519,0.0019832505,0.00020334974,0.000020086047,0.000004748618,0.000088170724,0.00016208066,0.00007174933],"category_scores_gemma":[0.00035179977,0.00011547859,0.00044119856,0.00012900938,0.00018329854,0.00007406889,0.000046950885,0.00026036493,0.0000056833132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013834055,0.06253034,0.9059805,0.00003063932,0.0004510961,0.0051657753,0.00017556311,5.059133e-7,0.000110081186,0.00007037447,0.0001704872,0.01148055],"study_design_scores_gemma":[0.10021521,0.05970799,0.8381906,0.00018957253,0.000418127,0.00028243635,0.00013775876,0.00001907063,0.0003952241,0.000035731362,0.00031291074,0.0000953261],"about_ca_topic_score_codex":0.0004597524,"about_ca_topic_score_gemma":0.0002282881,"teacher_disagreement_score":0.08638116,"about_ca_system_score_codex":0.0004200059,"about_ca_system_score_gemma":0.00075000024,"threshold_uncertainty_score":0.47090805},"labels":[],"label_agreement":null},{"id":"W2152105599","doi":"10.1200/jco.2012.43.7509","title":"Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness","year":2012,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Rituximab; Hepatitis B; Cost effectiveness; Virology; Oncology; Immunology; Intensive care medicine; Internal medicine; Antibody","score_opus":0.10066762345893622,"score_gpt":0.44100951960693013,"score_spread":0.3403418961479939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152105599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8723559,0.012684155,0.00021383015,0.108738445,0.0030924953,0.0018660686,0.000040911018,0.0000222261,0.0009859747],"genre_scores_gemma":[0.8487289,0.009900798,0.0023171061,0.12623952,0.012429373,0.00012892147,0.000037276637,0.00009619212,0.00012190841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99469817,0.0023301493,0.0016700418,0.0004057993,0.00048294844,0.00041287876],"domain_scores_gemma":[0.9845786,0.012438539,0.0018020229,0.00024385212,0.00045824886,0.00047872547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0043323804,0.0003994184,0.003794802,0.00021039422,0.0000756648,0.000031201365,0.000119238335,0.0020556357,0.000050988216],"category_scores_gemma":[0.002298399,0.0002631468,0.0005851978,0.00009354994,0.0005063473,0.00014416523,0.0001256904,0.002764341,0.000015586755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021306446,0.0016869815,0.5844155,0.00078129617,0.0014956351,0.006884301,0.000017946271,1.6712546e-7,0.0000049274454,0.000013269816,0.042831518,0.3597378],"study_design_scores_gemma":[0.016810657,0.013372158,0.6028025,0.000999478,0.0013937511,0.002475342,0.0000029727464,0.0000023722582,0.000028518287,0.00007504686,0.36188507,0.00015213803],"about_ca_topic_score_codex":0.00017396967,"about_ca_topic_score_gemma":0.000014675336,"teacher_disagreement_score":0.35958567,"about_ca_system_score_codex":0.00031701487,"about_ca_system_score_gemma":0.000789278,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W2152162065","doi":"10.1016/s1470-2045(15)00169-2","title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":613,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; H. Lundbeck A/S; University of British Columbia; Celgene; Terry Fox Research Institute; Genome British Columbia; Dr. Mildred Scheel Stiftung für Krebsforschung; Michael Smith Health Research BC; Amgen; Alfred Benzon Foundation; Genome Canada; Deutsche Krebshilfe","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Oncology; Population; Vincristine; Prednisone; International Prognostic Index; Cyclophosphamide; Lymphoma; Surgery; Chemotherapy","score_opus":0.06967241767753558,"score_gpt":0.3970410134681473,"score_spread":0.3273685957906117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152162065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924354,0.000069132846,0.0033590805,0.0005894536,0.00006087209,0.0033650843,0.00009761544,0.0000070403044,0.000016330283],"genre_scores_gemma":[0.9898498,0.000082238,0.008038856,0.000031075157,0.000071165116,0.0012486669,0.0006683157,0.000007678799,0.0000022054742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878746,0.00018651613,0.00060368073,0.00021067559,0.000109652916,0.00010200858],"domain_scores_gemma":[0.99765456,0.0011615584,0.00057771354,0.00019690208,0.00038421378,0.000025034813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011888477,0.000085684565,0.0006481889,0.00018244295,0.000030066363,0.0000047710037,0.00004457736,0.00011137907,9.22583e-7],"category_scores_gemma":[0.0034988744,0.00006149389,0.00011632469,0.00045339623,0.000056419347,0.00003736616,0.000006127255,0.00004316618,6.609819e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020965936,0.0022143754,0.96662915,0.00002096135,0.0003464284,3.2078356e-7,0.00082146155,0.00030869333,0.000035953995,0.00019559424,0.000009953661,0.008451179],"study_design_scores_gemma":[0.095708214,0.003712841,0.8830721,0.000046091547,0.00087651506,3.2252106e-7,0.0000842412,0.014415066,0.00067069934,0.001357782,0.000011346883,0.000044817534],"about_ca_topic_score_codex":0.0006432296,"about_ca_topic_score_gemma":0.0013566847,"teacher_disagreement_score":0.08355708,"about_ca_system_score_codex":0.000583307,"about_ca_system_score_gemma":0.00019052229,"threshold_uncertainty_score":0.41887322},"labels":[],"label_agreement":null},{"id":"W2152391407","doi":"10.1186/1748-717x-6-182","title":"PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: A case series","year":2011,"lang":"en","type":"article","venue":"Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Nova Scotia Cancer Centre; Dalhousie University","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Stage (stratigraphy); Natural history; Radiology; Radiation treatment planning; Nuclear medicine; Internal medicine","score_opus":0.028278891580138604,"score_gpt":0.31518533163354967,"score_spread":0.28690644005341104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152391407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994305,0.0036303003,0.00006229623,0.00027240746,0.00040309643,0.0005101461,0.000013543557,0.000024769362,0.0007784122],"genre_scores_gemma":[0.99548405,0.00031894507,0.0030780227,0.00024936127,0.00009906638,0.00006434492,0.00001860633,0.000018414503,0.0006691911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927974,0.000064222666,0.00021664829,0.00017587851,0.00008177155,0.000181769],"domain_scores_gemma":[0.9993607,0.00024349369,0.00013571774,0.00014309604,0.000051795138,0.00006518926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016980559,0.00012531124,0.000275635,0.000076444165,0.00011523285,0.000009569205,0.000041378575,0.000025014502,0.00005720327],"category_scores_gemma":[0.000030138302,0.000085998385,0.000064840184,0.000085380554,0.00009784221,0.00008683255,0.000011408877,0.000046121473,0.0000015630084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004859862,0.0016915009,0.8312498,0.00026026065,0.0008038483,0.00989779,0.021092787,0.00003522846,0.0016405368,0.0052018627,0.001507807,0.12175874],"study_design_scores_gemma":[0.062231567,0.015267166,0.7058837,0.00011196652,0.0008606392,0.037394013,0.0065646246,0.005874708,0.016926797,0.00017728352,0.14805114,0.00065640826],"about_ca_topic_score_codex":0.00026934926,"about_ca_topic_score_gemma":0.000018435592,"teacher_disagreement_score":0.14654332,"about_ca_system_score_codex":0.00020692816,"about_ca_system_score_gemma":0.00019300832,"threshold_uncertainty_score":0.35069123},"labels":[],"label_agreement":null},{"id":"W2152518936","doi":"10.1182/blood-2004-12-4689","title":"High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Surgery; Transplantation; Chemotherapy; Malignancy; Refractory (planetary science); Lymphoma; Chemotherapy regimen","score_opus":0.012806834983711046,"score_gpt":0.2453881516376033,"score_spread":0.23258131665389226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152518936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766314,0.00036141087,0.000002520763,0.00031138564,0.0000707875,0.0013865902,0.000038966373,0.000032278902,0.00013291022],"genre_scores_gemma":[0.997675,0.00047221035,0.00023578817,0.0009149456,0.00004525486,0.0002873403,0.00012812471,0.000027196947,0.00021412493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998869,0.000044639604,0.00038094356,0.00029644123,0.00017090268,0.00023807512],"domain_scores_gemma":[0.9993792,0.00022365189,0.00010721429,0.00021399852,0.000025503752,0.00005043965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011662179,0.00020772203,0.0003604888,0.000115862866,0.000052106654,0.000015400976,0.000071485745,0.00013240255,0.000015086386],"category_scores_gemma":[0.000005219879,0.00012712242,0.00006317836,0.0001343779,0.000028625764,0.000094418945,0.0000064516125,0.000053505213,0.0000045563875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015913172,0.007823455,0.93605125,0.00023161292,0.0000534342,0.00022940332,0.001302279,0.0000017179797,0.000045766643,0.00000226133,0.00018127389,0.052486222],"study_design_scores_gemma":[0.064464,0.0010019308,0.931295,0.00010313427,0.00022985329,0.000022630747,0.00002818466,0.0000063099556,0.0023405799,0.000001917489,0.00037464028,0.00013184387],"about_ca_topic_score_codex":0.00014442168,"about_ca_topic_score_gemma":0.0020169998,"teacher_disagreement_score":0.062872685,"about_ca_system_score_codex":0.00023685968,"about_ca_system_score_gemma":0.000052841664,"threshold_uncertainty_score":0.5183902},"labels":[],"label_agreement":null},{"id":"W2152575451","doi":"10.1039/c5mb00654f","title":"Comparative proteomic profiling of Hodgkin lymphoma cell lines","year":2015,"lang":"en","type":"article","venue":"Molecular BioSystems","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Excellence in Mining Innovation","funders":"","keywords":"Biology; Blot; Flow cytometry; Proteomics; Pathogenesis; Cell culture; Lymphoma; Cell; Gene expression profiling; Cytoskeleton; Computational biology; Cell biology; Molecular biology; Gene expression; Genetics; Gene; Immunology","score_opus":0.03649296891045664,"score_gpt":0.29031746377187406,"score_spread":0.25382449486141745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152575451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909637,0.0027774663,0.00010315676,0.00013115203,0.00015879341,0.0012670096,0.000016276388,0.000044046777,0.004538376],"genre_scores_gemma":[0.99720955,0.000007890054,0.0023387005,0.00005838552,0.000070236325,0.00013655396,0.000041266903,0.000019046103,0.000118391865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988272,0.000081698076,0.00033584508,0.000249315,0.00031833243,0.0001875717],"domain_scores_gemma":[0.9990989,0.000015736252,0.00016211647,0.00032648497,0.000221255,0.00017549169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016248423,0.00017772094,0.0004961392,0.00008926385,0.000021444517,0.0000142937915,0.000075080476,0.000084383595,0.0000039605043],"category_scores_gemma":[0.0000243239,0.00013355124,0.00012490603,0.00017381662,0.000041563893,0.000026945345,0.00003621096,0.000028823022,0.000069530906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025850983,0.0013770447,0.050797414,0.00048447726,0.00032156543,0.00034798274,0.00082940457,0.00003737586,0.9438943,0.00033177083,0.0007929613,0.00052717596],"study_design_scores_gemma":[0.004092315,0.0006335933,0.0019705216,0.00020260001,0.00013049813,0.000045872515,0.00031857644,0.000415251,0.9913506,0.000015813866,0.0006998973,0.00012448554],"about_ca_topic_score_codex":0.00017614066,"about_ca_topic_score_gemma":0.0000026489945,"teacher_disagreement_score":0.048826892,"about_ca_system_score_codex":0.00014773096,"about_ca_system_score_gemma":0.00023953037,"threshold_uncertainty_score":0.54460615},"labels":[],"label_agreement":null},{"id":"W2152716432","doi":"10.6000/1927-7229.2012.01.01.1","title":"Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles","year":2012,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; USC Norris Comprehensive Cancer Center; Children's Hospital Los Angeles; Ronald McDonald House Charities","keywords":"Syk; Apoptosis; Chemistry; Mantle cell lymphoma; Cancer research; Molecular biology; Lymphoma; Biochemistry; Immunology; Medicine; Biology; Receptor; Tyrosine kinase","score_opus":0.020329134709108618,"score_gpt":0.30192341299362113,"score_spread":0.2815942782845125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152716432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889584,0.0010986993,0.00005578184,0.0026781184,0.00016321373,0.000075676726,9.609753e-7,0.000008000949,0.0069611347],"genre_scores_gemma":[0.9953919,0.00015649736,0.003077892,0.0006656961,0.0004874533,0.0000018040224,0.0000012954636,0.000013103564,0.00020433245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875015,0.00006096086,0.00044565098,0.000094133226,0.0002762883,0.00037278904],"domain_scores_gemma":[0.9988166,0.00022180431,0.0002610709,0.00010529802,0.00016414697,0.0004310607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037993144,0.00012409632,0.00054470997,0.00010384794,0.00004743429,0.0000111478985,0.00006312626,0.00009413852,0.00022495554],"category_scores_gemma":[0.00008313901,0.00007197228,0.00014539085,0.00014558788,0.00009599889,0.00012850991,0.000025410605,0.00009810932,0.00008145831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011682411,0.011326246,0.94251233,0.000060702518,0.0006863292,0.0029078024,0.00038140194,0.00003787483,0.010342071,0.0012206403,0.015599187,0.013757178],"study_design_scores_gemma":[0.02376804,0.012882903,0.7355324,0.00018125196,0.003137828,0.007593756,0.0011464935,0.0007640182,0.053624336,0.00008703195,0.16093373,0.00034819098],"about_ca_topic_score_codex":0.00000820886,"about_ca_topic_score_gemma":0.0000010349477,"teacher_disagreement_score":0.2069799,"about_ca_system_score_codex":0.0003352275,"about_ca_system_score_gemma":0.00028161242,"threshold_uncertainty_score":0.29349446},"labels":[],"label_agreement":null},{"id":"W2153285528","doi":"10.1093/annonc/mds623","title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Retrospective cohort study; Gastric lymphoma; Internal medicine; Term (time); Outcome (game theory); Oncology","score_opus":0.05928667877931365,"score_gpt":0.36606790598217875,"score_spread":0.3067812272028651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153285528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927202,0.00028185066,0.00035837488,0.0012255522,0.00019618946,0.004820569,0.00004919202,0.00006908766,0.00027900827],"genre_scores_gemma":[0.9956049,0.000103301456,0.0018106863,0.00042863554,0.00016661316,0.00094260916,0.000078424826,0.000056384943,0.0008084579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975102,0.00015700786,0.0007102137,0.00065272313,0.00045063128,0.0005192097],"domain_scores_gemma":[0.9981354,0.0001918749,0.00038154895,0.00042969466,0.0006263281,0.00023515582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002853995,0.00040368387,0.0010981135,0.00034831895,0.000094882475,0.000036193585,0.00023497002,0.00013552583,0.00036898724],"category_scores_gemma":[0.000049696377,0.00029103644,0.00023241593,0.00029437654,0.00013352718,0.00017208315,0.000051919258,0.00005689782,0.000025105352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034134914,0.061809026,0.841691,0.000025983716,0.0025014903,0.0006032307,0.00066550774,0.0000014606765,0.00015758035,0.000023130706,0.00043113486,0.08867693],"study_design_scores_gemma":[0.07389919,0.033446554,0.89036196,0.000037930742,0.00041164152,0.00022361624,0.00078033854,0.00012125335,0.00013534904,0.0000034584739,0.00036375073,0.00021493886],"about_ca_topic_score_codex":0.00096254726,"about_ca_topic_score_gemma":0.00049908354,"teacher_disagreement_score":0.08846199,"about_ca_system_score_codex":0.0006475098,"about_ca_system_score_gemma":0.00017664972,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W2153666842","doi":"10.1158/1078-0432.ccr-12-3064","title":"New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Lymphoma; Disease; Hodgkin lymphoma; Risk stratification; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.4180967346009461,"score_gpt":0.5835940175821612,"score_spread":0.16549728298121513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153666842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076692854,0.98725855,0.000006959517,0.00031317206,0.00021394831,0.0033072697,0.00010154087,0.000028962748,0.0011002914],"genre_scores_gemma":[0.00033196202,0.9935162,0.0013782822,0.00006201602,0.00089284877,0.0020236436,0.00009136454,0.00008071457,0.001622963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954503,0.0006130604,0.0012814624,0.0011258435,0.0007300613,0.00079923717],"domain_scores_gemma":[0.9961485,0.0021227687,0.000266087,0.0006873235,0.00016331208,0.00061195873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014619011,0.000497432,0.0025322349,0.00037915024,0.00011044011,0.0001787321,0.0002393075,0.0006758508,0.0003265802],"category_scores_gemma":[0.0004002556,0.0003153517,0.0004900297,0.0005588931,0.0002930702,0.00012707796,0.0002753158,0.00091543753,0.0002713682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000695185,0.000918067,0.024243137,0.002999362,0.0006446228,0.00014824155,0.000021283791,7.5551014e-8,2.048872e-7,0.00012664308,0.0023602988,0.96846855],"study_design_scores_gemma":[0.011755554,0.0013873592,0.035877272,0.019262448,0.0018282323,0.000050167357,0.00008337895,0.000011020446,0.0000052358646,0.0005561339,0.92871267,0.00047053423],"about_ca_topic_score_codex":0.0073631746,"about_ca_topic_score_gemma":0.00029243802,"teacher_disagreement_score":0.967998,"about_ca_system_score_codex":0.001053139,"about_ca_system_score_gemma":0.004513485,"threshold_uncertainty_score":0.99992985},"labels":[],"label_agreement":null},{"id":"W2153722638","doi":"10.1182/blood.v124.21.2960.2960","title":"Role of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the PET/CT Era","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Bone marrow; Biopsy; Radiology; Iliac crest; Positron emission tomography; Stage (stratigraphy); Cancer; Hodgkin lymphoma; Nuclear medicine; Internal medicine; Surgery","score_opus":0.005938800234037085,"score_gpt":0.2188793578069199,"score_spread":0.2129405575728828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153722638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939181,0.0009868491,7.7113054e-7,0.0005475167,0.00001590779,0.00029095568,0.000015248767,0.0000063630323,0.004218255],"genre_scores_gemma":[0.9994171,0.000070762886,0.00009947981,0.00028689086,0.00002937318,0.000046188547,0.000011675243,0.00001028093,0.0000281961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900734,0.0001279079,0.0002712207,0.00014296951,0.00025197453,0.00019855419],"domain_scores_gemma":[0.9992209,0.0002134731,0.0000999118,0.0004191227,0.000020078327,0.000026532018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004966763,0.000110960005,0.00027266564,0.00008522229,0.000023238168,0.000008285538,0.00012833763,0.000011342006,0.000015052528],"category_scores_gemma":[0.000047013924,0.00005821533,0.00008499239,0.00019990277,0.00003445294,0.000025119165,0.000030189067,0.00005150259,0.0000072737716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006471519,0.042301103,0.9416552,0.00014212746,0.00006095064,0.0006371035,0.0030111298,8.5556326e-7,0.007757823,0.0017135213,0.00011932916,0.0025361432],"study_design_scores_gemma":[0.039238114,0.00033533087,0.92034197,0.00017357206,0.00022256545,0.00035057927,0.0023848454,0.00012116414,0.0353642,0.00020970224,0.0011608142,0.00009717293],"about_ca_topic_score_codex":0.0004610859,"about_ca_topic_score_gemma":0.00008977703,"teacher_disagreement_score":0.041965775,"about_ca_system_score_codex":0.000020445243,"about_ca_system_score_gemma":0.000041011957,"threshold_uncertainty_score":0.23739523},"labels":[],"label_agreement":null},{"id":"W2153921055","doi":"10.1158/1078-0432.ccr-08-0529","title":"Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Chemoimmunotherapy; Radioimmunotherapy; Follicular lymphoma; Ibritumomab tiuxetan; CHOP; Nuclear medicine; Vincristine; Lymphoma; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Immunology; Antibody","score_opus":0.1457220537021659,"score_gpt":0.4981432744785355,"score_spread":0.3524212207763696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319167,0.011630457,0.0000010113715,0.0017248611,0.00016543838,0.0024775253,0.00007855054,0.000038846076,0.0006916277],"genre_scores_gemma":[0.9850834,0.012851735,0.00006472164,0.00012861288,0.0002943367,0.00066265796,0.00006771962,0.000044074877,0.0008027293],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955082,0.00055486744,0.0012034439,0.00085652526,0.0010953572,0.00078160904],"domain_scores_gemma":[0.9975185,0.0007256342,0.00012190596,0.0007052921,0.00033030804,0.0005983861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017123474,0.00028652625,0.0012960095,0.00020410793,0.00021555499,0.000021363312,0.0002144424,0.00030939135,0.00018199804],"category_scores_gemma":[0.0007445407,0.0002266628,0.00034204073,0.00069258123,0.0008192689,0.00010359726,0.00018903517,0.00035636086,0.000016185655],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17974861,0.20263214,0.2042956,0.00027290196,0.0012802277,0.005045186,0.0006289476,7.6741435e-7,0.0015067853,0.00009751106,0.06143166,0.34305966],"study_design_scores_gemma":[0.84454757,0.035998087,0.097875886,0.0006310008,0.0004539073,0.00011182296,0.000098023374,0.00023729148,0.0057282797,0.00009047818,0.013832419,0.00039520915],"about_ca_topic_score_codex":0.0017343847,"about_ca_topic_score_gemma":0.00027280507,"teacher_disagreement_score":0.664799,"about_ca_system_score_codex":0.00040584657,"about_ca_system_score_gemma":0.0013032483,"threshold_uncertainty_score":0.92430407},"labels":[],"label_agreement":null},{"id":"W2153944703","doi":"10.1182/blood-2009-03-212191","title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":584,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Terry Fox Foundation; National Institutes of Health; Michael Smith Health Research BC","keywords":"Chromosomal translocation; Follicular lymphoma; Lymphoma; International Prognostic Index; Fluorescence in situ hybridization; Rituximab; Internal medicine; Aggressive lymphoma; Diffuse large B-cell lymphoma; Oncology; Biology; Cytogenetics; Chemotherapy; Gene rearrangement; Medicine; Cancer research; Gene; Chromosome; Genetics","score_opus":0.026946947333257434,"score_gpt":0.26977379390569606,"score_spread":0.24282684657243864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153944703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311966,0.0011148955,0.000025904972,0.004151036,0.000030322743,0.00030009172,0.000020327037,0.00005120586,0.0011865569],"genre_scores_gemma":[0.99950576,0.000051100717,0.000039945364,0.00025184153,0.000040354666,0.00002625581,0.000037324142,0.000009874858,0.000037528636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992256,0.000039190378,0.000114594215,0.00018813414,0.00024272817,0.00018974266],"domain_scores_gemma":[0.9993524,0.00026642415,0.00002742487,0.0001555611,0.000078265584,0.000119944016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006420145,0.00014533424,0.00021174569,0.000023436083,0.00012256816,0.00003237681,0.000037869704,0.00004460486,0.000021818485],"category_scores_gemma":[0.000057053705,0.000068541245,0.00003373045,0.000121172314,0.00012700509,0.000040910727,0.0000039248625,0.00005331178,0.0000023136429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011896735,0.008538183,0.97191834,0.000028074372,0.0008821105,0.00016614694,0.001582456,0.0000012251406,0.00014900546,0.00895712,0.00020372598,0.007454622],"study_design_scores_gemma":[0.009214694,0.0015441932,0.98480123,0.00015779833,0.0011115993,0.00005617689,0.00030546947,0.000010480492,0.002330434,0.00005577836,0.00029474805,0.00011740576],"about_ca_topic_score_codex":0.000029679672,"about_ca_topic_score_gemma":0.0000452606,"teacher_disagreement_score":0.0128828585,"about_ca_system_score_codex":0.000038796425,"about_ca_system_score_gemma":0.00010649257,"threshold_uncertainty_score":0.27950308},"labels":[],"label_agreement":null},{"id":"W2153978703","doi":"10.3109/10428194.2010.504872","title":"Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone","year":2010,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Rituximab; Prednisone; International Prognostic Index; Internal medicine; Cyclophosphamide; CHOP; B symptoms; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Anthracycline; Gastroenterology; Doxorubicin; Chemotherapy; Cancer","score_opus":0.004040064221313318,"score_gpt":0.2000309562857332,"score_spread":0.19599089206441989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153978703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946375,0.001520566,0.00002632445,0.00015043152,0.00006399415,0.002309379,0.00026729357,0.00014367863,0.0008808729],"genre_scores_gemma":[0.9958927,0.00067095045,0.0017168394,0.00039865045,0.00006304517,0.00053347467,0.0004023819,0.00013836738,0.00018358951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957769,0.00008631543,0.0010151283,0.0013999295,0.0006729408,0.0010488051],"domain_scores_gemma":[0.99712527,0.00033461416,0.00048117113,0.0009525231,0.00034882472,0.00075758825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024459988,0.0009889497,0.0014020344,0.0004421967,0.00034164506,0.00012474644,0.00021765061,0.0004458889,0.000024666375],"category_scores_gemma":[0.000068143294,0.0007330009,0.00011154707,0.000727125,0.00069352007,0.0003510015,0.0002075112,0.0001466227,0.000006802808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027639605,0.01006669,0.95004994,0.00049703376,0.00027492002,0.00018924047,0.0006546306,0.0000013387829,0.0014157917,0.00058847753,0.00012131872,0.033376634],"study_design_scores_gemma":[0.16054319,0.0020252885,0.8292954,0.00046634497,0.0007180657,0.00032066295,0.00021700257,0.00031456267,0.004578233,0.000066127854,0.0007803516,0.00067476183],"about_ca_topic_score_codex":0.0027760016,"about_ca_topic_score_gemma":0.0010234505,"teacher_disagreement_score":0.15777922,"about_ca_system_score_codex":0.0016975447,"about_ca_system_score_gemma":0.001531737,"threshold_uncertainty_score":0.9995121},"labels":[],"label_agreement":null},{"id":"W2154736427","doi":"10.1158/1078-0432.ccr-06-0474","title":"High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Phases of clinical research; Lymphoma; Oncology; Surgery","score_opus":0.03089044926751248,"score_gpt":0.3818962638238433,"score_spread":0.3510058145563308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154736427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989981,0.007431735,5.4865677e-7,0.0006703694,0.00011793056,0.0016104849,0.000035450612,0.00001508084,0.00013741845],"genre_scores_gemma":[0.9921208,0.0064843264,0.00016512058,0.00037556863,0.00016292091,0.00048283784,0.000039251085,0.000041766576,0.00012741721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997166,0.00049640663,0.0005003071,0.00091347564,0.00038378808,0.00054004934],"domain_scores_gemma":[0.99743927,0.0013881404,0.00020212778,0.0003959661,0.00022712038,0.00034737212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134211,0.00026638494,0.00076994166,0.000234688,0.00015640081,0.000038569713,0.00009431214,0.0002581489,0.000064531785],"category_scores_gemma":[0.00017815101,0.0001901021,0.00005210761,0.00023976108,0.00087337417,0.00013706634,0.000106296764,0.00037165874,0.000006828018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008383481,0.001783595,0.7604776,0.00003805959,0.00012112779,0.00014446113,0.00014252891,7.9788435e-7,0.00003555015,0.00002351293,0.000599081,0.22825019],"study_design_scores_gemma":[0.040883273,0.008324616,0.9485381,0.00020364215,0.00004995187,0.0000055651585,0.000036617468,0.000022530321,0.000500364,0.00017757485,0.0010740238,0.0001837339],"about_ca_topic_score_codex":0.007839332,"about_ca_topic_score_gemma":0.0010442728,"teacher_disagreement_score":0.22806646,"about_ca_system_score_codex":0.00070638634,"about_ca_system_score_gemma":0.00033369364,"threshold_uncertainty_score":0.99876755},"labels":[],"label_agreement":null},{"id":"W2155486792","doi":"10.5430/jst.v4n1p56","title":"Unusual presentation of Precursor B Lymphoblastic Lymphoma originating from the stomach: One more case and review of the literature","year":2014,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Terminal deoxynucleotidyl transferase; Immunohistochemistry; Pathology; CD34; Stomach; Medicine; Lymphoblastic lymphoma; CD20; Lymphoma; Biopsy; Biology; T cell; Gastroenterology; Immunology; Immune system","score_opus":0.012837158134983656,"score_gpt":0.2901448572391305,"score_spread":0.2773076991041469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155486792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751286,0.022292977,0.000014468804,0.0020161637,0.00012257847,0.00027696148,0.000044247277,0.0000036625443,0.000100360776],"genre_scores_gemma":[0.9964597,0.002524137,0.00029325057,0.00045928787,0.00021692844,0.0000055876826,0.0000045091374,0.000011682693,0.00002489847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986099,0.0001538708,0.0005998493,0.000103156526,0.00042239562,0.00011082879],"domain_scores_gemma":[0.9979354,0.00050838594,0.00091323565,0.00022057642,0.00033961778,0.00008279499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003752608,0.0001285882,0.00047913316,0.00004895504,0.00006256582,0.000013896017,0.0001066204,0.000039557788,0.000012308771],"category_scores_gemma":[0.0006182356,0.00006165557,0.00016865831,0.00021255357,0.00011005195,0.000093107956,0.00004035859,0.000084111176,5.8244257e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021165835,0.0070442944,0.5578302,0.024667587,0.0043324367,0.005550385,0.032486025,0.00018374549,0.009838728,0.0020845644,0.01993786,0.33392754],"study_design_scores_gemma":[0.010645794,0.0017365967,0.83883715,0.08642974,0.002974525,0.018135224,0.0012771172,0.0011113792,0.03733731,0.00037643794,0.0009158856,0.00022287713],"about_ca_topic_score_codex":0.000077048964,"about_ca_topic_score_gemma":0.0000059275667,"teacher_disagreement_score":0.33370468,"about_ca_system_score_codex":0.00008786457,"about_ca_system_score_gemma":0.00016183406,"threshold_uncertainty_score":0.2514241},"labels":[],"label_agreement":null},{"id":"W2156013764","doi":"10.1158/1078-0432.ccr-04-2282","title":"High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"MALT lymphoma; Gastroenterology; Medicine; Lymphoma; Trisomy; Internal medicine; Mucosa-associated lymphoid tissue; Chemotherapy; Pathology; Biology","score_opus":0.1009771849710758,"score_gpt":0.4403394357388169,"score_spread":0.33936225076774107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156013764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906411,0.00065946457,7.4116144e-7,0.0066881385,0.00033086006,0.00095152954,0.000025511325,0.00003382385,0.0006688065],"genre_scores_gemma":[0.994323,0.0011244155,0.00018818828,0.0011106168,0.00056102435,0.00035214788,0.00004349428,0.00004324109,0.0022538821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965414,0.00041253646,0.00068138476,0.000660816,0.0009557152,0.0007481884],"domain_scores_gemma":[0.9976154,0.0007826368,0.000084097366,0.000585725,0.00043997847,0.0004921864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017436987,0.00019848139,0.0005834422,0.00019664629,0.0001205593,0.000037768026,0.00019366076,0.00019696896,0.00058310805],"category_scores_gemma":[0.00063525833,0.00013383692,0.0001313894,0.00057335733,0.00027250047,0.00013120561,0.00012264973,0.0003967629,0.00043569616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004725475,0.0022959146,0.84741277,0.000031232943,0.0001176267,0.00014393008,0.00007191607,0.000006955752,0.0000025047134,0.000056330966,0.008787435,0.1363479],"study_design_scores_gemma":[0.03776636,0.0017058667,0.9475651,0.00037129736,0.000045267854,0.0000013287121,0.000023895087,0.00003163654,0.00028047484,0.00003898269,0.012026573,0.00014325633],"about_ca_topic_score_codex":0.0013921794,"about_ca_topic_score_gemma":0.0013811594,"teacher_disagreement_score":0.13620465,"about_ca_system_score_codex":0.0008714973,"about_ca_system_score_gemma":0.00081780297,"threshold_uncertainty_score":0.6384624},"labels":[],"label_agreement":null},{"id":"W2156134727","doi":"10.1182/blood-2007-04-060715","title":"Pathobiology of ALK+ anaplastic large-cell lymphoma","year":2007,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Alberta Cancer Foundation","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; CD30; Lymphoma; Biology; Immunophenotyping; Tyrosine kinase; Nucleophosmin; BCL10; Medicine; Signal transduction; Pathology; Flow cytometry; Immunology; Tumor cells; Cell biology","score_opus":0.035262052957552296,"score_gpt":0.32222109065286136,"score_spread":0.28695903769530906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156134727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091088936,0.99117374,0.0000046920636,0.0000042966553,0.0001903911,0.00066670903,0.00017876393,0.00003475565,0.0068357773],"genre_scores_gemma":[0.0011255017,0.9973619,0.00027614748,0.000055311877,0.00020240126,0.000082512764,0.00044148168,0.00004991902,0.00040480524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830973,0.00006785051,0.0006544737,0.00040277952,0.00017310135,0.00039204533],"domain_scores_gemma":[0.9985987,0.00033025088,0.00034894355,0.00050157227,0.00006201309,0.000158541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001642363,0.0003945953,0.0021344938,0.00022081943,0.00002926093,0.0000046858104,0.000121674435,0.0004583545,0.00011712984],"category_scores_gemma":[0.000053837215,0.00026652694,0.0006642552,0.00023744836,0.00004992908,0.000011564638,0.00006959658,0.0000841748,0.00026138322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002041681,0.013671301,0.00081828097,0.018582314,0.0009156417,0.0012638211,0.000020908019,5.920292e-9,0.0000013188524,0.00017031883,0.0006401956,0.9638955],"study_design_scores_gemma":[0.008851701,0.0008995198,0.00027056257,0.0061627263,0.007819942,0.00066485454,0.000006035201,1.4075991e-7,0.00009174801,0.000004190132,0.9750256,0.00020300216],"about_ca_topic_score_codex":0.000015394044,"about_ca_topic_score_gemma":0.0000065960717,"teacher_disagreement_score":0.9743854,"about_ca_system_score_codex":0.00009237202,"about_ca_system_score_gemma":0.00044028874,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W2156202004","doi":"10.1186/1476-4598-9-14","title":"Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B)","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Biology; Molecular biology; Lymphoma; Bone marrow; CD34; Cancer research; Lymph; Pathology; Immunology; Medicine; Stem cell; Genetics","score_opus":0.006057509725405186,"score_gpt":0.2737831554165044,"score_spread":0.2677256456910992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156202004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039775,0.0018047781,0.00004523428,0.0006796828,0.00026543014,0.0018505574,0.00008006248,0.00006205023,0.004814469],"genre_scores_gemma":[0.99591464,0.00017583609,0.0008189369,0.00090612174,0.000113995884,0.0013948212,0.000040222494,0.00006066582,0.0005747573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759746,0.000070665425,0.00043314794,0.0008178145,0.00051194534,0.0005689533],"domain_scores_gemma":[0.9985154,0.000056095494,0.00034992196,0.00058942277,0.00015139265,0.00033773505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015243482,0.00045225615,0.0006537666,0.00024001727,0.00011772209,0.00010604095,0.00016821586,0.00028613373,0.00046345138],"category_scores_gemma":[0.0002352883,0.00040072095,0.0001642005,0.00033273973,0.00036239755,0.00016545496,0.00014632879,0.00018387285,0.00008557345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065352,0.0009050585,0.028467525,0.00016830592,0.00038225742,0.009794923,0.00045136875,0.0000066679286,0.933439,0.0026313462,0.0006388731,0.022461155],"study_design_scores_gemma":[0.016337134,0.00032556718,0.27704757,0.0010850702,0.00021006494,0.00049802836,0.00007929356,0.0001138839,0.69857836,0.0005348014,0.00465925,0.0005309951],"about_ca_topic_score_codex":0.0033269748,"about_ca_topic_score_gemma":0.00068995636,"teacher_disagreement_score":0.24858004,"about_ca_system_score_codex":0.00046502045,"about_ca_system_score_gemma":0.0010007204,"threshold_uncertainty_score":0.9998445},"labels":[],"label_agreement":null},{"id":"W2156365530","doi":"10.3324/haematol.13071","title":"Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health; National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg; Comisión Interministerial de Ciencia y Tecnología","keywords":"Comparative genomic hybridization; Biology; Lymphoma; Gene; Gene expression; Genetics; Burkitt's lymphoma; Cancer research; Genome; Immunology","score_opus":0.03160698927732969,"score_gpt":0.2620339191997436,"score_spread":0.23042692992241393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156365530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717134,0.0010267142,0.00024326621,0.00016075352,0.000043529417,0.00055130397,0.00004259352,0.000061658255,0.0006988591],"genre_scores_gemma":[0.99566185,0.00018997218,0.0035234643,0.000085892934,0.000020174035,0.00017238245,0.00028738918,0.000011861803,0.00004699827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987156,0.00008570727,0.00047835594,0.0003117595,0.0001872498,0.00022134106],"domain_scores_gemma":[0.99924135,0.00012765765,0.00017886392,0.00026514588,0.00009148905,0.000095486306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044459775,0.00019198576,0.0005931772,0.00011352432,0.00011760424,0.0000073344577,0.00007730232,0.000099403645,0.00014745072],"category_scores_gemma":[0.000051770487,0.00014623784,0.00008631087,0.00024186529,0.00011784634,0.00006946451,0.000031714004,0.00004294534,0.000042798438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005607496,0.004078132,0.46469653,0.000076679135,0.00014374021,0.0013446773,0.0019990583,0.0000827115,0.52044845,0.00052575074,0.0056218626,0.00042166314],"study_design_scores_gemma":[0.003675059,0.00034556517,0.42082566,0.00007399484,0.000037860274,0.00084442296,0.000070728114,0.00035029836,0.573422,0.00003764993,0.00018782218,0.00012890015],"about_ca_topic_score_codex":0.000094871706,"about_ca_topic_score_gemma":0.000018464294,"teacher_disagreement_score":0.052973602,"about_ca_system_score_codex":0.00014457914,"about_ca_system_score_gemma":0.0001117889,"threshold_uncertainty_score":0.59634066},"labels":[],"label_agreement":null},{"id":"W2157591656","doi":"10.1200/jco.2009.26.8748","title":"Radioimmunotherapy of Lymphoma: A Treatment Approach Ahead of Its Time or Past Its Sell-By Date?","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioimmunotherapy; Ibritumomab tiuxetan; Medicine; Rituximab; Lymphoma; Oncology; Clinical trial; Non-Hodgkin's lymphoma; CD20; Internal medicine; Monoclonal antibody; Immunology; Antibody","score_opus":0.09311115547889183,"score_gpt":0.4318470478798739,"score_spread":0.33873589240098206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157591656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945415,0.0026693814,0.000014405914,0.00238574,0.0006605637,0.00043680813,0.000036885325,0.00000826188,0.00433379],"genre_scores_gemma":[0.98735857,0.005315474,0.004279302,0.00050115323,0.0006940683,0.00001613513,0.000015531956,0.000028753546,0.0017909998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961219,0.00028739197,0.0027037796,0.00023543427,0.00039512504,0.00025639852],"domain_scores_gemma":[0.99473476,0.0017698037,0.00232963,0.00034005175,0.00047935237,0.00034637685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014075147,0.00023572623,0.0025487912,0.00012467355,0.000029807718,0.0000053097133,0.00019875713,0.0005047209,0.0005594734],"category_scores_gemma":[0.0006149971,0.00013037874,0.0007378251,0.00016162074,0.00021032122,0.00008723524,0.000030263998,0.00026592132,0.00004029188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027803048,0.09405153,0.09563569,0.00018946928,0.006461067,0.0009932827,0.000612204,0.0000089332525,0.0397276,0.00029029563,0.024025062,0.7102018],"study_design_scores_gemma":[0.11190558,0.09233961,0.30884725,0.0002595052,0.0025484553,0.0028119215,0.00012139829,0.0003600536,0.039903976,0.00003147199,0.44055477,0.00031602688],"about_ca_topic_score_codex":0.000022255219,"about_ca_topic_score_gemma":0.000006411627,"teacher_disagreement_score":0.7098858,"about_ca_system_score_codex":0.00017014626,"about_ca_system_score_gemma":0.0018224024,"threshold_uncertainty_score":0.6125842},"labels":[],"label_agreement":null},{"id":"W2158267770","doi":"10.1182/blood-2003-05-1545","title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; U.S. Department of Health and Human Services","keywords":"Tissue microarray; Microarray; Lymphoma; Germinal center; Immunohistochemistry; Diffuse large B-cell lymphoma; Pathology; Biology; International Prognostic Index; Gene expression profiling; Microarray analysis techniques; Complementary DNA; Gene expression; Medicine; B cell; Antibody; Gene; Immunology; Genetics","score_opus":0.008936389457920729,"score_gpt":0.24885822921689454,"score_spread":0.23992183975897383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158267770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948158,0.0025459116,0.0001318389,0.000044744156,0.000029749292,0.00025255018,0.000025832034,0.000007016847,0.002146555],"genre_scores_gemma":[0.9993285,0.000026914864,0.00043217317,0.00004051315,0.0000051259626,0.000014261592,0.000028462742,0.000010640663,0.00011338431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935853,0.00003640391,0.00023376841,0.00011761626,0.0001524145,0.00010125728],"domain_scores_gemma":[0.9993389,0.000017283946,0.00019951948,0.00033881658,0.000073704236,0.000031743726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000637977,0.000089892135,0.0001678587,0.000018719353,0.000034070556,0.0000039019083,0.00005512738,0.000068465604,0.000020001167],"category_scores_gemma":[0.00003412242,0.00006674174,0.000075604825,0.00009717777,0.000043644257,0.00001780672,0.000010660645,0.000021775759,0.0000023726798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012270265,0.007437288,0.0061049745,0.00009863589,0.00006194841,0.0000027407511,0.00012263423,2.0326385e-7,0.98569,0.00024927704,0.000089689245,0.00013032988],"study_design_scores_gemma":[0.012075259,0.000048546637,0.0056184926,0.00007312521,0.00033724392,0.00003267324,0.00008458525,0.000015961827,0.98048985,0.000009114753,0.0011606681,0.000054491687],"about_ca_topic_score_codex":0.000041870553,"about_ca_topic_score_gemma":2.5580172e-7,"teacher_disagreement_score":0.012062989,"about_ca_system_score_codex":0.000059478614,"about_ca_system_score_gemma":0.00009659185,"threshold_uncertainty_score":0.2721649},"labels":[],"label_agreement":null},{"id":"W2158340787","doi":"","title":"Le traitement du lymphome de Hodgkin chez l'adulte","year":2010,"lang":"fr","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Gynecology; Procarbazine; Dacarbazine; Humanities; Vincristine; Surgery; Philosophy; Cyclophosphamide; Chemotherapy","score_opus":0.007035980373667228,"score_gpt":0.23902273801654947,"score_spread":0.23198675764288224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158340787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86128193,0.003904986,0.00023887631,0.04039756,0.003498757,0.0005732277,0.000036052003,0.000109100365,0.08995951],"genre_scores_gemma":[0.9703273,0.0011349944,0.00280737,0.0030482886,0.0018762817,0.00013042451,0.00003464282,0.0000449209,0.02059577],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800175,0.000075336815,0.0003902847,0.00042838376,0.00030206758,0.00080219365],"domain_scores_gemma":[0.9986139,0.00014754907,0.00008347921,0.00047902344,0.00008520141,0.0005908649],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00047617435,0.00032632687,0.0004182142,0.00008474012,0.00014905928,0.00006810971,0.00015036447,0.00026926497,0.007055139],"category_scores_gemma":[0.00009244829,0.00027750366,0.00024834706,0.00016414533,0.00019883548,0.00011827879,0.00006778243,0.00016595625,0.0017298383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013594163,0.009675589,0.24757542,0.0002969147,0.0009142136,0.0012082419,0.0038817385,0.000015905813,0.023248442,0.33291182,0.051919498,0.32821625],"study_design_scores_gemma":[0.012093852,0.00057951466,0.4295267,0.0002270382,0.00050075824,0.0005479766,0.0008606826,0.0012024152,0.08331853,0.00043925823,0.4702977,0.00040556374],"about_ca_topic_score_codex":0.008457182,"about_ca_topic_score_gemma":0.0024800224,"teacher_disagreement_score":0.4183782,"about_ca_system_score_codex":0.0004292331,"about_ca_system_score_gemma":0.0010448601,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W2158453609","doi":"10.1093/jncimonographs/lgu003","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Sporadic Burkitt Lymphoma/Leukemia: The Interlymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Family history; Lymphoma; Internal medicine; Confidence interval; Epidemiology; Medical history; Immunology","score_opus":0.0213937200035711,"score_gpt":0.25987611489325313,"score_spread":0.23848239488968204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158453609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941904,0.0054177507,0.00038499804,0.00031242633,0.0012599194,0.0013246819,0.00007418963,0.00015978576,0.0016472288],"genre_scores_gemma":[0.99485654,0.0010458424,0.0007309611,0.001517292,0.00048790895,0.00059260405,0.00024145708,0.00007889476,0.00044851177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997003,0.00016134541,0.00065203605,0.000769405,0.0008330106,0.0005811672],"domain_scores_gemma":[0.99746335,0.0008335148,0.00039183127,0.0006910899,0.00017514674,0.00044505444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007622625,0.0005455791,0.00074116455,0.00042105216,0.0002462132,0.000035273682,0.00032134837,0.00038779672,0.000083227445],"category_scores_gemma":[0.00050836406,0.00035661503,0.00049923547,0.00022361398,0.0005776331,0.00014636171,0.00008778811,0.00012645993,0.000021271835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007403864,0.00097390695,0.73001575,0.0001371432,0.000634198,0.000050604107,0.002518899,0.000001306849,0.00003969525,0.0009461791,0.1791415,0.084800445],"study_design_scores_gemma":[0.0066633453,0.00091317174,0.66642934,0.00011133927,0.00047239318,0.00007639654,0.0002815025,0.0018471399,0.00007384242,0.00008984436,0.32273108,0.00031063473],"about_ca_topic_score_codex":0.004518468,"about_ca_topic_score_gemma":0.00017243336,"teacher_disagreement_score":0.14358956,"about_ca_system_score_codex":0.0030601195,"about_ca_system_score_gemma":0.0019930957,"threshold_uncertainty_score":0.9998886},"labels":[],"label_agreement":null},{"id":"W2159393668","doi":"10.1309/ajcp2z0tagmuyjeb","title":"Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"National Cancer Institute","keywords":"Biology; Diffuse large B-cell lymphoma; Gene; Messenger RNA; Gene dosage; Lymphoma; Cancer research; Comparative genomic hybridization; Molecular biology; Gene expression; Locus (genetics); Germinal center; Chromosome; B cell; Genetics; Immunology; Antibody","score_opus":0.013008064378048854,"score_gpt":0.29811143131054973,"score_spread":0.2851033669325009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159393668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983973,0.00022071127,0.00022052805,0.0003478055,0.000088984474,0.0004952926,0.0000033312313,0.000008396204,0.00021763783],"genre_scores_gemma":[0.9951957,0.00025527301,0.003698395,0.00066370144,0.00009373758,0.000033540262,0.000008696077,0.000021859289,0.000029102806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971504,0.00061147,0.0013569186,0.00029021004,0.0002679528,0.00032302047],"domain_scores_gemma":[0.9972146,0.0010554476,0.0011167522,0.00015765948,0.0001916494,0.00026389505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010520933,0.00019188218,0.0010545811,0.00031327608,0.000038914088,0.000025680749,0.00009027307,0.0001025008,0.000032950767],"category_scores_gemma":[0.00067314046,0.00013985053,0.00011293303,0.0005580571,0.00034749162,0.00016214578,0.00005224959,0.00027483204,0.000022093987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009876594,0.005831484,0.9683732,0.00001885031,0.000054668097,0.0021673485,0.00019191825,0.0000055212968,0.00132509,0.000007143227,0.00006839716,0.020968715],"study_design_scores_gemma":[0.03870097,0.0043142624,0.9528026,0.00019305579,0.00011788848,0.001118153,0.00058109086,0.00024521624,0.0016977673,0.000043916894,0.00003831973,0.0001467838],"about_ca_topic_score_codex":0.00044413932,"about_ca_topic_score_gemma":0.000088967216,"teacher_disagreement_score":0.03771331,"about_ca_system_score_codex":0.00013192302,"about_ca_system_score_gemma":0.00025805176,"threshold_uncertainty_score":0.5702939},"labels":[],"label_agreement":null},{"id":"W2159403621","doi":"10.1182/blood-2014-05-577627","title":"The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Stage (stratigraphy); Medicine; Lymphoma; Disease; Positron emission tomography; Hodgkin lymphoma; Oncology; Internal medicine; Nuclear medicine; Biology","score_opus":0.02088860018484849,"score_gpt":0.3022961687054133,"score_spread":0.2814075685205648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159403621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013220569,0.98393065,7.091545e-7,0.000022458138,0.000046378045,0.001961239,0.00029643942,0.000014445865,0.0005071089],"genre_scores_gemma":[0.042350847,0.9552262,0.00030470488,0.000011369819,0.000061159095,0.001762528,0.00014187946,0.000054850523,0.00008649955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982997,0.00009624528,0.00075615646,0.0003164984,0.0002480582,0.00028330047],"domain_scores_gemma":[0.99799466,0.0007479908,0.0005353901,0.0005162751,0.00007247252,0.00013321283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000301221,0.0003052317,0.0015734716,0.00012824424,0.00004404675,0.000014307177,0.00018290657,0.00010274909,0.0000076214496],"category_scores_gemma":[0.00026688675,0.00018039212,0.0007030507,0.00018955431,0.000071814684,0.000020022193,0.00006403494,0.000052164534,0.000009003557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006759548,0.0026421372,0.053596452,0.0150316255,0.00071433384,0.000046222038,0.00004497393,9.369204e-8,3.9741712e-7,0.0016338957,0.000041092826,0.9261812],"study_design_scores_gemma":[0.00673551,0.0007028968,0.01530228,0.024053533,0.00795905,0.000022988226,0.000031130825,0.0000070889478,0.00018302789,0.00010998215,0.9446341,0.00025843704],"about_ca_topic_score_codex":0.00011795918,"about_ca_topic_score_gemma":0.0000194807,"teacher_disagreement_score":0.944593,"about_ca_system_score_codex":0.00006522145,"about_ca_system_score_gemma":0.00047148476,"threshold_uncertainty_score":0.7356177},"labels":[],"label_agreement":null},{"id":"W2159862107","doi":"10.1200/jco.2011.41.0985","title":"Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":973,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"Vincristine; Medicine; Chromosomal translocation; International Prognostic Index; Immunohistochemistry; Rituximab; Lymphoma; Cyclophosphamide; Prednisone; Diffuse large B-cell lymphoma; Cancer research; CHOP; Internal medicine; Oncology; Cohort; Immunophenotyping; Pathology; Chemotherapy; Immunology; Flow cytometry; Biology; Gene","score_opus":0.04353290157636887,"score_gpt":0.38137566916005605,"score_spread":0.3378427675836872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159862107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886658,0.009759297,0.000026002797,0.00046397865,0.0002325973,0.0002844362,0.000015263275,0.0000063479156,0.0005462398],"genre_scores_gemma":[0.99413466,0.004234363,0.0010071269,0.00031428237,0.00022303413,0.000009576138,0.000005179845,0.000016957372,0.000054805085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726564,0.00026264053,0.0016623312,0.00020017834,0.00028735658,0.00032184532],"domain_scores_gemma":[0.9964409,0.0014274409,0.0012608339,0.00015631874,0.0001885627,0.00052597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011386602,0.00020334151,0.0018172668,0.00012424744,0.000032123116,0.0000063425214,0.00006476943,0.00029118438,0.000024158917],"category_scores_gemma":[0.00053305144,0.00011977463,0.0001419042,0.00011307087,0.00022244519,0.00013775697,0.0000766683,0.00024636943,0.0000023169907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004259559,0.042658456,0.91595995,0.00010511476,0.00014569373,0.00037279128,0.00027750517,4.2529493e-7,0.00033465793,0.000057755104,0.00057015324,0.035257924],"study_design_scores_gemma":[0.16740967,0.01219377,0.80979145,0.0004038129,0.00045495684,0.0004354477,0.00016970818,0.000040479412,0.003333733,0.000011964593,0.0056496006,0.00010540844],"about_ca_topic_score_codex":0.000054872322,"about_ca_topic_score_gemma":0.000030639098,"teacher_disagreement_score":0.16315012,"about_ca_system_score_codex":0.0001969788,"about_ca_system_score_gemma":0.00045566587,"threshold_uncertainty_score":0.48842674},"labels":[],"label_agreement":null},{"id":"W2160248310","doi":"10.1093/annonc/mdl329","title":"A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; International Prognostic Index; Cyclophosphamide; Internal medicine; Vincristine; Prednisone; CHOP; Chemotherapy; Nodular sclerosis; Lymphoma; Cancer; Population; Oncology; Surgery; Hodgkin lymphoma","score_opus":0.02963235841265658,"score_gpt":0.32330615225135845,"score_spread":0.29367379383870185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160248310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653745,0.00036720716,3.624477e-7,0.00010468779,0.00005688155,0.002350866,0.00029039153,0.000016894199,0.00027528967],"genre_scores_gemma":[0.99911594,0.000035509198,0.000041068426,0.00020277804,0.000040981606,0.0003115941,0.00019443968,0.000016891752,0.000040770206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775916,0.00033253018,0.00084263686,0.00041020583,0.00045324292,0.00020220729],"domain_scores_gemma":[0.9976519,0.0003258717,0.0009050775,0.0003348683,0.0007259324,0.000056403107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020793585,0.00015518386,0.0011657408,0.00004090749,0.00012295516,0.000015591602,0.00010056054,0.00012413325,0.0000959489],"category_scores_gemma":[0.00009399845,0.00012518038,0.00010638283,0.00030123387,0.000121676516,0.00004282836,0.00004541954,0.00006426334,4.864011e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012121737,0.06876093,0.9179791,0.0000148181325,0.00034512518,0.00034399988,0.0003480149,0.000017021783,0.000010917548,7.162835e-7,0.0008891014,0.010078036],"study_design_scores_gemma":[0.02377003,0.030352388,0.944608,0.00011755159,0.00068976305,0.0000033847612,0.00027908353,0.0000036243853,0.000030533232,0.00003077493,0.000016205131,0.000098676755],"about_ca_topic_score_codex":0.42742592,"about_ca_topic_score_gemma":0.20052668,"teacher_disagreement_score":0.22689924,"about_ca_system_score_codex":0.00020228057,"about_ca_system_score_gemma":0.0002960189,"threshold_uncertainty_score":0.81406164},"labels":[],"label_agreement":null},{"id":"W2160305510","doi":"10.1016/s1470-2045(06)70664-7","title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","year":2006,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2085,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; CHOP; Internal medicine; Vincristine; International Prognostic Index; Chemotherapy; Clinical endpoint; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Prednisone; Surgery; Cyclophosphamide; Gastroenterology; Randomized controlled trial","score_opus":0.011568933367359015,"score_gpt":0.2673967495049783,"score_spread":0.2558278161376193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160305510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734367,0.0005853328,0.000039275033,0.006485387,0.0023896205,0.011198374,0.00008594783,0.000100384445,0.005678972],"genre_scores_gemma":[0.9877065,0.0006240792,0.00017269564,0.0033751924,0.002035218,0.004848215,0.00031292022,0.000087943496,0.00083723065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962612,0.0006201012,0.000927905,0.0006544058,0.00071102247,0.0008253797],"domain_scores_gemma":[0.9970536,0.0013978968,0.00061212067,0.00068407075,0.00013708226,0.000115206814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011544727,0.0005698652,0.002038391,0.00012505276,0.0002144192,0.000088947905,0.0005683306,0.00032041452,0.00022778899],"category_scores_gemma":[0.00007045313,0.00029824828,0.00042649094,0.00027918833,0.00024744534,0.00010694559,0.00006523229,0.00028931044,0.00003821738],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9362409,0.039760977,0.009694339,0.000012005089,0.0010438066,0.000041853662,0.00053547794,0.0000024683914,0.000062573745,0.00013565065,0.00851318,0.003956763],"study_design_scores_gemma":[0.9374016,0.0055430788,0.015823886,0.000033689437,0.00045481668,0.000014785025,0.00008266584,0.00022570293,0.000108988024,0.000043990007,0.03997402,0.00029280572],"about_ca_topic_score_codex":0.0012052536,"about_ca_topic_score_gemma":0.0012042302,"teacher_disagreement_score":0.034217898,"about_ca_system_score_codex":0.0015189352,"about_ca_system_score_gemma":0.0003287251,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2160410546","doi":"10.1177/2040620712471553","title":"The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation","keywords":"Anaplastic lymphoma kinase; Cancer research; Carcinogenesis; Anaplastic large-cell lymphoma; Tyrosine kinase; STAT protein; Signal transduction; STAT3; Biology; Medicine; Lymphoma; Cell biology; Cancer; Pathology; Immunology; Internal medicine; Lung cancer","score_opus":0.01015474149840613,"score_gpt":0.2801749200807791,"score_spread":0.270020178582373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160410546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8884607,0.09808639,0.00007201197,0.010006229,0.00049234455,0.00110621,0.000006482542,0.00003142007,0.0017381986],"genre_scores_gemma":[0.9916842,0.0060244454,0.00019086634,0.001674092,0.000029457455,0.0002595262,0.000004743946,0.000015187407,0.0001174786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998697,0.00017064833,0.00042384458,0.00024023901,0.00011254067,0.00035572692],"domain_scores_gemma":[0.9986301,0.00047757424,0.00018942457,0.0005855711,0.00007077694,0.00004653347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014424698,0.00017335173,0.00045553528,0.00003946297,0.0000971615,0.000006007993,0.0002327322,0.00010349985,0.0001306232],"category_scores_gemma":[0.00005375997,0.00008203227,0.00012324103,0.0002053611,0.0005299303,0.00006248582,0.00008733277,0.00012657915,0.00005920928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004746912,0.0012237772,0.38969302,0.00013814835,0.00029997967,0.0000828294,0.00046849635,0.000018502373,0.0040941755,0.1560126,0.0003796074,0.44711417],"study_design_scores_gemma":[0.015272591,0.0018262777,0.34056917,0.0005075096,0.0005751075,0.0029876123,0.0009623824,0.0005255663,0.11288083,0.12464311,0.39857757,0.00067226915],"about_ca_topic_score_codex":0.00006548502,"about_ca_topic_score_gemma":0.000102139136,"teacher_disagreement_score":0.4464419,"about_ca_system_score_codex":0.00007034304,"about_ca_system_score_gemma":0.00008474189,"threshold_uncertainty_score":0.3345179},"labels":[],"label_agreement":null},{"id":"W2160881152","doi":"10.1182/blood-2008-02-137372","title":"Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Rituximab; Survival analysis; Gene expression profiling; Biology; Oncology; Cancer research; Chemotherapy; Gene; Internal medicine; Medicine; Gene expression; Genetics","score_opus":0.013454216082044761,"score_gpt":0.23230082174344488,"score_spread":0.21884660566140013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160881152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962254,0.0011905262,0.0000035508654,0.000032419248,0.00003177488,0.0004650146,0.000047193233,0.00007290563,0.0019311944],"genre_scores_gemma":[0.997656,0.00066653796,0.0008140102,0.000046030123,0.000060696682,0.00007237097,0.0001017515,0.00003453174,0.00054810144],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985616,0.000058791233,0.00031914277,0.00034676178,0.00037657563,0.000337128],"domain_scores_gemma":[0.99916905,0.00007292289,0.00012220434,0.00040959453,0.00006317271,0.00016305521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006321306,0.00024455052,0.00052857905,0.000115849885,0.000051205,0.0000063766347,0.00007890522,0.00011818109,0.000046864996],"category_scores_gemma":[0.000021422069,0.00016834041,0.00008197603,0.00017473454,0.000052554977,0.000070750175,0.00004189366,0.00004587764,0.00001854208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000752573,0.051052254,0.9200859,0.00007867471,0.00015247258,0.002300478,0.00089418056,0.0000041600465,0.024117587,0.000012531284,0.00028690943,0.000262289],"study_design_scores_gemma":[0.07942642,0.0007681212,0.43647993,0.00018796507,0.00017152521,0.00011053949,0.00003665694,0.00002135759,0.4825078,0.0000023770854,0.00016358036,0.0001237347],"about_ca_topic_score_codex":0.0002208375,"about_ca_topic_score_gemma":0.000034534096,"teacher_disagreement_score":0.48360595,"about_ca_system_score_codex":0.000059528655,"about_ca_system_score_gemma":0.000115794,"threshold_uncertainty_score":0.6864723},"labels":[],"label_agreement":null},{"id":"W2162350156","doi":"10.1111/bjh.12630","title":"Phase <scp>IA</scp>/<scp>II</scp>, multicentre, open‐label study of the <scp>CD</scp>40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐<scp>H</scp>odgkin or <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Lymphoma; Medicine; Follicular lymphoma; Internal medicine; Monoclonal antibody; Radioimmunotherapy; Refractory (planetary science); Gastroenterology; MALT lymphoma; Antibody; Immunology; Biology","score_opus":0.013425289530544553,"score_gpt":0.29821879913674515,"score_spread":0.2847935096062006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162350156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433876,0.0043484755,0.00006666086,0.00017775511,0.001723741,0.007227615,0.0004623556,0.00011598202,0.0015386479],"genre_scores_gemma":[0.99078834,0.0021945548,0.0021676817,0.001187337,0.0003559034,0.00069816696,0.00029964058,0.0003787225,0.0019296698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98608786,0.0012893309,0.0046449495,0.0021230236,0.0027309048,0.003123929],"domain_scores_gemma":[0.9815181,0.0072567747,0.004786855,0.0018041312,0.0030347097,0.0015994688],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010942278,0.0019470053,0.005241566,0.0011838649,0.0010482261,0.00062181894,0.0027106854,0.0009683497,0.000040562376],"category_scores_gemma":[0.012564307,0.0015430908,0.00078262883,0.0020595524,0.000995573,0.001697843,0.0013683153,0.0015327312,0.00018519915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000495609,0.15289359,0.66912735,0.0012961986,0.0057917424,0.06326319,0.01512446,0.0002271396,0.0022256842,0.00020720207,0.063922405,0.025425443],"study_design_scores_gemma":[0.20629421,0.016770348,0.68126464,0.0055740774,0.0032001499,0.040121995,0.024636408,0.0010080098,0.011311188,0.00023686732,0.009305326,0.00027679544],"about_ca_topic_score_codex":0.0022084266,"about_ca_topic_score_gemma":0.0016051361,"teacher_disagreement_score":0.2057986,"about_ca_system_score_codex":0.0011806118,"about_ca_system_score_gemma":0.0024100281,"threshold_uncertainty_score":0.9993273},"labels":[],"label_agreement":null},{"id":"W2162410017","doi":"10.3109/10428194.2014.971409","title":"Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta; University of Calgary","funders":"Alberta Health Services","keywords":"Salvage therapy; Medicine; Internal medicine; Refractory (planetary science); Oncology; Chemotherapy; Lymphoma; Diffuse large B-cell lymphoma; Population; Surgery; Biology","score_opus":0.013599289130931717,"score_gpt":0.2619701770272454,"score_spread":0.24837088789631367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162410017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582905,0.00048299646,0.00064908597,0.000029636758,0.0001552755,0.0017195408,0.00045994887,0.00011430118,0.0005601864],"genre_scores_gemma":[0.99603564,0.00018752599,0.00037698756,0.00045449665,0.00011338524,0.0007128245,0.0015177625,0.00012260616,0.00047876398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99441135,0.0006667636,0.0014147975,0.0016190008,0.0006826785,0.0012054114],"domain_scores_gemma":[0.9949572,0.002079355,0.00070174737,0.0013082123,0.00034786278,0.0006056262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007254524,0.0012199696,0.0041157715,0.0016962058,0.00035631747,0.00016402491,0.00041465016,0.00055275974,0.00006456174],"category_scores_gemma":[0.000098917466,0.0008959851,0.0011718429,0.00275808,0.000362507,0.00034480004,0.00018350167,0.00009288448,0.000012720347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0129500255,0.016445057,0.90892094,0.00049272366,0.020072151,0.00010225387,0.013989933,0.0006846256,0.004963392,0.0011291165,0.00003468501,0.020215085],"study_design_scores_gemma":[0.11823201,0.0024822098,0.762077,0.00025705327,0.011879929,0.000049465205,0.0052431575,0.073801465,0.024143144,0.00014936496,0.00056523463,0.0011200093],"about_ca_topic_score_codex":0.019841824,"about_ca_topic_score_gemma":0.03384397,"teacher_disagreement_score":0.146844,"about_ca_system_score_codex":0.005845361,"about_ca_system_score_gemma":0.0012884692,"threshold_uncertainty_score":0.99934906},"labels":[],"label_agreement":null},{"id":"W2162489311","doi":"10.1093/carcin/bgq229","title":"Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential","year":2010,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Phosphorylation; Serine; MAP2K7; Anaplastic lymphoma kinase; Kinase; Casein kinase 2; Molecular biology; MAP kinase kinase kinase; c-Raf; MAPK14; Biology; Chemistry; Cyclin-dependent kinase 2; Biochemistry; Protein kinase A; Medicine","score_opus":0.015634154074626223,"score_gpt":0.2475891563946481,"score_spread":0.23195500232002186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162489311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911558,0.00008343736,0.00010811806,0.007073823,0.00026437695,0.0010280319,0.0000442737,0.000016547914,0.00022556324],"genre_scores_gemma":[0.99886006,0.000024770323,0.000037988895,0.0006511994,0.00008577039,0.000108517575,0.000027191965,0.000020009491,0.0001845187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987577,0.000057697394,0.0003308176,0.00025139624,0.0004346612,0.00016767951],"domain_scores_gemma":[0.9984465,0.00015226785,0.00023249714,0.0005377717,0.00056354236,0.000067388646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002121719,0.0001701927,0.00026879876,0.000091972135,0.0001209554,0.000012716712,0.00013735902,0.000117357245,0.0001617938],"category_scores_gemma":[0.00033903972,0.00009999547,0.00015586487,0.00045533903,0.00003462091,0.000058049365,0.00006232119,0.00009667829,0.000015359466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037711186,0.00043603257,0.06212723,0.00004101744,0.00017172615,0.0000012993492,0.00020428411,0.00012879419,0.9279823,0.0005886713,0.00040120768,0.0075403294],"study_design_scores_gemma":[0.00080876413,0.00012730566,0.43417192,0.000055110406,0.000138061,0.0000022688312,0.000047694182,0.00021848475,0.56416225,0.000021120364,0.00019889227,0.00004813006],"about_ca_topic_score_codex":0.00030856932,"about_ca_topic_score_gemma":0.00004759501,"teacher_disagreement_score":0.37204468,"about_ca_system_score_codex":0.00016970359,"about_ca_system_score_gemma":0.00018509402,"threshold_uncertainty_score":0.4077697},"labels":[],"label_agreement":null},{"id":"W2162737502","doi":"10.1016/s0360-3016(01)02495-6","title":"Clinical stage I &amp; II diffuse large-cell lymphoma: results of combined modality therapy and prognostic factor analysis","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphoma; CHOP; Internal medicine; Gastroenterology; Radiation therapy; B symptoms; Histology; Surgery","score_opus":0.04746992974076747,"score_gpt":0.37103310008512536,"score_spread":0.3235631703443579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162737502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431765,0.0006355691,0.0014527462,0.0020920145,0.0006086302,0.00027422188,0.00032601116,0.000020518672,0.0002726259],"genre_scores_gemma":[0.99218464,0.0049491697,0.0013676449,0.0005127699,0.00055700686,0.000009519672,0.0002707399,0.00001568095,0.00013283982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975253,0.0003333101,0.0013109457,0.0002915192,0.00032532262,0.00021359995],"domain_scores_gemma":[0.9961714,0.0009987709,0.0016111545,0.00023029036,0.00079507404,0.00019331202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007230027,0.00021314027,0.0008710462,0.00022312615,0.00007622633,0.000017811455,0.00021996706,0.00025029908,0.000054787844],"category_scores_gemma":[0.0004491306,0.00016140468,0.00047826397,0.00027701727,0.00018569487,0.00014841383,0.00007557148,0.00018789113,0.0000065665026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023378136,0.013670482,0.9264888,0.000005172994,0.00296833,0.00005427214,0.00040482107,0.000034434208,0.00029387054,0.00093329215,0.00024103261,0.05256765],"study_design_scores_gemma":[0.06294437,0.0031387925,0.9097861,0.000025659594,0.0006929283,0.00004395318,0.000045549274,0.0010588251,0.00055862736,0.0010257324,0.020537153,0.00014233231],"about_ca_topic_score_codex":0.00006738926,"about_ca_topic_score_gemma":0.000021397724,"teacher_disagreement_score":0.060606554,"about_ca_system_score_codex":0.00037507294,"about_ca_system_score_gemma":0.0004063491,"threshold_uncertainty_score":0.6581892},"labels":[],"label_agreement":null},{"id":"W2162848902","doi":"10.1200/jco.2005.09.085","title":"Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":321,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Radiation therapy; Vinblastine; Internal medicine; Randomized controlled trial; Lymphoma; Surgery; Bleomycin; Cancer; Chemotherapy; Oncology; Vincristine; Cyclophosphamide","score_opus":0.16870968164632547,"score_gpt":0.47590214868908043,"score_spread":0.30719246704275494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162848902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990829,0.0016312092,0.000069179805,0.0053449697,0.00036688798,0.0014032312,0.00001926813,0.0000025957422,0.000333651],"genre_scores_gemma":[0.9914296,0.0051480336,0.00076452247,0.0021332873,0.00039837518,0.00006263551,0.0000149960615,0.000014583387,0.000033932345],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9912717,0.003459637,0.00409868,0.00024317815,0.00072781765,0.00019898341],"domain_scores_gemma":[0.9819484,0.0116195185,0.005381975,0.00013614849,0.0007201502,0.0001938238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010661525,0.00023280605,0.0047033164,0.00012640677,0.00004919144,0.000012728841,0.00014236003,0.00031869902,0.000030375322],"category_scores_gemma":[0.0020788836,0.00010610036,0.0003274459,0.00016127004,0.00089460256,0.00021954636,0.00002413544,0.00037165426,1.6310031e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3655764,0.0060684346,0.45299244,0.000010267002,0.0017264775,0.000020322199,0.0003134716,0.00023744951,0.0000015831305,0.00024979818,0.00025698697,0.17254637],"study_design_scores_gemma":[0.50972205,0.014777339,0.46918967,0.00011483918,0.00030902424,0.000010325595,0.00015062488,0.0006007643,0.000039836563,0.000025206433,0.0049860985,0.00007424381],"about_ca_topic_score_codex":0.011077495,"about_ca_topic_score_gemma":0.12686111,"teacher_disagreement_score":0.17247213,"about_ca_system_score_codex":0.000664122,"about_ca_system_score_gemma":0.0072456673,"threshold_uncertainty_score":0.99838233},"labels":[],"label_agreement":null},{"id":"W2163086758","doi":"10.1371/journal.pone.0078812","title":"Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Deutsche Forschungsgemeinschaft","keywords":"Histiocyte; Lymphoma; Pathology; Biology; Immunohistochemistry; Medicine","score_opus":0.015236664717175101,"score_gpt":0.20067632557609485,"score_spread":0.18543966085891975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163086758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877842,0.0076583135,0.000026494956,0.00042448833,0.000047090296,0.0014655532,0.00021886862,0.00005739959,0.002317601],"genre_scores_gemma":[0.99305266,0.0026144984,0.0024322881,0.00016099676,0.00010434257,0.00024786076,0.00007599317,0.00007115434,0.0012402115],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970768,0.00009043362,0.00075619353,0.0006317234,0.0008319768,0.00061288994],"domain_scores_gemma":[0.99778396,0.00015516767,0.0004275166,0.00087168167,0.0002212947,0.00054039265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018373314,0.00042139372,0.001144146,0.00023822564,0.00009374352,0.000026966309,0.00017972387,0.00014997718,0.0005846719],"category_scores_gemma":[0.000085102496,0.0003694758,0.0002058418,0.00028907813,0.00018324939,0.00014708389,0.00019163902,0.00004493397,0.0002051662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038224282,0.20821738,0.44319507,0.00887728,0.0030929993,0.00065238215,0.0015913951,0.000003711088,0.31811947,0.00069703185,0.0011898634,0.010540978],"study_design_scores_gemma":[0.022413284,0.00084542774,0.35105908,0.00093126216,0.0015671658,0.000012281254,0.00006932489,0.0007660069,0.621747,0.00017728878,0.00012845453,0.00028340583],"about_ca_topic_score_codex":0.00055596937,"about_ca_topic_score_gemma":0.000015131233,"teacher_disagreement_score":0.30362755,"about_ca_system_score_codex":0.0005047358,"about_ca_system_score_gemma":0.000415472,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W2163347800","doi":"10.1016/j.hoc.2008.01.004","title":"Hodgkin Lymphoma: The Follow-Up of Long-Term Survivors","year":2008,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Disease; Medicine; Hodgkin lymphoma; Pediatrics; Young adult; Intensive care medicine; Gerontology; Internal medicine","score_opus":0.05787343204547818,"score_gpt":0.37737770541829563,"score_spread":0.31950427337281745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163347800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019134728,0.976044,0.000015979782,0.00023870807,0.0012714501,0.001987675,0.00016851557,0.000060433278,0.001078499],"genre_scores_gemma":[0.0044831345,0.99312276,0.00045993476,0.00042044694,0.00013561184,0.00045902585,0.0005970025,0.00010211565,0.00021996652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99397993,0.00080760964,0.0031328942,0.00090777176,0.0004594204,0.0007123941],"domain_scores_gemma":[0.9883323,0.005425007,0.0038725084,0.0017150518,0.00037572364,0.0002794674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032910935,0.00088687387,0.008641194,0.00037430122,0.00014427245,0.0000042833626,0.00077148946,0.0010556742,0.00011510816],"category_scores_gemma":[0.00072028185,0.0005528331,0.0025565575,0.00086741825,0.002185713,0.000040002782,0.00034834773,0.0004903409,0.00020847796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017693762,0.0023413354,0.15845494,0.0049117673,0.0023956606,0.001366954,0.00011097209,2.415554e-7,9.111939e-9,0.000052593357,0.002805759,0.8273828],"study_design_scores_gemma":[0.0051751733,0.0029391628,0.03167169,0.0036053844,0.0065704808,0.006231149,0.000037679227,0.0000021047663,0.0000027217673,0.000010122641,0.943269,0.00048530256],"about_ca_topic_score_codex":0.0001825099,"about_ca_topic_score_gemma":0.00043067534,"teacher_disagreement_score":0.94046324,"about_ca_system_score_codex":0.00030614063,"about_ca_system_score_gemma":0.0033249613,"threshold_uncertainty_score":0.9996923},"labels":[],"label_agreement":null},{"id":"W2163401417","doi":"10.1038/nature09754","title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","year":2011,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":612,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CIITA; Biology; Cancer research; Lymphoma; Major histocompatibility complex; MHC class II; Fusion gene; MHC class I; Gene; Genetics; Immunology","score_opus":0.021215741037002182,"score_gpt":0.2779963934526211,"score_spread":0.2567806524156189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163401417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98524517,0.0060013807,0.0000019611648,0.002073062,0.00045293395,0.00040417636,0.00004512623,0.00003806563,0.005738125],"genre_scores_gemma":[0.99510413,0.0009059661,0.00026284906,0.0029579846,0.00009203733,0.000091863716,0.00003216683,0.000020352269,0.0005326631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892175,0.000022400985,0.00018137094,0.00033575995,0.00026850193,0.00027019694],"domain_scores_gemma":[0.9994504,0.000017283608,0.00004984024,0.00027958277,0.00005185427,0.0001510505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006653577,0.00018654391,0.0002730898,0.00009305775,0.00006222272,0.0000054381394,0.00007676863,0.00068426575,0.00071267603],"category_scores_gemma":[0.000013618855,0.00013435243,0.00011897482,0.00021768117,0.000027550934,0.00005752342,0.000020514106,0.0004883106,0.000026408285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053739236,0.008812851,0.42110932,0.00033404585,0.0009777095,0.0017648919,0.0260179,0.0000045163097,0.020065777,0.0011160788,0.16617231,0.3482507],"study_design_scores_gemma":[0.015419146,0.0014711305,0.51153225,0.0006063883,0.00034882274,0.00015825912,0.00026747724,0.00015452427,0.23789504,0.0002041424,0.23141752,0.0005252802],"about_ca_topic_score_codex":0.00043641735,"about_ca_topic_score_gemma":0.00020657694,"teacher_disagreement_score":0.3477254,"about_ca_system_score_codex":0.00071372604,"about_ca_system_score_gemma":0.00024119174,"threshold_uncertainty_score":0.7803303},"labels":[],"label_agreement":null},{"id":"W2163450464","doi":"10.1200/jco.2014.59.2139","title":"Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20<sup>+</sup> Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"BC Cancer Agency; Weill Cornell Medical College; Houston Methodist Research Institute; Università di Bologna; Queen's University; National Cancer Institute; University of Rochester; University of Toronto; Memorial Sloan-Kettering Cancer Center; F. Hoffmann-La Roche; Sveučilište u Zagrebu; Pharmacyclics; Genentech; Università degli Studi del Piemonte Orientale; Celgene","keywords":"Obinutuzumab; Medicine; Rituximab; CD20; Lymphoma; Internal medicine; Oncology; Nuclear medicine","score_opus":0.10196309160295615,"score_gpt":0.4113322242863002,"score_spread":0.30936913268334404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163450464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621934,0.00010019713,0.00003288555,0.00045206893,0.00036779325,0.0022184106,0.000006560491,0.000005809972,0.0005969648],"genre_scores_gemma":[0.9987317,0.000028525255,0.00059274543,0.0002749185,0.00022474074,0.00005941674,0.000010783662,0.00002191421,0.000055277196],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99228823,0.0018823578,0.0039015112,0.0003701227,0.0012178705,0.00033990483],"domain_scores_gemma":[0.9921346,0.0025185712,0.0035811355,0.00050134317,0.0008193961,0.00044500025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005759041,0.00032612105,0.005766459,0.00044326193,0.00007462882,0.00001535731,0.00032273066,0.00026293632,0.000028973765],"category_scores_gemma":[0.0016756671,0.00015374029,0.0010418937,0.00088187185,0.00037734062,0.00012015989,0.00013923984,0.0005577585,0.0000032299297],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5811405,0.09005007,0.31850636,0.000008015765,0.00390182,0.00027119182,0.0009518921,0.0011974307,1.9800451e-7,0.0000031375055,0.00018739811,0.003782],"study_design_scores_gemma":[0.7151914,0.08914223,0.18173993,0.00012657653,0.010635556,0.000015672527,0.0005510519,0.0022970983,0.00001189501,0.0000071458194,0.00016619927,0.00011519402],"about_ca_topic_score_codex":0.0002740895,"about_ca_topic_score_gemma":0.00022853032,"teacher_disagreement_score":0.13676642,"about_ca_system_score_codex":0.0010147598,"about_ca_system_score_gemma":0.0038948096,"threshold_uncertainty_score":0.6909225},"labels":[],"label_agreement":null},{"id":"W2163510906","doi":"10.1093/annonc/mdh392","title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","year":2004,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; CHOP; Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Internal medicine; International Prognostic Index; T-cell lymphoma; Oncology; Not Otherwise Specified; Chemotherapy; B symptoms; Gastroenterology; Pathology; Diffuse large B-cell lymphoma; T cell; Immunology","score_opus":0.051622763006591105,"score_gpt":0.3209718690295545,"score_spread":0.26934910602296336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163510906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114186,0.0000854655,0.00004934787,0.0056150625,0.000043757726,0.00025490983,0.000016414178,0.000007018111,0.0027861758],"genre_scores_gemma":[0.99849564,0.00044168526,0.000062779654,0.00077581126,0.000024707966,0.00003825401,0.000115605784,0.0000054172124,0.00004009025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993379,0.00004613835,0.00027417048,0.0001225187,0.000103394086,0.00011585704],"domain_scores_gemma":[0.9994372,0.000023451652,0.00026258704,0.00014249815,0.000099890465,0.00003437002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007985114,0.000073919975,0.00025999316,0.00006004321,0.000023138553,0.0000027438994,0.000048742415,0.000043628326,0.0000074705326],"category_scores_gemma":[0.000024818042,0.000052782878,0.00004949084,0.00025334652,0.000194506,0.00005551332,0.000011273604,0.000032934702,0.0000029415796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005243928,0.0076173805,0.46702665,0.0000559941,0.00006926324,0.000019561332,0.0018228149,0.00003593396,0.3180526,0.0012720107,0.00030612195,0.2031973],"study_design_scores_gemma":[0.0022793896,0.0024674537,0.8952154,0.000028497572,0.000025700278,0.000010802456,0.00011579256,0.000026452037,0.090839855,0.000018412276,0.008927866,0.00004440953],"about_ca_topic_score_codex":0.0006456764,"about_ca_topic_score_gemma":0.0004185402,"teacher_disagreement_score":0.42818874,"about_ca_system_score_codex":0.00020042113,"about_ca_system_score_gemma":0.0002335688,"threshold_uncertainty_score":0.21524233},"labels":[],"label_agreement":null},{"id":"W2163637450","doi":"10.1016/j.jacr.2011.01.009","title":"ACR Appropriateness Criteria® on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II","year":2011,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"ABVD; Procarbazine; Medicine; Vinblastine; Dacarbazine; Vincristine; Bleomycin; Oncology; Radiation therapy; Chemotherapy; Internal medicine; Lymphoma; Stage (stratigraphy); Prednisone; Etoposide; Hodgkin's lymphoma; Regimen; Cyclophosphamide","score_opus":0.04438669332646841,"score_gpt":0.3219333325211303,"score_spread":0.27754663919466194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163637450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957826,0.00039707124,0.000013427424,0.001736297,0.00056426565,0.00019917345,0.000041551328,0.000005748069,0.0012598546],"genre_scores_gemma":[0.99505574,0.00084961223,0.0024018723,0.0010577008,0.00020711315,0.000004864661,5.4956195e-7,0.000016477308,0.00040608674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834996,0.00035275586,0.00069868757,0.00018359577,0.00019618106,0.00021883156],"domain_scores_gemma":[0.9979171,0.00027808905,0.0011145152,0.00036404683,0.00015492894,0.00017133115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006734897,0.0001643751,0.0010610019,0.00011904681,0.00009488419,0.0000029808814,0.0002280738,0.00007352399,0.00006236345],"category_scores_gemma":[0.00022386508,0.00009044376,0.00029652723,0.00019858648,0.0007374743,0.000045290013,0.000105051025,0.00013024996,0.000002216098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01858506,0.008402142,0.8695433,0.00012652346,0.0031380514,0.0031479148,0.0011774545,0.000010355743,0.003542234,0.004622104,0.038013555,0.049691297],"study_design_scores_gemma":[0.007959851,0.01721641,0.95146924,0.00015452421,0.00048602652,0.006276853,0.0007929572,0.000038601815,0.0041942345,0.0003521144,0.010906468,0.00015272017],"about_ca_topic_score_codex":0.00008913672,"about_ca_topic_score_gemma":0.000004128238,"teacher_disagreement_score":0.08192593,"about_ca_system_score_codex":0.000103191356,"about_ca_system_score_gemma":0.00029567484,"threshold_uncertainty_score":0.36881894},"labels":[],"label_agreement":null},{"id":"W2163693301","doi":"10.1093/annonc/mdl302","title":"Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials","year":2006,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Confidence interval; Radiation therapy; Internal medicine; Breast cancer; Odds ratio; Chemoradiotherapy; Chemotherapy; Clinical trial; Lymphoma; Cancer; Oncology; Nuclear medicine","score_opus":0.34287321402057147,"score_gpt":0.45399459057918434,"score_spread":0.11112137655861287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163693301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035112647,0.98664314,0.0000014316367,0.00016515361,0.00007567578,0.0033007984,0.0027876643,0.000010042583,0.0035048064],"genre_scores_gemma":[0.009072587,0.9882509,0.00006639612,0.00006509537,0.00004281807,0.00083426986,0.0005137909,0.000041856925,0.0011122753],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99251646,0.0031588706,0.0030181871,0.0005044332,0.00046771008,0.00033432123],"domain_scores_gemma":[0.98425573,0.0059774695,0.008155243,0.000992205,0.0005193174,0.000100021185],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0020318641,0.00065312017,0.022692857,0.00056747516,0.000048085327,0.0000049423143,0.00022934037,0.0005928964,0.0007337603],"category_scores_gemma":[0.00070901454,0.00027718404,0.013776506,0.0012315086,0.0002689844,0.000023191345,0.000040077433,0.00006928162,0.0000028772529],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009817369,0.0066820495,0.00037742997,0.0010022398,0.66794467,0.00006537015,0.000068263194,0.000007957264,7.1475597e-7,0.000032048967,0.0013361594,0.32150137],"study_design_scores_gemma":[0.022665234,0.003897176,0.0016705497,0.00044071497,0.67051566,0.000012226722,0.000006769968,0.0000010104427,0.0002853011,0.000014854912,0.30034858,0.00014195808],"about_ca_topic_score_codex":0.0006564302,"about_ca_topic_score_gemma":0.00061591604,"teacher_disagreement_score":0.32135943,"about_ca_system_score_codex":0.00032700924,"about_ca_system_score_gemma":0.0015240264,"threshold_uncertainty_score":0.99996805},"labels":[],"label_agreement":null},{"id":"W2163769934","doi":"10.1007/978-0-387-73744-7_10","title":"Rare B-cell Lymphomas: Primary Mediastinal, Intravascular, and Primary Effusion Lymphoma","year":2007,"lang":"en","type":"review","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Primary effusion lymphoma; Pathology; Medicine; Diffuse large B-cell lymphoma","score_opus":0.0330513073485168,"score_gpt":0.2995138057238169,"score_spread":0.2664624983753001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163769934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038235294,0.9407166,0.000018451206,0.000045505876,0.00038477124,0.002341707,0.00004312336,0.00022207537,0.055845365],"genre_scores_gemma":[0.000028892546,0.9910399,0.0023931942,0.00092507986,0.0005436575,0.0002794172,0.001661486,0.00017863566,0.002949745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955911,0.00015445398,0.0012508897,0.0012612861,0.00095106516,0.0007912078],"domain_scores_gemma":[0.9969068,0.0007240145,0.00043266066,0.0010504108,0.00013572509,0.0007503963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052197574,0.0012194713,0.0039821137,0.00056260865,0.00016768683,0.000084125655,0.00024720412,0.000905226,0.0004199792],"category_scores_gemma":[0.00006423172,0.00081125007,0.0010886505,0.0005064308,0.00020394033,0.00011271631,0.00040411897,0.00021841621,0.00036843642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005503728,0.0015527299,0.00023881208,0.04263589,0.00047331557,0.0018403868,0.000038034872,1.4983708e-8,0.0000015051213,0.00004438882,0.0057191714,0.9474007],"study_design_scores_gemma":[0.00649345,0.00046465293,0.0022799645,0.01932545,0.0054803644,0.0034806628,0.000019847235,0.000001568644,0.000022719432,0.0000057225325,0.96168274,0.00074286613],"about_ca_topic_score_codex":0.00008345706,"about_ca_topic_score_gemma":0.0000043560613,"teacher_disagreement_score":0.95596355,"about_ca_system_score_codex":0.0017318957,"about_ca_system_score_gemma":0.0015926514,"threshold_uncertainty_score":0.9994338},"labels":[],"label_agreement":null},{"id":"W2163799862","doi":"10.5539/cco.v1n2p1","title":"Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature","year":2012,"lang":"en","type":"review","venue":"Cancer and Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CD20; Rituximab; B cell; Lymphoma; Medicine; Immunohistochemistry; Radiation therapy; Non-Hodgkin's lymphoma; Cancer research; Antibody; Oncology; Immunology; Internal medicine","score_opus":0.09081503101938194,"score_gpt":0.46758822064884525,"score_spread":0.3767731896294633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163799862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031002294,0.9957425,5.6556314e-7,0.00046688772,0.0006480564,0.0021776273,0.00026234656,0.000004801645,0.00038718464],"genre_scores_gemma":[0.0005778706,0.99495965,0.00012099249,0.002011916,0.00053540623,0.0014297126,0.000051779673,0.00002743353,0.00028525808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977986,0.00027806865,0.0012403679,0.0003414822,0.00013882935,0.00020265002],"domain_scores_gemma":[0.9972431,0.0010766862,0.0008893223,0.00047465521,0.00017445056,0.00014177705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048941304,0.00028751956,0.0033998992,0.00002990854,0.000024027699,0.000003096037,0.0001435143,0.0006504019,0.00016027752],"category_scores_gemma":[0.00010047582,0.00012917515,0.0014092855,0.00013657204,0.00023614046,0.000023401877,0.00008141739,0.00021207544,0.0000025589884],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030260062,0.0024624704,0.0017754094,0.098695494,0.00028453008,0.0000081249655,0.000033698176,4.7572923e-10,1.9329039e-7,0.000013967802,0.002373914,0.8940496],"study_design_scores_gemma":[0.006098605,0.0010090771,0.0007929996,0.14198549,0.003566469,0.000028171153,0.0000021371784,4.1426468e-8,0.000013541134,0.000013590567,0.8463918,0.000098052435],"about_ca_topic_score_codex":0.0000065536155,"about_ca_topic_score_gemma":0.0000028036866,"teacher_disagreement_score":0.89395154,"about_ca_system_score_codex":0.00014655017,"about_ca_system_score_gemma":0.0010332722,"threshold_uncertainty_score":0.526761},"labels":[],"label_agreement":null},{"id":"W2163976592","doi":"10.1182/blood-2011-02-335216","title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; T-cell lymphoma; Peripheral T-cell lymphoma; Pathology; Enteropathy; Internal medicine; T cell; Immunology; Immune system; Disease","score_opus":0.043460758850315515,"score_gpt":0.2700865285249623,"score_spread":0.22662576967464676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163976592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881588,0.0011144173,0.00000274055,0.00038094775,0.0004305618,0.00038991077,0.00006290769,0.00007996496,0.009379752],"genre_scores_gemma":[0.99683034,0.00041097854,0.000570053,0.0011532264,0.00020075282,0.000075402124,0.00009452886,0.000023987803,0.0006406973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836034,0.00011627746,0.00044578215,0.0004941501,0.00029851592,0.00028493293],"domain_scores_gemma":[0.9991328,0.00022320737,0.00014445596,0.00029327968,0.00006934107,0.00013687664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002528546,0.00024340083,0.0003980907,0.000038044418,0.00012058377,0.00004689046,0.00022847642,0.00020200244,0.0002135029],"category_scores_gemma":[0.00014172502,0.0001502616,0.00022465493,0.00007604793,0.00019663422,0.00006186186,0.0001574747,0.00008143511,0.00006197374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002740493,0.016960805,0.9744681,0.000006086561,0.0003228916,0.0004367256,0.0009877125,5.436911e-9,0.00027395407,0.00004092611,0.0031116533,0.003117062],"study_design_scores_gemma":[0.037034888,0.00089729886,0.95266235,0.000050631428,0.0006433174,0.0001070827,0.00023353932,0.00003325629,0.0036109122,0.000067474764,0.0044796667,0.00017960934],"about_ca_topic_score_codex":0.0008180603,"about_ca_topic_score_gemma":0.0000506729,"teacher_disagreement_score":0.03676084,"about_ca_system_score_codex":0.00015073594,"about_ca_system_score_gemma":0.00017210015,"threshold_uncertainty_score":0.61274904},"labels":[],"label_agreement":null},{"id":"W2163990748","doi":"10.1182/blood-2005-04-1399","title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Comparative genomic hybridization; Biology; Gene expression profiling; Lymphoma; Gene dosage; Cancer research; Germinal center; Gene; Locus (genetics); Gene expression; Large-cell lymphoma; Chromosomal region; Genetics; B cell; Chromosome; Immunology","score_opus":0.007700153296512909,"score_gpt":0.23287804211083285,"score_spread":0.22517788881431994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163990748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969304,0.001437505,0.00007785689,0.00014659365,0.000101479876,0.00066901004,0.00034123717,0.00010633834,0.00018956764],"genre_scores_gemma":[0.99727595,0.00009920245,0.0016062915,0.00024561715,0.00024546645,0.00026083045,0.00016379592,0.000033470944,0.000069367576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851555,0.000071529925,0.00028206786,0.00052105857,0.0002057515,0.0004040532],"domain_scores_gemma":[0.99903977,0.0001367496,0.00013531891,0.0003905154,0.000063074855,0.00023456367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010013468,0.0002773445,0.00034489395,0.00008041643,0.0001419028,0.000031668616,0.00008439357,0.00012376456,0.000028089182],"category_scores_gemma":[0.000054994376,0.0002048587,0.00009104608,0.000062561536,0.000098228535,0.00006815546,0.000070222195,0.00006083489,0.000023656961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010986384,0.009055571,0.94555926,0.00007425121,0.00005760763,0.00009235246,0.00007238956,0.0000015567359,0.043150306,0.000010354063,0.00003376496,0.0017827415],"study_design_scores_gemma":[0.02483484,0.0004624357,0.66012055,0.000056190263,0.00025746014,0.000047133457,0.000026500504,0.00038508096,0.31323916,0.000011318268,0.0004190416,0.0001402966],"about_ca_topic_score_codex":0.000102716105,"about_ca_topic_score_gemma":0.00004183446,"teacher_disagreement_score":0.2854387,"about_ca_system_score_codex":0.000081779974,"about_ca_system_score_gemma":0.0001210549,"threshold_uncertainty_score":0.83538955},"labels":[],"label_agreement":null},{"id":"W2164526402","doi":"10.1093/annonc/mdu387","title":"Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Refractory (planetary science); Chemotherapy; Lymphoma; Transplantation; Oncology; Surgery; Cohort; Chemotherapy regimen; Gastroenterology","score_opus":0.026469964237844316,"score_gpt":0.30107362316226977,"score_spread":0.27460365892442545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164526402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899885,0.0007620228,0.000048017577,0.007845144,0.000041119558,0.00043752568,0.00004499001,0.000021061036,0.0008116353],"genre_scores_gemma":[0.9927468,0.0026240204,0.0014457953,0.0027659182,0.000038303366,0.0000770314,0.00004171123,0.00001961132,0.00024083476],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991818,0.00004888905,0.00021292616,0.00026176946,0.0001009107,0.00019367423],"domain_scores_gemma":[0.9991322,0.0003431381,0.00016841448,0.00015982064,0.00009173407,0.00010469049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017132814,0.00014951806,0.00047554044,0.000062221676,0.00004893632,0.0000057840502,0.000035729976,0.00014022665,0.0000070553456],"category_scores_gemma":[0.000009952091,0.00011256659,0.000039648556,0.000049991726,0.00014510196,0.000040614297,0.000005662211,0.00003264524,4.1562416e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016165875,0.003128456,0.04724083,0.0012784628,0.00052024244,0.00019295813,0.0028596455,0.0000035872451,0.01684688,0.0029358251,0.0043216,0.9045056],"study_design_scores_gemma":[0.03175462,0.017180081,0.8341218,0.00012471004,0.000287742,0.00019297352,0.00011993275,0.000044128636,0.08213143,0.00033683592,0.033491064,0.00021468764],"about_ca_topic_score_codex":0.00017244522,"about_ca_topic_score_gemma":0.00017817282,"teacher_disagreement_score":0.904291,"about_ca_system_score_codex":0.00005176265,"about_ca_system_score_gemma":0.00012558387,"threshold_uncertainty_score":0.45903322},"labels":[],"label_agreement":null},{"id":"W2164571519","doi":"10.1002/hon.2251","title":"Concomitant high expression of Toll‐like receptor (TLR) and B‐cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Calgary Laboratory Services; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation; Calgary Laboratory Services","keywords":"breakpoint cluster region; Cancer research; Syk; Biology; B-cell receptor; Mantle cell lymphoma; Toll-like receptor; Signal transduction; TLR7; Bruton's tyrosine kinase; TLR9; Receptor; Immunology; B cell; Gene expression; Cell biology; Innate immune system; Immune system; Gene; Lymphoma; Genetics; Tyrosine kinase; Antibody","score_opus":0.08521364045476884,"score_gpt":0.3416249336855472,"score_spread":0.2564112932307784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164571519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042296,0.0017019958,0.00013900826,0.0038882524,0.00022644085,0.00062369445,0.000025131956,0.000050175746,0.0029223158],"genre_scores_gemma":[0.9820789,0.0007447392,0.016132604,0.00061522453,0.000061349514,0.00015850407,0.00006105186,0.000018938272,0.00012868947],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757516,0.00033490642,0.0009924083,0.00054989936,0.00019307104,0.0003545662],"domain_scores_gemma":[0.99764395,0.0011432427,0.0003401678,0.0003127962,0.00014229085,0.00041753697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004625045,0.00024167173,0.0011336945,0.00009676503,0.00006124521,0.000012655882,0.00013765866,0.0005357831,0.00016747709],"category_scores_gemma":[0.00025345525,0.00016923543,0.00014299556,0.00015571663,0.00037282938,0.000046408517,0.0001591116,0.00015752592,0.000104828054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041113687,0.03332616,0.7193285,0.00044476087,0.00014421853,0.0011332238,0.00095592387,0.000019538902,0.15339519,0.010807641,0.05957221,0.016761228],"study_design_scores_gemma":[0.07926635,0.01762091,0.16220824,0.0007994767,0.00057903427,0.0010064323,0.002030469,0.0003703533,0.5883537,0.0050028097,0.14155237,0.0012098463],"about_ca_topic_score_codex":0.000057683712,"about_ca_topic_score_gemma":0.000014028213,"teacher_disagreement_score":0.55712026,"about_ca_system_score_codex":0.00026630593,"about_ca_system_score_gemma":0.000391123,"threshold_uncertainty_score":0.690122},"labels":[],"label_agreement":null},{"id":"W2164572104","doi":"10.1136/jclinpath-2012-201417","title":"T-cell clonality is detected in a high frequency among patients with incidental lymphocytosis by PCR assays for <i>TCR</i> gene rearrangements","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Lymphocytosis; Immunophenotyping; T-cell receptor; Gene rearrangement; Biology; Immunology; CD8; Molecular biology; Pathology; T cell; Virology; Medicine; Antigen; Gene; Genetics; Immune system","score_opus":0.02161864181639766,"score_gpt":0.30497064783186717,"score_spread":0.2833520060154695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164572104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764705,0.00025195433,0.00007889887,0.0006122149,0.00034147428,0.000816777,0.00009629948,0.000009442376,0.00014592003],"genre_scores_gemma":[0.9930235,0.00018381755,0.0045328024,0.0018759753,0.00015880527,0.00008569056,0.000057571004,0.000027601798,0.000054246568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968902,0.000268312,0.0017155164,0.0003378667,0.00043303077,0.0003550641],"domain_scores_gemma":[0.9972437,0.0005481256,0.0010578289,0.0002673537,0.0005591138,0.0003238759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008232385,0.00022633105,0.0010069008,0.0001194065,0.000046386358,0.000019156485,0.00015775638,0.0003020264,0.0001695195],"category_scores_gemma":[0.00049131527,0.00015180242,0.00029419674,0.00015607808,0.00016331128,0.00018279564,0.00004670312,0.0002680632,0.000025295954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086528517,0.0037612023,0.98351,0.000026906326,0.00016102931,0.00025870395,0.000054028777,4.86199e-7,0.0009248565,0.0000019005496,0.0065169455,0.00391865],"study_design_scores_gemma":[0.030946413,0.0044252025,0.96129084,0.00009202704,0.000288946,0.00006716532,0.00002116095,0.000007951624,0.0023520063,0.00023842865,0.00013112268,0.00013876733],"about_ca_topic_score_codex":0.00038029207,"about_ca_topic_score_gemma":0.000042191074,"teacher_disagreement_score":0.030081129,"about_ca_system_score_codex":0.00027993147,"about_ca_system_score_gemma":0.00022489588,"threshold_uncertainty_score":0.6190323},"labels":[],"label_agreement":null},{"id":"W2164606502","doi":"10.1158/0008-5472.can-04-4108","title":"Alteration of <i>SMRT</i> Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Lymphoma; Biology; Suppressor; Tumor suppressor gene; Gene; Genetics; Carcinogenesis; Immunology","score_opus":0.049118236942208834,"score_gpt":0.38808283325512605,"score_spread":0.3389645963129172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164606502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915955,0.0008524885,0.000025743419,0.0034099757,0.000080224774,0.0007457357,0.000021812699,0.000013746749,0.0032547414],"genre_scores_gemma":[0.9980324,0.0003941694,0.00008797109,0.00019889946,0.00023219683,0.00060456264,0.000029460793,0.000017303395,0.0004030604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985397,0.00006565542,0.0002742843,0.00024795017,0.0005267403,0.00034565636],"domain_scores_gemma":[0.99936134,0.00009321148,0.000031828044,0.00022035291,0.00018099816,0.00011224897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040237652,0.000100496065,0.00023815081,0.0002524977,0.000048858765,0.000015997119,0.00006714604,0.000056001867,0.00052601326],"category_scores_gemma":[0.000032189408,0.00008112441,0.0000662619,0.00038838136,0.00007764851,0.00013349735,0.000016700973,0.00012329257,0.000045878693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054258374,0.003426551,0.18287763,0.0007526862,0.00023311048,0.00015386703,0.0034975633,0.00042794968,0.5905935,0.0008115657,0.017582063,0.19421765],"study_design_scores_gemma":[0.008556245,0.00076080754,0.23487519,0.0003412244,0.000038986134,0.000013267288,0.00014789127,0.000574548,0.7391496,0.000066634006,0.0153759,0.00009975058],"about_ca_topic_score_codex":0.0013071012,"about_ca_topic_score_gemma":0.00092546805,"teacher_disagreement_score":0.1941179,"about_ca_system_score_codex":0.00072322576,"about_ca_system_score_gemma":0.00045087968,"threshold_uncertainty_score":0.57594764},"labels":[],"label_agreement":null},{"id":"W2164900174","doi":"10.1200/jco.2012.43.4803","title":"Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"ABVD; Medicine; Dacarbazine; Internal medicine; Vinblastine; Clinical endpoint; Regimen; Hazard ratio; Oncology; Randomized controlled trial; Surgery; Chemotherapy; Vincristine; Confidence interval","score_opus":0.10115284983228293,"score_gpt":0.4710100978370195,"score_spread":0.3698572480047366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164900174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933804,0.0011935591,0.00029404042,0.000814479,0.0009689992,0.0031624287,0.000007463873,0.000007221969,0.00017135718],"genre_scores_gemma":[0.9961233,0.002208088,0.00036438226,0.00065727194,0.0003720385,0.00013417935,0.0000112605185,0.000023136605,0.00010634134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99356,0.0029160022,0.0025781505,0.00026514,0.00037109863,0.00030958626],"domain_scores_gemma":[0.9898547,0.0064298785,0.002579922,0.00023234125,0.00056077325,0.0003423881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00547649,0.00028027286,0.0033672277,0.00013824803,0.00005607937,0.000017681821,0.00015198607,0.00028608463,0.000029111487],"category_scores_gemma":[0.001866011,0.0001291992,0.00022983497,0.0002037231,0.0005120072,0.0004242623,0.000042734773,0.00038287637,9.600788e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6848746,0.027884712,0.014439757,0.0000043494574,0.0012874046,0.00025989383,0.0019268787,0.0000049113646,0.000031416082,0.00003259741,0.000073307994,0.26918018],"study_design_scores_gemma":[0.738669,0.24793047,0.0045858733,0.000055175427,0.0006491664,0.00010282461,0.00523291,0.00022764123,0.00006766918,0.00000452223,0.002372566,0.00010218048],"about_ca_topic_score_codex":0.000188951,"about_ca_topic_score_gemma":0.0006127618,"teacher_disagreement_score":0.26907802,"about_ca_system_score_codex":0.00042890993,"about_ca_system_score_gemma":0.0012931284,"threshold_uncertainty_score":0.526859},"labels":[],"label_agreement":null},{"id":"W2165207421","doi":"10.1182/blood-2008-05-154013","title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Cancer Research UK","keywords":"International Prognostic Index; Follicular lymphoma; Internal medicine; Lymphoma; Oncology; Mutation; Multivariate analysis; Medicine; Biology; Immunology; Pathology; Diffuse large B-cell lymphoma; Gene; Genetics","score_opus":0.005409346239000455,"score_gpt":0.21239328898450696,"score_spread":0.2069839427455065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165207421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814695,0.00080240675,0.0000015084605,0.0000831291,0.000021913009,0.00080952194,0.00010603119,0.000009459107,0.000019065334],"genre_scores_gemma":[0.9991891,0.0003178711,0.0001853693,0.000010281209,0.000011830527,0.00016506878,0.00007277216,0.000013012761,0.00003469588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884826,0.00006166891,0.00026596303,0.000206268,0.0004892716,0.00012858315],"domain_scores_gemma":[0.9990461,0.00019204256,0.00021021314,0.00026947,0.0001588261,0.0001233853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077495366,0.00012515581,0.00028138142,0.000046411595,0.00008948211,0.0000055562173,0.00005767142,0.000031807023,0.000015425827],"category_scores_gemma":[0.00011645955,0.00007056957,0.000066843844,0.00011035498,0.00013226789,0.000054213502,0.000069558046,0.000013534194,0.0000023906857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010112252,0.0033177487,0.99137133,0.00007849991,0.0003046561,0.000051233088,0.00024933595,0.000005084096,0.00021620184,0.000023651086,0.000071035975,0.0033000119],"study_design_scores_gemma":[0.007226294,0.0010748926,0.96706164,0.00025627718,0.00071190915,0.0000035980308,0.000012299509,0.000015713118,0.023523748,0.000022356033,0.000021828717,0.00006941783],"about_ca_topic_score_codex":0.00031577653,"about_ca_topic_score_gemma":0.000024814184,"teacher_disagreement_score":0.02430965,"about_ca_system_score_codex":0.000025602461,"about_ca_system_score_gemma":0.000038841998,"threshold_uncertainty_score":0.28777438},"labels":[],"label_agreement":null},{"id":"W2165278034","doi":"10.3899/jrheum.080805","title":"Drs. Thompson and Graydon reply","year":2009,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reprint; Family medicine; Library science; Gerontology; Pediatrics","score_opus":0.01063521730890547,"score_gpt":0.26275487748664933,"score_spread":0.25211966017774384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165278034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96816033,0.0037016554,0.000020763506,0.027080096,0.000108077584,0.00006194019,2.8633687e-7,0.0000063195785,0.00086054776],"genre_scores_gemma":[0.9940469,0.0042589926,0.00026585168,0.001341763,0.000010929779,3.7514275e-7,3.5344706e-7,0.000003654258,0.000071154085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994168,0.000060111626,0.00025643568,0.00005007741,0.00010466329,0.00011190121],"domain_scores_gemma":[0.99940825,0.00013912062,0.00019117963,0.00013087009,0.0000572817,0.00007327548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002769546,0.00007071857,0.00029751332,0.000054417058,0.00004718404,0.0000056231675,0.000054515724,0.000035219276,0.000029642455],"category_scores_gemma":[0.00007239948,0.00003517396,0.00005561978,0.00004751088,0.000053803273,0.000033786087,0.000009880728,0.00009338587,0.000007381215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001103175,0.00053210167,0.88916403,0.000028709517,0.00029182926,0.00021635169,0.0014122087,0.0000028182453,0.00063240837,0.00459926,0.023389084,0.078628026],"study_design_scores_gemma":[0.005660118,0.0033780162,0.8588968,0.00029734612,0.00044487033,0.11042224,0.00036413796,0.00003341226,0.0016118168,0.0038069743,0.014985487,0.000098794524],"about_ca_topic_score_codex":0.00003953123,"about_ca_topic_score_gemma":0.000003852939,"teacher_disagreement_score":0.11020589,"about_ca_system_score_codex":0.000027227636,"about_ca_system_score_gemma":0.000043485576,"threshold_uncertainty_score":0.14343525},"labels":[],"label_agreement":null},{"id":"W2165548890","doi":"10.1182/asheducation-2005.1.299","title":"Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas","year":2005,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hematopathology; Mantle cell lymphoma; Lymphoma; Fluorescence in situ hybridization; Comparative genomic hybridization; Biology; Gene expression profiling; Pathology; Microarray; Computational biology; Bioinformatics; Cytogenetics; Medicine; Gene; Immunology; Gene expression; Genetics; Genome","score_opus":0.07562158559383968,"score_gpt":0.2638788042271999,"score_spread":0.1882572186333602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165548890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422444,0.0043154806,0.000029060515,0.0070386073,0.00004784495,0.0007424149,0.00000799419,0.000047499714,0.0035466412],"genre_scores_gemma":[0.99084055,0.00031329406,0.0070762993,0.00083430106,0.000044840635,0.0007774618,0.000009706517,0.000021766444,0.000081793754],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998701,0.000051652627,0.0003945029,0.0003978164,0.00013698904,0.00031803868],"domain_scores_gemma":[0.9991845,0.00015585405,0.00010917576,0.00029209637,0.00004037287,0.00021801882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111260255,0.00020340316,0.00069343444,0.00018113558,0.00004060439,0.000005809661,0.00006843886,0.00015993629,0.00009602005],"category_scores_gemma":[0.00005277277,0.00016366989,0.00009755809,0.00015492793,0.000121558405,0.000036833775,0.00010636738,0.00005249727,0.00008744949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011070536,0.0030019258,0.95662266,0.00035869077,0.000083684,0.00016002133,0.0010583486,0.000002630733,0.00020697429,0.014645849,0.0017216516,0.022026855],"study_design_scores_gemma":[0.009187882,0.0020839057,0.32079852,0.00032880576,0.0005337215,0.0051742513,0.0005461819,0.00010366094,0.64278877,0.0003294504,0.01767453,0.00045032095],"about_ca_topic_score_codex":0.000021990112,"about_ca_topic_score_gemma":0.000020366737,"teacher_disagreement_score":0.6425818,"about_ca_system_score_codex":0.000065187975,"about_ca_system_score_gemma":0.000062193845,"threshold_uncertainty_score":0.66742647},"labels":[],"label_agreement":null},{"id":"W2165807556","doi":"10.3109/10428194.2012.738365","title":"Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"Karolinska Institutet","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Anaplastic lymphoma kinase; Biology; Gene expression; Cancer research; STAT protein; Pathogenesis; Gene expression profiling; Real-time polymerase chain reaction; Lymph node; STAT3; Gene; Pathology; Immunology; Medicine; Genetics","score_opus":0.0033394312183381014,"score_gpt":0.18860214547219378,"score_spread":0.18526271425385568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165807556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156153,0.004881435,0.000011034908,0.000057094687,0.00041332797,0.0018458236,0.00021064052,0.000307862,0.0007112594],"genre_scores_gemma":[0.9947819,0.0013059571,0.00009294822,0.001363835,0.00034102684,0.00054003124,0.00075486995,0.00024781984,0.0005715785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416286,0.0002637792,0.0010175676,0.0014856007,0.0010728446,0.0019973225],"domain_scores_gemma":[0.9956044,0.00039035722,0.00052120915,0.0011499115,0.0002179159,0.0021162126],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00023520929,0.001542793,0.001534957,0.0006692991,0.00048566642,0.00021037467,0.000276271,0.0007226148,0.000047665606],"category_scores_gemma":[0.000071685936,0.0011858372,0.00028881815,0.0004946944,0.00036988934,0.0007314361,0.00040403812,0.00019092439,0.00003978928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032375294,0.016878368,0.9564663,0.00068286515,0.00034579026,0.0007927242,0.0010789384,0.000014992856,0.0016411708,0.00014031588,0.0006677117,0.01805328],"study_design_scores_gemma":[0.13785282,0.00063976616,0.84119165,0.0004889173,0.00067558023,0.00012372933,0.00018287444,0.00042998302,0.015057006,0.00004640589,0.0021173365,0.0011939539],"about_ca_topic_score_codex":0.0009881336,"about_ca_topic_score_gemma":0.0001778514,"teacher_disagreement_score":0.13461529,"about_ca_system_score_codex":0.008260065,"about_ca_system_score_gemma":0.0016069266,"threshold_uncertainty_score":0.9997321},"labels":[],"label_agreement":null},{"id":"W2165963235","doi":"10.1182/asheducation-2004.1.184","title":"Hodgkin’s Lymphoma: Evolving Concepts with Implications for Practice","year":2004,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Lymphoma; Medicine; Positron emission tomography; Cancer; Disease; Minimal residual disease; Carcinogenesis; Pathology; Immunology; Leukemia; Nuclear medicine; Internal medicine","score_opus":0.056111468349698504,"score_gpt":0.41787268242676945,"score_spread":0.36176121407707096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165963235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022478052,0.99238175,0.00034607216,0.0015251084,0.000113201124,0.0025908812,0.00007953285,0.00008936662,0.0028718528],"genre_scores_gemma":[0.0001950469,0.9837489,0.010942684,0.0003789735,0.00010022901,0.003906639,0.00046537435,0.0000786434,0.00018350127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840474,0.00006400423,0.0004951232,0.0005537685,0.00010316888,0.00037917728],"domain_scores_gemma":[0.99721307,0.0012686745,0.00048346564,0.0006202438,0.00025617977,0.00015838801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009700468,0.00040228484,0.0020521958,0.00012516073,0.00012011264,0.000020639858,0.000116096286,0.00036764285,0.000043157474],"category_scores_gemma":[0.00034264236,0.0002645981,0.00037508295,0.00019816839,0.000110548506,0.00006777873,0.000037682243,0.00008404399,0.00013148143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006239495,0.0016128883,0.00022034334,0.031710535,0.001872079,0.00036692468,0.000085160296,1.3078687e-7,5.4411643e-8,0.10033763,0.006594558,0.8571373],"study_design_scores_gemma":[0.0029493743,0.00044229772,0.000086033324,0.011652036,0.0058362293,0.021101262,0.00002809809,3.187461e-7,0.0000024667436,0.00016353451,0.9575028,0.00023559168],"about_ca_topic_score_codex":0.00003058387,"about_ca_topic_score_gemma":0.000008826893,"teacher_disagreement_score":0.9509082,"about_ca_system_score_codex":0.0006646732,"about_ca_system_score_gemma":0.0018399111,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W2166580185","doi":"10.1016/j.ctrv.2006.10.005","title":"Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; Queen's University; Health Sciences Centre; McMaster University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; Oncology; Follicular lymphoma; Randomized controlled trial; Guideline; Hematology; Chemotherapy; Disease; Pathology","score_opus":0.09197429490376997,"score_gpt":0.43287013386808737,"score_spread":0.3408958389643174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166580185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042351326,0.9768231,6.1185347e-7,0.0006977932,0.000298138,0.020315936,0.0005339005,0.00004621231,0.00128007],"genre_scores_gemma":[7.143831e-7,0.9730473,0.0011326021,0.0031604853,0.00022620302,0.019983882,0.0010584113,0.00011092519,0.0012794689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99325323,0.0006669272,0.0036667872,0.0013765675,0.00040917378,0.0006272911],"domain_scores_gemma":[0.9951859,0.00067305774,0.0020238466,0.0014206776,0.00027553627,0.0004209545],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00057753816,0.0015356329,0.014066694,0.00024370567,0.00009031638,0.000055245328,0.0001861968,0.00042366964,0.00048418698],"category_scores_gemma":[0.00026781435,0.0008979009,0.0012813215,0.0005325541,0.00008357109,0.00007993036,0.00008039671,0.00022864003,0.00021758357],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017179302,0.0008332736,0.000108399436,0.46898928,0.0013838264,0.0006307019,0.0002144472,1.7674518e-8,5.559743e-9,0.0000025972386,0.0035017077,0.5243186],"study_design_scores_gemma":[0.0032086303,0.0001352866,0.00000921951,0.4251833,0.062304243,0.00020676914,0.000029337732,1.1121505e-7,2.2268135e-7,5.0388206e-7,0.508588,0.00033437123],"about_ca_topic_score_codex":0.15434998,"about_ca_topic_score_gemma":0.1042184,"teacher_disagreement_score":0.5239842,"about_ca_system_score_codex":0.017915985,"about_ca_system_score_gemma":0.0035372458,"threshold_uncertainty_score":0.9997392},"labels":[],"label_agreement":null},{"id":"W2167355583","doi":"10.1016/s1470-2045(11)70150-4","title":"Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Clinical endpoint; Lymphoma; Oncology; Clinical trial; Surgery; Multiple myeloma","score_opus":0.05732662351427194,"score_gpt":0.3184787071032654,"score_spread":0.2611520835889935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167355583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821003,0.00051513326,0.000059930262,0.001465771,0.0011806709,0.0060838205,0.00015903352,0.00019121476,0.008244143],"genre_scores_gemma":[0.99285215,0.00034882966,0.0025218602,0.001566708,0.0007664821,0.0013152901,0.00029729452,0.0001064519,0.00022491215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99495894,0.00085205864,0.0010842399,0.0010483387,0.00073331187,0.0013231253],"domain_scores_gemma":[0.99628,0.0011182881,0.00058689085,0.0012919554,0.00034129448,0.00038157066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010642748,0.0007844082,0.003546779,0.00029398763,0.00029026714,0.000042669217,0.00045092765,0.00049340783,0.0003710532],"category_scores_gemma":[0.0005033579,0.0004644581,0.00040338945,0.00063531904,0.00060744624,0.00022804402,0.00018785924,0.00045473513,0.0004482662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91673243,0.059008498,0.002743847,0.00006267176,0.0012893771,0.0037898624,0.0018420711,0.0000018793668,0.000013344057,0.0003510195,0.0029726925,0.011192287],"study_design_scores_gemma":[0.94974166,0.020688085,0.016196147,0.00018237712,0.0016967194,0.00017025678,0.00035865235,0.00013782225,0.00053549476,0.000089873865,0.009655544,0.0005473866],"about_ca_topic_score_codex":0.001230822,"about_ca_topic_score_gemma":0.0007687646,"teacher_disagreement_score":0.03832041,"about_ca_system_score_codex":0.001857334,"about_ca_system_score_gemma":0.0012453968,"threshold_uncertainty_score":0.9997807},"labels":[],"label_agreement":null},{"id":"W2167555906","doi":"10.1200/jco.2005.05.016","title":"State-of-the-Art Therapeutics: Hodgkin's Lymphoma","year":2005,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Dacarbazine; Bleomycin; Vinblastine; Disease; Chemotherapy; Lymphoma; Internal medicine; Oncology; Adverse effect; Regimen; Radiation therapy; Surgery; Intensive care medicine; Vincristine; Cyclophosphamide","score_opus":0.24525710644478751,"score_gpt":0.5256802401579725,"score_spread":0.28042313371318506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167555906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041901835,0.99074817,0.000005357728,0.0021561515,0.0024316148,0.00051703025,0.000014276148,0.0000060384828,0.0037023227],"genre_scores_gemma":[0.00027598202,0.99364436,0.0010601876,0.001870608,0.0018015361,0.000013249638,0.000004522545,0.000042899333,0.0012866388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99270266,0.0009635031,0.005236624,0.00024479447,0.0005699735,0.00028242654],"domain_scores_gemma":[0.9878857,0.0041858614,0.0066833072,0.0005133569,0.00040535245,0.00032643272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023594238,0.0003571139,0.00681086,0.00015479655,0.00003453244,0.000009031867,0.000435504,0.0007942741,0.00015151393],"category_scores_gemma":[0.00090972387,0.00016984071,0.0042406316,0.00020942416,0.0003087526,0.000049672602,0.000110729525,0.00075318373,0.00013000317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002638948,0.0035773874,0.0007586218,0.0007548652,0.0026962692,0.00040602707,0.00001530402,3.6000566e-7,4.210777e-8,0.000029035802,0.0070238984,0.9844743],"study_design_scores_gemma":[0.005399999,0.005672301,0.00460176,0.0055983164,0.008580249,0.001609031,0.000003941689,0.0000010765933,0.0000015772804,0.00007337919,0.96833104,0.00012735152],"about_ca_topic_score_codex":0.0000041504927,"about_ca_topic_score_gemma":0.0000119328315,"teacher_disagreement_score":0.9843469,"about_ca_system_score_codex":0.00064885616,"about_ca_system_score_gemma":0.008008186,"threshold_uncertainty_score":0.9976155},"labels":[],"label_agreement":null},{"id":"W2167849560","doi":"10.1002/hon.703","title":"Increasing incidence of non‐Hodgkin's lymphoma in Canada, 1970–1996: age–period–cohort analysis","year":2003,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"","keywords":"Incidence (geometry); Medicine; Cohort; Lymphoma; Non-Hodgkin's lymphoma; Cohort effect; Cancer registry; Demography; Hodgkin lymphoma; Cohort study; Cancer; Pediatrics; Internal medicine","score_opus":0.017368339432354163,"score_gpt":0.29223887590384456,"score_spread":0.2748705364714904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167849560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868458,0.0005350412,0.000028768352,0.00043451064,0.000084104744,0.0003825481,0.000005955376,0.000017180215,0.011666083],"genre_scores_gemma":[0.9956422,0.00012138698,0.0032928456,0.00075573666,0.000012627408,0.000109505716,0.00002213144,0.000009807458,0.000033760807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763966,0.00033809405,0.0007455726,0.00047314735,0.00033700903,0.0004665025],"domain_scores_gemma":[0.9983339,0.00071358803,0.00023520549,0.00038054213,0.00008750982,0.0002492991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047580304,0.00023823687,0.0016120052,0.00023830742,0.00005133771,0.00000633467,0.00012657249,0.0002483781,0.00041714843],"category_scores_gemma":[0.00073919236,0.00017591758,0.00021788213,0.00095342926,0.0001611539,0.00003760988,0.00006098693,0.00011161805,0.000015272743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016384608,0.0009465832,0.9848946,0.000035858913,0.00046079504,0.009126955,0.00007887744,0.00002560346,0.00029471377,0.0010563093,0.00015318453,0.002762726],"study_design_scores_gemma":[0.0024581135,0.00043694986,0.99028265,0.000052233147,0.0007670244,0.0015954621,0.00022832978,0.00017800854,0.0021916525,0.00009696433,0.0015507791,0.00016182206],"about_ca_topic_score_codex":0.57453704,"about_ca_topic_score_gemma":0.67184395,"teacher_disagreement_score":0.09730691,"about_ca_system_score_codex":0.0020031452,"about_ca_system_score_gemma":0.0022069605,"threshold_uncertainty_score":0.71737105},"labels":[],"label_agreement":null},{"id":"W2167989195","doi":"10.1016/j.hoc.2008.07.008","title":"Classification of Non-Hodgkin's Lymphoma","year":2008,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Pathology; Key (lock); Immunophenotyping; Medicine; Biology; Computational biology; Immunology; Flow cytometry","score_opus":0.06405533045855175,"score_gpt":0.4000877029061507,"score_spread":0.336032372447599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167989195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003856819,0.9905361,0.000037540845,0.00015482186,0.0005058006,0.0016212338,0.0001476984,0.000054367396,0.0030856035],"genre_scores_gemma":[0.0030790516,0.991605,0.003522416,0.00023254176,0.000108330154,0.00044119888,0.00084210455,0.00008002292,0.000089376575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949777,0.00033935596,0.0030003733,0.0008391059,0.00034286044,0.0005005766],"domain_scores_gemma":[0.99154365,0.0023581514,0.0041464046,0.0012767636,0.00040648604,0.00026855269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017043344,0.000678734,0.007784421,0.00050449057,0.00007443224,0.0000022739814,0.0004168705,0.0011092625,0.00007201679],"category_scores_gemma":[0.00047487364,0.00053472666,0.0016509771,0.0007564748,0.0013067217,0.000041332336,0.0001652562,0.0003365334,0.00025757772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120288816,0.0033432215,0.030947438,0.0064245616,0.0013383758,0.0004831461,0.00005816062,2.5760932e-7,8.835555e-8,0.00008150537,0.005124111,0.9520788],"study_design_scores_gemma":[0.0024543526,0.0027134349,0.021360558,0.002972212,0.0032375664,0.0024173958,0.00002929561,0.000017458719,0.000002416004,0.00000906451,0.9644613,0.00032491185],"about_ca_topic_score_codex":0.000043741147,"about_ca_topic_score_gemma":0.000021946615,"teacher_disagreement_score":0.95933723,"about_ca_system_score_codex":0.0003664836,"about_ca_system_score_gemma":0.003585354,"threshold_uncertainty_score":0.99971044},"labels":[],"label_agreement":null},{"id":"W2168681651","doi":"10.1093/annonc/mdj030","title":"Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience","year":2005,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; CHOP; International Prognostic Index; Cohort; Internal medicine; Radiation therapy; Lymphoma; Diffuse large B-cell lymphoma; Oncology; Chemotherapy regimen; Stage (stratigraphy); Chemotherapy; Surgery","score_opus":0.07205577914638595,"score_gpt":0.3388548055384577,"score_spread":0.26679902639207176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168681651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671407,0.0016631221,0.0000058467754,0.0020819681,0.00010060142,0.0002827522,0.000020183805,0.000011015306,0.02869385],"genre_scores_gemma":[0.9958247,0.0003675337,0.00047488319,0.0025592817,0.000075794196,0.00006755875,0.00001246144,0.0000070539318,0.0006107247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987614,0.00006426183,0.0005035781,0.00018813876,0.00020858264,0.00027401862],"domain_scores_gemma":[0.9992158,0.00016204623,0.00019594627,0.00021562229,0.00013372109,0.00007687478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000299097,0.00008212659,0.00048031268,0.000036695463,0.000085271764,0.000021007841,0.00012170845,0.0001038518,0.00016732639],"category_scores_gemma":[0.00011765055,0.00008302618,0.00010164036,0.00019366542,0.00024362915,0.000091387104,0.00006691591,0.000053450494,0.000012139062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017020288,0.017307604,0.79183185,0.000106174535,0.000046961028,0.00039957682,0.0011764053,0.000008055082,0.00082193036,0.00009920777,0.010335851,0.17769615],"study_design_scores_gemma":[0.009817917,0.002129141,0.8294996,0.00013676188,0.00004127545,0.00028629598,0.00044396223,0.00002329572,0.0047468883,0.00003722018,0.15274061,0.00009702694],"about_ca_topic_score_codex":0.0070974636,"about_ca_topic_score_gemma":0.023267737,"teacher_disagreement_score":0.17759913,"about_ca_system_score_codex":0.00018652507,"about_ca_system_score_gemma":0.00037001792,"threshold_uncertainty_score":0.99951434},"labels":[],"label_agreement":null},{"id":"W2168861745","doi":"10.1002/hon.2210","title":"I. Hodgkin lymphoma: special challenges and solutions","year":2015,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Immunology","score_opus":0.2753937735336374,"score_gpt":0.4161582098693922,"score_spread":0.1407644363357548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168861745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019143408,0.9295292,9.582941e-7,0.0011210161,0.00040752292,0.0009044446,0.000019757774,0.00008879603,0.067909166],"genre_scores_gemma":[0.00003917148,0.9972658,0.0005204957,0.00016767679,0.0011530421,0.0004958561,0.00008499688,0.000028989129,0.00024395784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976627,0.00031365402,0.00063527026,0.0006598014,0.00021747401,0.00051107106],"domain_scores_gemma":[0.99824554,0.00060109096,0.00026956527,0.0003544287,0.00008339523,0.00044596594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003313172,0.00048000948,0.004058341,0.0001449359,0.000086192376,0.00001140179,0.00011659674,0.0012199482,0.00025083366],"category_scores_gemma":[0.00022597173,0.0002890508,0.00043911033,0.00011324682,0.0003175969,0.000026123169,0.0002526659,0.0002026825,0.0006144091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024741574,0.0014056601,0.000007579452,0.0028512334,0.00026548342,0.0023112954,0.00004576359,2.5434663e-9,6.026543e-9,0.026587382,0.011378591,0.95512223],"study_design_scores_gemma":[0.0019766125,0.0013190147,0.00013500251,0.0017423376,0.0019868999,0.013087927,0.000045207293,4.7104433e-7,1.00412464e-7,0.0008863621,0.9785734,0.0002466687],"about_ca_topic_score_codex":0.000004886501,"about_ca_topic_score_gemma":0.000017410479,"teacher_disagreement_score":0.9671948,"about_ca_system_score_codex":0.00080057356,"about_ca_system_score_gemma":0.0009455692,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W2168937900","doi":"10.1200/jco.2010.32.8401","title":"Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment","year":2011,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Immune system; Medicine; Lymphoma; Chemokine; Cancer research; Immunology; Disease; Phenotype; Pathology; Biology; Gene","score_opus":0.1796136450142673,"score_gpt":0.4531361394043717,"score_spread":0.2735224943901044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168937900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18121292,0.81712765,0.0000029421733,0.00040327723,0.0005618374,0.00051707064,0.000014646642,0.000001015564,0.00015865033],"genre_scores_gemma":[0.11412295,0.8845423,0.00083178567,0.00028722585,0.00016135248,0.0000106027865,6.3121564e-7,0.000025246833,0.000017939547],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9918569,0.0019588298,0.005171596,0.00025009658,0.0005634287,0.00019920149],"domain_scores_gemma":[0.982309,0.0037816733,0.01261705,0.00086774165,0.00025909103,0.00016543387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003739005,0.0002994338,0.0051022274,0.00007994766,0.000027948588,0.000001956064,0.0006913526,0.00058905163,0.00004834657],"category_scores_gemma":[0.0041097673,0.00013153937,0.0037048643,0.0002108901,0.0006594347,0.000037083963,0.00031249496,0.000376842,0.0000020996886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005826586,0.0037695235,0.100312926,0.0038523315,0.0018409055,0.000244523,0.00003596735,9.986902e-7,0.00011853713,0.00008143114,0.00014648189,0.8890137],"study_design_scores_gemma":[0.005159005,0.006834492,0.4901486,0.05858161,0.022750817,0.0022512446,0.000031723765,8.5022594e-7,0.00096301915,0.00011065055,0.41294172,0.00022628416],"about_ca_topic_score_codex":0.00004801632,"about_ca_topic_score_gemma":0.000008864934,"teacher_disagreement_score":0.88878745,"about_ca_system_score_codex":0.00040059997,"about_ca_system_score_gemma":0.0036678463,"threshold_uncertainty_score":0.6506602},"labels":[],"label_agreement":null},{"id":"W2169478074","doi":"10.1182/blood-2005-10-4222","title":"Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Genentech; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"CHOP; Vincristine; Internal medicine; Rituximab; International Prognostic Index; Medicine; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Cyclophosphamide; Oncology; Chemotherapy","score_opus":0.009727508956446652,"score_gpt":0.24144774217015924,"score_spread":0.2317202332137126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169478074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915492,0.00021307873,0.00000934616,0.00003298858,0.000008594304,0.006613848,0.000014555906,0.000050571176,0.0015078395],"genre_scores_gemma":[0.99598426,0.0000030661724,0.00057647796,0.000006478455,0.00003398094,0.0024819914,0.000011792903,0.000025148265,0.00087679335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987073,0.00007247149,0.00030612884,0.0003926823,0.00030084632,0.00022055657],"domain_scores_gemma":[0.9993012,0.00010235233,0.00016408079,0.00024771196,0.0001234602,0.00006120085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007462024,0.00021553722,0.0004328366,0.00010717754,0.000039525494,0.000010079081,0.000051257324,0.000060964292,0.00003222941],"category_scores_gemma":[0.00007658575,0.00012429444,0.000041211533,0.00043288234,0.00006502501,0.00006564861,0.000020112346,0.000094697556,0.000008573498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016560144,0.0355096,0.95374113,0.000054970948,0.00014476349,0.0007662411,0.000813835,0.0000063812745,0.0070172613,0.000017323815,0.000025817213,0.0002466826],"study_design_scores_gemma":[0.030765042,0.0056017307,0.8549272,0.0007789849,0.00033349876,0.00002342765,0.0005500345,0.000008563446,0.10685464,0.000021687105,0.000009107979,0.0001260914],"about_ca_topic_score_codex":0.0007348634,"about_ca_topic_score_gemma":0.0003524537,"teacher_disagreement_score":0.09983738,"about_ca_system_score_codex":0.00011603204,"about_ca_system_score_gemma":0.0001590817,"threshold_uncertainty_score":0.50685805},"labels":[],"label_agreement":null},{"id":"W2169530872","doi":"10.1182/blood-2003-03-0786","title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Ibrutinib; Clathrin; Anaplastic lymphoma kinase; Crizotinib; Medicine; Chemistry; Molecular biology; Pathology; Biology; Leukemia; Chronic lymphocytic leukemia; Internal medicine; Lung cancer; Endocytosis; Receptor","score_opus":0.011808442146278578,"score_gpt":0.2414543560233285,"score_spread":0.2296459138770499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169530872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95979726,0.0008554975,0.0000041170147,0.00011576847,0.000046907386,0.0004638748,0.00011888098,0.000046975983,0.03855073],"genre_scores_gemma":[0.99676186,0.0001348893,0.00027941985,0.00038892508,0.00002597372,0.000060507886,0.00013130641,0.000034642148,0.0021824841],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850225,0.000059100308,0.00034965438,0.00035930777,0.00039900927,0.00033065313],"domain_scores_gemma":[0.9988236,0.00011769083,0.00026645846,0.00044557103,0.00019559445,0.00015108129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015767346,0.00022537808,0.00045954273,0.00007372274,0.00007687176,0.000013163514,0.00004830387,0.000103611164,0.00012028576],"category_scores_gemma":[0.00017412254,0.00016642125,0.00013473185,0.00021838276,0.00004911762,0.00005708144,0.000023307271,0.000043310483,0.000023035313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026436948,0.12073424,0.8213062,0.00009828308,0.0030519448,0.046697043,0.0011673959,1.4376462e-7,0.0016387717,0.00038188073,0.004045176,0.00061454205],"study_design_scores_gemma":[0.17024009,0.0037345083,0.39249393,0.0008685693,0.004740124,0.0064717145,0.00067164324,0.0000034989428,0.40758032,0.00004526912,0.012602254,0.0005480662],"about_ca_topic_score_codex":0.00016943796,"about_ca_topic_score_gemma":0.00004791967,"teacher_disagreement_score":0.42881227,"about_ca_system_score_codex":0.000119774326,"about_ca_system_score_gemma":0.00016972315,"threshold_uncertainty_score":0.67864615},"labels":[],"label_agreement":null},{"id":"W2169676118","doi":"10.1182/blood-2005-04-1510","title":"Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CIITA; Biology; Diffuse large B-cell lymphoma; Locus (genetics); Gene; Major histocompatibility complex; Cancer research; Genetics; MHC class II; Lymphoma; Immunology","score_opus":0.006803894941725787,"score_gpt":0.2315509391024203,"score_spread":0.22474704416069452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169676118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964648,0.00048335848,0.00002208676,0.0013867909,0.000043767657,0.00104612,0.00020060003,0.000042983957,0.00030950675],"genre_scores_gemma":[0.997805,0.000034418023,0.001176712,0.0004199496,0.000056481527,0.00018479637,0.000074236385,0.000027143778,0.00022123971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833643,0.000058715763,0.00052893505,0.0004668406,0.00025076102,0.0003583153],"domain_scores_gemma":[0.99889416,0.00008362075,0.00013589652,0.00056162657,0.00009945285,0.00022522322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014736566,0.00025568242,0.00060076034,0.0001648732,0.00013110427,0.000012025204,0.00010152684,0.00014727587,0.00007951141],"category_scores_gemma":[0.00003815067,0.00021643448,0.00011829005,0.00025040744,0.000060960218,0.000090277135,0.00018901742,0.00007650695,0.000039691808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067322125,0.08101502,0.52855814,0.00030981723,0.00014044179,0.0004206935,0.0032260914,0.0000032794208,0.3820959,0.000051069448,0.0014900756,0.0020162773],"study_design_scores_gemma":[0.04335178,0.000499938,0.55125517,0.00023207245,0.00016158767,0.000041768028,0.000028066584,0.0001457283,0.40293851,0.0000035380617,0.0011860951,0.0001557401],"about_ca_topic_score_codex":0.00036170302,"about_ca_topic_score_gemma":0.0002917566,"teacher_disagreement_score":0.08051508,"about_ca_system_score_codex":0.00022319466,"about_ca_system_score_gemma":0.00008253237,"threshold_uncertainty_score":0.88259417},"labels":[],"label_agreement":null},{"id":"W2169740355","doi":"10.1002/gcc.10181","title":"Characterization of the recurrent translocation t(1;1)(p36.3;q21.1–2) in non‐Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis","year":2003,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Dicentric chromosome; Fluorescence in situ hybridization; Breakpoint; Gene duplication; Biology; Locus (genetics); Molecular biology; Genetics; Karyotype; Bacterial artificial chromosome; Comparative genomic hybridization; Chromosomal rearrangement; Chromosome; Cytogenetics; Gene; Genome","score_opus":0.008896910656055452,"score_gpt":0.24906669389403163,"score_spread":0.2401697832379762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169740355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478036,0.004401086,0.00005843105,0.00026025512,0.00006737209,0.00038303956,0.000025734475,0.0000041526837,0.000019550665],"genre_scores_gemma":[0.9850429,0.014640276,0.00004477639,0.000058212605,0.000014002305,0.00011771542,0.00005516247,0.0000072181715,0.000019729805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992316,0.000047949794,0.00024484313,0.00022538494,0.00012353409,0.00012673692],"domain_scores_gemma":[0.99969846,0.000020138834,0.00009509958,0.000112027854,0.000033355827,0.000040920095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008912215,0.00011218602,0.00025928643,0.000118007316,0.00004007588,0.000013996954,0.000027647784,0.000048892387,0.000018922394],"category_scores_gemma":[0.000011235122,0.00008116946,0.000042481734,0.00054092193,0.00004145154,0.000071844974,0.000009268711,0.000023100773,2.0152287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003600118,0.00020011936,0.5990969,0.000071149676,0.00007002425,0.0000019252104,0.0006651635,0.000028917086,0.28512248,0.000022462604,0.000004129948,0.11468071],"study_design_scores_gemma":[0.0018600345,0.000047243324,0.73515326,0.00016892048,0.00017233643,0.0000030176734,0.0000687713,0.0012095779,0.26103786,0.0000032658004,0.00020526432,0.000070450515],"about_ca_topic_score_codex":0.0002542292,"about_ca_topic_score_gemma":0.0005266246,"teacher_disagreement_score":0.13605633,"about_ca_system_score_codex":0.00015194023,"about_ca_system_score_gemma":0.00006145297,"threshold_uncertainty_score":0.33099946},"labels":[],"label_agreement":null},{"id":"W2170329898","doi":"10.1182/blood-2007-11-125658","title":"IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Cancer research; Crizotinib; ALK inhibitor; Tyrosine kinase; Lymphoma; Tyrosine-kinase inhibitor; Biology; Medicine; Immunology; Cancer; Oncology; Internal medicine; Signal transduction; Lung cancer; Cell biology","score_opus":0.009829024830245297,"score_gpt":0.23513762699595517,"score_spread":0.22530860216570986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170329898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878493,0.0006279397,0.000031925472,0.00035407304,0.00018780144,0.0005886101,0.000077731296,0.000058284815,0.01022434],"genre_scores_gemma":[0.996323,0.000078870406,0.0016956108,0.00078101736,0.00016871799,0.000027344746,0.00006972101,0.000043656393,0.0008120686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980336,0.000051700696,0.00042121828,0.0005040291,0.0004702345,0.0005192639],"domain_scores_gemma":[0.9984689,0.00014750037,0.00017694684,0.00057371357,0.00017748127,0.00045548734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012722105,0.00037271413,0.00064314995,0.00018480963,0.00006431325,0.000028493365,0.00015860138,0.00011969106,0.00008812376],"category_scores_gemma":[0.000040400475,0.0002828186,0.00013677609,0.00040881266,0.000032300093,0.000073051466,0.0000626722,0.00008003648,0.0001820239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030486966,0.112684615,0.02694877,0.0004161729,0.00061528484,0.004334253,0.0015273594,0.00006123072,0.83507526,0.00015458514,0.0041506137,0.010983148],"study_design_scores_gemma":[0.032230128,0.0064707235,0.0396587,0.00031609094,0.00074511784,0.000077526296,0.00012353821,0.00001608082,0.9171516,0.0000058729247,0.002907837,0.0002968356],"about_ca_topic_score_codex":0.000120289,"about_ca_topic_score_gemma":0.00009880798,"teacher_disagreement_score":0.10621389,"about_ca_system_score_codex":0.00013940128,"about_ca_system_score_gemma":0.00029088176,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2170362988","doi":"10.1093/annonc/mdl316","title":"A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Bortezomib; Discontinuation; Internal medicine; Adverse effect; Toxicity; Clinical trial; Surgery; Lymphoma; Multiple myeloma","score_opus":0.23859705678650286,"score_gpt":0.5021967957604048,"score_spread":0.2635997389739019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170362988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914647,0.0005512808,5.532982e-7,0.0024402034,0.0006344119,0.0013136591,0.00011472537,0.0000028753163,0.0034775927],"genre_scores_gemma":[0.9984683,0.00020805969,0.000025347583,0.0005884864,0.00036411468,0.00018467967,0.000025282496,0.0000072450994,0.00012849923],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969891,0.0004907407,0.0016926501,0.00021279512,0.00042305465,0.00019169533],"domain_scores_gemma":[0.9975718,0.0010364022,0.000878169,0.00017390471,0.0002780226,0.00006168616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026594102,0.00012758268,0.0011835747,0.000107399035,0.000041661056,0.0000016889338,0.00012292323,0.00012784565,0.00006618423],"category_scores_gemma":[0.00055680465,0.00008214933,0.00017952322,0.00020436762,0.00014379207,0.000037652444,0.000053539326,0.000069876216,4.4905525e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12617126,0.4039244,0.115131944,0.00015261701,0.0019393819,0.00050722284,0.0011562922,0.00017053795,0.00093431555,0.0018915974,0.1958363,0.15218411],"study_design_scores_gemma":[0.6430099,0.053904016,0.21484503,0.00008096424,0.0005166858,0.000010928028,0.00045511842,0.000056634733,0.005065845,0.00030449164,0.08159461,0.00015576444],"about_ca_topic_score_codex":0.35061225,"about_ca_topic_score_gemma":0.48184562,"teacher_disagreement_score":0.51683867,"about_ca_system_score_codex":0.00020015458,"about_ca_system_score_gemma":0.0035807996,"threshold_uncertainty_score":0.6537121},"labels":[],"label_agreement":null},{"id":"W2170365438","doi":"10.1136/jcp.2006.044222","title":"Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Lymphatic system; Transcription factor; Pathology; Biology; Immunology; Medicine; Cancer research; Genetics; Gene","score_opus":0.048933794631803154,"score_gpt":0.3363976400371074,"score_spread":0.2874638454053043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170365438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958495,0.0003263846,0.00011121898,0.00086909096,0.00071192253,0.00039807628,0.000073646566,0.00002820579,0.0016319422],"genre_scores_gemma":[0.9972116,0.00008200342,0.001193375,0.00056649616,0.0003635958,0.000016577844,0.0000524144,0.00002647052,0.00048747085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966662,0.00039081776,0.0017962657,0.00030431224,0.0004934448,0.00034894625],"domain_scores_gemma":[0.99732673,0.0005097531,0.001252544,0.0002313756,0.00040132526,0.00027827363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006770626,0.00026138904,0.0013238214,0.00011104994,0.00007201737,0.000023804225,0.00010357316,0.0002632422,0.00020904388],"category_scores_gemma":[0.00020965876,0.00016491007,0.0005723075,0.00012794965,0.00024214796,0.00008502643,0.000018188142,0.00018560287,0.00005729701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024734908,0.010478725,0.96376675,0.000031114963,0.0005531695,0.005063215,0.00005431256,0.0000060487237,0.003360245,0.000055386314,0.0047490234,0.009408536],"study_design_scores_gemma":[0.02606271,0.0058574327,0.95764095,0.00019768148,0.0007415939,0.002323199,0.000029647641,0.000034979577,0.0030803168,0.00008326235,0.0037854488,0.00016275876],"about_ca_topic_score_codex":0.000038571965,"about_ca_topic_score_gemma":0.00006164045,"teacher_disagreement_score":0.02358922,"about_ca_system_score_codex":0.00031992502,"about_ca_system_score_gemma":0.00043200777,"threshold_uncertainty_score":0.67248374},"labels":[],"label_agreement":null},{"id":"W2170520623","doi":"10.1093/jjco/hym007","title":"Primary Bone Lymphoma: A New and Detailed Characterization of 28 Patients in a Single-Institution Study","year":2007,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lymphoma; Primary bone; Internal medicine; Oncology; Pathology","score_opus":0.055453472985352414,"score_gpt":0.3806641597000207,"score_spread":0.3252106867146683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170520623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998513,0.000045338416,0.000037763195,0.0004298955,0.0002585098,0.00038535663,5.765254e-7,0.0000042578176,0.00032530032],"genre_scores_gemma":[0.9987131,0.000085534724,0.00060269656,0.00038317568,0.00018345508,0.000002379714,0.0000049030814,0.000005844503,0.000018918854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997424,0.0001640549,0.0018620809,0.00013881044,0.00026535135,0.00014571591],"domain_scores_gemma":[0.9978275,0.00060743204,0.0009826213,0.0001009416,0.00024258411,0.0002389219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016731968,0.00009917117,0.00091757026,0.00018642048,0.000019366356,0.0000037055274,0.00004162308,0.00014237639,0.000010868424],"category_scores_gemma":[0.0009679956,0.000068297486,0.00012206743,0.00017832738,0.00008394411,0.00014194184,0.000031090713,0.00010364554,0.0000023829725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004338689,0.017244538,0.7992196,0.000012505713,0.00008086908,0.00041732186,0.00064289145,4.7050884e-7,0.0026879704,0.000008846929,0.000004803189,0.1753415],"study_design_scores_gemma":[0.035660885,0.014296936,0.9486687,0.00007482517,0.00017915589,0.00020060648,0.00019832728,0.0000057324373,0.0003071496,0.000012376597,0.00034589384,0.00004936341],"about_ca_topic_score_codex":0.00004745168,"about_ca_topic_score_gemma":0.0001227066,"teacher_disagreement_score":0.17529213,"about_ca_system_score_codex":0.0002854199,"about_ca_system_score_gemma":0.0004283566,"threshold_uncertainty_score":0.27850908},"labels":[],"label_agreement":null},{"id":"W2170684315","doi":"10.1200/jco.2009.24.9516","title":"Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Pathology; Biology","score_opus":0.05360879883891786,"score_gpt":0.42688598487018903,"score_spread":0.3732771860312712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170684315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982442,0.00034234917,0.000077103046,0.010401091,0.0024296113,0.00045274943,0.0000061948995,0.000012833264,0.0038360222],"genre_scores_gemma":[0.9893242,0.0007611708,0.00475914,0.004011928,0.001001842,0.000027038946,0.000005061017,0.000023716004,0.000085871536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956002,0.00027439298,0.0029243412,0.00027869843,0.0005244336,0.00039789328],"domain_scores_gemma":[0.9953876,0.0013446646,0.0017309611,0.00033126713,0.00045314105,0.0007523491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025898656,0.00024112068,0.0017904916,0.0003695983,0.000050486255,0.00001970496,0.00024645656,0.00062252465,0.00020399243],"category_scores_gemma":[0.0032982565,0.00016607207,0.0006600967,0.00029267676,0.00015153355,0.00020170063,0.000048038768,0.00031319904,0.00015425413],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061111776,0.0058907513,0.05364031,0.000025183652,0.00024313084,0.0050972104,0.00052903255,0.000016297274,0.00082337804,0.00042133252,0.0016452938,0.9255569],"study_design_scores_gemma":[0.049241703,0.01104489,0.74398494,0.0002822238,0.00035879508,0.0034847986,0.00019879156,0.00020250508,0.003614198,0.00026426814,0.18712594,0.00019693928],"about_ca_topic_score_codex":0.000108809174,"about_ca_topic_score_gemma":0.00027253374,"teacher_disagreement_score":0.92535996,"about_ca_system_score_codex":0.00069446,"about_ca_system_score_gemma":0.0029816888,"threshold_uncertainty_score":0.6772223},"labels":[],"label_agreement":null},{"id":"W2171440950","doi":"10.3109/10428194.2014.970550","title":"Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chromosomal translocation; Fluorescence in situ hybridization; Immunohistochemistry; Lymphoma; Internal medicine; Cancer research; Gene expression; Oncology; Gene; Risk stratification; Progression-free survival; Biology; Medicine; Overall survival; Genetics","score_opus":0.006580176482716248,"score_gpt":0.2217849288754741,"score_spread":0.21520475239275785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171440950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264026,0.0032608698,0.00025654255,0.0002110725,0.00014881058,0.0015600147,0.00008079947,0.00019649735,0.0016451154],"genre_scores_gemma":[0.9932552,0.002001953,0.0024465495,0.0004925233,0.00022369662,0.00063004106,0.00027033748,0.00011316769,0.0005665459],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99559176,0.00033878785,0.0010632046,0.0014828705,0.00055373495,0.0009696292],"domain_scores_gemma":[0.99733907,0.00039460798,0.0005045908,0.00091632165,0.00013366365,0.0007117601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063242705,0.0008600779,0.0010575808,0.0004275995,0.00074228196,0.00036396825,0.00019491542,0.0005494322,0.000014257741],"category_scores_gemma":[0.0001970953,0.0007499877,0.00015497126,0.0004006371,0.0003089765,0.0005503363,0.00026125734,0.00014033011,0.000023420838],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018114276,0.009991149,0.14769135,0.0011777923,0.0003482333,0.00042850856,0.006523712,0.000016775139,0.29542232,0.0063379216,0.00093670265,0.5293141],"study_design_scores_gemma":[0.13564491,0.0011647136,0.6781931,0.0009317654,0.0005251741,0.00065365207,0.0009965963,0.025608338,0.14780453,0.0013882992,0.005738878,0.0013500601],"about_ca_topic_score_codex":0.0016198341,"about_ca_topic_score_gemma":0.00021204507,"teacher_disagreement_score":0.5305017,"about_ca_system_score_codex":0.0023504884,"about_ca_system_score_gemma":0.0010057186,"threshold_uncertainty_score":0.9994951},"labels":[],"label_agreement":null},{"id":"W2171696638","doi":"10.1182/blood-2002-10-3236","title":"MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Deutsche Krebshilfe; National Cancer Institute; Kay Kendall Leukaemia Fund","keywords":"Comparative genomic hybridization; Biology; Molecular biology; Fluorescence in situ hybridization; Chromosomal translocation; Lymphoma; Immunoglobulin heavy chain; Gene rearrangement; Breakpoint; Polymerase chain reaction; BCL10; Gene; Genetics; Chromosome","score_opus":0.0070901649814802195,"score_gpt":0.22236945182885173,"score_spread":0.21527928684737152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171696638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948873,0.0024821106,0.000060297167,0.0003656606,0.00002329367,0.00041656935,0.000011872347,0.000025709758,0.001727193],"genre_scores_gemma":[0.99821943,0.00050221686,0.0006460978,0.0002645483,0.000016024831,0.00007626382,0.0000692453,0.00001779061,0.00018840884],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991704,0.000029807898,0.00021103292,0.00027835282,0.00013006754,0.00018029363],"domain_scores_gemma":[0.9996041,0.000025341069,0.000050359555,0.00019915319,0.000025067988,0.00009596937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007605415,0.00013550579,0.00019049259,0.00006434706,0.000041117528,0.00001830834,0.000028468841,0.00009759253,0.000064337175],"category_scores_gemma":[0.000008648212,0.00012187282,0.00003501156,0.00016649808,0.000027548867,0.000054982575,0.0000037705859,0.000027311306,0.000024472247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014394821,0.017604595,0.7615402,0.000271292,0.00023074227,0.00012323594,0.0023045568,0.0000017218618,0.17228432,0.0006031072,0.0026805738,0.04221171],"study_design_scores_gemma":[0.020406518,0.00031311647,0.48148045,0.00009773015,0.00018115844,0.000103266946,0.000077316065,0.00008114723,0.4950704,0.000064578024,0.0019679826,0.00015632785],"about_ca_topic_score_codex":0.00013048926,"about_ca_topic_score_gemma":0.000017147742,"teacher_disagreement_score":0.3227861,"about_ca_system_score_codex":0.00006225052,"about_ca_system_score_gemma":0.000078114965,"threshold_uncertainty_score":0.49698296},"labels":[],"label_agreement":null},{"id":"W2171705417","doi":"10.1155/2012/984986","title":"Rituximab-Induced Coronary Vasospasm","year":2012,"lang":"en","type":"article","venue":"Case Reports in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Niagara Health System","funders":"","keywords":"Medicine; Rituximab; Coronary vasospasm; Vasospasm; Adverse effect; Cardiology; Ischemia; Hemodynamics; Myocardial ischemia; Internal medicine; Lymphoma; Anesthesia; Angina; Myocardial infarction","score_opus":0.03545982049318933,"score_gpt":0.31546328316430033,"score_spread":0.280003462671111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171705417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98825175,0.0030146625,0.0000037613386,0.00036065967,0.0006474466,0.00036093235,9.91882e-7,0.000056310353,0.0073034945],"genre_scores_gemma":[0.9988391,0.00004814044,0.00043424495,0.00030343304,0.000090925656,0.00013651699,0.000016019101,0.000018654398,0.000112978414],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9987145,0.000037463873,0.0004643319,0.00025773214,0.00011402156,0.00041194956],"domain_scores_gemma":[0.9990289,0.00011784381,0.00013265606,0.00046392932,0.000036889523,0.0002197375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002147046,0.00015581411,0.0005280227,0.00010729411,0.00004179587,0.000003823812,0.000014381014,0.00016964128,0.0002632754],"category_scores_gemma":[0.0001381319,0.00012739642,0.00009006162,0.000114379,0.000047823443,0.00007149324,0.000044132667,0.000105087005,0.00008581806],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016003858,0.0010565593,0.5653718,0.000037072554,0.000038616825,0.42958632,0.00012194982,7.827689e-8,0.000046848007,0.0014202442,0.0004586035,0.0018459322],"study_design_scores_gemma":[0.0014123183,0.00009835335,0.14202794,0.000054996828,0.00009127305,0.8484265,0.000105509476,0.0000062296676,0.0050126566,0.00013052241,0.0025275461,0.00010610384],"about_ca_topic_score_codex":0.0001893455,"about_ca_topic_score_gemma":0.000035937926,"teacher_disagreement_score":0.42334384,"about_ca_system_score_codex":0.00016979165,"about_ca_system_score_gemma":0.000094989446,"threshold_uncertainty_score":0.5195075},"labels":[],"label_agreement":null},{"id":"W2171744360","doi":"10.1093/annonc/mdt289","title":"Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Doxorubicin; CHOP; Cardiotoxicity; Regimen; Ejection fraction; Diffuse large B-cell lymphoma; Gastroenterology; Oncology; Lymphoma; Heart failure; Chemotherapy","score_opus":0.0883804530999401,"score_gpt":0.39367191242018873,"score_spread":0.30529145932024865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171744360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908935,0.0019428314,0.00014421996,0.0036572218,0.000054482804,0.00201688,0.00010095393,0.000022307633,0.0011675903],"genre_scores_gemma":[0.9957502,0.00032107462,0.002236544,0.0008412419,0.000044254844,0.0005251905,0.00010546589,0.000035735833,0.00014028065],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982134,0.00009836865,0.00069290464,0.000322663,0.00025342047,0.00041924114],"domain_scores_gemma":[0.99743456,0.00064715935,0.00070348685,0.0005446004,0.0005063976,0.00016380368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014112768,0.00029447878,0.0014797181,0.00018453818,0.000045230816,0.0000045090833,0.000113894355,0.00018134962,0.000116567266],"category_scores_gemma":[0.000021601092,0.00018877361,0.00033002446,0.00015288885,0.0001942103,0.00004010229,0.00001025256,0.000022465887,0.000008941043],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017711602,0.28026512,0.48723093,0.00055832806,0.0017914851,0.00004381971,0.0014532926,0.00011048695,0.0435037,0.00043651796,0.013117172,0.15377754],"study_design_scores_gemma":[0.11687896,0.074238904,0.07267506,0.00011758656,0.00032578903,0.0000037859984,0.0002620728,0.0009582221,0.70520014,0.000034926958,0.029132377,0.00017220963],"about_ca_topic_score_codex":0.0006763072,"about_ca_topic_score_gemma":0.00006748369,"teacher_disagreement_score":0.66169643,"about_ca_system_score_codex":0.00015052898,"about_ca_system_score_gemma":0.0006278748,"threshold_uncertainty_score":0.7697965},"labels":[],"label_agreement":null},{"id":"W2171873783","doi":"10.1200/jco.2012.44.7524","title":"Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":428,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Disease; Lymphoma; Oncology; Peripheral; Internal medicine; Peripheral T-cell lymphoma; T cell; Immunology; Immune system","score_opus":0.02960347864657775,"score_gpt":0.35222057892783,"score_spread":0.32261710028125223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171873783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639374,0.00063865725,0.0000040717846,0.0018590587,0.00044500674,0.00045428931,0.000014579101,0.0000039729975,0.0001866429],"genre_scores_gemma":[0.99827135,0.0005587531,0.00054891343,0.00018166882,0.00023279617,0.000019338477,0.0000066362263,0.000018549197,0.00016201186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734926,0.00021939138,0.0015739625,0.0001986736,0.00045289166,0.00020583121],"domain_scores_gemma":[0.99638873,0.00091502926,0.0014657605,0.00022323354,0.0004170682,0.0005901916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044076817,0.00017846885,0.0013636786,0.00007283003,0.000027254395,0.00000846386,0.00009897753,0.00018767892,0.000581934],"category_scores_gemma":[0.00039498362,0.000090633344,0.00028321965,0.000094489165,0.00034159078,0.00013599999,0.00006660569,0.00015625135,0.000004433263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024922773,0.011470129,0.94090354,0.00019607435,0.0002816871,0.0008499911,0.000082103325,7.5588594e-7,0.0000012180958,0.0000038422186,0.00024740852,0.02104046],"study_design_scores_gemma":[0.025904063,0.021969968,0.9504644,0.00042902792,0.00055732264,0.000034348443,0.00003551358,0.000006376046,0.000038843227,0.000018662227,0.00045093743,0.00009048995],"about_ca_topic_score_codex":0.000032557575,"about_ca_topic_score_gemma":0.0002018022,"teacher_disagreement_score":0.02094997,"about_ca_system_score_codex":0.00010937623,"about_ca_system_score_gemma":0.0008478273,"threshold_uncertainty_score":0.63717693},"labels":[],"label_agreement":null},{"id":"W2172208779","doi":"10.1073/pnas.1137463100","title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy","year":2003,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Germinal center; Follicular lymphoma; Lymphoma; Biology; Cancer research; MAPK/ERK pathway; Canine Lymphoma; Cell growth; Microarray; BCL10; Protein kinase A; Diffuse large B-cell lymphoma; Signal transduction; Kinase; Molecular biology; B cell; Immunology; Gene expression; Gene; Cell biology; Antibody; Genetics","score_opus":0.05637964735641955,"score_gpt":0.2955128721070149,"score_spread":0.23913322475059534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172208779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996627,0.00039471808,0.000003516755,0.00091652875,0.000011404186,0.0013619093,0.000019261694,0.0000066275643,0.0006590311],"genre_scores_gemma":[0.99655455,0.000036433463,0.0029765067,0.00014709924,0.000016228072,0.0002478141,0.0000010672064,0.0000049614287,0.000015315523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839556,0.000008806588,0.00044047058,0.00018997386,0.0008157962,0.00014938212],"domain_scores_gemma":[0.99922055,0.00008980174,0.00034035018,0.000010408982,0.00030040392,0.000038467024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009221132,0.000111711066,0.00023640637,0.00017322887,0.00009577453,0.000009142354,0.00018108789,0.00007232717,0.000012018493],"category_scores_gemma":[0.00033455456,0.00007044497,0.00013181368,0.0005910429,0.00019646628,0.00023875061,0.000012312118,0.000038090388,2.841517e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019229815,0.00063620694,0.013109203,0.00016930222,0.000056047422,3.0618907e-8,0.001045351,0.000073790645,0.9543693,0.029002527,0.000022596365,0.001323355],"study_design_scores_gemma":[0.0037731384,0.00038251784,0.011955993,0.00028499358,0.000013046088,0.0000035837916,0.0005175237,0.0003924604,0.9689681,0.013226306,0.00041543855,0.000066874985],"about_ca_topic_score_codex":0.000022588894,"about_ca_topic_score_gemma":1.0928086e-7,"teacher_disagreement_score":0.01577622,"about_ca_system_score_codex":0.00010326255,"about_ca_system_score_gemma":0.00013143421,"threshold_uncertainty_score":0.28726625},"labels":[],"label_agreement":null},{"id":"W2173798589","doi":"10.1002/cncr.29781","title":"Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma","year":2015,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Medicine; Lymphoma; Oncogene; Oncology; Germinal center; Cancer research; Gene rearrangement; Internal medicine; Immunology; B cell; Cancer; Biology; Cell cycle; Gene; Genetics; Antibody","score_opus":0.031656370983318374,"score_gpt":0.3296367680380395,"score_spread":0.2979803970547211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173798589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976491,0.00009760779,0.0000016683688,0.00019307119,0.00010762482,0.0005455259,0.00007829322,0.000010554622,0.0013165555],"genre_scores_gemma":[0.999294,0.000032589618,0.00003056849,0.00019426265,0.00003855804,0.00015673357,0.000040911375,0.00001977086,0.00019261215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904704,0.000012341789,0.00019234214,0.00020321163,0.0003417085,0.00020335571],"domain_scores_gemma":[0.9993457,0.000015432182,0.00009124231,0.00027708948,0.00011154,0.00015897745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005257912,0.00016486735,0.00036908072,0.000094297364,0.000010550767,0.0000061437136,0.00005138661,0.000044897002,0.00013630909],"category_scores_gemma":[0.000006240636,0.00009614332,0.000085620675,0.000111198744,0.00001986588,0.000037405553,0.000019301366,0.000026460435,0.000019425219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017962181,0.0018914337,0.97120047,0.000020182111,0.00029267583,0.000028971313,0.0003221681,0.00006732019,0.0000127954645,0.0000039699908,0.00080044597,0.023563365],"study_design_scores_gemma":[0.03115045,0.0025986556,0.9643741,0.00023120407,0.00008919886,6.4871864e-7,0.000026686792,0.000005800717,0.0011967538,0.0000019736804,0.00022505962,0.00009945669],"about_ca_topic_score_codex":0.004078719,"about_ca_topic_score_gemma":0.0003433726,"teacher_disagreement_score":0.029354231,"about_ca_system_score_codex":0.001313687,"about_ca_system_score_gemma":0.000269971,"threshold_uncertainty_score":0.61658305},"labels":[],"label_agreement":null},{"id":"W2174357566","doi":"10.1007/s13139-015-0368-7","title":"FDG PET/CT Response Assessment Criteria for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma at End of Therapy: A Multiparametric Approach","year":2015,"lang":"en","type":"article","venue":"Nuclear Medicine and Molecular Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Lymphoma; Positron emission tomography; Nuclear medicine; PET-CT; Radiology; Internal medicine","score_opus":0.021042444842707356,"score_gpt":0.30329147294206704,"score_spread":0.2822490280993597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174357566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449146,0.0014036511,0.0002294739,0.0016121448,0.000062079576,0.0010753832,0.0000142695535,0.000027445081,0.0010841159],"genre_scores_gemma":[0.9763076,0.00013206022,0.02168323,0.0016497583,0.000028532751,0.00007150053,0.000047823523,0.0000591761,0.000020373043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845505,0.000097477525,0.00028747637,0.00044185598,0.00043864865,0.00027949884],"domain_scores_gemma":[0.99884385,0.00015190078,0.00014611162,0.00032164485,0.00022416338,0.000312314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049713964,0.00026743938,0.0005386231,0.00026892367,0.00008503671,0.00002343556,0.00006189413,0.000016745078,0.000018118939],"category_scores_gemma":[0.00017769332,0.00017908198,0.00006040974,0.00018828046,0.0002507733,0.00007540955,0.00007507611,0.000051368563,9.836108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025674863,0.0057163914,0.7749214,0.0008077715,0.0014405862,0.002578315,0.0059947493,0.0000039924626,0.027373409,0.0003361849,0.013358832,0.14179347],"study_design_scores_gemma":[0.08601304,0.0083260825,0.8644367,0.00061788573,0.00084910745,0.0012109854,0.0020922248,0.0053262804,0.0016243688,0.00006173613,0.028919818,0.00052177464],"about_ca_topic_score_codex":0.00017059872,"about_ca_topic_score_gemma":8.8633305e-7,"teacher_disagreement_score":0.1412717,"about_ca_system_score_codex":0.00017944278,"about_ca_system_score_gemma":0.00010832299,"threshold_uncertainty_score":0.7302751},"labels":[],"label_agreement":null},{"id":"W2179085550","doi":"10.1002/ajh.24239","title":"Reply to H.J adams et al: “Is <scp>FDG‐PET/CT</scp> a sensitive and specific method for the detection of extranodal involvement in diffuse large <scp>B</scp>‐cell lymphoma?”","year":2015,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Bone marrow; Rituximab; Radiology; Nuclear medicine; Internal medicine","score_opus":0.01974240030807576,"score_gpt":0.2907686698551946,"score_spread":0.27102626954711884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179085550","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72110724,0.008018706,0.010641495,0.25652963,0.00085424277,0.0022953171,0.0002580627,0.00003092155,0.00026434686],"genre_scores_gemma":[0.35426772,0.0028803856,0.012651744,0.6289776,0.0005267848,0.00020826138,0.000060051967,0.00016866774,0.0002587684],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617124,0.0005902796,0.0012788438,0.0006068458,0.00065180135,0.0007009864],"domain_scores_gemma":[0.99196887,0.004894337,0.001734951,0.0005579365,0.0005603833,0.00028349666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013624354,0.000556792,0.002201744,0.0006333489,0.00007564148,0.000031865435,0.00023073386,0.00009831599,0.0000033857061],"category_scores_gemma":[0.0005646676,0.0003812652,0.00046221568,0.00041489647,0.00029194684,0.000076304605,0.000110550405,0.00063807325,0.0000066270186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027782453,0.002545811,0.0032583505,0.00026313186,0.0013937273,0.011254499,0.004794193,0.000003465755,0.0010810163,0.00004462704,0.96225816,0.012825177],"study_design_scores_gemma":[0.013726248,0.0046887607,0.0023824591,0.00047121028,0.0008165452,0.023675794,0.008222921,0.00008334508,0.023160249,0.00011797391,0.9225394,0.00011505676],"about_ca_topic_score_codex":0.00057398365,"about_ca_topic_score_gemma":0.00008772579,"teacher_disagreement_score":0.37244797,"about_ca_system_score_codex":0.00043585774,"about_ca_system_score_gemma":0.00044365955,"threshold_uncertainty_score":0.9998639},"labels":[],"label_agreement":null},{"id":"W2180741372","doi":"10.1667/0033-7587(2003)159[0161:lcatfh]2.0.co;2","title":"Lung Cancer after Treatment for Hodgkin's Disease: Focus on Radiation Effects","year":2003,"lang":"en","type":"article","venue":"Radiation Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Cancer; Disease; Population; Internal medicine; Lung; Oncology; Chemotherapy; Relative risk; Nuclear medicine; Gastroenterology; Confidence interval; Environmental health","score_opus":0.03617037476396504,"score_gpt":0.4159514829524412,"score_spread":0.37978110818847616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180741372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95940065,0.021605631,0.0001287137,0.00898627,0.00042621748,0.006500512,0.0001713529,0.00007737571,0.0027032732],"genre_scores_gemma":[0.98779786,0.0020774025,0.00011456881,0.00020624485,0.00028774122,0.007656035,0.00007657981,0.000029303823,0.0017542606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836236,0.00020359785,0.0001539189,0.00036003772,0.00051020004,0.00040989544],"domain_scores_gemma":[0.99840546,0.0007929709,0.00003681482,0.00030290848,0.0001373348,0.00032453446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960778,0.00015305098,0.00020200455,0.00025001494,0.00016709554,0.000047686404,0.000032000225,0.000070859045,0.0002585915],"category_scores_gemma":[0.00039088077,0.00011541915,0.0001339429,0.00025531903,0.00002930369,0.000063027364,0.0000058141095,0.000065803455,0.0000690759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002082328,0.0022221599,0.50165457,0.00031292962,0.00046318964,0.00015129184,0.0003621152,0.00011861184,0.00015484465,0.0067313025,0.018493727,0.46725294],"study_design_scores_gemma":[0.011725906,0.0017386279,0.86413336,0.00016713841,0.00026038178,0.0000022011366,0.000014910506,0.0016488996,0.02205895,0.0005428704,0.097524635,0.00018214367],"about_ca_topic_score_codex":0.00013725454,"about_ca_topic_score_gemma":0.000019151861,"teacher_disagreement_score":0.4670708,"about_ca_system_score_codex":0.0019714602,"about_ca_system_score_gemma":0.000453973,"threshold_uncertainty_score":0.51553},"labels":[],"label_agreement":null},{"id":"W2181937169","doi":"","title":"Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Gene rearrangement; Immunophenotyping; Lymphoid hyperplasia; Lymphoma; Lymphoproliferative disorders; Pathology; Medicine; Hyperplasia; Immunology; Biology; Gene; Antigen; Genetics","score_opus":0.03206356015399338,"score_gpt":0.2639114075705838,"score_spread":0.23184784741659042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181937169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665046,0.00084872794,0.0000043813943,0.00025432743,0.00005807099,0.0011649786,0.000024215811,0.000005874646,0.0009889371],"genre_scores_gemma":[0.9960611,0.0007272242,0.000022285514,0.000061341496,0.000017006345,0.0030502602,0.000012870463,0.0000062446593,0.000041709747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895275,0.00005319524,0.00036887327,0.00017315784,0.00026152577,0.00019048328],"domain_scores_gemma":[0.999385,0.00013496612,0.0001251708,0.00026814683,0.000037992086,0.000048735736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115899216,0.000118605334,0.00032765462,0.000076977296,0.000024895142,0.00000570517,0.000095950345,0.000031996187,0.000051772655],"category_scores_gemma":[0.00012401972,0.00007336781,0.00011647485,0.00028494737,0.00022140358,0.000105153646,0.000017360282,0.00002756244,9.643387e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003210047,0.0026633816,0.8298437,0.00007452169,0.000053005337,0.000057488443,0.004078067,0.0000058482774,0.00004657248,0.00012746626,0.000017918353,0.16271101],"study_design_scores_gemma":[0.0034950108,0.00024446435,0.96083236,0.00014186367,0.00008827341,0.000035771012,0.0004870585,0.0000039133997,0.03453299,0.000022465605,0.000052540443,0.0000633036],"about_ca_topic_score_codex":0.0010702369,"about_ca_topic_score_gemma":0.00071266457,"teacher_disagreement_score":0.16264771,"about_ca_system_score_codex":0.00011117214,"about_ca_system_score_gemma":0.000053448046,"threshold_uncertainty_score":0.29918525},"labels":[],"label_agreement":null},{"id":"W2182385064","doi":"10.1200/jco.2015.33.15_suppl.8552","title":"CD30+ expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD30; Medicine; Anaplastic large-cell lymphoma; CHOP; Internal medicine; Pathology; Brentuximab vedotin; Biopsy; Prospective cohort study; Oncology; Lymphoma","score_opus":0.12346976728067173,"score_gpt":0.4418044659431663,"score_spread":0.3183346986624946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182385064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807014,0.0011141521,0.000043686916,0.0069250385,0.0008960407,0.00033155747,0.000014726021,0.000007817159,0.009965615],"genre_scores_gemma":[0.9930682,0.0005953089,0.0031960409,0.0017346138,0.0010088428,0.00002564763,0.000019233585,0.000012742726,0.00033936062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669254,0.00047261117,0.0017518116,0.0002768651,0.0006037842,0.00020238267],"domain_scores_gemma":[0.99599165,0.0016909499,0.0012861942,0.0002678173,0.00048707906,0.00027631808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020870082,0.00016779697,0.0012766364,0.00017909803,0.000030786625,0.000029303821,0.00030691462,0.0002843285,0.00017300235],"category_scores_gemma":[0.0013847856,0.00008938946,0.0006850624,0.00037800212,0.000121421785,0.00012789064,0.000102252234,0.00046044606,0.000021456477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041174316,0.007270099,0.9623885,0.0000032357668,0.0008612816,0.0010001723,0.0009931092,0.000048778835,0.00023042376,0.000017887802,0.016558528,0.0065105273],"study_design_scores_gemma":[0.028473374,0.006008031,0.9113122,0.000077812234,0.0017250564,0.00008074414,0.0018320105,0.00050577126,0.0015994221,0.00058343075,0.04766688,0.0001352168],"about_ca_topic_score_codex":0.00048532587,"about_ca_topic_score_gemma":0.00045492637,"teacher_disagreement_score":0.051076274,"about_ca_system_score_codex":0.00094054756,"about_ca_system_score_gemma":0.0024148123,"threshold_uncertainty_score":0.42837736},"labels":[],"label_agreement":null},{"id":"W2182872902","doi":"10.1111/bjh.13855","title":"A phase <scp>II</scp> study of cyclophosphamide, etoposide, vincristine and prednisone ( <scp>CEOP</scp> ) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma ( <scp>PTCL</scp> ): final results from the T‐ cell consortium trial","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Genentech; Spectrum Pharmaceuticals","keywords":"Vincristine; Etoposide; Medicine; Cyclophosphamide; Prednisone; Lymphoma; Internal medicine; Chemotherapy","score_opus":0.02110693813914477,"score_gpt":0.2709042396403967,"score_spread":0.24979730150125196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182872902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543257,0.009261117,0.000074712116,0.00016377789,0.00047935935,0.0036103353,0.0005022511,0.000039468705,0.00043640152],"genre_scores_gemma":[0.9943722,0.0009057304,0.0029151195,0.00030382635,0.00041896696,0.00019124402,0.00017424877,0.000109440436,0.0006092112],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99485713,0.0004514326,0.0020424353,0.00078107615,0.0010728285,0.00079507835],"domain_scores_gemma":[0.9917262,0.002934227,0.002845283,0.00050908077,0.001384823,0.0006003625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085035356,0.0006534888,0.0021015347,0.00016106527,0.00035424702,0.00015396421,0.0004131451,0.00025481725,0.000004936053],"category_scores_gemma":[0.0019189498,0.0004537181,0.00025577072,0.00021941404,0.000363376,0.00029070248,0.00015129618,0.0003496464,0.000002972196],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09949318,0.16341233,0.54609615,0.0004385498,0.007707365,0.050182696,0.04471727,0.00033931702,0.00050779234,0.00003289124,0.05932038,0.027752094],"study_design_scores_gemma":[0.7962459,0.107599705,0.051316004,0.0010854178,0.001861348,0.016524965,0.008501696,0.00026602703,0.011055872,0.00014392385,0.0052457717,0.00015341816],"about_ca_topic_score_codex":0.0020901777,"about_ca_topic_score_gemma":0.0005028191,"teacher_disagreement_score":0.69675267,"about_ca_system_score_codex":0.0002289505,"about_ca_system_score_gemma":0.0010329293,"threshold_uncertainty_score":0.99979144},"labels":[],"label_agreement":null},{"id":"W2183796916","doi":"10.1016/j.clml.2015.11.008","title":"Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network; McMaster University; Juravinski Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Alemtuzumab; Medicine; CD52; CHOP; Gastroenterology; Internal medicine; Cyclophosphamide; Vincristine; Chemotherapy; Urology; Transplantation","score_opus":0.07798139945745185,"score_gpt":0.39170102953465846,"score_spread":0.3137196300772066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183796916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880264,0.0068064746,0.00009349411,0.0007667038,0.0006454521,0.0032350754,0.000083475206,0.000070022754,0.00027292583],"genre_scores_gemma":[0.993475,0.0020046346,0.0013017491,0.0008026819,0.00044383254,0.000910725,0.00005711303,0.00007555849,0.000928714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99686325,0.0001822568,0.0012021422,0.0008648795,0.0003444678,0.0005430286],"domain_scores_gemma":[0.9964006,0.000955657,0.0008563928,0.00092462753,0.0003116504,0.0005510604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040247958,0.0005412553,0.0013915774,0.00008900753,0.00017118987,0.000036014742,0.00022866578,0.0002935264,0.00004831324],"category_scores_gemma":[0.00026336475,0.00032905964,0.000587522,0.0001529689,0.00056675886,0.000076481985,0.00006413312,0.00006607286,0.000020691934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008185268,0.040543284,0.21885283,0.000047417267,0.001213691,0.00044191294,0.003427923,0.0000025939912,0.000050350398,0.000030752413,0.0022879615,0.72491604],"study_design_scores_gemma":[0.2909936,0.030325724,0.61967075,0.000075454045,0.0011448029,0.00032441472,0.0015869942,0.0025835265,0.0010182764,0.00003112826,0.051877365,0.0003679754],"about_ca_topic_score_codex":0.0002945671,"about_ca_topic_score_gemma":0.000055601467,"teacher_disagreement_score":0.72454804,"about_ca_system_score_codex":0.0024837973,"about_ca_system_score_gemma":0.0012663233,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2187586176","doi":"","title":"Radioimmunotherapy: a novel treatment of non-Hodgkin lymphoma","year":2010,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioimmunotherapy; Ibritumomab tiuxetan; Rituximab; Medicine; Nuclear medicine; CD20; Follicular lymphoma; Lymphoma; Therapeutic index; Internal medicine; Antibody; Immunology; Pharmacology; Monoclonal antibody; Drug","score_opus":0.013794341700579927,"score_gpt":0.28161436353992575,"score_spread":0.26782002183934583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187586176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136896,0.00023266878,0.00011455959,0.0005494658,0.00021623055,0.00042604722,0.00001081191,0.00004210036,0.017039176],"genre_scores_gemma":[0.98874736,0.000207732,0.008070951,0.0002225608,0.00009997204,0.00008593556,0.000015884556,0.00002031065,0.002529274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999253,0.0000042541515,0.00022040159,0.00019610584,0.00015089661,0.00017537255],"domain_scores_gemma":[0.9992944,0.000052544394,0.000060288137,0.0004404989,0.000051427563,0.000100868085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003866514,0.00016503388,0.00035849796,0.00007554957,0.000031726868,0.0000083461755,0.000042145264,0.000082091276,0.00071252754],"category_scores_gemma":[0.0000066216453,0.00010319458,0.00018985017,0.00010185467,0.00005944275,0.000030266363,0.000008031206,0.000017634535,0.000063332845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043104956,0.012179751,0.10450416,0.000022476157,0.00071601965,0.000061973835,0.00063749915,5.605076e-7,0.39372104,0.0022879832,0.00071458,0.48472288],"study_design_scores_gemma":[0.02244918,0.0024161784,0.6095742,0.00002513998,0.00017610536,0.00018588567,0.0000499777,0.00016194265,0.3020448,0.000018521996,0.06276436,0.00013368146],"about_ca_topic_score_codex":0.00081755803,"about_ca_topic_score_gemma":0.00005728744,"teacher_disagreement_score":0.50507003,"about_ca_system_score_codex":0.000112701106,"about_ca_system_score_gemma":0.00013980016,"threshold_uncertainty_score":0.7801677},"labels":[],"label_agreement":null},{"id":"W2188151624","doi":"10.1182/blood.v118.21.1605.1605","title":"CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Internal medicine; Medicine; Gastroenterology; Clinical endpoint; CHOP; Diffuse large B-cell lymphoma; Phases of clinical research; Oncology; Lymphoma; Randomized controlled trial; Chemotherapy","score_opus":0.06869787425977714,"score_gpt":0.3452803908395079,"score_spread":0.27658251657973076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188151624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354924,0.0018194779,0.000028985978,0.00018928661,0.0004367927,0.009973636,0.00010906938,0.00010000152,0.0037934834],"genre_scores_gemma":[0.9925793,0.0009297574,0.0009652774,0.0007237799,0.00021105874,0.0036932272,0.000090876565,0.00008467502,0.0007220447],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775064,0.0001258645,0.0005770045,0.00065599504,0.00031758184,0.000572896],"domain_scores_gemma":[0.9980329,0.000496602,0.0002176093,0.00077113585,0.00015526605,0.00032646983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048581098,0.00044881497,0.0011038167,0.00010957219,0.00023230682,0.00008119639,0.0003381355,0.00012260996,0.0003228319],"category_scores_gemma":[0.00018803096,0.00030988062,0.00027711733,0.00013911485,0.00006432735,0.0001570811,0.00016057308,0.00006414955,0.00019362409],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34596014,0.6368595,0.0058196643,0.000044731318,0.0023540212,0.00043435278,0.0027207574,2.319298e-8,0.000073501535,0.000117732736,0.00053953566,0.0050760633],"study_design_scores_gemma":[0.96723485,0.012420446,0.0013436503,0.00006392202,0.002446686,0.000015944723,0.0003772399,0.00011010762,0.009759913,0.000032203057,0.0058788494,0.00031618774],"about_ca_topic_score_codex":0.00045830433,"about_ca_topic_score_gemma":0.00009505751,"teacher_disagreement_score":0.624439,"about_ca_system_score_codex":0.00008908519,"about_ca_system_score_gemma":0.00012753093,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W2188157087","doi":"","title":"PhD Positions - Program in Sciences & Medical Biotechnology Joint DOCTORAL POSITION UPO-ULaval, Canada AVAILABLE The co-tutoring position is a unique opportunity to enhance the international dimension of doctoral studies both on individual and inter-university lev el.","year":2014,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Position (finance); Dimension (graph theory); Position paper; Joint (building); Library science; Political science; Engineering ethics; Sociology; Computer science; Engineering; Business; World Wide Web; Mathematics","score_opus":0.06564025268116817,"score_gpt":0.33727525573590456,"score_spread":0.27163500305473637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188157087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93652064,0.000059622253,0.000034935536,0.061849706,0.0001363043,0.00050131127,0.00003161868,0.000032531083,0.00083333283],"genre_scores_gemma":[0.9962893,0.00017704682,0.0003542704,0.0029852986,0.000035237237,0.000025289295,0.000026546059,0.000004604075,0.00010241787],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862653,0.00012301771,0.00023913778,0.00028910665,0.0005227333,0.00019946053],"domain_scores_gemma":[0.9992742,0.00019648613,0.00010146853,0.00018848418,0.00010071914,0.00013863278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005687689,0.00013968568,0.00022905452,0.00016610081,0.00027191947,0.00003055112,0.00018280873,0.00008091835,0.00012394805],"category_scores_gemma":[0.00019009112,0.00008185348,0.000040103932,0.00024224918,0.00037821438,0.000096797405,0.00018178992,0.00015620847,0.0000027851484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024517733,0.012355317,0.3305454,0.00037718457,0.0033849382,0.0010954413,0.014302056,0.00009829281,0.045176227,0.16297787,0.19147871,0.23575677],"study_design_scores_gemma":[0.0069245426,0.015140671,0.42740878,0.0037948024,0.0007010806,0.00058234925,0.011118368,0.0037121726,0.49241447,0.0008874886,0.03633238,0.0009828766],"about_ca_topic_score_codex":0.07734797,"about_ca_topic_score_gemma":0.06825153,"teacher_disagreement_score":0.44723824,"about_ca_system_score_codex":0.0004929229,"about_ca_system_score_gemma":0.00045096074,"threshold_uncertainty_score":0.94875044},"labels":[],"label_agreement":null},{"id":"W2190884983","doi":"10.1016/s0140-6736(15)00667-4","title":"Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":462,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Refractory (planetary science); Open label; Medicine; Oncology; Lymphoma; Phases of clinical research; Internal medicine; Clinical trial; Discovery and development of mTOR inhibitors; Materials science; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.10872023234791166,"score_gpt":0.3677079421229318,"score_spread":0.2589877097750201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190884983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820037,0.00008162981,5.735242e-7,0.00046371637,0.00038784262,0.0020455671,0.000038181417,0.000039238545,0.008742902],"genre_scores_gemma":[0.99822724,0.00004366714,0.00017226042,0.0004332582,0.0002545848,0.00023709345,0.00012824155,0.000027547083,0.0004761382],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985834,0.00015579734,0.00027380793,0.0003131357,0.00041964976,0.00025420956],"domain_scores_gemma":[0.99869776,0.0001664131,0.00014193538,0.0007268633,0.00010996067,0.00015706952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046132333,0.00019187816,0.0005292083,0.00006394907,0.0000568517,0.00007221102,0.00046044803,0.000045586123,0.000059603204],"category_scores_gemma":[0.00012143863,0.000097190765,0.000019504867,0.00014839793,0.00004579684,0.0002325831,0.00012018746,0.000080763304,0.000059289647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50305575,0.06402034,0.41007826,0.000013950203,0.00039064273,0.00042603587,0.0021707516,0.0000041560074,0.000010554289,0.000026887155,0.009333771,0.010468888],"study_design_scores_gemma":[0.8329839,0.011776598,0.14496973,0.00005340604,0.00018091407,0.0000050751632,0.0006656828,0.000059568243,0.000056428282,0.00000665063,0.009101759,0.00014028745],"about_ca_topic_score_codex":0.0003601659,"about_ca_topic_score_gemma":0.00014730924,"teacher_disagreement_score":0.32992816,"about_ca_system_score_codex":0.0003171507,"about_ca_system_score_gemma":0.00019503821,"threshold_uncertainty_score":0.39633244},"labels":[],"label_agreement":null},{"id":"W2193707124","doi":"10.1158/1078-0432.ccr-15-2123","title":"Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Quebec - Clinical Research Organization in Cancer; Dalhousie University; University of British Columbia; McGill University; McGill Genome Centre; Hôpital du Sacré-Cœur de Montréal; Concordia University; BC Cancer Agency; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Exome sequencing; Biology; Mutation; Lymphoma; Diffuse large B-cell lymphoma; Cancer; Gene; Somatic evolution in cancer; Exome; Oncology; Medicine; Genetics; Immunology","score_opus":0.1875933151340006,"score_gpt":0.48015110530225413,"score_spread":0.29255779016825356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193707124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98134995,0.012963798,0.0000014442361,0.0009239362,0.00013646422,0.00033367806,0.000025094123,0.000017665092,0.004247979],"genre_scores_gemma":[0.9908833,0.0071303626,0.00017976266,0.00017518002,0.00027271107,0.000084329964,0.00000747792,0.000020165171,0.001246729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979578,0.0002693104,0.00043690932,0.00035253272,0.00062458025,0.00035885567],"domain_scores_gemma":[0.9978539,0.0007637366,0.000072934716,0.00040508842,0.00036168695,0.0005426958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013655944,0.000106132466,0.00040838533,0.00009736847,0.000051457137,0.000014912345,0.00010205889,0.00015338138,0.00012870753],"category_scores_gemma":[0.00066364807,0.000075165764,0.00009592807,0.00019153593,0.0002107571,0.00003359465,0.00015076344,0.00023741444,0.00005781083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011009864,0.0064311773,0.95483696,0.00012925126,0.000090905836,0.00015974724,0.00023460052,3.3397515e-7,0.0001534964,0.00009134647,0.020085307,0.01668589],"study_design_scores_gemma":[0.044867635,0.0031321445,0.8471973,0.00018493224,0.00011785952,0.000013391182,0.00028406281,0.00013427617,0.0014568545,0.00026908217,0.10220816,0.00013431303],"about_ca_topic_score_codex":0.0004054585,"about_ca_topic_score_gemma":0.00011500715,"teacher_disagreement_score":0.10763966,"about_ca_system_score_codex":0.00016009886,"about_ca_system_score_gemma":0.0007296347,"threshold_uncertainty_score":0.3065171},"labels":[],"label_agreement":null},{"id":"W2198189555","doi":"10.1182/blood.v120.21.1586.1586","title":"A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Queen's University; University of Toronto; Toronto General Hospital; University Health Network; BC Cancer Agency; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Cancer research; Biology; Cyclin D1; microRNA; Pathogenesis; Lymphoma; Cell cycle; Immunology; Cell; Gene; Genetics","score_opus":0.009596013486732861,"score_gpt":0.22702645997411647,"score_spread":0.2174304464873836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198189555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527426,0.0126339905,0.000045336943,0.00045638342,0.00005254348,0.0014105738,0.000067206915,0.000029250728,0.000030443403],"genre_scores_gemma":[0.9967356,0.0010781932,0.0011980926,0.00039021717,0.00015787529,0.00020928674,0.00008192748,0.000038112084,0.00011075222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829394,0.000145337,0.00054330606,0.0003473395,0.0003037446,0.0003663356],"domain_scores_gemma":[0.9986854,0.00033597375,0.0002816621,0.00023306956,0.0001248449,0.0003390447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006048827,0.00029187274,0.0005498793,0.00010933178,0.00013169063,0.000029763816,0.00008803405,0.00017585763,0.00002624774],"category_scores_gemma":[0.00025684977,0.00018129287,0.00010308725,0.00019049022,0.000087115695,0.000076866665,0.00007524728,0.000108580796,0.000012891515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052776845,0.0018941085,0.095959716,0.00023753311,0.00022844432,0.000092209215,0.0012084839,4.3890518e-7,0.8968872,0.00005326626,0.000058935348,0.0028519006],"study_design_scores_gemma":[0.01009547,0.00058372447,0.17314787,0.00038740292,0.0010373906,0.000288489,0.00022044998,0.000037729034,0.8136795,0.000044156535,0.0002422391,0.00023557348],"about_ca_topic_score_codex":0.0001540965,"about_ca_topic_score_gemma":0.000005769007,"teacher_disagreement_score":0.0832077,"about_ca_system_score_codex":0.000050160506,"about_ca_system_score_gemma":0.00009820732,"threshold_uncertainty_score":0.73929083},"labels":[],"label_agreement":null},{"id":"W2198963567","doi":"10.1155/2000/201928","title":"Primary Lymphoma of the Liver: A Case Report and Review","year":2000,"lang":"en","type":"review","venue":"Canadian Journal of Gastroenterology and Hepatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Primary (astronomy); Medicine; Physics","score_opus":0.02375639739508762,"score_gpt":0.272109273060841,"score_spread":0.24835287566575337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198963567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020586431,0.9776434,4.1100893e-7,0.000977158,0.00020032542,0.00039608916,0.00004646964,0.0000014675634,0.00014829134],"genre_scores_gemma":[0.003930887,0.9938633,0.000059556052,0.0019951002,0.00006267746,0.000013033962,0.000013584479,0.000016269214,0.000045584828],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.998096,0.00030620332,0.0009975531,0.00021826265,0.000075563585,0.00030640542],"domain_scores_gemma":[0.998121,0.0000885354,0.0008998612,0.00029934227,0.00009777246,0.00049343746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002931895,0.00026706306,0.0025411332,0.00024083565,0.000088377084,0.0000052829346,0.00011108832,0.000258036,0.00009550299],"category_scores_gemma":[0.000070219234,0.00015974535,0.0004318953,0.00008153451,0.0005107177,0.000027931406,0.000030554147,0.00023602531,0.0000014926667],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007040863,0.000066435954,0.064042404,0.013335054,0.00076662045,0.37241128,0.000034648652,4.662229e-9,7.3191337e-9,0.000023990739,0.0040616603,0.5451875],"study_design_scores_gemma":[0.00055478665,0.00052347925,0.0027089948,0.009385679,0.0027695084,0.5691689,0.0000018115162,9.115589e-8,3.8299344e-8,0.0000044194135,0.41484663,0.000035626894],"about_ca_topic_score_codex":0.0015949077,"about_ca_topic_score_gemma":0.010036697,"teacher_disagreement_score":0.5451519,"about_ca_system_score_codex":0.00020195806,"about_ca_system_score_gemma":0.0023742677,"threshold_uncertainty_score":0.6514227},"labels":[],"label_agreement":null},{"id":"W2199710607","doi":"10.1182/blood.v122.21.4277.4277","title":"Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; ABVD; Univariate analysis; Proportional hazards model; Oncology; International Prognostic Index; Survival analysis; Progression-free survival; Multivariate analysis; Surgery; Rituximab; Lymphoma; Overall survival; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.02690904124616717,"score_gpt":0.26691789352268935,"score_spread":0.2400088522765222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199710607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541515,0.00009390051,0.00002232237,0.000046952173,0.000056971174,0.003964394,0.00010271826,0.000039164494,0.0002584406],"genre_scores_gemma":[0.9968788,0.0000056676763,0.0010933846,0.00006538452,0.000031941472,0.0016309968,0.00023105802,0.00003269005,0.000030094669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986023,0.000028900857,0.00026005603,0.00030694937,0.00058235414,0.00021945355],"domain_scores_gemma":[0.99853265,0.00012774159,0.00017069404,0.0002741936,0.0007897628,0.00010497888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000759054,0.00021175794,0.00031965508,0.00009823345,0.000037573045,0.00001494802,0.000056459114,0.00006818086,0.00007139373],"category_scores_gemma":[0.00026348664,0.00013727037,0.00008866103,0.0001317496,0.000032219486,0.00009035273,0.000014857582,0.000022756714,0.000018071869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042973796,0.021667464,0.87490225,0.000078576166,0.00056968274,0.0000023465636,0.00016351976,0.000009148518,0.0010883178,0.000019755724,0.000048509974,0.101020716],"study_design_scores_gemma":[0.059391644,0.0076326584,0.9118897,0.0005294015,0.001401701,0.000004844201,0.000022392973,0.000421036,0.018533729,0.000013717963,0.000025574465,0.00013365631],"about_ca_topic_score_codex":0.0001057162,"about_ca_topic_score_gemma":0.000024351653,"teacher_disagreement_score":0.10088706,"about_ca_system_score_codex":0.0001772589,"about_ca_system_score_gemma":0.00012687252,"threshold_uncertainty_score":0.5597723},"labels":[],"label_agreement":null},{"id":"W2202753625","doi":"10.1200/jco.2006.24.18_suppl.17560","title":"Ten year retrospective analysis of BOP (bleomycin, vincristine, predinisone)—A novel non-myelosuppressive chemotherapy regimen for treatment of non-Hodgkin’s lymphoma","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Regimen; Follicular lymphoma; International Prognostic Index; Vincristine; Rituximab; Population; Gastroenterology; Chemotherapy; Surgery; Oncology; Lymphoma; Cyclophosphamide","score_opus":0.044257092865388356,"score_gpt":0.4109944625329651,"score_spread":0.36673736966757675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202753625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036187,0.0003088807,0.0007430602,0.0027493788,0.00043646173,0.0007531928,0.00016648666,0.0000077906225,0.004472882],"genre_scores_gemma":[0.9797157,0.00075312814,0.017585788,0.00028111832,0.0010560016,0.000044313078,0.00003635381,0.000030658695,0.00049692165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957804,0.00009051156,0.0030038229,0.00035947343,0.00046463954,0.0003011533],"domain_scores_gemma":[0.991889,0.002049489,0.0039448696,0.00040598927,0.0014665646,0.00024411429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089061854,0.00028059073,0.0038364707,0.0003957523,0.00003997278,0.00000693037,0.00017744473,0.00044386866,0.00009011644],"category_scores_gemma":[0.0007306678,0.00018632419,0.0019297746,0.00045353218,0.00025539685,0.00007256503,0.000027897322,0.00009306324,0.0000023059922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011924831,0.025312344,0.9030275,0.000055208417,0.0155791445,0.00017437268,0.00028649572,0.0000820376,0.0019155941,0.0002069844,0.008587249,0.03284825],"study_design_scores_gemma":[0.04364229,0.036894824,0.8960233,0.00010031967,0.009166446,0.000052149197,0.00014311931,0.0006660582,0.00695843,0.0001736922,0.0060502104,0.00012921155],"about_ca_topic_score_codex":0.00038255862,"about_ca_topic_score_gemma":0.000069651396,"teacher_disagreement_score":0.03271904,"about_ca_system_score_codex":0.0008504506,"about_ca_system_score_gemma":0.0013225155,"threshold_uncertainty_score":0.759808},"labels":[],"label_agreement":null},{"id":"W2204619207","doi":"10.1200/jco.2006.24.18_suppl.6544","title":"Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Internal medicine; Salvage therapy; Etoposide; Regimen; Chemotherapy; Lymphoma; Oncology; Progressive disease; Chemotherapy regimen; Peripheral T-cell lymphoma; Anthracycline; Surgery; Gastroenterology; Cancer; T cell; Immunology; Breast cancer","score_opus":0.0552286787571971,"score_gpt":0.3841384925059169,"score_spread":0.3289098137487198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204619207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878369,0.0051814555,0.00023315073,0.0010695657,0.0016831397,0.0009374729,0.00016492986,0.000040476658,0.0028529197],"genre_scores_gemma":[0.9854551,0.0038384267,0.003535662,0.0028266893,0.0014076321,0.000050541454,0.000045855915,0.000119039294,0.0027210363],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920453,0.0006295602,0.0048471396,0.00070404104,0.0007777882,0.0009961849],"domain_scores_gemma":[0.9884072,0.0059121368,0.003613143,0.00062919984,0.00062877114,0.00080956455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026667542,0.00066721183,0.0036553491,0.00033256286,0.00020046432,0.0000435656,0.00039979242,0.0011095746,0.0001701443],"category_scores_gemma":[0.0010180377,0.00044265657,0.0015351338,0.00028118578,0.0003395148,0.00025677326,0.00013538517,0.00031762445,0.000024900313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05172445,0.36492994,0.45774594,0.0005830088,0.00091069454,0.0040052733,0.0003822616,0.0000046689293,0.0017031807,0.00032995787,0.02058546,0.09709516],"study_design_scores_gemma":[0.3840834,0.036419757,0.37049955,0.0001379965,0.0009846024,0.0004118669,0.00024323924,0.00026321723,0.0017703329,0.00014596617,0.20462017,0.00041989243],"about_ca_topic_score_codex":0.000100446996,"about_ca_topic_score_gemma":0.00017351103,"teacher_disagreement_score":0.33235896,"about_ca_system_score_codex":0.00085030386,"about_ca_system_score_gemma":0.0021818406,"threshold_uncertainty_score":0.99980253},"labels":[],"label_agreement":null},{"id":"W2207837802","doi":"10.1038/leu.2015.357","title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cancer research; Lymphoma; Medicine; Immunology; Peripheral T-cell lymphoma; Peripheral; T cell; Biology; Pathology; Internal medicine; Immune system","score_opus":0.03142646855532666,"score_gpt":0.28751407954854125,"score_spread":0.2560876109932146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207837802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754122,0.00043868358,0.000010040841,0.00018766597,0.00010391109,0.00018111693,0.0000040599107,0.00001981935,0.02364249],"genre_scores_gemma":[0.9981344,0.00001907434,0.0012693403,0.00008301871,0.00005140833,0.00004115841,0.00003063233,0.000010662471,0.00036033947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929506,0.000023650007,0.00021514352,0.00014302043,0.0001777886,0.00014531786],"domain_scores_gemma":[0.99955463,0.000048227983,0.00007198054,0.00015664638,0.000060851435,0.000107678265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080637656,0.000092312745,0.0001989167,0.000066918525,0.000016595535,0.0000063046828,0.00003811058,0.000050097136,0.000045443914],"category_scores_gemma":[0.00007276978,0.00007642147,0.000053285272,0.00016749947,0.000027874428,0.000051420302,0.000020664878,0.000051160237,0.000020005295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035545358,0.0016796822,0.8866487,0.00016956271,0.00008251938,0.00023452497,0.007288382,0.00054159865,0.004788865,0.00083343213,0.0033665078,0.09401074],"study_design_scores_gemma":[0.031024102,0.0014501048,0.8222654,0.0006186347,0.00014181537,0.00010212861,0.0035154487,0.004191017,0.124102496,0.00072780513,0.011476002,0.0003850363],"about_ca_topic_score_codex":0.00048650647,"about_ca_topic_score_gemma":0.000040905154,"teacher_disagreement_score":0.119313635,"about_ca_system_score_codex":0.0015118567,"about_ca_system_score_gemma":0.0006054755,"threshold_uncertainty_score":0.39534527},"labels":[],"label_agreement":null},{"id":"W2208894887","doi":"10.1007/978-0-387-92988-0_36","title":"Non-Hodgkin’s Lymphoma","year":2010,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Incidence (geometry); Lymphoma; Rheumatoid arthritis; Immunology","score_opus":0.007682458002656108,"score_gpt":0.26123988009218324,"score_spread":0.25355742208952714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208894887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8129608,0.000016990209,0.000008832542,0.0013831045,0.00024677144,0.00013120881,9.834998e-7,0.000058467827,0.18519285],"genre_scores_gemma":[0.99026656,0.000011742097,0.0022344333,0.0013013041,0.0001600312,0.000032695934,0.000007973807,0.000009816634,0.005975415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950993,0.0000018211564,0.00009072261,0.00014172548,0.000114765586,0.0001410148],"domain_scores_gemma":[0.9995359,0.000020046917,0.00001532967,0.0002618939,0.000032760014,0.00013407654],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000037927202,0.00008173461,0.00012719128,0.000034102235,0.00003333586,0.000012439946,0.00003468226,0.000057431454,0.0017180842],"category_scores_gemma":[0.0000126856585,0.000053119613,0.00006993153,0.000055674383,0.00002518789,0.00002899734,0.000018492967,0.000030060775,0.0010087154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007059925,0.0017252741,0.6823681,0.000020209143,0.0001375669,0.0003242777,0.00011974978,8.0867856e-8,0.01754752,0.0090865465,0.04755395,0.24104613],"study_design_scores_gemma":[0.003132417,0.00017117984,0.85158753,0.000008825559,0.000054221287,0.00016531628,0.000020324416,0.000053778742,0.04654682,0.000095808464,0.098087326,0.00007642612],"about_ca_topic_score_codex":0.00016602577,"about_ca_topic_score_gemma":0.0000601923,"teacher_disagreement_score":0.2409697,"about_ca_system_score_codex":0.00002978733,"about_ca_system_score_gemma":0.00006631293,"threshold_uncertainty_score":0.9997691},"labels":[],"label_agreement":null},{"id":"W2208929471","doi":"","title":"The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CHOP; Fludarabine; Adverse effect; Indirect costs; Lymphoma; Pharmacoeconomics; Internal medicine; Intensive care medicine; Chemotherapy; Accounting; Cyclophosphamide","score_opus":0.026047046865788893,"score_gpt":0.25643167849928505,"score_spread":0.23038463163349615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208929471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939442,0.00009470187,0.0000049155065,0.00045377863,0.00005274317,0.00065222057,0.00003672583,0.000012897725,0.00474781],"genre_scores_gemma":[0.9988189,0.0000976719,0.000100785284,0.00007469115,0.00003984805,0.0005334372,0.000043249114,0.000012234394,0.00027919485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985904,0.00007950289,0.00045058495,0.00025289174,0.00038897665,0.00023762143],"domain_scores_gemma":[0.99881876,0.0002907019,0.0002957398,0.00037395742,0.00012929569,0.00009154963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037757322,0.00012320615,0.00038821495,0.00032485253,0.000048918908,0.000025956453,0.00013146708,0.00006092777,0.000024257115],"category_scores_gemma":[0.0004033795,0.000085196465,0.00017549755,0.0007016819,0.000078663885,0.00010663075,0.000042604883,0.000052601164,9.94974e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013325065,0.000745335,0.86412805,0.000004804414,0.00085888675,0.000020267007,0.00078314886,0.000071786664,0.00001790152,0.00010786646,0.00011745213,0.13301127],"study_design_scores_gemma":[0.0032873184,0.000102375176,0.9894577,0.000033099066,0.00054669677,0.0000036104202,0.0002677348,0.004253679,0.0014401787,0.000005410505,0.00053628755,0.00006587783],"about_ca_topic_score_codex":0.0002706108,"about_ca_topic_score_gemma":0.00021156855,"teacher_disagreement_score":0.13294539,"about_ca_system_score_codex":0.00052594213,"about_ca_system_score_gemma":0.000015826068,"threshold_uncertainty_score":0.3474211},"labels":[],"label_agreement":null},{"id":"W2209623626","doi":"10.5539/gjhs.v8n8p108","title":"BCL-1 Gene Rearrangements in Iranian Non-Hodgkin Lymphoma Patients","year":2015,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Iran National Science Foundation; National Science Foundation","keywords":"Lymphoma; Chromosomal translocation; Mantle cell lymphoma; Gene rearrangement; Incidence (geometry); Cancer research; Gene; Medicine; Non-Hodgkin's lymphoma; Pathology; Internal medicine; Oncology; Biology; Genetics","score_opus":0.03556247207541583,"score_gpt":0.3467797623071213,"score_spread":0.31121729023170547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209623626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950877,0.0007674933,0.000021285648,0.0017269155,0.00068255956,0.00025968225,0.00000736312,0.000005119617,0.0014419004],"genre_scores_gemma":[0.995836,0.00016313202,0.0025384757,0.0013779174,0.00006579045,0.0000025545048,0.0000018121191,0.0000040750165,0.000010198557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974705,0.000035481225,0.00065531925,0.00020214576,0.0011685304,0.00046799652],"domain_scores_gemma":[0.99825865,0.000008377676,0.00039359686,0.00018625942,0.00043847502,0.0007146614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014055432,0.00011913584,0.00036676592,0.0001767542,0.00009036086,0.000033880693,0.00024282093,0.000032597116,0.0000067841897],"category_scores_gemma":[0.00011384338,0.00008629171,0.00006068887,0.0007979509,0.00013029473,0.00026247505,0.000058913167,0.000050459785,0.00003435367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001402153,0.0008841788,0.9077478,0.0000142158315,0.000008958912,0.00013049567,0.00013283183,0.000008524456,0.00001810256,0.00001634363,0.0021788073,0.08871953],"study_design_scores_gemma":[0.008619534,0.0015433492,0.98742235,0.00021596685,0.000012213598,0.00033789972,0.00011141254,0.000034619057,0.00014515257,0.00008846249,0.0014056809,0.00006334288],"about_ca_topic_score_codex":0.0004796986,"about_ca_topic_score_gemma":0.000025393618,"teacher_disagreement_score":0.08865619,"about_ca_system_score_codex":0.0025639327,"about_ca_system_score_gemma":0.0026341209,"threshold_uncertainty_score":0.67045945},"labels":[],"label_agreement":null},{"id":"W2210718864","doi":"10.1378/chest.2272480","title":"Finding Room to Breathe Within Narrow Margins","year":2015,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lung cancer; Crackles; Mediastinal lymphadenopathy; Bronchoalveolar lavage; Lymphoma; Bendamustine; Radiology; Rituximab; Lung; Internal medicine","score_opus":0.06860546088281193,"score_gpt":0.3127677825986632,"score_spread":0.24416232171585128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210718864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843333,0.00051940966,0.00007101921,0.006724626,0.00047557944,0.00013087655,0.0000027492383,0.000024624622,0.007717862],"genre_scores_gemma":[0.99270374,0.000014333286,0.0037123137,0.00090464856,0.00062422425,0.000009052623,0.0000033330762,0.00001808665,0.0020102884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914736,0.00002147429,0.0001965305,0.00012641928,0.00028760722,0.00022064146],"domain_scores_gemma":[0.99896675,0.000024787201,0.00007102723,0.00015568275,0.000099328805,0.0006824415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303858,0.0001181645,0.00020081547,0.00009280212,0.000092840564,0.00006626484,0.000073615025,0.000049757607,0.00011619962],"category_scores_gemma":[0.00011471902,0.0000798612,0.000084399835,0.000120139295,0.000013262697,0.0000710599,0.000025751508,0.00014068872,0.0003299437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043603303,0.0012812333,0.79678434,0.000055955967,0.0003447593,0.004497059,0.013647406,0.0001805686,0.0017729525,0.00049821363,0.16344948,0.01705197],"study_design_scores_gemma":[0.0111719305,0.00201217,0.746538,0.0005527462,0.00038201528,0.015246473,0.0026512349,0.00014238751,0.019555522,0.0007379631,0.20060849,0.00040106726],"about_ca_topic_score_codex":0.000019341294,"about_ca_topic_score_gemma":0.000007960043,"teacher_disagreement_score":0.050246377,"about_ca_system_score_codex":0.00043460686,"about_ca_system_score_gemma":0.00025315894,"threshold_uncertainty_score":0.42408687},"labels":[],"label_agreement":null},{"id":"W2213105167","doi":"10.1200/jco.2015.33.18_suppl.lba8502","title":"GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Obinutuzumab; Bendamustine; Rituximab; Internal medicine; Clinical endpoint; Refractory (planetary science); Neutropenia; Gastroenterology; Surgery; Lymphoma; Clinical trial; Chemotherapy","score_opus":0.09359959574866157,"score_gpt":0.40353619201802515,"score_spread":0.3099365962693636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2213105167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967416,0.00023078556,0.000022218772,0.00047597234,0.000519135,0.0012472098,0.00012205113,0.000013454281,0.0006275998],"genre_scores_gemma":[0.9953513,0.000069284615,0.0032302828,0.0005312804,0.0005389474,0.000023404926,0.00018619263,0.00004077383,0.000028493869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926614,0.00056120387,0.0045247213,0.00053266075,0.0013020254,0.0004179949],"domain_scores_gemma":[0.9911011,0.0019248915,0.00420284,0.00055741577,0.001356527,0.0008572441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002048253,0.00041522202,0.0041306727,0.00034703032,0.000040465973,0.000012407366,0.0002835122,0.00034002506,0.000029981402],"category_scores_gemma":[0.0011145304,0.0002523614,0.00023748739,0.00038307445,0.0002803644,0.00019627945,0.00013255232,0.0006609939,0.000007870681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3666448,0.14237383,0.43739995,0.000033743716,0.0015932041,0.0037622298,0.0023895947,0.00039669633,0.000008195033,0.0000010397345,0.0020206412,0.04337607],"study_design_scores_gemma":[0.40138125,0.09015692,0.5049401,0.00038999206,0.0008486646,0.000050708706,0.0006947863,0.000115019284,0.000021160553,0.0000035085407,0.0012584452,0.00013946886],"about_ca_topic_score_codex":0.0014688489,"about_ca_topic_score_gemma":0.0008764546,"teacher_disagreement_score":0.067540124,"about_ca_system_score_codex":0.002213396,"about_ca_system_score_gemma":0.006587294,"threshold_uncertainty_score":0.99999285},"labels":[],"label_agreement":null},{"id":"W2214065438","doi":"10.1182/blood.v122.21.4292.4292","title":"Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vincristine; Mantle cell lymphoma; Radiation therapy; CHOP; Rituximab; Univariate analysis; Cyclophosphamide; Surgery; Internal medicine; Chemotherapy; Stage (stratigraphy); Median follow-up; Lymphoma; Prednisone; Oncology; Gastroenterology; Multivariate analysis","score_opus":0.015496779654960945,"score_gpt":0.27473944238643694,"score_spread":0.259242662731476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214065438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434686,0.00035903585,0.000012390783,0.0019599095,0.00030147893,0.001591102,0.000093804716,0.000035527806,0.0012998877],"genre_scores_gemma":[0.9957524,0.00014038211,0.001071308,0.0008511265,0.00011008621,0.000414316,0.0003721507,0.000032794134,0.0012554689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800634,0.00010541411,0.000781569,0.0003994564,0.0004400576,0.0002671681],"domain_scores_gemma":[0.99852484,0.00024949695,0.00046999796,0.0005266585,0.00012886057,0.00010012936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027727606,0.00022771658,0.000534698,0.00008637145,0.00007052847,0.000029325029,0.00021251863,0.00014487091,0.00053750514],"category_scores_gemma":[0.0001065867,0.00014134363,0.00013188641,0.00015933787,0.00006932283,0.00015961319,0.00008393117,0.000052462707,0.000030474755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043271133,0.019856183,0.9627676,0.000029059494,0.00034876252,0.00023639559,0.00065765233,0.000002096941,0.00074713485,0.000043539236,0.0010530278,0.013825816],"study_design_scores_gemma":[0.05050353,0.0012986205,0.9321078,0.00004581928,0.00015802875,0.000033980432,0.00014498144,0.00015795059,0.006089452,0.00008142117,0.009232582,0.0001458151],"about_ca_topic_score_codex":0.012194137,"about_ca_topic_score_gemma":0.00042141948,"teacher_disagreement_score":0.05007082,"about_ca_system_score_codex":0.00057816214,"about_ca_system_score_gemma":0.00026950476,"threshold_uncertainty_score":0.99438375},"labels":[],"label_agreement":null},{"id":"W2214404358","doi":"10.1111/bjh.13876","title":"Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Epidemiology; Internal medicine; Follicular lymphoma; Gastroenterology","score_opus":0.06435771200033749,"score_gpt":0.29654128465463137,"score_spread":0.23218357265429387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214404358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10795533,0.8908171,2.8197144e-7,0.000091414346,0.000065240376,0.00079555943,0.000098901706,0.0000022926563,0.00017388152],"genre_scores_gemma":[0.047442265,0.9522212,0.00016489743,0.000032710173,0.000028781842,0.000040009603,0.000036646972,0.000024055806,0.000009439398],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9965336,0.0006775419,0.0019545252,0.00023396505,0.00031632546,0.00028405982],"domain_scores_gemma":[0.9965459,0.0006520831,0.0019347769,0.0002041093,0.0005342628,0.00012884686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058627845,0.00029364374,0.004323175,0.00037753856,0.000023069564,0.000008261087,0.00019739187,0.00024731757,0.000031308526],"category_scores_gemma":[0.0013246194,0.00020542534,0.00032337382,0.00091085915,0.000236777,0.00008643898,0.00006280332,0.000325679,0.0000025885527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105661864,0.0021563314,0.057739917,0.1078513,0.0014268644,0.15118553,0.0017529749,1.4392289e-7,2.4049024e-7,0.0001707132,0.0020068313,0.6756035],"study_design_scores_gemma":[0.0042025046,0.0008350295,0.050762612,0.4418879,0.0029222057,0.463151,0.00024128915,5.2646726e-7,0.0000022948414,0.00008193358,0.03565916,0.00025354215],"about_ca_topic_score_codex":0.0008719615,"about_ca_topic_score_gemma":0.002111536,"teacher_disagreement_score":0.67534995,"about_ca_system_score_codex":0.00036030303,"about_ca_system_score_gemma":0.0018880063,"threshold_uncertainty_score":0.83770025},"labels":[],"label_agreement":null},{"id":"W2215631084","doi":"10.1182/blood.v122.21.4394.4394","title":"Siltuximab Reverses Muscle Wasting In Patients With Multicentric Castleman’s Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Wasting","score_opus":0.006031593902683029,"score_gpt":0.19581289054301224,"score_spread":0.1897812966403292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215631084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834245,0.00023390538,6.0989476e-7,0.00018507086,0.0000289352,0.0006765953,0.000008363578,0.000028900933,0.0004951425],"genre_scores_gemma":[0.999033,0.000014684921,0.0005180515,0.00016065626,0.000032791828,0.00010372918,0.000030286526,0.000014772562,0.00009207043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923086,0.00001559557,0.0001395784,0.00020247781,0.00018997882,0.0002214969],"domain_scores_gemma":[0.99946284,0.000042248572,0.000045544388,0.00019876657,0.000066447086,0.00018413775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021256335,0.000115748204,0.00016267307,0.0000673175,0.00003471291,0.000016925174,0.000033510012,0.000023212322,0.0001568035],"category_scores_gemma":[0.0000790526,0.000078566,0.000035277317,0.00013500193,0.000017863895,0.00009076615,0.00002559003,0.000041114024,0.00015781198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003426675,0.0051154424,0.99082303,0.00005529139,0.000041548752,0.00014351458,0.00009140746,0.000002680356,0.000013184684,0.0000050132207,0.00014981511,0.0035247952],"study_design_scores_gemma":[0.01807295,0.00018719757,0.9808578,0.00021075233,0.00023200235,0.0000021419153,0.000055979002,0.00005023036,0.00012801784,0.0000036053711,0.000107375134,0.000091938906],"about_ca_topic_score_codex":0.00023970786,"about_ca_topic_score_gemma":0.000012681794,"teacher_disagreement_score":0.018038683,"about_ca_system_score_codex":0.00006462496,"about_ca_system_score_gemma":0.00004578234,"threshold_uncertainty_score":0.32038286},"labels":[],"label_agreement":null},{"id":"W2216659987","doi":"10.1182/blood-2015-05-647602","title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Chugai Pharmaceutical; Sunesis; Celgene; Amgen","keywords":"Internal medicine; Oncology; Medicine; Overall survival","score_opus":0.0189819917800764,"score_gpt":0.24759458164756087,"score_spread":0.22861258986748448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216659987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966554,0.00010956862,2.3574796e-7,0.000039410494,0.00005364902,0.0013040797,0.000038600505,0.000033892822,0.0017651469],"genre_scores_gemma":[0.9995178,0.000020195142,0.00007281848,0.000029152978,0.00002976427,0.0001304125,0.000045274188,0.000028490223,0.00012611957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865365,0.00009379007,0.00029408323,0.00027953938,0.0004710606,0.00020790196],"domain_scores_gemma":[0.9991144,0.000041984218,0.00017079746,0.00032831918,0.00021661558,0.00012789888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012875807,0.00020348893,0.00048211723,0.00012163056,0.00002102528,0.000008885024,0.000074108204,0.00005490807,0.000020895353],"category_scores_gemma":[0.000057002508,0.0001383221,0.000050905237,0.00030550102,0.000044539625,0.000057283978,0.000029905734,0.000060982962,0.000008548671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009127121,0.029157305,0.964929,0.00001821114,0.0010369165,0.00010715908,0.0033094322,6.562691e-7,0.000055701625,0.0000011259078,0.00009309221,0.00037872232],"study_design_scores_gemma":[0.07229102,0.004809163,0.9158638,0.00017877524,0.00045505902,0.0000026754221,0.0021179016,0.0000018042657,0.004133223,0.000004278756,0.00003397591,0.00010832876],"about_ca_topic_score_codex":0.0010036167,"about_ca_topic_score_gemma":0.00023177252,"teacher_disagreement_score":0.071378306,"about_ca_system_score_codex":0.00012668494,"about_ca_system_score_gemma":0.00008819848,"threshold_uncertainty_score":0.56406116},"labels":[],"label_agreement":null},{"id":"W2220332556","doi":"10.1111/bjh.13885","title":"Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Epidemiology; Medicine; Follicular lymphoma; Internal medicine; Demography; Human immunodeficiency virus (HIV); Oncology; Immunology","score_opus":0.0644318610691131,"score_gpt":0.3120596814207806,"score_spread":0.24762782035166753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220332556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481785,0.044671807,0.00003241506,0.0045268903,0.00045223106,0.00051270536,0.00010184981,0.000009434497,0.0015141674],"genre_scores_gemma":[0.9879562,0.009972459,0.000737153,0.00088685617,0.0002139963,0.00005456445,0.00005485019,0.000024677038,0.000099241865],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99755275,0.00021069315,0.0011797631,0.00024465655,0.00056446274,0.0002476871],"domain_scores_gemma":[0.9976826,0.0003952939,0.00091942464,0.00027859924,0.00059331633,0.00013082127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082810095,0.0001906882,0.00097311195,0.00016160063,0.0000409415,0.000035267512,0.00036657418,0.00013806227,0.00009210833],"category_scores_gemma":[0.0009873385,0.00014551767,0.00025566536,0.0002627234,0.00015129328,0.0001251146,0.00007698106,0.00011170851,0.00003803161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016667446,0.006898042,0.31390575,0.0012973105,0.001756972,0.115159646,0.0064147143,0.000004626595,0.0004778578,0.0003640234,0.21389987,0.33815446],"study_design_scores_gemma":[0.031180397,0.0017691862,0.3934801,0.038250726,0.0013304054,0.46959716,0.008467563,0.00033041264,0.001908595,0.0007401075,0.052387204,0.0005581502],"about_ca_topic_score_codex":0.0028648167,"about_ca_topic_score_gemma":0.0005188333,"teacher_disagreement_score":0.35443753,"about_ca_system_score_codex":0.00042775687,"about_ca_system_score_gemma":0.0012071322,"threshold_uncertainty_score":0.5934038},"labels":[],"label_agreement":null},{"id":"W2224648422","doi":"10.1182/blood.v124.21.1630.1630","title":"Prognostic Impact of Extranodal Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy and PET/CT Staging","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Diffuse large B-cell lymphoma; Univariate analysis; International Prognostic Index; B symptoms; Lymphoma; Internal medicine; Proportional hazards model; Radiology; Nuclear medicine; Gastroenterology; Multivariate analysis","score_opus":0.006198984263775764,"score_gpt":0.24663351963893818,"score_spread":0.2404345353751624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224648422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974878,0.001540344,0.0000041668245,0.00010418976,0.000011363175,0.0003448254,0.000015987223,0.000008408144,0.00048293226],"genre_scores_gemma":[0.9994287,0.00027549692,0.0001508882,0.000070539485,0.000018902669,0.00002201246,0.000009652066,0.000013470384,0.000010367116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992529,0.000058877828,0.00021367484,0.00013630811,0.0001584063,0.00017982571],"domain_scores_gemma":[0.9993893,0.00019702676,0.00008658008,0.000259145,0.000027283724,0.000040655206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020254722,0.00012439612,0.00028334887,0.00004665582,0.000022723643,0.000008981615,0.00006727784,0.000009815321,0.000016788592],"category_scores_gemma":[0.000035089593,0.00007185474,0.000106745305,0.00010003469,0.000043479165,0.00002848331,0.000014586543,0.000042271357,0.0000014127436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008705836,0.018472347,0.9697575,0.00010829232,0.00014211178,0.00012621812,0.00080763205,2.5274238e-7,0.0064152917,0.00007987886,0.00001648312,0.0039869105],"study_design_scores_gemma":[0.041144285,0.0009015661,0.9337191,0.00015915811,0.000196476,0.00023613794,0.00013284954,0.00007223357,0.023293713,0.000037172886,0.000038300048,0.00006898544],"about_ca_topic_score_codex":0.00028585424,"about_ca_topic_score_gemma":0.000008397601,"teacher_disagreement_score":0.041057225,"about_ca_system_score_codex":0.000021657968,"about_ca_system_score_gemma":0.00006477221,"threshold_uncertainty_score":0.29301512},"labels":[],"label_agreement":null},{"id":"W2240490390","doi":"10.4049/jimmunol.188.supp.163.15","title":"SLAM/ SAP signaling positively regulates the differentiation of TH17 cells and experimental autoimmune encephalitis (163.15)","year":2012,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Experimental autoimmune encephalomyelitis; Biology; Effector; Cell biology; Autoimmune encephalitis; Immune system; Immunology; Receptor; T cell; Cellular differentiation; Autoimmune disease; Signal transduction; Antibody; Encephalitis; Virus; Gene; Genetics","score_opus":0.011793330903788962,"score_gpt":0.24997632566138434,"score_spread":0.23818299475759538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240490390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618848,0.036700252,0.000019588002,0.00090037985,0.00024317195,0.00013442418,0.0000030968624,0.0000040382806,0.000110278874],"genre_scores_gemma":[0.99861765,0.0010242497,0.00009787542,0.00008381221,0.00008888377,0.0000031372085,0.0000020778853,0.000008566737,0.000073728675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990514,0.00021105884,0.0003628215,0.000049751376,0.00014778602,0.00017718096],"domain_scores_gemma":[0.99900985,0.00030947107,0.00040942105,0.00015108369,0.000088121575,0.000032069333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003808496,0.000108826964,0.00029254478,0.00005520938,0.00010824945,0.000008216749,0.00010359223,0.000056862224,0.00009817576],"category_scores_gemma":[0.000023370178,0.00005207636,0.00009229205,0.00005377284,0.00020865696,0.00009958667,0.000054928747,0.000117963486,0.0000037606392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042823533,0.00040858978,0.00901907,0.0000066308357,0.00059607066,0.00000609712,0.0052989717,0.0000039745773,0.9817238,0.00039404165,0.000064442655,0.0020500608],"study_design_scores_gemma":[0.0012440567,0.0005618682,0.37030953,0.00007810093,0.0002352443,0.0005552542,0.0017723445,0.0000061245473,0.62509614,0.000047557267,0.00005993464,0.00003385151],"about_ca_topic_score_codex":0.00007642605,"about_ca_topic_score_gemma":5.729211e-7,"teacher_disagreement_score":0.36129045,"about_ca_system_score_codex":0.000073693096,"about_ca_system_score_gemma":0.000032885357,"threshold_uncertainty_score":0.21236123},"labels":[],"label_agreement":null},{"id":"W2243412420","doi":"10.1200/jco.2013.31.15_suppl.2574","title":"Phase I study of inotuzumab ozogamicin (INO) combined with R-GDP for relapsed CD22+ B-cell non-Hodgkin lymphoma (B-NHL).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Gastroenterology; Neutropenia; Rituximab; Internal medicine; Calicheamicin; Febrile neutropenia; Toxicity; Lymphoma; Gemcitabine; Regimen; Chemotherapy","score_opus":0.07489875581887857,"score_gpt":0.43374164324938835,"score_spread":0.3588428874305098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243412420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361694,0.0001246108,0.00009564321,0.0022894193,0.00066806126,0.0018720885,0.0000077824025,0.00001068821,0.001314756],"genre_scores_gemma":[0.9940428,0.000120296914,0.0037973304,0.0010487647,0.00042240557,0.00008658502,0.0000065299737,0.000035790694,0.00043945544],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9954311,0.0003179933,0.0031032814,0.0003077102,0.00049592933,0.00034395032],"domain_scores_gemma":[0.991989,0.0033812185,0.0027271747,0.00040308337,0.0010056564,0.0004938611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015403207,0.00026874628,0.0025841792,0.00019315249,0.000058631544,0.000013662768,0.00023516885,0.00035438847,0.00013966681],"category_scores_gemma":[0.00088240666,0.00016137217,0.0005540073,0.00018846647,0.00018388349,0.00014642192,0.0000555141,0.00030729393,0.000032669563],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06483603,0.2999313,0.27170694,0.00015934321,0.0030212929,0.001588211,0.0010052554,0.000026225836,0.001007153,0.00006977425,0.029002966,0.32764554],"study_design_scores_gemma":[0.3244532,0.41190994,0.2527269,0.00015106415,0.0017556995,0.00020784598,0.0010697296,0.0002740798,0.0018072597,0.00012473855,0.0053554745,0.0001640476],"about_ca_topic_score_codex":0.0002204055,"about_ca_topic_score_gemma":0.0000776655,"teacher_disagreement_score":0.3274815,"about_ca_system_score_codex":0.00034244513,"about_ca_system_score_gemma":0.0017428005,"threshold_uncertainty_score":0.6580566},"labels":[],"label_agreement":null},{"id":"W2244528295","doi":"10.1200/jco.2004.22.14_suppl.6526","title":"CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma (DLBCL)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; CHOP; Internal medicine; Oncology; Lymphoma; Stage (stratigraphy); Rituximab; Biology","score_opus":0.053011621939452344,"score_gpt":0.40569978897706094,"score_spread":0.3526881670376086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244528295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933491,0.0019183612,0.0000079386655,0.0035502098,0.00031819945,0.0003692672,0.0000033459135,0.000005826222,0.00047777506],"genre_scores_gemma":[0.9918164,0.0050408253,0.00060894946,0.0022333676,0.00023170956,0.000014316388,0.0000010299213,0.000012937532,0.0000404813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690807,0.00032286078,0.0019369511,0.00017243081,0.00040537486,0.00025431017],"domain_scores_gemma":[0.9953539,0.0024936649,0.001429491,0.00027396705,0.00022683376,0.00022217874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016151316,0.00015844665,0.0011323602,0.00010961145,0.000037601683,0.0000045853812,0.00021508617,0.0002850798,0.00002611621],"category_scores_gemma":[0.0018079606,0.00007920429,0.0004716337,0.00016871252,0.00018111487,0.00012781669,0.0000583242,0.00032897305,0.000014991039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036477274,0.086351134,0.8731461,0.00003458794,0.0001744607,0.0013224476,0.00051408756,0.000105451494,0.00085857906,0.00012219018,0.0003942691,0.03332894],"study_design_scores_gemma":[0.11555936,0.0063386187,0.8629396,0.0003422294,0.00011509977,0.00013717913,0.00015612523,0.0000063422804,0.0014793478,0.000299119,0.012560745,0.000066208166],"about_ca_topic_score_codex":0.00004335996,"about_ca_topic_score_gemma":0.000034133518,"teacher_disagreement_score":0.11191163,"about_ca_system_score_codex":0.0002669558,"about_ca_system_score_gemma":0.0014584194,"threshold_uncertainty_score":0.32298574},"labels":[],"label_agreement":null},{"id":"W2246539308","doi":"10.1200/jco.2007.25.18_suppl.8004","title":"Cyclophosphamide and fludarabine (CF) in advanced indolent lymphoma: Results from the ECOG/CALGB intergroup E1496 trial","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cyclophosphamide; Fludarabine; Vincristine; Gastroenterology; Internal medicine; Randomized controlled trial; Randomization; Prednisone; Surgery; Chemotherapy","score_opus":0.07671177949783103,"score_gpt":0.43714446991985567,"score_spread":0.36043269042202464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246539308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805476,0.002092035,0.000024695315,0.012976786,0.0024233563,0.00043894508,0.000012709157,0.0000077178065,0.0014761342],"genre_scores_gemma":[0.9895291,0.003124169,0.0016470238,0.0037721915,0.0018322384,0.0000070697392,0.000008963233,0.000014302104,0.0000649748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9951118,0.00034247054,0.0035685438,0.00029805562,0.00036670192,0.00031241024],"domain_scores_gemma":[0.9875169,0.010062913,0.0015730067,0.0002798789,0.00017607489,0.0003912257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052379505,0.00019215255,0.0014849105,0.0000953157,0.00004254478,0.000013036053,0.00017554713,0.0003826344,0.000033426593],"category_scores_gemma":[0.0069706626,0.00010576144,0.00039453455,0.00015325227,0.00021945109,0.00009557227,0.00009689347,0.00052088825,0.000014324798],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25939775,0.0052089584,0.09732447,0.00000428,0.00031056252,0.0026337288,0.00029355625,0.000004022542,0.000035310914,0.00004968454,0.0022044922,0.6325332],"study_design_scores_gemma":[0.26202312,0.011981304,0.6859673,0.00017063796,0.00020524336,0.00015507337,0.00020453459,0.0000120462255,0.00017305529,0.00028426564,0.038746558,0.00007683982],"about_ca_topic_score_codex":0.00021472461,"about_ca_topic_score_gemma":0.0006991801,"teacher_disagreement_score":0.63245636,"about_ca_system_score_codex":0.0004318192,"about_ca_system_score_gemma":0.0007470053,"threshold_uncertainty_score":0.83450377},"labels":[],"label_agreement":null},{"id":"W2249623145","doi":"10.1200/jco.2010.28.15_suppl.e18564","title":"Economic burden of relapsed/refractory diffuse large B-cell non-Hodgkin's lymphoma (DLBCL): A review of the literature.","year":2010,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Population; Oncology; Lymphoma; Internal medicine; Intensive care medicine; Environmental health","score_opus":0.058520778799501134,"score_gpt":0.43620388201748145,"score_spread":0.3776831032179803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249623145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032622465,0.98795426,6.877209e-7,0.0011144308,0.0036281766,0.0010318153,0.000116233176,0.0000043666437,0.0028878136],"genre_scores_gemma":[0.0011543554,0.99447185,0.00037961212,0.001110225,0.0022244374,0.000027943335,0.000025740319,0.000060905153,0.00054496306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900397,0.0011795033,0.007549695,0.0003916151,0.000489171,0.00035030543],"domain_scores_gemma":[0.9793066,0.004835482,0.013788644,0.0010901656,0.0005319627,0.00044718443],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004480032,0.00052635116,0.010453634,0.00021654539,0.00003969859,0.000010163483,0.0007884479,0.0018271588,0.00020988539],"category_scores_gemma":[0.0028010393,0.00026254388,0.0061690686,0.00022647243,0.00031230637,0.000089028516,0.00024596465,0.0018085705,0.0000570185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027516836,0.014649976,0.00037292417,0.04260355,0.0012541832,0.00046130188,0.000049675346,4.0171127e-8,8.776633e-7,0.00005222328,0.016088355,0.9241917],"study_design_scores_gemma":[0.016098721,0.0045359326,0.00086263684,0.13261399,0.0075653982,0.0008555579,0.0000064165506,7.160212e-7,0.0000041425865,0.000020235304,0.8372788,0.00015750191],"about_ca_topic_score_codex":0.000016205187,"about_ca_topic_score_gemma":0.000010825722,"teacher_disagreement_score":0.92403424,"about_ca_system_score_codex":0.00056290376,"about_ca_system_score_gemma":0.008649386,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W2249669966","doi":"10.1182/blood.v106.11.350.350","title":"Mabthera (Rituximab) Plus CVP Chemotherapy for First-Line Treatment of Stage III/IV Follicular Non-Hodgkin’s Lymphoma (NHL): Confirmed Efficacy with Longer Follow-Up.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; International Prognostic Index; Surgery; Lymphoma","score_opus":0.016765597841438107,"score_gpt":0.26862097987216554,"score_spread":0.25185538203072744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249669966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910028,0.0025743293,0.00027661567,0.0016550171,0.000104282,0.0034552405,0.00012851018,0.000107231965,0.00069594715],"genre_scores_gemma":[0.98966414,0.0010364208,0.0036240981,0.00051555276,0.00039287953,0.0009440995,0.00020394976,0.000121886194,0.0034969933],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976878,0.000024604427,0.0005817987,0.00066468253,0.00043802508,0.0006030921],"domain_scores_gemma":[0.99821013,0.00020724797,0.0002707607,0.00082925847,0.00019107515,0.00029152696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010463326,0.00058253965,0.0012763116,0.00013596586,0.00014027317,0.000033625536,0.00014325694,0.00019132318,0.00032639454],"category_scores_gemma":[0.00001532793,0.0003961063,0.0005281764,0.00020440521,0.000113429836,0.00008256468,0.000019137813,0.000038023576,0.000043115764],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055625908,0.27559105,0.1070316,0.0015241979,0.03378106,0.0025134408,0.017249504,0.00049862283,0.012558251,0.0011751836,0.0046859565,0.48776522],"study_design_scores_gemma":[0.60550445,0.014569877,0.04568483,0.00043083666,0.0033805133,0.00020157061,0.00019654538,0.00076289126,0.25067014,0.000013737611,0.07784032,0.00074426853],"about_ca_topic_score_codex":0.00031861832,"about_ca_topic_score_gemma":0.0002406949,"teacher_disagreement_score":0.54987854,"about_ca_system_score_codex":0.00048633135,"about_ca_system_score_gemma":0.00038257436,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W2253719787","doi":"10.1182/blood.v122.21.1821.1821","title":"Phase I Study Of Inotuzumab Ozogamicin (InO) Combined With R-GDP For Relapsed/Refractory CD22+ B-Cell Non-Hodgkin Lymphoma (B-NHL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Calicheamicin; Internal medicine; Rituximab; Refractory (planetary science); Gastroenterology; Regimen; Adverse effect; Neutropenia; Febrile neutropenia; Lymphoma; Toxicity","score_opus":0.012222366603137521,"score_gpt":0.2561606938958768,"score_spread":0.2439383272927393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253719787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404657,0.00023421993,0.00001952297,0.00012250945,0.000101151854,0.003953214,0.000039334478,0.00006642758,0.0014170464],"genre_scores_gemma":[0.99701256,0.00002977757,0.0008397909,0.0001689457,0.00008779919,0.00091620977,0.00006961026,0.000067007495,0.00080828764],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815154,0.000046621997,0.00051760266,0.00048471964,0.00039593436,0.00040356023],"domain_scores_gemma":[0.9983101,0.00021507255,0.00027197166,0.00071802206,0.0002562868,0.00022854243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001168811,0.00035360843,0.0007386013,0.00016169944,0.000097727905,0.000027058337,0.00015527966,0.000121684614,0.000104373124],"category_scores_gemma":[0.00003415879,0.00025001995,0.00014971055,0.00021658135,0.000067845445,0.00013055018,0.000052208645,0.00007060451,0.00007568809],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068334085,0.59072953,0.31447694,0.00070912373,0.0030551662,0.0005609685,0.0051157274,0.000007225827,0.029841477,0.000096179625,0.00864891,0.03992532],"study_design_scores_gemma":[0.5271458,0.11917679,0.17127639,0.00029081854,0.0031041945,0.00007787016,0.002494357,0.00015848684,0.17459284,0.000047772588,0.0010997106,0.000534948],"about_ca_topic_score_codex":0.0009660038,"about_ca_topic_score_gemma":0.000074008945,"teacher_disagreement_score":0.5203124,"about_ca_system_score_codex":0.00013797493,"about_ca_system_score_gemma":0.00023431722,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2254870088","doi":"10.1016/j.clml.2016.01.001","title":"Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Bendamustine; Vincristine; Internal medicine; Prednisone; CHOP; Quality of life (healthcare); Nausea; Cyclophosphamide; Oncology; Lymphoma; Surgery; Chemotherapy","score_opus":0.031877460195867464,"score_gpt":0.3067462599513314,"score_spread":0.27486879975546397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254870088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964727,0.00046697303,0.000018777837,0.00030195626,0.00016408638,0.0018567237,0.00019504862,0.000088871035,0.00043484615],"genre_scores_gemma":[0.9973872,0.0007403308,0.0007733208,0.00031820463,0.00014101063,0.00021850028,0.00009926503,0.0000970298,0.00022519636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992795,0.00054071355,0.0031169958,0.0015411534,0.0009223843,0.0010837851],"domain_scores_gemma":[0.9938653,0.002794481,0.001085253,0.001099768,0.0003000396,0.0008551568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093040586,0.0008776346,0.003027214,0.00041957982,0.00009803984,0.000043450156,0.00041886282,0.0006329865,0.000094855575],"category_scores_gemma":[0.0011327787,0.0005182326,0.0003172301,0.00078035763,0.00068432844,0.0003207506,0.00031402515,0.00013140967,0.00006066167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006827441,0.00370928,0.60455614,0.00021595559,0.00015490329,0.00010701019,0.0001486363,3.3893147e-7,0.000036749003,0.000018439907,0.000051373918,0.38417372],"study_design_scores_gemma":[0.13320395,0.003827262,0.85900664,0.0018172495,0.00021919035,0.000008180172,0.00011060446,0.000027530205,0.0009965509,0.000034079258,0.00014446619,0.0006043165],"about_ca_topic_score_codex":0.0011615185,"about_ca_topic_score_gemma":0.00053404237,"teacher_disagreement_score":0.3835694,"about_ca_system_score_codex":0.0018751938,"about_ca_system_score_gemma":0.002086119,"threshold_uncertainty_score":0.99972695},"labels":[],"label_agreement":null},{"id":"W2256261346","doi":"10.1200/jco.2007.25.18_suppl.8089","title":"Cost-effectiveness of tositumomab and iodine I-131 tositumomab (Bexxar therapeutic regimen (BTR)), in treatment of non- Hodgkin lymphoma (NHL)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Cost effectiveness; Oncology; Internal medicine; Regimen; Progression-free survival; Overall survival","score_opus":0.1402994411472832,"score_gpt":0.4780220877665644,"score_spread":0.3377226466192812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256261346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926651,0.0032549652,0.00013521835,0.0008227304,0.00043480992,0.0008057479,0.000006269097,0.000005237123,0.0018699251],"genre_scores_gemma":[0.995791,0.0025875322,0.0010681864,0.00022376544,0.00024456502,0.00001916497,0.000003985173,0.000020145966,0.000041658986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958777,0.0005227472,0.002616327,0.00028174085,0.00037039895,0.0003311166],"domain_scores_gemma":[0.99207014,0.0052727326,0.0016972905,0.0002854047,0.00032913778,0.00034529882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035529274,0.0002577167,0.0026912636,0.000307758,0.000026691027,0.0000050496674,0.00012402737,0.0003884984,0.00002564361],"category_scores_gemma":[0.0003433586,0.00017022854,0.00062012015,0.0002469044,0.00031371068,0.000087980894,0.000041810254,0.0001682566,0.0000032460732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019446315,0.016650243,0.51259726,0.000114739116,0.0011771021,0.0020181632,0.00027937663,0.000014490231,0.002763521,0.00017554489,0.000049660062,0.4447136],"study_design_scores_gemma":[0.050340377,0.046162326,0.8759785,0.00041759116,0.00088882924,0.0007942579,0.0001540718,0.00004143073,0.022383882,0.00014402623,0.0025812762,0.00011341201],"about_ca_topic_score_codex":0.0001857874,"about_ca_topic_score_gemma":0.0000873095,"teacher_disagreement_score":0.44460016,"about_ca_system_score_codex":0.00076143135,"about_ca_system_score_gemma":0.0010501185,"threshold_uncertainty_score":0.69417185},"labels":[],"label_agreement":null},{"id":"W2260128833","doi":"10.1158/1557-3265.hemmal14-b12","title":"Abstract B12: EIF4E deregulation drives simultaneous expression of B-cell lymphoma oncogenes.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Biology; Nuclear export signal; Cancer research; Oncogene; Eukaryotic translation; Translation (biology); EIF4A1; Messenger RNA; Molecular biology; Cell cycle; Cell biology; Gene; Cytoplasm; Cell nucleus; Genetics","score_opus":0.26007171454945693,"score_gpt":0.5127443101287255,"score_spread":0.2526725955792685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260128833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896121,0.0028673832,0.000007124462,0.00068662583,0.00021893834,0.00052415335,0.000018546101,0.000030074687,0.006035079],"genre_scores_gemma":[0.9967286,0.0011954701,0.00043855107,0.00009764456,0.00044625008,0.000088867564,0.000027157117,0.000026730017,0.0009507162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727017,0.00020919958,0.00064811105,0.0004334813,0.0010638238,0.0003751947],"domain_scores_gemma":[0.99621755,0.0017780819,0.00014388014,0.00050124776,0.0008119824,0.0005472738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013103196,0.00014144693,0.00044735518,0.00011763752,0.000072972296,0.000020689826,0.00016162072,0.00022049266,0.00030977817],"category_scores_gemma":[0.0011633408,0.000102953214,0.00017888709,0.00025496073,0.00032517442,0.000067163935,0.00012829922,0.00017631271,0.0001360732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005105601,0.011516141,0.44740498,0.000409862,0.00016815533,0.00069688936,0.0005676465,0.00031834262,0.028291345,0.000074945536,0.028316434,0.47712967],"study_design_scores_gemma":[0.025974926,0.0028477751,0.58843607,0.0008567968,0.0001293758,0.000017037979,0.00053704885,0.0009357796,0.3426929,0.00047914757,0.036797713,0.0002954319],"about_ca_topic_score_codex":0.00056560436,"about_ca_topic_score_gemma":0.000047375364,"teacher_disagreement_score":0.47683424,"about_ca_system_score_codex":0.0004053533,"about_ca_system_score_gemma":0.0011921925,"threshold_uncertainty_score":0.419831},"labels":[],"label_agreement":null},{"id":"W2261523254","doi":"10.1038/sj.bmt.1702625","title":"Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin’s lymphoma (NHL): results of a provincial strategy","year":2000,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Northeast Cancer Centre; McMaster University; University Health Network; University of Toronto; Hamilton Health Sciences; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Surgery; Lymphoma; Internal medicine; Transplantation; Bone marrow; Non-Hodgkin's lymphoma","score_opus":0.017262983448556563,"score_gpt":0.26776591699837005,"score_spread":0.25050293354981346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261523254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903849,0.00026202254,0.00065000827,0.0007353295,0.00015752447,0.002589109,0.0020912422,0.00014286613,0.0029870337],"genre_scores_gemma":[0.9885121,0.002205184,0.0030153461,0.00019322995,0.00016994298,0.0005574823,0.0037123195,0.00006341186,0.0015709867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971139,0.00009423973,0.0010923533,0.0006719978,0.0005021919,0.00052533904],"domain_scores_gemma":[0.9987532,0.0002455084,0.00028491492,0.00034841464,0.00016416307,0.00020383805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032925047,0.00044090176,0.00076178525,0.00023862439,0.00016109024,0.000035552155,0.00010914089,0.00031702855,0.00022099614],"category_scores_gemma":[0.000021223004,0.00036275754,0.00030832473,0.00028923465,0.00010630001,0.0002185096,0.000003415286,0.00007634872,0.000038709728],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18395488,0.0055680526,0.007624872,0.0066710534,0.0010110975,0.0048544942,0.006580572,0.0008351056,0.12112105,0.0006216934,0.0026976736,0.6584595],"study_design_scores_gemma":[0.11596168,0.011254885,0.5892014,0.0016189296,0.005355563,0.0055643,0.00030681866,0.002772868,0.26300567,0.00036281315,0.0031937077,0.001401379],"about_ca_topic_score_codex":0.00086539524,"about_ca_topic_score_gemma":0.0016390509,"teacher_disagreement_score":0.65705806,"about_ca_system_score_codex":0.0002166416,"about_ca_system_score_gemma":0.0005753977,"threshold_uncertainty_score":0.99988246},"labels":[],"label_agreement":null},{"id":"W2264937704","doi":"10.1016/j.ijrobp.2016.01.053","title":"A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Cog; Radiation therapy; Breast cancer; Stage (stratigraphy); Cancer; Adverse effect; Cohort; Dosimetry; Clinical trial; Nuclear medicine; Radiation treatment planning; Internal medicine; Oncology","score_opus":0.07237581270751257,"score_gpt":0.4147474701387968,"score_spread":0.3423716574312842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264937704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882705,0.00087594683,0.0007869209,0.0042387284,0.0017379917,0.0036542288,0.0003751222,0.000010331252,0.000050205235],"genre_scores_gemma":[0.9931639,0.0036375138,0.0003978753,0.00044605575,0.0015326022,0.0006404743,0.00015637893,0.000020268399,0.00000496933],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968976,0.0011595176,0.0010456415,0.00027502218,0.00043282163,0.00018939169],"domain_scores_gemma":[0.9912856,0.004508512,0.0021676784,0.00013548744,0.0018243783,0.00007834454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031556557,0.00022510187,0.000892343,0.00015988761,0.0001179216,0.000019254925,0.00019025574,0.00016415879,0.000052050837],"category_scores_gemma":[0.0016344861,0.00012597052,0.00020713342,0.00010717636,0.0001132964,0.00018140975,0.00002615537,0.00008012212,0.0000016892734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023984858,0.004032553,0.30599573,0.0000021859414,0.0016260407,4.2616742e-7,0.0011606743,0.0000319625,0.0005265639,0.0006426873,0.00053269695,0.68305],"study_design_scores_gemma":[0.06101809,0.017732669,0.90202063,0.00009218582,0.0006985499,0.00001220894,0.00017149388,0.00021765176,0.007908218,0.001957491,0.008024007,0.00014682942],"about_ca_topic_score_codex":0.000044201588,"about_ca_topic_score_gemma":0.0000317512,"teacher_disagreement_score":0.6829032,"about_ca_system_score_codex":0.0014030422,"about_ca_system_score_gemma":0.000727616,"threshold_uncertainty_score":0.51369286},"labels":[],"label_agreement":null},{"id":"W22652894","doi":"10.1007/pl00022788","title":"Therapeutic consequences of pathology and prognostic factors in aggressive NHL – Analysis of ALCL","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hematology; Medicine; Internal medicine; Oncology; Pathology; Aggressive lymphoma; Lymphoma","score_opus":0.13818486139775843,"score_gpt":0.41661491941416445,"score_spread":0.278430058016406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22652894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12329119,0.8758213,8.2224375e-7,0.00012059577,0.000025009907,0.0004891153,0.00008016413,0.0000041808094,0.00016760512],"genre_scores_gemma":[0.33297473,0.66683495,0.000018449151,0.000031082236,0.0000025145278,0.000042346208,0.000083563784,0.000008441226,0.0000039099564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980099,0.0002573265,0.0010478646,0.00032114598,0.00013347703,0.00023025],"domain_scores_gemma":[0.996791,0.0011998486,0.0015206614,0.00030697545,0.00012157419,0.000059913174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014210174,0.0002830625,0.004795225,0.0009477003,0.000010004475,0.0000014524225,0.00010095848,0.00034855056,0.00005684908],"category_scores_gemma":[0.00026022832,0.00018197228,0.00055573334,0.0007737382,0.00062326033,0.000016257794,0.000040721636,0.00009322867,8.9227336e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006910956,0.0017041569,0.576678,0.020380931,0.013182594,0.0035862632,0.00046533666,7.7775235e-7,0.000012946308,0.005399374,0.000042749096,0.3784778],"study_design_scores_gemma":[0.011002222,0.015477357,0.37378013,0.1921841,0.26504788,0.027748348,0.0019782628,0.000032992895,0.017656129,0.0068309503,0.085087396,0.0031742328],"about_ca_topic_score_codex":0.00015059048,"about_ca_topic_score_gemma":0.00004642742,"teacher_disagreement_score":0.37530357,"about_ca_system_score_codex":0.0000095660735,"about_ca_system_score_gemma":0.00021559585,"threshold_uncertainty_score":0.74206144},"labels":[],"label_agreement":null},{"id":"W2267074358","doi":"10.1182/blood.v124.21.4447.4447","title":"Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Vincristine; Rituximab; CHOP; Chemotherapy regimen; Internal medicine; Prednisone; Regimen; Surgery; Oncology; Radiation therapy; Clinical trial; Cyclophosphamide; Cancer; Lymphoma; Chemotherapy","score_opus":0.010335413178426268,"score_gpt":0.24978642282110622,"score_spread":0.23945100964267996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267074358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978519,0.0003689879,0.0000012567467,0.00020350692,0.0001670286,0.00064585573,0.00042670948,0.000034820154,0.00029992402],"genre_scores_gemma":[0.9970037,0.00083875767,0.000352256,0.0005353851,0.00018346505,0.00013124691,0.0006627332,0.000035584413,0.00025687495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.0000972855,0.00045604477,0.0005092128,0.000317637,0.0003958821],"domain_scores_gemma":[0.9986988,0.00041607747,0.00020089623,0.0003339984,0.000040714738,0.00030954063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009558917,0.00032443952,0.0007830658,0.000054120006,0.00006470521,0.000020293679,0.000068758614,0.00012819875,0.0000999325],"category_scores_gemma":[0.000037981677,0.00020794258,0.000090599635,0.00006301881,0.000066626526,0.000065466316,0.000090089714,0.000056143304,0.000021549304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044564277,0.024027353,0.94978815,0.000039627488,0.00027771745,0.00020061109,0.00025533006,3.904939e-8,0.000004156033,0.0000047972244,0.00008607148,0.024870483],"study_design_scores_gemma":[0.07975723,0.0011548927,0.9139891,0.00017941199,0.00071651366,0.0000032723292,0.000017748249,0.000009050279,0.00019687113,0.0000017854233,0.0037717621,0.00020235403],"about_ca_topic_score_codex":0.0005660652,"about_ca_topic_score_gemma":0.0014400402,"teacher_disagreement_score":0.07931159,"about_ca_system_score_codex":0.00031570965,"about_ca_system_score_gemma":0.00011560553,"threshold_uncertainty_score":0.8479652},"labels":[],"label_agreement":null},{"id":"W2268781386","doi":"10.1182/blood.v122.21.4301.4301","title":"Predicting Cell Of Origin In Diffuse Large B-Cell Lymphoma By High Dimensional Flow Cytometry","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Flow cytometry; Immunohistochemistry; Germinal center; Lymph node; Pathology; CD19; Immunophenotyping; B cell; Staining; Biology; Antibody; Medicine; Cancer research; Immunology","score_opus":0.005598824189835827,"score_gpt":0.2128075641963486,"score_spread":0.2072087400065128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268781386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968201,0.0011876131,0.000003816878,0.00012233235,0.00009340428,0.00038866405,0.00008941789,0.000037721453,0.0012569375],"genre_scores_gemma":[0.997902,0.00006974965,0.0010204228,0.00019338206,0.00006792436,0.0000803323,0.000107424836,0.000025240235,0.0005335208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871296,0.000030606872,0.0003350587,0.0002768447,0.00031780882,0.0003267478],"domain_scores_gemma":[0.9992865,0.00011919075,0.00010233719,0.0002766445,0.000058694473,0.0001566574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009002364,0.00017790157,0.00035254582,0.00013092904,0.000034793447,0.000011577384,0.00007148173,0.000106754065,0.00021974026],"category_scores_gemma":[0.000028210961,0.000138994,0.000089669746,0.00023167155,0.00002528144,0.00007223118,0.000060462302,0.00005693206,0.00014117951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032617096,0.056974772,0.9192172,0.00012039005,0.0000798099,0.00010672952,0.00012511485,0.0000012587193,0.019090008,0.000017558245,0.0032571508,0.0009773638],"study_design_scores_gemma":[0.11521297,0.00065328483,0.5693272,0.00019917215,0.0003248113,0.000036577778,0.000085713364,0.0008573358,0.31222492,0.000031796986,0.0008100044,0.00023625462],"about_ca_topic_score_codex":0.0007498827,"about_ca_topic_score_gemma":0.000010297523,"teacher_disagreement_score":0.34989005,"about_ca_system_score_codex":0.00007966035,"about_ca_system_score_gemma":0.000080933416,"threshold_uncertainty_score":0.5668011},"labels":[],"label_agreement":null},{"id":"W2269406332","doi":"10.1200/jco.2006.24.18_suppl.7528","title":"A phase II, multicenter study of bendamustine HCl plus rituximab in relapsed indolent B-cell and mantle-cell non-Hodgkin’s lymphoma (NHL)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Rituximab; Medicine; Internal medicine; Population; Phases of clinical research; Gastroenterology; Lymphoma; Oncology; Chemotherapy","score_opus":0.05246717604675004,"score_gpt":0.41230813439612307,"score_spread":0.359840958349373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269406332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455816,0.0008110556,0.00000858711,0.001140923,0.0005499618,0.00069310004,0.000008174338,0.000006081458,0.0022239555],"genre_scores_gemma":[0.9971372,0.00034975962,0.0012967493,0.00050069793,0.00041762815,0.000016073418,0.0000045949027,0.000022925668,0.00025438797],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99526566,0.00033583475,0.0033204486,0.00032335313,0.00044100732,0.00031368292],"domain_scores_gemma":[0.99589986,0.0013311974,0.0019291918,0.0002580675,0.000276836,0.00030485253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016365319,0.00024657394,0.002198317,0.00027304923,0.000047846548,0.000008245393,0.00014434465,0.00033520782,0.00008078122],"category_scores_gemma":[0.0003539918,0.0001735101,0.00034741362,0.00015938471,0.00014936402,0.00006999005,0.00013267892,0.00041585616,0.00000876936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023504246,0.5130571,0.35376891,0.00012671025,0.00035566124,0.00849538,0.0009970205,0.000039954095,0.00049241673,0.0000084382145,0.0030840915,0.09607007],"study_design_scores_gemma":[0.45666102,0.08955601,0.4466957,0.00016240016,0.0008504846,0.0001681231,0.0007397125,0.00057945325,0.0007866523,0.000021605583,0.0036417674,0.00013710164],"about_ca_topic_score_codex":0.00047932693,"about_ca_topic_score_gemma":0.00032457508,"teacher_disagreement_score":0.43315676,"about_ca_system_score_codex":0.00037768277,"about_ca_system_score_gemma":0.0007888505,"threshold_uncertainty_score":0.7075537},"labels":[],"label_agreement":null},{"id":"W2271944552","doi":"10.1200/jco.2006.24.18_suppl.17570","title":"Clinical findings in a large cohort of adult patients (pts) with Hodgkin’s disease (Hd) in Argentina: A report from two institutions","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Cohort; Disease; Pediatrics; Notice; Medical record; Demography; Family medicine; Surgery; Internal medicine","score_opus":0.06136422203749658,"score_gpt":0.4459844748784273,"score_spread":0.3846202528409307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271944552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956391,0.00016360586,0.000034044693,0.0017740688,0.00062416255,0.00042116438,0.000036572375,0.000005486916,0.0013018253],"genre_scores_gemma":[0.99636847,0.00032245737,0.0019194043,0.00076014013,0.00048066318,0.000018495311,0.00006441493,0.000012678998,0.000053249987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938708,0.00035328988,0.0046669184,0.0003281881,0.0005005376,0.0002802891],"domain_scores_gemma":[0.9952735,0.0014890585,0.0020319396,0.0002780147,0.000530405,0.00039710978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021988952,0.00016769595,0.0018618015,0.00020736527,0.000025512136,0.000005762258,0.00012247865,0.00026194775,0.00007477028],"category_scores_gemma":[0.0047911583,0.000111850706,0.0005173898,0.00024976794,0.00024052316,0.00011560384,0.000057800968,0.0006167694,0.000010395428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046973224,0.023420429,0.95460206,0.000013235741,0.00024597475,0.0107827075,0.000021209244,0.000019927165,9.573658e-7,0.00028108497,0.0013688962,0.0045461897],"study_design_scores_gemma":[0.04124996,0.0036775367,0.9443965,0.00041271863,0.00058457715,0.00008334495,0.0000207918,0.000038188056,0.0000057779343,0.0003051342,0.009131269,0.00009422514],"about_ca_topic_score_codex":0.0009041795,"about_ca_topic_score_gemma":0.0030141755,"teacher_disagreement_score":0.036552638,"about_ca_system_score_codex":0.0003559607,"about_ca_system_score_gemma":0.00260858,"threshold_uncertainty_score":0.57358104},"labels":[],"label_agreement":null},{"id":"W2272141431","doi":"10.1212/wnl.80.7_supplement.p03.235","title":"Contribution of CSF to the Diagnosis of McDonald MS: Retrospective Analysis in the BENEFIT Study (P03.235)","year":2013,"lang":"en","type":"article","venue":"Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine","score_opus":0.011570174712444849,"score_gpt":0.2672081689485003,"score_spread":0.25563799423605543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272141431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97934,0.00013124388,0.0000035881314,0.018942306,0.00004841346,0.0012580703,0.000019277153,0.000005979254,0.00025108643],"genre_scores_gemma":[0.99660087,0.00005856867,0.0000053984268,0.0026244093,0.00003581147,0.0006531486,0.000010020982,0.000005335069,0.0000064317637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886316,0.00018157421,0.00030974354,0.00023164251,0.00024123081,0.00017263387],"domain_scores_gemma":[0.9986901,0.00048778922,0.00012477108,0.0004403859,0.00022026975,0.000036649726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026414683,0.00010561143,0.00045333055,0.00016501074,0.000034972283,0.000005878607,0.00014646405,0.000057601163,0.00018645982],"category_scores_gemma":[0.00024383987,0.000054160024,0.00014028398,0.00077056413,0.0000573812,0.00002593251,0.000048976086,0.000100898586,0.000022832959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014690404,0.0016432644,0.9949324,0.0000022585589,0.00046431366,0.000020429468,0.00094379834,0.000074987045,0.00004522657,0.00058306206,0.0005316664,0.00061168405],"study_design_scores_gemma":[0.0015388421,0.004107864,0.99227804,0.0000036710637,0.0008636944,0.000005499487,0.00012076211,0.000064523505,0.00046676255,0.0001898008,0.0003253134,0.000035215813],"about_ca_topic_score_codex":0.004892825,"about_ca_topic_score_gemma":0.00408713,"teacher_disagreement_score":0.01726084,"about_ca_system_score_codex":0.000039488827,"about_ca_system_score_gemma":0.000016591628,"threshold_uncertainty_score":0.73965204},"labels":[],"label_agreement":null},{"id":"W2274060198","doi":"10.1182/blood.v122.21.3041.3041","title":"Accrual Of Patients With Relapsed and Refractory DLBCL Onto Clinical Trials","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Clinical trial; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Progressive disease; Interim analysis; Chemotherapy regimen; Lenalidomide; Surgery; Disease; Cancer; Multiple myeloma","score_opus":0.05035598214498882,"score_gpt":0.342667363834602,"score_spread":0.2923113816896132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274060198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787295,0.00033417653,6.881052e-7,0.00015564132,0.000055364144,0.00059895584,0.00001220213,0.000014087354,0.0009559088],"genre_scores_gemma":[0.9989611,0.00010892404,0.00049164344,0.00015558687,0.00007349756,0.000042681506,0.000023775157,0.000010125926,0.00013268678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898857,0.000117727985,0.0004485499,0.00016901355,0.00017193629,0.00010420089],"domain_scores_gemma":[0.99894637,0.0004263716,0.00018761696,0.00020765356,0.00009748051,0.00013452422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034134163,0.000091534144,0.00049023126,0.00002776488,0.000017692648,0.000007905212,0.00002704531,0.0000792285,0.00013318888],"category_scores_gemma":[0.00044749054,0.000052177606,0.00007597306,0.000035076948,0.00005311031,0.000055041874,0.00001956116,0.00005091019,0.000026946198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022580322,0.0068195253,0.9768056,0.000020452384,0.00032954756,0.000007189638,0.000057360532,6.868793e-9,0.00006288706,0.000023364546,0.0011517196,0.014496531],"study_design_scores_gemma":[0.034442093,0.0022023844,0.9606387,0.00007049153,0.0005628764,0.00000242512,0.000023926286,5.5337273e-7,0.0008555835,0.000015487412,0.0011306218,0.000054836597],"about_ca_topic_score_codex":0.000101783895,"about_ca_topic_score_gemma":0.0000074674663,"teacher_disagreement_score":0.03421629,"about_ca_system_score_codex":0.000012366959,"about_ca_system_score_gemma":0.00005995721,"threshold_uncertainty_score":0.2127741},"labels":[],"label_agreement":null},{"id":"W2276467555","doi":"10.1155/2013/168593","title":"Challenges in the Diagnosis of Enteropathy-Associated T Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Enteropathy; Lymphoma; Medicine; Internal medicine; Cancer research; Disease","score_opus":0.027928315287800574,"score_gpt":0.23085443842774672,"score_spread":0.20292612313994615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276467555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611754,0.0020930117,0.0000010330964,0.01030789,0.00017525672,0.00019645682,0.000009206706,0.000001575453,0.0010980226],"genre_scores_gemma":[0.99767464,0.00088298967,0.000041888747,0.0012851284,0.000055258595,0.0000338728,0.0000035605722,0.000010250098,0.000012379668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872726,0.000192371,0.00046035985,0.0001107955,0.00013863889,0.00037056278],"domain_scores_gemma":[0.99896044,0.00009846149,0.00028998952,0.00018379612,0.00015907029,0.00030824653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028954353,0.00012568297,0.00043009585,0.00030937482,0.000027565247,0.000011749538,0.00019828184,0.00007425038,0.00014722804],"category_scores_gemma":[0.000081397186,0.00008260582,0.00016260493,0.00007697053,0.0000994024,0.00006672781,0.000009099784,0.000099100136,0.000014396962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006863431,0.0006028902,0.9891718,0.0000175367,0.0000899393,0.000601426,0.0008639291,0.0000020146304,0.000020604955,0.000026606454,0.0030955195,0.005439091],"study_design_scores_gemma":[0.0048887995,0.0034967102,0.98865724,0.000119378834,0.000089937574,0.00068600517,0.000702327,0.0000049329956,0.00016602696,0.00005697805,0.0010985436,0.000033106022],"about_ca_topic_score_codex":0.004513729,"about_ca_topic_score_gemma":0.036110748,"teacher_disagreement_score":0.03159702,"about_ca_system_score_codex":0.00025362908,"about_ca_system_score_gemma":0.00024910393,"threshold_uncertainty_score":0.98147774},"labels":[],"label_agreement":null},{"id":"W2276781572","doi":"10.1182/blood-2015-07-658401","title":"Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Cell of origin; Clinical trial; Medicine; Oncology; Biology; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.01607402377836165,"score_gpt":0.3091935196842825,"score_spread":0.29311949590592085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276781572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904822,0.0076546976,0.000002739089,0.00008932067,0.000046955836,0.0003319124,0.000025606525,0.000024434661,0.0013421477],"genre_scores_gemma":[0.99886596,0.00032999768,0.00043315123,0.00017044596,0.00005270449,0.000025034607,0.000027428532,0.000024797522,0.00007047777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864423,0.00008920357,0.0003826787,0.00031858668,0.0002666756,0.0002986027],"domain_scores_gemma":[0.99898875,0.00007954161,0.000105435,0.0003910791,0.00007179598,0.00036340012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002812875,0.00020727381,0.00056026276,0.000107398744,0.000016872964,0.000014510166,0.000072875155,0.00017208925,0.000006280766],"category_scores_gemma":[0.00013779836,0.00014799967,0.0002777847,0.00016621547,0.000058923888,0.00004482508,0.00007615696,0.000040690993,0.00001196303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022613643,0.048015013,0.94364893,0.00004117209,0.00033667154,0.0014943843,0.000200271,5.6019667e-7,0.0007161909,0.000112828864,0.00054464646,0.004663184],"study_design_scores_gemma":[0.13122676,0.0013463416,0.8534844,0.00008366849,0.00040563874,0.00019975578,0.00006358062,0.000018830135,0.012613818,0.00008288368,0.00033779946,0.00013653157],"about_ca_topic_score_codex":0.00038297768,"about_ca_topic_score_gemma":0.000027916478,"teacher_disagreement_score":0.13100062,"about_ca_system_score_codex":0.00009625795,"about_ca_system_score_gemma":0.00028184606,"threshold_uncertainty_score":0.6035251},"labels":[],"label_agreement":null},{"id":"W2279791399","doi":"10.1182/blood.v122.21.2941.2941","title":"Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Advanced Stage Follicular Lymphoma: A Cost-Effectiveness Analysis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Asymptomatic; Watchful waiting; Internal medicine; Oncology; Randomized controlled trial; Quality-adjusted life year; Maintenance therapy; Cohort; Cost effectiveness; Lymphoma; Surgery; Chemotherapy; Cancer; Prostate cancer","score_opus":0.021518877538591188,"score_gpt":0.282634407681047,"score_spread":0.2611155301424558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279791399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948956,0.0012642436,0.0052310773,0.00017208804,0.00005989016,0.0035367282,0.000032471886,0.00008064872,0.00013327952],"genre_scores_gemma":[0.9832464,0.00016631739,0.01153792,0.000051539024,0.00006764373,0.0045471904,0.00023447323,0.00003360253,0.00011495145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987336,0.000064695385,0.00024786484,0.00046452897,0.00020396875,0.00028536082],"domain_scores_gemma":[0.99909145,0.00017116792,0.00010649476,0.0003530468,0.00012530205,0.00015253267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014691526,0.00025230116,0.0006599226,0.00013285472,0.00010578153,0.00004964252,0.00005323704,0.00011883097,0.000033902295],"category_scores_gemma":[0.000042532425,0.00019276248,0.00024833326,0.00034435274,0.000039608858,0.00015564119,0.000021018615,0.000036131587,0.0000094119405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008451028,0.07153305,0.3778358,0.0017950643,0.058495235,0.00011316349,0.0020648553,0.0010271916,0.020874409,0.00073808385,0.0002632209,0.4568089],"study_design_scores_gemma":[0.3251279,0.0033400117,0.57664275,0.00012918605,0.016069666,0.000049697184,0.00072922336,0.023150517,0.052394263,0.00013524429,0.0014987353,0.00073280936],"about_ca_topic_score_codex":0.000364828,"about_ca_topic_score_gemma":0.00001273961,"teacher_disagreement_score":0.4560761,"about_ca_system_score_codex":0.00016901054,"about_ca_system_score_gemma":0.00004783539,"threshold_uncertainty_score":0.7860626},"labels":[],"label_agreement":null},{"id":"W2280269954","doi":"10.1182/blood-2015-10-676700","title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; CancerCare Manitoba; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Immunohistochemistry; Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Cancer research; Pathology","score_opus":0.006757360245682148,"score_gpt":0.25368122213541267,"score_spread":0.2469238618897305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280269954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798566,0.0010397049,4.4622465e-7,0.000081424376,0.000007683975,0.00012307512,0.0001033631,0.0000028247296,0.0006557978],"genre_scores_gemma":[0.99937624,0.00048680854,0.000023039476,0.0000046530504,0.00000814131,0.000011278636,0.000003972304,0.0000058640644,0.000079981626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950105,0.000025674153,0.00018545162,0.000096178446,0.00011640833,0.000075226504],"domain_scores_gemma":[0.99937683,0.00018152098,0.00014517014,0.00023960134,0.000025098672,0.000031788306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008860516,0.000074740536,0.00019971731,0.000022168448,0.00001061531,8.0367994e-7,0.000032138418,0.000043382264,0.000047340814],"category_scores_gemma":[0.00012506683,0.00003239332,0.00007532999,0.000039166745,0.00007084056,0.000013781455,0.000022817754,0.000033018507,0.0000010853797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014564756,0.002036323,0.41285375,0.000021436921,0.00008480187,0.000005293495,0.00012606638,6.3361114e-8,0.5833278,0.000011471263,0.0006511392,0.00073623075],"study_design_scores_gemma":[0.005453551,0.00046328746,0.366476,0.00038788843,0.00009474436,0.0000071427485,0.00002357793,3.066737e-7,0.62704194,0.000018744611,0.000008821974,0.000024004708],"about_ca_topic_score_codex":0.00022558264,"about_ca_topic_score_gemma":6.0303336e-7,"teacher_disagreement_score":0.04637774,"about_ca_system_score_codex":0.000029830122,"about_ca_system_score_gemma":0.000040350926,"threshold_uncertainty_score":0.13209611},"labels":[],"label_agreement":null},{"id":"W2280310901","doi":"10.1182/blood.v124.21.136.136","title":"Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Autologous stem-cell transplantation; Medicine; Oncology; Internal medicine; Transplantation; Salvage therapy; Biopsy; Lymphoma; Chemotherapy; Pathology; Cyclophosphamide; Vincristine","score_opus":0.01110529996399508,"score_gpt":0.2407113772746209,"score_spread":0.22960607731062582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280310901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821866,0.00015338785,0.00015475442,0.00025892848,0.000024440702,0.00021564346,0.00003844633,0.000027532249,0.0009082261],"genre_scores_gemma":[0.99875456,0.000029621304,0.00066393643,0.00008189847,0.000013482444,0.000078631354,0.00006909655,0.000011256867,0.00029753323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989947,0.00007304456,0.0003697925,0.0002220547,0.00018950949,0.00015090783],"domain_scores_gemma":[0.9993382,0.00018820795,0.00011469966,0.00024480422,0.00004291961,0.0000711333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011334827,0.0001312163,0.00047561745,0.00032024676,0.000022450398,0.000007558677,0.000038008802,0.000096128926,0.000022930686],"category_scores_gemma":[0.000009504691,0.00009220376,0.00012974032,0.000538312,0.00005148824,0.000042492422,0.0000065248732,0.000039889965,0.000013291045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021495266,0.0016782994,0.99489933,0.00007868092,0.0004204071,0.00015752153,0.00052478974,0.00008424449,0.00016282334,0.00013704007,0.000007722196,0.0016341567],"study_design_scores_gemma":[0.006533329,0.00042873464,0.9839141,0.00006813092,0.006455742,0.00003864129,0.000056508354,0.00042458164,0.0019456154,0.000007867795,0.000031638905,0.00009515644],"about_ca_topic_score_codex":0.000093101335,"about_ca_topic_score_gemma":0.00026488444,"teacher_disagreement_score":0.010985307,"about_ca_system_score_codex":0.000049287064,"about_ca_system_score_gemma":0.000036861024,"threshold_uncertainty_score":0.37599602},"labels":[],"label_agreement":null},{"id":"W2282026400","doi":"10.1158/1078-0432.ccr-15-2305","title":"Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Institut National Du Cancer","keywords":"Diffuse large B-cell lymphoma; DNA sequencing; Computational biology; Lymphoma; Divergence (linguistics); Cancer research; Biology; Medicine; Genetics; DNA; Pathology","score_opus":0.437137671494779,"score_gpt":0.4702727758321284,"score_spread":0.0331351043373494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282026400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925392,0.0031578836,0.000013254618,0.0028791355,0.00013646152,0.00093785377,0.000015518968,0.000024441464,0.00029624646],"genre_scores_gemma":[0.98952967,0.008588643,0.000020759726,0.00048789673,0.00018601549,0.00044113278,0.0000045424663,0.000023675217,0.00071766524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711245,0.0006294321,0.0005125578,0.0005829255,0.00066181715,0.00050082913],"domain_scores_gemma":[0.9983243,0.00063539634,0.00006238976,0.00043577005,0.00021673793,0.00032540204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016815492,0.00016187855,0.00038124426,0.00016966987,0.00013574417,0.0000501031,0.00013408002,0.00011753389,0.00014134964],"category_scores_gemma":[0.00018818854,0.00009699329,0.000081963946,0.00023796159,0.00018845321,0.000098095894,0.00016588914,0.00013155951,0.00003317797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070532627,0.017563377,0.81606525,0.00008769556,0.0002501851,0.002566564,0.0013409539,5.555565e-7,0.017662898,0.0011647926,0.00063011347,0.1419623],"study_design_scores_gemma":[0.13694006,0.008053604,0.8088249,0.0009339041,0.0003552935,0.00002875589,0.0037168094,0.0012531392,0.024568764,0.0007176982,0.013856099,0.0007509456],"about_ca_topic_score_codex":0.00102568,"about_ca_topic_score_gemma":0.00066730706,"teacher_disagreement_score":0.14121136,"about_ca_system_score_codex":0.00082862773,"about_ca_system_score_gemma":0.0008356574,"threshold_uncertainty_score":0.39552715},"labels":[],"label_agreement":null},{"id":"W2283880462","doi":"10.3109/10428194.2016.1140161","title":"B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)","year":2016,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Refractory (planetary science); Chemotherapy; Transplantation; Autologous stem-cell transplantation; Lymphoma; Gastroenterology; Oncology; Clinical endpoint; Randomized controlled trial; Multiple myeloma","score_opus":0.010912618588100553,"score_gpt":0.25292783276751835,"score_spread":0.2420152141794178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283880462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877025,0.0023087254,0.00007133934,0.0014634246,0.0017492984,0.005044584,0.00054283143,0.00026045257,0.0008568346],"genre_scores_gemma":[0.988525,0.0042360947,0.00029801164,0.00080448977,0.00036652107,0.0011392094,0.00029716105,0.000223321,0.0041102148],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920811,0.0007583029,0.0026458316,0.0016953903,0.0013829274,0.0014364264],"domain_scores_gemma":[0.99420506,0.0017545456,0.0014573298,0.0016649985,0.00024247434,0.0006755965],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001153628,0.0014795818,0.0033438012,0.0005543186,0.0005669906,0.00009601063,0.0007158939,0.0012325349,0.00015318455],"category_scores_gemma":[0.00022690916,0.0008774308,0.0012299651,0.0010442536,0.0009896811,0.00046161565,0.00018351406,0.00017948021,0.000038708993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.6994758,0.003955436,0.00035327015,0.00032732432,0.00094343093,0.00077845587,0.0028481714,0.0000092689415,0.005480781,0.00036401444,0.0036447712,0.28181925],"study_design_scores_gemma":[0.9372476,0.00748597,0.005967781,0.00099396,0.0017360462,0.00040212984,0.00040588644,0.0005765842,0.037201155,0.000120079,0.006864522,0.0009982944],"about_ca_topic_score_codex":0.0040953103,"about_ca_topic_score_gemma":0.0005889703,"teacher_disagreement_score":0.28082097,"about_ca_system_score_codex":0.0133755095,"about_ca_system_score_gemma":0.007427762,"threshold_uncertainty_score":0.9997954},"labels":[],"label_agreement":null},{"id":"W2286363045","doi":"10.1200/jco.2007.25.18_suppl.8037","title":"Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: The impact of the addition of rituximab to CHOP chemotherapy","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Population; Lymphoma; Chemotherapy; Oncology; Univariate analysis; Surgery; Gastroenterology; Multivariate analysis","score_opus":0.021960227721177387,"score_gpt":0.36132483607590504,"score_spread":0.33936460835472765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286363045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867225,0.000097305776,0.000055155204,0.0002498974,0.00020045157,0.00061343226,0.00006084132,0.0000019445856,0.00004874219],"genre_scores_gemma":[0.99925476,0.00015167904,0.00032799068,0.0001396464,0.00010351063,0.0000044252197,0.0000023226344,0.000010213663,0.0000054746024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979651,0.00019033239,0.001250934,0.00011584839,0.00026091922,0.0002168444],"domain_scores_gemma":[0.99535966,0.002377598,0.0016398799,0.00017677764,0.00026302136,0.00018307297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014412742,0.000117557465,0.00088212866,0.000064360895,0.00003720512,0.000003516144,0.00011477325,0.00016074676,0.0000057139464],"category_scores_gemma":[0.0009345482,0.000047072695,0.0003451245,0.00013002446,0.000101831225,0.000051569685,0.00002586172,0.00016382559,3.063978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008211952,0.015463438,0.96091604,0.000027444257,0.00022728987,0.000016801094,0.0004170647,0.0000075789726,0.000007546159,0.000016112757,0.0003017903,0.014386933],"study_design_scores_gemma":[0.0671291,0.012774212,0.9189537,0.00018702132,0.00024380394,0.000018269946,0.00024435553,0.000027632159,0.0001880589,0.000014186254,0.0001783761,0.00004129048],"about_ca_topic_score_codex":0.00026533037,"about_ca_topic_score_gemma":0.00014436203,"teacher_disagreement_score":0.05891715,"about_ca_system_score_codex":0.0004360029,"about_ca_system_score_gemma":0.0004591568,"threshold_uncertainty_score":0.19195688},"labels":[],"label_agreement":null},{"id":"W2287537024","doi":"10.1200/jco.2007.25.18_suppl.18527","title":"Outcome of localized and advanced diffuse large B-cell non-Hodgkin bone lymphoma (DBL)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Boréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cyclophosphamide; Vincristine; Hazard ratio; Internal medicine; CHOP; Prednisone; Regimen; Chemotherapy; Anthracycline; Rituximab; Surgery; Median follow-up; Gastroenterology; Lymphoma; Cancer; Confidence interval; Breast cancer","score_opus":0.06283831123038348,"score_gpt":0.4535946498689129,"score_spread":0.39075633863852943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287537024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248797,0.0014463969,0.0006503295,0.0016344938,0.00073039497,0.00020954717,0.0000051838674,0.0000068229792,0.0028288758],"genre_scores_gemma":[0.9867887,0.0013850343,0.008913628,0.002233026,0.0003663418,0.0000021918406,0.0000019090328,0.000017579014,0.00029161066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583226,0.0001423803,0.0031574413,0.0001948623,0.0003569607,0.0003160882],"domain_scores_gemma":[0.9943831,0.0027131224,0.0018332904,0.00022102884,0.0003039578,0.00054547505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003447297,0.00017096025,0.0021071816,0.00014624206,0.000031416657,0.0000038246494,0.00009003061,0.0003762077,0.000059776543],"category_scores_gemma":[0.001560867,0.00011188731,0.00054002553,0.00012131261,0.00018692204,0.00007416518,0.000069675356,0.00026712182,0.00001303496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007942902,0.026471639,0.7139109,0.00007470057,0.00030641526,0.0030879201,0.000093072005,0.000001073793,0.0004322248,0.00016420479,0.000949106,0.24656583],"study_design_scores_gemma":[0.12275108,0.013496517,0.7675433,0.000106246436,0.00057746866,0.00054849917,0.00015868523,0.000042577107,0.0015914236,0.00009768487,0.092978634,0.00010784879],"about_ca_topic_score_codex":0.000019257803,"about_ca_topic_score_gemma":0.000040258878,"teacher_disagreement_score":0.246458,"about_ca_system_score_codex":0.00017835831,"about_ca_system_score_gemma":0.00045966305,"threshold_uncertainty_score":0.4562632},"labels":[],"label_agreement":null},{"id":"W2289506799","doi":"10.1182/blood.v122.21.4322.4322","title":"Predictors Of Delay In Diagnosis and Treatment In Diffuse Large B-Cell Lymphoma and Impact On Survival","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Rituximab; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Cyclophosphamide; Population; Chemotherapy regimen; Chemotherapy; Lymphoma; Oncology; Surgery","score_opus":0.010257475342171958,"score_gpt":0.2434817534815077,"score_spread":0.23322427813933574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289506799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729186,0.0013840182,5.9757454e-8,0.00012148863,0.000027553584,0.00067046296,0.00004642439,0.000011355204,0.0004467531],"genre_scores_gemma":[0.997372,0.0021824078,0.000026377795,0.000037757934,0.000023757713,0.00029158095,0.000016552576,0.000015035781,0.0000345567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913,0.000043650543,0.00022310734,0.00023795465,0.00012871623,0.00023658307],"domain_scores_gemma":[0.9994024,0.00020192811,0.000050101717,0.00018120358,0.000016097936,0.00014823931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006488221,0.00018756081,0.00039283288,0.00015100114,0.000015984451,0.0000121894145,0.000024982133,0.000076061566,0.000029607396],"category_scores_gemma":[0.000021975595,0.000120177814,0.000058285077,0.00010988839,0.000031476182,0.000051012234,0.000025453279,0.000025193704,0.000007219121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067853056,0.0400429,0.95495325,0.000026360492,0.00011632634,0.00013053209,0.0004776005,3.3751334e-7,0.000087745786,0.000015779817,0.00004426271,0.0040370435],"study_design_scores_gemma":[0.06103992,0.0020817863,0.93019843,0.00010282582,0.00014883032,0.000014455939,0.00009784171,0.000027775313,0.0061243894,0.0000106951475,0.00006769132,0.000085345826],"about_ca_topic_score_codex":0.0033908929,"about_ca_topic_score_gemma":0.00063611194,"teacher_disagreement_score":0.06097207,"about_ca_system_score_codex":0.00012847924,"about_ca_system_score_gemma":0.000047238416,"threshold_uncertainty_score":0.5126038},"labels":[],"label_agreement":null},{"id":"W2291198845","doi":"10.1016/j.bbmt.2016.01.015","title":"Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis","year":2016,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Confounding; Oncology; Follicular lymphoma; Single Center; Chemotherapy; Lymphoma; Proportional hazards model; Population; Transplantation; Multivariate analysis; Surgery","score_opus":0.011515043882303434,"score_gpt":0.2442077540049923,"score_spread":0.23269271012268888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291198845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923194,0.00024413964,0.006190528,0.00007526777,0.00006671948,0.0004264345,0.00060812454,0.000016786867,0.000052587427],"genre_scores_gemma":[0.99393827,0.0012929734,0.0035406242,0.000024872797,0.0000108174045,0.000054552125,0.0011192696,0.000008295773,0.000010304695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910676,0.000030434767,0.00038071186,0.0002454893,0.00008594038,0.00015063492],"domain_scores_gemma":[0.9994206,0.00015496674,0.00018376892,0.00009987255,0.0000886127,0.000052215164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009887661,0.0001339034,0.00041093794,0.0001911048,0.000050287643,0.0000023154682,0.000034784014,0.00014360869,0.000015564523],"category_scores_gemma":[0.00000798114,0.000091371265,0.00014922387,0.00014985519,0.0000780267,0.00006772908,0.000002796414,0.000012233251,4.8449954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010119083,0.00058768,0.73197985,0.00041375202,0.0015931348,0.0000050575286,0.00020799832,0.0000025471643,0.23545296,0.0015094094,0.0000014296988,0.02723425],"study_design_scores_gemma":[0.01726421,0.0014143607,0.67450905,0.00017259069,0.009058011,0.00003711889,0.00001625831,0.000052157957,0.2970486,0.00028885002,0.000019765263,0.00011904636],"about_ca_topic_score_codex":0.00018409522,"about_ca_topic_score_gemma":0.00005929468,"teacher_disagreement_score":0.061595626,"about_ca_system_score_codex":0.000017700242,"about_ca_system_score_gemma":0.000029135743,"threshold_uncertainty_score":0.3726012},"labels":[],"label_agreement":null},{"id":"W2291808939","doi":"10.1186/s12943-016-0499-1","title":"Erratum to: ‘Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs’","year":2016,"lang":"en","type":"erratum","venue":"Molecular Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Granzyme B; Biology; Apoptosis; Cancer research; Granzyme; Cytotoxicity; Biochemistry; In vitro; Perforin","score_opus":0.009515444518963039,"score_gpt":0.270556642165909,"score_spread":0.261041197646946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291808939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54278994,0.045047306,0.0023447978,0.037914824,0.11032751,0.013439585,0.003204971,0.0007681579,0.24416289],"genre_scores_gemma":[0.8267988,0.0022975365,0.0020747068,0.009504131,0.0032500967,0.0011464378,0.0004083148,0.00045369408,0.15406626],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996582,0.00010312657,0.0005999788,0.001041259,0.00097343687,0.00070025347],"domain_scores_gemma":[0.9976834,0.00004790106,0.0002937145,0.0010048412,0.0003543366,0.00061578467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015078657,0.0006962123,0.0013077611,0.0003793649,0.000088461085,0.000038087237,0.00024104363,0.00053695997,0.0002599091],"category_scores_gemma":[0.00006011291,0.00050865684,0.0005188081,0.00034626605,0.000050613395,0.00004665656,0.00024109955,0.0003390422,0.0001911737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102412494,0.00013538492,0.00003242019,0.00020109315,0.00017169109,0.0001660108,0.0002783791,0.000013104339,0.43664658,0.000010314241,0.5597617,0.0024808792],"study_design_scores_gemma":[0.0013797678,0.00028275722,0.00023682909,0.00642908,0.00047922545,0.000009254837,0.000041286246,0.0000030125032,0.73638535,0.000021737469,0.25430006,0.0004316467],"about_ca_topic_score_codex":0.00077917334,"about_ca_topic_score_gemma":0.000030549778,"teacher_disagreement_score":0.30546167,"about_ca_system_score_codex":0.0007649667,"about_ca_system_score_gemma":0.00071978424,"threshold_uncertainty_score":0.9997365},"labels":[],"label_agreement":null},{"id":"W2292975070","doi":"10.1111/bjh.14007","title":"Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Randomization; Lymphoma; Randomized controlled trial; Oncology; Asymptomatic; Gastroenterology; Surgery","score_opus":0.02048215489209315,"score_gpt":0.3183431877896765,"score_spread":0.29786103289758337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292975070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94015646,0.0006444985,0.0015907951,0.0020579975,0.0006502581,0.054364383,0.000065674976,0.000034413235,0.00043551013],"genre_scores_gemma":[0.947897,0.00026309557,0.0060899197,0.00041592625,0.00088766316,0.04347297,0.000017094078,0.00008409535,0.00087221287],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962071,0.0003492709,0.0016070924,0.0005926762,0.0004990352,0.00074478384],"domain_scores_gemma":[0.9968409,0.00049344107,0.0011168529,0.0003378486,0.0007282406,0.00048274343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061561284,0.0004708032,0.0023527038,0.00024693232,0.00019605902,0.000073900344,0.00029470725,0.0004267196,0.00039257176],"category_scores_gemma":[0.00039356426,0.00030754873,0.000637696,0.000170877,0.00023834614,0.00023388631,0.00010635243,0.00021013813,0.00009533826],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2839782,0.049986884,0.002472485,0.0011334057,0.003941828,0.35420993,0.0011821054,0.000010951395,0.006427307,0.0002761199,0.016995782,0.27938503],"study_design_scores_gemma":[0.70162374,0.046156507,0.0012260297,0.003482685,0.000996463,0.18969573,0.00048549622,0.00011622915,0.038782258,0.00017768299,0.01674488,0.0005122722],"about_ca_topic_score_codex":0.000092727976,"about_ca_topic_score_gemma":0.00012920743,"teacher_disagreement_score":0.41764557,"about_ca_system_score_codex":0.0011831552,"about_ca_system_score_gemma":0.0021156098,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2294719018","doi":"","title":"[Generalized thymic lymphoma in a 9-month-old ARK/J mouse].","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cegep de Saint Hyacinthe","funders":"","keywords":"Neoplasm; Histopathological examination; Lymphoma; Pathology; Generalized lymphadenopathy; Strain (injury); Biology; Medicine; Internal medicine","score_opus":0.017960960336713523,"score_gpt":0.22962535714876992,"score_spread":0.2116643968120564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294719018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890001,0.0009321004,0.000003050614,0.0022410343,0.00014232445,0.0011459249,0.000007225984,0.000097579075,0.006430675],"genre_scores_gemma":[0.99216104,0.00018376872,0.00031267168,0.0015415649,0.000115564915,0.0033476998,0.0000293157,0.000028046225,0.0022803189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867874,0.000024059915,0.00027014763,0.00031819858,0.00023628186,0.00047256213],"domain_scores_gemma":[0.99931616,0.000022162583,0.000053446434,0.00035077383,0.000026133195,0.00023134344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116527495,0.00018603983,0.0003473774,0.00015226957,0.00003500252,0.000024212684,0.00007924499,0.000093300005,0.000025542406],"category_scores_gemma":[0.000062085564,0.00014708313,0.00012730232,0.00023624356,0.00003689104,0.00006660537,0.000033482876,0.000043500022,0.00007865637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014138361,0.009473426,0.55511993,0.00014363174,0.00059122365,0.0026803918,0.0011414527,0.0001817339,0.0010976478,0.01603574,0.0036407849,0.4084802],"study_design_scores_gemma":[0.020019466,0.00006752252,0.9587073,0.000030035746,0.000069691036,0.000061525716,0.000036403766,0.000008360243,0.015982794,0.00044064762,0.0044170986,0.00015915574],"about_ca_topic_score_codex":0.0014626028,"about_ca_topic_score_gemma":0.00027117832,"teacher_disagreement_score":0.40832105,"about_ca_system_score_codex":0.0008469394,"about_ca_system_score_gemma":0.000086460874,"threshold_uncertainty_score":0.5997876},"labels":[],"label_agreement":null},{"id":"W2296845301","doi":"10.1200/jco.2013.31.15_suppl.10000","title":"Treatment of pediatric lymphocyte predominant Hodgkin lymphoma (LPHL): A report from the Children's Oncology Group.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vincristine; Stage (stratigraphy); Cyclophosphamide; Radiation therapy; Surgery; Prednisone; Chemotherapy; Lymphoma; Internal medicine; Lymph node; Gastroenterology","score_opus":0.06882586978832474,"score_gpt":0.40914644701508807,"score_spread":0.34032057722676334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296845301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808728,0.0053186747,0.000021925502,0.009657103,0.0015611447,0.0008812176,0.000018903434,0.00001362214,0.0016545801],"genre_scores_gemma":[0.97777647,0.012845555,0.0038476088,0.0010147041,0.0041792034,0.00007824062,0.000026726744,0.00002938326,0.00020208556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993761,0.00074948266,0.0041588433,0.00039541957,0.0005399097,0.00039533369],"domain_scores_gemma":[0.9872958,0.006477526,0.004516916,0.00063472573,0.0005382624,0.00053678936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014016661,0.00031993387,0.0027894038,0.00012712204,0.000075924574,0.00001573303,0.00028984362,0.0006203244,0.0005055678],"category_scores_gemma":[0.001979936,0.00015968706,0.0013517612,0.00020914605,0.00033650317,0.00011877415,0.000087393295,0.00021671399,0.00011639228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002127013,0.012106835,0.5308311,0.000005201995,0.0015068465,0.0033781796,0.00015425467,0.0000020663272,0.000035032932,0.000035489622,0.008443899,0.4413741],"study_design_scores_gemma":[0.033276103,0.033509832,0.8617353,0.000032354408,0.0027514542,0.0051892675,0.00010151425,0.000024528703,0.00015851032,0.0002559715,0.06284469,0.00012047594],"about_ca_topic_score_codex":0.0020875544,"about_ca_topic_score_gemma":0.00010535976,"teacher_disagreement_score":0.44125363,"about_ca_system_score_codex":0.0013477536,"about_ca_system_score_gemma":0.004064236,"threshold_uncertainty_score":0.72097796},"labels":[],"label_agreement":null},{"id":"W2300863317","doi":"10.1200/jco.2006.24.18_suppl.7510","title":"The impact of initial treatment of advanced stage indolent lymphoma on the risk of transformation","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Vincristine; Stage (stratigraphy); Follicular lymphoma; Cyclophosphamide; Bleomycin; Chlorambucil; Lymphoma; Nodular sclerosis; Gastroenterology; Oncology; Vindesine; Etoposide; B symptoms; Chemotherapy; Hodgkin lymphoma","score_opus":0.07673498519144932,"score_gpt":0.47602369118546567,"score_spread":0.39928870599401634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300863317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943928,0.0005083793,0.000014934164,0.0015477146,0.00021976723,0.00034446095,0.0000420158,0.000001791862,0.0029280991],"genre_scores_gemma":[0.9959511,0.0036284642,0.000113912916,0.000049944032,0.00021098783,0.000007747642,0.0000032033101,0.0000067158685,0.000027898175],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967257,0.00045955283,0.002272999,0.00007495566,0.0003318431,0.00013499653],"domain_scores_gemma":[0.9918338,0.0047387136,0.0028405949,0.00020310731,0.0002994089,0.000084376275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012990702,0.0001232327,0.0011085869,0.000063710475,0.000041405605,0.0000026151763,0.00009700101,0.00014601983,0.000039678132],"category_scores_gemma":[0.0005647344,0.00004694424,0.0010485157,0.00008967835,0.00023915518,0.000047013404,0.000007526826,0.000111618145,0.0000018336438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021768115,0.02026821,0.14720073,0.000025168722,0.0020781185,0.00008840985,0.00066414895,0.0012437854,0.00033410144,0.0013721049,0.0004308286,0.80452627],"study_design_scores_gemma":[0.021711119,0.06460224,0.8991264,0.00009436132,0.00057408056,0.00003772263,0.00030321584,0.00008490406,0.009936965,0.00036776616,0.0031225253,0.000038687824],"about_ca_topic_score_codex":0.00035364195,"about_ca_topic_score_gemma":0.000056545487,"teacher_disagreement_score":0.8044876,"about_ca_system_score_codex":0.00034614722,"about_ca_system_score_gemma":0.0010011998,"threshold_uncertainty_score":0.19143306},"labels":[],"label_agreement":null},{"id":"W2302748882","doi":"","title":"Detection of immunoglobulin IGH gene rearrangements on formalin-fixed, paraffin embedded tissue in lymphoid malignancies.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphoma; Immunophenotyping; Immunohistochemistry; Pathology; Immunoglobulin heavy chain; Biology; Gene rearrangement; Antibody; B cell; Lymphoproliferative disorders; Polyclonal antibodies; Medicine; Molecular biology; Immunology; Gene; Flow cytometry; Genetics","score_opus":0.01472875236360106,"score_gpt":0.22890735056633707,"score_spread":0.21417859820273602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302748882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949731,0.00046849737,0.000087221175,0.00022179853,0.00025954784,0.0011855685,0.000009969585,0.000043583488,0.0027506854],"genre_scores_gemma":[0.99711674,0.00014205492,0.00027836883,0.00030320865,0.000092910595,0.0016501765,0.000031772724,0.0000212412,0.00036351735],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856615,0.000059996943,0.00040210295,0.00027174863,0.00030613254,0.00039384863],"domain_scores_gemma":[0.99925673,0.000050832114,0.00014224184,0.00037488347,0.000056779863,0.00011854979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035975766,0.00018039337,0.0003720094,0.00017025137,0.00003702993,0.000012022354,0.000083137216,0.00010393289,0.000022551101],"category_scores_gemma":[0.00010909419,0.00014977183,0.000085647865,0.00022758168,0.00003340094,0.000065818655,0.000032960386,0.000052302363,0.00005360081],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014814007,0.0021596353,0.07897502,0.00015259293,0.00022373386,0.00007671421,0.0003215921,0.00006619099,0.02681546,0.0003966682,0.0003341171,0.8889969],"study_design_scores_gemma":[0.004961942,0.00025380493,0.5309199,0.000043276388,0.00005501192,0.000024163755,0.000017745093,0.000047116773,0.46080366,0.000040529725,0.0027366176,0.00009624932],"about_ca_topic_score_codex":0.00036279418,"about_ca_topic_score_gemma":0.00007531258,"teacher_disagreement_score":0.88890064,"about_ca_system_score_codex":0.00033481626,"about_ca_system_score_gemma":0.000027251372,"threshold_uncertainty_score":0.6107518},"labels":[],"label_agreement":null},{"id":"W2307302685","doi":"10.1093/ajcp/140.suppl1.176","title":"Primary Anaplastic Large Cell Lymphoma of the Lung in a Child","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Anaplastic large-cell lymphoma; Primary (astronomy); Lung; Medicine; Pathology; Lymphoma; Large cell; Internal medicine; Adenocarcinoma; Cancer","score_opus":0.010715179851286928,"score_gpt":0.31025544251141446,"score_spread":0.2995402626601275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307302685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940644,0.0005228092,0.000032991997,0.0026121885,0.00030340016,0.00017699933,0.0000041134736,0.0000029859418,0.0022801221],"genre_scores_gemma":[0.9961748,0.00032365604,0.0006614415,0.002640307,0.0001439228,0.0000063661782,0.0000010830236,0.000011035287,0.000037391874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780905,0.00036590858,0.0012384853,0.00014764821,0.00021101543,0.00022786477],"domain_scores_gemma":[0.99756926,0.00083767617,0.0010451465,0.00026299275,0.00013053496,0.0001543635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006207894,0.00011422982,0.000953232,0.00009306336,0.000023048253,0.0000036396161,0.00016507338,0.00007262002,0.00007184164],"category_scores_gemma":[0.00053730217,0.00006327217,0.0003830345,0.00022937825,0.00040583956,0.000044560333,0.00006827763,0.00022928797,0.000017897213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033113605,0.0038720674,0.9502454,0.000021710519,0.00007245903,0.00055115577,0.000118136624,0.0000037276982,0.00005276247,0.000038712093,0.0011706888,0.043522064],"study_design_scores_gemma":[0.008328304,0.0029785198,0.98647726,0.00013169994,0.00013392624,0.0010058471,0.00014241415,0.000035369896,0.00008256631,0.00005471877,0.0005752655,0.000054118256],"about_ca_topic_score_codex":0.00003887841,"about_ca_topic_score_gemma":0.0000066871453,"teacher_disagreement_score":0.043467946,"about_ca_system_score_codex":0.000067123,"about_ca_system_score_gemma":0.00025639046,"threshold_uncertainty_score":0.25801644},"labels":[],"label_agreement":null},{"id":"W2309112759","doi":"10.1182/blood-2015-11-624320","title":"The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Rituximab; Stem cell; Hematopoietic stem cell transplantation; Oncology; Autologous stem-cell transplantation; Disease; Internal medicine; Immunology; Biology","score_opus":0.01387089511952282,"score_gpt":0.2557726020030322,"score_spread":0.24190170688350937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309112759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023229571,0.9726159,7.4320775e-7,0.000021138481,0.00002930662,0.0011825005,0.00004639941,0.000005344373,0.0028690938],"genre_scores_gemma":[0.062638216,0.9369545,0.000038228725,0.000009250781,0.000015269488,0.00022957961,0.000021632704,0.000014757863,0.00007859272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881905,0.0001331294,0.0004709046,0.00020434789,0.00021739554,0.00015517481],"domain_scores_gemma":[0.99910694,0.00021601928,0.00028758674,0.00034166357,0.000017884398,0.000029922621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021777299,0.00020558409,0.00066927116,0.00006557498,0.000031539454,0.000006916926,0.00015208096,0.00010823619,0.0000026017765],"category_scores_gemma":[5.775049e-7,0.00008599877,0.00018807553,0.00009757978,0.00005330188,0.000010523215,0.00002616742,0.00003626642,0.000006123378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019794497,0.0016207052,0.00050928025,0.01238379,0.00036427565,0.00011995234,0.00023477427,2.7192895e-8,0.0000049709033,0.00021713314,0.000005965608,0.9845193],"study_design_scores_gemma":[0.026724894,0.0012997702,0.01666868,0.04174671,0.023019493,0.0006425409,0.0009243871,7.507948e-7,0.0064518205,0.00009621944,0.8819664,0.00045832022],"about_ca_topic_score_codex":0.000020030973,"about_ca_topic_score_gemma":0.0000058459523,"teacher_disagreement_score":0.984061,"about_ca_system_score_codex":0.000038387203,"about_ca_system_score_gemma":0.000078827245,"threshold_uncertainty_score":0.3506928},"labels":[],"label_agreement":null},{"id":"W2309349001","doi":"10.1200/jco.2011.29.15_suppl.8001","title":"Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; CHOP; Gastroenterology; Randomization; Randomized controlled trial; Clinical endpoint; Surgery; Confidence interval; Chemotherapy","score_opus":0.07212641106862692,"score_gpt":0.39454719560265206,"score_spread":0.3224207845340251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309349001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820696,0.00015235353,0.0022263182,0.002298576,0.004499032,0.0079881195,0.0006955565,0.000024342342,0.000046086265],"genre_scores_gemma":[0.9838942,0.0005133219,0.009878016,0.0018565573,0.0016655405,0.0017091449,0.00029003213,0.00009814202,0.00009500429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937479,0.00031396674,0.0039385543,0.00064741785,0.00044945697,0.00090271974],"domain_scores_gemma":[0.98560303,0.008215291,0.0034939519,0.00036101553,0.0006767586,0.001649969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020784172,0.00059323444,0.0051775933,0.0004130131,0.00021023951,0.000048780592,0.00046840782,0.00058524637,0.000070612325],"category_scores_gemma":[0.003127851,0.00034729223,0.0016511274,0.00013505435,0.00031095423,0.00021347175,0.00004923399,0.0002971244,0.000006174733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9229385,0.017494688,0.0058391676,0.00009397008,0.0035056344,0.00036253163,0.00055343437,0.0000019847264,0.000020175905,0.000100621786,0.01590713,0.03318211],"study_design_scores_gemma":[0.8991956,0.066993885,0.020540422,0.00079987344,0.0040405104,0.000050384282,0.00007074004,0.00021961884,0.00060324906,0.000286415,0.006803645,0.0003956485],"about_ca_topic_score_codex":0.0019971568,"about_ca_topic_score_gemma":0.0073089213,"teacher_disagreement_score":0.0494992,"about_ca_system_score_codex":0.00083433074,"about_ca_system_score_gemma":0.0017928322,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W2311813521","doi":"10.1136/jclinpath-2015-202955","title":"<i>CD10-positive mantle cell lymphoma</i>: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Somatic hypermutation; Mantle cell lymphoma; Immunophenotyping; Lymphoma; Biology; Germinal center; Gene expression profiling; Gene; Pathology; Cancer research; Gene expression; B cell; Bioinformatics; Medicine; Genetics; Immunology; Antibody; Flow cytometry","score_opus":0.0955201446384009,"score_gpt":0.38362443615010955,"score_spread":0.28810429151170863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311813521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583983,0.00089527114,0.00019327976,0.0005315551,0.00062174874,0.00036036826,0.000038704504,0.000018059332,0.0015012067],"genre_scores_gemma":[0.98207694,0.0006216913,0.01603131,0.0006680625,0.00033893384,0.00002121589,0.000035315166,0.000019948797,0.00018655628],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99652594,0.0009949262,0.001582912,0.00035520975,0.00023496321,0.00030604313],"domain_scores_gemma":[0.99760556,0.00052937254,0.00078404363,0.000345065,0.0003833715,0.00035258543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013787502,0.00024385555,0.0011340915,0.00008439921,0.00006609254,0.000020109615,0.00015616429,0.00039443193,0.00010395427],"category_scores_gemma":[0.0009798309,0.00013621457,0.00025101678,0.00015414185,0.000281125,0.00028566865,0.00012441627,0.000336783,0.000026963186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033026487,0.028850777,0.3657201,0.00009915356,0.00023052152,0.5262139,0.0038822538,0.000011915657,0.02173549,0.00024672976,0.0021043064,0.017878365],"study_design_scores_gemma":[0.056661304,0.048180673,0.61963105,0.00062042073,0.00067139394,0.17606048,0.0017706739,0.00004236762,0.08589696,0.002840512,0.0068984316,0.0007257055],"about_ca_topic_score_codex":0.00007822934,"about_ca_topic_score_gemma":0.00013341356,"teacher_disagreement_score":0.35015342,"about_ca_system_score_codex":0.0001507592,"about_ca_system_score_gemma":0.0006412803,"threshold_uncertainty_score":0.5554669},"labels":[],"label_agreement":null},{"id":"W2312551322","doi":"10.1097/01.cot.0000438506.81242.4c","title":"Certain Past Regimens for Hodgkin Lymphoma Can Raise Stomach Cancer Risk—Findings Point to Need for Continued Monitoring","year":2013,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stomach; Cancer; Stomach cancer; Internal medicine; Radiation therapy; Adenocarcinoma; Lymphoma; Gastric lymphoma; Gastroenterology","score_opus":0.019690133776576937,"score_gpt":0.31981634773900935,"score_spread":0.30012621396243244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312551322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971778,0.0004333025,0.00008740467,0.021257639,0.00064548175,0.0037566358,0.00019863162,0.0001040772,0.0017388271],"genre_scores_gemma":[0.97013855,0.00008301233,0.007774973,0.0011214152,0.0007729692,0.008956058,0.00007065625,0.000064657965,0.011017729],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983908,0.000053193817,0.00034617988,0.00046189086,0.00013805693,0.0006098943],"domain_scores_gemma":[0.99829155,0.00064669375,0.00016255667,0.00029334985,0.0002672659,0.00033859338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022520058,0.00027972966,0.00066662417,0.00015534823,0.00021251758,0.000035202247,0.00011722291,0.00020982759,0.00022238282],"category_scores_gemma":[0.0002100212,0.00022661232,0.0002089188,0.00013230626,0.000061990715,0.00006212145,0.000049642444,0.000057582347,0.00006968267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013150678,0.0011758181,0.38426453,0.00009139376,0.0009341156,0.000043876047,0.0026015982,0.000017637958,0.0070276093,0.00026123034,0.3855449,0.21672224],"study_design_scores_gemma":[0.032935813,0.0057227644,0.5352687,0.0002946792,0.001242945,0.000060979968,0.0019646843,0.00038406765,0.054862887,0.0003969316,0.36625636,0.0006091421],"about_ca_topic_score_codex":0.0042457203,"about_ca_topic_score_gemma":0.0002570855,"teacher_disagreement_score":0.21611309,"about_ca_system_score_codex":0.001230607,"about_ca_system_score_gemma":0.0003339756,"threshold_uncertainty_score":0.9240982},"labels":[],"label_agreement":null},{"id":"W2313331779","doi":"10.1097/mph.0b013e3182459f0a","title":"Thymic Mucosa-associated Lymphoid Tissue Lymphoma in an Adolescent Girl","year":2012,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; MALT lymphoma; Lymphoma; Rituximab; Vincristine; Cyclophosphamide; Prednisone; Mucosa-associated lymphoid tissue; Pathology; Lymphoblastic lymphoma; Radiation therapy; Immunodeficiency; Gastroenterology; Internal medicine; Immunology; Chemotherapy; T cell; Immune system","score_opus":0.03135888317072278,"score_gpt":0.34465613683679847,"score_spread":0.3132972536660757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313331779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394096,0.010816577,0.000021111367,0.002261392,0.0014479052,0.000382287,0.000007292782,0.000034741555,0.0010877282],"genre_scores_gemma":[0.99428946,0.0020882848,0.000946648,0.00095169066,0.0015817374,0.000027515256,0.0000171515,0.000040291437,0.000057252146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642414,0.0005155591,0.0014483643,0.00027746288,0.0004264831,0.0009080059],"domain_scores_gemma":[0.9970336,0.00044562612,0.0011303871,0.0003088169,0.00031632456,0.00076524797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010837684,0.00034661408,0.0015400924,0.000769397,0.000075228556,0.000013886979,0.0002456834,0.0006768787,0.00019187003],"category_scores_gemma":[0.00046622122,0.00027112308,0.00026248486,0.00057380716,0.00009385678,0.0003291473,0.00007904389,0.0003160494,0.00015855634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004757551,0.012805001,0.9545107,0.000071461895,0.00017424751,0.0036906006,0.0008464839,0.0000021431797,0.00026408996,0.00025791922,0.008915497,0.01798614],"study_design_scores_gemma":[0.022984354,0.005080959,0.91747195,0.00009114964,0.0013130734,0.026733683,0.0006699235,0.000029392493,0.0022582393,0.0001318475,0.02285622,0.00037919023],"about_ca_topic_score_codex":0.000049125458,"about_ca_topic_score_gemma":0.00006671925,"teacher_disagreement_score":0.037038695,"about_ca_system_score_codex":0.0027141145,"about_ca_system_score_gemma":0.0015796893,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W2313425325","doi":"10.1097/pai.0000000000000181","title":"Immunohistochemistry as a Surrogate for Molecular Testing","year":2015,"lang":"en","type":"review","venue":"Applied immunohistochemistry & molecular morphology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Gene; Molecular diagnostics; Computational biology; Fusion gene; Immunohistochemistry; Fusion protein; Molecular pathology; Epigenetics; Genetics; Recombinant DNA; Immunology","score_opus":0.04097338320963227,"score_gpt":0.3619092392813828,"score_spread":0.3209358560717505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313425325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045505315,0.967035,0.00013688981,0.000053062857,0.0003025273,0.003908528,0.0001884337,0.0003036105,0.023521433],"genre_scores_gemma":[0.0045156484,0.9565538,0.011573898,0.0011589156,0.00037229733,0.014818822,0.0075507597,0.0009180947,0.0025377206],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940573,0.00008207564,0.0017416616,0.002093641,0.0006678589,0.0013574802],"domain_scores_gemma":[0.99455607,0.00032648537,0.0011974486,0.0027169792,0.00060090097,0.0006021028],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00048303188,0.0018302526,0.004726165,0.0002226122,0.00022318958,0.00007260513,0.00087199657,0.0017866828,0.00014614568],"category_scores_gemma":[0.00055477396,0.0017978679,0.0018127221,0.0006456917,0.00050705177,0.00003343521,0.00043964185,0.0009659367,0.0003978038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020979292,0.0006854874,9.0285033e-7,0.01203625,0.0019458892,0.0028084745,0.000026696087,0.0000016437275,0.72330546,0.0002364656,0.0023263027,0.25641662],"study_design_scores_gemma":[0.008845302,0.00084901496,0.0000012691695,0.00868587,0.015079887,0.015100227,0.00006509222,0.000003972455,0.10831742,0.00062890834,0.8395647,0.0028583405],"about_ca_topic_score_codex":0.000069370246,"about_ca_topic_score_gemma":1.06992575e-8,"teacher_disagreement_score":0.8372384,"about_ca_system_score_codex":0.0027277935,"about_ca_system_score_gemma":0.0031772011,"threshold_uncertainty_score":0.9995092},"labels":[],"label_agreement":null},{"id":"W2313508924","doi":"10.1016/j.bbmt.2015.11.316","title":"Carmustine-Free Conditioning Regimens Offer Comparable Efficacy to BEAM: The First Report of the Canadian Blood and Marrow Transplant Group Registry","year":2016,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Hôtel-Dieu de Québec; BC Cancer Agency; Foothills Medical Centre; Hôpital de l'Enfant-Jésus; University of Manitoba; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Hamilton Health Sciences; University of Toronto","funders":"Mundipharma Pharmaceuticals srl; Università degli Studi di Urbino Carlo Bo","keywords":"Medicine; Melphalan; Carmustine; Etoposide; Internal medicine; Oncology; Regimen; Progression-free survival; Transplantation; Surgery; Chemotherapy","score_opus":0.011571016664851639,"score_gpt":0.22892204753287854,"score_spread":0.2173510308680269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313508924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990095,0.0005877454,0.000018936755,0.007967472,0.00008804635,0.0005094062,0.00041002486,0.000011335343,0.00050608173],"genre_scores_gemma":[0.9987519,0.000552914,0.00013793343,0.00024874855,0.00003761597,0.0000402375,0.00012313208,0.000009038454,0.00009850045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990831,0.000044431243,0.0003148838,0.00025328106,0.0001057638,0.00019852215],"domain_scores_gemma":[0.9991561,0.00020562878,0.00014264874,0.00031462676,0.000056537297,0.00012444526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018400801,0.00014592285,0.00028926882,0.00006531469,0.00020229298,0.0000068147706,0.00009751458,0.000116418785,0.000015156901],"category_scores_gemma":[0.000029780605,0.00007451367,0.00006624849,0.0000809705,0.0002924566,0.00003092851,0.000009226763,0.000056757028,5.3968245e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004013198,0.00031479142,0.8186724,0.00035368386,0.0006247751,0.00027144593,0.0012034989,0.0000025677018,0.17490146,0.0020305442,0.0007040178,0.00051948964],"study_design_scores_gemma":[0.009076872,0.00065933453,0.844772,0.0009075112,0.0025416103,0.0031664239,0.00006455194,0.0000014650391,0.13712484,0.00014793046,0.0013749312,0.00016254302],"about_ca_topic_score_codex":0.015375666,"about_ca_topic_score_gemma":0.04950338,"teacher_disagreement_score":0.037776615,"about_ca_system_score_codex":0.000017286648,"about_ca_system_score_gemma":0.00010631807,"threshold_uncertainty_score":0.991181},"labels":[],"label_agreement":null},{"id":"W2313771340","doi":"10.1139/bcb-2012-0110","title":"Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin","year":2013,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Lymphoma; Beta-2 microglobulin; Biology; Lactate dehydrogenase; Cell adhesion molecule; Immunology; CD11c; Dendritic cell; Pathology; Molecular biology; Medicine; Immune system; Phenotype; Enzyme","score_opus":0.005173797635539071,"score_gpt":0.1991574380999462,"score_spread":0.19398364046440714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313771340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069536,0.008223461,0.000043987187,0.000072188464,0.000019967154,0.0005356874,0.0000106198195,0.000013985946,0.0003847616],"genre_scores_gemma":[0.99838024,0.00070399756,0.0005370019,0.00002396714,0.000015665784,0.00010462036,0.00009584921,0.000015535521,0.00012312345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889016,0.00005037941,0.000317501,0.0004469326,0.00006436693,0.00023068332],"domain_scores_gemma":[0.9993879,0.00006620241,0.00013237343,0.00020129392,0.00005292095,0.00015928593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075253076,0.00023308126,0.0003331738,0.000073226445,0.000059838203,0.000018359706,0.000046618825,0.00025386305,0.00003602256],"category_scores_gemma":[0.000013539792,0.00017011545,0.000038002327,0.00011371015,0.0002431433,0.00003956967,0.000062905856,0.00011007191,0.0000062935583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001724312,0.0005409583,0.015120749,0.00030245955,0.000018869541,0.000106881154,0.00015584381,3.9162737e-7,0.981206,0.0000075842836,0.000028800874,0.0023390285],"study_design_scores_gemma":[0.0038171783,0.0005570769,0.004867783,0.0006908824,0.000052480682,0.00010235914,0.0004149708,0.00019121148,0.9890827,0.000022570737,0.000027808415,0.00017301383],"about_ca_topic_score_codex":0.00006568783,"about_ca_topic_score_gemma":0.0000012876188,"teacher_disagreement_score":0.010252967,"about_ca_system_score_codex":0.000056498586,"about_ca_system_score_gemma":0.000049810733,"threshold_uncertainty_score":0.6937107},"labels":[],"label_agreement":null},{"id":"W2313941482","doi":"10.1097/ppo.0b013e31826c5907","title":"Chemotherapy Alone for Localized Diffuse Large B-Cell Lymphoma","year":2012,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Radiation therapy; Chemotherapy; Stage (stratigraphy); Disease; Lymphoma; Oncology; Systemic therapy; Internal medicine; Cancer","score_opus":0.061141207731143336,"score_gpt":0.3667364698082605,"score_spread":0.3055952620771172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313941482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000987206,0.9963201,0.00013744402,0.00068175426,0.00078635133,0.0014806867,0.0001462111,0.000025188136,0.00032351873],"genre_scores_gemma":[0.00016890754,0.99255455,0.00017192536,0.0012523311,0.003246955,0.0006933797,0.00005996894,0.0001228289,0.0017291459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980743,0.00011417442,0.00060187874,0.00025439906,0.00032289507,0.00063233066],"domain_scores_gemma":[0.9982549,0.0001957534,0.0005930121,0.0005077481,0.0001089124,0.0003396729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052788825,0.00048276724,0.0018582988,0.00009064013,0.00027558714,0.00007006701,0.0003099088,0.00023205834,0.00056256494],"category_scores_gemma":[0.000014009704,0.00023171789,0.0012236952,0.00014681692,0.000053480286,0.000051218278,0.000041248208,0.00023324731,0.00008153937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013162073,0.002803372,0.00004762593,0.0031579908,0.0010720878,0.000032392178,0.00010626782,3.4728323e-8,4.1407975e-7,0.00003430418,0.017404187,0.9752097],"study_design_scores_gemma":[0.026358258,0.00015091384,0.000032692078,0.0044542146,0.006592962,0.00091481063,0.000013505811,0.0000032622945,0.000026369202,0.000042017844,0.9611668,0.00024416624],"about_ca_topic_score_codex":0.000022705553,"about_ca_topic_score_gemma":0.0000057750362,"teacher_disagreement_score":0.9749655,"about_ca_system_score_codex":0.0011063935,"about_ca_system_score_gemma":0.00086667656,"threshold_uncertainty_score":0.94491816},"labels":[],"label_agreement":null},{"id":"W2314368967","doi":"10.1097/00001622-200203000-00005","title":"Hematopoietic stem cell transplantation in Hodgkin disease","year":2002,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Disease; Autologous stem-cell transplantation; Malignancy; Oncology; Internal medicine","score_opus":0.14395037942004787,"score_gpt":0.4270457725093057,"score_spread":0.2830953930892578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314368967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000914952,0.9940516,0.0000056492436,0.00013646374,0.0032632025,0.0017263965,0.000072896226,0.000026537036,0.000625808],"genre_scores_gemma":[0.00033434646,0.99728245,0.000020198651,0.000016490307,0.0002631524,0.0011681003,0.0008150154,0.00003406136,0.00006617061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977405,0.0003204929,0.0008830464,0.0005269033,0.00019624474,0.00033281685],"domain_scores_gemma":[0.9988783,0.00032576994,0.00026300314,0.00029869095,0.000020850443,0.00021339698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001500893,0.00038212936,0.0016778077,0.00048674858,0.000020481335,0.000009536658,0.00011459963,0.00029948432,0.00015713375],"category_scores_gemma":[0.0000087418675,0.00030630088,0.00033449146,0.00035746617,0.00004441526,0.000036189995,0.000026480895,0.00035372988,0.00029139713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038050763,0.0026361481,0.0016902044,0.0574886,0.00001977321,0.00020589124,0.00022849574,0.0000010648992,8.911443e-9,0.00014753763,0.0016711445,0.9358731],"study_design_scores_gemma":[0.0030476872,0.0002508001,0.0014392905,0.034456935,0.00044427064,0.000101589154,0.000016930566,0.000010796832,2.3180571e-7,0.000016992088,0.9599835,0.00023096497],"about_ca_topic_score_codex":0.000009448728,"about_ca_topic_score_gemma":0.0000051035045,"teacher_disagreement_score":0.9583124,"about_ca_system_score_codex":0.0013267999,"about_ca_system_score_gemma":0.0005967154,"threshold_uncertainty_score":0.9999389},"labels":[],"label_agreement":null},{"id":"W2314580041","doi":"10.1097/rlu.0b013e318219b0ec","title":"Progressive Transformation of Germinal Centers in a Pediatric Patient","year":2011,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Hospital; Brandon Regional Health Authority","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Radiology; Germinal center; Pathology; B cell","score_opus":0.06510094886623823,"score_gpt":0.3437059554865532,"score_spread":0.27860500662031495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314580041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888058,0.00037593764,0.0000018832267,0.0012094161,0.00019858731,0.00044718833,0.000001925342,0.000021196414,0.0089381095],"genre_scores_gemma":[0.99828166,0.0005148507,0.00033254284,0.0006971223,0.00013106366,0.00001259262,0.00000968764,0.000012696586,0.000007783108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853957,0.000056735928,0.00082592247,0.00018142116,0.00023363897,0.00016269686],"domain_scores_gemma":[0.9992991,0.000097730015,0.00018571224,0.00017859957,0.00006792897,0.00017091504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002495487,0.000107916516,0.00043539167,0.000119234435,0.000014666757,0.000001021306,0.000053846503,0.00009355569,0.0004728843],"category_scores_gemma":[0.0001849775,0.00007088484,0.0001120982,0.00017314787,0.00017688861,0.000047951133,0.000015930178,0.00012963054,0.000034055007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018016747,0.0049990215,0.87177753,0.00027399912,0.0000836923,0.0007083799,0.009166126,1.5470849e-7,0.00002934681,0.00085410284,0.0021001997,0.10820574],"study_design_scores_gemma":[0.007121982,0.005704121,0.98405826,0.0003512019,0.00025311735,0.000053560507,0.00063143927,0.000056973287,0.000071860464,0.00006359048,0.0015634269,0.00007048969],"about_ca_topic_score_codex":0.000048139587,"about_ca_topic_score_gemma":0.0000024752815,"teacher_disagreement_score":0.112280674,"about_ca_system_score_codex":0.00004214974,"about_ca_system_score_gemma":0.000039775718,"threshold_uncertainty_score":0.5177751},"labels":[],"label_agreement":null},{"id":"W2315911875","doi":"10.1200/jco.2007.25.18_suppl.6623","title":"Cost-effectiveness (CE) analysis of CHOP and rituximab for diffuse large B-cell lymphoma (DLBCL) in British Columbia (BC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; CHOP; Population; Diffuse large B-cell lymphoma; Vincristine; Internal medicine; Oncology; Clinical endpoint; Surgery; Lymphoma; Cyclophosphamide; Chemotherapy; Clinical trial","score_opus":0.08858813902838873,"score_gpt":0.44731816839298244,"score_spread":0.3587300293645937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315911875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710435,0.0009920545,0.00033438572,0.00022637392,0.0003251658,0.0005857109,0.000039156716,0.000004386116,0.00038840316],"genre_scores_gemma":[0.9967323,0.0011049074,0.0013140006,0.0005286389,0.00018870365,0.00001751958,0.000009666802,0.0000143563175,0.0000898931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967794,0.00027193673,0.0021394242,0.00024286636,0.00025326875,0.000313148],"domain_scores_gemma":[0.9913597,0.006525738,0.0012083562,0.00015703976,0.00039933497,0.00034979937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005203134,0.000109239125,0.0024620867,0.00022755649,0.000039406812,0.00002212029,0.00009434437,0.00039103554,0.000049087983],"category_scores_gemma":[0.0018581543,0.000116848496,0.00078344287,0.00039179606,0.00014711363,0.00007679604,0.000044610817,0.00019513794,0.0000013692007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022382895,0.05640761,0.7566884,0.00006704899,0.0012977606,0.001009959,0.00004234162,0.0000013434701,0.00001834548,0.000011603575,0.00042615502,0.18179111],"study_design_scores_gemma":[0.15271689,0.005477347,0.82831115,0.00012513236,0.0028858187,0.0001391063,0.00010674337,0.00015850831,0.00005835768,0.000079683414,0.009861573,0.00007970393],"about_ca_topic_score_codex":0.002178787,"about_ca_topic_score_gemma":0.038470812,"teacher_disagreement_score":0.1817114,"about_ca_system_score_codex":0.00036215116,"about_ca_system_score_gemma":0.000571515,"threshold_uncertainty_score":0.9790746},"labels":[],"label_agreement":null},{"id":"W2316581641","doi":"10.1097/rlu.0b013e318217742f","title":"Primary Peripheral T-Cell Lymphoma of the Colon Mimics Inflammatory Bowel Disease","year":2011,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Lymphoma; Inflammatory bowel disease; Ulcerative colitis; Colonoscopy; Biopsy; Pathology; Peripheral T-cell lymphoma; Colectomy; T-cell lymphoma; Radiology; Gastroenterology; Disease; Internal medicine; Colorectal cancer; T cell; Cancer; Immunology; Immune system","score_opus":0.0376097106605379,"score_gpt":0.2855220814501203,"score_spread":0.24791237078958242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316581641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714214,0.0007082687,0.0000010396981,0.0035070989,0.00068210403,0.00047674504,0.000007775916,0.000051147643,0.023144428],"genre_scores_gemma":[0.9901376,0.0006122166,0.00023855448,0.008018815,0.00039071724,0.0000115860785,0.000010900594,0.000040642655,0.00053896697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981258,0.00012261063,0.00079818803,0.00032215787,0.00039321987,0.00023803215],"domain_scores_gemma":[0.99820316,0.00019804208,0.00026278,0.00075992796,0.00010971571,0.00046635568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038149796,0.0001986691,0.0005325592,0.000037256596,0.00007684882,0.0000030002645,0.00022908664,0.00014502379,0.0007351838],"category_scores_gemma":[0.00039898732,0.00011172325,0.00032133595,0.00010936749,0.00091250584,0.000040927087,0.00013950824,0.00014503971,0.000072601884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025347825,0.0052687684,0.94978553,0.0003716663,0.00020220756,0.00034028068,0.0009994431,3.302858e-7,0.00045013687,0.0013827897,0.027090494,0.011573584],"study_design_scores_gemma":[0.009832222,0.0011448694,0.96518755,0.0003681162,0.0005229915,0.000015689731,0.00017675686,0.000057996498,0.00010573157,0.00016097157,0.022320606,0.000106481],"about_ca_topic_score_codex":0.000042781085,"about_ca_topic_score_gemma":0.0000027055391,"teacher_disagreement_score":0.02260546,"about_ca_system_score_codex":0.00012643433,"about_ca_system_score_gemma":0.00023958793,"threshold_uncertainty_score":0.80497473},"labels":[],"label_agreement":null},{"id":"W2317004379","doi":"10.1038/sj.bmt.1703297","title":"Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma","year":2002,"lang":"en","type":"review","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Bone marrow; Stem cell; Lymphoma; CD20; Autologous stem-cell transplantation; Transplantation; Non-Hodgkin's lymphoma; Immunology; Oncology; Internal medicine; Cancer research; Biology","score_opus":0.03268560898214515,"score_gpt":0.31171795588849077,"score_spread":0.2790323469063456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317004379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019379616,0.9933065,0.00006530992,0.000121127,0.00025087115,0.0019345391,0.00011000716,0.00008611696,0.00218754],"genre_scores_gemma":[0.0040139644,0.9926941,0.0010150337,0.000106189655,0.00009390974,0.00043986668,0.0008910071,0.0001004191,0.00064550544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973236,0.000120408,0.0009798895,0.00065604463,0.00047171663,0.0004483853],"domain_scores_gemma":[0.9989122,0.00016312132,0.0002883791,0.00043811084,0.000039396346,0.00015878341],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019047536,0.0006505384,0.0024199896,0.0004597866,0.00007851969,0.00005413333,0.00011169179,0.00045773553,0.00010571869],"category_scores_gemma":[0.00001322767,0.0005082987,0.00082072645,0.0004150966,0.00003980171,0.00012630677,0.000010467818,0.0001664227,0.0002380742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093184084,0.0008092853,0.0014356226,0.018909141,0.0003712301,0.0032637853,0.00021823244,0.0000085398915,0.0000018377003,0.00003097788,0.00016484484,0.9746933],"study_design_scores_gemma":[0.02377408,0.00068892335,0.03816685,0.097916774,0.013986048,0.0038151788,0.000050917286,0.0002176958,0.000060200222,0.000026403968,0.8193145,0.001982438],"about_ca_topic_score_codex":0.00016362767,"about_ca_topic_score_gemma":0.00004016479,"teacher_disagreement_score":0.9727109,"about_ca_system_score_codex":0.0005627936,"about_ca_system_score_gemma":0.00017957018,"threshold_uncertainty_score":0.99973685},"labels":[],"label_agreement":null},{"id":"W2317709849","doi":"10.1017/s0317167100014426","title":"Intra-abdominal T-cell Lymphoma Presenting with Seizures and MRI Changes","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Radiology; Neuroscience; Psychology; Pathology","score_opus":0.022146116976302796,"score_gpt":0.2446834368402465,"score_spread":0.2225373198639437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317709849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801202,0.0017757699,0.000006966447,0.01409259,0.0002460753,0.00027315426,0.000003833821,0.000014158567,0.0034672844],"genre_scores_gemma":[0.99168533,0.0006076409,0.0031755995,0.0041995062,0.0002458246,0.000008776047,2.2571663e-7,0.00001108934,0.00006600158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967245,0.00037073498,0.0005298788,0.00049555756,0.0006893772,0.0011899772],"domain_scores_gemma":[0.99616045,0.00043560873,0.00053619896,0.00012829906,0.00043197564,0.0023074464],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0013855026,0.00033152665,0.0005385668,0.0006924662,0.0018198363,0.0008564941,0.00069098105,0.00014037598,0.00019164859],"category_scores_gemma":[0.00050237967,0.00018272248,0.00012509788,0.0007316626,0.0050692935,0.0007323426,0.00005634215,0.00044861354,0.0000047945614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008278834,0.0000902367,0.9772524,0.000015144431,0.000026604828,0.0107052075,0.0003699793,0.00012998958,0.000054168315,0.0001579798,0.0010724935,0.010042992],"study_design_scores_gemma":[0.0017061519,0.09106518,0.772742,0.00008151861,0.00014724476,0.12554857,0.0006265636,0.0010172265,0.0006555165,0.003768615,0.002286813,0.0003546068],"about_ca_topic_score_codex":0.002784472,"about_ca_topic_score_gemma":0.027323999,"teacher_disagreement_score":0.20451042,"about_ca_system_score_codex":0.00018445391,"about_ca_system_score_gemma":0.0022729922,"threshold_uncertainty_score":0.99947965},"labels":[],"label_agreement":null},{"id":"W2317813998","doi":"10.1016/j.berh.2016.03.001","title":"Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link","year":2016,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Royal Victoria Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Autoimmunity; Cancer; Disease; Immunology; Population; Immune system; Internal medicine","score_opus":0.31971072690964236,"score_gpt":0.5817988703174294,"score_spread":0.262088143407787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317813998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026807183,0.93516755,0.000013829339,0.05918625,0.0005713117,0.0031719538,0.000030328883,0.000046870304,0.0015438115],"genre_scores_gemma":[0.0003139898,0.99513465,0.00044671388,0.0003582986,0.00038725883,0.0022054529,0.000027734688,0.00008905917,0.0010368522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99055266,0.004335268,0.0018196463,0.0012063939,0.0009953954,0.0010906575],"domain_scores_gemma":[0.9586276,0.03745968,0.00070654554,0.0014784561,0.0009918086,0.0007359391],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009564309,0.000525204,0.0034014331,0.0003234004,0.00066107966,0.00023002144,0.00053669675,0.00089272857,0.00022314941],"category_scores_gemma":[0.03809464,0.00026224533,0.0004818451,0.000626299,0.001368639,0.00022983694,0.0015504026,0.0026373342,0.001373652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024262888,0.0010293683,0.007176687,0.0032754373,0.0012406331,0.00073675363,0.00004726953,8.5709155e-9,4.3312475e-8,0.0014766146,0.0044638426,0.98031074],"study_design_scores_gemma":[0.0012016299,0.0012738097,0.0010756208,0.036895394,0.0016392136,0.00360737,0.00006078152,0.0000014660368,1.9927124e-7,0.000108428365,0.9538866,0.0002494665],"about_ca_topic_score_codex":0.0015785585,"about_ca_topic_score_gemma":0.00015019887,"teacher_disagreement_score":0.98006123,"about_ca_system_score_codex":0.0004827892,"about_ca_system_score_gemma":0.004539969,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W2317900691","doi":"10.1136/annrheumdis-2014-eular.1750","title":"FRI0318 Two-Year Retention and Effectiveness of IV Abatacept in Real-Life Setting: Results from the Action Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Abatacept; Internal medicine; Retention rate; Cohort; Surgery","score_opus":0.05294223653561911,"score_gpt":0.3396118354689946,"score_spread":0.2866695989333755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317900691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977713,0.00028780958,0.0000027183073,0.0008247143,0.000068451554,0.00076516194,0.000093610564,0.000011161676,0.00017505453],"genre_scores_gemma":[0.9995103,0.00031082373,0.0000120407985,0.000052273568,0.000020191343,0.000043768356,0.000034361383,0.000008493985,0.000007759161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854046,0.0005693911,0.00034555723,0.0001787944,0.00026369104,0.00010211249],"domain_scores_gemma":[0.99770314,0.0014560673,0.000258207,0.00044966541,0.00007188784,0.00006105575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070230453,0.0001065638,0.00031745338,0.000034921133,0.000052938045,0.00001221085,0.00008968459,0.00002358216,0.000007930058],"category_scores_gemma":[0.001485112,0.00005594921,0.00010234443,0.00011359577,0.00006973019,0.00006117688,0.000060678864,0.00003683943,0.000002555645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017090671,0.0020928928,0.98101234,0.00031962793,0.00040971054,0.0000015891558,0.0010818556,0.00006522355,0.00009992974,0.00031548974,0.0006094782,0.012282802],"study_design_scores_gemma":[0.004750317,0.00032976025,0.98950106,0.0016153542,0.000271626,5.257472e-7,0.0014202857,0.00028808278,0.00093818735,0.00082922063,0.000006105571,0.000049462193],"about_ca_topic_score_codex":0.002271353,"about_ca_topic_score_gemma":0.00007649085,"teacher_disagreement_score":0.01223334,"about_ca_system_score_codex":0.000017750197,"about_ca_system_score_gemma":0.00004238464,"threshold_uncertainty_score":0.34336215},"labels":[],"label_agreement":null},{"id":"W2318743788","doi":"10.1136/annrheumdis-2012-eular.459","title":"AB0459 Analysis of integrated radiographic data for two long-term, open-label extension studies of adalimumab","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adalimumab; Radiography; Rheumatoid arthritis; Placebo; Clinical trial; Post-hoc analysis; Internal medicine; Nuclear medicine; Surgery; Pathology","score_opus":0.2830504771859936,"score_gpt":0.4622822381015675,"score_spread":0.1792317609155739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318743788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561508,0.041015342,0.0000315334,0.00052581093,0.00009177027,0.00082228286,0.001334446,0.000009200363,0.000018796045],"genre_scores_gemma":[0.9950741,0.003897288,0.00027153603,0.00014512768,0.000010847989,0.000065766784,0.0004856422,0.000013907904,0.000035784236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985149,0.00010220396,0.0006355872,0.00021468684,0.0003194559,0.00021319231],"domain_scores_gemma":[0.99681705,0.00058944017,0.00057205284,0.0014538213,0.0004446942,0.00012292377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043036943,0.00017802908,0.001094518,0.00024322607,0.000059887207,0.000009800393,0.000535471,0.000027637121,0.00003845456],"category_scores_gemma":[0.0009190955,0.000097557866,0.00033535733,0.00081804086,0.00022808115,0.0002067656,0.000377473,0.000023051405,8.310457e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008245018,0.009415671,0.90742046,0.0014215527,0.028356703,0.0000020048672,0.00036449044,0.00002672723,0.0001487825,0.00040188016,0.008141014,0.04347623],"study_design_scores_gemma":[0.004568229,0.00037231334,0.96991354,0.0024426826,0.018130789,0.000002533323,0.0003643354,0.0009031839,0.0029481926,0.00020572825,0.000028241111,0.000120245706],"about_ca_topic_score_codex":0.00029821045,"about_ca_topic_score_gemma":0.000034600787,"teacher_disagreement_score":0.062493086,"about_ca_system_score_codex":0.000016969701,"about_ca_system_score_gemma":0.00009381961,"threshold_uncertainty_score":0.39782944},"labels":[],"label_agreement":null},{"id":"W2319088965","doi":"10.1038/sj.bmt.1703772","title":"‘Relative’ chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma","year":2002,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Salvage therapy; Chemotherapy; Refractory (planetary science); Lymphoma; Oncology; Stem cell; Internal medicine; Aggressive lymphoma; Surgery; Rituximab","score_opus":0.012876744373950179,"score_gpt":0.2671450648145489,"score_spread":0.2542683204405987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319088965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953442,0.0003905672,0.0011813211,0.0005456997,0.0000440198,0.0013975453,0.00039615564,0.000026093852,0.0006743803],"genre_scores_gemma":[0.9971079,0.0012595853,0.0010535726,0.000101853235,0.000026246315,0.000085852655,0.00007344307,0.000034123404,0.00025742594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987458,0.00009780978,0.0003960046,0.00029851525,0.0002263596,0.00023552953],"domain_scores_gemma":[0.99867976,0.0005168191,0.00034466726,0.00024559945,0.00010175511,0.00011138566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019953559,0.0002484377,0.000531983,0.0000894941,0.00008235711,0.000008999385,0.000039532042,0.00013682405,0.000033082226],"category_scores_gemma":[0.000006904722,0.00016501962,0.00023594024,0.00014203953,0.0000919029,0.000093246985,0.000003662248,0.000057283636,0.0000057606744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022547936,0.006045765,0.15152866,0.00308203,0.0026646683,0.0019388882,0.08955062,0.00020277356,0.44545642,0.00037295627,0.002469041,0.27414027],"study_design_scores_gemma":[0.02405892,0.0032151213,0.76255006,0.0011335727,0.0014123594,0.0013362352,0.00031215776,0.0014951577,0.20389977,0.000055142336,0.0001420598,0.0003894354],"about_ca_topic_score_codex":0.00024422354,"about_ca_topic_score_gemma":0.000023168082,"teacher_disagreement_score":0.6110214,"about_ca_system_score_codex":0.00012056232,"about_ca_system_score_gemma":0.0000617474,"threshold_uncertainty_score":0.6729305},"labels":[],"label_agreement":null},{"id":"W2319891590","doi":"10.1097/mph.0000000000000090","title":"Childhood Lymphomatoid Granulomatosis","year":2014,"lang":"en","type":"review","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lymphomatoid granulomatosis; Disease; Lymphoma; Mortality rate; Pediatrics; Lymphoproliferative disease; Dermatology; Leukemia; Survival rate; Rare disease; Pathology; Surgery; Internal medicine","score_opus":0.03126947666259258,"score_gpt":0.3580264525043191,"score_spread":0.32675697584172647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319891590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004917983,0.99281317,0.000029198394,0.0005858146,0.0019113258,0.00089464284,0.000029075365,0.000057582707,0.0031873998],"genre_scores_gemma":[0.00038404972,0.9933614,0.0019803753,0.00043057004,0.003468924,0.00011071923,0.000057259564,0.00012249852,0.000084186686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99348915,0.0007995296,0.0037014808,0.000576723,0.0006310016,0.0008021115],"domain_scores_gemma":[0.99116236,0.0019929304,0.0049342276,0.000679855,0.00042738873,0.0008032227],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012220041,0.00093231443,0.010071654,0.0015570915,0.00012943211,0.00002895166,0.00056610914,0.0019734378,0.00022904201],"category_scores_gemma":[0.00070570706,0.0006175047,0.003010148,0.00078693754,0.00015538964,0.00010213254,0.00016888871,0.000985964,0.0006585512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073062314,0.00389522,0.0032074803,0.013846539,0.0024080472,0.007121839,0.00014295246,1.3512351e-7,8.552595e-8,0.0006642664,0.057602085,0.9110383],"study_design_scores_gemma":[0.0046957694,0.002352496,0.00019722302,0.0023162323,0.01681669,0.10059609,0.000030590676,5.4153764e-7,0.0000020050152,0.00010116694,0.8725052,0.0003860112],"about_ca_topic_score_codex":0.000007431158,"about_ca_topic_score_gemma":0.0000023065174,"teacher_disagreement_score":0.9106523,"about_ca_system_score_codex":0.0015577581,"about_ca_system_score_gemma":0.006350961,"threshold_uncertainty_score":0.99962765},"labels":[],"label_agreement":null},{"id":"W2320121061","doi":"10.1136/annrheumdis-2012-eular.3146","title":"SAT0199 An estimate of the proportion of patients with sle receiving off-label treatment with rituximab in european countries","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; European union; Rituximab; Rheumatology; Population; Internal medicine; Specialty; Family medicine; Demography; Pediatrics; Environmental health","score_opus":0.027780369814081413,"score_gpt":0.292356506755357,"score_spread":0.2645761369412756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320121061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974652,0.0011991212,0.0000012591822,0.0003426859,0.000043891516,0.00069816236,0.000092344235,0.000008621979,0.000148697],"genre_scores_gemma":[0.999437,0.00029051382,0.0001202146,0.00004483811,0.000008508508,0.000030433925,0.000023565328,0.000017000255,0.000027960263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884826,0.00011967208,0.0003442633,0.0001090326,0.00040559925,0.00017316842],"domain_scores_gemma":[0.9988169,0.000057477337,0.00043630012,0.00045450413,0.00015650247,0.000078303485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013749674,0.0001467449,0.00036192982,0.000041035284,0.00004619676,0.000006290814,0.00010187564,0.000014451897,0.000017208084],"category_scores_gemma":[0.000056992987,0.00005986626,0.00007011784,0.00014209631,0.00016429991,0.00014751148,0.000033658533,0.000019512141,0.0000020281677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045552454,0.00966208,0.9572687,0.00029372572,0.0002192114,0.0000010177914,0.00076875463,0.000016195258,0.0000028956952,0.00009434093,0.000053098953,0.03116447],"study_design_scores_gemma":[0.0046690986,0.0011119366,0.98946327,0.001864483,0.0003805054,0.0000018857605,0.00014116609,0.00004194483,0.0021884057,0.000026282589,0.00004510285,0.000065920656],"about_ca_topic_score_codex":0.0001694609,"about_ca_topic_score_gemma":0.000036932724,"teacher_disagreement_score":0.03219458,"about_ca_system_score_codex":0.000041700638,"about_ca_system_score_gemma":0.0001020269,"threshold_uncertainty_score":0.24412751},"labels":[],"label_agreement":null},{"id":"W2321528081","doi":"10.1038/sj.bmt.1703573","title":"Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma","year":2002,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Busulfan; Total body irradiation; Hematopoietic stem cell transplantation; Surgery; Follicular lymphoma; Transplantation; Lymphoma; Internal medicine; Methotrexate; Cyclophosphamide; Chemotherapy; Gastroenterology","score_opus":0.016970014256398717,"score_gpt":0.23807276196828903,"score_spread":0.2211027477118903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321528081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884808,0.0036384629,0.0029210658,0.0007670673,0.00015168879,0.0020839164,0.00019082695,0.00015360319,0.001612578],"genre_scores_gemma":[0.99359447,0.0019480656,0.0017992412,0.00028139324,0.00008118581,0.00085482915,0.0007336237,0.000046177913,0.0006610233],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984477,0.000045266283,0.00040793137,0.00042131828,0.0003340798,0.00034371615],"domain_scores_gemma":[0.9992959,0.00010046892,0.00013347203,0.00021942,0.00009198859,0.00015876791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095976306,0.00027735854,0.0003623238,0.00012950395,0.00014600245,0.000036905927,0.000058609035,0.00014727916,0.0001233916],"category_scores_gemma":[0.0000018451152,0.00024217604,0.00025285754,0.00015951207,0.00003826181,0.00013201126,0.0000023549103,0.000036903562,0.000081528684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01192711,0.018272731,0.12621121,0.031634014,0.0023668357,0.01729721,0.043324847,0.0005366974,0.20079584,0.0062362617,0.008300893,0.5330963],"study_design_scores_gemma":[0.05939571,0.0029935865,0.14643912,0.0014050042,0.0069710943,0.0063639726,0.00062405225,0.002402201,0.7672409,0.00035759172,0.004387529,0.0014192521],"about_ca_topic_score_codex":0.000017091328,"about_ca_topic_score_gemma":0.000011689953,"teacher_disagreement_score":0.56644505,"about_ca_system_score_codex":0.00012587485,"about_ca_system_score_gemma":0.00003873004,"threshold_uncertainty_score":0.9875653},"labels":[],"label_agreement":null},{"id":"W2321971599","doi":"10.3899/jrheum.140725","title":"Prolonged Remission of Marginal Zone Lymphoma in a Patient with Rheumatoid Arthritis Treated with Anti-tumor Necrosis Factor Agents","year":2014,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Infliximab; Internal medicine; Context (archaeology); Lymphoproliferative disorders; Lymphocytosis; Lymphoma; Rheumatology; Gastroenterology; Arthritis; Tumor necrosis factor alpha; Immunology; Oncology","score_opus":0.011983912056955622,"score_gpt":0.22720755603311069,"score_spread":0.21522364397615507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321971599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95431536,0.0012350774,0.000016860695,0.043512598,0.00010305356,0.0006939489,0.000026102141,0.000015013647,0.00008198107],"genre_scores_gemma":[0.98463094,0.00424569,0.00026510243,0.010641308,0.000025268508,0.000032802738,0.000045384124,0.000079183585,0.000034319415],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9965544,0.00049237686,0.0013092813,0.00030761104,0.00078015844,0.0005561935],"domain_scores_gemma":[0.9961817,0.0004046087,0.002332927,0.0005437919,0.00038216365,0.00015478903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029157507,0.00055409444,0.002296316,0.00047769974,0.00007801895,0.000017670267,0.00027955996,0.00040710182,0.00014242934],"category_scores_gemma":[0.00007310355,0.00027283275,0.0002120295,0.00029318893,0.00031290294,0.00007628609,0.000051365823,0.000678087,0.000009266426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006381746,0.0011787162,0.9027901,0.00047826098,0.0013822939,0.0084338775,0.0009620651,0.000011331766,0.000097613,0.0000035483029,0.06897798,0.009302452],"study_design_scores_gemma":[0.055720888,0.021914568,0.4071997,0.03354084,0.0010842652,0.43188745,0.00033444617,0.000094055256,0.0051348517,0.000027373195,0.042077363,0.0009841825],"about_ca_topic_score_codex":0.0010613631,"about_ca_topic_score_gemma":0.00009404659,"teacher_disagreement_score":0.4955904,"about_ca_system_score_codex":0.000304677,"about_ca_system_score_gemma":0.0005261922,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W2321975865","doi":"10.1097/00043426-200305000-00017","title":"The CCC System: Is It Really the Answer to Pediatric MDS?","year":2003,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; MEDLINE; Family medicine; Medical physics","score_opus":0.024799585083484194,"score_gpt":0.3247496959856695,"score_spread":0.2999501109021853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321975865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8554896,0.022654712,0.00022907734,0.08686613,0.004699994,0.0013130886,0.000011978387,0.000047159047,0.02868824],"genre_scores_gemma":[0.98355114,0.007148552,0.0011455851,0.00473934,0.0025767484,0.00007554129,0.0000011901323,0.000036522913,0.0007253851],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639875,0.0005992352,0.0014449296,0.000306277,0.0005782208,0.00067258405],"domain_scores_gemma":[0.9951009,0.0021964817,0.0010642637,0.0005295692,0.0006246578,0.00048408785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021831817,0.0003139482,0.0010485684,0.00034655936,0.00039346117,0.000041936353,0.0004269517,0.00038654238,0.00013418701],"category_scores_gemma":[0.00107593,0.0001534531,0.0004372966,0.00077415694,0.00010225045,0.000079680525,0.00007532544,0.0005329645,0.00039806162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045561237,0.001140816,0.26163542,0.00016594757,0.00048399722,0.0034544277,0.0016080309,0.0000062332533,0.000015237959,0.01177039,0.717016,0.002247881],"study_design_scores_gemma":[0.009483393,0.006357647,0.036189627,0.000050339622,0.005244391,0.042008337,0.0056229043,0.000015524582,0.0004259121,0.00041252305,0.89377075,0.0004186232],"about_ca_topic_score_codex":0.000023632158,"about_ca_topic_score_gemma":0.000026314308,"teacher_disagreement_score":0.2254458,"about_ca_system_score_codex":0.00078312994,"about_ca_system_score_gemma":0.0020650066,"threshold_uncertainty_score":0.6257636},"labels":[],"label_agreement":null},{"id":"W2321999105","doi":"10.1532/lh96.12023","title":"Rapid Separation of Mononuclear Hodgkin from Multinuclear Reed-Sternberg Cells","year":2014,"lang":"en","type":"article","venue":"Laboratory Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Reed–Sternberg cell; Bone marrow; Multinucleate; Peripheral blood mononuclear cell; Pathology; Lymph node; Lymphoma; Lymph node biopsy; Hodgkin lymphoma; Lymph; Haematopoiesis; Medicine; Biology; Stem cell; Cell biology; Biochemistry","score_opus":0.009774387390671421,"score_gpt":0.2562667764826917,"score_spread":0.24649238909202026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321999105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638766,0.00065244053,0.00006207175,0.0003990738,0.00029881674,0.00022491402,0.000048565544,0.000073340765,0.0018531181],"genre_scores_gemma":[0.9959459,0.00008722304,0.0030640285,0.000657148,0.00009766153,0.000020392623,0.000040111507,0.000031039497,0.000056506615],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988172,0.00014291059,0.00037244218,0.00031102775,0.00015364548,0.00020279158],"domain_scores_gemma":[0.9988417,0.0002289469,0.0001894907,0.00047118525,0.00014357174,0.00012508828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121560835,0.00016901946,0.00055244006,0.00007551326,0.000040288174,0.000007841702,0.00008084325,0.00018872715,0.00048151292],"category_scores_gemma":[0.00008189086,0.00014555454,0.00008236774,0.00014295641,0.00009185893,0.00006110429,0.000038130165,0.000079912184,0.00048776192],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021104265,0.005176774,0.4686537,0.00070128177,0.0015639819,0.0006006047,0.004020076,0.00005785316,0.38795593,0.03248371,0.066743106,0.029932544],"study_design_scores_gemma":[0.0076748235,0.001227255,0.08599901,0.00018716928,0.0003598533,0.00003798598,0.00022955915,0.0012463517,0.7528531,0.00031099335,0.14952818,0.00034573683],"about_ca_topic_score_codex":0.00010991167,"about_ca_topic_score_gemma":0.000025701667,"teacher_disagreement_score":0.3826547,"about_ca_system_score_codex":0.00004639969,"about_ca_system_score_gemma":0.00006271455,"threshold_uncertainty_score":0.62693554},"labels":[],"label_agreement":null},{"id":"W2322778337","doi":"10.1200/jco.2007.25.18_suppl.8120","title":"Outcome following multiple lines of salvage chemotherapy prior to autologous stem cell transplant for relapsed or refractory diffuse large B-cell lymphoma (DLBCL)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Salvage therapy; Chemotherapy; Internal medicine; Oncology; Etoposide; Surgery; Refractory (planetary science); Rituximab; Chemotherapy regimen; Progressive disease; Lymphoma","score_opus":0.0879643907061783,"score_gpt":0.42701208812698166,"score_spread":0.3390476974208034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322778337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992641,0.0005898265,0.0019097186,0.0019661593,0.001744215,0.000815971,0.000033229782,0.000023710933,0.00027617512],"genre_scores_gemma":[0.97870636,0.00042549445,0.015581758,0.0037391444,0.0006401,0.000015069494,0.0000058075357,0.000049056816,0.0008371824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476784,0.0001829289,0.0038040127,0.00031857274,0.00041702273,0.0005096178],"domain_scores_gemma":[0.98894894,0.008052266,0.0017684161,0.00031936195,0.00028503328,0.0006259966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00373741,0.0002816126,0.002504201,0.00021197506,0.000067718254,0.000007502021,0.00023825621,0.00062760507,0.000023975641],"category_scores_gemma":[0.0008961975,0.00017441866,0.0014587912,0.00015429303,0.0000640851,0.000079423495,0.000029058487,0.00030515026,0.000011520671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049277127,0.08616024,0.53685886,0.00031245276,0.0009958143,0.0048132367,0.0012331177,0.000003204482,0.0044268225,0.000017622448,0.0021130538,0.31378844],"study_design_scores_gemma":[0.25882563,0.040396277,0.5166242,0.00029136808,0.0014285068,0.00026660776,0.00045221843,0.00008357042,0.01462889,0.000012521958,0.16669548,0.0002947371],"about_ca_topic_score_codex":0.000017924405,"about_ca_topic_score_gemma":0.00010273818,"teacher_disagreement_score":0.3134937,"about_ca_system_score_codex":0.00036767864,"about_ca_system_score_gemma":0.0010110441,"threshold_uncertainty_score":0.71125865},"labels":[],"label_agreement":null},{"id":"W2325286257","doi":"10.5114/reum.2013.34828","title":"Professor Irena Fiedorowicz-Fabrycy awarded with the title of honorary member of the Polish Society of Rheumatology","year":2013,"lang":"en","type":"article","venue":"Reumatologia/Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Internal medicine","score_opus":0.01426822955456669,"score_gpt":0.2488793803153694,"score_spread":0.23461115076080272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325286257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438543,0.00096968596,0.000021093276,0.0072398246,0.00024220608,0.00078563066,0.000017549539,0.00004095739,0.0062976],"genre_scores_gemma":[0.9981572,0.00043468038,0.00052730634,0.00014371284,0.0000028508744,0.00011845024,0.000013411574,0.000025398516,0.0005769983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834704,0.00015757553,0.00064642006,0.00027047767,0.00024189531,0.00033656866],"domain_scores_gemma":[0.9977943,0.0004809144,0.0006210032,0.0007961399,0.00024430407,0.000063361076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015508388,0.00023562975,0.0010493101,0.000054719225,0.000076167824,0.000004962891,0.00033821436,0.00029433006,0.0007091516],"category_scores_gemma":[0.0001003162,0.000114373004,0.00026711487,0.00027405386,0.00089143665,0.000051239775,0.0001732161,0.0001906272,0.000067424095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009654086,0.0005325399,0.81233525,0.000876588,0.0008183462,0.000003629025,0.0009213141,0.000001945021,0.00026116654,0.019463148,0.1639092,0.0007803351],"study_design_scores_gemma":[0.028345494,0.0022486113,0.79157937,0.0042752745,0.001902291,0.012220135,0.010577001,0.0008403195,0.10151618,0.0051866304,0.039640024,0.0016686845],"about_ca_topic_score_codex":0.0015247795,"about_ca_topic_score_gemma":0.000052508585,"teacher_disagreement_score":0.124269165,"about_ca_system_score_codex":0.000039008723,"about_ca_system_score_gemma":0.00037703157,"threshold_uncertainty_score":0.77647126},"labels":[],"label_agreement":null},{"id":"W2326948361","doi":"10.1093/annonc/mdw137","title":"The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Danish; Bone marrow; Lymphoma; Biopsy; Diffuse large B-cell lymphoma; Radiology; Nuclear medicine; Pathology","score_opus":0.015777188157726694,"score_gpt":0.27672746232095025,"score_spread":0.26095027416322353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326948361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445206,0.00013336491,9.97938e-7,0.0028069543,0.000043013653,0.0009437121,0.00009321998,0.000008486084,0.0015182201],"genre_scores_gemma":[0.9990518,0.00007595332,0.00008486651,0.00035999317,0.000015005803,0.0000803783,0.000014404086,0.000023575785,0.00029398678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983577,0.000167351,0.00040377097,0.00027452467,0.00029460332,0.00050204777],"domain_scores_gemma":[0.998551,0.00025922584,0.00027553816,0.0004588556,0.00024076425,0.00021458854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044005405,0.00019206757,0.0005698051,0.00015672843,0.00007820335,0.0000055843984,0.00012804427,0.000025844209,0.000033207314],"category_scores_gemma":[0.00007033259,0.00008748636,0.00005846879,0.00022108175,0.00015871448,0.00005337671,0.000047069196,0.00004558589,0.000009912861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019625975,0.026111528,0.962348,0.000019509731,0.00024033687,0.001341737,0.00031870895,2.8909648e-7,0.00003524346,0.00022594543,0.00045389886,0.0069422233],"study_design_scores_gemma":[0.063878484,0.015427173,0.9159142,0.0001090473,0.000119200835,0.000056359513,0.0005463333,0.0000021332098,0.0010810053,0.000014730767,0.0027425182,0.00010881131],"about_ca_topic_score_codex":0.011667707,"about_ca_topic_score_gemma":0.044064518,"teacher_disagreement_score":0.061915882,"about_ca_system_score_codex":0.0002027317,"about_ca_system_score_gemma":0.00057715084,"threshold_uncertainty_score":0.9949137},"labels":[],"label_agreement":null},{"id":"W2327048936","doi":"10.1182/blood.v122.21.4369.4369","title":"Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Splenic marginal zone lymphoma; Splenectomy; Rituximab; Chemotherapy; Internal medicine; Lymphoma; Regimen; Gastroenterology; Aggressive lymphoma; Chemotherapy regimen; Surgery; Spleen","score_opus":0.006550659157891226,"score_gpt":0.21613586765784593,"score_spread":0.2095852084999547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327048936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987621,0.00017428023,1.3958763e-7,0.00006023285,0.00002141206,0.00050048967,0.000055717337,0.000017259117,0.0004084112],"genre_scores_gemma":[0.9988032,0.000069422895,0.000100817844,0.00006327753,0.0000085913825,0.00015458305,0.00017970795,0.00001319769,0.0006071747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875283,0.000039842664,0.00044194277,0.00027049115,0.00024019316,0.00025469856],"domain_scores_gemma":[0.9994083,0.000064489854,0.00009983552,0.0002514162,0.00008302429,0.00009294462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000556265,0.00011200973,0.0007116331,0.00025441783,0.000018111334,0.00003777138,0.00006501962,0.00008352463,0.000799436],"category_scores_gemma":[0.00004432642,0.00013566633,0.00018595839,0.0008645894,0.000035464338,0.00007038088,0.00003155555,0.000031786967,0.000033220098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012171756,0.011456564,0.9786281,0.000022522783,0.0010023299,0.00016630076,0.000059575133,0.0000011811304,0.00001638006,8.0697646e-7,0.00023081622,0.0084032575],"study_design_scores_gemma":[0.021106359,0.00029018466,0.97654164,0.00008766323,0.0015897114,0.0000063993316,0.00003710737,0.000051168372,0.00014351332,0.000005045834,0.00003289721,0.00010831374],"about_ca_topic_score_codex":0.30367213,"about_ca_topic_score_gemma":0.1869124,"teacher_disagreement_score":0.11675975,"about_ca_system_score_codex":0.00014429247,"about_ca_system_score_gemma":0.000042970903,"threshold_uncertainty_score":0.87532634},"labels":[],"label_agreement":null},{"id":"W2328740639","doi":"10.1136/annrheumdis-2014-eular.1816","title":"SAT0227 Two-Year Retention and Effectiveness of IV Abatacept Monotherapy and Combination in PTS with RA Previously Treated with at Least One Biologic Agent in A Real-Life Setting: Subgroup Analysis from the Action Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Abatacept; Combination therapy; Internal medicine; Cohort; Population; Surgery","score_opus":0.040333413424293876,"score_gpt":0.30344804423062227,"score_spread":0.2631146308063284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328740639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784476,0.0005404191,0.000011060751,0.00023864995,0.000006683454,0.0013184226,0.000021226942,0.000009316094,0.000009486082],"genre_scores_gemma":[0.9988063,0.0009517043,0.000013305184,0.000025670613,0.00000296125,0.00012374444,0.000063778396,0.000008662219,0.0000038659446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985374,0.00066696014,0.00026119864,0.00022170428,0.0002076217,0.000105079635],"domain_scores_gemma":[0.9987711,0.0005535132,0.0002797935,0.00028177848,0.00006235915,0.00005146541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045094977,0.00013674035,0.00047810085,0.00010525966,0.000049819635,0.000013986198,0.000052575262,0.00002496592,0.0000072914477],"category_scores_gemma":[0.000110643065,0.0000658158,0.000062721556,0.00035289832,0.00009564938,0.00006157515,0.00002863557,0.00003064781,2.6101097e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00243262,0.002126802,0.98923105,0.00015504015,0.0011417269,0.0000014569711,0.0007427102,0.00015003867,0.00008806825,0.000033842665,0.0000040833024,0.0038925337],"study_design_scores_gemma":[0.0077990354,0.0014743035,0.9859858,0.0011975537,0.0011421817,8.022397e-7,0.000883705,0.00093990524,0.0004118737,0.00009689918,2.0863789e-7,0.00006772928],"about_ca_topic_score_codex":0.0035912374,"about_ca_topic_score_gemma":0.001346273,"teacher_disagreement_score":0.0053664153,"about_ca_system_score_codex":0.000051937288,"about_ca_system_score_gemma":0.000022818844,"threshold_uncertainty_score":0.5428901},"labels":[],"label_agreement":null},{"id":"W2328774052","doi":"10.1136/annrheumdis-2012-eular.2644","title":"FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University; St Joseph's Health Care","funders":"","keywords":"Abatacept; Medicine; Internal medicine; Randomized controlled trial; Physical therapy","score_opus":0.029589761190132943,"score_gpt":0.32791498286120346,"score_spread":0.2983252216710705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328774052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926836,0.0045582247,2.0232514e-7,0.0013417673,0.000035713056,0.0007109037,0.00053916866,0.000006506463,0.00012391302],"genre_scores_gemma":[0.99856037,0.0011007517,0.000007252954,0.00017952769,0.000012349177,0.00006761208,0.000048170088,0.000010335774,0.000013632884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987114,0.0004059356,0.00026305908,0.00015989676,0.0002206698,0.00023903504],"domain_scores_gemma":[0.99788433,0.0014150465,0.00013573183,0.0003969172,0.000061422936,0.00010654008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011075448,0.00014935568,0.0004347498,0.000106184416,0.000054275428,0.000010840634,0.00009055837,0.000026894579,0.00006778344],"category_scores_gemma":[0.0008486265,0.000080411155,0.00007182554,0.00021105909,0.00015867494,0.00015846202,0.00025569854,0.000053159638,0.0000014735464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006290963,0.0015686882,0.99103266,0.0012456768,0.00012287161,0.0000035558312,0.0006388777,7.2633026e-7,0.00032900268,0.0003190861,0.00014314472,0.003966585],"study_design_scores_gemma":[0.0019717459,0.00010313278,0.99291164,0.0024542073,0.00013461048,0.000004157925,0.00021225502,0.00006541469,0.0019375195,0.00011372485,0.000015838315,0.000075769596],"about_ca_topic_score_codex":0.0018566495,"about_ca_topic_score_gemma":0.0007655623,"teacher_disagreement_score":0.0058767665,"about_ca_system_score_codex":0.000038453883,"about_ca_system_score_gemma":0.000053451924,"threshold_uncertainty_score":0.32790717},"labels":[],"label_agreement":null},{"id":"W2329052349","doi":"10.1016/j.bbmt.2016.03.018","title":"Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes","year":2016,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"Cancer Center, University of Illinois at Chicago; Otsuka Pharmaceutical Development and Commercialization; Baylor University; University of California, San Francisco; University of Texas Health Science Center at San Antonio; Weill Cornell Medical College; West Virginia University; Otsuka Pharmaceutical; University of Illinois at Urbana-Champaign; Virginia Commonwealth University; University of South Carolina; Emory University; Baylor University Medical Center; McGill University Health Centre; McGill University; University of Oklahoma; University of Ottawa; Celgene; University of Arizona; National Cancer Institute; Loyola University Chicago; University of Arizona Cancer Center; University of Nebraska Medical Center; Sanofi; Louisiana State University; Pfizer","keywords":"Medicine; Busulfan; Etoposide; Internal medicine; Follicular lymphoma; Autologous stem-cell transplantation; Melphalan; Carmustine; Mantle cell lymphoma; Transplantation; Cyclophosphamide; Oncology; Lymphoma; Surgery; Gastroenterology; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.01604358518632727,"score_gpt":0.30846127824507114,"score_spread":0.2924176930587439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329052349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628055,0.0019069884,0.00018950982,0.00011579879,0.000045304078,0.0009957236,0.00043496166,0.00001952212,0.000011631247],"genre_scores_gemma":[0.99609214,0.0030256573,0.0006571658,0.00001716237,0.000007525118,0.00004996931,0.00013152133,0.0000091358015,0.000009732679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905324,0.0000624263,0.0004439163,0.00025316208,0.00006598646,0.00012125179],"domain_scores_gemma":[0.9990605,0.0005100426,0.00022688342,0.00006494375,0.00007388763,0.000063749074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100888814,0.00015842545,0.00051502715,0.000103279686,0.00006771862,0.0000031613265,0.000021369058,0.000086615226,0.000003007898],"category_scores_gemma":[0.0000078337525,0.00010956468,0.000038802347,0.000039945957,0.00019160849,0.000049763545,0.0000064192504,0.000020077696,4.2689315e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038777594,0.0025605094,0.60457355,0.00081643095,0.0004006157,0.000010544066,0.0030191678,3.261206e-7,0.3320132,0.000041270745,0.0000032466878,0.052683376],"study_design_scores_gemma":[0.05138832,0.0044881436,0.6071067,0.0001703615,0.002310797,0.00003664475,0.00020159683,0.000039419312,0.33415723,0.000012275102,0.0000055754845,0.00008295003],"about_ca_topic_score_codex":0.00007210129,"about_ca_topic_score_gemma":0.000027242471,"teacher_disagreement_score":0.052600425,"about_ca_system_score_codex":0.0000057490197,"about_ca_system_score_gemma":0.000019395777,"threshold_uncertainty_score":0.4467918},"labels":[],"label_agreement":null},{"id":"W2330157152","doi":"10.1097/01.cot.0000295290.67148.c0","title":"Follow-Up for Hodgkin's Disease","year":2006,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Internal medicine","score_opus":0.015551853144631736,"score_gpt":0.3029811735548656,"score_spread":0.28742932041023384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330157152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72710854,0.003420546,0.00018659554,0.028440941,0.0010855296,0.0017604359,0.00013637647,0.00022794858,0.2376331],"genre_scores_gemma":[0.93283653,0.000030101824,0.0019769731,0.0011225468,0.00038400586,0.00038540666,0.00019861986,0.00001636668,0.063049436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994148,0.00001547262,0.00012402043,0.00018328609,0.0000709153,0.00019147704],"domain_scores_gemma":[0.9994957,0.00014901717,0.00003936263,0.00015903787,0.000044320135,0.00011254834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053234122,0.00009704167,0.00022609682,0.00003941542,0.00006159309,0.0000061761802,0.000034137604,0.00006969551,0.00040833355],"category_scores_gemma":[0.000040396702,0.00007270398,0.00014093034,0.000041502975,0.000047851292,0.000023351246,0.000014877074,0.000024448025,0.00016696703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000948514,0.0018265285,0.1815663,0.000043583335,0.00016116093,0.0003565684,0.000035013145,0.0000036401657,0.00020364474,0.012439738,0.7615431,0.04087224],"study_design_scores_gemma":[0.0074441335,0.0007773534,0.21051173,0.000018300398,0.00041961914,0.000019312785,0.000013750025,0.000059829355,0.0008696501,0.002243894,0.77753705,0.00008540449],"about_ca_topic_score_codex":0.000058172096,"about_ca_topic_score_gemma":0.000024949857,"teacher_disagreement_score":0.20572801,"about_ca_system_score_codex":0.00017309866,"about_ca_system_score_gemma":0.00021331242,"threshold_uncertainty_score":0.44709662},"labels":[],"label_agreement":null},{"id":"W2330386899","doi":"10.3928/01913913-20111213-01","title":"Bilateral Benign Reactive Lymphoid Hyperplasia of the Conjunctiva in a Pediatric Patient","year":2011,"lang":"en","type":"article","venue":"Journal of Pediatric Ophthalmology & Strabismus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lymphoid hyperplasia; Asymptomatic; Conjunctiva; Pathology; Biopsy; Lesion; Hyperplasia; Dermatology; Lymphoma","score_opus":0.030255550744521142,"score_gpt":0.253781077318121,"score_spread":0.22352552657359986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330386899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268293,0.0012197241,8.466027e-7,0.00020105205,0.000876378,0.00037791947,0.000011507283,0.000005537231,0.0046241228],"genre_scores_gemma":[0.9985917,0.00037820212,0.0003799884,0.000068247675,0.0004917849,0.000014141215,0.0000015287503,0.000022221573,0.000052185096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766874,0.0001944048,0.0010802743,0.0002520167,0.00044023703,0.00036434756],"domain_scores_gemma":[0.9979067,0.00021435079,0.0010805882,0.00032055133,0.00029259737,0.00018522538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030264768,0.00026665741,0.0007548563,0.00047694403,0.00004835045,0.0000058123487,0.00023125227,0.00022765658,0.00017079098],"category_scores_gemma":[0.00016819665,0.00016164294,0.00041462478,0.0005818741,0.00009956714,0.00013243963,0.00007307054,0.00034844066,0.000008132116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007866568,0.0023151617,0.99122524,0.000047937116,0.00014160445,0.0032988028,0.0011263335,0.0000066673842,0.0001732944,0.000067353685,0.00024283337,0.00056810206],"study_design_scores_gemma":[0.004107421,0.0032152575,0.96527606,0.000024601466,0.00090129214,0.023720345,0.00023848277,0.0000022045738,0.001956283,0.00039972836,0.000028310578,0.0001299845],"about_ca_topic_score_codex":0.00013455306,"about_ca_topic_score_gemma":0.0000017719357,"teacher_disagreement_score":0.025949163,"about_ca_system_score_codex":0.00028009329,"about_ca_system_score_gemma":0.0006664055,"threshold_uncertainty_score":0.65916073},"labels":[],"label_agreement":null},{"id":"W2331978332","doi":"10.1158/1538-7445.am2013-3265","title":"Abstract 3265: PI3Kδ inhibitor, GS-1101, impacts transcription and translation in mantle cell lymphoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Mantle cell lymphoma; Cancer research; Cell cycle; Cyclin D1; Biology; Cell biology; Apoptosis; Chemistry; Molecular biology; Signal transduction; Lymphoma; Immunology; Biochemistry","score_opus":0.07073239549172139,"score_gpt":0.36971030736419175,"score_spread":0.29897791187247036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331978332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853556,0.0064020036,0.0000016486315,0.0025684524,0.00007390564,0.0009261798,0.000012670393,0.000021637852,0.0046378635],"genre_scores_gemma":[0.9954515,0.0035294164,0.00007524593,0.00008726879,0.0001340394,0.00040236392,0.000023672494,0.000021991422,0.00027450477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985518,0.000054935215,0.00021724777,0.00030156868,0.00044059032,0.0004338636],"domain_scores_gemma":[0.9993367,0.00010665512,0.00002474565,0.00018122779,0.00011782934,0.0002328357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031244868,0.00012882549,0.0002014049,0.00024533985,0.000086755725,0.00006707863,0.000050201208,0.00011198328,0.00060980994],"category_scores_gemma":[0.000016518126,0.00010368356,0.00004880884,0.00027557855,0.00008547144,0.00023155127,0.000011606585,0.00013877478,0.00014483814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046245268,0.0016625143,0.09138484,0.00070297316,0.000057187088,0.0001408002,0.003320766,0.000005366552,0.6056468,0.000073490664,0.0063550407,0.29018775],"study_design_scores_gemma":[0.007607954,0.00028413426,0.8574586,0.00032982515,0.000020993952,0.0000102760705,0.0003790741,0.000060806637,0.13048288,0.00022558283,0.0030130707,0.0001267751],"about_ca_topic_score_codex":0.0075538415,"about_ca_topic_score_gemma":0.0006216695,"teacher_disagreement_score":0.76607376,"about_ca_system_score_codex":0.00050634966,"about_ca_system_score_gemma":0.00023838178,"threshold_uncertainty_score":0.99905497},"labels":[],"label_agreement":null},{"id":"W2332040155","doi":"10.5732/cjc.009.10552","title":"Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma","year":2010,"lang":"en","type":"article","venue":"Chinese Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Myeloid; Antigen; Lymphoma; Medicine; Lymphoblastic lymphoma; Clinical significance; Internal medicine; Survival rate; Gastroenterology; Immunology; T cell; Immune system","score_opus":0.00806134747781189,"score_gpt":0.29110250092652074,"score_spread":0.28304115344870884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332040155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488026,0.00321399,0.000019515119,0.00037753698,0.00070666143,0.00019287122,0.000008539325,0.000005417303,0.0005952103],"genre_scores_gemma":[0.9977455,0.0009335478,0.0006999715,0.00008872196,0.0004004279,0.000020213718,0.0000013339157,0.000018185401,0.00009208717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987317,0.000026229276,0.00055696163,0.00013778267,0.00036947196,0.00017785894],"domain_scores_gemma":[0.9988243,0.0001252612,0.00045629215,0.00020121671,0.00023313229,0.00015979788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018176879,0.0001718711,0.0005424104,0.00019539165,0.000022677727,0.0000117214295,0.00012943574,0.000089981746,0.00024367937],"category_scores_gemma":[0.00018179619,0.00010042697,0.00017424407,0.0002497885,0.000071313785,0.00016386465,0.000023677976,0.00011325708,0.0000046148393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006242467,0.00072232523,0.70370436,0.00008271797,0.000074985466,0.00012917728,0.00035191322,0.00004337455,0.2705148,0.000010345677,0.00038522235,0.023356577],"study_design_scores_gemma":[0.005330475,0.00025257675,0.84384644,0.0005830799,0.000059410184,0.00012311699,0.000027263643,0.00005808939,0.14825335,0.00012322009,0.0012586125,0.00008435608],"about_ca_topic_score_codex":0.00008451526,"about_ca_topic_score_gemma":0.00012264041,"teacher_disagreement_score":0.14014211,"about_ca_system_score_codex":0.00016493662,"about_ca_system_score_gemma":0.00056373875,"threshold_uncertainty_score":0.4095293},"labels":[],"label_agreement":null},{"id":"W2332746373","doi":"10.1097/01.cot.0000333619.42036.2f","title":"Updates on DLBCL from the International Conference on Malignant Lymphoma","year":2008,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Malignant lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.044517884678071155,"score_gpt":0.3042906015117285,"score_spread":0.2597727168336573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332746373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73297024,0.00015193707,0.0000012217964,0.035743877,0.00039681277,0.00016449728,0.000042758602,0.000039283746,0.23048939],"genre_scores_gemma":[0.98384947,0.00051835825,0.00021295075,0.008819614,0.0002533712,0.000056779347,0.00012290427,0.000009405879,0.0061571565],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99926174,0.000040197876,0.0001383503,0.0002275077,0.00018960191,0.00014262246],"domain_scores_gemma":[0.9992639,0.00032661276,0.00006107731,0.00023689981,0.000048699967,0.00006282544],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054717304,0.00012218478,0.00020607247,0.00003075363,0.000104016064,0.000009601742,0.00014027131,0.00008729472,0.0024209323],"category_scores_gemma":[0.000043126558,0.00006723362,0.00007139741,0.000034480963,0.00012505258,0.00002137058,0.000040181647,0.000050586164,0.0016469117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012168837,0.0063429717,0.19132863,0.0000026455523,0.0008246368,0.0024567822,0.001001378,0.0000039353454,0.0008888379,0.043579485,0.66709596,0.08525784],"study_design_scores_gemma":[0.007724012,0.0019316587,0.5907003,0.00010709076,0.0001173655,0.0002744653,0.00021365893,0.00020859644,0.011963424,0.00092538365,0.38569197,0.00014204539],"about_ca_topic_score_codex":0.00019971172,"about_ca_topic_score_gemma":0.00002097145,"teacher_disagreement_score":0.3993717,"about_ca_system_score_codex":0.00026542126,"about_ca_system_score_gemma":0.00023886978,"threshold_uncertainty_score":0.9991304},"labels":[],"label_agreement":null},{"id":"W2334564347","doi":"10.1200/jco.2004.22.14_suppl.6588","title":"Long-term follow up of limited stage primary testicular lymphoma: Outcome and patterns of relapse after combined-modality treatment","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Modality (human–computer interaction); Lymphoma; Internal medicine; Term (time); Primary treatment","score_opus":0.08707164086731019,"score_gpt":0.4117274669052473,"score_spread":0.32465582603793713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334564347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498504,0.0010426752,0.0000494684,0.0028166892,0.00054631877,0.00035153964,0.00003750842,0.000006760198,0.00016401034],"genre_scores_gemma":[0.9962581,0.0012706266,0.0013369352,0.00075668667,0.00014771592,0.000012559189,0.000011680413,0.000017606164,0.0001881387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960904,0.00022923594,0.0028501502,0.0002317895,0.00038242963,0.0002159991],"domain_scores_gemma":[0.9955954,0.0014456165,0.0018892436,0.00033091646,0.00034247388,0.0003963306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094699074,0.00022431942,0.0023318266,0.00012375355,0.000020582876,0.000005296105,0.0000946027,0.00033866343,0.000055866203],"category_scores_gemma":[0.0008529264,0.00014071264,0.0007584148,0.00008582252,0.00021927849,0.000082759114,0.000063581574,0.00017005895,0.0000033283354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006467549,0.014322976,0.94148606,0.0001766155,0.0011042558,0.0036463789,0.0001075421,0.0000051118895,0.00006878701,0.00009223064,0.000016492973,0.03250597],"study_design_scores_gemma":[0.063483015,0.028854022,0.9045528,0.0002841133,0.0015432321,0.0003211162,0.000027311116,0.0000020992256,0.00048379725,0.00011268989,0.00024281674,0.00009294339],"about_ca_topic_score_codex":0.0001145967,"about_ca_topic_score_gemma":0.00007067281,"teacher_disagreement_score":0.057015464,"about_ca_system_score_codex":0.0006239524,"about_ca_system_score_gemma":0.001259968,"threshold_uncertainty_score":0.5738095},"labels":[],"label_agreement":null},{"id":"W2335146809","doi":"10.1097/01.pat.0000443471.87883.6e","title":"Hodgkin lymphoma: from discovery to clinical translation","year":2014,"lang":"en","type":"article","venue":"Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Malignancy; Lymphoma; Hodgkin lymphoma; Neoplastic cell; Cancer; Cancer research; Medicine; Tumor microenvironment; Immune system; Biology; Pathology; Oncology; Cell; Immunology; Internal medicine; Genetics","score_opus":0.04325111126234645,"score_gpt":0.34276874180472333,"score_spread":0.2995176305423769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335146809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864716,0.00019406938,0.003935264,0.003388634,0.0004796581,0.00019801805,0.000019818748,0.000043010834,0.0030943474],"genre_scores_gemma":[0.9914518,0.000047869307,0.004940151,0.002839759,0.00046034117,0.00004117908,0.00007815528,0.000012148056,0.00012860303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999071,0.00012571196,0.0002535579,0.0003000333,0.00009030376,0.00015941786],"domain_scores_gemma":[0.999237,0.0003088372,0.00003783476,0.0002767648,0.000019454295,0.00012011338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019936824,0.00009828268,0.00030419414,0.000042105967,0.000027573225,0.000010610547,0.000043820175,0.00011519715,0.000059019738],"category_scores_gemma":[0.00012339695,0.00007513244,0.00011175,0.000056394547,0.00003963281,0.00003921341,0.000018772495,0.000033880435,0.00047914963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021312707,0.00070035906,0.5051112,0.0000046195146,0.00004514187,0.00018314198,0.00021108644,0.0000016503955,0.00077966717,0.00063514034,0.0011197918,0.49099502],"study_design_scores_gemma":[0.0039237733,0.0007229141,0.9681084,0.00001877863,0.000114580296,0.00004630773,0.000013492735,0.00006764233,0.0011033798,0.0006351394,0.025163798,0.000081763355],"about_ca_topic_score_codex":0.00006835945,"about_ca_topic_score_gemma":0.00003713684,"teacher_disagreement_score":0.49091327,"about_ca_system_score_codex":0.000039893635,"about_ca_system_score_gemma":0.00003273744,"threshold_uncertainty_score":0.6158659},"labels":[],"label_agreement":null},{"id":"W2335871284","doi":"10.1111/bjh.14074","title":"Adolescent and young adult non‐Hodgkin lymphoma","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Young adult; Lymphoblastic lymphoma; Incidence (geometry); Population; Anaplastic large-cell lymphoma; Oncology; Internal medicine; Pediatrics; Immunology; T cell; Environmental health","score_opus":0.01933729423817133,"score_gpt":0.3062607323202361,"score_spread":0.2869234380820648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335871284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022440795,0.9957588,0.0000206206,0.000226983,0.0007451699,0.00046155447,0.000043664175,0.000011978015,0.00048718732],"genre_scores_gemma":[0.0013652632,0.99740326,0.0002975719,0.00020323628,0.00038537307,0.000029506295,0.000012984972,0.000056885423,0.00024594142],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99754924,0.00016994488,0.0012918343,0.00031737983,0.0002928309,0.00037875798],"domain_scores_gemma":[0.99788886,0.00015016104,0.0010722048,0.00022195205,0.00032107413,0.00034575275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022017732,0.00037500056,0.0037391342,0.00025152834,0.00007207857,0.000051458683,0.00016715971,0.0004317188,0.000091645146],"category_scores_gemma":[0.000207674,0.00027209384,0.00074320275,0.00010091752,0.00016329908,0.00007536907,0.00008313531,0.0002266718,0.00007600163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022272687,0.00039266987,0.0005041203,0.006656553,0.00063077087,0.12402835,0.000014659743,1.2768131e-9,1.0908882e-7,0.00007864473,0.0085888095,0.85908306],"study_design_scores_gemma":[0.0023000163,0.00018601831,0.0007921027,0.07678282,0.0013481084,0.5261073,0.000007443161,1.1228503e-7,0.0000024168487,0.000021654147,0.39231446,0.00013750765],"about_ca_topic_score_codex":0.00005727236,"about_ca_topic_score_gemma":0.000028429497,"teacher_disagreement_score":0.85894555,"about_ca_system_score_codex":0.00035692437,"about_ca_system_score_gemma":0.0008973934,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2337865916","doi":"","title":"Clinical implications of antiangiogenic therapies.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; CHOP; Oncology; Vincristine; Aggressive lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Chemotherapy regimen; Prednisone; Population; Chemotherapy; Cyclophosphamide","score_opus":0.05174642173895903,"score_gpt":0.3190704341382423,"score_spread":0.2673240123992833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337865916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731394,0.0023476225,0.000015699366,0.014239328,0.000057508234,0.0005859775,0.000010552987,0.000033440396,0.009570469],"genre_scores_gemma":[0.9970496,0.00043961557,0.000652475,0.00071070885,0.00017319061,0.0005642756,0.00000921153,0.0000065159734,0.00039435696],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99944985,0.000013770596,0.00022095988,0.00011335781,0.000069468246,0.00013259264],"domain_scores_gemma":[0.999525,0.000048361504,0.000052727697,0.00023997333,0.00003686885,0.00009703802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012763572,0.00005016829,0.00015776427,0.000031651798,0.00001612972,0.000003000558,0.00004030228,0.000038597806,0.0000486094],"category_scores_gemma":[0.000030167706,0.000036470523,0.0001568779,0.00008174457,0.000042414038,0.000022540145,0.000012278951,0.000023030108,0.00003284655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011719679,0.00044737893,0.47977895,0.0000027382769,0.0001204657,8.417937e-7,0.000013477736,1.2690847e-7,0.000008405067,0.00077940384,0.0023845658,0.51645195],"study_design_scores_gemma":[0.0012076136,0.000027637756,0.9479229,0.0000029749692,0.00010200452,0.00001044912,0.00000386313,0.0000020337977,0.0008278603,0.000064473315,0.049798027,0.000030165736],"about_ca_topic_score_codex":0.000009364616,"about_ca_topic_score_gemma":0.0000064066976,"teacher_disagreement_score":0.5164218,"about_ca_system_score_codex":0.000036084115,"about_ca_system_score_gemma":0.000025376428,"threshold_uncertainty_score":0.14872247},"labels":[],"label_agreement":null},{"id":"W2339030197","doi":"10.2217/fon-2016-0130","title":"ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Lymphoma; Oncology; Placebo; Pathology; Clinical trial; Multiple myeloma","score_opus":0.024355709995883844,"score_gpt":0.28347919032453645,"score_spread":0.2591234803286526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339030197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96845037,0.0024291996,0.0000102976755,0.006883131,0.002154956,0.0011196929,0.000037146478,0.00015307411,0.018762155],"genre_scores_gemma":[0.9905221,0.0025505272,0.0004343421,0.0011924971,0.0010224404,0.00020755651,0.00006568826,0.00006694995,0.0039378842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733293,0.0002353896,0.0005285006,0.00070549175,0.00028940564,0.0009082848],"domain_scores_gemma":[0.99798095,0.00065347744,0.00020283845,0.0006440457,0.00014802534,0.00037067244],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031808412,0.00043533792,0.00086998,0.00024364328,0.000105721745,0.000019511106,0.00020014164,0.00058426405,0.00074968836],"category_scores_gemma":[0.00020243789,0.00027016335,0.00020249681,0.0004347922,0.00009475267,0.00011398789,0.00011305035,0.00014383545,0.0009097147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12062939,0.087269805,0.24304566,0.0005055662,0.001993947,0.01724965,0.0041893837,0.0000159528,0.011382488,0.005073534,0.24533741,0.2633072],"study_design_scores_gemma":[0.34771484,0.0048646037,0.05373899,0.0002459192,0.0005085582,0.00025285778,0.00036772722,0.000036855272,0.0028488734,0.000034873134,0.58890384,0.00048205888],"about_ca_topic_score_codex":0.00014761719,"about_ca_topic_score_gemma":0.0010933022,"teacher_disagreement_score":0.34356645,"about_ca_system_score_codex":0.0020598127,"about_ca_system_score_gemma":0.0007126404,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2339100371","doi":"10.5539/cco.v5n1p73","title":"Soft Tissue Lymphoma Mimicking a Lipomatous Tumor on Fine Needle Aspiration: A Diagnostic Pitfall","year":2016,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Soft tissue; Medicine; Fine-needle aspiration; Biopsy; Lymphoma; Magnetic resonance imaging; Radiology; Diffuse large B-cell lymphoma; Soft tissue sarcoma; Pathology; Liposarcoma; Soft tissue pathology; Sarcoma","score_opus":0.05442415288189884,"score_gpt":0.3961095721303709,"score_spread":0.34168541924847207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339100371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739043,0.0027264298,0.000057464764,0.018361717,0.00084600586,0.00046309922,0.000023578888,0.00006781574,0.0035495972],"genre_scores_gemma":[0.9874127,0.0015768773,0.00013017787,0.008741309,0.0009934243,0.00025328484,0.0000063890857,0.000020868407,0.000864957],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985125,0.00009385522,0.00053623883,0.00043405258,0.00013928085,0.00028407897],"domain_scores_gemma":[0.99527365,0.003941999,0.00015653302,0.00024057362,0.000077119636,0.00031013976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024521307,0.00018420868,0.0006341246,0.000046057103,0.00007715161,0.000012001136,0.00006436668,0.00018544044,0.00040709216],"category_scores_gemma":[0.0012321454,0.00010893332,0.0001217816,0.00007701022,0.00019140555,0.00004256129,0.000050181043,0.00007145889,0.00019522216],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041542065,0.0013285811,0.1685006,0.000020897813,0.00014077114,0.0006133493,0.000045372853,4.6258165e-7,0.00007467141,0.00036944615,0.0062284786,0.8222619],"study_design_scores_gemma":[0.018820465,0.010971455,0.6363433,0.00047656347,0.00046324692,0.00023091046,0.000027845797,0.000028960956,0.00081898534,0.0002713877,0.33132342,0.00022346797],"about_ca_topic_score_codex":0.00014020524,"about_ca_topic_score_gemma":0.00028610692,"teacher_disagreement_score":0.8220385,"about_ca_system_score_codex":0.00035093573,"about_ca_system_score_gemma":0.00050858373,"threshold_uncertainty_score":0.4457374},"labels":[],"label_agreement":null},{"id":"W2339180098","doi":"10.1111/bjh.14100","title":"Outcomes of <scp>MYC</scp>‐associated lymphomas after R‐<scp>CHOP</scp> with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup <scp>SWOG</scp> S9704","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Vincristine; CHOP; Rituximab; Medicine; Cyclophosphamide; Autologous stem-cell transplantation; Lymphoma; Internal medicine; Prednisolone; Stem cell; Oncology; Immunology; Chemotherapy; Biology","score_opus":0.008891470140877315,"score_gpt":0.24090978472075344,"score_spread":0.23201831457987612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339180098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075305,0.006144248,0.00031543622,0.00015118725,0.00031371275,0.0012062127,0.00061386736,0.000038343205,0.00046396718],"genre_scores_gemma":[0.995739,0.0029506541,0.0003060342,0.00015294025,0.000050623366,0.00012288612,0.00004876634,0.00006377341,0.0005653128],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941858,0.0010147913,0.0026645083,0.00059150194,0.0007899208,0.00075348304],"domain_scores_gemma":[0.988015,0.007223729,0.003097379,0.0003804265,0.00083011726,0.0004533506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012732268,0.00061235204,0.007059227,0.00092935754,0.00009796925,0.00005673006,0.0003093032,0.00050489587,0.000036585898],"category_scores_gemma":[0.0014310508,0.0004103944,0.0013547986,0.00059787615,0.0010728507,0.00026041584,0.000074050135,0.00028795135,0.000006051437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037732217,0.003981703,0.8836417,0.00037935938,0.040490776,0.02301942,0.0063040378,0.000007196629,0.0005117464,0.00018088696,0.0020415601,0.0017093593],"study_design_scores_gemma":[0.7029486,0.002615869,0.23194216,0.0020187723,0.024506625,0.022538127,0.0016243336,0.000046813508,0.0113340905,0.00012670102,0.00018792223,0.000110024754],"about_ca_topic_score_codex":0.0003352417,"about_ca_topic_score_gemma":0.0006477388,"teacher_disagreement_score":0.6652163,"about_ca_system_score_codex":0.00024660485,"about_ca_system_score_gemma":0.00051278097,"threshold_uncertainty_score":0.9998348},"labels":[],"label_agreement":null},{"id":"W2340319415","doi":"10.1056/nejm-jw.na36060","title":"Re-Induction Therapy for Relapsed Aggressive Lymphoma","year":2014,"lang":"en","type":"article","venue":"Journal watch","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Aggressive lymphoma; Oncology; Lymphoma; Gemcitabine; Refractory (planetary science); Internal medicine; Salvage therapy; Autologous stem-cell transplantation; Chemotherapy; Transplantation; Rituximab","score_opus":0.023186309895202067,"score_gpt":0.29642872453181945,"score_spread":0.27324241463661736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340319415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95857596,0.00065028516,0.00028083377,0.03801596,0.0008005001,0.0003511625,0.0000023972639,0.000030065072,0.0012928573],"genre_scores_gemma":[0.9916765,0.0022732075,0.0014759573,0.0011829024,0.0014190692,0.000051529943,0.000010548352,0.000024080784,0.0018861931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991408,0.000041584666,0.00023455995,0.00015075658,0.00022102272,0.00021126433],"domain_scores_gemma":[0.9991297,0.00010718235,0.00024996148,0.00017407762,0.00017371245,0.00016535936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026244554,0.0001248662,0.00024197028,0.00004817,0.00020560359,0.000043910557,0.000053173782,0.000088686436,0.000087930865],"category_scores_gemma":[0.00014492977,0.00007880068,0.0002005937,0.00007044497,0.000019270235,0.00008310417,0.0000074197605,0.00006784633,0.00003920496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013285999,0.0011941368,0.023419043,0.000024596335,0.00039041645,0.00014641118,0.00082239433,0.000006575372,0.0021409271,0.00023662897,0.14498934,0.82530093],"study_design_scores_gemma":[0.042347822,0.0060484502,0.17823265,0.0004965484,0.00033522738,0.0027359861,0.0004939682,0.00030268714,0.05676909,0.0059685665,0.7059195,0.0003494819],"about_ca_topic_score_codex":0.000013004466,"about_ca_topic_score_gemma":0.0000034153593,"teacher_disagreement_score":0.82495147,"about_ca_system_score_codex":0.0002870606,"about_ca_system_score_gemma":0.000081112245,"threshold_uncertainty_score":0.32133985},"labels":[],"label_agreement":null},{"id":"W2340840224","doi":"10.1097/coc.0000000000000215","title":"ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Appropriate Use Criteria; Guideline; Medical physics; Positron emission tomography; Radiation therapy; Diffuse large B-cell lymphoma; Appropriateness criteria; Multidisciplinary approach; Lymphoma; Radiology; Internal medicine; Pathology","score_opus":0.17736043082327232,"score_gpt":0.5224009550491343,"score_spread":0.34504052422586196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340840224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004614613,0.98812383,0.000027569507,0.0007088272,0.0026439177,0.0005861801,0.00005726749,0.000024729146,0.0032130831],"genre_scores_gemma":[0.0023009726,0.9904075,0.0024989138,0.0013695202,0.0028993213,0.000046404515,0.000049388425,0.00009936172,0.00032857605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913608,0.0019574703,0.0048397044,0.0005460542,0.00066880713,0.00062717014],"domain_scores_gemma":[0.9876246,0.0027924916,0.006795042,0.0006811371,0.0007497206,0.0013570426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003826395,0.0006398245,0.012173026,0.00030334888,0.000051579034,0.000027131164,0.000544825,0.00073018234,0.000115479845],"category_scores_gemma":[0.0013127568,0.00038401404,0.0030276708,0.00044906707,0.0006761239,0.0000827159,0.00021416652,0.00080823194,0.0002675985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625177,0.026139839,0.00043491935,0.0010804444,0.0013143654,0.006932244,0.000051503615,1.8969093e-8,3.5091578e-8,0.000025991514,0.0067605074,0.9565976],"study_design_scores_gemma":[0.02530758,0.01624694,0.00034776705,0.0028672914,0.007343692,0.005360677,0.00011699624,0.0000013751733,3.3060175e-7,0.000028327479,0.9420694,0.0003095936],"about_ca_topic_score_codex":0.000027150934,"about_ca_topic_score_gemma":0.000003429035,"teacher_disagreement_score":0.95628804,"about_ca_system_score_codex":0.00093021576,"about_ca_system_score_gemma":0.008690882,"threshold_uncertainty_score":0.9998612},"labels":[],"label_agreement":null},{"id":"W2341062134","doi":"10.1016/j.hoc.2010.06.011","title":"Preface","year":2010,"lang":"en","type":"article","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph's Hospital; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Adverse effect; Hazard ratio; Confidence interval; Randomized controlled trial; Interim; Internal medicine; Meta-analysis; Relative risk; Clinical trial; Cochrane Library; Radiation therapy; Oncology","score_opus":0.017549106538992443,"score_gpt":0.338407902996088,"score_spread":0.32085879645709553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341062134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864176,0.00034104052,0.000035701185,0.0029611995,0.00064230594,0.00041261234,0.000019957144,0.000077050405,0.009092543],"genre_scores_gemma":[0.98586494,0.00040939855,0.011249862,0.0020368195,0.0000815439,0.00008389264,0.00005720795,0.000020816671,0.00019552247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838173,0.00006088635,0.0006732782,0.0003810294,0.00015588032,0.0003472155],"domain_scores_gemma":[0.9977408,0.00078933325,0.0004387933,0.00060850714,0.00018634424,0.00023621203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013933294,0.00019991715,0.0009957037,0.00010667117,0.00005954467,0.0000025276363,0.00016296541,0.00028542537,0.0003306032],"category_scores_gemma":[0.00048260612,0.00016120305,0.00023381066,0.00021567974,0.000666609,0.000037263686,0.00009147581,0.00039578482,0.00034624725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023719584,0.0019227727,0.9036802,0.00004676065,0.00021483368,0.0002902234,0.000096462456,0.0000014553284,0.00007437312,0.00068290497,0.004366292,0.08838653],"study_design_scores_gemma":[0.0038840529,0.0027162759,0.6786482,0.000023227387,0.0003751786,0.000955348,0.00006960152,0.00007783616,0.0009598942,0.00016639686,0.31193602,0.00018802007],"about_ca_topic_score_codex":0.00003837329,"about_ca_topic_score_gemma":0.00020335874,"teacher_disagreement_score":0.3075697,"about_ca_system_score_codex":0.00003816362,"about_ca_system_score_gemma":0.00050464517,"threshold_uncertainty_score":0.657367},"labels":[],"label_agreement":null},{"id":"W2341386228","doi":"10.1097/pai.0000000000000367","title":"New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Immunohistochemistry; Bivariate analysis; Biology; Classifier (UML); Pathology; Medicine; Mathematics; Artificial intelligence; Statistics; Computer science","score_opus":0.008503654402056374,"score_gpt":0.25345086661923255,"score_spread":0.2449472122171762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341386228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436198,0.0011834778,0.050669994,0.0014318388,0.000108091874,0.000915294,0.00004675995,0.000083614905,0.0019411707],"genre_scores_gemma":[0.9710145,0.00006935542,0.02643771,0.0012263233,0.00003537168,0.00055168656,0.00017954547,0.00007169558,0.00041384198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748075,0.000063259045,0.0006096391,0.00087804074,0.0002982862,0.00067003444],"domain_scores_gemma":[0.9984678,0.00015791868,0.00018112066,0.00081786927,0.000069314105,0.00030594962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016136207,0.00048524482,0.0006541945,0.00018008084,0.000077767065,0.000019713445,0.00026131998,0.00034078612,0.000084840765],"category_scores_gemma":[0.00010633769,0.0003759443,0.00021262097,0.00033391366,0.00012653873,0.000034144025,0.00008166936,0.00019256872,0.00010399778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008052409,0.001979141,0.00042391193,0.00003997687,0.00015232973,0.00039382593,0.0007392318,0.000008847716,0.9704344,0.00042534643,0.0005643686,0.024033327],"study_design_scores_gemma":[0.025188273,0.00042203197,0.0032716251,0.00019211798,0.00016041666,0.00022559079,0.00025431038,0.0000133041785,0.96907157,0.00027034988,0.0005211668,0.0004092251],"about_ca_topic_score_codex":0.00021541606,"about_ca_topic_score_gemma":0.000003419784,"teacher_disagreement_score":0.027394712,"about_ca_system_score_codex":0.0008056283,"about_ca_system_score_gemma":0.00033605128,"threshold_uncertainty_score":0.9998692},"labels":[],"label_agreement":null},{"id":"W2341938238","doi":"10.1093/rheumatology/kev088.069","title":"069. Prognostic Factors for Intravenous Abatacept Retention in Patients Who have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study","year":2015,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Abatacept; Czech; Internal medicine; Pediatrics; General surgery; Family medicine","score_opus":0.05389931905330549,"score_gpt":0.29157807349216297,"score_spread":0.23767875443885747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341938238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919267,0.00004346005,0.0000039708093,0.00028716502,0.00031427422,0.0046399487,0.0006983346,0.00006717863,0.0020189355],"genre_scores_gemma":[0.994844,0.00008095583,0.0003646484,0.000036739464,0.00014030217,0.0004781415,0.0028350658,0.000033153574,0.0011869683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794024,0.00009853239,0.0005380871,0.0006778031,0.000427825,0.00031751208],"domain_scores_gemma":[0.9986973,0.00018993871,0.0002593448,0.00037281765,0.0003011755,0.00017942551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023512731,0.0002611896,0.00048710057,0.00019267206,0.00007972788,0.000046609708,0.00014698114,0.00010726102,0.000041886306],"category_scores_gemma":[0.000789702,0.00020811228,0.000105276944,0.00017788229,0.000045162076,0.00011827935,0.00012038883,0.00011153831,0.000055764875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037986229,0.0055662324,0.9823451,0.000013182977,0.00033582374,0.000036310852,0.0047465046,0.0000048320767,0.000030755447,0.000010969899,0.00082928414,0.0022824025],"study_design_scores_gemma":[0.02517307,0.0034389144,0.96841276,0.00020694493,0.00020680526,6.764506e-7,0.001128589,0.000073327625,0.00030743176,0.00009930293,0.0007559201,0.00019626445],"about_ca_topic_score_codex":0.0022568228,"about_ca_topic_score_gemma":0.0026976173,"teacher_disagreement_score":0.021374447,"about_ca_system_score_codex":0.0014054368,"about_ca_system_score_gemma":0.000076820725,"threshold_uncertainty_score":0.84865725},"labels":[],"label_agreement":null},{"id":"W2343867010","doi":"10.1200/jco.2015.33.15_suppl.8503","title":"Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed/refractory (RR) follicular lymphoma (FL): Durable responses at lower dose level.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Toxicity; Gastroenterology; Follicular lymphoma; Surgery; Animal science; Lymphoma","score_opus":0.08271772342329124,"score_gpt":0.40698990089155107,"score_spread":0.3242721774682598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343867010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938047,0.0014847035,0.0000039145034,0.0017898517,0.0012579088,0.00045313075,0.000023084427,0.0000136353765,0.0011690503],"genre_scores_gemma":[0.9954467,0.0011284511,0.0013425193,0.0011902457,0.0003280495,0.0000073586516,0.000020277177,0.00004502624,0.00049138285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99394417,0.001041585,0.0031657843,0.0004210528,0.0009495722,0.00047783818],"domain_scores_gemma":[0.99219036,0.0027749208,0.0027140481,0.0004877288,0.0010747876,0.00075815484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028333052,0.0003602169,0.0026384564,0.00034161002,0.000060431885,0.000015147778,0.00026412267,0.0004238482,0.0000787937],"category_scores_gemma":[0.0038931118,0.00023091368,0.00055903074,0.00031909902,0.0004212419,0.00027192186,0.00014060769,0.0004841667,0.00005427619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054234944,0.017403994,0.9069878,0.000036188616,0.0006399716,0.0041226572,0.00026815955,0.000040000865,0.00031432195,0.000042399082,0.0048969355,0.011012667],"study_design_scores_gemma":[0.09522986,0.025797656,0.8425434,0.00051186234,0.00046183847,0.00034449674,0.00018654935,0.000019427373,0.001019935,0.000053620977,0.033620182,0.00021113144],"about_ca_topic_score_codex":0.00044763915,"about_ca_topic_score_gemma":0.00023959763,"teacher_disagreement_score":0.06444432,"about_ca_system_score_codex":0.0012742963,"about_ca_system_score_gemma":0.0039508175,"threshold_uncertainty_score":0.94163865},"labels":[],"label_agreement":null},{"id":"W2344077496","doi":"10.2967/jnumed.115.166280","title":"Response Assessment Criteria and Their Applications in Lymphoma: Part 1","year":2016,"lang":"en","type":"review","venue":"Journal of Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Lymphoma; Disease; Medicine; Medical physics; Intensive care medicine; Computer science; Risk analysis (engineering); Pathology","score_opus":0.04896900361530101,"score_gpt":0.3897690832142972,"score_spread":0.3408000795989962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344077496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005165826,0.99279493,0.000007292311,0.00499395,0.00022536164,0.00058167375,0.00001939921,0.000010101937,0.0008507075],"genre_scores_gemma":[0.00073164114,0.9977331,0.00020603595,0.00041954417,0.0006790033,0.00003331164,0.000008487489,0.000052574538,0.00013629603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785256,0.00030203722,0.0011178892,0.00022690353,0.0002956851,0.00020492158],"domain_scores_gemma":[0.9977243,0.0007654688,0.0007523041,0.00033968122,0.0001253175,0.0002929592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012446882,0.00034023923,0.0022595506,0.00048918615,0.000047375965,0.000014177288,0.00013572015,0.00018702385,0.0003854032],"category_scores_gemma":[0.00018179136,0.00015275426,0.0002780452,0.0002118691,0.00015149322,0.00006172584,0.000052980817,0.0001833024,0.000019008106],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021333604,0.0005224901,0.00007324817,0.0017605114,0.0003629571,0.000372893,0.00017589887,2.592495e-9,0.000013108615,0.00017991578,0.014610855,0.9817148],"study_design_scores_gemma":[0.0036166976,0.0010719179,0.0031151,0.042031728,0.000782793,0.002057848,0.0001668411,5.5115754e-7,3.3106156e-7,0.00004557558,0.9469945,0.00011611197],"about_ca_topic_score_codex":0.0000050897393,"about_ca_topic_score_gemma":5.9681616e-7,"teacher_disagreement_score":0.9815987,"about_ca_system_score_codex":0.0006298659,"about_ca_system_score_gemma":0.00047670616,"threshold_uncertainty_score":0.62291384},"labels":[],"label_agreement":null},{"id":"W2344483783","doi":"10.1016/j.bbmt.2016.04.019","title":"Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients","year":2016,"lang":"en","type":"review","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Lymphoma; Rituximab; Follicular lymphoma; Transplantation; Mantle cell lymphoma; Oncology; Non-Hodgkin's lymphoma; Internal medicine; Hematopoietic cell; Hematopoietic stem cell transplantation; Haematopoiesis; Stem cell","score_opus":0.007659336842529486,"score_gpt":0.2723426487479681,"score_spread":0.2646833119054386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344483783","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58063304,0.40598315,0.0016417247,0.00007179864,0.00012934356,0.009321067,0.0020194587,0.000044548913,0.00015584257],"genre_scores_gemma":[0.32880482,0.6643519,0.00048926024,0.00006867749,0.00003207584,0.0011514754,0.0050534015,0.000038262402,0.000010180286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998247,0.00010570068,0.0005993275,0.0006149865,0.00016874948,0.0002642044],"domain_scores_gemma":[0.99866086,0.0002861074,0.00044779532,0.00020337786,0.00023542716,0.00016640921],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009563944,0.0004699279,0.0011282092,0.00023092837,0.00009238471,0.000011389689,0.000095586336,0.0003490653,0.00001086785],"category_scores_gemma":[0.0000075563385,0.00029049156,0.00019568691,0.00014683559,0.000087519904,0.00008101762,0.000005495224,0.00004278359,0.000007917704],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002231744,0.003044406,0.057525363,0.0137065565,0.00083099224,0.0000077949235,0.0007630772,1.278791e-7,0.0002966695,0.00009931212,0.000019530307,0.92147446],"study_design_scores_gemma":[0.259224,0.0603923,0.35667792,0.08556182,0.057604864,0.0005359163,0.00014517063,0.0000028723612,0.037906796,0.00045353893,0.13615368,0.0053411205],"about_ca_topic_score_codex":0.00006777687,"about_ca_topic_score_gemma":0.000013953436,"teacher_disagreement_score":0.9161333,"about_ca_system_score_codex":0.000049995277,"about_ca_system_score_gemma":0.00021248916,"threshold_uncertainty_score":0.9999547},"labels":[],"label_agreement":null},{"id":"W2344653911","doi":"10.1371/journal.pone.0153823","title":"Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi","keywords":"Cyclin D1; TLR5; TLR2; Mantle cell lymphoma; Cell biology; Cell growth; Cyclin D3; Cancer research; Biology; Toll-like receptor; Cell culture; Protein kinase B; CD40; Cyclin D; CD5; Signal transduction; Receptor; Cell cycle; Lymphoma; Cell; Immunology; Cytotoxic T cell; TLR4; Genetics; Innate immune system","score_opus":0.019726166983347473,"score_gpt":0.2308271109622446,"score_spread":0.21110094397889712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344653911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996503,0.0014815446,0.0000017781717,0.0014397335,0.000017547822,0.0003769667,0.000007442267,0.000008175304,0.00016381335],"genre_scores_gemma":[0.9962743,0.002765543,0.00029722214,0.00010065217,0.00004110953,0.000068333786,0.000003366339,0.000008197543,0.00044130595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994111,0.000021943977,0.00015582309,0.00017937933,0.00013586011,0.00009590099],"domain_scores_gemma":[0.9996065,0.000115461764,0.000060588292,0.00013423299,0.000028064242,0.0000551345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095591786,0.0000856263,0.00019180999,0.000036411042,0.000035315377,0.00000992291,0.000021088104,0.000058353606,0.000013822691],"category_scores_gemma":[0.00004029077,0.000044069937,0.000009924084,0.000042453063,0.0000543609,0.000068167334,0.00003668714,0.000021945189,0.0000034958493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016461384,0.0014395736,0.2151651,0.00011529547,0.000023429538,0.0000044134867,0.00055430684,9.3363015e-9,0.7721989,0.0000127017065,0.00014346304,0.010178211],"study_design_scores_gemma":[0.0029175542,0.00025642355,0.14776017,0.0007321149,0.00004977512,0.0000036124698,0.000050281316,0.000010303708,0.848081,0.00003255538,0.000057152356,0.00004908293],"about_ca_topic_score_codex":0.000019151512,"about_ca_topic_score_gemma":0.00001293745,"teacher_disagreement_score":0.07588209,"about_ca_system_score_codex":0.000028661214,"about_ca_system_score_gemma":0.000024306506,"threshold_uncertainty_score":0.17971198},"labels":[],"label_agreement":null},{"id":"W2346079079","doi":"10.1177/1740774516645338","title":"Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting","year":2016,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Takeda Pharmaceuticals International; National Cancer Institute; University of Washington; Fred Hutchinson Cancer Research Center; Leukemia and Lymphoma Society","keywords":"Medicine; Concordance; Confidence interval; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Clinical trial; Oncology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research","score_opus":0.31204559873543886,"score_gpt":0.5583891974410428,"score_spread":0.2463435987056039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346079079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732181,0.004649994,0.00012515167,0.016038576,0.00070559286,0.0050918683,0.000033159442,0.00002404224,0.00011353117],"genre_scores_gemma":[0.98646617,0.010111483,0.0004048656,0.0017559127,0.0007522096,0.00042656454,0.00001804882,0.000019541463,0.000045213368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97258085,0.018655192,0.00648058,0.0009846055,0.0007724771,0.00052632415],"domain_scores_gemma":[0.961056,0.036682673,0.0010749749,0.00057013327,0.00014669994,0.00046953026],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.10864818,0.00026110193,0.002774551,0.00011334163,0.000033046425,0.00002336501,0.00011944203,0.00038526667,0.00015201143],"category_scores_gemma":[0.06338822,0.00015776111,0.0005055733,0.00021544531,0.00024123378,0.00010723159,0.00011013876,0.00025888567,0.000032189524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022759207,0.001204211,0.51315695,0.00005541311,0.00010762934,0.00007823137,0.000009608999,1.595738e-7,0.000004884313,0.000029057186,0.00044085312,0.4621538],"study_design_scores_gemma":[0.23913792,0.0020410346,0.7526555,0.0025383448,0.00074127805,0.0000074775458,0.000016949962,0.000033086933,0.000015062591,0.00022355493,0.0024503833,0.00013939239],"about_ca_topic_score_codex":0.0000438702,"about_ca_topic_score_gemma":0.000049524017,"teacher_disagreement_score":0.4620144,"about_ca_system_score_codex":0.00082223036,"about_ca_system_score_gemma":0.0018180215,"threshold_uncertainty_score":0.9445013},"labels":[],"label_agreement":null},{"id":"W2346128427","doi":"10.1158/1078-0432.ccr-15-2488","title":"Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Calicheamicin; Medicine; Rituximab; Gastroenterology; Internal medicine; Neutropenia; Tolerability; Leukopenia; Lymphoma; Febrile neutropenia; Adverse effect; Chemotherapy","score_opus":0.16024338282444303,"score_gpt":0.5031085037615861,"score_spread":0.34286512093714305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346128427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375695,0.00036049806,0.000029118652,0.0013664863,0.00020734259,0.0032317166,0.00008229192,0.000032281318,0.000933321],"genre_scores_gemma":[0.9950095,0.0006278344,0.00014099557,0.00015176227,0.00034029878,0.0012273899,0.000014036377,0.00006109983,0.0024271018],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99639493,0.00034509934,0.00088909746,0.00075316813,0.0009791176,0.0006385693],"domain_scores_gemma":[0.99424964,0.0033386357,0.0002177586,0.0009216308,0.0008395215,0.00043281273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018146794,0.00024310502,0.00088461104,0.00021418609,0.00014053354,0.000018356397,0.0002876831,0.000190582,0.0002555977],"category_scores_gemma":[0.0005336778,0.0001330797,0.00021112431,0.00039120187,0.00047065777,0.00008866102,0.00014092139,0.00021626042,0.000060017752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069535606,0.11757798,0.41175786,0.00034458513,0.00093161804,0.0003409855,0.0006180587,9.773585e-7,0.0036401865,0.000077213226,0.026077151,0.3690978],"study_design_scores_gemma":[0.48840603,0.26546228,0.19229284,0.0011094868,0.0005768021,0.000007793114,0.0011238679,0.00007395344,0.030527737,0.00013392001,0.019854883,0.00043041186],"about_ca_topic_score_codex":0.0008078611,"about_ca_topic_score_gemma":0.00030566464,"teacher_disagreement_score":0.41887042,"about_ca_system_score_codex":0.0006614662,"about_ca_system_score_gemma":0.0013938985,"threshold_uncertainty_score":0.54268324},"labels":[],"label_agreement":null},{"id":"W2346632551","doi":"10.1200/jco.2012.30.15_suppl.8002","title":"ABVD (8 cycles) versus BEACOPP (4 escalated cycles =&gt; 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup  randomized phase III clinical trial.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; ABVD; Internal medicine; Clinical endpoint; Randomization; Discontinuation; Stage (stratigraphy); Clinical trial; Hazard ratio; Gastroenterology; Surgery; Chemotherapy; Confidence interval; Vincristine; Cyclophosphamide","score_opus":0.1127364686926511,"score_gpt":0.4625864656085583,"score_spread":0.34984999691590724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346632551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842439,0.0018684504,0.00020119012,0.003111838,0.007609778,0.0016827871,0.00009698497,0.000032439857,0.0011525818],"genre_scores_gemma":[0.981501,0.010851114,0.0028955773,0.0006701399,0.003600587,0.000055443328,0.000070809794,0.0000566537,0.00029869933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9788518,0.0049288413,0.01382602,0.0006170737,0.00092468737,0.00085158664],"domain_scores_gemma":[0.9443547,0.043820374,0.009090123,0.00075993105,0.0006303506,0.0013444923],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03427537,0.00056120765,0.0078037707,0.00049545453,0.00008735015,0.000025926649,0.0004457891,0.0013864498,0.0002741859],"category_scores_gemma":[0.03741164,0.00037999722,0.0027226815,0.00042282298,0.0008817015,0.00044148113,0.00019515934,0.001223253,0.000046073732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7830634,0.04064268,0.0231834,0.000029553565,0.0024039093,0.0009544119,0.00019469163,0.000022997134,0.000011637801,0.0001313518,0.0062531983,0.14310874],"study_design_scores_gemma":[0.8563985,0.025937932,0.09178139,0.00040001483,0.0030506542,0.00008096605,0.0001459763,0.0004919043,0.00014179313,0.000057739824,0.02123539,0.00027769204],"about_ca_topic_score_codex":0.00091834384,"about_ca_topic_score_gemma":0.0006446221,"teacher_disagreement_score":0.14283104,"about_ca_system_score_codex":0.0006617175,"about_ca_system_score_gemma":0.0016602358,"threshold_uncertainty_score":0.99990994},"labels":[],"label_agreement":null},{"id":"W2352122307","doi":"","title":"[Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD20; CD15; Lymphoma; CD30; Medicine; Immunohistochemistry; Internal medicine; Hazard ratio; Proportional hazards model; Gastroenterology; Pathology; Oncology; Biology; CD34; Stem cell","score_opus":0.025259810475952077,"score_gpt":0.22299734244197858,"score_spread":0.1977375319660265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2352122307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637437,0.0009570439,0.000016176786,0.0002195531,0.000074911135,0.00092741917,0.000016380915,0.000017125296,0.0013970294],"genre_scores_gemma":[0.99784344,0.000543929,0.0004829726,0.00006689407,0.000046178335,0.0006669032,0.0000065209974,0.000017133289,0.0003260483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986392,0.000060609764,0.00040328744,0.00030291014,0.00029977103,0.00029418664],"domain_scores_gemma":[0.9991101,0.00023348277,0.00016107714,0.0002681792,0.00005336668,0.00017376208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001468203,0.00016033945,0.0005024151,0.00012843675,0.000023604445,0.000003964416,0.00007223333,0.00010477655,0.000010889681],"category_scores_gemma":[0.00012327134,0.00012461531,0.00007899042,0.00019275399,0.00020117838,0.000058634934,0.000056084504,0.000048248276,0.0000024218573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004437117,0.0015840667,0.9254115,0.00020954548,0.000053927644,0.0002816937,0.0003693414,0.000004563147,0.0074178223,0.00006440821,0.001000493,0.063158885],"study_design_scores_gemma":[0.0036407649,0.00014054927,0.7984619,0.00013785553,0.000049823004,0.00003421395,0.000028818607,0.000026591348,0.19681968,0.000023095232,0.00055238575,0.00008432788],"about_ca_topic_score_codex":0.000109853565,"about_ca_topic_score_gemma":0.00001403361,"teacher_disagreement_score":0.18940185,"about_ca_system_score_codex":0.00009462566,"about_ca_system_score_gemma":0.00006535728,"threshold_uncertainty_score":0.5081665},"labels":[],"label_agreement":null},{"id":"W2369916872","doi":"","title":"[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"DHAP; Medicine; Regimen; Neutropenia; Salvage therapy; Refractory (planetary science); Internal medicine; Cytarabine; Gastroenterology; Surgery; Febrile neutropenia; Toxicity; Chemotherapy","score_opus":0.019533281745187325,"score_gpt":0.22508528654017362,"score_spread":0.2055520047949863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2369916872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903826,0.0002066919,0.0000018155499,0.00044744607,0.000096353084,0.0044071814,0.000014932699,0.00004918605,0.0043937624],"genre_scores_gemma":[0.99207985,0.000038635564,0.00009982277,0.000411201,0.00007611558,0.005502046,0.000021551852,0.000038794617,0.001731974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874026,0.000025779356,0.00018789881,0.0004120548,0.00028905598,0.00034498022],"domain_scores_gemma":[0.9990939,0.00014204967,0.00009490474,0.00037291372,0.00007351529,0.00022272136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001050494,0.00021078782,0.0003248936,0.00009813099,0.00010151097,0.000022860298,0.000055129793,0.00006725341,0.0000126387795],"category_scores_gemma":[0.000065212735,0.0001435645,0.00005208218,0.00009432491,0.000041202253,0.000080069585,0.000029025245,0.000041045183,0.00001254235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023917034,0.010880972,0.738687,0.000040050945,0.0003287209,0.000083746534,0.0007237633,3.2574403e-7,3.2631266e-7,0.00001800766,0.010593614,0.23625182],"study_design_scores_gemma":[0.025204575,0.007510146,0.96135265,0.0000448014,0.0003034732,0.000006124214,0.00014367297,0.000020806574,0.000045991546,0.000006370492,0.005205697,0.00015566694],"about_ca_topic_score_codex":0.00001899212,"about_ca_topic_score_gemma":0.00000207951,"teacher_disagreement_score":0.23609614,"about_ca_system_score_codex":0.00020768304,"about_ca_system_score_gemma":0.000012279383,"threshold_uncertainty_score":0.585439},"labels":[],"label_agreement":null},{"id":"W2372010367","doi":"","title":"BCL-6,CD10 and BCL-2 protein expression in B-cell Non-Hodgkin's lymphoma and its clinicopathologic significance","year":2006,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Lymphoma; Germinal center; Mantle cell lymphoma; Lymphoid hyperplasia; Pathology; Mantle zone; Follicular lymphoma; Diffuse large B-cell lymphoma; MALT lymphoma; Follicular hyperplasia; Marginal zone; B cell; Lymphoplasmacytic Lymphoma; Lymph node; Immunohistochemistry; Medicine; Cancer research; Antibody; Immunology; Waldenstrom macroglobulinemia","score_opus":0.011522928662274588,"score_gpt":0.25029437823767586,"score_spread":0.23877144957540128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2372010367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890606,0.0055922903,0.000016824899,0.00048695473,0.000106348714,0.0013566848,0.000018055494,0.00008254559,0.0032797186],"genre_scores_gemma":[0.9956689,0.00059760216,0.0013629838,0.0002102209,0.00017645232,0.00034496127,0.00003135902,0.000040831423,0.0015667258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792945,0.00010399605,0.0005033432,0.0007228891,0.00027716914,0.00046313438],"domain_scores_gemma":[0.99907506,0.00014773651,0.00017528835,0.00034801834,0.00006912111,0.00018479126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003288471,0.00034960688,0.00056663854,0.00016111114,0.00012280811,0.00005261955,0.00009017667,0.00023260328,0.00003656437],"category_scores_gemma":[0.000076396725,0.0002735009,0.000073139476,0.00024739956,0.000098923956,0.00015051794,0.00010876789,0.00013785892,0.0000571263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006801483,0.005414034,0.67461187,0.0007794148,0.000037256206,0.0027330492,0.0006821158,0.00001769315,0.25244045,0.00034843807,0.002175154,0.06008036],"study_design_scores_gemma":[0.012389008,0.00082077365,0.85073596,0.00070571527,0.000080942336,0.00010700589,0.00014713749,0.0002983871,0.13078839,0.00029693297,0.0032264374,0.00040330703],"about_ca_topic_score_codex":0.00017998675,"about_ca_topic_score_gemma":0.000049844988,"teacher_disagreement_score":0.1761241,"about_ca_system_score_codex":0.0001314929,"about_ca_system_score_gemma":0.000108410284,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W2393780027","doi":"10.1053/j.seminhematol.2016.05.009","title":"Nodular lymphocyte-predominant Hodgkin lymphoma","year":2016,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Lymphocyte; Immunology; Pathology","score_opus":0.028077245961957188,"score_gpt":0.33993086760641095,"score_spread":0.31185362164445374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2393780027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026558424,0.99369806,0.00000567402,0.00017972098,0.00070381834,0.0016158744,0.00006436532,0.00009065647,0.0033762383],"genre_scores_gemma":[0.00016147066,0.99618274,0.0006137481,0.0001574531,0.00017641053,0.0011273875,0.00015621462,0.00013841683,0.0012861292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594617,0.0002765191,0.001379405,0.001137135,0.00032999797,0.00093076896],"domain_scores_gemma":[0.9969745,0.00085113704,0.0005128372,0.0013204957,0.00006275995,0.00027826786],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033337672,0.0009198917,0.0051467326,0.0006930509,0.000064154294,0.000017043716,0.00037223974,0.0011825565,0.0005735467],"category_scores_gemma":[0.0002539244,0.00058880274,0.0009605813,0.00045462733,0.0002537314,0.00004818078,0.00025413575,0.00015966005,0.0020639559],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006138149,0.0007143222,0.00064141885,0.009695835,0.000353558,0.00881593,0.000046666537,1.5129187e-8,3.733223e-7,0.0018926869,0.0043104584,0.97346735],"study_design_scores_gemma":[0.003739414,0.00027625693,0.000032851847,0.08278807,0.0010085094,0.017324237,0.000015813092,0.0000017803269,0.000073629926,0.00014798091,0.89409924,0.0004922274],"about_ca_topic_score_codex":0.000050126568,"about_ca_topic_score_gemma":0.00001213554,"teacher_disagreement_score":0.97297513,"about_ca_system_score_codex":0.0019290088,"about_ca_system_score_gemma":0.0012472122,"threshold_uncertainty_score":0.9996563},"labels":[],"label_agreement":null},{"id":"W2397442087","doi":"10.1080/10428194.2016.1179295","title":"Validation of the NCCN-IPI in both <i>de novo</i> and transformed diffuse large B cell lymphoma","year":2016,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Medicine; Lymphoma; Risk stratification; Internal medicine; Oncology","score_opus":0.0074482426832511335,"score_gpt":0.21808160447531527,"score_spread":0.21063336179206413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397442087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95604146,0.004674649,0.00002537993,0.031040885,0.0006439481,0.002075364,0.00069268246,0.00016412292,0.004641531],"genre_scores_gemma":[0.89412975,0.005804031,0.00018322004,0.09334474,0.0015750235,0.0005169399,0.0004542185,0.00032798608,0.0036640586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926148,0.00043377344,0.0017705961,0.0018100688,0.0013351167,0.002035617],"domain_scores_gemma":[0.9958394,0.00083894277,0.000887776,0.0017378235,0.00018487989,0.0005111853],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00065676175,0.0016461799,0.002329129,0.000644808,0.0003967639,0.00017162929,0.00069130014,0.0023980206,0.00007566378],"category_scores_gemma":[0.0001079516,0.0011212409,0.0007821775,0.00073502056,0.0007109936,0.00036807384,0.00035759262,0.00040521214,0.000039434548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0045041805,0.009206516,0.20014223,0.011579902,0.002561416,0.010201567,0.008972303,0.000008484612,0.012603763,0.0010927707,0.43610817,0.3030187],"study_design_scores_gemma":[0.18001156,0.00074219774,0.21395354,0.0042310013,0.002198769,0.0037685467,0.00033326016,0.0002988003,0.05865811,0.0006470494,0.5328032,0.002354011],"about_ca_topic_score_codex":0.001690714,"about_ca_topic_score_gemma":0.00011833942,"teacher_disagreement_score":0.30066466,"about_ca_system_score_codex":0.011785549,"about_ca_system_score_gemma":0.006025765,"threshold_uncertainty_score":0.99962854},"labels":[],"label_agreement":null},{"id":"W2397619099","doi":"10.1016/j.critrevonc.2016.04.019","title":"Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Tolerability; Medicine; Internal medicine; Oncology; Refractory (planetary science); Anaplastic large-cell lymphoma; Lymphoma; Clinical trial; Hodgkin lymphoma; Adverse effect","score_opus":0.09861715029883955,"score_gpt":0.4469495262259395,"score_spread":0.3483323759270999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397619099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000623369,0.98349786,0.000003145099,0.004692972,0.00087962026,0.008932247,0.0005398712,0.00007312834,0.0013188501],"genre_scores_gemma":[0.00010481176,0.98515064,0.00153156,0.0028002171,0.00017267127,0.0044206115,0.005697832,0.000105568855,0.000016109952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847715,0.005794456,0.005581587,0.002173741,0.0005457544,0.0011329906],"domain_scores_gemma":[0.9863053,0.006440399,0.0015645318,0.0049118255,0.0003055902,0.00047235822],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035100586,0.0011256961,0.011542408,0.00035621822,0.000068126516,0.0000335153,0.0019405447,0.0014816667,0.0016499531],"category_scores_gemma":[0.018148648,0.0005965956,0.00084950787,0.0010668625,0.0010774746,0.0002511393,0.0010818706,0.0009850501,0.00048189546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000686229,0.009362604,0.00029280994,0.035530448,0.00019501304,0.0010056674,0.000032507407,8.816152e-10,1.15104356e-7,0.0018224003,0.044123113,0.9075667],"study_design_scores_gemma":[0.0027159043,0.0012112989,0.00010936594,0.2538318,0.0017335307,0.00064054265,0.000015574125,0.0000028520851,9.3621907e-7,0.00019046696,0.7391776,0.00037012243],"about_ca_topic_score_codex":0.0001323114,"about_ca_topic_score_gemma":0.00022397537,"teacher_disagreement_score":0.9071966,"about_ca_system_score_codex":0.001489824,"about_ca_system_score_gemma":0.0027968094,"threshold_uncertainty_score":0.9998146},"labels":[],"label_agreement":null},{"id":"W2400126805","doi":"10.1200/jco.2015.65.3469","title":"Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Vincristine; Cyclophosphamide; Stage (stratigraphy); Chemotherapy; Prednisone; Cohort; Surgery; Internal medicine; Lymphoma; Radiation therapy; Gastroenterology","score_opus":0.05331043239669568,"score_gpt":0.39750194928583704,"score_spread":0.34419151688914135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400126805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499596,0.004545622,0.000060721468,0.007286365,0.001802399,0.0005381372,0.000074090494,0.000013920407,0.0006828053],"genre_scores_gemma":[0.9689442,0.023020238,0.002838433,0.00052787486,0.0044234693,0.00003596809,0.000012705337,0.000032294913,0.00016480705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99293995,0.0011379962,0.0044091656,0.00048139543,0.000590504,0.00044101063],"domain_scores_gemma":[0.9793788,0.013097238,0.005861396,0.00068583275,0.00042934832,0.0005473944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026455305,0.00035597506,0.002981926,0.00014577858,0.00008927361,0.000008783911,0.0003220635,0.00068705034,0.00030178498],"category_scores_gemma":[0.00453945,0.00015037972,0.0016153943,0.00019472442,0.00047634818,0.000098612996,0.00010045848,0.00019521176,0.000070554146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006196302,0.011258626,0.55699855,0.000004510956,0.001188508,0.0046493826,0.000102030346,5.4230793e-7,0.000057262016,0.000021698637,0.0035720805,0.41595054],"study_design_scores_gemma":[0.05557016,0.03914991,0.8508527,0.000092791626,0.003266555,0.0038741415,0.00006916457,0.000004855578,0.00047921686,0.00016673525,0.046333563,0.00014015881],"about_ca_topic_score_codex":0.0006787198,"about_ca_topic_score_gemma":0.00015226506,"teacher_disagreement_score":0.41581038,"about_ca_system_score_codex":0.0017451091,"about_ca_system_score_gemma":0.0048666573,"threshold_uncertainty_score":0.8633241},"labels":[],"label_agreement":null},{"id":"W2400940566","doi":"10.1182/blood-2015-09-672352","title":"Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Lymphoma; Computational biology; Disease; Genetic heterogeneity; Drug discovery; Diffuse large B-cell lymphoma; Cancer research; Biology; Medicine; Bioinformatics; Immunology; Genetics; Pathology; Gene; Phenotype","score_opus":0.01230967202451227,"score_gpt":0.21223435149573153,"score_spread":0.19992467947121925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400940566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942823,0.0038892603,0.00003125099,0.00109557,0.00002960271,0.00042639038,0.00012816618,0.00001807962,0.00009938383],"genre_scores_gemma":[0.9989725,0.0002512727,0.000035895246,0.0006377238,0.00001536366,0.000058894653,0.0000056125145,0.000010524221,0.000012256729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991981,0.000080382146,0.00014683983,0.00021422884,0.00016644922,0.00019400807],"domain_scores_gemma":[0.99925244,0.00005990561,0.00007088141,0.0004395996,0.000037139733,0.00014005628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004165628,0.00014133964,0.00017783909,0.000013631332,0.000075968244,0.000007963519,0.000092729766,0.00005996052,0.0000073007036],"category_scores_gemma":[0.000032516135,0.00004855891,0.00015534024,0.000052790696,0.00012759818,0.00002438602,0.00013065341,0.000022787559,0.0000029356347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041744413,0.039745573,0.80234873,0.00008833742,0.0006436771,0.00037627987,0.00077009137,0.0000019266254,0.14674017,0.0019462724,0.00019378187,0.0067277187],"study_design_scores_gemma":[0.04438108,0.0004961313,0.48546296,0.00015729961,0.000988967,0.000059314923,0.00010396928,0.000051870084,0.46653765,0.0007483838,0.0007905904,0.0002217996],"about_ca_topic_score_codex":0.000018681005,"about_ca_topic_score_gemma":0.000004162306,"teacher_disagreement_score":0.3197975,"about_ca_system_score_codex":0.000017110715,"about_ca_system_score_gemma":0.00004026762,"threshold_uncertainty_score":0.1980175},"labels":[],"label_agreement":null},{"id":"W2403295133","doi":"10.1182/blood.v122.21.4273.4273","title":"Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Population; Cancer; Pediatrics; Young adult; Transplantation; Internal medicine; Lymphoma; Psychosocial; Surgery","score_opus":0.015357926754503013,"score_gpt":0.2767751322434405,"score_spread":0.2614172054889375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403295133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977903,0.00040549325,4.7607708e-7,0.00049817335,0.000096620446,0.00065960444,0.00001017388,0.000034635996,0.0005045398],"genre_scores_gemma":[0.9981297,0.0007378514,0.0003525985,0.00016833501,0.00008863431,0.0002373346,0.000018364823,0.000017004879,0.00025016256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998925,0.00003404305,0.00040137803,0.00028702055,0.00012911376,0.00022345183],"domain_scores_gemma":[0.9993458,0.00009783357,0.00007075771,0.00026451965,0.000038781494,0.00018230203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006192601,0.00018226096,0.0004991335,0.000058098256,0.00002997095,0.000034703382,0.000034598204,0.0001028238,0.000040656203],"category_scores_gemma":[0.000060172315,0.000120586614,0.00013089716,0.000059660255,0.000041054464,0.00006113783,0.000026292018,0.000030190695,0.00012197165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031980217,0.0046376702,0.957704,0.000014364222,0.0002482611,0.00025667826,0.00018023221,4.300012e-9,0.000014385768,0.000037560654,0.000023955661,0.03685092],"study_design_scores_gemma":[0.021200206,0.0010725209,0.9765389,0.00008888972,0.0003132221,0.00007240659,0.000048187387,0.0000083781715,0.00022176794,0.000016853424,0.00030751023,0.00011114293],"about_ca_topic_score_codex":0.0016413211,"about_ca_topic_score_gemma":0.00006111482,"teacher_disagreement_score":0.036739778,"about_ca_system_score_codex":0.00007428109,"about_ca_system_score_gemma":0.000046066125,"threshold_uncertainty_score":0.49173793},"labels":[],"label_agreement":null},{"id":"W2403437089","doi":"10.1007/978-1-59745-390-5_16","title":"Predicting Survival in Follicular Lymphoma Using Tissue Microarrays","year":2007,"lang":"en","type":"review","venue":"Methods in molecular biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"","keywords":"Subgroup analysis; Follicular lymphoma; Medicine; Internal medicine; Oncology; Survival analysis; Stage (stratigraphy); Lymphoma; Meta-analysis; Biology","score_opus":0.10089952908173933,"score_gpt":0.49017067136753983,"score_spread":0.3892711422858005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403437089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006188379,0.923888,0.07269737,0.00001603421,0.0005817208,0.0013897895,0.000018344943,0.00003692543,0.0007529247],"genre_scores_gemma":[0.000007853734,0.60516834,0.3943033,0.00008295742,0.00010331591,0.0001143746,0.00012466554,0.00007375269,0.000021453305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99419266,0.0025349406,0.0012980289,0.0010090105,0.00016253337,0.00080283487],"domain_scores_gemma":[0.99797326,0.00073958543,0.0003624422,0.00071851234,0.00004955724,0.00015661148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027397117,0.00069118314,0.0033922393,0.000961018,0.000039898507,0.000015494585,0.00025262166,0.0012351833,0.00003187181],"category_scores_gemma":[0.00057849,0.0005607316,0.0005790961,0.00095843646,0.0001440088,0.000017959435,0.00020285262,0.00035807694,0.0000134897955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022227563,0.0003652881,0.0034750614,0.0023652017,0.00031092265,0.002791138,0.000042492746,0.0000024666406,0.0012845087,0.00027336623,0.0000016827939,0.98906565],"study_design_scores_gemma":[0.0032384836,0.00034916104,0.0002808238,0.010363555,0.0015251213,0.0011807528,0.000029482768,0.00006502945,0.004600713,0.00019015143,0.9774392,0.00073749415],"about_ca_topic_score_codex":0.0008039286,"about_ca_topic_score_gemma":0.00005620207,"teacher_disagreement_score":0.98832816,"about_ca_system_score_codex":0.0008590017,"about_ca_system_score_gemma":0.00048544962,"threshold_uncertainty_score":0.9996844},"labels":[],"label_agreement":null},{"id":"W2404263296","doi":"10.1182/blood.v122.21.5542.5542","title":"Stem Cell Dose and Time To Engraftment Does Not Predict Outcome After Autologous Stem Cell Transplantation For Relapsed Aggressive NHL","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Etoposide; Filgrastim; Internal medicine; Stem cell; Transplantation; Melphalan; Oncology; Plerixafor; Hematopoietic stem cell transplantation; Surgery; Chemotherapy; Granulocyte colony-stimulating factor; Biology; CXCR4","score_opus":0.008555921466623867,"score_gpt":0.22379104754396442,"score_spread":0.21523512607734055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404263296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518585,0.00057489786,0.000017384089,0.00073603605,0.00009520005,0.0025666638,0.00024587748,0.00007897788,0.000499108],"genre_scores_gemma":[0.992416,0.000085683016,0.0008612085,0.0005850322,0.00006644151,0.001759402,0.00005573613,0.000030704578,0.0041397903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998769,0.000035808163,0.00032597824,0.00038035444,0.0001986635,0.000290233],"domain_scores_gemma":[0.9991655,0.00015577827,0.00012895463,0.00024248436,0.00006889571,0.00023838815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070461116,0.00023507976,0.00036084518,0.00007801802,0.000064219596,0.00004080929,0.000053388034,0.00011404146,0.000120891964],"category_scores_gemma":[0.0000026450036,0.0001486091,0.00010732125,0.000048503025,0.000023409737,0.000074104304,0.000019891224,0.00005128412,0.000317777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063676056,0.020974206,0.6855541,0.0064953384,0.0019612059,0.0040395977,0.019428415,0.000025842093,0.09165545,0.00007425761,0.005196264,0.15822773],"study_design_scores_gemma":[0.026635604,0.0031703766,0.57248163,0.00026214443,0.0022450692,0.00010556265,0.00020012898,0.00008377547,0.3935448,0.000017178125,0.00088249805,0.00037123635],"about_ca_topic_score_codex":0.00003494498,"about_ca_topic_score_gemma":0.000004736299,"teacher_disagreement_score":0.30188936,"about_ca_system_score_codex":0.00006178947,"about_ca_system_score_gemma":0.0000371609,"threshold_uncertainty_score":0.6060103},"labels":[],"label_agreement":null},{"id":"W2404321413","doi":"10.1053/j.seminhematol.2016.05.002","title":"Hodgkin lymphoma in the elderly, pregnant, and HIV-infected","year":2016,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Vinblastine; Chemotherapy; Lymphoma; Intensive care medicine; Pregnancy; Drug; Chemoimmunotherapy; Disease; Human immunodeficiency virus (HIV); Oncology; Internal medicine; Surgery; Pediatrics; Immunology; Rituximab; Pharmacology","score_opus":0.02641870394568633,"score_gpt":0.32737695359137803,"score_spread":0.3009582496456917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404321413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028332241,0.9928663,0.0000010021216,0.0003801019,0.00013816994,0.0015450645,0.000025048555,0.000028240263,0.0021828876],"genre_scores_gemma":[0.0014198148,0.9971402,0.0000877986,0.00008965571,0.000048816146,0.00087043346,0.00007212535,0.00004109698,0.0002300289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767435,0.00038992084,0.00071468344,0.0005775142,0.000166468,0.00047709467],"domain_scores_gemma":[0.99754745,0.0014900352,0.00023621408,0.0006260644,0.000020911588,0.00007933568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030686337,0.00046833424,0.002276403,0.00038679282,0.00003653086,0.000015091509,0.00020565644,0.00057833345,0.000065457876],"category_scores_gemma":[0.00020031798,0.00023811996,0.0002233362,0.00036399858,0.00018046449,0.000032177213,0.000106653264,0.00017651243,0.000119695425],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001654695,0.00049287395,0.010048742,0.0053533795,0.00009112129,0.0029833901,0.00018311634,3.1556064e-9,7.665102e-8,0.0017526357,0.0018223306,0.97725576],"study_design_scores_gemma":[0.0027764826,0.000495745,0.0011721967,0.104794756,0.00051326683,0.011867873,0.00006076555,8.383266e-7,0.0000059955546,0.0002839307,0.87772983,0.00029832893],"about_ca_topic_score_codex":0.000031391653,"about_ca_topic_score_gemma":0.000045858626,"teacher_disagreement_score":0.97695744,"about_ca_system_score_codex":0.0002610849,"about_ca_system_score_gemma":0.00029189338,"threshold_uncertainty_score":0.971025},"labels":[],"label_agreement":null},{"id":"W2404692795","doi":"10.1200/jco.2015.65.7171","title":"Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly and Company","keywords":"Medicine; Internal medicine; Hazard ratio; Placebo; Oncology; International Prognostic Index; Rituximab; Clinical endpoint; Diffuse large B-cell lymphoma; Gastroenterology; Cyclophosphamide; Maintenance therapy; Cumulative incidence; Surgery; Lymphoma; Randomized controlled trial; Chemotherapy; Transplantation; Confidence interval; Pathology","score_opus":0.08525202088888015,"score_gpt":0.42642757468919085,"score_spread":0.3411755538003107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404692795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924924,0.00040550693,0.00019803719,0.0020104288,0.0021568476,0.0025698876,0.00003939672,0.000006577252,0.00012091643],"genre_scores_gemma":[0.9923393,0.005412205,0.0006457387,0.00024002163,0.0010516266,0.00016417654,0.000009273313,0.000027444936,0.00011021917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994563,0.0006949363,0.0036715693,0.0002905205,0.0004390261,0.00034094165],"domain_scores_gemma":[0.9838414,0.012036146,0.003100725,0.0002829164,0.00037769278,0.00036107373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005031694,0.00024884462,0.002878804,0.00021061451,0.00004434269,0.0000071802665,0.00015708328,0.00047570182,0.00010032395],"category_scores_gemma":[0.003649469,0.00012515942,0.0010932292,0.000098698256,0.00014041281,0.00012472572,0.000058585603,0.0002249166,0.0000054013863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7623263,0.075477384,0.020883866,0.000018526736,0.00042161503,0.000088180124,0.00006997849,5.687031e-7,0.000008398587,0.000017892644,0.00030318863,0.14038412],"study_design_scores_gemma":[0.92353547,0.056135885,0.0100383535,0.00027149692,0.00074182195,0.0000042571205,0.00001420218,0.000013869187,0.00057101686,0.00006802895,0.008487444,0.0001181734],"about_ca_topic_score_codex":0.000026121692,"about_ca_topic_score_gemma":0.000051916628,"teacher_disagreement_score":0.16120917,"about_ca_system_score_codex":0.0003543586,"about_ca_system_score_gemma":0.00072589796,"threshold_uncertainty_score":0.5103853},"labels":[],"label_agreement":null},{"id":"W2404824632","doi":"10.1182/blood.v124.21.4457.4457","title":"Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Cohort; Rituximab; Refractory (planetary science); Gastroenterology; Follicular lymphoma; Lymphoma; Oncology; Hodgkin lymphoma","score_opus":0.007494244142693291,"score_gpt":0.2521085767412386,"score_spread":0.24461433259854531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404824632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952332,0.0001993862,0.00000821916,0.00006300076,0.0001089015,0.0034251204,0.000101701626,0.00005280756,0.00080766535],"genre_scores_gemma":[0.9985496,0.000030605777,0.0006495282,0.000055074426,0.000044937664,0.00019393067,0.00027256244,0.00006490177,0.00013887719],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961205,0.00043947092,0.0014812063,0.0006859377,0.0008027529,0.00047012686],"domain_scores_gemma":[0.9971454,0.0005005476,0.00084399525,0.0009520812,0.00034861383,0.0002093451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007858754,0.00048667015,0.0022724338,0.00043468902,0.00009455872,0.000013248174,0.00023177346,0.00019296902,0.00005045074],"category_scores_gemma":[0.00075624906,0.00031761776,0.0002323803,0.0006164761,0.00020361062,0.00012584655,0.00013692102,0.00016116432,0.000013373584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6713828,0.26481014,0.046568114,0.00017293422,0.0018742072,0.0002520267,0.00398936,0.000012245046,0.0003398105,0.00004331081,0.00028088913,0.0102741895],"study_design_scores_gemma":[0.8467834,0.027176786,0.11820855,0.0005454162,0.001267688,0.000010619148,0.00023782226,0.00028672206,0.0050287824,0.000009987974,0.00016432072,0.00027989442],"about_ca_topic_score_codex":0.0013496542,"about_ca_topic_score_gemma":0.00019087289,"teacher_disagreement_score":0.23763336,"about_ca_system_score_codex":0.00029894063,"about_ca_system_score_gemma":0.0005948009,"threshold_uncertainty_score":0.9999276},"labels":[],"label_agreement":null},{"id":"W2407062960","doi":"10.18632/oncotarget.9500","title":"Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent <i>CARD11</i> mutations","year":2016,"lang":"en","type":"article","venue":"Oncotarget","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Family medicine; Oncology; Lymphoma","score_opus":0.00980387200947298,"score_gpt":0.2652948717094818,"score_spread":0.2554909997000088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407062960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471456,0.0024957976,0.000015665015,0.00020093439,0.00006627187,0.00030811245,0.00008387791,0.00001597782,0.0020988188],"genre_scores_gemma":[0.9977253,0.0009669646,0.001012654,0.000070230984,0.000030756688,0.000041038333,0.000025992453,0.00001563281,0.000111418594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908787,0.00004335426,0.00027358535,0.00023868281,0.00015587239,0.00020063871],"domain_scores_gemma":[0.99940324,0.000091170754,0.00008848166,0.00024323261,0.00004020881,0.00013364448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076956916,0.00014457584,0.00031670317,0.00009019678,0.000022744134,0.0000053452395,0.00004073761,0.00006233112,0.00007662442],"category_scores_gemma":[0.000020244237,0.00008770022,0.00013258429,0.00010420503,0.00006082478,0.000047939706,0.000034141594,0.000028511593,0.000027183602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013636313,0.0008486104,0.9765932,0.000056099292,0.00006111515,0.000067948706,0.00010570561,0.0000034634736,0.013735282,0.0000092271575,0.0009036603,0.007479333],"study_design_scores_gemma":[0.006062451,0.0007220269,0.9809264,0.00014633698,0.00007743716,0.0000394961,0.000008486579,0.000017190987,0.011263479,0.000073586125,0.00056725816,0.000095886564],"about_ca_topic_score_codex":0.00015466596,"about_ca_topic_score_gemma":0.000028368851,"teacher_disagreement_score":0.007383446,"about_ca_system_score_codex":0.0004473478,"about_ca_system_score_gemma":0.00019918548,"threshold_uncertainty_score":0.35763112},"labels":[],"label_agreement":null},{"id":"W2407071467","doi":"10.1097/rlu.0b013e3181f49aa1","title":"Unsuspected Synchronous Thyroid Carcinoma Revealed on a Post-Therapy F-18 FDG PET/CT, in a Patient With Follicular Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Malignancy; Lymphoma; Radiology; Biopsy; Lymph node; Thyroid; PET-CT; Positron emission tomography; Carcinoma; Chemotherapy; Lymph; Lesion; Follicular lymphoma; Nuclear medicine; Pathology; Internal medicine","score_opus":0.01936638933437932,"score_gpt":0.2993808498339628,"score_spread":0.28001446049958345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407071467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815849,0.00050126703,3.5308454e-7,0.010891982,0.00048515614,0.0013038747,0.000010350357,0.00014250561,0.0050796256],"genre_scores_gemma":[0.9872578,0.00042097594,0.00043263572,0.011012417,0.00052687846,0.00006864023,0.00006388369,0.00010219023,0.00011462615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966963,0.00017650459,0.0010501383,0.0008586611,0.00066547614,0.0005529338],"domain_scores_gemma":[0.99718297,0.00061818195,0.00026596303,0.0010588986,0.00023037793,0.00064362085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004777,0.00045835375,0.0012069349,0.00022659598,0.00010587813,0.00001673401,0.00019862074,0.00008835983,0.0013202301],"category_scores_gemma":[0.0007638953,0.0002770357,0.00024315725,0.00043663982,0.00051334925,0.000051278577,0.000055102428,0.0005278508,0.00026123816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01835005,0.023808341,0.582335,0.00015011689,0.0010726749,0.13738653,0.0013470668,0.0000027869264,0.0052633528,0.0013684146,0.03142591,0.19748975],"study_design_scores_gemma":[0.044296175,0.030741213,0.8822438,0.00065220165,0.00023824094,0.0047069136,0.00040937893,0.00011325386,0.00022572938,0.000040810406,0.03596002,0.00037225007],"about_ca_topic_score_codex":0.0006282822,"about_ca_topic_score_gemma":0.00017752785,"teacher_disagreement_score":0.29990882,"about_ca_system_score_codex":0.00023288812,"about_ca_system_score_gemma":0.00025279273,"threshold_uncertainty_score":0.9999682},"labels":[],"label_agreement":null},{"id":"W2407347175","doi":"","title":"Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; CHOP; Cyclophosphamide; Medicine; Vincristine; Rituximab; Etoposide; Non-Hodgkin's lymphoma; Oncology; Cancer research; Internal medicine; Chemotherapy","score_opus":0.01774092259210376,"score_gpt":0.23384977979715435,"score_spread":0.21610885720505058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407347175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905604,0.0005891483,0.000013706266,0.0035124698,0.00016914318,0.0018444011,0.0000042643874,0.000047425357,0.0032590562],"genre_scores_gemma":[0.9958859,0.000103590195,0.00013409337,0.0006632414,0.00014775865,0.0027146079,0.000009599603,0.00002065443,0.000320559],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881434,0.000023022258,0.00023116176,0.00024588988,0.00023228306,0.0004533208],"domain_scores_gemma":[0.99947417,0.000053538755,0.000059039347,0.00025383008,0.000028197454,0.00013119876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017565927,0.00015499556,0.00024091399,0.00007067815,0.00006750219,0.000031533073,0.00009487992,0.000062111954,0.000018529621],"category_scores_gemma":[0.00012423228,0.000090149864,0.000084298175,0.00022061597,0.00004442836,0.00006610409,0.000040139133,0.00005958295,0.00005303271],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016593005,0.0020641934,0.48555887,0.00010506151,0.00021509988,0.00040569546,0.0015708867,0.00013155007,0.00008155934,0.00070181524,0.001065148,0.5079342],"study_design_scores_gemma":[0.0050585647,0.000044212273,0.98966885,0.00004095225,0.00004165607,0.000023590621,0.000090262896,0.000023327168,0.002418733,0.00009992759,0.0023881458,0.0001017797],"about_ca_topic_score_codex":0.00026269507,"about_ca_topic_score_gemma":0.000025012509,"teacher_disagreement_score":0.5078324,"about_ca_system_score_codex":0.0005370348,"about_ca_system_score_gemma":0.000077428886,"threshold_uncertainty_score":0.3676205},"labels":[],"label_agreement":null},{"id":"W2407413189","doi":"10.1097/00001813-200211002-00006","title":"Stem-cell transplantation in non-Hodgkinʼs lymphoma: improving outcome","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Autologous stem-cell transplantation; Medicine; Rituximab; Transplantation; Oncology; Stem cell; Minimal residual disease; Lymphoma; Follicular lymphoma; Internal medicine; Mantle cell lymphoma; Non-Hodgkin's lymphoma; Immunology; Leukemia; Biology","score_opus":0.04044046465829004,"score_gpt":0.3316298935328376,"score_spread":0.2911894288745476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407413189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050464016,0.9892082,0.000005909895,0.00006256178,0.000498544,0.0016896892,0.00020303448,0.00006426804,0.0032213943],"genre_scores_gemma":[0.011691821,0.984141,0.00007355796,0.00020255132,0.0002613735,0.00077733654,0.0002658003,0.00011317949,0.0024734014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708945,0.00008170376,0.0010850193,0.0007807943,0.0004072183,0.0005558077],"domain_scores_gemma":[0.99865097,0.00014750648,0.00045808606,0.00052607903,0.000047820275,0.00016952827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018364783,0.0006851291,0.0025209016,0.00038582375,0.00007056848,0.00004965808,0.00019829113,0.00040880466,0.00019863721],"category_scores_gemma":[0.0000023597001,0.00052420207,0.00070977164,0.00046327233,0.00004293522,0.00012806017,0.000036521935,0.00020943911,0.00037064817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000116982455,0.0006509284,0.004043664,0.030224489,0.00015824285,0.00034654213,0.0003072371,6.6494067e-7,0.0000017893348,0.000005970261,0.0003332314,0.9639155],"study_design_scores_gemma":[0.010896041,0.0002211729,0.0055215955,0.028846476,0.006106493,0.0001585703,0.000092973016,0.00005190754,0.00019588026,0.0000017058461,0.9467538,0.0011533998],"about_ca_topic_score_codex":0.0011757695,"about_ca_topic_score_gemma":0.000051907526,"teacher_disagreement_score":0.9627621,"about_ca_system_score_codex":0.0010471542,"about_ca_system_score_gemma":0.00035086003,"threshold_uncertainty_score":0.99972093},"labels":[],"label_agreement":null},{"id":"W2410070419","doi":"10.1111/1440-1681.12603","title":"<scp>CD</scp>19<sup>+</sup><scp>CD</scp>20<sup>−</sup><scp>CD</scp>27<sup>hi</sup><scp>IL</scp>‐s10‐producing B cells are overrepresented in R‐<scp>CHOP</scp>‐treated <scp>DLBCL</scp> patients in complete remission","year":2016,"lang":"en","type":"article","venue":"Clinical and Experimental Pharmacology and Physiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada","funders":"","keywords":"Rituximab; CD20; Diffuse large B-cell lymphoma; CD8; B cell; Immunology; Population; CHOP; Lymphoma; Antibody; Immunophenotyping; Medicine; Internal medicine; Molecular biology; Immune system; Biology; Antigen","score_opus":0.032333233954488574,"score_gpt":0.32972120287381057,"score_spread":0.297387968919322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410070419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794899,0.008977609,0.000010932537,0.0005300873,0.0021743167,0.0045106695,0.0012454074,0.00057900214,0.0024820482],"genre_scores_gemma":[0.9752711,0.0076164827,0.00030508582,0.005370206,0.0024898862,0.0012688433,0.0017882364,0.00043585163,0.0054542995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9787997,0.0036345483,0.0050683543,0.006201583,0.0014751777,0.004820621],"domain_scores_gemma":[0.97175026,0.02003457,0.0020857723,0.0021635941,0.00065138045,0.0033144092],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.002114885,0.0033361558,0.005860874,0.001366428,0.0013099877,0.00024051165,0.0015985518,0.0031250487,0.0001991653],"category_scores_gemma":[0.006039404,0.002704737,0.0015376585,0.0017844497,0.003365552,0.0011435067,0.0024565936,0.0029305418,0.00094685884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053465285,0.020504814,0.49641812,0.00070793234,0.0027976742,0.0019828302,0.009471717,0.0012587154,0.16836105,0.00009224013,0.29576603,0.0021042356],"study_design_scores_gemma":[0.08691954,0.009397558,0.52739245,0.0019381677,0.0022774132,0.0004199471,0.017991139,0.008987097,0.1457178,0.0009555812,0.19733459,0.00066875544],"about_ca_topic_score_codex":0.0009990626,"about_ca_topic_score_gemma":0.000059391023,"teacher_disagreement_score":0.09843144,"about_ca_system_score_codex":0.0010659781,"about_ca_system_score_gemma":0.00063528505,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W2411200550","doi":"10.1002/hon.2305","title":"<i>FCGR3A</i>/<i>2A</i> polymorphisms and diffuse large B‐cell lymphoma outcome treated with immunochemotherapy: a meta‐analysis on 1134 patients from two prospective cohorts","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Fondation de France; National Cancer Institute; Fondation Philippe Wiener - Maurice Anspach","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Oncology; Single-nucleotide polymorphism; Lymphoma; Diffuse large B-cell lymphoma; Immunology; Genotype; Confidence interval; Biology; Gene; Genetics","score_opus":0.04268589500698621,"score_gpt":0.3397128301533769,"score_spread":0.29702693514639067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411200550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024573598,0.9683638,0.000014511783,0.00028368307,0.00008298149,0.0035038746,0.00085973844,0.00018925336,0.0021285198],"genre_scores_gemma":[0.06189877,0.93279874,0.0004976818,0.0013851876,0.00008157529,0.0019699743,0.00071288756,0.00012592434,0.0005292716],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99477154,0.0006152137,0.0013862413,0.0017989498,0.0005410801,0.00088696904],"domain_scores_gemma":[0.99535096,0.0017544453,0.0011400987,0.0010809985,0.00017050233,0.00050300127],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002081544,0.0014123168,0.012028414,0.00042639315,0.00017978626,0.000044485394,0.00026213742,0.0010111982,0.0006702726],"category_scores_gemma":[0.00006503501,0.0006445731,0.0025004933,0.0006948351,0.000338952,0.000059452042,0.00017398591,0.00030478038,0.00025106675],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002424206,0.058056936,0.38316813,0.0018930733,0.36112383,0.0065997113,0.00014793599,5.955762e-8,0.0000012568767,0.001366345,0.00048884406,0.18472965],"study_design_scores_gemma":[0.060894426,0.0072502987,0.018989868,0.0015469247,0.5741005,0.0005158825,0.000016898332,0.000002026271,0.00008660187,0.0001566922,0.3349839,0.001456031],"about_ca_topic_score_codex":0.00021784869,"about_ca_topic_score_gemma":0.00006589392,"teacher_disagreement_score":0.36417827,"about_ca_system_score_codex":0.001024136,"about_ca_system_score_gemma":0.00033659633,"threshold_uncertainty_score":0.9998627},"labels":[],"label_agreement":null},{"id":"W2411938662","doi":"10.1080/10428194.2016.1185785","title":"Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning","year":2016,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Carmustine; Melphalan; Medicine; Etoposide; Bendamustine; Oncology; Busulfan; Tolerability; Lymphoma; Internal medicine; Regimen; Brentuximab vedotin; Transplantation; Cyclophosphamide; Chemotherapy; Surgery; Hodgkin lymphoma; Rituximab","score_opus":0.015033059829724846,"score_gpt":0.27165723905321304,"score_spread":0.2566241792234882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411938662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2381151,0.73714453,0.004623555,0.00028165383,0.0009005914,0.014877343,0.0022019825,0.000347063,0.0015081847],"genre_scores_gemma":[0.07079872,0.91194177,0.007290484,0.0006846047,0.0004403209,0.0056041754,0.00057840627,0.00047609434,0.0021854513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922382,0.00018623316,0.0021774338,0.002639296,0.0012023974,0.0015564336],"domain_scores_gemma":[0.99347246,0.0018229886,0.0015484912,0.0016896548,0.0004046858,0.0010617175],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000654684,0.0021746098,0.003968132,0.0009019584,0.00079843664,0.00023211307,0.00081412424,0.00093583146,0.000022464115],"category_scores_gemma":[0.000029366738,0.0014003587,0.00085210777,0.00091601233,0.0005278505,0.0003630107,0.0003609057,0.00012690808,0.00006672898],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032515223,0.000858288,0.00010099399,0.019439142,0.0028277389,0.0006823329,0.0023076592,0.0000160604,0.000077762896,0.00044615494,0.0008762134,0.96911615],"study_design_scores_gemma":[0.1107507,0.0076982947,0.04225275,0.105091825,0.017840507,0.006832823,0.0025123989,0.0002058015,0.0036342659,0.00004268521,0.69918096,0.003957008],"about_ca_topic_score_codex":0.0007341239,"about_ca_topic_score_gemma":0.00007378087,"teacher_disagreement_score":0.9651591,"about_ca_system_score_codex":0.008892342,"about_ca_system_score_gemma":0.0035137963,"threshold_uncertainty_score":0.99909943},"labels":[],"label_agreement":null},{"id":"W2413516833","doi":"10.1136/annrheumdis-2015-eular.2369","title":"AB1029 Serum 14-3-3ETA is Present in JIA and is not Associated with RF+ Polyarthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Polyarthritis; Oligoarthritis; Arthritis; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Rheumatoid factor; Enthesitis; Rheumatology","score_opus":0.063621284613068,"score_gpt":0.3066270151905692,"score_spread":0.2430057305775012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413516833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97314095,0.0055653034,2.8450324e-7,0.019997297,0.000044122087,0.00042295342,0.0002600714,0.000018276329,0.00055073726],"genre_scores_gemma":[0.99644583,0.0009215548,0.00001409232,0.0019590298,0.000015588295,0.000042485834,0.000012872799,0.000015365136,0.0005731663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878186,0.0000603741,0.00028003956,0.00019357895,0.00045418923,0.00022998296],"domain_scores_gemma":[0.9989459,0.00014498772,0.00015674815,0.00037529352,0.00013412477,0.00024294094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012986279,0.00016152259,0.00041172263,0.000057784644,0.00003932236,0.000026059515,0.00009994071,0.00004252527,0.00008306663],"category_scores_gemma":[0.00029185246,0.000094197974,0.00010549819,0.00016745557,0.00011558923,0.000088342684,0.00007958771,0.00004050762,0.000011552633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031822713,0.002232428,0.8872634,0.0001985909,0.0007524862,0.0000487385,0.0018633367,0.000007458767,0.0000031254856,0.000085982305,0.072718844,0.03450738],"study_design_scores_gemma":[0.0040590055,0.0004094185,0.9895413,0.0021890695,0.00022908511,0.000011542569,0.00025794006,0.00015882173,0.0018000253,0.0007652566,0.00045928112,0.000119232966],"about_ca_topic_score_codex":0.0005557602,"about_ca_topic_score_gemma":0.00007021741,"teacher_disagreement_score":0.10227792,"about_ca_system_score_codex":0.0000352595,"about_ca_system_score_gemma":0.00016197808,"threshold_uncertainty_score":0.38412818},"labels":[],"label_agreement":null},{"id":"W2413787178","doi":"10.1074/jbc.m116.736868","title":"Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; Blood Cancer UK; Leukaemia and Lymphoma Research; Cancer Research UK","keywords":"BCL6; Cancer research; Lymphoma; Phosphorylation; Cell culture; Cell growth; Chemistry; STAT3; Biology; B cell; Immunology; Antibody; Cell biology; Genetics; Biochemistry","score_opus":0.024406081711031962,"score_gpt":0.2425958037195396,"score_spread":0.21818972200850764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413787178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491954,0.0020116928,0.000014214306,0.0019212812,0.000104473,0.00016362281,0.00007810523,0.000027244405,0.0007598407],"genre_scores_gemma":[0.99801505,0.0008687564,0.00039335972,0.00012291354,0.00034691725,0.00002028398,0.000011556541,0.000019371368,0.00020177681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793255,0.00008575131,0.00069957995,0.0003773276,0.00044093255,0.00046383997],"domain_scores_gemma":[0.9982882,0.0005336066,0.00041763997,0.0002681787,0.00011244275,0.00037993907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032028393,0.00033753068,0.00073409645,0.00006713044,0.000049109687,0.00003543922,0.00023399713,0.00036093197,0.0003734761],"category_scores_gemma":[0.00026771397,0.00016791235,0.00032721588,0.000109316745,0.00022687153,0.000100544035,0.00009394695,0.00018998,0.000025267316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492835,0.0046772184,0.2425915,0.00010523576,0.0001604453,0.0045288326,0.000044490156,0.0000011370548,0.73498863,0.000014905129,0.00048856373,0.011549755],"study_design_scores_gemma":[0.009374919,0.0007359952,0.06500584,0.0006662883,0.00007737307,0.0019451134,0.00019153795,0.0000012722699,0.9207588,0.0002419092,0.0007767522,0.00022421787],"about_ca_topic_score_codex":0.000032812874,"about_ca_topic_score_gemma":0.0000026295972,"teacher_disagreement_score":0.18577015,"about_ca_system_score_codex":0.00036986836,"about_ca_system_score_gemma":0.0002399284,"threshold_uncertainty_score":0.6847267},"labels":[],"label_agreement":null},{"id":"W2415747453","doi":"10.1200/jco.2015.65.4194","title":"Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Internal medicine; Dacarbazine; Relative survival; Proportional hazards model; Vinblastine; Stage (stratigraphy); Cancer; Cancer registry; Surgery; Pediatrics; Chemotherapy","score_opus":0.06695666980818155,"score_gpt":0.3981091551290772,"score_spread":0.33115248532089564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415747453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938137,0.00024337452,0.000004405268,0.0050344765,0.00032990568,0.0003519252,0.000014806529,0.0000015646275,0.00020583073],"genre_scores_gemma":[0.9991614,0.0002391108,0.00024014291,0.00007565821,0.00015511215,0.0000069005423,0.0000020499742,0.000009316371,0.00011030629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939287,0.0030782027,0.0017564973,0.00016775574,0.0009188936,0.00014998224],"domain_scores_gemma":[0.9944153,0.0029640885,0.0018602161,0.00025711904,0.00040414516,0.00009913684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00972505,0.000086317246,0.0011009071,0.0000438776,0.00003578285,0.000008475985,0.00015344056,0.00022565143,0.00007642371],"category_scores_gemma":[0.004791109,0.00004897033,0.0002106716,0.00014641022,0.00028956495,0.00006810968,0.0001240713,0.00019611967,0.0000014254359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012019486,0.0017598835,0.85717106,0.0000051204565,0.00017448385,0.000030573123,0.000040597693,0.000030038285,0.000041571904,0.0000145052445,0.0010780859,0.1384521],"study_design_scores_gemma":[0.031106662,0.0033131053,0.96257013,0.00027239157,0.0006715878,0.000102761645,0.00004333276,0.00085224374,0.000026859507,0.00077864237,0.00021016151,0.0000520942],"about_ca_topic_score_codex":0.003944905,"about_ca_topic_score_gemma":0.15017915,"teacher_disagreement_score":0.14623424,"about_ca_system_score_codex":0.00058135233,"about_ca_system_score_gemma":0.0007490451,"threshold_uncertainty_score":0.8653279},"labels":[],"label_agreement":null},{"id":"W2416748499","doi":"10.1182/blood-2015-11-683003","title":"Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Breakpoint; Cancer research; Biology; Computational biology; Ligand (biochemistry); Genetics; Molecular biology; Chemistry; Gene; Receptor; Chromosomal translocation","score_opus":0.015206915539770723,"score_gpt":0.2533705947125114,"score_spread":0.23816367917274067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416748499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985293,0.00010021055,0.0000051904885,0.0001628856,0.00006304736,0.00062459207,0.00002438578,0.000019650151,0.00047069712],"genre_scores_gemma":[0.99916476,0.00012018407,0.00030658298,0.00006426208,0.000047849986,0.00006584907,0.00006348507,0.000014976666,0.00015207627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991609,0.000020310961,0.00024657056,0.00020369956,0.0001756281,0.00019291477],"domain_scores_gemma":[0.9995137,0.000028729515,0.00010791625,0.00019737039,0.00007811048,0.00007416195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032090375,0.00013162162,0.00027250632,0.00008513519,0.000019105939,0.0000074954896,0.00004710231,0.000060480426,0.000030167528],"category_scores_gemma":[0.000009722236,0.00008161516,0.00005864524,0.00011128168,0.00002912407,0.0000603483,0.000027333099,0.000019407797,0.000015662892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095669275,0.0009836074,0.6207327,0.000067443325,0.000071326634,0.000057340927,0.00014796708,2.5021256e-8,0.36562282,0.000017001914,0.000006740511,0.0121973585],"study_design_scores_gemma":[0.014006202,0.0003122296,0.6355004,0.00016406747,0.000090614914,0.000014631103,0.000012703567,0.0000033618514,0.3495807,0.000012730734,0.00024224189,0.000060133363],"about_ca_topic_score_codex":0.00007460595,"about_ca_topic_score_gemma":0.0000059411327,"teacher_disagreement_score":0.016042111,"about_ca_system_score_codex":0.000059110484,"about_ca_system_score_gemma":0.00005451614,"threshold_uncertainty_score":0.33281696},"labels":[],"label_agreement":null},{"id":"W2417603443","doi":"","title":"Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chromosomal translocation; Follicular lymphoma; Lymphoma; Polymerase chain reaction; Non-Hodgkin's lymphoma; Pathology; Oncology; Follicular phase; Transplantation; Internal medicine; Biology; Gene; Genetics","score_opus":0.009603222057304487,"score_gpt":0.23569958709933425,"score_spread":0.22609636504202976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417603443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9235137,0.047570705,0.000008309552,0.0031247851,0.00009183724,0.0028257696,0.000009294582,0.000061687344,0.022793887],"genre_scores_gemma":[0.945835,0.041492216,0.00018745066,0.0061454857,0.000069319416,0.0057320707,0.000039516573,0.000030396788,0.000468535],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998524,0.000041141677,0.00032514194,0.00033649054,0.00029688538,0.00047633378],"domain_scores_gemma":[0.9991646,0.00006288633,0.00004437502,0.0004446646,0.000036099245,0.00024738396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020632285,0.00020431074,0.0004564741,0.000080895334,0.000026968519,0.000015559679,0.00009117855,0.00008224334,0.0001780106],"category_scores_gemma":[0.00016973467,0.00016644875,0.00017949041,0.0003546508,0.00003346931,0.000050982606,0.000023512768,0.000051459872,0.00018497802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006358231,0.0015907111,0.07769316,0.0003112279,0.0001332719,0.0036560004,0.00003418861,0.000008204921,0.000005525959,0.00013720481,0.010836058,0.90553087],"study_design_scores_gemma":[0.0050556413,0.000068188514,0.8970292,0.00054882874,0.00029187213,0.00011688704,0.0000036801873,0.000026808524,0.0015474253,0.00006690903,0.09505133,0.0001932162],"about_ca_topic_score_codex":0.00012433044,"about_ca_topic_score_gemma":0.000009450513,"teacher_disagreement_score":0.90533763,"about_ca_system_score_codex":0.00027014542,"about_ca_system_score_gemma":0.000055682594,"threshold_uncertainty_score":0.67875826},"labels":[],"label_agreement":null},{"id":"W2419412633","doi":"10.1080/10428194.2016.1187274","title":"Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12<sup>*</sup>","year":2016,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Queen's University; Juravinski Hospital; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Rituximab; CHOP; Internal medicine; Cohort; Oncology; Autologous stem-cell transplantation; Transplantation; Chemotherapy; Surgery; Salvage therapy; Lymphoma; Gastroenterology","score_opus":0.022262845710548543,"score_gpt":0.3168151131251936,"score_spread":0.2945522674146451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419412633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837066,0.001661586,0.000086933585,0.00061482075,0.00045837628,0.007695651,0.00076405896,0.00011378014,0.0002341562],"genre_scores_gemma":[0.9960227,0.00067850394,0.00016883563,0.0011943778,0.00035360333,0.0012218509,0.00008283639,0.0001303133,0.00014698811],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9887544,0.003650709,0.0035289933,0.0016734456,0.0013689862,0.0010234559],"domain_scores_gemma":[0.98642445,0.009151244,0.0016793921,0.0019260684,0.00018098467,0.0006378662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004556044,0.0011356743,0.0043476266,0.00032678366,0.00030823002,0.000076259916,0.000935794,0.000699225,0.00008591967],"category_scores_gemma":[0.0006893989,0.00057447853,0.0010657645,0.00083778705,0.00051497074,0.00017872067,0.00029253247,0.00016235845,0.00006517231],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012239161,0.0038564727,0.4677309,0.0001729762,0.0009955824,0.00031333065,0.005435679,0.00003128107,0.0017923624,0.00003056404,0.00225722,0.5051445],"study_design_scores_gemma":[0.107684396,0.0063289213,0.8435687,0.0022520607,0.0019189114,0.0001679752,0.00102146,0.0005380407,0.034131438,0.000027133337,0.0017385802,0.0006223698],"about_ca_topic_score_codex":0.0043222304,"about_ca_topic_score_gemma":0.00045606526,"teacher_disagreement_score":0.5045221,"about_ca_system_score_codex":0.0050846096,"about_ca_system_score_gemma":0.0019604785,"threshold_uncertainty_score":0.9996707},"labels":[],"label_agreement":null},{"id":"W2419510300","doi":"","title":"[Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Regimen; Epoch (astronomy); Internal medicine; Etoposide; Vincristine; Mucositis; Surgery; Chemotherapy; Gastroenterology; Epirubicin; Febrile neutropenia; Neutropenia; Cyclophosphamide","score_opus":0.01434385803169327,"score_gpt":0.23861046115451884,"score_spread":0.22426660312282556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419510300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897082,0.00032311576,0.000027514532,0.00035591706,0.00016901297,0.0049753073,0.00012439035,0.00011554724,0.004201033],"genre_scores_gemma":[0.97785455,0.000039930972,0.0017135169,0.0004875971,0.000026393342,0.010305815,0.00029677103,0.0000821425,0.009193293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775803,0.000047996135,0.00047408487,0.0006062478,0.00038861457,0.0007250519],"domain_scores_gemma":[0.9984263,0.0002049925,0.00021607774,0.0005795982,0.00019308954,0.00037991794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017347909,0.00037886668,0.000612534,0.000111054214,0.0001530584,0.000030223679,0.00009760301,0.00014016543,0.000028439514],"category_scores_gemma":[0.00032445768,0.00023772685,0.0001480297,0.00030789996,0.00006332309,0.00012608524,0.000019481477,0.000049299186,0.000012711405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027681844,0.0062081427,0.8651739,0.00020252031,0.0006703212,0.0002607716,0.00012325749,0.0000017640047,0.0000346477,0.00018704624,0.018921034,0.080534786],"study_design_scores_gemma":[0.042743582,0.003457387,0.91958445,0.00007159951,0.000518861,0.000021543334,0.000057731464,0.0000051319043,0.0036335108,0.000027700453,0.029537173,0.00034130632],"about_ca_topic_score_codex":0.000035644116,"about_ca_topic_score_gemma":0.000009426751,"teacher_disagreement_score":0.08019348,"about_ca_system_score_codex":0.0005904712,"about_ca_system_score_gemma":0.00010397324,"threshold_uncertainty_score":0.969422},"labels":[],"label_agreement":null},{"id":"W2423969118","doi":"10.3324/haematol.2016.144550","title":"Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Rituximab; Medicine; CHOP; Pathological; Internal medicine; Oncology; Chemotherapy; Vincristine; Pathology; Cyclophosphamide","score_opus":0.008859314499504379,"score_gpt":0.2305589043802064,"score_spread":0.221699589880702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423969118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93198025,0.0005189253,0.000022713668,0.06460206,0.00028630867,0.001704305,0.00004978436,0.00006722764,0.0007684117],"genre_scores_gemma":[0.8976563,0.0008361458,0.0015361741,0.09787902,0.00033714887,0.0004780135,0.0002860821,0.00011200793,0.0008791127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731,0.000093600356,0.0005260056,0.0009094959,0.00049634144,0.0006645502],"domain_scores_gemma":[0.99850106,0.0001588083,0.0006118495,0.00053111673,0.000079537516,0.000117601994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008394665,0.0006612845,0.0014782882,0.00024690034,0.000116695715,0.000056352408,0.00015779193,0.0005054391,0.00007215052],"category_scores_gemma":[0.00002945612,0.00032898076,0.00018126068,0.00020310808,0.00016556153,0.00012536971,0.00008994571,0.00044757625,0.000042980228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005310895,0.0037890952,0.73591757,0.0009384458,0.00072982203,0.04318193,0.00035908024,2.022582e-7,0.000063995125,0.000011594153,0.1834254,0.026271982],"study_design_scores_gemma":[0.13537085,0.004723166,0.73442924,0.015817882,0.00076009927,0.0023488032,0.00008211247,0.000009592719,0.0022403498,0.00011188721,0.10241214,0.0016938499],"about_ca_topic_score_codex":0.00007484516,"about_ca_topic_score_gemma":0.000012543625,"teacher_disagreement_score":0.13005996,"about_ca_system_score_codex":0.00040336268,"about_ca_system_score_gemma":0.00013051639,"threshold_uncertainty_score":0.9999162},"labels":[],"label_agreement":null},{"id":"W2432804309","doi":"10.1097/coc.0000000000000294","title":"ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Guideline; Stage (stratigraphy); Appropriate Use Criteria; Intensive care medicine; Delphi method; Medical physics; Internal medicine; Pathology","score_opus":0.19357822069068492,"score_gpt":0.5475453707828247,"score_spread":0.3539671500921398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432804309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011667382,0.98011667,0.000050577917,0.0020547737,0.0030761573,0.0007537296,0.00007489424,0.000028732775,0.0021771125],"genre_scores_gemma":[0.0015931635,0.98829466,0.0040322933,0.0015146402,0.0034772847,0.000042534513,0.00001613751,0.00009757685,0.00093173725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876818,0.0030718849,0.0072211195,0.0008333732,0.00054537825,0.0006464596],"domain_scores_gemma":[0.9804922,0.008804359,0.008106221,0.00073823857,0.000497062,0.001361953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066951783,0.0007079315,0.013357861,0.00030356288,0.00012647189,0.00003507473,0.00048600652,0.0009807129,0.00033358354],"category_scores_gemma":[0.0031431739,0.0003865355,0.0028773497,0.0003364379,0.002019446,0.00013003734,0.00039006246,0.0009326318,0.00010504978],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009874529,0.0038532321,0.0024912897,0.00086517655,0.002513924,0.0029211817,0.000025442912,1.7451814e-8,1.0792202e-7,0.00008633722,0.0030087982,0.98324704],"study_design_scores_gemma":[0.008815678,0.031031692,0.0032833808,0.0075982967,0.0044747735,0.0033177286,0.000064891385,0.0000010365277,3.6904592e-7,0.000043711527,0.9410086,0.0003598283],"about_ca_topic_score_codex":0.0000431426,"about_ca_topic_score_gemma":0.000004999445,"teacher_disagreement_score":0.9828872,"about_ca_system_score_codex":0.000497321,"about_ca_system_score_gemma":0.00657473,"threshold_uncertainty_score":0.9998587},"labels":[],"label_agreement":null},{"id":"W2460247604","doi":"10.1080/10428194.2016.1193852","title":"Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma","year":2016,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Salvage therapy; Medicine; Internal medicine; Regimen; Oncology; Diffuse large B-cell lymphoma; Refractory (planetary science); Lymphoma; Dexamethasone; Chemotherapy; Surgery; Biology","score_opus":0.009841282103977077,"score_gpt":0.2455668701614619,"score_spread":0.2357255880574848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460247604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774195,0.015787961,0.00024392316,0.00052157353,0.00038465933,0.003630317,0.0005628991,0.00042753608,0.00102161],"genre_scores_gemma":[0.97550154,0.01589039,0.0016486425,0.0031040672,0.00047742433,0.0011847869,0.00021196858,0.00038263373,0.0015985757],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99216735,0.00049110444,0.0013974758,0.0030458493,0.00087540835,0.0020228329],"domain_scores_gemma":[0.99332327,0.0022936559,0.0007061185,0.0014778532,0.00039169966,0.0018073788],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009663803,0.001978314,0.0023741997,0.00067822076,0.0010980945,0.00046688793,0.0003703057,0.0013122553,0.000082515435],"category_scores_gemma":[0.00024855006,0.0014578947,0.00040871763,0.0006097662,0.0010031381,0.0011274588,0.0004077568,0.00013029162,0.000046305715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076406025,0.0054846895,0.0846614,0.0006389431,0.0010637501,0.00067142013,0.003390013,4.2331305e-7,0.020280614,0.0009912467,0.0035849381,0.8715919],"study_design_scores_gemma":[0.2625751,0.0046503106,0.6514587,0.0008072863,0.0009919327,0.0018702244,0.000779433,0.0021268507,0.033550467,0.0006273926,0.038507495,0.002054852],"about_ca_topic_score_codex":0.0013263511,"about_ca_topic_score_gemma":0.0001601379,"teacher_disagreement_score":0.8695371,"about_ca_system_score_codex":0.004327113,"about_ca_system_score_gemma":0.0015688378,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W2460609230","doi":"10.1182/blood.v114.22.2314.2314","title":"High Dose Chemotherapy and Autologous Stem Cell Transplantation in the Primary Therapy of Advanced Follicular Lymphoma in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; Sunnybrook Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Autologous stem-cell transplantation; Follicular lymphoma; Transplantation; Clinical trial; Randomized controlled trial; Rituximab; Chemotherapy regimen; Interim analysis; Chemotherapy; Hematopoietic stem cell transplantation; Surgery; Lymphoma","score_opus":0.06126703303032959,"score_gpt":0.36742572454958045,"score_spread":0.30615869151925085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460609230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006637833,0.97956413,0.0000024100461,0.00011693282,0.000009307582,0.013557964,0.00008843138,0.000007327688,0.000015658663],"genre_scores_gemma":[0.0026846349,0.9945246,0.00024980263,0.00041335466,0.000007777714,0.0019316345,0.00016149726,0.000019963622,0.000006715707],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98743236,0.007032745,0.0045774686,0.00046377096,0.00034394732,0.00014968496],"domain_scores_gemma":[0.9906944,0.006059487,0.0025534874,0.00057470903,0.00006449225,0.000053450745],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009783802,0.0004684971,0.027969401,0.00036689968,0.000012870642,0.000009796249,0.0001410132,0.00026567944,0.000009546315],"category_scores_gemma":[0.00020957552,0.00020591464,0.0041228402,0.0007256182,0.00008408417,0.0000330377,0.0000070350507,0.00010138739,2.9602964e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004415301,0.003801301,0.00002229196,0.68587565,0.13931923,0.00012446115,0.00034060114,2.8676155e-7,2.7336216e-7,0.00002174996,0.0000021732262,0.16607665],"study_design_scores_gemma":[0.17215236,0.00031824832,0.0004092943,0.05405579,0.7727406,0.00005907708,0.000015595491,0.000001418962,0.0000058504174,0.0000057910092,0.00009565821,0.0001402935],"about_ca_topic_score_codex":0.00005854561,"about_ca_topic_score_gemma":0.000011249769,"teacher_disagreement_score":0.6334214,"about_ca_system_score_codex":0.00003722667,"about_ca_system_score_gemma":0.0001524141,"threshold_uncertainty_score":0.9864614},"labels":[],"label_agreement":null},{"id":"W2461665465","doi":"10.1182/blood-2016-02-698977","title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"Direction Générale de l’offre de Soins; Fondation Medic; Institut National Du Cancer","keywords":"T-cell receptor; Gene; Biology; Cancer research; Immunology; Pathogenesis; Mutation; Signal transduction; T cell; Genetics; Immune system","score_opus":0.011199767392676023,"score_gpt":0.24024019387184237,"score_spread":0.22904042647916634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461665465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975489,0.0012641626,0.00001777514,0.00038340985,0.00002177539,0.0003450251,0.0000044406543,0.000026113057,0.00038839597],"genre_scores_gemma":[0.9986234,0.000037168073,0.00095042866,0.00014024996,0.000015091566,0.00010496623,0.000003072254,0.000022453822,0.000103191735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992,0.00003598185,0.00022806089,0.0002306505,0.00010468026,0.0002006479],"domain_scores_gemma":[0.9995605,0.00016937008,0.000041494535,0.00013482077,0.000021588188,0.00007225487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008251219,0.00012385691,0.00020351207,0.00015879593,0.0000361612,0.000012415819,0.000030500176,0.000064409716,0.00005666535],"category_scores_gemma":[0.00007309746,0.00008456516,0.00004123693,0.00021553332,0.000020512494,0.000048485595,0.000025352138,0.000026891548,0.000028542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033642893,0.0008641209,0.42821115,0.000017647337,0.00008024482,0.00015915399,0.0010200448,0.000025553658,0.5619507,0.00004914888,0.0000029563178,0.007585677],"study_design_scores_gemma":[0.018855277,0.00026804034,0.40943086,0.000872976,0.00013294394,0.00006441893,0.00041176914,0.000031797965,0.5693426,0.00012092095,0.00026611684,0.00020228229],"about_ca_topic_score_codex":0.00018730147,"about_ca_topic_score_gemma":0.000034964858,"teacher_disagreement_score":0.018821634,"about_ca_system_score_codex":0.00008899091,"about_ca_system_score_gemma":0.000051606654,"threshold_uncertainty_score":0.3448467},"labels":[],"label_agreement":null},{"id":"W2461798448","doi":"10.1038/leu.2016.175","title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Center for Research Resources; National Institute of General Medical Sciences; Lymphoma Research Foundation","keywords":"Biology; Follicular lymphoma; Gene; Transcription factor; Cancer research; Genetics; Epigenetics; PTEN; Lymphoma; Signal transduction; PI3K/AKT/mTOR pathway; Immunology","score_opus":0.009936883995875695,"score_gpt":0.23402337441748855,"score_spread":0.22408649042161286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461798448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983645,0.00005889086,0.00045739656,0.00016981343,0.000018189652,0.00023624378,0.00003217606,0.000035411693,0.0006273808],"genre_scores_gemma":[0.999448,0.000079608064,0.00007852942,0.00005137602,0.000008085217,0.00003818671,0.00014048147,0.000009596779,0.00014612869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.00003481537,0.0002424483,0.00015388991,0.00024322026,0.00012175365],"domain_scores_gemma":[0.99943644,0.000102558355,0.00013475752,0.00014438936,0.00011645474,0.00006542693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001047167,0.00011377498,0.00032302737,0.00009099526,0.000043971657,0.000012647758,0.000025757112,0.00007377355,0.000061993785],"category_scores_gemma":[0.000032402033,0.0000663178,0.00011644792,0.00032680566,0.000053987416,0.00012763125,0.000005892822,0.000013818787,0.000013569912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058177824,0.00050266384,0.9511878,0.00008008679,0.005605807,0.00013133195,0.0019131518,0.00002118389,0.011428777,0.0011419449,0.00018444545,0.027221022],"study_design_scores_gemma":[0.011438427,0.00032042645,0.87204754,0.00016896662,0.0028719294,0.000019116223,0.00012820226,0.00028131893,0.112385884,0.00019752422,0.000034158773,0.00010653115],"about_ca_topic_score_codex":0.00018145738,"about_ca_topic_score_gemma":0.00008121444,"teacher_disagreement_score":0.1009571,"about_ca_system_score_codex":0.00051961216,"about_ca_system_score_gemma":0.0001251111,"threshold_uncertainty_score":0.27043614},"labels":[],"label_agreement":null},{"id":"W2462762289","doi":"10.3324/haematol.2016.148809","title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Oncology; Classical Hodgkin lymphoma; Hodgkin's lymphoma; Internal medicine","score_opus":0.07290797828020769,"score_gpt":0.33914493590097056,"score_spread":0.2662369576207629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462762289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9359936,0.0071799955,0.00012883813,0.04674677,0.00029914366,0.002045946,0.000071098,0.0000524705,0.0074821063],"genre_scores_gemma":[0.98237276,0.01053219,0.0012617774,0.004845577,0.0001069998,0.0006635276,0.00006720057,0.0000162437,0.00013373361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979533,0.00017292416,0.0006957331,0.00041944746,0.00049000775,0.00026858202],"domain_scores_gemma":[0.9973337,0.0014566398,0.0003760488,0.0006427449,0.00015091425,0.000039928054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005808541,0.00025443142,0.0005876577,0.00012852793,0.000096625474,0.000029785422,0.0004937312,0.00009045625,0.00018111177],"category_scores_gemma":[0.0005884716,0.000102183614,0.00018181883,0.0004928054,0.0001508078,0.00009284351,0.00011170295,0.000044753375,0.00010273703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000578972,0.0022389055,0.5245442,0.0010882718,0.0005403545,0.0018137896,0.0013188001,1.5635865e-7,0.00089423556,0.013200118,0.093068086,0.36071414],"study_design_scores_gemma":[0.0035546962,0.00018144613,0.91748315,0.012252359,0.0001761509,0.00075088115,0.00041192712,0.000034160214,0.0037016436,0.00034249196,0.060895395,0.00021570147],"about_ca_topic_score_codex":0.0006142946,"about_ca_topic_score_gemma":0.00030424917,"teacher_disagreement_score":0.39293897,"about_ca_system_score_codex":0.00033973262,"about_ca_system_score_gemma":0.00038088352,"threshold_uncertainty_score":0.41669267},"labels":[],"label_agreement":null},{"id":"W2463649602","doi":"10.1182/blood.v126.23.2667.2667","title":"Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Immunophenotyping; Pathology; Peripheral T-cell lymphoma; Lymphoma; CD5; Flow cytometry; T cell; Medicine; Biology; Immunology; Immune system","score_opus":0.021326999590626634,"score_gpt":0.22918984977159285,"score_spread":0.2078628501809662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463649602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591655,0.00159988,0.000033964916,0.000041416715,0.00014201623,0.00042589972,0.00015167183,0.00003704207,0.001651572],"genre_scores_gemma":[0.99804556,0.00035323162,0.00084928033,0.00007292808,0.0001229323,0.000030256617,0.00010870872,0.00004501422,0.00037211363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847096,0.000051526957,0.00047861543,0.0003270667,0.00040503184,0.00026679962],"domain_scores_gemma":[0.9987651,0.00012494171,0.0002854703,0.0003973008,0.00021198679,0.0002152131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011769636,0.00026926355,0.0005934883,0.00031684875,0.0000401452,0.000022508968,0.00009660181,0.0001265409,0.00007726024],"category_scores_gemma":[0.00007643615,0.0002260513,0.0001416781,0.00055484555,0.00009669613,0.00010416262,0.00006108643,0.00002549633,0.000024524792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032951757,0.04608495,0.27207553,0.0014175439,0.0008239414,0.0012918126,0.004007997,0.000025193915,0.6291023,0.00007353408,0.00026459072,0.041537438],"study_design_scores_gemma":[0.02924848,0.0015741218,0.46868646,0.00010842667,0.0006150591,0.00021757661,0.00015925353,0.0002817564,0.49840325,0.000003155344,0.0005022452,0.00020023197],"about_ca_topic_score_codex":0.00019294032,"about_ca_topic_score_gemma":0.00000565088,"teacher_disagreement_score":0.19661093,"about_ca_system_score_codex":0.00013104292,"about_ca_system_score_gemma":0.00023896473,"threshold_uncertainty_score":0.92181045},"labels":[],"label_agreement":null},{"id":"W2463938745","doi":"10.1016/j.ijrobp.2015.07.191","title":"A Population-Based Analysis of Secondary Breast Cancer Risk According to Radiation Volume in Women With Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Chemotherapy; Radiation therapy; Population; Oncology; Cancer","score_opus":0.013742094563961386,"score_gpt":0.31432518750792127,"score_spread":0.3005830929439599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463938745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994775,0.00023851784,0.0015423477,0.002215687,0.0005022531,0.0002250564,0.00039231457,0.000015062187,0.00009376001],"genre_scores_gemma":[0.9968389,0.00014615184,0.0013221034,0.0008768725,0.00052792305,0.000049156384,0.0002085548,0.000019530715,0.000010750231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818766,0.00020521358,0.0007797421,0.00023501395,0.0003724437,0.00021994558],"domain_scores_gemma":[0.99723345,0.00025787365,0.0012388612,0.00015178055,0.00088592054,0.00023213128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005915427,0.00018849487,0.00074861274,0.00079020736,0.00003379694,0.000020150264,0.0001903574,0.00014722084,0.00008991577],"category_scores_gemma":[0.00019125467,0.00015376165,0.00016195506,0.0008756053,0.00005104392,0.00023142647,0.000027041382,0.00015085057,0.0000066673824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017029154,0.0005876035,0.7418104,0.0000039164015,0.0018576541,0.000023981873,0.00057320145,0.025255151,0.000069534195,0.000092249924,0.00019470506,0.22782871],"study_design_scores_gemma":[0.010667338,0.0011652485,0.9759044,0.0000650195,0.0007264338,0.000032357475,0.00025678793,0.009149427,0.00020668707,0.0002968313,0.0013939097,0.00013557526],"about_ca_topic_score_codex":0.0011238081,"about_ca_topic_score_gemma":0.0001529929,"teacher_disagreement_score":0.23409401,"about_ca_system_score_codex":0.004000318,"about_ca_system_score_gemma":0.0015691578,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2464635942","doi":"10.1182/blood-2016-05-717355","title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Medicine; Oncology; Lymphoma; Internal medicine","score_opus":0.011415217609621567,"score_gpt":0.2552736184447872,"score_spread":0.24385840083516563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464635942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120355,0.0072996216,0.00019124805,0.0002929703,0.00006348812,0.0006337918,0.00006203358,0.00005390224,0.00019940465],"genre_scores_gemma":[0.99308205,0.0049095037,0.0013837898,0.00006805955,0.00011916338,0.0002511937,0.000007645315,0.00003723686,0.00014134418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865234,0.00004242228,0.00040841277,0.0003248127,0.00032189506,0.0002501215],"domain_scores_gemma":[0.9989216,0.00009143355,0.00018276303,0.0005710991,0.00010087356,0.00013224503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012905653,0.00020331745,0.00037958557,0.000065296066,0.000040983214,0.000008487491,0.00008880546,0.00013423013,0.00009782546],"category_scores_gemma":[0.000032324522,0.00011188903,0.000255046,0.0000975464,0.00007760027,0.00006438782,0.00004079682,0.000026875663,0.000037484937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008201386,0.0056133233,0.8566529,0.00005453493,0.00060197245,0.00011439158,0.0001681992,0.0000022290856,0.0020484824,0.000017994487,0.000048984966,0.13385686],"study_design_scores_gemma":[0.035355408,0.0031553893,0.8054065,0.0010275088,0.000994356,0.000052589672,0.0000049255837,0.00007563477,0.15251842,0.00054975715,0.0006764077,0.00018308089],"about_ca_topic_score_codex":0.000047929363,"about_ca_topic_score_gemma":0.000005369765,"teacher_disagreement_score":0.15046994,"about_ca_system_score_codex":0.000042106858,"about_ca_system_score_gemma":0.00008023266,"threshold_uncertainty_score":0.45627022},"labels":[],"label_agreement":null},{"id":"W2464971697","doi":"10.1182/blood.v112.11.262.262","title":"Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: Results of An International Study (NHL-003)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Mantle cell lymphoma; Internal medicine; Regimen; Chemotherapy regimen; Phases of clinical research; Lymphoma; Oncology; Surgery; Refractory (planetary science); Progressive disease; Gastroenterology; Clinical trial; Chemotherapy; Multiple myeloma","score_opus":0.01446357016416299,"score_gpt":0.24718857717597179,"score_spread":0.2327250070118088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464971697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998775,0.000037277034,5.941029e-7,0.00003737256,0.00003226206,0.000739233,0.00004866208,0.0000046811347,0.00032491874],"genre_scores_gemma":[0.9996202,0.000070109214,0.00018366723,0.000020255638,0.000009073951,0.000010803404,0.00003439296,0.00000925708,0.000042219286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989875,0.000076750104,0.0004214549,0.00014758653,0.00029763367,0.00006906034],"domain_scores_gemma":[0.9992045,0.00009875383,0.00030300062,0.00025009026,0.000113186055,0.000030451938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012301066,0.000094981864,0.0002641341,0.00007259196,0.000021813572,0.0000019560925,0.00007322982,0.000037298767,0.000009549654],"category_scores_gemma":[0.000049641883,0.000052858763,0.000027089067,0.00011164006,0.00007274583,0.00007297628,0.000018682129,0.00002765255,3.1614567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016117502,0.029760191,0.9492469,0.000023324184,0.00020461065,0.000016219945,0.0023283062,0.000007811209,0.0003309268,0.000006751621,0.000016186383,0.001941264],"study_design_scores_gemma":[0.1517363,0.0027573179,0.8323438,0.00009818708,0.00010161715,0.0000057083166,0.00016402133,0.000010999562,0.012698979,0.0000010279555,0.00003920713,0.00004279168],"about_ca_topic_score_codex":0.00030775854,"about_ca_topic_score_gemma":0.00006181732,"teacher_disagreement_score":0.1356188,"about_ca_system_score_codex":0.000032913314,"about_ca_system_score_gemma":0.000093734525,"threshold_uncertainty_score":0.21555178},"labels":[],"label_agreement":null},{"id":"W2466421941","doi":"10.1111/bjh.14201","title":"The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Helse Sør-Øst RHF; Norges Forskningsråd; Kreftforeningen","keywords":"Follicular lymphoma; CD68; CD163; Tumor microenvironment; Rituximab; Medicine; FOXP3; CD20; Lymphoma; CD8; Internal medicine; Oncology; Survival analysis; Pathology; Immunology; Cancer research; Immunohistochemistry; Cancer; Biology; Macrophage; Antigen; Immune system","score_opus":0.0067823435448768855,"score_gpt":0.228218332319174,"score_spread":0.2214359887742971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466421941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438693,0.0035655624,0.000014317843,0.021582376,0.000041916104,0.00024104286,0.000003743385,0.0000018919519,0.00016224489],"genre_scores_gemma":[0.9975561,0.0018432288,0.00007192114,0.00046022589,0.000025046375,0.000019754956,6.618189e-7,0.000005007298,0.0000180678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891585,0.0001791572,0.00043693735,0.00008997705,0.00019100634,0.0001870833],"domain_scores_gemma":[0.9994884,0.000251418,0.000102552396,0.00007454723,0.000024559225,0.000058519166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586238,0.00008079339,0.00033072816,0.00007021378,0.000062364685,0.00003314842,0.00010509546,0.00004490521,0.000023680257],"category_scores_gemma":[0.00007436484,0.000041423904,0.00006013304,0.000074278,0.000089267065,0.0000989601,0.000014527344,0.00005658509,0.000027286429],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001389306,0.0036987686,0.18217102,0.00011162008,0.0003676892,0.085589096,0.0042021126,0.000021961932,0.006227176,0.0016310323,0.0045351014,0.7100551],"study_design_scores_gemma":[0.011661442,0.00047629536,0.8301774,0.00075465365,0.00006419729,0.1471919,0.00045997283,0.00001053576,0.0015091737,0.00046510334,0.007135433,0.00009387001],"about_ca_topic_score_codex":0.000089761765,"about_ca_topic_score_gemma":0.00018398644,"teacher_disagreement_score":0.70996124,"about_ca_system_score_codex":0.00011369337,"about_ca_system_score_gemma":0.00006539727,"threshold_uncertainty_score":0.16892178},"labels":[],"label_agreement":null},{"id":"W2468043300","doi":"","title":"Successful treatment of primary renal lymphoma using image guided helical tomotherapy.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tomotherapy; Medicine; Nuclear medicine; Renal cell carcinoma; Radiation treatment planning; Radiology; Radiation therapy; Internal medicine","score_opus":0.040033510888012436,"score_gpt":0.2816917714981825,"score_spread":0.24165826061017004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468043300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883554,0.0014262586,0.000034405384,0.0011828464,0.00006945797,0.0010884312,0.0000151993045,0.000061108054,0.0077669066],"genre_scores_gemma":[0.9954707,0.00040498588,0.0024241821,0.0007411901,0.00020584343,0.00032309844,0.000032851865,0.000019220051,0.0003779311],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863154,0.00003544967,0.00036337096,0.0002933001,0.0002886706,0.00038764675],"domain_scores_gemma":[0.9991862,0.000037341808,0.000113044916,0.00036067943,0.00007602857,0.00022671513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008826197,0.00021984476,0.0005293669,0.00010939589,0.000046100264,0.000020740268,0.00006424626,0.00007980442,0.000050968258],"category_scores_gemma":[0.000018602546,0.00015167029,0.00022878934,0.0001732011,0.000060208742,0.000082888495,0.000011013414,0.000016277127,0.000007786001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005179644,0.00498787,0.047813825,0.000028246097,0.00030707795,0.0003427452,0.00012556158,0.0000026351524,0.0043375753,0.00010601715,0.0006748572,0.9407556],"study_design_scores_gemma":[0.009383331,0.00057262473,0.90086865,0.000027801025,0.00025504106,0.00020070534,0.0000095413625,0.00004570952,0.08376289,0.00006788675,0.004673865,0.00013197504],"about_ca_topic_score_codex":0.00018676072,"about_ca_topic_score_gemma":0.0000033820959,"teacher_disagreement_score":0.94062364,"about_ca_system_score_codex":0.00089122273,"about_ca_system_score_gemma":0.00011752333,"threshold_uncertainty_score":0.6184935},"labels":[],"label_agreement":null},{"id":"W2469109222","doi":"10.1016/s1470-2045(16)30097-3","title":"Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche; Gilead Sciences","keywords":"Bendamustine; Obinutuzumab; Medicine; Rituximab; Internal medicine; Neutropenia; Population; Oncology; Surgery; Lymphoma; Chemotherapy","score_opus":0.055703202204740475,"score_gpt":0.36469524390968916,"score_spread":0.3089920417049487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469109222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982556,0.00041917822,0.00004153198,0.003395673,0.0010430663,0.010265208,0.00013002679,0.0000678574,0.0020814673],"genre_scores_gemma":[0.9933901,0.0006791112,0.0007572304,0.0015051152,0.0009893286,0.0022323837,0.00010157282,0.00007036208,0.00027481036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99639237,0.00056994735,0.0009470468,0.00070198625,0.00048292862,0.0009057103],"domain_scores_gemma":[0.9957838,0.0022041071,0.00063053315,0.0008840189,0.00022334448,0.0002741784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009224884,0.0005540237,0.002633352,0.00017565613,0.0001624976,0.000049068847,0.0005604739,0.00026716522,0.00034426412],"category_scores_gemma":[0.00044919696,0.00026345084,0.00015245905,0.00026175336,0.00026861092,0.00018422843,0.00018687491,0.00021255299,0.00011351119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8672314,0.016816115,0.0021113823,0.000022691074,0.00084242894,0.00024494898,0.00045022604,0.000008016613,0.000114391434,0.00006106199,0.002123691,0.10997361],"study_design_scores_gemma":[0.9476983,0.024462795,0.008547101,0.00024876374,0.00065175124,0.000015154758,0.00008005757,0.0002745062,0.0001859273,0.000014072523,0.01749084,0.00033075028],"about_ca_topic_score_codex":0.0004398847,"about_ca_topic_score_gemma":0.0004231529,"teacher_disagreement_score":0.10964286,"about_ca_system_score_codex":0.0033259955,"about_ca_system_score_gemma":0.0014245405,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W2469819289","doi":"","title":"Clinical analysis of primary systemic anaplastic large cell lymphoma: a report of 57 cases.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Anaplastic lymphoma kinase; Internal medicine; Anaplastic large-cell lymphoma; Lymphoma; Stage (stratigraphy); Gastroenterology; Chemotherapy; International Prognostic Index; Cancer; Survival rate; B symptoms; Oncology; Diffuse large B-cell lymphoma; Lung cancer","score_opus":0.027926692437208654,"score_gpt":0.28116907807333796,"score_spread":0.25324238563612933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469819289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919043,0.0015882545,0.000036055313,0.00011547159,0.00011811085,0.0006440845,0.00005457201,0.000027847642,0.0055112573],"genre_scores_gemma":[0.9987362,0.00018757369,0.00011706893,0.00017718303,0.0000610199,0.00016703951,0.00012646527,0.00000900893,0.0004184487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790967,0.00006285693,0.0010481685,0.00032613255,0.00035357033,0.0002996114],"domain_scores_gemma":[0.99830055,0.0002727115,0.00050945487,0.00056372746,0.00013906133,0.00021446476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006431555,0.00014588176,0.0011046912,0.00028791346,0.000020088446,0.0000046962614,0.00007192386,0.00011116026,0.000015987458],"category_scores_gemma":[0.00030671046,0.00011167858,0.00055117515,0.0006859283,0.000045257733,0.000034386983,0.000026360416,0.000037647642,0.0000035062142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040502968,0.008465498,0.930675,0.00023043696,0.0021524075,0.0044106655,0.000046420788,0.000009336157,0.000020742398,0.000061321065,0.0017437702,0.051779352],"study_design_scores_gemma":[0.0058186003,0.00029140356,0.9859425,0.000042630556,0.006181368,0.00050884037,0.000024714607,0.000078304285,0.00044655005,0.000003497409,0.00057691446,0.00008467856],"about_ca_topic_score_codex":0.000087911205,"about_ca_topic_score_gemma":0.000019575577,"teacher_disagreement_score":0.05526748,"about_ca_system_score_codex":0.0002220027,"about_ca_system_score_gemma":0.00015602134,"threshold_uncertainty_score":0.45541203},"labels":[],"label_agreement":null},{"id":"W2470838233","doi":"10.1080/10428194.2016.1196815","title":"FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study","year":2016,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University; BC Cancer Agency; Princess Margaret Cancer Centre; Kingston General Hospital; University of Toronto","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Follicular lymphoma; Internal medicine; Hazard ratio; Oncology; Positron emission tomography; Lymphoma; Obinutuzumab; Nuclear medicine; Standardized uptake value; Rituximab; Progression-free survival; Prospective cohort study; PET-CT; Overall survival; Confidence interval","score_opus":0.013231878525028678,"score_gpt":0.2600789023359821,"score_spread":0.2468470238109534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470838233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173,0.0023737517,0.000065606,0.0005423095,0.00030030974,0.004030188,0.0004984992,0.00011129838,0.00034803737],"genre_scores_gemma":[0.99620426,0.0005293772,0.00027408407,0.0004011481,0.00013417203,0.0019474374,0.000059182898,0.00011241673,0.00033793808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99439824,0.00039373894,0.0013676079,0.0016137365,0.001226296,0.0010003828],"domain_scores_gemma":[0.9952404,0.001376281,0.0006517757,0.0018360605,0.0003782287,0.0005172884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092499837,0.0009207078,0.001962037,0.0007526348,0.00038553192,0.000084861465,0.0005673647,0.0003775781,0.000029546087],"category_scores_gemma":[0.000728007,0.0005400838,0.0006713071,0.0018385833,0.0006466738,0.0002905565,0.00057276397,0.000072561445,0.0000057908487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022630957,0.002755778,0.91828626,0.00022048935,0.0041381484,0.00043646002,0.0030743585,0.000016673963,0.00075965916,0.00040773352,0.00094508193,0.06669625],"study_design_scores_gemma":[0.06538109,0.0017423644,0.9150428,0.0008823453,0.0061881305,0.00016379757,0.0021392682,0.0024944048,0.0039792918,0.00044386205,0.0009137626,0.00062886503],"about_ca_topic_score_codex":0.0005673115,"about_ca_topic_score_gemma":0.00029327025,"teacher_disagreement_score":0.06606738,"about_ca_system_score_codex":0.0046801823,"about_ca_system_score_gemma":0.0024733215,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W2471799713","doi":"10.1182/blood-2015-12-682591","title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute; Broad Institute","keywords":"Follicular lymphoma; Lymphoma; MAPK/ERK pathway; Cancer research; BCL10; Biology; Medicine; Immunology; Genetics; Signal transduction","score_opus":0.012658559891151494,"score_gpt":0.2261881892800804,"score_spread":0.2135296293889289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471799713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551225,0.0008965158,0.000110689485,0.00074667693,0.000114509436,0.00052012224,0.00007935026,0.00017520283,0.0018446727],"genre_scores_gemma":[0.9970057,0.00017066725,0.0016309097,0.00022712421,0.00031564196,0.0001814523,0.00008426766,0.000034336364,0.0003498971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837625,0.000050041624,0.0003110876,0.000503076,0.00033616243,0.00042337403],"domain_scores_gemma":[0.99877787,0.00017669401,0.00012632222,0.0004515711,0.00017774574,0.00028981676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091486676,0.00030129438,0.00038725935,0.000092789836,0.00013613595,0.00002881721,0.00011534141,0.00013267672,0.0001748792],"category_scores_gemma":[0.00013223478,0.00014716784,0.00016072718,0.00029122925,0.000092954375,0.000069133326,0.00005107884,0.000023391209,0.00036294197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023984436,0.007734852,0.96681285,0.000042648255,0.00050288514,0.0026520712,0.00008145884,3.5264668e-7,0.003131829,0.0012664068,0.00030317053,0.017231641],"study_design_scores_gemma":[0.028142955,0.0026062494,0.946234,0.00010908971,0.0011379702,0.0007944744,0.000029845485,0.000002056109,0.015677735,0.00023500019,0.0046802647,0.00035037345],"about_ca_topic_score_codex":0.0000663297,"about_ca_topic_score_gemma":0.00002415041,"teacher_disagreement_score":0.027903112,"about_ca_system_score_codex":0.0001790779,"about_ca_system_score_gemma":0.0003920533,"threshold_uncertainty_score":0.600133},"labels":[],"label_agreement":null},{"id":"W2472813907","doi":"10.1182/blood.v124.21.495.495","title":"The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Tissue microarray; Immunohistochemistry; Lymphoma; Medicine; Oncology; Internal medicine; Gene expression profiling; Pathology; Biology; Cancer research; B cell; Antibody; Gene expression; Immunology; Gene; Germinal center","score_opus":0.00603476281861366,"score_gpt":0.22362022161915657,"score_spread":0.21758545880054292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472813907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582696,0.0012469803,0.0000034987584,0.00007413347,0.000089090034,0.0011013377,0.00011010115,0.000021998756,0.0015258814],"genre_scores_gemma":[0.99954873,0.00012375569,0.000013894574,0.00001563631,0.00006474367,0.00013600578,0.0000144231635,0.000021761505,0.000061036066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983184,0.0003452242,0.000442245,0.00022620225,0.0003077132,0.00036023566],"domain_scores_gemma":[0.9984702,0.0003877692,0.00035591316,0.000613586,0.00005265524,0.00011990806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004287653,0.0002123449,0.00040660377,0.000050889557,0.000104458915,0.000014126759,0.00015984732,0.000090944486,0.000014917775],"category_scores_gemma":[0.00014147586,0.00009278009,0.00027883268,0.00011240819,0.00006572143,0.000029024084,0.00006304795,0.00012087154,0.000011923763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019345774,0.16470377,0.7385894,0.0014229331,0.0013093693,0.00023119953,0.0041842065,0.00002930013,0.036756832,0.0056446334,0.003158018,0.042035732],"study_design_scores_gemma":[0.07232466,0.0022065903,0.65288824,0.0016384968,0.00034950057,0.000029009576,0.0005587277,0.00043933888,0.2689148,0.000036725414,0.00044943162,0.00016451602],"about_ca_topic_score_codex":0.00046038447,"about_ca_topic_score_gemma":0.000024496558,"teacher_disagreement_score":0.23215795,"about_ca_system_score_codex":0.00015500018,"about_ca_system_score_gemma":0.00015568353,"threshold_uncertainty_score":0.3783462},"labels":[],"label_agreement":null},{"id":"W2472868589","doi":"10.1093/ajcp/aqw013","title":"MYC Immunohistochemistry Assessment in High-Grade Lymphomas","year":2016,"lang":"en","type":"editorial","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"BCL6; Fluorescence in situ hybridization; Biology; Chromosomal translocation; Burkitt's lymphoma; Vincristine; Lymphoma; Cancer research; Breakpoint; B cell; Molecular biology; Gene; Cyclophosphamide; Chemotherapy; Genetics; Immunology; Antibody; Chromosome; Germinal center","score_opus":0.0175994622469304,"score_gpt":0.41504644006526337,"score_spread":0.397446977818333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472868589","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33647406,0.0013882387,0.00004033602,0.00319369,0.656971,0.00025213242,0.00010968641,0.000020464653,0.0015503967],"genre_scores_gemma":[0.3758202,0.0068584713,0.0035154407,0.00053336564,0.6125304,0.00003451159,0.00008935269,0.000084975436,0.00053331535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939267,0.00068458566,0.0033543073,0.0005809722,0.00094092294,0.00051249436],"domain_scores_gemma":[0.9891665,0.005424832,0.0037436897,0.000702668,0.00051537494,0.00044693958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021423667,0.0004707524,0.0037221482,0.00026603852,0.000035277015,0.000015617625,0.00042588287,0.0009325938,0.00015486637],"category_scores_gemma":[0.00347314,0.00031094856,0.0010193776,0.00019662423,0.001075554,0.00005693754,0.00012305395,0.0018024094,0.0000407878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018917011,0.0038973708,0.079536006,0.00007287536,0.00086886674,0.01838906,0.000042757492,6.9537793e-7,0.0003249418,0.00004703393,0.7629163,0.13201237],"study_design_scores_gemma":[0.03059101,0.01625356,0.24863185,0.0018908816,0.0014008663,0.0018657495,0.00012981164,0.0000011035966,0.00011567327,0.00054121605,0.6979284,0.0006498585],"about_ca_topic_score_codex":0.000090382375,"about_ca_topic_score_gemma":0.0000040052714,"teacher_disagreement_score":0.16909584,"about_ca_system_score_codex":0.0009704326,"about_ca_system_score_gemma":0.0040643904,"threshold_uncertainty_score":0.99993426},"labels":[],"label_agreement":null},{"id":"W2473498748","doi":"10.1200/jco.2016.67.3467","title":"Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":672,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Brentuximab vedotin; Pembrolizumab; Internal medicine; Oncology; Cohort; Adverse effect; Lymphoma; Gastroenterology; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.03249842587650171,"score_gpt":0.355362388881699,"score_spread":0.3228639630051973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473498748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850191,0.00011070023,0.000037026297,0.013729762,0.00022036921,0.00047456636,0.0000057790066,0.000013970893,0.0003887495],"genre_scores_gemma":[0.99467087,0.00006641378,0.0037192171,0.00085513014,0.00046727376,0.000052988536,0.000003313257,0.000032867814,0.000131901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964498,0.00033527514,0.0017284426,0.00034790658,0.000666781,0.00047176375],"domain_scores_gemma":[0.9964454,0.0011458733,0.0010879707,0.00028032254,0.00044713594,0.0005932893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006875096,0.00027325074,0.0016511795,0.0001691797,0.00002568998,0.000015575992,0.0001525682,0.00040966584,0.00011786823],"category_scores_gemma":[0.00060900464,0.00011742913,0.00032695712,0.00017328885,0.00028845787,0.00014626422,0.00005081731,0.00033439862,0.000032840126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031736113,0.011633422,0.707744,0.000011787429,0.0003671875,0.0021071937,0.000029735813,3.596223e-7,0.0000026322807,0.000030909338,0.00048191685,0.24585472],"study_design_scores_gemma":[0.10764057,0.039653048,0.82049805,0.0004685295,0.00044976588,0.00037089406,0.000017108907,0.0000026132739,0.00004660735,0.00004117181,0.030672066,0.00013955668],"about_ca_topic_score_codex":0.000014508818,"about_ca_topic_score_gemma":0.0002074225,"teacher_disagreement_score":0.24571517,"about_ca_system_score_codex":0.0006384597,"about_ca_system_score_gemma":0.0018428655,"threshold_uncertainty_score":0.4788621},"labels":[],"label_agreement":null},{"id":"W2473839398","doi":"10.1182/blood.v126.23.3171.3171","title":"Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Lymphoma; Mantle cell lymphoma; Surgery; Oncology","score_opus":0.018959670573517908,"score_gpt":0.2632550391210027,"score_spread":0.24429536854748476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473839398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979098,0.00009661362,0.00010633456,0.00007066617,0.000033218646,0.0012607753,0.00029553854,0.00003613068,0.00019091957],"genre_scores_gemma":[0.9991466,0.000024098652,0.00028494667,0.000059648202,0.000025619229,0.000051243358,0.00030811655,0.000022528155,0.000077189165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905574,0.00003013819,0.00024633235,0.00024965598,0.00024313867,0.0001750039],"domain_scores_gemma":[0.9991734,0.00014515853,0.000121774225,0.00018296175,0.000114297334,0.00026238515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007296478,0.00017113371,0.00037059095,0.0000414081,0.00004157736,0.000009118964,0.000032887714,0.0000655946,0.0000039999913],"category_scores_gemma":[0.000048885096,0.00011192808,0.00006057407,0.00006298683,0.000079947094,0.000047702157,0.000008353409,0.000025106834,0.0000023647453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006365614,0.005922251,0.98409605,0.0003917302,0.00018653582,0.00036416476,0.0011831243,0.0000026393368,0.000020215813,0.000012254156,0.000032981956,0.0014224333],"study_design_scores_gemma":[0.06614951,0.0019789012,0.9260592,0.0001212637,0.0012432999,0.000032331012,0.000094817675,0.000014795395,0.0041406085,0.000011588632,0.000035101766,0.00011862352],"about_ca_topic_score_codex":0.00004575924,"about_ca_topic_score_gemma":0.000026172305,"teacher_disagreement_score":0.0597839,"about_ca_system_score_codex":0.000047338333,"about_ca_system_score_gemma":0.00016790933,"threshold_uncertainty_score":0.45642945},"labels":[],"label_agreement":null},{"id":"W2474984667","doi":"10.1002/cncr.30137","title":"Randomized phase 3 study in low‐grade lymphoma comparing maintenance anti‐CD20 antibody with observation after induction therapy: A trial of the ECOG‐ACRIN Cancer Research Group (E1496)","year":2016,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Hazard ratio; Rituximab; Internal medicine; Follicular lymphoma; Vincristine; Clinical endpoint; Induction chemotherapy; Prednisone; Surgery; Maintenance therapy; Cyclophosphamide; Gastroenterology; Randomized controlled trial; Lymphoma; Oncology; Chemotherapy; Confidence interval","score_opus":0.09838738969729825,"score_gpt":0.40473198498067675,"score_spread":0.3063445952833785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474984667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922523,0.0010516545,0.000013774435,0.0017169464,0.00041796349,0.004464462,0.000016723177,0.000017861748,0.000048301466],"genre_scores_gemma":[0.99375653,0.002030124,0.000016117696,0.00011413951,0.00027007313,0.0035974374,0.000004999944,0.000028330416,0.00018226213],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776655,0.00044405,0.00046002396,0.00040762394,0.00056773383,0.0003539879],"domain_scores_gemma":[0.99885416,0.00022277489,0.00019830861,0.0004332568,0.00022216587,0.00006932192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090439606,0.00020165576,0.0007358568,0.0001490649,0.000077135104,0.00002131312,0.00012792365,0.00006832355,0.000087092005],"category_scores_gemma":[0.00008050892,0.00008900387,0.00012760457,0.00054136134,0.00025312207,0.00015481669,0.000044901117,0.000100128775,0.0000026076007],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4647831,0.0040516662,0.5039094,0.00003884661,0.0003206015,0.000032173288,0.00095181563,0.000008217742,0.0044750744,0.0000324844,0.000084620246,0.02131201],"study_design_scores_gemma":[0.5559552,0.0005792401,0.43642327,0.0009299554,0.00007878092,0.000002364989,0.000147592,0.0000425414,0.0055606607,0.000019681807,0.000178468,0.00008229648],"about_ca_topic_score_codex":0.0049106586,"about_ca_topic_score_gemma":0.0018857246,"teacher_disagreement_score":0.09117206,"about_ca_system_score_codex":0.000764247,"about_ca_system_score_gemma":0.0003524701,"threshold_uncertainty_score":0.74234796},"labels":[],"label_agreement":null},{"id":"W2480622474","doi":"10.1158/1538-7445.am2016-3335","title":"Abstract 3335: The high cMyc expression characterizes a small cell subpopulation in ALK-positive anaplastic large cell lymphoma that carry cancer stem-like properties","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer research; Biology; SOX2; Transfection; Luciferase; Cell; Ectopic expression; Anaplastic large-cell lymphoma; Cell culture; Molecular biology; Lymphoma; Transcription factor; Gene; Immunology; Biochemistry; Genetics","score_opus":0.08284343539010063,"score_gpt":0.3266995064549125,"score_spread":0.24385607106481189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480622474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931396,0.0054491987,0.0000034726054,0.0029026915,0.00031405667,0.0013773028,0.00019739008,0.000034190478,0.00040771128],"genre_scores_gemma":[0.99057895,0.0039092638,0.0000071647164,0.00016274168,0.00026541093,0.0018591615,0.000029887973,0.000050803937,0.0031366327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99731874,0.0002332589,0.00030586822,0.0005665691,0.0007751316,0.0008004333],"domain_scores_gemma":[0.99862856,0.0003228772,0.00011860317,0.00046512677,0.0002642161,0.00020064332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047476846,0.00026653442,0.0003650035,0.00021010241,0.00026676667,0.000075335745,0.00021884048,0.00015006206,0.00031312057],"category_scores_gemma":[0.000025489164,0.00013064772,0.00009464409,0.0002825591,0.00017975394,0.00020321459,0.0001494306,0.00018700745,0.00008104838],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030263902,0.0019897313,0.3609412,0.0005919672,0.00009725938,0.0003002228,0.0029836306,0.000010393106,0.5901326,0.000028817358,0.0020569337,0.037840847],"study_design_scores_gemma":[0.005521011,0.00019884495,0.5654341,0.0015029014,0.000032036438,0.0000031123577,0.0004345365,0.0000137112465,0.42452562,0.000008994452,0.0021818827,0.00014326173],"about_ca_topic_score_codex":0.009232475,"about_ca_topic_score_gemma":0.0027841055,"teacher_disagreement_score":0.20449291,"about_ca_system_score_codex":0.0015847273,"about_ca_system_score_gemma":0.0006599308,"threshold_uncertainty_score":0.9973651},"labels":[],"label_agreement":null},{"id":"W2482802485","doi":"10.1182/blood.v106.11.415.415","title":"Gene Expression Distinguishes Burkitt Lymphoma from Other Aggressive Lymphomas and Identifies Patients Who Are Highly Curable with Intensive Chemotherapeutic Regimens.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Burkitt's lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Immunophenotyping; Cancer research; Oncology; Gene expression profiling; Medicine; Germinal center; Biology; Internal medicine; Immunology; B cell; Gene; Antibody; Gene expression; Genetics; Antigen","score_opus":0.009498632206852663,"score_gpt":0.22039505022958755,"score_spread":0.2108964180227349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482802485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923486,0.0055663,0.0000039155475,0.00065397617,0.000081063874,0.0004810347,0.00007763224,0.000088271256,0.0006991666],"genre_scores_gemma":[0.99569696,0.0004901708,0.0010668394,0.0013666652,0.00028135433,0.00009512888,0.000079621816,0.00006691661,0.0008563502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836636,0.000038212944,0.00028795388,0.0005902113,0.0003733433,0.000343901],"domain_scores_gemma":[0.9984723,0.000105756495,0.0004033648,0.00046183373,0.0003604108,0.00019636338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033112225,0.0003599691,0.0005449818,0.00007707261,0.00016593744,0.00008387653,0.00009272964,0.00012145646,0.00006753848],"category_scores_gemma":[0.00010613369,0.00022374788,0.00008055177,0.00011089257,0.00014333354,0.00014918765,0.000072623836,0.00004836175,0.00003663418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058406714,0.0031705962,0.96535367,0.00007193614,0.00091497146,0.00032595734,0.0020747103,0.0000015698903,0.0042757983,0.000013962718,0.0024653948,0.020747371],"study_design_scores_gemma":[0.022454536,0.0004195049,0.48597595,0.0019879963,0.00078668876,0.00009343274,0.00047579463,0.000017863165,0.48395443,0.00007276828,0.0034210114,0.00034002066],"about_ca_topic_score_codex":0.0003475173,"about_ca_topic_score_gemma":0.00004622878,"teacher_disagreement_score":0.47967863,"about_ca_system_score_codex":0.00012974115,"about_ca_system_score_gemma":0.00006247395,"threshold_uncertainty_score":0.91241735},"labels":[],"label_agreement":null},{"id":"W2484616545","doi":"10.1182/blood-2016-02-699520","title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Ozmosis Research (Canada); McGill University; Health Sciences Centre; University of British Columbia; Hôpital du Sacré-Cœur de Montréal; BC Cancer Agency; Princess Margaret Cancer Centre; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Panobinostat; Rituximab; Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Medicine; Refractory (planetary science); Cancer research; Biology; Genetics","score_opus":0.013963312564516661,"score_gpt":0.27180898345464327,"score_spread":0.2578456708901266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484616545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979971,0.0001775263,0.0000039896536,0.00010705785,0.00002905204,0.0010455372,0.00003964433,0.000041880518,0.00055821793],"genre_scores_gemma":[0.9987968,0.00005736615,0.00015603662,0.000073520314,0.00002780596,0.00015518384,0.000006977221,0.000032414355,0.00069388817],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99867594,0.0000562133,0.0003224617,0.00033877755,0.00030096812,0.00030565792],"domain_scores_gemma":[0.9991012,0.00010989579,0.00011968262,0.00047514107,0.000060277136,0.00013380454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094719355,0.00020888282,0.0005472838,0.0001234182,0.000032471453,0.000007236859,0.00007727852,0.000058614165,0.0000585525],"category_scores_gemma":[0.00003430373,0.00009879098,0.00005139203,0.00020208507,0.000038974624,0.000050742125,0.000038384795,0.000029929035,0.000038997463],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002275688,0.46753955,0.52344084,0.00004061652,0.00017655783,0.0010723582,0.00095880235,1.1386625e-8,0.001614925,0.000011434625,0.000056626362,0.002812617],"study_design_scores_gemma":[0.8469838,0.017301086,0.08639071,0.00032509185,0.0007129666,0.000088738496,0.00096257357,0.0000040886734,0.04667946,0.000004042612,0.00037056496,0.00017686341],"about_ca_topic_score_codex":0.00015776597,"about_ca_topic_score_gemma":0.0003482741,"teacher_disagreement_score":0.84470814,"about_ca_system_score_codex":0.00007642312,"about_ca_system_score_gemma":0.00015638547,"threshold_uncertainty_score":0.40285793},"labels":[],"label_agreement":null},{"id":"W2485578826","doi":"10.1182/blood.v106.11.1006.1006","title":"Use of a Tissue Microarray To Assess the Accuracy of Lymphoma Classification by Needle Biopsy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Mantle cell lymphoma; Pathology; Marginal zone B-cell lymphoma; Biopsy; Anaplastic large-cell lymphoma; Chronic lymphocytic leukemia; Medical diagnosis; Lymphoid hyperplasia; Diffuse large B-cell lymphoma; Not Otherwise Specified; B cell; Internal medicine; Leukemia; Marginal zone; Antibody","score_opus":0.0583783329191686,"score_gpt":0.3074438142440557,"score_spread":0.2490654813248871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485578826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544257,0.00049611734,0.000036633428,0.0029437689,0.000030544754,0.00043809926,0.000053908923,0.00001579732,0.0005425699],"genre_scores_gemma":[0.9966686,0.00007752577,0.0023934157,0.00032523015,0.00005968612,0.000057756566,0.000032089087,0.0000124958415,0.00037321183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925756,0.000028096196,0.0002590474,0.0001547941,0.00017419996,0.00012626912],"domain_scores_gemma":[0.9990966,0.00019252229,0.00013480968,0.0004050916,0.000096826014,0.00007415854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074396936,0.00010060112,0.00020824652,0.000049607126,0.000029521927,0.000013520792,0.0000881345,0.000052752293,0.000047147838],"category_scores_gemma":[0.00012821227,0.000063998516,0.00006017127,0.00018291787,0.000040500086,0.000068231915,0.000024177776,0.000019230893,0.000038280174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071372066,0.005465363,0.07331866,0.000047383546,0.00023322046,0.0000064654073,0.0006126439,0.0000021030596,0.8488342,0.00029232935,0.010022982,0.061093263],"study_design_scores_gemma":[0.0020990379,0.00018913647,0.23763022,0.00005455289,0.00024331124,0.00003896793,0.00009584062,0.000010537431,0.7149016,0.0000025865852,0.04467823,0.000055942397],"about_ca_topic_score_codex":0.00024342997,"about_ca_topic_score_gemma":0.000010071433,"teacher_disagreement_score":0.16431156,"about_ca_system_score_codex":0.0000428595,"about_ca_system_score_gemma":0.00007403227,"threshold_uncertainty_score":0.26097837},"labels":[],"label_agreement":null},{"id":"W2491175387","doi":"10.1158/1538-7445.am2016-117","title":"Abstract 117: Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University","funders":"","keywords":"Cancer research; Diffuse large B-cell lymphoma; Mutation; Exome sequencing; KRAS; Lymphoma; Biology; Gene; Somatic evolution in cancer; Exome; Oncology; Medicine; Genetics; Immunology","score_opus":0.03747784840525626,"score_gpt":0.3503774187578832,"score_spread":0.31289957035262694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491175387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654354,0.009058812,0.0000014187119,0.00083471276,0.00005289336,0.00028347777,0.000067339846,0.000016553455,0.003141245],"genre_scores_gemma":[0.9875875,0.010490296,0.000042875257,0.000042880547,0.000111975096,0.00011360234,0.0000039372344,0.000021681866,0.0015852213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986618,0.000050410665,0.00018758293,0.00027863524,0.0004441506,0.00037737773],"domain_scores_gemma":[0.9989424,0.00030403584,0.000047908747,0.00033356008,0.00016263367,0.00020951583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025967453,0.00010654022,0.00023020618,0.00013811536,0.00006911544,0.000011765019,0.00007888171,0.00008345609,0.0005936133],"category_scores_gemma":[0.00007155298,0.00006152391,0.000053245734,0.0001266205,0.00010825296,0.000046784782,0.0000698085,0.00008001404,0.00005997859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084213226,0.0041729407,0.6267871,0.0005594184,0.0001742104,0.0003467332,0.0005449673,1.8128549e-7,0.2830772,0.00020047974,0.012795895,0.070498735],"study_design_scores_gemma":[0.015827194,0.0004500678,0.83700794,0.0003928672,0.000039824114,0.000009692979,0.000085844134,0.0000025886186,0.11535266,0.000083284474,0.030648762,0.000099246776],"about_ca_topic_score_codex":0.0003239542,"about_ca_topic_score_gemma":0.00007969203,"teacher_disagreement_score":0.21022086,"about_ca_system_score_codex":0.00023944881,"about_ca_system_score_gemma":0.0002961503,"threshold_uncertainty_score":0.6499649},"labels":[],"label_agreement":null},{"id":"W2496661747","doi":"10.1016/b978-0-323-47913-4.00008-2","title":"Diffuse Aggressive B-Cell Lymphomas","year":2018,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer research","score_opus":0.014171528041952616,"score_gpt":0.24247179928505458,"score_spread":0.22830027124310195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496661747","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002395339,0.006115092,1.9395769e-7,0.0001139327,0.00050515076,0.0010229754,0.00007724135,0.00013094538,0.9896391],"genre_scores_gemma":[0.0055009713,0.00086419214,0.00025857065,0.0012601814,0.0011438718,0.00012021461,0.0001312778,0.00018092836,0.9905398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977604,0.000017381475,0.00050754886,0.0007440312,0.0005374771,0.00043311797],"domain_scores_gemma":[0.9976848,0.00007924416,0.0005639617,0.001072948,0.00020012981,0.00039892676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000080120146,0.00071909075,0.0010069833,0.00018898846,0.00012455144,0.00004529729,0.00018480832,0.0005453494,0.0026428634],"category_scores_gemma":[0.000021292275,0.0005535201,0.000590303,0.000011602349,0.0002753775,0.000024475012,0.00015977613,0.0002166788,0.0041287784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001189727,0.00032108076,0.00015863597,0.00021706271,0.00056430243,0.0023605567,0.0003377777,9.473287e-9,0.000024210804,0.0012400275,0.0075019975,0.9871554],"study_design_scores_gemma":[0.0055490322,0.0005963972,0.00020405016,0.0017307727,0.0012366197,0.00030918667,0.000008658341,0.0000011955707,0.0010688832,0.0025749695,0.98620677,0.0005134463],"about_ca_topic_score_codex":0.0000013391316,"about_ca_topic_score_gemma":0.000008660747,"teacher_disagreement_score":0.98664194,"about_ca_system_score_codex":0.00048610748,"about_ca_system_score_gemma":0.00038180794,"threshold_uncertainty_score":0.9996916},"labels":[],"label_agreement":null},{"id":"W2498241992","doi":"10.1200/jco.2004.22.90140.6521","title":"Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Follicular lymphoma; Radiation therapy; Internal medicine; Gastroenterology; Incidence (geometry); Surgery; Cumulative incidence; Lymphoma; Cohort","score_opus":0.09243860262198297,"score_gpt":0.42922491079748964,"score_spread":0.3367863081755067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498241992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890438,0.0028262176,0.00003602218,0.007304806,0.00030091556,0.0003288527,9.1782516e-7,0.000006826001,0.00015166463],"genre_scores_gemma":[0.9916319,0.0047928398,0.000994464,0.002231314,0.00024052117,0.000014346543,0.0000037815473,0.000012605603,0.000078224555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979858,0.00012245474,0.0012841241,0.00018544048,0.00023279851,0.00018939632],"domain_scores_gemma":[0.9981772,0.00071478897,0.00064535317,0.00015016405,0.00006048849,0.00025203367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007118253,0.00016234045,0.0012532055,0.00011839346,0.00004770564,0.000010620255,0.000053380358,0.00024450518,0.00002103408],"category_scores_gemma":[0.00022597102,0.00009244961,0.00036092856,0.000096869306,0.000047273257,0.00011081716,0.00001767896,0.00014023135,0.000002293812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021198501,0.0043744263,0.76070195,0.0000060128996,0.000556024,0.004613291,0.00016751893,0.000009664113,0.000027956703,0.000027174752,0.0000097464645,0.2273864],"study_design_scores_gemma":[0.07479484,0.046093486,0.875443,0.00010203848,0.00027927032,0.00016476713,0.000044824697,0.0000045979127,0.0006043441,0.00004829738,0.0023393768,0.00008120259],"about_ca_topic_score_codex":0.00017852792,"about_ca_topic_score_gemma":0.0003472666,"teacher_disagreement_score":0.2273052,"about_ca_system_score_codex":0.00063752214,"about_ca_system_score_gemma":0.00081430277,"threshold_uncertainty_score":0.37699857},"labels":[],"label_agreement":null},{"id":"W2500482667","doi":"10.1182/blood-2016-02-699850","title":"Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Complete remission; Gastroenterology; Hodgkin lymphoma; Chemotherapy; Biology","score_opus":0.009244482184418111,"score_gpt":0.22310387392984643,"score_spread":0.2138593917454283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500482667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837357,0.0000667093,3.9581928e-7,0.00025548312,0.000046785724,0.00039461377,0.000112941896,0.000020004123,0.0007295131],"genre_scores_gemma":[0.9994281,0.000061938,0.00022772941,0.000017698474,0.000022192418,0.000019985151,0.000022134209,0.000015322397,0.00018489888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878436,0.000076845594,0.00033285865,0.00033718243,0.00027526714,0.00019349284],"domain_scores_gemma":[0.99902755,0.0002731256,0.00013161406,0.00037081304,0.00009403578,0.00010288477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017898795,0.00014936904,0.00036103005,0.00006948241,0.000021078418,0.0000050381814,0.000048446072,0.000076396995,0.000028972981],"category_scores_gemma":[0.0003113856,0.00007576846,0.00003808229,0.00012152915,0.000100311176,0.00006683552,0.000037706875,0.000029680077,0.000008688475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006285593,0.0074980147,0.97305274,0.000048067453,0.00010155756,0.00004882372,0.00013864554,3.253616e-8,0.00015904536,0.000022938662,0.000086105785,0.012558446],"study_design_scores_gemma":[0.10533869,0.002524815,0.8885709,0.00030873623,0.00011361645,0.000004626056,0.000039712257,3.178932e-7,0.0027835013,0.000011645555,0.00020997235,0.00009344917],"about_ca_topic_score_codex":0.00023073354,"about_ca_topic_score_gemma":0.00014408208,"teacher_disagreement_score":0.0990531,"about_ca_system_score_codex":0.00009426856,"about_ca_system_score_gemma":0.00012924836,"threshold_uncertainty_score":0.30897483},"labels":[],"label_agreement":null},{"id":"W2502145464","doi":"10.1182/blood.v110.11.1673.1673","title":"Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Etoposide; Melphalan; Population; Oncology; Autologous stem-cell transplantation; Transplantation; Cumulative incidence; Cytarabine; Surgery; Chemotherapy regimen; Chemotherapy","score_opus":0.007702134531715824,"score_gpt":0.24148028239116637,"score_spread":0.23377814785945053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502145464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917329,0.0031877372,0.000246437,0.00008550456,0.0003379051,0.001008048,0.00012515602,0.00007918245,0.0031971233],"genre_scores_gemma":[0.9967492,0.00031127318,0.00073458283,0.00048218953,0.0001741873,0.00043423404,0.0000860816,0.000050487564,0.0009777476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843836,0.000020621646,0.00039559745,0.00042993994,0.0002443891,0.00047111558],"domain_scores_gemma":[0.9989012,0.00022222966,0.00023991946,0.00031727133,0.00009310483,0.00022629586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014954992,0.0002805422,0.00041466343,0.00012393837,0.00009555982,0.000021102202,0.00007843158,0.00020885386,0.00016560314],"category_scores_gemma":[0.000006103555,0.00023514501,0.00021712022,0.0001067381,0.000057459292,0.00008670272,0.000011409798,0.0000664714,0.00006290559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020840272,0.031526837,0.4753788,0.013439361,0.0055204704,0.048687883,0.051547613,0.000043015807,0.033301465,0.0004271714,0.01527953,0.30400756],"study_design_scores_gemma":[0.050524794,0.0027717329,0.49316385,0.00078266044,0.0026507522,0.0014536504,0.0007935291,0.000030190038,0.44012007,0.00006451681,0.0070243254,0.00061991945],"about_ca_topic_score_codex":0.00006759428,"about_ca_topic_score_gemma":0.00020428977,"teacher_disagreement_score":0.4068186,"about_ca_system_score_codex":0.00036492836,"about_ca_system_score_gemma":0.00030417458,"threshold_uncertainty_score":0.9588935},"labels":[],"label_agreement":null},{"id":"W2502299239","doi":"10.1201/b13347-4","title":"Epidemiology and etiology of plasma cell neoplasms","year":2004,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Etiology; Epidemiology; Medicine; Pathology","score_opus":0.023594168530065004,"score_gpt":0.2847723002290484,"score_spread":0.2611781316989834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502299239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797157,0.00039079812,0.00006426888,0.0029282612,0.000046506982,0.000114344875,0.0000021864096,0.000015452464,0.01672245],"genre_scores_gemma":[0.9924866,0.00030178178,0.0059691905,0.00077709486,0.00001879062,0.000010652993,0.000007164388,0.0000039751235,0.0004247267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995228,0.000020919815,0.00017162967,0.00013169482,0.000026464355,0.0001264769],"domain_scores_gemma":[0.9995247,0.00023215328,0.00004275338,0.00010670775,0.000018214057,0.0000754356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087265544,0.00006520054,0.0002832347,0.000033387827,0.000013586873,3.3818984e-7,0.000015811273,0.000074293006,0.00009934292],"category_scores_gemma":[0.000059321897,0.00004229793,0.000039058024,0.000029589748,0.000085124986,0.000010211085,0.000017441344,0.000027121565,0.000038187653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021538335,0.0008611784,0.943592,0.00008315685,0.00010769307,0.00006972864,0.00020540992,0.000052380277,0.003017801,0.044421107,0.0011991137,0.00617506],"study_design_scores_gemma":[0.014250462,0.0033998133,0.79953766,0.000051226496,0.00019286807,0.0005049102,0.00015204199,0.000063632164,0.17000833,0.005541378,0.006161189,0.00013651417],"about_ca_topic_score_codex":0.00025289503,"about_ca_topic_score_gemma":0.00003115352,"teacher_disagreement_score":0.16699053,"about_ca_system_score_codex":0.000034616965,"about_ca_system_score_gemma":0.000048102764,"threshold_uncertainty_score":0.17248593},"labels":[],"label_agreement":null},{"id":"W2504204972","doi":"10.1182/blood.v124.21.292.292","title":"Brentuximab Vedotin Combined with ABVD or AVD for Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma: Long Term Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Brentuximab vedotin; Dacarbazine; Medicine; Vinblastine; Regimen; Internal medicine; Bleomycin; Surgery; Oncology; Gastroenterology; Lymphoma; Vincristine; Chemotherapy; CD30","score_opus":0.009953442662376038,"score_gpt":0.2470614320194354,"score_spread":0.23710798935705935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504204972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965869,0.00006482348,0.00031477422,0.00023500824,0.000110008645,0.0022562782,0.00008924557,0.00013386046,0.00020905258],"genre_scores_gemma":[0.9932302,0.000016487413,0.0040443907,0.00047221428,0.00004831855,0.0007231084,0.0003156434,0.000084767424,0.0010648638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981354,0.000038905822,0.0003356891,0.0005463794,0.0004335688,0.00051006593],"domain_scores_gemma":[0.99833816,0.0004342732,0.00022245341,0.00057885546,0.00017946387,0.00024679716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008008552,0.00042359112,0.00073787075,0.00009752554,0.0001363726,0.00006470985,0.00013527354,0.00008741838,0.00003671985],"category_scores_gemma":[0.00015464744,0.00023685495,0.00012387676,0.00016161242,0.00006320905,0.000174894,0.00004100086,0.00004847814,0.000019092475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039084707,0.014253928,0.9606669,0.00017784003,0.0006094396,0.00016509324,0.00013218157,0.000003971504,0.000016439993,0.0001480112,0.000121606245,0.019796116],"study_design_scores_gemma":[0.18610619,0.009819818,0.8007672,0.00027841862,0.00077289884,0.000011843149,0.000031805415,0.00001199005,0.0016222288,0.000011375661,0.0002721519,0.00029407698],"about_ca_topic_score_codex":0.00004908145,"about_ca_topic_score_gemma":0.00019822422,"teacher_disagreement_score":0.18219772,"about_ca_system_score_codex":0.000112403955,"about_ca_system_score_gemma":0.00016164673,"threshold_uncertainty_score":0.96586645},"labels":[],"label_agreement":null},{"id":"W2504623699","doi":"10.1016/s1470-2045(16)30167-x","title":"Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":924,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"NIHR Oxford Biomedical Research Centre; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Oncology; Autologous stem-cell transplantation; Clinical endpoint; Transplantation; Lymphoma; Surgery; Clinical trial; Hodgkin lymphoma; Immunotherapy; Cancer","score_opus":0.033560026239753946,"score_gpt":0.3124283474722595,"score_spread":0.27886832123250554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504623699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903803,0.00043808483,0.00045487308,0.0061330595,0.0002903796,0.0017666998,0.00019614023,0.000048044472,0.0002924155],"genre_scores_gemma":[0.99665457,0.00030644482,0.0014720694,0.0004089352,0.00042105615,0.00046429996,0.00002805663,0.000023686058,0.00022086344],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854475,0.00018717037,0.00039303536,0.00033213376,0.0001581626,0.0003847735],"domain_scores_gemma":[0.9983104,0.001002184,0.00021614843,0.0002933206,0.00006645816,0.000111522444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002367314,0.00020683375,0.0007761262,0.00005551912,0.00006140576,0.000010949534,0.0000976558,0.0001935058,0.000047572594],"category_scores_gemma":[0.000036925085,0.000110304754,0.00014298737,0.00005581271,0.00024016287,0.000053032923,0.000025135296,0.000052226158,0.00000939279],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.290303,0.019752966,0.007708684,0.00044878264,0.0004874701,0.00039212912,0.002147906,8.066588e-7,0.013161451,0.00032468428,0.0027802414,0.66249186],"study_design_scores_gemma":[0.8808955,0.024965467,0.030187948,0.00025058366,0.0020699133,0.00040076568,0.00022377605,0.00043523975,0.019013705,0.000107953856,0.041150328,0.00029882145],"about_ca_topic_score_codex":0.00003475613,"about_ca_topic_score_gemma":0.00015923107,"teacher_disagreement_score":0.66219306,"about_ca_system_score_codex":0.00025957226,"about_ca_system_score_gemma":0.00017071162,"threshold_uncertainty_score":0.44980973},"labels":[],"label_agreement":null},{"id":"W2506051311","doi":"10.1158/1538-7445.am2016-3405","title":"Abstract 3405: The analysis of TRPV6 expression in lymphoid tumours","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Lymphoma; Internal medicine; Medicine; Follicular lymphoma; Oncology; Chronic lymphocytic leukemia; Survival analysis; Proportional hazards model; Diffuse large B-cell lymphoma; Pathology; Leukemia","score_opus":0.0854602531922986,"score_gpt":0.43192560238846384,"score_spread":0.34646534919616523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506051311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925477,0.001555337,0.0000018088617,0.0037296347,0.000029369632,0.00024771265,0.000026183716,0.000006114022,0.0018561506],"genre_scores_gemma":[0.9974689,0.0016503204,0.000010274443,0.000043013137,0.000042664953,0.00016601702,0.0000039158044,0.000008310049,0.00060658035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869245,0.00007875811,0.00018981138,0.00020924865,0.0005498756,0.00027987067],"domain_scores_gemma":[0.9989097,0.0004432908,0.000040628827,0.0003755251,0.0001410172,0.00008983844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059088063,0.000071192124,0.00024385685,0.00037208357,0.000043815664,0.0000084388275,0.00013092112,0.000044125587,0.00105231],"category_scores_gemma":[0.000116656825,0.000030491055,0.000114972594,0.0008930725,0.00014717728,0.00004184424,0.000052199255,0.000071281,0.000031596934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028692256,0.00034400038,0.812253,0.000026505528,0.00026313198,0.000057752786,0.0002917105,0.0000119783535,0.13837107,0.000061680636,0.002873175,0.045159087],"study_design_scores_gemma":[0.0013930289,0.000050514216,0.809945,0.0002631324,0.00009252267,0.0000012058726,0.00011566769,0.0000068072904,0.18687981,0.000035518788,0.0011844668,0.0000323512],"about_ca_topic_score_codex":0.0018173185,"about_ca_topic_score_gemma":0.00051687955,"teacher_disagreement_score":0.048508756,"about_ca_system_score_codex":0.0004986101,"about_ca_system_score_gemma":0.00028302468,"threshold_uncertainty_score":0.9998609},"labels":[],"label_agreement":null},{"id":"W2506330890","doi":"10.1182/blood.v126.23.2636.2636","title":"Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cog; ABVD; Young adult; Internal medicine; Hodgkin lymphoma; Chemotherapy regimen; Clinical trial; Randomized controlled trial; Pediatrics; Oncology; Chemotherapy; Lymphoma; Cyclophosphamide; Vincristine","score_opus":0.021829035189813176,"score_gpt":0.30520732927716804,"score_spread":0.2833782940873549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506330890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989776,0.00016886095,0.000008359921,0.00010259971,0.000025494473,0.009374083,0.00006755978,0.00007406582,0.00040293776],"genre_scores_gemma":[0.99396986,0.000041625124,0.0004619578,0.00034214297,0.000047593414,0.0048185443,0.00026150476,0.000031603067,0.000025169524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741036,0.00036216454,0.000500491,0.0009104514,0.00037892442,0.00043760517],"domain_scores_gemma":[0.9985522,0.00006573567,0.00022741783,0.00041913943,0.00023772457,0.00049778656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001839938,0.0005480372,0.001373387,0.00043269247,0.00010078466,0.00007863449,0.00011455395,0.00019862581,0.000006833245],"category_scores_gemma":[0.000053299227,0.00036728088,0.000096529926,0.0006378348,0.00022457604,0.00022877859,0.00007710127,0.00015191846,0.0000077854775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004732652,0.015553451,0.9703251,0.0000368995,0.0023289905,0.0004285275,0.0031365138,0.0000048149022,0.000035710298,0.0001092949,0.000018944116,0.0032890893],"study_design_scores_gemma":[0.0649116,0.016757304,0.912852,0.0007450712,0.0018952453,0.00018818487,0.0011187241,0.00028125037,0.0008706328,0.0000053486283,0.000014033756,0.00036061343],"about_ca_topic_score_codex":0.0036115297,"about_ca_topic_score_gemma":0.016249683,"teacher_disagreement_score":0.060178943,"about_ca_system_score_codex":0.00030192517,"about_ca_system_score_gemma":0.000095149735,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W2508655015","doi":"10.1182/blood.v118.21.427.427","title":"CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Reed–Sternberg cell; Gene expression profiling; Lymph node; Lymphoma; CD68; Tissue microarray; Internal medicine; Oncology; Pathology; Phenotype; Immunohistochemistry; Cancer research; Gene expression; Biology; Hodgkin lymphoma; Chemotherapy; Gene; Vincristine","score_opus":0.017159621181930217,"score_gpt":0.22884347825105902,"score_spread":0.21168385706912882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508655015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983164,0.00032679783,8.1131157e-7,0.00022836721,0.0000094022325,0.0006183466,0.00004908303,0.0000063685934,0.00044441805],"genre_scores_gemma":[0.998978,0.00012227678,0.0001905355,0.00024556328,0.0000051162096,0.00006627189,0.000007839129,0.000016818933,0.00036754247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990836,0.000077519144,0.00024296246,0.00020344363,0.00023427315,0.00015820994],"domain_scores_gemma":[0.9992847,0.000095427866,0.00022207087,0.0003362772,0.000020316487,0.00004121567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094631396,0.00018347909,0.00035291412,0.000026168147,0.00003551652,0.0000056088334,0.00007318905,0.00004571184,0.00013130739],"category_scores_gemma":[0.0000034561538,0.000072509974,0.00005302949,0.000088818604,0.00012162612,0.000023017043,0.000026211655,0.00005414985,0.000005741212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003680149,0.0046998123,0.9776138,0.000022847435,0.0003951545,0.00024307106,0.0073403637,3.4975227e-7,0.009045028,0.000002742137,0.000115936426,0.00015290186],"study_design_scores_gemma":[0.009168257,0.0011307078,0.6054778,0.00019194065,0.0006894014,0.000057247475,0.00059732917,0.000001898301,0.38258743,0.0000023049283,0.000035114164,0.000060579627],"about_ca_topic_score_codex":0.0005250414,"about_ca_topic_score_gemma":0.000042751748,"teacher_disagreement_score":0.3735424,"about_ca_system_score_codex":0.0000486283,"about_ca_system_score_gemma":0.000021525415,"threshold_uncertainty_score":0.29568708},"labels":[],"label_agreement":null},{"id":"W2508701852","doi":"10.1182/blood.v124.21.3084.3084","title":"A Phase 1 -2 Study of Brentuximab Vedotin (Bv) and Bendamustine (B) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Bendamustine; Medicine; Internal medicine; Oncology; Regimen; Refractory (planetary science); Salvage therapy; Progressive disease; Chemotherapy; Lymphoma; Surgery; Gastroenterology; Rituximab; Hodgkin lymphoma","score_opus":0.007415717431819893,"score_gpt":0.23379663349968477,"score_spread":0.22638091606786487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508701852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830616,0.00030953085,0.000003624561,0.000024659204,0.000045913923,0.0010035244,0.00005652327,0.00003319033,0.00021689708],"genre_scores_gemma":[0.9993873,0.000045673954,0.00022798651,0.000073033756,0.000035794215,0.00007399043,0.00006288871,0.00004185099,0.00005146956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981641,0.00011015258,0.0004542551,0.00052790745,0.00038490546,0.0003586446],"domain_scores_gemma":[0.99883336,0.0002338811,0.00022264202,0.00038903244,0.00010095817,0.00022012829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018588219,0.0003199783,0.00068564,0.00022637624,0.00007569323,0.000021542557,0.000067720975,0.0000965899,0.00002398999],"category_scores_gemma":[0.0001340926,0.0002193374,0.000036170368,0.00026132664,0.000068321024,0.000089802365,0.00008263594,0.000053325904,0.0000039450097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044595073,0.16310595,0.80910504,0.00017679922,0.00020800764,0.00019283488,0.0008826223,3.701965e-7,0.00008910993,0.000012846044,0.00005128584,0.021715606],"study_design_scores_gemma":[0.3154828,0.027382193,0.6549607,0.00021600274,0.0006417824,0.000027317357,0.00028048144,0.000069715425,0.00057984865,0.000002761745,0.00018007423,0.00017633321],"about_ca_topic_score_codex":0.00018631518,"about_ca_topic_score_gemma":0.00030145983,"teacher_disagreement_score":0.31102327,"about_ca_system_score_codex":0.00007079819,"about_ca_system_score_gemma":0.000100856596,"threshold_uncertainty_score":0.89443195},"labels":[],"label_agreement":null},{"id":"W2511162379","doi":"10.5858/arpa.2015-0482-sa","title":"The Pathology of Reactive Lymphadenopathies: A Discussion of Common Reactive Patterns and Their Malignant Mimics","year":2016,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Context (archaeology); Surgical pathology; Medicine; Lymphoma; Pathology; Lymph node; Medical diagnosis","score_opus":0.019817207933132925,"score_gpt":0.30926956849991005,"score_spread":0.28945236056677714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511162379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032926638,0.962987,0.000033399894,0.00076303264,0.00026590982,0.0012206881,0.0013855578,0.000018041841,0.0003997169],"genre_scores_gemma":[0.04427975,0.95501256,0.0000766075,0.0000754891,0.00013426054,0.00016487607,0.00014419673,0.000061086146,0.000051174182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959822,0.0012115614,0.0015114653,0.00063899695,0.00026267458,0.0003930914],"domain_scores_gemma":[0.9925589,0.0038806666,0.0020895253,0.0010975606,0.00019375555,0.00017962416],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006999175,0.0006428584,0.0039984477,0.0003928447,0.000097171986,0.0000020626846,0.0003186694,0.00036921265,0.000011682897],"category_scores_gemma":[0.0005164121,0.0002378941,0.00034626198,0.00024284289,0.0033233212,0.000046366647,0.00026057774,0.00029824607,0.0000017813659],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000488746,0.00087461533,0.005435392,0.008710343,0.0011232317,0.0012145909,0.0066506136,1.4249739e-8,0.0055797445,0.0013866875,0.000076868164,0.9684591],"study_design_scores_gemma":[0.01999517,0.021915624,0.07868557,0.32770517,0.015031692,0.0072546327,0.014865916,0.000004340929,0.017197078,0.0045924205,0.4910708,0.0016815889],"about_ca_topic_score_codex":0.00003986295,"about_ca_topic_score_gemma":0.000023968165,"teacher_disagreement_score":0.96677756,"about_ca_system_score_codex":0.00008688285,"about_ca_system_score_gemma":0.0005995653,"threshold_uncertainty_score":0.99938905},"labels":[],"label_agreement":null},{"id":"W2513682947","doi":"10.3324/haematol.2016.147116","title":"Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Medicine; Lymphoma; Cancer; Malignancy; Hodgkin lymphoma; Internal medicine; Ataxia-telangiectasia; Incidence (geometry); Pediatrics; Epidemiology; Non-Hodgkin's lymphoma; Cumulative incidence; Oncology; Cohort","score_opus":0.03482524352224295,"score_gpt":0.34146321822440817,"score_spread":0.30663797470216525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513682947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997694,0.00034878877,0.000009267412,0.0011495133,0.00005720075,0.00049692305,0.00004411434,0.00003818145,0.0001620209],"genre_scores_gemma":[0.99800503,0.0011532548,0.00027034397,0.00040435145,0.00005330059,0.000036088495,0.000017935517,0.00001204886,0.000047654303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869,0.00005196534,0.00050550944,0.00040707013,0.0001028826,0.00024256045],"domain_scores_gemma":[0.99926126,0.00021445144,0.00014153482,0.0001855659,0.000018538665,0.00017862517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019587483,0.00018600038,0.0006094301,0.00006881196,0.00007471869,0.000027048463,0.00003995812,0.0001400907,0.000025744477],"category_scores_gemma":[0.00026510502,0.00011017369,0.000042781314,0.00005321716,0.00023750792,0.00005802046,0.00010237655,0.000057975943,0.000017618966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011451679,0.0003947536,0.9834503,0.0000598543,0.000038722206,0.0003223079,0.000040843788,2.493056e-9,0.000018176392,0.00043190017,0.00008281595,0.015045795],"study_design_scores_gemma":[0.00574468,0.0003360418,0.9914194,0.00065864925,0.000082016406,0.0011599811,0.000012686588,0.000012880278,0.000079806516,0.00028531044,0.00007150044,0.00013708883],"about_ca_topic_score_codex":0.000043154352,"about_ca_topic_score_gemma":0.000015864362,"teacher_disagreement_score":0.014908706,"about_ca_system_score_codex":0.000041308045,"about_ca_system_score_gemma":0.000023448774,"threshold_uncertainty_score":0.44927529},"labels":[],"label_agreement":null},{"id":"W2515380104","doi":"10.1002/hon.2339","title":"Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B‐cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group‐37 study","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research UK; National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Concordance; Positron emission tomography; Lymphoma; Nuclear medicine; Radiology; Radiation therapy; Interim; Clinical endpoint; Mediastinum; Clinical trial; Medical physics; Internal medicine","score_opus":0.11099691710297598,"score_gpt":0.3821411964883498,"score_spread":0.27114427938537383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515380104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13297841,0.8585909,0.0000064836604,0.0011868109,0.00039300264,0.005922087,0.000016302398,0.00002354931,0.00088244525],"genre_scores_gemma":[0.3728907,0.62403125,0.00006300448,0.00082555145,0.00008514455,0.0020061126,0.000048399343,0.000023963461,0.000025826392],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9921024,0.0030104946,0.002446939,0.0009819538,0.0009083109,0.00054989295],"domain_scores_gemma":[0.9952372,0.0022763112,0.0012428967,0.0010302066,0.00009871222,0.00011471692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024767222,0.00075032003,0.0042112065,0.00038910954,0.00011483967,0.000032018143,0.0014528523,0.0003553864,0.00013521],"category_scores_gemma":[0.00029481173,0.00027302743,0.0016034599,0.0013169636,0.00029147955,0.000072225375,0.00071167893,0.000365084,0.000007604808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002880487,0.02959066,0.043601558,0.0031780722,0.0023662385,0.0011878149,0.004274722,9.836878e-8,0.000011101843,0.00002946087,0.00027882456,0.9151934],"study_design_scores_gemma":[0.025646076,0.012395309,0.66577923,0.07219043,0.019687502,0.002163377,0.015800517,0.00001794377,0.000013128589,0.000041874824,0.18507159,0.0011930214],"about_ca_topic_score_codex":0.00016036286,"about_ca_topic_score_gemma":0.00030357027,"teacher_disagreement_score":0.9140004,"about_ca_system_score_codex":0.0012276482,"about_ca_system_score_gemma":0.00043426512,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W2517435317","doi":"10.1016/j.critrevonc.2012.06.004","title":"Anaplastic large cell lymphoma, ALK-negative","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Lymphoma; Medicine; CD30; Internal medicine; Pathology; Large cell; B symptoms; Oncology; Cancer; Adenocarcinoma; Lung cancer","score_opus":0.09508870384681826,"score_gpt":0.4356182006152879,"score_spread":0.3405294967684696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517435317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008255017,0.9698819,0.000040983505,0.000494587,0.0012648337,0.0032730738,0.00008109551,0.000068803536,0.024886467],"genre_scores_gemma":[0.0005000917,0.9918701,0.00208195,0.0012651845,0.0003771635,0.0032418505,0.00021197817,0.00011574539,0.0003359279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921189,0.0018298184,0.0027628308,0.0012276433,0.00030079146,0.0017599987],"domain_scores_gemma":[0.9891354,0.008240627,0.0005887255,0.0010772691,0.00014585134,0.0008121579],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013085348,0.0011917283,0.010806844,0.00052064384,0.0001237672,0.000019753475,0.0004244943,0.0019839506,0.0012164923],"category_scores_gemma":[0.004979442,0.0008293617,0.0014692823,0.0007061145,0.000602789,0.000101866215,0.0003509621,0.00081168074,0.0065667764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042726173,0.008934933,0.00021658167,0.0419957,0.00017516414,0.0026943528,0.000075008254,2.8697413e-9,4.755194e-8,0.033241708,0.00620163,0.90642214],"study_design_scores_gemma":[0.0038625577,0.0009711641,0.00003034199,0.029750742,0.0051788418,0.00421523,0.000025727564,0.0000024331803,0.0000044234785,0.0003621955,0.95501107,0.00058528275],"about_ca_topic_score_codex":0.000012839322,"about_ca_topic_score_gemma":0.000060820603,"teacher_disagreement_score":0.94880944,"about_ca_system_score_codex":0.0020754389,"about_ca_system_score_gemma":0.0014361906,"threshold_uncertainty_score":0.99969655},"labels":[],"label_agreement":null},{"id":"W2518279290","doi":"10.11359/chubu.2008.967","title":"Vancouver分類 type B3ステム周辺骨折に対する同種骨プレートを使用した再建術の経験","year":2008,"lang":"ja","type":"article","venue":"中部日本整形外科災害外科学会雑誌","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type (biology); Geology","score_opus":0.031152397793883534,"score_gpt":0.26502559211255455,"score_spread":0.233873194318671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518279290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82649875,0.026416209,0.000021645628,0.0021358079,0.0074716266,0.0013826803,0.00012047692,0.00042886674,0.13552395],"genre_scores_gemma":[0.9388559,0.01106483,0.0006066697,0.0020391596,0.0018099102,0.000068214205,0.00012117919,0.00013790773,0.045296226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560195,0.00014012563,0.0008781677,0.0010917238,0.001012715,0.0012753],"domain_scores_gemma":[0.9967735,0.00028566632,0.00027252766,0.0014064423,0.0004007862,0.00086110656],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000231672,0.0008381755,0.001185023,0.00028297128,0.0005926325,0.000054192347,0.00037464782,0.0004860532,0.005615405],"category_scores_gemma":[0.00025641132,0.0007292115,0.0005084543,0.00089799083,0.00045174715,0.00025444763,0.00018591997,0.00042238654,0.01587482],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014163546,0.0075725,0.28322643,0.0004760426,0.0023270436,0.012959418,0.0052030105,0.000039278904,0.0013512379,0.0016693311,0.6486211,0.035138257],"study_design_scores_gemma":[0.0115359025,0.0030725822,0.28207624,0.00076269585,0.0013390617,0.001427248,0.00071223767,0.00029124288,0.0078625465,0.00010979074,0.68951416,0.0012962971],"about_ca_topic_score_codex":0.00057286734,"about_ca_topic_score_gemma":0.00007870927,"teacher_disagreement_score":0.11235716,"about_ca_system_score_codex":0.0007980439,"about_ca_system_score_gemma":0.00095215044,"threshold_uncertainty_score":0.9995159},"labels":[],"label_agreement":null},{"id":"W2518549838","doi":"10.1182/blood.v126.23.5630.5630","title":"National Trend in Splenectomy for Splenic Marginal Zone Lymphoma (SMZL): An Analysis of Surveillance, Epidemiology and End Results (SEER) Database","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Splenectomy; Splenic marginal zone lymphoma; Surveillance, Epidemiology, and End Results; Population; Poisson regression; Epidemiology; Rituximab; Database; Internal medicine; Surgery; Cancer registry; Lymphoma","score_opus":0.06159040810683565,"score_gpt":0.34013597863150186,"score_spread":0.2785455705246662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518549838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956422,0.0010266338,0.00003422841,0.00047924207,0.000034287932,0.00027828175,0.002040944,0.000015269557,0.00044893872],"genre_scores_gemma":[0.9919092,0.00014330373,0.004164776,0.000115430135,0.00008841325,0.00007812371,0.003432819,0.000011161984,0.000056741308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984136,0.00014689368,0.0005349002,0.0004239904,0.0002184622,0.00026215546],"domain_scores_gemma":[0.99830556,0.0008554351,0.00018506909,0.00030009059,0.00013495646,0.00021888429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013541918,0.00015827543,0.0007375249,0.0004664735,0.00002436886,0.000005045422,0.00006449693,0.000084333704,0.000020265477],"category_scores_gemma":[0.0008331757,0.0001297639,0.00011445372,0.00046369244,0.000082480175,0.00007550581,0.000036029585,0.000029369805,0.0000017085156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012668361,0.0030801776,0.98911977,0.000044391196,0.0012366003,0.000057690675,0.0001726839,0.000051432417,0.00011604714,0.0010476179,0.0007194642,0.0030873173],"study_design_scores_gemma":[0.030012578,0.0007802176,0.96320194,0.000029590243,0.0011207962,0.00006116412,0.00008701598,0.0023541022,0.0004922843,0.00009506118,0.0016417396,0.00012349189],"about_ca_topic_score_codex":0.00067438185,"about_ca_topic_score_gemma":0.0066402503,"teacher_disagreement_score":0.02874574,"about_ca_system_score_codex":0.00009769277,"about_ca_system_score_gemma":0.00022312865,"threshold_uncertainty_score":0.5291618},"labels":[],"label_agreement":null},{"id":"W2519431380","doi":"10.1016/j.jasc.2015.09.123","title":"Value of Fine Needle Aspiration Combined with Ancillary Tests as a Diagnostic Modality in Hodgkin Lymphoma: A 10-Year Experience in One Academic Institution","year":2015,"lang":"en","type":"article","venue":"Journal of the American Society of Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hodgkin lymphoma; Modality (human–computer interaction); Value (mathematics); Lymphoma; Radiology; Fine-needle aspiration; Medical physics; Internal medicine; Biopsy; Artificial intelligence; Statistics","score_opus":0.044496314609232285,"score_gpt":0.3156367805934778,"score_spread":0.27114046598424546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519431380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666864,0.0003480733,0.00008861161,0.0024848979,0.00005861724,0.00026641096,0.000004006989,0.0000041560374,0.00007656398],"genre_scores_gemma":[0.9967315,0.00019393611,0.0024251596,0.00055828685,0.00005411559,0.000017557879,0.0000017792242,0.000008393923,0.000009278884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984498,0.00020270889,0.0006198488,0.00014126432,0.000410222,0.00017617045],"domain_scores_gemma":[0.9982066,0.00023759641,0.0010074207,0.00021955359,0.00023960388,0.000089227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065276853,0.00012947303,0.0006941831,0.00008602157,0.000020954914,0.0000027372712,0.00015675064,0.000082358376,0.0000040290047],"category_scores_gemma":[0.00081085274,0.000086163294,0.00015268443,0.0005678766,0.0006584857,0.000115257215,0.00006054518,0.00017056851,0.0000011742613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016071324,0.0013803401,0.98045135,0.000037758477,0.000046496687,0.00008833452,0.0040626936,0.0006754164,0.008077776,0.00019250333,0.00019076453,0.0031894173],"study_design_scores_gemma":[0.0078102695,0.005170173,0.9769738,0.00038254677,0.00008902404,0.0004558534,0.002046692,0.00015666708,0.006424469,0.0003777381,0.000036238947,0.00007658128],"about_ca_topic_score_codex":0.00048154977,"about_ca_topic_score_gemma":0.00003148877,"teacher_disagreement_score":0.006203137,"about_ca_system_score_codex":0.00047328838,"about_ca_system_score_gemma":0.00072638155,"threshold_uncertainty_score":0.35136372},"labels":[],"label_agreement":null},{"id":"W2520661042","doi":"10.1177/1066896916671195","title":"Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Mantle cell lymphoma; Follicular lymphoma; Medicine; Non-Hodgkin's lymphoma; Lymph node; Pathology","score_opus":0.01264871181757791,"score_gpt":0.28014235749981914,"score_spread":0.2674936456822412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520661042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991204,0.0004959196,0.00024535297,0.0054931683,0.00095779815,0.00024661067,0.00012806512,0.000014067862,0.0012149886],"genre_scores_gemma":[0.9977975,0.0005315409,0.0008189238,0.00035736465,0.00020428492,0.000025118745,0.00001861172,0.00003081486,0.00021582362],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99685496,0.00031251975,0.001441651,0.00035425083,0.0006585044,0.00037809418],"domain_scores_gemma":[0.9973761,0.00070207956,0.0007748359,0.0002442298,0.00058520207,0.00031755125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004765841,0.00030684142,0.0009577886,0.0005328114,0.00003519575,0.00001998961,0.0002934736,0.0002891969,0.00020225624],"category_scores_gemma":[0.00018329188,0.0001979046,0.0005153077,0.0002205399,0.00026000978,0.00018565416,0.0001328407,0.000101245634,0.000024123481],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008495581,0.0075186663,0.14848284,0.000025175863,0.0007543276,0.53375787,0.00043604788,0.000005957999,0.024733925,0.0014011713,0.0065402845,0.26784813],"study_design_scores_gemma":[0.13366477,0.0068863137,0.16920045,0.0015519267,0.00039140694,0.5633906,0.00022959479,0.00023676654,0.06216007,0.0014053793,0.060166623,0.0007160838],"about_ca_topic_score_codex":0.00011534183,"about_ca_topic_score_gemma":0.000029379831,"teacher_disagreement_score":0.26713204,"about_ca_system_score_codex":0.00089989963,"about_ca_system_score_gemma":0.00035247926,"threshold_uncertainty_score":0.8070316},"labels":[],"label_agreement":null},{"id":"W2521453944","doi":"10.1182/blood.v120.21.3689.3689","title":"Long-Term Survival Analyses of an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; CD30; Population; Refractory (planetary science); Phases of clinical research; Lymphoma; Surgery; Chemotherapy","score_opus":0.040776685882515824,"score_gpt":0.33981409046630995,"score_spread":0.29903740458379413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521453944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989159,0.00021430696,8.3360334e-7,0.0000036165868,0.00006435998,0.0006629813,0.00002050626,0.00001753897,0.00009992681],"genre_scores_gemma":[0.9996444,0.000011407595,0.00014001159,0.000010138031,0.000044688535,0.000033620643,0.0000751403,0.000026243366,0.000014349445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845517,0.00013357386,0.00045566537,0.00024180482,0.00044937886,0.00026439477],"domain_scores_gemma":[0.9989191,0.00010322662,0.00027112316,0.00045268342,0.00010166437,0.00015215247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017393219,0.00019541151,0.000594492,0.00020041532,0.000026225365,0.0000060920033,0.00008336918,0.00005790126,0.000052328767],"category_scores_gemma":[0.000057346046,0.00012706126,0.000059685666,0.00029510853,0.00004013717,0.00016546206,0.00003558231,0.000044345685,0.0000026979571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019988217,0.16921872,0.8176461,0.00006399896,0.00049910444,0.000083270555,0.0009710824,7.539295e-7,0.0003762365,0.0000010746545,0.0000017619989,0.009139071],"study_design_scores_gemma":[0.10590732,0.012085193,0.8697584,0.00018249545,0.0010323445,0.000006079696,0.00034866817,0.0000017450094,0.010563587,1.9949022e-7,0.0000020504172,0.00011187686],"about_ca_topic_score_codex":0.00047089375,"about_ca_topic_score_gemma":0.00026340384,"teacher_disagreement_score":0.15713352,"about_ca_system_score_codex":0.000079209334,"about_ca_system_score_gemma":0.00010506047,"threshold_uncertainty_score":0.5181408},"labels":[],"label_agreement":null},{"id":"W2521817506","doi":"10.1182/blood.v104.11.697.697","title":"High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Cyclin D1; Biology; Molecular biology; Mantle cell lymphoma; Cell growth; Gene; Untranslated region; Gene expression; Cyclin; Cancer research; Cyclin D; Messenger RNA; Genetics; Cell cycle; Lymphoma; Immunology","score_opus":0.010036719467475015,"score_gpt":0.22856251152927282,"score_spread":0.2185257920617978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521817506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976995,0.0007263511,0.00003117075,0.00034498918,0.000019673265,0.0008061116,0.00031725073,0.000025657253,0.00002932205],"genre_scores_gemma":[0.9985717,0.00041582625,0.00042954812,0.00013557727,0.000010164079,0.000114776194,0.00028348455,0.00002122524,0.000017702896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873066,0.00013681776,0.00032844816,0.0004129681,0.00019027466,0.00020085984],"domain_scores_gemma":[0.999137,0.0002334501,0.0001891218,0.0002072478,0.00008256354,0.00015062184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023346774,0.00020861362,0.00040289832,0.000081192906,0.0001165985,0.000032003085,0.000031616368,0.00011913134,0.00002271417],"category_scores_gemma":[0.00007924035,0.00016963194,0.000030567564,0.00013901027,0.000114208204,0.00011003006,0.000027416902,0.00005566972,0.0000012385904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025603297,0.0047659893,0.7984774,0.00009033933,0.00014552764,0.000029701803,0.0011697469,0.000003597961,0.19482416,0.000007797393,0.000024115705,0.0002056032],"study_design_scores_gemma":[0.016849894,0.00023517966,0.5296884,0.00014830376,0.00025865546,0.0000055907176,0.00011581077,0.00003502032,0.4524873,0.0000682378,0.000004121967,0.000103488936],"about_ca_topic_score_codex":0.0018068333,"about_ca_topic_score_gemma":0.0007093069,"teacher_disagreement_score":0.268789,"about_ca_system_score_codex":0.00012701984,"about_ca_system_score_gemma":0.00019092303,"threshold_uncertainty_score":0.69173896},"labels":[],"label_agreement":null},{"id":"W2522067962","doi":"10.1182/blood.v110.11.643.643","title":"90Y-Ibritumomab Tiuxetan (Zevalin®) Consolidation of First Remission in Advanced Stage Follicular Non-Hodgkin’s Lymphoma: First Results of the International Randomized Phase 3 First-Line Indolent Trial (FIT) in 414 Patients.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ibritumomab tiuxetan; Internal medicine; Follicular lymphoma; Tolerability; Clinical endpoint; Gastroenterology; Radioimmunotherapy; Surrogate endpoint; Rituximab; Neutropenia; Surgery; Lymphoma; Randomized controlled trial; Chemotherapy; Adverse effect; Immunology","score_opus":0.015682039471903168,"score_gpt":0.2934166943824472,"score_spread":0.27773465491054405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522067962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480677,0.00024266858,0.00002024382,0.00057807943,0.00039582574,0.0030715114,0.00015702976,0.0000149836,0.00071288965],"genre_scores_gemma":[0.9986982,0.0003535892,0.0002819879,0.00005232693,0.00009123031,0.00014969474,0.0002762817,0.000022890028,0.000073815245],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968379,0.00010505602,0.0016336708,0.00041158244,0.00073286827,0.00027891496],"domain_scores_gemma":[0.99768174,0.0007090544,0.0007989905,0.0004825097,0.00022174674,0.00010597017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011442221,0.000263997,0.0009229485,0.00028848078,0.000059618276,0.00001161439,0.00021095233,0.00015570769,0.000036089317],"category_scores_gemma":[0.0014572737,0.0001835062,0.0003258129,0.0003884025,0.00010797705,0.00010338586,0.000105193154,0.00009588954,0.0000024461115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8337946,0.044193886,0.1121756,0.00026046915,0.00046342908,0.00018605635,0.0016834725,0.00028822426,0.0008586957,0.000059419403,0.00017112325,0.00586505],"study_design_scores_gemma":[0.8643401,0.00095400086,0.0419708,0.0011262381,0.00025504126,0.0000059444224,0.00008059467,0.00060868805,0.089234926,0.000017395567,0.0012615033,0.00014472904],"about_ca_topic_score_codex":0.0006083686,"about_ca_topic_score_gemma":0.0011774164,"teacher_disagreement_score":0.08837623,"about_ca_system_score_codex":0.00034621183,"about_ca_system_score_gemma":0.00015945014,"threshold_uncertainty_score":0.7483166},"labels":[],"label_agreement":null},{"id":"W2522288054","doi":"10.1182/blood.v126.23.3986.3986","title":"Phase 1b Study of PD-1 Blockade with Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Population; Phases of clinical research; Cohort; Clinical trial; Immunotherapy; Cancer","score_opus":0.011035163639854916,"score_gpt":0.23569552636451696,"score_spread":0.22466036272466205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522288054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599886,0.0003860367,0.000002082735,0.000027862132,0.00005111166,0.0012029292,0.000040956027,0.00004197798,0.0022482125],"genre_scores_gemma":[0.9991949,0.000010367683,0.00026520237,0.00008228777,0.00006190196,0.00012769211,0.00011159844,0.000047280577,0.00009876286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978329,0.000079304555,0.00040569194,0.00043150428,0.0008574372,0.0003931909],"domain_scores_gemma":[0.99865603,0.00006726033,0.00023014132,0.0005015685,0.00021837349,0.0003266463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015249102,0.00030761873,0.0006077222,0.000191454,0.0000395848,0.000010992553,0.000116701405,0.000085408625,0.000017431475],"category_scores_gemma":[0.000033596003,0.00020204451,0.00004836021,0.00030050406,0.00005756431,0.00011037198,0.000062026,0.00010338749,0.000017328799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051048915,0.33697706,0.65419984,0.00006537551,0.00023008758,0.00063389196,0.0015879269,0.000001256754,0.00002391271,0.000002420596,0.00012259078,0.0010507249],"study_design_scores_gemma":[0.43426722,0.03033378,0.5324611,0.00014665484,0.00069704326,0.000033231383,0.0006118597,0.0000039475694,0.0010662489,0.0000013839882,0.0002113769,0.00016613274],"about_ca_topic_score_codex":0.00016476611,"about_ca_topic_score_gemma":0.00011570283,"teacher_disagreement_score":0.42916232,"about_ca_system_score_codex":0.00022708632,"about_ca_system_score_gemma":0.0005331863,"threshold_uncertainty_score":0.8239136},"labels":[],"label_agreement":null},{"id":"W2522335594","doi":"10.1182/blood.v118.21.2701.2701","title":"First Evidence for High Incidence of Complete and Sustained Molecular Remissions and Maintenance of Immune Responses in Patients Receiving Consolidation with Y90 Ibritumomab Tiuxetan (90Y-RIT) Post R-CHOP for Newly Diagnosed Advanced Stage High and Intermediate Risk Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Ibritumomab tiuxetan; Internal medicine; Follicular lymphoma; Maintenance therapy; Regimen; Chemotherapy regimen; Gastroenterology; Clinical endpoint; Oncology; Chemotherapy; Lymphoma; Surgery; Radioimmunotherapy; Immunology; Clinical trial; Antibody","score_opus":0.013893546371635406,"score_gpt":0.24635784212886425,"score_spread":0.23246429575722885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522335594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956722,0.001555267,0.00032243185,0.00012988849,0.000022900422,0.0019972639,0.0002808118,0.000014488889,0.000004694513],"genre_scores_gemma":[0.99070716,0.0011112316,0.0077925017,0.000036467492,0.0000053618905,0.00026187755,0.000046646634,0.000027454393,0.0000112893185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853086,0.00007894869,0.00053131016,0.00041661455,0.00017889784,0.00026334642],"domain_scores_gemma":[0.9974498,0.0012637208,0.0004590626,0.00030692006,0.0003950749,0.00012543499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026811557,0.00022642178,0.0005738282,0.00014935042,0.00009093805,0.0000142281715,0.000077210876,0.00007286934,0.000003097908],"category_scores_gemma":[0.0026170688,0.00018034888,0.000052871135,0.00014358114,0.00021625872,0.0001969656,0.00007976427,0.000042105046,6.992844e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013205421,0.0017652079,0.9625258,0.0012767629,0.00031512915,0.00016582645,0.0016551586,0.0000057506327,0.012380737,0.0009915666,0.0000070664155,0.005705593],"study_design_scores_gemma":[0.035770718,0.004035151,0.9204278,0.0030670483,0.0004453155,0.00001832373,0.00037434732,0.00009146069,0.03524603,0.00034103554,0.0000068873246,0.000175875],"about_ca_topic_score_codex":0.0010167243,"about_ca_topic_score_gemma":0.00026502647,"teacher_disagreement_score":0.04209797,"about_ca_system_score_codex":0.00006424183,"about_ca_system_score_gemma":0.00013010879,"threshold_uncertainty_score":0.73544145},"labels":[],"label_agreement":null},{"id":"W2522966186","doi":"10.1182/blood.v126.23.2699.2699","title":"Outcome of Observation As Initial Strategy in Patients with Mantle Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Lymphoma; B symptoms; Surgery","score_opus":0.038644228152236317,"score_gpt":0.27623849583019255,"score_spread":0.23759426767795624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522966186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925986,0.000051745275,6.495979e-7,0.000039419247,0.000027160795,0.0002408153,0.000008737438,0.000010663188,0.007022225],"genre_scores_gemma":[0.9994895,0.0000023192788,0.00018671095,0.00010040035,0.000020915611,0.0000166514,0.00006039795,0.0000093586605,0.00011376369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993676,0.00001378914,0.00018613657,0.000112611284,0.00021622621,0.00010363133],"domain_scores_gemma":[0.9996226,0.000014489897,0.00006299941,0.00013769622,0.00008776758,0.00007444118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043533502,0.00008077806,0.00017670463,0.000047348323,0.00000743513,0.0000049687537,0.000029689914,0.000041519466,0.000017072975],"category_scores_gemma":[0.000016627768,0.000057280362,0.00002316021,0.00009716711,0.000015288724,0.000054211316,0.00001194922,0.000017276125,0.000031003045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018422381,0.005937431,0.9924764,0.000026263902,0.000028939041,0.00005337373,0.000096132855,0.0000040083937,0.000009766156,0.00006801427,0.000048882222,0.0010665876],"study_design_scores_gemma":[0.034156244,0.001603555,0.95562893,0.000036787696,0.000107020845,0.0000035871751,0.000070327245,0.000004548859,0.008228447,0.000035102796,0.00006820802,0.000057209614],"about_ca_topic_score_codex":0.00044563098,"about_ca_topic_score_gemma":0.000024805964,"teacher_disagreement_score":0.036847416,"about_ca_system_score_codex":0.00005164219,"about_ca_system_score_gemma":0.00011248767,"threshold_uncertainty_score":0.23358254},"labels":[],"label_agreement":null},{"id":"W2523611938","doi":"10.1182/blood.v122.21.500.500","title":"Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Lymphoma; Proportional hazards model; Cancer research; Oncology; Medicine; Immunology; Internal medicine","score_opus":0.007682276603494731,"score_gpt":0.22125829962040677,"score_spread":0.21357602301691203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523611938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148685,0.0045579807,0.0000065462677,0.00015982188,0.000119626944,0.000762668,0.00003517115,0.000038746377,0.002832566],"genre_scores_gemma":[0.9975788,0.0005461353,0.00043487785,0.0001026945,0.00009429244,0.0003849201,0.000064404245,0.000029907627,0.00076397916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985968,0.000058674494,0.0004094278,0.00031589073,0.00020533605,0.0004139084],"domain_scores_gemma":[0.99929523,0.00007135537,0.00006277667,0.00039321478,0.000045315213,0.00013210904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008264307,0.00020357333,0.000331874,0.00014434983,0.000058954032,0.000057621637,0.00009168304,0.000099874975,0.00016195033],"category_scores_gemma":[0.000016255455,0.00017139084,0.00009497913,0.00020578584,0.00003149787,0.00008795159,0.000063574094,0.000054911845,0.00023930392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026886664,0.053301815,0.9334559,0.000074747484,0.000042873417,0.00037401647,0.0004887499,0.000006432991,0.010628574,0.000025364065,0.00012791029,0.0014467645],"study_design_scores_gemma":[0.058775306,0.00023987258,0.9035804,0.000057187015,0.000093554285,0.000025055071,0.00012810937,0.000261814,0.036137212,0.000026068366,0.000522786,0.00015258693],"about_ca_topic_score_codex":0.0017283162,"about_ca_topic_score_gemma":0.00046940625,"teacher_disagreement_score":0.058748417,"about_ca_system_score_codex":0.00009566179,"about_ca_system_score_gemma":0.0001232142,"threshold_uncertainty_score":0.69891155},"labels":[],"label_agreement":null},{"id":"W2524351293","doi":"10.1016/j.ijrobp.2016.09.031","title":"Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK","keywords":"Positron emission tomography; Nuclear medicine; Positron Emission Tomography-Computed Tomography; Lymphoma; Computed tomography; Tomography; Medicine; Medical physics; Radiology; Internal medicine","score_opus":0.022704247675201895,"score_gpt":0.3352175630200913,"score_spread":0.3125133153448894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524351293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933316,0.0008912494,0.0017756828,0.0027317519,0.0006032515,0.0005474664,0.000016103448,0.000012648911,0.00009024444],"genre_scores_gemma":[0.9968735,0.0005282442,0.0014039488,0.0005705512,0.0005400551,0.000040368795,0.000021313917,0.000018800096,0.0000032431083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978712,0.0005389048,0.00078481005,0.00023052776,0.00040513696,0.00016939829],"domain_scores_gemma":[0.99764335,0.0006419931,0.0010082488,0.00021088292,0.00043379,0.00006174188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078593276,0.00020092218,0.00039791927,0.00026908508,0.00007735399,0.000033843324,0.0002804831,0.00013880355,0.000016864231],"category_scores_gemma":[0.000040620864,0.00010644243,0.00017357398,0.00026634277,0.00015731144,0.00022589069,0.000040972394,0.00014526231,8.0563706e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080894545,0.0037270284,0.8203762,0.000009819072,0.000375423,0.000023182267,0.0015926944,0.000010601197,0.044990614,0.00020404786,0.000095576885,0.12778588],"study_design_scores_gemma":[0.013010482,0.0020441294,0.9799047,0.00011776513,0.00020818211,0.00012265846,0.0004597802,0.0008416811,0.0021138075,0.00066603563,0.00040541103,0.0001053607],"about_ca_topic_score_codex":0.000040136656,"about_ca_topic_score_gemma":0.0000037632024,"teacher_disagreement_score":0.15952851,"about_ca_system_score_codex":0.0006520343,"about_ca_system_score_gemma":0.0003313113,"threshold_uncertainty_score":0.43405962},"labels":[],"label_agreement":null},{"id":"W2524477322","doi":"10.1182/blood.v120.21.745.745","title":"Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Université de Montréal; Queen's University; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; University of Manitoba; Juravinski Cancer Centre; Credit Valley Hospital; Saskatchewan Cancer Agency; CancerCare Manitoba; Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"DHAP; Medicine; Internal medicine; Autologous stem-cell transplantation; Transplantation; Oncology; Gemcitabine; Urology; Gastroenterology; Chemotherapy; Surgery","score_opus":0.02409864014999413,"score_gpt":0.29737026374673914,"score_spread":0.273271623596745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524477322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861214,0.0014210118,0.000659261,0.00043688662,0.00026106965,0.010342198,0.0003958804,0.00007590364,0.00028637538],"genre_scores_gemma":[0.9878696,0.00015307586,0.009507985,0.00037119005,0.00014105656,0.0014225696,0.000093672745,0.000075182754,0.00036563727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615735,0.000509871,0.0013166827,0.0007248572,0.0006292503,0.00066198746],"domain_scores_gemma":[0.9951762,0.0023884356,0.00092912954,0.0007679759,0.0002709866,0.0004672754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014295976,0.00057277904,0.0017307042,0.00027022028,0.00023130285,0.000036934685,0.000243664,0.00021002314,0.000027837388],"category_scores_gemma":[0.00044809017,0.00038942148,0.00035662524,0.00050135166,0.0001282718,0.00015086171,0.000055735673,0.00015899414,0.000009408004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70376694,0.04617572,0.07503376,0.000852003,0.0030451466,0.00020046771,0.053643752,0.00010318831,0.03423964,0.00008957374,0.0016832139,0.081166565],"study_design_scores_gemma":[0.745836,0.0035276716,0.16815263,0.0004894437,0.0035550166,0.00014114307,0.0011015745,0.00019423914,0.07623131,0.000011094878,0.00030372376,0.0004561229],"about_ca_topic_score_codex":0.00028591347,"about_ca_topic_score_gemma":0.00007672194,"teacher_disagreement_score":0.09311886,"about_ca_system_score_codex":0.0001689085,"about_ca_system_score_gemma":0.00023334981,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2524578933","doi":"10.1182/blood.v122.21.368.368","title":"High Response Rates To Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Trillium Health Centre","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Medicine; Lymphoma; Anaplastic large-cell lymphoma; Internal medicine; ALK inhibitor; Cancer research; Lung cancer; Oncology","score_opus":0.006270069326756354,"score_gpt":0.23959348460421814,"score_spread":0.23332341527746178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524578933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661845,0.00019212502,4.4796488e-7,0.0015844571,0.00008886166,0.0008658875,0.00001658268,0.000044964407,0.0005882523],"genre_scores_gemma":[0.9963202,0.000026191166,0.0016752308,0.0009784817,0.00003965676,0.0004284797,0.00003079097,0.000025088317,0.00047591192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881357,0.000046981855,0.0002771209,0.0003169608,0.00022744053,0.00031790297],"domain_scores_gemma":[0.9991566,0.00013199732,0.000050147337,0.00033795196,0.000104742045,0.00021859675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089172216,0.0001794706,0.00030030106,0.00012371517,0.0000371485,0.00002492394,0.00007581982,0.000059831,0.00019672558],"category_scores_gemma":[0.00025632247,0.00013922887,0.0000621907,0.0002199058,0.000020212998,0.000078229634,0.00005077362,0.000029472674,0.00063371606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022500043,0.010312277,0.94490564,0.000045227884,0.000093946,0.00028520083,0.00037891767,0.00000263589,0.009758538,0.00010049756,0.003019803,0.028847335],"study_design_scores_gemma":[0.01774191,0.00082514196,0.88289964,0.000121737634,0.00005790338,0.000008434107,0.00006054815,0.000001315505,0.09595833,0.000044377444,0.0021477542,0.0001329099],"about_ca_topic_score_codex":0.00035583202,"about_ca_topic_score_gemma":0.000026411823,"teacher_disagreement_score":0.08619979,"about_ca_system_score_codex":0.00014483342,"about_ca_system_score_gemma":0.00008223559,"threshold_uncertainty_score":0.8145349},"labels":[],"label_agreement":null},{"id":"W2524880168","doi":"10.1182/blood.v116.21.1751.1751","title":"Outcome of Patients with Chemotherapy Refractory and Early Progressive Diffuse Large B Cell Lymphoma After R-CHOP Treatment","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Refractory (planetary science); CHOP; Internal medicine; Rituximab; Gastroenterology; Diffuse large B-cell lymphoma; Lymphoma; B symptoms; Stage (stratigraphy); Chemotherapy; Progressive disease; Surgery","score_opus":0.0046010594749470515,"score_gpt":0.22424474328594318,"score_spread":0.21964368381099614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524880168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983851,0.0004675191,2.8703639e-7,0.00005915592,0.000042868378,0.0006560759,0.000057414738,0.000025006026,0.0003065923],"genre_scores_gemma":[0.99891454,0.000050772913,0.00045613843,0.000110808876,0.000045737335,0.00017822406,0.000015698568,0.000029788656,0.00019831925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991324,0.000011592506,0.00019656504,0.00025134394,0.00019863031,0.0002094996],"domain_scores_gemma":[0.9992986,0.000031230993,0.00011644971,0.0003304784,0.00007542704,0.00014783497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024863304,0.00020299811,0.00033306394,0.000053863758,0.000032491742,0.000013885748,0.000034210745,0.000085885935,0.000059738722],"category_scores_gemma":[0.000006188883,0.0001190152,0.00007131347,0.000052680058,0.00006156732,0.000054357566,0.000016974058,0.00003882715,0.000008249895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074654,0.043967158,0.94947356,0.00003852787,0.00021800332,0.00010352153,0.0004977278,1.2555487e-9,0.0002250809,0.000007682828,0.000007013913,0.0049542626],"study_design_scores_gemma":[0.07968625,0.0026044731,0.90258336,0.0000333375,0.00038190302,0.0000078362245,0.000013992132,2.4460584e-7,0.013041125,0.0000026676742,0.0015351403,0.000109686334],"about_ca_topic_score_codex":0.000042887845,"about_ca_topic_score_gemma":0.000019019391,"teacher_disagreement_score":0.07917878,"about_ca_system_score_codex":0.000035754634,"about_ca_system_score_gemma":0.00004114788,"threshold_uncertainty_score":0.48532993},"labels":[],"label_agreement":null},{"id":"W2524912268","doi":"10.1182/blood.v116.21.284.284","title":"Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Follicular lymphoma; Mantle cell lymphoma; Lymphoma; Internal medicine; Gastroenterology; Diffuse large B-cell lymphoma; Chronic lymphocytic leukemia; Oncology; Leukemia","score_opus":0.035364657079066546,"score_gpt":0.3763803681274077,"score_spread":0.34101571104834116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524912268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959387,0.00003879105,0.000001512412,0.00012716667,0.0006604528,0.0023972227,0.00005458042,0.00005270366,0.0007288739],"genre_scores_gemma":[0.9981967,0.00010787377,0.00061750493,0.00013369485,0.00036469597,0.0002546288,0.00008626541,0.00006681033,0.00017177987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557626,0.00042755538,0.001845468,0.000962629,0.00060043065,0.00058767403],"domain_scores_gemma":[0.9966472,0.001030744,0.0006922718,0.0010332345,0.00016708519,0.00042945758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012494181,0.00048818157,0.0017757294,0.00034281137,0.0000681077,0.000019523954,0.00024130942,0.00070251944,0.00017915166],"category_scores_gemma":[0.0011420607,0.00032942428,0.00040877706,0.00061819353,0.0003154528,0.00018315713,0.00012760957,0.00066429557,0.000034086494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11038796,0.15561959,0.64439917,0.000033740063,0.00029386114,0.00045277772,0.00012416289,1.3150728e-7,0.00014860297,0.0000050723343,0.00017425638,0.08836066],"study_design_scores_gemma":[0.41634837,0.025497027,0.5549408,0.00018770722,0.00042061022,0.000016476857,0.000014909576,0.000021646933,0.0018728307,0.0000041635503,0.0004654241,0.00021004022],"about_ca_topic_score_codex":0.00084418815,"about_ca_topic_score_gemma":0.0017723172,"teacher_disagreement_score":0.30596042,"about_ca_system_score_codex":0.000169098,"about_ca_system_score_gemma":0.0009942921,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2525064106","doi":"10.1182/blood.v114.22.1942.1942","title":"Diffuse Large B-Cell Lymphoma in the Very Elderly, a Study of Outcome in Patients Aged 80 and Older.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; International Prognostic Index; Regimen; Confidence interval; Lymphoma; Chemotherapy regimen; Oncology; Surgery; Chemotherapy","score_opus":0.011730174661212168,"score_gpt":0.2530456933996745,"score_spread":0.2413155187384623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525064106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984169,0.00031204423,6.105701e-8,0.000098686185,0.000019145986,0.00080579636,0.0000064892424,0.000008147932,0.00033270437],"genre_scores_gemma":[0.9995699,0.000029353805,0.000011527476,0.00030650815,0.000010917834,0.00003539506,0.000007963529,0.000006441307,0.000021977023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999078,0.000072291616,0.00027952244,0.0001785999,0.00021436984,0.00017724524],"domain_scores_gemma":[0.9995608,0.00006840683,0.00005911568,0.00025678883,0.000014567191,0.000040339066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013948676,0.00011851358,0.0002853927,0.00009071221,0.000024651585,0.000010014858,0.000064329746,0.000043622385,0.000004279789],"category_scores_gemma":[0.000028072618,0.000074316944,0.0000380349,0.00015208586,0.000010364709,0.000033726352,0.000022707054,0.00004418902,0.0000027927722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058684473,0.14565367,0.8488974,0.000017197102,0.000022414335,0.0001548585,0.0031498598,3.689569e-8,0.000015708449,0.000005974854,0.00003534654,0.0019888617],"study_design_scores_gemma":[0.12097539,0.0025787957,0.8752242,0.000041818897,0.00012726065,0.0000036202011,0.0007583767,0.0000012656332,0.00020800637,0.000009272754,0.000014411795,0.000057612386],"about_ca_topic_score_codex":0.00018173813,"about_ca_topic_score_gemma":0.0001820997,"teacher_disagreement_score":0.14307487,"about_ca_system_score_codex":0.000029323606,"about_ca_system_score_gemma":0.000014768165,"threshold_uncertainty_score":0.3030557},"labels":[],"label_agreement":null},{"id":"W2525078780","doi":"10.1200/jco.2007.25.18_suppl.8016","title":"Late treatment mortality and secondary cancers after autologous stem cell transplant for relapsed or refractory Hodgkin lymphoma (HL)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Salvage therapy; Chemotherapy; Melphalan; Surgery; Refractory (planetary science); Oncology; Gastroenterology","score_opus":0.10626775221254174,"score_gpt":0.42888301977899046,"score_spread":0.3226152675664487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525078780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935988,0.0023323451,0.00007085313,0.0012116686,0.0011492847,0.00048125122,0.000053768854,0.0000140133725,0.0010879909],"genre_scores_gemma":[0.9911127,0.0039212625,0.0017702314,0.0017498697,0.0006242033,0.000032132168,0.0000065933277,0.000022413442,0.00076057663],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99688435,0.00019074585,0.0020504291,0.00029241847,0.00022500151,0.00035705869],"domain_scores_gemma":[0.99479324,0.0031844901,0.0010842129,0.00020566488,0.0001640692,0.0005683323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001939688,0.00023296254,0.0016294689,0.000102116224,0.000053608906,0.000008931427,0.000073226875,0.0004933213,0.00010081834],"category_scores_gemma":[0.00010174238,0.00013439014,0.00055994594,0.000061921615,0.00018449314,0.00008174308,0.000013927629,0.0002268943,0.0000051773372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038577683,0.004345194,0.2317339,0.00010065386,0.0013094043,0.010807466,0.0005164662,0.0000029256325,0.00007011802,0.000013478577,0.0009052964,0.7116174],"study_design_scores_gemma":[0.03487825,0.041172653,0.82774293,0.00010042332,0.0016683495,0.0007553379,0.00012640993,0.000026656464,0.00075529976,0.000040344068,0.09260085,0.0001325066],"about_ca_topic_score_codex":0.00017185675,"about_ca_topic_score_gemma":0.0010548271,"teacher_disagreement_score":0.7114849,"about_ca_system_score_codex":0.0012399021,"about_ca_system_score_gemma":0.003162781,"threshold_uncertainty_score":0.56106377},"labels":[],"label_agreement":null},{"id":"W2525440522","doi":"10.1016/s2352-3026(16)30108-9","title":"The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Internal medicine; Hazard ratio; Vinblastine; Oncology; Interim analysis; Cohort; Chemotherapy regimen; Chemotherapy; Clinical trial; Vincristine; Confidence interval; Cyclophosphamide","score_opus":0.023154701309825797,"score_gpt":0.28746616756845117,"score_spread":0.2643114662586254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525440522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520016,0.0002436637,0.0000012274143,0.002396562,0.00007569286,0.0010993786,0.000027449063,0.000016725886,0.0009391227],"genre_scores_gemma":[0.99947786,0.00028888293,0.000022324894,0.000025802026,0.000018812561,0.000105717394,0.0000037317066,0.000012100254,0.000044770575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985336,0.00041211807,0.00046773933,0.00023889268,0.00011938295,0.00022823462],"domain_scores_gemma":[0.99896103,0.0003732376,0.0001771121,0.0004088106,0.000038431077,0.00004138932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044954938,0.00014754978,0.0008538362,0.00007794062,0.00003534266,0.0000047208014,0.00010517279,0.000033244392,0.00000791539],"category_scores_gemma":[0.00013268398,0.00006269641,0.000054381773,0.00012252043,0.0002846177,0.000025078818,0.00007678675,0.000036856465,0.000003718579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013368734,0.0015598837,0.9905528,0.00001831409,0.0002637587,0.00018750911,0.0008447571,2.1361768e-7,0.00035709722,0.00047911564,0.000048634105,0.0043510357],"study_design_scores_gemma":[0.01784639,0.0015499414,0.9784752,0.00010457906,0.00014989103,0.00016135938,0.00083782163,0.00010532672,0.00051240565,0.00009378062,0.00011637843,0.00004691422],"about_ca_topic_score_codex":0.00045183222,"about_ca_topic_score_gemma":0.0010331783,"teacher_disagreement_score":0.016509516,"about_ca_system_score_codex":0.00043595125,"about_ca_system_score_gemma":0.000053640193,"threshold_uncertainty_score":0.25566855},"labels":[],"label_agreement":null},{"id":"W2525561810","doi":"10.1111/bjh.14325","title":"Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B‐cell lymphoma is associated with poor outcomes and a high frequency of secondary <scp>CNS</scp> involvement","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal","keywords":"Medicine; Diffuse large B-cell lymphoma; Hazard ratio; Concomitant; Rituximab; Oncology; Internal medicine; Uterus; Lymphoma; Confidence interval; Gynecology","score_opus":0.011641997026197897,"score_gpt":0.24066100495847698,"score_spread":0.22901900793227908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525561810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994443,0.0021998829,0.0000626837,0.0019696648,0.00017722459,0.000514074,0.000523609,0.000018203857,0.000091660826],"genre_scores_gemma":[0.9957,0.0009785854,0.000634315,0.0009803057,0.000048443475,0.00004034299,0.00006415223,0.00003856348,0.0015153165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976253,0.00016584068,0.00090534985,0.00043752676,0.0004727623,0.00039325212],"domain_scores_gemma":[0.99762344,0.0003165687,0.0010662451,0.00027093405,0.00049558654,0.00022721903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035220291,0.00026507338,0.0010914191,0.00015021698,0.00011128822,0.000029216473,0.00012495003,0.00015031232,0.00013999177],"category_scores_gemma":[0.00033346988,0.00019263105,0.00013790271,0.00012581566,0.00018149114,0.00023405725,0.00012129307,0.00009311788,0.0000059744484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002719533,0.010742512,0.91975355,0.0003650459,0.0025952843,0.018308677,0.0016853091,7.943789e-8,0.022249416,0.00018769152,0.019450366,0.004390118],"study_design_scores_gemma":[0.04885909,0.0015211542,0.683638,0.00081182574,0.0005722579,0.016758777,0.0006860667,0.0000012234437,0.24605764,0.0002076957,0.0007487833,0.00013748041],"about_ca_topic_score_codex":0.0007304664,"about_ca_topic_score_gemma":0.00035997288,"teacher_disagreement_score":0.23611555,"about_ca_system_score_codex":0.00044475106,"about_ca_system_score_gemma":0.00029344353,"threshold_uncertainty_score":0.78552663},"labels":[],"label_agreement":null},{"id":"W2526251459","doi":"10.14740/jocmr2733w","title":"Primary B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma of the Hard Palate and Parotid Gland: Report of One Case and Review of the Literature","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; MALT lymphoma; Hard palate; Lymphoma; Parotid gland; Pathology; Lymphatic system; Mucosa-associated lymphoid tissue; Salivary gland; Biopsy; Rituximab; CHOP; Surgery","score_opus":0.09768679206375312,"score_gpt":0.4388473421380443,"score_spread":0.3411605500742912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526251459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91670156,0.05465047,8.6894397e-7,0.027161403,0.00020106432,0.00060954894,0.00002335331,0.0000019897313,0.00064976135],"genre_scores_gemma":[0.8617279,0.13689491,0.00008518795,0.00041001724,0.00026621725,0.0000054547286,0.0000021031337,0.00001306293,0.0005951822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943968,0.0011007042,0.0024560108,0.00022998647,0.0015697989,0.00024671256],"domain_scores_gemma":[0.9913339,0.004100523,0.0018804073,0.0006238294,0.0017424114,0.00031893037],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009575375,0.00015876825,0.0015583097,0.00012225435,0.00006511271,0.0000052625683,0.00021348339,0.00018334876,0.000059016063],"category_scores_gemma":[0.014187529,0.000057086498,0.00029066572,0.0004907069,0.0010353083,0.000061157036,0.00020712863,0.00033570273,5.155529e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081873767,0.0023610494,0.88785416,0.0058969427,0.0006763596,0.003981238,0.00026245645,2.0139717e-8,0.004910471,0.000028488987,0.012974885,0.080235206],"study_design_scores_gemma":[0.01725853,0.0037671647,0.8622183,0.08408236,0.000859205,0.015538782,0.00006301206,0.000001122893,0.011037619,0.0002176329,0.004879057,0.00007718334],"about_ca_topic_score_codex":0.00009904543,"about_ca_topic_score_gemma":0.000007853795,"teacher_disagreement_score":0.08224443,"about_ca_system_score_codex":0.00011885083,"about_ca_system_score_gemma":0.000763269,"threshold_uncertainty_score":0.99411637},"labels":[],"label_agreement":null},{"id":"W2526857253","doi":"10.1080/17474086.2016.1242404","title":"Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Immune system; Non-Hodgkin's lymphoma; Cancer research; Immunology; Immune checkpoint; Oncology; Immunotherapy","score_opus":0.014657470093788282,"score_gpt":0.29658655355149294,"score_spread":0.2819290834577047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526857253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033998538,0.7284473,0.000012406243,0.024546796,0.20806083,0.0043255924,0.00009445659,0.00006897246,0.00044507926],"genre_scores_gemma":[0.05369487,0.83090717,0.003834957,0.0014088199,0.107106194,0.0018644015,0.00022889797,0.00022543124,0.0007292579],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969176,0.00021119099,0.0010918139,0.0008341387,0.00045510774,0.0004901202],"domain_scores_gemma":[0.996894,0.0012860906,0.00052142603,0.0008535199,0.0001882145,0.00025673246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056479854,0.00065541535,0.0031244273,0.00021559348,0.000043329266,0.000031366857,0.00019387926,0.0007315065,0.0000691421],"category_scores_gemma":[0.0016998439,0.00040475026,0.00029510865,0.00015198541,0.00017411231,0.000100021134,0.00033593015,0.00019424279,0.000029072673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023892408,0.00046912744,0.0075072823,0.0058284495,0.00026218037,0.0003767139,0.0007579685,1.9202984e-9,0.00007750347,0.000108551605,0.951919,0.032454297],"study_design_scores_gemma":[0.0045138495,0.00043539194,0.0028000912,0.062827535,0.00020605754,0.0002305245,0.000044940876,1.2096022e-7,0.0020400845,0.000070922506,0.9263913,0.00043920949],"about_ca_topic_score_codex":0.00040171423,"about_ca_topic_score_gemma":0.000046607667,"teacher_disagreement_score":0.10245985,"about_ca_system_score_codex":0.00026553805,"about_ca_system_score_gemma":0.00029419162,"threshold_uncertainty_score":0.99984044},"labels":[],"label_agreement":null},{"id":"W2527747276","doi":"10.1200/jco.2010.28.15_suppl.8059","title":"Clinically significant delayed cardiac morbidity following ABVD chemotherapy for Hodgkin lymphoma: A population-based study.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cohort; Population; Relative risk; Chemotherapy; Risk factor; Cardiotoxicity; Cumulative incidence; Surgery; Gastroenterology; Confidence interval","score_opus":0.08153598012980946,"score_gpt":0.46023551347404956,"score_spread":0.3786995333442401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527747276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876107,0.000062987754,0.00032777808,0.0049171816,0.004548474,0.0011364904,0.000016529995,0.000022983892,0.0002065058],"genre_scores_gemma":[0.97992074,0.000051054376,0.015057866,0.002629661,0.002155872,0.000061566956,0.000016760554,0.000037088474,0.00006936891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947539,0.00044192025,0.0035566976,0.00037407447,0.0005379837,0.0003354519],"domain_scores_gemma":[0.98861814,0.007872955,0.0020246445,0.00041821154,0.00052296,0.000543106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067167166,0.0002474293,0.0024362507,0.00012475261,0.00010020773,0.000030152985,0.0002183809,0.0005698852,0.00005516246],"category_scores_gemma":[0.005784546,0.00016990183,0.0022054766,0.00013942787,0.00007282179,0.00011365422,0.000025546253,0.0005163437,0.000009117225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063052694,0.01315639,0.84950435,0.000010222551,0.001466192,0.00039608992,0.0000464192,0.000007863615,0.00023538459,0.00003614306,0.0014813157,0.12735437],"study_design_scores_gemma":[0.039521888,0.025000341,0.9204663,0.000033732504,0.0014577297,0.000016415124,0.00007191386,0.00016337502,0.00012075319,0.0001865262,0.0128079755,0.00015304041],"about_ca_topic_score_codex":0.00018595449,"about_ca_topic_score_gemma":0.00009325272,"teacher_disagreement_score":0.12720132,"about_ca_system_score_codex":0.00025133032,"about_ca_system_score_gemma":0.0026329102,"threshold_uncertainty_score":0.69283956},"labels":[],"label_agreement":null},{"id":"W2528175579","doi":"10.1182/blood.v104.11.157.157","title":"First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Interim analysis; Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy regimen; Regimen; Clinical endpoint; CHOP; Surgery; Median follow-up; International Prognostic Index; Neutropenia; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Clinical trial","score_opus":0.0039887029909557985,"score_gpt":0.19879649946753983,"score_spread":0.19480779647658403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528175579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968422,0.000027873046,0.000036273825,0.00007801835,0.000039182432,0.0016755885,0.0012783799,0.000006477319,0.000016009913],"genre_scores_gemma":[0.9992112,0.000016362594,0.00011100777,0.000034074703,0.000011226644,0.00014749476,0.00043702457,0.000019407438,0.000012229958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981969,0.000045376724,0.0006325149,0.00031002256,0.00064853433,0.00016666262],"domain_scores_gemma":[0.9980787,0.00010608605,0.00087987195,0.00047340826,0.00038584776,0.00007608915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015942985,0.00019772502,0.00053488463,0.00022196407,0.000050671144,0.000015542291,0.0001663633,0.000042533982,0.0000074990808],"category_scores_gemma":[0.000055273485,0.00010408482,0.00012002469,0.0005209836,0.00012505679,0.000100963676,0.000048876675,0.00004674869,7.0264775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015517875,0.044966083,0.93651485,0.00011665741,0.0016724329,0.0000022113986,0.00082225003,0.000054618926,0.00023771888,0.000020270949,0.000010995697,0.0000640177],"study_design_scores_gemma":[0.1947418,0.0013988245,0.7994341,0.00020645127,0.0027112854,3.0430022e-7,0.00011317573,0.0001223634,0.0011737379,0.000004643779,0.0000061217715,0.00008719869],"about_ca_topic_score_codex":0.0012397654,"about_ca_topic_score_gemma":0.0010988273,"teacher_disagreement_score":0.17922392,"about_ca_system_score_codex":0.000118475655,"about_ca_system_score_gemma":0.00009236739,"threshold_uncertainty_score":0.4244456},"labels":[],"label_agreement":null},{"id":"W2528368797","doi":"10.1016/j.ijrobp.2016.06.1879","title":"Total Body Irradiation in Relapsed Follicular Lymphoma: Outcomes and Early Toxicity","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Total body irradiation; Regimen; Follicular lymphoma; Melphalan; Surgery; Internal medicine; Transplantation; Urology; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.013553262360357574,"score_gpt":0.303963271064536,"score_spread":0.29041000870417844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528368797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064314,0.00046104725,0.00060607225,0.0067443545,0.0010247064,0.00021622477,0.000026521691,0.00002138714,0.00025656962],"genre_scores_gemma":[0.997418,0.00055412424,0.00070633215,0.0005591963,0.0006432772,0.000018019298,0.0000137947145,0.000017480108,0.00006977093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846834,0.00014685033,0.00069039705,0.00022714595,0.0002629522,0.00020431282],"domain_scores_gemma":[0.99829304,0.00047674388,0.00064970955,0.00012633097,0.00031487172,0.00013932901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003731938,0.00018783864,0.00051140477,0.00021053448,0.000041076248,0.000020926911,0.00013627078,0.00021853068,0.000032655877],"category_scores_gemma":[0.00037184186,0.00012498313,0.00020354823,0.00010941247,0.00010897308,0.0002539254,0.00004310095,0.000109994005,0.000022502622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022203715,0.0007391358,0.8496115,0.0000027271033,0.00039671373,0.00010262041,0.00017412647,0.000012111386,0.0031928963,0.0054672547,0.000162263,0.13991657],"study_design_scores_gemma":[0.018274684,0.0010216201,0.9713113,0.00006846135,0.00010525704,0.00023702112,0.000020549185,0.00013209495,0.0023143743,0.00397179,0.0024166338,0.00012621576],"about_ca_topic_score_codex":0.000053442458,"about_ca_topic_score_gemma":0.000005397858,"teacher_disagreement_score":0.13979036,"about_ca_system_score_codex":0.0012651006,"about_ca_system_score_gemma":0.00034045643,"threshold_uncertainty_score":0.5096664},"labels":[],"label_agreement":null},{"id":"W2528899113","doi":"10.1016/j.clon.2016.09.006","title":"Management of Early-stage Hodgkin Lymphoma: A Practice Guideline","year":2016,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; McMaster University; Juravinski Hospital; Cancer Care Ontario; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Northeast Cancer Centre","funders":"Cancer Care Ontario; National Cancer Research Institute","keywords":"Medicine; Guideline; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Oncology; Intensive care medicine; Internal medicine; Pathology","score_opus":0.08604856218510758,"score_gpt":0.4654914463950754,"score_spread":0.3794428842099678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528899113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8231975,0.00062081555,0.0007666465,0.06467402,0.0011128373,0.00092002057,0.000026080275,0.00010220513,0.108579874],"genre_scores_gemma":[0.9573605,0.0024589477,0.028831655,0.004419321,0.0003228008,0.0000730939,0.000008214787,0.000020516689,0.0065049436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977067,0.00021217225,0.0012175565,0.0003780798,0.00023063742,0.00025484254],"domain_scores_gemma":[0.99682605,0.0017650925,0.0004469005,0.00050764135,0.00022515915,0.00022913623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011851013,0.00014122626,0.0006771116,0.000052656622,0.00002426202,0.0000031566526,0.00011644337,0.00023087175,0.00035658712],"category_scores_gemma":[0.00088376366,0.00008077797,0.00025697215,0.00011835884,0.00020993168,0.00006739661,0.0001417275,0.000054563498,0.00045363104],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022536537,0.007869576,0.08405144,0.000048130434,0.000960687,0.003301206,0.000026529839,2.0348847e-7,0.00003708778,0.006748782,0.024372354,0.87033033],"study_design_scores_gemma":[0.015318127,0.0047666905,0.27182376,0.00013349531,0.00056183053,0.00006044665,0.0000938198,0.000003633448,0.00021830547,0.00012720401,0.70681083,0.000081888895],"about_ca_topic_score_codex":0.00007299225,"about_ca_topic_score_gemma":0.000005867543,"teacher_disagreement_score":0.87024844,"about_ca_system_score_codex":0.00027141618,"about_ca_system_score_gemma":0.0002704558,"threshold_uncertainty_score":0.58306605},"labels":[],"label_agreement":null},{"id":"W2529899930","doi":"10.1016/j.ijrobp.2016.10.004","title":"Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Hazard ratio; Radiation therapy; Chemotherapy; Confidence interval; Internal medicine; Cancer; Cumulative incidence; Surgery; Oncology; Cohort","score_opus":0.006949511641562102,"score_gpt":0.28000621527318015,"score_spread":0.27305670363161805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529899930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867413,0.0009702116,0.0008533851,0.009249834,0.00090775883,0.00021715155,0.00070881366,0.000025232066,0.00032629594],"genre_scores_gemma":[0.99265015,0.004264747,0.0003315433,0.0012168906,0.0012392418,0.00006428862,0.00006366481,0.000028715549,0.00014076757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983112,0.00019866526,0.00063731894,0.00026325145,0.00029238558,0.00029713105],"domain_scores_gemma":[0.9978968,0.00028173786,0.0010250745,0.00014054515,0.0004731576,0.00018270558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039557973,0.00022029191,0.0004938058,0.00019359574,0.00005009209,0.00002128929,0.0002137026,0.00019849288,0.00043048724],"category_scores_gemma":[0.0000900217,0.00014190908,0.0001049088,0.00017976285,0.00014832265,0.00037907241,0.000031630156,0.0001761558,0.000043218333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010686335,0.00056621083,0.503331,0.0000025619215,0.0004808881,0.000044112527,0.00022180307,0.000028444247,0.0007365467,0.00013966973,0.0046013542,0.4887788],"study_design_scores_gemma":[0.02418344,0.0016356563,0.8946023,0.00013544977,0.00012504047,0.0004239053,0.000069076916,0.00016115834,0.0014347184,0.0012491586,0.075785294,0.00019479569],"about_ca_topic_score_codex":0.00015154359,"about_ca_topic_score_gemma":0.000022773253,"teacher_disagreement_score":0.48858398,"about_ca_system_score_codex":0.003937774,"about_ca_system_score_gemma":0.0011683665,"threshold_uncertainty_score":0.9998859},"labels":[],"label_agreement":null},{"id":"W2530152170","doi":"10.1182/blood.v120.21.1638.1638","title":"CSF1R Inhibition by PLX3397 in Patients with Relapsed or Refractory Hodgkin Lymphoma: Results From a Phase 2 Single Agent Clinical Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Leukopenia; Refractory (planetary science); Anemia; Progression-free survival; Clinical endpoint; Adverse effect; Transplantation; Clinical trial; Surgery; Oncology; Toxicity; Chemotherapy","score_opus":0.04885471872648443,"score_gpt":0.3190104074154474,"score_spread":0.27015568868896295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530152170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711204,0.00030004833,0.0000025645613,0.00014686547,0.00037394476,0.0011206425,0.00042937178,0.00005496718,0.00045957725],"genre_scores_gemma":[0.99658346,0.00005041204,0.00046955427,0.0003121331,0.0005106216,0.00010685617,0.0018141683,0.00003388012,0.00011891044],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781823,0.00017634362,0.0007864013,0.00042860204,0.0004197989,0.00037061874],"domain_scores_gemma":[0.99856436,0.0003631857,0.00028114853,0.00042129226,0.000057051424,0.00031295008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033912592,0.00023444205,0.00049196096,0.00007928879,0.00004802602,0.000020277204,0.000048396294,0.0002080644,0.000081682876],"category_scores_gemma":[0.00045002848,0.00015433934,0.000111746594,0.00016694747,0.000057999983,0.00016617056,0.000034371456,0.00010490935,0.00007027148],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31446666,0.31885326,0.3113078,0.000019911315,0.0004973631,0.0003310705,0.00072957674,1.0702217e-7,0.00034277164,0.0000046942405,0.012179084,0.041267704],"study_design_scores_gemma":[0.7228714,0.014189722,0.24954769,0.00023471635,0.0005065182,0.0000046135897,0.000040631017,0.0000014226159,0.004116404,0.0000035854546,0.008286708,0.00019655439],"about_ca_topic_score_codex":0.0002278341,"about_ca_topic_score_gemma":0.000040146417,"teacher_disagreement_score":0.4084048,"about_ca_system_score_codex":0.00024427293,"about_ca_system_score_gemma":0.0001429402,"threshold_uncertainty_score":0.6293776},"labels":[],"label_agreement":null},{"id":"W2530541558","doi":"10.1182/blood.v118.21.1603.1603","title":"Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD + Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Radiation therapy; Surgery; Chemotherapy regimen; Mediastinum; Randomized controlled trial; Regimen; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.013625426442576315,"score_gpt":0.2457542506291422,"score_spread":0.23212882418656589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530541558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953999,0.000059085214,0.000032941607,0.00024218549,0.000022873615,0.004062403,0.00007880255,0.000026724574,0.000075067095],"genre_scores_gemma":[0.99825907,0.00012397957,0.00029374138,0.00024330478,0.000044100132,0.0008016561,0.000101036545,0.000042702657,0.00009040287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99780905,0.0002813225,0.0006394995,0.000366885,0.00053034996,0.0003728686],"domain_scores_gemma":[0.99831015,0.0003862293,0.0005181149,0.000600415,0.00008935571,0.00009576583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042285922,0.00037135897,0.0011470435,0.00018568963,0.00006352241,0.000023543822,0.00026590843,0.000048090933,0.000064754546],"category_scores_gemma":[0.000054251814,0.00013321679,0.00012725125,0.00057673285,0.00025247555,0.000107590175,0.000030341947,0.000113589915,8.534451e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4918323,0.011362842,0.48405272,0.00001905726,0.0006927294,0.00024660188,0.006589527,5.5071024e-7,0.0000039491656,0.0000124370235,0.000021907352,0.005165382],"study_design_scores_gemma":[0.6658345,0.012438368,0.3193156,0.00018358734,0.00048687326,0.00001810518,0.0010050472,0.000007652764,0.0004805727,6.785854e-7,0.00008987333,0.00013915815],"about_ca_topic_score_codex":0.0048414324,"about_ca_topic_score_gemma":0.010153996,"teacher_disagreement_score":0.17400219,"about_ca_system_score_codex":0.0001160567,"about_ca_system_score_gemma":0.00017552852,"threshold_uncertainty_score":0.731883},"labels":[],"label_agreement":null},{"id":"W2530569835","doi":"10.1182/blood.v108.11.481.481","title":"MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Confidence interval; Prednisone; Vincristine; Internal medicine; International Prognostic Index; Surgery; Gastroenterology; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.002525771565474547,"score_gpt":0.19702309622568995,"score_spread":0.1944973246602154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530569835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939446,0.0030016203,0.000012663095,0.0001933966,0.00006273391,0.0018872748,0.000040133644,0.00011046182,0.00074711593],"genre_scores_gemma":[0.99643004,0.00055464264,0.001862253,0.00019043707,0.000081280654,0.0002865764,0.0002364565,0.00008872648,0.0002696095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978311,0.000043084627,0.00047718853,0.00068265665,0.0004014817,0.00056447694],"domain_scores_gemma":[0.9989648,0.00006926936,0.00018357656,0.0004690237,0.0001360096,0.00017730838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010175686,0.0004830244,0.00085914903,0.0001207609,0.00009095874,0.000048641406,0.00009858841,0.00014891513,0.000031685497],"category_scores_gemma":[0.000019891875,0.0003576956,0.00009596666,0.0003231019,0.00009533609,0.0001290853,0.00004339186,0.00007313944,0.000012196731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022239743,0.011154242,0.9580265,0.00014487715,0.00038688717,0.00037514852,0.0002167048,0.000009505451,0.0013202684,0.000032507276,0.00007991399,0.026029443],"study_design_scores_gemma":[0.12790552,0.001944288,0.8599444,0.00028792798,0.00035386163,0.000037887818,0.000029548599,0.00007039344,0.0085089095,0.000033463424,0.0005340221,0.00034980773],"about_ca_topic_score_codex":0.0021463712,"about_ca_topic_score_gemma":0.00034854852,"teacher_disagreement_score":0.12568153,"about_ca_system_score_codex":0.00027912276,"about_ca_system_score_gemma":0.00016191503,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W2530914402","doi":"10.1182/blood.v106.11.4674.4674","title":"BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Rituximab; Lymphoma; Internal medicine; CHOP; Gastroenterology; Oncology","score_opus":0.012768652552861307,"score_gpt":0.2563079367040805,"score_spread":0.24353928415121917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530914402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941755,0.0016424173,0.000002903719,0.00028544632,0.00010458885,0.00062764937,0.0000551969,0.00014194711,0.0029643842],"genre_scores_gemma":[0.9969395,0.00014505479,0.00016179738,0.00031114378,0.00011546828,0.00012969566,0.00009241662,0.000039738108,0.0020652069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827707,0.000107408465,0.00043046946,0.00037818708,0.00032740016,0.000479488],"domain_scores_gemma":[0.9991192,0.00012115922,0.00014785324,0.00039103432,0.000033747383,0.00018695567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002186977,0.0002658286,0.0005281894,0.00014690367,0.00006671883,0.000019563126,0.000101414815,0.00018788624,0.00007290963],"category_scores_gemma":[0.000067826055,0.00020200213,0.00018407538,0.0001897172,0.000014963928,0.00009129061,0.00006343138,0.000078348436,0.00053938536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068305264,0.031932775,0.9593348,0.00013554461,0.00008534434,0.0005044636,0.0003491423,0.0000021140859,0.0055368086,0.000026313131,0.0015039411,0.00052045874],"study_design_scores_gemma":[0.15810087,0.00032862354,0.7691922,0.0010918395,0.00060645485,0.00013547332,0.00025208402,0.00009159569,0.0658403,0.0000025683248,0.0039680917,0.00038986237],"about_ca_topic_score_codex":0.00006441002,"about_ca_topic_score_gemma":0.000055989633,"teacher_disagreement_score":0.19014254,"about_ca_system_score_codex":0.0004464748,"about_ca_system_score_gemma":0.000075623146,"threshold_uncertainty_score":0.82374084},"labels":[],"label_agreement":null},{"id":"W2531019340","doi":"10.1182/blood.v114.22.4350.4350","title":"Preference of Patients and Physicians Concerning Treatment Options for Relapsed Follicular Lymphoma: A Discrete Choice Experiment.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Follicular lymphoma; Radioimmunotherapy; Chemotherapy; Autologous stem-cell transplantation; Transplantation; Lymphoma; Oncology; Tolerability; Internal medicine; Adverse effect; Immunology","score_opus":0.026201862895615963,"score_gpt":0.27704980069445784,"score_spread":0.25084793779884185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531019340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996844,0.0014827108,0.0000327358,0.00016665083,0.000026467087,0.0008671374,0.00006935576,0.000027439377,0.00048352923],"genre_scores_gemma":[0.9977667,0.0002011603,0.0014046823,0.00008851959,0.000043718162,0.00024241346,0.00011003336,0.0000106483385,0.00013214248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928355,0.000014363984,0.00018042498,0.0002343514,0.00012112611,0.00016620362],"domain_scores_gemma":[0.999529,0.00005976145,0.00009594507,0.00018144998,0.00005954817,0.000074312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018083823,0.00014875384,0.00028951812,0.000032787768,0.000073905365,0.000010747395,0.000031118965,0.000043589214,0.000005272596],"category_scores_gemma":[0.000022383938,0.00011217048,0.00011027778,0.00005743883,0.00003127031,0.00005139088,0.000009901647,0.000011307496,0.0000014825326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007027398,0.04845028,0.7718938,0.00018034242,0.0024797285,0.000045210734,0.0062258276,0.000014835131,0.03289724,0.0041369344,0.00037021155,0.13260284],"study_design_scores_gemma":[0.048995975,0.00651105,0.7767401,0.00021845697,0.0014190222,0.0000053304393,0.00016194627,0.000066973946,0.16348156,0.00009392071,0.0021143025,0.00019138666],"about_ca_topic_score_codex":0.000054508408,"about_ca_topic_score_gemma":0.0000033323975,"teacher_disagreement_score":0.13241145,"about_ca_system_score_codex":0.00007806298,"about_ca_system_score_gemma":0.00003863276,"threshold_uncertainty_score":0.45741794},"labels":[],"label_agreement":null},{"id":"W2531065045","doi":"10.1182/blood.v126.23.2721.2721","title":"Gender and Obesity Do Not Impact Survival in Diffuse Large B-Cell Lymphoma: Justification for Full Weight-Based Chemotherapy Dosing in All Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Febrile neutropenia; Diffuse large B-cell lymphoma; Neutropenia; Internal medicine; Rituximab; Chemotherapy; Vincristine; Population; Cyclophosphamide; Chemotherapy regimen; Dosing; Lymphoma; Oncology; Surgery","score_opus":0.037283778952045266,"score_gpt":0.2910235548419686,"score_spread":0.25373977588992336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531065045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984712,0.000365669,0.00003940324,0.00011345466,0.00007032574,0.00073212077,0.00005632331,0.000019822626,0.00013165192],"genre_scores_gemma":[0.99888337,0.00004567954,0.00051859836,0.00023112181,0.000047915775,0.000077952114,0.00016288224,0.000023274726,0.000009218544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989617,0.000043222804,0.00022931445,0.000293146,0.00019318308,0.0002794382],"domain_scores_gemma":[0.9993969,0.00008170026,0.00007666917,0.00021382199,0.00006995576,0.00016092879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024088597,0.00017017566,0.0002792062,0.00011381083,0.000026496622,0.000024563775,0.000043603904,0.00009808169,0.0000048685697],"category_scores_gemma":[0.000040745595,0.00013361068,0.000064987566,0.00010668365,0.000015481673,0.000061183564,0.00001418328,0.00003332431,0.0000050765807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006435424,0.04348847,0.9528579,0.000070132555,0.00004608935,0.000016017768,0.00062271114,0.0000010062085,0.0005363868,0.000024856752,0.00009933045,0.0015935324],"study_design_scores_gemma":[0.16487427,0.00041974787,0.8235414,0.00003834934,0.00012149807,0.0000022600836,0.00005500579,0.00032373855,0.010188229,0.000028386243,0.00027963976,0.00012747577],"about_ca_topic_score_codex":0.00017682218,"about_ca_topic_score_gemma":0.000067289555,"teacher_disagreement_score":0.16423073,"about_ca_system_score_codex":0.00026031496,"about_ca_system_score_gemma":0.00013843225,"threshold_uncertainty_score":0.54484856},"labels":[],"label_agreement":null},{"id":"W2531128131","doi":"10.1182/blood.v124.21.3972.3972","title":"Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Chemoimmunotherapy; Rituximab; Follicular lymphoma; Transplantation; Internal medicine; Population; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Oncology; Chemotherapy regimen; Radiation therapy; Cancer; Lymphoma; Surgery","score_opus":0.008131069744632735,"score_gpt":0.22661918433901307,"score_spread":0.21848811459438033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531128131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978209,0.000034209632,0.00021123566,0.000007587477,0.000040687584,0.0011296957,0.0003400756,0.000015514928,0.0004000835],"genre_scores_gemma":[0.99829215,0.000008318762,0.00091726205,0.000008123143,0.000009900392,0.00022910134,0.00048734582,0.000011589009,0.000036224585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988902,0.00010363669,0.00032350954,0.00032081173,0.00018177523,0.00018001856],"domain_scores_gemma":[0.9989675,0.00051194994,0.00017652474,0.00019138066,0.00009051683,0.000062085484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019297986,0.00017348604,0.00063248427,0.00014808183,0.000051344796,0.000010179774,0.00005029615,0.00007801294,0.0000067921596],"category_scores_gemma":[0.000008783311,0.000116070725,0.000101629135,0.00039173223,0.000033737306,0.00006859742,0.000008892038,0.000025625577,0.0000010720123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013617899,0.012917914,0.96552014,0.0010590132,0.00274316,0.000034227556,0.0015253403,0.00019080871,0.00066024746,0.000103382554,0.000008209045,0.0016196363],"study_design_scores_gemma":[0.06978239,0.003937425,0.8697759,0.00016367146,0.0027671282,0.000005305352,0.00010037207,0.00033597017,0.05294328,0.000007204979,0.00005379201,0.00012753431],"about_ca_topic_score_codex":0.00025252232,"about_ca_topic_score_gemma":0.0007453918,"teacher_disagreement_score":0.095744245,"about_ca_system_score_codex":0.00009162119,"about_ca_system_score_gemma":0.00007759278,"threshold_uncertainty_score":0.4733227},"labels":[],"label_agreement":null},{"id":"W2531432151","doi":"10.1111/bjh.14392","title":"Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of <scp>CNS</scp> relapse in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Roche","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Internal medicine; Vincristine; Prednisone; Lymphoma; Cyclophosphamide; Hazard ratio; Oncology; CHOP; Chemotherapy; Confidence interval","score_opus":0.00952445031165164,"score_gpt":0.22998264182981218,"score_spread":0.22045819151816054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531432151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901553,0.008492053,0.00008310314,0.00069598947,0.00006686746,0.00025960937,0.000038115195,0.000006576985,0.00020240713],"genre_scores_gemma":[0.9945372,0.004180221,0.00074836944,0.00039832134,0.000039721723,0.000015537265,0.0000025497313,0.000018768182,0.000059343343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982454,0.0002227354,0.00070859096,0.00018701403,0.00032168007,0.0003145585],"domain_scores_gemma":[0.99811095,0.0008075641,0.00056457595,0.00021969876,0.00016432928,0.00013286462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571511,0.00016657193,0.0008349078,0.00014297757,0.00006718721,0.00002285589,0.00014450158,0.00010770336,0.000012187733],"category_scores_gemma":[0.0005736087,0.000091499045,0.00012675906,0.00013346778,0.00018988684,0.000110177985,0.000046972105,0.00014088243,0.000007003844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007344748,0.0073712273,0.9363514,0.00012004881,0.00023608198,0.04996559,0.0004271925,2.0329173e-7,0.00006734949,0.00025761852,0.0015410356,0.0035887635],"study_design_scores_gemma":[0.071075864,0.0013759442,0.74071807,0.0011970064,0.00073558005,0.18054682,0.0005830734,0.000005763444,0.001151701,0.0003882392,0.0021501854,0.00007177707],"about_ca_topic_score_codex":0.00013403388,"about_ca_topic_score_gemma":0.00024072705,"teacher_disagreement_score":0.1956334,"about_ca_system_score_codex":0.00008358026,"about_ca_system_score_gemma":0.00015027622,"threshold_uncertainty_score":0.37312227},"labels":[],"label_agreement":null},{"id":"W2532960187","doi":"10.1182/blood.v120.21.153.153","title":"Mature Results From ECOG Study E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for Previously Untreated Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Rituximab; Bortezomib; Mantle cell lymphoma; Vincristine; Internal medicine; Surgery; Cyclophosphamide; Maintenance therapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.015373236774151637,"score_gpt":0.2680676121240122,"score_spread":0.25269437534986056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532960187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273616,0.0011433627,0.0000040725863,0.000101345846,0.0000890442,0.0045511643,0.00057879504,0.00007614585,0.00071993493],"genre_scores_gemma":[0.99729776,0.000037236798,0.00074125885,0.00006875313,0.00017006598,0.00056323,0.0002262999,0.000055213688,0.0008401542],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980081,0.000069672256,0.000512391,0.00052755844,0.0003614199,0.000520875],"domain_scores_gemma":[0.9983425,0.00015650855,0.00029489968,0.00078940875,0.0001793366,0.00023732646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020274396,0.00035700685,0.00077265425,0.00008759363,0.00013642116,0.00001867064,0.00013978897,0.00009854616,0.000029755827],"category_scores_gemma":[0.00005739443,0.00023186124,0.000112476635,0.00021367961,0.000035992256,0.00010364027,0.00007473346,0.000061556726,0.000022427083],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013001511,0.697926,0.25904214,0.00013880152,0.0026366978,0.0005625321,0.01723332,0.0000013785627,0.00059720327,0.000011017711,0.0029749402,0.00587449],"study_design_scores_gemma":[0.6600658,0.050772596,0.2470604,0.00037331795,0.007211083,0.00008122406,0.007527873,0.00002077522,0.024786092,0.00001030642,0.0016603057,0.00043019638],"about_ca_topic_score_codex":0.0010685707,"about_ca_topic_score_gemma":0.00034364677,"teacher_disagreement_score":0.6471534,"about_ca_system_score_codex":0.00009256762,"about_ca_system_score_gemma":0.00010246153,"threshold_uncertainty_score":0.9455027},"labels":[],"label_agreement":null},{"id":"W2532989698","doi":"10.1200/jco.2009.27.15_suppl.8581","title":"Prognostic significance of vascular endothelial growth factor (VEGF), VEGF receptors (VEGFR), and vascularity in diffuse large B-cell lymphoma treated with immunochemotherapy (R-CHOP)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; CHOP; International Prognostic Index; Oncology; Proportional hazards model; Vascular endothelial growth factor; Diffuse large B-cell lymphoma; Lymphoma; Kinase insert domain receptor; Pathology; Vascular endothelial growth factor A; VEGF receptors","score_opus":0.03100431380021391,"score_gpt":0.34267811404794263,"score_spread":0.3116738002477287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532989698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567217,0.0020921044,0.00004434579,0.0010514299,0.0001839238,0.00059017085,0.0000130535045,0.000013407976,0.00033942095],"genre_scores_gemma":[0.99101686,0.0062443367,0.0016884921,0.0007354426,0.00023071196,0.000012284791,0.0000051110233,0.000024967598,0.00004177042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630785,0.0005152923,0.001956365,0.0003499732,0.0004902474,0.00038026387],"domain_scores_gemma":[0.9959861,0.0016586429,0.0013246232,0.00028424617,0.00038039836,0.00036598174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012371622,0.0002992774,0.002117843,0.00019712241,0.00003992525,0.0000135251,0.00016646045,0.0004350624,0.000044710603],"category_scores_gemma":[0.0010877522,0.00019097397,0.0005549183,0.00025766392,0.00021914922,0.00012584514,0.000022943761,0.0004007764,0.0000038014014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060452875,0.051239822,0.86981696,0.0000718105,0.00078602234,0.0008912735,0.00030305528,7.7460174e-7,0.00161303,0.000049564995,0.00009372824,0.069088645],"study_design_scores_gemma":[0.10340776,0.020862253,0.86679965,0.00024720238,0.0005310751,0.00014643755,0.00007706714,0.000019060255,0.004477325,0.000103087674,0.003161076,0.0001679842],"about_ca_topic_score_codex":0.00010701903,"about_ca_topic_score_gemma":0.00003453554,"teacher_disagreement_score":0.09736247,"about_ca_system_score_codex":0.00029053472,"about_ca_system_score_gemma":0.00096428685,"threshold_uncertainty_score":0.7787692},"labels":[],"label_agreement":null},{"id":"W2533615934","doi":"10.1182/blood.v118.21.435.435","title":"Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Cyclin-dependent kinase 6; Diffuse large B-cell lymphoma; Cyclin-dependent kinase; Molecular biology; Cell cycle; Lymphoma; Gene; Genetics","score_opus":0.03349978620515748,"score_gpt":0.27113155496616315,"score_spread":0.23763176876100567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533615934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439336,0.0021810466,4.9464916e-7,0.00011593111,0.000080119105,0.0003094203,0.0000075176235,0.00002123544,0.012890867],"genre_scores_gemma":[0.9988808,0.00025361415,0.00046721,0.00009010824,0.000032033375,0.00017064078,0.00002576666,0.000010735288,0.00006910644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992551,0.000028040597,0.00021654803,0.00019656196,0.00011369213,0.00019001275],"domain_scores_gemma":[0.99960226,0.00003774534,0.000073947056,0.00017975885,0.000025286796,0.00008098723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055667606,0.0001043407,0.00019312996,0.00015241075,0.00001768276,0.000004458151,0.000045021978,0.000055564684,0.00016888419],"category_scores_gemma":[0.00006517935,0.000086250875,0.00006206447,0.00021284608,0.000026464608,0.000038246446,0.0000215539,0.00005014317,0.000117939184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008544956,0.010058954,0.95988667,0.000025150566,0.00009725514,0.0025857869,0.0027957403,4.902927e-7,0.00014274064,0.0006934738,0.00009908733,0.023529194],"study_design_scores_gemma":[0.013643239,0.00039623337,0.9702068,0.00029972746,0.00016299346,0.00016132758,0.00020169369,0.00000975268,0.014060324,0.00049504417,0.00025740117,0.00010543935],"about_ca_topic_score_codex":0.00042222784,"about_ca_topic_score_gemma":0.0004188168,"teacher_disagreement_score":0.023423756,"about_ca_system_score_codex":0.00013272479,"about_ca_system_score_gemma":0.00014007115,"threshold_uncertainty_score":0.35172087},"labels":[],"label_agreement":null},{"id":"W2533737381","doi":"10.1182/blood.v126.23.3863.3863","title":"Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Proportional hazards model; Stage (stratigraphy); Oncology; Lymphoma; Cancer; Cancer registry; Classical Hodgkin lymphoma; Cohort; Hodgkin lymphoma; Biology","score_opus":0.020529453056335686,"score_gpt":0.2706861000937934,"score_spread":0.2501566470374577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533737381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893781,0.003950545,0.00000876127,0.0026189259,0.0005658019,0.0010544946,0.00022516669,0.00015799521,0.0020402195],"genre_scores_gemma":[0.99380904,0.00076329184,0.0009901152,0.00067428185,0.00028732503,0.00024286879,0.00012222207,0.00010890684,0.003001967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957926,0.00018166179,0.0009602983,0.0009446816,0.0012093884,0.0009113501],"domain_scores_gemma":[0.9969771,0.00021384869,0.00047874957,0.0011318366,0.00035125425,0.0008472055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003366333,0.00068565144,0.0016155164,0.0001992818,0.00013185568,0.000045983394,0.00038444716,0.00035996852,0.00031275448],"category_scores_gemma":[0.00022093866,0.00050904095,0.00051131746,0.00037263494,0.00027828795,0.00014476312,0.000400509,0.00006511241,0.00021026272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014181739,0.007943805,0.9554013,0.00021481265,0.0014658229,0.0011072635,0.0007083819,0.000010093741,0.0006296168,0.00040440727,0.0057486296,0.024947716],"study_design_scores_gemma":[0.0632474,0.0008486953,0.7804885,0.00045057767,0.0018934362,0.00037730523,0.00018780142,0.00017262003,0.10811487,0.000059886283,0.04355916,0.00059979485],"about_ca_topic_score_codex":0.0015408525,"about_ca_topic_score_gemma":0.00049251923,"teacher_disagreement_score":0.17491281,"about_ca_system_score_codex":0.0017674174,"about_ca_system_score_gemma":0.0013022717,"threshold_uncertainty_score":0.99973613},"labels":[],"label_agreement":null},{"id":"W2534379449","doi":"10.1182/blood.v114.22.408.408","title":"R-CHOP with Etoposide Substituted for Doxorubicin (R-CEOP): Excellent Outcome in Diffuse Large B Cell Lymphoma for Patients with a Contraindication to Anthracyclines.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Anthracycline; Vincristine; Rituximab; Doxorubicin; Contraindication; Population; Surgery; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Cyclophosphamide; Cancer; Breast cancer; Pathology","score_opus":0.009399722993428778,"score_gpt":0.26131768316793624,"score_spread":0.25191796017450746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534379449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926599,0.00013616287,0.0007941005,0.0013861057,0.000046781926,0.0046358826,0.00013589057,0.00005539298,0.00014972695],"genre_scores_gemma":[0.9929425,0.000020747748,0.004240757,0.001353864,0.000070995244,0.00090108364,0.0003370658,0.000034213037,0.00009873913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838877,0.000015999516,0.00040915905,0.00045297845,0.00026325,0.00046984138],"domain_scores_gemma":[0.9989613,0.00014242898,0.00015378624,0.00034989518,0.00016831736,0.0002242413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011597331,0.00028582106,0.0005092344,0.00017219622,0.00009192594,0.000025338964,0.00008557237,0.000095966345,0.000004461705],"category_scores_gemma":[0.00007006412,0.00018782726,0.00009538369,0.00021392787,0.000022629525,0.00007700908,0.000010533997,0.000037855152,0.000007725446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033195473,0.078789525,0.91214615,0.00012080911,0.00014067584,0.00006125604,0.0005906804,0.000003691364,0.00050730037,0.0003178091,0.00019695685,0.0038056034],"study_design_scores_gemma":[0.20562246,0.0037936051,0.7750041,0.00018159661,0.000516075,0.0000075803678,0.000062121995,0.000036461868,0.012910604,0.000023995248,0.0015941694,0.00024724926],"about_ca_topic_score_codex":0.0000608737,"about_ca_topic_score_gemma":0.00017213584,"teacher_disagreement_score":0.20230292,"about_ca_system_score_codex":0.00015430046,"about_ca_system_score_gemma":0.00011465776,"threshold_uncertainty_score":0.7659373},"labels":[],"label_agreement":null},{"id":"W2534762074","doi":"10.1016/j.clon.2016.09.004","title":"Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline","year":2016,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Oncology; Fludarabine; Chlorambucil; Follicular lymphoma; Lymphoma; Chemoimmunotherapy; Hematology; Chemotherapy; Immunology; Leukemia; Cyclophosphamide","score_opus":0.053563053255971736,"score_gpt":0.4376305806898832,"score_spread":0.3840675274339115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534762074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92462045,0.004955094,0.000081946724,0.05567454,0.00063393865,0.0006137473,0.0000075475523,0.000072565024,0.013340192],"genre_scores_gemma":[0.97815037,0.0060892543,0.0035464992,0.0109098395,0.000634583,0.000093603136,0.0000075459543,0.000022515473,0.0005457736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746436,0.00028763965,0.0011694933,0.00053713535,0.0001624275,0.0003789608],"domain_scores_gemma":[0.9948466,0.0040741256,0.0002521992,0.00038166015,0.00013623034,0.00030920852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011821082,0.00018692215,0.0009257171,0.00008686114,0.000035556255,0.00000790443,0.00008492215,0.00043233865,0.00016643002],"category_scores_gemma":[0.0041425615,0.00011190619,0.00013930122,0.00013280258,0.00033876783,0.00012032591,0.00012455943,0.000100774225,0.00046129758],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013338883,0.0043838634,0.06336152,0.000025014146,0.00016320795,0.0025912055,0.000030811017,3.9775813e-7,0.00009181256,0.0010471775,0.013783169,0.9131879],"study_design_scores_gemma":[0.09001869,0.005825911,0.14436676,0.00019330361,0.00035069164,0.0011978041,0.000047330504,0.00016748202,0.00014791569,0.0003524139,0.75715894,0.00017274822],"about_ca_topic_score_codex":0.00018389912,"about_ca_topic_score_gemma":0.00023627047,"teacher_disagreement_score":0.9130152,"about_ca_system_score_codex":0.0048144157,"about_ca_system_score_gemma":0.0036185216,"threshold_uncertainty_score":0.9990059},"labels":[],"label_agreement":null},{"id":"W2535579634","doi":"10.1182/blood.v108.11.2739.2739","title":"Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; CHOP; Population; Stage (stratigraphy); Lymphoma; Gastroenterology; Performance status; Oncology; Cancer","score_opus":0.007077245684217713,"score_gpt":0.1979980715226487,"score_spread":0.19092082583843098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535579634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947825,0.00015884648,0.0000014417335,0.0001586059,0.000011962092,0.00091680145,0.003460169,0.00009633705,0.00041334977],"genre_scores_gemma":[0.9969618,0.000022675551,0.00011239595,0.00029643424,0.000019423087,0.00010371343,0.0011087144,0.00006526583,0.0013096182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982088,0.000044104276,0.00034374272,0.00048589683,0.00038275492,0.0005346648],"domain_scores_gemma":[0.9991469,0.000037213984,0.00013033941,0.00035424076,0.00007289214,0.00025840977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005515735,0.0003805888,0.0004906962,0.00012933365,0.00008599947,0.000036553167,0.00006477728,0.00010742496,0.000024198916],"category_scores_gemma":[0.000008735766,0.00024969014,0.00004595618,0.000271064,0.000060827282,0.0000876954,0.00003623532,0.00007111417,0.0000023985094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048174377,0.039370228,0.958773,0.00006777433,0.00018790785,0.0005341312,0.00011912864,8.7494016e-7,0.0000821213,0.000006197172,0.00021270833,0.00016417737],"study_design_scores_gemma":[0.18254136,0.0012844101,0.80360156,0.00007857685,0.00045660674,0.000016766402,0.000040536688,0.000024234416,0.01120032,7.1741425e-7,0.0005108101,0.00024409062],"about_ca_topic_score_codex":0.0023030613,"about_ca_topic_score_gemma":0.001865596,"teacher_disagreement_score":0.1820596,"about_ca_system_score_codex":0.0001604255,"about_ca_system_score_gemma":0.000093848554,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2536848274","doi":"10.1182/blood.v106.11.2085.2085","title":"Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Chemotherapy; Chemotherapy regimen; Internal medicine; Melphalan; Transplantation; Oncology; Autologous stem-cell transplantation; Surgery; Diffuse large B-cell lymphoma; Regimen; Hematopoietic stem cell transplantation","score_opus":0.010484356149444552,"score_gpt":0.24408833761440074,"score_spread":0.2336039814649562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536848274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460423,0.0015755416,0.0001804972,0.00053671974,0.00013047257,0.0015767723,0.0007163808,0.00012800313,0.000551373],"genre_scores_gemma":[0.9913747,0.0010189719,0.0037975588,0.0019266454,0.00014831695,0.00027998697,0.0001948586,0.00009589139,0.001163097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975606,0.000069549234,0.0006981122,0.00061185186,0.00042240764,0.00063746254],"domain_scores_gemma":[0.9982141,0.0004470582,0.00037508705,0.00047555298,0.00012140145,0.00036679438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023314814,0.000483709,0.0009786831,0.00020998206,0.00014314488,0.000029739973,0.00015448917,0.00027470526,0.000043909633],"category_scores_gemma":[0.000021658103,0.00036781954,0.0002436222,0.00017337178,0.000047658803,0.00014358113,0.000041310093,0.00006577141,0.000027839807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007695116,0.19263622,0.6721247,0.0049466267,0.0007550997,0.0010883517,0.009727576,0.0000017780446,0.034208693,0.00004931075,0.002289104,0.074477434],"study_design_scores_gemma":[0.15864556,0.0017865904,0.69620883,0.00016219963,0.0009070309,0.00009054484,0.00033190777,0.0000270922,0.13461009,0.0000026690025,0.006867685,0.00035979575],"about_ca_topic_score_codex":0.000028331839,"about_ca_topic_score_gemma":0.000091305876,"teacher_disagreement_score":0.19084963,"about_ca_system_score_codex":0.0002195855,"about_ca_system_score_gemma":0.00028757803,"threshold_uncertainty_score":0.9998774},"labels":[],"label_agreement":null},{"id":"W2537557937","doi":"10.1182/blood.v116.21.324.324","title":"A miRNA Risk Score for the Prediction of Response to Rituximab-CHOP Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Gene expression profiling; Diffuse large B-cell lymphoma; Biology; CHOP; Gene expression; Oncology; Cancer research; Lymphoma; Gene; Immunology; Medicine; Genetics","score_opus":0.010552525419542495,"score_gpt":0.22448283048362502,"score_spread":0.21393030506408253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537557937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977982,0.00023184286,0.000019545761,0.00011695368,0.000082533836,0.001085378,0.0006239434,0.000012159117,0.000029463868],"genre_scores_gemma":[0.99917483,0.00013990606,0.0004061601,0.00004865475,0.00003701619,0.00012305725,0.00001843889,0.000017011365,0.00003492908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928766,0.000038524355,0.00016977948,0.00016564743,0.00020310543,0.00013529664],"domain_scores_gemma":[0.9990103,0.00034652173,0.00011295225,0.00030615652,0.00014467206,0.00007935389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020785922,0.00011101854,0.0002266064,0.00005049122,0.00006468502,0.000006827645,0.000052103518,0.000053072283,0.000007389537],"category_scores_gemma":[0.00010200762,0.000059486865,0.000059171278,0.00008558753,0.00004952345,0.000026950205,0.000019752739,0.000034448472,9.791477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007754378,0.026793176,0.9569326,0.00003297488,0.00022068387,0.0000022403503,0.0005405012,7.190461e-8,0.0032735358,0.000021491805,0.000070906375,0.0043574516],"study_design_scores_gemma":[0.110975295,0.0025611557,0.8635515,0.000036443365,0.0003298162,0.000002313247,0.000052854783,0.000012040958,0.02118677,0.000007312814,0.0012394978,0.000045029017],"about_ca_topic_score_codex":0.00007980511,"about_ca_topic_score_gemma":0.00005653974,"teacher_disagreement_score":0.10322092,"about_ca_system_score_codex":0.000009778185,"about_ca_system_score_gemma":0.00005841908,"threshold_uncertainty_score":0.2425804},"labels":[],"label_agreement":null},{"id":"W2537667379","doi":"10.1017/9781139939508.009","title":"Anaplastic lymphoma kinase (ALK)","year":2016,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anaplastic lymphoma kinase; Content (measure theory); Computer science; Cancer research; Medicine; Oncology; Mathematics","score_opus":0.018366560334764557,"score_gpt":0.204718078148184,"score_spread":0.18635151781341944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537667379","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012713056,0.00041141055,0.00003678916,0.00007020336,0.00028769046,0.00060235563,0.0005147994,0.00017872492,0.99662673],"genre_scores_gemma":[0.019234214,0.00034167737,0.000051615647,0.0001630363,0.00025904042,0.0000024689518,0.00008665603,0.00007099093,0.97979033],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983941,0.0000198352,0.0002114319,0.00064932957,0.00035633674,0.00036899824],"domain_scores_gemma":[0.9983368,0.00012128462,0.00019299067,0.0007514044,0.00016664753,0.00043086303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000040432515,0.0005162922,0.0006673634,0.00023544596,0.00014977796,0.000024180245,0.0002149273,0.00042739493,0.000038277863],"category_scores_gemma":[0.000013291318,0.000446514,0.00041637797,0.000007098539,0.00024679396,0.000055347853,0.00023371099,0.00012312314,0.00021503144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007430197,0.00011234518,0.000053637887,0.00016662202,0.0008043277,0.008587299,0.000016282542,9.733249e-8,0.000047128982,0.8988645,0.059964698,0.030640027],"study_design_scores_gemma":[0.0057776943,0.00039937283,0.00055259763,0.0009067667,0.0013185985,0.00016899328,0.000008366051,0.000004993154,0.00078690855,0.000008148727,0.9896089,0.00045867363],"about_ca_topic_score_codex":0.00006996359,"about_ca_topic_score_gemma":0.000002331597,"teacher_disagreement_score":0.92964417,"about_ca_system_score_codex":0.00094913226,"about_ca_system_score_gemma":0.00031683792,"threshold_uncertainty_score":0.99979866},"labels":[],"label_agreement":null},{"id":"W2538425459","doi":"10.1182/blood.v104.11.1407.1407","title":"Rapid Infusion Rituximab in Combination with Steroid Containing Chemotherapy Can Be Given Safely and Substantially Reduces Resource Utilization.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Cytokine release syndrome; Rash; Chemotherapy; Prednisone; Dosing; Surgery; Anesthesia; Internal medicine; Lymphoma; Cancer; Immunotherapy","score_opus":0.022005853642565656,"score_gpt":0.2489310004317907,"score_spread":0.22692514678922504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538425459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935587,0.0010493486,0.000015890933,0.0041689393,0.000013972026,0.00043545724,0.000005599373,0.00003476269,0.00071731646],"genre_scores_gemma":[0.99806285,0.0005123526,0.00065118686,0.0006086744,0.000027378386,0.000026737565,0.00006931066,0.000017811863,0.000023709084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925196,0.00002600423,0.00017131603,0.00021658257,0.00018609349,0.00014804426],"domain_scores_gemma":[0.9996565,0.000029807361,0.00007266775,0.00012213328,0.00005069285,0.000068172565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009122683,0.00012545261,0.00022225526,0.0000997956,0.00006706761,0.000027125738,0.000032627504,0.00005648047,0.000013799608],"category_scores_gemma":[0.000015456892,0.00009864818,0.000019690493,0.00016147758,0.00004847884,0.00006021024,0.000012555875,0.000051360825,8.5442383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004573468,0.029991651,0.759748,0.00023652286,0.0007416598,0.0010986533,0.0275068,0.00004766842,0.030194784,0.0022712767,0.00016366667,0.14342585],"study_design_scores_gemma":[0.14441685,0.003939693,0.6991113,0.000712724,0.00020404448,0.00017620674,0.0012445255,0.000023429386,0.1476784,0.000115549854,0.002132342,0.00024492774],"about_ca_topic_score_codex":0.00024017847,"about_ca_topic_score_gemma":0.0002976789,"teacher_disagreement_score":0.14318092,"about_ca_system_score_codex":0.000085937696,"about_ca_system_score_gemma":0.000112115944,"threshold_uncertainty_score":0.4022756},"labels":[],"label_agreement":null},{"id":"W2539551211","doi":"10.1016/j.jval.2016.09.2181","title":"Real-World Treatment Patterns and Costs of Care Among Brentuximab Vendotin-Treated Patients with Hodgkin Lymphoma in The United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Discontinuation; Bendamustine; Pharmacy; Hodgkin lymphoma; Lymphoma; Rituximab; Family medicine","score_opus":0.018326210568359508,"score_gpt":0.2746963721163278,"score_spread":0.2563701615479683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539551211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735975,0.00022831911,7.9066126e-7,0.0007982407,0.000026535388,0.0012940264,0.00019325984,0.000017431596,0.000081632345],"genre_scores_gemma":[0.9972563,0.002097119,0.000037732865,0.0001423002,0.000012911686,0.00012674223,0.00028999927,0.00002087919,0.000016014437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984596,0.00028202587,0.00039807864,0.000283803,0.00025150063,0.00032501004],"domain_scores_gemma":[0.99895394,0.00036946402,0.00017909087,0.00030666383,0.000070196955,0.00012062206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013575862,0.00020519753,0.00042447573,0.0003162377,0.000043145996,0.00000930614,0.000057015244,0.000038273898,0.000007345033],"category_scores_gemma":[0.000015344844,0.00009581556,0.000035681755,0.00039697616,0.00006983875,0.000042101048,0.000017430402,0.000031172523,0.0000017124755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037416708,0.0014918833,0.95765424,0.00011562946,0.00004557822,0.00006902125,0.002801005,0.000026177539,7.2813026e-7,0.00006966042,0.000018577324,0.03733336],"study_design_scores_gemma":[0.017924463,0.003103398,0.97571445,0.0020068367,0.000041784388,0.0000042240704,0.00065063685,0.000064813896,0.00025951315,0.000007569684,0.00013286588,0.00008947424],"about_ca_topic_score_codex":0.25727642,"about_ca_topic_score_gemma":0.018339109,"teacher_disagreement_score":0.2389373,"about_ca_system_score_codex":0.0015280327,"about_ca_system_score_gemma":0.00016162032,"threshold_uncertainty_score":0.99957365},"labels":[],"label_agreement":null},{"id":"W2543665147","doi":"10.3747/co.23.3265","title":"Follow-Up Care for Survivors of Lymphoma Who Have Received Curative-Intent Treatment","year":2016,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Oakville-Trafalgar Memorial Hospital; Health Sciences Centre; Cancer Care Ontario; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Survivorship curve; Asymptomatic; MEDLINE; Lymphoma; Cochrane Library; Pediatrics; Cancer; Internal medicine; Meta-analysis","score_opus":0.18827219851849453,"score_gpt":0.4560895266290155,"score_spread":0.26781732811052095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543665147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026916308,0.98716474,0.00003268486,0.00017615224,0.003389542,0.005506108,0.0012389472,0.000046872006,0.002175803],"genre_scores_gemma":[0.00018722132,0.99162006,0.00009871922,0.000018906288,0.00047659702,0.0043749707,0.0014354693,0.00009506083,0.0016929825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996646,0.00032195574,0.0012397736,0.0009092888,0.0002757993,0.0006071975],"domain_scores_gemma":[0.99625653,0.0010759301,0.0010083729,0.00073864136,0.0006017724,0.00031874617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014443921,0.00089392805,0.005180416,0.0003226599,0.00010491894,0.00001142932,0.00022227124,0.00057418935,0.00013601115],"category_scores_gemma":[0.00018852267,0.0005092797,0.0021892427,0.00014522349,0.00020073343,0.00004257472,0.00009241193,0.000093091745,0.00009334027],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002715475,0.002024554,0.0007291279,0.0109463595,0.0015690351,0.0000467758,0.00082403235,2.0714877e-8,2.5329535e-7,0.0001899796,0.0034077812,0.97999054],"study_design_scores_gemma":[0.012261019,0.0055188267,0.00014598716,0.02325474,0.005342715,0.000077901124,0.0003236996,0.000002020694,0.000043817778,0.000019776107,0.9526198,0.000389681],"about_ca_topic_score_codex":0.00011012498,"about_ca_topic_score_gemma":0.00034318384,"teacher_disagreement_score":0.97960085,"about_ca_system_score_codex":0.005787703,"about_ca_system_score_gemma":0.0023020718,"threshold_uncertainty_score":0.9997359},"labels":[],"label_agreement":null},{"id":"W2546061993","doi":"10.1182/blood.v124.21.703.703","title":"Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; SNP array; Biology; CDKN2A; Population; PTEN; Cancer; Lymphoma; Cancer research; Internal medicine; Medicine; Genetics; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.0157311541427822,"score_gpt":0.280834132528888,"score_spread":0.2651029783861058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546061993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944194,0.00035294725,0.00005344933,0.00013466876,0.00006161218,0.00023438214,0.000009428655,0.000015191315,0.0047189333],"genre_scores_gemma":[0.99791706,0.00014406662,0.0013592645,0.0002090901,0.00008737565,0.000049465205,0.000008680406,0.000010257662,0.00021475874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991252,0.00005883695,0.00035819603,0.0001857502,0.00011907889,0.0001529324],"domain_scores_gemma":[0.99936324,0.00014892756,0.000077609104,0.0002907745,0.000031465865,0.00008798373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013436914,0.00008294651,0.00026039718,0.000043851676,0.000018814944,0.0000042326196,0.00004997583,0.00006668227,0.000027751355],"category_scores_gemma":[0.00007306718,0.00006728966,0.00008870413,0.00009696617,0.000033737644,0.000015139128,0.00001875299,0.000030098665,0.000048104368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019560033,0.041679762,0.9528773,0.00003945673,0.000036916168,0.000032387074,0.00009477662,6.965357e-7,0.00048562745,0.00026086075,0.00031499774,0.0041576573],"study_design_scores_gemma":[0.0369864,0.00041483642,0.9531122,0.000041551124,0.00016868429,0.0000066717566,0.000019451876,0.00011717895,0.006457865,0.0000595126,0.0025516965,0.00006398804],"about_ca_topic_score_codex":0.00005509832,"about_ca_topic_score_gemma":0.00006698377,"teacher_disagreement_score":0.041264925,"about_ca_system_score_codex":0.000017859244,"about_ca_system_score_gemma":0.000075425654,"threshold_uncertainty_score":0.27439925},"labels":[],"label_agreement":null},{"id":"W2546886377","doi":"10.1182/blood.v114.22.3944.3944","title":"Number of Lymphoma-Associated-Macrophages (LAM) Is An Independent Predictor of Survival in Patients with Mantle Cell Lymphoma (MCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Medicine; Lymphoma; Immunohistochemistry; Tissue microarray; Follicular lymphoma; Internal medicine; Oncology; Rituximab; CD20; Pathology; Cancer research; Cancer; CD163; Biology; Phenotype","score_opus":0.00686089275118308,"score_gpt":0.22739382071917222,"score_spread":0.22053292796798915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546886377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963657,0.00020497099,7.11115e-7,0.000038394966,0.000058763584,0.00044430295,0.0001469664,0.000027897728,0.0027122826],"genre_scores_gemma":[0.9993966,0.00004386368,0.00015576775,0.00008461533,0.000023474035,0.000016032043,0.000095253214,0.000025924013,0.00015843169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981918,0.000061721796,0.00045826673,0.00034283623,0.0006322694,0.00031315236],"domain_scores_gemma":[0.9989814,0.000041203253,0.00026678725,0.00040444967,0.00017743386,0.00012871879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012286752,0.00024084897,0.00059670454,0.00010023676,0.000028375604,0.000009852896,0.0001246005,0.0001437454,0.00012007907],"category_scores_gemma":[0.000019479587,0.00018399964,0.00010556456,0.00023520197,0.00005169419,0.00009268758,0.00003136164,0.000035591915,0.000014210981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035702772,0.03768438,0.9575815,0.000054078562,0.00021705938,0.00007841662,0.0006523644,8.903028e-7,0.00020009762,0.000028427663,0.00005416012,0.0030915763],"study_design_scores_gemma":[0.047226015,0.0019593516,0.8988622,0.00016226256,0.00038602663,0.000006315825,0.00012725726,0.000005221772,0.051069066,0.000030191584,0.000020640984,0.00014544281],"about_ca_topic_score_codex":0.00043438113,"about_ca_topic_score_gemma":0.000044975513,"teacher_disagreement_score":0.05871931,"about_ca_system_score_codex":0.00014024304,"about_ca_system_score_gemma":0.00016592053,"threshold_uncertainty_score":0.7503287},"labels":[],"label_agreement":null},{"id":"W2547569429","doi":"10.1182/blood.v118.21.5191.5191","title":"Prognostic Value of Epstein-Barr Virus Infected Tumor Cell Size in Patients with Extranodal Natural Killer T-Cell Lymphoma, Nasal Type","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Pathology; CD30; T-cell lymphoma; Epstein–Barr virus; Immunohistochemistry; Biology; Virus; Medicine; Virology","score_opus":0.006411175315301156,"score_gpt":0.1940415146247388,"score_spread":0.18763033930943762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547569429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954466,0.0004815624,3.222792e-7,0.000008218628,0.00021095473,0.00083720515,0.00001182852,0.000043788994,0.002959481],"genre_scores_gemma":[0.9987713,0.000011656375,0.0008067224,0.00009457207,0.000030735206,0.000047063055,0.00003791241,0.000040430783,0.00015959391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986362,0.000051282062,0.0003323793,0.0003177679,0.00033088573,0.00033152528],"domain_scores_gemma":[0.99914956,0.00012112393,0.00014151057,0.00030111938,0.00014797796,0.00013872565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005404853,0.0002596496,0.00041022955,0.00009727702,0.00002971836,0.000007559935,0.00009105773,0.00008086519,0.00013756298],"category_scores_gemma":[0.00007551941,0.0001816764,0.00008030751,0.00029182923,0.000067047724,0.00006179044,0.000035017445,0.00007894374,0.00005777349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008909615,0.019772794,0.97671777,0.00012013998,0.00012191689,0.00025125634,0.0004292697,7.2221604e-7,0.0013547174,0.00002289378,0.00004989136,0.00026766042],"study_design_scores_gemma":[0.03545633,0.0025948859,0.89325386,0.00016048712,0.00043017569,0.000014505304,0.000019869647,0.000007549089,0.06783544,0.0000086722775,0.000034093126,0.00018415399],"about_ca_topic_score_codex":0.00046642785,"about_ca_topic_score_gemma":0.000042052376,"teacher_disagreement_score":0.083463944,"about_ca_system_score_codex":0.00006953099,"about_ca_system_score_gemma":0.00022669762,"threshold_uncertainty_score":0.74085486},"labels":[],"label_agreement":null},{"id":"W2547863170","doi":"10.1182/blood.v104.11.2480.2480","title":"SDX-105 Demonstrates a High Response Rate as a Single-Agent with Acceptable Safety in Rituximab-Refractory, Relpased Indolent or Transformed Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Refractory (planetary science); Bendamustine; Gastroenterology; Lymphoma; Follicular lymphoma; Bone marrow; Oncology; Surgery; Biology","score_opus":0.012767488074740816,"score_gpt":0.2465276413827582,"score_spread":0.2337601533080174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547863170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941772,0.00044542638,0.00005498494,0.0022383495,0.000099124874,0.0017008089,0.00006177058,0.00013536701,0.0010869603],"genre_scores_gemma":[0.9959333,0.0003423735,0.0019438489,0.00080019806,0.00008021779,0.00043380487,0.000082504805,0.00008317849,0.00030058436],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99700654,0.00021549992,0.0007123957,0.000739101,0.0005218248,0.0008046415],"domain_scores_gemma":[0.9982773,0.00040281337,0.00018000037,0.00060312735,0.000109136374,0.00042758873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005781151,0.0005528988,0.00088822865,0.0003156419,0.00016701131,0.000083199964,0.0001776408,0.00024478484,0.00029125757],"category_scores_gemma":[0.00016750643,0.00037476723,0.00018194888,0.0006148551,0.00014327589,0.00024003521,0.00003553993,0.00016994617,0.00016691134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37867042,0.23178566,0.13257037,0.0009146078,0.004226749,0.050792336,0.010600921,0.0003875938,0.11694965,0.0004509899,0.00045406888,0.07219663],"study_design_scores_gemma":[0.17767665,0.010519775,0.5314068,0.0013216889,0.0009027195,0.0009935183,0.00063287927,0.000009878402,0.27331403,0.00007389288,0.0025453123,0.0006028266],"about_ca_topic_score_codex":0.001748424,"about_ca_topic_score_gemma":0.0012864331,"teacher_disagreement_score":0.39883646,"about_ca_system_score_codex":0.0010490854,"about_ca_system_score_gemma":0.0019606778,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W2548090821","doi":"10.1182/blood.v126.23.2702.2702","title":"Initial Therapy for Mantle Cell Lymphoma with Abbreviated R-CHOP Followed By Y90-Ibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ibritumomab tiuxetan; Medicine; Mantle cell lymphoma; Radioimmunotherapy; Internal medicine; Clinical endpoint; CHOP; Rituximab; Salvage therapy; Surgery; Gastroenterology; Oncology; Lymphoma; Clinical trial; Chemotherapy; Immunology","score_opus":0.025508167334232855,"score_gpt":0.28938422311778567,"score_spread":0.26387605578355283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548090821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354833,0.0010402867,0.000005767473,0.00023373563,0.00020548848,0.0026173294,0.0001969089,0.00005535508,0.0020967925],"genre_scores_gemma":[0.9980417,0.000048097958,0.00018556888,0.00018564977,0.00011270606,0.00037562937,0.0000813057,0.000060217466,0.00090910925],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840236,0.000083643376,0.00036297104,0.00037987743,0.00044621332,0.00032496496],"domain_scores_gemma":[0.9987654,0.00007950268,0.0001886078,0.0005899609,0.00018504901,0.00019149063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018157627,0.0002934267,0.00057023094,0.00005660471,0.00008384917,0.00002915119,0.00019611619,0.00008093325,0.000044414068],"category_scores_gemma":[0.000039686412,0.00017020787,0.00021739396,0.00023301154,0.00006246439,0.000069546986,0.000048712627,0.000048633,0.000023256676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020220244,0.2045392,0.6436384,0.00027755203,0.005843295,0.0008203371,0.006000995,0.0000022498846,0.014108288,0.00007764491,0.083146945,0.02132486],"study_design_scores_gemma":[0.6546982,0.022453975,0.042326014,0.00019780826,0.0028468056,0.00012479827,0.0021069162,0.000025127492,0.259128,0.000038920763,0.015522654,0.0005307608],"about_ca_topic_score_codex":0.0001935495,"about_ca_topic_score_gemma":0.000045455967,"teacher_disagreement_score":0.634478,"about_ca_system_score_codex":0.00007526631,"about_ca_system_score_gemma":0.0003137189,"threshold_uncertainty_score":0.69408756},"labels":[],"label_agreement":null},{"id":"W2548177080","doi":"10.1182/blood.v110.11.181.181","title":"Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Diffuse large B-cell lymphoma; clone (Java method); Somatic hypermutation; Lymphoma; Biology; Follicular lymphoma; Immunoglobulin heavy chain; Somatic evolution in cancer; Transplantation; Cancer research; Immunology; Antibody; B cell; Medicine; Internal medicine; Genetics; Cancer; Gene","score_opus":0.00833832788639711,"score_gpt":0.23590848741574102,"score_spread":0.22757015952934392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548177080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961106,0.00035102037,0.0007033008,0.00006648462,0.0000557993,0.00039055833,0.000012038492,0.000022120803,0.0022880605],"genre_scores_gemma":[0.99895644,0.000088516725,0.0007087077,0.00012569888,0.000035269597,0.000019753294,0.000024515803,0.00001658372,0.000024487414],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989088,0.000023181588,0.00040675135,0.0001365477,0.00030591214,0.00021879762],"domain_scores_gemma":[0.99928474,0.00009478031,0.00015998384,0.0002947431,0.000089022375,0.00007671308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029780786,0.00013977401,0.00028593096,0.00008512967,0.00006557458,0.000005900421,0.00009172325,0.00008658944,0.000012200419],"category_scores_gemma":[0.000021980919,0.00009009023,0.00017968318,0.00015045956,0.000032094347,0.000060757095,0.000022500535,0.000018334234,0.000007699405],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000930609,0.19060184,0.353099,0.0024214175,0.0022935723,0.0005312917,0.042374473,0.0000021002797,0.117326245,0.03634471,0.00017117044,0.2539036],"study_design_scores_gemma":[0.045733195,0.0005208211,0.15652579,0.000105306215,0.0007105642,0.000031317984,0.0005532348,0.00005893202,0.7949264,0.00021583251,0.00051747146,0.00010112405],"about_ca_topic_score_codex":0.000066936314,"about_ca_topic_score_gemma":0.000024991781,"teacher_disagreement_score":0.6776002,"about_ca_system_score_codex":0.000051528874,"about_ca_system_score_gemma":0.00006395435,"threshold_uncertainty_score":0.36737728},"labels":[],"label_agreement":null},{"id":"W2548276836","doi":"10.1182/blood-2018-07-865428","title":"Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"CDKN2A; Internal medicine; Follicular lymphoma; Hazard ratio; Medicine; Oncology; Progression-free survival; Chromosome abnormality; Lymphoma; Biology; Chromosome; Overall survival; Cancer; Genetics; Confidence interval","score_opus":0.010818751055209616,"score_gpt":0.24258895208941822,"score_spread":0.2317702010342086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548276836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958087,0.00018552282,0.0000018482536,0.00018816473,0.000026961492,0.0036856423,0.000021801738,0.000019068584,0.000062258005],"genre_scores_gemma":[0.9984586,0.000012614773,0.00014983761,0.00008922237,0.000057565878,0.0011385677,0.000046422538,0.00002054179,0.000026612683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906135,0.000026748174,0.000283813,0.00026144742,0.00014933638,0.00021729991],"domain_scores_gemma":[0.9994851,0.000062603314,0.000068203415,0.00025217378,0.00008009146,0.00005184333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010484146,0.00014490086,0.000227516,0.00008811483,0.00008465901,0.000023500166,0.000061146595,0.000034961213,0.00001591872],"category_scores_gemma":[0.000022944658,0.00007800221,0.000049191,0.00022009495,0.000032690532,0.000037861024,0.000018651834,0.000020796255,0.000008687612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002442278,0.0153052015,0.98173857,0.000006224399,0.00029890216,0.00004991146,0.00065490213,7.368972e-7,0.000024989213,0.000015697891,0.000035464866,0.0016251456],"study_design_scores_gemma":[0.036605716,0.0040269876,0.9566707,0.00005087136,0.00050940586,0.0000049720547,0.00015746623,0.00005516529,0.0017085505,0.0000057902535,0.00011515149,0.00008920099],"about_ca_topic_score_codex":0.0004485842,"about_ca_topic_score_gemma":0.0015426464,"teacher_disagreement_score":0.03636149,"about_ca_system_score_codex":0.00011314322,"about_ca_system_score_gemma":0.000077479715,"threshold_uncertainty_score":0.3180838},"labels":[],"label_agreement":null},{"id":"W2548326868","doi":"10.1182/blood.v110.11.52.52","title":"LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; Medicine; Internal medicine; CHOP; Lymphoma; Oncology; Germinal center; Anthracycline; Tissue microarray; BCL6; Chemotherapy regimen; International Prognostic Index; Regimen; Chemotherapy; Immunohistochemistry; Immunology; Cancer; B cell; Antibody","score_opus":0.005175678119563806,"score_gpt":0.2138879122406205,"score_spread":0.20871223412105672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548326868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648476,0.0004796899,0.0000017970507,0.000112933114,0.000024440315,0.0020922276,0.000041952997,0.000025190795,0.0007369854],"genre_scores_gemma":[0.9991669,0.00003752599,0.00017888531,0.000113668626,0.00003885045,0.00024670636,0.00009239195,0.000022657443,0.00010242497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985533,0.000076436314,0.00026227042,0.0003427445,0.00037451857,0.0003907794],"domain_scores_gemma":[0.99934214,0.00009126031,0.000072373005,0.00033525738,0.00004159094,0.00011738656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021181653,0.0002393674,0.00031599926,0.00011376866,0.00006159245,0.000024744062,0.00006908194,0.00009227606,0.000007118466],"category_scores_gemma":[0.000022976234,0.00012640581,0.000041564672,0.000157516,0.000033210552,0.00007742512,0.00003667946,0.000055299184,0.0000056859276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011160828,0.10702271,0.88636,0.000043651333,0.000041146428,0.00034686003,0.0016844311,1.04371736e-7,0.0004541431,0.000020143481,0.0000070007577,0.0029037315],"study_design_scores_gemma":[0.15767129,0.0027485415,0.82682735,0.00022033701,0.000107766995,0.000010554463,0.0002040439,0.0000027271124,0.011927153,0.0000043382424,0.00016488876,0.00011104068],"about_ca_topic_score_codex":0.00036075755,"about_ca_topic_score_gemma":0.00041681467,"teacher_disagreement_score":0.15655519,"about_ca_system_score_codex":0.00013961048,"about_ca_system_score_gemma":0.000072860574,"threshold_uncertainty_score":0.51546794},"labels":[],"label_agreement":null},{"id":"W2548934232","doi":"10.1182/blood.v104.11.905.905","title":"GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Salvage therapy; Gemcitabine; Autologous stem-cell transplantation; Internal medicine; Melphalan; Cytarabine; Filgrastim; Chemotherapy; Surgery; Transplantation; Oncology; Urology; Gastroenterology; Neutropenia","score_opus":0.028379540135469047,"score_gpt":0.29464323430954714,"score_spread":0.2662636941740781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548934232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920667,0.00049269927,0.00014414679,0.001504568,0.00030250716,0.0045444607,0.0004866802,0.00016348762,0.00029475894],"genre_scores_gemma":[0.972335,0.00019754573,0.024991682,0.0005315437,0.00012810092,0.0012072544,0.00026711664,0.00008108825,0.00026071272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970732,0.00010915448,0.00082429725,0.0008298315,0.00054257206,0.00062096096],"domain_scores_gemma":[0.9979941,0.0005750544,0.00017654426,0.00072655943,0.00014120886,0.0003865376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004512974,0.00044617374,0.00080825505,0.00031070894,0.00013654889,0.00005291876,0.0002508455,0.00025308126,0.000016009437],"category_scores_gemma":[0.00013833474,0.00033181522,0.0001725888,0.0004942833,0.000038555358,0.00012613072,0.000037995014,0.000098527315,0.000036576308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12815277,0.049591944,0.11386975,0.0013814206,0.00094494224,0.0047858665,0.037721984,0.00038097007,0.14290321,0.00011252683,0.002766916,0.5173877],"study_design_scores_gemma":[0.12913704,0.0077056233,0.66538674,0.00085448596,0.00033929592,0.00011046716,0.0004541099,0.00001305164,0.19255327,0.000015234527,0.0029157957,0.0005148785],"about_ca_topic_score_codex":0.00039028504,"about_ca_topic_score_gemma":0.0009321499,"teacher_disagreement_score":0.551517,"about_ca_system_score_codex":0.00038182648,"about_ca_system_score_gemma":0.00047970054,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W2549180194","doi":"10.1182/blood.v108.11.356.356","title":"Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Immunoglobulin class switching; Biology; Lymphoma; Chromosomal translocation; B cell; Large-cell lymphoma; Immunoglobulin heavy chain; Molecular biology; Cancer research; Antibody; Genetics; Gene; Immunology","score_opus":0.00614617362832149,"score_gpt":0.21496292099129657,"score_spread":0.2088167473629751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549180194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234873,0.0019031098,0.000022322189,0.00094090635,0.00008954034,0.00060339196,0.00002576975,0.00007536721,0.0039908676],"genre_scores_gemma":[0.9978602,0.0004595043,0.00024050071,0.00014955379,0.00004218084,0.00020635156,0.000217991,0.00003186201,0.0007918337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998649,0.00004791451,0.0003741,0.00037173738,0.00021526,0.00034198136],"domain_scores_gemma":[0.9993641,0.00007989544,0.000091941176,0.00030319855,0.000066323475,0.000094566574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012628472,0.0002286504,0.0003218161,0.00015887311,0.00010660043,0.000035814308,0.000065924374,0.00015556393,0.000035563928],"category_scores_gemma":[0.000008878967,0.00020067775,0.00008175949,0.00032999247,0.000025842952,0.00010061005,0.000020580901,0.000081904764,0.00003696934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000501968,0.2722761,0.46593705,0.00045701678,0.0003141727,0.0005453015,0.0018243782,0.000008813501,0.24391834,0.001005985,0.002630197,0.010580663],"study_design_scores_gemma":[0.11478664,0.00035871626,0.6386538,0.00013959443,0.00045958412,0.000071914474,0.00020332662,0.00018135757,0.24067733,0.00021168088,0.003944826,0.00031123508],"about_ca_topic_score_codex":0.0010208167,"about_ca_topic_score_gemma":0.00030584613,"teacher_disagreement_score":0.27191737,"about_ca_system_score_codex":0.00015512305,"about_ca_system_score_gemma":0.00011597373,"threshold_uncertainty_score":0.8183401},"labels":[],"label_agreement":null},{"id":"W2549385334","doi":"10.1182/blood.v118.21.4981.4981","title":"Rituximab Resistant Follicular Lymphoma: Predictors of Rituximab Resistance, Incidence of Transformation and Prognosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Maintenance therapy; Oncology; Lymphoma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.012702032061216721,"score_gpt":0.21635136003140196,"score_spread":0.20364932797018523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549385334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907876,0.0034044692,0.000019425517,0.0000752174,0.00003355565,0.0006034604,0.00005400546,0.000034235978,0.0049880343],"genre_scores_gemma":[0.9968175,0.00057197677,0.0024083848,0.000020487494,0.000019119147,0.00009451124,0.000016912898,0.000015105365,0.00003595914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986846,0.0000367598,0.00051282585,0.00022946777,0.00035052566,0.00018581789],"domain_scores_gemma":[0.9992158,0.000044442306,0.000200396,0.00027413128,0.00015688284,0.00010838047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017604111,0.0001652145,0.0005120081,0.00012595218,0.00004625138,0.000005484551,0.00007372162,0.00009660737,0.000023439052],"category_scores_gemma":[0.00004893329,0.00013171995,0.00012414959,0.00022003427,0.00014375332,0.00013824746,0.000021915685,0.000030891177,0.0000031190334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024949715,0.037461292,0.92449003,0.0027990893,0.0015552826,0.000259828,0.008284081,1.2565907e-7,0.009898508,0.0074018966,0.00028552365,0.005069389],"study_design_scores_gemma":[0.025684794,0.0009310817,0.65694064,0.0006815695,0.0013815265,0.000041045176,0.0002337238,0.000005098887,0.31324697,0.0002465752,0.00046972543,0.00013723734],"about_ca_topic_score_codex":0.00019082394,"about_ca_topic_score_gemma":0.00006837667,"teacher_disagreement_score":0.30334848,"about_ca_system_score_codex":0.000037161248,"about_ca_system_score_gemma":0.000108860535,"threshold_uncertainty_score":0.5371384},"labels":[],"label_agreement":null},{"id":"W2549524390","doi":"10.1182/blood.v116.21.857.857","title":"A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Bortezomib; Follicular lymphoma; Refractory (planetary science); Gastroenterology; Lymphoma; Phases of clinical research; Randomization; Oncology; Surgery; Clinical trial; Multiple myeloma","score_opus":0.011473744818631277,"score_gpt":0.2484935082809262,"score_spread":0.23701976346229492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549524390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504256,0.00011919683,0.000026400683,0.00017429709,0.00023560185,0.0031039594,0.000077464436,0.00014702788,0.0010734799],"genre_scores_gemma":[0.99538285,0.000020925365,0.003144383,0.00025544452,0.00024971337,0.00039013074,0.0003487006,0.00010248742,0.000105396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966119,0.00009022587,0.0006704813,0.0009506415,0.00087528065,0.0008015028],"domain_scores_gemma":[0.9979362,0.00015758537,0.00030178702,0.00086408283,0.00029861327,0.0004417378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021428936,0.00064650667,0.0016385893,0.00030768744,0.0001978517,0.000092122355,0.00017592267,0.00025724195,0.00007721492],"category_scores_gemma":[0.000111466674,0.00042204364,0.00018726804,0.00056889566,0.00022935135,0.00025917013,0.00009003535,0.0003452611,0.0001119403],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34787053,0.30533603,0.32657892,0.00016040659,0.002151096,0.009532783,0.00092327676,0.0000046427003,0.000238424,0.00020015323,0.00036538806,0.006638363],"study_design_scores_gemma":[0.8707375,0.010821608,0.1100895,0.00042760072,0.0015930347,0.000365698,0.00011329846,0.00013965263,0.004420593,0.000008088706,0.00073404965,0.00054938375],"about_ca_topic_score_codex":0.0007439298,"about_ca_topic_score_gemma":0.0012698489,"teacher_disagreement_score":0.52286696,"about_ca_system_score_codex":0.00027144482,"about_ca_system_score_gemma":0.0006432644,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2549638472","doi":"10.1182/blood.v114.22.624.624","title":"MicroRNA Are Useful Biomarkers for Prediction of Response to Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; microRNA; Lymphoma; Anthracycline; Cancer research; BCL6; Gene expression profiling; Biology; Carcinogenesis; Oncology; Gene expression; Gene; Medicine; Internal medicine; Cancer; Immunology; B cell; Antibody; Breast cancer; Genetics; Germinal center","score_opus":0.011860579349876759,"score_gpt":0.22483939562237118,"score_spread":0.21297881627249443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549638472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979855,0.00033666467,0.000011413779,0.0001951921,0.000028311864,0.00077607477,0.0006194883,0.0000141130395,0.00003327873],"genre_scores_gemma":[0.99919504,0.000065335735,0.0004982504,0.00010930579,0.00001222381,0.000027235232,0.00005302306,0.000011935128,0.00002768035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993193,0.000032300253,0.00017827295,0.00017600387,0.00015700421,0.0001370834],"domain_scores_gemma":[0.99940723,0.00008448781,0.000110770365,0.000189188,0.00011856903,0.000089757326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001132314,0.000112422924,0.00024981223,0.00008337143,0.000027443846,0.0000044141816,0.00003151093,0.000047194255,0.000002771424],"category_scores_gemma":[0.000031241776,0.00007784029,0.000053078566,0.000102110534,0.000020461499,0.000027308939,0.00000813752,0.000009702705,4.959934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012564811,0.025464866,0.9493705,0.000042204963,0.00022848838,0.0000059526856,0.0002654674,5.940661e-8,0.009971888,0.0000044015874,0.00017483426,0.0019065001],"study_design_scores_gemma":[0.08613915,0.004355398,0.8510111,0.00008588489,0.00017445107,0.0000018364955,0.00005797936,0.0000015388534,0.05748533,0.000003150081,0.00063092913,0.000053228396],"about_ca_topic_score_codex":0.000007657458,"about_ca_topic_score_gemma":0.0000038122555,"teacher_disagreement_score":0.0983594,"about_ca_system_score_codex":0.000024040137,"about_ca_system_score_gemma":0.000041767624,"threshold_uncertainty_score":0.3174235},"labels":[],"label_agreement":null},{"id":"W2549848218","doi":"10.1182/blood.v106.11.1919.1919","title":"C-myc Abnormalities in Non-Hodgkins Lymphoma - A Retrospective Review of Cytogenetic Patterns and Clinical Impact of c-myc Abnormalities by FISH Testing.","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Follicular lymphoma; Medicine; International Prognostic Index; Gastroenterology; Chromosomal translocation; Chromosome abnormality; Internal medicine; Diffuse large B-cell lymphoma; Histology; Pathology; Stage (stratigraphy); Non-Hodgkin's lymphoma; Large-cell lymphoma; Oncology; Biology; Karyotype; Chromosome","score_opus":0.0442738370873098,"score_gpt":0.37447319765478176,"score_spread":0.33019936056747196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549848218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08045778,0.9146095,2.8879487e-7,0.00002594545,0.00005978303,0.0017363462,0.0020613184,0.000024410016,0.0010246271],"genre_scores_gemma":[0.020518465,0.978102,0.00016333292,0.00015377237,0.00022684822,0.0002418719,0.00038708237,0.00008182547,0.00012478676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953271,0.00034692034,0.0026050676,0.00069091056,0.0005097476,0.0005202466],"domain_scores_gemma":[0.9963629,0.0009417078,0.0013741349,0.000795144,0.00026240127,0.0002636845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079474883,0.00077807315,0.005284458,0.00026464273,0.000037093214,0.00002108456,0.00023720069,0.00039571,0.000115141374],"category_scores_gemma":[0.0006200985,0.0005610818,0.0013378838,0.000452577,0.00024839517,0.000087264154,0.00016597593,0.00024710517,0.0000070636065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002316227,0.0037681584,0.43669084,0.09593703,0.0018661421,0.00017252396,0.00009396916,3.287534e-8,2.21622e-7,0.000008982276,0.0009500534,0.4604889],"study_design_scores_gemma":[0.0074571436,0.0037059118,0.5972618,0.3424118,0.011026632,0.0011767711,0.00003356661,0.0000015399794,0.000021478241,0.0000069526313,0.036228184,0.0006682316],"about_ca_topic_score_codex":0.0020949407,"about_ca_topic_score_gemma":0.00011327412,"teacher_disagreement_score":0.45982066,"about_ca_system_score_codex":0.0004240809,"about_ca_system_score_gemma":0.0009702651,"threshold_uncertainty_score":0.9996841},"labels":[],"label_agreement":null},{"id":"W2549915480","doi":"10.1182/blood.v110.11.3445.3445","title":"CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Regimen; CHOP; Interim analysis; Cyclophosphamide; Febrile neutropenia; Gastroenterology; Oncology; Surgery; Lymphoma; Neutropenia; Chemotherapy; Clinical trial","score_opus":0.0152712207846442,"score_gpt":0.28058744970144656,"score_spread":0.26531622891680234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549915480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984679,0.007111666,0.0012589225,0.0003873945,0.00037923333,0.0029347797,0.000690454,0.00035291395,0.0022056692],"genre_scores_gemma":[0.9882601,0.0024293538,0.0060989796,0.0010371243,0.00035375147,0.00035435054,0.0008340477,0.00021646719,0.00041584802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99121255,0.00022784766,0.00300301,0.00204384,0.0014170689,0.0020956954],"domain_scores_gemma":[0.9940359,0.0005667016,0.00093378103,0.0024245954,0.0006720169,0.0013670024],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013436835,0.0014277685,0.0034031116,0.0016393058,0.00030680868,0.00012253723,0.0009055978,0.0005415294,0.00031119213],"category_scores_gemma":[0.00030898236,0.0012807418,0.00091738545,0.0036532949,0.0002478854,0.00037665665,0.0003806877,0.00037989742,0.00011602765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006489687,0.19019811,0.7872777,0.00034772608,0.0023082367,0.0013237582,0.0014654316,0.000100434925,0.0043551857,0.0002138794,0.0010162856,0.0049035586],"study_design_scores_gemma":[0.13630088,0.0028435066,0.78989995,0.00035873614,0.0019732614,0.00008479342,0.00033455982,0.00064420636,0.059119876,0.00006263525,0.007302307,0.0010753301],"about_ca_topic_score_codex":0.0068179145,"about_ca_topic_score_gemma":0.0074606086,"teacher_disagreement_score":0.18735461,"about_ca_system_score_codex":0.00069484697,"about_ca_system_score_gemma":0.00039534317,"threshold_uncertainty_score":0.99984723},"labels":[],"label_agreement":null},{"id":"W2550074183","doi":"10.1182/blood.v118.21.2024.2024","title":"Allogeneic Stem Cell Transplantation Is Associated with Long Term Disease Control in Chemo Sensitive Follicular Lymphoma Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Follicular lymphoma; Transplantation; Surgery; Internal medicine; Chemotherapy; Rituximab; Autologous stem-cell transplantation; Gastroenterology; Chlorambucil; Lymphoma; Oncology; Cyclophosphamide","score_opus":0.009095405010583906,"score_gpt":0.1934741659445676,"score_spread":0.1843787609339837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550074183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850523,0.00016570152,0.000012830134,0.000031248663,0.00002078824,0.00069217995,0.0001221901,0.000030580744,0.0004192677],"genre_scores_gemma":[0.99909294,0.000056068275,0.00002332243,0.00044494087,0.000013097323,0.00008319173,0.00021055723,0.000021640715,0.000054217282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990786,0.00004700571,0.00017730141,0.0002606799,0.00021904628,0.00021738934],"domain_scores_gemma":[0.99948186,0.000033168377,0.00008710472,0.00015340441,0.00007914644,0.0001652941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043824024,0.00017094296,0.00026166192,0.0000596638,0.000033359607,0.000007906298,0.000031462998,0.00006410883,0.000016934664],"category_scores_gemma":[0.000003879875,0.00012789384,0.00008031068,0.00010084455,0.000022723676,0.000052263582,0.000004807865,0.000025890124,0.000016282234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060229335,0.0069636567,0.9865953,0.000048471433,0.0003692309,0.002691394,0.001147387,3.577511e-7,0.00020366632,0.00000216303,0.0000069876246,0.0013691367],"study_design_scores_gemma":[0.04082705,0.0004080523,0.9089387,0.00021246391,0.0015752942,0.000012680189,0.000026959666,0.000010201007,0.047854003,0.0000017800289,0.0000013252068,0.0001314762],"about_ca_topic_score_codex":0.00007945155,"about_ca_topic_score_gemma":0.00004905334,"teacher_disagreement_score":0.07765654,"about_ca_system_score_codex":0.00011663011,"about_ca_system_score_gemma":0.000078868,"threshold_uncertainty_score":0.521536},"labels":[],"label_agreement":null},{"id":"W2550477203","doi":"10.1016/j.ijrobp.2016.09.048","title":"Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized Trial","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Follicular phase; Progression-free survival; Internal medicine; Overall survival; Oncology; Follicular lymphoma; Gastroenterology; Lymphoma","score_opus":0.023995729258786788,"score_gpt":0.3369373101160606,"score_spread":0.3129415808572738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550477203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173003,0.00025173,0.00055670924,0.004319773,0.0011659416,0.0015703744,0.0003215197,0.00002044866,0.00006349863],"genre_scores_gemma":[0.99413174,0.0016352271,0.0025770334,0.00024107429,0.00090615806,0.00024559043,0.0001838902,0.000029041312,0.000050255552],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99661833,0.0005382721,0.001578647,0.0003815668,0.00063508237,0.00024812025],"domain_scores_gemma":[0.99529207,0.0016296091,0.0018237543,0.00033907426,0.000734069,0.00018143418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086371804,0.00033098913,0.001297328,0.00038303892,0.000042493688,0.000021362324,0.00042889352,0.000226686,0.00004676056],"category_scores_gemma":[0.00070401095,0.00018150674,0.0003689527,0.00019951284,0.00021079608,0.00035540713,0.00006429548,0.00009990978,0.0000021400795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71274096,0.007167019,0.07851821,0.000009228708,0.0020637827,0.00014967882,0.0011393486,0.0000774031,0.01102613,0.00039923238,0.00007423317,0.18663476],"study_design_scores_gemma":[0.8731698,0.018468367,0.04176713,0.0002841751,0.00022342932,0.00003602485,0.00012821001,0.0006556744,0.06292273,0.0006818794,0.0014275704,0.00023503561],"about_ca_topic_score_codex":0.0002489145,"about_ca_topic_score_gemma":0.00013813516,"teacher_disagreement_score":0.18639973,"about_ca_system_score_codex":0.0010556113,"about_ca_system_score_gemma":0.00088405906,"threshold_uncertainty_score":0.740163},"labels":[],"label_agreement":null},{"id":"W2550640392","doi":"10.1182/blood.v116.21.4921.4921","title":"Comparison of Single Agent GA101 In Japanese and European Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) – Results From Two Phase I Studies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Tolerability; Internal medicine; Lymphoma; Refractory (planetary science); Neutropenia; Clinical trial; Oncology; Phases of clinical research; Diffuse large B-cell lymphoma; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.025383273169698236,"score_gpt":0.29962790603400213,"score_spread":0.2742446328643039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550640392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959366,0.0009788645,2.3679044e-7,0.000049999533,0.0001301177,0.00042988255,0.00010445913,0.000023940298,0.0023459056],"genre_scores_gemma":[0.9989725,0.00007286898,0.000554731,0.00005011194,0.000077469565,0.00001348469,0.00015965723,0.000031758173,0.000067424764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985624,0.000070998,0.00048018928,0.0003946409,0.00027703715,0.00021472474],"domain_scores_gemma":[0.998858,0.00021336084,0.00025569936,0.000414878,0.00011402739,0.00014403011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014417784,0.00023013868,0.00053205114,0.00009801504,0.00004809497,0.000014152651,0.00007317254,0.000050410057,0.000009563951],"category_scores_gemma":[0.000105386745,0.00016302416,0.00004944087,0.000117243646,0.00012242884,0.00006431451,0.000073153176,0.00009414228,0.00001650672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017958103,0.050101392,0.90099466,0.000068526235,0.0003628624,0.00031453648,0.009523833,0.0000018367625,0.020462247,0.0000015103845,0.0003811251,0.015991673],"study_design_scores_gemma":[0.16288425,0.0044612335,0.7749606,0.00033897132,0.0005739837,0.000006009984,0.0010260621,0.000017375312,0.054635614,0.0000033246301,0.0008748822,0.00021770372],"about_ca_topic_score_codex":0.00046339093,"about_ca_topic_score_gemma":0.0003510455,"teacher_disagreement_score":0.16108844,"about_ca_system_score_codex":0.000048633243,"about_ca_system_score_gemma":0.000039006958,"threshold_uncertainty_score":0.6647932},"labels":[],"label_agreement":null},{"id":"W2550692709","doi":"10.1007/s00428-016-2041-7","title":"Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Hope Foundation; University of British Columbia; University of Arizona; Lymphoma Research Foundation","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cytoplasm; Pathology; Cancer research; Biology; Medicine; Cell biology","score_opus":0.02513503965667711,"score_gpt":0.3370692228208101,"score_spread":0.31193418316413296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550692709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864907,0.0029149163,0.0003689576,0.0016490017,0.00049326225,0.0013107829,0.00023001542,0.00020253344,0.0063398145],"genre_scores_gemma":[0.9923014,0.0033642824,0.002800279,0.00053954264,0.00021161804,0.00021180791,0.00018682226,0.00008050613,0.0003037592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99432105,0.0007825415,0.0013723571,0.0013195889,0.00089650333,0.0013079839],"domain_scores_gemma":[0.9948216,0.0020430388,0.00066579314,0.0018096319,0.00014907615,0.00051087874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012891854,0.0008213763,0.0017507805,0.0004996751,0.00017446368,0.000019196328,0.0007821587,0.00052279595,0.000114110735],"category_scores_gemma":[0.0013397846,0.00045292618,0.00047601224,0.00048101618,0.0010789131,0.00019909095,0.0007390066,0.00042807197,0.00010004798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060086846,0.035191383,0.27888554,0.0005775036,0.00046840438,0.0027868755,0.0018467503,0.000008491004,0.6022884,0.00399843,0.0037244856,0.06421503],"study_design_scores_gemma":[0.13140689,0.0046977764,0.39700624,0.0037676084,0.0007860676,0.000058618003,0.0014584565,0.00025544738,0.44772032,0.0054337783,0.006197703,0.0012110816],"about_ca_topic_score_codex":0.00013082392,"about_ca_topic_score_gemma":0.00006172697,"teacher_disagreement_score":0.15456809,"about_ca_system_score_codex":0.00020044553,"about_ca_system_score_gemma":0.00053453457,"threshold_uncertainty_score":0.9997923},"labels":[],"label_agreement":null},{"id":"W2550828294","doi":"10.1182/blood.v110.11.389.389","title":"Phase II Study of R-CHOP Followed by 90Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Neutropenia; Febrile neutropenia; Mantle cell lymphoma; Ibritumomab tiuxetan; Gastroenterology; Vincristine; Alemtuzumab; CHOP; Cyclophosphamide; Radioimmunotherapy; Surgery; Urology; Transplantation; Lymphoma; Chemotherapy; Immunology","score_opus":0.014200861247355942,"score_gpt":0.3031764204823627,"score_spread":0.2889755592350068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550828294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199575,0.0007944065,0.0000034529508,0.000050456936,0.000107636464,0.0028434214,0.000033266162,0.0000562307,0.0041154004],"genre_scores_gemma":[0.9987937,0.00002922175,0.000053290965,0.00008157346,0.000053768366,0.00017026514,0.00006965646,0.000041985233,0.0007065327],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99757016,0.00018937293,0.00076514133,0.00059504143,0.00040609456,0.00047421217],"domain_scores_gemma":[0.9988027,0.00017141737,0.00021222707,0.00047425868,0.000120053475,0.00021935048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034329205,0.00036406593,0.0009525748,0.00023760805,0.00011248474,0.000014971086,0.00014550441,0.00013518079,0.0000685296],"category_scores_gemma":[0.000033388704,0.00029539215,0.00010216927,0.0005112184,0.000058797053,0.00007947863,0.00011914825,0.000097896,0.000036724796],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017845288,0.54031277,0.43256322,0.000022453798,0.00073197647,0.005005172,0.006798547,6.7652775e-7,0.005642686,0.0000051651014,0.000509924,0.006622863],"study_design_scores_gemma":[0.5807895,0.17352737,0.17108884,0.00010896517,0.0025248628,0.00013402906,0.025258617,0.000032198903,0.044916138,0.000003609566,0.0011434092,0.00047243762],"about_ca_topic_score_codex":0.0017132695,"about_ca_topic_score_gemma":0.002654151,"teacher_disagreement_score":0.579005,"about_ca_system_score_codex":0.0002798604,"about_ca_system_score_gemma":0.00015965887,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2550997923","doi":"10.1182/blood.v108.11.3345.3345","title":"A Population-Based Analysis of the Frequency of Anemia and Its Management before and during Chemotherapy in Patients with Malignant Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Internal medicine; Anemia; Vincristine; CHOP; Rituximab; Vinblastine; Population; Chemotherapy; Surgery; Gastroenterology; Oncology; Lymphoma; Cyclophosphamide","score_opus":0.0027592056934062923,"score_gpt":0.19077218641681656,"score_spread":0.18801298072341027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550997923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993564,0.00017891964,2.8776472e-7,0.000050523417,0.0000032534756,0.0003138384,0.000015921138,0.0000036384583,0.0000772184],"genre_scores_gemma":[0.99973375,0.000009443774,0.00017134135,0.000020852332,0.0000032196858,0.000015039492,0.000027640794,0.0000058395444,0.00001290176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994702,0.000009944825,0.00016851374,0.00012714624,0.00014802687,0.000076166005],"domain_scores_gemma":[0.99971884,0.000008481595,0.00009159594,0.00013558991,0.00002677378,0.000018714441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026552669,0.00007657519,0.00021039687,0.00012799252,0.000019294677,0.0000029261203,0.000022352217,0.000022927323,0.0000058008295],"category_scores_gemma":[0.0000018685544,0.000044409033,0.00003558581,0.00030486332,0.000015845646,0.000016657608,0.000009581305,0.000008512123,4.561141e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046368932,0.0012468206,0.9975301,0.00012076409,0.00034392776,0.0000070817364,0.00004876188,0.00002050757,0.0000881208,0.00012364119,2.820809e-7,0.00042360136],"study_design_scores_gemma":[0.011816386,0.00011230374,0.9816997,0.00013808007,0.001199476,7.3868125e-7,0.000009063975,0.00004060572,0.004926558,0.000017699085,2.918308e-7,0.000039101444],"about_ca_topic_score_codex":0.0005832227,"about_ca_topic_score_gemma":0.0003434117,"teacher_disagreement_score":0.015830427,"about_ca_system_score_codex":0.000031929576,"about_ca_system_score_gemma":0.000010771319,"threshold_uncertainty_score":0.18109478},"labels":[],"label_agreement":null},{"id":"W2551225699","doi":"10.1182/blood.v114.22.1554.1554","title":"The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Internal medicine; Nodular sclerosis; Dacarbazine; Population; Chemotherapy regimen; Stage (stratigraphy); Vinblastine; Surgery; Cancer; Oncology; Gastroenterology; Lymphoma; Chemotherapy; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.0353803538980371,"score_gpt":0.27440296826576205,"score_spread":0.23902261436772496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551225699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633104,0.00024393952,5.992763e-7,0.0008198274,0.000048184123,0.0019183715,0.000052619347,0.00002975073,0.00055566727],"genre_scores_gemma":[0.99916875,0.000058419155,0.000048269398,0.00024576683,0.000020521675,0.0002623054,0.00013206081,0.0000118005255,0.000052093994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842,0.00012686606,0.00038879394,0.00034097486,0.00040466795,0.0003187036],"domain_scores_gemma":[0.9992435,0.00021499298,0.00009290226,0.00034133033,0.000066372086,0.000040898143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018226777,0.0002072599,0.0002496071,0.00016291841,0.000060888622,0.00006732585,0.0002176814,0.00007802144,0.00000891347],"category_scores_gemma":[0.00026833537,0.00011510511,0.000068494606,0.00039659263,0.000039450002,0.00009790068,0.000030828345,0.00011781937,0.000005399886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004809246,0.008423401,0.9245663,0.0000085671245,0.00003950841,0.00014292465,0.0015547938,0.0000038328317,0.000044578333,0.000019031826,0.000033919318,0.06468221],"study_design_scores_gemma":[0.019056136,0.0006773921,0.97815216,0.00016218208,0.0000356025,0.0000053649583,0.00016035771,0.00057725754,0.00080562115,0.000083438754,0.00017905662,0.00010544629],"about_ca_topic_score_codex":0.0003999517,"about_ca_topic_score_gemma":0.0011629424,"teacher_disagreement_score":0.06457676,"about_ca_system_score_codex":0.00023633418,"about_ca_system_score_gemma":0.00016266978,"threshold_uncertainty_score":0.46938503},"labels":[],"label_agreement":null},{"id":"W2551314481","doi":"10.1016/j.hoc.2016.07.004","title":"Management of Relapsed Diffuse Large B-cell Lymphoma","year":2016,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Rituximab; Medicine; Salvage therapy; Diffuse large B-cell lymphoma; Oncology; Lymphoma; Refractory (planetary science); Internal medicine; Chemotherapy; Clinical trial","score_opus":0.0315076230070602,"score_gpt":0.36071108476746405,"score_spread":0.3292034617604038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551314481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019823615,0.98797685,0.00004581136,0.00015833916,0.0006064231,0.0019502946,0.00039163954,0.000071849885,0.00681641],"genre_scores_gemma":[0.0016396071,0.9934388,0.0027819918,0.00026527798,0.00006621301,0.0005016978,0.000426307,0.000103314844,0.00077679096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945456,0.0003989263,0.002952102,0.0009643205,0.00037582545,0.0007632367],"domain_scores_gemma":[0.99243504,0.0019283161,0.0035349936,0.0015538756,0.00022410674,0.00032366012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032684376,0.00079494144,0.0075281966,0.00041994193,0.000068243295,0.000002950118,0.0005255278,0.0009080807,0.00016318625],"category_scores_gemma":[0.00012540621,0.0005389616,0.0017784594,0.0005310363,0.0007087673,0.000038033082,0.00044376962,0.00026518104,0.00058996177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020500431,0.020724257,0.0056891963,0.022898111,0.0026695477,0.0021855338,0.00003278659,2.1702647e-8,2.008277e-8,0.000551365,0.0030199464,0.94202423],"study_design_scores_gemma":[0.017738456,0.0021391683,0.000809375,0.009802741,0.006555576,0.00042727985,0.000039150298,0.0000012376867,0.0000029206712,0.0000284485,0.9620761,0.0003795488],"about_ca_topic_score_codex":0.000009499979,"about_ca_topic_score_gemma":0.000007821886,"teacher_disagreement_score":0.95905614,"about_ca_system_score_codex":0.00036986408,"about_ca_system_score_gemma":0.0010944066,"threshold_uncertainty_score":0.9997062},"labels":[],"label_agreement":null},{"id":"W2551413196","doi":"10.1182/blood.v106.11.4653.4653","title":"Are Ovaries a Sanctuary for Lymphoma? Report of a Cure of Recurrent Lymphoma in Both Ovaries after Bilateral Oophorectomy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Lymphoma; Follicular lymphoma; Abdomen; Abdominal pain; Surgery; Pathology","score_opus":0.014674465749908478,"score_gpt":0.26486467778562495,"score_spread":0.25019021203571645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551413196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187225,0.0060790014,0.000008790646,0.0006113185,0.00012858058,0.00081318815,0.00012528252,0.000033270924,0.00032833515],"genre_scores_gemma":[0.99526155,0.00021459459,0.0034777964,0.00017472614,0.00016587434,0.0004877917,0.00006099087,0.00003183804,0.00012484039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981916,0.000028740798,0.00077016436,0.0003889896,0.00029216945,0.00032831926],"domain_scores_gemma":[0.9987292,0.00010749231,0.0004412446,0.00047047564,0.00014858537,0.000102999715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016529532,0.0002692307,0.00076831004,0.00020754892,0.000030464042,0.00001329333,0.00008100865,0.00014318961,0.000066591136],"category_scores_gemma":[0.00012918995,0.00020750125,0.00027147605,0.00024059853,0.00012706898,0.00009513617,0.0000541193,0.00003179988,0.000003667155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005028988,0.013549304,0.94665915,0.00081589277,0.0007180661,0.0017858836,0.0017465424,0.0000032103464,0.0005301792,0.00016958162,0.0018434748,0.02714971],"study_design_scores_gemma":[0.017461158,0.0006871253,0.9315538,0.000801269,0.0005307103,0.00073397654,0.00011723922,0.000025251607,0.03828169,0.00016309324,0.009443999,0.00020068543],"about_ca_topic_score_codex":0.0001795604,"about_ca_topic_score_gemma":0.00021595994,"teacher_disagreement_score":0.03775151,"about_ca_system_score_codex":0.0001357698,"about_ca_system_score_gemma":0.00029275691,"threshold_uncertainty_score":0.8461655},"labels":[],"label_agreement":null},{"id":"W2551433805","doi":"10.1182/blood.v116.21.417.417","title":"Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Nodular sclerosis; Medicine; Stage (stratigraphy); Internal medicine; B symptoms; Gastroenterology; Lymphoma; Cancer; Surgery; Chemotherapy; Hodgkin lymphoma; Cyclophosphamide; Vincristine","score_opus":0.03977289244726998,"score_gpt":0.3057230368685737,"score_spread":0.2659501444213037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551433805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925596,0.00024722048,0.0000018547679,0.0013466208,0.00015929091,0.002718212,0.002745276,0.000107830616,0.000114058836],"genre_scores_gemma":[0.99316883,0.00015885815,0.00041579432,0.0012085845,0.00011110042,0.00053099106,0.0006755911,0.00008187877,0.0036483812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696016,0.000109130306,0.00073808135,0.0008170577,0.0007976,0.00057798525],"domain_scores_gemma":[0.9971028,0.00039435382,0.00034527743,0.0008721153,0.00014507254,0.0011403664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041121355,0.00053198927,0.0009966,0.00025412766,0.00029987437,0.00006445053,0.00015416506,0.0001472904,0.00036081512],"category_scores_gemma":[0.0013619846,0.00034727211,0.00015445091,0.00025731372,0.00015154805,0.00024487227,0.00030359838,0.00017553208,0.000005443731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018776486,0.022442553,0.9476212,0.00028778086,0.00047784753,0.0021955606,0.0006530578,0.000009199292,0.0013768909,0.00019246571,0.0001723741,0.0057945764],"study_design_scores_gemma":[0.08769124,0.002198027,0.8915032,0.00024616742,0.0011287781,0.0000024054414,0.000122693,0.000055572997,0.0064132605,0.000009112997,0.010170923,0.00045858082],"about_ca_topic_score_codex":0.00019400204,"about_ca_topic_score_gemma":0.0006340135,"teacher_disagreement_score":0.068914756,"about_ca_system_score_codex":0.0001292692,"about_ca_system_score_gemma":0.0005286794,"threshold_uncertainty_score":0.99989796},"labels":[],"label_agreement":null},{"id":"W2551649272","doi":"10.1182/blood.v108.11.2710.2710","title":"Phase II Results of Bendamustine in Combination with Rituximab in Relapsed Indolent and Mantle-Cell Non-Hodgkin’s Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Hôpital Notre-Dame; Northeast Cancer Centre; Ottawa Hospital","funders":"","keywords":"Bendamustine; Rituximab; Mantle cell lymphoma; Medicine; Internal medicine; Follicular lymphoma; Population; Gastroenterology; Lymphoma; Oncology","score_opus":0.006791410188091333,"score_gpt":0.23272023249351448,"score_spread":0.22592882230542313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551649272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950953,0.00045976555,0.0000020311834,0.00033037143,0.000019347965,0.00050604716,0.000032363798,0.000013528727,0.0035412344],"genre_scores_gemma":[0.99900275,0.00006262037,0.0005470241,0.000034823366,0.000020032438,0.00004919714,0.00011694887,0.00001434925,0.00015223348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989492,0.000024088515,0.00038443707,0.00026219015,0.00019967662,0.00018034846],"domain_scores_gemma":[0.99953103,0.000053977503,0.00012892806,0.00019020242,0.0000458406,0.000050015664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014253525,0.00014583523,0.00034057628,0.00021158537,0.000026934335,0.000006141623,0.000035067176,0.000072684794,0.000006050639],"category_scores_gemma":[0.000017424542,0.00011467591,0.000027270511,0.00023572255,0.000044186494,0.00003874885,0.000029860328,0.00004736678,0.000002479806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007759877,0.44620413,0.49657005,0.0004944497,0.00013392739,0.002250818,0.0019562114,0.000024106841,0.009112976,0.00042083775,0.0006670077,0.03440561],"study_design_scores_gemma":[0.43931252,0.005607723,0.48273426,0.00035228365,0.00015824536,0.000055625635,0.00007505659,0.00016197283,0.0712226,0.000045566852,0.0001524298,0.00012170767],"about_ca_topic_score_codex":0.0013312625,"about_ca_topic_score_gemma":0.00047321778,"teacher_disagreement_score":0.4405964,"about_ca_system_score_codex":0.00007795813,"about_ca_system_score_gemma":0.0000747782,"threshold_uncertainty_score":0.4676348},"labels":[],"label_agreement":null},{"id":"W2551670998","doi":"10.1186/s13045-016-0349-z","title":"A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Institute of Cancer Research; China Scholarship Council; University of Alberta; University of Ottawa; Li Ka Shing Foundation","keywords":"Regulator; Wnt signaling pathway; Cancer research; Biology; SOX2; Cell culture; Molecular biology; Transcriptional regulation; Lymphoma; Cell growth; Gene expression; Transcription factor; Cell biology; Signal transduction; Gene; Immunology; Genetics","score_opus":0.01148644348260239,"score_gpt":0.26496089130228523,"score_spread":0.2534744478196828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551670998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983228,0.0050235027,0.00011786405,0.009292678,0.0006297969,0.0005095307,0.000021141008,0.000018157763,0.0011593155],"genre_scores_gemma":[0.9973388,0.0007438194,0.0004265956,0.00094387826,0.00019321025,0.000044972752,0.000013856537,0.00003804549,0.00025683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688804,0.00052320823,0.001187174,0.00038640885,0.0003208258,0.00069436803],"domain_scores_gemma":[0.99581397,0.0021657874,0.0010927233,0.00023693309,0.00045622987,0.00023437217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060694065,0.00037254515,0.0012967044,0.0004566272,0.00016570227,0.000017640907,0.00023718915,0.00037807555,0.00008586778],"category_scores_gemma":[0.0002785504,0.00020431499,0.00035434382,0.00035823465,0.00023103844,0.00020216327,0.00010739602,0.0002483019,0.00013110042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009362391,0.018056063,0.8723181,0.00026887737,0.0013408331,0.02469845,0.0056555006,0.000019205734,0.040435545,0.007935785,0.0067493236,0.013159952],"study_design_scores_gemma":[0.058130823,0.011492116,0.7576106,0.0011046329,0.0016719031,0.026631884,0.0021005983,0.00013243902,0.13689841,0.001795999,0.0018524445,0.0005781194],"about_ca_topic_score_codex":0.00018528433,"about_ca_topic_score_gemma":0.00070044294,"teacher_disagreement_score":0.11470745,"about_ca_system_score_codex":0.0013529995,"about_ca_system_score_gemma":0.0008784343,"threshold_uncertainty_score":0.8331723},"labels":[],"label_agreement":null},{"id":"W2551684983","doi":"10.1182/blood.v112.11.520.520","title":"Genome-Wide Expression Profiling Predicts Treatment Outcome in Classical Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Oncology; Univariate analysis; Lymphoma; International Prognostic Index; Progression-free survival; Gene expression profiling; Immunohistochemistry; CD20; Rituximab; Diffuse large B-cell lymphoma; Logistic regression; Pathology; Multivariate analysis; Chemotherapy; Gene expression; Biology; Gene","score_opus":0.03628988350224209,"score_gpt":0.2729385662410259,"score_spread":0.2366486827387838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551684983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488693,0.0008915019,0.0000070030974,0.00042276978,0.000078960154,0.0007395359,0.000013089874,0.00010234896,0.0028578837],"genre_scores_gemma":[0.99651396,0.0003390445,0.001666542,0.00017768516,0.0001676187,0.0003040724,0.00007168248,0.000030231235,0.0007291796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844766,0.00004705219,0.00040498358,0.00041788843,0.00030072796,0.00038166367],"domain_scores_gemma":[0.99917257,0.00011149333,0.00007335623,0.0003814984,0.00002924423,0.00023182065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064254746,0.00025506451,0.00047281102,0.00013453397,0.00009117512,0.000010484785,0.00006789866,0.00013215495,0.000055500364],"category_scores_gemma":[0.00006857414,0.00017738083,0.00015880603,0.00015504022,0.000056146044,0.000062593404,0.000044227385,0.000051898303,0.000119609474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011852179,0.0077300533,0.98342884,0.000025651982,0.00009359445,0.002611702,0.0003067956,0.000003980501,0.0041057793,0.000018009587,0.000055958357,0.0015011037],"study_design_scores_gemma":[0.020257099,0.0009063765,0.8822152,0.00008703173,0.00016681083,0.00030716354,0.000038453396,0.000020337407,0.09397094,0.000011503935,0.0018737743,0.0001452952],"about_ca_topic_score_codex":0.000048184866,"about_ca_topic_score_gemma":0.000009612413,"teacher_disagreement_score":0.101213634,"about_ca_system_score_codex":0.00038818517,"about_ca_system_score_gemma":0.00018825516,"threshold_uncertainty_score":0.72333807},"labels":[],"label_agreement":null},{"id":"W2552031241","doi":"10.1182/blood-2016-02-636316","title":"Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Lymphoma; Germinal center; Fluorescence in situ hybridization; Oncology; Diffuse large B-cell lymphoma; Clinical trial; Medicine; Internal medicine; B cell; Cancer research; Biology; Immunology; Genetics; Gene; Chromosome","score_opus":0.04915020023697943,"score_gpt":0.2885356051003054,"score_spread":0.239385404863326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552031241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016296554,0.9793142,0.0000013828586,0.00023195289,0.00003303255,0.0029526928,0.00019287725,0.00002469629,0.00095258537],"genre_scores_gemma":[0.0055675437,0.99029785,0.0007899498,0.000057808993,0.00013073308,0.0022339907,0.000056757894,0.000059406313,0.0008059541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836975,0.00008419847,0.00037193013,0.0006275589,0.00026140435,0.0002851547],"domain_scores_gemma":[0.9986764,0.0002718127,0.00021116761,0.0005463399,0.00003340794,0.00026088013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008682463,0.0005315416,0.0016314859,0.0001274363,0.00009081421,0.00003576323,0.000081739556,0.0001570845,0.000016721333],"category_scores_gemma":[0.000014806829,0.00020549401,0.0001340082,0.00016315197,0.00011788378,0.000031151634,0.00008103313,0.00003847667,0.000009712498],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008667133,0.0066767307,0.0060711405,0.0048071826,0.0019711817,0.00010104407,0.00029989483,1.175929e-8,5.4532995e-7,0.00008482733,0.0004526097,0.97944814],"study_design_scores_gemma":[0.017644752,0.0042896196,0.0051301,0.008980564,0.012994045,0.00056585984,0.000058196125,1.8965714e-7,0.00013137024,0.000005502981,0.9498421,0.00035769143],"about_ca_topic_score_codex":0.0002704357,"about_ca_topic_score_gemma":0.000027172217,"teacher_disagreement_score":0.97909045,"about_ca_system_score_codex":0.00010580743,"about_ca_system_score_gemma":0.00014505767,"threshold_uncertainty_score":0.8379802},"labels":[],"label_agreement":null},{"id":"W2552034981","doi":"10.1182/blood.v114.22.133.133","title":"HLA-DR Protein Expression Correlates with Non-Neoplastic T-Cell Infiltration and Predicts Survival in Patients with Primary Mediastinal Large B Cell Lymphoma (PMBCL) Treated with CHOP Chemotherapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tissue microarray; CHOP; Medicine; Lymphoma; International Prognostic Index; Diffuse large B-cell lymphoma; CD8; Human leukocyte antigen; Immunohistochemistry; Cancer research; Pathology; Oncology; Antigen; Immunology","score_opus":0.0028529832276552184,"score_gpt":0.17413168719475255,"score_spread":0.17127870396709732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552034981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965196,0.00015488017,0.000050872408,0.00006052772,0.00001562366,0.0016956244,0.000025098461,0.00006684805,0.0014109177],"genre_scores_gemma":[0.9984314,0.000033351662,0.000806488,0.0001076428,0.000045644236,0.0001398638,0.00025525878,0.00004200572,0.00013838006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982942,0.00004338948,0.00027117244,0.00048136825,0.0005170273,0.00039287697],"domain_scores_gemma":[0.9991769,0.000063225045,0.00018154195,0.00025743255,0.00010854618,0.00021231822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007717867,0.0003762498,0.00045167573,0.00013171534,0.00008499662,0.000036818645,0.0000584826,0.00012732318,0.000015440932],"category_scores_gemma":[0.000009829956,0.00022423053,0.000026622052,0.00026623666,0.00005670832,0.00017238338,0.000014909044,0.00010280356,0.000004888867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045787957,0.016805485,0.97285956,0.00013499847,0.00006912013,0.00021063333,0.0004407525,0.000012718152,0.003580355,0.0000014349699,0.000031484058,0.0012746671],"study_design_scores_gemma":[0.10487664,0.009314134,0.8351022,0.00095927133,0.00027118652,0.000032546097,0.00004762762,0.000084134015,0.049051415,0.0000015803463,0.0000171597,0.0002421336],"about_ca_topic_score_codex":0.0000412425,"about_ca_topic_score_gemma":0.000034701854,"teacher_disagreement_score":0.13775739,"about_ca_system_score_codex":0.00009865042,"about_ca_system_score_gemma":0.00020229674,"threshold_uncertainty_score":0.91438556},"labels":[],"label_agreement":null},{"id":"W2552123441","doi":"10.1182/blood-2016-09-738815","title":"Is the lymphoma better? Not easy to determine","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Intensive care medicine; Immunology","score_opus":0.02447466684640398,"score_gpt":0.25474237090522805,"score_spread":0.23026770405882407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552123441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07042735,0.00036212575,0.0000027611136,0.92285144,0.0003599206,0.0008030755,0.00023537544,0.00007777849,0.004880179],"genre_scores_gemma":[0.019168586,0.00007870239,0.00021424826,0.9576423,0.009116982,0.00039755294,0.00008424368,0.00008953256,0.013207851],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979669,0.000045984,0.00031911352,0.0005781552,0.0005456123,0.00054424687],"domain_scores_gemma":[0.9982247,0.0002501076,0.00011690385,0.0011860499,0.00007688965,0.00014538999],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007830402,0.00043751777,0.00056732993,0.00011411581,0.00009727775,0.000051403204,0.000290857,0.00043622954,0.0004714022],"category_scores_gemma":[0.000041147672,0.00021661505,0.00036807283,0.00010325858,0.00005855808,0.00002724776,0.00012972046,0.00018014679,0.002300136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024443414,0.00028187127,0.0048602796,0.000070885355,0.0005917331,0.0029931061,0.00007150028,2.3493494e-9,0.00014430314,0.0000034000057,0.9383752,0.052583274],"study_design_scores_gemma":[0.0055001234,0.00036429465,0.018645477,0.0004472404,0.001288573,0.00051558466,0.0000018481146,2.6845444e-7,0.014370398,0.000022620825,0.95857096,0.00027261712],"about_ca_topic_score_codex":0.00007051058,"about_ca_topic_score_gemma":0.0000040353443,"teacher_disagreement_score":0.052310657,"about_ca_system_score_codex":0.00013721996,"about_ca_system_score_gemma":0.00013943587,"threshold_uncertainty_score":0.9984767},"labels":[],"label_agreement":null},{"id":"W2552187469","doi":"10.1182/blood.v112.11.3782.3782","title":"Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Chromosomal translocation; CHOP; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Tissue microarray; Medicine; Fluorescence in situ hybridization; Rituximab; Pathology; Cancer research; Oncology; Gastroenterology; Biology; Immunohistochemistry; Immunology; Germinal center; B cell; Genetics; Chromosome; Antibody","score_opus":0.009164332024263876,"score_gpt":0.20633243642297772,"score_spread":0.19716810439871385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552187469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806786,0.00035933265,0.0000074137292,0.000034131477,0.000010631527,0.0008072148,0.000026010486,0.000029227109,0.000658208],"genre_scores_gemma":[0.99922675,0.00018070769,0.00018325311,0.00004261773,0.0000127601,0.00017125864,0.000080348,0.000018746954,0.000083545456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909604,0.000027683693,0.0002364674,0.00022108175,0.00021945313,0.00019930744],"domain_scores_gemma":[0.9995014,0.000051792693,0.00008212865,0.00020073708,0.0000848808,0.00007908014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003151949,0.00014101445,0.0002690052,0.0000850305,0.00003237183,0.0000028746986,0.00004160963,0.00005523479,0.000009683903],"category_scores_gemma":[0.000019739991,0.000101857986,0.000046215016,0.0002560015,0.000041807085,0.000045581623,0.0000052356854,0.000026182313,0.000012131649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019593361,0.07441799,0.9229632,0.00006574458,0.00005787507,0.00015023131,0.00045679006,5.739877e-7,0.0005713033,0.000007281294,0.000021188624,0.0010918763],"study_design_scores_gemma":[0.08560136,0.0010435019,0.8569071,0.0001513162,0.00019273344,0.000018307202,0.000024719968,0.000013868739,0.055899292,0.0000014811704,0.00005537669,0.00009091048],"about_ca_topic_score_codex":0.00018141003,"about_ca_topic_score_gemma":0.000049256687,"teacher_disagreement_score":0.085405424,"about_ca_system_score_codex":0.00005477649,"about_ca_system_score_gemma":0.000107765365,"threshold_uncertainty_score":0.4153648},"labels":[],"label_agreement":null},{"id":"W2552201383","doi":"10.1182/blood.v112.11.2365.2365","title":"Does Location Matter? a Population-Based Analysis of Survival after Blood and Marrow Transplantation in Rural Versus Urban Manitobans","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Cancer registry; Rural area; Residence; Proportional hazards model; Demography; Population; Univariate analysis; Cancer; Pediatrics; Internal medicine; Multivariate analysis; Environmental health","score_opus":0.008956944190449326,"score_gpt":0.22764046704178445,"score_spread":0.21868352285133513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552201383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933237,0.00016271196,0.00001231036,0.00013772942,0.000048892533,0.00018287185,0.0000410314,0.000011750145,0.000070315444],"genre_scores_gemma":[0.99927944,0.00006925781,0.0001769785,0.0000382365,0.000025639909,0.00005193311,0.00033336383,0.000007906392,0.000017231147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933904,0.00003283759,0.00021572823,0.00014713663,0.00016368904,0.00010155908],"domain_scores_gemma":[0.9996546,0.00007200044,0.000057124234,0.00013247064,0.000039388204,0.000044395714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040538984,0.00009956557,0.00025369736,0.00024346619,0.000024729543,0.000005536455,0.00002017295,0.00004796664,0.000059190126],"category_scores_gemma":[0.000006594173,0.000069096706,0.00007083615,0.0003506265,0.000023069257,0.00004678761,0.0000028493387,0.000025665171,0.0000028074717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044583748,0.001007733,0.9970322,0.00008002431,0.00058707834,0.000094571595,0.00038047327,0.000033868186,0.00023441741,0.0000084690255,0.000001774545,0.000093521754],"study_design_scores_gemma":[0.009896252,0.00014111778,0.98175144,0.00006474075,0.004828036,0.0000072625203,0.00006870956,0.00012592276,0.0030376927,0.0000025817114,0.0000011825206,0.000075052514],"about_ca_topic_score_codex":0.0021951352,"about_ca_topic_score_gemma":0.0029820162,"teacher_disagreement_score":0.015280782,"about_ca_system_score_codex":0.000028461372,"about_ca_system_score_gemma":0.000028333534,"threshold_uncertainty_score":0.33184025},"labels":[],"label_agreement":null},{"id":"W2552384732","doi":"10.1182/blood.v114.22.2729.2729","title":"Sunitinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: Results of a Phase II Multi-Center Study of the NCIC Clinical Trials Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; University Health Network; Fraser Health; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; Gastroenterology; Lymphoma; Clinical trial; Chemotherapy; Cancer","score_opus":0.10995409880555077,"score_gpt":0.4067856245798212,"score_spread":0.2968315257742704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552384732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971953,0.00029222856,4.7090424e-7,0.00018342202,0.00015149685,0.0017195634,0.00017923531,0.000020395843,0.0002578889],"genre_scores_gemma":[0.9990711,0.00015618622,0.00010854931,0.00024127781,0.00009140138,0.00004536696,0.00003300252,0.000017202907,0.00023591972],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99616957,0.00097020494,0.0018615648,0.00036821284,0.0003642116,0.0002662524],"domain_scores_gemma":[0.9973749,0.00091645506,0.00072367664,0.0007741607,0.00008571957,0.0001251225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022195743,0.0002140648,0.0010972245,0.000111843954,0.000057711924,0.000005405528,0.00017214676,0.00015495822,0.000017802819],"category_scores_gemma":[0.0019647272,0.000115524985,0.00033011957,0.00027055028,0.00005023357,0.000034942,0.000080771686,0.00012536519,0.0000039977726],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008972714,0.89925086,0.080424175,0.00003657659,0.00025466253,0.00032632484,0.0020964579,6.9957075e-8,0.0012687441,0.0000065782856,0.00043937605,0.006923475],"study_design_scores_gemma":[0.6396367,0.016665382,0.33663154,0.00021500325,0.0007725862,0.000011279813,0.000665929,0.00001346361,0.004563549,0.0000026273642,0.0007238646,0.00009805226],"about_ca_topic_score_codex":0.00012677533,"about_ca_topic_score_gemma":0.00024218208,"teacher_disagreement_score":0.88258547,"about_ca_system_score_codex":0.000052408108,"about_ca_system_score_gemma":0.00015193064,"threshold_uncertainty_score":0.47109723},"labels":[],"label_agreement":null},{"id":"W2552673806","doi":"10.1182/blood.v104.11.3122.3122","title":"Prognostic Factors in Localized Hodgkin’s Lymphoma: How To Define Intermediate/Unfavourable Disease?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Lymphoma; Nomogram; Mediastinum; Chemotherapy; Gastroenterology; Classical Hodgkin lymphoma; Hodgkin lymphoma; Oncology; Surgery","score_opus":0.013752239020366742,"score_gpt":0.2401178732550698,"score_spread":0.22636563423470307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552673806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469405,0.0008182512,0.000029911525,0.0029171351,0.00013483537,0.0009619763,0.000035346387,0.00010387936,0.00030458323],"genre_scores_gemma":[0.9983452,0.00008431306,0.00045260158,0.00047805093,0.00008220871,0.00027886374,0.000095861265,0.000036208203,0.00014670767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985308,0.000028172164,0.0002455502,0.000421184,0.00030995323,0.00046434847],"domain_scores_gemma":[0.99888253,0.00009470238,0.000055471504,0.0003576708,0.00005263239,0.0005569661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007299308,0.00027216834,0.00042939337,0.00021341917,0.000047251608,0.00004709429,0.000108145185,0.00007830728,0.000045927907],"category_scores_gemma":[0.00040733282,0.00020509525,0.00014007938,0.00036842198,0.00004147135,0.00007827905,0.000063159714,0.000055992154,0.00013140724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019416824,0.0061946227,0.9896415,0.00007904109,0.00013104672,0.0013183187,0.00027927617,0.000019373598,0.00019456897,0.00021596784,0.0002730502,0.0014590921],"study_design_scores_gemma":[0.024349513,0.0006436769,0.96331775,0.00043798832,0.00043921798,0.000035342706,0.00010124633,0.000004637296,0.008848332,0.00021942558,0.0013743708,0.00022849649],"about_ca_topic_score_codex":0.0002754859,"about_ca_topic_score_gemma":0.00013160643,"teacher_disagreement_score":0.02632372,"about_ca_system_score_codex":0.00033403773,"about_ca_system_score_gemma":0.00032035395,"threshold_uncertainty_score":0.83635414},"labels":[],"label_agreement":null},{"id":"W2552704352","doi":"10.1182/blood.v108.11.2031.2031","title":"Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Bone marrow; Pathology; Malignancy; Not Otherwise Specified; Internal medicine; Stage (stratigraphy); Oncology; Biology","score_opus":0.015517804188697151,"score_gpt":0.2942985743858516,"score_spread":0.27878077019715447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552704352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577796,0.0023655738,0.000004587334,0.00018189884,0.00007903731,0.00055251404,0.00016566351,0.00003012251,0.00084261876],"genre_scores_gemma":[0.99859905,0.00036711866,0.00016879255,0.00011882957,0.00017024476,0.00007436877,0.0001922097,0.000029109433,0.00028026063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980741,0.000071689814,0.0007292806,0.00037669286,0.0003301576,0.0004180871],"domain_scores_gemma":[0.9988604,0.00010899824,0.00017760837,0.00052003283,0.00004005289,0.00029289594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002178961,0.0002455998,0.00059130543,0.000119314056,0.00003155901,0.000014396002,0.000085004685,0.000063925305,0.000062033985],"category_scores_gemma":[0.00003660414,0.00017156698,0.0004887108,0.00018153388,0.00006339262,0.000053811207,0.000085415995,0.00005936712,0.00003816098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027686902,0.15459442,0.8417694,0.00008279519,0.00012295583,0.001045725,0.000025654648,9.490481e-7,0.00027801903,0.00012677885,0.0011078332,0.0005685729],"study_design_scores_gemma":[0.08318608,0.00079071167,0.9119173,0.00015945925,0.0004939566,0.000014028544,0.000026217891,0.000042089676,0.0027445513,0.00012294631,0.00034873254,0.00015391063],"about_ca_topic_score_codex":0.0011552739,"about_ca_topic_score_gemma":0.00020518174,"teacher_disagreement_score":0.15380372,"about_ca_system_score_codex":0.00017179539,"about_ca_system_score_gemma":0.00028529,"threshold_uncertainty_score":0.69962984},"labels":[],"label_agreement":null},{"id":"W2553082272","doi":"10.1136/annrheumdis-2016-eular.1448","title":"AB0390 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance To Anti-TNF Biologic Therapy","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; TNF inhibitor; Internal medicine; Methotrexate; Placebo; Clinical endpoint; Gastroenterology; Pharmacology; Tumor necrosis factor alpha; Randomized controlled trial; Adalimumab","score_opus":0.020578046673543147,"score_gpt":0.27519098601038106,"score_spread":0.25461293933683793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553082272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950747,0.0016098993,0.000008175233,0.0019277866,0.000024199617,0.0010976327,0.00023531711,0.000012076764,0.0000102415115],"genre_scores_gemma":[0.99155456,0.008057944,0.00007067069,0.00022168206,0.0000037978193,0.000060574315,0.0000041823887,0.000014833833,0.000011754877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987049,0.00015348637,0.0004025309,0.00028401674,0.00023633035,0.00021869762],"domain_scores_gemma":[0.9981941,0.0009387082,0.00025683577,0.0002889135,0.00017763478,0.00014382208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001775488,0.0002123301,0.0006105828,0.00012220252,0.00005725906,0.000009511108,0.000086709595,0.00004611377,0.000013279475],"category_scores_gemma":[0.0008621856,0.00009394775,0.00006807035,0.00027666244,0.00024177409,0.00010948196,0.0000696779,0.00003719007,0.0000014818532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04897871,0.0031969317,0.36789772,0.00008425793,0.00039162344,0.0000048209645,0.0014142813,0.000005501366,0.00030321957,0.000058315392,0.00009749405,0.5775671],"study_design_scores_gemma":[0.014724865,0.0025049718,0.9687101,0.0055645015,0.000022269289,0.000005015305,0.00009836658,0.0000044419753,0.008116518,0.00007886102,0.000041368272,0.0001287109],"about_ca_topic_score_codex":0.00014140946,"about_ca_topic_score_gemma":0.000026302412,"teacher_disagreement_score":0.6008124,"about_ca_system_score_codex":0.00004161045,"about_ca_system_score_gemma":0.0001645619,"threshold_uncertainty_score":0.38310778},"labels":[],"label_agreement":null},{"id":"W2553084570","doi":"10.1182/blood.v126.23.sci-46.sci-46","title":"The Role of the Tumor Microenvironment in Lymphoid Malignancies","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tumor microenvironment; Biology; Immune system; Cancer research; Population; Immunology; Medicine","score_opus":0.008041100225880034,"score_gpt":0.20170292537103712,"score_spread":0.1936618251451571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553084570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898235,0.0059892996,5.9068324e-8,0.0007083493,0.000043028012,0.00021525388,0.00000406076,0.0000046192595,0.003211801],"genre_scores_gemma":[0.9994027,0.00011166079,0.000045443954,0.00015839447,0.000025226114,0.000045739358,9.9832e-7,0.0000057928787,0.00020403131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994792,0.000023861605,0.00012904326,0.000084665844,0.00016124973,0.000121991165],"domain_scores_gemma":[0.9996037,0.00003181013,0.00004601308,0.00026340087,0.000011711095,0.000043377604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009667255,0.00006382961,0.00010569258,0.000011127926,0.000030179408,0.0000053742306,0.00007829371,0.000015364345,0.000007196846],"category_scores_gemma":[0.000030569387,0.000029178285,0.000052313993,0.000054666365,0.000063089,0.000010933823,0.000052022875,0.000020804719,0.00002005264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027453909,0.0011762492,0.98854566,0.000005284153,0.000046393758,0.000022310975,0.00032799813,0.0000018549108,0.0074787973,0.00030622215,0.00027097904,0.0017908013],"study_design_scores_gemma":[0.0044191577,0.00013733954,0.6078375,0.00006234535,0.00010383256,0.00010799862,0.00062354095,0.0000045441207,0.36641166,0.00024961823,0.020001955,0.00004049882],"about_ca_topic_score_codex":0.00012751656,"about_ca_topic_score_gemma":0.000032730346,"teacher_disagreement_score":0.38070816,"about_ca_system_score_codex":0.000071030605,"about_ca_system_score_gemma":0.000081307866,"threshold_uncertainty_score":0.11898559},"labels":[],"label_agreement":null},{"id":"W2553096308","doi":"10.1182/blood.v126.23.1484.1484","title":"Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Demography","score_opus":0.06014153233966715,"score_gpt":0.3246387048681435,"score_spread":0.2644971725284764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553096308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976486,0.009039804,0.000021838465,0.008610356,0.00022002985,0.0017204543,0.00012432845,0.00002683245,0.0037503203],"genre_scores_gemma":[0.9916002,0.006046766,0.00040834604,0.00064482103,0.00022506772,0.0005290439,0.00036121995,0.000026242984,0.00015828348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997723,0.00019456308,0.0008065329,0.00039859183,0.00066130096,0.00021604047],"domain_scores_gemma":[0.9973686,0.00064843113,0.0006135648,0.000928568,0.00035975463,0.00008109458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073522516,0.00024177966,0.0004902244,0.0002548069,0.00006947044,0.000029471757,0.00042009342,0.000095195755,0.000022004657],"category_scores_gemma":[0.00039807067,0.00014316663,0.00023068636,0.0009310184,0.00020742776,0.00011877996,0.00008371806,0.00007448029,0.000016354415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003965806,0.0083436165,0.92177016,0.00056032866,0.0010515227,0.000095859854,0.0015685573,0.000002654096,0.001807097,0.0021337532,0.02085984,0.04141002],"study_design_scores_gemma":[0.0071208295,0.00027348296,0.97080076,0.0040201517,0.00079777825,0.00011636566,0.0011935738,0.00037760104,0.0018983565,0.00019383297,0.0130485315,0.00015875229],"about_ca_topic_score_codex":0.0032966689,"about_ca_topic_score_gemma":0.0012553496,"teacher_disagreement_score":0.049030576,"about_ca_system_score_codex":0.00022597192,"about_ca_system_score_gemma":0.0006668398,"threshold_uncertainty_score":0.5838166},"labels":[],"label_agreement":null},{"id":"W2553142552","doi":"10.1182/blood.v108.11.4699.4699","title":"Single Institution Experience with Y-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Fludarabine; Radioimmunotherapy; Ibritumomab tiuxetan; Lymphoma; Chemotherapy; Internal medicine; Surgery; Non-Hodgkin's lymphoma; Chlorambucil; Gastroenterology; Cyclophosphamide; Immunology; Antibody","score_opus":0.012388196634163413,"score_gpt":0.2433066486071378,"score_spread":0.2309184519729744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553142552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905397,0.0007487174,0.000009884321,0.00015222625,0.000027645263,0.00047113092,0.0000055782157,0.000017620918,0.008027457],"genre_scores_gemma":[0.99907535,0.00007227229,0.00045522084,0.0000502971,0.00007195316,0.00017804466,0.000022531676,0.000008573257,0.00006575863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918413,0.00002133703,0.00020344915,0.00019812076,0.00021988036,0.00017308653],"domain_scores_gemma":[0.9995455,0.00003490817,0.00006490557,0.00029388184,0.000027984079,0.000032783584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032237404,0.000141959,0.0002330998,0.00006017871,0.000045537097,0.000014248886,0.0000560337,0.000039840343,0.00001021179],"category_scores_gemma":[0.0000040488117,0.00007704157,0.00006107064,0.00021389486,0.00009447276,0.0000550592,0.00000555221,0.000012697059,0.000007826659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027226622,0.05026006,0.91517746,0.000036228947,0.000119943456,0.00117591,0.003585716,0.000018115214,0.00696925,0.00081885373,0.00007671227,0.02148946],"study_design_scores_gemma":[0.016601812,0.0036148066,0.8130846,0.00012143461,0.00024057754,0.00030348796,0.00041885313,0.000016397762,0.16223952,0.000021197962,0.0032340148,0.00010327625],"about_ca_topic_score_codex":0.0015524391,"about_ca_topic_score_gemma":0.00041227633,"teacher_disagreement_score":0.15527028,"about_ca_system_score_codex":0.00014865621,"about_ca_system_score_gemma":0.00008573255,"threshold_uncertainty_score":0.3141664},"labels":[],"label_agreement":null},{"id":"W2553146240","doi":"10.1182/blood.v120.21.58.58","title":"The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Ejection fraction; CHOP; Adverse effect; Bevacizumab; Hazard ratio; Gastroenterology; Oncology; Surgery; Urology; Lymphoma; Chemotherapy; Heart failure; Confidence interval","score_opus":0.008138752680167215,"score_gpt":0.24735177314037263,"score_spread":0.2392130204602054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553146240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931483,0.00021899784,0.0000033456497,0.00003337061,0.000008146751,0.003670663,0.002891043,0.000011694337,0.000014399816],"genre_scores_gemma":[0.9990902,0.00007762114,0.000039232633,0.000057235873,0.000007025117,0.0001776015,0.00051657174,0.000024585293,0.000009947495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976916,0.0006671417,0.00053491595,0.0002807583,0.00052482536,0.000300782],"domain_scores_gemma":[0.99755126,0.0009727968,0.00053914427,0.00053692143,0.0002521926,0.00014765904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006788279,0.0002955718,0.0012960032,0.00014477695,0.00010185111,0.000007799439,0.00010107736,0.000055147975,0.000027721257],"category_scores_gemma":[0.00012451677,0.00012726295,0.00014643461,0.000644948,0.0000664937,0.00009502152,0.000024629964,0.00005087636,2.9318514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13992573,0.05280673,0.7918491,0.0000054022184,0.011832405,0.000006644946,0.002831928,0.000006126438,0.000019753761,0.0000014177107,0.000004887662,0.0007098824],"study_design_scores_gemma":[0.36649805,0.006618864,0.61791337,0.00009397317,0.007616112,1.7804527e-7,0.0006583834,0.000013493168,0.00049385004,3.2700385e-7,0.000004484184,0.00008894295],"about_ca_topic_score_codex":0.0011013432,"about_ca_topic_score_gemma":0.00088441104,"teacher_disagreement_score":0.2265723,"about_ca_system_score_codex":0.00013611445,"about_ca_system_score_gemma":0.00014309118,"threshold_uncertainty_score":0.5189632},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2553233139","doi":"10.1182/blood.v118.21.lba-6.lba-6","title":"Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Interim analysis; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Oncology; Progression-free survival; Chemotherapy; Surgery; Lymphoma; Confidence interval","score_opus":0.043929145144591966,"score_gpt":0.33856769130066294,"score_spread":0.294638546156071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553233139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88346416,0.00009452567,0.0002519327,0.000023832728,0.000058853668,0.114573106,0.000029292387,0.00006284918,0.0014414238],"genre_scores_gemma":[0.8829209,0.000002808902,0.00081266573,0.000031659172,0.00012763194,0.11599534,0.000039771174,0.000035543413,0.000033637567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972117,0.00034273206,0.0011212406,0.00057341816,0.00033670707,0.00041418523],"domain_scores_gemma":[0.99822354,0.0003559423,0.0005266183,0.0004639949,0.00024497014,0.00018494195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004946891,0.00042620144,0.0021498594,0.00014176169,0.00012569758,0.000047394686,0.00016235492,0.000075948876,0.000024990606],"category_scores_gemma":[0.000105182895,0.00028496914,0.00037160245,0.00012431202,0.00016876466,0.00011948652,0.00009814675,0.00007364306,0.0000064323144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71074593,0.23568496,0.010112623,0.0005233127,0.006688223,0.0015170556,0.022054868,0.000017837701,0.0025820762,0.0008980828,0.000065684304,0.009109318],"study_design_scores_gemma":[0.9585574,0.011580756,0.0016611434,0.0004618854,0.0025445397,0.000077046796,0.0037910182,0.001600176,0.019286603,0.00008488329,0.00009111241,0.00026342206],"about_ca_topic_score_codex":0.001566608,"about_ca_topic_score_gemma":0.00040516947,"teacher_disagreement_score":0.24781147,"about_ca_system_score_codex":0.00013897404,"about_ca_system_score_gemma":0.0003033743,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2553261733","doi":"10.1182/blood.v108.11.2415.2415","title":"Transmission of a Follicular Lymphoma by Allogeneic Bone Marrow Tranplantation — Evidence to Support the Existence of a Lymphoma Progenitor Cell.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Follicular lymphoma; Lymphoma; Biology; Progenitor cell; Germinal center; Bone marrow; Cancer research; Fusion gene; Gene rearrangement; Chromosomal translocation; Immunology; B cell; Stem cell; Genetics; Gene; Antibody","score_opus":0.014148059898175138,"score_gpt":0.24796812798983975,"score_spread":0.2338200680916646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553261733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212724,0.0057737944,0.0001039181,0.0005151592,0.00003568917,0.0010078377,0.000050993473,0.000024536987,0.00036081846],"genre_scores_gemma":[0.99726415,0.00031374398,0.001707483,0.000115575545,0.000048735335,0.00019504807,0.000051380626,0.000020985754,0.00028290483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984075,0.000058970803,0.0004917989,0.00030257957,0.0004999797,0.00023915901],"domain_scores_gemma":[0.9991375,0.00010781617,0.00017135807,0.0003476386,0.000114791976,0.000120862154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018415472,0.0001941764,0.0003823009,0.000068395966,0.000056317258,0.000010145334,0.00013248036,0.00008682399,0.00003723681],"category_scores_gemma":[0.000018765304,0.00012708727,0.0002120814,0.0002658054,0.00006221945,0.000060307488,0.000015555031,0.00001769611,0.000011059458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006105163,0.007388153,0.06019367,0.00051021896,0.00017509713,0.0002410601,0.0005992951,0.000005678714,0.893009,0.000052096668,0.0018568389,0.035358366],"study_design_scores_gemma":[0.0067200735,0.0013616784,0.084907435,0.00036138468,0.00080919534,0.00024054006,0.000062642546,0.000011945704,0.9036358,0.000020189582,0.0017434303,0.00012570857],"about_ca_topic_score_codex":0.00046131035,"about_ca_topic_score_gemma":0.0000148840145,"teacher_disagreement_score":0.035232656,"about_ca_system_score_codex":0.00005588797,"about_ca_system_score_gemma":0.00021694954,"threshold_uncertainty_score":0.5182468},"labels":[],"label_agreement":null},{"id":"W2553333000","doi":"10.1136/annrheumdis-2016-eular.4373","title":"OP0173 How Much of A Barrier Is Excess Weight and Smoking for Achieving Sustained Remission in Early RA? Results from The Canadian Early Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia; Southlake Regional Health Center; University of Manitoba; Université de Montréal; Université de Sherbrooke; University of Toronto","funders":"","keywords":"Medicine; Overweight; Cohort; Internal medicine; Prospective cohort study; Body mass index; Cohort study; Smoking cessation; Obesity; Demography; Physical therapy; Pediatrics","score_opus":0.025127750061792794,"score_gpt":0.27146983238268785,"score_spread":0.24634208232089505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553333000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678055,0.002732928,0.0000029307562,0.027505154,0.00005346281,0.0007897702,0.0010079248,0.000006741831,0.00009555765],"genre_scores_gemma":[0.9979457,0.0013813691,0.000030928895,0.00032780532,0.000028574368,0.000072251765,0.00001638185,0.000015362159,0.00018158698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987714,0.00008839681,0.00036559306,0.00022782755,0.00028807807,0.00025865607],"domain_scores_gemma":[0.9979493,0.00094358454,0.00023240794,0.00048315158,0.00015908868,0.00023246142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030413806,0.00015121057,0.00039671137,0.00007128074,0.00014198023,0.000039977196,0.00016805549,0.000058256617,0.000023994437],"category_scores_gemma":[0.0016720621,0.00006883348,0.00015696677,0.00011158855,0.0001344381,0.00011876281,0.000056749457,0.00003466131,4.868552e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037789755,0.00012704654,0.92991763,0.00009829979,0.0003080302,0.000010281275,0.0014260176,1.8010432e-7,0.00004749502,0.00012597535,0.005290395,0.06227075],"study_design_scores_gemma":[0.003588046,0.00013560972,0.98542035,0.0056622275,0.00016564807,0.0000017377773,0.00028363918,0.000021101494,0.0027498838,0.0014658034,0.0004161969,0.00008978578],"about_ca_topic_score_codex":0.058591675,"about_ca_topic_score_gemma":0.00887289,"teacher_disagreement_score":0.062180962,"about_ca_system_score_codex":0.000060307517,"about_ca_system_score_gemma":0.00031421022,"threshold_uncertainty_score":0.94767725},"labels":[],"label_agreement":null},{"id":"W2553422306","doi":"10.1182/blood.v112.11.479.479","title":"Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; CHOP; Lymphoma; Cancer research; Medicine; Internal medicine; Pathology; Oncology","score_opus":0.025031357013272595,"score_gpt":0.24144383998781074,"score_spread":0.21641248297453813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553422306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974179,0.000618634,0.0000068847676,0.00003561878,0.000032413067,0.0010156285,0.00018273588,0.000088010616,0.0006021536],"genre_scores_gemma":[0.99855494,0.00019139347,0.00036441008,0.000092705115,0.00004289524,0.00014572788,0.00008164142,0.00006051116,0.00046574612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772894,0.00007343609,0.0004434595,0.0006302084,0.0005822849,0.0005416493],"domain_scores_gemma":[0.9985806,0.00008768942,0.00019884639,0.0006758348,0.000117222524,0.0003398399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000057556772,0.00038544458,0.000653236,0.00024829837,0.00011432876,0.000019920397,0.00014469899,0.00021344813,0.00016111034],"category_scores_gemma":[0.000038747217,0.00026559818,0.00011857403,0.0003837832,0.000054098127,0.00021137843,0.000059172653,0.00010784917,0.000040349063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026062195,0.08797603,0.87741256,0.000096763004,0.00009945288,0.0008964313,0.001372812,4.476192e-7,0.031317763,0.0000035617625,0.000076000084,0.00048755525],"study_design_scores_gemma":[0.056351177,0.0013296428,0.5180519,0.0002142444,0.0001378795,0.00010242579,0.00013298025,0.000011529972,0.42336145,0.000002595205,0.00012378552,0.00018035827],"about_ca_topic_score_codex":0.00056231255,"about_ca_topic_score_gemma":0.00006965897,"teacher_disagreement_score":0.39204368,"about_ca_system_score_codex":0.0001475463,"about_ca_system_score_gemma":0.00029170275,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W2553427969","doi":"10.3748/wjg.v22.i42.9411","title":"Potential model for differential diagnosis between Crohn's disease and primary intestinal lymphoma","year":2016,"lang":"en","type":"article","venue":"World Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Receiver operating characteristic; Gastroenterology; Internal medicine; Differential diagnosis; Crohn's disease; Univariate analysis; Area under the curve; Lymphoma; Pathology; Disease; Multivariate analysis","score_opus":0.01523045814600618,"score_gpt":0.25133265398006627,"score_spread":0.23610219583406009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553427969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680891,0.00022061891,0.022483997,0.0086600995,0.00019201274,0.0002590469,0.0000702162,0.000011654362,0.000013234891],"genre_scores_gemma":[0.99542546,0.00023408176,0.002736578,0.00071281893,0.00058854,0.00005166157,0.000010964037,0.000023704717,0.00021617381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986187,0.00005615637,0.00051842025,0.0002246082,0.00021034278,0.00037172742],"domain_scores_gemma":[0.9987025,0.00017979907,0.00032161028,0.00015409477,0.00016254,0.00047945866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012384879,0.0002074261,0.0005908613,0.00026542533,0.00006580561,0.000018961573,0.00010737216,0.000039862207,0.000048443355],"category_scores_gemma":[0.000073088246,0.0001256949,0.00028838706,0.000038242804,0.00016595896,0.0001119074,0.00007949548,0.00005942286,0.0000022136162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087539265,0.0007207893,0.9534706,0.000053331838,0.00042806525,0.0005608459,0.000020080412,0.000005644863,0.00042167722,0.000049755494,0.0025196,0.032995712],"study_design_scores_gemma":[0.014930901,0.0020929321,0.97985214,0.0002942771,0.0012080004,0.0004494069,0.000002963182,0.00024327177,0.00012600621,0.00046404568,0.00026274222,0.00007332368],"about_ca_topic_score_codex":0.000002380756,"about_ca_topic_score_gemma":0.000010326399,"teacher_disagreement_score":0.03292239,"about_ca_system_score_codex":0.00018270346,"about_ca_system_score_gemma":0.000109009416,"threshold_uncertainty_score":0.51256895},"labels":[],"label_agreement":null},{"id":"W2553445886","doi":"10.1182/blood.v118.21.2091.2091","title":"Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non−Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; International Prognostic Index; Autologous stem-cell transplantation; Oncology; Transplantation; Diffuse large B-cell lymphoma; Proportional hazards model; Melphalan; Performance status; Population; Surgery; Lymphoma; Cancer","score_opus":0.02261437515667966,"score_gpt":0.24938126208688952,"score_spread":0.22676688693020985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553445886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850243,0.00022358644,9.341073e-7,0.0000043824284,0.000008056958,0.00053449837,0.00016267346,0.0000072191965,0.0005562429],"genre_scores_gemma":[0.99979824,0.00009455709,0.000047799895,0.0000026129899,0.0000030190586,0.000013800296,0.000023247278,0.000012700677,0.0000040235645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908495,0.00008997921,0.0002951016,0.00016556116,0.00022036214,0.000144072],"domain_scores_gemma":[0.9992384,0.00018339787,0.00023261069,0.00021499806,0.00007207233,0.00005852336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010060652,0.00018556863,0.00075445784,0.00008151865,0.000024397388,0.0000033385872,0.000051871866,0.00005150661,0.0000064289884],"category_scores_gemma":[0.000002492308,0.000086306914,0.000049259517,0.000091977476,0.00037740174,0.000030037325,0.00001296559,0.00004248719,1.4404985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006840494,0.0071369703,0.9794963,0.00013572001,0.0004730366,0.000025575939,0.004954881,0.000004307725,0.000036282323,0.000036143305,0.000003827076,0.00085646077],"study_design_scores_gemma":[0.040819008,0.009321132,0.90506655,0.00029143773,0.0005434107,0.000008785211,0.00049716904,0.000036520843,0.04333382,0.0000029610064,1.7196767e-7,0.00007903453],"about_ca_topic_score_codex":0.0049141324,"about_ca_topic_score_gemma":0.00027482843,"teacher_disagreement_score":0.07442975,"about_ca_system_score_codex":0.000023304417,"about_ca_system_score_gemma":0.00006461466,"threshold_uncertainty_score":0.74287313},"labels":[],"label_agreement":null},{"id":"W2553478512","doi":"10.1182/blood.v110.11.1902.1902","title":"Prolonged Clinical and Molecular Remissions Following High-Dose Therapy/Autologous Stem Cell Transplantation (HDT/ASCT) and Rituximab and Interferon-alpha Maintenance for Relapsed High-Risk Follicular Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Autologous stem-cell transplantation; Transplantation; Salvage therapy; Maintenance therapy; Gastroenterology; Cyclophosphamide; Oncology; Surgery; Lymphoma; Chemotherapy","score_opus":0.012568968355577883,"score_gpt":0.26939498162371844,"score_spread":0.2568260132681406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553478512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880127,0.009023181,0.00082468515,0.00040752685,0.00014450376,0.0014104247,0.000038276416,0.0000746462,0.00006408792],"genre_scores_gemma":[0.99042124,0.005189831,0.0037833648,0.00027889822,0.000058765287,0.00012293427,0.000049081817,0.000043559954,0.00005233207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981748,0.000104613835,0.00052810967,0.00062134553,0.00018895553,0.00038217305],"domain_scores_gemma":[0.9988014,0.00040994876,0.00016084714,0.0002816879,0.000058872716,0.00028720702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335547,0.00029299286,0.0006082195,0.00007514812,0.00018540536,0.00003916827,0.0000595161,0.00024513697,0.0000018440584],"category_scores_gemma":[0.0000481805,0.000221489,0.00016754617,0.00009233997,0.0001137951,0.00007966305,0.000027093922,0.00011087888,0.0000013480413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009745176,0.012839711,0.50943893,0.0006920701,0.0027867206,0.0055198106,0.0021873037,0.0000013038112,0.020648805,0.0011470697,0.0002135504,0.43477952],"study_design_scores_gemma":[0.18031372,0.0052036606,0.70698774,0.0005470171,0.0033330838,0.0005771102,0.0002678114,0.00008815177,0.10092364,0.000585567,0.0006881607,0.0004843592],"about_ca_topic_score_codex":0.00009647825,"about_ca_topic_score_gemma":0.000021830174,"teacher_disagreement_score":0.43429515,"about_ca_system_score_codex":0.000035353965,"about_ca_system_score_gemma":0.000068700225,"threshold_uncertainty_score":0.90320593},"labels":[],"label_agreement":null},{"id":"W2553549203","doi":"10.1182/blood.v126.23.586.586","title":"The Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) Demonstrates Marked Activity in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL): Results of an International Multi Center Phase I/II Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Bendamustine; Tolerability; Internal medicine; Anaplastic large-cell lymphoma; Refractory (planetary science); Gastroenterology; Oncology; Lymphoma; Surgery; Rituximab; Adverse effect; Hodgkin lymphoma","score_opus":0.01620286099635074,"score_gpt":0.27134298050607547,"score_spread":0.2551401195097247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553549203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998792,0.00010780812,0.0000036679974,0.000056680296,0.0000585495,0.00053736946,0.00029596276,0.000016811915,0.00013116217],"genre_scores_gemma":[0.9992543,0.00008820103,0.00030817208,0.000013616116,0.000010527773,0.000043315344,0.00023042316,0.000016972219,0.000034506575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855715,0.00011943756,0.00040747438,0.00034970112,0.00035105925,0.00021516635],"domain_scores_gemma":[0.99880993,0.00021193724,0.0003226403,0.00024626186,0.00024732752,0.00016191664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021622695,0.00020940637,0.00034109273,0.000130141,0.00008002139,0.000021173935,0.00008700294,0.00007997397,0.00000304443],"category_scores_gemma":[0.00023647239,0.00013096629,0.000028566143,0.00017888531,0.00016829598,0.00023862344,0.00006533305,0.00004092648,3.0207977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029060222,0.11278174,0.82023424,0.000055909863,0.00016767457,0.00009563968,0.0017370242,7.62523e-7,0.0016489179,0.000014689202,0.00002302124,0.03418016],"study_design_scores_gemma":[0.25269267,0.007678521,0.7181863,0.00019554223,0.000118169984,0.000026025242,0.00034370623,0.0010832452,0.019509178,0.0000022720862,0.00005169701,0.00011267724],"about_ca_topic_score_codex":0.0003000837,"about_ca_topic_score_gemma":0.00033119615,"teacher_disagreement_score":0.22363244,"about_ca_system_score_codex":0.00010443289,"about_ca_system_score_gemma":0.00012925286,"threshold_uncertainty_score":0.534065},"labels":[],"label_agreement":null},{"id":"W2553666848","doi":"10.1182/blood.v124.21.3018.3018","title":"FAS Mutations Accelerate Lymphoma Growth and Induce Therapeutic Resistance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Fas ligand; Fas receptor; Cancer research; Apoptosis; Lymphoma; Immunology; Chemotherapy; Medicine; Biology; Rituximab; Programmed cell death; Internal medicine; Genetics","score_opus":0.017282354308950917,"score_gpt":0.24937727136809731,"score_spread":0.2320949170591464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553666848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983554,0.0011639874,0.000019528441,0.0016461044,0.000036784302,0.00017570703,0.0000044019753,0.000049781833,0.01334969],"genre_scores_gemma":[0.9979825,0.00014092075,0.0004790201,0.0008901651,0.0000763911,0.000055328714,0.0000129270675,0.00001381687,0.0003489085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940383,0.00002865261,0.00011633338,0.00019255924,0.00011472191,0.00014392652],"domain_scores_gemma":[0.9995733,0.00008522371,0.000038244558,0.00017111085,0.000039149127,0.000092994494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050549083,0.000104312894,0.00015634908,0.000041283187,0.0000902654,0.00003116091,0.00003477686,0.00004654072,0.00001691276],"category_scores_gemma":[0.00003590065,0.000080277976,0.000034203666,0.00009879289,0.000041541818,0.000048347916,0.000014676544,0.00002437046,0.00002830761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021163745,0.0073271645,0.83941245,0.00033389975,0.001254923,0.0002678759,0.0017953791,4.814174e-7,0.022607205,0.058837295,0.00095753797,0.06699415],"study_design_scores_gemma":[0.009320872,0.00022638879,0.92730826,0.00007427564,0.00047084884,0.000067829875,0.000049310485,0.00000960484,0.05700163,0.0017397727,0.0035978847,0.00013334255],"about_ca_topic_score_codex":0.00002711919,"about_ca_topic_score_gemma":0.00001665216,"teacher_disagreement_score":0.08789579,"about_ca_system_score_codex":0.000017918326,"about_ca_system_score_gemma":0.0000437948,"threshold_uncertainty_score":0.32736406},"labels":[],"label_agreement":null},{"id":"W2553811141","doi":"10.1182/blood.v106.11.349.349","title":"Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Hazard ratio; Internal medicine; Vincristine; Gastroenterology; Randomization; Cyclophosphamide; Prednisone; Surgery; Lymphoma; Chemotherapy; Confidence interval; Oncology; Randomized controlled trial","score_opus":0.023039637695874533,"score_gpt":0.33214290679565267,"score_spread":0.30910326909977814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553811141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854187,0.0046421858,0.0000014375208,0.007228993,0.00020716208,0.0020854038,0.00025236976,0.000009430015,0.00015432297],"genre_scores_gemma":[0.99519014,0.0018266366,0.0001859342,0.001736254,0.000298399,0.00063190714,0.00002330397,0.000018034389,0.000089367255],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971367,0.00051532144,0.0012228332,0.0005699907,0.00024340351,0.0003117444],"domain_scores_gemma":[0.99760985,0.0014029909,0.0002740236,0.0005697787,0.00005312561,0.000090241054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010586593,0.00026166014,0.00093167956,0.000035736484,0.000079521866,0.000025784031,0.00018979849,0.00017870041,0.000007294648],"category_scores_gemma":[0.0006215742,0.000115099196,0.00016408165,0.00018317084,0.00056724163,0.000092044844,0.00017022829,0.00021608698,0.0000023296734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52732795,0.012692505,0.32714304,0.000021960943,0.00062324083,0.0005032186,0.00739504,0.00001077607,0.0001743113,0.00024382673,0.00025935416,0.12360477],"study_design_scores_gemma":[0.7211743,0.0014237151,0.2715134,0.00028269645,0.0003613833,0.000026270094,0.0004671554,0.00028630445,0.00024884395,0.000029340017,0.0040644454,0.0001221411],"about_ca_topic_score_codex":0.0038261178,"about_ca_topic_score_gemma":0.015927989,"teacher_disagreement_score":0.19384636,"about_ca_system_score_codex":0.00027247664,"about_ca_system_score_gemma":0.00025682355,"threshold_uncertainty_score":0.8888192},"labels":[],"label_agreement":null},{"id":"W2553962359","doi":"10.1182/blood.v104.11.3259.3259","title":"Lymphoma-Associated Macrophage (LAM) Content Is an Independent Predictor of Survival in Patients with Follicular Lymphoma (FL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Internal medicine; CD68; Tissue microarray; CD20; Biopsy; Stage (stratigraphy); Survival analysis; High-power field; Pathology; Oncology; Rituximab; Cancer; Immunohistochemistry; Biology","score_opus":0.01467646296049819,"score_gpt":0.21822741827620287,"score_spread":0.2035509553157047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553962359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980405,0.00031347093,0.0000034724228,0.00009624233,0.00010409207,0.00091010804,0.00015581596,0.0000549521,0.0003213351],"genre_scores_gemma":[0.9991813,0.000034950575,0.00014871253,0.00019350428,0.000034407487,0.0000819479,0.00020690203,0.000045371744,0.00007293963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771804,0.00006540543,0.000495758,0.00046676784,0.00083382014,0.00042018885],"domain_scores_gemma":[0.99877423,0.000028994718,0.00022352408,0.00047643934,0.00023212876,0.0002646708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001525085,0.00030907267,0.00066204177,0.00014416347,0.000051351868,0.000020272335,0.00013444296,0.00017966364,0.000048599097],"category_scores_gemma":[0.00004685716,0.00022992311,0.00014755913,0.00028797652,0.000069791735,0.000114726165,0.00005235474,0.000046463312,0.000015642408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004905771,0.030849416,0.96497446,0.00003942505,0.0007535966,0.00045162236,0.0006443879,0.0000056371287,0.00021216656,0.00009810163,0.000009909138,0.0014707167],"study_design_scores_gemma":[0.10694595,0.0026335022,0.86963755,0.00025875072,0.0005205638,0.000013070154,0.00012740481,0.0000038694116,0.019611487,0.000027788908,0.000028985205,0.00019106345],"about_ca_topic_score_codex":0.00159218,"about_ca_topic_score_gemma":0.00032894293,"teacher_disagreement_score":0.10645537,"about_ca_system_score_codex":0.0005222981,"about_ca_system_score_gemma":0.00031097626,"threshold_uncertainty_score":0.93759924},"labels":[],"label_agreement":null},{"id":"W2553979195","doi":"10.2967/jnumed.116.184242","title":"Response Assessment Criteria and Their Applications in Lymphoma: Part 2","year":2016,"lang":"en","type":"review","venue":"Journal of Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"Society of Nuclear Medicine and Molecular Imaging","keywords":"Interim; Medicine; Medical physics; Lymphoma; Hodgkin lymphoma; Cornerstone; Disease; Clinical trial; Intensive care medicine; Pathology; Political science","score_opus":0.047141658950669074,"score_gpt":0.3890004478088089,"score_spread":0.3418587888581398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553979195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000512697,0.9928108,0.000007130279,0.004964338,0.00022649145,0.00058017665,0.000018952778,0.000010091423,0.00086933456],"genre_scores_gemma":[0.0007195166,0.9977405,0.00020143962,0.0004194033,0.0006887662,0.000032661337,0.000008520118,0.00005248065,0.00013669154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978525,0.00030193574,0.0011183915,0.00022673431,0.00029561197,0.00020484668],"domain_scores_gemma":[0.99773496,0.0007546771,0.00075335393,0.0003390303,0.00012503934,0.0002929163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012379136,0.0003401313,0.0022601015,0.0004888666,0.000047379428,0.000014208002,0.00013564476,0.00018702493,0.00037815713],"category_scores_gemma":[0.00017960151,0.00015270444,0.00027799152,0.00021170474,0.00015149114,0.00006176806,0.00005297338,0.00018326027,0.000018805682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021052045,0.00051824265,0.00007037599,0.0017625511,0.00036012707,0.0003800861,0.00017467269,2.5845965e-9,0.000012556741,0.00018164636,0.0142580345,0.98207116],"study_design_scores_gemma":[0.003648389,0.0010741812,0.0030711403,0.041614465,0.000781482,0.0020664004,0.00016546274,5.485452e-7,3.2964616e-7,0.00004602711,0.9474155,0.00011609413],"about_ca_topic_score_codex":0.0000051409356,"about_ca_topic_score_gemma":6.0034193e-7,"teacher_disagreement_score":0.9819551,"about_ca_system_score_codex":0.0006300459,"about_ca_system_score_gemma":0.00047458956,"threshold_uncertainty_score":0.6227106},"labels":[],"label_agreement":null},{"id":"W2554041296","doi":"10.1182/blood.v112.11.261.261","title":"PROPEL: A Multi-Center Phase 2 Open-Label Study of Pralatrexate (PDX) with Vitamin B12 and Folic Acid Supplementation in Patients with Replapsed or Refractory Peripheral T-Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim analysis; Clinical endpoint; Internal medicine; Phases of clinical research; Antifolate; Oncology; Refractory (planetary science); Clinical trial; Neutropenia; Peripheral T-cell lymphoma; Gastroenterology; Cancer; Surgery; Pharmacology; Chemotherapy; Immunology; Antimetabolite; T cell; Immune system","score_opus":0.03122741258708996,"score_gpt":0.29557249084233417,"score_spread":0.2643450782552442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554041296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964084,0.00005525112,0.0000019298036,0.000027930255,0.000019051076,0.0033391726,0.00005172559,0.000017873483,0.00007864696],"genre_scores_gemma":[0.9970642,0.00003818371,0.0020142007,0.000074187694,0.000011893179,0.00036038933,0.00015575797,0.0000375385,0.00024369647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859935,0.000072986906,0.0003496658,0.00042933755,0.00031239842,0.00023626929],"domain_scores_gemma":[0.99923396,0.00001905806,0.00020866607,0.00032174474,0.000101875434,0.00011466562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006774436,0.00023849451,0.00042237784,0.00010127633,0.00007236157,0.000021922178,0.00008069249,0.000041942225,0.00002877036],"category_scores_gemma":[0.000010584297,0.0001411394,0.000014779099,0.0001874335,0.00005647802,0.00023072577,0.0000619215,0.000045147437,0.0000019979755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066286335,0.22975607,0.7574969,0.00005476518,0.00022569766,0.000400084,0.0031702025,1.8464793e-7,0.0003538366,2.2165895e-7,0.000060849772,0.0018525404],"study_design_scores_gemma":[0.44669038,0.025380373,0.52253836,0.0001214586,0.0002650124,0.00004656859,0.00050527084,0.000013283583,0.004253041,6.382175e-8,0.00005389558,0.00013225677],"about_ca_topic_score_codex":0.00046654156,"about_ca_topic_score_gemma":0.00058507326,"teacher_disagreement_score":0.44006175,"about_ca_system_score_codex":0.00010222563,"about_ca_system_score_gemma":0.00016141524,"threshold_uncertainty_score":0.5755498},"labels":[],"label_agreement":null},{"id":"W2554081271","doi":"10.1182/blood.v120.21.895.895","title":"SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Wnt signaling pathway; Chromatin immunoprecipitation; Cell growth; Biology; Cancer research; Cell culture; Cell cycle; Molecular biology; Beta-catenin; Transcription factor; Catenin; Signal transduction; Mantle cell lymphoma; Cell; Cell biology; Gene expression; Lymphoma; Gene; Immunology; Genetics; Promoter","score_opus":0.009932888377457547,"score_gpt":0.2128905059918844,"score_spread":0.20295761761442685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554081271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716127,0.0016679377,0.000004640033,0.000031410367,0.00006120247,0.0005948964,0.000032291515,0.000035833644,0.00041049928],"genre_scores_gemma":[0.99890757,0.0001447823,0.00047413845,0.000028131746,0.000052552412,0.00010143927,0.000058576516,0.000034105866,0.00019868821],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988974,0.00003347793,0.00022739364,0.0003034111,0.00022941282,0.0003089085],"domain_scores_gemma":[0.9990333,0.00011274656,0.00017443691,0.00023525975,0.00027653706,0.00016776005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054882465,0.00025550017,0.00046994662,0.000071401635,0.00006443109,0.000022711163,0.000040024916,0.000055113956,0.000015785998],"category_scores_gemma":[0.000023084905,0.00014938823,0.000061959705,0.000105344276,0.00009457968,0.00012489878,0.000036131176,0.000024278977,0.0000049339064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075263565,0.0072315,0.97424227,0.0001206358,0.0008207701,0.000050828075,0.0014860287,3.8159558e-7,0.013594656,0.000012557571,0.000014119985,0.001673634],"study_design_scores_gemma":[0.017175145,0.0019433256,0.42994112,0.00015030491,0.0013475739,0.000028781345,0.00058618514,0.0000018451814,0.54865414,0.0000030077313,0.000028984881,0.00013962582],"about_ca_topic_score_codex":0.00076868903,"about_ca_topic_score_gemma":0.000059502177,"teacher_disagreement_score":0.54430115,"about_ca_system_score_codex":0.000060270006,"about_ca_system_score_gemma":0.00006208033,"threshold_uncertainty_score":0.6091875},"labels":[],"label_agreement":null},{"id":"W2554151492","doi":"10.1182/blood.v108.11.343.343","title":"Maintenance Therapy with Rituximab for Follicular Lymphoma Is Cost-Effective – A Canadian Perspective.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Roche (Canada)","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Maintenance therapy; Internal medicine; Oncology; Progression-free survival; Lymphoma; Surgery; Chemotherapy","score_opus":0.008133117094952168,"score_gpt":0.2399589474155724,"score_spread":0.2318258303206202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554151492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744095,0.003517352,0.000090984235,0.0039131013,0.00005036487,0.005513613,0.00017258526,0.00006564611,0.009235404],"genre_scores_gemma":[0.9941535,0.000081229955,0.0008776517,0.0014665263,0.0001621701,0.0026568107,0.000037464288,0.00003776084,0.00052686525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892217,0.0000160818,0.00011311956,0.00037423422,0.00015585823,0.00041856442],"domain_scores_gemma":[0.9991913,0.000057703222,0.00004692104,0.0002714293,0.00023946914,0.00019318063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005632339,0.00021098104,0.0003181101,0.00009295645,0.0001348302,0.000029444745,0.000057247056,0.00007463226,0.000037245587],"category_scores_gemma":[0.000015245704,0.00014366696,0.00014943609,0.00015734027,0.000054925516,0.00004443527,0.000005492151,0.000029187144,0.000029029301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041764453,0.045993615,0.73757684,0.00016903189,0.0070889164,0.005433399,0.0034925742,0.000009940266,0.0017139523,0.05176448,0.044613406,0.097967416],"study_design_scores_gemma":[0.1471679,0.0037171214,0.63469195,0.00023229186,0.0009143692,0.0007261015,0.00056077447,0.000049769522,0.06018774,0.0014380988,0.14979081,0.00052309386],"about_ca_topic_score_codex":0.13590604,"about_ca_topic_score_gemma":0.042683832,"teacher_disagreement_score":0.14299145,"about_ca_system_score_codex":0.0006046702,"about_ca_system_score_gemma":0.000405498,"threshold_uncertainty_score":0.9747847},"labels":[],"label_agreement":null},{"id":"W2554247170","doi":"10.1016/j.hoc.2016.07.010","title":"Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Lymphoma; Oncology; Intensive care medicine; Diffuse large B-cell lymphoma; Disease; Stage (stratigraphy); Internal medicine; Biology","score_opus":0.03676998350614432,"score_gpt":0.37339814345406785,"score_spread":0.33662815994792356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554247170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010215676,0.990848,0.000033048265,0.00027580294,0.00079735805,0.0015937735,0.00051345327,0.00012511935,0.004791881],"genre_scores_gemma":[0.0006447775,0.99493885,0.001165627,0.0009929639,0.00021180876,0.0005762493,0.0006039949,0.00013268132,0.0007330484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99446386,0.00048496798,0.0025939625,0.0011284221,0.00033778726,0.0009910205],"domain_scores_gemma":[0.99154705,0.0033951306,0.002777308,0.0015277155,0.00024738084,0.0005054381],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028595745,0.00094841735,0.008428042,0.00044320585,0.00011097075,0.000006279684,0.0005220649,0.0012760862,0.00026697852],"category_scores_gemma":[0.000466229,0.00061837264,0.0020471078,0.00049319986,0.0007519815,0.00004992756,0.0003826965,0.000376699,0.0022780558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011566445,0.018488204,0.008881386,0.0078832535,0.0011617662,0.0016158533,0.00003197319,7.2197848e-9,1.5058616e-8,0.00016834824,0.008540654,0.9531129],"study_design_scores_gemma":[0.013915094,0.0020815507,0.00043366323,0.004542655,0.0041377223,0.0012771129,0.000016215863,0.0000013082856,0.0000013344213,0.000021436732,0.97309655,0.00047534262],"about_ca_topic_score_codex":0.00001296737,"about_ca_topic_score_gemma":0.000024573126,"teacher_disagreement_score":0.9645559,"about_ca_system_score_codex":0.00049554394,"about_ca_system_score_gemma":0.0028501356,"threshold_uncertainty_score":0.99962676},"labels":[],"label_agreement":null},{"id":"W2554311364","doi":"10.1182/blood.v120.21.687.687","title":"Response-Adapted Therapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL)Based On Early [18F] FDG-PET Scanning: An Eastern Cooperative Oncology Group Study (E3404)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; CHOP; Nuclear medicine; Stage (stratigraphy); Oncology; Radiology","score_opus":0.028403923910432182,"score_gpt":0.31087513810236694,"score_spread":0.28247121419193477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554311364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944274,0.00033741558,0.00009425336,0.00040331171,0.00027173097,0.0034233043,0.000093260365,0.00013194418,0.0008173908],"genre_scores_gemma":[0.9949349,0.000020449657,0.0008262325,0.0018421374,0.0003394993,0.0013386874,0.00013211393,0.00010899191,0.00045697534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970469,0.00056129176,0.00044934027,0.0006435791,0.00044864888,0.0008502238],"domain_scores_gemma":[0.9976092,0.00066947046,0.00020329624,0.00078392547,0.00019625858,0.00053785695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008412065,0.00050182076,0.000789991,0.00022845407,0.0002803651,0.000062081686,0.00020010525,0.00014912387,0.00005017986],"category_scores_gemma":[0.000091593145,0.00037786085,0.00021256303,0.00024405564,0.000064950065,0.00019067062,0.00004694317,0.00011444674,0.00009411597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025669934,0.4612852,0.49315986,0.000025505555,0.00083165057,0.00079003634,0.0069915876,0.000002572751,0.0034940217,0.000088069064,0.00060515665,0.0070563965],"study_design_scores_gemma":[0.30397996,0.082125716,0.58261544,0.00009822207,0.000766978,0.00006682885,0.0021737276,0.0005791434,0.013704854,0.0000042760553,0.013350015,0.00053485675],"about_ca_topic_score_codex":0.00015042235,"about_ca_topic_score_gemma":0.000062176965,"teacher_disagreement_score":0.3791595,"about_ca_system_score_codex":0.00027676753,"about_ca_system_score_gemma":0.0003789228,"threshold_uncertainty_score":0.9998673},"labels":[],"label_agreement":null},{"id":"W2554353371","doi":"10.1182/blood.v114.22.1678.1678","title":"Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Peripheral T-cell lymphoma; Clinical trial; Phases of clinical research; CHOP; Antifolate; Oncology; Lymphoma; Gastroenterology; Methotrexate; Immunology; Antimetabolite; T cell","score_opus":0.007547297400685275,"score_gpt":0.22278721077641303,"score_spread":0.21523991337572776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554353371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953016,0.0005122796,1.5558156e-7,0.0004094808,0.00004327159,0.00038842333,0.000010300459,0.000057538105,0.0032769646],"genre_scores_gemma":[0.9983192,0.000052693507,0.0003901646,0.00051576423,0.000060063237,0.000027271675,0.0000380785,0.000018907218,0.0005778242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988308,0.00005372874,0.00022129856,0.00030864164,0.00029529797,0.0002902287],"domain_scores_gemma":[0.9993759,0.000043764074,0.000088880864,0.00029937798,0.00005923505,0.00013287217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006316785,0.0002063493,0.00028958893,0.00012161781,0.00004780478,0.000024870562,0.00006606156,0.00009228509,0.00003477879],"category_scores_gemma":[0.000024842719,0.00014289032,0.000054666652,0.00017773113,0.000031086973,0.000118794254,0.00001436908,0.000060617673,0.00003062511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013131219,0.016753161,0.9689361,0.00001539303,0.00006516149,0.00033651548,0.00028638076,6.7225994e-7,0.0007156404,0.00001941967,0.00019339928,0.01136504],"study_design_scores_gemma":[0.033981927,0.0037650592,0.95103824,0.000115559975,0.00014719913,0.000012891797,0.000029933606,8.1484313e-7,0.009410586,0.000011704957,0.0013235494,0.00016252833],"about_ca_topic_score_codex":0.000073035655,"about_ca_topic_score_gemma":0.000011689258,"teacher_disagreement_score":0.032668803,"about_ca_system_score_codex":0.00014503438,"about_ca_system_score_gemma":0.00016808379,"threshold_uncertainty_score":0.5826898},"labels":[],"label_agreement":null},{"id":"W2554544625","doi":"10.1182/blood.v112.11.1786.1786","title":"Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Diffuse large B-cell lymphoma; Cancer research; Major histocompatibility complex; MHC class II; MHC class I; Immunology; Lymphoma; Immune system","score_opus":0.011161958031149805,"score_gpt":0.22953216104503596,"score_spread":0.21837020301388615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554544625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970582,0.0018210183,0.000007222928,0.00031812297,0.000019800242,0.0004105035,0.00007128437,0.000012732445,0.00028112467],"genre_scores_gemma":[0.99830425,0.001011165,0.0003127538,0.000099942015,0.000016966,0.000033171727,0.000041173706,0.000016229087,0.00016435953],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893594,0.000040616134,0.00033476134,0.00027763628,0.00022871155,0.00018235006],"domain_scores_gemma":[0.9993869,0.000077872806,0.00015262958,0.00023607894,0.00004440648,0.000102097976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107670974,0.00016083661,0.00040057104,0.00010692746,0.00006282281,0.000003890127,0.00004235698,0.000111893976,0.000014120537],"category_scores_gemma":[0.000029729692,0.00012712822,0.000050526636,0.00010977851,0.000076560355,0.0000845393,0.000079292164,0.00003453856,7.4576127e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007287993,0.045297157,0.5264324,0.00044101165,0.00018636636,0.00020318141,0.009481656,1.5170747e-7,0.41322628,0.000047043217,0.0014760691,0.0024799022],"study_design_scores_gemma":[0.07775619,0.00077409187,0.14615224,0.00023110998,0.00016862551,0.000047609603,0.00019501663,0.00006935723,0.7741088,0.000014987225,0.00035919182,0.00012273376],"about_ca_topic_score_codex":0.00010273408,"about_ca_topic_score_gemma":0.000009113943,"teacher_disagreement_score":0.38028017,"about_ca_system_score_codex":0.000030055351,"about_ca_system_score_gemma":0.000040873834,"threshold_uncertainty_score":0.51841384},"labels":[],"label_agreement":null},{"id":"W2554613555","doi":"10.1182/blood.v108.11.4666.4666","title":"Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AIDS Vancouver; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; CHOP; Oncology; International Prognostic Index; Gastroenterology; Immunology","score_opus":0.004921524810031597,"score_gpt":0.18790758256617718,"score_spread":0.18298605775614557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554613555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492216,0.0006743646,0.000007600036,0.000043687844,0.0001643348,0.0032509237,0.00009916446,0.00007637489,0.0007613692],"genre_scores_gemma":[0.99856055,0.000072968054,0.00027800872,0.000071410665,0.000047119072,0.0003793746,0.00023285512,0.00011637769,0.00024132596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996565,0.00022801741,0.0009774793,0.0007515906,0.00080278,0.0006751765],"domain_scores_gemma":[0.9976656,0.000184999,0.00074366806,0.00087332126,0.00037545146,0.00015696787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023367805,0.00061561936,0.00093730714,0.00019195463,0.0001617473,0.00006320952,0.00027244646,0.00021517789,0.000019870322],"category_scores_gemma":[0.00001529185,0.00034065926,0.00016749944,0.0004635553,0.00015139735,0.00016170724,0.00006629842,0.00009323462,0.000016926393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025783682,0.020262228,0.9399507,0.00020327965,0.0004335342,0.00013026666,0.00089694076,0.00004202147,0.031595007,0.00000617429,0.000099361765,0.003802118],"study_design_scores_gemma":[0.09297855,0.002531228,0.6662808,0.001139789,0.00046105948,0.000016517986,0.00018805974,0.00010762362,0.23581202,0.0000044564267,0.000074799194,0.00040507814],"about_ca_topic_score_codex":0.0022165386,"about_ca_topic_score_gemma":0.0001996488,"teacher_disagreement_score":0.2736699,"about_ca_system_score_codex":0.00032661087,"about_ca_system_score_gemma":0.00041311973,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2555145245","doi":"10.1016/j.ijrobp.2015.07.468","title":"Patterns of IFRT Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma Treated With a Pediatric Approach","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Regimen; Protocol (science); Nuclear medicine; Pediatrics; Internal medicine; Pathology","score_opus":0.025627185216657515,"score_gpt":0.31218662747615095,"score_spread":0.2865594422594934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555145245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243563,0.00016562211,0.0013040955,0.00032576648,0.00022432973,0.0051832395,0.00004230296,0.00001847889,0.00030052382],"genre_scores_gemma":[0.9949708,0.00030990003,0.0020034225,0.0000865822,0.0008702365,0.0016427635,0.00008313541,0.000024444062,0.000008714649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983291,0.0001519179,0.00066561677,0.00025779192,0.00038981988,0.00020573214],"domain_scores_gemma":[0.9976045,0.0001591996,0.0010475225,0.00013407358,0.00086452736,0.00019020884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028220547,0.0002308725,0.00051221537,0.0003462265,0.000029670673,0.000018134446,0.00016269542,0.00016017201,0.000005956555],"category_scores_gemma":[0.00010949251,0.0001607158,0.000086084816,0.00032449185,0.00006318227,0.000205139,0.000037253747,0.00016997683,0.0000028245145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005924303,0.0025926386,0.9720282,0.00005245488,0.00028695402,0.00008925684,0.0005403025,0.00021112143,0.0000063510834,0.00037742162,0.00011294973,0.017778076],"study_design_scores_gemma":[0.06002893,0.0059754667,0.93134916,0.000096201125,0.00041640343,0.00034340512,0.0002501692,0.0006861282,0.00019229673,0.0000643469,0.00042792156,0.00016959473],"about_ca_topic_score_codex":0.00010318576,"about_ca_topic_score_gemma":0.000039469913,"teacher_disagreement_score":0.054104626,"about_ca_system_score_codex":0.0009519675,"about_ca_system_score_gemma":0.0010099285,"threshold_uncertainty_score":0.65538},"labels":[],"label_agreement":null},{"id":"W2555574679","doi":"10.1182/blood.v114.22.2923.2923","title":"The Percentage of Cytotoxic T-Cells in Mantle Cell Lymphoma (MCL) Biopsies Predicts Response to Rituximab.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Follicular lymphoma; Medicine; Lymphoma; Rituximab; Biopsy; Pathology; Bone marrow; Cyclin D1; Survivin; CD8; Gene signature; Immunophenotyping; Cancer research; Biology; Internal medicine; Immunology; Flow cytometry; Cancer; Cell cycle; Gene expression; Immune system","score_opus":0.00752316400009752,"score_gpt":0.23580274760942868,"score_spread":0.22827958360933115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555574679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487007,0.0011194807,4.9411994e-7,0.0014168009,0.00006348416,0.00056948065,0.00003388613,0.00003935291,0.0018869826],"genre_scores_gemma":[0.99830294,0.0002874729,0.00021098854,0.00048450692,0.00003284379,0.00003755758,0.0000055816763,0.000013005508,0.0006251322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998858,0.0000759564,0.00028533704,0.00023081672,0.0002577712,0.000292147],"domain_scores_gemma":[0.99919295,0.0001862204,0.000057184352,0.00041992503,0.000030724517,0.00011302142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022671859,0.00015451937,0.0002776853,0.000113966904,0.000063959356,0.00001897499,0.00012326018,0.00006746036,0.000018041197],"category_scores_gemma":[0.000051236006,0.000101822865,0.00009488538,0.00017641463,0.00004574863,0.000031541607,0.000036141293,0.00003740593,0.00010122146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055466653,0.039140195,0.062439453,0.000095588,0.000160013,0.0012727189,0.0024846748,0.0000072621297,0.8652819,0.00011674868,0.005270109,0.018184667],"study_design_scores_gemma":[0.015985455,0.001255999,0.44971514,0.00013121436,0.000107509695,0.000039152805,0.00026271818,0.0000087494755,0.52721465,0.0000133359235,0.005173441,0.000092641865],"about_ca_topic_score_codex":0.0000530404,"about_ca_topic_score_gemma":0.00001662363,"teacher_disagreement_score":0.3872757,"about_ca_system_score_codex":0.00009427878,"about_ca_system_score_gemma":0.0001075691,"threshold_uncertainty_score":0.4152216},"labels":[],"label_agreement":null},{"id":"W2555812629","doi":"10.1182/blood.v118.21.3643.3643","title":"Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD),","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Bleomycin; Vinblastine; Internal medicine; Surgery; Chemotherapy regimen; Pulmonary toxicity; Gastroenterology; Chemotherapy; Lung; Vincristine; Cyclophosphamide","score_opus":0.008961378640314979,"score_gpt":0.19879171144491,"score_spread":0.18983033280459502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555812629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681294,0.0009382709,0.000001966867,0.000045714136,0.000027868413,0.0007295149,0.000048827453,0.00004543434,0.0013494625],"genre_scores_gemma":[0.9987315,0.00040650705,0.00050469924,0.000097699216,0.000038022612,0.00007825298,0.0000502874,0.0000310324,0.00006198047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983347,0.000059184207,0.0004561759,0.0005132963,0.00030850127,0.00032811763],"domain_scores_gemma":[0.99893606,0.000093303555,0.00018894317,0.00033979135,0.00021209086,0.00022982807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012289091,0.00032781117,0.00060558674,0.00021401765,0.000046989167,0.000012556754,0.00008048531,0.00013440085,0.000030870415],"category_scores_gemma":[0.00011100706,0.00023614604,0.000043591746,0.00034425204,0.00018005967,0.00019841956,0.00010047607,0.0000710002,0.000002350671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007923994,0.0053614187,0.9885958,0.00013303684,0.00021784217,0.00039802288,0.0004191029,2.5459664e-7,0.0016672831,0.000021809969,0.00003244148,0.0023605875],"study_design_scores_gemma":[0.015395154,0.0028651527,0.92669916,0.0005293826,0.00055196695,0.00020156146,0.00006457983,0.000026572932,0.05342952,0.000016015278,0.000023066343,0.00019784381],"about_ca_topic_score_codex":0.0011818164,"about_ca_topic_score_gemma":0.00026188637,"teacher_disagreement_score":0.06189662,"about_ca_system_score_codex":0.00006175403,"about_ca_system_score_gemma":0.00009351256,"threshold_uncertainty_score":0.9629756},"labels":[],"label_agreement":null},{"id":"W2555859866","doi":"10.1016/j.ijrobp.2016.07.015","title":"Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Chemotherapy; Lymphoma; Stage (stratigraphy); Randomization; Clinical trial; Randomized controlled trial; Radiation therapy","score_opus":0.01801953788191235,"score_gpt":0.3253919433429864,"score_spread":0.307372405461074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555859866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837003,0.00038710635,0.009830164,0.0028321159,0.0010716208,0.0009870661,0.00113831,0.000017672628,0.000035641606],"genre_scores_gemma":[0.9950922,0.0022667146,0.0006676215,0.00047986483,0.0011808724,0.000057395657,0.00021486559,0.000023603468,0.0000168302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966232,0.000881403,0.0013804181,0.00036612595,0.0004982189,0.0002506028],"domain_scores_gemma":[0.9911178,0.0034975,0.0034917346,0.00030263534,0.001473447,0.000116889045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010173379,0.00029220423,0.0014664932,0.0011312324,0.00007760774,0.000010923416,0.00038005452,0.0003913276,0.000068863286],"category_scores_gemma":[0.0008608647,0.00017668057,0.0015788552,0.0013978033,0.00024996718,0.00018094912,0.00004259764,0.00013206128,0.0000014585091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06964734,0.002992063,0.64298534,0.0000027883084,0.041209184,0.0000057729203,0.00081527495,0.00036383962,0.0047465228,0.0009152049,0.00020051019,0.23611616],"study_design_scores_gemma":[0.081266776,0.0071496656,0.8907554,0.000016689806,0.009539724,0.000014349958,0.000048614835,0.0012873627,0.0079838475,0.00032433175,0.0014646162,0.00014862244],"about_ca_topic_score_codex":0.000047050784,"about_ca_topic_score_gemma":0.00001313485,"teacher_disagreement_score":0.24777007,"about_ca_system_score_codex":0.0018280824,"about_ca_system_score_gemma":0.0010853986,"threshold_uncertainty_score":0.7204824},"labels":[],"label_agreement":null},{"id":"W2556504054","doi":"10.1182/blood.v128.22.4144.4144","title":"Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Chemotherapy regimen; Peripheral T-cell lymphoma; Adverse effect; Progression-free survival; Lymphoma; Clinical endpoint; Phases of clinical research; Gastroenterology; Surgery; CD30; Chemotherapy; Clinical trial; Immunology; T cell","score_opus":0.01639331992627599,"score_gpt":0.25679773646639986,"score_spread":0.24040441654012387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556504054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725497,0.000153065,0.0000040923674,0.00001046955,0.00012854622,0.00094968785,0.0013764718,0.000030438543,0.00009225502],"genre_scores_gemma":[0.9993094,0.000021483012,0.00005632075,0.000010294265,0.000053311138,0.000042798067,0.00037453836,0.000035064262,0.00009675477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980994,0.00012797165,0.00044350917,0.0005546856,0.00048337664,0.0002910944],"domain_scores_gemma":[0.9982495,0.00031852955,0.00022040373,0.00099592,0.00008204797,0.00013364611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013156982,0.00023331704,0.00057169364,0.00011350658,0.000033646156,0.000010088889,0.00021670507,0.00007359455,0.00010477759],"category_scores_gemma":[0.000114257055,0.00012708691,0.00003600882,0.00017692336,0.000029776495,0.00012889077,0.00015023595,0.000046320096,0.00005404367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053012366,0.13535908,0.85687375,0.00006442932,0.0003655468,0.00038240323,0.00039219524,9.719472e-8,0.00021503813,0.0000014908604,0.00014545092,0.0008992754],"study_design_scores_gemma":[0.32841045,0.010142802,0.658941,0.0006057528,0.0006800743,0.000005081071,0.00061794673,0.000009114285,0.00039703143,5.620579e-7,0.000045281842,0.00014494352],"about_ca_topic_score_codex":0.0004724725,"about_ca_topic_score_gemma":0.0005002515,"teacher_disagreement_score":0.3231092,"about_ca_system_score_codex":0.0001255781,"about_ca_system_score_gemma":0.00020886557,"threshold_uncertainty_score":0.51824534},"labels":[],"label_agreement":null},{"id":"W2556671040","doi":"10.1182/blood.v124.21.3069.3069","title":"Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Transplantation; Oncology; Population; CHOP; Salvage therapy; Surgery; Chemotherapy regimen; Rituximab; Lymphoma; Cancer; Chemotherapy","score_opus":0.0097347692266039,"score_gpt":0.217364886351237,"score_spread":0.20763011712463308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556671040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718416,0.00016937948,0.000038067803,0.00007997332,0.000111219764,0.00066939567,0.000057149926,0.000089337256,0.0016013111],"genre_scores_gemma":[0.99787194,0.000043961267,0.00033094324,0.00071750954,0.000037747628,0.00008077704,0.00022451524,0.00005885701,0.00063372805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981156,0.00008767915,0.0004187148,0.00045807674,0.00047043146,0.00044947327],"domain_scores_gemma":[0.9990909,0.00013641901,0.00013781604,0.00038089024,0.00006531969,0.0001886674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013015374,0.00030573568,0.00046996653,0.00017825628,0.000091301954,0.000032435728,0.00009760652,0.00015261164,0.000025346622],"category_scores_gemma":[0.00000947406,0.00023553884,0.00014984715,0.00021379863,0.000014292799,0.00015339258,0.000014519701,0.000099937395,0.000083920924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000404577,0.032639578,0.9629969,0.00018243781,0.00011047558,0.00015783172,0.0014809982,4.171714e-7,0.00044711973,0.0000110702495,0.000097167765,0.0014714547],"study_design_scores_gemma":[0.17898579,0.0010483331,0.7954237,0.00018409947,0.0008041381,0.0000074332697,0.000056904028,0.000023202598,0.022243006,0.000005910468,0.0009448028,0.00027269096],"about_ca_topic_score_codex":0.00015347253,"about_ca_topic_score_gemma":0.00008915337,"teacher_disagreement_score":0.17858121,"about_ca_system_score_codex":0.00016296988,"about_ca_system_score_gemma":0.000085519976,"threshold_uncertainty_score":0.9604995},"labels":[],"label_agreement":null},{"id":"W2556823464","doi":"10.1182/blood.v120.21.1629.1629","title":"Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Dosing; Pharmacokinetics; Clinical endpoint; Chemotherapy; Internal medicine; Phases of clinical research; Gastroenterology; Urology; Pharmacology; Surgery; Randomized controlled trial; Lymphoma","score_opus":0.011807747936582538,"score_gpt":0.26929800657728414,"score_spread":0.25749025864070163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556823464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941617,0.000059525595,0.000021066955,0.0010712681,0.000014097501,0.004498301,0.00010034047,0.000014340924,0.000059325866],"genre_scores_gemma":[0.99913925,0.000034207664,0.00031720978,0.00018224331,0.000014122061,0.00012379799,0.00012704467,0.000035336503,0.000026775568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740374,0.0005195771,0.0007242007,0.00040155556,0.00059812324,0.00035277684],"domain_scores_gemma":[0.99843127,0.00030675408,0.0004994775,0.0005014006,0.00015435286,0.00010676195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010758843,0.00036220573,0.0006295925,0.00015561568,0.00009376659,0.000032726126,0.00015121483,0.00007485965,0.0000026638766],"category_scores_gemma":[0.000052009607,0.00019668124,0.000031641084,0.0005843843,0.00010485983,0.00015181616,0.00002330879,0.00014876592,3.331086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3916469,0.09765916,0.49693006,0.00010835024,0.0002848649,0.00037538604,0.010600475,0.00027718613,0.0004978373,0.000030169787,0.0000054408406,0.0015841927],"study_design_scores_gemma":[0.21648307,0.039966293,0.72738934,0.00046050843,0.0003230574,0.00013165115,0.0009905678,0.00015362543,0.013821235,0.0000015438044,0.00007691572,0.00020217663],"about_ca_topic_score_codex":0.00036436185,"about_ca_topic_score_gemma":0.0026662606,"teacher_disagreement_score":0.23045929,"about_ca_system_score_codex":0.00017690343,"about_ca_system_score_gemma":0.0003112643,"threshold_uncertainty_score":0.8020428},"labels":[],"label_agreement":null},{"id":"W2557113503","doi":"10.1182/blood.v122.21.4400.4400","title":"Final Results Of a Phase I Study Of The Anti-CD79b Antibody-Drug Conjugate DCDS4501A In Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Tolerability; Medicine; Neutropenia; Internal medicine; Gastroenterology; Adverse effect; Rituximab; Anemia; Hypokalemia; Fludarabine; Surgery; Toxicity; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.01929168676749963,"score_gpt":0.29220923973439844,"score_spread":0.2729175529668988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557113503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576485,0.00028821407,2.76709e-7,0.00025889973,0.00012448667,0.0019059984,0.00006045118,0.000021456648,0.0015753746],"genre_scores_gemma":[0.998793,0.00012222433,0.00011295442,0.00011478479,0.00004907117,0.00010144788,0.00002281765,0.000030109595,0.0006535951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977507,0.00016801232,0.0008805394,0.0004198186,0.00046223903,0.00031870438],"domain_scores_gemma":[0.99813676,0.00024679935,0.00045708843,0.0008779356,0.00016557224,0.00011581849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032140515,0.00027096926,0.0007230977,0.00015547498,0.000056218294,0.00001345509,0.00023147008,0.000099656325,0.000060947514],"category_scores_gemma":[0.00014952866,0.00015870684,0.00015721982,0.00041858663,0.00010861258,0.00007570603,0.00011100957,0.00010799966,0.00003485664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004650216,0.28980622,0.54876715,0.00047456907,0.0008704134,0.0011118855,0.00941954,0.000011102178,0.13155209,0.00001497229,0.004202157,0.009119679],"study_design_scores_gemma":[0.19777955,0.005915736,0.6461632,0.0005009352,0.0006121428,0.000044984678,0.0013763288,0.000077574805,0.14698535,0.000009601145,0.0003426829,0.00019191767],"about_ca_topic_score_codex":0.0035086484,"about_ca_topic_score_gemma":0.00015949985,"teacher_disagreement_score":0.2838905,"about_ca_system_score_codex":0.00006538851,"about_ca_system_score_gemma":0.00031164213,"threshold_uncertainty_score":0.6471877},"labels":[],"label_agreement":null},{"id":"W2557465898","doi":"10.1182/blood.v126.23.109.109","title":"Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Amplicon; Biology; Lymphoma; Gene expression profiling; Tissue microarray; SNP array; Population; Cancer research; Exon; Gene; Genetics; Single-nucleotide polymorphism; Cancer; Medicine; Gene expression; Genotype; Polymerase chain reaction; Immunology","score_opus":0.030808842962708624,"score_gpt":0.2953082477320594,"score_spread":0.26449940476935074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557465898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966602,0.0020687855,0.00009575026,0.00011785844,0.00005929543,0.000648016,0.000023452261,0.000024086637,0.00030261133],"genre_scores_gemma":[0.96911186,0.00036537318,0.030074779,0.00024357691,0.00006772815,0.00006424126,0.000015686217,0.000024802493,0.000031970358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857384,0.00007088003,0.00051686366,0.0003317837,0.00017694046,0.0003296667],"domain_scores_gemma":[0.99894506,0.0002108404,0.00011389676,0.00027048972,0.00014867334,0.00031101963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012790138,0.00018347775,0.00039095912,0.000120642304,0.000042626947,0.000026928585,0.00007423664,0.00009329688,0.0000034192985],"category_scores_gemma":[0.00009383636,0.00015825356,0.000060069382,0.00018858699,0.00003704343,0.00003365682,0.00006909104,0.00006044005,0.000021133392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011947357,0.008041916,0.9676226,0.00011685071,0.000047930207,0.00030981994,0.000477124,0.000035450983,0.022354832,0.000024971961,0.000022687318,0.0008263474],"study_design_scores_gemma":[0.059832834,0.0019966592,0.81142294,0.0002857785,0.00059960585,0.0002675624,0.0011971322,0.0011411788,0.12251984,0.000117880576,0.00028994435,0.0003286326],"about_ca_topic_score_codex":0.00010711144,"about_ca_topic_score_gemma":0.000042055133,"teacher_disagreement_score":0.15619965,"about_ca_system_score_codex":0.00007735249,"about_ca_system_score_gemma":0.00040882523,"threshold_uncertainty_score":0.6453393},"labels":[],"label_agreement":null},{"id":"W2557488260","doi":"10.14740/jmc.v7i12.2690","title":"Primary T-Cell Lymphoma With Small Intestinal Perforation: A Case Report","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Perforation; Etiology; Gastrointestinal perforation; Lymphoma; Diverticulosis; Gastroenterology; Internal medicine; Surgery; Peritonitis","score_opus":0.030278756800238695,"score_gpt":0.2751542084880119,"score_spread":0.24487545168777322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557488260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98577833,0.00088412565,0.00061066815,0.0111218495,0.00015545393,0.00010712829,0.0000025023242,0.000013840277,0.0013261259],"genre_scores_gemma":[0.9948447,0.00019244305,0.0029100222,0.00083478465,0.0007059589,0.0000074366058,0.0000029598207,0.00001418249,0.00048753154],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980583,0.000043847034,0.00055977923,0.00014795685,0.0010131481,0.00017697622],"domain_scores_gemma":[0.9979948,0.00052064296,0.0003747851,0.00018858958,0.0003321658,0.00058902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005791869,0.0001418578,0.00037247263,0.00009352019,0.00005577721,0.0000176035,0.00007475073,0.000089343834,0.00048482796],"category_scores_gemma":[0.0010278444,0.00006218712,0.00012900282,0.00009574574,0.00013012337,0.00009223629,0.00003131754,0.00009174474,0.000015253251],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005847814,0.0013129492,0.04365487,0.00005558332,0.00008194137,0.85689926,0.000038771697,9.909933e-8,0.00007488243,0.000019442496,0.0051270346,0.09215037],"study_design_scores_gemma":[0.00974908,0.0036220322,0.0135228345,0.0010595156,0.00031318396,0.9594616,0.00012408294,0.000004709061,0.0020992665,0.000010461532,0.009947158,0.00008605973],"about_ca_topic_score_codex":0.00005652099,"about_ca_topic_score_gemma":0.00003154817,"teacher_disagreement_score":0.10256234,"about_ca_system_score_codex":0.00027289483,"about_ca_system_score_gemma":0.0015386088,"threshold_uncertainty_score":0.5308526},"labels":[],"label_agreement":null},{"id":"W2557490043","doi":"10.1182/asheducation-2016.1.284","title":"Novel agents in follicular lymphoma: choosing the best target","year":2016,"lang":"en","type":"review","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Drug development; Computational biology; Clinical trial; Medicine; Bioinformatics; Risk analysis (engineering); Computer science; Drug; Biology; Lymphoma; Pharmacology; Immunology","score_opus":0.07227960147317095,"score_gpt":0.3596571336334283,"score_spread":0.2873775321602574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557490043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010811155,0.995641,0.000026284955,0.00053205143,0.00036531858,0.00116628,0.000029793084,0.000028365906,0.002102821],"genre_scores_gemma":[0.00031901413,0.9978119,0.00028147292,0.00030869537,0.0001394591,0.0005891997,0.00008220712,0.000060051225,0.00040796917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807817,0.00011083098,0.0006537816,0.00049551635,0.00019266116,0.0004690447],"domain_scores_gemma":[0.9985829,0.000332352,0.00027220172,0.0006642838,0.000033691587,0.00011455258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016442494,0.00044145458,0.0022478085,0.00018903756,0.00007066993,0.000014318631,0.00020196661,0.00043780368,0.00015473449],"category_scores_gemma":[0.00010292532,0.0002101911,0.0005426727,0.00023056244,0.000099510486,0.000027473377,0.00011419013,0.0001128387,0.0010571763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013278614,0.001866606,0.0024329922,0.007471959,0.00081725407,0.0021807437,0.000051566174,4.9782727e-8,3.8997484e-7,0.0050139306,0.0033525096,0.9767987],"study_design_scores_gemma":[0.002349416,0.000058156664,0.00019690559,0.01862336,0.000792308,0.005390405,0.0000114586865,0.0000015153636,0.000008794027,0.00005071601,0.97232056,0.00019642359],"about_ca_topic_score_codex":0.00007049935,"about_ca_topic_score_gemma":0.000011325319,"teacher_disagreement_score":0.9766023,"about_ca_system_score_codex":0.00045403707,"about_ca_system_score_gemma":0.00040919508,"threshold_uncertainty_score":0.99972063},"labels":[],"label_agreement":null},{"id":"W2557689159","doi":"10.1182/blood.v112.11.2585.2585","title":"A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada)","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Regimen; Rituximab; Chemotherapy regimen; Carboplatin; Gastroenterology; Lenalidomide; Phases of clinical research; Surgery; Oncology; Lymphoma; Chemotherapy; Dexamethasone","score_opus":0.011225189908982757,"score_gpt":0.2589632845206553,"score_spread":0.24773809461167257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557689159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599224,0.0010004679,0.0000013419518,0.000106704254,0.000042978507,0.002340014,0.000066373155,0.000022468674,0.00042742927],"genre_scores_gemma":[0.99917805,0.00005884857,0.00020390082,0.000106395164,0.00002402821,0.00027906988,0.000034664834,0.000027961349,0.000087064036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840266,0.00013701979,0.00042091898,0.00041633975,0.00034163042,0.0002814435],"domain_scores_gemma":[0.9989177,0.0002390913,0.00023086282,0.00034928802,0.00014777743,0.00011526757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015817702,0.0002536384,0.0006328817,0.00009098087,0.00014016568,0.0000068352456,0.00007436783,0.00009545777,0.000020669511],"category_scores_gemma":[0.00011009908,0.00015501684,0.000051055602,0.00018936823,0.000300308,0.00007938056,0.000079414116,0.00012010249,0.000002999104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030718253,0.16165079,0.8279955,0.000017855535,0.00052940205,0.00020778869,0.003220972,1.8285982e-7,0.00006865398,0.000006083532,0.00009322009,0.003137719],"study_design_scores_gemma":[0.25020015,0.021810314,0.7259112,0.000041432322,0.00054147624,0.00005111998,0.000546953,0.0000074840355,0.0006504495,0.000007782975,0.00011078162,0.000120873214],"about_ca_topic_score_codex":0.00037735124,"about_ca_topic_score_gemma":0.00021377175,"teacher_disagreement_score":0.24712832,"about_ca_system_score_codex":0.0002048783,"about_ca_system_score_gemma":0.00015606677,"threshold_uncertainty_score":0.6321403},"labels":[],"label_agreement":null},{"id":"W2557709742","doi":"10.1182/blood.v110.11.184.184","title":"Vascularization Predicts Overall Survival (OS) &amp; Risk of Transformation (RT) in Uniformly Treated Patients with Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; CD34; Angiogenesis; Medicine; Pathology; Tumor microenvironment; Lymphoma; Stage (stratigraphy); Radiation therapy; Internal medicine; Cancer; Biology","score_opus":0.006151472392422119,"score_gpt":0.20839546170370432,"score_spread":0.2022439893112822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557709742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965329,0.00010655736,0.0005980723,0.0000206986,0.0000326025,0.0008401592,0.00004742304,0.00004198774,0.0017795807],"genre_scores_gemma":[0.9985404,0.0001269302,0.00039723236,0.000025492713,0.000022221508,0.000024270232,0.00081439625,0.000020691336,0.000028335553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986362,0.00004657647,0.00040706326,0.00020160788,0.00046631123,0.00024223751],"domain_scores_gemma":[0.99927485,0.000048110367,0.00015380088,0.00025224168,0.00016450498,0.00010647171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025034376,0.00018037525,0.0003237612,0.00017733542,0.00004131332,0.000010369123,0.000045133296,0.00011729576,0.000018421155],"category_scores_gemma":[0.000038984657,0.00013090186,0.000102049,0.00032136965,0.00002680591,0.00016636362,0.000008087834,0.000041826373,0.0000085573065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046866664,0.004883256,0.9893061,0.00006665087,0.0004248308,0.00002537338,0.000603755,0.000046328256,0.000088717985,0.00018864711,0.000006069467,0.0038915926],"study_design_scores_gemma":[0.04147171,0.0006227135,0.94758797,0.00015308143,0.00078942085,0.0000074428185,0.000027524273,0.000047949427,0.008877808,0.000026520198,0.00026831147,0.00011955737],"about_ca_topic_score_codex":0.0008763236,"about_ca_topic_score_gemma":0.00061741937,"teacher_disagreement_score":0.04171815,"about_ca_system_score_codex":0.00012252753,"about_ca_system_score_gemma":0.00007481747,"threshold_uncertainty_score":0.5338023},"labels":[],"label_agreement":null},{"id":"W2557744148","doi":"10.1182/blood.v108.11.4680.4680","title":"Fludarabine, Mitoxantrone and Dexamethasone for the First Line Treatment of Patients with Indolent Non-Hodgkin Lymphoma (NHL): GATLA First Interim Report (Grupo Argentino de Tratamiento de la Leucemia Aguda).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitoxantrone; Internal medicine; Fludarabine; Vincristine; Gastroenterology; Prednisone; Interim analysis; Lymphoma; Cyclophosphamide; Surgery; Chemotherapy; Clinical trial","score_opus":0.007957061818872176,"score_gpt":0.24656747609851568,"score_spread":0.2386104142796435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557744148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956349,0.0013592034,0.00055098074,0.00046588358,0.00006487519,0.0015594801,0.00011508877,0.000034023404,0.0002155278],"genre_scores_gemma":[0.99481654,0.00043528722,0.003340049,0.000073209136,0.0001943389,0.00069253665,0.00022801913,0.000049328333,0.00017066894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825704,0.000037140264,0.00052161526,0.00044455132,0.0002931378,0.00044650387],"domain_scores_gemma":[0.99851286,0.0004145042,0.00029654734,0.0004942252,0.00012501859,0.00015683791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021124013,0.0003553098,0.00056165305,0.000089258836,0.00017718162,0.000042744123,0.00008279218,0.0001332424,0.000014758457],"category_scores_gemma":[0.000056586956,0.00021428359,0.000181381,0.00015103436,0.00017438416,0.00005226202,0.00003753307,0.000042987067,0.000001699382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011373968,0.016300408,0.97366554,0.00016519967,0.0008300118,0.00040654384,0.0004808971,0.000024947854,0.0005117836,0.000038769078,0.00066629745,0.0057721916],"study_design_scores_gemma":[0.03863964,0.0040535266,0.88901055,0.00024714242,0.0018396525,0.00042645395,0.00006253047,0.00012873487,0.05818779,0.000020246567,0.0071796007,0.00020411814],"about_ca_topic_score_codex":0.0010014672,"about_ca_topic_score_gemma":0.0004791598,"teacher_disagreement_score":0.08465499,"about_ca_system_score_codex":0.00033537464,"about_ca_system_score_gemma":0.00024995557,"threshold_uncertainty_score":0.8738231},"labels":[],"label_agreement":null},{"id":"W2557903862","doi":"10.1182/blood.v120.21.1602.1602","title":"Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Population; Context (archaeology); Oncology; Stage (stratigraphy); Surgery; Lymphoma","score_opus":0.010270966413909,"score_gpt":0.22516290101540204,"score_spread":0.21489193460149303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557903862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982416,0.00095667975,0.0000016153527,0.000032757733,0.000027123056,0.00054715347,0.000040243616,0.0000101367705,0.00014270612],"genre_scores_gemma":[0.9994511,0.0000390408,0.00010092579,0.00008248403,0.0000099227145,0.00009736102,0.00009454768,0.00001807069,0.00010656859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910885,0.00009128555,0.00023530374,0.0001556299,0.00017359316,0.00023531933],"domain_scores_gemma":[0.9995339,0.000089066096,0.00007551511,0.00023248208,0.000029363788,0.000039679708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001936674,0.00009270547,0.0003009179,0.0000324373,0.000026033642,0.000032094962,0.000060685357,0.000058524784,0.000018648785],"category_scores_gemma":[0.00002419051,0.00008227335,0.00004558658,0.00014097469,0.000019625257,0.00005836031,0.000019266536,0.000035350757,0.000002668314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030186031,0.007526468,0.985485,0.000032991436,0.000047573893,0.000040522806,0.00027394836,0.000005185075,0.00003585338,7.0326894e-7,0.000008897253,0.006512629],"study_design_scores_gemma":[0.011260222,0.0002419205,0.9877613,0.000047318783,0.00009169735,0.00008179733,0.000038277838,0.00009860439,0.00026493456,0.000012748506,0.000011300408,0.0000898853],"about_ca_topic_score_codex":0.35977262,"about_ca_topic_score_gemma":0.49405247,"teacher_disagreement_score":0.13427985,"about_ca_system_score_codex":0.00004821348,"about_ca_system_score_gemma":0.000035581903,"threshold_uncertainty_score":0.6444907},"labels":[],"label_agreement":null},{"id":"W2557976939","doi":"10.1182/blood.v120.21.2648.2648","title":"Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; PTEN; Biology; Comparative genomic hybridization; Chromosomal translocation; SNP array; Diffuse large B-cell lymphoma; Copy number analysis; Cancer research; Univariate analysis; Chromosome; Chromosome abnormality; Gene expression profiling; Genetics; Oncology; Karyotype; Gene; Internal medicine; Medicine; Copy-number variation; Single-nucleotide polymorphism; Immunology; Gene expression; Multivariate analysis; Genome; PI3K/AKT/mTOR pathway","score_opus":0.010740610537022943,"score_gpt":0.23070006359121256,"score_spread":0.21995945305418962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557976939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97336507,0.023675084,0.000009170609,0.0002332848,0.000087649816,0.0005247415,0.000011560751,0.000055125427,0.0020382951],"genre_scores_gemma":[0.9969519,0.0013160682,0.00077570486,0.00037256206,0.00017119074,0.00020689683,0.000020767682,0.0000327094,0.00015223207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985173,0.000046385005,0.00032416335,0.00026253585,0.00027725636,0.0005723965],"domain_scores_gemma":[0.9992682,0.000057636273,0.000045740504,0.0002910312,0.000027887707,0.00030952113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014783577,0.0002591222,0.00042012983,0.00013805709,0.00006952545,0.00002660265,0.00006000972,0.00013624635,0.00005291557],"category_scores_gemma":[0.00002167618,0.00020795088,0.00014521928,0.00017730852,0.00006662709,0.00014674157,0.00002685828,0.000027826683,0.00004164852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006129961,0.0037597893,0.97184646,0.00013318918,0.00032337962,0.0004392157,0.0012738092,6.5032117e-7,0.0003753686,0.00059844437,0.000074516545,0.021113893],"study_design_scores_gemma":[0.020248549,0.00023294926,0.9545202,0.000116005154,0.000602142,0.00093774754,0.00025857243,0.000012363017,0.016717698,0.00006588295,0.006055824,0.00023201798],"about_ca_topic_score_codex":0.00038659244,"about_ca_topic_score_gemma":0.000056728797,"teacher_disagreement_score":0.02358678,"about_ca_system_score_codex":0.00011330349,"about_ca_system_score_gemma":0.000094277246,"threshold_uncertainty_score":0.8479991},"labels":[],"label_agreement":null},{"id":"W2558098955","doi":"10.1182/blood.v118.21.585.585","title":"High-Resolution Chromatin Immunoprecipitation (ChIP) Sequencing Identifies Novel Binding Targets and Prognostic Role for SOX11 in Mantle Cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromatin immunoprecipitation; Biology; Transcription factor; Chromatin; Mantle cell lymphoma; Molecular biology; Gene; Immunoprecipitation; Chromosome conformation capture; Promoter; DNA methylation; Genetics; Cancer research; Computational biology; Gene expression; Lymphoma; Enhancer","score_opus":0.021899379373241986,"score_gpt":0.2281966931849598,"score_spread":0.20629731381171781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558098955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970894,0.0013776992,0.00012565956,0.00002946058,0.000111756344,0.00082921004,0.000027511738,0.000045169007,0.00036416715],"genre_scores_gemma":[0.98924804,0.00006230895,0.010121965,0.000018494315,0.00004996818,0.0002981513,0.000096286625,0.000022768307,0.00008204497],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990732,0.000017605209,0.00027085157,0.00026241943,0.0001258935,0.00025003572],"domain_scores_gemma":[0.99955493,0.00008760867,0.000109452885,0.0001403663,0.000048003578,0.000059621667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015447523,0.0001496786,0.00022558603,0.00014561684,0.000096171374,0.000027772612,0.000042847554,0.000078216784,0.000015508394],"category_scores_gemma":[0.000072506395,0.00013348844,0.000050705537,0.00010002489,0.000029688363,0.00014188426,0.00003094447,0.000029372959,0.000017811035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026812925,0.006654174,0.26973704,0.0006778123,0.00028692826,0.00009540364,0.009261852,0.0000083798,0.70693207,0.0009047956,0.000069314374,0.0051041185],"study_design_scores_gemma":[0.012026057,0.00042848248,0.598152,0.00028152196,0.00031489393,0.00004632828,0.00072292925,0.0003965875,0.38711306,0.0003569559,0.000014189889,0.00014697784],"about_ca_topic_score_codex":0.0007775625,"about_ca_topic_score_gemma":0.00009750317,"teacher_disagreement_score":0.32841498,"about_ca_system_score_codex":0.00013995844,"about_ca_system_score_gemma":0.00007301781,"threshold_uncertainty_score":0.5443501},"labels":[],"label_agreement":null},{"id":"W2558301987","doi":"10.1182/blood.v114.22.139.139","title":"Tyrosine 641 of the EZH2 Oncogene Is Frequently Mutated in Follicular and Diffuse Large B-Cell Lymphomas of Germinal Center Origin.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; Germinal center; Follicular lymphoma; Diffuse large B-cell lymphoma; Cancer research; Genetics; EZH2; Gene; B cell; Lymphoma; Histone; Immunology","score_opus":0.008534875285076397,"score_gpt":0.24221617540749896,"score_spread":0.23368130012242255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558301987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956749,0.0025158338,9.224819e-7,0.00046906446,0.00003359476,0.00032838708,0.00007564095,0.000009383712,0.0008922452],"genre_scores_gemma":[0.9988401,0.0003269104,0.00015620446,0.00046478448,0.00002567239,0.000009180782,0.000017834847,0.00001082373,0.00014851699],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990393,0.000030825893,0.00030354632,0.00020055116,0.00021850008,0.00020729126],"domain_scores_gemma":[0.999421,0.000023401553,0.00012096297,0.000307086,0.000051304196,0.000076259115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071451155,0.0001489869,0.00034463953,0.000067527726,0.000024744386,0.000005518973,0.0000712084,0.00007193201,0.000036034147],"category_scores_gemma":[0.000013161126,0.00009433201,0.00012003364,0.00019307157,0.00004350048,0.00003040959,0.000030096478,0.000042072337,0.0000033382846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018089334,0.037014764,0.89642483,0.000117919015,0.00018180803,0.00034573436,0.00073770754,3.0717894e-7,0.06291109,0.00023041187,0.0002798972,0.0015746232],"study_design_scores_gemma":[0.041572478,0.00048936816,0.46286497,0.00020052379,0.00036684587,0.00009718435,0.000037054855,0.000016438347,0.49329016,0.000053799387,0.0009256857,0.00008549696],"about_ca_topic_score_codex":0.00014817058,"about_ca_topic_score_gemma":0.000020751862,"teacher_disagreement_score":0.43355986,"about_ca_system_score_codex":0.000046559373,"about_ca_system_score_gemma":0.00007506914,"threshold_uncertainty_score":0.38467476},"labels":[],"label_agreement":null},{"id":"W2558410094","doi":"10.1182/blood.v110.11.3419.3419","title":"Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin’s Lymphoma (NHL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Regimen; Lymphoma; Gastroenterology; Refractory (planetary science); Oncology; Chemotherapy regimen; Chemotherapy; Surgery","score_opus":0.041996748575949476,"score_gpt":0.31457864161054594,"score_spread":0.27258189303459646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558410094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596715,0.00094294077,0.000008914492,0.00016622129,0.000135336,0.0021977765,0.00003572484,0.00004152369,0.0005044021],"genre_scores_gemma":[0.9985989,0.00010819661,0.0008679519,0.000104357714,0.00006243198,0.00011720856,0.000033984677,0.000038063677,0.00006892997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973202,0.00014551883,0.00080075715,0.00057546335,0.00062965654,0.00052841037],"domain_scores_gemma":[0.99834245,0.00052104256,0.00024377221,0.00060864916,0.00011157132,0.00017251722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007816817,0.00034968316,0.00079524535,0.0003172589,0.000090690686,0.000028257664,0.00015086305,0.00008774173,0.000010775827],"category_scores_gemma":[0.00013557707,0.0002486902,0.00018918319,0.0004034863,0.000060185044,0.00008147202,0.0000604605,0.00012520398,0.000018266248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087635174,0.10679326,0.7653524,0.00007867644,0.0014573954,0.00618889,0.009451715,0.000012181324,0.0024852161,0.000008400128,0.00012681786,0.020409856],"study_design_scores_gemma":[0.23354097,0.007109724,0.74595064,0.0006433768,0.00028469987,0.000049581726,0.0008163214,0.000029992498,0.011029302,0.0000010872697,0.0003510695,0.00019323596],"about_ca_topic_score_codex":0.0009781178,"about_ca_topic_score_gemma":0.0005378455,"teacher_disagreement_score":0.1459058,"about_ca_system_score_codex":0.00033968117,"about_ca_system_score_gemma":0.0003376365,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2558423221","doi":"10.1182/blood.v126.23.1472.1472","title":"Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Cancer research; Biology; Gene expression profiling; Gene; B cell; Gene expression; Genetics; Immunology; Antibody","score_opus":0.016554696944858074,"score_gpt":0.2774045934494269,"score_spread":0.26084989650456886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558423221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528205,0.0003837314,0.000016116031,0.000059527385,0.000028939568,0.00029777465,0.000085151914,0.000024055007,0.0038226342],"genre_scores_gemma":[0.99911606,0.00000870245,0.0002100296,0.00006778917,0.000033317032,0.00006650211,0.00015858712,0.0000092126975,0.00032978723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990313,0.000051552535,0.00023042643,0.00020661743,0.0003418,0.00013829091],"domain_scores_gemma":[0.99924505,0.00008265247,0.00009804703,0.00023523216,0.00019303898,0.00014598717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013014088,0.00012960681,0.00042714528,0.00023646948,0.000024939283,0.000010113066,0.000053911655,0.000038942784,0.00006958619],"category_scores_gemma":[0.00006126155,0.00008624419,0.00016994127,0.00057911064,0.00001801563,0.00003528649,0.00003189659,0.000023722274,0.000026323643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009939021,0.08013807,0.91011864,0.000008229479,0.003867236,0.00022297679,0.0047045746,0.0000030824986,0.00003837321,0.00009257084,0.0004356374,0.00027124182],"study_design_scores_gemma":[0.06564968,0.0012836498,0.90970355,0.000015528096,0.012130305,0.000013230956,0.007164939,0.00031277342,0.0034217394,0.000021724567,0.00017861564,0.00010427415],"about_ca_topic_score_codex":0.00013150462,"about_ca_topic_score_gemma":0.00015614022,"teacher_disagreement_score":0.07885443,"about_ca_system_score_codex":0.000047159985,"about_ca_system_score_gemma":0.00015225317,"threshold_uncertainty_score":0.3516936},"labels":[],"label_agreement":null},{"id":"W2558464910","doi":"10.1182/blood.v108.11.5222.5222","title":"Impact of Disease and Mobilizing Agents on Initial and Remobilization Failure.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Transplantation; Regimen; Mobilization; Population; Gastroenterology; Chemotherapy; Granulocyte colony-stimulating factor; Surgery; Apheresis; Oncology","score_opus":0.014384277948269535,"score_gpt":0.2926998192286883,"score_spread":0.2783155412804188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558464910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988607,0.00037132835,0.0000015735263,0.000055098895,0.000008748933,0.00020636014,0.000015523601,0.000011420528,0.0004692399],"genre_scores_gemma":[0.9997178,0.00006044641,0.00008078274,0.00002492654,0.000047649697,0.000010469963,0.000035595567,0.0000066483635,0.00001568727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999625,0.000009080346,0.000093616254,0.00011861118,0.00008310594,0.00007057535],"domain_scores_gemma":[0.9997559,0.000022401051,0.000031933967,0.000092715054,0.00002022002,0.000076803335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022297221,0.00006884955,0.000109762805,0.000039429084,0.00002258267,0.0000077885725,0.0000085514,0.000022284472,0.000016610951],"category_scores_gemma":[0.000018394609,0.000049328577,0.00003552422,0.000040746265,0.000025730573,0.00002727174,0.000010332428,0.000014357746,0.0000013267857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011605542,0.0018072091,0.9950556,0.00004672144,0.00007676759,0.0000418467,0.000036187404,0.000007077881,0.0014221123,0.0001223992,0.00016279212,0.0011052096],"study_design_scores_gemma":[0.00448684,0.0006066867,0.99132335,0.00008934785,0.000272268,0.000012631637,0.000008518344,0.00003108166,0.0030069712,0.000091899135,0.000028548888,0.000041860058],"about_ca_topic_score_codex":0.00012240725,"about_ca_topic_score_gemma":0.000008756703,"teacher_disagreement_score":0.004370785,"about_ca_system_score_codex":0.000018763985,"about_ca_system_score_gemma":0.000029043516,"threshold_uncertainty_score":0.2011561},"labels":[],"label_agreement":null},{"id":"W2558650210","doi":"10.1016/j.hoc.2016.07.008","title":"Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma","year":2016,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Central nervous system; Methotrexate; Lymphoma; Cerebrospinal fluid; Complication; Cytology; Pathology; Oncology; Internal medicine","score_opus":0.03343077776561032,"score_gpt":0.3555423191795037,"score_spread":0.32211154141389337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558650210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00097411487,0.99005985,0.00013359216,0.0001364196,0.0015364614,0.004935974,0.0008870293,0.00014742781,0.0011891432],"genre_scores_gemma":[0.0024314646,0.99065095,0.002739173,0.00022387928,0.0004187904,0.002417417,0.00067881006,0.0001519661,0.00028753307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940924,0.00044425088,0.0027612522,0.0012366482,0.00031602755,0.0011494152],"domain_scores_gemma":[0.98808134,0.004119581,0.005583859,0.0012185592,0.00046496512,0.00053169],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00023102998,0.0009899134,0.008487961,0.00037887617,0.00014311027,0.00000877758,0.00052155566,0.0013780625,0.000039358103],"category_scores_gemma":[0.00069383637,0.00063934125,0.0023736542,0.0003979804,0.000821852,0.000045160898,0.00021532303,0.0002935652,0.00029868569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002918085,0.0028966463,0.0039692507,0.036967643,0.0014747999,0.0013737908,0.000040473304,1.8756198e-7,2.3032268e-8,0.00016337952,0.0038443925,0.9489776],"study_design_scores_gemma":[0.0066946186,0.006490388,0.00037917757,0.0134675475,0.004848106,0.0028123574,0.000049373826,0.0000071212908,0.00000383984,0.000009251707,0.96471417,0.00052404],"about_ca_topic_score_codex":0.000022988079,"about_ca_topic_score_gemma":0.000014117484,"teacher_disagreement_score":0.9608698,"about_ca_system_score_codex":0.0011812217,"about_ca_system_score_gemma":0.004296391,"threshold_uncertainty_score":0.99991834},"labels":[],"label_agreement":null},{"id":"W2558706989","doi":"10.1182/blood.v110.11.2606.2606","title":"Gene Expression Model of Survival and Transformation in Follicular Lymphoma (FL): A Study by the LLMPP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bioconductor; Follicular lymphoma; Proportional hazards model; Survival analysis; Medicine; Oncology; Internal medicine; Biopsy; Gene expression profiling; Lymphoma; Gene expression; Gene; Biology; Genetics","score_opus":0.016335822115357,"score_gpt":0.25679401171520677,"score_spread":0.24045818959984977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558706989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770826,0.0008133553,0.00020625719,0.00009777574,0.000014377679,0.0005750817,0.000008376767,0.000009400007,0.0005671438],"genre_scores_gemma":[0.9995954,0.00009830472,0.0001934082,0.00002954824,0.000012384302,0.00003411242,0.000011297346,0.0000069242265,0.000018619361],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993266,0.000025561172,0.00021346932,0.00011437112,0.00020387393,0.00011611988],"domain_scores_gemma":[0.99970233,0.000042989876,0.0000397807,0.00014820955,0.000021892387,0.000044764587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002875866,0.00008337472,0.00017398498,0.000040370287,0.00003250495,0.0000053684053,0.00003341633,0.000039380582,0.0000025790332],"category_scores_gemma":[0.00000873106,0.000049674654,0.00003541299,0.000080878555,0.000017732817,0.00004253206,0.000012008284,0.000020715872,7.687033e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005887257,0.026416704,0.76256204,0.00010024724,0.00032342452,0.00011800844,0.013311975,0.00007132638,0.16247092,0.000153622,0.000119911296,0.033763085],"study_design_scores_gemma":[0.027475253,0.000594466,0.36384785,0.000069110385,0.00031783598,0.000028852342,0.0018823039,0.0007331991,0.6048662,0.000048608046,0.000041319156,0.000095014155],"about_ca_topic_score_codex":0.00015238031,"about_ca_topic_score_gemma":0.000058601032,"teacher_disagreement_score":0.44239527,"about_ca_system_score_codex":0.000024895695,"about_ca_system_score_gemma":0.000023257298,"threshold_uncertainty_score":0.20256735},"labels":[],"label_agreement":null},{"id":"W2559129390","doi":"10.1182/blood.v112.11.372.372","title":"Interim Positron Emission Tomography (PET) in Diffuse Large B-Cell Lymphoma: Independent Expert Nuclear Medicine Evaluation of ECOG 3404","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim; Diffuse large B-cell lymphoma; Nuclear medicine; Positron emission tomography; Concordance; Rituximab; Cohen's kappa; Lymphoma; Radiology; Internal medicine; Statistics","score_opus":0.024495990509121424,"score_gpt":0.28302685563606267,"score_spread":0.25853086512694123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559129390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916931,0.0035204664,0.0000018778861,0.00036157804,0.00010931582,0.00055052177,0.000006182868,0.000038422626,0.0037185305],"genre_scores_gemma":[0.9984551,0.00082641054,0.00012721935,0.0002899143,0.000097765005,0.0000605347,0.000058611146,0.000030164641,0.00005426712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980135,0.000113003334,0.00045738777,0.00034292453,0.000802866,0.00027029874],"domain_scores_gemma":[0.9991024,0.000047144178,0.00015172755,0.00038399905,0.00014794485,0.00016679996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036063476,0.0002147962,0.00044606705,0.0003059164,0.00006375712,0.00000504737,0.0001048957,0.0000955523,0.00023229836],"category_scores_gemma":[0.00006742034,0.00016081444,0.00013909211,0.00026760428,0.00006568682,0.00008072094,0.00006777818,0.00006647445,0.000017686083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009571559,0.18613726,0.6631074,0.00022759652,0.00054368016,0.0015015207,0.010834027,0.00000170103,0.120538294,0.000102364684,0.006123527,0.0099254865],"study_design_scores_gemma":[0.2152427,0.0022172963,0.6562934,0.0008889025,0.00090394303,0.00056148897,0.0009022647,0.00044903424,0.12065852,0.000055672754,0.0015252325,0.0003015547],"about_ca_topic_score_codex":0.00036332652,"about_ca_topic_score_gemma":0.000026295407,"teacher_disagreement_score":0.21428555,"about_ca_system_score_codex":0.00019499558,"about_ca_system_score_gemma":0.00012174506,"threshold_uncertainty_score":0.6557823},"labels":[],"label_agreement":null},{"id":"W2559341198","doi":"10.1007/s00277-016-2878-5","title":"Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Pharmacyclics; Genentech; H. Lundbeck A/S; Baxalta; Celgene; Gilead Sciences; Servier; Astellas Pharma; TG Therapeutics; Amgen; Pfizer; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bendamustine; Rituximab; Obinutuzumab; Internal medicine; Follicular lymphoma; Quality of life (healthcare); Lymphoma; Refractory (planetary science); Oncology; Surgery","score_opus":0.0440020925305904,"score_gpt":0.34137908049744936,"score_spread":0.29737698796685896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559341198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523383,0.0010606549,0.0000032772778,0.0016249985,0.000041232186,0.0018801296,0.000084067375,0.00001918016,0.000052655378],"genre_scores_gemma":[0.9993622,0.00011117663,0.00003498215,0.00023269434,0.000010140805,0.00013262157,0.00008365003,0.000027155987,0.00000538412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967305,0.00043002548,0.0013700887,0.0005086376,0.000469849,0.0004909181],"domain_scores_gemma":[0.99753404,0.0006874792,0.00082056737,0.0005525367,0.00021432922,0.0001910424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057595194,0.0003664383,0.0019115541,0.0003443123,0.00005105353,0.0000050529948,0.00014517222,0.00014452435,0.000028247518],"category_scores_gemma":[0.00017659095,0.0001860579,0.000070336755,0.00046347544,0.00031750946,0.00009471503,0.000060159546,0.00011326877,0.0000025594106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05538351,0.021419913,0.9079871,0.00021405653,0.00067726243,0.00020694276,0.002347395,0.000005367783,0.00002025038,0.00010890209,0.00010408034,0.011525215],"study_design_scores_gemma":[0.22411577,0.022453805,0.75138456,0.00054301263,0.00009859651,0.000032343956,0.000675963,0.000015928956,0.0005039546,0.000005189496,0.000010565373,0.00016029204],"about_ca_topic_score_codex":0.0057186815,"about_ca_topic_score_gemma":0.0021259198,"teacher_disagreement_score":0.16873226,"about_ca_system_score_codex":0.00017674998,"about_ca_system_score_gemma":0.0005112432,"threshold_uncertainty_score":0.86449736},"labels":[],"label_agreement":null},{"id":"W2559422573","doi":"10.1182/blood.v116.21.804.804","title":"Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Biology; Follicular lymphoma; Exome; Exome sequencing; Cancer research; Lymphoma; Gene expression profiling; Genetics; Gene; Mutation; B cell; Immunology; Gene expression","score_opus":0.00906692428152137,"score_gpt":0.2243887047164775,"score_spread":0.21532178043495614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559422573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821216,0.0012634167,0.000005413164,0.00010908188,0.00002032381,0.0002513757,0.000012390811,0.000013979469,0.00011188732],"genre_scores_gemma":[0.99925035,0.00021992222,0.00040574372,0.000025856347,0.000016523863,0.000028453034,0.000015593941,0.000009628784,0.00002789725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999447,0.000009713649,0.00018230402,0.00016810936,0.00009384857,0.00009901073],"domain_scores_gemma":[0.99970454,0.000016263328,0.000052413106,0.00012871297,0.000036715966,0.000061365434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008607937,0.00008200784,0.0001694998,0.00009088434,0.000020906284,0.000012231006,0.000021116337,0.00004485693,0.000009181893],"category_scores_gemma":[0.00000845371,0.00006110858,0.000014555249,0.00010138915,0.00006260445,0.00005781878,0.000005504187,0.000047300986,0.0000012104259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020690475,0.00033134734,0.31206027,0.00006436754,0.000055562163,0.00006372337,0.00052811956,3.6737148e-7,0.6859548,0.00006836729,3.2382877e-7,0.00085203635],"study_design_scores_gemma":[0.0059813457,0.00016946734,0.7558362,0.000042365908,0.00019670773,0.00021183954,0.00012877682,0.000019044106,0.23728816,0.00003924009,0.000025354575,0.00006147697],"about_ca_topic_score_codex":0.00020160663,"about_ca_topic_score_gemma":0.00018958878,"teacher_disagreement_score":0.44866666,"about_ca_system_score_codex":0.000015620406,"about_ca_system_score_gemma":0.00004502783,"threshold_uncertainty_score":0.24919355},"labels":[],"label_agreement":null},{"id":"W2559507836","doi":"10.1182/blood.v116.21.4927.4927","title":"Case Report of a Primary Splenic Marginal Zone Lymphoma Patient Presenting with Factor VII Inhibitor","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Splenic marginal zone lymphoma; Medicine; Lupus anticoagulant; Gastroenterology; Pathology; Internal medicine; Spleen; Splenectomy","score_opus":0.011212725838199244,"score_gpt":0.22631268797334642,"score_spread":0.21509996213514718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559507836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709636,0.00014242917,0.0000031229508,0.000094558236,0.000113666494,0.00050556933,0.000032821357,0.000044350047,0.0019671365],"genre_scores_gemma":[0.9967181,0.0000064333876,0.0027397242,0.000046471392,0.00017023168,0.00007118562,0.000040770938,0.000026425767,0.0001806376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987203,0.000015674637,0.00036125132,0.00030677987,0.0003548936,0.00024111185],"domain_scores_gemma":[0.99893177,0.000056493198,0.00023770047,0.0004757603,0.00012872618,0.00016953434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006205104,0.00017855663,0.0003517544,0.00007424509,0.000059252394,0.0000140172415,0.00003946946,0.00007931935,0.0001132674],"category_scores_gemma":[0.000047740552,0.00012334024,0.000104956736,0.00011691272,0.00006783424,0.000063627085,0.000059754126,0.00007543774,0.000009672971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022153044,0.007722889,0.6965216,0.0002220623,0.0004852675,0.2686976,0.0004682744,2.2791987e-7,0.015062962,0.000026086198,0.00018335573,0.010388202],"study_design_scores_gemma":[0.012488176,0.0012147668,0.5130162,0.00013149074,0.00074189436,0.28399923,0.0000846053,0.0000068553904,0.18640327,0.0000033486874,0.0017069136,0.00020324915],"about_ca_topic_score_codex":0.0003483969,"about_ca_topic_score_gemma":0.00007242726,"teacher_disagreement_score":0.18350536,"about_ca_system_score_codex":0.000046185567,"about_ca_system_score_gemma":0.00026392742,"threshold_uncertainty_score":0.50296694},"labels":[],"label_agreement":null},{"id":"W2559543703","doi":"10.1182/blood.v112.11.2049.2049","title":"Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Follicular lymphoma; Biology; Gene dosage; Gene expression profiling; Chromosomal translocation; SNP array; Copy-number variation; Copy number analysis; Lymphoma; Gene duplication; Cancer research; Genetics; Gene; Gene expression; Single-nucleotide polymorphism; Immunology; Genome; Genotype","score_opus":0.021395208109363177,"score_gpt":0.24738348448994765,"score_spread":0.22598827638058447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559543703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475926,0.0043290076,9.2092716e-7,0.000100315236,0.000009897049,0.00027035893,7.677736e-7,0.000007947359,0.00052151014],"genre_scores_gemma":[0.9969377,0.00029396501,0.0025404228,0.000087115586,0.000016617043,0.00009099336,0.00000508463,0.000004847215,0.000023236287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941957,0.000025553552,0.00017254225,0.00009971085,0.0001766103,0.00010600015],"domain_scores_gemma":[0.9997532,0.000032406275,0.000037292422,0.00012508559,0.000019551153,0.00003248078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007505864,0.00007500788,0.00014140281,0.0000400959,0.000045458703,0.0000036396648,0.00003553168,0.00003156594,0.000004204251],"category_scores_gemma":[0.000010870707,0.000042253283,0.000025780202,0.00007372244,0.00005048385,0.000017010916,0.00002014337,0.000014419205,0.000002275894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018963166,0.0015490849,0.98661715,0.00005642667,0.000057943183,0.00031870237,0.0038187744,1.8442242e-7,0.000117152136,0.00006121951,0.00003531571,0.0073490953],"study_design_scores_gemma":[0.004794695,0.00016431918,0.9619421,0.000113777496,0.000062260755,0.00021334006,0.00036250023,0.0000026080147,0.031395994,0.000015038029,0.00088692555,0.00004647876],"about_ca_topic_score_codex":0.000040611685,"about_ca_topic_score_gemma":0.000022162705,"teacher_disagreement_score":0.031278845,"about_ca_system_score_codex":0.000017409016,"about_ca_system_score_gemma":0.00009915684,"threshold_uncertainty_score":0.17230389},"labels":[],"label_agreement":null},{"id":"W2559772841","doi":"10.1182/blood.v118.21.430.430","title":"A Gene Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – a Correlative Study From the E2496 Intergroup Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency","funders":"","keywords":"Oncology; Medicine; ABVD; Internal medicine; Log-rank test; Stage (stratigraphy); Proportional hazards model; Clinical trial; Chemotherapy; Biology; Vincristine","score_opus":0.018238065820834804,"score_gpt":0.26275503174900616,"score_spread":0.24451696592817135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559772841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936958,0.0014798199,0.00009583902,0.00010790134,0.0003253548,0.0040094787,0.00009835438,0.000057340905,0.00013012675],"genre_scores_gemma":[0.996983,0.00021082068,0.0013391116,0.00014711714,0.00012570938,0.0009823474,0.00010253941,0.000041292722,0.00006806987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972754,0.00043019012,0.00070877746,0.0006911844,0.0004410061,0.00045342557],"domain_scores_gemma":[0.99717176,0.0018628434,0.00022941055,0.00048482505,0.00005377434,0.0001973993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030663153,0.00041866614,0.00077583425,0.000108059896,0.00007045249,0.000030126734,0.00019499149,0.00024270029,0.000060364313],"category_scores_gemma":[0.0009506526,0.00027663988,0.00008886537,0.00022503202,0.00008955968,0.00022144875,0.00020200743,0.0002880715,0.000008549921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123046994,0.058274217,0.7143974,0.0000678453,0.00071697356,0.0064889737,0.040884726,0.00011325312,0.011937045,0.000182766,0.00015118913,0.04373866],"study_design_scores_gemma":[0.32150656,0.006994405,0.6412158,0.000701617,0.00029809758,0.000013324227,0.002124165,0.00016873587,0.026431067,0.0001488059,0.00007003124,0.0003273504],"about_ca_topic_score_codex":0.00044333932,"about_ca_topic_score_gemma":0.0017334888,"teacher_disagreement_score":0.19845958,"about_ca_system_score_codex":0.0001518695,"about_ca_system_score_gemma":0.00015107385,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W2559781323","doi":"10.1182/blood.v108.11.4393.4393","title":"Bortezomib Activity Against Mantle Cell Lymphoma Overcomes Classic Mechanisms of Drug Resistance and Targets Cell Cycle Control.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Cyclin D1; Cancer research; Cell culture; Drug resistance; Cell cycle; Proteasome; Chemistry; Biology; Pharmacology; Cell; Lymphoma; Immunology; Biochemistry; Multiple myeloma; Genetics","score_opus":0.003315730825562614,"score_gpt":0.19019065101868396,"score_spread":0.18687492019312135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559781323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779686,0.0032095097,0.00009089341,0.00037279833,0.00006646945,0.0003992859,0.00007725673,0.00004610629,0.017769089],"genre_scores_gemma":[0.99645317,0.00017698045,0.0010273365,0.00019853261,0.000058365495,0.000040984363,0.00002076253,0.000026841408,0.0019970047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885106,0.000043180084,0.00023880176,0.00033111972,0.00025850662,0.00027733407],"domain_scores_gemma":[0.9992473,0.00010773383,0.00016856391,0.0003171377,0.000051494404,0.00010776357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097393546,0.00021318681,0.00045935976,0.000062946936,0.00007636861,0.000017270817,0.00006117998,0.0000843339,0.000017609698],"category_scores_gemma":[0.000008089179,0.0001775951,0.00011398992,0.00008784541,0.000058725065,0.00007165974,0.000032054155,0.000043086267,0.000012547855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016602725,0.054079894,0.18291,0.0016853259,0.00069412356,0.0017183879,0.00040204497,0.00002240732,0.7308666,0.0057851523,0.015025607,0.005150149],"study_design_scores_gemma":[0.029328605,0.00014950093,0.2239482,0.000080606194,0.00048301343,0.000009403982,0.000038587328,0.000052727977,0.74331224,0.0013028147,0.0010990773,0.00019523138],"about_ca_topic_score_codex":0.00018720333,"about_ca_topic_score_gemma":0.00009252809,"teacher_disagreement_score":0.05393039,"about_ca_system_score_codex":0.00007015104,"about_ca_system_score_gemma":0.00008234019,"threshold_uncertainty_score":0.7242118},"labels":[],"label_agreement":null},{"id":"W2559850121","doi":"10.1182/blood.v116.21.4881.4881","title":"Pralatrexate Reverses the Trend to Progressive Resistance to Successive Systemic Treatment Regimens In Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Internal medicine; Refractory (planetary science); Lymphoma; Progression-free survival; Oncology; Chemotherapy; Surgery; Immunology; T cell","score_opus":0.00498397604007538,"score_gpt":0.2199687550884725,"score_spread":0.2149847790483971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559850121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939186,0.000648392,4.9364667e-7,0.00093842833,0.00016973868,0.0024756768,0.00006529392,0.00005559522,0.0017278009],"genre_scores_gemma":[0.99502593,0.000025689336,0.000602348,0.0003092486,0.000115232324,0.0009836841,0.000049153925,0.000049297392,0.0028393937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980888,0.00007808024,0.00034482454,0.0006022682,0.0004125873,0.00047343504],"domain_scores_gemma":[0.9985062,0.00011331299,0.00020518433,0.0007363029,0.00012229799,0.00031671068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079349215,0.0003804131,0.00047500577,0.00013201077,0.00014481947,0.000055062344,0.00016310714,0.00011280632,0.000040191968],"category_scores_gemma":[0.000052866715,0.00020973296,0.00009862269,0.00036150956,0.000066700006,0.000100941616,0.000048274956,0.0001011964,0.0000535725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002008908,0.012130648,0.97522795,0.00008787094,0.00035050153,0.0008489765,0.0036844541,0.000006457854,0.001063985,0.00006305886,0.0012519902,0.0032752003],"study_design_scores_gemma":[0.044602424,0.0053453823,0.92741966,0.00094175024,0.0007214625,0.000058383284,0.0005190293,0.0000011422426,0.011067677,0.000003992836,0.008885791,0.0004333286],"about_ca_topic_score_codex":0.00018507012,"about_ca_topic_score_gemma":0.0015274317,"teacher_disagreement_score":0.047808312,"about_ca_system_score_codex":0.00045678538,"about_ca_system_score_gemma":0.0002449918,"threshold_uncertainty_score":0.8552662},"labels":[],"label_agreement":null},{"id":"W2559898561","doi":"10.1182/blood.v126.23.3927.3927","title":"Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Ifosfamide; Internal medicine; Oncology; Vinorelbine; Radiation therapy; Vincristine; Chemotherapy; Cyclophosphamide; ABVD; Vinblastine; Chemotherapy regimen; Cisplatin","score_opus":0.023640852799731753,"score_gpt":0.29485200536085504,"score_spread":0.27121115256112327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559898561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987893,0.004378733,0.00002720326,0.00058324944,0.0001117921,0.006394288,0.0005383149,0.00005575094,0.000017688299],"genre_scores_gemma":[0.99556446,0.0016539454,0.0005925255,0.00011208956,0.00026336548,0.0013990778,0.0003147222,0.00005752582,0.000042261687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973044,0.00052235066,0.00072028424,0.0005817773,0.00053472933,0.0003364771],"domain_scores_gemma":[0.99494374,0.002507864,0.0008095928,0.0013505891,0.00020913582,0.00017908313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065173296,0.00043045534,0.0010216532,0.00009076555,0.00018614122,0.000021002908,0.00025213545,0.00013408378,0.00001922967],"category_scores_gemma":[0.00021410566,0.0001977683,0.0002630243,0.00026337174,0.0002017948,0.000056952646,0.00004091269,0.000065778375,0.0000018623047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04542202,0.12159902,0.74224716,0.0000021517887,0.010104471,0.00053618656,0.005925262,0.000018523555,0.00016964495,0.000010099324,0.00066121976,0.07330424],"study_design_scores_gemma":[0.25055894,0.06458119,0.67324954,0.000034157132,0.0038003207,0.00017529879,0.0013349109,0.000006030605,0.005415746,0.000014850014,0.00068458286,0.00014442392],"about_ca_topic_score_codex":0.022071984,"about_ca_topic_score_gemma":0.0010751723,"teacher_disagreement_score":0.20513691,"about_ca_system_score_codex":0.00022116916,"about_ca_system_score_gemma":0.00055639085,"threshold_uncertainty_score":0.98444015},"labels":[],"label_agreement":null},{"id":"W2559903511","doi":"10.1182/blood.v110.11.4470.4470","title":"High Dose Aracytine, Rituximab, and Dexamethasone Based Chemotherapy for Elderly Patients with Mantle Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Chemotherapy; Chemotherapy regimen; Regimen; Gastroenterology; Dexamethasone; Surgery; Lymphoma","score_opus":0.005805039722158378,"score_gpt":0.2205581837468564,"score_spread":0.21475314402469803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559903511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976075,0.00037813906,0.00032886676,0.00023689358,0.000041481962,0.0009077774,0.000033421304,0.000047877078,0.0004179896],"genre_scores_gemma":[0.9747311,0.000030158979,0.024065543,0.00073684595,0.00008123214,0.000069920316,0.00009532629,0.00003776091,0.00015209653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998995,0.000008785336,0.00018730249,0.00030569683,0.00020289437,0.00030030706],"domain_scores_gemma":[0.9992318,0.00017134518,0.000085767235,0.000247169,0.000098289915,0.00016560567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001171061,0.00019664432,0.0003083977,0.00007182444,0.00006995522,0.000020492465,0.00004204761,0.0000781314,0.000033491193],"category_scores_gemma":[0.000015379599,0.00013885873,0.000060615494,0.00009490013,0.00004285507,0.000043751883,0.000008575838,0.00002714243,0.00000985612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002980056,0.03433109,0.8445679,0.0002249411,0.00032118178,0.00012201,0.00012326898,6.1527084e-7,0.0006911901,0.000076904216,0.00043130206,0.11612957],"study_design_scores_gemma":[0.17360306,0.0028409802,0.73606443,0.000071686954,0.0004195125,0.000010898103,0.000018558982,0.000014981452,0.084420115,0.000023015979,0.0023343677,0.00017839568],"about_ca_topic_score_codex":0.00009388489,"about_ca_topic_score_gemma":0.000018080544,"teacher_disagreement_score":0.170623,"about_ca_system_score_codex":0.000048547012,"about_ca_system_score_gemma":0.00006693772,"threshold_uncertainty_score":0.56624943},"labels":[],"label_agreement":null},{"id":"W2560151975","doi":"10.1158/1078-0432.ccr-16-1922","title":"Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Diffuse large B-cell lymphoma; Mutant; Cancer research; Lymphoma; Mutation; Biology; Gene; Genetics; Computational biology; Immunology","score_opus":0.17577848966985388,"score_gpt":0.49663357487402604,"score_spread":0.32085508520417216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560151975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557424,0.0022937756,0.000009276891,0.00095615984,0.00005928565,0.00048886216,0.0005271348,0.00000922367,0.000082057144],"genre_scores_gemma":[0.97494686,0.024492044,0.00007301176,0.00009686172,0.00006234849,0.00007325917,0.000038318154,0.000014106234,0.00020317224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963998,0.0007726205,0.0013695374,0.0006398255,0.00037277673,0.0004454049],"domain_scores_gemma":[0.98971504,0.008911161,0.00026252,0.00040134962,0.00039530953,0.0003146409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029211228,0.00016279983,0.0011711869,0.00033904632,0.000075872886,0.000011342489,0.000121412,0.00030065965,0.00011279567],"category_scores_gemma":[0.0046143467,0.00009908298,0.00026870522,0.0008752257,0.0009054963,0.00005529376,0.00020922789,0.0002112604,0.000008274426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011596306,0.009214923,0.9736028,0.00003061549,0.0007054388,0.00013863966,0.00006654304,6.916087e-7,0.00091305,0.000023144883,0.0002792151,0.013865316],"study_design_scores_gemma":[0.022945102,0.0017624942,0.97286147,0.0002041913,0.0004990307,0.0000029474766,0.000057010977,0.0004996725,0.00072761753,0.000051086514,0.00028498497,0.000104417224],"about_ca_topic_score_codex":0.00086739764,"about_ca_topic_score_gemma":0.0017815224,"teacher_disagreement_score":0.02219827,"about_ca_system_score_codex":0.00024566046,"about_ca_system_score_gemma":0.00041169277,"threshold_uncertainty_score":0.5524137},"labels":[],"label_agreement":null},{"id":"W2560172367","doi":"10.1182/blood.v124.21.1667.1667","title":"Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"clone (Java method); Germinal center; Tissue microarray; Diffuse large B-cell lymphoma; Immunohistochemistry; Context (archaeology); Lymphoma; Pathology; Biology; Gene expression profiling; Cancer research; Molecular biology; B cell; Antibody; Medicine; Gene; Gene expression; Immunology; Genetics","score_opus":0.021916762165122006,"score_gpt":0.26596518144859016,"score_spread":0.24404841928346815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560172367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959441,0.002623441,0.000056042765,0.0001433094,0.000034235043,0.00037734545,0.000024057483,0.0000061564615,0.00079132384],"genre_scores_gemma":[0.9987763,0.000754226,0.000282028,0.000079930425,0.000030706215,0.00001940211,0.000014401408,0.000012983787,0.000029978371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987973,0.00022414888,0.0003527476,0.00018482363,0.00025931303,0.00018164334],"domain_scores_gemma":[0.9984306,0.00064509717,0.00032904552,0.0004679972,0.000083499326,0.000043777552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004718757,0.00012377038,0.00029831252,0.00005253084,0.00004781034,0.000007054839,0.00009716907,0.000073798874,0.0000042137895],"category_scores_gemma":[0.00015153897,0.00006698342,0.00006339241,0.0001507644,0.00009274453,0.000043661246,0.000031999763,0.000039643648,0.0000011281177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021194352,0.013838971,0.75405365,0.0003435619,0.000049961283,0.000008981217,0.0037953274,0.0000014452648,0.22024524,0.001266642,0.0001944168,0.0059898705],"study_design_scores_gemma":[0.03295864,0.0004591987,0.530281,0.00045090547,0.0004299025,0.000014533872,0.0021380275,0.0010360806,0.42874137,0.00007356932,0.0032908292,0.00012593885],"about_ca_topic_score_codex":0.00020668081,"about_ca_topic_score_gemma":0.000022678205,"teacher_disagreement_score":0.22377264,"about_ca_system_score_codex":0.00004374467,"about_ca_system_score_gemma":0.00009875157,"threshold_uncertainty_score":0.27315047},"labels":[],"label_agreement":null},{"id":"W2560209617","doi":"10.1182/blood.v126.23.3978.3978","title":"Analysis of Minimal Residual Disease in Follicular Lymphoma Patients in Gadolin, a Phase III Study of Obinutuzumab Plus Bendamustine Versus Bendamustine in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Follicular lymphoma; Rituximab; Oncology; Surrogate endpoint; Gastroenterology; Lymphoma; Leukemia","score_opus":0.026164572999325782,"score_gpt":0.29756838606130903,"score_spread":0.27140381306198325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560209617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970288,0.00074802403,7.438453e-7,0.000030720763,0.00014400762,0.0017115494,0.0002091818,0.000020933754,0.000106017724],"genre_scores_gemma":[0.9989723,0.000060104947,0.000116500356,0.000026843001,0.000056501038,0.00026623593,0.00044076217,0.000045030232,0.000015753349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956058,0.0002495509,0.0016895033,0.00080107356,0.0010868057,0.00056722295],"domain_scores_gemma":[0.9975862,0.00023890441,0.00056476914,0.0008383967,0.0002865382,0.00048520064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005090782,0.00048755232,0.0017360031,0.001936831,0.000028388842,0.000011876945,0.00024368986,0.00018262134,0.000030923533],"category_scores_gemma":[0.0005364331,0.00044430932,0.0002813249,0.0024698924,0.0000939816,0.00011502666,0.0001995783,0.00011563601,0.000003994831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024957104,0.09552331,0.8659159,0.000105625186,0.0015852922,0.0021558611,0.005038308,0.0013881862,0.000057788053,0.0000038726457,0.00005092339,0.0032178143],"study_design_scores_gemma":[0.31439164,0.0063006156,0.67151386,0.00027432907,0.003616168,0.000002031634,0.0017056413,0.0013980974,0.00054266764,0.0000015124997,0.000015726358,0.0002376947],"about_ca_topic_score_codex":0.0092250435,"about_ca_topic_score_gemma":0.0051746843,"teacher_disagreement_score":0.28943452,"about_ca_system_score_codex":0.0016647985,"about_ca_system_score_gemma":0.0013752882,"threshold_uncertainty_score":0.99980086},"labels":[],"label_agreement":null},{"id":"W2560297658","doi":"10.1182/blood.v114.22.1948.1948","title":"High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; Lymphoma; Pathology; Internal medicine; Follicular lymphoma; Oncology; Chemotherapy; Chemotherapy regimen","score_opus":0.003814903704562985,"score_gpt":0.1905765277721619,"score_spread":0.18676162406759894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560297658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978441,0.00039613506,0.00001308232,0.00025569013,0.000019558525,0.0011801401,0.000024516023,0.00012466522,0.00014213864],"genre_scores_gemma":[0.99738973,0.000048864873,0.0010471991,0.0009410171,0.000028330798,0.000048087015,0.00020799445,0.0000652527,0.0002234967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794847,0.00004214743,0.00033833756,0.00060962304,0.00048075625,0.0005806567],"domain_scores_gemma":[0.9988554,0.0000359255,0.00015995087,0.000583454,0.00013699419,0.00022829088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007405418,0.00050322595,0.0009224225,0.00015204749,0.0001014176,0.00003912818,0.00011137465,0.00010083506,0.00002649605],"category_scores_gemma":[0.0000070447736,0.00029539593,0.00011285487,0.0003737926,0.00006508955,0.00010548135,0.000018405319,0.000108720466,0.00004035355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023865015,0.08675301,0.9075375,0.000034716126,0.0005068409,0.0013997442,0.00012614866,0.0000024862136,0.000049063885,0.00002199814,0.00004437088,0.0011376097],"study_design_scores_gemma":[0.3218719,0.0030856032,0.66200113,0.00016430729,0.0007806567,0.00011996897,0.000027705455,0.000010295337,0.011553327,0.000003206691,0.00009026543,0.00029166404],"about_ca_topic_score_codex":0.0005053224,"about_ca_topic_score_gemma":0.00013236399,"teacher_disagreement_score":0.3194854,"about_ca_system_score_codex":0.00028856183,"about_ca_system_score_gemma":0.00013016567,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2560333353","doi":"10.1182/blood.v106.11.4245.4245","title":"Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; Pegfilgrastim; CHOP; Haematopoiesis; Progenitor cell; Lymphoma; Medicine; Andrology; Rituximab; Chemotherapy; Stem cell; Immunology; Biology; Internal medicine; Neutropenia; Filgrastim","score_opus":0.006512409454660638,"score_gpt":0.20846990341093047,"score_spread":0.20195749395626983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560333353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529165,0.0006048316,0.00000514921,0.00006220099,0.00003190451,0.0032660398,0.0003239704,0.00007409341,0.00034014066],"genre_scores_gemma":[0.9966689,0.00018993363,0.002119896,0.000094863004,0.0000699056,0.00034651457,0.0002531801,0.00010936148,0.00014744251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996215,0.0001920735,0.00062292936,0.0009306264,0.0013370389,0.0007023743],"domain_scores_gemma":[0.99776113,0.00012616093,0.00041125613,0.00059592945,0.0006670123,0.0004385067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035859685,0.00068105076,0.00095055293,0.00033503547,0.000118929594,0.00007021942,0.000113385715,0.0002171737,0.00007224426],"category_scores_gemma":[0.00002122957,0.00045954227,0.0000755529,0.0005502811,0.00017796126,0.0002479035,0.000059737577,0.00013362494,0.000014989706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017801601,0.08814497,0.8997192,0.00022632469,0.0008290469,0.00029293058,0.00078216253,0.000021583663,0.0044718254,0.0000015131212,0.00013475123,0.0035955412],"study_design_scores_gemma":[0.29716846,0.0050149863,0.49227327,0.00039676318,0.0061809407,0.00003940729,0.00015530216,0.0003039245,0.19789863,0.0000012512642,0.00010232344,0.0004647422],"about_ca_topic_score_codex":0.0002605881,"about_ca_topic_score_gemma":0.0007261921,"teacher_disagreement_score":0.4074459,"about_ca_system_score_codex":0.00014901544,"about_ca_system_score_gemma":0.00038734247,"threshold_uncertainty_score":0.9997856},"labels":[],"label_agreement":null},{"id":"W2560645318","doi":"10.1182/blood.v116.21.3567.3567","title":"Rituximab Purging and Maintenance Improves Progression Free Survival but Not Overall Survival In Patients with Relapsed or Resistant Follicular Lymphoma Prior Receiving An Autologous Transplant","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Maintenance therapy; Chemotherapy; Rituximab; Internal medicine; Surgery; Progression-free survival; Chemotherapy regimen; Lymphoma; Transplantation; Clinical endpoint; Gastroenterology; Autologous stem-cell transplantation; Oncology; Clinical trial","score_opus":0.007361580718688364,"score_gpt":0.22749481188854798,"score_spread":0.2201332311698596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560645318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980278,0.00012201642,0.00000410135,0.00029144756,0.00019016473,0.0010330573,0.00007510701,0.000100091784,0.00015623671],"genre_scores_gemma":[0.99631226,0.000059118745,0.003212694,0.00006741566,0.000056468736,0.000113794275,0.00006844008,0.00005136296,0.000058440437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778134,0.00009218386,0.00040243365,0.0006535923,0.0005357545,0.0005346982],"domain_scores_gemma":[0.99874425,0.00014272823,0.00016050103,0.0006069826,0.00009656576,0.00024894363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034010885,0.00034371138,0.00064262166,0.00011494917,0.00015461615,0.00006528458,0.00015288034,0.00018665858,0.000012192596],"category_scores_gemma":[0.00015328749,0.00021296712,0.00006769269,0.00014092337,0.00010648591,0.00018950686,0.00005799346,0.00017838128,0.000001958133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072375727,0.009010053,0.94855934,0.00018675017,0.00020654598,0.0018296542,0.000524527,2.7348517e-7,0.0118480725,0.00021085527,0.0000071065147,0.020379227],"study_design_scores_gemma":[0.067570195,0.002262513,0.9212164,0.00066426507,0.0002969713,0.000092976356,0.00006412724,0.000047510533,0.0073750024,0.000022281018,0.00009597322,0.00029173782],"about_ca_topic_score_codex":0.0004937415,"about_ca_topic_score_gemma":0.0018486409,"teacher_disagreement_score":0.06033262,"about_ca_system_score_codex":0.00008220059,"about_ca_system_score_gemma":0.00020217731,"threshold_uncertainty_score":0.8684547},"labels":[],"label_agreement":null},{"id":"W2560907445","doi":"10.1200/jco.2011.29.15_suppl.tps226","title":"PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Bortezomib; Vincristine; Internal medicine; Rituximab; Oncology; International Prognostic Index; Lymphoma; Cyclophosphamide; Chemotherapy; Multiple myeloma","score_opus":0.08384203089736851,"score_gpt":0.41520540604603934,"score_spread":0.3313633751486708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560907445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150807,0.0054105753,0.00007180166,0.00051051204,0.0005817411,0.0015179917,0.000015841757,0.000014062962,0.00036943037],"genre_scores_gemma":[0.9810669,0.014583221,0.0030539217,0.00066963973,0.0002312726,0.00010803714,0.000009583331,0.000046784782,0.00023068397],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945412,0.0006181085,0.0034684653,0.00046792632,0.00047042148,0.00043383223],"domain_scores_gemma":[0.9923166,0.0025783824,0.0035374705,0.0003658849,0.00086117233,0.00034047934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036107555,0.00040734973,0.0040342775,0.00033443936,0.00012953223,0.000015740585,0.00021562401,0.00034800175,0.00008275137],"category_scores_gemma":[0.0013433285,0.00023667322,0.00053866685,0.00030421026,0.00076492125,0.00024138311,0.00012351832,0.00038788316,0.00000458808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49927682,0.15504226,0.3124114,0.000177767,0.0029957031,0.0020919552,0.008028353,4.1103007e-7,0.0015432177,0.000027073746,0.00054497534,0.017860053],"study_design_scores_gemma":[0.8195368,0.024013089,0.14533451,0.00039352986,0.0013620723,0.0002668756,0.0013364074,0.00016435157,0.006769563,0.00007650448,0.00051049277,0.00023577335],"about_ca_topic_score_codex":0.00009055516,"about_ca_topic_score_gemma":0.00011542582,"teacher_disagreement_score":0.32026002,"about_ca_system_score_codex":0.00039361612,"about_ca_system_score_gemma":0.0013111997,"threshold_uncertainty_score":0.9651254},"labels":[],"label_agreement":null},{"id":"W2560990514","doi":"","title":"Primary sino-nasal T cell lymphoma in a young female: A rare case report","year":2016,"lang":"en","type":"article","venue":"Annals of Pathology and Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Histopathology; Lymphoma; Radiation therapy; Immunohistochemistry; Chemotherapy; Girl; Young adult; Dermatology; Pathology; Surgery; Internal medicine","score_opus":0.02969244379743754,"score_gpt":0.30857718093630143,"score_spread":0.2788847371388639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560990514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833357,0.007216099,0.0000075108387,0.0058833887,0.00017180125,0.0002660197,0.000050668143,0.000027114775,0.0030417165],"genre_scores_gemma":[0.9957642,0.0013105823,0.00010313666,0.0022611793,0.00014544,0.000044220535,0.000024795017,0.00001725344,0.0003291893],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9984265,0.0001363717,0.0005506879,0.00040189788,0.00018872792,0.00029580077],"domain_scores_gemma":[0.9986975,0.00021287028,0.00021913486,0.00040104147,0.00026574178,0.00020370791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070584036,0.00021138471,0.0006674611,0.00021352587,0.000046389636,0.0000019816748,0.00004560035,0.00019341122,0.00010038872],"category_scores_gemma":[0.00032379435,0.0001243528,0.0000483742,0.0002604964,0.00046141096,0.00008576303,0.00004199562,0.00006257779,0.000007776886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033568378,0.0007339993,0.44823107,0.00016135674,0.00004681833,0.5334735,0.00073347753,3.075056e-8,0.0064993976,0.00011472271,0.0026870663,0.00698287],"study_design_scores_gemma":[0.01619718,0.0021187887,0.85271287,0.00084423576,0.00019238763,0.10392022,0.00094264065,0.0000010162813,0.019676734,0.00009878352,0.0030645782,0.00023054372],"about_ca_topic_score_codex":0.00009971186,"about_ca_topic_score_gemma":0.0000998734,"teacher_disagreement_score":0.42955327,"about_ca_system_score_codex":0.000040257255,"about_ca_system_score_gemma":0.00024267609,"threshold_uncertainty_score":0.507096},"labels":[],"label_agreement":null},{"id":"W2561128146","doi":"10.1111/bjh.14449","title":"Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Ifosfamide; Salvage therapy; Internal medicine; Cytarabine; Oncology; Melphalan; Autologous stem-cell transplantation; Chemotherapy; Carboplatin; Surgery; Refractory (planetary science); Cisplatin","score_opus":0.008487921881119955,"score_gpt":0.23021511396207464,"score_spread":0.22172719208095468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561128146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80620587,0.0028350411,0.0000026895814,0.19008534,0.00025338057,0.00046848756,0.00011760987,0.00001251065,0.000019058361],"genre_scores_gemma":[0.8876316,0.0015816474,0.0009629198,0.10787575,0.001195007,0.000041382496,0.00019996276,0.00015331483,0.0003584324],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99708396,0.0004637401,0.000943783,0.00048943184,0.0004946949,0.00052438106],"domain_scores_gemma":[0.99759597,0.0005406256,0.0009886038,0.0003034353,0.000430477,0.00014089134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041452557,0.0004110988,0.0018077542,0.00041265762,0.000066558016,0.000051362244,0.00017696945,0.00048520768,0.00013366812],"category_scores_gemma":[0.00024175229,0.00031194097,0.0001346211,0.00013036875,0.00028499204,0.00012383322,0.00004966097,0.0005775323,0.000010771939],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012279464,0.0020724088,0.18007591,0.0005168487,0.0010259739,0.24628364,0.00014162884,1.5621859e-7,0.000057713423,0.0000055777928,0.47715732,0.08038337],"study_design_scores_gemma":[0.03554742,0.0026602892,0.66444427,0.004139508,0.0002500969,0.10092612,0.000008468862,3.570512e-7,0.0001881955,0.00004676349,0.19146556,0.00032294978],"about_ca_topic_score_codex":0.00013519294,"about_ca_topic_score_gemma":0.000027347916,"teacher_disagreement_score":0.48436835,"about_ca_system_score_codex":0.00042084677,"about_ca_system_score_gemma":0.00058148353,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2561288620","doi":"10.1158/1538-7445.am2015-3941","title":"Abstract 3941: Recurrent IL4R mutations in primary mediastinal large B cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Biology; Signal transduction; Genetics","score_opus":0.12411493138617716,"score_gpt":0.42216080363062897,"score_spread":0.2980458722444518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561288620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682873,0.005461462,0.0000020293735,0.0019454715,0.00021986681,0.0005547129,0.00006102884,0.000027167656,0.02344096],"genre_scores_gemma":[0.9973518,0.00067044614,0.00011582211,0.00014807328,0.0002639528,0.0006023937,0.00011624664,0.000022188995,0.0007090386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784595,0.000084474275,0.00024594448,0.00033074085,0.0009069186,0.0005859723],"domain_scores_gemma":[0.9987046,0.00019910852,0.000037942795,0.0002780007,0.00034054884,0.00043979965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008226145,0.00012657019,0.00023476558,0.00027955577,0.000078118945,0.000031299172,0.00011998422,0.00007690815,0.00031963925],"category_scores_gemma":[0.00015909498,0.000103239705,0.000057919053,0.0004844717,0.00009789792,0.00008528637,0.00008820834,0.00020341716,0.0003669603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025347588,0.020693125,0.5318561,0.0011622445,0.00018212215,0.0040954743,0.007645714,0.00003858112,0.0049061486,0.00050788635,0.14063832,0.28573954],"study_design_scores_gemma":[0.016584873,0.00050144177,0.9279855,0.0003709809,0.000030442987,0.000024350727,0.000832318,0.00004749397,0.00684899,0.0001878478,0.046425335,0.00016046334],"about_ca_topic_score_codex":0.00089784263,"about_ca_topic_score_gemma":0.00031530493,"teacher_disagreement_score":0.39612937,"about_ca_system_score_codex":0.0022335374,"about_ca_system_score_gemma":0.0021299631,"threshold_uncertainty_score":0.5840622},"labels":[],"label_agreement":null},{"id":"W2561561373","doi":"10.1182/blood.v116.21.1753.1753","title":"Pralatrexate Is Effective In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with Prior Ifosfamide, Carboplatin, and Etoposide (ICE)-Based Regimens","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ifosfamide; Carboplatin; Regimen; Internal medicine; Etoposide; Oncology; Surgery; Chemotherapy regimen; Rituximab; Chemotherapy; Lymphoma; Cisplatin","score_opus":0.003302812425045068,"score_gpt":0.19966496025942582,"score_spread":0.19636214783438075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561561373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965287,0.00015476663,0.000001015155,0.00021267752,0.00005779877,0.0017128923,0.000023401908,0.00006332897,0.0012454494],"genre_scores_gemma":[0.9967352,0.000013447907,0.0020522042,0.00047443007,0.00004690789,0.00023876416,0.000040658942,0.00006299101,0.00033538186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983399,0.00006435746,0.0002602951,0.0005785122,0.00037719446,0.00037977853],"domain_scores_gemma":[0.9987754,0.00018783755,0.00018257285,0.00048516074,0.00013137351,0.00023764404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099917306,0.00036840342,0.00049247267,0.00012776132,0.00009501838,0.000036986516,0.00006414046,0.00017721619,0.000050591432],"category_scores_gemma":[0.000043870165,0.00022105449,0.000052759442,0.00023041012,0.00012686012,0.00011889162,0.000028156555,0.00019781763,0.000009039696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003702011,0.00670959,0.98262155,0.000110399975,0.00020907189,0.00049272075,0.0006928707,0.0000014121972,0.0011468726,0.000005949291,0.00007765392,0.004229887],"study_design_scores_gemma":[0.0850478,0.00607137,0.8880758,0.00029840771,0.000560142,0.000044534343,0.00005060805,0.000035296343,0.019142266,0.000002774061,0.00038576007,0.0002851973],"about_ca_topic_score_codex":0.00043197768,"about_ca_topic_score_gemma":0.0007140789,"teacher_disagreement_score":0.094545715,"about_ca_system_score_codex":0.00014250247,"about_ca_system_score_gemma":0.0003467703,"threshold_uncertainty_score":0.90143406},"labels":[],"label_agreement":null},{"id":"W2561792671","doi":"10.1371/journal.pmed.1002197","title":"Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study","year":2016,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"BC Cancer Foundation; Terry Fox Research Institute","keywords":"Somatic evolution in cancer; Biology; Population; Follicular lymphoma; Pathology; Genetics; Lymphoma; Cancer; Immunology; Medicine","score_opus":0.025083179614059956,"score_gpt":0.29153976994297864,"score_spread":0.26645659032891866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561792671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882397,0.001712616,0.00008387383,0.008131988,0.000054514556,0.0010155062,0.0000016162561,0.000046541383,0.0007136496],"genre_scores_gemma":[0.99928486,0.000160317,0.00007855557,0.00011879858,0.00008910783,0.00020036132,0.000009483062,0.0000075442294,0.000050990908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988639,0.00006066091,0.0002950828,0.00023511804,0.00037002537,0.00017524436],"domain_scores_gemma":[0.99955654,0.00008576076,0.00005512431,0.0001340149,0.000044468063,0.0001241193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020380747,0.00013334624,0.0003280434,0.00013649887,0.000042388816,0.0000025247964,0.000029474817,0.00006895755,0.000073166935],"category_scores_gemma":[0.00013322957,0.000061561266,0.000028060638,0.00013343127,0.00009840502,0.00008170483,0.000013234128,0.000031400043,0.000013836773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006109732,0.0047997828,0.8720624,0.00006568592,0.00009952953,0.00039095644,0.0016198403,6.648124e-8,0.0052738716,0.00078813895,0.00024075735,0.11404801],"study_design_scores_gemma":[0.02307566,0.0032235333,0.9705606,0.0008350486,0.00023621197,0.00012051403,0.00042437948,0.00008165391,0.0006140202,0.00021558102,0.00052732165,0.0000854375],"about_ca_topic_score_codex":0.00005928873,"about_ca_topic_score_gemma":0.000021432685,"teacher_disagreement_score":0.113962576,"about_ca_system_score_codex":0.00039616151,"about_ca_system_score_gemma":0.00004435312,"threshold_uncertainty_score":0.25103956},"labels":[],"label_agreement":null},{"id":"W2562042122","doi":"10.1093/bioinformatics/btw810","title":"Defining the clonality of peripheral T cell lymphomas using RNA-seq","year":2016,"lang":"en","type":"article","venue":"Bioinformatics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"RNA-Seq; Computational biology; RNA; Peripheral T-cell lymphoma; Peripheral; Biology; Virology; Computer science; T cell; Transcriptome; Genetics; Gene; Gene expression; Immune system","score_opus":0.02078213201240974,"score_gpt":0.26595058587321707,"score_spread":0.24516845386080732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562042122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775171,0.0006064319,0.00078594655,0.00057281187,0.00014573029,0.00024418198,0.00004030684,0.000030682826,0.020056799],"genre_scores_gemma":[0.9881118,0.000083495666,0.011238278,0.00031868526,0.000038147475,0.000006450903,0.000005655545,0.000008460039,0.00018905614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912965,0.000015003366,0.00036940837,0.00006402944,0.00024058453,0.00018130224],"domain_scores_gemma":[0.9992704,0.00011179802,0.00017838931,0.00029900952,0.0000694743,0.00007095447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015676166,0.00011405565,0.00020446652,0.000029144256,0.00007342379,0.0000129977125,0.00007613416,0.000053253745,0.00010170096],"category_scores_gemma":[0.000045088378,0.000050947983,0.000116648225,0.00008418899,0.00009685448,0.00010032461,0.00004828021,0.000023916515,0.000044922843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042378315,0.0015556075,0.67768544,0.0011760895,0.0006180387,0.00005322083,0.0076234704,0.00007128957,0.005945957,0.031316094,0.005064078,0.26846692],"study_design_scores_gemma":[0.03341775,0.0018986057,0.47088388,0.0022107838,0.001677598,0.0007469273,0.004637301,0.030162986,0.40488395,0.0011423734,0.047146678,0.001191182],"about_ca_topic_score_codex":0.00007084876,"about_ca_topic_score_gemma":0.0000025945678,"teacher_disagreement_score":0.398938,"about_ca_system_score_codex":0.00018607175,"about_ca_system_score_gemma":0.00018702752,"threshold_uncertainty_score":0.20775984},"labels":[],"label_agreement":null},{"id":"W2562058298","doi":"10.1182/blood.v112.11.2815.2815","title":"Combined FOXP3+ and PD1+ T Cell Density and Architectural Patterns Predict Overall Survival and Risk of Transformation in Uniformly Treated Patients with Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; FOXP3; Oncology; Lymphoma; Univariate analysis; Germinal center; Tissue microarray; Survival analysis; Antibody; Immunology; Multivariate analysis; Cancer; B cell; Immune system","score_opus":0.004769795071634621,"score_gpt":0.17548887306491065,"score_spread":0.17071907799327604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562058298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991058,0.00013268871,0.0000078023595,0.000023148048,0.000008186252,0.00053703494,0.00006933309,0.000015276994,0.00010072238],"genre_scores_gemma":[0.9992322,0.00053519825,0.00007994195,0.000012084435,0.000005664762,0.000013101975,0.00010573839,0.000009732777,0.0000063752286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992839,0.000042585758,0.0001909636,0.00017222791,0.00017036412,0.00013995683],"domain_scores_gemma":[0.99963075,0.000046127054,0.00007400821,0.000104108374,0.0000475758,0.00009740541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004833351,0.00014912002,0.00029730238,0.00007296405,0.000053490832,0.000006899305,0.000016895288,0.000053173797,0.0000017352969],"category_scores_gemma":[0.000007772344,0.000101816346,0.0000248352,0.0000696743,0.000061844636,0.000070526265,0.000013692896,0.000035614685,1.9007788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005176495,0.0013411962,0.9952029,0.00009639199,0.00014668687,0.00005307961,0.00085343485,0.0000015224751,0.00005310493,0.0000059947424,0.0000010083111,0.0017270349],"study_design_scores_gemma":[0.04544071,0.0016158111,0.9452522,0.00008690914,0.00040234663,0.0000615877,0.00003497096,0.00010334536,0.006896192,0.000009667016,0.0000024334518,0.000093872375],"about_ca_topic_score_codex":0.0013163197,"about_ca_topic_score_gemma":0.00023593592,"teacher_disagreement_score":0.04995074,"about_ca_system_score_codex":0.000022168435,"about_ca_system_score_gemma":0.000024948791,"threshold_uncertainty_score":0.41519502},"labels":[],"label_agreement":null},{"id":"W2562226353","doi":"10.1182/blood.v120.21.5106.5106","title":"Outcome of Young Children with Non-Hodgkin's Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Anaplastic large-cell lymphoma; Internal medicine; Incidence (geometry); Pediatrics; Lymphoblastic lymphoma; Gastroenterology; Immunology; T cell","score_opus":0.011676017144236835,"score_gpt":0.2518759554987278,"score_spread":0.240199938354491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562226353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927424,0.00054104894,0.000006492316,0.00006879778,0.000057685596,0.00026627327,0.000010806851,0.000027835744,0.006278622],"genre_scores_gemma":[0.99841565,0.000022307213,0.0010418567,0.00010446841,0.0001567936,0.000031431373,0.000019235571,0.000018772655,0.00018947126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992689,0.000008770368,0.00016987015,0.00012152769,0.00019840217,0.0002325577],"domain_scores_gemma":[0.9994643,0.000017482625,0.00006676827,0.000277043,0.00003363811,0.00014077076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062805884,0.00012464079,0.00027004036,0.00004682624,0.000027022923,0.0000048141133,0.00004606597,0.000047303667,0.00005497926],"category_scores_gemma":[0.000010709753,0.00007941049,0.0000761372,0.00009318783,0.000035140627,0.000059351012,0.000023103898,0.000021639376,0.00005655671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031859385,0.0033324035,0.9935405,0.000018179886,0.00042181075,0.000015634476,0.00015174053,9.555437e-8,0.0001606438,0.00011416943,0.00010691932,0.002106045],"study_design_scores_gemma":[0.009706169,0.000401981,0.96354306,0.000043208474,0.00077750435,0.00041357445,0.000023175546,5.6049214e-7,0.024864627,0.0000021891385,0.00013773177,0.00008619991],"about_ca_topic_score_codex":0.00021089436,"about_ca_topic_score_gemma":0.000007999795,"teacher_disagreement_score":0.02999742,"about_ca_system_score_codex":0.00003035459,"about_ca_system_score_gemma":0.000033465123,"threshold_uncertainty_score":0.32382658},"labels":[],"label_agreement":null},{"id":"W2562336370","doi":"10.1182/blood.v118.21.443.443","title":"Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma: A Phase 2 Study Update","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; CD30; Refractory (planetary science); Phases of clinical research; Adverse effect; Lymphoma; Clinical trial; Surgery; Gastroenterology","score_opus":0.012372046938557585,"score_gpt":0.2338100124608789,"score_spread":0.2214379655223213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562336370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720216,0.00035392947,0.0000031313803,0.000006728746,0.00013019597,0.0016042776,0.00006386075,0.000078316494,0.0005574073],"genre_scores_gemma":[0.99922615,0.000030212213,0.00014006598,0.00008334611,0.000037623515,0.00021453206,0.00008192092,0.00005208798,0.00013404991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980564,0.00010431163,0.00046560564,0.0005132768,0.00039981926,0.0004606039],"domain_scores_gemma":[0.9988965,0.000058061127,0.00019730275,0.00054991676,0.00008661165,0.00021164476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014351301,0.00032031766,0.00056103175,0.00019743537,0.00006987475,0.000017134249,0.00012159323,0.00009169804,0.00015437935],"category_scores_gemma":[0.000036971796,0.00020756123,0.00006682947,0.00030410223,0.000027270293,0.000107918306,0.000057946392,0.0000880523,0.00016328426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004247137,0.21244517,0.77870834,0.00011474852,0.00029209643,0.0016592373,0.0014139826,1.3399928e-7,0.00001547524,0.000005233268,0.00014049391,0.0009579706],"study_design_scores_gemma":[0.33619443,0.016770227,0.643529,0.00040593543,0.0011521761,0.000048537866,0.00066740165,0.0000100899315,0.00076940935,0.0000013429449,0.00018227701,0.00026916643],"about_ca_topic_score_codex":0.00014246754,"about_ca_topic_score_gemma":0.00014238857,"teacher_disagreement_score":0.3319473,"about_ca_system_score_codex":0.00020323248,"about_ca_system_score_gemma":0.00022255832,"threshold_uncertainty_score":0.8464101},"labels":[],"label_agreement":null},{"id":"W2562355380","doi":"10.1093/jnci/djw249","title":"Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations","year":2016,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Lymphoma; Hodgkin lymphoma; Intensive care medicine; Scope (computer science); Oncology; Internal medicine","score_opus":0.29015835067346224,"score_gpt":0.5290124720595307,"score_spread":0.23885412138606849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562355380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025544822,0.982999,0.000005834495,0.0021991627,0.0130120525,0.00076035707,0.00035605783,0.000005815252,0.00040621797],"genre_scores_gemma":[0.0001310304,0.9933108,0.00014868207,0.00024056526,0.0058111353,0.00007673154,0.00002714831,0.0000193654,0.00023450893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971304,0.00020136114,0.0014580402,0.00022239379,0.00079491484,0.00019291005],"domain_scores_gemma":[0.99692446,0.00047201043,0.0016378033,0.00015697528,0.00057572266,0.00023302507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073683826,0.00026884768,0.0012495422,0.0002076664,0.0001401579,0.000041672447,0.0002067787,0.0001741761,0.00010037919],"category_scores_gemma":[0.0008109851,0.00012610666,0.001034415,0.0002054144,0.00016401248,0.00017811866,0.000098597586,0.0003025472,0.000016863536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071296864,0.00052524364,0.0002082911,0.00043997436,0.00090405205,0.0000075456915,0.000007229698,2.1648376e-7,1.5182717e-8,0.00048681788,0.025503237,0.9712044],"study_design_scores_gemma":[0.027769972,0.000252054,0.0008836368,0.014633486,0.002122267,0.00024971616,9.624184e-7,4.6972218e-7,3.92094e-7,0.00017226362,0.95379174,0.00012306993],"about_ca_topic_score_codex":0.000015711757,"about_ca_topic_score_gemma":0.000021768607,"teacher_disagreement_score":0.9710813,"about_ca_system_score_codex":0.0020275752,"about_ca_system_score_gemma":0.0066086664,"threshold_uncertainty_score":0.99902296},"labels":[],"label_agreement":null},{"id":"W2562782982","doi":"10.1182/blood.v106.11.2817.2817","title":"Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Anaplastic large-cell lymphoma; Lymphoma; Peripheral T-cell lymphoma; CHOP; Stage (stratigraphy); Gastroenterology; Chemotherapy; Diffuse large B-cell lymphoma; T-cell lymphoma; Cancer; Not Otherwise Specified; Chemotherapy regimen; Oncology; T cell; Immunology","score_opus":0.013269817168679211,"score_gpt":0.2467155649051114,"score_spread":0.2334457477364322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562782982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840469,0.0013766575,0.000016961325,0.0010595972,0.00013532772,0.0006135915,0.0003091517,0.00010621742,0.012335641],"genre_scores_gemma":[0.9878063,0.0002850654,0.0015277459,0.0023353444,0.00027283988,0.00006926328,0.00007796954,0.00007316961,0.007552309],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768203,0.00006168359,0.0005108681,0.0005467287,0.00056429364,0.0006344024],"domain_scores_gemma":[0.9983698,0.00009245731,0.0001485329,0.00078307284,0.00014299274,0.00046315353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015586804,0.00039482632,0.00067255064,0.00015502052,0.00009719543,0.000032914224,0.0001952916,0.00017503154,0.0005070706],"category_scores_gemma":[0.00003585069,0.00033614077,0.00031602388,0.0003224501,0.000043040287,0.00009085864,0.00012623587,0.000045254375,0.0002794877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014212113,0.44203496,0.44868582,0.0007869055,0.0013532562,0.0013326129,0.006717608,0.000017042767,0.04882552,0.00039588413,0.01990416,0.028525028],"study_design_scores_gemma":[0.18245666,0.0017855223,0.108831435,0.00013709864,0.0010326342,0.000046366808,0.0005695609,0.0002500173,0.49787384,0.000006177524,0.20637399,0.000636705],"about_ca_topic_score_codex":0.0001363266,"about_ca_topic_score_gemma":0.00006620297,"teacher_disagreement_score":0.4490483,"about_ca_system_score_codex":0.00022338043,"about_ca_system_score_gemma":0.00021742073,"threshold_uncertainty_score":0.99990904},"labels":[],"label_agreement":null},{"id":"W2562819987","doi":"10.1182/blood.v120.21.2645.2645","title":"Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Biology; Primary immunodeficiency; Pathology; Molecular biology; Cancer research; Medicine","score_opus":0.009947555100507273,"score_gpt":0.24130619415743457,"score_spread":0.2313586390569273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562819987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979201,0.0012717868,0.000008163474,0.00022969847,0.000042716478,0.00028853046,0.000118743614,0.0000041405456,0.000116149466],"genre_scores_gemma":[0.9990066,0.00006827114,0.00077085465,0.000032385466,0.000040697927,0.000021805407,0.00001704065,0.0000063397747,0.000036002555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994625,0.00002982426,0.00018051294,0.00007755782,0.00013972397,0.000109920526],"domain_scores_gemma":[0.99948734,0.00010401966,0.00013343281,0.00015602993,0.00005373128,0.00006545582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010002904,0.00006903773,0.00020059117,0.00006190731,0.000030446612,0.0000031038305,0.000036732188,0.000035982623,0.000054385197],"category_scores_gemma":[0.00006326278,0.00004479032,0.00004237432,0.0001130614,0.00003945257,0.000024594536,0.000026388157,0.000030673033,0.0000040794807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003624134,0.0017853369,0.9217673,0.00026251914,0.0003421269,0.000013924877,0.004411857,7.5744083e-7,0.069316216,0.00020778376,0.00013932452,0.0017165944],"study_design_scores_gemma":[0.0013217153,0.00017411256,0.9130389,0.000163439,0.00046366884,0.000017643564,0.00035101912,9.820532e-7,0.0842205,0.000015701053,0.00019380897,0.000038479982],"about_ca_topic_score_codex":0.000042978034,"about_ca_topic_score_gemma":0.000010133065,"teacher_disagreement_score":0.014904286,"about_ca_system_score_codex":0.00001203873,"about_ca_system_score_gemma":0.00002455781,"threshold_uncertainty_score":0.18264961},"labels":[],"label_agreement":null},{"id":"W2563154257","doi":"10.1182/blood.v126.23.2736.2736","title":"Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Chemotherapy regimen; Oncology; Refractory (planetary science); Clinical endpoint; Lymphoma; Chemotherapy; Surgery; CD30; Clinical trial","score_opus":0.045830691656711095,"score_gpt":0.3027311426956338,"score_spread":0.2569004510389227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563154257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818933,0.00014256593,0.0000012034923,0.000031743803,0.00008510018,0.0008612941,0.00038690292,0.000035365145,0.0002664685],"genre_scores_gemma":[0.9984382,0.000006765298,0.00091352256,0.00001801482,0.00005081891,0.000038570775,0.00042235656,0.00003122398,0.00008056703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788976,0.00024721725,0.00047837934,0.0005213758,0.00060052105,0.00026276524],"domain_scores_gemma":[0.9982096,0.00033734407,0.00022759462,0.00090862426,0.00013212828,0.00018469366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003204928,0.0002295353,0.000549936,0.000121792924,0.00004563965,0.000023444796,0.000204968,0.000074534866,0.00003520969],"category_scores_gemma":[0.0005152595,0.00015844738,0.000030488709,0.00026492556,0.000052388892,0.00019216555,0.00014126224,0.000082424485,0.000011698605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012298116,0.06873896,0.91330063,0.000016210637,0.00038127525,0.0005241168,0.0011224824,9.842936e-7,0.00009514098,0.0000016179348,0.00018450075,0.003335989],"study_design_scores_gemma":[0.19226955,0.01200019,0.79104346,0.00022239146,0.0005192829,0.0000087181115,0.003093856,0.000034007808,0.0005937082,0.0000025101072,0.000053827836,0.00015847562],"about_ca_topic_score_codex":0.0023448085,"about_ca_topic_score_gemma":0.0010268426,"teacher_disagreement_score":0.17997143,"about_ca_system_score_codex":0.00010840074,"about_ca_system_score_gemma":0.00056200585,"threshold_uncertainty_score":0.64612967},"labels":[],"label_agreement":null},{"id":"W2563214243","doi":"10.1182/blood.v104.11.3124.3124","title":"Who Actually Detects Relapse in Hodgkin Lymphoma: Patient or Physician?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Asymptomatic; Internal medicine; Chemotherapy regimen; Surgery; Chest radiograph; B symptoms; Radiological weapon; Lymphoma; Cancer; Lung","score_opus":0.010922055954945841,"score_gpt":0.23675074411869718,"score_spread":0.22582868816375135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563214243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528474,0.0005542438,0.000003283553,0.00036645264,0.00007849805,0.0004329474,0.00000777805,0.000061643026,0.003210433],"genre_scores_gemma":[0.9974964,0.0001303794,0.0006938515,0.0013124819,0.00009135934,0.000112693924,0.000012165543,0.000027121367,0.00012351776],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988841,0.000020767988,0.00024008391,0.00029969495,0.00024750087,0.00030788087],"domain_scores_gemma":[0.9993949,0.00005049415,0.00006628871,0.00031977997,0.000035157147,0.00013335682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004202081,0.00019226318,0.00032250964,0.000096275486,0.00004322527,0.000016608512,0.000060842398,0.00008752132,0.000028922796],"category_scores_gemma":[0.00006381627,0.00013584392,0.00009783791,0.0002500495,0.00002835431,0.000065639666,0.000039784776,0.000050321563,0.00014407143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002712517,0.10132217,0.11844848,0.0004126575,0.0016035655,0.02705348,0.016342327,0.00014865272,0.010875214,0.0024415702,0.002329571,0.7163098],"study_design_scores_gemma":[0.09106744,0.005745415,0.512804,0.001231229,0.00067054905,0.0004476227,0.0006634078,0.000009819115,0.38187805,0.0006253727,0.0042874496,0.00056967215],"about_ca_topic_score_codex":0.00014687088,"about_ca_topic_score_gemma":0.00018542602,"teacher_disagreement_score":0.71574014,"about_ca_system_score_codex":0.0002488314,"about_ca_system_score_gemma":0.00026036732,"threshold_uncertainty_score":0.5539554},"labels":[],"label_agreement":null},{"id":"W2563219666","doi":"10.1182/blood.v116.21.2402.2402","title":"Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Surgery; Autologous stem-cell transplantation; Salvage therapy; Melphalan; Ifosfamide; Oncology; Hematopoietic stem cell transplantation; Progression-free survival; Cyclophosphamide; Chemotherapy regimen; Population; Transplantation; Chemotherapy","score_opus":0.005745132555379219,"score_gpt":0.2060522370650419,"score_spread":0.20030710450966266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563219666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831146,0.0005311335,0.000014598483,0.00008574577,0.000100423014,0.00062460674,0.000032284785,0.000047765472,0.00025197913],"genre_scores_gemma":[0.9986215,0.00023810174,0.0007797186,0.000064995875,0.000054557102,0.00007283308,0.000030520427,0.000019914984,0.000117856885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993244,0.000011939132,0.00012501935,0.00026633398,0.00010480608,0.00016751714],"domain_scores_gemma":[0.9996009,0.000030839827,0.000057474106,0.00015225403,0.000036926318,0.000121633835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052962736,0.00013928876,0.00020113058,0.000043015523,0.00007061079,0.000016671942,0.000024189563,0.00011279915,0.000002727533],"category_scores_gemma":[0.000003531618,0.00009897974,0.000031803746,0.00003355831,0.0000465143,0.000048053447,0.000006727674,0.00005125121,0.0000023294485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001835292,0.0033371826,0.9288617,0.0008005718,0.00012656959,0.00025244878,0.0009261625,3.672096e-8,0.011430116,0.000050918905,0.00009721726,0.052281793],"study_design_scores_gemma":[0.038465213,0.001610081,0.9310245,0.00040512308,0.00067745254,0.00065531046,0.00008948768,0.000025120387,0.026342709,0.0000062362014,0.00055722904,0.00014155018],"about_ca_topic_score_codex":0.00005589517,"about_ca_topic_score_gemma":0.00010974959,"teacher_disagreement_score":0.052140243,"about_ca_system_score_codex":0.000012946527,"about_ca_system_score_gemma":0.00004203628,"threshold_uncertainty_score":0.4036277},"labels":[],"label_agreement":null},{"id":"W2563222460","doi":"10.1093/ajcp/144.suppl2.196","title":"Pathologist Survey Reveals Inadequate Awareness of the Importance of High-Quality CD30 Staining in Accurate Diagnosis of T-Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Seagen (Canada)","funders":"","keywords":"Pathology; Staining; Lymphoma; CD30; Medicine","score_opus":0.15628561209536632,"score_gpt":0.4382576959316614,"score_spread":0.28197208383629513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563222460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978655,0.0005038976,0.00004915839,0.00083620305,0.00035275225,0.00020434552,0.000094716466,0.0000036629467,0.000089773355],"genre_scores_gemma":[0.9975269,0.0007785074,0.0011208083,0.00046840703,0.000059367165,0.000011751666,0.0000073351252,0.00001780493,0.000009113481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99177134,0.0032598786,0.003891774,0.00029430332,0.00048752248,0.00029516753],"domain_scores_gemma":[0.9870976,0.004630796,0.006466976,0.0006270751,0.00094357063,0.00023396953],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009142231,0.0002114052,0.00260151,0.00014141054,0.000019750698,0.0000032787984,0.00038317582,0.0001536815,0.000010948906],"category_scores_gemma":[0.010824909,0.00013179793,0.00044223096,0.0005900321,0.0015323438,0.000069954374,0.00015140907,0.00026165406,0.0000013116177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015265588,0.0026450779,0.975652,0.000052125873,0.00009156512,0.00046028232,0.00029128316,0.000045344677,0.00016546954,0.00007729316,0.00011165126,0.01888137],"study_design_scores_gemma":[0.007758593,0.0046227477,0.9826103,0.00023289942,0.00015354993,0.00012354359,0.0007131276,0.0000039207216,0.0030857367,0.0005706213,0.000019361532,0.000105583684],"about_ca_topic_score_codex":0.0014317451,"about_ca_topic_score_gemma":0.00027037188,"teacher_disagreement_score":0.018775785,"about_ca_system_score_codex":0.00011218471,"about_ca_system_score_gemma":0.0010982649,"threshold_uncertainty_score":0.99750733},"labels":[],"label_agreement":null},{"id":"W2563384795","doi":"","title":"A retrospective clinical analysis of 30 patients with primary testicular non-Hodgkin lymphoma","year":2006,"lang":"en","type":"article","venue":"Clinical Oncology and Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Hodgkin lymphoma; Oncology; Primary (astronomy); Lymphoma; Internal medicine; Retrospective cohort study","score_opus":0.07692319791446803,"score_gpt":0.4828752042898764,"score_spread":0.4059520063754084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563384795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914678,0.0008842514,0.000010520112,0.0010328388,0.00009359302,0.0005886979,0.00004528777,0.0000128436,0.0058642225],"genre_scores_gemma":[0.9971871,0.0013359607,0.00033808305,0.00040408166,0.00024404154,0.00015275792,0.00007116617,0.000014197374,0.00025264584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969653,0.00051730673,0.0009208057,0.0006170888,0.00060166366,0.00037783824],"domain_scores_gemma":[0.9962571,0.0020440877,0.00023001511,0.00038699366,0.00081229466,0.00026949434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022481757,0.00014780878,0.0013198747,0.00023214397,0.00011102347,0.000010095163,0.000105497886,0.00036156832,0.00022187359],"category_scores_gemma":[0.00056226866,0.00009606718,0.00028857135,0.0008973028,0.001333009,0.000037008245,0.000120500685,0.0003565317,0.000015029229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021045406,0.006926258,0.9003124,0.000027848471,0.0021041676,0.00014857376,0.000019425164,0.0000033567892,0.0000037354575,0.0001633415,0.0021330894,0.08605323],"study_design_scores_gemma":[0.012235649,0.009003504,0.9719018,0.00007455217,0.002099791,0.0000020289929,0.000017597902,0.00008509807,0.000021250311,0.00015258332,0.004311566,0.000094616495],"about_ca_topic_score_codex":0.0010139981,"about_ca_topic_score_gemma":0.00030285347,"teacher_disagreement_score":0.08595861,"about_ca_system_score_codex":0.00054614356,"about_ca_system_score_gemma":0.0012117884,"threshold_uncertainty_score":0.49115273},"labels":[],"label_agreement":null},{"id":"W2563394375","doi":"10.3747/co.23.3405","title":"Emerging Therapies for the Treatment of Relapsed or Refractory Follicular Lymphoma","year":2016,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada); Impact; McGill University; Jewish General Hospital; Dalhousie University; University of Toronto; Fluidigm (Canada); Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Follicular lymphoma; Lymphoma; Oncology; Cancer research; Bioinformatics; Internal medicine; Biology","score_opus":0.1803669530661882,"score_gpt":0.46154190568531117,"score_spread":0.28117495261912295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563394375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009056373,0.9934821,0.000039443144,0.0003913967,0.0020843747,0.0035445138,0.00015194497,0.000037216487,0.00017845085],"genre_scores_gemma":[0.00004153776,0.99413127,0.0001174683,0.000024212188,0.00076471805,0.0039157076,0.00015019136,0.00006504422,0.0007898808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979807,0.00017936446,0.00079442334,0.00047383073,0.00019498984,0.00037667222],"domain_scores_gemma":[0.9959861,0.0023759545,0.0006845949,0.0007134695,0.00012710209,0.000112768364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017591185,0.0005285168,0.0026032066,0.00016037899,0.000119281525,0.000008054899,0.000183715,0.00033228725,0.00019997095],"category_scores_gemma":[0.000087296925,0.00019887375,0.0014181369,0.00014908693,0.00016007033,0.000024934132,0.000031111176,0.00005616134,0.000051811843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024044208,0.003954903,0.00004991604,0.0035655336,0.0024069403,0.000042843094,0.00026281684,1.3721903e-8,3.8143565e-7,0.00019205814,0.0028085369,0.9864756],"study_design_scores_gemma":[0.007155374,0.00564095,0.00005758841,0.0069513703,0.006385435,0.00009331818,0.000051110354,0.0000016614422,0.0000073668075,0.00002089576,0.9734402,0.0001947478],"about_ca_topic_score_codex":0.000010464253,"about_ca_topic_score_gemma":0.000009830168,"teacher_disagreement_score":0.98628086,"about_ca_system_score_codex":0.0018644674,"about_ca_system_score_gemma":0.0013184549,"threshold_uncertainty_score":0.8109836},"labels":[],"label_agreement":null},{"id":"W2563472576","doi":"10.1182/blood.v114.22.3414.3414","title":"Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Etoposide; Internal medicine; Nuclear medicine; Chemotherapy; Lymphoma","score_opus":0.028751004194950577,"score_gpt":0.29048243621206593,"score_spread":0.26173143201711535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563472576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095595,0.0015666614,0.0003522794,0.0014095723,0.0003231117,0.004790038,0.0003631107,0.00017668332,0.000062595034],"genre_scores_gemma":[0.9874692,0.0028222564,0.006993359,0.0013698433,0.00019041418,0.00051978434,0.0003583324,0.00010769399,0.00016911588],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544346,0.00025410202,0.0015920115,0.0013179719,0.0005972913,0.0007951693],"domain_scores_gemma":[0.99667215,0.0006946631,0.0007535251,0.00058756355,0.00078311027,0.0005089658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005842794,0.00077706255,0.0016346205,0.00040387147,0.00028514766,0.00022988462,0.00018706034,0.00015851941,0.000013061412],"category_scores_gemma":[0.00014306261,0.0006297476,0.00029976456,0.0004257058,0.00018198864,0.00051947846,0.00006795074,0.00022174387,0.000008340274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05446075,0.2000404,0.2964895,0.0042987736,0.005001243,0.012128946,0.007229949,0.000055348686,0.24587974,0.0006166794,0.0067991028,0.16699953],"study_design_scores_gemma":[0.25444707,0.007935913,0.3217998,0.0010351969,0.0037250277,0.0024752095,0.00074724277,0.0001998438,0.40604898,0.00012878905,0.00052815326,0.00092876464],"about_ca_topic_score_codex":0.0018994587,"about_ca_topic_score_gemma":0.00021907638,"teacher_disagreement_score":0.19998631,"about_ca_system_score_codex":0.00017027298,"about_ca_system_score_gemma":0.0002794157,"threshold_uncertainty_score":0.9996154},"labels":[],"label_agreement":null},{"id":"W2563578391","doi":"10.1182/blood.v108.11.2049.2049","title":"Clinicopathologic Subtypes of Mantle Cell Lymphoma (MCL) Show Distinct Patterns of Genetic Copy Number Alteration.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Blastoid; Mantle cell lymphoma; Biology; Comparative genomic hybridization; Genome instability; Cancer research; Lymphoma; Chromosomal translocation; Genetics; Gene; Chromosome; Immunology; DNA damage","score_opus":0.010245239823613072,"score_gpt":0.24661229113751718,"score_spread":0.2363670513139041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563578391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507606,0.0007876273,0.00005688735,0.00004611445,0.00007104697,0.00023506318,0.00008165102,0.000020679443,0.0036248586],"genre_scores_gemma":[0.9981531,0.000097298995,0.0010529428,0.000048782407,0.000090460184,0.000028608534,0.00008136111,0.000015530837,0.00043192983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899924,0.000036618192,0.0004133308,0.00021327793,0.00018303945,0.00015447137],"domain_scores_gemma":[0.99932665,0.00008143566,0.00018231625,0.0002926573,0.00007680605,0.000040109673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065051885,0.00013457958,0.00033468843,0.000033941596,0.000025584051,0.0000070089613,0.000060899583,0.00006991236,0.00027433885],"category_scores_gemma":[0.000014370203,0.0001026359,0.00012767443,0.00006678521,0.00004288218,0.000020917669,0.000027586037,0.000021765358,0.000057607424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036406153,0.005495228,0.99073035,0.00013196479,0.00003761031,0.00013242169,0.000034074077,0.000003121533,0.0017341969,0.0000727324,0.00020040036,0.0013915],"study_design_scores_gemma":[0.0058788005,0.00034393914,0.8119492,0.000062670595,0.0003443954,0.00007544309,0.000014086819,0.000011633612,0.18096244,0.00007244309,0.00020929948,0.000075645024],"about_ca_topic_score_codex":0.00029490533,"about_ca_topic_score_gemma":0.000028856464,"teacher_disagreement_score":0.17922825,"about_ca_system_score_codex":0.000022314332,"about_ca_system_score_gemma":0.000057145946,"threshold_uncertainty_score":0.41853705},"labels":[],"label_agreement":null},{"id":"W2564480549","doi":"10.1182/blood.v112.11.804.804","title":"Lymphomas with Concurrent T(14;18) and 8q24 Translocations Are Under- Reported and Clinical Outcome Depends on the MYC Partner","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fluorescence in situ hybridization; Lymphoma; Chromosomal translocation; Follicular lymphoma; Diffuse large B-cell lymphoma; Lymphoblastic lymphoma; Gene rearrangement; Internal medicine; Karyotype; Medicine; Biology; Oncology; Pathology; Cancer research; Immunology; T cell; Chromosome; Gene; Genetics","score_opus":0.14020481656034703,"score_gpt":0.35274478670883863,"score_spread":0.2125399701484916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564480549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216664,0.0009274899,0.000012254669,0.004537926,0.00005656944,0.00038875052,0.000012574576,0.00004112176,0.0018566962],"genre_scores_gemma":[0.997876,0.0006615935,0.00006775957,0.0008923257,0.00006498141,0.00007088183,0.000018439587,0.000015849397,0.0003321845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891794,0.000049908896,0.00034556066,0.00030877526,0.00021567002,0.00016212268],"domain_scores_gemma":[0.9990638,0.00027816594,0.000112236805,0.00031963017,0.00005655768,0.0001696446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013549316,0.00015944039,0.00030875555,0.00003141745,0.00017312654,0.000016482185,0.000034213244,0.00007331646,0.00004425789],"category_scores_gemma":[0.000062417384,0.000083628576,0.000068921945,0.00008597313,0.00020822829,0.000026770582,0.000014001494,0.00008986469,0.000009131857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049547572,0.0022711465,0.99347997,0.000014344645,0.00043674698,0.0004207028,0.00011510945,4.3466346e-7,0.000005369407,0.00084265746,0.00046847714,0.0018954942],"study_design_scores_gemma":[0.010667672,0.0007135169,0.9839207,0.00008620452,0.0009399897,0.0013393656,0.00012775153,0.000013604363,0.00041859533,0.00002931354,0.00163275,0.00011056177],"about_ca_topic_score_codex":0.000036833022,"about_ca_topic_score_gemma":0.00008461368,"teacher_disagreement_score":0.010618124,"about_ca_system_score_codex":0.000022610411,"about_ca_system_score_gemma":0.00010019947,"threshold_uncertainty_score":0.34102744},"labels":[],"label_agreement":null},{"id":"W2564545457","doi":"10.1093/jnci/djw250","title":"General Biomarker Recommendations for Lymphoma","year":2016,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Follicular lymphoma; Context (archaeology); Disease; Lymphoma; Biomarker; Identification (biology); Oncology; Cancer; Internal medicine; Medical physics; Intensive care medicine","score_opus":0.10787628626214794,"score_gpt":0.3864190519763076,"score_spread":0.27854276571415965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564545457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6730841,0.00111475,0.0011139236,0.3111783,0.008767924,0.0006551195,0.0005151593,0.000017057602,0.0035536997],"genre_scores_gemma":[0.98773295,0.00041758709,0.0031936078,0.0037869946,0.0016932214,0.00007041102,0.000006172265,0.000010733899,0.0030883015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912447,0.000016079328,0.00029724973,0.000080606835,0.00037736975,0.00010422658],"domain_scores_gemma":[0.99882656,0.00008918865,0.0002556048,0.00007053498,0.0006853559,0.0000727387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019623454,0.00008000477,0.00014546725,0.0000855729,0.00011536101,0.000012698564,0.00011039345,0.000037661735,0.00011457834],"category_scores_gemma":[0.00021634017,0.0000361774,0.00023185022,0.000109336695,0.000057173314,0.00019206536,0.00002017551,0.000023038974,0.000005733443],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007448128,0.0006519073,0.03217839,0.000026665928,0.0010660286,0.000010939312,0.00006748554,0.000045771565,0.009395364,0.013380859,0.631861,0.3105708],"study_design_scores_gemma":[0.006313685,0.00009301299,0.15486433,0.00025230317,0.00016213782,0.00024179422,0.0000030840927,0.000031162806,0.008352896,0.0017213428,0.8278997,0.00006454686],"about_ca_topic_score_codex":0.000024645167,"about_ca_topic_score_gemma":0.000025550542,"teacher_disagreement_score":0.3146489,"about_ca_system_score_codex":0.0009659002,"about_ca_system_score_gemma":0.00085234444,"threshold_uncertainty_score":0.25257954},"labels":[],"label_agreement":null},{"id":"W2564657504","doi":"10.1182/blood.v110.11.348.348","title":"Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; CHOP; Lymphoma; Oncology; Chemotherapy regimen; Medicine; Internal medicine; Chemotherapy; Cancer research; Biology","score_opus":0.004820381490119565,"score_gpt":0.21267674191847852,"score_spread":0.20785636042835895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564657504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594283,0.0024132726,0.000015638478,0.000061028248,0.000035382516,0.0005283423,0.000035679717,0.00007542928,0.00089242123],"genre_scores_gemma":[0.9980547,0.00045666803,0.00057795877,0.00039664228,0.00012360852,0.000036103585,0.0000770632,0.000040595372,0.00023668552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986466,0.00003159823,0.00022946218,0.0004007723,0.0002815876,0.00040996217],"domain_scores_gemma":[0.99933636,0.000077479956,0.000073397656,0.0002801747,0.000036585396,0.0001959999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014656722,0.0002637973,0.00038313144,0.00012747974,0.00006165213,0.000024078021,0.000048665705,0.00017275361,0.000032895652],"category_scores_gemma":[0.000008111327,0.0001777936,0.000057499976,0.00013487929,0.000038195536,0.000069286514,0.000031281925,0.000075137235,0.0000056574404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022645656,0.06339521,0.88921386,0.00007996275,0.00017126942,0.0020262692,0.0005039975,4.137115e-7,0.039290328,0.000009632475,0.00032819656,0.0027162817],"study_design_scores_gemma":[0.15560985,0.00061834144,0.5704884,0.000118672004,0.00013656962,0.00007922239,0.000025923388,0.000014131424,0.27212968,0.0000037102984,0.00062447763,0.00015105428],"about_ca_topic_score_codex":0.00020344346,"about_ca_topic_score_gemma":0.00011190606,"teacher_disagreement_score":0.3187255,"about_ca_system_score_codex":0.000076073506,"about_ca_system_score_gemma":0.00005387758,"threshold_uncertainty_score":0.72502124},"labels":[],"label_agreement":null},{"id":"W2564661908","doi":"10.1182/blood.v126.23.111.111","title":"Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Biology; BCL6; Cancer research; Follicular lymphoma; Gene expression profiling; Lymphoma; Genetics; B cell; Gene; Immunology; Gene expression","score_opus":0.012870875767063797,"score_gpt":0.2552794388710029,"score_spread":0.2424085631039391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564661908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824226,0.00046736348,0.00005885558,0.000047602367,0.00004393818,0.00045989986,0.00006575957,0.00002242179,0.00059189217],"genre_scores_gemma":[0.9986082,0.00003802645,0.00095149636,0.00006709854,0.000042294443,0.000075792756,0.00007280359,0.000027324668,0.00011700112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986665,0.00005376822,0.000402762,0.00030386224,0.00031180668,0.0002612898],"domain_scores_gemma":[0.99918324,0.0000825593,0.00016718077,0.00024786795,0.000101552534,0.0002176246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010647563,0.00022076696,0.0003626368,0.00015116065,0.000050642644,0.000034919853,0.000055238877,0.00009329371,0.000018489343],"category_scores_gemma":[0.00002554605,0.00016456579,0.000056987956,0.000121528006,0.00004428696,0.00010743107,0.0000509647,0.00003444824,0.0000052929745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015402658,0.014963681,0.94782513,0.00014753944,0.000028010154,0.00023078549,0.0013962556,0.0000037988539,0.034265473,0.000021048449,0.00003033827,0.0009338955],"study_design_scores_gemma":[0.05418075,0.00071871694,0.65507275,0.00034748498,0.00020269526,0.00006719862,0.0003677343,0.00019925764,0.2884751,0.000008752781,0.00016925615,0.00019028586],"about_ca_topic_score_codex":0.000074676704,"about_ca_topic_score_gemma":0.00002902037,"teacher_disagreement_score":0.29275236,"about_ca_system_score_codex":0.000105422965,"about_ca_system_score_gemma":0.00015823562,"threshold_uncertainty_score":0.6710798},"labels":[],"label_agreement":null},{"id":"W2564775203","doi":"10.1093/annonc/mdw653","title":"Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Credit Valley Hospital; Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Queen's University; Princess Margaret Cancer Centre; Royal Victoria Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Eli Lilly Canada; Roche Canada","keywords":"Medicine; Internal medicine; Transplantation; Salvage therapy; Autologous stem-cell transplantation; Neutropenia; Gemcitabine; Febrile neutropenia; Surgery; Aggressive lymphoma; Chemotherapy regimen; Adverse effect; Chemotherapy; Oncology; Lymphoma; Rituximab","score_opus":0.029004844295455367,"score_gpt":0.3193116384750785,"score_spread":0.29030679417962313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564775203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194115,0.00025716505,0.00013442924,0.0042772787,0.00014405865,0.0023853644,0.0007901217,0.000024126835,0.000046276815],"genre_scores_gemma":[0.99618036,0.00094182405,0.00020168311,0.0016891528,0.00006086014,0.0005114325,0.00027846335,0.000029831182,0.00010641569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829835,0.00015526,0.0005053294,0.00047815236,0.00025041908,0.00031250616],"domain_scores_gemma":[0.99720716,0.0012857255,0.0007312142,0.0003493374,0.00026817524,0.0001583742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011863408,0.00031097396,0.0009934019,0.0001531086,0.00011094116,0.0000127070025,0.00008843362,0.0001790005,0.000043225682],"category_scores_gemma":[0.000043270433,0.00014781364,0.0002758278,0.00015181923,0.00008869236,0.00011914578,0.000013429383,0.000028839864,0.0000025998197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054146256,0.009316458,0.59632546,0.000019965988,0.002891301,0.000051284365,0.0030625404,0.0000012775524,0.000046843455,0.000003066411,0.00066677714,0.33346874],"study_design_scores_gemma":[0.23226924,0.01824243,0.74348146,0.00009795422,0.0021426333,0.0000013076069,0.00016741097,0.0000039379483,0.001527647,0.0000070870033,0.001913728,0.00014517253],"about_ca_topic_score_codex":0.00023736821,"about_ca_topic_score_gemma":0.00024812805,"teacher_disagreement_score":0.33332357,"about_ca_system_score_codex":0.00026441232,"about_ca_system_score_gemma":0.00012010704,"threshold_uncertainty_score":0.6027665},"labels":[],"label_agreement":null},{"id":"W2564817673","doi":"10.1182/blood.v118.21.2022.2022","title":"Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; ABVD; Internal medicine; Salvage therapy; Oncology; Chemotherapy; Chemotherapy regimen; Surgery; Progressive disease; Cyclophosphamide; Vincristine","score_opus":0.019383074225277915,"score_gpt":0.21488925732839664,"score_spread":0.19550618310311874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564817673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953793,0.0028372332,0.000011195834,0.0002367923,0.00004407902,0.0007196033,0.00007835419,0.000064568994,0.00062882743],"genre_scores_gemma":[0.99313956,0.0032411031,0.002663806,0.0003467432,0.00003580428,0.0001758951,0.000051654664,0.000035954487,0.0003094894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905276,0.00002423855,0.00018294578,0.0003640532,0.00015069687,0.00022529447],"domain_scores_gemma":[0.999368,0.000096152806,0.00010549478,0.00023987198,0.000053652355,0.0001367981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075256925,0.00021393877,0.000327079,0.000054995817,0.00009552777,0.00001705214,0.000042589672,0.00010912923,0.000009153117],"category_scores_gemma":[0.0000029848059,0.00015278975,0.00004093728,0.00006429702,0.000078880206,0.00007034919,0.0000063180937,0.000039201997,9.2604944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033378728,0.019866707,0.70586795,0.003024272,0.0025990233,0.0039899917,0.025189871,0.0000012382397,0.03977877,0.0031573125,0.0016020382,0.16154408],"study_design_scores_gemma":[0.03972878,0.0030055244,0.8405233,0.0001334928,0.0006482163,0.00023549056,0.00014519406,0.0000036953365,0.11437067,0.00007220171,0.00091484445,0.00021860139],"about_ca_topic_score_codex":0.0003774394,"about_ca_topic_score_gemma":0.00011348984,"teacher_disagreement_score":0.16132548,"about_ca_system_score_codex":0.000052262647,"about_ca_system_score_gemma":0.00009998365,"threshold_uncertainty_score":0.62305856},"labels":[],"label_agreement":null},{"id":"W2564860930","doi":"10.1158/1538-7445.am2015-4525","title":"Abstract 4525: The impact of chemoimmunotherapy dose intensity in diffuse large b-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Chemoimmunotherapy; International Prognostic Index; Cyclophosphamide; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; CHOP; Chemotherapy; Oncology; Doxorubicin; Lymphoma; Etoposide; Gastroenterology","score_opus":0.10880168487972303,"score_gpt":0.4353498910117899,"score_spread":0.32654820613206686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564860930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915776,0.004208223,2.586725e-7,0.00086555554,0.000054766704,0.0005338705,0.00002152394,0.000011597613,0.0027265623],"genre_scores_gemma":[0.99804014,0.0012239085,0.000007752949,0.00009743755,0.000082849,0.00013585418,0.0000098388355,0.000020666925,0.00038156114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985076,0.000059486425,0.00021679165,0.00021598597,0.0005401754,0.0004599338],"domain_scores_gemma":[0.99872285,0.0001277811,0.000051307892,0.00051710225,0.00040152846,0.00017942712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009620064,0.00012781417,0.00030935765,0.00014215105,0.00005229834,0.00002220242,0.00018190306,0.00007681197,0.00016067704],"category_scores_gemma":[0.0000785957,0.000069680085,0.00013937784,0.00041151195,0.0001531045,0.00005444712,0.00008262208,0.00017997908,0.00005687524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065703876,0.030406237,0.8587884,0.00013766419,0.00040876583,0.0003776275,0.007443608,0.000013957815,0.029846938,0.00007184393,0.03242508,0.03350951],"study_design_scores_gemma":[0.031166919,0.00048830407,0.9314114,0.0001304215,0.000011131646,0.0000106902025,0.00065448304,0.0000508023,0.034094132,0.000083776846,0.0018210751,0.000076854194],"about_ca_topic_score_codex":0.022109054,"about_ca_topic_score_gemma":0.00029574323,"teacher_disagreement_score":0.07262303,"about_ca_system_score_codex":0.001410718,"about_ca_system_score_gemma":0.001049643,"threshold_uncertainty_score":0.98440284},"labels":[],"label_agreement":null},{"id":"W2565123974","doi":"10.1182/blood.v116.21.415.415","title":"A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Regimen; Chemotherapy regimen; Internal medicine; Radiation therapy; Randomized controlled trial; Hazard ratio; Surgery; Oncology; Chemotherapy; Vincristine; Confidence interval; Cyclophosphamide","score_opus":0.012605152545392805,"score_gpt":0.30830502666910675,"score_spread":0.29569987412371396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565123974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219346,0.0006890509,0.00005238523,0.0002798366,0.00027152064,0.006359662,0.000039295275,0.000032768694,0.00008199897],"genre_scores_gemma":[0.9979539,0.00052100414,0.00006894308,0.00031943692,0.000078528436,0.00083501526,0.00010086674,0.000029481827,0.000092809605],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978191,0.0005131819,0.00071350386,0.00042817811,0.00025730417,0.00026868988],"domain_scores_gemma":[0.9984009,0.00048934383,0.00034804354,0.00042049662,0.00020350794,0.00013769441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089358236,0.00029342386,0.0011809516,0.00012628778,0.00007314902,0.000043952605,0.00013140349,0.0001489737,0.000023251669],"category_scores_gemma":[0.0002159583,0.00017889314,0.00011150441,0.00020951287,0.00019717684,0.00019715473,0.000044838285,0.00014885615,0.0000013290339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8073017,0.0404938,0.005067667,0.000013320831,0.00077417545,0.00023439291,0.0041045602,0.0000010036982,0.009365017,0.00009938461,0.00003542915,0.13250954],"study_design_scores_gemma":[0.9648025,0.02403503,0.0027879125,0.000034021745,0.000431388,0.000037594844,0.0017205597,0.00029398382,0.00528362,0.0000116661595,0.00039765626,0.00016409256],"about_ca_topic_score_codex":0.0009229332,"about_ca_topic_score_gemma":0.00079794845,"teacher_disagreement_score":0.15750076,"about_ca_system_score_codex":0.00007684273,"about_ca_system_score_gemma":0.00017803373,"threshold_uncertainty_score":0.72950506},"labels":[],"label_agreement":null},{"id":"W2565288421","doi":"10.1182/blood.v128.22.6.6","title":"Obinutuzumab-Based Induction and Maintenance Prolongs Progression-Free Survival (PFS) in Patients with Previously Untreated Follicular Lymphoma: Primary Results of the Randomized Phase 3 GALLIUM Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Obinutuzumab; Follicular lymphoma; Internal medicine; Medicine; Oncology; Progression-free survival; Phases of clinical research; Overall survival; Cancer research; Lymphoma; Chemotherapy; Rituximab","score_opus":0.006445635397728135,"score_gpt":0.22960351266996096,"score_spread":0.22315787727223282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565288421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343,0.00019354193,0.0000048891175,0.00042461965,0.0000586293,0.0057260315,0.000044117383,0.000033466637,0.000084680374],"genre_scores_gemma":[0.9990476,0.000027266668,0.00016538773,0.00003379398,0.000022837665,0.00058825774,0.00003683376,0.000022873322,0.000055146014],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99789584,0.00038472647,0.00050212094,0.00042084235,0.00053531147,0.00026117853],"domain_scores_gemma":[0.9985102,0.00021747628,0.0003399113,0.0006399213,0.00020200736,0.000090530295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006341726,0.00024168495,0.000711542,0.00008529776,0.000056699097,0.000012182135,0.00011988919,0.000078573445,0.0000029868086],"category_scores_gemma":[0.00043755988,0.00009771058,0.00009572902,0.00026043522,0.000164419,0.00007766675,0.00006835563,0.000044745924,0.0000011183189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14746101,0.022872483,0.82084805,0.000084581014,0.00052040844,0.00008721512,0.00037360334,9.877399e-7,0.00019040496,0.000008189041,0.000055461656,0.0074976194],"study_design_scores_gemma":[0.54556704,0.002102985,0.44863793,0.00067255524,0.0005628549,0.0000050056847,0.000020425374,0.0000049920327,0.0023259586,0.000008158925,0.0000119146525,0.00008020817],"about_ca_topic_score_codex":0.00019001504,"about_ca_topic_score_gemma":0.00007394343,"teacher_disagreement_score":0.398106,"about_ca_system_score_codex":0.00023963505,"about_ca_system_score_gemma":0.0003269252,"threshold_uncertainty_score":0.39845216},"labels":[],"label_agreement":null},{"id":"W2565605910","doi":"10.1182/blood.v110.11.5054.5054","title":"Allogeneic Stem Cell Transplantation for Relapsed Follicular Non-Hodgkin’s Lymphoma: Single Centre Experience.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Follicular lymphoma; Hematopoietic stem cell transplantation; Internal medicine; Surgery; Transplantation; Lymphoma; Gastroenterology; Radiation therapy","score_opus":0.013679472382362407,"score_gpt":0.243065971826445,"score_spread":0.22938649944408257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565605910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528986,0.00077942875,0.0008315379,0.0001259774,0.00017185275,0.0008500598,0.000024321118,0.000063695574,0.0018632874],"genre_scores_gemma":[0.9963663,0.00008885671,0.002357767,0.00021940208,0.00013053085,0.0000986747,0.00011508924,0.00003067009,0.00059270085],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987845,0.000012533929,0.00028374745,0.00032958385,0.00022337055,0.0003662699],"domain_scores_gemma":[0.99934816,0.00009171956,0.000080435326,0.0002394936,0.00006701624,0.00017318309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011247756,0.00018714943,0.00025256662,0.000070465765,0.000095990574,0.000018553821,0.000063717154,0.00011924199,0.000026513444],"category_scores_gemma":[0.0000044951266,0.00015511614,0.00018685097,0.000117129435,0.000024979532,0.000055875113,0.00000762779,0.000021724813,0.000028991248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016391476,0.030619372,0.4798988,0.0009380325,0.0008942732,0.0034077035,0.017620927,0.000013045623,0.3726207,0.00033256723,0.0013746511,0.09064077],"study_design_scores_gemma":[0.02348205,0.00064972014,0.097901344,0.00009493856,0.0007860141,0.00010665506,0.0008086215,0.000011112288,0.87174547,0.000010757503,0.0042076395,0.00019567138],"about_ca_topic_score_codex":0.000031136267,"about_ca_topic_score_gemma":0.000027806438,"teacher_disagreement_score":0.49912477,"about_ca_system_score_codex":0.000114577124,"about_ca_system_score_gemma":0.000059265607,"threshold_uncertainty_score":0.6325453},"labels":[],"label_agreement":null},{"id":"W2566075579","doi":"10.1182/blood.v104.11.5230.5230","title":"Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Etoposide; Salvage therapy; Oncology; Aggressive lymphoma; Autologous stem-cell transplantation; Chemotherapy; Gastroenterology; Lymphoma; Surgery","score_opus":0.01465447122387212,"score_gpt":0.3036123395581574,"score_spread":0.2889578683342853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566075579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899736,0.0021507957,0.000074336946,0.0018825646,0.00035458777,0.0027050762,0.000087277906,0.00014546035,0.0026262682],"genre_scores_gemma":[0.99208504,0.0006980712,0.0021630076,0.002179611,0.00077004713,0.0009985277,0.00014909836,0.00009034335,0.0008662547],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981216,0.000021929727,0.0004413059,0.00057236064,0.0003499633,0.0004927935],"domain_scores_gemma":[0.9985324,0.00013177526,0.00032991846,0.00058819907,0.00012276096,0.0002949486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014539837,0.00038010598,0.00073912775,0.00013629647,0.00026550598,0.000037283793,0.00014465602,0.00022767618,0.00015096484],"category_scores_gemma":[0.00018768529,0.00030452074,0.00044340218,0.00017792801,0.000083357496,0.00011491734,0.000042648153,0.00008130448,0.00015718014],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10077081,0.60772395,0.0010289428,0.00041665314,0.005151859,0.005284808,0.0050423075,0.000003534087,0.01751132,0.0030373363,0.013276897,0.24075156],"study_design_scores_gemma":[0.84561145,0.021093829,0.0008767742,0.0003510733,0.0010184356,0.0002533415,0.00007248313,0.00000557777,0.09542042,0.00063336734,0.03433032,0.0003329],"about_ca_topic_score_codex":0.00012499942,"about_ca_topic_score_gemma":0.0000106032885,"teacher_disagreement_score":0.7448407,"about_ca_system_score_codex":0.00030506463,"about_ca_system_score_gemma":0.0006121266,"threshold_uncertainty_score":0.9999407},"labels":[],"label_agreement":null},{"id":"W2566496740","doi":"10.1158/1538-7445.am2015-5303","title":"Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"BCL6; Internal medicine; Medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Oncology; Immunohistochemistry; Lymphoma; Clinical trial; Immunology; B cell","score_opus":0.054822729887369526,"score_gpt":0.3757569179760937,"score_spread":0.32093418808872415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566496740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930717,0.0005388347,0.0000029053322,0.00021509055,0.00015223633,0.004926596,0.00078020286,0.000037857997,0.0002745958],"genre_scores_gemma":[0.997788,0.00014312362,0.000088674096,0.00007508906,0.00007466742,0.0013027298,0.000088107176,0.00007311631,0.00036649496],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9946556,0.00089560036,0.0007237425,0.0009371765,0.0019546095,0.00083323976],"domain_scores_gemma":[0.99609995,0.0014511055,0.00024243923,0.00095929817,0.00058266235,0.00066456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022520241,0.0003752672,0.0008122719,0.0005948754,0.00015640483,0.00005501108,0.00030381538,0.00014654385,0.000043576198],"category_scores_gemma":[0.00079064467,0.00027378937,0.00010723365,0.0010084963,0.000081942526,0.00018030137,0.00018639734,0.0003774249,0.000048291684],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50587225,0.09665333,0.34662172,0.000018935283,0.00061434775,0.00079311023,0.037856586,0.000047784568,0.000614425,0.000002246564,0.0021248849,0.008780374],"study_design_scores_gemma":[0.47621268,0.015640335,0.49785194,0.00043045566,0.00007731097,5.4230435e-7,0.004496746,0.00002580737,0.0042087464,0.00001032103,0.00083445857,0.00021067896],"about_ca_topic_score_codex":0.03486647,"about_ca_topic_score_gemma":0.0033723325,"teacher_disagreement_score":0.15123022,"about_ca_system_score_codex":0.0019282679,"about_ca_system_score_gemma":0.001250502,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W2566511010","doi":"10.1182/blood.v108.11.816.816","title":"Addition of Rituximab (R) to CHOP Improves Survival in the Non-GCB Subtype of Diffuse Large B Cell Lymphoma (DLBCL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Rituximab; Lymphoma; Germinal center; Medicine; Internal medicine; Oncology; Vincristine; Chemotherapy; Cancer research; Immunology; B cell; Cyclophosphamide; Antibody","score_opus":0.006027008712655218,"score_gpt":0.22207531473487768,"score_spread":0.21604830602222247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566511010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934445,0.00032430922,0.000005202717,0.00021592365,0.0000642657,0.00045812604,0.00014335554,0.000011355112,0.00533296],"genre_scores_gemma":[0.9992391,0.00004046571,0.00022221872,0.0001260251,0.0001046221,0.00006855208,0.000092034395,0.0000144633395,0.000092523114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898034,0.00003915638,0.00030659616,0.00018581306,0.0002720344,0.00021603606],"domain_scores_gemma":[0.9993303,0.000112180925,0.000108325694,0.00033754556,0.000065003,0.000046650235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016241979,0.00013318681,0.00033145203,0.00009530921,0.000025455201,0.0000072179546,0.00009890348,0.000066783905,0.000031166994],"category_scores_gemma":[0.000029845953,0.00008894219,0.00010698792,0.00023147512,0.000027386986,0.000035110126,0.000030752006,0.00003230488,0.000026854319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069336145,0.3735952,0.53514767,0.00059220975,0.00024845434,0.0003458763,0.0018172946,0.0000013202239,0.074059546,0.0021261466,0.005567573,0.0058053257],"study_design_scores_gemma":[0.051682737,0.0006296342,0.8413998,0.00008277755,0.00022046192,0.000011447032,0.00018994386,0.000008799201,0.10469093,0.00007387371,0.00091905554,0.000090545516],"about_ca_topic_score_codex":0.0011356273,"about_ca_topic_score_gemma":0.00032392985,"teacher_disagreement_score":0.37296557,"about_ca_system_score_codex":0.00003727002,"about_ca_system_score_gemma":0.00007307719,"threshold_uncertainty_score":0.36269575},"labels":[],"label_agreement":null},{"id":"W2566891546","doi":"10.1182/blood.v114.22.4776.4776","title":"Single Agent Metronomic Cyclophosphamide in Refractory,Non-Hodgkin's Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Medicine; Cyclophosphamide; Lymphoma; Internal medicine; Oncology; Chemotherapy; Cancer; Refractory (planetary science); Thymoma; Surgery; Chronic lymphocytic leukemia; Gastroenterology; Nitrogen mustard; Leukemia","score_opus":0.012256973421053028,"score_gpt":0.24721631382339043,"score_spread":0.2349593404023374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566891546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984709,0.001973834,0.000003404086,0.00058568583,0.00011821281,0.00033583422,0.0000044541102,0.0000590364,0.012210538],"genre_scores_gemma":[0.9975596,0.00022936422,0.00087755494,0.0007743155,0.00013346864,0.000033146614,0.000027643897,0.000019070325,0.0003458057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988095,0.000021670015,0.0002981475,0.0003420487,0.00018310072,0.00034550877],"domain_scores_gemma":[0.999301,0.00004648109,0.00007636457,0.00038469138,0.00002312819,0.00016830527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095142685,0.00020262512,0.0003654842,0.00013941701,0.000036962712,0.000022718668,0.00008153768,0.000092370916,0.00008853717],"category_scores_gemma":[0.00003523646,0.00017260108,0.0001279666,0.00018162293,0.00002197791,0.000066899804,0.00002038568,0.000050473107,0.0001800339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039477836,0.04646194,0.60218745,0.00005143487,0.000454371,0.0032927725,0.0006161451,0.000015483083,0.021542123,0.00033142584,0.0029363048,0.32171574],"study_design_scores_gemma":[0.013447799,0.0012969467,0.9162356,0.00010370446,0.000227627,0.0000771423,0.00004424749,0.000009483709,0.055287637,0.00009044276,0.012998325,0.00018100312],"about_ca_topic_score_codex":0.00017545215,"about_ca_topic_score_gemma":0.000024065299,"teacher_disagreement_score":0.32153472,"about_ca_system_score_codex":0.00040974596,"about_ca_system_score_gemma":0.00010877122,"threshold_uncertainty_score":0.70384675},"labels":[],"label_agreement":null},{"id":"W2567093270","doi":"10.1182/blood.v116.21.4129.4129","title":"The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Peripheral T-cell lymphoma; Stage (stratigraphy); T-cell lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Cancer; Population; Oncology; T cell; Immunology","score_opus":0.009142072904371452,"score_gpt":0.2516117252617827,"score_spread":0.24246965235741127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567093270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974904,0.0005163278,0.000039075865,0.00046017324,0.00007931917,0.0008037789,0.00011810406,0.00006543582,0.00042739822],"genre_scores_gemma":[0.9973197,0.000036550937,0.001533711,0.00026675957,0.00006112421,0.00018942918,0.0001690626,0.000035700537,0.0003879635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980755,0.000073267714,0.0005329826,0.00045224998,0.00043848073,0.00042755526],"domain_scores_gemma":[0.9983327,0.00028031575,0.00024483807,0.0006574444,0.00015310159,0.00033160363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021219988,0.00030193783,0.00064626604,0.0002399649,0.0002567865,0.00008721456,0.00015406095,0.00014473448,0.00004663862],"category_scores_gemma":[0.000079965896,0.00020649031,0.0003049014,0.0007582962,0.00006112298,0.000048757465,0.00006821591,0.000064536944,0.000010595115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019638918,0.04044015,0.9501927,0.00007642467,0.00060583604,0.000027797358,0.00031113834,0.0000058758883,0.0030980145,0.000056431614,0.00010641967,0.0048828544],"study_design_scores_gemma":[0.04504931,0.00057443575,0.8967125,0.000028196035,0.0030003032,0.0000046457835,0.00017819078,0.0029039062,0.048783325,0.0000031624086,0.0025423954,0.00021965429],"about_ca_topic_score_codex":0.0011400093,"about_ca_topic_score_gemma":0.0017336182,"teacher_disagreement_score":0.053480193,"about_ca_system_score_codex":0.00007348002,"about_ca_system_score_gemma":0.00013087053,"threshold_uncertainty_score":0.84204304},"labels":[],"label_agreement":null},{"id":"W2567702298","doi":"10.1182/blood.v108.11.2027.2027","title":"Correlation of DNA Copy Number, Gene Expression, Protein Expression and Clinical Outcome in a Group of Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with CHOP Plus Rituximab (CHOP-R).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Comparative genomic hybridization; Biology; Lymphoma; Gene expression profiling; Human genome; Clinical significance; CHOP; Rituximab; Oncology; Gene; Cancer research; Internal medicine; Gene expression; Genetics; Medicine; Genome; Immunology; B cell; Antibody; Germinal center","score_opus":0.007772587053766929,"score_gpt":0.24237743916361876,"score_spread":0.23460485210985182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567702298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979817,0.00018995164,0.00006860094,0.000011433297,0.000019652007,0.0013957217,0.000084147505,0.000030305817,0.00021846985],"genre_scores_gemma":[0.9971514,0.000028310022,0.0023041104,0.000018484821,0.00002908771,0.00012960396,0.00021775012,0.000036565438,0.00008469237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980403,0.00010352716,0.00076386734,0.00041905406,0.0004157649,0.00025745702],"domain_scores_gemma":[0.9988286,0.00009538166,0.00045140294,0.00036965334,0.00012876911,0.00012619131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012970682,0.0002656966,0.0007267611,0.00009829704,0.000046046753,0.000009398137,0.000063007465,0.00017915675,0.000019915331],"category_scores_gemma":[0.000029465024,0.00016624136,0.00007767221,0.0001984091,0.0000904085,0.00010850668,0.000050021456,0.00007689272,0.0000040170235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023640902,0.07034883,0.9238394,0.00013126983,0.00005308506,0.000064769185,0.00008254439,0.0000012729646,0.0028696915,0.000009013813,0.000032692515,0.00020335373],"study_design_scores_gemma":[0.20163685,0.00122715,0.73189193,0.00057592714,0.0002664593,0.000007317334,0.00002465955,0.000037039103,0.06416798,0.0000051648954,0.000023186585,0.00013635028],"about_ca_topic_score_codex":0.00042039042,"about_ca_topic_score_gemma":0.00006525955,"teacher_disagreement_score":0.19927275,"about_ca_system_score_codex":0.000076628814,"about_ca_system_score_gemma":0.0000690894,"threshold_uncertainty_score":0.6779126},"labels":[],"label_agreement":null},{"id":"W2567915243","doi":"10.1182/blood.v124.21.1688.1688","title":"Somatic Mutations in E3 Ubiquitin Ligase Deltex 1 Are Associated with Survival in Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; Exome sequencing; Biology; Chemoimmunotherapy; PTEN; Cancer research; Exome; Survival analysis; Cancer; Genetics; Gene; Lymphoma; Mutation; Internal medicine; Medicine; Immunology; Immunotherapy","score_opus":0.009947358832023528,"score_gpt":0.2279877392477599,"score_spread":0.21804038041573637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567915243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971447,0.00013606867,0.000006519273,0.0003120932,0.000029743123,0.00038965305,0.00003566186,0.000057145306,0.0018884005],"genre_scores_gemma":[0.99915427,0.000016468182,0.000120836376,0.00021865386,0.000034221073,0.00014718008,0.00013639704,0.000029656172,0.00014229535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987134,0.000120131255,0.00029600048,0.0002615805,0.00024765846,0.0003612661],"domain_scores_gemma":[0.99916357,0.0002866021,0.00012452764,0.00025289177,0.00004337821,0.00012901274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022595034,0.0001848073,0.0004036019,0.00015534923,0.00004768316,0.000022671704,0.000062690735,0.00009194479,0.00002487392],"category_scores_gemma":[0.00021674154,0.00014528247,0.000059334172,0.00028178995,0.00002543835,0.000054101773,0.000026465445,0.00006148666,0.00006002505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003947175,0.05174759,0.9460697,0.000061776664,0.00008690681,0.00063897687,0.00060125504,0.00000383665,0.00016319922,0.00014034947,0.000033986405,0.00041292034],"study_design_scores_gemma":[0.091707885,0.0003288532,0.89919984,0.00044152298,0.00025267008,0.0000194593,0.00037856295,0.000449093,0.0069353157,0.00007547563,0.00004991928,0.00016140111],"about_ca_topic_score_codex":0.00021040546,"about_ca_topic_score_gemma":0.003339352,"teacher_disagreement_score":0.09166842,"about_ca_system_score_codex":0.00016177028,"about_ca_system_score_gemma":0.00010295834,"threshold_uncertainty_score":0.5924447},"labels":[],"label_agreement":null},{"id":"W2568386159","doi":"10.1182/blood.v118.21.556.556","title":"Epigenetic Profiling of Primary DLBCLs Reveals Novel DNA Methylation-Based Clusters and New Underlying Mechanisms of Lymphomagenesis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Gene expression profiling; Genetics; Diffuse large B-cell lymphoma; Methylation; Gene; Computational biology; Cancer research; Gene expression","score_opus":0.08223450647289832,"score_gpt":0.2681047403074706,"score_spread":0.1858702338345723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568386159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714095,0.0010957145,0.010134202,0.000060910148,0.00004021681,0.00054085086,0.000014776778,0.00002236934,0.0009499999],"genre_scores_gemma":[0.9073404,0.00004304374,0.09238394,0.00012584968,0.000013053395,0.000021835132,0.000015759899,0.000019748923,0.00003633951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990069,0.000027557842,0.00037391056,0.00022730773,0.00020878887,0.0001554794],"domain_scores_gemma":[0.99920595,0.00012913952,0.00020980631,0.00025611257,0.00007350321,0.00012549001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016652628,0.00014419439,0.00040659404,0.00011756918,0.000031758147,0.0000041222224,0.00005322305,0.00007706951,0.00002634851],"category_scores_gemma":[0.00004735946,0.00012181807,0.00009528487,0.0001365623,0.000040730833,0.000035380883,0.000028022345,0.000020721644,0.0000015358448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015443607,0.0026642685,0.111224264,0.00069774204,0.0005149758,0.00001989386,0.00049793377,0.000008513064,0.8710385,0.0010909464,0.0000071870077,0.012081372],"study_design_scores_gemma":[0.006786909,0.00038851053,0.29416466,0.00018633071,0.0007494862,0.000011077564,0.000059719518,0.00004433091,0.69700813,0.00051837537,0.0000012263779,0.000081229286],"about_ca_topic_score_codex":0.00023936675,"about_ca_topic_score_gemma":0.0000055999103,"teacher_disagreement_score":0.18294041,"about_ca_system_score_codex":0.00004426686,"about_ca_system_score_gemma":0.00027629256,"threshold_uncertainty_score":0.49675968},"labels":[],"label_agreement":null},{"id":"W2568986691","doi":"10.1182/blood.v122.21.847.847","title":"Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; B symptoms; Internal medicine; Diffuse large B-cell lymphoma; Univariate analysis; Lymphoma; Hypoalbuminemia; Stage (stratigraphy); Anemia; Gastroenterology; Retrospective cohort study; International Prognostic Index; Proportional hazards model; Oncology; Multivariate analysis","score_opus":0.015409755426859786,"score_gpt":0.2955500179360719,"score_spread":0.2801402625092121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568986691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559253,0.0010627923,0.000012361684,0.0006007557,0.00009383655,0.0017811131,0.000726102,0.000048282436,0.00008222626],"genre_scores_gemma":[0.99700236,0.0012549936,0.00023947786,0.00023941079,0.00017451598,0.0005567381,0.00041443366,0.00005179035,0.00006628557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623007,0.00036752253,0.0011356276,0.00096761854,0.0005668859,0.0007322779],"domain_scores_gemma":[0.99741536,0.00075443543,0.0005724422,0.0006688745,0.00017701935,0.00041183812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045177346,0.00065638125,0.002138861,0.00042301437,0.00014044814,0.00013261114,0.00020095844,0.00024254255,0.000020025322],"category_scores_gemma":[0.00017004159,0.00036110147,0.0004839225,0.00060537225,0.00032222125,0.00016657477,0.00016564834,0.00016809558,0.000011503841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031460155,0.062092572,0.86483413,0.00007931433,0.003598564,0.0001875366,0.0010923975,8.3763885e-9,0.000008256209,0.000051138308,0.000071023715,0.06767044],"study_design_scores_gemma":[0.09863386,0.002309387,0.8883432,0.0001678718,0.009183972,0.000026231828,0.000225337,0.000115970266,0.00019870786,0.000008701169,0.0004707298,0.00031602246],"about_ca_topic_score_codex":0.00047403303,"about_ca_topic_score_gemma":0.000690805,"teacher_disagreement_score":0.09831926,"about_ca_system_score_codex":0.00021987651,"about_ca_system_score_gemma":0.00016804611,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W2569734962","doi":"10.1182/blood.v120.21.548.548","title":"Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"ABVD; Medicine; Internal medicine; Chemotherapy regimen; Stage (stratigraphy); Oncology; Cancer; Chemotherapy; Vincristine","score_opus":0.19612051797201766,"score_gpt":0.45330023208905645,"score_spread":0.25717971411703877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569734962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988634,0.006228225,0.000006817712,0.00008277784,0.0002438229,0.0038627367,0.00085096323,0.000058295405,0.00003237778],"genre_scores_gemma":[0.99665296,0.0013776447,0.00054297113,0.000085467975,0.00027164415,0.00023643096,0.0007539384,0.00006382539,0.000015113461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416167,0.001067156,0.002312651,0.0009712061,0.0008662329,0.0006210642],"domain_scores_gemma":[0.9951382,0.001215979,0.0012340277,0.0016768789,0.00012037582,0.00061450474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002711402,0.0006480402,0.003015178,0.00020863369,0.0002034753,0.000060485756,0.00030232721,0.00030093346,0.000035806755],"category_scores_gemma":[0.00021037892,0.00046156207,0.0002771311,0.0002393856,0.0003240462,0.00043057874,0.00035955268,0.000120961806,0.000003343629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022764222,0.12677178,0.7799285,0.00008152422,0.0027507092,0.000061602965,0.0071851104,1.0780812e-7,0.0006895605,0.00005703655,0.000066805755,0.08013083],"study_design_scores_gemma":[0.08100193,0.04510183,0.8639592,0.00007228901,0.0030666483,0.0000453663,0.0013896103,0.00005472234,0.004680717,0.000026249249,0.0002582484,0.00034319505],"about_ca_topic_score_codex":0.001701621,"about_ca_topic_score_gemma":0.000330831,"teacher_disagreement_score":0.08403068,"about_ca_system_score_codex":0.000094627285,"about_ca_system_score_gemma":0.0001410697,"threshold_uncertainty_score":0.99978364},"labels":[],"label_agreement":null},{"id":"W2569899586","doi":"10.1182/blood.v114.22.4630.4630","title":"Fibrosis in Nodular Sclerosis Hodgkin Lymphoma Is Predictive of a Residual Mass Following Therapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Biopsy; Lymphoma; Nodular sclerosis; Radiology; Stage (stratigraphy); Fibrosis; Positron emission tomography; Pathology; Hodgkin lymphoma","score_opus":0.018285770705369662,"score_gpt":0.2467269497378719,"score_spread":0.22844117903250225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569899586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436647,0.0028256227,0.000006330482,0.0009297805,0.0000433192,0.00045201863,0.000033638968,0.00004145855,0.0013013693],"genre_scores_gemma":[0.99732685,0.0005829343,0.0012242809,0.0006508932,0.00006908644,0.000050486273,0.000016611231,0.000018066103,0.00006076528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986777,0.000043907647,0.00032337088,0.00032432933,0.000356485,0.00027420965],"domain_scores_gemma":[0.99936515,0.000062922576,0.00008514219,0.00034793545,0.000042740714,0.00009612855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012872569,0.00019229716,0.00043974735,0.00015334414,0.00003915084,0.0000135205655,0.00008559909,0.00011650923,0.000043717162],"category_scores_gemma":[0.000032107593,0.00015741639,0.00022667761,0.0003077364,0.000027434578,0.000078114856,0.000016321415,0.000042399162,0.000010496237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064411864,0.00829,0.859467,0.000033443765,0.0008510602,0.00032575655,0.0020268841,0.000004279005,0.090163365,0.000060298516,0.0007365502,0.03739724],"study_design_scores_gemma":[0.0147559075,0.0014473002,0.6574973,0.00034052038,0.00022200434,0.000008230084,0.00008491199,0.000011588664,0.32531232,0.00010768449,0.00011507932,0.000097163545],"about_ca_topic_score_codex":0.00018546626,"about_ca_topic_score_gemma":0.000004489955,"teacher_disagreement_score":0.23514897,"about_ca_system_score_codex":0.00008864434,"about_ca_system_score_gemma":0.000101395744,"threshold_uncertainty_score":0.64192545},"labels":[],"label_agreement":null},{"id":"W2570113530","doi":"10.1182/blood-2016-11-746701","title":"Exposing Hodgkin-Reed-Sternberg cells","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Reed–Sternberg cell; Lymphoma; Cancer research; Phenotype; Classical Hodgkin lymphoma; Medicine; Immunology; Biology; Hodgkin lymphoma; Genetics; Gene","score_opus":0.025057916329853727,"score_gpt":0.26164228749370777,"score_spread":0.23658437116385406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570113530","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1733953,0.006034461,0.000007453076,0.7055547,0.0031084265,0.0018067941,0.00025332178,0.0003463007,0.109493196],"genre_scores_gemma":[0.07649963,0.00073221757,0.0019502442,0.8384915,0.025211135,0.0003302289,0.0011250577,0.00033201533,0.055327967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830204,0.000025305471,0.00027200163,0.0005292701,0.00042568712,0.0004456847],"domain_scores_gemma":[0.9982884,0.00007942616,0.00024872745,0.0012148992,0.000059618393,0.000108916254],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000058689366,0.00040622838,0.0006593829,0.00010738422,0.00014743485,0.00012689567,0.00023337507,0.00065659126,0.00019811801],"category_scores_gemma":[0.000020932628,0.00031886777,0.0003388637,0.000027849672,0.000068239846,0.00004882253,0.00009300251,0.00051525974,0.0007990995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010754939,0.00063882937,0.00469767,0.00024889884,0.0007246878,0.015841424,0.00006253225,3.8933518e-8,0.000628611,0.0000036422466,0.9747855,0.0023574124],"study_design_scores_gemma":[0.0055831517,0.0003228504,0.003911035,0.0008357522,0.0023228237,0.00055762293,0.0000033285396,6.1132937e-7,0.031952582,0.000018894258,0.95415205,0.0003393177],"about_ca_topic_score_codex":0.00016736367,"about_ca_topic_score_gemma":0.000004358619,"teacher_disagreement_score":0.13293676,"about_ca_system_score_codex":0.00009353522,"about_ca_system_score_gemma":0.00014597081,"threshold_uncertainty_score":0.9999789},"labels":[],"label_agreement":null},{"id":"W2570613797","doi":"10.1182/blood.v106.11.4379.4379","title":"Effect of Bax G125A Single Nucleotide Polymorphism (SNP) on Bax Gene Expression in Diffuse Large Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Mantle cell lymphoma; Single-nucleotide polymorphism; Lymphoma; SNP; Biology; Follicular lymphoma; Molecular biology; Allele; Cancer research; Genotype; Gene; Genetics; Immunology","score_opus":0.008276828658188571,"score_gpt":0.23680512472471318,"score_spread":0.2285282960665246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570613797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936679,0.0017418144,0.0000022359322,0.00019326876,0.0001092743,0.00049041666,0.000031770647,0.000053563585,0.0037097374],"genre_scores_gemma":[0.99836755,0.0001447454,0.00046709063,0.0002720262,0.00025610428,0.000058790978,0.000038273636,0.000043619766,0.00035182218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984846,0.0001049844,0.00034346024,0.00036430074,0.0003229539,0.00037968886],"domain_scores_gemma":[0.99899966,0.0002044072,0.000118516175,0.00048364804,0.000022077758,0.00017169218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017190605,0.00026419412,0.00049061165,0.00016570579,0.000047034628,0.000011324842,0.000097376775,0.00012785777,0.00009483651],"category_scores_gemma":[0.000042966123,0.00019414493,0.00017139043,0.00014953001,0.00002890863,0.000061611456,0.00006150886,0.000060349677,0.00015656033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011084451,0.13672836,0.19125551,0.0002828207,0.00014926984,0.0009068691,0.00062292005,0.0000063985945,0.64183,0.00003853559,0.0015474888,0.025523333],"study_design_scores_gemma":[0.06861565,0.002044039,0.043052256,0.00033064568,0.00022924285,0.000030135105,0.00001164093,0.000025713756,0.88361114,0.0000033949987,0.0018989386,0.0001472219],"about_ca_topic_score_codex":0.000069525144,"about_ca_topic_score_gemma":0.000015739724,"teacher_disagreement_score":0.24178107,"about_ca_system_score_codex":0.00016231037,"about_ca_system_score_gemma":0.000042646938,"threshold_uncertainty_score":0.79170007},"labels":[],"label_agreement":null},{"id":"W2570654636","doi":"10.1182/blood.v120.21.685.685","title":"Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Regimen; Cytarabine; Chemotherapy regimen; Randomization; Cyclophosphamide; Randomized controlled trial; Gastroenterology; Surgery; Chemotherapy; Lymphoma; Oncology","score_opus":0.008948696926539802,"score_gpt":0.24784237510676627,"score_spread":0.23889367818022647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570654636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6650526,0.0000073082906,0.000005863517,0.00020503867,0.000019783354,0.33350426,0.0002879237,0.000034131775,0.0008831127],"genre_scores_gemma":[0.628435,6.3550334e-7,0.00036007536,0.00003881571,0.000038646656,0.3708759,0.00006206826,0.0000354644,0.00015336294],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966152,0.0005324709,0.0011902205,0.00038883102,0.0008466489,0.00042663747],"domain_scores_gemma":[0.99595195,0.00067398977,0.0016648942,0.00092978193,0.00063576346,0.00014359254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063427386,0.00047986727,0.0014367049,0.00013912441,0.00010247472,0.000016574471,0.00028118218,0.00014224634,0.000040884934],"category_scores_gemma":[0.0004980696,0.00019662708,0.00037571715,0.0005126777,0.0007268529,0.00019547371,0.00010613881,0.000117346404,0.0000043726213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41021824,0.038598116,0.5395744,0.00080891995,0.0032483754,0.000011870155,0.002323741,0.0000015184071,0.001569719,0.00023451277,0.0006729728,0.002737666],"study_design_scores_gemma":[0.49058744,0.0025852916,0.403839,0.00078248134,0.001414006,0.0000142072,0.00018535256,0.000011468748,0.10003216,0.000015209874,0.00036080327,0.00017260383],"about_ca_topic_score_codex":0.00033826602,"about_ca_topic_score_gemma":0.000046611665,"teacher_disagreement_score":0.13573538,"about_ca_system_score_codex":0.0001110881,"about_ca_system_score_gemma":0.00017390902,"threshold_uncertainty_score":0.80182195},"labels":[],"label_agreement":null},{"id":"W2570893191","doi":"10.1182/blood.v108.11.2406.2406","title":"The Tumor Microenvironment Measured by Flow Cytometry Predicts Overall Survival (OS) and Transformation Risk (TR) in Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD19; CD5; Immunoglobulin light chain; Follicular lymphoma; CD20; Lymphoma; CD8; Flow cytometry; CD3; CD23; Immunophenotyping; CD38; Biology; Antibody; Pathology; Immunology; Medicine; Antigen; CD34; Stem cell","score_opus":0.004652618496617838,"score_gpt":0.1911235884170518,"score_spread":0.18647096992043397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570893191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186665,0.00627557,0.000043339474,0.00043514432,0.00005714519,0.00058461993,0.00008581815,0.000029179164,0.00062255014],"genre_scores_gemma":[0.99799263,0.0014261083,0.00016122524,0.00008402,0.000060781913,0.00009637668,0.000095993295,0.000017800421,0.00006507919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987303,0.000097187694,0.0002994472,0.00023287802,0.0003664433,0.00027374082],"domain_scores_gemma":[0.9995089,0.00009195019,0.00007464711,0.00022174795,0.000014366702,0.00008839184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003237059,0.00017989466,0.0002406663,0.000056225774,0.00014876758,0.000039744533,0.000054340635,0.000062026884,0.000009650365],"category_scores_gemma":[0.000026708633,0.00012084066,0.0000822512,0.00010279267,0.000050682007,0.00007267031,0.00001573388,0.000062296516,0.00001381754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037891,0.005709057,0.96787024,0.00008003104,0.00042620726,0.00019228284,0.00039436886,0.000039031802,0.008725499,0.0000928648,0.001809233,0.014357381],"study_design_scores_gemma":[0.0219747,0.00023830644,0.93822783,0.00006355929,0.00042069535,0.000076166616,0.000065344655,0.00029956372,0.030997047,0.000077335135,0.00741709,0.00014235718],"about_ca_topic_score_codex":0.00050040433,"about_ca_topic_score_gemma":0.0001253303,"teacher_disagreement_score":0.02964242,"about_ca_system_score_codex":0.00015004925,"about_ca_system_score_gemma":0.00003329357,"threshold_uncertainty_score":0.49277392},"labels":[],"label_agreement":null},{"id":"W2571445838","doi":"10.1182/blood.v118.21.265.265","title":"Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Bortezomib; Oncology; Follicular lymphoma; Refractory (planetary science); Progression-free survival; Phases of clinical research; Biomarker; Population; Lymphoma; Clinical trial; Multiple myeloma; Chemotherapy; Biology","score_opus":0.03461630046728208,"score_gpt":0.2997340328390153,"score_spread":0.2651177323717332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571445838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972865,0.0003180418,0.0000047505746,0.000015197235,0.000116338495,0.0020494575,0.00006334651,0.000027659687,0.00011869393],"genre_scores_gemma":[0.99910295,0.000011476804,0.0005309707,0.000007815634,0.000013025404,0.00023005264,0.00005348425,0.000041883526,0.000008319978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997017,0.00016229477,0.00093019934,0.00052869716,0.0010488863,0.00031291172],"domain_scores_gemma":[0.99733585,0.00013823413,0.00086811907,0.0011509102,0.00038902744,0.000117842996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273306,0.00034677636,0.0007225389,0.0002043893,0.00012106192,0.000018510611,0.0002521343,0.00010766598,0.000030909756],"category_scores_gemma":[0.00015553762,0.00018193426,0.00014250693,0.0007200077,0.00019027208,0.00018126739,0.000102750084,0.00007853884,0.000002001364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012910947,0.12944031,0.842867,0.00007925681,0.0013686396,0.00014115988,0.0011630845,9.838412e-7,0.000685624,0.000011934593,0.000004869933,0.011326155],"study_design_scores_gemma":[0.17112678,0.007949668,0.7849102,0.00040653913,0.0019849716,0.000007815508,0.001210662,0.00001964921,0.032191444,0.0000048146503,0.0000014884388,0.00018598624],"about_ca_topic_score_codex":0.00052705035,"about_ca_topic_score_gemma":0.0004798224,"teacher_disagreement_score":0.15821584,"about_ca_system_score_codex":0.00012964278,"about_ca_system_score_gemma":0.00022863189,"threshold_uncertainty_score":0.74190634},"labels":[],"label_agreement":null},{"id":"W2571616205","doi":"10.1182/blood.v120.21.2687.2687","title":"A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients with Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma: an Eastern Cooperative Oncology Group Study (E3402).","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Radioimmunotherapy; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Ibritumomab tiuxetan; Follicular lymphoma; CHOP; Oncology; Gastroenterology; Lymphoma; Immunology","score_opus":0.010813288822096244,"score_gpt":0.29107461148762936,"score_spread":0.2802613226655331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571616205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909654,0.0013465425,0.00002665228,0.000032768166,0.00013087365,0.007073334,0.00033170654,0.000040860632,0.000051851086],"genre_scores_gemma":[0.997508,0.00018645803,0.00032758314,0.00010303958,0.00011331553,0.0009933338,0.00041976542,0.000066577115,0.00028191978],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980112,0.00020996247,0.00049934397,0.0004530586,0.00030565815,0.0005207982],"domain_scores_gemma":[0.99863344,0.0001634728,0.00031346822,0.0004278955,0.00018427613,0.000277437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030392944,0.0004005747,0.00096023554,0.000096953416,0.0002661485,0.000021988204,0.00009537278,0.00014757989,0.000024289851],"category_scores_gemma":[0.00003235957,0.00027112057,0.00010891095,0.00014627124,0.00007638987,0.00019798623,0.000062395964,0.00005700885,0.000001613796],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07059011,0.6693347,0.236423,0.000052804113,0.0016027746,0.000032044343,0.012873071,6.8435845e-8,0.001549287,0.0000056747735,0.00026066188,0.007275775],"study_design_scores_gemma":[0.7440456,0.23626427,0.011175307,0.000055122007,0.0018935539,0.0000064729547,0.00063191546,0.0000140634575,0.004264848,7.1791726e-7,0.0014121276,0.00023600907],"about_ca_topic_score_codex":0.00015467656,"about_ca_topic_score_gemma":0.00005712159,"teacher_disagreement_score":0.6734555,"about_ca_system_score_codex":0.000115429815,"about_ca_system_score_gemma":0.000153534,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W2571881266","doi":"10.1182/blood.v108.11.3139.3139","title":"Long Term Results of Myeloablative Allogeneic Stem Cell Transplantation Using Related and Unrelated Donors in Patients with Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Stem cell; Univariate analysis; Gastroenterology; Lymphoma; Multivariate analysis; Surgery; Oncology; Biology","score_opus":0.008731107297371723,"score_gpt":0.2149846374896232,"score_spread":0.20625353019225148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571881266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853635,0.00047060775,0.000011659546,0.0000219817,0.000024014667,0.0006802355,0.000084118234,0.000024592735,0.00014642622],"genre_scores_gemma":[0.9990603,0.00031820338,0.0001992466,0.000009723316,0.0000069370017,0.000010600775,0.00035602562,0.000024449992,0.000014532984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868244,0.00006140634,0.00051943527,0.00032063955,0.00019499406,0.00022109918],"domain_scores_gemma":[0.9994628,0.00009452664,0.0001987653,0.00011224732,0.000049177197,0.000082487866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095403506,0.00022045248,0.0003825093,0.00020540383,0.0000638874,0.000013973846,0.00003179198,0.00012767092,9.531282e-7],"category_scores_gemma":[0.0000020909918,0.00017194948,0.000040356455,0.0002325365,0.00010344275,0.00012897229,0.0000103069515,0.00006924972,3.5605882e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015613172,0.0018581767,0.9875432,0.00028158008,0.00018249937,0.00018885237,0.002165339,0.00006534019,0.0045059156,0.000004800045,4.729306e-7,0.0016424764],"study_design_scores_gemma":[0.059998445,0.0006555032,0.8805135,0.0012159523,0.00073052227,0.000046684938,0.000047884343,0.000119153556,0.05651034,0.000008533809,3.2669396e-7,0.0001531494],"about_ca_topic_score_codex":0.00043496277,"about_ca_topic_score_gemma":0.00018945344,"teacher_disagreement_score":0.10702973,"about_ca_system_score_codex":0.00009637744,"about_ca_system_score_gemma":0.00004411077,"threshold_uncertainty_score":0.70118964},"labels":[],"label_agreement":null},{"id":"W2572395858","doi":"10.1182/blood.v126.23.175.175","title":"Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Internal medicine; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.042400746508425714,"score_gpt":0.25966351958422174,"score_spread":0.21726277307579603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572395858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960009,0.0020761753,0.000019896968,0.000020535843,0.00011087074,0.0012151522,0.00043938303,0.00004299032,0.000074095246],"genre_scores_gemma":[0.99034315,0.00028417466,0.0086797625,0.00001979174,0.00009210461,0.00006413735,0.00047450693,0.00002740964,0.000014986563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.00005954568,0.0005598681,0.00037347595,0.00035467223,0.0002052231],"domain_scores_gemma":[0.998952,0.00004227159,0.00030453847,0.00035899103,0.00014058308,0.00020165429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059922528,0.00029033297,0.0006509276,0.00011525277,0.000048342336,0.000009756369,0.000042840657,0.00011074317,0.0000042541396],"category_scores_gemma":[0.00003283111,0.00019731131,0.0001315957,0.00009510261,0.00005630532,0.00008016549,0.000058111505,0.000019816827,0.0000012213673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042017797,0.017806493,0.9387953,0.00008116441,0.00047528648,0.000018323854,0.0008654117,0.000013242952,0.03426323,0.000001495848,0.0000063739794,0.007253495],"study_design_scores_gemma":[0.020155713,0.0020633459,0.56511635,0.00024713544,0.00086744525,0.000010335341,0.00007532794,0.00004174252,0.41133264,0.000007570681,0.00001044587,0.000071962924],"about_ca_topic_score_codex":0.00036149478,"about_ca_topic_score_gemma":0.000002521349,"teacher_disagreement_score":0.3770694,"about_ca_system_score_codex":0.0005533942,"about_ca_system_score_gemma":0.00022515602,"threshold_uncertainty_score":0.80461216},"labels":[],"label_agreement":null},{"id":"W2573048303","doi":"10.3760/cma.j.issn.1009-9921.2008.04.007","title":"Relationship between serum VEGF level and clinical feature in children and adolescent with lymphoid malignancy","year":2008,"lang":"en","type":"article","venue":"Baixuebing linbaliu","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Malignancy; Lymphoma; Stage (stratigraphy); Biology","score_opus":0.06879454911005847,"score_gpt":0.3061600376016105,"score_spread":0.237365488491552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573048303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959324,0.0018237623,0.000009727531,0.0014099812,0.000032153708,0.00046188885,0.00004224921,0.000043873824,0.00024393988],"genre_scores_gemma":[0.997235,0.000366358,0.001336924,0.00038420415,0.00020741129,0.000015449768,0.000063636864,0.000025954832,0.00036504093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873936,0.0000651804,0.00030907025,0.00042410672,0.00020323318,0.00025907168],"domain_scores_gemma":[0.99923825,0.00018188564,0.00008827744,0.00024164037,0.00003306863,0.00021689056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018814499,0.00020786165,0.0004091419,0.0001011021,0.00013313052,0.000020931373,0.00004538743,0.00019160626,0.0000038574904],"category_scores_gemma":[0.00008699631,0.00015528504,0.000055442062,0.00017363878,0.00013481764,0.00007369027,0.000049493578,0.00020369196,0.00000943954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076655895,0.00027954468,0.9956442,0.000028931,0.000067906614,0.0001291184,0.0001071199,4.6973645e-7,0.0000016928149,0.00011095427,0.00063093245,0.0029224535],"study_design_scores_gemma":[0.0070414552,0.0003259983,0.99068356,0.00047530181,0.0001793543,0.00080964545,0.000019836396,0.00000700601,0.000072687915,0.00003474652,0.00017751339,0.00017291652],"about_ca_topic_score_codex":0.00011886193,"about_ca_topic_score_gemma":0.00003220836,"teacher_disagreement_score":0.006964799,"about_ca_system_score_codex":0.00010131254,"about_ca_system_score_gemma":0.00013764345,"threshold_uncertainty_score":0.633234},"labels":[],"label_agreement":null},{"id":"W2573913157","doi":"10.1182/blood.v118.21.4525.4525","title":"Allogeneic Stem Cell Transplantation Is Associated with Prolonged Disease Control in Chemosensitive Aggressive Histology Lymphoma Patients When Done Early","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Transplantation; Internal medicine; Fludarabine; Follicular lymphoma; Surgery; Lymphoma; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.010517424436819833,"score_gpt":0.188283065968567,"score_spread":0.17776564153174718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573913157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784243,0.00040099557,0.000005099811,0.00010475649,0.00003401714,0.000973519,0.0001550734,0.000036451096,0.0004476707],"genre_scores_gemma":[0.9988787,0.000044870423,0.000054375247,0.0005291528,0.0000135726505,0.0002019159,0.00016066927,0.000024357616,0.000092348244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988619,0.0000965503,0.00022555821,0.00033234395,0.00021072978,0.00027291913],"domain_scores_gemma":[0.9992153,0.000059791062,0.00023967338,0.00017014937,0.00014190305,0.00017315315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048986774,0.00020009818,0.0003688184,0.000084714215,0.000041743308,0.0000059414183,0.000045994017,0.00010411587,0.000024435061],"category_scores_gemma":[0.000012994564,0.00015236312,0.000067713714,0.00008600257,0.000058165835,0.000057849415,0.0000067037017,0.00004549583,0.000019359442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027233835,0.007882166,0.97772855,0.00004005571,0.0004100208,0.0035775476,0.005828839,1.5707599e-7,0.00020491707,0.000004398171,0.000034113567,0.0015658736],"study_design_scores_gemma":[0.0511248,0.0012267054,0.9296889,0.0001977764,0.0014678277,0.000023229228,0.000041861815,0.000005824482,0.016052859,0.000015445008,0.000004306097,0.00015047975],"about_ca_topic_score_codex":0.00025368124,"about_ca_topic_score_gemma":0.00013180045,"teacher_disagreement_score":0.04840142,"about_ca_system_score_codex":0.00016265239,"about_ca_system_score_gemma":0.00012642033,"threshold_uncertainty_score":0.62131876},"labels":[],"label_agreement":null},{"id":"W2574226053","doi":"10.1182/blood.v126.23.3971.3971","title":"Prevalence and Prognostic Value of BCL2 and MYC Protein Expression within ABC and GCB Subtypes in Patients with Previously Untreated, Diffuse Large B-Cell Lymphoma: Analysis from the Phase III MAIN Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Tissue microarray; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Medicine; clone (Java method); CHOP; Internal medicine; Immunohistochemistry; Pathology; Cancer research; Biology","score_opus":0.007591549933702428,"score_gpt":0.22901253228905588,"score_spread":0.22142098235535346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574226053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434847,0.0027590564,0.0000031421937,0.00002885561,0.000006498793,0.0027373147,0.00008515395,0.000015622054,0.0000158825],"genre_scores_gemma":[0.9993532,0.00006911154,0.0002484404,0.000018838238,0.000013051292,0.00021034888,0.000040558883,0.000015999396,0.000030466332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985943,0.00017646373,0.0003059224,0.000424319,0.00030163868,0.00019734769],"domain_scores_gemma":[0.99911207,0.00012776774,0.00018211837,0.00033401165,0.00007325747,0.00017077339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026074608,0.0002197963,0.00045692894,0.00009224544,0.000062840525,0.000031743584,0.00006177872,0.00005752135,0.0000034787183],"category_scores_gemma":[0.00007990394,0.00011910857,0.000027262595,0.00026387552,0.00008443237,0.00008441487,0.000090886155,0.00004871608,5.180952e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011253586,0.03830207,0.9546646,0.000088277964,0.00046963737,0.000064207474,0.0048818253,7.741341e-7,0.00010436744,0.0000037983646,0.0000063727225,0.00028869614],"study_design_scores_gemma":[0.14541437,0.0029005085,0.84422666,0.00038433677,0.0037705062,0.000003749393,0.00066860364,0.00008464086,0.0024122905,0.000015020436,0.0000020031782,0.00011732949],"about_ca_topic_score_codex":0.00076344836,"about_ca_topic_score_gemma":0.00020172108,"teacher_disagreement_score":0.144289,"about_ca_system_score_codex":0.00003109663,"about_ca_system_score_gemma":0.00007351248,"threshold_uncertainty_score":0.48571065},"labels":[],"label_agreement":null},{"id":"W2574289250","doi":"10.1182/blood.v126.23.3950.3950","title":"Maintenance Rituximab Following R-CHOP Chemotherapy in Patients with Composite or Discordant, Indolent and Aggressive, B-Cell Non-Hodgkin Lymphomas","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Internal medicine; CHOP; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Mantle cell lymphoma; Chemotherapy; B symptoms; Aggressive lymphoma; Gastroenterology; Oncology","score_opus":0.007914555491966384,"score_gpt":0.2283367514092352,"score_spread":0.22042219591726883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574289250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974032,0.00065684447,0.000010425118,0.00018938012,0.00007321027,0.0006976168,0.000012228045,0.000026737098,0.0009303557],"genre_scores_gemma":[0.9970703,0.00011865303,0.0020508165,0.00041650428,0.0000345659,0.00007672093,0.000028639284,0.000035564346,0.00016820933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873495,0.000026222693,0.00023449892,0.00036332506,0.00031763013,0.00032337758],"domain_scores_gemma":[0.9992637,0.00003866602,0.00014483131,0.0002692187,0.000058022943,0.00022558053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007611841,0.00024673215,0.0004561431,0.00008944318,0.000044352186,0.000034148,0.00007010492,0.000049916856,0.0000071748354],"category_scores_gemma":[0.000020232585,0.00015032857,0.000059995764,0.0001763756,0.000048928956,0.00009998215,0.00004596579,0.00006772397,0.0000123693235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016842249,0.009674536,0.9821083,0.000041852432,0.00016181852,0.0013347166,0.00051337975,7.4690996e-7,0.00009818829,0.0000045680563,0.00018948031,0.004188165],"study_design_scores_gemma":[0.17937991,0.0018975155,0.8116618,0.0008667123,0.00021442283,0.000082128216,0.00011813731,0.000021880485,0.005222216,0.000011116161,0.00030040726,0.00022378023],"about_ca_topic_score_codex":0.00014327554,"about_ca_topic_score_gemma":0.000040796593,"teacher_disagreement_score":0.17769568,"about_ca_system_score_codex":0.0001337577,"about_ca_system_score_gemma":0.00013840609,"threshold_uncertainty_score":0.61302215},"labels":[],"label_agreement":null},{"id":"W2574480355","doi":"10.1182/blood.v114.22.1676.1676","title":"Durable Responses After Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory (R/R) Aggressive Non-Hodgkin's Lymphoma (a-NHL): Results From An International Phase 2 Study (CC-5013-NHL-003).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Mantle cell lymphoma; Lymphoma; Neutropenia; Diffuse large B-cell lymphoma; Oncology; Gastroenterology; Follicular lymphoma; Aggressive lymphoma; Rituximab; Chemotherapy; Multiple myeloma","score_opus":0.01289076447935709,"score_gpt":0.30015439284438994,"score_spread":0.28726362836503283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574480355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708235,0.00016032303,0.0000022451861,0.0004511796,0.00016774036,0.0014179484,0.00039438324,0.00007308411,0.00025076888],"genre_scores_gemma":[0.9969113,0.0001151049,0.0008333773,0.0009386598,0.00017249848,0.00021294151,0.00047079247,0.00005169233,0.00029364624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972465,0.00021593613,0.000663879,0.0007994678,0.0006830773,0.00039116162],"domain_scores_gemma":[0.9981453,0.00021959087,0.0004147487,0.0007637903,0.00021665727,0.00023994094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022537065,0.0004153599,0.0005982102,0.0002944275,0.00008375644,0.00008562258,0.00021562348,0.00014074521,0.00013673386],"category_scores_gemma":[0.00024406798,0.00028020111,0.0000870601,0.00028476163,0.00004811412,0.0004497546,0.00003155387,0.00012492437,0.000030888903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18823111,0.1467138,0.6303259,0.0000043640275,0.0007378468,0.0046831216,0.0027266836,0.0000026941793,0.00021562866,0.000001650746,0.00039391083,0.02596327],"study_design_scores_gemma":[0.2963481,0.0123247225,0.6878402,0.00027148536,0.0002592068,0.000013934092,0.00024250486,0.000016012222,0.0020124356,0.00001137786,0.00041238277,0.00024760753],"about_ca_topic_score_codex":0.0007901036,"about_ca_topic_score_gemma":0.0003145163,"teacher_disagreement_score":0.13438907,"about_ca_system_score_codex":0.00027900914,"about_ca_system_score_gemma":0.0002974042,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2575159787","doi":"10.1182/blood.v106.11.817.817","title":"Relapse Patterns and Subsequent Outcomes of Patients Treated on the NCIC CTG HD.6 (ECOG JHD06) Randomized Trial Evaluating ABVD Alone in Patients with Limited Stage Hodgkin Lymphoma (HL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"ABVD; Medicine; Randomized controlled trial; Internal medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy regimen; Rituximab; Randomization; Chemotherapy; Surgery; Oncology; Lymphoma; Vincristine","score_opus":0.01926074541019198,"score_gpt":0.26442736224135854,"score_spread":0.24516661683116656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575159787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950038,0.00009903021,6.368613e-7,0.00032513216,0.000066544315,0.0042077117,0.00012001885,0.000032865395,0.00014424737],"genre_scores_gemma":[0.99864286,0.0000556553,0.00011872829,0.00029704298,0.000039870512,0.0004429691,0.00022864157,0.000040309435,0.00013389385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972449,0.00042713078,0.00082341203,0.0004341595,0.00072844385,0.0003419395],"domain_scores_gemma":[0.9979834,0.0008164292,0.0004449568,0.00047009005,0.00016222059,0.00012292412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060971716,0.000365236,0.0011417129,0.0001928189,0.00007495321,0.000032805638,0.00009563936,0.00011217751,0.00005393521],"category_scores_gemma":[0.0005452201,0.0001947062,0.0001796401,0.00020040506,0.000079361824,0.00010277881,0.00004648455,0.0000889383,0.000008874142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22510096,0.009871934,0.75986266,0.000023582155,0.0005750803,0.000017797925,0.0003936255,0.0000033451336,0.0000055170517,0.000016843218,0.000011497222,0.0041171866],"study_design_scores_gemma":[0.48862123,0.0024439364,0.50705296,0.0001403877,0.0005572146,6.4028717e-7,0.00002464313,0.000031604675,0.0010152117,0.0000024067854,0.000004843058,0.000104934115],"about_ca_topic_score_codex":0.00049379707,"about_ca_topic_score_gemma":0.00018885832,"teacher_disagreement_score":0.26352027,"about_ca_system_score_codex":0.00019149345,"about_ca_system_score_gemma":0.000087265784,"threshold_uncertainty_score":0.7939888},"labels":[],"label_agreement":null},{"id":"W2575338530","doi":"10.1182/blood.v104.11.701.701","title":"Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; Germinal center; Mantle cell lymphoma; Diffuse large B-cell lymphoma; Microarray; Significance analysis of microarrays; Cancer research; DNA microarray; Biology; Gene expression profiling; Gene; B cell; Gene expression; Immunology; Genetics; Antibody","score_opus":0.009388363780397606,"score_gpt":0.2506048230573112,"score_spread":0.24121645927691357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575338530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312717,0.0028571936,0.000049529604,0.0017670434,0.000053603708,0.0016359105,0.000030205134,0.000050466544,0.0004288638],"genre_scores_gemma":[0.9896326,0.0005373097,0.0064261234,0.0006481645,0.00006569458,0.0025839536,0.000034644694,0.00004364426,0.000027867887],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986365,0.000016392529,0.00029306117,0.00047740046,0.00017477713,0.0004018806],"domain_scores_gemma":[0.9993549,0.00008474755,0.00006604408,0.00024572827,0.00005730837,0.00019125012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011416936,0.0002550458,0.00042154235,0.00016713899,0.000061592225,0.00003753421,0.000072469564,0.00013892225,0.000010708194],"category_scores_gemma":[0.00006943318,0.00021841121,0.00015145793,0.00022639625,0.000059649738,0.000064544874,0.000042226882,0.000032231554,0.00001885273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018248284,0.01290077,0.93720555,0.00031180395,0.00049148564,0.001159071,0.0007197917,0.0000092235005,0.008978686,0.00063066435,0.00028899417,0.03712149],"study_design_scores_gemma":[0.057104502,0.0013841323,0.46605134,0.0006350011,0.0009048498,0.0003404748,0.000117807285,0.0000113987835,0.47036064,0.0004694117,0.002242584,0.00037786682],"about_ca_topic_score_codex":0.00032079214,"about_ca_topic_score_gemma":0.000053382442,"teacher_disagreement_score":0.4711542,"about_ca_system_score_codex":0.00018682487,"about_ca_system_score_gemma":0.00016229144,"threshold_uncertainty_score":0.8906551},"labels":[],"label_agreement":null},{"id":"W2575531189","doi":"10.1182/blood.v120.21.902.902","title":"An Open-Label, Randomized Study of Bendamustine and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL): The Bright Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Vincristine; Rituximab; Bendamustine; Internal medicine; CHOP; Prednisone; Gastroenterology; Cyclophosphamide; Regimen; Surgery; Chemotherapy; Lymphoma","score_opus":0.014174613242557789,"score_gpt":0.27005066347700735,"score_spread":0.25587605023444954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575531189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756879,0.006562383,0.000018640005,0.00008641992,0.0001104569,0.016913982,0.0004236125,0.00007964804,0.00011695319],"genre_scores_gemma":[0.9917716,0.0021316924,0.0032054048,0.00007117044,0.000074292155,0.0022512309,0.0001900421,0.00017872729,0.00012585317],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935493,0.0005600054,0.0020789965,0.001574482,0.0011381496,0.001099062],"domain_scores_gemma":[0.99484384,0.001187318,0.0013079321,0.0015055662,0.00051923504,0.00063611224],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008315763,0.0014224409,0.004509014,0.00037632693,0.00047337325,0.00014543514,0.00047396985,0.00021189399,0.000054037304],"category_scores_gemma":[0.00015543643,0.00075905776,0.000090745896,0.00090436696,0.0007139504,0.00061291043,0.00046279,0.00015425017,0.0000029488747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19618498,0.30171132,0.48698384,0.00039097236,0.0013824024,0.00029519494,0.005032157,0.000010579243,0.000076421245,0.00000457014,0.000017743452,0.007909843],"study_design_scores_gemma":[0.51816887,0.02777517,0.44580948,0.00043748863,0.0032006255,0.000115672214,0.00183584,0.00017236892,0.0018983126,0.0000036067363,0.000070332666,0.00051222317],"about_ca_topic_score_codex":0.006226383,"about_ca_topic_score_gemma":0.003512064,"teacher_disagreement_score":0.3219839,"about_ca_system_score_codex":0.00030772513,"about_ca_system_score_gemma":0.00035075672,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W2577706754","doi":"10.1182/blood.v126.23.1995.1995","title":"Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Cytarabine; Rituximab; Internal medicine; CHOP; Surgery; Induction chemotherapy; Autologous stem-cell transplantation; Chemotherapy; Oncology; Lymphoma","score_opus":0.018229834114505242,"score_gpt":0.23787264047757842,"score_spread":0.21964280636307318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577706754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549526,0.0013407636,0.00009663357,0.00019344957,0.000058983518,0.0011066851,0.00020697874,0.000042668762,0.0014585848],"genre_scores_gemma":[0.99758995,0.00028114687,0.000717116,0.000054697623,0.00003224196,0.00019405443,0.00047789034,0.000024786188,0.00062813],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998862,0.000032822198,0.00031931076,0.0003622207,0.00018492203,0.00023870339],"domain_scores_gemma":[0.9992369,0.000083774314,0.00020284607,0.00021944987,0.00010217912,0.00015487777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011571144,0.00022173354,0.00045759333,0.00006231988,0.000052388383,0.000015517346,0.000038662536,0.00010099791,0.0000013880019],"category_scores_gemma":[0.000004914315,0.00015486556,0.00006701265,0.00006524835,0.000056930305,0.00007873705,0.000008634548,0.000025706635,0.000004306003],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07433164,0.09980357,0.6099354,0.0024410428,0.002910142,0.0030789413,0.016444407,0.000021071344,0.07812516,0.00020602616,0.0033818423,0.109320775],"study_design_scores_gemma":[0.28805536,0.0170536,0.064261116,0.0004392197,0.0022987544,0.00088047737,0.0005139161,0.000045677512,0.6256033,0.000013822353,0.0005059036,0.0003288395],"about_ca_topic_score_codex":0.00018836201,"about_ca_topic_score_gemma":0.000027235088,"teacher_disagreement_score":0.54747814,"about_ca_system_score_codex":0.00021892702,"about_ca_system_score_gemma":0.00026316784,"threshold_uncertainty_score":0.63152343},"labels":[],"label_agreement":null},{"id":"W2578034297","doi":"10.1182/blood.v108.11.4667.4667","title":"Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AIDS Vancouver; BC Cancer Agency; University of British Columbia","funders":"","keywords":"CD30; Medicine; Anaplastic large-cell lymphoma; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Internal medicine; T-cell lymphoma; Oncology; Rituximab; B symptoms; Pathology; Immunology","score_opus":0.005286514178820113,"score_gpt":0.20920402721297465,"score_spread":0.20391751303415454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578034297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953961,0.00028927863,0.000016372287,0.00009064559,0.00009674278,0.002427597,0.000039281575,0.000053906035,0.0015900737],"genre_scores_gemma":[0.99872863,0.000024341989,0.00009725789,0.00007814631,0.000038069324,0.00036330568,0.00011418778,0.00003874201,0.0005173397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979216,0.000040709405,0.00089314237,0.00039122044,0.0004108908,0.0003424377],"domain_scores_gemma":[0.9989371,0.00006837762,0.0004440443,0.00031420105,0.00014958056,0.00008672402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016126408,0.00030181828,0.0007982155,0.00023175066,0.00005066958,0.000020172818,0.00006048719,0.00014270828,0.000026619839],"category_scores_gemma":[0.000018833969,0.00021138597,0.0001714223,0.00025771683,0.000030785286,0.00009470166,0.000033396318,0.0000680576,0.000046973713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061059074,0.009539582,0.9862892,0.00034309187,0.00027482185,0.000054373475,0.00016607462,0.000021526417,0.0013449073,0.000026875503,0.00011058515,0.001218386],"study_design_scores_gemma":[0.15957147,0.001772929,0.80691636,0.0005616843,0.000978543,0.000016900813,0.000044707176,0.00027250318,0.029562013,0.000009790788,0.000061697974,0.00023139287],"about_ca_topic_score_codex":0.0012941193,"about_ca_topic_score_gemma":0.000059573744,"teacher_disagreement_score":0.17937282,"about_ca_system_score_codex":0.00037880873,"about_ca_system_score_gemma":0.000115328614,"threshold_uncertainty_score":0.86200696},"labels":[],"label_agreement":null},{"id":"W2578976908","doi":"10.1182/blood.v104.11.3253.3253","title":"Transformed Lymphoma: Incidence and Long-Term Outcome.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Lymphoplasmacytic Lymphoma; Internal medicine; Population; Incidence (geometry); Gastroenterology; Marginal zone; Immunology; Waldenstrom macroglobulinemia; B cell; Antibody","score_opus":0.01699762616396155,"score_gpt":0.27650044243866967,"score_spread":0.2595028162747081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578976908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960917,0.0014094969,0.000023560584,0.0009174658,0.00004588272,0.000270234,0.000004401126,0.000052922514,0.0011843003],"genre_scores_gemma":[0.9986803,0.00031987904,0.00034947623,0.00043591732,0.000054492906,0.000039980918,0.000009640541,0.000011684141,0.00009860852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993021,0.0000054009397,0.00016707173,0.00019191418,0.00015283853,0.00018069895],"domain_scores_gemma":[0.9996134,0.000023938264,0.000025825484,0.0001674541,0.000021703125,0.00014767525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042592514,0.00012107749,0.00021392122,0.000042074404,0.000051837033,0.000016492337,0.000036481542,0.0000558605,0.000026959578],"category_scores_gemma":[0.000019094654,0.00008950394,0.000064825945,0.00007060875,0.000047316964,0.00006050665,0.00001424879,0.000024882895,0.00004725445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027663482,0.0017002455,0.985416,0.000065128654,0.0000989295,0.0007397681,0.00019755853,1.7787735e-7,0.0003586124,0.00029783743,0.0000067988935,0.011091309],"study_design_scores_gemma":[0.018613275,0.00030220795,0.9614879,0.00010118353,0.00036665704,0.0007276561,0.000013976449,2.451169e-7,0.018138899,0.00008942589,0.00006634774,0.00009223478],"about_ca_topic_score_codex":0.000068156136,"about_ca_topic_score_gemma":0.000060906856,"teacher_disagreement_score":0.02392808,"about_ca_system_score_codex":0.00006927558,"about_ca_system_score_gemma":0.000085678046,"threshold_uncertainty_score":0.36498648},"labels":[],"label_agreement":null},{"id":"W2579282512","doi":"10.1016/s1499-3872(16)60169-8","title":"Percutaneous liver biopsy: retrospective study of primary and secondary hepatic lymphoma in twenty-one patients","year":2017,"lang":"en","type":"article","venue":"Hepatobiliary & pancreatic diseases international","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Histopathology; Pathological; Pathology; Liver biopsy; Radiology; Chronic lymphocytic leukemia; Internal medicine; Leukemia","score_opus":0.011901635257725002,"score_gpt":0.25277685816757434,"score_spread":0.24087522290984933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579282512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403185,0.0005464294,0.0000010704405,0.00009000467,0.00033304343,0.0010650129,0.00022959207,0.000027835213,0.0036751374],"genre_scores_gemma":[0.9986987,0.0004303427,0.00014785428,0.00011409711,0.00007889854,0.00011928522,0.00018193254,0.000026485937,0.00020239849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808884,0.000069174865,0.00048379123,0.0005144935,0.0006259827,0.00021772954],"domain_scores_gemma":[0.9985731,0.00010565303,0.00029657382,0.00062248856,0.00021234057,0.00018979913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008651026,0.0002565549,0.0006318189,0.00018948971,0.0001371063,0.00007395505,0.00022675708,0.00006131195,0.00031568686],"category_scores_gemma":[0.00029038548,0.00022766925,0.00012051435,0.00005903269,0.00023913984,0.0002615593,0.00024222529,0.000068922134,0.00001527334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007084354,0.01238742,0.97316,0.00013801557,0.00056763575,0.00090972695,0.00048036885,6.717397e-7,0.000033990313,0.00011889535,0.00007894478,0.011415865],"study_design_scores_gemma":[0.007758743,0.0009305374,0.9892205,0.00037260598,0.0005308069,0.000113439855,0.00018141165,0.00045562614,0.000027906995,0.0001890165,0.000036974023,0.00018243158],"about_ca_topic_score_codex":0.0017956238,"about_ca_topic_score_gemma":0.0000955668,"teacher_disagreement_score":0.01606047,"about_ca_system_score_codex":0.0006398262,"about_ca_system_score_gemma":0.0001804885,"threshold_uncertainty_score":0.92840827},"labels":[],"label_agreement":null},{"id":"W2580290952","doi":"10.1182/blood.v118.21.500.500","title":"Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Internal medicine; Etoposide; Melphalan; Oncology; Transplantation; Nuclear medicine; Surgery; Lymphoma; Chemotherapy","score_opus":0.06271588304624544,"score_gpt":0.3080659076009948,"score_spread":0.24535002455474936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580290952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942174,0.00017512971,0.00020609908,0.00033174732,0.001174003,0.0031860922,0.00029325383,0.0002609417,0.00015536454],"genre_scores_gemma":[0.9946594,0.00052504323,0.0019796554,0.00039813013,0.00036399925,0.0011211459,0.0002393386,0.00010767077,0.0006056066],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966135,0.00019268066,0.0011653551,0.00093234447,0.00044452935,0.00065160857],"domain_scores_gemma":[0.9981297,0.0002301016,0.00061456306,0.00054732227,0.00021527942,0.00026301295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060778455,0.00052052614,0.00088509114,0.00020749407,0.00024548455,0.00010818077,0.00021233207,0.00010928727,0.000049330203],"category_scores_gemma":[0.000028041033,0.00033669916,0.0004064459,0.00015840835,0.00010093052,0.0002883754,0.000041187282,0.000144994,0.00003170925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022350794,0.18688254,0.519183,0.002887522,0.003816882,0.007437293,0.0059901956,0.0000012215434,0.2016828,0.00060831493,0.00044542243,0.048714068],"study_design_scores_gemma":[0.13457662,0.0026268335,0.07824392,0.00013009194,0.0023457478,0.0004776018,0.00036186137,0.00002389522,0.780524,0.000046093523,0.0002043764,0.00043895032],"about_ca_topic_score_codex":0.000657893,"about_ca_topic_score_gemma":0.00009419431,"teacher_disagreement_score":0.5788412,"about_ca_system_score_codex":0.00016706246,"about_ca_system_score_gemma":0.00023279728,"threshold_uncertainty_score":0.9999085},"labels":[],"label_agreement":null},{"id":"W2580771489","doi":"10.1182/blood.v110.11.50.50","title":"Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Gene; Proportional hazards model; Biology; Oncology; Cancer research; Lymphoma; Internal medicine; Immunology; Medicine; B cell; Genetics; Antibody","score_opus":0.009677157934338883,"score_gpt":0.23769951852909055,"score_spread":0.22802236059475167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580771489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977702,0.000524707,0.000020470712,0.000023024479,0.000091449336,0.0011970808,0.00015873839,0.000067080466,0.00014726032],"genre_scores_gemma":[0.9984517,0.000054648935,0.0007501324,0.00010927367,0.00003274121,0.000039145594,0.00037438964,0.000048700498,0.00013925247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997544,0.0001247871,0.000593029,0.0006345817,0.00042548447,0.00067812664],"domain_scores_gemma":[0.99884015,0.000109257766,0.0002762033,0.00033319634,0.00012061619,0.00032055186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031500336,0.00042841968,0.0007139528,0.00016374179,0.0002269165,0.00003859652,0.000068102636,0.00025174342,0.000017772052],"category_scores_gemma":[0.000031932897,0.00033690076,0.0000789609,0.00017597705,0.00007622748,0.00018611498,0.00013435491,0.00013199073,0.0000025835466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660889,0.0434899,0.9498766,0.00008131473,0.0001245374,0.0005076753,0.0009395572,8.0224424e-7,0.0027033999,0.0000036720267,0.00004201285,0.00076442957],"study_design_scores_gemma":[0.16432066,0.00094703824,0.8139604,0.00032208677,0.00039986245,0.0000555859,0.0000616435,0.00054419256,0.01896569,0.0000044825174,0.0000979478,0.0003204442],"about_ca_topic_score_codex":0.00058135396,"about_ca_topic_score_gemma":0.000535983,"teacher_disagreement_score":0.16285457,"about_ca_system_score_codex":0.00043900692,"about_ca_system_score_gemma":0.00007002898,"threshold_uncertainty_score":0.9999083},"labels":[],"label_agreement":null},{"id":"W2580774047","doi":"10.1182/blood.v106.11.923.923","title":"Bendamustine HCl (TREANDATM) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; Hôpital Notre-Dame; Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Non-Hodgkin's lymphoma; Population; Lymphoma; Oncology","score_opus":0.008431412163650037,"score_gpt":0.24654799173247222,"score_spread":0.23811657956882218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580774047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464214,0.00022555204,6.7491584e-7,0.00022302417,0.000040048133,0.003534445,0.00075428927,0.000034956964,0.0005448731],"genre_scores_gemma":[0.99761444,0.00011338691,0.0006606382,0.000057897974,0.000037476388,0.00034332584,0.0009245516,0.000052362782,0.00019589183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690974,0.00024867663,0.00084923307,0.0010182724,0.00050157635,0.00047252566],"domain_scores_gemma":[0.99841046,0.0003707545,0.0003446477,0.0005650151,0.00012472756,0.00018438703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027597594,0.000527405,0.0007947013,0.0005182938,0.00010078708,0.00003839165,0.0000922837,0.0001426937,0.000011530932],"category_scores_gemma":[0.00007307494,0.00037209172,0.000048862657,0.00038897173,0.00006682448,0.00022658975,0.00007752685,0.00015488676,0.000011783005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07355038,0.31411615,0.5877661,0.000019750132,0.00016431398,0.0009855292,0.012265477,0.0000151326085,0.000094399606,2.806036e-7,0.000026788905,0.010995701],"study_design_scores_gemma":[0.42164347,0.02172136,0.547593,0.00025836978,0.00028058173,0.000002518515,0.00097539683,0.00007559282,0.0071378434,7.6189826e-7,0.00009310854,0.00021801436],"about_ca_topic_score_codex":0.0050823013,"about_ca_topic_score_gemma":0.008603286,"teacher_disagreement_score":0.34809306,"about_ca_system_score_codex":0.000979568,"about_ca_system_score_gemma":0.0002241347,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W2580892928","doi":"10.1182/blood.v114.22.3699.3699","title":"Identification of Potential Surrogate Endpoints in Randomized Clinical Trials of Aggressive Non-Hodgkin Lymphoma: Correlation of Complete Response, Time-to-Event and Overall Survival Data.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Surrogate endpoint; Medicine; Internal medicine; Clinical endpoint; Randomized controlled trial; Mantle cell lymphoma; Progression-free survival; Oncology; Aggressive lymphoma; Lymphoma; Clinical trial; Rituximab; Overall survival","score_opus":0.046596878227355976,"score_gpt":0.3686681641389251,"score_spread":0.32207128591156914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580892928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970786,0.00040878367,0.00031141544,0.00033619933,0.00011997597,0.0013844453,0.00030740912,0.0000070027236,0.000046174137],"genre_scores_gemma":[0.9989109,0.00024695764,0.00041293915,0.000024698673,0.000044518292,0.0000161176,0.00027215693,0.000009142788,0.000062568564],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99464434,0.002102006,0.0024054975,0.00034211855,0.00037035625,0.00013567583],"domain_scores_gemma":[0.99402654,0.0029874374,0.0022166127,0.0005089897,0.00016642107,0.00009399496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011024451,0.00014704584,0.0018061509,0.00021162408,0.000017057393,0.000007352459,0.00011682408,0.00011124067,0.00003799365],"category_scores_gemma":[0.0076957135,0.00011657531,0.00024717313,0.00014936004,0.000107027445,0.00007292053,0.00006579311,0.000043380885,0.000010020749],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6582418,0.022530407,0.060954694,0.00024338135,0.0022075772,0.00025785042,0.000870769,0.00020529846,0.20412907,0.00023502544,0.00060001947,0.04952408],"study_design_scores_gemma":[0.34151557,0.00072276074,0.6319554,0.00045246747,0.0011538399,0.000018802059,0.000021748254,0.0031880108,0.02075295,0.00011421974,0.00001350623,0.00009075755],"about_ca_topic_score_codex":0.000076016484,"about_ca_topic_score_gemma":0.000005199378,"teacher_disagreement_score":0.5710007,"about_ca_system_score_codex":0.000027569089,"about_ca_system_score_gemma":0.00015860454,"threshold_uncertainty_score":0.92130435},"labels":[],"label_agreement":null},{"id":"W2580964459","doi":"10.1182/blood.v116.21.2359.2359","title":"Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Internal medicine; Surgery; Hematopoietic stem cell transplantation; Incidence (geometry); Retrospective cohort study; Autologous stem-cell transplantation; Gastroenterology","score_opus":0.018982690318023628,"score_gpt":0.2647679251694675,"score_spread":0.24578523485144388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580964459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98603565,0.0015036688,0.00026768717,0.0014592877,0.00009768748,0.0052423496,0.0053608706,0.000029163175,0.0000036673655],"genre_scores_gemma":[0.9952955,0.0007986929,0.0012799993,0.0003018881,0.00011757999,0.0017583107,0.0003911674,0.00003312624,0.000023736666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986267,0.000053343723,0.00036570034,0.00039810565,0.00029605176,0.00026010568],"domain_scores_gemma":[0.9988561,0.00042346944,0.00017050348,0.00030569846,0.00012907572,0.0001151209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019271922,0.00024413202,0.00036434556,0.000026013564,0.00022833762,0.000038674916,0.00008829354,0.000089616406,0.000031668522],"category_scores_gemma":[0.000023956656,0.00013352199,0.00036288172,0.00009598839,0.000095323056,0.00006650495,0.0000070760684,0.00007095353,6.211055e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113722,0.0037407868,0.9633405,0.00014213104,0.001303509,0.000009957914,0.011952627,8.649152e-8,0.016279258,0.0000299078,0.00010722045,0.0023826335],"study_design_scores_gemma":[0.027982289,0.0009679799,0.924276,0.00003058416,0.0034819455,0.00000555485,0.00049710873,0.000047526213,0.042193692,0.00023627383,0.0001402902,0.00014078521],"about_ca_topic_score_codex":0.0006905399,"about_ca_topic_score_gemma":0.00044561402,"teacher_disagreement_score":0.039064538,"about_ca_system_score_codex":0.00003519343,"about_ca_system_score_gemma":0.0000999324,"threshold_uncertainty_score":0.5444869},"labels":[],"label_agreement":null},{"id":"W2581166283","doi":"10.1182/blood.v110.11.4457.4457","title":"Single Institution Outcomes for Early Stage Follicular Lymphomas Treated with Radiation Therapy Alone as Initial Therapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Follicular lymphoma; Surgery; Lymphoma; Internal medicine; Gastroenterology","score_opus":0.024778155724331213,"score_gpt":0.2857142948610816,"score_spread":0.26093613913675034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581166283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543816,0.001036945,0.00015486983,0.00021399299,0.00006309217,0.0013431953,0.000022233738,0.00011327185,0.0016142343],"genre_scores_gemma":[0.9979332,0.00026731414,0.0004980598,0.0005235559,0.00014722053,0.00015520767,0.00015433962,0.0000321692,0.00028893835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989447,0.000019748899,0.00022911138,0.00026645727,0.00026161768,0.00027833637],"domain_scores_gemma":[0.9993541,0.000084611274,0.00010346301,0.000238629,0.00009800148,0.0001211981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013407145,0.0002157565,0.00031225506,0.00011514047,0.00012224627,0.000036158825,0.00004463855,0.00010897642,0.000036354555],"category_scores_gemma":[0.000023682542,0.00014039646,0.00013490353,0.00016737085,0.000046682755,0.00012217424,0.0000052491773,0.000032064265,0.000016628848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002057925,0.006884078,0.9172117,0.000013372483,0.001110746,0.00034044342,0.00042673838,0.0000020720056,0.004067342,0.0005372245,0.000025958137,0.067322396],"study_design_scores_gemma":[0.04672129,0.0038925628,0.63654095,0.000027196143,0.00019478353,0.000047233905,0.000032627067,0.000002660682,0.30675498,0.000022046936,0.0056157582,0.00014789993],"about_ca_topic_score_codex":0.000697809,"about_ca_topic_score_gemma":0.00003966616,"teacher_disagreement_score":0.30268764,"about_ca_system_score_codex":0.0001358203,"about_ca_system_score_gemma":0.00012185858,"threshold_uncertainty_score":0.57252014},"labels":[],"label_agreement":null},{"id":"W2581187342","doi":"10.1182/blood.v104.11.5203.5203","title":"A Simplified Real-Time PCR Method for the Quantification of Minimal Residual Disease in Follicular Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Minimal residual disease; Follicular lymphoma; Polymerase chain reaction; clone (Java method); Real-time polymerase chain reaction; Medicine; Internal medicine; Molecular biology; Biology; Oncology; Lymphoma; Bone marrow; DNA","score_opus":0.02464778563486529,"score_gpt":0.30591447122937876,"score_spread":0.28126668559451345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581187342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513775,0.0007291787,0.00047893927,0.0023237574,0.000025378205,0.0010463907,0.000061792736,0.000024933734,0.00017189288],"genre_scores_gemma":[0.9900458,0.000115064904,0.009175792,0.000086772176,0.00006708141,0.00033781538,0.000076302895,0.00001695587,0.00007842698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910474,0.00003789027,0.0002747988,0.00023299867,0.00018019919,0.00016934687],"domain_scores_gemma":[0.9990657,0.00031210046,0.00009169131,0.0003821322,0.000060210397,0.00008814552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025365042,0.00011335547,0.0002403113,0.00006162459,0.000046559744,0.000009556399,0.000073548494,0.00004976445,0.000010408428],"category_scores_gemma":[0.00016922868,0.000073888026,0.00013243713,0.00014614167,0.000033300694,0.00002801525,0.000017469914,0.000016912474,0.000011490782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013301969,0.08314675,0.3844964,0.001663497,0.004776644,0.0012726363,0.00512466,0.0021245456,0.35646793,0.07267556,0.0030378231,0.0719116],"study_design_scores_gemma":[0.025759019,0.00044959635,0.84429985,0.00015403701,0.0015312033,0.000017935416,0.00010087073,0.00033467275,0.12570144,0.0010036984,0.000516238,0.00013145067],"about_ca_topic_score_codex":0.00057301397,"about_ca_topic_score_gemma":0.00002677156,"teacher_disagreement_score":0.45980346,"about_ca_system_score_codex":0.00006390589,"about_ca_system_score_gemma":0.00022991773,"threshold_uncertainty_score":0.30130664},"labels":[],"label_agreement":null},{"id":"W2581270594","doi":"10.1182/blood.v104.11.4581.4581","title":"Evaluation of Early Stage Hodgkin’s Lymphoma Treatment: Two Decades of Progress.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Chemotherapy; Lymphoma; Surgery; Survival rate; Chemotherapy regimen; Internal medicine; Oncology","score_opus":0.04432307033459863,"score_gpt":0.3355037672619981,"score_spread":0.29118069692739945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581270594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940697,0.0034090406,0.0000020197483,0.000116576935,0.000030546755,0.000710842,0.00003263316,0.000024107025,0.0016045604],"genre_scores_gemma":[0.99818236,0.00012867962,0.0013982907,0.0000110680085,0.000040812898,0.0001529882,0.000023225568,0.000014968751,0.00004758759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987358,0.00004564651,0.00026655017,0.00018914459,0.00061309297,0.00014980906],"domain_scores_gemma":[0.9991964,0.000022600701,0.00015823508,0.00028735708,0.00025994953,0.00007543677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021797954,0.0001361799,0.00030481128,0.000092333525,0.000023958952,0.000006413586,0.000044064196,0.000051553518,0.000047154197],"category_scores_gemma":[0.000033740263,0.000098827426,0.00012711942,0.00014240122,0.00006396826,0.000049930917,0.000012962123,0.000012030671,0.00001304002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016602669,0.017829815,0.78353196,0.00008219714,0.0014975922,0.00007657409,0.0012197632,0.000031245472,0.002172066,0.0013186861,0.000006173331,0.1920679],"study_design_scores_gemma":[0.042985275,0.0025393239,0.56878275,0.00015282763,0.0027022387,0.000025428491,0.00006774151,0.000011341232,0.38230377,0.000275426,0.00008309227,0.00007079293],"about_ca_topic_score_codex":0.0007081358,"about_ca_topic_score_gemma":0.000049617058,"teacher_disagreement_score":0.3801317,"about_ca_system_score_codex":0.00023562199,"about_ca_system_score_gemma":0.0004824012,"threshold_uncertainty_score":0.40300652},"labels":[],"label_agreement":null},{"id":"W2581871698","doi":"10.1182/blood.v108.11.4665.4665","title":"Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitoxantrone; Internal medicine; Fludarabine; International Prognostic Index; Oncology; Follicular lymphoma; Hematology; Transplantation; Performance status; Cyclophosphamide; Rituximab; Surgery; Lymphoma; Chemotherapy","score_opus":0.012416748922372383,"score_gpt":0.2753732552975033,"score_spread":0.2629565063751309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581871698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921603,0.0034609148,0.000114900846,0.0018456533,0.00014643212,0.0014140257,0.00005740996,0.0000361285,0.00076424284],"genre_scores_gemma":[0.9950341,0.00095012825,0.0022387959,0.00012816871,0.00020398838,0.00069325365,0.00015764129,0.0000392318,0.0005546943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983039,0.00006569571,0.00064688205,0.00048677236,0.00015327688,0.00034347465],"domain_scores_gemma":[0.9980284,0.00080673373,0.00045657094,0.0004882769,0.00010870831,0.00011131285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011960841,0.0003236496,0.00094945397,0.00008733865,0.00015100525,0.0000129478685,0.00007484463,0.00012706127,0.000019536743],"category_scores_gemma":[0.00005540597,0.00020059843,0.00018950934,0.00015186078,0.00041184918,0.00003736389,0.000042133826,0.000049029964,0.00000601375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006749316,0.18296021,0.5936952,0.0008246329,0.005924692,0.010791486,0.0050202417,0.00003273273,0.12090142,0.0018801974,0.013542534,0.0576773],"study_design_scores_gemma":[0.091844484,0.039521497,0.42737216,0.00027676066,0.004256361,0.0038833863,0.0012966044,0.0003213526,0.35737965,0.00005632207,0.07316811,0.0006233087],"about_ca_topic_score_codex":0.0018630257,"about_ca_topic_score_gemma":0.00092415774,"teacher_disagreement_score":0.23647822,"about_ca_system_score_codex":0.0002780495,"about_ca_system_score_gemma":0.00018512685,"threshold_uncertainty_score":0.81801665},"labels":[],"label_agreement":null},{"id":"W2582009911","doi":"10.1182/blood.v126.23.3961.3961","title":"Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Sudbury Regional Hospital; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Dalhousie University","funders":"","keywords":"Bendamustine; Medicine; Lymphoma; Stem cell; Oncology; Internal medicine; Pathology; Rituximab; Biology","score_opus":0.012580554309340616,"score_gpt":0.2254333859239497,"score_spread":0.2128528316146091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582009911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719965,0.0007638524,0.0000020254229,0.000051272724,0.00009414908,0.0011830439,0.000017218515,0.000049482755,0.0006393191],"genre_scores_gemma":[0.9988732,0.00003384695,0.00015416346,0.00012751238,0.00002201888,0.0001328483,0.00012956455,0.00003534599,0.000491523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986054,0.000042579435,0.0003203019,0.00038139973,0.0003257175,0.00032463518],"domain_scores_gemma":[0.99926466,0.000034443703,0.0001150496,0.000252208,0.000080078105,0.00025353898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011826254,0.0002743524,0.0005007569,0.0001651524,0.00006111234,0.00003488869,0.000048835107,0.000101429425,0.000009321804],"category_scores_gemma":[0.000009530136,0.00019716499,0.0000720375,0.00027279797,0.000024219353,0.00010720417,0.000046709963,0.000059630387,0.000008556954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031764814,0.0042323014,0.98930323,0.00009439554,0.00022077013,0.00044088904,0.0005832172,7.8275104e-7,0.00002325326,5.786256e-7,0.00015915986,0.0046237516],"study_design_scores_gemma":[0.06703299,0.002185118,0.9262248,0.00034074893,0.0005525721,0.00004052094,0.00006002062,0.0000044875546,0.0033274153,6.9193226e-7,0.0000410405,0.0001895751],"about_ca_topic_score_codex":0.00026083455,"about_ca_topic_score_gemma":0.00020899353,"teacher_disagreement_score":0.066715345,"about_ca_system_score_codex":0.00032166293,"about_ca_system_score_gemma":0.0002805508,"threshold_uncertainty_score":0.80401546},"labels":[],"label_agreement":null},{"id":"W2582225016","doi":"10.1182/blood.v126.23.4804.4804","title":"Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Foothills Medical Centre","funders":"","keywords":"Follicular lymphoma; Medicine; Chemoimmunotherapy; Watchful waiting; Oncology; Internal medicine; Progression-free survival; Bioinformatics; Lymphoma; Cancer; Rituximab; Chemotherapy; Biology; Prostate cancer","score_opus":0.027676001665709656,"score_gpt":0.3006476489902151,"score_spread":0.27297164732450546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582225016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668986,0.0012688548,0.00021811608,0.00005481823,0.00015505377,0.0010043606,0.0000820188,0.000031085005,0.0004958476],"genre_scores_gemma":[0.9918605,0.00004115288,0.007488377,0.000013953692,0.000079781035,0.00028881725,0.00017781212,0.000015378168,0.000034199686],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990533,0.000018725177,0.00026020352,0.00018752713,0.0003502918,0.00012992515],"domain_scores_gemma":[0.9993648,0.000017011107,0.00011339078,0.00024198125,0.00008164563,0.00018120348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011763061,0.00010679088,0.00022572387,0.000057215417,0.000029496523,0.000004231242,0.000045598612,0.000046489626,0.0000029581975],"category_scores_gemma":[0.000023637092,0.00007917454,0.00019799116,0.000077834564,0.000018712555,0.000053387106,0.00004397375,0.000010157827,0.0000013643933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004191825,0.02735985,0.87081015,0.002281222,0.0025575676,0.0007854335,0.00056188786,0.00002843406,0.026974022,0.0005040353,0.001612003,0.06233354],"study_design_scores_gemma":[0.04194316,0.0016186631,0.20048533,0.0017675189,0.0029641392,0.00000977154,0.00013473503,0.000098931174,0.7499799,0.00020968782,0.000681004,0.000107110085],"about_ca_topic_score_codex":0.000004332851,"about_ca_topic_score_gemma":1.1514245e-7,"teacher_disagreement_score":0.7230059,"about_ca_system_score_codex":0.00004301629,"about_ca_system_score_gemma":0.000078393525,"threshold_uncertainty_score":0.32286438},"labels":[],"label_agreement":null},{"id":"W2582281568","doi":"10.1182/blood.v120.21.3659.3659","title":"Outcomes in Adolescents and Young Adults with Hodgkin Lymphoma Treated with and without Radiation Therapy On CCG 5942: A Report From the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Population; Randomization; Young adult; Internal medicine; Pediatrics; Cohort; Chemotherapy; Chemotherapy regimen; Disease; Stage (stratigraphy); Randomized controlled trial; Surgery; Oncology","score_opus":0.008468161456805063,"score_gpt":0.24476378645050642,"score_spread":0.23629562499370135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582281568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970454,0.001592325,0.0000010546663,0.0002945978,0.000029195762,0.00086592516,0.000011478097,0.000032037216,0.00012795956],"genre_scores_gemma":[0.99871993,0.00045039877,0.00013475648,0.00037771487,0.00008908205,0.00011564701,0.00007282865,0.00002437496,0.000015253386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903756,0.00006925186,0.00018212099,0.000292489,0.0001889023,0.00022969714],"domain_scores_gemma":[0.9994216,0.000054427877,0.00013562152,0.00025307387,0.000020629968,0.00011465674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010838018,0.00021052292,0.0003515688,0.00005391368,0.00006539033,0.000020015248,0.00003314596,0.0000831134,0.0000031650054],"category_scores_gemma":[0.000019332287,0.000101476064,0.000024177642,0.000091649956,0.00006620341,0.00007736583,0.000013705152,0.000058028025,0.0000018244918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014095019,0.0037612254,0.96575886,0.0000054241636,0.0003698451,0.00013892699,0.0011698446,7.464711e-8,0.0000209117,0.000006624715,0.000009536691,0.027349204],"study_design_scores_gemma":[0.044286776,0.0017728015,0.951689,0.0003019277,0.00029827433,0.00079719507,0.00010420405,0.000002975509,0.00057658076,0.0000019077636,0.000046082863,0.00012224134],"about_ca_topic_score_codex":0.0028896194,"about_ca_topic_score_gemma":0.0006401209,"teacher_disagreement_score":0.04287727,"about_ca_system_score_codex":0.000081665035,"about_ca_system_score_gemma":0.000041723946,"threshold_uncertainty_score":0.43682596},"labels":[],"label_agreement":null},{"id":"W2582311578","doi":"10.1182/blood.v110.11.183.183","title":"High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Loss of heterozygosity; Uniparental disomy; Biology; Comparative genomic hybridization; SNP array; Follicular lymphoma; Genetics; Single-nucleotide polymorphism; Chromosomal translocation; Molecular biology; Chromosome; Allele; Lymphoma; Gene; Karyotype; Genotype","score_opus":0.01186004379127759,"score_gpt":0.252662106105563,"score_spread":0.24080206231428541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582311578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847144,0.00059269305,0.000041275827,0.000094293544,0.000059915285,0.00029664452,0.000015406273,0.000017126866,0.0004112239],"genre_scores_gemma":[0.9979992,0.00011189956,0.0016857039,0.00007219739,0.000047756483,0.000014564697,0.00002493837,0.000012178652,0.00003158072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892426,0.000023390161,0.00041258402,0.00018890556,0.00024718858,0.00020366783],"domain_scores_gemma":[0.99935687,0.00006729603,0.00013431805,0.00028087117,0.00008056504,0.00008007651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019496902,0.00012574908,0.00037942172,0.00012350972,0.00001666679,0.0000025510913,0.000060510778,0.000104079954,0.00006180035],"category_scores_gemma":[0.000050657123,0.00009283592,0.00011180402,0.0002291293,0.00004991919,0.000040080955,0.000022527318,0.000028392786,0.000009462268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021388876,0.006522813,0.9743304,0.00014696976,0.00019718015,0.0009357887,0.00014177561,0.0000014358725,0.012003975,0.00065436505,0.000024202485,0.0048271907],"study_design_scores_gemma":[0.009833181,0.00046034672,0.7043172,0.00016028601,0.00019812625,0.00009423499,0.00002204534,0.0000013664672,0.28470638,0.00009835806,0.000043038137,0.000065443564],"about_ca_topic_score_codex":0.0017130894,"about_ca_topic_score_gemma":0.00036446052,"teacher_disagreement_score":0.2727024,"about_ca_system_score_codex":0.000095705815,"about_ca_system_score_gemma":0.00008078641,"threshold_uncertainty_score":0.3785739},"labels":[],"label_agreement":null},{"id":"W2582318610","doi":"10.1182/blood.v110.11.692.692","title":"CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Germinal center; Cancer research; Lymphoma; BCL10; B cell; Genetics; Antibody; Immunology","score_opus":0.009707787612356423,"score_gpt":0.2663298896683076,"score_spread":0.2566221020559512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582318610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766894,0.0010413979,0.0000034224993,0.000086034,0.00007735279,0.00025032836,0.000011564175,0.000050860264,0.021789646],"genre_scores_gemma":[0.99815017,0.00012397607,0.0003201473,0.00061583007,0.00015897794,0.000021852295,0.00004647545,0.000023247952,0.00053932285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989305,0.00001969198,0.0002075838,0.0002631956,0.00020829665,0.00037070658],"domain_scores_gemma":[0.9993133,0.00004161309,0.000037982278,0.00034063065,0.000028861019,0.00023760641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019122097,0.00014367909,0.00024079572,0.000103959006,0.000037198286,0.000011558974,0.0000605595,0.00009567246,0.000059179045],"category_scores_gemma":[0.000019262463,0.00011775569,0.00007929424,0.00015213464,0.000015491967,0.000046066216,0.000029081073,0.000036263766,0.00020458718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018358568,0.121263966,0.85388273,0.000046620895,0.00011804113,0.0054953913,0.00090883864,1.3299301e-7,0.00487398,0.000508448,0.0002497635,0.012468529],"study_design_scores_gemma":[0.09549262,0.00089920656,0.6536328,0.000053721367,0.00030955984,0.00020529339,0.00029368122,0.0000050264625,0.23499078,0.00006235185,0.013854894,0.00020005075],"about_ca_topic_score_codex":0.00045726344,"about_ca_topic_score_gemma":0.0004027351,"teacher_disagreement_score":0.2301168,"about_ca_system_score_codex":0.00011660456,"about_ca_system_score_gemma":0.00010236242,"threshold_uncertainty_score":0.48019376},"labels":[],"label_agreement":null},{"id":"W2582318813","doi":"10.1182/blood.v114.22.50.50","title":"Tandem Autologous-Allogeneic Nonmyeloablative Sibling Transplant in Relapsed Follicular Lymphoma Leads to Impressive Progression Free Survival with Minimal Toxicity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Regimen; Cyclophosphamide; Follicular lymphoma; Transplantation; Surgery; Gastroenterology; Chemotherapy; Progression-free survival; Oncology; Urology; Lymphoma","score_opus":0.012121351958159355,"score_gpt":0.2619618747990991,"score_spread":0.24984052284093974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582318813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950144,0.0008502796,0.00004825562,0.0013472395,0.0000562284,0.0011204433,0.000028419827,0.00010282143,0.0014319095],"genre_scores_gemma":[0.9958821,0.000055753575,0.0032791363,0.0004051385,0.00010005722,0.00014212684,0.000040691782,0.000029453995,0.000065535554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787396,0.000084894455,0.00038368217,0.00059198844,0.0005166421,0.0005488014],"domain_scores_gemma":[0.9989679,0.000110641406,0.00011817016,0.00044059448,0.00008255291,0.00028013735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018075798,0.00035505125,0.00064083375,0.00024131924,0.000103092476,0.000029089942,0.00016934448,0.00019842238,0.000022256298],"category_scores_gemma":[0.000064019936,0.00024579573,0.000130882,0.00048783264,0.00004769981,0.00006723841,0.000033173495,0.000103555336,0.000014523627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015758858,0.007448882,0.9172666,0.00004487463,0.00037481723,0.0073925676,0.0019528787,0.000083798965,0.047721967,0.00017801575,0.00007939764,0.015880328],"study_design_scores_gemma":[0.025152108,0.004445948,0.78174263,0.00079431216,0.00048655196,0.0003138632,0.00012467557,0.000059165082,0.18645489,0.00004452216,0.00006764434,0.0003136633],"about_ca_topic_score_codex":0.00004613295,"about_ca_topic_score_gemma":0.00014613984,"teacher_disagreement_score":0.13873293,"about_ca_system_score_codex":0.0001622898,"about_ca_system_score_gemma":0.00021679854,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2582390665","doi":"10.1182/blood.v110.11.369.369","title":"Treatment Decisions for Young Women with Supra-Diaphragmatic, Limited-Stage Hodgkin Lymphoma: Exploration of Options Using a Markov Decision Analysis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"ABVD; Medicine; Oncology; Radiation therapy; Breast cancer; Internal medicine; Stage (stratigraphy); Relative risk; Surgery; Cancer; Chemotherapy; Cyclophosphamide","score_opus":0.03893762170799528,"score_gpt":0.30937328451227425,"score_spread":0.270435662804279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582390665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961495,0.00036653582,0.03650821,0.00006392611,0.000044501805,0.0011114986,0.000107079286,0.000043551776,0.00025971077],"genre_scores_gemma":[0.9180169,0.00025701185,0.08102907,0.00002601122,0.00005559706,0.0002956005,0.00014875468,0.00003009612,0.00014096688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820507,0.000032572316,0.0005815951,0.0003838169,0.00040026632,0.00039670288],"domain_scores_gemma":[0.99807763,0.00064984587,0.00024511377,0.00054391904,0.00023827472,0.00024522797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033601312,0.00026357995,0.0006511363,0.000630562,0.00016722469,0.000034997636,0.00006944646,0.00010303777,0.000041266227],"category_scores_gemma":[0.00014265372,0.00018219752,0.00026102495,0.001001753,0.00004267377,0.0002041933,0.000024475745,0.000023622415,0.0000049689197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011235109,0.06504117,0.6303973,0.00021379831,0.026007364,0.0011436751,0.010746729,0.0033710515,0.01823113,0.0023709892,0.00017274778,0.23106892],"study_design_scores_gemma":[0.08371309,0.010771188,0.7963876,0.0005832576,0.027626218,0.0003473062,0.0075766975,0.00504721,0.065236956,0.00043218565,0.0014508098,0.0008274498],"about_ca_topic_score_codex":0.000161479,"about_ca_topic_score_gemma":0.00042965118,"teacher_disagreement_score":0.23024146,"about_ca_system_score_codex":0.0005376755,"about_ca_system_score_gemma":0.00019820318,"threshold_uncertainty_score":0.7429799},"labels":[],"label_agreement":null},{"id":"W2582752763","doi":"10.14740/jocmr2929w","title":"Composite Lymphoma: Opposite Ends of Spectrum Meet","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; Lymphoma; Rituximab; Prednisone; Etoposide; Lung; B-cell lymphoma; Surgery; Cyclophosphamide; Radiology; Internal medicine; Chemotherapy","score_opus":0.33061309281525375,"score_gpt":0.5793473239257546,"score_spread":0.24873423111050086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582752763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9039892,0.0027626203,0.000015389089,0.05696853,0.00081478717,0.00025888233,0.0000044528283,0.0000062090235,0.035179906],"genre_scores_gemma":[0.9908672,0.0047748443,0.0005516698,0.00025325984,0.0028107297,0.0000036567483,0.0000018329745,0.00002105351,0.00071575673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945114,0.00044469582,0.002152703,0.00025645416,0.0021835277,0.00045118088],"domain_scores_gemma":[0.9928855,0.0027642704,0.0013248452,0.0009610727,0.0012105576,0.0008538024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0089197885,0.00017502137,0.0016279093,0.0004104078,0.00025188265,0.00003502266,0.00063615036,0.00019398311,0.00027262786],"category_scores_gemma":[0.007054741,0.000102270606,0.000496283,0.000178133,0.0014143509,0.00015486145,0.00021867576,0.00053202896,0.000027496819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034068685,0.0033762685,0.8399726,0.0001812231,0.0009605216,0.0029904505,0.00015501774,7.461227e-7,0.0016825334,0.0012110312,0.026569778,0.11949297],"study_design_scores_gemma":[0.020337544,0.010609143,0.94087976,0.0024112114,0.00037187155,0.00076480384,0.00010827149,0.000056083925,0.0076377136,0.0012324842,0.015505046,0.000086059765],"about_ca_topic_score_codex":0.00024047983,"about_ca_topic_score_gemma":0.000015628882,"teacher_disagreement_score":0.11940691,"about_ca_system_score_codex":0.0001480944,"about_ca_system_score_gemma":0.00072850013,"threshold_uncertainty_score":0.8445694},"labels":[],"label_agreement":null},{"id":"W2582849955","doi":"10.1182/blood.v104.11.3325.3325","title":"Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Internal medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Gastroenterology; Bone marrow; Median follow-up; Diffuse large B-cell lymphoma; Surgery; Chemotherapy","score_opus":0.011361254335391596,"score_gpt":0.25018305627935494,"score_spread":0.23882180194396335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582849955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535555,0.00035666057,0.0005700126,0.00026646143,0.00026491235,0.0025802169,0.0001513252,0.00005718597,0.00039767765],"genre_scores_gemma":[0.99236405,0.0002588625,0.0050587263,0.0002603782,0.00006883995,0.0011895521,0.00036803854,0.00006246648,0.00036911154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983957,0.000017438886,0.00043353543,0.00045142774,0.00026320165,0.00043874272],"domain_scores_gemma":[0.9988465,0.0002244267,0.00029140429,0.00030622055,0.00016473979,0.00016670921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009552191,0.00029959576,0.00050856586,0.000102971164,0.00018178835,0.000037144764,0.00011224097,0.00015470102,0.000019492201],"category_scores_gemma":[0.00003297348,0.00024139907,0.00032549747,0.00010483974,0.000024655908,0.0001211114,0.000015778267,0.00003219023,0.000027395417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010437268,0.017163256,0.93977743,0.0019570685,0.0012251039,0.00019991853,0.0039037399,0.00006662421,0.0022517492,0.00018512708,0.00053764944,0.031688575],"study_design_scores_gemma":[0.11460138,0.0029576698,0.7031446,0.0007146513,0.00297867,0.00006529036,0.0003180316,0.0000118156995,0.17393935,0.00031315972,0.00045638316,0.0004990268],"about_ca_topic_score_codex":0.00003944728,"about_ca_topic_score_gemma":0.00003203379,"teacher_disagreement_score":0.23663288,"about_ca_system_score_codex":0.00022248503,"about_ca_system_score_gemma":0.00018288507,"threshold_uncertainty_score":0.9843969},"labels":[],"label_agreement":null},{"id":"W2583428393","doi":"10.1182/blood.v114.22.1916.1916","title":"Trends in the Incidence of HIV-Related Hematologic Malignancies in the Era of Combination Antiretroviral Therapy and Predictors of HIV-Related Non-Hodgkin's Lymphoma Development and Survival.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cart; Incidence (geometry); Internal medicine; Hazard ratio; Proportional hazards model; Poisson regression; Lymphoma; Survival analysis; Multiple myeloma; Cohort; Oncology; Immunology; Population; Confidence interval","score_opus":0.011970394924396804,"score_gpt":0.23928175250731257,"score_spread":0.22731135758291576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583428393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668306,0.0019761045,6.805829e-7,0.0005608228,0.000022688251,0.0003498551,0.000007118661,0.000008179445,0.00039150126],"genre_scores_gemma":[0.9991995,0.0005704003,0.000099131175,0.000056389625,0.0000030769336,0.00002032157,0.000032651667,0.000005621433,0.000012913296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986749,0.0001373778,0.0005404655,0.00018233822,0.0003126939,0.00015217703],"domain_scores_gemma":[0.99929446,0.00019541103,0.000237531,0.00019777661,0.000051174782,0.000023657136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005102559,0.00015677843,0.0004293312,0.0001734153,0.000033171924,0.0000076209767,0.00011397892,0.000103595565,0.0000056741355],"category_scores_gemma":[0.000039859773,0.000086064145,0.00004719962,0.00051419425,0.00013995546,0.00006151595,0.00001972938,0.00006990666,3.3729367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008425121,0.0028298781,0.9736049,0.00003696244,0.000091157264,0.000055167617,0.008334573,0.0000013509086,0.0011832748,0.0008500644,0.000021439535,0.012906947],"study_design_scores_gemma":[0.010390545,0.0011158955,0.9687215,0.0003015408,0.00008140925,0.00006870515,0.00072285184,0.00003935909,0.018333,0.00014494892,0.0000073512783,0.00007286524],"about_ca_topic_score_codex":0.00010903776,"about_ca_topic_score_gemma":0.000021039348,"teacher_disagreement_score":0.017149724,"about_ca_system_score_codex":0.00002663698,"about_ca_system_score_gemma":0.00006772359,"threshold_uncertainty_score":0.3509594},"labels":[],"label_agreement":null},{"id":"W2583767956","doi":"10.1182/blood.v110.11.213.213","title":"FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Chemotherapy; Lymphoma; Radiation therapy; Radiology; Nuclear medicine; Positron emission tomography; Progressive disease; Dacarbazine; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.006887419519681552,"score_gpt":0.24891706256382792,"score_spread":0.24202964304414637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583767956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542177,0.0002758324,0.0000075039175,0.00036301828,0.000034406883,0.0011202168,0.0001010328,0.00006834695,0.00260785],"genre_scores_gemma":[0.9950735,0.0001074196,0.0024988186,0.0015332176,0.00006267402,0.00006992263,0.00014606249,0.00006452552,0.00044383275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.000052710384,0.000348504,0.00043593472,0.0005169532,0.0004950319],"domain_scores_gemma":[0.99893385,0.00013698933,0.00017085094,0.00042560397,0.00016584243,0.00016688215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001848207,0.0003612072,0.00050829956,0.00021407763,0.00007550935,0.000028494997,0.00009465037,0.00004278636,0.00011651869],"category_scores_gemma":[0.000021625425,0.0002381243,0.00004970358,0.00026174268,0.00012467915,0.00012937727,0.000011528828,0.00007487401,0.0000093010085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091054225,0.007820475,0.9675835,0.00004399461,0.0007071093,0.0014949271,0.0010976196,0.00001762693,0.00018065612,0.0003243349,0.0002301505,0.011394233],"study_design_scores_gemma":[0.08507539,0.0075416714,0.86137617,0.00033932604,0.00009202887,0.0001034759,0.0005747925,0.0000010114493,0.043598965,0.0000041031954,0.0010001861,0.0002929032],"about_ca_topic_score_codex":0.0003990414,"about_ca_topic_score_gemma":0.00023718244,"teacher_disagreement_score":0.10620731,"about_ca_system_score_codex":0.00034249635,"about_ca_system_score_gemma":0.00024190196,"threshold_uncertainty_score":0.9710427},"labels":[],"label_agreement":null},{"id":"W2583981099","doi":"10.1182/blood.v124.21.1712.1712","title":"Addition of Rituximab to Salvage Chemotherapy in Aggressive CD20+ Lymphoma Prior to Autologous Stem Cell Transplant (ASCT): A Cohort Comparison from the NCIC CTG Study LY.12","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; McMaster University; London Health Sciences Centre; Queen's University; Juravinski Hospital; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; DHAP; Salvage therapy; Regimen; Chemotherapy regimen; Rituximab; Oncology; Autologous stem-cell transplantation; Febrile neutropenia; Chemotherapy; Gemcitabine; Progressive disease; Surgery; Gastroenterology; Neutropenia; Lymphoma","score_opus":0.010487158471967274,"score_gpt":0.2493796478773854,"score_spread":0.23889248940541813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583981099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954083,0.0004932337,0.000057579884,0.0007059204,0.000093287425,0.0026042657,0.00019258165,0.00005309319,0.00039175703],"genre_scores_gemma":[0.99796677,0.000046266803,0.00040176307,0.00084904965,0.00010202948,0.00047971535,0.00008461993,0.000033124546,0.000036651894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810326,0.00017777766,0.00051387877,0.0004716175,0.0004243051,0.00030917462],"domain_scores_gemma":[0.9986304,0.00034651926,0.00021967392,0.0005748826,0.00005779843,0.00017069558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024074664,0.0002724995,0.00081123423,0.00010215438,0.00007111739,0.000021233407,0.00019537595,0.00010195341,0.00007015071],"category_scores_gemma":[0.00002290322,0.00018432061,0.000118605814,0.00020985673,0.000033811004,0.000032451913,0.000032124306,0.00007500569,0.00008029172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010915772,0.030032465,0.89741033,0.000048612073,0.0005354704,0.0002823857,0.014266279,0.000013272769,0.0017165998,0.000014542029,0.0012594089,0.05332905],"study_design_scores_gemma":[0.028017936,0.002467233,0.9218247,0.00038776404,0.0006874687,0.000024589985,0.00089220644,0.000055359353,0.04460217,0.000007776454,0.0008501275,0.00018264866],"about_ca_topic_score_codex":0.0013584765,"about_ca_topic_score_gemma":0.0009058192,"teacher_disagreement_score":0.053146403,"about_ca_system_score_codex":0.00013341298,"about_ca_system_score_gemma":0.00009200937,"threshold_uncertainty_score":0.75163764},"labels":[],"label_agreement":null},{"id":"W2583999202","doi":"10.1182/blood.v106.11.492.492","title":"Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; CHOP; Population; Chemotherapy regimen; Oncology; Lymphoma; Cancer; Surgery","score_opus":0.006231290860206991,"score_gpt":0.22351511049676276,"score_spread":0.21728381963655577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583999202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956125,0.00026657555,0.000037035094,0.0011481474,0.000028591909,0.001852792,0.0008137128,0.00004035779,0.00020026552],"genre_scores_gemma":[0.99786025,0.000055036515,0.0006201614,0.00062757946,0.00011863623,0.0003598568,0.0001407097,0.00004286519,0.0001749151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984817,0.000025796588,0.00034803196,0.00035388715,0.0005002387,0.00029033562],"domain_scores_gemma":[0.99894476,0.00013538272,0.00020700398,0.00032713966,0.00025478742,0.00013093847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007821526,0.00027381082,0.00044692485,0.00008640463,0.000085845924,0.00003987655,0.0001137071,0.00007642195,0.00003860243],"category_scores_gemma":[0.00003760527,0.0001419336,0.00009442211,0.00011226706,0.00008559299,0.00010220025,0.00004380251,0.000054220614,0.0000040364826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017756979,0.023425898,0.97127837,0.00011930229,0.0006710822,0.000015860118,0.00029744007,1.1137343e-7,0.0000072726198,0.000014638494,0.00030253534,0.002091801],"study_design_scores_gemma":[0.19720733,0.0019929842,0.7942356,0.00024264255,0.0010461584,0.000016497406,0.00003138053,0.00006736745,0.0009264646,0.000003400083,0.004085508,0.00014465144],"about_ca_topic_score_codex":0.000025573167,"about_ca_topic_score_gemma":0.000027425098,"teacher_disagreement_score":0.19543163,"about_ca_system_score_codex":0.00009408302,"about_ca_system_score_gemma":0.00007321477,"threshold_uncertainty_score":0.5787884},"labels":[],"label_agreement":null},{"id":"W2584246182","doi":"10.1182/blood.v128.22.1108.1108","title":"Pembrolizumab in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Long-Term Efficacy from the Phase 1b Keynote-013 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Internal medicine; Cohort; Transplantation; Phases of clinical research; Autologous stem-cell transplantation; Lymphoma; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.007994738585659232,"score_gpt":0.2436282702871269,"score_spread":0.23563353170146767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584246182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965664,0.0002250134,0.000007545989,0.0012200329,0.00009100301,0.001678529,0.0000961942,0.000061517996,0.000053756914],"genre_scores_gemma":[0.9989245,0.00001352013,0.000059105292,0.00024904692,0.00020010676,0.0003655427,0.00006729137,0.000051953826,0.000068955735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773896,0.00015242353,0.0004012645,0.0006332846,0.0006071817,0.00046688522],"domain_scores_gemma":[0.9984534,0.00033582828,0.000119036864,0.00080477295,0.00007768369,0.000209286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008630405,0.00037759883,0.0005181669,0.00007942831,0.00007387193,0.00005673802,0.00020050022,0.00010540683,0.00022183805],"category_scores_gemma":[0.00006851243,0.0001736687,0.00013122555,0.00019970736,0.000115026945,0.000109849956,0.00010993597,0.00008928685,0.00019850634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003859667,0.09081899,0.8641478,0.000006813003,0.00045143728,0.00066243875,0.00044674863,4.437494e-8,0.000028871113,0.000004229188,0.00020366427,0.039369326],"study_design_scores_gemma":[0.25024086,0.00334128,0.74456364,0.00026604562,0.0006604869,0.000011707025,0.000030814095,8.01008e-7,0.00053934054,0.0000041223443,0.00015434083,0.0001865777],"about_ca_topic_score_codex":0.00012478424,"about_ca_topic_score_gemma":0.0003509055,"teacher_disagreement_score":0.24638121,"about_ca_system_score_codex":0.00020173355,"about_ca_system_score_gemma":0.0001411657,"threshold_uncertainty_score":0.7082004},"labels":[],"label_agreement":null},{"id":"W2584502966","doi":"10.1182/blood.v120.21.235.235","title":"Quality of Life Results From Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Indolent Non-Hodgkin's Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anxiety; Rituximab; Randomization; Randomized controlled trial; Internal medicine; Hospital Anxiety and Depression Scale; Follicular lymphoma; Quality of life (healthcare); Coping (psychology); Physical therapy; Lymphoma; Psychiatry; Nursing","score_opus":0.07198776164159298,"score_gpt":0.39594213869872813,"score_spread":0.32395437705713515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584502966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89986354,0.00016752929,0.00058990385,0.000052541956,0.0001319375,0.098359495,0.000114111215,0.000053760756,0.00066717394],"genre_scores_gemma":[0.9093316,0.000005070962,0.00073128456,0.00007999127,0.00033950192,0.0893228,0.00014313204,0.00003382844,0.000012768439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960352,0.0007595208,0.0016588859,0.00055027584,0.00047222566,0.00052385643],"domain_scores_gemma":[0.9965932,0.0014704632,0.0008345534,0.0005327588,0.00021710285,0.00035195946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011467795,0.00046587604,0.002747646,0.00011714312,0.00014286111,0.00006195122,0.00015199625,0.00012599805,0.00002296348],"category_scores_gemma":[0.00029222533,0.00031773705,0.00037752322,0.000113203496,0.00016206763,0.00019517381,0.00013660656,0.00010594483,0.000007729987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5851098,0.24664891,0.13227849,0.00024384363,0.0051570004,0.00004850277,0.019298451,0.000011543547,0.0017095406,0.0003484012,0.00007112371,0.009074435],"study_design_scores_gemma":[0.93363667,0.004797793,0.048436835,0.00028644098,0.0015267387,0.0000058234873,0.0049387976,0.0005462726,0.005415122,0.000037236226,0.00008447531,0.00028778863],"about_ca_topic_score_codex":0.0031633084,"about_ca_topic_score_gemma":0.0006594656,"teacher_disagreement_score":0.3485269,"about_ca_system_score_codex":0.00020691284,"about_ca_system_score_gemma":0.00038281354,"threshold_uncertainty_score":0.99992746},"labels":[],"label_agreement":null},{"id":"W2584580642","doi":"10.1182/blood.v104.11.4553.4553","title":"Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunohistochemistry; Tissue microarray; In situ hybridization; Immunoglobulin light chain; Hematopathology; Pathology; Molecular biology; Biology; Monoclonal; Streptavidin; Frozen section procedure; Gene expression profiling; Monoclonal antibody; Gene expression; Antibody; Medicine; Biotin; Gene; Genetics; Cytogenetics","score_opus":0.009513318920748363,"score_gpt":0.2626384238780327,"score_spread":0.25312510495728435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584580642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980938,0.0009997156,0.00024367998,0.000028577726,0.000018795356,0.0005370941,0.00001660697,0.000010241796,0.00005148158],"genre_scores_gemma":[0.99553835,0.00018359546,0.003967594,0.000012237968,0.00002390704,0.00013384754,0.00011990139,0.00000868097,0.0000118852495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993899,0.000014410512,0.00021408698,0.00019847139,0.00007935739,0.000103814295],"domain_scores_gemma":[0.9997125,0.000028881774,0.000089544665,0.00010092354,0.000034187804,0.000033947537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104827996,0.000090222056,0.00017187597,0.00006202905,0.000025965674,0.000006677809,0.000017037404,0.00007250478,6.6108225e-7],"category_scores_gemma":[0.000041618925,0.000083231476,0.00002363331,0.00006205385,0.000016028305,0.00005394055,0.00001911713,0.000021431668,1.4972618e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020391207,0.009215414,0.17710617,0.00023792543,0.000007869313,0.000014687206,0.00030027027,0.000002264763,0.81152064,0.0000070876868,0.0000017076455,0.0013820342],"study_design_scores_gemma":[0.039837778,0.00012082072,0.16687056,0.000121542704,0.000049284816,0.000018245597,0.000034878383,0.000074417876,0.7927361,0.0000732708,0.000005212614,0.00005789169],"about_ca_topic_score_codex":0.000077373996,"about_ca_topic_score_gemma":0.0000346443,"teacher_disagreement_score":0.039633866,"about_ca_system_score_codex":0.00010456938,"about_ca_system_score_gemma":0.000049056453,"threshold_uncertainty_score":0.3394081},"labels":[],"label_agreement":null},{"id":"W2584624237","doi":"10.1182/blood.v118.21.96.96","title":"Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Anaplastic large-cell lymphoma; Not Otherwise Specified; Population; Anaplastic lymphoma kinase; Oncology; B symptoms; Gastroenterology; Lung cancer","score_opus":0.013514180569326645,"score_gpt":0.2229407522020368,"score_spread":0.20942657163271014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584624237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962076,0.0012137833,0.0000022553215,0.000022230137,0.00019152481,0.00035062604,0.000046597706,0.000021670678,0.0019436954],"genre_scores_gemma":[0.99946463,0.00013354595,0.00012424662,0.000017008459,0.00003330863,0.000017083856,0.00005376256,0.000026061212,0.00013033209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886614,0.000043645105,0.00031834544,0.00026334837,0.00029160755,0.00021692472],"domain_scores_gemma":[0.9992205,0.000039746978,0.00013385082,0.00032560548,0.000048615035,0.00023170409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000728589,0.00018505067,0.00041769887,0.000067306624,0.00003813975,0.000005824376,0.00007145107,0.000059822298,0.000116112016],"category_scores_gemma":[0.00003097803,0.00015045186,0.00019859595,0.00010358593,0.000063901716,0.0000679847,0.00006324375,0.00003486725,0.0000037408745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029893345,0.005906843,0.9916036,0.00023159533,0.0003196951,0.0002067426,0.000510266,6.620589e-8,0.00025435537,0.000092746486,0.000008401339,0.00056676375],"study_design_scores_gemma":[0.010161876,0.00077243085,0.96666986,0.00017454465,0.00094587874,0.0000040347677,0.00005582746,0.0000013703842,0.021030728,0.000051368763,0.0000046417786,0.00012742812],"about_ca_topic_score_codex":0.00030333834,"about_ca_topic_score_gemma":0.000063878084,"teacher_disagreement_score":0.02493372,"about_ca_system_score_codex":0.00003527576,"about_ca_system_score_gemma":0.00008695379,"threshold_uncertainty_score":0.61352485},"labels":[],"label_agreement":null},{"id":"W2584734171","doi":"10.3324/haematol.2016.159087","title":"Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Public Health Ontario; University of Toronto; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Terry Fox Research Institute; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Rituximab; Prednisone; Vincristine; Cyclophosphamide; Medicine; Lymphoma; Doxorubicin; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Cancer research; Chemotherapy","score_opus":0.008323216266862688,"score_gpt":0.22480587435944302,"score_spread":0.21648265809258033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584734171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95755464,0.0046746023,0.000006772664,0.030900858,0.00025605984,0.0047498983,0.0008623326,0.00015217415,0.0008426556],"genre_scores_gemma":[0.91627693,0.0006289879,0.0014233555,0.0744524,0.0005174384,0.0015716384,0.0020628755,0.00020486144,0.0028615117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956708,0.000096218595,0.000828171,0.0014958364,0.00071092363,0.0011980582],"domain_scores_gemma":[0.99683714,0.00047117306,0.0007654875,0.0014194074,0.0001832606,0.00032352287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011612451,0.0010524116,0.0022760085,0.00023638947,0.00041032204,0.0001026544,0.00037998465,0.0011610894,0.000107483866],"category_scores_gemma":[0.00023171087,0.0007159999,0.00028521556,0.0001147246,0.00032158272,0.000079226964,0.000359822,0.00038203772,0.00012424977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039889966,0.025800098,0.49631858,0.001587819,0.00048331794,0.011720544,0.00018008762,1.382959e-7,0.000008276229,0.0000267516,0.4587699,0.0011154788],"study_design_scores_gemma":[0.17433509,0.0034302096,0.6022343,0.0011951048,0.0012538808,0.00075642066,0.000006282059,0.000016391281,0.00035746014,0.00007447055,0.21547179,0.0008685798],"about_ca_topic_score_codex":0.00022957851,"about_ca_topic_score_gemma":0.000036956244,"teacher_disagreement_score":0.24329811,"about_ca_system_score_codex":0.0004724599,"about_ca_system_score_gemma":0.00022050255,"threshold_uncertainty_score":0.9995291},"labels":[],"label_agreement":null},{"id":"W2585047090","doi":"10.1182/blood.v108.11.3067.3067","title":"Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Rituximab; Cytarabine; Salvage therapy; Autologous stem-cell transplantation; Oncology; Gastroenterology; Progression-free survival; Transplantation; Surgery; Chemotherapy; Lymphoma","score_opus":0.006022726009628075,"score_gpt":0.23060519740513613,"score_spread":0.22458247139550805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585047090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123186,0.0046868497,0.0000011156806,0.0008271751,0.000027984981,0.0005570474,0.000039320854,0.000050437066,0.0025782108],"genre_scores_gemma":[0.9982417,0.00019558604,0.00044706804,0.00038977162,0.000069128255,0.00014039417,0.000028329156,0.00002604391,0.0004619613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876285,0.00008141178,0.0002836697,0.0003496059,0.00021987701,0.0003025812],"domain_scores_gemma":[0.9991791,0.0002577413,0.00007521162,0.00025349387,0.000039281826,0.0001951293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621963,0.0002043848,0.00037818047,0.0002063065,0.00005668077,0.00002310304,0.000053618896,0.00010871954,0.00003521628],"category_scores_gemma":[0.00012876498,0.00016747703,0.00007158885,0.00020044966,0.00004540958,0.000049768558,0.000023506222,0.00005004086,0.00006575821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019378329,0.10884058,0.7889978,0.00030418497,0.00026118688,0.014750712,0.0013873996,0.0000037197615,0.031532608,0.00025784515,0.004594469,0.02969117],"study_design_scores_gemma":[0.096339226,0.0016519019,0.8424956,0.00041233195,0.0003337304,0.000427288,0.00012872068,0.0000053105923,0.050744876,0.00008793473,0.0071068867,0.00026614516],"about_ca_topic_score_codex":0.001602597,"about_ca_topic_score_gemma":0.0003021262,"teacher_disagreement_score":0.10718867,"about_ca_system_score_codex":0.00013379006,"about_ca_system_score_gemma":0.00016658349,"threshold_uncertainty_score":0.6829515},"labels":[],"label_agreement":null},{"id":"W2585127179","doi":"10.1182/blood.v116.21.961.961","title":"Complete Remissions with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; CD30; Tolerability; Internal medicine; Oncology; Antibody-drug conjugate; Lymphoma; Gastroenterology; Adverse effect; Immunology; Antibody","score_opus":0.0065421425777565795,"score_gpt":0.20742874197655595,"score_spread":0.20088659939879938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585127179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975684,0.00013142724,0.0000048092625,0.00005674337,0.00013124761,0.0008018386,0.000105207655,0.000077658355,0.0011226231],"genre_scores_gemma":[0.9984085,0.000018642524,0.00071955874,0.0001176655,0.00006049207,0.00009414406,0.00017306536,0.000055111555,0.00035282184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824274,0.000049524424,0.00034985333,0.00046253082,0.00043569953,0.00045964925],"domain_scores_gemma":[0.9986768,0.0001575333,0.00018122024,0.0005801822,0.00011060944,0.00029370675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000933876,0.0003030042,0.0004940726,0.00015195226,0.00011202168,0.000024685885,0.00011594356,0.00013820973,0.00012375244],"category_scores_gemma":[0.00006142618,0.00017514333,0.00005557146,0.0002938849,0.000054252727,0.00007869402,0.000043247146,0.00018390428,0.00007243415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021512753,0.023242794,0.971141,0.00019671416,0.0001579096,0.0006660014,0.00022728113,0.0000012311983,0.0011438966,0.00002580564,0.0003724151,0.00067366695],"study_design_scores_gemma":[0.12722336,0.0045164386,0.861643,0.0012016731,0.0005907164,0.00020234752,0.00011481687,0.00003638299,0.0012071644,0.0000016507379,0.0029463642,0.000316054],"about_ca_topic_score_codex":0.000082629915,"about_ca_topic_score_gemma":0.0003708327,"teacher_disagreement_score":0.12507209,"about_ca_system_score_codex":0.0001283711,"about_ca_system_score_gemma":0.00036447312,"threshold_uncertainty_score":0.7142138},"labels":[],"label_agreement":null},{"id":"W2585907801","doi":"10.1182/blood.v108.11.344.344","title":"The Potential for Lost Productivity and Daily Activity Impairment in Patients with Follicular (FL) and Other Indolent Non-Hodgkin’s Lymphoma (NHL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Cancer; Hematology; Stage (stratigraphy); Lymphoma","score_opus":0.0035466345246427285,"score_gpt":0.2030042947814467,"score_spread":0.19945766025680395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585907801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728125,0.00031232173,0.000016577429,0.00043891865,0.00004202013,0.0017797711,0.0000329116,0.00001255555,0.00008369623],"genre_scores_gemma":[0.9993586,0.000014846482,0.00018129329,0.000052836953,0.00009096548,0.00021615799,0.000010433908,0.00002209319,0.00005279496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989858,0.000031447587,0.00014226479,0.000356892,0.00021932878,0.0002642276],"domain_scores_gemma":[0.99951273,0.000043902026,0.000080357684,0.00024439712,0.00004780762,0.00007079766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014261849,0.00018581102,0.00024135715,0.00004315135,0.00013837495,0.00004304799,0.000034728237,0.000054663753,0.0000016709666],"category_scores_gemma":[0.000011062485,0.00010744044,0.000045804158,0.00007155794,0.00007773837,0.00006525909,0.000041894793,0.000033882967,0.0000013993005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009406122,0.0066502877,0.9791881,0.00004817682,0.00016531072,0.000021673386,0.00009370702,0.0000020877326,0.00021191672,0.000024525985,0.00007140011,0.01258223],"study_design_scores_gemma":[0.027904587,0.0014910409,0.96358484,0.00006319085,0.0002662035,0.000021305916,0.000023544162,0.000026474065,0.006018773,0.00003834174,0.0004369791,0.0001247237],"about_ca_topic_score_codex":0.00077527197,"about_ca_topic_score_gemma":0.0005022883,"teacher_disagreement_score":0.026963973,"about_ca_system_score_codex":0.000093221766,"about_ca_system_score_gemma":0.00006960955,"threshold_uncertainty_score":0.43812943},"labels":[],"label_agreement":null},{"id":"W2586216319","doi":"10.1182/blood.v116.21.2560.2560","title":"The Association Between Smoking and Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Medicine; Observational study; Odds ratio; Confidence interval; Publication bias; Hazard ratio; Relative risk; Meta-analysis; MEDLINE; Prospective cohort study; Internal medicine; Demography","score_opus":0.008445733565004875,"score_gpt":0.240761830238193,"score_spread":0.23231609667318812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586216319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935163,0.00028692518,5.163071e-7,0.0013952145,0.00010151288,0.000114600196,0.0000041310022,0.00002680252,0.004553981],"genre_scores_gemma":[0.999031,0.00008601967,0.00009859256,0.00010214544,0.00027366073,0.000018752618,0.0000067426467,0.0000068932886,0.00037618517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999525,0.000012818392,0.000087261666,0.00009909932,0.00014691347,0.00012891022],"domain_scores_gemma":[0.999492,0.00023894785,0.000050699968,0.00013182976,0.000028736318,0.000057808917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784744,0.000059182003,0.00009716859,0.000014734036,0.00013648973,0.000039257677,0.000028149276,0.000068501155,0.00000770834],"category_scores_gemma":[0.00012306299,0.00003587629,0.000032569278,0.000041977662,0.000016663806,0.000022270113,0.00002026155,0.00004601203,0.000012699083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029259395,0.00013939098,0.95332175,0.0000030050326,0.000206744,0.000008371663,0.00004933427,2.6255362e-9,0.00035306136,0.00038050066,0.00024936607,0.045285538],"study_design_scores_gemma":[0.003332,0.00006675644,0.9642323,0.0000102253625,0.00043964596,0.00001778032,0.000013954418,0.0000010341088,0.008515531,0.00013289753,0.023198891,0.000038945716],"about_ca_topic_score_codex":0.00004891716,"about_ca_topic_score_gemma":0.00003391745,"teacher_disagreement_score":0.04524659,"about_ca_system_score_codex":0.000033429795,"about_ca_system_score_gemma":0.000030808118,"threshold_uncertainty_score":0.14629927},"labels":[],"label_agreement":null},{"id":"W2586243815","doi":"10.1182/blood.v108.11.3334.3334","title":"Follow-Up of Patients with Curable Lymphomas Ouside of Clinical Trials: A National Survey of Practice Patterns.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lymphoma; Limiting; Clinical trial; Cancer; Internal medicine; Family medicine; Pediatrics","score_opus":0.0893511662953068,"score_gpt":0.38727667990010683,"score_spread":0.2979255136048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586243815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662393,0.00022734728,0.000010648661,0.00006855637,0.00009541623,0.00043303648,0.0003973947,0.000007423906,0.002136254],"genre_scores_gemma":[0.9987374,0.000044520893,0.0007194286,0.000055834204,0.000052572203,0.000020557245,0.00028567362,0.000013580194,0.0000704383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730897,0.00048473658,0.0012215973,0.00019681215,0.0006687586,0.00011910061],"domain_scores_gemma":[0.9946549,0.0028338889,0.0011130709,0.0002181269,0.0011231648,0.000056872454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023584065,0.00011853417,0.00085417135,0.00006785776,0.000015039627,0.0000033738554,0.000058372916,0.00008299471,0.0000552835],"category_scores_gemma":[0.004867015,0.00007967514,0.00017470695,0.00015938608,0.00006631206,0.000075683,0.000021794594,0.000039655646,0.0000030217475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016307597,0.014886001,0.9807309,0.00007538388,0.0007087842,0.000010252868,0.00003400449,0.0000030896647,0.000022404034,0.00012258846,0.00062904204,0.0011467932],"study_design_scores_gemma":[0.043098826,0.0011977764,0.9487853,0.00015181882,0.00089899194,0.0000052797645,0.000020140678,0.0000050742838,0.005532772,0.000023793491,0.00021558661,0.00006463382],"about_ca_topic_score_codex":0.004814281,"about_ca_topic_score_gemma":0.0003129256,"teacher_disagreement_score":0.04146807,"about_ca_system_score_codex":0.000027636137,"about_ca_system_score_gemma":0.0004617269,"threshold_uncertainty_score":0.7277785},"labels":[],"label_agreement":null},{"id":"W2586449045","doi":"10.1182/blood.v106.11.2412.2412","title":"Gene Expression Analysis Uncovers Possible Resistance Mechanisms to Bortezomib in Mantle Cell Lymphoma That Differ from Mechanisms Identified in Other Lymphoid Malignancies.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Cancer research; Multiple myeloma; Cell culture; Chemistry; IC50; Lymphoma; Medicine; Biology; Immunology","score_opus":0.010758879382520984,"score_gpt":0.22680788922229,"score_spread":0.21604900983976902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586449045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507713,0.0010625445,0.001281577,0.00033079935,0.000111521615,0.000647815,0.00016910516,0.00006281071,0.0012566815],"genre_scores_gemma":[0.98055506,0.00013849951,0.015466099,0.0010745144,0.000069695096,0.00023286766,0.000109642286,0.000055852117,0.0022977965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739575,0.000082398,0.0005168031,0.0008425879,0.0006003544,0.000562091],"domain_scores_gemma":[0.9986867,0.00007939927,0.00015365235,0.00078321097,0.00004226844,0.0002547985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020954863,0.00038199383,0.00075165235,0.00057149614,0.00006949188,0.00006803228,0.00022002109,0.00020425569,0.00040629486],"category_scores_gemma":[0.000018971235,0.00032532885,0.00026202796,0.0008881014,0.000019451729,0.00015564598,0.00010807145,0.000057189296,0.00014791409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071402034,0.008689633,0.28100845,0.000053132848,0.000663589,0.001075956,0.0012476175,0.00016483352,0.70436555,0.0003283647,0.0008170467,0.00087177905],"study_design_scores_gemma":[0.013944392,0.000079696896,0.14979836,0.00021246694,0.00074825814,0.00000618479,0.0002240487,0.000043756118,0.8336528,0.00073293585,0.0002599152,0.0002971848],"about_ca_topic_score_codex":0.0015519535,"about_ca_topic_score_gemma":0.0045266454,"teacher_disagreement_score":0.13121009,"about_ca_system_score_codex":0.0005944637,"about_ca_system_score_gemma":0.0001220174,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W2586504089","doi":"10.1182/blood.v108.11.2269.2269","title":"Long Term Follow-Up Results for Patients with Hodgkin Lymphoma after First Remission of Longer Than Ten Years: A Population Based Study of 954 Patients from the British Columbia Cancer Agency.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Internal medicine; Malignancy; Population; Cancer; Lymphoma; Stage (stratigraphy); Gastroenterology; Proportional hazards model; Pediatrics; Surgery","score_opus":0.007000475242966353,"score_gpt":0.21871586829889897,"score_spread":0.21171539305593262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586504089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968804,0.00014929577,0.0000010123766,0.000016478549,0.00009006169,0.001977365,0.00084867777,0.000014202293,0.000022489428],"genre_scores_gemma":[0.9983553,0.000006170364,0.00012143967,0.000026989628,0.00006335499,0.00037275918,0.000893252,0.000027524145,0.00013318984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863183,0.00003873501,0.00041384847,0.0003176288,0.00042902541,0.00016890939],"domain_scores_gemma":[0.9990137,0.0001023954,0.00028621175,0.00034484017,0.00020019253,0.000052633168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059178168,0.00012622835,0.00030830942,0.000024265508,0.00009779576,0.00005169611,0.000076566175,0.000069010304,0.000030107522],"category_scores_gemma":[0.000047992213,0.000106715495,0.000097164324,0.00012573824,0.000019252007,0.000056349923,0.000026769245,0.000022738914,5.5240656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011922144,0.0119005125,0.9785446,0.000042249,0.0001564353,0.000021320295,0.0003450487,0.000002133616,0.000004580506,1.9424746e-8,0.00065077085,0.0071401116],"study_design_scores_gemma":[0.05639631,0.0016973416,0.93990946,0.0008679117,0.00083731615,3.7698763e-7,0.000021842407,0.00000505758,0.0001279031,0.0000035662313,0.000023174021,0.00010973443],"about_ca_topic_score_codex":0.12527788,"about_ca_topic_score_gemma":0.19258328,"teacher_disagreement_score":0.0673054,"about_ca_system_score_codex":0.00009303009,"about_ca_system_score_gemma":0.000062194005,"threshold_uncertainty_score":0.880547},"labels":[],"label_agreement":null},{"id":"W2586578392","doi":"10.1182/blood.v128.22.151.151","title":"The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Clinical trial; Immunohistochemistry; Medicine; Cancer research; Pathology; Biology; B cell; Immunology; Gene; Germinal center; Antibody; Genetics","score_opus":0.11520768825068846,"score_gpt":0.43345536407772817,"score_spread":0.3182476758270397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586578392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952022,0.00077626965,0.0000012049738,0.0010994157,0.00016142098,0.0019788453,0.000053241227,0.0000073244714,0.00072012347],"genre_scores_gemma":[0.99836034,0.0011609757,0.000027353739,0.000027968474,0.00008612388,0.00012286515,0.000001765218,0.000013270278,0.0001993173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996258,0.0014096226,0.0015794948,0.00026536876,0.00029086747,0.000196597],"domain_scores_gemma":[0.9926232,0.0051816734,0.0011356742,0.00082978373,0.00015801741,0.0000716437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043860683,0.00016140252,0.0007926913,0.000025829462,0.00007647274,0.00001201992,0.00021494915,0.00014794506,0.00001390593],"category_scores_gemma":[0.0020692267,0.000042426396,0.00056464266,0.00020373864,0.0008746535,0.000039429768,0.000082048806,0.0001572951,0.0000018808371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032023438,0.002945763,0.98782235,0.000013335236,0.00046669116,0.0000011337772,0.0004244159,6.289094e-7,0.0020323545,0.0011832245,0.00021838542,0.0016893735],"study_design_scores_gemma":[0.050627165,0.0005685185,0.9058203,0.00018304047,0.0006956529,0.0000036893916,0.00016471726,0.00001315743,0.04136677,0.00040369434,0.00010413362,0.000049166345],"about_ca_topic_score_codex":0.0005374082,"about_ca_topic_score_gemma":0.000109779685,"teacher_disagreement_score":0.08200206,"about_ca_system_score_codex":0.00005925071,"about_ca_system_score_gemma":0.00043078308,"threshold_uncertainty_score":0.32226974},"labels":[],"label_agreement":null},{"id":"W2586723043","doi":"10.3324/haematol.2016.157495","title":"Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; University of Toronto; Helsingin Yliopisto","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Mutation; Biology; Internal medicine; Genetics; Oncology; Medicine; Immunology; Gene","score_opus":0.02855342721875413,"score_gpt":0.2795198590606242,"score_spread":0.25096643184187006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586723043","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43124944,0.0025651571,0.00002122946,0.504655,0.001402278,0.002546243,0.0010157154,0.00041904475,0.056125928],"genre_scores_gemma":[0.8295366,0.00045761652,0.00038858844,0.15829696,0.00095807126,0.0007893636,0.0029622505,0.00010415535,0.0065063806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701124,0.00016641652,0.00061449443,0.0008245013,0.0005534467,0.0008299153],"domain_scores_gemma":[0.99778813,0.00039718306,0.00040943373,0.0011434471,0.00010030055,0.00016148781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001837858,0.0005923824,0.0014725387,0.00027200993,0.00025011465,0.000095698306,0.00039257162,0.0011949678,0.00027990804],"category_scores_gemma":[0.00024924974,0.00043008526,0.0004057663,0.00011611344,0.00016259194,0.000080041886,0.0001718562,0.0005318237,0.0007659688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082583334,0.008738088,0.046934918,0.00051635096,0.00021448369,0.06713458,0.00012496515,1.4675297e-7,0.000003049732,0.00015690968,0.87528664,0.00080726104],"study_design_scores_gemma":[0.036959637,0.0004852208,0.07341741,0.0007048537,0.00073846476,0.001822451,0.00006973095,0.00007267162,0.00025069126,0.0003312915,0.88447773,0.0006698628],"about_ca_topic_score_codex":0.00026955415,"about_ca_topic_score_gemma":0.00010663727,"teacher_disagreement_score":0.39828718,"about_ca_system_score_codex":0.0003158785,"about_ca_system_score_gemma":0.0003124622,"threshold_uncertainty_score":0.9998151},"labels":[],"label_agreement":null},{"id":"W2587200722","doi":"10.1182/blood.v124.21.1757.1757","title":"Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Tolerability; Refractory (planetary science); Progressive disease; Population; Salvage therapy; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; Oncology; Adverse effect; Chemotherapy","score_opus":0.016510344002501908,"score_gpt":0.27811597323357745,"score_spread":0.26160562923107555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587200722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756503,0.0008478154,0.000010088203,0.0001117001,0.000019502813,0.00069933926,0.00027473806,0.000013559512,0.0004582053],"genre_scores_gemma":[0.99891347,0.0002331065,0.00022525864,0.000027996184,0.000025774942,0.000069085174,0.00035469883,0.000013752148,0.00013686587],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99838686,0.00018465564,0.0005603904,0.00037195446,0.00028659654,0.00020954676],"domain_scores_gemma":[0.99879766,0.0002631227,0.00027372863,0.00052116223,0.00006194943,0.000082406346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027569046,0.00022820648,0.00075521634,0.00022032717,0.000045619312,0.000010410318,0.00008822775,0.00007396031,0.00002159947],"category_scores_gemma":[0.00004067069,0.00014060571,0.00015020595,0.0005268722,0.00006580908,0.000037008664,0.000021929018,0.000037183483,0.0000034153368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008050049,0.59652555,0.32996145,0.0001494201,0.005809787,0.0005971331,0.013271297,0.000014740091,0.013681608,0.000037218724,0.0006185716,0.031283155],"study_design_scores_gemma":[0.36401257,0.016223628,0.57403064,0.00004972455,0.01012254,0.000019327681,0.0008835829,0.00081629475,0.032071523,0.000006793908,0.0015721852,0.0001912367],"about_ca_topic_score_codex":0.00372049,"about_ca_topic_score_gemma":0.00028833587,"teacher_disagreement_score":0.58030194,"about_ca_system_score_codex":0.00008523068,"about_ca_system_score_gemma":0.000055574907,"threshold_uncertainty_score":0.57337344},"labels":[],"label_agreement":null},{"id":"W2587302424","doi":"10.1182/blood.v126.23.579.579","title":"Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Radiation therapy; Stage (stratigraphy); Chemotherapy; Radiology; Salvage therapy; B symptoms; Lymphoma; Dacarbazine; Chemotherapy regimen; Oncology; Surgery; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.020611843153929763,"score_gpt":0.2905276796174142,"score_spread":0.26991583646348444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587302424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943227,0.0002732974,0.00017790937,0.0007984591,0.000057032426,0.0039166985,0.00023051468,0.00003445982,0.0001888841],"genre_scores_gemma":[0.99418247,0.00003571803,0.0023321,0.00012087358,0.00003507813,0.0012544125,0.0001930654,0.000053227865,0.0017930856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982922,0.00010248975,0.0003020544,0.0004308097,0.0005650208,0.00030739143],"domain_scores_gemma":[0.99834263,0.00035228668,0.00030420697,0.00044081034,0.00024244965,0.0003175891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073095885,0.00036498523,0.00064780714,0.000067219946,0.00013088046,0.000032966294,0.000084462896,0.000035475525,0.0000064799287],"category_scores_gemma":[0.000054136417,0.00017850698,0.00019701396,0.00010279724,0.00016929132,0.00013819794,0.000025721294,0.000029589848,0.0000011943296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012121057,0.006478858,0.9724517,0.000041794647,0.0025306686,0.00008820631,0.0036468334,0.00006336924,0.000057133326,0.00006612765,0.000055549306,0.0023987282],"study_design_scores_gemma":[0.1938553,0.011523759,0.7712525,0.00030601333,0.002835252,0.000009947483,0.0028063904,0.00028792507,0.015987908,0.000025992082,0.0007512837,0.00035770854],"about_ca_topic_score_codex":0.00017378571,"about_ca_topic_score_gemma":0.00017316859,"teacher_disagreement_score":0.20119916,"about_ca_system_score_codex":0.00063246663,"about_ca_system_score_gemma":0.00040782482,"threshold_uncertainty_score":0.7279303},"labels":[],"label_agreement":null},{"id":"W2587561344","doi":"10.1182/blood.v104.11.3273.3273","title":"HLA-DR Protein Status Predicts Survival in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with the MACOP-B Chemotherapy Regimen.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy regimen; Regimen; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Rituximab; Chemotherapy; Lymphoma","score_opus":0.004658303319586693,"score_gpt":0.19594653798043038,"score_spread":0.1912882346608437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587561344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530303,0.00023196841,0.0000048603074,0.00064755353,0.000016805516,0.0021797328,0.00006876632,0.000091625814,0.0014556726],"genre_scores_gemma":[0.9983807,0.000050944,0.00020723075,0.0002942765,0.000048260947,0.00034277572,0.00013101473,0.00006827789,0.00047651381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981499,0.000055431836,0.0002226639,0.00043342903,0.00053465395,0.0006039438],"domain_scores_gemma":[0.99900264,0.00003077156,0.00012953737,0.00053771207,0.000090947586,0.00020840808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008646515,0.00034381438,0.00039587516,0.00008545229,0.00009934737,0.000035760975,0.00010888221,0.00009619629,0.000024088698],"category_scores_gemma":[0.000007947774,0.00017717869,0.00006060862,0.00035549406,0.00007615471,0.00007854527,0.000026853024,0.00008650163,0.00002309856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020354032,0.0673156,0.9280211,0.000055304452,0.00037085038,0.0003913772,0.00069687533,0.0000038387598,0.00013975124,0.0000544317,0.0000967656,0.0008187572],"study_design_scores_gemma":[0.25081664,0.0030058348,0.7216246,0.00023242715,0.0002637192,0.000010279598,0.00011716968,0.0000027233546,0.022770084,0.0000064871538,0.0009524456,0.00019756309],"about_ca_topic_score_codex":0.0006223484,"about_ca_topic_score_gemma":0.00026434648,"teacher_disagreement_score":0.24878125,"about_ca_system_score_codex":0.0002657275,"about_ca_system_score_gemma":0.0002676775,"threshold_uncertainty_score":0.72251374},"labels":[],"label_agreement":null},{"id":"W2587613230","doi":"10.1182/blood.v128.22.1760.1760","title":"Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Lymphoma; DNA sequencing; Biology; Immunology; Medicine; Oncology; Cancer research; DNA; Genetics","score_opus":0.018389300689762453,"score_gpt":0.24684720902255702,"score_spread":0.22845790833279456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587613230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993218,0.0005233922,0.00002864528,0.0028999345,0.00017085034,0.00038986083,0.000010680527,0.00012636535,0.0026322692],"genre_scores_gemma":[0.99577945,0.00021345713,0.0007036228,0.00018334527,0.0014399614,0.000096492346,0.000017194181,0.00002210761,0.0015443801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990355,0.000022975943,0.00018335115,0.00032160516,0.00018987068,0.0002467106],"domain_scores_gemma":[0.99941653,0.000032974178,0.000057282607,0.0003445043,0.00006329345,0.00008539641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009533197,0.0001406711,0.00020750734,0.00009405722,0.000060192826,0.000014524431,0.000047926053,0.000062908715,0.00012463107],"category_scores_gemma":[0.00007084499,0.00008155396,0.00008926692,0.00013365106,0.00003782108,0.00008269032,0.000027910959,0.000019243214,0.00025968795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030632908,0.005486795,0.14675994,0.00018226783,0.0014329995,0.001136111,0.00087066245,7.791285e-7,0.6737496,0.0024723941,0.0068633403,0.16073878],"study_design_scores_gemma":[0.031649463,0.0016640171,0.3362375,0.00025738572,0.0012631832,0.002450387,0.00019437277,0.0000037387463,0.48296806,0.00026328184,0.14256565,0.0004829435],"about_ca_topic_score_codex":0.000094927746,"about_ca_topic_score_gemma":0.0000053078415,"teacher_disagreement_score":0.19078153,"about_ca_system_score_codex":0.0003274391,"about_ca_system_score_gemma":0.00022950038,"threshold_uncertainty_score":0.33378497},"labels":[],"label_agreement":null},{"id":"W2587629215","doi":"10.1182/blood.v116.21.1357.1357","title":"The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Internal medicine; Oncology; Transplantation; Rituximab; Minimal residual disease; Chemotherapy; Surgery; Gastroenterology; Lymphoma; Leukemia","score_opus":0.005183612643181809,"score_gpt":0.22653661867834285,"score_spread":0.22135300603516103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587629215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971203,0.00031538654,0.000026051039,0.0008427512,0.000049619466,0.0015161214,0.00008268329,0.00002250594,0.000024570385],"genre_scores_gemma":[0.99715227,0.00026405105,0.0021707662,0.0000343106,0.00001764478,0.00023532908,0.000072736446,0.000019071016,0.000033823184],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992107,0.00002734347,0.00016857423,0.0002726103,0.00017665674,0.00014407799],"domain_scores_gemma":[0.99938214,0.00011169682,0.000092428156,0.00021925088,0.00009099651,0.00010351793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010134796,0.00014057719,0.00022087358,0.000035202745,0.00013888394,0.000024209632,0.00004269641,0.00007208486,0.0000029989312],"category_scores_gemma":[0.0000213315,0.000074241536,0.00002492576,0.000058590573,0.000056908746,0.000050596354,0.000013762597,0.000033228767,1.748767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029608665,0.023341382,0.2229162,0.0021074926,0.0011184382,0.00022178855,0.003593802,0.000001201059,0.2779298,0.0007339305,0.0006988644,0.43772843],"study_design_scores_gemma":[0.053753212,0.0057442286,0.43641397,0.00042424334,0.00061755267,0.000060692575,0.00010616071,0.00002339235,0.50226074,0.00007348391,0.00035825378,0.0001640245],"about_ca_topic_score_codex":0.000023822768,"about_ca_topic_score_gemma":0.000028009725,"teacher_disagreement_score":0.4375644,"about_ca_system_score_codex":0.000010748817,"about_ca_system_score_gemma":0.00004208116,"threshold_uncertainty_score":0.3027482},"labels":[],"label_agreement":null},{"id":"W2587772896","doi":"10.1182/blood.v104.11.608.608","title":"Phase II Trial of Bortezomib in Mantle Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Bortezomib; Mantle cell lymphoma; Nausea; Internal medicine; Surgery; Neutropenia; Adverse effect; Chills; Vomiting; Progressive disease; Phases of clinical research; Gastroenterology; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.013791357118979336,"score_gpt":0.2736314929560739,"score_spread":0.2598401358370946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587772896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136734,0.0005037979,0.0000014621581,0.000223835,0.000084497115,0.00044011892,0.000012698994,0.000017140788,0.0073491205],"genre_scores_gemma":[0.99913764,0.00011265451,0.00032507,0.00008482102,0.00009201252,0.000046143516,0.000019007737,0.000010636909,0.00017202752],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992968,0.000009578536,0.00023714679,0.00015487989,0.00014970156,0.0001519103],"domain_scores_gemma":[0.9996157,0.00001799015,0.00005918565,0.00021540682,0.00001946313,0.00007220008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006241664,0.00009572329,0.00026125548,0.00007456142,0.000021931442,0.0000031947955,0.00004144555,0.000056464385,0.000043150998],"category_scores_gemma":[0.000016465989,0.00007639461,0.00009182108,0.00011605429,0.000023017405,0.000025738464,0.000023287996,0.000021596641,0.000026503625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031220231,0.87330747,0.020942917,0.00026538578,0.0004909489,0.0030616615,0.0018253486,0.0000098124765,0.026316697,0.001570641,0.0008040317,0.040184855],"study_design_scores_gemma":[0.71686107,0.0064353044,0.0048671695,0.000070396956,0.00023170967,0.000026241638,0.00003550023,0.0000012812143,0.27031448,0.000112349204,0.0009758804,0.00006860915],"about_ca_topic_score_codex":0.00022422263,"about_ca_topic_score_gemma":0.000019960693,"teacher_disagreement_score":0.8668722,"about_ca_system_score_codex":0.00006409906,"about_ca_system_score_gemma":0.00016861492,"threshold_uncertainty_score":0.31152818},"labels":[],"label_agreement":null},{"id":"W2587780046","doi":"10.1182/blood.v120.21.3701.3701","title":"Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Autologous stem-cell transplantation; Internal medicine; Oncology; Hazard ratio; Univariate analysis; Cohort; Surgery; Transplantation; Lymphoma; Hodgkin lymphoma; Multivariate analysis; Confidence interval","score_opus":0.007492525847188684,"score_gpt":0.1969964912514361,"score_spread":0.1895039654042474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587780046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997015,0.0005287393,0.000019181554,0.000058601934,0.00009364489,0.0012523334,0.0002828018,0.00010584467,0.0006438639],"genre_scores_gemma":[0.99778116,0.000028606635,0.000654018,0.000113845395,0.00008759181,0.0004866228,0.00035154863,0.000070922535,0.00042565702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837255,0.000031194035,0.00026379921,0.00037831682,0.0003462102,0.00060794264],"domain_scores_gemma":[0.9990458,0.00009921621,0.00011641144,0.0003527768,0.00010258259,0.0002832235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000660199,0.00036553992,0.0005181646,0.00007562302,0.000077633995,0.00002267064,0.00006931246,0.00012910434,0.000040129315],"category_scores_gemma":[0.0000018173245,0.00022571681,0.00012388437,0.00010514027,0.000041774016,0.00010989945,0.000012698444,0.000047123678,0.000028077327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004569617,0.014340198,0.9761149,0.00012327533,0.00053525326,0.00012152752,0.0005175664,0.000001283271,0.000043134467,0.000038121332,0.000044556367,0.0035505178],"study_design_scores_gemma":[0.07057859,0.0042737015,0.9136889,0.00020068475,0.0019830656,0.00006758479,0.000030218062,0.000006796053,0.008339108,0.0000022075592,0.00052683486,0.00030229357],"about_ca_topic_score_codex":0.000104814375,"about_ca_topic_score_gemma":0.00003902416,"teacher_disagreement_score":0.06600897,"about_ca_system_score_codex":0.00011947443,"about_ca_system_score_gemma":0.00007418379,"threshold_uncertainty_score":0.92044646},"labels":[],"label_agreement":null},{"id":"W2587785428","doi":"10.1182/blood.v108.11.347.347","title":"Delays in the Cancer Pathway from Symptom Onset to Initiation of Treatment – A Retrospective Study in Patients with Non-Hodgkin’s Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Hematology; Referral; Cancer; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Biopsy; Lymphoma; Pediatrics; Pathological; Surgery; Family medicine","score_opus":0.00785519564484285,"score_gpt":0.24023190710277345,"score_spread":0.2323767114579306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587785428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973735,0.00008014874,0.0000010368925,0.0000957529,0.000025669375,0.0017936521,0.00020123462,0.000008856685,0.00042012928],"genre_scores_gemma":[0.99880534,0.000008969921,0.000084833955,0.000107500586,0.000037219903,0.0008271022,0.000107686414,0.000014129609,0.000007238664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894154,0.00006242968,0.0002621222,0.00029231858,0.0002730372,0.00016855121],"domain_scores_gemma":[0.9994514,0.000059344395,0.00008948187,0.000296355,0.000067501176,0.000035929475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007109422,0.00016469425,0.00032248694,0.00011814165,0.000026211088,0.000011208035,0.00006209276,0.000040761875,0.000015688049],"category_scores_gemma":[0.000010196835,0.0000950385,0.00003873594,0.0003122875,0.000014392326,0.000039390474,0.000015696882,0.000026114103,0.0000053358244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033746,0.022712497,0.97179115,0.0000032962396,0.00015514044,0.00008599797,0.0035983715,0.000019627962,0.000014865701,0.000009782194,0.00002358432,0.0012482379],"study_design_scores_gemma":[0.03286655,0.0048764157,0.9598373,0.00011854691,0.00027518286,0.000001201847,0.00044114728,0.000004593865,0.0014516251,0.000024452012,0.000013167951,0.0000898189],"about_ca_topic_score_codex":0.031137163,"about_ca_topic_score_gemma":0.02045834,"teacher_disagreement_score":0.03252909,"about_ca_system_score_codex":0.0007447467,"about_ca_system_score_gemma":0.00016964524,"threshold_uncertainty_score":0.9974157},"labels":[],"label_agreement":null},{"id":"W2587810005","doi":"10.1182/blood.v128.22.2992.2992","title":"Serum Biomarkers Predict Outcomes in Advanced Hodgkin Lymphoma Independent of International Prognostic Score (IPS) and Treatment: Correlative Analysis from a Large North American Cooperative Group Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Internal medicine; Medicine; Oncology; CD163; International Prognostic Index; Chemokine; Nodular sclerosis; Immunology; CXCL9; CD68; Lymphoma; Chemokine receptor; Rituximab; Receptor; Hodgkin lymphoma; Biology; Phenotype; Immunohistochemistry","score_opus":0.011030550047900448,"score_gpt":0.2558911846757545,"score_spread":0.24486063462785407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587810005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968216,0.00019096374,0.00004718109,0.0001790341,0.00009406832,0.0011748979,0.0013666508,0.00002622972,0.000099396784],"genre_scores_gemma":[0.99870664,0.00028768496,0.0002732568,0.000035654728,0.000038337006,0.0003204088,0.00025842927,0.000016149459,0.00006344905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841595,0.00010661642,0.0004392706,0.00047234143,0.00032640883,0.00023943764],"domain_scores_gemma":[0.99879396,0.00048029795,0.00027030622,0.00023291665,0.000085224434,0.00013726816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007785072,0.00026352392,0.0007816552,0.00033827368,0.00003751998,0.000014601363,0.00007807954,0.000054221557,0.00007164757],"category_scores_gemma":[0.0001820799,0.00015434099,0.00019391577,0.0005073715,0.00013331596,0.00011657409,0.00005690155,0.000029732078,0.000005765219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064774207,0.0068001994,0.95723474,0.0000033755282,0.008833811,0.00015781424,0.0005892376,0.0000017151481,0.000069269336,0.000021680744,0.0000030375274,0.019807683],"study_design_scores_gemma":[0.15548289,0.002812298,0.8381182,0.00008366235,0.0024004243,0.0000045047436,0.00026043743,0.00006173591,0.0006243746,0.0000051265474,0.000021893618,0.0001244657],"about_ca_topic_score_codex":0.00069429516,"about_ca_topic_score_gemma":0.0038431422,"teacher_disagreement_score":0.14900547,"about_ca_system_score_codex":0.0002538065,"about_ca_system_score_gemma":0.00010997018,"threshold_uncertainty_score":0.6293843},"labels":[],"label_agreement":null},{"id":"W2587995109","doi":"10.1182/blood.v116.21.283.283","title":"Results of a Pivotal Phase 2 Study of Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; CD30; Internal medicine; Oncology; Phases of clinical research; Refractory (planetary science); Antibody-drug conjugate; Gastroenterology; Anaplastic large-cell lymphoma; Lymphoma; Chemotherapy; Immunology; Antibody; Monoclonal antibody","score_opus":0.00971226627271056,"score_gpt":0.26128068393581677,"score_spread":0.2515684176631062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587995109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982537,0.000039453465,1.2056907e-7,0.00002592878,0.000092484035,0.0010403811,0.00008648247,0.000020602887,0.0004408639],"genre_scores_gemma":[0.999463,0.0000067607343,0.00026984356,0.000019059704,0.000033214208,0.000058244023,0.00005427839,0.0000252866,0.00007031209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834216,0.000056089844,0.0005851446,0.00034135339,0.00045737042,0.00021789194],"domain_scores_gemma":[0.9987441,0.00012464054,0.0003158819,0.0005644991,0.00013810607,0.000112822054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015454314,0.0001998229,0.0005321193,0.00017573738,0.000024137045,0.000005644398,0.00009833063,0.000091983566,0.000036959125],"category_scores_gemma":[0.00018300093,0.00012904966,0.000060085476,0.0002837039,0.0000656298,0.000063322295,0.000042484764,0.00009741612,0.000004970157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124243675,0.21468705,0.7548145,0.000056650715,0.00034103586,0.00025459175,0.001468969,4.238254e-7,0.0012742371,0.0000046326913,0.00011271993,0.014560814],"study_design_scores_gemma":[0.24972615,0.020644084,0.7207147,0.00015760955,0.00036549632,0.000010297266,0.00022598874,0.0000033741303,0.007937126,0.0000011557526,0.000111272006,0.000102733546],"about_ca_topic_score_codex":0.0005661982,"about_ca_topic_score_gemma":0.00053950143,"teacher_disagreement_score":0.23730178,"about_ca_system_score_codex":0.000044524466,"about_ca_system_score_gemma":0.00020590708,"threshold_uncertainty_score":0.52624923},"labels":[],"label_agreement":null},{"id":"W2588040117","doi":"10.1182/blood.v120.21.1549.1549","title":"FAS Mutations Are Associated with Therapeutic Resistance in Follicular Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Biology; Cancer research; Follicular lymphoma; Autoimmune lymphoproliferative syndrome; Fas receptor; Germinal center; Fas ligand; Lymphoma; Immunology; Apoptosis; Programmed cell death; B cell; Genetics; Antibody","score_opus":0.01649894936772708,"score_gpt":0.24601059361369343,"score_spread":0.22951164424596635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588040117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914063,0.0044807843,0.0000041697917,0.00047319103,0.000025167876,0.00026146596,0.000009329143,0.000041868978,0.0032977024],"genre_scores_gemma":[0.9988434,0.000031018888,0.0002091298,0.0002960075,0.000037031372,0.00011857742,0.000035790075,0.000016362881,0.00041272907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993031,0.000034107878,0.00012050977,0.00012644786,0.00017365962,0.00024218069],"domain_scores_gemma":[0.9995645,0.000069133646,0.00006472984,0.00017372667,0.00003946112,0.00008841136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074800504,0.0001061156,0.00018883073,0.000052619886,0.000045699344,0.0000098060345,0.00003015584,0.000053397693,0.000023574723],"category_scores_gemma":[0.000037963422,0.000075142925,0.000045980792,0.00022641801,0.000025040032,0.000059173566,0.000006679176,0.000027032127,0.000028494582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031206197,0.0043773865,0.9936361,0.000011591652,0.0003069614,0.00015408719,0.00041452088,5.261061e-7,0.00008600653,0.00052134093,0.000058941783,0.00040138853],"study_design_scores_gemma":[0.009265139,0.00008604891,0.98602206,0.00019721349,0.0004237639,0.000020054058,0.00014065615,0.0000016188568,0.0027619472,0.00006809518,0.0009234558,0.00008995499],"about_ca_topic_score_codex":0.00002887022,"about_ca_topic_score_gemma":0.00030744905,"teacher_disagreement_score":0.009233932,"about_ca_system_score_codex":0.00012821227,"about_ca_system_score_gemma":0.00005595446,"threshold_uncertainty_score":0.30642396},"labels":[],"label_agreement":null},{"id":"W2588237687","doi":"10.1182/blood.v116.21.416.416","title":"Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Nova Scotia Cancer Centre","funders":"","keywords":"ABVD; Medicine; Regimen; Radiation therapy; Chemotherapy regimen; Clinical endpoint; Randomized controlled trial; Mediastinum; Surgery; Internal medicine; Stage (stratigraphy); Chemotherapy; Vincristine","score_opus":0.010226310094974654,"score_gpt":0.2610506480138724,"score_spread":0.25082433791889774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588237687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526966,0.00022926166,0.000015833517,0.00018581013,0.00025621738,0.0038579393,0.000045034783,0.000015449494,0.00012477707],"genre_scores_gemma":[0.99910593,0.00006168008,0.00012857112,0.00008140991,0.00013858666,0.00034183197,0.00005850145,0.000019177027,0.00006433151],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791884,0.00024010666,0.0007292435,0.00032359915,0.00052809407,0.0002600978],"domain_scores_gemma":[0.9981113,0.00065872126,0.00050030975,0.00054918876,0.00008009207,0.0001004098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011107957,0.00026692462,0.0016418566,0.00022399395,0.00011723022,0.000045916553,0.00018862655,0.00008969771,0.0000427023],"category_scores_gemma":[0.00023055421,0.00012069615,0.00038470063,0.0005346333,0.00043173417,0.00007962606,0.000072184914,0.00014167737,2.5918553e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91320497,0.008089191,0.07133728,0.000010984619,0.0044865175,0.000013654867,0.0016418096,0.000003842569,0.00004623828,0.00016957792,0.000017612983,0.0009782962],"study_design_scores_gemma":[0.94902664,0.001961238,0.04162116,0.000062806,0.005988287,0.0000043652976,0.000065287306,0.000511995,0.00054377376,0.000007270116,0.000083959465,0.00012324238],"about_ca_topic_score_codex":0.0008011911,"about_ca_topic_score_gemma":0.0009893004,"teacher_disagreement_score":0.035821624,"about_ca_system_score_codex":0.00006614765,"about_ca_system_score_gemma":0.00013551995,"threshold_uncertainty_score":0.49218464},"labels":[],"label_agreement":null},{"id":"W2588294992","doi":"10.1182/blood.v114.22.3967.3967","title":"FAS Mutations in Follicular Lymphoma Are Rare but Associated with Aggressive Clinical Behavior.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Biology; Exon; Fas receptor; Genetics; Cancer research; Diffuse large B-cell lymphoma; Lymphoma; Gene; Immunology; Apoptosis; Programmed cell death","score_opus":0.024119771397125674,"score_gpt":0.30380545477721727,"score_spread":0.2796856833800916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588294992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973506,0.00074037805,0.0000013288939,0.00060647994,0.00003755305,0.00052059756,0.000040077517,0.00006523683,0.00063775847],"genre_scores_gemma":[0.99870896,0.00007059587,0.00019335095,0.0004899996,0.000061021994,0.00012349401,0.0001745972,0.000015053402,0.00016291122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882334,0.00006539882,0.00032326157,0.00029559177,0.00025164452,0.00024078367],"domain_scores_gemma":[0.99914646,0.00011100627,0.00023491409,0.0002491803,0.00010490474,0.00015355901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008861328,0.00016448386,0.00039648428,0.000077370016,0.00006103558,0.000019819192,0.00005652558,0.00014477182,0.000028765002],"category_scores_gemma":[0.00024848888,0.000120629695,0.00013361369,0.00023193746,0.00004577105,0.000049288854,0.0000116643505,0.00007308897,0.000028996868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004944391,0.012246535,0.9698583,0.0000034955629,0.00019760402,0.009144084,0.00009807478,0.0000015784661,0.000029322708,0.00003016227,0.00015584633,0.00818554],"study_design_scores_gemma":[0.021780854,0.0010074442,0.9737486,0.0004316124,0.0010322703,0.00018627866,0.00016066618,0.000006677314,0.0014092774,0.00002983978,0.000071741844,0.00013469718],"about_ca_topic_score_codex":0.0000518407,"about_ca_topic_score_gemma":0.00011180816,"teacher_disagreement_score":0.02173141,"about_ca_system_score_codex":0.00011211521,"about_ca_system_score_gemma":0.00015558329,"threshold_uncertainty_score":0.49191365},"labels":[],"label_agreement":null},{"id":"W2588308748","doi":"10.1182/blood.v120.21.4823.4823","title":"Clinical Course and Pathological Findings in a Series of Patients with Aggressive Natural Killer (NK) Cell Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pancytopenia; Leukemia; Medicine; Immunology; Hemophagocytic lymphohistiocytosis; Pathology; Acute leukemia; Bone marrow; Biology; Disease","score_opus":0.010623633690095549,"score_gpt":0.26422082074030573,"score_spread":0.25359718705021017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588308748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773747,0.0016115006,9.4464845e-8,0.000046524714,0.00009051416,0.00022801253,0.00000771699,0.000008853206,0.00026930706],"genre_scores_gemma":[0.99894613,0.00017244088,0.0006204497,0.000099260455,0.000040014445,0.000019093663,0.000022265378,0.0000073912734,0.00007298098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993041,0.000032529104,0.00020129862,0.00014399033,0.00013646792,0.00018159131],"domain_scores_gemma":[0.99956197,0.000079022655,0.00010348778,0.000110473404,0.000042263702,0.00010280107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008818234,0.00010468697,0.0002917408,0.000025918165,0.000018160623,0.0000039525244,0.000025492356,0.00008478399,0.000020560747],"category_scores_gemma":[0.000059377056,0.000060562725,0.000040269628,0.000055194658,0.00011876886,0.00006903562,0.000035100427,0.000093335424,0.0000046085993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025686726,0.0036273366,0.9944281,0.000030088906,0.00004720281,0.00011378307,0.00028473407,4.565193e-8,0.000017561928,0.00002447065,0.00011760588,0.0010521932],"study_design_scores_gemma":[0.011855431,0.0009812878,0.98529255,0.00012682557,0.00021740014,0.000033876597,0.00007578313,6.613437e-7,0.0012153613,0.0000042292554,0.00012556124,0.0000710086],"about_ca_topic_score_codex":0.0000096263775,"about_ca_topic_score_gemma":0.0000051449356,"teacher_disagreement_score":0.011598564,"about_ca_system_score_codex":0.000025534642,"about_ca_system_score_gemma":0.000048607923,"threshold_uncertainty_score":0.24696761},"labels":[],"label_agreement":null},{"id":"W2588333435","doi":"10.1182/blood.v112.11.4459.4459","title":"Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Refractory (planetary science); Cumulative incidence; Transplantation; Surgery; Gastroenterology; Incidence (geometry); Lymphoma; Population; Chemotherapy","score_opus":0.01238958380997837,"score_gpt":0.23278582197242972,"score_spread":0.22039623816245135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588333435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571985,0.00037847031,0.000071424365,0.0002667037,0.00005594762,0.0026595383,0.00021103614,0.0000842201,0.00055278616],"genre_scores_gemma":[0.9960432,0.0006485061,0.0010224526,0.0010516617,0.000039387436,0.0006508927,0.0002051874,0.000052986565,0.00028574813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998581,0.000034871653,0.00027837438,0.00042855646,0.00032252938,0.00035464737],"domain_scores_gemma":[0.9992252,0.00011234273,0.000070483,0.00023796965,0.00013826424,0.00021576774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004431772,0.0002942226,0.00042313524,0.00011159461,0.00017632477,0.000013320683,0.000076495024,0.00012694167,0.00005240107],"category_scores_gemma":[0.0000038191533,0.00020490619,0.00015532791,0.00017164768,0.000047948506,0.00009400485,0.0000034748275,0.000037758797,0.000044677403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018108126,0.028668066,0.76660436,0.00035284527,0.0021069015,0.0010322825,0.044187438,0.000006200544,0.011668315,0.00003367769,0.0005742256,0.12665758],"study_design_scores_gemma":[0.0562257,0.010875916,0.75394124,0.00008989139,0.0004414149,0.00011074799,0.00012846064,0.0000026456917,0.17534477,0.0000050642043,0.0025601243,0.00027404027],"about_ca_topic_score_codex":0.000075716736,"about_ca_topic_score_gemma":0.000016633985,"teacher_disagreement_score":0.16367644,"about_ca_system_score_codex":0.000119162076,"about_ca_system_score_gemma":0.00026969373,"threshold_uncertainty_score":0.83558315},"labels":[],"label_agreement":null},{"id":"W2588373857","doi":"10.1182/blood.v120.21.2149.2149","title":"Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cancer; Cohort; Lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.01756122313501451,"score_gpt":0.27842884941103874,"score_spread":0.2608676262760242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588373857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918211,0.006520495,0.0000017527107,0.00017596595,0.00010082394,0.00018741489,0.000008738156,0.00001622082,0.0011674728],"genre_scores_gemma":[0.99929,0.00023051728,0.00019931498,0.00004166913,0.000074443626,0.00006267044,0.0000036473552,0.0000102179265,0.00008753784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937195,0.00001075012,0.00015896527,0.000096919604,0.00012245477,0.00023893542],"domain_scores_gemma":[0.99972075,0.00002760288,0.00004831921,0.00012272112,0.0000094189845,0.000071166134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007170511,0.00008312934,0.00021935646,0.000077988145,0.000016817563,0.000004142853,0.000026918207,0.00003643907,0.00008144618],"category_scores_gemma":[0.000014491224,0.00006498946,0.000050727656,0.00012291028,0.000020480884,0.000070857466,0.00002006014,0.000030082892,0.0000071582476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018788312,0.0014704918,0.993102,0.00008240319,0.0000913489,0.0000827303,0.0006819224,7.7748126e-7,0.0038960734,0.00016016248,0.000032899217,0.0003804168],"study_design_scores_gemma":[0.0027620697,0.00012330932,0.8532681,0.00054832647,0.00019551255,0.00017038683,0.00012440766,0.0000018424979,0.14264607,0.000018295043,0.00008414961,0.00005752637],"about_ca_topic_score_codex":0.00035137904,"about_ca_topic_score_gemma":0.000037437447,"teacher_disagreement_score":0.13983388,"about_ca_system_score_codex":0.00007364127,"about_ca_system_score_gemma":0.000042981952,"threshold_uncertainty_score":0.2650193},"labels":[],"label_agreement":null},{"id":"W2588462476","doi":"10.1182/blood.v114.22.622.622","title":"Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes: Integration of Tumor and Microenvironment Contributions.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Oncology; Survival analysis; Biology; Gene; Lymphoma; Internal medicine; Medicine; Computational biology; Genetics","score_opus":0.010597088637092978,"score_gpt":0.22748691115468458,"score_spread":0.21688982251759162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588462476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985945,0.00045869898,0.0000956459,0.00017441125,0.000018089528,0.00036584484,0.00015457442,0.0000046337536,0.00013358616],"genre_scores_gemma":[0.9995609,0.00013661865,0.00014767912,0.00006151201,0.000012925619,0.000020814105,0.000049415077,0.000003997196,0.0000061184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993044,0.00006452741,0.00026185668,0.00011656409,0.00016719397,0.0000854393],"domain_scores_gemma":[0.9995241,0.000096656506,0.00013483608,0.00018452042,0.000029904271,0.00002997837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015542877,0.000083689636,0.0002128728,0.000059135942,0.000019795727,0.0000019693296,0.000028586963,0.000030561918,0.000009013572],"category_scores_gemma":[0.00003412348,0.00005142045,0.000049666614,0.000064958804,0.000033639968,0.000019030656,0.000009450281,0.00002308198,4.554407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002974825,0.041617736,0.21652904,0.000045902718,0.00002110889,0.0000099769895,0.00020060358,0.000007740883,0.7394811,0.0002843991,0.00003352187,0.0014714177],"study_design_scores_gemma":[0.024472443,0.000570596,0.34272823,0.00019754068,0.00008712163,0.0000019189545,0.000074004725,0.0002685985,0.6315421,0.000018379127,0.00001757509,0.000021523749],"about_ca_topic_score_codex":0.000040794643,"about_ca_topic_score_gemma":0.0000059431018,"teacher_disagreement_score":0.12619919,"about_ca_system_score_codex":0.000044949662,"about_ca_system_score_gemma":0.000030398935,"threshold_uncertainty_score":0.20968652},"labels":[],"label_agreement":null},{"id":"W2588661613","doi":"10.1182/blood.v124.21.392.392","title":"Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Burnaby Hospital; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Interim analysis; Interim; Stage (stratigraphy); Internal medicine; Oncology; Nuclear medicine; Clinical trial; Lymphoma; Surgery","score_opus":0.007200698574824707,"score_gpt":0.239697087658289,"score_spread":0.23249638908346432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588661613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978555,0.00011315906,0.0000016837464,0.000014997896,0.00008447908,0.0014061301,0.000106201274,0.000024087556,0.0003937913],"genre_scores_gemma":[0.9990318,0.00013207635,0.00016187211,0.00010880096,0.00003463427,0.000180662,0.0001504728,0.000034377146,0.00016531849],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985436,0.00008331908,0.00042073007,0.00034042174,0.00029097422,0.0003209288],"domain_scores_gemma":[0.99924976,0.00006093061,0.00016785129,0.00034046665,0.00006712743,0.00011386258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013432319,0.00015512906,0.00055043516,0.00008061307,0.000027516406,0.000042095977,0.00009329872,0.000058298043,0.00007921456],"category_scores_gemma":[0.00004775381,0.00017131885,0.00008246334,0.00019569122,0.000045690176,0.000087081644,0.000031305488,0.00005419324,0.000004710569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013943208,0.25714475,0.6956682,0.000052258267,0.000077911245,0.00020221013,0.0001966424,2.298889e-7,0.00013266376,0.0000026350076,0.00006530294,0.03251398],"study_design_scores_gemma":[0.6247447,0.010816238,0.3622235,0.00020397195,0.000045176366,0.0000037911188,0.000055844932,0.000011097007,0.0013229516,0.000003844557,0.0004503854,0.00011848505],"about_ca_topic_score_codex":0.0053660693,"about_ca_topic_score_gemma":0.017477838,"teacher_disagreement_score":0.6108015,"about_ca_system_score_codex":0.00010364097,"about_ca_system_score_gemma":0.000099823046,"threshold_uncertainty_score":0.97530437},"labels":[],"label_agreement":null},{"id":"W2588672442","doi":"10.1182/blood-2016-08-737239","title":"IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council; Institut National Du Cancer; Versus Arthritis; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Michael Smith Health Research BC","keywords":"Stromal cell; Germinal center; Cancer research; Biology; Bone marrow; Follicular lymphoma; Stroma; Tumor microenvironment; Follicular dendritic cells; CXCL13; Mantle zone; B cell; Cell biology; Lymphoma; Immunology; Chemokine; T cell; Immune system; Chemokine receptor; Antigen-presenting cell; Antibody","score_opus":0.01429776879337591,"score_gpt":0.24906864149858624,"score_spread":0.23477087270521033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588672442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953021,0.0008718169,0.0000035053106,0.0005970646,0.00014340115,0.00037236523,0.00003291615,0.00002943126,0.0026474032],"genre_scores_gemma":[0.9985677,0.0001207098,0.00028064675,0.00018157935,0.000118635275,0.00006751801,0.000019981591,0.000024923194,0.0006182984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874115,0.000022196555,0.00031752308,0.00033530628,0.00032087704,0.00026294673],"domain_scores_gemma":[0.9985897,0.000026081148,0.00022008564,0.0009490828,0.000081686114,0.0001333964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011439082,0.00019309115,0.00043118568,0.00010731004,0.00010987528,0.00003550647,0.00013705231,0.00013125347,0.0001015848],"category_scores_gemma":[0.00007184407,0.00016018466,0.00019065767,0.00008268752,0.000073840194,0.00012375649,0.00006731694,0.0000288857,0.00005962639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024504802,0.0042225746,0.9760749,0.000087925444,0.0004413161,0.00028873334,0.00017865657,6.162947e-7,0.0060710073,0.0005381475,0.0006993631,0.011151747],"study_design_scores_gemma":[0.021018375,0.0006336156,0.87991804,0.00022209398,0.00054591574,0.000121226396,0.00004737444,0.000031423675,0.0945833,0.00012354346,0.0026217445,0.00013335639],"about_ca_topic_score_codex":0.0007514572,"about_ca_topic_score_gemma":0.000049222133,"teacher_disagreement_score":0.096156836,"about_ca_system_score_codex":0.00012221909,"about_ca_system_score_gemma":0.00016989655,"threshold_uncertainty_score":0.6532141},"labels":[],"label_agreement":null},{"id":"W2588684164","doi":"10.1182/blood.v114.22.2681.2681","title":"Bendamustine Produces Durable Responses with An Acceptable Long-Term Safety Profile in Patients with Rituximab-Refractory Non-Hodgkin's Lymphoma: A Pooled Analysis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Refractory (planetary science); Regimen; Salvage therapy; Population; Follicular lymphoma; Chemotherapy regimen; Oncology; Gastroenterology; Surgery; Chemotherapy; Lymphoma","score_opus":0.006593143173261565,"score_gpt":0.24249322082871366,"score_spread":0.2359000776554521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588684164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707335,0.00029919922,0.000008143015,0.00028879254,0.000021979266,0.001392315,0.00007723735,0.00009042768,0.00074853],"genre_scores_gemma":[0.99671376,0.000036841873,0.0015892308,0.00021569876,0.00007514969,0.00014057764,0.00070752116,0.000037859667,0.00048338197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975022,0.00009664123,0.00044153075,0.00080599234,0.0005800168,0.0005735938],"domain_scores_gemma":[0.9983908,0.00006175782,0.0002252135,0.0008118482,0.00024069201,0.00026971143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002103168,0.00041628673,0.00088415394,0.00046456108,0.00014859396,0.00007022543,0.00015800154,0.00011144212,0.00025555107],"category_scores_gemma":[0.000052646486,0.00026987557,0.00010829905,0.0011840491,0.00007046147,0.00041049646,0.000030156592,0.000104994986,0.000022463197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074421326,0.034436524,0.9452506,0.000050145558,0.001313702,0.00047797602,0.00021120397,0.00001244148,0.00014681561,0.000004772382,0.000039439423,0.0106142815],"study_design_scores_gemma":[0.046488903,0.006998759,0.9356955,0.0002091143,0.0042744996,0.000028155204,0.000044891094,0.000016913813,0.0058572986,0.00000180769,0.000057192792,0.00032691043],"about_ca_topic_score_codex":0.00025852586,"about_ca_topic_score_gemma":0.00048735202,"teacher_disagreement_score":0.03904677,"about_ca_system_score_codex":0.0002099775,"about_ca_system_score_gemma":0.00038013293,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2588774828","doi":"10.1182/blood.v128.22.2994.2994","title":"Outcome of Hodgkin Lymphoma after Progression Following Autologous Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Autologous stem-cell transplantation; Internal medicine; Oncology; ABVD; Population; Surgery; Progression-free survival; Transplantation; Chemotherapy regimen; Lymphoma; Chemotherapy; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.01290261446109875,"score_gpt":0.267485376512859,"score_spread":0.2545827620517602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588774828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978339,0.00069423614,0.000045214358,0.00020766041,0.000100803074,0.00029474607,0.000017254324,0.000049099835,0.0007570622],"genre_scores_gemma":[0.998769,0.00006710749,0.0006874914,0.000049399117,0.000029514838,0.0000947872,0.000006100654,0.000014645975,0.00028198803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917805,0.000026892501,0.00025233193,0.00018251428,0.00020041154,0.00015982495],"domain_scores_gemma":[0.9995899,0.000062565225,0.0000710214,0.00018221,0.000023003631,0.00007129345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000666309,0.00011647731,0.00024621957,0.000055898603,0.000021723345,0.0000046054165,0.000037047226,0.00007433691,0.000030477026],"category_scores_gemma":[0.0000038444396,0.00006382081,0.00015687438,0.000057709884,0.000019698733,0.000051187526,0.000009795012,0.0000127505455,0.000038883347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016657698,0.0014525562,0.90538305,0.00013227822,0.00009643375,0.0007036166,0.00019786358,3.283736e-8,0.0090301605,0.000015499358,0.000013151511,0.0828088],"study_design_scores_gemma":[0.010354289,0.00039394578,0.70609796,0.00033926306,0.00056873646,0.00006975671,0.00001484734,6.21055e-7,0.28195855,0.0000081582975,0.00012212268,0.00007173803],"about_ca_topic_score_codex":0.000011078914,"about_ca_topic_score_gemma":0.0000031478044,"teacher_disagreement_score":0.2729284,"about_ca_system_score_codex":0.00003922841,"about_ca_system_score_gemma":0.000036672696,"threshold_uncertainty_score":0.2602537},"labels":[],"label_agreement":null},{"id":"W2588808924","doi":"10.1182/blood.v108.11.4603.4603","title":"Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Univariate analysis; Oncology; Immunohistochemistry; Internal medicine; Pathology; Tissue microarray; Survival analysis; Multivariate analysis","score_opus":0.01987890567061137,"score_gpt":0.2866864409767795,"score_spread":0.26680753530616813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588808924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987116,0.0005552085,0.0000035538226,0.00011322813,0.000044093318,0.00036935278,0.0000067037486,0.000016568312,0.00017972407],"genre_scores_gemma":[0.9997261,0.000052952557,0.000062704494,0.000014504878,0.000017404986,0.000027233444,0.000043272415,0.0000079375895,0.00004787513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912995,0.00003567391,0.00043103265,0.0001808293,0.00012135872,0.00010113454],"domain_scores_gemma":[0.9995515,0.000115597875,0.00009254286,0.00015988083,0.000034691948,0.000045815246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001470531,0.00008429104,0.00023783771,0.00007204063,0.000015236865,0.000008327419,0.000025718671,0.000069166585,0.000006164429],"category_scores_gemma":[0.00009329648,0.000063961605,0.0000682765,0.00012513319,0.000066354514,0.000027765827,0.00001539096,0.000016455215,0.000004526797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033497538,0.0047846306,0.99132824,0.000034755463,0.0000776691,0.000044207467,0.00001938136,1.1561696e-7,0.0022064254,0.0002532373,0.000053383563,0.001164465],"study_design_scores_gemma":[0.010324734,0.00018571447,0.9665663,0.000055681972,0.00028066782,0.000011502321,0.00001742852,0.000033066655,0.022274796,0.00014075282,0.00005539514,0.000053930733],"about_ca_topic_score_codex":0.00018664674,"about_ca_topic_score_gemma":0.000024217901,"teacher_disagreement_score":0.024761902,"about_ca_system_score_codex":0.000014309813,"about_ca_system_score_gemma":0.00003708998,"threshold_uncertainty_score":0.26082784},"labels":[],"label_agreement":null},{"id":"W2588856514","doi":"10.1182/blood.v110.11.358.358","title":"The Architecural Pattern of FOXP3+ T Cells Predicts Risk of Transformation in Patients with Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; FOXP3; Lymphoma; CD68; Tissue microarray; Internal medicine; Medicine; Oncology; Univariate analysis; Pathology; Cancer research; Immunology; Immunohistochemistry; Multivariate analysis; Immune system","score_opus":0.0032098421261298284,"score_gpt":0.19188410115354965,"score_spread":0.18867425902741983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588856514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986932,0.00015924433,0.00009599601,0.00003210606,0.00002680401,0.00054535334,0.000038636816,0.0000079108495,0.00040072712],"genre_scores_gemma":[0.99974424,0.0000675302,0.00010082816,0.000018702396,0.00001287481,0.000015050827,0.000027153663,0.000008826079,0.0000048138804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990865,0.000026228621,0.00031768897,0.00009718873,0.00030462714,0.00016775333],"domain_scores_gemma":[0.9994628,0.00008924794,0.00014489918,0.00018996366,0.00006124526,0.00005183684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017301159,0.00009652499,0.00018918811,0.000064092215,0.000028609053,0.0000034236284,0.000052169165,0.000039595172,0.0000031857012],"category_scores_gemma":[0.000010443623,0.000053372263,0.00006812288,0.00011949383,0.0000478772,0.0000352374,0.000008133431,0.000030185814,0.0000018095808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029130175,0.0025954049,0.94449556,0.000055968936,0.00018681999,0.000009416816,0.0010191492,0.0000067780525,0.00010365597,0.000017833743,0.000005179781,0.051212944],"study_design_scores_gemma":[0.017491316,0.000984937,0.8970386,0.00013739093,0.0002796566,0.0000028573736,0.000089988884,0.000016430608,0.083836235,0.00001507006,0.000061075836,0.00004646651],"about_ca_topic_score_codex":0.00029909587,"about_ca_topic_score_gemma":0.00016294133,"teacher_disagreement_score":0.083732575,"about_ca_system_score_codex":0.00002874657,"about_ca_system_score_gemma":0.00003336082,"threshold_uncertainty_score":0.21764576},"labels":[],"label_agreement":null},{"id":"W2588876159","doi":"10.1182/blood.v128.22.1110.1110","title":"Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Brentuximab vedotin; Oncology; Autologous stem-cell transplantation; Cohort; Progression-free survival; Clinical endpoint; Transplantation; Lymphoma; Surgery; Chemotherapy; Clinical trial; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.009844112837785985,"score_gpt":0.2363699067996585,"score_spread":0.2265257939618725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588876159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782354,0.00010438173,0.0000032589621,0.00017480634,0.00007137986,0.0012882211,0.00004966539,0.000046843903,0.0004378883],"genre_scores_gemma":[0.9990433,0.000025265368,0.00016956369,0.00006472424,0.000040535968,0.00019044874,0.000035774272,0.00005297778,0.000377441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979289,0.000082292805,0.00044756258,0.00052941433,0.0006064158,0.00040537506],"domain_scores_gemma":[0.99871135,0.00007608429,0.00024168464,0.0006314028,0.00012171049,0.00021778424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106065185,0.00033221277,0.00067807577,0.00017036237,0.0000466912,0.000013443257,0.00012321096,0.00010282389,0.000072682495],"category_scores_gemma":[0.000037050373,0.0001745896,0.000079130594,0.00021817918,0.00009895804,0.00015195282,0.00005264189,0.00006153876,0.000026743186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008552087,0.08338606,0.8840123,0.000027642613,0.00073843775,0.0004949998,0.00057798944,1.9360965e-7,0.00016485385,0.000010052764,0.00033671004,0.021698704],"study_design_scores_gemma":[0.28666946,0.024719574,0.6841982,0.00038048002,0.00072022306,0.000013016455,0.00017130516,0.0000026002092,0.0022788807,0.000003551393,0.0006325376,0.00021015403],"about_ca_topic_score_codex":0.0001591379,"about_ca_topic_score_gemma":0.00044966722,"teacher_disagreement_score":0.2781174,"about_ca_system_score_codex":0.00018596285,"about_ca_system_score_gemma":0.00020390135,"threshold_uncertainty_score":0.7119557},"labels":[],"label_agreement":null},{"id":"W2588964553","doi":"10.1182/blood.v116.21.4187.4187","title":"BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Follicular lymphoma; Lymphoma; Biology; Sanger sequencing; Mantle cell lymphoma; Cancer research; IGHV@; B cell; Gene; Genetics; Chronic lymphocytic leukemia; Mutation; Antibody; Leukemia; Immunology","score_opus":0.00605661490227594,"score_gpt":0.23071091586968784,"score_spread":0.2246543009674119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588964553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910962,0.00027656922,5.08845e-7,0.00074893073,0.00015626501,0.0002651311,0.000031471372,0.000069576694,0.0073553305],"genre_scores_gemma":[0.9974545,0.0000719585,0.0002696937,0.0009930617,0.00009739202,0.000056199053,0.000041731342,0.00002410196,0.000991319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990316,0.0000140898255,0.00019868751,0.00026597158,0.00017632871,0.00031329307],"domain_scores_gemma":[0.9993539,0.000043097418,0.00004450827,0.0003653182,0.000034940473,0.00015827677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070059985,0.00015655621,0.00024654242,0.00009583148,0.000038330858,0.000018176323,0.00007038591,0.00012171251,0.00019645417],"category_scores_gemma":[0.00002639137,0.0001221164,0.00008775961,0.00016932213,0.000024041397,0.000041692623,0.000037177324,0.00007946001,0.00042440067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010267628,0.14022817,0.820125,0.00007681512,0.00017891946,0.0023865837,0.0010193374,3.042895e-8,0.026923673,0.0005187096,0.0037053884,0.004734741],"study_design_scores_gemma":[0.13690686,0.0003078074,0.55354655,0.000050799797,0.00029578657,0.00013984839,0.00005594987,0.00003223391,0.2849703,0.00007003116,0.023417702,0.00020612933],"about_ca_topic_score_codex":0.00022439727,"about_ca_topic_score_gemma":0.00014701704,"teacher_disagreement_score":0.26657844,"about_ca_system_score_codex":0.000033935426,"about_ca_system_score_gemma":0.00008697283,"threshold_uncertainty_score":0.54549533},"labels":[],"label_agreement":null},{"id":"W2589043944","doi":"10.1182/blood.v114.22.1100.1100","title":"MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Cancer research; CHOP; Gene expression profiling; Oncology; Internal medicine; Biology; Gene; Gene expression; Genetics","score_opus":0.007797327228993337,"score_gpt":0.25010714161352876,"score_spread":0.24230981438453542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589043944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984744,0.0002657987,0.00000441922,0.0005271256,0.000006673258,0.00034476287,0.000013888905,0.000026471022,0.00033646188],"genre_scores_gemma":[0.9985713,0.00015213579,0.0008206072,0.00033252945,0.000017923205,0.000034087123,0.000038835216,0.000007968132,0.000024617628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926203,0.000017630775,0.00026626376,0.00019102912,0.00011404478,0.00014900982],"domain_scores_gemma":[0.99957126,0.000037858015,0.00006983253,0.00015814252,0.000040470124,0.0001224581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005516836,0.000102888436,0.00019340878,0.00004859388,0.000032743945,0.0000091382,0.000024405506,0.000062294544,0.000011552568],"category_scores_gemma":[0.000033244658,0.00006714082,0.000029152106,0.0001013009,0.000018899866,0.000034972887,0.000003721794,0.000051063296,0.0000021908618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018341401,0.0074323323,0.98871505,0.000008667228,0.0000291609,0.00014168787,0.00017440232,4.0510812e-7,0.00036755626,0.000007611011,0.000028398777,0.002911325],"study_design_scores_gemma":[0.021442847,0.0010524517,0.97374725,0.0002753664,0.0001848965,0.000020282514,0.000031361393,0.0000047226113,0.003082674,0.000023681305,0.000060646154,0.000073831296],"about_ca_topic_score_codex":0.000026344273,"about_ca_topic_score_gemma":0.000040336974,"teacher_disagreement_score":0.021259433,"about_ca_system_score_codex":0.000027756267,"about_ca_system_score_gemma":0.000052367035,"threshold_uncertainty_score":0.27379233},"labels":[],"label_agreement":null},{"id":"W2589225088","doi":"10.1182/blood.v120.21.1612.1612","title":"Primary Mediastinal B Cell Lymphoma Treated with CHOP-Like Chemotherapy with or without Rituximab: 5-Year Results of the Mabthera International Trial Group (MInT) Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Lymphoma; CHOP; Oncology; Chemotherapy; Surgery; Gastroenterology","score_opus":0.012838535536045536,"score_gpt":0.24295674212259233,"score_spread":0.2301182065865468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589225088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421483,0.00010722068,0.0000044240137,0.00020418726,0.00017459171,0.001964249,0.000042807973,0.000049263454,0.0032384333],"genre_scores_gemma":[0.9972992,0.000034135668,0.00085690664,0.0002282981,0.0004617001,0.00021232708,0.00004408298,0.000050332157,0.00081301556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981575,0.00008750535,0.0003930338,0.00033389236,0.0007200335,0.00030804682],"domain_scores_gemma":[0.99882764,0.000107238615,0.00028454568,0.0005113853,0.00011759222,0.00015159414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000247332,0.00029295147,0.0005146631,0.00007702355,0.00006926238,0.000022087426,0.00019573589,0.00007284818,0.00008721457],"category_scores_gemma":[0.000020823005,0.00013411188,0.000098626086,0.00022661372,0.00011871599,0.00010494067,0.000044513843,0.00007770503,0.000013975414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14793353,0.05739894,0.7879926,0.00002981294,0.0010617544,0.00006954398,0.0015340674,2.1314324e-7,0.00027909508,0.0000057442817,0.0002290643,0.0034656173],"study_design_scores_gemma":[0.4814553,0.0068967263,0.50348747,0.00012425246,0.0008235524,0.00015011724,0.00037394214,0.0000029931534,0.005717781,5.381735e-7,0.0008204938,0.00014685497],"about_ca_topic_score_codex":0.00028957054,"about_ca_topic_score_gemma":0.00009228441,"teacher_disagreement_score":0.33352178,"about_ca_system_score_codex":0.00014249732,"about_ca_system_score_gemma":0.00022406889,"threshold_uncertainty_score":0.54689234},"labels":[],"label_agreement":null},{"id":"W2589278117","doi":"10.1200/jco.2016.34.7_suppl.18","title":"Cost-effectiveness of brentuximab vedotin in relapsed or refractory systemic anaplastic large cell lymphoma.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Anaplastic large-cell lymphoma; Adverse effect; Chemotherapy; Lymphoma; Hodgkin lymphoma","score_opus":0.1165858313692119,"score_gpt":0.4453076312071934,"score_spread":0.3287217998379815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589278117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600124,0.0008765985,0.00010418815,0.0004701823,0.0012863472,0.00045636378,0.000014358823,0.000006926879,0.00078380917],"genre_scores_gemma":[0.99789613,0.0011968734,0.00024194043,0.00019549395,0.00027411486,0.000020400086,0.0000016502737,0.000018798364,0.00015460498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953558,0.001246682,0.0025272882,0.00023044385,0.00034533857,0.00029448068],"domain_scores_gemma":[0.9838182,0.01340566,0.0018840617,0.00024051222,0.00034491217,0.0003066709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041999873,0.00017011055,0.0020659808,0.0002079579,0.000018113551,0.0000030065794,0.00014887453,0.00042183412,0.00011042591],"category_scores_gemma":[0.0045564305,0.00008482952,0.00044405766,0.0001699672,0.000129459,0.000075252465,0.00005012043,0.00023071062,0.000043503856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058301907,0.043009456,0.67752343,0.000544352,0.0005787133,0.0057207947,0.00009565833,0.000006305156,0.0025818523,0.00014366512,0.0012364754,0.21025737],"study_design_scores_gemma":[0.13789372,0.029284455,0.8169445,0.002562635,0.00044126005,0.0007889329,0.00009289946,0.000019012201,0.0013697941,0.000056947552,0.010435085,0.00011075955],"about_ca_topic_score_codex":0.000018497034,"about_ca_topic_score_gemma":0.000046948007,"teacher_disagreement_score":0.2101466,"about_ca_system_score_codex":0.00095271505,"about_ca_system_score_gemma":0.0026129195,"threshold_uncertainty_score":0.54548025},"labels":[],"label_agreement":null},{"id":"W2589413304","doi":"10.1182/blood.v110.11.1674.1674","title":"Risk of Acute Leukemia Post-Autologous Stem Cell Tranplant (ASCT) for Hodgkin’s Lymphoma (HL) Depends on Choice of Salvage Chemotherapy and Use of Radiation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Salvage therapy; Internal medicine; Gemcitabine; Oncology; Cytarabine; Chemotherapy; Melphalan; Surgery; Chemotherapy regimen; Regimen","score_opus":0.011712078419037293,"score_gpt":0.25002451767656697,"score_spread":0.23831243925752968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589413304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735016,0.0009801368,0.0000706264,0.000057157406,0.000044516422,0.00064351363,0.0006664025,0.000018937842,0.00016853676],"genre_scores_gemma":[0.9971672,0.0011984902,0.0012343238,0.00018075174,0.00003864966,0.000021852595,0.00006369404,0.000026713555,0.000068297755],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888194,0.000027161312,0.00043778797,0.00023459598,0.000211565,0.00020693688],"domain_scores_gemma":[0.9985408,0.0006139286,0.0003526681,0.00029128898,0.00010331097,0.00009796676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017487397,0.00018014088,0.000521587,0.00013552608,0.000030940908,0.0000051151205,0.00006103872,0.00013624251,0.000008875117],"category_scores_gemma":[0.000022919206,0.00014084796,0.0001705699,0.00009958003,0.000055359127,0.000047468493,0.000009920668,0.000035356974,9.113388e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035926318,0.0070311637,0.6180428,0.0005951296,0.0031382053,0.00012097406,0.0014532106,0.000013641804,0.07072798,0.00017991067,0.00040048352,0.29470384],"study_design_scores_gemma":[0.015152368,0.0016372763,0.48906022,0.000059535407,0.0009725024,0.000023860664,0.000029367695,0.000022975055,0.49264312,0.0000043667833,0.00032624585,0.00006816285],"about_ca_topic_score_codex":0.00057071913,"about_ca_topic_score_gemma":0.00004295922,"teacher_disagreement_score":0.42191514,"about_ca_system_score_codex":0.000085774445,"about_ca_system_score_gemma":0.00012413607,"threshold_uncertainty_score":0.5743613},"labels":[],"label_agreement":null},{"id":"W2589522228","doi":"10.1200/jco.2016.34.7_suppl.271","title":"Diffuse large B-cell lymphoma: A single-institution experience of patient outcomes.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; University of Toronto","funders":"","keywords":"Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; Cancer; Lymphoma; Population; Performance status; Retrospective cohort study; Cohort; Oncology","score_opus":0.07884245237558474,"score_gpt":0.4154093438504994,"score_spread":0.33656689147491464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589522228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920154,0.00029063504,0.00017394616,0.0038548633,0.0011899892,0.00013936844,0.0000057184275,0.0000067936244,0.002323286],"genre_scores_gemma":[0.99655044,0.0004157276,0.0011498258,0.0015523216,0.0001732615,0.000006252515,5.247909e-7,0.000007923017,0.00014374376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704796,0.00016372903,0.0020544636,0.00015666848,0.0003687696,0.0002083858],"domain_scores_gemma":[0.9960695,0.0013912731,0.0016840267,0.00021653881,0.0003189579,0.00031971722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065199303,0.00012466015,0.0012051754,0.00008493694,0.000027001282,0.0000031268064,0.00010369024,0.00023160386,0.00007817751],"category_scores_gemma":[0.0022079595,0.000059876278,0.0005751734,0.00007337454,0.00020665131,0.00011159227,0.00005474765,0.000091677626,0.000027371112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017874211,0.07577287,0.62689495,0.000017056971,0.00022247684,0.0009994084,0.00034728347,2.393528e-7,0.0008902418,0.00044282502,0.0012321996,0.291393],"study_design_scores_gemma":[0.109388925,0.024299458,0.68744403,0.00029872073,0.00041621912,0.00035491015,0.000262363,0.0000052391842,0.00892459,0.0001397902,0.1683333,0.00013246271],"about_ca_topic_score_codex":0.000012658727,"about_ca_topic_score_gemma":0.000009546037,"teacher_disagreement_score":0.29126054,"about_ca_system_score_codex":0.00036693073,"about_ca_system_score_gemma":0.0008206884,"threshold_uncertainty_score":0.26432934},"labels":[],"label_agreement":null},{"id":"W2589537887","doi":"10.1182/blood.v108.11.348.348","title":"Pathology the Gold Standard – A Retrospective Analysis of Discordant “Second-Opinion” Lymphoma Pathology and Its Impact on Patient Care.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Surgical pathology; Retrospective cohort study; Anatomical pathology; Pathological; Pathology; Clinical pathology; Immunohistochemistry","score_opus":0.006002989227844861,"score_gpt":0.2594789498924781,"score_spread":0.25347596066463324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589537887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316525,0.003938101,0.0000024572937,0.00017393469,0.000078315796,0.0004007869,0.00067189586,0.000018983237,0.0015502877],"genre_scores_gemma":[0.9993108,0.00024743492,0.000043367294,0.0001225336,0.00005176238,0.00006846387,0.00011312697,0.000014557522,0.00002799021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876004,0.000092792914,0.00030949718,0.00036094154,0.00022967922,0.00024703573],"domain_scores_gemma":[0.9991284,0.000114081115,0.0001793487,0.0003758558,0.0001299987,0.00007232126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086835724,0.00020914094,0.00064045936,0.00019879235,0.000062646366,0.000011932219,0.00005678197,0.000070876835,0.00006808017],"category_scores_gemma":[0.00003668777,0.00011373693,0.0002812368,0.00034582257,0.00009588888,0.000025444282,0.00004894437,0.00005318252,0.000003824218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539864,0.0028702572,0.98016655,0.000042175037,0.0026910636,0.001499104,0.0015204151,0.000024594454,0.0017749176,0.002923419,0.0003477235,0.0055999183],"study_design_scores_gemma":[0.005085185,0.0048558353,0.97421294,0.00003497895,0.0023456009,0.000289992,0.00025676223,0.000015758527,0.01253097,0.000091228925,0.00017187615,0.00010885083],"about_ca_topic_score_codex":0.00013565274,"about_ca_topic_score_gemma":0.00015535396,"teacher_disagreement_score":0.010756053,"about_ca_system_score_codex":0.00018620498,"about_ca_system_score_gemma":0.00008818983,"threshold_uncertainty_score":0.46380574},"labels":[],"label_agreement":null},{"id":"W2589695286","doi":"10.1016/s1470-2045(17)30085-2","title":"Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma","year":2017,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Rituximab; Oncology; Stage (stratigraphy); Internal medicine; Interim; Classical Hodgkin lymphoma; Follicular lymphoma; Hodgkin lymphoma; Progression-free survival; Positron emission tomography; Nuclear medicine; Overall survival","score_opus":0.033576701464211094,"score_gpt":0.3488544561523942,"score_spread":0.3152777546881831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589695286","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42997777,0.0005862024,0.0000011056451,0.55358124,0.000987602,0.00093031407,0.00018396224,0.00007223627,0.013679585],"genre_scores_gemma":[0.56459385,0.00031784127,0.00033821486,0.42780113,0.003657425,0.0010353532,0.00024342543,0.00007202449,0.0019407296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973447,0.00036042838,0.0004894936,0.0006473403,0.00030859507,0.00084947306],"domain_scores_gemma":[0.9973265,0.00073617935,0.00048425546,0.0012863721,0.000084633284,0.00008204291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039427617,0.0005268082,0.0019553127,0.00017272588,0.00013205435,0.000053450884,0.000528485,0.00056352536,0.00014318789],"category_scores_gemma":[0.00022577729,0.00032203572,0.00029304507,0.00007483361,0.0003100456,0.000084517975,0.00030236025,0.00087323977,0.00013732097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027555886,0.00060599484,0.5118071,0.00022702312,0.0009913004,0.04411148,0.0011140343,0.0000010309444,0.000017076027,0.000027792013,0.3920521,0.046289504],"study_design_scores_gemma":[0.009072025,0.00086897984,0.5962225,0.0006985021,0.00037178578,0.0011319666,0.000058666228,0.000011802131,0.000046289886,0.000098212964,0.39116666,0.00025261907],"about_ca_topic_score_codex":0.000645569,"about_ca_topic_score_gemma":0.00059488084,"teacher_disagreement_score":0.13461608,"about_ca_system_score_codex":0.0016987572,"about_ca_system_score_gemma":0.00045922413,"threshold_uncertainty_score":0.99992317},"labels":[],"label_agreement":null},{"id":"W2589788830","doi":"10.1002/ajh.24693","title":"A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene; Sanofi; Eli Lilly and Company; Amgen","keywords":"Medicine; Lenalidomide; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Cyclophosphamide; Lymphoplasmacytic Lymphoma; Dexamethasone; Lymphoma; Waldenstrom macroglobulinemia; Macroglobulinemia; Marginal zone B-cell lymphoma; Surgery; Oncology; Multiple myeloma; Chemotherapy; Immunology; B cell; Marginal zone","score_opus":0.027037348486308777,"score_gpt":0.34947976618728904,"score_spread":0.32244241770098026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589788830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559903,0.0021944658,0.00014808311,0.0010801434,0.00014731892,0.0007452918,0.000010260297,0.000010721048,0.00006468478],"genre_scores_gemma":[0.9958915,0.0010559203,0.0026669998,0.00019530213,0.00008221715,0.000051522806,0.0000027391582,0.000036984027,0.000016819957],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99805915,0.000111674686,0.0008991726,0.0003042603,0.0002596107,0.00036612267],"domain_scores_gemma":[0.9964915,0.00053448847,0.001870717,0.00054889,0.00030543865,0.0002489463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040392065,0.00029095213,0.0018217686,0.00023505362,0.00020719571,0.000035813016,0.00024098533,0.00007007112,0.000016518658],"category_scores_gemma":[0.00028463503,0.00020958373,0.00023403707,0.0001237076,0.0005934028,0.00014709035,0.000057092606,0.000096317366,0.000001859517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013938725,0.029770074,0.5518094,0.00013234616,0.003384378,0.0025717642,0.0025324016,0.0000036385377,0.0047104135,0.00019719926,0.00040161322,0.39054805],"study_design_scores_gemma":[0.39440936,0.09093168,0.3786676,0.0010320735,0.0019961945,0.012649237,0.006744025,0.00021321236,0.11124162,0.00048070055,0.000989309,0.0006450075],"about_ca_topic_score_codex":0.0005542845,"about_ca_topic_score_gemma":0.0000320261,"teacher_disagreement_score":0.38990304,"about_ca_system_score_codex":0.00009027376,"about_ca_system_score_gemma":0.00019406801,"threshold_uncertainty_score":0.85465765},"labels":[],"label_agreement":null},{"id":"W2589931311","doi":"10.1200/jco.2010.28.15_suppl.8073","title":"Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma (FL) treated with radiotherapy.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Lymphoma; Incidence (geometry); Cohort; Stage (stratigraphy); Radiation therapy; Gastroenterology; Aggressive lymphoma; Cancer; Surgery; Oncology; Rituximab","score_opus":0.041357263025294445,"score_gpt":0.398741871788049,"score_spread":0.3573846087627545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589931311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942645,0.00043076617,0.00011884487,0.0035614192,0.00027960035,0.00042710936,0.0000058639566,0.000008316691,0.0009036155],"genre_scores_gemma":[0.9927186,0.00088130013,0.0046630125,0.0014013973,0.00023153532,0.000016957305,0.000003908838,0.000017779394,0.000065537664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685866,0.00022235644,0.002065402,0.00019104095,0.00042784505,0.00023472676],"domain_scores_gemma":[0.99593747,0.0011391864,0.0018362339,0.00024503603,0.0004404696,0.00040159066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135115,0.0001839861,0.0015080897,0.0003004695,0.00002560297,0.00000860512,0.00016262764,0.0003891126,0.00008481566],"category_scores_gemma":[0.0010690652,0.00011304341,0.0003574858,0.00035443163,0.00015656957,0.00017246237,0.000014243253,0.00023095089,0.0000072498756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010123344,0.005745193,0.4921874,0.0000367471,0.00050734787,0.0036156252,0.0006623416,0.00006969334,0.0020800228,0.00026239222,0.00022541918,0.48448446],"study_design_scores_gemma":[0.03352686,0.02086777,0.91595477,0.00037906662,0.00029537125,0.0012479833,0.00014495784,0.00021135288,0.005385362,0.000025872409,0.021836618,0.00012401237],"about_ca_topic_score_codex":0.00018028263,"about_ca_topic_score_gemma":0.00045376667,"teacher_disagreement_score":0.48436046,"about_ca_system_score_codex":0.0003130559,"about_ca_system_score_gemma":0.0014259737,"threshold_uncertainty_score":0.46097764},"labels":[],"label_agreement":null},{"id":"W2590065183","doi":"10.1182/blood.v112.11.1559.1559","title":"Supportive Efficacy Analyses for the Phase 3 Study of Temsirolimus Versus Investigator’s Choice Therapy for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temsirolimus; Medicine; Hazard ratio; Mantle cell lymphoma; Internal medicine; Clinical endpoint; Population; Refractory (planetary science); Progression-free survival; Oncology; Randomized controlled trial; Lymphoma; Confidence interval; Chemotherapy; Discovery and development of mTOR inhibitors; Biology; PI3K/AKT/mTOR pathway","score_opus":0.09279054521882356,"score_gpt":0.3546920991419785,"score_spread":0.26190155392315495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590065183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316365,0.0014329039,0.0000046409496,0.00007455987,0.00008696461,0.0050176904,0.00016673747,0.000015937389,0.000036923306],"genre_scores_gemma":[0.99767697,0.00073975365,0.00013158462,0.000055708628,0.00007901613,0.0010496838,0.00006748607,0.000032511856,0.00016727149],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988119,0.000044313405,0.00036368557,0.0002727883,0.00029877207,0.0002085367],"domain_scores_gemma":[0.99655235,0.0022285297,0.00034485236,0.00055492326,0.0002128184,0.00010654958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006270408,0.00023728395,0.000475459,0.00005746932,0.00018975214,0.0000056685285,0.00011533717,0.000048232538,0.00001653256],"category_scores_gemma":[0.0001079436,0.00009375215,0.00019200692,0.00017029617,0.00014412281,0.000035430287,0.000009447599,0.000020630887,9.2750673e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06322633,0.46465483,0.41786483,0.000098981545,0.012502679,0.00006307885,0.01197376,0.00002885581,0.0007563757,0.0000065945515,0.0013535888,0.027470093],"study_design_scores_gemma":[0.3653225,0.08747387,0.48482418,0.000023859033,0.0044442513,0.0000022494362,0.0011324224,0.000026212198,0.05168705,8.549917e-7,0.0049403766,0.00012216679],"about_ca_topic_score_codex":0.00037232455,"about_ca_topic_score_gemma":0.00005274325,"teacher_disagreement_score":0.37718096,"about_ca_system_score_codex":0.00008424298,"about_ca_system_score_gemma":0.00031718414,"threshold_uncertainty_score":0.38231018},"labels":[],"label_agreement":null},{"id":"W2590078033","doi":"10.1182/blood.v114.22.1661.1661","title":"The VcR-CVAD Regimen Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma (MCL): First Analysis of E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for MCL.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Mantle cell lymphoma; Vincristine; Rituximab; Bortezomib; Cyclophosphamide; Internal medicine; Surgery; Chemotherapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Lymphoma; Multiple myeloma","score_opus":0.012704438226657754,"score_gpt":0.2603393007549339,"score_spread":0.24763486252827613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590078033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463564,0.00087999273,0.000004496545,0.0017323169,0.000022066499,0.0023854217,0.00020467101,0.000033009255,0.00010236748],"genre_scores_gemma":[0.99852943,0.00012730742,0.00024470012,0.00009065824,0.000021076145,0.0003399476,0.00007168175,0.000026174745,0.0005489915],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976617,0.00024791536,0.00068697624,0.0005927158,0.0003604954,0.0004502151],"domain_scores_gemma":[0.9976062,0.00062601484,0.00044894428,0.000921814,0.00029995202,0.00009706469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077888905,0.0003337075,0.0010994927,0.0003686066,0.00021691137,0.000023031449,0.0002224285,0.000067715984,0.000012166403],"category_scores_gemma":[0.00018028576,0.00019935785,0.00019795621,0.0012858091,0.0001212368,0.00006369209,0.000047448302,0.00005351273,0.0000025836055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20343381,0.5686275,0.12972368,0.00054750347,0.0212525,0.0019655218,0.019223757,0.0004020224,0.034748074,0.000375227,0.0021009888,0.017599422],"study_design_scores_gemma":[0.25159264,0.04068618,0.5891878,0.0004989512,0.012489487,0.00003138199,0.0026274547,0.00068584783,0.10035803,0.000048908383,0.0013685899,0.00042474412],"about_ca_topic_score_codex":0.0011811566,"about_ca_topic_score_gemma":0.0012129841,"teacher_disagreement_score":0.5279413,"about_ca_system_score_codex":0.00012981355,"about_ca_system_score_gemma":0.00017743932,"threshold_uncertainty_score":0.8129577},"labels":[],"label_agreement":null},{"id":"W2590570686","doi":"10.1182/blood.v120.21.3681.3681","title":"Sustained Immune Competency and Long Term Molecular Remissions in FL Patients with FLIPI Risk Factors &gt;1, Treated Front Line with R-CHOP Followed by Consolidative 90 Y-Radioimmunotherapy and Maintenance Rituximab","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; Internal medicine; Follicular lymphoma; Chemotherapy regimen; Surgery; Radioimmunotherapy; Regimen; Fludarabine; Maintenance therapy; Ibritumomab tiuxetan; Clinical endpoint; Progressive disease; Median follow-up; Oncology; Chemotherapy; Gastroenterology; Lymphoma; Clinical trial; Immunology; Cyclophosphamide","score_opus":0.0037553235389250817,"score_gpt":0.21067491337067262,"score_spread":0.20691958983174755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590570686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924555,0.0059840763,0.00004310333,0.00011262826,0.000020729753,0.0010807655,0.00011074984,0.00003986739,0.00015261474],"genre_scores_gemma":[0.9982479,0.00067086203,0.00054402684,0.0000648792,0.000011919726,0.000081555714,0.00021261562,0.000045130317,0.00012111166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985832,0.00008623305,0.00029946832,0.00035776867,0.00022051237,0.00045280682],"domain_scores_gemma":[0.99905354,0.00009528104,0.00018058789,0.00031854733,0.000108133616,0.00024388301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008302546,0.0003574243,0.0006177567,0.00010069012,0.00011685227,0.000026632883,0.000051301635,0.00009448582,0.000026041456],"category_scores_gemma":[0.0000452223,0.00021417503,0.000048815007,0.0001510729,0.00015392268,0.00013416649,0.000038262733,0.00013749843,0.0000013559926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905405,0.005552723,0.9889113,0.000030441724,0.00065121276,0.00011521747,0.0010896208,3.1384087e-7,0.0016482399,0.000014521241,0.000028633058,0.000967294],"study_design_scores_gemma":[0.062695764,0.0018196107,0.9234409,0.0004129206,0.00062765565,0.000030968506,0.00027965475,0.0000080919845,0.010338596,0.0000043701475,0.00007490932,0.00026660523],"about_ca_topic_score_codex":0.00038143902,"about_ca_topic_score_gemma":0.000037507485,"teacher_disagreement_score":0.06547039,"about_ca_system_score_codex":0.00011473036,"about_ca_system_score_gemma":0.00007011291,"threshold_uncertainty_score":0.8733804},"labels":[],"label_agreement":null},{"id":"W2590724842","doi":"10.1182/blood.v128.22.920.920","title":"An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Peripheral T-cell lymphoma; Oncology; T-cell lymphoma; Aggressive lymphoma; Not Otherwise Specified; Cancer; B symptoms; Chemotherapy; Pathology; Immunology; T cell; Rituximab","score_opus":0.015359037758739721,"score_gpt":0.28201460952763696,"score_spread":0.26665557176889726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590724842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937171,0.00031713655,0.00001668759,0.0007215598,0.0003994227,0.00028471896,0.00009534748,0.000022297072,0.004425772],"genre_scores_gemma":[0.9982299,0.00044666216,0.0005794622,0.000039981867,0.00011164371,0.00005526602,0.00003891366,0.000020984846,0.00047714316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985571,0.000080555066,0.000337337,0.00034459739,0.00044913922,0.00023125728],"domain_scores_gemma":[0.999116,0.00008943393,0.00010370781,0.00045509855,0.000073639705,0.00016211678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000222503,0.00018226301,0.00034132105,0.00008776142,0.00003277578,0.000015435118,0.00016251963,0.00007603684,0.00019489207],"category_scores_gemma":[0.000031669246,0.00012322617,0.000083540464,0.00006564938,0.000067925685,0.0001227848,0.00012573064,0.00002867265,0.000004685143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014021427,0.0058223894,0.96942747,0.000027045584,0.00015107091,0.00018085225,0.00010386897,0.0000015974518,0.019145615,0.0007051315,0.000042100957,0.004252647],"study_design_scores_gemma":[0.030860845,0.0006614744,0.9472932,0.00010362154,0.000114440125,0.000039027655,0.000071924354,0.00006896194,0.020042438,0.00007444745,0.0005312645,0.00013832553],"about_ca_topic_score_codex":0.00041559117,"about_ca_topic_score_gemma":0.0006516267,"teacher_disagreement_score":0.03072063,"about_ca_system_score_codex":0.0003737807,"about_ca_system_score_gemma":0.0001547973,"threshold_uncertainty_score":0.5025017},"labels":[],"label_agreement":null},{"id":"W2590965473","doi":"10.1016/j.clinimag.2017.02.004","title":"Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on 18 F-FDG PET/CT and histology","year":2017,"lang":"en","type":"article","venue":"Clinical Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; University of Alberta","funders":"","keywords":"Lymphoma; Medicine; Follicular lymphoma; Positron emission tomography; Histology; Diffuse large B-cell lymphoma; Spleen; PET-CT; Pathology; Nuclear medicine; Radiology; Internal medicine","score_opus":0.02416188922351294,"score_gpt":0.34482226727807724,"score_spread":0.3206603780545643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590965473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928483,0.0026492793,0.00007063992,0.001473637,0.00026299563,0.00043050392,0.000009293009,0.00003576783,0.002219577],"genre_scores_gemma":[0.99732476,0.0008982451,0.00053261203,0.00093900383,0.00008929497,0.000027367376,0.000008617868,0.000037577887,0.00014249279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778956,0.00009446448,0.000820208,0.0006158654,0.0002270072,0.00045286462],"domain_scores_gemma":[0.9979897,0.00062863133,0.0003145897,0.0007778576,0.00005074238,0.00023845234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005002694,0.00028273612,0.00090615865,0.00010959335,0.00021076624,0.00004083518,0.00021810897,0.00003602465,0.000014242217],"category_scores_gemma":[0.00068227126,0.00023734305,0.0002668079,0.000059745194,0.0004021466,0.00012674116,0.00009657268,0.00011438034,0.000024336867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063893787,0.011318043,0.7122153,0.00026686135,0.00009996098,0.018427262,0.00022297361,0.0000032094792,0.00025548832,0.00025689925,0.00013168414,0.25616336],"study_design_scores_gemma":[0.17803593,0.0016950179,0.75460553,0.0024524636,0.0007133497,0.0026181417,0.00036409704,0.018792408,0.006857571,0.00061471044,0.032273624,0.0009771653],"about_ca_topic_score_codex":0.0005332496,"about_ca_topic_score_gemma":0.0001124502,"teacher_disagreement_score":0.25518617,"about_ca_system_score_codex":0.00019398464,"about_ca_system_score_gemma":0.00012723674,"threshold_uncertainty_score":0.9678569},"labels":[],"label_agreement":null},{"id":"W2591022778","doi":"10.1182/blood.v108.11.3051.3051","title":"Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; BC Cancer Agency; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Autologous stem-cell transplantation; Surgery; Internal medicine; Vincristine; Cyclophosphamide; Chemotherapy regimen; Transplantation; Regimen; Oncology; Chemotherapy; Lymphoma","score_opus":0.005429387968229044,"score_gpt":0.20775490870634447,"score_spread":0.20232552073811544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591022778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948194,0.0018424096,0.0010172622,0.00045574296,0.000026864904,0.00091047323,0.0003369246,0.000064190404,0.0005267481],"genre_scores_gemma":[0.9949329,0.00023755594,0.0032492226,0.00016117969,0.000027289298,0.00019126853,0.000091315625,0.00003769693,0.0010715533],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850994,0.000026040603,0.00037819133,0.00044054337,0.00026862905,0.00037666888],"domain_scores_gemma":[0.9991609,0.000084600724,0.00018988294,0.00034538817,0.00010823242,0.00011103925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013829563,0.0002839302,0.0009790607,0.00013839292,0.00006388634,0.00001926739,0.00007340569,0.00009547418,0.00002207554],"category_scores_gemma":[0.0000016365566,0.00019476215,0.0002824507,0.00026727072,0.0000860254,0.000039343595,0.000009478957,0.00003359499,0.0000019773736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031613726,0.07222608,0.8296888,0.0039319457,0.01119841,0.0026099056,0.0033575548,0.000023440789,0.019296924,0.0009473914,0.005067786,0.020038042],"study_design_scores_gemma":[0.2783125,0.0047467966,0.26496306,0.00028815394,0.013024105,0.00028432126,0.00033328807,0.0003035004,0.4343865,0.00018805833,0.002607573,0.00056214986],"about_ca_topic_score_codex":0.00025287512,"about_ca_topic_score_gemma":0.00015204515,"teacher_disagreement_score":0.56472576,"about_ca_system_score_codex":0.00006761557,"about_ca_system_score_gemma":0.00014006367,"threshold_uncertainty_score":0.794217},"labels":[],"label_agreement":null},{"id":"W2591671154","doi":"10.3747/co.24.3470","title":"A Canadian Perspective on the Subcutaneous Administration of Rituximab in Non-Hodgkin Lymphoma","year":2017,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; Roche (Canada); Impact; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Fluidigm (Canada); Dalhousie University","funders":"H. Lundbeck A/S; Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Medicine; Rituximab; Dosing; Pharmacokinetics; Lymphoma; Health care; Quality of life (healthcare); Drug administration; Administration (probate law); Intensive care medicine; Pharmacology; Internal medicine; Nursing","score_opus":0.20263945162379415,"score_gpt":0.4858178831310749,"score_spread":0.2831784315072807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591671154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009833843,0.9794102,1.893418e-7,0.0012604671,0.0008279318,0.0019277467,0.00013961563,0.000008054302,0.015442449],"genre_scores_gemma":[0.047775023,0.9511916,0.00000896498,0.00004963599,0.00021005675,0.00050491514,0.00014008014,0.000026528744,0.000093186725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832475,0.00019878423,0.0005249848,0.00042756283,0.00018181415,0.00034212173],"domain_scores_gemma":[0.9980858,0.00044658463,0.00049704383,0.00064877316,0.00012657,0.00019521813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023464998,0.00035198388,0.0018584526,0.00033851358,0.000098129145,0.000018380673,0.00026351193,0.00036089736,0.000090019734],"category_scores_gemma":[0.00026677077,0.00021723892,0.00040417665,0.00013320282,0.00014007384,0.000018711353,0.000035414265,0.0002501659,0.00015051191],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009230999,0.0026105242,0.00011320708,0.0011431229,0.00016383425,0.0014514724,0.00022127188,1.9032276e-8,1.6355774e-8,0.0019574726,0.0013181977,0.99092853],"study_design_scores_gemma":[0.0023757422,0.0021945327,0.0006095974,0.0077984035,0.00085982867,0.0009436026,0.00012597664,0.0000038865624,0.0000012489271,0.00008364922,0.9848372,0.00016638069],"about_ca_topic_score_codex":0.021326944,"about_ca_topic_score_gemma":0.10273776,"teacher_disagreement_score":0.9907622,"about_ca_system_score_codex":0.007598045,"about_ca_system_score_gemma":0.00769195,"threshold_uncertainty_score":0.9979335},"labels":[],"label_agreement":null},{"id":"W2591823319","doi":"10.1182/blood.v118.21.4944.4944","title":"Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Non-Hodgkin Lymphomas (DLBCL) Receiving Initial Therapy in Hospital Compared with An Out-Patient Setting","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Logistic regression; Population; Pediatrics; Retrospective cohort study; Lymphoma; Internal medicine; Surgery","score_opus":0.016120373190133545,"score_gpt":0.24374436762886545,"score_spread":0.2276239944387319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591823319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997436,0.0000731407,0.000011406038,0.000024265648,0.00009857384,0.0012646485,0.000074019496,0.00005127024,0.00096669636],"genre_scores_gemma":[0.9964639,0.000019677578,0.0029396866,0.00016646755,0.000041612737,0.00015558719,0.000139893,0.00006493759,0.000008237221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796796,0.00007714639,0.0005535367,0.000464136,0.00045812532,0.00047909503],"domain_scores_gemma":[0.99870956,0.00009086715,0.0003201201,0.0005006915,0.00015825746,0.00022052755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108195134,0.00036298003,0.0006429783,0.00016142438,0.0000705007,0.000020363786,0.0001359868,0.000097412856,0.00004634348],"category_scores_gemma":[0.000027778235,0.00024404339,0.0000901327,0.00019774128,0.00006640146,0.00018423487,0.000050998096,0.00010856069,0.000008684366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010273086,0.08965301,0.8960322,0.00004352133,0.00017580492,0.00034838068,0.010711221,9.3532844e-7,0.000024097117,0.0000057679226,0.000014228359,0.0019635332],"study_design_scores_gemma":[0.12975533,0.009713678,0.8510286,0.0002416263,0.00018182496,0.0000045470324,0.00079113495,0.00002117562,0.007946948,0.0000038553685,0.000027574035,0.00028370458],"about_ca_topic_score_codex":0.0005140981,"about_ca_topic_score_gemma":0.00047062538,"teacher_disagreement_score":0.12872802,"about_ca_system_score_codex":0.00009907066,"about_ca_system_score_gemma":0.0001147174,"threshold_uncertainty_score":0.9951801},"labels":[],"label_agreement":null},{"id":"W2592055730","doi":"10.1182/blood.v116.21.3094.3094","title":"A Retrospective Study on the Incidence of Rituximab-Related Interstitial Pneumonitis In Patients Undergoing Immunochemotherapy for Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Ofatumumab; Internal medicine; Vincristine; Lymphoma; Incidence (geometry); CHOP; Retrospective cohort study; CD20; Concomitant; Diffuse large B-cell lymphoma; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.007846380834312477,"score_gpt":0.2542861580910291,"score_spread":0.24643977725671665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592055730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744165,0.000019351364,0.0000022864606,0.00023152717,0.00017386177,0.0016200874,0.00001660115,0.00001576434,0.00047889346],"genre_scores_gemma":[0.9994853,0.00001341539,0.000094559466,0.00011832446,0.000031812855,0.00020876738,0.00000909929,0.000021572156,0.000017156819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990131,0.000032979427,0.00029853024,0.0002501804,0.00022516647,0.00017999092],"domain_scores_gemma":[0.99919677,0.00019664917,0.00013190042,0.0003279803,0.00010926863,0.00003746245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016865671,0.0001534291,0.00031445638,0.00009165733,0.00006300917,0.000014482451,0.000112256756,0.000072734736,0.0000268072],"category_scores_gemma":[0.00019805373,0.00010429689,0.00010130537,0.00016273926,0.00006175255,0.000042136908,0.000032739572,0.000099266086,0.000008809081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003350001,0.01796569,0.97449046,0.000013068787,0.00031010766,0.000026356935,0.0019464059,1.5341863e-7,0.0025955192,0.00022581848,0.000022275377,0.0020691375],"study_design_scores_gemma":[0.03744562,0.005620307,0.93489766,0.00020908359,0.00013319377,0.000007610915,0.00041043575,0.000015467667,0.020971049,0.00019572601,0.0000053668036,0.00008845138],"about_ca_topic_score_codex":0.00024565545,"about_ca_topic_score_gemma":0.00017609721,"teacher_disagreement_score":0.039592776,"about_ca_system_score_codex":0.00011929369,"about_ca_system_score_gemma":0.000097389224,"threshold_uncertainty_score":0.42531037},"labels":[],"label_agreement":null},{"id":"W2592087354","doi":"10.1182/blood.v116.21.2835.2835","title":"HIV-Associated Diffuse Large B Cell Lymphoma: Determinants of Survival In the Era of Rituximab and HAART.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Providence Health Care; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Rituximab; Medicine; International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Chemotherapy regimen; Univariate analysis; Retrospective cohort study; Oncology; Cohort; Regimen; Chemotherapy; Multivariate analysis","score_opus":0.007876683118470413,"score_gpt":0.2371652752037719,"score_spread":0.22928859208530147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592087354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859256,0.00026657904,1.5846852e-7,0.00012172301,0.00005900889,0.00021994635,0.000069774476,0.0000075796065,0.0006626796],"genre_scores_gemma":[0.99969214,0.000083801344,0.000066225235,0.000053632495,0.00002146943,0.000017851853,0.000012866479,0.000009760928,0.000042279225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920267,0.000047634847,0.00024160274,0.00013991774,0.00019095775,0.00017723316],"domain_scores_gemma":[0.99938154,0.00016757734,0.00011336287,0.000248594,0.000042816813,0.000046078458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023596836,0.00010621841,0.00035808273,0.000037429203,0.000027801441,0.0000062362105,0.000073598305,0.00008472612,0.000012091029],"category_scores_gemma":[0.000083760664,0.00006714909,0.000062810104,0.00010220582,0.000054596883,0.000026534804,0.000034465273,0.00007103634,0.0000046458217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035675246,0.04068836,0.95265824,0.000053030893,0.000039403323,0.000104857834,0.0007199046,4.6556115e-9,0.0045105033,0.000058779333,0.000037785805,0.0010934611],"study_design_scores_gemma":[0.05504261,0.0002165418,0.8842598,0.00006276089,0.00022201544,0.000024027995,0.00013484228,0.000014757291,0.059840105,0.000023646695,0.000101284546,0.00005757719],"about_ca_topic_score_codex":0.00023151652,"about_ca_topic_score_gemma":0.00058348826,"teacher_disagreement_score":0.0683984,"about_ca_system_score_codex":0.00000991535,"about_ca_system_score_gemma":0.000057634777,"threshold_uncertainty_score":0.27382606},"labels":[],"label_agreement":null},{"id":"W2592234056","doi":"10.1182/blood.v128.22.1107.1107","title":"Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Clinical endpoint; Brentuximab vedotin; Phases of clinical research; Refractory (planetary science); Cohort; Chemotherapy regimen; Lymphoma; Chemotherapy; Cancer; Clinical trial; Immunotherapy; Hodgkin lymphoma","score_opus":0.01326816067492311,"score_gpt":0.2703291171265829,"score_spread":0.25706095645165983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592234056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607396,0.00044577743,0.0000044552708,0.00087636395,0.000080558435,0.000669524,0.000054119908,0.000029592427,0.00176567],"genre_scores_gemma":[0.99917173,0.00006276812,0.000040742165,0.00019732765,0.00006400682,0.00010781799,0.00001348194,0.000022160737,0.00031996565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997982,0.00018848536,0.0005318481,0.00043394402,0.0005653831,0.00029830245],"domain_scores_gemma":[0.998418,0.00033413555,0.00019598503,0.0008511451,0.00006544816,0.00013530988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002649277,0.00023323124,0.00073806755,0.00031172117,0.000050170547,0.000009843189,0.00017607558,0.000108612556,0.0002181603],"category_scores_gemma":[0.00014824742,0.000116846655,0.00039318245,0.0007253798,0.000121881196,0.000056328085,0.00011818941,0.0000721201,0.000020852005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001081105,0.069046706,0.8791689,0.000026031761,0.0035794554,0.00046469457,0.00065919734,0.0000012958617,0.005629565,0.0000937944,0.00028320632,0.03996604],"study_design_scores_gemma":[0.077368505,0.0016717948,0.90792924,0.000096282536,0.0056922613,0.000024989777,0.0001225071,0.000011262619,0.006522416,0.000023189494,0.00040628845,0.000131268],"about_ca_topic_score_codex":0.00018232387,"about_ca_topic_score_gemma":0.00019105447,"teacher_disagreement_score":0.0762874,"about_ca_system_score_codex":0.00035384903,"about_ca_system_score_gemma":0.00028224502,"threshold_uncertainty_score":0.47648683},"labels":[],"label_agreement":null},{"id":"W2592287337","doi":"10.1182/blood.v128.22.4194.4194","title":"Polatuzumab Vedotin Combined with Bendamustine (B) and Rituximab (R) or Obinutuzumab (G) in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib/II Dose-Escalation Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Tolerability; Rituximab; Bendamustine; Follicular lymphoma; Oncology; Gastroenterology; Adverse effect; Lymphoma; Surgery","score_opus":0.009850781726426483,"score_gpt":0.23951556851764386,"score_spread":0.22966478679121738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592287337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533796,0.00025162386,0.000005765535,0.00011913396,0.00006154774,0.003660645,0.00034697252,0.00011252785,0.00010380919],"genre_scores_gemma":[0.99776477,0.000093726565,0.0006492253,0.00007061895,0.000051258146,0.00032135396,0.00024214134,0.0001151827,0.0006917405],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961207,0.00020583415,0.0010766195,0.001039896,0.00088798447,0.00066899107],"domain_scores_gemma":[0.9972003,0.00046071998,0.00064823614,0.0010170181,0.00030550527,0.00036823723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027158434,0.0006845749,0.0012336969,0.00038643795,0.00020960082,0.00003015704,0.00018388357,0.00023707139,0.00003802],"category_scores_gemma":[0.00030135553,0.0003265329,0.000101097045,0.000674884,0.00014721965,0.00031441788,0.00018087716,0.000093946415,0.000008923395],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3597594,0.44314027,0.18102281,0.00024612618,0.00081239536,0.0024721113,0.0021066277,4.7750837e-7,0.00032217824,0.000009488846,0.0001360695,0.009972065],"study_design_scores_gemma":[0.5320613,0.096323445,0.3665319,0.00089304836,0.0011583612,0.00007577454,0.00033387737,0.000040901476,0.002048023,0.0000015731742,0.00019645561,0.00033535907],"about_ca_topic_score_codex":0.00032280147,"about_ca_topic_score_gemma":0.0005009292,"teacher_disagreement_score":0.34681684,"about_ca_system_score_codex":0.0006696071,"about_ca_system_score_gemma":0.001007002,"threshold_uncertainty_score":0.9999187},"labels":[],"label_agreement":null},{"id":"W2592310779","doi":"10.3747/co.24.3369","title":"Economic Evaluation of Brentuximab Vedotin for Persistent Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; University of Ottawa","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Brentuximab vedotin; Medicine; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine","score_opus":0.22852907812062928,"score_gpt":0.4646473024822531,"score_spread":0.23611822436162383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592310779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885305,0.0022841897,0.00001390431,0.0013760703,0.0019434106,0.0010420942,0.000046877292,0.000012474253,0.0047504446],"genre_scores_gemma":[0.9987834,0.00020158099,0.00020172299,0.000027149365,0.00027159558,0.00036876247,0.00008035656,0.00001118817,0.000054210745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990588,0.000053705047,0.00027602853,0.00025838744,0.00016280291,0.00019031782],"domain_scores_gemma":[0.99882823,0.00009319565,0.00033394856,0.00045302592,0.00020296563,0.00008861324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000494453,0.000120249955,0.0003876274,0.00006285025,0.00013524147,0.000014997249,0.00012493246,0.000080845646,0.00014492538],"category_scores_gemma":[0.00018588804,0.00010212923,0.0002721004,0.000010062161,0.000109337285,0.000051741077,0.000053534535,0.000025788588,0.000050635022],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824102,0.0021329343,0.09706053,0.00008626842,0.00022630174,0.0000021820758,0.00017912005,0.000012678069,0.000090464295,0.00069635897,0.0047274632,0.8945033],"study_design_scores_gemma":[0.03962278,0.0030011393,0.78428507,0.00016675281,0.0023547565,0.00005368368,0.00017220186,0.009824372,0.0025440028,0.00043121263,0.15736143,0.00018262649],"about_ca_topic_score_codex":0.00004329816,"about_ca_topic_score_gemma":0.000052414132,"teacher_disagreement_score":0.89432067,"about_ca_system_score_codex":0.0012835255,"about_ca_system_score_gemma":0.0007140205,"threshold_uncertainty_score":0.41647092},"labels":[],"label_agreement":null},{"id":"W2592462257","doi":"10.1182/blood.v120.21.1641.1641","title":"Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Rituximab; Medicine; Tolerability; Dosing; Pharmacokinetics; CD20; Internal medicine; Follicular lymphoma; Confidence interval; Oncology; Adverse effect; Gastroenterology; Urology; Surgery; Lymphoma","score_opus":0.011247776682651513,"score_gpt":0.24537154497197097,"score_spread":0.23412376828931947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592462257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976796,0.0001284033,0.000005609518,0.00006742882,0.00002747055,0.0017665835,0.00009328111,0.0000068526665,0.00022475427],"genre_scores_gemma":[0.9994431,0.000082883555,0.00032485317,0.000020692825,0.000017880755,0.000040877905,0.000044357366,0.000016326067,0.00000900416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984912,0.00007974576,0.000582896,0.00021980076,0.00040913615,0.000217189],"domain_scores_gemma":[0.99886715,0.00006853249,0.00045512913,0.00030816914,0.00021409866,0.00008693009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016191888,0.00021304116,0.000489211,0.000056845784,0.000042805947,0.000008140887,0.00008075735,0.00005655895,0.0000041128183],"category_scores_gemma":[0.000021897627,0.00012588833,0.00004814475,0.00021814948,0.00014907576,0.0000656,0.000018095932,0.000054947614,4.3131632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028603874,0.033733428,0.93047357,0.000076176875,0.000424146,0.000110469926,0.0013337521,0.000008608122,0.00086849934,0.000024091669,0.0000033151207,0.004340092],"study_design_scores_gemma":[0.06906729,0.016283128,0.8434046,0.0002635367,0.0004528842,0.00019877013,0.0002610794,0.000019738678,0.06992509,0.0000034486204,0.000009723491,0.00011072928],"about_ca_topic_score_codex":0.0001411896,"about_ca_topic_score_gemma":0.00015199448,"teacher_disagreement_score":0.08706897,"about_ca_system_score_codex":0.000045500346,"about_ca_system_score_gemma":0.00031033473,"threshold_uncertainty_score":0.5133577},"labels":[],"label_agreement":null},{"id":"W2592808937","doi":"10.1182/blood.v112.11.4676.4676","title":"Review of Current Patterns of Treatment and Costs in Follicular Non-Hodgkin’s Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Incidence (geometry); Malignancy; Demography; Disease; Oncology; Internal medicine","score_opus":0.024672004009994593,"score_gpt":0.2904089879460761,"score_spread":0.26573698393608153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592808937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87404525,0.12511645,0.0000013375803,0.000073687654,0.000026036922,0.000497991,0.00002525207,0.000004986154,0.00020901226],"genre_scores_gemma":[0.7907798,0.20895731,0.00005799141,0.00007522521,0.000015976517,0.00007463717,0.000021498701,0.000007206623,0.0000103031525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992627,0.000024686628,0.00031085065,0.00017111232,0.00010891933,0.000121721685],"domain_scores_gemma":[0.9995082,0.00003582671,0.00010167404,0.00023529705,0.00004337169,0.000075616175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005177737,0.0001298861,0.0004955308,0.00006171233,0.000012639325,9.828562e-7,0.000029202136,0.000030762447,0.000021138176],"category_scores_gemma":[0.000016387852,0.000091098635,0.0001103788,0.00008860773,0.000027639042,0.000018922943,0.000019693643,0.000014142778,0.0000033515798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021275126,0.0053897887,0.9409594,0.0018753294,0.00016231506,0.00013852712,0.0001579553,5.801395e-8,0.00019846571,0.00002460345,0.00010067724,0.050971612],"study_design_scores_gemma":[0.01699208,0.0014792266,0.93345416,0.014654888,0.00063288206,0.0002583465,0.000015983042,0.0000028141276,0.029466406,0.0000026343314,0.0029385106,0.00010204784],"about_ca_topic_score_codex":0.00046088753,"about_ca_topic_score_gemma":0.000026397249,"teacher_disagreement_score":0.08384086,"about_ca_system_score_codex":0.00012764022,"about_ca_system_score_gemma":0.000112612026,"threshold_uncertainty_score":0.37148944},"labels":[],"label_agreement":null},{"id":"W2593116899","doi":"10.1182/blood.v112.11.2824.2824","title":"Assessment of Microrna Expression in Mantle Cell Lymphoma Using High Throughput Techniques","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Mantle cell lymphoma; microRNA; Follicular lymphoma; Blastoid; Lymphoma; Biology; Cancer research; Population; Gene expression; Gene expression profiling; Pathology; Gene; Medicine; Immunology; Genetics","score_opus":0.020834626419359747,"score_gpt":0.2857635119999962,"score_spread":0.2649288855806365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593116899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953317,0.00055035576,0.00005521299,0.000036228277,0.00003356778,0.00029301946,0.000008108767,0.000034371922,0.0036574067],"genre_scores_gemma":[0.9568491,0.000377164,0.04254873,0.0000623188,0.000044080633,0.000027053993,0.000014441787,0.000015678079,0.00006142126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918246,0.000025055217,0.00024577798,0.00020122387,0.00018473378,0.00016076094],"domain_scores_gemma":[0.9995407,0.000027899541,0.0000948825,0.0002517658,0.000035316458,0.000049437094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005480756,0.00012249788,0.00028882877,0.00008820332,0.000038808394,0.0000034283967,0.000051831677,0.00007743509,0.000029132632],"category_scores_gemma":[0.000003897224,0.00009569399,0.000069618814,0.00011299761,0.000039288258,0.000046958354,0.000048001242,0.00003315095,0.0000031342581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020185886,0.008015523,0.49190253,0.000100921534,0.000033692766,0.00057423435,0.00013630922,0.0000013470827,0.4981368,0.000038485934,0.00012771474,0.0009122803],"study_design_scores_gemma":[0.0043993094,0.00018043727,0.3306002,0.00023995631,0.00006475756,0.00011717766,0.000021325131,0.000010003629,0.6640976,0.000015499154,0.00019236878,0.00006135936],"about_ca_topic_score_codex":0.00034338742,"about_ca_topic_score_gemma":0.0000036438073,"teacher_disagreement_score":0.1659608,"about_ca_system_score_codex":0.00011443187,"about_ca_system_score_gemma":0.00014398024,"threshold_uncertainty_score":0.39022878},"labels":[],"label_agreement":null},{"id":"W2593126380","doi":"10.1093/annonc/mdx005","title":"ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; BC Children's Hospital","funders":"Terry Fox Research Institute; Canadian Institutes of Health Research; Genome British Columbia; Genome Canada","keywords":"Medicine; ABVD; Hodgkin lymphoma; Radiation therapy; Chemotherapy; Lymphoma; Chemotherapy regimen; Dacarbazine; Pediatrics; Oncology; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.029486455225050095,"score_gpt":0.3421117743743025,"score_spread":0.3126253191492524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593126380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957494,0.0012267695,7.447027e-7,0.00210199,0.00002403552,0.0005922482,0.000010883135,0.000007231107,0.00028666813],"genre_scores_gemma":[0.98956335,0.009657895,0.00015648964,0.00049129716,0.000033439464,0.00003500712,0.00002000496,0.000016204227,0.000026336826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917895,0.00004538072,0.00022319012,0.0002295207,0.0001396974,0.0001832711],"domain_scores_gemma":[0.99909747,0.000028628067,0.00038538812,0.00030123777,0.00012240025,0.0000648901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013490343,0.00014884128,0.00046262864,0.00009369629,0.000039162678,0.000012541648,0.000085033906,0.00009651449,0.000006712354],"category_scores_gemma":[0.000020453777,0.00009701008,0.000034308956,0.00004639544,0.00018097264,0.00011889826,0.000013814597,0.000035072157,5.8706866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004070208,0.001401851,0.78786916,0.00002822981,0.0002527601,0.000024906221,0.0006419413,6.125277e-7,0.00086946116,0.00001732556,0.0001133841,0.20471014],"study_design_scores_gemma":[0.023369767,0.0068636807,0.9014681,0.00032299102,0.000030485182,0.000059271424,0.000052607997,0.000005458799,0.067552306,0.000014110516,0.00017672685,0.00008447617],"about_ca_topic_score_codex":0.0011249355,"about_ca_topic_score_gemma":0.00020158029,"teacher_disagreement_score":0.20462567,"about_ca_system_score_codex":0.000038362927,"about_ca_system_score_gemma":0.00015340016,"threshold_uncertainty_score":0.39559564},"labels":[],"label_agreement":null},{"id":"W2593299098","doi":"10.1182/blood.v114.22.1230.1230","title":"The Impact of Prior Exposure to Rituximab On Autologous Stem Cell Transplantation in Patients with Follicular and Transformed Follicular Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Autologous stem-cell transplantation; Internal medicine; Lymphoma; CD20; Transplantation; Oncology; Single Center; Gastroenterology; Immunology; Surgery","score_opus":0.004597439398691838,"score_gpt":0.21953297853284512,"score_spread":0.21493553913415328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593299098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980303,0.0005329531,0.0000056925214,0.00015689981,0.000009872903,0.0010430642,0.000024624434,0.000016097976,0.00018046885],"genre_scores_gemma":[0.999603,0.00013459103,0.000104598534,0.00006400826,0.000007472149,0.00004200266,0.000022976781,0.000010649286,0.000010748521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991117,0.000031848384,0.00021555611,0.0002008612,0.00023182265,0.00020818025],"domain_scores_gemma":[0.9995658,0.000049328886,0.000052582207,0.00018874256,0.00004084327,0.00010274117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066206274,0.00016556444,0.00029450175,0.00007251032,0.00005606841,0.000013208763,0.000045259112,0.000063768945,0.0000017180789],"category_scores_gemma":[0.0000029077833,0.000087208326,0.000090217836,0.00014752155,0.000018613093,0.00003728734,0.0000020887146,0.000031041018,0.0000024352842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035914143,0.014179715,0.8455443,0.000086545035,0.0003256274,0.00026477128,0.002208986,0.00006119465,0.0005624066,0.000044781278,0.00001812894,0.13311215],"study_design_scores_gemma":[0.03838541,0.00898901,0.9313834,0.00014625341,0.0002908168,0.000019776011,0.000038902628,0.0000041004264,0.020631878,0.000008109647,0.000010222627,0.000092159265],"about_ca_topic_score_codex":0.000068767135,"about_ca_topic_score_gemma":0.000023395245,"teacher_disagreement_score":0.13301998,"about_ca_system_score_codex":0.00007317941,"about_ca_system_score_gemma":0.00007219875,"threshold_uncertainty_score":0.35562524},"labels":[],"label_agreement":null},{"id":"W2593447424","doi":"10.1182/blood.v108.11.3383.3383","title":"AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Leukapheresis; Apheresis; Filgrastim; Urology; CD34; Transplantation; Multiple myeloma; Progenitor cell; Granulocyte colony-stimulating factor; Internal medicine; Chemotherapy; Stem cell; Platelet","score_opus":0.005669353608637306,"score_gpt":0.22627583363586476,"score_spread":0.22060648002722746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593447424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940106,0.0021152901,0.00017826424,0.00010131594,0.00006153061,0.003192205,0.00006264057,0.00008991902,0.00018821424],"genre_scores_gemma":[0.99256027,0.000322116,0.0051594707,0.000114980096,0.0001609725,0.0011890206,0.0002368083,0.00006381828,0.00019257516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983625,0.00004041782,0.00040258083,0.000579175,0.00021804123,0.00039729418],"domain_scores_gemma":[0.9991896,0.00010982213,0.0001433266,0.00023842417,0.00016551166,0.00015330882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009498534,0.00035023078,0.00042339842,0.0001384693,0.00013529428,0.00006823116,0.000059053982,0.00014299764,0.000011846443],"category_scores_gemma":[0.000023883002,0.0002839062,0.000058511436,0.000228238,0.000107496104,0.00011554785,0.00003843893,0.00004736173,0.0000016617902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043149627,0.008612484,0.9703975,0.00039316402,0.00022297078,0.0001711608,0.00045845745,0.00017723395,0.013379737,0.000047746456,0.00016314615,0.0055449368],"study_design_scores_gemma":[0.07556322,0.0029968407,0.63296366,0.00015993381,0.0016794377,0.00043709195,0.00022582668,0.005955608,0.2779054,0.000049017166,0.0015704774,0.0004934613],"about_ca_topic_score_codex":0.00020109053,"about_ca_topic_score_gemma":0.00019544575,"teacher_disagreement_score":0.3374338,"about_ca_system_score_codex":0.00009034519,"about_ca_system_score_gemma":0.000120056844,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W2593462836","doi":"10.1182/blood.v128.22.619.619","title":"Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Refractory (planetary science); Internal medicine; Oncology; Population; Lymphoma; Phases of clinical research; Clinical trial; Surgery; Adverse effect; Cancer; Immunotherapy","score_opus":0.011302247285985749,"score_gpt":0.2363130380389587,"score_spread":0.22501079075297295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593462836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967365,0.00020266096,0.0000016154486,0.0001450739,0.00015287106,0.0017112832,0.0003102414,0.00003012203,0.0007095815],"genre_scores_gemma":[0.99924743,0.00003352203,0.000065580556,0.000104622195,0.00021167971,0.00011355593,0.00012411669,0.000032215194,0.00006727021],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977359,0.00016896079,0.0006197765,0.0004641323,0.00067564717,0.00033555157],"domain_scores_gemma":[0.99793196,0.0008509278,0.00033366217,0.0006498553,0.000105193634,0.0001284084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026547586,0.00025546257,0.00051730353,0.000088018234,0.00007172922,0.000012128641,0.00015935818,0.00009018029,0.000025103951],"category_scores_gemma":[0.00024320124,0.00012193151,0.000087937864,0.00016970582,0.000056188066,0.00010368557,0.00008331108,0.000082010025,0.000022021426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16988748,0.45191485,0.36224216,0.000021697495,0.0004216059,0.00029766356,0.0024573233,1.4664748e-7,0.0001882562,0.0000038493117,0.0004815653,0.012083423],"study_design_scores_gemma":[0.57338595,0.011672412,0.41317785,0.00019122307,0.00042084136,0.0000018044379,0.00016085543,6.029948e-7,0.0006934676,0.0000024562007,0.00019812782,0.00009442573],"about_ca_topic_score_codex":0.00037416338,"about_ca_topic_score_gemma":0.0001542475,"teacher_disagreement_score":0.44024244,"about_ca_system_score_codex":0.00017912856,"about_ca_system_score_gemma":0.0002853926,"threshold_uncertainty_score":0.49722227},"labels":[],"label_agreement":null},{"id":"W2593772058","doi":"10.1182/blood.v106.11.604.604","title":"Insights into Disease Evolution of Transformed Follicular Lymphoma Derived from Cytogenetics.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Follicular lymphoma; Biopsy; Diffuse large B-cell lymphoma; Cytogenetics; Pathology; Internal medicine; Medicine; Biology; Chromosome; Genetics","score_opus":0.008312444818462163,"score_gpt":0.22632247508640851,"score_spread":0.21801003026794635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593772058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867958,0.011860004,0.00016839209,0.00039479774,0.000036029727,0.00034004898,0.000018868626,0.00003685247,0.00034924145],"genre_scores_gemma":[0.9974009,0.0003832341,0.0017495947,0.000111561756,0.00017262502,0.00006326907,0.000083164115,0.000016442387,0.000019217185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991453,0.000021333426,0.00023681096,0.00022113493,0.0002355224,0.00013986153],"domain_scores_gemma":[0.99935323,0.00002875622,0.000052480562,0.0002827763,0.000057097226,0.00022566524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015479738,0.00014193427,0.00024688867,0.000063910455,0.000044049735,0.0000059971885,0.00005543813,0.00006387132,0.000048594167],"category_scores_gemma":[0.00001976491,0.00011181576,0.00016128024,0.00009944447,0.000045229855,0.00004903322,0.000013509767,0.00001745633,0.000040273593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008212141,0.020328745,0.6798616,0.00018694336,0.0018914609,0.00042208272,0.002365952,0.00004371989,0.22843027,0.0012286695,0.00018083054,0.06423848],"study_design_scores_gemma":[0.011552135,0.00017261603,0.6408067,0.00008848566,0.0010286145,0.0000032596827,0.000037276564,0.00008230897,0.34434423,0.0003528892,0.0014328735,0.000098641096],"about_ca_topic_score_codex":0.00031267203,"about_ca_topic_score_gemma":0.00011678441,"teacher_disagreement_score":0.115913965,"about_ca_system_score_codex":0.00015943617,"about_ca_system_score_gemma":0.00019451781,"threshold_uncertainty_score":0.45597145},"labels":[],"label_agreement":null},{"id":"W2593913848","doi":"10.1186/s13256-017-1209-3","title":"Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature","year":2017,"lang":"en","type":"review","venue":"Journal of Medical Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Surgical oncology; Larynx; Lymphoma; Dermatology; Burkitt's lymphoma; Pathology; Oncology; Surgery","score_opus":0.0411158457282783,"score_gpt":0.3692616695212596,"score_spread":0.3281458237929813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593913848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048867757,0.9905065,3.2890267e-7,0.0020421925,0.0010427143,0.001070186,0.000025730606,0.000003865437,0.0004217396],"genre_scores_gemma":[0.0025180911,0.99613136,0.000046691795,0.00046335044,0.0005205656,0.00002308472,0.000014204805,0.000036968733,0.000245659],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.992774,0.00043434525,0.0037703307,0.00034663233,0.002437913,0.00023676778],"domain_scores_gemma":[0.98706025,0.0004376208,0.009490314,0.0018711248,0.00063901825,0.00050164794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044841007,0.00044740975,0.0038815574,0.00012537013,0.00014656202,0.000031897194,0.00025101288,0.00056431897,0.00007908151],"category_scores_gemma":[0.007330257,0.00017657323,0.0021495689,0.0003015811,0.00040239352,0.00008352651,0.00036380065,0.0007105697,3.358865e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006702299,0.00029664353,0.00023330702,0.07779837,0.00058038713,0.6225182,0.000030296507,2.4406739e-9,5.0596555e-8,0.000004262412,0.0036795242,0.29485226],"study_design_scores_gemma":[0.0003389452,0.00007679101,0.00015775595,0.22997859,0.0041777967,0.43715632,0.0000040278655,5.8295765e-8,0.0000017220752,0.0000065308914,0.32804218,0.00005927515],"about_ca_topic_score_codex":0.000093049224,"about_ca_topic_score_gemma":0.000009387638,"teacher_disagreement_score":0.32436267,"about_ca_system_score_codex":0.00032302353,"about_ca_system_score_gemma":0.0058509745,"threshold_uncertainty_score":0.99978495},"labels":[],"label_agreement":null},{"id":"W2593953634","doi":"10.1182/blood.v120.21.1558.1558","title":"CD30 Expression in Diffuse Large B-Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD30; Diffuse large B-cell lymphoma; CHOP; BCL6; Lymphoma; Immunohistochemistry; Tissue microarray; Brentuximab vedotin; Pathology; Medicine; Cancer research; Large-cell lymphoma; Vincristine; Oncology; Chemotherapy; Internal medicine; Germinal center; B cell; Immunology; Antibody; Cyclophosphamide","score_opus":0.011306287013033654,"score_gpt":0.2455517415188752,"score_spread":0.23424545450584155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593953634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878379,0.0028993613,0.000002887936,0.00009742768,0.00009548988,0.00019582633,0.0000070308793,0.00003798058,0.008826089],"genre_scores_gemma":[0.99844295,0.00013834618,0.0003873601,0.00028077228,0.00016306706,0.00006271503,0.000020921736,0.000015954603,0.00048792796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921626,0.0000228434,0.00013907513,0.00013840555,0.0001479162,0.00033549708],"domain_scores_gemma":[0.9995097,0.00003597159,0.00003277028,0.0002407642,0.000011654495,0.00016912477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008076018,0.00011180078,0.0001773137,0.00005995776,0.000030811607,0.0000070714664,0.000038573027,0.00007080459,0.000084476895],"category_scores_gemma":[0.00001878998,0.00008108371,0.00006369779,0.00008318453,0.000009348008,0.00007339492,0.000042252286,0.00002921699,0.00024499907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033302767,0.08920119,0.9012266,0.000035482524,0.000021148067,0.00012039273,0.00045394897,1.47162655e-8,0.0062735626,0.000089431574,0.0010202143,0.0015247331],"study_design_scores_gemma":[0.068591714,0.0001177731,0.6830981,0.00010319257,0.00011915489,0.000047203717,0.000088122586,0.000002744824,0.23377323,0.000010037311,0.013942263,0.000106513195],"about_ca_topic_score_codex":0.000023067814,"about_ca_topic_score_gemma":0.0000046723185,"teacher_disagreement_score":0.22749966,"about_ca_system_score_codex":0.000053316806,"about_ca_system_score_gemma":0.000027559752,"threshold_uncertainty_score":0.33064976},"labels":[],"label_agreement":null},{"id":"W2594107028","doi":"10.1182/blood.v126.23.1532.1532","title":"Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Obinutuzumab; Medicine; Rituximab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Refractory (planetary science); Lymphoma; Phases of clinical research; Oncology; Surgery; Gastroenterology; Clinical trial","score_opus":0.03667813950631183,"score_gpt":0.3057816624668234,"score_spread":0.2691035229605116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594107028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484223,0.00041357926,0.0000049323794,0.0003313273,0.00008629021,0.0033933164,0.0007450838,0.000020544783,0.00016269667],"genre_scores_gemma":[0.9986651,0.000014586164,0.0004426162,0.00013672467,0.00003571184,0.00010212712,0.00055818114,0.000035918023,0.000009023928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951143,0.00056931283,0.0020025095,0.0005186744,0.0014439187,0.00035127607],"domain_scores_gemma":[0.99564034,0.00041618277,0.0019754823,0.0011766521,0.00052839424,0.00026294426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009255116,0.00039235284,0.0017844338,0.000112709815,0.00007827729,0.000009686012,0.0003163037,0.000097004646,0.00000999293],"category_scores_gemma":[0.00015992043,0.00020016162,0.00010686105,0.0005857643,0.00021909087,0.00007411843,0.0001792165,0.00020513564,8.9307144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03385725,0.10318274,0.850747,0.00016436096,0.0014317656,0.000025582258,0.008582852,0.00025781288,0.000071600596,0.000005547378,0.00027560658,0.0013978631],"study_design_scores_gemma":[0.3328539,0.009469518,0.654253,0.0006071392,0.0004801512,0.0000024392104,0.0016978895,0.00006622625,0.00042946474,0.0000019454128,0.000012286182,0.00012605393],"about_ca_topic_score_codex":0.033019,"about_ca_topic_score_gemma":0.002791627,"teacher_disagreement_score":0.29899666,"about_ca_system_score_codex":0.00078977895,"about_ca_system_score_gemma":0.0027936248,"threshold_uncertainty_score":0.9734202},"labels":[],"label_agreement":null},{"id":"W2594208126","doi":"10.3747/co.24.3586","title":"Updates from the 2016 American Society of Hematology Annual Meeting: Practice-Changing Studies in Untreated Follicular Lymphoma","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Ottawa Hospital; Fluidigm (Canada); Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"H. Lundbeck A/S; Gilead Sciences","keywords":"Rituximab; Medicine; Obinutuzumab; Follicular lymphoma; Hematology; Bendamustine; Internal medicine; Oncology; Lymphoma","score_opus":0.10795830794902768,"score_gpt":0.4382977407800185,"score_spread":0.3303394328309908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594208126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590032,0.022446927,0.0000062136005,0.016927361,0.000593215,0.0004176111,0.000052973897,0.000025988244,0.000526496],"genre_scores_gemma":[0.9890943,0.009340607,0.00065548264,0.00050315965,0.00019275269,0.00011880108,0.000047375182,0.000014965329,0.000032526907],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998576,0.0001943078,0.00037699201,0.00033378426,0.00016323375,0.0003557207],"domain_scores_gemma":[0.99720895,0.0012934636,0.0006594069,0.0005323461,0.00023821386,0.000067624605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037210438,0.00019825214,0.00079094345,0.000056419794,0.00022808772,0.000012051135,0.0002020618,0.000085959575,0.000013948339],"category_scores_gemma":[0.00081617606,0.000120555254,0.00018111317,0.00012245365,0.0007856544,0.00009870128,0.0002563294,0.00009238397,0.000021036925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041881617,0.0030956564,0.77112573,0.00007666422,0.0016702967,0.00027292775,0.010667574,0.0000022664422,0.0001101572,0.0006212781,0.0352406,0.17669804],"study_design_scores_gemma":[0.018515298,0.0018371674,0.4421038,0.0013389506,0.0018113721,0.00027487794,0.05899008,0.00030889458,0.0050032106,0.00040888475,0.4690067,0.00040076533],"about_ca_topic_score_codex":0.0011936716,"about_ca_topic_score_gemma":0.00017666903,"teacher_disagreement_score":0.4337661,"about_ca_system_score_codex":0.00038195716,"about_ca_system_score_gemma":0.00023610595,"threshold_uncertainty_score":0.49161005},"labels":[],"label_agreement":null},{"id":"W2594366765","doi":"10.1182/blood.v106.11.2812.2812","title":"Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Proportional hazards model; Stage (stratigraphy); Cancer; Diffuse large B-cell lymphoma; Not Otherwise Specified; Oncology; Gastroenterology; T cell; Immunology; Immune system; Biology","score_opus":0.0354041682120084,"score_gpt":0.29179782440031704,"score_spread":0.25639365618830867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594366765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899253,0.002136473,0.00008044413,0.00053934206,0.00006235956,0.0014042314,0.000011568315,0.0000352177,0.00580504],"genre_scores_gemma":[0.9959495,0.00003744403,0.0023784628,0.00015076919,0.00038811952,0.00024623345,0.000041768926,0.000021567834,0.0007861473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987653,0.00003062282,0.00025953937,0.00022522156,0.00052232266,0.00019697876],"domain_scores_gemma":[0.9992034,0.000052030602,0.00010047935,0.00023424487,0.0002834453,0.00012639911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002637954,0.00013956099,0.00024964733,0.000060617163,0.00003623739,0.000012002521,0.00005279724,0.000077061195,0.00020719715],"category_scores_gemma":[0.00011732074,0.00011315424,0.00013507073,0.00010117045,0.000022006385,0.000049541304,0.000013360488,0.000019841938,0.000025138219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005428081,0.02592238,0.5096923,0.00021971218,0.0009438218,0.000018890127,0.0011925437,0.0001640535,0.0057937996,0.00036528375,0.007645684,0.4474987],"study_design_scores_gemma":[0.11295556,0.0016315463,0.75336105,0.00017284263,0.004963345,0.000055281667,0.00010025856,0.003485707,0.10660781,0.000309089,0.016104287,0.00025319378],"about_ca_topic_score_codex":0.000077550394,"about_ca_topic_score_gemma":0.00004951611,"teacher_disagreement_score":0.4472455,"about_ca_system_score_codex":0.00017852349,"about_ca_system_score_gemma":0.0006185187,"threshold_uncertainty_score":0.4614296},"labels":[],"label_agreement":null},{"id":"W2594553173","doi":"10.1182/blood.v106.11.2407.2407","title":"Combination Bortezomib (PS341, Velcade) and Rituximab Treatment Affects Multiple Survival and Death Pathways To Promote Apoptosis in Mantle Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Rituximab; Apoptosis; Cancer research; Medicine; Programmed cell death; Proteasome; Lymphoma; Pharmacology; Immunology; Chemistry; Multiple myeloma; Biochemistry","score_opus":0.016339821527128054,"score_gpt":0.23814267788218457,"score_spread":0.22180285635505653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594553173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960074,0.0011044589,0.000004051299,0.0006501064,0.000045268414,0.0011228827,0.000031409683,0.00005153899,0.0009828992],"genre_scores_gemma":[0.9974434,0.00054086105,0.0014522347,0.00010068165,0.00006539442,0.00021813133,0.000047231162,0.00002737783,0.00010473037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988448,0.00004012514,0.00019765826,0.00042472323,0.0001869374,0.00030577488],"domain_scores_gemma":[0.99938726,0.00008742504,0.00005148601,0.00021313236,0.000026663864,0.00023404957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010414316,0.00024915495,0.00040639157,0.0001379145,0.000075551354,0.000037276663,0.000036436835,0.000098707846,0.0000074688096],"category_scores_gemma":[0.000024629408,0.00020311354,0.00005140683,0.00012128009,0.00001828825,0.00008137474,0.000045735527,0.0000324961,0.000027994429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002986611,0.047280658,0.8045958,0.00016433676,0.00023827545,0.0002079336,0.002186322,0.000002571843,0.014487688,0.0003988303,0.00008856486,0.1300503],"study_design_scores_gemma":[0.07832096,0.0019155245,0.62873477,0.00012502608,0.00036071736,0.00004663069,0.000116468305,0.00025252663,0.28830048,0.000025393967,0.0015623851,0.00023914744],"about_ca_topic_score_codex":0.0002736238,"about_ca_topic_score_gemma":0.00019692881,"teacher_disagreement_score":0.2738128,"about_ca_system_score_codex":0.00023156236,"about_ca_system_score_gemma":0.000060672326,"threshold_uncertainty_score":0.82827294},"labels":[],"label_agreement":null},{"id":"W2596450036","doi":"10.1182/blood.v128.22.4145.4145","title":"Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Lymphoma; Medicine; CD30; Not Otherwise Specified; CD15; Pathology; B cell; Immunology; Biology","score_opus":0.026249397051790153,"score_gpt":0.2906882922959565,"score_spread":0.26443889524416636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596450036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957503,0.0006283282,0.000030142122,0.0012865632,0.0001672296,0.001441523,0.0003856033,0.00017566691,0.00013461895],"genre_scores_gemma":[0.99752146,0.00036185625,0.000768956,0.00047304883,0.00026946238,0.00018430529,0.00008088331,0.00007412472,0.00026589568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962711,0.00044435862,0.00087031914,0.0012535898,0.0005157109,0.00064495625],"domain_scores_gemma":[0.9962305,0.0018213209,0.00039120042,0.0008233219,0.00012829444,0.0006053795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040432878,0.00064091035,0.0012655845,0.00016123638,0.00019060262,0.000104583065,0.00017669883,0.00037548816,0.000016047934],"category_scores_gemma":[0.0002924922,0.00034520857,0.00021822247,0.00013843316,0.00053261785,0.00010229389,0.0002473414,0.00009393367,0.00004952063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095245213,0.04771792,0.88555586,0.00002518485,0.0010301437,0.001407879,0.0003588353,1.5181199e-9,0.00019799848,0.000026827642,0.00016270166,0.0625642],"study_design_scores_gemma":[0.19979855,0.0028914623,0.7928414,0.00016254133,0.002313298,0.00013697421,0.0006980362,0.000007747716,0.0004577723,0.000021233413,0.00030687952,0.000364158],"about_ca_topic_score_codex":0.00020572673,"about_ca_topic_score_gemma":0.0003258441,"teacher_disagreement_score":0.1988461,"about_ca_system_score_codex":0.0001974638,"about_ca_system_score_gemma":0.00014570149,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2596667382","doi":"10.1148/rg.2017160077","title":"Spectrum of CT Findings in Thoracic Extranodal Non-Hodgkin Lymphoma","year":2017,"lang":"en","type":"review","venue":"Radiographics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Radiology; Lymphoma; Pericardial effusion; Pathology; Surgery","score_opus":0.08188015364591017,"score_gpt":0.4011146390608978,"score_spread":0.3192344854149876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596667382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034967978,0.9917558,0.000003767295,0.000085828644,0.00034890504,0.0013861129,0.00010400272,0.00003617495,0.0027826063],"genre_scores_gemma":[0.013406088,0.9855149,0.00021824522,0.000022736538,0.00018486004,0.00017888525,0.00019562512,0.00009535426,0.00018334929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727654,0.00009582988,0.0009822234,0.0006441002,0.00047516235,0.0005261512],"domain_scores_gemma":[0.9977067,0.00022566291,0.0005634055,0.0012503777,0.000038868355,0.00021494857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046056218,0.00066213537,0.0034050022,0.0015764657,0.00009460569,0.00004727419,0.0004182464,0.00037393524,0.00004148491],"category_scores_gemma":[0.000062909996,0.0005078457,0.0018649518,0.0009208691,0.0002436327,0.00007907628,0.00006860047,0.0002765026,0.000030820313],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031481348,0.000917804,0.026047023,0.015471418,0.00081337895,0.0013763753,0.00004471914,7.290108e-8,2.3176369e-7,0.00037925295,0.00042806868,0.9544902],"study_design_scores_gemma":[0.002279728,0.0003890034,0.02746494,0.037087433,0.003179323,0.0010504972,0.000006638784,0.000005311247,0.000026059684,0.00006985003,0.9279496,0.0004915883],"about_ca_topic_score_codex":0.00023078058,"about_ca_topic_score_gemma":0.000093740644,"teacher_disagreement_score":0.95399857,"about_ca_system_score_codex":0.0002926649,"about_ca_system_score_gemma":0.0006391844,"threshold_uncertainty_score":0.9997373},"labels":[],"label_agreement":null},{"id":"W2597035387","doi":"10.1200/jco.2012.30.15_suppl.8007","title":"A subgroup analysis of small lymphocytic and marginal zone lymphomas in the Eastern Cooperative Oncology Group protocol E4402 (RESORT): A randomized phase III study comparing two different rituximab dosing strategies for low tumor burden indolent non-Hodgkin lymphoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Clinical endpoint; Gastroenterology; Randomized controlled trial; Lymphoma; Progression-free survival; Neutropenia; Dosing; Chemotherapy; Oncology; Surgery","score_opus":0.10232580207271426,"score_gpt":0.45872859381288655,"score_spread":0.3564027917401723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597035387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649481,0.0003936581,0.0015007658,0.00031486075,0.00027062968,0.0323168,0.0000078922385,0.000008332065,0.00023893703],"genre_scores_gemma":[0.98611856,0.00006618136,0.0012548171,0.00043289896,0.00060494867,0.011473289,0.000011127239,0.000028414079,0.0000097648945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99061275,0.0029135223,0.004782555,0.00044819363,0.00060519885,0.00063778786],"domain_scores_gemma":[0.9866763,0.008582986,0.003470106,0.00036872047,0.00044925665,0.00045264885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008556535,0.0004925544,0.007187854,0.00064078346,0.00011355871,0.00006499832,0.00033490444,0.00026163217,0.00002946156],"category_scores_gemma":[0.00083303184,0.00027514843,0.0012000917,0.0005098073,0.0005712805,0.0002360943,0.00015272475,0.00037428387,0.0000017422952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5228963,0.0896145,0.30051342,0.00020197681,0.011098148,0.0011836397,0.009495823,0.00033092147,0.000074578544,0.00033222145,0.000033970508,0.06422455],"study_design_scores_gemma":[0.781492,0.029441908,0.14238583,0.00032674853,0.01058374,0.00040732426,0.007931311,0.026804674,0.000037513168,0.000046871446,0.0003136925,0.00022838241],"about_ca_topic_score_codex":0.0010660947,"about_ca_topic_score_gemma":0.0019095854,"teacher_disagreement_score":0.25859573,"about_ca_system_score_codex":0.0013640708,"about_ca_system_score_gemma":0.0023795182,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W2597269601","doi":"10.1200/jco.2016.70.7901","title":"New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Medicine; Concordance; Lymphoma; Vincristine; Gene expression profiling; Oncology; Pathology; Biopsy; Cancer research; Internal medicine; Cyclophosphamide; Gene expression; Chemotherapy; Biology; Gene","score_opus":0.07130655620119355,"score_gpt":0.4386988255223168,"score_spread":0.36739226932112323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597269601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90481895,0.0013083348,0.008486452,0.079231344,0.0013752405,0.0019229451,0.0000073856568,0.000012144181,0.002837211],"genre_scores_gemma":[0.97863686,0.0002178472,0.01568483,0.0039982013,0.00084000884,0.000068687616,0.0000030702051,0.000015562035,0.0005349364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979472,0.000120041805,0.0012338897,0.00018563519,0.00025969435,0.0002535467],"domain_scores_gemma":[0.9963455,0.0016180614,0.0011132114,0.00037609454,0.00023942406,0.00030771448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002189986,0.00014421361,0.0009219484,0.000071323775,0.00012874887,0.00005151079,0.00029635537,0.00036169088,0.000025683445],"category_scores_gemma":[0.0018935045,0.000080523496,0.0004034832,0.000056757803,0.0000582448,0.00011328056,0.00006575902,0.00023488316,0.000020656633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014419458,0.008594385,0.08494603,0.00010198402,0.00085089944,0.0013676449,0.00044324537,0.0006442033,0.0055317334,0.003555764,0.0703938,0.8091509],"study_design_scores_gemma":[0.07504993,0.020343078,0.48412368,0.00025808578,0.0013167356,0.00035123146,0.00025296406,0.0021122866,0.058718257,0.002877558,0.3542354,0.00036079332],"about_ca_topic_score_codex":0.00004208934,"about_ca_topic_score_gemma":0.00008948623,"teacher_disagreement_score":0.8087901,"about_ca_system_score_codex":0.00017081792,"about_ca_system_score_gemma":0.0012934883,"threshold_uncertainty_score":0.3283653},"labels":[],"label_agreement":null},{"id":"W2597463500","doi":"10.1200/jco.2012.30.15_suppl.4535","title":"Large retroperitoneal lymph nodes (RPLN) as a novel risk factor for venous thromboembolism (VTE) in germ cell tumor (GCT) patients (pts) receiving first-line chemotherapy (chemo).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; University of Toronto; Cancer Care Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Venous thromboembolism; Internal medicine; Cancer; Retrospective cohort study; Incidence (geometry); Surgery; Thrombosis","score_opus":0.06538234753893979,"score_gpt":0.4057966986002745,"score_spread":0.3404143510613347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597463500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430645,0.0007065123,0.00011724753,0.0014916948,0.0018629322,0.00060709525,0.000101371326,0.00001547105,0.00079124636],"genre_scores_gemma":[0.98883486,0.0019971076,0.0036424468,0.0031013202,0.0022391106,0.000029562481,0.000011407438,0.0000594697,0.00008472859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957869,0.00022291776,0.0025114303,0.00031423266,0.0004575856,0.0007069049],"domain_scores_gemma":[0.9936014,0.0026860407,0.002382124,0.00028866285,0.00042886546,0.00061295356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022321218,0.00031653763,0.0023815385,0.00015334415,0.0001062363,0.000017813412,0.00021030597,0.0004899945,0.00027221986],"category_scores_gemma":[0.0037911024,0.000219996,0.0007694596,0.00014991844,0.000104195606,0.0002187587,0.000068603695,0.0006004417,0.00004199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034341982,0.041098528,0.874789,0.0000782011,0.0003918221,0.00009325067,0.0009636044,0.0000039737697,0.00015037261,0.000022431022,0.00056758896,0.07840703],"study_design_scores_gemma":[0.045435697,0.008915343,0.912907,0.00017963405,0.00038273513,0.00011579411,0.000116251846,0.00008101092,0.0011587047,0.000059231017,0.03044998,0.00019859304],"about_ca_topic_score_codex":0.00010157361,"about_ca_topic_score_gemma":0.000051178722,"teacher_disagreement_score":0.07820844,"about_ca_system_score_codex":0.0008992443,"about_ca_system_score_gemma":0.0009832522,"threshold_uncertainty_score":0.8971176},"labels":[],"label_agreement":null},{"id":"W2597768246","doi":"","title":"Preliminary results of a phase II study of brentuximab vedotin using a response adapted design for the first line treatment of patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (BREVITY)","year":2016,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Wojskowy Instytut Medyczny; Universitätsklinikum Köln; Université de Lorraine; Assistance publique-Hôpitaux de Paris; Humanitas University; Aalborg Universitetshospital; Université de Namur; Università di Bologna; Všeobecná Fakultní Nemocnice v Praze; Memorial Sloan-Kettering Cancer Center; Rigshospitalet; Università degli Studi di Firenze; University of California, Los Angeles; Institut National de la Santé et de la Recherche Médicale; Gentofte Hospital; Barbara Ann Karmanos Cancer Institute; University of Toronto; Brigham and Women's Hospital; Emory University; Università Degli Studi di Modena e Reggio Emila; Bristol-Myers Squibb; BC Cancer Agency; Università degli Studi di Pavia; Aalborg Universitet; Univerzita Karlova v Praze","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Lymphoma; Chemotherapy; Hodgkin lymphoma","score_opus":0.21733167336540365,"score_gpt":0.3722261433574812,"score_spread":0.15489446999207757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597768246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926175,0.00006896633,0.0023697894,0.0010582944,0.000014650134,0.0068500713,0.00036502222,0.000009586344,0.0000018632662],"genre_scores_gemma":[0.9979484,0.00014421884,0.0016890484,0.00001108408,0.000019478974,0.0000768514,0.000018989987,0.000023484094,0.00006842921],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9979244,0.00035610958,0.00037987324,0.00038188667,0.0006059348,0.00035183443],"domain_scores_gemma":[0.99401057,0.0040730354,0.0003177784,0.00073318544,0.00074547005,0.00011994416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010575418,0.0002094589,0.0006740439,0.00025590326,0.00029604233,0.000005391063,0.0002992331,0.00006549058,0.000016780272],"category_scores_gemma":[0.0003697494,0.00010636961,0.00016496456,0.0004028165,0.0003239299,0.00009636293,0.0001161852,0.000033067023,8.264382e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78403723,0.060466114,0.008630266,0.00043104572,0.00186378,0.000098804085,0.05549899,0.00012407919,0.003574345,0.0000039314555,0.0009540573,0.084317364],"study_design_scores_gemma":[0.24909617,0.32406402,0.2996147,0.0016478291,0.0010635101,0.0000072235507,0.016941508,0.00054117263,0.09974305,0.000015155297,0.006991605,0.00027404938],"about_ca_topic_score_codex":0.00017037144,"about_ca_topic_score_gemma":0.00006627189,"teacher_disagreement_score":0.5349411,"about_ca_system_score_codex":0.0004786778,"about_ca_system_score_gemma":0.0004458971,"threshold_uncertainty_score":0.43376267},"labels":[],"label_agreement":null},{"id":"W2597813658","doi":"10.4103/1450-1147.203070","title":"False negative 18F-fluorodeoxyglucose positron emission tomography/computed tomography in primary b-cell lymphoma of the bone","year":2017,"lang":"en","type":"article","venue":"World Journal of Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Ottawa","funders":"","keywords":"Medicine; Positron emission tomography; Lymphoma; Nuclear medicine; Osteomyelitis; Radiology; Positron Emission Tomography-Computed Tomography; Mandible (arthropod mouthpart); Fluorodeoxyglucose; Biopsy; Pathology; Surgery","score_opus":0.01008500584008048,"score_gpt":0.24391867260201835,"score_spread":0.23383366676193787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597813658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745664,0.005270223,0.0000027949616,0.011546246,0.00052023557,0.00038924074,0.000004826904,0.000013534171,0.007686515],"genre_scores_gemma":[0.9966786,0.0005021559,0.0009909229,0.0012693572,0.00031442597,0.0000024713647,0.000002700045,0.000036373243,0.00020301608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758935,0.00012716839,0.0009474153,0.00023592074,0.0007976531,0.0003024778],"domain_scores_gemma":[0.9971292,0.0001727734,0.0013725692,0.000746996,0.00028430106,0.00029413842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000581651,0.00028001977,0.0009725332,0.00069084123,0.00021996502,0.000024054392,0.0004512303,0.00007463225,0.00009768704],"category_scores_gemma":[0.00016462093,0.00015837877,0.000447341,0.0005274767,0.0004633735,0.00018068176,0.00015592609,0.0002843853,0.0000036593701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005075673,0.00927962,0.72853327,0.00053787953,0.000899918,0.0024479462,0.0031935326,0.000009582854,0.085500576,0.00041973894,0.047904383,0.11619789],"study_design_scores_gemma":[0.019722102,0.0013095893,0.95902526,0.0035848913,0.0004491631,0.00037074657,0.00019701535,0.000032584594,0.0073830313,0.0002678357,0.007520422,0.00013734345],"about_ca_topic_score_codex":0.00019369989,"about_ca_topic_score_gemma":0.000029358947,"teacher_disagreement_score":0.23049203,"about_ca_system_score_codex":0.0002299724,"about_ca_system_score_gemma":0.00014983147,"threshold_uncertainty_score":0.6458498},"labels":[],"label_agreement":null},{"id":"W2597981368","doi":"10.1200/jco.2014.32.15_suppl.8519","title":"Preliminary results of a phase II randomized study (ROMULUS) of polatuzumab vedotin (PoV) or pinatuzumab vedotin (PiV) plus rituximab (RTX) in patients (Pts) with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Gastroenterology; Rituximab; Adverse effect; Febrile neutropenia; Refractory (planetary science); Nausea; Diarrhea; Lymphoma; Surgery; Toxicity","score_opus":0.041500481084312306,"score_gpt":0.3980693829016003,"score_spread":0.356568901817288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597981368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436,0.00039384008,0.00004572027,0.0008264337,0.00083071116,0.0021302649,0.000025894207,0.000014651944,0.001372461],"genre_scores_gemma":[0.9962148,0.00039557053,0.0024015894,0.0003437427,0.00034920764,0.000056804536,0.000019681522,0.000057434376,0.00016118916],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98776245,0.002532933,0.0073652235,0.0006138039,0.0011929523,0.0005326647],"domain_scores_gemma":[0.9809256,0.009605538,0.0070245345,0.0007585402,0.0011367016,0.0005490854],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007470956,0.0005117632,0.006833244,0.0006148516,0.000088720684,0.000009723842,0.00044773717,0.00066240143,0.000065200285],"category_scores_gemma":[0.012801016,0.00030545352,0.0009548947,0.0004848481,0.00062960084,0.00021607743,0.00022497773,0.0008376425,0.000010919646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7367303,0.13806233,0.020073608,0.000094883486,0.0012258113,0.0009552132,0.0014277381,0.000039878614,0.000019760027,0.000019455343,0.0011039545,0.10024706],"study_design_scores_gemma":[0.57584125,0.25630954,0.16323602,0.0006833201,0.0012091533,0.000088917455,0.00032919494,0.0005473916,0.00011787614,0.000033197684,0.0014300335,0.00017413145],"about_ca_topic_score_codex":0.00043556278,"about_ca_topic_score_gemma":0.00018528686,"teacher_disagreement_score":0.16088907,"about_ca_system_score_codex":0.0010337398,"about_ca_system_score_gemma":0.0041599427,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W2598696175","doi":"10.1182/blood-2016-11-747022","title":"Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Cell of origin; Biology; Gene expression profiling; Lymphoma; Cancer research; Profiling (computer programming); Cell; Computational biology; Genetics; Gene; Immunology; Gene expression","score_opus":0.031713977297532815,"score_gpt":0.3348248998591481,"score_spread":0.30311092256161526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598696175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498266,0.0037893164,0.0000018322163,0.000023421855,0.00008907894,0.000357687,0.0000316319,0.000009510135,0.0007148886],"genre_scores_gemma":[0.9963295,0.0020742824,0.0013744296,0.0000145160275,0.0001116099,0.000019613413,0.0000064635296,0.000019373134,0.000050216455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987958,0.000036165937,0.00049473497,0.00027910882,0.0001559606,0.00023822678],"domain_scores_gemma":[0.9987937,0.00013353769,0.0002845938,0.0006014346,0.000048252004,0.00013847717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001711377,0.00016601039,0.0005250365,0.00007610949,0.000053805004,0.00002036199,0.000117231815,0.00010893701,0.000011747674],"category_scores_gemma":[0.00006083347,0.00012079592,0.00016202465,0.000041156385,0.00010199817,0.000046550394,0.000079635785,0.000045353772,0.000006816599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009749877,0.019258572,0.9707673,0.00014641066,0.000057948197,0.00022803848,0.00008646979,1.0161409e-7,0.0041968753,0.000008648365,0.000033925713,0.005118192],"study_design_scores_gemma":[0.04703838,0.0006719083,0.88063186,0.00012864836,0.00021394169,0.00003421408,0.000024631938,0.000044671724,0.070950665,0.000017642169,0.00014639994,0.00009702044],"about_ca_topic_score_codex":0.000109236345,"about_ca_topic_score_gemma":0.000016860546,"teacher_disagreement_score":0.09013544,"about_ca_system_score_codex":0.000024418785,"about_ca_system_score_gemma":0.000109410226,"threshold_uncertainty_score":0.49259147},"labels":[],"label_agreement":null},{"id":"W2599179050","doi":"10.1007/s00247-017-3835-8","title":"FDG uptake in cervical lymph nodes in children without head and neck cancer","year":2017,"lang":"en","type":"article","venue":"Pediatric Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Brampton Civic Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Lymph; Cervical lymph nodes; Lymphoma; Lymph node; Head and neck cancer; Positron emission tomography; Radiology; Cervical lymphadenopathy; Biopsy; Standardized uptake value; Lymph node biopsy; Cancer; Cervical cancer; Pathology; Internal medicine; Radiation therapy; Metastasis; Disease","score_opus":0.016522177261623392,"score_gpt":0.30137338295551414,"score_spread":0.2848512056938907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599179050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989819,0.0072131758,6.3142835e-7,0.0016953467,0.00014429276,0.00028885264,0.0000124726985,0.000016258007,0.00080999127],"genre_scores_gemma":[0.99071866,0.00797082,0.00018092424,0.00030810852,0.0006094475,0.00011342688,0.000013563924,0.000013817645,0.000071199385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989494,0.000040176514,0.00025206237,0.00035255324,0.00008141622,0.00032438283],"domain_scores_gemma":[0.9993865,0.000055253604,0.000093267714,0.00032805584,0.000015635307,0.000121289144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117619355,0.00015631563,0.00046881745,0.00015047433,0.00007218876,0.000017697228,0.0001089393,0.00016124014,0.00005478122],"category_scores_gemma":[0.000094220384,0.00012142543,0.0000431363,0.00007120912,0.00008675837,0.000055881224,0.00006144344,0.000099636,0.000018247345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009724748,0.00021836237,0.99060214,0.000020343914,0.000030446303,0.00009422196,0.00009034364,0.0000046361383,0.000004193557,0.000077828525,0.00017164442,0.0085886],"study_design_scores_gemma":[0.0077830083,0.00010399914,0.9913249,0.000018488932,0.00009202844,0.00024755127,0.0000060228576,0.000084943145,0.0000072526236,0.000082799466,0.00013959587,0.000109431014],"about_ca_topic_score_codex":0.004590369,"about_ca_topic_score_gemma":0.0005576239,"teacher_disagreement_score":0.008479169,"about_ca_system_score_codex":0.00016987327,"about_ca_system_score_gemma":0.00013849232,"threshold_uncertainty_score":0.6939295},"labels":[],"label_agreement":null},{"id":"W2599723835","doi":"10.1200/jco.2013.31.15_suppl.8565","title":"Different safety profiles of first-line bendamustine-rituximab (BR), R-CHOP, and R-CVP in an open-label, randomized study of indolent non-Hodgkin lymphoma (NHL) and mantle cell lymphoma (MCL): The BRIGHT study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Dalhousie University","funders":"","keywords":"Medicine; Bendamustine; Mantle cell lymphoma; Internal medicine; Rituximab; Gastroenterology; Tolerability; CHOP; Rash; Adverse effect; Surgery; Lymphoma","score_opus":0.07524653254316141,"score_gpt":0.4107670444412533,"score_spread":0.33552051189809184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599723835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115884,0.0010515423,0.0000065334925,0.0017990317,0.00034973494,0.0053201676,0.000011825099,0.000004953805,0.00029738527],"genre_scores_gemma":[0.996839,0.0019803373,0.00042820352,0.0002614387,0.00017572106,0.00022310903,0.0000040543187,0.00002843008,0.000059706283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925414,0.0017022184,0.0044231205,0.0004442096,0.0005690699,0.0003200215],"domain_scores_gemma":[0.9903452,0.0055693146,0.002764284,0.00047787957,0.00049958075,0.0003437751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004158143,0.00036460304,0.0044940314,0.00021246381,0.00009891973,0.000040808416,0.00042543982,0.00027839246,0.00011595515],"category_scores_gemma":[0.0009929929,0.0001854523,0.00020756389,0.00018117297,0.0004626267,0.0002145292,0.00045299545,0.00029543083,0.0000028029958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104489736,0.17750353,0.5382443,0.00011414772,0.0009878516,0.00034934087,0.0019343083,0.000004336778,0.000101507736,0.000018958897,0.00022014468,0.17603183],"study_design_scores_gemma":[0.4264095,0.030112365,0.5402056,0.00013562413,0.00082708633,0.000083411745,0.0014608757,0.00027178793,0.00014507268,0.00007978317,0.00016903253,0.000099855424],"about_ca_topic_score_codex":0.0011131916,"about_ca_topic_score_gemma":0.0010777051,"teacher_disagreement_score":0.32191977,"about_ca_system_score_codex":0.00018952042,"about_ca_system_score_gemma":0.0004991861,"threshold_uncertainty_score":0.7562525},"labels":[],"label_agreement":null},{"id":"W2600359049","doi":"10.1182/blood.v128.22.617.617","title":"Phase 2 Study of Venetoclax Plus Rituximab or Randomized Ven Plus Bendamustine+Rituximab (BR) Versus BR in Patients with Relapsed/Refractory Follicular Lymphoma: Interim Data","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Venetoclax; Ven; Internal medicine; Chemotherapy regimen; Regimen; Chemotherapy; Chemoimmunotherapy; Follicular lymphoma; Clinical endpoint; Gastroenterology; Oncology; Lymphoma; Leukemia; Randomized controlled trial; Chronic lymphocytic leukemia","score_opus":0.03353409437138315,"score_gpt":0.30083518320600355,"score_spread":0.2673010888346204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600359049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953336,0.00067291455,0.000014255591,0.00006337669,0.00027301224,0.0031155895,0.00027860876,0.000060470593,0.00018815731],"genre_scores_gemma":[0.99861634,0.00010023663,0.00031835912,0.000040591713,0.00009883057,0.00033886262,0.0003300385,0.00006608516,0.0000906854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99695927,0.00024041721,0.00084397086,0.000807987,0.00069464225,0.000453686],"domain_scores_gemma":[0.99707156,0.00057911465,0.00039554609,0.0015682487,0.0001702165,0.00021529237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038112738,0.00044350096,0.0017373794,0.0002331089,0.00006473668,0.000022653283,0.00041468593,0.00013991981,0.00012380489],"category_scores_gemma":[0.00054163975,0.00024430378,0.00014432364,0.00029126919,0.00015942173,0.0002546678,0.00031623943,0.00009313045,0.000040887153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77884686,0.1675965,0.030037638,0.00018818004,0.004157009,0.001645017,0.0015392444,0.000004885252,0.00015220563,0.00002311673,0.00051357073,0.015295791],"study_design_scores_gemma":[0.96648544,0.012907,0.015174622,0.00066254556,0.0028119984,0.000019419995,0.0002949303,0.000067801724,0.0006505671,0.0000032689802,0.00061779877,0.0003046311],"about_ca_topic_score_codex":0.0009372693,"about_ca_topic_score_gemma":0.00027599197,"teacher_disagreement_score":0.18763858,"about_ca_system_score_codex":0.00090060715,"about_ca_system_score_gemma":0.0009514715,"threshold_uncertainty_score":0.9962419},"labels":[],"label_agreement":null},{"id":"W2600971427","doi":"10.1200/jco.2013.31.15_suppl.8537","title":"Secondary efficacy subanalysis by histology from the phase III BRIGHT study: First-line bendamustine-rituximab (BR) compared with standard R-CHOP/R-CVP for patients with advanced indolent non-Hodgkin lymphoma (NHL) or mantle cell lymphoma (MCL).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Bendamustine; Tolerability; Internal medicine; Rituximab; Clinical endpoint; CHOP; Gastroenterology; Phases of clinical research; Lymphoma; Surgery; Adverse effect; Clinical trial","score_opus":0.03227101687520967,"score_gpt":0.3674593381366304,"score_spread":0.33518832126142073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600971427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078226,0.00084998325,0.0005911345,0.003891852,0.0006083836,0.0027554664,0.000317456,0.000024559771,0.00017890372],"genre_scores_gemma":[0.99188703,0.00031181393,0.0046802014,0.0020215544,0.00042027494,0.00022054277,0.00021108822,0.00007271377,0.00017476722],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940199,0.00045345284,0.003312618,0.00072161446,0.0008557048,0.0006366807],"domain_scores_gemma":[0.98755604,0.0064410456,0.0033254086,0.0006972568,0.0013582396,0.0006220373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009805489,0.00057835516,0.0038741957,0.00016708601,0.0002923171,0.00005055374,0.000493847,0.00037263936,0.00078163896],"category_scores_gemma":[0.0006228329,0.00028035472,0.00074823585,0.0003097232,0.0004309764,0.00023632101,0.00011038701,0.0004157884,0.000028875222],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15959519,0.117632195,0.17033046,0.00005528827,0.0055774483,0.0008890065,0.0009471691,0.000048098475,0.00001973604,0.0000028061252,0.029979223,0.51492333],"study_design_scores_gemma":[0.47300184,0.096699074,0.33632767,0.00019130869,0.005011405,0.00010417331,0.0006515549,0.0002291741,0.00019031961,0.0000220231,0.08720791,0.00036351837],"about_ca_topic_score_codex":0.0005602237,"about_ca_topic_score_gemma":0.00095868675,"teacher_disagreement_score":0.51455986,"about_ca_system_score_codex":0.0011355318,"about_ca_system_score_gemma":0.0023245993,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2601321703","doi":"10.1200/jco.2012.30.15_suppl.8049","title":"Transformation of follicular lymphoma in the era of immunochemotherapy: A population-based study from British Columbia.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Chemotherapy; Internal medicine; Rituximab; Lymphoma; Fludarabine; Chemotherapy regimen; Oncology; Population; Surgery; Cancer; Gastroenterology; Cyclophosphamide","score_opus":0.05261087983352297,"score_gpt":0.39704901860647834,"score_spread":0.34443813877295537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601321703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972098,0.00086117163,0.000018985013,0.0010977212,0.00024767872,0.0004041057,0.000008632368,0.0000018099911,0.00015008243],"genre_scores_gemma":[0.9981643,0.00015842755,0.0005595459,0.0008968273,0.00019077268,0.00000973194,0.000009809138,0.000006556118,0.0000040189984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692476,0.0005142807,0.0020261332,0.000067061155,0.0003515241,0.00011625203],"domain_scores_gemma":[0.99682975,0.0016090161,0.0011650184,0.00015013566,0.00016802632,0.000078040066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023465022,0.00006251446,0.0009757032,0.000035006917,0.000019772135,0.00000865155,0.0001041811,0.00015806963,0.00011140274],"category_scores_gemma":[0.00043664358,0.000050809038,0.00037737485,0.00012667057,0.000042590687,0.00009653032,0.000005156319,0.00016468049,0.0000010388565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063251675,0.014758996,0.8504757,0.000010239259,0.00028248623,0.000048404694,0.00062430307,0.000005809138,0.00002310068,0.0000043292334,0.0001643641,0.13296974],"study_design_scores_gemma":[0.021973979,0.0057147746,0.97000664,0.00011558982,0.00038109138,0.00003769809,0.00054920657,0.000026320848,0.000053107047,0.00007381543,0.0010294701,0.00003827901],"about_ca_topic_score_codex":0.013789469,"about_ca_topic_score_gemma":0.0047431337,"teacher_disagreement_score":0.13293146,"about_ca_system_score_codex":0.00013721586,"about_ca_system_score_gemma":0.00043783864,"threshold_uncertainty_score":0.99277776},"labels":[],"label_agreement":null},{"id":"W2602310116","doi":"10.1182/blood.v128.22.607.607","title":"Frequent Genetic Alterations of PI3K-AKT Pathway and Their Clinical Significance in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; PTEN; Germinal center; PI3K/AKT/mTOR pathway; Cancer research; Biology; Protein kinase B; Lymphoma; B cell; Genetics; Signal transduction; Immunology","score_opus":0.015329869750786982,"score_gpt":0.25679796478888284,"score_spread":0.24146809503809585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602310116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969449,0.0014047936,0.00006208473,0.00028287122,0.00010219845,0.00042381024,0.0001530352,0.00001799198,0.00060830795],"genre_scores_gemma":[0.99785584,0.00088765385,0.00045538845,0.00029476485,0.00010435233,0.000087631735,0.000014123493,0.000020666332,0.00027955842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858904,0.00009159317,0.0005244832,0.00036668658,0.00014347382,0.00028469786],"domain_scores_gemma":[0.99905586,0.00021641259,0.00012984916,0.0003722933,0.00005033709,0.00017522786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014346055,0.00018942267,0.00038532674,0.00007022319,0.000038014907,0.000011946328,0.000073715724,0.00009725722,0.00004257719],"category_scores_gemma":[0.00002537332,0.000111449815,0.00012927635,0.000073014955,0.00008944969,0.00004375984,0.000050849365,0.000042457308,0.000026688527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095053205,0.05834999,0.9045727,0.00008526935,0.00008952721,0.0002592691,0.00034598913,7.218879e-8,0.021084206,0.00009325412,0.00022769911,0.01479693],"study_design_scores_gemma":[0.10842957,0.0014443618,0.72429925,0.00033723676,0.0001997897,0.0000939894,0.000094152514,0.000027985609,0.16003868,0.00008494138,0.0046966444,0.00025337437],"about_ca_topic_score_codex":0.000038675702,"about_ca_topic_score_gemma":0.00005391209,"teacher_disagreement_score":0.18027347,"about_ca_system_score_codex":0.000047972597,"about_ca_system_score_gemma":0.00014328578,"threshold_uncertainty_score":0.45447916},"labels":[],"label_agreement":null},{"id":"W2603167456","doi":"10.1182/blood.v128.22.1103.1103","title":"Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Vincristine; Internal medicine; Regimen; Prednisone; Maintenance therapy; International Prognostic Index; Surgery; Cyclophosphamide; Oncology; Chemotherapy; Lymphoma","score_opus":0.011638767461707184,"score_gpt":0.25444124668042095,"score_spread":0.24280247921871376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603167456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811274,0.00015106521,0.0000014165333,0.0002177893,0.000021759852,0.0009325214,0.00012507038,0.000017111734,0.00042054345],"genre_scores_gemma":[0.99975646,0.000038353213,0.000056548157,0.000016104997,0.000019594443,0.000010676291,0.000011160928,0.000012170019,0.00007895422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907154,0.000049202914,0.00031412262,0.00021437315,0.00021127624,0.00013946595],"domain_scores_gemma":[0.9991193,0.00012478112,0.00015646481,0.000444443,0.000084398234,0.00007066049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008184512,0.00013160527,0.00039163325,0.00003335884,0.00003875706,0.000004220268,0.00007391028,0.00003102603,0.000020011255],"category_scores_gemma":[0.00003446781,0.000057439083,0.00003813894,0.000102232814,0.00014022115,0.000017921993,0.000042747382,0.000032600285,0.0000030415595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049375173,0.21500027,0.624909,0.00016696024,0.0038635444,0.002901143,0.0065647135,0.0000013762759,0.032751966,0.00006767821,0.0003509328,0.06404727],"study_design_scores_gemma":[0.21377145,0.008782057,0.71932024,0.00037246925,0.0013390529,0.00063697627,0.00016826543,0.00000135114,0.055376742,0.0000033305466,0.00012147312,0.00010662379],"about_ca_topic_score_codex":0.00008493749,"about_ca_topic_score_gemma":0.000046980604,"teacher_disagreement_score":0.20621821,"about_ca_system_score_codex":0.00002422237,"about_ca_system_score_gemma":0.000060863567,"threshold_uncertainty_score":0.23422979},"labels":[],"label_agreement":null},{"id":"W2603456398","doi":"10.1016/j.hoc.2016.11.009","title":"Peripheral T-Cell Lymphoma, Not Otherwise Specified","year":2017,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Oncology; Lymphoma; Internal medicine; Autologous stem-cell transplantation; Transplantation; Peripheral; Chemotherapy; Refractory (planetary science); T cell; Immunology; Biology; Immune system","score_opus":0.12089430205460704,"score_gpt":0.4189685174617788,"score_spread":0.29807421540717177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603456398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013247016,0.9800102,0.00000985914,0.0003031455,0.0011211906,0.0019205424,0.00024314858,0.00010408429,0.014963137],"genre_scores_gemma":[0.0011941411,0.99225295,0.0025717686,0.00087771344,0.00035427892,0.00051114464,0.00054052356,0.00015667485,0.0015408336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944147,0.00043449152,0.0026307942,0.0012617558,0.00038704652,0.0008712465],"domain_scores_gemma":[0.99097157,0.0017203734,0.0041739927,0.002376136,0.00026154585,0.0004963744],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003162055,0.0010694064,0.00973482,0.00035403378,0.00022212246,0.000020668364,0.0008655613,0.0013437698,0.00039676766],"category_scores_gemma":[0.00044857062,0.0008252715,0.002346169,0.0002854346,0.001441769,0.000066301174,0.00033631854,0.0005520276,0.0009882973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033616836,0.0044111153,0.0065912236,0.007133706,0.0012607077,0.0021810525,0.000069479145,2.1667638e-7,3.6709434e-8,0.00006181746,0.0048339698,0.9731205],"study_design_scores_gemma":[0.0054785185,0.0021846923,0.0015665108,0.0021635876,0.004615779,0.0014246607,0.000028195625,0.000005141758,0.0000028226164,0.000009321342,0.9819511,0.0005696587],"about_ca_topic_score_codex":0.000074137024,"about_ca_topic_score_gemma":0.000106966,"teacher_disagreement_score":0.9771171,"about_ca_system_score_codex":0.00062389433,"about_ca_system_score_gemma":0.0037069158,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W2604118521","doi":"10.1002/hon.2411","title":"Follicular lymphoma: State‐of‐the‐art ICML workshop in Lugano 2015","year":2017,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Instituto de Ciencias del Mar y Limnología, Universidad Nacional Autónoma de México; European School of Oncology; Cancer Research UK; American Association for Cancer Research","keywords":"Follicular lymphoma; Epigenetics; Clinical Oncology; Lymphoma; Medicine; Oncology; Internal medicine; Cancer; Biology; Genetics; Gene","score_opus":0.12830900746607302,"score_gpt":0.43407985912802716,"score_spread":0.30577085166195417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604118521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064348284,0.9883118,0.0000025723366,0.0012294985,0.0005345535,0.0018770628,0.000022482713,0.000039923973,0.007338581],"genre_scores_gemma":[0.001320502,0.995361,0.00026265663,0.00026678265,0.00007757861,0.0006715857,0.000056917394,0.000040152026,0.0019428328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966299,0.000452238,0.0013061948,0.0006892657,0.00033794405,0.0005844658],"domain_scores_gemma":[0.9963634,0.0010631416,0.0010320146,0.0012306224,0.00008442345,0.00022640245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042206259,0.000577943,0.005419339,0.00017256175,0.00009533601,0.000017222557,0.0005572404,0.0011173594,0.00019114294],"category_scores_gemma":[0.0008605029,0.0002971988,0.0012163394,0.00028213108,0.0004410756,0.000035592024,0.0004017411,0.00035505794,0.00050743314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059241785,0.002883419,0.0019315155,0.004558766,0.0003924655,0.004437742,0.0000307073,2.5569756e-7,9.916031e-8,0.00080897997,0.015421483,0.9694753],"study_design_scores_gemma":[0.002573323,0.0003798886,0.0014301626,0.008495941,0.0011072743,0.0027487145,0.000007616198,0.0000013910657,0.000006305912,0.00022354934,0.9827716,0.00025426634],"about_ca_topic_score_codex":0.000023801316,"about_ca_topic_score_gemma":0.00009244691,"teacher_disagreement_score":0.96922106,"about_ca_system_score_codex":0.00096239214,"about_ca_system_score_gemma":0.0014203162,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W2604580699","doi":"10.1093/annonc/mdx097","title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","year":2017,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Cancer Institute; Genentech; University of Iowa; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Lymphoma; Clinical trial; Response Evaluation Criteria in Solid Tumors; Oncology; Positron emission tomography; Internal medicine; Nuclear medicine; Phases of clinical research","score_opus":0.5210154106997881,"score_gpt":0.5584069266435905,"score_spread":0.03739151594380241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604580699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018929574,0.9595043,2.468091e-7,0.002225922,0.001284167,0.0010973365,0.00005388042,0.00001363934,0.03392756],"genre_scores_gemma":[0.009701129,0.9885786,0.00021573828,0.00025511376,0.0003050976,0.000383279,0.00028524603,0.00002888376,0.00024692368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691844,0.0009720781,0.00095555506,0.0004525326,0.0004131527,0.00028826957],"domain_scores_gemma":[0.9967244,0.0011977511,0.001035803,0.00059139734,0.00034425824,0.00010638006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002931275,0.00031501745,0.0020323095,0.00051956135,0.00005154949,0.000022990554,0.0002791469,0.0005326919,0.00029135984],"category_scores_gemma":[0.0017247207,0.00025684995,0.00046255402,0.00010423809,0.00015575862,0.000037616384,0.000121881385,0.00012383462,0.00008619003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010525548,0.0010393879,0.00021071706,0.000633159,0.000512164,0.00087160117,0.00007025585,1.1765085e-7,0.000002847195,0.000061751336,0.009411063,0.9861344],"study_design_scores_gemma":[0.003765405,0.0010902754,0.0054179346,0.009944938,0.0007553622,0.0007283637,0.00001478745,0.000015301493,0.0000049619384,0.000059485348,0.97803324,0.00016995078],"about_ca_topic_score_codex":0.00011810262,"about_ca_topic_score_gemma":0.000050944178,"teacher_disagreement_score":0.9859644,"about_ca_system_score_codex":0.0007948977,"about_ca_system_score_gemma":0.001858029,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W2604901999","doi":"10.1080/21556660.2017.1315336","title":"Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"CD22; Medicine; Refractory (planetary science); Calicheamicin; Lymphoma; Internal medicine; Oncology; CD20","score_opus":0.015372535247445678,"score_gpt":0.3181207012641905,"score_spread":0.3027481660167448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604901999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663323,0.00016663609,0.00008178613,0.00031306437,0.00020916629,0.0022777864,0.000054097873,0.0000042957718,0.00025995623],"genre_scores_gemma":[0.99819964,0.00019788527,0.0011567803,0.000027668408,0.00007721278,0.00010014605,0.000013936951,0.00003678657,0.0001899586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978446,0.00006609906,0.0007984231,0.00022405379,0.0008287308,0.00023813616],"domain_scores_gemma":[0.9957414,0.00033862912,0.0022755843,0.0008140678,0.0006733032,0.0001569997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027750136,0.0003173561,0.0009758904,0.00014182592,0.00023507522,0.00004075926,0.00026686955,0.000049004917,0.000016517952],"category_scores_gemma":[0.000016492413,0.0001472922,0.00023365303,0.000073082025,0.00011583576,0.00017200907,0.000031271917,0.00007765041,6.3276656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016039817,0.18992478,0.7495099,0.0001172375,0.0030852035,0.00015421676,0.0030135126,0.000063950705,0.00018148987,0.000014102818,0.0005242693,0.03737153],"study_design_scores_gemma":[0.19762406,0.14304517,0.6473155,0.00027002435,0.00248323,0.000011244706,0.0024107723,0.000097092176,0.005856344,0.000005079004,0.00075227825,0.00012918777],"about_ca_topic_score_codex":0.00026184059,"about_ca_topic_score_gemma":0.00010123803,"teacher_disagreement_score":0.18158424,"about_ca_system_score_codex":0.0007561874,"about_ca_system_score_gemma":0.0006516225,"threshold_uncertainty_score":0.6006401},"labels":[],"label_agreement":null},{"id":"W2605009867","doi":"10.1158/1078-0432.ccr-16-2818","title":"A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; American Association for Cancer Research","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Neutropenia; Clinical endpoint; Oncology; Rituximab; Thalidomide; Phases of clinical research; Febrile neutropenia; Gastroenterology; Surgery; Lymphoma; Multiple myeloma; Randomized controlled trial; Clinical trial; Chemotherapy","score_opus":0.2495991745781395,"score_gpt":0.5288692121540582,"score_spread":0.27927003757591873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605009867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896305,0.00035404667,5.026469e-7,0.0016640648,0.00019368577,0.007865031,0.00008012475,0.000008815111,0.00020322467],"genre_scores_gemma":[0.9980468,0.00040160993,0.0000749613,0.00039103863,0.00010436535,0.00073985185,0.000015454638,0.000032077136,0.00019385146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99570405,0.0014087041,0.00090091483,0.00064809184,0.00084733486,0.0004909279],"domain_scores_gemma":[0.9892906,0.007989343,0.0003295303,0.0012993371,0.0004446337,0.0006465695],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040759286,0.00022860728,0.0012138091,0.00010635096,0.00043137398,0.00013964623,0.00071115646,0.00006275326,0.00004128037],"category_scores_gemma":[0.01118907,0.00011586141,0.00006843005,0.0002039774,0.0008563204,0.0001513487,0.000892966,0.0003724166,0.0000132376745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49255162,0.10926642,0.3908052,0.00004267538,0.00026359543,0.00005271456,0.00048533344,1.8501439e-7,0.0000024651597,0.000005895207,0.00097255793,0.0055513005],"study_design_scores_gemma":[0.60975873,0.006169539,0.38157165,0.0003573147,0.00016169497,1.2510787e-7,0.00020387633,0.000038662984,0.000035815643,0.0000010694364,0.0016165111,0.00008500413],"about_ca_topic_score_codex":0.006343098,"about_ca_topic_score_gemma":0.005167111,"teacher_disagreement_score":0.11720711,"about_ca_system_score_codex":0.00032997676,"about_ca_system_score_gemma":0.00082749146,"threshold_uncertainty_score":0.9971401},"labels":[],"label_agreement":null},{"id":"W2606266333","doi":"10.1182/blood.v128.22.1113.1113","title":"Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Population; Oncology; Regimen; Vincristine; Hazard ratio; Cytarabine; Etoposide; Cyclophosphamide; Leukemia; Chemotherapy; Confidence interval","score_opus":0.005736648885363281,"score_gpt":0.20236256222605137,"score_spread":0.19662591334068807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606266333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965117,0.00016556954,0.000004627483,0.0005284749,0.00013523053,0.0018032271,0.000694716,0.00010592667,0.000050523828],"genre_scores_gemma":[0.99607515,0.00008536705,0.0014795494,0.00044824608,0.000043728825,0.0003767488,0.0005675265,0.0001278207,0.0007958434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958369,0.00029882416,0.0010036555,0.0010517918,0.00092107226,0.0008877447],"domain_scores_gemma":[0.99724036,0.00084112893,0.0003690246,0.00069058064,0.00038763965,0.00047123284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022799736,0.00063678954,0.0017381153,0.00021755953,0.0001906831,0.00013168927,0.00018903712,0.0002155202,0.00010476589],"category_scores_gemma":[0.00042469433,0.0004939382,0.00008146752,0.00073468074,0.00013713329,0.00020988104,0.00007008973,0.00016663797,0.0000056312456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002614917,0.0066987104,0.97805506,0.00014527331,0.0003796912,0.00493762,0.000037435428,0.000018718683,0.000034269528,0.000008140785,0.00019283418,0.006877356],"study_design_scores_gemma":[0.16578858,0.0014590571,0.8295249,0.0011987602,0.0005736655,0.00008315984,0.000048383223,0.000025939575,0.00065370783,0.00001549633,0.00003310298,0.0005952888],"about_ca_topic_score_codex":0.9885318,"about_ca_topic_score_gemma":0.9942248,"teacher_disagreement_score":0.16317366,"about_ca_system_score_codex":0.0014980319,"about_ca_system_score_gemma":0.0013415643,"threshold_uncertainty_score":0.9997512},"labels":[],"label_agreement":null},{"id":"W2606472448","doi":"10.1182/blood-2017-03-691345","title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Follicular lymphoma; Transformation (genetics); Liquid biopsy; Disease; Medicine; Lymphoma; Precision medicine; Malignant transformation; Bioinformatics; Biology; Oncology; Pathology; Cancer; Internal medicine; Genetics; Gene","score_opus":0.06144884763105181,"score_gpt":0.3243587914494427,"score_spread":0.2629099438183909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606472448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002583118,0.9940192,0.0000011197033,0.000113768365,0.000060113547,0.0013794946,0.00034715535,0.000032941727,0.0014631039],"genre_scores_gemma":[0.004701571,0.9940027,0.00007879053,0.000019774443,0.000045878518,0.00024207841,0.0007209156,0.000022701985,0.00016558121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988448,0.000056245983,0.00048368445,0.00025313563,0.0002001025,0.00016205317],"domain_scores_gemma":[0.9989346,0.000043549393,0.00040740194,0.00045370386,0.00004836037,0.00011238423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009155945,0.0002843459,0.0015129439,0.00011697845,0.000068275775,0.000012848066,0.00009851975,0.00027250018,0.000017707602],"category_scores_gemma":[0.00004798064,0.0001916967,0.0003773871,0.000059821665,0.00007217287,0.00003733228,0.00002380956,0.00005157139,0.0000017940308],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000084897,0.0013837317,0.00037935268,0.017421203,0.0012000405,0.00013388896,0.000116413044,6.559357e-9,4.5337032e-7,0.000120414785,0.00014721944,0.9790888],"study_design_scores_gemma":[0.0054468364,0.0005005945,0.0016162898,0.012586564,0.013957307,0.0007816045,0.0000072984326,0.0000010654096,0.000051285064,0.000014684342,0.96486384,0.00017264797],"about_ca_topic_score_codex":0.00010233117,"about_ca_topic_score_gemma":0.000016200174,"teacher_disagreement_score":0.97891617,"about_ca_system_score_codex":0.000104359126,"about_ca_system_score_gemma":0.00032454325,"threshold_uncertainty_score":0.78171647},"labels":[],"label_agreement":null},{"id":"W2606563895","doi":"10.1111/bjh.14667","title":"Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Health Sciences North; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Dalhousie University","funders":"National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Internal medicine; Lymphoma; Rituximab; Follicular lymphoma; Oncology; Surgery","score_opus":0.009923570703720143,"score_gpt":0.24021416140833168,"score_spread":0.23029059070461155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606563895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714696,0.0017191574,0.000006449192,0.00021336209,0.00019477015,0.00041510304,0.000010489415,0.000008952435,0.00028472324],"genre_scores_gemma":[0.9990793,0.00027562512,0.00021663657,0.00010508493,0.000019722978,0.000015137981,0.000011685733,0.000022987322,0.00025380618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868417,0.000059775146,0.0005404734,0.00021085338,0.00021788215,0.00028682686],"domain_scores_gemma":[0.99886376,0.00006108246,0.00057670823,0.00019450196,0.00014831245,0.00015566648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017016302,0.00018542263,0.0009402813,0.0001658929,0.00022468025,0.000100168436,0.000107133026,0.00011796305,0.000021795111],"category_scores_gemma":[0.000041064268,0.00015504999,0.00013069824,0.00006373678,0.0000882761,0.00024097208,0.00004803853,0.00011234543,0.0000021700148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030915986,0.00082338013,0.93456584,0.00012356287,0.00022518462,0.041691925,0.0001557049,3.4961113e-7,0.000010283476,0.000001384865,0.00031311726,0.02178012],"study_design_scores_gemma":[0.024914559,0.0011175759,0.9378808,0.0012119068,0.00032572958,0.033742875,0.000037212765,0.0000027010287,0.00059908826,0.0000044819867,0.000034640467,0.00012839041],"about_ca_topic_score_codex":0.00030158603,"about_ca_topic_score_gemma":0.00063111103,"teacher_disagreement_score":0.024605399,"about_ca_system_score_codex":0.00021107798,"about_ca_system_score_gemma":0.0002554806,"threshold_uncertainty_score":0.63227546},"labels":[],"label_agreement":null},{"id":"W2606755458","doi":"10.3324/haematol.2017.165415","title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genentech; Celgene; Teva Pharmaceutical Industries; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Tissue microarray; Medicine; Rituximab; BCL6; Oncology; Internal medicine; Biomarker; CD163; Diffuse large B-cell lymphoma; Pathology; Cancer research; Immunology; Immunohistochemistry; Biology; Germinal center; B cell","score_opus":0.02448926550737075,"score_gpt":0.2778355668725093,"score_spread":0.2533463013651386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606755458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335223,0.0035253062,0.000002633741,0.0007317286,0.000025933196,0.0017904156,0.000019447802,0.000020115327,0.000532187],"genre_scores_gemma":[0.99907804,0.00034762322,0.00014067556,0.00006655191,0.000004464593,0.00028031095,0.0000074741342,0.000015927864,0.00005891509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850196,0.00011020094,0.00044456046,0.00040886065,0.00027439577,0.00026004098],"domain_scores_gemma":[0.99826723,0.0004300725,0.0004197976,0.00069780514,0.000089107736,0.000095955445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002734663,0.00025422487,0.0008923719,0.000064650245,0.00016516424,0.000032436954,0.00016264718,0.00009533029,0.000017313841],"category_scores_gemma":[0.00040713805,0.00013510171,0.00005546941,0.00011901489,0.0007360255,0.00006950205,0.0001401292,0.00003457051,0.0000015381878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097592693,0.0035192454,0.98694986,0.00020122371,0.00032054223,0.0011178654,0.0004123939,2.0090107e-7,0.0006396467,0.00025991624,0.0003434293,0.0052597565],"study_design_scores_gemma":[0.01632892,0.0028015315,0.9737068,0.00044726502,0.00035580588,0.000754396,0.0005406407,0.0001151252,0.004544437,0.00012598066,0.00012353569,0.00015556545],"about_ca_topic_score_codex":0.00038949764,"about_ca_topic_score_gemma":0.0000917145,"teacher_disagreement_score":0.015352992,"about_ca_system_score_codex":0.000041527834,"about_ca_system_score_gemma":0.00008100183,"threshold_uncertainty_score":0.5509288},"labels":[],"label_agreement":null},{"id":"W2607545593","doi":"10.1182/blood.v128.22.4677.4677","title":"Tandem Autologous Followed By Nonmyeloablative Allogeneic Transplantation in Relapsed High Risk Follicular Lymphoma Leads to Excellent Long Term Progression-Free Survival after 8 Years of Follow-up","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Oncology; Follicular lymphoma; Transplantation; Chemotherapy; Surgery; Lymphoma","score_opus":0.007555878386590273,"score_gpt":0.24148124231136223,"score_spread":0.23392536392477195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607545593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969427,0.00095824554,0.00008275957,0.00037160542,0.00022477539,0.0010542976,0.00018310263,0.000051188745,0.00013135244],"genre_scores_gemma":[0.9980876,0.00053830026,0.000529878,0.00005514335,0.000044090204,0.00041095936,0.000058496124,0.00004057895,0.00023494764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997962,0.00014751547,0.0004872601,0.00050377706,0.00050889875,0.00039052477],"domain_scores_gemma":[0.99885434,0.00021291296,0.00017835465,0.000494024,0.00006707672,0.00019327896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002360638,0.00027221095,0.00057336537,0.00016499565,0.00003982948,0.000010245393,0.00015170412,0.00019731517,0.00006547426],"category_scores_gemma":[0.00010077588,0.00018914774,0.00021241205,0.0002369557,0.000062268584,0.0000585763,0.000048552723,0.000049536156,0.0000344379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011287909,0.002321359,0.94591546,0.000049048176,0.00038560148,0.001195152,0.00064305984,9.377645e-7,0.014930537,0.000018097218,0.00010104036,0.03331091],"study_design_scores_gemma":[0.03881094,0.0010252483,0.8770387,0.0006015911,0.00075946853,0.000032933996,0.000019590907,8.804302e-7,0.08141179,0.00004162674,0.000047407244,0.00020982565],"about_ca_topic_score_codex":0.00019286628,"about_ca_topic_score_gemma":0.00038800796,"teacher_disagreement_score":0.068876766,"about_ca_system_score_codex":0.00017799204,"about_ca_system_score_gemma":0.000120592544,"threshold_uncertainty_score":0.7713221},"labels":[],"label_agreement":null},{"id":"W2607884045","doi":"10.1111/ijlh.12678","title":"Ten‐color 15‐antibody flow cytometry panel for immunophenotyping of lymphocyte population","year":2017,"lang":"en","type":"article","venue":"International Journal of Laboratory Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Immunophenotyping; Population; Medicine; Lymphocyte; Pathology; CD8; Immunology; Flow cytometry; Antigen","score_opus":0.027213921945260938,"score_gpt":0.35888065886950415,"score_spread":0.3316667369242432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607884045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379766,0.0016163053,0.00089479436,0.001541631,0.0017353981,0.00018685279,0.00008162892,0.000008458571,0.00013729878],"genre_scores_gemma":[0.9934153,0.00018639954,0.005774479,0.0002276582,0.00030824068,0.00001041935,0.00003779033,0.000016610296,0.000023098564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998659,0.00003296345,0.0006852579,0.00013463972,0.0003412613,0.00014688657],"domain_scores_gemma":[0.9966955,0.0001801957,0.0012514354,0.0002537986,0.0015360647,0.000083007275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002982413,0.00013172023,0.00053396623,0.00028539627,0.00009860441,0.00003667335,0.00032340188,0.00011860404,0.000055202203],"category_scores_gemma":[0.00072535354,0.000105263556,0.0001962501,0.000053641437,0.000084014435,0.0002409233,0.000055353612,0.00007560117,0.0000075783005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026845792,0.0010468721,0.9449062,0.00016768696,0.0022366957,0.0007539526,0.00018843192,0.00004763228,0.02691268,0.008665469,0.0006440176,0.011745789],"study_design_scores_gemma":[0.013644029,0.00079914706,0.9069881,0.0007628576,0.0004167771,0.0019077084,0.00013896455,0.000760282,0.069729,0.00097418507,0.0036876805,0.00019128593],"about_ca_topic_score_codex":0.000032299256,"about_ca_topic_score_gemma":0.000005643084,"teacher_disagreement_score":0.04281632,"about_ca_system_score_codex":0.00025887744,"about_ca_system_score_gemma":0.00033810345,"threshold_uncertainty_score":0.42925233},"labels":[],"label_agreement":null},{"id":"W2609208895","doi":"10.1182/blood.v128.22.2939.2939","title":"Revealing the Tumor Ecosystem in Follicular Lymphoma By Mass Cytometry","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mass cytometry; Biology; Immune system; Follicular lymphoma; Population; Somatic evolution in cancer; Immunology; Lymphoma; Cancer research; Phenotype; Cancer; Genetics; Medicine; Gene","score_opus":0.007744966061271533,"score_gpt":0.22605863332457604,"score_spread":0.2183136672633045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609208895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410886,0.0022106764,0.000044973032,0.001879277,0.00007425159,0.0003625988,0.000035680758,0.000039847724,0.0012438138],"genre_scores_gemma":[0.9987709,0.00012065243,0.00013793385,0.00037725488,0.00010224519,0.000120605044,0.0000056644753,0.000019064304,0.00034571023],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990225,0.000051074632,0.00023114137,0.0002303646,0.00021569735,0.0002492609],"domain_scores_gemma":[0.9993203,0.00014610408,0.00006371912,0.00035649913,0.000025712341,0.00008766063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020795915,0.00013181727,0.00024510408,0.00006534153,0.00004553392,0.000015545704,0.000091444876,0.00004728337,0.000045601595],"category_scores_gemma":[0.000069191316,0.000060635513,0.000098276665,0.00019517977,0.000016567543,0.000037556732,0.00002535273,0.000022919869,0.0001462978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066643835,0.0023966741,0.9146761,0.00010238448,0.0004107871,0.0014126142,0.00010659093,1.9234072e-7,0.06414632,0.00037156825,0.004381022,0.011929139],"study_design_scores_gemma":[0.048601948,0.00059828744,0.3794021,0.0017927883,0.00077508244,0.000901059,0.00024721885,0.000021414176,0.5171853,0.00016774543,0.049863916,0.0004431542],"about_ca_topic_score_codex":0.00005468758,"about_ca_topic_score_gemma":0.000014752854,"teacher_disagreement_score":0.53527397,"about_ca_system_score_codex":0.00015359228,"about_ca_system_score_gemma":0.0000572574,"threshold_uncertainty_score":0.24726444},"labels":[],"label_agreement":null},{"id":"W2610140576","doi":"10.1182/blood.v128.22.3037.3037","title":"Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Lymphoma; Biology; Cancer research; BCL6; Prednisone; CHOP; Rituximab; Oncology; Cyclophosphamide; Medicine; B cell; Internal medicine; Immunology; Genetics; Chemotherapy; Germinal center","score_opus":0.0359742485564188,"score_gpt":0.29630831159421195,"score_spread":0.26033406303779316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610140576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764997,0.0015630367,0.00009138797,0.00008872286,0.00013175882,0.00034458653,0.000034286415,0.000027144166,0.000069109534],"genre_scores_gemma":[0.99805075,0.0010133996,0.00068140106,0.00003136839,0.00007927874,0.000046904228,0.000009334804,0.00002684604,0.000060746628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979942,0.000123739,0.00082404626,0.00035629058,0.00039694304,0.00030479676],"domain_scores_gemma":[0.99858063,0.00055818615,0.00033458447,0.00036178262,0.000057715508,0.0001070909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015686596,0.00025613012,0.0009014467,0.00013021228,0.000037876103,0.000009824346,0.00013441281,0.000115400566,0.000044170978],"category_scores_gemma":[0.000081443904,0.00012443223,0.0002683112,0.00012971288,0.00007417494,0.00009666922,0.00006322427,0.00004255121,0.0000015829396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055471103,0.026397124,0.91761327,0.000063653206,0.00017367295,0.00007245511,0.000082828185,3.415943e-8,0.05254543,0.000034984412,0.000006471157,0.00245537],"study_design_scores_gemma":[0.064972915,0.0011978784,0.68871754,0.00047818598,0.00016435354,0.00000436183,0.000057256104,0.0000018995281,0.24422932,0.000021524176,0.00003723382,0.00011755147],"about_ca_topic_score_codex":0.00005645784,"about_ca_topic_score_gemma":0.000027141245,"teacher_disagreement_score":0.22889575,"about_ca_system_score_codex":0.00002511611,"about_ca_system_score_gemma":0.000094056246,"threshold_uncertainty_score":0.5074199},"labels":[],"label_agreement":null},{"id":"W2610540653","doi":"10.1182/blood-2016-11-750174","title":"Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Follicular lymphoma; Lymphoma; Leukopenia; Adverse effect; Gastroenterology; Mantle cell lymphoma; Febrile neutropenia; Oncology; Chemotherapy","score_opus":0.005920226534403244,"score_gpt":0.21683525894195574,"score_spread":0.2109150324075525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610540653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659705,0.0000130605995,0.000001143352,0.00009920016,0.000013812803,0.00046047894,0.000011143525,0.000014338453,0.0027897612],"genre_scores_gemma":[0.9990635,0.000007773036,0.0007158456,0.00007111069,0.000029192326,0.000038507194,0.000025239939,0.000022459573,0.00002637678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992556,0.000009373872,0.000156237,0.00020853578,0.00022274793,0.00014749136],"domain_scores_gemma":[0.9992673,0.000011134189,0.00017381736,0.0003434645,0.00013933377,0.00006499435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004465562,0.00012459233,0.00025672177,0.00006381863,0.000068731286,0.000014694731,0.000045184483,0.000050177176,0.000014534375],"category_scores_gemma":[0.000019280265,0.00008080225,0.000030223146,0.00006565125,0.00006149706,0.0001022894,0.000022681581,0.00003107918,0.000010309133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006757202,0.0056528472,0.99095595,0.00003371133,0.00014994026,0.00009830581,0.00028499987,4.5592725e-7,0.00017406263,0.000020743262,0.000099491874,0.0018537799],"study_design_scores_gemma":[0.031498082,0.0026023532,0.94804263,0.0003709575,0.00019414301,0.000012748939,0.000044535387,0.00000476047,0.017081508,0.0000060444095,0.00005029385,0.00009193473],"about_ca_topic_score_codex":0.00022507232,"about_ca_topic_score_gemma":0.0000646964,"teacher_disagreement_score":0.042913303,"about_ca_system_score_codex":0.00006385961,"about_ca_system_score_gemma":0.00010053343,"threshold_uncertainty_score":0.32950202},"labels":[],"label_agreement":null},{"id":"W2610723615","doi":"10.1182/blood.v128.22.5404.5404","title":"Clinical Retrospective Analysis of 42 Patients with Primary Bone Lymphoma Treated at Maisonneuve-Rosemont Hospital","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Retrospective cohort study; Survival analysis; Biopsy; Surgery; Internal medicine","score_opus":0.006701570003698607,"score_gpt":0.23529407517508294,"score_spread":0.22859250517138432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610723615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977193,0.00015674935,0.0000030273814,0.0001882426,0.00004823377,0.00043334436,0.0002126063,0.00004864085,0.0011898463],"genre_scores_gemma":[0.9987785,0.00012064017,0.00030933702,0.000080563805,0.000039018196,0.000040425457,0.00014847684,0.000024373401,0.0004586715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829274,0.000047330486,0.00048601182,0.00048087983,0.00043400456,0.00025905133],"domain_scores_gemma":[0.9986272,0.00013663397,0.0002780562,0.0005266729,0.00023408457,0.00019738027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009738465,0.00022007477,0.0009120998,0.0001694053,0.000049264778,0.000005279188,0.000059682123,0.000119170254,0.0001182694],"category_scores_gemma":[0.00007446604,0.00011599464,0.00038796986,0.00046504274,0.0001427239,0.000060787002,0.000067355504,0.000027496393,0.000032959968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052991015,0.013425436,0.9742693,0.000011701377,0.005916408,0.00015246213,0.00008255011,6.4759014e-8,0.00012536068,0.000024288132,0.00021050006,0.005252051],"study_design_scores_gemma":[0.030877773,0.0038730348,0.952776,0.00010682671,0.009157102,0.000005239725,0.000010008431,0.000001178611,0.00294806,0.000004167393,0.00008593512,0.00015466254],"about_ca_topic_score_codex":0.00006136616,"about_ca_topic_score_gemma":0.00004416753,"teacher_disagreement_score":0.030347863,"about_ca_system_score_codex":0.00038055488,"about_ca_system_score_gemma":0.00007185823,"threshold_uncertainty_score":0.47301242},"labels":[],"label_agreement":null},{"id":"W2610790606","doi":"10.1182/blood.v128.22.4095.4095","title":"Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Burkitt's lymphoma; Medicine; Lymphoma; Oncology; Chromosomal translocation; Gene expression profiling; SNP; Gene; Cancer research; Internal medicine; Biology; Single-nucleotide polymorphism; Genetics; Genotype; Gene expression","score_opus":0.010270463955659939,"score_gpt":0.22857775645666878,"score_spread":0.21830729250100883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610790606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473715,0.0036332628,0.00007347253,0.0006439659,0.00012576941,0.00035517258,0.000080872276,0.00003623004,0.0003141358],"genre_scores_gemma":[0.99825925,0.00038529903,0.00019990059,0.00042517149,0.00011586649,0.000057675163,0.00003947767,0.000024172838,0.0004931954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985972,0.00009578748,0.00037917157,0.0003275086,0.00033778453,0.00026255433],"domain_scores_gemma":[0.998743,0.00021612483,0.0002105896,0.00047604518,0.00025868314,0.000095538024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079542784,0.0002120145,0.00050297193,0.0001715706,0.00010746318,0.000026560318,0.0001545692,0.000082005645,0.00047395704],"category_scores_gemma":[0.000022389411,0.000107895416,0.00048538888,0.00033202392,0.00011940864,0.00004720823,0.000056917706,0.000031238902,0.00014991093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021085108,0.0025567792,0.032859176,0.000047820227,0.0077273287,0.00008385434,0.0006897349,0.000020233556,0.94817054,0.00020356843,0.00011571905,0.0073144217],"study_design_scores_gemma":[0.009689834,0.0004053436,0.06828925,0.00008551597,0.007928685,0.000029286883,0.00055622077,0.000043012817,0.91117936,0.00016507406,0.0014453093,0.00018309122],"about_ca_topic_score_codex":0.00023341567,"about_ca_topic_score_gemma":0.000007138204,"teacher_disagreement_score":0.03699114,"about_ca_system_score_codex":0.00006859305,"about_ca_system_score_gemma":0.00012853295,"threshold_uncertainty_score":0.51894975},"labels":[],"label_agreement":null},{"id":"W2610809040","doi":"10.24953/turkjped.2016.03.003","title":"Serum IL-13 levels at diagnosis and remission in children with malignant lymphoma","year":2016,"lang":"en","type":"article","venue":"The Turkish Journal of Pediatrics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Gastroenterology; Lymphoma; Internal medicine; Histology; Pathogenesis; Complete remission; Chemotherapy","score_opus":0.014607742726269177,"score_gpt":0.23938189430620724,"score_spread":0.22477415157993808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610809040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060696,0.0042167474,0.000007632526,0.0046913424,0.00008439148,0.0002480633,0.00003819387,0.000008298767,0.00009838734],"genre_scores_gemma":[0.987834,0.01104507,0.00018257552,0.00024794473,0.0004485708,0.000008698336,0.0000012152113,0.000020948917,0.00021099507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986754,0.00006665212,0.00039755527,0.00016538263,0.000436443,0.0002585757],"domain_scores_gemma":[0.99883217,0.00028355583,0.00033420188,0.00021259823,0.000116975636,0.00022047567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000423193,0.00018134323,0.00035713645,0.00015959318,0.00008262396,0.00002136801,0.00012482001,0.00007989081,0.00006583087],"category_scores_gemma":[0.00012729154,0.00007209519,0.00008708204,0.00022489998,0.00006902566,0.00011846582,0.00007975209,0.00007396101,0.000010625456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022471338,0.00027159386,0.9483634,0.00001483736,0.00006239933,0.00023854799,0.00015365856,0.0000016099945,0.000104807215,0.000012827174,0.002595495,0.047956087],"study_design_scores_gemma":[0.0073350756,0.00071301643,0.98402184,0.00023801153,0.00042808862,0.0028843991,0.000038282473,0.0000011462549,0.0030724125,0.00009215692,0.0010604815,0.00011507986],"about_ca_topic_score_codex":0.000034091583,"about_ca_topic_score_gemma":0.000014082015,"teacher_disagreement_score":0.047841005,"about_ca_system_score_codex":0.00032791795,"about_ca_system_score_gemma":0.00016436196,"threshold_uncertainty_score":0.29399565},"labels":[],"label_agreement":null},{"id":"W2611251974","doi":"10.1111/bjh.14702","title":"Physical activity, obesity and survival in diffuse large B‐cell and follicular lymphoma cases","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Jubilee Hospital; Public Health Ontario; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Health and Medical Research Council; Canadian Institutes of Health Research; Killam Trusts; Michael Smith Health Research BC","keywords":"Follicular lymphoma; Medicine; Lymphoma; Hazard ratio; Internal medicine; Diffuse large B-cell lymphoma; Body mass index; Confidence interval; International Prognostic Index; Non-Hodgkin's lymphoma; Oncology; Obesity; Proportional hazards model; Gastroenterology","score_opus":0.01669004799159555,"score_gpt":0.28590569905521374,"score_spread":0.26921565106361817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611251974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961283,0.0028662987,0.0000051542547,0.0005671787,0.000102778366,0.000109930676,0.000011659515,0.0000042305423,0.0002044205],"genre_scores_gemma":[0.99828094,0.00148363,0.00006872086,0.000049221402,0.00007147152,0.0000033874576,9.789752e-7,0.000009883656,0.00003178938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923164,0.00007869926,0.00017674494,0.00015885991,0.00014279044,0.00021128406],"domain_scores_gemma":[0.99925095,0.00015327733,0.00023043905,0.00014987093,0.000056113575,0.00015933171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001630282,0.000110792505,0.00069757993,0.000057591064,0.00016029846,0.00007623051,0.000072033225,0.00007995187,0.0000050784033],"category_scores_gemma":[0.00019390066,0.00010290129,0.000088490815,0.000020058515,0.00014070935,0.00015687819,0.00010755016,0.00009407246,0.000001806298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015789807,0.0089732045,0.7093137,0.00010302004,0.00009416156,0.2585207,0.00012890667,3.7307665e-8,0.00016133353,0.00022796071,0.00018469073,0.02213442],"study_design_scores_gemma":[0.015688777,0.00026969722,0.77507657,0.00021420828,0.00011845535,0.2064664,0.00005035828,0.000026418862,0.0016524825,0.00015050973,0.00021083473,0.00007531106],"about_ca_topic_score_codex":0.0005937216,"about_ca_topic_score_gemma":0.0006354333,"teacher_disagreement_score":0.06576288,"about_ca_system_score_codex":0.000051466304,"about_ca_system_score_gemma":0.000085563915,"threshold_uncertainty_score":0.4196193},"labels":[],"label_agreement":null},{"id":"W2611645469","doi":"10.1016/s2352-3026(17)30078-9","title":"Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"European Commission; F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Follicular lymphoma; Vincristine; Internal medicine; Prednisone; International Prognostic Index; Clinical endpoint; Surgery; Cyclophosphamide; Lymphoma; Oncology; Chemotherapy; Randomized controlled trial","score_opus":0.09747788966554995,"score_gpt":0.3848782168562778,"score_spread":0.2874003271907279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611645469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584074,0.0027343002,0.00007051475,0.0043284097,0.00037871918,0.005907883,0.00019739932,0.000023887822,0.0005181235],"genre_scores_gemma":[0.99534345,0.0027794803,0.00080248486,0.00006072934,0.00022968506,0.0006169652,0.00006754973,0.000029732766,0.00006990601],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982826,0.000104715014,0.0006384521,0.00039771592,0.00016119394,0.00041533133],"domain_scores_gemma":[0.996672,0.001267988,0.000607769,0.0012240678,0.00011149777,0.00011669394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030330417,0.00031025155,0.0028521772,0.000053627136,0.00036677756,0.000038955975,0.00041631013,0.00015417078,0.000028701577],"category_scores_gemma":[0.0004015086,0.00019115675,0.00017527299,0.000046636378,0.00046942427,0.000054332955,0.0001426173,0.000039472725,0.0000076116285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9021352,0.023858728,0.00017677358,0.00027773442,0.0014056563,0.0011020876,0.0005365448,0.0000015016478,0.000101488215,0.0035326749,0.00017836875,0.06669322],"study_design_scores_gemma":[0.96017516,0.024649078,0.00031515077,0.00014569193,0.0018767794,0.0017069663,0.00003092737,0.00018111493,0.0051067844,0.00033819367,0.0053130314,0.00016114365],"about_ca_topic_score_codex":0.00039012326,"about_ca_topic_score_gemma":0.00015617507,"teacher_disagreement_score":0.066532075,"about_ca_system_score_codex":0.00015648079,"about_ca_system_score_gemma":0.00021796825,"threshold_uncertainty_score":0.7795146},"labels":[],"label_agreement":null},{"id":"W2612248406","doi":"10.1182/blood.v128.22.2923.2923","title":"Chromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; Oncology; Internal medicine; Chlorambucil; Blockade; Polysomy; Cohort; Autologous stem-cell transplantation; Reed–Sternberg cell; PD-L1; Transplantation; Lymphoma; Cancer research; Chemotherapy; CD30; Receptor; Cyclophosphamide; Hodgkin lymphoma; Cancer; Biology; Immunotherapy; Chromosome","score_opus":0.007392563174687249,"score_gpt":0.2152760438936839,"score_spread":0.20788348071899665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612248406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702096,0.00028974292,0.0000050524154,0.0009419527,0.000029857805,0.0011839523,0.00011953197,0.000087230044,0.00032172902],"genre_scores_gemma":[0.99767864,0.0001977312,0.00058116275,0.0000905561,0.00006727139,0.00038439,0.00009265094,0.000055145818,0.0008524655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979694,0.00008135927,0.00038149042,0.000716588,0.0003938252,0.0004573309],"domain_scores_gemma":[0.9987591,0.00018109215,0.0001406124,0.0004804905,0.00008591006,0.0003527972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004601869,0.0004959574,0.00073813787,0.00019006354,0.0001686476,0.00006389124,0.00006290964,0.00015709428,0.000055435838],"category_scores_gemma":[0.000027390428,0.00024246055,0.000072190756,0.0001786714,0.00017589149,0.00019451504,0.00005495067,0.000051039082,0.000017134415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010668639,0.009352494,0.97805053,0.000023676392,0.00042571532,0.00026668265,0.00030332344,4.227452e-7,0.0011151704,0.000023559809,0.000058518395,0.009313049],"study_design_scores_gemma":[0.07625623,0.006179668,0.89940286,0.0005935902,0.00066255406,0.00008399249,0.000044087574,0.000010306922,0.016041376,0.000008525458,0.0004039793,0.00031285398],"about_ca_topic_score_codex":0.00021529011,"about_ca_topic_score_gemma":0.00025978766,"teacher_disagreement_score":0.07864769,"about_ca_system_score_codex":0.00033152234,"about_ca_system_score_gemma":0.00014265842,"threshold_uncertainty_score":0.9887254},"labels":[],"label_agreement":null},{"id":"W2612422239","doi":"10.1182/blood-2016-12-758383","title":"Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; H. Lundbeck A/S; Università di Bologna; Argenx; PharmaMar; Celgene; Gilead Sciences; Servier; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Tolerability; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Adverse effect; Immunotherapy; Cancer; Biology","score_opus":0.005873927897826031,"score_gpt":0.21331301627289417,"score_spread":0.20743908837506814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612422239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310565,0.0003329341,0.0000011265092,0.00008757032,0.00003996507,0.00037627982,0.000052304753,0.000011834611,0.0059923353],"genre_scores_gemma":[0.99945706,0.00008261595,0.00023569047,0.000068920584,0.000026706695,0.000016201431,0.000043748747,0.000013911068,0.0000551694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989367,0.000030140136,0.00027578737,0.00027543693,0.00026954128,0.00021237963],"domain_scores_gemma":[0.9989874,0.00006738338,0.00020330495,0.00054403086,0.0000766527,0.00012125574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013374243,0.00015072255,0.0004141926,0.00004808776,0.00009631822,0.000012760184,0.00008362253,0.00007555925,0.00002384549],"category_scores_gemma":[0.000073980984,0.00010761395,0.000044595978,0.000032172164,0.00011263005,0.000106268984,0.00008265297,0.00005541027,0.000004026865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001632539,0.018163718,0.9738851,0.00015420726,0.000058641814,0.00006120398,0.00015260406,6.6140785e-8,0.00003129147,0.000023610133,0.000019903815,0.005817072],"study_design_scores_gemma":[0.095067486,0.0012085857,0.90209204,0.00015105237,0.00017969246,0.000009477174,0.000014126906,0.0000020698678,0.00082193484,0.000007975352,0.00035256424,0.000093007046],"about_ca_topic_score_codex":0.000090493515,"about_ca_topic_score_gemma":0.000040346145,"teacher_disagreement_score":0.093434945,"about_ca_system_score_codex":0.000096738535,"about_ca_system_score_gemma":0.00015750235,"threshold_uncertainty_score":0.43883696},"labels":[],"label_agreement":null},{"id":"W2613415121","doi":"","title":"Only focal bone marrow FDG uptake in baseline FDG Pet scan has a diagnostic and prognostic impact in Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"VBN Forskningsportal (Aalborg Universitet)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Winship Cancer Institute; University of Texas MD Anderson Cancer Center; Universitätsklinikum Köln; Humanitas University; Aalborg Universitetshospital; Università di Bologna; Všeobecná Fakultní Nemocnice v Praze; Università degli Studi di Firenze; Barbara Ann Karmanos Cancer Institute; BC Cancer Agency; Bristol-Myers Squibb; Brigham and Women's Hospital; Emory University; University of Toronto; Aalborg Universitet; University of California, Los Angeles; Memorial Sloan-Kettering Cancer Center; Univerzita Karlova v Praze","keywords":"Medicine; Lymphoma; Bone marrow; Baseline (sea); Nuclear medicine; Hodgkin lymphoma; Positron emission tomography; Radiology; Oncology; Pathology; Biology","score_opus":0.01058146377825529,"score_gpt":0.23124700448045557,"score_spread":0.2206655407022003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613415121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479777,0.0007875306,0.000028418692,0.0017414765,0.00009054646,0.0009334721,0.00012504695,0.00009640626,0.0013993114],"genre_scores_gemma":[0.9978988,0.0003725026,0.00037245092,0.00020503862,0.00008412686,0.000027267199,0.00015718257,0.000053468302,0.000829144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728274,0.00007460981,0.0005803535,0.0007875313,0.0004418147,0.00083296857],"domain_scores_gemma":[0.9979396,0.000769317,0.00021814047,0.00041754884,0.00010251952,0.0005528996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037545714,0.00052083767,0.00080086244,0.00082051056,0.00011665218,0.000050609473,0.00015102646,0.00017600002,0.00044841028],"category_scores_gemma":[0.0006988064,0.00038490747,0.00022424568,0.00076568156,0.00028061194,0.00039996553,0.00010461293,0.00013932091,0.000070885515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006665324,0.0011508875,0.9301045,0.0000557431,0.000120623336,0.01443259,0.00041426814,0.000005598666,0.0003028049,0.00039736615,0.0013824145,0.050966665],"study_design_scores_gemma":[0.015537152,0.0012059299,0.97581583,0.0012626838,0.00025997512,0.0010761209,0.0005035521,0.00024311998,0.00026275634,0.000089514215,0.0032851282,0.00045826263],"about_ca_topic_score_codex":0.0029108804,"about_ca_topic_score_gemma":0.002691906,"teacher_disagreement_score":0.050508402,"about_ca_system_score_codex":0.0011056758,"about_ca_system_score_gemma":0.0007555392,"threshold_uncertainty_score":0.9998603},"labels":[],"label_agreement":null},{"id":"W2614736655","doi":"10.1080/10428194.2017.1307980","title":"Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia","funders":"","keywords":"Bleomycin; Medicine; ABVD; Dacarbazine; Vinblastine; Internal medicine; Pulmonary toxicity; Lymphoma; Oncology; Discontinuation; Incidence (geometry); Gastroenterology; Chemotherapy; Toxicity; Hodgkin's lymphoma; Surgery; Cyclophosphamide; Vincristine","score_opus":0.013137404206686028,"score_gpt":0.25038566945046503,"score_spread":0.237248265243779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614736655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001336,0.000530924,0.00001706863,0.0008075326,0.0005654151,0.0018122866,0.0003082539,0.00018964913,0.0057555176],"genre_scores_gemma":[0.99520785,0.00036690402,0.00045404563,0.0015836495,0.0003380591,0.00029628846,0.00014830037,0.00015775191,0.0014471654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943092,0.00021760639,0.0012684972,0.0014726921,0.0014570844,0.0012749064],"domain_scores_gemma":[0.9939283,0.00060567295,0.0012761699,0.002989197,0.0004936236,0.0007069943],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006023361,0.001228918,0.0018188558,0.0002864352,0.0015480377,0.00031564885,0.0010446924,0.00057406846,0.00010370267],"category_scores_gemma":[0.0003741611,0.00068936247,0.00061612314,0.00031399605,0.0013758272,0.00068126875,0.00060914,0.00014215759,0.000074228505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033046165,0.0013185554,0.82379216,0.000376054,0.00076826726,0.0006478634,0.00036658018,0.000010006423,0.00075945037,0.00063305674,0.000582299,0.1674411],"study_design_scores_gemma":[0.03133758,0.0008761716,0.93722993,0.00047431167,0.0010723693,0.0003718191,0.00026203008,0.00047636937,0.021876223,0.00010378387,0.0050594797,0.00085993606],"about_ca_topic_score_codex":0.004552304,"about_ca_topic_score_gemma":0.00034815373,"teacher_disagreement_score":0.16658115,"about_ca_system_score_codex":0.004954665,"about_ca_system_score_gemma":0.0020175858,"threshold_uncertainty_score":0.9997518},"labels":[],"label_agreement":null},{"id":"W2616989782","doi":"10.3109/10428194.2010.532893","title":"Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop","year":2010,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Penn State Hershey Cancer Institute; National Institutes of Health; University of Rochester; Moffitt Cancer Center; University of Virginia; Lymphoma Research Foundation","keywords":"Mantle cell lymphoma; Cyclin D1; Lymphoma; Medicine; Cancer research; Epigenetics; Bioinformatics; Biology; Cell cycle; Immunology; Internal medicine; Cancer; Gene; Genetics","score_opus":0.020294859893623795,"score_gpt":0.27303801513273673,"score_spread":0.25274315523911295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616989782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09156496,0.87159324,0.000012598229,0.00019428605,0.0046211635,0.0047076284,0.00061022677,0.00045488414,0.026240997],"genre_scores_gemma":[0.03299253,0.92293936,0.000861406,0.0008198805,0.0014782371,0.0012697908,0.0011053638,0.00084687734,0.037686534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847492,0.00067295966,0.0051485584,0.0039808284,0.0025449435,0.002903523],"domain_scores_gemma":[0.9849392,0.001628568,0.004587222,0.006444991,0.00066570623,0.0017342747],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012477173,0.0039328425,0.008316012,0.0010636536,0.0012178774,0.00041728164,0.0022517713,0.0044435314,0.00036744654],"category_scores_gemma":[0.00039944713,0.0028036288,0.0042936695,0.0021617995,0.0019099906,0.00046536984,0.001715682,0.00067308155,0.00065998046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00037142288,0.0040412648,0.0011975821,0.016208421,0.0012540485,0.0068891556,0.0004185211,0.0000024555789,0.00014205254,0.00029590807,0.030792495,0.9383867],"study_design_scores_gemma":[0.02905933,0.00038630064,0.005822372,0.010504355,0.009138064,0.023069838,0.00029404365,0.00008610777,0.003888467,0.00009496651,0.9150153,0.0026408455],"about_ca_topic_score_codex":0.002535698,"about_ca_topic_score_gemma":0.00018543168,"teacher_disagreement_score":0.93574584,"about_ca_system_score_codex":0.012983079,"about_ca_system_score_gemma":0.022756983,"threshold_uncertainty_score":0.997441},"labels":[],"label_agreement":null},{"id":"W2619344667","doi":"10.1002/path.4920","title":"Angioimmunoblastic T‐cell lymphoma: more than a disease of T follicular helper cells","year":2017,"lang":"en","type":"letter","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Leukemia and Lymphoma Society","keywords":"Angioimmunoblastic T-cell lymphoma; Lymphoma; CD20; Cancer research; Biology; Pathology; Follicular dendritic cells; Mutation; Haematopoiesis; T cell; Immunology; Medicine; Stem cell; Antigen-presenting cell; Genetics; Immune system; Gene","score_opus":0.01359494219806796,"score_gpt":0.25539954607315063,"score_spread":0.24180460387508268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619344667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7518608,0.019501314,0.000040891464,0.22610608,0.001331376,0.00051779667,0.00013413244,0.00001114998,0.00049643725],"genre_scores_gemma":[0.9189711,0.0022411703,0.00021857808,0.072931804,0.0028073413,0.000016583912,0.000052884046,0.00009184408,0.0026686494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801356,0.00027602998,0.00065851747,0.00018881877,0.0005039915,0.00035908783],"domain_scores_gemma":[0.9967861,0.0003004213,0.0014749009,0.0010236347,0.000275792,0.0001391555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038725475,0.00035807473,0.0010965535,0.00020666471,0.000107304004,0.000015778332,0.0005255603,0.00040058492,0.000073754556],"category_scores_gemma":[0.000096298645,0.00019396463,0.0007861921,0.000052453837,0.00037117174,0.000047016263,0.000113182636,0.0004896746,0.00004932083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013152111,0.0020195802,0.0044838293,0.0007706834,0.0013714792,0.16458105,0.0011079347,0.000021048105,0.008759634,0.0000062430117,0.81431293,0.0012503618],"study_design_scores_gemma":[0.04346941,0.008317213,0.2566349,0.0051599653,0.038395103,0.055047184,0.00044320436,0.00005379161,0.036117934,0.0008369391,0.5540802,0.0014441622],"about_ca_topic_score_codex":0.000031252614,"about_ca_topic_score_gemma":8.3397975e-7,"teacher_disagreement_score":0.26023275,"about_ca_system_score_codex":0.00015666819,"about_ca_system_score_gemma":0.00047885423,"threshold_uncertainty_score":0.79096484},"labels":[],"label_agreement":null},{"id":"W2619591234","doi":"10.1093/annonc/mdx274","title":"Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Les Laboratories Pierre Fabre","keywords":"Busulfan; Medicine; Fludarabine; Internal medicine; Univariate analysis; Cumulative incidence; Gastroenterology; Lymphoma; Surgery; Transplantation; Hematopoietic stem cell transplantation; Chemotherapy; Multivariate analysis; Cyclophosphamide","score_opus":0.04443666498109376,"score_gpt":0.3786825139286443,"score_spread":0.33424584894755055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619591234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898624,0.000034498968,0.00004954287,0.005180319,0.00045752907,0.0019288122,0.00023124464,0.000030616433,0.002225047],"genre_scores_gemma":[0.9970357,0.000031924097,0.0006032091,0.0016770979,0.00011244683,0.00038859752,0.000066094966,0.000038872993,0.000046049838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978118,0.00029132163,0.00052252715,0.0004994099,0.00034217158,0.00053277146],"domain_scores_gemma":[0.9960117,0.0006055746,0.0010289958,0.0008131619,0.0013606651,0.00017989932],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007121932,0.00032195164,0.0009770651,0.00011776133,0.00048664768,0.000016577396,0.00030478375,0.00029580572,0.000020234856],"category_scores_gemma":[0.0017145211,0.00025170724,0.00043718345,0.00016081496,0.00046137624,0.00007975885,0.000100592784,0.00018498866,0.000003010715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033053864,0.035160948,0.8397474,0.00016881463,0.0039653257,0.00020783336,0.015420658,0.00022367584,0.03939454,0.00052389427,0.017620938,0.014512098],"study_design_scores_gemma":[0.02323496,0.014561839,0.75160867,0.0002225575,0.00033526824,0.0000055287915,0.0014304837,0.00025734442,0.20783453,0.00029479983,0.000059880833,0.00015413227],"about_ca_topic_score_codex":0.0015826261,"about_ca_topic_score_gemma":0.0003452224,"teacher_disagreement_score":0.16843998,"about_ca_system_score_codex":0.0010313953,"about_ca_system_score_gemma":0.0013742946,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W2620735312","doi":"10.1016/s2352-3026(17)30079-0","title":"Subcutaneous rituximab—a meaningful advance in care","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; CD20; Lymphoma; Internal medicine; Oncology","score_opus":0.031390697028140034,"score_gpt":0.3347144156308049,"score_spread":0.3033237186026649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620735312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95721525,0.002751225,0.0000029988255,0.012494483,0.00021765429,0.00027880073,0.0000071071886,0.00004055695,0.026991941],"genre_scores_gemma":[0.9981073,0.00036632866,0.00033563637,0.000819025,0.00013822394,0.00005729479,0.000007977198,0.000012385437,0.00015580523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992081,0.000040118524,0.00015188084,0.00020541236,0.00008156795,0.00031295212],"domain_scores_gemma":[0.99875766,0.000094321134,0.00010354935,0.00096193247,0.0000369916,0.000045542085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007904527,0.00012024893,0.00070237514,0.000028045704,0.00018184181,0.00002211793,0.00026394174,0.000070422444,0.000052024432],"category_scores_gemma":[0.00012927146,0.00007371531,0.000054994118,0.000026916805,0.00015902263,0.000048565686,0.00008579882,0.000118239994,0.00021268181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007563279,0.00042131206,0.9125187,0.0002820607,0.00008589057,0.019564051,0.0035492245,0.0000078734365,0.000083243816,0.04414778,0.0017967945,0.016786786],"study_design_scores_gemma":[0.03400969,0.0010688518,0.8209107,0.0008312914,0.0004208474,0.03393999,0.0016652313,0.00018201067,0.0076654768,0.008839169,0.08983455,0.0006321979],"about_ca_topic_score_codex":0.00022233947,"about_ca_topic_score_gemma":0.0008357824,"teacher_disagreement_score":0.09160796,"about_ca_system_score_codex":0.00010361492,"about_ca_system_score_gemma":0.00006529781,"threshold_uncertainty_score":0.30060232},"labels":[],"label_agreement":null},{"id":"W2621307470","doi":"10.1016/j.carj.2016.08.007","title":"Imaging Intra-abdominal Burkitt's Lymphoma: From Discrete Bowel Wall Thickening to Diffuse Soft Tissue Infiltration","year":2017,"lang":"en","type":"review","venue":"Canadian Association of Radiologists Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Mesentery; Infiltration (HVAC); Pathology; Pancreas; Radiology; Thickening; Soft tissue; Lymphatic system; Internal medicine","score_opus":0.035839153875423094,"score_gpt":0.33243464159121705,"score_spread":0.29659548771579397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621307470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009270474,0.9905571,0.00022370102,0.003972629,0.0013599206,0.0010484123,0.00063465675,0.00003441023,0.001242158],"genre_scores_gemma":[0.012428408,0.98226184,0.0011466517,0.0006438654,0.0016629355,0.000076166216,0.00078729965,0.00007878205,0.00091405713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660397,0.00037152803,0.0012537566,0.0004964657,0.00053946703,0.0007348159],"domain_scores_gemma":[0.99487203,0.00050590443,0.0025083097,0.00055196474,0.00034460158,0.0012171812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010350083,0.0005640063,0.0022942729,0.00063180755,0.00051714963,0.00033925695,0.00045615487,0.0005937685,0.0001222028],"category_scores_gemma":[0.0023652192,0.000456533,0.0006674876,0.00014190916,0.00008975178,0.00023429588,0.000039760664,0.000505926,0.00009183085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025205816,0.000079916455,0.01663248,0.00037906133,0.0010338036,0.00083710667,0.00026871025,0.0000025899892,0.0000027696228,0.00004050787,0.02306376,0.9576341],"study_design_scores_gemma":[0.0022078815,0.00017328591,0.020950658,0.005869448,0.0022316468,0.00072890584,0.00003770953,0.00002203218,0.000005880138,0.000079006444,0.96726376,0.0004297728],"about_ca_topic_score_codex":0.024789505,"about_ca_topic_score_gemma":0.016041076,"teacher_disagreement_score":0.95720434,"about_ca_system_score_codex":0.010166831,"about_ca_system_score_gemma":0.004356259,"threshold_uncertainty_score":0.99978864},"labels":[],"label_agreement":null},{"id":"W2621632916","doi":"10.1002/hon.2437_86","title":"HIGHER MUTATIONAL BURDEN BUT DOES NOT IMPACT TREATMENT EFFICACY IN FOLLICULAR LYMPHOMA","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Proportional hazards model; Oncology; Cohort; Gastroenterology; Lymphoma; Surgery","score_opus":0.052059824726519835,"score_gpt":0.37864398756473805,"score_spread":0.32658416283821823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621632916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800476,0.00026254106,0.0000025943066,0.011155949,0.00023364181,0.0006079748,0.000025209274,0.000057614223,0.0076068696],"genre_scores_gemma":[0.9971181,0.00012569787,0.00061539595,0.00047212193,0.00019922382,0.00028400056,0.000046982117,0.000015176428,0.0011232748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836844,0.000096036085,0.00040148175,0.00047259437,0.00021801294,0.00044342093],"domain_scores_gemma":[0.9984704,0.0004847271,0.00020895661,0.00052537286,0.00005477654,0.00025574403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011548382,0.00028945398,0.0009428262,0.00008459638,0.00019508543,0.000041846073,0.00016067391,0.00034838406,0.00095068064],"category_scores_gemma":[0.00021017394,0.00014526819,0.00033329174,0.000044912194,0.00022648953,0.000068009416,0.00008190924,0.00006659362,0.00032369647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027712414,0.018643212,0.7628121,0.000052581596,0.0010573297,0.04427408,0.00039482626,0.000026192183,0.0019236532,0.015673198,0.00075765303,0.15161394],"study_design_scores_gemma":[0.018144565,0.0025694764,0.956699,0.000043192264,0.00017679684,0.0010760771,0.0000366919,0.000061474915,0.00516777,0.0005148307,0.015327798,0.00018230436],"about_ca_topic_score_codex":0.0008869795,"about_ca_topic_score_gemma":0.000076510565,"teacher_disagreement_score":0.19388692,"about_ca_system_score_codex":0.0012810763,"about_ca_system_score_gemma":0.00030244334,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W2621834912","doi":"10.1002/hon.2439_120","title":"PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Follicular lymphoma; Minimal residual disease; Autologous stem-cell transplantation; Surgery; Bone marrow; Lymphoma","score_opus":0.021357904200114533,"score_gpt":0.3296958586988849,"score_spread":0.3083379544987704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621834912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617493,0.0006451101,0.000013871184,0.0017794464,0.000015849462,0.00080751145,0.000002042393,0.000024829073,0.0005363991],"genre_scores_gemma":[0.99812454,0.00053492194,0.00087806745,0.0002980156,0.000005167125,0.00011335205,0.000019050369,0.000012859988,0.000014047253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988005,0.00015168417,0.00029897483,0.00042484901,0.00011696659,0.00020703179],"domain_scores_gemma":[0.99915004,0.0001801114,0.00018469301,0.00026237805,0.0000618909,0.00016090063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017421752,0.00019229054,0.00072484807,0.000054797878,0.00014603797,0.000033227818,0.000055467015,0.0002590936,0.000008611603],"category_scores_gemma":[0.00012041084,0.00010623083,0.00003292192,0.000040906645,0.00046535843,0.000065603985,0.0000704027,0.000104200175,0.0000014649568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031088179,0.0043490157,0.9537848,0.000025981388,0.00013906951,0.0011162489,0.000058727062,2.4793879e-8,0.0000716094,0.00056100765,0.000015035411,0.036769662],"study_design_scores_gemma":[0.043692872,0.013663871,0.94060934,0.00018862118,0.00013705941,0.0005712864,0.000030932293,0.00006710854,0.0003781633,0.00013177078,0.00040322085,0.0001257378],"about_ca_topic_score_codex":0.00007282849,"about_ca_topic_score_gemma":0.00007338274,"teacher_disagreement_score":0.040584054,"about_ca_system_score_codex":0.00009237292,"about_ca_system_score_gemma":0.00004875035,"threshold_uncertainty_score":0.43319675},"labels":[],"label_agreement":null},{"id":"W2622149297","doi":"10.1002/hon.2437_20","title":"PROGNOSTIC VALUE OF PET‐CT AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR FOLLICULAR LYMPHOMA IN THE PHASE III GALLIUM STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"","keywords":"Medicine; Follicular lymphoma; Bendamustine; Internal medicine; Rituximab; Population; PET-CT; Nuclear medicine; Prospective cohort study; Clinical endpoint; Lymphoma; Oncology; Positron emission tomography; Clinical trial","score_opus":0.03901549088674564,"score_gpt":0.37590643109384436,"score_spread":0.3368909402070987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622149297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028885,0.00079804636,0.00006531995,0.004770704,0.00011343919,0.0034455343,0.000010557139,0.00002167601,0.0004858658],"genre_scores_gemma":[0.9955412,0.00015528765,0.00077393703,0.00077991677,0.000058817554,0.0026174611,0.000018960936,0.000015528634,0.000038897142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998351,0.00013940169,0.0005617936,0.00037917044,0.00021472755,0.00035394836],"domain_scores_gemma":[0.99794436,0.00085978064,0.000296051,0.0007372109,0.0000854814,0.00007710872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050017197,0.0002355859,0.0009894451,0.000057040328,0.00017296066,0.000022982102,0.00031754945,0.0000726652,0.000085506836],"category_scores_gemma":[0.00044526148,0.00012560947,0.00026004013,0.000068379035,0.00022796358,0.000041614454,0.00007673848,0.000078625555,0.000015619162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007630019,0.070365526,0.8865317,0.00020383057,0.00053297466,0.01790508,0.0011196227,0.0000032399507,0.0001278265,0.003128413,0.00056292186,0.011888804],"study_design_scores_gemma":[0.092457235,0.021255156,0.8676814,0.00016905027,0.0006975842,0.0031617638,0.0006980596,0.00038885625,0.0015432974,0.0012442998,0.010443941,0.00025939848],"about_ca_topic_score_codex":0.00009218106,"about_ca_topic_score_gemma":0.000119803946,"teacher_disagreement_score":0.084827214,"about_ca_system_score_codex":0.0001436426,"about_ca_system_score_gemma":0.00013255967,"threshold_uncertainty_score":0.51222056},"labels":[],"label_agreement":null},{"id":"W2622171693","doi":"10.1002/hon.2438_45","title":"END OF TREATMENT <scp>PET‐CT</scp> PREDICTS PROGRESSION‐FREE SURVIVAL IN <scp>DLBCL</scp> AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III <scp>GOYA</scp> STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta","funders":"","keywords":"Medicine; Nuclear medicine; Internal medicine; Clinical endpoint; Rituximab; PET-CT; Diffuse large B-cell lymphoma; Progression-free survival; CHOP; Phases of clinical research; Oncology; Clinical trial; Positron emission tomography; Lymphoma; Overall survival","score_opus":0.05398042620619866,"score_gpt":0.3550490730967307,"score_spread":0.3010686468905321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622171693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97798556,0.0030213762,0.0000054712323,0.0018777924,0.0007087689,0.0050288527,0.0010178869,0.00018349323,0.010170783],"genre_scores_gemma":[0.9919388,0.0018450689,0.00052585546,0.00027625734,0.00044822955,0.003034456,0.00046101306,0.0000770187,0.0013932728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931125,0.0008095013,0.0020081424,0.0017566398,0.00089551165,0.0014176796],"domain_scores_gemma":[0.98158985,0.013136089,0.0013944468,0.002925404,0.00022628794,0.0007279118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008459206,0.0011504089,0.0032415187,0.00021511302,0.0006143211,0.00011274294,0.00095262897,0.00043892354,0.000071713155],"category_scores_gemma":[0.006909384,0.0006193659,0.00065329915,0.00030102133,0.0010269829,0.00019557486,0.0006824121,0.00043037138,0.00014997787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012837647,0.095816374,0.8314591,0.000073490344,0.0020406016,0.040200613,0.006797931,0.000012964581,0.00008768127,0.0003911592,0.0072399443,0.014596401],"study_design_scores_gemma":[0.18817899,0.049899377,0.65056676,0.00054850033,0.002458412,0.0012496808,0.005119022,0.00024436344,0.006524437,0.0008218859,0.09423652,0.00015204785],"about_ca_topic_score_codex":0.0018780611,"about_ca_topic_score_gemma":0.0053953696,"teacher_disagreement_score":0.18689522,"about_ca_system_score_codex":0.00139364,"about_ca_system_score_gemma":0.000679615,"threshold_uncertainty_score":0.99962574},"labels":[],"label_agreement":null},{"id":"W2623105223","doi":"10.1002/hon.2437_46","title":"MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; BC Cancer Agency","funders":"","keywords":"Lymphoma; Gene expression profiling; Medicine; Diffuse large B-cell lymphoma; Molecular diagnostics; Tissue microarray; Cancer research; Pathology; Computational biology; Gene; Gene expression; Immunohistochemistry; Bioinformatics; Biology","score_opus":0.09364401329832947,"score_gpt":0.3877165753220415,"score_spread":0.294072562023712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623105223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835442,0.00037167282,0.0007171084,0.0006487531,0.0001801372,0.00089618494,0.00002373781,0.00006423873,0.013553981],"genre_scores_gemma":[0.9840296,0.00007006279,0.015122197,0.00038464833,0.00010253974,0.00010924888,0.00011598859,0.000022629229,0.000043069143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978889,0.00015333912,0.00061302667,0.0005057991,0.00032795398,0.0005109398],"domain_scores_gemma":[0.9979861,0.00017102093,0.0006590284,0.0007875957,0.00016871655,0.00022754636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032897096,0.00027834068,0.0010296304,0.00010480447,0.00023939044,0.000026494514,0.00027140195,0.00042915813,0.00010385372],"category_scores_gemma":[0.00018901976,0.00020362106,0.00016083887,0.000084581116,0.0002928459,0.00015005014,0.0001716295,0.00011168075,0.00004829957],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043802164,0.06441609,0.188834,0.0014070874,0.0005931652,0.01578212,0.0015193209,0.000015207458,0.6063588,0.060596716,0.0018440018,0.054253254],"study_design_scores_gemma":[0.031480264,0.008697637,0.50595605,0.00022374478,0.0010408785,0.0041691624,0.000625497,0.002894526,0.428228,0.00069294416,0.015292852,0.00069848093],"about_ca_topic_score_codex":0.000060187846,"about_ca_topic_score_gemma":0.0000241677,"teacher_disagreement_score":0.31712204,"about_ca_system_score_codex":0.00040264672,"about_ca_system_score_gemma":0.00055803295,"threshold_uncertainty_score":0.83034265},"labels":[],"label_agreement":null},{"id":"W2623197015","doi":"10.1002/hon.2440","title":"ROBUST: PHASE III RANDOMIZED STUDY OF LENALIDOMIDE/R‐CHOP VS PLACEBO/R‐CHOP IN UNTREATED ABC‐TYPE DIFFUSE LARGE B‐CELL LYMPHOMA AND FEASIBILITY OF CELL OF ORIGIN SUBTYPING","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lenalidomide; Diffuse large B-cell lymphoma; Medicine; CHOP; Internal medicine; Rituximab; Oncology; Clinical endpoint; Lymphoma; Randomized controlled trial; Multiple myeloma","score_opus":0.08100994556227097,"score_gpt":0.37326443969028955,"score_spread":0.29225449412801857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623197015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944189,0.00069551717,0.000014668207,0.0001769452,0.000108165295,0.0029449498,0.000020096968,0.000024806455,0.0015959326],"genre_scores_gemma":[0.99881864,0.0004535753,0.0004352607,0.000052058935,0.000016447953,0.00012540864,0.0000138802325,0.000016882028,0.00006783538],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965403,0.0007194998,0.0014659652,0.00059118116,0.00026738815,0.0004156341],"domain_scores_gemma":[0.99558187,0.0019579842,0.0012426744,0.00077703287,0.00023729689,0.00020311933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259229,0.00034469287,0.0036692757,0.00017590109,0.00010882311,0.000010611107,0.00023137005,0.00038775342,0.00013893719],"category_scores_gemma":[0.0011646568,0.00022810877,0.00023886809,0.00016938151,0.00055324694,0.00007388634,0.00021440553,0.00014393382,0.000005122829],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3137936,0.106566325,0.5724935,0.0005305335,0.00029214885,0.0009827359,0.0013837315,0.000005853209,0.00295915,0.0004781308,0.000074273616,0.00044002893],"study_design_scores_gemma":[0.9008578,0.0058489204,0.07525594,0.00016798616,0.0007426338,0.00009407082,0.000838117,0.0005678742,0.015245178,0.00013641245,0.00005304593,0.00019199563],"about_ca_topic_score_codex":0.0007632412,"about_ca_topic_score_gemma":0.00038378852,"teacher_disagreement_score":0.5870642,"about_ca_system_score_codex":0.00022638807,"about_ca_system_score_gemma":0.0002701665,"threshold_uncertainty_score":0.9302006},"labels":[],"label_agreement":null},{"id":"W2623202484","doi":"10.1002/hon.2437_130","title":"FIRST‐LINE TREATMENT OF INHL OR MCL PATIENTS WITH BR OR R‐CHOP/R‐CVP: RESULTS OF THE BRIGHT 5‐YEAR FOLLOW‐UP STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Prednisone; CHOP; Internal medicine; Hazard ratio; Gastroenterology; Mantle cell lymphoma; Cyclophosphamide; Confidence interval; Lymphoma; Surgery; Oncology; Chemotherapy","score_opus":0.06503796508252431,"score_gpt":0.3461452574412059,"score_spread":0.2811072923586816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623202484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993271,0.000061139865,0.0000016034533,0.00212217,0.00022210463,0.0018852385,0.00006698659,0.000022500808,0.0023472374],"genre_scores_gemma":[0.99786955,0.0001077729,0.00036385897,0.00010917867,0.00004044113,0.00018106792,0.000014775365,0.0000145216545,0.0012988542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981652,0.00012876045,0.00065731944,0.000421217,0.00033329517,0.00029421912],"domain_scores_gemma":[0.9974103,0.0005818656,0.0006605726,0.0010090717,0.00019927036,0.00013889857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121491794,0.00026478726,0.0012379466,0.000044749944,0.00022080069,0.000009756603,0.00025485634,0.00020649737,0.00024167949],"category_scores_gemma":[0.00061418914,0.00009474866,0.00018346624,0.00010651173,0.00037530414,0.000040546398,0.00014296842,0.00007524456,0.000022883025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021248847,0.026174702,0.9449356,0.00005242431,0.0005610997,0.0005750452,0.00062921585,0.0000014228258,0.000006426736,0.00021732059,0.00090051873,0.004697348],"study_design_scores_gemma":[0.062017966,0.042569544,0.8833182,0.00013249839,0.0006116339,0.00009603779,0.00017098789,0.0000062779645,0.0014977574,0.00004457236,0.00941578,0.00011876402],"about_ca_topic_score_codex":0.00034036065,"about_ca_topic_score_gemma":0.0018000447,"teacher_disagreement_score":0.06161745,"about_ca_system_score_codex":0.00025148608,"about_ca_system_score_gemma":0.00026562126,"threshold_uncertainty_score":0.38637385},"labels":[],"label_agreement":null},{"id":"W2623319799","doi":"10.1002/hon.2439_17","title":"<i>BCL2</i><scp>mRNA</scp> or protein abundance is superior to gene rearrangement status in predicting clinical outcomes in patients with diffuse large <scp>B</scp>‐cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; BC Cancer Agency; Queen's University","funders":"","keywords":"Fluorescence in situ hybridization; Immunohistochemistry; Messenger RNA; Biopsy; Biology; Molecular biology; Pathology; In situ hybridization; Diffuse large B-cell lymphoma; Lymphoma; Gene expression; Gene; Medicine; Immunology; Genetics","score_opus":0.03500791177400745,"score_gpt":0.3337833299450458,"score_spread":0.2987754181710383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623319799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307865,0.00020117126,0.000013073206,0.0008637655,0.00026079867,0.0033600333,0.000101202226,0.00009313515,0.0020281882],"genre_scores_gemma":[0.99110514,0.00017871245,0.0037398378,0.0027606029,0.000076547825,0.0011961968,0.000045005792,0.00005300663,0.000844963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99515635,0.00031124058,0.0013579476,0.0011531585,0.0005924719,0.0014288528],"domain_scores_gemma":[0.9959494,0.0015810947,0.00056189887,0.0010352499,0.00016177434,0.00071058894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006657914,0.00055189454,0.0020458617,0.00019142995,0.00025750278,0.00007822532,0.00042642365,0.0006177642,0.00005587247],"category_scores_gemma":[0.003982973,0.00033855182,0.00022485793,0.0002213645,0.00026788795,0.0001588366,0.00048144755,0.00035497398,0.00018064695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000557253,0.026594622,0.96526545,0.00010589156,0.00013584987,0.0026690979,0.0008221626,7.2736805e-7,0.0000494045,0.00006175861,0.0012995424,0.002438228],"study_design_scores_gemma":[0.050816115,0.0067307106,0.9207529,0.00025647186,0.00010487353,0.00004588343,0.00048528987,0.000026334787,0.0012791267,0.000024045712,0.019368455,0.00010982555],"about_ca_topic_score_codex":0.00036796264,"about_ca_topic_score_gemma":0.0011465931,"teacher_disagreement_score":0.05025886,"about_ca_system_score_codex":0.00078771723,"about_ca_system_score_gemma":0.0004604702,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2623711786","doi":"10.1002/hon.2437_11","title":"CVP OR R‐CVP GIVEN AFTER INVOLVED‐FIELD RADIOTHERAPY IMPROVES PROGRESSION FREE SURVIVAL IN STAGE I‐II FOLLICULAR LYMPHOMA: RESULTS OF AN INTERNATIONAL RANDOMIZED TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Vincristine; Randomized controlled trial; Progression-free survival; Follicular lymphoma; Internal medicine; Surgery; Radiation therapy; Stage (stratigraphy); Gastroenterology; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.03600107695463218,"score_gpt":0.37193222761093775,"score_spread":0.3359311506563056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623711786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878326,0.00038460773,0.00001890168,0.006591246,0.0007782313,0.002106488,0.000035944246,0.000040712843,0.0022112583],"genre_scores_gemma":[0.99329984,0.0004749353,0.0043608206,0.00042390445,0.00023848159,0.00083989,0.000047705777,0.000016430447,0.00029798513],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736404,0.0004595102,0.0009347123,0.00052768545,0.00038652297,0.0003275486],"domain_scores_gemma":[0.99705124,0.0012216383,0.00062785204,0.0008170568,0.00010838098,0.00017381615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011313825,0.0002646461,0.0017313437,0.00012235642,0.00011497605,0.000033016408,0.00044243794,0.00050010544,0.00027053338],"category_scores_gemma":[0.0032114326,0.00014663201,0.00032830823,0.000057943318,0.00037281084,0.00016428638,0.00025618568,0.00012974025,0.0000041517496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9544434,0.0071672746,0.014143849,0.000043271706,0.0003231889,0.0029544819,0.00027003573,3.7747884e-7,0.00054201076,0.00096412585,0.00025730973,0.01889066],"study_design_scores_gemma":[0.95855325,0.009633274,0.019025413,0.00015818478,0.00012020895,0.00008586933,0.00007378455,0.0003267578,0.004734243,0.0004379646,0.006668829,0.00018223995],"about_ca_topic_score_codex":0.0003428344,"about_ca_topic_score_gemma":0.00040460934,"teacher_disagreement_score":0.01870842,"about_ca_system_score_codex":0.0002580826,"about_ca_system_score_gemma":0.00027286244,"threshold_uncertainty_score":0.59794796},"labels":[],"label_agreement":null},{"id":"W2623923854","doi":"10.1002/hon.2439_189","title":"ENGAGING ADMINISTRATIVE DATA TO DETERMINE TIME TO DIAGNOSIS AND TREATMENT OF LYMPHOMA: A POPULATION BASED STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Cancer registry; Referral; Cumulative incidence; Population; Incidence (geometry); Cohort; Diagnosis code; Pediatrics; Cancer; Internal medicine; Family medicine","score_opus":0.22143945473183244,"score_gpt":0.427478478394114,"score_spread":0.20603902366228158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623923854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262965,0.00007431963,0.000008357953,0.004841287,0.000038191178,0.0016647301,0.00005394865,0.000027577094,0.00066194066],"genre_scores_gemma":[0.99543154,0.000013423762,0.0034439059,0.0003685359,0.00003670842,0.0005691186,0.000061308616,0.000009324813,0.00006613208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986539,0.000121850506,0.00034490408,0.0005225753,0.00014336836,0.00021339895],"domain_scores_gemma":[0.9979702,0.00064115477,0.00017004422,0.00088465307,0.00005178306,0.00028214246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016065246,0.00019311214,0.00084393995,0.00007816753,0.00018560608,0.000023768376,0.0001712344,0.0001013093,0.00018581447],"category_scores_gemma":[0.0006471448,0.00012739714,0.00005054687,0.000054378976,0.000048187885,0.000056079527,0.0002025037,0.000023304465,0.00007086577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005390525,0.008959306,0.8795564,0.000014355698,0.00012198882,0.0010314595,0.00025591702,7.551654e-7,0.00007595329,0.000035864286,0.0002220352,0.10918691],"study_design_scores_gemma":[0.006138282,0.016768733,0.9711984,0.000053463977,0.0003140123,0.000101740574,0.00012766647,0.00017839344,0.0012161769,0.000011002738,0.0037745337,0.000117641386],"about_ca_topic_score_codex":0.00024976654,"about_ca_topic_score_gemma":0.00023027303,"teacher_disagreement_score":0.109069265,"about_ca_system_score_codex":0.00027603575,"about_ca_system_score_gemma":0.00011239132,"threshold_uncertainty_score":0.51951045},"labels":[],"label_agreement":null},{"id":"W2624153561","doi":"10.1002/hon.2437_10","title":"OUTCOME OF CURATIVE RADIOTHERAPY FOR LOCALISED FOLLICULAR LYMPHOMA IN THE ERA OF <sup>18</sup>F‐FDG PET‐CT STAGING: AN INTERNATIONAL COLLABORATIVE STUDY ON BEHALF OF ILROG","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Follicular lymphoma; Radiation therapy; Stage (stratigraphy); Nuclear medicine; Multivariate analysis; Proportional hazards model; International Prognostic Index; Retrospective cohort study; Internal medicine; Radiology; Lymphoma; Oncology; Rituximab","score_opus":0.07821086845207646,"score_gpt":0.42442757323974944,"score_spread":0.34621670478767297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624153561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937094,0.00010720332,0.00005556122,0.0026117607,0.00007819157,0.0022169643,0.00008950318,0.000009463319,0.0011219573],"genre_scores_gemma":[0.99773645,0.000052560852,0.0012766519,0.00037631422,0.000027805287,0.00047725564,0.000027026445,0.000011590423,0.000014343639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800074,0.00034878557,0.0007602951,0.00034305232,0.00034229213,0.00020485332],"domain_scores_gemma":[0.9973467,0.0010799799,0.00063620874,0.00055287307,0.00031551498,0.00006870264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052176235,0.00021349202,0.0011999505,0.000090937174,0.00008214456,0.000012402523,0.0004048918,0.0000725725,0.000082469254],"category_scores_gemma":[0.0005369078,0.00012047174,0.0001863668,0.000111126246,0.00040201875,0.00008963199,0.000050296745,0.00009895595,0.0000012399473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027195953,0.017646074,0.9557252,0.00005163939,0.0006434105,0.0012417508,0.0041991426,0.000072853996,0.00014306481,0.013702239,0.00016490844,0.0036901333],"study_design_scores_gemma":[0.033175096,0.023417464,0.92014974,0.0001355453,0.00027738351,0.00025084658,0.012224662,0.0014706112,0.0062248777,0.0005065426,0.0019700378,0.00019720604],"about_ca_topic_score_codex":0.00015989617,"about_ca_topic_score_gemma":0.000052514257,"teacher_disagreement_score":0.03557546,"about_ca_system_score_codex":0.0002949222,"about_ca_system_score_gemma":0.00023490674,"threshold_uncertainty_score":0.49126953},"labels":[],"label_agreement":null},{"id":"W2624425537","doi":"10.1002/hon.2437_13","title":"DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Maintenance therapy; Internal medicine; Surgery; Oncology; Lymphoma; Salvage therapy; Chemotherapy; Progression-free survival","score_opus":0.022196431573017688,"score_gpt":0.2645807255552944,"score_spread":0.2423842939822767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624425537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332845,0.00017622119,0.000004120201,0.0013252046,0.0004512068,0.0014976271,0.000017727336,0.000028082775,0.003171363],"genre_scores_gemma":[0.9985594,0.000053382446,0.00070210866,0.00025794675,0.000035031066,0.00020279089,0.000019369383,0.000024008847,0.00014591873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742144,0.00015393473,0.00085406506,0.00052574376,0.0004828433,0.00056195364],"domain_scores_gemma":[0.99732786,0.00036747768,0.0009417689,0.0009876982,0.00022863237,0.0001465748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033139123,0.00032336506,0.0016007217,0.00008862089,0.0002144875,0.000018887235,0.00044255445,0.00043943245,0.000071983115],"category_scores_gemma":[0.00071401487,0.00017209233,0.00039486995,0.00017277173,0.00054281787,0.00008001231,0.00024532757,0.00010761136,0.000015008587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03250066,0.009030201,0.9455956,0.00006953313,0.00024500236,0.00030526635,0.00013434651,0.0000024894955,0.000039964685,0.0049325614,0.0002152477,0.0069290763],"study_design_scores_gemma":[0.24892756,0.00338749,0.743795,0.00042641108,0.00022931788,0.000067489935,0.00007729559,0.000017050586,0.0013009458,0.0004121907,0.0012001325,0.00015915386],"about_ca_topic_score_codex":0.00036002434,"about_ca_topic_score_gemma":0.00026847632,"teacher_disagreement_score":0.21642691,"about_ca_system_score_codex":0.0004102876,"about_ca_system_score_gemma":0.00035676177,"threshold_uncertainty_score":0.70177215},"labels":[],"label_agreement":null},{"id":"W2624535566","doi":"10.1002/hon.2437_81","title":"THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Oncology; Clinical endpoint; Lymphoma; Internal medicine; Context (archaeology); Stage (stratigraphy); Interim analysis; Dacarbazine; Surrogate endpoint; Clinical trial; Nuclear medicine; Chemotherapy; Biology; Cyclophosphamide","score_opus":0.0370597856809882,"score_gpt":0.3473945094879564,"score_spread":0.3103347238069682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624535566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799646,0.00020890898,0.00003856674,0.015353048,0.00084505184,0.0016409238,0.00009306923,0.000050603045,0.001805235],"genre_scores_gemma":[0.9941209,0.000168523,0.0011657316,0.0018207538,0.00022942857,0.00202881,0.000058245805,0.000023438377,0.0003841616],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995728,0.0011485214,0.0011019703,0.0008153468,0.0004735372,0.0007325795],"domain_scores_gemma":[0.9951399,0.0027722586,0.00050205016,0.0013194794,0.00006643927,0.00019987943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001546838,0.0004116951,0.0010974532,0.000116144445,0.00030407193,0.00014111304,0.000762777,0.000403246,0.00007331849],"category_scores_gemma":[0.002472809,0.00017147536,0.00028705664,0.00011551285,0.0007047793,0.00013878042,0.00037338753,0.0003779964,0.000039266997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6011412,0.028626455,0.22294274,0.00014673467,0.00030823186,0.057378773,0.001555716,0.000022177393,0.012887701,0.0021516504,0.0046968567,0.06814175],"study_design_scores_gemma":[0.21543784,0.009510658,0.68662316,0.00054501963,0.00014169473,0.0007784921,0.0004912306,0.0005876212,0.04961932,0.00037042593,0.035381325,0.0005132036],"about_ca_topic_score_codex":0.0000850274,"about_ca_topic_score_gemma":0.0013624891,"teacher_disagreement_score":0.46368042,"about_ca_system_score_codex":0.0006754313,"about_ca_system_score_gemma":0.0003167783,"threshold_uncertainty_score":0.6992562},"labels":[],"label_agreement":null},{"id":"W2625416898","doi":"10.1200/jco.2017.35.15_suppl.7500","title":"First-line treatment of iNHL or MCL patients with BR or R-CHOP/R-CVP: Results of the BRIGHT 5-year follow-up study.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Prednisone; Internal medicine; CHOP; Hazard ratio; Gastroenterology; Cyclophosphamide; Mantle cell lymphoma; Surgery; Oncology; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.14402185482939456,"score_gpt":0.45239754558155587,"score_spread":0.3083756907521613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625416898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919843,0.00006972593,0.0000014140444,0.004868964,0.0011348135,0.0007772539,0.00004247992,0.0000034189115,0.0011175943],"genre_scores_gemma":[0.99660486,0.0005838075,0.00049101963,0.00020691154,0.00042299932,0.000011336531,0.00000251121,0.00001722858,0.0016593258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996206,0.0002701838,0.0024920227,0.00023510879,0.00058731413,0.00020937229],"domain_scores_gemma":[0.9918908,0.002112063,0.0042411974,0.00078706926,0.0007124506,0.00025643894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009466729,0.00020615985,0.0019546954,0.00006805595,0.00013174645,0.000010843708,0.00032348323,0.00022426437,0.00011667244],"category_scores_gemma":[0.0040363506,0.0000757883,0.0005540244,0.000085824664,0.00033945954,0.00008966866,0.00009027717,0.00020909694,0.000007072967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07462805,0.030290931,0.83861005,0.000020745125,0.0016431676,0.00043609666,0.0003281704,0.0000048309766,0.0000017512455,0.000009513298,0.0018292379,0.05219744],"study_design_scores_gemma":[0.11212054,0.10373659,0.7595628,0.00022890473,0.0013721676,0.000042062606,0.0000825431,0.000004224993,0.00013786441,0.000018919813,0.022631286,0.00006211052],"about_ca_topic_score_codex":0.00029721693,"about_ca_topic_score_gemma":0.002274654,"teacher_disagreement_score":0.079047285,"about_ca_system_score_codex":0.0002605373,"about_ca_system_score_gemma":0.0014522492,"threshold_uncertainty_score":0.48321804},"labels":[],"label_agreement":null},{"id":"W2625576907","doi":"10.1002/cncr.30824","title":"Hodgkin lymphoma classification: Are we at a crossroads?","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Germinal center; Lymphoma; Medicine; Phenotype; Follicular lymphoma; Pathology; CD30; Hodgkin lymphoma; B cell; Cancer research; Gene; Immunology; Biology; Genetics; Antibody","score_opus":0.10214518152063592,"score_gpt":0.37504351329638064,"score_spread":0.27289833177574474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625576907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503796,0.0054820376,0.00000359846,0.02579309,0.0004926289,0.00025983126,0.000038793,0.00004939001,0.017501017],"genre_scores_gemma":[0.98194355,0.0022442127,0.000060846338,0.00071925635,0.0004003185,0.00029246305,0.000009730786,0.000016012571,0.014313589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928725,0.0000073582055,0.00011523389,0.00025419472,0.00015444148,0.00018155009],"domain_scores_gemma":[0.99890614,0.000016487631,0.00015525009,0.0007232252,0.00006810235,0.00013076977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003435104,0.000115346586,0.00019673779,0.000021275298,0.00037908935,0.00007014531,0.00011059401,0.0000684418,0.00076589687],"category_scores_gemma":[0.000028898721,0.00008707326,0.000087452994,0.000025841302,0.00011515227,0.00006879889,0.00005976583,0.000022475486,0.0003039064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112873626,0.00020896026,0.815059,0.00004217998,0.00010294123,0.00012136645,0.00013838675,5.423451e-7,0.00050104246,0.00035389114,0.060988173,0.12237062],"study_design_scores_gemma":[0.0022931339,0.00003307307,0.7064571,0.00013777023,0.000067989306,0.000019881383,0.000027577478,0.00003315293,0.0041001034,0.000029828327,0.28672978,0.000070644994],"about_ca_topic_score_codex":0.0001679033,"about_ca_topic_score_gemma":0.00018200272,"teacher_disagreement_score":0.22574162,"about_ca_system_score_codex":0.0006863996,"about_ca_system_score_gemma":0.00013279394,"threshold_uncertainty_score":0.8386034},"labels":[],"label_agreement":null},{"id":"W2658794391","doi":"10.14740/jh320w","title":"Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes","year":2017,"lang":"en","type":"review","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lenalidomide; Diffuse large B-cell lymphoma; Rituximab; Oncology; Internal medicine; Ibrutinib; Vincristine; Lymphoma; Bortezomib; CHOP; BCL6; Cyclophosphamide; Immunology; Chronic lymphocytic leukemia; B cell; Germinal center; Multiple myeloma; Leukemia; Chemotherapy","score_opus":0.06276450527285497,"score_gpt":0.3474912599193609,"score_spread":0.28472675464650593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2658794391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13828956,0.8594902,0.00011638237,0.000037972914,0.0002995724,0.0015319212,0.00007526811,0.000018945118,0.0001401793],"genre_scores_gemma":[0.028602641,0.9675856,0.0030139291,0.00026568054,0.000105279854,0.00010512156,0.00017544076,0.00013815654,0.000008133872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99483097,0.0011990174,0.0020268005,0.0005623738,0.00068571704,0.00069511385],"domain_scores_gemma":[0.9933851,0.00067899877,0.004369106,0.0009223003,0.00034348763,0.00030100468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009006922,0.0008848137,0.006024296,0.0010169278,0.00016883577,0.00008112619,0.00058961374,0.00085782504,0.000044555774],"category_scores_gemma":[0.00038537337,0.00057761883,0.0015904572,0.00030098425,0.00013050938,0.00013176908,0.00007064747,0.0005598574,0.000016224325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010816391,0.08645487,0.045205966,0.0036412317,0.0024737606,0.0059198197,0.00025729625,0.0000026964026,0.0000018641449,0.00008804642,0.00037350773,0.8544993],"study_design_scores_gemma":[0.31639096,0.0027427385,0.0035875328,0.011415961,0.0034799015,0.0019413626,0.00005310433,0.000119515316,0.00017282412,0.00006716175,0.6590252,0.0010037521],"about_ca_topic_score_codex":0.00010790256,"about_ca_topic_score_gemma":0.00000815824,"teacher_disagreement_score":0.85349554,"about_ca_system_score_codex":0.00053073256,"about_ca_system_score_gemma":0.0015222108,"threshold_uncertainty_score":0.9996675},"labels":[],"label_agreement":null},{"id":"W2673558759","doi":"10.1002/ijc.30838","title":"<i>TP53</i> mutation and survival in aggressive B cell lymphoma","year":2017,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity","keywords":"Internal medicine; Medicine; Hazard ratio; Gastroenterology; Rituximab; Lymphoma; International Prognostic Index; Proportional hazards model; Mutation; Oncology; Biology; Gene; Genetics; Confidence interval","score_opus":0.014249472384151135,"score_gpt":0.3388079587462265,"score_spread":0.32455848636207535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2673558759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828465,0.0026550093,0.000010100704,0.004005,0.0009974729,0.00004962769,0.000008943658,0.0000017011242,0.0039875214],"genre_scores_gemma":[0.9970823,0.002025387,0.0001097229,0.00025083497,0.00037760404,0.0000053271456,0.0000017093843,0.000005514182,0.00014158455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993346,0.000010945293,0.00020309303,0.000070601876,0.00031463674,0.00006612005],"domain_scores_gemma":[0.9990654,0.00003786307,0.0005173963,0.000071524846,0.00024848827,0.00005935571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000878819,0.000061747494,0.0001459477,0.00008584393,0.000031496013,0.00006054811,0.000109038374,0.000028860952,0.000050528284],"category_scores_gemma":[0.00007065353,0.000046467554,0.000052258198,0.0000119886145,0.000038410944,0.00014464429,0.000027473221,0.000038763505,0.0000028860807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006098309,0.00045196022,0.7807289,0.000012802483,0.00026715896,0.0043495204,0.00031685948,0.000023318771,0.0006122407,0.0002851851,0.00059010985,0.21175213],"study_design_scores_gemma":[0.010438228,0.00012263871,0.97581995,0.000366218,0.000069192065,0.00042630313,0.000056623947,0.000056538658,0.007896425,0.00033441593,0.0043616304,0.00005185802],"about_ca_topic_score_codex":0.0003422801,"about_ca_topic_score_gemma":0.00015406535,"teacher_disagreement_score":0.21170028,"about_ca_system_score_codex":0.00022952743,"about_ca_system_score_gemma":0.00015595289,"threshold_uncertainty_score":0.18948919},"labels":[],"label_agreement":null},{"id":"W2681911255","doi":"10.1002/cncr.30672","title":"[<sup>18</sup>F]‐FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; Queen's University; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Nuclear medicine; Lymphoma; Positron emission tomography; Radiology; PET-CT; Internal medicine","score_opus":0.026398872861509676,"score_gpt":0.3280894686639011,"score_spread":0.30169059580239144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2681911255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927855,0.00081846374,7.3444875e-7,0.0007519086,0.00006392572,0.0017461515,0.000018491492,0.000009856806,0.00380495],"genre_scores_gemma":[0.99775946,0.000767387,0.00006572466,0.00015566719,0.000051792224,0.0008035555,0.0000027588064,0.000013842783,0.00037981855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897105,0.000037363512,0.00020354317,0.0003192842,0.00026625584,0.00020248126],"domain_scores_gemma":[0.99907523,0.00003069225,0.00014696721,0.0006488807,0.00004508722,0.000053148135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018201773,0.00015876774,0.0002745727,0.000044067896,0.00013612994,0.000053827524,0.00016119315,0.000005842949,0.00004315017],"category_scores_gemma":[0.000017019041,0.00010014303,0.00005209342,0.000048247315,0.00010206911,0.000076124685,0.00012950567,0.000054906588,0.0000037347743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020685597,0.0018301153,0.98274845,0.00020657468,0.00034386563,0.0036934144,0.0027285297,0.000008727952,0.0000036244166,0.00009618984,0.00041687887,0.007716749],"study_design_scores_gemma":[0.012400633,0.00020001824,0.9771441,0.0005615871,0.00028496888,0.00007201875,0.008177006,0.00014843173,0.00017856219,0.00001525494,0.00072304264,0.000094349016],"about_ca_topic_score_codex":0.0012189349,"about_ca_topic_score_gemma":0.0001680467,"teacher_disagreement_score":0.012193777,"about_ca_system_score_codex":0.00033915185,"about_ca_system_score_gemma":0.000052476134,"threshold_uncertainty_score":0.40837142},"labels":[],"label_agreement":null},{"id":"W2687135656","doi":"10.1182/blood.v128.22.1794.1794","title":"Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ibritumomab tiuxetan; Follicular lymphoma; Rituximab; Internal medicine; Surgery; Asymptomatic; Lymphoma; Gastroenterology; Radioimmunotherapy; Immunology","score_opus":0.01132159949779818,"score_gpt":0.23088958304358548,"score_spread":0.2195679835457873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2687135656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970149,0.0016524973,0.00006127776,0.00014834077,0.00013999859,0.0005411612,0.000060113965,0.000057818208,0.00032391024],"genre_scores_gemma":[0.99557674,0.0016877404,0.002339797,0.000079818565,0.00010078745,0.00005241221,0.000011979458,0.000033597094,0.00011712601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860364,0.000053347885,0.00036764468,0.0003868441,0.00028432955,0.0003041938],"domain_scores_gemma":[0.99901134,0.00010533283,0.00019220232,0.00043631456,0.00006127105,0.00019354434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101169906,0.0002391613,0.0004579428,0.000114180555,0.000059647464,0.000015821268,0.00008483671,0.00008421103,0.000051207266],"category_scores_gemma":[0.000034440767,0.00015495229,0.00013632627,0.00014911254,0.000100612495,0.00008235464,0.000115256924,0.000026220705,0.00002304713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029644227,0.0046406155,0.7480652,0.00038292666,0.0029942656,0.0030714553,0.00020275232,0.0000012786096,0.0045406003,0.00074938935,0.00036738627,0.23468773],"study_design_scores_gemma":[0.04187198,0.00058987684,0.9201918,0.0011009487,0.0030276792,0.00014619477,0.00010045198,0.00003808537,0.031912107,0.000108491025,0.0006971673,0.00021516946],"about_ca_topic_score_codex":0.00037495518,"about_ca_topic_score_gemma":0.00001743138,"teacher_disagreement_score":0.23447256,"about_ca_system_score_codex":0.00009588789,"about_ca_system_score_gemma":0.000042037766,"threshold_uncertainty_score":0.63187706},"labels":[],"label_agreement":null},{"id":"W2713994360","doi":"10.1182/blood.v128.22.4651.4651","title":"Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Dalhousie University","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Aggressive lymphoma; Oncology; Lymphoma; Transplantation; CHOP; Randomized controlled trial; International Prognostic Index; Diffuse large B-cell lymphoma; Regimen; Rituximab","score_opus":0.00745717083887135,"score_gpt":0.25330941368189336,"score_spread":0.245852242843022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2713994360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342674,0.00021597487,0.0035244853,0.00037888405,0.00028036512,0.0014273424,0.00030500325,0.000085286396,0.0003559198],"genre_scores_gemma":[0.9964261,0.0008339391,0.00089878356,0.000108487955,0.00027502858,0.0007215005,0.0004396276,0.000028631248,0.00026789488],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840623,0.00006784027,0.00045223153,0.0005002851,0.0002561714,0.00031725081],"domain_scores_gemma":[0.99836737,0.0004976219,0.00049218076,0.00034818499,0.0001409106,0.00015373713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017737398,0.0002615343,0.00058556866,0.00027377444,0.00012261921,0.000033422086,0.00009323696,0.00018163917,0.00011560156],"category_scores_gemma":[0.0001378177,0.00016981583,0.00041228533,0.0002860287,0.00006283416,0.00011109409,0.0000148028175,0.00003472853,0.00008980313],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17299259,0.04722931,0.39583936,0.00080232596,0.03353116,0.0034879365,0.0043572853,0.00002461806,0.032133594,0.0028029406,0.0030235832,0.3037753],"study_design_scores_gemma":[0.5152279,0.0072768116,0.16542304,0.00028319558,0.03530745,0.00016941526,0.00009283341,0.000089725996,0.27476528,0.0006227492,0.00028414768,0.00045743008],"about_ca_topic_score_codex":0.00057114323,"about_ca_topic_score_gemma":0.00013161825,"teacher_disagreement_score":0.34223536,"about_ca_system_score_codex":0.0001501107,"about_ca_system_score_gemma":0.00015330758,"threshold_uncertainty_score":0.6924889},"labels":[],"label_agreement":null},{"id":"W2724318712","doi":"10.1093/annonc/mdx334","title":"Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Stage (stratigraphy); Lymphoma; Oncology; Internal medicine; Radiation oncology; Radiation therapy","score_opus":0.046306779075229725,"score_gpt":0.3621593806278016,"score_spread":0.3158526015525719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724318712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93862647,0.00048403774,0.000039227638,0.014552968,0.00054220913,0.00035628377,0.00018417055,0.000024371991,0.045190282],"genre_scores_gemma":[0.9946933,0.0013050658,0.0004121125,0.0020956397,0.0003921823,0.00009729835,0.00020636145,0.000017536928,0.0007804963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983056,0.00013231229,0.00045517975,0.00044415082,0.0003575706,0.00030518498],"domain_scores_gemma":[0.99748677,0.00045303692,0.0008069392,0.00083861,0.00027841097,0.00013621758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042983048,0.0002060806,0.000750634,0.0001686644,0.00026648806,0.000054585762,0.00049373467,0.0002645511,0.00048131283],"category_scores_gemma":[0.0002518171,0.00014765134,0.0004418802,0.00015523446,0.00027460238,0.00015677414,0.00019586553,0.00007093929,0.0000991887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071626535,0.0038743212,0.80729246,0.000006339197,0.0034848724,0.00035500497,0.0009329398,0.0000041559606,0.00041442204,0.0014273721,0.008856123,0.17263569],"study_design_scores_gemma":[0.0074702045,0.0019295835,0.86968565,0.000012108359,0.0009430011,0.000010585816,0.00016771935,0.00024180436,0.0037746811,0.00035470282,0.11530126,0.00010869086],"about_ca_topic_score_codex":0.0072833966,"about_ca_topic_score_gemma":0.0010470218,"teacher_disagreement_score":0.172527,"about_ca_system_score_codex":0.00063938275,"about_ca_system_score_gemma":0.00034076994,"threshold_uncertainty_score":0.9993272},"labels":[],"label_agreement":null},{"id":"W2725925241","doi":"10.1111/bjh.14820","title":"Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab <i>versus</i> chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pfizer","keywords":"Rituximab; Medicine; Calicheamicin; Internal medicine; Oncology; Hazard ratio; Interim analysis; Refractory (planetary science); CD22; Clinical endpoint; Aggressive lymphoma; Lymphoma; CD20; Clinical trial; Confidence interval","score_opus":0.02536001530919176,"score_gpt":0.31448059661853234,"score_spread":0.2891205813093406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725925241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7910817,0.061441064,0.0009505249,0.11238959,0.015673976,0.013548487,0.00173564,0.00009936605,0.003079606],"genre_scores_gemma":[0.742249,0.062503226,0.008830369,0.1483318,0.02574653,0.0020959673,0.0027673333,0.0012923426,0.006183433],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929563,0.00065729214,0.0033253748,0.0008758436,0.0011269358,0.0010582791],"domain_scores_gemma":[0.98480177,0.0028112698,0.009792496,0.0010451085,0.0012221072,0.00032724996],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012362752,0.0010205639,0.009829811,0.0006746379,0.00031692698,0.00015417827,0.00097256206,0.0021971262,0.00021024991],"category_scores_gemma":[0.0016665857,0.0009518191,0.0032142466,0.00012359272,0.0011024575,0.00029692697,0.00012569844,0.0014392012,0.000033334618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4713548,0.0044172513,0.0000021430772,0.0008347275,0.002345419,0.114623375,0.00018581499,9.1526414e-7,0.0000170943,0.000007875259,0.39224324,0.013967324],"study_design_scores_gemma":[0.75931036,0.0055730077,0.0000033769406,0.0033228567,0.00402947,0.09210863,0.000049085702,0.000045776065,0.0019070012,0.00015319447,0.13295224,0.0005449891],"about_ca_topic_score_codex":0.0006358624,"about_ca_topic_score_gemma":0.00003947219,"teacher_disagreement_score":0.28795555,"about_ca_system_score_codex":0.0015206975,"about_ca_system_score_gemma":0.0045467876,"threshold_uncertainty_score":0.9992932},"labels":[],"label_agreement":null},{"id":"W2726940470","doi":"10.1093/annonc/mdx333","title":"Observation as the initial management strategy in patients with mantle cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"BC Cancer Agency; BC Cancer Foundation; Michael Smith Health Research BC; Leukemia and Lymphoma Society of Canada","keywords":"Medicine; Mantle cell lymphoma; Asymptomatic; Blastoid; Internal medicine; Lymphoma; Population; Gastroenterology; Surgery","score_opus":0.09104855501445426,"score_gpt":0.372146900938614,"score_spread":0.2810983459241598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726940470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90574116,0.000042777123,6.326285e-7,0.0034804349,0.00005290065,0.00037300546,0.0000044158483,0.0000043712294,0.0903003],"genre_scores_gemma":[0.9978785,0.00012811366,0.00007216295,0.0013981177,0.000028477047,0.000047203048,0.000024116676,0.0000068639806,0.00041643932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936414,0.000031422594,0.00017037029,0.00013408232,0.00014868204,0.00015132102],"domain_scores_gemma":[0.99931026,0.00003863179,0.00018270416,0.00033921376,0.00009162748,0.000037578946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011191694,0.00008281655,0.0001953422,0.000041203737,0.000077600795,0.000012761851,0.00011552982,0.00005602754,0.00004435875],"category_scores_gemma":[0.000013642427,0.000049076927,0.00003541514,0.00003438566,0.000084080515,0.000071173505,0.000048449747,0.000027093542,0.000032231084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009963302,0.0040614246,0.7122325,0.000044499047,0.00012490513,0.00022468812,0.00014267438,0.000008795398,0.0000044340404,0.001694629,0.00234712,0.27811804],"study_design_scores_gemma":[0.008674346,0.0037595981,0.9732726,0.00004092293,0.000052040567,0.0000025763259,0.0000836872,0.000008004862,0.001248659,0.00024646084,0.01256336,0.00004774683],"about_ca_topic_score_codex":0.0004340937,"about_ca_topic_score_gemma":0.00009072058,"teacher_disagreement_score":0.2780703,"about_ca_system_score_codex":0.000050323237,"about_ca_system_score_gemma":0.00009038405,"threshold_uncertainty_score":0.2001299},"labels":[],"label_agreement":null},{"id":"W2728246735","doi":"10.3324/haematol.2017.166827","title":"Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Molecular biology; Medicine; Cancer research; Biology; Pathology","score_opus":0.13163995836435766,"score_gpt":0.3298766199857031,"score_spread":0.19823666162134546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728246735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8475608,0.028652942,0.0009733799,0.110823624,0.0019240357,0.004286142,0.0020212075,0.00025961333,0.00349825],"genre_scores_gemma":[0.9080786,0.0072447546,0.0122999195,0.06167728,0.0029395223,0.00065038603,0.0053130803,0.00022090756,0.0015755543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955392,0.0008948898,0.0012904889,0.0009115565,0.00075836247,0.0006055396],"domain_scores_gemma":[0.9927388,0.0020249095,0.0024878047,0.0023859409,0.00024836397,0.000114182425],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011833301,0.0006476698,0.0025159763,0.0001427093,0.0004962085,0.00011954023,0.00060034526,0.0014696075,0.00034805606],"category_scores_gemma":[0.0010561113,0.00034904058,0.0006918051,0.00011196465,0.00022295088,0.000093675124,0.00021218836,0.00032408326,0.0001032315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040594803,0.003793378,0.017031975,0.00039598765,0.0004938294,0.0018149929,0.00017955653,7.3535085e-7,0.017763063,0.00009745676,0.9567518,0.0012712637],"study_design_scores_gemma":[0.020076526,0.00026596003,0.017995892,0.0022148541,0.0025937846,0.00043520535,0.00010612458,0.00013357037,0.13290152,0.0005929963,0.8219402,0.000743391],"about_ca_topic_score_codex":0.00053499243,"about_ca_topic_score_gemma":0.0000056152016,"teacher_disagreement_score":0.13481164,"about_ca_system_score_codex":0.0003179945,"about_ca_system_score_gemma":0.00036817734,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2734906749","doi":"10.1136/bmjopen-2016-015106","title":"Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data","year":2017,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba; George & Fay Yee Centre for Healthcare Innovation","funders":"Sanofi Pasteur; H. Lundbeck A/S; Celgene; Gilead Sciences; Sanofi; GlaxoSmithKline; Manitoba Medical Service Foundation; Pfizer","keywords":"Medicine; Relative survival; Poisson regression; Incidence (geometry); Demography; Cancer registry; Population; Epidemiology; Cohort; Proportional hazards model; Mortality rate; Standardized rate; Cohort study; Survival analysis; Internal medicine; Environmental health","score_opus":0.12424565876832637,"score_gpt":0.41158007596864654,"score_spread":0.28733441720032016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734906749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970592,0.00007509898,1.15849886e-7,0.00010513135,0.00007070108,0.0021227824,0.00026737418,0.000003112635,0.00029646695],"genre_scores_gemma":[0.9992141,0.0000043955874,0.00002045976,0.00002408665,0.000027644532,0.00016404173,0.00043638944,0.000012477407,0.00009637839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862474,0.00007885036,0.00038278368,0.00040257032,0.00033875488,0.0001722756],"domain_scores_gemma":[0.9981629,0.000044163444,0.0003541858,0.0013094294,0.000040989748,0.00008829403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044860475,0.0001447816,0.00047590965,0.00006890058,0.00008029602,0.00006895054,0.0004514294,0.000051415947,0.000062743056],"category_scores_gemma":[0.000110355126,0.00012644207,0.000015675088,0.000107011765,0.00004031488,0.00025930136,0.00040791457,0.00004503955,3.4308255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032526912,0.0005840441,0.9958982,0.000057696958,0.00006552369,0.00048065177,0.000049845192,0.0000075742096,0.000006417075,9.888113e-7,0.00019556646,0.002328225],"study_design_scores_gemma":[0.0064242114,0.000066373235,0.9911953,0.0007117835,0.000099907775,0.0000033527979,0.00010788424,0.0012298714,0.000030287141,9.480904e-7,0.0000019238958,0.00012816371],"about_ca_topic_score_codex":0.99351263,"about_ca_topic_score_gemma":0.9973617,"teacher_disagreement_score":0.0060989424,"about_ca_system_score_codex":0.0006180694,"about_ca_system_score_gemma":0.00095050235,"threshold_uncertainty_score":0.51561576},"labels":[],"label_agreement":null},{"id":"W2736085962","doi":"10.1182/blood.v128.22.1795.1795","title":"Is Prior Rituximab Exposure Associated with a Difference in Outcomes in Relapsed Low-Grade Lymphomas Retreated with Rituximab in Comparison to Rituximab NaïVe Patients?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Regimen; Follicular lymphoma; Internal medicine; Progression-free survival; Oncology; Mantle cell lymphoma; Surgery; Lymphoma; Chemotherapy","score_opus":0.01266687284968091,"score_gpt":0.24454450607804867,"score_spread":0.23187763322836777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736085962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958064,0.00025269567,0.0000038673024,0.0015212437,0.00004740124,0.0019085277,0.000117280964,0.000107679036,0.0002349365],"genre_scores_gemma":[0.9981861,0.000031229054,0.00039684423,0.00044771284,0.000014868377,0.00050558214,0.00006988608,0.00007547707,0.00027228863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962362,0.00019604331,0.00090490666,0.0009776467,0.0007951291,0.00089009403],"domain_scores_gemma":[0.99818164,0.00037066062,0.00028188736,0.0006918073,0.00017300695,0.00030097453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021203443,0.00063297653,0.0017638047,0.00060245994,0.00006423608,0.00004448529,0.00022739758,0.00030141577,0.000051188574],"category_scores_gemma":[0.00032977943,0.00037100315,0.0001155204,0.0011624686,0.00010785717,0.00013028586,0.0000859476,0.00023453342,0.00007575112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013786107,0.0765297,0.9167578,0.000047061723,0.00029467113,0.00075543305,0.0015423978,0.0000010041184,0.00012543655,0.000017383732,0.00005248962,0.0024979718],"study_design_scores_gemma":[0.23329762,0.0028703918,0.756096,0.0025496199,0.00022795376,0.000014615309,0.00012010013,0.00001866435,0.0043594623,0.000018170394,0.000014586373,0.0004128139],"about_ca_topic_score_codex":0.0011410393,"about_ca_topic_score_gemma":0.0064049303,"teacher_disagreement_score":0.231919,"about_ca_system_score_codex":0.0010754971,"about_ca_system_score_gemma":0.00029040792,"threshold_uncertainty_score":0.9998742},"labels":[],"label_agreement":null},{"id":"W2736445090","doi":"","title":"Ocular adnexal lymphoma: an 11-year retrospective study of different subtypes and their clinical implications","year":2017,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lymphoma; Dermatology; Retrospective cohort study; Internal medicine","score_opus":0.07865633481825576,"score_gpt":0.40684049001143346,"score_spread":0.3281841551931777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736445090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799156,0.000038580718,3.792556e-7,0.00057502824,0.00013069861,0.0006787603,0.000015776082,0.000019499814,0.0005496857],"genre_scores_gemma":[0.99959505,0.000010508813,0.00015120894,0.00005873715,0.00006569424,0.00007735569,0.0000046801306,0.000011202221,0.000025590078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980557,0.00018247079,0.0003811923,0.0008000918,0.0002690269,0.00031151393],"domain_scores_gemma":[0.9979317,0.00013255277,0.0003549546,0.0008077586,0.00032332694,0.00044970962],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00061500154,0.00022473803,0.00056984235,0.000102984624,0.0007632083,0.000066153414,0.0003974681,0.000099052784,0.000019236615],"category_scores_gemma":[0.0008676679,0.00014833637,0.00007237215,0.00017537363,0.005885921,0.0002823465,0.00033405572,0.00009487912,0.000005750423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048116468,0.003646785,0.9728112,0.0000049192718,0.00007765839,0.00006033027,0.0010383497,9.012541e-8,0.020626,0.001091361,0.000005281242,0.0005898924],"study_design_scores_gemma":[0.0025143092,0.0061467765,0.9614381,0.00003116542,0.000086651366,0.00015444323,0.0009899007,0.00004825784,0.024491202,0.003969644,0.0000023997052,0.00012715673],"about_ca_topic_score_codex":0.0004947423,"about_ca_topic_score_gemma":0.000047056645,"teacher_disagreement_score":0.011373124,"about_ca_system_score_codex":0.0001478691,"about_ca_system_score_gemma":0.0003075846,"threshold_uncertainty_score":0.9968195},"labels":[],"label_agreement":null},{"id":"W2736866953","doi":"10.1182/blood.v128.22.690.690","title":"Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Dalhousie University; Juravinski Hospital; Queen's University; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Canadian Partnership Against Cancer","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Gemcitabine; Oncology; Transplantation; Salvage therapy; Surgery; Chemotherapy; Mitoxantrone","score_opus":0.03304076690110804,"score_gpt":0.33272631868295566,"score_spread":0.29968555178184764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736866953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957518,0.00011759551,0.0000060935754,0.00007268434,0.00009671336,0.001907189,0.0020041293,0.000004602493,0.00003920681],"genre_scores_gemma":[0.9993644,0.00011459778,0.000055359265,0.00002200205,0.000047969334,0.00023387183,0.00012025263,0.000014525692,0.000027056392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818337,0.00023343142,0.0008264373,0.0002625505,0.00025138774,0.00024280086],"domain_scores_gemma":[0.9978238,0.0007478083,0.0008651823,0.00028618606,0.00013235814,0.00014470339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050639495,0.00017142581,0.0010826796,0.00024814403,0.000039579543,0.000006462401,0.00010073163,0.00014829118,0.00005037871],"category_scores_gemma":[0.00009604935,0.00007569268,0.00062523526,0.00032377485,0.00007648218,0.000040215127,0.0000065357503,0.000027259703,6.762214e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02027876,0.0027871642,0.9582009,0.000035483667,0.003493309,0.000015437883,0.0002414488,0.000007981176,0.00003359229,0.0000061414994,0.00007557735,0.014824232],"study_design_scores_gemma":[0.17348546,0.0030190859,0.81297636,0.00022543113,0.008398432,9.641063e-7,0.000009238989,0.00002039869,0.0017782128,0.000003423162,0.0000055463015,0.000077433026],"about_ca_topic_score_codex":0.058206942,"about_ca_topic_score_gemma":0.19447647,"teacher_disagreement_score":0.1532067,"about_ca_system_score_codex":0.00027219058,"about_ca_system_score_gemma":0.0010485107,"threshold_uncertainty_score":0.94806457},"labels":[],"label_agreement":null},{"id":"W2737383904","doi":"10.1182/blood-2017-05-784678","title":"Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Brentuximab vedotin; ABVD; Dacarbazine; Medicine; Oncology; Vinblastine; Internal medicine; Classical Hodgkin lymphoma; Lymphoma; Stage (stratigraphy); Bleomycin; Hodgkin lymphoma; Chemotherapy; Vincristine; Cyclophosphamide; Biology","score_opus":0.019684991130865064,"score_gpt":0.26962220136689946,"score_spread":0.2499372102360344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737383904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7770539,0.0013591794,0.00006705221,0.20160702,0.0018542806,0.007888798,0.003265645,0.00031554294,0.0065886024],"genre_scores_gemma":[0.6037508,0.00062805525,0.012236305,0.11307011,0.006866465,0.0040823827,0.007127741,0.0009110183,0.2513271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997249,0.000052411677,0.0005404196,0.00084293657,0.0006558557,0.00065937644],"domain_scores_gemma":[0.99719685,0.00039420687,0.0006533084,0.0013405413,0.0002501279,0.00016498956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010467961,0.00065943133,0.0015983015,0.0001602382,0.00015676451,0.000075057535,0.00037855402,0.00068595016,0.00010771754],"category_scores_gemma":[0.0001783843,0.00043165486,0.00050756696,0.000091409966,0.00021867293,0.00011334936,0.00009906498,0.00029368085,0.00004107975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011440425,0.008360717,0.009538384,0.0027456046,0.004214853,0.007126682,0.00023553033,6.241097e-7,0.0001919317,0.00023643882,0.94596523,0.009943576],"study_design_scores_gemma":[0.22983003,0.013558235,0.012978951,0.0025338193,0.0051539573,0.0002957327,0.00006148086,0.000012439555,0.009549016,0.000051125768,0.72511506,0.000860168],"about_ca_topic_score_codex":0.00007298961,"about_ca_topic_score_gemma":0.000056858356,"teacher_disagreement_score":0.24473849,"about_ca_system_score_codex":0.00017304569,"about_ca_system_score_gemma":0.0007355737,"threshold_uncertainty_score":0.9998135},"labels":[],"label_agreement":null},{"id":"W2737437839","doi":"10.1182/blood.v112.11.839.839","title":"The Addition of Rituximab Eliminates the Negative Prognostic Impact of PMBCL Compared to DLBCL in Young Patients with CD20-Positive Aggressive Lymphomas Receiving a CHOP-Like Chemotherapy: Results of a Subgroup Analysis of the Mabthera International Trial Group (MInT) Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Stage (stratigraphy); Oncology; Chemotherapy; International Prognostic Index; Radiation therapy; Subgroup analysis; Gastroenterology; Surgery; Confidence interval","score_opus":0.008444756382393205,"score_gpt":0.2549183131276354,"score_spread":0.2464735567452422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737437839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619555,0.00008326233,0.0000035202959,0.00010818638,0.000058127516,0.002879717,0.00057375396,0.0000056881463,0.00009217748],"genre_scores_gemma":[0.99947774,0.000047565536,0.00006683872,0.000015959133,0.000024982224,0.00023496561,0.000107335254,0.000016564516,0.000008053301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977878,0.00027800613,0.0007742804,0.00028000044,0.00069490296,0.00018503456],"domain_scores_gemma":[0.99664956,0.0010637376,0.0012386364,0.00043478826,0.00056831865,0.000044945526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003180012,0.00022053647,0.0007075588,0.00023092148,0.00009786728,0.000010340239,0.0002627995,0.000047777463,0.000013890391],"category_scores_gemma":[0.00054082094,0.00010096196,0.00032228816,0.0010402285,0.0002509261,0.00006587887,0.00006579216,0.00007792083,3.2717148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03471026,0.023386806,0.91425014,0.000011451932,0.007151882,0.000012070464,0.019039609,0.0000559462,0.00014328468,0.0000066749813,0.000026319562,0.0012055702],"study_design_scores_gemma":[0.12636846,0.0041624233,0.8625696,0.00045215408,0.001855695,0.00000628882,0.0015315852,0.0001483246,0.0028215975,0.000008187215,5.0503985e-7,0.000075218246],"about_ca_topic_score_codex":0.0029637436,"about_ca_topic_score_gemma":0.0014472181,"teacher_disagreement_score":0.091658205,"about_ca_system_score_codex":0.00020428417,"about_ca_system_score_gemma":0.00015292005,"threshold_uncertainty_score":0.44803137},"labels":[],"label_agreement":null},{"id":"W2737588912","doi":"10.1002/path.4944","title":"Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Taipei Medical University; Michael Smith Health Research BC; American Society of Hematology","keywords":"Monoamine oxidase A; Dacarbazine; Lymphoma; Clorgyline; Cancer research; Hodgkin's lymphoma; Pathology; Monoamine oxidase B; Biology; Monoamine oxidase; Medicine; Melanoma; Biochemistry; Enzyme","score_opus":0.02782915504216004,"score_gpt":0.30491501428590834,"score_spread":0.2770858592437483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737588912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97188526,0.0005871003,0.000027690234,0.02626504,0.00019615355,0.00011084515,0.0000061671676,0.000004497253,0.0009172704],"genre_scores_gemma":[0.9974621,0.0004895457,0.00031968186,0.0012025468,0.00022024351,0.000005484564,7.9508277e-7,0.0000111402915,0.0002884407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900866,0.00013512038,0.0003673113,0.00010118896,0.00018203144,0.0002057141],"domain_scores_gemma":[0.998736,0.00016487404,0.0004054427,0.0005066401,0.00007960275,0.00010743596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004870439,0.00012135444,0.0004132161,0.00009761152,0.000102896374,0.000019712146,0.0002615966,0.000095385774,0.000053209336],"category_scores_gemma":[0.00022031408,0.00006567362,0.00012264421,0.000034940593,0.00017756861,0.00007995692,0.00007551647,0.000121119825,0.000033582928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00686209,0.007845309,0.43747884,0.0000799204,0.00058910437,0.074084945,0.0077199037,0.00001209022,0.20729864,0.0014175541,0.04062906,0.21598253],"study_design_scores_gemma":[0.010861571,0.0012907762,0.9442058,0.00012825766,0.00022559927,0.005781409,0.00011668422,0.00005616203,0.029779425,0.0006917948,0.006779276,0.000083210776],"about_ca_topic_score_codex":0.000039782157,"about_ca_topic_score_gemma":0.000016988843,"teacher_disagreement_score":0.506727,"about_ca_system_score_codex":0.00011328123,"about_ca_system_score_gemma":0.000108264794,"threshold_uncertainty_score":0.26780927},"labels":[],"label_agreement":null},{"id":"W2737686344","doi":"10.1200/jco.2017.35.15_suppl.7535","title":"Copanlisib in patients with relapsed or refractory follicular lymphoma.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Gastroenterology; Follicular lymphoma; Phases of clinical research; Bendamustine; Lymphoma; Surgery; Chemotherapy; Rituximab","score_opus":0.09130624193372662,"score_gpt":0.44105235070447285,"score_spread":0.34974610877074624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737686344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215746,0.00014487721,0.0000029496641,0.0031637684,0.0007643044,0.00021647732,0.0000022134182,0.0000043390396,0.0035436356],"genre_scores_gemma":[0.99607503,0.00035720607,0.0015321504,0.0013290094,0.00039053435,0.000005052489,0.0000026895855,0.0000148220115,0.00029352732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975098,0.00018489429,0.0015201434,0.00017985448,0.00039909413,0.00020624309],"domain_scores_gemma":[0.99572885,0.0009699925,0.002181145,0.00043277693,0.00034955755,0.00033769687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012657109,0.00013478685,0.001362342,0.00008994024,0.00007331814,0.000018711258,0.0002068862,0.00031425172,0.00010339843],"category_scores_gemma":[0.0039385683,0.00006909466,0.00027967108,0.000045563498,0.0001898966,0.00018125983,0.000051355426,0.00029327665,0.000027264088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014134996,0.007744124,0.8102971,0.00000880656,0.00028536833,0.0030235886,0.00002502498,9.089521e-7,0.0000010436735,0.000025446454,0.002170155,0.16228347],"study_design_scores_gemma":[0.06169529,0.026954353,0.8476752,0.00019713154,0.00028354727,0.000078604375,0.00001758031,0.000004114062,0.000013727173,0.000033211916,0.0629783,0.00006893662],"about_ca_topic_score_codex":0.000050514234,"about_ca_topic_score_gemma":0.00010480493,"teacher_disagreement_score":0.16221452,"about_ca_system_score_codex":0.00037861458,"about_ca_system_score_gemma":0.0018061033,"threshold_uncertainty_score":0.47151184},"labels":[],"label_agreement":null},{"id":"W2738121207","doi":"","title":"A prospective correlative study of Bcl-6 expression in diffuse, large B-cell lymphoma treated with CHOP or R-CHOP","year":2006,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CHOP; Diffuse large B-cell lymphoma; Lymphoma; Correlative; Medicine; Cancer research; Pathology","score_opus":0.008665948110828315,"score_gpt":0.24508168389105053,"score_spread":0.2364157357802222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738121207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97785026,0.0001334389,0.000017867314,0.000027792807,0.000019265772,0.0021442825,0.000014431695,0.00006233482,0.019730298],"genre_scores_gemma":[0.9914325,0.000015145879,0.00021490124,0.000035903708,0.000025356458,0.00039311164,0.000020469755,0.00002919899,0.0078334175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853873,0.00006191279,0.00035825383,0.00042468644,0.00033196533,0.00028445708],"domain_scores_gemma":[0.9992093,0.0001250294,0.00014616722,0.00031507833,0.00012059,0.000083864485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006558698,0.00026576794,0.000541641,0.00017033305,0.00005421482,0.000011207031,0.000054788234,0.00008529147,0.00013322497],"category_scores_gemma":[0.000017636683,0.00013933839,0.00005422571,0.00048022385,0.00003825796,0.000090851725,0.000039033956,0.000057671983,0.000019407924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002895358,0.115069374,0.8784836,0.000023921542,0.000081465085,0.0004984246,0.0015960333,0.00000385043,0.0005148725,0.000047615293,0.00044407562,0.0003414367],"study_design_scores_gemma":[0.1338486,0.004511079,0.8378811,0.00019649543,0.00015415234,0.000019984798,0.0034172009,0.00008201425,0.019657588,0.000010791665,0.00007391113,0.0001470713],"about_ca_topic_score_codex":0.0024608339,"about_ca_topic_score_gemma":0.0023650157,"teacher_disagreement_score":0.13095324,"about_ca_system_score_codex":0.00035950588,"about_ca_system_score_gemma":0.00010658083,"threshold_uncertainty_score":0.5682055},"labels":[],"label_agreement":null},{"id":"W2738690589","doi":"10.1038/s41598-017-07226-4","title":"Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphoma","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Helse Sør-Øst RHF; Norges Forskningsråd; Kreftforeningen","keywords":"BCL6; Biology; Genetics; Gene; Follicular lymphoma; Regulatory sequence; Computational biology; Transcription factor; Lymphoma; B cell; Immunology","score_opus":0.020857984802419915,"score_gpt":0.2975483738354483,"score_spread":0.2766903890330284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738690589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747527,0.00075588387,0.000006238925,0.00030006934,0.00024879162,0.00036319086,0.000018758716,0.000008825287,0.0008229782],"genre_scores_gemma":[0.9979858,0.000022757955,0.00031021854,0.000013748728,0.000009291425,0.00005634494,0.00012178245,0.0000066098505,0.001473475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982265,0.000047287227,0.0005833074,0.00059782784,0.00035197116,0.00019307891],"domain_scores_gemma":[0.9981157,0.000037717633,0.00048192922,0.0011045064,0.0001544542,0.00010566622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009926651,0.00013689761,0.0004911337,0.00058485754,0.00017688535,0.00011750306,0.00008606737,0.000064543485,0.000019378205],"category_scores_gemma":[0.00033661135,0.000104916355,0.00013626022,0.0005717108,0.00047762817,0.00019530364,0.00006399586,0.00003801039,0.0000028431768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012933065,0.00033783616,0.96050453,0.000029376974,0.0001917524,0.0021237717,0.0016402449,0.00007009874,0.03125014,0.00012612861,0.00008300064,0.0036301622],"study_design_scores_gemma":[0.00068451784,0.000036184825,0.9886323,0.00019672945,0.00028402155,0.00010430962,0.00042925563,0.00015617863,0.0065602157,0.0021977306,0.00062300987,0.00009549798],"about_ca_topic_score_codex":0.0006005791,"about_ca_topic_score_gemma":0.0014012081,"teacher_disagreement_score":0.028127797,"about_ca_system_score_codex":0.00022132936,"about_ca_system_score_gemma":0.00022114819,"threshold_uncertainty_score":0.42783648},"labels":[],"label_agreement":null},{"id":"W2739450639","doi":"10.1182/blood.v128.22.1831.1831","title":"Patient Subgroup Analysis of Quality-of-Life Outcomes in Checkmate 205, a Phase 2 Study of Nivolumab in Patients with Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Quality of life (healthcare); Cohort; Brentuximab vedotin; Oncology; Visual analogue scale; Cancer; Lymphoma; Surgery; Hodgkin lymphoma; Immunotherapy","score_opus":0.01904726363066952,"score_gpt":0.29892047991076104,"score_spread":0.27987321628009154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739450639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989734,0.000056139386,0.000002397568,0.00007390435,0.00001755794,0.0007275393,0.000097391516,0.000007938961,0.00004372004],"genre_scores_gemma":[0.9997609,0.000009060597,0.00007689915,0.000025855643,0.0000035982353,0.00007638017,0.000022967857,0.000013309529,0.0000109938455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776405,0.00015586402,0.0009985582,0.00030258996,0.00057086296,0.00020807267],"domain_scores_gemma":[0.99865675,0.00019987319,0.0004490055,0.00046377917,0.00012716035,0.00010342347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865866,0.00018726326,0.0012819278,0.0005167744,0.000010156181,0.0000025348775,0.000076933145,0.000063267034,0.00004177777],"category_scores_gemma":[0.00015769924,0.00010597314,0.00016703458,0.0007530395,0.00006897964,0.000052383093,0.000049197133,0.000026986829,0.0000013068748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014682561,0.112356365,0.8769479,0.00004809421,0.002289349,0.00002253174,0.0011150625,0.0000022932136,0.00013014438,0.000023436056,0.000003445139,0.005593152],"study_design_scores_gemma":[0.10562355,0.0057387496,0.88466895,0.00013016515,0.0014653614,1.8786184e-7,0.0003744849,0.0000074336763,0.0018833256,0.000003051239,0.000003139934,0.000101603604],"about_ca_topic_score_codex":0.0016724274,"about_ca_topic_score_gemma":0.0013683448,"teacher_disagreement_score":0.106617615,"about_ca_system_score_codex":0.000110690395,"about_ca_system_score_gemma":0.00009652776,"threshold_uncertainty_score":0.4321459},"labels":[],"label_agreement":null},{"id":"W2739872419","doi":"10.1136/jclinpath-2017-204548","title":"Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"Universiti Kebangsaan Malaysia; Alberta Cancer Foundation","keywords":"Concordance; Immunohistochemistry; Gold standard (test); Lymphoma; Pathology; Diffuse large B-cell lymphoma; RNA; Medicine; Biology; Internal medicine; Gene; Genetics","score_opus":0.08961304594578164,"score_gpt":0.43181758714478113,"score_spread":0.3422045411989995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739872419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953071,0.0002895906,0.00012642982,0.0024857593,0.0002287594,0.0006272926,0.000013091815,0.000002115855,0.0009198494],"genre_scores_gemma":[0.9983775,0.00010180471,0.0011749278,0.0001672966,0.00009374939,0.000027159098,0.0000037642596,0.000012994355,0.000040782706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960783,0.00057949015,0.0025374629,0.0002123015,0.00037497692,0.00021743774],"domain_scores_gemma":[0.99515754,0.00089881243,0.0028702,0.0006688738,0.00026812905,0.00013642442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037393265,0.00014942217,0.0014515902,0.00020371727,0.00003152615,0.0000071092686,0.00035496993,0.00024533278,0.000021377018],"category_scores_gemma":[0.001730522,0.00009373585,0.0003463489,0.00012310027,0.00020334563,0.000047118738,0.000058735124,0.00025286124,0.0000069627717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011480605,0.016349332,0.9709469,0.00010003039,0.000039358718,0.00021819785,0.00018816658,0.000043029704,0.006476917,0.00013547984,0.0001614635,0.004193031],"study_design_scores_gemma":[0.019983342,0.0019924457,0.96118236,0.0003572629,0.00016027814,0.000017967626,0.0001092352,0.0009973831,0.014580696,0.00005611651,0.0004938171,0.00006912377],"about_ca_topic_score_codex":0.00006178928,"about_ca_topic_score_gemma":0.000063323656,"teacher_disagreement_score":0.018835282,"about_ca_system_score_codex":0.000118047785,"about_ca_system_score_gemma":0.0005019407,"threshold_uncertainty_score":0.3822437},"labels":[],"label_agreement":null},{"id":"W2741152687","doi":"10.1158/1538-7445.am2017-2447","title":"Abstract 2447: The mutational landscape of chemo-refractory Burkitt lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Institute; Fraser Health; Simon Fraser University; Université de Montréal; McGill University","funders":"","keywords":"Cancer research; Lymphoma; Biology; Mutation; Exome sequencing; Missense mutation; Medicine; Genetics; Immunology; Gene","score_opus":0.10027272897972947,"score_gpt":0.4331984253548513,"score_spread":0.3329256963751218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741152687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96749866,0.0021475814,3.529514e-7,0.005091375,0.00011343085,0.0002931403,0.000032369677,0.000008826077,0.02481429],"genre_scores_gemma":[0.9972634,0.0006287717,0.000017751989,0.000083891384,0.00033722562,0.00018842536,0.000015349695,0.000013451748,0.0014517771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998679,0.000026928508,0.0001498983,0.00019281382,0.00068793836,0.00026343644],"domain_scores_gemma":[0.99865496,0.00019543614,0.00008789325,0.0006302522,0.00032284355,0.00010863636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044584397,0.00008373013,0.00017025905,0.00006560088,0.0003760548,0.000057089466,0.0002649741,0.00005848519,0.0011316026],"category_scores_gemma":[0.00021755496,0.00004941702,0.00008124092,0.00006706925,0.00033051014,0.00007326725,0.00008771541,0.00011145997,0.00009996742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009328116,0.0021127926,0.5135884,0.00042792136,0.0007867742,0.0005166828,0.0013944159,0.000012228032,0.027268486,0.0021817712,0.07758952,0.3731882],"study_design_scores_gemma":[0.0022689921,0.00010210468,0.94495475,0.00012410125,0.000024534604,0.000012285851,0.00013423324,0.000014823219,0.031716768,0.00014835622,0.020450264,0.000048773087],"about_ca_topic_score_codex":0.0015990282,"about_ca_topic_score_gemma":0.00008219685,"teacher_disagreement_score":0.43136635,"about_ca_system_score_codex":0.00021738713,"about_ca_system_score_gemma":0.00068601704,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W2741305525","doi":"10.1158/1538-7445.am2017-2445","title":"Abstract 2445: Integrative genetic analysis identifies therapeutic relevance of cell of origin-specific genetic alterations in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"PTEN; Diffuse large B-cell lymphoma; Biology; Cancer research; Tissue microarray; Germinal center; Population; Cancer; Lymphoma; Genetics; PI3K/AKT/mTOR pathway; Oncology; B cell; Medicine; Immunology; Signal transduction","score_opus":0.07320957182474293,"score_gpt":0.3995682224925213,"score_spread":0.32635865066777836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741305525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847172,0.0127796,0.000057458357,0.00020138336,0.00008211185,0.0005558169,0.00010115935,0.0000067709907,0.00149848],"genre_scores_gemma":[0.98398256,0.014246966,0.00024637574,0.0000158989,0.000060293354,0.00026085656,0.00001757663,0.000021964606,0.0011475309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791276,0.00011567178,0.00048851455,0.00042658247,0.0006383728,0.00041807248],"domain_scores_gemma":[0.9977938,0.0002968734,0.00024069543,0.0010612118,0.00048636523,0.00012105472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032848958,0.000179016,0.0005425959,0.00052531034,0.000203804,0.00007491948,0.0003500987,0.00008481721,0.00026865472],"category_scores_gemma":[0.000055126042,0.00013691382,0.00020823124,0.00054924004,0.00033373034,0.000096379794,0.000090808295,0.0001531239,0.000028642733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072757807,0.01567352,0.72497416,0.0006632641,0.0011519637,0.0003081421,0.0047600823,0.00013455174,0.22398204,0.00035843506,0.0008406225,0.026425652],"study_design_scores_gemma":[0.006205947,0.00016249633,0.78507006,0.00018218867,0.0001824586,0.0000010476847,0.000388847,0.00016050844,0.20660834,0.00013058892,0.0008113116,0.000096218886],"about_ca_topic_score_codex":0.0026948284,"about_ca_topic_score_gemma":0.0024614562,"teacher_disagreement_score":0.060095888,"about_ca_system_score_codex":0.00042454313,"about_ca_system_score_gemma":0.0004070654,"threshold_uncertainty_score":0.5583184},"labels":[],"label_agreement":null},{"id":"W2743064314","doi":"10.1182/blood-2017-02-767335","title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Burkitt's lymphoma; Lymphoma; Cancer research; Biology; Medicine; Immunology","score_opus":0.006180129369933306,"score_gpt":0.21600429647024255,"score_spread":0.20982416710030924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743064314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837245,0.012564312,0.000008644832,0.0015096263,0.00019067942,0.0005451544,0.000033841166,0.00008508062,0.0013382083],"genre_scores_gemma":[0.995922,0.0009809867,0.001042767,0.00081557216,0.00036222284,0.00007477604,0.00005453874,0.00006287854,0.00068424357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840975,0.000033495107,0.00019948347,0.00056303735,0.00034430347,0.00044994272],"domain_scores_gemma":[0.99857694,0.000035999477,0.00020128654,0.00082088064,0.00009661847,0.0002682469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000058637655,0.00038630495,0.0004631223,0.000077930665,0.00049493596,0.00020179662,0.00022005805,0.00021329687,0.00003334751],"category_scores_gemma":[0.00001512171,0.00026248556,0.00012215102,0.00004496033,0.00019322468,0.00012187944,0.00009730829,0.000073039526,0.000034178094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004851522,0.05555552,0.5019145,0.0009422113,0.009071802,0.017662644,0.0022998266,0.000013674013,0.15781908,0.005903399,0.0090014,0.23496443],"study_design_scores_gemma":[0.046995692,0.0010158279,0.8678149,0.00009480417,0.0016078741,0.001191956,0.00006326152,0.000012867602,0.07954774,0.00022089196,0.0010879509,0.00034622682],"about_ca_topic_score_codex":0.0004313993,"about_ca_topic_score_gemma":0.00004632065,"teacher_disagreement_score":0.3659004,"about_ca_system_score_codex":0.00008332316,"about_ca_system_score_gemma":0.00016443187,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W2744261860","doi":"10.1182/blood-2017-03-769620","title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1683,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Medicine; Ibrutinib; Lymphoma; Refractory (planetary science); Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.02363812012859347,"score_gpt":0.29211759367235235,"score_spread":0.2684794735437589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744261860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907908,0.00021677396,1.1777411e-7,0.0023903085,0.00031442908,0.00040865294,0.00019061183,0.00002505733,0.0056632906],"genre_scores_gemma":[0.9982092,0.00007695473,0.000064865744,0.00046309,0.00017273301,0.000057075613,0.000057964786,0.000014223572,0.0008839205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886465,0.000045915072,0.00026475673,0.0003059962,0.0003408814,0.00017778703],"domain_scores_gemma":[0.9985175,0.00022486915,0.0001557053,0.0009905087,0.000042014683,0.000069361355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030670888,0.00014189912,0.00023722132,0.000037408157,0.00023449546,0.00013715608,0.0003783231,0.00005610424,0.000028461494],"category_scores_gemma":[0.00065175473,0.0000831015,0.00008542073,0.000023023096,0.000026136817,0.00013518064,0.00020112826,0.00010515065,0.00012398792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015445762,0.06634201,0.9301407,0.0000013515835,0.00024751335,0.00045663823,0.0008584035,2.097412e-8,0.00007780234,0.000014695635,0.00057249266,0.0011339338],"study_design_scores_gemma":[0.1228621,0.00016481428,0.8690551,0.000032176937,0.00017634104,0.0000033579959,0.00043919735,0.000003234439,0.000749285,0.000018466157,0.0064224117,0.000073512456],"about_ca_topic_score_codex":0.0017400346,"about_ca_topic_score_gemma":0.0008718834,"teacher_disagreement_score":0.12270764,"about_ca_system_score_codex":0.00009156326,"about_ca_system_score_gemma":0.000067574176,"threshold_uncertainty_score":0.3388781},"labels":[],"label_agreement":null},{"id":"W2744822218","doi":"10.1002/pbc.26753","title":"Variant histology, IgD and CD30 expression in low‐risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group","year":2017,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; State University of New York Upstate Medical University; National Institutes of Health; State University of New York","keywords":"Immunoglobulin D; CD30; Histology; Medicine; Lymphoma; Lymphocyte; Pathology; Large cell; B cell; Internal medicine; Antibody; Immunology; Adenocarcinoma; Cancer","score_opus":0.008676374641657145,"score_gpt":0.26558904508057146,"score_spread":0.2569126704389143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744822218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9364062,0.059787687,0.000019825586,0.0012258281,0.0009552302,0.0010987434,0.00019201725,0.000055229073,0.00025922543],"genre_scores_gemma":[0.927933,0.06696828,0.0007511907,0.00032698136,0.00310413,0.0006934207,0.00008190155,0.000055029188,0.00008608683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967689,0.00021980115,0.0007962969,0.0011146836,0.0004397522,0.0006605488],"domain_scores_gemma":[0.9965672,0.0004610405,0.0011021668,0.0014775493,0.00009201145,0.00030005243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005886932,0.00047809663,0.0009412794,0.00018550044,0.0005940594,0.00008534031,0.00041373813,0.00041169816,0.0001382739],"category_scores_gemma":[0.00048477322,0.00031815202,0.00021093355,0.00021082022,0.0001980929,0.00017185658,0.00040443608,0.00024979378,0.000024613377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004436857,0.0017974967,0.97288525,0.000060531667,0.00019851618,0.0043176604,0.0004002344,0.0000046837454,0.00004388911,0.000011815503,0.0031629957,0.016673261],"study_design_scores_gemma":[0.019841515,0.00039269848,0.9711512,0.00008760728,0.0038303286,0.0011444676,0.00003165778,0.00005277602,0.0002726989,0.00009208325,0.0027594017,0.00034360227],"about_ca_topic_score_codex":0.024210481,"about_ca_topic_score_gemma":0.0013440535,"teacher_disagreement_score":0.022866426,"about_ca_system_score_codex":0.0006608629,"about_ca_system_score_gemma":0.0010339288,"threshold_uncertainty_score":0.99992704},"labels":[],"label_agreement":null},{"id":"W2745982028","doi":"10.1097/moh.0000000000000383","title":"Autologous hematopoietic cell transplantation of mantle cell lymphoma: emerging trends","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Mantle cell lymphoma; Medicine; Rituximab; Oncology; Minimal residual disease; Internal medicine; Transplantation; Autologous stem-cell transplantation; Hematopoietic stem cell transplantation; Stem cell; Lymphoma; Surgery; Leukemia; Biology","score_opus":0.11113117473743576,"score_gpt":0.4133479190571178,"score_spread":0.30221674431968204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745982028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015901869,0.9933567,0.000022781705,0.00005399782,0.0037037267,0.0006927797,0.00009087225,0.000043949778,0.0018761506],"genre_scores_gemma":[0.0036799316,0.9944563,0.00010246205,0.0000030006265,0.00012406068,0.00037995676,0.0010793706,0.000055609908,0.00011931246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970649,0.00017323068,0.0013698126,0.0006701535,0.00025823337,0.00046365385],"domain_scores_gemma":[0.99770033,0.00024155101,0.0010841138,0.0007796244,0.00005558361,0.00013879486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016633306,0.0005768456,0.0032620763,0.0008058737,0.000079183876,0.0000143308325,0.0002895017,0.0004945459,0.00012232263],"category_scores_gemma":[0.000021423542,0.00046713513,0.0007173069,0.00025588836,0.00013739557,0.000055704284,0.00006613615,0.00021391397,0.000109279776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000287512,0.0021693748,0.0014658483,0.15699805,0.00007710295,0.00012228826,0.00023703686,2.8003038e-7,1.7322263e-7,0.0007366856,0.0011879044,0.8369765],"study_design_scores_gemma":[0.005064964,0.00023897618,0.00073449634,0.0418385,0.0013553079,0.0021750252,0.00002806854,0.000012496561,0.00009243732,0.000050291706,0.9479367,0.0004727343],"about_ca_topic_score_codex":0.000028295459,"about_ca_topic_score_gemma":0.0000027903227,"teacher_disagreement_score":0.9467488,"about_ca_system_score_codex":0.00021433969,"about_ca_system_score_gemma":0.00041431858,"threshold_uncertainty_score":0.99977803},"labels":[],"label_agreement":null},{"id":"W2749017086","doi":"10.14740/wjon1055w","title":"Prostatic Lymphoma Masquerading as Urinary Retention and Hematuria With Review of Literature","year":2017,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Urinary retention; Urinary system; Urology; Lymphoma; Internal medicine","score_opus":0.018739051348436574,"score_gpt":0.327718439761575,"score_spread":0.30897938841313843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749017086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.859057,0.116223425,0.000003248943,0.012888791,0.00023913273,0.000445243,0.0000032393878,0.000004862859,0.011135043],"genre_scores_gemma":[0.96472085,0.030523706,0.0031223977,0.00072793855,0.00012122456,0.000008075847,0.0000034701106,0.000009784962,0.0007625276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991872,0.000057829333,0.00037264058,0.000101252605,0.00017213664,0.00010896307],"domain_scores_gemma":[0.9984976,0.00007528959,0.000882516,0.00020584482,0.00023025059,0.00010848647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033310984,0.000103458835,0.00056579843,0.0001222981,0.000081510574,0.000021723741,0.000069856025,0.000045143468,0.000047266494],"category_scores_gemma":[0.00013384628,0.000061731596,0.00008917142,0.00006808375,0.0000924862,0.00013937161,0.000028312521,0.000092975526,0.0000019012022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007582945,0.006093895,0.33968118,0.02673797,0.0023233362,0.03982124,0.0018367163,5.243486e-7,0.0021722482,0.00766978,0.024073642,0.54200655],"study_design_scores_gemma":[0.016448889,0.016063929,0.72126967,0.096783504,0.0016939226,0.056980796,0.00007613546,0.0000056943572,0.0016464856,0.0010109806,0.08784085,0.00017912524],"about_ca_topic_score_codex":0.0000045319757,"about_ca_topic_score_gemma":0.0000051663324,"teacher_disagreement_score":0.54182744,"about_ca_system_score_codex":0.0001591095,"about_ca_system_score_gemma":0.00023371504,"threshold_uncertainty_score":0.25173414},"labels":[],"label_agreement":null},{"id":"W2749275095","doi":"10.1007/s40265-017-0796-z","title":"Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Antibody; Lymphoma; Immune system; Immunology; Cancer research; Antibody therapy; Clinical trial; Tumor microenvironment; Monoclonal antibody; Oncology; Internal medicine","score_opus":0.10697743891577456,"score_gpt":0.4122133735040457,"score_spread":0.30523593458827114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749275095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011209801,0.96865934,2.3890416e-7,0.0002701609,0.00021712646,0.0010709438,0.000041660485,0.000060469367,0.0285591],"genre_scores_gemma":[0.013193582,0.98320085,0.000017858503,0.00016722397,0.000277614,0.00023424222,0.00020841774,0.00007817459,0.0026220514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976516,0.00014968522,0.0006400651,0.0006696802,0.0003766338,0.000512359],"domain_scores_gemma":[0.99822134,0.00021179412,0.0003598614,0.00097432284,0.000043696724,0.00018900816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020889117,0.000640165,0.003017807,0.00029033716,0.00011497541,0.00012807247,0.00029771827,0.00048125163,0.0001252416],"category_scores_gemma":[0.000047863992,0.00042518668,0.00076144387,0.00015767271,0.00017251141,0.00007777739,0.00009814156,0.00021251646,0.0009695565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015412932,0.00081099087,0.00065560004,0.0038081463,0.00048458908,0.0011011319,0.00008650127,4.1363712e-8,1.8603963e-7,0.0009623052,0.0008077604,0.9912673],"study_design_scores_gemma":[0.0021168012,0.0002195526,0.0072793197,0.014527089,0.0015291204,0.00032103067,0.00004452353,0.000003935351,0.000004876086,0.000116244686,0.97345513,0.00038239942],"about_ca_topic_score_codex":0.0002710439,"about_ca_topic_score_gemma":0.000023195249,"teacher_disagreement_score":0.99088496,"about_ca_system_score_codex":0.00048583915,"about_ca_system_score_gemma":0.0012215215,"threshold_uncertainty_score":0.99982},"labels":[],"label_agreement":null},{"id":"W2750466678","doi":"10.5858/arpa.2016-0610-ra","title":"Lymphoproliferative Disorders of the Gastrointestinal Tract","year":2017,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Lymphoproliferative disorders; Gastrointestinal tract; Medicine; Pathology; Broad spectrum; Lymphoma; Internal medicine","score_opus":0.04506729844379913,"score_gpt":0.35595284951335393,"score_spread":0.3108855510695548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750466678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013893006,0.9920142,0.000011626778,0.0005727053,0.00027904924,0.0011533616,0.00027313863,0.000017647457,0.0042889686],"genre_scores_gemma":[0.0052815606,0.9934651,0.0004632513,0.000104352315,0.00022395489,0.00012892729,0.00008644586,0.000046591627,0.00019978467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974653,0.00047277988,0.00097049586,0.0004693043,0.00031367608,0.00030840977],"domain_scores_gemma":[0.9960125,0.0008964435,0.0015294661,0.0013009949,0.00010888865,0.0001516883],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00029384007,0.00050204905,0.0030336494,0.00024674804,0.00012163291,0.0000027028098,0.0004805529,0.0001445948,0.000057026034],"category_scores_gemma":[0.0010645051,0.0002556746,0.00058607844,0.00018929926,0.0029235743,0.000033263022,0.00014519671,0.00034197792,0.0000068472323],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120750075,0.0013616732,0.050790146,0.013466096,0.00042947588,0.00091057195,0.000985903,2.4700572e-7,0.0000942487,0.0009535349,0.00062577974,0.93026155],"study_design_scores_gemma":[0.0057721506,0.003805692,0.11063558,0.09974692,0.007799212,0.0035339664,0.00021102835,0.0000026230487,0.00008848757,0.00035892465,0.7676405,0.0004049125],"about_ca_topic_score_codex":0.000025303294,"about_ca_topic_score_gemma":0.000020034933,"teacher_disagreement_score":0.92985666,"about_ca_system_score_codex":0.00006221221,"about_ca_system_score_gemma":0.0015235659,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W2751927274","doi":"10.3747/co.24.3797","title":"ASCO 2017 Meeting Summary: Updates to Practice-Changing Studies in Untreated Non-Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Fluidigm (Canada); Université Laval; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Centre hospitalier universitaire de Québec; McGill University Health Centre","funders":"Lundbeck Canada; H. Lundbeck A/S","keywords":"Medicine; Rituximab; Prednisone; Vincristine; Cyclophosphamide; Bendamustine; CHOP; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine; Family medicine; Chemotherapy","score_opus":0.16994141188588707,"score_gpt":0.4919290930464527,"score_spread":0.32198768116056564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751927274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626794,0.009501648,0.000010000592,0.010086427,0.0031354167,0.001007609,0.000014307453,0.0000583324,0.013506855],"genre_scores_gemma":[0.9924074,0.004648986,0.0011419829,0.00050619175,0.00049480994,0.0003328859,0.000050635248,0.000029138148,0.00038797763],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982064,0.000117118,0.00038392298,0.00050310127,0.00020945535,0.0005800194],"domain_scores_gemma":[0.99815273,0.00044558,0.00033281592,0.0006380935,0.00023058719,0.00020020013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062374346,0.00027243182,0.000705278,0.00032249326,0.0003744274,0.000055551754,0.00021414015,0.000118787895,0.000017046652],"category_scores_gemma":[0.0020768405,0.00022135174,0.0000977898,0.00014669704,0.00014345603,0.00016903874,0.00040111266,0.00010282946,0.00020524237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076516933,0.0031069894,0.5419753,0.00015795382,0.00054382655,0.0017650393,0.004037663,0.000010390102,0.00020231445,0.00018412822,0.048611835,0.39863935],"study_design_scores_gemma":[0.015527766,0.0021959038,0.28369462,0.0021600828,0.00062766206,0.000317959,0.004667987,0.0002330302,0.0025434704,0.00009048476,0.68745714,0.00048388878],"about_ca_topic_score_codex":0.00022094518,"about_ca_topic_score_gemma":0.0003416232,"teacher_disagreement_score":0.6388453,"about_ca_system_score_codex":0.0010688495,"about_ca_system_score_gemma":0.0002624305,"threshold_uncertainty_score":0.9026462},"labels":[],"label_agreement":null},{"id":"W2752243987","doi":"10.1016/j.humpath.2017.08.025","title":"Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?","year":2017,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Stage (stratigraphy); T-cell lymphoma; Pathology; Nose; Dermatology; Internal medicine; Gastroenterology; Surgery; Biology","score_opus":0.024719749783454172,"score_gpt":0.29803211305561816,"score_spread":0.273312363272164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752243987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977988,0.0006321805,0.0000016055507,0.0001818855,0.00024924384,0.00040052802,0.000034579032,0.0000652292,0.020446768],"genre_scores_gemma":[0.99625796,0.00011385011,0.00020170287,0.00038337655,0.00011482573,0.000039647854,0.00026156698,0.000038526858,0.0025885624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857146,0.000099212855,0.00035531516,0.0004581087,0.00020313455,0.00031274825],"domain_scores_gemma":[0.9981782,0.00003884293,0.0002876239,0.0010902769,0.00013165583,0.0002733936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094922325,0.00024443836,0.0005534877,0.000094596384,0.00034790015,0.00003170548,0.00022460187,0.00017443165,0.00020197434],"category_scores_gemma":[0.000062490195,0.00020284875,0.00013847218,0.000041195886,0.00050441833,0.00009214288,0.00011640312,0.000062107174,0.00012176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025197936,0.01475581,0.7749479,0.0005400972,0.0005303966,0.09094116,0.003491048,0.000009599574,0.07709125,0.010208915,0.0027300569,0.022234019],"study_design_scores_gemma":[0.009999532,0.002099121,0.97706306,0.00009361011,0.00041207075,0.0013275546,0.0000484697,0.000028682141,0.0065566464,0.0014599138,0.0006539895,0.0002573668],"about_ca_topic_score_codex":0.00006191851,"about_ca_topic_score_gemma":0.00001996744,"teacher_disagreement_score":0.2021152,"about_ca_system_score_codex":0.00018756777,"about_ca_system_score_gemma":0.00025426404,"threshold_uncertainty_score":0.82719314},"labels":[],"label_agreement":null},{"id":"W2754371063","doi":"10.14740/jh327w","title":"Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL Deletion","year":2017,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vincristine; Medicine; Prednisone; Rituximab; Lymphoma; Diffuse large B-cell lymphoma; Etoposide; Cyclophosphamide; Regimen; Internal medicine; Oncology; Chemotherapy","score_opus":0.015412867306459604,"score_gpt":0.30348538193803043,"score_spread":0.2880725146315708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754371063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938138,0.0010377548,0.0002165777,0.0024629922,0.00014741004,0.0002347057,0.000015909904,0.000008746105,0.0020620974],"genre_scores_gemma":[0.9972852,0.00023233345,0.0011911571,0.00093681994,0.000102670885,0.000011357681,0.0000055591636,0.000017908493,0.00021703089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890774,0.000045761328,0.00040078076,0.0001855709,0.00019453364,0.00026557993],"domain_scores_gemma":[0.99851394,0.00010211471,0.00054828293,0.00030951554,0.00021266977,0.00031346345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017621911,0.00018672712,0.0006550584,0.00015107093,0.0001975886,0.000050230377,0.00011627966,0.00011364434,0.000096676136],"category_scores_gemma":[0.00010842092,0.00012245578,0.000092493035,0.00003784987,0.00010236447,0.00019052766,0.000056938345,0.00012592465,0.000022161381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011347672,0.039857432,0.75423384,0.0007624816,0.0021578935,0.040235966,0.0047723325,0.0000027575584,0.013432734,0.0035099958,0.08040404,0.049282864],"study_design_scores_gemma":[0.275842,0.0133713735,0.48806688,0.0010280828,0.0012167537,0.06924086,0.0011261227,0.00007910815,0.10211567,0.0005273789,0.046790693,0.00059506024],"about_ca_topic_score_codex":0.000025943913,"about_ca_topic_score_gemma":0.000055238128,"teacher_disagreement_score":0.26616696,"about_ca_system_score_codex":0.00014620923,"about_ca_system_score_gemma":0.0003334505,"threshold_uncertainty_score":0.49936017},"labels":[],"label_agreement":null},{"id":"W2754460311","doi":"10.1002/cncr.30979","title":"Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Cog; Medicine; Young adult; Internal medicine; Anemia; Hodgkin lymphoma; Radiation therapy; Lymphoma; Pediatrics","score_opus":0.023769795441326954,"score_gpt":0.34695637202214363,"score_spread":0.3231865765808167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754460311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107605,0.0002175955,0.0000064470332,0.00021214139,0.000047352325,0.007926621,0.0000950286,0.000035173016,0.000383602],"genre_scores_gemma":[0.9900749,0.00020311525,0.00011351548,0.00044445763,0.000060139446,0.008922288,0.00009915839,0.000024425055,0.0000580495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981104,0.00015534017,0.00034527923,0.0007988201,0.00023008254,0.0003600534],"domain_scores_gemma":[0.9986947,0.00003794323,0.00029402066,0.0005370174,0.00016149748,0.00027483221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009412468,0.00043624302,0.0011416869,0.00023975303,0.0002572296,0.00012265105,0.0001407813,0.00015374336,0.000024412671],"category_scores_gemma":[0.000031541145,0.0002857185,0.00008317129,0.00020610128,0.00033808235,0.0002700229,0.000073811825,0.00012861573,0.00000369094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048008896,0.0023879644,0.9679889,0.000045307635,0.0015128542,0.0001782314,0.001977584,0.000005936795,0.000038241255,0.00008758578,0.000026071368,0.020950435],"study_design_scores_gemma":[0.026415488,0.0052863597,0.9642619,0.001369986,0.00089087844,0.00003126872,0.00040346995,0.0004918644,0.0005044882,0.0000030374824,0.00003725884,0.00030400293],"about_ca_topic_score_codex":0.009509428,"about_ca_topic_score_gemma":0.050898742,"teacher_disagreement_score":0.041389313,"about_ca_system_score_codex":0.00057070376,"about_ca_system_score_gemma":0.000080290745,"threshold_uncertainty_score":0.99995947},"labels":[],"label_agreement":null},{"id":"W2755019703","doi":"10.1200/jco.2017.72.7925","title":"Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Autologous stem-cell transplantation; Internal medicine; Cohort; Gene expression profiling; Lymphoma; Prognostic model; Transplantation; Pathology; Overall survival; Gene expression; Gene; Biology","score_opus":0.10670400338220576,"score_gpt":0.43843369842636326,"score_spread":0.3317296950441575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755019703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685145,0.000093565824,0.00023429714,0.027145524,0.000894207,0.00044065848,0.000016172746,0.000011283185,0.002649817],"genre_scores_gemma":[0.9933284,0.00036816558,0.0029723102,0.0026136152,0.0002761508,0.000023779832,0.0000035613687,0.00001694914,0.00039706062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676913,0.00025877295,0.002007878,0.0002558755,0.00041106268,0.00029730424],"domain_scores_gemma":[0.9956819,0.0019437355,0.0012513334,0.00032910716,0.0002767038,0.00051724067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014929493,0.00018540365,0.0016732207,0.00015880317,0.00007735679,0.000028254999,0.00027890687,0.00043189706,0.000016731796],"category_scores_gemma":[0.0016179313,0.00012065283,0.00048101117,0.000044090873,0.00014527039,0.00015064434,0.000047851314,0.00033046756,0.00004145419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037718846,0.0061437585,0.76935613,0.00003629193,0.00017606567,0.0039910492,0.00015535514,0.00013605802,0.000052254592,0.00011018995,0.0006226037,0.21544835],"study_design_scores_gemma":[0.019488791,0.013236725,0.9634268,0.00014763029,0.00059438194,0.00029376964,0.00004793005,0.0012800123,0.00009570097,0.00019021459,0.0010932897,0.00010472319],"about_ca_topic_score_codex":0.000033642347,"about_ca_topic_score_gemma":0.00015466388,"teacher_disagreement_score":0.21534362,"about_ca_system_score_codex":0.00029803527,"about_ca_system_score_gemma":0.0017396645,"threshold_uncertainty_score":0.49200797},"labels":[],"label_agreement":null},{"id":"W2756719694","doi":"10.1200/jco.2017.35.15_suppl.tps7577","title":"CheckMate 436: A phase 1-2 study to evaluate safety and efficacy of nivolumab plus brentuximab vedotin in patients with CD30-expressing relapsed/refractory non-Hodgkin lymphomas.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; CD30; Mycosis fungoides; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Oncology; Cancer research; Immunotherapy; Cancer","score_opus":0.06945349368179177,"score_gpt":0.45274504277057276,"score_spread":0.383291549088781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756719694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968484,0.00015222677,0.000017234837,0.00085149053,0.00056738267,0.00093851535,0.000008341272,0.000005283786,0.00061113003],"genre_scores_gemma":[0.9981466,0.00014788196,0.0011191722,0.00023600397,0.00026207278,0.000008652213,0.0000034095415,0.000026916343,0.000049319326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562097,0.00046438837,0.0025894132,0.0003679296,0.00064158184,0.00031573235],"domain_scores_gemma":[0.9942246,0.0012191246,0.0030213376,0.0005620857,0.00048452913,0.00048833265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030927819,0.0002506687,0.0023135846,0.0001985678,0.00012867732,0.00003248472,0.00026566742,0.00020617976,0.00003342108],"category_scores_gemma":[0.003013058,0.00016375692,0.00024507125,0.0000880728,0.00025273708,0.00021036691,0.00018313057,0.00043303,0.000007544632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05297907,0.0398376,0.6820093,0.00002815054,0.0004983909,0.00064958696,0.0008115475,0.000023344042,0.000027195434,0.0000018057284,0.00015986859,0.22297418],"study_design_scores_gemma":[0.21287651,0.05381633,0.7308399,0.000487849,0.00061142375,0.000029898718,0.00015318878,0.00009925822,0.000055573622,0.000006279444,0.000914079,0.000109715795],"about_ca_topic_score_codex":0.00013961364,"about_ca_topic_score_gemma":0.00008297473,"teacher_disagreement_score":0.22286446,"about_ca_system_score_codex":0.00058294326,"about_ca_system_score_gemma":0.0015556297,"threshold_uncertainty_score":0.66778135},"labels":[],"label_agreement":null},{"id":"W2757218723","doi":"10.1016/j.ijrobp.2017.06.1634","title":"Management and Outcomes of Women Diagnosed With Primary Breast Lymphoma","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Cohort; Biopsy; Follicular lymphoma; Stage (stratigraphy); Radiology; Internal medicine; Surgery","score_opus":0.011773922612414913,"score_gpt":0.298174302221145,"score_spread":0.2864003796087301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757218723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453497,0.00022262846,0.00026883354,0.002556525,0.00051825156,0.00020050493,0.00004399794,0.000011129927,0.0016431627],"genre_scores_gemma":[0.99580044,0.0010128224,0.0020932797,0.0005851964,0.0003680463,0.000023963841,0.000026335145,0.000015415957,0.0000744925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988771,0.00005345107,0.0004513134,0.00016984793,0.00026019412,0.00018808543],"domain_scores_gemma":[0.9979181,0.00020075317,0.0011521636,0.0002221729,0.00036490255,0.00014186736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028792908,0.00016270042,0.00054916233,0.00011200236,0.00008724577,0.00003273541,0.00026815294,0.000097856326,0.000028388893],"category_scores_gemma":[0.000065834975,0.0001133007,0.00011751027,0.000034243785,0.00024921994,0.00022571455,0.00009214472,0.000080350575,0.0000057217358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004616969,0.000828315,0.7100015,0.000013131355,0.00152732,0.00022150208,0.00027580708,0.0000075596326,0.00006425268,0.004473108,0.00010802895,0.28201774],"study_design_scores_gemma":[0.014881417,0.0011085712,0.9764791,0.00007883649,0.00021173549,0.00042357706,0.000115761824,0.000034027475,0.00027778413,0.0014251245,0.0048676,0.00009642874],"about_ca_topic_score_codex":0.00002933972,"about_ca_topic_score_gemma":0.0000025898012,"teacher_disagreement_score":0.2819213,"about_ca_system_score_codex":0.0010896117,"about_ca_system_score_gemma":0.00025770476,"threshold_uncertainty_score":0.46202683},"labels":[],"label_agreement":null},{"id":"W2758486852","doi":"10.1038/s41467-017-00320-1","title":"Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility","year":2017,"lang":"en","type":"review","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Instituto de Salud Carlos III; Medical Research Council; National Institutes of Health; Heinz Nixdorf Stiftung; Blood Cancer UK; Institut Gustave-Roussy; University of Glasgow; Deutsche Krebshilfe; Mutuelle Générale de l'Education Nationale; Associazione Italiana per la Ricerca sul Cancro; European Commission; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Hellenic Health Foundation; Kay Kendall Leukaemia Fund; University of Cambridge; Wellcome Trust; Cancer Research UK; Cancer Research Institute; National Cancer Research Institute; Royal Marsden NHS Foundation Trust; Institut National de la Santé et de la Recherche Médicale; Multiple Myeloma Research Foundation; Centre International de Recherche sur le Cancer; World Cancer Research Fund; Stavros Niarchos Foundation","keywords":"Disease; Lymphoma; Genome; Genome-wide association study; Computational biology; Key (lock); Biology; Genetics; Medicine; Gene; Genotype; Single-nucleotide polymorphism; Immunology; Pathology; Ecology","score_opus":0.06875192995547195,"score_gpt":0.39157368512800533,"score_spread":0.32282175517253336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758486852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016268585,0.97961134,2.77203e-7,0.0006507194,0.00017611116,0.0022959579,0.0002915778,0.00003656486,0.00066885346],"genre_scores_gemma":[0.34154674,0.6569604,0.00008774847,0.000015338364,0.00004212208,0.00022586079,0.00068908295,0.000027988299,0.0004047148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996954,0.000674761,0.0011105614,0.0004190007,0.0006369199,0.00020471016],"domain_scores_gemma":[0.98913544,0.0017963394,0.0019506769,0.0063495506,0.0005803399,0.00018762151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006622263,0.0003674003,0.0020956635,0.00024964433,0.00027500387,0.0000390838,0.0012567553,0.0006761624,0.000021326778],"category_scores_gemma":[0.003020185,0.00028649357,0.00082603015,0.00029526677,0.00021905339,0.00008617754,0.00063584093,0.0005262598,0.000015088196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012312553,0.028244745,0.6258328,0.010738633,0.0056574843,0.000020561423,0.00083158124,4.0517756e-7,0.0000016933808,0.00092259754,0.005437227,0.32218915],"study_design_scores_gemma":[0.0009996339,0.00015588367,0.49976033,0.0023850389,0.0050685992,9.999901e-7,0.00006518431,9.2522527e-7,0.0000013739881,0.00003528435,0.49137872,0.00014803123],"about_ca_topic_score_codex":0.000082903694,"about_ca_topic_score_gemma":0.0006734842,"teacher_disagreement_score":0.4859415,"about_ca_system_score_codex":0.0011724114,"about_ca_system_score_gemma":0.0008671077,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W2760837506","doi":"10.1182/blood.v128.22.1183.1183","title":"ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Barrie Urology Group; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Procarbazine; Oncology; Internal medicine; Hodgkin's lymphoma; Vincristine; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.016459228457309967,"score_gpt":0.28451435202651354,"score_spread":0.2680551235692036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760837506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962841,0.0014206287,0.00032097925,0.0006995027,0.00010511229,0.0008084216,0.00009002968,0.00003750064,0.0002336847],"genre_scores_gemma":[0.9970181,0.0015149065,0.00077308196,0.000069801965,0.000036474048,0.00023431581,0.00015640451,0.00001991891,0.00017699564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981532,0.00013721958,0.00052153977,0.00042493918,0.00047195074,0.00029115754],"domain_scores_gemma":[0.9972518,0.0016854567,0.0001955717,0.00063961936,0.000119390505,0.00010814311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026380474,0.00027095215,0.00061188,0.00037479145,0.000058029833,0.000019089932,0.00012485575,0.00011498617,0.00007858876],"category_scores_gemma":[0.00025627902,0.00013924291,0.00034942402,0.00097468833,0.000051035986,0.000120788274,0.000018917985,0.00002507557,0.00002287157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003872994,0.062097054,0.32930577,0.00003562387,0.00361633,0.0011566845,0.0012128185,0.0000878748,0.0037750243,0.00064733875,0.0003037634,0.5938887],"study_design_scores_gemma":[0.15796913,0.005577816,0.8054055,0.00021690628,0.0051952465,0.00000951608,0.00024208472,0.00023729184,0.023377407,0.00011568509,0.001422516,0.00023092281],"about_ca_topic_score_codex":0.00031788606,"about_ca_topic_score_gemma":0.0005091125,"teacher_disagreement_score":0.5936578,"about_ca_system_score_codex":0.00036112592,"about_ca_system_score_gemma":0.00010349581,"threshold_uncertainty_score":0.56781614},"labels":[],"label_agreement":null},{"id":"W2761077531","doi":"10.1200/jco.2017.35.15_suppl.e18339","title":"Cost effectiveness of treating endemic Burkitt lymphoma in Uganda.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cost effectiveness; Gross domestic product; Per capita; Economic evaluation; Cohort; Health care; Environmental health; Population; Internal medicine; Economic growth","score_opus":0.18464470412989129,"score_gpt":0.512403221797509,"score_spread":0.32775851766761765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761077531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990744,0.00040157765,0.000013771903,0.0010352521,0.0007128469,0.00022731116,0.0000025348154,0.0000028763393,0.0068598464],"genre_scores_gemma":[0.99798197,0.00074343773,0.0006519753,0.00017200767,0.00039234722,0.000008376859,0.000001160617,0.000009816218,0.000038930888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723125,0.00047967528,0.0017255606,0.00014984241,0.00023439131,0.00017927116],"domain_scores_gemma":[0.9920744,0.0049059587,0.0022658084,0.00029152713,0.00024733212,0.00021501094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041265297,0.000115663686,0.001737167,0.00010410059,0.0000514119,0.00000899309,0.00018567343,0.0003058349,0.000032431137],"category_scores_gemma":[0.00703274,0.00007621583,0.00043659026,0.000045416302,0.00018775766,0.00010349493,0.000059016784,0.00023972755,0.000007938358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032139812,0.0025762266,0.70808566,0.000044069417,0.00022035146,0.001119449,0.00004138474,0.0000037070706,0.00020985267,0.0001084674,0.000090009235,0.28428683],"study_design_scores_gemma":[0.030743048,0.0067021493,0.95534825,0.00064874685,0.0002794358,0.0003739705,0.000048772614,0.000030002644,0.001907897,0.00024514305,0.0036167912,0.00005579589],"about_ca_topic_score_codex":0.0001600202,"about_ca_topic_score_gemma":0.000054080032,"teacher_disagreement_score":0.28423104,"about_ca_system_score_codex":0.00037369214,"about_ca_system_score_gemma":0.0013146779,"threshold_uncertainty_score":0.84193546},"labels":[],"label_agreement":null},{"id":"W2761277905","doi":"10.1371/journal.pone.0180261","title":"Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Bristol-Myers Squibb; American Society of Hematology","keywords":"Medicine; Brentuximab vedotin; Retrospective cohort study; Internal medicine; Bendamustine; Cohort; Surgery; Lymphoma; Hodgkin lymphoma; Rituximab","score_opus":0.01806126167392936,"score_gpt":0.24653109200872042,"score_spread":0.22846983033479107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761277905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948254,0.000089565714,5.470121e-7,0.00009769765,0.0000046694404,0.0046321442,0.00026977484,0.0000144325395,0.00006574347],"genre_scores_gemma":[0.9983837,0.00025891184,0.00007234569,0.000027447575,0.000010498474,0.000789088,0.00041321,0.000026694372,0.000018107357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988495,0.00006753444,0.00019016612,0.00035878786,0.00035075378,0.00018324771],"domain_scores_gemma":[0.9988101,0.00013479582,0.00021451664,0.00050509267,0.00026207566,0.000073379044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068348716,0.00022862184,0.000572579,0.00010271109,0.00016548239,0.00004169912,0.00006419333,0.000045094326,0.000002529577],"category_scores_gemma":[0.000043312633,0.000119283606,0.000023128132,0.00007467676,0.000100570716,0.000065806606,0.00002272554,0.000037505488,2.939058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030853846,0.02653522,0.96234155,0.00008115573,0.0012550645,0.00007047426,0.004940911,1.8503366e-7,0.0000052251185,0.000003972903,0.000002425509,0.0016784308],"study_design_scores_gemma":[0.043515645,0.03338901,0.917699,0.0006335787,0.0015206354,0.0000029809314,0.0026984713,0.000030323094,0.0003877054,0.0000013190862,0.00000437435,0.000116976145],"about_ca_topic_score_codex":0.0064219628,"about_ca_topic_score_gemma":0.002510707,"teacher_disagreement_score":0.04464257,"about_ca_system_score_codex":0.00054449163,"about_ca_system_score_gemma":0.000048076767,"threshold_uncertainty_score":0.9708129},"labels":[],"label_agreement":null},{"id":"W2761334736","doi":"10.1007/s00432-017-2529-9","title":"Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries","year":2017,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Région Normandie; Institut National Du Cancer","keywords":"Medicine; Mantle cell lymphoma; Clinical trial; Internal medicine; Population; Lymphoma","score_opus":0.35772156350260487,"score_gpt":0.5721468645732327,"score_spread":0.21442530107062785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761334736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561317,0.005860007,4.958962e-7,0.0065834746,0.00077539415,0.00077136175,0.00005585427,0.000001599051,0.00033863186],"genre_scores_gemma":[0.95659477,0.04216921,0.000044459757,0.0001499479,0.0008413299,0.000055155873,0.0000022900256,0.000010850502,0.00013199831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99400425,0.0019963905,0.0026058694,0.0003320473,0.0007444766,0.00031695788],"domain_scores_gemma":[0.9871993,0.009606843,0.0017867058,0.0004313764,0.0005931228,0.0003826332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01481465,0.00015036725,0.0020071056,0.00009498733,0.00019388138,0.00005934794,0.00029455216,0.0002494476,0.00009630079],"category_scores_gemma":[0.0059175882,0.0000795735,0.00031007864,0.00008379594,0.00090043613,0.00009004292,0.00028567942,0.0006074376,0.0000011643102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066944296,0.007939825,0.79961145,0.000015763882,0.0006063212,0.00018734479,0.0001774876,1.5019474e-7,0.000008944076,0.00001511838,0.0017489363,0.1829942],"study_design_scores_gemma":[0.056037296,0.01625335,0.92194074,0.00021812269,0.00035820666,0.0000034994912,0.0005206657,0.000008599093,0.000036849626,0.0004514519,0.0041084704,0.000062726096],"about_ca_topic_score_codex":0.01577622,"about_ca_topic_score_gemma":0.02184949,"teacher_disagreement_score":0.18293148,"about_ca_system_score_codex":0.00027954107,"about_ca_system_score_gemma":0.001238879,"threshold_uncertainty_score":0.9959992},"labels":[],"label_agreement":null},{"id":"W2761878534","doi":"10.1056/nejmoa1614598","title":"Obinutuzumab for the First-Line Treatment of Follicular Lymphoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":788,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Cancer Research UK","keywords":"Obinutuzumab; Rituximab; Medicine; Follicular lymphoma; Internal medicine; Oncology; Chemotherapy; Hazard ratio; Adverse effect; Lymphoma; CD20; Surgery; Confidence interval","score_opus":0.042785291391202906,"score_gpt":0.31808837758965824,"score_spread":0.27530308619845534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761878534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9020374,0.020066654,0.00072135415,0.07359252,0.0014156001,0.0008948157,0.000013662614,0.000009613645,0.0012483802],"genre_scores_gemma":[0.98903304,0.005355293,0.0004073258,0.00030038028,0.0042199404,0.00001399668,0.000005050637,0.000016187092,0.0006487964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987753,0.000016530146,0.000534349,0.00011817701,0.00037665825,0.00017900119],"domain_scores_gemma":[0.9978428,0.00047900563,0.00069351564,0.00051792123,0.00025303813,0.00021371036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036096573,0.00018140905,0.0007151966,0.0000801463,0.00021683273,0.00001428416,0.00019007275,0.000056659614,0.00007687376],"category_scores_gemma":[0.0003851593,0.00007721076,0.0002825065,0.000039245664,0.00015398214,0.00005864074,0.00001534986,0.000036300567,0.000002025319],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032533698,0.0007048129,0.030768082,0.00006730865,0.0015194946,0.00047902312,0.0011165094,0.0000428158,0.00030031148,0.00042054738,0.009734675,0.95159304],"study_design_scores_gemma":[0.26410463,0.016998507,0.13447313,0.0006780894,0.0026455077,0.0017275815,0.000116592266,0.00019059093,0.0059070606,0.0005700781,0.5724913,0.00009693876],"about_ca_topic_score_codex":0.0005778165,"about_ca_topic_score_gemma":0.000104399514,"teacher_disagreement_score":0.9514961,"about_ca_system_score_codex":0.00030384652,"about_ca_system_score_gemma":0.00035561327,"threshold_uncertainty_score":0.31485635},"labels":[],"label_agreement":null},{"id":"W2762226752","doi":"10.1200/jco.2017.75.4648","title":"Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"American Society of Clinical Oncology; Gilead Sciences; Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Lymphoma; Phases of clinical research; Gastroenterology; Refractory (planetary science); Oncology; Phosphatidylinositol; Progression-free survival; Chemotherapy; Kinase","score_opus":0.11078530689965123,"score_gpt":0.4613984961863448,"score_spread":0.3506131892866936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762226752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428595,0.000992309,0.0000062299086,0.009746841,0.0014287408,0.0002660134,0.000008248604,0.000007884953,0.0032577957],"genre_scores_gemma":[0.99291766,0.0024033806,0.00083150883,0.0026790805,0.00073279446,0.000012587136,0.000006811006,0.000017276234,0.0003989016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964038,0.0002993048,0.0023831658,0.00024015045,0.00041316226,0.00026039055],"domain_scores_gemma":[0.9944965,0.0014865104,0.0028877386,0.00041437583,0.0002724634,0.0004424114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019888943,0.00017708939,0.0014870008,0.00011279213,0.00010754097,0.000026611177,0.00017058098,0.00043104327,0.00017019863],"category_scores_gemma":[0.005177686,0.000112860245,0.0004029841,0.000058202808,0.00023431802,0.00019606616,0.00007511123,0.00045191217,0.00004614803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013761155,0.015215326,0.42282882,0.000033289456,0.0002575862,0.010739889,0.00011470327,0.000001429023,0.00026691888,0.00008778157,0.037494916,0.4991982],"study_design_scores_gemma":[0.048632376,0.016110433,0.81341475,0.000451272,0.00025829877,0.00042175324,0.00007447537,0.000023139968,0.0025359849,0.00007898467,0.11788367,0.00011484246],"about_ca_topic_score_codex":0.00013981768,"about_ca_topic_score_gemma":0.00012509037,"teacher_disagreement_score":0.49908334,"about_ca_system_score_codex":0.0006648129,"about_ca_system_score_gemma":0.0019475375,"threshold_uncertainty_score":0.61985475},"labels":[],"label_agreement":null},{"id":"W2764339126","doi":"10.1182/blood-2017-05-780049","title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Hodgkin lymphoma; Biology","score_opus":0.007575507668794034,"score_gpt":0.22328376742191533,"score_spread":0.2157082597531213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764339126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966555,0.00015292768,4.840961e-7,0.000032663225,0.000101748905,0.000513187,0.0001707816,0.000021431892,0.0023512326],"genre_scores_gemma":[0.9990985,0.000046398512,0.0001366497,0.000021384465,0.00003759156,0.000030332316,0.00008352962,0.000025654974,0.0005199621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998646,0.00004014458,0.00038208233,0.00032858292,0.00032526368,0.00027792604],"domain_scores_gemma":[0.9985235,0.00010255632,0.00038311345,0.0007726977,0.00010620664,0.000111970265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012004385,0.00018369703,0.0004382443,0.00010090529,0.00008779899,0.000020607245,0.00014654735,0.00009933574,0.00001785478],"category_scores_gemma":[0.00021194112,0.000119984485,0.000060134535,0.00007389817,0.000048448746,0.00008698281,0.000060264738,0.000056764322,0.00004516677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006221405,0.021435201,0.96994156,0.00028734285,0.0001504884,0.00034018117,0.0003260565,8.132855e-7,0.000075399665,0.000015634329,0.00043787304,0.00076806184],"study_design_scores_gemma":[0.16722861,0.0030502966,0.82620955,0.00094687985,0.00027028646,0.000011982633,0.000080827034,0.0000075106987,0.0018583748,0.0000012731595,0.00021756411,0.000116868534],"about_ca_topic_score_codex":0.00021629171,"about_ca_topic_score_gemma":0.00013195431,"teacher_disagreement_score":0.1610072,"about_ca_system_score_codex":0.00011579348,"about_ca_system_score_gemma":0.00019577901,"threshold_uncertainty_score":0.48928252},"labels":[],"label_agreement":null},{"id":"W2765240381","doi":"10.1182/blood.v128.22.4096.4096","title":"Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; SNP array; Lymphoma; SNP; Comparative genomic hybridization; Biology; Copy-number variation; Single-nucleotide polymorphism; Cancer research; Gene; Genetics; Medicine; Oncology; Chromosome; T cell; Genotype; Immunology","score_opus":0.006730647651362611,"score_gpt":0.20116274142313625,"score_spread":0.19443209377177365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765240381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921852,0.0031688653,0.0001168471,0.00013559873,0.00004675094,0.000238643,0.00007533066,0.000037110836,0.003995698],"genre_scores_gemma":[0.9988594,0.00012274584,0.00057890255,0.00008826506,0.0000474535,0.000053995947,0.000019721941,0.000027506152,0.00020201504],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990072,0.00002589002,0.00022756106,0.00026241236,0.00023851458,0.00023836788],"domain_scores_gemma":[0.9993091,0.000041794076,0.000079554105,0.00036250873,0.000056318615,0.00015070273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003587285,0.00016869624,0.0002762048,0.000030127881,0.000026881182,0.0000068987824,0.0000774597,0.00006987144,0.00014851638],"category_scores_gemma":[0.00002207599,0.000103717786,0.00015114472,0.0000704947,0.00006494322,0.000024127998,0.000047584923,0.000014892446,0.000047282872],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009542839,0.009633144,0.48664618,0.00010293819,0.00030205815,0.00065303984,0.00013486015,2.1236728e-7,0.46691746,0.00013571896,0.0011120951,0.034266848],"study_design_scores_gemma":[0.020113824,0.000928581,0.26390922,0.000112624024,0.00046059708,0.00008922689,0.000018949975,0.0000064467254,0.7130135,0.000102724334,0.0010774839,0.00016679052],"about_ca_topic_score_codex":0.00006695431,"about_ca_topic_score_gemma":0.0000030966908,"teacher_disagreement_score":0.24609607,"about_ca_system_score_codex":0.00007464531,"about_ca_system_score_gemma":0.0000852688,"threshold_uncertainty_score":0.42294887},"labels":[],"label_agreement":null},{"id":"W2765486607","doi":"10.1111/bjh.14951","title":"Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Lymphoma Foundation; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Epoch (astronomy); Vincristine; Etoposide; Confidence interval; Rituximab; Prednisone; Lymphoma; Internal medicine; Chemotherapy; Pediatrics; Cyclophosphamide; Surgery","score_opus":0.008756289721170108,"score_gpt":0.225588035526222,"score_spread":0.2168317458050519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765486607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487156,0.0034071628,0.0000092769005,0.00025621787,0.000055346456,0.0003320157,0.000029796434,0.000014332627,0.0010242916],"genre_scores_gemma":[0.99709517,0.0008486264,0.0017034855,0.00012892192,0.000052094547,0.000010629366,0.000020408776,0.000031809872,0.00010887834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839854,0.00006439954,0.000578522,0.00025551286,0.00038234834,0.00032068047],"domain_scores_gemma":[0.9977184,0.00020255688,0.0011319229,0.0003071674,0.00035891976,0.0002810114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014223097,0.00024727944,0.0013265675,0.00013736117,0.00014796006,0.000055094286,0.00019326844,0.00013680004,0.000011961626],"category_scores_gemma":[0.00018869228,0.00017392673,0.00012033534,0.000061007962,0.00046472804,0.00018201012,0.000059383183,0.00013034255,0.0000026999146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054219324,0.0013042751,0.9448641,0.00013745738,0.0008615934,0.037678603,0.00018224271,5.634449e-7,0.000037196252,0.00001897922,0.00040411568,0.013968702],"study_design_scores_gemma":[0.022019798,0.0017479733,0.68576586,0.000903471,0.0006426315,0.28687188,0.0000955715,0.000002155691,0.0018567014,0.000009350292,0.000026397895,0.000058198522],"about_ca_topic_score_codex":0.00066483323,"about_ca_topic_score_gemma":0.00024129862,"teacher_disagreement_score":0.25909823,"about_ca_system_score_codex":0.00007350734,"about_ca_system_score_gemma":0.0003540808,"threshold_uncertainty_score":0.70925266},"labels":[],"label_agreement":null},{"id":"W2766398642","doi":"10.14740/gr860w","title":"Concurrent Primary Gastric and Pulmonary Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review","year":2017,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Primary (astronomy); Pathology; Gastric lymphoma; Internal medicine; Gastroenterology","score_opus":0.03496422256608178,"score_gpt":0.35587072207742815,"score_spread":0.32090649951134637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766398642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253773,0.068800405,0.000003712127,0.00388751,0.00009106245,0.0008486398,0.000059692742,0.000020985248,0.0009106961],"genre_scores_gemma":[0.9349191,0.06308269,0.00009282292,0.00079916837,0.00011328532,0.00020637787,0.00011108575,0.000020985699,0.0006544983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976276,0.00025945556,0.00034136366,0.00065758644,0.00035872476,0.00075527735],"domain_scores_gemma":[0.998144,0.00009988495,0.00015510194,0.00091546396,0.00023688418,0.00044872353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010549977,0.00023196657,0.00056811,0.00017995486,0.00057201466,0.00011451156,0.00013799674,0.000120791155,0.000018620718],"category_scores_gemma":[0.00023456474,0.0001738215,0.000089284826,0.000080320286,0.00044115575,0.00013612822,0.0006168305,0.00031264604,0.000013092858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001718149,0.0027947968,0.6058943,0.0013882737,0.00006444364,0.37833273,0.0000416803,1.102998e-9,0.00006014959,0.00001079139,0.0041383076,0.0071026753],"study_design_scores_gemma":[0.010492754,0.0007684476,0.52626604,0.0014292806,0.00013154707,0.45846185,0.000027487924,0.000018039102,0.000016629534,0.000008464071,0.002314574,0.00006487731],"about_ca_topic_score_codex":0.000049452236,"about_ca_topic_score_gemma":0.000027229567,"teacher_disagreement_score":0.080129124,"about_ca_system_score_codex":0.00012394552,"about_ca_system_score_gemma":0.00009742251,"threshold_uncertainty_score":0.7088235},"labels":[],"label_agreement":null},{"id":"W2766489122","doi":"10.1200/jco.2017.73.8195","title":"International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Peripheral T-cell lymphoma; Internal medicine; Lymphoma; Population; Cohort; Refractory (planetary science); Clinical endpoint; Progression-free survival; Young adult; Overall survival; Surgery; Clinical trial; T cell; Immunology","score_opus":0.10389749999057629,"score_gpt":0.4602181108227659,"score_spread":0.35632061083218963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766489122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96456546,0.0003491092,0.000015541582,0.00946474,0.0036885475,0.00016332597,0.000013091885,0.0000027732096,0.02173741],"genre_scores_gemma":[0.99431497,0.0023786186,0.0019551397,0.0002105016,0.00062242517,0.000005919493,0.000004175545,0.000012490514,0.0004957527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996757,0.00030630297,0.0019348455,0.00021704704,0.00058169384,0.00020315728],"domain_scores_gemma":[0.9958636,0.0010365781,0.0020810368,0.0004193789,0.000300886,0.00029849293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026691542,0.00015534354,0.0013872769,0.000094405914,0.00006199955,0.000022154376,0.00038312384,0.00025812158,0.00017633397],"category_scores_gemma":[0.0015670168,0.000111088164,0.0004035361,0.000027781407,0.00027346413,0.00013903658,0.0003154277,0.00024846866,0.0000024767849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019357139,0.0056026326,0.9400962,0.00002209868,0.00035143716,0.0012961933,0.000052201693,0.000010328979,0.00019763803,0.0003391326,0.0007063883,0.04939003],"study_design_scores_gemma":[0.036460225,0.004445852,0.93941617,0.00009241614,0.00018026265,0.00015676442,0.00008598015,0.0002839977,0.00015261215,0.00018527368,0.018457817,0.000082659004],"about_ca_topic_score_codex":0.00024364032,"about_ca_topic_score_gemma":0.00071260304,"teacher_disagreement_score":0.04930737,"about_ca_system_score_codex":0.00078514346,"about_ca_system_score_gemma":0.0011898543,"threshold_uncertainty_score":0.45300436},"labels":[],"label_agreement":null},{"id":"W2766549235","doi":"10.1016/j.jcjo.2017.09.005","title":"Mantle cell lymphoma: conjunctival mass in a female patient","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mantle cell lymphoma; Medicine; Lymphoma; Dermatology; Pathology","score_opus":0.026572972627059745,"score_gpt":0.2730973566304412,"score_spread":0.24652438400338147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766549235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278028,0.00070124964,9.231479e-7,0.00067314965,0.00063921633,0.00012485143,0.000010513141,9.838358e-7,0.07004633],"genre_scores_gemma":[0.9988404,0.000006710591,0.00027165998,0.000075156786,0.000095080824,0.0000059763,0.0000023642062,0.000013698264,0.0006889496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990614,0.000040416002,0.00031752407,0.00013674128,0.000108898974,0.00033502435],"domain_scores_gemma":[0.9986561,0.000039639945,0.00028777646,0.0003159562,0.00011046992,0.00059005304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012708805,0.00012509103,0.00037878088,0.00023737735,0.00013722279,0.000034625493,0.00016918448,0.00010666987,0.00068251643],"category_scores_gemma":[0.00011556411,0.000102085214,0.0001208118,0.000038529077,0.0001359194,0.00008351185,0.000013935313,0.000091940834,0.00004863253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000949723,0.0002118679,0.8016338,0.000015491689,0.000049121318,0.19555634,0.0002045958,0.0000039220367,0.00008132993,0.000079132886,0.0005618581,0.0015075674],"study_design_scores_gemma":[0.0055238535,0.0012858597,0.8910343,0.00009445547,0.00005534013,0.09780613,0.00022309639,0.0000068407935,0.0019634967,0.00016501329,0.0017389726,0.00010262965],"about_ca_topic_score_codex":0.008126787,"about_ca_topic_score_gemma":0.00034847538,"teacher_disagreement_score":0.09775021,"about_ca_system_score_codex":0.00048558955,"about_ca_system_score_gemma":0.0014451513,"threshold_uncertainty_score":0.9984782},"labels":[],"label_agreement":null},{"id":"W2766663088","doi":"10.3324/haematol.2017.179309","title":"A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Toronto; Alberta Health Services; Queen's University; University of Calgary; University of Saskatchewan","funders":"Canadian Cancer Society Research Institute; Alberta Cancer Foundation","keywords":"BCL6; Tissue microarray; Immunohistochemistry; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Fluorescence in situ hybridization; Lymphoma; Gene expression profiling; Cancer research; Biology; Pathology; Gene expression; Medicine; Gene; Antibody; Immunology; B cell; Germinal center","score_opus":0.08115966950695878,"score_gpt":0.34242491001075404,"score_spread":0.26126524050379524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766663088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564856,0.00091102516,0.00003831498,0.00064178417,0.00013239995,0.00068297994,0.000026362957,0.000079428675,0.0018391666],"genre_scores_gemma":[0.99719316,0.00024548115,0.0018074174,0.00040642772,0.000039087925,0.000085432635,0.000011609071,0.000025827241,0.00018557742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812764,0.000059760183,0.000548558,0.0005401096,0.00024969463,0.00047425876],"domain_scores_gemma":[0.9984129,0.00024956162,0.00028059582,0.00074732443,0.000044857057,0.0002647583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002634447,0.00028057076,0.00081059797,0.00009672659,0.00028384477,0.00007199271,0.00017513786,0.00030022892,0.000018287586],"category_scores_gemma":[0.0008648888,0.00019479563,0.00013278727,0.000049864862,0.00019947061,0.00010297869,0.00025523655,0.00013572995,0.000043116444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002036189,0.009638239,0.98600864,0.00015868466,0.00004093802,0.0022654072,0.00014431201,0.000003862913,0.00006972742,0.0005093276,0.00012518643,0.00083203707],"study_design_scores_gemma":[0.038963225,0.0005924182,0.93123585,0.00039852117,0.00031703003,0.00042953226,0.00008093042,0.026498666,0.00027926711,0.00053136295,0.00036134588,0.00031183148],"about_ca_topic_score_codex":0.000059291047,"about_ca_topic_score_gemma":0.000027453523,"teacher_disagreement_score":0.05477279,"about_ca_system_score_codex":0.000121808946,"about_ca_system_score_gemma":0.00012567872,"threshold_uncertainty_score":0.79435354},"labels":[],"label_agreement":null},{"id":"W2767130856","doi":"10.3390/cancers9110148","title":"Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers","year":2017,"lang":"en","type":"review","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Cancer research; Anaplastic large-cell lymphoma; Crizotinib; Tyrosine kinase; Receptor tyrosine kinase; Lymphoma; Biology; Receptor Protein-Tyrosine Kinases; Kinase; Medicine; Signal transduction; Immunology; Lung cancer; Pathology; Genetics","score_opus":0.13104130506595293,"score_gpt":0.3806893129005836,"score_spread":0.24964800783463068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767130856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014927004,0.992374,0.0000020939815,0.000055668155,0.00038154065,0.0009705642,0.000042191725,0.00003320917,0.0046480107],"genre_scores_gemma":[0.016992647,0.98152393,0.00015189228,0.000056326946,0.00021709842,0.00076475844,0.00013428043,0.00010254834,0.000056510533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973593,0.000076856086,0.0007206358,0.0008773102,0.00031521867,0.0006507325],"domain_scores_gemma":[0.9983785,0.00011278824,0.0005221623,0.0007221097,0.00004089435,0.0002235242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023205382,0.0006307478,0.0022544402,0.00045852867,0.00012232766,0.00005504037,0.00029199405,0.00036016692,0.00002975118],"category_scores_gemma":[0.00015167503,0.00054740463,0.0003884385,0.00019044425,0.00012704289,0.0000906788,0.000096622956,0.0002384709,0.000013344744],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023287193,0.000106540654,0.00012511111,0.010234044,0.00022606281,0.0019900808,0.00020979058,0.00010363468,0.000020027315,0.00008481536,0.00015332528,0.9867233],"study_design_scores_gemma":[0.00474132,0.00019593853,0.00053777796,0.089593165,0.0007847032,0.00006377688,0.00016100978,0.000052935753,0.000041353247,0.000009216347,0.903172,0.0006467698],"about_ca_topic_score_codex":0.0051271603,"about_ca_topic_score_gemma":0.0021858534,"teacher_disagreement_score":0.98607653,"about_ca_system_score_codex":0.01697854,"about_ca_system_score_gemma":0.0036088892,"threshold_uncertainty_score":0.99969774},"labels":[],"label_agreement":null},{"id":"W2767633842","doi":"10.1182/blood-2017-08-799080","title":"FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"Terry Fox Research Institute","keywords":"Rituximab; Follicular lymphoma; Oncology; Chemotherapy; Lymphoma; Internal medicine; Medicine; Chemotherapy regimen; Biomarker; Adverse effect; Gene expression; Immunology; Cancer research; Gene; Biology; Genetics","score_opus":0.013824745892446809,"score_gpt":0.25733546440602173,"score_spread":0.24351071851357492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767633842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963222,0.00092556817,0.0000020623477,0.0009104484,0.000010433631,0.0005986475,0.000006937645,0.00003317658,0.0011905308],"genre_scores_gemma":[0.99858314,0.00023750243,0.00058078056,0.00024779106,0.000020244639,0.00015181222,0.000011134504,0.000024081752,0.00014349278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991611,0.000015473606,0.00013266926,0.00031975604,0.00016162658,0.00020936082],"domain_scores_gemma":[0.99928,0.000027244112,0.00008280888,0.00046598146,0.000031968797,0.0001120465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051398816,0.00017919824,0.00030438803,0.000065494765,0.00012626252,0.000065256565,0.000064964304,0.00008259708,0.000034456487],"category_scores_gemma":[0.00002681909,0.000113221104,0.000047417976,0.00005388414,0.000073378345,0.00008304962,0.00003057905,0.00002377005,0.0000116678075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037876,0.0044028405,0.9721827,0.000039868894,0.00018334393,0.00077992416,0.00016432474,9.704484e-9,0.0030860922,0.0000065323056,0.0001369048,0.018713685],"study_design_scores_gemma":[0.05045948,0.00044949257,0.8838489,0.0004889105,0.00023819524,0.00018815568,0.000019260728,0.000025621785,0.06348703,0.000016341797,0.0006549468,0.00012362935],"about_ca_topic_score_codex":0.00026082635,"about_ca_topic_score_gemma":0.000022330929,"teacher_disagreement_score":0.088333756,"about_ca_system_score_codex":0.00003339223,"about_ca_system_score_gemma":0.000047529527,"threshold_uncertainty_score":0.4617023},"labels":[],"label_agreement":null},{"id":"W2767762193","doi":"10.1002/cncr.31114","title":"Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Total body irradiation; Population; Transplantation; Oncology; Hematopoietic stem cell transplantation; International Prognostic Index; Confidence interval; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.018470145400243703,"score_gpt":0.2953899936230549,"score_spread":0.2769198482228112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767762193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974793,0.00085346616,0.000089084744,0.00017710762,0.0001969304,0.0005026955,0.0001828934,0.000020021018,0.00049846445],"genre_scores_gemma":[0.99779874,0.0010448059,0.00012647637,0.000074750256,0.000035210865,0.00016643752,0.00003477812,0.000021134,0.00069768575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927145,0.000012336415,0.00018187784,0.00021630598,0.00011496114,0.00020308644],"domain_scores_gemma":[0.9993039,0.00007522738,0.000163618,0.00031430816,0.00004711581,0.00009585901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006472381,0.0001444033,0.0003525625,0.0000396339,0.00012463758,0.000024885718,0.00007497285,0.00008351166,0.000038180548],"category_scores_gemma":[0.000011975468,0.00010892102,0.00010495759,0.000017651859,0.00008905307,0.00006959139,0.000017064573,0.000021383668,0.0000034009295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012505958,0.00092956115,0.9939311,0.0007549106,0.00006261415,0.00004560494,0.0006848664,2.944086e-7,0.00019640847,0.000056512603,0.000109143555,0.0031039338],"study_design_scores_gemma":[0.016533522,0.00013471993,0.9576411,0.00013182037,0.00035968758,0.00000682486,0.000045641547,0.000019670346,0.024901642,0.000023257078,0.00009688694,0.00010521716],"about_ca_topic_score_codex":0.00056160137,"about_ca_topic_score_gemma":0.00073745946,"teacher_disagreement_score":0.03628998,"about_ca_system_score_codex":0.000066525456,"about_ca_system_score_gemma":0.000059006892,"threshold_uncertainty_score":0.44416705},"labels":[],"label_agreement":null},{"id":"W2769578901","doi":"10.1002/cyto.b.21603","title":"Initial flow cytometric evaluation of the Clearllab lymphoid screen","year":2017,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Calgary Laboratory Services; London Health Sciences Centre","funders":"","keywords":"Population; Malignancy; Immunophenotyping; Hematologic Neoplasms; CD5; Antibody; Medicine; CD20; Minimal residual disease; Flow cytometry; Pathology; Lymphoma; Leukemia; Immunology; Internal medicine; Transplantation","score_opus":0.20606446333993572,"score_gpt":0.47375186607275144,"score_spread":0.2676874027328157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769578901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97148293,0.0010485629,0.000078941266,0.0010499392,0.0023400462,0.0013046956,0.00017182226,0.00008542011,0.022437641],"genre_scores_gemma":[0.9960554,0.00032370613,0.00074779487,0.0007934489,0.0014404077,0.000084555686,0.00005730332,0.000065358894,0.00043199302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99324,0.0006332649,0.0017245214,0.00092216616,0.002819109,0.0006609501],"domain_scores_gemma":[0.99218595,0.0013780183,0.0012903988,0.0034164852,0.0011773988,0.0005517677],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006168649,0.0004601718,0.0013216784,0.0009546066,0.0007180528,0.00017350218,0.0010872297,0.00056682,0.0011282238],"category_scores_gemma":[0.018494196,0.00031231606,0.0011593017,0.0024394193,0.0009369363,0.00032110568,0.00073673314,0.00051139685,0.00049779424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036800085,0.001769476,0.85297877,0.000058295507,0.0005645634,0.000034283556,0.000019671174,0.0000066975667,0.00009888664,0.000054938715,0.0038385831,0.14020784],"study_design_scores_gemma":[0.012401187,0.0008447527,0.97015244,0.0002828049,0.0016283395,0.000107953994,0.000044349406,0.0011256391,0.00688613,0.00011201047,0.0060977857,0.00031658442],"about_ca_topic_score_codex":0.000103833954,"about_ca_topic_score_gemma":0.000013024041,"teacher_disagreement_score":0.13989125,"about_ca_system_score_codex":0.00060164306,"about_ca_system_score_gemma":0.00092905294,"threshold_uncertainty_score":0.9999329},"labels":[],"label_agreement":null},{"id":"W2771658548","doi":"10.1093/annonc/mdx764","title":"Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre","funders":"","keywords":"Everolimus; Medicine; Internal medicine; Hazard ratio; Rituximab; Placebo; Common Terminology Criteria for Adverse Events; Clinical endpoint; Oncology; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Lymphoma; Confidence interval; Pathology","score_opus":0.0702101635286362,"score_gpt":0.37389617729927827,"score_spread":0.3036860137706421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771658548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165035,0.0015519606,0.0000055460423,0.010608922,0.000662581,0.0016130693,0.0005882159,0.000018614903,0.0033007474],"genre_scores_gemma":[0.9913876,0.005943571,0.000105366846,0.0014289758,0.0004883559,0.00019064925,0.00017107419,0.000018928813,0.00026547062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99723417,0.0006028746,0.0009834588,0.00042943415,0.00029831732,0.00045174852],"domain_scores_gemma":[0.99476343,0.0027737636,0.0010966216,0.0010632592,0.00014749756,0.00015539785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018088765,0.00025864545,0.0016989189,0.0000802093,0.00024285993,0.00002763045,0.0003449832,0.00025858168,0.0000618732],"category_scores_gemma":[0.0024451155,0.00015251772,0.00042253878,0.0000601085,0.0003193692,0.000084083535,0.00016045386,0.00014210255,0.00004683344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89953643,0.031711858,0.0018335093,0.000007652648,0.00042394662,0.000657695,0.0008577402,9.783604e-7,0.0000448759,0.00017953628,0.01197442,0.05277138],"study_design_scores_gemma":[0.94685435,0.004673218,0.025551649,0.00007265196,0.00055016985,0.000009735828,0.000085684216,0.00011814915,0.0018140106,0.0005665164,0.019571228,0.00013262146],"about_ca_topic_score_codex":0.009776102,"about_ca_topic_score_gemma":0.001115792,"teacher_disagreement_score":0.052638758,"about_ca_system_score_codex":0.00009851445,"about_ca_system_score_gemma":0.00042956902,"threshold_uncertainty_score":0.9968179},"labels":[],"label_agreement":null},{"id":"W2772214850","doi":"10.1182/blood-2018-09-872549","title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National University of Singapore; University of Nebraska Medical Center","keywords":"Biology; Lymphoma; Genetics; Cancer research; Immunology","score_opus":0.006008785433177785,"score_gpt":0.2009641097093744,"score_spread":0.1949553242761966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772214850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951524,0.0014334519,0.0000030804279,0.000018009427,0.000041514788,0.00032859907,0.000009836502,0.000008946676,0.0030041442],"genre_scores_gemma":[0.99863374,0.000120208926,0.0010862851,0.000049152983,0.000011138974,0.000014677851,0.000007965294,0.000015353946,0.00006150248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918115,0.000022057962,0.00025086713,0.00018469495,0.0002005176,0.00016071627],"domain_scores_gemma":[0.9994971,0.000019647165,0.00008761651,0.00029413894,0.000039145838,0.000062329425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040525534,0.0001130602,0.00032624495,0.00007437358,0.000005673926,0.000002174412,0.00006697121,0.000067387635,0.0000970639],"category_scores_gemma":[0.000006198002,0.00009809158,0.00014227393,0.00012884285,0.000030853393,0.000017337186,0.000028516279,0.00002262138,0.000023525687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046826088,0.004075889,0.70971745,0.00013090507,0.00010572749,0.00023089681,0.00034846592,0.000017565064,0.2836198,0.000102678016,0.000007231282,0.0015965999],"study_design_scores_gemma":[0.01715291,0.00077393046,0.49142694,0.00007940033,0.00018959213,0.000029854746,0.000107775544,0.0000341753,0.49003834,0.000025453812,0.000064402724,0.00007721601],"about_ca_topic_score_codex":0.00015790372,"about_ca_topic_score_gemma":0.000008180369,"teacher_disagreement_score":0.21829048,"about_ca_system_score_codex":0.00006503275,"about_ca_system_score_gemma":0.00013441939,"threshold_uncertainty_score":0.40000588},"labels":[],"label_agreement":null},{"id":"W2772253366","doi":"10.1038/s41408-017-0033-8","title":"MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sigrid Juséliuksen Säätiö; National Cancer Institute; Academy of Finland; Helsingin Yliopisto","keywords":"microRNA; Cancer research; Biology; Diffuse large B-cell lymphoma; Signal transduction; MAPK/ERK pathway; Chemoimmunotherapy; Lymphoma; Cancer; Biological pathway; Immunology; Gene expression; Gene; Cell biology; Genetics","score_opus":0.013978233493338417,"score_gpt":0.2677070162185166,"score_spread":0.2537287827251782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772253366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209464,0.0060307574,0.0000012538316,0.0004432524,0.00038165436,0.00021450226,0.000058007558,0.0000169563,0.0007589804],"genre_scores_gemma":[0.99428165,0.004819411,0.00020378098,0.00003724393,0.00034718515,0.000013598776,0.0000046275923,0.000031326108,0.0002612023],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859667,0.0000553496,0.00033363828,0.00027097168,0.0003465358,0.00039684147],"domain_scores_gemma":[0.99852204,0.000032973876,0.0006129887,0.00040307784,0.00014487054,0.00028407155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029924687,0.00023041737,0.00048933574,0.00006439913,0.00051348837,0.000097704564,0.00011970031,0.00010739187,0.000029506093],"category_scores_gemma":[0.000032372813,0.00016963265,0.00015153026,0.000035628316,0.00010293426,0.00015008054,0.00014259461,0.00013021614,0.0000036097542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005802104,0.00979695,0.57577276,0.00050887506,0.0003354965,0.00181721,0.00087890803,4.0145744e-7,0.3937806,0.000009318546,0.00021791438,0.016301353],"study_design_scores_gemma":[0.03145483,0.00015738478,0.44780025,0.00043265996,0.0003284147,0.00037212446,0.00003746769,0.0000071750273,0.51907426,0.000012021504,0.00021636723,0.000107019594],"about_ca_topic_score_codex":0.00008919818,"about_ca_topic_score_gemma":0.000039981423,"teacher_disagreement_score":0.12797251,"about_ca_system_score_codex":0.00011054941,"about_ca_system_score_gemma":0.00023164948,"threshold_uncertainty_score":0.6917419},"labels":[],"label_agreement":null},{"id":"W277399393","doi":"10.1182/blood.v124.21.3064.3064","title":"Efficacy and Safety of Frontline Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Vs R-CHOP in a Subset of Newly Diagnosed Mantle Cell Lymphoma (MCL) Patients (Pts) Medically Eligible for Transplantation in the Randomized Phase 3 LYM-3002 Study (NCT00722137)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Clinical endpoint; Transplantation; Prednisone; CHOP; Regimen; Bortezomib; Mantle cell lymphoma; Vincristine; Oncology; Autologous stem-cell transplantation; Gastroenterology; Cyclophosphamide; Adverse effect; Urology; Surgery; Lymphoma; Clinical trial; Chemotherapy","score_opus":0.006136237237894708,"score_gpt":0.2507294225807201,"score_spread":0.2445931853428254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W277399393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918677,0.002223643,0.00011914867,0.00017720732,0.000051196977,0.0052090585,0.00018698443,0.000014798026,0.00015025989],"genre_scores_gemma":[0.995803,0.002589319,0.0006188518,0.00015548505,0.00003093675,0.0005322321,0.00023026331,0.00002802908,0.000011857309],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734247,0.00032754333,0.001118869,0.00045108513,0.0004475632,0.00031247918],"domain_scores_gemma":[0.9971916,0.0019008265,0.00033707658,0.0003377095,0.00011209898,0.00012066905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109638,0.00030975012,0.0013502768,0.00019467644,0.00005636866,0.000016467799,0.00012705296,0.00012889734,0.00001288058],"category_scores_gemma":[0.00040783302,0.00020612538,0.00012911519,0.00022823093,0.00015982543,0.00008293198,0.00002772914,0.000071550705,0.0000011695555],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2962186,0.17028196,0.46590984,0.0013266245,0.0007410396,0.00018430069,0.015082994,0.000010609502,0.0012033795,0.00008718969,0.00017310155,0.048780367],"study_design_scores_gemma":[0.6820378,0.0028053138,0.30752617,0.00026878607,0.0012858105,0.000008617745,0.00027085832,0.00033927493,0.0052022184,0.000049201528,0.000068086556,0.00013789035],"about_ca_topic_score_codex":0.0010386435,"about_ca_topic_score_gemma":0.0003232359,"teacher_disagreement_score":0.38581917,"about_ca_system_score_codex":0.000038691516,"about_ca_system_score_gemma":0.00008887463,"threshold_uncertainty_score":0.84055483},"labels":[],"label_agreement":null},{"id":"W2774408258","doi":"10.1182/bloodadvances.2017009472","title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nodular sclerosis; CD30; Medicine; Vincristine; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Pathology; Cyclophosphamide; Chemotherapy; Hodgkin lymphoma","score_opus":0.02281939306840379,"score_gpt":0.31848659060466666,"score_spread":0.29566719753626286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774408258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957072,0.0024305088,0.0000013937344,0.00040448003,0.00009226823,0.0005000135,0.000025981066,0.000032712094,0.0008054241],"genre_scores_gemma":[0.9985885,0.00039431246,0.0005998668,0.000053084084,0.00014497127,0.000047425227,0.0000063456782,0.000014216623,0.00015130412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887395,0.00005109426,0.00027782132,0.00036657567,0.000226278,0.00020430672],"domain_scores_gemma":[0.99873316,0.00024374117,0.0003193974,0.0004969224,0.00006781826,0.00013898434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012230781,0.00020140271,0.0006166259,0.000051035982,0.00017484734,0.000035018285,0.00012231214,0.00006750612,0.0000037509335],"category_scores_gemma":[0.00014530975,0.00011847548,0.000053692824,0.000036591424,0.00045148324,0.00006984257,0.00009349452,0.00006633382,0.0000034039872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031892434,0.0032925971,0.9336883,0.00004763573,0.00024001814,0.00073262793,0.0002378968,2.0489338e-7,0.000039535957,0.000034082263,0.000040653296,0.06132752],"study_design_scores_gemma":[0.018743662,0.006361556,0.97029185,0.0001738305,0.00088766956,0.000160566,0.00060370244,7.3230683e-7,0.0021390873,0.00006039396,0.00045072366,0.00012623511],"about_ca_topic_score_codex":0.00007382941,"about_ca_topic_score_gemma":0.00023814554,"teacher_disagreement_score":0.061201286,"about_ca_system_score_codex":0.000014957129,"about_ca_system_score_gemma":0.000050600705,"threshold_uncertainty_score":0.483129},"labels":[],"label_agreement":null},{"id":"W2774688774","doi":"10.1038/s41409-017-0054-8","title":"Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Tolerability; Stem cell; Lymphoma; Autologous stem-cell transplantation; Oncology; Internal medicine; Adverse effect; Biology","score_opus":0.013171263393268061,"score_gpt":0.2389355052902251,"score_spread":0.225764241896957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774688774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693832,0.002839289,0.0012757389,0.019594776,0.00027599317,0.0030561408,0.003101958,0.00006135001,0.00041158672],"genre_scores_gemma":[0.9919884,0.0032431295,0.00040809263,0.0021153097,0.00014895048,0.0004204004,0.0012843381,0.000058292,0.00033308478],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9980361,0.000101832135,0.0005180553,0.0007146653,0.0002612404,0.00036812262],"domain_scores_gemma":[0.99839896,0.0006110743,0.00035296622,0.00042590752,0.00011783349,0.00009328203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028442565,0.00046321464,0.0011812192,0.000119503304,0.00018098399,0.00003710387,0.00009228842,0.0005677494,0.0000066832577],"category_scores_gemma":[0.000005188936,0.00038537369,0.00020834818,0.000037447073,0.00019048176,0.000089426,0.000010136387,0.00017737046,0.0000024733736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038165554,0.011851203,0.2007265,0.5129831,0.0020980618,0.021169081,0.0072935238,0.00003489043,0.014390397,0.00014760687,0.04757626,0.14356385],"study_design_scores_gemma":[0.13007064,0.005288248,0.63573426,0.010126599,0.010047592,0.0040535713,0.00007039249,0.00091398036,0.17059928,0.0005359514,0.030598788,0.0019607167],"about_ca_topic_score_codex":0.00028222692,"about_ca_topic_score_gemma":0.00006940782,"teacher_disagreement_score":0.5028565,"about_ca_system_score_codex":0.0001279657,"about_ca_system_score_gemma":0.00010046548,"threshold_uncertainty_score":0.9998598},"labels":[],"label_agreement":null},{"id":"W2775616175","doi":"10.1182/blood-2017-10-807172","title":"The ecosystem of classical Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Classical Hodgkin lymphoma; Lymphoma; Reed–Sternberg cell; Cancer research; Tumor microenvironment; Hodgkin lymphoma; Medicine; Immunology; Biology; Tumor cells","score_opus":0.018062467028314003,"score_gpt":0.25526398864059086,"score_spread":0.23720152161227687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775616175","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09501495,0.0044196118,8.0482204e-7,0.8657013,0.0010412764,0.0010606474,0.00024348381,0.00007312012,0.032444756],"genre_scores_gemma":[0.76885647,0.001429319,0.00024066518,0.18174386,0.016981656,0.00068079296,0.00055508176,0.00022651776,0.029285619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985248,0.00006434316,0.00033958833,0.00031008504,0.00044765088,0.00031353004],"domain_scores_gemma":[0.99793214,0.00030989863,0.0003566165,0.0012486948,0.000086338114,0.0000662887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012194309,0.0002637353,0.0006272745,0.00004670789,0.00017575533,0.00005617838,0.00030199465,0.0005221649,0.000027312095],"category_scores_gemma":[0.00008964766,0.00014339379,0.00036588885,0.000029216288,0.00010340269,0.000018686294,0.00007782309,0.00021665126,0.0001444451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023588558,0.00062876684,0.004189565,0.00025092033,0.0009980489,0.002801491,0.000018928635,8.4417815e-9,0.000013551652,0.00008074793,0.98280853,0.008185856],"study_design_scores_gemma":[0.0052921544,0.00032077584,0.012400113,0.00049957715,0.0013946539,0.00051863666,0.000004901684,0.000001950729,0.002015854,0.000034448585,0.9773827,0.00013421601],"about_ca_topic_score_codex":0.00004130285,"about_ca_topic_score_gemma":0.000019557408,"teacher_disagreement_score":0.68395746,"about_ca_system_score_codex":0.000089690024,"about_ca_system_score_gemma":0.0002881294,"threshold_uncertainty_score":0.58474284},"labels":[],"label_agreement":null},{"id":"W2776378913","doi":"","title":"Rituximab immunotherapy in the treatment of B-cell non-Hodgkin's lymphoma","year":2005,"lang":"en","type":"article","venue":"Pure Amsterdam UMC","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Rituximab; Medicine; Immunotherapy; Lymphoma; Oncology; Internal medicine; Non-Hodgkin's lymphoma; Immunology; Cancer","score_opus":0.011260785555904885,"score_gpt":0.26553973425780497,"score_spread":0.2542789487019001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776378913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97930455,0.0042006546,0.000009414889,0.002966476,0.00008209985,0.00080171693,0.000013329218,0.0000221695,0.012599576],"genre_scores_gemma":[0.9952026,0.0019463494,0.00069301616,0.001012619,0.00020194733,0.00023443843,0.000027623684,0.00002465873,0.0006567433],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987809,0.000051666397,0.00034622446,0.00025768435,0.00027296814,0.00029055297],"domain_scores_gemma":[0.9991144,0.00010792098,0.00010205998,0.000580703,0.000035561243,0.00005935103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010470462,0.00023804966,0.00046964784,0.00010211016,0.00004963871,0.000020999947,0.00013746106,0.00008579726,0.00012809744],"category_scores_gemma":[0.000003025077,0.0001366942,0.00022913924,0.00018765422,0.00005916044,0.00006411265,0.00001128028,0.000032890122,0.00014724744],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010649052,0.045183342,0.109052524,0.000084374915,0.0003184211,0.00033213632,0.009795488,0.000010187744,0.0039954837,0.00022144523,0.0024400272,0.82750165],"study_design_scores_gemma":[0.07397297,0.0075641926,0.54142934,0.00015809303,0.0003612327,0.00022025192,0.0007374679,0.00021270773,0.076114595,0.00010235739,0.2987426,0.00038417068],"about_ca_topic_score_codex":0.00020183218,"about_ca_topic_score_gemma":0.000093776696,"teacher_disagreement_score":0.8271175,"about_ca_system_score_codex":0.00033227835,"about_ca_system_score_gemma":0.00007933103,"threshold_uncertainty_score":0.55742276},"labels":[],"label_agreement":null},{"id":"W2776569330","doi":"10.1097/01.ccm.0000529014.84015.64","title":"1007: ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED IN A PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION","year":2017,"lang":"en","type":"article","venue":"Critical Care Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Extracorporeal membrane oxygenation; Anaplastic large-cell lymphoma; Lymphoma; Extracorporeal; Internal medicine","score_opus":0.01985153982341704,"score_gpt":0.30771456287416993,"score_spread":0.2878630230507529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776569330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960265,0.0013202761,0.000026125532,0.006666161,0.00074534956,0.00063037145,0.000050127615,0.000056295165,0.030240335],"genre_scores_gemma":[0.9973175,0.00012697247,0.0000894179,0.0016283159,0.00040007388,0.00015800944,0.00017001387,0.000032952536,0.000076780685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977735,0.000061916115,0.0004630871,0.00051549484,0.0006712809,0.0005146846],"domain_scores_gemma":[0.99783087,0.00067951286,0.000097234595,0.0007267817,0.00023432293,0.00043128373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017328907,0.0002961071,0.00058002566,0.00020792632,0.00025218545,0.000035679728,0.00014891244,0.00015935086,0.00032710636],"category_scores_gemma":[0.002311782,0.00021301089,0.00010730803,0.0001004687,0.00028092385,0.00009472858,0.00006206808,0.00013784059,0.00009968756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059609464,0.031492095,0.40963796,0.0042079873,0.00022109294,0.07641718,0.01350576,0.000013410071,0.003920453,0.040567223,0.015107094,0.3989488],"study_design_scores_gemma":[0.046863068,0.00937151,0.9173557,0.001961752,0.00048109057,0.0001375626,0.0036285939,0.00034932687,0.010865868,0.00030065395,0.008248912,0.00043592864],"about_ca_topic_score_codex":0.0003306543,"about_ca_topic_score_gemma":0.00027119438,"teacher_disagreement_score":0.5077178,"about_ca_system_score_codex":0.000464219,"about_ca_system_score_gemma":0.00012851738,"threshold_uncertainty_score":0.8686332},"labels":[],"label_agreement":null},{"id":"W2776736524","doi":"10.1016/s1470-2045(17)30912-9","title":"Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; BC Cancer Agency; University of British Columbia","keywords":"Brentuximab vedotin; Medicine; Bendamustine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Regimen; Lymphoma; Chemotherapy; Chemotherapy regimen; Refractory (planetary science); Surgery; CD30; Rituximab","score_opus":0.15133620773205653,"score_gpt":0.43123620369396665,"score_spread":0.2798999959619101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776736524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762187,0.00014956741,0.000004164636,0.01070439,0.0020011605,0.00094928354,0.000044732715,0.00006744061,0.009860534],"genre_scores_gemma":[0.99459213,0.0003630569,0.0006448728,0.001285513,0.002144681,0.00016057842,0.00010675313,0.000028358325,0.0006740591],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982164,0.0002393704,0.0004367727,0.00040791696,0.0002607765,0.0004387679],"domain_scores_gemma":[0.99786973,0.00042227405,0.0004279222,0.0010484912,0.00008665753,0.00014492206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005708588,0.00022892319,0.0007722151,0.000098068194,0.00021354412,0.000069841175,0.00056538597,0.00018474551,0.0004370606],"category_scores_gemma":[0.0009177689,0.00014018863,0.00009916503,0.00006119031,0.00021131533,0.00015532516,0.00015885105,0.00017790604,0.00008081919],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4206067,0.058773234,0.012444201,0.000057107376,0.00053245114,0.004338177,0.0025190422,0.000018941557,0.0013148494,0.00069438055,0.0074903294,0.49121058],"study_design_scores_gemma":[0.71075845,0.013420738,0.06275389,0.00012551167,0.00029377377,0.00021838477,0.00030369114,0.0013514517,0.00064794393,0.000072466806,0.20982465,0.00022902714],"about_ca_topic_score_codex":0.0005507993,"about_ca_topic_score_gemma":0.0011530695,"teacher_disagreement_score":0.49098155,"about_ca_system_score_codex":0.0013034537,"about_ca_system_score_gemma":0.00047571963,"threshold_uncertainty_score":0.5716726},"labels":[],"label_agreement":null},{"id":"W2778936640","doi":"10.1002/pbc.26932","title":"Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch‐and‐wait strategy after complete resection","year":2017,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Chemotherapy; Pediatrics; Resection; Lymphoma; General surgery; Surgery; Internal medicine","score_opus":0.017193572462424086,"score_gpt":0.26285233120918516,"score_spread":0.24565875874676107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778936640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507904,0.0026281404,0.0000065787303,0.0009859578,0.00003940332,0.0011021693,0.000066006935,0.000047798643,0.00004489801],"genre_scores_gemma":[0.9896728,0.0081286905,0.0002792076,0.00023130924,0.0008556224,0.00056122756,0.000027624712,0.000054773984,0.00018874973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983815,0.0000316485,0.0002049244,0.0006215753,0.0003705419,0.00038980012],"domain_scores_gemma":[0.9988992,0.0000130650715,0.00020721178,0.00043819466,0.00012306268,0.00031923837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007245282,0.000343229,0.00042013827,0.00008826511,0.0002822336,0.00016961867,0.000094168114,0.00010152723,0.00006386806],"category_scores_gemma":[0.0000042885213,0.00020712051,0.0000413045,0.000098580065,0.00014032135,0.00019856184,0.000044783257,0.00009369139,0.0000026010434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00741076,0.0016377558,0.9710933,0.00018933178,0.00036863345,0.00018771627,0.00023517745,0.0000013781338,0.000017690045,0.0000011779467,0.000109732864,0.018747326],"study_design_scores_gemma":[0.023632783,0.004173065,0.96878785,0.00035808436,0.0017375259,0.0003346553,0.000043645177,0.000048317885,0.00045042226,0.00000215531,0.00014143737,0.00029004013],"about_ca_topic_score_codex":0.0032915242,"about_ca_topic_score_gemma":0.0023192682,"teacher_disagreement_score":0.018457286,"about_ca_system_score_codex":0.00009008271,"about_ca_system_score_gemma":0.00020502048,"threshold_uncertainty_score":0.84461296},"labels":[],"label_agreement":null},{"id":"W2779078157","doi":"","title":"ReBel studie: een gerandomiseerde fase I/II studie naar de effectiviteit en veiligheid van behandeling met lenalidomide en rituximab, met of zonder bendamustine, bij volwassen patienten met recidief folliculair lymfoom","year":2012,"lang":"nl","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Lenalidomide; Medicine; Bendamustine; Rituximab; Multiple myeloma; Internal medicine; Lymphoma","score_opus":0.01603559497502886,"score_gpt":0.2849053998475772,"score_spread":0.2688698048725483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779078157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95902014,0.03331709,0.00072577974,0.00030962905,0.0009295761,0.0021534923,0.0029160972,0.00016077414,0.0004674248],"genre_scores_gemma":[0.978208,0.009916018,0.004545694,0.00038792784,0.0021342568,0.00029645965,0.004027734,0.00018636366,0.00029753248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99101186,0.0023985016,0.0017396541,0.0017331225,0.0010603628,0.0020564971],"domain_scores_gemma":[0.98991984,0.0054869787,0.0009671578,0.0023911279,0.00023967652,0.0009952094],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0050170375,0.0013964298,0.0029290838,0.00040957954,0.0010721989,0.00013377174,0.0013011895,0.0003664781,0.00007938822],"category_scores_gemma":[0.00047186684,0.0010935733,0.00048468725,0.0006793881,0.00024086362,0.00083624246,0.0030968506,0.00068088376,0.000046634123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075294417,0.010566688,0.83278173,0.0044388184,0.018644348,0.00036681356,0.039242223,0.001407556,0.003966029,0.00011245444,0.005039545,0.075904325],"study_design_scores_gemma":[0.14871442,0.008552387,0.6231128,0.017629793,0.044431493,0.00043170105,0.022188623,0.08645311,0.0067953384,0.00035290516,0.0364199,0.0049175182],"about_ca_topic_score_codex":0.006024418,"about_ca_topic_score_gemma":0.0014538107,"teacher_disagreement_score":0.20966895,"about_ca_system_score_codex":0.00042646576,"about_ca_system_score_gemma":0.00018804593,"threshold_uncertainty_score":0.9998786},"labels":[],"label_agreement":null},{"id":"W2780018527","doi":"10.1097/mph.0000000000001076","title":"Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"Medicine; Dacarbazine; ABVD; Vincristine; Vinblastine; Regimen; Prednisone; Internal medicine; Etoposide; Oncology; Bleomycin; Radiation therapy; Chemotherapy regimen; Retrospective cohort study; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.012373593694800308,"score_gpt":0.31170701743856477,"score_spread":0.2993334237437645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780018527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951565,0.0019287328,0.00006635742,0.0020472158,0.00034931567,0.00042613602,0.0000074002837,0.000008820785,0.000009507854],"genre_scores_gemma":[0.99474454,0.0020022602,0.0028279293,0.00021118885,0.00015428434,0.000012924437,0.0000016962134,0.000027403756,0.000017745182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977224,0.00040535268,0.0009533485,0.00026980796,0.00031662532,0.00033248917],"domain_scores_gemma":[0.996836,0.000570182,0.0018373624,0.00038005062,0.00010646453,0.0002699047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009594173,0.00027236322,0.0015345871,0.0005822747,0.000115399744,0.000018161472,0.00024801388,0.000302522,0.000019572219],"category_scores_gemma":[0.0006337086,0.0001587069,0.00023062424,0.00011466813,0.00016297106,0.00011300843,0.00006368538,0.00022345684,0.0000020399468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013557119,0.0019581714,0.96871924,0.00006881498,0.00037190397,0.0027375366,0.00026073164,0.000004424079,0.0000634614,0.000004111538,0.00031165848,0.0119427955],"study_design_scores_gemma":[0.047095377,0.0062446673,0.9438358,0.00028610983,0.0007626422,0.000892372,0.00007009244,0.00001998024,0.0005357819,0.000015885957,0.00010399768,0.00013730706],"about_ca_topic_score_codex":0.00019028096,"about_ca_topic_score_gemma":0.00005610365,"teacher_disagreement_score":0.033538256,"about_ca_system_score_codex":0.00046780324,"about_ca_system_score_gemma":0.0011794899,"threshold_uncertainty_score":0.64718795},"labels":[],"label_agreement":null},{"id":"W2781185561","doi":"10.1016/j.blre.2017.12.001","title":"The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies","year":2017,"lang":"en","type":"review","venue":"Blood Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Terry Fox Research Institute","keywords":"Diffuse large B-cell lymphoma; Germinal center; CIITA; Lymphoma; Biology; Cancer research; B cell; Immunology; Immune system; T cell; Antibody","score_opus":0.13687053912963998,"score_gpt":0.3792709783086949,"score_spread":0.2424004391790549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781185561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011920867,0.9917651,0.00004321761,0.00018564235,0.00014817393,0.0064292913,0.00062434183,0.00002113944,0.0007711899],"genre_scores_gemma":[0.000011894255,0.99108994,0.0015919015,0.00015396936,0.00021201452,0.005650244,0.0006336555,0.000059915943,0.00059644366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977381,0.00014347628,0.00116879,0.00047961992,0.00009401935,0.0003759447],"domain_scores_gemma":[0.99539864,0.0008997143,0.0015249413,0.0019335249,0.00013616467,0.00010701092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072286197,0.00050191884,0.0034404628,0.000060499322,0.00035187518,0.000032829965,0.00046692096,0.00027954782,0.000004881545],"category_scores_gemma":[0.0004720897,0.00023154599,0.0016862019,0.00009526785,0.0001421619,0.000024438565,0.00012066716,0.00008355107,0.00003720607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000046338396,0.0076453793,0.000086351705,0.021036834,0.00054984225,0.0000033589438,0.0000178451,4.3414716e-10,0.000010869062,0.0007995594,0.0016132972,0.96823204],"study_design_scores_gemma":[0.00631969,0.0002475182,0.00044588544,0.009025996,0.0098284725,0.00016461553,0.0000021414755,7.972041e-8,0.0000050762146,0.000025523472,0.973733,0.00020201092],"about_ca_topic_score_codex":0.000006390564,"about_ca_topic_score_gemma":0.0000038494572,"teacher_disagreement_score":0.9721197,"about_ca_system_score_codex":0.00010075668,"about_ca_system_score_gemma":0.0005363376,"threshold_uncertainty_score":0.94421715},"labels":[],"label_agreement":null},{"id":"W2781647923","doi":"10.1111/pin.12621","title":"Gastrointestinal follicular lymphoma: Current knowledge and future challenges","year":2018,"lang":"en","type":"review","venue":"Pathology International","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Pathology; Duodenum; Lymphoma; Follicular lymphoma; Gastrointestinal tract; CD99; Immunophenotyping; Medicine; Biology; Immunohistochemistry; Internal medicine; Antigen; Immunology","score_opus":0.05727545927946504,"score_gpt":0.3653191226832838,"score_spread":0.3080436634038188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781647923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008517082,0.9909022,0.00000770561,0.00055861584,0.0027810347,0.0004087152,0.00008645143,0.000051178344,0.0051189293],"genre_scores_gemma":[0.000026573367,0.9930785,0.0006418883,0.00003300178,0.0052494896,0.00027257937,0.00043655612,0.000036827547,0.00022459809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984319,0.000103706865,0.0004129746,0.0006155567,0.00018724671,0.0002486051],"domain_scores_gemma":[0.9990495,0.00010956313,0.00022276619,0.00028627116,0.00018281136,0.00014910601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001604559,0.00041758482,0.0010329892,0.00024067437,0.000055628374,0.000019052455,0.00016757654,0.00016309909,0.00014636079],"category_scores_gemma":[0.000057950478,0.000297884,0.00038644648,0.000060407583,0.00015648174,0.00003485391,0.00016624639,0.00015211654,0.00039989172],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012530338,0.00070392,0.0002966702,0.0022075619,0.00026192938,0.0009436837,0.00005799364,1.1988494e-9,5.8871855e-8,0.0021318041,0.003093847,0.99029],"study_design_scores_gemma":[0.0011668794,0.0002728966,0.0023253793,0.006754961,0.0008866453,0.026078934,0.00001202372,0.000002445677,4.1074614e-7,0.000047809477,0.96226543,0.00018616878],"about_ca_topic_score_codex":0.0000010454298,"about_ca_topic_score_gemma":0.000003102661,"teacher_disagreement_score":0.99010384,"about_ca_system_score_codex":0.00029730797,"about_ca_system_score_gemma":0.00025997654,"threshold_uncertainty_score":0.9999473},"labels":[],"label_agreement":null},{"id":"W2781674579","doi":"10.1016/j.ijrobp.2018.01.002","title":"Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Pediatric oncology; Hodgkin lymphoma; Radiation oncology; Lymphoma; Oncology; Radiation therapy; Pediatrics; Protocol (science); Internal medicine; Cancer; Pathology; Alternative medicine","score_opus":0.018294217598341662,"score_gpt":0.3227460742267264,"score_spread":0.30445185662838475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781674579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891033,0.0003368154,0.0013466039,0.002519759,0.00096563756,0.0055148276,0.000053728327,0.000017022756,0.00014229065],"genre_scores_gemma":[0.99285567,0.0013910859,0.0008554834,0.0007749928,0.0026481315,0.0012889478,0.00016030083,0.000022065675,0.000003327046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979576,0.00028139027,0.00091678987,0.0003044524,0.00033395537,0.00020581963],"domain_scores_gemma":[0.99667954,0.0007188591,0.0016400826,0.00021485047,0.0006442891,0.000102395345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046868695,0.00022704313,0.0004962301,0.00018035753,0.00007664879,0.000022562665,0.00024306403,0.0002450245,0.000032289943],"category_scores_gemma":[0.0003005001,0.00015222968,0.00013604104,0.0002159942,0.00012624516,0.00020572377,0.000052952844,0.00023383564,0.0000039403644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003806404,0.0014454348,0.8144382,0.00000613729,0.00043599194,0.00006990015,0.0006742812,0.0000070495776,0.000061060295,0.00043942503,0.00035496056,0.17826113],"study_design_scores_gemma":[0.033090856,0.0060057,0.95383763,0.00010766069,0.00018029405,0.00022865132,0.00013251779,0.00015000073,0.0011365273,0.00030532537,0.004690019,0.00013483826],"about_ca_topic_score_codex":0.0005366299,"about_ca_topic_score_gemma":0.00039724758,"teacher_disagreement_score":0.17812629,"about_ca_system_score_codex":0.00093468395,"about_ca_system_score_gemma":0.0007922797,"threshold_uncertainty_score":0.6207746},"labels":[],"label_agreement":null},{"id":"W2782500168","doi":"10.1182/blood.v130.suppl_1.651.651","title":"Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stage (stratigraphy); Medicine; Classical Hodgkin lymphoma; Internal medicine; Lymphoma; Phases of clinical research; Nivolumab; Oncology; Hodgkin lymphoma; Chemotherapy; Cancer; Biology; Immunotherapy","score_opus":0.03561818650001681,"score_gpt":0.33332527162124137,"score_spread":0.29770708512122457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782500168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105865,0.00054413493,0.000023785351,0.00287843,0.00033597407,0.0025652873,0.0012297924,0.00009969339,0.0012642696],"genre_scores_gemma":[0.9957206,0.00012423638,0.0007614722,0.00038484458,0.0005405782,0.0007631034,0.00024353119,0.0000516843,0.0014099221],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979421,0.00006342994,0.00047064185,0.00068225246,0.00038555375,0.00045602093],"domain_scores_gemma":[0.9967341,0.000780179,0.00034654242,0.0018044369,0.000102902115,0.00023188272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026671306,0.00033187502,0.0005525906,0.000033155487,0.00069997186,0.00019329092,0.00042953083,0.00011467921,0.00006164931],"category_scores_gemma":[0.0011119017,0.00021189913,0.00025565538,0.000054522614,0.00013576403,0.00015429963,0.00015118085,0.00008267599,0.00006885933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019547481,0.15689671,0.19200313,0.000096756376,0.005023778,0.005525508,0.0057463204,0.000011157423,0.003212292,0.0010464757,0.046119623,0.56477076],"study_design_scores_gemma":[0.39199454,0.0051240544,0.5449117,0.00019029558,0.001960015,0.000020992946,0.0008263473,0.00022434471,0.009966436,0.00023320776,0.04415547,0.00039264793],"about_ca_topic_score_codex":0.0013173916,"about_ca_topic_score_gemma":0.00072270114,"teacher_disagreement_score":0.56437814,"about_ca_system_score_codex":0.00011196097,"about_ca_system_score_gemma":0.0001762401,"threshold_uncertainty_score":0.86409956},"labels":[],"label_agreement":null},{"id":"W2782888072","doi":"10.1182/blood.v130.suppl_1.484.484","title":"Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Rituximab; Vincristine; Bendamustine; Medicine; Maintenance therapy; Internal medicine; Prednisone; Follicular lymphoma; Cyclophosphamide; Surgery; Oncology; Lymphoma; Gastroenterology; Chemotherapy","score_opus":0.008873379052378016,"score_gpt":0.258439779029947,"score_spread":0.24956639997756902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782888072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977698,0.00018830477,0.000045534347,0.0005218559,0.00007820476,0.00093354867,0.0002370194,0.000015657723,0.00021008075],"genre_scores_gemma":[0.9978304,0.000040166127,0.0013297448,0.00012937532,0.0001394422,0.00022946637,0.0002491431,0.00002216107,0.000030110132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820435,0.00006107946,0.00043854667,0.00047784307,0.000523857,0.00029433577],"domain_scores_gemma":[0.9978991,0.000092253205,0.0003429943,0.0013849731,0.00015968186,0.00012096379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018111034,0.00025741654,0.00080298405,0.00009623672,0.00016649342,0.00007094828,0.00027006448,0.00009106848,0.00010438892],"category_scores_gemma":[0.000069183436,0.00014130598,0.00025484312,0.00018368886,0.00012144874,0.00014850167,0.00008676399,0.00006978372,0.0000058791593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004825324,0.03127221,0.96072775,0.000013979696,0.0013630926,0.00019821755,0.0000859661,0.00000668049,0.0000013313169,0.000043197433,0.000018276241,0.001443959],"study_design_scores_gemma":[0.28543544,0.00094688934,0.70928246,0.00011865819,0.003648011,0.0000014820229,0.000014671397,0.00014138265,0.00013094622,0.000021352223,0.00013926731,0.00011946944],"about_ca_topic_score_codex":0.0028406885,"about_ca_topic_score_gemma":0.0033535156,"teacher_disagreement_score":0.2806101,"about_ca_system_score_codex":0.00012041684,"about_ca_system_score_gemma":0.00013034319,"threshold_uncertainty_score":0.57622904},"labels":[],"label_agreement":null},{"id":"W2783028863","doi":"10.1016/j.ijrobp.2018.01.011","title":"The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group","year":2018,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Salvage therapy; Medicine; Radiation therapy; Refractory (planetary science); Oncology; Lymphoma; Disease; Clinical trial; Internal medicine; Chemotherapy","score_opus":0.034953274709932536,"score_gpt":0.35684126481640194,"score_spread":0.3218879901064694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783028863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058114406,0.9278569,0.0001795538,0.0029216409,0.007531593,0.0021398466,0.0006359306,0.00004876209,0.0005713343],"genre_scores_gemma":[0.030259805,0.9607558,0.00082464336,0.0009023574,0.0050652334,0.00017028867,0.0018849935,0.00009076695,0.0000460691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442434,0.0010037102,0.0027190358,0.00055459404,0.0009193248,0.0003790026],"domain_scores_gemma":[0.9880235,0.003650871,0.0058345147,0.00051434425,0.0018305748,0.00014617873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014069298,0.0006245822,0.0018159609,0.0003660093,0.00017369537,0.00007942377,0.0012660883,0.0007957072,0.00008975813],"category_scores_gemma":[0.001201649,0.0003276968,0.0006919036,0.0004221038,0.00042208857,0.00037370817,0.00013676599,0.00042407314,0.000034631972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002533349,0.0020988213,0.07885459,0.00002305863,0.0029202846,0.000027377702,0.00028930546,0.000010246502,0.000004051122,0.0008135057,0.0029096038,0.9095158],"study_design_scores_gemma":[0.020012233,0.004451977,0.047930785,0.001057921,0.000723966,0.00008209955,0.00008248987,0.00014835177,0.000049863247,0.001139496,0.9240321,0.00028872633],"about_ca_topic_score_codex":0.00021333543,"about_ca_topic_score_gemma":0.00007635207,"teacher_disagreement_score":0.9211225,"about_ca_system_score_codex":0.005015782,"about_ca_system_score_gemma":0.0034706732,"threshold_uncertainty_score":0.9999175},"labels":[],"label_agreement":null},{"id":"W2783177516","doi":"10.14740/jh346w","title":"Follicular Lymphomas of Oral Region Treated by Rituximab Monotherapy: About Two Cases","year":2018,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular phase; Follicular lymphoma; Lymphoma; Dermatology; Internal medicine; Pathology; Oncology","score_opus":0.021292877679364216,"score_gpt":0.3081798269516527,"score_spread":0.28688694927228847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783177516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905105,0.007196516,0.00007799535,0.0014214211,0.00014818176,0.00013725263,0.000003679242,0.000011449963,0.0004929961],"genre_scores_gemma":[0.99808675,0.0005729696,0.000693835,0.00040521726,0.00009363314,0.000004950552,0.000004646691,0.00001848114,0.00011949293],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988074,0.000074398486,0.0005841168,0.0001344417,0.00019369114,0.00020595941],"domain_scores_gemma":[0.9987277,0.000103450846,0.0005182407,0.00021036589,0.00031105836,0.00012920814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011404903,0.00015738947,0.0008446013,0.00015460233,0.000043978904,0.0000066848143,0.00008131475,0.00010708926,0.000123732],"category_scores_gemma":[0.00006188498,0.00010512106,0.0002414869,0.00013404699,0.00017231703,0.000065747605,0.000013411392,0.000058323883,0.000018778288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061930143,0.008328331,0.83713955,0.0001457927,0.00273306,0.015617241,0.00074947585,9.735177e-7,0.008158164,0.0032795721,0.095887646,0.021767184],"study_design_scores_gemma":[0.08117662,0.013927863,0.047929693,0.0009324773,0.0017772237,0.1662221,0.00026362936,0.00010920688,0.6217438,0.0009886012,0.0645287,0.0004001055],"about_ca_topic_score_codex":0.00022246086,"about_ca_topic_score_gemma":0.000021897653,"teacher_disagreement_score":0.78920984,"about_ca_system_score_codex":0.0001174246,"about_ca_system_score_gemma":0.00013062841,"threshold_uncertainty_score":0.4286712},"labels":[],"label_agreement":null},{"id":"W2783537843","doi":"10.1101/225870","title":"Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma","year":2017,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"Terry Fox Research Institute; BC Cancer Agency; Canada Research Chairs; Genome British Columbia; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Biology; Diffuse large B-cell lymphoma; Gene; Genetics; Lymphoma; Somatic cell; Genome; Oncogene; Cancer research; Computational biology; Cell cycle; Immunology","score_opus":0.012751631434505575,"score_gpt":0.22340919711138993,"score_spread":0.21065756567688435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783537843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994024,0.003888576,0.00007137771,0.00014878887,0.00040379827,0.0010664419,0.00026416802,0.00008580108,0.000047048772],"genre_scores_gemma":[0.99690056,0.0016967173,0.0008062053,0.00011582551,0.00015073837,0.00018809532,0.0000014243766,0.00011652241,0.000023912868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970806,0.00010428682,0.0007809107,0.0009794704,0.0004479837,0.0006067494],"domain_scores_gemma":[0.9966056,0.00014981345,0.00078030216,0.0020010013,0.0001715745,0.00029174803],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005655993,0.00062034815,0.0012967052,0.00039770018,0.00015026054,0.00018974455,0.00034369872,0.0005038521,0.000010250104],"category_scores_gemma":[0.00028748807,0.0005893138,0.00020698053,0.00015749846,0.00016721812,0.00024981887,0.00067140703,0.00025765732,0.000015437536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015442935,0.008951498,0.8190423,0.0037679148,0.000484312,0.0009932969,0.000071684335,0.0000024567555,0.16594219,0.00052540674,0.000058969435,0.0000055088217],"study_design_scores_gemma":[0.01296985,0.00008596,0.915879,0.0020670826,0.0003846501,1.05923576e-7,0.000006809195,0.00012124314,0.06780548,0.0000048379466,0.0002043056,0.00047065312],"about_ca_topic_score_codex":0.00011755223,"about_ca_topic_score_gemma":0.0000079715255,"teacher_disagreement_score":0.09813671,"about_ca_system_score_codex":0.00062768516,"about_ca_system_score_gemma":0.0008677763,"threshold_uncertainty_score":0.99965584},"labels":[],"label_agreement":null},{"id":"W2783841710","doi":"10.14740/jh363w","title":"Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature","year":2018,"lang":"en","type":"review","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mantle cell lymphoma; Pancytopenia; Lymphoma; Pathology; Bone marrow; Cytarabine; Bendamustine; Rituximab; Internal medicine; Leukemia","score_opus":0.028091987739945402,"score_gpt":0.34641949959285384,"score_spread":0.3183275118529084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783841710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004991127,0.9939696,0.0000019222057,0.0001699564,0.0001194126,0.00051788293,0.0000320872,0.0000029129187,0.00019509226],"genre_scores_gemma":[0.001258842,0.997795,0.00056281115,0.00011211911,0.00010159534,0.000011642441,0.000056442317,0.000025641546,0.00007591113],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99797624,0.00023543002,0.0011735717,0.0002256679,0.00024966637,0.0001394445],"domain_scores_gemma":[0.9971068,0.0001936248,0.0018077198,0.00027795395,0.00037055957,0.00024336904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025918495,0.0002682517,0.0024022255,0.00024945146,0.000028388085,0.000013435886,0.000087938686,0.00020098999,0.000053401673],"category_scores_gemma":[0.00020506693,0.00016887704,0.00035542183,0.0001668499,0.00012085548,0.00012731858,0.000048342306,0.000112262205,0.0000022198885],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000304503,0.0015531561,0.0014175997,0.56240064,0.00067410193,0.00289302,0.0003657301,9.048445e-9,0.000004085204,0.00037790992,0.006594779,0.42341447],"study_design_scores_gemma":[0.0032645275,0.0014342248,0.0006885477,0.5993787,0.007977168,0.024843523,0.00005457974,0.0000019556112,0.00008946245,0.0002494891,0.36181474,0.00020309011],"about_ca_topic_score_codex":0.0000062034765,"about_ca_topic_score_gemma":0.0000010381832,"teacher_disagreement_score":0.42321137,"about_ca_system_score_codex":0.000067639696,"about_ca_system_score_gemma":0.00049461017,"threshold_uncertainty_score":0.6886606},"labels":[],"label_agreement":null},{"id":"W2783856957","doi":"10.1182/blood.v130.suppl_1.2735.2735","title":"The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Lymph node; Pathology; Lymphoma; Follicular hyperplasia; Medicine; Biology; Cancer research","score_opus":0.00840595834896702,"score_gpt":0.2197076728861736,"score_spread":0.2113017145372066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783856957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099886,0.0051819496,0.0000026954754,0.0009370154,0.000031285734,0.00017259426,0.0000069885036,0.000006204465,0.002662412],"genre_scores_gemma":[0.9986067,0.0004216315,0.00063323247,0.000056745317,0.0000432006,0.00003081243,0.000018721368,0.0000072439707,0.00018175537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994627,0.000011277547,0.0001477086,0.00012231691,0.00014938692,0.00010659768],"domain_scores_gemma":[0.9994144,0.00007442984,0.0001186215,0.00032341972,0.000019868428,0.000049296432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008560807,0.00008292698,0.0001563589,0.000013799874,0.00023334705,0.000029490673,0.00007606206,0.000024920111,0.000014637716],"category_scores_gemma":[0.0000463874,0.000050390463,0.00005987584,0.000010289601,0.0001314706,0.000029530895,0.00007493508,0.00001913956,0.000008513578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013378811,0.001985358,0.9486128,0.000060987262,0.00046324354,0.0002546764,0.000114683884,4.4602467e-7,0.010298232,0.00063035346,0.00017734827,0.0372681],"study_design_scores_gemma":[0.0065484587,0.00021718025,0.9645328,0.00007337099,0.0002745967,0.00037530327,0.000030659063,0.000008315349,0.026686395,0.0000925987,0.0011129853,0.000047372534],"about_ca_topic_score_codex":0.000037262656,"about_ca_topic_score_gemma":0.0000028383793,"teacher_disagreement_score":0.037220728,"about_ca_system_score_codex":0.000023662735,"about_ca_system_score_gemma":0.000047246926,"threshold_uncertainty_score":0.20548634},"labels":[],"label_agreement":null},{"id":"W2785021126","doi":"10.1182/blood.v130.suppl_1.650.650","title":"Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Brentuximab vedotin; Oncology; Refractory (planetary science); Phases of clinical research; Clinical trial; Lymphoma; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.020506625118198552,"score_gpt":0.3048106614559048,"score_spread":0.28430403633770623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785021126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950704,0.0003255821,2.1649481e-7,0.0015833095,0.0001630181,0.0022274053,0.000093083305,0.0000647951,0.00047219088],"genre_scores_gemma":[0.9983882,0.000035642042,0.00025040115,0.0002563324,0.000119083925,0.00061923196,0.00012584012,0.000048446884,0.0001568546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997803,0.00013562951,0.0004155444,0.0006190379,0.000628812,0.00039798484],"domain_scores_gemma":[0.99755126,0.00017991569,0.0003464316,0.0014858075,0.00008037656,0.00035617975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012370649,0.00043739256,0.00072829676,0.00006113299,0.00042460664,0.00016314762,0.00029027252,0.00012850543,0.000049237446],"category_scores_gemma":[0.00018010804,0.00021734594,0.00013193631,0.00008296436,0.00021377657,0.00020174072,0.000115021205,0.00010666154,0.000038072583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007393209,0.085980035,0.88237685,0.0000067765354,0.0008660933,0.00058073865,0.0006725216,9.327866e-8,0.000022625569,0.000012010294,0.00024762284,0.028495286],"study_design_scores_gemma":[0.14602906,0.008517765,0.84140515,0.00014967128,0.0009945655,0.0000031061759,0.00018614573,0.000005268253,0.0012241651,0.000023131,0.0012528304,0.00020913947],"about_ca_topic_score_codex":0.0008808314,"about_ca_topic_score_gemma":0.00046818846,"teacher_disagreement_score":0.14528973,"about_ca_system_score_codex":0.0003316845,"about_ca_system_score_gemma":0.00041729116,"threshold_uncertainty_score":0.886311},"labels":[],"label_agreement":null},{"id":"W2785430226","doi":"10.1182/blood.v128.22.4645.4645","title":"Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Chemotherapy regimen; Gemcitabine; Internal medicine; Progression-free survival; Salvage therapy; Diffuse large B-cell lymphoma; Chemotherapy; Transplantation; Lymphoma; Oncology; Nuclear medicine","score_opus":0.010632128441959598,"score_gpt":0.23622632263690035,"score_spread":0.22559419419494076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785430226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473226,0.0011793046,0.0000994438,0.0013829342,0.00014305346,0.0012374264,0.0004821095,0.00007920444,0.0006642516],"genre_scores_gemma":[0.9940349,0.00025159869,0.0023693023,0.0004435026,0.00012477345,0.00046054195,0.000023428354,0.00005750762,0.002234456],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827415,0.000036850313,0.00051659095,0.0005005411,0.00026192205,0.00040994716],"domain_scores_gemma":[0.9986578,0.0003104743,0.00016797554,0.0005332081,0.0000988939,0.00023164676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017584342,0.00028068625,0.00051648583,0.0001254283,0.0000541536,0.000009319471,0.00012575835,0.00012751431,0.0000320284],"category_scores_gemma":[0.00002004235,0.00017942075,0.00023198502,0.00009984639,0.000052869065,0.00006781879,0.00002337537,0.000033561515,0.000038464706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09169813,0.031939697,0.08824122,0.001693856,0.0020736142,0.0034490346,0.013371795,0.000005281387,0.11887246,0.000064358595,0.014534341,0.6340562],"study_design_scores_gemma":[0.08114245,0.011305448,0.32100442,0.0017172166,0.0009964069,0.0003614009,0.00012221154,0.000008813985,0.5622991,0.000015710291,0.02061476,0.0004120665],"about_ca_topic_score_codex":0.000044982244,"about_ca_topic_score_gemma":0.000008968615,"teacher_disagreement_score":0.63364416,"about_ca_system_score_codex":0.0001366026,"about_ca_system_score_gemma":0.00019654595,"threshold_uncertainty_score":0.73165655},"labels":[],"label_agreement":null},{"id":"W2785579624","doi":"10.1182/blood.v116.21.113.113","title":"Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Salvage therapy; Medicine; Internal medicine; Regimen; Oncology; Dexamethasone; Refractory (planetary science); Chemotherapy regimen; Diffuse large B-cell lymphoma; Transplantation; Surgery; Chemotherapy; Gastroenterology","score_opus":0.008520843326517624,"score_gpt":0.24411519858818992,"score_spread":0.2355943552616723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785579624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926878,0.0037339935,0.000021828955,0.00020004007,0.00023193221,0.0023513932,0.00020368776,0.00010433278,0.000464954],"genre_scores_gemma":[0.9950858,0.0010597415,0.0018281195,0.0010185845,0.00015555914,0.0004884619,0.00009806605,0.00009892672,0.00016678237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772745,0.00012009265,0.000404845,0.0009009126,0.0002865104,0.0005601919],"domain_scores_gemma":[0.9979997,0.0005771919,0.00020851925,0.000551102,0.00014972586,0.00051375583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028795598,0.00054046087,0.0007127589,0.00017346996,0.00029397363,0.00012254641,0.00008399638,0.00035750965,0.00003500063],"category_scores_gemma":[0.00009910147,0.00042413603,0.0001170178,0.000137846,0.00016827129,0.00022159632,0.00008536542,0.00013051824,0.000011350869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030300003,0.07726368,0.5311371,0.00039509533,0.0012117646,0.0004063935,0.010875218,8.345735e-8,0.056549966,0.000317905,0.0014348358,0.31737792],"study_design_scores_gemma":[0.19203216,0.006529164,0.68561774,0.00011216573,0.00076195813,0.00023417911,0.0003894224,0.00032286978,0.10409636,0.00011502337,0.009171887,0.00061708834],"about_ca_topic_score_codex":0.00017489771,"about_ca_topic_score_gemma":0.00015711716,"teacher_disagreement_score":0.31676084,"about_ca_system_score_codex":0.000059036032,"about_ca_system_score_gemma":0.00009226735,"threshold_uncertainty_score":0.99982107},"labels":[],"label_agreement":null},{"id":"W2786320243","doi":"10.1007/s10549-018-4671-8","title":"Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Institution; Oncology; Lymphoma; Internal medicine; Family medicine; Gynecology; Cancer; Political science","score_opus":0.03323221631856504,"score_gpt":0.34173096650705864,"score_spread":0.3084987501884936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786320243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665564,0.0008936811,0.000009424127,0.00060737634,0.000028039127,0.0010314367,0.00012866623,0.000027377244,0.0006183789],"genre_scores_gemma":[0.9944782,0.0024647263,0.0005161918,0.00005977562,0.000054694756,0.0018662043,0.000014595993,0.000016642023,0.0005289417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827445,0.0000405928,0.00018634422,0.00047240657,0.00046779608,0.0005584143],"domain_scores_gemma":[0.9989673,0.000056497804,0.000051660678,0.00031364622,0.00020050634,0.00041037172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012744394,0.0002298251,0.00041121792,0.00018063035,0.00022134739,0.00003785268,0.00005485292,0.00004530237,0.00006837686],"category_scores_gemma":[0.0000036749148,0.00013593685,0.00003707778,0.00023778513,0.00078583584,0.000112127644,0.00009078572,0.000031011477,0.00000800177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019649388,0.0031123979,0.7486536,0.000094431976,0.00068627077,0.00043071885,0.002082041,1.5402996e-7,0.000054849763,0.0003399482,0.000018220053,0.24256244],"study_design_scores_gemma":[0.015735691,0.0021188736,0.97862864,0.00023878865,0.000094634335,0.0004428858,0.0012156826,0.000010925214,0.0007037943,0.000012505402,0.0006778693,0.00011969236],"about_ca_topic_score_codex":0.003494512,"about_ca_topic_score_gemma":0.00034920743,"teacher_disagreement_score":0.24244276,"about_ca_system_score_codex":0.0016993845,"about_ca_system_score_gemma":0.00023983422,"threshold_uncertainty_score":0.55433434},"labels":[],"label_agreement":null},{"id":"W2788380546","doi":"10.1182/blood-2017-12-820605","title":"High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Biology; Cancer research; Medicine; Pathology; B cell; Antibody; Immunology; Germinal center","score_opus":0.00948183249674868,"score_gpt":0.2246054535518878,"score_spread":0.2151236210551391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788380546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952805,0.0011789772,0.00001492617,0.00044670835,0.00007445639,0.00068748684,0.00005782607,0.0001036585,0.0021554711],"genre_scores_gemma":[0.9931768,0.00060431147,0.0029144776,0.0010256374,0.00020792626,0.00013484985,0.000055347235,0.00007381236,0.001806804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804705,0.000054682547,0.0002611922,0.0006999048,0.00033734716,0.0005998113],"domain_scores_gemma":[0.9987546,0.00007867818,0.00014220671,0.000554928,0.000096448435,0.00037309097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000102527025,0.00041783613,0.0005712037,0.00013194402,0.00020769048,0.00005401135,0.000099789,0.00015674929,0.000091936425],"category_scores_gemma":[0.00001209976,0.00025094167,0.00004594808,0.00021045253,0.0002987203,0.00010066458,0.00010752132,0.000047588568,0.000078516256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057765506,0.13925532,0.81735307,0.0005789223,0.0017470149,0.00789747,0.0021253277,9.97135e-8,0.009035294,0.00046624016,0.004957138,0.010807548],"study_design_scores_gemma":[0.39142632,0.013956837,0.48104128,0.00031916707,0.0026164148,0.002883656,0.00046447385,0.000018795328,0.094106734,0.000032993143,0.01244552,0.00068780343],"about_ca_topic_score_codex":0.00039061563,"about_ca_topic_score_gemma":0.0002031052,"teacher_disagreement_score":0.38564977,"about_ca_system_score_codex":0.00007116282,"about_ca_system_score_gemma":0.00014339302,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2788989790","doi":"10.4084/mjhid.2018.020","title":"OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE","year":2018,"lang":"en","type":"article","venue":"Mediterranean Journal of Hematology and Infectious Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Medicine; Lymphoma; Pediatrics; Incidence (geometry); Retrospective cohort study; Medical record; Hodgkin lymphoma; Lymphoblastic lymphoma; Non-Hodgkin's lymphoma; Internal medicine; Immunology","score_opus":0.011577478865984476,"score_gpt":0.26346183337837253,"score_spread":0.25188435451238805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788989790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983011,0.0011438433,0.00009106746,0.00012015327,0.00012086931,0.00017829839,0.0000069086436,0.0000091428055,0.000028657867],"genre_scores_gemma":[0.999317,0.00022589746,0.000023985995,0.00029337354,0.000121878234,0.000007349052,0.0000023896605,0.00000695337,0.0000011802388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921554,0.000040543124,0.00029624338,0.00017013706,0.00012064755,0.00015688382],"domain_scores_gemma":[0.9994755,0.00002602576,0.00014689635,0.0000806393,0.000062052815,0.00020888764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006410581,0.00014569495,0.00039754377,0.00016347045,0.0000901613,0.000020688225,0.000028408194,0.000061582316,0.000010410561],"category_scores_gemma":[0.0000614147,0.00009696406,0.000031166768,0.00006958528,0.00038987995,0.00017653305,0.000027077587,0.000059316102,5.8456203e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035552587,0.00090119475,0.9921188,0.00008333433,0.000060131646,0.00031251248,0.0006739546,1.4409815e-7,0.00004707661,0.000012997965,0.000019728657,0.005414611],"study_design_scores_gemma":[0.0077890093,0.0021740482,0.9748819,0.0007200776,0.00015389935,0.013176042,0.000108659755,0.000016588243,0.00085110037,0.000026971848,0.000008342517,0.00009335225],"about_ca_topic_score_codex":0.00003747504,"about_ca_topic_score_gemma":0.000055270397,"teacher_disagreement_score":0.01723688,"about_ca_system_score_codex":0.000047171838,"about_ca_system_score_gemma":0.00004359868,"threshold_uncertainty_score":0.39540797},"labels":[],"label_agreement":null},{"id":"W2789411140","doi":"10.1111/hel.12474","title":"Anti‐<i>Helicobacter pylori</i> therapy in localized gastric mucosa‐associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan","year":2018,"lang":"en","type":"article","venue":"Helicobacter","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Helicobacter pylori; Internal medicine; MALT lymphoma; Gastroenterology; Rabeprazole; Lymphoma; Mucosa-associated lymphoid tissue; Rituximab; Gastric lymphoma; Prospective cohort study; Gastrectomy; Cancer","score_opus":0.01713802045833704,"score_gpt":0.2860661803435674,"score_spread":0.26892815988523033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789411140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388397,0.00024601998,0.00000471195,0.0005312248,0.00039263372,0.0033640785,0.00003103074,0.00014668512,0.0013996286],"genre_scores_gemma":[0.9962229,0.00024630976,0.00012849602,0.0016899618,0.00029664382,0.000751098,0.00008795119,0.00009204503,0.00048455328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630016,0.00026446322,0.00092343835,0.000977104,0.0006414835,0.00089337927],"domain_scores_gemma":[0.99832,0.00015128327,0.00023380914,0.0006586211,0.00038701587,0.00024926197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004397,0.000585579,0.0009924287,0.0006952303,0.00012182526,0.000111401554,0.0002134159,0.00025387382,0.0004662782],"category_scores_gemma":[0.00017225202,0.0004697203,0.00016224853,0.0013377089,0.00014085534,0.00031884428,0.00010742613,0.00015930028,0.00052995194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009597068,0.013340062,0.9668948,0.000017095774,0.0002818379,0.00024939582,0.002341514,6.5381624e-7,0.0026056292,0.000012843571,0.00032441018,0.012972075],"study_design_scores_gemma":[0.05101456,0.0020985643,0.9330843,0.00021210562,0.00008939488,0.000046715453,0.00033971702,0.00010052902,0.008948007,0.000015783058,0.0036475826,0.00040273133],"about_ca_topic_score_codex":0.0019156437,"about_ca_topic_score_gemma":0.0026958643,"teacher_disagreement_score":0.050054856,"about_ca_system_score_codex":0.0014474947,"about_ca_system_score_gemma":0.0002601678,"threshold_uncertainty_score":0.99977547},"labels":[],"label_agreement":null},{"id":"W2790446180","doi":"10.1038/s41408-018-0064-9","title":"Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era","year":2018,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; ECOG-ACRIN Cancer Research Group; Harvard T.H. Chan School of Public Health; National Cancer Institute; National Institutes of Health; American College of Radiology Imaging Network","keywords":"Medicine; Lenalidomide; Diffuse large B-cell lymphoma; Internal medicine; Lymphoma; Oncology; Retrospective cohort study; Clinical trial; Population; Multiple myeloma","score_opus":0.1007839434411648,"score_gpt":0.4406180394919117,"score_spread":0.3398340960507469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790446180","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62249917,0.25868356,0.00024741996,0.1100624,0.0019517661,0.005809359,0.00029212137,0.00002780013,0.0004264431],"genre_scores_gemma":[0.14965725,0.8001264,0.0043583424,0.017826643,0.025905238,0.0017892196,0.00008100182,0.000075121934,0.00018080753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967499,0.0006146341,0.0015722081,0.0003915666,0.00029428667,0.00037739798],"domain_scores_gemma":[0.99591917,0.002668085,0.00069006043,0.0002744366,0.00022615645,0.00022208122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010062859,0.0002513059,0.0015175012,0.000100654834,0.00019513027,0.000035935125,0.00018916873,0.00018636588,0.0002621166],"category_scores_gemma":[0.0016868723,0.00012644076,0.0003720377,0.00015546354,0.00017541769,0.00008246981,0.000027802796,0.00016461831,0.0000041062654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034830237,0.0019745757,0.016361086,0.00059530063,0.0007476876,0.00018032684,0.00070185005,1.2918015e-7,0.0003411587,0.00037240118,0.11437608,0.86086637],"study_design_scores_gemma":[0.12738386,0.015268353,0.2869055,0.010093455,0.007795719,0.008299326,0.0002838283,0.00012765099,0.00035322263,0.0016301073,0.5414108,0.000448164],"about_ca_topic_score_codex":0.00005207023,"about_ca_topic_score_gemma":0.00009588794,"teacher_disagreement_score":0.8604182,"about_ca_system_score_codex":0.00009654181,"about_ca_system_score_gemma":0.00045064543,"threshold_uncertainty_score":0.51561046},"labels":[],"label_agreement":null},{"id":"W2791154088","doi":"10.1038/s41375-018-0023-2","title":"Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; Pfizer","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Medicine; Lymphoma; Open label; Internal medicine; Oncology; Phases of clinical research; Randomized controlled trial; Clinical trial; Leukemia; Chemistry; Discovery and development of mTOR inhibitors; Chronic lymphocytic leukemia","score_opus":0.026927290412992036,"score_gpt":0.30075145038505535,"score_spread":0.27382415997206333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791154088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899439,0.0001283833,0.000006154189,0.00010663421,0.0005117838,0.0031699303,0.00016199946,0.000036709498,0.005934485],"genre_scores_gemma":[0.9977636,0.00005912476,0.0002511012,0.00020903154,0.00017940083,0.00026775425,0.00038916373,0.00003825738,0.0008425771],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99823487,0.00015953695,0.00045544145,0.00042014892,0.00048358538,0.00024640764],"domain_scores_gemma":[0.9981592,0.0004988899,0.00029923025,0.0006424963,0.00028288306,0.00011725121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024486159,0.00027120844,0.0007076931,0.00005447349,0.00011669509,0.0000691795,0.00041837333,0.00007297858,0.00033548145],"category_scores_gemma":[0.00012943218,0.00014600152,0.000102082,0.00017483156,0.00018666107,0.000121282515,0.00016944334,0.000055338718,0.00013094548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63243026,0.020566689,0.31562144,0.000019784486,0.0034828603,0.00009077748,0.0041580363,0.0000010876105,0.000084363106,0.00004670649,0.012691104,0.010806926],"study_design_scores_gemma":[0.94632715,0.0046160854,0.041791905,0.00012612925,0.0013859239,9.966041e-7,0.00047469555,0.00011738341,0.002141281,0.000009593947,0.0028425648,0.00016630984],"about_ca_topic_score_codex":0.0026890335,"about_ca_topic_score_gemma":0.00018567983,"teacher_disagreement_score":0.3138969,"about_ca_system_score_codex":0.0005114788,"about_ca_system_score_gemma":0.00027889802,"threshold_uncertainty_score":0.5953769},"labels":[],"label_agreement":null},{"id":"W2791254844","doi":"10.1111/bjh.15118","title":"Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Vincristine; Rituximab; Autologous stem-cell transplantation; Cyclophosphamide; Follicular lymphoma; Etoposide; Anthracycline; Progression-free survival; Salvage therapy; Transplantation; Chemotherapy; Gastroenterology; Surgery; Lymphoma; Cancer","score_opus":0.009935397769000119,"score_gpt":0.24685820627028415,"score_spread":0.23692280850128403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791254844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762488,0.01184927,0.0000107554615,0.011268216,0.000104038416,0.00047211995,0.000025697687,0.000005139427,0.000015944659],"genre_scores_gemma":[0.9903288,0.003220618,0.0002975256,0.0060258796,0.000041536627,0.000011960666,0.0000349399,0.000029923172,0.000008829834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979983,0.0003194984,0.00092817866,0.00029593302,0.0002466848,0.00021139612],"domain_scores_gemma":[0.9987214,0.00016470942,0.00066958694,0.00013437445,0.00021612598,0.00009378659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002765288,0.00022987615,0.001456425,0.00017991234,0.000042819545,0.00002578087,0.00008291932,0.0006002465,0.000005926194],"category_scores_gemma":[0.000019829808,0.00018702255,0.000094566676,0.00006185472,0.0004297634,0.00006635081,0.000028861152,0.00043543358,2.3626872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035600774,0.005915845,0.7372287,0.0016159066,0.0018529503,0.14473747,0.0010680268,9.42803e-8,0.0001016679,0.000018618066,0.012525494,0.09137514],"study_design_scores_gemma":[0.067493916,0.01046676,0.7861495,0.0068373694,0.0010424332,0.123575315,0.000069316324,0.000008753993,0.0013898993,0.00015170118,0.0024330672,0.0003819857],"about_ca_topic_score_codex":0.000046867728,"about_ca_topic_score_gemma":0.000011410512,"teacher_disagreement_score":0.09099316,"about_ca_system_score_codex":0.00004764841,"about_ca_system_score_gemma":0.00018010697,"threshold_uncertainty_score":0.76265585},"labels":[],"label_agreement":null},{"id":"W2791545369","doi":"10.1182/blood.v130.suppl_1.418.418","title":"BCL2 Expression Identifies a Population with Unmet Medical Need in Previously Untreated (1L) Patients with DLBCL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Venetoclax; Chemoimmunotherapy; Rituximab; Obinutuzumab; Medicine; Population; Internal medicine; Oncology; Vincristine; Diffuse large B-cell lymphoma; Immunohistochemistry; CHOP; Lymphoma; Cyclophosphamide; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.006761546769676733,"score_gpt":0.2442388575797485,"score_spread":0.23747731081007176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791545369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983456,0.000101367055,0.0000024880312,0.00030813372,0.000038652295,0.0005997924,0.0000061533183,0.000040225623,0.0005575992],"genre_scores_gemma":[0.9992324,0.000032048156,0.0002156166,0.00006297003,0.00004150212,0.00008561844,0.00017706314,0.000020668522,0.00013211323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871904,0.000032569635,0.00020299236,0.00027672175,0.00055323815,0.00021545442],"domain_scores_gemma":[0.999102,0.000030664778,0.00015728611,0.00047724985,0.00006896382,0.0001638611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420745,0.00016400074,0.00029723113,0.0000815122,0.00014019002,0.00006095697,0.00010154671,0.00009699931,0.000068161564],"category_scores_gemma":[0.00012753769,0.0000943436,0.000032825355,0.000070949645,0.00005705742,0.00016371188,0.000046843652,0.00007254881,0.000015487693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036368406,0.003519346,0.99332064,0.000041290685,0.000100765326,0.00037101578,0.0001840708,5.922635e-7,0.000040527557,0.000011097043,0.00009002387,0.001956952],"study_design_scores_gemma":[0.02965525,0.0006744673,0.9644091,0.0012224437,0.000279985,0.00003096627,0.00002976631,0.0000106261605,0.003520149,0.000013965737,0.000037128644,0.000116138595],"about_ca_topic_score_codex":0.0012746649,"about_ca_topic_score_gemma":0.00074229843,"teacher_disagreement_score":0.029291565,"about_ca_system_score_codex":0.000059207367,"about_ca_system_score_gemma":0.00007329697,"threshold_uncertainty_score":0.38472205},"labels":[],"label_agreement":null},{"id":"W2791573308","doi":"10.1182/blood-2017-09-772632","title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Classical Hodgkin lymphoma; Lymphoma; Medicine; Hodgkin lymphoma; Immunology; Biology; Internal medicine; Oncology; Cancer research","score_opus":0.0847715086468631,"score_gpt":0.3691724369392336,"score_spread":0.28440092829237046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791573308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006179929,0.99649006,0.000047314228,0.0003741702,0.000046878515,0.0016856374,0.000501533,0.000025424391,0.00021099263],"genre_scores_gemma":[0.0012475128,0.99306864,0.0030733151,0.000036094487,0.00022464778,0.0020064048,0.00026125758,0.000033484142,0.00004865867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990056,0.000024243054,0.00038684817,0.00035619372,0.000045787867,0.00018129245],"domain_scores_gemma":[0.99894017,0.00034481884,0.00023237795,0.00030419367,0.00009753491,0.00008088012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007803917,0.00024616224,0.0012302016,0.00009779181,0.000049343067,0.000009015001,0.00008010574,0.00026873293,0.0000064437404],"category_scores_gemma":[0.00006182322,0.00015435302,0.0003576116,0.00011267532,0.00018070936,0.0000125201095,0.000044345958,0.000028372691,0.0000048039524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008226862,0.0036866083,0.0028530653,0.004873993,0.001604988,7.090009e-7,0.000022964738,1.4989382e-10,0.0000106939415,0.006345976,0.00046173474,0.98013103],"study_design_scores_gemma":[0.004002702,0.00093677285,0.003901038,0.0026151014,0.006391593,0.00014822374,0.00000376897,1.6246288e-7,0.000066652334,0.00019557578,0.98159534,0.00014304832],"about_ca_topic_score_codex":0.0000087411,"about_ca_topic_score_gemma":0.0000029317632,"teacher_disagreement_score":0.98113364,"about_ca_system_score_codex":0.00003648372,"about_ca_system_score_gemma":0.0002556102,"threshold_uncertainty_score":0.62943333},"labels":[],"label_agreement":null},{"id":"W2792952263","doi":"10.3324/haematol.2018.187773","title":"Impact of age on genetics and treatment efficacy in follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Lymphoma; Medicine; Oncology; Internal medicine; Follicular phase","score_opus":0.04232993865396901,"score_gpt":0.3164919456697417,"score_spread":0.2741620070157727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792952263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429,0.0015663636,2.3393434e-7,0.021409761,0.00006149739,0.0009416202,0.000052615294,0.000032144235,0.0016457255],"genre_scores_gemma":[0.96938163,0.0018441349,0.00031237197,0.027264882,0.00036917513,0.00015963175,0.00032672475,0.000048005,0.00029346853],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983506,0.00008451389,0.0004088799,0.00052607874,0.00025408692,0.000375833],"domain_scores_gemma":[0.99882066,0.00023663543,0.00019722276,0.0006052238,0.000045720204,0.00009453324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004682274,0.0004737436,0.0013403625,0.00021788932,0.000032481832,0.000016459198,0.000086911365,0.00067502377,0.00011835792],"category_scores_gemma":[0.000047362515,0.00027089036,0.00040383995,0.00012352133,0.00017046707,0.000010053794,0.000044112807,0.00011579853,0.00006397291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086999,0.009671912,0.24492188,0.00044422832,0.0027589109,0.10730961,0.00055827113,0.0000045195347,0.00006320466,0.000076800105,0.5924153,0.040905397],"study_design_scores_gemma":[0.011631973,0.013070335,0.8520554,0.0008091659,0.000709309,0.0013338992,0.0000075315993,0.0000137541365,0.0013483685,0.00007361192,0.1185455,0.00040119642],"about_ca_topic_score_codex":0.00024966817,"about_ca_topic_score_gemma":0.000013394767,"teacher_disagreement_score":0.60713345,"about_ca_system_score_codex":0.0004987166,"about_ca_system_score_gemma":0.00012912178,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2793042391","doi":"10.1002/path.5043","title":"Novel insights into the disease dynamics of B‐cell lymphomas in the Genomics Era","year":2018,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network; BC Cancer Agency","funders":"","keywords":"Somatic evolution in cancer; Disease; Tumor microenvironment; Biology; Tumor progression; Lymphoma; Precision medicine; Cancer; Medicine; Immunology; Genetics; Pathology","score_opus":0.031191147798648122,"score_gpt":0.3081091630063576,"score_spread":0.2769180152077095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793042391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02650322,0.97107255,0.00004743724,0.0009803604,0.00035526548,0.00061876856,0.000020214524,0.0000023798943,0.00039982732],"genre_scores_gemma":[0.014984476,0.9838196,0.00021070655,0.00045680365,0.000399674,0.000019317875,0.000020184178,0.000031431646,0.000057790632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976277,0.0006868065,0.0010262242,0.00014831337,0.0002995831,0.00021142053],"domain_scores_gemma":[0.99679506,0.0009220135,0.0012932101,0.00074977754,0.00014948673,0.0000904453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012085517,0.00030944753,0.0013240695,0.00018134253,0.00009296093,0.000012137974,0.000737898,0.00018394411,0.000015641404],"category_scores_gemma":[0.00013149975,0.00010699036,0.00057828554,0.00024087745,0.00039449788,0.000029097413,0.00012531262,0.00041951434,0.000019107158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012757718,0.008817466,0.0011796618,0.0115720825,0.0020683822,0.010739699,0.0308286,0.000027103639,0.000086817396,0.0065304628,0.0028454042,0.9240286],"study_design_scores_gemma":[0.0066066263,0.0025375078,0.008575331,0.009819151,0.018478489,0.02197397,0.0015030148,0.00011475887,0.000024544386,0.0029795882,0.9269055,0.0004815045],"about_ca_topic_score_codex":0.000038406662,"about_ca_topic_score_gemma":0.00009200112,"teacher_disagreement_score":0.9240601,"about_ca_system_score_codex":0.00050921185,"about_ca_system_score_gemma":0.0010552314,"threshold_uncertainty_score":0.43629402},"labels":[],"label_agreement":null},{"id":"W2793121285","doi":"10.1080/10428194.2017.1365855","title":"Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study","year":2018,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rituximab; Vincristine; Mantle cell lymphoma; Internal medicine; Bortezomib; Hazard ratio; Prednisone; CHOP; Neutropenia; Gastroenterology; Cyclophosphamide; Autologous stem-cell transplantation; Transplantation; Bendamustine; Surgery; Oncology; Lymphoma; Chemotherapy; Confidence interval; Multiple myeloma","score_opus":0.010090361013395142,"score_gpt":0.27379315675973653,"score_spread":0.26370279574634137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793121285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774683,0.0037073968,0.00016830619,0.00015433494,0.00018239937,0.007152092,0.00044133727,0.000053746375,0.00039354374],"genre_scores_gemma":[0.98972774,0.0069563678,0.0011764383,0.00047181372,0.00015445052,0.000919354,0.00039977022,0.0000966679,0.000097414944],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99391246,0.0005245587,0.0024767339,0.0012510829,0.00094035827,0.00089482457],"domain_scores_gemma":[0.99468684,0.0029555028,0.000828668,0.00078315724,0.0003199836,0.00042582158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016951829,0.0009185379,0.002814175,0.00055682403,0.0002549782,0.00007411561,0.0003635136,0.00044841398,0.000036599577],"category_scores_gemma":[0.0006274801,0.0006282173,0.00025589502,0.00077574933,0.0009983039,0.00028362632,0.00013905819,0.0001064807,0.0000041263465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6227808,0.026607776,0.10804724,0.0023566752,0.0009312609,0.0013955365,0.026586305,0.00002655273,0.0012252769,0.00022142672,0.0010694516,0.20875168],"study_design_scores_gemma":[0.6591945,0.004217758,0.32496765,0.0007634513,0.001209026,0.00018179402,0.0013966418,0.0034984343,0.0035529751,0.00008362954,0.00045592154,0.00047822003],"about_ca_topic_score_codex":0.008871607,"about_ca_topic_score_gemma":0.0018679322,"teacher_disagreement_score":0.2169204,"about_ca_system_score_codex":0.0019140013,"about_ca_system_score_gemma":0.0018586834,"threshold_uncertainty_score":0.9996169},"labels":[],"label_agreement":null},{"id":"W2794405583","doi":"10.4274/mirt.07088","title":"Primary Thyroid Lymphoma: External Beam Radiation Therapy Induced Thyroiditis Mimics Residual Disease on Serial 18F-FDG PET/CT Imaging","year":2018,"lang":"en","type":"article","venue":"Molecular Imaging and Radionuclide Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Nuclear medicine; Radiation therapy; Lymphoma; Thyroid; Positron emission tomography; Radiology; PET-CT; Biopsy; Pathology; Internal medicine","score_opus":0.009543494156020935,"score_gpt":0.2538680851395094,"score_spread":0.2443245909834885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794405583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97557986,0.01813901,0.00008166572,0.0041338066,0.00060335436,0.0007297937,0.000032610107,0.0001912827,0.00050863886],"genre_scores_gemma":[0.9802978,0.0074950643,0.0005528109,0.010156817,0.0010930041,0.00008351028,0.00014503891,0.00011528882,0.000060633458],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974681,0.00018457348,0.0004221285,0.00078743143,0.00057789206,0.000559831],"domain_scores_gemma":[0.99850976,0.00009127572,0.00018797487,0.0006535366,0.00012685497,0.00043059714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029268756,0.0005119453,0.0004959919,0.00025009425,0.00042430448,0.00022363605,0.00016880335,0.00001755282,0.00005005506],"category_scores_gemma":[0.000040189305,0.00041842356,0.0002316506,0.00020033805,0.00023408135,0.00022611323,0.000044736425,0.00014403615,0.000032895605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005944463,0.00243703,0.10129005,0.00004327711,0.0005895606,0.01594409,0.0006656739,0.000012303016,0.40573862,0.00032507398,0.007756811,0.45925304],"study_design_scores_gemma":[0.043507285,0.0019595062,0.59269816,0.00042389266,0.00029211928,0.0056874026,0.00012378544,0.0008226894,0.33726677,0.0009301566,0.015071602,0.0012166424],"about_ca_topic_score_codex":0.00018753044,"about_ca_topic_score_gemma":0.0000010399077,"teacher_disagreement_score":0.4914081,"about_ca_system_score_codex":0.00033960992,"about_ca_system_score_gemma":0.00027105896,"threshold_uncertainty_score":0.9998268},"labels":[],"label_agreement":null},{"id":"W2795058050","doi":"10.1200/jco.2017.76.3656","title":"Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bendamustine; Obinutuzumab; Internal medicine; Rituximab; Gastroenterology; Neutropenia; Hazard ratio; Refractory (planetary science); Follicular lymphoma; Surgery; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.05563711913773614,"score_gpt":0.380538862532708,"score_spread":0.3249017433949719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795058050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965008,0.00011432637,0.000007213148,0.00097010547,0.00095535815,0.0009593908,0.000005960482,0.0000058765677,0.00048098405],"genre_scores_gemma":[0.9972869,0.00035054362,0.00039349764,0.001050146,0.00081420114,0.000028283564,0.0000064225783,0.000023445193,0.00004653759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956365,0.00067496987,0.0022006165,0.00040918353,0.00067893486,0.000399788],"domain_scores_gemma":[0.996117,0.0012994787,0.0014351975,0.00033654852,0.00057071564,0.00024103909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030652648,0.00028806945,0.0018075088,0.0002542466,0.00007024407,0.00002353466,0.00022452317,0.000339281,0.000034898963],"category_scores_gemma":[0.0010173508,0.00016089903,0.00017147086,0.00028092047,0.00031159443,0.00021111187,0.0000869161,0.00070185616,0.000007906086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02262426,0.012063706,0.8622687,0.00001768522,0.000272268,0.00075392035,0.0019867085,0.000026040363,0.0000023409157,0.000025184925,0.0005317396,0.09942744],"study_design_scores_gemma":[0.10169205,0.048312385,0.84606224,0.00033394265,0.00021861584,0.00010370047,0.00086284074,0.00009834193,0.0000049541704,0.00009015392,0.0020838089,0.00013698745],"about_ca_topic_score_codex":0.001053214,"about_ca_topic_score_gemma":0.002864201,"teacher_disagreement_score":0.09929045,"about_ca_system_score_codex":0.0028587654,"about_ca_system_score_gemma":0.0021341532,"threshold_uncertainty_score":0.74755716},"labels":[],"label_agreement":null},{"id":"W2795810770","doi":"10.1182/blood-2017-10-810630","title":"The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Universität Zürich","keywords":"Diffuse large B-cell lymphoma; Cancer research; Lymphoma; Transforming growth factor; In vivo; Biology; Signal transduction; In vitro; Immunology; Cell biology; Genetics","score_opus":0.010369576097939912,"score_gpt":0.25087357832482116,"score_spread":0.24050400222688123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795810770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941628,0.0016849845,0.0000032174637,0.0008125599,0.00022230498,0.0005431239,0.000054125572,0.000061453815,0.0024554185],"genre_scores_gemma":[0.998295,0.00014277223,0.00010410089,0.0006296532,0.00024751778,0.00013806323,0.00003086912,0.00003641148,0.00037557606],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982689,0.0000865218,0.00035292958,0.0004168929,0.00031732375,0.00055740745],"domain_scores_gemma":[0.9988327,0.00020205982,0.00014444467,0.0005095845,0.0001384035,0.00017281061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017388818,0.00026184754,0.0003422719,0.00009659234,0.00025198955,0.00006071084,0.00017067423,0.00009067514,0.0001330426],"category_scores_gemma":[0.00010659526,0.00016914234,0.00013407516,0.00031222097,0.00010376045,0.0000979687,0.00009817562,0.00009770932,0.0001930403],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024713334,0.20757589,0.6758273,0.00032064284,0.0014696544,0.0036164562,0.012484332,3.6567585e-7,0.040057432,0.0008837377,0.027204785,0.028088044],"study_design_scores_gemma":[0.09191171,0.0012331198,0.056657527,0.00043050546,0.0005197521,0.0001629043,0.0007373168,0.000093953415,0.81790394,0.00019040491,0.02978977,0.00036907638],"about_ca_topic_score_codex":0.0001773145,"about_ca_topic_score_gemma":0.000055034674,"teacher_disagreement_score":0.7778465,"about_ca_system_score_codex":0.00016433558,"about_ca_system_score_gemma":0.00015809444,"threshold_uncertainty_score":0.68974245},"labels":[],"label_agreement":null},{"id":"W2796416879","doi":"10.1080/10428194.2018.1452208","title":"Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi","year":2018,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"","keywords":"Panobinostat; Medicine; Internal medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Lymphoma; Oncology; Overall survival; Gastroenterology; Biology","score_opus":0.04424755085223389,"score_gpt":0.31793521721302564,"score_spread":0.2736876663607918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796416879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251056,0.0015872739,0.00020979036,0.0001582072,0.0008334468,0.0035369368,0.0005312909,0.00013613775,0.00049633847],"genre_scores_gemma":[0.99547476,0.00039022043,0.0007192227,0.0010345009,0.0005268779,0.00023982025,0.00042068437,0.00016378911,0.0010301118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994194,0.00029883633,0.0019614196,0.0017382482,0.0008187348,0.000988787],"domain_scores_gemma":[0.9944789,0.00089777255,0.0011253806,0.0024536997,0.00037979207,0.00066446257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008909448,0.00094330125,0.001617982,0.00026258032,0.00077934534,0.00015122103,0.0006214885,0.0005367453,0.000023150616],"category_scores_gemma":[0.00030492336,0.0006390871,0.00033333478,0.00049214065,0.00080897653,0.0004720314,0.00077240367,0.00013508448,0.000030337356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012991421,0.058210395,0.7177869,0.00063284184,0.0018590621,0.00039355058,0.0047979895,0.0000058349924,0.0017588512,0.0002918248,0.0061118263,0.1951595],"study_design_scores_gemma":[0.35785764,0.014609624,0.5742953,0.00036852338,0.0033022407,0.00059906096,0.0026732313,0.0069915154,0.001555238,0.000038563194,0.036747072,0.0009619908],"about_ca_topic_score_codex":0.00075265946,"about_ca_topic_score_gemma":0.00039222802,"teacher_disagreement_score":0.34486622,"about_ca_system_score_codex":0.003729459,"about_ca_system_score_gemma":0.0024140263,"threshold_uncertainty_score":0.999606},"labels":[],"label_agreement":null},{"id":"W2797584152","doi":"10.1056/nejmoa1801445","title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Frederick National Laboratory for Cancer Research; Leidos; Medical Research Council; Center for Strategic Scientific Initiatives, National Cancer Institute","keywords":"Biology; Germinal center; Diffuse large B-cell lymphoma; Lymphoma; Cell of origin; Gene expression profiling; Genetics; Gene; Pathogenesis; B cell; Cancer research; Gene expression; Immunology; Antibody","score_opus":0.014153204345949378,"score_gpt":0.26279554263697025,"score_spread":0.24864233829102086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797584152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98635995,0.009949101,0.00013020511,0.0019747189,0.000298224,0.00009337292,0.0000052588143,0.000004746933,0.0011843952],"genre_scores_gemma":[0.99147475,0.004005337,0.0010767141,0.00050063286,0.0026744797,6.360443e-7,0.0000027973595,0.000014124542,0.00025053794],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99883366,0.000042985852,0.00047407203,0.0001093995,0.00037160667,0.00016830729],"domain_scores_gemma":[0.99878013,0.00013670247,0.00030079603,0.00017067969,0.00026105723,0.0003506418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037880405,0.00013637375,0.0005153074,0.0001461642,0.00003535202,0.000003779112,0.00006346521,0.000059722388,0.00011112791],"category_scores_gemma":[0.00012573684,0.00007959376,0.000066893605,0.000112679256,0.00013819576,0.000029706953,0.000025205205,0.000047039503,0.0000034620257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016849401,0.0041449857,0.35205102,0.00016416193,0.00037009383,0.0008913,0.0030216873,2.6864208e-7,0.030405268,0.00016459587,0.011064112,0.59603757],"study_design_scores_gemma":[0.39492863,0.010715979,0.45953253,0.00068627164,0.0012618263,0.002941185,0.00032176683,0.000051503885,0.027096303,0.00024030155,0.10208636,0.00013733332],"about_ca_topic_score_codex":0.0000381289,"about_ca_topic_score_gemma":0.0000147453375,"teacher_disagreement_score":0.59590024,"about_ca_system_score_codex":0.000038023074,"about_ca_system_score_gemma":0.0001515055,"threshold_uncertainty_score":0.32457393},"labels":[],"label_agreement":null},{"id":"W2799318639","doi":"10.1111/bjh.15255","title":"Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University; Juravinski Hospital","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Stage (stratigraphy); Positron emission tomography; Quality of life (healthcare); Lymphoma; Internal medicine; Hodgkin lymphoma; Oncology; Nuclear medicine; Pediatrics","score_opus":0.029527695126070064,"score_gpt":0.30520773175521354,"score_spread":0.2756800366291435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799318639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860068,0.0008460045,0.01102254,0.0014654249,0.00020057191,0.00033129158,0.000007895056,0.000009290261,0.00011019778],"genre_scores_gemma":[0.9966176,0.00010383467,0.0015972826,0.0015116195,0.0000961643,0.000013450318,0.0000044494664,0.000018334855,0.000037266804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837995,0.00012871907,0.0007039721,0.00017991682,0.0003246816,0.00028279005],"domain_scores_gemma":[0.99899805,0.00016102818,0.00024782456,0.00018227145,0.00028610343,0.00012475379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706093,0.00014484613,0.0005693164,0.00016706312,0.00008582957,0.000054666973,0.00013450092,0.00009471877,0.000028625756],"category_scores_gemma":[0.0000945577,0.00010948917,0.00015622201,0.00013265779,0.00005105728,0.00011385231,0.00003700395,0.00011027436,0.000024896472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078947854,0.0022289287,0.5939404,0.00006463791,0.00036229484,0.087442055,0.006348124,0.036225878,0.000028780756,0.00013307457,0.00050920417,0.27192718],"study_design_scores_gemma":[0.008107208,0.0018883034,0.8854449,0.0007993251,0.00021672841,0.06460953,0.00019022921,0.036991816,0.00048418462,0.0005631439,0.0004534992,0.00025116905],"about_ca_topic_score_codex":0.0003403777,"about_ca_topic_score_gemma":0.0002263014,"teacher_disagreement_score":0.2915045,"about_ca_system_score_codex":0.00014851881,"about_ca_system_score_gemma":0.000118939555,"threshold_uncertainty_score":0.44648388},"labels":[],"label_agreement":null},{"id":"W2799453140","doi":"10.11606/t.5.2017.tde-07082017-102257","title":"Análise do perfil de expressão de genes de proliferação/regulação celular, resposta inflamatória e angiogênese e do padrão de metilação dos genes p15INK4b e p16INK4a em portadores de linfoma de células T periféricas","year":2017,"lang":"pt","type":"dissertation","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Faculdade de Medicina da Universidade de São Paulo; Universidade de São Paulo; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Molecular biology; Cancer research; Biology","score_opus":0.019853430385877776,"score_gpt":0.31057260652339547,"score_spread":0.2907191761375177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799453140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371007,0.05368786,0.0007101508,0.0007370937,0.00075973716,0.0039464883,0.00049558375,0.000579006,0.001983395],"genre_scores_gemma":[0.94297653,0.016075108,0.012771051,0.0012796539,0.0022497363,0.0037940773,0.0023909786,0.00077574386,0.017687095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98564184,0.0015530998,0.002743466,0.0029312081,0.001983754,0.005146609],"domain_scores_gemma":[0.987637,0.0010623215,0.002151725,0.0041913847,0.0014093823,0.0035482142],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030522596,0.003246365,0.0034191736,0.0014270304,0.002051744,0.002215665,0.0023541767,0.0034385205,0.0030101608],"category_scores_gemma":[0.0020447734,0.0029048892,0.002305124,0.00071402284,0.00045574474,0.00081815844,0.00043399323,0.0012398195,0.00023660244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006583106,0.0038666967,0.7454473,0.0030950217,0.0043180636,0.012564616,0.072314896,0.0007386657,0.060862407,0.0003977331,0.009938958,0.079872526],"study_design_scores_gemma":[0.013631467,0.002008338,0.55735743,0.0046002055,0.008801333,0.0036786373,0.030038204,0.007888343,0.3534757,0.0005574505,0.013780679,0.0041822256],"about_ca_topic_score_codex":0.006353515,"about_ca_topic_score_gemma":0.0025081995,"teacher_disagreement_score":0.2926133,"about_ca_system_score_codex":0.0045995386,"about_ca_system_score_gemma":0.011455394,"threshold_uncertainty_score":0.99924743},"labels":[],"label_agreement":null},{"id":"W2800507359","doi":"10.1111/bjh.15262","title":"Excellent real‐world outcomes of adults with Burkitt lymphoma treated with <scp>CODOX</scp>‐M/<scp>IVAC</scp> plus or minus rituximab","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Vincristine; Regimen; Hazard ratio; Oncology; Cytarabine; Methotrexate; Population; Progression-free survival; Cyclophosphamide; Folinic acid; Chemotherapy; Lymphoma; Gastroenterology; Confidence interval; Fluorouracil","score_opus":0.014055335191638763,"score_gpt":0.25617953853306774,"score_spread":0.24212420334142898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800507359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902233,0.0034177764,0.000046150755,0.00032184986,0.00024473362,0.00067852024,0.000058414782,0.000059539903,0.0049497364],"genre_scores_gemma":[0.99152356,0.0015608771,0.0028137392,0.00034262295,0.00022516507,0.000048349662,0.000028251938,0.000097356344,0.003360088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623924,0.00018688879,0.0013900251,0.00054686837,0.0008123036,0.0008246635],"domain_scores_gemma":[0.99536043,0.0010826372,0.0013614129,0.0005190643,0.0011169646,0.00055948156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027088835,0.0005429819,0.002681111,0.00049768644,0.00017597123,0.00006215917,0.00035070913,0.0002546832,0.000094847754],"category_scores_gemma":[0.0004912383,0.00037142404,0.0003391638,0.0005637461,0.00069921196,0.00020478682,0.00009029348,0.00022857629,0.000052686406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025544232,0.0079424,0.63311654,0.00067444274,0.0044312454,0.29175824,0.0024961005,0.0000056803688,0.000078824705,0.00023323843,0.039105717,0.017603148],"study_design_scores_gemma":[0.06881993,0.011265914,0.52895486,0.0044726147,0.0020741916,0.35846218,0.0028843307,0.000041888612,0.013643638,0.000051542473,0.009153873,0.00017502725],"about_ca_topic_score_codex":0.002479293,"about_ca_topic_score_gemma":0.004604651,"teacher_disagreement_score":0.10416166,"about_ca_system_score_codex":0.00043024292,"about_ca_system_score_gemma":0.0010464764,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W2800579414","doi":"10.14740/wjon1093w","title":"Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dacarbazine; ABVD; Vinblastine; Neutropenia; Confidence interval; Internal medicine; Odds ratio; Bleomycin; Lymphoma; Chemotherapy; Hodgkin lymphoma; Surgery; Vincristine; Cyclophosphamide","score_opus":0.014633046647929304,"score_gpt":0.32222281887758714,"score_spread":0.30758977222965783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800579414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576443,0.00007110021,0.00000492558,0.0006999357,0.00018529182,0.00019156703,0.000010840708,0.0000029991377,0.0030688932],"genre_scores_gemma":[0.998362,0.000012507533,0.0008753752,0.00022593596,0.00010914144,0.0000029075914,0.0000024947929,0.000012833765,0.00039679877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988572,0.00005950378,0.00051725935,0.000096842115,0.00030149604,0.00016768707],"domain_scores_gemma":[0.9982057,0.00015102648,0.0007930273,0.0001749357,0.00054841343,0.00012686556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014757164,0.00013246885,0.0007328271,0.00028822967,0.000020900381,0.0000027628023,0.00008144974,0.000052794192,0.00033857435],"category_scores_gemma":[0.00008466847,0.00006996584,0.00022858949,0.00017172031,0.0001726849,0.000053341155,0.000019055427,0.000058755864,0.000012369099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003020603,0.0042547155,0.93095815,0.000013899256,0.0008339065,0.00007850088,0.00017244667,0.0000034999448,0.000041327323,0.000038690454,0.004593042,0.05599121],"study_design_scores_gemma":[0.013189822,0.035399783,0.944698,0.00011735155,0.00029558834,0.00005503492,0.000016634487,0.0000028839709,0.0006339018,0.000022978995,0.005513986,0.000054083623],"about_ca_topic_score_codex":0.000077563054,"about_ca_topic_score_gemma":0.00007551233,"teacher_disagreement_score":0.055937126,"about_ca_system_score_codex":0.00053430983,"about_ca_system_score_gemma":0.00059245725,"threshold_uncertainty_score":0.37071517},"labels":[],"label_agreement":null},{"id":"W2800645590","doi":"10.1007/s12022-018-9529-4","title":"Fit-for-Purpose Immunohistochemical Biomarkers","year":2018,"lang":"en","type":"review","venue":"Endocrine Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Immunohistochemistry; Medicine; Pathology; Quality assurance; Companion diagnostic; Biomarker; Medical physics; Internal medicine; Cancer; Biology; External quality assessment","score_opus":0.07837462604614741,"score_gpt":0.4062226470612881,"score_spread":0.32784802101514066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800645590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008771671,0.99350214,0.000015093467,0.0001411889,0.0007729934,0.001952468,0.00018319493,0.0001058332,0.003239379],"genre_scores_gemma":[0.00002212015,0.99169946,0.0024363417,0.00016578373,0.00069698226,0.0018268606,0.0011421908,0.00009429632,0.0019159638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977357,0.00009965682,0.00069410587,0.000754223,0.00014157781,0.0005747756],"domain_scores_gemma":[0.9982801,0.0003256939,0.00026492693,0.0008451097,0.000099598146,0.00018455835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013186639,0.00056380563,0.00232784,0.00024193041,0.00007651557,0.0000116826595,0.0002033654,0.00030711346,0.0003029375],"category_scores_gemma":[0.00025831236,0.00040769202,0.0011006801,0.00017767001,0.00024989768,0.000020083267,0.00014668335,0.00019007863,0.0006956213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008433789,0.00048541752,0.0000412755,0.0072541144,0.0008279221,0.00235785,0.000020340996,3.0189393e-9,0.000011928282,0.00026628718,0.04271418,0.9459363],"study_design_scores_gemma":[0.0019393521,0.000717563,0.000025253741,0.0028410228,0.0028592441,0.008714906,0.0000037596624,5.601438e-7,0.0000586967,0.000036180274,0.98249185,0.00031160607],"about_ca_topic_score_codex":0.0000097722705,"about_ca_topic_score_gemma":9.4178506e-7,"teacher_disagreement_score":0.9456247,"about_ca_system_score_codex":0.00041597593,"about_ca_system_score_gemma":0.00033789882,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W2800681950","doi":"10.1200/jco.2013.31.15_suppl.tps8618","title":"A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with bendamustine and rituximab for previously treated indolent non-Hodgkin lymphomas (iNHL).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Idelalisib; Bendamustine; Rituximab; Internal medicine; Follicular lymphoma; Lymphoma; Oncology; Ofatumumab; Clinical endpoint; Ibrutinib; Gastroenterology; Clinical trial; Leukemia; Chronic lymphocytic leukemia","score_opus":0.09848421511876561,"score_gpt":0.4642473764283994,"score_spread":0.3657631613096338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800681950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831867,0.0007891549,0.000097364915,0.0028102435,0.00013229751,0.012789273,0.0000027442238,0.000005806131,0.00018641294],"genre_scores_gemma":[0.99715865,0.0005271404,0.0010911529,0.00025238242,0.00016119891,0.00074260816,0.000007287311,0.000019049272,0.00004055762],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99405086,0.0011841132,0.0037617662,0.00029477393,0.00045019953,0.00025830907],"domain_scores_gemma":[0.98096037,0.014869205,0.0029288942,0.00020826017,0.0007910851,0.00024217478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011273601,0.0002597433,0.004000533,0.00020292922,0.00008700563,0.000029038407,0.00010960619,0.00022061501,0.000029910272],"category_scores_gemma":[0.0035503444,0.00012537221,0.00034024118,0.00016841809,0.00030623208,0.00013847784,0.000052814343,0.00032173426,8.634773e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85496193,0.031398535,0.022333523,0.00003982762,0.0017717287,0.000072519455,0.0009969707,0.000029702633,0.000025551679,0.00005088922,0.00005955643,0.08825929],"study_design_scores_gemma":[0.87598515,0.077632494,0.037480813,0.0003267332,0.003699084,0.0001689681,0.0005239458,0.0039450736,0.000036688165,0.00006833842,0.00003343101,0.00009930997],"about_ca_topic_score_codex":0.00029643925,"about_ca_topic_score_gemma":0.00014102973,"teacher_disagreement_score":0.08815998,"about_ca_system_score_codex":0.00019357592,"about_ca_system_score_gemma":0.0008220126,"threshold_uncertainty_score":0.51125306},"labels":[],"label_agreement":null},{"id":"W2800764700","doi":"10.17925/ohr.2018.14.1.21","title":"Pediatric Anaplastic Large Cell Lymphoma—A Review","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Lymphoma; Pathology","score_opus":0.022440804423905357,"score_gpt":0.34836774670896703,"score_spread":0.3259269422850617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800764700","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34782684,0.58123744,0.000091480084,0.007384856,0.0015247606,0.0033006682,0.0000198202,0.00016423197,0.058449887],"genre_scores_gemma":[0.5840858,0.38729712,0.002279828,0.024041941,0.0006589083,0.0009026479,0.000074384094,0.00005789791,0.0006014496],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996579,0.00047504657,0.0012133715,0.00070218794,0.0002030344,0.0008273617],"domain_scores_gemma":[0.9978952,0.0005183603,0.00039439116,0.0007601965,0.00016715216,0.00026472012],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00079509,0.00040296285,0.0023727405,0.00028833435,0.00010339122,0.000005789909,0.00024936555,0.00037027744,0.0019310482],"category_scores_gemma":[0.0004936304,0.0003086635,0.00028663018,0.0007372869,0.00022290816,0.00006663158,0.00016077563,0.00017803987,0.0048396704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047727124,0.019286754,0.36894867,0.016579498,0.00023015469,0.015578587,0.0006302658,1.537658e-7,0.000029396762,0.0060315235,0.3616814,0.21052633],"study_design_scores_gemma":[0.010709292,0.0026641304,0.020903157,0.0014941887,0.0010978275,0.0046641324,0.00002255789,0.000017956823,0.00019387352,0.00015840685,0.9577428,0.00033166047],"about_ca_topic_score_codex":0.000030267633,"about_ca_topic_score_gemma":0.00024748797,"teacher_disagreement_score":0.5960614,"about_ca_system_score_codex":0.0006984751,"about_ca_system_score_gemma":0.0009848069,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W2800810996","doi":"10.1002/hon.2513","title":"Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with <sup>90</sup>Y ibritumomab tiuxetan in a phase II study","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Spectrum Pharmaceuticals","keywords":"Medicine; Ibritumomab tiuxetan; Follicular lymphoma; Internal medicine; Rituximab; International Prognostic Index; Oncology; Gastroenterology; Immunotherapy; Vincristine; Lymphoma; Cyclophosphamide; Radioimmunotherapy; Surgery; Immunology; Chemotherapy; Cancer; Antibody","score_opus":0.014193834309545334,"score_gpt":0.2984657552718471,"score_spread":0.28427192096230175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800810996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956792,0.00051760185,0.000047327132,0.00035452275,0.00006572044,0.0019528084,0.000023501309,0.00006888645,0.0012904577],"genre_scores_gemma":[0.9965134,0.0007257891,0.001900539,0.00019041263,0.00006140778,0.00052393536,0.000021987727,0.000024817442,0.000037665242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973522,0.00033917456,0.000744693,0.00073734863,0.00032374467,0.0005028518],"domain_scores_gemma":[0.99840105,0.00039792736,0.0003457856,0.00048779507,0.00009812524,0.00026933308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035822054,0.00037220918,0.0014229629,0.00019277414,0.00014049132,0.000013480155,0.00015854229,0.0002351166,0.00016634588],"category_scores_gemma":[0.00011097004,0.00023503772,0.00011415665,0.00037187105,0.00052220066,0.000063319334,0.00028365737,0.00014386234,0.000036955487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004180615,0.040374294,0.78033626,0.00012911021,0.0010598911,0.025871223,0.0020388432,0.000005846893,0.0000105362415,0.00198115,0.00036999898,0.14364225],"study_design_scores_gemma":[0.10621288,0.085134536,0.79664063,0.00033072653,0.0016314213,0.0009258951,0.0039515314,0.0004660581,0.0006647287,0.0006091103,0.0030630697,0.00036938844],"about_ca_topic_score_codex":0.000497376,"about_ca_topic_score_gemma":0.00032479636,"teacher_disagreement_score":0.14327286,"about_ca_system_score_codex":0.00026549364,"about_ca_system_score_gemma":0.00010662194,"threshold_uncertainty_score":0.958456},"labels":[],"label_agreement":null},{"id":"W2801611492","doi":"10.1182/blood-2018-02-832147","title":"Improving on R-ICE in relapsed DLBCL","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Ifosfamide; Rituximab; Medicine; Carboplatin; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Etoposide; Lymphoma; Chemotherapy; Leukemia; Cisplatin; Chronic lymphocytic leukemia","score_opus":0.013951492984184986,"score_gpt":0.2403761922440867,"score_spread":0.22642469925990172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801611492","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4984909,0.000741835,6.0009944e-7,0.4626637,0.0007907802,0.0011286826,0.000053242387,0.0001482206,0.035982043],"genre_scores_gemma":[0.06296848,0.00006890172,0.0004660877,0.91747326,0.008137281,0.00024291592,0.00039946486,0.000122031364,0.010121598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863917,0.00003498916,0.00024398773,0.00044560022,0.00030141088,0.0003348506],"domain_scores_gemma":[0.9991637,0.000114705144,0.00010752635,0.0005213486,0.00003707793,0.000055639946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077481636,0.00026788484,0.00042956276,0.00017740781,0.000031096402,0.000019760559,0.00009220659,0.00055902696,0.00012826957],"category_scores_gemma":[0.00007648436,0.00020650243,0.00013751765,0.00010254901,0.000033068576,0.000014245924,0.00003586442,0.0005320523,0.0006577513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047671532,0.0023155804,0.014272478,0.00025506032,0.0002471214,0.00849905,0.00007873862,3.2778694e-8,0.00008306709,0.000012360753,0.9710598,0.0031290327],"study_design_scores_gemma":[0.026102358,0.0019598058,0.031021677,0.0014246827,0.0011349579,0.00023952241,0.000008631855,0.0000055873757,0.0057023647,0.000033229026,0.9319192,0.00044794276],"about_ca_topic_score_codex":0.00027002493,"about_ca_topic_score_gemma":0.000019301606,"teacher_disagreement_score":0.45480955,"about_ca_system_score_codex":0.00015991782,"about_ca_system_score_gemma":0.00013328005,"threshold_uncertainty_score":0.8454281},"labels":[],"label_agreement":null},{"id":"W2802617257","doi":"10.1186/s12885-018-4300-2","title":"Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Canadian Institutes of Health Research; China Scholarship Council; University of Alberta","keywords":"SOX2; Cancer research; Wnt signaling pathway; Stem cell; Cancer stem cell; CD44; Anaplastic large-cell lymphoma; Cell growth; Biology; Cell culture; Cancer cell; Flow cytometry; Chemistry; Cell; Molecular biology; Cell biology; Cancer; Immunology; Lymphoma; Signal transduction; Biochemistry; Transcription factor","score_opus":0.011362445919250348,"score_gpt":0.26119795778343907,"score_spread":0.24983551186418873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802617257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662536,0.0013001625,0.00006422715,0.00031019017,0.00024201591,0.00067328534,0.00010095201,0.000011088285,0.00067271985],"genre_scores_gemma":[0.9985832,0.00019199621,0.00003913128,0.00024409399,0.00015973805,0.0001714856,0.000011127627,0.000014270871,0.0005849586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988689,0.00011229554,0.00021319288,0.00029858912,0.0002715223,0.00023553809],"domain_scores_gemma":[0.9990987,0.0002852778,0.0001952412,0.0002163082,0.00015025931,0.00005421032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010874398,0.00018655956,0.00027333703,0.00005210592,0.0001512844,0.000018924293,0.00011370009,0.00007208127,0.000049087586],"category_scores_gemma":[0.000029033356,0.000097803604,0.00007483057,0.00027031038,0.00022577534,0.00009050602,0.000075789874,0.00006859651,0.00000424387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003395755,0.0038003246,0.8575739,0.00042049924,0.0006574466,0.000019337798,0.017020736,0.00004266129,0.084061444,0.0004963232,0.0028906013,0.029620925],"study_design_scores_gemma":[0.0022005818,0.00021797694,0.50125104,0.00022424545,0.00008789558,0.00000408872,0.00060728675,0.00007308639,0.4951083,0.00002698258,0.00012928023,0.000069221736],"about_ca_topic_score_codex":0.0032205374,"about_ca_topic_score_gemma":0.009814383,"teacher_disagreement_score":0.41104686,"about_ca_system_score_codex":0.00030087808,"about_ca_system_score_gemma":0.00024123404,"threshold_uncertainty_score":0.5476656},"labels":[],"label_agreement":null},{"id":"W2804219602","doi":"10.1182/blood-2018-03-838136","title":"A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; BC Cancer Agency","funders":"European Regional Development Fund; Instituto de Salud Carlos III; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Mantle cell lymphoma; Lymphoma; Outcome (game theory); Gene signature; Signature (topology); Biology; Computational biology; Cancer research; Bioinformatics; Oncology; Gene; Medicine; Genetics; Immunology; Gene expression; Mathematics","score_opus":0.016956971499266515,"score_gpt":0.24578776240413516,"score_spread":0.22883079090486866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804219602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070966,0.0018920964,0.000011134283,0.00022235102,0.00021702141,0.00028142598,0.000080825565,0.00007149127,0.006513971],"genre_scores_gemma":[0.99647385,0.0000665395,0.00094946305,0.00030685228,0.0005972591,0.00003780659,0.000097025106,0.000023338682,0.001447892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989552,0.00001947767,0.00019249605,0.00032577707,0.00025881274,0.0002482726],"domain_scores_gemma":[0.99940425,0.0000594388,0.000078596524,0.00022422077,0.00007098965,0.00016252189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000782794,0.00018710435,0.0002639654,0.000051123327,0.00011871732,0.00003194703,0.00006438938,0.00011433181,0.00017387707],"category_scores_gemma":[0.000035731366,0.00014238375,0.00009976433,0.0000674283,0.00012993006,0.000042956202,0.00006649492,0.00004986075,0.00008327138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093030314,0.0021483887,0.99007595,0.000110063476,0.00021626425,0.00036906655,0.00012341536,5.905112e-8,0.0034539124,0.00011813759,0.0018195572,0.0014721348],"study_design_scores_gemma":[0.018152928,0.00067543506,0.8767763,0.0001064171,0.0006304642,0.0005608259,0.000075720585,0.000039137543,0.099501796,0.00008757261,0.0032086729,0.00018472079],"about_ca_topic_score_codex":0.00005593597,"about_ca_topic_score_gemma":0.000009954644,"teacher_disagreement_score":0.11329966,"about_ca_system_score_codex":0.00006977555,"about_ca_system_score_gemma":0.00009335527,"threshold_uncertainty_score":0.5806241},"labels":[],"label_agreement":null},{"id":"W2804803500","doi":"10.1200/edbk_200679","title":"New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Hodgkin lymphoma; Clinical trial; Intensive care medicine; Disease; Oncology; Lymphoma; Internal medicine; Cancer; Immunotherapy","score_opus":0.2095668149700712,"score_gpt":0.5368109536088498,"score_spread":0.32724413863877855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804803500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027195542,0.9724347,0.000012056891,0.017935753,0.00094732415,0.0018138292,0.00008739975,0.000033650183,0.006463339],"genre_scores_gemma":[0.0000127920675,0.9012047,0.032551996,0.0059352685,0.002654658,0.00061752705,0.000419803,0.00005846619,0.05654481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947483,0.00046295405,0.0028120254,0.0010338771,0.00043574462,0.0005071166],"domain_scores_gemma":[0.98838973,0.008116794,0.0019045236,0.0007292786,0.00024583365,0.00061383453],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007009859,0.0006494217,0.00567651,0.00011161,0.00007101934,0.000012801946,0.00030725304,0.0007342048,0.00159778],"category_scores_gemma":[0.0005739263,0.00042845987,0.0028843132,0.0005425837,0.0014006045,0.00006908398,0.0001046686,0.00028481855,0.00037431598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011745996,0.006109913,0.0015859008,0.00042943898,0.0013368415,0.000019188661,0.00021794731,4.609155e-8,1.3339417e-8,0.000105219144,0.22498406,0.765094],"study_design_scores_gemma":[0.0046039904,0.007499285,0.010332362,0.0015961288,0.0023268939,0.00012891633,0.00019196642,0.0000038350327,7.564957e-7,0.00007305706,0.9729078,0.00033499827],"about_ca_topic_score_codex":0.0013847008,"about_ca_topic_score_gemma":0.00005016199,"teacher_disagreement_score":0.76475894,"about_ca_system_score_codex":0.003431681,"about_ca_system_score_gemma":0.03778221,"threshold_uncertainty_score":0.9998167},"labels":[],"label_agreement":null},{"id":"W2806039308","doi":"10.1016/j.clml.2018.05.022","title":"An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Gastroenterology; Peripheral edema; Anemia; Hypoalbuminemia; Adverse effect; Leukopenia; Hyponatremia; Surgery; Chemotherapy","score_opus":0.0460260974443202,"score_gpt":0.3835334315622945,"score_spread":0.33750733411797434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806039308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989796,0.00039604126,0.000019717761,0.0004913866,0.001173494,0.003456311,0.00032856976,0.00017165947,0.0041668415],"genre_scores_gemma":[0.9925147,0.00032048003,0.0015340458,0.0017517235,0.0021319631,0.00047995913,0.00042272118,0.00016353691,0.0006808666],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919349,0.00075241475,0.003071926,0.0019141089,0.0009556192,0.0013710139],"domain_scores_gemma":[0.9942731,0.00091623777,0.0010109663,0.0019892415,0.0006342186,0.001176198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001994489,0.00092480885,0.0025257657,0.00039834928,0.00039505746,0.00014058445,0.0010504251,0.000885767,0.00023261346],"category_scores_gemma":[0.0011875252,0.0008002249,0.00043624273,0.0012414533,0.000813035,0.0005389787,0.00090951927,0.0002769998,0.00027082386],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15616682,0.3573297,0.02387852,0.0001312151,0.00047601966,0.0013692838,0.0009844749,2.1091955e-7,0.0060519567,0.00085252646,0.011520497,0.44123876],"study_design_scores_gemma":[0.6866194,0.061695166,0.19733725,0.00043526865,0.00050418766,0.00007621074,0.00011125552,0.00053796015,0.031488094,0.00017091485,0.0203151,0.00070919236],"about_ca_topic_score_codex":0.0010557091,"about_ca_topic_score_gemma":0.00033580046,"teacher_disagreement_score":0.53045255,"about_ca_system_score_codex":0.0022619676,"about_ca_system_score_gemma":0.0036637078,"threshold_uncertainty_score":0.99944484},"labels":[],"label_agreement":null},{"id":"W2806153787","doi":"10.1002/ccr3.1580","title":"Indolent T‐cell‐rich small B‐cell hepatic lymphoma in a Golden Retriever","year":2018,"lang":"en","type":"article","venue":"Clinical Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Lymphoma; Labrador Retriever; Lymph; Pathology; Cell; Population; Biology","score_opus":0.051401480353367515,"score_gpt":0.3438366592138484,"score_spread":0.29243517886048087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806153787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985393,0.0006680517,0.0000067843985,0.00029423434,0.00073812867,0.00075522903,0.0000034989173,0.00006668237,0.012074393],"genre_scores_gemma":[0.9955378,0.00021250555,0.00057885266,0.001164733,0.00055747293,0.00007335651,0.00002161566,0.000038474445,0.0018151759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966534,0.00014323529,0.0016406854,0.0007865167,0.0003344027,0.00044175523],"domain_scores_gemma":[0.99739635,0.00050099386,0.0004468222,0.0009859804,0.00019328989,0.0004765756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010847208,0.00027451228,0.00075056066,0.00011837952,0.00006845147,0.00002882746,0.000047959198,0.00031621926,0.00024442817],"category_scores_gemma":[0.0008254295,0.00021375672,0.00030272864,0.00036038816,0.00018175929,0.000050294027,0.00012766299,0.0001618328,0.00025599686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014810696,0.0032223584,0.6244818,0.00006426268,0.000041896663,0.3595126,0.00014959482,1.7587101e-7,0.000020070767,0.0000037630243,0.0025626284,0.009792732],"study_design_scores_gemma":[0.011338476,0.003451067,0.86119497,0.00041939752,0.0006308372,0.09172567,0.00015987844,0.0001341612,0.00870778,0.00018727464,0.021536753,0.00051371736],"about_ca_topic_score_codex":0.00056288566,"about_ca_topic_score_gemma":0.0002063428,"teacher_disagreement_score":0.26778692,"about_ca_system_score_codex":0.00033618798,"about_ca_system_score_gemma":0.00050256023,"threshold_uncertainty_score":0.8716746},"labels":[],"label_agreement":null},{"id":"W2807946057","doi":"10.1016/j.leukres.2018.06.008","title":"Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity","year":2018,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunosuppression; Internal medicine; Lymphoma; Gastroenterology; Inflammatory bowel disease; Ulcerative colitis; Chemotherapy; Gastrointestinal tract; Disease","score_opus":0.07467158238057321,"score_gpt":0.39730007063406203,"score_spread":0.32262848825348883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807946057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4696671,0.52599376,5.191908e-7,0.000036143025,0.000085175474,0.003385347,0.00026301426,0.000014694149,0.00055424444],"genre_scores_gemma":[0.14286895,0.85523325,0.00025026433,0.000022502196,0.00029355576,0.0004438329,0.00030542605,0.00011596286,0.00046627317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949069,0.00090565823,0.0013558166,0.0005985873,0.0016880312,0.00054501084],"domain_scores_gemma":[0.9964166,0.00081822753,0.0005988872,0.0011997531,0.0006218548,0.00034467594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016273861,0.00035910355,0.001570018,0.00034482873,0.00006475559,0.000017238111,0.0005079497,0.00021342002,0.000099765246],"category_scores_gemma":[0.0011446654,0.00019436113,0.00071431865,0.0006368336,0.00091260305,0.000059869846,0.00029607382,0.00058460236,0.00003005301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005718844,0.002252979,0.8574106,0.012491233,0.00011397228,0.00028369456,0.00001761027,1.7275136e-7,3.19313e-8,0.000038241462,0.0010543171,0.12576523],"study_design_scores_gemma":[0.0048022363,0.0011345607,0.9059635,0.046437163,0.00042982676,0.00003975087,0.000008794319,0.0000033830847,0.0000014763376,0.000010748819,0.041038185,0.00013042393],"about_ca_topic_score_codex":0.00015857302,"about_ca_topic_score_gemma":0.00006063315,"teacher_disagreement_score":0.3292395,"about_ca_system_score_codex":0.0017953753,"about_ca_system_score_gemma":0.009958773,"threshold_uncertainty_score":0.99565387},"labels":[],"label_agreement":null},{"id":"W2808358670","doi":"10.3390/cancers10060204","title":"The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma","year":2018,"lang":"en","type":"review","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Brentuximab vedotin; Medicine; Oncology; Immunotherapy; Blockade; Immune system; Lymphoma; Disease; Population; Chemotherapy; Internal medicine; Immune checkpoint; Hodgkin lymphoma; Immunology","score_opus":0.022798177605853457,"score_gpt":0.3090184520822098,"score_spread":0.28622027447635634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808358670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005936015,0.993228,9.210201e-8,0.0000749146,0.00044312354,0.0007917916,0.000020604115,0.00001548374,0.0048323693],"genre_scores_gemma":[0.0022615707,0.9965111,0.000022369135,0.000019574043,0.0003791771,0.00041756217,0.000035845456,0.000041291692,0.00031150976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818057,0.00007988536,0.0008469023,0.0003268622,0.0002534772,0.0003123056],"domain_scores_gemma":[0.99870086,0.00019191655,0.00039838004,0.00054846256,0.000052556752,0.00010780916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024670505,0.00031616562,0.0014114807,0.000107938096,0.000051803636,0.000014280224,0.00017625357,0.00024660505,0.00003545244],"category_scores_gemma":[0.000087299544,0.00017543201,0.000713872,0.00031720288,0.00027639477,0.000020212014,0.00007480741,0.00011638486,0.00006488671],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031511798,0.00006991528,0.0001168103,0.0013867315,0.0002505015,0.000027641492,0.00006001476,1.3537031e-7,0.0000014862866,0.00014083598,0.0010612467,0.9968532],"study_design_scores_gemma":[0.0010726778,0.00022022914,0.00030355132,0.013938534,0.00056506356,0.000032698623,0.000072241986,0.0000060858074,0.00029778283,0.00003482002,0.9833097,0.00014660772],"about_ca_topic_score_codex":0.0006517319,"about_ca_topic_score_gemma":0.0001140895,"teacher_disagreement_score":0.99670655,"about_ca_system_score_codex":0.004935353,"about_ca_system_score_gemma":0.0027864843,"threshold_uncertainty_score":0.9988845},"labels":[],"label_agreement":null},{"id":"W2808676644","doi":"10.1038/s41409-018-0253-y","title":"A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg","year":2018,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Kyowa Hakko Kirin; Sanofi","keywords":"Plerixafor; Medicine; Regimen; Clinical endpoint; Granulocyte colony-stimulating factor; Urology; Randomized controlled trial; Surgery; Internal medicine; Gastroenterology; Chemotherapy; CXCR4","score_opus":0.023444984173261924,"score_gpt":0.2958958444227188,"score_spread":0.2724508602494569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808676644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888824,0.00006976181,0.0013523487,0.000062058265,0.00015913743,0.009287257,0.00012004327,0.000021613034,0.00004536853],"genre_scores_gemma":[0.9949384,0.000037254846,0.0031774626,0.00002480218,0.000027278498,0.0011022162,0.0006545785,0.000034066787,0.00000395332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998097,0.00015907116,0.00070988,0.0004040068,0.00036778394,0.00026226378],"domain_scores_gemma":[0.9986191,0.00053153466,0.00035437,0.00018855363,0.00021127338,0.00009516689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005151532,0.00028120927,0.00103805,0.00028706813,0.000082340215,0.00005833953,0.00007853737,0.00009324579,0.000004316907],"category_scores_gemma":[0.000047734764,0.00020516594,0.00004916528,0.00022869286,0.00010766813,0.0002631083,0.000010499167,0.00005350283,6.23193e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9417553,0.008618352,0.041491743,0.0007265728,0.00020831994,0.00004759526,0.001981846,0.000016598826,0.00046943556,0.000042789467,0.000005533335,0.0046359026],"study_design_scores_gemma":[0.9326282,0.018520324,0.035812292,0.0028958926,0.0007722238,0.000006356826,0.000107400556,0.00626114,0.0027785418,0.0000036129388,0.000003602937,0.00021041268],"about_ca_topic_score_codex":0.0004363317,"about_ca_topic_score_gemma":0.0006373434,"teacher_disagreement_score":0.009901972,"about_ca_system_score_codex":0.0002859693,"about_ca_system_score_gemma":0.0002022938,"threshold_uncertainty_score":0.83664244},"labels":[],"label_agreement":null},{"id":"W2809201980","doi":"10.1038/s41586-018-0290-0","title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":403,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Ibrutinib; breakpoint cluster region; Bruton's tyrosine kinase; Cancer research; Syk; B-cell receptor; Biology; Signal transducing adaptor protein; B cell; Signal transduction; Cell biology; Tyrosine kinase; Chronic lymphocytic leukemia; Leukemia; Genetics; Receptor","score_opus":0.014750320354824195,"score_gpt":0.2877688406829173,"score_spread":0.2730185203280931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809201980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920517,0.003671233,0.000026953569,0.0017192082,0.0001556298,0.0005379693,0.000007983846,0.00005936864,0.0017699379],"genre_scores_gemma":[0.9944546,0.000044850578,0.0020567044,0.0027079172,0.0004939173,0.00005662432,0.000021720109,0.000020931566,0.00014269985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892884,0.000030489202,0.00021184146,0.0002972765,0.00024043553,0.00029114058],"domain_scores_gemma":[0.99943995,0.000086451844,0.00003605183,0.00020312416,0.00012692137,0.00010750017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001391888,0.0001618231,0.00031719686,0.00011847082,0.00006499373,0.000019639909,0.000075959375,0.0006520376,0.00017713149],"category_scores_gemma":[0.00011932607,0.00012322163,0.00011852721,0.00021746967,0.000050338822,0.00005506803,0.000024175613,0.00036138005,0.00013394018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040333485,0.0056553707,0.392337,0.00023566597,0.00094959594,0.003255455,0.0031854927,0.000037309987,0.27946866,0.0049292166,0.0059004887,0.30001238],"study_design_scores_gemma":[0.06459103,0.002099181,0.5442032,0.0012987516,0.000377191,0.0003876623,0.00041883372,0.010449688,0.2831725,0.00091106986,0.09126284,0.0008280286],"about_ca_topic_score_codex":0.00020724772,"about_ca_topic_score_gemma":0.00017733399,"teacher_disagreement_score":0.29918435,"about_ca_system_score_codex":0.00032367022,"about_ca_system_score_gemma":0.00012552018,"threshold_uncertainty_score":0.5029111},"labels":[],"label_agreement":null},{"id":"W2810132656","doi":"10.4274/tjh.2018.0186","title":"Skeletal Muscle Diffuse Large B-Cell Lymphoma in the Gluteal Region","year":2018,"lang":"en","type":"letter","venue":"Turkish Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"Universidad Autónoma de Nuevo León","keywords":"Medicine; Diffuse large B-cell lymphoma; Gluteal muscles; Lymphoma; Anatomy; Pathology","score_opus":0.017141415511095305,"score_gpt":0.26166181540769046,"score_spread":0.24452039989659516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810132656","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48426184,0.006264156,0.000016663376,0.5049803,0.001154222,0.00047299758,0.000018750572,0.000018689014,0.0028123653],"genre_scores_gemma":[0.62526697,0.00075459946,0.00016487388,0.36877918,0.0043997564,0.000025922818,0.00008552111,0.000064003165,0.0004591879],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972235,0.00033795083,0.0009350341,0.0003067515,0.0005748233,0.0006219708],"domain_scores_gemma":[0.9978802,0.00041048837,0.00087553146,0.0005379554,0.00019611463,0.000099664816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040485754,0.00039630447,0.0012410295,0.0003724241,0.000079789716,0.00003541034,0.0004420767,0.0008436789,0.000083560684],"category_scores_gemma":[0.00009183129,0.00023097843,0.00054429553,0.00018279896,0.00017371679,0.00007844183,0.00006918358,0.00092820876,0.00010909991],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000747165,0.0034894743,0.0030013048,0.00018526618,0.00016248012,0.06574624,0.00044329386,2.1176982e-8,0.0000042390216,0.000084527885,0.92572874,0.0010796697],"study_design_scores_gemma":[0.019776033,0.0010850506,0.01048222,0.00043517296,0.000515169,0.06623546,0.00016117824,0.0000038412772,0.000120503355,0.00025387813,0.90071905,0.00021242264],"about_ca_topic_score_codex":0.000031760323,"about_ca_topic_score_gemma":0.000016332197,"teacher_disagreement_score":0.14100511,"about_ca_system_score_codex":0.00026336484,"about_ca_system_score_gemma":0.0003169612,"threshold_uncertainty_score":0.9419027},"labels":[],"label_agreement":null},{"id":"W2810254284","doi":"10.1016/j.jval.2018.04.1510","title":"1. Indirect Treatment Comparison of Pembrolizumab Versus Standard-of-Care for Relapsed and Refractory Classical Hodgkin’s Lymphoma Using Time-Varying Hazard Ratios","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Pembrolizumab; Medicine; Hazard ratio; Internal medicine; Population; Oncology; Brentuximab vedotin; Proportional hazards model; Refractory (planetary science); Confidence interval; Lymphoma; Cancer; Hodgkin lymphoma","score_opus":0.08550170059292984,"score_gpt":0.37566668849101037,"score_spread":0.29016498789808054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810254284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936754,0.0040916204,0.000040333573,0.00035574363,0.00023403911,0.0012345344,0.00009178838,0.000024120794,0.0002524252],"genre_scores_gemma":[0.9930839,0.00025739893,0.0063657453,0.000039258397,0.00011575859,0.000048917358,0.00004632237,0.00002738706,0.000015310427],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983192,0.00015152634,0.0006414574,0.000319779,0.00026808472,0.0002999294],"domain_scores_gemma":[0.99859536,0.00049970107,0.00033669473,0.0002688055,0.00014077916,0.00015864089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000209251,0.00019665602,0.0009480187,0.00018291154,0.00012411983,0.000009021547,0.000042801148,0.000117114396,0.000014245522],"category_scores_gemma":[0.00011136552,0.00016135543,0.000109312125,0.00015232801,0.00013059925,0.000051745337,0.00002300634,0.00004309504,0.000002160562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096874565,0.0068651866,0.35852328,0.004344165,0.0011674487,0.00006213998,0.034997024,0.0006364751,0.0023475648,0.0010376732,0.001121265,0.49202323],"study_design_scores_gemma":[0.280857,0.23656961,0.19623348,0.00788448,0.001611876,0.0000959866,0.004445568,0.09977794,0.1432241,0.00019689988,0.027977675,0.0011253769],"about_ca_topic_score_codex":0.0006824367,"about_ca_topic_score_gemma":0.00014115608,"teacher_disagreement_score":0.49089783,"about_ca_system_score_codex":0.0020402605,"about_ca_system_score_gemma":0.0011949475,"threshold_uncertainty_score":0.65798837},"labels":[],"label_agreement":null},{"id":"W2810985327","doi":"10.1016/j.jval.2018.04.1692","title":"Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Roche (Canada); Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Rituximab; Medicine; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Population; Oncology; Internal medicine","score_opus":0.08634858034312419,"score_gpt":0.3644915796989373,"score_spread":0.2781429993558131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810985327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936223,0.0023501662,3.038086e-7,0.0018305074,0.0001602066,0.0010188875,0.000020682244,0.0000119671195,0.0009849704],"genre_scores_gemma":[0.99877775,0.00049039634,0.000046020752,0.0004858905,0.00010905009,0.00003706899,0.00003221166,0.000010581023,0.000011035539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985473,0.00024437183,0.0003297838,0.00016961998,0.00046949406,0.00023940796],"domain_scores_gemma":[0.9990771,0.00012280008,0.00012396587,0.00022166489,0.00023541303,0.00021904925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012510755,0.000095422714,0.00023804957,0.00019404588,0.000052196705,0.000007997978,0.00003388106,0.00006015984,0.00007104125],"category_scores_gemma":[0.00017874893,0.00007641612,0.000034126337,0.00016482579,0.000027435757,0.000025056415,0.0000020438006,0.000034300774,0.000042381405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021214793,0.005739744,0.64230925,0.0010657179,0.00032177288,0.0003639751,0.008178759,0.00052912673,0.0015019987,0.004976427,0.0021396233,0.33075213],"study_design_scores_gemma":[0.021496417,0.032710318,0.90584093,0.0043839854,0.00016179727,0.0013162565,0.0005279585,0.01417286,0.017249694,0.000754833,0.0010486414,0.0003363298],"about_ca_topic_score_codex":0.24710105,"about_ca_topic_score_gemma":0.05957013,"teacher_disagreement_score":0.3304158,"about_ca_system_score_codex":0.0018818332,"about_ca_system_score_gemma":0.004460006,"threshold_uncertainty_score":0.9575903},"labels":[],"label_agreement":null},{"id":"W2811117276","doi":"10.1080/10428194.2018.1473576","title":"Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world","year":2018,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Chemoimmunotherapy; Medicine; Retrospective cohort study; Transplantation; Single Center; Surgery; Follicular lymphoma; Lymphoma; Internal medicine; Rituximab; Oncology","score_opus":0.011123329664823167,"score_gpt":0.2756643720021961,"score_spread":0.26454104233737297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811117276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965522,0.00018672294,0.000032045533,0.000032028725,0.00019850014,0.001908635,0.00065878034,0.00005527477,0.000375771],"genre_scores_gemma":[0.9970388,0.0005637544,0.0005387335,0.00029566017,0.00005558623,0.00031035324,0.0009831699,0.00007594804,0.00013799504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960435,0.00029566805,0.0013681534,0.0009442021,0.00069901085,0.0006494424],"domain_scores_gemma":[0.9970523,0.0005248441,0.00090085535,0.0006997525,0.0006534379,0.00016878007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000501525,0.00064267457,0.0016871532,0.0008717022,0.00019185703,0.00005515128,0.00031800006,0.00031136477,0.000011312285],"category_scores_gemma":[0.0001275957,0.0004981533,0.0006008285,0.0018170972,0.00067741616,0.00021687467,0.00005427267,0.00006642364,0.0000033560275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061649503,0.0033140897,0.9521465,0.00013401525,0.0029114892,0.000069895104,0.0067322855,0.000007823033,0.000767836,0.0003504773,0.000080305115,0.027320342],"study_design_scores_gemma":[0.08256508,0.0018882505,0.89592946,0.00029113906,0.0024513933,0.000017165143,0.0003679367,0.0032386095,0.0126836505,0.00004668953,0.00010967151,0.00041098922],"about_ca_topic_score_codex":0.010059548,"about_ca_topic_score_gemma":0.0033199266,"teacher_disagreement_score":0.07640012,"about_ca_system_score_codex":0.0036476096,"about_ca_system_score_gemma":0.00097429403,"threshold_uncertainty_score":0.99974704},"labels":[],"label_agreement":null},{"id":"W2811238399","doi":"10.1016/s2352-3026(18)30093-0","title":"Rituximab as a first step in tackling transformation","year":2018,"lang":"en","type":"letter","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Research UK; European Hematology Association","keywords":"Follicular lymphoma; Medicine; Lymphoma; Population; Rituximab; Biopsy; Internal medicine","score_opus":0.029958309741099653,"score_gpt":0.29690645844765395,"score_spread":0.2669481487065543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811238399","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063058175,0.0008217366,0.000020857653,0.921368,0.0003748813,0.0007874872,0.000025116251,0.0000735755,0.013470154],"genre_scores_gemma":[0.17171499,0.00073298754,0.00031208122,0.8214969,0.0040539205,0.000429114,0.00052575336,0.000059322767,0.00067491195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985034,0.000111267815,0.00038996042,0.00028767044,0.00021554988,0.00049216236],"domain_scores_gemma":[0.9989426,0.00026069893,0.00014147337,0.00057680364,0.000047064943,0.000031347907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002021196,0.00026867955,0.0014654318,0.00013306031,0.0000842839,0.000021152782,0.0002095889,0.0005886152,0.00027850957],"category_scores_gemma":[0.00004842394,0.00016472716,0.00013243608,0.00012618123,0.00014671347,0.000043744123,0.000032127275,0.00064905116,0.0012662299],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017218819,0.00018512145,0.0033157254,0.00086786406,0.00014564056,0.0044407235,0.0014618671,5.5618784e-7,9.178273e-7,0.0008226843,0.9878095,0.00077723165],"study_design_scores_gemma":[0.0066991053,0.00022732538,0.0014816977,0.000616265,0.00026920286,0.0044071893,0.000043657794,0.00007965468,0.00014814832,0.0007836681,0.9850606,0.0001834884],"about_ca_topic_score_codex":0.00033256534,"about_ca_topic_score_gemma":0.00031343222,"teacher_disagreement_score":0.10865681,"about_ca_system_score_codex":0.00021388607,"about_ca_system_score_gemma":0.00014763423,"threshold_uncertainty_score":0.9995114},"labels":[],"label_agreement":null},{"id":"W2811327015","doi":"10.3747/co.25.3979","title":"Ode to My Oncologist","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Royal Roads University","funders":"","keywords":"Medicine; Ode; Follicular lymphoma; Radiation oncologist; Family medicine; Lymphoma; Oncology; Internal medicine; Literature","score_opus":0.17425676892445366,"score_gpt":0.47620423591487393,"score_spread":0.3019474669904203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811327015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180498,0.00078121334,0.00014211312,0.008946182,0.002972399,0.0006136723,0.000008948164,0.00010674621,0.06837893],"genre_scores_gemma":[0.99470145,0.00011483554,0.0011342022,0.0020277852,0.0012456948,0.0001643897,0.000023266213,0.000011966339,0.00057639484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990482,0.00004119403,0.00019638544,0.00029051062,0.00012437711,0.0002993452],"domain_scores_gemma":[0.99919367,0.000086682085,0.00004921116,0.0002639141,0.00013708456,0.00026945365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011284181,0.00012716968,0.00031478095,0.000084888416,0.00007401632,0.000007882262,0.000082118124,0.00009098449,0.00063423876],"category_scores_gemma":[0.00012783823,0.00009508505,0.000077336,0.0001525863,0.00015248921,0.000021115635,0.00008273634,0.00008004431,0.0028629766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000293911,0.0029396173,0.17351577,0.000024205905,0.00006981334,0.00012229237,0.00060901814,2.6057077e-7,0.00028013362,0.001707301,0.21740533,0.60303235],"study_design_scores_gemma":[0.002181102,0.003970152,0.14456488,0.000037216872,0.000090767106,0.00006851651,0.000054368582,0.00001514398,0.0015430357,0.00009090115,0.8472994,0.00008452277],"about_ca_topic_score_codex":0.000026264672,"about_ca_topic_score_gemma":0.00008891327,"teacher_disagreement_score":0.6298941,"about_ca_system_score_codex":0.00069381425,"about_ca_system_score_gemma":0.0002731173,"threshold_uncertainty_score":0.9979134},"labels":[],"label_agreement":null},{"id":"W2823828888","doi":"10.1016/j.beha.2018.07.003","title":"Dissecting aggressive B-cell lymphoma through genomic analysis – What is clinically relevant?","year":2018,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"BCL6; Lymphoma; Biology; Epigenetics; Cancer research; Aggressive lymphoma; B-cell lymphoma; Bromodomain; Computational biology; Diffuse large B-cell lymphoma; Gene expression profiling; B cell; Gene; Germinal center; Genetics; Gene expression; Immunology; Rituximab; Antibody","score_opus":0.27612431898089884,"score_gpt":0.5802519833887466,"score_spread":0.3041276644078478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2823828888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022098282,0.9800766,0.000019336767,0.003505195,0.0015531952,0.0033459733,0.000070899834,0.00011135081,0.009107584],"genre_scores_gemma":[0.0003574121,0.9881202,0.00388646,0.0014169868,0.0018637246,0.0008408333,0.00040276855,0.00023628668,0.0028753453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9774549,0.008193859,0.0064359875,0.0036313424,0.0020839768,0.0021999194],"domain_scores_gemma":[0.9092499,0.07634056,0.005534711,0.0039597433,0.003638872,0.0012762236],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.012710182,0.0012505905,0.010506028,0.0010212149,0.0007402428,0.0006267055,0.0014127456,0.0031050555,0.0008137444],"category_scores_gemma":[0.056307927,0.0009136857,0.0051766797,0.0031937952,0.0023715831,0.0010900965,0.0017121453,0.0031180708,0.011700935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012914838,0.02359354,0.0022115216,0.009833593,0.020196507,0.026789533,0.00044665992,7.495795e-8,7.66791e-8,0.0004250673,0.009835803,0.90537614],"study_design_scores_gemma":[0.0039787963,0.0051922323,0.000054201504,0.014682365,0.04055877,0.005062794,0.001093534,0.000018586554,0.000002423844,0.00023688044,0.9284306,0.00068877],"about_ca_topic_score_codex":0.00047629236,"about_ca_topic_score_gemma":0.00007003392,"teacher_disagreement_score":0.91859484,"about_ca_system_score_codex":0.0012534265,"about_ca_system_score_gemma":0.0067754774,"threshold_uncertainty_score":0.99933136},"labels":[],"label_agreement":null},{"id":"W2864061373","doi":"10.1111/joim.12813","title":"<scp>FDG</scp>‐<scp>PET</scp>/<scp>CT</scp> in the management of lymphomas: current status and future directions","year":2018,"lang":"en","type":"review","venue":"Journal of Internal Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"Kræftens Bekæmpelse","keywords":"Medicine; Lymphoma; Radiation therapy; Positron emission tomography; Stage (stratigraphy); Chemotherapy; Radiology; Salvage therapy; Disease; Fluorodeoxyglucose; Oncology; Nuclear medicine; Internal medicine","score_opus":0.02850325891185492,"score_gpt":0.3367056186423339,"score_spread":0.308202359730479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2864061373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018473582,0.963092,0.000015183822,0.00033905162,0.0044330456,0.0013185418,0.00007143247,0.000024728552,0.012232395],"genre_scores_gemma":[0.00096180016,0.990839,0.00029281678,0.0003614673,0.005401772,0.00011704071,0.00005290973,0.00010357683,0.001869619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930569,0.0004527607,0.0030678655,0.0006633202,0.0018754241,0.000883739],"domain_scores_gemma":[0.9920073,0.0027669987,0.0031207874,0.0008116729,0.0005749218,0.00071832025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017323712,0.0010791738,0.0038658746,0.0013405385,0.00013505126,0.0000742376,0.00078129495,0.00022020243,0.00004943074],"category_scores_gemma":[0.0011059282,0.0005694403,0.0010688999,0.0009927693,0.00046460892,0.00019206578,0.00025365074,0.0012330349,0.00003885169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023669321,0.0023496395,0.0042156717,0.015833376,0.0054459437,0.0059694704,0.0032666014,4.0078805e-7,0.0000014732234,0.0004094838,0.13507375,0.8274105],"study_design_scores_gemma":[0.0055157132,0.0023213301,0.006574408,0.075130336,0.0071733533,0.009685335,0.005269236,0.0000037112002,0.000011916938,0.00009888414,0.88815284,0.00006291934],"about_ca_topic_score_codex":0.0001760894,"about_ca_topic_score_gemma":0.00003589806,"teacher_disagreement_score":0.8273476,"about_ca_system_score_codex":0.0010502652,"about_ca_system_score_gemma":0.0004984221,"threshold_uncertainty_score":0.9996757},"labels":[],"label_agreement":null},{"id":"W2866628310","doi":"10.3324/haematol.2018.196782","title":"Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Interim; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Oncology; Chemotherapy; Internal medicine; Cyclophosphamide; Vincristine; Biology","score_opus":0.04868299079263632,"score_gpt":0.28875085606207046,"score_spread":0.24006786526943413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2866628310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8847225,0.0008441224,0.0000038448147,0.09227506,0.00018101788,0.0020638553,0.00010714932,0.000802841,0.018999623],"genre_scores_gemma":[0.69789344,0.0012605307,0.0010112289,0.29148963,0.0007935312,0.00092447415,0.0016835505,0.00018457013,0.0047590234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964872,0.00030333092,0.00071397173,0.0011231746,0.00053507544,0.00083722424],"domain_scores_gemma":[0.998079,0.00028417338,0.00041366255,0.0008422488,0.00024079184,0.00014013334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012602027,0.0009362242,0.0019190891,0.00052231125,0.000095726675,0.00012022258,0.00032164654,0.0009276725,0.000804736],"category_scores_gemma":[0.00008548835,0.00056847534,0.00028127033,0.0005524625,0.00028917668,0.00010554975,0.00008835912,0.0005227689,0.00034124876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027014718,0.0022282093,0.03789993,0.00033853654,0.0011422685,0.29161558,0.0002744358,2.2724053e-7,0.00007861018,0.00003344805,0.6568335,0.0068537774],"study_design_scores_gemma":[0.02802513,0.013013777,0.18509007,0.0037063458,0.0006120373,0.020313563,0.00012442196,0.00005906435,0.0071901293,0.000060235725,0.739961,0.0018442075],"about_ca_topic_score_codex":0.0005065905,"about_ca_topic_score_gemma":0.00009791081,"teacher_disagreement_score":0.271302,"about_ca_system_score_codex":0.00043650507,"about_ca_system_score_gemma":0.00028365402,"threshold_uncertainty_score":0.99967664},"labels":[],"label_agreement":null},{"id":"W2883371432","doi":"10.1016/j.beha.2018.07.014","title":"Management of relapsed/refractory DLBCL","year":2018,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Salvage therapy; Lymphoma; Oncology; Diffuse large B-cell lymphoma; Regimen; Disease; Standard of care; Internal medicine; Intensive care medicine; Transplantation; Surgery; Chemotherapy","score_opus":0.39321799612250213,"score_gpt":0.6073804883458568,"score_spread":0.21416249222335465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883371432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011165974,0.94077367,0.0000048215147,0.0012185206,0.0007196968,0.002817413,0.000029839373,0.00004588088,0.05427849],"genre_scores_gemma":[0.000092219685,0.99134016,0.003150842,0.00012804219,0.00048754908,0.0006841813,0.00012836156,0.00010857984,0.0038800533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98832464,0.004643923,0.0030734674,0.0013967576,0.0015261467,0.0010350555],"domain_scores_gemma":[0.97487724,0.019463494,0.001421278,0.0022999062,0.0012720305,0.000666055],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008755356,0.0005648773,0.0050514126,0.00055067183,0.00017309727,0.00004074805,0.0007131458,0.0014267114,0.00052337407],"category_scores_gemma":[0.009556862,0.0004015718,0.0013878123,0.00086861535,0.0017200646,0.00020041836,0.0010042642,0.0022291546,0.00735783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004815097,0.019928943,0.00018696132,0.031580523,0.004053428,0.019152218,0.000024773739,2.7076552e-9,8.955965e-9,0.006715726,0.021716565,0.89615935],"study_design_scores_gemma":[0.0028282125,0.0054243947,0.000037862712,0.026378054,0.006410166,0.0038679014,0.00015881169,6.67495e-7,6.8643163e-7,0.00011559615,0.95452344,0.0002541767],"about_ca_topic_score_codex":0.00010504693,"about_ca_topic_score_gemma":0.000007727641,"teacher_disagreement_score":0.9328069,"about_ca_system_score_codex":0.0005350474,"about_ca_system_score_gemma":0.0027440568,"threshold_uncertainty_score":0.99986964},"labels":[],"label_agreement":null},{"id":"W2883968669","doi":"10.1007/978-3-319-74942-6_9","title":"Molecular Applications in Hematolymphoid Cytology","year":2018,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Toronto General Hospital; Queen's University; University Health Network; University of Toronto","funders":"","keywords":"Cytopathology; Medicine; Medical diagnosis; Hematopathology; Pathology; Molecular diagnostics; Medical physics; Cytology; Bioinformatics; Biology; Cytogenetics","score_opus":0.013235577298946814,"score_gpt":0.26397112063783085,"score_spread":0.25073554333888404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883968669","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024366367,0.0015663548,0.0001046566,0.00047364965,0.000036529156,0.00081321795,0.00001285818,0.000058860776,0.99449724],"genre_scores_gemma":[0.123440504,0.0008031267,0.0016991963,0.002359106,0.00022014411,0.0006793538,0.00058773457,0.00012925125,0.8700816],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990865,0.0000037074776,0.00025915026,0.00035267425,0.00013762143,0.00016037429],"domain_scores_gemma":[0.999266,0.000037329966,0.00006966052,0.00047219387,0.00005499149,0.00009982204],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00002763617,0.00023589532,0.0004799915,0.0001619121,0.000019606981,0.0000057996435,0.00006425768,0.00030082706,0.0028314672],"category_scores_gemma":[0.0000042955703,0.00018203638,0.00014333424,0.00002424624,0.00008505579,0.000010223412,0.00004277007,0.000069128706,0.0014216128],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003711661,0.00045517355,0.0044036154,0.0001238661,0.00036497027,0.0008829834,0.000059034217,2.0596592e-7,0.000098031305,0.9797013,0.009296062,0.0045776325],"study_design_scores_gemma":[0.0032679294,0.000344827,0.0012175355,0.0003158816,0.0004786376,0.00057698874,0.000020365842,0.000008002877,0.0065365466,0.02814496,0.95866394,0.00042438845],"about_ca_topic_score_codex":0.00003518269,"about_ca_topic_score_gemma":0.000042682874,"teacher_disagreement_score":0.9515563,"about_ca_system_score_codex":0.0002205051,"about_ca_system_score_gemma":0.00013875688,"threshold_uncertainty_score":0.9993559},"labels":[],"label_agreement":null},{"id":"W2884928079","doi":"10.1097/01.cdr.0000544118.00228.5c","title":"CT Imaging of Primary Pulmonary Lymphoma","year":2018,"lang":"en","type":"article","venue":"Contemporary Diagnostic Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University","funders":"","keywords":"Medicine; Lymphoma; Lymphoproliferative disorders; Lymphoproliferative disease; Radiology; Pathology; Disease; Lung; Internal medicine","score_opus":0.020540359935644154,"score_gpt":0.25591862224547884,"score_spread":0.2353782623098347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884928079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89127624,0.015908925,0.00005696567,0.0017270155,0.00065062795,0.000641629,0.000035696234,0.00010267307,0.08960025],"genre_scores_gemma":[0.9961081,0.00038077534,0.0003063751,0.0021228706,0.0004868862,0.00010049755,0.00016948921,0.00003383764,0.0002911453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983297,0.00012458459,0.0005595576,0.00046307917,0.00017649017,0.0003465678],"domain_scores_gemma":[0.9973203,0.0015429338,0.00020754548,0.0005757012,0.00014819612,0.00020532803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020716726,0.00026208637,0.00078936503,0.000180794,0.000078875426,0.0000075043044,0.00015839246,0.00006638701,0.00017059145],"category_scores_gemma":[0.0006664964,0.00021433245,0.00019145342,0.00018915163,0.00068484276,0.00011468371,0.0000876514,0.000058865848,0.00017296114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023589653,0.0009016479,0.9115552,0.00008552407,0.00019191086,0.003979327,0.000088481014,2.2268027e-7,0.00095454534,0.0006685804,0.030334517,0.051004164],"study_design_scores_gemma":[0.0037742169,0.00082104735,0.95662814,0.00023612891,0.00014201652,0.0044218907,0.000060322072,0.00007487166,0.0050855298,0.00037066286,0.02817653,0.00020863405],"about_ca_topic_score_codex":0.00019628077,"about_ca_topic_score_gemma":0.0000017740169,"teacher_disagreement_score":0.104831904,"about_ca_system_score_codex":0.00017824135,"about_ca_system_score_gemma":0.00052772457,"threshold_uncertainty_score":0.8740224},"labels":[],"label_agreement":null},{"id":"W2885321887","doi":"10.1111/bjh.15518","title":"The <scp>MCL</scp>35 gene expression proliferation assay predicts high‐risk <scp>MCL</scp> patients in a Norwegian cohort of younger patients given intensive first line therapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Cytarabine; International Prognostic Index; Oncology; Proliferation index; Cohort; Alemtuzumab; Rituximab; Chemotherapy; Immunohistochemistry; Lymphoma; Transplantation","score_opus":0.008423637202699478,"score_gpt":0.2330102971033561,"score_spread":0.22458665990065663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885321887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951232,0.0020225646,0.00008693296,0.00028339447,0.0009332597,0.001258548,0.00010060496,0.000017859104,0.00017364888],"genre_scores_gemma":[0.99137765,0.007110956,0.000400281,0.00044092923,0.0003257031,0.00008965513,0.00013027775,0.000048969065,0.00007556039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964403,0.00046171143,0.0014131038,0.0003905871,0.00076147227,0.00053283904],"domain_scores_gemma":[0.9943633,0.0008857104,0.0015036565,0.00033699925,0.0026512516,0.00025909176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006488417,0.00032217405,0.0010970812,0.00024559328,0.0002901165,0.00006414416,0.0002794412,0.00031735166,0.00001899566],"category_scores_gemma":[0.0034629533,0.00023941141,0.00023329351,0.0002514742,0.00034197496,0.0002823979,0.000107417756,0.0003948777,0.000017159113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019492241,0.0022272682,0.967366,0.00004730131,0.00046455444,0.0011350602,0.0015287824,0.000007197443,0.0001702712,0.00001209104,0.017249415,0.009597184],"study_design_scores_gemma":[0.01297945,0.0038791262,0.94914675,0.0012970841,0.00023555597,0.0036265475,0.0002742994,0.000055080534,0.025552845,0.00016096277,0.0027328192,0.000059501337],"about_ca_topic_score_codex":0.00037301666,"about_ca_topic_score_gemma":0.0002993761,"teacher_disagreement_score":0.025382575,"about_ca_system_score_codex":0.0002593244,"about_ca_system_score_gemma":0.0002670748,"threshold_uncertainty_score":0.97629136},"labels":[],"label_agreement":null},{"id":"W2886638978","doi":"10.1111/bjh.15519","title":"Validation of the <scp>MCL</scp>35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Medicine; International Prognostic Index; Oncology; Lymphoma; Clinical trial; Internal medicine; Proliferation index; Cancer research; Immunohistochemistry; Diffuse large B-cell lymphoma","score_opus":0.021410796049099793,"score_gpt":0.2683324955108397,"score_spread":0.24692169946173992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886638978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938104,0.0027127294,0.0002532581,0.00025871908,0.00059932383,0.00074634707,0.0000074072373,0.0000037443554,0.0016080526],"genre_scores_gemma":[0.998159,0.0005026947,0.0007698517,0.000114397546,0.00033610183,0.000012700977,0.0000049647233,0.000015571915,0.00008470011],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99356824,0.00427318,0.0015509396,0.00012404154,0.00031442643,0.0001691867],"domain_scores_gemma":[0.9963079,0.0012071864,0.0019302267,0.00021177277,0.0002941653,0.00004875176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056549325,0.00011277126,0.0013432922,0.00006980121,0.000081556995,0.000017684975,0.00018035322,0.00009165797,0.00002466672],"category_scores_gemma":[0.0030079829,0.00006458152,0.00044452757,0.00016866591,0.00020165266,0.00006808489,0.00006906188,0.00008715328,0.0000030775134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028340513,0.01458619,0.48960456,0.0013552768,0.0028008665,0.008583326,0.007966569,0.0011706938,0.2371081,0.0012405287,0.12813637,0.07910701],"study_design_scores_gemma":[0.12672083,0.00022648495,0.04746202,0.0020796112,0.0005369804,0.014947033,0.00008107023,0.00006501183,0.8067971,0.00065614155,0.00038741497,0.000040334435],"about_ca_topic_score_codex":0.000039664974,"about_ca_topic_score_gemma":0.000017434113,"teacher_disagreement_score":0.569689,"about_ca_system_score_codex":0.000059950435,"about_ca_system_score_gemma":0.00021804926,"threshold_uncertainty_score":0.36010537},"labels":[],"label_agreement":null},{"id":"W2886776738","doi":"10.1158/1538-7445.am2018-221","title":"Abstract 221: Inherited variants at 3q13.33 and 3p24.1 influences risk of diffuse large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Genotyping; Odds ratio; Single-nucleotide polymorphism; Meta-analysis; Heritability; Diffuse large B-cell lymphoma; Lymphoma; Genetic association; Biology; Oncology; Genetics; Internal medicine; Medicine; Genotype; Gene","score_opus":0.05480390068234936,"score_gpt":0.3861801328818536,"score_spread":0.33137623219950424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886776738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184066,0.0033709733,5.969204e-7,0.00027937576,0.00008694907,0.000427017,0.00021646568,0.000022472506,0.0037555157],"genre_scores_gemma":[0.99360394,0.005074616,0.000055493594,0.00009574884,0.00020243828,0.00012264721,0.000012527732,0.000023537976,0.0008090575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981241,0.00010231805,0.00025656167,0.00038379032,0.0006178976,0.0005153189],"domain_scores_gemma":[0.99858826,0.00025377527,0.00009269047,0.00041069693,0.0003784713,0.00027612943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443615,0.00015023886,0.00030652795,0.00017313892,0.00024292212,0.000032038275,0.00012812942,0.00011547103,0.0007052912],"category_scores_gemma":[0.00016678104,0.00011021598,0.0000598105,0.0003611683,0.0004324272,0.000086037755,0.00019056651,0.000115657014,0.00013280385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089617155,0.0038686746,0.9324686,0.00028263434,0.00025928434,0.00015374033,0.0011793684,2.1610764e-7,0.037588917,0.00006425153,0.006181514,0.017056629],"study_design_scores_gemma":[0.012097267,0.0005406924,0.9127914,0.00021197007,0.00006322698,0.000010044054,0.00013973765,0.00002860155,0.062385555,0.00006303459,0.0115686245,0.00009987869],"about_ca_topic_score_codex":0.0038558058,"about_ca_topic_score_gemma":0.00055546936,"teacher_disagreement_score":0.02479664,"about_ca_system_score_codex":0.00035794187,"about_ca_system_score_gemma":0.00031327942,"threshold_uncertainty_score":0.77224445},"labels":[],"label_agreement":null},{"id":"W2886836166","doi":"10.1111/his.13728","title":"Expression of T‐cell receptor signalling pathway components in extranodal <scp>NK</scp>/T‐cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"Japan Society for the Promotion of Science","keywords":"Lymphoma; T-cell receptor; T-cell lymphoma; Biology; T cell; Cancer research; Immunology; Immune system","score_opus":0.0225591839881198,"score_gpt":0.2367975318691208,"score_spread":0.21423834788100102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886836166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843328,0.001742747,0.000109030145,0.000045816443,0.0005094964,0.00034002092,0.000019917454,0.000046354777,0.012853841],"genre_scores_gemma":[0.9948055,0.00014966434,0.0030698664,0.00021031729,0.00016984929,0.000054870816,0.00006191852,0.00003490069,0.0014430799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822974,0.00014447834,0.0005137434,0.00046882493,0.00024196613,0.0004012528],"domain_scores_gemma":[0.99896413,0.00018335377,0.00021933722,0.00037205836,0.000108939406,0.00015216946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021161351,0.00024298292,0.00056391367,0.00023229037,0.00007359233,0.0000050670083,0.00014015613,0.00023583886,0.00015473113],"category_scores_gemma":[0.00005851617,0.0002114477,0.00013564008,0.00016205142,0.00023340153,0.0000526334,0.00006998365,0.00008846095,0.0002774205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119648335,0.0025255552,0.06253974,0.000116059855,0.000002503934,0.00040562326,0.00174232,0.0000014197027,0.9299379,0.000038785984,0.0014438439,0.0011265932],"study_design_scores_gemma":[0.006971391,0.0010538826,0.12655832,0.00021686144,0.000043049404,0.00009039941,0.0001719106,0.0000420924,0.8484269,0.00004809959,0.016291043,0.00008607566],"about_ca_topic_score_codex":0.00008361359,"about_ca_topic_score_gemma":0.000013091622,"teacher_disagreement_score":0.08151103,"about_ca_system_score_codex":0.00028472178,"about_ca_system_score_gemma":0.00012965393,"threshold_uncertainty_score":0.86225873},"labels":[],"label_agreement":null},{"id":"W2888158309","doi":"10.1016/j.jcjo.2018.06.019","title":"Hodgkin lymphoma presenting with orbital involvement","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Orbit (dynamics); Hodgkin lymphoma; Malignancy; Scopus; Disease; Dermatology; Pathology; MEDLINE","score_opus":0.03157347814978929,"score_gpt":0.26665611708936077,"score_spread":0.2350826389395715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888158309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81482816,0.0013632934,0.0000016954392,0.15556893,0.0012381702,0.0003760235,0.000056464978,0.0000054049556,0.02656186],"genre_scores_gemma":[0.9324609,0.0000072214607,0.0009483452,0.052758496,0.007366465,0.000025806537,0.00015907762,0.00011150588,0.0061621596],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977324,0.00011370031,0.0006472264,0.00033659206,0.00039158823,0.0007784814],"domain_scores_gemma":[0.99754596,0.00011750503,0.00065809995,0.00042109648,0.00053966575,0.0007176509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021643212,0.00040254812,0.00094809226,0.0006731158,0.00013150224,0.00006358016,0.00029359033,0.000640396,0.0022678718],"category_scores_gemma":[0.000092377246,0.0002902647,0.0002832755,0.0001773675,0.00035913082,0.00007881638,0.000025462923,0.0005483954,0.000084001185],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041000938,0.000046068308,0.089000866,0.000070912596,0.0006684042,0.45785835,0.00010998905,3.9803137e-7,0.0000010180114,0.000004979914,0.45209152,0.00010648141],"study_design_scores_gemma":[0.0025745083,0.0029769512,0.0468735,0.00040634163,0.000600968,0.66270417,0.000056651796,0.000001481252,0.0001242727,0.000074900614,0.28334075,0.0002655062],"about_ca_topic_score_codex":0.0063450276,"about_ca_topic_score_gemma":0.00021855869,"teacher_disagreement_score":0.2048458,"about_ca_system_score_codex":0.0010278156,"about_ca_system_score_gemma":0.005069976,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W2888444682","doi":"10.1182/blood-2018-03-837252","title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"NODAL; Biology; Immune system; Mutation; Cancer research; Immune escape; Immunology; Genetics; Gene","score_opus":0.006708021906625637,"score_gpt":0.20607972822612577,"score_spread":0.19937170631950013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888444682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928232,0.0054141013,0.00001121899,0.00059699133,0.0000775442,0.00051917887,0.000048232163,0.00004233272,0.00046722262],"genre_scores_gemma":[0.9980388,0.00047734883,0.00021878787,0.0002558073,0.00015895057,0.000075447875,0.0001472311,0.000035274174,0.0005923064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905705,0.000040278825,0.00019419708,0.00031701114,0.0001504644,0.0002409979],"domain_scores_gemma":[0.99943817,0.000035387893,0.000072010575,0.0003060153,0.00004198163,0.000106445215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070565635,0.00023311055,0.00027958385,0.000036222187,0.00011799459,0.000030297175,0.000055821754,0.00008468698,0.0001507651],"category_scores_gemma":[0.000012563749,0.00014509949,0.00007979123,0.0000798184,0.00012973549,0.000048233174,0.0000519094,0.000037939597,0.000070039605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037041848,0.006854226,0.37263376,0.000081166254,0.0016588907,0.00019000136,0.002893032,1.9613493e-7,0.60085356,0.0001290695,0.002377935,0.011957767],"study_design_scores_gemma":[0.0063843043,0.00082873856,0.3261658,0.00007235286,0.00028699677,0.00020468024,0.00018608848,0.000021863338,0.661299,0.000060994495,0.0043378947,0.00015129347],"about_ca_topic_score_codex":0.000059053986,"about_ca_topic_score_gemma":0.0000049838513,"teacher_disagreement_score":0.060445443,"about_ca_system_score_codex":0.000058281166,"about_ca_system_score_gemma":0.000033872548,"threshold_uncertainty_score":0.5916985},"labels":[],"label_agreement":null},{"id":"W2888474659","doi":"10.1016/j.jid.2018.06.019","title":"LB1489 Long-term incidence, mortality and geographic trends of follicular lymphoma in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University","funders":"","keywords":"Follicular lymphoma; Incidence (geometry); Epidemiology; Medicine; Lymphoma; Demography; Etiology; Mortality rate; Cancer registry; Malignancy; Internal medicine","score_opus":0.02579611263414244,"score_gpt":0.287096820948905,"score_spread":0.26130070831476254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888474659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967288,0.0013589009,0.000003412489,0.0014942348,0.00011009372,0.000077503224,0.0000070937886,0.000002318159,0.00021764955],"genre_scores_gemma":[0.99881554,0.00017658249,0.00023657974,0.00070604926,0.000044254015,0.0000047621716,0.0000037814614,0.000007482679,0.000005000984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985653,0.00012961769,0.0006778588,0.00014353114,0.00027816516,0.00020551625],"domain_scores_gemma":[0.9986622,0.00011824208,0.00052774645,0.00015426546,0.0002925425,0.00024501313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001404302,0.00015252554,0.00068107137,0.00036374948,0.000033588098,0.000005193134,0.00008698899,0.00007708885,0.000034737946],"category_scores_gemma":[0.00014446312,0.00011320046,0.00009100291,0.0003656869,0.0006900907,0.00009854728,0.0000366256,0.00008689682,7.4131253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005758884,0.00014717515,0.9934987,0.000052649084,0.00030825805,0.0027725562,0.00024925199,5.405542e-7,0.00082655373,0.00019630462,0.00035775438,0.0015326805],"study_design_scores_gemma":[0.0028529037,0.0003115435,0.920609,0.00023005654,0.00017643998,0.004305312,0.00009914516,0.000023778042,0.070911355,0.00034852515,0.000054382668,0.000077547396],"about_ca_topic_score_codex":0.15219632,"about_ca_topic_score_gemma":0.39314035,"teacher_disagreement_score":0.24094403,"about_ca_system_score_codex":0.0002687112,"about_ca_system_score_gemma":0.0013872829,"threshold_uncertainty_score":0.8534493},"labels":[],"label_agreement":null},{"id":"W2888815731","doi":"10.14740/jh406w","title":"A Great Mimicker in Thoracic Spine: Spinal Double Expressor Lymphoma","year":2018,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Disease; Diffuse large B-cell lymphoma; Pathology; Chemotherapy; Aggressive lymphoma; CHOP; Internal medicine; Rituximab","score_opus":0.02855244488342277,"score_gpt":0.3440863482727017,"score_spread":0.3155339033892789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888815731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166656,0.0028388565,0.000035597477,0.0027539087,0.0003500592,0.00015131457,6.9928126e-7,0.000009475256,0.0021935252],"genre_scores_gemma":[0.9967003,0.00012082256,0.0021755951,0.0004999324,0.0003091472,0.000010215986,0.0000011896499,0.000014959827,0.00016785444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873805,0.000041250303,0.00056873274,0.000156249,0.00021110433,0.0002845958],"domain_scores_gemma":[0.9991273,0.000028525163,0.00028550567,0.00020472686,0.00020024233,0.00015366176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001940256,0.00015275538,0.00063412095,0.00027746544,0.000036466445,0.000012065824,0.00010398274,0.00012622942,0.0002423413],"category_scores_gemma":[0.000048060843,0.00010469952,0.00016258912,0.00016344081,0.00012433388,0.000100944926,0.00003579988,0.000086995824,0.00010779539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011145785,0.0041340776,0.8980451,0.00032791452,0.0006156153,0.018883836,0.0008680832,0.0000014165712,0.0047283163,0.005327994,0.01913379,0.03678803],"study_design_scores_gemma":[0.032854784,0.007926337,0.6337254,0.0016722912,0.0004808268,0.095543936,0.0002895047,0.00005431113,0.19374782,0.0009497974,0.032421097,0.00033388814],"about_ca_topic_score_codex":0.00002919522,"about_ca_topic_score_gemma":0.000030055966,"teacher_disagreement_score":0.26431975,"about_ca_system_score_codex":0.00016913986,"about_ca_system_score_gemma":0.0002083046,"threshold_uncertainty_score":0.42695224},"labels":[],"label_agreement":null},{"id":"W2889063843","doi":"10.1038/s41409-018-0328-9","title":"High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation","year":2018,"lang":"en","type":"letter","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Transplantation; Stem cell; Lymphoma; Autologous stem-cell transplantation; Surgery; Hematopoietic stem cell transplantation; Internal medicine","score_opus":0.011620776637734594,"score_gpt":0.2174447917405704,"score_spread":0.20582401510283582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889063843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802443,0.00021242975,0.00013508534,0.014351992,0.001210673,0.0018654844,0.000786651,0.00022402816,0.0009693962],"genre_scores_gemma":[0.96363527,0.0010254967,0.0008263222,0.01293714,0.00082392414,0.00028976437,0.019660722,0.0002020141,0.0005993719],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99572986,0.00024189103,0.00093853136,0.0011428186,0.0011539707,0.0007929389],"domain_scores_gemma":[0.99799067,0.00062720844,0.00048574927,0.0005428173,0.00016849968,0.00018505538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016350101,0.0008793529,0.0010818376,0.00060840347,0.0001706063,0.00007595323,0.00017008057,0.0012508711,0.00008804899],"category_scores_gemma":[0.000006720846,0.00075659435,0.00024590068,0.0003530261,0.00017169635,0.00030865546,0.000011012116,0.00067553495,0.00013807707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18266785,0.018514864,0.27593967,0.027091784,0.0039953687,0.06612433,0.010261954,0.0004098516,0.0009789503,0.00019427747,0.30991334,0.10390778],"study_design_scores_gemma":[0.117934756,0.0096680615,0.8471027,0.0030421251,0.004757464,0.000280559,0.00008200277,0.00003253911,0.003698027,0.000028906357,0.011785664,0.0015871801],"about_ca_topic_score_codex":0.00031803738,"about_ca_topic_score_gemma":0.0006257812,"teacher_disagreement_score":0.57116306,"about_ca_system_score_codex":0.0012279727,"about_ca_system_score_gemma":0.00059280486,"threshold_uncertainty_score":0.99948853},"labels":[],"label_agreement":null},{"id":"W2889117618","doi":"10.1016/j.jcjo.2018.06.007","title":"Triple-hit lymphoma of the cavernous sinus","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cavernous sinus; Lymphoma; Medicine; Radiology; Internal medicine","score_opus":0.02447293734405591,"score_gpt":0.25797399383118336,"score_spread":0.23350105648712743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889117618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6664088,0.003355114,4.5063817e-7,0.28504464,0.005378063,0.00045543865,0.00019689491,0.000002950492,0.03915766],"genre_scores_gemma":[0.932206,0.0000127528165,0.00009058825,0.054114155,0.0038492186,0.000007466974,0.000028384422,0.000061056315,0.009630392],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9979807,0.00016992743,0.0007324586,0.00022341346,0.00034710256,0.0005464038],"domain_scores_gemma":[0.9974313,0.00014503337,0.00088697544,0.000590445,0.000513725,0.0004325575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019098962,0.0003145485,0.0010131012,0.00041591047,0.00010924396,0.000017971395,0.0004978842,0.00082461635,0.0020396959],"category_scores_gemma":[0.000261213,0.00020125974,0.0006205335,0.00021201215,0.0005270905,0.000032133892,0.000027728103,0.00051371224,0.00004660038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040808347,0.000054971813,0.030683992,0.00007375643,0.00055182213,0.2489327,0.00013579699,3.7096456e-7,0.000004196302,0.000009262996,0.7190655,0.00044681615],"study_design_scores_gemma":[0.0019945076,0.0011862712,0.07372164,0.000336324,0.00056709326,0.57194704,0.000019371695,5.492676e-7,0.00022942456,0.000120315686,0.34973833,0.0001391429],"about_ca_topic_score_codex":0.009988365,"about_ca_topic_score_gemma":0.00025095724,"teacher_disagreement_score":0.36932716,"about_ca_system_score_codex":0.0010499045,"about_ca_system_score_gemma":0.0070298887,"threshold_uncertainty_score":0.9988726},"labels":[],"label_agreement":null},{"id":"W2889132102","doi":"10.1016/j.clml.2018.08.015","title":"The Adverse Consequences of Initial Watchful Waiting for Patients With Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Watchful waiting; Follicular lymphoma; Medicine; Adverse effect; Follicular phase; Lymphoma; Internal medicine; Cancer; Prostate cancer","score_opus":0.02672849279340848,"score_gpt":0.3369291938266099,"score_spread":0.3102007010332014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889132102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470353,0.00018695768,0.000038028546,0.0006757528,0.00061054603,0.0013646721,0.000077069475,0.0000847756,0.002258692],"genre_scores_gemma":[0.9960184,0.00009334756,0.001661763,0.00084912387,0.00079921813,0.00023359872,0.00009997648,0.000058349782,0.00018622464],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965075,0.00016008917,0.0013498709,0.0006895304,0.0006163929,0.00067656283],"domain_scores_gemma":[0.9949674,0.002291243,0.00063038117,0.00080431404,0.00093502784,0.00037163848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007000122,0.0004068089,0.00088273844,0.00006710654,0.00050899567,0.000041519674,0.00033027006,0.0002929554,0.00004365929],"category_scores_gemma":[0.0012636066,0.00023520706,0.0005546187,0.0002768233,0.002186757,0.00013761237,0.000119607954,0.00006770123,0.00008391127],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041508195,0.0010245743,0.37045312,0.00006509737,0.0007564409,0.000094679956,0.00012942319,6.8170624e-7,0.000044979457,0.0020678155,0.0018563223,0.61935604],"study_design_scores_gemma":[0.021259326,0.005079646,0.94194067,0.00035367385,0.00059188897,0.000056427332,0.00019194468,0.00020819438,0.005953852,0.00049070804,0.023562063,0.0003116033],"about_ca_topic_score_codex":0.00014612978,"about_ca_topic_score_gemma":0.000042164036,"teacher_disagreement_score":0.6190444,"about_ca_system_score_codex":0.0005438521,"about_ca_system_score_gemma":0.0017239607,"threshold_uncertainty_score":0.95914656},"labels":[],"label_agreement":null},{"id":"W2889710159","doi":"10.1200/jco.2017.35.15_suppl.7547","title":"Rapid, real-time central pathology review for E1412: A novel and successful paradigm for future National Clinical Trials Network diffuse large B cell lymphoma studies.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Lenalidomide; Lymphoma; Internal medicine; Clinical trial; Multiple myeloma","score_opus":0.2970037648933071,"score_gpt":0.5463932405795847,"score_spread":0.24938947568627762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889710159","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63543206,0.1578462,0.00075553014,0.17958272,0.017359456,0.0068570906,0.0005051653,0.00004121639,0.0016205633],"genre_scores_gemma":[0.23412044,0.6903953,0.021636756,0.021013971,0.031991642,0.0002909862,0.0000695729,0.00006926408,0.00041204723],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916598,0.0011964177,0.0056722076,0.0004847961,0.00038027077,0.00060648157],"domain_scores_gemma":[0.96701205,0.023731586,0.007143032,0.00041950177,0.0009993206,0.00069453736],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028384918,0.00030889464,0.0055490267,0.00005822705,0.00032404196,0.00003415152,0.00031481878,0.00074772665,0.000045821653],"category_scores_gemma":[0.035792068,0.00019276778,0.0020171134,0.000048071226,0.0003353259,0.00014871698,0.00012612302,0.0003365343,0.0000063722828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021553969,0.039492235,0.09546281,0.0012845647,0.005033393,0.0008650589,0.00011774478,0.0000012204717,0.000017034161,0.0035510892,0.47097674,0.36164415],"study_design_scores_gemma":[0.13805188,0.013688031,0.27835083,0.0008643425,0.0036599066,0.0004948163,0.00004522748,0.000105110434,0.000006667652,0.0015964819,0.5629374,0.00019932535],"about_ca_topic_score_codex":0.0000031942868,"about_ca_topic_score_gemma":0.000017464396,"teacher_disagreement_score":0.5325491,"about_ca_system_score_codex":0.00024449988,"about_ca_system_score_gemma":0.0021819244,"threshold_uncertainty_score":0.9837703},"labels":[],"label_agreement":null},{"id":"W2889797671","doi":"10.1002/em.22216","title":"Genomic chaos in peripheral blood lymphocytes of Hodgkin's lymphoma patients one year after ABVD chemotherapy/radiotherapy","year":2018,"lang":"en","type":"article","venue":"Environmental and Molecular Mutagenesis","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"Consejo Nacional de Ciencia y Tecnología; Instituto Nacional de Pediatria","keywords":"ABVD; Vinblastine; Radiation therapy; Dacarbazine; Chemotherapy; Bleomycin; Biology; Genome instability; Cancer; Lymphoma; Pathology; Clonogenic assay; Cancer research; Oncology; Internal medicine; Medicine; Immunology; Genetics; Vincristine; Cell; DNA damage; Cyclophosphamide","score_opus":0.0033221861834711237,"score_gpt":0.1889120220076172,"score_spread":0.18558983582414607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889797671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963632,0.0029137759,0.000015358217,0.00007185238,0.0000405507,0.00042133275,0.000034305347,0.000011697987,0.00012789096],"genre_scores_gemma":[0.99622726,0.001482768,0.0011885046,0.00076512835,0.000059100115,0.00007809132,0.000035779547,0.00004491006,0.000118467615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889976,0.000034001743,0.00023865436,0.0003647675,0.00022077313,0.00024204327],"domain_scores_gemma":[0.99955314,0.000008719942,0.000068208836,0.00025462912,0.0000063176035,0.00010897843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004232146,0.00022439189,0.00033050554,0.000085744425,0.00003406278,0.000013273129,0.000058543315,0.00009214942,0.0003761874],"category_scores_gemma":[0.000001917212,0.00020360341,0.00010965173,0.000057095454,0.00020079387,0.000052468826,0.000045782148,0.000019943525,0.000020995285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005202053,0.0022824323,0.7272345,0.000024216828,0.00031472364,0.00006488584,0.00057576556,5.235326e-7,0.24560809,0.000007330719,0.000006431197,0.023360895],"study_design_scores_gemma":[0.008539008,0.0008459121,0.76171625,0.000034554992,0.00012561344,0.00001052661,0.0000400516,0.000011270732,0.22812384,0.0000062100466,0.00039700468,0.00014976446],"about_ca_topic_score_codex":0.00007415132,"about_ca_topic_score_gemma":0.000004878656,"teacher_disagreement_score":0.034481753,"about_ca_system_score_codex":0.0002508282,"about_ca_system_score_gemma":0.00002519037,"threshold_uncertainty_score":0.83027065},"labels":[],"label_agreement":null},{"id":"W2891211505","doi":"10.1182/blood-2018-06-855296","title":"Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill Genome Centre","funders":"Medical Research Council; National Heart, Lung, and Blood Institute; Blood Cancer UK; European Commission; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Wellcome Trust","keywords":"Genome-wide association study; Genetic predisposition; Biology; Germinal center; Lymphoma; Genetics; Genetic association; Immune system; Immunology; Gene; Cancer research; B cell; Single-nucleotide polymorphism; Genotype","score_opus":0.0356225186678527,"score_gpt":0.3046171304650697,"score_spread":0.268994611797217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891211505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120255105,0.8766062,0.0000010906678,0.00003944038,0.000087262604,0.0024404468,0.00001022986,0.000020217009,0.00053998694],"genre_scores_gemma":[0.036941875,0.9608315,0.00018114556,0.00003703155,0.00016081975,0.0013796668,0.00028559426,0.000039909286,0.00014245976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978034,0.00021569779,0.0009726848,0.0003457498,0.0004217118,0.00024076289],"domain_scores_gemma":[0.99823695,0.00047824267,0.0006625939,0.00048827732,0.00009571701,0.000038191105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093563594,0.00031146492,0.0012752443,0.0001823698,0.00007488704,0.000021992204,0.00018570613,0.00019570447,0.000025804102],"category_scores_gemma":[0.00018411518,0.00018172844,0.00027618228,0.0003911564,0.000015783278,0.000026397945,0.00006758837,0.00007970897,0.00011612672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025614167,0.021795098,0.23074228,0.0042589214,0.0038944483,0.00005386145,0.0026197617,2.2188077e-8,0.0000030120152,0.0000054125276,0.00018797696,0.7364136],"study_design_scores_gemma":[0.0045214766,0.00054549734,0.62094635,0.002160342,0.0040850607,0.000017407785,0.00021879806,2.9066861e-8,0.00004495073,0.000004670084,0.36728424,0.00017119628],"about_ca_topic_score_codex":0.00005233579,"about_ca_topic_score_gemma":0.00005689858,"teacher_disagreement_score":0.7362424,"about_ca_system_score_codex":0.00073278265,"about_ca_system_score_gemma":0.00052037573,"threshold_uncertainty_score":0.74106705},"labels":[],"label_agreement":null},{"id":"W2891440744","doi":"10.1200/jco.2016.34.15_suppl.7510","title":"Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Gene signature; Mantle cell lymphoma; Oncology; Biopsy; Gene expression; Log-rank test; Gene expression profiling; Pathology; Lymph node; Cancer research; Lymphoma; Internal medicine; Gene; Survival analysis; Biology","score_opus":0.07063665507013846,"score_gpt":0.3815942314998427,"score_spread":0.31095757642970423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891440744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961747,0.0005574464,0.00020299209,0.0018242901,0.00044991894,0.00060343836,0.000007833953,0.0000041591493,0.00017523648],"genre_scores_gemma":[0.99683475,0.00013978129,0.0025043914,0.00019108491,0.00024217823,0.00001500906,0.0000016345463,0.000013032914,0.000058131143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698615,0.0003286571,0.001884973,0.00018658109,0.00039325305,0.0002203567],"domain_scores_gemma":[0.9966972,0.0012849817,0.0014244275,0.00019337208,0.00026232074,0.00013770662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011371297,0.00014636364,0.00094097055,0.00011730566,0.000020488966,0.000009797123,0.00015133053,0.00037174742,0.00001324348],"category_scores_gemma":[0.0020332912,0.00006960301,0.00022501359,0.00019351165,0.000132358,0.00020545442,0.000050905368,0.0002054099,0.0000034263467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040419307,0.007644817,0.6641638,0.00006351882,0.00007641298,0.00054965605,0.00022672991,0.00013458681,0.2530695,0.000017819277,0.00026581393,0.069745384],"study_design_scores_gemma":[0.026584078,0.0037799696,0.50405973,0.0009820353,0.00016093599,0.00019426372,0.000068312926,0.00018698844,0.46274674,0.0002218827,0.000885348,0.00012974958],"about_ca_topic_score_codex":0.00000767622,"about_ca_topic_score_gemma":0.000027032207,"teacher_disagreement_score":0.20967723,"about_ca_system_score_codex":0.00034834456,"about_ca_system_score_gemma":0.0013824626,"threshold_uncertainty_score":0.28672564},"labels":[],"label_agreement":null},{"id":"W2891476546","doi":"10.14740/wjon1136w","title":"Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An <i>In Silico</i> Approach","year":2018,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Trisomy; Diffuse large B-cell lymphoma; Chromosomal translocation; Monosomy; Lymphoma; Medicine; Biology; Internal medicine; Oncology; Karyotype; Chromosome; Genetics","score_opus":0.010337829181796944,"score_gpt":0.2628070815130557,"score_spread":0.2524692523312588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891476546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823448,0.0001528469,0.000006357463,0.0004242448,0.00018879944,0.0003122685,0.0000050117865,0.000008963778,0.016556721],"genre_scores_gemma":[0.99753076,0.00002157088,0.0013987684,0.0004860679,0.00014346241,0.00001589104,0.000028299142,0.000020451034,0.00035473995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998478,0.0001464512,0.0006028273,0.00020030298,0.00024295258,0.00032948662],"domain_scores_gemma":[0.9990471,0.000068255154,0.0003233435,0.0001999165,0.00016155577,0.0001998246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002532934,0.00016715351,0.0005484737,0.00043838113,0.000057847545,0.000012861723,0.000107222855,0.00011202845,0.00007701787],"category_scores_gemma":[0.000022153985,0.00011658435,0.00007535745,0.00049039634,0.00013036304,0.00015628952,0.000026957474,0.00017400422,0.000017787788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014479486,0.08653132,0.8999081,0.000017234419,0.00012160143,0.0012433999,0.0015666765,0.000012271795,0.00015273379,0.00027534488,0.0015922087,0.0071311616],"study_design_scores_gemma":[0.09421491,0.0074404622,0.88885504,0.00008827472,0.00014001045,0.00017540442,0.00013408113,0.000100829006,0.00019837619,0.00003841416,0.008490139,0.0001240362],"about_ca_topic_score_codex":0.000048239235,"about_ca_topic_score_gemma":0.0015012053,"teacher_disagreement_score":0.09276696,"about_ca_system_score_codex":0.0007151768,"about_ca_system_score_gemma":0.00038286875,"threshold_uncertainty_score":0.4754172},"labels":[],"label_agreement":null},{"id":"W2891861976","doi":"10.1002/hon.2560","title":"Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Refractory (planetary science); Anaplastic large-cell lymphoma; Internal medicine; Salvage therapy; Surgery; Gastroenterology; Lymphoma; Chemotherapy; Oncology; CD30","score_opus":0.023676171663027976,"score_gpt":0.3013416210523374,"score_spread":0.2776654493893094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891861976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990899,0.000095167234,0.00007286422,0.00028397137,0.0001673485,0.00063698797,0.0000416079,0.00006551404,0.0077375197],"genre_scores_gemma":[0.9970659,0.000021262123,0.0012979798,0.0007906722,0.000059373877,0.00008270919,0.0000655703,0.000024816954,0.0005917052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785477,0.00014243582,0.0006778017,0.00048584703,0.00032919462,0.00050993706],"domain_scores_gemma":[0.99805933,0.0006477459,0.00036449012,0.00039995805,0.00027515015,0.00025332996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013768443,0.00029517052,0.0012529154,0.00010962591,0.00009494453,0.0000067406827,0.00013352213,0.00037470585,0.0011547381],"category_scores_gemma":[0.0003230452,0.00015801197,0.0001379427,0.00017994485,0.0003537213,0.000052109783,0.000107495915,0.00011507208,0.00023250005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061686547,0.017157529,0.970431,0.00012606227,0.00012707239,0.00072196615,0.00015980423,1.1204154e-7,0.0000151109,0.00045969957,0.0026217098,0.0020112246],"study_design_scores_gemma":[0.045915253,0.025443602,0.90216404,0.000102228005,0.0003119927,0.0000918808,0.00013386883,0.00006498853,0.0015835935,0.000035030633,0.023932448,0.00022108165],"about_ca_topic_score_codex":0.000018941362,"about_ca_topic_score_gemma":0.00012087461,"teacher_disagreement_score":0.068267025,"about_ca_system_score_codex":0.0003532847,"about_ca_system_score_gemma":0.00022723102,"threshold_uncertainty_score":0.99975836},"labels":[],"label_agreement":null},{"id":"W2892009646","doi":"10.1111/bjh.15552","title":"An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Gilead Sciences","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Gastroenterology; Neutropenia; Follicular lymphoma; Lymphoma; Marginal zone B-cell lymphoma; Nausea; Non-Hodgkin's lymphoma; Adverse effect; Chemotherapy; Immunology; Marginal zone; B cell","score_opus":0.02868457587111895,"score_gpt":0.3463085454962921,"score_spread":0.31762396962517314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892009646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958366,0.0016447769,0.000023497896,0.00031402666,0.00037554363,0.0006132026,0.000026512313,0.0000053992544,0.0011604372],"genre_scores_gemma":[0.9969458,0.00096164166,0.0014852576,0.00030379955,0.0002006918,0.00002182653,0.000010444111,0.000023972754,0.00004658632],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979348,0.00018533765,0.0010219542,0.000268067,0.00027228068,0.0003175518],"domain_scores_gemma":[0.99855214,0.000113718655,0.00060517737,0.00023021574,0.00023809055,0.00026064826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056224153,0.0001786684,0.0011367087,0.00022469796,0.00006197524,0.000058487163,0.00027337027,0.00016604678,0.00016262666],"category_scores_gemma":[0.000100703655,0.00017290209,0.00007935353,0.00015742524,0.00025535168,0.00019665626,0.000111654386,0.00007350078,0.000010200497],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076522596,0.08152458,0.024810683,0.00035297722,0.0004925295,0.12070855,0.0018767884,4.2887868e-7,0.005460644,0.00034235328,0.006751944,0.6811559],"study_design_scores_gemma":[0.7267432,0.022237608,0.04976437,0.0009179304,0.00031441406,0.15370047,0.00036468997,0.00008140652,0.042258617,0.00023555792,0.0031322746,0.00024945752],"about_ca_topic_score_codex":0.0005610934,"about_ca_topic_score_gemma":0.0002498229,"teacher_disagreement_score":0.6809065,"about_ca_system_score_codex":0.00012791758,"about_ca_system_score_gemma":0.0004835604,"threshold_uncertainty_score":0.70507425},"labels":[],"label_agreement":null},{"id":"W2892168338","doi":"10.1093/ajcp/aqy108","title":"NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Enteropathy; Lymphoproliferative disorders; Pathology; Lymphocytosis; Intraepithelial lymphocyte; Lymphoma; Gastroenterology; Internal medicine; Disease","score_opus":0.05758183337108208,"score_gpt":0.4291812132983353,"score_spread":0.3715993799272532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892168338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019017953,0.97866786,0.00003614078,0.0004831367,0.00076510163,0.00047629184,0.000028455437,0.000010266572,0.00051480473],"genre_scores_gemma":[0.006596436,0.9897921,0.0012814201,0.0011984013,0.0009849787,0.000023928751,0.000014281976,0.00005305598,0.00005535969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949527,0.0012101702,0.0026817415,0.0005123797,0.00029494186,0.0003481076],"domain_scores_gemma":[0.9941648,0.0014140876,0.0032939175,0.0003994271,0.00020542253,0.00052232784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012463006,0.0004898037,0.0054305242,0.00024432343,0.000054198023,0.000017997141,0.0002071139,0.00030801003,0.00004462559],"category_scores_gemma":[0.0006492663,0.00030143058,0.0014769753,0.00018860919,0.0014500822,0.000047042035,0.00013007995,0.0006366239,0.00005920869],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024573618,0.0013924689,0.009770328,0.0008073123,0.00057201367,0.0014178532,0.00013034436,3.434229e-8,8.264707e-8,0.00000795647,0.0008392826,0.9848166],"study_design_scores_gemma":[0.004776539,0.022976328,0.0037945556,0.0055649397,0.004478132,0.005474372,0.00015020258,0.0000011454775,0.0000012711971,0.00007301661,0.952389,0.00032049368],"about_ca_topic_score_codex":0.000006291261,"about_ca_topic_score_gemma":0.0000033894198,"teacher_disagreement_score":0.9844961,"about_ca_system_score_codex":0.00012001539,"about_ca_system_score_gemma":0.0008012127,"threshold_uncertainty_score":0.9999438},"labels":[],"label_agreement":null},{"id":"W2892202190","doi":"10.1200/jco.2018.36.15_suppl.7534","title":"Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Neutropenia; Internal medicine; ABVD; Dacarbazine; Febrile neutropenia; Chemotherapy regimen; Surgery; Gastroenterology; Chemotherapy; Lymphoma; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.03357932821953199,"score_gpt":0.38376293910968273,"score_spread":0.35018361089015076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892202190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959083,0.00009847032,0.00015232373,0.0022971828,0.00051432237,0.00052325154,0.000005409934,0.000014970893,0.00048572445],"genre_scores_gemma":[0.98560655,0.00010996852,0.010195749,0.0035639296,0.00030826204,0.000015992986,0.000005255758,0.00003846422,0.00015580762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967883,0.00020787492,0.0017354216,0.00032719408,0.0005470269,0.0003941885],"domain_scores_gemma":[0.9954881,0.0014806947,0.0018194269,0.00030573548,0.0005212978,0.00038471862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009005436,0.00027372324,0.0019113517,0.00016841007,0.00004825776,0.000017361723,0.00017551567,0.0002578359,0.000111306865],"category_scores_gemma":[0.0010426767,0.00015006863,0.0002598118,0.00020803121,0.0002573185,0.0001904773,0.000040025414,0.00031202403,0.000016554133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017211955,0.0062457873,0.7004156,0.000015001115,0.0003387579,0.00064190675,0.00011860074,0.000012349761,0.000004444964,0.00002018198,0.00020438129,0.27477103],"study_design_scores_gemma":[0.15906622,0.04191012,0.7952205,0.0001790424,0.00019079432,0.00003170839,0.00009996712,0.000048223115,0.000073433155,0.00001971087,0.0030215646,0.00013869739],"about_ca_topic_score_codex":0.00013365883,"about_ca_topic_score_gemma":0.0004045487,"teacher_disagreement_score":0.27463233,"about_ca_system_score_codex":0.0007190034,"about_ca_system_score_gemma":0.0020262063,"threshold_uncertainty_score":0.61196214},"labels":[],"label_agreement":null},{"id":"W2892342442","doi":"10.3324/haematol.2018.203224","title":"<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Lymphoma; Somatic hypermutation; JUNB; Pathology; Histiocyte; Cancer research; BCL6; B cell; Germinal center; Biology; Medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.012321291891290267,"score_gpt":0.24434431335100992,"score_spread":0.23202302145971965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892342442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486403,0.0061335536,0.00003286041,0.001579442,0.00031653562,0.0011476048,0.00010586784,0.00033984196,0.041703984],"genre_scores_gemma":[0.9898757,0.0015081175,0.0013152155,0.005689355,0.00016751695,0.00027416248,0.00011959107,0.00008000994,0.00097036705],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958946,0.00019294157,0.0009198112,0.0012253176,0.00055746,0.0012098575],"domain_scores_gemma":[0.9975686,0.0003416149,0.00043361937,0.000874044,0.00025451195,0.0005276243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039599757,0.0007279982,0.0013860232,0.00026432512,0.00035529237,0.00010006228,0.0002866305,0.00047764706,0.0002709933],"category_scores_gemma":[0.00017943679,0.0005783011,0.00022180882,0.0008029763,0.0004416687,0.00019102411,0.00025124138,0.00023831753,0.00074772775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001992846,0.027245205,0.8268629,0.0014232016,0.00035625295,0.017826624,0.0018576564,0.000002782192,0.016735723,0.002474335,0.097861595,0.0053609014],"study_design_scores_gemma":[0.09014786,0.0036175277,0.17836301,0.0013110895,0.0010894035,0.005201539,0.0019146929,0.00034000084,0.51709384,0.0012145863,0.1970941,0.0026123486],"about_ca_topic_score_codex":0.00027148082,"about_ca_topic_score_gemma":0.000235433,"teacher_disagreement_score":0.64849985,"about_ca_system_score_codex":0.00034251937,"about_ca_system_score_gemma":0.00022635043,"threshold_uncertainty_score":0.99966687},"labels":[],"label_agreement":null},{"id":"W2892392661","doi":"10.1182/blood-2018-05-851154","title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Concordance; Lymphoma; Molecular diagnostics; Medicine; Pathology; Diffuse large B-cell lymphoma; Biopsy; Mediastinum; Computational biology; Oncology; Radiology; Bioinformatics; Internal medicine; Biology","score_opus":0.028917160059069837,"score_gpt":0.2649211411833282,"score_spread":0.23600398112425838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892392661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96481067,0.0008798975,0.0001523296,0.00009026229,0.00008900347,0.0002819002,0.000022904962,0.000035103785,0.033637952],"genre_scores_gemma":[0.99489594,0.000033686305,0.0041232724,0.00016888646,0.0002486035,0.0000133731455,0.000058730984,0.000025184345,0.0004322993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884045,0.00002563242,0.0002933428,0.00027857185,0.00029716807,0.00026483618],"domain_scores_gemma":[0.99916464,0.000031077303,0.0001550729,0.0003664954,0.00016222987,0.00012049376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012618315,0.00015057948,0.00029821662,0.00007828118,0.00006046924,0.000010617168,0.00007046379,0.000081142134,0.00033436055],"category_scores_gemma":[0.000030539522,0.00013040577,0.00007224216,0.00017332924,0.00007563743,0.000047505302,0.000046739355,0.00002917323,0.0003008904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010343884,0.01185374,0.061556812,0.0001393567,0.00017785045,0.00022990356,0.00019349117,3.0959944e-7,0.9224821,0.00039151267,0.0010838318,0.0017876532],"study_design_scores_gemma":[0.013851105,0.0006334634,0.15974748,0.000109833956,0.00065350276,0.0001253693,0.00003919452,0.00014783048,0.8193994,0.000014186883,0.005150711,0.0001278939],"about_ca_topic_score_codex":0.00005555421,"about_ca_topic_score_gemma":0.0000038360367,"teacher_disagreement_score":0.10308268,"about_ca_system_score_codex":0.00011666793,"about_ca_system_score_gemma":0.00022635816,"threshold_uncertainty_score":0.5317793},"labels":[],"label_agreement":null},{"id":"W2895099958","doi":"10.1097/ppo.0000000000000333","title":"Advanced-Stage Hodgkin Lymphoma","year":2018,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Stage (stratigraphy); Chemotherapy; Premature Menopause; Oncology; Disease; Internal medicine; Menopause","score_opus":0.07899013285659208,"score_gpt":0.4084619910494464,"score_spread":0.32947185819285435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895099958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008419521,0.9951617,0.000006779915,0.0004853678,0.001219913,0.00059458334,0.000070781236,0.000028258364,0.0023484067],"genre_scores_gemma":[0.000026336935,0.9915102,0.00011886879,0.000494168,0.0033010761,0.00021354112,0.000019224635,0.00007470873,0.0042418693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812895,0.0001454448,0.00058951374,0.00031184236,0.000404709,0.00041954385],"domain_scores_gemma":[0.9982626,0.00010282216,0.00061418855,0.0006198979,0.00013230508,0.00026822352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003740854,0.0004386756,0.001434957,0.0001121086,0.0002875964,0.00008984813,0.00038812865,0.00017427502,0.0012303884],"category_scores_gemma":[0.000042222826,0.00020528554,0.00088000455,0.00022810159,0.00010705398,0.000061231105,0.000085857435,0.00030334052,0.0003668975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029831346,0.00010693806,0.000034017678,0.0015565556,0.0007914943,0.00028733004,0.00004431201,3.584639e-7,8.80584e-8,0.00004013837,0.027463201,0.96964574],"study_design_scores_gemma":[0.0014719567,0.00022320509,0.000114119895,0.016694099,0.002979103,0.0028053003,0.000023540822,9.007122e-7,0.0000061694977,0.00004195548,0.9754356,0.0002040606],"about_ca_topic_score_codex":0.000029955836,"about_ca_topic_score_gemma":0.000010893115,"teacher_disagreement_score":0.96944165,"about_ca_system_score_codex":0.0015342922,"about_ca_system_score_gemma":0.0016739136,"threshold_uncertainty_score":0.9996826},"labels":[],"label_agreement":null},{"id":"W2895131191","doi":"10.1097/mph.0000000000001308","title":"Gray Zone Lymphoma Arising in the Neck of a Teenager With a Germline Mutation in TP53","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège de Maisonneuve; Pediatric Oncology Group","funders":"","keywords":"Medicine; Vincristine; Rituximab; Germline mutation; Lymphoma; Etoposide; Cyclophosphamide; Pathology; Internal medicine; Chemotherapy; Mutation","score_opus":0.016214652565145912,"score_gpt":0.31296510816099793,"score_spread":0.296750455595852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895131191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302137,0.0015944514,0.00017158673,0.0038270636,0.00017731024,0.00031340527,0.0000015303712,0.000005248214,0.0008880082],"genre_scores_gemma":[0.99455273,0.00039726915,0.0039464356,0.00053617853,0.0005202187,0.000018125063,0.0000027882625,0.0000134506845,0.000012811886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787,0.00027288205,0.001078388,0.00017414274,0.00030345414,0.00030110488],"domain_scores_gemma":[0.9978206,0.0006635549,0.00095091184,0.00019052038,0.0002856219,0.000088776345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009995989,0.0001687996,0.0009267162,0.00071704795,0.000036509227,0.00000672628,0.00014577496,0.00023559025,0.000035908586],"category_scores_gemma":[0.000263287,0.00009339939,0.00012002975,0.0007888048,0.00017413369,0.00009691608,0.000026138958,0.00020924871,0.000011647727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021151258,0.005198416,0.95207363,0.00014870442,0.00017895446,0.013797645,0.005415796,0.000015844642,0.00013215304,0.0005712417,0.0023486668,0.018003803],"study_design_scores_gemma":[0.03200638,0.014394201,0.90613383,0.00022417652,0.0010856247,0.037626795,0.002825044,0.00016297551,0.001229202,0.0005605984,0.0035369918,0.00021418429],"about_ca_topic_score_codex":0.00012518703,"about_ca_topic_score_gemma":0.00031708498,"teacher_disagreement_score":0.04593982,"about_ca_system_score_codex":0.00037431094,"about_ca_system_score_gemma":0.0009186938,"threshold_uncertainty_score":0.38087165},"labels":[],"label_agreement":null},{"id":"W2895277650","doi":"10.1097/ppo.0000000000000334","title":"Novel Biomarker Approaches in Classic Hodgkin Lymphoma","year":2018,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"Japan Society for the Promotion of Science; Michael Smith Health Research BC","keywords":"Brentuximab vedotin; Tumor microenvironment; Hodgkin lymphoma; Lymphoma; Medicine; Immune system; Cancer research; Biomarker; Disease; Oncology; Immunology; Biology; Internal medicine","score_opus":0.2594286816409469,"score_gpt":0.3872389197914404,"score_spread":0.12781023815049347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895277650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012432913,0.9956756,0.000021867318,0.000732047,0.0006609597,0.0006438513,0.000036234676,0.000014540607,0.002090556],"genre_scores_gemma":[0.00018465075,0.99690056,0.000190496,0.0002287837,0.0015951175,0.00028998705,0.000020976453,0.00006674869,0.0005226786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979803,0.00016038446,0.00070240785,0.00035409397,0.00036840013,0.00043442115],"domain_scores_gemma":[0.99858445,0.0001443409,0.0005134743,0.0005045346,0.00005829724,0.00019491967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006710753,0.00044647016,0.001455161,0.00024211603,0.00014557302,0.000100352714,0.00036904353,0.00025205218,0.0003066951],"category_scores_gemma":[0.000040142506,0.00021391796,0.0006785559,0.00041530715,0.00017032133,0.000060477832,0.00009066181,0.00031779998,0.00010493668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039041945,0.0003825278,0.00024247782,0.0013399386,0.0008211383,0.00013036805,0.000072643,2.5331966e-7,2.9672913e-7,0.000043041713,0.011881206,0.98504704],"study_design_scores_gemma":[0.0023996818,0.00010038176,0.0028770692,0.01712242,0.002118318,0.0041313805,0.000026018235,0.000018604298,0.0000023997586,0.000044932898,0.97093385,0.0002249545],"about_ca_topic_score_codex":0.00009691959,"about_ca_topic_score_gemma":0.000059461272,"teacher_disagreement_score":0.9848221,"about_ca_system_score_codex":0.0019047299,"about_ca_system_score_gemma":0.0016634322,"threshold_uncertainty_score":0.8723321},"labels":[],"label_agreement":null},{"id":"W2896385061","doi":"10.1002/pbc.27402","title":"A role for surgery in the treatment of relapsed Hodgkin lymphoma","year":2018,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Refractory (planetary science); Hematopoietic stem cell transplantation; Disease; Biopsy; Transplantation; Surgery; Chemotherapy; Stage (stratigraphy); Oncology; Internal medicine","score_opus":0.022974628416119684,"score_gpt":0.2886148874073053,"score_spread":0.2656402589911856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896385061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98300546,0.0146066975,0.0000018151682,0.0007597243,0.00020854331,0.0008048746,0.0000577478,0.000017767934,0.0005373587],"genre_scores_gemma":[0.9881772,0.0083596725,0.00015841561,0.00028559164,0.0015615288,0.0012782948,0.00001884864,0.000018772345,0.00014170764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894017,0.00003588668,0.00030501728,0.00024507265,0.00020117288,0.0002726907],"domain_scores_gemma":[0.9989521,0.00047082288,0.00012396954,0.00030340147,0.000087545355,0.00006215651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015013159,0.0001597759,0.00039028478,0.00013984229,0.00005065076,0.0000086669825,0.00006405758,0.00007123478,0.00007964067],"category_scores_gemma":[0.000037956008,0.00009486361,0.00022374421,0.0003669535,0.00004425407,0.000029096691,0.000006960549,0.000015862455,0.00001125231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004355282,0.005263042,0.9317383,0.00009347051,0.00021171494,0.000029577614,0.0016044755,7.4597943e-7,0.0000694275,0.00006315082,0.004676113,0.05581441],"study_design_scores_gemma":[0.013736415,0.0030581767,0.9418468,0.000053961983,0.0024203043,0.000028896637,0.00017881003,0.000031026568,0.007833825,0.00012790947,0.030506724,0.00017715928],"about_ca_topic_score_codex":0.0013893355,"about_ca_topic_score_gemma":0.00038003328,"teacher_disagreement_score":0.05563725,"about_ca_system_score_codex":0.00014505503,"about_ca_system_score_gemma":0.00035968842,"threshold_uncertainty_score":0.38684258},"labels":[],"label_agreement":null},{"id":"W2896458230","doi":"10.1016/s1470-2045(18)30618-1","title":"Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"National Health and Medical Research Council; AstraZeneca Australia; Siemens; National Health Research Institutes; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Follicular lymphoma; Vincristine; Bendamustine; Rituximab; Internal medicine; Prednisone; Clinical endpoint; CHOP; Oncology; Cyclophosphamide; Surgery; Lymphoma; Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.03272674167592464,"score_gpt":0.3595032829152931,"score_spread":0.32677654123936845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896458230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940763,0.00072456844,0.00025366293,0.0022063784,0.00024685985,0.0021707886,0.00016088867,0.000014334504,0.00014618634],"genre_scores_gemma":[0.99671185,0.00027053675,0.0013506823,0.000293317,0.00047888383,0.00073657866,0.00007677887,0.00001731189,0.00006404335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983406,0.00038396812,0.0006358206,0.0002285082,0.00018409634,0.00022700836],"domain_scores_gemma":[0.9970863,0.0015948478,0.00048538644,0.00053110765,0.00025467388,0.000047721944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014825654,0.0001643166,0.001372138,0.00020249498,0.000048306156,0.0000034249706,0.00013288653,0.00010859689,0.00031296193],"category_scores_gemma":[0.00041930372,0.00010259196,0.0005256138,0.0003849735,0.0003331264,0.000028903265,0.00002578416,0.00004563317,0.000002397502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95156294,0.0038556508,0.0023084963,0.00010761942,0.0050744656,0.000032389566,0.0011665086,0.000009725997,0.010481895,0.00009494338,0.00034197702,0.024963384],"study_design_scores_gemma":[0.8270851,0.024861146,0.051330943,0.0001030891,0.00949965,0.00006775875,0.00010953867,0.0011110781,0.07159489,0.00020724296,0.013888089,0.00014151951],"about_ca_topic_score_codex":0.00009700675,"about_ca_topic_score_gemma":0.00007385877,"teacher_disagreement_score":0.124477886,"about_ca_system_score_codex":0.0001672723,"about_ca_system_score_gemma":0.00045817214,"threshold_uncertainty_score":0.41835788},"labels":[],"label_agreement":null},{"id":"W2896637894","doi":"10.1080/17474086.2018.1537778","title":"Optimal frontline management of mantle cell lymphoma: can we agree?","year":2018,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Mantle (geology); Intensive care medicine; Lymphoma; Oncology; Cancer research; Internal medicine; Geochemistry; Geology","score_opus":0.01045945692812617,"score_gpt":0.30996336456101303,"score_spread":0.29950390763288687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896637894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022197611,0.76586986,0.000016304033,0.0013740503,0.22586796,0.0012558354,0.0001557662,0.00003129639,0.005206963],"genre_scores_gemma":[0.00038789609,0.87664455,0.009903574,0.00033399867,0.10894918,0.00039020047,0.0009836924,0.00008658644,0.0023203082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968027,0.00010572587,0.0013239351,0.00064441346,0.00071622187,0.00040703794],"domain_scores_gemma":[0.9971939,0.00023535178,0.0008998403,0.0011334488,0.000378905,0.00015859281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024927198,0.0005390452,0.0030028825,0.00013811761,0.000034576482,0.000003718506,0.000349244,0.00055623916,0.0007558373],"category_scores_gemma":[0.00008489805,0.00039267648,0.0005950977,0.00015125712,0.00022644129,0.000021831007,0.00023701006,0.00011818143,0.00012808178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009439064,0.0016525132,0.000032570053,0.050966598,0.0006987019,0.0005574049,0.00009193876,2.5081835e-8,0.0000055515834,0.00014803694,0.9388406,0.0069116647],"study_design_scores_gemma":[0.004184776,0.0007211823,0.000016136164,0.041282184,0.0010632229,0.00011245339,0.00006361762,0.0000017755199,0.0032807395,0.000011145817,0.9490035,0.00025922028],"about_ca_topic_score_codex":0.00020171938,"about_ca_topic_score_gemma":0.000012309356,"teacher_disagreement_score":0.11691878,"about_ca_system_score_codex":0.00023853999,"about_ca_system_score_gemma":0.0003667719,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W2896704395","doi":"10.1182/bloodadvances.2018023572","title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"BCL6; Breakpoint; Biology; Gene rearrangement; Lymphoma; Fluorescence in situ hybridization; Gene duplication; Chromosomal translocation; Locus (genetics); Cancer research; Gene; Diffuse large B-cell lymphoma; Comparative genomic hybridization; Genetics; Molecular biology; B cell; Antibody; Chromosome; Immunology; Germinal center","score_opus":0.00887678908744598,"score_gpt":0.25382857226473066,"score_spread":0.24495178317728467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896704395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261165,0.006110012,0.00002269599,0.00033940302,0.000051203482,0.00022313582,0.000009544501,0.000015124844,0.0006172372],"genre_scores_gemma":[0.9941363,0.000763099,0.0047248392,0.00012675722,0.00009385394,0.000044469987,0.000013308076,0.0000093065,0.000088086286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993244,0.000023795665,0.00014641124,0.00021713848,0.0001235578,0.00016468694],"domain_scores_gemma":[0.9996548,0.000029536175,0.000069766495,0.0001526529,0.000042058786,0.000051141025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004552912,0.00011136621,0.00024052853,0.00007864539,0.00003099492,0.0000037610862,0.000032346405,0.000041332318,0.000024237115],"category_scores_gemma":[0.0000118161015,0.00007194135,0.000019386405,0.000112277514,0.00018916324,0.000049153765,0.000021891656,0.000019547051,0.00000432094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006148758,0.0014284153,0.8872322,0.000086021406,0.00015863853,0.0001571843,0.0002743702,0.000015416159,0.0053475774,0.0003609683,0.00006548336,0.10425889],"study_design_scores_gemma":[0.0113588385,0.0020008506,0.9165694,0.00018961592,0.00019577653,0.0001900003,0.0000731055,0.000007686991,0.06262846,0.00027441795,0.0064049964,0.00010686139],"about_ca_topic_score_codex":0.00021043883,"about_ca_topic_score_gemma":0.00033049184,"teacher_disagreement_score":0.104152024,"about_ca_system_score_codex":0.000017729886,"about_ca_system_score_gemma":0.000028301129,"threshold_uncertainty_score":0.2933683},"labels":[],"label_agreement":null},{"id":"W2896936188","doi":"10.1016/j.ejca.2018.09.020","title":"Letter comments on a published article in the New England Journal of Medicine","year":2018,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Seattle Genetics; Takeda Pharmaceuticals U.S.A.","keywords":"Brentuximab vedotin; ABVD; Dacarbazine; Vinblastine; Medicine; Bleomycin; Oncology; Internal medicine; Antibody-drug conjugate; Hodgkin lymphoma; Lymphoma; Vincristine; Chemotherapy; Immunology; Antibody; Monoclonal antibody; Cyclophosphamide","score_opus":0.028634672669147057,"score_gpt":0.29400175790170036,"score_spread":0.2653670852325533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896936188","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033942036,0.0025952528,0.000009254844,0.95722795,0.0014238049,0.00013922065,0.000004163988,0.0000021296146,0.004656182],"genre_scores_gemma":[0.11517247,0.0005740605,0.000069328475,0.8347786,0.04858875,0.0000011804037,0.0000044327453,0.00004344152,0.00076775305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687296,0.0006966688,0.0009947951,0.00012819933,0.0010579336,0.00024944879],"domain_scores_gemma":[0.9977595,0.00023141749,0.0011981449,0.0002955823,0.00037698046,0.00013833182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017859743,0.00023447092,0.00064811314,0.00030691706,0.000030645562,0.0000655071,0.00040291966,0.00007326825,0.0008883339],"category_scores_gemma":[0.00026447172,0.00010977962,0.00021268206,0.00016733442,0.000114172486,0.00011696865,0.000026109075,0.0013383781,0.00002621714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043938367,0.00015092769,0.004148782,0.000026831378,0.00038289293,0.012610029,0.001730561,0.0000019506647,0.000032776392,0.0000012741422,0.9585797,0.02189486],"study_design_scores_gemma":[0.018854294,0.002866045,0.044133574,0.002018908,0.00046869577,0.0012671145,0.000036105703,6.5244797e-7,0.00010417403,0.000028949304,0.9301367,0.000084805884],"about_ca_topic_score_codex":0.000033116467,"about_ca_topic_score_gemma":0.000008630772,"teacher_disagreement_score":0.12244937,"about_ca_system_score_codex":0.00026142652,"about_ca_system_score_gemma":0.0002459876,"threshold_uncertainty_score":0.9726633},"labels":[],"label_agreement":null},{"id":"W2897022880","doi":"10.1093/annonc/mdy286.002","title":"Copanlisib monotherapy activity in relapsed or refractory indolent B-cell lymphoma: Combined analysis from phase I and II studies","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Janssen Research and Development; Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Nausea; Phases of clinical research; Gastroenterology; Lymphoma; Common Terminology Criteria for Adverse Events; Pneumonitis; Clinical endpoint; Tolerability; Follicular lymphoma; Refractory (planetary science); Rituximab; Bendamustine; Surgery; Chemotherapy; Clinical trial; Lung","score_opus":0.1147246556444247,"score_gpt":0.4352797038092064,"score_spread":0.3205550481647817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897022880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920984,0.003900106,0.0000026821108,0.0029403286,0.00010251427,0.0003172626,0.00005763927,0.000018066237,0.000563028],"genre_scores_gemma":[0.99062353,0.007366291,0.00021156545,0.0014620749,0.00007530544,0.00005510212,0.0000274539,0.000012325368,0.00016634857],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869424,0.00016357905,0.00037869776,0.0003561923,0.00016998607,0.00023729289],"domain_scores_gemma":[0.99857104,0.0005236473,0.0002686993,0.0003155815,0.00020490745,0.00011615448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028627596,0.0001882429,0.0010558587,0.00029945484,0.00007297649,0.0000046613663,0.00007111829,0.00016492589,0.00012655322],"category_scores_gemma":[0.0001041686,0.00013408138,0.0001333496,0.00040221383,0.00029558162,0.00005507071,0.00007868259,0.000060853246,0.000006585891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04615039,0.089246586,0.20056993,0.00010061383,0.011098029,0.00093733496,0.012843819,0.000002930593,0.017547667,0.00007169953,0.011882457,0.60954857],"study_design_scores_gemma":[0.12510598,0.08061133,0.6126807,0.00013807465,0.001985704,0.000010187982,0.001330201,0.00030437307,0.15123902,0.0002925018,0.02595738,0.000344544],"about_ca_topic_score_codex":0.00091789896,"about_ca_topic_score_gemma":0.0009701321,"teacher_disagreement_score":0.609204,"about_ca_system_score_codex":0.00016572728,"about_ca_system_score_gemma":0.00023274633,"threshold_uncertainty_score":0.546768},"labels":[],"label_agreement":null},{"id":"W2897571764","doi":"10.1080/10428194.2018.1515937","title":"A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†","year":2018,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Health Sciences Centre; Saint John Regional Hospital; Dalhousie University; University of New Brunswick","funders":"","keywords":"Romidepsin; Gemcitabine; Medicine; Internal medicine; Cisplatin; Lymphoma; Dexamethasone; Peripheral T-cell lymphoma; Cancer; Phases of clinical research; Chemotherapy; Oncology; Gastroenterology; Chemistry; Immunology; T cell","score_opus":0.03095222513590106,"score_gpt":0.31236087569468546,"score_spread":0.2814086505587844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897571764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98475575,0.008838539,0.0000032189241,0.00022337965,0.00020750093,0.0053420095,0.00014922807,0.000034879726,0.00044551262],"genre_scores_gemma":[0.99302197,0.004801148,0.000079448255,0.0004857042,0.00019751444,0.0010982936,0.000058811132,0.000082356935,0.0001747875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946968,0.0011408814,0.001489492,0.0010258694,0.00080433197,0.0008426163],"domain_scores_gemma":[0.99642426,0.0011196706,0.00075590966,0.0010126114,0.0002546483,0.00043289858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016842285,0.000861798,0.0018978752,0.00045537043,0.00068963994,0.0001810775,0.00032063515,0.00032014365,0.000044094166],"category_scores_gemma":[0.00010369151,0.00050664146,0.00023399976,0.0007687529,0.0005561082,0.00021298155,0.000085956504,0.00007761675,0.0000025387233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058600875,0.100376345,0.42878273,0.00018034353,0.0012703872,0.00046735557,0.07782594,0.0000033206343,0.0025992722,0.00025035543,0.0004161301,0.38196772],"study_design_scores_gemma":[0.35244104,0.024088351,0.59964204,0.000121327896,0.0011575696,0.00013538939,0.014297751,0.0014807606,0.0039440067,0.000067020206,0.0021393436,0.00048536574],"about_ca_topic_score_codex":0.25809044,"about_ca_topic_score_gemma":0.17051761,"teacher_disagreement_score":0.38148236,"about_ca_system_score_codex":0.004838402,"about_ca_system_score_gemma":0.0021990335,"threshold_uncertainty_score":0.9997385},"labels":[],"label_agreement":null},{"id":"W2898419651","doi":"10.1038/s41598-018-34199-9","title":"The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1","year":2018,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Government of Canada; University of Alberta; Alberta Cancer Foundation","keywords":"JUNB; Anaplastic large-cell lymphoma; Cancer research; Cell growth; Cell cycle; c-jun; Anaplastic lymphoma kinase; Lymphoma; CD30; Cell culture; Biology; Chemistry; Transcription factor; Cell; Molecular biology; Immunology; Medicine; Pathology; Genetics; Gene; Tumor cells","score_opus":0.030273475817436567,"score_gpt":0.257479605380451,"score_spread":0.22720612956301445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898419651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922352,0.0005956309,0.0000764621,0.0019412432,0.0029928098,0.0005445907,0.000011634137,0.000031129184,0.0015713064],"genre_scores_gemma":[0.9963496,0.00006934789,0.00008254707,0.00005185177,0.00007011991,0.000023507804,0.00001731794,0.00001141942,0.003324313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980169,0.0000774127,0.0005048716,0.00052293297,0.0005756369,0.00030224424],"domain_scores_gemma":[0.9987381,0.00012333061,0.00018032067,0.00067868683,0.00016990186,0.00010965788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007825243,0.0001787744,0.0002668659,0.000043178155,0.0006232475,0.00013565748,0.00008891557,0.00006732136,0.000050608687],"category_scores_gemma":[0.000054105898,0.00008355161,0.00018263659,0.00027465948,0.001453413,0.000114546674,0.000021598722,0.000052571362,0.000015195165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042350593,0.0018143792,0.048795596,0.00018922595,0.0005593502,0.00078805437,0.03631389,0.000005885852,0.74956965,0.001061863,0.087612815,0.07286579],"study_design_scores_gemma":[0.0011900202,0.00038504397,0.15835372,0.000093624505,0.0002992729,0.00034507108,0.0015766129,0.0000779736,0.5822456,0.0027411245,0.25252298,0.00016899729],"about_ca_topic_score_codex":0.00017070716,"about_ca_topic_score_gemma":0.00011584451,"teacher_disagreement_score":0.16732407,"about_ca_system_score_codex":0.00006937757,"about_ca_system_score_gemma":0.00015613822,"threshold_uncertainty_score":0.5355161},"labels":[],"label_agreement":null},{"id":"W2899175992","doi":"10.1182/blood-2018-99-118828","title":"Brentuximab Vedotin Plus Chemotherapy in Patients with Advanced-Stage Classical Hodgkin Lymphoma (cHL): Evaluation of Modified Progression-Free Survival (mPFS) and Traditional PFS in the Phase 3 ECHELON-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Internal medicine; Medicine; Classical Hodgkin lymphoma; Oncology; Chemotherapy; Progression-free survival; Chemotherapy regimen; Hodgkin lymphoma; Overall survival; Lymphoma; Stage (stratigraphy); Biology","score_opus":0.04121726497175998,"score_gpt":0.326195023048547,"score_spread":0.284977758076787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899175992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968297,0.00013774438,0.0000043432465,0.00028247837,0.000048411595,0.0022957295,0.00006039379,0.000013360252,0.00032785928],"genre_scores_gemma":[0.9992234,0.000011122124,0.00023757656,0.00006802747,0.00006953973,0.00027249404,0.00009413027,0.000018122013,0.0000055736236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977832,0.00023371169,0.00033113096,0.00034457783,0.0011022392,0.00020512944],"domain_scores_gemma":[0.9991228,0.00013713905,0.0001375471,0.00037234958,0.00016597193,0.00006420777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681307,0.00019160224,0.00035010476,0.00011362738,0.00005281759,0.00001717153,0.00012109329,0.000065236636,0.000034350218],"category_scores_gemma":[0.00008774168,0.000116502444,0.000037441707,0.00025490898,0.00013901279,0.000087948276,0.000027098897,0.000066978755,0.0000013993949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004634326,0.093068086,0.7921699,0.0000383177,0.00021665827,0.00004440861,0.0035325265,0.000009769578,0.00008751446,0.00017049671,0.000048179547,0.10597977],"study_design_scores_gemma":[0.1986582,0.006106857,0.7926127,0.00012964032,0.00020147281,0.0000047262242,0.00046384044,0.0006406048,0.00097629725,0.00008979008,0.0000144921205,0.00010140065],"about_ca_topic_score_codex":0.00004862411,"about_ca_topic_score_gemma":0.00017752995,"teacher_disagreement_score":0.19402388,"about_ca_system_score_codex":0.00016618562,"about_ca_system_score_gemma":0.00025941862,"threshold_uncertainty_score":0.4750832},"labels":[],"label_agreement":null},{"id":"W2899246565","doi":"10.3747/co.25.4231","title":"Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; Hôpital du Sacré-Cœur de Montréal; Baker Hughes (Canada); Roche (Canada); University of Calgary","funders":"H. Lundbeck A/S; Gilead Sciences; University of Calgary; Celgene; Bristol-Myers Squibb; Servier; Amgen","keywords":"Rituximab; Chemoimmunotherapy; Medicine; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Population; Internal medicine; Oncology; Malignancy; Environmental health","score_opus":0.19513617395831562,"score_gpt":0.45013313782302866,"score_spread":0.25499696386471304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899246565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989247,0.0025829342,0.0000011287482,0.00061960705,0.0008752234,0.00068210164,0.000019289906,0.000014894239,0.0059578046],"genre_scores_gemma":[0.99911255,0.00029199815,0.000017199314,0.00009868235,0.00028042623,0.00009497098,0.00007753074,0.000007750575,0.000018901634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99895585,0.0001485544,0.00021870763,0.00018095528,0.00032733142,0.00016860584],"domain_scores_gemma":[0.998882,0.000109410015,0.00010261149,0.00019146317,0.0005815715,0.00013295548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004228443,0.00009911963,0.00024165893,0.00012629,0.000051259023,0.000005252735,0.00004363346,0.00008798067,0.00033790423],"category_scores_gemma":[0.0001302769,0.000077485376,0.00005293732,0.0000885675,0.00007366478,0.000017922985,0.0000042189076,0.000037834077,0.00014797675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004681901,0.002656007,0.056628086,0.000037790287,0.00013169355,0.000059125618,0.0004918264,9.749824e-7,0.0005634402,0.00082465576,0.0025191733,0.93561906],"study_design_scores_gemma":[0.06336273,0.09261987,0.4911034,0.0015531809,0.0029834216,0.0044355183,0.00086814887,0.0038128935,0.077524744,0.0011040078,0.25980496,0.0008270982],"about_ca_topic_score_codex":0.0016338459,"about_ca_topic_score_gemma":0.014208541,"teacher_disagreement_score":0.9347919,"about_ca_system_score_codex":0.0012573738,"about_ca_system_score_gemma":0.0020523958,"threshold_uncertainty_score":0.7928699},"labels":[],"label_agreement":null},{"id":"W2899283766","doi":"10.1182/blood-2018-99-111893","title":"Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Internal medicine; Hazard ratio; Gastroenterology; Oncology; Confidence interval; Surgery; Chemotherapy; Vincristine; Lymphoma; Hodgkin lymphoma","score_opus":0.0260380212226272,"score_gpt":0.3034584903612505,"score_spread":0.2774204691386233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899283766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788207,0.000058856545,9.2407294e-7,0.00020567446,0.00014329044,0.00084854075,0.000012888489,0.0000087943245,0.00083897234],"genre_scores_gemma":[0.99927115,0.000043923887,0.00007546714,0.00023276292,0.00018689244,0.000070610346,0.000023545896,0.000009787696,0.00008583147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989817,0.00014537665,0.00029789802,0.0001863232,0.00021767162,0.00017100084],"domain_scores_gemma":[0.9995081,0.00006545324,0.00008313738,0.0002491423,0.000058334703,0.000035833033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020189262,0.00010434604,0.00023490674,0.000074263306,0.000028337687,0.000010399104,0.00007635992,0.000058690937,0.000044393746],"category_scores_gemma":[0.00020836909,0.00006115736,0.00005419184,0.00022284202,0.000054692835,0.000060069586,0.000019138773,0.000064891654,0.000009293018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10949965,0.06707447,0.786431,0.000074401796,0.00012931372,0.00041989327,0.008491974,0.0000013004442,0.0010671117,0.000060418617,0.0016725814,0.025077855],"study_design_scores_gemma":[0.28724185,0.010255762,0.6977873,0.00012425934,0.000102458056,0.000007358705,0.00008711512,0.000042542015,0.0036450934,0.000013571059,0.000622271,0.00007043694],"about_ca_topic_score_codex":0.00019920668,"about_ca_topic_score_gemma":0.00015843805,"teacher_disagreement_score":0.1777422,"about_ca_system_score_codex":0.000060509636,"about_ca_system_score_gemma":0.000081345854,"threshold_uncertainty_score":0.24939248},"labels":[],"label_agreement":null},{"id":"W2899297281","doi":"10.1182/blood-2018-99-112178","title":"Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Dacarbazine; ABVD; Brentuximab vedotin; Internal medicine; Chemotherapy regimen; Tolerability; Regimen; Population; Bleomycin; Vinblastine; Oncology; Gastroenterology; Surgery; Adverse effect; Vincristine; Chemotherapy; Lymphoma; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.011473343163321065,"score_gpt":0.2686328478128635,"score_spread":0.25715950464954246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899297281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730366,0.00018773248,0.000022480084,0.00030470875,0.000041141746,0.001554656,0.000073590076,0.000097695214,0.00041433802],"genre_scores_gemma":[0.99848014,0.000012702243,0.00021733608,0.00038239927,0.0002072614,0.0002596421,0.0002560166,0.000034872726,0.00014963429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979641,0.00016741682,0.00035397225,0.0006041735,0.00053392287,0.00037642883],"domain_scores_gemma":[0.9983171,0.00019073102,0.00015493824,0.0008680305,0.00024125236,0.0002279498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011887175,0.00032986188,0.0006234415,0.0001096938,0.00019790958,0.00006914542,0.00017295741,0.00009464986,0.0003888008],"category_scores_gemma":[0.00006511463,0.00016838964,0.00021215314,0.000853543,0.00015149075,0.00006019649,0.00006878134,0.0000641553,0.00017096901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008577244,0.042777095,0.93403596,0.0000039880215,0.008868744,0.00021204565,0.0016453658,1.9568614e-7,0.00001961169,0.0000033640595,0.00048117217,0.0110947285],"study_design_scores_gemma":[0.07738283,0.0075709065,0.8898754,0.00006113703,0.022224043,0.000008506569,0.00030693057,0.000084773914,0.001983672,0.0000040482146,0.00030604607,0.00019170628],"about_ca_topic_score_codex":0.00075647444,"about_ca_topic_score_gemma":0.0021444855,"teacher_disagreement_score":0.076525114,"about_ca_system_score_codex":0.00013079669,"about_ca_system_score_gemma":0.00014163472,"threshold_uncertainty_score":0.686673},"labels":[],"label_agreement":null},{"id":"W2899428983","doi":"10.1182/blood-2018-99-110563","title":"The ECHELON-2 Trial: Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Vincristine; CHOP; Oncology; Anaplastic large-cell lymphoma; Chemotherapy regimen; Prednisone; Phases of clinical research; Lymphoma; Cyclophosphamide; Chemotherapy; CD30","score_opus":0.024992037168233224,"score_gpt":0.3012498438549492,"score_spread":0.27625780668671596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899428983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865575,0.000770971,4.5970776e-7,0.00014861427,0.0001207488,0.009481777,0.000070313596,0.000008794446,0.0007425457],"genre_scores_gemma":[0.9985623,0.00023602533,0.00006121929,0.000008214739,0.00009724968,0.00091027876,0.0000414152,0.000020197725,0.00006314969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765795,0.0003799914,0.00087720755,0.0003404955,0.0005049415,0.00023939842],"domain_scores_gemma":[0.99731904,0.0010836619,0.00071129436,0.0005620471,0.00025400575,0.00006992896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902228,0.00030002734,0.0015357626,0.000101108555,0.00008902461,0.000016794667,0.00013193022,0.00007164567,0.000009412559],"category_scores_gemma":[0.00014147158,0.00012863538,0.0002356437,0.0002088328,0.00027794656,0.000049252467,0.000028665834,0.000047342284,7.7073804e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88534445,0.095642865,0.0077912635,0.000017232698,0.002086207,0.000015698048,0.005768759,8.3738337e-7,0.000057100297,0.000008236665,0.00001072492,0.003256658],"study_design_scores_gemma":[0.92788756,0.04554833,0.015328216,0.00005805036,0.003495755,0.0000020824948,0.0016863537,0.00003284203,0.0057972567,0.000002482201,0.00006140676,0.00009964124],"about_ca_topic_score_codex":0.0010349127,"about_ca_topic_score_gemma":0.0005705773,"teacher_disagreement_score":0.05009453,"about_ca_system_score_codex":0.0001007972,"about_ca_system_score_gemma":0.0001714974,"threshold_uncertainty_score":0.52455986},"labels":[],"label_agreement":null},{"id":"W2901204098","doi":"10.1182/blood-2018-04-843540","title":"Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Radiation therapy; Medicine; Nuclear medicine; Positron emission tomography; Lymphoma; Radiology; Pathology","score_opus":0.010438094308450493,"score_gpt":0.2782999149906337,"score_spread":0.2678618206821832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901204098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891332,0.004688506,0.0001630458,0.00044066084,0.00011880265,0.0037843466,0.00071765506,0.00010906818,0.0008447587],"genre_scores_gemma":[0.9940238,0.000286191,0.001815638,0.0010718042,0.0001664917,0.0015116431,0.00024861228,0.00007245418,0.0008033443],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804074,0.00014385374,0.00035924392,0.0005923065,0.00037838795,0.00048544852],"domain_scores_gemma":[0.9985856,0.00024940984,0.00015348097,0.00042645243,0.0003486805,0.00023638668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022997764,0.00036477132,0.00069526874,0.00007050016,0.00027819956,0.00006168499,0.00011560567,0.00003236634,0.00013657256],"category_scores_gemma":[0.00010646731,0.00028580398,0.0001720962,0.00035138015,0.00015612388,0.00007248905,0.00002863676,0.000041882082,0.000045504326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013109415,0.19784808,0.28987718,0.00025461015,0.030816164,0.0070395316,0.014745873,7.2512574e-7,0.023651935,0.0014922234,0.39632663,0.024837606],"study_design_scores_gemma":[0.33700296,0.03517773,0.01182095,0.00021155957,0.0045342175,0.00056352536,0.008320565,0.00008137066,0.3865348,0.00013572085,0.21446346,0.0011531389],"about_ca_topic_score_codex":0.00020148251,"about_ca_topic_score_gemma":0.000049556744,"teacher_disagreement_score":0.36288288,"about_ca_system_score_codex":0.00023890768,"about_ca_system_score_gemma":0.00028937502,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2901204777","doi":"10.1182/blood-2018-99-116868","title":"Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Lymphoma; Ibrutinib; Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.016858601160989892,"score_gpt":0.27331609459260914,"score_spread":0.2564574934316192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901204777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516976,0.003183449,0.0000019589318,0.00024434127,0.00007417478,0.0009685069,0.000024108958,0.000030996638,0.0003027024],"genre_scores_gemma":[0.9987829,0.00032453885,0.00017171641,0.0002714731,0.00009088872,0.00009876776,0.000011201071,0.000031855874,0.00021670849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982959,0.00019445946,0.00039434832,0.00046257098,0.00022781178,0.00042492765],"domain_scores_gemma":[0.9989702,0.0003303291,0.000100884485,0.00037903458,0.000049754093,0.00016981462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048232352,0.0002761607,0.0004156294,0.00016346599,0.00015553215,0.000066399196,0.000090216294,0.000106384985,0.000023818862],"category_scores_gemma":[0.00013491999,0.00018277699,0.000046055702,0.00024624114,0.00015388856,0.00009207547,0.000083982995,0.00010140749,0.000016803788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001451821,0.12407673,0.86044216,0.000042563486,0.00013507817,0.0011074956,0.0037192518,1.1330502e-7,0.0043021613,0.0000069215685,0.00014492277,0.0045707896],"study_design_scores_gemma":[0.17657565,0.006025886,0.79876727,0.00014913281,0.0004728218,0.00015498132,0.004375001,0.00021863813,0.011753097,0.000022758722,0.0012082786,0.00027650184],"about_ca_topic_score_codex":0.000584415,"about_ca_topic_score_gemma":0.0034219972,"teacher_disagreement_score":0.17512383,"about_ca_system_score_codex":0.000107045395,"about_ca_system_score_gemma":0.00015958349,"threshold_uncertainty_score":0.7453429},"labels":[],"label_agreement":null},{"id":"W2901864796","doi":"10.14740/jh459w","title":"Efficacy of ESHAP Regimen in Transplant Ineligible Patients With Relapsed/Refractory T-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Regimen; Salvage therapy; Chemotherapy regimen; Cytarabine; Autologous stem-cell transplantation; Transplantation; Chemotherapy; Oncology; Surgery; Gastroenterology","score_opus":0.008743734254321149,"score_gpt":0.24585017447015398,"score_spread":0.23710644021583283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901864796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696285,0.00077631685,0.00001207389,0.0003187299,0.00012612696,0.00017325112,0.0000032724574,0.000004722418,0.0016226646],"genre_scores_gemma":[0.9989781,0.00013373888,0.00063303515,0.00014087763,0.00005138536,0.0000030756873,0.0000048615793,0.000014593302,0.000040348354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987879,0.000046657984,0.00059339625,0.0001272855,0.0002463289,0.0001984534],"domain_scores_gemma":[0.998881,0.00014673702,0.0004580537,0.00018031258,0.00022138385,0.0001125177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012575516,0.00013448403,0.0006291793,0.00025737123,0.000019866817,0.0000030246981,0.00008868389,0.00010518116,0.00005789356],"category_scores_gemma":[0.000033163567,0.00008379506,0.00009749029,0.00014811629,0.000115494004,0.00006728238,0.000011543994,0.000081381935,0.000016497946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004659854,0.007181315,0.98226005,0.00010842792,0.00018708355,0.0008091465,0.0007534696,0.0000014200534,0.0003100791,0.00021053798,0.001798685,0.0017199396],"study_design_scores_gemma":[0.06563424,0.008587176,0.88429916,0.0009357839,0.0003315841,0.0017143704,0.00008325642,0.000008129285,0.035575815,0.000080554135,0.0026076275,0.00014229472],"about_ca_topic_score_codex":0.000029720617,"about_ca_topic_score_gemma":0.000015028012,"teacher_disagreement_score":0.09796088,"about_ca_system_score_codex":0.00010906615,"about_ca_system_score_gemma":0.00022959898,"threshold_uncertainty_score":0.3417063},"labels":[],"label_agreement":null},{"id":"W2902351677","doi":"10.1148/radiol.2018181519","title":"Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry","year":2018,"lang":"en","type":"article","venue":"Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; McMaster University; Cancer Care Ontario; Women's College Hospital; Hamilton Health Sciences; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Hazard ratio; Confidence interval; Stage (stratigraphy); Hodgkin lymphoma; Propensity score matching; Proportional hazards model; Prospective cohort study; Internal medicine; Nuclear medicine; Lymphoma","score_opus":0.010160482443502615,"score_gpt":0.2844535606352985,"score_spread":0.2742930781917959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902351677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997909,0.00035106819,0.000003709763,0.00044219237,0.00005333652,0.00055935123,0.000008249005,0.000006818451,0.0006662447],"genre_scores_gemma":[0.99915177,0.00019028604,0.00021993212,0.00021335336,0.000024385901,0.00008481044,0.0000031479158,0.000010098792,0.0001022489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918437,0.000116294796,0.00017716143,0.0002247381,0.00009874338,0.00019868859],"domain_scores_gemma":[0.99894154,0.0004671537,0.00019529121,0.00030608146,0.000026782385,0.0000631493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019138285,0.00015128545,0.00046735458,0.000048769023,0.000040056784,0.0000036048966,0.00005190762,0.000015466378,0.000017432065],"category_scores_gemma":[0.0000644897,0.0000701647,0.000041532647,0.00004757589,0.00046880887,0.000013300769,0.000046584097,0.00002801954,0.0000043141486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017041492,0.0003271939,0.98199964,0.00020387114,0.0010931,0.0012972553,0.00023408343,4.3977897e-7,0.00012684402,0.00029576584,0.00045595906,0.012261709],"study_design_scores_gemma":[0.009920656,0.005748049,0.96846,0.0003218439,0.0006120441,0.0007261316,0.00009827515,0.00010139365,0.013765042,0.000012310602,0.00016062708,0.00007361635],"about_ca_topic_score_codex":0.00005824917,"about_ca_topic_score_gemma":0.0000122022675,"teacher_disagreement_score":0.013638198,"about_ca_system_score_codex":0.000032552212,"about_ca_system_score_gemma":0.000013622752,"threshold_uncertainty_score":0.28612334},"labels":[],"label_agreement":null},{"id":"W2902600349","doi":"10.1182/blood-2019-127280","title":"Three-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Lymphoma; Oncology; Internal medicine; Surgery; Cancer; Immunotherapy","score_opus":0.012815881808589792,"score_gpt":0.24030197541749965,"score_spread":0.22748609360890987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902600349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991816,0.0015893596,0.000004955703,0.00025540576,0.0002760099,0.00071625796,0.000016876958,0.00005539163,0.005269743],"genre_scores_gemma":[0.9982018,0.00029036216,0.00030750813,0.00021078368,0.00009827964,0.000075181626,0.00002349556,0.000054427896,0.0007381868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836093,0.00004191348,0.000428954,0.00042585237,0.0003819718,0.00036037262],"domain_scores_gemma":[0.9988333,0.00012303404,0.000167215,0.0006830688,0.00006335856,0.00013003836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001297457,0.00026721501,0.0006292282,0.00020622852,0.00002650811,0.000013077847,0.00014201002,0.00020499737,0.00035598184],"category_scores_gemma":[0.000032120355,0.0002185882,0.00024380784,0.00025598193,0.00005282044,0.00006838466,0.00003995267,0.0000974436,0.00031141593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002024388,0.0056681065,0.9678888,0.00010491238,0.0004257158,0.00015800685,0.00040417767,0.0000029601472,0.0057704607,0.0007591001,0.00067353627,0.016119836],"study_design_scores_gemma":[0.11896384,0.002062392,0.8538804,0.0003081994,0.00025631452,0.00004825422,0.000080956925,0.000050484286,0.020682951,0.00026935415,0.0031472442,0.00024962964],"about_ca_topic_score_codex":0.0004556386,"about_ca_topic_score_gemma":0.00019527636,"teacher_disagreement_score":0.11693945,"about_ca_system_score_codex":0.00018735608,"about_ca_system_score_gemma":0.00027433658,"threshold_uncertainty_score":0.89137685},"labels":[],"label_agreement":null},{"id":"W2902652237","doi":"10.1182/blood-2018-99-113675","title":"Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Medicine; Follicular lymphoma; Rituximab; Internal medicine; Population; Regimen; Oncology; Lymphoma; Surgery","score_opus":0.00557072672014043,"score_gpt":0.2196003428673482,"score_spread":0.21402961614720778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902652237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947368,0.002060966,0.000015011035,0.00036328664,0.000021697186,0.0024744098,0.00018527677,0.000059595004,0.000082955914],"genre_scores_gemma":[0.99684674,0.00020049115,0.0019516291,0.00013525815,0.000048414488,0.0005281426,0.00019468964,0.00006768775,0.000026953863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777466,0.000046834826,0.00039114096,0.00065067835,0.00067842286,0.00045828754],"domain_scores_gemma":[0.9987593,0.000036257443,0.00021391579,0.00035934773,0.0002592629,0.00037186625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009371929,0.0004507049,0.00069331675,0.00013650706,0.0001291202,0.000035928122,0.00009667085,0.00010811488,0.000023515853],"category_scores_gemma":[0.000013107237,0.0002552664,0.00007102598,0.00035427776,0.0003634749,0.00022417653,0.000026635857,0.000052291703,0.00000132592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006934587,0.030976037,0.9354989,0.000174676,0.0005010981,0.00014338866,0.0005764753,1.9094252e-7,0.00008854174,0.0000030198246,0.00009734134,0.025005726],"study_design_scores_gemma":[0.12417448,0.007915835,0.8426962,0.0013849358,0.00091040594,0.000015033307,0.00008703334,0.00006676851,0.022242785,0.0000036051574,0.00019732075,0.0003055864],"about_ca_topic_score_codex":0.0006749849,"about_ca_topic_score_gemma":0.00037076348,"teacher_disagreement_score":0.1172399,"about_ca_system_score_codex":0.000104410195,"about_ca_system_score_gemma":0.00022204556,"threshold_uncertainty_score":0.9999899},"labels":[],"label_agreement":null},{"id":"W2902790828","doi":"10.1182/blood-2018-99-117448","title":"Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Blockade; Medicine; Lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.019498867215680917,"score_gpt":0.27856004572648846,"score_spread":0.25906117851080757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902790828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916275,0.0027232997,0.000005454735,0.0029776918,0.00017130109,0.001023661,0.000016656424,0.0000751026,0.001379337],"genre_scores_gemma":[0.99277806,0.0025699812,0.0008212378,0.0027287486,0.00064701383,0.00016385083,0.000012381433,0.000045622382,0.00023312135],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983956,0.000049860217,0.0002917549,0.0005106744,0.00032958746,0.0004225104],"domain_scores_gemma":[0.9987911,0.000058668295,0.00013974853,0.00048824452,0.00015457402,0.0003676625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014616875,0.00032297778,0.0004391619,0.00011782834,0.00013062726,0.000048746286,0.00008178736,0.00012228462,0.000101934536],"category_scores_gemma":[0.000030457717,0.00022663029,0.0001296673,0.00017809636,0.00012791295,0.000039260318,0.00006192043,0.000052961324,0.00015731064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032042162,0.014286935,0.2747428,0.000066748325,0.0029493212,0.0039950893,0.010806599,0.0000010325948,0.24471886,0.00019666975,0.003002121,0.4420296],"study_design_scores_gemma":[0.020460073,0.0028275303,0.39464223,0.00019967768,0.000102807404,0.00057239935,0.000109700435,0.000008093318,0.57425195,0.000037403046,0.006557588,0.00023053218],"about_ca_topic_score_codex":0.00027447718,"about_ca_topic_score_gemma":0.000026057523,"teacher_disagreement_score":0.44179907,"about_ca_system_score_codex":0.000103075305,"about_ca_system_score_gemma":0.00013931667,"threshold_uncertainty_score":0.9241715},"labels":[],"label_agreement":null},{"id":"W2902802838","doi":"10.1182/blood-2018-99-116827","title":"The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Population; Oncology; Biology; Gene signature; Gene; Internal medicine; Cancer research; Gene expression; Medicine; Genetics; B cell; Germinal center; Antibody","score_opus":0.022561162751613236,"score_gpt":0.2816231978053977,"score_spread":0.25906203505378445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902802838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938699,0.002434108,0.000016447724,0.0012266577,0.00015716667,0.00038461023,0.000011625795,0.00007239985,0.0018270988],"genre_scores_gemma":[0.9958746,0.00033902403,0.002467555,0.00050913705,0.00046583408,0.00007292173,0.000027068925,0.000015180621,0.0002286813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882174,0.000051713658,0.0003353093,0.00036471637,0.0001824064,0.00024412388],"domain_scores_gemma":[0.99893904,0.00030733994,0.00013050037,0.00035790098,0.00010545729,0.00015975053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028198241,0.00018598045,0.00026828155,0.00002046855,0.00028128288,0.000053333,0.000111391564,0.00018027816,0.000033895827],"category_scores_gemma":[0.00019911834,0.00008569535,0.000088802,0.00009122041,0.0002643231,0.00002954885,0.00011439269,0.000117855896,0.00003894694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019786623,0.003826767,0.9504859,0.000030147949,0.00031825397,0.00023925494,0.00029267377,9.329626e-8,0.031901002,0.0013024816,0.0018840822,0.0077406806],"study_design_scores_gemma":[0.028717019,0.004477819,0.8746257,0.00027736128,0.00070683897,0.00032889034,0.000080037404,0.000018292083,0.08211072,0.0011772048,0.007147216,0.00033291886],"about_ca_topic_score_codex":0.000028854487,"about_ca_topic_score_gemma":0.000040246694,"teacher_disagreement_score":0.07586022,"about_ca_system_score_codex":0.0000143834495,"about_ca_system_score_gemma":0.00005585514,"threshold_uncertainty_score":0.3494555},"labels":[],"label_agreement":null},{"id":"W2902885481","doi":"10.1007/s11912-018-0748-0","title":"Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better?","year":2018,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Biosimilar; CD20; Monoclonal antibody; Lymphoma; Clinical trial; Intensive care medicine; Immunology; Internal medicine; Antibody","score_opus":0.1361164820367197,"score_gpt":0.4160074340311069,"score_spread":0.2798909519943872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902885481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005594727,0.9842975,0.0000015582917,0.00008527072,0.0039563477,0.0022068487,0.000045447207,0.00016308384,0.003649224],"genre_scores_gemma":[0.00045575734,0.99621403,0.0002559564,0.00011277352,0.0011102996,0.00025956446,0.00090162456,0.000104989726,0.0005849998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955339,0.0002635441,0.002030587,0.0011152595,0.0005104751,0.0005462349],"domain_scores_gemma":[0.9942025,0.00020002629,0.0035134964,0.0013268321,0.0003015142,0.00045561948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003375343,0.00082183,0.0046641435,0.00034489954,0.000077686986,0.000018002098,0.00020642985,0.00075245,0.00040540803],"category_scores_gemma":[0.000120412195,0.0005756574,0.0012290025,0.00043060607,0.00019113513,0.00004810779,0.00014397515,0.00028244083,0.00010678566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021490703,0.0035927559,0.015325097,0.0052515175,0.00081887335,0.003892877,0.00007824375,1.6606295e-8,0.0000016563929,0.0000013144189,0.10139793,0.86961824],"study_design_scores_gemma":[0.002094072,0.0008555792,0.009914846,0.014235755,0.0024871924,0.0024676456,0.0000052582727,3.8922045e-7,0.00007472989,0.000021382344,0.9675061,0.00033705513],"about_ca_topic_score_codex":0.000064818654,"about_ca_topic_score_gemma":0.000008567254,"teacher_disagreement_score":0.8692812,"about_ca_system_score_codex":0.0009848234,"about_ca_system_score_gemma":0.0038098714,"threshold_uncertainty_score":0.9996695},"labels":[],"label_agreement":null},{"id":"W2902987035","doi":"10.1182/blood-2018-99-116677","title":"Prediction and Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Cell of Origin (COO) Subtypes Using Genomic Features from Targeted Next-Generation Sequencing","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Cancer research; Medicine; Biology; Oncology; Lymphoma; Internal medicine","score_opus":0.036568247213582844,"score_gpt":0.232895199376039,"score_spread":0.19632695216245616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902987035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837434,0.0007549237,0.000097738906,0.000013336122,0.00014414795,0.0002840753,0.00023642482,0.000025269768,0.00006972718],"genre_scores_gemma":[0.99766356,0.0002377896,0.001042541,0.000042456777,0.0003669629,0.0000077846835,0.0005805867,0.0000204693,0.00003787546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917454,0.000037510305,0.00027167724,0.00023239914,0.00014486673,0.00013902613],"domain_scores_gemma":[0.9994027,0.000019987,0.00021527353,0.00018607758,0.00011282509,0.00006315675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006535228,0.00013614233,0.00025169112,0.00008860676,0.00007007973,0.000017699387,0.000032603275,0.00010490089,0.000023553499],"category_scores_gemma":[0.000011124233,0.00011773901,0.000047724956,0.000100818295,0.00004125196,0.00012129442,0.0000235596,0.000024881694,0.0000027359815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057184312,0.0024744202,0.13491733,0.000055674947,0.000071886636,0.0000054891802,0.0005680699,5.981108e-7,0.8614951,0.000010209273,0.000010660131,0.0003333728],"study_design_scores_gemma":[0.010547962,0.00024634262,0.2961334,0.000056107085,0.00040839694,0.000008568041,0.000042359923,0.0015666883,0.69087654,0.0000046023224,0.00004631993,0.00006272444],"about_ca_topic_score_codex":0.000501744,"about_ca_topic_score_gemma":0.000033993656,"teacher_disagreement_score":0.17061856,"about_ca_system_score_codex":0.00009306154,"about_ca_system_score_gemma":0.00012025399,"threshold_uncertainty_score":0.48012576},"labels":[],"label_agreement":null},{"id":"W2903157580","doi":"10.1182/blood-2018-99-115024","title":"Primary Mediastinal B-Cell Lymphoma: Evaluation of Clinicopathologic Diagnosis Compared to Gene Expression Based Diagnosis in a Clinical Trial with CD30+ B-Cell Lymphomas","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; CD30; Clinical trial; Biopsy; Pathology; Follicular lymphoma; Diffuse large B-cell lymphoma; Large-cell lymphoma; Oncology; Internal medicine","score_opus":0.07992429991209805,"score_gpt":0.3515623862252238,"score_spread":0.27163808631312575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903157580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323183,0.0009422987,0.000032641998,0.00028182927,0.0003882738,0.003382786,0.00005591049,0.00006902211,0.0016153858],"genre_scores_gemma":[0.98287255,0.0002156832,0.012160663,0.00075121335,0.0006171421,0.003168091,0.00014454842,0.000053474236,0.000016629889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99466056,0.00082612457,0.0015827604,0.001007526,0.0013920346,0.0005309913],"domain_scores_gemma":[0.9959744,0.0014669994,0.00061027537,0.0008965617,0.000605208,0.00044651495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002695156,0.00044943573,0.0012584528,0.0003444465,0.00009492212,0.000026674605,0.00025906978,0.00030589054,0.00024238785],"category_scores_gemma":[0.0008501951,0.00033187942,0.00033282075,0.0006206289,0.00025777306,0.00009494801,0.0001347288,0.00011376933,0.0000944383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022797834,0.07344049,0.8871001,0.00011449195,0.00007200572,0.00025891248,0.00023817441,0.000019795561,0.0012076535,0.0000014934279,0.0009772024,0.013771855],"study_design_scores_gemma":[0.34068465,0.010899712,0.4734789,0.0005224811,0.0015094539,0.000022525357,0.000055743603,0.00018713892,0.17216977,0.000011525518,0.00018090804,0.00027718462],"about_ca_topic_score_codex":0.00009924391,"about_ca_topic_score_gemma":0.00006969742,"teacher_disagreement_score":0.4136212,"about_ca_system_score_codex":0.00034809342,"about_ca_system_score_gemma":0.0013249663,"threshold_uncertainty_score":0.99991333},"labels":[],"label_agreement":null},{"id":"W2903278833","doi":"10.1200/jco.18.01583","title":"Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":420,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Simon Fraser University; University Health Network; Spinal Cord Injury BC","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"BCL6; Germinal center; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Biology; Oncology; Cancer research; B cell; Genetics; Internal medicine; Antibody","score_opus":0.057047727094527635,"score_gpt":0.392159535548267,"score_spread":0.33511180845373933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903278833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911204,0.001302673,0.00011104783,0.00119817,0.0017987582,0.0002506952,0.000027795835,0.000012808373,0.0041776756],"genre_scores_gemma":[0.9916321,0.0006034633,0.003452854,0.001509881,0.002179553,0.000008573307,0.000017559058,0.000031227435,0.0005647776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959488,0.0002986203,0.0024377024,0.0003306922,0.00056266703,0.00042152507],"domain_scores_gemma":[0.9948759,0.0012115157,0.002310542,0.00037485998,0.00066781614,0.00055937713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001307663,0.0002796323,0.001792674,0.00014722529,0.00008160604,0.000012411794,0.00026043723,0.0006519896,0.00027078285],"category_scores_gemma":[0.00036694,0.0001726282,0.0008917786,0.00015011292,0.00029456033,0.0001109093,0.00015265757,0.00040017723,0.000055113906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03285717,0.16138446,0.70941806,0.00019794953,0.00056663656,0.004402655,0.00042501316,4.586535e-7,0.010939714,0.000097155775,0.042818733,0.036892004],"study_design_scores_gemma":[0.27000895,0.032395452,0.44636112,0.0005074883,0.0014869622,0.001397992,0.00012922216,0.000053493102,0.047008682,0.00015024062,0.20015468,0.00034569544],"about_ca_topic_score_codex":0.000023724206,"about_ca_topic_score_gemma":0.00003468333,"teacher_disagreement_score":0.2630569,"about_ca_system_score_codex":0.00020370513,"about_ca_system_score_gemma":0.0009003233,"threshold_uncertainty_score":0.7039574},"labels":[],"label_agreement":null},{"id":"W2903308035","doi":"10.1016/s0140-6736(18)32984-2","title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":726,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Brentuximab vedotin; Medicine; Chemotherapy; Oncology; Internal medicine; Lymphoma; Peripheral; CD30; Peripheral T-cell lymphoma; Double blind; Phases of clinical research; Immunology; Pathology; T cell; Alternative medicine","score_opus":0.03926279559710762,"score_gpt":0.3382484745491339,"score_spread":0.2989856789520263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903308035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779921,0.0004868248,0.00038937537,0.006732006,0.0003115247,0.0048924377,0.00015332935,0.00010167765,0.008940737],"genre_scores_gemma":[0.9901409,0.00012183694,0.0012967824,0.002998206,0.0036892816,0.0010489587,0.00011778621,0.00003995289,0.00054628256],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998494,0.000059791404,0.00028385714,0.0003879428,0.00028418278,0.0004902201],"domain_scores_gemma":[0.99879426,0.00014168725,0.00016250744,0.0005990934,0.0001625333,0.00013994434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031169,0.0003051471,0.000809187,0.000025276046,0.00021393891,0.000084081374,0.00021725522,0.0000971373,0.00013481408],"category_scores_gemma":[0.00001799113,0.00016603981,0.00022400855,0.0001874686,0.00022111693,0.000061194805,0.000025770714,0.000053605105,0.000050526854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9617366,0.0040794774,0.00071760727,0.000034603374,0.0005272504,0.000027423193,0.00057880254,4.9927536e-7,0.0002568914,0.00023040417,0.013740174,0.01807027],"study_design_scores_gemma":[0.95125544,0.0073618023,0.0007246095,0.000091668284,0.00046816256,0.00007882345,0.00008708313,0.00012830649,0.019842137,0.00009541482,0.01965987,0.00020669117],"about_ca_topic_score_codex":0.00012897991,"about_ca_topic_score_gemma":0.000039497994,"teacher_disagreement_score":0.019585246,"about_ca_system_score_codex":0.00029762142,"about_ca_system_score_gemma":0.00027614855,"threshold_uncertainty_score":0.6770907},"labels":[],"label_agreement":null},{"id":"W2903856391","doi":"10.1182/blood-2018-07-862151","title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Regional Development Fund; Barcelona Supercomputing Center; Instituto de Salud Carlos III; Ministerio de Economía y Competitividad; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Cyclin D1; Mantle cell lymphoma; Cyclin D2; Cancer research; Fluorescence in situ hybridization; Biology; Cyclin D; Molecular biology; Genetics; Cell cycle; Lymphoma; Gene; Immunology","score_opus":0.0064014389525026616,"score_gpt":0.2319694801515984,"score_spread":0.22556804119909574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903856391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762054,0.0039385324,0.0000038081455,0.0006414686,0.00020496383,0.0003687904,0.000009192678,0.000050231785,0.018577587],"genre_scores_gemma":[0.99662304,0.00075938803,0.000614513,0.00042716248,0.00025593495,0.000058796057,0.00001500397,0.000028094033,0.0012180392],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987288,0.00003582726,0.00029853254,0.00039357232,0.00018925448,0.0003540065],"domain_scores_gemma":[0.99931014,0.000055816723,0.00007463797,0.00036420056,0.000044528373,0.00015069555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013257707,0.00021667672,0.0003466243,0.0001091615,0.00006931858,0.000026803253,0.00007945698,0.0001284321,0.00015847907],"category_scores_gemma":[0.000026738866,0.00017768137,0.000075569085,0.00017603117,0.00008619208,0.00005309376,0.00006805985,0.000051619285,0.00040328444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00129767,0.03239903,0.74548674,0.00057231257,0.0008692318,0.0029588495,0.005269499,7.38187e-7,0.115680456,0.00053951325,0.011780624,0.083145365],"study_design_scores_gemma":[0.03279179,0.0013660385,0.4132707,0.00027929601,0.00031403484,0.00016444399,0.00027291474,0.000035297115,0.53586215,0.00014819563,0.015174675,0.00032045678],"about_ca_topic_score_codex":0.00040206307,"about_ca_topic_score_gemma":0.00008991082,"teacher_disagreement_score":0.4201817,"about_ca_system_score_codex":0.000119248965,"about_ca_system_score_gemma":0.00010367599,"threshold_uncertainty_score":0.7245636},"labels":[],"label_agreement":null},{"id":"W2903975502","doi":"10.1097/pas.0000000000001198","title":"Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Fondation ARC pour la Recherche sur le Cancer; Institut National de la Santé et de la Recherche Médicale; Achievement Rewards for College Scientists Foundation","keywords":"Immunophenotyping; Lymphoma; Pathology; B-cell lymphoma; Fluorescence in situ hybridization; Medicine; Biology; Immunology; Genetics; Gene","score_opus":0.012325437912203745,"score_gpt":0.27376649963042493,"score_spread":0.2614410617182212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903975502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929465,0.0011254986,0.00009521281,0.0039336737,0.0001300217,0.00011053976,0.000013641434,0.000015680509,0.0016292244],"genre_scores_gemma":[0.996503,0.0009802373,0.0004481482,0.0010060592,0.0008887996,0.000004183256,0.000003350389,0.000021678368,0.0001445215],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833643,0.00026463374,0.00049656373,0.00021073292,0.00028271315,0.00040891502],"domain_scores_gemma":[0.99824464,0.0004380148,0.0005346395,0.00029180723,0.00018079745,0.00031008504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006628855,0.00020488062,0.00086982665,0.00012513412,0.00014675387,0.000017031893,0.00016789281,0.000062061015,0.00006743361],"category_scores_gemma":[0.000035267058,0.00011189667,0.00020830166,0.00026472606,0.0012063886,0.00005217342,0.00009946649,0.00009573591,0.000069555026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002365919,0.002958104,0.42479163,0.000019408464,0.00042016993,0.010707333,0.001029781,1.4261181e-7,0.00059715484,0.00052113034,0.0017360921,0.55485314],"study_design_scores_gemma":[0.02147801,0.009361843,0.8500756,0.000067536035,0.0005925979,0.024431417,0.0005544979,0.000008259893,0.002169984,0.00029956625,0.09075415,0.0002065501],"about_ca_topic_score_codex":0.000032662516,"about_ca_topic_score_gemma":0.0000021628898,"teacher_disagreement_score":0.5546466,"about_ca_system_score_codex":0.00009449391,"about_ca_system_score_gemma":0.00011671231,"threshold_uncertainty_score":0.45630136},"labels":[],"label_agreement":null},{"id":"W2904214839","doi":"10.1002/cncr.31807","title":"Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma—Identification of high‐risk populations to guide surveillance: A report from the Late Effects Study Group","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Cohort; Cumulative incidence; Population; Internal medicine; Epidemiology; Cohort study; Relative risk; Incidence (geometry); Oncology; Confidence interval; Pediatrics","score_opus":0.011099456585725986,"score_gpt":0.2925987005887608,"score_spread":0.28149924400303483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904214839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955263,0.00090687204,0.0001902025,0.0002601675,0.0007227154,0.0016610264,0.0006782188,0.000028706254,0.000025758674],"genre_scores_gemma":[0.9979984,0.00028455872,0.00026376164,0.000121224024,0.00028913846,0.0007822137,0.0000955473,0.000029152758,0.00013597019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980472,0.00019229027,0.000749565,0.0004009469,0.00039580188,0.0002142278],"domain_scores_gemma":[0.9978722,0.00017525213,0.0006161015,0.00094734656,0.00028083829,0.00010826139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004796169,0.00020081662,0.00047524332,0.00006870396,0.00010582019,0.000015378762,0.000121122845,0.00006481266,0.00008212563],"category_scores_gemma":[0.0002724641,0.00012804473,0.00013891047,0.0002829881,0.00008174207,0.00004627022,0.000066642504,0.00004426424,0.000026313304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000225964,0.001084813,0.9828522,0.000016758022,0.000622237,0.00005859745,0.0022246868,0.000049839397,0.0011923459,0.000011236157,0.0011572852,0.010504035],"study_design_scores_gemma":[0.0029017243,0.00054066244,0.9747611,0.00017318745,0.0007795259,0.00001017195,0.00013217598,0.000032192947,0.020121232,0.00012225444,0.00030347487,0.00012225688],"about_ca_topic_score_codex":0.03192286,"about_ca_topic_score_gemma":0.008181495,"teacher_disagreement_score":0.023741364,"about_ca_system_score_codex":0.00030622684,"about_ca_system_score_gemma":0.00014966902,"threshold_uncertainty_score":0.97452366},"labels":[],"label_agreement":null},{"id":"W2904699949","doi":"10.1182/blood-2018-99-113368","title":"Prognostic Significance of MYC Single, Double, Triple Hit and MYC-Translocation Partner Status in Diffuse Large B-Cell Lymphoma - a Study By the Lunenburg Lymphoma Biomarker Consortium (LLBC)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Lymphoma; Tissue microarray; Cancer research; Medicine; Chromosomal translocation; Oncology; Context (archaeology); Internal medicine; Biology; B cell; Cancer; Immunology; Antibody; Gene; Germinal center; Genetics","score_opus":0.02082289218833942,"score_gpt":0.2655952379511926,"score_spread":0.2447723457628532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904699949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922998,0.0034007395,0.000014691528,0.00030833186,0.00010214542,0.002768374,0.000087941604,0.00004971963,0.0009682545],"genre_scores_gemma":[0.99842554,0.00020455659,0.00007088006,0.00015148205,0.000067841196,0.00058963406,0.00006193591,0.000040124512,0.00038799067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997724,0.00015180979,0.0006142264,0.00054522656,0.00041303,0.0005517124],"domain_scores_gemma":[0.99862105,0.00025434454,0.000230448,0.0005410279,0.00016199239,0.0001911532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003444737,0.00031753248,0.0005214333,0.00012982782,0.000130387,0.000048034333,0.00012312854,0.000114094,0.000036703488],"category_scores_gemma":[0.00006527743,0.0002175756,0.000086148306,0.0004898231,0.00026613692,0.00009802811,0.00005236817,0.000041900443,0.000015414795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001266163,0.14447668,0.82482874,0.00013530596,0.00047177126,0.00012289721,0.0032850564,8.4261146e-8,0.014231493,0.00004602011,0.0016083891,0.009527376],"study_design_scores_gemma":[0.16739036,0.0023869516,0.7528014,0.00015922106,0.0010270519,0.00004441261,0.001179989,0.00007319191,0.07115429,0.000020381987,0.0034698837,0.0002928571],"about_ca_topic_score_codex":0.00086495024,"about_ca_topic_score_gemma":0.00041170977,"teacher_disagreement_score":0.1661242,"about_ca_system_score_codex":0.00011718355,"about_ca_system_score_gemma":0.00023630612,"threshold_uncertainty_score":0.8872475},"labels":[],"label_agreement":null},{"id":"W2905334699","doi":"10.1093/oso/9780190238667.003.0040","title":"The Non-Hodgkin Lymphomas","year":2017,"lang":"en","type":"book","venue":"Oxford University Press eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Immunology; Immunodeficiency; Medicine; Immune system; Biology","score_opus":0.019949437201330352,"score_gpt":0.23260546373191932,"score_spread":0.21265602653058896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905334699","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022331646,0.00035721724,0.000006511118,0.00012890223,0.00033874757,0.0007634282,0.00008107578,0.00007733616,0.99802345],"genre_scores_gemma":[0.0013168355,0.0015609107,0.00007007718,0.00008428623,0.00026183738,0.000005525044,0.00007876603,0.000044054214,0.9965777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864197,0.000029517594,0.0001594363,0.0004379886,0.00035998452,0.00037111784],"domain_scores_gemma":[0.99786615,0.00014301446,0.00030074822,0.0013386476,0.00012405572,0.0002273856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000096397125,0.00037840274,0.00050531497,0.00007557738,0.0009105457,0.00010972076,0.00057319336,0.00038529746,0.000017820556],"category_scores_gemma":[0.000015357424,0.0002791893,0.00039858834,0.0000051978095,0.00035096923,0.00005010404,0.0003813761,0.00022855369,0.000008373002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011998686,0.00023906447,0.0005547791,0.00028673638,0.002519203,0.004810075,0.0003312048,8.098616e-7,0.000007811548,0.22602992,0.59754103,0.16647951],"study_design_scores_gemma":[0.0030931884,0.00020163898,0.00097359926,0.00035178883,0.0009200028,0.00005555896,0.000022178448,0.000013162837,0.00014583598,0.00015347115,0.99380904,0.00026055498],"about_ca_topic_score_codex":0.00013637225,"about_ca_topic_score_gemma":0.00004363362,"teacher_disagreement_score":0.396268,"about_ca_system_score_codex":0.0009260704,"about_ca_system_score_gemma":0.0009232495,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W2905649019","doi":"10.1182/blood-2018-99-114409","title":"Avadomide (CC-122), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Obinutuzumab; Diffuse large B-cell lymphoma; Oncology; Refractory (planetary science); Gastroenterology; Lenalidomide; Tolerability; Lymphoma; Adverse effect; Multiple myeloma","score_opus":0.015568378575487164,"score_gpt":0.23924584669105659,"score_spread":0.22367746811556943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905649019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971157,0.0001539234,0.000031142023,0.00008904118,0.00011907697,0.00085197116,0.000022850201,0.00008107961,0.0015352173],"genre_scores_gemma":[0.99551743,0.000015902531,0.0033832367,0.0003562641,0.00017903815,0.000108027714,0.000074440366,0.000059704365,0.00030594005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998123,0.000038170114,0.00040446152,0.0005277861,0.00045821228,0.00044838522],"domain_scores_gemma":[0.9988574,0.00007388999,0.0001799104,0.00055124186,0.00014680506,0.00019079962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113861555,0.00030778119,0.0005328649,0.0001559431,0.00011624371,0.000030538657,0.00010306796,0.00014479696,0.000045400746],"category_scores_gemma":[0.00012420565,0.00020739132,0.000101910315,0.00030800467,0.00008244351,0.00012590944,0.000065806336,0.00007914683,0.00011368521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003886386,0.24196562,0.73862255,0.00013808151,0.00084481115,0.00072539505,0.0010803291,0.0000021220865,0.00030178868,0.00007145039,0.00040670953,0.011954782],"study_design_scores_gemma":[0.44788212,0.0025133723,0.54442745,0.00048456492,0.00044769084,0.000050501294,0.000053673382,0.0001866959,0.002463124,0.0000075911903,0.0012215474,0.00026163438],"about_ca_topic_score_codex":0.0005410339,"about_ca_topic_score_gemma":0.00025040683,"teacher_disagreement_score":0.44399574,"about_ca_system_score_codex":0.0004082999,"about_ca_system_score_gemma":0.0002458942,"threshold_uncertainty_score":0.84571725},"labels":[],"label_agreement":null},{"id":"W2905757675","doi":"10.1182/blood-2018-99-118551","title":"Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase (Ph) Ib/II Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Bendamustine; Gastroenterology; Oncology; Nuclear medicine; Lymphoma","score_opus":0.01508975381121335,"score_gpt":0.2740723254785748,"score_spread":0.25898257166736144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905757675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385345,0.0007337342,0.00000519494,0.00013624092,0.00017714199,0.0020570485,0.00047119553,0.00017301487,0.0023929789],"genre_scores_gemma":[0.99698377,0.00007452674,0.00076177466,0.00020961167,0.00026459247,0.00016363418,0.0003609263,0.000116056595,0.0010650986],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99585265,0.0001835168,0.0012072305,0.001053376,0.00081214233,0.0008910985],"domain_scores_gemma":[0.99720967,0.00018240702,0.00055574183,0.001339743,0.00035112206,0.00036133904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034925865,0.0006683271,0.0013322223,0.0004212874,0.0002513307,0.00003192797,0.00031103814,0.00026589943,0.00015565881],"category_scores_gemma":[0.0002166111,0.00046882866,0.00017299016,0.0010299189,0.00021329903,0.0001752499,0.00023994572,0.0002469287,0.000090357236],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064413324,0.8732381,0.025509402,0.00028554458,0.0017323372,0.007543464,0.014950351,0.0000021185886,0.0051251766,0.00008055179,0.003937363,0.0031822848],"study_design_scores_gemma":[0.88287336,0.04862126,0.027173022,0.00055400416,0.0019490166,0.00030694337,0.0023871108,0.00026476357,0.028321749,0.000008957925,0.006909326,0.0006305054],"about_ca_topic_score_codex":0.0016532119,"about_ca_topic_score_gemma":0.0016751627,"teacher_disagreement_score":0.82461685,"about_ca_system_score_codex":0.0009014492,"about_ca_system_score_gemma":0.001571025,"threshold_uncertainty_score":0.99977636},"labels":[],"label_agreement":null},{"id":"W2906129219","doi":"10.1182/blood-2018-99-118519","title":"Venetoclax Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) Improves Outcomes in BCL2-Positive First-Line Diffuse Large B-Cell Lymphoma (DLBCL): First Safety, Efficacy and Biomarker Analyses from the Phase II CAVALLI Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"","keywords":"Medicine; Venetoclax; Rituximab; Internal medicine; CHOP; International Prognostic Index; Oncology; Population; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Cyclophosphamide; Gastroenterology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.02116876407871913,"score_gpt":0.3110601321079146,"score_spread":0.28989136802919546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906129219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706293,0.008459422,0.000014434211,0.0011410203,0.00015279329,0.0023391624,0.0005684595,0.000085752676,0.00017600543],"genre_scores_gemma":[0.99686927,0.0016317344,0.00022262648,0.00046639366,0.00020625381,0.00020144277,0.00015861157,0.0000642008,0.00017944402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970796,0.00013561896,0.00077448983,0.0009623872,0.0004236671,0.00062422716],"domain_scores_gemma":[0.99743533,0.0010627775,0.0002598331,0.00079357735,0.00013994877,0.00030855907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002962831,0.0006245297,0.001171668,0.00015334325,0.0007925237,0.000093970215,0.00020760692,0.0001710322,0.000041846182],"category_scores_gemma":[0.00027290807,0.0004019276,0.00014659086,0.00036162342,0.0003708342,0.00013136455,0.0004862424,0.00013005981,0.000018375522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068712025,0.2075983,0.7562961,0.00011512311,0.0036208187,0.0013996077,0.007422175,0.0000021675344,0.0034105899,0.000014592782,0.0004593246,0.012789982],"study_design_scores_gemma":[0.2681646,0.004988217,0.7177274,0.00020829965,0.0021831586,0.00004357303,0.0003916204,0.00046807012,0.004925771,0.00001785327,0.0005498297,0.00033158823],"about_ca_topic_score_codex":0.009821859,"about_ca_topic_score_gemma":0.005263792,"teacher_disagreement_score":0.2612934,"about_ca_system_score_codex":0.00033730373,"about_ca_system_score_gemma":0.00017223704,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W2906135263","doi":"10.1182/blood-2018-99-116845","title":"No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Diffuse large B-cell lymphoma; Medicine; Lymphoma; CHOP; Internal medicine; Phases of clinical research; Oncology; Chemotherapy","score_opus":0.011417399477641605,"score_gpt":0.24798358695039535,"score_spread":0.23656618747275374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906135263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958355,0.00013398964,3.044555e-7,0.00010268858,0.00013632936,0.0012007797,0.0009072268,0.000021409956,0.0016618073],"genre_scores_gemma":[0.99878734,0.00004635816,0.00012416736,0.000060715454,0.00008524946,0.00008015491,0.0006786388,0.000022891572,0.00011450495],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833435,0.00005633716,0.000564318,0.00035848503,0.0004645602,0.00022197478],"domain_scores_gemma":[0.99838495,0.0003063082,0.00032298043,0.0005400085,0.00036523913,0.00008051719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012469648,0.00022379923,0.00048813038,0.000082388186,0.000049086648,0.000015736514,0.00023300077,0.00006386622,0.00009135239],"category_scores_gemma":[0.00012569127,0.00013436752,0.00007697697,0.00015430983,0.000088116576,0.00007068054,0.00010209766,0.000045201763,0.000023148996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044121165,0.3988747,0.54755265,0.000020763164,0.0015701046,0.00008325433,0.0053917863,2.1417854e-7,0.0001842805,0.00002849463,0.0006460503,0.001526531],"study_design_scores_gemma":[0.6674765,0.010254139,0.31139383,0.00021002068,0.00081546203,9.806583e-7,0.00038067042,0.00004406185,0.008980198,0.00000868225,0.00031884908,0.00011664157],"about_ca_topic_score_codex":0.002655843,"about_ca_topic_score_gemma":0.0019744644,"teacher_disagreement_score":0.6233553,"about_ca_system_score_codex":0.000097113254,"about_ca_system_score_gemma":0.00008504592,"threshold_uncertainty_score":0.54793483},"labels":[],"label_agreement":null},{"id":"W2906562397","doi":"10.1182/blood-2018-99-115930","title":"Minimal Residual Disease Response at End of Induction and during Maintenance Correlates with Updated Outcome in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-Based Immunochemotherapy in Previously Untreated Follicular Lymphoma Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Obinutuzumab; Follicular lymphoma; Minimal residual disease; Internal medicine; Bendamustine; Rituximab; Oncology; Alemtuzumab; Maintenance therapy; Induction chemotherapy; Hazard ratio; Chemotherapy regimen; Chemotherapy; Surgery; Immunology; Lymphoma; Bone marrow; Confidence interval; Transplantation","score_opus":0.011792630741376752,"score_gpt":0.26488086493538404,"score_spread":0.2530882341940073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906562397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788654,0.00019553285,2.5475703e-7,0.000072410636,0.00001988209,0.0017702421,0.000034472334,0.000014759298,0.0000059177587],"genre_scores_gemma":[0.9996011,0.000024126857,0.000055425433,0.000044953245,0.000012669259,0.00013585128,0.000065705004,0.000022488952,0.00003763123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983198,0.00024367077,0.00053935027,0.00033445354,0.00032028498,0.00024246388],"domain_scores_gemma":[0.9990209,0.00012406618,0.00024614204,0.00040531336,0.00012862735,0.000074986296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026459518,0.00022393953,0.00048121417,0.00018639865,0.00006259097,0.000010011188,0.00008908825,0.00006252296,0.000023930781],"category_scores_gemma":[0.00009567241,0.00012803008,0.00004237368,0.0003887468,0.00017747073,0.00006232903,0.000030776806,0.000050714236,0.0000013281036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09748954,0.0243054,0.8721743,0.00005947895,0.00021324132,0.00047224373,0.0028548064,0.0000037392704,0.0022420215,9.261159e-7,0.00000905909,0.00017519105],"study_design_scores_gemma":[0.18756531,0.0077748024,0.7844918,0.00030046617,0.00037209256,0.000025535812,0.00061133556,0.000035399113,0.018713392,9.274386e-7,0.0000051355237,0.00010383572],"about_ca_topic_score_codex":0.0005340956,"about_ca_topic_score_gemma":0.00036394494,"teacher_disagreement_score":0.090075776,"about_ca_system_score_codex":0.00026076884,"about_ca_system_score_gemma":0.00021199477,"threshold_uncertainty_score":0.5220915},"labels":[],"label_agreement":null},{"id":"W2907100365","doi":"10.1182/blood-2018-99-112067","title":"Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Internal medicine; Nivolumab; Oncology; Clinical endpoint; Transplantation; Refractory (planetary science); Brentuximab vedotin; Phases of clinical research; Surgery; Lymphoma; Toxicity; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.02067717367996881,"score_gpt":0.281082601874021,"score_spread":0.2604054281940522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907100365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961198,0.00030410642,0.000079511,0.00024653756,0.00044441546,0.0021614956,0.000102556645,0.00009631943,0.000445261],"genre_scores_gemma":[0.9973638,0.00003223893,0.000597099,0.00017749211,0.00016504187,0.0005547091,0.000037368747,0.000057936242,0.0010142903],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979786,0.00012053075,0.00058752426,0.0005040346,0.00041549033,0.0003937937],"domain_scores_gemma":[0.9985914,0.00018789199,0.00025941225,0.00064839807,0.00016868256,0.00014420989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018679335,0.00032280985,0.0005925111,0.00009082663,0.00015059712,0.000025638055,0.00016821698,0.00018060119,0.00016935272],"category_scores_gemma":[0.00007200194,0.0001982548,0.00030656974,0.00021088467,0.0001866727,0.000078193254,0.000035666526,0.000072413524,0.000025703368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07839602,0.5569861,0.053759284,0.0029401171,0.004221178,0.0032313915,0.03199382,0.0000010975205,0.1626495,0.00022336986,0.0039504897,0.10164766],"study_design_scores_gemma":[0.2402114,0.043464243,0.18172677,0.00053081027,0.0074248016,0.0005623927,0.0010062616,0.00013535186,0.52163726,0.00013456048,0.0026151326,0.00055103435],"about_ca_topic_score_codex":0.000048637707,"about_ca_topic_score_gemma":0.00012897822,"teacher_disagreement_score":0.51352185,"about_ca_system_score_codex":0.0001455804,"about_ca_system_score_gemma":0.00025459178,"threshold_uncertainty_score":0.8084596},"labels":[],"label_agreement":null},{"id":"W2907119357","doi":"10.1182/blood-2018-99-117636","title":"New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Oncology; International Prognostic Index; Internal medicine; Medicine; CHOP; Lymphoma; Concordance; Biology; Cancer research; Immunology; B cell; Germinal center","score_opus":0.014994731413112701,"score_gpt":0.2550936897779762,"score_spread":0.2400989583648635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907119357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985994,0.00003228884,0.00019784797,0.00003856279,0.000027722223,0.00065472984,0.00008726058,0.000044338936,0.0003178584],"genre_scores_gemma":[0.99509126,0.000012318592,0.0043909424,0.00012964035,0.00007109313,0.000027645467,0.0001299963,0.00003599871,0.00011109756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875236,0.000038797236,0.00031244435,0.00039932,0.00021049392,0.00028655992],"domain_scores_gemma":[0.9991619,0.00008350218,0.00008372697,0.00025124566,0.00008920208,0.00033040225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070974456,0.00023527694,0.00038036084,0.00009706255,0.0000713817,0.000030187224,0.0000546692,0.00008148891,0.0000113098695],"category_scores_gemma":[0.000036567584,0.00014232774,0.000044134013,0.0001382285,0.00004313857,0.00007007279,0.000041136736,0.00005708883,0.000009243406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051342696,0.009565975,0.98808,0.00000777582,0.00016325474,0.000025562993,0.0006125466,0.0000053229373,0.00006015735,0.000012519835,0.00003681022,0.0009166073],"study_design_scores_gemma":[0.07866862,0.0030749647,0.9161244,0.000082009625,0.00036752358,0.0000038940007,0.0000642727,0.00054377393,0.00089496665,0.000007100195,0.000017240682,0.00015121688],"about_ca_topic_score_codex":0.00054948864,"about_ca_topic_score_gemma":0.0006757496,"teacher_disagreement_score":0.07815519,"about_ca_system_score_codex":0.00009397253,"about_ca_system_score_gemma":0.00021045333,"threshold_uncertainty_score":0.5803957},"labels":[],"label_agreement":null},{"id":"W2907456071","doi":"10.1016/j.leukres.2019.01.002","title":"Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"Université de Montréal; Hoechst Marion Roussel","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Population; Context (archaeology); Lymphoma; Hematopoietic cell; Oncology; Surgery; Stem cell; Haematopoiesis","score_opus":0.018073278266295643,"score_gpt":0.2787530836565074,"score_spread":0.2606798053902118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907456071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996922,0.00024121879,0.000007543923,0.0001575083,0.000021116146,0.002224104,0.00009034526,0.000017246952,0.00031891261],"genre_scores_gemma":[0.99858993,0.000024169023,0.00012796686,0.00004547839,0.00000915905,0.00018218269,0.00010012797,0.000031061794,0.000889923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982372,0.00008814247,0.00028253844,0.00041432198,0.00051677966,0.0004610501],"domain_scores_gemma":[0.99863255,0.0004281358,0.00005721048,0.00030163684,0.000356324,0.00022416415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002098475,0.00017758223,0.00045936013,0.00018492996,0.000046006928,0.000014978154,0.00007774239,0.000098622055,0.000021879756],"category_scores_gemma":[0.000013492623,0.0001250059,0.000053085663,0.00026753577,0.000101146456,0.00005006152,0.0000366607,0.00010902421,0.0000146130915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024107771,0.0015116162,0.9900572,0.0018225978,0.00004255805,0.0001665459,0.0019042592,0.000006322384,0.00040520186,0.000035009587,0.00012180685,0.0015161503],"study_design_scores_gemma":[0.028434247,0.000872749,0.94269824,0.0003606724,0.000079543635,0.000007900358,0.00027867302,0.0005768316,0.026489142,0.000024478837,0.000034572215,0.00014294012],"about_ca_topic_score_codex":0.00023808907,"about_ca_topic_score_gemma":0.000027508848,"teacher_disagreement_score":0.047358904,"about_ca_system_score_codex":0.0006983461,"about_ca_system_score_gemma":0.00057675893,"threshold_uncertainty_score":0.50975925},"labels":[],"label_agreement":null},{"id":"W2907712464","doi":"10.1182/blood-2018-99-117672","title":"Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Blockade; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.02823176709554303,"score_gpt":0.28415972426768377,"score_spread":0.25592795717214073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907712464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688215,0.0013168496,0.000006954566,0.005119051,0.00022657705,0.00083764654,0.0000139099,0.00015989813,0.0054369923],"genre_scores_gemma":[0.9915667,0.0008336659,0.0013684203,0.0042381925,0.0009623967,0.00013862463,0.000015374271,0.000052317006,0.0008242812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983536,0.000054119126,0.00029443362,0.0004735821,0.00036307113,0.00046119222],"domain_scores_gemma":[0.9987415,0.00005148938,0.00006856353,0.00064207346,0.00015538416,0.00034099704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001703234,0.0003011568,0.0004023501,0.00010926134,0.00011858613,0.000041758733,0.00010727854,0.00011580509,0.00035658354],"category_scores_gemma":[0.000026125712,0.00021370182,0.00020238331,0.00024297857,0.00008915291,0.000035894143,0.000040037383,0.00004412601,0.000790287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00264943,0.022453513,0.2092517,0.000040072246,0.0030636396,0.0024223416,0.0045320517,0.0000012679291,0.4297258,0.00084217533,0.0085772965,0.31644073],"study_design_scores_gemma":[0.016903007,0.002439973,0.26410428,0.0000644069,0.00009452297,0.00037400317,0.000055977383,0.000004607082,0.6662885,0.00006091398,0.04938181,0.00022797109],"about_ca_topic_score_codex":0.00032560597,"about_ca_topic_score_gemma":0.000028322613,"teacher_disagreement_score":0.31621274,"about_ca_system_score_codex":0.00013084404,"about_ca_system_score_gemma":0.00016011835,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2908171531","doi":"10.3324/haematol.2018.209031","title":"Convergence of risk prediction models in follicular lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Follicular lymphoma; Lymphoma; Internal medicine; Medicine; Oncology; Follicular phase","score_opus":0.024587332290219584,"score_gpt":0.24158274211294123,"score_spread":0.21699540982272164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908171531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87005115,0.006498161,0.00018660497,0.10842739,0.0011777056,0.0029588714,0.00073534873,0.00020630324,0.00975845],"genre_scores_gemma":[0.9268378,0.0025507133,0.00050925894,0.06861453,0.00024294003,0.00023536422,0.00060296006,0.000040754338,0.00036566972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802315,0.00011645844,0.00059530605,0.00052259327,0.00041713184,0.00032535163],"domain_scores_gemma":[0.99858195,0.0002612325,0.0003852014,0.0006407334,0.00008970098,0.000041202624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001249987,0.0003231548,0.0011715454,0.0002001361,0.000025692845,0.0000074314585,0.00014103825,0.0009212374,0.00018415938],"category_scores_gemma":[0.00009009559,0.00022994856,0.00030552575,0.00018263834,0.00008070621,0.000056119283,0.000060625756,0.00029559873,0.00015735158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016528103,0.000750634,0.19980904,0.0009744812,0.00041604505,0.0065867635,0.00021399188,0.00010729148,0.000009256395,0.0004157326,0.78893656,0.0016148885],"study_design_scores_gemma":[0.025016095,0.002748831,0.41281492,0.0058482066,0.0035609656,0.0040637855,0.00018213115,0.01129489,0.004993677,0.008790679,0.5190074,0.0016784668],"about_ca_topic_score_codex":0.00038451512,"about_ca_topic_score_gemma":0.0000068408176,"teacher_disagreement_score":0.26992923,"about_ca_system_score_codex":0.0001924961,"about_ca_system_score_gemma":0.00014480532,"threshold_uncertainty_score":0.9377031},"labels":[],"label_agreement":null},{"id":"W2908320450","doi":"10.1200/jco.2014.32.15_suppl.8585","title":"Mantle cell lymphoma: Toll-like receptors (TLRs) and B-cell receptor (BCR) gene expression analysis for identification of a distinct BCR-activated subset, with germinal center signature and indolent biology.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"breakpoint cluster region; Germinal center; Mantle cell lymphoma; B-cell receptor; Cancer research; B cell; Biology; Gene expression profiling; Syk; Medicine; Gene expression; Gene; Immunology; Receptor; Lymphoma; Internal medicine; Genetics; Tyrosine kinase; Antibody","score_opus":0.03338232921223511,"score_gpt":0.3595329396474885,"score_spread":0.3261506104352534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908320450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969691,0.00059152505,0.00093201885,0.0006074501,0.0004469184,0.00032689268,0.00003234005,0.000006082847,0.00008764326],"genre_scores_gemma":[0.99422354,0.0007737363,0.0042859265,0.00020946309,0.00028195253,0.000018346576,0.00007095154,0.000016331058,0.00011978528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973063,0.00038478838,0.0015637625,0.00033938518,0.00020284465,0.00020290798],"domain_scores_gemma":[0.995607,0.001400759,0.0021343064,0.00020441186,0.0003560541,0.00029747933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001391255,0.00019652644,0.0013917481,0.00021050301,0.00006047347,0.000011486503,0.000095147574,0.0004351031,0.000038596194],"category_scores_gemma":[0.00035856597,0.0001186577,0.00032833894,0.00017711267,0.0002267567,0.00007925059,0.000046568664,0.00021224603,0.0000015126144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010735191,0.008172249,0.8423659,0.00015978666,0.0011428072,0.000042796903,0.0002177988,0.0000071252575,0.07631096,0.000010015522,0.001956313,0.058879018],"study_design_scores_gemma":[0.045276146,0.019154819,0.74273473,0.00021326017,0.004044982,0.00014149382,0.0002555633,0.00025194164,0.15962768,0.000053194024,0.027979612,0.00026661198],"about_ca_topic_score_codex":0.000013732624,"about_ca_topic_score_gemma":0.0000149037205,"teacher_disagreement_score":0.09963123,"about_ca_system_score_codex":0.00011986794,"about_ca_system_score_gemma":0.00022939473,"threshold_uncertainty_score":0.48387206},"labels":[],"label_agreement":null},{"id":"W2908539961","doi":"10.1182/blood-2018-99-110473","title":"Recurrent IL4R Somatic Mutations in Diffuse Large B-Cell Lymphoma Lead to an Altered Gene Expression Profile and Changes in Tumor Microenvironment Composition","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Biology; Cancer research; Diffuse large B-cell lymphoma; Janus kinase; JAK-STAT signaling pathway; Lymphoma; Tumor microenvironment; STAT protein; Signal transduction; STAT3; Immunology; Cell biology; Tyrosine kinase","score_opus":0.013576140935969242,"score_gpt":0.2542137003401468,"score_spread":0.24063755940417755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908539961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981513,0.0003911088,0.0000107856695,0.00034926774,0.000051730833,0.0009095238,0.000055979082,0.000020271702,0.0000600575],"genre_scores_gemma":[0.9958255,0.00006617437,0.0031637722,0.00025444868,0.000087563574,0.00038346282,0.00017907872,0.000016879656,0.000023116949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990679,0.000058889207,0.00019984116,0.00030202596,0.00013452375,0.00023680643],"domain_scores_gemma":[0.99956614,0.000022117007,0.00005507164,0.0002119828,0.000012115355,0.00013258413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000696528,0.0001434584,0.00021255173,0.00014569552,0.000059118236,0.000017383352,0.000040145005,0.00003699125,0.000031224557],"category_scores_gemma":[0.000006212458,0.000121241166,0.00002038736,0.00008406294,0.000028752298,0.0000535249,0.000051045794,0.000028148186,0.00005402438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021299359,0.06966421,0.16163054,0.00016200803,0.000025712083,0.00019844138,0.00512099,4.7265576e-7,0.7573069,0.000006620999,0.00011779578,0.0055533685],"study_design_scores_gemma":[0.023612112,0.001083353,0.36360595,0.0003254369,0.0000646495,0.00004040007,0.00022817381,0.00014682888,0.61069703,0.000009698098,0.00007795973,0.00010840327],"about_ca_topic_score_codex":0.00004269996,"about_ca_topic_score_gemma":0.00025413412,"teacher_disagreement_score":0.2019754,"about_ca_system_score_codex":0.00012906721,"about_ca_system_score_gemma":0.00002076416,"threshold_uncertainty_score":0.49440712},"labels":[],"label_agreement":null},{"id":"W2908656034","doi":"10.1182/blood-2018-99-113247","title":"The Prognostic Impact of Baseline Positron Emission Tomography (PET) Imaging in Untreated High Risk (HR) Follicular Lymphoma (FL): Analysis from E2408, the Bortezomib Induction or Novel Imid® Continuation (BIONIC) Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Positron emission tomography; Follicular lymphoma; Bendamustine; Context (archaeology); Progression-free survival; Nuclear medicine; Log-rank test; Surgery; Survival analysis; Lymphoma; Overall survival","score_opus":0.009055247994627667,"score_gpt":0.2662754435938216,"score_spread":0.25722019559919396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908656034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395925,0.0041942867,0.000054881577,0.00013643522,0.000055832155,0.0014776897,0.00006542719,0.00004457124,0.000011598738],"genre_scores_gemma":[0.9981702,0.0011269639,0.00017318604,0.000015758294,0.00012841598,0.00013945813,0.00021422557,0.00002390528,0.000007860197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979227,0.00031708454,0.0006305866,0.0004430174,0.00038958748,0.00029703375],"domain_scores_gemma":[0.9980169,0.00053786486,0.00043985614,0.0006447127,0.0002580066,0.00010269197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062968524,0.0002912591,0.0005637296,0.00033480933,0.00027783314,0.000072681316,0.00015183468,0.000060731756,0.000043371674],"category_scores_gemma":[0.0003306219,0.00013336739,0.00040628656,0.0017840909,0.00011144455,0.00010750724,0.000055116772,0.000081817794,0.0000053241456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006092435,0.006635722,0.95629233,0.000005774501,0.0039696964,0.0000541526,0.00047807122,0.000013713072,0.0018192512,0.0000029000446,0.0000192333,0.03009994],"study_design_scores_gemma":[0.012953742,0.0012493773,0.9645933,0.00015852858,0.013952848,0.000027687092,0.00049079675,0.0014736318,0.0049200524,0.000017221002,0.000024531297,0.00013831878],"about_ca_topic_score_codex":0.020124018,"about_ca_topic_score_gemma":0.0013632075,"teacher_disagreement_score":0.029961621,"about_ca_system_score_codex":0.00018599207,"about_ca_system_score_gemma":0.00017577618,"threshold_uncertainty_score":0.9864011},"labels":[],"label_agreement":null},{"id":"W2908676058","doi":"10.1182/blood-2018-99-112069","title":"Nivolumab Combined with Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Preliminary Results from the Phase 2 CheckMate 436 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; CD30; Oncology; Internal medicine; Lymphoma; Population; Cancer research; Immunology; Immunotherapy; Cancer","score_opus":0.015925346957359265,"score_gpt":0.25692168728656334,"score_spread":0.24099634032920408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908676058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074936,0.00097436615,0.000039766383,0.000995479,0.00056172884,0.0026796097,0.0010944324,0.00014443,0.0027608054],"genre_scores_gemma":[0.99308497,0.00008052282,0.0014169936,0.0006951758,0.001771848,0.00050885236,0.0017060254,0.00007683679,0.0006587985],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99745727,0.00010884583,0.0006113254,0.00069491036,0.00053383864,0.00059384305],"domain_scores_gemma":[0.9974223,0.0008764258,0.00037434266,0.00086234993,0.00021709944,0.00024748003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040924986,0.00040554858,0.0006252686,0.00006163748,0.00034255622,0.00005260413,0.0002512862,0.00017634958,0.000060792197],"category_scores_gemma":[0.00024248874,0.00024817762,0.0002269125,0.00017097352,0.00020865405,0.000115199015,0.00010656578,0.00012213805,0.00009995451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81224984,0.13588212,0.0016430333,0.00012609761,0.001129249,0.0005244172,0.002006916,1.4859577e-7,0.001378695,0.000059756374,0.032983366,0.0120163355],"study_design_scores_gemma":[0.88986623,0.056137387,0.016171945,0.0002883948,0.0023533127,0.00007308325,0.00018295055,0.000084793406,0.017736485,0.000036370708,0.016753342,0.000315685],"about_ca_topic_score_codex":0.00014655312,"about_ca_topic_score_gemma":0.000045161996,"teacher_disagreement_score":0.07974474,"about_ca_system_score_codex":0.00016312678,"about_ca_system_score_gemma":0.0006197988,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2909334052","doi":"10.1200/jco.18.00766","title":"Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Cilag; National Cancer Institute; Pharmacyclics; Genentech; Servier; Incyte; Celgene; LAM Therapeutics; Adaptive Biotechnologies; Astex Pharmaceuticals; Regeneron Pharmaceuticals; Janssen Pharmaceuticals; Kite Pharma; Gilead Sciences; Bristol-Myers Squibb; AstraZeneca; Takeda Oncology; Amgen; Pfizer","keywords":"Medicine; Nivolumab; Cohort; Internal medicine; Refractory (planetary science); Transplantation; Surgery; Adverse effect; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Cancer; Immunotherapy","score_opus":0.07914781576734928,"score_gpt":0.4257238446997092,"score_spread":0.34657602893235995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909334052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950873,0.00014174901,0.0001237168,0.0006695402,0.001421113,0.0022727498,0.000047597732,0.000014675947,0.00022153021],"genre_scores_gemma":[0.99594855,0.00013854662,0.0020896813,0.0008709481,0.00032072898,0.00010428223,0.000035682322,0.000033061024,0.00045849502],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99618196,0.00024651192,0.0025318272,0.00033950317,0.00031230046,0.00038791506],"domain_scores_gemma":[0.9940827,0.0035210024,0.0014630572,0.00022819868,0.0004304396,0.00027459487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583478,0.00022337881,0.0017838632,0.00022895528,0.00008355767,0.000013654044,0.00015754031,0.0003807417,0.0000696894],"category_scores_gemma":[0.0012458132,0.00014922873,0.0005376448,0.00013838321,0.000042541553,0.00017437435,0.000033499775,0.00023839773,0.000010880496],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06389696,0.43220052,0.40863237,0.0001455779,0.00036765102,0.0005509694,0.00089055975,0.00000323753,0.0000447575,0.000012570146,0.0015987424,0.09165609],"study_design_scores_gemma":[0.46124384,0.2834924,0.23568879,0.00014599136,0.00082161574,0.00004428047,0.00034972225,0.00016483363,0.000096627096,0.00003371333,0.017779186,0.00013903347],"about_ca_topic_score_codex":0.000015996298,"about_ca_topic_score_gemma":0.00012738013,"teacher_disagreement_score":0.39734688,"about_ca_system_score_codex":0.0005440255,"about_ca_system_score_gemma":0.0011897687,"threshold_uncertainty_score":0.6085371},"labels":[],"label_agreement":null},{"id":"W2909637775","doi":"10.1182/blood-2018-99-114371","title":"Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Plerixafor; Bendamustine; Mantle cell lymphoma; Internal medicine; Rituximab; Univariate analysis; Apheresis; Surgery; Population; Oncology; Lymphoma; CXCR4; Multivariate analysis","score_opus":0.004469381499133683,"score_gpt":0.18556027031006475,"score_spread":0.18109088881093108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909637775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737054,0.00017322859,9.768382e-7,0.000016851858,0.00013664128,0.0009593014,0.00007591811,0.000016665714,0.0012498497],"genre_scores_gemma":[0.9991292,0.000010267551,0.00005316031,0.000079445825,0.000031449366,0.000052691383,0.00006154821,0.000026597274,0.0005556466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869835,0.000058880458,0.00027060296,0.00028836148,0.0004225073,0.00026129445],"domain_scores_gemma":[0.99918026,0.00005860631,0.0002051398,0.00031112158,0.00014988368,0.00009499615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051531253,0.00013529976,0.00034983712,0.0000289779,0.000100768826,0.000034099998,0.00010486602,0.000069821224,0.000066052155],"category_scores_gemma":[0.000010556383,0.00013263564,0.00004713189,0.00029164765,0.000093597366,0.00005305221,0.00005046534,0.000049907754,0.0000032279377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005160493,0.0048543434,0.9898205,0.00013960412,0.000044787226,0.00003414485,0.00021178863,0.000012800798,0.00005634855,3.7090157e-7,0.0031944888,0.0015792525],"study_design_scores_gemma":[0.018120749,0.00087270106,0.96189797,0.0004007392,0.00026423324,0.0000060625694,0.0002333202,0.00010363616,0.01745324,5.265899e-7,0.0005163191,0.00013052158],"about_ca_topic_score_codex":0.7141932,"about_ca_topic_score_gemma":0.96279705,"teacher_disagreement_score":0.24860382,"about_ca_system_score_codex":0.00023817527,"about_ca_system_score_gemma":0.00043898745,"threshold_uncertainty_score":0.54087245},"labels":[],"label_agreement":null},{"id":"W2909767830","doi":"10.5430/jst.v9n1p7","title":"Prognostic significance of CXCR4 and mTOR expression in diffuse large B-cell lymphoma patients","year":2019,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CXCR4; Diffuse large B-cell lymphoma; Medicine; PI3K/AKT/mTOR pathway; Lymphoma; Internal medicine; Lactate dehydrogenase; Immunohistochemistry; Oncology; Discovery and development of mTOR inhibitors; Receptor; Chemokine; Biology; Apoptosis","score_opus":0.006551780461767403,"score_gpt":0.23791790667818666,"score_spread":0.23136612621641925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909767830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871916,0.0005216025,0.0000030596361,0.00006393134,0.00012622117,0.000339864,0.000013411305,0.0000031206923,0.00020962696],"genre_scores_gemma":[0.99939156,0.00013556662,0.00025138614,0.00006841324,0.000042724758,0.000006615216,0.0000028653967,0.000013385585,0.000087508524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988574,0.000035128895,0.0004941114,0.00012151015,0.0003116134,0.00018027949],"domain_scores_gemma":[0.99907357,0.0001045216,0.00043479976,0.00012460838,0.00012565717,0.00013683851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014061414,0.00011903108,0.0004396776,0.00014324821,0.000015519458,0.000006707021,0.000059820028,0.000044949473,0.000025344369],"category_scores_gemma":[0.00008059488,0.00008072148,0.00008324272,0.000095467345,0.000024006491,0.00010404019,0.000032310407,0.00006423641,0.000009078889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002912673,0.009924622,0.9819968,0.00016439415,0.000021244818,0.00017159435,0.0003798715,0.000002130062,0.0058720354,0.000005077554,0.00024639763,0.00092461455],"study_design_scores_gemma":[0.028526817,0.0013310254,0.92185855,0.0009718714,0.000056810477,0.000045265962,0.00017745126,0.00003824365,0.046695914,0.000020664293,0.0002031622,0.0000742182],"about_ca_topic_score_codex":0.000007919968,"about_ca_topic_score_gemma":0.0000012767978,"teacher_disagreement_score":0.060138192,"about_ca_system_score_codex":0.00010774942,"about_ca_system_score_gemma":0.00010846671,"threshold_uncertainty_score":0.32917267},"labels":[],"label_agreement":null},{"id":"W2910069319","doi":"10.1182/blood.v130.suppl_1.734.734","title":"A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; Radiation therapy; Stage (stratigraphy); Oncology; Chemotherapy; Lymphoma; Internal medicine; Hodgkin lymphoma; Dacarbazine; Chemotherapy regimen; Biology","score_opus":0.01568668766621641,"score_gpt":0.2655099403892108,"score_spread":0.24982325272299435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910069319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948212,0.0031685454,0.000003999573,0.00019138459,0.00008073057,0.0012471974,0.0000827547,0.000037038644,0.0003671738],"genre_scores_gemma":[0.9966942,0.002019529,0.00029679787,0.00012813145,0.00006015129,0.00011783692,0.000016796643,0.000053056945,0.00061351137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998269,0.0001100653,0.00041437973,0.0005141901,0.0003368565,0.0003555071],"domain_scores_gemma":[0.9984105,0.00009470076,0.00037788437,0.00089631253,0.00005466581,0.00016590254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003015411,0.0003085914,0.00073897024,0.00013460853,0.0001821145,0.00009579593,0.0001933918,0.00006599332,0.000045696564],"category_scores_gemma":[0.00005174826,0.00025809451,0.00008062193,0.000117937954,0.00010079112,0.00014452665,0.00005583237,0.00008916564,0.0000069374814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095158775,0.028988281,0.95491385,0.000040881867,0.00064630865,0.00013420808,0.0015979395,6.999342e-7,0.006067521,0.000008169205,0.00062796584,0.006022604],"study_design_scores_gemma":[0.104805216,0.010261352,0.87348765,0.000119773686,0.00028656132,0.000009021929,0.00019302273,0.00003332691,0.009649503,0.000014896102,0.0009276614,0.00021202634],"about_ca_topic_score_codex":0.016441254,"about_ca_topic_score_gemma":0.002417846,"teacher_disagreement_score":0.10385363,"about_ca_system_score_codex":0.000100744524,"about_ca_system_score_gemma":0.00010664734,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2910162610","doi":"10.23937/2469-5807/1510082","title":"Biological Role of Transcription Factor Twist1 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"International Journal of Pathology and Clinical Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Fondation ARC pour la Recherche sur le Cancer; Institut Carnot Santé Animale; Institut National de la Santé et de la Recherche Médicale","keywords":"Immunohistochemistry; Lymphoma; Pathology; Follicular lymphoma; Stromal cell; Diffuse large B-cell lymphoma; Lymph; Biology; Polymerase chain reaction; Real-time polymerase chain reaction; Medicine; Gene","score_opus":0.09174168101353276,"score_gpt":0.44357398857836544,"score_spread":0.3518323075648327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910162610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965653,0.001832827,0.000026765914,0.0009463432,0.0001889703,0.000107766085,0.000020742302,0.0000026135178,0.00030866326],"genre_scores_gemma":[0.9948711,0.0044037397,0.00023478718,0.0001847429,0.00025359384,0.000003854946,0.000004634929,0.000005502886,0.000038046248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814564,0.00037631512,0.00066038093,0.00020104952,0.00041378295,0.00020285578],"domain_scores_gemma":[0.9982817,0.00071782334,0.0001529111,0.00009502419,0.00058929203,0.00016323256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016420743,0.00008763547,0.0003599061,0.00024504267,0.00003589902,0.0000142760955,0.00013806582,0.00021730046,0.00005751756],"category_scores_gemma":[0.0008154351,0.000058692225,0.00013718953,0.00008549627,0.00054192625,0.00006381204,0.00007864974,0.0001639289,0.000007934102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002530102,0.01233465,0.8787864,0.000011632014,0.00016669773,0.002330665,0.000426201,1.6865423e-8,0.009797412,0.0011596398,0.00005579615,0.09240079],"study_design_scores_gemma":[0.024125192,0.003392262,0.9631753,0.00010256368,0.000027094473,0.0008379516,0.00027463658,0.000051215095,0.0038480742,0.0015883476,0.00252694,0.000050439845],"about_ca_topic_score_codex":0.000024357021,"about_ca_topic_score_gemma":0.00003134212,"teacher_disagreement_score":0.09235035,"about_ca_system_score_codex":0.00007547063,"about_ca_system_score_gemma":0.00013418347,"threshold_uncertainty_score":0.23933995},"labels":[],"label_agreement":null},{"id":"W2910201624","doi":"10.1111/bjh.15734","title":"Mature B‐<scp>NHL</scp> in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Clinical trial; Oncology; Chemotherapy; Immunotherapy; Internal medicine; Disease; Intensive care medicine; Cancer","score_opus":0.02410139797830113,"score_gpt":0.30930287162341014,"score_spread":0.285201473645109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910201624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06577402,0.93261576,0.0000058278383,0.0000164509,0.00029672548,0.0011231211,0.000045956076,0.0000105461995,0.000111568035],"genre_scores_gemma":[0.036881793,0.9626423,0.00011066613,0.000022633732,0.00013330599,0.000053575543,0.00007673425,0.0000503313,0.000028658156],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.997643,0.00023423239,0.001016003,0.00045132713,0.00024388915,0.00041156588],"domain_scores_gemma":[0.99865395,0.00009074044,0.00078259566,0.00019369571,0.00008625893,0.00019275682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016601002,0.0005034986,0.0033081777,0.00035064775,0.000061461156,0.000118395736,0.00012420958,0.00036896943,0.00000387988],"category_scores_gemma":[0.00003390132,0.00038882688,0.000384611,0.00015254485,0.000111865134,0.00013383654,0.000058945385,0.00055370765,0.000004314372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001963225,0.0011049516,0.026707755,0.012365221,0.00089916633,0.0047408952,0.00024949282,2.5488654e-7,4.6689802e-8,0.00006717854,0.00012663443,0.9537188],"study_design_scores_gemma":[0.0083362,0.00078576244,0.038638216,0.09557129,0.004535308,0.75047266,0.00056180806,0.0000071399663,7.9318824e-7,0.000051363582,0.100804865,0.00023456653],"about_ca_topic_score_codex":0.00012583991,"about_ca_topic_score_gemma":0.000037782473,"teacher_disagreement_score":0.9534842,"about_ca_system_score_codex":0.0002648478,"about_ca_system_score_gemma":0.0005206484,"threshold_uncertainty_score":0.99985635},"labels":[],"label_agreement":null},{"id":"W2910240398","doi":"10.1182/blood-2018-99-117251","title":"Prolonged Overall Survival (OS) in a Subset of Responders to the Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL): Results of an International Multi- Center Phase I/II Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Bendamustine; Refractory (planetary science); Population; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Surgery; Hodgkin lymphoma; Rituximab","score_opus":0.021566203594226972,"score_gpt":0.2996807255284848,"score_spread":0.27811452193425784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910240398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853253,0.000016591903,0.0000013027227,0.00019046458,0.00005623021,0.0008569491,0.00029164934,0.000008174801,0.00004608517],"genre_scores_gemma":[0.9991967,0.000012913537,0.00035903262,0.000042906173,0.000013273035,0.00005800717,0.00028107796,0.000013760568,0.00002230461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850476,0.00013875008,0.00052750757,0.00030524892,0.00036300858,0.00016070686],"domain_scores_gemma":[0.9990009,0.00009813973,0.0002731408,0.00029172108,0.00026551346,0.0000706018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002521611,0.00015264389,0.0003383038,0.0002394081,0.000027332097,0.000005859682,0.00011474236,0.00006195587,0.0000116515275],"category_scores_gemma":[0.00027478658,0.00009644472,0.000028330625,0.00027810605,0.00013572324,0.00013034279,0.000053251864,0.00004412902,3.7886178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0468021,0.057179164,0.8777481,0.000036944468,0.0001190362,0.00004449354,0.009812623,0.0000020602824,0.0030481177,0.000011893651,0.000024023424,0.0051714666],"study_design_scores_gemma":[0.15055686,0.010890341,0.81498855,0.0003080044,0.00004782973,0.000005665746,0.00028254825,0.00015952585,0.022638325,0.000001076466,0.00004496077,0.000076286124],"about_ca_topic_score_codex":0.000985069,"about_ca_topic_score_gemma":0.0019232255,"teacher_disagreement_score":0.10375477,"about_ca_system_score_codex":0.000090581176,"about_ca_system_score_gemma":0.00008922281,"threshold_uncertainty_score":0.39329016},"labels":[],"label_agreement":null},{"id":"W2910383185","doi":"10.1080/10428194.2018.1563691","title":"Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis","year":2019,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; University of Calgary; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Oncology; Autologous stem-cell transplantation; Lymphoma; Randomized controlled trial; Transplantation; Aggressive lymphoma; Randomization; Subgroup analysis; Gastroenterology; Surgery; Rituximab; Confidence interval","score_opus":0.005829918759344031,"score_gpt":0.24275891050548834,"score_spread":0.23692899174614432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910383185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883006,0.0013724476,0.0011371141,0.00015771635,0.0011743454,0.004441647,0.00048061847,0.00034801447,0.0025874458],"genre_scores_gemma":[0.98803777,0.0032263955,0.0015224459,0.0009613399,0.00052396173,0.0013930134,0.0025063439,0.0001786727,0.0016500893],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99348044,0.00031667828,0.0017034776,0.00213651,0.0009829815,0.0013798797],"domain_scores_gemma":[0.99469423,0.0011880597,0.0016141806,0.0013299292,0.00040853565,0.0007650588],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00064681435,0.0013063999,0.002399559,0.0010796691,0.000578095,0.0003121347,0.00044820204,0.0010375006,0.0002414064],"category_scores_gemma":[0.0001970436,0.0011584125,0.0012341293,0.0013594194,0.0003193808,0.0005508823,0.00013467782,0.00014450704,0.0003843659],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21123803,0.0071643456,0.16803783,0.003215681,0.016358562,0.003690101,0.00778397,0.0008157162,0.0076442957,0.005189372,0.005728289,0.5631338],"study_design_scores_gemma":[0.5569246,0.008766156,0.33770716,0.00078714965,0.01920746,0.001718618,0.0010849627,0.017509762,0.048867084,0.0010989258,0.0040054526,0.002322721],"about_ca_topic_score_codex":0.0077759516,"about_ca_topic_score_gemma":0.00031139315,"teacher_disagreement_score":0.5608111,"about_ca_system_score_codex":0.007706749,"about_ca_system_score_gemma":0.0033533107,"threshold_uncertainty_score":0.99996877},"labels":[],"label_agreement":null},{"id":"W2910474565","doi":"10.1182/blood-2018-99-114097","title":"Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; BC Cancer Agency; CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Stage (stratigraphy); Positron emission tomography; Radiation therapy; Lymphoma; Rituximab; Watchful waiting; Radiology; Nuclear medicine; Oncology; Internal medicine; Cancer; Prostate cancer","score_opus":0.021450753864987127,"score_gpt":0.3060370750388127,"score_spread":0.2845863211738256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910474565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996742,0.00026843807,5.028501e-7,0.0016297144,0.00008364411,0.00078860985,0.00021465591,0.000010233563,0.00026221073],"genre_scores_gemma":[0.9991569,0.00008334061,0.00023595712,0.00025554808,0.00006836273,0.00007003996,0.000024978344,0.000012400083,0.000092467584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855924,0.00014417247,0.00034428164,0.00028172732,0.00051307725,0.00015753148],"domain_scores_gemma":[0.9989052,0.0001632388,0.00018444854,0.00048767673,0.00020521926,0.000054256467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003118683,0.00017773635,0.00036029302,0.00003264875,0.00009337378,0.000029378927,0.00026195383,0.000014874873,0.000048913193],"category_scores_gemma":[0.00009258447,0.00009604531,0.000059605656,0.00021362948,0.00018517648,0.00011094425,0.00007834204,0.000037618945,0.0000024339827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010835228,0.0076921275,0.9820148,0.000007560113,0.0007627358,0.0003513067,0.0066729095,5.7602574e-7,0.00018432591,0.0002787753,0.00009536821,0.0018311663],"study_design_scores_gemma":[0.013459269,0.0013346813,0.96783435,0.000077879056,0.0003041057,0.00002412257,0.009304547,0.000013684335,0.00639476,0.000040411982,0.0011245133,0.00008765594],"about_ca_topic_score_codex":0.0023363167,"about_ca_topic_score_gemma":0.0009093721,"teacher_disagreement_score":0.0141804265,"about_ca_system_score_codex":0.0000649511,"about_ca_system_score_gemma":0.00015985561,"threshold_uncertainty_score":0.3916614},"labels":[],"label_agreement":null},{"id":"W2910789228","doi":"10.4251/wjgo.v11.i1.59","title":"Gut-associated lymphoid tissue or so-called “dome” carcinoma of the colon: Review","year":2019,"lang":"en","type":"article","venue":"World Journal of Gastrointestinal Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pathology; Medicine; Desmoplasia; Germinal center; Lymphatic system; Asymptomatic; Immunohistochemistry; Immunology; B cell","score_opus":0.019127565582199413,"score_gpt":0.310061754487307,"score_spread":0.2909341889051076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910789228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96170396,0.00826332,0.000017677197,0.021418028,0.00067290245,0.0010782994,0.000009758883,0.000014644636,0.0068214256],"genre_scores_gemma":[0.98981726,0.0007699955,0.0028742768,0.0027182791,0.0001643644,0.00001152683,0.0000036535184,0.000023151764,0.003617469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762666,0.00029257502,0.0010908536,0.0001827358,0.0004601783,0.0003470182],"domain_scores_gemma":[0.9966168,0.0007017543,0.0015037811,0.00031947088,0.00064433774,0.00021386248],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007070365,0.00022854531,0.0013085818,0.00016046896,0.00006134008,0.000008742432,0.00028665512,0.000052670788,0.0013660529],"category_scores_gemma":[0.00086142076,0.00012412593,0.00038475933,0.000490628,0.0001735587,0.000055118384,0.000095423544,0.00030027534,0.00006312822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002938947,0.0029308475,0.94407433,0.0006312414,0.00035808425,0.0028059436,0.00008292674,0.00000826994,0.0088461265,0.00026211882,0.025365552,0.011695593],"study_design_scores_gemma":[0.017968021,0.021206884,0.79595125,0.014160893,0.0015511205,0.0640822,0.00010074883,0.000019970812,0.0012571338,0.000058474612,0.08345041,0.00019293459],"about_ca_topic_score_codex":0.0000431063,"about_ca_topic_score_gemma":0.00017111373,"teacher_disagreement_score":0.14812313,"about_ca_system_score_codex":0.0010162563,"about_ca_system_score_gemma":0.0018454453,"threshold_uncertainty_score":0.9995468},"labels":[],"label_agreement":null},{"id":"W2910821381","doi":"10.1038/s41467-018-08105-w","title":"Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility","year":2019,"lang":"en","type":"erratum","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"Medical Research Council; Cancer Research UK","keywords":"Spelling; Key (lock); Genome-wide association study; Computational biology; Association (psychology); Genome; Lymphoma; Disease; Computer science; Genetics; Biology; Medicine; Single-nucleotide polymorphism; Gene; Internal medicine; Genotype; Psychology; Linguistics; Philosophy; Computer security","score_opus":0.02060319209738305,"score_gpt":0.31302374879335876,"score_spread":0.2924205566959757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910821381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87953585,0.03624085,0.000006569483,0.020911898,0.03561259,0.0073839347,0.0011288581,0.00028342774,0.01889599],"genre_scores_gemma":[0.89870906,0.0009415999,0.00010978662,0.000121135236,0.00024687982,0.00017829245,0.0026179652,0.00004956524,0.09702569],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965756,0.0005978046,0.0010042114,0.00053859997,0.0010282047,0.00025556533],"domain_scores_gemma":[0.9910424,0.0014850167,0.0013129066,0.0047556143,0.0011994764,0.00020463827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006032831,0.00038867327,0.0011330142,0.00033399803,0.00021503876,0.000035632358,0.00082998234,0.0011814601,0.00007516709],"category_scores_gemma":[0.002725536,0.0003466402,0.00048985676,0.0006213356,0.00018259275,0.0000982706,0.0005112216,0.0011329178,0.000027083612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014726218,0.0066304626,0.46605402,0.00017331885,0.0008048826,0.0000028564373,0.0005645315,0.0000027104861,0.000009928717,0.000099544246,0.5251147,0.00039572208],"study_design_scores_gemma":[0.0017831364,0.00045331995,0.83225495,0.00032630554,0.0018024691,0.0000011301371,0.0005932299,0.000066011264,0.00003192489,0.00004190033,0.1624469,0.0001987414],"about_ca_topic_score_codex":0.00021859453,"about_ca_topic_score_gemma":0.0019552216,"teacher_disagreement_score":0.3662009,"about_ca_system_score_codex":0.0017607736,"about_ca_system_score_gemma":0.0011103649,"threshold_uncertainty_score":0.99989855},"labels":[],"label_agreement":null},{"id":"W2910893459","doi":"10.1158/1078-0432.ccr-18-2435","title":"Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Seattle Genetics; Takeda Oncology; Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Chemotherapy; Stage (stratigraphy); Oncology; Lymphoma; Internal medicine; Hodgkin lymphoma; Biology","score_opus":0.10157173452621963,"score_gpt":0.4519525788486962,"score_spread":0.35038084432247657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910893459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312806,0.00049849204,0.0000028330041,0.002910955,0.00015864644,0.0020430125,0.000034517918,0.00005720744,0.0011662539],"genre_scores_gemma":[0.9892487,0.0041629947,0.0002098298,0.0015610282,0.00037594818,0.0006371791,0.000036979134,0.00007733804,0.0036900265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956858,0.00041270285,0.0007098716,0.0009805424,0.0011868617,0.0010242031],"domain_scores_gemma":[0.9960841,0.002004022,0.00017389297,0.00090505916,0.00028619435,0.00054672797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011487041,0.0003092531,0.0011035334,0.0002632662,0.00008764718,0.000067291134,0.0003334742,0.00012382942,0.0011153216],"category_scores_gemma":[0.00030363924,0.00019818563,0.00017390552,0.0016776329,0.0006064898,0.00009486029,0.0001339398,0.00051265064,0.0002829284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014844126,0.0023374748,0.8278401,0.00008754152,0.00017574732,0.0010161548,0.0003092595,0.000023801509,0.000015182132,0.00001884908,0.0018943916,0.15143737],"study_design_scores_gemma":[0.05769704,0.0060188514,0.9196406,0.000252753,0.000032250173,0.000009174149,0.00042241852,0.00026030574,0.00033418598,0.0000029242117,0.015088581,0.00024094031],"about_ca_topic_score_codex":0.015485543,"about_ca_topic_score_gemma":0.038362157,"teacher_disagreement_score":0.15119644,"about_ca_system_score_codex":0.0013402706,"about_ca_system_score_gemma":0.0030369554,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W2911608346","doi":"10.1182/blood-2018-99-118063","title":"PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"STAT6; Biology; Mutant; Follicular lymphoma; Gene; Molecular biology; Cancer research; Lymphoma; Cell biology; Genetics; Transcription factor; Immunology","score_opus":0.018019898871330316,"score_gpt":0.2642321548697092,"score_spread":0.24621225599837887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911608346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949425,0.00120934,0.00004288683,0.0008906737,0.00009062082,0.00048250292,0.0000229762,0.000045864672,0.0022726539],"genre_scores_gemma":[0.996227,0.00008889627,0.0012090654,0.001996172,0.00015800433,0.00011355343,0.000013982887,0.000024583725,0.00016873634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989193,0.000016885642,0.00021810085,0.00029930656,0.00023122324,0.00031516232],"domain_scores_gemma":[0.9993966,0.00003203865,0.000048467544,0.00034868674,0.000055728626,0.00011846373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085551466,0.00017099932,0.00028052487,0.00007658161,0.00004736677,0.00001708781,0.00006817807,0.00007848727,0.00033093538],"category_scores_gemma":[0.000014498761,0.00012647256,0.00010173007,0.00018150586,0.000060683575,0.000040047988,0.00002912831,0.00003098467,0.00024858382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007465346,0.033238485,0.90566075,0.00010042606,0.0017133815,0.0013624568,0.0037894475,8.250355e-7,0.033156067,0.0018911144,0.0012385221,0.017101998],"study_design_scores_gemma":[0.07415288,0.0016653552,0.63698775,0.00018802872,0.0006011144,0.000324639,0.00015875489,0.00019772166,0.24741633,0.00051576574,0.037459075,0.00033257777],"about_ca_topic_score_codex":0.00020527471,"about_ca_topic_score_gemma":0.000021952597,"teacher_disagreement_score":0.26867297,"about_ca_system_score_codex":0.00008728431,"about_ca_system_score_gemma":0.00013878242,"threshold_uncertainty_score":0.51574016},"labels":[],"label_agreement":null},{"id":"W2911905058","doi":"10.1182/blood-2018-99-114182","title":"Single-Cell Profiling Reveals Distinct Tumor Subtypes and Their Associated T-Cell Environments in Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Mass cytometry; Germinal center; Follicular lymphoma; Tumor microenvironment; Lymphoma; Malignancy; Phenotype; Cancer research; B cell; Immune system; Computational biology; Pathology; Immunology; Medicine; Genetics; Antibody; Gene","score_opus":0.011840313258328905,"score_gpt":0.21159649058641491,"score_spread":0.199756177328086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911905058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489534,0.0012754995,0.0000024326962,0.00006916366,0.00004430095,0.0004600796,0.000022119382,0.00003123998,0.0031997978],"genre_scores_gemma":[0.99887645,0.000044028566,0.00026150627,0.00016260527,0.00008157649,0.00005055939,0.00004907318,0.000028490163,0.0004457368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888587,0.000057109784,0.00024881036,0.00035234998,0.00015426075,0.00030158256],"domain_scores_gemma":[0.999429,0.00008179982,0.00011097521,0.00023859015,0.000017934055,0.00012172599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015758983,0.0002058368,0.00033074003,0.000060189137,0.000072211245,0.000022365455,0.000055177876,0.000077264944,0.000027700282],"category_scores_gemma":[0.00006503817,0.000151805,0.00006700252,0.000112946625,0.0000613028,0.0000420971,0.000055200264,0.00003859619,0.00005395048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004441667,0.0072617442,0.90504247,0.0000422629,0.00009191972,0.0002226441,0.00023366722,6.3713195e-8,0.08605606,0.000008280954,0.000058938458,0.00093752815],"study_design_scores_gemma":[0.011161107,0.000718861,0.47558087,0.00013029709,0.00019792705,0.00003452892,0.000078192956,0.00002240814,0.51131415,0.00005192152,0.0005552298,0.0001544872],"about_ca_topic_score_codex":0.00005961173,"about_ca_topic_score_gemma":0.000022389704,"teacher_disagreement_score":0.4294616,"about_ca_system_score_codex":0.00013729365,"about_ca_system_score_gemma":0.0000372471,"threshold_uncertainty_score":0.6190428},"labels":[],"label_agreement":null},{"id":"W2911906784","doi":"10.1182/blood-2018-99-114913","title":"Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Bendamustine; Obinutuzumab; CHOP; Lymphoma; Surgery; Oncology","score_opus":0.010191179172773545,"score_gpt":0.2654772174291932,"score_spread":0.25528603825641966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911906784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429005,0.0018108716,0.000009266801,0.00033638402,0.000022596776,0.002766808,0.00063983374,0.000028198792,0.00009599093],"genre_scores_gemma":[0.99810237,0.00040824266,0.00080030516,0.00014650765,0.00005280455,0.00017170435,0.00023076686,0.000034883094,0.00005243533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99677557,0.0009900003,0.00087429077,0.00054363743,0.00043926248,0.00037721824],"domain_scores_gemma":[0.9966294,0.0017199592,0.0006130386,0.0006511654,0.00018754558,0.00019886522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019920198,0.0004184171,0.001656368,0.00013230885,0.0001173757,0.00005736093,0.00008651761,0.00013967926,0.000016144822],"category_scores_gemma":[0.00037427072,0.00020693445,0.00014400312,0.00028098686,0.0003366859,0.000087655106,0.000049369166,0.00005124923,0.0000010839788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7326199,0.0427272,0.21284744,0.000034335786,0.0016478831,0.00024887314,0.0014926484,2.5228807e-8,0.0071022906,0.0000071982677,0.000048936137,0.0012233194],"study_design_scores_gemma":[0.5697763,0.0022928196,0.40810347,0.00022011592,0.0013446643,0.000021897775,0.00010582661,0.0000248721,0.01791063,0.0000052163477,0.000048968624,0.00014519643],"about_ca_topic_score_codex":0.0023531038,"about_ca_topic_score_gemma":0.00017633257,"teacher_disagreement_score":0.19525604,"about_ca_system_score_codex":0.00011512525,"about_ca_system_score_gemma":0.00028133485,"threshold_uncertainty_score":0.8438542},"labels":[],"label_agreement":null},{"id":"W2912499188","doi":"10.1182/blood-2018-99-111047","title":"Validation of a Simplified International Prognostic Score (IPS-3) in Patients with Advanced Stage Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Internal medicine; Oncology; Chemotherapy regimen; Hazard ratio; Progression-free survival; Proportional hazards model; B symptoms; Cancer; Surgery; Lymphoma; Chemotherapy; Confidence interval; Vincristine; Cyclophosphamide","score_opus":0.010763282935626627,"score_gpt":0.24672947740824483,"score_spread":0.2359661944726182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912499188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998297,0.000020114312,0.000009892769,0.000059627087,0.000064806845,0.0005465131,0.000030827625,0.000019297353,0.0009519648],"genre_scores_gemma":[0.99882823,0.0000043162877,0.00079623755,0.00005406501,0.000042418844,0.00006122099,0.0001495773,0.0000124966655,0.000051437157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992086,0.000014816516,0.00019755597,0.00018676158,0.00026641204,0.0001258086],"domain_scores_gemma":[0.99946284,0.000031821255,0.00010650096,0.00016729945,0.0001825537,0.000048996575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044468918,0.00010042832,0.0001673532,0.0001005339,0.000017390097,0.000008216922,0.000055028282,0.00003571527,0.000057187615],"category_scores_gemma":[0.0000788721,0.000074147436,0.000028220544,0.00014071612,0.000039923358,0.00007417271,0.000024127961,0.000018330053,0.00001432873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045024717,0.004160575,0.986562,0.000026200372,0.000110391586,0.000017295237,0.00018765226,0.0000021514634,0.00026732555,0.00008168334,0.000015318334,0.008119127],"study_design_scores_gemma":[0.021333998,0.0016476952,0.9339539,0.0002151381,0.000097985954,0.0000030786719,0.000037919723,0.0000090314325,0.04252696,0.000016256889,0.00008861107,0.000069462665],"about_ca_topic_score_codex":0.000024962854,"about_ca_topic_score_gemma":0.000013007566,"teacher_disagreement_score":0.05260817,"about_ca_system_score_codex":0.00006533626,"about_ca_system_score_gemma":0.00007586233,"threshold_uncertainty_score":0.30236447},"labels":[],"label_agreement":null},{"id":"W2912753039","doi":"10.14309/00000434-201710001-01577","title":"A Case of Colonic ALK-Positive Anaplastic Large Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Gastroenterology; Vincristine; Internal medicine; CHOP; Anaplastic lymphoma kinase; Diffuse large B-cell lymphoma; T-cell lymphoma; Pathology; Chemotherapy; Pleural effusion","score_opus":0.009647565862738773,"score_gpt":0.2724417303125516,"score_spread":0.2627941644498128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912753039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969906,0.000108450506,0.00012270338,0.0022862689,0.00013626454,0.00011380859,0.000027501972,0.000002999391,0.00021137917],"genre_scores_gemma":[0.9986301,0.00011174547,0.00031860734,0.00079208525,0.0001030279,0.000004156383,0.0000012241394,0.00001239215,0.00002663033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988982,0.00016003576,0.0003813353,0.00011290009,0.00013980601,0.00030769443],"domain_scores_gemma":[0.9976173,0.00014959779,0.0014994591,0.00041135526,0.00017395591,0.00014831492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027131292,0.00013666874,0.0007067491,0.000091674105,0.00016187203,0.00001395225,0.00023725734,0.000020612768,0.000022604156],"category_scores_gemma":[0.000067711066,0.00008176116,0.000225796,0.000038743037,0.00061517674,0.00005303331,0.000088182525,0.00009679555,0.0000070127703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046313908,0.0053985976,0.8936043,0.00003673895,0.0017509795,0.037420668,0.0013918577,0.000014572116,0.00096419296,0.00009981542,0.0013936656,0.011610707],"study_design_scores_gemma":[0.01789303,0.06575312,0.811262,0.000109008935,0.0010353118,0.10103036,0.0008650107,0.00008636672,0.001641564,0.000037956826,0.0002205104,0.00006575131],"about_ca_topic_score_codex":0.0001547791,"about_ca_topic_score_gemma":0.0001021999,"teacher_disagreement_score":0.08234228,"about_ca_system_score_codex":0.00008091084,"about_ca_system_score_gemma":0.000101152546,"threshold_uncertainty_score":0.33341232},"labels":[],"label_agreement":null},{"id":"W2912934187","doi":"10.1182/blood-2018-99-114484","title":"Results of the Primary Analysis of Complement A+B: A Phase III Study of Ofatumumab in Combination with Bendamustine Versus Bendamustine Alone in Patients with Indolent Non-Hodgkin's Lymphoma That Is Unresponsive Following Rituximab or Rituximab-Containing Regimen","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Bendamustine; Medicine; Ofatumumab; Rituximab; Regimen; Internal medicine; Phases of clinical research; Gastroenterology; Clinical endpoint; Lymphoma; Surgery; Chemotherapy; Clinical trial","score_opus":0.02245756639100244,"score_gpt":0.2913779166618864,"score_spread":0.26892035027088396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912934187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970068,0.00005332939,0.0000073263163,0.00009870466,0.000054937547,0.0024003596,0.00018390974,0.000010933237,0.00018372518],"genre_scores_gemma":[0.9990376,0.0000061050696,0.00050975126,0.00005077113,0.000012665198,0.00011265493,0.00023004966,0.00002834983,0.000012055538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968214,0.00018331695,0.0010405226,0.00053991086,0.0010711721,0.00034366234],"domain_scores_gemma":[0.99741846,0.0003484356,0.0009591419,0.00075127865,0.0004387631,0.00008388911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004899926,0.0003430504,0.0015063698,0.00079700776,0.00007644696,0.000009772951,0.0002058141,0.00007363996,0.000017810426],"category_scores_gemma":[0.00011386331,0.00021103442,0.00016330513,0.0020032402,0.00014943746,0.00011433573,0.0001605804,0.00009375384,4.2934167e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11343155,0.11028772,0.75490487,0.00009210504,0.0062412685,0.00013476818,0.011688967,0.00002381153,0.00014460381,0.000007093731,0.000019822302,0.0030234281],"study_design_scores_gemma":[0.39244178,0.022849083,0.5687622,0.0006410067,0.005062003,0.000001652962,0.0026566458,0.00010930831,0.007343748,6.3534907e-7,0.0000047988888,0.00012714101],"about_ca_topic_score_codex":0.0026107258,"about_ca_topic_score_gemma":0.0035890401,"teacher_disagreement_score":0.27901024,"about_ca_system_score_codex":0.0003414093,"about_ca_system_score_gemma":0.00034613904,"threshold_uncertainty_score":0.8605734},"labels":[],"label_agreement":null},{"id":"W2913179347","doi":"10.1016/j.ijrobp.2019.02.001","title":"The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","year":2019,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radiation oncology; Medicine; Medical physics; Lymphoma; Radiation therapy; Radiation treatment planning; Image-guided radiation therapy; Clinical Practice; Oncology; Radiology; Internal medicine; Family medicine","score_opus":0.08255142012749436,"score_gpt":0.40705650731410153,"score_spread":0.3245050871866072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913179347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0080800215,0.9669222,0.0020777916,0.008706918,0.010577297,0.002584921,0.0008886194,0.000036091755,0.00012609163],"genre_scores_gemma":[0.005952509,0.9815774,0.0026997656,0.0016147229,0.0056218724,0.00031603634,0.0020702903,0.000090457615,0.00005697863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947105,0.0007186873,0.0029515193,0.00055497687,0.00064982113,0.00041447286],"domain_scores_gemma":[0.9852585,0.0073979436,0.00515511,0.00046643143,0.0015993478,0.00012262378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016738119,0.0006008708,0.0019448341,0.00037950464,0.00015516783,0.00014183481,0.0011891386,0.00061782764,0.00003654578],"category_scores_gemma":[0.0016062115,0.00037096604,0.0012969897,0.00029764228,0.00028279642,0.0005084205,0.00015033963,0.00034575857,0.000022717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086194155,0.0010927105,0.024052922,0.00005041,0.0023946676,0.000029517169,0.00023318925,0.00017876587,0.000018635497,0.002858896,0.006900259,0.9613281],"study_design_scores_gemma":[0.014550435,0.0009841438,0.0081041185,0.0008862099,0.0009509538,0.00022503428,0.000075765536,0.0027270885,0.00005581448,0.0010007372,0.9701538,0.00028591065],"about_ca_topic_score_codex":0.00022848303,"about_ca_topic_score_gemma":0.00002573923,"teacher_disagreement_score":0.96325356,"about_ca_system_score_codex":0.004706667,"about_ca_system_score_gemma":0.003158239,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2913684592","doi":"10.1182/blood-2018-99-117235","title":"Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"","keywords":"Bendamustine; Medicine; Follicular lymphoma; Internal medicine; Rituximab; Lymphoma; Oncology; Nuclear medicine","score_opus":0.010318130048000295,"score_gpt":0.2672494228489772,"score_spread":0.2569312928009769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913684592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962759,0.0006923922,0.000023510136,0.00045363602,0.000041170526,0.0023631535,0.00007596741,0.000042989846,0.000031263335],"genre_scores_gemma":[0.9979595,0.0005294402,0.00025514732,0.0006554148,0.00006302478,0.0002889765,0.00014868355,0.000043596843,0.00005621309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781483,0.00015928678,0.0005573003,0.0005370216,0.0004939478,0.00043763782],"domain_scores_gemma":[0.9987398,0.00018479786,0.00018404557,0.0005928445,0.00018584795,0.00011266586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043948862,0.0003979138,0.0008575343,0.00030148262,0.00011053736,0.00004604339,0.00017573754,0.000046473255,0.000024198165],"category_scores_gemma":[0.00020269537,0.00021837793,0.00009578112,0.000849504,0.00012394262,0.000100395686,0.00004795418,0.000081013,0.000008186289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013406657,0.036984608,0.9576363,0.0000200781,0.0005813774,0.0008491413,0.00085703644,6.787953e-7,0.00033746104,0.0000030072104,0.00003096788,0.0013586917],"study_design_scores_gemma":[0.1363096,0.005551727,0.85233194,0.00010436358,0.0006938705,0.00007211405,0.0002635789,0.00035602722,0.0038152565,0.0000014877337,0.00029707333,0.0002029862],"about_ca_topic_score_codex":0.0012582497,"about_ca_topic_score_gemma":0.0005770517,"teacher_disagreement_score":0.13496894,"about_ca_system_score_codex":0.00007918106,"about_ca_system_score_gemma":0.00008494638,"threshold_uncertainty_score":0.8905194},"labels":[],"label_agreement":null},{"id":"W2913987637","doi":"10.1200/jco.18.00915","title":"DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; McGill University","funders":"Verastem Oncology","keywords":"Medicine; Internal medicine; Refractory (planetary science); Neutropenia; Tolerability; Rituximab; Adverse effect; Lymphoma; Gastroenterology; Nausea; Oncology; Surgery; Chemotherapy","score_opus":0.04454469984713691,"score_gpt":0.4284871544306216,"score_spread":0.38394245458348464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913987637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687576,0.00008915374,0.0000020478767,0.00043526836,0.0007609208,0.00084623223,0.0000049762243,0.0000040533905,0.0009815666],"genre_scores_gemma":[0.9986864,0.000089996036,0.00034462812,0.0005749844,0.00018767577,0.000011423297,0.0000045574884,0.000019932468,0.00008040371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579614,0.00034099136,0.0026892638,0.00026381642,0.0006615297,0.00024825518],"domain_scores_gemma":[0.99555266,0.0010482802,0.0022464471,0.0003426114,0.0004949244,0.00031508468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015332849,0.00019707334,0.002074997,0.0002503086,0.000024455612,0.0000045524175,0.00017016107,0.00028001412,0.00014157382],"category_scores_gemma":[0.0005660027,0.000118914606,0.00028733493,0.00020244076,0.00008742577,0.00012896708,0.00009193931,0.0003845569,0.000019134044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017837515,0.117370434,0.72459716,0.000019673682,0.00050385616,0.0004921565,0.0005186934,0.000009377929,0.00000822459,0.0000039874376,0.0003571791,0.13828173],"study_design_scores_gemma":[0.13513392,0.21662168,0.64505327,0.0001843674,0.00028006654,0.000020177735,0.00033498215,0.000020367084,0.000018263103,0.0000056337662,0.0022559802,0.00007128847],"about_ca_topic_score_codex":0.0000928511,"about_ca_topic_score_gemma":0.00010592304,"teacher_disagreement_score":0.13821045,"about_ca_system_score_codex":0.0005007269,"about_ca_system_score_gemma":0.0013965749,"threshold_uncertainty_score":0.4849197},"labels":[],"label_agreement":null},{"id":"W2914020209","doi":"10.1182/blood-2018-99-116715","title":"Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Bendamustine; Regimen; Population; Clinical endpoint; Adverse effect; Rituximab; Phases of clinical research; Oncology; Salvage therapy; Neutropenia; Refractory (planetary science); Lymphoma; Gastroenterology; Surgery; Chemotherapy; Clinical trial","score_opus":0.010597715923788036,"score_gpt":0.24323089587957988,"score_spread":0.23263317995579186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914020209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960361,0.000053123887,0.0000019399063,0.00008904255,0.000047292135,0.0033572216,0.0000610635,0.000046597343,0.0003076318],"genre_scores_gemma":[0.9982371,0.000018038887,0.0003195757,0.0002547906,0.00008031895,0.0007581208,0.00008117158,0.000042850104,0.00020804642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846786,0.000102050115,0.00029123004,0.00041335518,0.00040510308,0.0003203723],"domain_scores_gemma":[0.99869645,0.00027829863,0.00018632032,0.00058825646,0.00015805644,0.00009263143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014891595,0.0002935007,0.00045627536,0.00009972209,0.00014192931,0.00003030088,0.00013531494,0.00006948018,0.00002859094],"category_scores_gemma":[0.00005069648,0.00012288848,0.000056999314,0.00024506447,0.000086341395,0.00006902895,0.000024089259,0.00006195964,0.000025347115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031178654,0.050806627,0.94159836,0.000022673907,0.00044832495,0.00012403143,0.0014004341,2.531755e-7,0.000002820613,0.0000038682438,0.00022028812,0.0022544318],"study_design_scores_gemma":[0.13584252,0.03609377,0.82475084,0.00007993065,0.001219381,0.000006959658,0.0006543069,0.000001590904,0.0008478575,0.0000016404723,0.00034781525,0.00015339002],"about_ca_topic_score_codex":0.00087075913,"about_ca_topic_score_gemma":0.00090408284,"teacher_disagreement_score":0.13272464,"about_ca_system_score_codex":0.00014973152,"about_ca_system_score_gemma":0.00017137371,"threshold_uncertainty_score":0.5011247},"labels":[],"label_agreement":null},{"id":"W2914598974","doi":"10.1182/blood-2018-08-864728","title":"Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital","funders":"","keywords":"Nucleolus; Burkitt's lymphoma; Bone marrow; Lymphoma; Presentation (obstetrics); Pathology; Medicine; Bone marrow aspirate; Chromatin; Biology; Radiology; Genetics","score_opus":0.008771280507293519,"score_gpt":0.2435758252875199,"score_spread":0.2348045447802264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914598974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997718,0.000060030663,0.0000028965935,0.000091981194,0.00005184287,0.0005331162,0.0000057199545,0.00001629058,0.0015201288],"genre_scores_gemma":[0.9993515,0.0000108118575,0.00029588392,0.000084759304,0.000022142141,0.000048724803,0.00008994987,0.000010805657,0.000085428765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992721,0.000028602455,0.00018289078,0.00017743796,0.00022587941,0.00011305274],"domain_scores_gemma":[0.9995762,0.000023620232,0.00007983728,0.00020176517,0.00006429055,0.000054246837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035631765,0.00009029759,0.00017118272,0.00007877281,0.000012026934,0.000008982978,0.000027272672,0.000044672957,0.00003858496],"category_scores_gemma":[0.000005278683,0.000066536515,0.000027032625,0.00012542441,0.00001522925,0.00011290385,0.000008841694,0.000018684314,0.000015418134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023581262,0.005222122,0.9693978,0.00005391989,0.00008267283,0.000039904033,0.0013865753,0.00002719266,0.003354362,0.00016330092,0.00005407842,0.019982275],"study_design_scores_gemma":[0.013505468,0.0054106736,0.91795784,0.0001128312,0.00013763884,0.000031877058,0.0004727158,0.00009434246,0.06200869,0.000013237253,0.0001711377,0.00008356654],"about_ca_topic_score_codex":0.00024740782,"about_ca_topic_score_gemma":0.00017414184,"teacher_disagreement_score":0.05865433,"about_ca_system_score_codex":0.000044274653,"about_ca_system_score_gemma":0.00008140351,"threshold_uncertainty_score":0.27132803},"labels":[],"label_agreement":null},{"id":"W2915036163","doi":"10.1182/blood-2018-99-115539","title":"Gemcitabine, Dexamethasone, Cisplatin +/- Rituximab (GDP +/- R) Is Highly Effective As a Mobilization Regimen in Relapsed or Refractory Lymphoma (COLLYM STUDY)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Plerixafor; Rituximab; Regimen; Internal medicine; Gemcitabine; Chemotherapy regimen; Autologous stem-cell transplantation; Cyclophosphamide; Surgery; Oncology; Transplantation; Gastroenterology; Urology; Chemotherapy; Lymphoma","score_opus":0.013147775919567123,"score_gpt":0.28851874612038403,"score_spread":0.2753709702008169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915036163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040836,0.000461529,0.000008170265,0.00028404227,0.0001873522,0.003370596,0.00001992472,0.00013482863,0.0051251776],"genre_scores_gemma":[0.9955321,0.00007191752,0.0008323891,0.00065166637,0.00025317373,0.001026576,0.000025832129,0.00007055096,0.0015358052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973732,0.00024682286,0.00055301015,0.0008205259,0.00053784717,0.00046856597],"domain_scores_gemma":[0.99807996,0.0004573907,0.00021738216,0.0007821026,0.0002470517,0.00021613046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004054943,0.00040207835,0.0007391595,0.00033945203,0.00014426987,0.00004510814,0.00014761808,0.0002320774,0.00037328622],"category_scores_gemma":[0.00054541044,0.0003058243,0.00012879375,0.00089660607,0.00011569163,0.00014522245,0.000092277965,0.00010939513,0.00048040162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063258447,0.09046573,0.83027226,0.00019177454,0.0016251544,0.002695338,0.009293955,0.000001558236,0.0033029425,0.00019664326,0.004068371,0.051560413],"study_design_scores_gemma":[0.110890776,0.016215745,0.8338889,0.00040673223,0.0011610206,0.00018450728,0.00101201,0.00010924317,0.03333045,0.00011511147,0.0022291634,0.00045635272],"about_ca_topic_score_codex":0.0011906562,"about_ca_topic_score_gemma":0.0005346095,"teacher_disagreement_score":0.104564935,"about_ca_system_score_codex":0.0004923123,"about_ca_system_score_gemma":0.00037907524,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W2915039250","doi":"10.4045/tidsskr.18.0608","title":"Screening for tarmkreft har effekt, men bare for menn","year":2018,"lang":"no","type":"article","venue":"Tidsskrift for Den norske legeforening","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Magnus Chemicals (Canada)","funders":"","keywords":"Psychology","score_opus":0.035873904789361366,"score_gpt":0.32536633041627516,"score_spread":0.2894924256269138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915039250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4450533,0.02231812,0.40957466,0.013465093,0.012190944,0.061016805,0.013042553,0.0018543741,0.021484166],"genre_scores_gemma":[0.85618293,0.00010228398,0.112536184,0.0011583855,0.009926102,0.00669345,0.0025760364,0.0005071072,0.010317502],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938971,0.000080831975,0.001381773,0.0016585444,0.000671079,0.0023106695],"domain_scores_gemma":[0.9950625,0.0017192713,0.00047544876,0.0010845008,0.0008975543,0.00076073286],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0013580355,0.0011748285,0.0016987827,0.00041286784,0.0016163087,0.0002830432,0.0006210728,0.00064547954,0.00041789786],"category_scores_gemma":[0.00061407016,0.0010273715,0.0013398643,0.0003171128,0.00037387747,0.00046558862,0.0002350733,0.00025212683,0.00023053898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017639242,0.002353046,0.10212851,0.0062149707,0.012229406,0.00011158439,0.01152213,0.00008278074,0.005274991,0.023429316,0.50182295,0.31719106],"study_design_scores_gemma":[0.06560816,0.02178152,0.011831974,0.0044633043,0.010789801,0.00013813979,0.002659278,0.03899511,0.086268626,0.0024719215,0.7521699,0.0028222352],"about_ca_topic_score_codex":0.00040502552,"about_ca_topic_score_gemma":0.00021677544,"teacher_disagreement_score":0.41112965,"about_ca_system_score_codex":0.00058267947,"about_ca_system_score_gemma":0.00039905103,"threshold_uncertainty_score":0.99968344},"labels":[],"label_agreement":null},{"id":"W2915458344","doi":"10.1056/oh201107050000004","title":"ASCO 2011 Report: Malignant Hematology","year":2011,"lang":"en","type":"article","venue":"Journal watch","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; International Prognostic Index; Vincristine; Prednisone; Rituximab; Autologous stem-cell transplantation; Oncology; Hematology; Cyclophosphamide; CHOP; Lymphoma; Chemotherapy; Gastroenterology","score_opus":0.042602220221034465,"score_gpt":0.2802713091312901,"score_spread":0.23766908891025565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915458344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095127,0.0012632881,0.00006395819,0.0142811695,0.0007540789,0.00016694535,0.0000015407037,0.000035502908,0.022482263],"genre_scores_gemma":[0.989252,0.0009040835,0.0025608223,0.00052504457,0.00024678875,0.000011931751,0.000004225022,0.000017254859,0.006477854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898136,0.000026914951,0.00038177296,0.00015553492,0.00020148177,0.00025295664],"domain_scores_gemma":[0.9991821,0.00002055857,0.0001851374,0.00025408872,0.00010901264,0.00024907562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021627008,0.00011869244,0.00030918242,0.00004831099,0.000089652276,0.0000128502315,0.00006157794,0.00008181185,0.0024367727],"category_scores_gemma":[0.00003687271,0.00007336523,0.00016460763,0.00004344129,0.000030284858,0.00006198698,0.000026503176,0.00013553012,0.0006255894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016485657,0.0012336799,0.7762879,0.000024872357,0.00036276068,0.07174754,0.00077160355,8.71761e-8,0.00031541268,0.0010957831,0.14308703,0.0049084504],"study_design_scores_gemma":[0.003960355,0.0010100664,0.53432995,0.00020576688,0.00046718205,0.33238778,0.00020874414,0.000005447246,0.041003466,0.0038219744,0.082369745,0.00022955016],"about_ca_topic_score_codex":0.00009855194,"about_ca_topic_score_gemma":0.000007747536,"teacher_disagreement_score":0.26064023,"about_ca_system_score_codex":0.00012285532,"about_ca_system_score_gemma":0.00011389194,"threshold_uncertainty_score":0.99847513},"labels":[],"label_agreement":null},{"id":"W2916437498","doi":"10.1182/blood-2018-99-113103","title":"Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Procarbazine; Hodgkin's lymphoma; Quality-adjusted life year; Oncology; Cost effectiveness; Vincristine; Internal medicine; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.049330074411012406,"score_gpt":0.3458001553955375,"score_spread":0.2964700809845251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916437498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656004,0.0012847055,0.000009435749,0.00004504305,0.000050287843,0.0011939728,0.00012460246,0.000008666992,0.00072323607],"genre_scores_gemma":[0.9990313,0.00048681456,0.00011426091,0.00001934818,0.00002390224,0.00026016484,0.000040055136,0.000007326647,0.000016836771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00012934247,0.00024652667,0.0002677791,0.00019835163,0.00016973288],"domain_scores_gemma":[0.9988482,0.00046514507,0.00011232381,0.0004315039,0.000085925174,0.00005687394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020068887,0.00015615851,0.00055880664,0.00015640233,0.000036425175,0.0000072750286,0.000060831557,0.000058236037,0.000025284058],"category_scores_gemma":[0.00004681887,0.00009676002,0.0001624263,0.00053815433,0.00015189966,0.0000453198,0.00001603529,0.000016103859,0.0000017350574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002296312,0.013422148,0.840542,0.00007180093,0.003185939,0.00007644782,0.0016955023,0.00000765196,0.00088501594,0.00013446921,0.0000067143988,0.13767599],"study_design_scores_gemma":[0.026293138,0.0034276457,0.90662533,0.000044200584,0.0038893688,0.0000039083934,0.00043747635,0.0000641675,0.05825646,0.000006391865,0.0008851746,0.00006676735],"about_ca_topic_score_codex":0.0006613536,"about_ca_topic_score_gemma":0.00065941183,"teacher_disagreement_score":0.13760923,"about_ca_system_score_codex":0.0001252588,"about_ca_system_score_gemma":0.00006489789,"threshold_uncertainty_score":0.3945759},"labels":[],"label_agreement":null},{"id":"W2916635613","doi":"10.1182/blood-2018-99-112076","title":"Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; CHOP; Alemtuzumab; Internal medicine; Clinical endpoint; Interim analysis; Progression-free survival; Surgery; Randomized controlled trial; Lymphoma; Chemotherapy; Transplantation","score_opus":0.0197811737049774,"score_gpt":0.3063851743890686,"score_spread":0.2866040006840912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916635613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686575,0.00028839445,0.0000069817033,0.00017026077,0.00009744532,0.0018482205,0.0002844106,0.00000974006,0.00042881965],"genre_scores_gemma":[0.99874884,0.000106897605,0.00029666416,0.00006640012,0.00006751333,0.00029909262,0.00016278439,0.0000140318725,0.0002377736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985367,0.000076033706,0.0006693613,0.00029975898,0.0002304828,0.00018764827],"domain_scores_gemma":[0.9988699,0.00016197405,0.00031451244,0.00031301737,0.00024542093,0.00009515928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017648937,0.00019356616,0.00089118833,0.00024012323,0.000040232146,0.00001609134,0.000098843295,0.0000681655,0.00013051354],"category_scores_gemma":[0.00016070409,0.00011749839,0.0003364261,0.00041100467,0.000054203614,0.000042050633,0.000029530669,0.000009777611,0.0000011752259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007810905,0.049051635,0.82706046,0.000060975115,0.014533397,0.000014953822,0.0063585127,0.0000053135445,0.010347344,0.000041830113,0.00028668588,0.08442799],"study_design_scores_gemma":[0.32030264,0.01653332,0.4515448,0.00019415522,0.023760946,0.000007315301,0.00024302592,0.00046222482,0.18599139,0.000013618999,0.00071862875,0.00022792951],"about_ca_topic_score_codex":0.000850798,"about_ca_topic_score_gemma":0.00070353877,"teacher_disagreement_score":0.37551567,"about_ca_system_score_codex":0.00026047477,"about_ca_system_score_gemma":0.0001404117,"threshold_uncertainty_score":0.47914454},"labels":[],"label_agreement":null},{"id":"W2917436728","doi":"10.1182/blood.v130.suppl_1.4160.4160","title":"The Efficacy of PET-CT in Detecting Bone Marrow Involvement in Patients with Newly Diagnosed Lymphoma: A Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lymphoma; Positron emission tomography; Bone marrow; Biopsy; Retrospective cohort study; Radiology; Stage (stratigraphy); Nuclear medicine; PET-CT; Cancer; Pathology; Internal medicine","score_opus":0.011057630791984924,"score_gpt":0.24529626903765167,"score_spread":0.23423863824566674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917436728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977144,0.0001548418,1.0929114e-7,0.000096209165,0.000053760927,0.0016917718,0.0000044872145,0.000012663417,0.00027176767],"genre_scores_gemma":[0.9996236,0.000023635752,0.00006193348,0.000019405732,0.000025544012,0.00020365346,0.0000039060833,0.00001959168,0.000018723616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986247,0.000059879527,0.00034060268,0.00031563098,0.00038845226,0.0002707593],"domain_scores_gemma":[0.99872035,0.00016017602,0.00027364228,0.000701584,0.000078054436,0.00006619099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028802414,0.00017739038,0.00039678524,0.00008830774,0.00019506243,0.000043535558,0.00014755025,0.000014075347,0.0000041616076],"category_scores_gemma":[0.00041804937,0.000107729604,0.00005799669,0.00012788802,0.00007226462,0.00006758808,0.00009863928,0.00007037312,0.0000032571065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042674877,0.019689515,0.97317904,0.000014589542,0.00019623437,0.0010359968,0.0008010949,0.0000013230397,0.000012544996,0.000009337057,0.0000058082446,0.004627743],"study_design_scores_gemma":[0.08786657,0.0023507625,0.90749,0.00022772496,0.00018369243,0.000007949048,0.0008031427,0.0000037453929,0.00095402804,0.000008959389,0.000005894919,0.00009749964],"about_ca_topic_score_codex":0.002393018,"about_ca_topic_score_gemma":0.0052357498,"teacher_disagreement_score":0.08743982,"about_ca_system_score_codex":0.00025945948,"about_ca_system_score_gemma":0.000095477044,"threshold_uncertainty_score":0.43930858},"labels":[],"label_agreement":null},{"id":"W2917537905","doi":"10.1200/jco.18.00605","title":"First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Bendamustine; Mantle cell lymphoma; CHOP; Internal medicine; Hazard ratio; Prednisone; Cyclophosphamide; Oncology; Gastroenterology; Lymphoma; Surgery; Chemotherapy; Confidence interval","score_opus":0.06547427927673023,"score_gpt":0.37185667375765874,"score_spread":0.3063823944809285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917537905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944083,0.000103678045,0.000003992024,0.00077622215,0.0014872134,0.0019470096,0.00009204274,0.0000085464,0.0011729624],"genre_scores_gemma":[0.9968568,0.00038655923,0.0009215875,0.0001535688,0.00031208788,0.000029310831,0.000014541388,0.000047158697,0.001278393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945493,0.00035715874,0.0031054716,0.0004840318,0.001099575,0.00040451263],"domain_scores_gemma":[0.99096984,0.003157403,0.0037852146,0.00079405337,0.0009174628,0.0003760443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008610602,0.00043995355,0.0030492756,0.00017180626,0.00007454252,0.000011107905,0.0003455385,0.00031893974,0.00015827981],"category_scores_gemma":[0.00061526074,0.00017629398,0.000600382,0.00039315387,0.00027231258,0.000105093204,0.00011410758,0.00018215513,0.000024091718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42242858,0.08021083,0.45398152,0.00008239836,0.0023331542,0.00088337524,0.0006494746,0.00007006493,0.0000029661508,0.0000046979903,0.0004548262,0.03889813],"study_design_scores_gemma":[0.34146184,0.1701364,0.48037776,0.00028168707,0.0016907292,0.00005752575,0.00032645685,0.00003297683,0.0002371454,0.000001226631,0.0052817552,0.00011447946],"about_ca_topic_score_codex":0.0003474299,"about_ca_topic_score_gemma":0.0014133817,"teacher_disagreement_score":0.08992557,"about_ca_system_score_codex":0.0010362292,"about_ca_system_score_gemma":0.003593068,"threshold_uncertainty_score":0.718906},"labels":[],"label_agreement":null},{"id":"W2919325005","doi":"10.1182/blood-2018-99-120313","title":"Diagnosis to Treatment Interval in DLBCL Is Predictive of Overall Survival in a Large, Population-Based Registry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Population; Internal medicine; Hazard ratio; Rituximab; Proportional hazards model; Lymphoma; Oncology; Confidence interval","score_opus":0.01781749140102718,"score_gpt":0.2882148490005848,"score_spread":0.27039735759955763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919325005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973694,0.00013007152,0.000006773801,0.00083806936,0.00007965075,0.0005801878,0.00015280262,0.000018101504,0.000824936],"genre_scores_gemma":[0.9987508,0.00003254584,0.0003151717,0.00034214064,0.00009363151,0.00030736058,0.00006497998,0.0000152027205,0.00007815616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989179,0.00004397938,0.00031973812,0.00029273258,0.00019790362,0.00022778746],"domain_scores_gemma":[0.99935174,0.00010793956,0.0000739456,0.00030470025,0.000057015306,0.00010467435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091987116,0.00015670138,0.0003872554,0.00017412899,0.000018078857,0.0000069783327,0.000054441974,0.000077907964,0.00013195607],"category_scores_gemma":[0.000085729574,0.00012721689,0.00010269806,0.00021420495,0.000021026175,0.000034002598,0.000025736035,0.000037184072,0.000019685504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031077437,0.010951806,0.9862842,0.000027832522,0.00011597056,0.000092435344,0.00077691354,0.0000045135575,0.00003148242,0.000049698523,0.0001252415,0.0012291054],"study_design_scores_gemma":[0.017741065,0.002134464,0.9647659,0.00038606365,0.00014119051,0.0000030705587,0.000065590204,0.00009439218,0.014100701,0.000029386125,0.00044600488,0.00009216099],"about_ca_topic_score_codex":0.0042599672,"about_ca_topic_score_gemma":0.0031486666,"teacher_disagreement_score":0.021518316,"about_ca_system_score_codex":0.0003218548,"about_ca_system_score_gemma":0.00010766151,"threshold_uncertainty_score":0.64398247},"labels":[],"label_agreement":null},{"id":"W2919604435","doi":"10.1111/joim.12889","title":"Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age","year":2019,"lang":"en","type":"article","venue":"Journal of Internal Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Cumulative incidence; Comorbidity; Internal medicine; Proportional hazards model; Incidence (geometry); Diffuse large B-cell lymphoma; Cohort; Cyclophosphamide; Cumulative dose; Surgery; Lymphoma; Chemotherapy","score_opus":0.010326155199279092,"score_gpt":0.2721294169174071,"score_spread":0.261803261718128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919604435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821156,0.00030593164,0.000035482302,0.000022830565,0.00008465969,0.00080833264,0.000099515804,0.0000025928568,0.00042908188],"genre_scores_gemma":[0.99957824,0.00021135638,0.00007025008,0.00003591631,0.000008251594,0.0000058050186,0.000025161035,0.000018037472,0.00004699565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664277,0.00020162035,0.0018588806,0.00028258556,0.000731032,0.0002831112],"domain_scores_gemma":[0.9940935,0.0005975273,0.002756234,0.00022833075,0.0021295482,0.00019486745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042045978,0.0003580966,0.002163643,0.00061593176,0.000012952803,0.0000032742423,0.0001745142,0.000119626115,0.000027152017],"category_scores_gemma":[0.0009892159,0.0002124668,0.00018122396,0.00040691244,0.00042349275,0.0002476969,0.00012233769,0.00035801088,6.898437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018227989,0.009912317,0.9583231,0.0001915084,0.00085369014,0.00016197297,0.009453153,0.0000030034964,0.0025581701,0.00002141987,0.00005928333,0.00023438944],"study_design_scores_gemma":[0.06790286,0.022866493,0.890301,0.011846855,0.00028331677,0.000035750527,0.0013581483,0.0004294023,0.00481391,0.000032911055,8.753387e-7,0.00012850677],"about_ca_topic_score_codex":0.003084715,"about_ca_topic_score_gemma":0.00019860505,"teacher_disagreement_score":0.06802213,"about_ca_system_score_codex":0.0005829056,"about_ca_system_score_gemma":0.0001533299,"threshold_uncertainty_score":0.8664145},"labels":[],"label_agreement":null},{"id":"W2919654992","doi":"10.1182/blood-2018-99-117640","title":"Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Hôpital Fleurimont; Université de Sherbrooke","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Internal medicine; Population; Performance status; Lymphoma; Chemotherapy regimen; CHOP; Chemotherapy; Surgery","score_opus":0.006891637688299459,"score_gpt":0.25017249624536536,"score_spread":0.2432808585570659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919654992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93576324,0.001116331,0.000006845928,0.0013178925,0.00006554514,0.0011734728,0.000008539999,0.000013603045,0.06053451],"genre_scores_gemma":[0.99753094,0.00050436455,0.0004616658,0.000859751,0.00006963002,0.00025725356,0.000007717953,0.000017584272,0.00029111022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986591,0.00004319717,0.00023546911,0.0003270481,0.00039835303,0.00033687582],"domain_scores_gemma":[0.99904966,0.000055441826,0.00006687477,0.00061318174,0.000103549304,0.00011127426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025106003,0.00018124793,0.00019960104,0.00016371193,0.00017337808,0.000031952877,0.0002888914,0.00005024641,0.00004834591],"category_scores_gemma":[0.000008866226,0.000094971394,0.000084831445,0.00049996644,0.00008367428,0.000044171087,0.000074594915,0.000044864835,0.000073226125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008910244,0.13159552,0.35804495,0.0013606107,0.0041194805,0.01116599,0.2907338,0.000002939051,0.00006645725,0.12166609,0.004260259,0.07609285],"study_design_scores_gemma":[0.043789513,0.0008608278,0.8872146,0.00076629064,0.0015323082,0.000054727425,0.04220212,0.00003464539,0.0035519132,0.002152808,0.017575186,0.00026506474],"about_ca_topic_score_codex":0.018876271,"about_ca_topic_score_gemma":0.044019286,"teacher_disagreement_score":0.5291696,"about_ca_system_score_codex":0.0003072562,"about_ca_system_score_gemma":0.00008720889,"threshold_uncertainty_score":0.9876571},"labels":[],"label_agreement":null},{"id":"W2920660555","doi":"10.1016/j.cmet.2019.02.002","title":"GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors","year":2019,"lang":"en","type":"article","venue":"Cell Metabolism","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Horizon 2020 Framework Programme; Canceropôle Provence-Alpes-Côte d’Azur; Centre Hospitalier Universitaire de Nice; European Commission; Centre Scientifique de Monaco; Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Fondation de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"Glutaminolysis; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; CHOP; Medicine; Oncology; Biology; Internal medicine; Cancer; Cancer cell","score_opus":0.005415924043500427,"score_gpt":0.22488639707436925,"score_spread":0.21947047303086883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920660555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97475666,0.015241973,0.00000396578,0.004587731,0.00089106784,0.0039506247,0.00010471039,0.000042643533,0.0004206443],"genre_scores_gemma":[0.99286455,0.000751015,0.00028963177,0.003984322,0.00022164155,0.00052580924,0.000009041779,0.00006505692,0.0012889134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99514806,0.0018751527,0.0007064705,0.0006106903,0.0010028072,0.0006568124],"domain_scores_gemma":[0.9952554,0.002075164,0.00031104573,0.001606863,0.00028574845,0.0004657642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002773493,0.00045824196,0.0009910504,0.00025899056,0.00028250169,0.00008486225,0.0004322467,0.00009850884,0.0000931238],"category_scores_gemma":[0.001566289,0.00019089642,0.0003011412,0.0007418884,0.00025413034,0.00012807453,0.00045955047,0.00025124085,0.00020533164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2147365,0.0057356395,0.25803852,0.00024088574,0.0014850057,0.00006443594,0.06321756,0.00014163453,0.3940901,0.0054434096,0.037511628,0.019294666],"study_design_scores_gemma":[0.010330945,0.00022879406,0.6204953,0.000083214705,0.0005762165,0.00000579462,0.00059268635,0.000007757748,0.12351062,0.000047999612,0.24396186,0.00015879313],"about_ca_topic_score_codex":0.0002489177,"about_ca_topic_score_gemma":0.0000056167873,"teacher_disagreement_score":0.3624568,"about_ca_system_score_codex":0.00004712044,"about_ca_system_score_gemma":0.00025900675,"threshold_uncertainty_score":0.778453},"labels":[],"label_agreement":null},{"id":"W2920983629","doi":"10.1111/bjh.15860","title":"Identification of high‐risk <i> <scp>DUSP</scp> 22 </i> ‐rearranged <scp>ALK</scp> ‐negative anaplastic large cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Francis Xavier University; University Health Network; Spinal Cord Injury BC","funders":"National Cancer Institute; Michael Smith Health Research BC; Terry Fox Research Institute; Mayo Clinic","keywords":"Anaplastic lymphoma kinase; Identification (biology); Lymphoma; Anaplastic large-cell lymphoma; Cancer research; Biology; Medicine; Immunology; Internal medicine; Lung cancer","score_opus":0.007333538314844853,"score_gpt":0.22504839674683372,"score_spread":0.21771485843198887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920983629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96910316,0.01344859,0.00026622275,0.010151468,0.0027005025,0.0011449433,0.0013746284,0.000052928805,0.0017575329],"genre_scores_gemma":[0.9444769,0.008086648,0.00053300045,0.03777113,0.0022221047,0.00008972625,0.0007349106,0.00026113904,0.005824432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937523,0.0007592717,0.002509861,0.00077441946,0.0011930746,0.0010110714],"domain_scores_gemma":[0.9891499,0.0038783695,0.0047936323,0.0007009582,0.0012084334,0.00026869628],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00078344904,0.00069273286,0.0032999371,0.0007186255,0.00019085956,0.00012369809,0.00058993377,0.0015140346,0.00007868741],"category_scores_gemma":[0.0025137183,0.00071286625,0.0009800857,0.0004160132,0.00032347563,0.0002543336,0.00013981182,0.0014623065,0.00030360027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037694695,0.0019133319,0.0063408785,0.001194672,0.001543384,0.072323464,0.00038696002,0.000006109405,0.00019352276,0.00003346216,0.9142628,0.0017637798],"study_design_scores_gemma":[0.048224237,0.0032026798,0.07285414,0.0051979376,0.00808938,0.31840602,0.0009731333,0.00006147422,0.03267308,0.0013200146,0.5086103,0.00038762734],"about_ca_topic_score_codex":0.0004251931,"about_ca_topic_score_gemma":0.00008770742,"teacher_disagreement_score":0.40565246,"about_ca_system_score_codex":0.00051531405,"about_ca_system_score_gemma":0.0010226553,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W2921470786","doi":"10.1016/j.ijporl.2019.03.013","title":"Rhinologic manifestations of Burkitt Lymphoma in a pediatric population: Case series and systematic review","year":2019,"lang":"en","type":"review","venue":"International Journal of Pediatric Otorhinolaryngology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lymphoma; Dermatology; Burkitt's lymphoma; Pediatrics; Intensive care medicine; Pathology","score_opus":0.035229029742495525,"score_gpt":0.34165406253339026,"score_spread":0.3064250327908947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921470786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019846462,0.97723603,0.0000022488691,0.00020926376,0.00094065804,0.0016012148,0.0000879411,0.000011048314,0.00006512989],"genre_scores_gemma":[0.010079917,0.98845685,0.00024671026,0.00014124464,0.00077911647,0.00008918774,0.000088084285,0.0000351543,0.000083726685],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.9955983,0.0004166052,0.002850723,0.00032803425,0.00057231984,0.00023402198],"domain_scores_gemma":[0.99485534,0.0007921182,0.003310565,0.00032154436,0.0005858604,0.00013459602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006272775,0.00043509464,0.0035466733,0.0016018728,0.000027810685,0.00002525326,0.00034681734,0.00036174717,0.000049862017],"category_scores_gemma":[0.00078451494,0.00031061436,0.0006893002,0.0004640124,0.000041794927,0.00024471473,0.00012986107,0.00029260365,0.000020933534],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006893544,0.0008521565,0.06334261,0.8679076,0.001338872,0.05431597,0.00008627151,9.325132e-7,3.6830272e-8,0.00039903139,0.00046947887,0.0112181185],"study_design_scores_gemma":[0.004022206,0.0015485045,0.018203378,0.15763067,0.040191058,0.77176255,0.000045945788,0.0000039189167,1.9516322e-7,0.000107570064,0.005915284,0.0005687054],"about_ca_topic_score_codex":0.00007740086,"about_ca_topic_score_gemma":0.000017459693,"teacher_disagreement_score":0.7174466,"about_ca_system_score_codex":0.00051657436,"about_ca_system_score_gemma":0.00070296944,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W2921852648","doi":"10.1016/j.ijrobp.2019.03.004","title":"Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG","year":2019,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Radiation therapy; Medicine; Salvage therapy; Oncology; Lymphoma; Internal medicine; Medical physics; Chemotherapy","score_opus":0.020383579871086934,"score_gpt":0.3324639325062861,"score_spread":0.3120803526351992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921852648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941214,0.0012553132,0.00023849054,0.000972518,0.0015627445,0.0014001384,0.00009306176,0.000016876602,0.00033947593],"genre_scores_gemma":[0.99717087,0.0009972776,0.00061528507,0.00034727697,0.0005580465,0.000087276516,0.00015311092,0.00002851958,0.000042366002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832445,0.00024946875,0.0006793141,0.0002789201,0.00029541794,0.00017242364],"domain_scores_gemma":[0.9974027,0.0008470863,0.00096635707,0.00016828353,0.00051893,0.00009659463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004669183,0.00024207208,0.0007750756,0.00017911787,0.000059809405,0.000021775608,0.00013370409,0.00016558007,0.000012080855],"category_scores_gemma":[0.00011528325,0.00018355955,0.0003397495,0.00014786412,0.000055655575,0.00017767449,0.000022401737,0.00008016804,0.0000061090077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019092722,0.0054905606,0.77674,0.0000073429114,0.003506108,0.000043891556,0.0017085937,0.00009429591,0.004029341,0.0017488652,0.000104752755,0.20461693],"study_design_scores_gemma":[0.09032799,0.03318734,0.8485729,0.00009931465,0.00076546526,0.00005013663,0.000862658,0.00030349416,0.011888308,0.0011506912,0.012521544,0.00027016905],"about_ca_topic_score_codex":0.000027333781,"about_ca_topic_score_gemma":0.000002956672,"teacher_disagreement_score":0.20434678,"about_ca_system_score_codex":0.0014096637,"about_ca_system_score_gemma":0.00060223864,"threshold_uncertainty_score":0.7485341},"labels":[],"label_agreement":null},{"id":"W2921964142","doi":"10.1111/bjh.15859","title":"Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Hematology; Internal medicine; Medicine; Oncology; Hematology analyzer; Medical physics","score_opus":0.025382776882994854,"score_gpt":0.29401247669001146,"score_spread":0.2686296998070166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921964142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85489494,0.027465459,0.0000011142195,0.11536755,0.0005900563,0.0007526639,0.000025012583,0.000005053509,0.00089814176],"genre_scores_gemma":[0.94751674,0.0011557661,0.00008263863,0.050187957,0.00048321512,0.00002886283,0.000019505456,0.000041486306,0.00048385118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739116,0.00036240445,0.0010895872,0.00026590595,0.00050592684,0.0003850248],"domain_scores_gemma":[0.99745667,0.00089547416,0.0010517752,0.00033105596,0.00020523394,0.0000597633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026202304,0.00028945855,0.001702826,0.00012382632,0.00008369424,0.00008752224,0.00037368824,0.0005027125,0.00013618683],"category_scores_gemma":[0.00034327718,0.00018086577,0.000352752,0.00013029556,0.00039273233,0.00008001505,0.00013061483,0.0010386279,0.000011599741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012498879,0.0005907533,0.5590387,0.0006652299,0.00033234578,0.035480488,0.0004682571,0.0000063601706,0.000016282675,0.00003988011,0.39953926,0.0036974102],"study_design_scores_gemma":[0.008963801,0.0013945443,0.43919313,0.0062310547,0.001168215,0.43758228,0.00035390438,0.000039744908,0.0008329369,0.00032420078,0.103577495,0.00033868974],"about_ca_topic_score_codex":0.000380752,"about_ca_topic_score_gemma":0.000115338524,"teacher_disagreement_score":0.40210178,"about_ca_system_score_codex":0.00018870896,"about_ca_system_score_gemma":0.0007329311,"threshold_uncertainty_score":0.7375492},"labels":[],"label_agreement":null},{"id":"W2922237910","doi":"10.1182/blood-2018-11-880526","title":"Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cilag; Pharmacyclics; National Cancer Institute; H. Lundbeck A/S; Servier; Amgen; TG Therapeutics; Genentech; Celgene; Gilead Sciences; F. Hoffmann-La Roche","keywords":"Venetoclax; CHOP; Medicine; Internal medicine; Lymphoma; Radioimmunotherapy; Oncology; Cancer research; Immunology; Leukemia; Chronic lymphocytic leukemia; Antibody","score_opus":0.0250096202725218,"score_gpt":0.2999874654202687,"score_spread":0.2749778451477469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922237910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929409,0.00049523095,7.203509e-7,0.00071496115,0.00048212067,0.0017307022,0.00016882662,0.000037249516,0.0034293027],"genre_scores_gemma":[0.9972082,0.00015442212,0.00015518928,0.0005245089,0.0006312835,0.00016656838,0.00015932418,0.000027627653,0.00097290945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984415,0.000069557886,0.00043029562,0.0004296996,0.00031876026,0.00031017236],"domain_scores_gemma":[0.99845254,0.00057593803,0.00011753255,0.00070024177,0.000033566386,0.000120184304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023015111,0.00021343207,0.0004466314,0.000051374045,0.00004827976,0.00003462734,0.00015922103,0.00013015194,0.00016333892],"category_scores_gemma":[0.00019500409,0.00012000071,0.00013602352,0.00019666122,0.000034556077,0.000047450976,0.00005811645,0.000080809674,0.0004539592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7112298,0.06925939,0.06290647,0.00014828297,0.0034867504,0.008948167,0.01205765,0.00009971583,0.0046927747,0.0003102325,0.032569773,0.094290964],"study_design_scores_gemma":[0.9370598,0.0030218596,0.04107529,0.0002479225,0.0004821142,0.000039338156,0.00019043607,0.000269927,0.005247995,0.0000403203,0.012124922,0.00020006922],"about_ca_topic_score_codex":0.0038368073,"about_ca_topic_score_gemma":0.00043556915,"teacher_disagreement_score":0.22582997,"about_ca_system_score_codex":0.00043625062,"about_ca_system_score_gemma":0.00075869635,"threshold_uncertainty_score":0.58348787},"labels":[],"label_agreement":null},{"id":"W2922343615","doi":"10.1016/j.anorl.2018.10.017","title":"Unusual presentation for small lymphocytic lymphoma: Case report of a man with bilateral ear involvement and review of the literature","year":2019,"lang":"en","type":"review","venue":"European Annals of Otorhinolaryngology Head and Neck Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Earlobe; Lymphoma; Biopsy; Nodule (geology); Lesion; Otorhinolaryngology; Differential diagnosis; Radiation therapy; Radiology; Prednisone; Presentation (obstetrics); Surgery; Pathology","score_opus":0.07663637506822314,"score_gpt":0.3509073867013931,"score_spread":0.27427101163316997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922343615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23836608,0.7586782,1.6398324e-7,0.00008812402,0.00006269252,0.0022060599,0.0004942742,0.000008745573,0.00009567099],"genre_scores_gemma":[0.011051307,0.987573,0.00005560545,0.0004546237,0.0000803431,0.000067816654,0.00047886948,0.00005114186,0.00018728687],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977989,0.00037285147,0.0009338685,0.00048577835,0.00019009755,0.00021845628],"domain_scores_gemma":[0.997734,0.00019062188,0.0010091009,0.0006164652,0.00028274726,0.00016707362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024487177,0.00040043503,0.0018714962,0.0001453195,0.00005498178,0.000013129363,0.000116697716,0.000097091666,0.000004757042],"category_scores_gemma":[0.00013521602,0.00021721117,0.0004980794,0.00019376096,0.00023580351,0.000059521266,0.00013597916,0.000062688625,8.54035e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076150714,0.0020259675,0.03860801,0.80432457,0.0026630796,0.018728284,0.000371416,2.1484962e-7,0.000003573591,0.00014559532,0.003168807,0.129199],"study_design_scores_gemma":[0.008648613,0.0050681317,0.13966276,0.5467491,0.013842224,0.05207934,0.00004540935,0.0000049288005,0.000083686486,0.000014957214,0.2331727,0.00062814215],"about_ca_topic_score_codex":0.000058622478,"about_ca_topic_score_gemma":0.000005978074,"teacher_disagreement_score":0.25757542,"about_ca_system_score_codex":0.000044778164,"about_ca_system_score_gemma":0.00051548367,"threshold_uncertainty_score":0.8857615},"labels":[],"label_agreement":null},{"id":"W2922392474","doi":"10.1182/blood.v130.suppl_1.2821.2821","title":"Addition of Polatuzumab Vedotin to Bendamustine and Rituximab (BR) Improves Outcomes in Transplant-Ineligible Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Versus BR Alone: Results from a Randomized Phase 2 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Diffuse large B-cell lymphoma; Refractory (planetary science); Internal medicine; Oncology; Lymphoma","score_opus":0.010540814596921865,"score_gpt":0.2612747554390845,"score_spread":0.25073394084216266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922392474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415433,0.0003493543,0.000002749754,0.00013243868,0.00015509101,0.002471228,0.0024830604,0.000039743652,0.00021202507],"genre_scores_gemma":[0.99835354,0.00015243213,0.00034213037,0.000049678816,0.00005189587,0.00021109995,0.0007523009,0.000040801144,0.000046091027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977347,0.00011357428,0.0007152302,0.0006177057,0.00045045558,0.0003683376],"domain_scores_gemma":[0.9977998,0.0005974387,0.00044977115,0.00079061463,0.00011520154,0.00024717287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002291214,0.0003876261,0.0013836955,0.00020754979,0.00016687544,0.00005349447,0.00016087505,0.00012024293,0.000012155303],"category_scores_gemma":[0.00045353986,0.00027004533,0.00014243486,0.00008891064,0.0000858621,0.00019444249,0.00007171603,0.00010009456,0.000009431176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.400765,0.33244553,0.25772482,0.000071541785,0.0012272594,0.00037199684,0.0034304822,1.943911e-7,0.0007720059,0.0000053795893,0.00007178121,0.0031140002],"study_design_scores_gemma":[0.64991784,0.0031916564,0.3426969,0.00022367976,0.001219817,0.0000020871446,0.0001693276,0.000017595265,0.0023413473,0.0000041344506,0.000033581524,0.00018201134],"about_ca_topic_score_codex":0.0028086533,"about_ca_topic_score_gemma":0.0007831927,"teacher_disagreement_score":0.32925385,"about_ca_system_score_codex":0.000088581364,"about_ca_system_score_gemma":0.00011468739,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2923453543","doi":"10.1200/jco.18.02403","title":"Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":616,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Population; CHOP; Hazard ratio; Cyclophosphamide; Gastroenterology; Oncology; Lymphoma; Chemotherapy; Leukemia; Chronic lymphocytic leukemia; Confidence interval","score_opus":0.03015399178565479,"score_gpt":0.38829917842144357,"score_spread":0.35814518663578876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923453543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914711,0.00197169,0.000024055378,0.0009888334,0.0010399561,0.0015176898,0.000024148647,0.000006271807,0.0029562402],"genre_scores_gemma":[0.9924,0.0048251026,0.001066521,0.00079585693,0.00043309334,0.000022236654,0.0000100354855,0.000024546423,0.00042261317],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99420696,0.00064948865,0.003937433,0.00037890824,0.0004307862,0.00039640983],"domain_scores_gemma":[0.9917858,0.0046742894,0.0025387695,0.00027155803,0.00024590545,0.0004836365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042218277,0.00030281142,0.0049192198,0.00021642593,0.000033561908,0.000015389754,0.00013371593,0.00047653404,0.000092494396],"category_scores_gemma":[0.0012665129,0.00020171324,0.0006560002,0.00013097018,0.00032912876,0.00012551203,0.00012987693,0.00041050356,0.000012518367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8507441,0.10545584,0.025564903,0.00015373917,0.00030194974,0.0011122159,0.0002454925,4.276998e-7,0.00015931288,0.00003811615,0.00072882086,0.015495024],"study_design_scores_gemma":[0.9567341,0.018880017,0.016670214,0.00024164544,0.000936233,0.00032722726,0.00012701494,0.0004647571,0.00053630635,0.000059659997,0.00486553,0.00015727768],"about_ca_topic_score_codex":0.00009312084,"about_ca_topic_score_gemma":0.000019956047,"teacher_disagreement_score":0.10598996,"about_ca_system_score_codex":0.00018933379,"about_ca_system_score_gemma":0.0010143267,"threshold_uncertainty_score":0.8225627},"labels":[],"label_agreement":null},{"id":"W2927509568","doi":"10.1182/blood.v130.suppl_1.822.822","title":"The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their <i>ALK</i>, <i>DUSP22</i> and <i>TP63</i> Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Anaplastic large-cell lymphoma; Oncology; Internal medicine; Medicine; Lymphoma; Autologous stem-cell transplantation; CHOP; Fluorescence in situ hybridization; Cancer research; Biology; Genetics; Gene","score_opus":0.012790078093340372,"score_gpt":0.254559342506017,"score_spread":0.2417692644126766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927509568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971693,0.00070175366,0.000008297336,0.00039692197,0.000037466856,0.00093597337,0.00038380869,0.000013274349,0.00035316503],"genre_scores_gemma":[0.9977576,0.0018470702,0.000101147794,0.00012288801,0.000024874329,0.00007126461,0.000040824605,0.000022960234,0.000011372925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983517,0.000108113076,0.00042730887,0.0004119004,0.00033627666,0.00036468985],"domain_scores_gemma":[0.9980998,0.00041240844,0.00037430125,0.0007691958,0.00012402657,0.000220272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032275068,0.0003062814,0.00074541377,0.00009110729,0.00036558264,0.000071744464,0.00014763829,0.00006961371,0.000006073412],"category_scores_gemma":[0.00007772035,0.00013662697,0.0001844674,0.00013913446,0.00023623636,0.00006223959,0.000088687724,0.00006236302,7.428353e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571087,0.0014396188,0.9772919,0.000039581697,0.0035678996,0.000023141722,0.0007000321,0.0000019152067,0.0007178968,0.0000334159,0.00003987618,0.014587646],"study_design_scores_gemma":[0.012933082,0.0035807935,0.9774573,0.00018450135,0.0030055526,0.000014483008,0.00027163798,0.000041545984,0.0023172835,0.000014814284,0.000029803577,0.00014923154],"about_ca_topic_score_codex":0.0018836666,"about_ca_topic_score_gemma":0.0006234849,"teacher_disagreement_score":0.014438415,"about_ca_system_score_codex":0.00004362275,"about_ca_system_score_gemma":0.000067179426,"threshold_uncertainty_score":0.55714864},"labels":[],"label_agreement":null},{"id":"W2934686121","doi":"10.1016/s2352-3026(19)30026-2","title":"Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)","year":2019,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; BC Cancer Agency","funders":"Celgene; MorphoSys; Servier; Innovative Research Group Project of the National Natural Science Foundation of China; F. Hoffmann-La Roche; Genentech; AstraZeneca; Gilead Sciences; TG Therapeutics; Pfizer; Takeda Oncology; Amgen","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Rituximab; Refractory (planetary science); Lymphoma; Oncology; Phases of clinical research; Hodgkin lymphoma; Clinical trial","score_opus":0.029094146801748787,"score_gpt":0.30191791391980216,"score_spread":0.2728237671180534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934686121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926148,0.00022307591,0.00000701686,0.0011479536,0.0003876488,0.004617763,0.00018640021,0.000107466396,0.0007078977],"genre_scores_gemma":[0.9973262,0.000042846703,0.000408879,0.00066970196,0.0001529421,0.00037377194,0.0003620755,0.00007091062,0.00059265195],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615055,0.00054377294,0.0009886759,0.00093994796,0.0005561568,0.00082087755],"domain_scores_gemma":[0.99618495,0.001457421,0.0005147507,0.0015345146,0.00013423226,0.00017412801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005114908,0.0005550603,0.0027653803,0.00020572437,0.00014783046,0.00003932495,0.0004476885,0.00025922304,0.00031395012],"category_scores_gemma":[0.0005014762,0.0002833656,0.00013701536,0.00044011208,0.0001663162,0.00012827465,0.00015899783,0.00037086074,0.00039991052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79826856,0.029938655,0.14826559,0.00014448697,0.0008523407,0.005608637,0.006961841,0.000017063709,0.000035546844,0.00004973911,0.0030570407,0.006800527],"study_design_scores_gemma":[0.7009798,0.008991875,0.28622127,0.00039781252,0.00043480736,0.00016012175,0.0006756543,0.00042570735,0.00019483214,0.000032350446,0.0011457899,0.00033991484],"about_ca_topic_score_codex":0.0016431564,"about_ca_topic_score_gemma":0.0010195116,"teacher_disagreement_score":0.1379557,"about_ca_system_score_codex":0.00088604627,"about_ca_system_score_gemma":0.0011225363,"threshold_uncertainty_score":0.99996185},"labels":[],"label_agreement":null},{"id":"W2936108326","doi":"10.1007/s10637-019-00768-6","title":"A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors","year":2019,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Brentuximab vedotin; Medicine; CD30; Antibody-drug conjugate; Internal medicine; Adverse effect; Nausea; Mesothelioma; Oncology; Germ cell tumors; Phases of clinical research; Gastroenterology; Toxicity; Chemotherapy; Antibody; Immunology; Lymphoma; Pathology; Monoclonal antibody","score_opus":0.027656533319971862,"score_gpt":0.3151312772962788,"score_spread":0.28747474397630696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936108326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705815,0.000031542855,9.811614e-7,0.00037526025,0.000051622752,0.0015380868,0.000016287071,0.000014005472,0.0009140834],"genre_scores_gemma":[0.99798447,6.857872e-7,0.0011056382,0.00038680475,0.000029797107,0.00005654614,0.00013116536,0.00001996801,0.00028494766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985547,0.000043459317,0.00038991132,0.0003192994,0.00051654095,0.0001760644],"domain_scores_gemma":[0.99917185,0.00007640082,0.00019572293,0.0002599363,0.00011512496,0.00018094367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010002283,0.00016531107,0.0003894963,0.00012195236,0.00003572425,0.000034772358,0.00013639835,0.000033335975,0.000070163405],"category_scores_gemma":[0.00003952597,0.0001262805,0.000020197376,0.00024868606,0.000055058445,0.00021050747,0.00008420442,0.00007714159,0.000039507217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067314185,0.031685155,0.96056366,0.000036160964,0.00011195478,0.00001926054,0.0023606236,0.00006482222,0.00035205408,0.00025919956,0.0006196229,0.0032543235],"study_design_scores_gemma":[0.15865093,0.004531725,0.83258516,0.0007083884,0.00008537709,0.0000034672046,0.0004386257,0.00030608964,0.002136666,0.000283437,0.000101649035,0.00016847996],"about_ca_topic_score_codex":0.00071262463,"about_ca_topic_score_gemma":0.000023360879,"teacher_disagreement_score":0.15797779,"about_ca_system_score_codex":0.00013452915,"about_ca_system_score_gemma":0.00054705824,"threshold_uncertainty_score":0.51495695},"labels":[],"label_agreement":null},{"id":"W2938396047","doi":"10.1007/978-3-030-11769-6_13","title":"Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Oncology; Disease; Clinical trial; Diffuse large B-cell lymphoma; Immunotherapy; Lymphoblastic lymphoma; Internal medicine; Immunology; Intensive care medicine; Cancer; Immune system; T cell","score_opus":0.011522485629967449,"score_gpt":0.22503497924008178,"score_spread":0.21351249361011435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938396047","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02469863,0.006828927,0.0000068822483,0.0004489587,0.00033836038,0.0009930487,0.00013680384,0.0001672864,0.9663811],"genre_scores_gemma":[0.14420779,0.003830895,0.0001964763,0.0019623684,0.00026277953,0.000027415872,0.00026028312,0.00014491803,0.8491071],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977657,0.000010303469,0.00044318233,0.00082695874,0.00047364426,0.00048018582],"domain_scores_gemma":[0.9982907,0.000128512,0.00018960143,0.000896763,0.00009878618,0.00039563174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000860512,0.0007174557,0.001061415,0.0002094513,0.00008845133,0.000059332408,0.00011446312,0.0006219109,0.001529602],"category_scores_gemma":[0.000010018043,0.0005337192,0.00036056127,0.000025643327,0.000084979976,0.0000624381,0.00020343099,0.00007509415,0.0026994292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008993152,0.022615163,0.01906527,0.0019827394,0.002957143,0.005052526,0.00045847544,7.598362e-8,0.00012503787,0.5468598,0.14791144,0.252073],"study_design_scores_gemma":[0.0491217,0.00066465477,0.009582831,0.00045224925,0.0010251285,0.00037202728,0.00002655541,0.000024718485,0.0004781425,0.0007736245,0.9368149,0.00066345953],"about_ca_topic_score_codex":0.000079558245,"about_ca_topic_score_gemma":0.00003313872,"teacher_disagreement_score":0.7889035,"about_ca_system_score_codex":0.00041441745,"about_ca_system_score_gemma":0.0003647271,"threshold_uncertainty_score":0.99971145},"labels":[],"label_agreement":null},{"id":"W2938912331","doi":"10.3324/haematol.2018.213512","title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Oncology; Lymphoma; Internal medicine; Anaplastic lymphoma kinase; Cancer research","score_opus":0.014647189949418797,"score_gpt":0.2568785740166578,"score_spread":0.24223138406723901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938912331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617326,0.0002744272,0.000006032633,0.000049556238,0.00007392567,0.00077138084,0.0012147414,0.000029815033,0.0014068368],"genre_scores_gemma":[0.9937215,0.000046648736,0.00039125825,0.0003078808,0.0000063583893,0.000041326904,0.005458174,0.000013892632,0.000012954808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780047,0.00013246437,0.00057765434,0.00066064927,0.00046276895,0.00036600005],"domain_scores_gemma":[0.99822676,0.00021151813,0.00029213203,0.0009800342,0.00013219581,0.00015736782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013793525,0.00024602364,0.0009650434,0.0004202686,0.000037490852,0.000015429378,0.00028813718,0.00014853243,0.00028489184],"category_scores_gemma":[0.00010597166,0.0001771882,0.00013745505,0.00079729647,0.00004515758,0.0001561077,0.00029098126,0.000059906684,0.000083892635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007518401,0.013009258,0.97728586,0.00008865729,0.0012273384,0.0002508808,0.0010200633,0.000015170378,0.000007812441,0.00013820681,0.00022034167,0.005984567],"study_design_scores_gemma":[0.011911871,0.002720052,0.9787358,0.00020772628,0.0024487083,0.000010897695,0.00065828906,0.0022199792,0.0007376078,0.0000107608175,0.00014734961,0.00019095521],"about_ca_topic_score_codex":0.00023978719,"about_ca_topic_score_gemma":0.0002654363,"teacher_disagreement_score":0.011160031,"about_ca_system_score_codex":0.00010684327,"about_ca_system_score_gemma":0.00007816535,"threshold_uncertainty_score":0.7225525},"labels":[],"label_agreement":null},{"id":"W2940120576","doi":"10.1016/j.jid.2019.03.219","title":"143 Molecular targeting of the DNA binding domain of TOX protein results in selective inhibition of cutaneous T cell lymphoma cells","year":2019,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"In silico; Small molecule; Cutaneous T-cell lymphoma; Biology; DNA; Lymphoma; Thymocyte; Cell culture; Computational biology; Cancer research; DNA-binding protein; Molecular biology; Cell biology; T cell; Chemistry; Biochemistry; Transcription factor; Genetics; Immunology; Gene; Immune system; Mycosis fungoides","score_opus":0.006930875026382566,"score_gpt":0.2190010457038478,"score_spread":0.21207017067746523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940120576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740607,0.0002019249,0.0000067672677,0.0009498186,0.00006985536,0.0005905381,0.000023091048,0.0000024373624,0.0007495106],"genre_scores_gemma":[0.99784476,0.000016136675,0.001978862,0.00011064291,0.0000113758115,0.0000065071827,0.0000041603384,0.000013622025,0.000013956285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977766,0.0003896606,0.001151559,0.0001542927,0.00033249494,0.00019536796],"domain_scores_gemma":[0.9972339,0.00023783157,0.00189628,0.00016605493,0.00038546327,0.00008045454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028711054,0.00016199758,0.0007542384,0.00027412034,0.000021424945,0.0000027737972,0.000105664796,0.00013657987,0.0000069005905],"category_scores_gemma":[0.00031184475,0.00010950887,0.00019593904,0.00041125572,0.00031836279,0.00007027241,0.000050058305,0.00015614218,0.0000028256038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042818417,0.00058251445,0.013090158,0.00027232894,0.00012936331,0.00046537543,0.002718659,0.000076939614,0.98166895,0.0003593859,0.00015078983,0.00005734046],"study_design_scores_gemma":[0.0062852358,0.00074070384,0.0061559677,0.0010868526,0.0000778074,0.0008531988,0.0010456627,0.000034305158,0.9823487,0.0012674397,0.000026705791,0.00007743422],"about_ca_topic_score_codex":0.000049972277,"about_ca_topic_score_gemma":0.000004990017,"teacher_disagreement_score":0.00693419,"about_ca_system_score_codex":0.00021053584,"about_ca_system_score_gemma":0.00045144945,"threshold_uncertainty_score":0.4465642},"labels":[],"label_agreement":null},{"id":"W2940713869","doi":"10.1038/s41379-019-0279-8","title":"Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified","year":2019,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Exome sequencing; Exome; Lymphoma; Biology; T-cell lymphoma; Peripheral T-cell lymphoma; Epigenetics; Mutation; Gene; Tumor suppressor gene; Cancer research; Genetics; T cell; Carcinogenesis; Immunology","score_opus":0.03551794023435979,"score_gpt":0.29778706115038767,"score_spread":0.2622691209160279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940713869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935552,0.00014119942,0.00010038167,0.0007452381,0.00023971032,0.00076218497,0.000064005486,0.00007193234,0.0043201502],"genre_scores_gemma":[0.9938097,0.00001808188,0.0021505326,0.0023794295,0.0001402548,0.00011440839,0.000070279035,0.00006111446,0.0012561976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977054,0.00018632093,0.0006616883,0.0006669654,0.00023761936,0.00054199254],"domain_scores_gemma":[0.9986087,0.0003195763,0.00021737667,0.0006189024,0.00006452372,0.00017093358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038021975,0.00028500383,0.0006706978,0.00016755106,0.00006729978,0.000028876175,0.00012830556,0.00017902956,0.00021345686],"category_scores_gemma":[0.00013509853,0.00024272772,0.00018348783,0.00013382612,0.00006674,0.000084888474,0.00005667278,0.00016410138,0.00045631346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011999999,0.0020427024,0.1898584,0.00008665948,0.00006450592,0.0052105356,0.004432381,0.0013960209,0.7900836,0.00008188077,0.00008973301,0.0054536224],"study_design_scores_gemma":[0.029014247,0.0029945523,0.85390466,0.00027170678,0.00017191068,0.0013281032,0.00087490067,0.008203949,0.10148218,0.0008003977,0.0002908247,0.0006625362],"about_ca_topic_score_codex":0.00008078613,"about_ca_topic_score_gemma":0.00003230061,"teacher_disagreement_score":0.6886014,"about_ca_system_score_codex":0.0007180846,"about_ca_system_score_gemma":0.00020922266,"threshold_uncertainty_score":0.9898149},"labels":[],"label_agreement":null},{"id":"W2941404034","doi":"10.3324/haematol.2018.214957","title":"Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Epigenetics; Genetics; Biology; DNA sequencing; Computational biology; Evolutionary biology; Gene","score_opus":0.13369967544279251,"score_gpt":0.31145699692775386,"score_spread":0.17775732148496134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941404034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8906359,0.035265837,0.00024430655,0.07188604,0.0002583678,0.0010642927,0.00003671968,0.000040708288,0.0005677972],"genre_scores_gemma":[0.8184945,0.009128614,0.0034971589,0.16664757,0.0006175967,0.00012532866,0.00091502495,0.000060000293,0.0005142413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802035,0.00011433366,0.00060095,0.0005450624,0.0004287416,0.00029058792],"domain_scores_gemma":[0.99828094,0.00032922212,0.00044045222,0.00071384,0.00017542753,0.00006012492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008233398,0.0004254162,0.0010171987,0.00012435768,0.0001308056,0.000058798516,0.00018304071,0.0007126724,0.000049102266],"category_scores_gemma":[0.00007594633,0.0002390181,0.00018666197,0.00017423244,0.00021998404,0.000034571814,0.0001187548,0.0002167413,0.00002531069],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066721026,0.0005623464,0.010270062,0.0013511032,0.00183995,0.0011746899,0.0018264408,0.0000555143,0.11080902,0.00016838139,0.8608672,0.011008589],"study_design_scores_gemma":[0.0075634513,0.002277418,0.010804844,0.0009808688,0.004997191,0.0019738884,0.000530982,0.00862375,0.30484056,0.00036162804,0.65558237,0.0014630684],"about_ca_topic_score_codex":0.00032579192,"about_ca_topic_score_gemma":0.000033035874,"teacher_disagreement_score":0.20528483,"about_ca_system_score_codex":0.00020081903,"about_ca_system_score_gemma":0.00024229684,"threshold_uncertainty_score":0.9746875},"labels":[],"label_agreement":null},{"id":"W2941781683","doi":"10.1007/978-3-030-11515-9_5","title":"Mature B-Cell Neoplasms","year":2019,"lang":"en","type":"book-chapter","venue":"Pathology for clinicians","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Marginal zone; Pathology; Atypia; Follicular lymphoma; Immunohistochemistry; B cell; Pathological; Plasmablastic lymphoma; Medicine; Biology; Cancer research; Immunology; Antibody","score_opus":0.027089391244971082,"score_gpt":0.294146760817883,"score_spread":0.26705736957291193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941781683","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027744852,0.0040068366,0.000034633653,0.0022486714,0.002278702,0.0021994752,0.0006037909,0.00024907477,0.98560435],"genre_scores_gemma":[0.005867906,0.0012748002,0.0014502694,0.005628034,0.00068541575,0.00010892067,0.0007482914,0.0003533974,0.98388296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983072,0.000011934417,0.0005235793,0.0006668435,0.0001420573,0.0003483322],"domain_scores_gemma":[0.99828583,0.00042161197,0.0003304995,0.0007340293,0.000105100895,0.00012291962],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015527035,0.00043227876,0.0010868153,0.00012320404,0.00004623066,0.000009281146,0.00011742877,0.0013509991,0.0006469765],"category_scores_gemma":[0.00004073748,0.00035154104,0.00081032346,0.00001306327,0.00010930218,0.000016422888,0.00004650531,0.00036744002,0.0055854074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018270462,0.0021787586,0.014721021,0.0018688587,0.0016510655,0.0048764166,0.00055082736,0.000004120833,0.00011120464,0.119580306,0.8206327,0.0319977],"study_design_scores_gemma":[0.005369869,0.002202743,0.0011342702,0.00028483666,0.0016047471,0.0003413559,0.000017463051,0.0000065950417,0.00012433474,0.0034829793,0.9850756,0.0003552029],"about_ca_topic_score_codex":0.000002524158,"about_ca_topic_score_gemma":0.000017444241,"teacher_disagreement_score":0.16444293,"about_ca_system_score_codex":0.00011213285,"about_ca_system_score_gemma":0.00023475045,"threshold_uncertainty_score":0.99994546},"labels":[],"label_agreement":null},{"id":"W2943067820","doi":"10.1182/blood.v130.suppl_1.2780.2780","title":"Bendamustine and Rituximab As Initial Therapy in Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma in a Canadian Population; Highly Effective with Frequent Infections","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Mantle cell lymphoma; Internal medicine; Follicular lymphoma; Lymphoma; Population; Marginal zone B-cell lymphoma; Macroglobulinemia; Chronic lymphocytic leukemia; Aggressive lymphoma; Oncology; Leukemia; Immunology; Multiple myeloma; B cell; Antibody; Marginal zone","score_opus":0.006971393602849175,"score_gpt":0.2569838505892882,"score_spread":0.25001245698643904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943067820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946498,0.0005102788,5.0571776e-7,0.00045314248,0.00006387247,0.0010638027,0.000031629515,0.000016466074,0.003210459],"genre_scores_gemma":[0.9989285,0.00031330134,0.00010863968,0.00019149696,0.00007245603,0.00029998255,0.000038277034,0.000025883388,0.000021452048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998873,0.00004307631,0.00020350545,0.0003719156,0.00015176456,0.00035671657],"domain_scores_gemma":[0.9991843,0.0000650643,0.00009883452,0.00031424037,0.00004270233,0.000294866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011752232,0.00023137676,0.0003709277,0.00031083176,0.00024134856,0.00009067352,0.000057683195,0.000116230716,0.00001809402],"category_scores_gemma":[0.00003791609,0.00018489621,0.00003346855,0.00010605479,0.00008563519,0.00014530208,0.00003615427,0.00005892836,0.000008139626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018381847,0.0041879336,0.95595926,0.00003556446,0.000083040555,0.00096673,0.00055228977,0.0000011833121,0.00004942124,0.00008486846,0.0000069805938,0.037888933],"study_design_scores_gemma":[0.06779835,0.001566276,0.9258045,0.00019489063,0.00010086051,0.0002997826,0.000059315906,0.000029568624,0.0037189869,0.00007771904,0.00016947562,0.00018031048],"about_ca_topic_score_codex":0.58338374,"about_ca_topic_score_gemma":0.4583889,"teacher_disagreement_score":0.124994814,"about_ca_system_score_codex":0.0003541729,"about_ca_system_score_gemma":0.00031660346,"threshold_uncertainty_score":0.75398487},"labels":[],"label_agreement":null},{"id":"W2943174192","doi":"10.1007/978-3-030-11515-9_1","title":"Basic Concepts in Lymph Node Pathology","year":2019,"lang":"en","type":"book-chapter","venue":"Pathology for clinicians","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pathology; Lymph node; Lymphoma; Lymph node biopsy; Lymph; Lymphatic system; Biopsy; Pathological; Immunohistochemistry; Flow cytometry; Cytogenetics; Biology; Medicine; Immunology; Gene","score_opus":0.04223345202845416,"score_gpt":0.3422278791934653,"score_spread":0.2999944271650111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943174192","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0665643,0.0077139894,0.000090800626,0.00485944,0.004462563,0.0048217685,0.001086092,0.00039987313,0.91000116],"genre_scores_gemma":[0.19035374,0.0047477465,0.0025038514,0.02555454,0.0015373587,0.00091012625,0.001999125,0.0010641331,0.7713294],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997122,0.000056517758,0.0010076276,0.0010538069,0.0001633482,0.0005967289],"domain_scores_gemma":[0.997548,0.0008407549,0.00044484413,0.0009090504,0.00012124863,0.00013613104],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042203517,0.00057211804,0.0018087762,0.00031103,0.000043257958,0.000007787199,0.000180108,0.0015633351,0.0006243082],"category_scores_gemma":[0.00017573574,0.0005114098,0.00072701386,0.00003248642,0.00033579548,0.000028418404,0.000081998645,0.00037450306,0.0029461768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031830166,0.0035992106,0.5472082,0.0016420572,0.0016457811,0.03595035,0.001888032,0.000022217448,0.00019332458,0.24276781,0.05111994,0.11078009],"study_design_scores_gemma":[0.042957455,0.005119508,0.16295797,0.0021054256,0.0030874591,0.0033476576,0.00017731969,0.00007194277,0.00015392338,0.02279894,0.7553156,0.0019068272],"about_ca_topic_score_codex":0.0000125254655,"about_ca_topic_score_gemma":0.00007043134,"teacher_disagreement_score":0.7041956,"about_ca_system_score_codex":0.00033878983,"about_ca_system_score_gemma":0.00043866472,"threshold_uncertainty_score":0.99973375},"labels":[],"label_agreement":null},{"id":"W2943412515","doi":"10.3747/co.26.4345","title":"Review of Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre; Fluidigm (Canada); BC Cancer Agency; Foothills Medical Centre; Impact; University of Calgary","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Mantle cell lymphoma; Medicine; Bruton's tyrosine kinase; Ibrutinib; Tyrosine kinase; Refractory (planetary science); Cancer research; Lymphoma; Oncology; Internal medicine; Bioinformatics; Leukemia; Biology; Chronic lymphocytic leukemia; Receptor","score_opus":0.1938884262347178,"score_gpt":0.4498050806863323,"score_spread":0.2559166544516145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943412515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006154801,0.9899322,0.0000025224258,0.00015463543,0.0024324253,0.00663493,0.00036526253,0.000018100727,0.0003983828],"genre_scores_gemma":[0.000024367966,0.9961766,0.000083589955,0.00007709431,0.00040035398,0.0016359917,0.00072274054,0.00006692372,0.0008123231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972513,0.00021722997,0.0014309158,0.00052392366,0.00023950878,0.00033717527],"domain_scores_gemma":[0.9953129,0.001799639,0.0015454906,0.000978632,0.00023714594,0.0001261561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002781396,0.00057707663,0.004196366,0.00016692217,0.000047042722,0.000003639373,0.00020896755,0.00036180232,0.00017598538],"category_scores_gemma":[0.00013399545,0.00027434764,0.0015607588,0.00028123875,0.00015420785,0.000024114725,0.000053630974,0.00009607728,0.00006464798],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016545544,0.0088050375,0.000028744049,0.2003561,0.00040555483,0.000018524213,0.0000389827,1.9843025e-8,0.0000010009019,0.000021069389,0.018835861,0.7713236],"study_design_scores_gemma":[0.006371424,0.008594963,0.000022164235,0.103835694,0.012561425,0.00005321014,0.000011967777,0.0000014379386,0.00010925358,0.0000014279707,0.8682516,0.00018541735],"about_ca_topic_score_codex":0.00002778204,"about_ca_topic_score_gemma":0.0000064734913,"teacher_disagreement_score":0.8494158,"about_ca_system_score_codex":0.0017126368,"about_ca_system_score_gemma":0.0021740592,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W2944009275","doi":"10.1136/lupus-2019-000324","title":"Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival","year":2019,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Calgary; Jewish General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"BCL6; Medicine; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Population; Oncology; Internal medicine; Tissue microarray; CD20; Cancer; Pathology; Immunology; B cell; Antibody","score_opus":0.019134157253102472,"score_gpt":0.2884678500807176,"score_spread":0.26933369282761516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944009275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581844,0.0012513015,0.000006185657,0.00014737833,0.00080902054,0.00078778644,0.00000915696,0.000024839313,0.00114591],"genre_scores_gemma":[0.9992517,0.00017983532,0.000022477143,0.0001166091,0.000020981044,0.000014068041,0.000017242934,0.000021084918,0.00035596796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969514,0.00012456755,0.00074430706,0.00064770586,0.00095313124,0.0005788827],"domain_scores_gemma":[0.99833626,0.00045799484,0.00029352662,0.0004768496,0.00012531292,0.00031006098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015672634,0.00028229598,0.0010616742,0.00040920355,0.000038766484,0.000012972879,0.00021668877,0.00013330895,0.000025592415],"category_scores_gemma":[0.00031347934,0.00017183182,0.0000651465,0.0011475091,0.0005707905,0.00013174175,0.0000705062,0.00013749572,0.000008468946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114746814,0.0043250923,0.98917025,0.00014479645,0.000019904543,0.0002616049,0.001427728,0.000002891007,0.0042952774,0.000113061185,0.00003330332,0.00009132109],"study_design_scores_gemma":[0.12287113,0.0028234173,0.8577121,0.0034904848,0.00023912576,0.00028864693,0.005443327,0.0009434315,0.005690243,0.000023814313,0.00010466649,0.00036960343],"about_ca_topic_score_codex":0.0004262365,"about_ca_topic_score_gemma":0.00021026912,"teacher_disagreement_score":0.13145816,"about_ca_system_score_codex":0.00044015583,"about_ca_system_score_gemma":0.0004100618,"threshold_uncertainty_score":0.7007099},"labels":[],"label_agreement":null},{"id":"W2944446579","doi":"10.1093/jnci/djz037","title":"Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Hospital for Sick Children; Princess Margaret Cancer Centre; SickKids Foundation; University of Toronto; Pediatric Oncology Group; University of Waterloo","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Hodgkin lymphoma; Breast cancer; Lymphoma; Oncology; Radiation therapy; Internal medicine; Radiology; Cancer","score_opus":0.040065546030906084,"score_gpt":0.3506534106533176,"score_spread":0.31058786462241156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944446579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949365,0.0014160122,0.0000043222585,0.0013761935,0.0010319856,0.00045102433,0.00044080956,0.00000367657,0.00033944024],"genre_scores_gemma":[0.9986741,0.00077005825,0.000036062123,0.00019766149,0.00020525427,0.00001958793,0.000007575499,0.000010267025,0.00007945896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792993,0.000105327985,0.00070847577,0.0001506,0.00094871514,0.00015693904],"domain_scores_gemma":[0.99772954,0.000096604774,0.00083461584,0.0001591763,0.0010993403,0.00008070846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005255026,0.00015012425,0.00049128826,0.00019329425,0.00003213292,0.000008740943,0.00019706263,0.00007961195,0.00014667994],"category_scores_gemma":[0.000094063165,0.00009842664,0.00022205038,0.0005145452,0.000107593325,0.00020194698,0.000033934597,0.000118343916,0.0000029150187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012328881,0.0005898893,0.9754117,0.00013075025,0.00023128017,0.000006492175,0.00012820527,0.0016000847,0.00057149574,0.000056438028,0.0004584199,0.019582361],"study_design_scores_gemma":[0.003129523,0.00008059422,0.9861832,0.00075251784,0.000070431364,0.000057453868,0.000014565935,0.00021773246,0.008245808,0.000032838103,0.0011349604,0.000080374164],"about_ca_topic_score_codex":0.004613394,"about_ca_topic_score_gemma":0.001889808,"teacher_disagreement_score":0.019501986,"about_ca_system_score_codex":0.0010454523,"about_ca_system_score_gemma":0.0015684094,"threshold_uncertainty_score":0.6974102},"labels":[],"label_agreement":null},{"id":"W2944978620","doi":"10.1182/blood.v130.suppl_1.4081.4081","title":"Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McGill University; University of Calgary; Juravinski Cancer Centre; McMaster University; Queen's University","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Internal medicine; Population; Chemotherapy regimen; Oncology; Vinblastine; Survival analysis; Cancer; Surgery; Chemotherapy; Vincristine","score_opus":0.02303102582636087,"score_gpt":0.29204542761465074,"score_spread":0.2690144017882899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944978620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623793,0.00012504002,6.6078144e-7,0.00010556349,0.00006979249,0.0014801701,0.001570131,0.000007848091,0.00040285167],"genre_scores_gemma":[0.99911094,0.000008751841,0.000048858445,0.000047443482,0.000019661626,0.00011072427,0.00043194636,0.000021350088,0.00020032401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832153,0.00007871223,0.0005476609,0.00027914875,0.00052735646,0.00024557958],"domain_scores_gemma":[0.9977955,0.00007624418,0.00094729837,0.00085613877,0.00015887275,0.00016592891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010465315,0.00023950823,0.0013508435,0.00022637163,0.0001584678,0.00002965185,0.00022569114,0.0001119952,0.00005907263],"category_scores_gemma":[0.000057976697,0.00012755733,0.00027750846,0.00033040467,0.0001989144,0.00007470595,0.00003240928,0.000057966845,2.7056464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048274536,0.006217943,0.93525875,0.000034979927,0.008176322,0.000021131335,0.00029624416,0.0000036407366,0.00006176662,0.0000075272387,0.00010926571,0.0015378863],"study_design_scores_gemma":[0.32802492,0.0024768293,0.6581449,0.00006575231,0.0072719175,1.9498817e-7,0.00003747588,0.000010891897,0.0037891483,2.8757987e-7,0.00008950059,0.000088176974],"about_ca_topic_score_codex":0.37912598,"about_ca_topic_score_gemma":0.5502538,"teacher_disagreement_score":0.27975038,"about_ca_system_score_codex":0.00016218591,"about_ca_system_score_gemma":0.00055274053,"threshold_uncertainty_score":0.62500846},"labels":[],"label_agreement":null},{"id":"W2945383488","doi":"10.1016/j.cca.2019.04.024","title":"Urinary MMP-2 as a potential biomarker of severity of obstructive sleep apnea","year":2019,"lang":"en","type":"article","venue":"Clinica Chimica Acta","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Sleep & Circadian Network; University of Saskatchewan","funders":"","keywords":"Medicine; Rheumatoid factor; Internal medicine; Rheumatoid arthritis; Biomarker; Gastroenterology; Antibody; Obstructive sleep apnea; Population; Grass carp; Urinary system; Autoantibody; Immunology; Fish <Actinopterygii>; Biology","score_opus":0.018599346001297826,"score_gpt":0.2980059912423943,"score_spread":0.2794066452410965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945383488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880913,0.00009296677,8.686223e-7,0.00088612013,0.00038014608,0.00051518215,0.00006396018,0.000025670352,0.009943816],"genre_scores_gemma":[0.9986432,0.00010585732,0.0005918979,0.00020229128,0.00006652367,0.00001464253,0.000048548754,0.000022149636,0.0003048713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845403,0.00006410835,0.0006217113,0.00037478268,0.00027380657,0.00021155215],"domain_scores_gemma":[0.99841446,0.00026611527,0.00036051587,0.0006839604,0.00013513365,0.0001398336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015452517,0.00018649266,0.000679145,0.000086013395,0.000024624722,0.000004753291,0.00015655081,0.00017521187,0.0008568186],"category_scores_gemma":[0.00016797602,0.00014780216,0.00039005277,0.00014817088,0.00018236115,0.00006967523,0.00014417802,0.00011617774,0.00009964578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062757754,0.011454262,0.85364807,0.0006114199,0.0027515416,0.00016005752,0.0006323188,9.0375147e-7,0.101859756,0.00036761528,0.002646172,0.019592099],"study_design_scores_gemma":[0.0050808755,0.0015045428,0.9728402,0.0001297979,0.00041479827,0.00013687614,0.00012285844,0.00018336574,0.017725121,0.0002578697,0.0014604273,0.00014327255],"about_ca_topic_score_codex":0.00005183742,"about_ca_topic_score_gemma":9.4093696e-7,"teacher_disagreement_score":0.119192116,"about_ca_system_score_codex":0.000053348744,"about_ca_system_score_gemma":0.0001382756,"threshold_uncertainty_score":0.93815625},"labels":[],"label_agreement":null},{"id":"W2945439268","doi":"10.18192/uojm.v9i1.4160","title":"Rituximab and Immune Molecule Modulation in Burkitt’s Lymphoma Cell Lines","year":2019,"lang":"en","type":"article","venue":"University of Ottawa Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Raji cell; Rituximab; Immune system; CD20; Lymphoma; Immunotherapy; Immunology; Monoclonal antibody; Cancer research; Burkitt's lymphoma; Antibody; B cell; Medicine","score_opus":0.006427368800262108,"score_gpt":0.2057554679998321,"score_spread":0.19932809919957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945439268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904689,0.0026528582,0.00004470503,0.0029275105,0.00010156415,0.00012804779,0.00000136842,0.0000033495476,0.003671704],"genre_scores_gemma":[0.99807477,0.00072738907,0.00059601787,0.00007687929,0.000052285013,2.8902978e-8,0.000004138634,0.0000054391917,0.00046303766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999233,0.000030882034,0.00027844525,0.00009745386,0.00026071395,0.00009948778],"domain_scores_gemma":[0.9992604,0.00006656529,0.000291932,0.00011834367,0.00016554346,0.0000972166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023474307,0.0000922003,0.00048271642,0.00028512202,0.00001992814,0.0000016541342,0.0000679484,0.000059660444,0.00016779437],"category_scores_gemma":[0.000033398002,0.000074315285,0.00006789889,0.0001329241,0.00009477022,0.00009259135,0.00002423648,0.00006245477,0.0000060939487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010753723,0.0026044794,0.9163857,0.0004081701,0.00027272358,0.0017034254,0.0026624626,0.00011320959,0.04062541,0.00068799034,0.0027028134,0.030758262],"study_design_scores_gemma":[0.04699007,0.0017811719,0.9371988,0.0008464598,0.00024923123,0.00029412395,0.0016109986,0.000658089,0.006021236,0.000073105,0.0041896882,0.00008700473],"about_ca_topic_score_codex":0.0004041187,"about_ca_topic_score_gemma":0.000013210106,"teacher_disagreement_score":0.0459147,"about_ca_system_score_codex":0.00011255564,"about_ca_system_score_gemma":0.000080845864,"threshold_uncertainty_score":0.30304894},"labels":[],"label_agreement":null},{"id":"W2945661283","doi":"10.1200/jco.19.00315","title":"Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Internal medicine; Dacarbazine; Adverse effect; Neutropenia; Clinical endpoint; Tolerability; Rash; Oncology; Surgery; Cancer; Chemotherapy; Clinical trial; Immunotherapy","score_opus":0.07774469496044747,"score_gpt":0.46104854099773945,"score_spread":0.38330384603729195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945661283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98962885,0.0007859219,0.000024184865,0.006186897,0.0007985705,0.0017578166,0.000012359998,0.000007683936,0.00079770276],"genre_scores_gemma":[0.99528986,0.0010194688,0.00072884274,0.0021292889,0.00037500536,0.00004018405,0.0000051675534,0.000019452487,0.00039272022],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964218,0.00048593496,0.0021445435,0.00029960944,0.00033743356,0.00031063528],"domain_scores_gemma":[0.9904756,0.0075616017,0.0012280452,0.00031864177,0.00017292779,0.00024319628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036567464,0.00020406501,0.0017047416,0.000111223584,0.00008643019,0.000016364482,0.00020474022,0.00024013723,0.00009649243],"category_scores_gemma":[0.0025153358,0.00011534323,0.0004197076,0.00015077763,0.00012076304,0.00012532622,0.000073958065,0.0003359856,0.000012055688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026370998,0.06983307,0.11323563,0.000040752777,0.0005510481,0.001720516,0.0010259104,0.000039512353,0.00003837027,0.00034902373,0.0021135309,0.7846816],"study_design_scores_gemma":[0.22489326,0.08504176,0.5792916,0.00008723456,0.00045208455,0.00014051268,0.0010182579,0.00015529568,0.000012882119,0.00009064213,0.108713366,0.00010310638],"about_ca_topic_score_codex":0.00003394136,"about_ca_topic_score_gemma":0.000122413,"teacher_disagreement_score":0.7845785,"about_ca_system_score_codex":0.0002940984,"about_ca_system_score_gemma":0.0008573591,"threshold_uncertainty_score":0.47035605},"labels":[],"label_agreement":null},{"id":"W2946486395","doi":"10.1016/s1470-2045(19)30091-9","title":"Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Open label; Medicine; Internal medicine; Oncology; Lymphoma; Brentuximab vedotin; Phases of clinical research; Diffuse large B-cell lymphoma; Clinical trial; Hodgkin lymphoma","score_opus":0.018808620936235258,"score_gpt":0.3208220799402624,"score_spread":0.30201345900402715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946486395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911921,0.00013058513,0.0000020822906,0.0004010086,0.000059500635,0.006889974,0.000012403154,0.00003050552,0.0012818339],"genre_scores_gemma":[0.9981705,0.00006690197,0.00013766489,0.00073521945,0.000028056069,0.00049708504,0.00018351883,0.000042364514,0.0001386705],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99813765,0.00039858418,0.0003503242,0.0004231682,0.00022816496,0.0004621254],"domain_scores_gemma":[0.99874985,0.00017287952,0.000218195,0.0006897876,0.00008953488,0.00007975811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004977711,0.00027260458,0.000996538,0.0001226294,0.000063004016,0.00003774616,0.00032518106,0.00010397976,0.00003946995],"category_scores_gemma":[0.000013258488,0.00015041353,0.000018294262,0.000348493,0.00005122146,0.0001557085,0.00007483771,0.00013992301,0.000035761528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07708689,0.25749868,0.6565954,0.000026202,0.00016207718,0.00012485293,0.0036368414,0.0000019653512,0.00012338742,0.000030970332,0.00006433398,0.0046484116],"study_design_scores_gemma":[0.57552654,0.029419927,0.3938788,0.00007395621,0.00009068096,0.000006250712,0.00035870657,0.00015086179,0.00012677655,0.000007889273,0.00023996782,0.000119635304],"about_ca_topic_score_codex":0.0010048179,"about_ca_topic_score_gemma":0.0013607536,"teacher_disagreement_score":0.49843967,"about_ca_system_score_codex":0.00079442974,"about_ca_system_score_gemma":0.0003066534,"threshold_uncertainty_score":0.6133686},"labels":[],"label_agreement":null},{"id":"W2946858619","doi":"10.1200/jco.2019.37.15_suppl.e15701","title":"Comprehensive characterization of pseudomyxoma peritonei.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"GNAS complex locus; KRAS; Pseudomyxoma peritonei; Medicine; Stromal cell; Neuroblastoma RAS viral oncogene homolog; Pathology; Deep sequencing; Cancer research; Internal medicine; Biology; Cancer; Gene; Appendix; Colorectal cancer; Genetics; Genome","score_opus":0.10254429420385829,"score_gpt":0.45151573837171055,"score_spread":0.34897144416785225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946858619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277693,0.00012846128,0.0000118480375,0.0034834554,0.001213103,0.00016550963,0.000003015097,0.0000032957448,0.0022143584],"genre_scores_gemma":[0.9964416,0.000562589,0.00091531145,0.0013587673,0.0004897752,0.0000013713153,0.0000055524324,0.0000073119263,0.0002177104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792063,0.00015170404,0.001511144,0.00009684441,0.0002212479,0.000098421515],"domain_scores_gemma":[0.99698365,0.0007823213,0.0014328307,0.00013576957,0.0005062891,0.00015916917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045715537,0.00007723796,0.0012082085,0.000068314686,0.000009407012,0.0000025914217,0.00006533345,0.0001984781,0.0003133843],"category_scores_gemma":[0.00028689086,0.00005056399,0.00039480164,0.000067067595,0.00007792862,0.00006731073,0.000024239915,0.00020444432,0.00006278625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029287618,0.003922659,0.8578656,0.0000739225,0.00057442783,0.00038149202,0.000094131676,0.000001882883,0.028413136,0.00030615905,0.0006162176,0.10482166],"study_design_scores_gemma":[0.008391126,0.011270732,0.90561706,0.000092120084,0.00021241636,0.0003658886,0.000046562687,0.000028293392,0.0017839308,0.00003153049,0.07212146,0.000038863465],"about_ca_topic_score_codex":0.000005471196,"about_ca_topic_score_gemma":5.5188406e-7,"teacher_disagreement_score":0.10478279,"about_ca_system_score_codex":0.000075290416,"about_ca_system_score_gemma":0.0006266743,"threshold_uncertainty_score":0.34313387},"labels":[],"label_agreement":null},{"id":"W2947330283","doi":"10.1200/jco.2019.37.15_suppl.6511","title":"Longitudinal toxicity analysis with novel summary metrics of lenalidomide maintenance in follicular lymphoma in ECOG-ACRIN 2408.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Lenalidomide; Internal medicine; Adverse effect; Follicular lymphoma; Bendamustine; Gastroenterology; Area under the curve; Rituximab; Surgery; Toxicity; Lymphoma; Multiple myeloma","score_opus":0.07840256986650905,"score_gpt":0.403790824738665,"score_spread":0.32538825487215595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947330283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956222,0.00059854146,0.000233175,0.0018434691,0.00024899346,0.00029684723,0.000007863,0.0000029226521,0.0011459563],"genre_scores_gemma":[0.99394494,0.0009813027,0.004135639,0.0006729477,0.00011116391,0.000007156187,0.000003657664,0.000012295035,0.00013087277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995927,0.0002513706,0.0027061298,0.00029806845,0.0005045304,0.00031290588],"domain_scores_gemma":[0.9950244,0.0022930657,0.0017698596,0.00029989803,0.0003635939,0.00024920003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003071675,0.00018811085,0.0028780273,0.0008317702,0.0000102697595,0.000005969252,0.00018505829,0.000305303,0.000080102196],"category_scores_gemma":[0.0014989696,0.00011850059,0.0007964412,0.0014806418,0.00013259923,0.00012393338,0.000061906074,0.0003421467,0.000006354268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009569972,0.0086041745,0.9636855,0.000038143597,0.0017984408,0.0022411763,0.000034565637,0.00060052436,0.00009169532,0.00015618381,0.00014121355,0.013038414],"study_design_scores_gemma":[0.05067354,0.0074728657,0.93692833,0.00025195815,0.0013295498,0.0002502334,0.00008494716,0.00050459325,0.00043837496,0.0000365851,0.0019202012,0.00010879489],"about_ca_topic_score_codex":0.00039784174,"about_ca_topic_score_gemma":0.0012863026,"teacher_disagreement_score":0.041103568,"about_ca_system_score_codex":0.00068900327,"about_ca_system_score_gemma":0.0013171452,"threshold_uncertainty_score":0.48323137},"labels":[],"label_agreement":null},{"id":"W2947430416","doi":"10.1200/jco.2019.37.15_suppl.e18347","title":"Real-world demographic and clinical characteristics of patients diagnosed with diffuse large B-cell lymphoma (DLBCL) in the United States (US).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Lymphoma; Comorbidity; International Prognostic Index; Diagnosis code; Oncology; Population","score_opus":0.035913725050773004,"score_gpt":0.37627531164420264,"score_spread":0.34036158659342963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947430416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974133,0.00008284895,0.0000018486112,0.0012182996,0.00039055548,0.00043985678,0.00002567201,0.0000046036,0.00042301908],"genre_scores_gemma":[0.9889073,0.007562331,0.00029319146,0.0029456422,0.00018034312,0.000005975913,0.00004651982,0.000017707764,0.000041015595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954844,0.00085080334,0.0027487318,0.0002239487,0.00041966562,0.0002724163],"domain_scores_gemma":[0.98866814,0.008152105,0.0021864485,0.00029601023,0.00041384075,0.00028343056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029153388,0.00018591696,0.001721623,0.00029026822,0.000027897519,0.000011338306,0.0001787226,0.00026756356,0.000027421873],"category_scores_gemma":[0.0009793855,0.00009537987,0.00034535475,0.0003910566,0.00026273416,0.00006740773,0.000056209316,0.00045769304,0.000007176379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004055911,0.05252862,0.92804205,0.000044974833,0.00029095574,0.0006122981,0.00015892614,3.662873e-7,6.590328e-7,0.00006383993,0.00044822876,0.013753145],"study_design_scores_gemma":[0.08468486,0.017888183,0.8795419,0.00016325341,0.0005431747,0.000025118525,0.0001591191,0.00007444119,0.0000031392592,0.000032381035,0.016799383,0.00008505326],"about_ca_topic_score_codex":0.00019449781,"about_ca_topic_score_gemma":0.00039857536,"teacher_disagreement_score":0.080628954,"about_ca_system_score_codex":0.0000846255,"about_ca_system_score_gemma":0.0005193525,"threshold_uncertainty_score":0.3889478},"labels":[],"label_agreement":null},{"id":"W2947443070","doi":"10.1182/blood.2019000012","title":"Follicular lymphoma with composite in situ mantle cell neoplasia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital","funders":"","keywords":"Axillary Lymphadenopathy; Follicular lymphoma; Mantle cell lymphoma; Pathology; Lymphoma; Population; Lymph node; CD5; Mediastinum; Biology; Medicine; Internal medicine; Anatomy; Breast cancer; Cancer","score_opus":0.004247111547884484,"score_gpt":0.19873589739316863,"score_spread":0.19448878584528415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947443070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681297,0.0006035935,0.0000014041872,0.00017199972,0.000036109832,0.00040498038,0.0000029565756,0.00003172669,0.030617505],"genre_scores_gemma":[0.998135,0.000039291263,0.0006202185,0.00025574912,0.000029287405,0.000031204483,0.000027168753,0.00001885593,0.0008432298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992553,0.000014133107,0.00012292199,0.0002290088,0.00017377376,0.00020488081],"domain_scores_gemma":[0.999551,0.000026988053,0.00003597718,0.00027900597,0.00001999641,0.00008702737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033129756,0.00013268134,0.0002491559,0.00006310244,0.000018147724,0.000014114665,0.000046540994,0.000053256033,0.000064091335],"category_scores_gemma":[0.0000014059549,0.000092956405,0.00005692454,0.0001276615,0.0000133827325,0.000037098263,0.00002176146,0.000030202838,0.0005340788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114738905,0.0037113603,0.97676367,0.00006766329,0.00010856576,0.0011378364,0.00014656832,0.000005031949,0.016971083,0.00007572882,0.00012131926,0.00077643245],"study_design_scores_gemma":[0.025121635,0.00068403315,0.76793915,0.00014792137,0.00023525923,0.00026659048,0.000056913697,0.000013452688,0.20311113,0.0000083514915,0.002285606,0.00012998187],"about_ca_topic_score_codex":0.000111306654,"about_ca_topic_score_gemma":0.00004847249,"teacher_disagreement_score":0.20882455,"about_ca_system_score_codex":0.00005520019,"about_ca_system_score_gemma":0.00006260367,"threshold_uncertainty_score":0.68646806},"labels":[],"label_agreement":null},{"id":"W2947924227","doi":"10.1111/bjh.15965","title":"Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Key (lock); Element (criminal law); Precision medicine; Medicine; Data science; Computer science; Computational biology; Intensive care medicine; Biology; Pathology; Political science; Computer security; Law","score_opus":0.10610159408223732,"score_gpt":0.4056930360424656,"score_spread":0.29959144196022824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947924227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003105065,0.9933547,0.00002812713,0.0005522092,0.0005600757,0.0018810591,0.00019856205,0.00000812338,0.00031207537],"genre_scores_gemma":[0.0004495008,0.9967139,0.0014276346,0.00018951859,0.00031434177,0.00007448397,0.00037220266,0.000057020905,0.0004014036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960056,0.000266373,0.0022614447,0.0005808081,0.0004448203,0.00044094483],"domain_scores_gemma":[0.99626726,0.0009938583,0.0016887322,0.00057555875,0.00023398038,0.00024060826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014716794,0.00039766158,0.0054084095,0.00063627545,0.00005130197,0.00004499709,0.0004553202,0.00024279012,0.00011303316],"category_scores_gemma":[0.0007145967,0.0003118055,0.00034643747,0.00025498483,0.0001675282,0.00013471827,0.00026530304,0.00024527297,0.000017882272],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016963664,0.000489545,0.000560663,0.011389063,0.00079555035,0.030742873,0.000049231876,9.218964e-8,8.497761e-7,0.00032649926,0.01860547,0.9368705],"study_design_scores_gemma":[0.0054855007,0.0010202166,0.0003045752,0.08056799,0.003112329,0.27351174,0.000040944262,0.0000034939858,0.0000022763925,0.00018799082,0.6355691,0.00019381865],"about_ca_topic_score_codex":0.0008990129,"about_ca_topic_score_gemma":0.0007851492,"teacher_disagreement_score":0.9366767,"about_ca_system_score_codex":0.00039587464,"about_ca_system_score_gemma":0.001328249,"threshold_uncertainty_score":0.9999334},"labels":[],"label_agreement":null},{"id":"W2948321946","doi":"10.1200/jco.19.00014","title":"Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"Genentech; MorphoSys; National Cancer Institute; Celgene","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Cumulative incidence; Aggressive lymphoma; Incidence (geometry); Oncology; Rituximab; Cohort","score_opus":0.021605431312223554,"score_gpt":0.3417026623509291,"score_spread":0.3200972310387056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948321946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959124,0.0002315202,0.0000020438242,0.0008490624,0.00018102133,0.00035008587,0.0000035956039,0.000008171149,0.002462131],"genre_scores_gemma":[0.9964728,0.00045013207,0.00073008944,0.0015587437,0.00009480559,0.0000046940454,0.000007941131,0.000025531355,0.00065527775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780923,0.00018263479,0.0012160294,0.00019913052,0.00033045732,0.00026251195],"domain_scores_gemma":[0.99750125,0.00070868526,0.0010569857,0.00024325305,0.00027301157,0.00021683417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000610068,0.00017674062,0.0013522791,0.00012103695,0.000018679544,0.000008120339,0.00010064652,0.00025306913,0.00011548343],"category_scores_gemma":[0.00011023331,0.000090509,0.00021054293,0.0001592517,0.00007118192,0.000101615675,0.000019029925,0.0002606424,0.000053770906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019531293,0.04442396,0.9143636,0.000013781334,0.00038755298,0.0005685415,0.000064730106,0.0000022833071,0.000011650471,0.000010714218,0.00023932807,0.020382516],"study_design_scores_gemma":[0.19537556,0.03457422,0.7612676,0.00016059272,0.00019160876,0.000039974973,0.000029227094,0.000008805446,0.00013139268,0.0000074421096,0.0081299795,0.0000836066],"about_ca_topic_score_codex":0.000031873114,"about_ca_topic_score_gemma":0.000026587622,"teacher_disagreement_score":0.17584427,"about_ca_system_score_codex":0.0002847492,"about_ca_system_score_gemma":0.0007144544,"threshold_uncertainty_score":0.36908498},"labels":[],"label_agreement":null},{"id":"W2948592421","doi":"10.1007/s10552-019-01188-w","title":"Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences; Medical Research Council; Cancer Council NSW; Institut National Du Cancer; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Health and Medical Research Council; Michael Smith Health Research BC; University of California, San Francisco; National Institutes of Health; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Bundesamt für Strahlenschutz; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; José Carreras Leukämie-Stiftung; Fondation de France; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; National Cancer Institute; Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; Health Research Board; Blood Cancer UK; Yale University","keywords":"Medicine; Odds ratio; Confidence interval; Blood transfusion; Body mass index; Demography; Logistic regression; Population; Socioeconomic status; Internal medicine; Environmental health","score_opus":0.0072859326592408106,"score_gpt":0.24661226921948412,"score_spread":0.2393263365602433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948592421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858083,0.012690961,0.00010200175,0.000119752345,0.0002145554,0.0005703719,0.00009830684,0.00003156996,0.0003641836],"genre_scores_gemma":[0.9952417,0.0037817233,0.000054426888,0.00039719883,0.00008282866,0.00012675914,0.000020553902,0.000022899834,0.0002719089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987676,0.00007125699,0.00032022022,0.00040678345,0.00021672907,0.00021741832],"domain_scores_gemma":[0.99897736,0.000098020384,0.00017673892,0.00044052326,0.00012177311,0.00018556775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012289562,0.0002138291,0.0007896382,0.00022273102,0.000030726187,0.000008748836,0.00007170549,0.00009901322,0.0005614257],"category_scores_gemma":[0.000014415554,0.00016679644,0.00027320406,0.00018021198,0.00007307647,0.00009877599,0.000011989173,0.000044265387,0.000008339369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073357724,0.00079264876,0.9415873,0.000072787494,0.0076526334,0.00003819815,0.0008101968,0.000036996615,0.012614476,0.00002589255,0.00009849373,0.035536785],"study_design_scores_gemma":[0.02552305,0.001144331,0.9333005,0.00010792744,0.031657234,0.0000124021735,0.000116039635,0.0017465238,0.0046039736,0.000005648481,0.0015946953,0.0001876782],"about_ca_topic_score_codex":0.006448419,"about_ca_topic_score_gemma":0.0014179231,"teacher_disagreement_score":0.035349105,"about_ca_system_score_codex":0.00044627307,"about_ca_system_score_gemma":0.00025088675,"threshold_uncertainty_score":0.9748123},"labels":[],"label_agreement":null},{"id":"W2948851811","doi":"10.1182/blood.v130.suppl_1.1228.1228","title":"Functional Investigation of the Gene NFKBIZ and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Untranslated region; Genetics; Gene; Germinal center; Three prime untranslated region; Mutation; Locus (genetics); Five prime untranslated region; Somatic hypermutation; Cancer research; B cell; Messenger RNA","score_opus":0.016111810455539808,"score_gpt":0.2539010740458301,"score_spread":0.23778926359029032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948851811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982489,0.00035848116,0.00000158218,0.00055037055,0.000028256147,0.00025579816,0.000035563935,0.0000029287846,0.00051815744],"genre_scores_gemma":[0.9997187,0.000056769473,0.00004217071,0.000038795235,0.000027400896,0.000028808648,0.000013701508,0.000004903063,0.00006874972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954283,0.00003428901,0.00014662233,0.00008274652,0.00011844106,0.00007506331],"domain_scores_gemma":[0.99937063,0.000088347326,0.00015681572,0.0003076214,0.000043638764,0.000032924716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011608738,0.000064203676,0.00014380434,0.000027765836,0.0001053594,0.000010662289,0.000057081295,0.000031579013,0.000010359719],"category_scores_gemma":[0.00009516696,0.000030240675,0.00008903439,0.00004532495,0.00018390207,0.000039629787,0.000039806553,0.000021744934,0.0000016364845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006612626,0.0034352974,0.9915869,0.000017516859,0.00010889528,0.0000035181536,0.0005066304,0.000002540691,0.0034638683,0.0004860538,0.0000811674,0.00024146498],"study_design_scores_gemma":[0.04675635,0.00007633396,0.9091922,0.000036443787,0.00018927487,0.000016419563,0.000037866615,0.000080496786,0.043157462,0.00042715375,0.0000050679405,0.000024901852],"about_ca_topic_score_codex":0.00065192237,"about_ca_topic_score_gemma":0.000055798657,"teacher_disagreement_score":0.08239469,"about_ca_system_score_codex":0.000025544916,"about_ca_system_score_gemma":0.0001194849,"threshold_uncertainty_score":0.1233179},"labels":[],"label_agreement":null},{"id":"W2949084717","doi":"10.1111/bjh.16014","title":"Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Pediatric oncology; Pediatrics; Cancer","score_opus":0.010637086228555123,"score_gpt":0.25825139555063376,"score_spread":0.24761430932207862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949084717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97499746,0.017823365,0.0001427229,0.004184598,0.00035170847,0.0022361318,0.00022361903,0.000018051662,0.000022315398],"genre_scores_gemma":[0.98392355,0.012844882,0.002043843,0.0005644271,0.0002462405,0.00017867729,0.000096548145,0.00004860115,0.000053227668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972926,0.00059008435,0.0009949562,0.00037258473,0.00037427395,0.0003755505],"domain_scores_gemma":[0.9936756,0.0037847743,0.0015116014,0.00060350116,0.00028547965,0.00013903664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818473,0.00030435002,0.0014254373,0.00009189829,0.00019322585,0.00003709018,0.00029901322,0.00021232695,0.00012794383],"category_scores_gemma":[0.0002650065,0.00016082573,0.0004963958,0.00015488591,0.0002721332,0.00007365618,0.000025806517,0.00014159564,0.000007359442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01573894,0.0044511235,0.7268975,0.0000045459824,0.0057913116,0.0153418565,0.00062162516,0.000022191696,0.00007611839,0.00007518295,0.003244645,0.22773498],"study_design_scores_gemma":[0.036472186,0.011718609,0.7598177,0.00016680123,0.0010206858,0.1829293,0.00015650284,0.000008007757,0.0010139197,0.00010359431,0.0064669317,0.00012574397],"about_ca_topic_score_codex":0.008697747,"about_ca_topic_score_gemma":0.0010708071,"teacher_disagreement_score":0.22760925,"about_ca_system_score_codex":0.0003674177,"about_ca_system_score_gemma":0.00073184504,"threshold_uncertainty_score":0.9979034},"labels":[],"label_agreement":null},{"id":"W2949220394","doi":"10.1097/01.hs9.0000561568.20578.1a","title":"S822 NIVOLUMAB AND BRENTUXIMAB VEDOTIN‐BASED, RESPONSE‐ADAPTED TREATMENT IN PRIMARY REFRACTORY AND IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CHECKMATE 744","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Nivolumab; Refractory (planetary science); Cohort; Oncology; Salvage therapy; Regimen; Bendamustine; Surgery; Lymphoma; Chemotherapy; Rituximab; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.007223904925934763,"score_gpt":0.21527984959316313,"score_spread":0.20805594466722838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949220394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945047,0.0026434318,4.8340803e-7,0.0002906815,0.00007317557,0.0013647613,0.000021996384,0.00004206699,0.0010587337],"genre_scores_gemma":[0.998124,0.00047651798,0.00033584423,0.00019420794,0.000033798617,0.00018093074,0.000089019835,0.000060011465,0.0005056444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975625,0.00022924665,0.00053218025,0.00076402636,0.00040399408,0.0005080082],"domain_scores_gemma":[0.9987141,0.0003945341,0.00017317531,0.0004500549,0.000046095058,0.00022204807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021718952,0.00043757775,0.0008029004,0.00030816364,0.000037076814,0.000028053906,0.000066030836,0.0002558246,0.00010109124],"category_scores_gemma":[0.000051842002,0.00033702556,0.00006388775,0.0004252423,0.00007896701,0.00018621987,0.00006178701,0.00017999606,0.00003652453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011548406,0.006463546,0.9611192,0.00020709637,0.00003564586,0.0005470249,0.00034716973,0.000008232826,0.00009866482,0.0000066053576,0.00010617189,0.019512288],"study_design_scores_gemma":[0.061002534,0.0033847329,0.93275404,0.0003916173,0.00008916572,0.000017715387,0.00013073572,0.00015286801,0.0001350851,0.000005615484,0.0016223199,0.0003135756],"about_ca_topic_score_codex":0.00034762183,"about_ca_topic_score_gemma":0.0008099673,"teacher_disagreement_score":0.04945413,"about_ca_system_score_codex":0.0018786045,"about_ca_system_score_gemma":0.00058930303,"threshold_uncertainty_score":0.99990815},"labels":[],"label_agreement":null},{"id":"W2949315927","doi":"10.1097/01.hs9.0000563256.18006.bf","title":"PS1244 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF PATIENTS DIAGNOSED WITH CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ANTI‐PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Pediatrics; Internal medicine; Retrospective cohort study; Cancer; Immunotherapy","score_opus":0.01748511497946377,"score_gpt":0.25687475519915653,"score_spread":0.23938964021969278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949315927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994825,0.00017609417,0.0000022904676,0.0011434613,0.000025286543,0.0016868977,0.00004636877,0.00006798121,0.0020266299],"genre_scores_gemma":[0.99723953,0.00021543122,0.000114231436,0.0006105087,0.00003664874,0.00013396589,0.0012722417,0.000059105605,0.00031832373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768794,0.00021847185,0.00053360395,0.00048338837,0.0006637358,0.00041288225],"domain_scores_gemma":[0.9984228,0.00026305634,0.00030294355,0.0006089635,0.00024277202,0.00015946855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016106287,0.0003548286,0.00061268156,0.0001837151,0.000072000854,0.000027638558,0.00012479011,0.00012824319,0.00010000399],"category_scores_gemma":[0.00003162806,0.00019359041,0.0000866435,0.0014562956,0.00013042132,0.0000864634,0.00003460504,0.00012890087,0.000020040483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012345207,0.0023112954,0.9887163,0.00026167874,0.000109448825,0.0001574063,0.0013226644,0.00011651688,0.000020562557,0.00018631828,0.0011411855,0.0044221263],"study_design_scores_gemma":[0.013092466,0.0027090851,0.9681856,0.0012461476,0.00014454497,0.000013554883,0.0020541386,0.00039882853,0.003487175,0.000008452409,0.008430016,0.00022997695],"about_ca_topic_score_codex":0.0062327846,"about_ca_topic_score_gemma":0.004097967,"teacher_disagreement_score":0.020530662,"about_ca_system_score_codex":0.00036465653,"about_ca_system_score_gemma":0.00017848719,"threshold_uncertainty_score":0.9422147},"labels":[],"label_agreement":null},{"id":"W2949376168","doi":"10.1002/hon.131_2631","title":"PRIMARY PANCREATIC LYMPHOMA: CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND OUTCOME IN A MULTICENTRIC ITALIAN EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Hematology; Lymphoma; Medical record; International Prognostic Index; Gastroenterology; Radiation therapy; Oncology; Diffuse large B-cell lymphoma","score_opus":0.06891196737359159,"score_gpt":0.4040591967374352,"score_spread":0.33514722936384356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949376168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148804,0.0017626587,0.0000022614136,0.002018249,0.00020020506,0.0014181876,0.000004246863,0.00005463019,0.0030514987],"genre_scores_gemma":[0.99412644,0.0019617898,0.0012026251,0.0014070863,0.000040869632,0.0009418923,0.00002803623,0.000012407276,0.00027888216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776995,0.00024093955,0.00084073876,0.0005958202,0.00015643949,0.00039608436],"domain_scores_gemma":[0.99758637,0.0016306743,0.00016484004,0.00030391474,0.000040202263,0.0002739844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018375689,0.00024738838,0.0012055786,0.00010317529,0.00004097247,0.000015245949,0.00007433813,0.00029874893,0.000313921],"category_scores_gemma":[0.00031043298,0.00015877107,0.00015480592,0.000192083,0.00018936342,0.00007558995,0.00008188649,0.00007696519,0.0002444223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032606345,0.0060437312,0.9702308,0.00007071526,0.000071889226,0.0011716443,0.0004652515,6.663101e-7,0.000013928253,0.00052617927,0.0001071012,0.020972027],"study_design_scores_gemma":[0.01248337,0.0027173634,0.9730502,0.00005435037,0.00014430242,0.00058156316,0.00035509828,0.00008808091,0.00015369397,0.00005373569,0.010164347,0.0001539175],"about_ca_topic_score_codex":0.00014808234,"about_ca_topic_score_gemma":0.000030962718,"teacher_disagreement_score":0.020818109,"about_ca_system_score_codex":0.0006906343,"about_ca_system_score_gemma":0.00015381878,"threshold_uncertainty_score":0.6474496},"labels":[],"label_agreement":null},{"id":"W2949542758","doi":"10.1002/hon.36_2630","title":"RESULTS OF A MULTICENTER PHASE2 TRIAL OF INVOLVED FIELD RADIOTHERAPY ALONE FOR LOCALIZED NON‐GASTRIC MARGINAL ZONE LYMPHOMA: TROG 05.02","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Marginal zone B-cell lymphoma; Lymphoma; Splenic marginal zone lymphoma; Gastroenterology; Internal medicine; Radiation therapy; Population; Mantle cell lymphoma; Stage (stratigraphy); Surgery; Marginal zone; B cell; Splenectomy; Spleen; Antibody; Immunology","score_opus":0.02820743010664234,"score_gpt":0.329768612454491,"score_spread":0.3015611823478487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949542758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990997,0.00053947855,0.0015527551,0.002566153,0.00041372987,0.0029353644,0.000048728594,0.000031407086,0.00091535464],"genre_scores_gemma":[0.9850926,0.00023801914,0.012973855,0.000940028,0.00010986773,0.00032034752,0.000071898685,0.000017180228,0.00023623486],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99782836,0.0001304444,0.000979361,0.00043478384,0.00024060134,0.00038642672],"domain_scores_gemma":[0.99697876,0.0018263424,0.0004887016,0.0003864709,0.0001620401,0.00015768183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003231659,0.00024785445,0.001779591,0.00013298573,0.00002710837,0.0000040796094,0.0001376108,0.00041777059,0.0002627312],"category_scores_gemma":[0.0003425527,0.00016508132,0.0004314843,0.00018853343,0.00015060691,0.000034221885,0.00004191641,0.00008111771,0.000018374814],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85569346,0.035571016,0.024724972,0.00066054304,0.0011711129,0.0005710451,0.00033563637,0.0000061771734,0.010536039,0.0013568561,0.014437351,0.054935794],"study_design_scores_gemma":[0.84523594,0.060745977,0.0050559756,0.00019349318,0.00050012884,0.00026229175,0.00014540016,0.0013852007,0.052904543,0.00009017608,0.033248365,0.00023249077],"about_ca_topic_score_codex":0.00010012087,"about_ca_topic_score_gemma":0.000015780157,"teacher_disagreement_score":0.054703306,"about_ca_system_score_codex":0.00021766775,"about_ca_system_score_gemma":0.00023319386,"threshold_uncertainty_score":0.6731821},"labels":[],"label_agreement":null},{"id":"W2949614109","doi":"10.1002/hon.106_2630","title":"PHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF &gt;4 YEARS OF FOLLOW‐UP","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Pembrolizumab; Autologous stem-cell transplantation; Oncology; Cohort; Population; Lymphoma; Progression-free survival; Surgery; Chemotherapy; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.01381244760435406,"score_gpt":0.28203078677181476,"score_spread":0.2682183391674607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949614109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973922,0.00010927781,0.0000014844418,0.00016679376,0.000116722695,0.0015633506,0.00004417628,0.000017455757,0.00058856135],"genre_scores_gemma":[0.9993392,0.000011772957,0.00032415768,0.00007444459,0.000009807335,0.00013150388,0.00004181752,0.000018683528,0.000048573187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745244,0.00022634369,0.0010323902,0.00048641424,0.00045889837,0.0003435246],"domain_scores_gemma":[0.9981755,0.00045002485,0.0005648598,0.00050732435,0.00018373845,0.000118578006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018667855,0.00024830442,0.0016118508,0.00021042873,0.000010970658,0.0000029055757,0.00014828313,0.0002831141,0.00012712757],"category_scores_gemma":[0.00016323122,0.000169396,0.00015412515,0.0003557929,0.00018276408,0.00004900662,0.0001113603,0.0001063125,0.000029394696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040975824,0.10418581,0.837823,0.00016963064,0.0003108359,0.00052274246,0.0010496464,0.0000033107797,0.00013630177,0.00015407654,0.0003349304,0.014333894],"study_design_scores_gemma":[0.22507262,0.040961333,0.73143876,0.0001799886,0.00020299795,0.000034358753,0.00035395962,0.000017460843,0.0010772832,0.000023105427,0.00050753646,0.00013058662],"about_ca_topic_score_codex":0.0001137584,"about_ca_topic_score_gemma":0.00015551102,"teacher_disagreement_score":0.1840968,"about_ca_system_score_codex":0.00023444241,"about_ca_system_score_gemma":0.0002221968,"threshold_uncertainty_score":0.69077677},"labels":[],"label_agreement":null},{"id":"W2949669062","doi":"10.1002/hon.99_2629","title":"CONCORDANCE BETWEEN IMMUNOHISTOCHEMISTRY AND GENE EXPRESSION PROFILING SUBTYPING FOR DIFFUSE LARGE B‐CELL LYMPHOMA IN THE PHASE 3 PHOENIX TRIAL","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC","funders":"","keywords":"Subtyping; Immunohistochemistry; Concordance; Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Germinal center; Pathology; B cell; Immunology; Antibody","score_opus":0.03413755928242088,"score_gpt":0.3608417598344579,"score_spread":0.32670420055203697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949669062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994773,0.0014213865,0.00010831367,0.0004646536,0.00012575583,0.002189383,0.00002417356,0.000031273514,0.0008620859],"genre_scores_gemma":[0.9963691,0.000093631985,0.0020384998,0.000492822,0.00012498614,0.000702365,0.00009920021,0.00001241573,0.000066976456],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985359,0.00011209369,0.0004354971,0.00040910344,0.00013277377,0.00037466915],"domain_scores_gemma":[0.99824315,0.0011705013,0.00017666482,0.00028294127,0.000037101374,0.00008964498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037942204,0.0001925729,0.00073897565,0.00003515852,0.00008958216,0.000013204091,0.00012147419,0.00028836657,0.000035999972],"category_scores_gemma":[0.00016733122,0.00011297779,0.00012182005,0.00007970339,0.000080814076,0.00003534398,0.00007234788,0.00011715732,0.00001643213],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086070865,0.055946138,0.35168445,0.0011640969,0.00018312097,0.0013886527,0.0018079722,5.2074466e-7,0.48333558,0.0020738724,0.0014343782,0.014910347],"study_design_scores_gemma":[0.60149413,0.005667874,0.0065460084,0.0001563129,0.00018896276,0.00040343477,0.00061001244,0.00010660251,0.37514848,0.00029026906,0.009108561,0.000279381],"about_ca_topic_score_codex":0.000006252984,"about_ca_topic_score_gemma":6.7187676e-7,"teacher_disagreement_score":0.51542324,"about_ca_system_score_codex":0.00020134095,"about_ca_system_score_gemma":0.00014213733,"threshold_uncertainty_score":0.46071005},"labels":[],"label_agreement":null},{"id":"W2949673037","doi":"10.1097/01.hs9.0000558628.70462.93","title":"S102 POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Regimen; Follicular lymphoma; Interim analysis; Gastroenterology; Rituximab; Adverse effect; Lymphoma; Clinical trial","score_opus":0.01006676472665592,"score_gpt":0.25852921532171413,"score_spread":0.24846245059505823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949673037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544936,0.0014669898,0.0000072579696,0.00006354825,0.00015851433,0.001398675,0.000049510258,0.00003907076,0.0013670631],"genre_scores_gemma":[0.99853426,0.00010864067,0.00030222832,0.00013870923,0.00005130354,0.00009679116,0.00019141355,0.00004893179,0.00052771997],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99753743,0.00010693078,0.0007298122,0.0006643144,0.00055186154,0.00040964497],"domain_scores_gemma":[0.9984018,0.00013505053,0.00037763413,0.000713316,0.00013934699,0.0002328409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015915016,0.00041161,0.0013353392,0.00032834386,0.00006500047,0.000024763185,0.000121552366,0.00021184271,0.00059520506],"category_scores_gemma":[0.00007011849,0.00030707082,0.00035370124,0.00086080766,0.00009045954,0.00019190292,0.00010692671,0.00012804226,0.000030235964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1827724,0.026048196,0.723432,0.0005365716,0.010251862,0.00049897196,0.0034462698,0.000094379844,0.0020452952,0.00047326396,0.00096498674,0.049435783],"study_design_scores_gemma":[0.72674745,0.025979958,0.22746566,0.0011070097,0.006003597,0.000026824118,0.0010135808,0.0013718166,0.0044571944,0.000028073851,0.0050571696,0.00074166706],"about_ca_topic_score_codex":0.0009013801,"about_ca_topic_score_gemma":0.0002677297,"teacher_disagreement_score":0.54397506,"about_ca_system_score_codex":0.0010398881,"about_ca_system_score_gemma":0.00038336802,"threshold_uncertainty_score":0.99993813},"labels":[],"label_agreement":null},{"id":"W2949706248","doi":"10.1002/hon.103_2629","title":"STAGE I‐II NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA IN THE MODERN ERA: A MULTI‐INSTITUTIONAL EXPERIENCE OF ADULT PATIENTS BY ILROG","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Rituximab; CD20; Internal medicine; Oncology; Lymphoma; Hodgkin lymphoma; Radiation therapy; Chemotherapy; Progression-free survival; Overall survival; Retrospective cohort study","score_opus":0.01791784213219566,"score_gpt":0.2938603189074094,"score_spread":0.2759424767752137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949706248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551845,0.00059523,0.000078464276,0.00064166373,0.00016157232,0.0010852161,0.00005029056,0.000026071573,0.001843063],"genre_scores_gemma":[0.9961242,0.00017103954,0.0013365835,0.0017037087,0.000014563238,0.00038590588,0.000078289835,0.000010331989,0.00017538588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788254,0.00017754633,0.00061086525,0.0004950554,0.00041566067,0.0004183169],"domain_scores_gemma":[0.9987824,0.00033696243,0.00021481434,0.0004057196,0.00014416821,0.00011595184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001584128,0.0002691527,0.00086309476,0.000059289625,0.000096300355,0.0000074639406,0.00024907826,0.0003085566,0.0002833718],"category_scores_gemma":[0.00023808774,0.00014419216,0.00017863997,0.00019629094,0.00033307102,0.0000707156,0.00014551007,0.0001036755,0.000094873576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017619466,0.02590349,0.9259745,0.00017836186,0.00012930443,0.0012320653,0.004959781,0.000041879488,0.0024229276,0.011206948,0.0011175404,0.025071288],"study_design_scores_gemma":[0.094517075,0.010428761,0.81478894,0.0005072266,0.00021239746,0.0013330246,0.002163235,0.009636605,0.025645772,0.00046236848,0.039488073,0.000816526],"about_ca_topic_score_codex":0.0002514195,"about_ca_topic_score_gemma":0.000039784834,"teacher_disagreement_score":0.11118553,"about_ca_system_score_codex":0.0005941834,"about_ca_system_score_gemma":0.00031510272,"threshold_uncertainty_score":0.58799857},"labels":[],"label_agreement":null},{"id":"W2949734536","doi":"10.1097/01.hs9.0000560652.54765.fe","title":"PF591 EFFICACY AND SAFETY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (D‐RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED SUBGROUP ANALYSIS OF POLLUX BASED ON CYTOGENETIC RISK","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Institute of Cancer Research; Leukemia & Lymphoma Society of Canada; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Internal medicine; Medicine; Lenalidomide; Tolerability; Oncology; Multiple myeloma; Gastroenterology; Adverse effect","score_opus":0.01260982214245829,"score_gpt":0.25760121233349176,"score_spread":0.24499139019103347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949734536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671084,0.0015336593,0.00001878384,0.00009058476,0.000034423596,0.0008075919,0.00010624706,0.000020673428,0.00067717436],"genre_scores_gemma":[0.9977999,0.00045884823,0.0012599082,0.00008664292,0.000011971438,0.000021106809,0.000113426344,0.000030099178,0.00021810162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980694,0.00017952011,0.0006497117,0.0005124067,0.0003312576,0.0002576778],"domain_scores_gemma":[0.9978008,0.00095414126,0.00036002923,0.00063923333,0.000084863226,0.0001609193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031455042,0.00028123494,0.0011334426,0.0002911736,0.000041178642,0.000008592253,0.000070076545,0.00018429449,0.0007703587],"category_scores_gemma":[0.00022185719,0.00020395782,0.00015639329,0.0009190376,0.000119742195,0.000038953833,0.00004447037,0.00014717922,0.000007749096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011581976,0.0015402946,0.9658266,0.00018066466,0.0012152183,0.000076947246,0.0002945716,0.0006645621,0.0058937795,0.000024013463,0.0001027828,0.012598645],"study_design_scores_gemma":[0.033167966,0.0015733456,0.94083416,0.0003932341,0.0018696567,0.0000066139933,0.00024618543,0.007735862,0.013682701,0.0000035670448,0.0002931225,0.00019360485],"about_ca_topic_score_codex":0.0009119796,"about_ca_topic_score_gemma":0.0010308607,"teacher_disagreement_score":0.024992405,"about_ca_system_score_codex":0.00013162469,"about_ca_system_score_gemma":0.00012177829,"threshold_uncertainty_score":0.84348875},"labels":[],"label_agreement":null},{"id":"W2949786431","doi":"10.1002/hon.113_2629","title":"OUTCOME OF PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA IN THE RITUXIMAB ERA: IMPACT OF A PET‐GUIDED APPROACH","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Diffuse large B-cell lymphoma; Pericardial effusion; CHOP; Nuclear medicine; Internal medicine; Radiology; Oncology","score_opus":0.0446453396361501,"score_gpt":0.34547408597828105,"score_spread":0.30082874634213097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949786431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592441,0.0004981174,0.000016667062,0.00047411452,0.00005717656,0.0007774754,0.000018394852,0.000017065327,0.03889691],"genre_scores_gemma":[0.9968955,0.00004985119,0.0021773686,0.00065155356,0.00002227997,0.00009743178,0.000043755645,0.000010185161,0.00005210544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794203,0.00025432973,0.00078180176,0.00031370125,0.0003154425,0.0003927215],"domain_scores_gemma":[0.99827,0.00086856703,0.0002943822,0.0003930144,0.00007885095,0.00009519102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005683227,0.00021680222,0.0014994282,0.00011260773,0.000020234464,0.0000032218427,0.00021023102,0.00020404332,0.00028444114],"category_scores_gemma":[0.00013209334,0.00010722752,0.0003843383,0.00025666875,0.0001519968,0.000031997854,0.00010178914,0.00015089421,0.00006656378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061693205,0.027142478,0.9656298,0.00036794302,0.00009288652,0.00085475727,0.00035206246,0.000003297481,0.00038732705,0.0027964073,0.00093679805,0.00081928796],"study_design_scores_gemma":[0.027691666,0.003445236,0.9631866,0.000044416338,0.00014007968,0.0038819872,0.00027544194,0.00018618545,0.00041530194,0.00015061263,0.00046487365,0.00011756647],"about_ca_topic_score_codex":0.00010353803,"about_ca_topic_score_gemma":0.0000072738217,"teacher_disagreement_score":0.038844805,"about_ca_system_score_codex":0.00037355477,"about_ca_system_score_gemma":0.0003535217,"threshold_uncertainty_score":0.43726113},"labels":[],"label_agreement":null},{"id":"W2949885403","doi":"10.1002/hon.98_2630","title":"CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Medicine; Internal medicine; ABVD; Stage (stratigraphy); Chemotherapy; Population; Surgery; Radiation therapy; Gastroenterology; Chemotherapy regimen; Cyclophosphamide; Vincristine","score_opus":0.02222822920117366,"score_gpt":0.3169711645304888,"score_spread":0.2947429353293151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949885403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851596,0.00006018297,7.0806493e-7,0.00019873686,0.00008773821,0.00059445057,0.000017104818,0.000016000604,0.00050910766],"genre_scores_gemma":[0.99911386,0.00005429294,0.00011167896,0.0005420411,0.000019948799,0.000030921008,0.000036536858,0.000011553861,0.000079171834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868506,0.00012331906,0.0005081168,0.0002903434,0.00016538905,0.00022776605],"domain_scores_gemma":[0.99884456,0.0005500289,0.00020908931,0.00024505606,0.000051215124,0.00010006755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018163297,0.0001489887,0.00085040636,0.000052969663,0.000014908273,0.000006746898,0.000073688,0.00025336724,0.00017033338],"category_scores_gemma":[0.00009691274,0.0000771222,0.00007579098,0.0001322443,0.00021307259,0.0000241117,0.000071860675,0.00010999099,0.000038252547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056372944,0.0019879977,0.98844135,0.000024727331,0.000080521364,0.00060730183,0.00007922477,1.229221e-7,0.0000018423507,0.00017653673,0.00019093089,0.007845703],"study_design_scores_gemma":[0.010837039,0.0021425323,0.9845905,0.000057671754,0.00009943085,0.000058783116,0.000032463788,0.000010351497,0.00000599968,0.000013923684,0.0020626506,0.00008867038],"about_ca_topic_score_codex":0.00004558479,"about_ca_topic_score_gemma":0.00005567531,"teacher_disagreement_score":0.010273309,"about_ca_system_score_codex":0.00007888572,"about_ca_system_score_gemma":0.00005326114,"threshold_uncertainty_score":0.31449518},"labels":[],"label_agreement":null},{"id":"W2949969572","doi":"10.1002/hon.4_2629","title":"IDENTIFYING MUTATIONS ENRICHED IN RELAPSED‐REFRACTORY DLBCL TO DERIVE GENETIC FACTORS UNDERLYING TREATMENT RESISTANCE","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; McGill University; Queen's University; Genome British Columbia; Princess Margaret Cancer Centre; Simon Fraser University","funders":"","keywords":"Oncology; Diffuse large B-cell lymphoma; Internal medicine; Exome sequencing; Population; Exome; Medicine; Lymphoma; Germline mutation; Cohort; Mutation; Biology; Gene; Genetics","score_opus":0.08466862076756414,"score_gpt":0.3714651027956474,"score_spread":0.2867964820280832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949969572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910204,0.0010929194,0.00009536367,0.0013444114,0.0002121119,0.0010904832,0.0000045042384,0.000075291,0.0050645145],"genre_scores_gemma":[0.9936584,0.00014571953,0.0045212107,0.00054201356,0.000017249726,0.00028903846,0.00002792931,0.000018811028,0.00077961973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982198,0.00013984046,0.0004816317,0.0005358662,0.00018787303,0.00043499187],"domain_scores_gemma":[0.99847496,0.00079252315,0.00012607551,0.00031421552,0.000050217503,0.00024203911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000804023,0.00024978849,0.00079655,0.00019255537,0.00007436772,0.000015868625,0.00008750919,0.0002655382,0.0003875704],"category_scores_gemma":[0.0001582227,0.00017574597,0.00015037066,0.00030016777,0.0000600476,0.00003808856,0.00004928708,0.00012976705,0.0005645068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035936123,0.0042333174,0.97877324,0.00008204425,0.00017004716,0.0022767435,0.0022440178,0.000042912357,0.0037724436,0.003218748,0.00020767756,0.004619431],"study_design_scores_gemma":[0.0062647285,0.0022497296,0.9796093,0.00009738757,0.000121014666,0.00014521781,0.0015018855,0.000019985771,0.0011453956,0.0008865784,0.007745525,0.00021321897],"about_ca_topic_score_codex":0.00007459424,"about_ca_topic_score_gemma":0.00044766907,"teacher_disagreement_score":0.0075378474,"about_ca_system_score_codex":0.0016314852,"about_ca_system_score_gemma":0.00022260196,"threshold_uncertainty_score":0.72557807},"labels":[],"label_agreement":null},{"id":"W2950234208","doi":"10.1002/hon.106_2629","title":"COST‐EFFECTIVENESS AND COST‐UTILITY ANALYSIS OF MULTIPLE TREATMENT STRATEGIES USING ABVD AND/OR BEACOPP IN THE TREATMENT OF ADVANCED‐STAGE HODGKIN LYMPHOMA","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"Karolinska Institutet","keywords":"Medicine; ABVD; Incremental cost-effectiveness ratio; Quality-adjusted life year; Life expectancy; Cost effectiveness; Brentuximab vedotin; Oncology; Hodgkin lymphoma; Internal medicine; Lymphoma; Population; Risk analysis (engineering); Environmental health; Chemotherapy","score_opus":0.09515614530214744,"score_gpt":0.397217687607386,"score_spread":0.3020615423052386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950234208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565965,0.0016205438,0.000046647576,0.00010174011,0.000034744146,0.0021782946,0.000058148296,0.000012448727,0.00028776252],"genre_scores_gemma":[0.99747765,0.0013863506,0.0007191762,0.000038355854,0.000005542372,0.00032061685,0.000029906101,0.0000068336517,0.000015540902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834377,0.00038009512,0.00045184905,0.00042319103,0.00014184685,0.00025925305],"domain_scores_gemma":[0.9971652,0.0021653143,0.00021600309,0.00031793574,0.00005463999,0.000080882746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021679414,0.00025275,0.001586136,0.00016547422,0.00003981785,0.000010406986,0.000054839184,0.00019315934,0.0000499365],"category_scores_gemma":[0.00005549695,0.00012356271,0.00019004916,0.00038108372,0.00023389136,0.00006814391,0.000027144528,0.000031842308,0.0000011762826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030401815,0.008965249,0.9152976,0.00014394164,0.0010573472,0.00040810718,0.0010888035,0.00019765411,0.001208793,0.0008579782,7.835309e-7,0.06773351],"study_design_scores_gemma":[0.014849096,0.00999995,0.960526,0.0000622684,0.0014525302,0.00014473908,0.0033899688,0.002332605,0.0061497088,0.000053574026,0.00092650426,0.00011308265],"about_ca_topic_score_codex":0.0007259316,"about_ca_topic_score_gemma":0.0007523389,"teacher_disagreement_score":0.067620434,"about_ca_system_score_codex":0.00052039465,"about_ca_system_score_gemma":0.00019201843,"threshold_uncertainty_score":0.5038741},"labels":[],"label_agreement":null},{"id":"W2950771228","doi":"10.1002/hon.42_2629","title":"CRYPTIC <i>MYC</i> AND <i>BCL2</i> REARRANGEMENTS ARE AMONG A RANGE OF GENETIC MECHANISMS UNDERLYING THE DOUBLE HIT SIGNATURE IN NON‐DOUBLE HIT DIFFUSE LARGE B‐CELL LYMPHOMA","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Biology; BCL6; Breakpoint; Gene rearrangement; Diffuse large B-cell lymphoma; Locus (genetics); Genetics; Population; Germline; Gene; Indel; Chromosomal translocation; Cancer research; Single-nucleotide polymorphism; B cell; Medicine; Germinal center","score_opus":0.024663027561924115,"score_gpt":0.2806197764140144,"score_spread":0.2559567488520903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950771228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904321,0.0018354504,0.000057971913,0.0011416556,0.0001707522,0.0018731857,0.000009420615,0.000044843542,0.0044346116],"genre_scores_gemma":[0.99672276,0.0003840323,0.0007383711,0.0014101353,0.00001558995,0.00031998483,0.000013376449,0.00002935419,0.00036637817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779516,0.00012943706,0.00057693967,0.00057137787,0.00032711797,0.00059998484],"domain_scores_gemma":[0.9985806,0.00036758202,0.0003346948,0.0004625212,0.00007252951,0.00018211974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002942998,0.00033045365,0.0011215392,0.000112380076,0.00009427011,0.000021402353,0.00020242708,0.0005347818,0.00023527611],"category_scores_gemma":[0.000023023904,0.00020191341,0.00016833734,0.00027476143,0.00015194749,0.00006306319,0.00021028392,0.00022450446,0.00008990687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026702774,0.017148554,0.9592452,0.00087399024,0.00030410584,0.00262739,0.0013843718,0.000009766621,0.0061723967,0.0055794143,0.0014424932,0.0025420133],"study_design_scores_gemma":[0.13248087,0.0028596197,0.85233355,0.00049867725,0.0005781928,0.0005135763,0.0019625633,0.00052835594,0.003324681,0.0018740741,0.0025468692,0.0004989514],"about_ca_topic_score_codex":0.000146931,"about_ca_topic_score_gemma":0.00019036676,"teacher_disagreement_score":0.1298106,"about_ca_system_score_codex":0.00025939714,"about_ca_system_score_gemma":0.000095325275,"threshold_uncertainty_score":0.823379},"labels":[],"label_agreement":null},{"id":"W2950951334","doi":"10.1182/blood.v130.suppl_1.823.823","title":"Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hôpital Charles-Le Moyne; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Stage (stratigraphy); Nuclear medicine; Radiation therapy; Lymphoma; Positron emission tomography; Cancer; Radiology; Internal medicine","score_opus":0.008040677581259705,"score_gpt":0.23356799256188834,"score_spread":0.22552731498062864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950951334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978655,0.00023619513,2.3652314e-7,0.00002304692,0.000019981842,0.001095387,0.00020057266,0.000022829952,0.000536262],"genre_scores_gemma":[0.998471,0.0005345687,0.00008008505,0.000042123917,0.000015514799,0.00010150685,0.00026821543,0.000032742755,0.0004542503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986732,0.00003728689,0.00034958814,0.00036923867,0.00028333548,0.00028732498],"domain_scores_gemma":[0.99885577,0.000034909746,0.000329604,0.0005838082,0.00010116984,0.00009473454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008364654,0.0001554653,0.0004142819,0.00006827327,0.00008591317,0.000091810514,0.00011074634,0.000061261206,0.000017550396],"category_scores_gemma":[0.000040764455,0.00015564334,0.000044184955,0.000117123906,0.000055419212,0.00017400848,0.000022964152,0.000045724835,0.000002592846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001126692,0.032686263,0.95122147,0.000042967844,0.00008725066,0.0008976016,0.00012924877,7.586189e-7,0.000038104125,4.3456328e-7,0.000035209883,0.013734019],"study_design_scores_gemma":[0.2713173,0.0017832828,0.72473127,0.0003808727,0.00006266127,0.0000127967105,0.000012784616,0.0000036587594,0.0015398442,5.163736e-7,0.0000316511,0.00012336382],"about_ca_topic_score_codex":0.011414126,"about_ca_topic_score_gemma":0.047780655,"teacher_disagreement_score":0.2701906,"about_ca_system_score_codex":0.00012992069,"about_ca_system_score_gemma":0.00010114576,"threshold_uncertainty_score":0.9951689},"labels":[],"label_agreement":null},{"id":"W2950978058","doi":"10.1002/hon.43_2629","title":"FUNCTIONAL CHARACTERIZATION OF <i>NFKBIZ</i> 3′ UTR MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Untranslated region; Diffuse large B-cell lymphoma; Biology; Three prime untranslated region; Signal transduction; Mutation; Gene; Genetics; Cancer research; Molecular biology; Messenger RNA","score_opus":0.019070139544184263,"score_gpt":0.27324969611325584,"score_spread":0.2541795565690716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950978058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990671,0.00007933876,0.00007757315,0.0010709825,0.00017792091,0.00045706704,0.00002151041,0.000033100427,0.00741151],"genre_scores_gemma":[0.9978981,0.0000654564,0.00024853923,0.00089319586,0.000026287416,0.00010454168,0.00029809965,0.000008630967,0.00045716058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891454,0.000071935414,0.0003888223,0.00025022935,0.00014728478,0.00022717347],"domain_scores_gemma":[0.9992967,0.0002393494,0.00014696442,0.00016735095,0.00006669656,0.000082928775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010057487,0.00012304212,0.0005264877,0.00010334409,0.000024105824,0.0000034985192,0.000044272605,0.00022051275,0.0007490643],"category_scores_gemma":[0.000045949393,0.000090038106,0.00009947917,0.00019478632,0.000052494972,0.00004918029,0.00004068456,0.00005970793,0.00040006186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005222579,0.041384287,0.9073983,0.00015474457,0.000052652995,0.00039282558,0.00019648967,0.0000017574357,0.030701617,0.016253473,0.00036425245,0.0025773768],"study_design_scores_gemma":[0.027578602,0.0010168232,0.94492805,0.000045790737,0.00006337628,0.00027930696,0.00009494918,0.00018174198,0.014029599,0.00022244066,0.011449979,0.000109330285],"about_ca_topic_score_codex":0.0000093303515,"about_ca_topic_score_gemma":0.000008279998,"teacher_disagreement_score":0.040367465,"about_ca_system_score_codex":0.00018824101,"about_ca_system_score_gemma":0.00015064854,"threshold_uncertainty_score":0.8201729},"labels":[],"label_agreement":null},{"id":"W2951153020","doi":"10.1097/01.hs9.0000561560.35825.0d","title":"S820 FRONTLINE BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE 3/4 CLASSICAL HODGKIN LYMPHOMA: 3‐YEAR UPDATE OF THE ECHELON‐1 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Dacarbazine; Procarbazine; Medicine; Brentuximab vedotin; Vinblastine; Bleomycin; Vincristine; Internal medicine; Oncology; Population; Chemotherapy; Lymphoma; Cyclophosphamide; Hodgkin lymphoma","score_opus":0.00953334348027245,"score_gpt":0.25238860756793524,"score_spread":0.24285526408766278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951153020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935526,0.0002819267,0.00008813913,0.0018601711,0.00013116308,0.0025721397,0.000050869123,0.00004585661,0.0014171266],"genre_scores_gemma":[0.9922723,0.000025510097,0.0018594015,0.00044972802,0.000091402435,0.0001573033,0.000024081519,0.000056649766,0.0050635906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855125,0.000044399618,0.00030438378,0.00039502542,0.00038555666,0.00031940083],"domain_scores_gemma":[0.9988144,0.00008833867,0.00017216077,0.0007205291,0.000108119464,0.00009644569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014779142,0.00025219464,0.0005583807,0.000021080674,0.000060962266,0.000017152033,0.00015919996,0.000089673085,0.000657254],"category_scores_gemma":[0.000017646085,0.0001379474,0.00018991058,0.00015691911,0.000065696135,0.00004763383,0.000058145655,0.00006609437,0.00007063794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003609193,0.0125889955,0.9539768,0.00031766458,0.00090368214,0.0000397398,0.00082760525,0.00002469341,0.0010802858,0.0011471089,0.008015594,0.017468615],"study_design_scores_gemma":[0.12272718,0.00797488,0.7414531,0.0004978359,0.000862591,0.00004467183,0.0042128996,0.0006918722,0.054059982,0.0000991072,0.066796675,0.00057921547],"about_ca_topic_score_codex":0.000070053386,"about_ca_topic_score_gemma":0.00010263807,"teacher_disagreement_score":0.21252373,"about_ca_system_score_codex":0.00016252192,"about_ca_system_score_gemma":0.00021354774,"threshold_uncertainty_score":0.71964705},"labels":[],"label_agreement":null},{"id":"W2951223200","doi":"10.1097/01.hs9.0000559496.29967.d6","title":"PF321 REAL‐WORLD TREATMENT PATTERNS OF PATIENTS DIAGNOSED WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; International Prognostic Index; Diagnosis code; Medical diagnosis; Oncology; Retrospective cohort study; Population; Radiology","score_opus":0.00875889552529891,"score_gpt":0.23278754855979186,"score_spread":0.22402865303449296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951223200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950271,0.00013448019,0.0000015703578,0.0001798396,0.00005071653,0.0013467814,0.00016199406,0.00003260484,0.003064879],"genre_scores_gemma":[0.9961722,0.0006970152,0.000056154637,0.0005803434,0.000024984343,0.0002158393,0.0008826866,0.000040716703,0.0013300697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998411,0.000094579875,0.00034592167,0.0003490212,0.00040201514,0.00039747608],"domain_scores_gemma":[0.9986916,0.0002791347,0.0001688636,0.0006574901,0.00009044528,0.00011243122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007695234,0.0003107435,0.0004934627,0.00011189944,0.000042942655,0.000019427796,0.000120391065,0.00006697311,0.00036922022],"category_scores_gemma":[0.000007737314,0.00016502116,0.00011884433,0.0004194791,0.000028111246,0.000057353423,0.000032975397,0.00005067158,0.000085859356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034781737,0.028084,0.9668756,0.00014676867,0.00012629594,0.00024737118,0.0022619166,0.000010620484,0.000005510302,0.00011852125,0.00040828987,0.0013672811],"study_design_scores_gemma":[0.05550247,0.0019491394,0.92718846,0.0002521702,0.00018461904,0.000003995934,0.0017483401,0.00008603672,0.0014364071,0.0000076693095,0.011467957,0.0001727337],"about_ca_topic_score_codex":0.009825624,"about_ca_topic_score_gemma":0.00723986,"teacher_disagreement_score":0.055154655,"about_ca_system_score_codex":0.0003479288,"about_ca_system_score_gemma":0.00008591589,"threshold_uncertainty_score":0.99676806},"labels":[],"label_agreement":null},{"id":"W2951331135","doi":"10.1097/01.hs9.0000562572.63485.4f","title":"PS1070 THE ECHELON‐2 TRIAL: RESULTS OF A RANDOMIZED, DOUBLE‐BLIND PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN AND CHP (A+CHP) VERSUS CHOP IN FRONTLINE TREATMENT OF PATIENTS WITH CD30+ PERIPHERAL T‐CELL LYMPHOMAS","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; CHOP; Internal medicine; Prednisone; Vincristine; Anaplastic large-cell lymphoma; Cyclophosphamide; Oncology; CD30; Lymphoma; Gastroenterology; Surgery; Chemotherapy","score_opus":0.025085509203232586,"score_gpt":0.2964247673137847,"score_spread":0.2713392581105521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951331135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889536,0.0015205229,6.911819e-7,0.000094475385,0.00016071867,0.0076484242,0.00007423415,0.000012272401,0.0015350597],"genre_scores_gemma":[0.9987113,0.00022773816,0.00013505649,0.000008498878,0.000039086615,0.00032855046,0.00008132672,0.00003214181,0.00043633694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976652,0.00018040655,0.00095172814,0.00044222688,0.0005104493,0.00024998884],"domain_scores_gemma":[0.9979793,0.00045143452,0.0006456394,0.00063877116,0.00018551231,0.00009937125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030341806,0.00034719566,0.0017053497,0.00007730116,0.000030598316,0.000010518708,0.00009776137,0.00010107646,0.00012847348],"category_scores_gemma":[0.00004803795,0.00018488389,0.00021570666,0.00024486764,0.00013464077,0.00006676751,0.00004154005,0.000058103935,0.0000033584445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8792921,0.041574202,0.07058481,0.00011561422,0.0008112111,0.000022295519,0.0038408146,0.000028567647,0.00004518731,0.000010192524,0.00003933077,0.0036357236],"study_design_scores_gemma":[0.9409545,0.025286932,0.026360426,0.00017666194,0.0010299898,0.0000020069715,0.0022618463,0.00010350905,0.0035343051,0.0000021945705,0.00014211456,0.00014549855],"about_ca_topic_score_codex":0.0018405591,"about_ca_topic_score_gemma":0.000511326,"teacher_disagreement_score":0.061662465,"about_ca_system_score_codex":0.00023613875,"about_ca_system_score_gemma":0.0001920349,"threshold_uncertainty_score":0.7539346},"labels":[],"label_agreement":null},{"id":"W2951347740","doi":"10.1097/01.hs9.0000563296.27415.ad","title":"PS1254 CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA AFTER RETREATMENT WITH SECOND‐LINE RITUXIMAB‐CONTAINING CHEMOTHERAPY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Chemotherapy; Radiation therapy; Surgery; Internal medicine; CHOP; Lymphoma","score_opus":0.005708754038137033,"score_gpt":0.2138741022099388,"score_spread":0.20816534817180177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951347740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975174,0.00043458422,0.000011715433,0.00015445177,0.00004522712,0.0009496491,0.000056072826,0.000034221117,0.00079667044],"genre_scores_gemma":[0.99620044,0.000038536455,0.0019368371,0.0004879931,0.000031309228,0.000094812,0.000110268054,0.000054680924,0.0010451056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986805,0.00001852262,0.00034136727,0.00038436704,0.0003159636,0.00025927988],"domain_scores_gemma":[0.99902135,0.000044555713,0.0002032156,0.00044523503,0.00013837744,0.00014727443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053227446,0.00030810296,0.0007232567,0.000036472084,0.000032881897,0.000017650056,0.00004188591,0.00009967052,0.00097416877],"category_scores_gemma":[0.000006852305,0.00018711852,0.00007952524,0.000107326305,0.000058417994,0.00008154835,0.000023888548,0.0000516094,0.000032006727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029638929,0.0016641752,0.9874056,0.00023859105,0.00048662777,0.00015315558,0.00027866804,2.7392383e-7,0.000034511635,0.000042474527,0.000025780919,0.0067062783],"study_design_scores_gemma":[0.03509461,0.0038740605,0.95660794,0.00039501826,0.000298663,0.000032700198,0.00011065663,0.000021612097,0.0016503455,0.0000052994715,0.0016911618,0.0002179569],"about_ca_topic_score_codex":0.000035408637,"about_ca_topic_score_gemma":0.000025571531,"teacher_disagreement_score":0.03213072,"about_ca_system_score_codex":0.00016220789,"about_ca_system_score_gemma":0.00006420234,"threshold_uncertainty_score":0.9999391},"labels":[],"label_agreement":null},{"id":"W2951443426","doi":"10.1097/01.hs9.0000565788.38670.37","title":"PB1821 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) PATIENTS INITIATED ON ANTI‐CANCER THERAPIES IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Diagnosis code; Internal medicine; Oncology; Medical diagnosis; Cancer; Retrospective cohort study; Population; Pathology","score_opus":0.030268310438438563,"score_gpt":0.2996516692063359,"score_spread":0.2693833587678973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951443426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948102,0.0014590176,4.484471e-7,0.00077134906,0.00004195043,0.0009052771,0.00012585348,0.00003093064,0.0018549325],"genre_scores_gemma":[0.9930996,0.0035316541,0.000013888061,0.002273655,0.000018046401,0.000062223524,0.0007277322,0.000030575557,0.00024267158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863285,0.00018626313,0.00030964153,0.00027991273,0.00032352417,0.00026783173],"domain_scores_gemma":[0.9990642,0.00021939562,0.00016658669,0.00034463534,0.00012898742,0.0000762077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013021914,0.00020499136,0.00034287572,0.000121029,0.00006349635,0.000019090854,0.000076098804,0.00008393067,0.00010166678],"category_scores_gemma":[0.000017418904,0.00013071511,0.000048207396,0.0005288458,0.000042879186,0.000052169875,0.00003163593,0.00007087308,0.00001299939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034488674,0.0053955987,0.98381966,0.00023043093,0.000054865308,0.000015610483,0.0026227427,0.000009918825,0.000034530065,0.0004977923,0.0008865054,0.00608747],"study_design_scores_gemma":[0.022084171,0.0006834735,0.96046555,0.0008452087,0.000050101702,0.0000014948123,0.002566729,0.0003232443,0.002323376,0.000019447842,0.010489778,0.00014739732],"about_ca_topic_score_codex":0.0030683689,"about_ca_topic_score_gemma":0.0012762476,"teacher_disagreement_score":0.023354072,"about_ca_system_score_codex":0.00018967649,"about_ca_system_score_gemma":0.000058447793,"threshold_uncertainty_score":0.53304076},"labels":[],"label_agreement":null},{"id":"W2951482915","doi":"10.1002/hon.99_2630","title":"EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Dacarbazine; Oncology; ABVD; Biomarker; Post-hoc analysis; Progression-free survival; Gastroenterology; Lymphoma; Overall survival; CD30; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.045777632030831635,"score_gpt":0.3204171451610274,"score_spread":0.27463951313019574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951482915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786645,0.00008583989,0.000012363857,0.0005717242,0.000014700408,0.001249728,0.000010619887,0.000013327875,0.00017523642],"genre_scores_gemma":[0.99897385,0.000007750874,0.00033981484,0.0004926326,0.0000031214624,0.00013456077,0.000024507031,0.000008392889,0.000015353075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815387,0.0004153932,0.00051087333,0.00038658016,0.0002805088,0.00025277634],"domain_scores_gemma":[0.9987097,0.0006098424,0.00018008109,0.0003302485,0.00010001697,0.000070123744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000639475,0.00019881749,0.0010931663,0.00028697235,0.000019852254,0.000006831055,0.000092443566,0.00014023225,0.00016066205],"category_scores_gemma":[0.00010271921,0.000088926245,0.000056026016,0.0009997287,0.00013241971,0.00006199215,0.000050279617,0.00014207157,0.000010795261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015832974,0.0074557806,0.98839456,0.000032824522,0.00042899765,0.0005860046,0.0005203451,0.000007807586,0.000016958154,0.000077696925,0.00001230523,0.00088342826],"study_design_scores_gemma":[0.013983253,0.004207605,0.97988725,0.00004312096,0.0004885931,0.000019354004,0.0010678192,0.000071567185,0.00006507709,0.0000144231635,0.000044868062,0.00010705982],"about_ca_topic_score_codex":0.00007799021,"about_ca_topic_score_gemma":0.00068936276,"teacher_disagreement_score":0.012399956,"about_ca_system_score_codex":0.00012771411,"about_ca_system_score_gemma":0.0000831002,"threshold_uncertainty_score":0.3626307},"labels":[],"label_agreement":null},{"id":"W2951720456","doi":"10.1002/hon.5_2629","title":"ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; Diffuse large B-cell lymphoma; CHOP; Internal medicine; Rituximab; Clinical endpoint; Placebo; Gastroenterology; Lymphoma; Vincristine; Oncology; Pathology; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Multiple myeloma","score_opus":0.02707653928937821,"score_gpt":0.3086064026914633,"score_spread":0.2815298634020851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951720456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722863,0.0010700005,0.000016921127,0.0005330084,0.00020028622,0.0070582605,0.000017676595,0.00010543924,0.0037697959],"genre_scores_gemma":[0.99721795,0.00062326354,0.0004166573,0.00026562618,0.00004625481,0.00066339265,0.00008769361,0.000049476217,0.0006297039],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99364567,0.0009912757,0.002835555,0.0010769382,0.0005930879,0.0008574745],"domain_scores_gemma":[0.99364066,0.0032213796,0.0013233656,0.0010845858,0.00036539708,0.0003646097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016692047,0.00064214476,0.0055809156,0.00037480536,0.000083174586,0.000013646471,0.00031425597,0.00071286765,0.0011396095],"category_scores_gemma":[0.0014592063,0.00042824252,0.00056756433,0.0006901387,0.0002791995,0.000098038574,0.00025045415,0.0002763182,0.00013360966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4576057,0.21609351,0.29472205,0.0008437205,0.0015034642,0.020377578,0.004807062,0.0003922936,0.00028873878,0.0006269808,0.0020817905,0.0006571189],"study_design_scores_gemma":[0.97018635,0.011970374,0.0057555805,0.00037085317,0.0013326746,0.0021989406,0.001625575,0.00264818,0.001349704,0.000067718654,0.0020742728,0.00041976012],"about_ca_topic_score_codex":0.00061125465,"about_ca_topic_score_gemma":0.00022945434,"teacher_disagreement_score":0.5125807,"about_ca_system_score_codex":0.00057645864,"about_ca_system_score_gemma":0.0005019684,"threshold_uncertainty_score":0.99981695},"labels":[],"label_agreement":null},{"id":"W2951734500","doi":"10.1101/674259","title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Texas MD Anderson Cancer Center; National Cancer Institute; U.S. Department of Health and Human Services; Andrew Sabin Family Foundation; Nebraska Department of Health and Human Services; Leukemia and Lymphoma Society","keywords":"Lymphoma; Follicular lymphoma; Mantle cell lymphoma; Comparative genomic hybridization; Gene; Mutation; BCL10; Disease","score_opus":0.01415526032686694,"score_gpt":0.23457826859839076,"score_spread":0.22042300827152383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951734500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915355,0.005512105,0.00017370732,0.00013502169,0.0006723632,0.0015577513,0.00015978064,0.00013017737,0.00012360653],"genre_scores_gemma":[0.9934417,0.0018050369,0.0036040822,0.0003061685,0.00032851862,0.00037257405,0.0000018510468,0.00012616179,0.000013899344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712324,0.00008200931,0.00065202784,0.0011897681,0.0003723737,0.0005805705],"domain_scores_gemma":[0.997761,0.00010123553,0.00028567459,0.0013079082,0.000196807,0.0003473539],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025902136,0.00062846416,0.0008647601,0.0004624414,0.00010933508,0.00021249305,0.00021831556,0.00048702522,0.00006412171],"category_scores_gemma":[0.000037733087,0.00063550344,0.00015856599,0.00032235647,0.00009211573,0.0000941436,0.00027082776,0.00033586414,0.00022541107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015661858,0.0018819615,0.87478864,0.001178071,0.00024700005,0.0008791779,0.000069438014,0.00017272927,0.11915461,0.00018556316,0.0012343315,0.000051883373],"study_design_scores_gemma":[0.0044055553,0.00016170373,0.88980097,0.00086051866,0.0001666171,2.0441885e-7,0.0000051442635,0.0007227632,0.096891634,8.4610286e-7,0.0063797645,0.00060430495],"about_ca_topic_score_codex":0.00015893564,"about_ca_topic_score_gemma":0.0000061057226,"teacher_disagreement_score":0.022262976,"about_ca_system_score_codex":0.0007287521,"about_ca_system_score_gemma":0.00077271764,"threshold_uncertainty_score":0.99960965},"labels":[],"label_agreement":null},{"id":"W2952045994","doi":"10.1038/s41409-019-0572-7","title":"XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT","year":2019,"lang":"en","type":"letter","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; Lymphoma; Genotype; Overall survival; XRCC1; Single-nucleotide polymorphism; Genetics; Gene","score_opus":0.010224660198177528,"score_gpt":0.20865518523692997,"score_spread":0.19843052503875244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952045994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356736,0.00049547805,0.000008897745,0.010563175,0.0002039806,0.0020358998,0.0011916178,0.000089223315,0.0018443791],"genre_scores_gemma":[0.96241546,0.0013087655,0.00016213128,0.019341089,0.00032665883,0.00018593058,0.014739836,0.00014101961,0.0013790862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969509,0.00016852333,0.0006095402,0.0008823223,0.00084198604,0.0005466808],"domain_scores_gemma":[0.99885,0.00022348612,0.000259523,0.00041468564,0.00013375105,0.000118540935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001375296,0.00063808274,0.0009470185,0.0003846029,0.00007001167,0.00006487891,0.000085227584,0.00064457336,0.00006598912],"category_scores_gemma":[0.000011031355,0.0004955974,0.0001240878,0.00021326868,0.000078981975,0.00014863157,0.000011256793,0.00031994106,0.000037435166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012245275,0.0014608775,0.9214055,0.0036331606,0.0009384202,0.012154051,0.0010949463,0.000011383303,0.0007523057,0.000025027704,0.04172692,0.004552122],"study_design_scores_gemma":[0.022525126,0.0019698017,0.9640477,0.0015640025,0.0014680915,0.00011885347,0.000015591015,0.00003260093,0.0006352125,0.000011361345,0.0070235385,0.00058817107],"about_ca_topic_score_codex":0.0012702749,"about_ca_topic_score_gemma":0.00054333446,"teacher_disagreement_score":0.04264214,"about_ca_system_score_codex":0.00046190005,"about_ca_system_score_gemma":0.00026195397,"threshold_uncertainty_score":0.99974954},"labels":[],"label_agreement":null},{"id":"W2952140490","doi":"10.1097/01.hs9.0000564652.16751.86","title":"S1601 NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE 2 CHECKMATE 436 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; CD30; Lymphoma; Anaplastic large-cell lymphoma; Oncology; Internal medicine; Cancer research; Immune system; Immunology; Immunotherapy","score_opus":0.011245016612673695,"score_gpt":0.25012934407963827,"score_spread":0.23888432746696459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952140490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898826,0.0016818672,0.000021649623,0.0006509678,0.0002217793,0.0038315665,0.00050606264,0.000105433726,0.0030981104],"genre_scores_gemma":[0.99594504,0.000119641016,0.0005876618,0.00042673174,0.00018664336,0.00018997928,0.0007782206,0.00007358184,0.0016925267],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99759835,0.0001073979,0.00054927845,0.00075722486,0.0004875923,0.00050015294],"domain_scores_gemma":[0.99741477,0.0010951945,0.0002892869,0.00084092456,0.00012619111,0.00023362861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036422964,0.00041952886,0.0007338319,0.000026350239,0.00023436613,0.000052781947,0.0001665925,0.00012233596,0.00020478347],"category_scores_gemma":[0.00009833811,0.00025254657,0.000119911725,0.00015114855,0.00008155134,0.00011208087,0.00011716127,0.0001419006,0.00010817307],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28323585,0.22977862,0.30718696,0.0011271588,0.003647916,0.0015467698,0.017789183,0.000013846919,0.0030519795,0.00025355787,0.043126985,0.10924118],"study_design_scores_gemma":[0.5323206,0.013945077,0.42744654,0.0004900461,0.0010734184,0.00005017051,0.0028014078,0.00021909982,0.0012325706,0.000015008856,0.019974537,0.00043151932],"about_ca_topic_score_codex":0.00021522971,"about_ca_topic_score_gemma":0.00013193405,"teacher_disagreement_score":0.24908476,"about_ca_system_score_codex":0.00026688486,"about_ca_system_score_gemma":0.00030480462,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2952257518","doi":"10.1136/jclinpath-2019-205837","title":"Diffuse large B-cell lymphoma in Southeast Asian cohort: expression patterns of B-cell receptor (BCR) repertoire and its linkage with molecular subtypes and response to R-CHOP therapy","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Cancer Foundation","keywords":"LYN; breakpoint cluster region; Bruton's tyrosine kinase; Cancer research; Diffuse large B-cell lymphoma; Vincristine; Oncology; B-cell receptor; Internal medicine; Biology; Targeted therapy; Ibrutinib; International Prognostic Index; Lymphoma; Medicine; B cell; Immunology; Chronic lymphocytic leukemia; Cyclophosphamide; Leukemia; Cancer; Chemotherapy; Tyrosine kinase; Receptor; Antibody","score_opus":0.01373990409033245,"score_gpt":0.30159152103012804,"score_spread":0.2878516169397956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952257518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659103,0.001336465,0.000022052476,0.001293707,0.00013642307,0.00044089454,0.000023097457,0.0000053244016,0.0001510211],"genre_scores_gemma":[0.99687433,0.0014749146,0.0008354622,0.00058080134,0.00006246464,0.000007928889,0.0000029417897,0.000026134863,0.00013501813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761385,0.0005914909,0.0009787726,0.00033018072,0.0002568419,0.00022886241],"domain_scores_gemma":[0.99815655,0.00056250487,0.0005453773,0.00028985736,0.00014811082,0.00029761557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014313277,0.00018907397,0.00095422467,0.00017154575,0.000022630426,0.000009875467,0.00008849024,0.0002493385,0.000039439732],"category_scores_gemma":[0.00032995912,0.00011658765,0.00013967499,0.000084436244,0.00005086171,0.00005767191,0.00006101285,0.0002136466,0.0000100508105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014749708,0.005939469,0.873196,0.00005763711,0.000050128223,0.0017406315,0.0006392135,4.869391e-7,0.09967949,0.000008752127,0.00002730238,0.003911166],"study_design_scores_gemma":[0.050156944,0.00832275,0.9104923,0.0005363373,0.00007849521,0.00039477408,0.0004922727,0.0000067625956,0.028609978,0.000011589795,0.0007655409,0.00013225299],"about_ca_topic_score_codex":0.0000043639902,"about_ca_topic_score_gemma":0.00000468117,"teacher_disagreement_score":0.071069516,"about_ca_system_score_codex":0.000033779597,"about_ca_system_score_gemma":0.00014940092,"threshold_uncertainty_score":0.47543064},"labels":[],"label_agreement":null},{"id":"W2952476145","doi":"10.1002/hon.35_2630","title":"SYSTEMIC THERAPY AFTER RADIATION THERAPY IN STAGE I‐II FOLLICULAR LYMPHOMA: FINAL RESULTS OF AN INTERNATIONAL RANDOMIZED TRIAL TROG 99.03","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Vincristine; Randomized controlled trial; Radiation therapy; Progression-free survival; Internal medicine; Surgery; Cyclophosphamide; Stage (stratigraphy); Lymphoma; Chemotherapy","score_opus":0.03015826436044576,"score_gpt":0.3268272183137123,"score_spread":0.29666895395326653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952476145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916652,0.0018669565,0.000005784938,0.0009469913,0.0005209562,0.0029928093,0.000023541566,0.000037330974,0.001940422],"genre_scores_gemma":[0.99589634,0.0019655456,0.00030322853,0.0005185647,0.000115982664,0.00085871055,0.00011905763,0.000013015168,0.0002095754],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974048,0.00062674953,0.0009636861,0.00043771238,0.00030997398,0.00025706008],"domain_scores_gemma":[0.9983296,0.0007632167,0.00038935902,0.00032389883,0.00009546165,0.00009846522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087385875,0.00022229886,0.0015028208,0.00016504493,0.000024924295,0.000010085848,0.00014098563,0.00036488616,0.00044430146],"category_scores_gemma":[0.00023798479,0.00013464286,0.0003405598,0.0001318981,0.000108773085,0.000096585594,0.000035145473,0.000089523906,0.00004804145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534393,0.006182272,0.017534113,0.000021293217,0.00029373894,0.0005698543,0.0003872679,0.000011121704,0.00032308084,0.0022717672,0.00006131981,0.018904865],"study_design_scores_gemma":[0.95906645,0.007708034,0.024691032,0.00006624665,0.000042967476,0.00025677984,0.00005859933,0.0003684964,0.002246188,0.00015894632,0.005203067,0.00013319867],"about_ca_topic_score_codex":0.000098958015,"about_ca_topic_score_gemma":0.000009942076,"teacher_disagreement_score":0.018771667,"about_ca_system_score_codex":0.00036907542,"about_ca_system_score_gemma":0.00022584053,"threshold_uncertainty_score":0.54905766},"labels":[],"label_agreement":null},{"id":"W2952692503","doi":"10.3324/haematol.2019.220475","title":"Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Celgene","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Distribution (mathematics); Variable (mathematics); Medicine; Pathology; Mathematics; Mathematical analysis","score_opus":0.027482284971366486,"score_gpt":0.2800336963888145,"score_spread":0.25255141141744797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952692503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796336,0.0012065187,0.00012526498,0.011527517,0.00035125445,0.002269095,0.0030362871,0.000039930535,0.0018104878],"genre_scores_gemma":[0.9794216,0.0001065574,0.00022941556,0.015865719,0.00020272928,0.00018465039,0.0037344391,0.000023826145,0.0002310645],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726534,0.00026428155,0.00083990954,0.0006165465,0.00053179846,0.00048209654],"domain_scores_gemma":[0.9975926,0.0006079292,0.00061124197,0.0010260544,0.000108617765,0.00005353739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023512916,0.0004599983,0.0016301105,0.000044800036,0.00006068421,0.000020348609,0.00035740124,0.00064448715,0.00020944659],"category_scores_gemma":[0.00007271301,0.0002690777,0.00026144285,0.00033959514,0.000088472676,0.000039430888,0.0001747887,0.0002965658,0.000067682966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007863306,0.08009653,0.26747835,0.0004992472,0.0004514356,0.0040980084,0.00027960882,0.0000038677545,0.000028959717,0.00032572795,0.64575404,0.00019790442],"study_design_scores_gemma":[0.42897698,0.006036938,0.14633825,0.0019193565,0.0054804073,0.0002956144,0.0015465918,0.00038802242,0.0029596644,0.00061509537,0.40399224,0.0014508542],"about_ca_topic_score_codex":0.0021825747,"about_ca_topic_score_gemma":0.000043341894,"teacher_disagreement_score":0.42819065,"about_ca_system_score_codex":0.00038821902,"about_ca_system_score_gemma":0.0002726609,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W2952759225","doi":"10.1097/01.hs9.0000565740.21637.cb","title":"PB1809 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMBCL) PATIENTS INITIATED ON ANTI‐CANCER THERAPIES IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Medical diagnosis; Lymphoma; Cancer; Health care; Internal medicine; Oncology; Pathology","score_opus":0.032379214920534936,"score_gpt":0.2922569784763064,"score_spread":0.25987776355577147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952759225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299735,0.0017257452,8.947106e-7,0.00075759646,0.000048900463,0.00088988285,0.00013366874,0.000030068048,0.003415923],"genre_scores_gemma":[0.9928836,0.0029560782,0.000031886335,0.002679458,0.000027796908,0.00006425197,0.00117026,0.00002910284,0.00015756494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984921,0.0001987694,0.00033789963,0.0002883379,0.0004048341,0.00027803765],"domain_scores_gemma":[0.99899787,0.00029053638,0.00018816395,0.00029334312,0.00014850183,0.0000815587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018023406,0.0002105195,0.00037830102,0.00012891686,0.00006161441,0.000015854308,0.00008042534,0.00008257506,0.00013518048],"category_scores_gemma":[0.00002036464,0.00013653682,0.000045861045,0.0005238615,0.00005266158,0.00005516805,0.00003587336,0.00008434723,0.000011310884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051151414,0.0022154113,0.9816865,0.00035721363,0.000051135732,0.000022351012,0.0024846059,0.000017077524,0.000045791287,0.00030984005,0.0010929729,0.01120563],"study_design_scores_gemma":[0.010583628,0.0007580007,0.97775215,0.0009216044,0.000048250997,0.0000025650215,0.0016657163,0.00021811506,0.0013670038,0.000015273868,0.006536057,0.00013161357],"about_ca_topic_score_codex":0.0019914864,"about_ca_topic_score_gemma":0.0008273358,"teacher_disagreement_score":0.011074017,"about_ca_system_score_codex":0.00026073927,"about_ca_system_score_gemma":0.00010646121,"threshold_uncertainty_score":0.556781},"labels":[],"label_agreement":null},{"id":"W2952793585","doi":"10.1136/annrheumdis-2019-eular.1607","title":"THU0116   COMPARATIVE SAFETY OF BIOLOGIC DMARDS AND ABATACEPT IN RHEUMATOID ARTHRITIS WITH COPD: A REAL-WORLD POPULATION-BASED OBSERVATIONAL STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science; Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Amgen; Astellas Foundation for Research on Metabolic Disorders; Japan Blood Products Organization; McGill University; Gilead Sciences; Teijin Pharma; Pfizer; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; COPD; Internal medicine; Rheumatoid arthritis; Adverse effect; Hazard ratio; Observational study; Population; Propensity score matching; Physical therapy; Confidence interval","score_opus":0.08153348263112065,"score_gpt":0.34337049019174487,"score_spread":0.2618370075606242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952793585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648654,0.001110961,0.0000014321739,0.0006502665,0.00002733606,0.0013000973,0.0001707388,0.000011949532,0.00024065339],"genre_scores_gemma":[0.9987204,0.00081467413,0.00010883504,0.00012794758,0.0000029691637,0.000075238866,0.00010691123,0.000007835242,0.000035167246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873465,0.00013264673,0.0004856164,0.00019567844,0.00031769674,0.00013372998],"domain_scores_gemma":[0.99861574,0.0005379626,0.00031378568,0.00033609744,0.00012913268,0.000067265806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155196,0.00015725763,0.0006331404,0.00010027542,0.00003870892,0.000007928771,0.00008562019,0.000021891246,0.000119776705],"category_scores_gemma":[0.00008333004,0.00008920591,0.00009165098,0.0002736096,0.00009043034,0.00007377774,0.000038123984,0.000034999706,0.0000036033584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005964735,0.001989261,0.99310917,0.0001378619,0.00023069711,0.000002371397,0.00028471192,0.00035931222,0.0000032232495,0.0008992104,0.00015953416,0.0022281674],"study_design_scores_gemma":[0.0041774735,0.00064800587,0.99179435,0.0019650175,0.000047915684,0.0000015404034,0.00047703952,0.00045116004,0.00010785612,0.00022964935,0.000009636794,0.00009038163],"about_ca_topic_score_codex":0.002525676,"about_ca_topic_score_gemma":0.0011863094,"teacher_disagreement_score":0.0035810003,"about_ca_system_score_codex":0.000026902773,"about_ca_system_score_gemma":0.00016329515,"threshold_uncertainty_score":0.38180834},"labels":[],"label_agreement":null},{"id":"W2952833516","doi":"10.1097/01.hs9.0000563300.27415.88","title":"PS1255 EFFICACY OF R-BAC IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA POST BTK INHIBITOR THERAPY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Follicular lymphoma; Internal medicine; Surgery; Chemotherapy; Radiation therapy; Refractory (planetary science); Lymphoma; Gastroenterology; Aggressive lymphoma","score_opus":0.004571677957232424,"score_gpt":0.20793314056298617,"score_spread":0.20336146260575375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952833516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911333,0.0018663306,4.7499412e-7,0.00012681325,0.00013581273,0.0010822831,0.00001544222,0.000035652803,0.0056039123],"genre_scores_gemma":[0.9976762,0.0003011105,0.00035331957,0.00035004897,0.00004401731,0.000032098378,0.000084037085,0.00006357944,0.0010956188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985308,0.000039420484,0.0003670249,0.0003768524,0.0003863909,0.0002995333],"domain_scores_gemma":[0.9988454,0.000096707336,0.00018900335,0.0006313213,0.00014091012,0.00009666416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000696583,0.0002779681,0.0005107847,0.000068833295,0.000027353239,0.000011179987,0.00010284529,0.00014919162,0.0011463669],"category_scores_gemma":[0.000008939844,0.00019222448,0.00013239287,0.00021488294,0.000051605784,0.000104719926,0.000023748722,0.000085609856,0.00022302574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005383474,0.011558363,0.946813,0.0001367298,0.00016262624,0.00003669086,0.000603445,0.0000028347972,0.0064187334,0.000027085653,0.0007230002,0.028134024],"study_design_scores_gemma":[0.059385035,0.0035614872,0.8758658,0.00037874794,0.000031303756,0.000004413738,0.0001783976,0.0000025288905,0.05602608,0.000004204707,0.004353319,0.00020867557],"about_ca_topic_score_codex":0.00019325089,"about_ca_topic_score_gemma":0.000011576846,"teacher_disagreement_score":0.070947185,"about_ca_system_score_codex":0.00023169494,"about_ca_system_score_gemma":0.00017690218,"threshold_uncertainty_score":0.9997667},"labels":[],"label_agreement":null},{"id":"W2953047243","doi":"10.1002/hon.108_2629","title":"DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"CD163; Follicular lymphoma; Follicular dendritic cells; Cancer research; In vivo; M2 Macrophage; CD68; Tumor microenvironment; Cell culture; CD20; Lymphoma; Tumor-associated macrophage; Chemistry; Molecular biology; Macrophage; Medicine; Immunology; Biology; Immunohistochemistry; In vitro; T cell; Immune system; Antigen-presenting cell; Tumor cells","score_opus":0.01941334795268278,"score_gpt":0.29901533824970034,"score_spread":0.27960199029701754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953047243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874697,0.0069641336,0.00022314028,0.0034648068,0.00016895587,0.00095784845,6.963362e-7,0.00004232483,0.0007083976],"genre_scores_gemma":[0.9956931,0.0006693733,0.001179685,0.0021849845,0.00005779184,0.00011930759,0.000008113399,0.000010411517,0.00007723972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987958,0.00012206333,0.00035128163,0.00029389688,0.00019046552,0.00024651358],"domain_scores_gemma":[0.9989029,0.00036790172,0.000119124394,0.00033188495,0.00010150494,0.00017664797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001283842,0.00016983457,0.0006803654,0.000043679167,0.000058698803,0.000007658869,0.0001285053,0.00021458017,0.00022044983],"category_scores_gemma":[0.00011791052,0.00008498629,0.0001773749,0.00020533454,0.000060431918,0.000025177995,0.000076728575,0.00004475227,0.00023464861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029349818,0.0043099886,0.5359756,0.00007128293,0.00079509645,0.0016267013,0.0017202008,0.000048111444,0.13053894,0.04611532,0.0023616834,0.2735021],"study_design_scores_gemma":[0.012612204,0.0055148466,0.6377778,0.00012012568,0.00015773207,0.0005767567,0.00022426702,0.00006283155,0.18343374,0.0020709387,0.15721647,0.00023229812],"about_ca_topic_score_codex":0.000086748885,"about_ca_topic_score_gemma":0.000024596276,"teacher_disagreement_score":0.2732698,"about_ca_system_score_codex":0.0002174254,"about_ca_system_score_gemma":0.00019681851,"threshold_uncertainty_score":0.34656405},"labels":[],"label_agreement":null},{"id":"W2953069975","doi":"10.1097/01.hs9.0000561564.12955.95","title":"S821 NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: 2‐YEAR EXTENDED FOLLOW‐UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Dacarbazine; Nivolumab; Medicine; Vinblastine; Internal medicine; Oncology; Stage (stratigraphy); Cohort; Chemotherapy; Cancer; Immunotherapy","score_opus":0.012768751058135743,"score_gpt":0.27930889893961003,"score_spread":0.2665401478814743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953069975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920097,0.001366478,0.00007194974,0.00037345206,0.00048817115,0.0043609487,0.00030340382,0.0000722453,0.00095366326],"genre_scores_gemma":[0.9928528,0.00011175827,0.0009941064,0.0001862811,0.00013418331,0.00047936215,0.00012409243,0.000076152035,0.005041253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974855,0.00007773109,0.00061306165,0.0007779926,0.0005433978,0.0005022765],"domain_scores_gemma":[0.9978533,0.00048124918,0.00030300563,0.00095564645,0.00016812082,0.00023871275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001923392,0.00044249342,0.0010808443,0.000040755964,0.00012790441,0.000032333526,0.00019921194,0.00016227522,0.0008269372],"category_scores_gemma":[0.00021582094,0.0002951676,0.0002953729,0.00023395442,0.00012550269,0.00011904263,0.00019453386,0.000111224734,0.00003502307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012334701,0.018491192,0.8731711,0.00061515614,0.0028543766,0.0004185199,0.0022241652,0.00006768192,0.023069851,0.0013666381,0.012264127,0.053122472],"study_design_scores_gemma":[0.24719265,0.006343121,0.7048305,0.00067331234,0.0018281748,0.000031595413,0.0032105923,0.002204434,0.023402834,0.00025298115,0.009398654,0.0006311023],"about_ca_topic_score_codex":0.00046027402,"about_ca_topic_score_gemma":0.00036477236,"teacher_disagreement_score":0.23485796,"about_ca_system_score_codex":0.00029416694,"about_ca_system_score_gemma":0.0002543098,"threshold_uncertainty_score":0.99995005},"labels":[],"label_agreement":null},{"id":"W2953143769","doi":"10.1182/blood.v130.suppl_1.4534.4534","title":"Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Melphalan; Medicine; Gemcitabine; Oncology; Transplantation; Internal medicine; Autologous stem-cell transplantation; Bendamustine; Chemotherapy; Tolerability; Lymphoma; Salvage therapy; Surgery; Hematopoietic stem cell transplantation; Rituximab; Adverse effect","score_opus":0.011351165151622144,"score_gpt":0.2694832333893683,"score_spread":0.25813206823774615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953143769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979614,0.000044415297,0.00008769705,0.00006279173,0.000048807502,0.0012900482,0.0004319399,0.000020385613,0.000052492967],"genre_scores_gemma":[0.99851704,0.000019322897,0.00073823583,0.00003096906,0.000021834912,0.00015558294,0.00045007773,0.0000156687,0.000051250474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989478,0.000028491175,0.00032431554,0.0003133591,0.00023410785,0.0001519297],"domain_scores_gemma":[0.9990143,0.000093848284,0.00027459904,0.0003293099,0.00015829655,0.00012961814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008659142,0.00016993504,0.00046126425,0.00016884854,0.00036012402,0.000024396564,0.00007534067,0.00005309462,0.000019425546],"category_scores_gemma":[0.000015495123,0.00012538671,0.00007049004,0.00008669545,0.00004191454,0.000110681634,0.000037376263,0.000027898357,0.0000010990669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007061494,0.07556897,0.85917836,0.00019506554,0.002955633,0.00012697186,0.0051309112,0.000012867646,0.000943007,0.000030857012,0.00002339268,0.048772443],"study_design_scores_gemma":[0.10413318,0.019370569,0.86754286,0.00008107016,0.005801637,0.0000069221487,0.00026627863,0.000018356477,0.0026227194,0.000002116132,0.000037696536,0.00011659497],"about_ca_topic_score_codex":0.0001889263,"about_ca_topic_score_gemma":0.00014963717,"teacher_disagreement_score":0.097071685,"about_ca_system_score_codex":0.000053335265,"about_ca_system_score_gemma":0.000057867153,"threshold_uncertainty_score":0.5113121},"labels":[],"label_agreement":null},{"id":"W2953463995","doi":"10.1200/jco.2019.37.15_suppl.7553","title":"Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Adverse effect; Clinical endpoint; Surgery; Follicular lymphoma; Progression-free survival; Refractory (planetary science); Lymphoma; Chemotherapy; Clinical trial","score_opus":0.04862068216639961,"score_gpt":0.3738936953132423,"score_spread":0.3252730131468427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953463995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965878,0.00029011135,0.00000925112,0.00047710055,0.00057914876,0.0005924743,0.0000099114195,0.000013121869,0.0014410946],"genre_scores_gemma":[0.9965121,0.0004923443,0.00084985263,0.0007514316,0.00021571915,0.00001054398,0.000024282412,0.000040458224,0.0011032618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961554,0.000320675,0.0021521011,0.00032369464,0.00073454826,0.0003136191],"domain_scores_gemma":[0.9937915,0.0015976289,0.0027332983,0.00044339962,0.0009568799,0.000477247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008168666,0.00028225424,0.0024037983,0.00016350059,0.000033479122,0.0000092404725,0.00018663605,0.00043902296,0.00042344464],"category_scores_gemma":[0.0005950038,0.00013702494,0.0005180738,0.00021571595,0.00020651634,0.00016405247,0.000040917024,0.0003154188,0.000058615562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054481775,0.010022048,0.87026757,0.000065712746,0.0017692008,0.0024312437,0.000061282924,0.0000032312246,0.000028562725,0.000016573293,0.0008932754,0.0599595],"study_design_scores_gemma":[0.09941826,0.09856808,0.79268426,0.0004797886,0.001478858,0.00033259526,0.00004098208,0.0000050933427,0.00031068537,0.000003701676,0.0065437085,0.00013395889],"about_ca_topic_score_codex":0.00004303569,"about_ca_topic_score_gemma":0.00008701645,"teacher_disagreement_score":0.08854604,"about_ca_system_score_codex":0.00046373968,"about_ca_system_score_gemma":0.0021760121,"threshold_uncertainty_score":0.5587715},"labels":[],"label_agreement":null},{"id":"W2953738724","doi":"10.1016/j.jval.2019.04.228","title":"PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Follicular lymphoma; Obinutuzumab; Hazard ratio; Internal medicine; Rituximab; Population; Regimen; Oncology; Confidence interval; Surgery; Progression-free survival; Chemotherapy; Lymphoma","score_opus":0.01568608151706712,"score_gpt":0.28868285891160483,"score_spread":0.2729967773945377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953738724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895055,0.00055159116,0.0000025123466,0.00017188792,0.0005597209,0.009044792,0.00014262897,0.000016281965,0.0000050693575],"genre_scores_gemma":[0.9964792,0.0014540901,0.00017185436,0.0004480883,0.00005803649,0.0010031671,0.00034628605,0.000032400912,0.000006877979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692804,0.000472377,0.0011466717,0.0006324672,0.00026428,0.0005561502],"domain_scores_gemma":[0.99848425,0.00044182205,0.00034200482,0.0003342847,0.00006911548,0.00032853984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009108524,0.00025755033,0.0008729991,0.00018041159,0.000046503505,0.000016270507,0.00006987878,0.0001449252,0.000007820747],"category_scores_gemma":[0.00022080749,0.00021260126,0.000061911276,0.00024647932,0.000040347448,0.00009908223,0.000032699278,0.00014110617,0.000004147607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008470646,0.0010139203,0.9528373,0.00021581205,0.00004316038,0.0000834854,0.0003053388,0.00036887397,5.8360496e-7,0.00014212356,0.00006191524,0.044080414],"study_design_scores_gemma":[0.03399312,0.004086136,0.9501626,0.00063642097,0.00004353995,0.000006841254,0.000097161195,0.010440649,0.000037559475,0.0001485015,0.00018082373,0.00016668045],"about_ca_topic_score_codex":0.97205406,"about_ca_topic_score_gemma":0.81986886,"teacher_disagreement_score":0.15218519,"about_ca_system_score_codex":0.0071413103,"about_ca_system_score_gemma":0.0034100546,"threshold_uncertainty_score":0.9966701},"labels":[],"label_agreement":null},{"id":"W2953981643","doi":"10.1200/jco.2019.37.15_suppl.7505","title":"Polatuzumab vedotin (Pola) + obinutuzumab (G) and lenalidomide (Len) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL): Interim analysis of a phase Ib/II trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Tolerability; Follicular lymphoma; Adverse effect; Gastroenterology; Febrile neutropenia; Surgery; Lymphoma; Chemotherapy","score_opus":0.04840317173428456,"score_gpt":0.40444398275506743,"score_spread":0.3560408110207829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953981643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966584,0.00085884647,0.000009459683,0.0005356331,0.0006547969,0.00064664875,0.000013041045,0.000006728217,0.00061648584],"genre_scores_gemma":[0.9977493,0.0006158886,0.00063623383,0.0006340531,0.00018986066,0.000011777256,0.00001920652,0.000024865882,0.00011878746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485266,0.0005775971,0.0032744496,0.00039146488,0.0005926964,0.00031111366],"domain_scores_gemma":[0.99401057,0.0017874432,0.0029321637,0.0004085422,0.0004423957,0.00041887953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017766954,0.00028169583,0.0035108386,0.00071203517,0.000036246427,0.000011387752,0.0001776781,0.0004582054,0.00016188834],"category_scores_gemma":[0.0013563766,0.00018143369,0.00092511927,0.0005826404,0.00019477383,0.00019964605,0.00010063092,0.00043786893,0.000008795534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29868233,0.035259485,0.540847,0.00005725793,0.0085302815,0.0007669301,0.00043845907,0.000038268787,0.00013833783,0.00008360373,0.00043443358,0.11472361],"study_design_scores_gemma":[0.43265644,0.114483304,0.4383671,0.00028892234,0.00505692,0.000049034225,0.00015335334,0.0002549942,0.000105758605,0.000027360866,0.008400159,0.00015666107],"about_ca_topic_score_codex":0.00018141571,"about_ca_topic_score_gemma":0.00010974052,"teacher_disagreement_score":0.13397412,"about_ca_system_score_codex":0.0011820481,"about_ca_system_score_gemma":0.0021375332,"threshold_uncertainty_score":0.7398651},"labels":[],"label_agreement":null},{"id":"W2954109926","doi":"10.1182/blood.v130.suppl_1.3291.3291","title":"Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Carmustine; Bendamustine; Internal medicine; Melphalan; Transplantation; Etoposide; Surgery; Autologous stem-cell transplantation; Salvage therapy; Oncology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.016771659613164853,"score_gpt":0.25747848850571314,"score_spread":0.2407068288925483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954109926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793935,0.00009624419,0.000013216329,0.000024597797,0.00017950336,0.00070899085,0.000049944018,0.000029561603,0.0009586156],"genre_scores_gemma":[0.999511,0.0000337248,0.00020017197,0.0000065215254,0.000025053421,0.000064858774,0.000118976255,0.000020541025,0.000019171566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987377,0.00012163551,0.00026372078,0.00034692697,0.00029656032,0.00023349043],"domain_scores_gemma":[0.9985353,0.0006163641,0.00026973226,0.00038777723,0.0000907553,0.000100076424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011128235,0.00022741518,0.00058948743,0.00009927814,0.00012624598,0.000021580936,0.00010937959,0.00012311719,0.0000055776736],"category_scores_gemma":[0.000018100925,0.00017381778,0.000070967464,0.00007177527,0.00012660472,0.00014212208,0.000024679026,0.00008386731,0.000010039547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013759508,0.013314677,0.96603394,0.00061240187,0.0004542944,0.00034043475,0.0006624147,0.00006835982,0.0006133948,0.00015448147,0.000011804864,0.0039743036],"study_design_scores_gemma":[0.09095477,0.0042972313,0.8545881,0.00059127127,0.00064018654,0.0000076724245,0.000064760316,0.000008471971,0.048687384,0.000007494387,0.0000069977373,0.00014568216],"about_ca_topic_score_codex":0.0001983588,"about_ca_topic_score_gemma":0.00017136933,"teacher_disagreement_score":0.11144585,"about_ca_system_score_codex":0.00019317101,"about_ca_system_score_gemma":0.00021929042,"threshold_uncertainty_score":0.7088083},"labels":[],"label_agreement":null},{"id":"W2954226397","doi":"10.1182/blood.2019003127","title":"Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Oncology","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Bleomycin; Internal medicine; Chemotherapy regimen; Population; Progression-free survival; Nuclear medicine; Oncology; Surgery; Chemotherapy; Lymphoma; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.016476718114087244,"score_gpt":0.2523826619715569,"score_spread":0.23590594385746966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954226397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188936,0.00012863716,0.000043344207,0.0057758223,0.000039591345,0.0016265524,0.000052406107,0.000045595058,0.00039870176],"genre_scores_gemma":[0.9975954,0.00002561766,0.00075874606,0.0011018118,0.00012970732,0.00014810394,0.000014184501,0.000036785386,0.0001895903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883664,0.000038003105,0.00024590312,0.00032542876,0.00031239758,0.00024160242],"domain_scores_gemma":[0.99923825,0.00006470653,0.00012467938,0.00037427156,0.000071323906,0.0001267817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093790244,0.00019156243,0.00041780117,0.000022066031,0.00006945847,0.000016447311,0.00014852118,0.000055228324,0.000058479814],"category_scores_gemma":[0.000029715426,0.00010707887,0.00014952758,0.00018656958,0.00006682028,0.00002945364,0.000055030472,0.000051089686,0.000011380027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00493798,0.048498176,0.9151331,0.00028806194,0.0031935615,0.00017514487,0.0038309125,0.0000054503457,0.0033517855,0.0012193196,0.0048612207,0.014505278],"study_design_scores_gemma":[0.22852193,0.00984441,0.58535576,0.0001545825,0.002144725,0.0000357722,0.0019892827,0.00015329356,0.15581225,0.000031959295,0.015574524,0.00038152587],"about_ca_topic_score_codex":0.000032265394,"about_ca_topic_score_gemma":0.00001701975,"teacher_disagreement_score":0.32977736,"about_ca_system_score_codex":0.00004201706,"about_ca_system_score_gemma":0.00018402733,"threshold_uncertainty_score":0.43665496},"labels":[],"label_agreement":null},{"id":"W2954339342","doi":"10.1007/s40264-019-00847-w","title":"Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cohort; Cumulative incidence; Rheumatoid arthritis; Population; Cohort study; Confidence interval; Oncology; Cancer","score_opus":0.005774240790760942,"score_gpt":0.25004341123668905,"score_spread":0.2442691704459281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954339342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915018,0.0026564787,0.000011119666,0.0007356916,0.00005096738,0.0049056406,0.00008370247,0.000014777483,0.000039805494],"genre_scores_gemma":[0.99181384,0.007124531,0.00007596882,0.00012910052,0.000012816773,0.00072230096,0.0000790994,0.000011204215,0.00003116337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993198,0.000055427427,0.00022527495,0.00016711881,0.00014582975,0.00008654343],"domain_scores_gemma":[0.99931383,0.00024258725,0.00013927369,0.00020298282,0.000074321404,0.000026977252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038401256,0.00008801539,0.00027031376,0.0000254103,0.00007205719,0.000008218771,0.000025728968,0.000019503765,0.000024541803],"category_scores_gemma":[0.00003048075,0.000050232557,0.00006325332,0.00006255568,0.000023983775,0.000029483292,0.00000761161,0.000026185642,0.0000016785751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001519979,0.00031625843,0.9656721,0.000013742061,0.0002657572,4.22534e-7,0.0007835613,0.000088174354,0.000005499649,0.0001027943,0.000034318502,0.031197444],"study_design_scores_gemma":[0.025280045,0.00016573402,0.97228336,0.000076700635,0.000052076073,0.0000010078983,0.00019376008,0.00090733834,0.0003993592,0.00009477395,0.0004932973,0.000052528263],"about_ca_topic_score_codex":0.0036571017,"about_ca_topic_score_gemma":0.0003449694,"teacher_disagreement_score":0.031144915,"about_ca_system_score_codex":0.00005196307,"about_ca_system_score_gemma":0.000059523285,"threshold_uncertainty_score":0.5528468},"labels":[],"label_agreement":null},{"id":"W2954789649","doi":"10.1200/jco.2019.37.15_suppl.tps7571","title":"POLARIX: A phase 3 study of polatuzumab vedotin (pola) plus R-CHP versus R-CHOP in patients (pts) with untreated DLBCL.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Phases of clinical research; Cyclophosphamide; Bendamustine; Surgery; Chemotherapy; Lymphoma","score_opus":0.08224978446287155,"score_gpt":0.45607575900181024,"score_spread":0.3738259745389387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954789649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957596,0.00017677198,0.0000012601804,0.00047131683,0.0010178526,0.00078637287,0.0000065909235,0.0000068720988,0.0017733646],"genre_scores_gemma":[0.99911684,0.00009047302,0.00025766887,0.00023633517,0.00019312426,0.0000058761916,0.0000070439005,0.000021906964,0.000070712114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610525,0.00042464052,0.0023180342,0.00027626503,0.0005884728,0.0002873595],"domain_scores_gemma":[0.99522746,0.0017538694,0.0018353646,0.0003285124,0.0004956449,0.0003591603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009064447,0.00021653333,0.002101892,0.00027330365,0.000022420481,0.000007306723,0.00016498435,0.00031485458,0.00013571783],"category_scores_gemma":[0.0010727593,0.00013577974,0.00029104072,0.00030378878,0.000093510775,0.00011886793,0.000056813522,0.00063833874,0.000036594254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07566394,0.05890941,0.83347505,0.000016103237,0.0010515354,0.0008041917,0.00037499852,0.000019984449,0.000012411677,0.000019915096,0.00018712398,0.029465362],"study_design_scores_gemma":[0.25584102,0.1526225,0.5888867,0.00011156992,0.00046848838,0.000025730968,0.00046668126,0.000039754977,0.000019993595,0.00000518706,0.0014362298,0.00007612651],"about_ca_topic_score_codex":0.0004074195,"about_ca_topic_score_gemma":0.00026709822,"teacher_disagreement_score":0.24458833,"about_ca_system_score_codex":0.00078924594,"about_ca_system_score_gemma":0.0018071351,"threshold_uncertainty_score":0.5536937},"labels":[],"label_agreement":null},{"id":"W2955140251","doi":"10.1016/j.ijrobp.2019.06.2505","title":"Keeping Our Finger on the Pulse: Reaffirming the Role of Radiation Therapy in the Curative Management of Early Stage Follicular Lymphoma","year":2019,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Follicular lymphoma; Radiation therapy; Stage (stratigraphy); Lymphoma; Oncology; Cancer; Internal medicine","score_opus":0.025454788983112143,"score_gpt":0.32138156654917643,"score_spread":0.2959267775660643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955140251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6845766,0.0025022195,0.00016668712,0.30730993,0.0017462594,0.0015996355,0.0001343675,0.000011537993,0.0019527613],"genre_scores_gemma":[0.93787754,0.0033994995,0.00010663905,0.056064073,0.0022065837,0.000082327846,0.00015194154,0.000034142446,0.00007723019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698275,0.0007716712,0.0010114117,0.00026892003,0.00071759656,0.00024765613],"domain_scores_gemma":[0.9951755,0.0014259884,0.0025096892,0.00040730758,0.00045683156,0.000024674779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001093176,0.00031678425,0.00068126066,0.00021115842,0.00008080981,0.00003553924,0.0007711371,0.00038606927,0.000030403016],"category_scores_gemma":[0.00011464847,0.00016462606,0.00047819217,0.00023509443,0.00012324314,0.0001410149,0.00006018217,0.0007005959,0.00001341645],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00125683,0.0019165234,0.14972979,0.000065247645,0.0073498697,0.00043119027,0.006001193,0.00093347393,0.0005230256,0.020318296,0.03407703,0.7773975],"study_design_scores_gemma":[0.018267047,0.0059325127,0.3070199,0.0012192996,0.0009227974,0.00017516203,0.0027132009,0.0011958469,0.008340166,0.006491138,0.64719474,0.0005281855],"about_ca_topic_score_codex":0.00013517438,"about_ca_topic_score_gemma":0.0000028646582,"teacher_disagreement_score":0.77686936,"about_ca_system_score_codex":0.0008824101,"about_ca_system_score_gemma":0.00037540245,"threshold_uncertainty_score":0.6713256},"labels":[],"label_agreement":null},{"id":"W2955663186","doi":"10.1158/1538-7445.am2019-5053","title":"Abstract 5053: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nodular sclerosis; Medicine; Cancer; Ethnic group; Population; Lymphoma; Pathology; Biopsy; Epstein–Barr virus; Oncology; Hodgkin lymphoma; Internal medicine; Virus; Immunology","score_opus":0.0668762382934313,"score_gpt":0.38447328217783366,"score_spread":0.31759704388440235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955663186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909087,0.0049608084,5.0102767e-7,0.0018261486,0.0001426177,0.0015470457,0.000063792424,0.00003730506,0.0005130698],"genre_scores_gemma":[0.99495476,0.002036332,0.000039415947,0.00033356773,0.00006280965,0.00067824754,0.000051520252,0.00003629183,0.0018070554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655265,0.0003020254,0.00054454803,0.00080877997,0.0009716648,0.0008203319],"domain_scores_gemma":[0.998435,0.00048063902,0.00011572946,0.00057438377,0.00014978054,0.0002444233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009982816,0.00026170872,0.0005884605,0.00039060164,0.00007385855,0.00003070236,0.0002486365,0.00026421717,0.0010500123],"category_scores_gemma":[0.00031708356,0.00022035072,0.00011372837,0.0007320192,0.00015264288,0.00015842963,0.000111942994,0.0004577483,0.00032311707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017758886,0.0013814856,0.92985404,0.00042287086,0.00003305625,0.00036222892,0.0005139823,0.000044626595,0.040170662,0.0000334776,0.0028003517,0.022607354],"study_design_scores_gemma":[0.0063927914,0.00042915528,0.9646384,0.00060198293,0.000014759627,0.00001101986,0.000074337,0.00046689447,0.026033591,0.00004154917,0.0010858953,0.00020961335],"about_ca_topic_score_codex":0.022621932,"about_ca_topic_score_gemma":0.00437188,"teacher_disagreement_score":0.034784395,"about_ca_system_score_codex":0.0036749013,"about_ca_system_score_gemma":0.00052040635,"threshold_uncertainty_score":0.99986315},"labels":[],"label_agreement":null},{"id":"W2955782666","doi":"10.1200/jco.2019.37.15_suppl.e19050","title":"Real-world treatment patterns among patients (pts) diagnosed with primary mediastinal large B-cell lymphoma (PMBCL) in the United States (US).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Interquartile range; Internal medicine; Lymphoma; Medical diagnosis; Pathology","score_opus":0.039437693541047605,"score_gpt":0.3656568904139013,"score_spread":0.3262191968728537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955782666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994016,0.00006403704,0.0000041626467,0.0014862937,0.000493596,0.0007574526,0.00002906311,0.00001040086,0.003138996],"genre_scores_gemma":[0.9930776,0.0024827933,0.00024543094,0.0033781338,0.00034895702,0.000041107654,0.00016029073,0.000028002522,0.00023770992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959181,0.0007523464,0.0019253279,0.00029955184,0.0006619108,0.00044277334],"domain_scores_gemma":[0.99239886,0.005004781,0.0015596957,0.00035537902,0.00032161147,0.0003596722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015460675,0.00028989537,0.001572396,0.00031234504,0.000046238038,0.000020233365,0.00022849397,0.00022035086,0.00016361255],"category_scores_gemma":[0.00024823128,0.00013995907,0.0003957381,0.00034739447,0.00012491592,0.00011985117,0.000048529684,0.0003568936,0.000047991784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033353723,0.035684835,0.93547505,0.00003649124,0.00033221842,0.0031480794,0.00060344476,0.000024898676,7.742837e-7,0.000016014896,0.00090511364,0.020437706],"study_design_scores_gemma":[0.07752866,0.030083636,0.86886215,0.0002256077,0.0005072108,0.000057885314,0.0003880336,0.000075941214,0.000017732087,0.00001221839,0.022116931,0.00012395694],"about_ca_topic_score_codex":0.0021234518,"about_ca_topic_score_gemma":0.0037981202,"teacher_disagreement_score":0.07419329,"about_ca_system_score_codex":0.001008996,"about_ca_system_score_gemma":0.0010773891,"threshold_uncertainty_score":0.5707365},"labels":[],"label_agreement":null},{"id":"W2956178192","doi":"10.1182/blood.2019000258","title":"Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Bendamustine; Internal medicine; Oncology; Prednisone; Vincristine; Population; Hazard ratio; Lymphoma; Immunology; Cyclophosphamide; Confidence interval; Chemotherapy","score_opus":0.004026528704495895,"score_gpt":0.2221321651778771,"score_spread":0.2181056364733812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956178192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998136,0.00035607,0.0000042096417,0.00009466489,0.000025882171,0.00092782686,0.000103629485,0.000032533233,0.0003191873],"genre_scores_gemma":[0.99907845,0.00007323631,0.00045513085,0.00004863384,0.000009215526,0.00014022659,0.00007626893,0.000019585783,0.000099240795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894774,0.000037401744,0.00027250394,0.00021018853,0.00033001462,0.00020212303],"domain_scores_gemma":[0.9994416,0.000035694822,0.00015944961,0.00022055232,0.00008072687,0.000061937906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009874634,0.00015599647,0.00036758513,0.00009476082,0.00001929755,0.000009283708,0.000038763523,0.00009385648,0.00009142324],"category_scores_gemma":[0.000017712495,0.00010638492,0.00007994582,0.00021535065,0.000019708375,0.00014140873,0.000009805769,0.00004895501,0.000023387147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007274052,0.0052972767,0.9828992,0.00010731307,0.000295635,0.00012722096,0.0010925267,0.0000068219597,0.00057545456,0.00002762072,0.0000034530876,0.00884011],"study_design_scores_gemma":[0.048879378,0.0015318345,0.89759827,0.00072149094,0.00040545635,0.0000072577577,0.00007315712,0.00004091725,0.05054441,0.000010131899,0.0000744686,0.00011321682],"about_ca_topic_score_codex":0.00022647057,"about_ca_topic_score_gemma":0.000048673992,"teacher_disagreement_score":0.085300885,"about_ca_system_score_codex":0.00008341883,"about_ca_system_score_gemma":0.00006667303,"threshold_uncertainty_score":0.4338251},"labels":[],"label_agreement":null},{"id":"W2956596053","doi":"10.1200/jco.2013.31.15_suppl.8552","title":"Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma (DLBCL).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; CHOP; Chemotherapy; Internal medicine; Lymphoma; Chemotherapy regimen; Stage (stratigraphy); Cancer registry; Cancer; Diffuse large B-cell lymphoma; Surgery; Oncology","score_opus":0.0423084318410865,"score_gpt":0.3972867599556561,"score_spread":0.3549783281145696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956596053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977069,0.00005139416,0.000017473323,0.00083988917,0.00016302243,0.00043548792,0.00011355451,0.0000026951132,0.0006695807],"genre_scores_gemma":[0.99828047,0.00027661404,0.0007068518,0.0005266534,0.00013847342,0.000013234667,0.000021680804,0.000017175073,0.000018877481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971066,0.00029656666,0.0018086308,0.00015741063,0.0004617148,0.00016905282],"domain_scores_gemma":[0.9926434,0.003378641,0.00249016,0.00021149658,0.0009905949,0.00028568672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908291,0.00016646115,0.0017089619,0.00013321725,0.000013226609,0.0000032748817,0.00011523897,0.0002173236,0.0005120645],"category_scores_gemma":[0.00091443135,0.00009467061,0.00050546206,0.00014278243,0.000094326075,0.00010865027,0.000026198626,0.00012843304,0.000027485097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062518795,0.074625425,0.8812959,0.000011856063,0.0008751116,0.000017939063,0.00028831535,0.0000049502996,0.00011354853,0.0000087324015,0.0014270331,0.035079297],"study_design_scores_gemma":[0.06453753,0.048546754,0.8836797,0.00016325367,0.00027041,0.000001349667,0.000036336183,0.000018002916,0.0022343716,0.000048194535,0.00039611448,0.000067964604],"about_ca_topic_score_codex":0.00022581947,"about_ca_topic_score_gemma":0.000016554099,"teacher_disagreement_score":0.05828565,"about_ca_system_score_codex":0.00023404817,"about_ca_system_score_gemma":0.00066982274,"threshold_uncertainty_score":0.5606747},"labels":[],"label_agreement":null},{"id":"W2957076795","doi":"10.1200/jco.19.00525","title":"Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Neurocognitive; Pediatrics; Regimen; Non-Hodgkin's lymphoma; Relative risk; Late effect; Internal medicine; Cancer; Lymphoma; Psychiatry; Confidence interval; Cognition","score_opus":0.06839217710615138,"score_gpt":0.4419009932977658,"score_spread":0.3735088161916144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957076795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536881,0.0073311143,0.0000127337835,0.034191355,0.0023168225,0.0021012935,0.00006766835,0.0000138837095,0.00027706756],"genre_scores_gemma":[0.97065854,0.0019442234,0.00078675244,0.024299394,0.0013342256,0.0001793017,0.000015625483,0.000046707024,0.0007352544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995173,0.00068282144,0.002862707,0.0004107414,0.0004683104,0.00040245877],"domain_scores_gemma":[0.9917618,0.004188033,0.0027410425,0.00055529026,0.00032116668,0.00043266758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00457477,0.00030559464,0.0025784331,0.00007001411,0.00007116239,0.000027521855,0.00027341858,0.00039310294,0.00014762835],"category_scores_gemma":[0.0004647447,0.00015488628,0.0010318956,0.000111198,0.00008114753,0.00009290382,0.00006483034,0.00037723363,0.00002264268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076804184,0.014620646,0.9299196,0.000017679535,0.0017368919,0.001678757,0.00090413867,0.0000034887598,0.0000066654266,0.0000019166255,0.0107309325,0.032698836],"study_design_scores_gemma":[0.05648118,0.011647751,0.8827752,0.00012143924,0.00029732342,0.00019202217,0.00038280754,0.000013262735,0.000020976311,0.00009146848,0.0478453,0.00013127022],"about_ca_topic_score_codex":0.0022224828,"about_ca_topic_score_gemma":0.0004095452,"teacher_disagreement_score":0.048800763,"about_ca_system_score_codex":0.00055860577,"about_ca_system_score_gemma":0.0070809573,"threshold_uncertainty_score":0.998548},"labels":[],"label_agreement":null},{"id":"W2958564469","doi":"10.1200/jco.2006.24.18_suppl.7503","title":"Phase II study of rituximab + CHOP followed by <sup>90</sup>Y-ibritumomab tiuxetan in patients with previously untreated mantle cell lymphoma: An Eastern Cooperative Oncology Group Study (E1499)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Mantle cell lymphoma; Neutropenia; Vincristine; Febrile neutropenia; Gastroenterology; CHOP; International Prognostic Index; Ibritumomab tiuxetan; Cyclophosphamide; Lymphoma; Radioimmunotherapy; Chemotherapy; Immunology","score_opus":0.03392994213060223,"score_gpt":0.3841714004314493,"score_spread":0.3502414583008471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958564469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955308,0.00031710457,0.000005429073,0.00027467927,0.00023776587,0.0026232742,0.000026857071,0.000018077113,0.0009660191],"genre_scores_gemma":[0.9987077,0.000055465604,0.0003008212,0.00027451996,0.00025744297,0.000069774665,0.00006071181,0.00005071858,0.00022282638],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99222165,0.0018225139,0.0039912728,0.0006306791,0.00080381415,0.00053006574],"domain_scores_gemma":[0.99473655,0.0010372893,0.002472914,0.0004784271,0.0007777108,0.00049712666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016555764,0.000469316,0.0037852693,0.00029527012,0.00011551186,0.00002106384,0.0003197407,0.00042880737,0.00008133064],"category_scores_gemma":[0.00028406834,0.0003097522,0.00032235542,0.0004201854,0.00022786578,0.0002854249,0.0001262743,0.00051326293,0.000014485441],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02036651,0.42970467,0.5208405,0.000012762853,0.00062291266,0.0022240405,0.0010912893,0.00003178644,0.000010399677,0.0000022770766,0.0010873112,0.02400552],"study_design_scores_gemma":[0.31193012,0.38007692,0.30272102,0.00007204164,0.0012687009,0.00005647291,0.0020864077,0.000120819794,0.000031877084,0.0000051281986,0.0014639732,0.00016651458],"about_ca_topic_score_codex":0.000948105,"about_ca_topic_score_gemma":0.0018573843,"teacher_disagreement_score":0.2915636,"about_ca_system_score_codex":0.00086213474,"about_ca_system_score_gemma":0.001426426,"threshold_uncertainty_score":0.99993545},"labels":[],"label_agreement":null},{"id":"W2959261838","doi":"10.1182/blood.2019001126","title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cancer research; Lymphoma; CDKN2A; BCL10; Gene expression profiling; Gene; Genetics; Gene expression; Immunology","score_opus":0.005698343079260077,"score_gpt":0.21639656889591574,"score_spread":0.21069822581665568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959261838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929872,0.0013482785,0.00008888822,0.00007952438,0.00012202677,0.0004853684,0.00006443866,0.000042172527,0.0047820993],"genre_scores_gemma":[0.99687135,0.00018385981,0.0010695206,0.00028452542,0.000045804984,0.00009033669,0.00023460471,0.000023388302,0.0011965953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984414,0.000068277455,0.00035671293,0.00045941735,0.00031282761,0.0003613924],"domain_scores_gemma":[0.9991797,0.00009923218,0.00012072573,0.0004084531,0.000062535706,0.00012935337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022463512,0.00024540545,0.0006255338,0.00037931954,0.00003927178,0.000030202522,0.0001198715,0.000105743835,0.00036916684],"category_scores_gemma":[0.000023485869,0.00018665272,0.00033671464,0.00054756313,0.000021948275,0.000077647936,0.00009224489,0.00007307073,0.00049699604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025074967,0.01856075,0.85375094,0.0001708612,0.0029593005,0.0012221232,0.0025948356,0.0000058937944,0.11743096,0.0010176093,0.00014875669,0.0018871907],"study_design_scores_gemma":[0.022488771,0.00040937672,0.92789865,0.0000804998,0.003243323,0.000053111024,0.00067347515,0.00009912558,0.044493824,0.00020174256,0.00013190377,0.00022622959],"about_ca_topic_score_codex":0.00011033249,"about_ca_topic_score_gemma":0.0002002952,"teacher_disagreement_score":0.07414766,"about_ca_system_score_codex":0.0002526496,"about_ca_system_score_gemma":0.00019648323,"threshold_uncertainty_score":0.7611477},"labels":[],"label_agreement":null},{"id":"W2961112061","doi":"10.1182/bloodadvances.2019000251","title":"COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Aalborg Universitetshospital; Aalborg Universitet","keywords":"Oncology; Stage (stratigraphy); Internal medicine; Retrospective cohort study; Multicenter study; Outcome (game theory); Medicine; Overall survival; Biology","score_opus":0.005943054272169658,"score_gpt":0.24933367953388658,"score_spread":0.24339062526171693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961112061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583244,0.0005167105,0.0000010356579,0.000041977106,0.0001539769,0.0022791459,0.00016530204,0.000064019936,0.000945361],"genre_scores_gemma":[0.998532,0.00009101081,0.00025927302,0.00011555809,0.00004640352,0.00009065305,0.00003173066,0.000030098794,0.0008032591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832356,0.000033298336,0.00027818445,0.00052693207,0.00048238802,0.00035560774],"domain_scores_gemma":[0.99908715,0.000066712746,0.00016514696,0.00035118122,0.00013300328,0.00019679216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006929517,0.00026463345,0.000486192,0.00007027779,0.00010545883,0.000037198257,0.00005753204,0.00004191427,0.00006887268],"category_scores_gemma":[0.000038857226,0.00016750484,0.00005038906,0.00011130219,0.00008067527,0.0002933855,0.000086146996,0.0001024614,0.000020355033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005832913,0.0071813343,0.98951393,0.00006360106,0.00042785468,0.00007023953,0.0011968357,0.0000033410092,0.0000084346175,0.000013994158,0.000014697407,0.0009224294],"study_design_scores_gemma":[0.033336096,0.0061130263,0.95736164,0.00012062441,0.00045887745,0.0000014011079,0.0010916357,0.000009561374,0.00026457274,0.0000024480487,0.001058522,0.00018156784],"about_ca_topic_score_codex":0.00014228931,"about_ca_topic_score_gemma":0.000113449925,"teacher_disagreement_score":0.032752804,"about_ca_system_score_codex":0.00010025793,"about_ca_system_score_gemma":0.000030082945,"threshold_uncertainty_score":0.68306494},"labels":[],"label_agreement":null},{"id":"W2962917456","doi":"10.1097/cm9.0000000000000354","title":"A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Chinese Medical Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Retrospective cohort study; Lymphoma; Medical record; Cancer; Survival rate","score_opus":0.0038329868833420814,"score_gpt":0.25938140259628706,"score_spread":0.25554841571294495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962917456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959817,0.000121490186,0.000028923816,0.00035401923,0.00020170075,0.00030168556,0.000066935776,0.000017172157,0.002926379],"genre_scores_gemma":[0.9988938,0.00014393956,0.00016116374,0.00020726744,0.00008405816,0.000007765813,0.0000678672,0.000027714917,0.0004063997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662906,0.00008131164,0.0008027461,0.0003024857,0.0018379648,0.00034645523],"domain_scores_gemma":[0.99772346,0.0002144922,0.0005904103,0.00047324313,0.00043652006,0.00056189403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003760664,0.00032761294,0.0016390032,0.0006900861,0.00005941229,0.00001555532,0.00021745909,0.00012120235,0.0011086174],"category_scores_gemma":[0.000352564,0.00015744311,0.0006213775,0.0015424173,0.00010894121,0.000107473345,0.00007440711,0.00021991465,0.000014587329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004565458,0.015175598,0.9781966,0.00006105317,0.0036509333,0.00015331311,0.00041068695,0.0000018229681,0.000020345879,0.000049307022,0.000091920265,0.0017318808],"study_design_scores_gemma":[0.03937876,0.0012196827,0.9569103,0.00015214799,0.0017766535,0.000020779977,0.000034319186,0.00023758115,0.0000345789,0.000060496364,0.000034490375,0.00014021645],"about_ca_topic_score_codex":0.0001715061,"about_ca_topic_score_gemma":0.00027156834,"teacher_disagreement_score":0.038922213,"about_ca_system_score_codex":0.00025474062,"about_ca_system_score_gemma":0.00030463122,"threshold_uncertainty_score":0.9998045},"labels":[],"label_agreement":null},{"id":"W2963130316","doi":"10.1097/mph.0000000000001553","title":"Prognostic Factors and Treatment Outcome of Pediatric Anaplastic Large Cell Lymphoma Treated at the Children Cancer Hospital Egypt","year":2019,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Etoposide; Chemotherapy; Internal medicine; Hematopoietic stem cell transplantation; Lymphoma; Transplantation; Autologous stem-cell transplantation; Stage (stratigraphy); Surgery; Retrospective cohort study; Oncology","score_opus":0.013569707292887674,"score_gpt":0.28668345099025117,"score_spread":0.27311374369736346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963130316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445934,0.012610335,0.0000023877378,0.000866667,0.00070558547,0.0010315389,0.000092056376,0.000018653978,0.00021345324],"genre_scores_gemma":[0.9920186,0.006908982,0.00008122322,0.00008577689,0.00057509943,0.00004504525,0.000023525676,0.0000363725,0.00022541908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972767,0.00019611289,0.0012287309,0.00036796415,0.00036540927,0.0005650509],"domain_scores_gemma":[0.9962095,0.0014072902,0.0014898515,0.00030596124,0.00024948103,0.0003379015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002758974,0.00043631968,0.0016382901,0.00042912192,0.0001151273,0.000011690064,0.00017718381,0.0003827155,0.0002563036],"category_scores_gemma":[0.00018119451,0.00023275407,0.0004216563,0.0004176713,0.00010675431,0.000090479705,0.00011196352,0.00018038,0.000052149455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040473457,0.0048181005,0.9906837,0.00010676842,0.0005736321,0.00044269953,0.000555777,0.000004291838,0.00001450334,0.000026652344,0.0015105361,0.0008586334],"study_design_scores_gemma":[0.019527806,0.010749685,0.9620026,0.000013937758,0.0047802352,0.001140029,0.00023978205,0.000013503216,0.0005618062,0.000008037558,0.00076065445,0.00020195241],"about_ca_topic_score_codex":0.00016437023,"about_ca_topic_score_gemma":0.00009673059,"teacher_disagreement_score":0.028681101,"about_ca_system_score_codex":0.0011054052,"about_ca_system_score_gemma":0.0008069487,"threshold_uncertainty_score":0.9491436},"labels":[],"label_agreement":null},{"id":"W2963514687","doi":"10.1182/blood.v130.suppl_1.1460.1460","title":"Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Phenotype; Clinical phenotype; Disease; Medicine; Biology; Cancer research; Genetics; Pathology; Gene","score_opus":0.02013525932036717,"score_gpt":0.2905528530478353,"score_spread":0.2704175937274681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963514687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953442,0.0030633027,5.625157e-7,0.00051330356,0.00012769611,0.00036730253,0.00040892742,0.000023429282,0.00015125984],"genre_scores_gemma":[0.992894,0.0063474122,0.00008676614,0.00021283151,0.00011999205,0.00004668421,0.000083602994,0.000028811217,0.00017991551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988769,0.000041303112,0.00036677142,0.00035357932,0.0001281031,0.0002333374],"domain_scores_gemma":[0.9982684,0.00017855625,0.00029230092,0.00063928444,0.00005948729,0.00056196324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014101238,0.00019603787,0.0004883975,0.00002926084,0.00021764336,0.000038858485,0.00008624103,0.000100404475,0.00003181763],"category_scores_gemma":[0.00027630248,0.00015388406,0.00010102494,0.000019432713,0.00021726257,0.00005285529,0.00021516113,0.00004709673,0.000022651333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033159988,0.017935574,0.9746497,0.00013262365,0.00022288245,0.00050576776,0.00011738844,4.928608e-9,0.00017435406,0.000039394217,0.00034851613,0.0055421786],"study_design_scores_gemma":[0.035340626,0.00039383527,0.9595277,0.00011113992,0.0018824433,0.000022060705,0.000016417664,0.000033440563,0.0012804813,0.000028914807,0.0012197361,0.00014321192],"about_ca_topic_score_codex":0.000038391718,"about_ca_topic_score_gemma":0.000013422261,"teacher_disagreement_score":0.035009027,"about_ca_system_score_codex":0.000031584208,"about_ca_system_score_gemma":0.000116078554,"threshold_uncertainty_score":0.627521},"labels":[],"label_agreement":null},{"id":"W2964426877","doi":"10.1182/blood-2018-99-116600","title":"Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Gastroenterology; Internal medicine; Vinblastine; Prednisolone; Cyclophosphamide; Surgery; Chemotherapy; Gemcitabine; CHOP","score_opus":0.008263935582247806,"score_gpt":0.23970893129106874,"score_spread":0.23144499570882093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964426877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982495,0.0003760848,0.0000041690646,0.00016004086,0.000033881064,0.0006247867,0.0000104470255,0.000028048851,0.0005130727],"genre_scores_gemma":[0.9980688,0.0005493883,0.000905195,0.000051187737,0.00003884729,0.00005681194,0.000023212797,0.00002240074,0.000284138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990318,0.00003617812,0.00028945366,0.0002970526,0.00017581637,0.00016971021],"domain_scores_gemma":[0.99923724,0.00014484477,0.00015832578,0.00023703171,0.00008233613,0.00014022151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013220409,0.00018011377,0.00033110575,0.00014160012,0.000086558575,0.000008029913,0.000028242048,0.000084337036,0.000013832441],"category_scores_gemma":[0.00010684324,0.00012925413,0.000018538816,0.00020959758,0.00019390504,0.00011917565,0.000046567926,0.000056969915,0.000002240595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014400983,0.017658954,0.9234294,0.00047170438,0.00093249045,0.00044362617,0.0022855697,0.0000021313938,0.024303606,0.00012971647,0.00019112969,0.015750632],"study_design_scores_gemma":[0.0555306,0.007067223,0.91648173,0.0005582301,0.00040558135,0.00023888734,0.00013336519,0.00007251375,0.018993303,0.00001755132,0.00036919452,0.00013182557],"about_ca_topic_score_codex":0.00027389603,"about_ca_topic_score_gemma":0.000108508306,"teacher_disagreement_score":0.04112962,"about_ca_system_score_codex":0.00005520864,"about_ca_system_score_gemma":0.00007262976,"threshold_uncertainty_score":0.52708304},"labels":[],"label_agreement":null},{"id":"W2964704906","doi":"10.1182/blood.v130.suppl_1.607.607","title":"Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cog; Internal medicine; Ethnic group; Population; Clinical trial; Hazard ratio; Demography; Incidence (geometry); Cancer; Proportional hazards model; Oncology; Confidence interval","score_opus":0.021316472089275548,"score_gpt":0.29346448360750743,"score_spread":0.27214801151823187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964704906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996351,0.0008356703,9.704253e-7,0.0005590713,0.000021312218,0.0017671017,0.00039022975,0.0000065424333,0.00006809522],"genre_scores_gemma":[0.9987055,0.000663429,0.000016488408,0.00021178658,0.000042702843,0.00010679065,0.00023335346,0.000014348019,0.0000055879445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962763,0.0018291873,0.0008037255,0.00047645852,0.00034277624,0.00027155588],"domain_scores_gemma":[0.99800575,0.000818993,0.00054044666,0.0004668099,0.000048514044,0.000119499105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027518473,0.0002981513,0.0024501954,0.00022749398,0.00013272116,0.000048220118,0.00015545427,0.00014575117,0.000008735825],"category_scores_gemma":[0.0010453803,0.00016373249,0.00013089471,0.00027806737,0.00016595935,0.00005839779,0.000048275673,0.000102859485,2.29733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020919612,0.004531515,0.98375195,0.000009282689,0.0042144004,0.00009514963,0.00022477747,0.0000019620015,0.00025342059,0.00002648014,0.00007947544,0.004719598],"study_design_scores_gemma":[0.05567198,0.0016990645,0.9329671,0.00018189735,0.0075231907,0.000030337036,0.00008667552,0.000010106511,0.00167593,0.0000016274915,0.0000057661846,0.00014628367],"about_ca_topic_score_codex":0.5650853,"about_ca_topic_score_gemma":0.6497204,"teacher_disagreement_score":0.084635094,"about_ca_system_score_codex":0.0001907332,"about_ca_system_score_gemma":0.0002535313,"threshold_uncertainty_score":0.66768175},"labels":[],"label_agreement":null},{"id":"W2965079697","doi":"10.1200/jco.2013.31.15_suppl.e19520","title":"Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma (DLBCL) in clinical trials.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Clinical trial; Comorbidity; Oncology; Malignancy; Refractory (planetary science); Lymphoma; Surgery","score_opus":0.09385969368676302,"score_gpt":0.4560352599266496,"score_spread":0.3621755662398866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965079697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252415,0.00026016118,0.000018897808,0.0039311084,0.0014189968,0.0010393789,0.000016651082,0.0000050132826,0.0007856712],"genre_scores_gemma":[0.9935637,0.0005653705,0.0018418127,0.0034440416,0.000454465,0.000037597532,0.0000058282167,0.000020041554,0.000067127345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900981,0.0019224096,0.0066612447,0.0003099345,0.00063203694,0.00037625845],"domain_scores_gemma":[0.9881055,0.005855225,0.003354533,0.00033431713,0.00068822084,0.0016622265],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0097694285,0.0002260218,0.003509912,0.0002215907,0.000026782056,0.000010368951,0.00020369102,0.00043300993,0.00037504575],"category_scores_gemma":[0.015354121,0.00012766769,0.0009250767,0.00020455937,0.00013244865,0.000103444756,0.000091099646,0.00043697353,0.00006293183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084799435,0.056720752,0.7419196,0.000021147816,0.00035653677,0.00015814127,0.00009583268,0.0000012543288,0.0000025720985,0.000024177887,0.006655895,0.18556415],"study_design_scores_gemma":[0.14926483,0.033824716,0.78511745,0.00016982216,0.00041138087,0.000009430832,0.000110858426,0.00001868667,0.000034375404,0.00004114809,0.030897873,0.000099429526],"about_ca_topic_score_codex":0.00004038355,"about_ca_topic_score_gemma":0.00004719199,"teacher_disagreement_score":0.18546471,"about_ca_system_score_codex":0.000389807,"about_ca_system_score_gemma":0.002193759,"threshold_uncertainty_score":0.99293995},"labels":[],"label_agreement":null},{"id":"W2965773521","doi":"10.1007/s40262-019-00807-8","title":"Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Lymphoma; Medicine; Pharmacodynamics; Pharmacokinetics; Rituximab; Concomitant; Hodgkin lymphoma; Monoclonal antibody; Oncology; Drug; Mantle cell lymphoma; Pharmacology; Internal medicine; Immunology; Antibody","score_opus":0.17407227704052403,"score_gpt":0.5115206867791848,"score_spread":0.3374484097386608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965773521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004770722,0.98309624,0.000013606447,0.0002890338,0.0024876306,0.0042260806,0.00018188298,0.00012501127,0.004809777],"genre_scores_gemma":[0.0048831957,0.9882278,0.0014332017,0.0018849492,0.001616407,0.00036998012,0.00032648144,0.00021673864,0.0010412517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905151,0.0010916193,0.005155855,0.0018456848,0.00051154546,0.0008801568],"domain_scores_gemma":[0.9902583,0.006592185,0.0011763345,0.00088370685,0.00017807577,0.0009114378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001687865,0.0012275198,0.0060095983,0.00050855736,0.00011431986,0.00009485533,0.0002869889,0.00095610885,0.0006166811],"category_scores_gemma":[0.00071570405,0.0009987699,0.0017770558,0.000580855,0.0005342831,0.00010859523,0.00038178326,0.0013428346,0.00057791336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007996134,0.0029679202,0.013152794,0.007320986,0.0012195985,0.0010934776,0.000021957683,0.0000043413274,0.0000016406409,0.000032720098,0.0042110286,0.9698936],"study_design_scores_gemma":[0.021014415,0.00087339134,0.007249779,0.010289385,0.014600939,0.0005896009,0.000009213448,0.0020031277,0.0000043351624,0.000028432278,0.94239354,0.00094384345],"about_ca_topic_score_codex":0.000025905552,"about_ca_topic_score_gemma":0.0000056753493,"teacher_disagreement_score":0.96894974,"about_ca_system_score_codex":0.00037146552,"about_ca_system_score_gemma":0.00129173,"threshold_uncertainty_score":0.9992463},"labels":[],"label_agreement":null},{"id":"W2966660064","doi":"10.1200/jco.2012.30.15_suppl.e18535","title":"Expression of mTOR in diffuse large B-cell lymphoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Medicine; Univariate analysis; Diffuse large B-cell lymphoma; PI3K/AKT/mTOR pathway; Internal medicine; Oncology; Lymphoma; Stage (stratigraphy); Immunohistochemistry; Pathology; Multivariate analysis; Biology; Apoptosis","score_opus":0.09019162548205864,"score_gpt":0.44342162345375746,"score_spread":0.35322999797169885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966660064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211925,0.0017476567,0.00001156387,0.0010032973,0.00092436734,0.00010620425,0.0000027086674,0.0000029418331,0.0040819948],"genre_scores_gemma":[0.99550885,0.00094356894,0.001753676,0.0008589569,0.00076429703,0.0000033371837,0.0000013477974,0.000009477144,0.0001564955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997306,0.00027446033,0.0018206133,0.00008979577,0.000260614,0.0002485315],"domain_scores_gemma":[0.99657744,0.00152939,0.0012230985,0.00015874296,0.0001315656,0.0003797721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020703035,0.00009674437,0.0011785508,0.000109619956,0.000012380115,0.0000017197208,0.00008733808,0.00029786595,0.00011005017],"category_scores_gemma":[0.0012198711,0.000059075937,0.0003935176,0.000082767445,0.00006141054,0.0001051244,0.00005011649,0.00019968102,0.00002614689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018874151,0.09763429,0.8606356,0.000032127573,0.000063515785,0.00031318117,0.00019097084,2.9004596e-7,0.00067925407,0.000093003044,0.004655831,0.033814557],"study_design_scores_gemma":[0.07266112,0.004482208,0.83581334,0.00015219089,0.00018329358,0.0001185989,0.00012003264,0.000007582519,0.005267214,0.000041271625,0.0810989,0.00005421963],"about_ca_topic_score_codex":0.000011033354,"about_ca_topic_score_gemma":0.0000060543407,"teacher_disagreement_score":0.09315208,"about_ca_system_score_codex":0.00017999586,"about_ca_system_score_gemma":0.0005508953,"threshold_uncertainty_score":0.24090469},"labels":[],"label_agreement":null},{"id":"W2966938034","doi":"10.1182/blood-2018-99-111748","title":"Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Burkitt's lymphoma; Internal medicine; Lymphoma; Population; Rituximab; International Prognostic Index; Oncology; Pediatrics","score_opus":0.008242619169865946,"score_gpt":0.24103867549234473,"score_spread":0.2327960563224788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966938034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830234,0.000009278701,3.6236858e-7,0.000007757623,0.000056052293,0.0005350664,0.000032082007,0.0000104406445,0.0010466019],"genre_scores_gemma":[0.99947536,0.00007979331,0.00012636888,0.000040624956,0.000032112574,0.000038634767,0.00014175836,0.000018971132,0.000046404795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905515,0.00003569144,0.0003017748,0.0002128776,0.000289796,0.0001047333],"domain_scores_gemma":[0.9982427,0.000022070819,0.00016225669,0.00020583087,0.0013210142,0.000046145386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039672148,0.00012841474,0.00028540308,0.00016685243,0.000015590122,0.0000064903347,0.000050088718,0.00003854782,0.00003192661],"category_scores_gemma":[0.00004569812,0.00009791626,0.000021457736,0.00017728143,0.00006839811,0.000103504026,0.000029485347,0.000020436844,0.000003111255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002506365,0.017160546,0.976743,0.000019896577,0.00035754367,0.000005542035,0.0019553844,1.18614885e-7,0.000097786746,0.000018483594,0.0000074022787,0.0011279673],"study_design_scores_gemma":[0.03434267,0.0070911814,0.9530046,0.00022813758,0.00019088226,7.792112e-7,0.0003898135,0.000008659984,0.0046509216,0.0000021517687,0.000007788929,0.00008243722],"about_ca_topic_score_codex":0.0025040368,"about_ca_topic_score_gemma":0.001126311,"teacher_disagreement_score":0.031836305,"about_ca_system_score_codex":0.00005566618,"about_ca_system_score_gemma":0.000027583592,"threshold_uncertainty_score":0.3992909},"labels":[],"label_agreement":null},{"id":"W2967569980","doi":"10.1200/jco.19.01492","title":"Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Nivolumab; Adverse effect; Transplantation; Oncology; Lymphoma; Anaplastic large-cell lymphoma; Gastroenterology; Surgery; CD30; Cancer; Immunotherapy","score_opus":0.043628263859766474,"score_gpt":0.38423082836358635,"score_spread":0.34060256450381987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967569980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166065,0.0010588394,0.00003365277,0.0038916399,0.0010056978,0.0015268773,0.00004803556,0.000014812777,0.00075976085],"genre_scores_gemma":[0.995369,0.0004595938,0.0010482923,0.001984849,0.00076252606,0.000024823828,0.00003613006,0.0000337687,0.0002809969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996359,0.0004603419,0.001964479,0.00036964304,0.0004926401,0.00035393416],"domain_scores_gemma":[0.9896281,0.0075115133,0.0017591905,0.00037347147,0.00033450927,0.00039326554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026548128,0.00026865388,0.0019428367,0.00005953384,0.00016570983,0.000018314326,0.0002215499,0.00026228657,0.00010955352],"category_scores_gemma":[0.00089567027,0.00014083504,0.00035177675,0.00009636751,0.0001727664,0.000116541596,0.00013953495,0.00046612287,0.00002103298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18663481,0.26031098,0.31918213,0.00007475218,0.0024062193,0.0011348259,0.0012476551,0.0000024327346,0.00015989835,0.00004839817,0.0077059236,0.22109197],"study_design_scores_gemma":[0.3349209,0.13629009,0.4898044,0.00011680613,0.0013398023,0.000113256865,0.0003933049,0.00004841363,0.00002847464,0.00002130996,0.03681727,0.00010594808],"about_ca_topic_score_codex":0.000031418593,"about_ca_topic_score_gemma":0.000042751235,"teacher_disagreement_score":0.22098602,"about_ca_system_score_codex":0.00031256347,"about_ca_system_score_gemma":0.0016929755,"threshold_uncertainty_score":0.57430863},"labels":[],"label_agreement":null},{"id":"W2967665015","doi":"10.1182/blood.v128.22.5329.5329","title":"Risks and Benefits of Rituximab Maintenance in Elderly Patients with Advanced Follicular Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Adverse effect; Gastroenterology; Chemotherapy; Chemotherapy regimen; Maintenance therapy; Log-rank test; Surgery; Lymphoma; Survival analysis","score_opus":0.01026836671055691,"score_gpt":0.2224505972521075,"score_spread":0.21218223054155058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967665015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980602,0.0010997669,0.000004369398,0.00016663641,0.000015308618,0.00033173175,0.000028432456,0.000012258938,0.0002812406],"genre_scores_gemma":[0.99882966,0.00033583646,0.00067909656,0.000045844838,0.000009313694,0.000049723327,0.000005219216,0.000012356158,0.000032967677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992903,0.000010691912,0.00015913998,0.0002091273,0.00015719756,0.00017353709],"domain_scores_gemma":[0.9995502,0.00004214055,0.000069922455,0.00019465413,0.000071991795,0.000071060276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032922915,0.00011417196,0.0002655953,0.0000518248,0.000015357347,0.0000032208768,0.000031892367,0.000041679647,0.000008245459],"category_scores_gemma":[0.00003205515,0.000060521714,0.000030971936,0.00008408211,0.000043472934,0.000058915044,0.000018554561,0.000012939305,0.0000051710413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020030099,0.0033432383,0.8535379,0.000024594157,0.000072798095,0.000034299963,0.000041955765,3.970744e-7,0.0001019828,0.00014372778,0.00000907711,0.1424897],"study_design_scores_gemma":[0.06640016,0.0013632821,0.92011595,0.00063639286,0.00012049867,0.000013903842,0.000011520828,5.3400333e-7,0.011043966,0.000036818736,0.0001765437,0.00008041341],"about_ca_topic_score_codex":0.00007185277,"about_ca_topic_score_gemma":0.000043569227,"teacher_disagreement_score":0.1424093,"about_ca_system_score_codex":0.000036560898,"about_ca_system_score_gemma":0.00003208563,"threshold_uncertainty_score":0.24680038},"labels":[],"label_agreement":null},{"id":"W2967767513","doi":"10.1182/blood.v130.suppl_1.4064.4064","title":"Rituximab Maintenance for Two Years in Previously Untreated Follicular Lymphoma: No Difference in Outcome between Patients Receiving Treatment at Two Month Versus Three Month Interval","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Regimen; Internal medicine; Lymphoma; Maintenance therapy; Follicular phase; Surgery; Gastroenterology; Chemotherapy","score_opus":0.0357693816582513,"score_gpt":0.3041681683564822,"score_spread":0.2683987866982309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967767513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639356,0.00035823334,0.000004772907,0.00015057248,0.00023288233,0.0020558606,0.00010527165,0.000041492796,0.0006573232],"genre_scores_gemma":[0.99802464,0.000096811425,0.00049507816,0.000029967963,0.00010304524,0.00067500514,0.00016008728,0.000048116726,0.00036724246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977962,0.000047605678,0.0005730719,0.0006526908,0.000273746,0.00065669324],"domain_scores_gemma":[0.99834853,0.00019679275,0.00028232776,0.00089022226,0.000090255584,0.00019188614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014366451,0.00040340988,0.0009811581,0.000126597,0.00015191904,0.00006755992,0.00026682223,0.00011152746,0.0000142109075],"category_scores_gemma":[0.00029293043,0.00031445228,0.00026195965,0.00008301024,0.00007247675,0.00011756853,0.00016832787,0.000062431776,0.000060644605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010708097,0.0055522993,0.9527243,0.000037285656,0.00033487708,0.0002853833,0.0002665605,0.0000021094543,0.00001663166,0.000016188218,0.000023902681,0.039669655],"study_design_scores_gemma":[0.17498608,0.0020105205,0.8208885,0.0004525435,0.000531862,0.000003480218,0.000012103806,0.00013791105,0.00057346997,0.000031951407,0.00013757878,0.00023396553],"about_ca_topic_score_codex":0.006639999,"about_ca_topic_score_gemma":0.015449004,"teacher_disagreement_score":0.17391527,"about_ca_system_score_codex":0.0014770725,"about_ca_system_score_gemma":0.000084402345,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W2968693535","doi":"10.1097/mph.0000000000001580","title":"Hodgkin Lymphoma in an Adolescent With Isolated Bone Marrow and Bone Involvement: A Case Report and a Review of the Literature","year":2019,"lang":"en","type":"review","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Bone marrow; Medicine; Lymphoma; Lymph node; Presentation (obstetrics); Differential diagnosis; Primary bone; Pathology; Hodgkin lymphoma; Radiology","score_opus":0.032348326725837706,"score_gpt":0.338687541624281,"score_spread":0.3063392148984433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968693535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035252076,0.96183705,0.0000012198827,0.0008444933,0.0002485392,0.0017459809,0.000023759085,0.0000061248966,0.000040731364],"genre_scores_gemma":[0.0038167718,0.99481255,0.0004126379,0.0005395364,0.00025223926,0.000059691014,0.000029209858,0.000043385186,0.00003399705],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9954496,0.00077427365,0.002580152,0.00048300947,0.00034935807,0.00036362436],"domain_scores_gemma":[0.9941224,0.00039168366,0.0041731624,0.00057930907,0.00042749682,0.00030598106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013947752,0.00053850794,0.005360742,0.00064913044,0.00004811309,0.0000174403,0.00014548117,0.0007709357,0.000015883119],"category_scores_gemma":[0.000294485,0.00027915518,0.0004357193,0.0008724603,0.00015698548,0.00011235206,0.00015140332,0.00067256857,0.0000016559301],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035059883,0.002626008,0.02623056,0.2047323,0.00062582525,0.5356479,0.00038828867,4.690901e-8,4.871868e-7,0.00003752679,0.0029539943,0.22640644],"study_design_scores_gemma":[0.0044696955,0.0027882087,0.000588672,0.07432269,0.00812498,0.77925736,0.00006458761,0.0000013036748,7.544554e-7,0.0000075673506,0.13016759,0.00020657659],"about_ca_topic_score_codex":0.000019343863,"about_ca_topic_score_gemma":0.000050173323,"teacher_disagreement_score":0.24360944,"about_ca_system_score_codex":0.0006143927,"about_ca_system_score_gemma":0.0029170646,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2968755345","doi":"10.1002/gepi.22242","title":"Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes","year":2019,"lang":"en","type":"article","venue":"Genetic Epidemiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; University of Calgary; McGill University","funders":"National Center for Advancing Translational Sciences; National Center for Chronic Disease Prevention and Health Promotion; National Institute of Environmental Health Sciences; Utah Department of Health; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Human Genome Research Institute; Medical Research Council; National Institutes of Health; Blood Cancer UK; National Institute for Health and Care Research; Vlaamse regering; Cancerfonden; Bundesamt für Strahlenschutz; Leukemia and Lymphoma Research; National Health and Medical Research Council; National Center for Research Resources; Institut National Du Cancer; Associazione Italiana per la Ricerca sul Cancro; University of Utah; Fondation de France; Generalitat de Catalunya; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Bundesministerium für Bildung und Forschung; Academy of Finland; Institut National de la Santé et de la Recherche Médicale; Michael Smith Health Research BC; National Institute on Aging; Health Research Board; World Health Organization; Wellcome Trust; National Heart, Lung, and Blood Institute; Multiple Sclerosis Australia; Helsingin ja Uudenmaan Sairaanhoitopiiri; Multiple Sclerosis Society; Deutsche Forschungsgemeinschaft; Scleroseforeningen; National Natural Science Foundation of China; Lymphoma Foundation; Karolinska Institutet; Utah State University; Huntsman Cancer Institute; Wellcome; José Carreras Leukämie-Stiftung; European Commission; Biogen; U.S. Department of Veterans Affairs; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; U.S. Department of Health and Human Services","keywords":"Genome-wide association study; Lymphoma; Disease; Follicular lymphoma; Genetic association; Etiology; Rheumatoid arthritis; Oncology; Medicine; Immunology; Biology; Internal medicine; Genetics; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.019921030206170528,"score_gpt":0.287575941220815,"score_spread":0.26765491101464445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968755345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802288,0.016519867,0.000110046814,0.0015093435,0.0002683238,0.0006089699,0.000032047486,0.00006001275,0.0006625868],"genre_scores_gemma":[0.9903853,0.0016794654,0.005453986,0.001553293,0.00027307848,0.00007729648,0.000050175528,0.000033360535,0.00049402734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788904,0.0002343919,0.00058465253,0.00061821716,0.00011828573,0.00055541075],"domain_scores_gemma":[0.9976402,0.0012178777,0.0001702098,0.0006301138,0.000044344808,0.0002972651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022532068,0.0002908923,0.0010459527,0.00010535916,0.00006684903,0.000007658358,0.000111677626,0.00021155042,0.0002567111],"category_scores_gemma":[0.00030299713,0.00022617218,0.00016628807,0.00010609845,0.00016698055,0.00002384586,0.000120377365,0.000063915744,0.0005292917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055974026,0.0001319225,0.92860687,0.00007211982,0.00021782612,0.00004984517,0.00003839818,0.000023155437,0.00022475171,0.000092592076,0.0007167023,0.06976986],"study_design_scores_gemma":[0.0031738786,0.00083677855,0.9875987,0.00006848793,0.00042468967,0.00011946702,0.00002166599,0.00024947542,0.00012221637,0.0015415223,0.00563335,0.00020973601],"about_ca_topic_score_codex":0.00034771618,"about_ca_topic_score_gemma":0.0000054803313,"teacher_disagreement_score":0.069560125,"about_ca_system_score_codex":0.00010999429,"about_ca_system_score_gemma":0.0001339612,"threshold_uncertainty_score":0.9223034},"labels":[],"label_agreement":null},{"id":"W2968942240","doi":"10.1182/blood.2019000324","title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Oncology; Hodgkin lymphoma; Cancer; Immunotherapy; Biology","score_opus":0.013537593036623564,"score_gpt":0.24921475331283308,"score_spread":0.23567716027620952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968942240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895297,0.0006280101,5.3067987e-7,0.00016656554,0.00024487296,0.00057231163,0.000017439796,0.000044851608,0.008795692],"genre_scores_gemma":[0.9958994,0.00015603815,0.00029449473,0.00014432802,0.00006912749,0.000052252322,0.000027579952,0.000036556597,0.0033202604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852157,0.000051088104,0.00039338594,0.0003538167,0.00033960334,0.0003405291],"domain_scores_gemma":[0.99895597,0.00014366438,0.00013587785,0.00057824753,0.00006509071,0.0001211664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014454598,0.00020710977,0.0005563865,0.00016838331,0.000022636368,0.000008837976,0.00011004047,0.00016692324,0.00051542063],"category_scores_gemma":[0.0001141731,0.00015174811,0.00016672233,0.00025859693,0.0000369551,0.00005455761,0.000058020694,0.00007442479,0.00034736362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00513801,0.009648028,0.96615845,0.0003023146,0.00048505695,0.00071554584,0.0007392837,0.000002139317,0.006107178,0.00057724485,0.0014267495,0.008700015],"study_design_scores_gemma":[0.15308313,0.0029612111,0.8077798,0.0004894765,0.00045435253,0.00012982902,0.0002143923,0.000014880502,0.029991299,0.00005877736,0.0045635663,0.00025932296],"about_ca_topic_score_codex":0.0003185599,"about_ca_topic_score_gemma":0.00008305148,"teacher_disagreement_score":0.15837868,"about_ca_system_score_codex":0.00015702636,"about_ca_system_score_gemma":0.00032819458,"threshold_uncertainty_score":0.6188109},"labels":[],"label_agreement":null},{"id":"W2970333266","doi":"10.3747/co.26.5421","title":"Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Roche (Canada); University of Toronto; University of Alberta; Fluidigm (Canada); Impact; McGill University; Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital; University of Manitoba; Jewish General Hospital","funders":"","keywords":"Medicine; Salvage therapy; Lymphoma; Refractory (planetary science); Diffuse large B-cell lymphoma; Oncology; Transplantation; Internal medicine; Disease; Intensive care medicine; Chemotherapy","score_opus":0.19168001889525138,"score_gpt":0.4533081972162409,"score_spread":0.2616281783209895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970333266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004267183,0.99157566,0.000017103379,0.00013800825,0.0027750328,0.00442676,0.00030305647,0.00003640903,0.0003012351],"genre_scores_gemma":[0.00022840223,0.99452436,0.00008179506,0.000036766793,0.0005200609,0.002413004,0.00042717453,0.00008022772,0.0016882018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977929,0.00018981955,0.00081931305,0.00052641035,0.00020340086,0.00046813887],"domain_scores_gemma":[0.9957891,0.0023687484,0.0007827493,0.0008369184,0.000110915884,0.00011153568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017967589,0.000584916,0.0029169295,0.00017326434,0.000115635485,0.000010869246,0.00021122964,0.00037593307,0.00014403666],"category_scores_gemma":[0.000049218834,0.00026192478,0.001315312,0.00016874394,0.000092058996,0.000026559697,0.000046947607,0.000099553734,0.00008679743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002658698,0.030220067,0.00011188231,0.009882403,0.001180949,0.000026882457,0.0006479647,2.3982219e-8,2.9482442e-7,0.00008357495,0.0034689833,0.9541111],"study_design_scores_gemma":[0.022548864,0.0064358045,0.000069752234,0.0028561256,0.008738175,0.000038305116,0.00015038249,0.000009302042,0.0000066201637,0.0000046372443,0.9589211,0.00022093335],"about_ca_topic_score_codex":0.000012306641,"about_ca_topic_score_gemma":0.00001647172,"teacher_disagreement_score":0.95545214,"about_ca_system_score_codex":0.0016180488,"about_ca_system_score_gemma":0.0013528849,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W2970358718","doi":"10.1038/s41375-019-0559-9","title":"MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Rituximab; Follicular lymphoma; Hazard ratio; Gastroenterology; Refractory (planetary science); Surgery; Oncology; Lymphoma; Confidence interval; Leukemia; Biology","score_opus":0.0195550374906363,"score_gpt":0.2789786274909884,"score_spread":0.2594235900003521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970358718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368185,0.0005494192,0.0000013878288,0.00175348,0.00051505025,0.0019906966,0.000039183313,0.00004916014,0.0014197814],"genre_scores_gemma":[0.99180156,0.0000947063,0.0002438623,0.0018602762,0.00039860388,0.00047959757,0.00006617351,0.000048132057,0.0050070705],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972551,0.0003711223,0.00069851335,0.00057125196,0.0005327002,0.0005713378],"domain_scores_gemma":[0.99777746,0.0010184125,0.00014461348,0.0008679281,0.00005023424,0.00014136625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010017026,0.00036562994,0.00071639055,0.00031082978,0.000042766445,0.00003560727,0.00022506865,0.00027579753,0.0010511513],"category_scores_gemma":[0.00051657076,0.00022029715,0.00017292549,0.00056582445,0.00007019728,0.00009608968,0.00008658147,0.00051119376,0.00055823853],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93190885,0.0014960527,0.03768291,0.00018889757,0.00012598235,0.008127376,0.0046821604,0.00032579663,0.0007931988,0.0000958595,0.008447879,0.0061250473],"study_design_scores_gemma":[0.34659174,0.006447457,0.58953077,0.00077265175,0.00021048213,0.00031956483,0.0008018886,0.0010443893,0.00065356726,0.00003380273,0.05309986,0.00049379555],"about_ca_topic_score_codex":0.0011052437,"about_ca_topic_score_gemma":0.0007196342,"teacher_disagreement_score":0.5853171,"about_ca_system_score_codex":0.00395001,"about_ca_system_score_gemma":0.0020699017,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W2970789858","doi":"10.1200/jco.18.02365","title":"Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Ochsner Health; European Hematology Association; American Society of Clinical Oncology","keywords":"Immune system; Follicular lymphoma; Medicine; Immunology; Vincristine; Immune checkpoint; Lymphoma; Immunophenotyping; Rituximab; Immunotherapy; Cancer research; Cyclophosphamide; Internal medicine; Flow cytometry; Chemotherapy","score_opus":0.04676229437823062,"score_gpt":0.40194868731780287,"score_spread":0.3551863929395722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970789858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443793,0.00054667186,0.0000022085019,0.0035545367,0.00054536946,0.0004528364,0.0000032294017,0.000005957627,0.00045125108],"genre_scores_gemma":[0.9982454,0.00015384851,0.000838999,0.00051812216,0.00012716318,0.000010307159,0.000011870436,0.000013396705,0.00008089659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967392,0.0003392328,0.0021005033,0.00017745246,0.00046983812,0.00017374348],"domain_scores_gemma":[0.99621207,0.000630059,0.0023071063,0.00020071182,0.00036745783,0.00028258146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016118824,0.00014091097,0.001379761,0.000122921,0.000015752725,0.0000073545657,0.00009263298,0.00025395985,0.000059528425],"category_scores_gemma":[0.0015261956,0.00008390581,0.00032066315,0.00021544224,0.00010700838,0.00013002647,0.000024067587,0.00026632438,0.000006864389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015097808,0.009637593,0.941738,0.000039034956,0.00055154116,0.0014817194,0.00027808346,0.000043303582,0.0010686062,0.00009296069,0.00045290485,0.029518418],"study_design_scores_gemma":[0.026201135,0.019434953,0.9490399,0.0010114876,0.000436048,0.000075654665,0.000109409615,0.00030897552,0.0028469237,0.00013454442,0.0003146723,0.000086319546],"about_ca_topic_score_codex":0.000028801358,"about_ca_topic_score_gemma":0.000019786034,"teacher_disagreement_score":0.029432097,"about_ca_system_score_codex":0.00032130713,"about_ca_system_score_gemma":0.0024365778,"threshold_uncertainty_score":0.43223843},"labels":[],"label_agreement":null},{"id":"W2970914000","doi":"10.3747/co.26.4625","title":"Incidence and Mortality Trends and Geographic Patterns of Follicular Lymphoma in Canada","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University","funders":"","keywords":"Follicular lymphoma; Medicine; Incidence (geometry); Lymphoma; Follicular phase; Demography; Pathology; Internal medicine","score_opus":0.032552697949491664,"score_gpt":0.33328747383435287,"score_spread":0.3007347758848612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970914000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521387,0.0039437497,6.0747146e-7,0.00023797152,0.00023200583,0.00015516783,0.000019976555,0.0000037075665,0.00019296602],"genre_scores_gemma":[0.9987247,0.0011243809,0.000009572953,0.00006903942,0.000014913164,0.000025549776,0.00001780302,0.000004210336,0.000009817226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992674,0.000039273138,0.00020556383,0.00021137367,0.00012373623,0.0001526646],"domain_scores_gemma":[0.9995783,0.00007193893,0.00007407031,0.00015423793,0.000026459114,0.000094978954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008220352,0.00009679263,0.0003573888,0.00010422074,0.000010450963,0.0000023322707,0.00003180671,0.000043869524,0.0000504883],"category_scores_gemma":[0.000011702477,0.00007764937,0.00002972261,0.00010412979,0.00003531345,0.000025735915,0.0000476659,0.000039073708,7.8258813e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021607902,0.00025294334,0.8702774,0.00009146535,0.000036514528,0.000074430944,0.000062627405,3.960993e-7,0.000020928514,0.00009160843,0.000026712993,0.12904336],"study_design_scores_gemma":[0.00344609,0.00028625585,0.993145,0.00010522863,0.00007779162,0.000049273684,0.00007868436,0.00008834827,0.00012006054,0.00002488893,0.002514343,0.00006402949],"about_ca_topic_score_codex":0.5177098,"about_ca_topic_score_gemma":0.68660706,"teacher_disagreement_score":0.1688973,"about_ca_system_score_codex":0.00033131157,"about_ca_system_score_gemma":0.00043006294,"threshold_uncertainty_score":0.48550186},"labels":[],"label_agreement":null},{"id":"W2972329330","doi":"10.1016/j.bbmt.2019.09.007","title":"Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma","year":2019,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Université de Montréal; Hoechst Marion Roussel","keywords":"Medicine; Lymphoma; Hematopoietic stem cell transplantation; Stem cell; Transplantation; Haematopoiesis; Oncology; Quality of life (healthcare); Hematopoietic cell; Internal medicine; Nursing; Genetics","score_opus":0.018578609567568183,"score_gpt":0.2742490033116547,"score_spread":0.2556703937440865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972329330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998349,0.00027184113,0.000012877625,0.00004203354,0.00003130264,0.0008409219,0.00024902524,0.0000028805152,0.00020009873],"genre_scores_gemma":[0.99963224,0.00021484272,0.000023567785,0.000010384492,0.0000029405196,0.000015488442,0.00009236648,0.0000054488,0.0000027112883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987404,0.00029367616,0.00045484665,0.00013265974,0.00030037307,0.0000780665],"domain_scores_gemma":[0.9987174,0.00027094723,0.0005343841,0.00018045808,0.0002737346,0.000023042641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044938954,0.00011016483,0.00038486696,0.000055961653,0.000016938919,7.386896e-7,0.00005286851,0.00008913455,0.000021423444],"category_scores_gemma":[0.000009249672,0.0000534729,0.000115735675,0.00009098817,0.00014487731,0.000025464786,0.000002731483,0.00002431762,2.554661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015180262,0.0013335106,0.9126188,0.0012294308,0.00043225545,2.1274309e-7,0.0023244026,0.00006949828,0.07791439,0.00031982802,0.0000018716131,0.0022377651],"study_design_scores_gemma":[0.007706594,0.0014582948,0.74075603,0.00025096617,0.0011347781,0.000003528349,0.00010602489,0.000023868617,0.24848042,0.000042735137,6.230725e-8,0.000036701436],"about_ca_topic_score_codex":0.00031288082,"about_ca_topic_score_gemma":0.00001973179,"teacher_disagreement_score":0.1718628,"about_ca_system_score_codex":0.000014312972,"about_ca_system_score_gemma":0.0001680172,"threshold_uncertainty_score":0.21805616},"labels":[],"label_agreement":null},{"id":"W2972481950","doi":"10.1016/j.ijrobp.2019.06.1366","title":"Evaluating the Discussion of Late Effects and Screening Recommendations in Survivors of Adolescent and Young Adult (AYA) Lymphoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Cancer; Cohort; Lung cancer; Internal medicine; Chemotherapy; Breast cancer; Disease; Pediatrics","score_opus":0.024446656219542905,"score_gpt":0.3581417438999736,"score_spread":0.3336950876804307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972481950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423575,0.00045589573,0.00040038943,0.0038780647,0.0006399917,0.00028034017,0.000016034417,0.000004046991,0.00008947131],"genre_scores_gemma":[0.9968102,0.0010205504,0.0017170182,0.00023648425,0.00015285959,0.000007356813,0.000027091039,0.000009400159,0.000019012909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987431,0.0002526018,0.0005661623,0.00013507898,0.00019832667,0.00010468557],"domain_scores_gemma":[0.9980823,0.0005663738,0.0008377505,0.000091620226,0.00037255438,0.00004942715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060490414,0.00011092253,0.000364705,0.00012190952,0.00003267272,0.000008459516,0.00010106972,0.000091408874,0.000010220736],"category_scores_gemma":[0.00028305588,0.000065456494,0.00008720665,0.00010196928,0.00009792247,0.00012696235,0.000058331458,0.00012048376,0.0000011660514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023962236,0.00030619677,0.70816815,0.000024944142,0.00017918763,0.000003731718,0.000549159,0.000120091754,0.003093099,0.0009860279,0.000023912591,0.2863059],"study_design_scores_gemma":[0.009204221,0.0015274334,0.97596246,0.0005383166,0.00013087453,0.000075096665,0.00022469138,0.007810016,0.0031704125,0.0010780933,0.00020626087,0.00007211208],"about_ca_topic_score_codex":0.000118902266,"about_ca_topic_score_gemma":0.000025797728,"teacher_disagreement_score":0.28623378,"about_ca_system_score_codex":0.00021449987,"about_ca_system_score_gemma":0.00014846322,"threshold_uncertainty_score":0.26692384},"labels":[],"label_agreement":null},{"id":"W2972977533","doi":"10.1182/blood.v130.suppl_1.4053.4053","title":"Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Marginal zone B-cell lymphoma; Marginal zone; B cell; Immunology","score_opus":0.016015841514752494,"score_gpt":0.26419870347118507,"score_spread":0.24818286195643258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972977533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982879,0.00029563747,0.0000038500984,0.0002364822,0.000071225935,0.0008255315,0.000105573556,0.000013438857,0.00016035794],"genre_scores_gemma":[0.9990744,0.000107638,0.00023971559,0.00008570493,0.00013292134,0.00006479281,0.00019256987,0.00001985206,0.00008239159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998684,0.00007088411,0.00033691037,0.00031468717,0.0003952543,0.00019825462],"domain_scores_gemma":[0.9981553,0.00027305097,0.00036167048,0.0010600475,0.00006868189,0.00008126785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001406448,0.000189674,0.00059282803,0.00009317263,0.0001221622,0.00004095364,0.00023923116,0.00008708555,0.00017468816],"category_scores_gemma":[0.00010323068,0.00009754685,0.00016972014,0.00018664662,0.000121969606,0.000078550416,0.000034919834,0.00005930756,0.000010453179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07707075,0.011368342,0.90208393,0.0000055361656,0.002441039,0.000068788715,0.00024076246,0.000002056164,0.000017435093,0.0000056018403,0.00013580776,0.006559916],"study_design_scores_gemma":[0.31350687,0.001999363,0.68145764,0.0000614204,0.0020539698,5.9042964e-7,0.000020260344,0.0000060365014,0.0005184176,0.0000015797144,0.0002947344,0.00007912325],"about_ca_topic_score_codex":0.002238034,"about_ca_topic_score_gemma":0.0006628392,"teacher_disagreement_score":0.23643613,"about_ca_system_score_codex":0.000098453995,"about_ca_system_score_gemma":0.00019664771,"threshold_uncertainty_score":0.3977845},"labels":[],"label_agreement":null},{"id":"W2973070354","doi":"10.1016/j.ijrobp.2019.06.447","title":"Long-Term Outcomes for Patients with Limited Stage Follicular Lymphoma: An Update of a Population-based Study","year":2019,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Follicular lymphoma; Medicine; Population; Positron emission tomography; Proportional hazards model; Lymph node; Radiation therapy; Hazard ratio; Lymphoma; Nuclear medicine; Internal medicine; Oncology; Confidence interval; Biology","score_opus":0.017991355663477815,"score_gpt":0.3274102977972398,"score_spread":0.309418942133762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973070354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965144,0.000047329915,0.0009782306,0.00047749563,0.0007257111,0.0010627563,0.00015456416,0.0000189877,0.000020564898],"genre_scores_gemma":[0.99655694,0.000015776124,0.0016976251,0.0005055562,0.00022804562,0.00003904022,0.0009041078,0.00002894779,0.000023958004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983601,0.00013025643,0.0007207278,0.0002410679,0.00037525312,0.00017259853],"domain_scores_gemma":[0.99690354,0.0003637519,0.0012616571,0.0002257617,0.0011325631,0.0001127353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025262288,0.00021101422,0.0006449053,0.00019884716,0.00004202286,0.000018987828,0.00022224979,0.0001272884,0.000050892784],"category_scores_gemma":[0.0001116138,0.00014989998,0.00023927496,0.0001167349,0.000038208767,0.00024330025,0.000023472114,0.00008178856,0.00000767187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001464502,0.0078524025,0.9642666,0.000015250116,0.0013771984,0.000019420873,0.00012568593,0.00059841794,0.000044148557,0.0007419374,0.000020854362,0.023473559],"study_design_scores_gemma":[0.035836123,0.0074955355,0.95471877,0.00004641903,0.00035733462,0.0000058874707,0.00003759576,0.0006280212,0.00022849378,0.00014445213,0.0003714848,0.00012987276],"about_ca_topic_score_codex":0.00003902366,"about_ca_topic_score_gemma":0.000015479487,"teacher_disagreement_score":0.034371622,"about_ca_system_score_codex":0.0007092918,"about_ca_system_score_gemma":0.00037355916,"threshold_uncertainty_score":0.61127436},"labels":[],"label_agreement":null},{"id":"W2973607898","doi":"10.1182/blood.2019002600","title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Simon Fraser University","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Mitacs; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"BCL6; Biology; Diffuse large B-cell lymphoma; Germinal center; Fluorescence in situ hybridization; Cancer research; Lymphoma; Chromosomal translocation; Gene expression profiling; Copy-number variation; Genetics; Gene; B cell; Gene expression; Genome; Chromosome; Immunology","score_opus":0.00696804429419057,"score_gpt":0.22408201506769435,"score_spread":0.21711397077350378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973607898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186355,0.0014158156,0.000006457773,0.0013553008,0.00030746267,0.0016846444,0.000028133141,0.00009264074,0.003246006],"genre_scores_gemma":[0.98732674,0.00018118747,0.00017101673,0.00092785043,0.00017520339,0.00029750884,0.000042286854,0.000064251566,0.010813935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783003,0.000034954694,0.00031500158,0.0005500917,0.00062754826,0.00064237],"domain_scores_gemma":[0.99843645,0.000109142726,0.0001227266,0.00090256584,0.00013083561,0.00029825824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012279302,0.00035782356,0.00041511425,0.00008891703,0.00023725627,0.00013083522,0.0002832686,0.00015432465,0.00015102926],"category_scores_gemma":[0.00000971797,0.00021189336,0.00016882818,0.00029063682,0.000034887922,0.00008166484,0.00013645474,0.00010767324,0.0009776338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058762194,0.05911493,0.8982134,0.00058769656,0.0029440506,0.0015558089,0.0025761088,0.000035139947,0.005354634,0.0009432956,0.017790277,0.005008456],"study_design_scores_gemma":[0.25700316,0.0021532043,0.6584786,0.00055100414,0.0019352532,0.00023623383,0.00049939356,0.000025184816,0.047659453,0.00009252772,0.03063159,0.00073438144],"about_ca_topic_score_codex":0.00009370221,"about_ca_topic_score_gemma":0.00017042541,"teacher_disagreement_score":0.25112692,"about_ca_system_score_codex":0.000116781215,"about_ca_system_score_gemma":0.00016209055,"threshold_uncertainty_score":0.9998002},"labels":[],"label_agreement":null},{"id":"W2974500482","doi":"10.14740/wjon1213","title":"Primary Synovial Diffuse Large B-Cell Lymphoma Presenting as Loosening of Prosthetic Joint: A Case Report and Review of Literature","year":2019,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Arthrotomy; Diffuse large B-cell lymphoma; Hepatosplenomegaly; Surgery; Lymphoma; Scars; Joint pain; Knee Joint; Knee pain; Osteoarthritis; Arthroscopy; Pathology; Disease","score_opus":0.010691072841546577,"score_gpt":0.28694359839244904,"score_spread":0.27625252555090246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974500482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92800146,0.06430391,0.0000013237116,0.0010649078,0.00020868579,0.00046238131,0.0000059614986,0.0000040053706,0.005947367],"genre_scores_gemma":[0.99039495,0.006571361,0.0010444707,0.0006467376,0.000119997676,0.0000060838047,0.000008093679,0.000017043398,0.0011912659],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99812454,0.00013007926,0.0010848165,0.00017561932,0.00028210063,0.00020285767],"domain_scores_gemma":[0.9975308,0.00018934198,0.001521731,0.0002505281,0.00036652194,0.00014108287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007941821,0.00015338101,0.001080735,0.00024174171,0.00002923953,0.000008177506,0.00005557747,0.00008452342,0.00007526988],"category_scores_gemma":[0.00020192878,0.00010674603,0.00024573458,0.00023753884,0.00006029521,0.000085101165,0.000081755345,0.00015968525,0.0000033441218],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013530516,0.021365551,0.18394132,0.025751403,0.000888664,0.69962543,0.0031217388,6.937347e-7,0.008969458,0.00033943896,0.0050160075,0.04962724],"study_design_scores_gemma":[0.033492114,0.004047425,0.027972104,0.024730962,0.001382456,0.8607419,0.00020049984,0.000012303782,0.006178452,0.00006778767,0.040989786,0.00018420588],"about_ca_topic_score_codex":0.000017288741,"about_ca_topic_score_gemma":0.0000056360905,"teacher_disagreement_score":0.16111648,"about_ca_system_score_codex":0.0001943594,"about_ca_system_score_gemma":0.00052913796,"threshold_uncertainty_score":0.4352977},"labels":[],"label_agreement":null},{"id":"W2974531429","doi":"10.3760/cma.j.issn.0253-2727.2019.08.002","title":"[Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].","year":2019,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Medicine; Regimen; Internal medicine; Lymphoma; Gastroenterology; Stage (stratigraphy); Rituximab; Burkitt's lymphoma; Chemotherapy; Group B; Surgery","score_opus":0.02918953607319583,"score_gpt":0.2753124672007763,"score_spread":0.24612293112758046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974531429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954178,0.0012620416,0.0000047696312,0.00026758312,0.000104709834,0.0016079401,0.000035872137,0.0000130753115,0.0012862383],"genre_scores_gemma":[0.99399817,0.0043374556,0.0000711012,0.00006946605,0.00011728065,0.0010978801,0.000055289715,0.000012256265,0.00024110923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808323,0.00020126431,0.0006966725,0.00035017717,0.00037288782,0.00029577228],"domain_scores_gemma":[0.9981736,0.0005673026,0.0003591552,0.0007417559,0.000051368712,0.000106801075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005802827,0.00018115445,0.0009844566,0.000394563,0.0000177868,0.0000075139087,0.00013624864,0.000112873604,0.000022207803],"category_scores_gemma":[0.00006599574,0.00010334625,0.000546405,0.0011212165,0.000051873605,0.00003535965,0.00001999925,0.000037457175,0.000007478869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031741717,0.005476884,0.90413624,0.000023351133,0.0021022828,0.00002715476,0.00035913428,0.000053531272,8.318505e-7,0.0004836764,0.000097835386,0.08692164],"study_design_scores_gemma":[0.009899951,0.0007727256,0.98123246,0.000005472463,0.006991967,0.0000018123887,0.000079514764,0.00034653154,0.000087595734,0.000046346184,0.00045235548,0.00008324827],"about_ca_topic_score_codex":0.0022212907,"about_ca_topic_score_gemma":0.0001340539,"teacher_disagreement_score":0.086838394,"about_ca_system_score_codex":0.0002126959,"about_ca_system_score_gemma":0.000048226855,"threshold_uncertainty_score":0.42143375},"labels":[],"label_agreement":null},{"id":"W2975001300","doi":"10.1182/blood.2019000779","title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Medical Research Council; Medical Research Council; Singapore General Hospital; Tanoto Foundation; National Cancer Institute; National Institutes of Health; University of Nebraska Medical Center","keywords":"Immunohistochemistry; Pathology; Lymphoma; Medicine","score_opus":0.00494663866105653,"score_gpt":0.22244532650186885,"score_spread":0.21749868784081233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975001300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98462254,0.0045062904,0.000005363432,0.00041519842,0.000049815804,0.0003273557,0.0000061889896,0.000020810527,0.0100464355],"genre_scores_gemma":[0.99801826,0.00006428618,0.00014510685,0.00010783553,0.000027998769,0.000045227956,0.000046330948,0.000015065446,0.0015298717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992158,0.000015553147,0.00019183506,0.00027070526,0.00018172614,0.00012437813],"domain_scores_gemma":[0.99901766,0.000026076492,0.00010721678,0.0007561358,0.00005562099,0.000037304297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095953954,0.00010312881,0.00017183807,0.00001269302,0.000031947184,0.0000089876885,0.00008568779,0.000053745815,0.00007766811],"category_scores_gemma":[0.000025463742,0.00007034334,0.00010056448,0.00007704168,0.000036550162,0.000021340029,0.00002210062,0.000033406166,0.00003387563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003155256,0.0018275486,0.037117124,0.00007266642,0.000093635805,0.000009089807,0.000169963,0.0000010836259,0.95906055,0.00006791469,0.00049324124,0.0010556442],"study_design_scores_gemma":[0.0051580854,0.00014231847,0.027189804,0.000045994893,0.00021866593,0.000037990427,0.000092087525,0.00001620483,0.96560746,0.000007987579,0.0014097017,0.00007370718],"about_ca_topic_score_codex":0.00009812189,"about_ca_topic_score_gemma":1.3510834e-7,"teacher_disagreement_score":0.013395735,"about_ca_system_score_codex":0.000072729985,"about_ca_system_score_gemma":0.00009012188,"threshold_uncertainty_score":0.28685182},"labels":[],"label_agreement":null},{"id":"W2977190700","doi":"10.1182/blood.2019001880","title":"The whole-genome landscape of Burkitt lymphoma subtypes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Genetics; Gene; Genome; Cancer research; Virology","score_opus":0.006947996934359438,"score_gpt":0.2183594275006246,"score_spread":0.21141143056626516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977190700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830815,0.0022593264,2.1534215e-7,0.00082595786,0.000082549726,0.00023140383,0.000018551744,0.000020471145,0.013479998],"genre_scores_gemma":[0.9975256,0.0002133079,0.000036831134,0.00015087458,0.00007263314,0.00001751786,0.000027189351,0.0000108622435,0.0019452331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994069,0.000013093053,0.0001409348,0.00012905015,0.0001606549,0.00014940547],"domain_scores_gemma":[0.9994221,0.0000858289,0.000054895623,0.00033880176,0.00004446435,0.000053941847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007384826,0.00008431031,0.00017992717,0.000026032469,0.000038965572,0.000011299414,0.000072489354,0.000040014995,0.00008822055],"category_scores_gemma":[0.000016215627,0.000046895573,0.00008666659,0.00008198427,0.00002686662,0.000019164008,0.000028190647,0.000018452552,0.0002920528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118067226,0.0019368563,0.97752887,0.000065310516,0.0005049256,0.000053644042,0.00020038326,0.0000012087136,0.01090596,0.0011512452,0.00081200997,0.006721509],"study_design_scores_gemma":[0.008118763,0.0004808021,0.9043836,0.000043838798,0.000268641,0.00006491902,0.00011700097,0.0000059625436,0.017786086,0.000048769743,0.06860804,0.00007354988],"about_ca_topic_score_codex":0.000027273136,"about_ca_topic_score_gemma":0.000007423688,"teacher_disagreement_score":0.073145255,"about_ca_system_score_codex":0.000014798224,"about_ca_system_score_gemma":0.000066992674,"threshold_uncertainty_score":0.37538454},"labels":[],"label_agreement":null},{"id":"W2977473977","doi":"10.1182/blood.v128.22.1186.1186","title":"Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Chemoimmunotherapy; Medicine; Rituximab; Oncology; Regimen; Internal medicine; Bendamustine; Progression-free survival; Lymphoma; Chemotherapy","score_opus":0.015589283134948293,"score_gpt":0.2726982390252723,"score_spread":0.257108955890324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977473977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964355,0.00078430603,0.00018925275,0.00018140151,0.00005798225,0.001906857,0.0002734539,0.00003553519,0.00013571532],"genre_scores_gemma":[0.99714863,0.00022503785,0.00073078583,0.000044351516,0.000051928168,0.0012524102,0.00032797997,0.000027523145,0.00019136938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988642,0.00003388029,0.00020493372,0.00041868573,0.00022711704,0.0002512137],"domain_scores_gemma":[0.999012,0.0003093245,0.00011394149,0.00025584074,0.00016884354,0.00014003606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006961902,0.0002637119,0.0005446796,0.0001325798,0.00008759124,0.00001846166,0.000038382772,0.000069665395,0.00007661456],"category_scores_gemma":[0.00002175641,0.00014488595,0.00022231099,0.0001595892,0.00006451935,0.00005509981,0.00001657209,0.000013512576,0.000014211303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022309387,0.08939641,0.81070334,0.000082440405,0.011651098,0.000049594884,0.000112560934,9.3659025e-7,0.0004182125,0.00012380468,0.000025531886,0.065126695],"study_design_scores_gemma":[0.42520684,0.0070949593,0.5468087,0.00009770145,0.0059158877,0.000007311198,0.0000133257845,0.000010654649,0.012819318,0.000010289298,0.0018485244,0.00016647039],"about_ca_topic_score_codex":0.00012479053,"about_ca_topic_score_gemma":0.000028287084,"teacher_disagreement_score":0.40289745,"about_ca_system_score_codex":0.00032265656,"about_ca_system_score_gemma":0.00012957906,"threshold_uncertainty_score":0.59082776},"labels":[],"label_agreement":null},{"id":"W2977871256","doi":"10.1097/mph.0000000000001534","title":"The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD","year":2019,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Vinblastine; Bleomycin; Radiation therapy; Nuclear medicine; Positron emission tomography; Interim; Chemotherapy; Hodgkin lymphoma; Lymphoma; Radiology; Oncology; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.017477500480603637,"score_gpt":0.2957214900996718,"score_spread":0.27824398961906815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977871256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388444,0.0032958523,0.000055192875,0.0013974643,0.00018532964,0.0009260256,0.000005016511,0.0000098294695,0.00024086508],"genre_scores_gemma":[0.99498063,0.0018668842,0.0027331484,0.000051346335,0.0002481665,0.000039515133,0.0000055683404,0.00002283833,0.000051884534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820024,0.00018420874,0.0008195603,0.0002325354,0.00023405912,0.00032937093],"domain_scores_gemma":[0.99770486,0.00059668586,0.0010459656,0.00025462866,0.00029086252,0.00010697793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007871517,0.0002050758,0.0010168737,0.00029861403,0.000066189044,0.000010171241,0.0001421375,0.00006635854,0.000025936022],"category_scores_gemma":[0.00008688118,0.00010651873,0.00016460699,0.00037433906,0.00012487298,0.000112947935,0.000013812609,0.00011232807,0.000002043955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004722476,0.0013319103,0.98140097,0.000057349396,0.00060688873,0.00062440225,0.00014585319,0.000008895245,0.00012268258,0.00014801184,0.0016385124,0.0091920225],"study_design_scores_gemma":[0.036417805,0.014646268,0.8609309,0.00009093938,0.0010793246,0.080117635,0.0005455764,0.00012244165,0.0041166297,0.00006360366,0.0016819009,0.00018692818],"about_ca_topic_score_codex":0.00007424746,"about_ca_topic_score_gemma":0.000038273804,"teacher_disagreement_score":0.120470054,"about_ca_system_score_codex":0.0004645328,"about_ca_system_score_gemma":0.0010350453,"threshold_uncertainty_score":0.4343708},"labels":[],"label_agreement":null},{"id":"W2977980618","doi":"10.1097/01.hs9.0000563228.79887.e0","title":"PS1237 DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI‐CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Interim analysis; Vinblastine; Radiation therapy; Prospective cohort study; Surgery; Internal medicine; Nuclear medicine; Clinical trial; Chemotherapy; Vincristine","score_opus":0.01901969089911033,"score_gpt":0.3009490587376345,"score_spread":0.2819293678385242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977980618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99019325,0.0020111115,0.0000059235786,0.00049800915,0.00017648278,0.004446073,0.00031405687,0.00009330927,0.002261801],"genre_scores_gemma":[0.97478247,0.00060689397,0.00029428813,0.0002412698,0.00006727602,0.0003436868,0.00015386738,0.000088524175,0.023421746],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99666244,0.00009936087,0.0009942441,0.00093741616,0.0006322832,0.00067425024],"domain_scores_gemma":[0.99787724,0.00016909548,0.00038639302,0.0010611439,0.00023391291,0.00027222856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003433998,0.0005659911,0.0010525227,0.00014132287,0.00013474746,0.00007156749,0.00021616308,0.00023163264,0.00041491742],"category_scores_gemma":[0.00013733974,0.0004462807,0.00026478447,0.0005433388,0.00008702748,0.00039197478,0.00012616298,0.00017663148,0.00022652831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017427964,0.107432574,0.84108734,0.00021052781,0.0010313571,0.0012142523,0.008396124,0.000020952757,0.0037618268,0.000067771056,0.005767873,0.013581437],"study_design_scores_gemma":[0.45252874,0.03095714,0.44031605,0.0011443762,0.00023293673,0.00009558766,0.002980529,0.00038381148,0.054429293,0.00003628304,0.015964752,0.0009304941],"about_ca_topic_score_codex":0.004230987,"about_ca_topic_score_gemma":0.0013675569,"teacher_disagreement_score":0.4351008,"about_ca_system_score_codex":0.00051449565,"about_ca_system_score_gemma":0.00023950708,"threshold_uncertainty_score":0.9997989},"labels":[],"label_agreement":null},{"id":"W2978240167","doi":"10.1002/cncr.32526","title":"Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure","year":2019,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vincristine; Etoposide; Rituximab; Internal medicine; Salvage therapy; Cyclophosphamide; Cytarabine; Ifosfamide; Oncology; Chemotherapy; Surgery; Lymphoma","score_opus":0.004083342779164876,"score_gpt":0.2293381836001774,"score_spread":0.22525484082101252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978240167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964907,0.00074858096,8.9003976e-7,0.0008275077,0.00021176261,0.0011605992,0.00008799205,0.000019888928,0.0004520786],"genre_scores_gemma":[0.9950109,0.000106480045,0.00016140954,0.0014208518,0.000051140516,0.0006603674,0.00007076899,0.00003462247,0.002483471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988791,0.000015445969,0.00020203741,0.00038456154,0.00022020865,0.0002986757],"domain_scores_gemma":[0.9991317,0.000036175803,0.00013923128,0.0003540234,0.00021334027,0.00012556501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014411136,0.00028602054,0.0005437956,0.000095315154,0.00001770511,0.000013439219,0.000048320184,0.000085193235,0.00060304906],"category_scores_gemma":[0.0000095956875,0.0001644912,0.00010308452,0.000103750026,0.000034332847,0.00007189344,0.000026998396,0.00003973006,0.00023783889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011537573,0.0013342046,0.9852566,0.000029394305,0.00023508522,0.00023250363,0.0006400104,0.000011954765,0.0000124282815,0.0000013779382,0.0007566236,0.01033602],"study_design_scores_gemma":[0.028059192,0.0016046106,0.9650457,0.0003532667,0.00018934556,0.0000027207802,0.0001808148,0.000015835347,0.0015221463,0.0000024085195,0.0028374929,0.00018644739],"about_ca_topic_score_codex":0.0006154796,"about_ca_topic_score_gemma":0.0006170303,"teacher_disagreement_score":0.026905434,"about_ca_system_score_codex":0.0011428922,"about_ca_system_score_gemma":0.00017956419,"threshold_uncertainty_score":0.67077565},"labels":[],"label_agreement":null},{"id":"W2978692898","doi":"10.1097/op9.0000000000000006","title":"Treatment options for patients with mantle cell lymphoma post-transplantation","year":2018,"lang":"en","type":"article","venue":"European Journal of Oncology Pharmacy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Mantle cell lymphoma; Ibrutinib; Medicine; Autologous stem-cell transplantation; Oncology; Regimen; Internal medicine; Lymphoma; Randomized controlled trial; Refractory (planetary science); Leukemia; Biology","score_opus":0.02329371616774092,"score_gpt":0.31644314923921174,"score_spread":0.29314943307147084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978692898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804045,0.00014940828,0.00022694407,0.0010612623,0.00032923967,0.00040311532,0.00004713375,0.000012038166,0.009730438],"genre_scores_gemma":[0.99260825,0.00053532573,0.0055523063,0.00049219077,0.0004708419,0.000008703491,0.00005550924,0.000026963442,0.00024992728],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991336,0.00012975301,0.00031680532,0.00012365275,0.00012867899,0.00016752497],"domain_scores_gemma":[0.99889255,0.000087098066,0.00027719815,0.00009173036,0.0004829372,0.00016851569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013557018,0.00013498339,0.00023956636,0.000106315034,0.00010544902,0.000011218907,0.000064504165,0.000013090898,0.000102070444],"category_scores_gemma":[0.000009026822,0.00008403888,0.000121093355,0.000057577487,0.000071099916,0.000095239804,0.0000067648543,0.000032726766,0.00009136094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028134214,0.03201735,0.2919992,0.00012432985,0.0017043838,0.005166368,0.0037674957,0.0000135909495,0.004794755,0.00008836353,0.00795254,0.6242374],"study_design_scores_gemma":[0.11661454,0.057025164,0.47435462,0.000080871374,0.0020090803,0.001337824,0.00009424228,0.000024991035,0.014936062,0.00000403177,0.33336103,0.00015752598],"about_ca_topic_score_codex":0.0000050914396,"about_ca_topic_score_gemma":0.000002256694,"teacher_disagreement_score":0.6240799,"about_ca_system_score_codex":0.0003205374,"about_ca_system_score_gemma":0.00024574436,"threshold_uncertainty_score":0.3427006},"labels":[],"label_agreement":null},{"id":"W2978973518","doi":"10.14309/00000434-201510001-00762","title":"A Case of Hepatosplenic Gamma-delta T Cell Lymphoma with Intravascular Lymphoma Like Features in a Young Male With Autoimmune Hepatitis","year":2015,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Azathioprine; Lymphoma; Hepatosplenomegaly; Autoimmune hepatitis; Gastroenterology; Internal medicine; Hepatitis; Prednisone; T-cell lymphoma; Malignancy; Population; Autopsy; Pathology; Disease","score_opus":0.006960198751898839,"score_gpt":0.22144570802302974,"score_spread":0.2144855092711309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978973518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976834,0.00072246976,0.00015669107,0.0009977205,0.00007434443,0.00025591344,0.000012250364,0.000009372896,0.00008785578],"genre_scores_gemma":[0.9969046,0.00033122554,0.0020628702,0.00052299467,0.00006172906,0.000021944405,0.0000051697552,0.000035787885,0.000053662767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980265,0.00033618012,0.0005856388,0.00022100296,0.00037426993,0.00045640246],"domain_scores_gemma":[0.9980032,0.000073366886,0.0009440522,0.0004675475,0.00026157522,0.0002502487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004134966,0.0002849914,0.0011555835,0.00025559092,0.000040379116,0.000014818401,0.00022813662,0.00003901043,0.000013694903],"category_scores_gemma":[0.000020056483,0.00015549274,0.00017505743,0.0003126482,0.0006762829,0.0000869651,0.00006193828,0.00013689013,0.0000024310523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02824433,0.0017456134,0.933891,0.000026628877,0.00078533706,0.027814416,0.0017671003,0.00013475821,0.00012464158,0.000008419348,0.00033113832,0.0051266374],"study_design_scores_gemma":[0.0202482,0.042370528,0.5985124,0.00019579075,0.00060676254,0.3355099,0.0018900832,0.00011888128,0.00037516266,0.000006777723,0.00006708607,0.0000984297],"about_ca_topic_score_codex":0.005484062,"about_ca_topic_score_gemma":0.0031129695,"teacher_disagreement_score":0.3353786,"about_ca_system_score_codex":0.0003144372,"about_ca_system_score_gemma":0.00036184536,"threshold_uncertainty_score":0.82902974},"labels":[],"label_agreement":null},{"id":"W2979071352","doi":"10.1111/bjh.16201","title":"Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Lymphoma; Refractory (planetary science); Stem cell; Internal medicine; Hematopoietic stem cell transplantation; Chemotherapy; Surgery; Hodgkin lymphoma; Biology","score_opus":0.027315288273761344,"score_gpt":0.2859260486957481,"score_spread":0.2586107604219868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979071352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07945052,0.9172902,0.000048445898,0.00003218829,0.00048756512,0.0022361889,0.00041826707,0.000008890369,0.000027704775],"genre_scores_gemma":[0.018303152,0.98042256,0.00037783277,0.000034761288,0.00007750912,0.00029087934,0.00017039606,0.00006977938,0.00025315216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975036,0.00022549897,0.0013219424,0.00030723808,0.00032667886,0.00031507833],"domain_scores_gemma":[0.9964857,0.001040762,0.0017427786,0.00030229767,0.0003165561,0.000111918336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013934805,0.00041226918,0.0033102743,0.00018561166,0.000063325664,0.000024274086,0.0001683764,0.0003483237,0.00005966968],"category_scores_gemma":[0.000014415066,0.00022251013,0.0008672526,0.00012266496,0.00011460613,0.00006695638,0.000009247942,0.00011948302,0.000010695336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002875811,0.004108381,0.00073460134,0.011973547,0.00156731,0.01702133,0.00019773588,5.166672e-7,4.3104052e-8,0.0000037600762,0.00033403537,0.96118295],"study_design_scores_gemma":[0.034652147,0.01895328,0.011472289,0.026727434,0.025037618,0.15037945,0.00006665734,0.000002154437,0.000029421002,0.000003766301,0.7322788,0.00039697383],"about_ca_topic_score_codex":0.000036849597,"about_ca_topic_score_gemma":0.00004780462,"teacher_disagreement_score":0.960786,"about_ca_system_score_codex":0.00049265503,"about_ca_system_score_gemma":0.0012066942,"threshold_uncertainty_score":0.90737},"labels":[],"label_agreement":null},{"id":"W2979178674","doi":"10.1182/bloodadvances.2019000458","title":"Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Alliance; Stage (stratigraphy); Lymphoma; Randomized controlled trial; Follicular phase; Medicine; Oncology; Radiation therapy; Internal medicine; Biology; Political science","score_opus":0.0177656881242941,"score_gpt":0.3046307155433004,"score_spread":0.2868650274190063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979178674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481076,0.0011286106,4.7455376e-7,0.0020206643,0.0002657584,0.00094938895,0.00009122822,0.000019760062,0.0007133601],"genre_scores_gemma":[0.99812406,0.00027178598,0.0002767771,0.0005418287,0.00008999542,0.00012511273,0.000040494415,0.000013968859,0.0005159809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983365,0.0001056293,0.00034400937,0.00035041108,0.00065667153,0.00020678055],"domain_scores_gemma":[0.99886686,0.00019868593,0.00016098266,0.00065213663,0.00007173038,0.00004963018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025901425,0.0002047051,0.00037222714,0.00003303669,0.00007336284,0.00003317391,0.00045577728,0.00003038014,0.00012281431],"category_scores_gemma":[0.000056363842,0.00010278975,0.00012049123,0.00014717798,0.000057156114,0.0002680508,0.00006723654,0.00004444609,0.000024272113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008911673,0.0056936853,0.983657,0.000009561919,0.00039291105,0.00021538787,0.001441895,0.000022322745,0.00010238129,0.00034912012,0.000044834193,0.007981758],"study_design_scores_gemma":[0.009327468,0.0007340196,0.96989346,0.00006970181,0.00018115104,0.000018318693,0.004434654,0.000014962409,0.0009278428,0.00008201902,0.014205617,0.00011077076],"about_ca_topic_score_codex":0.0012853319,"about_ca_topic_score_gemma":0.0008564624,"teacher_disagreement_score":0.014160783,"about_ca_system_score_codex":0.000075685595,"about_ca_system_score_gemma":0.00007951645,"threshold_uncertainty_score":0.41916445},"labels":[],"label_agreement":null},{"id":"W2979296208","doi":"10.1182/blood.v124.21.3016.3016","title":"Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene expression profiling; Lymphoma; Pathology; Gene expression; Biology; Medicine; Gene; Cancer research; Genetics","score_opus":0.01801471228970975,"score_gpt":0.2771314768097298,"score_spread":0.2591167645200201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979296208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960903,0.002167786,0.00032066755,0.00003242814,0.00011499046,0.0006241566,0.00003538524,0.000035052828,0.00057923666],"genre_scores_gemma":[0.969631,0.0004614738,0.029490532,0.000043651104,0.00013809909,0.00012023825,0.000050005863,0.00003864308,0.000026335103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825865,0.00007391693,0.00060974236,0.00035020403,0.00037354694,0.00033392082],"domain_scores_gemma":[0.997929,0.00021736427,0.0010035943,0.0004987675,0.00019527909,0.00015601508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001804752,0.0002769492,0.00069936714,0.00013837867,0.00007540405,0.000013474232,0.0001357857,0.00015300562,0.00005507844],"category_scores_gemma":[0.00015320249,0.00021359322,0.0002026759,0.00018606066,0.000073314295,0.00011766669,0.00010807955,0.00005898747,0.000013136039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028627005,0.0056854794,0.3796573,0.0007949143,0.00029685983,0.00014907417,0.0009866504,0.0002693081,0.6083767,0.000091054586,0.00012358447,0.0032828434],"study_design_scores_gemma":[0.009539922,0.00069964863,0.009763494,0.0010654874,0.0007065991,0.00004719881,0.000119490105,0.000898016,0.9768846,0.000037666414,0.00004702464,0.0001908259],"about_ca_topic_score_codex":0.000110608526,"about_ca_topic_score_gemma":0.0000026212851,"teacher_disagreement_score":0.36989382,"about_ca_system_score_codex":0.000046082514,"about_ca_system_score_gemma":0.00012683634,"threshold_uncertainty_score":0.87100786},"labels":[],"label_agreement":null},{"id":"W2979301202","doi":"10.1182/blood.v114.22.1919.1919","title":"TNFRSF14 Is Mutated in a Subset of Follicular Lymphoma and Correlated with Inferior Prognosis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Loss of heterozygosity; Genetics; Comparative genomic hybridization; Gene; Follicular lymphoma; Cancer research; Mutation; Allele; Chromosome; Lymphoma; Immunology","score_opus":0.006622444621639754,"score_gpt":0.22405857994122275,"score_spread":0.217436135319583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979301202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971762,0.0011817988,9.49109e-7,0.00059444614,0.000008490948,0.0005237776,0.000010589716,0.000032501983,0.00047128458],"genre_scores_gemma":[0.9990082,0.00014322114,0.00035506737,0.00037148583,0.000008832038,0.00004121239,0.00002788611,0.000011016847,0.000033082517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919116,0.000018080984,0.00022524399,0.00022130081,0.00016209729,0.00018213323],"domain_scores_gemma":[0.9995806,0.000024161993,0.00007282884,0.00016775413,0.00005746415,0.00009713968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052517807,0.00014773125,0.0003516978,0.00010437087,0.000019120302,0.000009780506,0.000030802537,0.00008098602,0.000022246686],"category_scores_gemma":[0.000018455969,0.00010304534,0.00004372444,0.00030375662,0.000042829044,0.000041670377,0.000010342836,0.000032925724,0.000005297024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021916756,0.0042397007,0.9858769,0.000036365822,0.00020928445,0.000731628,0.0005050944,7.4153e-7,0.00095547055,0.00005101456,0.00008684172,0.0070877713],"study_design_scores_gemma":[0.021708172,0.0017688744,0.9274187,0.0003099087,0.00044368513,0.00028510825,0.000045222387,0.00004843423,0.047709152,0.000024386147,0.00013301591,0.00010535806],"about_ca_topic_score_codex":0.00016316662,"about_ca_topic_score_gemma":0.00003195195,"teacher_disagreement_score":0.058458235,"about_ca_system_score_codex":0.00002913192,"about_ca_system_score_gemma":0.00008857308,"threshold_uncertainty_score":0.42020673},"labels":[],"label_agreement":null},{"id":"W2979316304","doi":"10.1182/blood.v126.23.2720.2720","title":"Safety and Efficacy of Mini-CHOP-R Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in Very Elderly Patients: A Quality Assurance Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy regimen; Adverse effect; Lymphoma; Chemotherapy; Surgery; Oncology","score_opus":0.022182109144243553,"score_gpt":0.2953172491095272,"score_spread":0.27313513996528366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979316304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693644,0.00091014226,0.0000041797744,0.000065424596,0.000039160248,0.0017348976,0.00012930913,0.000010880849,0.00016957163],"genre_scores_gemma":[0.99922526,0.00023726588,0.00027016734,0.000031200176,0.00002246727,0.00011539254,0.000031363586,0.000016552438,0.000050347277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881625,0.000065381035,0.000465571,0.0002602493,0.00020958201,0.00018293547],"domain_scores_gemma":[0.9990065,0.00028015312,0.00018186549,0.00031105,0.0001119039,0.00010852196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017346155,0.0001719589,0.0006301168,0.00006290594,0.000018274686,0.0000045169263,0.00004166712,0.000058166854,0.000003129029],"category_scores_gemma":[0.00007485078,0.00012682524,0.0001000293,0.00010198148,0.000028505516,0.00003581657,0.00001289355,0.000009646186,9.173474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023320918,0.20838833,0.7740819,0.000083736566,0.00024472096,0.000008772397,0.0033802458,1.9114857e-7,0.00008913925,0.000008809484,0.000026566799,0.011355524],"study_design_scores_gemma":[0.2857716,0.008531311,0.69730663,0.00004620324,0.00022673854,9.721197e-7,0.0004355229,0.00000277138,0.007194055,0.0000056479466,0.00040380782,0.00007472635],"about_ca_topic_score_codex":0.00032670045,"about_ca_topic_score_gemma":0.00011369818,"teacher_disagreement_score":0.28343952,"about_ca_system_score_codex":0.000113233335,"about_ca_system_score_gemma":0.000112694994,"threshold_uncertainty_score":0.51717836},"labels":[],"label_agreement":null},{"id":"W2979335764","doi":"10.1182/blood.v114.22.439.439","title":"Base-Pair Resolution of Somatic and Germline-Derived Genome Rearrangement Breakpoints in Follicular Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breakpoint; Biology; Genome; Genetics; Gene rearrangement; Reference genome; Contig; Follicular lymphoma; Human genome; Computational biology; Chromosomal rearrangement; Chromosomal translocation; Gene; Chromosome; Karyotype; Lymphoma","score_opus":0.01063980709240351,"score_gpt":0.23102950305049613,"score_spread":0.22038969595809263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979335764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956385,0.0023078385,0.000008503537,0.00095605064,0.00001612678,0.00044098718,0.0000072771586,0.000030304922,0.0005944038],"genre_scores_gemma":[0.99794483,0.00024300376,0.0014622337,0.00020387997,0.000035765093,0.000028521661,0.000028198612,0.00000945691,0.000044088454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990875,0.000035990248,0.00029050486,0.00021514816,0.00018758555,0.00018324109],"domain_scores_gemma":[0.99951863,0.000026511118,0.000076988035,0.0002551611,0.000034028144,0.00008870308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013746337,0.00012801531,0.00030660885,0.000114410475,0.000026265025,0.0000069965677,0.0000355461,0.000059618316,0.000024583613],"category_scores_gemma":[0.000032246895,0.000105783234,0.00006974786,0.00012850558,0.000027319027,0.000039204253,0.000017645685,0.00002264059,0.000010456841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005034025,0.022658035,0.43485424,0.0006033939,0.00073727086,0.0015794021,0.001998301,0.000023988508,0.5011343,0.0005128871,0.0002924812,0.035102304],"study_design_scores_gemma":[0.013068603,0.000577972,0.9541023,0.00023501029,0.00027177614,0.00009140765,0.000049884035,0.00010648188,0.03109333,0.00015919717,0.00014925629,0.00009480364],"about_ca_topic_score_codex":0.00010996147,"about_ca_topic_score_gemma":0.000015268579,"teacher_disagreement_score":0.51924807,"about_ca_system_score_codex":0.00007735576,"about_ca_system_score_gemma":0.000046752237,"threshold_uncertainty_score":0.4313715},"labels":[],"label_agreement":null},{"id":"W2979335783","doi":"10.1182/blood.v120.21.155.155","title":"Differences in Quality of Life Between Bendamustine Plus Rituximab Compared with Standard First-Line Treatments in Patients with Previously Untreated Advanced Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Vincristine; Mantle cell lymphoma; CHOP; Internal medicine; Prednisone; Cyclophosphamide; Gastroenterology; Lymphoma; Surgery; Oncology; Chemotherapy","score_opus":0.02467016764433753,"score_gpt":0.26533158984352495,"score_spread":0.24066142219918743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979335783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661607,0.0005752473,0.000012809573,0.00004980633,0.000037303555,0.0020754253,0.00038639453,0.000045502482,0.0002014474],"genre_scores_gemma":[0.9978832,0.00013094462,0.0010655177,0.000037290174,0.000047017846,0.00026453089,0.00046234138,0.00005307316,0.000056077737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692726,0.00012715902,0.00092754356,0.0005389586,0.0007440341,0.0007350215],"domain_scores_gemma":[0.9981446,0.00024805302,0.00049560715,0.0005352382,0.00017135452,0.00040509348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001846965,0.0005515871,0.0017496629,0.00025481734,0.000070093265,0.000018456401,0.00015532618,0.00014222934,0.000053869615],"category_scores_gemma":[0.000053601645,0.00033135238,0.00009163711,0.00056422607,0.00011525614,0.00019006364,0.00007454798,0.00006737645,0.0000095295345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012344652,0.030951641,0.94948024,0.00036566597,0.000540993,0.000057926372,0.0014501974,0.000011601274,0.0000063772045,0.0000021836859,0.000007544932,0.0047809803],"study_design_scores_gemma":[0.2199804,0.005061398,0.7694009,0.00085217645,0.0006186166,0.0000034377672,0.0002099876,0.000009582911,0.00355171,0.0000011686053,0.000018696139,0.0002919133],"about_ca_topic_score_codex":0.0019039273,"about_ca_topic_score_gemma":0.0013006342,"teacher_disagreement_score":0.20763576,"about_ca_system_score_codex":0.0007717438,"about_ca_system_score_gemma":0.0004565456,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W2979356970","doi":"10.1182/blood.v108.11.293.293","title":"Survival Analysis of Anaplastic Large Cell Lymphoma, Systemic and Cutaneous-Types: Report from the International T-Cell Lymphoma Project.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Medicine; CHOP; Lymphoma; Immunophenotyping; Large cell; Internal medicine; Vincristine; T-cell lymphoma; Oncology; Large-cell lymphoma; Pathology; Chemotherapy; Immunology; Cancer; Cyclophosphamide; Adenocarcinoma","score_opus":0.007833225404596656,"score_gpt":0.22691961161227495,"score_spread":0.21908638620767829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979356970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901079,0.0020870182,0.00002579664,0.000084486506,0.0001926342,0.0003269294,0.00030655976,0.000038982373,0.0068296986],"genre_scores_gemma":[0.998062,0.00016520248,0.00016193127,0.00006111806,0.0001810005,0.00003518617,0.000561032,0.000020673051,0.000751861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983609,0.000049568243,0.00050159823,0.00040258173,0.00046667678,0.00021867454],"domain_scores_gemma":[0.9987036,0.00036705285,0.00029168476,0.00045128143,0.0001261842,0.000060168964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015533075,0.00020404924,0.00050576794,0.00016560686,0.00006979148,0.000038250426,0.00013770924,0.00009145965,0.000051740342],"category_scores_gemma":[0.000049915325,0.00013545928,0.00021494972,0.00037509884,0.0000490883,0.00003568742,0.00007249947,0.000027876491,0.000013398444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014810351,0.007914997,0.98342085,0.0000635677,0.002664764,0.0021147481,0.00021706383,0.000014862025,0.0018934764,0.00008339772,0.0011031027,0.00036108628],"study_design_scores_gemma":[0.037969608,0.0004952451,0.90188223,0.0002590075,0.024466427,0.0022758853,0.00095083064,0.0020960434,0.0239661,0.000047791014,0.0051387004,0.0004521168],"about_ca_topic_score_codex":0.004152489,"about_ca_topic_score_gemma":0.00070840435,"teacher_disagreement_score":0.08153859,"about_ca_system_score_codex":0.00010833267,"about_ca_system_score_gemma":0.00021000521,"threshold_uncertainty_score":0.6277349},"labels":[],"label_agreement":null},{"id":"W2979396924","doi":"10.1182/blood.v114.22.268.268","title":"Gene Expression Profiling of Microdissected Hodgkin Reed Sternberg Cells: Molecular Subtypes and Treatment Outcome Correlations.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Laser capture microdissection; Germinal center; Reed–Sternberg cell; Gene expression profiling; Cancer research; Biology; Gene expression; Microdissection; Lymphoma; Molecular biology; Pathology; Gene; Medicine; B cell; Immunology; Hodgkin lymphoma; Genetics; Antibody","score_opus":0.015680890463886533,"score_gpt":0.2602055001670626,"score_spread":0.24452460970317608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979396924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971492,0.0018456749,0.00003203765,0.00013892514,0.000033122746,0.00043974924,0.000014511757,0.000034267385,0.0003124633],"genre_scores_gemma":[0.9912651,0.00014289356,0.008302515,0.00005270226,0.000024996694,0.000020507432,0.000055486813,0.000010486992,0.00012527927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992641,0.000025400563,0.00024507777,0.00021889464,0.00011750665,0.00012902461],"domain_scores_gemma":[0.9995221,0.00003192637,0.000087477725,0.00023140093,0.000045100365,0.00008199876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035602192,0.00014054336,0.0002694781,0.00006579883,0.00003641746,0.000008907481,0.000026889256,0.00006564562,0.000014408056],"category_scores_gemma":[0.000015092203,0.00010080323,0.00007184021,0.00007767689,0.000018999352,0.000026687765,0.0000115224775,0.000028554698,0.00000613997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007498926,0.0017454658,0.2884225,0.000014924517,0.00008438125,0.00010852296,0.00011999395,0.000003442004,0.70734376,0.000024080224,0.0000090866215,0.0020488761],"study_design_scores_gemma":[0.0051383656,0.00075344427,0.21076028,0.00006380558,0.00037366862,0.00003408757,0.000023400282,0.000013366183,0.78273606,0.000013712902,0.00002207267,0.00006774445],"about_ca_topic_score_codex":0.000027890328,"about_ca_topic_score_gemma":0.000002086095,"teacher_disagreement_score":0.07766221,"about_ca_system_score_codex":0.00003770243,"about_ca_system_score_gemma":0.000031637992,"threshold_uncertainty_score":0.41106364},"labels":[],"label_agreement":null},{"id":"W2979430900","doi":"10.1182/blood.v110.11.787.787","title":"Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chemoimmunotherapy; Medicine; CHOP; Stage (stratigraphy); Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy; Gastroenterology; Lymphoma; Nuclear medicine; Oncology; Surgery; Rituximab; Biology","score_opus":0.007477208399966654,"score_gpt":0.223628791387473,"score_spread":0.21615158298750634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979430900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964085,0.00042207885,0.000023018907,0.000054979464,0.000025769397,0.001700953,0.00021563245,0.00012386567,0.0010251665],"genre_scores_gemma":[0.9984927,0.000052451654,0.0006164406,0.00022346673,0.000025232077,0.000109580105,0.000239418,0.00010413192,0.00013654282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777764,0.000059130973,0.0004168514,0.00054121384,0.00057991483,0.0006252697],"domain_scores_gemma":[0.99838585,0.00027062363,0.00033236304,0.00053269847,0.00023091599,0.0002475411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018349197,0.0005220005,0.0008723503,0.00022246379,0.00015534853,0.000028780942,0.00012966085,0.00010700846,0.000021358637],"category_scores_gemma":[0.000037700913,0.0003414534,0.00022542095,0.00060352945,0.00010488556,0.000107508626,0.000034333745,0.000094556155,0.0000047418876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025550276,0.044313964,0.9447301,0.00009996979,0.0022127733,0.0008023624,0.0008542172,5.47322e-7,0.002143632,0.000013372002,0.000014407546,0.0022596293],"study_design_scores_gemma":[0.16910534,0.0028393064,0.7213667,0.00047180132,0.0010812174,0.000023379982,0.00016847921,0.0000069578164,0.10458718,0.00000233675,0.00005961546,0.00028770632],"about_ca_topic_score_codex":0.002131457,"about_ca_topic_score_gemma":0.0016006505,"teacher_disagreement_score":0.2233634,"about_ca_system_score_codex":0.00027627527,"about_ca_system_score_gemma":0.0001700358,"threshold_uncertainty_score":0.99990374},"labels":[],"label_agreement":null},{"id":"W2979445655","doi":"10.1182/blood.v110.11.686.686","title":"CD20 Mutations at the Rituximab Binding Site Are Rare and Are Not a Significant Cause of R-CHOP Resistance in Patients with De Novo Diffuse Large B-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; CHOP; Diffuse large B-cell lymphoma; CD20; Lymphoma; Medicine; Chemotherapy regimen; Cancer research; Internal medicine; Immunology; Oncology; Chemotherapy","score_opus":0.008062252860932654,"score_gpt":0.22027380265435584,"score_spread":0.2122115497934232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979445655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804777,0.000595085,0.0000053817284,0.00021803132,0.000015175716,0.0005273469,0.00040048567,0.000017859491,0.00017286743],"genre_scores_gemma":[0.999136,0.000052953077,0.00025157613,0.0001969068,0.00001644201,0.000043168573,0.00007533174,0.000022781,0.00020484676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887747,0.000033110737,0.00025178358,0.00025948745,0.00026701187,0.00031111715],"domain_scores_gemma":[0.9991212,0.00018854179,0.00019652823,0.0002924499,0.00008570824,0.00011559797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014423286,0.00016279706,0.00028425525,0.0001035402,0.00012302707,0.00001527962,0.000051535422,0.00006211692,0.000009236895],"category_scores_gemma":[0.00006075598,0.00010478668,0.000043932832,0.00023726461,0.0000690755,0.000045989116,0.000041909712,0.00005078674,0.000009342153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005280386,0.016135944,0.9809211,0.000106232044,0.00009154997,0.0005370345,0.0011066783,3.8861404e-7,0.0004216524,0.000012648616,0.00007743557,0.00006132845],"study_design_scores_gemma":[0.0687532,0.00015751744,0.9173317,0.00035446466,0.00033978716,0.000014475589,0.0004122876,0.0000018081254,0.0123397065,0.0000027957637,0.00018134732,0.00011090246],"about_ca_topic_score_codex":0.00005556816,"about_ca_topic_score_gemma":0.0024796897,"teacher_disagreement_score":0.06822516,"about_ca_system_score_codex":0.00017926721,"about_ca_system_score_gemma":0.00005908869,"threshold_uncertainty_score":0.4273077},"labels":[],"label_agreement":null},{"id":"W2979475210","doi":"10.1182/blood.v124.21.1703.1703","title":"Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; B symptoms; CD30; Diffuse large B-cell lymphoma; Univariate analysis; Internal medicine; International Prognostic Index; Immunophenotyping; Rituximab; Lymphoma; Vincristine; Anaplastic large-cell lymphoma; Oncology; CD20; Gastroenterology; Chemotherapy; Multivariate analysis; Immunology; Cyclophosphamide","score_opus":0.009504412341319787,"score_gpt":0.26205442569274834,"score_spread":0.25255001335142857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979475210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818444,0.0007468205,0.000041408468,0.00011099019,0.000024596991,0.0004335773,0.00022426654,0.000049232167,0.00018465558],"genre_scores_gemma":[0.9991381,0.00010629356,0.00021885226,0.00013502632,0.000053929187,0.000044019023,0.00020533627,0.000057127003,0.000041318646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747443,0.000269191,0.00058045395,0.00056329905,0.0006454079,0.00046723863],"domain_scores_gemma":[0.997571,0.0009977657,0.00038787603,0.000506335,0.00023958375,0.000297431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043480974,0.0004928081,0.0015019935,0.00048210396,0.000103576276,0.000050204904,0.00012526254,0.00019557666,0.000013127982],"category_scores_gemma":[0.0001977871,0.00029454756,0.00022852505,0.0006590549,0.00035459572,0.000106685315,0.000060423994,0.000072015326,0.0000017495937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00156839,0.026059365,0.94063866,0.00010365594,0.0044736164,0.00009451198,0.00054988515,7.808551e-7,0.0007111556,0.00020398325,0.000010576152,0.0255854],"study_design_scores_gemma":[0.072925545,0.008619223,0.9023216,0.00019784698,0.005578823,0.00003645048,0.00010426291,0.00015455093,0.009753017,0.0000137248535,0.000013435647,0.0002815457],"about_ca_topic_score_codex":0.00025652815,"about_ca_topic_score_gemma":0.00009264518,"teacher_disagreement_score":0.07135715,"about_ca_system_score_codex":0.00017428494,"about_ca_system_score_gemma":0.000111876165,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W2979488430","doi":"10.1182/blood.v120.21.2650.2650","title":"Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Biomarker; Pathology; Data quality; Sample (material); Data collection; Medical physics; Data mining; Computer science; Statistics","score_opus":0.19438578130786338,"score_gpt":0.4312805722622565,"score_spread":0.23689479095439314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979488430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594265,0.0018017044,0.0000014531457,0.0000693369,0.000020209814,0.00055563415,0.0014621781,0.0000025994436,0.00014424695],"genre_scores_gemma":[0.99780107,0.000030386343,0.000086134896,0.000025045514,0.000018350405,0.000035635487,0.0019918294,0.000004325655,0.00000720427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847275,0.0004428336,0.0003283468,0.00016681824,0.0005216318,0.0000676208],"domain_scores_gemma":[0.99870586,0.0002297511,0.00019538618,0.0005003375,0.00034582953,0.000022802209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105541,0.00008086249,0.0003113707,0.00007036922,0.000012987284,0.0000055508194,0.00013580287,0.000031985976,0.00015307318],"category_scores_gemma":[0.00030633152,0.00004854908,0.000048493264,0.0003039993,0.00004171857,0.00013884366,0.00005654582,0.000025412704,2.8114334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008826034,0.014111956,0.9662031,0.0000072785456,0.0027730998,0.0000013554125,0.005096059,0.0000076156007,0.011086153,0.000004590365,0.00015976561,0.0004607757],"study_design_scores_gemma":[0.004708587,0.0002054147,0.97118556,0.000016268987,0.006604449,4.3826378e-7,0.005126125,0.0008672348,0.011228021,9.2232784e-7,0.0000131149645,0.000043838194],"about_ca_topic_score_codex":0.014298653,"about_ca_topic_score_gemma":0.0053550424,"teacher_disagreement_score":0.013906541,"about_ca_system_score_codex":0.00004303677,"about_ca_system_score_gemma":0.000108319975,"threshold_uncertainty_score":0.9922652},"labels":[],"label_agreement":null},{"id":"W2979498219","doi":"10.1182/blood.v116.21.428.428","title":"A Phase 2, Double-Blind, Placebo-Controlled Trial of Rituximab + Galiximab Vs Rituximab + Placebo In Advanced Follicular Non-Hodgkin's Lymphoma (NHL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; CD20; Immunology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.013479268799512315,"score_gpt":0.29742260063127457,"score_spread":0.28394333183176224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979498219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849258,0.00051481556,0.0000200537,0.0005085572,0.0007483716,0.009197188,0.000043509717,0.00011411498,0.003927576],"genre_scores_gemma":[0.99296016,0.000106941814,0.0020756812,0.00018119742,0.000444648,0.003716166,0.00009732913,0.000091449816,0.0003264465],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959877,0.00011655793,0.0013211374,0.0009027003,0.00084830896,0.00082356855],"domain_scores_gemma":[0.99728924,0.00038687786,0.00051425723,0.0011792581,0.00022514309,0.00040522453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007022258,0.00066705636,0.0023876338,0.00050719135,0.00011687285,0.00005727209,0.0003239138,0.00045435695,0.00021428848],"category_scores_gemma":[0.00024817418,0.00054542214,0.0007608041,0.000533702,0.00016123705,0.00022563993,0.00010619039,0.00031433415,0.00012496377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8523382,0.12670837,0.0013291235,0.000115429626,0.000920962,0.00089573767,0.00026700553,0.000003742921,0.011062202,0.00031260715,0.00010909309,0.00593756],"study_design_scores_gemma":[0.91797954,0.0060630543,0.0005198134,0.00021051691,0.0016498062,0.00019901653,0.00007634167,0.0002365128,0.07129095,0.00006231019,0.0012583168,0.0004538322],"about_ca_topic_score_codex":0.0002825409,"about_ca_topic_score_gemma":0.00022690483,"teacher_disagreement_score":0.120645314,"about_ca_system_score_codex":0.00015159299,"about_ca_system_score_gemma":0.00067026226,"threshold_uncertainty_score":0.9996997},"labels":[],"label_agreement":null},{"id":"W2979509136","doi":"10.1182/blood.v118.21.955.955","title":"Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; ABVD; Medicine; Internal medicine; Oncology; Dacarbazine; Regimen; Chemotherapy regimen; Hodgkin's lymphoma; Chemotherapy; Surgery; Lymphoma; CD30; Vincristine; Cyclophosphamide","score_opus":0.013137553990264885,"score_gpt":0.21696171838328743,"score_spread":0.20382416439302253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979509136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690783,0.0002670063,0.00003634474,0.00007748729,0.000042273397,0.0018721499,0.00004601252,0.00010747254,0.00064341334],"genre_scores_gemma":[0.9928211,0.00011089294,0.005618634,0.00037477174,0.000025118454,0.00040670237,0.00014668576,0.00009165379,0.0004044424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800396,0.000057401518,0.0003394362,0.00058573636,0.000501856,0.0005115932],"domain_scores_gemma":[0.9987127,0.00008873131,0.00020924714,0.0006080707,0.00015558998,0.00022566579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069936395,0.00046299183,0.0006880465,0.00014791125,0.00006914641,0.00003159979,0.00014333021,0.000091078036,0.00017265258],"category_scores_gemma":[0.000021762267,0.00024258193,0.00005436896,0.00036387055,0.00009020806,0.00022273361,0.000028709683,0.00008797438,0.00002062905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034160055,0.03162044,0.91817296,0.000040226885,0.00056555524,0.0014244217,0.00094805146,0.00000551769,0.000020265144,0.000055043656,0.00005389217,0.012933546],"study_design_scores_gemma":[0.23118205,0.02207169,0.74171644,0.00036777277,0.00021794261,0.000018851935,0.00016187617,0.0000057440534,0.003809934,0.00000766618,0.0001384287,0.00030161868],"about_ca_topic_score_codex":0.00057953736,"about_ca_topic_score_gemma":0.0010315622,"teacher_disagreement_score":0.19702199,"about_ca_system_score_codex":0.00013077304,"about_ca_system_score_gemma":0.00030120029,"threshold_uncertainty_score":0.9892204},"labels":[],"label_agreement":null},{"id":"W2979509462","doi":"10.1182/blood.v108.11.3068.3068","title":"Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients &gt; 60 Versus ≤ 60 Years of Age.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Melphalan; Surgery; Chemotherapy regimen; Regimen; Transplantation; Progression-free survival; Chemotherapy; Oncology","score_opus":0.011398951170519813,"score_gpt":0.26229187269958676,"score_spread":0.25089292152906695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979509462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971474,0.00045433952,0.0000026474222,0.00005779951,0.00041493,0.0012154189,0.0002581182,0.000038736307,0.0004106459],"genre_scores_gemma":[0.99758965,0.000081823964,0.0011943862,0.000036838035,0.00012208143,0.0005520206,0.00023656242,0.00004595024,0.00014066687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982581,0.000043005624,0.000492176,0.0003717463,0.00046275312,0.0003721806],"domain_scores_gemma":[0.9987378,0.000271518,0.00027574072,0.00049207587,0.000110888475,0.00011196967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113462935,0.0002466307,0.00052732066,0.0001564677,0.000034436278,0.00001534156,0.0001389702,0.00018868528,0.000050748808],"category_scores_gemma":[0.00016738575,0.00018800744,0.00017360986,0.0001677065,0.0000771911,0.00007811541,0.00005285486,0.000060562637,0.000012040031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025187524,0.0234789,0.8989631,0.0005164283,0.00061505835,0.009356122,0.0007644616,0.0000055462383,0.0005734577,0.00003917869,0.0010295932,0.039470665],"study_design_scores_gemma":[0.08153313,0.0031690917,0.9096596,0.00089865306,0.00045485265,0.000007714127,0.000016529617,0.000008155241,0.002903435,0.000022594028,0.0011318922,0.00019432262],"about_ca_topic_score_codex":0.00022645257,"about_ca_topic_score_gemma":0.00034769415,"teacher_disagreement_score":0.056345604,"about_ca_system_score_codex":0.0001568941,"about_ca_system_score_gemma":0.00025346424,"threshold_uncertainty_score":0.76667213},"labels":[],"label_agreement":null},{"id":"W2979525324","doi":"10.1182/blood.v116.21.3887.3887","title":"Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Radiation therapy; Lymphoma; Diffuse large B-cell lymphoma; Chemotherapy; Cancer; Vinblastine; Internal medicine; Oncology; Vincristine; Cyclophosphamide","score_opus":0.007020985185413978,"score_gpt":0.22547519973223126,"score_spread":0.2184542145468173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979525324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857146,0.00022085957,0.000010592192,0.00003514182,0.00005639945,0.00068542844,0.00019516298,0.000027893799,0.00019705106],"genre_scores_gemma":[0.99766713,0.00007378517,0.001650839,0.00004211963,0.000045165194,0.00005947372,0.00034551354,0.00002882372,0.00008715002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.000045581375,0.0004270204,0.00027824918,0.00039740404,0.00018742759],"domain_scores_gemma":[0.9984821,0.00010599548,0.0004451265,0.00047585505,0.00037031207,0.00012062605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011591845,0.00021969316,0.00050615566,0.00013740214,0.00004334565,0.000014287115,0.0000890566,0.00012071763,0.00005802286],"category_scores_gemma":[0.00011838424,0.00015036925,0.000095532974,0.00023752282,0.000121126504,0.00013876392,0.000043533495,0.000041992993,0.0000065713693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092353864,0.010712659,0.9718417,0.00017999088,0.000343708,0.000055984754,0.00012694724,0.000002336695,0.012448784,0.00030190896,0.000048819165,0.0030136385],"study_design_scores_gemma":[0.020046975,0.0012428777,0.6694511,0.0001612373,0.00047087832,0.0000117639975,0.000028866345,0.000026101474,0.3082117,0.000016760221,0.00022393098,0.000107776206],"about_ca_topic_score_codex":0.0006099052,"about_ca_topic_score_gemma":0.00013003369,"teacher_disagreement_score":0.30239058,"about_ca_system_score_codex":0.000046468784,"about_ca_system_score_gemma":0.0003123648,"threshold_uncertainty_score":0.613188},"labels":[],"label_agreement":null},{"id":"W2979544794","doi":"10.1182/blood.v108.11.3662.3662","title":"Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Transplantation; Autologous stem-cell transplantation; Chemotherapy; Lymphoma; Gastroenterology; Surgery","score_opus":0.00981939846412819,"score_gpt":0.23821807369363573,"score_spread":0.22839867522950755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979544794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994916,0.0031981796,0.00004835597,0.0004536527,0.00017138792,0.0010166453,0.0000555281,0.00006557606,0.00007466352],"genre_scores_gemma":[0.9959743,0.0021733271,0.0013294073,0.00007710325,0.000111882975,0.00011180429,0.00010041285,0.000042371812,0.00007937533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987432,0.00003147231,0.00033779768,0.0004263748,0.00017210544,0.00028909819],"domain_scores_gemma":[0.99943274,0.00020205264,0.000093686795,0.000115205774,0.000024547127,0.0001317758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015513021,0.00027261482,0.0004806546,0.000094343886,0.0002054268,0.00007755449,0.00003980828,0.00012180019,9.637316e-7],"category_scores_gemma":[0.00000285336,0.00022532175,0.00010501806,0.00007304743,0.000078279416,0.00017189038,0.000010492384,0.00004990015,4.4771838e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037274358,0.008671103,0.10331385,0.0032794094,0.0011334295,0.0005070488,0.0075438884,0.000001119114,0.698672,0.00027931403,0.000052711537,0.1728187],"study_design_scores_gemma":[0.10396101,0.0010528775,0.4657935,0.0005647187,0.0015608931,0.00013284295,0.00027304742,0.000088614084,0.42593783,0.0001963425,0.00009268183,0.00034564472],"about_ca_topic_score_codex":0.00014630226,"about_ca_topic_score_gemma":0.000036235142,"teacher_disagreement_score":0.36247963,"about_ca_system_score_codex":0.00004541856,"about_ca_system_score_gemma":0.00004216108,"threshold_uncertainty_score":0.91883546},"labels":[],"label_agreement":null},{"id":"W2979550461","doi":"10.1182/blood.v128.22.735.735","title":"Crebbp Mutations Disrupt Dynamic Enhancer Acetylation in B-Cells, Enabling HDAC3 to Drive Lymphomagenesis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Enhancer; Biology; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; Histone acetyltransferase; Molecular biology; Gene knockdown; Histone; Gene; Gene expression; Genetics; Immunology","score_opus":0.008501052353975032,"score_gpt":0.2647485629452033,"score_spread":0.2562475105912283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979550461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959332,0.00042976617,0.000464477,0.0018589201,0.000103814775,0.0004659698,0.0000248674,0.00005521708,0.0006637804],"genre_scores_gemma":[0.99687916,0.00024943473,0.0013548152,0.0003151534,0.000071510185,0.00021174343,0.0000239189,0.000023561093,0.00087071455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989906,0.000026945534,0.00023510608,0.0003147929,0.00018248863,0.00025004934],"domain_scores_gemma":[0.9993306,0.000119149154,0.00005175258,0.00025666234,0.00010346301,0.00013838928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007165945,0.00014559938,0.00020935605,0.00017410578,0.000055678498,0.00001687798,0.000052868923,0.00006723139,0.00013033453],"category_scores_gemma":[0.00010576958,0.00009962675,0.00007629572,0.00026313856,0.000022278493,0.000092860355,0.00003213349,0.000017296417,0.00034825283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013847991,0.005613854,0.16672263,0.00007572808,0.00033565334,0.0003337777,0.0018050416,0.00005411142,0.7184926,0.00016826112,0.0004545574,0.10580531],"study_design_scores_gemma":[0.012409606,0.00030166088,0.43366098,0.0004100032,0.00034561355,0.000031971198,0.00022023563,0.000071329334,0.551152,0.00009294749,0.0010710999,0.00023257901],"about_ca_topic_score_codex":0.000112564005,"about_ca_topic_score_gemma":0.00019517528,"teacher_disagreement_score":0.26693836,"about_ca_system_score_codex":0.0002909943,"about_ca_system_score_gemma":0.00010512945,"threshold_uncertainty_score":0.44762018},"labels":[],"label_agreement":null},{"id":"W2979554836","doi":"10.1182/blood.v108.11.3005.3005","title":"Favourable Overall Survival with Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Busulfan; Transplantation; Internal medicine; Cyclophosphamide; Rituximab; Surgery; Gastroenterology; Fludarabine; Alemtuzumab; Chemotherapy; Lymphoma","score_opus":0.009975011514347366,"score_gpt":0.21564022909604896,"score_spread":0.2056652175817016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979554836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919569,0.0007469585,0.0005880823,0.00014867474,0.00004553308,0.00081155315,0.0000763703,0.00005794511,0.005567979],"genre_scores_gemma":[0.9960225,0.000103073966,0.0017216033,0.00008769745,0.00010857508,0.00021249299,0.00026976774,0.000030174244,0.0014441041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990437,0.00002364135,0.00017912337,0.00027934604,0.00021664197,0.00025754157],"domain_scores_gemma":[0.999523,0.000083161845,0.00007247136,0.0001690031,0.000077809214,0.00007454426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006534049,0.00018370201,0.00028175602,0.000046980662,0.00008633753,0.000021940497,0.000040909516,0.00007010182,0.000014367239],"category_scores_gemma":[0.0000010531131,0.00013158898,0.0001157596,0.0000805918,0.000020854071,0.00006247281,0.00000413116,0.000019568968,0.0000147224555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030419966,0.018191155,0.91951823,0.0011545665,0.0021880881,0.001827976,0.0010651896,0.0006662582,0.034743387,0.006359544,0.001427097,0.009816517],"study_design_scores_gemma":[0.051437628,0.0015586622,0.53748727,0.00013514775,0.0023781904,0.00016974269,0.000106557745,0.000057874582,0.4028439,0.00019465016,0.0032989534,0.00033140497],"about_ca_topic_score_codex":0.0002996785,"about_ca_topic_score_gemma":0.00009221118,"teacher_disagreement_score":0.38203093,"about_ca_system_score_codex":0.00007081564,"about_ca_system_score_gemma":0.00010256613,"threshold_uncertainty_score":0.5366043},"labels":[],"label_agreement":null},{"id":"W2979588198","doi":"10.1182/blood.v104.11.915.915","title":"A Prospective Phase II Comparison of Stem Cell Source Using Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) RE—Induction, Then High Dose Fludarabine, Busulfan (FLUBU) and Autologous (ASCT) or Allogeneic (AlloSCT) Hematopoietic Blood Stem Cell Transplantation for Mantle Cell (MCL) and Relapsed Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Ifosfamide; Etoposide; Fludarabine; Busulfan; Surgery; Follicular lymphoma; Hematopoietic stem cell transplantation; Gastroenterology; Rituximab; Urology; Chemotherapy; Transplantation; Oncology; Lymphoma; Cyclophosphamide; Cisplatin","score_opus":0.015807966027398954,"score_gpt":0.26104568378791243,"score_spread":0.24523771776051348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979588198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122596,0.0040575266,0.00045880693,0.00012406902,0.00015172148,0.0034043714,0.00022147018,0.00013300878,0.00022308399],"genre_scores_gemma":[0.9917077,0.0005764639,0.006653697,0.000070454,0.00010686061,0.00027493117,0.00012445217,0.00013365674,0.0003517747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964055,0.00012119919,0.0011464497,0.0011217647,0.0005168952,0.0006881977],"domain_scores_gemma":[0.99782526,0.00026280616,0.00072214473,0.0005924012,0.00023223896,0.00036512653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025474103,0.00074333814,0.001424377,0.00029689434,0.00047874294,0.00006855312,0.00017354391,0.00041499262,0.000009798209],"category_scores_gemma":[0.0000066922235,0.00062138395,0.0002406674,0.0003809089,0.00020395471,0.00019180539,0.00007418435,0.00019868987,0.0000043891205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005930335,0.09432545,0.04053413,0.009960461,0.0013928612,0.0010467108,0.03905063,0.0010030668,0.80292207,0.00012698985,0.00009876985,0.0036085201],"study_design_scores_gemma":[0.12313147,0.006160713,0.012685451,0.0005232081,0.0057896385,0.00065730105,0.0029268176,0.0004996376,0.84690446,0.00008416823,0.000023790537,0.00061333325],"about_ca_topic_score_codex":0.00085043046,"about_ca_topic_score_gemma":0.00014427268,"teacher_disagreement_score":0.117201135,"about_ca_system_score_codex":0.00026979425,"about_ca_system_score_gemma":0.00044699156,"threshold_uncertainty_score":0.9996238},"labels":[],"label_agreement":null},{"id":"W2979591768","doi":"10.1182/blood.v120.21.1545.1545","title":"Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-Cell Lymphomas: A North American PTCL Study Group Project","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Medical diagnosis; Peripheral T-cell lymphoma; CD30; Lymphoma; Not Otherwise Specified; CD5; Immunophenotyping; Diffuse large B-cell lymphoma; Pathology; Oncology; Internal medicine; T cell; Antigen; Immunology","score_opus":0.01284821034073624,"score_gpt":0.2514833486208536,"score_spread":0.23863513828011734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979591768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986167,0.006378072,0.00018931838,0.000015303754,0.0000327502,0.0032583238,0.000029826579,0.000037948106,0.00019679412],"genre_scores_gemma":[0.9839388,0.00019799608,0.01401159,0.00009182536,0.000076938304,0.0015566426,0.00006577134,0.000047923004,0.000012499487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985803,0.000074498006,0.0003427284,0.00034863717,0.00022875411,0.0004251346],"domain_scores_gemma":[0.9988505,0.00032211508,0.00019254517,0.0004172949,0.00006525346,0.00015224163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000996957,0.00027691392,0.0005491722,0.0000925509,0.00007329123,0.000020495065,0.00009304656,0.000037893067,0.0000047818216],"category_scores_gemma":[0.00021632205,0.00021713141,0.00013451597,0.0002656549,0.00009581132,0.00006152379,0.000070143826,0.00004705378,0.0000018610027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020334382,0.021881562,0.9680534,0.00028172298,0.00054845866,0.000034786673,0.00162256,0.0000024759536,0.0012701396,0.00002921859,0.00002430384,0.006048032],"study_design_scores_gemma":[0.017343909,0.0039356267,0.9728753,0.000029915154,0.0020163006,0.0000832856,0.0009076582,0.00005626062,0.0024508466,0.000004283183,0.00007241304,0.00022418264],"about_ca_topic_score_codex":0.00059205526,"about_ca_topic_score_gemma":0.000024211802,"teacher_disagreement_score":0.017945934,"about_ca_system_score_codex":0.00006088535,"about_ca_system_score_gemma":0.00010423401,"threshold_uncertainty_score":0.8854362},"labels":[],"label_agreement":null},{"id":"W2979644514","doi":"10.1182/blood.v128.22.4207.4207","title":"Outcome of Bone Marrow Biopsy in Patients with Diffuse Large B-Cell Lymphoma Patients Staged by Combined 18 FGD-PET/CT Scan","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Concordance; Bone marrow; Stage (stratigraphy); Malignancy; Nuclear medicine; Radiology; PET-CT; Infiltration (HVAC); Positron emission tomography; Internal medicine","score_opus":0.0060974759857379485,"score_gpt":0.21043702477858464,"score_spread":0.2043395487928467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979644514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979272,0.00008925768,0.000001153359,0.00009306844,0.000073435454,0.00078092905,0.00051852525,0.00003889093,0.0004775339],"genre_scores_gemma":[0.9987758,0.000019262929,0.00012324209,0.00012985028,0.000010051309,0.0000698947,0.00021017694,0.000046181285,0.00061554153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980936,0.000058363905,0.00053112203,0.0003835404,0.000499129,0.00043422365],"domain_scores_gemma":[0.9988485,0.0000782952,0.00024003413,0.0005022825,0.00012172778,0.00020913864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099105615,0.00029030305,0.0006048803,0.00014912529,0.00004411797,0.00001050643,0.00009792449,0.00002766375,0.00011446149],"category_scores_gemma":[0.0000550953,0.00017063244,0.000103809754,0.00020383934,0.000064489504,0.000088818335,0.000065444794,0.000039491184,0.0000433449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005468623,0.081556864,0.9159122,0.00007290408,0.00013005687,0.00021464506,0.000033903358,1.0264385e-8,0.00031138537,0.00001275623,0.00055761886,0.0006507724],"study_design_scores_gemma":[0.2166694,0.0016214488,0.76905304,0.00019104828,0.00020405265,0.0000070651804,0.000014094607,5.204775e-7,0.011884984,0.0000039186925,0.00017373532,0.00017672665],"about_ca_topic_score_codex":0.00017160726,"about_ca_topic_score_gemma":0.000029102148,"teacher_disagreement_score":0.21612254,"about_ca_system_score_codex":0.00017315595,"about_ca_system_score_gemma":0.000058756203,"threshold_uncertainty_score":0.6958189},"labels":[],"label_agreement":null},{"id":"W2979675032","doi":"10.1182/blood.v116.21.2005.2005","title":"Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunohistochemistry; Diffuse large B-cell lymphoma; Germinal center; Fluorescence in situ hybridization; Vincristine; clone (Java method); Lymphoma; CHOP; Immunophenotyping; Pathology; Biology; Medicine; Cancer research; Internal medicine; Molecular biology; Antibody; Cyclophosphamide; Immunology; B cell; Flow cytometry; Gene; Chemotherapy","score_opus":0.01285526685516439,"score_gpt":0.30258160713388976,"score_spread":0.28972634027872535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979675032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998719,0.00024869578,3.3380834e-7,0.00006937978,0.00005068372,0.000614756,0.000022559789,0.000028854052,0.00024573843],"genre_scores_gemma":[0.9992537,0.000018175308,0.00014909204,0.000046328907,0.00004789897,0.00018846491,0.000075381,0.000016679554,0.00020430869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897414,0.000022138773,0.00036256152,0.0003065677,0.00015946572,0.00017509334],"domain_scores_gemma":[0.99939257,0.00004966037,0.00010856993,0.00025346628,0.000049256334,0.00014650171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069561545,0.00017514994,0.00033032757,0.0000282041,0.000035356148,0.000014528389,0.000049428792,0.00013150866,0.000026270833],"category_scores_gemma":[0.00007399056,0.00011266408,0.000049196547,0.000051248506,0.000086540196,0.00003975067,0.000036600057,0.00016593123,0.000006265364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008740628,0.0052244593,0.9306162,0.000042696716,0.00003388076,0.000054441007,0.000025977171,2.7441531e-9,0.057399936,6.873504e-7,0.00014109336,0.0063732457],"study_design_scores_gemma":[0.02852502,0.00068296184,0.8209773,0.00023784583,0.00013629034,0.000023701192,0.000008571933,0.0000025656198,0.14867775,0.0000010001777,0.0005853345,0.00014168267],"about_ca_topic_score_codex":0.00005433037,"about_ca_topic_score_gemma":0.000005285074,"teacher_disagreement_score":0.10963891,"about_ca_system_score_codex":0.000022874754,"about_ca_system_score_gemma":0.000034705638,"threshold_uncertainty_score":0.45943078},"labels":[],"label_agreement":null},{"id":"W2979692070","doi":"10.1182/blood.v124.21.628.628","title":"A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Rituximab; Oncology; Phases of clinical research; Transplantation; Lymphoma; Clinical trial; Multiple myeloma","score_opus":0.030729300273096775,"score_gpt":0.30688280287865816,"score_spread":0.2761535026055614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979692070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650127,0.00086208846,0.0000023384114,0.00027998775,0.000113255555,0.001650031,0.0000023992054,0.000021806452,0.0005668299],"genre_scores_gemma":[0.9994916,0.000070452465,0.00009188395,0.00014083378,0.0000686368,0.00010332652,0.0000061782407,0.000014570384,0.0000125448305],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985169,0.00038557022,0.00046839332,0.00024225481,0.00021078595,0.00017605103],"domain_scores_gemma":[0.99670947,0.0025864549,0.00016695351,0.00034434177,0.000037437076,0.00015536837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076319487,0.00016907573,0.00075123395,0.00007369534,0.000059353046,0.00001365288,0.000082149796,0.000043730706,0.000007986036],"category_scores_gemma":[0.001996208,0.000102539656,0.000092377406,0.000104530896,0.00016641182,0.00003414407,0.00006107112,0.00012094707,0.0000049261976],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19525012,0.06814678,0.72627527,0.00011585165,0.0016594635,0.000063992964,0.0037283439,0.00001193284,0.0010420934,0.00021225316,0.000105158724,0.0033887317],"study_design_scores_gemma":[0.8488634,0.001105963,0.14622718,0.00017424744,0.0011747049,0.000003880791,0.00019186903,0.0003210228,0.001496263,0.000004128957,0.00035528617,0.0000820412],"about_ca_topic_score_codex":0.0007657399,"about_ca_topic_score_gemma":0.00016466287,"teacher_disagreement_score":0.6536133,"about_ca_system_score_codex":0.000041712596,"about_ca_system_score_gemma":0.000057741192,"threshold_uncertainty_score":0.41814458},"labels":[],"label_agreement":null},{"id":"W2979762052","doi":"10.1182/blood.v118.21.3715.3715","title":"An Open-Label, Phase I Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with Relapsed/Refractory CD22-Positive B-Cell Non-Hodgkin Lymphoma,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Tolerability; Calicheamicin; Internal medicine; Refractory (planetary science); Regimen; Febrile neutropenia; Gastroenterology; Chemotherapy regimen; Vincristine; Cyclophosphamide; Phases of clinical research; Lymphoma; Chemotherapy; Oncology; Neutropenia; Adverse effect","score_opus":0.01756875012756951,"score_gpt":0.2685898187690278,"score_spread":0.2510210686414583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979762052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545586,0.000039319373,0.0000027678188,0.0000072607436,0.00002774833,0.002727492,0.000022437724,0.000016902928,0.0017001943],"genre_scores_gemma":[0.9990753,0.000008368652,0.00047537155,0.000056831464,0.00000739196,0.00019120424,0.000119515214,0.00004087103,0.000025160785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836284,0.00012659754,0.0004149325,0.00046411963,0.00036977063,0.0002617345],"domain_scores_gemma":[0.9989352,0.000047814578,0.00024721885,0.00048057854,0.00016757206,0.000121587145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015657862,0.00026679374,0.0005433486,0.0002922307,0.000041411164,0.000017374829,0.0001911344,0.000087731336,0.000021186765],"category_scores_gemma":[0.000009967931,0.0001935053,0.000014402666,0.00041232948,0.000054525593,0.00033198923,0.00006148451,0.00009290611,0.000006970455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004240247,0.3285941,0.65818805,0.000023438653,0.00012538517,0.0002775768,0.0050612767,7.614734e-7,0.00024526907,0.000013458912,0.0000061411047,0.0032243298],"study_design_scores_gemma":[0.27114776,0.06702406,0.6515898,0.0002285111,0.00027028244,0.000003878108,0.00086071756,0.00001729486,0.00869793,0.0000051079646,0.0000017161475,0.00015294053],"about_ca_topic_score_codex":0.0035564248,"about_ca_topic_score_gemma":0.00092950417,"teacher_disagreement_score":0.2669075,"about_ca_system_score_codex":0.00025322914,"about_ca_system_score_gemma":0.00020311662,"threshold_uncertainty_score":0.7890917},"labels":[],"label_agreement":null},{"id":"W2979765136","doi":"10.1182/blood.v120.21.2745.2745","title":"Long-Term Remissions Observed in an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; CD30; Oncology; Population; Phases of clinical research; Clinical endpoint; Lymphoma; Surgery; Chemotherapy; Gastroenterology; Clinical trial","score_opus":0.024482869844130693,"score_gpt":0.2785730313743936,"score_spread":0.2540901615302629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979765136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980922,0.0004180887,8.2948594e-7,0.0000036758288,0.0000856356,0.0012967201,0.000026285785,0.000030413608,0.000046194236],"genre_scores_gemma":[0.99958384,0.000015900781,0.00005477778,0.000016179145,0.000036295478,0.00010541491,0.000114671515,0.0000381362,0.00003480673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981508,0.00016024047,0.00054980995,0.00033462857,0.00036355513,0.00044096963],"domain_scores_gemma":[0.99883574,0.00013317991,0.00023087123,0.00047010623,0.000071301925,0.0002588115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019766141,0.00024280169,0.0005546016,0.00022155818,0.00004663521,0.0000105847785,0.00009974872,0.000095164236,0.000034578774],"category_scores_gemma":[0.00007317185,0.00016509584,0.000043344033,0.0003389513,0.000016813903,0.00019313175,0.000047311216,0.000090144444,0.000007674529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001636284,0.20893069,0.78628457,0.00018981924,0.00007402177,0.0002331994,0.0017094582,0.0000013521474,0.00032812392,6.5451235e-7,0.0000048985858,0.00060693483],"study_design_scores_gemma":[0.17741114,0.007529359,0.8119435,0.0009957493,0.00037705657,0.000013563444,0.0006562565,0.000012151758,0.0009146271,9.0926214e-8,0.000002645552,0.0001438787],"about_ca_topic_score_codex":0.000107706306,"about_ca_topic_score_gemma":0.00043022993,"teacher_disagreement_score":0.20140132,"about_ca_system_score_codex":0.0002444104,"about_ca_system_score_gemma":0.00016804399,"threshold_uncertainty_score":0.6732413},"labels":[],"label_agreement":null},{"id":"W2979766708","doi":"10.1182/blood.v126.23.2695.2695","title":"ABVD Chemotherapy Results in Excellent Outcomes with Reduced Radiation Therapy Rates in Children, Adolescents and Young Adults with Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Vinblastine; Cohort; Pediatrics; Population; Radiation therapy; Chemotherapy regimen; Regimen; Internal medicine; Surgery; Chemotherapy; Vincristine","score_opus":0.010607261620675315,"score_gpt":0.24328512799549887,"score_spread":0.23267786637482354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979766708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963592,0.0016002645,5.7561704e-7,0.0006809293,0.000030163697,0.001127888,0.000009765806,0.000033032975,0.00015812629],"genre_scores_gemma":[0.99782753,0.0014203247,0.00020330692,0.00024904206,0.000045303223,0.00010848672,0.000060864622,0.00003154533,0.000053601165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870235,0.00005217208,0.00028044716,0.00041260236,0.0002901271,0.00026227752],"domain_scores_gemma":[0.9993992,0.000021036121,0.00011438933,0.00026680203,0.00005389593,0.00014467281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015130336,0.00025107426,0.00037980723,0.00016003137,0.000024727573,0.00003537012,0.000054776578,0.00007987696,0.0000015633761],"category_scores_gemma":[0.000020671736,0.00015636279,0.000027751666,0.00022993065,0.00004170506,0.00011572634,0.0000110134415,0.000054206237,0.0000033056563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043509924,0.0038444826,0.97094774,0.000013415818,0.0001453789,0.00009092981,0.0019157643,0.0000022750894,0.0000677389,0.0000031080904,0.000041730895,0.018576445],"study_design_scores_gemma":[0.13878028,0.0013529082,0.8495986,0.0004514419,0.000042102303,0.00011279029,0.00016408486,0.000012715029,0.009294259,0.0000051149764,0.00002164945,0.00016409083],"about_ca_topic_score_codex":0.0012020007,"about_ca_topic_score_gemma":0.0003335718,"teacher_disagreement_score":0.13442929,"about_ca_system_score_codex":0.00013452489,"about_ca_system_score_gemma":0.00014351308,"threshold_uncertainty_score":0.637629},"labels":[],"label_agreement":null},{"id":"W2979810607","doi":"10.1182/blood.v128.22.2919.2919","title":"Targeted Sequencing Reveals Novel Gene Mutations Associated with Transformation and Early Progression in Follicular Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; CDKN2A; Medicine; Internal medicine; Progression-free survival; Oncology; Lymphoma; Cancer; Cohort; Pathology; Chemotherapy","score_opus":0.01432218670861094,"score_gpt":0.24345127967833197,"score_spread":0.22912909296972103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979810607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983271,0.00033401788,0.00013557698,0.00044107105,0.00001024785,0.00053139264,0.000019965497,0.000043944165,0.00015670985],"genre_scores_gemma":[0.9985264,0.00004043661,0.0011712284,0.000041771655,0.000013677576,0.00012561685,0.000036431342,0.000012680351,0.00003177464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992826,0.000022873026,0.00019264224,0.00015982837,0.00017728622,0.00016477451],"domain_scores_gemma":[0.999644,0.000052491494,0.00007075296,0.00009538291,0.00006061185,0.000076803175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011075526,0.00010573108,0.00018221674,0.00008574529,0.00005152966,0.000013797886,0.000019377834,0.000066840155,0.0000050706935],"category_scores_gemma":[0.000053591382,0.00005935992,0.000029426716,0.00016391693,0.000027206264,0.00013776372,0.0000052384466,0.000017734665,0.0000030852495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083913,0.0017783885,0.7833204,0.00003288617,0.00027164904,0.00018281183,0.0014400369,0.0000015205972,0.19948965,0.00015959932,0.000005154386,0.013233941],"study_design_scores_gemma":[0.01957707,0.00043002344,0.8638264,0.0007581164,0.00022477203,0.00008004753,0.000044093325,0.00001818524,0.11489383,0.000042935048,0.000013226128,0.00009130716],"about_ca_topic_score_codex":0.00006198957,"about_ca_topic_score_gemma":0.000030309713,"teacher_disagreement_score":0.084595814,"about_ca_system_score_codex":0.0001661744,"about_ca_system_score_gemma":0.000088642,"threshold_uncertainty_score":0.24206273},"labels":[],"label_agreement":null},{"id":"W2979864420","doi":"10.1182/blood.v116.21.111.111","title":"Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (&lt;61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Rituximab; Medicine; Regimen; Internal medicine; CHOP; Clinical endpoint; Chemotherapy regimen; Diffuse large B-cell lymphoma; Surgery; Oncology; Randomized controlled trial; Lymphoma; Chemotherapy","score_opus":0.006993248135219416,"score_gpt":0.24344037576304184,"score_spread":0.2364471276278224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979864420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860692,0.000022143606,0.000031836367,0.000090414294,0.00075678533,0.012670157,0.00025627823,0.000018760335,0.00008439477],"genre_scores_gemma":[0.997891,0.000043174754,0.00024507038,0.000029353158,0.0002570768,0.0011719732,0.00005886463,0.00008091648,0.00022256601],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99713695,0.00017777104,0.0008298906,0.0005429569,0.0009569194,0.00035552573],"domain_scores_gemma":[0.9967738,0.0004000603,0.0011934512,0.0012043667,0.00032856522,0.00009975244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460409,0.0004830739,0.0011622715,0.000104342835,0.00021094226,0.00004783982,0.00052902586,0.00012558862,0.00001970499],"category_scores_gemma":[0.00010787796,0.00018137143,0.00042577554,0.0002843671,0.00029062238,0.000082794664,0.00013522015,0.00014541899,0.0000011551059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5117803,0.11980143,0.36107248,0.000051372328,0.0027280815,0.000014278771,0.0037087935,0.0000013134488,0.00029524477,0.000008183333,0.0000334271,0.00050508045],"study_design_scores_gemma":[0.86563987,0.033196867,0.09095231,0.0003609892,0.0038763678,0.000019137542,0.0007437144,0.00007303943,0.0047062645,0.0000026551547,0.00022853227,0.00020026338],"about_ca_topic_score_codex":0.00096388056,"about_ca_topic_score_gemma":0.005678896,"teacher_disagreement_score":0.35385954,"about_ca_system_score_codex":0.00010647992,"about_ca_system_score_gemma":0.00032673546,"threshold_uncertainty_score":0.7396112},"labels":[],"label_agreement":null},{"id":"W2979874966","doi":"10.1182/blood.v116.21.854.854","title":"FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Stage (stratigraphy); Lymphoma; Radiation therapy; Radiology; Nuclear medicine; Internal medicine","score_opus":0.009785499901045713,"score_gpt":0.2544558754198473,"score_spread":0.2446703755188016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979874966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578875,0.00016171687,0.0000016738568,0.0001489527,0.00014294202,0.0012670167,0.00016097423,0.00008392316,0.0022440192],"genre_scores_gemma":[0.9971944,0.00008127797,0.0012116935,0.00050578883,0.00006416069,0.00023143327,0.00025924988,0.000065661494,0.00038633798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791634,0.00008266097,0.000427634,0.00049708615,0.00055809674,0.0005181829],"domain_scores_gemma":[0.99875975,0.000182453,0.0002332998,0.00052973995,0.00009903199,0.00019573294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018579245,0.0004108553,0.0005850416,0.00021752826,0.00015607158,0.000064676664,0.00012274747,0.000060188824,0.000047233534],"category_scores_gemma":[0.0000601203,0.0002727057,0.00010009795,0.00021803794,0.00007907863,0.00026167894,0.000030189995,0.00014653594,0.000013238866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013375027,0.019337,0.9751644,0.000027357291,0.00033392687,0.0004673097,0.00082307606,0.000017020404,0.00007132766,0.00015282197,0.00007004548,0.002198182],"study_design_scores_gemma":[0.21990058,0.0023209285,0.758621,0.00015935874,0.00021531858,0.000021355489,0.0004972583,0.000010697642,0.01733896,0.00000488657,0.0005581632,0.00035154368],"about_ca_topic_score_codex":0.00034361944,"about_ca_topic_score_gemma":0.00024624675,"teacher_disagreement_score":0.21856308,"about_ca_system_score_codex":0.00017824069,"about_ca_system_score_gemma":0.00021900376,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W2979885356","doi":"10.1182/blood.v110.11.790.790","title":"Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; CHOP; Oncology; Aggressive lymphoma; Chemotherapy; Lymphoplasmacytic Lymphoma; Chemotherapy regimen; Gastroenterology; Waldenstrom macroglobulinemia","score_opus":0.006081263969989547,"score_gpt":0.22558463689789424,"score_spread":0.2195033729279047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979885356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975852,0.000048501657,0.000082348786,0.000079990714,0.000037762013,0.00065511465,0.0001241664,0.000019128003,0.0013678317],"genre_scores_gemma":[0.9985057,0.000024156116,0.0011710183,0.00010297898,0.000037922055,0.000026682279,0.00008864676,0.000019328836,0.000023557875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901044,0.000009079904,0.00028397367,0.00017788702,0.0003256587,0.00019296634],"domain_scores_gemma":[0.9993787,0.000060363538,0.00009644768,0.00019192783,0.0001540421,0.000118550175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009958104,0.00013366887,0.00035326445,0.00009315778,0.000019477904,0.0000030891322,0.000047846323,0.000055253233,0.00006189613],"category_scores_gemma":[0.000014700981,0.00009419393,0.00008016381,0.00018506046,0.000042894342,0.000039941202,0.0000045433735,0.000018456622,0.0000047953267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007233514,0.058411337,0.67626303,0.00040547826,0.0013803382,0.00004590415,0.0017542384,4.3257026e-7,0.04668285,0.0002840795,0.00021004058,0.20732878],"study_design_scores_gemma":[0.030721229,0.0019287003,0.70348567,0.00007901513,0.00019299584,0.0000018192667,0.000076134944,3.2862152e-7,0.26319492,0.00000910863,0.00023626992,0.00007381244],"about_ca_topic_score_codex":0.0000791798,"about_ca_topic_score_gemma":0.000042030486,"teacher_disagreement_score":0.21651205,"about_ca_system_score_codex":0.000043314372,"about_ca_system_score_gemma":0.00007919216,"threshold_uncertainty_score":0.3841117},"labels":[],"label_agreement":null},{"id":"W2979889594","doi":"10.1182/blood.v120.21.303.303","title":"The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"CHOP; Medicine; Lymphoma; Mediastinum; Oncology; Internal medicine; Chemotherapy; Radiology","score_opus":0.022981081287490567,"score_gpt":0.26769107464787917,"score_spread":0.2447099933603886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979889594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042005,0.0063359095,0.0000013995475,0.0010122844,0.00013201663,0.0005181367,0.000021582382,0.000015720188,0.011542884],"genre_scores_gemma":[0.99816734,0.00047370262,0.00014749475,0.000477421,0.00020801226,0.00018009973,0.000021796897,0.0000147735445,0.00030936772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870306,0.000087995744,0.00033146658,0.00014361128,0.0003246334,0.00040921816],"domain_scores_gemma":[0.9988747,0.00045111807,0.00010273398,0.00044451855,0.000027391561,0.0000995082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038160442,0.00017652339,0.00030838564,0.000043307966,0.000097085474,0.00001302566,0.000125368,0.000057295052,0.00002697933],"category_scores_gemma":[0.000043060914,0.00007787763,0.00015868458,0.00013583887,0.000053267293,0.000047073172,0.00003635131,0.000048211794,0.000057331436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008626284,0.024020031,0.9613766,0.000036767502,0.00013984792,0.000085763575,0.0014218412,1.0061075e-7,0.0001554779,0.00054102583,0.00029785177,0.01183845],"study_design_scores_gemma":[0.022841044,0.0005442503,0.9563253,0.000029329203,0.0004914551,0.00012125816,0.00038399492,0.000002248502,0.0043184245,0.000015152811,0.014846863,0.00008067594],"about_ca_topic_score_codex":0.00014029598,"about_ca_topic_score_gemma":0.000054273863,"teacher_disagreement_score":0.023475781,"about_ca_system_score_codex":0.00015810874,"about_ca_system_score_gemma":0.00009798829,"threshold_uncertainty_score":0.31757575},"labels":[],"label_agreement":null},{"id":"W2979896943","doi":"10.1182/blood.v116.21.4130.4130","title":"The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Internal medicine; Lymphoma; Pathology; Gastroenterology; Oncology; Lung cancer","score_opus":0.004334842240175358,"score_gpt":0.2560303503450307,"score_spread":0.2516955081048553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979896943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994845,0.0003652299,0.0000042748766,0.0015885232,0.00041003036,0.000683639,0.000015459023,0.000061816034,0.0020260317],"genre_scores_gemma":[0.9980412,0.00012314126,0.00053016556,0.00031854236,0.00034731516,0.00015472135,0.000034005,0.000026937374,0.000423979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832875,0.00010858112,0.00039781892,0.0004123554,0.00026271722,0.00048979407],"domain_scores_gemma":[0.9983548,0.0006224185,0.00012208853,0.0006020098,0.00005024137,0.00024844665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080515613,0.00019477146,0.00031789942,0.00018681906,0.00014805773,0.000028568642,0.00014096862,0.00016028022,0.000028959805],"category_scores_gemma":[0.0006158571,0.00012891993,0.00010794411,0.00039561174,0.000032970973,0.000033875574,0.00009890855,0.00014921611,0.0001690514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011607468,0.014369776,0.97108865,0.000014209387,0.000074975454,0.0069412272,0.00021743211,3.475631e-7,0.0024691238,0.00014548158,0.001622534,0.0018955128],"study_design_scores_gemma":[0.018851615,0.0014569894,0.9534804,0.0000105235695,0.00034228273,0.0018295773,0.000031659954,0.0000047687254,0.0015433807,0.000014365406,0.022298785,0.00013563313],"about_ca_topic_score_codex":0.00011639006,"about_ca_topic_score_gemma":0.0006813242,"teacher_disagreement_score":0.020676252,"about_ca_system_score_codex":0.00010490524,"about_ca_system_score_gemma":0.00044687916,"threshold_uncertainty_score":0.52572024},"labels":[],"label_agreement":null},{"id":"W2979930904","doi":"10.1182/blood.v118.21.4012.4012","title":"Plasma Levels of Soluble Interleukin-7 Receptor Alpha (sIL-7Ra) and IL-7Ra Polymorphism After Allogeneic Stemcell Transplantation,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Single-nucleotide polymorphism; Transplantation; Biology; Immune system; Immunology; Cytokine; Genotype; Haplotype; Receptor; Internal medicine; Exon; Medicine; Genetics; Gene","score_opus":0.02588114631764317,"score_gpt":0.2250993458063265,"score_spread":0.19921819948868336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979930904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960017,0.0012940607,0.000019415918,0.00015181027,0.00017212504,0.0003458192,0.00014495151,0.000035169003,0.0018349114],"genre_scores_gemma":[0.99659234,0.00044807143,0.0017754153,0.00016744042,0.000064963184,0.00008569724,0.000030312563,0.000027937838,0.0008078011],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891603,0.000033085948,0.0003310712,0.00029833612,0.00018558391,0.00023592054],"domain_scores_gemma":[0.99938107,0.000045454934,0.0000976582,0.0002513621,0.000066689056,0.0001577938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084107,0.00020020982,0.00034253937,0.0000977984,0.00003521227,0.0000096390195,0.00006930576,0.000108455344,0.00059780566],"category_scores_gemma":[0.000007242028,0.00016052397,0.000100465695,0.00008062428,0.00008229105,0.00007686617,0.000023592911,0.00005464353,0.00006196679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019387273,0.007227939,0.9005295,0.0008308132,0.0018665406,0.0009139257,0.011438899,3.0179615e-7,0.05992814,0.00047153496,0.001166521,0.01368714],"study_design_scores_gemma":[0.011240049,0.0011239137,0.4296656,0.0002670327,0.0010477598,0.00026705992,0.00013324046,0.000003815345,0.5549747,0.00003984491,0.0010383083,0.0001986902],"about_ca_topic_score_codex":0.00019025739,"about_ca_topic_score_gemma":0.000075453056,"teacher_disagreement_score":0.49504656,"about_ca_system_score_codex":0.000026146496,"about_ca_system_score_gemma":0.0000713115,"threshold_uncertainty_score":0.65459776},"labels":[],"label_agreement":null},{"id":"W2979931387","doi":"10.1182/blood.v124.21.1659.1659","title":"No Increased Risk of Secondary Neoplasms in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma : A Meta-Analysis of 9 Trials","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; CD20; Clinical trial; Oncology; Hazard ratio; Clinical endpoint; Immunology; Confidence interval","score_opus":0.02316821813579454,"score_gpt":0.2641002941934727,"score_spread":0.24093207605767816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979931387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996983,0.0001761424,0.000020851629,0.000017958195,0.000013953973,0.0011716979,0.00082483364,0.000012974967,0.0007786042],"genre_scores_gemma":[0.99727565,0.000020591106,0.0018336184,0.00006273712,0.00001777752,0.00034625403,0.00036314124,0.000022999679,0.00005723449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795246,0.00026929303,0.0009071093,0.000346067,0.00031274656,0.00021231436],"domain_scores_gemma":[0.99726975,0.001058025,0.00074270554,0.000501747,0.0003161335,0.00011161372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085831265,0.00024976014,0.0031564399,0.00044375457,0.000026879732,0.00000745569,0.000082674,0.000104469626,0.00018688901],"category_scores_gemma":[0.00059979287,0.00015036561,0.0012100294,0.0005468998,0.000048058966,0.000046394503,0.000019762965,0.000033003693,0.000005347895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024433827,0.013925124,0.8159348,0.00010199111,0.165051,0.000006490409,0.0000936318,0.000006489726,0.00011046303,0.000013504095,0.00006645172,0.002246723],"study_design_scores_gemma":[0.06936331,0.0026748853,0.563906,0.000020808877,0.34874362,0.0000010408114,0.000008092029,0.00018018967,0.014913631,0.0000075046814,0.00008103997,0.00009988835],"about_ca_topic_score_codex":0.0032157078,"about_ca_topic_score_gemma":0.00045144485,"teacher_disagreement_score":0.25202876,"about_ca_system_score_codex":0.00004627677,"about_ca_system_score_gemma":0.00013801653,"threshold_uncertainty_score":0.6131731},"labels":[],"label_agreement":null},{"id":"W2979940110","doi":"10.1182/blood.v128.22.613.613","title":"Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Obinutuzumab; Follicular lymphoma; Medicine; Minimal residual disease; Bendamustine; Internal medicine; Rituximab; Oncology; Surrogate endpoint; Hazard ratio; Gastroenterology; Immunology; Lymphoma; Leukemia; Confidence interval","score_opus":0.009680727142649836,"score_gpt":0.2451488242248452,"score_spread":0.23546809708219538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979940110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719286,0.00021870634,0.0000011826437,0.0007037691,0.000011370713,0.0017971531,0.000029117198,0.000022906506,0.000022931406],"genre_scores_gemma":[0.99910265,0.00012043864,0.000065469365,0.00013584034,0.000037322152,0.00038499935,0.000038068403,0.00002792025,0.00008729818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864084,0.00008136942,0.00024897087,0.00040945903,0.00034355398,0.00027579692],"domain_scores_gemma":[0.99927795,0.00007408462,0.00008861065,0.00038620544,0.00007188513,0.00010128418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011379974,0.00025221144,0.00033552508,0.00010628713,0.000066212284,0.00002647124,0.00007821836,0.000047514495,0.000020868358],"category_scores_gemma":[0.00004111751,0.00010095481,0.000028952947,0.00027733133,0.000084079926,0.000113367736,0.000017283877,0.00004344059,0.0000062704567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02233059,0.037402596,0.9341261,0.000019103782,0.00024856147,0.0013513061,0.0007347633,6.296006e-7,0.000035807065,0.0000057125917,0.000023132334,0.0037217329],"study_design_scores_gemma":[0.216388,0.010697748,0.77105725,0.00034877076,0.00031202586,0.00004183655,0.0002550513,0.0000026077919,0.0006762521,0.0000058691894,0.00007658328,0.00013798995],"about_ca_topic_score_codex":0.00055680383,"about_ca_topic_score_gemma":0.00042755576,"teacher_disagreement_score":0.1940574,"about_ca_system_score_codex":0.00023572656,"about_ca_system_score_gemma":0.00020474121,"threshold_uncertainty_score":0.41168177},"labels":[],"label_agreement":null},{"id":"W2979952702","doi":"10.1182/blood.v118.21.2653.2653","title":"An Index of SNPs in Immune Genes May Enhance the Prognostic Value of IPI in Patients with Aggressive Non-Hodgkin's Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Oncology; Medicine; International Prognostic Index; Cohort; Internal medicine; Single-nucleotide polymorphism; Genotyping; Cancer; Immune system; Lymphoma; Blood sampling; Immunology; Genotype; Diffuse large B-cell lymphoma; Biology; Gene; Genetics","score_opus":0.006683805290195919,"score_gpt":0.2280399197516781,"score_spread":0.22135611446148218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979952702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980795,0.0007741312,0.0000023312516,0.000019117271,0.000030677355,0.0007613388,0.00001053716,0.000006279183,0.00031613756],"genre_scores_gemma":[0.99940234,0.00007089485,0.00032586275,0.000023261146,0.000013257235,0.00012580439,0.000014811527,0.00001674926,0.0000069944663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898916,0.00005723194,0.0003301321,0.00020258,0.00023446795,0.00018642697],"domain_scores_gemma":[0.99911606,0.00006360911,0.00029283683,0.00038527898,0.00009636679,0.00004583701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100642435,0.00014504939,0.00034407066,0.00010169855,0.000016446545,0.0000030580777,0.00012659194,0.00006220309,0.000018552933],"category_scores_gemma":[0.0000399525,0.00008394538,0.0000434878,0.00022991281,0.00009807862,0.000058077854,0.000033095697,0.000038335133,0.0000025815298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034030314,0.010289363,0.97785485,0.00005998078,0.00012191268,0.0000780713,0.0015008528,0.000004111357,0.0002727304,0.000037679347,0.000001453256,0.0094387205],"study_design_scores_gemma":[0.010870109,0.0015893696,0.88388854,0.00062063907,0.00014702354,0.000006207217,0.00012546018,0.000015899777,0.10263443,0.000023582106,0.0000021167764,0.000076595235],"about_ca_topic_score_codex":0.0011846469,"about_ca_topic_score_gemma":0.00010319648,"teacher_disagreement_score":0.1023617,"about_ca_system_score_codex":0.000033514712,"about_ca_system_score_gemma":0.00011846566,"threshold_uncertainty_score":0.34231934},"labels":[],"label_agreement":null},{"id":"W2979965207","doi":"10.1182/blood.v114.22.2922.2922","title":"Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Comparative genomic hybridization; Diffuse large B-cell lymphoma; Lymphoblastic lymphoma; Gene expression profiling; Cancer research; Pathology; Germinal center; B cell; Biology; Hematology; Oncology; Medicine; Gene; Immunology; Gene expression; Genetics; T cell; Chromosome; Antibody","score_opus":0.007971965767967668,"score_gpt":0.23806919359847328,"score_spread":0.23009722783050562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979965207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920384,0.0023596429,0.0000131489205,0.00049192295,0.000108937755,0.00052153127,0.000024859746,0.000064391,0.0043771164],"genre_scores_gemma":[0.99465805,0.00051015854,0.0032895545,0.00047855388,0.00052273856,0.00012991767,0.00010697139,0.00002215042,0.00028187636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850965,0.000038074053,0.00037426926,0.00041736613,0.00028603402,0.00037463827],"domain_scores_gemma":[0.99906343,0.00007817258,0.00017462729,0.00041253187,0.000062940904,0.00020828778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061639854,0.00025293446,0.00036903023,0.00021228268,0.00010316975,0.000035561206,0.0001018883,0.00013299989,0.00011468305],"category_scores_gemma":[0.00005726596,0.0002054346,0.00013427355,0.000333667,0.000018825263,0.00009666858,0.000034841472,0.000070036294,0.00015655397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046287014,0.054754116,0.7611501,0.00014827398,0.0001608291,0.010470127,0.0017309582,0.000052457264,0.14892499,0.00018063503,0.008502136,0.013462498],"study_design_scores_gemma":[0.02663311,0.0011265953,0.5709821,0.00015039963,0.00037769263,0.0002674679,0.000033239663,0.00005118459,0.3998386,0.00009184967,0.00017003575,0.00027775866],"about_ca_topic_score_codex":0.000045719262,"about_ca_topic_score_gemma":0.000006731298,"teacher_disagreement_score":0.2509136,"about_ca_system_score_codex":0.0001018181,"about_ca_system_score_gemma":0.0002370583,"threshold_uncertainty_score":0.837738},"labels":[],"label_agreement":null},{"id":"W2979994330","doi":"10.1182/blood.v128.22.1093.1093","title":"A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Oncology; Internal medicine; Transplantation; ABVD; Concordance; Chemotherapy regimen; Chemotherapy; Vincristine","score_opus":0.011777306645267549,"score_gpt":0.22417088622470108,"score_spread":0.21239357957943353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979994330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955792,0.00011812185,0.00029631495,0.0026311222,0.00005994323,0.0008524225,0.00023860595,0.000047916044,0.0001763458],"genre_scores_gemma":[0.99745286,0.00008150877,0.0010366541,0.0009006145,0.000015121479,0.00034576957,0.000056236302,0.000026463274,0.000084797386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849457,0.00007377495,0.00040305426,0.00046934816,0.00018353217,0.00037574803],"domain_scores_gemma":[0.99914247,0.0003743091,0.00009090809,0.00026275753,0.000015654354,0.00011393107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011039742,0.00026379336,0.00045301623,0.00024201062,0.000025730127,0.0000073388665,0.00008111645,0.00014478771,0.000007738506],"category_scores_gemma":[0.000031031548,0.00016272276,0.00009845304,0.00009692494,0.00008983469,0.000042053845,0.000017771486,0.000059497797,0.000037610178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074794475,0.015491865,0.9176808,0.00010421584,0.000055942903,0.00085849484,0.00019615091,0.00017860465,0.059477016,0.00009705382,0.000012782178,0.0050991443],"study_design_scores_gemma":[0.03662371,0.0017626372,0.92074406,0.00040572503,0.00021958626,0.000058992842,0.000033032826,0.0021568155,0.037761044,0.000025436604,0.00001801134,0.00019097084],"about_ca_topic_score_codex":0.000037705016,"about_ca_topic_score_gemma":0.00005482748,"teacher_disagreement_score":0.035875767,"about_ca_system_score_codex":0.00025809248,"about_ca_system_score_gemma":0.00015314689,"threshold_uncertainty_score":0.66356415},"labels":[],"label_agreement":null},{"id":"W2980004091","doi":"10.1182/blood.v122.21.155.155","title":"A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Saskatoon Medical Imaging; Université de Montréal; Dalhousie University; CancerCare Manitoba; Health Sciences Centre; University of Manitoba; Juravinski Cancer Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Juravinski Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Rituximab; Hazard ratio; Clinical endpoint; Salvage therapy; Surgery; Transplantation; Oncology; Regimen; Randomized controlled trial; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.027161036740339522,"score_gpt":0.25792133454448146,"score_spread":0.23076029780414195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980004091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308664,0.0003935635,0.00018055612,0.00017420798,0.00026585485,0.004880995,0.00017593271,0.00004621794,0.00079600746],"genre_scores_gemma":[0.9945003,0.00021264506,0.0030685074,0.0000633262,0.00009108219,0.0008705678,0.0004124001,0.00003190071,0.00074928586],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99763566,0.0002364788,0.0010917813,0.00038031262,0.00038281968,0.0002729279],"domain_scores_gemma":[0.99695724,0.0017277515,0.0006824353,0.00030710318,0.00022885234,0.00009662748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578193,0.00026542268,0.0012388078,0.00013853413,0.00007438477,0.000014993235,0.00009098219,0.00022232116,0.0000131973675],"category_scores_gemma":[0.00015765769,0.00019241637,0.0005824994,0.00015054867,0.00006095916,0.00017251309,0.000011345411,0.000056458444,0.000010276541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96791303,0.014381494,0.0004296156,0.00066684216,0.0006056195,0.00009549491,0.002057826,0.0000045428906,0.008905687,0.000023123686,0.0002657588,0.004650934],"study_design_scores_gemma":[0.8113674,0.0040751905,0.00775732,0.0003143779,0.00320892,0.000016729242,0.0001331471,0.00017487432,0.17273222,0.000030439001,0.000041583517,0.00014778828],"about_ca_topic_score_codex":0.00050736766,"about_ca_topic_score_gemma":0.000021992395,"teacher_disagreement_score":0.16382654,"about_ca_system_score_codex":0.0001142594,"about_ca_system_score_gemma":0.0003614189,"threshold_uncertainty_score":0.78465116},"labels":[],"label_agreement":null},{"id":"W2980025644","doi":"10.1182/blood.v120.21.295.295","title":"Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; SNP array; Population; Lymphoma; Biology; Vincristine; CHOP; CDKN2A; Internal medicine; Cancer research; Cancer; Medicine; Cyclophosphamide; Immunology; Genetics; Single-nucleotide polymorphism; Gene; Chemotherapy","score_opus":0.019773345774014885,"score_gpt":0.2749280046682969,"score_spread":0.255154658894282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980025644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996613,0.0010925314,0.0017038364,0.00011543871,0.000026126056,0.00035728936,0.0000124519765,0.000011067531,0.000068246634],"genre_scores_gemma":[0.98567593,0.00011365894,0.013988677,0.000024236131,0.000030782376,0.00007295293,0.0000683971,0.00000888012,0.000016484708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992585,0.00005318254,0.00027314035,0.00014047565,0.00012716392,0.00014749958],"domain_scores_gemma":[0.99966764,0.000046502497,0.000090286834,0.000104024366,0.000029775938,0.00006178833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018641641,0.00009607811,0.00021413638,0.00007824163,0.000035914603,0.000006361035,0.0000128517395,0.00007976763,0.000009816076],"category_scores_gemma":[0.00002516525,0.00007029601,0.000016003281,0.000099396224,0.00002548265,0.00013111994,0.000018045632,0.00005490921,0.0000018067934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056558623,0.0012313611,0.9759448,0.000045146873,0.0000118753815,0.0000052985188,0.00091507984,0.000013646331,0.021060988,0.00017657755,0.000010279828,0.0005283405],"study_design_scores_gemma":[0.0067462963,0.00012243143,0.9473122,0.00036645462,0.00008845482,0.000050533865,0.0002456064,0.00056212815,0.044386536,0.00004429338,0.000007336608,0.00006776442],"about_ca_topic_score_codex":0.00028089917,"about_ca_topic_score_gemma":0.0002160467,"teacher_disagreement_score":0.028632682,"about_ca_system_score_codex":0.00007090963,"about_ca_system_score_gemma":0.0000146596,"threshold_uncertainty_score":0.2866588},"labels":[],"label_agreement":null},{"id":"W2980035451","doi":"10.1182/blood.v114.22.619.619","title":"ABC and GCB DLBCLs Display Unique Biologically Distinct and Clinically Relevant Epigenetic Signatures.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Epigenetics; DNA methylation; Diffuse large B-cell lymphoma; Gene expression profiling; Germinal center; Biology; Cancer research; DNA microarray; Gene; Lymphoma; Gene expression; Oncology; Genetics; B cell; Medicine; Immunology","score_opus":0.011648649584348697,"score_gpt":0.2732922411509418,"score_spread":0.2616435915665931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980035451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909066,0.004723589,0.000018476769,0.0022382082,0.000029590612,0.00036878965,0.000016096881,0.000052335326,0.0016463023],"genre_scores_gemma":[0.9943761,0.0025205559,0.0016481738,0.0011970486,0.00008907651,0.000018758945,0.000026740177,0.000009085725,0.00011444288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989531,0.000049811744,0.00029858522,0.0003721948,0.00010158426,0.00022470641],"domain_scores_gemma":[0.9991666,0.00026034206,0.00007139155,0.00022691545,0.000037209345,0.00023753778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001594424,0.00017988718,0.00034349188,0.00003233197,0.00007385456,0.000025651343,0.000049340677,0.00016481579,0.000022417811],"category_scores_gemma":[0.00022797444,0.00011117054,0.000065302294,0.00006305421,0.00010803898,0.00002003466,0.0000374826,0.00011597958,0.000008803411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003159366,0.004871311,0.9082961,0.000055192955,0.0002549513,0.00091478013,0.000120729965,4.185479e-7,0.008564105,0.0022363153,0.00039523965,0.073974885],"study_design_scores_gemma":[0.004931996,0.0028095143,0.9870451,0.00010739864,0.0003396242,0.00013458959,0.0000069885577,0.000011395155,0.001530321,0.001149457,0.0017910255,0.00014258598],"about_ca_topic_score_codex":0.000012253054,"about_ca_topic_score_gemma":0.00000718011,"teacher_disagreement_score":0.07874897,"about_ca_system_score_codex":0.000014144609,"about_ca_system_score_gemma":0.0000423168,"threshold_uncertainty_score":0.45334032},"labels":[],"label_agreement":null},{"id":"W2980054153","doi":"10.1182/blood.v120.21.1633.1633","title":"An Open-Label, Phase 1 Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with CD22-Positive B-Cell Non-Hodgkin's Lymphoma: Preliminary Safety and Efficacy Data","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Calicheamicin; Internal medicine; Adverse effect; Rituximab; Gastroenterology; Refractory (planetary science); Lymphoma; Neutropenia; Regimen; Vincristine; Febrile neutropenia; Cyclophosphamide; Toxicity; Chemotherapy","score_opus":0.019772973559272888,"score_gpt":0.298823900790615,"score_spread":0.2790509272313421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980054153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642235,0.00014438297,0.000004367721,0.000024811861,0.0000194971,0.0030347486,0.000091616654,0.000010978474,0.00024723142],"genre_scores_gemma":[0.9986663,0.00002072493,0.00044348618,0.00003630789,0.000012868821,0.00006217403,0.0007208026,0.000029558892,0.00000780687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985257,0.0001196497,0.00034362005,0.00043901065,0.0003032303,0.0002687897],"domain_scores_gemma":[0.9988082,0.00010621164,0.00017510394,0.00068746746,0.00008212287,0.00014086453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023678715,0.00022856277,0.00048611045,0.00016688908,0.000050272247,0.000021787826,0.00021875864,0.00006144102,0.000004521057],"category_scores_gemma":[0.000016556733,0.00016365938,0.0000059758518,0.0003035454,0.00005337902,0.00056441856,0.0002247508,0.000066339875,0.000001765531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007969226,0.29822522,0.68322736,0.00003459571,0.00012003358,0.00007208306,0.0023938736,0.0000016744307,0.00006292779,0.0000069593,0.0000069215416,0.007879156],"study_design_scores_gemma":[0.27769783,0.03894245,0.6809347,0.00021895669,0.00042106153,0.000009185393,0.0005376716,0.00008168335,0.0010233112,5.0540905e-7,0.0000037735715,0.00012884276],"about_ca_topic_score_codex":0.00091840985,"about_ca_topic_score_gemma":0.00016452282,"teacher_disagreement_score":0.2697286,"about_ca_system_score_codex":0.00012937492,"about_ca_system_score_gemma":0.000108748754,"threshold_uncertainty_score":0.66738355},"labels":[],"label_agreement":null},{"id":"W2980105847","doi":"10.1182/blood.v104.11.914.914","title":"High Dose Therapy / ASCT with Rituximab for In-Vivo Purging and Post-ASCT Consolidation in Relapsed Follicular Lymphoma Achieves Prolonged Clinical and Molecular Remissions.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Autologous stem-cell transplantation; Surgery; Internal medicine; Regimen; Cyclophosphamide; Salvage therapy; Median follow-up; Minimal residual disease; Transplantation; Oncology; Lymphoma; Gastroenterology; Chemotherapy; Bone marrow","score_opus":0.012657508223058085,"score_gpt":0.2777905432569917,"score_spread":0.2651330350339336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980105847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929133,0.0030216377,0.00001201609,0.0025205833,0.000024527182,0.0014318844,0.000010111163,0.00002892979,0.00003702737],"genre_scores_gemma":[0.9948979,0.0008447457,0.0034289772,0.00048956554,0.000029799457,0.00024357784,0.000028087847,0.000025900606,0.000011428402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987811,0.000069873626,0.00035086938,0.0004143766,0.00015493292,0.0002288861],"domain_scores_gemma":[0.99936205,0.00013594922,0.000088641376,0.00022424448,0.00005510902,0.00013397491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915048,0.00019212397,0.00044778344,0.000101286896,0.000059831003,0.000029215864,0.000038688504,0.00013971094,0.000004034238],"category_scores_gemma":[0.00013234552,0.00013601578,0.00006280959,0.0001379224,0.000091684735,0.0000641563,0.000021644813,0.00007121416,8.4318435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038976853,0.013351625,0.9384566,0.00012046587,0.0005260071,0.0017006571,0.00060995115,0.000011699826,0.01783569,0.0010555558,0.000018330502,0.022415763],"study_design_scores_gemma":[0.1889767,0.0025578768,0.753778,0.0005266567,0.00027944124,0.0002913113,0.00010489119,0.000026404063,0.0526158,0.00041918637,0.00020249675,0.00022125187],"about_ca_topic_score_codex":0.00012519593,"about_ca_topic_score_gemma":0.000042805492,"teacher_disagreement_score":0.18507902,"about_ca_system_score_codex":0.0000477328,"about_ca_system_score_gemma":0.00019041992,"threshold_uncertainty_score":0.55465627},"labels":[],"label_agreement":null},{"id":"W2980121220","doi":"10.1182/blood.v122.21.4237.4237","title":"Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Vinblastine; Dacarbazine; Chemotherapy regimen; Chemotherapy; Internal medicine; Hodgkin's lymphoma; Bleomycin; Cancer; Lymphoma; Surgery; Performance status; Oncology; Vincristine; Cyclophosphamide","score_opus":0.018888842947638068,"score_gpt":0.3124675849527905,"score_spread":0.29357874200515244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980121220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851835,0.00001649332,0.0000014574784,0.00029889992,0.000021522133,0.0008629362,0.000074826676,0.000009862606,0.00019567831],"genre_scores_gemma":[0.99905896,0.000032860495,0.00036067842,0.00030340388,0.000017403165,0.00013900326,0.000060016646,0.000015652777,0.000012004899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989304,0.000050802308,0.00043443282,0.00020608492,0.00024602946,0.0001322347],"domain_scores_gemma":[0.9990001,0.0003180625,0.00017639123,0.00025181388,0.00014781531,0.00010584915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005591071,0.00015084018,0.00053523644,0.00009920381,0.000008511896,0.000005758936,0.000053805496,0.00006494256,0.00032542818],"category_scores_gemma":[0.00012230837,0.00008973152,0.00015965424,0.00012273678,0.000029586787,0.00005861704,0.000015362994,0.000029356135,0.00007645988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041349677,0.01789164,0.9657734,0.0000044463736,0.00057600136,0.0000037236255,0.00022663559,0.000002034193,0.000038655802,0.0000033045717,0.00016632587,0.01490036],"study_design_scores_gemma":[0.02256425,0.00800364,0.96407837,0.0001900739,0.000113588765,2.3257753e-7,0.000011766868,0.000004991281,0.004930453,0.000014434825,0.000006951762,0.000081233586],"about_ca_topic_score_codex":0.0013930226,"about_ca_topic_score_gemma":0.000018453746,"teacher_disagreement_score":0.022150751,"about_ca_system_score_codex":0.000092249735,"about_ca_system_score_gemma":0.000064588894,"threshold_uncertainty_score":0.3659145},"labels":[],"label_agreement":null},{"id":"W2980125828","doi":"10.1182/blood.v128.22.615.615","title":"Obinutuzumab plus Bendamustine Followed by Obinutuzumab Maintenance Prolongs Overall Survival Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Updated Results of the GADOLIN Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Obinutuzumab; Bendamustine; Rituximab; Internal medicine; Neutropenia; Refractory (planetary science); Clinical endpoint; Adverse effect; Surgery; Gastroenterology; Oncology; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.006972763046238773,"score_gpt":0.21212413540489797,"score_spread":0.20515137235865918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980125828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944512,0.00010658807,0.000009946201,0.00028351624,0.00016441765,0.003910811,0.00071975973,0.0000766627,0.000277057],"genre_scores_gemma":[0.9984561,0.000020013109,0.00025497022,0.00010365462,0.000060593884,0.0002961709,0.00034392404,0.00009096052,0.00037360968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995653,0.00022330286,0.001080596,0.0010040948,0.0012279098,0.00081110524],"domain_scores_gemma":[0.9970916,0.00018802559,0.00075133104,0.0012306849,0.00047937265,0.00025901623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036354392,0.0006894533,0.0014079708,0.00018200731,0.0001238807,0.000027576887,0.00040515722,0.00016231663,0.000031828513],"category_scores_gemma":[0.00013074832,0.0003367304,0.00015285402,0.0006013186,0.00026001807,0.0001799255,0.0002055718,0.00019359271,0.000014384986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036603566,0.03506719,0.9205802,0.00009783667,0.0012423041,0.0003778435,0.0013779356,0.00003619223,0.00066003075,0.000008737378,0.002789407,0.0011587578],"study_design_scores_gemma":[0.31012514,0.006036755,0.6780007,0.0009293768,0.0006633073,0.000022082526,0.00016242814,0.000026385476,0.0033219429,0.0000022166776,0.00035464563,0.00035503588],"about_ca_topic_score_codex":0.0027916457,"about_ca_topic_score_gemma":0.0014631688,"teacher_disagreement_score":0.27352157,"about_ca_system_score_codex":0.001775711,"about_ca_system_score_gemma":0.0011548619,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W2980136449","doi":"10.1093/hmg/ddz228","title":"Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways","year":2019,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; Division of Cancer Epidemiology and Genetics, National Cancer Institute; University of Texas MD Anderson Cancer Center; Memorial Sloan-Kettering Cancer Center; World Health Organization","keywords":"Genome-wide association study; Linkage disequilibrium; Single-nucleotide polymorphism; Biology; Locus (genetics); Genetics; Diffuse large B-cell lymphoma; Genetic association; SNP; Minor allele frequency; Genotyping; Allele; Genotype; Gene","score_opus":0.008661873852050824,"score_gpt":0.21032290078591157,"score_spread":0.20166102693386073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980136449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456626,0.0041613504,0.00001751017,0.00002410238,0.000018788318,0.0005776407,0.00017921338,0.000030851592,0.0004242982],"genre_scores_gemma":[0.9985191,0.0008067365,0.00020694654,0.00011747522,0.000008849293,0.000023674611,0.00012033698,0.000054822813,0.0001420326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.000077375895,0.0002842419,0.00038904717,0.00024353295,0.00030329358],"domain_scores_gemma":[0.9989004,0.00003905021,0.00029006932,0.00050669623,0.00010456756,0.0001591749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010236531,0.00025382207,0.0004726309,0.00007093716,0.00010143898,0.000023093007,0.0000667018,0.00013789374,0.00002521857],"category_scores_gemma":[0.000019995643,0.0002050942,0.00007272779,0.00011555959,0.00007741391,0.000017452374,0.00015605286,0.000058302714,0.000010582682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011287615,0.0032282458,0.7619633,0.000106596606,0.00049668795,0.00024431205,0.00037330092,0.0000025073346,0.23272634,0.000102315855,0.000035033598,0.00060845044],"study_design_scores_gemma":[0.023181396,0.00088841637,0.9286243,0.00014735387,0.0005279024,0.000039130708,0.00006371856,0.000165113,0.04593053,0.00006975973,0.00015736694,0.0002050507],"about_ca_topic_score_codex":0.00005772295,"about_ca_topic_score_gemma":0.00004172201,"teacher_disagreement_score":0.18679582,"about_ca_system_score_codex":0.00009235949,"about_ca_system_score_gemma":0.000035412355,"threshold_uncertainty_score":0.83634984},"labels":[],"label_agreement":null},{"id":"W2980165771","doi":"10.1182/blood.v128.22.470.470","title":"Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Health Services","funders":"","keywords":"Medicine; Obinutuzumab; Rituximab; Internal medicine; Diffuse large B-cell lymphoma; CHOP; International Prognostic Index; Febrile neutropenia; Neutropenia; Gastroenterology; Oncology; Lymphoma; Surgery; Chemotherapy","score_opus":0.02549305422727246,"score_gpt":0.29496860662074637,"score_spread":0.2694755523934739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980165771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913935,0.00022765808,0.000004458297,0.00012782446,0.00007447195,0.006850368,0.0008164085,0.000105560415,0.00039973375],"genre_scores_gemma":[0.9967791,0.00010955004,0.0003700774,0.00017560521,0.00007331568,0.0008846337,0.0005802666,0.00007243757,0.00095501606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99642956,0.0004408374,0.00087204564,0.0010218818,0.00059167494,0.0006440001],"domain_scores_gemma":[0.9974674,0.0005606242,0.000343669,0.0010691537,0.0001799609,0.0003791969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044829224,0.000528893,0.001700463,0.00016021304,0.00013261446,0.000109220804,0.00036331607,0.00013968197,0.00012224048],"category_scores_gemma":[0.00033789742,0.00026196946,0.000072203584,0.00031457984,0.00008511246,0.00033830875,0.00019330303,0.00007642758,0.00010115583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49437663,0.43510938,0.06299225,0.000017591174,0.00077310426,0.00139793,0.0013353574,1.1436643e-7,0.00003559826,0.000004798715,0.00020915103,0.0037481014],"study_design_scores_gemma":[0.9168309,0.013931449,0.065336436,0.00044534562,0.0020502592,0.00001012125,0.00011873985,0.000036925867,0.0006942724,0.0000074538207,0.00016885284,0.00036925275],"about_ca_topic_score_codex":0.0022540884,"about_ca_topic_score_gemma":0.0009377571,"teacher_disagreement_score":0.42245427,"about_ca_system_score_codex":0.0006894304,"about_ca_system_score_gemma":0.00073225115,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2980169763","doi":"10.1182/blood.v104.11.1375.1375","title":"Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.","year":2004,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Follicular phase; Radiation therapy; Gastroenterology; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Surgery","score_opus":0.020217842109453644,"score_gpt":0.2966447442041029,"score_spread":0.27642690209464926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980169763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042101517,0.9930986,0.000031982592,0.00015232965,0.00008343361,0.004908932,0.00013565623,0.00018610022,0.0009819295],"genre_scores_gemma":[0.0006812544,0.9950756,0.0014950061,0.000362454,0.00018993202,0.0012531775,0.0005284022,0.00020802426,0.0002061399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536425,0.00021613852,0.0012642109,0.0014891488,0.00088765495,0.0007786161],"domain_scores_gemma":[0.99715364,0.00010702007,0.0007178602,0.0012254626,0.00019817565,0.00059784006],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00028342573,0.0014056421,0.0069257496,0.00023091323,0.0002005449,0.000094288196,0.00026023024,0.00058770075,0.000109450375],"category_scores_gemma":[0.00007581605,0.00091482664,0.0012425976,0.0007948913,0.00024331262,0.00010027931,0.00012516479,0.00020331799,0.00012909019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016542558,0.014513883,0.005084121,0.20727195,0.015086435,0.008204408,0.00012613075,2.9668826e-7,6.928864e-7,0.0008731719,0.0010874075,0.7475861],"study_design_scores_gemma":[0.024808196,0.0013688287,0.0012665237,0.15028867,0.067526676,0.0066367425,0.000011025843,9.925852e-7,0.000022232385,0.000022874672,0.74708945,0.0009577556],"about_ca_topic_score_codex":0.00022334387,"about_ca_topic_score_gemma":0.000022765349,"teacher_disagreement_score":0.74662834,"about_ca_system_score_codex":0.001073872,"about_ca_system_score_gemma":0.0014900713,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W2980185927","doi":"10.1182/blood.v120.21.1531.1531","title":"The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Medicine; Internal medicine; Classical Hodgkin lymphoma; Oncology; Hodgkin lymphoma; Follicular lymphoma; Biology","score_opus":0.0195261788529377,"score_gpt":0.28718714716581983,"score_spread":0.2676609683128821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980185927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354076,0.0023890764,0.0001824887,0.00112477,0.00031662956,0.0014232566,0.00017326375,0.00016620615,0.0006835671],"genre_scores_gemma":[0.99369025,0.00016169965,0.0034415564,0.0005223423,0.00023612153,0.00048663115,0.00010000093,0.000085705644,0.0012757154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953176,0.0002665249,0.0013257221,0.0007552184,0.0010816467,0.0012532937],"domain_scores_gemma":[0.9958697,0.00064484414,0.000546019,0.0017893619,0.00026241242,0.0008876516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000784877,0.00067110057,0.0019232479,0.000371952,0.00031612947,0.00007592205,0.00047972173,0.00023746294,0.00013546033],"category_scores_gemma":[0.00030900692,0.00044287555,0.0010672475,0.001377965,0.00023693386,0.00018073084,0.00029608945,0.00007581545,0.00018976767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018869012,0.011276593,0.94352615,0.00016422794,0.006655854,0.00025691613,0.0012591385,0.000098456345,0.004067018,0.0007404552,0.00053430063,0.029533988],"study_design_scores_gemma":[0.029799147,0.0007553415,0.8765064,0.00012341003,0.0073253997,0.00010843962,0.0009948526,0.00036127173,0.057776153,0.000016113509,0.025663255,0.0005702346],"about_ca_topic_score_codex":0.00034534401,"about_ca_topic_score_gemma":0.00013057374,"teacher_disagreement_score":0.06701977,"about_ca_system_score_codex":0.00068921794,"about_ca_system_score_gemma":0.00029066842,"threshold_uncertainty_score":0.9998023},"labels":[],"label_agreement":null},{"id":"W2980200289","doi":"10.1182/blood.v116.21.1803.1803","title":"Front-Line Therapy with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) Followed by 2 Years of Rituximab Maintenance for Follicular Lymphoma (FL) Is Associated with Excellent Outcomes and Improved Progression-Free Survival (PFS) In Comparison to No Maintenance","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Maintenance therapy; Population; Follicular lymphoma; Vincristine; Internal medicine; Hazard ratio; Surgery; Interim analysis; Chemotherapy regimen; Prednisone; Cyclophosphamide; Oncology; Cancer; Chemotherapy; Randomized controlled trial; Confidence interval; Lymphoma","score_opus":0.007413235680799319,"score_gpt":0.2505795066936167,"score_spread":0.2431662710128174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980200289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934885,0.0020989035,0.00009647508,0.0010488927,0.00010294038,0.002689704,0.00034290476,0.00005556119,0.000076104785],"genre_scores_gemma":[0.9880311,0.00034964588,0.010091428,0.00031182825,0.00003271906,0.0006406861,0.00008427392,0.00007268174,0.00038565966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976416,0.000042647152,0.0005693254,0.00071129284,0.00046197258,0.0005731298],"domain_scores_gemma":[0.9982072,0.0002742833,0.00033946903,0.0005978452,0.00030306383,0.0002781217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034754715,0.0004415485,0.0013181469,0.00009593835,0.00008417953,0.00004131675,0.00018208177,0.0001802979,0.000015619584],"category_scores_gemma":[0.0003354509,0.00029391897,0.00010663132,0.00019375682,0.00017590118,0.000080595644,0.0000934248,0.00013064008,0.0000025575812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005248997,0.016211152,0.9595558,0.00012424875,0.00093354454,0.00013981965,0.00054259633,4.766303e-7,0.0059815957,0.000030841973,0.0022920978,0.008938844],"study_design_scores_gemma":[0.20085032,0.0057509546,0.773732,0.00083096867,0.00050313753,0.000039014547,0.00016454325,0.0005070318,0.014999446,0.000035606667,0.0020699697,0.00051702035],"about_ca_topic_score_codex":0.0006935954,"about_ca_topic_score_gemma":0.0010230672,"teacher_disagreement_score":0.19560133,"about_ca_system_score_codex":0.00008489702,"about_ca_system_score_gemma":0.00014053257,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2980223642","doi":"10.1182/blood.v126.23.817.817","title":"Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture Molecular and Biologic Heterogeneity and Inform Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"breakpoint cluster region; Biology; Cancer research; Germinal center; Diffuse large B-cell lymphoma; B-cell receptor; B cell; Lymphoma; Somatic cell; Immunology; Genetics; Gene; Antibody","score_opus":0.022665537814345185,"score_gpt":0.23796284176925872,"score_spread":0.21529730395491353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980223642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837323,0.014812837,0.000015057236,0.00013644186,0.000029317893,0.00043133763,0.000036563248,0.000052125266,0.00075403595],"genre_scores_gemma":[0.99743515,0.0011289723,0.00034124454,0.0009405535,0.000017517426,0.000057115787,0.00004970274,0.000016267557,0.000013445854],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915665,0.000021905124,0.00015940919,0.0002548233,0.00015457522,0.00025264866],"domain_scores_gemma":[0.9993386,0.000017134354,0.000060339764,0.00023940485,0.00006115085,0.00028332046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054006498,0.00020394879,0.00026904483,0.000047771624,0.000053023665,0.000029118391,0.00003951232,0.00012327508,0.0000020746334],"category_scores_gemma":[0.000009719965,0.00013566302,0.000060482907,0.000060562197,0.000052711413,0.00007495431,0.000069954694,0.000034285917,0.0000044428284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011261788,0.06885013,0.81406707,0.00020097094,0.001819021,0.0018793956,0.008877631,0.000010246094,0.0645238,0.00116573,0.0004278831,0.037051927],"study_design_scores_gemma":[0.2589666,0.006084095,0.08051478,0.00010151448,0.00079321815,0.0007344335,0.0012834249,0.0006449674,0.6431057,0.001352206,0.005526608,0.0008924877],"about_ca_topic_score_codex":0.00008933937,"about_ca_topic_score_gemma":0.000012551264,"teacher_disagreement_score":0.7335523,"about_ca_system_score_codex":0.000027350781,"about_ca_system_score_gemma":0.000043653996,"threshold_uncertainty_score":0.5532177},"labels":[],"label_agreement":null},{"id":"W2980241767","doi":"10.1182/blood.v116.21.687.687","title":"Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Follicular lymphoma; Rituximab; Autologous stem-cell transplantation; Internal medicine; International Prognostic Index; Transplantation; Oncology; Surgery; Lymphoma; Chemotherapy; Chemotherapy regimen; Gastroenterology","score_opus":0.01665442135254028,"score_gpt":0.26566532709463186,"score_spread":0.2490109057420916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980241767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937343,0.0013161299,0.00017925145,0.00083188474,0.0003256356,0.0028930707,0.00051931833,0.000114093215,0.00008629458],"genre_scores_gemma":[0.9947249,0.0013744698,0.0017218122,0.00027165355,0.00013094359,0.0012376679,0.0002668697,0.00004984968,0.00022182288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978176,0.000072737625,0.0006025624,0.00077379635,0.00035250638,0.00038081795],"domain_scores_gemma":[0.9985719,0.0002940695,0.0002808155,0.00038206895,0.00018446056,0.0002867221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017605622,0.00047074468,0.0006796773,0.00013809581,0.00019497306,0.000090747,0.00010253865,0.0003085655,0.000029040697],"category_scores_gemma":[0.00006207812,0.00032471368,0.00018788362,0.000111746,0.00012366039,0.00019801919,0.000033977,0.00007860723,0.0000030210772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038491688,0.013815847,0.86686116,0.00046051445,0.0017735661,0.0005941546,0.0027114314,9.432252e-7,0.0053938436,0.00011297965,0.000065126194,0.10436129],"study_design_scores_gemma":[0.10854929,0.005871203,0.84634435,0.00017454106,0.0029087923,0.0007313183,0.000278878,0.0012671603,0.03018844,0.000103520535,0.003110802,0.00047170874],"about_ca_topic_score_codex":0.00022275573,"about_ca_topic_score_gemma":0.00021336885,"teacher_disagreement_score":0.10470012,"about_ca_system_score_codex":0.00023105872,"about_ca_system_score_gemma":0.0003308928,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2980250637","doi":"10.1182/blood.v120.21.682.682","title":"Tumor-Associated Macrophages Predict Outcome in Follicular Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Oncology; CD163; Cancer; Vincristine; Cyclophosphamide; CD68; Prednisone; Pathology; Immunology; Gastroenterology; Chemotherapy; Immunohistochemistry; Phenotype; Biology","score_opus":0.0157364697953283,"score_gpt":0.26271878795040415,"score_spread":0.24698231815507585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980250637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993755,0.0028623168,6.1767696e-7,0.00020648535,0.00013930805,0.00033192773,0.000017990935,0.00008467999,0.0026016769],"genre_scores_gemma":[0.9987608,0.000046868307,0.00014056222,0.0004385961,0.0001312669,0.00009602741,0.00003561701,0.000023873152,0.00032639506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988188,0.00004107293,0.00027831158,0.0001796768,0.00024600388,0.00043611226],"domain_scores_gemma":[0.9994078,0.00005428228,0.00006786676,0.00024603622,0.00002623768,0.00019777463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017869359,0.0001663042,0.00034555217,0.00008692901,0.000037765436,0.000012387176,0.00005775538,0.000077243145,0.00009955194],"category_scores_gemma":[0.00011777859,0.00012848512,0.00013095792,0.00019294886,0.000023145942,0.00007619646,0.000037742404,0.000043816985,0.00017233177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018189674,0.0067808935,0.9906101,0.000022996477,0.00020052305,0.0005635077,0.0001245083,2.3789997e-7,0.00025869918,0.00008568667,0.00026780408,0.0010668115],"study_design_scores_gemma":[0.013869875,0.00017675868,0.9740409,0.00007150726,0.00037900044,0.000135812,0.000037931608,0.000005954733,0.010079074,0.00001317127,0.0010736029,0.000116382165],"about_ca_topic_score_codex":0.00016914024,"about_ca_topic_score_gemma":0.0000131259985,"teacher_disagreement_score":0.016569212,"about_ca_system_score_codex":0.00017575895,"about_ca_system_score_gemma":0.000046842182,"threshold_uncertainty_score":0.5239471},"labels":[],"label_agreement":null},{"id":"W2980266043","doi":"10.1182/blood.v112.11.975.975","title":"Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; St. Paul's Hospital","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; Transplantation; Lymphoma; Rituximab; Cumulative incidence; Population; International Prognostic Index; Oncology; Autologous stem-cell transplantation; Gastroenterology","score_opus":0.02767573097854681,"score_gpt":0.2692484739617451,"score_spread":0.2415727429831983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980266043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215144,0.000080264195,0.0002664653,0.00012877019,0.000029322538,0.0069621126,0.00023244922,0.00006694413,0.000082233586],"genre_scores_gemma":[0.9941752,0.000016493608,0.0027537332,0.00041869018,0.000028433426,0.0015394256,0.0009661151,0.00007283195,0.000029103474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737847,0.00011449888,0.00066679175,0.0007178443,0.000666359,0.00045605886],"domain_scores_gemma":[0.9986572,0.00023758179,0.00023193391,0.00044996926,0.00019697714,0.00022630116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013252955,0.0005251826,0.000905168,0.00027542724,0.00019067821,0.000025712548,0.00012209649,0.00010453339,0.0000035197659],"category_scores_gemma":[0.0000024683425,0.0003261644,0.000116989904,0.0004444995,0.00004924071,0.00014604678,0.0000044665803,0.00005900862,0.000005435999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027184479,0.024688754,0.93775284,0.000081143255,0.0004756042,0.0004510839,0.007757763,0.0004001003,0.000088608016,7.116885e-7,0.000019811376,0.0010990916],"study_design_scores_gemma":[0.19742914,0.011889875,0.784603,0.00022132648,0.00051254424,0.000019684778,0.00037767124,0.000042100473,0.0044812234,4.2082956e-7,0.000056121193,0.0003669325],"about_ca_topic_score_codex":0.00057163753,"about_ca_topic_score_gemma":0.0013311658,"teacher_disagreement_score":0.17024465,"about_ca_system_score_codex":0.00028863613,"about_ca_system_score_gemma":0.0002682876,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W2980279355","doi":"10.1182/blood.v114.22.1941.1941","title":"A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Plasmablastic lymphoma; Diffuse large B-cell lymphoma; Lymphoma; Biology; Major histocompatibility complex; Cancer research; Immunology; Antigen","score_opus":0.011953641619551451,"score_gpt":0.257491452968735,"score_spread":0.24553781134918354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980279355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974978,0.00057979464,0.00010344656,0.00012364275,0.000046316367,0.0008788798,0.00004964741,0.00006193132,0.0006585489],"genre_scores_gemma":[0.99845576,0.000014643628,0.0010260514,0.00017984258,0.000045185152,0.00009548941,0.000076731114,0.000027065375,0.0000792293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978843,0.00007264786,0.000606573,0.0005307847,0.00045482273,0.00045092136],"domain_scores_gemma":[0.9987057,0.00010197315,0.0002605473,0.00064112444,0.00007734239,0.00021334329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011271844,0.00033442694,0.00083022757,0.00015680993,0.00009358117,0.000013195958,0.00013918184,0.00014063616,0.00003544253],"category_scores_gemma":[0.000025922855,0.00024387475,0.00012820483,0.00022387238,0.00005562028,0.00007466946,0.00005208515,0.000061964274,0.000017576353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007610408,0.15767144,0.8111195,0.00018513527,0.0000743571,0.00028655192,0.00113284,0.000008897426,0.022952836,0.000009438275,0.00022188714,0.005576091],"study_design_scores_gemma":[0.087988265,0.0021133306,0.5637767,0.00044617764,0.00027282388,0.000038087925,0.000096506315,0.00052083255,0.3444175,0.000008564713,0.00012574636,0.00019549968],"about_ca_topic_score_codex":0.00013207947,"about_ca_topic_score_gemma":0.00015558023,"teacher_disagreement_score":0.3214647,"about_ca_system_score_codex":0.0002831804,"about_ca_system_score_gemma":0.00016971388,"threshold_uncertainty_score":0.99449235},"labels":[],"label_agreement":null},{"id":"W2980279621","doi":"10.1182/blood.v120.21.3705.3705","title":"Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Vincristine; CHOP; Prednisone; Internal medicine; Diffuse large B-cell lymphoma; Proportional hazards model; Lymphoma; Cyclophosphamide; Randomization; Oncology; Randomized controlled trial; Chemotherapy","score_opus":0.013546955892940799,"score_gpt":0.22138933082237197,"score_spread":0.20784237492943117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980279621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957522,0.0029549426,0.000005903274,0.00027110113,0.000014912426,0.0006837355,0.000021547865,0.000050255887,0.00024540655],"genre_scores_gemma":[0.9980827,0.0004988419,0.0008316132,0.000102470774,0.00003042807,0.00023064126,0.000025513247,0.000040847517,0.00015693581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983069,0.00006446689,0.00026462425,0.00047791118,0.00029045244,0.0005956547],"domain_scores_gemma":[0.9992463,0.00008271952,0.00012156243,0.00028465778,0.00004579756,0.00021898975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011713857,0.00041683123,0.00080638414,0.00022299743,0.00008524111,0.00005029705,0.000056532444,0.00012493371,0.000005344441],"category_scores_gemma":[0.00001426403,0.0002284213,0.000034799516,0.00029793452,0.00017842864,0.00027205437,0.00003989865,0.00006383723,0.0000044646627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068799715,0.039560974,0.95677054,0.00011727083,0.00021176874,0.00060185225,0.0005468927,5.805526e-8,0.00006545211,0.00013697316,0.0000026260916,0.0012975931],"study_design_scores_gemma":[0.147444,0.0011761694,0.8461769,0.00046492548,0.00040186683,0.0007675717,0.0007450449,0.000011235334,0.002471922,0.0000058512455,0.00004910038,0.0002854001],"about_ca_topic_score_codex":0.00060262444,"about_ca_topic_score_gemma":0.0012129522,"teacher_disagreement_score":0.146756,"about_ca_system_score_codex":0.00011164588,"about_ca_system_score_gemma":0.000074238,"threshold_uncertainty_score":0.931475},"labels":[],"label_agreement":null},{"id":"W2980412254","doi":"10.1182/blood.v118.21.590.590","title":"Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; Queen's University; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"ABVD; Medicine; Nodular sclerosis; Radiation therapy; Internal medicine; Surgery; Randomized controlled trial; Randomization; Stage (stratigraphy); Cumulative incidence; Oncology; Chemotherapy; Lymphoma; Transplantation; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.0363731819641558,"score_gpt":0.27078300285530243,"score_spread":0.23440982089114665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980412254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973488,0.0009055986,0.000039178103,0.000022484572,0.00001033991,0.0012248143,0.000035357156,0.000021066595,0.00039237028],"genre_scores_gemma":[0.99855536,0.00035015307,0.0006764668,0.000062628926,0.000010039973,0.0001381281,0.000152823,0.000026304837,0.00002806838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982252,0.00015145798,0.00058694754,0.00031762733,0.00049016415,0.00022860899],"domain_scores_gemma":[0.9986131,0.00015446231,0.00061751297,0.00037632056,0.00015831094,0.00008026581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025624176,0.00027571194,0.001635781,0.0005163934,0.000030386922,0.000013753434,0.00010031431,0.0001005397,0.000090929694],"category_scores_gemma":[0.000019156367,0.00016892179,0.0002446099,0.0007873758,0.00011550379,0.00011902152,0.000012327993,0.000049638526,0.0000010474263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07048532,0.0140562365,0.898048,0.000041928604,0.005772819,0.000015017282,0.0025890758,0.000032435757,0.00007071916,0.000036093155,0.000005472452,0.008846911],"study_design_scores_gemma":[0.2990221,0.0021619976,0.67054003,0.00009662134,0.0020362143,0.0000010521075,0.00014885848,0.00020002127,0.02566407,0.000006887779,0.0000042130337,0.00011795871],"about_ca_topic_score_codex":0.0013085448,"about_ca_topic_score_gemma":0.00040603834,"teacher_disagreement_score":0.22853677,"about_ca_system_score_codex":0.000078017256,"about_ca_system_score_gemma":0.00015799822,"threshold_uncertainty_score":0.6888431},"labels":[],"label_agreement":null},{"id":"W2980472943","doi":"10.1182/blood.v112.11.3777.3777","title":"Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Biopsy; Cohort; Lymphoma; International Prognostic Index; Cancer; Retrospective cohort study; Diffuse large B-cell lymphoma; Gastroenterology","score_opus":0.052228481596553154,"score_gpt":0.32071763955802535,"score_spread":0.2684891579614722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980472943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952521,0.0028859172,0.0000022012036,0.00083602994,0.000087382134,0.0005668597,0.00002398471,0.000060143484,0.00028538742],"genre_scores_gemma":[0.99435383,0.0035646665,0.00094964635,0.0003880192,0.00017863773,0.00008936703,0.000033291915,0.00003277824,0.00040974043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845225,0.00005894343,0.00045387744,0.00050823885,0.00022158756,0.0003051066],"domain_scores_gemma":[0.99898833,0.00015292838,0.000090868176,0.0003725378,0.000035071716,0.00036027574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014407103,0.0003008836,0.0006567895,0.00007046085,0.00015545056,0.000021476975,0.000044970893,0.0001698387,0.00002634958],"category_scores_gemma":[0.00004384998,0.00021225524,0.00021103617,0.000081340375,0.00014945329,0.000054096257,0.000051249575,0.00005015934,0.000029076125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006200266,0.005389774,0.9824979,0.000015706104,0.00038289654,0.0025455595,0.00017777257,7.4196436e-8,0.000058887555,0.00002770729,0.00024059633,0.00860118],"study_design_scores_gemma":[0.02316421,0.0018820749,0.9653773,0.000041706124,0.0014342209,0.0012628075,0.000041693795,0.00001520879,0.0044732033,0.000013468755,0.0020941384,0.0001999961],"about_ca_topic_score_codex":0.00027401972,"about_ca_topic_score_gemma":0.00004113359,"teacher_disagreement_score":0.023102207,"about_ca_system_score_codex":0.000070122944,"about_ca_system_score_gemma":0.000087731576,"threshold_uncertainty_score":0.86555177},"labels":[],"label_agreement":null},{"id":"W2980576711","doi":"10.1182/blood.v110.11.799.799","title":"Design and Development of Small Molecules for Specific Targeted Therapy of Diffuse Large B-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Corepressor; BCL6; Biology; Repressor; Small molecule; Transcription factor; Transactivation; Binding site; Cell biology; Chemistry; Genetics; Cancer research; Molecular biology; Gene; B cell; Germinal center","score_opus":0.030211249422522648,"score_gpt":0.24566981219154818,"score_spread":0.21545856276902553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980576711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373635,0.00626435,0.0190996,0.00001862822,0.000023696184,0.0006781823,0.0000100115585,0.000014377594,0.00015479313],"genre_scores_gemma":[0.86094815,0.0005689528,0.13831702,0.000043530297,0.000018180368,0.000035506222,0.000022736875,0.000016563457,0.000029351397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992107,0.000013121104,0.0002924769,0.00016803086,0.000117752075,0.00019791596],"domain_scores_gemma":[0.99945545,0.0001322842,0.000104257466,0.00015186337,0.00007611676,0.00008004851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022194926,0.00012451799,0.00026755457,0.00007370127,0.00003442778,0.0000036463566,0.00004153955,0.00005750423,0.000009125499],"category_scores_gemma":[0.000008732697,0.00009384442,0.000053148065,0.00006354071,0.000027425898,0.000011536834,0.000015188906,0.000012167721,0.0000016430131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003570497,0.16120145,0.12352217,0.0006438547,0.0017922043,0.00019394896,0.007841725,0.0000024194244,0.5211676,0.00090231496,0.00046574537,0.17869613],"study_design_scores_gemma":[0.04829396,0.0005068638,0.08691761,0.000042910546,0.000058829493,0.000008126031,0.00010961513,0.000011598558,0.86056733,0.00002041197,0.0033793116,0.00008345237],"about_ca_topic_score_codex":0.000004464779,"about_ca_topic_score_gemma":0.0000027266042,"teacher_disagreement_score":0.33939976,"about_ca_system_score_codex":0.000023195393,"about_ca_system_score_gemma":0.000094432726,"threshold_uncertainty_score":0.38268644},"labels":[],"label_agreement":null},{"id":"W2980658977","doi":"10.1182/blood.v118.21.437.437","title":"Inactivating Gene Alterations of MHC Class II Transactivator CIITA Are Recurrent in Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Cancer research; Gene; Genetics; Major histocompatibility complex; MHC class II","score_opus":0.021998688649079792,"score_gpt":0.22247436524657035,"score_spread":0.20047567659749055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980658977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536306,0.0011891861,0.000025563842,0.00013888412,0.00008839104,0.00043575824,0.00004810887,0.000029643577,0.0026814006],"genre_scores_gemma":[0.99629205,0.00021914438,0.0030774206,0.00011912899,0.0000798664,0.00011820364,0.000036809564,0.000026778338,0.00003058365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859947,0.00005892906,0.00044487423,0.00036264115,0.0002568461,0.00027725013],"domain_scores_gemma":[0.9991732,0.00010825598,0.0002081627,0.0002680716,0.00007418285,0.00016809555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001233473,0.00023317557,0.00046466143,0.00017072575,0.00009297667,0.00000952381,0.00007526519,0.00010675043,0.000045354052],"category_scores_gemma":[0.0000418932,0.00020144435,0.00008870799,0.00021484465,0.000073595555,0.00011962204,0.000046586232,0.0000548135,0.0000030277477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009292433,0.041636456,0.777426,0.000711607,0.0004375212,0.0006377916,0.008433613,0.0000011405721,0.06376986,0.00017161074,0.00017583696,0.10566932],"study_design_scores_gemma":[0.015082177,0.00089977926,0.6781262,0.00031894736,0.00024059358,0.00012319496,0.00025907677,0.000025623638,0.30464253,0.000027484484,0.00009869403,0.00015566935],"about_ca_topic_score_codex":0.00018425693,"about_ca_topic_score_gemma":0.000048223337,"teacher_disagreement_score":0.24087267,"about_ca_system_score_codex":0.00017552923,"about_ca_system_score_gemma":0.00023331323,"threshold_uncertainty_score":0.8214662},"labels":[],"label_agreement":null},{"id":"W2980717214","doi":"10.1182/blood-2018-99-119738","title":"Finding the Gaps: Perceived and Unperceived Needs in Malignant Hematology Training in Canadian Hematology Residents","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hematology; Medicine; Internal medicine; Curriculum; Certification; Family medicine; Medical education; Oncology; Psychology; Pedagogy","score_opus":0.02576872977373942,"score_gpt":0.27793394034915364,"score_spread":0.25216521057541424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980717214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930105,0.00088444754,1.4252544e-7,0.0027766903,0.00007469376,0.00033920695,0.0000032004239,0.0000131169145,0.0028979771],"genre_scores_gemma":[0.9988586,0.00012081635,0.00008053525,0.0007319156,0.0000515397,0.000062050356,0.000007831498,0.00001510445,0.00007163749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878407,0.000085356995,0.0002691076,0.00024375536,0.000093234994,0.00052447926],"domain_scores_gemma":[0.99939686,0.00013249998,0.000042265285,0.00021155388,0.00002552671,0.00019128091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021736306,0.00014848099,0.00037767197,0.00038203102,0.00009950387,0.0000165523,0.00008214007,0.00013138287,0.00008237184],"category_scores_gemma":[0.00012370184,0.00010327005,0.000034783865,0.00025557182,0.00015113747,0.000036187554,0.000030235182,0.00010275823,0.000029545517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027684411,0.00015730991,0.9798894,0.000020851108,0.000055686836,0.001114685,0.01608494,1.6061558e-7,0.00036640928,0.0017779948,0.00007371386,0.0004311451],"study_design_scores_gemma":[0.005358966,0.00020743003,0.98511344,0.00036533628,0.00008421412,0.0015808184,0.0050653145,0.000031184416,0.0016648412,0.00020828717,0.00021215471,0.000108025255],"about_ca_topic_score_codex":0.1338275,"about_ca_topic_score_gemma":0.52481484,"teacher_disagreement_score":0.39098734,"about_ca_system_score_codex":0.00012965819,"about_ca_system_score_gemma":0.00037397983,"threshold_uncertainty_score":0.87194043},"labels":[],"label_agreement":null},{"id":"W2980833094","doi":"10.36469/9820","title":"A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma","score_opus":0.09011777675505077,"score_gpt":0.4229909358078391,"score_spread":0.3328731590527883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980833094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541354,0.002694487,0.000022766297,0.0011146518,0.00011824386,0.000528725,0.000051627678,0.0000022238137,0.00005376149],"genre_scores_gemma":[0.98822886,0.01146284,0.000056699682,0.00008758426,0.000025176569,0.000022456345,0.0000031315433,0.00001456832,0.00009869353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747634,0.00049484096,0.0011140149,0.00022139466,0.00024842613,0.0004449989],"domain_scores_gemma":[0.99613017,0.002535462,0.00057379506,0.00024121646,0.00023239515,0.00028694666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004048475,0.00013706183,0.0013277059,0.0013933381,0.00007267335,0.000017783961,0.00010748035,0.000088037596,0.00003769761],"category_scores_gemma":[0.00031083112,0.00007536633,0.00022034613,0.00041524158,0.00006292878,0.00008182284,0.00005954705,0.00013114278,0.0000050977333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002334156,0.0022065926,0.94805944,0.0005666483,0.0008289734,0.00012462812,0.00034553616,0.000027190166,0.000057479345,0.00013818163,0.00006348368,0.045247678],"study_design_scores_gemma":[0.02409722,0.0023784055,0.97044766,0.0006287121,0.00017606243,0.00007763363,0.00044266574,0.0003988462,0.00012818593,0.000022596814,0.0011267533,0.000075236596],"about_ca_topic_score_codex":0.00022240933,"about_ca_topic_score_gemma":0.0003341559,"teacher_disagreement_score":0.04517244,"about_ca_system_score_codex":0.0017165558,"about_ca_system_score_gemma":0.0014145896,"threshold_uncertainty_score":0.44887337},"labels":[],"label_agreement":null},{"id":"W2980912885","doi":"10.1182/blood-2018-99-118524","title":"UBR5 Mutations in Mantle Cell Lymphoma Lead to Increased Proliferation through a Cyclin D1-Dependent Mechanism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; BC Cancer Agency; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Biology; Cell growth; Cell cycle; Genetics; Lymphoma; Gene; Immunology","score_opus":0.016389354055423445,"score_gpt":0.27068841144320493,"score_spread":0.25429905738778147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980912885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916627,0.000089613204,0.0002394667,0.0008095994,0.00013555841,0.0009454397,0.000021665337,0.00006683634,0.006029148],"genre_scores_gemma":[0.9934672,0.000021556316,0.004233234,0.0010953094,0.00023022026,0.00034873714,0.00006859973,0.000024353276,0.0005107539],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988333,0.000044940454,0.00027576342,0.00033278862,0.0002581479,0.0002550563],"domain_scores_gemma":[0.99940544,0.00004426793,0.00005648751,0.00028920267,0.00008630763,0.00011826964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010819872,0.00016079415,0.00023223876,0.000109191984,0.00008816925,0.00003050436,0.00006375579,0.00008847814,0.00011370736],"category_scores_gemma":[0.0000525077,0.00013803998,0.000059742062,0.00020649319,0.000023999772,0.00008631941,0.000036790847,0.000035295034,0.0007308427],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002004126,0.11999412,0.5221311,0.0005659922,0.0011651879,0.0041042096,0.027115667,0.00002963169,0.27734563,0.017397027,0.0061841663,0.021963168],"study_design_scores_gemma":[0.022144876,0.001440346,0.09507029,0.00013283863,0.00036012515,0.00011580247,0.00032824534,0.00012870056,0.8778701,0.0014621427,0.0007141202,0.00023241682],"about_ca_topic_score_codex":0.0007292329,"about_ca_topic_score_gemma":0.00053928443,"teacher_disagreement_score":0.6005245,"about_ca_system_score_codex":0.00014798394,"about_ca_system_score_gemma":0.00016243185,"threshold_uncertainty_score":0.93937486},"labels":[],"label_agreement":null},{"id":"W2981054177","doi":"10.1182/blood.v124.21.3040.3040","title":"Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Genetics; MHC class I; MHC class II; Major histocompatibility complex; Cancer research; Computational biology; Gene","score_opus":0.0065563403538149885,"score_gpt":0.19593731571910683,"score_spread":0.18938097536529183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981054177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972943,0.0003948304,0.00003041135,0.00074978994,0.00005922855,0.0005469559,0.000075175645,0.000024785923,0.0008245064],"genre_scores_gemma":[0.9989811,0.0000502113,0.00026299508,0.0003538762,0.00005405602,0.00012663825,0.000041582396,0.00002667156,0.00010284437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985661,0.00011893697,0.0003348471,0.00032289012,0.00037748783,0.00027973764],"domain_scores_gemma":[0.9990692,0.00016663737,0.00021429225,0.0003439851,0.00007302854,0.00013281684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013982675,0.0002171411,0.00040937387,0.00006616958,0.00021036754,0.000014314923,0.00009827901,0.0001247838,0.00002400605],"category_scores_gemma":[0.000070717084,0.00013323937,0.00008055171,0.00016603502,0.00007868225,0.000059302743,0.000060804945,0.000088737455,0.000001002978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025807784,0.027540829,0.91003597,0.00019392518,0.00028682544,0.000088659304,0.0023543427,0.000012502437,0.057338733,0.000051040228,0.00047933892,0.0013597502],"study_design_scores_gemma":[0.028690038,0.0009675306,0.88522184,0.00068583305,0.00043326893,0.000028734152,0.00011067338,0.0001277595,0.08324778,0.00001751122,0.00032398145,0.00014502743],"about_ca_topic_score_codex":0.000031269818,"about_ca_topic_score_gemma":0.00017452642,"teacher_disagreement_score":0.028431961,"about_ca_system_score_codex":0.00011678169,"about_ca_system_score_gemma":0.00017174102,"threshold_uncertainty_score":0.5433344},"labels":[],"label_agreement":null},{"id":"W2981261776","doi":"10.1182/blood.v106.11.18.18","title":"Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Clinical trial; Context (archaeology); Lymphoma; Internal medicine; Hodgkin lymphoma; Medical physics; Hematopathology; Oncology; Family medicine","score_opus":0.022418844617858345,"score_gpt":0.27795314620817707,"score_spread":0.2555343015903187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981261776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692286,0.0014314877,0.00004929341,0.0088007,0.00034973148,0.001743052,0.00036940392,0.000021982283,0.000311481],"genre_scores_gemma":[0.9967586,0.0001741333,0.0012759668,0.00091867126,0.00024207983,0.00017769662,0.000071964074,0.00002445556,0.00035647416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981281,0.00033189924,0.0005295627,0.00031669775,0.00047486724,0.00021886193],"domain_scores_gemma":[0.9977965,0.00070152164,0.00042317476,0.0008016115,0.00023715358,0.00004004616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005805729,0.00018562502,0.00031134475,0.000026077683,0.00016985157,0.00002824817,0.00048683878,0.00007216396,0.000069782436],"category_scores_gemma":[0.0005367404,0.000086439744,0.00027590705,0.0002872282,0.00016465086,0.00005736922,0.0001677487,0.000038909948,0.0000019089134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007665689,0.0066155484,0.689899,0.00015050276,0.002659037,0.000023557348,0.0026655176,0.0002029265,0.17419076,0.0023875437,0.106804945,0.0067349616],"study_design_scores_gemma":[0.0168435,0.00027516182,0.51528984,0.0014283586,0.0012587043,0.00007552429,0.0003507358,0.002467654,0.42889026,0.0001679328,0.032746904,0.00020541796],"about_ca_topic_score_codex":0.0005095381,"about_ca_topic_score_gemma":0.000044726097,"teacher_disagreement_score":0.2546995,"about_ca_system_score_codex":0.00012501376,"about_ca_system_score_gemma":0.00031939577,"threshold_uncertainty_score":0.35249105},"labels":[],"label_agreement":null},{"id":"W2981313668","doi":"10.1182/blood-2018-99-111278","title":"Incremental Survival with Nivolumab Relative to Standard of Care in Classical Hodgkin Lymphoma: A Canadian Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Nivolumab; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Clinical trial; Lymphoma; Relative survival; Immunotherapy; Cancer; Hodgkin lymphoma; Cancer registry","score_opus":0.008280108275120043,"score_gpt":0.2505535477007116,"score_spread":0.24227343942559154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981313668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906243,0.0001378775,0.0000104615765,0.00044676004,0.000026006484,0.00033887947,0.0001566093,0.000011333507,0.008247779],"genre_scores_gemma":[0.9985474,0.00000509983,0.0011484938,0.0000972292,0.000053000625,0.00003459197,0.000046483125,0.000013150423,0.000054581214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988949,0.000046740337,0.00020392209,0.00027398186,0.00031549457,0.00026500953],"domain_scores_gemma":[0.99918956,0.00003588114,0.000047355243,0.00025259797,0.00016866357,0.00030596717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007141838,0.00013761365,0.00047112672,0.00039255168,0.00004948255,0.0000095288315,0.000058676564,0.00006617664,0.00010263605],"category_scores_gemma":[0.00003317008,0.00010532943,0.00009360997,0.00087608956,0.000086218395,0.000038573282,0.000025462641,0.000034837616,0.000017087035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088941486,0.0006735946,0.9910873,0.000015695729,0.0014591727,0.00031370227,0.0022363442,0.0000015981554,0.00006609954,0.0003502055,0.000103377155,0.0028034977],"study_design_scores_gemma":[0.013486848,0.005577733,0.9669455,0.000111539135,0.0021167106,0.000013612789,0.0013662891,0.000008664775,0.00911243,0.000006857874,0.0011162502,0.00013753088],"about_ca_topic_score_codex":0.08842092,"about_ca_topic_score_gemma":0.7928148,"teacher_disagreement_score":0.7043939,"about_ca_system_score_codex":0.0007186703,"about_ca_system_score_gemma":0.00070795,"threshold_uncertainty_score":0.9176494},"labels":[],"label_agreement":null},{"id":"W2981315734","doi":"10.1182/blood.v122.21.3045.3045","title":"Improved Risk Stratification With Addition Of Male Sex (S) To The Elderly International Prognostic Index (S-EIPI) For DLBCL Patients &gt; 60 Years Treated With R-CHOP: An International Collaboration Of The US Intergroup, German High-Grade Non-Hodgkin Lymphoma Study Group and Groupe d’Etude De Lymphome d’Adultes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Internal medicine; Multivariate analysis; Rituximab; Risk factor; Oncology; Gerontology; Demography; Lymphoma","score_opus":0.004172184406075418,"score_gpt":0.2272438005034719,"score_spread":0.22307161609739648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981315734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955254,0.000010206054,0.00020568239,0.00015711546,0.00008745009,0.0036257186,0.0003350654,0.000021385307,0.000031970616],"genre_scores_gemma":[0.99691397,0.000013489684,0.0009637092,0.00004726013,0.00007865015,0.0014476833,0.00047476028,0.000030150693,0.000030310553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857014,0.0000899109,0.0003886555,0.0003594565,0.00041759844,0.00017421134],"domain_scores_gemma":[0.9985644,0.00011335999,0.00040410538,0.0003452856,0.00048117107,0.00009167065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014103514,0.00021132099,0.00025029038,0.00012841368,0.00009019289,0.00009051494,0.00021958795,0.00007002078,0.000021513624],"category_scores_gemma":[0.00006751629,0.00012349554,0.00004563814,0.00025141553,0.00007988832,0.000298927,0.00004467594,0.000046844074,0.0000012000642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006387599,0.009867075,0.97047836,0.000023450511,0.0007357875,0.0000052409146,0.0021871298,0.000027029879,0.0019654531,0.00004724942,0.00005122293,0.013973246],"study_design_scores_gemma":[0.018726498,0.0071034757,0.966754,0.00013495439,0.00050011143,0.000020823327,0.0009037447,0.0016400259,0.004039637,0.000022005057,0.000022510663,0.00013221188],"about_ca_topic_score_codex":0.001387146,"about_ca_topic_score_gemma":0.001306346,"teacher_disagreement_score":0.018087737,"about_ca_system_score_codex":0.00015777597,"about_ca_system_score_gemma":0.00009920654,"threshold_uncertainty_score":0.5036002},"labels":[],"label_agreement":null},{"id":"W2981559551","doi":"10.1200/jco.2012.30.15_suppl.6548","title":"Dose-intensive cyclophosphamide, etoposide, cisplatin reinduction for relapsed/refractory aggressive non-Hodgkin lymphoma (r/r-aNHL).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Etoposide; Gastroenterology; Salvage therapy; Cyclophosphamide; International Prognostic Index; Refractory (planetary science); Oncology; Urology; Chemotherapy; Surgery; Lymphoma","score_opus":0.10193094109642926,"score_gpt":0.44710194953217297,"score_spread":0.3451710084357437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981559551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97730833,0.00338276,0.00017282623,0.0077165994,0.007483945,0.00068852043,0.000010820164,0.000019637946,0.0032165379],"genre_scores_gemma":[0.97926867,0.002277815,0.0074086455,0.0051771016,0.005068917,0.000047936534,0.000015276733,0.000045849807,0.00068979413],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99545467,0.00031161858,0.00290564,0.00030214534,0.00047237254,0.0005535601],"domain_scores_gemma":[0.9879833,0.0045060962,0.0045990366,0.00034353285,0.0017104555,0.0008576188],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026949411,0.00029868828,0.0020683117,0.00018982847,0.000111344794,0.000013982512,0.00016286912,0.0008060073,0.00013104452],"category_scores_gemma":[0.0094327675,0.00020502292,0.0011301195,0.00016405775,0.00022946576,0.00034900475,0.00006238399,0.0005509201,0.00008980893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016042944,0.008883068,0.24116786,0.00007188544,0.0018981537,0.0016066039,0.0005352924,0.000010453625,0.00053760887,0.0004539448,0.092138976,0.63665324],"study_design_scores_gemma":[0.033491004,0.022713713,0.74679035,0.00037638878,0.0015534349,0.0024350556,0.0004810815,0.000040204617,0.00194171,0.0004242275,0.18952262,0.0002302215],"about_ca_topic_score_codex":0.000038406233,"about_ca_topic_score_gemma":0.000009779677,"teacher_disagreement_score":0.636423,"about_ca_system_score_codex":0.0007493118,"about_ca_system_score_gemma":0.0016424158,"threshold_uncertainty_score":0.9989112},"labels":[],"label_agreement":null},{"id":"W2981915086","doi":"10.29011/2577-2139.000005","title":"Re-Evaluating the Current ANCA Screening Method: Multiplex Indirect Immunofluorescence Assay in ANCA Testing","year":2017,"lang":"en","type":"article","venue":"International Journal of Clinical Pathology and Diagnosis","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Everett Chalmers Regional Hospital; McMaster University","funders":"","keywords":"Multiplex; Immunofluorescence; Indirect immunofluorescence; Medicine; Antibody; Immunology; Biology; Bioinformatics","score_opus":0.2782764364234254,"score_gpt":0.531314860387292,"score_spread":0.2530384239638666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981915086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983319,0.0030753573,0.00044574682,0.010856268,0.0015898783,0.00019339549,0.000010140891,0.000007791515,0.00050243957],"genre_scores_gemma":[0.97419465,0.0025578628,0.021687806,0.00079324655,0.0007108551,0.000034057768,0.0000030317756,0.000009941871,0.000008573287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972357,0.00064029184,0.001215518,0.00026264097,0.00044908474,0.0001967255],"domain_scores_gemma":[0.9886296,0.009132695,0.0013629427,0.0002813761,0.0004690393,0.00012433794],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0063736173,0.00015314281,0.0005774248,0.00013217746,0.00021846399,0.00009527077,0.00042087326,0.00012063402,0.000028913653],"category_scores_gemma":[0.033492755,0.00009616999,0.00023755456,0.000055080676,0.00025336666,0.00020645576,0.00021088182,0.00066585385,0.000004268522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026361507,0.0003318528,0.53423566,0.000004332012,0.00009611487,0.00050066586,0.00008409249,0.0000131390025,0.0000252491,0.000016530981,0.00013111705,0.46429762],"study_design_scores_gemma":[0.0047511794,0.00076822075,0.98990786,0.000899105,0.00014784111,0.0002677758,0.000057193527,0.0014979776,0.0003028221,0.00048090864,0.0008304052,0.00008873443],"about_ca_topic_score_codex":0.00007697173,"about_ca_topic_score_gemma":0.00005127572,"teacher_disagreement_score":0.4642089,"about_ca_system_score_codex":0.00005411889,"about_ca_system_score_gemma":0.00016377703,"threshold_uncertainty_score":0.97464854},"labels":[],"label_agreement":null},{"id":"W2981926059","doi":"10.1002/cyto.a.23919","title":"Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity","year":2019,"lang":"en","type":"article","venue":"Cytometry Part A","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"Japan Society for the Promotion of Science; Genome Canada; Terry Fox Research Institute; Leukemia and Lymphoma Society","keywords":"Phenotype; Mass cytometry; Biology; Lymphoma; Genetic heterogeneity; Diffuse large B-cell lymphoma; Cancer research; Context (archaeology); Pathology; Immunology; Genetics; Gene; Medicine","score_opus":0.02843418346740925,"score_gpt":0.2735828115848192,"score_spread":0.24514862811740992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981926059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953157,0.0015454541,0.000004807638,0.00006688064,0.00027351428,0.0004975273,0.00003101879,0.00003491753,0.0022302223],"genre_scores_gemma":[0.9982541,0.00005565888,0.0008931864,0.00016248751,0.00008273682,0.000019386478,0.000041789084,0.000021258893,0.00046937427],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886274,0.000049094215,0.00032284643,0.0003191969,0.00018547068,0.0002606271],"domain_scores_gemma":[0.9991878,0.0001322617,0.00013018181,0.00032360785,0.00006938919,0.00015673623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015169024,0.00018567198,0.0004891761,0.00015143909,0.000028490673,0.000021819562,0.000058350342,0.00006854336,0.00013112977],"category_scores_gemma":[0.00007628578,0.00014802864,0.00010366263,0.0002535543,0.0000715779,0.000075991855,0.00007816974,0.00007705757,0.0000686331],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029850326,0.0010418827,0.9438163,0.00043841163,0.000080205515,0.0001499802,0.00006408651,3.4398911e-7,0.052045025,0.000031205986,0.00047517905,0.0015588924],"study_design_scores_gemma":[0.0051277513,0.0019577544,0.374822,0.00046725018,0.00023051842,0.00033465147,0.00020753968,0.00007192147,0.615539,0.000029336868,0.00096473773,0.00024749228],"about_ca_topic_score_codex":0.00001847259,"about_ca_topic_score_gemma":0.0000031911134,"teacher_disagreement_score":0.5689943,"about_ca_system_score_codex":0.00009841539,"about_ca_system_score_gemma":0.000046290916,"threshold_uncertainty_score":0.6036433},"labels":[],"label_agreement":null},{"id":"W2981973487","doi":"10.1016/j.ebiom.2019.09.034","title":"Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles","year":2019,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Institut National Du Cancer; Gilead Sciences; Roche","keywords":"Diffuse large B-cell lymphoma; Computational biology; Biology; Copy-number variation; Gene expression profiling; Oncology; Comparative genomic hybridization; Bioinformatics; Gene; Lymphoma; Medicine; Genetics; Gene expression; Chromosome; Genome; Immunology","score_opus":0.011343054884228317,"score_gpt":0.26565437268165587,"score_spread":0.25431131779742755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981973487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995721,0.0013711319,0.00022344095,0.00021876473,0.00015145907,0.00029893738,0.000065931046,0.000056308872,0.0018930197],"genre_scores_gemma":[0.9968458,0.000041411,0.0014058849,0.000406231,0.0000442476,0.000015214716,0.00059432216,0.000032012016,0.0006148797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820215,0.0000501165,0.00051065587,0.00040483064,0.00046992046,0.00036235715],"domain_scores_gemma":[0.99875087,0.000084114596,0.00023356795,0.0005812361,0.00016630733,0.00018388894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024639684,0.00025952983,0.0009666407,0.0008264179,0.000037193906,0.0000089888445,0.00010170067,0.00012126682,0.00039627275],"category_scores_gemma":[0.000048856014,0.00018165642,0.000286423,0.0019064363,0.00007819801,0.000050859806,0.000059016253,0.000065632084,0.000044853143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003143598,0.0077030105,0.6701569,0.0002634462,0.0033661316,0.0004373747,0.00053399533,0.000014628778,0.3121067,0.00033164804,0.00024283715,0.004528991],"study_design_scores_gemma":[0.081814416,0.002665828,0.5866211,0.0012767563,0.018505031,0.00009507481,0.001718561,0.02078208,0.27757,0.000018444813,0.0082327975,0.0006999042],"about_ca_topic_score_codex":0.00055758085,"about_ca_topic_score_gemma":0.00001232158,"teacher_disagreement_score":0.0835358,"about_ca_system_score_codex":0.00024175123,"about_ca_system_score_gemma":0.00013740612,"threshold_uncertainty_score":0.7407734},"labels":[],"label_agreement":null},{"id":"W2983523128","doi":"10.1182/blood-2019-130255","title":"Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Follicular lymphoma; Chemoimmunotherapy; Biology; Germinal center; Oncology; Lymphoma; Exome sequencing; Rituximab; Internal medicine; Medicine; Genetics; Mutation; Gene; Immunology; B cell","score_opus":0.018396098843780892,"score_gpt":0.2609930547105817,"score_spread":0.2425969558668008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983523128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953304,0.00347755,0.0000029076696,0.0001474829,0.000057551315,0.0005866509,0.000031583597,0.000023444163,0.00034243191],"genre_scores_gemma":[0.9983276,0.00036098648,0.00090767373,0.00013401256,0.000041470907,0.00004090915,0.000019025856,0.000024108229,0.00014419126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848235,0.00006108617,0.0005972118,0.00036589723,0.00023387415,0.0002595824],"domain_scores_gemma":[0.99911475,0.00023285259,0.0001211971,0.00034569704,0.000047089048,0.00013843414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021876815,0.00018052102,0.0005773766,0.00009462984,0.000022127546,0.000012204029,0.00006465977,0.00010330564,0.00003483166],"category_scores_gemma":[0.000115616844,0.00014196288,0.00013308757,0.0001562065,0.00005740046,0.000046584955,0.000027756041,0.000048762144,0.000027993834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113017064,0.0010701129,0.9429308,0.0002457966,0.00016851867,0.0014966973,0.0002989597,0.0000021803548,0.05154267,0.00004612031,0.00001455381,0.0020705427],"study_design_scores_gemma":[0.012417773,0.0013282562,0.97752273,0.00054789474,0.0005098174,0.0006942193,0.000121160105,0.000033568278,0.0064075836,0.000095691525,0.00016718128,0.00015412022],"about_ca_topic_score_codex":0.00034927088,"about_ca_topic_score_gemma":0.00004873869,"teacher_disagreement_score":0.045135085,"about_ca_system_score_codex":0.00010981161,"about_ca_system_score_gemma":0.00014291717,"threshold_uncertainty_score":0.57890785},"labels":[],"label_agreement":null},{"id":"W2983593617","doi":"10.1182/blood-2019-126997","title":"The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Lomustine; Medicine; Internal medicine; Prednisone; Etoposide; Regimen; Chemotherapy regimen; Vincristine; Oncology; Aggressive lymphoma; Gastroenterology; Tolerability; Chemotherapy; Surgery; Adverse effect; Lymphoma; Rituximab; Cyclophosphamide","score_opus":0.034150980214548245,"score_gpt":0.2847645866593148,"score_spread":0.25061360644476655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983593617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962499,0.0017623187,7.473906e-7,0.0008463136,0.000041825337,0.0006625648,0.000013220577,0.000018002092,0.00040507864],"genre_scores_gemma":[0.99641556,0.0017454823,0.00091672404,0.00043189497,0.000030871124,0.00005228268,0.000018836085,0.000020644182,0.00036769125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903417,0.000059793078,0.00023340737,0.00026266923,0.00019188035,0.00021807099],"domain_scores_gemma":[0.9990545,0.00022192192,0.00020015331,0.00036662482,0.00006275313,0.00009402712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009085016,0.00016059136,0.000306645,0.00005090035,0.000035180714,0.000028614979,0.00006775165,0.000078195495,0.000024723047],"category_scores_gemma":[0.000061720944,0.00009989118,0.00005448982,0.000109049186,0.00008050121,0.000100225836,0.00003196782,0.000052867847,0.000007241254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004973412,0.0021766464,0.9833296,0.00004651608,0.00040766867,0.000113948525,0.0016921702,0.000005404995,0.002094395,0.00067135226,0.00032584436,0.008639093],"study_design_scores_gemma":[0.01976895,0.0011611896,0.93918896,0.0002956352,0.00022436511,0.00005068871,0.00026272578,0.0001760289,0.035363857,0.00012494127,0.003239709,0.00014294212],"about_ca_topic_score_codex":0.00040653365,"about_ca_topic_score_gemma":0.00012457861,"teacher_disagreement_score":0.04414065,"about_ca_system_score_codex":0.000050772604,"about_ca_system_score_gemma":0.000086528744,"threshold_uncertainty_score":0.40734443},"labels":[],"label_agreement":null},{"id":"W2983654225","doi":"10.1021/acsomega.9b02910","title":"Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"ACS Omega","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Medicine and Dentistry, University of Alberta; Ministry of Higher Education and Scientific Research; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Micelle; Chemistry; Ethylene oxide; Polymer chemistry; Population; PEG ratio; Polymerization; Nuclear chemistry; Copolymer; Organic chemistry; Polymer; Aqueous solution","score_opus":0.011762042092542132,"score_gpt":0.24407580572554097,"score_spread":0.23231376363299883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983654225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960854,0.0014903368,0.000054084172,0.000112232665,0.00012395148,0.00072755665,0.00005242239,0.000015350288,0.0013386623],"genre_scores_gemma":[0.9892416,0.00006833411,0.009252798,0.00006561032,0.000020350513,0.000057500543,0.00015592646,0.000027035789,0.0011108363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854034,0.000015277676,0.0006642051,0.00024777165,0.00028452984,0.0002478728],"domain_scores_gemma":[0.99891603,0.00018091773,0.00036494527,0.00025467214,0.00021147293,0.00007194622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020990224,0.00018528056,0.00057270913,0.00009129934,0.000037528243,0.0000058489536,0.0000995278,0.00010694562,0.000017940001],"category_scores_gemma":[0.000045577664,0.00015426826,0.00014161492,0.00012703653,0.000041475145,0.00007739898,0.000038872775,0.000027732805,0.000015915784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001044405,0.0061147213,0.036796257,0.0015712922,0.00024389973,0.0000025305937,0.0027272382,0.000007101885,0.9398805,0.00013883792,0.0030145284,0.008458722],"study_design_scores_gemma":[0.013733771,0.0004693745,0.0148175005,0.00023180152,0.00014001339,0.0000043164487,0.00058928714,0.00007727152,0.96385056,0.000012418342,0.005935528,0.00013818493],"about_ca_topic_score_codex":0.00011927134,"about_ca_topic_score_gemma":0.000005116498,"teacher_disagreement_score":0.02397007,"about_ca_system_score_codex":0.0001065034,"about_ca_system_score_gemma":0.00021532625,"threshold_uncertainty_score":0.62908775},"labels":[],"label_agreement":null},{"id":"W2984501600","doi":"10.1182/blood.v104.11.3126.3126","title":"Addition of Rituximab to CHOP Is an Attractive Strategy as Primary Therapy for Diffuse Large B Cell Lymphoma (DLBCL) in Patients Age &amp;lt;60 Years: An Economic Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; CHOP; Rituximab; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Surgery; Autologous stem-cell transplantation; Prednisone; Chemotherapy; Cyclophosphamide; Lymphoma","score_opus":0.017720453440519014,"score_gpt":0.2756589028839406,"score_spread":0.2579384494434216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984501600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758625,0.00014015906,0.000009352629,0.000040909825,0.000030735235,0.0009476466,0.0008345342,0.000022448965,0.0003879681],"genre_scores_gemma":[0.99642247,0.000103516504,0.0007991207,0.0005531418,0.00006515296,0.00018574746,0.001812222,0.00002952536,0.000029076282],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99876493,0.00003602831,0.00033338254,0.0004230125,0.0001699448,0.00027271252],"domain_scores_gemma":[0.99915963,0.000036644564,0.00014472513,0.0004164696,0.000056531906,0.00018600667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009622233,0.0001950179,0.0005097728,0.00026118744,0.000038519847,0.000025963547,0.00009243304,0.00010822119,0.00009960586],"category_scores_gemma":[0.000007680836,0.00018011384,0.00019150204,0.00018222697,0.000019388752,0.00020495517,0.00001666024,0.000035037352,0.0000507392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038877348,0.66306037,0.28239822,0.00013480497,0.0037721521,0.00029846784,0.00807419,0.0001353659,0.003128816,0.00030706124,0.0004540389,0.034348786],"study_design_scores_gemma":[0.10882713,0.0029714305,0.8790335,0.00002985292,0.0006554389,0.0000018036293,0.000078586396,0.0000063307302,0.0075176787,0.00018258399,0.00052834675,0.00016732204],"about_ca_topic_score_codex":0.00080768537,"about_ca_topic_score_gemma":0.0007172345,"teacher_disagreement_score":0.66008896,"about_ca_system_score_codex":0.0003560818,"about_ca_system_score_gemma":0.00018764082,"threshold_uncertainty_score":0.73448294},"labels":[],"label_agreement":null},{"id":"W2984521104","doi":"10.1182/blood-2019-126745","title":"Prediction of High-Risk Group of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using a CT-Based Radiomics Model with Machine Learning","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire en santé mentale de Montréal; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Regimen; Vincristine; Internal medicine; Chemotherapy regimen; Univariate analysis; CHOP; Refractory (planetary science); Lymphoma; Surgery; Cyclophosphamide; Oncology; Chemotherapy; Multivariate analysis","score_opus":0.009023547200362659,"score_gpt":0.19034204825056714,"score_spread":0.18131850105020447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984521104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786204,0.00042827363,0.00068407325,0.000003921492,0.00005125794,0.000522162,0.00025075683,0.000038926602,0.00015858919],"genre_scores_gemma":[0.99642116,0.00012946226,0.0028461784,0.00004138552,0.000020867845,0.000014370498,0.0004408108,0.00004479734,0.00004097615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873954,0.000057035555,0.0003481104,0.00028149228,0.00035935122,0.00021446808],"domain_scores_gemma":[0.9989775,0.00006809268,0.00041569184,0.00034532827,0.00009956201,0.00009381401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011526577,0.00019869581,0.00048594028,0.00013482147,0.000048765905,0.000005401664,0.000059274087,0.00006875226,0.000008096452],"category_scores_gemma":[0.000018862242,0.00015170671,0.000110029505,0.00013212158,0.000034156983,0.00008346281,0.00003419403,0.00008585052,0.000002335702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059658755,0.045520753,0.94726354,0.0002942954,0.00025164752,0.000019716816,0.00009880472,0.0018711531,0.0031124977,0.000014074157,0.000005714963,0.0009511969],"study_design_scores_gemma":[0.21725114,0.0039669396,0.56996435,0.0004220951,0.0020105094,0.000020343745,0.000028180282,0.18352346,0.022533042,0.0000048668444,0.00006269467,0.00021239389],"about_ca_topic_score_codex":0.0004530869,"about_ca_topic_score_gemma":0.000007564472,"teacher_disagreement_score":0.37729922,"about_ca_system_score_codex":0.00019062031,"about_ca_system_score_gemma":0.00015325322,"threshold_uncertainty_score":0.61864203},"labels":[],"label_agreement":null},{"id":"W2984625937","doi":"10.1182/blood-2019-123433","title":"Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; CHOP; International Prognostic Index; Neutropenia; Gastroenterology; Febrile neutropenia; Oncology; Lymphoma; Surgery; Chemotherapy","score_opus":0.01666141507619155,"score_gpt":0.2813330558796354,"score_spread":0.26467164080344385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984625937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928077,0.00032061027,0.0000021745177,0.000009343643,0.000025521029,0.0062462087,0.00012035163,0.000019558558,0.0004485314],"genre_scores_gemma":[0.9986142,0.00006530819,0.00013810408,0.000041025738,0.000007523012,0.0004011021,0.00018807,0.000031644056,0.0005130277],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743897,0.0002120368,0.0009080472,0.00053982914,0.0005305123,0.00037060227],"domain_scores_gemma":[0.99807537,0.00024291156,0.00052848435,0.00078445626,0.00022859617,0.00014016936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003169287,0.00034693314,0.0028214778,0.0004597304,0.00003832083,0.00002518552,0.00024776848,0.00009220848,0.00013932769],"category_scores_gemma":[0.000065091444,0.00020947643,0.00016627085,0.0012707585,0.00005333523,0.00011811049,0.00015447757,0.00005988342,0.000014386076],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2354273,0.39948517,0.35562417,0.000117618685,0.006796405,0.00017258356,0.0018835996,0.000008304941,0.000018001778,0.000009800768,0.000022008848,0.0004350437],"study_design_scores_gemma":[0.8963883,0.010477666,0.073482536,0.00022252835,0.01776345,0.0000036132005,0.00036772445,0.0005353724,0.0005517342,7.645072e-7,0.000012817969,0.00019349856],"about_ca_topic_score_codex":0.0025606386,"about_ca_topic_score_gemma":0.00074812124,"teacher_disagreement_score":0.660961,"about_ca_system_score_codex":0.0003160956,"about_ca_system_score_gemma":0.00046323834,"threshold_uncertainty_score":0.8542201},"labels":[],"label_agreement":null},{"id":"W2984844451","doi":"10.1182/blood-2019-123948","title":"Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"CHOP; Medicine; Lenalidomide; Chemotherapy; Internal medicine; Placebo; Vincristine; Chemotherapy regimen; Quality of life (healthcare); Oncology; Gastroenterology; Cyclophosphamide; Multiple myeloma; Nursing; Pathology","score_opus":0.01924093849634835,"score_gpt":0.26770726773550924,"score_spread":0.2484663292391609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984844451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937762,0.00012190393,0.000008927933,0.0005441825,0.000042425978,0.004339565,0.0010201308,0.00003111915,0.00011556029],"genre_scores_gemma":[0.9985565,0.00006187372,0.000101680096,0.00053760794,0.000010683327,0.00008452027,0.0005077554,0.00005574897,0.00008363962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947848,0.00088549213,0.0019512265,0.0006188782,0.0013385813,0.0004210418],"domain_scores_gemma":[0.9943689,0.0007332469,0.0026917981,0.0010364451,0.00092035497,0.00024923682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009847711,0.0005007527,0.0021712317,0.00035390558,0.000074854834,0.000019115218,0.00044568864,0.00015735872,0.00020235222],"category_scores_gemma":[0.0002642397,0.00028558957,0.00031378158,0.0021279305,0.00016393914,0.0001228557,0.00007767006,0.00017158854,0.0000022726122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047752846,0.07354622,0.8570236,0.00018802697,0.0073527563,9.927687e-7,0.0058883782,0.0004588857,0.007422946,0.000006043492,0.00021414743,0.0001451435],"study_design_scores_gemma":[0.2133945,0.002368411,0.7565041,0.0002369745,0.0007206669,4.3962174e-7,0.0011955858,0.00018288851,0.02517668,0.0000010581699,0.000008297195,0.00021036403],"about_ca_topic_score_codex":0.010180696,"about_ca_topic_score_gemma":0.0011640199,"teacher_disagreement_score":0.16564164,"about_ca_system_score_codex":0.00046372812,"about_ca_system_score_gemma":0.0007818827,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W2984927918","doi":"10.1200/jco.19.00172","title":"Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":772,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Seagen (Canada); Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"TG Therapeutics; H. Lundbeck A/S; BeiGene; Pharmacyclics; Genentech; Exelixis; Karyopharm Therapeutics; MEI Pharma; Astex Pharmaceuticals; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Kite Pharma; National Cancer Institute; Gilead Sciences; Sanofi; MorphoSys; Celgene; American Society of Clinical Oncology; Bristol-Myers Squibb; AstraZeneca; Spectrum Pharmaceuticals; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Internal medicine; Bendamustine; Rituximab; Neutropenia; Hazard ratio; Cohort; Diffuse large B-cell lymphoma; Transplantation; Gastroenterology; Surgery; Oncology; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.06801833353446632,"score_gpt":0.4233675724693748,"score_spread":0.35534923893490844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984927918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854438,0.000961564,0.0000023062526,0.0025989204,0.0016429778,0.00025290166,0.0000030704955,0.000009594343,0.009084875],"genre_scores_gemma":[0.99163026,0.0011456998,0.00088317686,0.0035050602,0.00057392713,0.000004158208,0.0000029816279,0.000022834893,0.002231885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963262,0.00040227684,0.0023353614,0.00023908592,0.0003661171,0.000330931],"domain_scores_gemma":[0.99468195,0.0030312282,0.0013936557,0.00031004418,0.00017859944,0.00040454525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017713167,0.00017240981,0.0017128628,0.00018949642,0.000020920208,0.000007734182,0.00016369819,0.0005401575,0.0004663332],"category_scores_gemma":[0.0019155804,0.00010375655,0.00053082674,0.00016730915,0.00006186616,0.00008588007,0.00006375115,0.00054569816,0.0003472771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018400589,0.093996525,0.7667812,0.0000669388,0.0003347149,0.007812946,0.00025291607,0.000002027659,0.000243529,0.0001855405,0.008129993,0.103793055],"study_design_scores_gemma":[0.1362647,0.020747615,0.6246415,0.0001577057,0.0001967162,0.0003366221,0.0001754876,0.00006541247,0.000101312595,0.00006105538,0.21715072,0.000101167614],"about_ca_topic_score_codex":0.00003192472,"about_ca_topic_score_gemma":0.00007299961,"teacher_disagreement_score":0.20902072,"about_ca_system_score_codex":0.00069380074,"about_ca_system_score_gemma":0.0027758006,"threshold_uncertainty_score":0.5106022},"labels":[],"label_agreement":null},{"id":"W2985160385","doi":"10.1182/blood-2019-123083","title":"Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Lenalidomide; Medicine; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Placebo; Regimen; Prednisone; Lymphoma; Multiple myeloma; Pathology","score_opus":0.023142996810195052,"score_gpt":0.27696555880415885,"score_spread":0.2538225619939638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985160385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923966,0.005740163,2.5500572e-7,0.00021667051,0.000069611684,0.001248057,0.00003119727,0.00003475917,0.0002627191],"genre_scores_gemma":[0.9977084,0.001832846,0.00001760386,0.00014381594,0.000039356702,0.00005619597,0.000039832998,0.00002971781,0.00013222956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834114,0.00014914277,0.00031280957,0.00041449408,0.00026749275,0.0005149408],"domain_scores_gemma":[0.999061,0.0003066325,0.00012708538,0.00036149993,0.000031889376,0.00011188455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000238556,0.00034129948,0.00062306685,0.00016540448,0.00006115247,0.000055819266,0.00011869423,0.000106917396,0.00004796557],"category_scores_gemma":[0.00008204919,0.00018791847,0.00016581659,0.00022948887,0.000048552465,0.00010592337,0.00008554764,0.00009837708,0.0000402375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002334597,0.019709775,0.9743601,0.0001022011,0.0003599138,0.0005427765,0.0037080387,0.000011653506,0.00032512654,0.000009917757,0.00013081939,0.00050620426],"study_design_scores_gemma":[0.08699776,0.0006025497,0.9068684,0.0002176211,0.0004373364,0.00009487743,0.00209319,0.000030673535,0.002386206,0.0000071328204,0.00007890782,0.00018534655],"about_ca_topic_score_codex":0.00074152526,"about_ca_topic_score_gemma":0.00033873983,"teacher_disagreement_score":0.086764306,"about_ca_system_score_codex":0.00017795058,"about_ca_system_score_gemma":0.000079112804,"threshold_uncertainty_score":0.7663093},"labels":[],"label_agreement":null},{"id":"W2985653147","doi":"10.1182/blood-2019-123669","title":"Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population in a Phase Ib/II Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Follicular lymphoma; Tolerability; Obinutuzumab; Population; Regimen; Oncology; Clinical endpoint; Neutropenia; Phases of clinical research; Gastroenterology; Rituximab; Adverse effect; Lymphoma; Clinical trial; Multiple myeloma; Chemotherapy","score_opus":0.006201895072607609,"score_gpt":0.22832750612297756,"score_spread":0.22212561105036996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985653147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976631,0.00046919548,4.6488898e-7,0.000034279747,0.000069408845,0.0016179053,0.000021940288,0.000012564249,0.000111189336],"genre_scores_gemma":[0.9995291,0.000021289348,0.00006854479,0.00005688164,0.000024052444,0.000046627494,0.00020399198,0.000019448447,0.000030046314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839115,0.000111807676,0.0005064059,0.0003664005,0.00041032323,0.00021391804],"domain_scores_gemma":[0.99903196,0.0001151609,0.0002663002,0.00046780458,0.000047528232,0.000071226415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001499329,0.00020678419,0.0007532887,0.00037353914,0.000042596963,0.000011414685,0.000080445214,0.00011514912,0.000018011306],"category_scores_gemma":[0.00006635686,0.00013088934,0.0001851079,0.00082016736,0.000034895642,0.000093997674,0.00006606536,0.000081361104,0.0000021378728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03350881,0.0104190195,0.9518174,0.00005182777,0.0011322541,0.000029863346,0.0005821787,0.00019657458,0.0002504347,0.000027098344,0.0000060978005,0.0019784255],"study_design_scores_gemma":[0.34033707,0.00198361,0.6553192,0.00013474566,0.0017304139,0.000002180399,0.00002262599,0.0001584284,0.00019240701,0.000003329113,0.000022233153,0.000093709335],"about_ca_topic_score_codex":0.0011189949,"about_ca_topic_score_gemma":0.00023297401,"teacher_disagreement_score":0.30682826,"about_ca_system_score_codex":0.00093599013,"about_ca_system_score_gemma":0.00032626803,"threshold_uncertainty_score":0.53375125},"labels":[],"label_agreement":null},{"id":"W2985949593","doi":"10.1182/blood-2019-127399","title":"Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; McGill University; Queen's University; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Exome sequencing; Follicular lymphoma; Exome; Medicine; Cancer research; Mutation; Biology; Gene; Genetics","score_opus":0.009572199138379733,"score_gpt":0.24216311004469607,"score_spread":0.23259091090631634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985949593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699545,0.0011809962,0.0000031768416,0.000092869945,0.00013046882,0.00050082314,0.000015786618,0.000019059169,0.0010613544],"genre_scores_gemma":[0.9993764,0.00009350059,0.00013103079,0.000023258739,0.000040640316,0.00006761955,0.000036466965,0.000015301966,0.00021576474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909943,0.000026064208,0.00021435745,0.00023891381,0.00023805753,0.00018319263],"domain_scores_gemma":[0.9995221,0.000049076818,0.00007937554,0.00025386835,0.0000246915,0.000070894115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055483804,0.00014744488,0.0003151594,0.00009783291,0.000014823075,0.0000041598537,0.00003243672,0.000059075246,0.000056428766],"category_scores_gemma":[0.00000656729,0.000098930956,0.00012762123,0.000093008195,0.0000092265345,0.00003863947,0.000012614004,0.000051087827,0.000041020547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019397191,0.0077189687,0.98639745,0.00004435167,0.00028881253,0.00014161991,0.00022542087,0.0000022531372,0.00089483307,0.0000799121,0.0000075447174,0.004004893],"study_design_scores_gemma":[0.0295246,0.004607372,0.9599012,0.00055549736,0.000419301,0.000032452994,0.00012070412,0.000010621024,0.0042828806,0.000009616282,0.00043152392,0.00010419647],"about_ca_topic_score_codex":0.00042746257,"about_ca_topic_score_gemma":0.0001298194,"teacher_disagreement_score":0.029330628,"about_ca_system_score_codex":0.0003373154,"about_ca_system_score_gemma":0.0001327596,"threshold_uncertainty_score":0.40342873},"labels":[],"label_agreement":null},{"id":"W2986010331","doi":"10.1182/blood-2019-129024","title":"Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hôpital de l'Enfant-Jésus; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Lenalidomide; Population; Follicular lymphoma; Oncology; Cohort; Surgery; Multiple myeloma; Lymphoma","score_opus":0.014405276617013145,"score_gpt":0.26219586497157554,"score_spread":0.24779058835456239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986010331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873805,0.00006190682,0.000017124292,0.00017364955,0.00006791664,0.012135061,0.00012309231,0.000009606368,0.00003111678],"genre_scores_gemma":[0.9977387,0.00003178431,0.00038460104,0.0001413309,0.000021176607,0.0014457774,0.00019419589,0.000026367064,0.00001606111],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984527,0.000069960755,0.0005049633,0.0003330512,0.0004096078,0.00022970504],"domain_scores_gemma":[0.9981649,0.0008081328,0.0004247811,0.00036567386,0.00019638872,0.000040145176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019761497,0.00022627303,0.00059553946,0.000080154154,0.000052732805,0.000015149116,0.0001150834,0.00007417932,0.0000033292317],"category_scores_gemma":[0.00034581628,0.00011857956,0.00012134545,0.00017873375,0.000071209426,0.00005216057,0.000017553395,0.00006006604,6.7748505e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14753917,0.059244934,0.7813785,0.0005812216,0.00059762044,0.0000025013364,0.0013058971,0.000033986224,0.00013856322,0.00007015008,0.000082433,0.0090250205],"study_design_scores_gemma":[0.8226013,0.022463482,0.13442965,0.00067129947,0.00086938374,0.0000017256249,0.000065776745,0.0002399133,0.018390195,0.00004019384,0.00007981871,0.00014727638],"about_ca_topic_score_codex":0.00007901493,"about_ca_topic_score_gemma":0.00000843641,"teacher_disagreement_score":0.6750621,"about_ca_system_score_codex":0.00011997194,"about_ca_system_score_gemma":0.00012719605,"threshold_uncertainty_score":0.4835534},"labels":[],"label_agreement":null},{"id":"W2986040534","doi":"10.1182/blood-2019-130282","title":"The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; ABVD; Internal medicine; Population; Comorbidity; Chemotherapy; Vincristine","score_opus":0.03604234934206093,"score_gpt":0.31924731666894063,"score_spread":0.2832049673268797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986040534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565846,0.0006794908,7.0783443e-7,0.0008706534,0.000100165584,0.0017795366,0.00039732977,0.000006988119,0.0005066821],"genre_scores_gemma":[0.9982595,0.0012096483,0.000071574665,0.00009655704,0.00006106426,0.0000732022,0.00002238572,0.000023278984,0.00018282965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788433,0.00016429981,0.0010610331,0.0002585132,0.00040756457,0.00022426982],"domain_scores_gemma":[0.9952129,0.0032105409,0.00063114916,0.00077536266,0.00008297107,0.00008707134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083829125,0.00021499976,0.0010668371,0.00003445602,0.00003545108,0.00000871677,0.00015782924,0.000108002714,0.000015607122],"category_scores_gemma":[0.00030966938,0.0000829879,0.0007537065,0.00007921498,0.00047043827,0.000019223573,0.00007610507,0.00006434569,0.0000013036306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062894067,0.010122778,0.9663179,0.00016327943,0.0038670124,0.00006759916,0.00090305414,0.000001325765,0.0012996085,0.0050025615,0.0007375544,0.005227941],"study_design_scores_gemma":[0.036506683,0.0072372966,0.9507643,0.00015307737,0.0011278023,0.000015532125,0.000093343995,0.000063456224,0.0032946717,0.0003602318,0.000305928,0.0000777038],"about_ca_topic_score_codex":0.00051570806,"about_ca_topic_score_gemma":0.000024129038,"teacher_disagreement_score":0.030217277,"about_ca_system_score_codex":0.00010099011,"about_ca_system_score_gemma":0.00026624586,"threshold_uncertainty_score":0.33841482},"labels":[],"label_agreement":null},{"id":"W2986069530","doi":"10.1182/blood-2019-121467","title":"The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Medicine; Internal medicine; Oncology; Germinal center; Gastroenterology; Pathology; Immunology; B cell","score_opus":0.0047241167163117525,"score_gpt":0.19958277031844837,"score_spread":0.1948586536021366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986069530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970983,0.0003268285,0.0000020853695,0.00015543928,0.00007479803,0.0017993911,0.0001769208,0.00008724606,0.000278976],"genre_scores_gemma":[0.99809456,0.00022523126,0.00010339083,0.00034564149,0.000035129626,0.00016922152,0.0003799442,0.00010593158,0.0005409253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975752,0.00011559809,0.0003381942,0.00061507704,0.00072928856,0.0006266389],"domain_scores_gemma":[0.99795467,0.00019328238,0.000387547,0.00073210755,0.00057908404,0.00015332917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013983426,0.0005203749,0.0007035398,0.000102817015,0.00020798772,0.0000831985,0.00017381513,0.0002449374,0.000037679365],"category_scores_gemma":[0.000021624408,0.0002506981,0.000096575546,0.00041422207,0.00007449869,0.00012496355,0.000051474894,0.000215589,0.000026321784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009363465,0.016116899,0.9694025,0.000016266928,0.00095027976,0.00014408746,0.0009270618,0.0000018426744,0.0027522824,0.000005517636,0.000051231662,0.0002685989],"study_design_scores_gemma":[0.2214177,0.002410264,0.6709412,0.0003722245,0.00046910188,0.0000096997355,0.0002407749,0.000010341152,0.10381491,0.0000012138332,0.00003793656,0.0002746789],"about_ca_topic_score_codex":0.0012409616,"about_ca_topic_score_gemma":0.00061204884,"teacher_disagreement_score":0.2984613,"about_ca_system_score_codex":0.00025969621,"about_ca_system_score_gemma":0.00018112168,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2986592300","doi":"10.1182/blood-2019-122019","title":"Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Positron emission tomography; Nuclear medicine; Radiation therapy; Lymphoma; Oncology; Chemotherapy; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.03202130380728589,"score_gpt":0.28188593152165403,"score_spread":0.24986462771436813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986592300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938378,0.0017531362,0.000009380042,0.000037925984,0.000050342496,0.0012963668,0.000046850768,0.00002293013,0.0029452806],"genre_scores_gemma":[0.99768066,0.00011266505,0.0016863217,0.000035738343,0.000020893234,0.00007566874,0.000065587796,0.000023915236,0.00029857337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981396,0.00011593892,0.0005141218,0.0003403655,0.00069502223,0.00019493914],"domain_scores_gemma":[0.99874127,0.000089077796,0.0002771906,0.0005140096,0.00027763649,0.00010083418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060092093,0.00019594279,0.0006509001,0.0001474282,0.000022521468,0.000008234855,0.00007078208,0.00007839579,0.000102491875],"category_scores_gemma":[0.00011779744,0.00015033339,0.00013462479,0.00019083785,0.000057620044,0.000056822344,0.00005631181,0.000026770238,0.0000129239015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005326658,0.0069772685,0.9621938,0.00075327954,0.0008507755,0.000043553136,0.00051679375,0.000048072678,0.0147531815,0.0005050963,0.000020999927,0.012804527],"study_design_scores_gemma":[0.05829434,0.0010840378,0.84935904,0.0002222263,0.002448235,0.00017404532,0.0003158493,0.009208784,0.07845586,0.000019304818,0.00022574734,0.00019251466],"about_ca_topic_score_codex":0.00021855782,"about_ca_topic_score_gemma":0.000004988828,"teacher_disagreement_score":0.11283473,"about_ca_system_score_codex":0.00012871817,"about_ca_system_score_gemma":0.0002309638,"threshold_uncertainty_score":0.6130418},"labels":[],"label_agreement":null},{"id":"W2986637688","doi":"10.1182/blood-2019-122302","title":"A Matching-Adjusted Indirect Comparison of Nivolumab Versus Brentuximab Vedotin for Relapsed/Refractory Classical Hodgkin Lymphoma after Failure of Autologous Hematopoietic Cell Transplantation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vancouver Coastal Health","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Oncology; Cohort; Population; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Surgery; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.014828383432838899,"score_gpt":0.25849113698388543,"score_spread":0.24366275355104652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986637688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972528,0.0008146124,0.000055960794,0.00012247732,0.00022525061,0.0009305029,0.000105595514,0.000050372288,0.00044241647],"genre_scores_gemma":[0.9977808,0.00003415057,0.0017054728,0.00002146137,0.000036852096,0.00012768045,0.00015086753,0.000035863814,0.000106850515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984729,0.000062122235,0.0005391779,0.00033661484,0.00032130835,0.0002678294],"domain_scores_gemma":[0.998828,0.0003473942,0.0003038082,0.00033171687,0.000093118186,0.00009594423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008908756,0.00023372687,0.00081383396,0.00013429092,0.000029058083,0.000008531646,0.000093826384,0.00022193184,0.00007793282],"category_scores_gemma":[0.000014687628,0.00020093183,0.00027088315,0.00013884548,0.000061409984,0.000059296086,0.000018495843,0.00008128575,0.00003170575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030370211,0.061700698,0.7980115,0.010737908,0.0026217743,0.0003471439,0.017352171,0.000047377507,0.057283964,0.000640208,0.0013461191,0.01954094],"study_design_scores_gemma":[0.12537916,0.008228751,0.4721573,0.00088049925,0.0040450506,0.00012276694,0.0011284198,0.00016731817,0.38684967,0.00006807679,0.00056391465,0.00040905966],"about_ca_topic_score_codex":0.00006742348,"about_ca_topic_score_gemma":0.00006647523,"teacher_disagreement_score":0.3295657,"about_ca_system_score_codex":0.000089858135,"about_ca_system_score_gemma":0.00017372584,"threshold_uncertainty_score":0.81937623},"labels":[],"label_agreement":null},{"id":"W2987067520","doi":"10.3324/haematol.2019.227892","title":"Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Provincial Health Services Authority","funders":"F. Hoffmann-La Roche","keywords":"Cell of origin; Diffuse large B-cell lymphoma; Biology; Lymphoma; Large-cell lymphoma; Somatic cell; Proportional hazards model; Large cell; Cancer research; Mutation; Hazard ratio; Gene; Oncology; Cancer; Internal medicine; Pathology; Genetics; Adenocarcinoma; Medicine; Immunology; Confidence interval","score_opus":0.059598015126062255,"score_gpt":0.3559190621808619,"score_spread":0.2963210470547996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987067520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964051,0.00056074397,0.000015144694,0.00017850625,0.000031247917,0.0022082329,0.00025599907,0.000018639807,0.00032637198],"genre_scores_gemma":[0.99923754,0.000015561749,0.0003185202,0.00004067702,0.0000075321514,0.0001020004,0.00023274017,0.000010512299,0.000034921402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875855,0.00012441953,0.0004336201,0.00030861874,0.00019016898,0.00018464614],"domain_scores_gemma":[0.9974594,0.00141656,0.00017772656,0.0008196479,0.00003705006,0.00008960948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021114184,0.00015615419,0.0005173294,0.00007999079,0.00005280405,0.000014206988,0.00018577205,0.00005728115,0.00009696431],"category_scores_gemma":[0.00025866175,0.00008646988,0.000059381236,0.00023293828,0.000039301547,0.00006991196,0.00015154171,0.000050620423,0.00007192906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015988169,0.023727642,0.9729652,0.000061610954,0.00008104472,0.0000964802,0.0023135825,0.0000026074356,0.00009322553,0.000087759116,0.00023867976,0.00017227465],"study_design_scores_gemma":[0.032078512,0.0012350669,0.9632302,0.00013127533,0.00032593706,0.000020855734,0.0018883224,0.0006247894,0.00020875272,0.00015062191,0.000019707933,0.000085949025],"about_ca_topic_score_codex":0.00055409997,"about_ca_topic_score_gemma":0.00012893451,"teacher_disagreement_score":0.03191863,"about_ca_system_score_codex":0.00005239287,"about_ca_system_score_gemma":0.00011789391,"threshold_uncertainty_score":0.35261396},"labels":[],"label_agreement":null},{"id":"W2987355547","doi":"10.1182/blood-2019-127129","title":"CD20 Is an Unstable Target in Primary-Refractory High-Grade Lymphomas","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"","keywords":"Rituximab; Lymphoma; Medicine; CD20; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Biopsy; Oncology; BCL6; CHOP; Prednisone; Cyclophosphamide; Pathology; B cell; Immunology; Chemotherapy; Antibody; Germinal center","score_opus":0.010313964620829121,"score_gpt":0.22965886677576694,"score_spread":0.21934490215493782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987355547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98608047,0.0012391072,7.404724e-7,0.0004978967,0.00015200002,0.00044821156,0.000027235053,0.00006361473,0.011490732],"genre_scores_gemma":[0.99532694,0.0001592146,0.0011436119,0.0014842171,0.00010833329,0.000047857313,0.0001278305,0.00003162029,0.0015703898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875456,0.000032040236,0.00023048765,0.000377487,0.00027156496,0.00033386875],"domain_scores_gemma":[0.99918985,0.000042623316,0.0000611321,0.00050456065,0.0000304546,0.0001713807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009337862,0.00018823457,0.0003831721,0.00010957396,0.000028904342,0.000020770245,0.000090064634,0.00011507083,0.00092325354],"category_scores_gemma":[0.000009294842,0.00015277555,0.00007798409,0.00016424664,0.000023047667,0.00015405803,0.000036837806,0.00007370976,0.000510363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007310921,0.008732945,0.98101735,0.00008374035,0.00014684258,0.00027267958,0.0003445918,0.0000026672278,0.0061212997,0.00044954053,0.0012856305,0.0014696104],"study_design_scores_gemma":[0.021300135,0.0009178408,0.90065145,0.000109357534,0.00017491638,0.000058793168,0.000073766525,0.000018352433,0.051650062,0.0002005082,0.024618002,0.0002267987],"about_ca_topic_score_codex":0.00069511076,"about_ca_topic_score_gemma":0.00002295798,"teacher_disagreement_score":0.080365874,"about_ca_system_score_codex":0.00021783002,"about_ca_system_score_gemma":0.00022342747,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W2987592445","doi":"10.1182/blood-2019-123422","title":"Sustained Overall Survival Benefit of Obinutuzumab Plus Bendamustine Followed By Obinutuzumab Maintenance Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Final Results of the Gadolin Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Bendamustine; Obinutuzumab; Rituximab; Internal medicine; Neutropenia; Hazard ratio; Refractory (planetary science); Oncology; Surgery; Gastroenterology; Confidence interval; Lymphoma; Chemotherapy","score_opus":0.007766365193135204,"score_gpt":0.2157758252711723,"score_spread":0.2080094600780371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987592445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994654,0.0001499552,0.0000042088404,0.00007913622,0.00015358774,0.0037984627,0.0005957056,0.000034149984,0.000530806],"genre_scores_gemma":[0.99856275,0.000015621761,0.00031275142,0.000055200737,0.000040181614,0.0000972986,0.00037535638,0.00007466072,0.0004661987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958257,0.00013475648,0.0011839083,0.00084099674,0.0013099496,0.0007046619],"domain_scores_gemma":[0.99684715,0.00022822879,0.0009022264,0.0012211935,0.0006107973,0.00019040096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034781577,0.0006263167,0.0016735818,0.00021136946,0.00007826307,0.000019834388,0.00039248998,0.00014717146,0.00003375328],"category_scores_gemma":[0.00009606537,0.00038151303,0.0001919611,0.0006399213,0.00017343908,0.00013368874,0.0002584743,0.00022818061,0.0000065806253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03566912,0.030077789,0.9293364,0.00031316778,0.0009890471,0.0001651221,0.0016993906,0.0005518604,0.000299112,0.000029045303,0.0004483343,0.00042156948],"study_design_scores_gemma":[0.29246944,0.0083039645,0.69417244,0.0008969609,0.0006488589,0.000013284933,0.0007279196,0.00012899135,0.0022522078,0.0000039800952,0.000066861045,0.00031510377],"about_ca_topic_score_codex":0.0046462696,"about_ca_topic_score_gemma":0.0012708335,"teacher_disagreement_score":0.25680032,"about_ca_system_score_codex":0.0014839132,"about_ca_system_score_gemma":0.001254009,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W2987650717","doi":"10.1016/s0167-8140(19)33308-0","title":"243 Evaluating the Discussion of Late Effects and Screening Recommendations in Survivors of Adolescent and Young Adult (AYA) Lymphoma","year":2019,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hodgkin lymphoma; Medicine; Psychology; Lymphoma; Internal medicine","score_opus":0.018928408027210006,"score_gpt":0.3330171170183638,"score_spread":0.31408870899115376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987650717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932539,0.0027833462,0.000036349556,0.003190191,0.00009389901,0.000512938,0.000003926901,0.000004529094,0.00012093046],"genre_scores_gemma":[0.99420094,0.0040990585,0.0012654393,0.00030962343,0.000020553687,0.000020785375,0.000006223269,0.000008159967,0.00006919198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992561,0.0001889518,0.00021069635,0.0001562398,0.00007924007,0.00010881658],"domain_scores_gemma":[0.99936324,0.00034387736,0.000116298324,0.00010648194,0.000029049354,0.000041038616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003438055,0.00008967257,0.00032981928,0.00006390952,0.0000413151,0.0000044153235,0.000023661953,0.00007062285,0.000014952811],"category_scores_gemma":[0.00003388681,0.00004720549,0.000027551565,0.000075761294,0.000081920094,0.00003421612,0.000020193673,0.000043215834,1.769771e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029812954,0.00020129098,0.61985624,0.000116720854,0.000056059747,0.0000032453029,0.0015344499,0.0000035101173,0.004994855,0.0001168548,0.000016729387,0.37280193],"study_design_scores_gemma":[0.00921916,0.002252705,0.9825489,0.00047149518,0.00006490878,0.000045497298,0.0003711495,0.0033791014,0.0010679201,0.00003870218,0.00048116327,0.000059278256],"about_ca_topic_score_codex":0.00045506208,"about_ca_topic_score_gemma":0.00034143205,"teacher_disagreement_score":0.37274265,"about_ca_system_score_codex":0.00008923023,"about_ca_system_score_gemma":0.000041515523,"threshold_uncertainty_score":0.1924984},"labels":[],"label_agreement":null},{"id":"W2987801113","doi":"10.1136/bjophthalmol-2019-314653","title":"Epidemiology of ophthalmic lymphoma in Canada during 1992–2010","year":2019,"lang":"en","type":"article","venue":"British Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Ottawa Hospital; McGill University; University of Ottawa; Dalhousie University","funders":"Canadian Dermatology Foundation","keywords":"Medicine; Epidemiology; Incidence (geometry); Demography; Cancer registry; Population; Follicular lymphoma; Lymphoma; Cancer; Environmental health; Pathology; Internal medicine","score_opus":0.020640992983983208,"score_gpt":0.26966100007033106,"score_spread":0.24902000708634786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987801113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901557,0.0068664714,2.6435396e-7,0.0003212623,0.0006907548,0.00018918913,0.000016171785,0.0000019551735,0.0017582601],"genre_scores_gemma":[0.9989791,0.00026503272,0.000333353,0.00007874807,0.00007945922,0.0000051219095,0.000005493861,0.000018156088,0.00023555051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795365,0.00019993751,0.0010541618,0.00020730638,0.00019498487,0.0003899607],"domain_scores_gemma":[0.9985033,0.00041861093,0.00057883223,0.00019573995,0.00012604038,0.0001774653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041600893,0.00014659854,0.0011136082,0.00017191874,0.000020883659,0.0000017589936,0.00016240441,0.00013119691,0.0007198764],"category_scores_gemma":[0.00032521255,0.00014809506,0.00018048323,0.00015345613,0.000065084336,0.00006903559,0.000050415518,0.0001780727,0.000010866516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026805658,0.0003615921,0.9304648,0.000097606906,0.00013773023,0.066335745,0.0000167368,0.00005494775,0.00035222425,0.000022715762,0.00015859779,0.001729219],"study_design_scores_gemma":[0.0036646188,0.00038900052,0.6094781,0.0003230068,0.000029573961,0.38525844,0.000056319204,0.000007227569,0.0006348174,0.00007331874,0.000021401609,0.000064138425],"about_ca_topic_score_codex":0.6230625,"about_ca_topic_score_gemma":0.028278753,"teacher_disagreement_score":0.5947838,"about_ca_system_score_codex":0.0008105688,"about_ca_system_score_gemma":0.0014650176,"threshold_uncertainty_score":0.9894526},"labels":[],"label_agreement":null},{"id":"W2987880211","doi":"10.1182/blood-2019-127995","title":"Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Population; Rituximab; Cumulative incidence; Pediatrics; Young adult; Survival analysis; Internal medicine; Lymphoma; Relative survival; Transplantation; Epidemiology; Cancer registry","score_opus":0.006935902756192617,"score_gpt":0.24502794897073754,"score_spread":0.2380920462145449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987880211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972524,0.000010766493,8.9453846e-7,0.00006435146,0.000041891086,0.0025688293,0.000022364868,0.000010554553,0.000027963582],"genre_scores_gemma":[0.99921393,0.000010895388,0.00007380785,0.00025354675,0.0000123138725,0.00016076972,0.00024088506,0.000019892825,0.000013938143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990795,0.00003219186,0.00023066685,0.00023773676,0.00029785975,0.00012200969],"domain_scores_gemma":[0.9990544,0.000030885865,0.00014751595,0.00023542384,0.00049868686,0.00003310141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003971154,0.00016432995,0.00028211385,0.000088615176,0.000028311457,0.000019795356,0.00006817432,0.000037315116,0.0000044147414],"category_scores_gemma":[0.000022882536,0.00008580892,0.000030177434,0.00008620345,0.00001855966,0.00011084756,0.000014800835,0.000027139591,6.858704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010527428,0.015711498,0.9760579,0.000026694652,0.0003556145,0.000004490515,0.0030291441,9.230014e-7,0.000009424222,0.000006687185,0.0000033505241,0.0037415735],"study_design_scores_gemma":[0.06588057,0.005491012,0.925889,0.00018198678,0.00024172795,0.0000052816335,0.0019759506,0.000019786068,0.00021574849,0.0000012348784,0.0000028211703,0.00009485028],"about_ca_topic_score_codex":0.001378466,"about_ca_topic_score_gemma":0.00029582475,"teacher_disagreement_score":0.06482783,"about_ca_system_score_codex":0.0000657705,"about_ca_system_score_gemma":0.000020325073,"threshold_uncertainty_score":0.3499186},"labels":[],"label_agreement":null},{"id":"W2988147901","doi":"10.1182/blood-2019-123488","title":"Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Ofatumumab; Rituximab; Mantle cell lymphoma; Internal medicine; Minimal residual disease; Autologous stem-cell transplantation; Oncology; Surgery; Gastroenterology; Transplantation; Lymphoma; Leukemia","score_opus":0.012344596887827346,"score_gpt":0.2569605922094742,"score_spread":0.24461599532164685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988147901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971138,0.00007082793,3.0636397e-7,0.0001075523,0.00007771723,0.002192333,0.00025942962,0.000018128436,0.00015986677],"genre_scores_gemma":[0.9992539,0.000006858996,0.00025389955,0.000034662226,0.00004096035,0.00011054152,0.00014492807,0.00002797659,0.00012623581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981444,0.00010798488,0.00050440343,0.00047086878,0.0005138464,0.00025849533],"domain_scores_gemma":[0.998717,0.00015395318,0.00022873348,0.0005314792,0.00016442251,0.00020441518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013986725,0.00024405279,0.00060168246,0.00021513202,0.000027420918,0.000010383901,0.00009585656,0.00006472249,0.000023784734],"category_scores_gemma":[0.00011856576,0.0001835541,0.0000653188,0.00036866142,0.00004859408,0.00011714875,0.000064395565,0.000055653272,0.000021533915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015387342,0.06979339,0.9102364,0.00012256113,0.00014038137,0.00015677065,0.0012733763,0.000026707201,0.0010673692,0.000004316737,0.00015087191,0.0016405177],"study_design_scores_gemma":[0.1786466,0.009891187,0.7775087,0.0001982093,0.00042817998,0.0000011038995,0.00039012276,0.0000059213003,0.03277781,0.0000025974346,0.000009722304,0.00013988964],"about_ca_topic_score_codex":0.0014875883,"about_ca_topic_score_gemma":0.00015368812,"teacher_disagreement_score":0.16325925,"about_ca_system_score_codex":0.00013399764,"about_ca_system_score_gemma":0.00029608633,"threshold_uncertainty_score":0.7485119},"labels":[],"label_agreement":null},{"id":"W2989035987","doi":"10.1182/blood-2019-121943","title":"TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Tissue microarray; Oncology; Population; Lymphoma; Internal medicine; Biology; Immunohistochemistry; Pathology; Medicine; Cancer research","score_opus":0.016924340947942835,"score_gpt":0.2831427425900293,"score_spread":0.2662184016420865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989035987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866563,0.000050523493,0.0000020594193,0.000042465777,0.00002181677,0.0008772031,0.000048248323,0.00002591586,0.00026611084],"genre_scores_gemma":[0.99913853,0.000011867269,0.0004782974,0.000067199115,0.000013825441,0.000047129208,0.00010657615,0.000024518535,0.00011205525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869156,0.00004436367,0.0003964157,0.0003546889,0.0003489514,0.00016403559],"domain_scores_gemma":[0.999122,0.00009378268,0.00019154807,0.00031394436,0.000112654765,0.00016604621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008173314,0.00017896417,0.00047102213,0.00008992666,0.000026161393,0.000011864931,0.00004515628,0.00010504695,0.000055536744],"category_scores_gemma":[0.000018293553,0.000095227544,0.00003190771,0.00013349662,0.000073997886,0.0001222653,0.000021639382,0.00011089591,0.000007505392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013690344,0.007982387,0.98942524,0.000042729633,0.00021880337,0.000047802503,0.00042709408,0.000005106457,0.000022512751,0.0000060554657,0.000009149949,0.0004440899],"study_design_scores_gemma":[0.054199345,0.0073023895,0.936001,0.0004451319,0.0005383851,0.000015006547,0.00015645268,0.00002967615,0.0011854983,0.0000026159778,0.000010200577,0.00011427168],"about_ca_topic_score_codex":0.00011880574,"about_ca_topic_score_gemma":0.000047180823,"teacher_disagreement_score":0.053424206,"about_ca_system_score_codex":0.000023757577,"about_ca_system_score_gemma":0.00008262131,"threshold_uncertainty_score":0.38832667},"labels":[],"label_agreement":null},{"id":"W2989047686","doi":"10.1182/bloodadvances.2019000449","title":"More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Health and Medical Research Council; National Institutes of Health","keywords":"Medicine; Oncology; Negativity effect; Internal medicine; Peri; Psychology; Developmental psychology","score_opus":0.008444506848344384,"score_gpt":0.2535488958911792,"score_spread":0.2451043890428348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989047686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97231424,0.026012676,0.00001606246,0.00012576995,0.0001936625,0.0006990025,0.000105662766,0.00006540583,0.00046750501],"genre_scores_gemma":[0.975781,0.021733882,0.0020292997,0.00008767237,0.0001821025,0.000075264536,0.000041209198,0.000033327015,0.000036197216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822754,0.00010552076,0.00034271082,0.00055283384,0.00036964237,0.0004017678],"domain_scores_gemma":[0.9990977,0.00019887181,0.00017271141,0.00028082466,0.000084350664,0.00016551654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188767,0.00027352356,0.0004794407,0.00014229522,0.00009007965,0.000052521198,0.00008457568,0.00010909373,0.000014857386],"category_scores_gemma":[0.00020118014,0.00021991682,0.0000999076,0.00015136431,0.000026738362,0.0003211104,0.000083668354,0.00019143065,0.000022839113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006634068,0.0005838828,0.98420006,0.00009653307,0.00013898658,0.000059716156,0.00072024163,0.0024469926,0.000109424,0.00002409532,0.0000060036564,0.010950628],"study_design_scores_gemma":[0.008420687,0.0011180635,0.9846732,0.00013147913,0.001154088,0.00007427793,0.00018198794,0.0028757309,0.0007007951,0.00013537043,0.00023665925,0.00029765777],"about_ca_topic_score_codex":0.0011803936,"about_ca_topic_score_gemma":0.00047299682,"teacher_disagreement_score":0.01065297,"about_ca_system_score_codex":0.00006364529,"about_ca_system_score_gemma":0.00011350932,"threshold_uncertainty_score":0.8967948},"labels":[],"label_agreement":null},{"id":"W2989507932","doi":"10.1182/blood-2019-127421","title":"NFKBIZ3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Untranslated region; Mutation; Gene; Three prime untranslated region; Cancer research; Signal transduction; B cell; Genetics; Lymphoma; Messenger RNA; Molecular biology; Immunology","score_opus":0.007060586903819591,"score_gpt":0.2375397344838326,"score_spread":0.230479147580013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989507932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456805,0.00062515883,0.000029460884,0.0005287624,0.000011613941,0.00073110353,0.000047466787,0.000039530376,0.0034188349],"genre_scores_gemma":[0.9984977,0.0002779158,0.00022723924,0.0003013107,0.000018100467,0.00021575541,0.000062572624,0.00002535355,0.00037400308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992227,0.00002790332,0.00013173207,0.00028836224,0.00010061574,0.0002286963],"domain_scores_gemma":[0.9994674,0.000102321486,0.000054568132,0.00021462193,0.00007367161,0.00008743932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036008245,0.00015587242,0.00022521213,0.00009805499,0.0000617641,0.000021025367,0.000039662114,0.00005433598,0.000022247326],"category_scores_gemma":[0.000005235768,0.00011215299,0.00003478417,0.00019208874,0.00003183166,0.000090194524,0.000020474827,0.00004338055,0.00004389246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009500578,0.014444384,0.9730587,0.000043401928,0.00020049841,0.0000311294,0.0005586591,2.5712316e-7,0.008221382,0.0025016335,0.00000985342,0.00083508337],"study_design_scores_gemma":[0.047363024,0.00039819462,0.89226824,0.00004485376,0.00032850957,0.00010222397,0.00033593783,0.000021091726,0.058427367,0.00016197452,0.00040497686,0.00014361666],"about_ca_topic_score_codex":0.000049444436,"about_ca_topic_score_gemma":0.00004446895,"teacher_disagreement_score":0.08079048,"about_ca_system_score_codex":0.00006186191,"about_ca_system_score_gemma":0.00011684242,"threshold_uncertainty_score":0.45734665},"labels":[],"label_agreement":null},{"id":"W2989572446","doi":"10.1182/blood.v112.11.2173.2173","title":"Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Cumulative incidence; Lymphoma; Gastroenterology; Population; Regimen; Refractory (planetary science); Surgery; Oncology; Transplantation; Biology","score_opus":0.04099135968089607,"score_gpt":0.30780328600167867,"score_spread":0.2668119263207826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989572446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945087,0.0045947963,0.000025081554,0.00009002757,0.000029522676,0.00043245236,0.00003141541,0.000058926682,0.00022906391],"genre_scores_gemma":[0.99865353,0.00043580824,0.0006669481,0.000051994535,0.000018750632,0.000010716613,0.00004465575,0.00003877887,0.00007882541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983808,0.000061577986,0.00063432386,0.0003168682,0.00023338624,0.00037307493],"domain_scores_gemma":[0.99909216,0.000161862,0.00017806268,0.00025064367,0.00004964396,0.00026764232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013975897,0.00025985707,0.000806866,0.00013368738,0.00015160427,0.000009350209,0.000055861306,0.00026588805,0.00001806591],"category_scores_gemma":[0.000036291247,0.00021559998,0.00011263175,0.00019140558,0.00013713686,0.00006267933,0.000032225013,0.00010845634,0.0000049328237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007119982,0.007892248,0.98132634,0.00018185264,0.000386736,0.00025529924,0.0019054324,6.94269e-7,0.007691997,0.000025576363,0.000007825465,0.00025477263],"study_design_scores_gemma":[0.06292666,0.00066192506,0.8755957,0.0001829969,0.0019510679,0.0007814798,0.00016667324,0.00011067686,0.057260327,0.000023746512,0.00010495823,0.00023381063],"about_ca_topic_score_codex":0.00008779061,"about_ca_topic_score_gemma":0.000008996778,"teacher_disagreement_score":0.10573068,"about_ca_system_score_codex":0.00008795724,"about_ca_system_score_gemma":0.000106329484,"threshold_uncertainty_score":0.8791912},"labels":[],"label_agreement":null},{"id":"W2989608063","doi":"10.1182/blood-2019-128722","title":"Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Stage (stratigraphy); Diffuse large B-cell lymphoma; Lymphoma; Population; Nuclear medicine; Internal medicine; Cancer; Oncology","score_opus":0.016792122963075543,"score_gpt":0.24133957572786305,"score_spread":0.2245474527647875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989608063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922696,0.00077631784,0.000002438913,0.000022633512,0.00010231762,0.0018203744,0.000215665,0.00003681865,0.0047538835],"genre_scores_gemma":[0.98985964,0.00031250925,0.0004885353,0.00007909549,0.00003506084,0.00022573954,0.00017900819,0.00004700452,0.00877338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980578,0.000051423394,0.00057946896,0.00051370007,0.00035876955,0.00043885154],"domain_scores_gemma":[0.998762,0.000072623654,0.00017693816,0.0006693479,0.00009326197,0.000225829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009653441,0.00022367145,0.00088897493,0.00012478499,0.000029966155,0.00004204075,0.00012832077,0.00010528178,0.00012596352],"category_scores_gemma":[0.000027020655,0.00026429,0.0003027524,0.0003191118,0.00003212968,0.00005447217,0.00006803108,0.000031360374,0.00004666664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009619839,0.12129234,0.8731711,0.00036324415,0.00030375674,0.0005581099,0.00053949706,6.444778e-7,0.0009308191,0.000012239622,0.00024804723,0.0024840322],"study_design_scores_gemma":[0.15009905,0.002114524,0.83613354,0.00031232304,0.0004934586,0.00016409747,0.00016690993,0.000023832376,0.009829543,0.0000021145609,0.00045576892,0.00020485537],"about_ca_topic_score_codex":0.014026363,"about_ca_topic_score_gemma":0.00992434,"teacher_disagreement_score":0.15000285,"about_ca_system_score_codex":0.00023023947,"about_ca_system_score_gemma":0.00017184734,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2990138720","doi":"10.1182/blood-2019-124879","title":"Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Kingston Health Sciences Centre; Juravinski Hospital; Queen's University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Cohort; Oncology; Rituximab; Progression-free survival; Median follow-up; Regimen; Surgery; Lymphoma; Overall survival","score_opus":0.010169980393006909,"score_gpt":0.24777238641895175,"score_spread":0.23760240602594485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990138720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974796,0.0006521347,0.0000067515675,0.0002566753,0.00012856055,0.00070783467,0.00030148646,0.000024240873,0.0004426971],"genre_scores_gemma":[0.99905634,0.00011775712,0.00017955816,0.00008273803,0.000024368692,0.00010903846,0.0001350031,0.000021378912,0.00027383634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985633,0.000074258336,0.00039014628,0.00038551824,0.00027083073,0.00031595447],"domain_scores_gemma":[0.9990053,0.0002798069,0.0001059949,0.00043808966,0.000051939096,0.00011885264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002722965,0.00021221126,0.0008632471,0.00025285443,0.000020207735,0.0000122824395,0.00009121112,0.00013540832,0.00010031665],"category_scores_gemma":[0.000046333553,0.00017336161,0.00030396294,0.00025838078,0.000043588443,0.000045205965,0.000033781915,0.0000680905,0.000009222854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016463994,0.0025748494,0.9914741,0.00015104175,0.0021232078,0.00024623497,0.00052678445,0.000007602228,0.00047434962,0.0005121205,0.000011057894,0.00025223292],"study_design_scores_gemma":[0.03543388,0.0010831662,0.95708114,0.00013151631,0.004504945,0.000026940172,0.000050729013,0.00033208833,0.0010011601,0.00012132058,0.00006792783,0.00016517245],"about_ca_topic_score_codex":0.001109994,"about_ca_topic_score_gemma":0.003051388,"teacher_disagreement_score":0.034392964,"about_ca_system_score_codex":0.000044515684,"about_ca_system_score_gemma":0.00008102151,"threshold_uncertainty_score":0.7069481},"labels":[],"label_agreement":null},{"id":"W2990138864","doi":"10.1182/blood.2019002699","title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Center for Advancing Translational Sciences; European Regional Development Fund; National Cancer Institute; Generalitat de Catalunya; Ministerio de Economía y Competitividad; Agència de Gestió d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III","keywords":"IRF4; Cancer research; Biology; CDKN2A; Germinal center; Lymphoma; Diffuse large B-cell lymphoma; B cell; Aggressive lymphoma; Gene expression profiling; B-cell lymphoma; Genetics; Gene; Immunology; Gene expression; Transcription factor; Antibody","score_opus":0.0053596945444788074,"score_gpt":0.22033434539175295,"score_spread":0.21497465084727413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990138864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95151174,0.00092746044,0.0000045163797,0.00008884225,0.000059665996,0.00049291877,0.000048031205,0.000035869245,0.046830937],"genre_scores_gemma":[0.99794346,0.000015745163,0.00041548404,0.00011173611,0.000031376254,0.00004444058,0.000071831666,0.000021721682,0.001344182],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991515,0.000021371472,0.00017636362,0.0002133288,0.00022348532,0.00021391943],"domain_scores_gemma":[0.9993745,0.000029314448,0.000071129536,0.00037943106,0.000053469284,0.00009217571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000673797,0.00012698772,0.00028810118,0.00004378101,0.000018971325,0.000005856544,0.00006000021,0.00006335202,0.00042495134],"category_scores_gemma":[0.000018362658,0.0000974864,0.00013750387,0.00010367317,0.000017173303,0.000023008983,0.000036448502,0.000025611214,0.000470357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015003323,0.027078789,0.8571533,0.00048468699,0.0004176726,0.00045937853,0.00022938784,1.5967014e-7,0.108888105,0.0007728894,0.0009786943,0.003386883],"study_design_scores_gemma":[0.036298808,0.0006798612,0.32809186,0.00011518719,0.00048059958,0.000046712088,0.000050838524,0.000016916898,0.6296394,0.00002290731,0.004420261,0.00013665819],"about_ca_topic_score_codex":0.000044196033,"about_ca_topic_score_gemma":0.0000021817643,"teacher_disagreement_score":0.52906144,"about_ca_system_score_codex":0.00002844538,"about_ca_system_score_gemma":0.00007842347,"threshold_uncertainty_score":0.6045644},"labels":[],"label_agreement":null},{"id":"W2990171626","doi":"10.1097/ppo.0000000000000335","title":"Introduction From the Guest Editor: Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"The Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Center (category theory); Columbia university; Cancer; Hodgkin lymphoma; Lymphoma; Library science; Medicine; Media studies; Sociology; Internal medicine; Computer science","score_opus":0.01375611775979292,"score_gpt":0.282785871344604,"score_spread":0.26902975358481107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990171626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8402877,0.0047405716,0.00003820963,0.12604868,0.02768929,0.00018734486,0.000019809902,0.00002830392,0.00096013455],"genre_scores_gemma":[0.6920348,0.0012022671,0.000053789037,0.0021183908,0.30423623,0.000020432919,0.000005021418,0.000012202658,0.00031685102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917907,0.000069915164,0.00016306639,0.00013632375,0.0002727629,0.00017888079],"domain_scores_gemma":[0.9992479,0.00007758583,0.00010919623,0.0003350621,0.00014390874,0.00008633675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026335617,0.00010261383,0.00013235972,0.000016658278,0.0003995498,0.00007240738,0.00016383338,0.00003751151,0.0013831586],"category_scores_gemma":[0.0000518401,0.000043159973,0.00008447511,0.00009155052,0.00015748703,0.00006268175,0.000032077096,0.000108999724,0.00022665408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015958284,0.00008932096,0.018912982,0.000001049103,0.0002129894,0.000011801556,0.00054365804,0.0000011934337,0.00045313637,0.000046448193,0.92837155,0.051196318],"study_design_scores_gemma":[0.001662589,0.00019907708,0.21374631,0.000047636135,0.0002619626,0.00027871024,0.00019100354,0.000016590944,0.0065829232,0.0003431469,0.7766148,0.000055268487],"about_ca_topic_score_codex":0.00054373126,"about_ca_topic_score_gemma":0.00011152972,"teacher_disagreement_score":0.27654696,"about_ca_system_score_codex":0.0003795342,"about_ca_system_score_gemma":0.0001935009,"threshold_uncertainty_score":0.9995297},"labels":[],"label_agreement":null},{"id":"W2990380228","doi":"10.1182/blood-2019-131450","title":"Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Cancer research; Diffuse large B-cell lymphoma; Medicine; Immunophenotyping; Phenotype; Biology; Oncology; Internal medicine; Pathology; Gene; Immunology; Genetics; Flow cytometry","score_opus":0.011188841456222294,"score_gpt":0.27004366637686683,"score_spread":0.25885482492064454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990380228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392676,0.0009216877,0.00005253214,0.00036752428,0.00007848159,0.0012004373,0.000047965867,0.00015316207,0.0032514709],"genre_scores_gemma":[0.99710774,0.000019682424,0.0005981907,0.00085786864,0.000047877693,0.00010413206,0.0002199041,0.00009292608,0.0009516921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714714,0.00018248512,0.00050622196,0.000838933,0.0007592831,0.00056593143],"domain_scores_gemma":[0.9979844,0.0001975782,0.00030779772,0.00096243306,0.00017213762,0.00037562405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002651002,0.0004292211,0.00082143786,0.00008064482,0.00007257445,0.000044679087,0.00017161919,0.00030966027,0.00011740277],"category_scores_gemma":[0.00019473683,0.00025868908,0.0002823388,0.0002826437,0.00006323375,0.000064733154,0.00012503828,0.0002780409,0.000108982385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078327884,0.028928671,0.9486418,0.00007518072,0.0007106316,0.005424182,0.00006529216,0.0000026422913,0.014965676,0.0000835052,0.00025310542,0.00006605899],"study_design_scores_gemma":[0.14321686,0.0046346835,0.71050936,0.0008878143,0.0026540952,0.00019001521,0.0000923116,0.000079313955,0.13587147,0.000025784975,0.0011375769,0.000700719],"about_ca_topic_score_codex":0.000037528258,"about_ca_topic_score_gemma":0.00001251722,"teacher_disagreement_score":0.23813242,"about_ca_system_score_codex":0.00011129973,"about_ca_system_score_gemma":0.0002096042,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2990515258","doi":"10.1097/pas.0000000000001414","title":"Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Institutes of Health; Agence Nationale de la Recherche","keywords":"Staining; Immunohistochemistry; Lymphoma; Pathology; Differential diagnosis; Marginal zone; T-cell lymphoma; Follicular hyperplasia; Biology; Medicine; B cell; Antibody; Immunology","score_opus":0.007259949086177266,"score_gpt":0.2505575440526488,"score_spread":0.24329759496647152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990515258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965924,0.00034360038,0.000019096482,0.0017027108,0.00014355045,0.00014535317,0.0000071488475,0.000003307009,0.0010428245],"genre_scores_gemma":[0.9985508,0.00053343695,0.00042249524,0.00029673908,0.000083475126,0.0000025857073,0.0000018809196,0.000011221408,0.00009738708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857116,0.0002786543,0.0005051683,0.00014138677,0.000272356,0.00023125838],"domain_scores_gemma":[0.9985794,0.0004419555,0.0005420376,0.00020893109,0.00012065285,0.000107053565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044963154,0.00013424623,0.0008173031,0.00014759356,0.00001777191,0.0000035319708,0.00012648065,0.000042467305,0.00012307263],"category_scores_gemma":[0.0000134739,0.00007509995,0.00021368626,0.0002532935,0.00039070434,0.000040679206,0.00004676885,0.00013996473,0.000045570163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021620473,0.004463485,0.529575,0.000060951363,0.00045314748,0.03707947,0.0023105135,0.00022173244,0.09576786,0.0009160158,0.00038370266,0.30714762],"study_design_scores_gemma":[0.011368504,0.008891091,0.940673,0.00025434353,0.0001706011,0.014731441,0.0010081978,0.000045520148,0.021273708,0.00008820818,0.0013565677,0.00013880654],"about_ca_topic_score_codex":0.00007217375,"about_ca_topic_score_gemma":0.0000012665797,"teacher_disagreement_score":0.411098,"about_ca_system_score_codex":0.000118241725,"about_ca_system_score_gemma":0.0001359068,"threshold_uncertainty_score":0.30624872},"labels":[],"label_agreement":null},{"id":"W2990732386","doi":"10.1182/blood-2019-129323","title":"Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Minimal residual disease; Rituximab; Lenalidomide; Internal medicine; Oncology; Bortezomib; Progression-free survival; Multiple myeloma; Surgery; Lymphoma; Chemotherapy; Leukemia","score_opus":0.016779149720129456,"score_gpt":0.299942393250783,"score_spread":0.28316324353065353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990732386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888484,0.0008142489,0.00024722377,0.0015729996,0.00035631852,0.0071521583,0.0005948162,0.000036544367,0.0003773319],"genre_scores_gemma":[0.99402475,0.00006261793,0.0016980924,0.00027274975,0.00023286519,0.0015872824,0.0019060306,0.000040907034,0.00017469208],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705416,0.00041965072,0.0010112828,0.00054018735,0.0005891028,0.00038561545],"domain_scores_gemma":[0.99752796,0.0011263705,0.00050349504,0.0005485756,0.00015706429,0.00013654926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011801533,0.0003593963,0.0012403181,0.00020107938,0.000086412816,0.00004552766,0.00016404675,0.00015091534,0.00016568293],"category_scores_gemma":[0.00032499727,0.00025037248,0.0004905536,0.00015925553,0.00008720565,0.00012858414,0.00002854384,0.00010604556,0.000023028251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8682367,0.114473954,0.0021884025,0.00048474927,0.00054149656,0.000075857446,0.0003406602,0.000015839327,0.008078523,0.00019494609,0.003563155,0.0018056968],"study_design_scores_gemma":[0.93990195,0.0026215329,0.000717708,0.00016693554,0.0027499865,0.000008184166,0.00031677622,0.0012327433,0.05131216,0.000075423806,0.0006604059,0.00023621491],"about_ca_topic_score_codex":0.00019923152,"about_ca_topic_score_gemma":0.000023791268,"teacher_disagreement_score":0.11185242,"about_ca_system_score_codex":0.00015854948,"about_ca_system_score_gemma":0.0007113437,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2991255594","doi":"10.1182/blood-2019-121584","title":"Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency; Terry Fox Research Institute; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"FOXP3; Tumor microenvironment; Biology; Immune system; Population; T cell; Cancer research; Mass cytometry; Immunology; Phenotype; Medicine; Genetics","score_opus":0.009301428537718532,"score_gpt":0.2095377803471642,"score_spread":0.20023635180944566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991255594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306226,0.0035731671,0.000001935449,0.00030097627,0.000036880298,0.0005313138,0.000066573484,0.000014647478,0.0024122458],"genre_scores_gemma":[0.99877614,0.0001123291,0.00022002452,0.00043961767,0.000019580315,0.00006180724,0.000073859155,0.000022736927,0.0002738885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845374,0.00010932168,0.00040031117,0.00036168544,0.00037248145,0.00030246476],"domain_scores_gemma":[0.9989932,0.00012669695,0.0001533579,0.0005901382,0.000014543336,0.00012205734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019151918,0.0002088601,0.00051151117,0.00019071235,0.00003088109,0.000017666638,0.00015011204,0.000045529872,0.00017097515],"category_scores_gemma":[0.000007801746,0.0001431166,0.0003565175,0.00044688728,0.000045414552,0.000040820792,0.000022690023,0.000051088802,0.00012888623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099614044,0.0103486795,0.90720725,0.0001797261,0.00031283608,0.00027981764,0.0006864376,0.000021689899,0.08037327,0.00002132044,0.00013045443,0.00033891058],"study_design_scores_gemma":[0.008966836,0.00040887465,0.91499555,0.000095763324,0.0037088706,0.0000121370895,0.0003216971,0.000026534479,0.07064396,0.000015213591,0.0006557949,0.00014877047],"about_ca_topic_score_codex":0.00007517279,"about_ca_topic_score_gemma":0.000012820786,"teacher_disagreement_score":0.009939805,"about_ca_system_score_codex":0.000107068816,"about_ca_system_score_gemma":0.00005687857,"threshold_uncertainty_score":0.58361256},"labels":[],"label_agreement":null},{"id":"W2991336532","doi":"10.1182/blood-2019-123626","title":"Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Nuclear medicine; Internal medicine; CHOP; Lymphoma; Concordance; International Prognostic Index; Oncology","score_opus":0.012215117717472853,"score_gpt":0.26138917562386216,"score_spread":0.2491740579063893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991336532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992035,0.0002988771,0.000020865444,0.00035173717,0.00012112042,0.0050394256,0.0019484939,0.00006947837,0.00011505438],"genre_scores_gemma":[0.9950643,0.000039425362,0.0023473327,0.0010129818,0.000038310092,0.00061960844,0.0004120804,0.00008940899,0.00037656268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725676,0.00016016811,0.0005063188,0.0008741586,0.00035349364,0.00084912503],"domain_scores_gemma":[0.9978689,0.00058205286,0.00022838499,0.00059398805,0.0003290893,0.00039756607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002395065,0.0005123887,0.00094529963,0.00020733858,0.00012481825,0.00012387944,0.00012896354,0.00011558243,0.000037658407],"category_scores_gemma":[0.00013643634,0.00036389733,0.00007078055,0.0002244717,0.00006290605,0.00020639844,0.000100269506,0.000074013566,0.00005419611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016291678,0.010669693,0.96780026,0.00026639277,0.00025256976,0.00026507906,0.0010901138,2.687455e-7,0.0025243808,0.000015305168,0.0005053785,0.00031890714],"study_design_scores_gemma":[0.1395419,0.008718676,0.84472466,0.0009083521,0.0006561272,0.00004846399,0.00015840471,0.000032286796,0.003950609,0.0000050169856,0.00081066205,0.0004448259],"about_ca_topic_score_codex":0.0003987941,"about_ca_topic_score_gemma":0.0001265678,"teacher_disagreement_score":0.12325022,"about_ca_system_score_codex":0.00027297554,"about_ca_system_score_gemma":0.00019924289,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W2991465708","doi":"10.1016/j.ajur.2019.11.002","title":"Primary lymphomas of the genitourinary tract: A population-based study","year":2019,"lang":"en","type":"article","venue":"Asian journal of urology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Genitourinary system; Urology; Prostate; Prostate cancer; Hazard ratio; Incidence (geometry); Population; Internal medicine; Logistic regression; Cumulative incidence; Epidemiology; Odds ratio; Proportional hazards model; Oncology; Gynecology; Cancer; Confidence interval; Cohort","score_opus":0.008141135240711818,"score_gpt":0.24346893297842073,"score_spread":0.23532779773770893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991465708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331236,0.00032324635,0.0000027020399,0.0037613555,0.00032873233,0.00031880834,0.0000019526974,0.000003422109,0.0019474414],"genre_scores_gemma":[0.9990884,0.0000036178812,0.00011837063,0.00060885015,0.00009857646,0.0000022353408,0.0000019304232,0.000010455943,0.00006753471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990147,0.00012161414,0.0004033601,0.00009406527,0.00024461822,0.000121664925],"domain_scores_gemma":[0.9991134,0.000089641566,0.00038592156,0.0002537195,0.0000893708,0.00006797423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018094732,0.00009427589,0.00036237264,0.000106591324,0.000027051718,0.0000033738663,0.00011722507,0.000057801484,0.0001549501],"category_scores_gemma":[0.00003443437,0.00005473815,0.00020242124,0.00010244506,0.000022421329,0.000038866947,0.00001949817,0.00010144005,0.000011171027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005126835,0.0024627731,0.9913873,0.000017338409,0.00016201504,0.00029112076,0.00022018944,0.000041755968,0.00018170569,0.00002568657,0.00009899366,0.0045984494],"study_design_scores_gemma":[0.0058125756,0.004185102,0.9879604,0.000021781994,0.000334053,0.00087825244,0.00014994125,0.00001002566,0.00014612274,0.00006587482,0.00039592158,0.00003993915],"about_ca_topic_score_codex":0.000017415445,"about_ca_topic_score_gemma":0.0000030788171,"teacher_disagreement_score":0.005776089,"about_ca_system_score_codex":0.00009764856,"about_ca_system_score_gemma":0.00027194392,"threshold_uncertainty_score":0.2232157},"labels":[],"label_agreement":null},{"id":"W2991549326","doi":"10.1182/blood-2019-127375","title":"Mutational Landscape of Grey Zone Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Exome sequencing; Exome; Lymphoma; Indel; Biology; Pathology; Medicine; Cancer research; Genetics; Gene; Single-nucleotide polymorphism; Mutation","score_opus":0.007585221847896805,"score_gpt":0.2292341970435312,"score_spread":0.2216489751956344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991549326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851708,0.00046925078,0.0000022426213,0.00017471654,0.000056020694,0.00015490247,0.000012186322,0.000016787682,0.013943111],"genre_scores_gemma":[0.99844766,0.000019215737,0.0004532338,0.000116220064,0.00004934556,0.000012489223,0.00004715092,0.0000071089758,0.00084757374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995301,0.0000064780957,0.00011381947,0.000107298794,0.00015746157,0.000084890475],"domain_scores_gemma":[0.9996769,0.000039901945,0.000040424988,0.00014315468,0.000052618765,0.000047024507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003071792,0.00006034002,0.00015401232,0.000039176288,0.000009876854,0.0000035434841,0.000025583673,0.00003249288,0.00051875843],"category_scores_gemma":[0.000011390366,0.000045377332,0.00006129132,0.00006502291,0.000011367106,0.00002373606,0.000011750376,0.0000105213,0.0002823459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052056766,0.002434853,0.9896651,0.00005431515,0.0002251637,0.00007831394,0.000097169344,0.0000016879967,0.0013497507,0.0010378371,0.00041232427,0.0045914548],"study_design_scores_gemma":[0.012836571,0.00037804374,0.9571426,0.000053972846,0.0001963341,0.00015248825,0.000043893822,0.000022968981,0.027807198,0.000039360293,0.0012739467,0.00005265041],"about_ca_topic_score_codex":0.000027676688,"about_ca_topic_score_gemma":0.0000022334325,"teacher_disagreement_score":0.0325225,"about_ca_system_score_codex":0.000011745441,"about_ca_system_score_gemma":0.00007279471,"threshold_uncertainty_score":0.56800413},"labels":[],"label_agreement":null},{"id":"W2992123204","doi":"10.1182/blood.v112.11.2179.2179","title":"Outcome of Transplant-Eligible Patients with Hodgkin Lymphoma with An Inadequate Response to Second Line Chemotherapy with Gemcitabine, Dexamethasone, Cisplatin (GDP).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Chemotherapy regimen; Chemotherapy; Gemcitabine; Melphalan; Internal medicine; Salvage therapy; Oncology; Progressive disease; Dacarbazine; Carmustine; Surgery","score_opus":0.01578763191336332,"score_gpt":0.24775741828504852,"score_spread":0.2319697863716852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992123204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978626,0.00007702876,0.00012254251,0.00029670197,0.000016952232,0.0011165086,0.00015522212,0.00006772677,0.00028473593],"genre_scores_gemma":[0.9858253,0.000026168915,0.0128067685,0.00059843843,0.000035718087,0.00012327611,0.000088391644,0.00008358939,0.00041232273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979377,0.00008507015,0.00043067752,0.0005279138,0.0005935543,0.00042510362],"domain_scores_gemma":[0.99844587,0.00015687985,0.00017515942,0.00062504935,0.0002221763,0.00037488635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017792183,0.00040853964,0.00074485544,0.00023227712,0.00009668925,0.000014697794,0.00013297386,0.00010375535,0.00011626351],"category_scores_gemma":[0.000019976394,0.00024584023,0.00006770311,0.0004881494,0.000118620825,0.00013796511,0.000012423391,0.00007718562,0.000015510452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03275776,0.006825905,0.9542869,0.000086009066,0.0005417705,0.00059288286,0.0013763444,0.000020742507,0.0007057238,0.000010325771,0.000039323433,0.0027563649],"study_design_scores_gemma":[0.061204176,0.01984897,0.8660552,0.00026164923,0.0004305307,0.00035672053,0.000051605643,0.000009859398,0.051137656,0.000002148054,0.00031610648,0.00032539121],"about_ca_topic_score_codex":0.00025254287,"about_ca_topic_score_gemma":0.00040583021,"teacher_disagreement_score":0.08823166,"about_ca_system_score_codex":0.00008072829,"about_ca_system_score_gemma":0.00025929607,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2992334141","doi":"10.1182/blood.v104.11.415.415","title":"Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; Comparative genomic hybridization; Cancer research; Chromosome; Large-cell lymphoma; Lymphoma; BCL6; Gene; Chromosomal translocation; Molecular biology; B cell; Genetics; Immunology","score_opus":0.005580039943411296,"score_gpt":0.22384367105558137,"score_spread":0.21826363111217006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992334141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945544,0.002490131,0.00006080867,0.0004992652,0.0003237787,0.0014676175,0.00039827323,0.0001263719,0.00007933757],"genre_scores_gemma":[0.9969628,0.00024663156,0.0009221393,0.0008894775,0.00018616846,0.00039099713,0.0002392381,0.000060841776,0.00010171688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968246,0.00015055416,0.00061501964,0.00096331496,0.0006334646,0.00081303186],"domain_scores_gemma":[0.99815565,0.00033008668,0.00026776807,0.0005933427,0.00014397709,0.00050914346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002952561,0.00058884674,0.0006586977,0.00019858716,0.00041329197,0.00013044261,0.00023836379,0.00033017533,0.000030614025],"category_scores_gemma":[0.00006589413,0.00040816193,0.00012241388,0.00039882242,0.00013890925,0.00019375271,0.00023589104,0.0002799095,0.000012297455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016374479,0.022188252,0.26627874,0.00014842601,0.0000966778,0.0006854376,0.0010305595,0.0001787777,0.70705634,0.0000035499468,0.00039121925,0.0003045605],"study_design_scores_gemma":[0.09696261,0.00076124084,0.13563299,0.0005993416,0.0002422233,0.000039241026,0.00009341628,0.00008145814,0.7644158,0.000008147715,0.00076978,0.00039374022],"about_ca_topic_score_codex":0.00021963673,"about_ca_topic_score_gemma":0.00007486774,"teacher_disagreement_score":0.13064575,"about_ca_system_score_codex":0.00021628,"about_ca_system_score_gemma":0.0002559681,"threshold_uncertainty_score":0.99983704},"labels":[],"label_agreement":null},{"id":"W2992515443","doi":"10.1111/bjh.16319","title":"Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Front line; Second line; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Progression-free survival; Overall survival; Salvage therapy; First line; Chemotherapy","score_opus":0.010816700181680735,"score_gpt":0.2613074448371707,"score_spread":0.25049074465549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992515443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239355,0.0033516407,0.00019183634,0.0021958821,0.00036583294,0.0013198662,0.00006697311,0.000020726733,0.00009367395],"genre_scores_gemma":[0.9947937,0.00030761122,0.00234922,0.0016719837,0.00004555905,0.00004780757,0.00011029237,0.00007277774,0.00060103415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975882,0.0000725756,0.0012016939,0.00033467697,0.00037556858,0.0004272731],"domain_scores_gemma":[0.9959886,0.00022718436,0.0010992085,0.0002918332,0.0022443167,0.00014883492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018972009,0.0003822773,0.00213619,0.00022601482,0.00007605158,0.000036279987,0.00021648362,0.00021103931,0.0003548106],"category_scores_gemma":[0.000114236034,0.00029248063,0.00075612776,0.00013569527,0.00011921633,0.00021097633,0.00003061044,0.00015733867,0.000011446324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02030149,0.006608661,0.8958729,0.000512236,0.015336691,0.008079061,0.001979544,0.000010431226,0.0081849005,0.00013437601,0.007163848,0.035815865],"study_design_scores_gemma":[0.335747,0.026296435,0.34325936,0.0062078726,0.002183137,0.07214216,0.0044354624,0.00012815863,0.20212513,0.00023580196,0.0060425517,0.0011969013],"about_ca_topic_score_codex":0.0002201103,"about_ca_topic_score_gemma":0.00011208102,"teacher_disagreement_score":0.5526135,"about_ca_system_score_codex":0.0002816537,"about_ca_system_score_gemma":0.00031285512,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W2992903207","doi":"10.1182/blood.v112.11.4445.4445","title":"Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Autologous stem-cell transplantation; Melphalan; Surgery; Internal medicine; Transplantation; Diffuse large B-cell lymphoma; Oncology; Chemotherapy","score_opus":0.012277405775385214,"score_gpt":0.2345383361343153,"score_spread":0.22226093035893008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992903207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965696,0.0017186977,0.000035328652,0.000103625396,0.000045582543,0.0005194686,0.00018143699,0.00003972533,0.00078656495],"genre_scores_gemma":[0.9956061,0.0017467148,0.00086899544,0.00048291145,0.00003236217,0.000059165555,0.00010534199,0.00002471183,0.0010736816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992186,0.000016297481,0.00024993625,0.00021138614,0.0001250033,0.00017878332],"domain_scores_gemma":[0.99944955,0.00013498169,0.00011295392,0.00018187966,0.000040050993,0.00008057776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052695283,0.00015586389,0.0003984167,0.000056989946,0.000057699664,0.0000034392383,0.00003743427,0.00009525961,0.000020343856],"category_scores_gemma":[0.0000018274721,0.00011908465,0.00010910016,0.000040311446,0.000035310542,0.00004442117,0.000006498598,0.000024913275,0.0000031303568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009474881,0.051584493,0.8928411,0.0019910175,0.0004949331,0.00038429172,0.0032982666,2.1671528e-7,0.031393435,0.000041558756,0.00046213914,0.01656105],"study_design_scores_gemma":[0.056772478,0.0007525728,0.74755114,0.00002230431,0.0003253124,0.00010728779,0.000037957045,0.000004243952,0.19322984,0.0000055783266,0.001094612,0.00009663936],"about_ca_topic_score_codex":0.000011646559,"about_ca_topic_score_gemma":0.0000070138312,"teacher_disagreement_score":0.16183642,"about_ca_system_score_codex":0.000034474404,"about_ca_system_score_gemma":0.00008147742,"threshold_uncertainty_score":0.4856131},"labels":[],"label_agreement":null},{"id":"W2992929603","doi":"10.1182/bloodadvances.2019000989","title":"Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Tissue microarray; Primary central nervous system lymphoma; Lymphoma; Immunohistochemistry; Diffuse large B-cell lymphoma; Germinal center; Pathology; Population; Biology; Cancer research; Medicine; Oncology; B cell; Immunology; Antibody","score_opus":0.004682424687550408,"score_gpt":0.24079021047376006,"score_spread":0.23610778578620967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992929603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97164917,0.023911638,0.000024886003,0.000024765415,0.00018106643,0.00063612405,0.000056642995,0.000028888226,0.0034868103],"genre_scores_gemma":[0.9970935,0.00018586549,0.0024422125,0.00006935235,0.000044707354,0.000013650804,0.000035047113,0.000021089654,0.00009455664],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988339,0.000032249663,0.00030386075,0.0002577029,0.00028981504,0.00028246417],"domain_scores_gemma":[0.999264,0.000034781424,0.00020816522,0.0003238119,0.0000830845,0.000086177984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006892121,0.00017052265,0.0005970961,0.000066100925,0.00002380341,0.0000057202487,0.00008271057,0.000068810325,0.000016063183],"category_scores_gemma":[0.000010748848,0.00013230224,0.00012821371,0.00012961481,0.000040903975,0.00007392637,0.000036512738,0.00002792731,0.0000048886423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020538404,0.001562719,0.69221646,0.0020802424,0.00060609373,0.0002976331,0.00015893442,0.000085012485,0.2912922,0.00085322757,0.000031779375,0.010610321],"study_design_scores_gemma":[0.0030932236,0.00027160064,0.4568749,0.00055601686,0.0004969842,0.0002097544,0.0001305309,0.000009702294,0.537128,0.0000037000966,0.0011316154,0.000093991235],"about_ca_topic_score_codex":0.00014472379,"about_ca_topic_score_gemma":0.0000050306494,"teacher_disagreement_score":0.24583578,"about_ca_system_score_codex":0.00010846356,"about_ca_system_score_gemma":0.00013559974,"threshold_uncertainty_score":0.5395129},"labels":[],"label_agreement":null},{"id":"W2992937776","doi":"10.1182/blood.v110.11.1559.1559","title":"Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Gastroenterology; B symptoms; Bone marrow; CHOP; Lymphoma; Histology; Stage (stratigraphy); Oncology","score_opus":0.0073523360818314315,"score_gpt":0.21575489421500413,"score_spread":0.2084025581331727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992937776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676603,0.00027291465,0.000026521962,0.00010255812,0.0000359395,0.0024543921,0.00017998363,0.000022937857,0.00013869918],"genre_scores_gemma":[0.9988998,0.000026177247,0.0003202244,0.0002684725,0.00002441947,0.00018780086,0.00006944114,0.00004461143,0.0001590261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980461,0.000031721233,0.000519096,0.00041325387,0.00052257127,0.00046723103],"domain_scores_gemma":[0.9989218,0.0000909455,0.00026248107,0.00044419212,0.000093434166,0.00018714258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023908463,0.0003185852,0.00055704237,0.000121563025,0.00007512926,0.000017830487,0.00009386159,0.0000655621,0.0000066385883],"category_scores_gemma":[0.000019067966,0.00015980554,0.00009684438,0.00020506055,0.00010082674,0.00006282554,0.000080921294,0.0000678542,8.4814906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021865321,0.03809409,0.9582167,0.00015506533,0.00028737422,0.00013873847,0.0002569644,4.350986e-7,0.0001487248,0.000048008522,0.000025796182,0.0004415241],"study_design_scores_gemma":[0.17446955,0.0026894335,0.81368893,0.0002843295,0.0006934425,0.00002295012,0.00022216678,0.0000121534,0.007645297,0.000005210595,0.00010260406,0.00016390467],"about_ca_topic_score_codex":0.00047262982,"about_ca_topic_score_gemma":0.0010319921,"teacher_disagreement_score":0.17228302,"about_ca_system_score_codex":0.00016879692,"about_ca_system_score_gemma":0.00011062367,"threshold_uncertainty_score":0.6516681},"labels":[],"label_agreement":null},{"id":"W2993344323","doi":"10.1182/blood.v110.11.2631.2631","title":"Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Diffuse large B-cell lymphoma; Biology; Lymphoma; Germinal center; Gene expression profiling; Cancer research; Locus (genetics); Copy-number variation; B cell; Genetics; Gene; Molecular biology; Gene expression; Genome; Immunology; Antibody","score_opus":0.004870220772332295,"score_gpt":0.22123690854469538,"score_spread":0.2163666877723631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993344323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952009,0.0018510399,0.00040293857,0.000050273862,0.000031900712,0.00028465074,0.00003715433,0.000028094162,0.0021130913],"genre_scores_gemma":[0.9985637,0.00004591164,0.0010781337,0.00006834974,0.000021833002,0.000028158443,0.00005177309,0.000019337764,0.00012281189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990489,0.000022983,0.00028510747,0.00020354982,0.00017872828,0.0002607218],"domain_scores_gemma":[0.99944204,0.000061855375,0.00007266563,0.0002679305,0.000044848377,0.00011064907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076892,0.00013395296,0.00022440098,0.00008951521,0.00002992054,0.000006596046,0.0000555986,0.000076776865,0.000034959852],"category_scores_gemma":[0.00004075674,0.000113882954,0.00007622534,0.0002111894,0.000028518585,0.00001777656,0.00001530735,0.000032415675,0.00001869415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006453134,0.03022907,0.72376496,0.00006566005,0.00011424561,0.00043438422,0.0002837284,3.5679497e-7,0.24345043,0.00003913926,0.00017940023,0.0013741229],"study_design_scores_gemma":[0.014130669,0.00017988349,0.52732444,0.000027293594,0.00016751266,0.0000162773,0.000029205255,0.000005089488,0.45771948,0.00001447489,0.00031444384,0.00007121201],"about_ca_topic_score_codex":0.00014102859,"about_ca_topic_score_gemma":0.00025567276,"teacher_disagreement_score":0.21426906,"about_ca_system_score_codex":0.000051035564,"about_ca_system_score_gemma":0.00005951606,"threshold_uncertainty_score":0.46440122},"labels":[],"label_agreement":null},{"id":"W2993371734","doi":"10.1182/blood.v110.11.2610.2610","title":"Developing a Multidimensional Prognostic Test for Follicular Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Gene expression profiling; Lymphoma; Significance analysis of microarrays; Carcinogenesis; Oncology; Microarray; DNA microarray; Survival analysis; Microarray analysis techniques; Clinical significance; Gene; Internal medicine; Gene expression; Gene signature; Medicine; Tissue microarray; Biology; Immunohistochemistry; Cancer; Genetics","score_opus":0.02119330908128852,"score_gpt":0.2797847300895112,"score_spread":0.2585914210082227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993371734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959835,0.00077114475,0.001188831,0.00051758357,0.000079132675,0.00090489775,0.000011714746,0.00007630918,0.00046690556],"genre_scores_gemma":[0.9417755,0.000017170061,0.05716663,0.0005214033,0.00015619575,0.00014969305,0.000056707868,0.000021108957,0.00013559888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990711,0.000004413211,0.00020646477,0.00023358919,0.00018160953,0.00030281965],"domain_scores_gemma":[0.99907184,0.0004905552,0.000046151523,0.00015029985,0.00011148079,0.00012969808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598257,0.0001356639,0.0001978856,0.00006282177,0.0000909138,0.000008696023,0.000032026295,0.000066977795,0.000010123115],"category_scores_gemma":[0.00036346947,0.00010440997,0.00011279335,0.000112189584,0.000021472326,0.000025786783,0.00002238755,0.000017534634,0.000042709096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108850036,0.0065051517,0.9620224,0.00013720186,0.00043779946,0.00077021675,0.00011247465,4.9018297e-7,0.0050695133,0.0040221373,0.00043762577,0.020376133],"study_design_scores_gemma":[0.01921808,0.00056259485,0.8389576,0.00023996267,0.0006133457,0.00042003748,0.00004049774,0.000035026504,0.12420468,0.00011854035,0.015402669,0.00018694824],"about_ca_topic_score_codex":0.000016250024,"about_ca_topic_score_gemma":0.00001033631,"teacher_disagreement_score":0.123064786,"about_ca_system_score_codex":0.000097870674,"about_ca_system_score_gemma":0.00019146927,"threshold_uncertainty_score":0.4257715},"labels":[],"label_agreement":null},{"id":"W2994020356","doi":"10.1182/blood.v108.11.830.830","title":"Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Medicine; Proteasome inhibitor; Gene expression; Gene expression profiling; Cancer research; Gene signature; Lymphoma; Internal medicine; Biology; Oncology; Immunology; Gene; Multiple myeloma; Genetics","score_opus":0.009327423891404257,"score_gpt":0.24968282173459902,"score_spread":0.24035539784319476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994020356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423224,0.0027790994,0.00006799946,0.0015169047,0.000028002638,0.0010321896,0.00024483792,0.000059369835,0.000039357845],"genre_scores_gemma":[0.9894188,0.0005253795,0.009177678,0.00013337455,0.00007970567,0.00033047784,0.00012537853,0.00003179529,0.00017737907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998801,0.00014161912,0.00027317324,0.00044799762,0.000112146685,0.00022407318],"domain_scores_gemma":[0.99913126,0.00025459664,0.00010888226,0.00032595053,0.00006182698,0.000117484924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034640272,0.00019700886,0.00028712384,0.00016637855,0.00012581052,0.00003952201,0.00004880383,0.00018940789,0.0000039266947],"category_scores_gemma":[0.00003872793,0.00016082423,0.000047919024,0.00012715999,0.000055145614,0.00014706719,0.000022861455,0.00005060159,4.603767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0129949665,0.0045167757,0.039779074,0.000040404608,0.000037228427,0.000039577048,0.00024353071,0.0000091928,0.94075304,0.000017864008,0.00033509897,0.0012332352],"study_design_scores_gemma":[0.024994317,0.0005532797,0.5304687,0.000084209656,0.00010435097,0.00007120613,0.00006201803,0.000035004585,0.4431287,0.000053662738,0.00034547388,0.00009910444],"about_ca_topic_score_codex":0.000056745524,"about_ca_topic_score_gemma":0.000006318713,"teacher_disagreement_score":0.49762437,"about_ca_system_score_codex":0.0000646555,"about_ca_system_score_gemma":0.00009989709,"threshold_uncertainty_score":0.65582216},"labels":[],"label_agreement":null},{"id":"W2994024326","doi":"10.1182/blood.v104.11.5.5","title":"Specific Peptide Disruption of the Bcl-6 Repression Complex Reveals Its Transcriptional Mechanism of Action in Normal and Malignant B-Cells and Is a Novel Therapeutic Approach for Diffuse Large B-Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Psychological repression; Repressor; Biology; Corepressor; Cell biology; Germinal center; Endogeny; Gene; Transcriptional regulation; Promoter; Cancer research; Transcription factor; Molecular biology; B cell; Gene expression; Genetics; Antibody; Biochemistry","score_opus":0.04470785498235028,"score_gpt":0.2648452568291223,"score_spread":0.22013740184677202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994024326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961204,0.0011450824,0.0012884061,0.00015627638,0.000033509943,0.00094529917,0.0002020596,0.000007252938,0.00010171934],"genre_scores_gemma":[0.99663,0.00082485547,0.002240144,0.00009417562,0.000023504264,0.00007662243,0.000034762303,0.000014486663,0.00006140873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990554,0.000025180185,0.00029959323,0.00026233972,0.00019872957,0.00015874793],"domain_scores_gemma":[0.99953055,0.000040740022,0.00014469193,0.00018634372,0.000047622856,0.000050072962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015022955,0.00013739504,0.00027526208,0.00006436038,0.000059458973,0.0000081262515,0.00004402537,0.000081370665,0.0000061648975],"category_scores_gemma":[0.0000048400734,0.000090602676,0.00009622679,0.0000887173,0.00003958528,0.0000628805,0.000022830118,0.000033478886,3.3372172e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002901649,0.019170584,0.0054826112,0.00040919657,0.00007374497,0.0000019271258,0.001092233,0.0000052066985,0.9693493,0.0035793039,0.0000087974995,0.0005369112],"study_design_scores_gemma":[0.07566064,0.00046739046,0.30738357,0.00034266373,0.0003883356,0.00008077714,0.000366194,0.00045916275,0.61411715,0.0004663488,0.00013328913,0.00013447506],"about_ca_topic_score_codex":0.00003235788,"about_ca_topic_score_gemma":0.00000505357,"teacher_disagreement_score":0.35523215,"about_ca_system_score_codex":0.00004383111,"about_ca_system_score_gemma":0.000034144174,"threshold_uncertainty_score":0.369467},"labels":[],"label_agreement":null},{"id":"W2994047002","doi":"10.1182/blood.v112.11.3052.3052","title":"Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Autologous stem-cell transplantation; Refractory (planetary science); Thalidomide; Transplantation; Regimen; Phases of clinical research; Gastroenterology; Surgery; Oncology; Clinical trial; Multiple myeloma","score_opus":0.020010048282270283,"score_gpt":0.26208813616875676,"score_spread":0.24207808788648646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994047002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818105,0.00011441196,5.499003e-7,0.000058950187,0.00006914372,0.0007518048,0.00001936622,0.000021655303,0.0007830845],"genre_scores_gemma":[0.99901927,0.000075612545,0.00034470423,0.000087700246,0.0000694728,0.00007109266,0.000046325804,0.000019204263,0.00026662846],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890774,0.00003977976,0.00033401378,0.00021691949,0.0003181271,0.00018344351],"domain_scores_gemma":[0.99932754,0.000075194155,0.00013860124,0.0002977512,0.0000646461,0.000096295655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007057654,0.00014741156,0.00041154673,0.000112899696,0.000049979,0.0000023123698,0.00005101407,0.000074521304,0.00007262814],"category_scores_gemma":[0.00009238077,0.00009090931,0.00007357912,0.00018143255,0.00006146975,0.00005756054,0.000022902892,0.00003904449,0.000009124551],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29219118,0.25743276,0.42739898,0.00005824839,0.00054240075,0.0013545081,0.00085605483,6.04253e-7,0.00028310856,0.00002367104,0.00096150144,0.018896997],"study_design_scores_gemma":[0.73679703,0.03274011,0.22039877,0.00013679393,0.0002466514,0.000028993094,0.000015267453,9.268395e-7,0.008553804,0.0000026048533,0.0009792795,0.000099787096],"about_ca_topic_score_codex":0.00011087697,"about_ca_topic_score_gemma":0.000018984647,"teacher_disagreement_score":0.44460586,"about_ca_system_score_codex":0.00008325628,"about_ca_system_score_gemma":0.0002718411,"threshold_uncertainty_score":0.37071738},"labels":[],"label_agreement":null},{"id":"W2994147959","doi":"10.1182/blood.v104.11.26.26","title":"Mechanisms of Bcl-2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; Gene expression profiling; Biology; Biomarker; Immunohistochemistry; Lymphoma; Oncology; Internal medicine; Cancer research; Pathology; Medicine; Gene expression; Gene; Genetics","score_opus":0.007736694115331765,"score_gpt":0.22432546442844234,"score_spread":0.21658877031311058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994147959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686587,0.00064834196,0.00013018158,0.00017373789,0.000032169286,0.0006609603,0.000015140981,0.000036295853,0.0014372945],"genre_scores_gemma":[0.99625826,0.000039458442,0.0031943722,0.00009891453,0.000022482716,0.00015405717,0.00001741049,0.000020590456,0.00019446312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.000022328268,0.00025772981,0.00023361934,0.00024207564,0.0002463751],"domain_scores_gemma":[0.99945647,0.000015452952,0.000084191604,0.000310209,0.000029405177,0.00010425539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008629697,0.00014660764,0.00029125414,0.00009664852,0.000027628352,0.0000061675264,0.00006691392,0.00009842904,0.000028443848],"category_scores_gemma":[0.000023288876,0.00010999113,0.0000927769,0.00013443682,0.000015623425,0.00004526029,0.000046956033,0.000036261816,0.000043495613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002093483,0.2634354,0.013547065,0.00033016305,0.00008122164,0.0010035598,0.00066869054,0.0000012120844,0.71409255,0.0049465923,0.00006564702,0.0016185557],"study_design_scores_gemma":[0.11976136,0.00047128997,0.020877982,0.000478972,0.000080255864,0.000024372946,0.00008233331,0.0000019460092,0.8567142,0.0012296567,0.00018243336,0.00009517454],"about_ca_topic_score_codex":0.000092008166,"about_ca_topic_score_gemma":0.000021953407,"teacher_disagreement_score":0.2629641,"about_ca_system_score_codex":0.0000837714,"about_ca_system_score_gemma":0.000110717,"threshold_uncertainty_score":0.44853082},"labels":[],"label_agreement":null},{"id":"W2994454378","doi":"10.1182/blood.v108.11.812.812","title":"Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; CHOP; Rituximab; Lymphoma; Immunohistochemistry; Internal medicine; Population; Oncology; Medicine; clone (Java method); Pathology; Cancer research; Biology","score_opus":0.014465876877807768,"score_gpt":0.2524514469081901,"score_spread":0.23798557003038234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994454378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770886,0.00025201327,0.000011931162,0.000050109007,0.000022880344,0.00058920536,0.00013283396,0.00006442557,0.0011677438],"genre_scores_gemma":[0.9979396,0.000027845059,0.0005182897,0.00010306807,0.000093057155,0.00012186421,0.00006256202,0.000052738244,0.0010810079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982826,0.000046939782,0.0004273181,0.00040041187,0.00040235906,0.00044033027],"domain_scores_gemma":[0.99906856,0.00004146953,0.00016158434,0.00048449248,0.000054717413,0.00018919747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010278377,0.00028369224,0.0004843761,0.00015194857,0.000044521083,0.000019642768,0.00011272065,0.00016685031,0.00019268903],"category_scores_gemma":[0.000011043648,0.00017441963,0.000088034096,0.00019096515,0.0000349893,0.00010749918,0.000042782387,0.00007071326,0.000011962543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054373767,0.05738108,0.93465465,0.00007799571,0.00008121191,0.000628072,0.00042910635,0.0000022796714,0.0058927136,0.000011215917,0.00007499058,0.00022292028],"study_design_scores_gemma":[0.09447419,0.0009983444,0.77156603,0.00019894747,0.0003195324,0.000072049144,0.00019075595,0.00004155522,0.13177824,0.0000027666579,0.0002011082,0.00015647255],"about_ca_topic_score_codex":0.001351177,"about_ca_topic_score_gemma":0.0006726285,"teacher_disagreement_score":0.16308865,"about_ca_system_score_codex":0.00019182528,"about_ca_system_score_gemma":0.0001355285,"threshold_uncertainty_score":0.71126264},"labels":[],"label_agreement":null},{"id":"W2994693426","doi":"10.1158/2159-8290.cd-19-0680","title":"Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Spinal Cord Injury BC; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"Terry Fox Research Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; European Hematology Association; Uehara Memorial Foundation; Genome Canada; Kanae Foundation for the Promotion of Medical Science; Michael Smith Health Research BC; Genome British Columbia","keywords":"Transcriptome; Lymphoma; Tumor microenvironment; Cancer research; Disease; Biology; Cell; Computational biology; Hodgkin lymphoma; Tumor cells; Medicine; Immunology; Gene; Pathology; Genetics; Gene expression","score_opus":0.013347780846316822,"score_gpt":0.23635757799463727,"score_spread":0.22300979714832045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994693426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98568034,0.01102222,0.000009762398,0.00061184977,0.0001307878,0.00060737657,0.00022931352,0.000011305777,0.001697054],"genre_scores_gemma":[0.9968541,0.00067671965,0.000041251744,0.0010846707,0.00003945272,0.0001799084,0.00010247569,0.000028898869,0.0009924738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824005,0.00009843845,0.00043649948,0.00045666957,0.00041910188,0.0003492307],"domain_scores_gemma":[0.99891126,0.00013095928,0.00019670824,0.0006293719,0.00001587827,0.000115802555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015986807,0.0002563798,0.0006096935,0.00019247152,0.000033831242,0.000040080544,0.00017610805,0.000046609963,0.00020788267],"category_scores_gemma":[0.0000061977476,0.00017330812,0.0004408721,0.0005190435,0.000082148734,0.00015164696,0.00002886254,0.00006574681,0.000055008666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035462403,0.0024287426,0.94949687,0.0003101272,0.00033843415,0.00014095605,0.0006394872,0.0002761403,0.04429469,0.00004921132,0.0006503668,0.00102038],"study_design_scores_gemma":[0.0051414766,0.00024825794,0.9692368,0.00028474332,0.0022444644,0.0000042498937,0.0005316843,0.000069572816,0.020410458,0.000024891122,0.0015874942,0.00021590546],"about_ca_topic_score_codex":0.00028551943,"about_ca_topic_score_gemma":0.000057729914,"teacher_disagreement_score":0.02388423,"about_ca_system_score_codex":0.0005791645,"about_ca_system_score_gemma":0.00017536768,"threshold_uncertainty_score":0.70672995},"labels":[],"label_agreement":null},{"id":"W2995810532","doi":"10.1200/jco.2012.30.15_suppl.9524","title":"Treatment of pediatric stage IA lymphocyte-predominant Hodgkin lymphoma with surgical resection alone: A report from the Children's Oncology Group.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Vincristine; Lymphoma; Cyclophosphamide; Lymph node; Chemotherapy; Prednisone; Nodular sclerosis; Surgery; Internal medicine; Hodgkin lymphoma","score_opus":0.07159168697889091,"score_gpt":0.4260902205038798,"score_spread":0.3544985335249889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995810532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864253,0.0072776987,0.000026309523,0.0029946775,0.0014093746,0.0005727729,0.000026613763,0.000013349405,0.0012539314],"genre_scores_gemma":[0.9795119,0.012047319,0.0020972774,0.00023739498,0.0058056586,0.00003829152,0.000036727623,0.000030702893,0.00019470333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99441415,0.0010502351,0.0030500498,0.00034175953,0.0006643488,0.00047948558],"domain_scores_gemma":[0.98881257,0.005951809,0.0037090285,0.0005379165,0.0003615572,0.0006271027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025510977,0.00031335294,0.0024784664,0.000137793,0.00009528499,0.000010458329,0.00018648499,0.0006002596,0.00022574863],"category_scores_gemma":[0.0010045662,0.00014922537,0.00088924513,0.00026844558,0.00034261533,0.00014750082,0.000064535605,0.0002695652,0.000024033956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019304637,0.017719414,0.79640263,0.000008243232,0.0016230418,0.008091718,0.00021135769,0.000004481425,0.000013272193,0.00006814961,0.001369262,0.15518379],"study_design_scores_gemma":[0.04505731,0.046657953,0.7924218,0.000036731017,0.0026869862,0.013612879,0.00013469602,0.000009323055,0.00024263738,0.000019154108,0.098997794,0.00012272774],"about_ca_topic_score_codex":0.0011692955,"about_ca_topic_score_gemma":0.00021693656,"teacher_disagreement_score":0.15506107,"about_ca_system_score_codex":0.0016439573,"about_ca_system_score_gemma":0.0029238546,"threshold_uncertainty_score":0.60852337},"labels":[],"label_agreement":null},{"id":"W2996543298","doi":"10.1016/j.urology.2019.12.011","title":"Do not Forget Burkitt´s Lymphoma! Unusual Case of Primary Malignant Lymphoma of the Prostate in a Young Patient","year":2019,"lang":"en","type":"article","venue":"Urology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Prostate; Lymphoma; Etiology; Differential diagnosis; Urinary system; Population; Burkitt's lymphoma; Pathology; Internal medicine; Oncology; Cancer","score_opus":0.008622663217946948,"score_gpt":0.23031214134970673,"score_spread":0.2216894781317598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996543298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946851,0.00046425255,0.0000011064461,0.0005571,0.00028792047,0.0009573862,0.000057115714,0.000011116681,0.0029788695],"genre_scores_gemma":[0.9989225,0.00004640335,0.00005155097,0.0007142266,0.000016976892,0.00007410848,0.000015622983,0.000019978706,0.0001386127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858266,0.00010200677,0.00049760495,0.00030554534,0.00020352668,0.00030863134],"domain_scores_gemma":[0.9989617,0.00012774987,0.00024280502,0.00052258145,0.00008103282,0.00006416937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014989112,0.00017520846,0.00052047824,0.00012690271,0.00002333005,0.0000032770738,0.000096138,0.0001267679,0.00003167688],"category_scores_gemma":[0.00004090121,0.00010948424,0.00014422454,0.00020269131,0.00012481975,0.000034750603,0.00014226457,0.000037557427,0.000013830212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016468887,0.0025205344,0.9348521,0.00020630627,0.00016564286,0.0021638414,0.0026350585,0.000052127325,0.0056683593,0.0013442325,0.00020507399,0.048539784],"study_design_scores_gemma":[0.014399758,0.0030316056,0.94133765,0.00011229315,0.00020352732,0.00546502,0.00031553503,0.00023051297,0.033284195,0.00015566382,0.001301377,0.00016288359],"about_ca_topic_score_codex":0.001019059,"about_ca_topic_score_gemma":0.00020464958,"teacher_disagreement_score":0.048376903,"about_ca_system_score_codex":0.00019811126,"about_ca_system_score_gemma":0.00025640675,"threshold_uncertainty_score":0.44646376},"labels":[],"label_agreement":null},{"id":"W2996645013","doi":"10.14740/jmc3386","title":"A Rare Case of Ovarian Follicular Lymphoma: Incidental Finding in a Woman With Postmenopausal Bleeding","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Abdominal distension; Abdominal pain; Lymphoma; Malignancy; Follicular lymphoma; Weight loss; Lower abdominal pain; Internal medicine; Gastroenterology; Gynecology; Surgery; Obesity","score_opus":0.015982179000513175,"score_gpt":0.2881926881872952,"score_spread":0.272210509186782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996645013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996739,0.0014514849,0.000006094856,0.0011859633,0.00014558999,0.0002220431,0.000006195142,0.0000059142176,0.00023775446],"genre_scores_gemma":[0.9989544,0.000092885006,0.00040962602,0.00033096687,0.0001654311,0.0000049983933,0.0000038861326,0.000016929185,0.000020845102],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99784887,0.000057261597,0.00062171434,0.00015181492,0.0010791672,0.00024116959],"domain_scores_gemma":[0.9986691,0.00033320562,0.00035142395,0.00014391237,0.00011571395,0.00038665402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005850524,0.0001622561,0.0006265468,0.0003024854,0.000031356016,0.000016784283,0.00010218576,0.00012983139,0.0004488691],"category_scores_gemma":[0.000375614,0.00010122336,0.00012791753,0.00026388676,0.00006385584,0.0001384063,0.00005309219,0.00016619032,0.000006823887],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011448122,0.0015548618,0.48701546,0.00016001207,0.0002969581,0.5031817,0.00059406686,0.0000049867695,0.00046730431,0.00018157093,0.00032528717,0.005072966],"study_design_scores_gemma":[0.032142285,0.008506701,0.20789325,0.004329677,0.00055897376,0.73791,0.0038358076,0.00017406464,0.0039909114,0.00002412597,0.00042682115,0.00020742117],"about_ca_topic_score_codex":0.0006957045,"about_ca_topic_score_gemma":0.0001567341,"teacher_disagreement_score":0.2791222,"about_ca_system_score_codex":0.00034071432,"about_ca_system_score_gemma":0.00059240847,"threshold_uncertainty_score":0.4914802},"labels":[],"label_agreement":null},{"id":"W2996675598","doi":"10.1111/bjh.16293","title":"Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Vinblastine; Stage (stratigraphy); Medicine; Bleomycin; Internal medicine; Oncology; Brentuximab vedotin; Lymphoma; Neoplasm staging; Hodgkin lymphoma; Chemotherapy; Vincristine; Cancer; Cyclophosphamide","score_opus":0.00815239974218571,"score_gpt":0.23888078609825175,"score_spread":0.23072838635606605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996675598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984226,0.0003186314,0.0000234472,0.00017907377,0.00025073855,0.00041661394,0.000017872911,0.0000057271477,0.00036527528],"genre_scores_gemma":[0.99902374,0.00006430014,0.0006846107,0.00008489605,0.000021391237,0.000010658745,0.000042260403,0.000015027876,0.00005309169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870557,0.00005505614,0.0005774184,0.00015460727,0.0003391807,0.00016818214],"domain_scores_gemma":[0.9988114,0.00010958796,0.00053980807,0.000109131404,0.00035644326,0.0000736068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001231374,0.00010929936,0.00055662217,0.00020141079,0.0000146429265,0.000015319203,0.0001043164,0.0000757267,0.00013312946],"category_scores_gemma":[0.00015288602,0.00009633429,0.00008454086,0.0001294883,0.000056367637,0.00016917738,0.000027344066,0.000084777996,0.000010413268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006720249,0.0014528988,0.96921974,0.00009504146,0.00015618945,0.0038384153,0.00008452363,0.000042672305,0.000056036344,0.00016861424,0.000095248506,0.024118578],"study_design_scores_gemma":[0.016117964,0.0012793604,0.96941125,0.0013805705,0.00007765132,0.009644096,0.000081306636,0.000017141125,0.0016268999,0.000069393696,0.00020850777,0.00008582906],"about_ca_topic_score_codex":0.00002447993,"about_ca_topic_score_gemma":0.000019375053,"teacher_disagreement_score":0.02403275,"about_ca_system_score_codex":0.00017557506,"about_ca_system_score_gemma":0.00023942714,"threshold_uncertainty_score":0.39283982},"labels":[],"label_agreement":null},{"id":"W2996879561","doi":"10.1002/hon.2708","title":"Radiotherapy in mantle cell lymphoma: A literature review","year":2019,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Radiation therapy; Lymphoma; Malignancy; Stage (stratigraphy); Disease; Oncology; Internal medicine; Systemic therapy; Cancer","score_opus":0.06253466837350785,"score_gpt":0.3986835428973755,"score_spread":0.33614887452386766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996879561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001076264,0.9831043,0.0000012561178,0.00118201,0.00027445535,0.0031072572,0.000024333722,0.0000620688,0.01223358],"genre_scores_gemma":[0.000007202039,0.9930258,0.0007787047,0.0035036625,0.00011724466,0.0009616486,0.00030897214,0.000050781964,0.0012460082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996826,0.00047596594,0.0011105062,0.0008281767,0.00022048676,0.0005388493],"domain_scores_gemma":[0.9978907,0.00071982684,0.00045038635,0.0006797272,0.00005264738,0.0002066718],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002920041,0.0006559047,0.0069926344,0.0002225684,0.000026298405,0.000016177268,0.00024058462,0.0014307719,0.00061611057],"category_scores_gemma":[0.000091107686,0.00036963564,0.0010997659,0.0006212691,0.00008159624,0.0000319126,0.00009157279,0.00041523014,0.0009976615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034589004,0.0033445251,0.00009948699,0.16374111,0.00015642696,0.011356174,0.00001750873,9.16069e-9,8.593163e-8,0.00069837726,0.016588213,0.8039635],"study_design_scores_gemma":[0.0031350483,0.00083696493,0.000031413118,0.122673675,0.0011666629,0.00897189,0.0000019809966,7.3453134e-7,6.815945e-7,0.00002286282,0.8628798,0.00027827485],"about_ca_topic_score_codex":0.000004035747,"about_ca_topic_score_gemma":0.0000022882882,"teacher_disagreement_score":0.8462916,"about_ca_system_score_codex":0.001224086,"about_ca_system_score_gemma":0.0008037782,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2997564067","doi":"10.14740/jh559","title":"The Use of R-Hyper-CVAD in a Rare Case of Primary Bone Marrow Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; Cyclophosphamide; Regimen; Cytarabine; Lymphoma; Rituximab; Bone marrow; Oncology; Dexamethasone; Internal medicine; Methotrexate; Surgery; Chemotherapy","score_opus":0.018971082342865743,"score_gpt":0.2509335615538851,"score_spread":0.23196247921101934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997564067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260765,0.0058174506,0.0000034307454,0.0008799892,0.0001721158,0.00023263504,0.000012008994,0.0000027910844,0.00027190204],"genre_scores_gemma":[0.99839604,0.00062720483,0.00049845886,0.00023914877,0.000021375721,0.000004436925,0.0000025333475,0.00001423342,0.0001965676],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99853414,0.000106433516,0.0008213267,0.00011000312,0.00019908133,0.00022898796],"domain_scores_gemma":[0.99813795,0.00061672414,0.0006643738,0.00031273343,0.00017751343,0.00009072134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002653952,0.00013017266,0.0008817745,0.00017381589,0.000025209727,0.000005976774,0.000084023224,0.00011392096,0.00004250568],"category_scores_gemma":[0.00012280668,0.00007556262,0.00022334207,0.00012878481,0.00007037579,0.00008445901,0.000054337288,0.000098105294,0.000010215535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021891799,0.017141793,0.9267176,0.0007423643,0.0003538201,0.033118315,0.0008253659,0.000004042268,0.0047213756,0.001577064,0.005730561,0.0068785143],"study_design_scores_gemma":[0.17699176,0.005741306,0.30695996,0.0019134799,0.0010946217,0.38837448,0.0023024767,0.00031152,0.071034655,0.0003532352,0.04446698,0.000455537],"about_ca_topic_score_codex":0.000079448815,"about_ca_topic_score_gemma":0.00006969095,"teacher_disagreement_score":0.61975765,"about_ca_system_score_codex":0.00012295293,"about_ca_system_score_gemma":0.00024955982,"threshold_uncertainty_score":0.30813542},"labels":[],"label_agreement":null},{"id":"W2997593504","doi":"10.1002/ajh.25711","title":"Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Clinical endpoint; Neutropenia; Pneumonitis; Common Terminology Criteria for Adverse Events; Gastroenterology; Surgery; Diarrhea; Clinical trial; Chemotherapy; Lung","score_opus":0.00603779465155581,"score_gpt":0.24111143628222584,"score_spread":0.23507364163067002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997593504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985056,0.00019475645,9.567455e-7,0.00026279935,0.00024403598,0.0007380942,0.0000052853648,0.0000022190738,0.000046278434],"genre_scores_gemma":[0.99975306,0.000043737175,0.000040758136,0.00009775062,0.00001751866,0.000004249821,9.791606e-7,0.000016298007,0.000025621106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983231,0.00023160006,0.0007035559,0.00016693158,0.0003827433,0.0001920936],"domain_scores_gemma":[0.99793446,0.00030047368,0.0011271873,0.0004024093,0.00015967953,0.00007576984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020481844,0.00016317447,0.0009328747,0.000106231266,0.000033961143,0.0000034622817,0.00017523083,0.000043084034,0.000027085842],"category_scores_gemma":[0.000114014976,0.00007075084,0.00012572814,0.00028439148,0.0003642702,0.000049580103,0.00010154842,0.00013562327,0.0000016705429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007912025,0.003445642,0.9807691,0.00004020882,0.00032623613,0.000040678984,0.0013946178,0.000002191474,0.000027443732,0.000016532405,0.000040659343,0.005984654],"study_design_scores_gemma":[0.037935194,0.011282011,0.94781333,0.00053669914,0.00023137104,0.00018910758,0.0010984918,5.727869e-7,0.0008132162,0.0000012031601,0.00003188638,0.00006688666],"about_ca_topic_score_codex":0.000077388795,"about_ca_topic_score_gemma":0.000055040935,"teacher_disagreement_score":0.03295575,"about_ca_system_score_codex":0.00016955289,"about_ca_system_score_gemma":0.0003771975,"threshold_uncertainty_score":0.28851354},"labels":[],"label_agreement":null},{"id":"W2997725763","doi":"10.1016/s0002-838x(19)30442-3","title":"10.1016/s0002-838x(19)30442-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; Internal medicine; Procarbazine; ABVD; Dacarbazine; Vinblastine; CHOP; Oncology; Lymphoma; Aggressive lymphoma; Prednisone; Rituximab; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.007188450792738678,"score_gpt":0.1968509166663416,"score_spread":0.18966246587360294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997725763","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057135266,0.00025394052,1.204875e-7,0.0016744217,0.000001408572,0.000326254,0.000015888905,0.00012864234,0.9918858],"genre_scores_gemma":[0.0016690014,0.0000022801748,0.00019200792,0.00028345152,0.00018065989,0.00006864993,0.00004148517,0.000024769297,0.9975377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910325,0.000018452442,0.00016420934,0.00024792706,0.00020373706,0.00026243346],"domain_scores_gemma":[0.9992323,0.00004422611,0.00001964356,0.000347589,0.00003331299,0.00032293942],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006198139,0.00015534558,0.0002433026,0.00006090515,0.000060387625,0.000020391673,0.000073807474,0.000049035563,0.9996057],"category_scores_gemma":[0.00002523135,0.00012348962,0.00009842058,0.00015182003,0.000024014882,0.00003997407,0.000021391088,0.00004940614,0.9971648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013118041,0.0003953433,0.0000074188933,0.0000073012257,0.000056227364,0.00008287555,0.000015645537,0.0000044989424,0.000018768013,9.4012125e-7,0.2856516,0.7136282],"study_design_scores_gemma":[0.0015564598,0.00042721417,0.0020717897,0.00004237749,0.000111065216,0.000069481786,0.0000010976081,0.000027063568,0.00054179615,0.000002886824,0.9950189,0.0001298573],"about_ca_topic_score_codex":0.000084334286,"about_ca_topic_score_gemma":2.462717e-7,"teacher_disagreement_score":0.71349835,"about_ca_system_score_codex":0.0001342552,"about_ca_system_score_gemma":0.000060747647,"threshold_uncertainty_score":0.50357604},"labels":[],"label_agreement":null},{"id":"W2998927302","doi":"10.1016/s2352-3026(19)30218-2","title":"Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study","year":2020,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Canadian Centre for Applied Research in Cancer Control; University of Toronto","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Hodgkin's lymphoma; Vinblastine; Brentuximab vedotin; Oncology; Internal medicine; Vinorelbine; Vincristine; Chemotherapy; Hodgkin lymphoma; Lymphoma; Cyclophosphamide","score_opus":0.1019888536688762,"score_gpt":0.3400904008033418,"score_spread":0.2381015471344656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998927302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987448,0.0003050255,0.0053784074,0.0015283173,0.000048873262,0.0050124554,0.0001536453,0.000050139755,0.000075136886],"genre_scores_gemma":[0.9959906,0.0001195379,0.0015627985,0.00013317386,0.000050008955,0.0020104684,0.00009427134,0.000025089046,0.000014090384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895066,0.00011295738,0.00024087855,0.000303199,0.000130275,0.00026203628],"domain_scores_gemma":[0.99880236,0.00048743704,0.00013684665,0.00036224877,0.00012696077,0.00008412052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109868386,0.00020341048,0.0010560706,0.000032414213,0.000104648316,0.000005963006,0.000099318284,0.0000465795,0.000009037781],"category_scores_gemma":[0.000037525115,0.000109955065,0.000094858406,0.00013573698,0.000062458115,0.000036142024,0.00003249316,0.00003108471,0.0000063412117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01471621,0.012686937,0.9301867,0.0008417463,0.0012954185,0.00018542183,0.003394389,0.026888665,0.000012498627,0.0027826424,0.00005817632,0.0069512255],"study_design_scores_gemma":[0.35418773,0.084068164,0.4843725,0.0010016008,0.0054520615,0.00019460841,0.0029273527,0.047379505,0.007942338,0.0007400759,0.010681687,0.0010523917],"about_ca_topic_score_codex":0.00006795949,"about_ca_topic_score_gemma":0.000052168,"teacher_disagreement_score":0.44581416,"about_ca_system_score_codex":0.00016888589,"about_ca_system_score_gemma":0.00008237931,"threshold_uncertainty_score":0.44838372},"labels":[],"label_agreement":null},{"id":"W2999799566","doi":"10.1002/pbc.28167","title":"Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Ifosfamide; Vinorelbine; Gemcitabine; Refractory (planetary science); Salvage therapy; Regimen; Internal medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Surgery; Chemotherapy; Etoposide","score_opus":0.014272566561148576,"score_gpt":0.24382060675541686,"score_spread":0.22954804019426828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999799566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782141,0.018628623,0.00001246931,0.0007026009,0.000117875185,0.0018427783,0.00006196876,0.0001242803,0.00029530853],"genre_scores_gemma":[0.977774,0.018662078,0.00022292053,0.0010463157,0.0011170577,0.00077897374,0.000040162227,0.000091336085,0.00026711417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973635,0.00014335869,0.00050402974,0.0009884397,0.0005182289,0.00048242917],"domain_scores_gemma":[0.99841464,0.00023299422,0.0002950653,0.00041051488,0.00014033954,0.0005064334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016161765,0.00047262892,0.00070001447,0.00028318362,0.00009307356,0.000041344658,0.00012252404,0.00020928022,0.00015388358],"category_scores_gemma":[0.000028210965,0.0003417547,0.00008391727,0.0011894035,0.00004405571,0.00019379208,0.00007816731,0.00018223346,0.000023614242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020918793,0.002379397,0.97759247,0.0010290163,0.00012435649,0.00055264833,0.0027533611,0.00005792279,0.00017141856,0.000006271167,0.002070991,0.011170253],"study_design_scores_gemma":[0.035303347,0.0080179265,0.94709903,0.00009487857,0.0036841999,0.00004797121,0.0005047923,0.0005235709,0.0030262256,0.000006566605,0.001002198,0.0006893051],"about_ca_topic_score_codex":0.00071141426,"about_ca_topic_score_gemma":0.00015809783,"teacher_disagreement_score":0.03321147,"about_ca_system_score_codex":0.0003269147,"about_ca_system_score_gemma":0.00046814614,"threshold_uncertainty_score":0.99990344},"labels":[],"label_agreement":null},{"id":"W3002196156","doi":"10.1007/s00428-020-02750-7","title":"Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11","year":2020,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC","funders":"National Cancer Institute; European Hematology Association","keywords":"Concordance; Mantle cell lymphoma; Reproducibility; Medicine; Biomarker; Cutoff; Oncology; Kappa; Internal medicine; Cohort; Lymphoma; Risk stratification; Pathology; Cytology; Biology; Statistics","score_opus":0.05710657995017191,"score_gpt":0.3480343213449117,"score_spread":0.29092774139473976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002196156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772737,0.009552678,0.0007793104,0.0069808923,0.00026111407,0.0025215456,0.00018085621,0.0002347181,0.002215171],"genre_scores_gemma":[0.97512895,0.001507821,0.019253092,0.0031683648,0.00018802729,0.00031962016,0.0003155123,0.00005594489,0.00006264608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944967,0.00046902365,0.0011776894,0.0026102087,0.00035477357,0.0008915972],"domain_scores_gemma":[0.9942681,0.0025883294,0.00061587023,0.0018048935,0.00018299543,0.00053978496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014074395,0.00068193773,0.0018550431,0.00017355078,0.00021006848,0.000018368713,0.00044992732,0.00040609256,0.000028781544],"category_scores_gemma":[0.006241794,0.0004798266,0.0004781845,0.0003680322,0.0018506707,0.00009905398,0.00041327052,0.000382257,0.000032009448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011622266,0.013482566,0.6644193,0.005416445,0.0030641032,0.0022180898,0.0057727867,0.00016390224,0.13071984,0.009507541,0.015664926,0.13794826],"study_design_scores_gemma":[0.04120926,0.027464002,0.70790666,0.00058213173,0.006748489,0.0002615001,0.0028083732,0.0037739163,0.17086564,0.019759992,0.016562108,0.0020579332],"about_ca_topic_score_codex":0.00011660423,"about_ca_topic_score_gemma":0.0000067739506,"teacher_disagreement_score":0.13589032,"about_ca_system_score_codex":0.000091780435,"about_ca_system_score_gemma":0.0004088636,"threshold_uncertainty_score":0.99976534},"labels":[],"label_agreement":null},{"id":"W3002249367","doi":"10.1182/blood.2019002414","title":"Leveraging Gene Expression Subgroups to Classify DLBCL Patients and Enrich for Clinical Benefit to a Novel Agent","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Diffuse large B-cell lymphoma; Gene expression profiling; Lymphoma; Oncology; Immune system; Internal medicine; Medicine; Biology; Cancer research; Gene expression; Immunology; Gene","score_opus":0.08255488850708192,"score_gpt":0.3271549367700174,"score_spread":0.24460004826293547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002249367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994147,0.00018684889,0.0007103541,0.0036783437,0.00011413883,0.001006726,0.00004682363,0.000035793968,0.00007396118],"genre_scores_gemma":[0.9780939,0.000048959937,0.014220559,0.007067032,0.00026892047,0.00018902749,0.00004744256,0.000023274602,0.0000408831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988567,0.000009660657,0.00029632318,0.00042743885,0.00018967049,0.00022018563],"domain_scores_gemma":[0.99905276,0.000099350895,0.000047644917,0.00016319989,0.00007545802,0.0005615743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007723128,0.00014426805,0.00030853465,0.00003584264,0.000064886735,0.000022842038,0.000055843557,0.00006865187,0.000013747386],"category_scores_gemma":[0.00017423178,0.00011259217,0.00009326203,0.00009173195,0.000008237602,0.000027309148,0.00011656066,0.000047429476,0.00003773131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039175543,0.0064455406,0.9624794,0.000063676765,0.00014868149,0.000025648558,0.0009856441,0.0000021009405,0.009360427,0.000029301556,0.004495161,0.015572629],"study_design_scores_gemma":[0.026593411,0.002413458,0.9194184,0.000116685966,0.00032459924,0.000006161993,0.00005515484,0.000045151344,0.03794936,0.00000814229,0.012892212,0.00017729726],"about_ca_topic_score_codex":0.000011899162,"about_ca_topic_score_gemma":0.000002128177,"teacher_disagreement_score":0.04306107,"about_ca_system_score_codex":0.000035033114,"about_ca_system_score_gemma":0.000028345676,"threshold_uncertainty_score":0.45913753},"labels":[],"label_agreement":null},{"id":"W3003625827","doi":"10.1038/s41584-020-0376-6","title":"Room for improvement in clinical trials for rare diseases","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Clinical trial; Disease; Intensive care medicine; Vasculitis; MEDLINE; Pathology","score_opus":0.19437001433219336,"score_gpt":0.5126811041774012,"score_spread":0.31831108984520784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003625827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001241375,0.97062886,0.000101763835,0.0012375965,0.0015067976,0.025479713,0.0009716805,0.000046125402,0.000026197313],"genre_scores_gemma":[0.0000055159694,0.976854,0.0012535206,0.0009242362,0.00038201566,0.01779298,0.0026166223,0.00009531513,0.00007577876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912269,0.0013191116,0.0055341306,0.0012035612,0.00017948875,0.0005367843],"domain_scores_gemma":[0.9885311,0.007872425,0.0023319877,0.00074961595,0.00012550186,0.00038932922],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0032014954,0.00083315244,0.017990269,0.00021295948,0.000055077027,0.000023840668,0.0003039013,0.0019868454,0.00006203995],"category_scores_gemma":[0.017569225,0.0004886811,0.0060450304,0.00029189384,0.00005016069,0.000033299806,0.00009434142,0.00079821225,0.00007386048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016572989,0.00058316713,0.00023153091,0.09426471,0.0007551441,0.000041122858,0.0000044397,3.4760077e-9,1.2232095e-8,0.00084430695,0.059231192,0.8438786],"study_design_scores_gemma":[0.005611768,0.00091973424,0.000020102452,0.039783437,0.0073403865,0.00014138533,0.000002972747,0.0000048280313,3.4165387e-7,0.00011418344,0.9457144,0.00034641975],"about_ca_topic_score_codex":0.000004839429,"about_ca_topic_score_gemma":0.000013080542,"teacher_disagreement_score":0.88648325,"about_ca_system_score_codex":0.00037041554,"about_ca_system_score_gemma":0.0011114969,"threshold_uncertainty_score":0.99975646},"labels":[],"label_agreement":null},{"id":"W3006069344","doi":"10.1097/01.hs9.0000562576.71109.e9","title":"PS1071 PRELIMINARY RESULTS OF A PHASE 1 DOSE ESCALATION STUDY OF THE FIRST-IN-CLASS ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC), STRO-001, IN PATIENTS WITH ADVANCED B-CELL MALIGNANCIES","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Vincristine; Prednisone; Internal medicine; CHOP; Cyclophosphamide; Lymphoma; Oncology; Clinical endpoint; CD30; Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.0056829639859802645,"score_gpt":0.24285167385767537,"score_spread":0.2371687098716951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006069344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962547,0.00019544782,2.6002468e-7,0.0001240952,0.000075185984,0.0025779165,0.000056408546,0.000012096685,0.0007039294],"genre_scores_gemma":[0.99942213,0.000026555017,0.00005429857,0.000031068827,0.000008541601,0.00005058451,0.00007349961,0.000021930911,0.00031136602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983916,0.000061829596,0.0005677034,0.00035271607,0.0003996639,0.000226431],"domain_scores_gemma":[0.9987867,0.000103465536,0.0003600895,0.0005658663,0.0001359769,0.000047912497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010858373,0.00021030697,0.0005287979,0.000057980753,0.000028359756,0.0000056845442,0.00010494289,0.000057055488,0.000031978252],"category_scores_gemma":[0.000026520693,0.00012997744,0.00006169781,0.00031708155,0.000050296883,0.00011818179,0.00006414807,0.000089514,0.000007921026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060456167,0.02354089,0.9658571,0.00027884205,0.0000563704,0.000046904584,0.0020003389,0.00050631515,0.0006316705,0.000008312545,0.00014429381,0.00088337733],"study_design_scores_gemma":[0.08994706,0.006522081,0.8925536,0.0009753071,0.00009942038,0.0000017222353,0.0015466152,0.00023719607,0.007904255,0.0000030542517,0.00008927611,0.00012036552],"about_ca_topic_score_codex":0.00046202302,"about_ca_topic_score_gemma":0.00035441847,"teacher_disagreement_score":0.08390144,"about_ca_system_score_codex":0.000103611965,"about_ca_system_score_gemma":0.00007425038,"threshold_uncertainty_score":0.53003263},"labels":[],"label_agreement":null},{"id":"W3008083943","doi":"10.24953/turkjped.2019.05.005","title":"A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation","year":2019,"lang":"en","type":"article","venue":"The Turkish Journal of Pediatrics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Autologous stem-cell transplantation; Oncology; Salvage therapy; Etoposide; Bendamustine; Rituximab; Carboplatin; Transplantation; Ifosfamide; CD30; Chemotherapy; Lymphoma; Gastroenterology; Cisplatin","score_opus":0.006070779175205137,"score_gpt":0.20979109517474218,"score_spread":0.20372031599953705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008083943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952221,0.0036257436,0.0000032425748,0.00014508891,0.00017785082,0.00070312497,0.00004102421,0.000015477139,0.00006634334],"genre_scores_gemma":[0.99038,0.008820103,0.00012584735,0.00019911968,0.0002611529,0.00001729905,0.00003028825,0.00004200232,0.00012422216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981423,0.00015214815,0.00060876814,0.00022866593,0.0005706457,0.00029744438],"domain_scores_gemma":[0.9986698,0.00021897886,0.00052001124,0.00021616866,0.00021255693,0.00016248549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030492555,0.00028259977,0.0005090932,0.00035612323,0.00004873757,0.000040230596,0.000119821925,0.00013296786,0.000042512576],"category_scores_gemma":[0.000010999582,0.00014291947,0.000114105256,0.0005581746,0.000031734435,0.00021504916,0.000014073057,0.00021574317,0.000011777539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009036569,0.0016667305,0.97589964,0.00016647397,0.00004534309,0.00058807526,0.0019012738,0.000008036937,0.000032197364,7.7539113e-7,0.00017981582,0.010475058],"study_design_scores_gemma":[0.02924976,0.0057537244,0.96334976,0.000070096234,0.00058112683,0.00019501016,0.00018375828,0.000009399724,0.00030682457,0.0000059852914,0.00013501862,0.00015953626],"about_ca_topic_score_codex":0.000044936245,"about_ca_topic_score_gemma":0.0000321916,"teacher_disagreement_score":0.02021319,"about_ca_system_score_codex":0.00024255531,"about_ca_system_score_gemma":0.00027838783,"threshold_uncertainty_score":0.5828087},"labels":[],"label_agreement":null},{"id":"W3009342698","doi":"10.3390/ijerph17051783","title":"Resources-Stratified Guidelines for Classical Hodgkin Lymphoma","year":2020,"lang":"en","type":"review","venue":"International Journal of Environmental Research and Public Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; BC Cancer Agency","funders":"MorphoSys; Cancer Research UK; Incyte; Celgene; Gilead Sciences; Servier; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Modalities; Malignancy; Disease; Health care; Oncology; Intensive care medicine; Internal medicine","score_opus":0.34394455330678314,"score_gpt":0.5097862262883415,"score_spread":0.16584167298155833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009342698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003490084,0.95355904,0.00004236724,0.04442613,0.00024002876,0.0007765093,0.00041378298,0.000005784375,0.00018737088],"genre_scores_gemma":[0.0009813796,0.9945041,0.0011998536,0.00094555214,0.0017045758,0.00006583516,0.0002030785,0.000036158122,0.00035944325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960371,0.00028431442,0.0012904145,0.0003317694,0.0015925155,0.00046384163],"domain_scores_gemma":[0.9970813,0.00073529634,0.0005861646,0.00015754237,0.00030263196,0.0011370693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017400795,0.00025722137,0.0012154861,0.00047371277,0.00012135314,0.00017249928,0.00036861733,0.00016752335,0.00012672007],"category_scores_gemma":[0.0010133184,0.00017339484,0.0004609261,0.000120647506,0.00021424396,0.000119820994,0.00016200187,0.00036889862,0.000024253186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013285335,0.0010317891,0.00010426133,0.0007476879,0.0007052779,0.0002615956,0.000065020715,1.7158243e-8,7.804475e-7,0.00023554625,0.018720234,0.9779949],"study_design_scores_gemma":[0.0021085262,0.002503726,0.00054245524,0.0025080403,0.000065225584,0.001407135,0.00014258859,0.0000090256035,9.942104e-7,0.000104024526,0.99050814,0.00010010159],"about_ca_topic_score_codex":0.000019185987,"about_ca_topic_score_gemma":0.0000043069754,"teacher_disagreement_score":0.97789484,"about_ca_system_score_codex":0.0017111049,"about_ca_system_score_gemma":0.0023388208,"threshold_uncertainty_score":0.70708364},"labels":[],"label_agreement":null},{"id":"W3009600316","doi":"10.1038/s41375-020-0791-3","title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Nomogram; International Prognostic Index; Medicine; Internal medicine; Oncology; Cohort; Anthracycline; Brier score; Lymphoma; Diffuse large B-cell lymphoma; Surgery; Cancer; Artificial intelligence; Breast cancer; Computer science","score_opus":0.03260578287880242,"score_gpt":0.3267888867971584,"score_spread":0.294183103918356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009600316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88397914,0.00041658833,0.11311312,0.00044589266,0.00001369271,0.0019610447,0.00001616893,0.000014613283,0.000039749615],"genre_scores_gemma":[0.9848681,0.000208788,0.014144517,0.00046041486,0.0000622313,0.00018749379,0.000043543016,0.000023065546,0.0000018627572],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989473,0.000051684758,0.0004061985,0.00030158128,0.00017126146,0.0001219653],"domain_scores_gemma":[0.9985016,0.0009118403,0.00026805256,0.00016226534,0.00009918653,0.00005706993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032398084,0.00013228535,0.0003144579,0.000047102203,0.00005582753,0.000028581268,0.00006242588,0.00011000226,0.0000017220145],"category_scores_gemma":[0.00014023234,0.00008613188,0.000051481024,0.00014152216,0.000063903404,0.00007939201,0.000009481627,0.000058100744,3.6087962e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045057465,0.0007682789,0.6133944,0.00020502301,0.00010677853,9.2392315e-7,0.0030374886,0.0008315924,0.00019922033,0.00018563651,0.00010865825,0.37665626],"study_design_scores_gemma":[0.025625374,0.0021037122,0.3405289,0.00031878368,0.00040527666,0.000006248142,0.00021882444,0.6254327,0.0018031994,0.0031593344,0.00023108606,0.00016653127],"about_ca_topic_score_codex":0.000033317014,"about_ca_topic_score_gemma":0.0000125536235,"teacher_disagreement_score":0.6246011,"about_ca_system_score_codex":0.000087844775,"about_ca_system_score_gemma":0.0001664674,"threshold_uncertainty_score":0.3512356},"labels":[],"label_agreement":null},{"id":"W3009821158","doi":"10.1182/bloodadvances.2019001114","title":"Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Angioimmunoblastic T-cell lymphoma; Cancer research; Lymphoma; Tumor microenvironment; Biology; B cell; B-cell activating factor; T cell; Germinal center; Immunology; Antibody; Immune system; Tumor cells","score_opus":0.007275264933565479,"score_gpt":0.27688971610077845,"score_spread":0.26961445116721294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009821158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643664,0.032954726,0.000002383724,0.0017614164,0.000021531063,0.00060683966,0.000050297418,0.000023349268,0.00021307175],"genre_scores_gemma":[0.9970202,0.00055550697,0.001650539,0.0005588367,0.00003936619,0.000083431136,0.000020838872,0.0000115936655,0.000059685324],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991995,0.000015498514,0.00018794027,0.000264277,0.0001865917,0.00014620947],"domain_scores_gemma":[0.99965096,0.000027767275,0.00009620455,0.00008426022,0.000033761266,0.000107042884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027718119,0.00012730545,0.0002681395,0.000024550918,0.000029215327,0.000010322455,0.000051302857,0.000058020323,0.00002443271],"category_scores_gemma":[0.000032457017,0.00009033759,0.000039153507,0.0001379304,0.00007563431,0.000111215544,0.000037806465,0.00007700486,0.0000024434519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002717149,0.0014102071,0.88346356,0.0005674855,0.00007904992,0.00029526497,0.0011562246,0.0000043009636,0.07767348,0.000023852735,0.0005807469,0.03447409],"study_design_scores_gemma":[0.007872217,0.0019212968,0.16083114,0.0009155868,0.00012260472,0.000038251506,0.00021012168,0.00005266643,0.8081727,0.00006086544,0.019601943,0.00020057702],"about_ca_topic_score_codex":0.000021246951,"about_ca_topic_score_gemma":0.000011153396,"teacher_disagreement_score":0.73049927,"about_ca_system_score_codex":0.000012867406,"about_ca_system_score_gemma":0.000035977413,"threshold_uncertainty_score":0.368386},"labels":[],"label_agreement":null},{"id":"W3010862135","doi":"10.1007/s41669-020-00204-z","title":"Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews","year":2020,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bell (Canada)","funders":"Janssen Pharmaceuticals","keywords":"Medicine; Rituximab; Follicular lymphoma; Cost effectiveness; Obinutuzumab; Systematic review; MEDLINE; Quality-adjusted life year; Bendamustine; Oncology; Internal medicine; Lymphoma","score_opus":0.32936076707084955,"score_gpt":0.47322178850499214,"score_spread":0.1438610214341426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010862135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02025334,0.9544085,0.0000035384408,0.00011069435,0.000043024247,0.024866527,0.0002620716,0.000011693208,0.000040604915],"genre_scores_gemma":[0.0046836385,0.991759,0.00017337978,0.00045515646,0.000018516128,0.0022826144,0.00052978046,0.00007175573,0.000026128335],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99412954,0.0020727348,0.0025199752,0.0008107923,0.00016619594,0.00030073838],"domain_scores_gemma":[0.9955641,0.0010989778,0.0022712818,0.0004788194,0.000070459515,0.00051636045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002344471,0.00063065864,0.008493211,0.00020411272,0.00006977221,0.00013045578,0.0002604912,0.00015134804,0.00002792349],"category_scores_gemma":[0.0002644143,0.00039761406,0.0002477108,0.0003365432,0.00007442606,0.00024208489,0.0003264604,0.00016809584,0.000013817103],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024347617,0.0016251142,0.06308495,0.5594091,0.00478862,0.000098980054,0.00014292983,0.000002961022,1.0707995e-7,0.000060736154,0.00057868543,0.3677731],"study_design_scores_gemma":[0.059379064,0.0014562085,0.10085652,0.30655313,0.010303024,0.00013425441,0.00005692618,0.00009744721,0.0000030607607,0.0000023661096,0.51992965,0.0012283494],"about_ca_topic_score_codex":0.0030432667,"about_ca_topic_score_gemma":0.0001639187,"teacher_disagreement_score":0.51935095,"about_ca_system_score_codex":0.0014894323,"about_ca_system_score_gemma":0.0008624193,"threshold_uncertainty_score":0.9998476},"labels":[],"label_agreement":null},{"id":"W3010901165","doi":"10.1038/s41598-020-61936-w","title":"Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein","year":2020,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; University of Alberta; University of Houston; Ladies Leukemia League; Cancer Prevention and Research Institute of Texas","keywords":"Anaplastic lymphoma kinase; Fusion protein; Anaplastic large-cell lymphoma; Fusion gene; Cancer research; Lymphoma; Molecular biology; Biology; Cell fusion; Cell culture; Nucleophosmin; Gene; Recombinant DNA; Medicine; Biochemistry; Pathology; Immunology; Genetics; Lung cancer","score_opus":0.016297822786883694,"score_gpt":0.25088980718276144,"score_spread":0.23459198439587775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010901165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967159,0.00029403972,0.00005384329,0.00068157446,0.0011104171,0.0010146598,0.000016336831,0.0000237957,0.00008943185],"genre_scores_gemma":[0.9982669,0.000055448403,0.000045945602,0.00006213007,0.000047829915,0.00013820207,0.0002153796,0.000016944608,0.0011512451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980605,0.00006339948,0.00067980407,0.00062146207,0.0003691682,0.00020562302],"domain_scores_gemma":[0.99856,0.000019449295,0.00059762853,0.000505348,0.00018851295,0.00012903918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034403914,0.00016204406,0.00029493135,0.000070496404,0.00024089737,0.00007002158,0.000076810444,0.00007224384,0.00008306802],"category_scores_gemma":[0.00011652493,0.00010661864,0.00006491733,0.0004015175,0.00010184581,0.0001257439,0.000095942545,0.000047549387,0.0000034542527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000413188,0.0010346826,0.11412531,0.00027845497,0.0000052953037,0.0000733761,0.00071018114,0.0000017471411,0.8821932,0.0000142485715,0.00042497963,0.0010971909],"study_design_scores_gemma":[0.0014027476,0.00009375767,0.34437183,0.00047060565,0.00004900536,0.00001804446,0.00008294517,0.00028014305,0.6482198,0.000044274162,0.0048567904,0.000110008965],"about_ca_topic_score_codex":0.00011317318,"about_ca_topic_score_gemma":0.000057353664,"teacher_disagreement_score":0.23397337,"about_ca_system_score_codex":0.0000941784,"about_ca_system_score_gemma":0.00020608092,"threshold_uncertainty_score":0.43477818},"labels":[],"label_agreement":null},{"id":"W3011225902","doi":"10.1200/jco.2012.30.15_suppl.8060","title":"Characteristics and outcomes of extranodal NK/t-cell lymphoma (ENKL): A North American (NA) multi-institutional experience.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Stage (stratigraphy); Lymphoma; T-cell lymphoma; Chemotherapy; Peripheral T-cell lymphoma; B symptoms; Surgery; T cell; Immunology; Immune system","score_opus":0.09030509670787502,"score_gpt":0.42646321354691463,"score_spread":0.3361581168390396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011225902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722993,0.00046717696,0.000115603776,0.00086272566,0.0008882822,0.0001301647,0.000015554155,0.0000054529696,0.00028508488],"genre_scores_gemma":[0.98969245,0.0013226694,0.0073181638,0.0010830511,0.00049880263,0.0000068954982,0.0000047932663,0.000009724989,0.00006344083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974459,0.00014516686,0.0016894224,0.00013745313,0.0003268098,0.0002552947],"domain_scores_gemma":[0.99634975,0.0011223244,0.0015764243,0.00014604795,0.00023811983,0.00056732364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006740142,0.00016629939,0.0016242051,0.00009000394,0.0000462944,0.0000053382696,0.0000945016,0.00013162299,0.00004110499],"category_scores_gemma":[0.0010776364,0.00010120803,0.0003948237,0.00009933847,0.00068064046,0.00013091243,0.000047253612,0.00017918284,0.000009257637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000586808,0.008923435,0.8598941,0.000020504873,0.00023144625,0.00022580563,0.00029842928,3.3699376e-7,0.000051988267,0.0000678618,0.000096043135,0.12960322],"study_design_scores_gemma":[0.01154804,0.003596104,0.97287273,0.000027472273,0.00038263327,0.00043970146,0.00014005866,0.000028565948,0.0001893919,0.0000021084197,0.010686644,0.00008651872],"about_ca_topic_score_codex":0.000046607438,"about_ca_topic_score_gemma":0.000019815405,"teacher_disagreement_score":0.1295167,"about_ca_system_score_codex":0.00015048073,"about_ca_system_score_gemma":0.0008304403,"threshold_uncertainty_score":0.41271436},"labels":[],"label_agreement":null},{"id":"W3011341107","doi":"10.1002/ajh.25783","title":"Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: <scp>CALGB</scp>/Alliance 50403","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Bortezomib; Etoposide; Progression-free survival; Surgery; Transplantation; Cytarabine; Clinical endpoint; Autologous stem-cell transplantation; Oncology; Gastroenterology; Multiple myeloma; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.013162266208827433,"score_gpt":0.2597290467004244,"score_spread":0.24656678049159697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011341107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879941,0.0026813624,0.0063438932,0.0022453289,0.0001363513,0.00036896107,0.000015632437,0.000021924212,0.00019249303],"genre_scores_gemma":[0.9871107,0.002325972,0.008590019,0.0017708595,0.00005245759,0.000025736908,0.000011161898,0.000028660945,0.000084446845],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869835,0.00006664728,0.0005509652,0.00023971697,0.00015005264,0.00029425017],"domain_scores_gemma":[0.9984341,0.00052507565,0.00062877126,0.00010912994,0.00011264472,0.00019024477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012417542,0.0001997881,0.00081780384,0.000059446415,0.000073191295,0.000017993392,0.00009558565,0.00006953227,0.0000063183484],"category_scores_gemma":[0.000036588805,0.00014688815,0.00019484977,0.00014879611,0.00014303869,0.000090754074,0.000008753248,0.000078001685,0.000006524772],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01484119,0.006144558,0.25494167,0.004070777,0.0040397537,0.019239116,0.02712926,0.00009399763,0.10700116,0.0020245856,0.02328336,0.53719056],"study_design_scores_gemma":[0.08187821,0.02619838,0.08752909,0.00104845,0.0029558905,0.028390389,0.016966289,0.0017168799,0.7311908,0.0002791954,0.021256154,0.00059029064],"about_ca_topic_score_codex":0.000012200657,"about_ca_topic_score_gemma":0.0000018181498,"teacher_disagreement_score":0.6241896,"about_ca_system_score_codex":0.000078004094,"about_ca_system_score_gemma":0.00021794521,"threshold_uncertainty_score":0.59899247},"labels":[],"label_agreement":null},{"id":"W3011722077","doi":"","title":"Socioeconomic status and survival among children with Hodgkin's and non-Hodgkin's lymphomas in Ontario","year":2012,"lang":"en","type":"article","venue":"Queensland's institutional digital repository (The University of Queensland)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socioeconomic status; Hodgkin lymphoma; Medicine; Lymphoma; Oncology; Demography; Internal medicine; Environmental health; Sociology; Population","score_opus":0.006699725941113352,"score_gpt":0.18503321167286338,"score_spread":0.17833348573175004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011722077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814737,0.0002523518,0.000024861956,0.00009556965,0.0000946308,0.00038037004,0.000032371052,0.000021825374,0.017624317],"genre_scores_gemma":[0.9988786,0.00007416461,0.00012588208,0.00002997715,0.00006384158,0.0000018970129,0.0000760828,0.000010822532,0.0007387448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988838,0.000033336997,0.00020036359,0.00030132345,0.00023921777,0.00034199262],"domain_scores_gemma":[0.9992401,0.000099064986,0.00013352938,0.00020943208,0.000059731436,0.00025816937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095539006,0.0002338771,0.00038429577,0.000113107,0.00028450147,0.000047877616,0.000078913305,0.000115833864,0.000024276527],"category_scores_gemma":[0.000009490574,0.00017546938,0.000084072955,0.00006252053,0.0008469041,0.0005677808,0.000097699565,0.0001565985,0.000010251625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004228043,0.00029248474,0.99611413,0.000018014362,0.00028813237,0.00008710476,0.0010780083,0.000021851207,0.000008957448,0.00082033285,0.00009142987,0.00075673894],"study_design_scores_gemma":[0.004447076,0.0002614803,0.99223953,0.00011390646,0.00016497099,0.00033417463,0.00037638008,0.000016334312,0.00006488127,0.000040885538,0.0017387095,0.00020168435],"about_ca_topic_score_codex":0.040804457,"about_ca_topic_score_gemma":0.015296748,"teacher_disagreement_score":0.025507709,"about_ca_system_score_codex":0.0005460906,"about_ca_system_score_gemma":0.000467968,"threshold_uncertainty_score":0.9655829},"labels":[],"label_agreement":null},{"id":"W3012258768","doi":"10.1200/jco.2012.30.15_suppl.8053","title":"LR-CD: Lenalidomide combination therapy for untreated low-grade B-cell NHL.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Lenalidomide; Internal medicine; Gastroenterology; Neutropenia; Dexamethasone; Febrile neutropenia; Cyclophosphamide; Toxicity; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Surgery; Chemotherapy","score_opus":0.14689824316387082,"score_gpt":0.4756972759796616,"score_spread":0.3287990328157908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012258768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313993,0.0018072352,0.00008170848,0.0106451465,0.0016119886,0.00044466724,0.0000042653546,0.00001118478,0.002253902],"genre_scores_gemma":[0.9900217,0.0022482872,0.0019693244,0.0035934302,0.0015992903,0.000019518202,0.000011533356,0.000018597953,0.0005182884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974816,0.00027199797,0.0015828004,0.00012366707,0.00025097938,0.0002889508],"domain_scores_gemma":[0.9947199,0.003057209,0.0012694729,0.00014768585,0.00037396073,0.00043173137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022359442,0.00014219004,0.0011454604,0.00009581738,0.000045996338,0.000008559668,0.00009172508,0.00033957046,0.00012143952],"category_scores_gemma":[0.0009747176,0.000087992514,0.00065581617,0.00008602716,0.000087690045,0.0001298817,0.00001504863,0.00027273534,0.000037946516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115714045,0.0489886,0.64069307,0.000054749642,0.0012220435,0.00021532911,0.00022628166,0.0000051337906,0.0010057994,0.0014213388,0.042491525,0.25210473],"study_design_scores_gemma":[0.08291358,0.02255091,0.62315655,0.00008231252,0.0006698203,0.00025004405,0.000069818525,0.000047657162,0.00668014,0.0005525542,0.26289916,0.00012745893],"about_ca_topic_score_codex":0.0000146225175,"about_ca_topic_score_gemma":0.0000037481846,"teacher_disagreement_score":0.25197726,"about_ca_system_score_codex":0.0002487503,"about_ca_system_score_gemma":0.00061114365,"threshold_uncertainty_score":0.35882306},"labels":[],"label_agreement":null},{"id":"W3013013456","doi":"10.1007/s10552-020-01297-x","title":"Correction to: Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study","year":2020,"lang":"en","type":"erratum","venue":"Cancer Causes & Control","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mononucleosis; Medicine; Lymphoma; Hematology; Hodgkin lymphoma; Immunology; Genotype; Epidemiology; Immune system; Internal medicine; Oncology; Virus; Biology; Genetics; Gene","score_opus":0.011277684652044,"score_gpt":0.28496507558340384,"score_spread":0.27368739093135985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013013456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7549115,0.058380734,0.0002627301,0.0034127524,0.15601563,0.015225813,0.0007976695,0.0011195826,0.009873619],"genre_scores_gemma":[0.97646505,0.0030885264,0.000015565847,0.0035358865,0.0033809235,0.0023248864,0.00025182913,0.0001955865,0.010741778],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99658954,0.00017690525,0.0008148375,0.0013089201,0.0004866925,0.0006231217],"domain_scores_gemma":[0.997485,0.00015565478,0.00041928288,0.00085472007,0.00035132695,0.0007340327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015587179,0.0008868749,0.0018879571,0.00031266626,0.00023979579,0.00021463272,0.00021432171,0.00043822773,0.00019796874],"category_scores_gemma":[0.00016162854,0.0007891797,0.0002870688,0.0003530568,0.00010516613,0.00016319206,0.0001262561,0.0004210074,0.00010833454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024412798,0.0030125908,0.16332221,0.0002703439,0.004726304,0.0009255753,0.0025814162,0.00002033196,0.00055043143,0.0000069870366,0.6801021,0.14204039],"study_design_scores_gemma":[0.026293332,0.010608612,0.6845621,0.0011293383,0.0060355044,0.00020324379,0.00080427644,0.0008620525,0.00031687348,0.0000061665132,0.26805368,0.0011248542],"about_ca_topic_score_codex":0.012061974,"about_ca_topic_score_gemma":0.00533957,"teacher_disagreement_score":0.5212399,"about_ca_system_score_codex":0.0016583285,"about_ca_system_score_gemma":0.0013439289,"threshold_uncertainty_score":0.9994559},"labels":[],"label_agreement":null},{"id":"W3013244600","doi":"10.1182/blood.2019003877","title":"Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Interquartile range; Internal medicine; Cohort; Radiation therapy; Retrospective cohort study; Stage (stratigraphy); Gastroenterology; Progression-free survival; Chemotherapy regimen; Lymphoma; Chemotherapy; Median follow-up; Oncology; Surgery","score_opus":0.014894463093366981,"score_gpt":0.24182051176096347,"score_spread":0.2269260486675965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013244600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731725,0.0005747424,0.000022917135,0.0001959215,0.00009376531,0.0012213521,0.00030611485,0.00006420468,0.000203698],"genre_scores_gemma":[0.9981785,0.00007993128,0.00067486643,0.00052822084,0.00006914438,0.0001538299,0.0001773361,0.000028116863,0.00011009551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809957,0.000052007315,0.00048507596,0.0004959332,0.00057934114,0.0002880967],"domain_scores_gemma":[0.99891645,0.000035880137,0.00017406966,0.00034686743,0.00023518609,0.0002915372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050552575,0.00029638968,0.0005622971,0.000046072608,0.00015678348,0.0000130137005,0.00014182787,0.00009020959,0.00008990324],"category_scores_gemma":[0.00016519135,0.00022023405,0.00016291416,0.0002228551,0.000073267525,0.0000746331,0.00014961601,0.00004305689,0.00005878536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007118643,0.10328761,0.88086534,0.00017776871,0.0011615165,0.00052396656,0.0032138233,0.000012220734,0.0022732208,0.000079973535,0.0014575437,0.006235151],"study_design_scores_gemma":[0.3045262,0.013037669,0.57704115,0.00024657493,0.0020279323,0.000036547633,0.0013459657,0.0007007225,0.09355184,0.0000019937934,0.00692064,0.0005627718],"about_ca_topic_score_codex":0.0005270665,"about_ca_topic_score_gemma":0.000030043866,"teacher_disagreement_score":0.3038242,"about_ca_system_score_codex":0.0001676793,"about_ca_system_score_gemma":0.00024491185,"threshold_uncertainty_score":0.8980884},"labels":[],"label_agreement":null},{"id":"W3015820067","doi":"10.1111/hiv.12136","title":"<scp>B</scp>ritish <scp>HIV</scp> Association guidelines for <scp>HIV</scp>‐associated malignancies 2014","year":2014,"lang":"en","type":"article","venue":"HIV Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rituximab; Guideline; Lymphoma; Internal medicine; Cancer; Oncology; Cervical cancer; Radiation therapy; Primary effusion lymphoma; Intensive care medicine; Pathology","score_opus":0.03113877944754835,"score_gpt":0.2930584713415473,"score_spread":0.26191969189399894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015820067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88335735,0.015215974,0.0030983358,0.030219926,0.0045532505,0.005118151,0.0013193055,0.0015837521,0.055533987],"genre_scores_gemma":[0.67303896,0.008099963,0.005629238,0.031073164,0.014160369,0.0025155873,0.010339621,0.0007105498,0.25443256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922759,0.0003576161,0.002093286,0.0013518072,0.0020300732,0.0018913534],"domain_scores_gemma":[0.98471063,0.009269503,0.0014794702,0.0010779953,0.0025029304,0.0009594624],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031501253,0.0010679936,0.0024316811,0.0005101998,0.0005450926,0.0001295307,0.00048895384,0.0008360349,0.00008059959],"category_scores_gemma":[0.062313396,0.00087546586,0.0006465066,0.00074898166,0.00027754845,0.00031103793,0.00016531326,0.00044534114,0.0010086409],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008907879,0.00072314666,0.15520027,0.00024167048,0.00071108696,0.00008739174,0.001098125,0.000015998889,0.001363333,0.0006515336,0.8381646,0.0017338959],"study_design_scores_gemma":[0.019613149,0.0015836135,0.21477538,0.001972487,0.00207088,0.00010053363,0.0024702912,0.0013705596,0.0044746213,0.00096183736,0.7504628,0.00014385751],"about_ca_topic_score_codex":0.00041268105,"about_ca_topic_score_gemma":0.0002519986,"teacher_disagreement_score":0.21031837,"about_ca_system_score_codex":0.0012421883,"about_ca_system_score_gemma":0.0003803133,"threshold_uncertainty_score":0.9997692},"labels":[],"label_agreement":null},{"id":"W3015964023","doi":"10.3324/haematol.2019.242206","title":"Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; King's Health Partners; Blood Cancer UK; University of Southampton; BC Cancer Agency; Engineering and Physical Sciences Research Council; European Hematology Association; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; King's College London; Queen Mary University of London","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Positron emission tomography; Cancer research; Medicine; Biology; Pathology; Nuclear medicine","score_opus":0.01638253983460799,"score_gpt":0.24610225658477844,"score_spread":0.22971971675017044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015964023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7511609,0.0015417698,0.000014809132,0.2451043,0.00027364146,0.0009933222,0.00047710483,0.00021363767,0.00022049583],"genre_scores_gemma":[0.7324179,0.00052735227,0.00023328567,0.26420388,0.000363461,0.00041605387,0.0012349149,0.000098378136,0.0005047845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953554,0.00071072305,0.0008845503,0.0013339561,0.000674949,0.0010404016],"domain_scores_gemma":[0.99783194,0.00045894997,0.00035041492,0.0009891089,0.00006153874,0.00030803087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090778834,0.0009228446,0.0019966436,0.000247798,0.00013250638,0.00007847396,0.0003970822,0.00091605034,0.000406355],"category_scores_gemma":[0.00012776765,0.0006782011,0.0005406957,0.00029447128,0.00013079643,0.000036946833,0.00028205404,0.0006306686,0.0007230899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002074441,0.008566576,0.009116327,0.0004247745,0.00023843267,0.108196594,0.000075636744,3.825278e-8,0.00056088937,0.000006287488,0.8705965,0.00014346096],"study_design_scores_gemma":[0.05050744,0.001945298,0.06534146,0.00041252922,0.00087353983,0.002844922,0.000018528437,0.00010201897,0.010533377,0.00005263456,0.8661697,0.0011985413],"about_ca_topic_score_codex":0.000073000934,"about_ca_topic_score_gemma":0.000013151981,"teacher_disagreement_score":0.10535167,"about_ca_system_score_codex":0.0004374898,"about_ca_system_score_gemma":0.00019577505,"threshold_uncertainty_score":0.9995669},"labels":[],"label_agreement":null},{"id":"W3016044607","doi":"10.1016/j.ccell.2020.03.015","title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","year":2020,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Research Institute; AbbVie; Genentech; Celgene; Janssen Biotech; Roche","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Computational biology; Cancer research; Probabilistic logic; Biology; Computer science; Immunology; Artificial intelligence","score_opus":0.03299643181904677,"score_gpt":0.27393374155446676,"score_spread":0.24093730973542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016044607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903938,0.0036197575,0.0013657154,0.0020359599,0.000030759827,0.0015088844,0.00015595354,0.000039762956,0.0008493642],"genre_scores_gemma":[0.99633527,0.00040942896,0.0010189207,0.00079502555,0.00007260799,0.001136958,0.00005150464,0.000025782543,0.00015453303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992721,0.0000124434255,0.00018731678,0.0002632181,0.000097306576,0.00016757737],"domain_scores_gemma":[0.9993384,0.00006523821,0.00011315237,0.00026077393,0.00012797654,0.000094448034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022209593,0.00012232401,0.00020741246,0.000015049073,0.000045879566,0.000009397127,0.000066118315,0.000044172797,0.000052158928],"category_scores_gemma":[0.00000748093,0.000087931156,0.000070446076,0.000114721624,0.000035729,0.000026929041,0.000010100374,0.000017549166,0.000009416146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022902656,0.022462947,0.77182883,0.0045021847,0.00056233094,0.000013777952,0.0043550604,0.00008536472,0.10977705,0.004985694,0.0048307893,0.07430568],"study_design_scores_gemma":[0.020840669,0.0013736162,0.90273356,0.00007103371,0.0010295135,0.0000044625763,0.00019332992,0.001994059,0.054964196,0.00014695074,0.016415333,0.0002332698],"about_ca_topic_score_codex":0.000038369995,"about_ca_topic_score_gemma":0.00002706957,"teacher_disagreement_score":0.13090472,"about_ca_system_score_codex":0.00017602168,"about_ca_system_score_gemma":0.0002714768,"threshold_uncertainty_score":0.35857284},"labels":[],"label_agreement":null},{"id":"W3016237720","doi":"10.1634/theoncologist.2020-0040","title":"Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Retrospective cohort study; Cohort; Blockade; Immune checkpoint; Internal medicine; Progression-free survival; Oncology; Chemotherapy","score_opus":0.03091760045063636,"score_gpt":0.33629506853513286,"score_spread":0.3053774680844965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016237720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889195,0.00094400643,0.000002116966,0.0054136193,0.000019542082,0.00087427313,0.000013061721,0.000035255292,0.003778655],"genre_scores_gemma":[0.9989727,0.00020457259,0.00039280514,0.0000942314,0.00006483615,0.00015956772,0.000022803351,0.000015990523,0.00007250217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999018,0.00006417093,0.00030053649,0.00022183232,0.00016392965,0.00023154069],"domain_scores_gemma":[0.99928665,0.00009321324,0.00016936634,0.0002977781,0.00003570689,0.000117290314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010885505,0.00020069926,0.00048813975,0.00003721201,0.000044840326,0.000009676673,0.00009676606,0.00006765895,0.00008232352],"category_scores_gemma":[0.000038378443,0.00008408921,0.00017949588,0.00024762738,0.00019122947,0.00002600433,0.000045521545,0.00004699284,0.000022625789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470014,0.006856691,0.7891256,0.00005970313,0.00076180935,0.0008587074,0.00295964,0.00018615073,0.01879682,0.00007677578,0.00023784918,0.1736102],"study_design_scores_gemma":[0.013079427,0.025097732,0.9116787,0.00012795962,0.0002466608,0.000101681326,0.00023398227,0.00021304785,0.04834739,0.000022416334,0.00073758943,0.00011344606],"about_ca_topic_score_codex":0.0014574503,"about_ca_topic_score_gemma":0.00008760302,"teacher_disagreement_score":0.17349675,"about_ca_system_score_codex":0.0011596158,"about_ca_system_score_gemma":0.00047313687,"threshold_uncertainty_score":0.34290585},"labels":[],"label_agreement":null},{"id":"W3016331040","doi":"10.1182/blood.2019004588","title":"Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Term (time); Stage (stratigraphy); Lymphoma; Population; Radiation therapy; Follicular phase; Oncology; Internal medicine; Pediatrics; Biology","score_opus":0.019311338204259124,"score_gpt":0.26443598825763165,"score_spread":0.24512465005337253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016331040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749213,0.000055673314,0.00003131548,0.0003768642,0.000023074741,0.0018568473,0.0001029667,0.00004380329,0.000017325723],"genre_scores_gemma":[0.99817663,0.0000014551413,0.0005877748,0.0005299287,0.000023074213,0.00018699699,0.00044866605,0.000026351558,0.000019098135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904585,0.000018388526,0.00025072595,0.00025729087,0.00027614812,0.0001515887],"domain_scores_gemma":[0.9993189,0.00006889587,0.00012785368,0.00025092388,0.00010776522,0.00012565608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030524345,0.00016471323,0.0003947343,0.000047024165,0.000042461044,0.00001129632,0.000057355177,0.000036085476,0.000022141821],"category_scores_gemma":[0.00005565023,0.00010882843,0.00012676255,0.0001276706,0.000009682702,0.000036741232,0.000017554255,0.00001568317,0.000005716403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032578045,0.014360878,0.98367375,0.000118250726,0.00066225225,0.000058604925,0.0001072685,0.000008508385,0.000004597772,0.000017285885,0.000016770395,0.00064603664],"study_design_scores_gemma":[0.049448084,0.002909717,0.94560534,0.000043324624,0.0012251367,4.2225324e-7,0.000023983455,0.00002782395,0.0005723563,9.941587e-7,0.000037448972,0.000105362],"about_ca_topic_score_codex":0.000051971834,"about_ca_topic_score_gemma":0.00002247069,"teacher_disagreement_score":0.049122304,"about_ca_system_score_codex":0.00003429342,"about_ca_system_score_gemma":0.000054302,"threshold_uncertainty_score":0.44378945},"labels":[],"label_agreement":null},{"id":"W3016424849","doi":"10.3747/co.27.5117","title":"Immunotherapy in Hematologic Malignancies","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Monoclonal antibody; Rituximab; Immunotherapy; Lymphoma; Melanoma; Monoclonal antibody therapy; Chemotherapy; Immunology; Antigen; Hematologic Neoplasms; Antibody; Immune system; Oncology; Cancer; Cancer research; Internal medicine","score_opus":0.23711001027352793,"score_gpt":0.47913633190610466,"score_spread":0.24202632163257673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016424849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049358743,0.9957538,0.0000019510342,0.00038483256,0.00090866355,0.0012417118,0.000020314597,0.00005546342,0.0015838915],"genre_scores_gemma":[0.000036883557,0.9984725,0.00009450005,0.00012703295,0.00018667211,0.00082818966,0.00017382338,0.000033139706,0.000047221893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982559,0.00017684083,0.00066779606,0.0004525787,0.00012976651,0.00031709397],"domain_scores_gemma":[0.99905396,0.00023578726,0.00027083888,0.00029282577,0.000031371936,0.000115204944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010253164,0.00039615188,0.003201579,0.00018597824,0.000023655619,0.000008910439,0.00014701155,0.00035498565,0.0002102777],"category_scores_gemma":[0.00006526868,0.00026272744,0.0005448588,0.00030161656,0.000074866846,0.00001769011,0.00007150262,0.00034558654,0.00056654913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019164556,0.0011084304,0.00078703085,0.007337597,0.00015055011,0.00099249,0.000067717316,7.482744e-9,1.3402057e-7,0.00049720594,0.002795793,0.9862439],"study_design_scores_gemma":[0.0016402495,0.00054728193,0.00019231255,0.00914153,0.0005254565,0.0006496772,0.0000129661385,7.177288e-7,0.0000010016272,0.00004097804,0.98705673,0.00019108957],"about_ca_topic_score_codex":0.0000065121462,"about_ca_topic_score_gemma":0.000005719698,"teacher_disagreement_score":0.9860528,"about_ca_system_score_codex":0.0011527662,"about_ca_system_score_gemma":0.000980391,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W3016882075","doi":"10.1182/bloodadvances.2019001261","title":"Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Obinutuzumab; Rituximab; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Chemotherapy; Follicular lymphoma; Aggressive lymphoma; Internal medicine; Bone marrow; Oncology; Biopsy","score_opus":0.009754244757057669,"score_gpt":0.2923774273024534,"score_spread":0.28262318254539576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016882075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677455,0.0019433522,4.1399753e-7,0.00053675903,0.000018331151,0.00041981367,0.000033758268,0.000016472986,0.00025654578],"genre_scores_gemma":[0.9983579,0.0009968592,0.00038222354,0.00015358778,0.00001290832,0.00004036349,0.00002435668,0.000016181875,0.000015650034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989356,0.0000828502,0.00031905738,0.0002777307,0.00018995444,0.00019483449],"domain_scores_gemma":[0.9994621,0.00012697176,0.00011344646,0.00015994438,0.000035839093,0.000101642654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000998221,0.00018354405,0.00042194643,0.00013072765,0.000015458383,0.000008644355,0.00004008687,0.00005230915,0.000027996139],"category_scores_gemma":[0.000065617736,0.00013394846,0.00007682694,0.0002813853,0.000043201333,0.000079140365,0.00002055975,0.00004779213,0.0000029292669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045970944,0.0035343424,0.97018814,0.000044862933,0.00009657603,0.000179656,0.00026121337,0.000012165249,0.009601686,0.0000078106,0.0000141359615,0.011462307],"study_design_scores_gemma":[0.017091181,0.0038813143,0.9665757,0.0002449239,0.00004077589,0.000009694432,0.00005816604,0.00003366422,0.011846654,0.000011520307,0.0000976097,0.00010882596],"about_ca_topic_score_codex":0.00033062196,"about_ca_topic_score_gemma":0.000021661648,"teacher_disagreement_score":0.012494085,"about_ca_system_score_codex":0.00016190401,"about_ca_system_score_gemma":0.000106124666,"threshold_uncertainty_score":0.54622597},"labels":[],"label_agreement":null},{"id":"W3017091259","doi":"10.1182/blood.v112.11.477.477","title":"Deletion in Chromosome 17p12 and Gains in Chromosome 9q33.3 by Array Comparative Hybridization Are Associated with R-CHOP Treatment Failure in Patients with Diffuse Large B Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Diffuse large B-cell lymphoma; CHOP; Oncology; PMS2; Internal medicine; Biology; International Prognostic Index; Lymphoma; Chromosome; Medicine; Bioinformatics; Cancer research; Genetics; Gene; Mutation; Germline mutation","score_opus":0.01106881339332029,"score_gpt":0.21394459496519422,"score_spread":0.20287578157187391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017091259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980243,0.00031505057,0.0000032538953,0.00010899824,0.000012015223,0.0012050518,0.00017061843,0.00003490437,0.00012583287],"genre_scores_gemma":[0.9983251,0.0001975984,0.000074351585,0.00008164813,0.000015840098,0.000252542,0.00097191223,0.00003220686,0.000048801543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983928,0.000107321524,0.00032623988,0.00046773907,0.0003136163,0.00039224466],"domain_scores_gemma":[0.99931043,0.00006594862,0.00019785647,0.00020238591,0.00009219034,0.00013117203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053662436,0.00033951798,0.0006280208,0.00020471367,0.00007626145,0.000017578619,0.000041066327,0.00011559238,0.000009951002],"category_scores_gemma":[0.000018756687,0.00024362693,0.000031312695,0.00055206474,0.000060306138,0.00016029389,0.000013677673,0.00007394893,0.000006440943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028981175,0.04910386,0.9477094,0.00002185053,0.00012029429,0.00040933242,0.001937969,0.0000102856575,0.00027384548,0.0000029869404,0.00006485992,0.000055542594],"study_design_scores_gemma":[0.12648733,0.0021227372,0.863229,0.00040578583,0.00012460224,0.000019197749,0.00022972914,0.000036832098,0.0070460285,0.0000018003796,0.0000667778,0.00023019568],"about_ca_topic_score_codex":0.00025835773,"about_ca_topic_score_gemma":0.0036957653,"teacher_disagreement_score":0.12619752,"about_ca_system_score_codex":0.00081763876,"about_ca_system_score_gemma":0.00012796093,"threshold_uncertainty_score":0.99348176},"labels":[],"label_agreement":null},{"id":"W3018916813","doi":"10.14740/jh607","title":"Diagnostic Dilemma: An Unusual Case of Angioimmunoblastic T-Cell Lymphoma Manifesting as Bone Marrow Non-Caseating Granuloma","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bone marrow; Pathology; Angioimmunoblastic T-cell lymphoma; Lymphoma; Granuloma; Biopsy; Lymph node biopsy; Lymph node; Anemia; T cell; Internal medicine; Immunology; Immune system","score_opus":0.01696256423463021,"score_gpt":0.2744892653681025,"score_spread":0.25752670113347226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018916813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575585,0.0020537744,0.00012170251,0.0009282745,0.00023472641,0.00024504494,0.000009133878,0.000019052195,0.0006324531],"genre_scores_gemma":[0.9972121,0.00006426923,0.0020491462,0.0003822505,0.00022468423,0.000009448438,0.000007842588,0.00003769887,0.000012538134],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978859,0.00011699852,0.0011089998,0.0002432879,0.00028980814,0.0003550264],"domain_scores_gemma":[0.9968763,0.0012630565,0.0008992859,0.00022093365,0.0003049155,0.0004355134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023880333,0.00026296874,0.0010628796,0.00018502754,0.000102188795,0.000019198505,0.00012104401,0.0001394175,0.00008307033],"category_scores_gemma":[0.0013678602,0.00020885856,0.0002921464,0.0002411587,0.00010524295,0.00015804799,0.000067761284,0.00016001974,0.00003653935],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011998062,0.004521801,0.21905658,0.0011969854,0.0005818084,0.75069225,0.002259064,0.00008935337,0.0104646385,0.0009235144,0.0010456783,0.007968518],"study_design_scores_gemma":[0.017484691,0.009371788,0.021266554,0.000898463,0.0014408353,0.8997911,0.0019170527,0.0013923994,0.045841217,0.00015878782,0.000125817,0.00031125318],"about_ca_topic_score_codex":0.00016610544,"about_ca_topic_score_gemma":0.000010196157,"teacher_disagreement_score":0.19779003,"about_ca_system_score_codex":0.000102039245,"about_ca_system_score_gemma":0.00032208647,"threshold_uncertainty_score":0.8517005},"labels":[],"label_agreement":null},{"id":"W3020554662","doi":"10.14740/jh596","title":"Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin’s Lymphoma","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Chemotherapy; Immunotherapy; Hodgkin lymphoma; Cancer","score_opus":0.016880044007171257,"score_gpt":0.26558761567583544,"score_spread":0.2487075716686642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020554662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97898346,0.008352062,0.000009734025,0.0120105,0.00010012539,0.0002869079,0.0000028701684,0.000018131163,0.00023618413],"genre_scores_gemma":[0.9965825,0.002218173,0.00014817221,0.00093889877,0.000038838505,0.000009808643,0.000013483734,0.000019990995,0.00003014663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985754,0.0001567494,0.0006035775,0.00021057038,0.00024423221,0.00020946389],"domain_scores_gemma":[0.9989626,0.00013777803,0.0004122503,0.00012147104,0.00012953633,0.00023640656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017028695,0.00018274257,0.0006897659,0.00015067034,0.00004227304,0.000014279903,0.000077135184,0.00018382135,0.00005751515],"category_scores_gemma":[0.00017845118,0.00013115119,0.0000980334,0.00016836042,0.000058861726,0.00011533548,0.000026117325,0.00017301485,0.0000064203286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009046083,0.0054032886,0.86704195,0.00018442167,0.0003622429,0.002739354,0.0018402418,0.0000012612721,0.019212877,0.00037014048,0.020378582,0.07341954],"study_design_scores_gemma":[0.13198541,0.019446477,0.7305902,0.00086967956,0.0002841793,0.013047307,0.00040763788,0.0006347199,0.086541116,0.000541241,0.015212325,0.0004396868],"about_ca_topic_score_codex":0.000024560506,"about_ca_topic_score_gemma":0.0000028392428,"teacher_disagreement_score":0.13645174,"about_ca_system_score_codex":0.00018312201,"about_ca_system_score_gemma":0.00017057618,"threshold_uncertainty_score":0.534819},"labels":[],"label_agreement":null},{"id":"W3020871161","doi":"10.1016/j.ijrobp.2008.06.1404","title":"Palliation by Low Dose Local Radiotherapy for Indolent Non-Hodgkin's Lymphoma","year":2008,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Radiation therapy; Progressive disease; Stage (stratigraphy); Lymphoma; Chemotherapy; Internal medicine; Palliative care; B symptoms; Disease; Localized disease; Surgery; Gastroenterology; Cancer","score_opus":0.018647932715161446,"score_gpt":0.3279891925758426,"score_spread":0.3093412598606811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020871161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8801119,0.0016242983,0.1099227,0.0048166406,0.0024933738,0.0006319899,0.00013286131,0.000039583105,0.00022668736],"genre_scores_gemma":[0.98605627,0.0038498766,0.004612471,0.0025479542,0.0024409331,0.00006793825,0.00031116745,0.00003706238,0.00007631222],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823713,0.0001009356,0.0007828263,0.00026596588,0.00034748402,0.0002656685],"domain_scores_gemma":[0.9975131,0.00041668463,0.00096303836,0.0001562441,0.0007682226,0.00018269879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003061132,0.00024782598,0.0005748502,0.00015018298,0.0001123638,0.000019609217,0.0002569361,0.00028179036,0.000055194552],"category_scores_gemma":[0.0001132912,0.00020648634,0.00038550806,0.00012293123,0.00019542578,0.00022383477,0.000024573577,0.00015041897,0.000021742639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022657115,0.0037506372,0.29437473,0.000015269985,0.0019990813,0.00013885029,0.0008871361,0.00077324914,0.00588605,0.0019598838,0.026464138,0.66148525],"study_design_scores_gemma":[0.11447276,0.0132678235,0.42420462,0.00027484616,0.00061633094,0.0016858334,0.00018309934,0.02232567,0.04565137,0.0041678553,0.37230727,0.0008425289],"about_ca_topic_score_codex":0.000027514883,"about_ca_topic_score_gemma":0.0000019237223,"teacher_disagreement_score":0.66064274,"about_ca_system_score_codex":0.002113769,"about_ca_system_score_gemma":0.0008104096,"threshold_uncertainty_score":0.8420268},"labels":[],"label_agreement":null},{"id":"W3021176573","doi":"10.1016/j.hoc.2020.02.004","title":"Initial Treatment of High Tumor Burden Follicular Lymphoma","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Teva Pharmaceutical Industries; Genentech; Roche","keywords":"Follicular lymphoma; Medicine; Lymphoma; Oncology; Disease; Intervention (counseling); Stage (stratigraphy); Internal medicine; Chemotherapy; Population; Intensive care medicine","score_opus":0.050976670744129995,"score_gpt":0.3844604198572935,"score_spread":0.33348374911316353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021176573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006172574,0.9890966,0.000011408628,0.00048982154,0.0005918735,0.0023639896,0.000518204,0.00008280936,0.0006727481],"genre_scores_gemma":[0.0049607027,0.98960024,0.0026649716,0.00034437384,0.0003594772,0.00075925916,0.001156255,0.00011110443,0.000043620308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944165,0.00048492764,0.0030514263,0.0010612903,0.0003716771,0.00061419804],"domain_scores_gemma":[0.99271,0.0021770722,0.003275026,0.0011066041,0.0002689558,0.00046235172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011076648,0.0009818714,0.011824326,0.0003673158,0.00006845888,0.00000476332,0.00038588274,0.00074802403,0.00016692125],"category_scores_gemma":[0.00037904273,0.00072391087,0.002395228,0.0006847103,0.0009213705,0.00003503652,0.00018823451,0.00021909278,0.00030770214],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003572768,0.004259668,0.0033023935,0.0057675606,0.004408203,0.006750736,0.00011743923,9.135871e-7,3.744228e-8,0.00016161047,0.0007005413,0.9741736],"study_design_scores_gemma":[0.006426256,0.01255952,0.00054126634,0.0021789037,0.011792201,0.0025983846,0.00004388779,0.000007530099,0.00001084045,0.000026877773,0.9634009,0.00041342943],"about_ca_topic_score_codex":0.00031157138,"about_ca_topic_score_gemma":0.00003758587,"teacher_disagreement_score":0.9737602,"about_ca_system_score_codex":0.00069444464,"about_ca_system_score_gemma":0.0040413886,"threshold_uncertainty_score":0.9995212},"labels":[],"label_agreement":null},{"id":"W3022476818","doi":"10.1182/bloodadvances.2020001646","title":"The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Kingston General Hospital; Queen's University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Population; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Oncology; Confidence interval; Lymphoma; Surgery","score_opus":0.011723917783342514,"score_gpt":0.25202227729299287,"score_spread":0.24029835950965037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022476818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238914,0.0057605635,0.00006651598,0.0007930968,0.000026520895,0.00013077323,0.0005903668,0.000014573606,0.00022845736],"genre_scores_gemma":[0.9981656,0.0011375173,0.00019806529,0.00014633678,0.000020492324,0.0000309596,0.00027345007,0.000005583367,0.000021992006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896145,0.000052040778,0.00033904018,0.00023339427,0.00027536412,0.00013869218],"domain_scores_gemma":[0.99916446,0.0003543334,0.00016170702,0.00015762493,0.000063712214,0.000098133154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008480533,0.00012674843,0.0006895468,0.0001509756,0.000053440996,0.00000784521,0.000058947608,0.000043157062,0.00008296843],"category_scores_gemma":[0.000034068362,0.00007922884,0.00033565305,0.0008499854,0.00019116791,0.000055939345,0.0000137417865,0.0000422343,9.651453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005328669,0.0004914365,0.9794335,0.000049387465,0.016729416,0.00008621597,0.0004655227,0.00012542066,0.00023968237,0.00074282754,0.000009777518,0.0010939733],"study_design_scores_gemma":[0.002397909,0.00037388183,0.95233387,0.000018126724,0.041888703,0.0000047105664,0.00013906948,0.0009759154,0.0013104965,0.000035963294,0.00044625674,0.00007508185],"about_ca_topic_score_codex":0.00006990176,"about_ca_topic_score_gemma":0.00055327755,"teacher_disagreement_score":0.027099585,"about_ca_system_score_codex":0.000009724311,"about_ca_system_score_gemma":0.000032930806,"threshold_uncertainty_score":0.32308584},"labels":[],"label_agreement":null},{"id":"W3022928951","doi":"10.1016/j.beha.2017.10.006","title":"Pathogenesis of follicular lymphoma","year":2017,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Leukemia and Lymphoma Society of Canada; European Hematology Association","keywords":"Epigenome; Follicular lymphoma; Cancer research; Biology; Lymphoma; Pathogenesis; Somatic cell; Germinal center; Chromosomal translocation; Bone marrow; Chromatin; Stromal cell; Immunology; Medicine; B cell; Genetics; Gene; DNA methylation; Gene expression","score_opus":0.5562121206030909,"score_gpt":0.6357444331501253,"score_spread":0.07953231254703441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022928951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002725224,0.98298997,0.000003359697,0.0014599672,0.00048558152,0.0025705458,0.00006885196,0.000034416396,0.01211478],"genre_scores_gemma":[0.00020216515,0.9954687,0.0014121806,0.00010476854,0.0004482675,0.0008134165,0.0001347099,0.000111663074,0.0013041807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877761,0.00548015,0.0029011702,0.0013510324,0.0014625072,0.0010290566],"domain_scores_gemma":[0.96840006,0.023876332,0.002100739,0.0033186188,0.00155432,0.0007499359],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008982121,0.00059969584,0.0074298754,0.00053993356,0.00034107032,0.00008334272,0.00096764235,0.0017889118,0.00019416885],"category_scores_gemma":[0.055528633,0.00041972793,0.002282694,0.0004428067,0.0015313515,0.00022259321,0.00087650825,0.0010704846,0.002487494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025819658,0.009548661,0.0005826756,0.013034867,0.0021960633,0.019083366,0.000015367174,5.0655236e-9,9.0686605e-8,0.0019332924,0.0025645967,0.95078284],"study_design_scores_gemma":[0.002384845,0.0026641465,0.00015162735,0.013819598,0.0066341916,0.010542184,0.000051559506,0.0000012859207,0.0000021784247,0.000070532515,0.9634018,0.00027605676],"about_ca_topic_score_codex":0.00040413527,"about_ca_topic_score_gemma":0.000023778473,"teacher_disagreement_score":0.9608372,"about_ca_system_score_codex":0.00042340934,"about_ca_system_score_gemma":0.00810968,"threshold_uncertainty_score":0.9998255},"labels":[],"label_agreement":null},{"id":"W3023457089","doi":"10.1080/01676830.2020.1760312","title":"Orbital marginal cell lymphoma and mantle cell lymphoma subclone in patient with monoclonal gammopathy of unknown significance","year":2020,"lang":"en","type":"article","venue":"Orbit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Mantle cell lymphoma; Lymphoma; Medicine; Chronic lymphocytic leukemia; Marginal zone; Cyclin D1; Rituximab; Pathology; Cancer research; Leukemia; B cell; Immunology; Antibody; Internal medicine; Cancer; Cell cycle","score_opus":0.009066014515764362,"score_gpt":0.1984654372734132,"score_spread":0.18939942275764884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023457089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923934,0.0018151292,0.000012436379,0.0006964391,0.00004175782,0.0004983876,0.00004572211,0.000029284296,0.007621484],"genre_scores_gemma":[0.9978789,0.00017633486,0.0012226182,0.0003305834,0.000055585817,0.00006998713,0.000037467304,0.00003625045,0.0001922463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983902,0.00003753432,0.0003762999,0.00048241913,0.00037081458,0.000342754],"domain_scores_gemma":[0.99917215,0.000069755464,0.00015943068,0.0002346784,0.00006879794,0.00029517812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005862787,0.00027950996,0.0005131046,0.00008140879,0.000039622017,0.000018320945,0.000080743346,0.000084336236,0.00011754238],"category_scores_gemma":[0.00001109183,0.00021666975,0.00007631455,0.00028460458,0.00012384348,0.00008044719,0.000065676155,0.000052009284,0.000045845798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00826886,0.015160113,0.8465081,0.0017212968,0.00022396795,0.01877904,0.0049646227,0.000067799585,0.022862995,0.00058609736,0.0030772162,0.07777988],"study_design_scores_gemma":[0.037074156,0.0072115613,0.61213464,0.00031963357,0.00031780993,0.0006528146,0.00087367074,0.00083533634,0.33175734,0.000040931627,0.0081177065,0.0006644061],"about_ca_topic_score_codex":0.00039673893,"about_ca_topic_score_gemma":0.00004229249,"teacher_disagreement_score":0.30889434,"about_ca_system_score_codex":0.00017150401,"about_ca_system_score_gemma":0.00024379544,"threshold_uncertainty_score":0.8835536},"labels":[],"label_agreement":null},{"id":"W3024102980","doi":"10.1182/bloodadvances.2019001265","title":"Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Confidence interval; Stage (stratigraphy); Subgroup analysis; Lymphoma; Oncology; Cohort; Proportional hazards model; Retrospective cohort study; B symptoms; Chemotherapy; Disease; Gastroenterology","score_opus":0.010232299588997757,"score_gpt":0.2585615000814247,"score_spread":0.24832920049242693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024102980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96550065,0.03086815,0.000010867151,0.002353068,0.000030931864,0.0008289142,0.00016187501,0.00003327985,0.00021227963],"genre_scores_gemma":[0.9974895,0.0014042832,0.00033381057,0.00036078552,0.000056353252,0.00019289224,0.00004319338,0.000016419652,0.00010272719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879754,0.000041622712,0.00029010104,0.00038553696,0.00025258758,0.00023263863],"domain_scores_gemma":[0.99901223,0.00033967246,0.00013651395,0.0002421354,0.000036201276,0.00023323121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007488123,0.00019171729,0.00033904205,0.000026050695,0.00005610376,0.000016003223,0.000096015116,0.000021904345,0.00001534142],"category_scores_gemma":[0.00046364273,0.000121960045,0.00006015372,0.0002337065,0.00013644034,0.00015628249,0.00007893212,0.000044399345,0.000004206508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042030087,0.0007874653,0.9783101,0.00033162185,0.00004123861,0.00024266036,0.00031439814,0.000024297127,0.0011651284,0.00019357572,0.00011531592,0.018053887],"study_design_scores_gemma":[0.008799673,0.0006428363,0.9797968,0.00042647836,0.0003114059,0.000018339231,0.0002640493,0.0002400035,0.00400756,0.00014363343,0.0051642978,0.000184887],"about_ca_topic_score_codex":0.00005393236,"about_ca_topic_score_gemma":0.00006873062,"teacher_disagreement_score":0.0319889,"about_ca_system_score_codex":0.000022071996,"about_ca_system_score_gemma":0.00006135501,"threshold_uncertainty_score":0.49733865},"labels":[],"label_agreement":null},{"id":"W3024741695","doi":"","title":"Le Rituximab dans le traitement d’entretien du lymphome folliculaire : analyse des pratiques au CHU de Nancy basée sur une revue d’utilisation québécoise","year":2014,"lang":"fr","type":"preprint","venue":"Publications Et Travaux Academiques de Lorraine (Universite de Lorraine)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.030402259592636625,"score_gpt":0.2472583232074515,"score_spread":0.21685606361481488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024741695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6411921,0.0033341807,0.087157585,0.22453567,0.00026930167,0.0030700276,0.0007363135,0.00092415616,0.03878071],"genre_scores_gemma":[0.9581341,0.0073265014,0.014882893,0.0030093312,0.001063989,0.00094234355,0.0052284496,0.00024892934,0.009163459],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99106866,0.0018997743,0.0017033172,0.0022023367,0.00079029234,0.0023356394],"domain_scores_gemma":[0.9926078,0.0009472925,0.001406332,0.0018968128,0.0013398572,0.0018019387],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0033068757,0.0015554705,0.001968362,0.0015534094,0.001435469,0.00043157724,0.0016110648,0.0020826422,0.00029868147],"category_scores_gemma":[0.001343138,0.001841114,0.0012650691,0.0021874527,0.0011891184,0.0017981159,0.0006142939,0.001650884,0.00008961601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003414332,0.0065263608,0.10824567,0.001865753,0.0025379355,0.0002688113,0.20416941,0.0059141405,0.0018950531,0.6418091,0.008219886,0.018206446],"study_design_scores_gemma":[0.012001095,0.00066327036,0.6905019,0.0027770693,0.0034540584,0.00083075126,0.02663019,0.0862343,0.0014324728,0.007152933,0.16625094,0.0020710088],"about_ca_topic_score_codex":0.09417688,"about_ca_topic_score_gemma":0.048776105,"teacher_disagreement_score":0.6346562,"about_ca_system_score_codex":0.013913262,"about_ca_system_score_gemma":0.013388379,"threshold_uncertainty_score":0.9998645},"labels":[],"label_agreement":null},{"id":"W3025072273","doi":"10.3324/haematol.2019.238675","title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Rituximab; Prednisone; Internal medicine; Cyclophosphamide; Oncology; Lymphoma; Vincristine; Regimen; B-cell lymphoma; CD30; Gastroenterology; Surgery; Chemotherapy","score_opus":0.010123700756752741,"score_gpt":0.22607936747927676,"score_spread":0.21595566672252403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025072273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923426,0.0009170971,0.00008963701,0.0024962549,0.000026284888,0.0029018046,0.00008031206,0.00008242172,0.0010636089],"genre_scores_gemma":[0.9940879,0.00020568402,0.0037650976,0.000780478,0.000017940449,0.00060784206,0.00041931026,0.00003418715,0.000081577986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998407,0.000043847216,0.0003334563,0.0006079279,0.0002581957,0.00034957475],"domain_scores_gemma":[0.9990737,0.00017179028,0.00017931843,0.00019448179,0.00014944836,0.00023125803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042021922,0.00036966172,0.0008370081,0.00006862287,0.000105283965,0.000032436117,0.0000578528,0.00011389608,0.000034581073],"category_scores_gemma":[0.000042351065,0.0002214681,0.00006868303,0.00019227725,0.00010412276,0.00009375325,0.000034344295,0.000055004588,0.00002527591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011181117,0.019734116,0.9577095,0.00021295826,0.00027227143,0.00066705985,0.0011594407,0.000008398819,0.00004499089,0.001023495,0.00033151943,0.007655157],"study_design_scores_gemma":[0.16582738,0.036654156,0.7797129,0.00039385605,0.0006355682,0.000138196,0.00033080406,0.00054231356,0.013893166,0.00018637013,0.00122269,0.0004625673],"about_ca_topic_score_codex":0.0002005495,"about_ca_topic_score_gemma":0.00005118127,"teacher_disagreement_score":0.17799653,"about_ca_system_score_codex":0.00026894262,"about_ca_system_score_gemma":0.00011732187,"threshold_uncertainty_score":0.9031207},"labels":[],"label_agreement":null},{"id":"W3025233783","doi":"10.1158/1078-0432.1065.11.3","title":"Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; Tissue microarray; Lymphoma; Internal medicine; Immunohistochemistry; Survival analysis; Oncology; Biology; Medicine; Pathology; Cancer research","score_opus":0.08804545974782862,"score_gpt":0.40457450689216684,"score_spread":0.3165290471443382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025233783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766505,0.00015994333,0.0000021511892,0.0007791533,0.00006559334,0.0008925046,0.00017116468,0.000012254155,0.00025216103],"genre_scores_gemma":[0.9991119,0.0001226247,0.000024201741,0.000121442856,0.00008075944,0.00012365117,0.000025414223,0.00002556937,0.00036443767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972218,0.0003913873,0.00044939792,0.0003707259,0.0011289363,0.0004376972],"domain_scores_gemma":[0.9984913,0.00041635006,0.00012569694,0.00041467638,0.00037964288,0.00017232727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061725633,0.00014871881,0.00041693068,0.000077711346,0.000087412795,0.000017229593,0.00016021257,0.00015119807,0.0001999897],"category_scores_gemma":[0.0001821949,0.00007529708,0.00011408954,0.000370077,0.00019882071,0.00009199842,0.00006129217,0.0002861237,0.000007852751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002483984,0.016012924,0.9746264,0.00003157854,0.000058658206,0.0000045862917,0.0003189066,0.0000018026409,0.00013618375,0.0000047653466,0.0003565874,0.005963623],"study_design_scores_gemma":[0.05177707,0.0016125643,0.9397447,0.0004892124,0.00004187041,8.762209e-8,0.00006496814,0.000028602242,0.0051677944,0.000001911415,0.0009882711,0.00008296682],"about_ca_topic_score_codex":0.00033015155,"about_ca_topic_score_gemma":0.0015075925,"teacher_disagreement_score":0.049293086,"about_ca_system_score_codex":0.00052694656,"about_ca_system_score_gemma":0.00049798726,"threshold_uncertainty_score":0.30705258},"labels":[],"label_agreement":null},{"id":"W3027036348","doi":"10.1111/bjh.16756","title":"Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pharmacyclics; Genentech; Incyte; Astex Pharmaceuticals; Adaptive Biotechnologies; Gilead Sciences; Celgene; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Pfizer; Regeneron Pharmaceuticals; American Cancer Society","keywords":"Medicine; Internal medicine; Refractory (planetary science); Regimen; Salvage therapy; Chemotherapy; Oncology; Lymphoma; Surgery","score_opus":0.03151984129911549,"score_gpt":0.275926385001685,"score_spread":0.24440654370256948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027036348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764278,0.00839219,0.00006984572,0.013698802,0.0003223789,0.00048581223,0.00002230195,0.00003557483,0.00054527825],"genre_scores_gemma":[0.9884191,0.0056059053,0.0015437417,0.003833448,0.00041407286,0.000028803295,0.000011436716,0.00004461164,0.00009886648],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979054,0.00012853886,0.0008612877,0.00033579837,0.00035203935,0.0004169634],"domain_scores_gemma":[0.9982991,0.00012463753,0.00037148982,0.00020581529,0.0002552287,0.0007437145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014236858,0.00028695134,0.0012423211,0.00013158808,0.00009732425,0.00005033499,0.00013125752,0.00016257515,0.00022852152],"category_scores_gemma":[0.00014768045,0.00025159545,0.0004578511,0.00018630884,0.000086647415,0.00009053846,0.000039280596,0.00012978121,0.00012562166],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026262228,0.004991686,0.017848797,0.00009815455,0.001986576,0.5767145,0.00273893,0.000032714473,0.015588413,0.00006585976,0.01386098,0.3634472],"study_design_scores_gemma":[0.028834652,0.014150721,0.10007461,0.0007637657,0.00054389006,0.6079746,0.0005123241,0.000033629472,0.15300289,0.000071451774,0.09357872,0.00045875728],"about_ca_topic_score_codex":0.00032152736,"about_ca_topic_score_gemma":0.000059251135,"teacher_disagreement_score":0.3629884,"about_ca_system_score_codex":0.0005353657,"about_ca_system_score_gemma":0.00061720645,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W3028882299","doi":"10.1200/jco.2020.38.15_suppl.8031","title":"Outcome of elderly patients with classical Hodgkin lymphoma (HL) in British Columbia.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; ABVD; Stage (stratigraphy); Internal medicine; Radiation therapy; Classical Hodgkin lymphoma; Cancer; Gastroenterology; Chemotherapy; Lymphoma; Hodgkin lymphoma; Oncology; Surgery; Pediatrics; Cyclophosphamide; Vincristine","score_opus":0.08608074583885651,"score_gpt":0.39859358734111694,"score_spread":0.31251284150226044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028882299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921875,0.00012588972,0.000009805016,0.0063782553,0.0002905133,0.00022813563,0.000009443922,0.000005621462,0.0007648376],"genre_scores_gemma":[0.9942475,0.00011665019,0.0017779515,0.0034550957,0.0003158109,0.000004325371,0.0000037011582,0.000014618129,0.000064375876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638224,0.00024509156,0.0025208679,0.00019803866,0.00045145236,0.00020229963],"domain_scores_gemma":[0.99660754,0.0011712603,0.0012560408,0.00011955032,0.00036192758,0.00048368727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000667989,0.00009640623,0.0018202806,0.00003993192,0.000016984684,0.000017312288,0.00012975284,0.00029327237,0.00015937755],"category_scores_gemma":[0.0022431891,0.000089557456,0.00037685168,0.00017744502,0.00019076365,0.00008038723,0.00004254886,0.00033036526,0.000010377593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013784117,0.0058313143,0.75511444,0.00002416532,0.00019564187,0.001649123,0.000030298248,0.0000015445283,0.0000011726678,0.00000549751,0.0037472718,0.23202112],"study_design_scores_gemma":[0.036251213,0.037226535,0.909396,0.00014557898,0.00026398047,0.00012227522,0.00004794597,0.000016381218,0.0000048428506,0.000030942207,0.016421108,0.000073227166],"about_ca_topic_score_codex":0.0007182777,"about_ca_topic_score_gemma":0.0056784083,"teacher_disagreement_score":0.23194788,"about_ca_system_score_codex":0.00019560991,"about_ca_system_score_gemma":0.0009689255,"threshold_uncertainty_score":0.3652047},"labels":[],"label_agreement":null},{"id":"W3028917365","doi":"10.1200/jco.2020.38.15_suppl.12068","title":"Lifelong disease burden of chemotherapy in Hodgkin lymphoma (HL): A simulation study from the St. Jude Lifetime (SJLIFE) Cohort and HL International Study for Individual Care (HoLISTIC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Queen's University","funders":"","keywords":"Medicine; Cohort; Life expectancy; Internal medicine; Population; Microsimulation; Cohort study; Pediatrics; Oncology; Environmental health","score_opus":0.12919196518976547,"score_gpt":0.4714911534300442,"score_spread":0.3422991882402787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028917365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856827,0.0006201604,0.00005307339,0.011631864,0.00037361565,0.0014996028,0.00010752953,0.0000057022694,0.000025737301],"genre_scores_gemma":[0.995133,0.0001358565,0.00039003562,0.0024064716,0.0018419578,0.0000387917,0.0000317194,0.000017169428,0.00000501171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968291,0.0004269344,0.0017855674,0.00027244253,0.0005494552,0.00013649189],"domain_scores_gemma":[0.9930978,0.0049705547,0.0010454864,0.0001637153,0.00038929103,0.00033319992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013318395,0.00015866855,0.0011293527,0.00006877711,0.000038530205,0.000021874843,0.00022279355,0.00012729998,0.000048542173],"category_scores_gemma":[0.004062113,0.00009996123,0.00024730637,0.000100355195,0.0000984401,0.00007472175,0.00008579859,0.00019906294,0.000001452778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009401998,0.0073904116,0.9152268,0.000011487511,0.00152723,0.00037057372,0.005298017,0.00055270345,0.0000013984292,0.0000045566676,0.00050180027,0.05971301],"study_design_scores_gemma":[0.040622342,0.013311543,0.9352012,0.00006118821,0.001281305,0.0000051568754,0.0048470357,0.0019515204,0.0000029418243,0.00004857857,0.0025907576,0.00007638508],"about_ca_topic_score_codex":0.00024200273,"about_ca_topic_score_gemma":0.000106800486,"teacher_disagreement_score":0.059636623,"about_ca_system_score_codex":0.00017209158,"about_ca_system_score_gemma":0.00084070594,"threshold_uncertainty_score":0.48630223},"labels":[],"label_agreement":null},{"id":"W3029433758","doi":"10.1200/jco.2020.38.15_suppl.e20019","title":"The Hodgkin lymphoma international study for individual care (HoLISTIC): Enhancing decision making in pediatric and adult Hodgkin lymphoma (HL).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Queen's University","funders":"","keywords":"Medicine; Hodgkin lymphoma; Cohort; Survivorship curve; Quality of life (healthcare); Nodular sclerosis; Clinical trial; Lymphoma; Internal medicine; Family medicine; Pediatrics; Cancer","score_opus":0.11986751887498075,"score_gpt":0.47336136035529575,"score_spread":0.353493841480315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029433758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066454,0.0015077619,0.00028470522,0.0052940026,0.0013561549,0.00060671475,0.00001413993,0.000008860336,0.0002631428],"genre_scores_gemma":[0.98945224,0.0013602943,0.004204638,0.0024747353,0.00244197,0.000034091103,0.000004913618,0.000020799529,0.0000062918007],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961261,0.00031380795,0.0023605747,0.0003249322,0.00059697777,0.00027758387],"domain_scores_gemma":[0.98917395,0.008498081,0.0012642546,0.00014807588,0.0006060606,0.0003095859],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002098142,0.00019453192,0.0010696789,0.00015457885,0.00011675903,0.000060870556,0.000297419,0.00025097688,0.000013826158],"category_scores_gemma":[0.011936361,0.00012087996,0.00033037085,0.00018771105,0.000085042666,0.00010817641,0.0001801467,0.00023594158,0.000005778992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041078343,0.0015110009,0.48494297,0.000019512083,0.00021827879,0.000616684,0.0011692378,0.000007084489,0.0000014190251,0.00007132003,0.00090039766,0.50643426],"study_design_scores_gemma":[0.032589406,0.0132011,0.9413855,0.00010131427,0.0006978172,0.0001938875,0.0034853262,0.00020070489,0.000015366955,0.00021802605,0.007799955,0.000111581445],"about_ca_topic_score_codex":0.000019589854,"about_ca_topic_score_gemma":0.00033672943,"teacher_disagreement_score":0.5063227,"about_ca_system_score_codex":0.00040056638,"about_ca_system_score_gemma":0.0011895811,"threshold_uncertainty_score":0.9963865},"labels":[],"label_agreement":null},{"id":"W3029795115","doi":"10.1200/jco.2020.38.15_suppl.11028","title":"Practice gaps and challenges integrating new immuno-oncology agents in the treatment of cancer patients in the United States: A mixed-method study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Family medicine; Feeling; Internal medicine; Oncology; Health care; Cancer; Psychology","score_opus":0.2674962295928081,"score_gpt":0.5374059690861474,"score_spread":0.26990973949333924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029795115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099155,0.0056500845,0.0000040391114,0.08323443,0.0002594732,0.0006520245,0.0000033291515,0.0000017835027,0.00027935288],"genre_scores_gemma":[0.91451037,0.07669558,0.0013439977,0.007128201,0.00026520382,0.00003881554,0.0000047161902,0.0000085819875,0.000004519665],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99408704,0.0033939753,0.0018306548,0.00018779375,0.00032478108,0.00017576088],"domain_scores_gemma":[0.98518324,0.012792097,0.0014995938,0.00014912184,0.00023105234,0.00014491848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030310934,0.00015354196,0.0011930224,0.00010778838,0.000032621614,0.000011015353,0.00017351023,0.00016817197,0.00001732664],"category_scores_gemma":[0.0037067614,0.00006801974,0.00017242682,0.00026736376,0.000093067334,0.00006925361,0.000031494958,0.0004097536,0.0000011808302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003964714,0.02677949,0.41159344,0.000022171764,0.00063901336,0.0010435759,0.05154513,0.000029839117,0.000001595763,0.00003392523,0.0007071523,0.50363994],"study_design_scores_gemma":[0.0238451,0.07428002,0.6976816,0.00008702976,0.00068927085,0.000059158214,0.042982288,0.00010069651,0.0000062798554,0.00004187497,0.16017844,0.000048241902],"about_ca_topic_score_codex":0.0028040633,"about_ca_topic_score_gemma":0.0030458174,"teacher_disagreement_score":0.5035917,"about_ca_system_score_codex":0.00033991135,"about_ca_system_score_gemma":0.0009765262,"threshold_uncertainty_score":0.44376075},"labels":[],"label_agreement":null},{"id":"W3029806582","doi":"10.1200/jco.2020.38.15_suppl.8005","title":"KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Pembrolizumab; Oncology; Refractory (planetary science); Lymphoma; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.2539880172298434,"score_gpt":0.5011283891179645,"score_spread":0.24714037188812116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029806582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852559,0.00095554354,0.000015508702,0.0073848236,0.0018735275,0.0020317824,0.000009827429,0.000018119845,0.00245499],"genre_scores_gemma":[0.9941282,0.001364507,0.0009933726,0.0023899896,0.0008444624,0.00007267782,0.000008334521,0.000048256778,0.0001501446],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98918676,0.002545011,0.0063612186,0.000585593,0.00085009297,0.000471347],"domain_scores_gemma":[0.98270893,0.01098197,0.0044692443,0.00048277035,0.00049766584,0.00085944287],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004642294,0.00042086781,0.0065436875,0.00026872288,0.00006639293,0.000030740353,0.0006742197,0.00058977836,0.00042011734],"category_scores_gemma":[0.011952449,0.00026968267,0.0006708778,0.00050941063,0.00037739394,0.00021879534,0.0003268942,0.0009118933,0.000039965802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7483604,0.0867192,0.0034178332,0.000045068016,0.0018460937,0.0054490967,0.00075473415,0.0000096164185,0.00007883051,0.00004658016,0.0044845906,0.14878799],"study_design_scores_gemma":[0.83571184,0.13599992,0.012383142,0.00020863645,0.0020330672,0.00017444916,0.0008883234,0.0004550892,0.0000877027,0.00003232109,0.011824202,0.0002013231],"about_ca_topic_score_codex":0.00022850724,"about_ca_topic_score_gemma":0.00023356274,"teacher_disagreement_score":0.14858666,"about_ca_system_score_codex":0.0007266119,"about_ca_system_score_gemma":0.0044316957,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W3029854097","doi":"10.3747/co.27.6041","title":"Update on the Subcutaneous Administration of Rituximab in Canadian Cancer Centres","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Roche (Canada); Université du Québec à Trois-Rivières; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Ottawa Hospital; Innovation and Economic Development Trois Rivières; Fluidigm (Canada); Burnaby Hospital; Université de Montréal; Impact; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Dosing; Follicular lymphoma; Chronic lymphocytic leukemia; Lymphoma; Drug administration; Internal medicine; Leukemia","score_opus":0.1003076707304336,"score_gpt":0.390656482094351,"score_spread":0.2903488113639174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029854097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9264734,0.0013619179,3.9810863e-7,0.06966659,0.00027610653,0.00032050846,0.00005595649,0.0000071609825,0.0018379808],"genre_scores_gemma":[0.9975472,0.0007124614,0.000008218404,0.0015371043,0.000093849,0.000051971376,0.000037019312,0.0000047809617,0.0000073846413],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994017,0.000044725,0.00015832098,0.00013416861,0.00008156009,0.00017951251],"domain_scores_gemma":[0.9995813,0.00007332779,0.0000537129,0.0000910245,0.000031021846,0.00016965257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004138645,0.00007380967,0.00019594021,0.0000390274,0.00002253125,0.0000033480449,0.000050282353,0.000044537668,0.00033228562],"category_scores_gemma":[0.000059777405,0.00004813376,0.000037849717,0.000098011864,0.000039416405,0.000009609025,0.000008788281,0.00008377786,0.000052582753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016860868,0.0045481403,0.5901367,0.00014628537,0.00013200646,0.0016976583,0.0017346065,0.000019119147,0.00012203955,0.011358252,0.03422082,0.3541983],"study_design_scores_gemma":[0.0063794293,0.0029359,0.1490096,0.0001598478,0.00014863143,0.000073786505,0.00023205018,0.00063887297,0.0031250562,0.00009591425,0.8370688,0.00013214267],"about_ca_topic_score_codex":0.017812764,"about_ca_topic_score_gemma":0.20413634,"teacher_disagreement_score":0.8028479,"about_ca_system_score_codex":0.00046223297,"about_ca_system_score_gemma":0.0009936688,"threshold_uncertainty_score":0.9887277},"labels":[],"label_agreement":null},{"id":"W3030606285","doi":"10.1200/jco.2020.38.15_suppl.tps8067","title":"An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Medicine; Brentuximab vedotin; Dacarbazine; Oncology; Internal medicine; Cancer; Stage (stratigraphy); Young adult; Nivolumab; Hodgkin lymphoma; Vinblastine; Lymphoma; Chemotherapy","score_opus":0.059519700755086766,"score_gpt":0.4348099893307484,"score_spread":0.3752902885756616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030606285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678416,0.00037353425,0.00021936616,0.011239438,0.0007361912,0.000515979,0.000015004874,0.000010919065,0.00010542833],"genre_scores_gemma":[0.9915398,0.00057694427,0.0033209738,0.0037022568,0.0007874372,0.00002098719,0.000009713019,0.000018470304,0.000023417715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721235,0.0002734223,0.0017574943,0.00029236573,0.00024451598,0.000219833],"domain_scores_gemma":[0.9975152,0.00050111004,0.00092856766,0.00012486218,0.00033520235,0.0005950441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007947745,0.0001596349,0.0012008939,0.000082104154,0.000031255044,0.000019968324,0.00010736913,0.00032099412,0.0000141951805],"category_scores_gemma":[0.002183931,0.00011801923,0.00021255987,0.0001559855,0.00010884482,0.00023195468,0.000035646823,0.00024952253,0.000004453563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030932099,0.005692016,0.5980707,0.000116850126,0.00014153836,0.0007737717,0.0006258005,0.000011924109,0.00040441338,0.00014252198,0.001100072,0.36198834],"study_design_scores_gemma":[0.06484803,0.044073638,0.8679506,0.00046655315,0.00021585324,0.000096268406,0.0011585605,0.0020797874,0.00030355118,0.000056523313,0.018612733,0.00013789731],"about_ca_topic_score_codex":0.000014106931,"about_ca_topic_score_gemma":0.00036731045,"teacher_disagreement_score":0.36185044,"about_ca_system_score_codex":0.00030530305,"about_ca_system_score_gemma":0.0008703516,"threshold_uncertainty_score":0.48126844},"labels":[],"label_agreement":null},{"id":"W3031235513","doi":"10.1002/pbc.28416","title":"Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma","year":2020,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Anaplastic large-cell lymphoma; Follicular lymphoma; Not Otherwise Specified; Marginal zone; Lymphoblastic lymphoma; Large cell; Marginal zone B-cell lymphoma; Pathology; Oncology; Internal medicine; B cell; T cell; Immunology; Cancer; Adenocarcinoma","score_opus":0.015312743195003496,"score_gpt":0.26107446872696133,"score_spread":0.24576172553195783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031235513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20642969,0.78880566,0.000017597027,0.00011181271,0.00038188984,0.0034240475,0.0005982789,0.00009453283,0.00013650155],"genre_scores_gemma":[0.18155117,0.813923,0.0009078392,0.00035448733,0.0017254658,0.0010307463,0.00014339227,0.0002593616,0.0001045038],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99313146,0.0003151927,0.001743442,0.0024168275,0.0011003669,0.0012927037],"domain_scores_gemma":[0.9949711,0.0012433468,0.0010566363,0.0008994797,0.00032798504,0.0015014514],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002956969,0.0019944464,0.0049294564,0.0007457605,0.0003239233,0.000173062,0.0004187336,0.0008807416,0.00004092758],"category_scores_gemma":[0.000281908,0.0016366682,0.0006692842,0.0019674934,0.00031016278,0.00009387739,0.000495208,0.00021671149,0.00002642849],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046517627,0.005972718,0.08464084,0.041566484,0.0016716819,0.0012164596,0.00083820336,0.0000039442934,0.0000025354109,0.00002853373,0.00083037344,0.86276305],"study_design_scores_gemma":[0.08245499,0.007034944,0.54805595,0.011483206,0.13613002,0.009464099,0.0004143127,0.00028700352,0.000045289562,0.000029294597,0.19865917,0.005941744],"about_ca_topic_score_codex":0.0006683779,"about_ca_topic_score_gemma":0.000028471908,"teacher_disagreement_score":0.8568213,"about_ca_system_score_codex":0.00058443216,"about_ca_system_score_gemma":0.0037209955,"threshold_uncertainty_score":0.99927986},"labels":[],"label_agreement":null},{"id":"W3031937200","doi":"10.3747/co.27.5775","title":"Epidemiology of Adult and Pediatric Burkitt Lymphoma in Canada: Sequelae of the HIV Epidemic","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; University of Ottawa; Université de Montréal","funders":"","keywords":"Medicine; Incidence (geometry); Epidemiology; Demography; Lymphoma; Population; Pediatrics; Immunology; Internal medicine; Environmental health","score_opus":0.0994165739992104,"score_gpt":0.3513142612308936,"score_spread":0.2518976872316832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031937200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775905,0.010417552,0.0000050267445,0.011082536,0.0003530821,0.00033087144,0.00004349169,0.00000499515,0.00017194642],"genre_scores_gemma":[0.9962374,0.0023699175,0.000080749756,0.0011323709,0.000121785815,0.00003381394,0.000012528168,0.0000073403517,0.000004095856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852306,0.00026577787,0.00063147274,0.00024506464,0.000099885074,0.0002347136],"domain_scores_gemma":[0.9983476,0.00092345144,0.0003186278,0.00018120576,0.00008271763,0.00014641239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017429424,0.00012886758,0.0007739322,0.00004873099,0.000016236685,2.0689824e-7,0.00010244292,0.00008865781,0.000024884112],"category_scores_gemma":[0.001248445,0.00008388684,0.0000798225,0.0002233196,0.000112908325,0.0000143093675,0.00010009555,0.0001034174,0.0000031252362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009070202,0.00024065701,0.973828,0.00021809488,0.000029957302,0.000019455001,0.00019182943,0.000008520895,0.000016139053,0.0005084487,0.0039779847,0.020870166],"study_design_scores_gemma":[0.0036659343,0.00030987523,0.99083745,0.00005438378,0.00016366715,0.000034907534,0.00015568006,0.00043097525,0.0002023538,0.00010604542,0.0039761695,0.00006254809],"about_ca_topic_score_codex":0.12033287,"about_ca_topic_score_gemma":0.11380149,"teacher_disagreement_score":0.020807618,"about_ca_system_score_codex":0.00068136625,"about_ca_system_score_gemma":0.0022031055,"threshold_uncertainty_score":0.9023693},"labels":[],"label_agreement":null},{"id":"W3032035362","doi":"10.1200/jco.2020.38.15_suppl.e20058","title":"Presenting international prognostic scoring system affects time to treatment: A retrospective single center review.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor","funders":"","keywords":"Medicine; Retrospective cohort study; Internal medicine; Single Center; Chemotherapy; Stage (stratigraphy); International Prognostic Index; Proportional hazards model; Cancer; Lymphoma; Diffuse large B-cell lymphoma; Oncology; Surgery","score_opus":0.11855910705570989,"score_gpt":0.4364936455012911,"score_spread":0.3179345384455812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032035362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8932137,0.0020448149,0.00004598972,0.07118764,0.0015019535,0.0012890893,0.000013164899,0.000047957317,0.030655712],"genre_scores_gemma":[0.9916209,0.0006331823,0.0013867093,0.0039032851,0.0021827766,0.000019649931,0.0000051978363,0.000016614484,0.00023170578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977271,0.00022645353,0.0012650547,0.0002375133,0.00035400395,0.00018986191],"domain_scores_gemma":[0.9971919,0.0008481364,0.000978981,0.00011506082,0.0003287165,0.0005372284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006692521,0.00014420493,0.0013377949,0.00006123777,0.000028760907,0.000015790489,0.00011999655,0.00011144046,0.00017136909],"category_scores_gemma":[0.004529816,0.00009397925,0.0005184915,0.00013030531,0.00003254653,0.00008641526,0.00006797446,0.000207868,0.0003085445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020423017,0.0054759444,0.88016605,0.00036263771,0.0018908047,0.0049104644,0.00019620475,0.0000067081896,0.00028728947,0.00006474217,0.017380219,0.08721661],"study_design_scores_gemma":[0.025994273,0.0626868,0.6145532,0.008527252,0.0025101255,0.0025215112,0.000089851506,0.0004604969,0.00055604894,0.000012496845,0.28183147,0.00025645818],"about_ca_topic_score_codex":0.000003057125,"about_ca_topic_score_gemma":0.0000013159608,"teacher_disagreement_score":0.26561284,"about_ca_system_score_codex":0.00090477424,"about_ca_system_score_gemma":0.00037468306,"threshold_uncertainty_score":0.542294},"labels":[],"label_agreement":null},{"id":"W3032329880","doi":"10.1182/bloodadvances.2019001075","title":"Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Occupational Cancer Research Centre","funders":"","keywords":"RHOA; Sanger sequencing; Exon; Molecular biology; Mutation; Biology; Cancer research; Genetics; Medicine; Gene","score_opus":0.0074789650766743905,"score_gpt":0.2056046915260458,"score_spread":0.1981257264493714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032329880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822026,0.0008061077,0.0000051059747,0.000088836816,0.000031222055,0.0003548862,0.00013203756,0.000031214608,0.0003303522],"genre_scores_gemma":[0.9967099,0.000058865666,0.0028354202,0.00007066434,0.000026966321,0.000060191396,0.00020309688,0.000015317335,0.000019617992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992026,0.000018737022,0.00020572222,0.0002396471,0.00019201523,0.00014129914],"domain_scores_gemma":[0.99952054,0.00010547008,0.00009863308,0.00011687415,0.000055553977,0.00010295422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000008272433,0.0001327731,0.0002649542,0.00003149953,0.00003364721,0.000005123525,0.000046251305,0.000035440233,0.00005926161],"category_scores_gemma":[0.000044492095,0.00009790005,0.00003939075,0.00017319259,0.00004216875,0.00009018938,0.000023672623,0.000024008761,0.000010483948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057783717,0.0019926112,0.9871645,0.000040680363,0.000064417865,0.000052530817,0.00081895,0.00010470658,0.0020023622,0.0000012518132,0.0000070600386,0.0071730907],"study_design_scores_gemma":[0.026716052,0.0009401522,0.8406213,0.00007918652,0.00014110601,0.0000012775927,0.00026952822,0.00028547752,0.13028102,0.0000046320233,0.00055611465,0.00010415194],"about_ca_topic_score_codex":0.00019714405,"about_ca_topic_score_gemma":0.00070068863,"teacher_disagreement_score":0.1465432,"about_ca_system_score_codex":0.000063042,"about_ca_system_score_gemma":0.000049768485,"threshold_uncertainty_score":0.39922482},"labels":[],"label_agreement":null},{"id":"W3032936560","doi":"10.1080/10428194.2020.1772472","title":"Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy","year":2020,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; University of Toronto","funders":"","keywords":"Follicular lymphoma; Rituximab; Medicine; Oncology; Internal medicine; Chemotherapy; Lymphoma; Follicular phase; Stage (stratigraphy)","score_opus":0.007847507902116808,"score_gpt":0.21658497532236864,"score_spread":0.20873746742025184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032936560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955634,0.0012103185,0.00006604604,0.00056368514,0.00011788776,0.0014623315,0.0001680205,0.00021301702,0.00063531694],"genre_scores_gemma":[0.992723,0.00046527962,0.0023640026,0.0033059518,0.00012917694,0.00018338529,0.00041280413,0.00019681144,0.00021957626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955467,0.00009804296,0.0010836537,0.0013777049,0.0009778761,0.00091605133],"domain_scores_gemma":[0.9970933,0.00028682276,0.0006533865,0.0007910947,0.00025345339,0.0009218963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018746336,0.0011690604,0.0023464002,0.00022242762,0.0003444001,0.0001355701,0.00022821578,0.00040873993,0.00007051881],"category_scores_gemma":[0.00008528223,0.0008189255,0.0003705617,0.0005428468,0.00034137422,0.00037179122,0.0001518319,0.00009959687,0.0000152328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051832795,0.0013167766,0.8929477,0.00037701926,0.0025383064,0.0010751928,0.0018129132,0.0000033564681,0.0002474008,0.00018626198,0.00014075213,0.09417106],"study_design_scores_gemma":[0.1135379,0.0047080144,0.86978483,0.00051572686,0.0014920905,0.00019342036,0.0003720082,0.0006020805,0.004642379,0.000020814168,0.0032896209,0.0008411313],"about_ca_topic_score_codex":0.00041408595,"about_ca_topic_score_gemma":0.000032672044,"teacher_disagreement_score":0.10835462,"about_ca_system_score_codex":0.003003072,"about_ca_system_score_gemma":0.0016205562,"threshold_uncertainty_score":0.9994262},"labels":[],"label_agreement":null},{"id":"W3033237799","doi":"10.1182/bloodadvances.2020001923","title":"Gene expression profiling of gray zone lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Biology; Gene expression profiling; Phenotype; Gene; Cancer research; Tumor microenvironment; Gene expression; Immunology; Genetics; Tumor cells","score_opus":0.0165713444203845,"score_gpt":0.2615862098945795,"score_spread":0.245014865474195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033237799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545784,0.0121501,0.00014220459,0.0005151398,0.00006203174,0.0002625795,0.0000148719,0.00005582896,0.0013393885],"genre_scores_gemma":[0.97608566,0.00077040633,0.02259427,0.0002955438,0.00014815279,0.00003624249,0.000021768352,0.000011755857,0.000036213023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992588,0.000013191903,0.00019476656,0.00021155748,0.00019024996,0.00013144116],"domain_scores_gemma":[0.99956733,0.00003603581,0.000089432964,0.00014024551,0.000043736192,0.0001232037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002669976,0.00010895683,0.00026141707,0.000023009026,0.00003263354,0.0000044327994,0.00005086966,0.000032646,0.00003908466],"category_scores_gemma":[0.000043982298,0.00007616044,0.00007643896,0.00011288582,0.000032594187,0.0000799161,0.000030712014,0.00001956462,0.00001894969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002624582,0.0014685044,0.41313303,0.000321028,0.0001317321,0.00020261666,0.00032200618,0.00002200374,0.5301228,0.00017568943,0.0001518821,0.053686243],"study_design_scores_gemma":[0.0036769053,0.00048140239,0.018679583,0.0001233144,0.00014586338,0.000023099432,0.00009399794,0.000015290576,0.9731248,0.000025702677,0.0035364886,0.000073570634],"about_ca_topic_score_codex":0.000007433512,"about_ca_topic_score_gemma":7.427374e-7,"teacher_disagreement_score":0.44300196,"about_ca_system_score_codex":0.000012123433,"about_ca_system_score_gemma":0.00004586244,"threshold_uncertainty_score":0.31057325},"labels":[],"label_agreement":null},{"id":"W3033379780","doi":"10.1007/s00256-020-03502-z","title":"An uncommon lymphoma mimic: lipogranulomas","year":2020,"lang":"en","type":"article","venue":"Skeletal Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Nodule (geology); Anabolism; Radiology; Biopsy; Complication; Connective tissue; Pathology; Surgery; Internal medicine","score_opus":0.019763813280891045,"score_gpt":0.2775359936815301,"score_spread":0.25777218040063904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033379780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836206,0.0011438136,0.00003891378,0.00703072,0.00019001732,0.00026936494,0.000014114452,0.00016939075,0.007523092],"genre_scores_gemma":[0.9932156,0.00012598565,0.0005865987,0.005267836,0.0005238727,0.000040249695,0.00015252033,0.000025256451,0.00006206333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885345,0.00008277947,0.00022504789,0.0003952566,0.000117965545,0.00032549285],"domain_scores_gemma":[0.9991307,0.000062029954,0.000052460044,0.0003084109,0.000032220094,0.0004141566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054287655,0.00019595194,0.00044408438,0.000050042683,0.000060828042,0.000011147738,0.00011741055,0.00014441996,0.00022927497],"category_scores_gemma":[0.000045763667,0.00015197205,0.00016799296,0.00015634215,0.00012374207,0.000059698534,0.000028620714,0.00006516479,0.0003585458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001103404,0.0025713984,0.5251535,0.00016397549,0.0008216609,0.0032264802,0.001375046,0.000023327919,0.026391052,0.009059116,0.02106116,0.40904984],"study_design_scores_gemma":[0.012527273,0.009251493,0.7581044,0.00003303118,0.00040617457,0.0019394937,0.00019031011,0.00090050773,0.008578561,0.00038997194,0.20719561,0.00048318537],"about_ca_topic_score_codex":0.00006617026,"about_ca_topic_score_gemma":0.00001113003,"teacher_disagreement_score":0.40856665,"about_ca_system_score_codex":0.000090815614,"about_ca_system_score_gemma":0.00008808923,"threshold_uncertainty_score":0.61972404},"labels":[],"label_agreement":null},{"id":"W3033465546","doi":"10.1111/bjh.16777","title":"Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Biomarker; Oncology; Lymphoma; Internal medicine; Transplantation; Cohort; Autologous stem-cell transplantation; Biology","score_opus":0.02296941156267117,"score_gpt":0.26572079870523535,"score_spread":0.24275138714256417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033465546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350953,0.0016121465,0.00058912614,0.0032874674,0.00021164237,0.0005001593,0.00003891641,0.000010349487,0.00024063872],"genre_scores_gemma":[0.99816257,0.00008820334,0.0012178386,0.00034928808,0.00007887354,0.000023561386,0.000020508307,0.00001883476,0.00004031118],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987195,0.00010079224,0.0005925823,0.00015377143,0.00026543357,0.00016791178],"domain_scores_gemma":[0.9986244,0.0003151585,0.0005327516,0.000114690534,0.0002744082,0.00013858154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018345696,0.00011178089,0.000521488,0.000048546306,0.00005424322,0.000036715617,0.0001305558,0.00010867486,0.00003432381],"category_scores_gemma":[0.0017030236,0.00008227359,0.00029619577,0.0001263857,0.00008523138,0.00012491514,0.000049972205,0.00005982898,0.0000065246973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045722625,0.0061020674,0.50672174,0.001262429,0.0022015993,0.041054703,0.0015514506,0.000027822847,0.098946996,0.0006290534,0.071232036,0.26569784],"study_design_scores_gemma":[0.022861067,0.0024005692,0.17124112,0.0025109916,0.00096707605,0.29501253,0.0002567302,0.00015803464,0.49757516,0.0010910309,0.00565621,0.00026948345],"about_ca_topic_score_codex":0.000009671038,"about_ca_topic_score_gemma":8.547318e-7,"teacher_disagreement_score":0.39862818,"about_ca_system_score_codex":0.0000605149,"about_ca_system_score_gemma":0.0003014501,"threshold_uncertainty_score":0.33550197},"labels":[],"label_agreement":null},{"id":"W3033804523","doi":"10.1007/s12308-020-00400-0","title":"Transformation of de novo high-grade B cell lymphoma with MYC and BCL2 rearrangements to double-hit B lymphoblastic leukemia/lymphoma: a case report and review of literature","year":2020,"lang":"en","type":"article","venue":"Journal of Hematopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"BCL6; Lymphoblastic lymphoma; Gene rearrangement; Terminal deoxynucleotidyl transferase; CD20; Lymphoma; Cancer research; Medicine; Bone marrow; PAX5; Pathology; B cell; Biology; Immunology; Immunohistochemistry; T cell; Antibody; Germinal center","score_opus":0.013139730179122023,"score_gpt":0.2591944518328024,"score_spread":0.24605472165368036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033804523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975633,0.021279283,0.00021422468,0.0021748682,0.000042121046,0.0004364918,0.000019609099,0.0000070238466,0.00019336169],"genre_scores_gemma":[0.98834914,0.0075018704,0.0030059863,0.001032615,0.000052684827,0.000014879646,0.000009481141,0.000018148716,0.000015175724],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983535,0.00006766257,0.0009147276,0.00019788243,0.00027816853,0.00018809289],"domain_scores_gemma":[0.9984888,0.000069750466,0.00067539385,0.00017578293,0.00029177486,0.00029851173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003747486,0.00020047603,0.00092436123,0.0001546883,0.000034220157,0.000011642789,0.00005668407,0.00010563747,0.00001069801],"category_scores_gemma":[0.0000790433,0.0001363476,0.00010309858,0.00026553942,0.000072580784,0.00012487489,0.00002762729,0.00006195665,9.227423e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007915558,0.0031668446,0.07001501,0.0560532,0.00072094274,0.8020362,0.016612697,0.000023163633,0.022009954,0.000699368,0.0017081659,0.019038865],"study_design_scores_gemma":[0.023401294,0.0037799035,0.016929049,0.010548167,0.001203807,0.91388446,0.00034941483,0.000024417626,0.02899969,0.000028546643,0.00068472815,0.0001665371],"about_ca_topic_score_codex":0.000024852987,"about_ca_topic_score_gemma":0.0000053309896,"teacher_disagreement_score":0.11184822,"about_ca_system_score_codex":0.0001962805,"about_ca_system_score_gemma":0.000364653,"threshold_uncertainty_score":0.55600935},"labels":[],"label_agreement":null},{"id":"W3033907870","doi":"10.1186/s13045-020-00900-7","title":"A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Genentech; H. Lundbeck A/S; Juno Therapeutics; Incyte; F. Hoffmann-La Roche; Gilead Sciences; Teva Pharmaceutical Industries; MorphoSys; Celgene; AstraZeneca; Bristol-Myers Squibb; Servier; TG Therapeutics; Amgen","keywords":"Obinutuzumab; Rituximab; Medicine; Internal medicine; Hematology; Diffuse large B-cell lymphoma; Oncology; CHOP; Lymphoma; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.03923046234378376,"score_gpt":0.34559044681061596,"score_spread":0.3063599844668322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033907870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958908,0.00087714527,0.000033432694,0.0005375788,0.0000690715,0.002353009,0.000029263161,0.000008190568,0.00020150008],"genre_scores_gemma":[0.99860203,0.00018537573,0.0006079957,0.0003935914,0.000019886016,0.00009893473,0.000027844446,0.000024707706,0.00003962184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99572814,0.00078669883,0.0022532525,0.0003866876,0.00042997443,0.00041526582],"domain_scores_gemma":[0.9954468,0.0009304337,0.0024130708,0.00034430285,0.0005786264,0.00028674517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006823672,0.00035024827,0.006402831,0.00068711065,0.000051889932,0.000010643255,0.00037537486,0.00023486032,0.00013056234],"category_scores_gemma":[0.00037730084,0.00020809141,0.00029864025,0.0011889901,0.00020475332,0.00013428066,0.00017823714,0.00021400668,0.0000042683187],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61887383,0.21135221,0.14964543,0.0001392242,0.009547419,0.004502116,0.004691429,0.000027046088,0.000016153157,0.00006456648,0.00036962476,0.0007709473],"study_design_scores_gemma":[0.93048024,0.040605582,0.010544276,0.00014314504,0.015506577,0.00031929955,0.0011970563,0.0006644366,0.00022909832,0.0000043985056,0.00015537109,0.00015051785],"about_ca_topic_score_codex":0.00038389128,"about_ca_topic_score_gemma":0.0006525065,"teacher_disagreement_score":0.3116064,"about_ca_system_score_codex":0.0008378341,"about_ca_system_score_gemma":0.0017677646,"threshold_uncertainty_score":0.84857213},"labels":[],"label_agreement":null},{"id":"W3034142645","doi":"10.1177/2040620720914490","title":"PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Oncology; Hodgkin lymphoma; Interim; Regimen; Lymphoma; Internal medicine; Radiation therapy; Clinical trial; Toxicity; Stage (stratigraphy); Medical physics","score_opus":0.15720279791341157,"score_gpt":0.369600646188655,"score_spread":0.21239784827524344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034142645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003935805,0.98991823,0.0006897453,0.0009098067,0.00034960508,0.0066478816,0.00005660804,0.00014360319,0.001245172],"genre_scores_gemma":[0.000420688,0.9819908,0.008818825,0.0015524898,0.00014812393,0.0065165684,0.00029293873,0.00016467828,0.00009486686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965652,0.0002053188,0.0010807321,0.001160571,0.00026288783,0.0007252903],"domain_scores_gemma":[0.99751526,0.0010181137,0.0004244985,0.000737224,0.000047371406,0.00025754588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001713839,0.0008998202,0.0049153557,0.00033471952,0.000074110874,0.000016342363,0.00038187343,0.00031509082,0.000041828625],"category_scores_gemma":[0.00005647408,0.00065520767,0.00069402833,0.00060519495,0.00012993022,0.00010803956,0.00009123239,0.00018948385,0.00008509144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000777168,0.00080460403,0.000051443505,0.00817229,0.00048019603,0.00029738405,0.00010011932,0.0000026246266,4.801693e-7,0.0067277574,0.00004033949,0.9825456],"study_design_scores_gemma":[0.0053542573,0.0012556203,0.000031732106,0.0043923035,0.0006288972,0.001258674,0.000040045994,0.000013854665,0.000031755495,0.0010724204,0.9853629,0.0005575519],"about_ca_topic_score_codex":0.0000026994917,"about_ca_topic_score_gemma":0.0000075207854,"teacher_disagreement_score":0.98532254,"about_ca_system_score_codex":0.00062589627,"about_ca_system_score_gemma":0.0006365341,"threshold_uncertainty_score":0.9995899},"labels":[],"label_agreement":null},{"id":"W3035473078","doi":"10.1158/1078-0432.ccr-20-1345","title":"A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Rituximab; Lenalidomide; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Follicular phase; Multiple myeloma","score_opus":0.25055410467248995,"score_gpt":0.5022630588164514,"score_spread":0.25170895414396144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035473078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880613,0.004253999,0.00002938418,0.0022997698,0.00006401775,0.0051447568,0.000018138875,0.00004428443,0.00008431909],"genre_scores_gemma":[0.9915735,0.0061132093,0.00012932335,0.00012211718,0.00023542563,0.0017017977,0.000042940366,0.000039363073,0.000042283922],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99552464,0.0009010842,0.0014192142,0.0007660699,0.00092643854,0.00046255],"domain_scores_gemma":[0.99685,0.0015006646,0.00028967424,0.00041483736,0.0005741471,0.00037068484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025635008,0.00026853246,0.002020216,0.00024916348,0.00013453775,0.00003131235,0.00016566721,0.00016855914,0.00044612898],"category_scores_gemma":[0.0021183183,0.00016168956,0.00025178023,0.0013095384,0.00037398763,0.00011490719,0.00013941377,0.0003602607,0.000022243335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58262545,0.04567091,0.052386083,0.00029713125,0.0015893127,0.0011749844,0.0015935138,0.000023110455,0.0000919058,0.000050149905,0.00042254498,0.3140749],"study_design_scores_gemma":[0.9518841,0.023654327,0.018001487,0.0006742706,0.0009847151,0.000019149884,0.0011061596,0.0014443699,0.000775661,0.000032824828,0.0012076081,0.0002153386],"about_ca_topic_score_codex":0.004762179,"about_ca_topic_score_gemma":0.0026862274,"teacher_disagreement_score":0.36925864,"about_ca_system_score_codex":0.00037784356,"about_ca_system_score_gemma":0.0010834477,"threshold_uncertainty_score":0.7199022},"labels":[],"label_agreement":null},{"id":"W3036060143","doi":"10.1084/jem.20191712","title":"Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial","year":2020,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Medicine; Autologous stem-cell transplantation; Mantle cell lymphoma; Minimal residual disease; CD8; Vaccination; Lymphoma; Immune system; Adoptive cell transfer; Immunotherapy; Immunology; T cell; Oncology; Internal medicine; Cancer research; Bone marrow","score_opus":0.018411314813734647,"score_gpt":0.28478479432057746,"score_spread":0.2663734795068428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036060143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863312,0.008667481,0.0000027424799,0.0028299561,0.00034709982,0.0010201823,0.000009840388,0.0000186035,0.00077284867],"genre_scores_gemma":[0.99791443,0.0001494079,0.00015422127,0.0011647975,0.000430801,0.000018882736,0.000013995469,0.000040421055,0.00011304259],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974485,0.00021414904,0.0010051377,0.00023924068,0.00073626306,0.0003567185],"domain_scores_gemma":[0.998268,0.0002196044,0.0007535696,0.00029218558,0.00012387453,0.00034275494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042146837,0.00036216562,0.0010038107,0.00020679744,0.00014060824,0.000011162003,0.0002760514,0.000060498845,0.00029226384],"category_scores_gemma":[0.00008202625,0.00018373235,0.00012751641,0.00035241453,0.00013827783,0.00013743379,0.00010287728,0.00022949936,0.000016641712],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5312902,0.04751853,0.010657311,0.0001305706,0.00023725997,0.003175547,0.0132203745,0.000006554338,0.38844064,0.000006245608,0.0042534205,0.0010633712],"study_design_scores_gemma":[0.39258933,0.07847328,0.01755655,0.00029362363,0.00032614512,0.00017652553,0.0034079084,0.000015123954,0.5065936,0.0000018643541,0.00040134307,0.0001647434],"about_ca_topic_score_codex":0.000096067204,"about_ca_topic_score_gemma":0.0000011237713,"teacher_disagreement_score":0.13870086,"about_ca_system_score_codex":0.00025750897,"about_ca_system_score_gemma":0.00024555495,"threshold_uncertainty_score":0.7492388},"labels":[],"label_agreement":null},{"id":"W3036608650","doi":"10.1016/j.kint.2020.01.012","title":"The Case | Severe hypophosphatemia in a patient with lymphoma","year":2020,"lang":"en","type":"article","venue":"Kidney International","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Rituximab; Prednisolone; Lymphoma; Diffuse large B-cell lymphoma; Gemcitabine; Internal medicine; Vincristine; Follicular lymphoma; Cyclophosphamide; Radiology; Surgery; Gastroenterology; Chemotherapy","score_opus":0.01013030667941945,"score_gpt":0.23278474498419288,"score_spread":0.22265443830477344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036608650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92469263,0.0001543642,0.000005169456,0.06489656,0.00019673572,0.00024501132,0.00004928752,0.000026218044,0.009733996],"genre_scores_gemma":[0.99171597,0.00004433689,0.00029498996,0.0075301505,0.00008723641,0.00007559679,0.00004385251,0.000009584726,0.00019827468],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999335,0.00001309677,0.00015616807,0.00016769257,0.0002069536,0.00012107642],"domain_scores_gemma":[0.99950784,0.000056756973,0.000046161633,0.00010182397,0.00006256864,0.00022484503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030151812,0.00009341871,0.00009707952,0.000022158501,0.000055339206,0.000032525033,0.000065052656,0.000026431719,0.00014882986],"category_scores_gemma":[0.00013275379,0.000052818064,0.000033359185,0.00009168312,0.000029395196,0.000046944013,0.000035443525,0.000038955972,0.00007226333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003169233,0.0017759255,0.35154414,0.00005485341,0.0011755223,0.15632638,0.003604571,0.00005437314,0.00016935404,0.010325349,0.22379543,0.24800485],"study_design_scores_gemma":[0.023077454,0.0018278726,0.079029374,0.0003344514,0.00014690298,0.035410207,0.0013738471,0.004083005,0.0047384407,0.00019097232,0.84939665,0.0003908352],"about_ca_topic_score_codex":0.00017039356,"about_ca_topic_score_gemma":0.000046750025,"teacher_disagreement_score":0.62560123,"about_ca_system_score_codex":0.00021595892,"about_ca_system_score_gemma":0.00021373786,"threshold_uncertainty_score":0.21538582},"labels":[],"label_agreement":null},{"id":"W3036940367","doi":"10.1182/bloodadvances.2019001367","title":"KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Leukemia and Lymphoma Society","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Internal medicine; Oncology; Hodgkin lymphoma; Lymphoma; Cancer research; Cancer; Immunotherapy","score_opus":0.010373646224218222,"score_gpt":0.24068443535989895,"score_spread":0.23031078913568073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036940367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883843,0.00454029,0.00001119134,0.00464539,0.00013475012,0.0004067369,0.000041689742,0.000058804584,0.0013227122],"genre_scores_gemma":[0.99695593,0.00037156642,0.0014747083,0.0006928997,0.00019467196,0.00012254399,0.000026871505,0.00003112686,0.0001297091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983214,0.00005075775,0.00043046786,0.00046234223,0.00038501256,0.00035002682],"domain_scores_gemma":[0.99922884,0.00009437644,0.00012114721,0.00026836872,0.00005989415,0.0002273928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049024595,0.0002633323,0.00062698295,0.000086266235,0.000026869737,0.000017193597,0.00012527018,0.00011107157,0.00019521113],"category_scores_gemma":[0.00011193624,0.00020942016,0.00021560585,0.00031917894,0.000096508724,0.00016022482,0.00007442995,0.00008956242,0.00008528898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053491197,0.004789825,0.92125946,0.00057104597,0.0004016244,0.0013224523,0.0013242114,0.000017829738,0.0024526073,0.0008260727,0.0020630162,0.05962272],"study_design_scores_gemma":[0.09462693,0.0032737541,0.7582609,0.00072206353,0.00076944794,0.000117520656,0.0007378117,0.00014004088,0.054134384,0.00026548718,0.08635786,0.0005937626],"about_ca_topic_score_codex":0.000034027686,"about_ca_topic_score_gemma":0.00011004697,"teacher_disagreement_score":0.16299854,"about_ca_system_score_codex":0.00006777549,"about_ca_system_score_gemma":0.0001449704,"threshold_uncertainty_score":0.8539906},"labels":[],"label_agreement":null},{"id":"W3037474453","doi":"10.1182/bloodadvances.2020001696","title":"Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Genome British Columbia; Spinal Cord Injury BC; Queen's University; McGill University; Princess Margaret Cancer Centre; Simon Fraser University","funders":"Fondation de l'Hôpital général juif; Jewish General Hospital; Terry Fox Research Institute; Cancer Research UK; Genome British Columbia; Michael Smith Health Research BC; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"CHOP; Rituximab; Missense mutation; Vincristine; Lymphoma; Cancer research; Nonsense mutation; Biology; CD20; Mutation; Oncology; Immunology; Internal medicine; Medicine; Cyclophosphamide; Genetics; Chemotherapy; Gene","score_opus":0.010694570391632404,"score_gpt":0.23190720499040354,"score_spread":0.22121263459877114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037474453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528104,0.04502978,0.000003279312,0.0006622961,0.000020617445,0.00025444053,0.00003038552,0.000016473357,0.0011723391],"genre_scores_gemma":[0.99160963,0.005336776,0.0026285225,0.00015837864,0.000041455267,0.00005369358,0.000008235371,0.000009488689,0.00015382949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993063,0.000019631769,0.00020484079,0.00023933209,0.00010318334,0.00012670166],"domain_scores_gemma":[0.99964315,0.000053263266,0.00006659053,0.00012171911,0.000019065266,0.00009621638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000012491282,0.000119070326,0.0002565231,0.000034111134,0.000020483394,0.0000030369856,0.000030119834,0.000030772986,0.000015491023],"category_scores_gemma":[0.000013285445,0.00009217647,0.00004594915,0.00009101182,0.000030988722,0.0000336536,0.000015264599,0.000014316224,0.0000042858683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020335907,0.0015159046,0.98889816,0.00019437798,0.00004928264,0.0002340645,0.0004023684,0.000012741947,0.00070381095,0.00006975409,0.00003292255,0.007683263],"study_design_scores_gemma":[0.013516383,0.0012807229,0.96680677,0.00015050983,0.0001653982,0.000016223188,0.00013715465,0.000022038945,0.010603158,0.000098252574,0.0071079335,0.00009548516],"about_ca_topic_score_codex":0.000069505324,"about_ca_topic_score_gemma":0.000088663815,"teacher_disagreement_score":0.039693005,"about_ca_system_score_codex":0.00007182779,"about_ca_system_score_gemma":0.000069741414,"threshold_uncertainty_score":0.37588477},"labels":[],"label_agreement":null},{"id":"W3037937011","doi":"10.1016/s2352-3026(20)30179-4","title":"Hyper-CVAD: a regimen for all seasons","year":2020,"lang":"en","type":"letter","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oncology; Transplantation; Regimen; Hematopoietic stem cell transplantation; Acute lymphocytic leukemia; Chemotherapy regimen; Internal medicine; Leukemia; Chemotherapy; Pediatrics; Immunology; Lymphoblastic Leukemia","score_opus":0.07289611587682732,"score_gpt":0.3215748360427885,"score_spread":0.2486787201659612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037937011","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014043255,0.0016846308,0.000026032978,0.98966116,0.0004003387,0.0013628702,0.00018553634,0.00015828261,0.0051167975],"genre_scores_gemma":[0.004271767,0.00028231414,0.00095907436,0.98355633,0.005831737,0.000950382,0.0009144633,0.000077199045,0.0031567547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837714,0.000112386486,0.000226378,0.00047282694,0.00019184755,0.0006194285],"domain_scores_gemma":[0.99819285,0.00063436717,0.00017519397,0.0008542871,0.00005888119,0.00008441481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008952878,0.00034444654,0.0018662269,0.000044575507,0.00008766013,0.000021444273,0.0003273024,0.0004858569,0.00011261914],"category_scores_gemma":[0.00012724685,0.00020107203,0.0003104118,0.00007241094,0.00014569877,0.00001574236,0.000094909774,0.0006183884,0.0004406859],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015990976,0.00005257446,0.0010389113,0.0005771039,0.0005980959,0.003956394,0.00019404995,9.861098e-8,0.000005588563,0.0011506153,0.99177796,0.00048868393],"study_design_scores_gemma":[0.003037658,0.00028239354,0.00019726017,0.00012487579,0.001234021,0.0031606483,0.000014529061,0.000023009226,0.000120504286,0.0013669817,0.9902489,0.00018919303],"about_ca_topic_score_codex":0.000030581676,"about_ca_topic_score_gemma":0.000008595966,"teacher_disagreement_score":0.006104877,"about_ca_system_score_codex":0.00013015316,"about_ca_system_score_gemma":0.00024313988,"threshold_uncertainty_score":0.81994796},"labels":[],"label_agreement":null},{"id":"W3039162285","doi":"10.1158/2159-8290.cd-20-0174","title":"Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma","year":2020,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Taxonomy (biology); Diffuse large B-cell lymphoma; Computational biology; Lymphoma; Molecular taxonomy; Identification (biology); Biology; Gene; Computer science; Immunology; Genetics; Phylogenetics; Ecology","score_opus":0.05907620249061243,"score_gpt":0.31212013492306667,"score_spread":0.25304393243245427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039162285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018387182,0.9947703,0.0001567814,0.00016836019,0.00031319598,0.0016263135,0.000610114,0.000036572277,0.0021345275],"genre_scores_gemma":[0.0011105284,0.9951526,0.00014861279,0.0004384697,0.0004057483,0.0009834178,0.00028169085,0.000095619005,0.0013833088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979993,0.000050689465,0.00062649936,0.0006246685,0.00032364082,0.00037522078],"domain_scores_gemma":[0.9985044,0.000065548884,0.00044001022,0.0006004951,0.00003702523,0.00035249462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000037225112,0.00057807006,0.0026432206,0.00011487283,0.0000231778,0.000043303702,0.00022016538,0.00024654114,0.00012781213],"category_scores_gemma":[0.00002227382,0.00042096432,0.0012978397,0.00031768065,0.000045157918,0.00010596875,0.0001615717,0.00011679181,0.00009113238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004936061,0.0027119038,0.00017540166,0.024938421,0.0012408502,0.0008829975,0.000059092185,1.481907e-7,0.0000024794583,0.0003164501,0.011998481,0.95762444],"study_design_scores_gemma":[0.008077693,0.00017272608,0.000030460365,0.012447703,0.004974126,0.000036396807,0.000017383998,9.821906e-7,0.00021220154,0.0000087826,0.9736873,0.00033425877],"about_ca_topic_score_codex":0.0002841422,"about_ca_topic_score_gemma":0.000006423634,"teacher_disagreement_score":0.9616888,"about_ca_system_score_codex":0.0008151735,"about_ca_system_score_gemma":0.0036980482,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W3039967857","doi":"10.1182/blood.2019004296","title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; St. Francis Xavier University","funders":"","keywords":"Medicine; Rituximab; Vincristine; CHOP; Prednisone; Nuclear medicine; Positron emission tomography; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Single Center; Cyclophosphamide; Chemotherapy; Oncology; Radiology","score_opus":0.045517969657952316,"score_gpt":0.28407290206333735,"score_spread":0.23855493240538503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039967857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946244,0.0007889744,0.00008437121,0.000057278365,0.000022465521,0.00033641813,0.00010345623,0.000031006923,0.003951633],"genre_scores_gemma":[0.9945285,0.00002338148,0.0051069725,0.00014489789,0.000090302645,0.000009558719,0.000053658277,0.000025923035,0.000016858367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986752,0.000034585835,0.00043901842,0.00024751094,0.0003527113,0.00025093424],"domain_scores_gemma":[0.9991601,0.000060204467,0.00020897873,0.00024471848,0.00008934358,0.0002366374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009316873,0.00019545916,0.0006632373,0.00006983038,0.00002539446,0.000004971337,0.00008868558,0.000055144294,0.00006363319],"category_scores_gemma":[0.00007173195,0.00014358446,0.00034199233,0.00023879131,0.000042353946,0.000044754383,0.00006955092,0.000048987982,0.0000070206356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038019463,0.017469706,0.95879406,0.0006869133,0.00062427064,0.00030918166,0.00053047086,0.000013255781,0.02038811,0.000037859667,0.00010223117,0.00066372374],"study_design_scores_gemma":[0.053140648,0.0017429435,0.91751003,0.0001235397,0.0017901713,0.0003592511,0.00016465937,0.0015964246,0.023284698,0.0000044729604,0.000067602065,0.00021555964],"about_ca_topic_score_codex":0.00016192613,"about_ca_topic_score_gemma":8.520721e-7,"teacher_disagreement_score":0.052760452,"about_ca_system_score_codex":0.000100438614,"about_ca_system_score_gemma":0.00029571698,"threshold_uncertainty_score":0.58552045},"labels":[],"label_agreement":null},{"id":"W3041559855","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1489","title":"A Case of Follicular Lymphoma Presenting as Severe Interstitial Pneumonia","year":2020,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Follicular lymphoma; Lymphoma; Interstitial pneumonia; Pneumonia; Medicine; Follicular phase; Computer science; Pathology; Internal medicine; Lung","score_opus":0.023348213079031944,"score_gpt":0.2736843606067751,"score_spread":0.25033614752774314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041559855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775258,0.000109305714,0.000027606104,0.0023341638,0.000044912988,0.00025476428,0.0000067999285,0.00005218304,0.019644516],"genre_scores_gemma":[0.9979654,0.000013238448,0.0004937941,0.0010782977,0.000099099125,0.000016496708,0.000008918414,0.000012459388,0.0003122834],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930096,0.000016524964,0.00020052872,0.0002008028,0.00013780525,0.00014337832],"domain_scores_gemma":[0.99951947,0.000041040683,0.00005197738,0.00015144623,0.00004962277,0.00018644736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027374783,0.00011055068,0.00024454965,0.0000273694,0.0000316015,0.000011386461,0.000039170518,0.00004423799,0.00042844337],"category_scores_gemma":[0.000075683,0.000082072875,0.00014632198,0.00010673479,0.000027571887,0.000045292498,0.00006695479,0.00002268287,0.00010409325],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016636624,0.0050932197,0.39240044,0.0014425017,0.0035790466,0.40374446,0.0133654345,0.000045828932,0.02672832,0.011675204,0.019738907,0.12052296],"study_design_scores_gemma":[0.06791633,0.009563892,0.101996206,0.0009852363,0.0041025975,0.19974756,0.012113009,0.015739629,0.53808665,0.0005098518,0.0475743,0.0016647396],"about_ca_topic_score_codex":0.00072211924,"about_ca_topic_score_gemma":0.000013180414,"teacher_disagreement_score":0.5113583,"about_ca_system_score_codex":0.000049277307,"about_ca_system_score_gemma":0.00007609981,"threshold_uncertainty_score":0.46911547},"labels":[],"label_agreement":null},{"id":"W3042331000","doi":"10.1002/pbc.28361","title":"Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group","year":2020,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto; Children's Hospital of Western Ontario; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Hodgkin lymphoma; Delphi method; Lymphoma; Harmonization; Pediatrics; Family medicine; Pathology","score_opus":0.0569886896349811,"score_gpt":0.3811526027114535,"score_spread":0.3241639130764724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042331000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08987465,0.89624435,0.000055213914,0.0007466286,0.00061117724,0.011434265,0.00095742405,0.00006807023,0.000008219861],"genre_scores_gemma":[0.027890524,0.959073,0.00066766725,0.00052056945,0.0018575107,0.009120246,0.00064358325,0.0001973147,0.000029550607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946977,0.0006805173,0.0014560325,0.0014315083,0.00088643277,0.00084784516],"domain_scores_gemma":[0.99690074,0.0008496271,0.00075651787,0.000527314,0.00056614674,0.00039964198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016764153,0.00092564354,0.0017675476,0.00062886643,0.00038251918,0.00022557589,0.00025215306,0.00031535883,0.000026721653],"category_scores_gemma":[0.0005443097,0.0007023868,0.00035545632,0.0008670042,0.00008889302,0.00015379922,0.00023834384,0.00016557406,0.0000034150878],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014452662,0.0023904275,0.09634736,0.02388732,0.001078993,0.00008126356,0.0032733625,0.0000025317045,0.0000028778063,0.00004829466,0.005869627,0.8655727],"study_design_scores_gemma":[0.15121329,0.004656374,0.3655805,0.015251397,0.07185565,0.00033823345,0.0017512629,0.00203565,0.00010053952,0.00013807809,0.38283962,0.0042394055],"about_ca_topic_score_codex":0.0009319386,"about_ca_topic_score_gemma":0.00021051145,"teacher_disagreement_score":0.86133325,"about_ca_system_score_codex":0.0013470561,"about_ca_system_score_gemma":0.002206003,"threshold_uncertainty_score":0.9995427},"labels":[],"label_agreement":null},{"id":"W3043817697","doi":"10.1002/cyto.b.21935","title":"A multicenter study evaluation of the <scp>ClearLLab 10C</scp> panels","year":2020,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; London Health Sciences Centre","funders":"","keywords":"Malignancy; Bone marrow; Medicine; Lymph node; Population; Internal medicine; Pathology","score_opus":0.19420103060116103,"score_gpt":0.4220139090346273,"score_spread":0.2278128784334663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043817697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916263,0.000650285,0.000027361562,0.0012631884,0.0007806315,0.002393135,0.000048644695,0.00009588197,0.0031145574],"genre_scores_gemma":[0.9959564,0.000077057106,0.00018687615,0.0024407317,0.00091522647,0.00012425621,0.000019620504,0.000052384516,0.00022744121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939993,0.00096743176,0.0015590959,0.0008713218,0.0021271994,0.0004756482],"domain_scores_gemma":[0.9947303,0.0023076902,0.0005621886,0.0011170638,0.00068778626,0.00059497356],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003179865,0.00036826252,0.0010932151,0.00025090197,0.00013312406,0.000046525405,0.0004276289,0.00027522768,0.0004049526],"category_scores_gemma":[0.014794198,0.00023904064,0.0007202938,0.0027438903,0.0002580648,0.00011867581,0.000391937,0.00050084497,0.00055935583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009096658,0.004555904,0.97479886,0.00007911281,0.0007830625,0.000037647256,0.0005191153,0.000009132928,0.00025450476,0.0000072349285,0.004073052,0.014791381],"study_design_scores_gemma":[0.01358576,0.0021537237,0.9684055,0.00011365193,0.0019320603,0.000008041996,0.0016219388,0.0007189086,0.0030621768,0.000010396995,0.008302823,0.00008504864],"about_ca_topic_score_codex":0.000016594078,"about_ca_topic_score_gemma":0.0000023333837,"teacher_disagreement_score":0.014706331,"about_ca_system_score_codex":0.00019642756,"about_ca_system_score_gemma":0.00031999356,"threshold_uncertainty_score":0.9935046},"labels":[],"label_agreement":null},{"id":"W3045027158","doi":"10.1093/aje/kwaa160","title":"Premature Mortality Due to Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Leukemia in Canada: A Nationwide Analysis From 1980 to 2015","year":2020,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Calgary; University of Alberta; Alberta Cancer Foundation; Alberta Health Services","funders":"Cumming School of Medicine, University of Calgary; University of Alberta; Faculty of Medicine and Dentistry, University of Alberta; Alberta Health Services; World Health Organization","keywords":"Medicine; Lymphoma; Multiple myeloma; Life span; Hodgkin lymphoma; Life expectancy; Leukemia; Internal medicine; Standardized rate; Mortality rate; Cancer; Oncology; Demography; Gerontology; Population; Environmental health","score_opus":0.023836801436139938,"score_gpt":0.3027738756272985,"score_spread":0.2789370741911586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045027158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764847,0.0009597008,0.0015566779,0.020300264,0.00013535778,0.00036090627,0.0001329497,0.0000104281135,0.00005902081],"genre_scores_gemma":[0.9628829,0.0001559288,0.012705627,0.023874817,0.000263562,0.000035171295,0.000047605958,0.00002509877,0.000009316507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628776,0.00067026383,0.0015000156,0.0006161077,0.00035628892,0.0005695358],"domain_scores_gemma":[0.99445283,0.0027006345,0.0008919521,0.00039559827,0.00023524924,0.0013237087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010334647,0.00036709633,0.0026622713,0.00041893587,0.00005650959,0.000011423874,0.0002541661,0.00010882484,0.000048630372],"category_scores_gemma":[0.0046241875,0.00028663565,0.00030190594,0.0014107046,0.00012733188,0.00008590919,0.00011682379,0.00016630522,0.000012398156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007941611,0.00010464093,0.945291,0.00001244373,0.0017197618,0.0010081179,0.0007338449,0.002803282,0.00016644638,0.000021590238,0.0064487057,0.040896002],"study_design_scores_gemma":[0.0030388597,0.001035264,0.9868741,0.000091315414,0.00092654396,0.00015000589,0.00071327446,0.0039342195,0.00022909154,0.00005464273,0.0027099655,0.00024274038],"about_ca_topic_score_codex":0.82061017,"about_ca_topic_score_gemma":0.66380584,"teacher_disagreement_score":0.15680431,"about_ca_system_score_codex":0.0028914697,"about_ca_system_score_gemma":0.0028432938,"threshold_uncertainty_score":0.9999586},"labels":[],"label_agreement":null},{"id":"W3045653281","doi":"10.1080/10428194.2020.1795161","title":"Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience","year":2020,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; University of Toronto","funders":"H. Lundbeck A/S; Seattle Genetics; AstraZeneca","keywords":"Brentuximab vedotin; Bendamustine; Medicine; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Malignancy; Hodgkin lymphoma; Biology; Rituximab","score_opus":0.020722327468934282,"score_gpt":0.2885611615219742,"score_spread":0.26783883405303993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045653281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779122,0.0002337628,0.000004665941,0.015188474,0.00032816303,0.002926251,0.0032559652,0.00008865177,0.000061899256],"genre_scores_gemma":[0.9736729,0.00023069252,0.0006482362,0.0112508,0.00021096526,0.00046724995,0.013250886,0.00014935256,0.00011890809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931316,0.0006521279,0.0020013838,0.0018799866,0.0015417296,0.0007932219],"domain_scores_gemma":[0.99603117,0.0005502213,0.001257562,0.0013325402,0.00045197413,0.0003765239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004292404,0.0011056878,0.0018418581,0.0008584524,0.00018839378,0.00009225634,0.00076177163,0.00090488046,0.000026140266],"category_scores_gemma":[0.000598285,0.0007528489,0.00016589563,0.0011092324,0.00050983403,0.00047628884,0.00048506953,0.00037263808,0.0000029081164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22923917,0.03372565,0.455432,0.00074811635,0.0015254399,0.00715109,0.029251982,0.000026245982,0.0014752959,0.000022281387,0.04049668,0.20090607],"study_design_scores_gemma":[0.3027945,0.008636601,0.6639245,0.0024944628,0.00035542648,0.000083807565,0.0006609979,0.0022595155,0.0021972223,0.000009891321,0.015744379,0.00083866075],"about_ca_topic_score_codex":0.006133379,"about_ca_topic_score_gemma":0.0014490223,"teacher_disagreement_score":0.20849255,"about_ca_system_score_codex":0.0048270863,"about_ca_system_score_gemma":0.0020742253,"threshold_uncertainty_score":0.9994922},"labels":[],"label_agreement":null},{"id":"W3046214598","doi":"10.1634/theoncologist.2020-0167","title":"Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"American Cancer Society","keywords":"Medicine; Blockade; Lymphoma; Hodgkin lymphoma; Oncology; Intensive care medicine; Internal medicine","score_opus":0.08913903546279209,"score_gpt":0.3272881326373819,"score_spread":0.2381490971745898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046214598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8398444,0.00068115216,0.000012249625,0.14780883,0.00013764086,0.0012666036,0.000022927363,0.00016255875,0.010063603],"genre_scores_gemma":[0.98240924,0.0007411147,0.0006243824,0.014319134,0.00051694806,0.00029328855,0.000025654243,0.000031420495,0.0010388303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851644,0.00011179608,0.00029978965,0.00041689645,0.0002672973,0.00038779693],"domain_scores_gemma":[0.9988136,0.0001623415,0.000087209395,0.00048789402,0.000056331002,0.00039261437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015270966,0.0003033712,0.00050068094,0.0000327752,0.00015211735,0.00003999914,0.00014234445,0.000092032285,0.00023225255],"category_scores_gemma":[0.000065540524,0.0001581504,0.0002472807,0.00022797428,0.00013235833,0.00002059818,0.00006718213,0.000052589232,0.0008299715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00822944,0.009614936,0.05251977,0.000059890142,0.00255195,0.0068819933,0.011919993,0.00022260417,0.09127668,0.002080034,0.0397348,0.7749079],"study_design_scores_gemma":[0.017411835,0.014017837,0.2198306,0.00005475525,0.00043179284,0.00041344613,0.0008515402,0.00014367333,0.2301878,0.000101522906,0.5161153,0.00043991863],"about_ca_topic_score_codex":0.0008412731,"about_ca_topic_score_gemma":0.00007820483,"teacher_disagreement_score":0.774468,"about_ca_system_score_codex":0.0011273363,"about_ca_system_score_gemma":0.00027168327,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W3046400044","doi":"10.1093/annonc/mdx814","title":"Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma","year":2018,"lang":"en","type":"erratum","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"National Cancer Institute; Wyeth Pharmaceuticals; National Institutes of Health","keywords":"Mantle cell lymphoma; Medicine; Temsirolimus; Cladribine; Rituximab; Internal medicine; Oncology; Clinical trial; Family medicine; Randomized controlled trial; Regimen; Lymphoma","score_opus":0.11861295183526281,"score_gpt":0.43666112918011896,"score_spread":0.31804817734485613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046400044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8970785,0.017033596,0.000010649233,0.0022443812,0.010735448,0.0043384763,0.0017995039,0.000027739901,0.0667317],"genre_scores_gemma":[0.9228055,0.055129696,0.00087001355,0.0017993596,0.0061394954,0.0005695811,0.0016623274,0.00014621008,0.010877821],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978856,0.0001088951,0.0009851467,0.00040222026,0.00027987448,0.0003382899],"domain_scores_gemma":[0.9972268,0.000455544,0.0010975805,0.00044293032,0.0006374842,0.00013967129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037039016,0.00034278745,0.0020888261,0.00027921482,0.000036258054,0.000004078114,0.00015316688,0.0008665819,0.0001132987],"category_scores_gemma":[0.0001264796,0.00026912012,0.00045709283,0.000106312145,0.00047420885,0.00003628026,0.00005862278,0.00010458754,0.000004419405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09525854,0.036964342,0.00004355873,0.0006441702,0.0008331142,0.00006879945,0.00025347088,2.6864925e-8,0.0005157473,0.00009020478,0.71068525,0.15464276],"study_design_scores_gemma":[0.32046685,0.09049806,0.00020493922,0.00019261017,0.00032292752,0.000028769498,0.00004208509,0.000010054489,0.029653795,0.0002100153,0.5582266,0.00014330636],"about_ca_topic_score_codex":0.00020390589,"about_ca_topic_score_gemma":0.000028436301,"teacher_disagreement_score":0.22520831,"about_ca_system_score_codex":0.000056742923,"about_ca_system_score_gemma":0.0013010484,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W3046714011","doi":"10.1182/bloodadvances.2020002068","title":"Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Rituximab; Medicine; Mantle cell lymphoma; Internal medicine; Vincristine; CHOP; Bendamustine; International Prognostic Index; Hazard ratio; Gastroenterology; Autologous stem-cell transplantation; Cyclophosphamide; Chemotherapy; Oncology; Surgery; Lymphoma; Confidence interval","score_opus":0.00821392251384283,"score_gpt":0.220686257138358,"score_spread":0.21247233462451515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046714011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885978,0.00936064,0.000003175642,0.00069206307,0.00002583482,0.00038435284,0.00001883839,0.000033181313,0.00088412815],"genre_scores_gemma":[0.98904085,0.009697959,0.0006275916,0.0004647719,0.000049011825,0.000036645764,0.000036466572,0.000015755038,0.000030974188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920374,0.000013232817,0.00014755562,0.00030689992,0.00015748225,0.00017108466],"domain_scores_gemma":[0.9996899,0.00002715562,0.000050538518,0.00008015424,0.000024573055,0.00012772316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023613193,0.00016285939,0.0002654761,0.00005745106,0.00004972515,0.000019653662,0.000027562057,0.000041324387,0.000014875315],"category_scores_gemma":[0.000004787338,0.000110997134,0.000018482917,0.00015749744,0.000041816766,0.00016754126,0.00001034488,0.000038576887,0.0000054001657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079487433,0.0028706817,0.9559083,0.00013413728,0.00005175324,0.000097320866,0.0006274551,0.0000034775992,0.000507713,0.000031216176,0.00003827829,0.0389348],"study_design_scores_gemma":[0.065264784,0.0035318334,0.88869685,0.00018781623,0.00017588695,0.00006204363,0.0002053626,0.000020087646,0.034495823,0.00007316466,0.007043599,0.00024274173],"about_ca_topic_score_codex":0.00012446118,"about_ca_topic_score_gemma":0.000024498144,"teacher_disagreement_score":0.067211434,"about_ca_system_score_codex":0.0000142504805,"about_ca_system_score_gemma":0.000035074616,"threshold_uncertainty_score":0.45263317},"labels":[],"label_agreement":null},{"id":"W3047354729","doi":"10.14785/lymphosign-2020-0006","title":"Dysregulated CARD11 signaling in the development of diffuse large B cell lymphoma","year":2020,"lang":"en","type":"article","venue":"LymphoSign Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Signal transduction; Cancer research; Biology; Lymphoma; PI3K/AKT/mTOR pathway; Cell biology; Immunology","score_opus":0.024549410625214957,"score_gpt":0.2469700828011274,"score_spread":0.22242067217591244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047354729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955045,0.0013472261,0.00053727254,0.0012192343,0.00008740394,0.000284877,0.0000052352575,0.000018960081,0.0009952916],"genre_scores_gemma":[0.9956403,0.00007293407,0.0025666952,0.0014914407,0.00015579665,0.000017876033,0.0000113263295,0.000023089271,0.00002056876],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807394,0.000105068735,0.0006793367,0.0002097747,0.0005484975,0.00038339698],"domain_scores_gemma":[0.99914527,0.00010591522,0.0002298828,0.0001827893,0.00009130712,0.00024482404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004628007,0.00021429459,0.00041848255,0.000102805985,0.00015142206,0.000043415585,0.00021536267,0.00008633138,0.00008509222],"category_scores_gemma":[0.000041102398,0.00013301826,0.0001791684,0.0003617917,0.000030603846,0.00007037119,0.000042582058,0.000098702134,0.00003205061],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030482842,0.03879836,0.5169575,0.00072083256,0.0015636986,0.00645533,0.1630538,0.00015678108,0.145844,0.0007927066,0.014070734,0.108537965],"study_design_scores_gemma":[0.12690815,0.0016469457,0.36423698,0.0009327897,0.0006947181,0.0018643966,0.009803605,0.0014136746,0.4675273,0.00020755426,0.023980878,0.000782997],"about_ca_topic_score_codex":0.000011832021,"about_ca_topic_score_gemma":0.0000044401736,"teacher_disagreement_score":0.32168332,"about_ca_system_score_codex":0.0003083433,"about_ca_system_score_gemma":0.0006071498,"threshold_uncertainty_score":0.5424327},"labels":[],"label_agreement":null},{"id":"W3047435965","doi":"10.1158/1538-7445.pedca19-a17","title":"Abstract A17: HHLA2 is a new immune checkpoint expressed in pediatric Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immune checkpoint; Lymphoma; Immune system; Oncology; Immunohistochemistry; Internal medicine; CD30; Cancer research; Immunology; Immunotherapy","score_opus":0.11008399795338839,"score_gpt":0.3954945733747507,"score_spread":0.2854105754213623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047435965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95572484,0.012253975,0.0000021396236,0.027447665,0.000078312005,0.00072836987,0.00002795322,0.000047559122,0.0036891866],"genre_scores_gemma":[0.99010444,0.0069672335,0.00009634417,0.0008115363,0.0008651395,0.00032419479,0.000015839381,0.000040732222,0.0007745598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975325,0.00006161634,0.00039175936,0.00054406933,0.0008136774,0.0006563699],"domain_scores_gemma":[0.9986673,0.0001563093,0.000057653375,0.00040599026,0.00014143361,0.0005713114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000350092,0.00019221284,0.0004000216,0.00023515474,0.0000737327,0.000057465248,0.00022739764,0.00012178182,0.002215092],"category_scores_gemma":[0.00020596418,0.0001601614,0.00014723481,0.00096840237,0.000060355836,0.00009305321,0.0001486315,0.0002675285,0.00059060776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003571295,0.0027208526,0.37084213,0.0014879537,0.0003467591,0.003388008,0.01024629,0.000031299845,0.11571874,0.00014874508,0.18120311,0.31029484],"study_design_scores_gemma":[0.010335117,0.0004389949,0.80746365,0.00020225486,0.000047496767,0.000007342316,0.00023182185,0.000048034555,0.14985915,0.000103467886,0.031053739,0.00020891715],"about_ca_topic_score_codex":0.0062678247,"about_ca_topic_score_gemma":0.00008718246,"teacher_disagreement_score":0.43662155,"about_ca_system_score_codex":0.0007329873,"about_ca_system_score_gemma":0.0016043507,"threshold_uncertainty_score":0.99869704},"labels":[],"label_agreement":null},{"id":"W3048784631","doi":"10.1182/blood.v130.suppl_1.2748.2748","title":"FOXP1 Expression Is a Prognostic Biomarker in Follicular Lymphoma Treated with Immunochemotherapy and Is Associated with Distinct Molecular Features","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Follicular lymphoma; Biomarker; Lymphoma; Oncology; Internal medicine; Medicine; Cancer research; Biology; Immunology; Computational biology; Genetics","score_opus":0.008895849934635896,"score_gpt":0.24300157064788916,"score_spread":0.23410572071325325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048784631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956758,0.002130509,0.000003466756,0.00059665594,0.000007842405,0.0007748791,0.000026080479,0.000045774883,0.0007390035],"genre_scores_gemma":[0.99887186,0.000104845974,0.00027901077,0.0002734552,0.000009148339,0.00017416832,0.000053634907,0.000044470777,0.0001894059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987879,0.000037377562,0.0001592318,0.0004362499,0.00028524938,0.00029399284],"domain_scores_gemma":[0.99900484,0.000048675553,0.00016971535,0.00057929603,0.00007429852,0.00012315215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069055954,0.00029491013,0.00042002596,0.0000777867,0.00018272287,0.00011019788,0.000098227836,0.00013293949,0.000024209618],"category_scores_gemma":[0.000065724285,0.00017527124,0.00006671562,0.00010988594,0.000119088996,0.000079860634,0.000038165654,0.000049201302,0.0000027102167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061675854,0.0028633287,0.97077465,0.000031706477,0.0009441788,0.0023051358,0.00031029456,4.5124533e-8,0.017607087,0.000004129957,0.00013889936,0.0044037546],"study_design_scores_gemma":[0.026271604,0.00077436696,0.78478605,0.0010095634,0.0005364525,0.00018578186,0.000023275843,0.000011335378,0.18613847,0.000011862502,0.00006588109,0.00018537039],"about_ca_topic_score_codex":0.00042649958,"about_ca_topic_score_gemma":0.000047731653,"teacher_disagreement_score":0.18598863,"about_ca_system_score_codex":0.00006785323,"about_ca_system_score_gemma":0.000075571465,"threshold_uncertainty_score":0.7147354},"labels":[],"label_agreement":null},{"id":"W3049070288","doi":"10.3324/haematol.2020.255950","title":"Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"BC Cancer Foundation; Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; European Hematology Association; Genome Canada; Hospital for Sick Children; Genome British Columbia","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Central nervous system; Medicine; Pathology; Internal medicine","score_opus":0.02799313388997275,"score_gpt":0.24356126216853355,"score_spread":0.2155681282785608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049070288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79142076,0.017665472,0.00006562454,0.18632811,0.00040805148,0.0022003148,0.00019573342,0.00047165202,0.0012442904],"genre_scores_gemma":[0.8922903,0.00046314712,0.00013411274,0.10600338,0.00017766036,0.00026929114,0.00048732088,0.00007836104,0.000096414136],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654514,0.00027242207,0.0007550576,0.0009863217,0.0004603028,0.0009807824],"domain_scores_gemma":[0.99849635,0.00026252988,0.00033491885,0.00059037266,0.000053635016,0.0002621942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009712804,0.0006822424,0.0018647964,0.00019020037,0.000121644356,0.0000882726,0.0002031872,0.0009862025,0.000012107366],"category_scores_gemma":[0.00007870068,0.0005130636,0.00030118274,0.00025105308,0.000076522345,0.000048373677,0.0001924273,0.0005564783,0.00012002193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002207271,0.003534999,0.04843001,0.018843394,0.0006192683,0.58938706,0.000584106,0.0000022521533,0.00018659612,0.0014433577,0.33603895,0.0007093209],"study_design_scores_gemma":[0.24492875,0.005137934,0.08422129,0.04832096,0.009998317,0.15753737,0.0057841726,0.0038289647,0.0057467744,0.0004962425,0.42592898,0.008070251],"about_ca_topic_score_codex":0.00011001234,"about_ca_topic_score_gemma":0.000005312492,"teacher_disagreement_score":0.43184966,"about_ca_system_score_codex":0.0007368976,"about_ca_system_score_gemma":0.00016489417,"threshold_uncertainty_score":0.9997321},"labels":[],"label_agreement":null},{"id":"W3055615651","doi":"10.1182/blood.v130.suppl_1.4069.4069","title":"Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Immunotherapy; Internal medicine; Lymphoma; Oncology; Interferon; Immunology; Cancer","score_opus":0.009970470727453681,"score_gpt":0.2710702917893195,"score_spread":0.26109982106186586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3055615651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791884,0.00081427966,0.0000027882106,0.0003689226,0.000008906917,0.000670172,0.000003998972,0.000016590891,0.00019547674],"genre_scores_gemma":[0.99906445,0.00044545488,0.00029025218,0.00007349734,0.0000068235095,0.0000557041,0.000021858987,0.0000187912,0.000023177972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918646,0.000048813476,0.0001835113,0.00030994334,0.00013314324,0.00013812979],"domain_scores_gemma":[0.99938506,0.00003496858,0.000113179856,0.00029976678,0.00005549406,0.00011155088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100857505,0.00015776325,0.00032771117,0.000052204137,0.00012538553,0.000060361814,0.00003954996,0.00008482162,0.0000021050685],"category_scores_gemma":[0.000037635633,0.00009833635,0.000022898146,0.000034810542,0.00014656263,0.00008537668,0.00003464311,0.000050693394,5.6493013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010124996,0.004810725,0.9714543,0.00002142038,0.00026884268,0.00021535436,0.00010708287,1.8396921e-8,0.0001924416,0.000024565572,0.000004053853,0.021888677],"study_design_scores_gemma":[0.081669584,0.004646676,0.9096572,0.00035360595,0.00031054372,0.00007678111,0.000018505489,0.000026426304,0.0030692199,0.000017845343,0.00004457683,0.000109039574],"about_ca_topic_score_codex":0.00017374818,"about_ca_topic_score_gemma":0.000054073196,"teacher_disagreement_score":0.08065708,"about_ca_system_score_codex":0.000026909409,"about_ca_system_score_gemma":0.000035341247,"threshold_uncertainty_score":0.40100402},"labels":[],"label_agreement":null},{"id":"W3080882593","doi":"10.1080/10428194.2020.1791846","title":"Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy","year":2020,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Neutropenia; Brentuximab vedotin; Internal medicine; Febrile neutropenia; Dacarbazine; Vinblastine; Adverse effect; Lymphoma; Chemotherapy; Gastroenterology; Surgery; Oncology; Hodgkin lymphoma","score_opus":0.0064694461906447676,"score_gpt":0.20612635667743887,"score_spread":0.1996569104867941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080882593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913423,0.0006125823,0.00006403126,0.00072242535,0.00010956223,0.004416846,0.00026697316,0.00054317235,0.0019221231],"genre_scores_gemma":[0.9887227,0.00033224237,0.0019207429,0.0054014423,0.00020211152,0.00094240217,0.00068295765,0.00042291693,0.0013725306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99200696,0.00021896482,0.0013940156,0.0026478823,0.0018187265,0.0019134472],"domain_scores_gemma":[0.99548316,0.00039203154,0.0008164948,0.001454109,0.00042605467,0.0014281325],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00022871897,0.0021110177,0.003054555,0.0005134103,0.0004069229,0.00035281747,0.000571245,0.00069028774,0.00011014285],"category_scores_gemma":[0.00006864055,0.0013878671,0.00034879227,0.0015505071,0.0007103642,0.0007639743,0.00023081154,0.00025308144,0.00006209899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.027007187,0.0028650719,0.81035316,0.00054711447,0.0013552515,0.003076435,0.0018362962,0.00009658105,0.00026113237,0.00006040947,0.00030554668,0.15223582],"study_design_scores_gemma":[0.23410305,0.010419258,0.74591,0.00058730616,0.0005729772,0.00017066125,0.0004698154,0.0007317884,0.003382123,0.0000048654633,0.0021715516,0.0014766239],"about_ca_topic_score_codex":0.0056058,"about_ca_topic_score_gemma":0.0003648184,"teacher_disagreement_score":0.20709586,"about_ca_system_score_codex":0.013866392,"about_ca_system_score_gemma":0.0063550076,"threshold_uncertainty_score":0.999278},"labels":[],"label_agreement":null},{"id":"W3082392838","doi":"10.1182/blood.2020005846","title":"Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Stage (stratigraphy); Lymphoma; Term (time); Nuclear medicine; Radiation therapy; Internal medicine; Oncology; Cancer research; Biology; Physics","score_opus":0.008668479568378662,"score_gpt":0.22485522056927543,"score_spread":0.21618674100089677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082392838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792796,0.00017100961,0.0000032326677,0.00013388877,0.000010982215,0.00079247914,0.00018101078,0.000046617482,0.0007328236],"genre_scores_gemma":[0.99885195,0.000080177015,0.00020872802,0.00017933146,0.000023382005,0.00004795345,0.00046440022,0.00003177034,0.00011229423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987232,0.000031771306,0.00033353784,0.00035664378,0.00030920602,0.0002456095],"domain_scores_gemma":[0.99920744,0.000041279385,0.00020189439,0.0002882603,0.000091893286,0.00016922722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037179845,0.00021027961,0.0003793853,0.00007811521,0.000027704295,0.000009959848,0.00006018271,0.000044441684,0.00001457192],"category_scores_gemma":[0.000037319944,0.00014114281,0.00004817719,0.0002993964,0.000028343049,0.000093634735,0.000021495145,0.000040377214,0.00001135377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003073312,0.022571823,0.97130424,0.00011643642,0.00013624642,0.0004816561,0.00037291096,0.000005715893,0.0001341291,0.000005475176,0.00004463171,0.0017534525],"study_design_scores_gemma":[0.22322851,0.0027163222,0.7567941,0.00015107657,0.00025068116,0.0000053966583,0.00002490802,0.000017780094,0.016616087,1.6115544e-7,0.00007518938,0.00011978412],"about_ca_topic_score_codex":0.00006214673,"about_ca_topic_score_gemma":0.00004090311,"teacher_disagreement_score":0.2201552,"about_ca_system_score_codex":0.000087940265,"about_ca_system_score_gemma":0.00008934767,"threshold_uncertainty_score":0.57556367},"labels":[],"label_agreement":null},{"id":"W3082806608","doi":"10.1158/1538-7445.am2020-2035","title":"Abstract 2035: Listen to the patients: Assessing the prognostic value of pre-treatment health-related quality of life in 1L DLBCL patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Quality of life (healthcare); Proportional hazards model; Hazard ratio; Oncology; International Prognostic Index; Diffuse large B-cell lymphoma; Progression-free survival; Lymphoma; Overall survival; Confidence interval","score_opus":0.1607710881039595,"score_gpt":0.46707680202327406,"score_spread":0.3063057139193146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082806608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779537,0.0018125243,6.633181e-7,0.01704089,0.000066916225,0.002665383,0.00007702993,0.000009571777,0.0003733763],"genre_scores_gemma":[0.99857295,0.0002479401,0.000019262205,0.0005248248,0.000046682144,0.0004931029,0.000045284953,0.000017276774,0.000032696054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971815,0.0004644536,0.000741047,0.000303417,0.00093029876,0.00037929477],"domain_scores_gemma":[0.9979483,0.00073517964,0.00022620913,0.00037658325,0.00044933223,0.00026441118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008784853,0.0001366386,0.00045684175,0.00007539505,0.00011743168,0.000024629659,0.00019493671,0.000055326756,0.000068976035],"category_scores_gemma":[0.0013199148,0.000069282534,0.00009613927,0.00064275216,0.00012534525,0.000057961544,0.000108956294,0.000194774,0.000011538029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038115543,0.0023288028,0.9672425,0.00027082663,0.00014273706,0.0000028929064,0.0035393804,0.00011058038,0.000050367365,0.00004941379,0.0011687629,0.02471263],"study_design_scores_gemma":[0.004016641,0.0013848775,0.9923998,0.00045795096,0.000023840481,9.618835e-8,0.00036604644,0.00004542905,0.0005815746,0.000013920673,0.00065574876,0.0000540444],"about_ca_topic_score_codex":0.015175682,"about_ca_topic_score_gemma":0.00044146483,"teacher_disagreement_score":0.025157379,"about_ca_system_score_codex":0.00081847125,"about_ca_system_score_gemma":0.0012584081,"threshold_uncertainty_score":0.99138236},"labels":[],"label_agreement":null},{"id":"W3082954457","doi":"10.1158/1538-7755.disp19-b092","title":"Abstract B092: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors by race/ethnicity in a multiethnic U.S. population","year":2020,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Incidence (geometry); Ethnic group; Population; Logistic regression; Oncology; Lymphoma; Internal medicine; Biopsy; Hodgkin lymphoma; Race (biology); Cancer; Demography; Pathology; Biology","score_opus":0.05799883956197173,"score_gpt":0.36203446032429176,"score_spread":0.30403562076232005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082954457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661402,0.02087502,0.000084453415,0.011119223,0.0002457202,0.001311068,0.000046291952,0.000081983264,0.0000960284],"genre_scores_gemma":[0.99313134,0.0035139513,0.00060348667,0.001610147,0.00012311403,0.0005884806,0.0002935866,0.000034124154,0.000101766185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959586,0.0008949345,0.0013087792,0.0009881246,0.00021067569,0.00063887093],"domain_scores_gemma":[0.9982378,0.00067011814,0.00039427212,0.0003286479,0.00004581476,0.00032338267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013909665,0.00038254558,0.0010281289,0.00022240744,0.00005873308,0.000007729769,0.0001641839,0.0004447004,0.0002439992],"category_scores_gemma":[0.0010947887,0.000348995,0.00030318435,0.0005689535,0.00017200521,0.00019694399,0.000070007765,0.00024841403,0.000048823746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012312293,0.0007471974,0.90815836,0.00029212426,0.00014352154,0.00007520662,0.0001479682,0.00007458121,0.005590246,0.00003068236,0.0044249985,0.079083875],"study_design_scores_gemma":[0.0060007283,0.00037310843,0.98786247,0.00093648484,0.00013381703,0.0000110757865,0.000039127495,0.0018866714,0.0014279982,0.00040207073,0.00064202945,0.00028439637],"about_ca_topic_score_codex":0.0033137756,"about_ca_topic_score_gemma":0.001660347,"teacher_disagreement_score":0.07970413,"about_ca_system_score_codex":0.0012763991,"about_ca_system_score_gemma":0.00021366532,"threshold_uncertainty_score":0.9998962},"labels":[],"label_agreement":null},{"id":"W3083227505","doi":"10.12688/f1000research.22257.1","title":"Treatment approaches in relapsed or refractory peripheral T-cell lymphomas","year":2020,"lang":"en","type":"preprint","venue":"F1000Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Medicine; Oncology; Transplantation; Population; Internal medicine; Autologous stem-cell transplantation; Tolerability; Clinical trial; Lymphoma; CD30; Adverse effect","score_opus":0.20093160784931258,"score_gpt":0.36277591430522116,"score_spread":0.16184430645590858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083227505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9168959,0.0062221605,0.000007698931,0.0095006265,0.00035235393,0.0045953877,0.00017576938,0.00025612407,0.06199393],"genre_scores_gemma":[0.9764095,0.002810294,0.0014331482,0.00017455293,0.0004802492,0.0020715778,0.0006142584,0.00013794747,0.015868455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995869,0.0003257828,0.00062155165,0.0013260449,0.0010296056,0.00082802],"domain_scores_gemma":[0.9976614,0.00030215914,0.0001298617,0.0011862394,0.00009710096,0.00062322913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026359942,0.00064072554,0.001159165,0.00038763045,0.00009505375,0.00011720909,0.000373851,0.0005923772,0.0012306068],"category_scores_gemma":[0.0001558882,0.00044021258,0.00041280547,0.00039039238,0.00017102825,0.00004198064,0.00071867596,0.00073875266,0.0004133596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025860162,0.050238546,0.5274526,0.0064829933,0.0030402408,0.050438497,0.014328965,0.00053699414,0.0031685396,0.0010327358,0.030430103,0.28698963],"study_design_scores_gemma":[0.104266636,0.027161105,0.55384344,0.002634979,0.001444117,0.00056698784,0.004007679,0.021386893,0.030455282,0.0015792985,0.24938327,0.0032702764],"about_ca_topic_score_codex":0.0018808409,"about_ca_topic_score_gemma":0.00020646461,"teacher_disagreement_score":0.28371936,"about_ca_system_score_codex":0.0045298394,"about_ca_system_score_gemma":0.0032553966,"threshold_uncertainty_score":0.999805},"labels":[],"label_agreement":null},{"id":"W3083729105","doi":"10.1007/s00330-020-07182-0","title":"Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study","year":2020,"lang":"en","type":"article","venue":"European Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; University of Ottawa","funders":"Stichting Kinderen Kankervrij","keywords":"Medicine; Concordance; Neuroradiology; Radiology; Nuclear medicine; Kappa; Stage (stratigraphy); Cohen's kappa; Prospective cohort study; Magnetic resonance imaging; Positron emission tomography; Standardized uptake value; PET-CT; Neurology; Pathology; Internal medicine","score_opus":0.03585677243929235,"score_gpt":0.29770663851611523,"score_spread":0.26184986607682287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083729105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947081,0.00036327654,0.00029044054,0.0007944241,0.00021857936,0.0020035661,0.00022859033,0.00012488199,0.001268117],"genre_scores_gemma":[0.9972253,0.000028676604,0.0018497152,0.00031367232,0.0002660249,0.00007889708,0.00015047993,0.000058125985,0.00002914501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978137,0.00048154095,0.00043783127,0.00067268714,0.00021509493,0.00037917064],"domain_scores_gemma":[0.99855924,0.000343865,0.00022078502,0.00040724865,0.00019034528,0.00027851074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031829515,0.00028319546,0.00065314927,0.00010612722,0.00009663236,0.000017152282,0.0001876796,0.000015248472,0.000038613416],"category_scores_gemma":[0.00031577275,0.00023088556,0.00012844404,0.0002320515,0.00009930649,0.00006253122,0.000066260654,0.000092354356,0.000045540826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030213805,0.007283811,0.9216402,0.00032489284,0.0014994397,0.009957419,0.0051119844,0.00035844123,0.00192598,0.00064010284,0.004152345,0.016891552],"study_design_scores_gemma":[0.12690586,0.04226024,0.80725586,0.000070301605,0.0015453397,0.00012811845,0.004405116,0.0023377268,0.0028717204,0.000010642193,0.011641915,0.00056716346],"about_ca_topic_score_codex":0.000029269911,"about_ca_topic_score_gemma":0.0000113923115,"teacher_disagreement_score":0.114384376,"about_ca_system_score_codex":0.00026449063,"about_ca_system_score_gemma":0.00023046888,"threshold_uncertainty_score":0.941524},"labels":[],"label_agreement":null},{"id":"W3084426004","doi":"10.3390/ijms21186623","title":"Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future","year":2020,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Lymphoma; Carcinogenesis; Immune system; Biology; Hodgkin lymphoma; Cancer research; Classical Hodgkin lymphoma; Signal transduction; Tumor microenvironment; Immunology; Computational biology; Neuroscience; Cancer; Genetics","score_opus":0.028978921089965793,"score_gpt":0.3426082382686106,"score_spread":0.3136293171786448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084426004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017741077,0.9940882,0.00019871593,0.0019964122,0.00095613085,0.00026911375,0.000047642017,0.0000072664234,0.00066243013],"genre_scores_gemma":[0.0056520826,0.9906907,0.002252253,0.00022356481,0.0011126606,0.000013615441,0.000016654378,0.000025610108,0.000012845759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964403,0.00016439936,0.0010246945,0.00033420438,0.0018410012,0.00019541149],"domain_scores_gemma":[0.99753326,0.00009826104,0.0013768487,0.0001967213,0.00057696475,0.00021797194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035329166,0.00033049882,0.001370489,0.000498115,0.0000343803,0.00007214196,0.0009413961,0.000157491,0.000041874096],"category_scores_gemma":[0.00007513278,0.00021776209,0.0013253444,0.0004659486,0.00019389128,0.00010349819,0.00016289459,0.00012459059,0.000011943812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030634674,0.00042136584,0.000119178214,0.0005587448,0.0015009786,0.0071161925,0.000042731474,0.00001277152,0.0001629057,0.0005164698,0.0004569631,0.98906106],"study_design_scores_gemma":[0.0011927094,0.00067044224,0.00022152229,0.0055280426,0.0016669013,0.0036673194,0.000056967954,0.0000107446485,0.0012331492,0.000086479544,0.9854607,0.00020500997],"about_ca_topic_score_codex":0.000009633749,"about_ca_topic_score_gemma":2.4211886e-7,"teacher_disagreement_score":0.9888561,"about_ca_system_score_codex":0.000224692,"about_ca_system_score_gemma":0.0013177001,"threshold_uncertainty_score":0.88800806},"labels":[],"label_agreement":null},{"id":"W3086825036","doi":"10.1111/bjh.17073","title":"Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Medical Research Council; Takeda Oncology; Blood Cancer UK; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Bloodwise; King’s College London; Health Research","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Adverse effect; Confidence interval; Classical Hodgkin lymphoma; Oncology; Surgery; Gastroenterology; Lymphoma; Hodgkin lymphoma","score_opus":0.2288983498756854,"score_gpt":0.4219077485188068,"score_spread":0.19300939864312142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086825036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994249,0.00036079696,0.00032187524,0.002743665,0.000044727472,0.002039083,0.0002323025,0.0000034746959,0.000005087641],"genre_scores_gemma":[0.9974693,0.00014530112,0.0020390556,0.00015949616,0.000045900295,0.00010444747,0.000012835671,0.000017010152,0.0000066569137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722093,0.0005375979,0.0010219284,0.00024598298,0.00071919995,0.00025434262],"domain_scores_gemma":[0.9969632,0.0011684189,0.0005649241,0.00014436251,0.001036798,0.00012229102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009486576,0.0001607646,0.0011512567,0.0002541472,0.00010768847,0.00001195169,0.00017338658,0.00008079801,0.000015480317],"category_scores_gemma":[0.0011151915,0.00010794626,0.00011159766,0.0006415374,0.00017894326,0.00006808083,0.000036694375,0.000092177674,1.6294835e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62408346,0.18273357,0.037598822,0.0006258381,0.002950219,0.032855064,0.017412046,0.0017920462,0.0015781753,0.00006791106,0.0050142603,0.093288586],"study_design_scores_gemma":[0.42061824,0.21603203,0.3263671,0.0032293256,0.0008060602,0.0074175405,0.0014722407,0.0008698948,0.017550895,0.00008545835,0.005199217,0.00035200425],"about_ca_topic_score_codex":0.0010475548,"about_ca_topic_score_gemma":0.0023962928,"teacher_disagreement_score":0.28876826,"about_ca_system_score_codex":0.00042291702,"about_ca_system_score_gemma":0.001647955,"threshold_uncertainty_score":0.44019207},"labels":[],"label_agreement":null},{"id":"W3087179831","doi":"10.1182/blood.2020006578","title":"A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"Cilag; Janssen Pharmaceuticals; Genentech; Daiichi Sankyo Europe; National Cancer Institute; Calithera Biosciences; Gilead Sciences; Servier; Juno Therapeutics; Eisai; TG Therapeutics; H. Lundbeck A/S; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Pharmacyclics; Agios Pharmaceuticals; Pfizer; Incyte; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Karyopharm Therapeutics; Kite Pharma; Unum Therapeutics; Sanofi; MorphoSys; Celgene; AstraZeneca; Amgen","keywords":"Venetoclax; International Prognostic Index; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Vincristine; CHOP; Prednisone; Hazard ratio; Population; Tolerability; Oncology; Cyclophosphamide; Lymphoma; Gastroenterology; Adverse effect; Confidence interval; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.01977755846897808,"score_gpt":0.27365886025117026,"score_spread":0.25388130178219215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087179831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593925,0.00024446024,0.000008745074,0.00014868806,0.000030376412,0.0031794403,0.00022150959,0.00004526921,0.00018228215],"genre_scores_gemma":[0.99849373,0.000048668822,0.00016786181,0.00022178613,0.000089126006,0.0006599289,0.00017239999,0.0000397706,0.00010670836],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987935,0.000018170196,0.00028569676,0.00037045672,0.00027091082,0.00026128587],"domain_scores_gemma":[0.99911344,0.0000802173,0.0001359074,0.0003151365,0.00010397816,0.0002513235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023367744,0.00025224852,0.0005163269,0.00004344677,0.000076321434,0.000011106483,0.00006578492,0.000049933107,0.000027227568],"category_scores_gemma":[0.000030071957,0.0001655812,0.0001228003,0.0001356056,0.000016523007,0.00003439668,0.000030788542,0.000018861068,0.00002025705],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008195657,0.7271551,0.24969587,0.00024505315,0.0019406477,0.00041128497,0.0064947056,0.000013909256,0.00006694672,0.000021406524,0.00025434291,0.0055050557],"study_design_scores_gemma":[0.82466704,0.135794,0.023578139,0.0000741495,0.0030308054,0.000006487524,0.00044932318,0.00022855146,0.008022279,0.000003523685,0.0039394074,0.00020628193],"about_ca_topic_score_codex":0.00018937897,"about_ca_topic_score_gemma":0.00005477077,"teacher_disagreement_score":0.8164714,"about_ca_system_score_codex":0.00028121096,"about_ca_system_score_gemma":0.0002474185,"threshold_uncertainty_score":0.6752205},"labels":[],"label_agreement":null},{"id":"W3087337481","doi":"10.1016/j.anndiagpath.2020.151636","title":"Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Texas MD Anderson Cancer Center","keywords":"Lymphoma; Hodgkin lymphoma; Downregulation and upregulation; Immunohistochemistry; Pathology; Chronic lymphocytic leukemia; Cancer research; Biology; Classical Hodgkin lymphoma; Medicine; Leukemia; Immunology; Gene; Genetics","score_opus":0.05968323785408726,"score_gpt":0.308987729183935,"score_spread":0.24930449132984778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087337481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891174,0.0007542218,0.00013220067,0.0078111207,0.00015836606,0.0009856609,0.00032627603,0.00009605932,0.00061869854],"genre_scores_gemma":[0.9914219,0.0003704628,0.0006267575,0.006738699,0.000080942395,0.00038783133,0.00008747779,0.000088065375,0.00019790173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962685,0.00040317417,0.0008186527,0.0009875599,0.00054231565,0.0009797824],"domain_scores_gemma":[0.9953966,0.0028536809,0.0004456306,0.00046366174,0.0002337145,0.00060671906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025772708,0.0005752245,0.0013024312,0.00038920582,0.00009283989,0.000027872018,0.0002588244,0.00044922766,0.0005295306],"category_scores_gemma":[0.0025930011,0.00045924375,0.00022922753,0.000925803,0.00018824651,0.00021062228,0.00015509162,0.00013803686,0.00021699734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016285267,0.0046047103,0.86966044,0.00014464252,0.0007950933,0.02146889,0.0079307165,0.000039606537,0.07341898,0.00013455773,0.0054799877,0.014693851],"study_design_scores_gemma":[0.0076811975,0.0037196486,0.82425725,0.0012698908,0.0002083972,0.0003316218,0.00016827848,0.000022724797,0.16128145,0.000101095546,0.00050868845,0.00044971393],"about_ca_topic_score_codex":0.00008316352,"about_ca_topic_score_gemma":0.00002612672,"teacher_disagreement_score":0.08786248,"about_ca_system_score_codex":0.00047260273,"about_ca_system_score_gemma":0.00044699965,"threshold_uncertainty_score":0.9997859},"labels":[],"label_agreement":null},{"id":"W3087748636","doi":"10.1097/iop.0000000000001729","title":"Helicobacter pylori Infection of the Gastric Mucosa and Ocular Adnexa—Lack of Association With Ocular Adnexal Lymphoma","year":2020,"lang":"en","type":"article","venue":"Ophthalmic Plastic and Reconstructive Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Medicine; Helicobacter pylori; Internal medicine; Gastroenterology; Chlamydia; Chlamydia psittaci; Serology; Gastritis; Immunology; Antibody; Pathology","score_opus":0.02084547698336228,"score_gpt":0.2265102601301841,"score_spread":0.20566478314682182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087748636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986393,0.00032016935,0.00003901111,0.00018248233,0.0002271771,0.00024169574,0.000058034446,0.000011122107,0.00028101253],"genre_scores_gemma":[0.9994209,0.00028103805,0.00012279904,0.000050817758,0.00006882572,0.000013500465,0.000013984198,0.000013043762,0.000015099682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892575,0.0000803804,0.00031675477,0.00026442195,0.00024232395,0.00017036212],"domain_scores_gemma":[0.9985814,0.00068466965,0.0003551268,0.000112435446,0.00013876507,0.0001275823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012316108,0.00017743683,0.0005162277,0.00008680404,0.00006243801,0.0000113155975,0.000023860392,0.00011000344,0.00003317459],"category_scores_gemma":[0.0003825271,0.00011089155,0.00012806169,0.00027497087,0.00018919952,0.00009105752,0.000037123198,0.000071343435,0.000002058056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002725577,0.00011657793,0.9899942,0.00015923574,0.0004718999,0.00003919068,0.000114643015,0.0000036733238,0.0012008061,0.000035682446,0.000062312254,0.007529201],"study_design_scores_gemma":[0.0017494916,0.00028701048,0.98899466,0.000316611,0.00042295794,0.0012225461,0.00010718325,0.00012993641,0.006542615,0.00002721974,0.000088712935,0.00011103342],"about_ca_topic_score_codex":0.00009520064,"about_ca_topic_score_gemma":0.000002263804,"teacher_disagreement_score":0.0074181673,"about_ca_system_score_codex":0.00011046669,"about_ca_system_score_gemma":0.00019186332,"threshold_uncertainty_score":0.45220265},"labels":[],"label_agreement":null},{"id":"W3088030098","doi":"10.1016/j.annonc.2020.08.006","title":"888MO Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Meta-analysis; Oncology; Confidence interval; Publication bias; Funnel plot; Adverse effect; Antibody-drug conjugate; Observational study; Lymphoma; Hodgkin lymphoma; Immunology; Monoclonal antibody","score_opus":0.16447647763766812,"score_gpt":0.43175853601136466,"score_spread":0.26728205837369656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088030098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006063829,0.9946242,0.0000014285459,0.0005538782,0.00003770183,0.0041898275,0.00012051813,0.000020363743,0.00039146113],"genre_scores_gemma":[0.0036554716,0.99408793,0.000051296836,0.00048522427,0.000014575712,0.0015068818,0.00010766204,0.000055231227,0.00003570565],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931363,0.0031777837,0.0023312666,0.00069858064,0.00034866936,0.00030742312],"domain_scores_gemma":[0.9935321,0.0030949307,0.002181048,0.00075856113,0.00024349541,0.00018985293],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0020139392,0.00062147324,0.024918022,0.00064799143,0.000016271892,0.000005718269,0.00022495205,0.0004863947,0.00006274558],"category_scores_gemma":[0.00082181056,0.00039154897,0.0040199393,0.0013512075,0.00016002975,0.000036985908,0.00013503796,0.00020077372,0.000017617484],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050561997,0.0018887302,0.0000277782,0.7904589,0.16655849,0.0003229671,0.000028912034,1.4349277e-7,2.1605022e-7,0.000094851275,0.00017832601,0.04039011],"study_design_scores_gemma":[0.0017413183,0.0021946453,0.00024577335,0.08714793,0.8234946,0.00013788372,0.000008266641,0.000001099038,0.0000053179538,0.000015668034,0.08478397,0.00022349117],"about_ca_topic_score_codex":0.00011876738,"about_ca_topic_score_gemma":0.000028250435,"teacher_disagreement_score":0.70331097,"about_ca_system_score_codex":0.00031170293,"about_ca_system_score_gemma":0.0009588848,"threshold_uncertainty_score":0.9998536},"labels":[],"label_agreement":null},{"id":"W3088378522","doi":"10.1182/blood.2020006338","title":"Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Diffuse large B-cell lymphoma; Primary central nervous system lymphoma; Lymphoma; Central nervous system; Medicine; Biology; Pathology; Oncology; Internal medicine","score_opus":0.006505323169240855,"score_gpt":0.1836649054443916,"score_spread":0.17715958227515075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088378522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680825,0.0045775664,0.000002173504,0.022530165,0.00052303483,0.0014811511,0.0005815287,0.00017093561,0.002050931],"genre_scores_gemma":[0.91081697,0.0003270474,0.00027798826,0.0835105,0.0024065375,0.00020226788,0.0018922513,0.00018021963,0.00038624313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716675,0.00011538109,0.0007755249,0.00067668606,0.00055626046,0.00070940086],"domain_scores_gemma":[0.9985256,0.00014657226,0.00034941325,0.0007016234,0.000052350453,0.00022442071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000687766,0.00053043384,0.001271847,0.00019762106,0.000038545466,0.000020370697,0.00022737359,0.0006233301,0.000015290556],"category_scores_gemma":[0.00004474578,0.00044307098,0.00039564725,0.0002144334,0.000055948294,0.000033680553,0.00014180996,0.00041141204,0.00007325697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017165056,0.02578594,0.54648983,0.0101854205,0.0014662482,0.0763461,0.00055169524,0.000001695453,0.00093167386,0.000016148671,0.33779472,0.0002588905],"study_design_scores_gemma":[0.12378284,0.001513304,0.7108019,0.003257593,0.00757608,0.0011298792,0.00009033843,0.000059030473,0.0037336922,0.000005073173,0.14712468,0.00092556915],"about_ca_topic_score_codex":0.00014730734,"about_ca_topic_score_gemma":0.0000032823928,"teacher_disagreement_score":0.19067006,"about_ca_system_score_codex":0.00079129904,"about_ca_system_score_gemma":0.0005514899,"threshold_uncertainty_score":0.9998021},"labels":[],"label_agreement":null},{"id":"W3088397291","doi":"10.1016/j.annonc.2020.08.004","title":"886MO Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"Merck Sharp and Dohme","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Health related quality of life; Population; Brentuximab vedotin; Pembrolizumab; Phases of clinical research; Stock options; Oncology; Surgery; Clinical trial; Cancer; Lymphoma; Hodgkin lymphoma; Disease","score_opus":0.23029157352544738,"score_gpt":0.4550039072882897,"score_spread":0.22471233376284233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088397291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97301954,0.0024923722,0.000008832495,0.019234816,0.00020985988,0.004006447,0.00019520248,0.00004216075,0.0007907841],"genre_scores_gemma":[0.9930501,0.0009417702,0.00035975146,0.00495962,0.00008451141,0.00032118842,0.0001547836,0.00005118407,0.00007709578],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9905951,0.0029512076,0.004260357,0.00089420384,0.0007030053,0.00059610436],"domain_scores_gemma":[0.99197084,0.0034846782,0.0027236908,0.0007717929,0.0004170987,0.0006319092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022777582,0.00049126864,0.0062670438,0.00027658851,0.00006859311,0.000012537198,0.00054145907,0.00047295835,0.00037865463],"category_scores_gemma":[0.0032641527,0.00037622653,0.00036420464,0.0006917852,0.00045422371,0.00013060367,0.00037915655,0.00033542584,0.000017714092],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8036582,0.122976825,0.0046177306,0.00028471035,0.0021652267,0.0003948223,0.0075017693,0.000009741962,0.0010400981,0.00020440576,0.008052396,0.049094085],"study_design_scores_gemma":[0.9165548,0.048825998,0.027790306,0.0003221733,0.000424946,0.000014618126,0.0020155343,0.0005834938,0.0015591123,0.00013262483,0.0014852871,0.00029109788],"about_ca_topic_score_codex":0.02178721,"about_ca_topic_score_gemma":0.0014584407,"teacher_disagreement_score":0.11289662,"about_ca_system_score_codex":0.00033520817,"about_ca_system_score_gemma":0.002896524,"threshold_uncertainty_score":0.999869},"labels":[],"label_agreement":null},{"id":"W3089359485","doi":"10.1007/s41669-020-00231-w","title":"Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bell (Canada)","funders":"Janssen Pharmaceuticals","keywords":"EconLit; MEDLINE; Medicine; Systematic review; Economic evaluation; Quality of life (healthcare); Cochrane Library; Mantle cell lymphoma; Resource (disambiguation); Family medicine; Meta-analysis; Lymphoma; Political science; Pathology; Computer science","score_opus":0.044622184933162896,"score_gpt":0.3441055139569483,"score_spread":0.2994833290237854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089359485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723595,0.02275715,8.775415e-7,0.000754185,0.000022835538,0.0030171513,0.00023564593,0.0000049682935,0.0008477334],"genre_scores_gemma":[0.9831032,0.012242348,0.00022450175,0.0040628277,0.000016194734,0.00013542338,0.00016952548,0.000019433164,0.000026551304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850595,0.00017550321,0.0008571456,0.00026767174,0.00008515469,0.00010856293],"domain_scores_gemma":[0.99875474,0.00021214908,0.0005504603,0.00023996465,0.00007515418,0.0001675521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004591677,0.00015602385,0.0009539064,0.000049571056,0.000018273806,0.000045494562,0.00015967077,0.000034074434,0.0000829104],"category_scores_gemma":[0.00008857814,0.00012276902,0.00006268621,0.00007303713,0.000028322596,0.00025517595,0.0001242874,0.00004042037,0.000016038724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009981777,0.0010410923,0.8576708,0.13556841,0.0004409693,0.000003837512,0.00047068213,0.000034466488,0.000033378787,0.0002565259,0.002799228,0.0006824273],"study_design_scores_gemma":[0.064303376,0.0009514012,0.82438827,0.10137528,0.0014969286,0.0000057455927,0.00020524167,0.0015990235,0.0035592187,0.000011423068,0.0015189932,0.00058507995],"about_ca_topic_score_codex":0.00017235425,"about_ca_topic_score_gemma":0.000014817981,"teacher_disagreement_score":0.0633052,"about_ca_system_score_codex":0.0002303205,"about_ca_system_score_gemma":0.00019526729,"threshold_uncertainty_score":0.50063753},"labels":[],"label_agreement":null},{"id":"W3089833778","doi":"10.1016/s2352-3026(20)30321-5","title":"Immunotherapy for older patients with classic Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Immunotherapy; Hodgkin lymphoma; Oncology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.027256223858852145,"score_gpt":0.27264843305991515,"score_spread":0.245392209201063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089833778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95700884,0.00048943196,0.0002801502,0.04019217,0.000083846775,0.00093693094,0.000023105118,0.00007610108,0.00090945314],"genre_scores_gemma":[0.9843873,0.000048391677,0.00086675765,0.014144116,0.00017154943,0.00024203114,0.000049815837,0.00002578801,0.000064284766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921066,0.000037690974,0.00015255265,0.00021116465,0.0001114303,0.00027649823],"domain_scores_gemma":[0.9993515,0.00014293508,0.00007994947,0.0002996449,0.000058103622,0.000067838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048176513,0.0001424585,0.0006391276,0.000016544838,0.000074893105,0.000010951794,0.000118954515,0.00006119551,0.000074740994],"category_scores_gemma":[0.000024781368,0.00007180769,0.00007384023,0.000085368796,0.000086920634,0.000024508738,0.000021114012,0.0000383597,0.00006692726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004450626,0.0009603405,0.8909519,0.00023145165,0.00067378354,0.00014703796,0.0020562042,0.0000024443218,0.00006204179,0.009051535,0.0409748,0.05043784],"study_design_scores_gemma":[0.036843643,0.0014981161,0.88364047,0.0000712099,0.00023009286,0.00016304359,0.000073689145,0.00009669929,0.0017166821,0.00032688436,0.07515612,0.00018337475],"about_ca_topic_score_codex":0.0000099562385,"about_ca_topic_score_gemma":0.0000042344477,"teacher_disagreement_score":0.050254468,"about_ca_system_score_codex":0.00004984708,"about_ca_system_score_gemma":0.000081860984,"threshold_uncertainty_score":0.29282328},"labels":[],"label_agreement":null},{"id":"W3092236290","doi":"10.1186/s12885-020-07374-3","title":"Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"Canadian Institutes of Health Research; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Genome Canada","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Chemotherapy regimen; Cost effectiveness; Cost-effectiveness analysis; Incremental cost-effectiveness ratio; Internal medicine; Cancer; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","score_opus":0.0681199910779398,"score_gpt":0.35072240883102485,"score_spread":0.28260241775308503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092236290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961625,0.0014793226,0.00026136514,0.00020369558,0.00005989821,0.0013349763,0.000117730255,0.000031740397,0.00034878528],"genre_scores_gemma":[0.9982562,0.0001127547,0.00033885954,0.00014524376,0.000033996548,0.0009950043,0.000045876346,0.000017325168,0.00005473226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987459,0.000107416105,0.00029663896,0.00039378973,0.00023736327,0.00021884864],"domain_scores_gemma":[0.99922216,0.00018918622,0.00011799631,0.00024327663,0.00008818709,0.00013920343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013269403,0.00017015002,0.00067517767,0.00012605665,0.000017813787,0.000007823222,0.00007026987,0.000053790845,0.00017977595],"category_scores_gemma":[0.00014330249,0.00014053365,0.00021621976,0.0009631158,0.00004121557,0.000048474853,0.000038985138,0.00003913014,0.000009767603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018552783,0.0011625914,0.9723426,0.00094071066,0.0005701163,0.000059232338,0.00036862792,0.0073443274,0.000926932,0.00015011473,0.000037443668,0.014241998],"study_design_scores_gemma":[0.011832456,0.00031084602,0.9780531,0.00023916647,0.0009439551,0.0000013897464,0.00012003249,0.002650245,0.005004323,0.000013878608,0.00069580786,0.00013480024],"about_ca_topic_score_codex":0.0012071123,"about_ca_topic_score_gemma":0.0017930857,"teacher_disagreement_score":0.0141071975,"about_ca_system_score_codex":0.0006627638,"about_ca_system_score_gemma":0.00040142122,"threshold_uncertainty_score":0.57307965},"labels":[],"label_agreement":null},{"id":"W3092484545","doi":"10.1016/s1470-2045(20)30441-1","title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Cilag; Takeda Pharmaceutical Company; AbbVie; National Cancer Institute; Merck Sharp and Dohme; Pharmacyclics; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Roche","keywords":"Open label; Medicine; Follicular lymphoma; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Follicular phase; Clinical trial; Lymphoma","score_opus":0.1386246272526778,"score_gpt":0.38730405804533874,"score_spread":0.24867943079266094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092484545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840698,0.0001470744,0.000043488923,0.009165845,0.00033698458,0.004950367,0.00014326218,0.00008547128,0.0010577118],"genre_scores_gemma":[0.981441,0.000085079875,0.0055958354,0.010462383,0.0009598135,0.0007688676,0.00046333502,0.000055460405,0.0001681871],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982566,0.0002445173,0.00035296453,0.00045958752,0.00023439324,0.0004518958],"domain_scores_gemma":[0.9982622,0.0005416351,0.00025765784,0.00049777795,0.00015728272,0.00028343612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025268045,0.00024894864,0.0008928779,0.000029645567,0.00016651428,0.000046346002,0.00035278036,0.00013623504,0.00011788213],"category_scores_gemma":[0.000393605,0.00012776826,0.00005140621,0.00017208132,0.00010274169,0.00015023586,0.000108802444,0.00008927446,0.000035595847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76882976,0.0732818,0.0017675017,0.00008116858,0.00074610935,0.00048130803,0.0014660512,0.000002227927,0.0005082683,0.00028071812,0.020814378,0.1317407],"study_design_scores_gemma":[0.58801293,0.12843464,0.0008670066,0.00003154034,0.00062319724,0.000012953134,0.00013805373,0.00016040643,0.0003567439,0.000024282544,0.28118482,0.00015344606],"about_ca_topic_score_codex":0.000052031846,"about_ca_topic_score_gemma":0.000072596835,"teacher_disagreement_score":0.26037043,"about_ca_system_score_codex":0.0004287475,"about_ca_system_score_gemma":0.00041335277,"threshold_uncertainty_score":0.52102387},"labels":[],"label_agreement":null},{"id":"W3092636096","doi":"10.1158/1078-0432.ccr-20-2868","title":"A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Regional Development Fund; Instituto de Salud Carlos III; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Generalitat de Catalunya; Ministerio de Economía y Competitividad; National Institutes of Health; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya","keywords":"Cyclin D1; Mantle cell lymphoma; Cancer research; Cyclin D; Biology; Cyclin; Cyclin A2; Cyclin B; Cell cycle; Chromatin; Cyclin D2; Lymphoma; Gene; Genetics; Immunology","score_opus":0.4512327535473243,"score_gpt":0.5734693192376064,"score_spread":0.12223656569028207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092636096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652419,0.0020577176,0.000007652688,0.02592807,0.00065999426,0.0021875482,0.00008570112,0.00012062502,0.0037107952],"genre_scores_gemma":[0.98943293,0.0030767322,0.0004864258,0.002949923,0.0016553698,0.001051976,0.000054265787,0.00004721914,0.0012451514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396455,0.00078820577,0.0018620074,0.0010770478,0.001465428,0.00084275816],"domain_scores_gemma":[0.99660844,0.0013302647,0.00011733676,0.00048408067,0.0002782893,0.0011816206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033170087,0.00024925644,0.00093752076,0.00013115353,0.00009822739,0.00006131901,0.0003561057,0.00040858297,0.00093074975],"category_scores_gemma":[0.0010886436,0.0001946804,0.00054224586,0.0005755753,0.00050437875,0.00008576763,0.00018898475,0.0009970512,0.0006914364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023229509,0.00942485,0.8531904,0.00018658303,0.000110024346,0.0008726597,0.00010733436,0.000004469846,0.000029941568,0.00007504405,0.01020624,0.12346946],"study_design_scores_gemma":[0.02290866,0.0040110066,0.9023491,0.00014865321,0.00009064664,0.000007713516,0.00010071697,0.0006253516,0.0001887344,0.00008314785,0.069303684,0.00018257988],"about_ca_topic_score_codex":0.00043099298,"about_ca_topic_score_gemma":0.00020807801,"teacher_disagreement_score":0.12328688,"about_ca_system_score_codex":0.0004136204,"about_ca_system_score_gemma":0.0012382495,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W3093017431","doi":"10.1182/blood.v130.suppl_1.415.415","title":"Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Immunohistochemistry; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Radiation therapy; Internal medicine; Oncology; CHOP; Pathology; Cancer research; Biology","score_opus":0.010917304930278567,"score_gpt":0.28692304630382687,"score_spread":0.2760057413735483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093017431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980157,0.00002842089,7.130928e-7,0.000013182956,0.000022880538,0.001036692,0.00043869452,0.000016691625,0.00042702074],"genre_scores_gemma":[0.99912125,0.000027474656,0.00027584698,0.000010807877,0.000010917498,0.0000570769,0.00012182958,0.000038988383,0.0003358256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986027,0.00003410599,0.00031592464,0.00041274275,0.0004049416,0.00022957813],"domain_scores_gemma":[0.99855,0.000020055293,0.00043597823,0.0007292448,0.00016067833,0.00010406145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078060344,0.0003130539,0.0006190765,0.00013075674,0.00009536371,0.000028116812,0.00016918436,0.00004845111,0.000032804888],"category_scores_gemma":[0.000021726413,0.00019600097,0.00008422841,0.00006144039,0.000073457,0.0001322776,0.000052488573,0.00006078477,7.198944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036505982,0.17695531,0.81589264,0.000025405847,0.00095452886,0.000084453626,0.00063527026,3.429131e-7,0.0017228489,0.000001666488,0.0000036638394,0.00007326815],"study_design_scores_gemma":[0.250235,0.009411411,0.73757917,0.00008892681,0.000196434,0.0000022339873,0.00007241906,0.0000097616885,0.0022705218,2.0777973e-7,0.0000031486995,0.00013079308],"about_ca_topic_score_codex":0.0014676661,"about_ca_topic_score_gemma":0.00006268908,"teacher_disagreement_score":0.24658439,"about_ca_system_score_codex":0.00034237068,"about_ca_system_score_gemma":0.000083545376,"threshold_uncertainty_score":0.7992687},"labels":[],"label_agreement":null},{"id":"W3093857188","doi":"10.1016/j.ijrobp.2020.07.959","title":"Prognostic Value of Chest X-ray and CT Defined Large Mediastinal Adenopathy in High Risk Pediatric Hodgkin Lymphoma (COG AHOD0831)","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Radiology; Nuclear medicine; Vincristine; Ifosfamide; Etoposide; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.01612224795028747,"score_gpt":0.2882421803434814,"score_spread":0.27211993239319393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093857188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173194,0.001919207,0.0012005742,0.0038314625,0.0007441764,0.00031053138,0.00015628917,0.00002136565,0.00008444739],"genre_scores_gemma":[0.9907511,0.0028742917,0.0036667532,0.000716371,0.0018505398,0.000020096832,0.000091994865,0.000025777508,0.0000030886163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977979,0.00030336218,0.0009859597,0.00029599018,0.00035466993,0.0002621365],"domain_scores_gemma":[0.996911,0.0009656082,0.0013616057,0.00010811325,0.00042172964,0.00023197627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054345303,0.0002425196,0.0007271091,0.0002140665,0.00004509456,0.000016549326,0.00023700313,0.0001533057,0.0000551845],"category_scores_gemma":[0.0014720806,0.00020333088,0.0001804667,0.0002705169,0.000117100695,0.00017249532,0.000084254636,0.00027951418,0.000021874834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051999994,0.0013522182,0.93999964,0.000029002354,0.00038492822,0.00032106487,0.0006128152,0.00021562463,0.00023746645,0.0033639907,0.00025339623,0.05270987],"study_design_scores_gemma":[0.017053414,0.003041739,0.9725781,0.000064665124,0.000608334,0.00026007756,0.00009654345,0.002049659,0.00064413453,0.0019061011,0.0015364054,0.00016080975],"about_ca_topic_score_codex":0.00006743539,"about_ca_topic_score_gemma":0.000006638879,"teacher_disagreement_score":0.05254906,"about_ca_system_score_codex":0.00039098848,"about_ca_system_score_gemma":0.00070086826,"threshold_uncertainty_score":0.8291593},"labels":[],"label_agreement":null},{"id":"W3093987483","doi":"10.1111/bjh.16922","title":"Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Canada","keywords":"Ibrutinib; Medicine; Discontinuation; Hazard ratio; Mantle cell lymphoma; Internal medicine; Retrospective cohort study; Proportional hazards model; Database; Oncology; Medical record; Population; Confidence interval; Survival analysis; Lymphoma","score_opus":0.012567597786852335,"score_gpt":0.2618785143198141,"score_spread":0.24931091653296178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093987483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919115,0.004482786,0.0000024897088,0.0026397102,0.000017912766,0.0008740486,0.00004183436,0.000008121838,0.000021607264],"genre_scores_gemma":[0.9572387,0.041076127,0.000014685621,0.0015039812,0.000015937125,0.000047423873,0.00008253482,0.000015428224,0.0000052358614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829066,0.00030721695,0.0005306594,0.00025858244,0.00034594207,0.00026695413],"domain_scores_gemma":[0.999061,0.00019782675,0.00028363883,0.0001280941,0.00010773937,0.00022169008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021424638,0.00019528481,0.00092833274,0.00008408692,0.00006561874,0.000026674748,0.00008830872,0.000052257383,0.000050409668],"category_scores_gemma":[0.0001478704,0.000116897616,0.00005997581,0.00019386924,0.00009719953,0.00007675122,0.00003529138,0.00015266567,0.0000015479293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023522788,0.0028908034,0.9486643,0.00017324358,0.00028505002,0.041832834,0.0006968348,3.227392e-8,9.6439166e-8,0.000003757475,0.0003156995,0.004902114],"study_design_scores_gemma":[0.019741619,0.007651726,0.9492914,0.0013865517,0.0006003838,0.02002646,0.0008472093,0.000021815924,0.0000098358305,0.0000033813035,0.00031598166,0.0001036369],"about_ca_topic_score_codex":0.0022442527,"about_ca_topic_score_gemma":0.0016201283,"teacher_disagreement_score":0.03659334,"about_ca_system_score_codex":0.00016734697,"about_ca_system_score_gemma":0.00014663911,"threshold_uncertainty_score":0.47669464},"labels":[],"label_agreement":null},{"id":"W3094390359","doi":"10.1016/j.ijrobp.2020.07.179","title":"Cost-Effectiveness Of Staging PET/CT in Limited-Stage Follicular Lymphoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Spinal Cord Injury BC; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Watchful waiting; Rituximab; Follicular lymphoma; Positron emission tomography; Population; Stage (stratigraphy); Radiology; Cost effectiveness; PET-CT; Nuclear medicine; Lymphoma; Internal medicine; Cancer; Prostate cancer","score_opus":0.04177713140266349,"score_gpt":0.3499430837749652,"score_spread":0.3081659523723017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094390359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932114,0.00057602057,0.0020588776,0.00246007,0.0006929369,0.00040969692,0.00006755563,0.000020032845,0.0005034208],"genre_scores_gemma":[0.9967957,0.00061280484,0.0009740876,0.00095348933,0.0005159359,0.00002531944,0.00009189892,0.000021535345,0.000009188464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982527,0.00032397622,0.00072090694,0.0002239063,0.00028746857,0.00019107157],"domain_scores_gemma":[0.99775934,0.0006739221,0.00080888416,0.000115259645,0.0004896108,0.00015296551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103134,0.00018694322,0.00064755545,0.0001685133,0.000027363347,0.000014049084,0.00023755369,0.000048533657,0.000048417598],"category_scores_gemma":[0.0003938164,0.0001603626,0.00028186812,0.00023732649,0.00010187762,0.00019398771,0.000058294998,0.00018178162,0.000015723825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010848832,0.0013475951,0.8998595,0.000046469355,0.0008644213,0.0016568037,0.00031254702,0.0017036069,0.0041135503,0.0062965904,0.00015570552,0.08255834],"study_design_scores_gemma":[0.048582837,0.004264897,0.8325733,0.00052802,0.00044017695,0.0011971561,0.00039667144,0.008797324,0.05916765,0.0024123224,0.041233838,0.00040582567],"about_ca_topic_score_codex":0.000047257792,"about_ca_topic_score_gemma":0.000002394064,"teacher_disagreement_score":0.082152516,"about_ca_system_score_codex":0.0011324285,"about_ca_system_score_gemma":0.00060643064,"threshold_uncertainty_score":0.6539397},"labels":[],"label_agreement":null},{"id":"W3094506760","doi":"10.1016/j.ijrobp.2020.07.2308","title":"Impact of Early PET Response and Use of Radiotherapy on Patterns of Relapse in Early-Stage, Low-Risk Pediatric Hodgkin Lymphoma: Secondary Analysis of COG AHOD 0431","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Positron emission tomography; Radiation therapy; Stage (stratigraphy); Internal medicine; Oncology; Hodgkin's lymphoma; Nuclear medicine; Lymphoma","score_opus":0.020326988436269733,"score_gpt":0.3297598906284108,"score_spread":0.3094329021921411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094506760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741167,0.00049803325,0.0003725626,0.0003574345,0.000165126,0.00021270942,0.0009642285,0.000005497824,0.0000127516405],"genre_scores_gemma":[0.9957245,0.0031049482,0.0007340213,0.00014477133,0.00019991842,0.00000466,0.00006071051,0.00001988658,0.0000066106895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744695,0.0005512319,0.00127369,0.0002313624,0.00034131922,0.00015544938],"domain_scores_gemma":[0.9948056,0.0016475704,0.0025950854,0.00018123261,0.0006327231,0.00013783875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669915,0.00021122908,0.0011362201,0.0007454657,0.000016435562,0.000008701468,0.00019802434,0.00016545694,0.000071370545],"category_scores_gemma":[0.00056359934,0.00017171261,0.0005603127,0.00054127444,0.00014437665,0.00020974339,0.000039106122,0.00021582565,8.745656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00986598,0.0017351002,0.9624718,0.000028723423,0.004507014,0.00009446301,0.0016526483,0.0023870796,0.0027925374,0.00018631491,0.00006455487,0.014213802],"study_design_scores_gemma":[0.012781084,0.0083535975,0.97348523,0.000061009974,0.0010622498,0.000023761038,0.000046796562,0.0014590435,0.002494953,0.00006486355,0.00006485436,0.00010258139],"about_ca_topic_score_codex":0.0005809719,"about_ca_topic_score_gemma":0.000013812985,"teacher_disagreement_score":0.014111221,"about_ca_system_score_codex":0.00048845424,"about_ca_system_score_gemma":0.00074438157,"threshold_uncertainty_score":0.70022374},"labels":[],"label_agreement":null},{"id":"W3094528257","doi":"10.1016/j.ijrobp.2020.07.2307","title":"The Value of Central Review of Deauville Scores for Response Adapted Treatment Protocols for Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Nuclear medicine; Clinical trial; Hodgkin lymphoma; Radiology; Randomized controlled trial; Chemotherapy; Clinical endpoint; Oncology; Internal medicine","score_opus":0.04602770984660888,"score_gpt":0.3784502067725964,"score_spread":0.3324224969259875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094528257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8025426,0.026157448,0.021865454,0.10565908,0.0023832496,0.038960412,0.0020505178,0.00006364449,0.0003175737],"genre_scores_gemma":[0.9744198,0.010290558,0.008454258,0.0023615637,0.0014466244,0.0027876364,0.00017554928,0.000036237623,0.000027825618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823165,0.00023448205,0.0009602587,0.00016479022,0.00022182066,0.00018701708],"domain_scores_gemma":[0.9954834,0.0017667862,0.001469156,0.00013564361,0.0010245201,0.00012050415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055761036,0.00016765154,0.000659276,0.00005104038,0.00005930781,0.000008347179,0.00024691178,0.00010484425,0.000015212756],"category_scores_gemma":[0.0013340665,0.00010565468,0.00051033247,0.000100131445,0.00013237161,0.00007234703,0.000025086058,0.000051673556,0.000001516948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040015705,0.0039239125,0.112166844,0.00076330046,0.0048103826,0.00003144397,0.0009459582,0.0003128018,0.010121789,0.036921017,0.009336504,0.7806503],"study_design_scores_gemma":[0.059771605,0.03945984,0.084059134,0.0032559023,0.0013992765,0.00016927283,0.00015006308,0.0041530975,0.10938664,0.004598214,0.693287,0.00030995838],"about_ca_topic_score_codex":0.000010749942,"about_ca_topic_score_gemma":0.0000015366776,"teacher_disagreement_score":0.7803404,"about_ca_system_score_codex":0.0007439866,"about_ca_system_score_gemma":0.0012649037,"threshold_uncertainty_score":0.4308473},"labels":[],"label_agreement":null},{"id":"W3094659087","doi":"10.1182/blood.v130.suppl_1.4705.4705","title":"Economic Burden in US Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Brentuximab Vedotin or Chemotherapy after Failure of Autologous Hematopoietic Cell Transplantation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Cohort; Internal medicine; Oncology; Transplantation; Anaplastic large-cell lymphoma; Salvage therapy; Chemotherapy; Lymphoma; Surgery; Hodgkin lymphoma","score_opus":0.006104071765334962,"score_gpt":0.22062061463429947,"score_spread":0.21451654286896452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094659087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985762,0.000052065698,0.0000022736028,0.0002873844,0.000023566201,0.0006965077,0.000055244636,0.000031699255,0.00027506065],"genre_scores_gemma":[0.99873203,0.00008498353,0.0006011593,0.000051515755,0.000034598645,0.00014246273,0.0000675001,0.00004376991,0.00024196011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988203,0.000038129372,0.00031999472,0.00037652501,0.00019000503,0.00025504234],"domain_scores_gemma":[0.999012,0.00006458665,0.00027269014,0.0005000625,0.000044398323,0.00010625272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004245766,0.00026652502,0.00054088933,0.000095095915,0.000060052083,0.000031024716,0.000114839815,0.00015087913,0.00014803704],"category_scores_gemma":[0.0000072837006,0.00015067772,0.00006338543,0.000050921655,0.00012233548,0.00011469784,0.000010862712,0.00006471843,0.000018421422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014270463,0.0055024284,0.97441286,0.00021003587,0.0002431609,0.0010203264,0.0006557171,0.0000031892148,0.00018027374,0.0000026928155,0.000038078906,0.0034608003],"study_design_scores_gemma":[0.07664234,0.0039565694,0.9026961,0.00045858586,0.0005383665,0.00012127871,0.000042934924,0.000014828058,0.0152055845,0.0000017304641,0.00013369974,0.00018801316],"about_ca_topic_score_codex":0.0003518327,"about_ca_topic_score_gemma":0.0009625243,"teacher_disagreement_score":0.07171676,"about_ca_system_score_codex":0.00015750059,"about_ca_system_score_gemma":0.00026949626,"threshold_uncertainty_score":0.6144459},"labels":[],"label_agreement":null},{"id":"W3094771674","doi":"10.1182/blood-2020-137541","title":"Generalizability of Landmark Clinical Trials in Diffuse Large B Cell Lymphoma to Real-World Patients: A Single-Centre Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Clinical trial; Internal medicine; Vincristine; CHOP; Prednisone; Oncology; Obinutuzumab; Retrospective cohort study; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.05990953475912904,"score_gpt":0.3462665462617078,"score_spread":0.28635701150257875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094771674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412936,0.000049734048,0.0000016838734,0.0006093401,0.00011319416,0.0034645887,0.00015542514,0.000040093375,0.0014365664],"genre_scores_gemma":[0.9987284,0.000030204186,0.00017981627,0.0006147237,0.00016217133,0.00011787068,0.00005997778,0.00002379906,0.00008303831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627346,0.0009807677,0.0014045415,0.0006229587,0.0004300185,0.00028823994],"domain_scores_gemma":[0.99819094,0.0005212248,0.00031622098,0.00044488272,0.00017213594,0.00035461294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018242372,0.00021966596,0.0015694252,0.00008699113,0.000029077843,0.0000142089475,0.00009937591,0.0000853466,0.00007365073],"category_scores_gemma":[0.0023659237,0.0001668294,0.00029746108,0.0004598878,0.000026411919,0.00003454516,0.00010712557,0.000071334405,0.00002437352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071230513,0.17657225,0.8199103,0.00003753897,0.0002819524,0.00008201043,0.00079636753,1.6823074e-7,0.00004198376,0.0000141256,0.0012550957,0.00029594667],"study_design_scores_gemma":[0.10231708,0.00303367,0.8920206,0.000044396806,0.0007624295,2.7644373e-7,0.00013914944,0.000007842558,0.0012180804,0.000007928209,0.00032340843,0.00012513506],"about_ca_topic_score_codex":0.00060863566,"about_ca_topic_score_gemma":0.001012978,"teacher_disagreement_score":0.17353858,"about_ca_system_score_codex":0.00025341936,"about_ca_system_score_gemma":0.00010618484,"threshold_uncertainty_score":0.68031055},"labels":[],"label_agreement":null},{"id":"W3094818118","doi":"10.1182/blood-2020-136356","title":"Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Retrospective cohort study; Cohort; Oncology; Lymphoma; Hodgkin lymphoma","score_opus":0.007622796488313747,"score_gpt":0.2232466161384331,"score_spread":0.21562381965011937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094818118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299985,0.00021599744,0.000004852646,0.0005487979,0.00007850642,0.005217304,0.00085815764,0.000037168236,0.00003935777],"genre_scores_gemma":[0.9965526,0.000016249334,0.00023578382,0.00048467566,0.000098452976,0.0023201245,0.00020078014,0.000053586784,0.00003777573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998492,0.000030783438,0.00022164645,0.0006157165,0.00027889383,0.0003609567],"domain_scores_gemma":[0.9986994,0.00011673512,0.00008188782,0.00022220692,0.00014603707,0.0007337264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008875843,0.00029336746,0.0005832294,0.00006838966,0.00013636728,0.000049225255,0.00005112483,0.00006526156,0.000007794698],"category_scores_gemma":[0.00020659121,0.00021157748,0.00008907366,0.00008911565,0.0000660473,0.00007753606,0.00003475197,0.00004524958,0.000001364568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012763218,0.0039610816,0.9908615,0.00010460462,0.00087450154,0.00019676186,0.0008346271,7.13231e-8,5.408413e-7,0.0000192611,0.00009972221,0.0017710573],"study_design_scores_gemma":[0.052260134,0.005880066,0.9391071,0.000045529065,0.0018441993,0.0000034989266,0.00021064225,0.000018027122,0.0000101396245,0.00001349985,0.00040008943,0.0002070819],"about_ca_topic_score_codex":0.0044488134,"about_ca_topic_score_gemma":0.03143677,"teacher_disagreement_score":0.051754355,"about_ca_system_score_codex":0.00019214647,"about_ca_system_score_gemma":0.0002663252,"threshold_uncertainty_score":0.986237},"labels":[],"label_agreement":null},{"id":"W3095131012","doi":"10.1182/blood-2020-138848","title":"Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Epoch (astronomy); Lymphoma; Internal medicine; Regimen; Oncology; Surgery","score_opus":0.07029184088477827,"score_gpt":0.2961280615567769,"score_spread":0.22583622067199863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095131012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890519,0.00019361866,0.0000017074248,0.0022503193,0.000052463278,0.00030881676,0.000010862352,0.000070206435,0.0080601135],"genre_scores_gemma":[0.9979953,0.000022109332,0.0007453052,0.000638359,0.00008527219,0.000023297143,0.000013199291,0.000015211005,0.00046191973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903643,0.000018202214,0.0003047414,0.00023692497,0.00022200133,0.00018168891],"domain_scores_gemma":[0.9993644,0.000049579612,0.00009461721,0.00023442727,0.000053110565,0.0002039142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023425804,0.00013015447,0.00033820368,0.000040336057,0.000020721543,0.000008319369,0.00006868538,0.000039422317,0.00023472642],"category_scores_gemma":[0.00007903878,0.000101247984,0.0001134034,0.0002602989,0.00004253666,0.00003497721,0.00004244373,0.000043468484,0.00005763233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000883037,0.0028348893,0.9814513,0.00010307664,0.00013397295,0.00033561254,0.00239654,6.0018584e-7,0.010850599,0.0004149494,0.00044543343,0.00094474346],"study_design_scores_gemma":[0.01651024,0.00091944117,0.7431918,0.00019233998,0.00077030977,0.000030005802,0.00079195696,0.000037544545,0.23252085,0.00001622659,0.00479006,0.00022923065],"about_ca_topic_score_codex":0.00017427906,"about_ca_topic_score_gemma":0.000050512128,"teacher_disagreement_score":0.2382595,"about_ca_system_score_codex":0.000037842223,"about_ca_system_score_gemma":0.000040414452,"threshold_uncertainty_score":0.41287732},"labels":[],"label_agreement":null},{"id":"W3095139603","doi":"10.1182/blood-2020-134867","title":"Lymphoma Microenvironment Deconvolution Links M1 Macrophage Infiltration to Clinical Outcome in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tumor microenvironment; Antibody-dependent cell-mediated cytotoxicity; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; CD20; CHOP; Immune system; Medicine; Immunology; Biology; Antibody; Monoclonal antibody","score_opus":0.028133248983853488,"score_gpt":0.29200754168625337,"score_spread":0.26387429270239987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095139603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947376,0.0006034078,0.00009960589,0.0028826857,0.00016674989,0.00084301236,0.00004799098,0.00007412457,0.0005448043],"genre_scores_gemma":[0.98966414,0.00026177216,0.0012550256,0.008096039,0.0003130951,0.00011084331,0.00009869655,0.000037558122,0.0001628066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977558,0.00009741967,0.00083904166,0.00058684783,0.0002870188,0.000433857],"domain_scores_gemma":[0.9988518,0.00009154595,0.00012967848,0.00037780867,0.000023086215,0.0005261306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021864501,0.0002725191,0.0005266261,0.00008678087,0.000063308085,0.000032160617,0.000119194345,0.00029854832,0.00008290234],"category_scores_gemma":[0.00012562658,0.00024357252,0.00022331398,0.00021004454,0.000033431377,0.00007754273,0.00011269204,0.00011302778,0.00094589376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023790511,0.03588982,0.9506979,0.00006684345,0.000085041655,0.0005939112,0.00036885086,0.000002128707,0.0023153347,0.00004035863,0.00058269344,0.009119212],"study_design_scores_gemma":[0.0800451,0.0011026328,0.8904167,0.00004889194,0.0002714859,0.000038392587,0.00007714122,0.00015390402,0.016137905,0.0000061530905,0.01147445,0.00022728097],"about_ca_topic_score_codex":0.00005756629,"about_ca_topic_score_gemma":0.0000331023,"teacher_disagreement_score":0.07980719,"about_ca_system_score_codex":0.00026249106,"about_ca_system_score_gemma":0.00009862612,"threshold_uncertainty_score":0.999832},"labels":[],"label_agreement":null},{"id":"W3095175361","doi":"10.1182/blood-2020-142275","title":"Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Gemcitabine; Internal medicine; Regimen; Febrile neutropenia; Phases of clinical research; Diffuse large B-cell lymphoma; Rituximab; Refractory (planetary science); Progressive disease; Salvage therapy; Oncology; Gastroenterology; Surgery; Dexamethasone; Lymphoma; Clinical trial; Chemotherapy; Materials science","score_opus":0.01719857402912654,"score_gpt":0.2624839824502298,"score_spread":0.24528540842110327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095175361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957502,0.0006080328,0.00014630698,0.00038364955,0.000031567786,0.0026185738,0.0003166819,0.000032904998,0.000112107526],"genre_scores_gemma":[0.9984671,0.00029089954,0.00022624014,0.00007752397,0.000028068014,0.00042893933,0.00031937196,0.000039464037,0.00012239115],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827003,0.00006848168,0.00063563837,0.00041310262,0.0003200039,0.00029272403],"domain_scores_gemma":[0.9989876,0.00016358442,0.000321478,0.00026788792,0.00011348172,0.0001459535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011533378,0.0002892615,0.00079525186,0.0001197445,0.00006214908,0.000007870928,0.000076239514,0.0000903688,0.0000084342655],"category_scores_gemma":[0.00002680731,0.00020925733,0.0001633506,0.0002593487,0.000031195254,0.00010370256,0.000011923101,0.0000295367,0.0000017581108],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01908583,0.72827893,0.17466931,0.00043758965,0.0009126772,0.00022947608,0.008986597,0.000011630751,0.06415312,0.00008692405,0.00063010736,0.0025177994],"study_design_scores_gemma":[0.6889549,0.05436523,0.012172158,0.00023306246,0.0015991143,0.000011061178,0.00079974683,0.0002981089,0.24075851,0.000010780928,0.0005874458,0.00020991667],"about_ca_topic_score_codex":0.00029241832,"about_ca_topic_score_gemma":0.00014583,"teacher_disagreement_score":0.6739137,"about_ca_system_score_codex":0.00015905304,"about_ca_system_score_gemma":0.00012279162,"threshold_uncertainty_score":0.8533266},"labels":[],"label_agreement":null},{"id":"W3095288097","doi":"10.1182/blood.2020007193","title":"Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Terry Fox Research Institute; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"BCL6; Biology; Copy-number variation; Gene duplication; Immunohistochemistry; Fluorescence in situ hybridization; Lymphoma; Cancer research; Gene dosage; Gene rearrangement; Genetics; Gene; Molecular biology; Gene expression; B cell; Antibody; Chromosome; Immunology; Genome","score_opus":0.014231407451181812,"score_gpt":0.26721038208986075,"score_spread":0.25297897463867897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095288097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991049,0.0002940786,0.000008070603,0.00013501314,0.000010093018,0.00024266593,0.00009780831,0.0000046490404,0.00010269149],"genre_scores_gemma":[0.99910384,0.000044570646,0.0007760435,0.00004288767,0.000009245096,0.000005531708,0.0000070811893,0.000008320504,0.000002459612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930716,0.00004133859,0.00026147158,0.00016996205,0.000102476806,0.000117588745],"domain_scores_gemma":[0.99952346,0.00009795933,0.0001419562,0.000101520665,0.000041656076,0.00009344795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057917016,0.000113027345,0.00049101474,0.000061677165,0.00000906929,0.0000018872803,0.000033232558,0.000055176115,0.000045305027],"category_scores_gemma":[0.000113691036,0.00008045537,0.00005447322,0.000115677525,0.00010061538,0.000031775995,0.000044702094,0.000043884877,4.7423305e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036652715,0.00094290136,0.8541816,0.00019679566,0.000547777,0.00022965703,0.0020872403,0.000003184888,0.13843048,0.0018223706,0.000014677432,0.0011768102],"study_design_scores_gemma":[0.009729903,0.0016858878,0.8334764,0.00007811321,0.00019179916,0.000095975956,0.00019059576,0.000048303627,0.15312475,0.0013273009,1.4732531e-7,0.000050791474],"about_ca_topic_score_codex":0.0005900508,"about_ca_topic_score_gemma":0.0000110424035,"teacher_disagreement_score":0.020705154,"about_ca_system_score_codex":0.000014440394,"about_ca_system_score_gemma":0.00006486926,"threshold_uncertainty_score":0.32808748},"labels":[],"label_agreement":null},{"id":"W3095898239","doi":"10.1182/blood-2020-136457","title":"Rituximab Monotherapy Compared to Observation in Patients with Newly Diagnosed Asymptomatic Advanced Stage Follicular Lymphoma: A Retrospective Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Asymptomatic; Internal medicine; Follicular lymphoma; Population; Cohort; Clinical endpoint; Pediatrics; Lymphoma; Clinical trial; Surgery; Oncology","score_opus":0.010369969872694278,"score_gpt":0.23586021938761412,"score_spread":0.22549024951491983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095898239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705535,0.00006439659,0.00043337245,0.0007302061,0.000014693032,0.0015173395,0.00006873974,0.00009050485,0.000025395293],"genre_scores_gemma":[0.9904326,0.0000036491408,0.006993783,0.0015523277,0.000021478882,0.000293567,0.0006641938,0.00003068721,0.000007718356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983911,0.00005280731,0.00037114116,0.0004756649,0.00046869137,0.00024062481],"domain_scores_gemma":[0.99907917,0.0000727616,0.00015737109,0.00033063957,0.00014300228,0.00021703479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004860443,0.00024570405,0.0007211232,0.00021642029,0.00005766695,0.000032359294,0.000076562304,0.000058222853,0.000027046939],"category_scores_gemma":[0.00008677437,0.00020000627,0.00015015661,0.001605331,0.00001070049,0.00010649811,0.000012484882,0.000039071525,0.00002655723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007070279,0.005677572,0.98760206,0.000031040203,0.0008759372,0.00005813071,0.0003755077,0.003820519,0.000030464127,0.000019910076,0.000009988205,0.00079183397],"study_design_scores_gemma":[0.07527193,0.0009899351,0.91820365,0.000083043844,0.0010206185,1.4546386e-7,0.000045019802,0.003682473,0.00048270824,0.0000049473374,0.000019681393,0.00019582048],"about_ca_topic_score_codex":0.0009386975,"about_ca_topic_score_gemma":0.0003967707,"teacher_disagreement_score":0.0745649,"about_ca_system_score_codex":0.000372609,"about_ca_system_score_gemma":0.00008301209,"threshold_uncertainty_score":0.8156019},"labels":[],"label_agreement":null},{"id":"W3096271945","doi":"10.4081/monaldi.2020.1459","title":"Multiple pulmonary nodules presenting a difficult diagnostic challenge","year":2020,"lang":"en","type":"article","venue":"Monaldi Archives for Chest Disease","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Christie (Canada)","funders":"","keywords":"Medicine; Anaplastic lymphoma kinase; ARDS; Autopsy; Anaplastic large-cell lymphoma; Granulomatosis with polyangiitis; Respiratory failure; Lymphoma; Oxygen therapy; Diffuse alveolar hemorrhage; Internal medicine; Lung; Pathology; Vasculitis; Lung cancer; Disease","score_opus":0.030162871776021536,"score_gpt":0.2523279926427473,"score_spread":0.22216512086672577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096271945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737634,0.0031790603,0.00022858041,0.019195033,0.00006620345,0.0017229961,0.00051439536,0.00019381502,0.001136504],"genre_scores_gemma":[0.995597,0.00037602516,0.0010161118,0.0007391787,0.0004884158,0.0009260332,0.00064823974,0.000050454903,0.00015855096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985311,0.000030944168,0.00026038106,0.00054994767,0.00023004677,0.00039754852],"domain_scores_gemma":[0.9974274,0.0012188554,0.00007374538,0.00027977632,0.000031868865,0.00096836215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022365908,0.0002689744,0.00032651922,0.000048172802,0.00015794308,0.00002829266,0.00012811957,0.000031469277,0.000031093226],"category_scores_gemma":[0.0012846547,0.00021770879,0.0003520376,0.000093553164,0.000112816335,0.00007295252,0.00011429475,0.000079638085,0.00004547797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027278773,0.007885027,0.9192462,0.0025478827,0.0005117951,0.0027582422,0.0023995219,0.0001485631,0.0019515788,0.0008574283,0.0017674135,0.057198457],"study_design_scores_gemma":[0.0033848442,0.00030851684,0.9625606,0.00019350527,0.00048100844,0.000010155748,0.00014832591,0.02121255,0.00062788633,0.00061451277,0.010183246,0.0002748448],"about_ca_topic_score_codex":0.000009425769,"about_ca_topic_score_gemma":0.000001961977,"teacher_disagreement_score":0.056923613,"about_ca_system_score_codex":0.000025742447,"about_ca_system_score_gemma":0.0000695683,"threshold_uncertainty_score":0.8877907},"labels":[],"label_agreement":null},{"id":"W3096309541","doi":"10.1182/blood-2020-139416","title":"Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Quality of life (healthcare); Lymphoma; Randomized controlled trial; Hodgkin lymphoma; Cancer; Immunotherapy; Biology","score_opus":0.029197509740673918,"score_gpt":0.32031984127558516,"score_spread":0.29112233153491124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096309541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926796,0.0013432,0.0000014349125,0.001522633,0.00008111314,0.0040708194,0.00004528961,0.0000541246,0.00020176325],"genre_scores_gemma":[0.9989285,0.00008353084,0.000008288224,0.00045856577,0.000039725863,0.0003583784,0.00006871569,0.00004860933,0.0000057253787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924069,0.0041173957,0.0015640785,0.000574558,0.0009067081,0.00043033343],"domain_scores_gemma":[0.9933514,0.0049180486,0.0008957632,0.00053201016,0.0000726873,0.00023009369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025153568,0.0004489053,0.002592411,0.0001936824,0.000055074615,0.000014895317,0.0002327554,0.00020406778,0.000026376772],"category_scores_gemma":[0.0017843196,0.00026703818,0.00035877895,0.00076394895,0.00019626452,0.000047286376,0.000034470173,0.00031668768,0.0000073309925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77495503,0.08115942,0.124544725,0.00021419096,0.002876011,0.00028266048,0.007256138,0.00003988972,0.00017446125,0.000105926774,0.00008250982,0.008309024],"study_design_scores_gemma":[0.82286745,0.041626267,0.132422,0.00036039666,0.0006425291,0.0000042722468,0.0003958583,0.00022224423,0.0012577674,0.000004221922,0.0000077126015,0.00018926352],"about_ca_topic_score_codex":0.0011967189,"about_ca_topic_score_gemma":0.00025044032,"teacher_disagreement_score":0.047912415,"about_ca_system_score_codex":0.00033970055,"about_ca_system_score_gemma":0.000483053,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W3096617937","doi":"10.1182/blood-2020-137700","title":"<i>Nfkbiz</i> 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Untranslated region; Biology; Diffuse large B-cell lymphoma; Three prime untranslated region; Mutation; Gene; Genetics; CRISPR; Cancer research; Molecular biology; Messenger RNA","score_opus":0.007595140182971929,"score_gpt":0.23904505350470087,"score_spread":0.23144991332172896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096617937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408287,0.0010103454,0.000009088203,0.0023321467,0.000023138258,0.0005984066,0.00008244074,0.00007344162,0.0017881017],"genre_scores_gemma":[0.9975589,0.00018880221,0.00019371968,0.0016793362,0.00005055026,0.00011571582,0.000044527264,0.00002903124,0.0001394387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988433,0.00015058435,0.00019385901,0.00036507222,0.00016687914,0.00028028377],"domain_scores_gemma":[0.9991339,0.00037553816,0.000052864532,0.00014549636,0.00005222321,0.0002400081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013727146,0.00019567675,0.0003248569,0.0000888582,0.00007045987,0.000025690624,0.000047470116,0.000062789775,0.000018654733],"category_scores_gemma":[0.0001826535,0.00016554425,0.00007346114,0.0002660088,0.00004068921,0.00008351969,0.000049324204,0.000072389106,0.00005375786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005867852,0.058760855,0.8941554,0.0003328768,0.00044049107,0.004461735,0.01236184,4.988717e-7,0.019530892,0.00090318784,0.0025191414,0.00066523015],"study_design_scores_gemma":[0.15801829,0.0015596264,0.6650367,0.000116854775,0.00066409487,0.00014997003,0.001096521,0.000102439735,0.17097943,0.00007105666,0.0018730981,0.00033195014],"about_ca_topic_score_codex":0.000053389223,"about_ca_topic_score_gemma":0.000029776143,"teacher_disagreement_score":0.22911872,"about_ca_system_score_codex":0.000069491674,"about_ca_system_score_gemma":0.00015326074,"threshold_uncertainty_score":0.6750698},"labels":[],"label_agreement":null},{"id":"W3096799668","doi":"10.1182/blood-2020-142871","title":"The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Queen's University; Jewish General Hospital","funders":"","keywords":"Diffuse large B-cell lymphoma; Exome sequencing; Exome; Copy-number variation; Medicine; Oncology; Lymphoma; Internal medicine; Cohort; CHOP; Copy number analysis; Biology; Mutation; Genetics; Genome; Gene","score_opus":0.009048029076662474,"score_gpt":0.2285128186527416,"score_spread":0.21946478957607912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096799668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797214,0.0023779278,0.0000010175632,0.0013703913,0.00003458687,0.00016766264,0.000019648047,0.000027362421,0.008029276],"genre_scores_gemma":[0.99790263,0.0010577333,0.00008434736,0.0005795938,0.00007638145,0.000016455548,0.000012422333,0.000013973404,0.00025644412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937,0.000024466157,0.00015525079,0.00015540824,0.00014751503,0.00014738657],"domain_scores_gemma":[0.9994458,0.00013274833,0.00006527753,0.00019203198,0.000031008774,0.00013313117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055090582,0.00009759507,0.00019256561,0.000008755592,0.000066001296,0.000011927373,0.000046876212,0.00005226846,0.000050405837],"category_scores_gemma":[0.000048938844,0.00005785169,0.000060877403,0.000068791116,0.000034071465,0.000022886514,0.000040832332,0.000034639997,0.00005629533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030859004,0.012840982,0.9705835,0.00011697713,0.00027511365,0.00018676415,0.0009119474,1.9873445e-8,0.0016535671,0.00051661837,0.010243657,0.0023622909],"study_design_scores_gemma":[0.19238397,0.0016940673,0.5500547,0.0001290189,0.0014325783,0.00013040332,0.00080541725,0.000060552942,0.087556936,0.00007004886,0.16538183,0.0003004633],"about_ca_topic_score_codex":0.000011380549,"about_ca_topic_score_gemma":0.0000031512766,"teacher_disagreement_score":0.42052877,"about_ca_system_score_codex":0.000009247285,"about_ca_system_score_gemma":0.000047957285,"threshold_uncertainty_score":0.23591234},"labels":[],"label_agreement":null},{"id":"W3096819820","doi":"10.7759/cureus.11287","title":"Nasal Lymphoma Presenting With Contralateral Proptosis and Vision Changes: A Case Report and Literature Review","year":2020,"lang":"en","type":"article","venue":"Cureus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Malignancy; Orbit (dynamics); Radiology; Paranasal sinuses; Diffuse large B-cell lymphoma; Nose; Positron emission tomography; Surgery; Pathology","score_opus":0.01634012123646765,"score_gpt":0.2906182190812626,"score_spread":0.27427809784479495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096819820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.881764,0.10670715,0.0000018261833,0.010463517,0.000024097748,0.0007253799,0.0000103850025,0.000043301214,0.00026037497],"genre_scores_gemma":[0.9786137,0.018308016,0.0004239068,0.0022763659,0.00014158325,0.00007851306,0.00004209369,0.000016790795,0.00009907093],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99919766,0.000023185394,0.00015703354,0.00033039134,0.00013256307,0.00015917455],"domain_scores_gemma":[0.9994317,0.000022819264,0.000080918326,0.00016275965,0.0000718774,0.00022990581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006549476,0.00015698274,0.0003188483,0.000014929898,0.00006747949,0.00006009752,0.000018739775,0.000053928445,0.0000144689275],"category_scores_gemma":[0.000065491564,0.000094492665,0.000029825753,0.00010889191,0.000039158367,0.00009396812,0.000045486737,0.00004319094,0.0000013671208],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033198678,0.00041982898,0.20005843,0.0065007545,0.0004612752,0.75265545,0.003938607,6.081038e-8,0.00039234513,0.0000643255,0.0064589567,0.028718004],"study_design_scores_gemma":[0.012633826,0.00386543,0.105112545,0.018007783,0.0017983128,0.8249322,0.00029912838,0.00031547595,0.0024793511,0.0000141484525,0.029960334,0.0005814602],"about_ca_topic_score_codex":0.000041473475,"about_ca_topic_score_gemma":0.000013965812,"teacher_disagreement_score":0.09684969,"about_ca_system_score_codex":0.000028402346,"about_ca_system_score_gemma":0.00003161543,"threshold_uncertainty_score":0.3853299},"labels":[],"label_agreement":null},{"id":"W3097004036","doi":"10.1158/1078-0432.ccr-20-2558","title":"Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centro de Investigación Biomédica en Red de Cáncer; Ministerio de Ciencia e Innovación; Canadian Institutes of Health Research; Generalitat de Catalunya","keywords":"Lymphoma; DNA; Population; Cell; Circulating tumor DNA; Cancer research; Biology; Cancer; Medicine; Computational biology; Genetics; Immunology; Environmental health","score_opus":0.09376157918107385,"score_gpt":0.4439612368853415,"score_spread":0.35019965770426764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097004036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908058,0.0008968315,0.0000012783217,0.006737225,0.000038662565,0.0011130391,0.00010012278,0.000019000016,0.00028803732],"genre_scores_gemma":[0.99813884,0.00008255323,0.000040833766,0.0008830154,0.00017632754,0.0004564585,0.00011118586,0.000024486342,0.00008630075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972217,0.00045865847,0.0005883538,0.0005757601,0.00074973766,0.00040578863],"domain_scores_gemma":[0.99757814,0.0015900098,0.00006724898,0.0002906423,0.00011953517,0.0003544435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011029685,0.00014603575,0.00045316172,0.00014528289,0.00006656262,0.000047771762,0.00016875571,0.00009120301,0.00020731748],"category_scores_gemma":[0.00086548773,0.000120334844,0.00006743086,0.0005379169,0.000049791743,0.00005454513,0.00013598405,0.00028520354,0.000025350986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009474004,0.016981246,0.97682244,0.00009854509,0.000021045624,0.0005425404,0.00027769117,0.0000076022425,0.000046499026,0.0000070895258,0.003315307,0.00093261077],"study_design_scores_gemma":[0.08410899,0.0011604115,0.91035664,0.00006520414,0.000026313892,6.942742e-7,0.000496021,0.0028747583,0.00013755933,0.000030291676,0.0006344915,0.00010862557],"about_ca_topic_score_codex":0.0024520524,"about_ca_topic_score_gemma":0.0012849318,"teacher_disagreement_score":0.08316159,"about_ca_system_score_codex":0.0002595894,"about_ca_system_score_gemma":0.0006386708,"threshold_uncertainty_score":0.49071127},"labels":[],"label_agreement":null},{"id":"W3097024120","doi":"10.1182/blood-2020-134985","title":"The Burkitt Lymphoma International Prognostic Index (BL-IPI)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"International Prognostic Index; Medicine; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Oncology; Lactate dehydrogenase; Censoring (clinical trials); Diffuse large B-cell lymphoma; Gastroenterology; Lymphoma; Pathology; Biology","score_opus":0.014450286184508835,"score_gpt":0.24135457275990724,"score_spread":0.2269042865753984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097024120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631294,0.0009814078,0.000015718535,0.02252035,0.00022700448,0.00036937563,0.000009946587,0.00009022344,0.012656587],"genre_scores_gemma":[0.9972369,0.00014960817,0.00008994657,0.0016956889,0.00044550057,0.0000794244,0.000021394213,0.000013024502,0.00026851756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923855,0.000015354044,0.00014851103,0.00018020479,0.00026105053,0.00015631109],"domain_scores_gemma":[0.99950176,0.00010762942,0.00004334057,0.00015105624,0.000056368735,0.00013981736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045582514,0.00010122473,0.00011878926,0.000016605576,0.000083610954,0.00004580774,0.00011774716,0.00003854708,0.00007876628],"category_scores_gemma":[0.00017516607,0.00006110829,0.00008021808,0.00009055884,0.00003894243,0.00003099998,0.000058219535,0.000035763678,0.00022107044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116831885,0.001544359,0.9576906,0.000017733395,0.00059909374,0.00038801302,0.00028992427,0.0000011245129,0.00016640344,0.0013814628,0.004929038,0.032875396],"study_design_scores_gemma":[0.010145639,0.00039592266,0.8892417,0.000048806785,0.0003164931,0.00014494409,0.00010409032,0.00025683982,0.0041880705,0.00010718499,0.094942756,0.00010754414],"about_ca_topic_score_codex":0.00002011457,"about_ca_topic_score_gemma":0.0000041187177,"teacher_disagreement_score":0.09001372,"about_ca_system_score_codex":0.000036162186,"about_ca_system_score_gemma":0.00009261397,"threshold_uncertainty_score":0.28414872},"labels":[],"label_agreement":null},{"id":"W3097146628","doi":"10.1182/blood-2020-139654","title":"Retrospective Review of Treatment Patterns and Outcomes of DLBCL in the Very Elderly: A Single Centre Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; International Prognostic Index; Chemotherapy regimen; Internal medicine; Diffuse large B-cell lymphoma; Comorbidity; Regimen; Rituximab; Retrospective cohort study; Performance status; Cancer; Single Center; CHOP; Chemotherapy; Surgery; Lymphoma","score_opus":0.025383728692776532,"score_gpt":0.27346081392878546,"score_spread":0.24807708523600894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097146628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888397,0.007533167,4.0954507e-7,0.0028302309,0.000009402771,0.0003829853,0.000021959897,0.000005034533,0.00037713547],"genre_scores_gemma":[0.99365956,0.0055124923,0.000041630497,0.0007270154,0.000012067148,0.00003007933,0.0000055112673,0.0000042648917,0.000007358652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994556,0.000028638866,0.000181362,0.00013534863,0.00011949477,0.00007956091],"domain_scores_gemma":[0.99967253,0.000045158158,0.00007004029,0.00015045468,0.000023244658,0.000038564565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030097346,0.00008654835,0.00034440626,0.000013511586,0.000009455933,0.0000027353374,0.000035960125,0.000017974562,0.000031131],"category_scores_gemma":[0.000058777867,0.00004668784,0.00007104401,0.00008494404,0.000027580287,0.000019523246,0.000014960124,0.000019395671,0.0000011064807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012390423,0.0021554367,0.99036974,0.00046556664,0.00009683782,0.000052637995,0.0045187385,1.2829965e-8,0.00015642085,0.000040486128,0.00002885355,0.0021028698],"study_design_scores_gemma":[0.0045093754,0.001706071,0.98029613,0.0014067537,0.0003243251,0.000010799884,0.00092308345,8.021427e-7,0.010545784,0.0000052667956,0.00022703542,0.00004454883],"about_ca_topic_score_codex":0.00015890879,"about_ca_topic_score_gemma":0.00002506222,"teacher_disagreement_score":0.010389362,"about_ca_system_score_codex":0.00004126996,"about_ca_system_score_gemma":0.000025401365,"threshold_uncertainty_score":0.19038749},"labels":[],"label_agreement":null},{"id":"W3097206381","doi":"10.1182/blood-2020-137245","title":"Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Internal medicine; Oncology; Phases of clinical research; Lymphoma; Pharmacology; Clinical trial","score_opus":0.03580417620057491,"score_gpt":0.31022156095091213,"score_spread":0.2744173847503372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097206381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967749,0.00029681172,0.0000037028885,0.00068115635,0.000056446144,0.0020651056,0.00008231197,0.000031290554,0.0000082730885],"genre_scores_gemma":[0.9992186,0.000029552852,0.000115984585,0.0004404041,0.0000335075,0.0000648573,0.000048651433,0.000035038087,0.000013409574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977814,0.00031716176,0.0006466698,0.00040517867,0.00064563984,0.0002039569],"domain_scores_gemma":[0.9980951,0.0007208707,0.00028779331,0.0005734407,0.0001402639,0.00018251638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025367254,0.00025780746,0.0006929582,0.00012495245,0.00004653929,0.000016100646,0.00018322794,0.00006035025,0.00004751653],"category_scores_gemma":[0.00072139024,0.00013349146,0.00013160984,0.00056717,0.00003986727,0.00006142242,0.00006752243,0.00006546987,0.0000065250006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032563232,0.0510277,0.8984267,0.000012186825,0.0018107473,0.00023288142,0.008445306,0.000014310667,0.004007522,4.076844e-7,0.00006737487,0.0033916442],"study_design_scores_gemma":[0.1093922,0.030797228,0.84132147,0.00014924997,0.00076984963,7.9429066e-7,0.0010618579,0.0000025554823,0.01624492,5.8128387e-7,0.00014730326,0.000111969835],"about_ca_topic_score_codex":0.00040510023,"about_ca_topic_score_gemma":0.000041554096,"teacher_disagreement_score":0.076828964,"about_ca_system_score_codex":0.00009031752,"about_ca_system_score_gemma":0.00015089424,"threshold_uncertainty_score":0.54436237},"labels":[],"label_agreement":null},{"id":"W3097472105","doi":"10.1182/blood-2020-136422","title":"SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Chemotherapy regimen; Oncology; Regimen; Procarbazine; Vincristine; Nivolumab; Surgery; Chemotherapy; Cyclophosphamide; Lymphoma; Cancer; Hodgkin lymphoma","score_opus":0.014650634502101146,"score_gpt":0.2650438985331142,"score_spread":0.2503932640310131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097472105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269336,0.00030523379,0.00005749948,0.00029564992,0.00009522119,0.0061317,0.00009251462,0.00010550338,0.00022330409],"genre_scores_gemma":[0.9976522,0.00005234836,0.0005890036,0.00036123552,0.00007391385,0.00088495505,0.00013649049,0.00007538503,0.00017451443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962913,0.00030953094,0.0011006457,0.00083200843,0.0009068966,0.0005596256],"domain_scores_gemma":[0.99764466,0.00068643596,0.00046870657,0.00057726534,0.00017382218,0.00044909213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020752843,0.0005432609,0.0023810184,0.00018228873,0.00007970893,0.000036398378,0.00022294685,0.00013628487,0.00021692357],"category_scores_gemma":[0.0005704755,0.00036365053,0.00024841822,0.00062018994,0.00015008071,0.00015205146,0.00013248711,0.0001602509,0.000022731363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7335052,0.12858005,0.10359016,0.00026213133,0.0022151335,0.0036023045,0.0089000845,0.00017752993,0.0001017393,0.000051950225,0.0004369595,0.018576749],"study_design_scores_gemma":[0.9408189,0.014126621,0.039763715,0.000300171,0.0015442871,0.000008306443,0.0011748909,0.00082847325,0.00092508394,0.000004589722,0.00013590854,0.00036901937],"about_ca_topic_score_codex":0.00050926756,"about_ca_topic_score_gemma":0.00036797032,"teacher_disagreement_score":0.20731373,"about_ca_system_score_codex":0.00036389814,"about_ca_system_score_gemma":0.00070533674,"threshold_uncertainty_score":0.99988157},"labels":[],"label_agreement":null},{"id":"W3097502162","doi":"10.1182/blood-2020-134929","title":"Single Cell Profiling Reveals Unique CXCL13 Positive T Cell Subsets in the Tumor Microenvironment of Lymphocyte Rich Classic Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Terry Fox Research Institute; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Tumor microenvironment; Immune system; Tissue microarray; Immunophenotyping; Pathology; Reed–Sternberg cell; T cell; Lymphoma; Lymph node; Biology; Lymphocyte; B cell; Immunohistochemistry; Cancer research; Flow cytometry; Antibody; Medicine; Immunology","score_opus":0.01502497760786854,"score_gpt":0.21730260625462144,"score_spread":0.20227762864675292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097502162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128515,0.0023303544,0.0000070974393,0.0012063986,0.000030897612,0.0011122092,0.000060045735,0.000025801868,0.0039420505],"genre_scores_gemma":[0.9959193,0.00020831954,0.0013942126,0.0021160604,0.0000803523,0.000115683484,0.000063207764,0.000035840898,0.000067009816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820054,0.00019291001,0.00046934382,0.00043150687,0.00034694257,0.00035874988],"domain_scores_gemma":[0.99904454,0.00018348153,0.00022238251,0.00036456305,0.000034941277,0.00015009576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001854789,0.00027413398,0.00047384255,0.00006804293,0.000055491142,0.000020626863,0.0001847661,0.00008439569,0.000028877294],"category_scores_gemma":[0.000030172498,0.00019489316,0.0001488262,0.00029665785,0.00006483157,0.000049545546,0.00007655798,0.000080509555,0.00006132453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044267153,0.01719183,0.24963666,0.0005236901,0.00018468744,0.0021379162,0.004444246,0.00001430653,0.723168,0.00010140468,0.0006855031,0.0014690481],"study_design_scores_gemma":[0.011095168,0.0011068907,0.11094199,0.00015519428,0.0003881889,0.00009212309,0.000609219,0.000026917047,0.87505484,0.000017750339,0.0003448783,0.0001668109],"about_ca_topic_score_codex":0.00007835777,"about_ca_topic_score_gemma":0.0000054760126,"teacher_disagreement_score":0.15188682,"about_ca_system_score_codex":0.00027967832,"about_ca_system_score_gemma":0.00017331266,"threshold_uncertainty_score":0.7947512},"labels":[],"label_agreement":null},{"id":"W3097505417","doi":"10.1182/blood-2020-134398","title":"The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Health Sciences Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Brentuximab vedotin; CHOP; Vincristine; Prednisone; Population; Surgery; Chemotherapy regimen; Randomization; Gastroenterology; Phases of clinical research; Cyclophosphamide; Randomized controlled trial; Confidence interval; Chemotherapy; Lymphoma; CD30","score_opus":0.025551533868815746,"score_gpt":0.28361959669868864,"score_spread":0.2580680628298729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097505417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289846,0.0007981492,6.864485e-7,0.00021139775,0.00006403505,0.005517889,0.0001628841,0.000011278843,0.00033522345],"genre_scores_gemma":[0.99907994,0.00030374838,0.00010569751,0.000009873909,0.00005260241,0.00030720254,0.00009341033,0.00002355087,0.000023959945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804777,0.00018640028,0.0007847502,0.00036998448,0.00040753238,0.00020356968],"domain_scores_gemma":[0.9984161,0.00046311974,0.00050296733,0.00031400006,0.00017583721,0.00012793239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020575667,0.00027157186,0.0012697552,0.00007352465,0.000043263924,0.000011567358,0.00008114659,0.00006680288,0.000005561762],"category_scores_gemma":[0.000089308836,0.0001517818,0.00017215205,0.00022005592,0.00013959652,0.00004320536,0.000038011312,0.0000394526,8.454779e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87822825,0.08500958,0.027652524,0.000038555492,0.0015085598,0.000043263466,0.0049668513,0.0000036941585,0.000052685722,0.000006142368,0.000009533863,0.0024803893],"study_design_scores_gemma":[0.9177506,0.04465412,0.02382314,0.000079820216,0.0022230078,0.0000010749192,0.0013319582,0.000037282945,0.009961211,7.0647604e-7,0.000027311538,0.00010977976],"about_ca_topic_score_codex":0.00085064274,"about_ca_topic_score_gemma":0.00015434274,"teacher_disagreement_score":0.040355463,"about_ca_system_score_codex":0.00009973358,"about_ca_system_score_gemma":0.00015355767,"threshold_uncertainty_score":0.6189482},"labels":[],"label_agreement":null},{"id":"W3097507376","doi":"10.1182/blood-2020-138796","title":"Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cog; Internal medicine; Histology; Proportional hazards model; Cumulative incidence; Radiation therapy; Cohort; Clinical trial; Oncology","score_opus":0.016250080824054308,"score_gpt":0.24903988358186813,"score_spread":0.23278980275781383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097507376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761597,0.002591338,0.000011483533,0.019402571,0.00009617784,0.00027991735,0.00003837018,0.000038351813,0.0013820933],"genre_scores_gemma":[0.9967704,0.00017141053,0.00030945407,0.0022123565,0.00020907352,0.00005653137,0.00021595375,0.000014036072,0.000040796152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989036,0.00011977892,0.00026424002,0.00037424796,0.00013618422,0.00020198483],"domain_scores_gemma":[0.9991982,0.0003642013,0.00007960737,0.00020970112,0.000010689479,0.00013762618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098566314,0.00014606034,0.00044178404,0.000016918651,0.00005191253,0.000014470279,0.00007148269,0.00014203474,0.000038057962],"category_scores_gemma":[0.00018246975,0.0000956291,0.00005848623,0.00009059239,0.00018631255,0.000023545674,0.00008354042,0.0000919338,0.000011193041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019973906,0.0028047224,0.9622857,0.0000062142367,0.00032623167,0.011796808,0.0007358219,4.090659e-8,0.00046910648,0.0006430446,0.0113646565,0.009367936],"study_design_scores_gemma":[0.011909065,0.0006761081,0.9420019,0.000012800297,0.0003778845,0.0007679844,0.00007818387,0.000005129967,0.00028736214,0.00012890565,0.043656852,0.00009786991],"about_ca_topic_score_codex":0.0013588088,"about_ca_topic_score_gemma":0.0004462273,"teacher_disagreement_score":0.0322922,"about_ca_system_score_codex":0.00008084287,"about_ca_system_score_gemma":0.000110501605,"threshold_uncertainty_score":0.38996413},"labels":[],"label_agreement":null},{"id":"W3097649246","doi":"10.1182/blood-2020-135935","title":"Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Stage (stratigraphy); Internal medicine; Oncology; Biology","score_opus":0.06775973462447611,"score_gpt":0.33323942319489197,"score_spread":0.2654796885704159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097649246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98328996,0.0007416192,0.00042325337,0.0041745505,0.00014882052,0.008964252,0.002003177,0.000064156724,0.00019021495],"genre_scores_gemma":[0.9876514,0.000026941885,0.0022754052,0.0016143327,0.00041826544,0.006756708,0.0011953055,0.000039554074,0.000022076287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809295,0.00011809246,0.0004352189,0.0005577847,0.0004889862,0.0003069796],"domain_scores_gemma":[0.9981488,0.0009963156,0.00018438861,0.00038416838,0.00021291156,0.000073428964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023189756,0.00026974385,0.00035067258,0.000057980113,0.00015852704,0.000119275486,0.00040220696,0.00008079207,0.000008090883],"category_scores_gemma":[0.0008356984,0.0001631343,0.00015478166,0.00019346813,0.000052632986,0.000093129354,0.000085385254,0.000059628157,0.000005214566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003398127,0.018133521,0.689067,0.00021916443,0.0022213364,0.00020298164,0.09080316,0.000043539847,0.00040658028,0.001233742,0.0020664968,0.19220433],"study_design_scores_gemma":[0.076407194,0.0036883731,0.87627786,0.00014461664,0.0021613042,0.000023670504,0.029774863,0.0017690639,0.002776802,0.0003322804,0.0062749344,0.00036905694],"about_ca_topic_score_codex":0.00032897436,"about_ca_topic_score_gemma":0.00028767632,"teacher_disagreement_score":0.19183527,"about_ca_system_score_codex":0.00013567884,"about_ca_system_score_gemma":0.00042531002,"threshold_uncertainty_score":0.6652424},"labels":[],"label_agreement":null},{"id":"W3097691142","doi":"10.1182/blood-2020-140624","title":"Three-Dimensional Telomere Analysis Using Teloview® Technology Predicts the Response of Classic Hodgkin's Lymphoma Patients to First Line Therapy at Point of Diagnosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Vinblastine; Chemotherapy regimen; Chlorambucil; Lymphoma; Chemotherapy; Vincristine; Hodgkin lymphoma","score_opus":0.024747470936385484,"score_gpt":0.256083679106671,"score_spread":0.23133620817028552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097691142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900321,0.001762216,0.000020306776,0.007087687,0.00003681771,0.0008626233,0.00013990937,0.000039885494,0.000018487248],"genre_scores_gemma":[0.99774325,0.0002170207,0.0010078772,0.0008179918,0.00004422829,0.00010833789,0.000029136232,0.000026558657,0.000005596956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982348,0.00007361633,0.0005478238,0.00040424088,0.00048263842,0.00025687122],"domain_scores_gemma":[0.99830455,0.00041734902,0.00028713295,0.0005595124,0.00025311633,0.00017837029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017764831,0.00024447445,0.0007272551,0.00032538196,0.00010173967,0.0000059841536,0.0001853033,0.00014158954,0.00012765407],"category_scores_gemma":[0.00039867047,0.00015262506,0.00032681657,0.0017150945,0.0001464174,0.00003204469,0.00020944749,0.000055392567,0.00001534718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020581286,0.0039463863,0.9813021,0.000042549345,0.0025325764,0.000051809147,0.00036001345,0.00014278802,0.0021380985,0.000012724823,0.00041218722,0.0070006563],"study_design_scores_gemma":[0.00919459,0.0031092707,0.8528234,0.00016148831,0.002501929,0.000012722286,0.000037074464,0.00034807704,0.13093632,0.000018280154,0.0007191782,0.00013767224],"about_ca_topic_score_codex":0.00010388735,"about_ca_topic_score_gemma":0.00007945418,"teacher_disagreement_score":0.12879823,"about_ca_system_score_codex":0.000121433404,"about_ca_system_score_gemma":0.00013895068,"threshold_uncertainty_score":0.62238693},"labels":[],"label_agreement":null},{"id":"W3097778032","doi":"10.1182/blood-2020-137258","title":"Double-Hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-Cell Lymphoma Treated with R-CHOP","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; CancerCare Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Germinal center; Lymphoma; Fluorescence in situ hybridization; Biology; Cancer research; Comparative genomic hybridization; Immunophenotyping; Oncology; Internal medicine; Pathology; Medicine; B cell; Immunology; Genetics; Gene; Flow cytometry","score_opus":0.007823083668783001,"score_gpt":0.1955919838357955,"score_spread":0.1877689001670125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097778032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518245,0.00023322518,0.0000021326543,0.00032073818,0.000035604073,0.0009436263,0.00019198288,0.00011562701,0.0029746233],"genre_scores_gemma":[0.9978529,0.00002720124,0.00013594476,0.00091551204,0.00010537254,0.00007687973,0.00046926946,0.00007404141,0.00034287362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798065,0.00004848743,0.00026899469,0.0005286297,0.00061877613,0.0005544831],"domain_scores_gemma":[0.99897933,0.00004045072,0.00012929819,0.0003036075,0.00018990245,0.00035740715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004767044,0.00043216263,0.0005618452,0.00008606034,0.00007569981,0.000048442012,0.00011636768,0.00014069819,0.000055646724],"category_scores_gemma":[0.0000068267527,0.0002525724,0.000057361052,0.00043990053,0.00006884657,0.00016031603,0.000047343594,0.0001451123,0.000027788046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012822627,0.02514342,0.958537,0.0001603384,0.00040398372,0.0017252349,0.0007368329,0.000002226535,0.000018594466,0.00002128849,0.00028551315,0.00014298393],"study_design_scores_gemma":[0.2934577,0.007961514,0.6915153,0.00037394118,0.0008803669,0.00006997201,0.0002292373,0.000013852831,0.003668294,4.636589e-7,0.0014537844,0.00037555947],"about_ca_topic_score_codex":0.0001530904,"about_ca_topic_score_gemma":0.00016116802,"teacher_disagreement_score":0.28063506,"about_ca_system_score_codex":0.000090677,"about_ca_system_score_gemma":0.0002065249,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W3097857700","doi":"10.1182/blood-2020-142565","title":"Effect of Pembrolizumab (Pembro) Monotherapy Versus Brentuximab Vedotin (BV) on Patients (Pts) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Internal medicine; Classical Hodgkin lymphoma; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Hodgkin lymphoma; Clinical trial; Cancer; Materials science; Immunotherapy","score_opus":0.014271756820089344,"score_gpt":0.2743418253335899,"score_spread":0.26007006851350056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097857700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995009,0.0013700065,0.000008075811,0.00018493347,0.0001096956,0.0030708194,0.0001420907,0.000036579364,0.000068812195],"genre_scores_gemma":[0.9988817,0.0004109939,0.000029498417,0.00014969561,0.000059537782,0.00032445136,0.000073735995,0.00005827889,0.000012104765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963572,0.00093049224,0.0009082556,0.0005646899,0.0009688236,0.00027054624],"domain_scores_gemma":[0.99663275,0.0013494538,0.0008456744,0.00077319425,0.00022090548,0.00017802214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038460604,0.0004820273,0.0022583583,0.00021102653,0.00006914724,0.000011518786,0.00027701326,0.0001371946,0.000047686866],"category_scores_gemma":[0.00027554735,0.00025763863,0.0008397346,0.0009184221,0.00027278316,0.0000708221,0.000050205515,0.00012874062,0.0000032098235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73110014,0.073906705,0.13114119,0.00013971447,0.020445867,0.000027583945,0.0026555897,0.000034142104,0.0037487552,0.000007507628,0.0002426478,0.036550194],"study_design_scores_gemma":[0.7832849,0.040546287,0.026907206,0.00012371053,0.009681668,7.152018e-7,0.00013375843,0.00017826892,0.13883795,5.66036e-7,0.0001130561,0.00019193675],"about_ca_topic_score_codex":0.00009074151,"about_ca_topic_score_gemma":0.000011370188,"teacher_disagreement_score":0.1350892,"about_ca_system_score_codex":0.000098281096,"about_ca_system_score_gemma":0.00019022387,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W3097923020","doi":"10.1182/blood-2020-135839","title":"Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Clinical trial; Oncology; Progressive disease; Lymphoma; Phases of clinical research; Gastroenterology; Chemotherapy","score_opus":0.033216889916838646,"score_gpt":0.3106191460288156,"score_spread":0.27740225611197694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097923020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970439,0.00008607142,0.000019063524,0.00025811925,0.00011124185,0.0022883455,0.000039109054,0.000097390126,0.000056731787],"genre_scores_gemma":[0.9971858,0.0000073004594,0.0014280111,0.00035981217,0.0002168336,0.00014478904,0.0006181446,0.000033160202,0.0000061442647],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785095,0.00012384968,0.0006884518,0.00063675386,0.0004299889,0.00027002027],"domain_scores_gemma":[0.9989512,0.00014543046,0.00019257735,0.00033723543,0.00007421933,0.00029936255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009562278,0.00025068125,0.00057525956,0.0000478074,0.00006179695,0.000039116178,0.00009591099,0.00015775199,0.00007401553],"category_scores_gemma":[0.00030876644,0.00018509121,0.0001445218,0.00029501776,0.00005891048,0.00013193866,0.00004194626,0.00010137508,0.000029355204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067802526,0.052788798,0.85574275,0.000011849959,0.0004086682,0.00042338244,0.0021653262,0.000009672619,0.00032510553,0.0000043701575,0.000108240194,0.020209324],"study_design_scores_gemma":[0.50767195,0.0035861023,0.48534617,0.00008625074,0.00034357925,0.0000014440524,0.00005020784,0.0005567671,0.001999428,0.0000011917795,0.0002082247,0.00014870633],"about_ca_topic_score_codex":0.00012364327,"about_ca_topic_score_gemma":0.000009715186,"teacher_disagreement_score":0.4398694,"about_ca_system_score_codex":0.00010481694,"about_ca_system_score_gemma":0.00017266792,"threshold_uncertainty_score":0.75478},"labels":[],"label_agreement":null},{"id":"W3098497307","doi":"10.1182/blood.v130.suppl_1.4041.4041","title":"Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Watchful waiting; Medicine; Follicular lymphoma; Retrospective cohort study; Lymphoma; Adverse effect; Pediatrics; Internal medicine; Cancer; Prostate cancer","score_opus":0.015029638595004332,"score_gpt":0.2744969535572582,"score_spread":0.2594673149622539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098497307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976188,0.000042387564,0.0000023107548,0.000060168994,0.00007371932,0.0008647491,0.00096208125,0.000006969457,0.000368792],"genre_scores_gemma":[0.9988468,0.000034804787,0.00027598147,0.00003678013,0.000031314623,0.0001802017,0.0005695102,0.000015837044,0.000008768266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983941,0.000045368673,0.0005917849,0.00039475536,0.00033364716,0.00024040115],"domain_scores_gemma":[0.99803746,0.0003983097,0.0006860645,0.00053926365,0.0002426509,0.00009627858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010276384,0.00019951662,0.00085996086,0.00020402375,0.00009184567,0.000012442506,0.0001658981,0.00010502404,0.00005750773],"category_scores_gemma":[0.0007127339,0.000161247,0.00038335763,0.00014184038,0.00019185925,0.00010978582,0.000059659065,0.000031425418,0.000002633568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002779174,0.0064499113,0.9882509,0.000033348253,0.0027493867,0.000043374414,0.00073606597,0.0000022235338,0.00022274778,0.00011853445,0.000016151826,0.0010994346],"study_design_scores_gemma":[0.02402243,0.00080679014,0.93499494,0.00016729983,0.0048034526,1.709344e-7,0.00015696285,0.0000766273,0.03470803,0.00010497294,0.000018328914,0.00013999411],"about_ca_topic_score_codex":0.02875838,"about_ca_topic_score_gemma":0.0022278337,"teacher_disagreement_score":0.053255964,"about_ca_system_score_codex":0.000101789,"about_ca_system_score_gemma":0.000112671296,"threshold_uncertainty_score":0.9777092},"labels":[],"label_agreement":null},{"id":"W3099090084","doi":"10.14740/jh554","title":"Unraveling the Mystery of Gray Zone Lymphoma in Human Immunodeficiency Virus-Seropositive Patients: Two Cases","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; CD30; Hepatosplenomegaly; Pathology; Lymph node biopsy; Generalized lymphadenopathy; Vincristine; CHOP; Rituximab; Anaplastic large-cell lymphoma; Diffuse large B-cell lymphoma; Lymph node; Internal medicine; Cyclophosphamide; Chemotherapy; Disease","score_opus":0.020786347009169166,"score_gpt":0.2895606301775417,"score_spread":0.26877428316837254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099090084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956446,0.0024753227,0.00005694922,0.0013056854,0.00011103995,0.00016845598,0.0000065025774,0.000004170962,0.00022725026],"genre_scores_gemma":[0.99899036,0.000103825296,0.0001395217,0.00069922686,0.00004418371,0.0000042564616,0.000003853098,0.000010913633,0.000003844744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985786,0.00011134569,0.0007816009,0.00011773435,0.00023276248,0.00017797542],"domain_scores_gemma":[0.9987931,0.00025302247,0.0005300933,0.00013291092,0.00021740778,0.000073412935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632267,0.00012938162,0.00062064326,0.00011860155,0.000057219764,0.000007303421,0.0001212482,0.00005300678,0.00003609045],"category_scores_gemma":[0.00015963532,0.00007560713,0.00016799929,0.00018093102,0.00010640919,0.0000664788,0.00004616037,0.000101754005,0.0000064711953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010733663,0.0035449523,0.9668772,0.00017619462,0.00045077925,0.0042604636,0.0049249395,0.000042986016,0.010528202,0.003250158,0.00043478652,0.0044359593],"study_design_scores_gemma":[0.034013014,0.010014489,0.7411512,0.0014946179,0.0008530798,0.011824383,0.0047929715,0.00015563075,0.19433114,0.0003355358,0.0006934804,0.00034046898],"about_ca_topic_score_codex":0.00020103363,"about_ca_topic_score_gemma":0.000032274278,"teacher_disagreement_score":0.22572602,"about_ca_system_score_codex":0.00011284086,"about_ca_system_score_gemma":0.00011756847,"threshold_uncertainty_score":0.30831695},"labels":[],"label_agreement":null},{"id":"W3099337393","doi":"10.1093/ajcp/aqaa191","title":"Laboratory Workup of Lymphoma in Adults","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Guideline; Grading (engineering); Lymphoma; Intensive care medicine; Medical physics; Appropriate Use Criteria; Diagnostic test; MEDLINE; Pathology; Internal medicine; Pediatrics","score_opus":0.03266359079412996,"score_gpt":0.3649245868758646,"score_spread":0.33226099608173465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099337393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240154,0.0005317025,0.000022248429,0.006427023,0.00017055009,0.000074895564,0.000006375593,0.0000050205235,0.00036067227],"genre_scores_gemma":[0.9914729,0.0006910655,0.0024440477,0.005085184,0.00029035425,0.0000019647432,0.0000011664464,0.000010619878,0.000002678015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977734,0.00031308236,0.0014058551,0.00016553506,0.00018489102,0.00015723977],"domain_scores_gemma":[0.9977235,0.00063648575,0.0009911612,0.00014740176,0.00020208198,0.00029932894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005584125,0.00010281889,0.0011665276,0.00007877652,0.000007158949,0.000001742794,0.00010827577,0.000074635296,0.000042648622],"category_scores_gemma":[0.0014796425,0.000074634336,0.00026336944,0.0003486456,0.0004375437,0.000035460613,0.000030515255,0.00017998378,0.000017312872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025505114,0.0010059101,0.7787798,0.000018055713,0.000075919364,0.0030493087,0.00027515338,0.0000029330695,0.00009186088,0.000042799555,0.00043758395,0.21367015],"study_design_scores_gemma":[0.008162567,0.009821556,0.9788598,0.00019374986,0.00008861158,0.0002026304,0.00042523164,0.00001377499,0.00022079576,0.00002934983,0.0019203916,0.000061564206],"about_ca_topic_score_codex":0.000012273514,"about_ca_topic_score_gemma":0.000002845305,"teacher_disagreement_score":0.2136086,"about_ca_system_score_codex":0.00003151807,"about_ca_system_score_gemma":0.00036878773,"threshold_uncertainty_score":0.30435},"labels":[],"label_agreement":null},{"id":"W3099852263","doi":"10.1182/bloodadvances.2020002814","title":"A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; International Prognostic Index; Confidence interval; Retrospective cohort study; Oncology; Framingham Risk Score; Proportional hazards model; Refractory (planetary science); Transplantation; Cohort; Gastroenterology; Lymphoma; Diffuse large B-cell lymphoma; Disease","score_opus":0.0380345259632921,"score_gpt":0.3125265435253339,"score_spread":0.2744920175620418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099852263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390794,0.012653018,0.0016445831,0.0002091563,0.0001094343,0.0007275606,0.0004894104,0.000077057135,0.0001818485],"genre_scores_gemma":[0.97322106,0.017040845,0.0091206655,0.00022911253,0.00017968523,0.0000979835,0.00006033529,0.000027007762,0.000023296929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861896,0.00005908583,0.0004183098,0.00048792578,0.00017390907,0.00024182857],"domain_scores_gemma":[0.9983273,0.00071687053,0.00042423804,0.0001656352,0.000068340414,0.00029760532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001232343,0.00024709574,0.00050737464,0.000030505624,0.00016905334,0.000021425927,0.000070481496,0.00011563154,0.0000075305807],"category_scores_gemma":[0.0009929764,0.00015713209,0.00020150833,0.000069220696,0.000101573336,0.00015261595,0.00002673996,0.00023280423,0.0000030895765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040602736,0.00054396695,0.9705836,0.00013021906,0.0003474443,0.000052896794,0.0013637899,0.00009132688,0.000051878156,0.000077201024,0.00013730279,0.026214352],"study_design_scores_gemma":[0.04674272,0.015226846,0.7788328,0.0025390254,0.009702876,0.00009995388,0.0028631487,0.11916307,0.011774668,0.0017724797,0.009899917,0.001382495],"about_ca_topic_score_codex":0.000060579318,"about_ca_topic_score_gemma":0.00006979064,"teacher_disagreement_score":0.1917508,"about_ca_system_score_codex":0.000020452526,"about_ca_system_score_gemma":0.00009040079,"threshold_uncertainty_score":0.6407661},"labels":[],"label_agreement":null},{"id":"W3100021516","doi":"10.1016/j.prro.2020.11.003","title":"Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review","year":2020,"lang":"en","type":"article","venue":"Practical Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Hazard ratio; Radiation therapy; Palliative care; Oncology; Refractory (planetary science); Retrospective cohort study; Progressive disease; Population; Odds ratio; Lymphoma; Confidence interval","score_opus":0.04634965300420114,"score_gpt":0.38675761795370606,"score_spread":0.3404079649495049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100021516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7670823,0.018603,0.0061099185,0.19231871,0.000602488,0.01310752,0.0003339895,0.0003261043,0.0015160096],"genre_scores_gemma":[0.9546803,0.020155795,0.0034422998,0.020417323,0.0002968082,0.0003574925,0.0005684612,0.000040175495,0.000041301486],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99788123,0.0002951129,0.00070194784,0.00048421897,0.00034727264,0.00029023027],"domain_scores_gemma":[0.9953349,0.003038139,0.0008199114,0.00027184797,0.00027615658,0.00025899685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038463323,0.0002530339,0.00085849443,0.00008371283,0.000096366835,0.000011637646,0.00007108923,0.00025635865,0.00035431187],"category_scores_gemma":[0.0043948586,0.0001926248,0.00027244704,0.00038465686,0.00004196395,0.00015581727,0.000010922464,0.00013720713,0.00003169635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060175292,0.10296061,0.234224,0.0021984691,0.001688255,0.00015313222,0.003213057,0.000019043306,0.0016138984,0.005463623,0.04341046,0.54488015],"study_design_scores_gemma":[0.14579625,0.010150279,0.59730357,0.00019814006,0.0005933068,0.0000057793964,0.000050054,0.003268858,0.0033275292,0.00008495906,0.23892707,0.00029420183],"about_ca_topic_score_codex":0.000032146218,"about_ca_topic_score_gemma":0.000005378269,"teacher_disagreement_score":0.54458594,"about_ca_system_score_codex":0.0013270064,"about_ca_system_score_gemma":0.0010398664,"threshold_uncertainty_score":0.7855011},"labels":[],"label_agreement":null},{"id":"W3100496148","doi":"10.1182/blood.2020008250","title":"Hodgkin lymphoma: outsmarting HRS cells","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Immunology; Cancer research","score_opus":0.018606444995281222,"score_gpt":0.23401402565069632,"score_spread":0.2154075806554151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100496148","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039940592,0.001630025,0.0000020007087,0.9317826,0.0005802873,0.0008437851,0.000121770994,0.00032532096,0.024773626],"genre_scores_gemma":[0.018293142,0.0002082165,0.00094277324,0.9625357,0.0077820765,0.0001491181,0.00056975434,0.0001382418,0.009380974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801683,0.000050956827,0.00038585134,0.00061063195,0.000463338,0.00047236658],"domain_scores_gemma":[0.9990014,0.000118476455,0.00015591676,0.0005086132,0.00005183933,0.00016378834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045801586,0.0004287227,0.00073743105,0.00006760997,0.000074164585,0.000052904972,0.00014335157,0.00047603948,0.0006087034],"category_scores_gemma":[0.00003749121,0.00034998418,0.00038177465,0.00013800878,0.00004476875,0.000027263552,0.00006491713,0.00035531455,0.0022248575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013312124,0.00071224547,0.0027753399,0.00030516443,0.0006821217,0.01659816,0.000104669634,1.0545044e-7,0.00014713529,0.0000019978647,0.9700474,0.008612306],"study_design_scores_gemma":[0.007564506,0.0003376478,0.0018855307,0.00028450985,0.0022584854,0.0002320882,0.000010262751,0.0000045840347,0.0108065065,0.000016872815,0.97626156,0.0003374252],"about_ca_topic_score_codex":0.00009715753,"about_ca_topic_score_gemma":0.0000016528903,"teacher_disagreement_score":0.03075311,"about_ca_system_score_codex":0.00012527288,"about_ca_system_score_gemma":0.00020049392,"threshold_uncertainty_score":0.9998952},"labels":[],"label_agreement":null},{"id":"W3100902974","doi":"10.1016/j.clml.2020.11.004","title":"BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Genentech; Celgene; MorphoSys; H. Lundbeck A/S; Juno Therapeutics; Incyte; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Janssen Pharmaceuticals; Gilead Sciences; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Hazard ratio; Medicine; Internal medicine; Lymphoma; Immunohistochemistry; Confidence interval; Oncology; Population; Proportional hazards model; Venetoclax; Multivariate analysis; Pathology; Leukemia","score_opus":0.02652340087100352,"score_gpt":0.28697465696309593,"score_spread":0.2604512560920924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100902974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938284,0.0007480606,0.000070263035,0.0024931403,0.00027544316,0.0016024166,0.00006532804,0.00027679797,0.0006401586],"genre_scores_gemma":[0.9929968,0.0004262371,0.001030354,0.004017608,0.00042525193,0.00046167284,0.000394146,0.00011313722,0.00013478324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949297,0.0002348715,0.0017838727,0.001353611,0.0008620505,0.0008359279],"domain_scores_gemma":[0.99717975,0.00055598246,0.000561469,0.00065323303,0.00018339326,0.0008662049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032567896,0.0006553618,0.0013054493,0.00017822973,0.00024950437,0.000112621135,0.000271364,0.00047908464,0.00010993471],"category_scores_gemma":[0.0005345724,0.0004857499,0.0004822587,0.0006897031,0.00015278991,0.000318128,0.00029339816,0.00018679239,0.00029489736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036967166,0.013965488,0.76708466,0.00033549313,0.00015836912,0.0018023732,0.00084863394,0.000030713796,0.00025804868,0.000042735723,0.0037845438,0.20799226],"study_design_scores_gemma":[0.050626677,0.0028204692,0.9254639,0.00082709733,0.0003001468,0.0000672026,0.00023150445,0.0024449567,0.008721525,0.000052730105,0.007893755,0.00055001676],"about_ca_topic_score_codex":0.00033005618,"about_ca_topic_score_gemma":0.0002046564,"teacher_disagreement_score":0.20744224,"about_ca_system_score_codex":0.0012979046,"about_ca_system_score_gemma":0.0005262872,"threshold_uncertainty_score":0.99975944},"labels":[],"label_agreement":null},{"id":"W3101574165","doi":"10.5858/arpa.2020-0261-sa","title":"Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists","year":2020,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Guideline; Grading (engineering); Medicine; Context (archaeology); Medical physics; Lymphoma; Intensive care medicine; MEDLINE; Pathology","score_opus":0.025461024810028453,"score_gpt":0.33133787458256625,"score_spread":0.3058768497725378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101574165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597602,0.0076137083,0.0001826787,0.029207574,0.000105566956,0.00095930224,0.0020986367,0.00002040161,0.00005196625],"genre_scores_gemma":[0.969613,0.0074573187,0.00854918,0.013837129,0.00028934414,0.00012284615,0.00009890682,0.00002965333,0.000002586423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962621,0.000981759,0.0016249567,0.00057445036,0.00024451182,0.00031223445],"domain_scores_gemma":[0.99153835,0.006007019,0.0013431241,0.0006482432,0.00029513857,0.00016811273],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0013671883,0.00029942172,0.0020083182,0.00007378404,0.000057409296,0.0000011578239,0.00031695163,0.000100527985,0.0000103374705],"category_scores_gemma":[0.0026637893,0.00016135721,0.0002922506,0.00072188623,0.013224554,0.000027801503,0.000165217,0.00021471341,6.946122e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013375877,0.0012132216,0.9042806,0.00024681838,0.000656603,0.00088876835,0.01216806,0.0000033887031,0.011392596,0.0020504144,0.0102850655,0.04343857],"study_design_scores_gemma":[0.027501926,0.005415553,0.948862,0.0004113817,0.00064185826,0.000034702593,0.011375561,0.00025027414,0.0010350089,0.00041227316,0.0038979396,0.00016150516],"about_ca_topic_score_codex":0.00022223614,"about_ca_topic_score_gemma":0.00008841967,"teacher_disagreement_score":0.044581402,"about_ca_system_score_codex":0.000023509667,"about_ca_system_score_gemma":0.0004227459,"threshold_uncertainty_score":0.9894609},"labels":[],"label_agreement":null},{"id":"W3103093219","doi":"10.1097/rlu.0000000000003381","title":"Focal Liver 18F-FDG Uptake in a Patient Who Underwent Thrombolysis for Brachiocephalic and Subclavian Thrombosis","year":2020,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Radiology; Thrombolysis; Superior vena cava; Thrombosis; Mediastinum; Lymphoma; Brachiocephalic vein; Lesion; Nuclear medicine; Pathology; Internal medicine","score_opus":0.09884284661530507,"score_gpt":0.3646768601393488,"score_spread":0.26583401352404373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103093219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327105,0.0013149974,0.000033926346,0.06370362,0.00018644838,0.0010438655,0.000017016582,0.00007423539,0.0009153436],"genre_scores_gemma":[0.9659873,0.00238398,0.0007843531,0.030198196,0.00048864895,0.000041325788,0.000037295264,0.000056127363,0.00002274075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744296,0.0001021527,0.0010061894,0.00071372505,0.0003564862,0.00037849654],"domain_scores_gemma":[0.99806976,0.00063413195,0.00016822499,0.00033553372,0.000079229234,0.0007131042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034966314,0.00029124098,0.0012064199,0.000080399106,0.000087726374,0.000016827977,0.000108001324,0.00017980703,0.00048541153],"category_scores_gemma":[0.0008922425,0.00020662863,0.00026332095,0.00025909016,0.00040604672,0.000068859,0.00010767201,0.00026594294,0.00006933277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029205526,0.006324772,0.49022472,0.0008577387,0.0015995486,0.0011959648,0.010171777,0.0000041098924,0.00056157773,0.0051905448,0.11010231,0.3708464],"study_design_scores_gemma":[0.014970371,0.010651573,0.8935087,0.00057999586,0.0009145016,0.00003964402,0.0012340401,0.0028098049,0.000030262341,0.00019563503,0.07479892,0.00026657738],"about_ca_topic_score_codex":0.00013601361,"about_ca_topic_score_gemma":0.000044998586,"teacher_disagreement_score":0.40328395,"about_ca_system_score_codex":0.000107096435,"about_ca_system_score_gemma":0.000061651685,"threshold_uncertainty_score":0.8426071},"labels":[],"label_agreement":null},{"id":"W3106693055","doi":"10.1158/2643-3249.lymphoma20-ia08","title":"Abstract IA08: The role of gene expression in the classification of aggressive B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Gene expression profiling; B cell; Immunophenotyping; Computational biology; Follicular lymphoma; Cancer research; Oncology; Biology; Medicine; Gene; Internal medicine; Immunology; Gene expression; Genetics; Antigen; Antibody","score_opus":0.018387532456470092,"score_gpt":0.25695840695917926,"score_spread":0.23857087450270917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106693055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824434,0.01300766,0.0000030811575,0.0017206117,0.00003536583,0.00037414633,0.00006772783,0.0000054386232,0.0023425734],"genre_scores_gemma":[0.9979388,0.0013383866,0.000036101974,0.00037308448,0.00011069216,0.00015481396,0.000021646263,0.000010159143,0.000016289743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991125,0.00003930551,0.0002649557,0.00017963337,0.0002876311,0.00011595791],"domain_scores_gemma":[0.9991129,0.000106077816,0.0004182855,0.00029033405,0.00003707398,0.00003529626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070750735,0.00010811007,0.00021093564,0.000023247785,0.000029268756,0.000012951199,0.00015076794,0.00004687921,0.000025455653],"category_scores_gemma":[0.000031432875,0.00005389646,0.00010594784,0.00015363643,0.000062423765,0.00008728787,0.000024608338,0.000046139146,0.0000030777715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004970547,0.003493067,0.26027596,0.00021807874,0.00015296481,0.000050038892,0.0043294774,0.0000588076,0.71242774,0.00016890575,0.0012173579,0.017110586],"study_design_scores_gemma":[0.0023366222,0.0001098313,0.45174372,0.00017476093,0.00014592374,0.0000033470517,0.0012360563,0.000021450953,0.54376704,0.000029642708,0.00039204856,0.000039526094],"about_ca_topic_score_codex":0.0003627048,"about_ca_topic_score_gemma":0.000026150796,"teacher_disagreement_score":0.19146778,"about_ca_system_score_codex":0.000039392497,"about_ca_system_score_gemma":0.00019174448,"threshold_uncertainty_score":0.21978338},"labels":[],"label_agreement":null},{"id":"W3107516644","doi":"10.1200/jco.20.02905","title":"Time to Change Direction in the Treatment of Relapsed Hodgkin Lymphoma?","year":2020,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine","score_opus":0.16888680036052317,"score_gpt":0.4373481157804325,"score_spread":0.2684613154199093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107516644","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066770025,0.0011966082,7.8036874e-7,0.92752117,0.0011559656,0.0008009729,0.000016057673,0.0000071064733,0.0025313026],"genre_scores_gemma":[0.024083354,0.005311079,0.00059477246,0.9518373,0.01693212,0.000121288336,0.000045217403,0.000043726726,0.0010311425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562246,0.0009277349,0.0024126174,0.0002679818,0.00052577397,0.00024345484],"domain_scores_gemma":[0.99378437,0.003696918,0.0018449035,0.0002957623,0.00018739342,0.00019063865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009669312,0.000262079,0.0027142577,0.00022938178,0.000021669175,0.00000706573,0.00020078121,0.0009249769,0.00022066761],"category_scores_gemma":[0.00089975883,0.0001374813,0.0010691604,0.00024780704,0.00011450894,0.00003920055,0.000022209138,0.00062301755,0.00021348956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016856894,0.0049533113,0.0036015783,0.000030885065,0.00061202294,0.011128149,0.00051529787,4.863471e-7,0.0000038622234,0.0000011169933,0.6658235,0.31164408],"study_design_scores_gemma":[0.010310091,0.050592277,0.09822713,0.00019451849,0.0010324414,0.00039899565,0.000025741714,0.000006903036,0.00001689272,0.000023907694,0.8390855,0.00008559266],"about_ca_topic_score_codex":0.000087204025,"about_ca_topic_score_gemma":0.000022315626,"teacher_disagreement_score":0.31155849,"about_ca_system_score_codex":0.00087267614,"about_ca_system_score_gemma":0.0009523998,"threshold_uncertainty_score":0.7134269},"labels":[],"label_agreement":null},{"id":"W3107716360","doi":"10.1016/j.annonc.2020.11.019","title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Celgene; Gilead Sciences; Roche; AbbVie; Merck; European Commission; British Microcirculation Society; Amgen","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Risk stratification; Nuclear medicine; Positron emission tomography; Lesion; Radiology; Oncology; Internal medicine; Pathology","score_opus":0.05648362318366265,"score_gpt":0.3604426578138295,"score_spread":0.3039590346301668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107716360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412775,0.0019900491,0.000059805592,0.0032032165,0.00003238834,0.00031111366,0.00011561488,0.000017403308,0.00014263886],"genre_scores_gemma":[0.99710566,0.0013621709,0.00067903684,0.0004985001,0.000075942095,0.000015667818,0.00023852172,0.000013108283,0.00001136938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886197,0.00017299913,0.00038143442,0.00028276624,0.00013399392,0.00016686115],"domain_scores_gemma":[0.9991414,0.00023541057,0.00024229767,0.00014314888,0.00010582041,0.0001319453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023092069,0.00013056872,0.00043095349,0.00008670233,0.000039628547,0.0000079563815,0.00004295227,0.000029464594,0.000038848375],"category_scores_gemma":[0.00024240947,0.00011049421,0.000059658483,0.00018097031,0.00003616019,0.000070195165,0.000032780335,0.000054710243,0.000007601702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00245989,0.03621815,0.3857281,0.0002862941,0.00055436284,0.0044883215,0.0052865697,0.00011917068,0.22074424,0.00072300824,0.002133029,0.34125888],"study_design_scores_gemma":[0.031316914,0.0015894403,0.6911735,0.00016824776,0.0006548257,0.00011943853,0.0010229019,0.07686803,0.18890816,0.00016339218,0.007739971,0.00027520777],"about_ca_topic_score_codex":0.0013675737,"about_ca_topic_score_gemma":0.00009612718,"teacher_disagreement_score":0.34098366,"about_ca_system_score_codex":0.000046124063,"about_ca_system_score_gemma":0.00011150654,"threshold_uncertainty_score":0.45058233},"labels":[],"label_agreement":null},{"id":"W3108231055","doi":"10.1084/jem.20201173","title":"Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma","year":2020,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; National Institutes of Health; Center for Cancer Research","keywords":"Germinal center; Fas ligand; Cancer research; Lymphoma; B cell; Apoptosis; Biology; Programmed cell death; Immunology; Antibody; Genetics","score_opus":0.026140982479829624,"score_gpt":0.30310053952731236,"score_spread":0.27695955704748276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108231055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839265,0.0072185774,0.000017156177,0.003325041,0.00018593144,0.00022886242,0.000008641815,0.000009412866,0.0006137097],"genre_scores_gemma":[0.997665,0.00038000135,0.00006168759,0.0014122941,0.0004080994,0.0000038389267,0.000019360925,0.000017009595,0.000032721116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867,0.00009342854,0.0005060696,0.00011112384,0.0004671622,0.000152257],"domain_scores_gemma":[0.99866873,0.000084638996,0.0006786676,0.00013613136,0.00016696475,0.00026488397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001651654,0.00017117838,0.00049995916,0.00005497702,0.000059353537,0.000005425294,0.00013429948,0.000044112418,0.00036126218],"category_scores_gemma":[0.00005729674,0.00009037444,0.00009155988,0.00012418714,0.00022533578,0.00010487283,0.000022136039,0.00008306644,0.0000055977303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008078422,0.0024184007,0.017461717,0.000041725987,0.00047833522,0.00027551735,0.009533467,0.0000017040193,0.9411698,0.000023482622,0.017558197,0.002959212],"study_design_scores_gemma":[0.021489242,0.020951144,0.014248159,0.0006486159,0.0005201768,0.0021491665,0.0081688585,0.00018398168,0.92971355,0.0000076151537,0.0018024403,0.00011704372],"about_ca_topic_score_codex":0.000100750076,"about_ca_topic_score_gemma":8.7780484e-7,"teacher_disagreement_score":0.018532744,"about_ca_system_score_codex":0.00015992053,"about_ca_system_score_gemma":0.00007137175,"threshold_uncertainty_score":0.39555675},"labels":[],"label_agreement":null},{"id":"W3108297018","doi":"10.1158/2643-3249.lymphoma20-po-22","title":"Abstract PO-22: Compromised counterselection by FAS creates a lethal subtype of germinal center lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Germinal center; Fas ligand; Biology; Apoptosis; Cancer research; B cell; Lymphoma; Programmed cell death; Immunology; Genetics; Antibody","score_opus":0.015872352401953147,"score_gpt":0.25832135466700124,"score_spread":0.2424490022650481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108297018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933746,0.0023027346,0.000008587774,0.0012465399,0.00014376965,0.00035145736,0.000395283,0.000042075517,0.002134996],"genre_scores_gemma":[0.997887,0.00049261434,0.000024929566,0.00085075543,0.00022868867,0.000085768,0.00015567544,0.000028565022,0.00024600312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877506,0.000017338743,0.0003008377,0.00034851683,0.00030570893,0.0002525483],"domain_scores_gemma":[0.99939984,0.0000398164,0.0001624093,0.00016865473,0.00007094971,0.00015833689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003449922,0.00021840382,0.0004135234,0.000037519672,0.00004547073,0.00004132948,0.00007625532,0.00008036987,0.0003027071],"category_scores_gemma":[0.000013502012,0.0001784005,0.00017740634,0.00014157363,0.00006926567,0.00019395124,0.000026726755,0.000059001006,0.000019707524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037002536,0.0061077415,0.820985,0.00076064444,0.0018039654,0.0003723824,0.00071759266,0.000012670892,0.12308059,0.000053850214,0.0322067,0.010198578],"study_design_scores_gemma":[0.020161211,0.0014964498,0.54332864,0.00046846026,0.0010688781,0.00010210855,0.00021481047,0.00005519597,0.4264431,0.000009080565,0.0063218665,0.0003302217],"about_ca_topic_score_codex":0.0015209676,"about_ca_topic_score_gemma":0.000035802168,"teacher_disagreement_score":0.3033625,"about_ca_system_score_codex":0.0001587781,"about_ca_system_score_gemma":0.0002772432,"threshold_uncertainty_score":0.72749615},"labels":[],"label_agreement":null},{"id":"W3108449195","doi":"10.1158/2643-3249.lymphoma20-po-32","title":"Abstract PO-32: NFKBIZ 3′ UTR mutations confer selective growth advantage and affect drug response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Spinal Cord Injury BC; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Untranslated region; Biology; Mutation; Three prime untranslated region; Cancer research; Mutant; Cell growth; Signal transduction; CRISPR; Gene; Genetics; Lymphoma; Messenger RNA; Molecular biology; Immunology","score_opus":0.009652214431649287,"score_gpt":0.26292263908623864,"score_spread":0.2532704246545894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108449195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900686,0.0042986344,0.000007808821,0.0030945102,0.00007423168,0.00072750513,0.00047252484,0.000058634858,0.001197561],"genre_scores_gemma":[0.9960105,0.0013714018,0.000038401886,0.001729704,0.00012479007,0.00031941512,0.00007314401,0.00004506062,0.000287588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984334,0.0000997542,0.00027913708,0.0005359885,0.00025800525,0.0003937156],"domain_scores_gemma":[0.9990435,0.0003541892,0.0001044509,0.00019310955,0.00005498606,0.00024975382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013437567,0.00029346213,0.00045173086,0.000113031725,0.000087268905,0.000077674995,0.00007265424,0.00008130458,0.000046796904],"category_scores_gemma":[0.000101030564,0.00024724807,0.00012274137,0.0002892498,0.000064926564,0.00035050468,0.00006286354,0.00011538114,0.000023055825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014383042,0.031185875,0.9108918,0.0009236128,0.0010452316,0.0035894087,0.009776615,0.0000115472185,0.021410005,0.00054898637,0.0041714073,0.002062526],"study_design_scores_gemma":[0.051553655,0.00059737434,0.8627887,0.00024889843,0.00055347366,0.000031201296,0.00097556075,0.000033997883,0.08209245,0.000044876182,0.00076178997,0.00031803377],"about_ca_topic_score_codex":0.0006597475,"about_ca_topic_score_gemma":0.00034665113,"teacher_disagreement_score":0.060682442,"about_ca_system_score_codex":0.00024442023,"about_ca_system_score_gemma":0.0005143364,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W3110658142","doi":"10.1002/jha2.151","title":"Primary mediastinal large B‐cell lymphoma","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Rituximab; Atelectasis; Lymphoma; Pleural effusion; Radiology; Prednisone; Mediastinal Shift; Pericardial effusion; Lung; Cyclophosphamide; Surgery; Internal medicine; Chemotherapy","score_opus":0.01851631812072328,"score_gpt":0.23517462444860202,"score_spread":0.21665830632787875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110658142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291976,0.0015007835,0.00006979205,0.007910575,0.00015175868,0.00027136935,0.000021290169,0.00014922973,0.06072757],"genre_scores_gemma":[0.98831755,0.000075625634,0.00091263006,0.009606333,0.00045575283,0.000028160945,0.00006125042,0.000020295724,0.0005224069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908286,0.000016446731,0.00015685383,0.00024447753,0.0002493389,0.00025000868],"domain_scores_gemma":[0.99939895,0.000045739307,0.00004050298,0.0001669746,0.0000317949,0.00031602939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047124315,0.00013517996,0.00024743355,0.000023617056,0.000049800245,0.000012144044,0.00006254645,0.000051507548,0.00044154748],"category_scores_gemma":[0.000034633424,0.00010512417,0.000106404426,0.00012082911,0.000017236915,0.000040814655,0.000059200058,0.000041345207,0.0011349684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012159173,0.0117870625,0.46860996,0.00086650753,0.0004607525,0.008909652,0.0065290052,0.0000022377249,0.009863276,0.0020160386,0.31413692,0.17560266],"study_design_scores_gemma":[0.02209896,0.0010113353,0.58786684,0.000075490454,0.00027282996,0.00015423905,0.0002495455,0.000186138,0.02629915,0.00002874257,0.36148873,0.00026799826],"about_ca_topic_score_codex":0.000011856825,"about_ca_topic_score_gemma":0.0000016465193,"teacher_disagreement_score":0.17533466,"about_ca_system_score_codex":0.00010810303,"about_ca_system_score_gemma":0.00013839408,"threshold_uncertainty_score":0.9996428},"labels":[],"label_agreement":null},{"id":"W3111002581","doi":"10.1016/j.clml.2020.12.011","title":"Does Up-front Autologous Stem-Cell Transplantation at First Relapse Improve Outcome in Transplant-Eligible Follicular Lymphoma Patients Whose Disease Relapses Within 24 Months?","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Transplantation; Chemoimmunotherapy; Internal medicine; Rituximab; Follicular lymphoma; Hematopoietic stem cell transplantation; Surgery; Oncology; Autologous stem-cell transplantation; Lymphoma; Melphalan","score_opus":0.019056866536807496,"score_gpt":0.2795864168338753,"score_spread":0.2605295502970678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111002581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897157,0.0022293734,0.000019680045,0.0011700055,0.0036873848,0.0016401444,0.00061907136,0.00027797453,0.0006406965],"genre_scores_gemma":[0.9859116,0.003382658,0.00047679924,0.0014649418,0.0002503924,0.0004940073,0.0012924043,0.00015333747,0.0065738326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99219954,0.00047389,0.0031056758,0.0020350479,0.0010592138,0.0011266199],"domain_scores_gemma":[0.99509317,0.0011110752,0.000677935,0.0015139985,0.00030227503,0.0013015611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060198177,0.0009898068,0.0019182233,0.00024212534,0.00037877582,0.00011610321,0.00039508563,0.0008324691,0.00014785877],"category_scores_gemma":[0.0002448452,0.00069782813,0.0011707486,0.0004449694,0.00032041842,0.00037612204,0.00016486435,0.00028835167,0.0005019401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054626036,0.0040715975,0.9051649,0.0008546723,0.0003475019,0.012517668,0.0011146562,0.00006759397,0.00012822644,0.0001025443,0.0012129721,0.068955086],"study_design_scores_gemma":[0.035250265,0.00085053995,0.9489072,0.0009193726,0.0014792014,0.00014956844,0.00015743129,0.00061511406,0.0070871194,0.00014106461,0.0035654458,0.00087769923],"about_ca_topic_score_codex":0.0005953214,"about_ca_topic_score_gemma":0.0012142387,"teacher_disagreement_score":0.068077385,"about_ca_system_score_codex":0.003764666,"about_ca_system_score_gemma":0.0018692603,"threshold_uncertainty_score":0.9995473},"labels":[],"label_agreement":null},{"id":"W3111005279","doi":"10.1002/hon.2830","title":"Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Population; Retrospective cohort study; Lymphoma; Surgery","score_opus":0.05213350040243925,"score_gpt":0.3476552728913584,"score_spread":0.29552177248891914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111005279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998302,0.00006804848,0.0000031146346,0.0007574711,0.00003302861,0.0003383981,0.000017354947,0.000022356631,0.00045824458],"genre_scores_gemma":[0.9978771,0.00009034729,0.00047822556,0.0014514528,0.000023671104,0.000024287609,0.000035785193,0.000009169582,0.000009923634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869365,0.00009804901,0.00060463627,0.00029391187,0.00012475587,0.0001849923],"domain_scores_gemma":[0.99913067,0.00032984072,0.00018318964,0.000112439695,0.000041301635,0.00020257477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009363359,0.00013821239,0.0009932371,0.000038061455,0.00001147976,0.0000037193122,0.0000446214,0.00023536578,0.00009603477],"category_scores_gemma":[0.00023803693,0.00008492904,0.000067086716,0.0001230557,0.00017358315,0.000019857698,0.0000547099,0.000086294895,0.000016225858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014701315,0.0020660337,0.97894406,0.00004927066,0.00006113594,0.002415306,0.00007474659,6.558109e-8,0.0000055728383,0.00016976507,0.00011265561,0.014631245],"study_design_scores_gemma":[0.0119796945,0.004965074,0.98059386,0.00003303274,0.00010414135,0.000056886834,0.000017941655,0.000043521726,0.000032800115,0.00001219112,0.0020756463,0.000085181455],"about_ca_topic_score_codex":0.000026682184,"about_ca_topic_score_gemma":0.000014471772,"teacher_disagreement_score":0.014546064,"about_ca_system_score_codex":0.00006610753,"about_ca_system_score_gemma":0.0000479319,"threshold_uncertainty_score":0.34633055},"labels":[],"label_agreement":null},{"id":"W3111069302","doi":"10.1007/s11523-020-00778-y","title":"Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA","year":2020,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Nivolumab; Internal medicine; Population; Cohort; Retrospective cohort study; Oncology; Cancer; Immunotherapy; Environmental health","score_opus":0.03138123723126232,"score_gpt":0.29211950405521697,"score_spread":0.2607382668239546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111069302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647094,0.000116212315,0.0000025717545,0.010355495,0.000010691692,0.0009708356,0.000013741266,0.000034634086,0.0020248934],"genre_scores_gemma":[0.9967493,0.000056156543,0.00018657955,0.0025354263,0.000039998187,0.00012505014,0.0002359443,0.000023761124,0.00004780125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983649,0.0003163219,0.0002926987,0.00041034873,0.00025695132,0.00035874313],"domain_scores_gemma":[0.9992856,0.00015953454,0.000110376546,0.00020199547,0.000064519896,0.00017801287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010182003,0.0002063803,0.00048007557,0.00015065452,0.0000631076,0.000012810629,0.00007636839,0.00013297806,0.00003263498],"category_scores_gemma":[0.00003827471,0.00011960294,0.000024589626,0.00073677534,0.00012756554,0.00005125324,0.000027714714,0.00014069125,0.000008106094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061295293,0.001181097,0.9732995,0.00003753287,0.000039819053,0.00041238978,0.0012976245,0.000008855739,0.000004693057,0.00025857202,0.00051826396,0.01681209],"study_design_scores_gemma":[0.025854938,0.007923138,0.95961165,0.00007524346,0.00007719097,0.00002449942,0.00025611592,0.00029470155,0.00004932332,0.0000078602825,0.0057051415,0.00012019196],"about_ca_topic_score_codex":0.0023100341,"about_ca_topic_score_gemma":0.015000879,"teacher_disagreement_score":0.019725408,"about_ca_system_score_codex":0.0006896252,"about_ca_system_score_gemma":0.00033347978,"threshold_uncertainty_score":0.83708423},"labels":[],"label_agreement":null},{"id":"W3112327018","doi":"10.1016/j.jval.2020.08.462","title":"PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Adverse effect; Refractory (planetary science); Population; Progressive disease; Oncology; Disease; Diffuse large B-cell lymphoma; Lymphoma; Environmental health","score_opus":0.05595646326215171,"score_gpt":0.3238289691381307,"score_spread":0.267872505875979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112327018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847,0.0010795089,0.000007017734,0.006523881,0.00019981495,0.0029174972,0.000602986,0.000054069296,0.000145213],"genre_scores_gemma":[0.9949509,0.00049652753,0.0006123937,0.003326359,0.00011398149,0.00009591,0.0003295183,0.000040040304,0.000034373297],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99562186,0.00063192664,0.0016699195,0.00071797735,0.0006170149,0.0007413149],"domain_scores_gemma":[0.997708,0.00025508233,0.00069013116,0.00053644273,0.00010174264,0.000708577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011818479,0.00033183047,0.0011801402,0.0002062947,0.000108923,0.000008244774,0.00013481715,0.00013917784,0.000015471565],"category_scores_gemma":[0.00034589553,0.0002556438,0.00012553688,0.0006762939,0.00006088586,0.00007964353,0.00008019302,0.00022946212,0.000011354936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27859968,0.46656057,0.16476853,0.0024772068,0.0001145714,0.00027821062,0.018180778,0.000042428393,0.000010591803,0.00009897251,0.008171465,0.060697],"study_design_scores_gemma":[0.8857078,0.0473539,0.051859442,0.00074221776,0.000034321623,0.0000038152484,0.00032612128,0.0032350987,0.00011896704,0.000014154097,0.010387249,0.00021691105],"about_ca_topic_score_codex":0.014717282,"about_ca_topic_score_gemma":0.00068968575,"teacher_disagreement_score":0.6071081,"about_ca_system_score_codex":0.0010233948,"about_ca_system_score_gemma":0.0025343993,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W3112812645","doi":"10.1080/10428194.2020.1849674","title":"Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Biomarker; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Oncology; Chemotherapy; Internal medicine; Cancer research; Biology","score_opus":0.021800845148916583,"score_gpt":0.275620091838249,"score_spread":0.2538192466893324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112812645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719258,0.003061686,0.0000020767725,0.009551421,0.00090519595,0.0055903406,0.000470093,0.00015851717,0.00833485],"genre_scores_gemma":[0.9816733,0.00018221073,0.0001479799,0.01502355,0.00087416754,0.0012303499,0.00035395598,0.00029384234,0.0002206195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98799765,0.0018894727,0.001980456,0.0020625638,0.0046905014,0.001379362],"domain_scores_gemma":[0.9919178,0.002676466,0.0017890072,0.0024572704,0.00079984154,0.00035961086],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022145456,0.0017565751,0.0030423203,0.0006693094,0.00033358263,0.00009596977,0.0010341441,0.0016947731,0.00003444952],"category_scores_gemma":[0.0027339107,0.0011776047,0.0009528716,0.0017895312,0.0006559093,0.0001944612,0.0008459815,0.0005166498,0.00002988874],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0062836446,0.008742888,0.41367078,0.0075892373,0.0028960698,0.0036125423,0.0016102598,0.00003116711,0.0025782322,0.000119905795,0.13420852,0.41865674],"study_design_scores_gemma":[0.2781024,0.0042272215,0.6400464,0.0070105004,0.0055193314,0.00049431744,0.00015632292,0.008398656,0.043385956,0.00045397168,0.010525178,0.0016796938],"about_ca_topic_score_codex":0.0011284208,"about_ca_topic_score_gemma":0.000081179525,"teacher_disagreement_score":0.41697705,"about_ca_system_score_codex":0.015501732,"about_ca_system_score_gemma":0.006554647,"threshold_uncertainty_score":0.99960124},"labels":[],"label_agreement":null},{"id":"W3113758571","doi":"10.3747/co.27.7053","title":"First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; Brampton Civic Hospital; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Transplantation; Mantle cell lymphoma; Etoposide; Vincristine; Autologous stem-cell transplantation; Cytarabine; Internal medicine; Cyclophosphamide; Surgery; Salvage therapy; Oncology; Lymphoma; Chemotherapy","score_opus":0.042135393069910806,"score_gpt":0.3082734721325442,"score_spread":0.26613807906263337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113758571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864179,0.005527584,0.00028701502,0.005288036,0.00017839418,0.0010395298,0.000069011105,0.000024517505,0.0011680474],"genre_scores_gemma":[0.943139,0.055448856,0.00023901575,0.00080400653,0.00003963293,0.00016700561,0.0001269446,0.00001230999,0.000023234883],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99882674,0.000102238126,0.0003718205,0.00030248374,0.0001746698,0.00022204549],"domain_scores_gemma":[0.99935704,0.0002178768,0.00013520295,0.00015164945,0.000056363624,0.00008185889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012834738,0.00017981963,0.00034207842,0.000061096776,0.000049797098,0.0000086309765,0.00011645549,0.00007790236,0.000026587984],"category_scores_gemma":[0.0000021174362,0.000120624936,0.00007235798,0.00017249033,0.000077325385,0.000044431974,0.0000135222635,0.0000737643,0.000015062507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004881117,0.011991047,0.16923249,0.006743942,0.00026294042,0.00511437,0.034497105,0.00013506577,0.0007821006,0.0012095332,0.0016305684,0.7635197],"study_design_scores_gemma":[0.03387352,0.003107009,0.94034326,0.00030984415,0.00050371356,0.00017390418,0.001814715,0.00036206987,0.0030166232,0.00005718519,0.016242461,0.00019569983],"about_ca_topic_score_codex":0.00005745088,"about_ca_topic_score_gemma":0.00005602111,"teacher_disagreement_score":0.7711108,"about_ca_system_score_codex":0.00008864037,"about_ca_system_score_gemma":0.00006789902,"threshold_uncertainty_score":0.49189422},"labels":[],"label_agreement":null},{"id":"W3115920829","doi":"10.1148/radiol.2020191329","title":"Case 285: Primary Breast Lymphoma","year":2020,"lang":"en","type":"article","venue":"Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Chills; Breast cancer; Physical examination; Axillary lymph nodes; Left breast; Quadrant (abdomen); Radiology; Family history; Erythema; Past medical history; Medical history; Surgery; Cancer; Internal medicine","score_opus":0.021402744021030037,"score_gpt":0.2412344424085735,"score_spread":0.21983169838754346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115920829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804248,0.0008078866,0.000025456977,0.009421371,0.00011552569,0.0001995963,0.000029612424,0.00009246468,0.008883255],"genre_scores_gemma":[0.98972636,0.00006777125,0.00042910193,0.009188903,0.0003872316,0.00002705489,0.000053986256,0.000013756344,0.000105859115],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9993067,0.000038304242,0.00014652114,0.00024547146,0.00006077278,0.00020222545],"domain_scores_gemma":[0.9994742,0.0000645874,0.000033359152,0.00016824438,0.000023228355,0.00023637709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003357501,0.00011608477,0.00031369488,0.000026054646,0.000042892843,0.000004635656,0.00003876506,0.00008720187,0.00024931648],"category_scores_gemma":[0.000023528002,0.000088143126,0.00008931095,0.000082779865,0.00006269155,0.000023269993,0.000031136213,0.00003517021,0.0003390118],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011069473,0.0013029673,0.3684928,0.00020590216,0.0008549546,0.24210581,0.0012299637,0.000006264683,0.0030802062,0.005231064,0.071417175,0.30496594],"study_design_scores_gemma":[0.009325971,0.0012103207,0.36356476,0.000019318348,0.00029861255,0.5610473,0.00010098599,0.00018843528,0.0007028566,0.000046223162,0.06328249,0.00021270092],"about_ca_topic_score_codex":0.000043076216,"about_ca_topic_score_gemma":0.0000017414468,"teacher_disagreement_score":0.3189415,"about_ca_system_score_codex":0.00013438404,"about_ca_system_score_gemma":0.00010615523,"threshold_uncertainty_score":0.4357424},"labels":[],"label_agreement":null},{"id":"W3116988381","doi":"10.1016/j.critrevonc.2020.103212","title":"Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Canada","keywords":"Mantle cell lymphoma; Medicine; Randomized controlled trial; Lymphoma; Internal medicine; Systematic review; Clinical trial; Oncology; Transplantation; Surgery; MEDLINE","score_opus":0.04686873006192244,"score_gpt":0.40904868239252035,"score_spread":0.3621799523305979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116988381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070590904,0.9871033,0.0000035990327,0.00068487943,0.00018602729,0.011297957,0.000074873635,0.000020078516,0.00055872626],"genre_scores_gemma":[0.00021107466,0.99601275,0.00096477475,0.00075380516,0.000047989193,0.0016014273,0.00031139507,0.00006909793,0.000027677823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99034595,0.002361079,0.00517756,0.0012063226,0.0003037783,0.0006052967],"domain_scores_gemma":[0.9915632,0.0057752156,0.0011026344,0.00092850445,0.00018228611,0.00044816948],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012427402,0.0009638076,0.01722856,0.00029390724,0.000042299453,0.000011620465,0.00029041374,0.0010963472,0.000051248247],"category_scores_gemma":[0.0056299865,0.00055700017,0.0008130981,0.00092089816,0.00044549565,0.000061187195,0.00021702723,0.0006183807,0.00011617403],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019477135,0.007511062,0.0066693584,0.6783731,0.00024405954,0.0020884383,0.00003166265,3.2174774e-9,1.0679468e-9,0.0004976203,0.00039817733,0.30399173],"study_design_scores_gemma":[0.009336159,0.0025933902,0.0007883216,0.6451543,0.0058214334,0.0006930556,0.0000028814093,0.0000010430432,8.176021e-8,0.000012341827,0.33532327,0.00027370694],"about_ca_topic_score_codex":0.0000029983821,"about_ca_topic_score_gemma":0.000015010629,"teacher_disagreement_score":0.33492512,"about_ca_system_score_codex":0.00074350124,"about_ca_system_score_gemma":0.0005355473,"threshold_uncertainty_score":0.99968815},"labels":[],"label_agreement":null},{"id":"W3117164373","doi":"10.14740/jmc3636","title":"Hepatic Hodgkin Lymphoma Presenting as Solitary Hepatic Mass Following Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder in a Patient With Rheumatoid Arthritis","year":2020,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Methotrexate; Rheumatoid arthritis; Discontinuation; Internal medicine; Chemotherapy; Lymphoma; Bleomycin; Lymphoproliferative disorders; Gastroenterology","score_opus":0.011766815230860742,"score_gpt":0.25816319889203354,"score_spread":0.2463963836611728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117164373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771545,0.016986223,0.000059174126,0.005069092,0.00014188068,0.0004170821,0.000009679699,0.000026467575,0.00013589875],"genre_scores_gemma":[0.9955762,0.001924592,0.00027469514,0.0020389007,0.00008347176,0.000043533928,0.000009125333,0.000043536333,0.0000059581207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957738,0.00027752286,0.0011302147,0.00029404252,0.00203686,0.00048755668],"domain_scores_gemma":[0.99804014,0.0005769158,0.00052262,0.00016742732,0.00015071011,0.00054218736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005087835,0.0003126352,0.0009761101,0.00016542309,0.00011541602,0.00005038591,0.00017916669,0.00016126751,0.0002814463],"category_scores_gemma":[0.0025658987,0.00021065198,0.00051135564,0.00045712673,0.000096857555,0.00019172797,0.00006928039,0.00023681312,0.000018732173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010738833,0.0033939453,0.8988479,0.000103805585,0.0015261779,0.06734176,0.005554027,0.00006242992,0.0001243643,0.000040763272,0.0004145633,0.021516383],"study_design_scores_gemma":[0.25555706,0.06317166,0.3975156,0.042588558,0.003942282,0.13554855,0.050563563,0.03140729,0.010778552,0.0010114309,0.004045639,0.003869828],"about_ca_topic_score_codex":0.0011387534,"about_ca_topic_score_gemma":0.00017879604,"teacher_disagreement_score":0.50133234,"about_ca_system_score_codex":0.0004591275,"about_ca_system_score_gemma":0.0012105294,"threshold_uncertainty_score":0.85901386},"labels":[],"label_agreement":null},{"id":"W3118514290","doi":"10.1158/1078-0432.ccr-20-2378","title":"Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Lymphoma; Germinal center; Cell of origin; Oncology; Medicine; Internal medicine; PTEN; Cancer research; Cyclophosphamide; Biology; B cell; Cancer; Immunology; Chemotherapy; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.06245815259684164,"score_gpt":0.3858503799449771,"score_spread":0.3233922273481355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118514290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931623,0.0008517512,0.0000011676915,0.0008623156,0.00012057955,0.0010226215,0.00020720366,0.000047486912,0.0037246079],"genre_scores_gemma":[0.99410355,0.00052298553,0.000069503025,0.0005565242,0.00023760862,0.00025616682,0.00036551274,0.000075299686,0.0038128246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955703,0.00041056663,0.0005394672,0.00087711244,0.0015866214,0.0010159243],"domain_scores_gemma":[0.9968449,0.00052861916,0.00011505083,0.0006357012,0.0013316998,0.00054403767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066668086,0.00035126175,0.00077881035,0.00015720521,0.00015601257,0.000091165064,0.00019320597,0.00026994818,0.0003349164],"category_scores_gemma":[0.00008002273,0.00020485502,0.000100365345,0.0010052242,0.00037159535,0.0001567586,0.0001515624,0.00064592256,0.00003958006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03516868,0.020758543,0.9368461,0.00018031594,0.00030769763,0.002829199,0.00016612944,0.0000025121208,0.0000041882863,0.000033465865,0.0017853377,0.0019178473],"study_design_scores_gemma":[0.14851747,0.0059934384,0.835402,0.00081669405,0.0001676907,0.000026039821,0.00025086806,0.000015961397,0.0007783251,0.0000028107954,0.0077645485,0.00026412218],"about_ca_topic_score_codex":0.00085653155,"about_ca_topic_score_gemma":0.002704923,"teacher_disagreement_score":0.1133488,"about_ca_system_score_codex":0.0005236683,"about_ca_system_score_gemma":0.0017607728,"threshold_uncertainty_score":0.8353746},"labels":[],"label_agreement":null},{"id":"W3119548493","doi":"10.1016/j.esmoop.2020.100001","title":"Sex as decisive variable in lymphoid neoplasms—an update","year":2021,"lang":"en","type":"editorial","venue":"ESMO Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Variable (mathematics); Mathematics; Biology; Mathematical analysis","score_opus":0.012617745334106664,"score_gpt":0.3292280976095206,"score_spread":0.31661035227541395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119548493","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005556328,0.00089396694,0.000009874255,0.0007400473,0.88518244,0.0024429185,0.00045384504,0.000073600975,0.10464696],"genre_scores_gemma":[0.0023264007,0.003017846,0.006532139,0.0020588108,0.9202947,0.0014103322,0.018309979,0.00026808845,0.045781687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690336,0.00016341692,0.0005511488,0.0010509057,0.00082150573,0.0005096709],"domain_scores_gemma":[0.997341,0.000682325,0.00020194684,0.001163158,0.0002624234,0.00034914672],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004989495,0.00049778825,0.0013310291,0.00016180713,0.000099069046,0.00040254343,0.0007024451,0.0009014961,0.003111688],"category_scores_gemma":[0.0008312756,0.00043228522,0.00014054119,0.00034655098,0.000038180875,0.0002736455,0.0006994687,0.00041244566,0.0009432075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031345253,0.0012122971,0.002330833,0.00005091363,0.00031698265,0.003596268,0.00018910618,0.0000072930925,0.0000036719646,0.00034479506,0.9867634,0.0048709614],"study_design_scores_gemma":[0.009033753,0.00046921417,0.0005260752,0.00074891315,0.0003545092,0.00009580405,0.00013290205,0.000015667914,0.000894054,0.00058446714,0.98673415,0.00041049198],"about_ca_topic_score_codex":0.025348654,"about_ca_topic_score_gemma":0.0023694446,"teacher_disagreement_score":0.05886527,"about_ca_system_score_codex":0.0010833933,"about_ca_system_score_gemma":0.0045530004,"threshold_uncertainty_score":0.99983466},"labels":[],"label_agreement":null},{"id":"W3119693976","doi":"10.1186/s40164-020-00197-9","title":"AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL","year":2021,"lang":"en","type":"review","venue":"Experimental Hematology and Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"Transcription factor; Lymphoma; Cancer research; Hodgkin lymphoma; Transcription (linguistics); Cell biology; Biology; Chemistry; Genetics; Gene; Immunology","score_opus":0.0726494717260614,"score_gpt":0.3470231436944375,"score_spread":0.2743736719683761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119693976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2610515,0.73698896,0.00000722158,0.000044768363,0.00020944202,0.00113419,0.000038568338,0.000022535829,0.00050278736],"genre_scores_gemma":[0.33891582,0.659906,0.00029792855,0.00007726842,0.000034989967,0.00043612288,0.00021201833,0.000035680685,0.00008412584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997454,0.0005082987,0.000690756,0.0007497894,0.00018846759,0.00040868428],"domain_scores_gemma":[0.9988379,0.00033059745,0.00033308016,0.00029686236,0.000021888674,0.00017965524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001411385,0.00058519153,0.0035520063,0.00028693222,0.00009531128,0.000014585735,0.00009005493,0.0010841145,0.000049933005],"category_scores_gemma":[0.00001430017,0.00045687833,0.00036491803,0.00015231087,0.0006567727,0.000096236385,0.00014708078,0.00022808094,0.0000035837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016569534,0.017230975,0.008626,0.017803527,0.0032234893,0.010056109,0.010790323,1.3291425e-7,0.0117366575,0.022960825,0.0009127763,0.89500225],"study_design_scores_gemma":[0.029905817,0.009480222,0.010156475,0.02300435,0.0049615777,0.0065985695,0.02454093,0.000024199353,0.07951256,0.00018317935,0.80964273,0.001989378],"about_ca_topic_score_codex":0.0001877213,"about_ca_topic_score_gemma":0.000040214196,"teacher_disagreement_score":0.8930129,"about_ca_system_score_codex":0.000536926,"about_ca_system_score_gemma":0.00045717676,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W3120351897","doi":"10.3390/curroncol28010053","title":"Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Saskatchewan Health Authority; University of Ottawa; Saskatchewan Health; Hôpital Maisonneuve-Rosemont; Occupational Cancer Research Centre; Ottawa Hospital; CancerCare Manitoba; University Health Network; Queen's University; University of Manitoba; Institut universitaire de cardiologie et de pneumologie de Québec; Centre Hospitalier de l’Université de Montréal; Université Laval; University of Saskatchewan; Université de Montréal; University of Calgary; Princess Margaret Cancer Centre; Research Institute in Oncology and Hematology","funders":"","keywords":"Medicine; Biomarker; Trk receptor; Cancer; Oncology; Internal medicine; Bioinformatics; Cancer research; Computational biology; Genetics; Biology","score_opus":0.13497805681081104,"score_gpt":0.40822924338289346,"score_spread":0.2732511865720824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120351897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98509485,0.010981897,4.5917815e-7,0.0023639316,0.00036700693,0.0004835524,0.00012101681,0.0000052957107,0.0005820242],"genre_scores_gemma":[0.99760365,0.0015291175,0.00044157638,0.000046748035,0.000054362106,0.00023096391,0.000040792555,0.000006831651,0.000045965975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99935496,0.000029366867,0.00018675577,0.00020013975,0.000040883027,0.00018788251],"domain_scores_gemma":[0.9992657,0.00032335447,0.0000525081,0.00008908594,0.00012251378,0.00014686456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039759074,0.00009102332,0.00029589818,0.000088162844,0.000029611734,0.0000022267034,0.000011563689,0.00006281061,0.000046457615],"category_scores_gemma":[0.00013025895,0.000071633614,0.000039658364,0.000116754345,0.000036635138,0.0000056294307,0.000008953759,0.000019180496,0.0000010515216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000126673,0.00061246636,0.49270064,0.00006147623,0.000031359483,0.00011626468,0.00019921635,5.7204255e-7,0.00023996644,0.000021213657,0.00026422038,0.50562596],"study_design_scores_gemma":[0.013442321,0.0014188016,0.92855966,0.0004921375,0.00016594709,0.00009527636,0.00020471943,0.000783736,0.001716423,0.000036665162,0.052997015,0.00008732698],"about_ca_topic_score_codex":0.04173203,"about_ca_topic_score_gemma":0.28436685,"teacher_disagreement_score":0.5055386,"about_ca_system_score_codex":0.0010817521,"about_ca_system_score_gemma":0.0012318284,"threshold_uncertainty_score":0.96464914},"labels":[],"label_agreement":null},{"id":"W3122500409","doi":"10.1177/0391560321990271","title":"Primary renal non-Hodgkin’s lymphoma: A narrative review of literature","year":2021,"lang":"en","type":"review","venue":"Urologia Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Nephrectomy; Non-Hodgkin's lymphoma; Kidney; Biopsy; Radiology; Pathology; Internal medicine","score_opus":0.023250391444990883,"score_gpt":0.33733733373556474,"score_spread":0.3140869422905739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122500409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000147036135,0.99517155,0.000006700254,0.0005019925,0.00044625223,0.0008667031,0.000068743495,0.00001685007,0.0029065225],"genre_scores_gemma":[0.000003962209,0.99496776,0.0010958376,0.002056386,0.0006930297,0.00010979739,0.00050830055,0.000050107556,0.0005148356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650645,0.0005083206,0.0014666556,0.00049242564,0.00061850244,0.00040762013],"domain_scores_gemma":[0.99681985,0.0002718009,0.0014194569,0.00059134304,0.00058413827,0.00031342226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007000062,0.0006563898,0.004635282,0.00027075448,0.00011946136,0.000062759405,0.00027256028,0.00056219695,0.0005602192],"category_scores_gemma":[0.0003619374,0.00038564779,0.0021666714,0.00065316557,0.00009647548,0.000088076275,0.00013547874,0.0007659617,0.000035994755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003419041,0.0007493642,0.00003973034,0.08965591,0.0018545806,0.006576649,0.00017799601,3.919399e-8,6.5485034e-7,0.000023283208,0.06961013,0.8312775],"study_design_scores_gemma":[0.0010527615,0.00061921356,0.00014229347,0.3296654,0.0038854592,0.020739581,0.000007823963,1.1380116e-7,0.0000014551828,0.000006854794,0.64369726,0.00018178883],"about_ca_topic_score_codex":0.0000015872902,"about_ca_topic_score_gemma":2.4930267e-7,"teacher_disagreement_score":0.8310957,"about_ca_system_score_codex":0.0006120636,"about_ca_system_score_gemma":0.0029201042,"threshold_uncertainty_score":0.9998596},"labels":[],"label_agreement":null},{"id":"W3122630168","doi":"10.1200/jco.20.03288","title":"Burkitt Lymphoma International Prognostic Index","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"International Prognostic Index; Lymphoma; Risk stratification; Overall survival; Survival analysis; Stage (stratigraphy); Index (typography)","score_opus":0.1068606257422721,"score_gpt":0.46839124888687095,"score_spread":0.36153062314459883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122630168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94858754,0.00081764173,0.00008372995,0.026421348,0.003311233,0.00008306263,0.0000022541788,0.0000082786355,0.02068489],"genre_scores_gemma":[0.9893668,0.0009599279,0.002469902,0.004514945,0.0018817259,0.0000039905453,0.0000056441568,0.000009247584,0.00078780594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975872,0.000177094,0.0015487692,0.00015127973,0.0003889398,0.00014670611],"domain_scores_gemma":[0.9962541,0.0016587089,0.00083714124,0.0001407314,0.0007838537,0.00032549552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091447996,0.00009404767,0.00087728596,0.00007193695,0.000021603753,0.000013292566,0.00010844921,0.0002472788,0.00055113446],"category_scores_gemma":[0.005546883,0.000064392625,0.00051535864,0.000099502984,0.00008810993,0.00007209902,0.000062024075,0.00022863716,0.00006575637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073136727,0.0049673887,0.62421227,0.000006825529,0.0006882343,0.008885067,0.000022178496,0.0000027868643,0.000023047898,0.00033732803,0.0072848885,0.35283864],"study_design_scores_gemma":[0.010609025,0.00268319,0.721203,0.00007578758,0.00027567786,0.0029711018,0.000052758223,0.00005267864,0.0001685096,0.00033780924,0.26152626,0.000044168322],"about_ca_topic_score_codex":0.0000065668346,"about_ca_topic_score_gemma":0.000010396407,"teacher_disagreement_score":0.35279447,"about_ca_system_score_codex":0.00025659276,"about_ca_system_score_gemma":0.0029995015,"threshold_uncertainty_score":0.6640538},"labels":[],"label_agreement":null},{"id":"W3123323752","doi":"10.1002/ctm2.236","title":"Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphoma","year":2021,"lang":"en","type":"letter","venue":"Clinical and Translational Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Power Generation","funders":"Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Diffuse large B-cell lymphoma; Medicine; Cerebrospinal fluid; Liquid biopsy; Lymphoma; Pathology; Oncology; International Prognostic Index; Internal medicine; Oncogene; Cancer research; Cancer; Cell cycle","score_opus":0.018805827602325714,"score_gpt":0.25459905503536207,"score_spread":0.23579322743303635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123323752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85003966,0.00074527314,0.000025688016,0.14776224,0.00016690292,0.0006829099,0.00048057918,0.000012105175,0.00008464855],"genre_scores_gemma":[0.92747545,0.00022648835,0.00031720713,0.065736696,0.0014310626,0.00005624918,0.0046373894,0.00003793384,0.00008153197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664277,0.00025370187,0.0010639635,0.00058839686,0.0011501595,0.00030102965],"domain_scores_gemma":[0.9964876,0.0021417798,0.0006452477,0.00032150385,0.0002892913,0.0001145764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045986302,0.00035587678,0.001061747,0.00006962165,0.00009681817,0.000013380689,0.00008989441,0.0003313751,0.0001435343],"category_scores_gemma":[0.00017170573,0.00018481711,0.00013446654,0.00021116434,0.00021788978,0.00004932836,0.000023270019,0.00056266546,0.0000027021804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050774886,0.0029946084,0.98297274,0.00014648048,0.00074425474,0.0001695937,0.000252738,0.0000013435315,0.0000013846815,0.000021127084,0.010423772,0.0017642222],"study_design_scores_gemma":[0.06306546,0.0015241151,0.92413604,0.001730519,0.0017177904,0.0000029155026,0.000046221186,0.00004152093,0.000010335102,0.00013264638,0.007409038,0.00018341157],"about_ca_topic_score_codex":0.0007242338,"about_ca_topic_score_gemma":0.00032032843,"teacher_disagreement_score":0.08202554,"about_ca_system_score_codex":0.00009377579,"about_ca_system_score_gemma":0.00028109178,"threshold_uncertainty_score":0.7536623},"labels":[],"label_agreement":null},{"id":"W3124016473","doi":"10.1038/s41409-020-01182-w","title":"Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial","year":2021,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Novo Nordisk Fonden","keywords":"Medicine; Rituximab; Follicular lymphoma; Lymphoma; Oncology; Internal medicine; Surgery","score_opus":0.008423622143924295,"score_gpt":0.20240795588862137,"score_spread":0.1939843337446971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124016473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973304,0.0002445639,0.000030646886,0.00032013425,0.00026985048,0.0010536875,0.00011850771,0.000023067265,0.0006091442],"genre_scores_gemma":[0.99842215,0.00018878332,0.0005087409,0.0001074675,0.000025244593,0.00010479844,0.00041448086,0.000033078082,0.00019524325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790376,0.00010207777,0.0006580434,0.00038880153,0.000627924,0.00031941704],"domain_scores_gemma":[0.9988343,0.00011239438,0.00030975117,0.00041008566,0.00025609447,0.00007737817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018514844,0.00025127808,0.0006273419,0.0001116801,0.00007695229,0.00001664788,0.00009652197,0.00013758907,0.000034193927],"category_scores_gemma":[0.00004691281,0.00017295025,0.00027098224,0.00047047035,0.00007559648,0.000107968845,0.000016476066,0.00005148404,0.000003830924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05898215,0.0048421677,0.9229446,0.00043206915,0.00036211024,0.0002757598,0.001114697,0.0000666776,0.0022295818,0.00063522125,0.000053426676,0.008061521],"study_design_scores_gemma":[0.25295275,0.0005721994,0.7238861,0.0011355814,0.0005292702,0.000034153367,0.00013162538,0.000029463916,0.020446548,0.00005747467,0.00007173891,0.00015310053],"about_ca_topic_score_codex":0.00054846547,"about_ca_topic_score_gemma":0.000776135,"teacher_disagreement_score":0.19905852,"about_ca_system_score_codex":0.00021129736,"about_ca_system_score_gemma":0.00030466003,"threshold_uncertainty_score":0.7052707},"labels":[],"label_agreement":null},{"id":"W3124795613","doi":"10.18203/issn.2454-5929.ijohns20210174","title":"Supraglottic laryngeal lymphomatoid granulomatosis in an immunocompetent patient: a case report","year":2021,"lang":"en","type":"article","venue":"International Journal of Otorhinolaryngology and Head and Neck Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Lymphomatoid granulomatosis; Histopathology; Differential diagnosis; Lymphoproliferative disease; Otorhinolaryngology; Dermatology; Pathology; Disease; Hematology; Lymphoma; Radiology; Internal medicine; Surgery","score_opus":0.018174664668943578,"score_gpt":0.2874124689460775,"score_spread":0.26923780427713395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124795613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913722,0.006443148,0.0000020929526,0.0013689277,0.00059364835,0.00007992147,0.000012755521,0.000008777552,0.000118521886],"genre_scores_gemma":[0.9970062,0.0018201055,0.00025408398,0.0007131099,0.00012691003,0.000008816539,0.00004398004,0.000010922536,0.00001591599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854213,0.00010958265,0.00070872175,0.00021958834,0.00023921368,0.00018076699],"domain_scores_gemma":[0.99881184,0.00026769558,0.00025955902,0.00013273708,0.00033992424,0.00018822549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027340953,0.00014909657,0.00051893445,0.00029692138,0.00006236203,0.000044387114,0.0000435773,0.000111065114,0.000052738647],"category_scores_gemma":[0.00011687903,0.00012323588,0.00015399419,0.000081909675,0.00007124911,0.00026839576,0.000056494242,0.0001447468,0.0000016394536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029646314,0.0006995651,0.6130107,0.000018934987,0.00019662935,0.37884986,0.00023336726,3.503758e-7,0.00036874262,0.0001421367,0.00007963078,0.0061035985],"study_design_scores_gemma":[0.0015134495,0.00019300211,0.5350961,0.00019825762,0.000045958725,0.4612511,0.000099495526,0.000015865016,0.00062765024,0.00007760412,0.0008163992,0.00006509841],"about_ca_topic_score_codex":0.00014272971,"about_ca_topic_score_gemma":0.00011516738,"teacher_disagreement_score":0.08240123,"about_ca_system_score_codex":0.000094994626,"about_ca_system_score_gemma":0.00028763714,"threshold_uncertainty_score":0.5025413},"labels":[],"label_agreement":null},{"id":"W3125135564","doi":"10.1002/hon.2838","title":"Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; BC Cancer Agency","funders":"Takeda Oncology","keywords":"Medicine; Dacarbazine; ABVD; Internal medicine; Neutropenia; Brentuximab vedotin; Hazard ratio; Vinblastine; Gastroenterology; Population; Febrile neutropenia; Subgroup analysis; Adverse effect; Surgery; Lymphoma; Oncology; Confidence interval; Chemotherapy; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.013377878726427905,"score_gpt":0.26856359267082425,"score_spread":0.2551857139443963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125135564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974364,0.00041010795,0.000030047075,0.00046240067,0.000086484186,0.0011216974,0.00017517735,0.000032623037,0.00024507954],"genre_scores_gemma":[0.9979759,0.00012910202,0.0009423158,0.00027986369,0.00002288806,0.00018070081,0.00041968576,0.000019370513,0.000030177878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968079,0.0005832513,0.00083174923,0.0008473505,0.000517333,0.00041242232],"domain_scores_gemma":[0.9966564,0.0018562824,0.00044023595,0.0005710644,0.0002897727,0.00018623246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865193,0.00035875538,0.00186421,0.0001580925,0.00008816543,0.000018162918,0.00015659959,0.00025594156,0.0002037854],"category_scores_gemma":[0.00055809907,0.00019824535,0.00016531674,0.001036199,0.0002585772,0.000057991216,0.00027518914,0.0002241853,0.000006784645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037511056,0.021091454,0.96156466,0.00001723558,0.0015062076,0.00054376514,0.0003976571,0.000048776663,0.000010002903,0.00027015217,0.00012879413,0.0106702],"study_design_scores_gemma":[0.04238446,0.0056883134,0.9479214,0.00005395979,0.0024194259,0.0000064328974,0.00043416835,0.00021398482,0.0002145636,0.000044566135,0.000435139,0.00018356681],"about_ca_topic_score_codex":0.00047778804,"about_ca_topic_score_gemma":0.0020968278,"teacher_disagreement_score":0.038633358,"about_ca_system_score_codex":0.00041383118,"about_ca_system_score_gemma":0.0002091673,"threshold_uncertainty_score":0.8084211},"labels":[],"label_agreement":null},{"id":"W3125708849","doi":"10.1007/s11764-020-00976-7","title":"Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis","year":2021,"lang":"en","type":"article","venue":"Journal of Cancer Survivorship","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Incidence (geometry); Malignancy; Lymphoma; Internal medicine; Cumulative incidence; Population; Epidemiology; Young adult; Pediatrics; Late effect; Radiation therapy; Surgery; Cohort","score_opus":0.010195291310567454,"score_gpt":0.2848164862214912,"score_spread":0.27462119491092374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125708849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994888,0.003863551,0.000064040956,0.00048466155,0.0003187424,0.00030899234,0.000020762382,0.000010167089,0.000041073545],"genre_scores_gemma":[0.99876326,0.0003796511,0.00021172452,0.0003096463,0.00011836509,0.00004956383,0.00004208653,0.000022923876,0.000102747385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984295,0.0001624614,0.00054801116,0.0002458973,0.0003570607,0.00025706724],"domain_scores_gemma":[0.99859184,0.00029840798,0.00033874848,0.00017553431,0.00037735686,0.00021809418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032346838,0.00020313743,0.00075759226,0.0004330971,0.00004901638,0.000041026084,0.000056099914,0.000110786306,0.000028362596],"category_scores_gemma":[0.00023911739,0.0001617462,0.0003543679,0.0008660192,0.000018512592,0.000095082134,0.000011708296,0.00007280773,0.0000010075487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017406656,0.0006069714,0.9846269,0.00036968762,0.0009504188,0.0004624416,0.00018917106,0.00020120131,0.00005227238,0.000017480537,0.0000111207955,0.010771655],"study_design_scores_gemma":[0.011669315,0.0003426057,0.9809344,0.001382867,0.0019421343,0.000030591735,0.00005754049,0.0012320543,0.0021626407,0.00006239414,0.000041868625,0.00014161604],"about_ca_topic_score_codex":0.038501997,"about_ca_topic_score_gemma":0.09983477,"teacher_disagreement_score":0.061332777,"about_ca_system_score_codex":0.00045364915,"about_ca_system_score_gemma":0.00029604734,"threshold_uncertainty_score":0.9679007},"labels":[],"label_agreement":null},{"id":"W3126964460","doi":"10.1182/bloodadvances.2020002910","title":"Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Refractory (planetary science); Gastroenterology; Nausea; Phases of clinical research; Diarrhea; Surgery; Chemotherapy","score_opus":0.006723838885264753,"score_gpt":0.2380142866764259,"score_spread":0.23129044779116115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126964460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936907,0.0050498075,0.0000025673723,0.000120861136,0.000040602765,0.00025842153,0.000021110294,0.0000128669335,0.0008030449],"genre_scores_gemma":[0.99626434,0.0013565822,0.0019493066,0.00008531438,0.0000214156,0.000016920028,0.000051089795,0.00001198994,0.00024302906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991369,0.00002921833,0.00022483687,0.0002449488,0.00021460369,0.00014948605],"domain_scores_gemma":[0.99941003,0.00014282482,0.00009270334,0.0001922028,0.000084606014,0.000077626464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004009293,0.00012536353,0.00033347897,0.000048895286,0.000028635131,0.000005766566,0.000028859096,0.00003864602,0.000057216123],"category_scores_gemma":[0.00006844448,0.000080338985,0.00002421742,0.00018452219,0.00006660523,0.000102436854,0.00002582483,0.00003343662,0.0000024406386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047797086,0.0048255264,0.9162278,0.00011693496,0.00012109729,0.00038363668,0.0001100029,0.0000030604256,0.000080043734,0.00006372255,0.000022406484,0.07326603],"study_design_scores_gemma":[0.041988403,0.0018178943,0.9446153,0.00048288034,0.000173316,0.000033986318,0.00008168542,0.0000010461063,0.0037270302,0.0000050804633,0.006981182,0.00009220148],"about_ca_topic_score_codex":0.000022302067,"about_ca_topic_score_gemma":0.00007085851,"teacher_disagreement_score":0.07317383,"about_ca_system_score_codex":0.000044964723,"about_ca_system_score_gemma":0.00014956956,"threshold_uncertainty_score":0.32761285},"labels":[],"label_agreement":null},{"id":"W3127011222","doi":"10.14740/jh766","title":"Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Immunophenotyping; Medicine; Bone marrow; Pathology; Lymphoma; Immunology; Flow cytometry","score_opus":0.010231428538100655,"score_gpt":0.2426480615753535,"score_spread":0.23241663303725285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127011222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243615,0.071441956,0.00007796684,0.0028698482,0.0003593102,0.0001242723,0.0000128081065,0.000014268007,0.0007380286],"genre_scores_gemma":[0.995573,0.0014368308,0.0008025927,0.0015001056,0.00006254657,0.000010722284,0.000035584326,0.000025766309,0.0005528452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983503,0.00011207139,0.0007237004,0.00020463318,0.0002919563,0.00031731243],"domain_scores_gemma":[0.99816924,0.00013292726,0.0009133257,0.00024245011,0.00034550187,0.00019653932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014262491,0.0002036041,0.00076183974,0.00009913102,0.000080061065,0.000024860157,0.00008873108,0.00014844538,0.000270022],"category_scores_gemma":[0.00010717848,0.00015905173,0.00021857226,0.00017155583,0.000060698432,0.00007468923,0.000058917787,0.00013232474,0.000041433887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012225137,0.010391972,0.04103274,0.0005745338,0.0023524584,0.031068524,0.000647761,0.000005057855,0.6076485,0.0007225938,0.27860758,0.025725761],"study_design_scores_gemma":[0.016454259,0.0013088543,0.003072134,0.0005529211,0.0005156764,0.014337705,0.0005218617,0.000022573078,0.93392444,0.00033164344,0.028727496,0.0002304591],"about_ca_topic_score_codex":0.000021491782,"about_ca_topic_score_gemma":0.0000050463073,"teacher_disagreement_score":0.3262759,"about_ca_system_score_codex":0.00031074687,"about_ca_system_score_gemma":0.00038675262,"threshold_uncertainty_score":0.64859414},"labels":[],"label_agreement":null},{"id":"W3127209017","doi":"10.1111/bjh.17281","title":"Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"NIH Clinical Center; Lymphoma Research Foundation","keywords":"Medicine; Internal medicine; Lenalidomide; Oncology; Refractory (planetary science); Rituximab; Chemotherapy; Chlorambucil; Brentuximab vedotin; Progression-free survival; Lymphoma; Salvage therapy; Surgery; Hodgkin lymphoma; Multiple myeloma; Cyclophosphamide","score_opus":0.011420359829982848,"score_gpt":0.2678203961424771,"score_spread":0.25640003631249425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127209017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852261,0.013839654,0.00010948053,0.00046101617,0.000118346754,0.00009022502,0.000029568138,0.00000823585,0.00011740875],"genre_scores_gemma":[0.992717,0.0045444537,0.0022558628,0.00032204945,0.000043758562,0.0000053270037,0.000018511886,0.000018870325,0.00007411212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785787,0.00019321605,0.0010835343,0.00026934576,0.00032785148,0.00026820292],"domain_scores_gemma":[0.99794173,0.00021904048,0.00084958324,0.0002729548,0.0004711173,0.00024555394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023640411,0.0001739656,0.0019025395,0.00031141573,0.00006134659,0.000023058938,0.00009697004,0.00008338605,0.000086944274],"category_scores_gemma":[0.00039007163,0.00016544251,0.0004994222,0.0006997516,0.00029182027,0.00007639769,0.00006732701,0.00010569879,0.0000041061594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028005874,0.0012664502,0.7901995,0.00010002932,0.002839513,0.14920665,0.00014340512,0.000008541905,0.0001970409,0.00004138295,0.00033193443,0.055385467],"study_design_scores_gemma":[0.006921193,0.0005615517,0.7673137,0.0001566444,0.0032381308,0.21811001,0.0002460773,0.000040718583,0.0018440426,0.000016005426,0.001423488,0.00012841927],"about_ca_topic_score_codex":0.0006246458,"about_ca_topic_score_gemma":0.0010137475,"teacher_disagreement_score":0.068903364,"about_ca_system_score_codex":0.00022899806,"about_ca_system_score_gemma":0.0004934828,"threshold_uncertainty_score":0.67465496},"labels":[],"label_agreement":null},{"id":"W3128028170","doi":"10.1200/jco.20.01375","title":"Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Medicine; Diffuse large B-cell lymphoma; Vincristine; Internal medicine; International Prognostic Index; Rituximab; Lenalidomide; Clinical endpoint; CHOP; Prednisone; Gastroenterology; Cyclophosphamide; Performance status; Phases of clinical research; Oncology; Lymphoma; Surgery; Randomized controlled trial; Chemotherapy; Multiple myeloma","score_opus":0.05037879450228988,"score_gpt":0.4354927524106929,"score_spread":0.385113957908403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128028170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323714,0.00048880524,0.000028069428,0.0037824733,0.00096042413,0.0010852651,0.000027084758,0.000007147459,0.00038362027],"genre_scores_gemma":[0.99470365,0.00074720994,0.0013092366,0.0026492137,0.00026018382,0.00012522444,0.0000103708735,0.000022518392,0.00017240789],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924109,0.0016459901,0.004785893,0.00036388985,0.00042092762,0.00037241998],"domain_scores_gemma":[0.98852795,0.008623004,0.0017368367,0.0003256206,0.0003607095,0.0004258935],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004449298,0.00027184107,0.0048167743,0.00041127583,0.00003020545,0.000013677092,0.00017838858,0.0002870051,0.00020714449],"category_scores_gemma":[0.013375373,0.00018438773,0.0011103452,0.000321188,0.00009655219,0.00014849938,0.00018334495,0.0003903086,0.000010161018],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17854086,0.41337278,0.28891534,0.00004425819,0.0010629337,0.014279269,0.0015733283,0.0000048565666,0.00075407216,0.000029564224,0.0010044888,0.10041824],"study_design_scores_gemma":[0.6781491,0.018715534,0.29919133,0.0002458448,0.0005538234,0.00010165033,0.0009407047,0.00004597145,0.0005146836,0.000087806955,0.0013397716,0.0001137797],"about_ca_topic_score_codex":0.00026077963,"about_ca_topic_score_gemma":0.002126712,"teacher_disagreement_score":0.49960825,"about_ca_system_score_codex":0.00050009013,"about_ca_system_score_gemma":0.0012668517,"threshold_uncertainty_score":0.9949354},"labels":[],"label_agreement":null},{"id":"W3129284555","doi":"10.14740/wjon1351","title":"Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico","year":2021,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Epidemiology; Follicular lymphoma; Internal medicine; Disease; Stage (stratigraphy); Hodgkin lymphoma; Regimen; Oncology","score_opus":0.05275186499528361,"score_gpt":0.4076466057198795,"score_spread":0.35489474072459587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129284555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871267,0.0021873023,0.00003495561,0.007945352,0.00057577644,0.000076840246,0.0000038660314,0.0000018563763,0.0020473253],"genre_scores_gemma":[0.98910475,0.0034393533,0.0050022644,0.001994994,0.00025402935,0.0000023305638,0.000004101921,0.0000081383105,0.00019006642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776065,0.00039631064,0.0014123119,0.00014691874,0.000088944464,0.0001948441],"domain_scores_gemma":[0.99678636,0.0019643363,0.0007262862,0.00014177506,0.00019967473,0.00018158232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014005785,0.00010231037,0.0013202904,0.00019530272,0.00001450311,0.0000014691877,0.00005486439,0.00013917308,0.00010444527],"category_scores_gemma":[0.0011938588,0.00007752806,0.00018806345,0.00017140202,0.00016763716,0.000029583733,0.00005287472,0.00017243596,0.000004672546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004198225,0.0015052663,0.7788502,0.000020122385,0.00017377253,0.0026316275,0.000052374337,4.79647e-7,0.00009266364,0.00031315887,0.000985202,0.21495534],"study_design_scores_gemma":[0.007633709,0.0021258856,0.95654035,0.00017047346,0.00021349585,0.0022663393,0.000049196533,0.000036632893,0.00034433414,0.00024234223,0.030326324,0.00005089594],"about_ca_topic_score_codex":0.000017520912,"about_ca_topic_score_gemma":0.00015542354,"teacher_disagreement_score":0.21490444,"about_ca_system_score_codex":0.0002199033,"about_ca_system_score_gemma":0.0007180058,"threshold_uncertainty_score":0.31615025},"labels":[],"label_agreement":null},{"id":"W3130424028","doi":"10.1016/j.ijrobp.2021.02.011","title":"Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group","year":2021,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Kyowa Hakko Kirin","keywords":"Medicine; Radiation therapy; Lymphoma; Oncology; Internal medicine; T-cell lymphoma; Radiation oncology; Medical physics","score_opus":0.05459431912829796,"score_gpt":0.37288176407024093,"score_spread":0.31828744494194294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130424028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01114092,0.97010475,0.0040249834,0.003448604,0.008005344,0.001799726,0.001210001,0.00006895729,0.00019672356],"genre_scores_gemma":[0.009147826,0.96729857,0.0057744067,0.0021262004,0.009192335,0.0002616537,0.0059393696,0.00014303422,0.00011661423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943212,0.0010362164,0.0025404003,0.0008890561,0.000739842,0.00047328655],"domain_scores_gemma":[0.98928225,0.0029270207,0.004734719,0.00047425603,0.0023143361,0.00026741263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014325018,0.0008711201,0.0024876785,0.00036492295,0.00027936543,0.00018093387,0.0009566019,0.001160319,0.00016214071],"category_scores_gemma":[0.0009411832,0.0006233513,0.0012952563,0.00034166893,0.00025151204,0.00042942652,0.00014151142,0.000491217,0.00002718563],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011748807,0.0024830634,0.011103926,0.000058937025,0.004817232,0.00007396329,0.00042037174,0.00007557175,0.00006538917,0.00065917446,0.01047206,0.96859545],"study_design_scores_gemma":[0.028650578,0.0022592759,0.0038073147,0.00057347707,0.0012986545,0.00037177568,0.000065527594,0.003915622,0.00011092218,0.0024416028,0.9560108,0.00049443636],"about_ca_topic_score_codex":0.00019222418,"about_ca_topic_score_gemma":0.000014688731,"teacher_disagreement_score":0.96810097,"about_ca_system_score_codex":0.0033039504,"about_ca_system_score_gemma":0.0038132945,"threshold_uncertainty_score":0.9996218},"labels":[],"label_agreement":null},{"id":"W3131792249","doi":"10.1016/j.jmoldx.2021.02.005","title":"Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin","year":2021,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; CancerCare Manitoba","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute","keywords":"Germinal center; Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Lymphoma; Cell of origin; Oncology; Cancer research; Pathology; B cell; Biology; Medicine; Gene; Internal medicine; Immunology; Cancer; Genetics; Chromosome; Antibody","score_opus":0.006896625422142562,"score_gpt":0.23954204295427933,"score_spread":0.23264541753213677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131792249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983974,0.0007566127,0.00018059679,0.00006021171,0.00013628505,0.00034687528,0.00007719306,0.0000017062532,0.000043091048],"genre_scores_gemma":[0.99837846,0.00032793192,0.0010814646,0.000078588215,0.000029676794,0.000006151548,0.00007073139,0.000021437027,0.0000055353557],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792445,0.00010783608,0.00069481373,0.00016366877,0.0009386065,0.0001706423],"domain_scores_gemma":[0.9977196,0.00011618905,0.0008626599,0.000355551,0.00083018356,0.00011585355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018838675,0.00016922604,0.0004967318,0.00012983744,0.000021293043,0.000009461661,0.0001474079,0.00013288796,0.000021402715],"category_scores_gemma":[0.00012877888,0.0001052231,0.0001810218,0.00023209133,0.000043063428,0.00008654702,0.00007353631,0.00013906627,3.270052e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066654175,0.022595825,0.9290076,0.00011020112,0.00014043282,0.00056890177,0.00022727899,0.00010999883,0.046231665,0.000034635224,0.00006297709,0.0002439575],"study_design_scores_gemma":[0.020138228,0.0004821971,0.45747015,0.00051108113,0.00028494702,0.000029782068,0.000042270123,0.000006863616,0.5209342,0.000016100932,0.000028907658,0.000055232136],"about_ca_topic_score_codex":0.000012148149,"about_ca_topic_score_gemma":0.000007278794,"teacher_disagreement_score":0.47470257,"about_ca_system_score_codex":0.00014350431,"about_ca_system_score_gemma":0.00033514312,"threshold_uncertainty_score":0.42908734},"labels":[],"label_agreement":null},{"id":"W3132205831","doi":"10.1200/jco.20.01366","title":"ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Chugai Pharmaceutical; MorphoSys; Kite Pharma; Incyte; Eisai; Karyopharm Therapeutics; Genentech; Celgene; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Medicine; CHOP; Lenalidomide; Internal medicine; International Prognostic Index; Placebo; Diffuse large B-cell lymphoma; Vincristine; Gastroenterology; Neutropenia; Clinical endpoint; Rituximab; Surgery; Lymphoma; Oncology; Cyclophosphamide; Chemotherapy; Pathology; Clinical trial; Multiple myeloma","score_opus":0.09420162739570512,"score_gpt":0.4095635778351286,"score_spread":0.3153619504394235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132205831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956602,0.0007547352,0.000010955797,0.00044710198,0.0010374401,0.0010815302,0.000012734301,0.000012614311,0.0009826729],"genre_scores_gemma":[0.9976996,0.0007438389,0.00048744978,0.0004641742,0.0002593318,0.000024189947,0.000023226945,0.00003888729,0.000259289],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99418545,0.0008991788,0.0032111933,0.0004549873,0.0007533084,0.00049587776],"domain_scores_gemma":[0.99240625,0.0031510862,0.0022575597,0.00047296844,0.001141762,0.0005704044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014733463,0.00034422043,0.002997529,0.0002318197,0.000059799582,0.000017117647,0.0002082681,0.00040400316,0.00015770439],"category_scores_gemma":[0.0023746477,0.00022924076,0.00041816264,0.0005155094,0.00013002813,0.00014356276,0.00012801775,0.0005045303,0.00001613676],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30426306,0.27603126,0.3813756,0.00008082706,0.0022876672,0.013696119,0.0015037312,0.0002667637,0.000016050246,0.000012888179,0.0015268971,0.018939134],"study_design_scores_gemma":[0.7236745,0.06862385,0.20097785,0.00028553177,0.0019480538,0.0001134215,0.001143689,0.00021038153,0.00009316567,0.00000473212,0.0027455618,0.00017930828],"about_ca_topic_score_codex":0.00018403718,"about_ca_topic_score_gemma":0.0010343138,"teacher_disagreement_score":0.4194114,"about_ca_system_score_codex":0.0012531205,"about_ca_system_score_gemma":0.0045106113,"threshold_uncertainty_score":0.93481666},"labels":[],"label_agreement":null},{"id":"W3132352516","doi":"10.1007/978-3-030-65403-0_8","title":"Clinical Features and Diagnostic Considerations","year":2021,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medical diagnosis; Mononucleosis; Medicine; Gold standard (test); Lymphoproliferative disease; Disease; Histopathology; Differential diagnosis; Clinical diagnosis; Pathology; Intensive care medicine; Dermatology; Radiology; Immunology; Virus","score_opus":0.044285255085169,"score_gpt":0.3272114065549988,"score_spread":0.2829261514698298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132352516","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048091696,0.017390605,0.0000023372527,0.0048174574,0.00024275469,0.00038498736,0.000033475855,0.000048543876,0.9765989],"genre_scores_gemma":[0.037075683,0.011893451,0.0014147004,0.0049136886,0.00045424796,0.000026958087,0.00020277269,0.000034443623,0.94398403],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912,0.000010945469,0.00029195423,0.00034177897,0.00013882476,0.0000964969],"domain_scores_gemma":[0.9975377,0.0018595392,0.00005768701,0.00027381393,0.00009227018,0.00017902584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005353225,0.00019877586,0.00050684146,0.000040356907,0.00005619153,0.000037961076,0.000012359526,0.00029221972,0.0037808123],"category_scores_gemma":[0.0004438247,0.00014373,0.00017783818,0.0000056498307,0.00010670504,0.0000142233785,0.000046606085,0.00017036186,0.00011663971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000791302,0.00020580256,0.018953929,0.000052888383,0.00071477727,0.0031002457,0.000017138183,4.908382e-8,6.940577e-7,0.7142841,0.24983093,0.0128315175],"study_design_scores_gemma":[0.004955892,0.0007990319,0.31876865,0.0013674535,0.0031889426,0.0033338747,0.0000246212,0.0000015161694,0.00007542812,0.02231141,0.6446275,0.0005456802],"about_ca_topic_score_codex":0.000017708264,"about_ca_topic_score_gemma":0.000094379335,"teacher_disagreement_score":0.69197273,"about_ca_system_score_codex":0.000037111255,"about_ca_system_score_gemma":0.0002185652,"threshold_uncertainty_score":0.99712986},"labels":[],"label_agreement":null},{"id":"W3132415718","doi":"10.1200/jco.20.01186","title":"Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Hodgkin lymphoma; Childhood cancer; Lymphoma; Oncology; Cancer; Pediatric cancer; Cancer therapy; Pediatrics; Internal medicine","score_opus":0.11489340953421741,"score_gpt":0.48009353934775706,"score_spread":0.36520012981353966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132415718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343836,0.0036661902,0.000019767776,0.00081999646,0.0010584099,0.0007022394,0.00023417339,0.000005136794,0.000055720873],"genre_scores_gemma":[0.9777468,0.019742202,0.0002762216,0.00020803834,0.0019438433,0.00002863982,0.00001490655,0.000023710429,0.000015655698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99501973,0.0011351875,0.0027934744,0.00030051943,0.00053717213,0.00021391772],"domain_scores_gemma":[0.9810667,0.011696506,0.00554328,0.00052750594,0.00093484577,0.00023113184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031155893,0.00021401289,0.0022338096,0.00008445244,0.000057448335,0.000007920949,0.00019113164,0.00026913226,0.00017862822],"category_scores_gemma":[0.0069683157,0.00010847545,0.0015886481,0.00023239784,0.00009014251,0.000043106476,0.00004796649,0.00037022866,0.0000018282051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058148447,0.027279824,0.8006082,0.0000059462354,0.004466367,0.0015033303,0.00032458975,0.000025389772,0.000007259816,0.0000010129929,0.0010207843,0.15894243],"study_design_scores_gemma":[0.033175144,0.026791021,0.93572557,0.00006477669,0.0034340157,0.00018708223,0.00012489944,0.000008725729,0.0001749726,0.00007332342,0.0001573,0.000083159706],"about_ca_topic_score_codex":0.0031342926,"about_ca_topic_score_gemma":0.001267844,"teacher_disagreement_score":0.15885927,"about_ca_system_score_codex":0.00026500417,"about_ca_system_score_gemma":0.0044149165,"threshold_uncertainty_score":0.8342228},"labels":[],"label_agreement":null},{"id":"W3133685805","doi":"10.1182/bloodadvances.2020002982","title":"Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Contraindication; Medicine; Internal medicine; Vincristine; International Prognostic Index; Rituximab; Population; Gastroenterology; Diffuse large B-cell lymphoma; Surgery; Oncology; Cyclophosphamide; Lymphoma; Chemotherapy; Pathology","score_opus":0.007586780525837057,"score_gpt":0.280367191135127,"score_spread":0.2727804106092899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133685805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971894,0.0013895468,0.000027571135,0.0008976728,0.00003808079,0.0003484794,0.00002538283,0.000007770209,0.00007609443],"genre_scores_gemma":[0.9985155,0.0002143078,0.0009609771,0.00017111558,0.000015158617,0.00003777806,0.00004159504,0.000006288829,0.000037283364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935305,0.000017234475,0.00017119486,0.00019446012,0.00015831219,0.000105773055],"domain_scores_gemma":[0.9995897,0.000052113803,0.00008010407,0.00011025591,0.00010495044,0.000062885054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021674621,0.00009816855,0.00027946767,0.000052613927,0.00002212331,0.000008324787,0.000022087837,0.000022844728,0.00001184049],"category_scores_gemma":[0.000061858394,0.000064962485,0.000026083544,0.00011149196,0.00004450034,0.00011209605,0.00001751104,0.000023773819,0.0000011578558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014383816,0.0022210109,0.9811201,0.000038044553,0.00011818332,0.00007413714,0.00022593956,0.0000024642852,0.0001154708,0.00004906365,0.0000024030878,0.015889315],"study_design_scores_gemma":[0.00923376,0.00049509434,0.9816644,0.00016801195,0.00015132823,0.0000063548296,0.00009579192,0.0000013007858,0.008073718,0.000016482458,0.000024813146,0.00006889979],"about_ca_topic_score_codex":0.000014515172,"about_ca_topic_score_gemma":0.00017247391,"teacher_disagreement_score":0.015820416,"about_ca_system_score_codex":0.000013804092,"about_ca_system_score_gemma":0.00004289786,"threshold_uncertainty_score":0.26490933},"labels":[],"label_agreement":null},{"id":"W3134300927","doi":"10.14740/jmc3660","title":"Primary Breast Diffuse Large B-Cell Lymphoma in a 42-Year-Old Female: A Case Report and Review of Literature","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; CHOP; Lymphoma; Radiology; Breast cancer; Malignancy; Cyclophosphamide; Radiation therapy; Biopsy; Mammography; Chemotherapy; Cancer; Internal medicine","score_opus":0.013076783983135349,"score_gpt":0.2894938312208002,"score_spread":0.27641704723766486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134300927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81838787,0.17581749,0.0000014848007,0.005298533,0.00009597376,0.00010987,0.000039401606,0.0000034374016,0.00024595106],"genre_scores_gemma":[0.9091356,0.08674733,0.00030523323,0.0033390066,0.00023512707,0.0000056905,0.00003091061,0.000013149319,0.00018799996],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977027,0.00011814367,0.0008757035,0.00017885769,0.00093915727,0.00018539056],"domain_scores_gemma":[0.9982715,0.00031885167,0.000392622,0.00023980194,0.00032005153,0.00045714047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009045786,0.00014861183,0.0007827159,0.00010203492,0.000023432567,0.00001747139,0.000056810615,0.00014702977,0.0002670557],"category_scores_gemma":[0.0016152955,0.00009614717,0.00021020546,0.00029559582,0.000055584467,0.00008262238,0.00008053086,0.00020750925,0.0000013516839],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001536685,0.0068862448,0.04478152,0.004831633,0.000083008395,0.9297231,0.00014579944,5.432538e-9,0.000025301728,0.00002962985,0.00446082,0.008879277],"study_design_scores_gemma":[0.0148466285,0.00033119082,0.039288886,0.02963254,0.00032123935,0.9105434,0.0002083111,0.0000020404702,0.00026914876,0.0000054571615,0.0044757407,0.00007544699],"about_ca_topic_score_codex":0.000032436546,"about_ca_topic_score_gemma":0.00002194973,"teacher_disagreement_score":0.09074769,"about_ca_system_score_codex":0.00013612442,"about_ca_system_score_gemma":0.00089478976,"threshold_uncertainty_score":0.39207676},"labels":[],"label_agreement":null},{"id":"W3134569209","doi":"10.1182/blood.2020009806","title":"Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Anaplastic large-cell lymphoma; Chemotherapy; Chemotherapy regimen; Anaplastic lymphoma kinase; Lymphoma; Hodgkin lymphoma; Lung cancer","score_opus":0.008790326467041958,"score_gpt":0.23731495414156306,"score_spread":0.2285246276745211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134569209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977116,0.00017670618,0.000010580414,0.0003503662,0.00005013773,0.0012173015,0.000060549413,0.000013697987,0.00040907765],"genre_scores_gemma":[0.9980814,0.000053448304,0.0011321931,0.00007836108,0.000071973416,0.00012992667,0.00037097232,0.00001898501,0.00006277806],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990819,0.000023937106,0.00026244114,0.00023773046,0.00024638267,0.00014760777],"domain_scores_gemma":[0.9992954,0.00010159525,0.00014630886,0.00019214157,0.00021463692,0.00004990173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007969706,0.00011764352,0.00029705738,0.00007493461,0.000020708132,0.0000086435,0.00003190813,0.000050953928,0.000007644106],"category_scores_gemma":[0.0000559648,0.000081687394,0.00004951829,0.0002511578,0.000017198307,0.000036797952,0.000008225108,0.00003429825,0.0000013184103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053763542,0.03837487,0.90076345,0.0001254031,0.000260172,0.000047670528,0.0003036604,0.0000022094614,0.000042654185,0.00009111699,0.0004281311,0.005797098],"study_design_scores_gemma":[0.54677576,0.0058186194,0.43805245,0.00007948628,0.0003977137,0.000003371104,0.00002271611,0.000007647913,0.008551328,0.000017663313,0.00019387138,0.000079403886],"about_ca_topic_score_codex":0.00003233715,"about_ca_topic_score_gemma":0.00003913232,"teacher_disagreement_score":0.4930122,"about_ca_system_score_codex":0.000035329507,"about_ca_system_score_gemma":0.00017512876,"threshold_uncertainty_score":0.33311152},"labels":[],"label_agreement":null},{"id":"W3134747077","doi":"10.6004/jnccn.2020.7654","title":"Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; Diffuse large B-cell lymphoma; Internal medicine; Proportional hazards model; Rituximab; Population; Confidence interval; Cohort; Lymphoma; Surgery","score_opus":0.028263567137291393,"score_gpt":0.3030276553712567,"score_spread":0.2747640882339653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134747077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921141,0.0019246071,0.000011816298,0.0048724073,0.00045768218,0.00034983386,0.00013353472,0.0000064564006,0.00012955992],"genre_scores_gemma":[0.99106544,0.00021587811,0.00015734724,0.007838504,0.00038014734,0.00009364749,0.00005472113,0.000025234025,0.0001690502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978262,0.00020851809,0.0005932709,0.00024908173,0.0007774457,0.0003454363],"domain_scores_gemma":[0.99778146,0.0005198157,0.00041722442,0.00017221854,0.00096931896,0.0001399536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593219,0.00024323801,0.0006200494,0.00013668709,0.00008180206,0.00004119337,0.00012491186,0.00010188767,0.000103788945],"category_scores_gemma":[0.00013958296,0.00016058589,0.000266024,0.0005627088,0.000017901939,0.00008002748,0.00005731716,0.00016556898,0.0000024250567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006459463,0.006346977,0.9807843,0.000017680082,0.00034431907,0.0003609471,0.00019581155,0.007888064,0.000014893014,0.000047766764,0.003063096,0.00029021033],"study_design_scores_gemma":[0.030204153,0.00031309953,0.9600165,0.0013907652,0.00014900415,0.00003315561,0.0000530368,0.00095573184,0.00023142765,0.00007642914,0.006423885,0.00015279895],"about_ca_topic_score_codex":0.0001615233,"about_ca_topic_score_gemma":0.002512776,"teacher_disagreement_score":0.029558206,"about_ca_system_score_codex":0.0031262988,"about_ca_system_score_gemma":0.00094786054,"threshold_uncertainty_score":0.81751627},"labels":[],"label_agreement":null},{"id":"W3135026042","doi":"10.1111/bjh.17404","title":"The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Positron emission tomography; Clinical trial; Lymphoma; Medical physics; Intensive care medicine; Oncology; Pathology; Radiology","score_opus":0.045986671335053575,"score_gpt":0.3238952963564847,"score_spread":0.2779086250214311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135026042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027951722,0.9956058,0.000001945851,0.00078686915,0.00032015564,0.00038660795,0.00001200745,0.000005236158,0.00008619666],"genre_scores_gemma":[0.0047016866,0.99492997,0.00007096421,0.00005958243,0.00012352999,0.000043591135,0.0000069026955,0.000038243368,0.000025527335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764335,0.0004450166,0.001116626,0.00022914517,0.0002932931,0.00027256558],"domain_scores_gemma":[0.9956855,0.0026834877,0.0009975579,0.00026563377,0.00021630022,0.00015150242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003877538,0.00027964276,0.003342937,0.000108683256,0.000101027705,0.0000381401,0.0001839208,0.0002903589,0.000016669994],"category_scores_gemma":[0.00060328696,0.00018596627,0.0008288518,0.000115165014,0.00024482986,0.000025743224,0.00007196075,0.00020447613,0.0000033424958],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051874795,0.000420893,0.000065434135,0.0047059986,0.0019595856,0.06640697,0.000039378465,2.7262535e-8,5.7024646e-8,0.0019044598,0.00033819163,0.9241538],"study_design_scores_gemma":[0.0011230614,0.00021864973,0.0005764488,0.02739885,0.0032805318,0.48190737,0.0000702667,1.7276274e-7,0.000004191332,0.00019184737,0.48513213,0.0000965047],"about_ca_topic_score_codex":0.00002459459,"about_ca_topic_score_gemma":0.000030946925,"teacher_disagreement_score":0.9240573,"about_ca_system_score_codex":0.00010569283,"about_ca_system_score_gemma":0.0007353973,"threshold_uncertainty_score":0.75834846},"labels":[],"label_agreement":null},{"id":"W3135339074","doi":"10.1182/bloodadvances.2020002690","title":"End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Rituximab; Vincristine; Internal medicine; International Prognostic Index; Confidence interval; Diffuse large B-cell lymphoma; Oncology; Progression-free survival; CHOP; Obinutuzumab; Prednisone; Nuclear medicine; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.013699833991832009,"score_gpt":0.2620760841848614,"score_spread":0.2483762501930294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135339074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95433444,0.04174164,0.0000010209894,0.00089903723,0.00011425541,0.00044692238,0.0007781798,0.00003273067,0.001651786],"genre_scores_gemma":[0.9735459,0.023594668,0.00137235,0.00007806959,0.00013008933,0.00025860817,0.00037302473,0.000020148813,0.0006271304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985455,0.000039163544,0.00042079593,0.0005509672,0.00017739624,0.00026617336],"domain_scores_gemma":[0.9989485,0.00033162915,0.00011259188,0.0004016912,0.000048381433,0.00015721121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003694857,0.00028836072,0.00056796893,0.00007067563,0.000042369167,0.000017026878,0.00003692603,0.00002048547,0.00010371602],"category_scores_gemma":[0.000069104695,0.00020153324,0.00012033325,0.00014987834,0.00007273873,0.00011738901,0.000036777798,0.000036370606,0.000013693582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010305608,0.008184568,0.9148365,0.00007386514,0.00059303996,0.014998426,0.00066755654,0.000035693458,0.00014458025,0.000033872697,0.000029903349,0.059371404],"study_design_scores_gemma":[0.07187686,0.0052733677,0.72174424,0.0011174934,0.001727133,0.0007908741,0.00031017076,0.0000772859,0.11932161,0.00036034823,0.0770221,0.00037850323],"about_ca_topic_score_codex":0.0010199422,"about_ca_topic_score_gemma":0.004395557,"teacher_disagreement_score":0.19309227,"about_ca_system_score_codex":0.00020498685,"about_ca_system_score_gemma":0.00017262112,"threshold_uncertainty_score":0.8218287},"labels":[],"label_agreement":null},{"id":"W3135457836","doi":"10.1093/jcag/gwab002.145","title":"A147 PRIMARY COLONIC MANTLE CELL LYMPHOMA: A RARE ENTITY","year":2021,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Colonoscopy; Mantle cell lymphoma; Gastroenterology; Internal medicine; Transverse colon; Abdomen; Dysplasia; Lymphoma; Colorectal cancer; Radiology; Pathology; Cancer","score_opus":0.00591972027281505,"score_gpt":0.20561817565310492,"score_spread":0.19969845538028988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135457836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771169,0.00015557198,0.0000025324207,0.020704748,0.00056860317,0.000089061105,0.000042532352,0.0000019914555,0.001318058],"genre_scores_gemma":[0.99459696,0.00008747643,0.00018182589,0.003477389,0.0001030331,0.000002140908,0.000010063605,0.000007905967,0.0015332169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998795,0.00019650432,0.0003821608,0.00008743253,0.000285502,0.00025340836],"domain_scores_gemma":[0.998391,0.00005683424,0.00072150276,0.00016117499,0.00046016305,0.0002093226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032794895,0.000084243125,0.00037220537,0.00010891241,0.00008336038,0.000013809574,0.00011450365,0.00010173747,0.000121900346],"category_scores_gemma":[0.0001701601,0.00006414686,0.00028976082,0.00010181096,0.00002893213,0.000046481236,0.0000306499,0.000107613676,0.00000809497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013748145,0.00038646476,0.9700247,0.000025496376,0.00029801714,0.0002249589,0.000076582175,0.000006318733,0.00042593622,0.00002222331,0.028214645,0.00015718726],"study_design_scores_gemma":[0.0062475023,0.0004963835,0.97977334,0.00005252479,0.00030691441,0.0004747391,0.000038963994,0.0000039804845,0.0013014976,0.000040194802,0.011235755,0.000028183935],"about_ca_topic_score_codex":0.002118706,"about_ca_topic_score_gemma":0.15631664,"teacher_disagreement_score":0.15419793,"about_ca_system_score_codex":0.0034202777,"about_ca_system_score_gemma":0.0016721246,"threshold_uncertainty_score":0.8943907},"labels":[],"label_agreement":null},{"id":"W3135826314","doi":"10.1182/blood.2020007683","title":"Characterization of DLBCL with a PMBL gene expression signature","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Terry Fox Research Institute; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Lymphoma; Germinal center; Diffuse large B-cell lymphoma; Pathology; Bone marrow; Biology; Large-cell lymphoma; Reed–Sternberg cell; Gene signature; BCL6; Cancer research; B cell; Medicine; Gene; Gene expression; Immunology; Genetics; Antibody; Hodgkin lymphoma","score_opus":0.0070007974373664785,"score_gpt":0.2135871744456708,"score_spread":0.20658637700830432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135826314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985206,0.00037541482,0.000040050098,0.00023448799,0.000023231056,0.00011232148,0.000015175779,0.000016177904,0.0006625391],"genre_scores_gemma":[0.99774104,0.00009338433,0.0014534218,0.00013989156,0.000059448375,0.000018724551,0.0002166316,0.000008821809,0.00026862088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958336,0.0000116320225,0.00008382559,0.00012355662,0.00012875997,0.00006887907],"domain_scores_gemma":[0.99965984,0.000009681597,0.00004610535,0.00015970808,0.00008065158,0.000044014254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014466739,0.000062462306,0.00013647086,0.000019342213,0.000017090022,0.0000046888604,0.000015646994,0.00004648167,0.000081020844],"category_scores_gemma":[0.000009372151,0.000040970346,0.00003197726,0.00008950438,0.000009409932,0.000026740565,0.000013092352,0.000026971236,0.000005187038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041673335,0.002163846,0.076640084,0.000038462884,0.00007622544,0.0002536958,0.00009935643,1.487993e-7,0.91998035,0.000028164386,0.000025731686,0.0006522712],"study_design_scores_gemma":[0.004009371,0.00015070794,0.22201094,0.00015658411,0.00016415374,0.00008432278,0.000012167376,0.0000011665837,0.7729964,0.000002596565,0.0003781003,0.000033479824],"about_ca_topic_score_codex":0.0000024455255,"about_ca_topic_score_gemma":0.0000010055556,"teacher_disagreement_score":0.14698394,"about_ca_system_score_codex":0.00000931578,"about_ca_system_score_gemma":0.00007125979,"threshold_uncertainty_score":0.16707222},"labels":[],"label_agreement":null},{"id":"W3136178209","doi":"10.1016/j.jasc.2020.12.006","title":"An approach to small lymph node biopsies: pearls and pitfalls of reporting in the real world","year":2021,"lang":"en","type":"review","venue":"Journal of the American Society of Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Biopsy; Lymph node; Pathology; Radiology; Fine-needle aspiration; Population","score_opus":0.08082915775953534,"score_gpt":0.3783547067851605,"score_spread":0.2975255490256251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136178209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2551054,0.7428631,0.000022836355,0.0009159387,0.00009141508,0.00047079747,0.000016539305,0.0000039405445,0.0005099746],"genre_scores_gemma":[0.016300604,0.97055477,0.011878238,0.00097088394,0.0001926411,0.000021043423,0.0000062516574,0.000029293218,0.000046297748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963472,0.0006623161,0.0021257116,0.0002703567,0.0003502173,0.00024418163],"domain_scores_gemma":[0.9915586,0.0003831919,0.007129693,0.0006336708,0.00019465276,0.000100178026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022725754,0.00027289087,0.003283584,0.00013261398,0.000046752644,0.00001408118,0.0004026205,0.00010284869,0.000002138916],"category_scores_gemma":[0.0002916425,0.0001367605,0.0013695826,0.0007685769,0.0005060901,0.000027769858,0.00013820427,0.00035590847,2.3883752e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012710881,0.0035176086,0.23322283,0.010023849,0.0015085947,0.0008014171,0.010360436,0.000021340617,0.0003986496,0.00015446718,0.0015042119,0.7383595],"study_design_scores_gemma":[0.0034494323,0.0025377409,0.7869916,0.033734888,0.009289486,0.02837738,0.021510372,0.000019512501,0.00010357013,0.00005028568,0.11318701,0.0007487292],"about_ca_topic_score_codex":0.00027736157,"about_ca_topic_score_gemma":0.00000812013,"teacher_disagreement_score":0.73761076,"about_ca_system_score_codex":0.0002100948,"about_ca_system_score_gemma":0.0006663611,"threshold_uncertainty_score":0.5576931},"labels":[],"label_agreement":null},{"id":"W3136954491","doi":"10.3390/curroncol28020119","title":"Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical trial; Internal medicine; Salvage therapy; Chemotherapy; Lymphoma; Oncology; Refractory (planetary science); Workload; Randomized controlled trial; Indirect costs","score_opus":0.2700835564735325,"score_gpt":0.5103858822678368,"score_spread":0.24030232579430427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136954491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808099,0.014421027,0.000002772069,0.00138324,0.0011310468,0.0017205795,0.00044138276,0.00000793509,0.000082116916],"genre_scores_gemma":[0.9972067,0.0013633016,0.000072187504,0.00030012234,0.00016576136,0.00048894156,0.0003648496,0.000018566583,0.000019556008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960031,0.0020436416,0.00097087916,0.00040434318,0.000286936,0.00029108653],"domain_scores_gemma":[0.9924861,0.0046319426,0.0017810995,0.0004047667,0.0005511482,0.00014489706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021450901,0.00019705792,0.0018203105,0.0001561269,0.00018734146,0.000008815466,0.00013237802,0.00030328202,0.000063735606],"category_scores_gemma":[0.0052393815,0.000105717336,0.00049363705,0.00048174025,0.0003869868,0.000019149069,0.000035586854,0.00015510646,1.794831e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02094613,0.002247376,0.5786764,0.00007077262,0.00864763,0.000038384253,0.0021882488,0.0000078742,0.000094917385,0.000076018994,0.0013097435,0.38569647],"study_design_scores_gemma":[0.16484784,0.0073283673,0.8002439,0.00041765792,0.01566695,0.000013353045,0.00064970343,0.00027282385,0.00042706935,0.000015337766,0.009944388,0.00017260735],"about_ca_topic_score_codex":0.0064018057,"about_ca_topic_score_gemma":0.42132008,"teacher_disagreement_score":0.4149183,"about_ca_system_score_codex":0.0019051324,"about_ca_system_score_gemma":0.0045812586,"threshold_uncertainty_score":0.96776575},"labels":[],"label_agreement":null},{"id":"W3137610925","doi":"10.1016/s1470-2045(21)00005-x","title":"Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Merck","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Interim analysis; Oncology; Internal medicine; Interim; Refractory (planetary science); Open label; Lymphoma; Hodgkin lymphoma; Clinical trial; Cancer; Immunotherapy; Materials science","score_opus":0.15786344631065277,"score_gpt":0.45622588838626277,"score_spread":0.29836244207561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137610925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938118,0.0004273477,0.0000074486143,0.0018874916,0.00038963024,0.0015103389,0.000054851607,0.00003613673,0.001874949],"genre_scores_gemma":[0.997632,0.00029324065,0.0004980154,0.0006308595,0.00017528169,0.00034090847,0.00015554084,0.000028366103,0.00024577384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99619216,0.0015574942,0.0008108636,0.00062431116,0.00032275662,0.00049240346],"domain_scores_gemma":[0.9965598,0.0016424159,0.0003601465,0.001088323,0.00016300521,0.0001862901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008662121,0.0002965576,0.0022129384,0.00024408629,0.000082670354,0.000040325944,0.00047950435,0.00018296964,0.000580889],"category_scores_gemma":[0.0007081621,0.00018655063,0.00017063995,0.0010359944,0.00017067506,0.00008935191,0.00033034387,0.00021868553,0.000023624916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6686434,0.14145903,0.02049245,0.000059628663,0.007760671,0.006027664,0.0060638157,0.000033490818,0.002480708,0.00017282041,0.0013015642,0.14550476],"study_design_scores_gemma":[0.8747726,0.01935252,0.08423259,0.00007534974,0.0066574104,0.00007013524,0.0035178193,0.004157695,0.00089114986,0.0000108532495,0.0060274894,0.00023437617],"about_ca_topic_score_codex":0.0005968799,"about_ca_topic_score_gemma":0.006125072,"teacher_disagreement_score":0.20612922,"about_ca_system_score_codex":0.0009851027,"about_ca_system_score_gemma":0.00095284206,"threshold_uncertainty_score":0.7607314},"labels":[],"label_agreement":null},{"id":"W3140390667","doi":"10.6000/1929-2279.2012.01.01.01","title":"Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study","year":2012,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Lymphoma; Medicine; Cervix; Pathology; Differential diagnosis; Uterine cervix; Histopathological examination; Disease; Internal medicine; Cancer; Carcinoma","score_opus":0.05389907946681535,"score_gpt":0.40967978228380475,"score_spread":0.35578070281698937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140390667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921806,0.005773954,0.000002596501,0.0008968001,0.00013404914,0.00051466294,0.000016106285,0.0000028169936,0.0004784016],"genre_scores_gemma":[0.9987701,0.00047156954,0.00025178114,0.000035947312,0.00026564044,0.000041620886,0.0000031791076,0.000020233218,0.00013991621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735117,0.000093727445,0.0006584171,0.0001275631,0.0014379987,0.00033112135],"domain_scores_gemma":[0.9975667,0.00023196405,0.0005502447,0.0005148244,0.00095944694,0.00017681804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011664416,0.00013836681,0.0005655016,0.00016053258,0.00006822701,0.000011577958,0.00026229417,0.000045791672,0.00015324759],"category_scores_gemma":[0.00015427946,0.00006842636,0.00016651694,0.00035157637,0.00028718845,0.0001577669,0.00018008545,0.00018902832,0.0000012419437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023041856,0.0037150907,0.9607848,0.0001716798,0.00096594205,0.0010541879,0.000413353,0.0000024524554,0.020104479,0.000011011344,0.0032999818,0.0071728257],"study_design_scores_gemma":[0.0039552455,0.002347032,0.87465674,0.0004824467,0.00025097842,0.0027349126,0.00029990912,0.0000012106143,0.112709984,0.000015528452,0.00248263,0.000063393214],"about_ca_topic_score_codex":0.0015008776,"about_ca_topic_score_gemma":0.000109099485,"teacher_disagreement_score":0.0926055,"about_ca_system_score_codex":0.0005412202,"about_ca_system_score_gemma":0.0009536444,"threshold_uncertainty_score":0.27903458},"labels":[],"label_agreement":null},{"id":"W3144497774","doi":"10.1002/pbc.28562","title":"Pediatric classical Hodgkin lymphoma","year":2021,"lang":"en","type":"review","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Cog; Chemotherapy; Procarbazine; Lymphoma; Disease; Internal medicine; Hodgkin lymphoma; Clinical trial; Vincristine; Cyclophosphamide","score_opus":0.04714299371303457,"score_gpt":0.35397026690399264,"score_spread":0.30682727319095804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144497774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060185004,0.99428314,0.0000013647107,0.00018886157,0.001539414,0.0013036078,0.00030403573,0.00018092846,0.0015968238],"genre_scores_gemma":[0.00008046035,0.97942203,0.00023299156,0.00027376364,0.015482319,0.0019315239,0.00042287816,0.00020117237,0.0019528641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536,0.00019952426,0.0012139679,0.0013930511,0.0009079333,0.00092547917],"domain_scores_gemma":[0.9969565,0.0004713381,0.0006464596,0.0010338139,0.00021580691,0.00067608047],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001890456,0.0010828521,0.0040434785,0.0005568446,0.00014213385,0.00009738009,0.00032049973,0.0008803015,0.0013022734],"category_scores_gemma":[0.00013903725,0.00081638363,0.001966466,0.0019004366,0.000049188006,0.00007573872,0.00024316492,0.00043220626,0.00055529637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009978592,0.0023786249,0.012760038,0.024755463,0.001189763,0.0019269108,0.000022642575,1.6456528e-7,1.4822117e-8,0.000087871085,0.04623093,0.9106376],"study_design_scores_gemma":[0.0031308157,0.00022705477,0.0015193127,0.0023110248,0.06839431,0.0005540379,0.000003946613,6.224961e-7,0.0000011360819,0.0000041199983,0.9231394,0.0007142466],"about_ca_topic_score_codex":0.00014807565,"about_ca_topic_score_gemma":0.000017219145,"teacher_disagreement_score":0.9099234,"about_ca_system_score_codex":0.0007078741,"about_ca_system_score_gemma":0.0054934467,"threshold_uncertainty_score":0.99961066},"labels":[],"label_agreement":null},{"id":"W3144522074","doi":"10.1186/s13223-021-00539-0","title":"Autoantibodies to speckled protein family in primary biliary cholangitis","year":2021,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Autoantibody; Anti-nuclear antibody; Immunofluorescence; Nuclear protein; Antibody; Immunology; Promyelocytic leukemia protein; Leukemia; Biology; Medicine; Pathology; Genetics; Gene","score_opus":0.019846518207785404,"score_gpt":0.30604631813087685,"score_spread":0.28619979992309147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144522074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782257,0.0071460977,0.0000071955865,0.006665276,0.00023869959,0.00030808532,0.0000056537265,0.000042499207,0.007360796],"genre_scores_gemma":[0.9856148,0.0055550653,0.0017331414,0.004058502,0.00012434724,0.00009408084,0.000078170204,0.000021030208,0.0027209064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983718,0.00016093862,0.0005505943,0.0004967033,0.000106944135,0.0003130665],"domain_scores_gemma":[0.99916387,0.00022149103,0.00005665276,0.00035375662,0.00007319944,0.00013105106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019329159,0.00017148782,0.0006031128,0.00008254912,0.000047069345,0.000017618717,0.00006751177,0.00023145243,0.00018338134],"category_scores_gemma":[0.00025226639,0.00014205599,0.00014461695,0.00017316456,0.00014323009,0.00004865849,0.00019505853,0.00022724776,0.0001628627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022383132,0.00783924,0.43782592,0.00008270616,0.0029586582,0.0100203715,0.0003912699,0.000001741643,0.03130246,0.006654116,0.0037900023,0.49689522],"study_design_scores_gemma":[0.0041812765,0.0009801625,0.93049836,0.00015127241,0.000019354686,0.00015188503,0.00013125314,0.0000048151915,0.0008578959,0.0001690172,0.06272211,0.00013259932],"about_ca_topic_score_codex":0.00019105955,"about_ca_topic_score_gemma":0.00023919351,"teacher_disagreement_score":0.4967626,"about_ca_system_score_codex":0.00007285661,"about_ca_system_score_gemma":0.00020879452,"threshold_uncertainty_score":0.5792875},"labels":[],"label_agreement":null},{"id":"W3145045505","doi":"10.1002/cnr2.1377","title":"Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies","year":2021,"lang":"en","type":"article","venue":"Cancer Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Central nervous system; Medicine; Anaplastic large-cell lymphoma; Lymphoma; Disease; Oncology; Internal medicine; Pediatrics; Pathology","score_opus":0.008033182687179424,"score_gpt":0.2434322301058962,"score_spread":0.23539904741871678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145045505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807721,0.013388402,0.00090477936,0.00067396805,0.00080696633,0.0008961264,0.000026467873,0.00008510164,0.0024460915],"genre_scores_gemma":[0.9981768,0.00017376996,0.00017784657,0.00017320385,0.0002797094,0.00023601706,0.000076245815,0.000035976744,0.00067044614],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99852014,0.000019761226,0.0003454479,0.00044549027,0.00022289474,0.00044629336],"domain_scores_gemma":[0.9992038,0.00002174227,0.00016375442,0.00033240428,0.000083723615,0.00019455282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005511842,0.00020520907,0.00039147877,0.000051944073,0.00007577447,0.000055378336,0.00002938249,0.00008286872,0.0000453317],"category_scores_gemma":[0.0000075688517,0.00015200874,0.00011946228,0.00018205187,0.000019330208,0.00008184065,0.000016855012,0.000051550633,0.0000016953187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056143603,0.012661623,0.41606408,0.0056038895,0.0027981217,0.4632114,0.0035531688,0.008359104,0.0013817069,0.0055662734,0.009660772,0.06552551],"study_design_scores_gemma":[0.052005332,0.0018847323,0.8509182,0.0038752188,0.0027154437,0.038496356,0.0058697467,0.0015709096,0.015777338,0.00023135202,0.025669303,0.0009860678],"about_ca_topic_score_codex":0.00052786694,"about_ca_topic_score_gemma":0.00081115373,"teacher_disagreement_score":0.43485412,"about_ca_system_score_codex":0.0006094515,"about_ca_system_score_gemma":0.0018671132,"threshold_uncertainty_score":0.61987364},"labels":[],"label_agreement":null},{"id":"W31457797","doi":"10.1007/pl00022794","title":"Management of localized (stage I and II) clinically aggressive lymphomas","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Disease; Lymphoma; Radiation therapy; Internal medicine; Hematology; Aggressive lymphoma; Clinical trial; Oncology; Refractory (planetary science); Chemotherapy; Randomized controlled trial; B symptoms; Rituximab","score_opus":0.11536952752844024,"score_gpt":0.43295082305079474,"score_spread":0.3175812955223545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31457797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079430034,0.99131256,0.0000045640345,0.0002755309,0.000083123094,0.00093102653,0.000052811454,0.0000179791,0.006528097],"genre_scores_gemma":[0.00091252994,0.99748945,0.0005479513,0.00019009614,0.00002239626,0.00012484289,0.0000974803,0.00003353545,0.0005816927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973746,0.0001243703,0.001504259,0.00046177028,0.00022138935,0.00031362567],"domain_scores_gemma":[0.99711555,0.0003444934,0.0016714241,0.00059987284,0.00011118749,0.00015745849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021090763,0.00038880596,0.0040429044,0.00020206052,0.000036017427,0.000003306847,0.0001501317,0.00040709108,0.00016673372],"category_scores_gemma":[0.00007923061,0.00027097602,0.0006776021,0.00021587673,0.0002929684,0.000019938867,0.00024404314,0.00009371569,0.000016230631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013415994,0.0013763695,0.0006595669,0.044361513,0.0030981388,0.00400213,0.00003513109,4.3361013e-8,4.405208e-8,0.011455844,0.0017614567,0.9331156],"study_design_scores_gemma":[0.0025191535,0.0011597079,0.00010287418,0.038287748,0.0028134217,0.0016595693,0.00004328654,0.0000010552144,0.000048344846,0.0002072922,0.95294356,0.00021400815],"about_ca_topic_score_codex":0.000027677961,"about_ca_topic_score_gemma":0.0000012376154,"teacher_disagreement_score":0.95118207,"about_ca_system_score_codex":0.000016841697,"about_ca_system_score_gemma":0.00016719972,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W3148446124","doi":"10.1182/blood.v130.suppl_1.419.419","title":"A Simulation Analysis to Evaluate the Effect of Prospective Biomarker Testing on Progression-Free Survival (PFS) in DLBCL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Randomization; Population; Internal medicine; Oncology; Prospective cohort study; Biomarker; Clinical trial; Surgery","score_opus":0.036270301535498546,"score_gpt":0.3683797931621523,"score_spread":0.33210949162665376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148446124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963076,0.000059939077,0.000005520767,0.00039476706,0.000036951475,0.0011164165,0.000007351528,0.000015101452,0.0020563656],"genre_scores_gemma":[0.99956435,0.000001017143,0.00016837346,0.000016351953,0.00003813655,0.00018136912,0.000004807963,0.000009235835,0.00001637496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896014,0.000108430555,0.00018052063,0.00023315114,0.00037553074,0.00014225881],"domain_scores_gemma":[0.9980517,0.0009371661,0.00011494667,0.00074751757,0.000094749055,0.000053945994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066857255,0.000121728415,0.0003243409,0.00013023282,0.0001288009,0.000029296792,0.00013316129,0.000039137558,0.0000085971515],"category_scores_gemma":[0.0034591935,0.00006283728,0.00011318279,0.00032055052,0.000036658792,0.000033231197,0.000082514474,0.000042951317,0.000009593238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003388524,0.0009209522,0.9816974,0.000020082183,0.0008134984,0.000035336183,0.000106111496,0.00052014587,0.000323822,0.000010954397,0.000005075437,0.01520776],"study_design_scores_gemma":[0.009754261,0.0014017596,0.9706113,0.00019598771,0.0018530245,0.0000011356163,0.000007993543,0.005378259,0.010705799,0.000028241917,0.0000030662507,0.00005919711],"about_ca_topic_score_codex":0.00020473692,"about_ca_topic_score_gemma":0.00012440504,"teacher_disagreement_score":0.015148563,"about_ca_system_score_codex":0.000058235662,"about_ca_system_score_gemma":0.00002675224,"threshold_uncertainty_score":0.41412276},"labels":[],"label_agreement":null},{"id":"W3149092134","doi":"10.1182/blood.2020007507","title":"Mutational landscape of gray zone lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Institut Carnot Santé Animale; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"Lymphoma; Biology; RELB; Mutation; Gene; Cancer research; Genetics; Immunology; P50","score_opus":0.014370583573348812,"score_gpt":0.2361975682613343,"score_spread":0.2218269846879855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149092134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930091,0.00059336965,0.000018548695,0.0015913133,0.000020879288,0.00010474582,0.000019184414,0.000026082987,0.0046168026],"genre_scores_gemma":[0.9983713,0.000023669363,0.0007668245,0.0006113754,0.00010428136,0.000013444893,0.000048417613,0.0000068504114,0.000053823936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995457,0.000007019994,0.00011710786,0.00010736984,0.00014839837,0.00007438396],"domain_scores_gemma":[0.9997253,0.00003110291,0.000035886223,0.00007657102,0.00003738301,0.00009378471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001756906,0.000060227023,0.00014954162,0.000019373634,0.0000140716975,0.0000032455127,0.000025985082,0.000026299076,0.00020816532],"category_scores_gemma":[0.000027382277,0.00004548782,0.00006271188,0.000089569585,0.000015706337,0.000016648379,0.00001231457,0.000011415063,0.00007210948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015933889,0.0041674366,0.97363245,0.0001316366,0.0005638298,0.00053145346,0.0007021549,0.000004452138,0.0036715302,0.0016430733,0.0033760571,0.011416597],"study_design_scores_gemma":[0.01823201,0.0007485473,0.8974649,0.000043711818,0.00048983213,0.00013509986,0.000096219585,0.000072281975,0.07882227,0.000040656338,0.003769077,0.00008542615],"about_ca_topic_score_codex":0.0000150836795,"about_ca_topic_score_gemma":0.000001350758,"teacher_disagreement_score":0.07616757,"about_ca_system_score_codex":0.0000066468656,"about_ca_system_score_gemma":0.00006603007,"threshold_uncertainty_score":0.22792643},"labels":[],"label_agreement":null},{"id":"W3149640503","doi":"10.3324/haematol.2020.274258","title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Lymphoma; Mantle cell lymphoma; Biology; Follicular lymphoma; Cancer research; Comparative genomic hybridization; B cell; Malignancy; B-cell lymphoma; Non-Hodgkin's lymphoma; Genetics; Gene; Immunology; Genome; Antibody","score_opus":0.02294369896182233,"score_gpt":0.2724843191269026,"score_spread":0.24954062016508025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149640503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848062,0.0043536657,0.000049372247,0.0004406355,0.000064814456,0.00023635235,0.0000074088616,0.000032250013,0.010009331],"genre_scores_gemma":[0.9953013,0.00090087316,0.0030022624,0.0004858114,0.000030310057,0.0000773881,0.000029565635,0.000010662166,0.00016182955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903756,0.000041558164,0.0002462701,0.0003348924,0.00011715225,0.00022254104],"domain_scores_gemma":[0.99944633,0.00010003443,0.0000464864,0.00025763354,0.00004055729,0.00010894764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050366154,0.00014142253,0.0003444383,0.00006988121,0.00007796141,0.0000394411,0.000038223447,0.00008450305,0.000249477],"category_scores_gemma":[0.000026137894,0.000113172326,0.000056042416,0.0001570968,0.000046701876,0.000032518044,0.000041568943,0.00004535989,0.00011995255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098956756,0.0022332491,0.9576556,0.00016394662,0.000052587566,0.012807112,0.0006392355,0.000011155871,0.0029743842,0.001677891,0.0039448305,0.017741058],"study_design_scores_gemma":[0.0048576943,0.00021944314,0.93436444,0.00015340048,0.00005183044,0.0020654134,0.00026275826,0.00023663805,0.04346262,0.00019123488,0.013938475,0.0001960696],"about_ca_topic_score_codex":0.00002996372,"about_ca_topic_score_gemma":0.000032867116,"teacher_disagreement_score":0.040488236,"about_ca_system_score_codex":0.00007147786,"about_ca_system_score_gemma":0.000084998,"threshold_uncertainty_score":0.46150336},"labels":[],"label_agreement":null},{"id":"W3153230195","doi":"10.20944/preprints202104.0376.v1","title":"Genetic Events Inhibiting Apoptosis in Diffuse Large B-cell Lymphoma","year":2021,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Apoptosis; Downregulation and upregulation; Cancer research; Chemoimmunotherapy; Lymphoma; Biology; Diffuse large B-cell lymphoma; Intrinsic apoptosis; Cell biology; Programmed cell death; Immunology; Genetics; Gene; Rituximab; Caspase","score_opus":0.059345272118209585,"score_gpt":0.3174834988053183,"score_spread":0.25813822668710873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153230195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908646,0.0011853192,0.00001488065,0.00040324178,0.00052710716,0.0013226913,0.00003987032,0.00014744524,0.0054948414],"genre_scores_gemma":[0.99533767,0.0013905884,0.0005820395,0.00047679155,0.00022577711,0.00080427557,0.00024575467,0.000106652704,0.00083048304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956669,0.00021727353,0.0009910669,0.0016761286,0.00064364617,0.000804986],"domain_scores_gemma":[0.99729854,0.000112826565,0.00038387187,0.0016780235,0.00016450393,0.0003622554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004162829,0.0006680818,0.0011152783,0.00032091627,0.000095355834,0.000036258454,0.0003409095,0.000582247,0.0006313993],"category_scores_gemma":[0.00024795058,0.00067114,0.00055772084,0.0002873196,0.00004271235,0.000069258575,0.002624534,0.0004989804,0.0009162186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007243367,0.019238401,0.9733915,0.00071288174,0.00025269183,0.0005288604,0.0011360766,0.000025182517,0.002775061,0.000012356213,0.000027452734,0.00182715],"study_design_scores_gemma":[0.017059632,0.000036315465,0.85554934,0.00162628,0.0003223363,0.000047863272,0.00029434526,0.00011172627,0.12393583,0.00008170645,0.00045839147,0.0004762545],"about_ca_topic_score_codex":0.0008498738,"about_ca_topic_score_gemma":0.000087912274,"teacher_disagreement_score":0.121160775,"about_ca_system_score_codex":0.0011361234,"about_ca_system_score_gemma":0.00059073605,"threshold_uncertainty_score":0.99986166},"labels":[],"label_agreement":null},{"id":"W3153841548","doi":"10.1182/blood.v130.suppl_1.5653.5653","title":"Side Effects and Supportive Care in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated in Later Lines of Therapy: A Pilot Analysis Conducted in 4 Countries","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Refractory (planetary science); Pembrolizumab; Chemotherapy regimen; Oncology; Lymphoma; Chemotherapy; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.017258968994376397,"score_gpt":0.2799360110748409,"score_spread":0.2626770420804645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153841548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982912,0.0007505591,2.3578353e-8,0.00011875626,0.00002508656,0.00063829916,0.00004513489,0.000011669105,0.00011929055],"genre_scores_gemma":[0.99924266,0.00038746136,0.000024200697,0.000061892286,0.000013280987,0.00010589616,0.00011356075,0.000015469705,0.000035602185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987868,0.00011257949,0.0003901175,0.00031540412,0.00018179392,0.00021327335],"domain_scores_gemma":[0.9990552,0.00022766308,0.0002035902,0.00034092765,0.00010140582,0.00007120689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008528192,0.00019570912,0.0007149017,0.00036558186,0.000035705754,0.000021610305,0.00006760803,0.00011965544,0.000014154972],"category_scores_gemma":[0.00020678095,0.00012944627,0.00006533222,0.00024594602,0.00012090781,0.00007859954,0.000035592868,0.00006015908,0.0000018136371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00244056,0.004699449,0.98599577,0.00009448252,0.00048320947,0.0006898403,0.0013105673,4.5079997e-7,0.0005084758,0.0000028137722,0.000007679531,0.0037666727],"study_design_scores_gemma":[0.048661314,0.0029877056,0.92457205,0.00026487137,0.00051139185,0.0000026561354,0.0000968676,0.000013057625,0.022733288,0.000005152671,0.000035678648,0.00011597077],"about_ca_topic_score_codex":0.0015237882,"about_ca_topic_score_gemma":0.0080401,"teacher_disagreement_score":0.061423756,"about_ca_system_score_codex":0.00013633404,"about_ca_system_score_gemma":0.00011879347,"threshold_uncertainty_score":0.52786654},"labels":[],"label_agreement":null},{"id":"W3156867275","doi":"10.1016/j.jcjo.2021.03.013","title":"Diffuse large B-cell lymphoma presenting with ocular involvement in an 8-year-old boy","year":2021,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Calgary","funders":"","keywords":"Lymphoma; Medicine; Diffuse large B-cell lymphoma; Dermatology; Pathology","score_opus":0.025639162263377518,"score_gpt":0.2579368067568961,"score_spread":0.2322976444935186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156867275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93977815,0.0022168513,9.304432e-7,0.05403705,0.00049614813,0.00035384705,0.00006383925,0.000003656264,0.0030495252],"genre_scores_gemma":[0.9552321,0.000028160253,0.00040420218,0.0395451,0.0014237833,0.000030081595,0.00034954952,0.00009963314,0.0028874045],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99718124,0.00026364898,0.0007141317,0.0004641739,0.00040500707,0.0009717779],"domain_scores_gemma":[0.9976844,0.000076314085,0.0004900973,0.0005875681,0.00034543232,0.00081613945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002817986,0.00043399408,0.0011016601,0.00078770606,0.00009289267,0.00008925085,0.00030557264,0.0006893154,0.00072513445],"category_scores_gemma":[0.00005876569,0.0003526491,0.00026810562,0.00027133714,0.00008788163,0.000122447,0.000036614085,0.0008288443,0.000016906537],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034494853,0.0008833505,0.37999776,0.00014186867,0.00024166224,0.56255627,0.00025468966,0.0000018173522,0.0000048704937,0.00000899826,0.055844635,0.000029565555],"study_design_scores_gemma":[0.049641583,0.004686046,0.26918995,0.0016940117,0.0012686172,0.4495174,0.0014703546,0.000022625363,0.0005391899,0.00009695852,0.22077285,0.001100402],"about_ca_topic_score_codex":0.0071110753,"about_ca_topic_score_gemma":0.0016366118,"teacher_disagreement_score":0.16492821,"about_ca_system_score_codex":0.0011798757,"about_ca_system_score_gemma":0.0039307885,"threshold_uncertainty_score":0.99989253},"labels":[],"label_agreement":null},{"id":"W3157181626","doi":"10.1111/bjh.17450","title":"Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Janssen Research and Development; National Institutes of Health","keywords":"Ibrutinib; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Rituximab; Concordance; CHOP; Oncology; Medicine; Hazard ratio; Immunohistochemistry; Lymphoma; Cyclophosphamide; Subtyping; Confidence interval; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.05427044841385749,"score_gpt":0.41826787618117156,"score_spread":0.3639974277673141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157181626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824736,0.0165447,0.00016316118,0.0001469455,0.0002021729,0.0003807891,0.000024005021,0.0000022857653,0.00006232808],"genre_scores_gemma":[0.99611753,0.0010312432,0.0026316287,0.000058472837,0.000098059965,0.000018976449,0.000023852423,0.000009935281,0.000010270675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783397,0.00019134789,0.0014529162,0.00016205396,0.00018060899,0.00017910774],"domain_scores_gemma":[0.9979858,0.00068309304,0.0008735254,0.00016591151,0.00022367413,0.00006799322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007909611,0.00010077453,0.0011242739,0.000047579655,0.00005288971,0.000011567625,0.00010111152,0.00015331668,0.000011482844],"category_scores_gemma":[0.0005960032,0.00008305579,0.00025521574,0.000072895535,0.00010716427,0.000039658375,0.00004543583,0.00013652115,1.5035216e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14302708,0.19062702,0.16918345,0.0029449235,0.0009694885,0.0396529,0.0034061933,0.0000030196957,0.3818193,0.0003109297,0.0042054825,0.06385017],"study_design_scores_gemma":[0.46060827,0.001582721,0.0034520344,0.0011403082,0.0003325566,0.028340345,0.0012833964,0.00007586227,0.50278515,0.000058873276,0.00025047612,0.00009005037],"about_ca_topic_score_codex":0.0000113619235,"about_ca_topic_score_gemma":0.00000376527,"teacher_disagreement_score":0.31758118,"about_ca_system_score_codex":0.00003718383,"about_ca_system_score_gemma":0.0003610299,"threshold_uncertainty_score":0.33869168},"labels":[],"label_agreement":null},{"id":"W3157658077","doi":"10.1182/blood.v130.suppl_1.40.40","title":"Genetic Characterization and Clinical Impact of Loss of MHC Class I and II Expression in De Novo Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; MHC class II; Cancer research; Genetics; Medicine; Immunology; Major histocompatibility complex; Gene","score_opus":0.014528656818758744,"score_gpt":0.3066935214741197,"score_spread":0.29216486465536096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157658077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936765,0.00028110427,0.000007013144,0.000045022804,0.000019307708,0.0001765446,0.00003874992,0.000003932326,0.000060643746],"genre_scores_gemma":[0.9985403,0.0011769105,0.00017311824,0.000018587516,0.00003653236,0.0000069257644,0.000012923309,0.000008758004,0.000025946469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936575,0.000029759522,0.00025269674,0.00014950409,0.00007999428,0.00012231],"domain_scores_gemma":[0.99938256,0.00004225584,0.00019110205,0.00026530935,0.000026526357,0.000092236245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010268422,0.0000857055,0.00027822366,0.00003959006,0.00004809573,0.000009366253,0.000042426826,0.000089756606,0.000006149038],"category_scores_gemma":[0.00006670026,0.00006184799,0.00005732957,0.000018863364,0.000067612906,0.00004578375,0.00008253622,0.000023815952,4.795795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011599194,0.011608514,0.9330256,0.000060725422,0.000042486543,0.000059588267,0.00016761373,2.6682434e-8,0.051552635,0.0000036258893,0.0000032422618,0.0033599716],"study_design_scores_gemma":[0.03660602,0.0007418272,0.9235213,0.00017956147,0.0001424003,0.000038115108,0.000007656407,0.00005876735,0.03862812,0.0000061444625,0.000022833054,0.000047300706],"about_ca_topic_score_codex":0.00006193047,"about_ca_topic_score_gemma":0.000012060963,"teacher_disagreement_score":0.036490027,"about_ca_system_score_codex":0.000019731187,"about_ca_system_score_gemma":0.00006571937,"threshold_uncertainty_score":0.2522088},"labels":[],"label_agreement":null},{"id":"W3157730269","doi":"10.1016/j.humpath.2021.04.014","title":"Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma","year":2021,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"BCL6; Follicular lymphoma; Gene rearrangement; Immunohistochemistry; Biology; Lymphoma; Fluorescence in situ hybridization; Pathology; Molecular biology; PAX8; Tissue microarray; Cancer research; Gene; Medicine; Genetics; Antibody; Immunology; Germinal center; Chromosome","score_opus":0.03008330761971788,"score_gpt":0.2991014746689264,"score_spread":0.2690181670492085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157730269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236417,0.0021963832,0.000026123837,0.00031391997,0.00011130705,0.00018825574,0.00003149632,0.000033135515,0.004735195],"genre_scores_gemma":[0.9968871,0.00041729954,0.0016669563,0.00042874625,0.00006797093,0.000036689573,0.00012652497,0.00001662626,0.00035209383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987374,0.00017914776,0.00040298843,0.00036558253,0.00011237822,0.00020250154],"domain_scores_gemma":[0.9991408,0.0001090018,0.00017468404,0.000366373,0.00011623791,0.00009289608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019100554,0.00016018018,0.00058451307,0.00006708562,0.0000811143,0.0000069056564,0.00004151328,0.00018748485,0.00014967102],"category_scores_gemma":[0.00021367481,0.0001334829,0.000126448,0.000097026576,0.00022242602,0.000038156162,0.000060408438,0.000074673655,0.00003075328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054715427,0.0012220076,0.902988,0.000087595276,0.00013703818,0.015272128,0.00086947996,2.1544308e-8,0.052162275,0.013965711,0.00010240544,0.013138578],"study_design_scores_gemma":[0.0033759624,0.0007840819,0.9847195,0.00007930804,0.00028619156,0.0018106736,0.00008939021,0.0000015041755,0.0053997864,0.0029286612,0.0004116787,0.00011327691],"about_ca_topic_score_codex":0.000010078331,"about_ca_topic_score_gemma":0.000007075638,"teacher_disagreement_score":0.08173144,"about_ca_system_score_codex":0.000052852763,"about_ca_system_score_gemma":0.00008721243,"threshold_uncertainty_score":0.5443275},"labels":[],"label_agreement":null},{"id":"W3158402787","doi":"10.14740/jh818","title":"<i>MYC</i>-Positive Diffuse Large B-Cell Lymphoma in Leukemic Phase at Presentation: A Diagnostic and Therapeutic Challenge","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunophenotyping; Vincristine; Lymphoma; Lenalidomide; Diffuse large B-cell lymphoma; Rituximab; Cyclophosphamide; Pathology; Internal medicine; Oncology; Multiple myeloma; Gastroenterology; Immunology; Chemotherapy; Flow cytometry","score_opus":0.015263379345944676,"score_gpt":0.29775552230799623,"score_spread":0.28249214296205155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158402787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953313,0.04227156,0.000018928993,0.0035255803,0.00013094986,0.00017222184,0.000008915135,0.0000056415975,0.0005531932],"genre_scores_gemma":[0.9934996,0.005374777,0.00011200496,0.00077875383,0.00006436348,0.000017449367,0.000010494523,0.000015033426,0.00012752351],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880785,0.00012861485,0.0004597934,0.00018119666,0.0001796613,0.00024288452],"domain_scores_gemma":[0.99850976,0.0008340501,0.00023221655,0.00014444656,0.00012976203,0.0001497391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011449007,0.000149122,0.000569718,0.0001253361,0.000048862334,0.000011276158,0.00004539279,0.000102794125,0.00007926607],"category_scores_gemma":[0.00012708711,0.00011521191,0.00011615159,0.00011018864,0.000051707815,0.00005937208,0.000053719978,0.00009331035,0.000015106501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033293078,0.105068326,0.70428294,0.0008048124,0.0014894275,0.1298808,0.009350107,0.0000034321272,0.009337732,0.006081008,0.0036916896,0.026680442],"study_design_scores_gemma":[0.39116335,0.006262224,0.3187535,0.0014362705,0.0017992882,0.12433027,0.0028832476,0.00037761318,0.14170514,0.0019721196,0.008731139,0.00058583356],"about_ca_topic_score_codex":0.000007967131,"about_ca_topic_score_gemma":0.00004591062,"teacher_disagreement_score":0.38783404,"about_ca_system_score_codex":0.00026302287,"about_ca_system_score_gemma":0.00022534005,"threshold_uncertainty_score":0.46982053},"labels":[],"label_agreement":null},{"id":"W3158563222","doi":"10.1182/bloodadvances.2020002773","title":"Treating lymphoma is now a bit EZ-er","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Simon Fraser University","funders":"","keywords":"EZH2; Medicine; Epigenetics; Germinal center; Cancer research; Lymphoma; Follicular lymphoma; Pharmacology; Oncology; Bioinformatics; Computational biology; Internal medicine; Immunology; Biology; B cell; Genetics","score_opus":0.033772514931445126,"score_gpt":0.3482347193749741,"score_spread":0.31446220444352896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158563222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007127041,0.98813236,0.0000010866404,0.00012454484,0.00025285225,0.0007046427,0.00010616818,0.00008874536,0.010518321],"genre_scores_gemma":[0.000015318437,0.9919455,0.0015133207,0.00029064986,0.000573233,0.0005001625,0.0002913953,0.00008070753,0.004789726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776393,0.00006973221,0.00062416086,0.0007617467,0.00036767166,0.00041272774],"domain_scores_gemma":[0.99845654,0.0002693487,0.000354861,0.0006278511,0.00008764043,0.00020378196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000070976435,0.0006156999,0.0025959052,0.00014683738,0.00011037771,0.00005889714,0.00013773296,0.00023873807,0.00042668753],"category_scores_gemma":[0.0000756332,0.00041460898,0.000998346,0.00043383654,0.000052463623,0.00010277278,0.00008531955,0.00009773533,0.00034752136],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031897848,0.00102527,0.0007756254,0.008444196,0.001066967,0.001056965,0.00003936732,3.923032e-8,1.7378547e-7,0.000058676153,0.0013057988,0.98622376],"study_design_scores_gemma":[0.0019090743,0.00020347378,0.000072844654,0.03363595,0.007772722,0.0009222938,0.000029970675,3.8983978e-7,0.0000772889,0.0000093813105,0.95501167,0.00035492875],"about_ca_topic_score_codex":0.00002417727,"about_ca_topic_score_gemma":0.000014424622,"teacher_disagreement_score":0.9858688,"about_ca_system_score_codex":0.00018104428,"about_ca_system_score_gemma":0.0005832135,"threshold_uncertainty_score":0.9998306},"labels":[],"label_agreement":null},{"id":"W3158601594","doi":"10.3324/haematol.2020.271957","title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Regional Development Fund; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya","keywords":"Lymphoma; Biology; Cancer research; Neuroblastoma RAS viral oncogene homolog; Comparative genomic hybridization; Plasmablastic lymphoma; Fluorescence in situ hybridization; MAPK/ERK pathway; PAX5; Mutation; Signal transduction; Gene; Genetics; Immunology; Chromosome; KRAS; Transcription factor","score_opus":0.02286479361307594,"score_gpt":0.24197304219745885,"score_spread":0.2191082485843829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158601594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341345,0.0011494491,0.000022541286,0.0008770446,0.000063740896,0.00017500165,0.0000065155523,0.00004760903,0.00424467],"genre_scores_gemma":[0.9981246,0.00023378729,0.0010431925,0.00032830072,0.000015570677,0.000047756952,0.000044123288,0.000008357507,0.00015432734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915683,0.000039451752,0.00020252165,0.00027996715,0.0001272589,0.00019395504],"domain_scores_gemma":[0.9995121,0.00013899963,0.000043439784,0.00017597119,0.000039662234,0.00008984842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050504186,0.00012474255,0.00033099655,0.000057855108,0.000046678924,0.000021006566,0.000022993567,0.00009091347,0.0001449781],"category_scores_gemma":[0.00011262475,0.0000930658,0.00004315473,0.00015391427,0.000044784334,0.0000414651,0.000046155004,0.000029624725,0.00006746202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036762084,0.0023026944,0.86944586,0.00037874412,0.00014405316,0.02441029,0.0008237945,0.000024386607,0.0022540826,0.038338065,0.0016356359,0.05987479],"study_design_scores_gemma":[0.004034211,0.0001949365,0.97412086,0.00019548077,0.00006516317,0.0025689644,0.00021527545,0.00063939753,0.014239709,0.0016046832,0.0019921195,0.00012921801],"about_ca_topic_score_codex":0.000018087125,"about_ca_topic_score_gemma":0.000049903007,"teacher_disagreement_score":0.104674995,"about_ca_system_score_codex":0.00008550762,"about_ca_system_score_gemma":0.000079534344,"threshold_uncertainty_score":0.3795113},"labels":[],"label_agreement":null},{"id":"W3158799514","doi":"10.1093/jncimonographs/lgu010","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Diffuse Large B-Cell Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Internal medicine; Body mass index; Family history; Confidence interval; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology","score_opus":0.018659795391507052,"score_gpt":0.25709271072139867,"score_spread":0.2384329153298916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158799514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905775,0.004415192,0.0005416564,0.00024367784,0.0010406938,0.0012337316,0.0001276313,0.00013695218,0.0016829345],"genre_scores_gemma":[0.9952871,0.0008261899,0.00055278506,0.0015096249,0.00033719657,0.0005792425,0.00022970873,0.00007314287,0.0006049914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972491,0.00017443931,0.00055913866,0.00069250003,0.0007246194,0.0006001702],"domain_scores_gemma":[0.9976425,0.00082925434,0.00033246083,0.00064265577,0.00015521926,0.0003979133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006743548,0.00049636775,0.0006390304,0.00033690443,0.0002512217,0.00003366358,0.0002853898,0.00031126596,0.000059380283],"category_scores_gemma":[0.00040227143,0.00031855385,0.0004761557,0.00016879408,0.0003414884,0.00012789598,0.000104627885,0.000100778765,0.000022236998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007371159,0.008970494,0.77115995,0.00017161813,0.0004799653,0.00003645909,0.0035080656,2.0446083e-7,0.000059601007,0.00078746805,0.18621764,0.027871419],"study_design_scores_gemma":[0.021617621,0.00090289675,0.58809775,0.00007272614,0.00044163503,0.000030574847,0.00032651998,0.001623899,0.00011854828,0.000045081724,0.3864128,0.0003099393],"about_ca_topic_score_codex":0.001807286,"about_ca_topic_score_gemma":0.00019651347,"teacher_disagreement_score":0.20019516,"about_ca_system_score_codex":0.001240679,"about_ca_system_score_gemma":0.00089902035,"threshold_uncertainty_score":0.9999266},"labels":[],"label_agreement":null},{"id":"W3159719331","doi":"10.3390/cancers13092167","title":"Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Apoptosis; Downregulation and upregulation; Cancer research; Chemoimmunotherapy; Lymphoma; Biology; Intrinsic apoptosis; Pathogenesis; MCL1; Programmed cell death; Immunology; Genetics; Gene; Rituximab; Caspase","score_opus":0.029679065684753383,"score_gpt":0.3106121011016269,"score_spread":0.28093303541687353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159719331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009803626,0.9874779,0.0000012875655,0.000016610771,0.00034389723,0.0008238557,0.00008298198,0.000029372464,0.001420474],"genre_scores_gemma":[0.0053871996,0.9925498,0.00013536417,0.00020179352,0.0002338112,0.00066554727,0.00023241402,0.00008168438,0.00051240786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979454,0.000097777054,0.0005874061,0.00059846666,0.0002669851,0.00050395844],"domain_scores_gemma":[0.99899167,0.00009618226,0.00023967808,0.0004266338,0.000038954422,0.00020689784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008418435,0.00044622144,0.001814928,0.00019675557,0.000049917508,0.000019699986,0.000107982356,0.00026980444,0.00011361198],"category_scores_gemma":[0.000037415844,0.0003678103,0.0005880923,0.00045575143,0.000020091598,0.000026426183,0.00009572481,0.00012796481,0.00010128775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004817374,0.001172582,0.0011690734,0.0113472855,0.00022459365,0.0004427601,0.00009527702,8.1353534e-7,4.2666662e-7,0.00000921437,0.0013088554,0.9842243],"study_design_scores_gemma":[0.0094466945,0.00006895275,0.00029171677,0.03858111,0.0014963358,0.000053989108,0.000069413014,0.0000056573704,0.000054460073,0.0000017011967,0.9495736,0.00035638514],"about_ca_topic_score_codex":0.00031424034,"about_ca_topic_score_gemma":0.00005078582,"teacher_disagreement_score":0.98386794,"about_ca_system_score_codex":0.0073255505,"about_ca_system_score_gemma":0.0026548596,"threshold_uncertainty_score":0.9998774},"labels":[],"label_agreement":null},{"id":"W3160242308","doi":"10.1182/blood.v130.suppl_1.5632.5632","title":"Treatment Patterns and Health/Economic Outcomes in Relapsed/Refractory Follicular Lymphoma: A Real-World Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont; Windsor Regional Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Refractory (planetary science); Health care; Lymphoma; Internal medicine; Pediatrics","score_opus":0.03490968824506855,"score_gpt":0.3279803172315923,"score_spread":0.29307062898652375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160242308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948061,0.0004226663,9.108248e-8,0.0022020657,0.00011927478,0.0011528237,0.000027746386,0.000035147248,0.0012340653],"genre_scores_gemma":[0.997722,0.00088514085,0.000043032913,0.0001423056,0.0000724413,0.00029349525,0.000013517037,0.00002585731,0.00080219173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876744,0.000043200704,0.00034446976,0.00042902867,0.00012128713,0.00029455798],"domain_scores_gemma":[0.99872667,0.000049736518,0.00019350967,0.00081733684,0.000010149943,0.00020258664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012724119,0.00024790777,0.0006702849,0.00012919487,0.00019935066,0.000063120744,0.00008771871,0.000047850408,0.000026025433],"category_scores_gemma":[0.000011205918,0.0001798249,0.00011024036,0.000019875246,0.000032559197,0.00006651624,0.000064927604,0.000034933902,0.000044054916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041259907,0.012285012,0.971886,0.000020854588,0.00046809114,0.00078343455,0.00060099276,2.1924504e-7,0.000002296442,0.000057545483,0.000036598674,0.013817698],"study_design_scores_gemma":[0.042900253,0.0020927312,0.9535495,0.0000636784,0.0002932687,0.000032575626,0.00019228287,0.0000050902386,0.0001340515,0.000012990535,0.0005905311,0.00013301834],"about_ca_topic_score_codex":0.042813953,"about_ca_topic_score_gemma":0.029014112,"teacher_disagreement_score":0.04285899,"about_ca_system_score_codex":0.0006580162,"about_ca_system_score_gemma":0.00019139657,"threshold_uncertainty_score":0.98870385},"labels":[],"label_agreement":null},{"id":"W3160513889","doi":"10.1038/s41375-021-01285-3","title":"Treatment resistance in diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Genome Canada; Leukemia and Lymphoma Society of Canada; European Hematology Association","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Resistance (ecology); Hematology; Cancer research; Oncology; Internal medicine; Pathology; Immunology; Biology","score_opus":0.030187779597018564,"score_gpt":0.31277867400067955,"score_spread":0.282590894403661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160513889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005124321,0.9815447,6.761547e-7,0.00004954011,0.00018603893,0.0010835195,0.00012465075,0.000057230154,0.016441256],"genre_scores_gemma":[0.00028618594,0.97860986,0.00027773005,0.000120537086,0.00020239303,0.0008507727,0.0008279482,0.00008988799,0.018734684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975631,0.00013443634,0.0006870225,0.00078043016,0.00028248862,0.00055246905],"domain_scores_gemma":[0.998341,0.00020727851,0.00022530125,0.0009688878,0.000036609792,0.00022089087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000073228155,0.000664036,0.0028106135,0.00019960002,0.000056240868,0.000040395324,0.00012890696,0.00043693683,0.00010068511],"category_scores_gemma":[0.000032345037,0.00046342492,0.0009016755,0.00044470903,0.000027518656,0.000034190518,0.00007169764,0.00012214722,0.00039419983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028692393,0.013049118,0.00028923491,0.010240701,0.00043093646,0.010582508,0.00015321985,2.5035904e-8,1.1720229e-7,0.0006684997,0.004314858,0.9602421],"study_design_scores_gemma":[0.021971213,0.00013415908,0.00017381157,0.01529365,0.0016533238,0.00012561967,0.000016813952,9.795068e-7,0.0000102970025,0.0000066278826,0.9602812,0.00033229857],"about_ca_topic_score_codex":0.00015036302,"about_ca_topic_score_gemma":0.00033838104,"teacher_disagreement_score":0.9599098,"about_ca_system_score_codex":0.011221068,"about_ca_system_score_gemma":0.0027504896,"threshold_uncertainty_score":0.9997817},"labels":[],"label_agreement":null},{"id":"W3162049986","doi":"10.1111/bjh.17420","title":"A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Ofatumumab; Bendamustine; Medicine; Rituximab; Internal medicine; Clinical endpoint; Neutropenia; Adverse effect; Combination therapy; Chemoimmunotherapy; Oncology; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.021369117207070507,"score_gpt":0.31655173029278194,"score_spread":0.2951826130857114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162049986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995099,0.002868061,0.00001997175,0.00031447876,0.00014915853,0.0013916772,0.000010639496,0.000008071865,0.00013895203],"genre_scores_gemma":[0.9991592,0.00014845103,0.00045669184,0.00007138705,0.00002777114,0.00008051651,0.000011961445,0.000020895655,0.000023099346],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967849,0.0006980245,0.0015015615,0.00025778275,0.0004919989,0.00026573308],"domain_scores_gemma":[0.99780726,0.000491953,0.0007474303,0.00023417447,0.0005695037,0.0001496763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073566637,0.00020018732,0.0027800712,0.0002663842,0.000048311944,0.000022119291,0.000110232606,0.000057222023,0.00024878234],"category_scores_gemma":[0.00044360314,0.00016484012,0.00020119794,0.00029931392,0.00011562794,0.000081242055,0.00006888182,0.000267651,0.000002181635],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11992283,0.2642514,0.08810932,0.00016413191,0.0029601853,0.51276463,0.0032209565,0.000007388088,0.00008398521,0.00007903695,0.00039496765,0.008041122],"study_design_scores_gemma":[0.8586747,0.0188702,0.035632428,0.00076711184,0.0013008511,0.078080185,0.0060100206,0.000019010458,0.00039103473,0.000037455564,0.00008644785,0.00013054015],"about_ca_topic_score_codex":0.00054124364,"about_ca_topic_score_gemma":0.0027073794,"teacher_disagreement_score":0.7387519,"about_ca_system_score_codex":0.0001461978,"about_ca_system_score_gemma":0.0005368551,"threshold_uncertainty_score":0.67219853},"labels":[],"label_agreement":null},{"id":"W3162834091","doi":"10.1007/s00330-021-08026-1","title":"Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study","year":2021,"lang":"en","type":"article","venue":"European Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Stichting Kinderen Kankervrij; Hospital for Sick Children","keywords":"Medicine; Neuroradiology; Nuclear medicine; Concordance; Radiology; Prospective cohort study; Magnetic resonance imaging; Interventional radiology; Lymphoma; Neurology; Pathology; Internal medicine","score_opus":0.02722374793128392,"score_gpt":0.32868780454063407,"score_spread":0.30146405660935016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162834091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996344,0.0005760446,0.0001235259,0.00047570025,0.00023239951,0.0013655325,0.00016634422,0.000065823464,0.000650661],"genre_scores_gemma":[0.9952982,0.00006173909,0.0040841415,0.00009471219,0.00010228969,0.00009990945,0.00009083457,0.000051724426,0.000116439005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966314,0.0015543122,0.00044298655,0.0007484132,0.00024463245,0.0003782495],"domain_scores_gemma":[0.9976956,0.0009656884,0.00020930188,0.0005888127,0.00032452887,0.00021604238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095925207,0.0002779093,0.0006245849,0.00016429475,0.00014214964,0.000036716097,0.000115018716,0.00001744235,0.000020572468],"category_scores_gemma":[0.0003807717,0.00023618512,0.00009707522,0.00021685321,0.0001278906,0.00007526119,0.00009181817,0.000107304455,0.000007347856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03196417,0.004478624,0.93520445,0.00010533143,0.0007273112,0.01744147,0.0014948461,0.00003640379,0.0026342708,0.00035147378,0.00040812689,0.0051535056],"study_design_scores_gemma":[0.042539746,0.012120668,0.9398261,0.000055176915,0.00055883854,0.00029382564,0.0018180255,0.0001940634,0.00081743824,0.000008500658,0.0015617455,0.00020592897],"about_ca_topic_score_codex":0.00004254628,"about_ca_topic_score_gemma":0.00003492434,"teacher_disagreement_score":0.017147643,"about_ca_system_score_codex":0.0004846809,"about_ca_system_score_gemma":0.00061560725,"threshold_uncertainty_score":0.963135},"labels":[],"label_agreement":null},{"id":"W3163736729","doi":"10.1038/s41409-021-01327-5","title":"Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy","year":2021,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Oncology; Autologous stem-cell transplantation; Quality-adjusted life year; Transplantation; Cost effectiveness; Lymphoma","score_opus":0.03903752270240791,"score_gpt":0.31039458363586353,"score_spread":0.27135706093345563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163736729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543226,0.0016369566,0.0009630096,0.000021770495,0.00024562574,0.0009597495,0.000629171,0.000020827336,0.00009063042],"genre_scores_gemma":[0.9960686,0.0020141986,0.000715856,0.000014004704,0.0000140148995,0.00018570862,0.0009459357,0.000029007173,0.0000126669365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983973,0.00015903368,0.0005938157,0.00031969752,0.0003426868,0.00018748737],"domain_scores_gemma":[0.99850094,0.00060942693,0.00031332593,0.0002996689,0.00021589415,0.00006075976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002510943,0.00020740941,0.00085605925,0.00023673364,0.000032489283,0.000006391378,0.000070624585,0.00016988118,0.000028216818],"category_scores_gemma":[0.000006007219,0.00019909588,0.0005583275,0.0005099053,0.00007834292,0.000059703118,0.0000031131378,0.000039125065,9.671109e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1798544,0.004458675,0.056960482,0.0018308902,0.0176499,0.00081035035,0.0125411255,0.0021105926,0.64369005,0.00049655384,0.00000536728,0.07959163],"study_design_scores_gemma":[0.040185347,0.001686576,0.30844072,0.00013322053,0.0041392646,0.000016386328,0.00014373726,0.00015573419,0.6449408,0.0000064634,0.000020262605,0.00013151535],"about_ca_topic_score_codex":0.00029380622,"about_ca_topic_score_gemma":0.00008896424,"teacher_disagreement_score":0.25148022,"about_ca_system_score_codex":0.000110183784,"about_ca_system_score_gemma":0.0002443704,"threshold_uncertainty_score":0.81188947},"labels":[],"label_agreement":null},{"id":"W3164391414","doi":"10.1101/2021.05.22.445261","title":"Non-coding <i>NFKBIZ</i> 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"National Cancer Institute; NIHR Cambridge Biomedical Research Centre; Canadian Institutes of Health Research; Medical Research Council; Terry Fox Research Institute; Cancer Research UK; Kay Kendall Leukaemia Fund; Michael Smith Health Research BC; Genome British Columbia; National Institute for Health and Care Research; Canada's Michael Smith Genome Sciences Centre; Genome Canada; U.S. Department of Health and Human Services; National Institutes of Health; Instituto Carlos Slim de la Salud","keywords":"Diffuse large B-cell lymphoma; Untranslated region; Biology; Cancer research; Mutation; Coding region; Somatic hypermutation; Germinal center; Biomarker; Lymphoma; Genetics; Gene; Computational biology; B cell; Messenger RNA; Immunology","score_opus":0.010533949383346751,"score_gpt":0.2231523495457967,"score_spread":0.21261840016244996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164391414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183774,0.0043424997,0.0003115037,0.0007801733,0.00040087535,0.0017902504,0.00026873843,0.0001763179,0.00009191359],"genre_scores_gemma":[0.9865304,0.0015613319,0.009856268,0.0010843314,0.00015672762,0.00061453664,0.000005070296,0.00016609249,0.000025225037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965846,0.000105472565,0.0007014696,0.0013499432,0.00047281955,0.0007856767],"domain_scores_gemma":[0.99756753,0.00009959142,0.0003090689,0.0011261047,0.00040819103,0.0004894814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032133763,0.00072534924,0.00096065877,0.00040459714,0.00018887324,0.00026562595,0.0002565205,0.0004955384,0.0000125366305],"category_scores_gemma":[0.00008133682,0.00073765113,0.0001827291,0.00085650693,0.00006741076,0.00012956299,0.0004198348,0.00038129935,0.00002409472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023145867,0.016254976,0.12317714,0.0032190746,0.00041482906,0.002174072,0.00052481954,0.000004461885,0.85345197,0.00028138803,0.00025949618,0.000006296186],"study_design_scores_gemma":[0.0124529805,0.0001172641,0.28965914,0.0014150791,0.00044856293,8.803205e-8,0.0000345818,0.00014116494,0.6933748,0.000002072278,0.0015774413,0.0007768285],"about_ca_topic_score_codex":0.00009040037,"about_ca_topic_score_gemma":0.000036589267,"teacher_disagreement_score":0.166482,"about_ca_system_score_codex":0.00065244496,"about_ca_system_score_gemma":0.0009723955,"threshold_uncertainty_score":0.9995074},"labels":[],"label_agreement":null},{"id":"W3164920465","doi":"10.3899/jrheum.201290","title":"Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm","year":2021,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sorafenib; Medicine; Internal medicine; Oncology; Vascular endothelial growth factor; Cancer; Cancer research; Sunitinib; Hepatocellular carcinoma","score_opus":0.013659861491941348,"score_gpt":0.2558123002775331,"score_spread":0.24215243878559176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164920465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928285,0.004180554,0.0002948174,0.005266173,0.00043649744,0.00012204656,0.0000025839336,0.0000058134647,0.00040868335],"genre_scores_gemma":[0.99689674,0.0017675154,0.0010202765,0.00017712796,0.0000131876595,0.000002574103,0.0000014231767,0.000016714821,0.00010443118],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984943,0.00020443741,0.0006784499,0.000097549855,0.00029475178,0.00023049439],"domain_scores_gemma":[0.99815977,0.0004091376,0.00068739976,0.0003569446,0.00031787902,0.000068890055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000535172,0.00013709688,0.000576673,0.00005146159,0.00014749858,0.000011205775,0.00020915316,0.000078341975,0.00013497526],"category_scores_gemma":[0.00033290178,0.0000657136,0.00019935427,0.00016940909,0.0001380253,0.00005180752,0.00008727107,0.00019873063,0.000009373852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016891275,0.00033373013,0.96771306,0.00016268923,0.000581097,0.0001709307,0.0019908862,0.00010947248,0.018067123,0.0017850662,0.0015176851,0.007399336],"study_design_scores_gemma":[0.011550736,0.001448395,0.16111897,0.005349213,0.0012188386,0.21545348,0.008861399,0.0010107721,0.5837802,0.0029467202,0.006857047,0.00040424566],"about_ca_topic_score_codex":0.00013186554,"about_ca_topic_score_gemma":0.00004311247,"teacher_disagreement_score":0.80659413,"about_ca_system_score_codex":0.00007717303,"about_ca_system_score_gemma":0.00036106573,"threshold_uncertainty_score":0.2679723},"labels":[],"label_agreement":null},{"id":"W3164941196","doi":"10.1136/annrheumdis-2021-eular.896","title":"AB0108 USING RNA SEQUENCING TO IDENTIFY GENE EXPRESSION SIGNATURES ASSOCIATED WITH RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Biomarker; Immunology; Arthritis; Oncology; Rituximab; Antibody; Biology","score_opus":0.028148336889958016,"score_gpt":0.3007881771137593,"score_spread":0.27263984022380133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164941196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969137,0.0013597406,0.000019187606,0.00077048206,0.000053316704,0.0006969917,0.00014581221,0.000024098395,0.000016682005],"genre_scores_gemma":[0.9984158,0.00013672038,0.0006164898,0.00065773417,0.0000055311666,0.00005690655,0.0000476398,0.00003100677,0.00003213612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980599,0.00025004,0.0003896842,0.00031723018,0.0006761118,0.00030698473],"domain_scores_gemma":[0.99835616,0.000301256,0.00020515714,0.00052456796,0.00034874282,0.00026410082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019689299,0.00021911919,0.0004983742,0.00014164762,0.00010642137,0.000047264628,0.00013179598,0.000050541745,0.000059790767],"category_scores_gemma":[0.0013473798,0.00013300791,0.00011205275,0.00054873026,0.00004382819,0.00012812218,0.000121362915,0.00006452022,0.0000056084173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007487228,0.0041814763,0.9482243,0.00022301912,0.0008944106,0.00037059092,0.0032843924,0.0060665384,0.015609177,0.000013820422,0.002695758,0.010949262],"study_design_scores_gemma":[0.0032160408,0.00041889187,0.9207731,0.014130358,0.00006406969,0.00000596082,0.0003405216,0.00003177884,0.06080733,0.000032889973,0.0000090740505,0.00016997085],"about_ca_topic_score_codex":0.0001291045,"about_ca_topic_score_gemma":0.00006007537,"teacher_disagreement_score":0.04519815,"about_ca_system_score_codex":0.00017384478,"about_ca_system_score_gemma":0.00041418662,"threshold_uncertainty_score":0.5423905},"labels":[],"label_agreement":null},{"id":"W3165001243","doi":"10.1182/blood.v130.suppl_1.1494.1494","title":"Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Rituximab","score_opus":0.02310662063401812,"score_gpt":0.3164304827836925,"score_spread":0.2933238621496744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165001243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981244,0.00025720726,2.1848075e-7,0.00019794893,0.000018467641,0.00035151027,0.000042348547,0.000010929598,0.0009969542],"genre_scores_gemma":[0.9993888,0.00021252249,0.00022802388,0.000012107496,0.000016077869,0.000043505835,0.0000075333096,0.000011565914,0.00007987552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936146,0.000011322097,0.00017198542,0.00016812136,0.00015218467,0.00013494048],"domain_scores_gemma":[0.9992056,0.00005124038,0.00017429527,0.00044075033,0.00003940173,0.000088736204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041424497,0.00015250732,0.0004646345,0.000056074827,0.000067236906,0.000015597594,0.00004973577,0.000026112184,0.000015911308],"category_scores_gemma":[0.00004501977,0.00008633457,0.0002326907,0.000019946914,0.000058203812,0.00003669365,0.000026846785,0.000009874518,0.0000025515149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006331094,0.0058882004,0.9779776,0.000039049635,0.001374586,0.00015178385,0.0001528576,3.6528e-7,0.00050466525,0.00007025575,0.000013883908,0.013763452],"study_design_scores_gemma":[0.013339591,0.002904853,0.9371667,0.00013396233,0.00081288244,0.000032150234,0.000021697091,0.000005500561,0.04548394,0.000014257254,0.00002294602,0.00006151744],"about_ca_topic_score_codex":0.00093295233,"about_ca_topic_score_gemma":0.0000073681717,"teacher_disagreement_score":0.044979274,"about_ca_system_score_codex":0.000076309036,"about_ca_system_score_gemma":0.00007528494,"threshold_uncertainty_score":0.35206217},"labels":[],"label_agreement":null},{"id":"W3165566500","doi":"10.1016/s2352-3026(21)00102-2","title":"Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Pharmacyclics; Genentech; Bayer Fund; Seattle Genetics; Janssen Pharmaceuticals; Gilead Sciences; Roche; Johnson and Johnson; AbbVie; Merck; Celgene; Bristol-Myers Squibb; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Brentuximab vedotin; Open label; Oncology; Internal medicine; Chemotherapy; Hodgkin lymphoma; Phases of clinical research; Lymphoma; Randomized controlled trial","score_opus":0.07474879554476967,"score_gpt":0.39146995681349683,"score_spread":0.3167211612687272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165566500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98003185,0.00014887887,0.00031245535,0.015895184,0.00031633108,0.0021234974,0.00015284622,0.00004060031,0.0009783343],"genre_scores_gemma":[0.9860933,0.0004831722,0.0076085716,0.0029334405,0.00047164317,0.0007945247,0.00040868533,0.000050308176,0.0011563716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99843246,0.00018200219,0.00045199276,0.00039766406,0.00021680846,0.00031905712],"domain_scores_gemma":[0.998346,0.00044748533,0.00026773402,0.00066767086,0.0001699277,0.00010121471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040272286,0.0002156483,0.0014257606,0.00004675907,0.00007817923,0.00005087268,0.00042204367,0.000115195355,0.00050081825],"category_scores_gemma":[0.0001495727,0.00011803059,0.000087697335,0.00013527484,0.00017747321,0.00010580026,0.000100028235,0.000073400115,0.000013452312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94331616,0.011885564,0.00064065953,0.000117587304,0.0012050617,0.001038655,0.0004240872,0.0000012802195,0.0007593516,0.012760467,0.0057066493,0.02214448],"study_design_scores_gemma":[0.9313973,0.003425915,0.00023715931,0.000096332034,0.0003092886,0.0008200096,0.00016775321,0.00044740678,0.026948556,0.00022694375,0.035769694,0.00015364467],"about_ca_topic_score_codex":0.0000328657,"about_ca_topic_score_gemma":0.00007657053,"teacher_disagreement_score":0.030063046,"about_ca_system_score_codex":0.00009371566,"about_ca_system_score_gemma":0.00064081355,"threshold_uncertainty_score":0.5483608},"labels":[],"label_agreement":null},{"id":"W3165727183","doi":"10.1016/s1470-2045(21)00290-4","title":"Pembrolizumab for relapsed or refractory Hodgkin lymphoma – Author's reply","year":2021,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Context (archaeology); Internal medicine; Clinical endpoint; Refractory (planetary science); Population; Lymphoma; Hodgkin lymphoma; Randomized controlled trial; Cancer; Immunotherapy","score_opus":0.10220128046909066,"score_gpt":0.3670396438270521,"score_spread":0.26483836335796146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165727183","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037388538,0.002365907,0.000023623703,0.9766623,0.002283478,0.0016214054,0.0002295294,0.00018268875,0.012892248],"genre_scores_gemma":[0.0024334532,0.0010415991,0.0022465005,0.922409,0.020565415,0.0016876141,0.0016434678,0.0001454935,0.04782744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967164,0.0005361055,0.0006144451,0.00083768176,0.0003870126,0.0009083571],"domain_scores_gemma":[0.9954509,0.001994965,0.00049090775,0.0017220771,0.00022813947,0.00011300225],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00062411,0.00052354584,0.0020778242,0.000119142314,0.00020323631,0.000044451725,0.00043174464,0.0013371654,0.0006394321],"category_scores_gemma":[0.00063073554,0.00029675476,0.0004967428,0.00019084319,0.0002096302,0.000036973197,0.00015010935,0.0008257323,0.00016486499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031538778,0.00046056387,0.0001640093,0.00039217694,0.0008691348,0.007729422,0.00025504123,2.797799e-7,0.000035952242,0.00013221194,0.95171624,0.0350911],"study_design_scores_gemma":[0.01822391,0.003617359,0.002419256,0.000269802,0.0013028536,0.0021265266,0.000062279265,0.000016325965,0.00012784635,0.0002553754,0.9712587,0.00031974696],"about_ca_topic_score_codex":0.00011932216,"about_ca_topic_score_gemma":0.000068096015,"teacher_disagreement_score":0.05425325,"about_ca_system_score_codex":0.0017571531,"about_ca_system_score_gemma":0.0022669327,"threshold_uncertainty_score":0.9999593},"labels":[],"label_agreement":null},{"id":"W3167315086","doi":"10.1200/jco.2021.39.15_suppl.e19540","title":"First-line treatment with Bendamustine plus Rituximab for patients with indolent non-Hodgkin’s lymphoma or Mantle cell lymphoma: Real-world experience.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Western University; Barrie Urology Group","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Mantle cell lymphoma; Follicular lymphoma; Lymphoplasmacytic Lymphoma; Internal medicine; Lymphoma; Marginal zone B-cell lymphoma; Gastroenterology; B symptoms; Malignancy; Surgery; Oncology; Waldenstrom macroglobulinemia; B cell; Immunology; Marginal zone; Antibody","score_opus":0.0777758476360086,"score_gpt":0.4087968008083785,"score_spread":0.3310209531723699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167315086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279803,0.0003030109,0.0001774504,0.0027081026,0.0008088995,0.0009219675,0.000048470214,0.000018459865,0.0022155826],"genre_scores_gemma":[0.9781809,0.0021504988,0.015162945,0.0011597687,0.00091685785,0.00017496121,0.000060772472,0.000057566598,0.00213574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959667,0.00014554408,0.002197021,0.00053964683,0.0006261481,0.0005249628],"domain_scores_gemma":[0.9938067,0.0021392535,0.0017673139,0.00045256526,0.001122424,0.00071173545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004497062,0.00042740162,0.0025754066,0.00016728269,0.0001470759,0.000029067218,0.0001673372,0.00028898258,0.0002206225],"category_scores_gemma":[0.00032047034,0.0002203118,0.0005583152,0.00031848153,0.00022156865,0.00014138142,0.000067786816,0.0001432584,0.000018524555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080063485,0.11027028,0.49622476,0.00018275793,0.0019325607,0.010672271,0.00086536905,0.00008036305,0.0000063394446,0.000047846268,0.0026856612,0.2969683],"study_design_scores_gemma":[0.2525539,0.10864842,0.5074769,0.00044320954,0.0018052863,0.00053657923,0.00034633212,0.00016700731,0.0009367895,0.000015298108,0.12678368,0.00028657482],"about_ca_topic_score_codex":0.00019734903,"about_ca_topic_score_gemma":0.0019072671,"teacher_disagreement_score":0.29668173,"about_ca_system_score_codex":0.0018701436,"about_ca_system_score_gemma":0.0055677323,"threshold_uncertainty_score":0.9876918},"labels":[],"label_agreement":null},{"id":"W3168021460","doi":"10.1200/jco.2021.39.15_suppl.e19565","title":"Clinical utility of interim CT scans in patients receiving bendamustine and rituximab for first line treatment of follicular lymphoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Bendamustine; Chemoimmunotherapy; Follicular lymphoma; Internal medicine; Interim analysis; Interim; Progressive disease; Clinical trial; Surgery; Lymphoma; Radiology; Chemotherapy","score_opus":0.14042864320139395,"score_gpt":0.4673864648399128,"score_spread":0.32695782163851883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168021460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951867,0.00136721,0.000051174215,0.0020730163,0.0006930002,0.00035314242,0.000039335264,0.0000027241504,0.00023368567],"genre_scores_gemma":[0.9909688,0.004389451,0.0040675444,0.00022305113,0.00027683467,0.000010367214,0.000018556824,0.00001267068,0.000032711767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950151,0.00035609317,0.003915264,0.0002781592,0.00023750524,0.00019791443],"domain_scores_gemma":[0.99269587,0.00424119,0.0018145601,0.00024742683,0.0007227124,0.00027824016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018213228,0.00016752657,0.002705155,0.00009630474,0.000022969569,0.0000037761763,0.000075209144,0.00023407368,0.00005107072],"category_scores_gemma":[0.005468362,0.00011552851,0.000776974,0.00014054908,0.00022546378,0.00005464729,0.00005823091,0.00013613806,7.3052166e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033974054,0.033479158,0.60079104,0.00007262424,0.00046286502,0.00024784182,0.000045249006,0.0000014038187,0.0000031318116,0.000010479812,0.00018156628,0.36130723],"study_design_scores_gemma":[0.08417028,0.03242811,0.8690684,0.00038744422,0.0007733135,0.00009027605,0.000057329456,0.00019131828,0.00041274153,0.00009162743,0.012262023,0.00006714125],"about_ca_topic_score_codex":0.000059038004,"about_ca_topic_score_gemma":0.00036226877,"teacher_disagreement_score":0.3612401,"about_ca_system_score_codex":0.00021747871,"about_ca_system_score_gemma":0.0012566494,"threshold_uncertainty_score":0.6546535},"labels":[],"label_agreement":null},{"id":"W3168899802","doi":"10.1200/jco.2021.39.15_suppl.tps7568","title":"A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Incyte","keywords":"Medicine; Lenalidomide; Rituximab; Follicular lymphoma; Internal medicine; Phases of clinical research; Lymphoma; CD20; Oncology; Clinical trial; Gastroenterology; Multiple myeloma","score_opus":0.06115347712354767,"score_gpt":0.4049968544559293,"score_spread":0.34384337733238163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168899802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247694,0.0024035755,0.000029937231,0.0028925657,0.00045288316,0.0015842452,0.000025156332,0.000008748728,0.00012592286],"genre_scores_gemma":[0.99628425,0.0013033061,0.0012947068,0.00073158176,0.00023381486,0.000039289636,0.000009275208,0.000039987306,0.00006380166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99383456,0.0014793266,0.0026653104,0.0006311173,0.00092696806,0.00046271502],"domain_scores_gemma":[0.99030334,0.006637826,0.0012087589,0.00046910948,0.00070514064,0.0006758063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035871523,0.00043851635,0.0031002893,0.00023685505,0.00014823461,0.00004433832,0.00018608422,0.00029255147,0.000048351194],"category_scores_gemma":[0.003764972,0.00024875527,0.0002549256,0.0003625169,0.00044612616,0.00019851036,0.0002679736,0.00040099755,0.000005379606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.634282,0.08954216,0.09571536,0.00009130856,0.0026393405,0.0067709694,0.0013825289,0.000022149576,0.000022134895,0.000037528745,0.00030266034,0.16919185],"study_design_scores_gemma":[0.5323523,0.04508533,0.41655093,0.00032545207,0.0018326241,0.00051743764,0.0009284816,0.00007604217,0.0000510836,0.000009779636,0.0021011538,0.00016935058],"about_ca_topic_score_codex":0.0001636823,"about_ca_topic_score_gemma":0.00044157694,"teacher_disagreement_score":0.32083556,"about_ca_system_score_codex":0.0009307283,"about_ca_system_score_gemma":0.0033538695,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W3170616394","doi":"10.1038/s41375-021-01314-1","title":"Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP","year":2021,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Max-Planck-Gesellschaft; Michael Smith Health Research BC","keywords":"Lymphoma; Classical Hodgkin lymphoma; Stage (stratigraphy); Oncology; Outcome (game theory); Internal medicine; Medicine; Hodgkin lymphoma; Gene expression; Cancer research; Gene; Biology; Genetics; Mathematics","score_opus":0.019679951194619863,"score_gpt":0.2598461626357538,"score_spread":0.24016621144113393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170616394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91354185,0.0008106948,0.00008928069,0.080223314,0.00041036148,0.0017495978,0.00062562764,0.00036175008,0.0021875123],"genre_scores_gemma":[0.51274,0.00014895281,0.008208445,0.41775057,0.003267845,0.0024994474,0.019337177,0.00048736253,0.035560194],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653465,0.0001597045,0.00071085495,0.0011008229,0.00082759146,0.00066639273],"domain_scores_gemma":[0.99816287,0.00026696766,0.00026190627,0.0009852614,0.00012016989,0.00020284619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008876699,0.00071595365,0.0012330813,0.00032858338,0.00008006398,0.00005497535,0.00015344501,0.0011395294,0.00040536196],"category_scores_gemma":[0.000060954964,0.00051592564,0.00028729977,0.00040832572,0.00009951104,0.0000863979,0.000052918484,0.0007702645,0.00006605079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016089071,0.001079061,0.5498849,0.0007572419,0.00041256662,0.049565688,0.00007938035,0.00037480867,0.0030168525,0.00000280359,0.3820489,0.011168879],"study_design_scores_gemma":[0.050921045,0.0024879624,0.40155944,0.004079223,0.001055854,0.00030123792,0.00006165985,0.0012507095,0.077155896,0.0000049883392,0.45988286,0.0012391058],"about_ca_topic_score_codex":0.00023419183,"about_ca_topic_score_gemma":0.00005230792,"teacher_disagreement_score":0.40080187,"about_ca_system_score_codex":0.005560355,"about_ca_system_score_gemma":0.0015305234,"threshold_uncertainty_score":0.9997292},"labels":[],"label_agreement":null},{"id":"W3170973356","doi":"10.1016/j.ejca.2021.05.004","title":"Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council","keywords":"Medicine; Gastroenterology; Internal medicine; Helicobacter pylori; Lymphoma; Stomach; Stage (stratigraphy); Pathology","score_opus":0.022011406955105117,"score_gpt":0.30919923522421594,"score_spread":0.2871878282691108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170973356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302936,0.0049735224,0.0000808182,0.0002704756,0.00015653069,0.0008825671,0.000027185784,0.0000039608944,0.0005755566],"genre_scores_gemma":[0.9971598,0.0022233867,0.00024842127,0.000047482827,0.00021252576,0.000031366868,0.000011879812,0.000025170608,0.00003999254],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780625,0.00050144905,0.0006126372,0.00018665876,0.0007185092,0.0001744674],"domain_scores_gemma":[0.9977031,0.00005549452,0.0007387739,0.00017343494,0.0012220797,0.000107124484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010560952,0.00017451135,0.0005261169,0.00019417684,0.000047641937,0.000017463653,0.000053492906,0.000026916112,0.000100421734],"category_scores_gemma":[0.00010193239,0.00012321555,0.00009884255,0.0003952082,0.000095972544,0.00018221003,0.00002203919,0.000121150275,5.195096e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09399038,0.0076174233,0.17017798,0.00005171978,0.0012810567,0.00031378272,0.0056633065,0.0001843694,0.0061813225,0.000020034648,0.0000968024,0.7144218],"study_design_scores_gemma":[0.26384625,0.014464219,0.69658,0.0003504716,0.00045147334,0.000074325195,0.00027735782,0.00015898958,0.0234498,0.000011884422,0.0002520349,0.00008318864],"about_ca_topic_score_codex":0.00010417949,"about_ca_topic_score_gemma":0.000032539552,"teacher_disagreement_score":0.71433866,"about_ca_system_score_codex":0.0007662433,"about_ca_system_score_gemma":0.0012411969,"threshold_uncertainty_score":0.5024584},"labels":[],"label_agreement":null},{"id":"W3171248167","doi":"10.1056/nejmc2105452","title":"Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Computer science; Medicine; Pathology","score_opus":0.0190622280842261,"score_gpt":0.2588298401390397,"score_spread":0.23976761205481362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171248167","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028256347,0.02701581,0.00006099162,0.93381774,0.0028128705,0.00024591252,0.000023377297,0.000023527784,0.0077433907],"genre_scores_gemma":[0.051638562,0.007907442,0.0005488862,0.81696624,0.1010464,0.00000588731,0.00042094765,0.0001213552,0.0213443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666554,0.00016401299,0.0010291095,0.0003192838,0.0013161392,0.00050594006],"domain_scores_gemma":[0.9972399,0.00048802924,0.0008192729,0.0005093275,0.0004334731,0.0005099915],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051159365,0.0004932955,0.0017655796,0.00038993332,0.00006039396,0.000024930096,0.00021527265,0.00055241317,0.0011085669],"category_scores_gemma":[0.0003255117,0.00029365325,0.00044061922,0.00021974725,0.00008176415,0.00006162818,0.00005224598,0.0010467021,0.00004031987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023618308,0.0015737948,0.0017822626,0.00024501854,0.00055577833,0.058317628,0.0003470063,1.0340784e-7,0.00006965859,0.0000086946,0.89678234,0.040081546],"study_design_scores_gemma":[0.244205,0.001691692,0.001224518,0.0018115611,0.0017379808,0.010130777,0.000054893488,0.0000019494585,0.00025318403,0.000058953756,0.73865956,0.00016994897],"about_ca_topic_score_codex":0.00009401492,"about_ca_topic_score_gemma":0.000010094471,"teacher_disagreement_score":0.24396881,"about_ca_system_score_codex":0.00033853203,"about_ca_system_score_gemma":0.0010429416,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W3171525383","doi":"10.1200/jco.2021.39.15_suppl.e19518","title":"Outcomes after initial refusal of curative treatment in patients with Hodgkin’s lymphoma in British Columbia.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Cohort; Stage (stratigraphy); Internal medicine; Cancer; Log-rank test; Radiation therapy; B symptoms; Surgery; Statistical significance; Survival analysis; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.05185446579312523,"score_gpt":0.41581073256228457,"score_spread":0.3639562667691593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171525383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973228,0.00021931175,8.029213e-7,0.0011415104,0.00036950453,0.0002514522,0.000021228874,0.000002229386,0.0006711566],"genre_scores_gemma":[0.9974956,0.0002699311,0.0010124289,0.00091008516,0.000106399275,0.00002512981,0.000009749164,0.00001209013,0.00015859188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685043,0.0004115082,0.0019994788,0.00020580558,0.00033125756,0.00020152617],"domain_scores_gemma":[0.99718183,0.0011890589,0.0008550463,0.0001475585,0.0004336513,0.00019284835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045325718,0.00011389361,0.0018156229,0.00007662316,0.0000118670205,0.0000151627,0.000055201413,0.0002415851,0.00023134865],"category_scores_gemma":[0.0008956199,0.00009928175,0.00031564967,0.00016836544,0.00014165803,0.000101476384,0.00003332093,0.00017613289,0.0000036224149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027886052,0.018127516,0.8111665,0.000009238875,0.0003547178,0.009827932,0.00011290233,0.0000011919901,4.4943636e-7,0.0000024214662,0.00015802294,0.15745048],"study_design_scores_gemma":[0.06051434,0.018316664,0.91774696,0.00027305383,0.00022485109,0.00016859522,0.00013437423,0.0000015906237,0.00001640194,0.00004788479,0.0024787576,0.0000765389],"about_ca_topic_score_codex":0.002140914,"about_ca_topic_score_gemma":0.06958701,"teacher_disagreement_score":0.15737393,"about_ca_system_score_codex":0.0007149415,"about_ca_system_score_gemma":0.0024353222,"threshold_uncertainty_score":0.9473906},"labels":[],"label_agreement":null},{"id":"W3173678266","doi":"10.1053/j.semtcvs.2021.06.010","title":"Endosonography-Guided Biopsy as a First Test in the Diagnosis of Lymphoma","year":2021,"lang":"en","type":"article","venue":"Seminars in Thoracic and Cardiovascular Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Institut Du Cancer de Montréal","keywords":"Medicine; Lymphoma; Radiology; Biopsy; Endoscopic ultrasound; Mediastinoscopy; Sampling (signal processing); Lymphoproliferative disorders; Mediastinal lymphadenopathy; Pathology","score_opus":0.022627027273293007,"score_gpt":0.27539565297244906,"score_spread":0.25276862569915604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173678266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.877966,0.119646676,0.0000025026416,0.0004370177,0.00009764309,0.0002752981,0.000016588683,0.000013932935,0.0015443641],"genre_scores_gemma":[0.9510169,0.048180714,0.00014092168,0.00019392262,0.000050841623,0.00033407458,0.000038464324,0.000018931903,0.000025201914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980659,0.00023601906,0.00045550565,0.00043432205,0.00049099483,0.00031725768],"domain_scores_gemma":[0.9974954,0.0015255053,0.00006877765,0.0007452934,0.00007771456,0.000087284134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013082981,0.00022754142,0.00089476164,0.00027537235,0.00006208762,0.000027325996,0.000079716534,0.00013104771,0.000033638178],"category_scores_gemma":[0.0005933894,0.00016753389,0.001036594,0.0010896362,0.0001359549,0.000065066866,0.00006170595,0.0000827593,0.000006115341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003640989,0.00087903737,0.8385706,0.00020937914,0.00046770778,0.006601836,0.000617496,0.0000052602218,0.000016201055,0.000031081127,0.00072314835,0.15184188],"study_design_scores_gemma":[0.0015602644,0.00008610242,0.9636205,0.0019972038,0.0007294204,0.0051595247,0.002948002,0.000011781195,0.008063686,0.00011646524,0.015440729,0.00026633282],"about_ca_topic_score_codex":0.0005012732,"about_ca_topic_score_gemma":0.000047373298,"teacher_disagreement_score":0.15157554,"about_ca_system_score_codex":0.0000647037,"about_ca_system_score_gemma":0.00017722511,"threshold_uncertainty_score":0.6831834},"labels":[],"label_agreement":null},{"id":"W3173996640","doi":"10.1080/15257770.2021.1929317","title":"Association between the IL-1A, IL-1B and IL-1R polymorphisms and lymphoma","year":2021,"lang":"en","type":"article","venue":"Nucleosides Nucleotides & Nucleic Acids","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Zahedan University of Medical Sciences","keywords":"Genotype; Genotyping; Lymphoma; Internal medicine; Polymorphism (computer science); Medicine; Biology; Gastroenterology; Immunology; Oncology; Genetics; Gene","score_opus":0.012538788575076893,"score_gpt":0.23885615047963762,"score_spread":0.22631736190456073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173996640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747731,0.0023278426,0.0000080250575,0.017025838,0.00030786413,0.0005981249,0.00028188137,0.0002600818,0.0044172597],"genre_scores_gemma":[0.9905842,0.0020797162,0.0013807837,0.003600218,0.0005962043,0.000054298827,0.00009250364,0.00013876076,0.0014733442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963877,0.0002187947,0.00073927734,0.0009787166,0.000813113,0.0008623704],"domain_scores_gemma":[0.99719787,0.0007658286,0.000352205,0.0008774911,0.0002778654,0.0005287231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005475403,0.00061791565,0.0009589444,0.00015424937,0.00072271173,0.00040277504,0.00022728278,0.0003822823,0.00037816956],"category_scores_gemma":[0.00043223385,0.00047457207,0.00029998567,0.00048217142,0.00037541176,0.00039138796,0.00040273194,0.00027288904,0.0002345796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014295874,0.00071008655,0.84528995,0.00011890432,0.0015500067,0.00040859767,0.001235134,9.4031867e-7,0.0061197607,0.0022348294,0.013971627,0.1282172],"study_design_scores_gemma":[0.0048924093,0.00049518567,0.886838,0.00023400315,0.0015388624,0.00038646857,0.00073023076,0.000094973104,0.009136991,0.0009961583,0.094159275,0.0004974467],"about_ca_topic_score_codex":0.0003230936,"about_ca_topic_score_gemma":0.00006289782,"teacher_disagreement_score":0.12771976,"about_ca_system_score_codex":0.00059337297,"about_ca_system_score_gemma":0.0001953355,"threshold_uncertainty_score":0.9997706},"labels":[],"label_agreement":null},{"id":"W3174532254","doi":"10.1002/hon.51_2879","title":"NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Nivolumab; Refractory (planetary science); Oncology; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; CD30; Chemotherapy; Cancer; Immunotherapy","score_opus":0.04112583095400109,"score_gpt":0.3361191188900827,"score_spread":0.29499328793608165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174532254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845056,0.0051794946,0.0002571445,0.003137891,0.0011545478,0.0020477471,0.00019956513,0.0001731388,0.003344872],"genre_scores_gemma":[0.99185276,0.00025347096,0.0017112724,0.0031281712,0.00034717497,0.0011197998,0.00067501847,0.000047837035,0.000864486],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962912,0.0004962415,0.00088364683,0.0010016278,0.00048724125,0.00084000593],"domain_scores_gemma":[0.99558264,0.002680964,0.00036113776,0.00076034514,0.00026275052,0.00035213248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000497763,0.00047410594,0.0016448598,0.000053746877,0.00034605624,0.000039392828,0.0002926574,0.0004511902,0.0007723502],"category_scores_gemma":[0.00073756726,0.00029477483,0.0004980491,0.00023871886,0.00019117627,0.00007500294,0.00032601185,0.00027489357,0.00020320603],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034148287,0.5118765,0.09550878,0.000669338,0.0037915476,0.05634636,0.008169873,0.0000023080622,0.0065000593,0.0040313713,0.12782279,0.15113273],"study_design_scores_gemma":[0.55076236,0.023090838,0.19079584,0.00021856363,0.0036565417,0.002728962,0.007962977,0.00045720662,0.00798427,0.0013223707,0.2100298,0.0009902662],"about_ca_topic_score_codex":0.000063874904,"about_ca_topic_score_gemma":0.00014865832,"teacher_disagreement_score":0.5166141,"about_ca_system_score_codex":0.001010582,"about_ca_system_score_gemma":0.0013691189,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W3174776325","doi":"10.1002/hon.24_2879","title":"WHOLE GENOME SEQUENCING OF MATCHED PRIMARY AND RELAPSED DLBCL REVEALS DISTINCT EVOLUTIONARY DYNAMICS ASSOCIATED WITH RELAPSE TIMING","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC","funders":"","keywords":"BCL6; Fluorescence in situ hybridization; Chromosomal translocation; Diffuse large B-cell lymphoma; Biology; Somatic evolution in cancer; Oncology; Internal medicine; Lymphoma; Cancer research; Biopsy; Liquid biopsy; Medicine; Gene; Chromosome; Genetics; Cancer; B cell","score_opus":0.030550038548892017,"score_gpt":0.2769660546229304,"score_spread":0.24641601607403837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174776325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927367,0.0013349312,0.000116957024,0.0023802847,0.000044724922,0.00029996538,0.000048630864,0.0000671787,0.0064336495],"genre_scores_gemma":[0.9921377,0.000107571366,0.006005612,0.00054048497,0.000017797207,0.000044713383,0.0005175737,0.000017187265,0.0006113753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841493,0.00019141521,0.00047656643,0.0004013107,0.00021061738,0.0003051469],"domain_scores_gemma":[0.99835783,0.00077965326,0.00026722424,0.0002377486,0.0001926064,0.00016492991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022689482,0.00019227453,0.001000412,0.000052003143,0.00009342852,0.0000064758347,0.00005232939,0.0003264767,0.00008418755],"category_scores_gemma":[0.0005610176,0.00013490731,0.00009440816,0.00023100132,0.0002462745,0.000045163404,0.00011642447,0.0001901359,0.000011604491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072585285,0.0040384117,0.9539469,0.0004726943,0.0007431476,0.015004147,0.00039749846,0.0000129410955,0.012640523,0.010150612,0.00056388485,0.0013033733],"study_design_scores_gemma":[0.006368734,0.0016305498,0.98357487,0.00039712174,0.00048658924,0.0046178573,0.00039180988,0.00043853378,0.00036107868,0.00101767,0.00050439866,0.00021079328],"about_ca_topic_score_codex":0.000016662992,"about_ca_topic_score_gemma":0.00003845872,"teacher_disagreement_score":0.029627949,"about_ca_system_score_codex":0.001386612,"about_ca_system_score_gemma":0.00049407594,"threshold_uncertainty_score":0.550136},"labels":[],"label_agreement":null},{"id":"W3175217849","doi":"10.1080/10428194.2021.1941936","title":"Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation","year":2021,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Biopsy; Medicine; Radiology; Follicular lymphoma; Fine-needle aspiration; Lymphoma; Positron emission tomography; Gold standard (test); Pathology","score_opus":0.01065069518265316,"score_gpt":0.25027051749929746,"score_spread":0.2396198223166443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175217849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574393,0.0008640776,0.000008149705,0.00038415074,0.00009170013,0.001128545,0.00010818085,0.000074782285,0.001596484],"genre_scores_gemma":[0.9982616,0.00020905967,0.00020987433,0.00057597,0.00006752158,0.0001337082,0.00033593277,0.000063333435,0.00014301081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690366,0.00019486723,0.0007493207,0.000807749,0.000648606,0.0006958258],"domain_scores_gemma":[0.9975812,0.0007423148,0.00023985707,0.0006672879,0.0003566224,0.00041272628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020521827,0.0006709452,0.0009922318,0.00037116965,0.00022110916,0.00008865961,0.00017678754,0.00032967082,0.00021909147],"category_scores_gemma":[0.00040155844,0.00043328822,0.00022595229,0.0011751212,0.00027133216,0.00020136884,0.00009517682,0.000081838334,0.000096288575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012350607,0.0042326157,0.81600755,0.00036678987,0.0012610494,0.003092945,0.0024546045,0.00016759134,0.0020665175,0.0013840771,0.0014246033,0.15519105],"study_design_scores_gemma":[0.027541641,0.0035470629,0.9627655,0.00065393763,0.00035279637,0.0009919541,0.00012070568,0.00042577667,0.002574115,0.00006819766,0.00046747742,0.00049082417],"about_ca_topic_score_codex":0.00092070963,"about_ca_topic_score_gemma":0.000045745386,"teacher_disagreement_score":0.15470022,"about_ca_system_score_codex":0.0056043705,"about_ca_system_score_gemma":0.002541385,"threshold_uncertainty_score":0.9998119},"labels":[],"label_agreement":null},{"id":"W3176099878","doi":"10.1002/hon.49_2879","title":"IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Thomas Hospital; University Health Network","funders":"Pharmacyclics; Swiss Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Celltrion; BeiGene; AstraZeneca; Celltrion Healthcare; Gilead Sciences; Celgene; Amgen; Pfizer; Cancer Research UK; Incyte; National Science Foundation","keywords":"Medicine; Clinical endpoint; Regimen; Rituximab; Chemoimmunotherapy; Internal medicine; Oncology; Population; Randomized controlled trial; Lymphoma; Surgery","score_opus":0.07152412977678226,"score_gpt":0.3516985184666783,"score_spread":0.2801743886898961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176099878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673964,0.00017902852,0.000002418684,0.0031121066,0.00015579646,0.00092938606,0.0000066422626,0.000009836538,0.008865177],"genre_scores_gemma":[0.99912804,0.00006902422,0.00007285717,0.0003812185,0.000073084826,0.00021118615,0.000013975018,0.0000061248834,0.00004450374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982186,0.00045772607,0.0005393252,0.00025686694,0.0002932714,0.00023419967],"domain_scores_gemma":[0.99737644,0.0018768812,0.00027907224,0.0003172464,0.00009185362,0.00005851047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032665636,0.0001704479,0.0008680725,0.00004505087,0.000037320475,0.000003941147,0.00010820277,0.00020639019,0.0001715878],"category_scores_gemma":[0.00050044875,0.00006698639,0.00030286497,0.0002148129,0.00020481597,0.000015508664,0.000057605324,0.00016913204,0.0000084100475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025820483,0.039845977,0.9068415,0.0001193122,0.00030438462,0.0015753685,0.0013060478,0.0000032726414,0.0023229334,0.01606408,0.0013074302,0.004489173],"study_design_scores_gemma":[0.036255963,0.009825988,0.9413498,0.00004908746,0.00015136458,0.000535506,0.0004513411,0.0000047879516,0.010316393,0.00091393065,0.00007730418,0.000068512396],"about_ca_topic_score_codex":0.000037401885,"about_ca_topic_score_gemma":0.000018419842,"teacher_disagreement_score":0.03450828,"about_ca_system_score_codex":0.00060346816,"about_ca_system_score_gemma":0.00031770792,"threshold_uncertainty_score":0.27316254},"labels":[],"label_agreement":null},{"id":"W3176976111","doi":"10.1002/hon.35_2880","title":"CLINICAL UTILITY OF INTERIM CT SCANS IN PATIENTS RECEIVING CHEMOIMMUNOTHERAPY FOR FIRST LINE TREATMENT OF FOLLICULAR LYMPHOMA","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemoimmunotherapy; Rituximab; Follicular lymphoma; Internal medicine; Surgery; Interim analysis; Prednisone; Vincristine; Progressive disease; Cyclophosphamide; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.07732641674997415,"score_gpt":0.39029687252761713,"score_spread":0.312970455777643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176976111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961674,0.0011433908,0.00007072933,0.00085387524,0.0001728197,0.0007537675,0.000028207447,0.000015583715,0.0007941836],"genre_scores_gemma":[0.99581486,0.0012995801,0.0023294324,0.00020588962,0.00002504549,0.00018946809,0.00008844756,0.00001155341,0.000035738798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980193,0.00015100391,0.0010633972,0.00038919668,0.00012703383,0.00025010685],"domain_scores_gemma":[0.99806523,0.0010076407,0.00028760053,0.00034596786,0.0002007284,0.00009282604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022592858,0.00018488926,0.0015183834,0.000051502768,0.000026223834,0.0000023769217,0.000068712514,0.00021289267,0.00019991281],"category_scores_gemma":[0.0004571175,0.00012629942,0.00042032258,0.00017395029,0.00017447147,0.000019096278,0.0000425823,0.000040764608,0.0000033572642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014444964,0.026401436,0.810914,0.000114237664,0.0002518534,0.00022101315,0.00009628333,7.0645393e-7,0.000048866823,0.0001949409,0.00010038484,0.1602118],"study_design_scores_gemma":[0.029063676,0.010596177,0.9313682,0.00018201568,0.00015779829,0.00008931156,0.000063337175,0.00014514099,0.016295072,0.00019142841,0.011744878,0.00010297439],"about_ca_topic_score_codex":0.000055677625,"about_ca_topic_score_gemma":0.00013882986,"teacher_disagreement_score":0.16010883,"about_ca_system_score_codex":0.0003092087,"about_ca_system_score_gemma":0.00028620975,"threshold_uncertainty_score":0.5150341},"labels":[],"label_agreement":null},{"id":"W3178156199","doi":"10.1186/s13045-021-01122-1","title":"Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study","year":2021,"lang":"en","type":"letter","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Karyopharm Therapeutics","keywords":"Medicine; Refractory (planetary science); Internal medicine; Regimen; Population; Lymphoma; Surgery; Gastroenterology; Hematology","score_opus":0.017846038838583666,"score_gpt":0.2586539734881255,"score_spread":0.24080793464954187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178156199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522122,0.0010035326,0.0000047986564,0.044278607,0.00055164663,0.0012741673,0.000030151214,0.00001733796,0.00062752323],"genre_scores_gemma":[0.945201,0.00010570982,0.00017819136,0.053120833,0.0006677479,0.00011167782,0.0002301012,0.000101088845,0.00028366258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99444634,0.0016979025,0.0014345751,0.00060946454,0.001012388,0.00079936034],"domain_scores_gemma":[0.9951076,0.0014353087,0.0018810937,0.00070803054,0.0006922878,0.00017571192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062051846,0.0007161422,0.002843234,0.0005143911,0.00012694299,0.00003781602,0.00040573452,0.0010943324,0.00009176792],"category_scores_gemma":[0.000109881556,0.0003637443,0.00033193297,0.00039423237,0.00025697154,0.00010916192,0.00009011856,0.0016858669,0.000013916288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018588644,0.06805159,0.72659856,0.000105340005,0.0013979544,0.12536912,0.0010462318,8.959785e-7,0.0000028757372,0.0000022849517,0.07524138,0.0003248791],"study_design_scores_gemma":[0.12721814,0.038117103,0.6640449,0.0005944669,0.0041837757,0.008689984,0.0027483918,0.0000021674325,0.00007913281,0.0000031010813,0.15382335,0.0004954986],"about_ca_topic_score_codex":0.00013330749,"about_ca_topic_score_gemma":0.0009914457,"teacher_disagreement_score":0.12535928,"about_ca_system_score_codex":0.0013339109,"about_ca_system_score_gemma":0.001275199,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W3179497842","doi":"10.1016/j.euroneuro.2021.08.246","title":"TH74. PSYCHIATRIC PROFESSIONALS BELIEVE POLYGENIC RISK SCORES FOR SCHIZOPHRENIA HAVE FUTURE CLINICAL UTILITY: RESERVATIONS ABOUT CURRENT INTEGRATION","year":2021,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Blastoid; Malignancy; Pathology; Mantle cell lymphoma; Lymphoma","score_opus":0.04767182796136307,"score_gpt":0.3994663028337906,"score_spread":0.35179447487242754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179497842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95950824,0.010807568,0.00026746417,0.013477009,0.0113168135,0.001814852,0.00029033556,0.0002817893,0.0022359148],"genre_scores_gemma":[0.97147125,0.011243671,0.0028813072,0.0064792484,0.0059862426,0.0002665663,0.0004173677,0.00016082614,0.0010935373],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99504274,0.0019324591,0.0011209096,0.0010692134,0.00033533497,0.0004993332],"domain_scores_gemma":[0.9971724,0.0006856755,0.000466425,0.0007026394,0.0005825637,0.00039030405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080788136,0.00039599944,0.0005843064,0.00019965981,0.00035975254,0.000052682695,0.00024811205,0.00012816722,0.0003504973],"category_scores_gemma":[0.00071656384,0.00031703073,0.0005610693,0.0004803909,0.00013545986,0.00011786165,0.00015150331,0.0008028907,0.0001993549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051742094,0.007915667,0.23840246,0.00015804665,0.0006123362,0.0004335351,0.00026462626,0.0000038126686,0.0030298973,0.00091745885,0.38221517,0.36087278],"study_design_scores_gemma":[0.010081186,0.00074173935,0.8278256,0.00010670237,0.0007662969,0.0000642622,0.0000665273,0.0002616178,0.00021076441,0.00016677578,0.1594778,0.00023069968],"about_ca_topic_score_codex":0.0000059168883,"about_ca_topic_score_gemma":0.000031344476,"teacher_disagreement_score":0.5894232,"about_ca_system_score_codex":0.0000669627,"about_ca_system_score_gemma":0.00048122887,"threshold_uncertainty_score":0.9999282},"labels":[],"label_agreement":null},{"id":"W3180789353","doi":"10.14740/wjon1388","title":"Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma","year":2021,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Refractory (planetary science); Internal medicine; Oncology; Lymphoma; Surgery; Immunotherapy; Cancer","score_opus":0.052135747712823206,"score_gpt":0.37215470987872473,"score_spread":0.32001896216590153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180789353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046589394,0.9874109,8.369887e-7,0.0014764621,0.0018574035,0.0004170547,0.000006230513,0.000010512193,0.008354714],"genre_scores_gemma":[0.00063169294,0.9950383,0.0006472013,0.00033336246,0.0015362899,0.000048239137,0.000026173127,0.00006559493,0.0016731776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956243,0.0006504476,0.0024146016,0.0003882977,0.00047064197,0.00045168432],"domain_scores_gemma":[0.99629986,0.0009445388,0.0017738297,0.00037329775,0.00020187128,0.00040659303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008554178,0.00050956674,0.0049806973,0.0012081967,0.000038212278,0.000022392116,0.00021686296,0.0006265384,0.00039147888],"category_scores_gemma":[0.00035653234,0.00035195102,0.001744233,0.00079855527,0.00014047872,0.000055193228,0.00012273787,0.00096999994,0.00008712818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009292946,0.00351573,0.0003965349,0.0013259689,0.00065397064,0.021340687,0.00005665269,3.0386374e-7,0.0000010024191,0.00015670709,0.019749071,0.95271045],"study_design_scores_gemma":[0.005916418,0.0019845648,0.0007239424,0.024013018,0.0021487402,0.008837543,0.000034977915,3.8330163e-7,0.0000071800755,0.000019479363,0.95607615,0.00023763182],"about_ca_topic_score_codex":0.000019774454,"about_ca_topic_score_gemma":0.00018852402,"teacher_disagreement_score":0.9524728,"about_ca_system_score_codex":0.0055003427,"about_ca_system_score_gemma":0.0059223543,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W3181303279","doi":"10.1038/s41598-021-93516-x","title":"BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy","year":2021,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Saskatchewan Cancer Agency; University of Saskatchewan","keywords":"Medicine; Regimen; Etoposide; Melphalan; Cytarabine; Cohort; Oncology; Internal medicine; Progression-free survival; Mucositis; Surgery; Chemotherapy","score_opus":0.01197430067237122,"score_gpt":0.27191253640082463,"score_spread":0.2599382357284534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181303279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893523,0.00028010918,0.000014949951,0.0045078974,0.0010966728,0.0003368058,0.0000071680665,0.00002918094,0.0043749553],"genre_scores_gemma":[0.9903725,0.000018790653,0.0008662778,0.0013147638,0.00007474846,0.000045225268,0.00007708168,0.000013145656,0.0072174883],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854684,0.000013057286,0.0002906783,0.0007285016,0.00021460855,0.00020628895],"domain_scores_gemma":[0.9989955,0.00003376446,0.00010763175,0.00048561342,0.0001282641,0.0002492362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023947586,0.00012091376,0.0002533264,0.0000831751,0.00017069462,0.00016887461,0.000028119142,0.000043626806,0.0005339017],"category_scores_gemma":[0.0000670906,0.00010554007,0.00007857519,0.00016021269,0.000134273,0.00006079318,0.000049694903,0.000045201185,0.00006961179],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031923683,0.004134678,0.25682423,0.00016716977,0.0017654935,0.029361183,0.015352593,0.00015535705,0.07207512,0.0017650553,0.5310432,0.08703675],"study_design_scores_gemma":[0.002571379,0.00024616014,0.077827804,0.00021997321,0.00013893473,0.003342304,0.00030096335,0.000099943136,0.6898332,0.0037258724,0.22138704,0.00030641828],"about_ca_topic_score_codex":0.000025537234,"about_ca_topic_score_gemma":0.000007792793,"teacher_disagreement_score":0.6177581,"about_ca_system_score_codex":0.00015064936,"about_ca_system_score_gemma":0.00018665146,"threshold_uncertainty_score":0.5845849},"labels":[],"label_agreement":null},{"id":"W3181454351","doi":"10.5812/ijcm.97892","title":"Multicentric Study of Clinicopathological Features of Primary Gastrointestinal Lymphoma of Iran: from 2011 - 2016","year":2021,"lang":"en","type":"article","venue":"International Journal of Cancer Management","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Pathological; Stomach; Abdominal pain; Internal medicine; Gastrointestinal tract; Gastroenterology","score_opus":0.02839716024596165,"score_gpt":0.32892008650147725,"score_spread":0.3005229262555156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181454351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931894,0.0039166897,0.00010655433,0.00049126096,0.0005295003,0.000207095,0.00005249187,0.0000031133484,0.0015038957],"genre_scores_gemma":[0.99347776,0.0018424646,0.0040958845,0.0001540324,0.00017642588,0.000008924766,0.000011737736,0.0000079423935,0.00022485503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979167,0.00006684167,0.000875299,0.00016101333,0.0008786795,0.000101495294],"domain_scores_gemma":[0.99790215,0.0001434358,0.0009161247,0.00017101923,0.00080119795,0.00006605516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018279048,0.000120401135,0.0005044706,0.00018178056,0.000009777119,0.0000077474415,0.00022194814,0.000025090076,0.00040973167],"category_scores_gemma":[0.000054388838,0.00008731499,0.00022253515,0.00008135991,0.00005187518,0.000060281585,0.00014290113,0.000061480045,0.0000023489904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026500744,0.012016311,0.85669565,0.00010462751,0.00212495,0.0038390337,0.00030194907,0.00015175909,0.0014930549,0.00013229488,0.0020743364,0.11841597],"study_design_scores_gemma":[0.011590598,0.0011958411,0.98008186,0.0009175302,0.0007244639,0.00017324978,0.00066592137,0.0000109940975,0.0040696603,0.0000662681,0.0004488072,0.000054836513],"about_ca_topic_score_codex":0.00027045427,"about_ca_topic_score_gemma":0.000023194365,"teacher_disagreement_score":0.12338619,"about_ca_system_score_codex":0.0002543731,"about_ca_system_score_gemma":0.00016590055,"threshold_uncertainty_score":0.44862744},"labels":[],"label_agreement":null},{"id":"W3182360203","doi":"10.3390/cancers13133369","title":"The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Research Foundation of Korea","keywords":"Medicine; Meta-analysis; Confidence interval; Internal medicine; Incidence (geometry); Diffuse large B-cell lymphoma; Odds ratio; Oncology; Lymphoma; Biomarker; Logistic regression; Gastroenterology; Biology","score_opus":0.03739061345904742,"score_gpt":0.31554554786549666,"score_spread":0.27815493440644923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182360203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019369686,0.97774774,3.099934e-7,0.000022521725,0.0000064953606,0.002724923,0.00011610804,0.0000027021242,0.000009500437],"genre_scores_gemma":[0.021322329,0.9773575,0.000031785818,0.000031059673,0.0000018414623,0.0010524208,0.000036160087,0.000016513339,0.00015036894],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99806833,0.0004043206,0.00073266786,0.00037989585,0.00026074334,0.000154022],"domain_scores_gemma":[0.9979091,0.00058714603,0.00072597724,0.00057609665,0.00009944829,0.000102194856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042238663,0.00033520543,0.005325773,0.0001352918,0.00004637257,0.000014953398,0.00005962574,0.00007970836,0.000008280626],"category_scores_gemma":[0.00006831401,0.00014216651,0.00045150748,0.0004294939,0.000088009736,0.000034477704,0.00006329874,0.00003489645,2.1649664e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066451496,0.0016934923,0.00322785,0.9203707,0.068602726,0.000082582264,0.0005167575,4.1197265e-7,3.7541324e-7,0.000013909322,0.00005195256,0.004774737],"study_design_scores_gemma":[0.0107347965,0.0005913471,0.0008294267,0.11030947,0.87396514,0.000012229791,0.0000916179,0.0000012485816,0.000023893252,3.0320885e-7,0.0032579657,0.00018255012],"about_ca_topic_score_codex":0.00023340654,"about_ca_topic_score_gemma":0.00009917116,"teacher_disagreement_score":0.8100612,"about_ca_system_score_codex":0.00074999273,"about_ca_system_score_gemma":0.0005332105,"threshold_uncertainty_score":0.5797382},"labels":[],"label_agreement":null},{"id":"W3183608863","doi":"10.1182/blood.v130.suppl_1.3298.3298","title":"Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Follicular lymphoma; Chemoimmunotherapy; Melphalan; Rituximab; Internal medicine; Surgery; Salvage therapy; Retrospective cohort study; Transplantation; International Prognostic Index; Alemtuzumab; Univariate analysis; Etoposide; Oncology; Lymphoma; Chemotherapy; Multivariate analysis","score_opus":0.013172906686767101,"score_gpt":0.27705856654892785,"score_spread":0.2638856598621607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183608863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815315,0.000052062864,0.0000029597738,0.000045799992,0.00004329878,0.0011701476,0.00043404932,0.000010781047,0.000087770386],"genre_scores_gemma":[0.9990143,0.00017624439,0.00023832559,0.000022688377,0.0000064596425,0.00008740641,0.00039240316,0.00001689182,0.000045272544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998709,0.00009097663,0.00045806632,0.00028976754,0.00026725666,0.00018490695],"domain_scores_gemma":[0.9985333,0.000169088,0.00058175623,0.00041411133,0.00026521875,0.00003650466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018479051,0.00018054832,0.0006788604,0.0002224062,0.000090535315,0.00001999386,0.00014895001,0.00008635791,0.0000032239186],"category_scores_gemma":[0.00012859785,0.00012866026,0.00027645341,0.0003084951,0.00012852394,0.00007159085,0.000011946707,0.00003854892,4.0447287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013153285,0.0071252896,0.98297447,0.000048126924,0.0028667902,0.000025265614,0.0036693828,0.0000016190862,0.00040564762,0.00007316615,0.0000046118334,0.001490286],"study_design_scores_gemma":[0.03836145,0.00074704044,0.9368327,0.000121105935,0.0037281516,6.2397226e-7,0.0001621092,0.00016673909,0.019760538,0.000012108253,0.000002436525,0.00010498745],"about_ca_topic_score_codex":0.0034449329,"about_ca_topic_score_gemma":0.0027250582,"teacher_disagreement_score":0.046141773,"about_ca_system_score_codex":0.000097282216,"about_ca_system_score_gemma":0.000069950955,"threshold_uncertainty_score":0.52466136},"labels":[],"label_agreement":null},{"id":"W3183715267","doi":"10.1080/10428194.2021.1957865","title":"Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Neutropenia; Adverse effect; Confidence interval; Oncology; Meta-analysis; Anemia; Lymphoma; Observational study; Gastroenterology; Hodgkin lymphoma; Chemotherapy","score_opus":0.04153131334834914,"score_gpt":0.3275803715179592,"score_spread":0.28604905816961007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183715267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042190985,0.9870524,0.000012277519,0.000045604582,0.00013457148,0.0077463416,0.00036745227,0.00013867747,0.0002835834],"genre_scores_gemma":[0.006184738,0.98603463,0.00036098255,0.0005890603,0.00006196733,0.004783789,0.00072280597,0.00032180315,0.0009402424],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9862949,0.0035870261,0.00460969,0.0029460555,0.0013029814,0.0012593359],"domain_scores_gemma":[0.98907286,0.004110196,0.0027154745,0.0029199258,0.0004098029,0.0007717612],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002647567,0.0027417026,0.030443206,0.001760924,0.00022382238,0.00018042138,0.00066391315,0.0015786637,0.00023504441],"category_scores_gemma":[0.000701262,0.0018133579,0.0060264594,0.004093588,0.00046664238,0.00024698494,0.00042072812,0.00027686122,0.000034420063],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004128886,0.0014741238,0.00006801417,0.7492909,0.15847443,0.002079849,0.00016735942,0.0000023957168,0.0000033626206,0.00016883953,0.0001603121,0.08769751],"study_design_scores_gemma":[0.019074356,0.0007772535,0.0009817842,0.18554561,0.76889014,0.002966156,0.000085794265,0.00006210177,0.000046010402,0.000019540903,0.019935194,0.001616063],"about_ca_topic_score_codex":0.0019390818,"about_ca_topic_score_gemma":0.00012886121,"teacher_disagreement_score":0.6104157,"about_ca_system_score_codex":0.012557283,"about_ca_system_score_gemma":0.0089216735,"threshold_uncertainty_score":0.9997175},"labels":[],"label_agreement":null},{"id":"W3184807749","doi":"10.1016/j.clml.2021.07.020","title":"Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Sierra Oncology; Pfizer","keywords":"Medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Oncology; Internal medicine; Lymphoma; Oligonucleotide; Cancer research; DNA; Genetics","score_opus":0.0171050615275064,"score_gpt":0.2825302489685589,"score_spread":0.2654251874410525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184807749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996105,0.00097552023,0.000004465376,0.00022705086,0.00020722757,0.00084182434,0.00006807868,0.00007966816,0.001491171],"genre_scores_gemma":[0.99417543,0.0027650811,0.00066436426,0.0013638063,0.00012459676,0.000039806946,0.00019403514,0.00009613396,0.0005767646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568415,0.0003540058,0.001627948,0.0010508756,0.00060765835,0.00067538087],"domain_scores_gemma":[0.9958782,0.0016636556,0.00049508805,0.0011202985,0.00030698153,0.00053574686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004914922,0.0005342276,0.0015216004,0.00015752079,0.000117400574,0.000036842484,0.00019663907,0.00044173532,0.00013715884],"category_scores_gemma":[0.0007220778,0.00036671595,0.00034157795,0.00058068667,0.00033205064,0.00016246206,0.00019076138,0.00017073951,0.000048459693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016690213,0.025436299,0.56029147,0.00008541471,0.00030280644,0.0010392136,0.00022625277,5.192502e-7,0.000076318975,0.000097478005,0.0002965166,0.3954575],"study_design_scores_gemma":[0.18710391,0.003451536,0.79769546,0.00042243814,0.00018060977,0.000043494558,0.00007391891,0.00003259498,0.0014715317,0.00001453027,0.009175969,0.00033401235],"about_ca_topic_score_codex":0.000095492884,"about_ca_topic_score_gemma":0.00007958848,"teacher_disagreement_score":0.39512348,"about_ca_system_score_codex":0.0010166897,"about_ca_system_score_gemma":0.0019596093,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W3184863509","doi":"10.1182/blood.2021012206","title":"High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine","score_opus":0.022666973621216068,"score_gpt":0.2818213398882308,"score_spread":0.25915436626701477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184863509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454546,0.0010594198,0.0000044380927,0.0019694704,0.0006154647,0.0012976438,0.0003638143,0.0000064779438,0.0001377886],"genre_scores_gemma":[0.9983364,0.00048447453,0.00016741006,0.00003890958,0.0003218944,0.00011653957,0.00006353101,0.000011980867,0.00045889977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987584,0.00005553847,0.0004914761,0.00022036466,0.0003431026,0.00013116185],"domain_scores_gemma":[0.9985641,0.00029189052,0.00034337788,0.00052621064,0.00023539593,0.00003900316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012303809,0.00013442256,0.00039167982,0.00003230546,0.00005863271,0.000005941867,0.00007427772,0.00008596143,0.000037776226],"category_scores_gemma":[0.0001273907,0.000068128924,0.0003450104,0.00014811163,0.00007383669,0.00002068295,0.00002723036,0.00003364273,0.00000146894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23340216,0.25200787,0.04501777,0.0009962195,0.027218394,0.00026386324,0.017150763,0.00012645284,0.2604562,0.0041605476,0.008277431,0.1509223],"study_design_scores_gemma":[0.1507717,0.002924774,0.04139309,0.00008008487,0.0029013834,0.000026782449,0.0002347898,0.000006745854,0.8005178,0.000053636755,0.0010392466,0.000049978138],"about_ca_topic_score_codex":0.0006288489,"about_ca_topic_score_gemma":0.00006563288,"teacher_disagreement_score":0.5400616,"about_ca_system_score_codex":0.000048210422,"about_ca_system_score_gemma":0.0002570011,"threshold_uncertainty_score":0.2778217},"labels":[],"label_agreement":null},{"id":"W3185533154","doi":"10.2217/fon-2021-0370","title":"Prediction and Characterization of Diffuse Large B-Cell Lymphoma Cell-of-Origin Subtypes Using Targeted Sequencing","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Foundation Medicine; H. Lundbeck A/S; Amgen; TG Therapeutics; Genentech; Celgene; F. Hoffmann-La Roche","keywords":"Exome sequencing; Somatic cell; DNA sequencing; Germinal center; Carcinogenesis; Diffuse large B-cell lymphoma; Biology; Ion semiconductor sequencing; Computational biology; Cell of origin; Germline mutation; Genetics; Cell; DNA; Mutation; Gene; B cell; Antibody","score_opus":0.018923713725034052,"score_gpt":0.262826755363928,"score_spread":0.24390304163889398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185533154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728304,0.0010306439,0.00007121759,0.00020097401,0.00046079615,0.00017701136,0.00010200356,0.000018969087,0.0006553173],"genre_scores_gemma":[0.99729764,0.0005963825,0.001166246,0.00014091372,0.00029395544,0.000008200107,0.00036685934,0.0000136415665,0.00011612835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992121,0.000069475995,0.00026252365,0.00019915227,0.000108633576,0.00014815573],"domain_scores_gemma":[0.9994156,0.00004137379,0.00018930504,0.0001486319,0.00013817642,0.000066949484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076815806,0.000109560184,0.00034890854,0.000071939845,0.00004310942,0.000004003524,0.000022304745,0.00018086754,0.00005339899],"category_scores_gemma":[0.000013540016,0.00009379905,0.000055625515,0.00015581638,0.000031327905,0.000054279408,0.000029063249,0.00004121023,0.0000014972517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014148025,0.002856574,0.121949375,0.000227644,0.00006961385,0.00015657359,0.00078955817,9.3191215e-7,0.87055373,0.00017130261,0.00006351331,0.0030196963],"study_design_scores_gemma":[0.015882762,0.0007183121,0.3158842,0.00010082393,0.00043144877,0.00018484502,0.0005570407,0.0006963433,0.65102535,0.000013385803,0.014399181,0.00010631163],"about_ca_topic_score_codex":0.00003864184,"about_ca_topic_score_gemma":0.00001517878,"teacher_disagreement_score":0.21952839,"about_ca_system_score_codex":0.00028646318,"about_ca_system_score_gemma":0.00045122582,"threshold_uncertainty_score":0.38250142},"labels":[],"label_agreement":null},{"id":"W3188155770","doi":"10.1016/j.critrevonc.2021.103430","title":"Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Eusko Jaurlaritza","keywords":"Oncology; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Disease; Clinical trial; Germline mutation; Aggressive lymphoma; Mutation; Bioinformatics; Rituximab; Biology; Genetics; Gene","score_opus":0.05634092512945823,"score_gpt":0.4154295717266789,"score_spread":0.3590886465972207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188155770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006651377,0.9884577,0.000018774514,0.00061910454,0.00016629146,0.010138733,0.000029635963,0.000024281411,0.00047896334],"genre_scores_gemma":[0.00097268645,0.98843575,0.0007447919,0.0011134307,0.000021898628,0.008483506,0.00012702426,0.00006830843,0.00003263051],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98970115,0.0038042036,0.004530257,0.00091161276,0.0002858938,0.0007668724],"domain_scores_gemma":[0.9880358,0.009650088,0.00089427567,0.0009985227,0.00014259895,0.00027869188],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019235845,0.0008118625,0.015989993,0.00047155435,0.00005148215,0.00001499378,0.00028020205,0.00082856126,0.00007863818],"category_scores_gemma":[0.011630401,0.0005556307,0.0009712468,0.0008692465,0.00039463947,0.000044875713,0.00020333256,0.0004571827,0.0001481837],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034708144,0.013480021,0.00022800436,0.9026913,0.00017966631,0.0018535153,0.000090988375,3.1441534e-9,6.799318e-8,0.024057472,0.000087115346,0.05732835],"study_design_scores_gemma":[0.0047451085,0.00042225575,0.000031279003,0.90712905,0.015102664,0.0052757785,0.000066076886,0.000017153594,8.685325e-7,0.00039708242,0.066436484,0.00037620394],"about_ca_topic_score_codex":0.000007793262,"about_ca_topic_score_gemma":0.000024907766,"teacher_disagreement_score":0.066349365,"about_ca_system_score_codex":0.0007534895,"about_ca_system_score_gemma":0.0013556847,"threshold_uncertainty_score":0.9996895},"labels":[],"label_agreement":null},{"id":"W3189384160","doi":"10.1016/j.ijrobp.2021.07.1711","title":"Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Proton therapy; Radiation therapy; Population; Cost effectiveness; Internal medicine; Oncology; Risk analysis (engineering)","score_opus":0.017932545338991215,"score_gpt":0.32601417855509995,"score_spread":0.30808163321610876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189384160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859789,0.00037657062,0.008999774,0.0014848005,0.00093755283,0.0019237547,0.000097322016,0.000014875749,0.0001864528],"genre_scores_gemma":[0.9920392,0.00042853988,0.0052880505,0.00048805584,0.0009214909,0.00039298163,0.00040811652,0.000023040146,0.000010513041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857813,0.0001583504,0.00055658416,0.0002151521,0.0003268489,0.00016490706],"domain_scores_gemma":[0.99512994,0.00087326736,0.001077045,0.000122082,0.0027025612,0.00009511724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285626,0.00017015002,0.0004583495,0.00011541239,0.000049523096,0.000023423667,0.00015502083,0.000143564,0.000026563384],"category_scores_gemma":[0.00056767603,0.00012784061,0.00018645776,0.00015443745,0.00010183065,0.00027385168,0.00002571993,0.0001091566,0.0000023600292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017237581,0.002262115,0.5452967,0.000014183311,0.0007591579,0.000016970014,0.00026155647,0.00009364609,0.0007904567,0.0013970999,0.00017800524,0.4472063],"study_design_scores_gemma":[0.049784467,0.009473801,0.8377611,0.00025973964,0.00032496153,0.00015427178,0.000114247065,0.00072053366,0.07104612,0.0023055277,0.02783697,0.00021825642],"about_ca_topic_score_codex":0.000013256629,"about_ca_topic_score_gemma":0.000003344144,"teacher_disagreement_score":0.44698805,"about_ca_system_score_codex":0.00085761986,"about_ca_system_score_gemma":0.00094719394,"threshold_uncertainty_score":0.52131885},"labels":[],"label_agreement":null},{"id":"W3190230963","doi":"10.1016/j.tranon.2021.101188","title":"CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Fondation de l'Association des radiologistes du Québec","keywords":"Radiomics; Machine learning; Artificial intelligence; Medicine; Receiver operating characteristic; Test set; Random forest; Population; Refractory (planetary science); Diffuse large B-cell lymphoma; Computer science; Lymphoma; Pathology","score_opus":0.01847252781725116,"score_gpt":0.2700362768282605,"score_spread":0.2515637490110093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190230963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687565,0.0009717202,0.02249045,0.0051883915,0.00004059492,0.0008435099,0.00014664514,0.00006177488,0.0015004326],"genre_scores_gemma":[0.9736238,0.00007008134,0.023071602,0.00061652885,0.000055808643,0.00030690935,0.0018594923,0.00003298956,0.00036276568],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99884087,0.00007204661,0.00029091327,0.00034146063,0.00016209777,0.0002925939],"domain_scores_gemma":[0.99911636,0.00049129885,0.00008169123,0.00012809971,0.000076447024,0.00010607397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012447289,0.00020004308,0.00045152713,0.00010036246,0.00009727923,0.00000929916,0.000033394652,0.00009220806,0.000024967865],"category_scores_gemma":[0.000014636252,0.00015717148,0.0001359258,0.00013405364,0.000031123174,0.000049917846,0.0000056924437,0.00007222557,0.0000026479802],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043018493,0.054199718,0.7645155,0.0002584612,0.00051341887,0.0020732486,0.0010955506,0.13094893,0.0013914618,0.001422465,0.000090677626,0.03918869],"study_design_scores_gemma":[0.15663452,0.0018524627,0.03456306,0.00006375779,0.00043476297,0.00020904769,0.000064470805,0.7905211,0.0018678983,0.00005178154,0.013539475,0.00019768579],"about_ca_topic_score_codex":0.00003116238,"about_ca_topic_score_gemma":0.0010276437,"teacher_disagreement_score":0.72995245,"about_ca_system_score_codex":0.00079033,"about_ca_system_score_gemma":0.0014236869,"threshold_uncertainty_score":0.6409267},"labels":[],"label_agreement":null},{"id":"W3190511974","doi":"10.1002/9780471420194.tnmm32","title":"Lymphoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Immunosuppression; Chemotherapy; Histology; Working Formulation; Bone marrow; Stage (stratigraphy); Pathology; Non-Hodgkin's lymphoma; Internal medicine","score_opus":0.0254300818931643,"score_gpt":0.3213254481756725,"score_spread":0.2958953662825082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190511974","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024018898,0.003625757,0.0000011510725,0.0007367106,0.00033793823,0.00032505163,0.0024078973,0.00023709306,0.9920882],"genre_scores_gemma":[0.0006359437,0.0014498648,0.0012267911,0.00052229036,0.0015214683,0.000034247096,0.0033967397,0.00031836843,0.99089426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924517,0.000007374233,0.00010357136,0.0002720167,0.00018441421,0.00018742763],"domain_scores_gemma":[0.9988617,0.000015365118,0.00015598566,0.00081163243,0.000019620604,0.0001357073],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000018548215,0.00023956646,0.00046554167,0.000110459754,0.00003429357,0.00001455438,0.00011223701,0.00024118638,0.014032736],"category_scores_gemma":[0.000040802348,0.00017460609,0.00014579378,0.000023959698,0.00005562622,0.00000928588,0.00004638479,0.0000431931,0.0013562952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001444995,0.0007837091,0.00085164106,0.0000617857,0.00022203782,0.00045629218,0.000004725875,3.3350245e-9,0.0000020317375,0.000036076668,0.87436885,0.1231984],"study_design_scores_gemma":[0.0026070199,0.00012506086,0.013422974,0.00096063095,0.0002666351,0.000077668345,0.0000022625761,0.0000032581513,0.000026067217,0.000008821736,0.9823479,0.00015166514],"about_ca_topic_score_codex":0.00043024422,"about_ca_topic_score_gemma":0.00029660456,"teacher_disagreement_score":0.12304673,"about_ca_system_score_codex":0.00010429804,"about_ca_system_score_gemma":0.0001722031,"threshold_uncertainty_score":0.99942124},"labels":[],"label_agreement":null},{"id":"W3191255749","doi":"10.1002/pbc.29259","title":"Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report","year":2021,"lang":"en","type":"letter","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Burkitt's lymphoma; Pediatrics; Internal medicine","score_opus":0.03085711052519842,"score_gpt":0.29131499499483565,"score_spread":0.26045788446963725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191255749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8527503,0.12652956,0.0000042134293,0.016315075,0.0015372363,0.0015746492,0.00061418494,0.00012222544,0.00055254175],"genre_scores_gemma":[0.45560026,0.24133305,0.005202811,0.12733568,0.15155472,0.004660284,0.0062912656,0.0012431007,0.0067788307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9942386,0.00017150061,0.001710396,0.0015845373,0.001261309,0.0010336498],"domain_scores_gemma":[0.9955725,0.00039876637,0.0015142882,0.0015850652,0.0005835477,0.00034580342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015883391,0.0011684997,0.0027723422,0.00076549914,0.00018952443,0.00007390455,0.00019403687,0.0010874519,0.000709711],"category_scores_gemma":[0.000073200456,0.0009824934,0.0011405635,0.0012735062,0.00009053457,0.00012770502,0.00013980742,0.00038370155,0.000024288229],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064744294,0.004441206,0.36685628,0.0034181958,0.0016500147,0.55135226,0.00014140006,0.000004911721,0.000004954202,5.6789247e-7,0.06975788,0.002307616],"study_design_scores_gemma":[0.07092252,0.0041294578,0.04193585,0.0009875504,0.24616595,0.4387575,0.00012967947,0.00011483524,0.0016395018,0.000038055547,0.19095646,0.0042226273],"about_ca_topic_score_codex":0.014279743,"about_ca_topic_score_gemma":0.0001321773,"teacher_disagreement_score":0.39715004,"about_ca_system_score_codex":0.0020013063,"about_ca_system_score_gemma":0.005163851,"threshold_uncertainty_score":0.9992626},"labels":[],"label_agreement":null},{"id":"W3191718476","doi":"10.1111/his.14535","title":"<i>In‐situ</i> follicular neoplasia: a clinicopathological spectrum","year":2021,"lang":"en","type":"article","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hôpital Maisonneuve-Rosemont; Collège d'Alma; McGill University","funders":"","keywords":"Lymphoma; Follicular lymphoma; Germinal center; Medicine; Pathology; B cell; Immunology; Antibody","score_opus":0.016373677747327682,"score_gpt":0.2797403778996977,"score_spread":0.26336670015237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191718476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517516,0.0040287497,0.00005426777,0.009503543,0.00066936034,0.00019632652,0.000004604139,0.00006300227,0.03372856],"genre_scores_gemma":[0.9891064,0.00035404708,0.0015974328,0.005931373,0.00017764643,0.00007496446,0.00003456936,0.00001737352,0.0027061794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998475,0.00013840247,0.00034811918,0.00052920496,0.0001391889,0.00037009132],"domain_scores_gemma":[0.99923897,0.00008352447,0.000060756,0.00044525156,0.000039411894,0.00013205982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017833477,0.00017590656,0.00054927904,0.00009025926,0.000048715025,0.0000075948738,0.000059143447,0.00020921048,0.00044069235],"category_scores_gemma":[0.00014379076,0.00014933443,0.00020374282,0.00022171489,0.000105803025,0.00003819354,0.00007115719,0.00018965367,0.00053509505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001991567,0.003187522,0.59100986,0.000048149133,0.0000098061555,0.35893545,0.00031548127,0.000002435849,0.027383877,0.01029408,0.0062696533,0.002344517],"study_design_scores_gemma":[0.004020641,0.00054639933,0.8312161,0.00003565005,0.000113942275,0.021987481,0.00005031364,0.0000042601737,0.008360758,0.0012243328,0.13227928,0.00016083129],"about_ca_topic_score_codex":0.000012600717,"about_ca_topic_score_gemma":0.00009483215,"teacher_disagreement_score":0.33694798,"about_ca_system_score_codex":0.0002499267,"about_ca_system_score_gemma":0.00019799457,"threshold_uncertainty_score":0.6877743},"labels":[],"label_agreement":null},{"id":"W3193510908","doi":"10.3324/haematol.2021.278663","title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia","funders":"Mundipharma EDO; Genentech; EUSA Pharma; Celgene; MorphoSys; H. Lundbeck A/S; Juno Therapeutics; Incyte; F. Hoffmann-La Roche; Bristol-Myers Squibb; AstraZeneca; Kite Pharma; Gilead Sciences; Servier; Amgen","keywords":"Hazard ratio; Standardized uptake value; Medicine; Positron emission tomography; Retrospective cohort study; Internal medicine; Nuclear medicine; Quartile; Proportional hazards model; Diffuse large B-cell lymphoma; Oncology; Confidence interval; Lymphoma","score_opus":0.011200039875509236,"score_gpt":0.2461010715508001,"score_spread":0.23490103167529086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193510908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955359,0.0005472498,0.00000730806,0.00040368648,0.00012464239,0.0021922207,0.000098169214,0.000050077233,0.0010407295],"genre_scores_gemma":[0.9976129,0.000017465805,0.0001869413,0.00052665756,0.000043149303,0.0011113483,0.000118264885,0.000022741731,0.00036053872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981932,0.00018637507,0.0003148362,0.0004539337,0.000430843,0.00042080443],"domain_scores_gemma":[0.99890757,0.00024158039,0.00010544265,0.0004915076,0.00014364382,0.00011024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019164626,0.00025165273,0.00067125564,0.00005098038,0.00012636329,0.000046002846,0.00012790473,0.000060587234,0.00010230799],"category_scores_gemma":[0.00020020948,0.00012979489,0.00013985553,0.00025871486,0.000040565632,0.00005265444,0.00008047267,0.000060331684,0.00006610121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005181037,0.0650111,0.92973137,0.00004766673,0.00015710136,0.0020324523,0.0010455616,2.4690482e-7,0.0000025535978,0.0005662003,0.0006058687,0.00028177717],"study_design_scores_gemma":[0.045835916,0.0023352148,0.9445997,0.000038331505,0.0003858039,0.00020711512,0.0022376364,0.00003154683,0.0001811116,0.000040347357,0.003951554,0.00015575407],"about_ca_topic_score_codex":0.00006997892,"about_ca_topic_score_gemma":0.00010823685,"teacher_disagreement_score":0.06267588,"about_ca_system_score_codex":0.00005779036,"about_ca_system_score_gemma":0.00015439314,"threshold_uncertainty_score":0.5292882},"labels":[],"label_agreement":null},{"id":"W3193558506","doi":"10.2967/jnumed.121.262324","title":"PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma","year":2021,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Western University; BC Cancer Agency; Princess Margaret Cancer Centre; Spinal Cord Injury BC; London Health Sciences Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Population; Stage (stratigraphy); PET-CT; Cost effectiveness; Nuclear medicine; Radiology; Positron emission tomography; Lymphoma; Internal medicine","score_opus":0.017669241511236465,"score_gpt":0.2925530199273849,"score_spread":0.27488377841614847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193558506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788147,0.0015550869,0.000026308113,0.016970059,0.0002851259,0.00044089946,0.0000051597754,0.00001456619,0.0018880588],"genre_scores_gemma":[0.9913199,0.000349892,0.0006747063,0.0070845354,0.00031156585,0.000010664539,0.0000050337703,0.000038076145,0.00020563758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818367,0.000108864166,0.0005750443,0.0002129354,0.0006449495,0.00027456097],"domain_scores_gemma":[0.9985835,0.00020502161,0.00029971916,0.00027285432,0.00033890715,0.0003000128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043987916,0.00019855541,0.0007318612,0.00028925276,0.00005102695,0.000017699565,0.00008714052,0.00006232606,0.0008920606],"category_scores_gemma":[0.0003126951,0.00013981409,0.00022336189,0.00039126672,0.00008550303,0.0001006374,0.000029365157,0.00019053681,0.000035611833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029516707,0.0060004,0.6205768,0.00054879877,0.0017235634,0.1678019,0.0074752234,0.00010828769,0.015237465,0.00072835025,0.035730366,0.14111716],"study_design_scores_gemma":[0.031579826,0.0023880503,0.7861932,0.0023157191,0.0005075346,0.0015898598,0.0015971673,0.0005576752,0.0054329326,0.0000387213,0.16761959,0.00017971905],"about_ca_topic_score_codex":0.00012737977,"about_ca_topic_score_gemma":0.000008163482,"teacher_disagreement_score":0.16621204,"about_ca_system_score_codex":0.0005857356,"about_ca_system_score_gemma":0.00026898875,"threshold_uncertainty_score":0.97674376},"labels":[],"label_agreement":null},{"id":"W3193720686","doi":"","title":"褐色細胞腫・パラガングリオーマ(PPGL)におけるMIBGを用いた診断・治療の最前線","year":2021,"lang":"ja","type":"article","venue":"Pharma Medica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.030003403150735762,"score_gpt":0.319406679318017,"score_spread":0.28940327616728123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193720686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.405955,0.23146395,0.0001650481,0.13107625,0.01976647,0.0022543168,0.000611044,0.00067445566,0.20803349],"genre_scores_gemma":[0.94366133,0.023254499,0.00036004515,0.01202645,0.0045934715,0.00019080631,0.00041901416,0.00011561382,0.015378747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99459505,0.00032787648,0.0009810805,0.0011847919,0.001606772,0.0013044503],"domain_scores_gemma":[0.9959577,0.00053511275,0.00027157192,0.0011509106,0.0003659783,0.0017187602],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054830156,0.00072130386,0.0011929859,0.00017687007,0.00030897764,0.000115103954,0.00035608085,0.00035664887,0.03427081],"category_scores_gemma":[0.00069924217,0.00063049444,0.0005893432,0.0007202234,0.0003197625,0.00018654636,0.00032087398,0.0006082435,0.0077847326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045194398,0.007985663,0.026980886,0.0011646819,0.004681923,0.03929869,0.0041381614,0.000008609427,0.008764048,0.00086974696,0.55248266,0.35317296],"study_design_scores_gemma":[0.018515032,0.0004987977,0.02229873,0.0013118142,0.0031675296,0.001207972,0.0010811936,0.00063173776,0.057528146,0.00009902831,0.89291346,0.0007465881],"about_ca_topic_score_codex":0.0001782522,"about_ca_topic_score_gemma":0.000017902245,"teacher_disagreement_score":0.5377064,"about_ca_system_score_codex":0.0005911867,"about_ca_system_score_gemma":0.0017356225,"threshold_uncertainty_score":0.99961466},"labels":[],"label_agreement":null},{"id":"W3194397741","doi":"10.1182/bloodadvances.2021004375","title":"Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Vinblastine; Medicine; Bleomycin; Stage (stratigraphy); Nuclear medicine; Positron emission tomography; Chemotherapy; Radiation therapy; Lymphoma; Oncology; Vincristine; Hodgkin's lymphoma; Internal medicine; Radiology; Cyclophosphamide","score_opus":0.01675286529882216,"score_gpt":0.2905401237329178,"score_spread":0.2737872584340957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194397741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625051,0.034068912,0.000033307202,0.00013275429,0.000042593812,0.0004229492,0.00008155858,0.000020059619,0.0026927744],"genre_scores_gemma":[0.9932727,0.0033208628,0.0028603517,0.000060027207,0.000037359216,0.000053927954,0.00003225768,0.000020025896,0.0003424636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985516,0.000098599194,0.00048773986,0.00032551182,0.00030145896,0.0002350961],"domain_scores_gemma":[0.9986933,0.00026571506,0.00026158747,0.0005119517,0.00015889005,0.00010856923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019209975,0.00023598436,0.0008330276,0.00007033845,0.00005776094,0.000014084808,0.000100247154,0.000048238962,0.000048528484],"category_scores_gemma":[0.00021283058,0.00012752737,0.00034930668,0.00028081064,0.0002788523,0.00008758991,0.00008765799,0.00003710682,0.0000019874208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021236613,0.005887541,0.94831395,0.0006881076,0.0020362781,0.0007953761,0.00079313497,0.0002186974,0.0044340827,0.0032650395,0.000049894796,0.03139426],"study_design_scores_gemma":[0.07577863,0.001358982,0.7964138,0.00041507737,0.0020423776,0.0018128422,0.0016735591,0.0020125632,0.11572694,0.00021142386,0.0021614933,0.00039230136],"about_ca_topic_score_codex":0.0004093678,"about_ca_topic_score_gemma":0.000016804406,"teacher_disagreement_score":0.15190013,"about_ca_system_score_codex":0.000072057264,"about_ca_system_score_gemma":0.00022845564,"threshold_uncertainty_score":0.5200415},"labels":[],"label_agreement":null},{"id":"W3194849531","doi":"10.1158/1078-0432.ccr-21-0573","title":"Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; microRNA; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Cancer research; BCL6; Epigenetics; GATA3; Gene expression profiling; Lymphoma; T cell; Protein kinase B; Signal transduction; Immunology; B cell; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.1145110103807511,"score_gpt":0.4535532877613276,"score_spread":0.33904227738057646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194849531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536444,0.01034438,0.000025259771,0.00068676274,0.00011588166,0.00042255575,0.000022363465,0.000011245537,0.0030071365],"genre_scores_gemma":[0.99477524,0.0026580645,0.0015159684,0.00013326253,0.00015272044,0.00012364356,0.000033733973,0.000027189655,0.0005801825],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715847,0.00039348402,0.0007351874,0.00046365216,0.0008635723,0.00038563553],"domain_scores_gemma":[0.9974569,0.0006907138,0.00012974754,0.00059907703,0.000852471,0.0002710844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176,0.00012775163,0.0005828787,0.00008131918,0.000054986405,0.000011987122,0.00015940334,0.00016260472,0.0006149059],"category_scores_gemma":[0.00068052293,0.00010058103,0.00031276984,0.0003905821,0.00030972352,0.00003652837,0.00022052621,0.00021358985,0.000015639209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008527385,0.0035369666,0.57820636,0.0005291047,0.00013070973,0.00054667494,0.00011926498,0.000011322006,0.4067546,0.00006168961,0.00039704647,0.008853539],"study_design_scores_gemma":[0.005201483,0.0006129307,0.23107801,0.00030111082,0.00005010548,0.0000045231204,0.00017055708,0.000025481388,0.7609223,0.000082762104,0.0014763133,0.00007438454],"about_ca_topic_score_codex":0.00018119175,"about_ca_topic_score_gemma":0.0000141510445,"teacher_disagreement_score":0.35416773,"about_ca_system_score_codex":0.00023926387,"about_ca_system_score_gemma":0.0013302233,"threshold_uncertainty_score":0.67327887},"labels":[],"label_agreement":null},{"id":"W3195024161","doi":"10.1111/bjh.17811","title":"Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Medical Research Council; National Institute for Health and Care Research; Michael Smith Health Research BC; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; Wellcome Trust","keywords":"Subtyping; Computational biology; Lymphoma; Profiling (computer programming); Precision medicine; Diffuse large B-cell lymphoma; Clinical trial; Bioinformatics; Biology; Medicine; Computer science; Pathology","score_opus":0.018647779673183526,"score_gpt":0.3013110141533433,"score_spread":0.2826632344801598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195024161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042748176,0.9561073,0.000025809728,0.000061627274,0.00028369154,0.00041708487,0.000041729178,0.0000069492958,0.00030761227],"genre_scores_gemma":[0.010436652,0.988443,0.0007065525,0.00013785613,0.00007321276,0.000027078175,0.00006886002,0.000060183043,0.00004660446],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9970078,0.00035072002,0.0016016288,0.00031412492,0.00032720141,0.0003985441],"domain_scores_gemma":[0.9978776,0.00020420886,0.0011900365,0.00027924305,0.0002852164,0.00016368285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003695635,0.0003286722,0.004404874,0.00037095638,0.000036716618,0.000034876164,0.00021255892,0.00044902563,0.00007373502],"category_scores_gemma":[0.00024317246,0.00030335164,0.00096702756,0.00031275387,0.000091124966,0.000055000866,0.00010287662,0.0003218758,0.000014023596],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046065576,0.012835767,0.0009797426,0.024921285,0.0011667736,0.58133924,0.000060949606,4.895992e-7,0.0000047552753,0.00097444135,0.001381911,0.37628856],"study_design_scores_gemma":[0.014830773,0.0003338461,0.000121360725,0.062283155,0.0033659616,0.46313772,0.000059976348,0.0000034843758,0.0004553157,0.00005677025,0.45502487,0.00032676946],"about_ca_topic_score_codex":0.00007124153,"about_ca_topic_score_gemma":0.000037704216,"teacher_disagreement_score":0.45364296,"about_ca_system_score_codex":0.00026282977,"about_ca_system_score_gemma":0.0016601938,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W3196332160","doi":"10.1016/s2152-2650(21)01891-7","title":"ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Diffuse large B-cell lymphoma; Observational study; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Overall survival; Multiple myeloma","score_opus":0.10291016399823841,"score_gpt":0.3575752979245393,"score_spread":0.25466513392630086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196332160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98614514,0.0013282596,0.000093172035,0.0066299434,0.0012222072,0.0026535534,0.00081510824,0.00028006287,0.0008325482],"genre_scores_gemma":[0.9766195,0.00047567236,0.0025096168,0.008867098,0.0012042907,0.00090446585,0.0013894361,0.00023711174,0.0077928356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914531,0.0009609366,0.0026799708,0.0020783488,0.0015524635,0.0012751551],"domain_scores_gemma":[0.9836966,0.011145767,0.0010677318,0.0025275967,0.0008518246,0.00071049714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015981776,0.0012091827,0.0026804989,0.000112410125,0.0007213001,0.00034994908,0.00080454024,0.0006576836,0.00042241698],"category_scores_gemma":[0.0022235683,0.0007126604,0.0012832037,0.00052940694,0.0003140628,0.00040328887,0.00043004312,0.00034301865,0.0001789409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020117607,0.034459926,0.8951899,0.00010036563,0.0036894646,0.0023597628,0.0012467824,0.0000032380062,0.000102176135,0.00044408542,0.012340207,0.029946527],"study_design_scores_gemma":[0.1660421,0.0035273896,0.787006,0.0002662967,0.0015153822,0.0000674935,0.0020665466,0.00017657207,0.00048713837,0.0001907913,0.037909087,0.00074515713],"about_ca_topic_score_codex":0.00071296096,"about_ca_topic_score_gemma":0.0011180345,"teacher_disagreement_score":0.1459245,"about_ca_system_score_codex":0.002575568,"about_ca_system_score_gemma":0.006450671,"threshold_uncertainty_score":0.99953246},"labels":[],"label_agreement":null},{"id":"W3196729012","doi":"10.2196/24936","title":"Role of 18F-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Imaging in the Prediction of Prognosis in Patients With Indolent Lymphoma: Prospective Study","year":2021,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Positron emission tomography; Standardized uptake value; Nuclear medicine; Lymphoma; Fluorodeoxyglucose; Chemoimmunotherapy; Prospective cohort study; PET-CT; Radiology; Rituximab; Internal medicine","score_opus":0.012466675611002682,"score_gpt":0.30181447270787315,"score_spread":0.2893477970968705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196729012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517316,0.00045611316,0.0000026460993,0.000092676346,0.000019447256,0.0036172308,0.000041307743,0.000014797647,0.00058262027],"genre_scores_gemma":[0.9987237,0.000020221543,0.000070912494,0.000008421708,0.000013060168,0.001066619,0.00007992782,0.000014834829,0.000002345682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967721,0.00055820565,0.0005348347,0.00034750573,0.0013917474,0.00039560738],"domain_scores_gemma":[0.9983323,0.00019739094,0.00015828043,0.00034240767,0.0008893479,0.00008025937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007103358,0.00019035835,0.0004136196,0.00086622976,0.000098439465,0.000028340923,0.00015529458,0.0000478326,0.0000075144244],"category_scores_gemma":[0.00003741331,0.00011664262,0.00011228428,0.0027509537,0.00015522318,0.00026722855,0.00013675312,0.00023342129,0.0000010303986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010281182,0.024573792,0.9367198,0.00013680031,0.00014846127,0.000036057656,0.022732718,0.000003343524,0.00035544886,0.000032549055,0.000047796108,0.014185148],"study_design_scores_gemma":[0.011843889,0.003986723,0.94298494,0.0007874662,0.00003859396,0.000007033875,0.012937208,0.00016902167,0.027089763,0.00006837523,0.000007954938,0.000079004996],"about_ca_topic_score_codex":0.00021026023,"about_ca_topic_score_gemma":0.000044294477,"teacher_disagreement_score":0.026734313,"about_ca_system_score_codex":0.00033345772,"about_ca_system_score_gemma":0.00020809716,"threshold_uncertainty_score":0.4756548},"labels":[],"label_agreement":null},{"id":"W3197211115","doi":"10.1182/blood.2020008376","title":"Primary mediastinal large B-cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rituximab; Lymphoma; Medicine; Phenotype; Cancer research; Disease; Oncology; Bioinformatics; Immunology; Pathology; Biology; Gene; Genetics","score_opus":0.00868751703938859,"score_gpt":0.22523528684941518,"score_spread":0.2165477698100266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197211115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336437,0.0039288104,0.000008278791,0.0006027658,0.00011860039,0.00010683662,0.00002125159,0.00005795565,0.061511803],"genre_scores_gemma":[0.9938499,0.0002494813,0.001560119,0.0015979309,0.00024765154,0.00003346178,0.00014411208,0.000017614264,0.0022997705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913156,0.00002070318,0.00014292117,0.00023358513,0.00022854384,0.0002426833],"domain_scores_gemma":[0.9994187,0.000053438875,0.000032499418,0.0002684851,0.00006938028,0.00015749846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053239153,0.00011477122,0.00021606863,0.00002839396,0.000050247923,0.000014609691,0.00003698341,0.000056793997,0.0003375769],"category_scores_gemma":[0.00003442016,0.00009431788,0.000111150526,0.00011717589,0.000015758656,0.000028859278,0.000055415043,0.000031142063,0.0003072474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014949085,0.11234393,0.78161037,0.00053229084,0.0007946532,0.025789067,0.0005649373,1.8147767e-7,0.023751158,0.0014213384,0.017050292,0.035992317],"study_design_scores_gemma":[0.04844866,0.0003008241,0.6850539,0.000103642975,0.0007882787,0.00133169,0.000094641546,0.000004192392,0.21058764,0.000043769927,0.053070627,0.00017214795],"about_ca_topic_score_codex":0.0000074582204,"about_ca_topic_score_gemma":0.0000049918367,"teacher_disagreement_score":0.18683648,"about_ca_system_score_codex":0.00005637765,"about_ca_system_score_gemma":0.00031782693,"threshold_uncertainty_score":0.3949146},"labels":[],"label_agreement":null},{"id":"W3197397941","doi":"10.5858/arpa.2020-0726-oa","title":"Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma","year":2021,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Lymphoma; CD8; Pathology; Flow cytometry; Lymphocyte; Malignancy; Medicine; Immunophenotyping; Biology; Immunology; Immune system","score_opus":0.01097765889214018,"score_gpt":0.2487008909203197,"score_spread":0.23772323202817952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197397941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503596,0.011349822,0.0001273454,0.0011760695,0.00052964274,0.0006621194,0.00021679523,0.000026100062,0.00087612594],"genre_scores_gemma":[0.9956547,0.0023117766,0.00066520384,0.0009263412,0.00015985647,0.00008890462,0.000060194663,0.000045443565,0.00008758938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968069,0.0005359998,0.00093782396,0.00071241416,0.0005201219,0.000486713],"domain_scores_gemma":[0.9969765,0.0010640353,0.0004920095,0.0009704493,0.0003065991,0.00019041155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043190012,0.00040505972,0.001177323,0.0007432053,0.00011978349,0.000006432801,0.00025183219,0.00021201845,0.00012388847],"category_scores_gemma":[0.00043629596,0.00027784714,0.00024258909,0.0021139418,0.0009902947,0.000088636734,0.00018216376,0.000188932,0.00000973421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013372706,0.002245398,0.40350097,0.00033042248,0.00024883632,0.0043222453,0.0050334013,0.000024671772,0.5684695,0.00008205496,0.0002269977,0.014178206],"study_design_scores_gemma":[0.014123944,0.00067057466,0.40146768,0.0006884531,0.00036834847,0.0003780675,0.00042988922,0.00013881868,0.5809122,0.000056437322,0.0006240067,0.00014160058],"about_ca_topic_score_codex":0.00021074421,"about_ca_topic_score_gemma":0.00014463045,"teacher_disagreement_score":0.014036605,"about_ca_system_score_codex":0.00031551495,"about_ca_system_score_gemma":0.0008164129,"threshold_uncertainty_score":0.9999674},"labels":[],"label_agreement":null},{"id":"W3198075822","doi":"10.14740/jh890","title":"Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Tanoto Foundation; Duke-NUS Medical School","keywords":"Medicine; Internal medicine; Mantle cell lymphoma; Refractory (planetary science); Progression-free survival; Population; Lymphoma; Oncology; Overall survival; Surgery","score_opus":0.009800478165260645,"score_gpt":0.24629764810922009,"score_spread":0.23649716994395945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198075822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716604,0.00090037903,0.000011236398,0.0008469206,0.00017750323,0.00009432849,0.000014227111,0.000003558308,0.0007857841],"genre_scores_gemma":[0.9989248,0.0003172372,0.00044288582,0.00007498308,0.000020640959,0.0000030099645,0.0000103913635,0.00001359476,0.0001924405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904317,0.000057714165,0.00040746233,0.00012872633,0.00021374601,0.00014916161],"domain_scores_gemma":[0.99901104,0.00012690084,0.00036260285,0.00017081494,0.00019888976,0.00012972618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041267707,0.00014596552,0.0007338494,0.000087317094,0.000025424579,0.0000057959605,0.00003423152,0.00007363974,0.000072076764],"category_scores_gemma":[0.000023472994,0.0000845291,0.0001275868,0.000045040495,0.00003667476,0.000049055827,0.000020385465,0.00004186616,0.0000035992036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026275212,0.004364659,0.9874827,0.00008138396,0.0004408236,0.002047739,0.0002166727,1.8404383e-7,0.0000377367,0.00015209841,0.00006989102,0.0048433044],"study_design_scores_gemma":[0.019691333,0.002908176,0.96569914,0.00010747087,0.00040387435,0.0016032236,0.00035877767,6.882218e-7,0.00805249,0.000020703863,0.0010838062,0.00007033332],"about_ca_topic_score_codex":0.000025181074,"about_ca_topic_score_gemma":0.000029192248,"teacher_disagreement_score":0.021783631,"about_ca_system_score_codex":0.00011512703,"about_ca_system_score_gemma":0.00019811612,"threshold_uncertainty_score":0.34469965},"labels":[],"label_agreement":null},{"id":"W3198471783","doi":"10.1093/ajcp/aqab111","title":"Global Cytopathology-Hematopathology Practice Trends","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Hematopathology; Cytopathology; Medicine; Fine-needle aspiration; Biopsy; Telepathology; Medical diagnosis; Lymphoma; Subspecialty; Second opinion; Radiology; Pathology; Cytology; Telemedicine; Health care","score_opus":0.03853336403839513,"score_gpt":0.4456406198392156,"score_spread":0.40710725580082047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198471783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95899355,0.0014945033,0.0004902977,0.02259456,0.0012741073,0.000053601536,0.000015902333,0.000025410844,0.0150580425],"genre_scores_gemma":[0.95615387,0.0011615854,0.029116089,0.012625904,0.0006922708,0.000004986022,0.00001000859,0.000017707449,0.0002175825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955865,0.0013960882,0.0018639982,0.0004302368,0.0003246484,0.00039853947],"domain_scores_gemma":[0.9950214,0.0014712996,0.0016490389,0.0005091958,0.000890683,0.000458385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017650616,0.00022603596,0.0018619585,0.000121830446,0.00005051782,0.000013217571,0.00016187086,0.00020573862,0.00020075921],"category_scores_gemma":[0.0059537776,0.00017219668,0.0007774048,0.0006154825,0.00092967105,0.00011231486,0.0001051591,0.0004560996,0.00007240621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010681372,0.0026439957,0.54530865,0.0000063928146,0.00024208528,0.09576048,0.00007212936,0.0000026694331,0.0000981404,0.0013696055,0.002097157,0.35133055],"study_design_scores_gemma":[0.004458176,0.0076611484,0.7192516,0.000041296058,0.00082370156,0.23073812,0.0005447393,0.000003400021,0.00009605815,0.0004207377,0.03582715,0.0001339054],"about_ca_topic_score_codex":0.000008637554,"about_ca_topic_score_gemma":0.000008640918,"teacher_disagreement_score":0.35119665,"about_ca_system_score_codex":0.00010836082,"about_ca_system_score_gemma":0.0007715328,"threshold_uncertainty_score":0.71276575},"labels":[],"label_agreement":null},{"id":"W3198840476","doi":"10.3390/curroncol28050297","title":"New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Splenic marginal zone lymphoma; Lymphoma; Splenectomy; Medicine; Epigenetics; Marginal zone; Tumor microenvironment; Bioinformatics; Cancer research; Pathology; Biology; Computational biology; Immunology; B cell; Spleen; Gene; Tumor cells; Genetics","score_opus":0.11742896125218796,"score_gpt":0.438086589337093,"score_spread":0.32065762808490506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198840476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070918445,0.99583346,0.000015805026,0.00059392676,0.0013722088,0.0009637902,0.000017800754,0.000019856496,0.0004739723],"genre_scores_gemma":[0.00032051702,0.99761987,0.00026708914,0.0000646188,0.0006065407,0.00057972356,0.00037907745,0.00003412707,0.00012842925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977035,0.000432826,0.0007796972,0.00061156537,0.00015528829,0.00031712675],"domain_scores_gemma":[0.9974224,0.0011641195,0.00049017236,0.0005715799,0.00011013111,0.0002416138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015120796,0.00047609844,0.002995439,0.00021415942,0.000079664445,0.000012014931,0.00020465985,0.0004701063,0.00037433585],"category_scores_gemma":[0.0001392999,0.0002653196,0.00057451974,0.00035934523,0.00028227307,0.00002418879,0.00030577744,0.0002870089,0.000048425867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015278678,0.00080958207,0.0038277886,0.004046358,0.00065792724,0.0000988076,0.00027976948,9.455015e-9,1.4705516e-7,0.0038205609,0.006697237,0.9797465],"study_design_scores_gemma":[0.0019623747,0.0008837092,0.0006181382,0.007144254,0.00434757,0.0003560993,0.00003747928,8.0213925e-7,0.0000063751972,0.00013691383,0.98430455,0.00020172285],"about_ca_topic_score_codex":0.00018818464,"about_ca_topic_score_gemma":0.00010427686,"teacher_disagreement_score":0.9795448,"about_ca_system_score_codex":0.0006410564,"about_ca_system_score_gemma":0.0023374625,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W3198972272","doi":"10.1111/bjh.17793","title":"9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Deutsche Krebshilfe; European Hematology Association","keywords":"Lymphoma; Cancer research; Classical Hodgkin lymphoma; Aggressive lymphoma; Stage (stratigraphy); Pathology; Biology; Oncology; Medicine; Hodgkin lymphoma; Rituximab","score_opus":0.02258221528194429,"score_gpt":0.30006858239557443,"score_spread":0.2774863671136302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198972272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552315,0.0028130966,0.00010628016,0.00066446635,0.00015685182,0.0006416509,0.000035570654,0.0000128216225,0.00004611013],"genre_scores_gemma":[0.9978337,0.00042224297,0.0012032227,0.00014761236,0.00017268679,0.00006259883,0.00006799857,0.000019986344,0.000069900445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728817,0.0007804388,0.00084708515,0.0003847805,0.00037954305,0.00031999193],"domain_scores_gemma":[0.99846435,0.00044337998,0.00036251626,0.00030228597,0.00017260262,0.00025484574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048449342,0.00019638016,0.0010603308,0.00017382804,0.00019109217,0.00024627912,0.00014399471,0.0001467314,0.00006227519],"category_scores_gemma":[0.00014926401,0.00015235259,0.00023274326,0.0003815823,0.000084720596,0.00022273391,0.00007788005,0.0002393637,0.0000021608832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043638526,0.016442528,0.8351545,0.000025516272,0.0012516658,0.12880386,0.0032951662,0.00001407847,0.0008286108,0.000084863204,0.0004724072,0.009262948],"study_design_scores_gemma":[0.08460159,0.002769618,0.8928693,0.00023702654,0.0020943994,0.01128132,0.0021438322,0.00024578883,0.002843215,0.00019088852,0.00051650516,0.00020654661],"about_ca_topic_score_codex":0.0015801481,"about_ca_topic_score_gemma":0.004906862,"teacher_disagreement_score":0.117522545,"about_ca_system_score_codex":0.00013097576,"about_ca_system_score_gemma":0.00029851487,"threshold_uncertainty_score":0.62127584},"labels":[],"label_agreement":null},{"id":"W3200668385","doi":"10.1016/j.jmoldx.2021.09.002","title":"DNA Methylation-Based Classification of Small B-Cell Lymphomas","year":2021,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Seventh Framework Programme; Canadian Institutes of Health Research; Terry Fox Research Institute; Princess Margaret Cancer Foundation; European Commission; Government of Ontario; University of Toronto; Ontario Institute for Cancer Research","keywords":"Mantle cell lymphoma; Medical diagnosis; Follicular lymphoma; Concordance; DNA methylation; Lymphoma; Chronic lymphocytic leukemia; Methylation; Computational biology; Biology; Pathology; Computer science; Medicine; Bioinformatics; Leukemia; Immunology; Gene; Genetics; Gene expression","score_opus":0.01978921822908271,"score_gpt":0.2603741962996482,"score_spread":0.2405849780705655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200668385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005766,0.007068834,0.009204213,0.0016921351,0.00021261444,0.00014583244,0.000011956911,0.0000072083812,0.001599531],"genre_scores_gemma":[0.984567,0.00086800207,0.013903849,0.0004983597,0.000073258845,0.0000050272483,0.000031094754,0.000020061887,0.000033338976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863,0.00009181767,0.00059624173,0.00012923525,0.00041834416,0.0001343749],"domain_scores_gemma":[0.9974853,0.00060673663,0.0005272476,0.00027702618,0.00094329537,0.00016040799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020115463,0.00013102798,0.00038011456,0.00013629596,0.000025628937,0.00001613519,0.000075173935,0.00009839214,0.000060065835],"category_scores_gemma":[0.001158958,0.00011119909,0.0003024935,0.00023880572,0.000038073904,0.000030050951,0.000016838467,0.00008880057,0.00000827041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030291785,0.010511815,0.3071746,0.00051869213,0.0009106128,0.007999067,0.00024225628,0.0017145688,0.6319657,0.0035521227,0.003345347,0.03176234],"study_design_scores_gemma":[0.0046934504,0.0005048751,0.16156432,0.0002680348,0.0008463498,0.00015326495,0.000067416906,0.00035308563,0.82896054,0.00024753297,0.002246297,0.00009485937],"about_ca_topic_score_codex":0.0000046605674,"about_ca_topic_score_gemma":0.0000022840659,"teacher_disagreement_score":0.19699484,"about_ca_system_score_codex":0.00016213843,"about_ca_system_score_gemma":0.0008698332,"threshold_uncertainty_score":0.45345673},"labels":[],"label_agreement":null},{"id":"W3200845029","doi":"10.1182/bloodadvances.2021004765","title":"Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Center for Advancing Translational Sciences; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Winship Cancer Institute; Seagen; Incyte; Astellas Pharma; Adaptive Biotechnologies; TG Therapeutics; H. Lundbeck A/S; BeiGene; Purdue Pharma; Regeneron Pharmaceuticals; National Institutes of Health; Ohio State University; Omeros Corporation; Verastem Oncology; Spectrum Pharmaceuticals; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Purdue University; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Emory University","keywords":"Medicine; Intensive care; Oncology; Internal medicine; Intensive care medicine","score_opus":0.015180867002017012,"score_gpt":0.2590935902796956,"score_spread":0.24391272327767857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200845029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889858,0.008861774,0.000013236117,0.0008578556,0.000500544,0.00044496622,0.00006559765,0.00005639726,0.0002138383],"genre_scores_gemma":[0.9936671,0.001914861,0.0006407742,0.0018718429,0.00014114293,0.00017456143,0.00010254484,0.000039291233,0.0014478682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985332,0.00005179215,0.00029130097,0.00045931552,0.0003709031,0.00029348637],"domain_scores_gemma":[0.99709284,0.0001591964,0.00012219157,0.00037646794,0.0021106696,0.00013865392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003784648,0.00028258492,0.0005392372,0.00006297015,0.000075100885,0.000059149475,0.00006785575,0.000068043526,0.00017675698],"category_scores_gemma":[0.00031377355,0.00016639385,0.00011132319,0.00019198749,0.00012912614,0.0002945499,0.00006325483,0.000109947156,0.00004198012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002756012,0.0011577378,0.98155123,0.00004517669,0.00068016193,0.0014580076,0.0010272734,0.0000012024094,0.00012959327,0.0000233586,0.00016543339,0.011004798],"study_design_scores_gemma":[0.012363407,0.0014607548,0.9609484,0.0004494512,0.00036859966,0.000051820145,0.0028675925,6.1821754e-7,0.016463172,0.00004702174,0.004733864,0.00024526674],"about_ca_topic_score_codex":0.00010204234,"about_ca_topic_score_gemma":0.00044920904,"teacher_disagreement_score":0.020602811,"about_ca_system_score_codex":0.000047160265,"about_ca_system_score_gemma":0.00014697853,"threshold_uncertainty_score":0.6785344},"labels":[],"label_agreement":null},{"id":"W3202324966","doi":"10.1038/s41416-021-01525-4","title":"Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Hazard ratio; Internal medicine; Population; Cancer; Lymphoma; Regimen; Proportional hazards model; Cancer registry; Pediatrics; Oncology; Confidence interval","score_opus":0.014400843372268678,"score_gpt":0.3071092908532081,"score_spread":0.29270844748093944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202324966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968452,0.0022808055,0.0000011808612,0.00013113527,0.000063408224,0.00008031074,0.0004923892,0.0000011076169,0.000104455255],"genre_scores_gemma":[0.99072367,0.008853718,0.00014517832,0.000108739856,0.00003184593,0.0000026697946,0.000059656544,0.000009868183,0.00006468006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987799,0.0000857634,0.00049747265,0.00015880507,0.0003413327,0.0001367064],"domain_scores_gemma":[0.99897873,0.000148618,0.00040314844,0.00020735827,0.00018612102,0.00007600232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024362029,0.00007867431,0.0005935141,0.00025350245,0.000007713211,0.00001871962,0.000085133375,0.000032821517,0.00006321994],"category_scores_gemma":[0.0001325015,0.00007644417,0.00008743793,0.00040658793,0.00002182749,0.0001750001,0.00008009739,0.000072776515,2.2467998e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014978711,0.0063741095,0.959329,0.000045376,0.00070941495,0.0010478124,0.00042783975,0.0000019191714,0.0000052268156,0.0000014793223,0.00008514104,0.031822875],"study_design_scores_gemma":[0.026660627,0.00009369148,0.9701327,0.00053059513,0.0010509097,0.000022907807,0.00022120659,0.000013034237,0.00015919226,0.0000012936003,0.0010538594,0.0000599879],"about_ca_topic_score_codex":0.009176668,"about_ca_topic_score_gemma":0.06774043,"teacher_disagreement_score":0.058563765,"about_ca_system_score_codex":0.0001159046,"about_ca_system_score_gemma":0.00014704299,"threshold_uncertainty_score":0.9974213},"labels":[],"label_agreement":null},{"id":"W3203617810","doi":"10.1073/pnas.2105822118","title":"Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"Terry Fox Research Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome British Columbia; National Cancer Institute; Government of Canada; Paul G. Allen Family Foundation","keywords":"CXCL13; CXCR5; Lymphoma; Hodgkin lymphoma; Lymphocyte; Immunology; Cancer research; Biology; B cell; Antibody; Chemokine; Germinal center; Chemokine receptor; Immune system","score_opus":0.05291523164229645,"score_gpt":0.3149897342153894,"score_spread":0.26207450257309295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203617810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840881,0.0020487313,1.7258752e-7,0.005446518,0.00002750512,0.00029381437,0.000015824447,0.0000067513142,0.008072532],"genre_scores_gemma":[0.99725276,0.0001962122,0.0016895648,0.000613854,0.00005644724,0.000033222583,8.1990106e-7,0.0000054812463,0.00015165073],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980472,0.000019236895,0.0005998284,0.00033898302,0.00077862485,0.00021615345],"domain_scores_gemma":[0.9985259,0.00035807682,0.00063967815,0.000025341755,0.00041261062,0.00003837432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011937218,0.00013055973,0.00034689123,0.00014984606,0.00010542354,0.000012441052,0.00042985988,0.00011731622,0.000017239121],"category_scores_gemma":[0.00088623806,0.00007198532,0.00012024773,0.0012864424,0.0006649345,0.00015367028,0.00015127845,0.00007823949,0.0000011837998],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003548013,0.000452464,0.635004,0.0001270056,0.000029037723,1.6739968e-7,0.00017360055,0.000007278984,0.34310046,0.019663524,0.00019298532,0.0012140254],"study_design_scores_gemma":[0.0010216488,0.00012294967,0.27527383,0.00020331767,0.000033439297,0.00003854016,0.00036098636,0.00013863192,0.71226853,0.0103402985,0.00013617924,0.000061625],"about_ca_topic_score_codex":0.000011156759,"about_ca_topic_score_gemma":5.516698e-7,"teacher_disagreement_score":0.3691681,"about_ca_system_score_codex":0.00022617831,"about_ca_system_score_gemma":0.00026848709,"threshold_uncertainty_score":0.29354763},"labels":[],"label_agreement":null},{"id":"W3204045414","doi":"10.1182/bloodadvances.2021005682","title":"Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute","keywords":"BCL6; Cancer research; Lymphoma; Biology; Ubiquitin ligase; Molecular biology; B cell; Gene; Genetics; Ubiquitin; Immunology; Antibody","score_opus":0.009868486249774931,"score_gpt":0.2757344045850493,"score_spread":0.26586591833527434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204045414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94238627,0.04700195,0.00001565496,0.001995813,0.00015005734,0.00025800648,0.000021351978,0.000032999873,0.008137882],"genre_scores_gemma":[0.994261,0.002024194,0.0025815037,0.00043938486,0.000052938954,0.000104382125,0.000058087895,0.00001435112,0.00046411454],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897915,0.000039800492,0.00029462462,0.00026047303,0.00022823703,0.0001977204],"domain_scores_gemma":[0.9993752,0.00011460903,0.0000873753,0.0002475814,0.000095606774,0.00007958407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047764683,0.00014079566,0.000330602,0.00008341869,0.000036233323,0.000009957141,0.000054761746,0.000048524267,0.0002496888],"category_scores_gemma":[0.000051010113,0.00011124615,0.000105319705,0.00030243298,0.000056017092,0.000098843055,0.000020945747,0.000030990886,0.00003513731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017114045,0.013829537,0.8426923,0.00035018518,0.000959896,0.0034768635,0.0015749519,0.00012813695,0.026550207,0.027237102,0.00012892019,0.08290075],"study_design_scores_gemma":[0.009758318,0.0005684122,0.32312056,0.00035715158,0.00044238166,0.0002975827,0.000680991,0.000021531761,0.6010541,0.0056680324,0.05781308,0.00021790786],"about_ca_topic_score_codex":0.00012624305,"about_ca_topic_score_gemma":0.00008335896,"teacher_disagreement_score":0.57450384,"about_ca_system_score_codex":0.00006658391,"about_ca_system_score_gemma":0.00026668466,"threshold_uncertainty_score":0.45364863},"labels":[],"label_agreement":null},{"id":"W3204760583","doi":"10.1200/jco.21.00920","title":"Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Prednisone; Vincristine; Rituximab; Cyclophosphamide; Multicenter study; Phases of clinical research","score_opus":0.03384742794814694,"score_gpt":0.35893940788864404,"score_spread":0.3250919799404971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204760583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010485,0.0067201983,0.000011808168,0.002079091,0.00017684653,0.0007939459,0.000011011347,0.000008721994,0.00009352857],"genre_scores_gemma":[0.9857974,0.008644361,0.00323159,0.0017986596,0.00043350368,0.000016841446,0.000014083964,0.000026339754,0.00003723664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702114,0.0003410188,0.0015021438,0.00043119767,0.00039840498,0.0003060669],"domain_scores_gemma":[0.99738353,0.0006672034,0.0009541762,0.00017727178,0.00028959848,0.00052823126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087049237,0.00028923716,0.0018807041,0.000115414965,0.000067224406,0.000024979157,0.00006841967,0.00026995776,0.000015237519],"category_scores_gemma":[0.0003715639,0.00017272757,0.000113520924,0.0001505864,0.00037754423,0.00013018517,0.000101697835,0.0004190808,6.80779e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3339159,0.035971124,0.4780023,0.00006201602,0.00043099848,0.004036331,0.00021834816,9.219404e-7,0.00013430898,0.000002474461,0.0001303367,0.14709495],"study_design_scores_gemma":[0.44087988,0.047518525,0.5077474,0.0004044343,0.0004389931,0.0022859154,0.000057437523,0.0000259042,0.00021217755,0.000004182905,0.00032602123,0.000099119105],"about_ca_topic_score_codex":0.00011314931,"about_ca_topic_score_gemma":0.00011392911,"teacher_disagreement_score":0.14699583,"about_ca_system_score_codex":0.00021394812,"about_ca_system_score_gemma":0.0016230291,"threshold_uncertainty_score":0.70436263},"labels":[],"label_agreement":null},{"id":"W3205072810","doi":"10.1182/bloodadvances.2021004970","title":"Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Brentuximab vedotin; Internal medicine; Quality of life (healthcare); Oncology; Confidence interval; Classical Hodgkin lymphoma; Hazard ratio; Lymphoma; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.029216302996506044,"score_gpt":0.3286447617787381,"score_spread":0.299428458782232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205072810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193073,0.015039403,0.00018740297,0.0007121557,0.00017130686,0.0002887699,0.00022125235,0.000034435983,0.0014145413],"genre_scores_gemma":[0.9943419,0.0011894658,0.003395497,0.0002633854,0.00010143347,0.000090378555,0.00023811906,0.000021597325,0.00035819295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793774,0.00010954776,0.00078678643,0.0004473527,0.00044376947,0.000274796],"domain_scores_gemma":[0.9977748,0.000804697,0.00042866496,0.0005067993,0.0003065113,0.00017854305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018116478,0.00021781726,0.0012551423,0.00020414057,0.000056552275,0.00001049356,0.00010487128,0.00010884884,0.00011189351],"category_scores_gemma":[0.0006345772,0.00017938916,0.00071874226,0.0006778063,0.00012398441,0.00010827188,0.000048418256,0.00004735678,0.000004305967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041732076,0.022511324,0.835633,0.0013059883,0.013356517,0.00013205667,0.00041902054,0.00012173409,0.009627427,0.008435084,0.0009230346,0.10336162],"study_design_scores_gemma":[0.031072458,0.0015286738,0.85357726,0.00019882424,0.008406954,0.000018201654,0.00039929987,0.00018545239,0.06537295,0.00026882437,0.038661,0.00031011045],"about_ca_topic_score_codex":0.00004687491,"about_ca_topic_score_gemma":0.00010443832,"teacher_disagreement_score":0.10305151,"about_ca_system_score_codex":0.000072674404,"about_ca_system_score_gemma":0.0004519381,"threshold_uncertainty_score":0.73152775},"labels":[],"label_agreement":null},{"id":"W3205486870","doi":"10.1016/j.medj.2021.09.006","title":"Cell-free DNA in Hodgkin Lymphoma: A future standard?","year":2021,"lang":"no","type":"letter","venue":"Med","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Uehara Memorial Foundation","keywords":"Hodgkin lymphoma; Lymphoma; DNA; Cancer research; Medicine; Computational biology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.010591110688536711,"score_gpt":0.2335308052138205,"score_spread":0.22293969452528378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205486870","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23717716,0.07811478,0.000008694677,0.6459648,0.00863228,0.0026146083,0.001511209,0.00015642171,0.025820049],"genre_scores_gemma":[0.28010738,0.026505781,0.0022955092,0.54801583,0.055880338,0.0026054406,0.010647618,0.0009749415,0.07296714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99409145,0.0004619191,0.0010495984,0.0014797867,0.0015610047,0.0013562591],"domain_scores_gemma":[0.9962341,0.00042201753,0.0003770066,0.0023667421,0.00022708542,0.00037300622],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004282371,0.0011500763,0.0022373775,0.00045219762,0.00013945307,0.000151573,0.00062959193,0.0016987713,0.003819139],"category_scores_gemma":[0.00021307085,0.00095906225,0.00068814965,0.0007323864,0.000138992,0.00008500807,0.00040277393,0.00084593834,0.00059535686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035020235,0.0015748803,0.015031463,0.0009924727,0.0005330011,0.044654973,0.0011841344,6.341723e-7,0.00009628632,0.000035957302,0.91872025,0.016825736],"study_design_scores_gemma":[0.032116827,0.0005991072,0.04121448,0.0017807551,0.0010592694,0.00018569497,0.00069969724,0.000005972642,0.0046539945,0.00007035888,0.9167817,0.0008321368],"about_ca_topic_score_codex":0.0005607141,"about_ca_topic_score_gemma":0.00039834375,"teacher_disagreement_score":0.097948946,"about_ca_system_score_codex":0.002851358,"about_ca_system_score_gemma":0.0017585288,"threshold_uncertainty_score":0.99959725},"labels":[],"label_agreement":null},{"id":"W3205641125","doi":"10.1016/j.clml.2021.10.004","title":"Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Outcome (game theory); Lymphoma; Retrospective cohort study; T-cell lymphoma; Internal medicine; Oncology","score_opus":0.03910560402765996,"score_gpt":0.3267734776531193,"score_spread":0.28766787362545937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205641125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970083,0.00089975196,0.00010784024,0.00017760943,0.00043011756,0.0003998726,0.000146855,0.00005651337,0.000773122],"genre_scores_gemma":[0.9933988,0.0012641437,0.0036907329,0.00085139944,0.00019415877,0.00009700706,0.00016890574,0.000036686033,0.0002982099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961351,0.00015597584,0.0017044455,0.0009848188,0.00051004096,0.00050958694],"domain_scores_gemma":[0.9976562,0.00048592142,0.0004206367,0.0006678181,0.00031880513,0.00045058312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002302344,0.00044716388,0.0014721821,0.000130535,0.00012251343,0.000037592992,0.00017750074,0.000299919,0.000098268116],"category_scores_gemma":[0.0010408729,0.00037944605,0.00040412458,0.0006030543,0.00088888145,0.00016014757,0.00020823177,0.00015787185,0.00006127317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003578374,0.002659412,0.85358113,0.000112399954,0.00008946154,0.002455216,0.0004565626,0.0000015898596,0.00032299667,0.00022542078,0.000038229384,0.13969976],"study_design_scores_gemma":[0.014822402,0.00043613295,0.9794963,0.00016892554,0.00015289595,0.00034224326,0.0002441885,0.00060221495,0.0017222419,0.000019678635,0.0016528406,0.00033993585],"about_ca_topic_score_codex":0.00025697923,"about_ca_topic_score_gemma":0.00016580377,"teacher_disagreement_score":0.13935982,"about_ca_system_score_codex":0.0014982892,"about_ca_system_score_gemma":0.0015490622,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W3206259885","doi":"10.1038/s41572-021-00319-5","title":"Author Correction: Hodgkin lymphoma","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Internal medicine","score_opus":0.05395681137816038,"score_gpt":0.4024501873325598,"score_spread":0.3484933759543994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206259885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.4849496e-7,0.9895677,0.00000335225,0.00039338053,0.0035776256,0.0037834914,0.0000961284,0.00013388325,0.0024438158],"genre_scores_gemma":[0.0000025108955,0.9861089,0.0004988723,0.0010038175,0.0009371118,0.0013948792,0.002096156,0.00013191915,0.007825826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958142,0.000584275,0.0011884754,0.0012500897,0.0006338855,0.0005290794],"domain_scores_gemma":[0.99622357,0.00022962564,0.00069128344,0.0015429028,0.00017053721,0.0011421046],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003892991,0.0010764571,0.0050455984,0.00027246666,0.00014538923,0.000082687555,0.00026018266,0.0010325295,0.00089952315],"category_scores_gemma":[0.0009021239,0.00072092516,0.0039572455,0.0010414694,0.00007708743,0.00007581381,0.00013788413,0.0007449221,0.0010755226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015565382,0.000647385,0.000036286496,0.020750474,0.0007023635,0.00076038385,0.000005316305,1.3940666e-8,1.336051e-8,0.000102700804,0.1700755,0.80690396],"study_design_scores_gemma":[0.00067075226,0.00005707797,0.0001962621,0.0784368,0.017739415,0.00034081074,0.0000035317369,9.628758e-7,8.028775e-7,0.0000026335997,0.90201026,0.0005406638],"about_ca_topic_score_codex":0.000007322595,"about_ca_topic_score_gemma":0.0000012885758,"teacher_disagreement_score":0.80636334,"about_ca_system_score_codex":0.0013211782,"about_ca_system_score_gemma":0.00284242,"threshold_uncertainty_score":0.9997023},"labels":[],"label_agreement":null},{"id":"W3206296081","doi":"10.1182/blood.2021011941","title":"A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"National Cancer Institute; National Institutes of Health; BC Cancer Foundation; Michael Smith Health Research BC; Genome British Columbia; Children’s Oncology Group; Paul G. Allen Frontiers Group; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada; St. Baldrick's Foundation","keywords":"Oncology; Internal medicine; Medicine; Cohort; Gene expression profiling; Lymphoma; Biology; Gene expression; Gene","score_opus":0.0138069628895325,"score_gpt":0.24511071673448184,"score_spread":0.23130375384494933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206296081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807096,0.00042176485,0.00020086182,0.00036947938,0.00003458555,0.0003842304,0.00008432976,0.00006611427,0.0003676794],"genre_scores_gemma":[0.992849,0.000061698105,0.005876965,0.00057963585,0.0000994436,0.00018994272,0.00015379976,0.00003662071,0.00015291512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984311,0.00006512242,0.00032378078,0.00048212832,0.00036300052,0.00033488625],"domain_scores_gemma":[0.9990505,0.000063375046,0.00009096944,0.00049361814,0.000058034806,0.00024347659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007840341,0.00024113905,0.0004357137,0.00010135755,0.000047978898,0.000025687672,0.00008741708,0.00013031201,0.000052936004],"category_scores_gemma":[0.00009119213,0.00016644438,0.00012128533,0.00019693913,0.000059023158,0.00005525984,0.000071728195,0.00010934896,0.000033223685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015162354,0.0061009265,0.98954594,0.000018170109,0.00019912854,0.0007443055,0.00008930942,0.00019967063,0.0008712657,0.000011164866,0.00018543316,0.0018830836],"study_design_scores_gemma":[0.029471718,0.00039371182,0.87277555,0.00019673412,0.0005032887,0.00020369244,0.00001742917,0.0027575959,0.09346355,0.000023539946,0.000022200402,0.00017099998],"about_ca_topic_score_codex":0.000030998628,"about_ca_topic_score_gemma":0.000055857814,"teacher_disagreement_score":0.11677038,"about_ca_system_score_codex":0.000110811496,"about_ca_system_score_gemma":0.000443144,"threshold_uncertainty_score":0.6787405},"labels":[],"label_agreement":null},{"id":"W3206937390","doi":"10.4236/ojpm.2021.119029","title":"Meta-Analysis of the Efficacy and Adverse Reactions of Ibrutinib in the Treatment of Refractory/Relapsed Mantle Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Open Journal of Preventive Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Nanchang University; Natural Science Foundation of Jiangxi Province; National Natural Science Foundation of China","keywords":"Ibrutinib; Mantle cell lymphoma; Medicine; Adverse effect; Regimen; Oncology; Internal medicine; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.08735224467307104,"score_gpt":0.3510344496526964,"score_spread":0.26368220497962536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206937390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490894,0.008909157,0.000009992377,0.0023885858,0.00008335632,0.0005592899,0.000030266667,6.456977e-7,0.003109761],"genre_scores_gemma":[0.9961245,0.0022261506,0.00025251822,0.00006969671,0.000028384871,0.000012750982,0.000010023554,0.0000071674167,0.0012687753],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9978121,0.00046940672,0.0009934799,0.00015627428,0.00046161943,0.00010713765],"domain_scores_gemma":[0.9971308,0.00078781584,0.0012271252,0.00045656165,0.00032828294,0.00006939537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008310549,0.00015369144,0.0015427662,0.00020693074,0.0000386248,0.0000042904935,0.00020957513,0.000042957752,0.00063515117],"category_scores_gemma":[0.00016941692,0.000064938,0.00075149786,0.000767714,0.00019061877,0.00007158648,0.000050286915,0.00006458917,5.411531e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049829264,0.08525638,0.23213592,0.0005662847,0.5373313,0.001808795,0.04636417,0.00022083813,0.05593406,0.0011191536,0.0025835508,0.031696647],"study_design_scores_gemma":[0.021231048,0.0036089232,0.64969987,0.00031638006,0.2715894,0.0001321826,0.005375574,0.000011066036,0.042796176,0.00007475951,0.005092091,0.000072558716],"about_ca_topic_score_codex":0.00039263957,"about_ca_topic_score_gemma":0.000095984185,"teacher_disagreement_score":0.41756392,"about_ca_system_score_codex":0.00010183169,"about_ca_system_score_gemma":0.0002283605,"threshold_uncertainty_score":0.695446},"labels":[],"label_agreement":null},{"id":"W3208049794","doi":"10.1016/j.ijrobp.2021.07.243","title":"Prospective Phase II Trial of Radiation Therapy in Localized Non-Gastric Marginal Zone Lymphoma With Evaluation of Autoimmunity and Helicobacter Pylori Status","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Helicobacter pylori; Radiation therapy; Rituximab; Population; Lymphoma; Surgery; Pathology","score_opus":0.026054776554790517,"score_gpt":0.3497680894113484,"score_spread":0.3237133128565579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208049794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956304,0.001163113,0.0011072565,0.00066002953,0.00055226847,0.0006568552,0.00006187685,0.0000066603834,0.00016158006],"genre_scores_gemma":[0.9954156,0.002691725,0.0011067908,0.000116496085,0.0004115838,0.000048399357,0.0001849996,0.000015303349,0.000009073652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978334,0.00041399253,0.00084208767,0.00021027379,0.0005267265,0.00017356478],"domain_scores_gemma":[0.9963722,0.00029658267,0.0013102565,0.00014811815,0.0017860756,0.00008671756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008703615,0.00018319665,0.00065189734,0.0002572603,0.00004586341,0.000012468286,0.00010186561,0.00015977577,0.00006352169],"category_scores_gemma":[0.00026774243,0.00014543036,0.00013955134,0.00032032086,0.00017023196,0.00023301324,0.000035557478,0.00016216638,0.0000010355687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027846016,0.007244754,0.33785877,0.000009524786,0.0010404779,0.00003404622,0.0010058364,0.00024169704,0.0044142506,0.0006151138,0.00003031357,0.6196592],"study_design_scores_gemma":[0.38376975,0.017618604,0.5665048,0.0001229145,0.0004220073,0.00019405773,0.0001833572,0.0034959377,0.02523179,0.0011835125,0.0011339122,0.0001393784],"about_ca_topic_score_codex":0.00010654605,"about_ca_topic_score_gemma":0.00001457781,"teacher_disagreement_score":0.6195198,"about_ca_system_score_codex":0.0013457047,"about_ca_system_score_gemma":0.0021136168,"threshold_uncertainty_score":0.59304774},"labels":[],"label_agreement":null},{"id":"W3209172262","doi":"10.3390/cancers13215395","title":"Lymphoma-Associated Biomarkers Are Increased in Current Smokers in Twin Pairs Discordant for Smoking","year":2021,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canada Excellence Research Chairs, Government of Canada; Academy of Finland; Centre for Addiction and Mental Health","keywords":"Cotinine; Medicine; Biomarker; Lymphoma; Follicular lymphoma; Internal medicine; Cohort; Oncology; Immunology; Nicotine; Biology","score_opus":0.028264499073359227,"score_gpt":0.2975217260011486,"score_spread":0.2692572269277894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209172262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932455,0.004476066,0.0000093299805,0.0007560348,0.0004668616,0.00061107223,0.000097846416,0.000036312413,0.00030101708],"genre_scores_gemma":[0.9981294,0.00054154085,0.000084343716,0.00041755475,0.000047077076,0.000492668,0.00022621489,0.000029416984,0.000031777767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984447,0.00007218646,0.00036364756,0.00044532766,0.00022106338,0.00045312237],"domain_scores_gemma":[0.9992132,0.00017720052,0.0001320551,0.00024277026,0.000073211726,0.00016154828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021469145,0.00021514457,0.00047044072,0.00018116966,0.000047717724,0.000022742634,0.00006515444,0.00006958851,0.000044324937],"category_scores_gemma":[0.00031989347,0.00019715341,0.00017906036,0.00057908305,0.000051282444,0.00006159679,0.00003252553,0.00006623298,0.0000024778483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028503875,0.00047516564,0.9746128,0.00013035067,0.0002522307,0.0006862014,0.00027904226,0.00010215316,0.00016579933,0.000042979646,0.0024009827,0.020567264],"study_design_scores_gemma":[0.018218605,0.00011763019,0.96895885,0.0017196502,0.00017055603,0.000012566836,0.0017850677,0.0009263064,0.0039540427,0.000056237972,0.0038190975,0.00026136363],"about_ca_topic_score_codex":0.0038383396,"about_ca_topic_score_gemma":0.0052564493,"teacher_disagreement_score":0.020305902,"about_ca_system_score_codex":0.009372079,"about_ca_system_score_gemma":0.0015924233,"threshold_uncertainty_score":0.9944308},"labels":[],"label_agreement":null},{"id":"W3209505414","doi":"10.1186/s13256-021-03079-8","title":"Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Pembrolizumab; Ifosfamide; CD30; Anaplastic large-cell lymphoma; Etoposide; Pathology; Lymphoma; Chemotherapy; Internal medicine; Cancer; Immunotherapy","score_opus":0.009652315182442462,"score_gpt":0.27467807886852874,"score_spread":0.26502576368608627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209505414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910353,0.0032623915,0.000008321649,0.0034101887,0.0012777037,0.00032808632,0.000001927721,0.000021052403,0.0006550344],"genre_scores_gemma":[0.9975532,0.00013487544,0.00071619055,0.00067359523,0.0002809119,0.000017873375,0.000012004401,0.00004690182,0.0005644473],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99466676,0.00023782023,0.001749107,0.0005235654,0.0023603057,0.0004624519],"domain_scores_gemma":[0.9960577,0.00033539522,0.00087223895,0.0006525637,0.000744952,0.0013371792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016412439,0.00034870708,0.0009476828,0.00035297216,0.0000908437,0.000047569665,0.000055783745,0.00027324754,0.0004259612],"category_scores_gemma":[0.0029703602,0.00023280962,0.00028995113,0.0006478352,0.000088222456,0.00014988714,0.00008979906,0.00045726774,0.000005499412],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065481765,0.0022774243,0.027665114,0.00008438241,0.00019592213,0.94947326,0.0009103183,0.0000037451377,0.0003624096,0.0000012168816,0.0019320354,0.010546021],"study_design_scores_gemma":[0.009265116,0.0017921013,0.026035005,0.00091524696,0.00031323696,0.95074886,0.0007055866,0.000017972867,0.0036076854,0.000004814751,0.006360961,0.00023343218],"about_ca_topic_score_codex":0.0004990839,"about_ca_topic_score_gemma":0.0005373203,"teacher_disagreement_score":0.010312589,"about_ca_system_score_codex":0.00096460513,"about_ca_system_score_gemma":0.004265633,"threshold_uncertainty_score":0.9493701},"labels":[],"label_agreement":null},{"id":"W3209530143","doi":"10.1182/blood-2021-145872","title":"Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Follicular lymphoma; Internal medicine; Salvage therapy; Oncology; Bendamustine; Lymphoma; Rituximab; Chemotherapy","score_opus":0.013910371336629356,"score_gpt":0.2705252749562076,"score_spread":0.2566149036195782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209530143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929906,0.0016486382,0.000008818645,0.000092688526,0.00004985759,0.004446856,0.0006882354,0.00004462051,0.000029663122],"genre_scores_gemma":[0.99588555,0.0008469426,0.00073815644,0.00008885736,0.00009175802,0.0008193425,0.0013281313,0.000058349615,0.00014290049],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980912,0.0001572129,0.00045349853,0.00076180097,0.00029825888,0.00023800983],"domain_scores_gemma":[0.998385,0.00020369634,0.0002785418,0.0005356926,0.0004289045,0.00016817209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082155246,0.000397395,0.0007508311,0.000084135456,0.00018247744,0.00003578269,0.000050391704,0.00013598091,0.000018834551],"category_scores_gemma":[0.000032078788,0.00027038032,0.00013142628,0.00014100737,0.00005013889,0.00013047174,0.000019225557,0.000038984665,0.0000012844423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061340697,0.2890964,0.29659107,0.000045982346,0.009644677,0.0003823079,0.027878368,0.000012064093,0.0071889735,0.000003641547,0.00008659804,0.3077292],"study_design_scores_gemma":[0.36507365,0.08479723,0.4327379,0.00020006335,0.00141432,0.000008727095,0.0008193694,0.00032739423,0.1137184,0.0000120821,0.0006206717,0.00027019254],"about_ca_topic_score_codex":0.0007781099,"about_ca_topic_score_gemma":0.00013275967,"teacher_disagreement_score":0.30745903,"about_ca_system_score_codex":0.00018552317,"about_ca_system_score_gemma":0.00016759297,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W3209852691","doi":"10.14338/ijpt-21-00012.1","title":"Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Particle Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Proton therapy; Radiation therapy; Context (archaeology); Receipt; Hodgkin lymphoma; Radiation oncology; Lymphoma; Systemic therapy","score_opus":0.12966377087839953,"score_gpt":0.43326758630779477,"score_spread":0.30360381542939524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209852691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924338,0.0026419142,0.00006351778,0.0029660654,0.0004492495,0.0013949461,0.000018061764,0.000008268929,0.000024218976],"genre_scores_gemma":[0.9952662,0.0019695677,0.0010875073,0.0009010794,0.00032655592,0.0003442666,0.000036748617,0.000018103738,0.000049967814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982129,0.00024834654,0.0007427513,0.0001852654,0.00042732016,0.00018344118],"domain_scores_gemma":[0.9986546,0.00044755486,0.0003896499,0.00011391729,0.0003193016,0.00007495635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007415467,0.00013639865,0.00038513012,0.00015229141,0.000025853651,0.000063398315,0.00010922914,0.00007081401,0.000047841666],"category_scores_gemma":[0.00029619492,0.00011008984,0.00017791767,0.00012859442,0.000031073094,0.00039921547,0.000015025134,0.00008574354,0.0000013870962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08995924,0.004707067,0.60499495,0.000006175043,0.0003823526,0.00038489996,0.0006054127,0.00019080055,0.010551524,0.0005103193,0.00005112788,0.28765613],"study_design_scores_gemma":[0.31676832,0.005553371,0.60829,0.00016450879,0.000014079195,0.00013013481,0.00016770359,0.00091455743,0.0655754,0.00035849717,0.001942166,0.00012123429],"about_ca_topic_score_codex":0.00017351688,"about_ca_topic_score_gemma":0.000062664,"teacher_disagreement_score":0.28753492,"about_ca_system_score_codex":0.0005895501,"about_ca_system_score_gemma":0.00054338016,"threshold_uncertainty_score":0.44893333},"labels":[],"label_agreement":null},{"id":"W3210213267","doi":"10.1016/j.ijrobp.2021.07.242","title":"An International, Multi-Centre Study of Radiotherapy for Bilateral Indolent Orbital Adnexal Lymphomas (IOAL)","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Orbit (dynamics); Retrospective cohort study; Surgery","score_opus":0.03136212576019206,"score_gpt":0.3673210431402265,"score_spread":0.33595891738003447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210213267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911426,0.00055305404,0.0026742935,0.0016753578,0.0031899074,0.0004998945,0.00014700819,0.000024491195,0.00009342873],"genre_scores_gemma":[0.9895394,0.0005862538,0.006952606,0.0005854266,0.0019109512,0.000030210358,0.00029881945,0.000034585835,0.00006178049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978148,0.00021719513,0.0010236795,0.00033417804,0.00038936915,0.00022078966],"domain_scores_gemma":[0.99652964,0.0003004235,0.0010772912,0.00023381028,0.0016897391,0.0001690765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033854364,0.0002431962,0.00065918406,0.00019034931,0.000059692447,0.00004094066,0.00037043102,0.00019379612,0.00014619874],"category_scores_gemma":[0.00020134715,0.0002052337,0.0003514498,0.00011745016,0.00009231416,0.00034562222,0.00004972129,0.00017332054,0.000006037121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013991368,0.015429189,0.88290524,0.000009893068,0.003135318,0.00028106896,0.0024285037,0.00056876277,0.0066847294,0.001991977,0.00034551875,0.084820665],"study_design_scores_gemma":[0.14559479,0.01509549,0.7529728,0.0002468079,0.001082095,0.0017532466,0.003591258,0.012754665,0.033991635,0.0014531953,0.030776674,0.0006873441],"about_ca_topic_score_codex":0.000046507725,"about_ca_topic_score_gemma":0.000016389631,"teacher_disagreement_score":0.14419565,"about_ca_system_score_codex":0.0012168331,"about_ca_system_score_gemma":0.00078627723,"threshold_uncertainty_score":0.8369187},"labels":[],"label_agreement":null},{"id":"W3210624555","doi":"10.1002/ajh.26400","title":"Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase <scp>IB</scp>/<scp>II</scp> study","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Internal medicine; Obinutuzumab; Tolerability; Rituximab; Oncology; Bendamustine; Antibody-drug conjugate; Lymphoma; Phases of clinical research; Follicular lymphoma; Refractory (planetary science); Gastroenterology; Chemotherapy; Immunology; Adverse effect; Monoclonal antibody; Antibody; Biology","score_opus":0.01415377187334877,"score_gpt":0.29010160797930074,"score_spread":0.27594783610595197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210624555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719665,0.010889613,0.00013019789,0.013812247,0.0008643595,0.0016927723,0.00016655533,0.00003619454,0.00044154195],"genre_scores_gemma":[0.9531329,0.0025255813,0.0027562587,0.038266037,0.0018084462,0.0001357229,0.00029261305,0.00028487178,0.0007975424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938928,0.0005911422,0.0026031202,0.0009683263,0.00089560024,0.0010490065],"domain_scores_gemma":[0.98593897,0.0075799534,0.00418082,0.0009937162,0.0008245435,0.00048197422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057553325,0.0010198666,0.005179494,0.00090905745,0.0002393951,0.00004312677,0.0004956771,0.00068672927,0.000022377126],"category_scores_gemma":[0.0024797767,0.00082946644,0.0010986598,0.0005914439,0.00084025366,0.00013376847,0.00024543543,0.0014352524,0.000009480586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023159424,0.019630114,0.020680051,0.0014893843,0.017448626,0.04124773,0.014738021,0.000013945481,0.0009805574,0.00013933178,0.8449269,0.036389425],"study_design_scores_gemma":[0.10507799,0.07705944,0.0110657755,0.0024996197,0.008025249,0.03676284,0.018656164,0.000054014323,0.0050734053,0.00009371917,0.7352027,0.00042908042],"about_ca_topic_score_codex":0.00016365187,"about_ca_topic_score_gemma":0.000012749265,"teacher_disagreement_score":0.109724164,"about_ca_system_score_codex":0.0011246942,"about_ca_system_score_gemma":0.0027941603,"threshold_uncertainty_score":0.99941564},"labels":[],"label_agreement":null},{"id":"W3210991186","doi":"10.1182/blood-2021-148949","title":"Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Obinutuzumab; Medicine; Mantle cell lymphoma; Tolerability; Internal medicine; Dosing; Gastroenterology; Cytokine release syndrome; Pharmacology; Rituximab; Lymphoma; Oncology; Adverse effect; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.011081378863928492,"score_gpt":0.2364690204649568,"score_spread":0.2253876416010283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210991186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561054,0.0026570684,0.0000012923804,0.00035698444,0.00022732126,0.0009081621,0.000094148745,0.000058430865,0.00008604509],"genre_scores_gemma":[0.99721265,0.00036468543,0.00094017613,0.00027341506,0.00007158246,0.000108742366,0.00018095992,0.00008209871,0.0007656741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729943,0.00030971732,0.0006572925,0.0006711224,0.0006021503,0.00046030586],"domain_scores_gemma":[0.9979938,0.00040820014,0.00035101303,0.00070457225,0.00036398755,0.00017841377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002497781,0.00043927322,0.0008061753,0.0002403431,0.00014044641,0.000073976844,0.00013401889,0.00023248022,0.00013907877],"category_scores_gemma":[0.00019636325,0.00030456667,0.00011424618,0.00073098304,0.00013371701,0.00021024184,0.000083536106,0.000136812,0.00002252067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04517918,0.05091752,0.68292236,0.0003513245,0.00068208243,0.0028292167,0.0019710031,0.0000019943816,0.16853721,0.000019134312,0.000700474,0.04588846],"study_design_scores_gemma":[0.06737831,0.0029237464,0.4942478,0.0006542162,0.00018816149,0.000018043504,0.00029041705,0.0000032165626,0.4331805,0.0000021000972,0.00089255726,0.00022091136],"about_ca_topic_score_codex":0.00043669128,"about_ca_topic_score_gemma":0.00009514468,"teacher_disagreement_score":0.2646433,"about_ca_system_score_codex":0.00031835094,"about_ca_system_score_gemma":0.001189814,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W3211066619","doi":"10.1111/bjh.17684","title":"The impact of surveillance imaging after curative‐intent radiotherapy for limited‐stage follicular lymphoma","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Asymptomatic; Radiology; Positron emission tomography; Biopsy; Follicular lymphoma; Radiation therapy; Cancer; Lymphoma; Surgery; Internal medicine","score_opus":0.014292579778912665,"score_gpt":0.29188823638578976,"score_spread":0.2775956566068771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211066619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45697436,0.27053565,0.00062072277,0.26897526,0.0011688228,0.0011372482,0.00045463466,0.000017359414,0.000115952666],"genre_scores_gemma":[0.74064326,0.0638385,0.003354185,0.1834629,0.004656029,0.0004891215,0.00053159636,0.00040828716,0.0026161165],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.997315,0.00032581386,0.0011302049,0.0003103105,0.00039229137,0.0005263718],"domain_scores_gemma":[0.9963355,0.00092134543,0.0012240226,0.00036940424,0.0010342194,0.00011548543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039873112,0.0003631225,0.0018981802,0.00015254557,0.00011103557,0.00010641143,0.00024406271,0.00033162656,0.00012579729],"category_scores_gemma":[0.0003242487,0.0002531151,0.0017562732,0.00013083954,0.00025251167,0.00007914191,0.000039347648,0.00042623508,0.0000014665194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005171243,0.00040117322,0.029137207,0.00028873698,0.0039446424,0.2493448,0.000105280735,0.000004266949,0.0000511422,0.00001169073,0.696846,0.01934795],"study_design_scores_gemma":[0.009242424,0.0009128283,0.050000362,0.0023100032,0.00043807103,0.4894343,0.00009109883,0.00009098136,0.0003948741,0.000079253216,0.4466724,0.0003333737],"about_ca_topic_score_codex":0.000251081,"about_ca_topic_score_gemma":0.000037996444,"teacher_disagreement_score":0.2836689,"about_ca_system_score_codex":0.00059572724,"about_ca_system_score_gemma":0.0009541845,"threshold_uncertainty_score":0.99999213},"labels":[],"label_agreement":null},{"id":"W3211368441","doi":"10.1182/blood-2021-147837","title":"Comparative Analysis of Mature T-Cell and NK/T-Cell Lymphomas in Patients with and without HIV: Results from the NA-Accord and Complete Cohorts","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Cohort; Population; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Pediatrics","score_opus":0.012257262357492325,"score_gpt":0.22809761018699198,"score_spread":0.21584034782949965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211368441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954634,0.0026693447,0.000001014969,0.00014709758,0.000010387609,0.00031227508,0.00051405706,0.000006619026,0.0008758236],"genre_scores_gemma":[0.99854547,0.00022047307,0.00056063157,0.00014538364,0.000010001837,0.000012432611,0.00044573625,0.0000077152135,0.000052170624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990093,0.00006675641,0.00024293704,0.00035790258,0.00019543737,0.00012768348],"domain_scores_gemma":[0.9992253,0.00018831328,0.00013529554,0.00027715872,0.0000882364,0.0000856613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058047564,0.00016558937,0.0006116168,0.00006350587,0.000049882336,0.000027944592,0.000031390926,0.000054440552,0.000009849778],"category_scores_gemma":[0.000013479174,0.00009898989,0.000036956415,0.0002965827,0.000105198196,0.00003572839,0.000058911228,0.00005698359,6.948576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005389224,0.0015031555,0.99476486,0.000025655805,0.0010056567,0.00004290526,0.0015594254,0.0000028174197,0.0003349761,0.000008479375,0.0000768186,0.00013633653],"study_design_scores_gemma":[0.024351276,0.00026851415,0.96700615,0.000111410336,0.003469591,0.000005753362,0.00045832468,0.00009667439,0.004011085,0.0000068331037,0.00011234184,0.000102058446],"about_ca_topic_score_codex":0.00047021775,"about_ca_topic_score_gemma":0.00048207294,"teacher_disagreement_score":0.027758714,"about_ca_system_score_codex":0.000017430788,"about_ca_system_score_gemma":0.000048781734,"threshold_uncertainty_score":0.40366906},"labels":[],"label_agreement":null},{"id":"W3211674543","doi":"10.1182/blood-2021-151808","title":"Brentuximab Vedotin As Consolidation Therapy Following Autologous Stem Cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Center Retrospective Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Autologous stem-cell transplantation; Oncology; Salvage therapy; Transplantation; Clinical endpoint; Retrospective cohort study; Surgery; Clinical trial; Lymphoma; Chemotherapy; CD30","score_opus":0.007169298363502249,"score_gpt":0.23236415373453026,"score_spread":0.225194855371028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211674543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977236,0.0014985033,0.000051919877,0.000054290722,0.000033844284,0.00046671185,0.00003472907,0.000040788418,0.00009565459],"genre_scores_gemma":[0.99814844,0.0010274281,0.00029859776,0.00012563176,0.000018522349,0.0000462471,0.00027715685,0.000021846277,0.00003610193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871093,0.00010962386,0.0002475176,0.00047395861,0.00024133854,0.00021660479],"domain_scores_gemma":[0.9995064,0.000023481805,0.00010833601,0.0002123539,0.00005913057,0.00009028724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078522375,0.00020716936,0.00043416745,0.00018886081,0.000063731255,0.000036705424,0.000036360452,0.00010176009,0.000009724396],"category_scores_gemma":[0.0000054288425,0.00016837085,0.0001402484,0.00042268238,0.000028339915,0.00009727842,0.000011349591,0.0000762714,0.0000069167113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027721073,0.009631191,0.98272264,0.000026006906,0.0012319431,0.00072817475,0.000829316,0.0000028668626,0.00074562087,0.0000032556497,0.0000021962612,0.0037995744],"study_design_scores_gemma":[0.065301985,0.00043326788,0.91231674,0.000216824,0.0019183183,0.00024444508,0.00012104158,0.00003095999,0.019261023,0.0000018497869,0.000003605773,0.00014991271],"about_ca_topic_score_codex":0.0001963673,"about_ca_topic_score_gemma":0.00015597847,"teacher_disagreement_score":0.07040588,"about_ca_system_score_codex":0.00014801131,"about_ca_system_score_gemma":0.00012893102,"threshold_uncertainty_score":0.6865964},"labels":[],"label_agreement":null},{"id":"W3211879125","doi":"10.1182/blood-2021-146036","title":"Outcomes in Relapsed/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; University of Calgary; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Lymphoma; Burkitt's lymphoma; Chemotherapy regimen; Regimen; Immunophenotyping; Chemotherapy; Stage (stratigraphy); Gastroenterology; Surgery; Immunology","score_opus":0.017873112375156115,"score_gpt":0.2620726234395241,"score_spread":0.24419951106436796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211879125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943651,0.0016773124,4.2418853e-7,0.0013053517,0.00015547249,0.00019063038,0.000018081548,0.000031550542,0.0022560924],"genre_scores_gemma":[0.99617195,0.00011056466,0.0006436782,0.0009853697,0.000036373676,0.000054868327,0.000028998707,0.000018084978,0.001950096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888366,0.000031352633,0.0002124294,0.00032896994,0.00017226333,0.00037134014],"domain_scores_gemma":[0.99914277,0.00004188981,0.00003313188,0.00036391232,0.000058014215,0.00036027012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037660695,0.00016111454,0.00030249602,0.00010479597,0.0000552636,0.000019431434,0.000062057275,0.00009839269,0.00024234087],"category_scores_gemma":[0.00014625417,0.00013607141,0.000098182725,0.0001942871,0.000030770443,0.0000416131,0.000028705657,0.0000527116,0.00012872637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006343811,0.0049315738,0.98394185,0.000014037566,0.000087881825,0.0061296546,0.0015070345,3.642106e-7,0.00028678344,0.000070291986,0.00016870139,0.0028554725],"study_design_scores_gemma":[0.017404305,0.000054300886,0.964795,0.000090196074,0.000097235665,0.00014202716,0.0009876299,0.000011436315,0.007954032,0.000004800549,0.008312193,0.00014682446],"about_ca_topic_score_codex":0.04404918,"about_ca_topic_score_gemma":0.13061346,"teacher_disagreement_score":0.08656427,"about_ca_system_score_codex":0.0003349424,"about_ca_system_score_gemma":0.00075944,"threshold_uncertainty_score":0.9623166},"labels":[],"label_agreement":null},{"id":"W3211966340","doi":"10.1182/blood-2021-145694","title":"Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Follicular lymphoma; Internal medicine; Refractory (planetary science); Population; Cytokine release syndrome; Oncology; Gastroenterology; Lymphoma; Cancer; Multiple myeloma; Immunotherapy","score_opus":0.013166044199786413,"score_gpt":0.24545393056901374,"score_spread":0.23228788636922731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211966340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976628,0.00016740843,0.000009098735,0.00019089745,0.000028014862,0.0013698604,0.0001105637,0.000028202456,0.00043315676],"genre_scores_gemma":[0.9988985,0.00002047794,0.0003903746,0.00004461174,0.000019820787,0.00016543744,0.00039948215,0.000025466123,0.00003584522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829745,0.00016613216,0.00031858403,0.0005630276,0.00040202859,0.00025279817],"domain_scores_gemma":[0.9991589,0.00015092162,0.00014668376,0.0003465366,0.00009822369,0.00009872101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001819046,0.00022948727,0.0004568909,0.00013812051,0.00009107367,0.000055391916,0.000043582255,0.00006978213,0.000014605603],"category_scores_gemma":[0.00007854819,0.00017467489,0.000030379382,0.00035060983,0.00004553508,0.00023995245,0.000054571145,0.00010952075,0.000002591594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012837648,0.07737999,0.89009815,0.00004280749,0.00048565093,0.004852741,0.0026205059,0.000013041277,0.00010561218,0.000007481214,0.000020331354,0.011536049],"study_design_scores_gemma":[0.2728468,0.002654309,0.7193481,0.00034947094,0.00034441444,0.000013768494,0.0005557284,0.00009465396,0.0035720647,0.000010278424,0.000053929343,0.00015650614],"about_ca_topic_score_codex":0.0023781136,"about_ca_topic_score_gemma":0.0015562502,"teacher_disagreement_score":0.26000914,"about_ca_system_score_codex":0.00030246872,"about_ca_system_score_gemma":0.00030335656,"threshold_uncertainty_score":0.7123035},"labels":[],"label_agreement":null},{"id":"W3212004376","doi":"10.1182/blood-2021-149728","title":"A Large Multicenter Real-World Evidence (RWE) Analysis of Autoimmune (AI) Diseases and Lymphoma: Histologic Associations, Disease Characteristics, Survival, and Prognostication","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Univariate analysis; Diffuse large B-cell lymphoma; Proportional hazards model; Disease; Rituximab; Rheumatoid arthritis; Survival analysis; Oncology; Multivariate analysis","score_opus":0.021407496171548072,"score_gpt":0.2953472159676918,"score_spread":0.27393971979614373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212004376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870252,0.010472596,0.000015211968,0.0015583573,0.000050628587,0.00028985273,0.0004998542,0.000035496156,0.000052791795],"genre_scores_gemma":[0.9943606,0.004355186,0.00017896772,0.00014216905,0.000028747201,0.000071666436,0.0006727115,0.000009549622,0.00018040367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988485,0.00010691231,0.0003315526,0.0003295972,0.00021514244,0.00016830495],"domain_scores_gemma":[0.9986762,0.00041244415,0.00019296946,0.00030250908,0.00023837379,0.00017754793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117835014,0.00013757583,0.0004938212,0.00014634315,0.000087844004,0.000033286193,0.000034352546,0.000038008067,0.000051613926],"category_scores_gemma":[0.0011291446,0.0001175547,0.00011751991,0.0003964206,0.00006171949,0.000087692155,0.00006937723,0.0000272577,0.0000023450705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006771289,0.004520144,0.99169624,0.00013984121,0.0014105089,0.0001516382,0.00011424553,1.2343602e-7,0.00018534315,0.00066047,0.000044274995,0.0010094313],"study_design_scores_gemma":[0.0029708466,0.00005432255,0.9796734,0.0001869847,0.016240222,0.0000021165667,0.000047002522,0.0003905862,0.0001619658,0.000021953269,0.00015037134,0.00010022959],"about_ca_topic_score_codex":0.00016276723,"about_ca_topic_score_gemma":0.0001248028,"teacher_disagreement_score":0.014829714,"about_ca_system_score_codex":0.00009654865,"about_ca_system_score_gemma":0.00020117604,"threshold_uncertainty_score":0.47937417},"labels":[],"label_agreement":null},{"id":"W3212101598","doi":"10.1182/blood-2021-149745","title":"Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Transcriptome; Exome sequencing; Exome; Population; Cancer; Medicine; Biology; Cancer research; Gene; Genetics; Pathology; Gene expression; Mutation","score_opus":0.009339733984790783,"score_gpt":0.2005546087269797,"score_spread":0.1912148747421889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212101598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967748,0.0014118244,0.000028444589,0.00019802368,0.000048398448,0.00009347391,0.000108602115,0.00001111905,0.0013253293],"genre_scores_gemma":[0.9979877,0.00047992528,0.00046394783,0.00024520568,0.00008085841,0.000011400768,0.000534953,0.000008412987,0.00018761038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99949336,0.000014744616,0.00013780985,0.00013760405,0.00011997939,0.00009649965],"domain_scores_gemma":[0.9997428,0.000015550275,0.000039953153,0.000088486835,0.000050203584,0.00006301173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036027504,0.00006962675,0.00016582766,0.00002764172,0.00002447603,0.00000573155,0.000015167892,0.00003717956,0.000101106205],"category_scores_gemma":[0.000005328504,0.00006201168,0.00004614661,0.000051150866,0.000017839977,0.000029137622,0.000013738474,0.000014952305,0.0000071047575],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003794771,0.0045866035,0.15968895,0.0001245323,0.00007104063,0.00010440029,0.00019742246,1.7111871e-8,0.83229494,0.00031401074,0.000009761469,0.0025703802],"study_design_scores_gemma":[0.010413433,0.00009656813,0.82843316,0.000035450248,0.00023971255,0.00017148578,0.000015587075,0.0000036795818,0.15945911,0.000007950336,0.0010812739,0.000042609478],"about_ca_topic_score_codex":0.0000036009108,"about_ca_topic_score_gemma":0.000001535939,"teacher_disagreement_score":0.6728358,"about_ca_system_score_codex":0.000024970443,"about_ca_system_score_gemma":0.00015587159,"threshold_uncertainty_score":0.25287628},"labels":[],"label_agreement":null},{"id":"W3212171289","doi":"10.1182/blood-2021-147881","title":"Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Classical Hodgkin lymphoma; Pembrolizumab; Medicine; Refractory (planetary science); Internal medicine; Oncology; Lymphoma; Gastroenterology; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.01331762239791026,"score_gpt":0.2520312517522002,"score_spread":0.23871362935428994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212171289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914856,0.0026210104,0.000003985198,0.0008494997,0.00020824002,0.00030822138,0.000028330809,0.0000505048,0.0044446406],"genre_scores_gemma":[0.9958724,0.0007577856,0.0005115876,0.00036926134,0.00015473632,0.00007649194,0.000052241263,0.000047869697,0.0021576232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981803,0.00010080356,0.0004680653,0.0004782545,0.00040554308,0.00036699817],"domain_scores_gemma":[0.9988076,0.00017133255,0.0001281901,0.00059706194,0.00011478921,0.00018102795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010793182,0.000261962,0.00065657485,0.00014135354,0.00004166237,0.000017097496,0.00011095776,0.00022854823,0.00031372075],"category_scores_gemma":[0.00012457643,0.00022702807,0.00029403027,0.00032973848,0.00007710614,0.00005512627,0.000056537596,0.00011881091,0.000081228136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056819967,0.037712954,0.85026693,0.00031738757,0.0018331499,0.0055678636,0.0024586339,0.0000095121695,0.027427383,0.0032266404,0.00563946,0.05985806],"study_design_scores_gemma":[0.14304277,0.0014954344,0.72831815,0.0003993392,0.00047000393,0.00022814231,0.00025988667,0.000044247005,0.1151337,0.00022897805,0.010047719,0.0003316223],"about_ca_topic_score_codex":0.00018786661,"about_ca_topic_score_gemma":0.00012157354,"teacher_disagreement_score":0.13736078,"about_ca_system_score_codex":0.00019697454,"about_ca_system_score_gemma":0.00052253495,"threshold_uncertainty_score":0.9257936},"labels":[],"label_agreement":null},{"id":"W3212201454","doi":"10.1182/blood-2021-154492","title":"Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Salvage therapy; Surgery; Lymphoma; Chemotherapy; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.013241617105003286,"score_gpt":0.23633808770450832,"score_spread":0.22309647059950502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212201454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973833,0.00055715226,0.0000034484256,0.0006631582,0.00010070672,0.0004900478,0.00017940633,0.000016722068,0.0006060655],"genre_scores_gemma":[0.99882054,0.0002346816,0.00007961231,0.00039336385,0.00001548309,0.00006391747,0.00035553492,0.000014610183,0.00002227742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983942,0.00017792516,0.0005632559,0.0002864515,0.0003109105,0.00026724674],"domain_scores_gemma":[0.99926907,0.00019277203,0.00011523531,0.000296432,0.00007111495,0.00005539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014913335,0.0001857841,0.00043664765,0.00009168284,0.000029003202,0.000014103789,0.00010208332,0.00011105295,0.000027411792],"category_scores_gemma":[0.000009983314,0.00012952929,0.000120026976,0.00024511965,0.00003907532,0.000045314908,0.000012478122,0.00011172153,0.000016893335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001562666,0.011157611,0.9759432,0.00017437119,0.0000615081,0.0012392316,0.0027614983,0.000003873005,0.00093857927,0.00008575013,0.000013860341,0.0074642356],"study_design_scores_gemma":[0.02118832,0.00044824858,0.94111955,0.0002894536,0.0003083502,0.00015408163,0.0003326932,0.00002396506,0.03595027,0.0000074676204,0.00006117247,0.00011640583],"about_ca_topic_score_codex":0.00035732763,"about_ca_topic_score_gemma":0.00047677002,"teacher_disagreement_score":0.03501169,"about_ca_system_score_codex":0.00008463514,"about_ca_system_score_gemma":0.00020164002,"threshold_uncertainty_score":0.52820516},"labels":[],"label_agreement":null},{"id":"W3212256991","doi":"10.1182/blood-2018-99-117045","title":"Two-Year Follow-up of Keynote-087 Study: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Cohort; Population; Salvage therapy; Refractory (planetary science); Clinical endpoint; Autologous stem-cell transplantation; Chemotherapy regimen; Transplantation; Surgery; Lymphoma; Chemotherapy; Clinical trial; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.017963725474459166,"score_gpt":0.27775886340980166,"score_spread":0.2597951379353425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212256991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913649,0.0006338848,0.0000019213637,0.00016824939,0.00027717717,0.000872757,0.000012922628,0.000065649874,0.006602533],"genre_scores_gemma":[0.9984049,0.00011660093,0.00026914736,0.00020862148,0.0002842581,0.0001306584,0.000011222215,0.00005635372,0.00051819487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981068,0.00011344211,0.00049822783,0.00047463382,0.00042753093,0.0003794106],"domain_scores_gemma":[0.9987368,0.00010866138,0.00017712922,0.00070682593,0.00011905414,0.00015154971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002041729,0.0002866468,0.00063020113,0.00024164928,0.000061662824,0.000016894479,0.00015840818,0.0001335562,0.0002144601],"category_scores_gemma":[0.000059870847,0.00023481635,0.00018163452,0.00034393911,0.00012370509,0.0000653044,0.000053568776,0.00008545879,0.00015023888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031444929,0.021305244,0.95165396,0.000039869294,0.0007387003,0.00035049464,0.002459812,6.1355667e-7,0.002926667,0.000354648,0.0006995052,0.016326],"study_design_scores_gemma":[0.17430879,0.006903141,0.79488856,0.0001786957,0.00046983798,0.000044654636,0.00071490736,0.000014409972,0.020572128,0.00011546332,0.001541029,0.00024841315],"about_ca_topic_score_codex":0.0007635066,"about_ca_topic_score_gemma":0.0005040636,"teacher_disagreement_score":0.17116429,"about_ca_system_score_codex":0.00019755053,"about_ca_system_score_gemma":0.00027711302,"threshold_uncertainty_score":0.9575533},"labels":[],"label_agreement":null},{"id":"W3212456862","doi":"10.1182/blood-2021-146352","title":"Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Hematopoietic stem cell transplantation; Refractory (planetary science); Progression-free survival; Lymphoma; Peripheral T-cell lymphoma; Gastroenterology; Transplantation; Chemotherapy regimen; Salvage therapy; Anthracycline; Cancer; T cell; Immunology; Breast cancer; Immune system","score_opus":0.015376599245650819,"score_gpt":0.23868589176268584,"score_spread":0.22330929251703502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212456862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953139,0.0033080105,0.0001105032,0.00031577397,0.00003696662,0.00065700006,0.000030827974,0.000026024527,0.00020103146],"genre_scores_gemma":[0.99609756,0.0010024102,0.0021900926,0.00020574543,0.000026179765,0.00010326043,0.000050591534,0.000034430188,0.0002897107],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989432,0.000045962635,0.0003400213,0.00033823322,0.00016841547,0.00016413796],"domain_scores_gemma":[0.99927205,0.00010824385,0.00019593976,0.00019964174,0.00012575138,0.00009835491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009161928,0.00022376586,0.0004749904,0.00004308186,0.00007416414,0.000025541038,0.0000322507,0.00009138818,0.000014415074],"category_scores_gemma":[0.0000029179819,0.00015602293,0.00008270795,0.00009225448,0.00007956029,0.00008286752,0.000009928804,0.000049585953,5.1010545e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035674456,0.015110012,0.7605254,0.0016699241,0.0009923609,0.0005153134,0.011997206,0.0000016625966,0.18027233,0.0006017246,0.000043937787,0.024702676],"study_design_scores_gemma":[0.107591026,0.004989329,0.14168964,0.0005527248,0.0006446883,0.00035520346,0.002784944,0.000066955254,0.7405673,0.00014787624,0.00024513653,0.00036515488],"about_ca_topic_score_codex":0.000054257285,"about_ca_topic_score_gemma":0.000017979319,"teacher_disagreement_score":0.61883575,"about_ca_system_score_codex":0.000047792262,"about_ca_system_score_gemma":0.000106592386,"threshold_uncertainty_score":0.63624305},"labels":[],"label_agreement":null},{"id":"W3212509541","doi":"10.1182/blood-2021-153237","title":"Single-Cell Profiling Reveals Clinically Relevant Evolutionary Trajectories and Alternate Biologies in Human Follicular Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Terry Fox Research Institute","funders":"","keywords":"Follicular lymphoma; Biology; Germinal center; CD8; Lymphoma; Immunology; Mass cytometry; B cell; Immune system; Diffuse large B-cell lymphoma; Cytotoxic T cell; Immunophenotyping; Cluster of differentiation; Phenotype; Cell of origin; Flow cytometry; Cell; Antibody; Genetics; Gene","score_opus":0.027154530611760035,"score_gpt":0.28096618479846747,"score_spread":0.2538116541867074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212509541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988253,0.009783757,0.0000016204731,0.0003398529,0.00010581673,0.0002635869,0.000014353852,0.00005667305,0.0011813205],"genre_scores_gemma":[0.99467504,0.0010334391,0.003628468,0.00016652649,0.00010593006,0.00003618023,0.000068739944,0.000016299726,0.00026935473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987161,0.0000783706,0.00042345191,0.0003934017,0.00014899793,0.00023966757],"domain_scores_gemma":[0.9993167,0.00017286526,0.000088761866,0.00025876446,0.00007637435,0.00008652914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015438671,0.00015912476,0.00036894277,0.000056687106,0.00007065122,0.000023402392,0.000047976744,0.00011009208,0.00001216879],"category_scores_gemma":[0.00021027609,0.00012717713,0.00009858067,0.00012745016,0.000059050377,0.000048265058,0.00007481858,0.00005625608,0.000006476159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050859595,0.003730674,0.88946456,0.00010247271,0.00012361725,0.00181147,0.00009938103,0.000001004029,0.10278151,0.00045611238,0.000054437216,0.001323927],"study_design_scores_gemma":[0.0151170725,0.0012326527,0.7044817,0.0004428584,0.00037629213,0.0005142283,0.00030254573,0.000012797161,0.27509332,0.0016173662,0.00055145123,0.00025768488],"about_ca_topic_score_codex":0.000052072588,"about_ca_topic_score_gemma":0.000010916276,"teacher_disagreement_score":0.18498282,"about_ca_system_score_codex":0.00008010984,"about_ca_system_score_gemma":0.000118267824,"threshold_uncertainty_score":0.5186133},"labels":[],"label_agreement":null},{"id":"W3212555506","doi":"10.3390/curroncol28060407","title":"Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pathology; Lymphoma; Follicular lymphoma; Immunophenotyping; Lymphoplasmacytic Lymphoma; Splenic marginal zone lymphoma; Malignancy; Spleen; Lymphoproliferative disorders; Chronic lymphocytic leukemia; B cell; Splenectomy; Bone marrow; Leukemia; Immunology; Antibody; Flow cytometry; Waldenstrom macroglobulinemia","score_opus":0.09683199640598461,"score_gpt":0.38297607465424394,"score_spread":0.2861440782482593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212555506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001604297,0.9854786,0.000012858994,0.00015678364,0.0033270656,0.0029121048,0.00029099957,0.00015839242,0.0060589225],"genre_scores_gemma":[0.000092060975,0.9892635,0.00038038875,0.00038152255,0.0012795161,0.0015120808,0.006172341,0.00019447602,0.00072412967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941688,0.0008181202,0.0015593293,0.0017387061,0.00056666264,0.0011483544],"domain_scores_gemma":[0.995875,0.000862786,0.0009358583,0.0013245068,0.0002866378,0.0007152197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00032811303,0.0014128614,0.0062664496,0.0004621717,0.00018457806,0.00006665702,0.00047728422,0.0012345111,0.00022664909],"category_scores_gemma":[0.0000992101,0.0011194407,0.0027677957,0.0007182943,0.00024408207,0.00006490673,0.00051620277,0.00039128368,0.0009845413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003651024,0.017654922,0.00013928936,0.018917501,0.0012557259,0.0040103355,0.00009399267,7.277775e-8,0.0000014557297,0.00016721239,0.0072217085,0.95050126],"study_design_scores_gemma":[0.010400296,0.0010014646,0.0006053125,0.023537517,0.010459572,0.0023955884,0.000031986685,0.0000025326185,0.00006581017,0.000008714235,0.9506312,0.0008600118],"about_ca_topic_score_codex":0.000041949024,"about_ca_topic_score_gemma":0.000013722724,"teacher_disagreement_score":0.9496413,"about_ca_system_score_codex":0.007182796,"about_ca_system_score_gemma":0.007067444,"threshold_uncertainty_score":0.99986213},"labels":[],"label_agreement":null},{"id":"W3212704623","doi":"10.1182/blood-2021-148982","title":"Outcomes of Patients with Indolent Lymphoma Treated with Bendamustine Plus Rituximab Compared to Rituximab Plus CVP or CHOP Chemoimmunotherapy in Ontario","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; Bendamustine; CHOP; Internal medicine; Vincristine; Population; Diffuse large B-cell lymphoma; Cyclophosphamide; Surgery; Oncology; Lymphoma; Chemotherapy","score_opus":0.015450881672926174,"score_gpt":0.23752959049002828,"score_spread":0.2220787088171021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212704623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976271,0.00022087866,0.0000045930565,0.00024556377,0.00003953244,0.0011430542,0.000070768765,0.000050130195,0.00059838936],"genre_scores_gemma":[0.99613905,0.000020919566,0.0020179916,0.00046223224,0.000015525911,0.00020685382,0.00030814644,0.00005350531,0.0007758033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979015,0.000040644827,0.00052798033,0.0005377918,0.00056175253,0.00043035304],"domain_scores_gemma":[0.9986329,0.00007960327,0.00017283246,0.00061803986,0.0002976943,0.00019893811],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005839757,0.00041943017,0.0013650336,0.00018200811,0.000056039327,0.000028083237,0.00012240958,0.00009843479,0.00030086303],"category_scores_gemma":[0.000027048716,0.00025895805,0.00010720897,0.000500574,0.000060795224,0.000073246774,0.000059948947,0.00009833693,0.00002075443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069735614,0.028301334,0.95931727,0.00006539595,0.0010690691,0.0008295844,0.0016044736,0.000021549338,0.00007984993,0.000008072675,0.000034754015,0.0016950744],"study_design_scores_gemma":[0.21351095,0.0016841379,0.7742373,0.00042553173,0.00048274494,0.000055227945,0.00014916934,0.000008025737,0.008741639,7.190877e-7,0.00045878673,0.00024580315],"about_ca_topic_score_codex":0.025969183,"about_ca_topic_score_gemma":0.08552337,"teacher_disagreement_score":0.20653738,"about_ca_system_score_codex":0.00101865,"about_ca_system_score_gemma":0.0013158151,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W3212751896","doi":"10.1016/s1470-2045(21)00536-2","title":"Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novartis Pharmaceuticals Corporation","keywords":"Ceritinib; Anaplastic large-cell lymphoma; Lymphoma; Phases of clinical research; Phase (matter)","score_opus":0.04317782784484444,"score_gpt":0.3491828933605973,"score_spread":0.3060050655157529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212751896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963492,0.00033464603,0.0000046506757,0.0008324833,0.00012640253,0.0017312343,0.000058167978,0.000029764306,0.000533407],"genre_scores_gemma":[0.99770266,0.00018940038,0.0006307701,0.0008232601,0.00014703245,0.00021502383,0.00023783017,0.000022271828,0.000031760694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981797,0.00047930412,0.00029791464,0.0004648514,0.00022472141,0.0003535442],"domain_scores_gemma":[0.9987513,0.0004330879,0.00014012883,0.0003730715,0.0001663755,0.00013607687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002822873,0.00020879574,0.0006185501,0.00007559545,0.00013964524,0.00005244501,0.00012930634,0.00009246511,0.00003236557],"category_scores_gemma":[0.00011357351,0.000132268,0.000015227773,0.00037015145,0.0000811981,0.00016551813,0.00015695438,0.00009293901,0.000011674323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009017782,0.043958638,0.825494,0.00004734711,0.00017605971,0.0015794539,0.0035722866,0.000019340017,0.00028349087,0.000117943106,0.00019274751,0.115540914],"study_design_scores_gemma":[0.113133855,0.013805835,0.8700922,0.0000945666,0.00031168936,0.00004255147,0.0015600822,0.00034794142,0.00014676068,0.000022148992,0.00030159607,0.00014078936],"about_ca_topic_score_codex":0.00024854194,"about_ca_topic_score_gemma":0.0012668644,"teacher_disagreement_score":0.11540013,"about_ca_system_score_codex":0.0003918871,"about_ca_system_score_gemma":0.00029961154,"threshold_uncertainty_score":0.5393732},"labels":[],"label_agreement":null},{"id":"W3212812892","doi":"10.1182/blood-2021-153724","title":"Integrative Genomic Analysis Uncovers Unique Diffuse Large B Cell Lymphoma (DLBCL) Immune Environments and Identifies Associations with Specific Oncogenic Alterations","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Immune system; Biology; Immune checkpoint; CD8; Cancer research; Lymphoma; Large-cell lymphoma; Chemoimmunotherapy; T cell; Immunology; Immunotherapy","score_opus":0.006890774325263639,"score_gpt":0.21712832006145005,"score_spread":0.21023754573618642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212812892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957038,0.0022990268,0.0002871946,0.00023951179,0.000036506855,0.00025713528,0.0002557015,0.000022253394,0.0008988615],"genre_scores_gemma":[0.9938599,0.0019695328,0.0007025687,0.00012968725,0.000036561014,0.000070556714,0.000850162,0.000019942578,0.0023611267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884033,0.000081420796,0.0002669459,0.00037368436,0.00021556363,0.00022204743],"domain_scores_gemma":[0.99922186,0.00010777878,0.0001327229,0.0003638001,0.00005322487,0.000120584766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006689225,0.00020240605,0.00040892453,0.00013682239,0.000215299,0.000088069464,0.00004743688,0.00007038354,0.00009435783],"category_scores_gemma":[0.000018120028,0.00015819319,0.0001901216,0.00039742576,0.00004909296,0.000099186844,0.00005732379,0.000059068345,0.000035770714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006507512,0.036482047,0.90103006,0.000025299349,0.01088748,0.00078912446,0.0032564076,0.000019259413,0.045981817,0.00073465495,0.00026759962,0.00046117618],"study_design_scores_gemma":[0.023973137,0.0001974355,0.7996341,0.00003505697,0.0064410465,0.000044999513,0.00128014,0.000029174085,0.16614345,0.000040622737,0.0019679633,0.0002128717],"about_ca_topic_score_codex":0.00009853107,"about_ca_topic_score_gemma":0.0004066045,"teacher_disagreement_score":0.12016163,"about_ca_system_score_codex":0.0003048983,"about_ca_system_score_gemma":0.00015065844,"threshold_uncertainty_score":0.64509314},"labels":[],"label_agreement":null},{"id":"W3212856509","doi":"10.3390/curroncol28060390","title":"How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CD5; Lymphoma; Pathology; Medicine; Splenic marginal zone lymphoma; Differential diagnosis; Mantle cell lymphoma; Chronic lymphocytic leukemia; Spleen; Immunophenotyping; Hairy cell leukemia; Marginal zone; Immunohistochemistry; Lymphoplasmacytic Lymphoma; B cell; Leukemia; Cancer research; Flow cytometry; Immunology; Waldenstrom macroglobulinemia; Antibody","score_opus":0.17677177982340767,"score_gpt":0.44623856877007073,"score_spread":0.2694667889466631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212856509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038053314,0.9924392,0.0000037959298,0.003002633,0.0010496748,0.0020780258,0.00011380695,0.000038486447,0.0008938443],"genre_scores_gemma":[0.00017257984,0.996122,0.00008156182,0.00032064522,0.0008479469,0.0013877865,0.00045265595,0.00005522841,0.00055958517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976384,0.0004392489,0.00043924127,0.000779166,0.00023780609,0.00046610986],"domain_scores_gemma":[0.9970723,0.001571727,0.00025157596,0.0005887545,0.0001412705,0.00037438757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020054779,0.00058705034,0.0025560202,0.0001798125,0.0001658194,0.000110293935,0.00017906421,0.0003438573,0.0000675939],"category_scores_gemma":[0.00040338084,0.00033416075,0.000545828,0.00036027684,0.00014328293,0.000049095128,0.0003681874,0.00029399822,0.000058446687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000104390965,0.0008120415,0.00093543925,0.0025744196,0.0004431036,0.0006625131,0.0003007997,1.3360678e-8,1.352882e-7,0.000815351,0.016675234,0.9767705],"study_design_scores_gemma":[0.001368177,0.00068909756,0.00081979984,0.012626272,0.0046173483,0.0008666568,0.00014332082,0.0000010815999,0.000005243005,0.000010859661,0.97856843,0.00028368618],"about_ca_topic_score_codex":0.0000524095,"about_ca_topic_score_gemma":0.00007753516,"teacher_disagreement_score":0.9764868,"about_ca_system_score_codex":0.0015284328,"about_ca_system_score_gemma":0.0010090689,"threshold_uncertainty_score":0.99991107},"labels":[],"label_agreement":null},{"id":"W3213035572","doi":"10.3390/curroncol28060383","title":"Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma—A Single-Center Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Oncology; Lymphoma; Log-rank test; Multivariate analysis; Exact test; Retrospective cohort study; CHOP; Single Center; Proportional hazards model","score_opus":0.07767255129222164,"score_gpt":0.3877361500242055,"score_spread":0.31006359873198386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213035572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864436,0.0020849442,0.0000031467362,0.00018814673,0.0007853803,0.002609739,0.000024795541,0.000021338035,0.007838938],"genre_scores_gemma":[0.99862635,0.00013625402,0.00003360961,0.00006819759,0.000080237834,0.0008176685,0.00012728295,0.000019781375,0.000090628986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721336,0.000657623,0.00048103687,0.000520426,0.00080375595,0.00032378532],"domain_scores_gemma":[0.9983179,0.00018291362,0.00018907618,0.00036070406,0.0008367608,0.00011263748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011071338,0.00020033473,0.00063296413,0.00014671755,0.00003625826,0.00001067905,0.00006338413,0.00011081184,0.00038097962],"category_scores_gemma":[0.0008550438,0.00017281756,0.00012112337,0.0003202095,0.000049731298,0.00004941476,0.0001075858,0.000102595855,0.00006558653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015867766,0.19121678,0.7899058,0.00004252965,0.00019096793,0.00023205804,0.0007321099,2.8549462e-7,0.00007996214,0.000031737316,0.00041050048,0.016998636],"study_design_scores_gemma":[0.06869681,0.0021603054,0.92354566,0.00014887533,0.0012721597,0.000067290675,0.0006244165,0.00026860394,0.00047462713,0.00008171066,0.002538667,0.000120865414],"about_ca_topic_score_codex":0.000034621004,"about_ca_topic_score_gemma":0.00033571591,"teacher_disagreement_score":0.18905647,"about_ca_system_score_codex":0.0028262816,"about_ca_system_score_gemma":0.00094659295,"threshold_uncertainty_score":0.7390628},"labels":[],"label_agreement":null},{"id":"W3213050308","doi":"10.1182/bloodadvances.2021005794","title":"Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Bendamustine; Hazard ratio; Internal medicine; Cohort; Confidence interval; Rituximab; Clinical endpoint; Randomized controlled trial; Oncology; Surgery; Lymphoma","score_opus":0.03337199370905094,"score_gpt":0.2962263346243567,"score_spread":0.2628543409153058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213050308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8902329,0.10749107,0.000010528857,0.0012938462,0.00021822419,0.00023482727,0.000059040285,0.000038409053,0.00042111138],"genre_scores_gemma":[0.96814907,0.026368072,0.0042007715,0.00034945746,0.00019883804,0.000009677098,0.0004391072,0.000025052432,0.00025997745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985003,0.000049158203,0.00028168855,0.00068027305,0.00023796869,0.0002506375],"domain_scores_gemma":[0.9989121,0.00015487103,0.00008082962,0.00058506377,0.00005139393,0.00021576906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013732248,0.00020735544,0.000500733,0.00006748074,0.000069254966,0.000033792883,0.00007915832,0.000075602344,0.000038167866],"category_scores_gemma":[0.00023833792,0.00017284117,0.000026887807,0.00016164077,0.00006908099,0.0002378883,0.00025400618,0.0001334055,0.000010162309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042414002,0.004278649,0.8411232,0.00020227405,0.0002680381,0.0031102896,0.00018533728,0.000004749207,0.0012245663,0.0004935824,0.00084047334,0.14784466],"study_design_scores_gemma":[0.042405237,0.00035156644,0.8882309,0.0004726199,0.00066421117,0.00056385825,0.00034664397,0.00020971532,0.0023671573,0.0002995642,0.06377602,0.00031250645],"about_ca_topic_score_codex":0.00030847962,"about_ca_topic_score_gemma":0.0006714252,"teacher_disagreement_score":0.14753215,"about_ca_system_score_codex":0.000053121847,"about_ca_system_score_gemma":0.00028843613,"threshold_uncertainty_score":0.7048258},"labels":[],"label_agreement":null},{"id":"W3213194096","doi":"10.1182/blood-2021-145883","title":"Event-Free and Overall Survival in over 6,000 Patients Treated with Frontline Immunochemotherapy for Follicular Lymphoma between 2002-2018: First Report from the International FLIPI24 Consortium","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Event (particle physics); Internal medicine; Oncology; Lymphoma","score_opus":0.011083558379022748,"score_gpt":0.2369471744649472,"score_spread":0.22586361608592445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213194096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957201,0.001193738,0.000017262997,0.0015255258,0.00012944033,0.000581289,0.0005390818,0.000021924829,0.00027165335],"genre_scores_gemma":[0.9963957,0.00023264726,0.0005436113,0.00038531848,0.0002486879,0.00013250024,0.00148669,0.00003275361,0.0005420798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869317,0.000029603643,0.00035987407,0.00039313987,0.0003240773,0.0002001099],"domain_scores_gemma":[0.9988954,0.0002331403,0.0001392636,0.00052100123,0.00013571818,0.00007545942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100532794,0.00020388626,0.0003721663,0.000032866672,0.00006515403,0.000046432375,0.00011604825,0.00008518833,0.00015633134],"category_scores_gemma":[0.00011505178,0.00013163718,0.00010297506,0.00007741893,0.000042189058,0.00006247424,0.00006511711,0.000041978412,0.000002740161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034442337,0.0020810852,0.9921074,0.000008875956,0.0012953473,0.00035400988,0.0001088325,7.998806e-7,0.00010865503,0.000012154046,0.002672374,0.00090606755],"study_design_scores_gemma":[0.046558253,0.0002647152,0.9355075,0.00014426617,0.00046228527,0.000043134805,0.000026845257,0.000024387018,0.005395729,0.000053217685,0.0113791805,0.0001405342],"about_ca_topic_score_codex":0.0017149083,"about_ca_topic_score_gemma":0.0007177556,"teacher_disagreement_score":0.056599922,"about_ca_system_score_codex":0.00012143553,"about_ca_system_score_gemma":0.000115014875,"threshold_uncertainty_score":0.5368008},"labels":[],"label_agreement":null},{"id":"W3213442100","doi":"10.1182/blood-2021-148942","title":"Risk Stratification for Relapsed/Refractory Classical Hodgkin Lymphoma Integrating Pretransplant Deauville Score and Residual Metabolic Tumor Volume","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; ABVD; Internal medicine; Dacarbazine; Autologous stem-cell transplantation; Oncology; Vinblastine; Standardized uptake value; Salvage therapy; Nuclear medicine; Positron emission tomography; Transplantation; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.015066095320018794,"score_gpt":0.24699186625536168,"score_spread":0.2319257709353429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213442100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249536,0.005357357,0.00016819272,0.0005122801,0.00010107602,0.0005293757,0.00020420371,0.0000622779,0.0005698794],"genre_scores_gemma":[0.99124503,0.00065197865,0.0068030558,0.00012964367,0.00023801682,0.00022091909,0.0003431229,0.00003004788,0.00033818782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986525,0.00008749329,0.00033315088,0.0004533891,0.00022005675,0.0002534183],"domain_scores_gemma":[0.9990368,0.00021410728,0.00013053593,0.00031123,0.00013897495,0.0001683595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017194175,0.00020125195,0.00037115152,0.000056697056,0.00016442499,0.000058832764,0.000049320388,0.00010783683,0.000028508366],"category_scores_gemma":[0.0002953549,0.000159545,0.00011508298,0.00012172912,0.00006388131,0.000085961394,0.000019487472,0.00009726676,0.000013017989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006025208,0.008593483,0.85005534,0.00041953463,0.0014823552,0.0008185721,0.0013789545,0.0000016122274,0.033918202,0.009954127,0.0026248887,0.090150416],"study_design_scores_gemma":[0.014941434,0.00091099023,0.8737293,0.00028620384,0.0024738023,0.0005354263,0.00041740751,0.00031040836,0.097104274,0.00029236235,0.008728409,0.0002699754],"about_ca_topic_score_codex":0.00006520162,"about_ca_topic_score_gemma":0.00013985121,"teacher_disagreement_score":0.08988044,"about_ca_system_score_codex":0.00004656385,"about_ca_system_score_gemma":0.00031893427,"threshold_uncertainty_score":0.6506056},"labels":[],"label_agreement":null},{"id":"W3213547762","doi":"10.1182/blood-2021-151105","title":"Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in Patients with CD30-Expressing Peripheral T-Cell Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Etoposide; Internal medicine; Anaplastic large-cell lymphoma; Vincristine; CHOP; CD30; Oncology; Cyclophosphamide; Chemotherapy regimen; Chemotherapy; Prednisone; Autologous stem-cell transplantation; Lymphoma; Gastroenterology","score_opus":0.004026462495773129,"score_gpt":0.200203021382474,"score_spread":0.19617655888670088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213547762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283355,0.004153161,0.000012904406,0.0002213128,0.000101296566,0.0006431829,0.000053981876,0.000057410853,0.0019232114],"genre_scores_gemma":[0.9969277,0.00023862315,0.0013212129,0.0003125475,0.00004153284,0.00009505229,0.00049587287,0.00004824917,0.0005192314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981021,0.00007574222,0.00040492197,0.00060056086,0.0004033479,0.00041328595],"domain_scores_gemma":[0.99906397,0.00007560437,0.0001554052,0.00035579363,0.00014493972,0.00020430562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007681119,0.00032612198,0.00054219627,0.0000715464,0.0001176812,0.00009854756,0.000061321,0.00013930183,0.000083658866],"category_scores_gemma":[0.000045158507,0.00027439496,0.000072472474,0.00025278528,0.000079087935,0.00016951762,0.000074876305,0.00010459201,0.000009168131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052052643,0.006446195,0.97780687,0.0001175999,0.00018372084,0.00029850905,0.00053334225,0.000007563406,0.011637028,0.00002116685,0.0007476543,0.0016798176],"study_design_scores_gemma":[0.0917233,0.0008455356,0.6851389,0.0005070841,0.0005906807,0.00006546184,0.00021362418,0.00007814231,0.21959238,0.000015532065,0.000840398,0.00038901417],"about_ca_topic_score_codex":0.00023374778,"about_ca_topic_score_gemma":0.000053452313,"teacher_disagreement_score":0.292668,"about_ca_system_score_codex":0.00025657137,"about_ca_system_score_gemma":0.0003062915,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W3213661800","doi":"10.1182/blood-2021-147780","title":"Glofitamab Plus R-CHOP Induces High Response Rates with Minimal Cytokine Release Syndrome (CRS) in Patients (pts) with Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and Previously Untreated (1L) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results from a Dose-Escalation and Safety Run-in Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytokine release syndrome; Rituximab; CHOP; Obinutuzumab; Internal medicine; Vincristine; Prednisone; Lymphoma; Gastroenterology; Cyclophosphamide; Diffuse large B-cell lymphoma; Oncology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.007138151283826661,"score_gpt":0.23236526270599306,"score_spread":0.2252271114221664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213661800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944822,0.0012397956,0.0000011943147,0.0001884302,0.000048953316,0.0031957843,0.00071458565,0.000082807186,0.00004625475],"genre_scores_gemma":[0.99739194,0.00037345392,0.00040180245,0.00009645735,0.000036015408,0.00040547262,0.0010699136,0.00010551144,0.000119417804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954233,0.0006280779,0.0010638759,0.0014971349,0.0006854918,0.0007021245],"domain_scores_gemma":[0.9971489,0.00089010794,0.00044490446,0.00085314177,0.00021238383,0.00045059936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004614524,0.0007472211,0.001229919,0.00041014134,0.00018690155,0.00010586015,0.0001283944,0.00030261895,0.000014644007],"category_scores_gemma":[0.00030837697,0.00057046226,0.00007064335,0.0008027955,0.00013100603,0.00039049715,0.00018354104,0.00018727742,0.000009081403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22137523,0.16908397,0.5781606,0.00012659092,0.00059599185,0.02010313,0.0047251023,0.0000054190973,0.00079844426,0.000001625217,0.000025571591,0.004998363],"study_design_scores_gemma":[0.38074207,0.019608334,0.594298,0.0008927102,0.00083606277,0.00022088522,0.00087255123,0.000100340774,0.0020226862,0.0000020860623,0.00002903053,0.00037520844],"about_ca_topic_score_codex":0.0019262828,"about_ca_topic_score_gemma":0.0007995241,"teacher_disagreement_score":0.15936686,"about_ca_system_score_codex":0.000634113,"about_ca_system_score_gemma":0.00072784966,"threshold_uncertainty_score":0.9996747},"labels":[],"label_agreement":null},{"id":"W3213910503","doi":"10.1016/j.ijrobp.2021.10.152","title":"Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma","score_opus":0.02465539161494222,"score_gpt":0.3661823909240698,"score_spread":0.34152699930912755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213910503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743117,0.000659021,0.0046888576,0.0029351602,0.001640217,0.00074903434,0.0018676476,0.000016042195,0.000012825076],"genre_scores_gemma":[0.9926686,0.00054264773,0.00268831,0.00091922545,0.0017307666,0.000085713626,0.0013257319,0.000033318258,0.000005668224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962933,0.0012188399,0.0014869936,0.00037819258,0.00042533522,0.00019730272],"domain_scores_gemma":[0.99051183,0.0047337827,0.0030380827,0.00039922656,0.0012101114,0.00010696536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009781466,0.00026005725,0.000968534,0.00013443416,0.000083772225,0.00001732497,0.00036795618,0.00028107624,0.00011307111],"category_scores_gemma":[0.0011259039,0.00018740928,0.00044040653,0.00015510245,0.00013662451,0.000115467185,0.000063788735,0.00024439621,0.0000024083552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016707055,0.01547915,0.7283726,0.0000023603022,0.0038843632,0.0005888628,0.0011393467,0.00008599696,0.0035502517,0.00026284123,0.00044958811,0.22947758],"study_design_scores_gemma":[0.09840798,0.017793149,0.8505786,0.0000948488,0.000976704,0.00026112454,0.00055431895,0.00020870371,0.024023833,0.0028182375,0.0041111344,0.00017138093],"about_ca_topic_score_codex":0.0013376959,"about_ca_topic_score_gemma":0.000104066225,"teacher_disagreement_score":0.2293062,"about_ca_system_score_codex":0.00079687004,"about_ca_system_score_gemma":0.0017323687,"threshold_uncertainty_score":0.7642329},"labels":[],"label_agreement":null},{"id":"W3214080616","doi":"10.1016/s2152-2650(21)01925-x","title":"TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Prednisone; Vincristine; CHOP; Clinical endpoint; Progression-free survival; Anaplastic large-cell lymphoma; Cyclophosphamide; Phases of clinical research; Gastroenterology; Oncology; Surgery; Lymphoma; Randomized controlled trial; Chemotherapy; CD30","score_opus":0.04101108403857088,"score_gpt":0.34309924268759184,"score_spread":0.30208815864902094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214080616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911904,0.0012189688,0.0000024285664,0.00022617847,0.0004150498,0.005732842,0.0002807736,0.00002762032,0.0009057466],"genre_scores_gemma":[0.99731266,0.0009136526,0.0003263685,0.00004941944,0.00018276382,0.0006177683,0.00034180091,0.000066312015,0.00018922749],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99362093,0.00097488676,0.002947915,0.0010710708,0.000882162,0.0005030623],"domain_scores_gemma":[0.99317914,0.0031787679,0.0014734747,0.0011742418,0.0006777153,0.0003166419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010702693,0.00064986886,0.0034794742,0.00018951317,0.000096147334,0.000032195774,0.000237148,0.0003379114,0.00003975782],"category_scores_gemma":[0.00063636503,0.00039920802,0.0007470099,0.0005975474,0.0007283023,0.00011764178,0.00016189551,0.00012192814,0.0000053165654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78091884,0.059635326,0.06459223,0.000067240915,0.0018208437,0.00028325856,0.0016931721,0.0000099386425,0.000019875519,0.000029891471,0.00004925335,0.090880126],"study_design_scores_gemma":[0.6130716,0.019981973,0.36134672,0.00020773766,0.0016308663,0.000008479778,0.00091454055,0.00009729744,0.0024028043,0.0000054502752,0.00012522956,0.00020727277],"about_ca_topic_score_codex":0.0015222261,"about_ca_topic_score_gemma":0.0003837023,"teacher_disagreement_score":0.29675448,"about_ca_system_score_codex":0.001258916,"about_ca_system_score_gemma":0.0017341753,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W3214205179","doi":"10.1182/blood-2021-145124","title":"The Echelon-2 Trial: 5-Year Exploratory Subgroup Analyses of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Vs CHOP in Frontline Treatment of Pts with CD30-Positive Peripheral T-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Subgroup analysis; Medicine; Internal medicine; Oncology; Exploratory analysis; Randomized controlled trial; Phases of clinical research; Clinical trial; Hodgkin lymphoma; Lymphoma; Confidence interval","score_opus":0.04121522537111414,"score_gpt":0.3278261193347301,"score_spread":0.28661089396361594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214205179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892801,0.00715468,0.000003406182,0.00011465399,0.000051656054,0.0031683117,0.000045570574,0.0000121062585,0.00016949237],"genre_scores_gemma":[0.99731064,0.0016565365,0.00017926059,0.000011404857,0.00005832547,0.00062069984,0.000054452725,0.000029926521,0.00007873297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772525,0.00037316553,0.0008179905,0.00042181878,0.00042196343,0.00023981297],"domain_scores_gemma":[0.9981874,0.00046515238,0.000474485,0.00049034186,0.00026800472,0.000114610935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034571454,0.0003224904,0.001772297,0.000143907,0.00005882645,0.000019968284,0.00007732241,0.000079916084,0.000017237326],"category_scores_gemma":[0.00004790169,0.00018442026,0.0002736944,0.0003617482,0.00019084332,0.00006776372,0.000042722088,0.00004479602,7.3287424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8107749,0.13425069,0.040654622,0.00008248585,0.0035850233,0.00039940103,0.0049256347,0.0000068948625,0.0031114307,0.000014790318,0.000007154514,0.0021869612],"study_design_scores_gemma":[0.8032528,0.012227208,0.0090207765,0.00015403732,0.003756145,0.000021035585,0.0045880983,0.00002439438,0.16682106,0.0000029461912,0.00001036134,0.00012112678],"about_ca_topic_score_codex":0.0010742182,"about_ca_topic_score_gemma":0.00066632195,"teacher_disagreement_score":0.16370963,"about_ca_system_score_codex":0.0001321777,"about_ca_system_score_gemma":0.0003644649,"threshold_uncertainty_score":0.752044},"labels":[],"label_agreement":null},{"id":"W3214210779","doi":"10.1182/blood-2021-148218","title":"Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R 2) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lenalidomide; Follicular lymphoma; Vincristine; Interim analysis; Oncology; CHOP; Bendamustine; Chemotherapy; Gastroenterology; Randomized controlled trial; Cyclophosphamide; Surgery; Lymphoma; Multiple myeloma","score_opus":0.015711766455278255,"score_gpt":0.27915610990993456,"score_spread":0.2634443434546563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214210779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819522,0.0042053806,0.00012484498,0.0036735863,0.0006268375,0.0074396497,0.0014594233,0.00022382897,0.00029428574],"genre_scores_gemma":[0.99011534,0.00162314,0.0024745502,0.0013354723,0.00021018558,0.0016205742,0.0017724519,0.00016167715,0.0006866167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943293,0.0006829135,0.0014683522,0.0015402175,0.0009844934,0.0009947639],"domain_scores_gemma":[0.9915625,0.0051290193,0.0006377302,0.001670841,0.0006738717,0.0003260568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009832846,0.00089382014,0.0028875675,0.00007948802,0.00046053802,0.00019246261,0.00043014195,0.00025853212,0.00006396231],"category_scores_gemma":[0.0055568814,0.0005934095,0.0011766662,0.00044795408,0.00018301244,0.00020405572,0.00013603123,0.0001928844,0.000056704124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64814764,0.19173095,0.07868182,0.00015291007,0.019254483,0.0015720207,0.0043641375,0.000011243606,0.0006225862,0.00007870524,0.036742885,0.018640626],"study_design_scores_gemma":[0.97042894,0.0015624497,0.0059460625,0.0004438189,0.0053659156,0.000013126043,0.00062551344,0.00025531847,0.008126274,0.00006734721,0.006556,0.0006092559],"about_ca_topic_score_codex":0.00075886154,"about_ca_topic_score_gemma":0.00032125358,"teacher_disagreement_score":0.32228127,"about_ca_system_score_codex":0.0005638756,"about_ca_system_score_gemma":0.00043334093,"threshold_uncertainty_score":0.99965173},"labels":[],"label_agreement":null},{"id":"W3214389996","doi":"10.1182/blood-2021-147916","title":"Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Somatic hypermutation; Biology; Lymphoma; Burkitt's lymphoma; Genome; Genetics; Cancer research; Oncology; Immunology; Medicine; Gene; B cell","score_opus":0.011476197009913026,"score_gpt":0.22637604249415644,"score_spread":0.2148998454842434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214389996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961818,0.001746032,0.0000052707414,0.00032614893,0.0001290608,0.00021452898,0.000049538747,0.000045504406,0.0013021432],"genre_scores_gemma":[0.99522585,0.00072415976,0.0021772154,0.0012342844,0.00025839132,0.00006523199,0.00010705454,0.000019221116,0.00018857022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990169,0.000014608305,0.00025055624,0.00033051975,0.00015344383,0.00023397327],"domain_scores_gemma":[0.9992796,0.00007497539,0.000074310454,0.0002918227,0.00011684065,0.00016242747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041633768,0.00017862434,0.00028103273,0.000071776805,0.00005952303,0.000025652966,0.00004398674,0.00012598159,0.00008207897],"category_scores_gemma":[0.00011718497,0.00013967659,0.00007083334,0.00016624446,0.000028258173,0.000031242325,0.000057208727,0.000046994242,0.00006380727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012109025,0.0050531244,0.9734932,0.00014837428,0.0002573592,0.0014968948,0.00058312464,0.00000168132,0.003017069,0.000853282,0.000319977,0.014654779],"study_design_scores_gemma":[0.015257996,0.0008101491,0.9688721,0.00004998695,0.00055476074,0.0013700033,0.000085482796,0.000024077543,0.012392515,0.000042661613,0.00037625167,0.00016402015],"about_ca_topic_score_codex":0.000075937634,"about_ca_topic_score_gemma":0.000041906053,"teacher_disagreement_score":0.015136906,"about_ca_system_score_codex":0.000045898207,"about_ca_system_score_gemma":0.00018379268,"threshold_uncertainty_score":0.5695846},"labels":[],"label_agreement":null},{"id":"W3214525102","doi":"10.1182/blood-2021-145870","title":"A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Retrospective cohort study; Cohort; Salvage therapy; Population; Oncology; Progression-free survival; Rituximab; Chemotherapy regimen; Hazard ratio; Clinical trial; Surgery; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.00844342573270342,"score_gpt":0.23980056453208995,"score_spread":0.23135713879938652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214525102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773014,0.00012057767,6.118196e-7,0.00003970205,0.00007825694,0.0015713539,0.00006786887,0.000031587624,0.00035992102],"genre_scores_gemma":[0.9986812,0.00013267156,0.000366071,0.000048613107,0.000021279433,0.00026715,0.000077027464,0.000035993842,0.00036999662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820507,0.00007508987,0.00047644618,0.00047381414,0.00054847595,0.00022110288],"domain_scores_gemma":[0.9982859,0.00008485585,0.0002958903,0.0006979564,0.0005072377,0.00012815007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041093936,0.00029168517,0.0010405304,0.000087718596,0.000047154786,0.0000068694344,0.00006179624,0.00008344794,0.00007601941],"category_scores_gemma":[0.00011671221,0.0001705107,0.00019372324,0.00029339927,0.000045095185,0.000050006187,0.000035857705,0.000037070393,0.000005609976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005362827,0.08196687,0.9102157,0.000045073793,0.0048002196,0.00053113594,0.00074767135,5.7243244e-7,0.00007794097,0.000016587355,0.000025236515,0.001036732],"study_design_scores_gemma":[0.063239604,0.015446205,0.90692323,0.00015996837,0.0031283642,0.000014521892,0.00059444044,0.0000014304488,0.010300671,0.00000385287,0.00004041856,0.00014731483],"about_ca_topic_score_codex":0.0009914973,"about_ca_topic_score_gemma":0.00052264734,"teacher_disagreement_score":0.06652067,"about_ca_system_score_codex":0.00047950415,"about_ca_system_score_gemma":0.00032470093,"threshold_uncertainty_score":0.69532245},"labels":[],"label_agreement":null},{"id":"W3214708416","doi":"10.1182/blood-2021-151275","title":"Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Medicine; Bendamustine; Rituximab; Internal medicine; Hazard ratio; International Prognostic Index; Oncology; Cohort; Lymphoma; Confidence interval","score_opus":0.01761964910597387,"score_gpt":0.2833849990435385,"score_spread":0.2657653499375646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214708416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679214,0.0002948743,0.000001710674,0.00008241801,0.00015432417,0.00016413668,0.0000157672,0.00001513636,0.00247952],"genre_scores_gemma":[0.9981779,0.00017072787,0.0011970715,0.00009170377,0.00006565148,0.000013595942,0.00012311185,0.000014606533,0.00014564606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888736,0.000065451786,0.00043077092,0.00024812014,0.00021125302,0.00015703641],"domain_scores_gemma":[0.9993517,0.00011709637,0.00010606152,0.00024922096,0.00010082422,0.00007514521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014309977,0.00009391514,0.0003130644,0.00006060987,0.000015427047,0.0000102980675,0.000042903182,0.000088232635,0.00010481034],"category_scores_gemma":[0.00016792535,0.00008949355,0.000110865905,0.00017490075,0.000022386288,0.000051197567,0.000048813792,0.000044380868,0.000054386728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029642168,0.016806938,0.9639644,0.000062905114,0.00005016742,0.00020934848,0.00010747911,8.599601e-7,0.00026893217,0.0000135261935,0.00018893281,0.018296866],"study_design_scores_gemma":[0.024606496,0.0002452806,0.9058315,0.00016582214,0.00019732218,0.0000113738115,0.000057221165,0.0000075416588,0.06827827,0.000017955375,0.00050732115,0.00007387381],"about_ca_topic_score_codex":0.000057247984,"about_ca_topic_score_gemma":0.000013858516,"teacher_disagreement_score":0.06800934,"about_ca_system_score_codex":0.000047111225,"about_ca_system_score_gemma":0.00013882463,"threshold_uncertainty_score":0.3649441},"labels":[],"label_agreement":null},{"id":"W3214925166","doi":"10.1182/blood-2021-153162","title":"Complex Structural Variation Associated with Enhancer Hijacking and Loss of Tumor Suppressors in Mantle Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Chromothripsis; Biology; Mantle cell lymphoma; Chromosomal translocation; Breakpoint; Lymphoma; Gene; Cancer research; Genetics; Molecular biology; DNA; Genome instability; DNA damage","score_opus":0.011366768799382268,"score_gpt":0.23473530571873757,"score_spread":0.22336853691935532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214925166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871117,0.00035605143,0.000001984882,0.00008387344,0.000021508395,0.0001279001,0.000024359604,0.000010741695,0.0006624196],"genre_scores_gemma":[0.999352,0.000023122624,0.00040740005,0.00005136443,0.000017605675,0.000010709526,0.000072547125,0.000009916252,0.000055383254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937975,0.00003169023,0.00015135478,0.0001656198,0.00014330617,0.00012825048],"domain_scores_gemma":[0.9996358,0.000063191765,0.00008371615,0.00010942917,0.00006806356,0.00003976058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039127208,0.00008891438,0.00022947515,0.00003538256,0.000023386376,0.000010685713,0.000020434773,0.000032794553,0.00008662203],"category_scores_gemma":[0.000028707225,0.00006882246,0.000024583187,0.00012423626,0.000026095768,0.00003773868,0.000022142702,0.000022597438,0.0000012418006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006793442,0.0015150661,0.9759696,0.00008632406,0.00017844349,0.00061718625,0.0007505325,0.0000056502913,0.02030373,0.00009010117,0.000017378905,0.0003980151],"study_design_scores_gemma":[0.011474754,0.00012589445,0.8213473,0.00013039952,0.0001871965,0.00006553608,0.000070152,0.000104062354,0.1663883,0.00003395663,0.000011873933,0.00006054374],"about_ca_topic_score_codex":0.00014369156,"about_ca_topic_score_gemma":0.00013044414,"teacher_disagreement_score":0.15462232,"about_ca_system_score_codex":0.000057047902,"about_ca_system_score_gemma":0.00007704331,"threshold_uncertainty_score":0.28064984},"labels":[],"label_agreement":null},{"id":"W3215055844","doi":"10.1182/blood-2021-144892","title":"Transformation of Follicular Lymphoma into Primary Mediastinal B-Cell Lymphoma-like Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"BCL6; CD30; Pathology; Lymphoma; Follicular lymphoma; Immunophenotyping; Reed–Sternberg cell; Biology; Diffuse large B-cell lymphoma; Anaplastic large-cell lymphoma; Germinal center; B cell; Medicine; Immunology; Antibody; Flow cytometry","score_opus":0.0073122393817467565,"score_gpt":0.22025579322521646,"score_spread":0.21294355384346972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215055844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725054,0.0075085512,0.00021449591,0.00036813956,0.0002751623,0.00056549563,0.000082042796,0.000113195056,0.018367544],"genre_scores_gemma":[0.9934993,0.0009851576,0.0029821917,0.0009033291,0.00016555579,0.00012826423,0.000702416,0.00006517737,0.00056863757],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970626,0.00011251625,0.00080733607,0.00057348906,0.00085027295,0.0005937456],"domain_scores_gemma":[0.9982625,0.00013755173,0.0002530902,0.00070036104,0.00028081817,0.0003656602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025817982,0.00044172074,0.000817704,0.00018237774,0.00015648917,0.00003846897,0.00017670674,0.00026151564,0.0001481336],"category_scores_gemma":[0.00003939498,0.00039537606,0.00051609735,0.0005105313,0.00008033534,0.00021472714,0.000093476374,0.000045628985,0.00014183891],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017229308,0.3766581,0.13514453,0.008859339,0.0032247752,0.011279766,0.01378869,0.000010532583,0.13055475,0.0020493392,0.0051367744,0.31157047],"study_design_scores_gemma":[0.15471628,0.00096848345,0.114295326,0.00042146596,0.0023813813,0.0010703374,0.00084489165,0.00012885072,0.6986886,0.000111805035,0.025784668,0.00058787],"about_ca_topic_score_codex":0.00012618431,"about_ca_topic_score_gemma":0.0000264494,"teacher_disagreement_score":0.5681339,"about_ca_system_score_codex":0.00034322048,"about_ca_system_score_gemma":0.001059464,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W3215611510","doi":"10.14309/crj.0000000000000678","title":"Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis","year":2021,"lang":"en","type":"article","venue":"ACG Case Reports Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Tofacitinib; Medicine; Ulcerative colitis; Malignancy; Sarcoma; Janus kinase inhibitor; Dermatology; Adverse effect; Biopsy; Janus kinase; Internal medicine; Pathology; Rheumatoid arthritis","score_opus":0.012314482012635108,"score_gpt":0.25893532475849657,"score_spread":0.24662084274586146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215611510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956963,0.0011193514,0.0000047348444,0.0007567053,0.00013714212,0.00027679544,0.000017916282,0.000020051535,0.0019710027],"genre_scores_gemma":[0.99866766,0.00016362529,0.00036947164,0.00045606936,0.000075204836,0.000042276013,0.000045924604,0.000022356366,0.00015741997],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99815035,0.00013045993,0.0006376369,0.00029557943,0.0004235563,0.00036242502],"domain_scores_gemma":[0.9985601,0.00007223799,0.00039346964,0.00024872314,0.00040894048,0.00031658672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022634899,0.00019347841,0.00043096108,0.00010147809,0.0001589856,0.000078106306,0.000014115909,0.00008256264,0.00038907918],"category_scores_gemma":[0.00019981455,0.00014193865,0.00023377952,0.0002901002,0.000036200185,0.00011031734,0.000030022158,0.00024916287,0.0000050094504],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014858089,0.0010073863,0.17668405,0.000007991087,0.0005061997,0.8147376,0.0006345235,0.000005901227,0.00005962466,0.00001877438,0.0007637173,0.0054256315],"study_design_scores_gemma":[0.003763153,0.00076099136,0.113155924,0.00030000808,0.0003008984,0.87447286,0.0008100909,0.000008069455,0.0048182113,0.00007965695,0.0013909865,0.00013914659],"about_ca_topic_score_codex":0.00019710837,"about_ca_topic_score_gemma":0.0009668613,"teacher_disagreement_score":0.063528135,"about_ca_system_score_codex":0.0007689086,"about_ca_system_score_gemma":0.0009597618,"threshold_uncertainty_score":0.578809},"labels":[],"label_agreement":null},{"id":"W3215940921","doi":"10.1182/blood-2021-145690","title":"Protein Profiling Identify Distinct Tumor-Tissue Protein Expression Pattern Specific for Relapsing Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Lymphoma; Rituximab; Medicine; Oncology; Gene expression profiling; Internal medicine; Etoposide; Clinical trial; Cancer research; Biology; Gene expression; Gene; Chemotherapy","score_opus":0.01677689605969993,"score_gpt":0.26594995224675083,"score_spread":0.2491730561870509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215940921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920393,0.0025434063,0.0011628072,0.00021054802,0.00015800222,0.0030264403,0.00010860849,0.00013457339,0.00061629707],"genre_scores_gemma":[0.98924136,0.00002060301,0.006504058,0.00008184728,0.0004011075,0.0015649273,0.00031307308,0.000083016566,0.0017900303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978004,0.00008067802,0.00046275122,0.0007123145,0.0003947965,0.0005490679],"domain_scores_gemma":[0.99874324,0.00006357471,0.00018807381,0.0006278646,0.00015941243,0.00021783424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018112373,0.00032349527,0.00046250626,0.00007175156,0.0002511933,0.00011697861,0.00010873762,0.00011784194,0.000098661854],"category_scores_gemma":[0.00012048448,0.00026859893,0.00020386702,0.0001686567,0.000028977543,0.00011245026,0.00013291156,0.00009065819,0.00008450761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001511143,0.026040833,0.030230818,0.0009836304,0.000105501735,0.0028724375,0.00022601036,1.02490404e-7,0.9294238,0.00010301169,0.00034929835,0.009513456],"study_design_scores_gemma":[0.038604617,0.0003224084,0.010505332,0.0015608998,0.00021408201,0.00014818537,0.00016468999,0.000024127827,0.94204867,0.000097356555,0.0060308976,0.00027871144],"about_ca_topic_score_codex":0.000018863688,"about_ca_topic_score_gemma":0.00000930384,"teacher_disagreement_score":0.0384535,"about_ca_system_score_codex":0.00017173964,"about_ca_system_score_gemma":0.00021019905,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W3216487577","doi":"10.1182/blood-2021-144888","title":"First Line B+R in Elderly Patients with Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma: A Real-World Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Regional Health Centre; Western University; University of Toronto","funders":"","keywords":"Medicine; Bendamustine; Mantle cell lymphoma; Rituximab; Internal medicine; Lymphoma; Cytopenia; Gastroenterology; Surgery; Bone marrow","score_opus":0.007790462150406807,"score_gpt":0.22960905797552136,"score_spread":0.22181859582511457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216487577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944056,0.00061733526,0.0000038504427,0.0002031262,0.00006491393,0.00043203236,0.000017070377,0.000031121675,0.004224934],"genre_scores_gemma":[0.9976628,0.0006008344,0.00071829575,0.0002273687,0.000057860463,0.00017828314,0.000058521622,0.00003123282,0.00046480514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851745,0.000024767924,0.0002877603,0.0005064705,0.00031707415,0.00034646603],"domain_scores_gemma":[0.99914426,0.000069622285,0.00008691083,0.00039813452,0.00009901933,0.00020208608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004434966,0.00024990214,0.0003937364,0.00012150604,0.000081704995,0.00004022268,0.0000651638,0.000073227464,0.000064114356],"category_scores_gemma":[0.000017096347,0.0001931047,0.00005499256,0.0003745679,0.00006059612,0.000087423265,0.00008606975,0.0000377925,0.000020008067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019366379,0.012483775,0.96905535,0.000110938265,0.000070800386,0.0014929958,0.0013143439,0.0000016456347,0.00005482591,0.000020400794,0.00007420038,0.015127044],"study_design_scores_gemma":[0.044358764,0.000983684,0.931301,0.00031701438,0.00016576507,0.00005426711,0.00020504424,0.000018891855,0.021124722,0.000008859019,0.0012534023,0.00020857024],"about_ca_topic_score_codex":0.00070825254,"about_ca_topic_score_gemma":0.001928799,"teacher_disagreement_score":0.044165097,"about_ca_system_score_codex":0.00014161228,"about_ca_system_score_gemma":0.00018939612,"threshold_uncertainty_score":0.7874581},"labels":[],"label_agreement":null},{"id":"W3216581958","doi":"10.1182/blood-2021-145954","title":"Population-Wide Introduction of Dose-Adjusted EPOCH-R Is Associated with Improved Outcome of High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements with Diffuse Large B-Cell Lymphoma Morphology","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Medicine; Rituximab; Population; Internal medicine; Epoch (astronomy); BCL6; Lymphoma; Prednisone; Oncology; Cyclophosphamide; Chemotherapy; Immunology; B cell","score_opus":0.010717542123750031,"score_gpt":0.22245726122753812,"score_spread":0.21173971910378808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216581958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978477,0.00046955468,0.0000176225,0.00065569114,0.00006130104,0.00064680167,0.00013512903,0.000051801955,0.00011443584],"genre_scores_gemma":[0.996751,0.00009759316,0.0014021224,0.00026128505,0.00006148448,0.00006910478,0.0006599128,0.00006393771,0.0006335326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785995,0.00010274119,0.0005566572,0.00062881946,0.00045554247,0.0003963049],"domain_scores_gemma":[0.99819344,0.000110695124,0.000568287,0.000601619,0.0003621123,0.00016384311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013202007,0.0003649611,0.00092552823,0.00015626107,0.00007824746,0.000018659799,0.00007515094,0.0001716902,0.00005995743],"category_scores_gemma":[0.00006913405,0.00025156964,0.00008404224,0.00048976945,0.00011213618,0.000106781445,0.000056956225,0.000061970066,0.0000034192644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009917585,0.03757275,0.9485365,0.0002696671,0.0012467048,0.00045241072,0.00040477514,0.0000019791,0.009954268,0.000057163103,0.000175493,0.0003365312],"study_design_scores_gemma":[0.12569077,0.0020607999,0.7408022,0.00013140663,0.0022113828,0.00024611602,0.00023751677,0.000020868563,0.12829334,0.000014079197,0.00006414479,0.00022734214],"about_ca_topic_score_codex":0.0012641818,"about_ca_topic_score_gemma":0.00039640494,"teacher_disagreement_score":0.20773426,"about_ca_system_score_codex":0.00014740576,"about_ca_system_score_gemma":0.00014881557,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W3216889628","doi":"10.1182/blood-2021-153585","title":"Outcomes of High Grade B- Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements: An Atlantic Canadian Centre Perspective","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; BCL6; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Regimen; Burkitt's lymphoma; Chemoimmunotherapy; Aggressive lymphoma; Rituximab; Immunology; B cell","score_opus":0.009925915419526676,"score_gpt":0.23014141537095995,"score_spread":0.22021549995143327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216889628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954956,0.0010297498,2.8367586e-7,0.0018706658,0.000025730273,0.00023491224,0.00004706806,0.0000149605075,0.0012810417],"genre_scores_gemma":[0.9980907,0.0003614629,0.00061157474,0.00030614212,0.000027424308,0.0000109114735,0.00004416169,0.00001731147,0.00053035095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999185,0.000029060491,0.00012097856,0.00029421624,0.00015233528,0.00021838376],"domain_scores_gemma":[0.99927574,0.000038019043,0.000044268854,0.00022901669,0.000102459955,0.0003105005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029281524,0.00014944105,0.0003194439,0.00007018528,0.000060999886,0.000020361662,0.000029714329,0.000049123693,0.00008028532],"category_scores_gemma":[0.000020328322,0.00009853616,0.000031299187,0.00010942194,0.000055027576,0.000050984097,0.00001980531,0.000025775982,0.0000033040028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062163446,0.002446,0.9925774,0.000069756825,0.00046983955,0.0014759789,0.0013851499,9.583777e-8,0.00014008311,0.0006235765,0.000107535634,0.00064241816],"study_design_scores_gemma":[0.016247384,0.0005677142,0.970535,0.00009732693,0.00090414734,0.00024746134,0.0038989217,0.000002379291,0.006955862,0.000043669857,0.00037550423,0.00012465302],"about_ca_topic_score_codex":0.13637279,"about_ca_topic_score_gemma":0.13452019,"teacher_disagreement_score":0.022042427,"about_ca_system_score_codex":0.00009998264,"about_ca_system_score_gemma":0.00030568536,"threshold_uncertainty_score":0.88127255},"labels":[],"label_agreement":null},{"id":"W3216956782","doi":"10.1182/blood-2021-154729","title":"The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Vincristine; Internal medicine; Prednisone; International Prognostic Index; Cyclophosphamide; Diffuse large B-cell lymphoma; Clinical endpoint; Gastroenterology; Placebo; Bendamustine; Surgery; Oncology; Chemotherapy; Lymphoma; Clinical trial; Pathology","score_opus":0.004783608112453132,"score_gpt":0.20937665576874326,"score_spread":0.20459304765629013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216956782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96270925,0.032083057,0.0000052450687,0.00040838978,0.00017488224,0.0037907509,0.00017492959,0.00019144347,0.00046206315],"genre_scores_gemma":[0.99199194,0.005718099,0.0006594976,0.0003264823,0.000103198756,0.00037954055,0.00025352245,0.00019526089,0.00037246893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434286,0.000340721,0.0010168698,0.0017027626,0.0011517698,0.0014449884],"domain_scores_gemma":[0.9962757,0.00062852976,0.00046854035,0.0014511176,0.0005335517,0.00064255233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003906177,0.0011630373,0.0016220361,0.0002221757,0.000764842,0.00033672558,0.00029576354,0.00030743153,0.00003567239],"category_scores_gemma":[0.00018202278,0.0007446616,0.00014417365,0.0010988542,0.0003804979,0.00032498332,0.0003287179,0.00040212646,0.00001905107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015436342,0.09594912,0.8778172,0.00013325276,0.0014500212,0.0013692009,0.0015104633,0.000001179994,0.00023028896,0.000066146815,0.0001324435,0.0059043146],"study_design_scores_gemma":[0.35845917,0.008424229,0.6253378,0.00033715717,0.0011441319,0.00010695484,0.0007711698,0.000023704386,0.0036496469,0.00001584176,0.001130228,0.00060000346],"about_ca_topic_score_codex":0.0020147625,"about_ca_topic_score_gemma":0.002132564,"teacher_disagreement_score":0.34302282,"about_ca_system_score_codex":0.00040465387,"about_ca_system_score_gemma":0.00062423054,"threshold_uncertainty_score":0.99950045},"labels":[],"label_agreement":null},{"id":"W3217353697","doi":"10.1016/s2352-3026(21)00311-2","title":"Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study","year":2021,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Roche","keywords":"Lenalidomide; Medicine; Follicular lymphoma; Obinutuzumab; Internal medicine; Rituximab; Oncology; Lymphoma; Cohort; Neutropenia; Tolerability; Brentuximab vedotin; Gastroenterology; Chemotherapy; Adverse effect; Multiple myeloma; CD30","score_opus":0.02440419732320716,"score_gpt":0.28496713509118393,"score_spread":0.2605629377679768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217353697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659747,0.0012694965,0.0000042845995,0.00036911646,0.00008585846,0.0014095893,0.000020228352,0.00003215959,0.00021177848],"genre_scores_gemma":[0.99896747,0.00009030586,0.00031163852,0.00032363948,0.000033973287,0.00012063031,0.000054543536,0.000029185207,0.000068627254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980791,0.00031387105,0.00048598496,0.00044034675,0.00029752892,0.0003831641],"domain_scores_gemma":[0.99846077,0.00037450128,0.00023973851,0.0006745996,0.00014935793,0.00010104273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018244372,0.00025851835,0.0015075454,0.000092242866,0.0000660467,0.000014462835,0.00011290777,0.000106246756,0.000044702625],"category_scores_gemma":[0.00024923615,0.0001461561,0.00006538376,0.00028520316,0.00015412914,0.000058134654,0.00010145132,0.00011566047,0.0000073378087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016392142,0.021150269,0.9487895,0.00021999881,0.0008882716,0.0060883113,0.0040636766,0.000009740443,0.00010058435,0.0001717457,0.00020422434,0.0019215407],"study_design_scores_gemma":[0.2769307,0.0066466695,0.70853925,0.00046064288,0.0012303671,0.0008901538,0.0021793954,0.00024507623,0.0019444991,0.000037982034,0.0006139514,0.0002813347],"about_ca_topic_score_codex":0.0004195524,"about_ca_topic_score_gemma":0.0006066536,"teacher_disagreement_score":0.26053855,"about_ca_system_score_codex":0.000795779,"about_ca_system_score_gemma":0.0007502466,"threshold_uncertainty_score":0.5960073},"labels":[],"label_agreement":null},{"id":"W3217466224","doi":"10.1016/j.cpet.2021.09.006","title":"Artificial Intelligence in Lymphoma PET Imaging","year":2021,"lang":"en","type":"article","venue":"PET Clinics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NIH Clinical Center; National Institutes of Health","keywords":"Medicine; Lymphoma; Risk stratification; Pet imaging; Segmentation; Artificial intelligence; Positron emission tomography; Radiology; Pathology; Computer science; Internal medicine","score_opus":0.03816215394911705,"score_gpt":0.3492320684004292,"score_spread":0.31106991445131216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217466224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882763,0.000992119,0.00012169237,0.0040959055,0.00048295167,0.00014167035,0.000011482283,0.000048060272,0.0058298022],"genre_scores_gemma":[0.9948257,0.00081788446,0.002510209,0.0013525472,0.00016914248,0.000022356018,0.000046610123,0.000015946196,0.000239558],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987872,0.000040406194,0.00044191492,0.0003135521,0.00018093435,0.00023599784],"domain_scores_gemma":[0.9991722,0.0002545108,0.000059849022,0.0003229502,0.00008615932,0.00010430973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021122464,0.000120455756,0.000275846,0.00006085698,0.000035476496,0.000029228602,0.000055715387,0.000022680078,0.00029834805],"category_scores_gemma":[0.00039077812,0.00010992149,0.00011991068,0.00023576632,0.000042363168,0.00005714251,0.00006050706,0.00006879687,0.0003205606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009270441,0.002284179,0.39486,0.00004228058,0.00004975253,0.01706698,0.00025506056,0.000014553068,0.00007572146,0.0054716603,0.00043189677,0.57935524],"study_design_scores_gemma":[0.004050081,0.00046125223,0.8670018,0.00086113374,0.00048115783,0.005803787,0.0030085056,0.029259382,0.023311144,0.020814579,0.044063754,0.0008834672],"about_ca_topic_score_codex":0.000052008578,"about_ca_topic_score_gemma":0.00013312149,"teacher_disagreement_score":0.5784718,"about_ca_system_score_codex":0.00015447641,"about_ca_system_score_gemma":0.00031741537,"threshold_uncertainty_score":0.44824684},"labels":[],"label_agreement":null},{"id":"W3217481197","doi":"10.1182/blood-2021-153445","title":"Constrained FL: A Genetically Distinct Subgroup of Follicular Lymphoma with Low Rates of Somatic Hypermutation and a Reduced Propensity for Histologic Transformation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Somatic hypermutation; BCL6; Biology; Follicular lymphoma; Germinal center; Somatic cell; Genetics; Lymphoma; Cell of origin; Diffuse large B-cell lymphoma; Fluorescence in situ hybridization; Cancer research; Gene; B cell; Chromosome; Immunology","score_opus":0.01613062665789393,"score_gpt":0.2415695368399892,"score_spread":0.22543891018209528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217481197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777913,0.0004734889,0.0005434048,0.00023614783,0.000009081163,0.0007849097,0.000023892842,0.000011406632,0.00013854941],"genre_scores_gemma":[0.9945425,0.000029252098,0.005187703,0.000022508639,0.0000069723933,0.00009242416,0.00010364114,0.0000073607284,0.000007673131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993678,0.000027280239,0.00025172814,0.0001411772,0.0001183355,0.000093692404],"domain_scores_gemma":[0.99946594,0.0000771458,0.00010650605,0.00011070328,0.0001911075,0.000048577513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063665604,0.00009492843,0.0003287649,0.000029029534,0.000030169842,0.0000061028786,0.000017124265,0.00004341409,0.0000063532348],"category_scores_gemma":[0.0000789082,0.00006505641,0.00005848574,0.00008217274,0.00008889947,0.000032837743,0.000005158778,0.000010851056,3.146002e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016936589,0.012445042,0.26099625,0.0057173893,0.0016457657,0.00036406913,0.0030683444,0.000010534791,0.6623786,0.0029551627,0.000010575371,0.048714597],"study_design_scores_gemma":[0.013544853,0.0011190466,0.4602265,0.0002470242,0.0009808985,0.00037954698,0.00013260187,0.00037698343,0.52278185,0.00013297651,0.000005294358,0.00007239957],"about_ca_topic_score_codex":0.000015486807,"about_ca_topic_score_gemma":0.000015774898,"teacher_disagreement_score":0.19923025,"about_ca_system_score_codex":0.000022421305,"about_ca_system_score_gemma":0.00018267697,"threshold_uncertainty_score":0.26529235},"labels":[],"label_agreement":null},{"id":"W3217732564","doi":"10.6004/jnccn.2021.5109","title":"Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Disease; Intensive care medicine","score_opus":0.03837105324427232,"score_gpt":0.31363689596042993,"score_spread":0.2752658427161576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217732564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83174115,0.14888744,0.00028910208,0.013892813,0.003605059,0.00076141884,0.0001696087,0.000019988662,0.0006334145],"genre_scores_gemma":[0.97719234,0.0062601836,0.0015819757,0.011397689,0.0027429967,0.000053092575,0.000018887895,0.00003004897,0.0007227956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853885,0.00008547912,0.00037430355,0.00016655297,0.00059862906,0.00023620711],"domain_scores_gemma":[0.99669105,0.00048178041,0.0004200509,0.00014697349,0.0020743872,0.00018578403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109225315,0.00016279527,0.00033655664,0.00004322649,0.00022224935,0.000032212476,0.00013066256,0.000056405835,0.000062369116],"category_scores_gemma":[0.000101140286,0.00010377156,0.00052073936,0.0002019841,0.0000349076,0.000088080866,0.00005161932,0.00011768244,0.0000024072594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011714047,0.028053744,0.085807204,0.0003312355,0.004131294,0.00063947914,0.0005900104,0.03686408,0.0033984715,0.003299537,0.8093354,0.015835505],"study_design_scores_gemma":[0.06988123,0.00042810058,0.2509582,0.0008055459,0.00062303914,0.00018775169,0.00010336786,0.0012057206,0.0022410227,0.0020731902,0.6712169,0.00027592317],"about_ca_topic_score_codex":0.000001775867,"about_ca_topic_score_gemma":0.0000015686607,"teacher_disagreement_score":0.165151,"about_ca_system_score_codex":0.0005924775,"about_ca_system_score_gemma":0.0011341255,"threshold_uncertainty_score":0.42316815},"labels":[],"label_agreement":null},{"id":"W336660519","doi":"10.1007/pl00022799","title":"Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Hematology; Internal medicine; Medicine; Histology; Lymphoma; Aggressive lymphoma; Oncology; Rituximab","score_opus":0.06579895834791276,"score_gpt":0.36604472815729977,"score_spread":0.300245769809387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W336660519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014053008,0.9815394,8.0125744e-7,0.00020522761,0.000090881374,0.0012421309,0.00005255893,0.000024352308,0.0027916366],"genre_scores_gemma":[0.012728092,0.98605907,0.00008256007,0.00006676111,0.000024151761,0.0004695313,0.00044179012,0.00004638458,0.000081638864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772173,0.00015536179,0.0008821865,0.0005513847,0.00018733188,0.00050198694],"domain_scores_gemma":[0.9978712,0.00027790113,0.0010448602,0.00054099836,0.00013376371,0.00013124189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000034140157,0.0005961219,0.0040957914,0.00046705245,0.00003009322,0.0000078685425,0.00013019142,0.0004911339,0.00007329667],"category_scores_gemma":[0.000037032725,0.00035861827,0.00043907025,0.000303689,0.0002125434,0.00005532924,0.000032778735,0.00007996256,0.00004312689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019742457,0.003950451,0.012520393,0.0043230425,0.0011075668,0.0042297323,0.000085530024,1.8755662e-7,1.0591778e-8,0.0022598293,0.0003337568,0.9709921],"study_design_scores_gemma":[0.00784717,0.009396246,0.0041046357,0.014902669,0.001818084,0.0037006647,0.000075790944,3.6362968e-7,0.00002017628,0.00016911756,0.9575014,0.00046367705],"about_ca_topic_score_codex":0.000318301,"about_ca_topic_score_gemma":0.00015684908,"teacher_disagreement_score":0.9705284,"about_ca_system_score_codex":0.00017330972,"about_ca_system_score_gemma":0.0009713079,"threshold_uncertainty_score":0.9998866},"labels":[],"label_agreement":null},{"id":"W37750213","doi":"10.1177/09622802231198795","title":"Iconography : Localisation primitive « anale et œsophagienne » d'un lymphome non hodgkinien du Malt","year":2008,"lang":"en","type":"article","venue":"Statistical Methods in Medical Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"MALT lymphoma; Medicine; Lymphoma; Pathology","score_opus":0.12630805879344958,"score_gpt":0.5251216464006785,"score_spread":0.3988135876072289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W37750213","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4691425,0.0009653597,0.48422936,0.0125946,0.00034985648,0.0018897296,0.0001199423,0.00010223151,0.030606426],"genre_scores_gemma":[0.7010495,0.0018653314,0.29540053,0.0010429615,0.0001536251,0.00029921057,0.0000878419,0.000029944926,0.00007108379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9920312,0.003214582,0.0006983575,0.00073993276,0.0023627228,0.0009532073],"domain_scores_gemma":[0.9857221,0.012220453,0.000061783205,0.0004465085,0.00038984828,0.001159283],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009358867,0.00024699306,0.0006928742,0.0006479734,0.00021259257,0.000028977227,0.0002536036,0.00031132318,0.0029812537],"category_scores_gemma":[0.020796059,0.0001901513,0.0001239387,0.0013138958,0.0015163491,0.00009225604,0.00022231693,0.00085392233,0.00011697242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007173383,0.0026572095,0.14777808,0.00013676725,0.00016058297,0.0077594346,0.0011507684,0.0000014129283,0.00018876314,0.035126574,0.0029427153,0.80138034],"study_design_scores_gemma":[0.005940293,0.0013411694,0.9708596,0.00025156408,0.00004577316,0.00037101778,0.00030821268,0.0038239136,0.0022015227,0.010930045,0.0037202667,0.00020666177],"about_ca_topic_score_codex":0.0005833874,"about_ca_topic_score_gemma":0.000029362944,"teacher_disagreement_score":0.8230815,"about_ca_system_score_codex":0.00049353275,"about_ca_system_score_gemma":0.0010815682,"threshold_uncertainty_score":0.99793017},"labels":[],"label_agreement":null},{"id":"W39936271","doi":"10.1007/978-94-017-1763-2_24","title":"Which lessons can be drawn from the study of Helicobacter pylori related MALT lymphoma?","year":2003,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Helicobacter pylori; MALT lymphoma; Medicine; Lymphoma; Gastroenterology; Immunology","score_opus":0.03204679100776032,"score_gpt":0.2680308061004601,"score_spread":0.23598401509269978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W39936271","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31077415,0.0012485347,5.656689e-7,0.015924076,0.0005330575,0.002302984,0.00038709576,0.000099726065,0.6687298],"genre_scores_gemma":[0.7250309,0.00049070857,0.00004073122,0.0016343063,0.00013596442,0.00008356989,0.00042708215,0.000110024404,0.2720467],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975251,0.000057825535,0.0007467101,0.00069392385,0.00065696577,0.0003195024],"domain_scores_gemma":[0.99752015,0.00028819032,0.00035108166,0.0013510255,0.000289422,0.0002001144],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014531716,0.0006015711,0.0010613725,0.00010919787,0.00017159464,0.000049759834,0.0002165005,0.0004761324,0.0031854094],"category_scores_gemma":[0.000039412786,0.0003498642,0.00028209083,0.00009066785,0.000119999655,0.00003062839,0.00010695831,0.00021497504,0.00013168927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001719676,0.030076161,0.24259108,0.00034140775,0.057043444,0.003260394,0.028694864,0.000010855895,0.0003715515,0.2836261,0.25740716,0.09485729],"study_design_scores_gemma":[0.04130375,0.0049755545,0.2919688,0.0016689404,0.01390328,0.00023591013,0.003083239,0.000011491888,0.0020442107,0.004257028,0.6347466,0.0018012178],"about_ca_topic_score_codex":0.0072496235,"about_ca_topic_score_gemma":0.009448781,"teacher_disagreement_score":0.41425678,"about_ca_system_score_codex":0.00040106423,"about_ca_system_score_gemma":0.0004338899,"threshold_uncertainty_score":0.99989533},"labels":[],"label_agreement":null},{"id":"W4200026256","doi":"10.3390/curroncol28060456","title":"Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Medicine; Lymphoma; Clinical trial; Refractory (planetary science); Oncology; Bioinformatics; Pathology; Immunology; T cell; Biology","score_opus":0.13109518733169614,"score_gpt":0.4356033476902684,"score_spread":0.3045081603585723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200026256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008244171,0.9965422,5.625687e-7,0.000056289173,0.0008755229,0.001022787,0.00003806278,0.0000125265315,0.0006276194],"genre_scores_gemma":[0.00009985467,0.99847406,0.00005404159,0.000023566452,0.0001015253,0.000999967,0.00020182742,0.000031109143,0.000014076229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980876,0.0002540658,0.0007379277,0.00047826456,0.0001603637,0.0002817854],"domain_scores_gemma":[0.9983164,0.00076197064,0.000397917,0.00031940444,0.00009518466,0.00010913768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014031479,0.00038120802,0.0027035126,0.00025231473,0.000023260285,0.0000074254335,0.000097755335,0.000273587,0.0001559684],"category_scores_gemma":[0.00008372033,0.0002732648,0.00034518275,0.00037211998,0.00011409088,0.00003936102,0.00009066408,0.00014165175,0.000014107525],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025219953,0.0053846026,0.0036980354,0.005957096,0.00011651361,0.00013855114,0.000064551044,7.7010974e-8,7.592545e-8,0.000025977146,0.00039568485,0.9841936],"study_design_scores_gemma":[0.00397328,0.0009060102,0.00077436183,0.015022456,0.000598013,0.00009469965,0.000026077676,7.012423e-7,0.000011522643,0.000007944614,0.97839785,0.00018711346],"about_ca_topic_score_codex":0.000005844079,"about_ca_topic_score_gemma":0.000010256936,"teacher_disagreement_score":0.9840065,"about_ca_system_score_codex":0.0006031841,"about_ca_system_score_gemma":0.00091027404,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W4200098179","doi":"10.1016/j.jtct.2021.12.005","title":"Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Cumulative incidence; Internal medicine; Transplantation; Confidence interval; Lymphoma; Refractory (planetary science); Incidence (geometry); Oncology; Retrospective cohort study; Salvage therapy; Disease; Surgery; Chemotherapy","score_opus":0.02074587167349031,"score_gpt":0.26663452494819356,"score_spread":0.24588865327470324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200098179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932245,0.004209023,0.00034594294,0.0009892919,0.000034368146,0.00062731124,0.00015697334,0.000008434278,0.00040414504],"genre_scores_gemma":[0.9806936,0.018263098,0.00046171687,0.00030234669,0.0000080127575,0.000073871975,0.00013001224,0.0000150125425,0.000052363586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909866,0.000082821505,0.00029323294,0.00022504896,0.00014582713,0.0001544037],"domain_scores_gemma":[0.9993533,0.00025964403,0.00009357493,0.0001430718,0.000083772466,0.00006662222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016061253,0.00015764408,0.00034678367,0.00012084207,0.000060174287,0.000011307077,0.000045192122,0.00007750175,0.000013868528],"category_scores_gemma":[0.0000012584533,0.00011055914,0.00009355203,0.00015065735,0.000071382994,0.000042499047,0.0000010260018,0.000051344814,2.3008702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037888703,0.0046267817,0.40539578,0.0020460123,0.0012351575,0.0007618322,0.2872398,0.00003699666,0.21818192,0.022442807,0.000019956778,0.05422411],"study_design_scores_gemma":[0.018857226,0.0006593084,0.7991777,0.00018737314,0.0003773646,0.00014046348,0.00990926,0.000049213275,0.17005703,0.00024292087,0.00015419355,0.00018792097],"about_ca_topic_score_codex":0.014042023,"about_ca_topic_score_gemma":0.022051426,"teacher_disagreement_score":0.39378196,"about_ca_system_score_codex":0.000067591,"about_ca_system_score_gemma":0.00022993563,"threshold_uncertainty_score":0.9957936},"labels":[],"label_agreement":null},{"id":"W4200115086","doi":"10.1182/blood-2021-149046","title":"Impact of Disease Extent and Distribution on Outcomes in Stage II Follicular Lymphoma Treated with Curative-Intent Radiation Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Stage (stratigraphy); Internal medicine; Disease; Radiation therapy; Lymphoma; Oncology; Cancer; B symptoms; Progression-free survival; Surgery; Chemotherapy","score_opus":0.013263577872438736,"score_gpt":0.2795579557964124,"score_spread":0.26629437792397365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200115086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775314,0.0012623298,0.000005198465,0.0003655118,0.0000082306315,0.00037921048,0.00018253949,0.00001334675,0.000030460704],"genre_scores_gemma":[0.9986398,0.0007269291,0.000013061476,0.000042829877,0.000008085537,0.000060605722,0.00041592086,0.000008802024,0.00008392608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930966,0.00004156146,0.00015577192,0.00020213003,0.00016868426,0.00012218501],"domain_scores_gemma":[0.99952817,0.00003518297,0.00006801,0.00018475404,0.00006654348,0.000117317526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032476222,0.00013963225,0.00027107474,0.000040189712,0.00003566597,0.000009643047,0.00001543084,0.00002849779,0.000024408275],"category_scores_gemma":[0.000033729248,0.00008129686,0.00010350287,0.00013034046,0.000023558501,0.000043348482,0.000010646727,0.000019162659,9.468864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007007508,0.008671001,0.98289454,0.000012963687,0.00045941645,0.00037282315,0.00011458549,0.000011060697,0.00055431115,0.00011917956,0.000010529746,0.006078812],"study_design_scores_gemma":[0.020518575,0.002237751,0.95551866,0.00010413871,0.00017460326,0.000010061027,0.00003789324,0.00004322359,0.021231672,0.0000062095824,0.000041177118,0.00007603007],"about_ca_topic_score_codex":0.00025827077,"about_ca_topic_score_gemma":0.000013227415,"teacher_disagreement_score":0.027375901,"about_ca_system_score_codex":0.00017402945,"about_ca_system_score_gemma":0.00013129051,"threshold_uncertainty_score":0.33151895},"labels":[],"label_agreement":null},{"id":"W4200124339","doi":"10.14740/jh929","title":"Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bleomycin; Pulmonary toxicity; DLCO; ABVD; Pulmonary function testing; Pulmonary fibrosis; Internal medicine; Prospective cohort study; Lung; Gastroenterology; Surgery; Chemotherapy; Diffusing capacity; Vincristine","score_opus":0.025813348098268733,"score_gpt":0.2897693933653337,"score_spread":0.26395604526706495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200124339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994253,0.0019163372,0.000009855214,0.0007055108,0.00018931997,0.0003274682,0.0000070662545,0.0000072609373,0.0025841903],"genre_scores_gemma":[0.9990744,0.000098306766,0.00047632726,0.0000977933,0.00007689289,0.000016177582,0.0000030211656,0.000013488653,0.00014360152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866384,0.000117533964,0.0006151393,0.00018096386,0.00023595191,0.0001865625],"domain_scores_gemma":[0.99873984,0.00013838882,0.00041745446,0.00022330001,0.00036073758,0.00012025583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009743941,0.00016310804,0.0009053554,0.0001293766,0.000034518136,0.0000075288094,0.000056920646,0.00007805225,0.0001228002],"category_scores_gemma":[0.00009219829,0.0001102188,0.0002838604,0.00016512543,0.000057212746,0.00006215507,0.000036035923,0.000050299055,0.000008582309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007762635,0.043762248,0.92126036,0.000044041037,0.0012548112,0.021363426,0.00076769275,6.363229e-7,0.0034915607,0.00027412712,0.0001592599,0.006845573],"study_design_scores_gemma":[0.025044056,0.015335227,0.5578319,0.00031303405,0.0010853349,0.120055586,0.0023504666,0.000010338433,0.27645567,0.000379755,0.000978109,0.00016054571],"about_ca_topic_score_codex":0.000011762926,"about_ca_topic_score_gemma":0.000019852137,"teacher_disagreement_score":0.36342847,"about_ca_system_score_codex":0.0004018353,"about_ca_system_score_gemma":0.0003112302,"threshold_uncertainty_score":0.44945922},"labels":[],"label_agreement":null},{"id":"W4200139163","doi":"10.1182/blood.2021013998","title":"Limited-stage diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; Medicine; Vincristine; Oncology; Radiation therapy; Lymphoma; Clinical trial; Internal medicine; Population; Stage (stratigraphy); Cyclophosphamide; Chemotherapy; Biology","score_opus":0.036066013690203194,"score_gpt":0.30855543925608303,"score_spread":0.27248942556587985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200139163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005010047,0.9861629,9.275273e-7,0.000027959244,0.00021663611,0.0008786675,0.00033267954,0.000115289746,0.011763937],"genre_scores_gemma":[0.00008430327,0.98499113,0.00017808848,0.00023040216,0.00038264197,0.00034292752,0.0013647127,0.00011785159,0.012307937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977681,0.00011084797,0.00057261845,0.0006815371,0.00035501196,0.0005118892],"domain_scores_gemma":[0.9981525,0.00018592559,0.00025317247,0.0010247779,0.00006925261,0.00031439663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010238225,0.0006069764,0.0024714407,0.00016212517,0.00008237485,0.000060082904,0.00016048661,0.0004414201,0.0003438377],"category_scores_gemma":[0.00006268124,0.000435273,0.0012577075,0.00034859375,0.000024945695,0.000031485055,0.00016716326,0.00014324073,0.00079811894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050850217,0.09111425,0.0003835956,0.026085,0.0020834887,0.009465124,0.00005229147,2.9725222e-9,4.7416682e-7,0.00043429213,0.005588849,0.8647875],"study_design_scores_gemma":[0.020680357,0.00017431629,0.0000543555,0.011905955,0.010722459,0.0004787509,0.000015361147,2.439366e-7,0.000044012148,7.250106e-7,0.9555707,0.00035273976],"about_ca_topic_score_codex":0.000017535063,"about_ca_topic_score_gemma":0.000004833213,"teacher_disagreement_score":0.94998187,"about_ca_system_score_codex":0.00019292593,"about_ca_system_score_gemma":0.00073877577,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4200236941","doi":"10.1016/j.ekir.2021.12.020","title":"A Diverse Spectrum of Immune Complex– and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Kidney International Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Mantle cell lymphoma; Medicine; Lymphoma; Kidney; Immune system; Mantle (geology); Pathology; Biopsy; Immunology; Internal medicine; Biology","score_opus":0.014604174724669228,"score_gpt":0.2541822565995089,"score_spread":0.23957808187483964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200236941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97658306,0.0002805409,0.000013125974,0.007573781,0.00033204322,0.00032660793,0.0015654193,0.000052601434,0.013272831],"genre_scores_gemma":[0.9913258,0.0001287417,0.00022361695,0.0023791033,0.00004828429,0.000024323204,0.0044716275,0.000019557241,0.0013789206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832666,0.000026563308,0.00048871606,0.00036067973,0.0006012306,0.00019617002],"domain_scores_gemma":[0.99846834,0.0000805776,0.0004056419,0.0002775643,0.00030428736,0.00046358525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007592124,0.00018437106,0.00038214904,0.000094303046,0.0000628759,0.00003186877,0.000054229742,0.00004565799,0.0028110845],"category_scores_gemma":[0.00057080545,0.00015085463,0.00012512594,0.00014469531,0.00009079417,0.00007391231,0.00011578773,0.000036756028,0.000011675451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017719046,0.0035510047,0.9200733,0.000078243356,0.0018204781,0.009955599,0.00022522088,7.168644e-7,0.0038294499,0.00018292818,0.05963455,0.00047131663],"study_design_scores_gemma":[0.008107719,0.00024678768,0.9334909,0.0004562948,0.0005326248,0.0010342904,0.0002218175,0.00019438322,0.026972024,0.0001500598,0.028393807,0.0001992931],"about_ca_topic_score_codex":0.00029346833,"about_ca_topic_score_gemma":0.00001760106,"teacher_disagreement_score":0.031240745,"about_ca_system_score_codex":0.00024401938,"about_ca_system_score_gemma":0.0006359648,"threshold_uncertainty_score":0.99810046},"labels":[],"label_agreement":null},{"id":"W4200256437","doi":"10.1016/j.annonc.2021.12.002","title":"The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Takeda Oncology; Chugai Pharmaceutical; Genentech; MorphoSys; Ono Pharmaceutical; Sanofi; Kyowa Hakko Kirin; Astellas Pharma; Celltrion; Eisai; Seagen; Pfizer; Incyte; Astex Pharmaceuticals; Alexion Pharmaceuticals; Regeneron Pharmaceuticals; Daiichi-Sankyo; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences; Bayer HealthCare; Celgene; Bristol-Myers Squibb; EUSA Pharma; AstraZeneca; TG Therapeutics; Amgen; Kite Pharma; Meiji Seika Pharma","keywords":"Brentuximab vedotin; Medicine; Oncology; Chemotherapy; Internal medicine; Peripheral T-cell lymphoma; Lymphoma; Peripheral; CD30; Immunology; T cell","score_opus":0.041469251079505644,"score_gpt":0.37409008026651946,"score_spread":0.3326208291870138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200256437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887781,0.00091511686,0.000021210255,0.0036796085,0.000113450355,0.003405718,0.00008059254,0.000008760762,0.0029974277],"genre_scores_gemma":[0.9973146,0.0009766256,0.00045428667,0.00031556629,0.000077769364,0.0004010939,0.00004655671,0.000022016664,0.00039148875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791056,0.00037403838,0.00091307785,0.00029699504,0.00026403874,0.00024127979],"domain_scores_gemma":[0.99614364,0.0018153288,0.0007527872,0.00039265078,0.0008204563,0.00007511736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010047937,0.00018653405,0.0015956769,0.00005810111,0.000062178085,0.000006319749,0.0001059172,0.00010588423,0.00001848673],"category_scores_gemma":[0.0002996594,0.00010942081,0.0003713914,0.00017388967,0.0002584819,0.00002795321,0.00003124678,0.00004450276,6.547086e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9081843,0.042206384,0.000239208,0.000047341433,0.0019936848,0.00006996556,0.0034732225,0.000003291816,0.0010548026,0.00011685427,0.001686844,0.040924136],"study_design_scores_gemma":[0.8464577,0.043225087,0.0007860788,0.00007336475,0.0005754919,0.000018916546,0.0027882806,0.000031791908,0.10335856,0.000044162527,0.0025605408,0.000079983445],"about_ca_topic_score_codex":0.0003018032,"about_ca_topic_score_gemma":0.00011650395,"teacher_disagreement_score":0.10230376,"about_ca_system_score_codex":0.000064779975,"about_ca_system_score_gemma":0.0007376601,"threshold_uncertainty_score":0.4462051},"labels":[],"label_agreement":null},{"id":"W4200321533","doi":"10.1182/bloodadvances.2021006189","title":"Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Orionin Tutkimussäätiö; Academy of Finland; Biocenter Finland; Helsingin Yliopisto","keywords":"Classical Hodgkin lymphoma; Tumor microenvironment; Lymphoma; Protein expression; Outcome (game theory); Cancer research; Hodgkin lymphoma; Oncology; Expression (computer science); Medicine; Internal medicine; Biology; Tumor cells; Computer science; Genetics; Gene","score_opus":0.012840922598093335,"score_gpt":0.25250506780368964,"score_spread":0.2396641452055963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200321533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226797,0.004138582,0.000002939498,0.0024162962,0.000053672702,0.00060250185,0.000013193356,0.000007947869,0.00049688364],"genre_scores_gemma":[0.9977705,0.00018206962,0.0010694274,0.0005050517,0.00004478003,0.0002804172,0.000018411658,0.000010201357,0.00011916086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876153,0.00010719145,0.0003610284,0.00023840168,0.00034640986,0.00018544527],"domain_scores_gemma":[0.9993154,0.000116471645,0.00013511998,0.0003653104,0.000028352255,0.000039373444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011483271,0.00014825712,0.00026808772,0.000023672548,0.000060097158,0.000012471601,0.00011853226,0.000029456598,0.000031323736],"category_scores_gemma":[0.000113477996,0.000068201356,0.00011774861,0.00012121849,0.00009296354,0.000054729295,0.000073969735,0.000053792137,0.000010780941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008771261,0.005565651,0.9672636,0.0000923327,0.000037753507,0.00017143073,0.00028421538,0.000003803667,0.014380064,0.00015175885,0.00008286778,0.011878809],"study_design_scores_gemma":[0.0034480162,0.00023318155,0.69668,0.00019757028,0.00007531175,0.000028691173,0.00029963767,0.0000017362654,0.2893174,0.00009522879,0.009559566,0.00006368003],"about_ca_topic_score_codex":0.0000186939,"about_ca_topic_score_gemma":0.000034879173,"teacher_disagreement_score":0.27493733,"about_ca_system_score_codex":0.00004805199,"about_ca_system_score_gemma":0.000038578222,"threshold_uncertainty_score":0.27811706},"labels":[],"label_agreement":null},{"id":"W4200347843","doi":"10.1016/s2352-3026(21)00349-5","title":"Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials","year":2021,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Lymphoma Research Foundation; Children’s Oncology Group; Irving Medical Center, Columbia University; St. Baldrick's Foundation","keywords":"Pooled analysis; Lymphoma; Meta-analysis; Retrospective cohort study; Survival analysis; Hodgkin lymphoma; MEDLINE; Clinical trial","score_opus":0.019518349032160386,"score_gpt":0.28792850178472795,"score_spread":0.2684101527525676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200347843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952618,0.0021640249,0.000018522653,0.0015299662,0.00007273518,0.00053242524,0.0001231197,0.000016556547,0.00028084638],"genre_scores_gemma":[0.99824065,0.0006278552,0.00015622153,0.000513953,0.00005484818,0.000058925994,0.00031933343,0.000012716808,0.000015483647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778247,0.000818083,0.00050718145,0.00037212923,0.00021655305,0.00030356704],"domain_scores_gemma":[0.99854183,0.0005788145,0.00033182482,0.00038789856,0.00008726273,0.00007235529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380045,0.00018720714,0.0028438955,0.00019292292,0.000037093083,0.000008651501,0.00008799253,0.00013611055,0.000037377995],"category_scores_gemma":[0.0003115954,0.00010893645,0.00015291045,0.0008766921,0.00015764036,0.00002382868,0.00008171962,0.000098287506,0.0000020676584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009568815,0.0020229407,0.98987305,0.00003758486,0.0024571747,0.00045961599,0.00029599844,0.000001989179,0.0000293008,0.0006178447,0.00070051115,0.002547102],"study_design_scores_gemma":[0.017458776,0.0005245255,0.9764385,0.000037337213,0.0048153475,0.00007702885,0.0000761222,0.000011051975,0.00027415474,0.00010561072,0.0000813802,0.000100125806],"about_ca_topic_score_codex":0.00018623605,"about_ca_topic_score_gemma":0.0007500176,"teacher_disagreement_score":0.016501894,"about_ca_system_score_codex":0.00028362658,"about_ca_system_score_gemma":0.00014059867,"threshold_uncertainty_score":0.44422996},"labels":[],"label_agreement":null},{"id":"W4200358412","doi":"10.1182/blood.2021013172","title":"B-lymphoblastic lymphoma presenting as a primary breast mass with periductal invasion","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Primary (astronomy); Lymphoblastic lymphoma; Pathology; Oncology; Internal medicine; Immunology","score_opus":0.007800158083805725,"score_gpt":0.21390528073572543,"score_spread":0.20610512265191971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200358412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826989,0.00078274426,0.00000899531,0.0005918008,0.00008049666,0.00023894856,0.000014871759,0.00008714694,0.015496057],"genre_scores_gemma":[0.99624807,0.00007231064,0.0016949719,0.0004155876,0.0002510425,0.000064656786,0.00010958623,0.00003768762,0.0011061127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986085,0.000035160898,0.00019505729,0.00042522815,0.00041661263,0.0003194099],"domain_scores_gemma":[0.99914294,0.00007422104,0.000066373315,0.00037913243,0.00013107907,0.00020623705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047850088,0.00020857519,0.00031566806,0.000054360968,0.00010911586,0.000059454665,0.00005900498,0.000070440714,0.00021788543],"category_scores_gemma":[0.00004647455,0.00015407865,0.00011012249,0.0002247221,0.00005172986,0.000092491355,0.00007814006,0.000042070333,0.00014592703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046270312,0.010541182,0.89856917,0.00050361716,0.0012795103,0.025076143,0.0005899476,0.000004400592,0.05041709,0.000469814,0.00041960226,0.011666793],"study_design_scores_gemma":[0.02315124,0.00057079794,0.8166073,0.0006199548,0.0011687605,0.034411203,0.00040489555,0.000026165912,0.12155103,0.00006192711,0.0011150446,0.00031170298],"about_ca_topic_score_codex":0.000049494352,"about_ca_topic_score_gemma":0.0000066633547,"teacher_disagreement_score":0.081961915,"about_ca_system_score_codex":0.00013314249,"about_ca_system_score_gemma":0.0006868974,"threshold_uncertainty_score":0.6283145},"labels":[],"label_agreement":null},{"id":"W4200362073","doi":"10.1101/2021.12.01.21267132","title":"Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Instituto de Salud Carlos III; NIHR Maudsley Biomedical Research Centre; National Institutes of Health; Moonshot Research and Development Program; Kementerian Kesihatan Malaysia; Versus Arthritis; Kanae Foundation for the Promotion of Medical Science; Astellas Pharma; National Institute for Health and Care Research; Ministerio de Ciencia e Innovación; Vetenskapsrådet; Fonds National de la Recherche Luxembourg; King's College London; Qatar National Research Fund; Qatar Foundation; Department of Health and Social Care; Japan Agency for Medical Research and Development; South London and Maudsley NHS Foundation Trust; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research","keywords":"Genome-wide association study; Genetic association; Genetic genealogy; Biology; Rheumatoid arthritis; Genetics; Genetic architecture; Candidate gene; Computational biology; Evolutionary biology; Gene; Genotype; Single-nucleotide polymorphism; Medicine; Phenotype; Population; Immunology","score_opus":0.02462211877773814,"score_gpt":0.26667705226155985,"score_spread":0.2420549334838217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200362073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997533,0.005831559,0.0005756404,0.00089031615,0.0009405215,0.001477343,0.00004504106,0.00007736388,0.00018685532],"genre_scores_gemma":[0.9885067,0.008861085,0.0010742147,0.0002152643,0.00008134121,0.0007957758,0.00017481181,0.000054237637,0.00023657078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970299,0.00014227975,0.00079873146,0.0008643651,0.0007579145,0.00040682522],"domain_scores_gemma":[0.9984949,0.00021104816,0.0003178785,0.0006729374,0.00015997989,0.00014324952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005088345,0.00040962093,0.0010088243,0.00020985858,0.000070302674,0.00015126758,0.00018755622,0.00035688924,0.00027507392],"category_scores_gemma":[0.00027906804,0.0004056982,0.00028355402,0.00022394292,0.00002062625,0.00005926487,0.00018912806,0.00043064854,0.000027925877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021751925,0.0030874829,0.98957735,0.00015307376,0.0005896692,0.0010172485,0.0024584047,0.00012528265,0.0012885042,0.000005810738,0.000030113,0.0016453235],"study_design_scores_gemma":[0.0043652323,0.00016633508,0.99041593,0.0008379353,0.00017221418,0.000018704159,0.0012773755,0.000029087476,0.0020613943,0.00021922233,0.00013174099,0.00030484927],"about_ca_topic_score_codex":0.00077856577,"about_ca_topic_score_gemma":0.0022000936,"teacher_disagreement_score":0.0043434803,"about_ca_system_score_codex":0.0008422372,"about_ca_system_score_gemma":0.00035919377,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W4200371186","doi":"10.1101/2021.12.05.21267216","title":"Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Biology; Somatic hypermutation; Lymphoma; Germline mutation; Cancer research; Gene; Mutation; Genetics; B cell; Immunology; Antibody","score_opus":0.013156193513097603,"score_gpt":0.24990268470868734,"score_spread":0.23674649119558974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200371186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934072,0.0038256256,0.0000030292597,0.00050566095,0.0004973541,0.0006020646,0.00002061466,0.000045902518,0.0010925482],"genre_scores_gemma":[0.98767036,0.010209997,0.00041112938,0.000814208,0.00034947126,0.00028746694,0.00014111624,0.00003396828,0.00008227307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812466,0.00007226396,0.0004951787,0.00069959654,0.0002386965,0.00036960983],"domain_scores_gemma":[0.99877286,0.00014136198,0.00015405874,0.00062798965,0.000108659544,0.00019506646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013787908,0.00038934554,0.0007292346,0.00030762094,0.000034468907,0.00003944273,0.00011526293,0.00046548716,0.000062170635],"category_scores_gemma":[0.00017172312,0.0003134531,0.00015317577,0.00018698176,0.000053219326,0.00002172783,0.00034260828,0.0002324202,0.000044396693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007875098,0.0006148388,0.9759458,0.00034892774,0.00006672446,0.0017250981,0.00036989132,0.000008918469,0.000028046843,0.00007338178,0.00007988897,0.02065974],"study_design_scores_gemma":[0.0034694797,0.00036290957,0.9943981,0.000246163,0.00021738719,0.00016386677,0.00007436643,0.00008192329,0.0003270075,0.00007478405,0.0003296538,0.0002543431],"about_ca_topic_score_codex":0.00040990408,"about_ca_topic_score_gemma":0.00018679911,"teacher_disagreement_score":0.020405395,"about_ca_system_score_codex":0.0002844674,"about_ca_system_score_gemma":0.00032776786,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W4200378581","doi":"10.1016/j.clml.2021.12.016","title":"Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pharmacyclics; MorphoSys; Genentech; AstraZeneca; Celgene; Gilead Sciences; Astellas Pharma; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Internal medicine; Oncology; Refractory (planetary science); Chemoimmunotherapy; Diffuse large B-cell lymphoma; Adverse effect; Population; Nausea; Lymphoma; Gastroenterology; Rituximab","score_opus":0.01333812479618569,"score_gpt":0.29545439313857635,"score_spread":0.2821162683423907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200378581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969879,0.00064516376,5.5892644e-7,0.00029553316,0.000085829,0.0017557772,0.00018496325,0.000013080476,0.00003121304],"genre_scores_gemma":[0.9991072,0.00031180526,0.000027163684,0.00032893452,0.000030627445,0.00006222348,0.00006252583,0.000035418754,0.000034145727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960728,0.0010312482,0.0012187519,0.0006717788,0.0006905136,0.00031485423],"domain_scores_gemma":[0.9939431,0.0036384247,0.0005951858,0.0011787526,0.00035052368,0.00029400553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796771,0.00040206697,0.0015557237,0.00014820579,0.000102128106,0.000019051526,0.00022455849,0.00014829838,0.000019003302],"category_scores_gemma":[0.0012327303,0.00019088246,0.00041097938,0.0010416149,0.00035491146,0.000058830894,0.00022952832,0.000113355505,0.0000010724107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029082589,0.025021968,0.79385537,0.00009639066,0.0014583827,0.000075813536,0.00030124997,0.000002755256,0.000027980695,0.000032593765,0.000013750223,0.15003115],"study_design_scores_gemma":[0.11113294,0.007407922,0.8775574,0.00024943822,0.0025118582,0.0000022202257,0.000115583076,0.00011680732,0.0006441463,0.0000030831814,0.00010000991,0.00015862416],"about_ca_topic_score_codex":0.00016875053,"about_ca_topic_score_gemma":0.00009480126,"teacher_disagreement_score":0.14987253,"about_ca_system_score_codex":0.00028306743,"about_ca_system_score_gemma":0.00082075445,"threshold_uncertainty_score":0.77839607},"labels":[],"label_agreement":null},{"id":"W4200391276","doi":"10.3390/curroncol28060431","title":"A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Red pulp; Splenic marginal zone lymphoma; Pathology; Chemoimmunotherapy; CD5; Lymphocytosis; Rituximab; Mantle cell lymphoma; Immunophenotyping; Bone marrow; Splenectomy; Hairy cell leukemia; CD20; Lymphoma; White pulp; Spleen; Immunology; Leukemia; Antigen","score_opus":0.21028361971298307,"score_gpt":0.4393622010460383,"score_spread":0.22907858133305523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200391276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002466285,0.9883646,8.2595585e-7,0.0005479373,0.002266873,0.0029641427,0.000084913336,0.000090574686,0.0056554726],"genre_scores_gemma":[0.0000027895226,0.9933521,0.00008583287,0.0010936679,0.00069876155,0.0019052024,0.0019096368,0.00010580506,0.0008461742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960133,0.00065266155,0.0012552461,0.0011371847,0.00029674117,0.00064485363],"domain_scores_gemma":[0.99672425,0.00061590935,0.0007482914,0.0012940721,0.00016439593,0.0004530972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003033784,0.0009036918,0.005702012,0.00023876686,0.0000774485,0.000021648671,0.0003096619,0.00057967636,0.0005645578],"category_scores_gemma":[0.00029650252,0.00062931475,0.0019424794,0.0004911959,0.00008004449,0.000019915582,0.00022193267,0.00043849373,0.0012765165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013241233,0.010353165,0.00002104205,0.094907574,0.00031462242,0.0007950112,0.000011122187,2.8490732e-9,3.56392e-8,0.000067060224,0.07827157,0.81524557],"study_design_scores_gemma":[0.0046376265,0.0009369115,0.000017210099,0.19594097,0.008241875,0.0006848347,0.0000033580409,3.6994058e-7,0.0000011631419,0.0000033898607,0.7891656,0.00036668815],"about_ca_topic_score_codex":0.0000074761447,"about_ca_topic_score_gemma":0.000008624015,"teacher_disagreement_score":0.8148789,"about_ca_system_score_codex":0.002538363,"about_ca_system_score_gemma":0.002678979,"threshold_uncertainty_score":0.9996158},"labels":[],"label_agreement":null},{"id":"W4200436075","doi":"10.1002/cncr.34065","title":"Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population‐based cohort","year":2021,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Breast cancer; Radiation therapy; Odds ratio; Internal medicine; Interquartile range; Malignancy; Cancer; Population; Oncology; Male breast cancer; Epidemiology; Cancer registry; Cohort; Gynecology","score_opus":0.016548457573603848,"score_gpt":0.2964335296124172,"score_spread":0.27988507203881335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200436075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348843,0.0032154869,0.0000043564187,0.0006964972,0.00008793607,0.0010409254,0.0013589287,0.000029321258,0.00007814318],"genre_scores_gemma":[0.9942968,0.0015297469,0.00038428413,0.00073393434,0.00010767352,0.0016234831,0.0012057425,0.000023642628,0.00009467747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875766,0.00006485294,0.00034984294,0.00041810382,0.0001834086,0.00022611368],"domain_scores_gemma":[0.9989394,0.00031200555,0.00021139304,0.00029516136,0.0001551974,0.00008682372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012717137,0.00017500471,0.0004835067,0.000083102816,0.00003826879,0.000012898429,0.000045599,0.00010900741,0.00007889769],"category_scores_gemma":[0.00008828641,0.00012550993,0.00008249754,0.0003097654,0.000033569337,0.00004618936,0.0000064137894,0.000036827867,7.452957e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066084336,0.0005658205,0.8494222,0.00002113226,0.00016600484,0.00010506892,0.0003514505,0.00023630926,0.00027611485,0.000004243705,0.00039973287,0.14184347],"study_design_scores_gemma":[0.037645508,0.0004410375,0.9541064,0.0002637217,0.00010837989,0.0000065252552,0.00009027013,0.0000977432,0.0065768296,0.000014994454,0.0005210367,0.0001275676],"about_ca_topic_score_codex":0.008520876,"about_ca_topic_score_gemma":0.0015972698,"teacher_disagreement_score":0.1417159,"about_ca_system_score_codex":0.0015694367,"about_ca_system_score_gemma":0.0008527509,"threshold_uncertainty_score":0.99808145},"labels":[],"label_agreement":null},{"id":"W4200579559","doi":"10.1016/s2152-2650(21)01540-8","title":"Poster: IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Follicular phase; Medicine; Oncology; Internal medicine; Lymphoma; Medical physics","score_opus":0.052081749084664515,"score_gpt":0.3529540528641047,"score_spread":0.3008723037794402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200579559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916086,0.0024976623,0.000028023007,0.00072495895,0.0017519572,0.0020799267,0.00033679308,0.00033466867,0.0006373926],"genre_scores_gemma":[0.9900986,0.00034023236,0.0023288638,0.0018100558,0.0013007164,0.00041291866,0.0032989637,0.00014974983,0.0002599001],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99146456,0.00079523394,0.0030778134,0.0024853197,0.0010272503,0.0011498175],"domain_scores_gemma":[0.99298406,0.0028563035,0.0006601936,0.0021794601,0.00029605537,0.001023915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054629997,0.00094104785,0.0024489625,0.00019327614,0.00028201417,0.00023597301,0.00053378363,0.0010246718,0.00076248],"category_scores_gemma":[0.0031362593,0.0008497637,0.0011676613,0.00096151937,0.00042749828,0.0003668361,0.00044212438,0.00033196877,0.00050434953],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08327125,0.022204762,0.13186967,0.000034283545,0.0013378437,0.023058234,0.0018928288,0.00001155755,0.0068025608,0.000053343898,0.0023924946,0.72707117],"study_design_scores_gemma":[0.3882185,0.0012215738,0.57824457,0.00054405245,0.00050579675,0.00011861883,0.00027435485,0.0017037297,0.01861993,0.00013754987,0.009738466,0.0006728931],"about_ca_topic_score_codex":0.0030666683,"about_ca_topic_score_gemma":0.00023035839,"teacher_disagreement_score":0.7263983,"about_ca_system_score_codex":0.0034059535,"about_ca_system_score_gemma":0.0035517723,"threshold_uncertainty_score":0.9993953},"labels":[],"label_agreement":null},{"id":"W4200580093","doi":"10.1016/j.prro.2021.11.010","title":"Is Radiation Therapy Cost-Effective in the Positron Emission Tomography/Computed Tomography Era for Early-Stage Favorable Hodgkin Lymphoma With Alternative Payment Models?","year":2021,"lang":"en","type":"article","venue":"Practical Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Positron emission tomography; Stage (stratigraphy); Positron Emission Tomography-Computed Tomography; Lymphoma; Hodgkin lymphoma; Computed tomography; Radiation therapy; Tomography; Radiology; Nuclear medicine; Medical physics; Internal medicine","score_opus":0.03693874571114818,"score_gpt":0.3617080702972828,"score_spread":0.3247693245861346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200580093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93780607,0.00226872,0.019241348,0.028427407,0.00033941123,0.008649169,0.00009157327,0.00008110081,0.003095192],"genre_scores_gemma":[0.9872867,0.0010892214,0.0034788419,0.004620676,0.00017125814,0.0030124623,0.00025454626,0.000027887294,0.00005841479],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99760896,0.0006390039,0.00037283148,0.00056212133,0.0004198109,0.0003972877],"domain_scores_gemma":[0.99666595,0.002304353,0.00028624447,0.0003034388,0.00026921555,0.0001707782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005406336,0.00026819436,0.00045945696,0.00024289775,0.00017313632,0.00008218546,0.00008586095,0.00020699512,0.00005751934],"category_scores_gemma":[0.00015492817,0.00017743037,0.0001997756,0.0006854392,0.00006940486,0.00037407494,0.000022699785,0.00019782949,0.000006612503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080192685,0.011381248,0.16229552,0.00006146996,0.0014246698,0.00063012843,0.007640857,0.0010066975,0.0006805345,0.011870859,0.0026726036,0.79231614],"study_design_scores_gemma":[0.034542162,0.009297531,0.778632,0.00009496387,0.00042756766,0.00021099765,0.00074927614,0.046313733,0.032286987,0.0018368879,0.095198564,0.00040934127],"about_ca_topic_score_codex":0.00028825924,"about_ca_topic_score_gemma":0.000039228715,"teacher_disagreement_score":0.7919068,"about_ca_system_score_codex":0.00082890823,"about_ca_system_score_gemma":0.0005645953,"threshold_uncertainty_score":0.72354},"labels":[],"label_agreement":null},{"id":"W4205157347","doi":"10.1259/bjr.20191041","title":"Maxillofacial lymphomas","year":2020,"lang":"en","type":"review","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Radiation therapy; Radiology; Lymphoma; Magnetic resonance imaging; Biopsy; Pathology","score_opus":0.0334916355622928,"score_gpt":0.3150214460859141,"score_spread":0.2815298105236213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205157347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043911823,0.99715346,0.0000063981297,0.00018300091,0.0008408073,0.0003087558,0.00005681876,0.000014884981,0.0013919364],"genre_scores_gemma":[0.000031069147,0.9978754,0.00045069883,0.00026404334,0.0011210138,0.000015081133,0.0000501053,0.00004582705,0.0001467805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802864,0.00017061862,0.0010592667,0.000247981,0.0002186347,0.00027488265],"domain_scores_gemma":[0.99848104,0.00009603173,0.00081490085,0.00013934723,0.00012123659,0.00034744575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018725632,0.00029480908,0.0035206259,0.00015684198,0.00005050152,0.00003273912,0.0002021117,0.00040227323,0.00031087204],"category_scores_gemma":[0.0002586118,0.00025129333,0.0013949068,0.00016882543,0.0001055196,0.000043670534,0.00004522694,0.0004036487,0.00011100728],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027689968,0.0001592911,0.000063687505,0.0015451495,0.0011031999,0.053860225,0.000009832179,3.578453e-8,7.934598e-8,0.000053204913,0.017685529,0.92549205],"study_design_scores_gemma":[0.0011332674,0.00046949176,0.0001947967,0.0053210747,0.001763138,0.4381517,0.0000029204934,9.829868e-8,1.7981048e-7,0.000015269754,0.55285203,0.00009606398],"about_ca_topic_score_codex":0.00002332916,"about_ca_topic_score_gemma":0.0000015443629,"teacher_disagreement_score":0.925396,"about_ca_system_score_codex":0.0004561589,"about_ca_system_score_gemma":0.0012161802,"threshold_uncertainty_score":0.9999939},"labels":[],"label_agreement":null},{"id":"W4205286061","doi":"10.1182/bloodadvances.2021006208","title":"Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institute of Nursing Research; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Eye Institute; National Institute on Aging; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research; National Institutes of Health; Government of Alberta; Agency for Healthcare Research and Quality; National Center for Advancing Translational Sciences; Health Resources and Services Administration; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institute on Minority Health and Health Disparities; National Center for Research Resources; Centers for Disease Control and Prevention","keywords":"Lymphoma; Medicine; Internal medicine; Confidence interval; Cohort; Oncology; Anaplastic large-cell lymphoma; Human immunodeficiency virus (HIV); Pediatrics; Immunology","score_opus":0.009679304087547386,"score_gpt":0.26335519745897956,"score_spread":0.25367589337143215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205286061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800854,0.016655756,0.00000987065,0.0005661956,0.00004260309,0.0009217727,0.00009321247,0.000032003558,0.0015932315],"genre_scores_gemma":[0.9888914,0.00042024438,0.008935868,0.00050921657,0.000018026054,0.0005821182,0.00003562153,0.000024869714,0.00058262114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987972,0.00003562629,0.00020300996,0.00048435174,0.00020241749,0.00027739463],"domain_scores_gemma":[0.99933475,0.00021489116,0.00009360886,0.0001593908,0.000030822823,0.00016652622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009888971,0.00026003187,0.0006273279,0.00012795362,0.0002096808,0.000039273655,0.000050371033,0.000035026063,0.000012697918],"category_scores_gemma":[0.000013661985,0.00019010039,0.000032747117,0.0001833315,0.000059236147,0.000120166886,0.00010742038,0.00006232816,0.0000014156917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005203571,0.0007523077,0.9932923,0.00019279456,0.00007915535,0.000034400728,0.0030073149,0.000041755586,0.00031777407,0.0003501975,0.00009971689,0.0013119419],"study_design_scores_gemma":[0.04188813,0.0034904962,0.91989535,0.0001937642,0.00061053486,0.0003782671,0.010278542,0.000121547404,0.00836272,0.0002124413,0.014026594,0.0005416002],"about_ca_topic_score_codex":0.00007782361,"about_ca_topic_score_gemma":0.00023083323,"teacher_disagreement_score":0.07339692,"about_ca_system_score_codex":0.00006703698,"about_ca_system_score_gemma":0.000084774685,"threshold_uncertainty_score":0.7752069},"labels":[],"label_agreement":null},{"id":"W4205536854","doi":"10.1111/bjh.18016","title":"Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Medicine; Positron emission tomography; Lymphoma; Standardized uptake value; Thresholding; Nuclear medicine; Bone marrow; Follicular lymphoma; Stage (stratigraphy); Diffuse large B-cell lymphoma; Receiver operating characteristic; Radiology; Pathology; Internal medicine; Biology","score_opus":0.02800837093846967,"score_gpt":0.31771224054511343,"score_spread":0.28970386960664374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205536854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08019291,0.917205,0.0000010864934,0.00012425173,0.0013261584,0.00078466366,0.000121385754,0.00001650168,0.00022809293],"genre_scores_gemma":[0.0064342986,0.9920212,0.00017670543,0.000077403805,0.00022412134,0.00023546745,0.00008244061,0.00007653932,0.0006717913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960857,0.00059111946,0.001887869,0.00046855476,0.00043501996,0.0005317498],"domain_scores_gemma":[0.997703,0.000341513,0.001290674,0.00032309038,0.00008455132,0.00025714075],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003554904,0.00053930946,0.0059297006,0.0005678399,0.00011536429,0.000073361814,0.00026765736,0.00030000374,0.0016811668],"category_scores_gemma":[0.00012801583,0.00040173528,0.0015203493,0.00031617578,0.000113077826,0.00012580017,0.00014527566,0.00034909655,0.0000911325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005601956,0.0027962893,0.008054934,0.003408194,0.0014352079,0.20624998,0.000069811904,4.6800517e-7,1.0801526e-7,0.00008133799,0.0018107772,0.77603686],"study_design_scores_gemma":[0.0026719456,0.00038010234,0.0099645965,0.005631787,0.0025725162,0.47367018,0.000036841207,6.453664e-7,0.0000037664747,0.000025273483,0.5048356,0.00020673798],"about_ca_topic_score_codex":0.0014981412,"about_ca_topic_score_gemma":0.0004244228,"teacher_disagreement_score":0.77583015,"about_ca_system_score_codex":0.0011792198,"about_ca_system_score_gemma":0.0017210963,"threshold_uncertainty_score":0.9998435},"labels":[],"label_agreement":null},{"id":"W4205555576","doi":"10.1038/s41598-021-04736-0","title":"Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Simon Fraser University; Université de Montréal; McGill University; Jewish General Hospital","funders":"Michael Smith Health Research BC; Cole Foundation; Generalitat de Catalunya; Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"MAPK/ERK pathway; Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Mutant; Downregulation and upregulation; Mutation; Biology; Cell growth; Signal transduction; Immunology; Cell biology; Genetics; Gene","score_opus":0.009467316650790777,"score_gpt":0.23511025509246253,"score_spread":0.22564293844167174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205555576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617374,0.00018860448,0.0000043838686,0.0002539332,0.0010054365,0.00083058886,0.000006257255,0.00006282154,0.0014742502],"genre_scores_gemma":[0.9963341,0.000005455077,0.00012589387,0.000093570336,0.000026791404,0.000276026,0.00020046861,0.000019566045,0.002918152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997913,0.00009570363,0.00043845843,0.0006209824,0.0006062745,0.00032556057],"domain_scores_gemma":[0.9989591,0.000061028026,0.00036891148,0.00043204616,0.000064184766,0.00011470575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011530787,0.00013964887,0.00024020742,0.0002329949,0.00054365984,0.00008896185,0.00004201754,0.000052166026,0.000115538554],"category_scores_gemma":[0.00019259809,0.00012620282,0.0000647916,0.00054043165,0.000047657348,0.00013664778,0.00013912068,0.00010915733,0.0000060527686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013573637,0.020390991,0.855452,0.0001392616,0.00008580134,0.004921168,0.0065402137,0.000017820845,0.09210369,0.000064553125,0.0089947535,0.011153999],"study_design_scores_gemma":[0.022812765,0.000604478,0.78173554,0.00023006868,0.0001396051,0.000646889,0.0032840227,0.0006220271,0.12253274,0.0013014794,0.06551176,0.0005786423],"about_ca_topic_score_codex":0.00021550432,"about_ca_topic_score_gemma":0.00003643266,"teacher_disagreement_score":0.0737165,"about_ca_system_score_codex":0.0008425195,"about_ca_system_score_gemma":0.0002923201,"threshold_uncertainty_score":0.5146402},"labels":[],"label_agreement":null},{"id":"W4205735812","doi":"10.1182/blood-2018-99-114502","title":"Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Brentuximab vedotin; Refractory (planetary science); Oncology; Phases of clinical research; Clinical trial; Lymphoma; Surgery; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.016509765708378265,"score_gpt":0.2847018162377192,"score_spread":0.2681920505293409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205735812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543124,0.0005119068,8.5124464e-7,0.00056134484,0.00026510702,0.002534235,0.00007430321,0.00010379515,0.0005171855],"genre_scores_gemma":[0.99774253,0.000031842064,0.00039561928,0.00036953465,0.00031400804,0.0007056298,0.00021277709,0.00006351017,0.00016451594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972831,0.00022506613,0.00049516564,0.0007710906,0.00072754663,0.000498033],"domain_scores_gemma":[0.99804586,0.00017399582,0.0002313738,0.0009602926,0.00015765232,0.0004308475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014872036,0.00048589119,0.00066548144,0.00009419304,0.00023558874,0.00007441365,0.0001939677,0.00015516496,0.00012455402],"category_scores_gemma":[0.00011014442,0.0002587827,0.00013260287,0.00035235574,0.00027050063,0.00015115549,0.00008319929,0.00010891027,0.000075345466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026777745,0.09161808,0.85241276,0.000008069815,0.00092794484,0.00045678983,0.0017784281,4.3001688e-8,0.00012725503,0.00001753811,0.00095554243,0.049019776],"study_design_scores_gemma":[0.18792346,0.02338442,0.778821,0.0002075202,0.0012087328,0.000006723427,0.0003886325,0.000011722232,0.005074094,0.00004061361,0.0026780185,0.0002550699],"about_ca_topic_score_codex":0.0004702712,"about_ca_topic_score_gemma":0.00052864273,"teacher_disagreement_score":0.18524568,"about_ca_system_score_codex":0.00044572164,"about_ca_system_score_gemma":0.000603104,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W4206037028","doi":"10.1017/cjn.2021.367","title":"P.089 A report of a patient presenting with orbital apex syndrome secondary to NK cell lymphoma (nasal type)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Biopsy; Etiology; Work-up; Radiology; Pathology","score_opus":0.01945306688395988,"score_gpt":0.24856160441232542,"score_spread":0.22910853752836555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206037028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902344,0.001254485,0.0000049543532,0.0030903572,0.00053836335,0.00020536958,0.000011100339,0.000011202113,0.004649788],"genre_scores_gemma":[0.9941621,0.000089244335,0.0034542496,0.0021139807,0.00009818286,0.0000036315705,9.0650536e-7,0.0000130207845,0.00006467964],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99583554,0.0004136279,0.0010438861,0.00060294283,0.0010221155,0.0010819001],"domain_scores_gemma":[0.9952612,0.00035828372,0.0008510223,0.0002255494,0.0009840564,0.002319883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014044334,0.0003149008,0.0007207013,0.0006660165,0.0010094246,0.00032444834,0.00068290805,0.00013572953,0.00022129717],"category_scores_gemma":[0.001455518,0.00019533139,0.0002477882,0.0017021158,0.002248808,0.00048349478,0.00009631601,0.00047516232,0.000003606591],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015523376,0.00019973802,0.74080217,0.00002128632,0.000038913586,0.25552687,0.00036962086,0.000602913,0.0001162778,0.000067468856,0.00049168407,0.0016077898],"study_design_scores_gemma":[0.0008758867,0.0839602,0.41084063,0.00011040833,0.000109429304,0.49823827,0.00043301552,0.0000755004,0.0024478193,0.0005833866,0.0020796931,0.0002457854],"about_ca_topic_score_codex":0.001451589,"about_ca_topic_score_gemma":0.017364763,"teacher_disagreement_score":0.32996157,"about_ca_system_score_codex":0.00029458312,"about_ca_system_score_gemma":0.010200949,"threshold_uncertainty_score":0.99541026},"labels":[],"label_agreement":null},{"id":"W4206197791","doi":"10.3389/fonc.2021.770988","title":"Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Priority Academic Program Development of Jiangsu Higher Education Institutions; Government of Jiangsu Province; Science and Technology Program of Suzhou; National Natural Science Foundation of China; National Science and Technology Major Project; York University","keywords":"Rituximab; Mantle cell lymphoma; Medicine; Lymphoma; Oncology; Overall survival; Internal medicine","score_opus":0.01692242014179655,"score_gpt":0.3180191809114163,"score_spread":0.3010967607696197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206197791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493796,0.0001628496,0.0000012066439,0.0007074646,0.0008758298,0.0015265348,0.00010211557,0.0000114243785,0.0016746415],"genre_scores_gemma":[0.99812853,0.00037655066,0.00006815789,0.0004234778,0.000028315895,0.00060041796,0.000105670166,0.000019287354,0.00024960347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979347,0.0005954524,0.00047849742,0.00036641964,0.00031476113,0.0003101688],"domain_scores_gemma":[0.99924725,0.00022479244,0.00017216394,0.00027805165,0.000014624506,0.00006309073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030782944,0.00023413685,0.0008315235,0.0003609181,0.000104457096,0.000004408817,0.0001646533,0.00006645578,0.000043213953],"category_scores_gemma":[0.000017509472,0.00015451081,0.00009455329,0.00026458796,0.00006922077,0.00003607335,0.0002219195,0.00015786757,0.0000019423057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010952608,0.016474215,0.9651923,0.000022106482,0.00017446394,0.00070572924,0.0058937185,0.0000050002977,0.0000013492781,0.0000048036145,0.00094954704,0.009481465],"study_design_scores_gemma":[0.047104746,0.0034119284,0.9432811,0.000009265933,0.00016521731,0.0000099270665,0.00477624,0.000036129342,0.000011600827,0.000024091862,0.0010635853,0.000106130065],"about_ca_topic_score_codex":0.0037007802,"about_ca_topic_score_gemma":0.0054307817,"teacher_disagreement_score":0.04600949,"about_ca_system_score_codex":0.0024132608,"about_ca_system_score_gemma":0.000089392495,"threshold_uncertainty_score":0.6310593},"labels":[],"label_agreement":null},{"id":"W4206340164","doi":"10.21065/19257430.2.180","title":"HODGKIN'S LYMPHOMA THERAPY OF A FEMALE IN HOSPITAL OF ISLAMABAD, PAKISTAN; A CASE REPORT","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Applied Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Etiology; Lymphoma; Hodgkin lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.02296073238223709,"score_gpt":0.28892802058565115,"score_spread":0.26596728820341403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206340164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908732,0.0017230241,0.000002549217,0.00027768064,0.00017599532,0.0001821997,0.000008058356,0.0000013111,0.006755952],"genre_scores_gemma":[0.999035,0.00005224577,0.000744187,0.000067163615,0.000074585485,0.0000055377095,6.9269134e-7,0.000005763976,0.000014830657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987176,0.00001471832,0.0005495129,0.000114673414,0.00029471467,0.00030879446],"domain_scores_gemma":[0.99879926,0.00006323944,0.00044978765,0.00014700567,0.000108798544,0.00043192136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081555016,0.00010398606,0.00036922723,0.0003583495,0.00006475332,0.000014380118,0.000118361335,0.00004892926,0.000073387506],"category_scores_gemma":[0.000039184608,0.00007296821,0.00010482782,0.00045239212,0.00039404974,0.00011393091,0.0000066451657,0.000045419067,0.0000013758765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001362226,0.0009923892,0.911412,0.000035191802,0.00013989987,0.037347972,0.011607422,0.000015988175,0.0010734908,0.003754932,0.0005461256,0.032938357],"study_design_scores_gemma":[0.008429408,0.0031074637,0.8566858,0.0003488025,0.000113652226,0.06098621,0.019249175,0.000012965875,0.045225434,0.0005155452,0.00499105,0.00033447726],"about_ca_topic_score_codex":0.006813041,"about_ca_topic_score_gemma":0.0040969662,"teacher_disagreement_score":0.05472619,"about_ca_system_score_codex":0.0001944393,"about_ca_system_score_gemma":0.0021533566,"threshold_uncertainty_score":0.9998007},"labels":[],"label_agreement":null},{"id":"W4206514610","doi":"10.1002/9781444300857.ch42","title":"Follicular Lymphoma","year":2008,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Follicular lymphoma; Information retrieval; Computer science; Biology; Lymphoma; Immunology","score_opus":0.012898704592097293,"score_gpt":0.24767896643319076,"score_spread":0.23478026184109346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206514610","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016777318,0.005298639,0.000007701252,0.00024284,0.0001434675,0.0003383028,0.0000102557815,0.00029819412,0.99349284],"genre_scores_gemma":[0.0012280939,0.0032933971,0.0011046751,0.00088096375,0.00034989466,0.000053885142,0.0000924801,0.00031026584,0.99268633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993166,0.0000062521826,0.00009726062,0.00023528101,0.00019090627,0.00015373107],"domain_scores_gemma":[0.9994547,0.000008148777,0.000044322638,0.00036349625,0.000010911878,0.00011843034],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000009242743,0.0002006613,0.00035969814,0.000115678355,0.000015892188,0.000004702475,0.000037863207,0.00021235588,0.01101774],"category_scores_gemma":[0.0000050766225,0.00013288327,0.00018064701,0.00006098709,0.000028751349,0.0000048906845,0.000017993043,0.000018414186,0.002925037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058011337,0.00039669278,0.0027438186,0.000029491339,0.00033202666,0.0010467964,0.0000056620524,6.897433e-9,0.0000014124994,0.0003263445,0.98056704,0.014544937],"study_design_scores_gemma":[0.0025255918,0.000089890855,0.004869416,0.00015839495,0.00016994007,0.00032532346,0.0000031585068,0.0000010778992,0.000183284,0.0000036853396,0.99153966,0.00013060728],"about_ca_topic_score_codex":0.0006857057,"about_ca_topic_score_gemma":0.000032444557,"teacher_disagreement_score":0.014414329,"about_ca_system_score_codex":0.000102132035,"about_ca_system_score_gemma":0.00010450109,"threshold_uncertainty_score":0.9978513},"labels":[],"label_agreement":null},{"id":"W4206901398","doi":"10.1158/1078-0432.ccr-21-3284","title":"Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Radioligand; CXCR4; Medicine; Mantle cell lymphoma; Cancer research; Chemokine receptor; Biodistribution; Lymphoma; Pathology; Receptor; Internal medicine; Chemokine; Biology; In vivo","score_opus":0.20004507388978945,"score_gpt":0.4930952004430603,"score_spread":0.2930501265532709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206901398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96972466,0.026665512,0.0000054578577,0.0018976593,0.00048490395,0.00076196756,0.000042679036,0.000027803037,0.00038933964],"genre_scores_gemma":[0.9850625,0.011506739,0.0006806852,0.0006896888,0.00086575944,0.00032646942,0.00005379648,0.00004852159,0.0007658625],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979751,0.00021202349,0.0003842326,0.0004886815,0.00047661376,0.00046335327],"domain_scores_gemma":[0.99831676,0.00085778267,0.0000844311,0.0002647299,0.00025440857,0.00022190475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020935736,0.00012984262,0.00035957107,0.0001050133,0.00048575638,0.00003464567,0.00012261956,0.000056082245,0.0006979833],"category_scores_gemma":[0.00026168535,0.00010690327,0.000113982765,0.0002903024,0.00017111887,0.000049646966,0.00019299284,0.00027397063,0.000006959846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007744016,0.0037060485,0.44666052,0.00024020125,0.00028015432,0.00014006226,0.00046795356,0.000024703084,0.03854071,0.0000504994,0.096811555,0.40533358],"study_design_scores_gemma":[0.026764676,0.0032407364,0.031221516,0.00011853133,0.00009141921,0.000035752273,0.000873575,0.004142563,0.018481465,0.0001341166,0.9145459,0.0003497547],"about_ca_topic_score_codex":0.00027459158,"about_ca_topic_score_gemma":0.0000012516799,"teacher_disagreement_score":0.81773436,"about_ca_system_score_codex":0.0005472145,"about_ca_system_score_gemma":0.00063324964,"threshold_uncertainty_score":0.7642428},"labels":[],"label_agreement":null},{"id":"W4210397531","doi":"10.3390/cancers14030791","title":"The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Diffuse large B-cell lymphoma; Internal medicine; Adverse effect; Lymphoma; Nausea; Lactate dehydrogenase; Oncology; Lymphocyte; Refractory (planetary science); Gastroenterology","score_opus":0.008747672830980513,"score_gpt":0.24452394255207904,"score_spread":0.23577626972109852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210397531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678993,0.00076373364,2.2606586e-7,0.001214496,0.000066001005,0.0009821638,0.000081066384,0.0000030409842,0.00009936251],"genre_scores_gemma":[0.9989305,0.0004972731,0.0000015043518,0.0002903229,0.000034306046,0.00019684406,0.000016680671,0.0000057164593,0.000026867658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900526,0.0002611526,0.0002389916,0.000118069154,0.00024339758,0.00013310302],"domain_scores_gemma":[0.99873763,0.0009255231,0.00014047677,0.00015490575,0.000019486957,0.000021989832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006881091,0.00007523923,0.00019998284,0.000023530898,0.00016759234,0.000013783889,0.00006361864,0.000017818928,0.0000028273093],"category_scores_gemma":[0.00010230985,0.000036081165,0.000023659939,0.00013125532,0.00003844952,0.0000125400375,0.000067280205,0.00007411436,2.5054075e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056984735,0.0012324936,0.9688955,0.000009418502,0.000076735996,0.00001199132,0.012760182,0.00000374405,0.0000026551952,0.000056010173,0.00016395803,0.016217439],"study_design_scores_gemma":[0.0349663,0.000346631,0.9531902,0.000012307525,0.000120609286,0.0000012853508,0.006620475,0.000098931574,0.000011697694,0.0000069897737,0.004587354,0.000037193466],"about_ca_topic_score_codex":0.0006437171,"about_ca_topic_score_gemma":0.0002651068,"teacher_disagreement_score":0.03439645,"about_ca_system_score_codex":0.0010725285,"about_ca_system_score_gemma":0.00013247736,"threshold_uncertainty_score":0.28046247},"labels":[],"label_agreement":null},{"id":"W4210470918","doi":"10.1097/mph.0000000000002378","title":"Clinicopathologic Profile and Treatment Outcomes of Children With Diffuse Large B-cell Lymphomas: Experience From a Tertiary Cancer Center in India","year":2022,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Complete response; Cancer; Lymphoma; Overall survival; Center (category theory); Survival analysis; Rest (music); Single Center","score_opus":0.01507005715867534,"score_gpt":0.3089301202177813,"score_spread":0.293860063059106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210470918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288857,0.0054898816,0.0000026507819,0.0005724295,0.00022950905,0.0005238139,0.00015708356,0.000009319041,0.0001267669],"genre_scores_gemma":[0.99512607,0.003051026,0.00082792,0.0005402503,0.00012361354,0.0002610097,0.000022266237,0.000018088784,0.000029739098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978606,0.00029074066,0.00092908856,0.00031002774,0.00026041837,0.0003491065],"domain_scores_gemma":[0.9981851,0.00038898483,0.0009778466,0.00020749698,0.000066034736,0.00017452629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025451087,0.00024385349,0.001271055,0.00036135878,0.000072314135,0.000004542023,0.00014279423,0.0001558589,0.00023988742],"category_scores_gemma":[0.000046760862,0.0001524199,0.00016107256,0.00022726106,0.00011572141,0.00007307669,0.00013740962,0.00022887721,0.0000025734798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007145229,0.017125472,0.9742119,0.00001753835,0.00022341339,0.002822047,0.0030073216,0.0000013905137,0.000030084,0.000012062381,0.000305012,0.0015292494],"study_design_scores_gemma":[0.03961268,0.005170292,0.94999725,0.000014944424,0.00056624034,0.0022712275,0.0013930344,0.000007347302,0.0004291778,0.000014163705,0.00039841156,0.0001252415],"about_ca_topic_score_codex":0.00017153041,"about_ca_topic_score_gemma":0.000051834042,"teacher_disagreement_score":0.03889816,"about_ca_system_score_codex":0.00066803995,"about_ca_system_score_gemma":0.0008164961,"threshold_uncertainty_score":0.6215504},"labels":[],"label_agreement":null},{"id":"W4211005943","doi":"10.3390/curroncol29020081","title":"Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Pathology; Urinary bladder; Urinary system; Differential diagnosis; Biopsy; Disease; Internal medicine","score_opus":0.05314877393030605,"score_gpt":0.3498650897684516,"score_spread":0.29671631583814556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211005943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010488587,0.9837815,8.915398e-7,0.00027599008,0.0016068307,0.0024130854,0.00087455864,0.000035872592,0.00052266294],"genre_scores_gemma":[0.0046300963,0.99214506,0.000008312319,0.00033223032,0.00030746273,0.0011030707,0.0012643037,0.000068649606,0.00014079675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970563,0.00059805054,0.0007126185,0.0007178575,0.00045531456,0.0004598802],"domain_scores_gemma":[0.9970722,0.001072047,0.00059984456,0.0008562128,0.000039162333,0.00036051066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017441652,0.00058017776,0.0020042062,0.0001899244,0.00019411417,0.000014614606,0.00032460003,0.00021137217,0.00034788897],"category_scores_gemma":[0.00022364856,0.0003605548,0.00087110436,0.00022947106,0.00018454481,0.000031399093,0.00080949545,0.00034302144,0.00005349937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020417056,0.05012241,0.0012464647,0.016008673,0.0004841015,0.0016339232,0.000055603785,1.07667084e-7,1.3734501e-7,0.00017479516,0.009541864,0.92052776],"study_design_scores_gemma":[0.011273515,0.0011838742,0.0074420604,0.004038505,0.007748628,0.00029828664,0.000014032258,0.000002332573,7.244103e-7,0.000027139356,0.9676837,0.00028722754],"about_ca_topic_score_codex":0.0000035824512,"about_ca_topic_score_gemma":9.751692e-7,"teacher_disagreement_score":0.9581418,"about_ca_system_score_codex":0.0010017161,"about_ca_system_score_gemma":0.0016237478,"threshold_uncertainty_score":0.99988467},"labels":[],"label_agreement":null},{"id":"W4211016453","doi":"10.1007/978-3-319-64263-5_46","title":"Non-Hodgkin Lymphoma of Childhood","year":2017,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Disease; Lymphoma; Medicine; Hodgkin lymphoma; Presentation (obstetrics); Oncology; Immunology; Internal medicine; Surgery","score_opus":0.01545675315192925,"score_gpt":0.25580431111663376,"score_spread":0.24034755796470453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211016453","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016874231,0.00090209226,0.0000021871156,0.00031462198,0.00018922238,0.000505037,0.000045106404,0.000035722715,0.9963186],"genre_scores_gemma":[0.19790775,0.00089924556,0.00033859737,0.0002644548,0.00026583197,0.00001799957,0.00010583365,0.0000608325,0.8001395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884886,0.0000018467819,0.0003256752,0.0003386548,0.0003150687,0.00016992072],"domain_scores_gemma":[0.99842495,0.000030748717,0.00030141292,0.0009978382,0.00009649136,0.00014856429],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000050086215,0.00033597488,0.00080983207,0.00011506668,0.000056397046,0.000014555283,0.00014039686,0.00032622513,0.002086566],"category_scores_gemma":[0.00001279381,0.00023892839,0.00040266398,0.0000044123963,0.000099706755,0.000028575329,0.00008194335,0.000057636058,0.00058998424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023069892,0.0024684025,0.009745215,0.00049815956,0.0042345393,0.0015192556,0.00030526347,1.7860474e-7,0.000049214184,0.17216194,0.087819956,0.7209672],"study_design_scores_gemma":[0.011966494,0.0016089746,0.22805381,0.002515975,0.0019602547,0.00034540737,0.000009599382,0.0000040984587,0.0044235173,0.0049342625,0.74353504,0.00064257206],"about_ca_topic_score_codex":0.00013144614,"about_ca_topic_score_gemma":0.00002217345,"teacher_disagreement_score":0.72032464,"about_ca_system_score_codex":0.00012982222,"about_ca_system_score_gemma":0.00029347025,"threshold_uncertainty_score":0.99882567},"labels":[],"label_agreement":null},{"id":"W4211072569","doi":"10.1002/14651858.cd012643.pub2","title":"Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies","year":2019,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Natural Science Foundation of China; Cancer Research UK","keywords":"Interim; Medicine; Checklist; Interim analysis; Positron emission tomography; Internal medicine; Data extraction; Oncology; MEDLINE; Clinical trial; Medical physics; Nuclear medicine; Psychology","score_opus":0.24266846619158344,"score_gpt":0.42915852462330417,"score_spread":0.18649005843172073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211072569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014154522,0.90456027,0.0000150805545,0.000041109182,0.000040608444,0.09037313,0.0049246405,0.000017716313,0.0000133001295],"genre_scores_gemma":[0.00015075938,0.9480045,0.0011054596,0.00005286724,0.000011177316,0.048194863,0.0023027577,0.000079757454,0.00009786388],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9853805,0.0020527644,0.009932377,0.001301574,0.00089166616,0.0004411521],"domain_scores_gemma":[0.98063296,0.0058335857,0.009664104,0.0027977638,0.00087482814,0.00019677413],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004514904,0.001485709,0.06333735,0.0010507844,0.000036326284,0.00003006441,0.000499802,0.0001520732,0.000026008702],"category_scores_gemma":[0.009922909,0.00067668833,0.005279653,0.0018975744,0.00015523181,0.00015782849,0.00019544645,0.0001269772,0.000026340556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047834612,0.00069634424,0.000008372961,0.81063217,0.1878665,0.00006127936,0.00019102173,4.9170332e-8,4.976637e-8,0.000015529475,0.00015380427,0.0003270767],"study_design_scores_gemma":[0.0011091334,0.00042278905,0.0000021663898,0.50812274,0.489612,0.00017997743,0.00007630218,0.0000062610693,6.970798e-7,1.2897968e-7,0.00020651384,0.00026126264],"about_ca_topic_score_codex":0.000038167702,"about_ca_topic_score_gemma":0.00005913022,"teacher_disagreement_score":0.30250937,"about_ca_system_score_codex":0.00029516083,"about_ca_system_score_gemma":0.00032720438,"threshold_uncertainty_score":0.99978924},"labels":[],"label_agreement":null},{"id":"W4211103460","doi":"10.1038/s41572-020-0189-6","title":"Hodgkin lymphoma","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Nodular sclerosis; Medicine; Lymphoma; Immune system; Brentuximab vedotin; Chemotherapy; Tumor microenvironment; Lymph node; Lymphocyte; Cancer research; Pathology; CD30; Immunology; Oncology; Internal medicine; Hodgkin lymphoma","score_opus":0.044655815210613306,"score_gpt":0.38290308107919074,"score_spread":0.33824726586857745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211103460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.4759725e-7,0.9907762,0.0000013955298,0.0005780441,0.0004812952,0.005061496,0.00017998267,0.00014809999,0.0027731778],"genre_scores_gemma":[0.0000033052656,0.9934434,0.00061383966,0.0022576652,0.00075185014,0.0011217804,0.0012408673,0.00014412258,0.00042316708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963321,0.00035039315,0.0010972623,0.0011521516,0.00057162147,0.0004964798],"domain_scores_gemma":[0.9964364,0.00014558768,0.00063956284,0.0011904353,0.00006883401,0.0015191613],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002147171,0.0011052135,0.005196868,0.00020323518,0.00008610489,0.000052969976,0.00035382796,0.00079827535,0.00038308097],"category_scores_gemma":[0.00057151134,0.0006966157,0.0036401125,0.0007754067,0.00007542456,0.00006502442,0.00015058751,0.0006590229,0.002963747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032756278,0.00043143064,0.000026569216,0.04722336,0.0007316948,0.0010243524,0.0000055212913,2.9804141e-9,2.0176882e-8,0.00019781411,0.03601471,0.91431177],"study_design_scores_gemma":[0.00090622285,0.00007778851,0.00013581675,0.044305377,0.018407943,0.000105283005,0.0000010267248,4.984932e-7,3.9706495e-7,0.000008740298,0.93552023,0.00053069496],"about_ca_topic_score_codex":0.0000036815256,"about_ca_topic_score_gemma":3.440567e-7,"teacher_disagreement_score":0.91378105,"about_ca_system_score_codex":0.00094709,"about_ca_system_score_gemma":0.0020244787,"threshold_uncertainty_score":0.9995485},"labels":[],"label_agreement":null},{"id":"W4212851543","doi":"10.1002/cncr.34106","title":"Ofatumumab plus HyperCVAD/HD‐MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; National Comprehensive Cancer Network; Roswell Park Cancer Institute","keywords":"Medicine; Internal medicine; Mantle cell lymphoma; Minimal residual disease; Ofatumumab; Rituximab; Surgery; Oncology; Gastroenterology; Lymphoma","score_opus":0.01960594937588766,"score_gpt":0.2912329741779556,"score_spread":0.2716270248020679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212851543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996899,0.00022712562,4.484354e-7,0.0003194393,0.00015821934,0.0015369466,0.0007806822,0.00001328362,0.000064854146],"genre_scores_gemma":[0.99871,0.000014661907,0.00006892766,0.000091239046,0.000054693348,0.0007281751,0.00014315637,0.000024474904,0.00016467799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830246,0.0001237272,0.00040505137,0.0004068588,0.0005418022,0.00022012458],"domain_scores_gemma":[0.9990424,0.00009664607,0.00020618344,0.00035711908,0.00013244341,0.00016520756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012723188,0.00018865475,0.0004706254,0.00017894489,0.00006636897,0.0000062855433,0.000089154004,0.000028805782,0.00009236586],"category_scores_gemma":[0.000069433845,0.00015169922,0.000051212275,0.0004635908,0.000056159362,0.00007920219,0.00009470001,0.00006722431,0.000002337852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033553515,0.027533045,0.92323565,0.00009801947,0.00011499782,0.0002201297,0.003092948,0.00063394126,0.00043486134,0.000004608457,0.002202169,0.008876126],"study_design_scores_gemma":[0.09641155,0.006164959,0.8885345,0.000093320305,0.00024364627,5.955402e-7,0.0009674419,0.000018992368,0.0073001725,0.000003092518,0.0001264848,0.00013525196],"about_ca_topic_score_codex":0.004271006,"about_ca_topic_score_gemma":0.00043926528,"teacher_disagreement_score":0.06285804,"about_ca_system_score_codex":0.00083570526,"about_ca_system_score_gemma":0.00056728435,"threshold_uncertainty_score":0.6456513},"labels":[],"label_agreement":null},{"id":"W4212859128","doi":"10.1002/ajh.26500","title":"Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Internal medicine; Hazard ratio; Refractory (planetary science); Oncology; Gastroenterology; Transplantation; Lymphoma; Classical Hodgkin lymphoma; Salvage therapy; Confidence interval; Chemotherapy; Hodgkin lymphoma","score_opus":0.011533827656359238,"score_gpt":0.2596016456974174,"score_spread":0.24806781804105815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212859128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409324,0.002853834,0.0005763835,0.0018551394,0.00016502159,0.0002985849,0.00006613581,0.00001465288,0.000076985176],"genre_scores_gemma":[0.99274755,0.00028217168,0.0064149103,0.00028631891,0.000098795426,0.00008589633,0.00002809303,0.000023355087,0.00003288838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834985,0.00027393206,0.00062331004,0.00023595057,0.0002672488,0.0002497161],"domain_scores_gemma":[0.9981949,0.00044545715,0.0008786297,0.00017754278,0.00013055999,0.00017291823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004182006,0.00017043599,0.00076220994,0.00018741122,0.0002251859,0.00001551133,0.000106572545,0.000033353554,0.000041570653],"category_scores_gemma":[0.00021079456,0.00013008023,0.00015787825,0.00016826559,0.000259871,0.00007135522,0.00002863836,0.0002284732,0.0000021473986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00436778,0.0024385361,0.75473034,0.00010943646,0.0013238707,0.001249612,0.002448516,0.000022903312,0.0023577856,0.014194859,0.0059880097,0.21076833],"study_design_scores_gemma":[0.020819224,0.03320059,0.81002307,0.00030782953,0.0034552573,0.060363196,0.014480543,0.0016108691,0.007484751,0.0015839207,0.04597384,0.0006969031],"about_ca_topic_score_codex":0.000079958576,"about_ca_topic_score_gemma":0.000020933276,"teacher_disagreement_score":0.21007143,"about_ca_system_score_codex":0.00013398826,"about_ca_system_score_gemma":0.0003647352,"threshold_uncertainty_score":0.5304518},"labels":[],"label_agreement":null},{"id":"W4212971766","doi":"10.1002/jha2.394","title":"Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Neutropenia; Rituximab; Lenalidomide; Internal medicine; Follicular lymphoma; Febrile neutropenia; Gastroenterology; Diffuse large B-cell lymphoma; Tolerability; Lymphoma; Refractory (planetary science); Adverse effect; Clinical endpoint; Phases of clinical research; Surgery; Chemotherapy; Clinical trial; Multiple myeloma","score_opus":0.00703040522547299,"score_gpt":0.2307756252306112,"score_spread":0.22374522000513822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212971766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760175,0.0003714202,0.0000023999623,0.000055640143,0.000051296694,0.0016746462,0.000033980097,0.000025328496,0.00018353926],"genre_scores_gemma":[0.9992106,0.000020662357,0.000063631,0.00010761617,0.000008307145,0.00036513116,0.00011083565,0.000040296996,0.00007291036],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980604,0.00017013466,0.00039655372,0.00044513273,0.0006258429,0.00030191304],"domain_scores_gemma":[0.9991432,0.0000847771,0.00020557306,0.00038679547,0.00006866415,0.00011100383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021838146,0.00025474268,0.0005752152,0.0003188728,0.00010806649,0.000013642292,0.00008882604,0.000050505903,0.000018909868],"category_scores_gemma":[0.000018846264,0.00019521272,0.00004031016,0.0004390416,0.000038145066,0.0001281369,0.000106121464,0.00008504448,0.0000035583305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028263726,0.46347582,0.526262,0.00003637936,0.000075033095,0.00050542585,0.002580355,0.0000015342363,0.000008641625,0.000025029527,0.000044683882,0.004158715],"study_design_scores_gemma":[0.5074748,0.010293427,0.47970667,0.00006149984,0.00011323905,0.000009540666,0.0016282372,0.00007500888,0.00019883736,0.000006674163,0.00029772843,0.00013432848],"about_ca_topic_score_codex":0.0006770409,"about_ca_topic_score_gemma":0.0005122622,"teacher_disagreement_score":0.50464845,"about_ca_system_score_codex":0.0006178843,"about_ca_system_score_gemma":0.00012781852,"threshold_uncertainty_score":0.79605436},"labels":[],"label_agreement":null},{"id":"W4213052277","doi":"10.3390/cancers14040908","title":"Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"Genome Canada","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.027749891904693694,"score_gpt":0.2953980692032102,"score_spread":0.26764817729851653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213052277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966495,0.00060065615,0.000008511297,0.000039839142,0.00015479486,0.001519283,0.00009596606,0.00001265737,0.0009187986],"genre_scores_gemma":[0.99796945,0.00007841133,0.000023353932,0.00022639758,0.000007809709,0.001441067,0.00013768609,0.000023487297,0.000092335016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987163,0.00017015767,0.00025878893,0.00030279683,0.0002653924,0.00028659127],"domain_scores_gemma":[0.9994373,0.00007999955,0.00008243055,0.00027561668,0.00003720822,0.00008744953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013237442,0.00017221316,0.00039347875,0.00017763292,0.000040617364,0.0000048594093,0.00006865384,0.000040861123,0.000055559896],"category_scores_gemma":[0.000012849136,0.00015249783,0.00010812676,0.00033296546,0.00002606461,0.000035256577,0.000055452198,0.00004069705,0.000004610766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012959453,0.024794802,0.96405673,0.00011886129,0.00015473747,0.0004285487,0.0009240338,0.0015080605,0.00043597614,0.00015919244,0.00016043027,0.0059626936],"study_design_scores_gemma":[0.14019954,0.0015491733,0.8458343,0.00009523503,0.00008422691,0.0000032047762,0.00036628448,0.00022241028,0.009853813,0.000034290337,0.001609366,0.00014813662],"about_ca_topic_score_codex":0.00362087,"about_ca_topic_score_gemma":0.0002203071,"teacher_disagreement_score":0.13890359,"about_ca_system_score_codex":0.014031512,"about_ca_system_score_gemma":0.00067201,"threshold_uncertainty_score":0.9897534},"labels":[],"label_agreement":null},{"id":"W4213439089","doi":"10.51626/ijor.2021.02.00008","title":"The Role of Radiotherapy in Relapse/Refractory Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"International Journal on Oral Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Radiation therapy; Adverse effect; Refractory (planetary science); Salvage therapy; Lymphoma; Chemotherapy","score_opus":0.05671579578733299,"score_gpt":0.40108064263147347,"score_spread":0.3443648468441405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213439089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053977376,0.9934088,0.0000029281891,0.0048339777,0.00008777795,0.0014466107,0.000090694375,0.000003327198,0.0000719294],"genre_scores_gemma":[0.0019526891,0.9928294,0.00005970707,0.0046324944,0.000056503504,0.00025220655,0.000056232457,0.000024638666,0.00013611937],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99452996,0.0019890764,0.0019875448,0.0002899411,0.00093122746,0.00027226636],"domain_scores_gemma":[0.9965261,0.0010998736,0.0016202052,0.00044929827,0.00017671772,0.00012775604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029688303,0.0003602426,0.0054692333,0.00046405778,0.00008617727,0.00009046385,0.00043897118,0.00010810976,0.00006234859],"category_scores_gemma":[0.0001577982,0.00015202811,0.0019656534,0.00054784777,0.000033923403,0.00005888899,0.000040360865,0.00046546606,0.0000067216115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001695984,0.044724114,0.00040059836,0.39447072,0.2837379,0.0025449388,0.0010534719,0.000001624675,5.015269e-8,0.004226731,0.0023394872,0.26633075],"study_design_scores_gemma":[0.010341358,0.0006800071,0.00025483905,0.115999244,0.27058864,0.0024580813,0.00021074654,0.00002434734,2.4595911e-7,0.00007048991,0.5990704,0.00030156973],"about_ca_topic_score_codex":0.00015926835,"about_ca_topic_score_gemma":0.0002544062,"teacher_disagreement_score":0.59673095,"about_ca_system_score_codex":0.0012428222,"about_ca_system_score_gemma":0.00083035935,"threshold_uncertainty_score":0.6199526},"labels":[],"label_agreement":null},{"id":"W4214565043","doi":"10.1155/2022/5896696","title":"Concurrent Primary Follicular Lymphoma and a Mature Cystic Teratoma of the Ovary: A Case Report and Review of Literature","year":2022,"lang":"en","type":"article","venue":"Case Reports in Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Credit Valley Hospital; Trillium Health Centre; University Health Network; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Ovary; Follicular lymphoma; Lymphoma; Teratoma; Mature Cystic Teratoma; Pathology; Ovarian Teratoma; Follicular phase; Internal medicine","score_opus":0.0077992434606998975,"score_gpt":0.2605733032528822,"score_spread":0.2527740597921823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214565043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81562215,0.18293218,0.0000010264382,0.00032250214,0.00020477183,0.0007278056,0.00005187188,0.0000073762626,0.00013031262],"genre_scores_gemma":[0.99605644,0.0028586043,0.00013896558,0.00059287675,0.000018508932,0.00021431627,0.000063158346,0.00001285264,0.00004430217],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983272,0.00021476152,0.0007372032,0.00038935058,0.00018768328,0.00014382358],"domain_scores_gemma":[0.9986078,0.00008685665,0.0005374888,0.00060791237,0.00009006816,0.0000698877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063636986,0.00016347456,0.00064723764,0.00008824841,0.00007212286,0.0000048143324,0.000021253132,0.00008434072,0.00001874756],"category_scores_gemma":[0.00027643677,0.000107271575,0.000113743685,0.00028507804,0.00014866875,0.000024875677,0.00021720411,0.00013288249,4.1628507e-8],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022435026,0.00035098853,0.041984115,0.0031988022,0.00005112528,0.947143,0.00042719467,2.7450872e-7,0.00017919908,0.000062637744,0.00036650363,0.006213697],"study_design_scores_gemma":[0.0010750124,0.0002363043,0.037958317,0.0024373515,0.00033647043,0.95518243,0.00008058896,0.0000046492833,0.00022622725,0.000049554797,0.0023328795,0.00008020342],"about_ca_topic_score_codex":0.000035597168,"about_ca_topic_score_gemma":0.000006153118,"teacher_disagreement_score":0.18043426,"about_ca_system_score_codex":0.00012558473,"about_ca_system_score_gemma":0.00022045684,"threshold_uncertainty_score":0.43744078},"labels":[],"label_agreement":null},{"id":"W4214636377","doi":"10.14740/wjon1436","title":"Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Exome sequencing; Transplantation; Oncology; Hematopoietic stem cell transplantation; Cancer research; Exome; Internal medicine; Biology; Mutation; Genetics","score_opus":0.02082244105277792,"score_gpt":0.35493380199725955,"score_spread":0.33411136094448163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214636377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952117,0.0008094889,0.000035467645,0.0030476896,0.00022154347,0.00021275123,0.000027678387,0.000010694583,0.00042298387],"genre_scores_gemma":[0.9965518,0.00012554484,0.0010137783,0.0011695279,0.0002779449,0.00002532071,0.000024851244,0.000020445117,0.00079079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977973,0.0002744488,0.0008832105,0.00033152328,0.0004123977,0.00030108102],"domain_scores_gemma":[0.99744403,0.00033400443,0.00071678095,0.00038557244,0.00016328583,0.00095631415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010145112,0.0001836663,0.0009638712,0.0003737061,0.00021780399,0.00001925475,0.00009675366,0.000055258883,0.00035256313],"category_scores_gemma":[0.0000644056,0.00012825978,0.00036816057,0.0005573669,0.00014160265,0.00008003571,0.00011191047,0.00028145374,0.0000028803152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038176712,0.023553526,0.4983687,0.0000074017166,0.0011413486,0.46787643,0.00007659022,0.0000075716375,0.0000012850804,0.000023120803,0.0011540481,0.003972292],"study_design_scores_gemma":[0.035168108,0.007822767,0.7402082,0.000014387406,0.009719045,0.17778757,0.0003949053,0.00042369764,0.0000029698053,0.000020578102,0.028301952,0.00013580655],"about_ca_topic_score_codex":0.00003957377,"about_ca_topic_score_gemma":0.0005387708,"teacher_disagreement_score":0.29008886,"about_ca_system_score_codex":0.00047553316,"about_ca_system_score_gemma":0.0011020425,"threshold_uncertainty_score":0.5230282},"labels":[],"label_agreement":null},{"id":"W4214650182","doi":"10.3410/f.1163325.625030","title":"Faculty Opinions recommendation of Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.","year":2009,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Tumor microenvironment; Medicine; Immunohistochemistry; Pathology; Follicular phase; Lymphoma; Vincristine; FOXP3; Oncology; Cyclophosphamide; Internal medicine; Chemotherapy; Immunology; Cancer; Immune system","score_opus":0.038397662062825445,"score_gpt":0.3669401818893305,"score_spread":0.328542519826505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214650182","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013750541,0.00067134784,5.020265e-7,0.094017014,0.00017387314,0.018392097,0.88655525,0.000013020051,0.000039379323],"genre_scores_gemma":[0.0004752393,0.00074571103,0.00014887901,0.002650532,0.0001237114,0.006708453,0.9888689,0.000029948487,0.00024861412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99469596,0.00045100917,0.0018306344,0.00084336905,0.0017778688,0.00040115442],"domain_scores_gemma":[0.9947867,0.0001161806,0.0017928376,0.0019847162,0.0010434162,0.0002761686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006056311,0.00076776044,0.0014802224,0.0003973863,0.00013763188,0.000059521026,0.000871884,0.00045476816,0.00032970143],"category_scores_gemma":[0.0006994565,0.00036776683,0.0016010677,0.0013295381,0.0002288349,0.00010185239,0.00019932432,0.00039722156,0.000038608727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016048887,0.009425897,0.00055096514,0.0021892688,0.00043185172,0.0000031971756,0.00011644612,7.760139e-7,0.000005711256,0.000031199652,0.97806185,0.009022359],"study_design_scores_gemma":[0.003940758,0.0024201074,0.1172089,0.023027012,0.00030695423,0.000064918706,0.000011962026,0.0000020980822,0.00078371045,0.0000058513688,0.85199237,0.00023537598],"about_ca_topic_score_codex":0.00015852423,"about_ca_topic_score_gemma":0.0000065396275,"teacher_disagreement_score":0.12606949,"about_ca_system_score_codex":0.0016554592,"about_ca_system_score_gemma":0.0007061707,"threshold_uncertainty_score":0.99987745},"labels":[],"label_agreement":null},{"id":"W4214709642","doi":"10.1016/j.clon.2022.01.042","title":"Treatment Outcomes of Low-grade Lymphoma of the Orbit","year":2022,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Radioimmunotherapy; Stage (stratigraphy); MALT lymphoma; Lymphoma; Radiation therapy; Surgery; Cohort; External beam radiotherapy; Orbit (dynamics); Population; Radiology; Internal medicine; Brachytherapy","score_opus":0.08965838607819156,"score_gpt":0.4232456120185305,"score_spread":0.33358722594033896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214709642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576695,0.00023406521,4.3540416e-7,0.008851812,0.00076021696,0.00042245467,0.00003243915,0.000011743617,0.0039198925],"genre_scores_gemma":[0.99704814,0.00014407637,0.00014687091,0.0012176633,0.00006281325,0.00012698695,0.000009000848,0.0000098042865,0.0012346664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837923,0.00028487496,0.0007634908,0.0002089508,0.00021169415,0.0001517472],"domain_scores_gemma":[0.99769455,0.0013560336,0.00035451222,0.0004633091,0.000041537558,0.000090075475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024945484,0.000110958725,0.00086792384,0.000033429893,0.00006190775,8.635942e-7,0.00014141762,0.00009353216,0.00037827506],"category_scores_gemma":[0.00024569916,0.000059240447,0.00058156915,0.00013192956,0.00025491405,0.000008408163,0.00017156733,0.000068860696,0.000013018775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026780178,0.013684043,0.9189356,0.000013758231,0.00049493386,0.00009441712,0.0001074562,0.0000054693337,0.000048473346,0.000991892,0.0012451565,0.064110994],"study_design_scores_gemma":[0.010528327,0.0075953337,0.92212766,0.00000871843,0.00039249216,0.0000532903,0.00012377658,0.000017705928,0.0009430451,0.00012921155,0.05803499,0.000045452645],"about_ca_topic_score_codex":0.00015164564,"about_ca_topic_score_gemma":0.0000234683,"teacher_disagreement_score":0.06406554,"about_ca_system_score_codex":0.00048732103,"about_ca_system_score_gemma":0.00068629644,"threshold_uncertainty_score":0.41418466},"labels":[],"label_agreement":null},{"id":"W4214747639","doi":"10.1016/s2152-2650(21)01485-3","title":"Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Stage (stratigraphy); Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Chemotherapy; Lymphoma; Biology","score_opus":0.015252845093914086,"score_gpt":0.287328684901338,"score_spread":0.2720758398074239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214747639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339724,0.00022284227,0.00002845521,0.00120534,0.00030122045,0.0039115637,0.00019854248,0.00013660161,0.00059819064],"genre_scores_gemma":[0.9949804,0.00013433001,0.0010786195,0.0014523475,0.00022829091,0.0003774005,0.0003323958,0.00017129237,0.0012449541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434793,0.00045285936,0.0016689015,0.0014635245,0.0010897608,0.0009770183],"domain_scores_gemma":[0.9948513,0.00092033716,0.0008543338,0.0019165324,0.0009370106,0.0005204732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000589546,0.00080538925,0.0018943714,0.00010110515,0.00028735117,0.000099555175,0.0005107098,0.00041161058,0.00014091367],"category_scores_gemma":[0.00034135647,0.0004701972,0.0006841268,0.00076654996,0.00057855493,0.00016025537,0.00028796095,0.00019871925,0.000043156906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011478547,0.014808476,0.81875044,0.00013501852,0.0018231827,0.00030278804,0.00032999806,0.0000034432067,0.00002661447,0.00014840931,0.0012763169,0.15091679],"study_design_scores_gemma":[0.108194724,0.008080298,0.87392986,0.00049543945,0.0012592048,0.000067923815,0.00029769397,0.00007345575,0.0026862503,0.000025560497,0.004397771,0.0004918068],"about_ca_topic_score_codex":0.00015792316,"about_ca_topic_score_gemma":0.00020008718,"teacher_disagreement_score":0.15042497,"about_ca_system_score_codex":0.0014442188,"about_ca_system_score_gemma":0.0032869913,"threshold_uncertainty_score":0.999775},"labels":[],"label_agreement":null},{"id":"W4214761613","doi":"10.14740/jmc3830","title":"Intestinal T-Cell Lymphoma With Lung and Lymph Node Involvement at Relapse","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Hilum (anatomy); Perforation; Vincristine; Gemcitabine; Biopsy; Prednisolone; Gastroenterology; Radiology; Internal medicine; Surgery; Cyclophosphamide","score_opus":0.017776643014458287,"score_gpt":0.2652472850819748,"score_spread":0.24747064206751654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214761613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599595,0.0062548677,0.00001803595,0.006972776,0.00016643787,0.00011282529,0.0000067355795,0.00001043259,0.00046194514],"genre_scores_gemma":[0.9958321,0.00061586447,0.00055738643,0.0024574036,0.00019659878,0.000019992052,0.000007873535,0.000016380895,0.000296388],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99744964,0.00007965961,0.0004137753,0.00015839818,0.0016956504,0.0002028755],"domain_scores_gemma":[0.9985839,0.00035917148,0.00026190042,0.00013706718,0.00009197737,0.0005659998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054008554,0.00014695743,0.0003617483,0.00011725796,0.00017805737,0.000015892976,0.000109696695,0.00004422267,0.0011504759],"category_scores_gemma":[0.0002507898,0.00009177951,0.00009711477,0.00012585797,0.00011075271,0.000049605052,0.00020484313,0.00014954877,0.0000039029946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027830522,0.004979968,0.8332024,0.00024077501,0.00034666655,0.096219555,0.00052637,0.00001547849,0.00015958084,0.00012279765,0.041311674,0.020091664],"study_design_scores_gemma":[0.08386254,0.0155932065,0.36875716,0.0020332127,0.0023494533,0.43887603,0.004415167,0.0011340963,0.0042820615,0.00006573224,0.07805038,0.00058095885],"about_ca_topic_score_codex":0.000105311025,"about_ca_topic_score_gemma":0.000010254562,"teacher_disagreement_score":0.46444526,"about_ca_system_score_codex":0.0007878863,"about_ca_system_score_gemma":0.000642161,"threshold_uncertainty_score":0.9997626},"labels":[],"label_agreement":null},{"id":"W4220705330","doi":"10.1055/a-1666-2511","title":"Die Rolle der [18F]FDG PET/CT bei pädiatrischen Lymphomen","year":2022,"lang":"de","type":"article","venue":"Angewandte Nuklearmedizin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Nuclear medicine; Gynecology","score_opus":0.01503185267185052,"score_gpt":0.2538155196571078,"score_spread":0.23878366698525727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220705330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5460656,0.40937448,0.000003539313,0.0116078155,0.006989142,0.0024168955,0.0010580396,0.0003348976,0.022149539],"genre_scores_gemma":[0.9531982,0.021032019,0.0002748602,0.0045946524,0.0032768159,0.0011188023,0.0010448344,0.00025376177,0.01520604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99360955,0.0005677797,0.0010503603,0.0014184761,0.0016371316,0.0017166855],"domain_scores_gemma":[0.9965858,0.00051462,0.00046044818,0.001312498,0.00015202952,0.00097462133],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010222739,0.0009501886,0.0014220079,0.00047740777,0.0013079663,0.00016658408,0.00064911915,0.000053797306,0.009642605],"category_scores_gemma":[0.00018076993,0.000880247,0.0008061175,0.00079478294,0.00027050823,0.00021919863,0.00097611564,0.0007195668,0.004115177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002329575,0.011110928,0.22236481,0.0005553357,0.011587451,0.084488004,0.0042208643,0.00018613822,0.0002779575,0.0007823858,0.61244565,0.049650893],"study_design_scores_gemma":[0.01641337,0.002130479,0.017179614,0.00013565546,0.005112607,0.00060646934,0.0023274575,0.00017163227,0.003910704,0.00020242282,0.95084673,0.00096285815],"about_ca_topic_score_codex":0.0017671935,"about_ca_topic_score_gemma":0.00010693696,"teacher_disagreement_score":0.40713257,"about_ca_system_score_codex":0.0019875036,"about_ca_system_score_gemma":0.0011813153,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W4220811326","doi":"10.1002/cam4.4692","title":"Patient‐reported outcomes provide prognostic information for survival in patients with diffuse large B‐cell lymphoma: Analysis of 1239 patients from the <scp>GOYA</scp> study","year":2022,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; International Prognostic Index; Oncology; Diffuse large B-cell lymphoma; Proportional hazards model; Quality of life (healthcare); Rituximab; Lymphoma; Population; B symptoms; Performance status; Cancer; Progression-free survival; Prognostic variable; Chemotherapy","score_opus":0.011378883413943075,"score_gpt":0.25356440828619903,"score_spread":0.24218552487225595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220811326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368805,0.0002448472,0.000015155095,0.00020261065,0.00034403696,0.0045921407,0.0007976173,0.000027348808,0.00008820732],"genre_scores_gemma":[0.99418133,0.000013434663,0.000019241968,0.0007052898,0.0000311236,0.0023401375,0.0026497075,0.000023077855,0.000036629543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971519,0.00012078178,0.00089834,0.00033695073,0.0011511148,0.00034092428],"domain_scores_gemma":[0.99745345,0.0007914723,0.00071247644,0.00051228923,0.00040793078,0.00012236548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002739594,0.00028115677,0.0008990169,0.00034305084,0.00015939874,0.000010613251,0.0001450736,0.000040143404,0.00005543872],"category_scores_gemma":[0.00059763103,0.00015637962,0.00013261587,0.0011085336,0.00006192426,0.0001403287,0.000108257176,0.00009114138,9.580814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034544492,0.014882603,0.96743953,0.000044558747,0.0019936077,0.000009055688,0.009982861,0.00005600853,7.0491393e-7,0.000003508203,0.0008807864,0.004361359],"study_design_scores_gemma":[0.0691236,0.0036444315,0.9141484,0.0000671174,0.0048876633,1.17560504e-7,0.006044835,0.00019188465,0.000014948325,0.000003623739,0.0018078634,0.00006554743],"about_ca_topic_score_codex":0.0028766613,"about_ca_topic_score_gemma":0.0007278382,"teacher_disagreement_score":0.068778165,"about_ca_system_score_codex":0.0005531608,"about_ca_system_score_gemma":0.00021763274,"threshold_uncertainty_score":0.6376976},"labels":[],"label_agreement":null},{"id":"W4220879174","doi":"10.21203/rs.3.rs-1417451/v1","title":"Influence of Age on Long-term Net Survival Benefit for Early-stage MALT Lymphomas Treated With Radiotherapy: a SEER Database Analysis (2000-2015)","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Stage (stratigraphy); Lymphoma; Proportional hazards model; Epidemiology; Chemotherapy; Incidence (geometry); Oncology; Survival analysis; Gastroenterology; Database; Biology","score_opus":0.054041737074044756,"score_gpt":0.39086569976002317,"score_spread":0.3368239626859784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220879174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749787,0.0016779479,0.000047383557,0.00031340326,0.000037808135,0.0040859506,0.005800595,0.000080643644,0.0004583934],"genre_scores_gemma":[0.98242664,0.0015726927,0.0004150336,0.00006302078,0.00013001631,0.0025120005,0.007896727,0.00012742987,0.0048564086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941031,0.00042026606,0.0006319444,0.0014067702,0.0024414242,0.000996499],"domain_scores_gemma":[0.9950348,0.00088006957,0.00030430563,0.0024424659,0.00082294346,0.00051541673],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013148296,0.0006048054,0.0015554259,0.0015535502,0.00026287654,0.00012511904,0.0005585007,0.00028533177,0.0012879997],"category_scores_gemma":[0.0001567365,0.00045891738,0.00061191426,0.0017112057,0.000267514,0.00009360657,0.0005540313,0.00066418183,0.000011730707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057350495,0.0026369544,0.96601695,0.002109695,0.0068497183,0.0024228054,0.00057745364,0.011683929,0.00016917798,0.00021926488,0.00026382616,0.0013152055],"study_design_scores_gemma":[0.007544115,0.0041115726,0.9822249,0.0011043408,0.0014593716,0.000009275319,0.00010676153,0.000467336,0.0013338247,0.0000120632485,0.0012147144,0.00041174193],"about_ca_topic_score_codex":0.00983761,"about_ca_topic_score_gemma":0.0012446526,"teacher_disagreement_score":0.016207961,"about_ca_system_score_codex":0.0022811142,"about_ca_system_score_gemma":0.0012491122,"threshold_uncertainty_score":0.99978626},"labels":[],"label_agreement":null},{"id":"W4220891617","doi":"10.14740/jmc3890","title":"A Case of Angioimmunoblastic T-cell Lymphoma Hidden in Plain Sight: A Delay in Diagnosis and Management","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angioimmunoblastic T-cell lymphoma; Lymphoma; Biopsy; Lymph node biopsy; Pleural effusion; Radiology; Cervical lymphadenopathy; Lymph node; Surgery; Pathology; T cell","score_opus":0.01930688780155375,"score_gpt":0.27527849446010655,"score_spread":0.2559716066585528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220891617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989465,0.008401235,0.0000028613144,0.0015852748,0.00010143646,0.00022842064,0.000012017679,0.0000029174323,0.00020086142],"genre_scores_gemma":[0.99640596,0.0029354126,0.00019890978,0.0003144918,0.000039728708,0.00007381898,0.000002527323,0.000010733011,0.000018444103],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980466,0.00014310675,0.0006754917,0.00013717775,0.00080946245,0.00018815993],"domain_scores_gemma":[0.9986978,0.0007141374,0.00022412969,0.00011697077,0.000030299876,0.00021663462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073416316,0.00012335715,0.00046589324,0.0004550396,0.00004102721,0.000007831407,0.000100243626,0.000055025645,0.0003803969],"category_scores_gemma":[0.0002471818,0.00009290836,0.000112826645,0.0003072491,0.00006462294,0.00004612709,0.00015355626,0.00015684585,0.0000011003646],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007576391,0.006954235,0.15078671,0.00030981112,0.0001686865,0.75066257,0.0009375362,0.000022484344,0.000013142741,0.00012082489,0.0030673845,0.08619895],"study_design_scores_gemma":[0.08625445,0.012301569,0.32070315,0.003403947,0.0013202957,0.5437951,0.012612332,0.0011054898,0.001258464,0.00025391273,0.016489433,0.00050183776],"about_ca_topic_score_codex":0.00057284447,"about_ca_topic_score_gemma":0.0002555272,"teacher_disagreement_score":0.20686747,"about_ca_system_score_codex":0.00035271104,"about_ca_system_score_gemma":0.00018785802,"threshold_uncertainty_score":0.41650793},"labels":[],"label_agreement":null},{"id":"W4220953526","doi":"10.1097/mph.0000000000002423","title":"Hodgkin Lymphoma in Children Under 5 Years: Do They Behave Differently?","year":2022,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Cohort; Pediatrics; Disease; Lymphoma; Presentation (obstetrics); Hodgkin lymphoma; Population; Cohort study; Internal medicine; Surgery; Environmental health","score_opus":0.016108222547424958,"score_gpt":0.2981235201915581,"score_spread":0.28201529764413313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220953526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107873,0.0045534438,0.000008302809,0.0024152359,0.0006267301,0.0003603158,0.0000149451025,0.000016999122,0.00092529604],"genre_scores_gemma":[0.99697566,0.0011172399,0.00043177803,0.000719203,0.0005894451,0.000062519925,0.000013917567,0.00002933023,0.000060897288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740326,0.0004263213,0.000982733,0.00028140243,0.0004561627,0.0004501202],"domain_scores_gemma":[0.99827194,0.00039824806,0.00073758024,0.00025914365,0.00009056129,0.00024252516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006428467,0.00022767698,0.0010764783,0.0007720741,0.000086916436,0.000012157068,0.00026385064,0.00023559859,0.00049478584],"category_scores_gemma":[0.00009404705,0.00018583826,0.00031361196,0.0003542501,0.00005860647,0.00006874331,0.00020547348,0.00044443694,0.00003907525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042903062,0.004623125,0.97148985,0.000014326036,0.00029896953,0.0038643111,0.0007562536,0.000030401812,0.000022133832,0.0011065195,0.0065056416,0.010859464],"study_design_scores_gemma":[0.014711619,0.0036636705,0.950988,0.000012090625,0.00074838503,0.023872118,0.0008398549,0.0000058871656,0.000055474877,0.0015221204,0.0033994126,0.00018135912],"about_ca_topic_score_codex":0.00008422199,"about_ca_topic_score_gemma":0.000023146227,"teacher_disagreement_score":0.020501815,"about_ca_system_score_codex":0.0015434888,"about_ca_system_score_gemma":0.0011316872,"threshold_uncertainty_score":0.7578264},"labels":[],"label_agreement":null},{"id":"W4220963054","doi":"10.1093/jjco/hyac037","title":"International variations in lymphoma incidence in children and adolescents","year":2022,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Pediatrics; Lymphoma; Oncology; Internal medicine","score_opus":0.0350785686497237,"score_gpt":0.3995799566491181,"score_spread":0.3645013879993944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220963054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942767,0.00006255532,0.0000027342514,0.004741226,0.00030989674,0.00013367661,0.0000020056998,0.000002600426,0.00046863087],"genre_scores_gemma":[0.9978166,0.00017839248,0.0004908869,0.0013258068,0.00015116256,0.000013295125,0.0000029639314,0.000004101503,0.00001675143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998189,0.00028039038,0.0010323041,0.00012806676,0.00025772926,0.00011252202],"domain_scores_gemma":[0.99884915,0.0004979257,0.00038209185,0.00007626871,0.0000713905,0.00012319598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014851496,0.00006263924,0.00043860768,0.00020172125,0.000029880874,0.000005047197,0.00011571629,0.000059404618,0.0001246869],"category_scores_gemma":[0.0008969995,0.000049282582,0.00009372143,0.00016118723,0.00005124876,0.00008716873,0.00011003827,0.00022633476,0.0000036960616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008852826,0.00365121,0.94486934,0.0000014299005,0.000055279153,0.00048452933,0.00029952874,0.000041881292,0.000023982504,0.00007958407,0.00005881434,0.04954911],"study_design_scores_gemma":[0.014919069,0.0015631573,0.9797844,0.00003251262,0.000032514057,0.0022235438,0.0001662415,0.00021643666,0.0000040175178,0.00015103858,0.00086802983,0.000039013536],"about_ca_topic_score_codex":0.00014009533,"about_ca_topic_score_gemma":0.000050403167,"teacher_disagreement_score":0.049510095,"about_ca_system_score_codex":0.0004036337,"about_ca_system_score_gemma":0.00034637135,"threshold_uncertainty_score":0.20096853},"labels":[],"label_agreement":null},{"id":"W4220970057","doi":"10.1080/10428194.2022.2047674","title":"Long-term follow up of relapsed/refractory non-Hodgkin lymphoma patients treated with single-agent selinexor – a retrospective, single center study","year":2022,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Single Center; Refractory (planetary science); Lymphoma; Internal medicine; Adverse effect; Retrospective cohort study; Oncology; Cohort; Gastroenterology; Surgery","score_opus":0.012991366514394826,"score_gpt":0.23037435745385598,"score_spread":0.21738299093946115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220970057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917512,0.0008321097,0.000016607713,0.00006340607,0.0007842845,0.0033653413,0.00039839145,0.00033026622,0.0024584197],"genre_scores_gemma":[0.99427617,0.0001710184,0.00021248624,0.00062497676,0.00023070669,0.0010087735,0.00090618845,0.0003200009,0.0022496707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918208,0.00044712544,0.0017527589,0.0022495063,0.0022230446,0.0015067395],"domain_scores_gemma":[0.99523354,0.00027176982,0.0011452899,0.001832846,0.0006266078,0.0008899781],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00044464722,0.0015257095,0.0022891087,0.0007996462,0.00091061095,0.00016760713,0.00061946263,0.00039831406,0.00030405624],"category_scores_gemma":[0.00010437549,0.001285029,0.00064530724,0.0014532694,0.00043657064,0.00045398978,0.00070303323,0.00021419836,0.00004550144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007545382,0.022458525,0.8871148,0.0002237525,0.0017543881,0.0019896678,0.0023964134,0.00002058972,0.0016905043,0.000020292307,0.0018629556,0.072922714],"study_design_scores_gemma":[0.122937344,0.018375678,0.8458696,0.00040713078,0.0014591522,0.0011008893,0.0010546525,0.00019979636,0.0048231184,0.000010099725,0.0026186255,0.0011439262],"about_ca_topic_score_codex":0.0021075066,"about_ca_topic_score_gemma":0.00026321659,"teacher_disagreement_score":0.11539196,"about_ca_system_score_codex":0.026842467,"about_ca_system_score_gemma":0.0024822245,"threshold_uncertainty_score":0.9997492},"labels":[],"label_agreement":null},{"id":"W4221033379","doi":"10.1158/1055-9965.epi-21-0875","title":"B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS","year":2022,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canadian Centre for Applied Research in Cancer Control","funders":"National Cancer Institute; Cancer Council NSW; Medical Research Council; Cancerfonden; Canadian Institutes of Health Research; Institut National Du Cancer; National Health and Medical Research Council; Michael Smith Health Research BC; University of California, San Francisco; Instituto de Salud Carlos III; Bundesamt für Strahlenschutz; Stockholms Läns Landsting; European Regional Development Fund; Bundesministerium für Bildung und Forschung; Ministerstvo Školství, Mládeže a Tělovýchovy; José Carreras Leukämie-Stiftung; University of Sydney; Blood Cancer UK; Karolinska Institutet; Compagnia di San Paolo; European Commission; Fondation de France; National Institutes of Health; Friends of José Carreras International Leukemia Foundation; Health Research Board; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Yale University","keywords":"Medicine; Immunology","score_opus":0.03089908156191701,"score_gpt":0.3246233621047775,"score_spread":0.2937242805428605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221033379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776832,0.016745929,0.00008575117,0.0034858373,0.00028763353,0.0007601593,0.00015630276,0.00009038483,0.0007047878],"genre_scores_gemma":[0.9938736,0.0014967864,0.00033096093,0.00058902736,0.000029481791,0.0009735079,0.00080094475,0.000020965672,0.0018847188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795604,0.0008501216,0.00036407245,0.0004103853,0.00011106432,0.00030833145],"domain_scores_gemma":[0.9986189,0.00054919824,0.00043536097,0.00022983219,0.000054492277,0.00011222171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010651189,0.00017600725,0.0004557627,0.00013780977,0.00040329344,0.00000431329,0.000055623004,0.00009823884,0.00068667304],"category_scores_gemma":[0.00022813879,0.00014464816,0.00012683214,0.0002673142,0.00018552464,0.000053795487,0.000065233144,0.00017686606,0.000007983907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038234555,0.000608115,0.97625625,0.000021682195,0.0011952429,0.000027137517,0.00006783769,0.00005453542,0.00020872016,0.00020833447,0.01664557,0.0043242085],"study_design_scores_gemma":[0.004758711,0.0010447229,0.9851738,0.00010192357,0.0010132405,0.00003891791,0.00012436676,0.00039757206,0.0001011796,0.0013941573,0.0056991405,0.0001522702],"about_ca_topic_score_codex":0.00053817825,"about_ca_topic_score_gemma":0.00010950948,"teacher_disagreement_score":0.016190391,"about_ca_system_score_codex":0.0005647276,"about_ca_system_score_gemma":0.0002157751,"threshold_uncertainty_score":0.75185883},"labels":[],"label_agreement":null},{"id":"W4221132712","doi":"10.3324/haematol.2022.280721","title":"A BAFFling &lt;i&gt;ménage à trois&lt;/i&gt; in mantle cell lymphoma","year":2022,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Cancer research; Chemistry; Lymphoma; Geology; Internal medicine; Geochemistry; Biology; Medicine","score_opus":0.01933096996494044,"score_gpt":0.24076534449651932,"score_spread":0.22143437453157888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221132712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5797933,0.109846435,0.00003571403,0.12653187,0.007428925,0.0047832658,0.0006879375,0.0005650941,0.17032751],"genre_scores_gemma":[0.8574555,0.008167072,0.0018218083,0.0891387,0.0030781603,0.003298224,0.002109538,0.00037759764,0.0345534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99140036,0.000874071,0.0017760942,0.0021551736,0.0013373352,0.0024569784],"domain_scores_gemma":[0.995429,0.0014812808,0.0007990082,0.0017207322,0.00010359549,0.0004663891],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0006874068,0.0015737112,0.0032726687,0.0007691766,0.0005307864,0.0001439243,0.00094137236,0.0016366858,0.017259859],"category_scores_gemma":[0.00024398939,0.0013430784,0.0010659586,0.0009366388,0.00040443733,0.00015280131,0.0008194258,0.0010404204,0.0046654423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056956784,0.008319799,0.013070713,0.0029295937,0.0007169825,0.20958193,0.0013652247,0.00006681467,0.0011813554,0.0052732974,0.74713254,0.009792177],"study_design_scores_gemma":[0.011185735,0.0014077288,0.01670666,0.0014169718,0.001072835,0.0036289478,0.00022274604,0.00031478595,0.0014043233,0.00035548638,0.96094894,0.0013348556],"about_ca_topic_score_codex":0.00021223209,"about_ca_topic_score_gemma":0.00017631815,"teacher_disagreement_score":0.27766225,"about_ca_system_score_codex":0.0025095483,"about_ca_system_score_gemma":0.00055905513,"threshold_uncertainty_score":0.9997011},"labels":[],"label_agreement":null},{"id":"W4223929697","doi":"10.1016/j.clml.2022.04.010","title":"Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Vincristine; Oncology; Rituximab; Prednisone; Lymphoma; Cyclophosphamide; B symptoms; Diffuse large B-cell lymphoma; Gastroenterology; Chemotherapy","score_opus":0.03097032527377933,"score_gpt":0.33002867521397455,"score_spread":0.2990583499401952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223929697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707086,0.0014094417,0.000050501865,0.005476139,0.001288558,0.0024632127,0.0017436645,0.00016707036,0.00033056678],"genre_scores_gemma":[0.9814336,0.00012872073,0.003472951,0.008600062,0.0012158527,0.0019464408,0.0011040393,0.0001335727,0.0019648117],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9943883,0.00034647537,0.0021784236,0.0015171125,0.0007177988,0.00085191615],"domain_scores_gemma":[0.99486405,0.0025309029,0.0004436306,0.0013237182,0.00023687929,0.00060081336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015826981,0.00056891434,0.0015503886,0.00024482282,0.00025606412,0.000065797496,0.00044339857,0.0002068039,0.00052978174],"category_scores_gemma":[0.0027121103,0.0005160976,0.00071198045,0.00079534197,0.00011355961,0.00011907755,0.0003496586,0.00029967361,0.00025560413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016826697,0.0059759365,0.23330729,0.000051516592,0.00072202826,0.0010885238,0.0007913133,0.00005508233,0.00083678024,0.00013550752,0.035462305,0.704747],"study_design_scores_gemma":[0.028187655,0.0015858179,0.77514714,0.00011236301,0.00025975655,0.000090576155,0.00013593842,0.0014992286,0.0015008864,0.00013552676,0.190906,0.0004391021],"about_ca_topic_score_codex":0.0017629523,"about_ca_topic_score_gemma":0.000042070715,"teacher_disagreement_score":0.7043079,"about_ca_system_score_codex":0.002019446,"about_ca_system_score_gemma":0.0016707475,"threshold_uncertainty_score":0.99972904},"labels":[],"label_agreement":null},{"id":"W4224233239","doi":"10.14740/jh984","title":"Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Univariate analysis; Lymphoma; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Stage (stratigraphy); Malignancy; Survival analysis; Epidemiology; Multivariate analysis; Biology; Confidence interval","score_opus":0.015828599523270023,"score_gpt":0.24927437067204802,"score_spread":0.23344577114877801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224233239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931465,0.0048472756,0.0003038311,0.000518216,0.00023566038,0.00027234972,0.00009265421,0.000021848826,0.00056165765],"genre_scores_gemma":[0.9973197,0.00018965662,0.0019426497,0.0001642342,0.000098202734,0.000017896302,0.000031434185,0.000051516894,0.00018472123],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969515,0.0002491454,0.0010818659,0.00036507647,0.00071873347,0.0006336484],"domain_scores_gemma":[0.99749464,0.00043745415,0.0010771712,0.0003807773,0.00023667842,0.00037327936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004659873,0.0003757489,0.0014805238,0.0003222494,0.00022830111,0.00002547797,0.00021401983,0.000082730054,0.00019897902],"category_scores_gemma":[0.000038471288,0.00028262817,0.0002740759,0.00023122456,0.00015390408,0.000086273496,0.00020770742,0.0002375559,0.000013310206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003750166,0.095948085,0.8837139,0.0002574575,0.00017909464,0.007131408,0.0008399451,0.000004447201,0.0023121461,0.00118732,0.004210494,0.00046552488],"study_design_scores_gemma":[0.4275242,0.017739058,0.37761906,0.0005572249,0.0012624797,0.11777957,0.006916958,0.00077779585,0.013838647,0.00009880204,0.035081927,0.00080426224],"about_ca_topic_score_codex":0.000022988408,"about_ca_topic_score_gemma":0.000034951892,"teacher_disagreement_score":0.5060948,"about_ca_system_score_codex":0.0002790789,"about_ca_system_score_gemma":0.00031477303,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W4224247201","doi":"10.1182/bloodadvances.2022007371","title":"Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Internal medicine; Bendamustine; Autologous stem-cell transplantation; Hazard ratio; DHAP; International Prognostic Index; Population; Vincristine; Cytarabine; Oncology; CHOP; Gastroenterology; Transplantation; Surgery; Confidence interval; Chemotherapy; Cyclophosphamide; Lymphoma","score_opus":0.010377656319082246,"score_gpt":0.23452596157555222,"score_spread":0.22414830525646998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224247201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940029,0.002893226,0.000019922505,0.00096946314,0.000164118,0.0005632897,0.00010407557,0.00008445475,0.0011986003],"genre_scores_gemma":[0.9960821,0.00043605827,0.0020206112,0.00031783138,0.00008190224,0.00045325872,0.00020127681,0.000025191133,0.0003817503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986029,0.00004725958,0.00025599767,0.0004068443,0.00037501287,0.00031194446],"domain_scores_gemma":[0.9994607,0.000071782975,0.00009606775,0.00024247532,0.000030135436,0.0000988209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087207074,0.00022310724,0.0003779426,0.00018866769,0.0001554303,0.000013981394,0.000090281326,0.00003743286,0.00029000052],"category_scores_gemma":[0.0000059369017,0.00015592322,0.000057079284,0.0004505371,0.00003673771,0.00013023753,0.000015668626,0.00009367334,0.0000136995295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031654835,0.13245806,0.632269,0.001898331,0.00062832993,0.020358758,0.0016179052,0.010130759,0.013593759,0.00088550703,0.0011125157,0.15339221],"study_design_scores_gemma":[0.2784897,0.013603435,0.3349757,0.0006462417,0.0016167919,0.001770117,0.001352977,0.00045325301,0.29500124,0.00012731714,0.07083556,0.0011276525],"about_ca_topic_score_codex":0.00043918766,"about_ca_topic_score_gemma":0.00030787507,"teacher_disagreement_score":0.29729334,"about_ca_system_score_codex":0.00012188241,"about_ca_system_score_gemma":0.00026199588,"threshold_uncertainty_score":0.6358364},"labels":[],"label_agreement":null},{"id":"W4224249897","doi":"10.23937/2572-4061.1510044","title":"Meta-Analyses of Glyphosate and Non-Hodgkin's Lymphoma: Expert Panel Conclusions and Recommendations","year":2022,"lang":"en","type":"article","venue":"Journal of Toxicology and Risk Assessment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Confidence interval; Transparency (behavior); Meta-analysis; Delphi method; Delphi; Medicine; Actuarial science; Psychology; Computer science; Internal medicine; Artificial intelligence; Business","score_opus":0.10865569742734502,"score_gpt":0.4060788755900521,"score_spread":0.29742317816270714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224249897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97993886,0.009719834,0.00011340837,0.009569625,0.00018548276,0.0001957903,0.00005433477,0.000003573785,0.00021910116],"genre_scores_gemma":[0.97760886,0.015613063,0.006058022,0.00053681876,0.00003891368,0.000039476574,0.0000069267344,0.0000076014735,0.00009031124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987182,0.0002659747,0.0005201248,0.00016064783,0.00020456091,0.00013049979],"domain_scores_gemma":[0.99859524,0.00043866195,0.00058806647,0.000121470424,0.00010097495,0.00015561823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006198998,0.00013958389,0.00077705755,0.00017805575,0.00037721306,0.000013498307,0.000050736384,0.000056534136,0.0003282147],"category_scores_gemma":[0.000036813213,0.00008819881,0.00018166448,0.00008857445,0.00012255185,0.00007453701,0.0001893196,0.00015078034,1.6510417e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016696615,0.013159792,0.68720233,0.00014586693,0.07559165,0.0015399163,0.0057316897,0.00021964956,0.04034075,0.001971465,0.021734955,0.15069225],"study_design_scores_gemma":[0.011760384,0.007189938,0.9243192,0.000038041795,0.024002522,0.0027985482,0.004238169,0.00047954192,0.00404457,0.00068805687,0.020234099,0.0002069376],"about_ca_topic_score_codex":0.00017759956,"about_ca_topic_score_gemma":0.000016639142,"teacher_disagreement_score":0.23711684,"about_ca_system_score_codex":0.00012293199,"about_ca_system_score_gemma":0.00020281701,"threshold_uncertainty_score":0.35966432},"labels":[],"label_agreement":null},{"id":"W4224951853","doi":"10.5858/arpa.2021-0270-oa","title":"Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus","year":2022,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"CD30; Immunohistochemistry; Lymphoma; Interpretation (philosophy); Expression (computer science)","score_opus":0.09004673625816205,"score_gpt":0.378134560592077,"score_spread":0.28808782433391494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224951853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872696,0.007151183,0.0000039313422,0.0017930506,0.00011892135,0.00025638685,0.000022569484,0.000029178504,0.0033551753],"genre_scores_gemma":[0.99641025,0.00016345305,0.002315099,0.00072855287,0.000066192166,0.00013482063,0.00006848534,0.000017397093,0.0000957724],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99805087,0.0002631929,0.000895183,0.00040467776,0.00019583416,0.000190215],"domain_scores_gemma":[0.99687827,0.0008269784,0.0016765342,0.0003999099,0.00009663054,0.0001216795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006364325,0.0001663335,0.00053991046,0.00017331656,0.00010639355,0.0000027037195,0.00008972276,0.00004368343,0.000064894375],"category_scores_gemma":[0.004983656,0.00014067555,0.000027850061,0.00022300314,0.00069364236,0.0000388307,0.00009964405,0.0002353999,6.741713e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005410315,0.0010197363,0.4746893,0.00011467538,0.00006899728,0.0058482396,0.012364986,0.000006234109,0.4935566,0.00008502097,0.00022295384,0.01148222],"study_design_scores_gemma":[0.01129281,0.0088390345,0.91141,0.0009510271,0.00046298196,0.008036374,0.03515249,0.00063450926,0.018686745,0.00052749313,0.0035723154,0.00043422944],"about_ca_topic_score_codex":0.00036410007,"about_ca_topic_score_gemma":0.000015009731,"teacher_disagreement_score":0.47486985,"about_ca_system_score_codex":0.000061194885,"about_ca_system_score_gemma":0.0003393985,"threshold_uncertainty_score":0.59662616},"labels":[],"label_agreement":null},{"id":"W4225293015","doi":"10.1182/bloodadvances.2021005884","title":"Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphatic system; Biology; Cell; Pathology; Medicine; Immunology; Genetics","score_opus":0.00688538274554182,"score_gpt":0.2418810157163055,"score_spread":0.23499563297076367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225293015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768919,0.016045615,0.0000032434884,0.0017379798,0.00035576778,0.0006790823,0.00007185183,0.00002792238,0.004186634],"genre_scores_gemma":[0.99660444,0.0004133943,0.0003101271,0.0010675624,0.0000798225,0.00032643168,0.000031557218,0.000023172259,0.0011434614],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869984,0.00007109821,0.0002851514,0.00031602202,0.00035220312,0.00027568405],"domain_scores_gemma":[0.99925387,0.000118377946,0.00012544425,0.0003808479,0.000032200627,0.00008926246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013532309,0.00018457437,0.00031550284,0.00009900174,0.00009458888,0.000009994567,0.00020880323,0.000036018322,0.00021854068],"category_scores_gemma":[0.00001165182,0.00012464085,0.000106472915,0.00032661977,0.00003342058,0.000056166897,0.00012529978,0.00008887392,0.000034238863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064871926,0.005429417,0.9591378,0.00033241746,0.000099468045,0.00033261525,0.0022589527,0.00081553357,0.0042457916,0.00014588512,0.0040001892,0.022553219],"study_design_scores_gemma":[0.014735438,0.0024352681,0.1507036,0.00015175133,0.00042541974,0.0001502683,0.0021601452,0.00003710021,0.228071,0.00024410711,0.6004324,0.0004535029],"about_ca_topic_score_codex":0.00030712475,"about_ca_topic_score_gemma":0.0000812302,"teacher_disagreement_score":0.8084342,"about_ca_system_score_codex":0.00014875439,"about_ca_system_score_gemma":0.00014974736,"threshold_uncertainty_score":0.5082707},"labels":[],"label_agreement":null},{"id":"W4225305158","doi":"10.1080/10428194.2022.2064981","title":"Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL","year":2022,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Blinatumomab; Medicine; Chemotherapy; Oncology; Internal medicine; Leukemia; Lymphoblastic Leukemia","score_opus":0.009542903617033152,"score_gpt":0.2629823416724143,"score_spread":0.25343943805538116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225305158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911615,0.003195075,0.000011776445,0.0002568739,0.00027767755,0.0040198294,0.0003171634,0.00013902984,0.0006210755],"genre_scores_gemma":[0.99197984,0.0011662623,0.0010978135,0.0013486379,0.00016844811,0.0032503265,0.00026025288,0.00020188236,0.00052655325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99400944,0.00044610535,0.0014156329,0.0017883042,0.001269767,0.0010707639],"domain_scores_gemma":[0.99655616,0.00039839654,0.0007457061,0.0015188355,0.000200752,0.0005801531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000602701,0.0010429823,0.0019620962,0.0006717588,0.00048585003,0.0001470621,0.00080587226,0.0002661515,0.00036218512],"category_scores_gemma":[0.00006913303,0.0008686416,0.00016051196,0.0013544911,0.00026870501,0.0004502167,0.0008783379,0.00028368138,0.000020487201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06597168,0.057725012,0.46118817,0.00031089905,0.001328603,0.012158435,0.0096667,0.00019879935,0.00014908529,0.00020239594,0.0025341974,0.38856602],"study_design_scores_gemma":[0.47398984,0.019676104,0.4914822,0.00046092106,0.00071390194,0.0007996419,0.005113047,0.0019805895,0.0007701466,0.000094619776,0.0040151034,0.0009038581],"about_ca_topic_score_codex":0.030736612,"about_ca_topic_score_gemma":0.0020841628,"teacher_disagreement_score":0.40801817,"about_ca_system_score_codex":0.008133803,"about_ca_system_score_gemma":0.003016292,"threshold_uncertainty_score":0.9993764},"labels":[],"label_agreement":null},{"id":"W4225424677","doi":"10.1016/j.clml.2021.10.018","title":"Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Outcome (game theory); Lymphoma; Retrospective cohort study; T-cell lymphoma; Internal medicine; Oncology; General surgery; Family medicine","score_opus":0.03910560402765996,"score_gpt":0.3267734776531193,"score_spread":0.28766787362545937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225424677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970083,0.00089975196,0.00010784024,0.00017760943,0.00043011756,0.0003998726,0.000146855,0.00005651337,0.000773122],"genre_scores_gemma":[0.9933988,0.0012641437,0.0036907329,0.00085139944,0.00019415877,0.00009700706,0.00016890574,0.000036686033,0.0002982099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961351,0.00015597584,0.0017044455,0.0009848188,0.00051004096,0.00050958694],"domain_scores_gemma":[0.9976562,0.00048592142,0.0004206367,0.0006678181,0.00031880513,0.00045058312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002302344,0.00044716388,0.0014721821,0.000130535,0.00012251343,0.000037592992,0.00017750074,0.000299919,0.000098268116],"category_scores_gemma":[0.0010408729,0.00037944605,0.00040412458,0.0006030543,0.00088888145,0.00016014757,0.00020823177,0.00015787185,0.00006127317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003578374,0.002659412,0.85358113,0.000112399954,0.00008946154,0.002455216,0.0004565626,0.0000015898596,0.00032299667,0.00022542078,0.000038229384,0.13969976],"study_design_scores_gemma":[0.014822402,0.00043613295,0.9794963,0.00016892554,0.00015289595,0.00034224326,0.0002441885,0.00060221495,0.0017222419,0.000019678635,0.0016528406,0.00033993585],"about_ca_topic_score_codex":0.00025697923,"about_ca_topic_score_gemma":0.00016580377,"teacher_disagreement_score":0.13935982,"about_ca_system_score_codex":0.0014982892,"about_ca_system_score_gemma":0.0015490622,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W4225775959","doi":"10.1097/hs9.0000000000000705","title":"Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Germinal center; Medicine; Internal medicine; Oncology; Cancer research; Pathology; B cell; Immunology; Antibody","score_opus":0.027527033035187592,"score_gpt":0.2662789280037343,"score_spread":0.23875189496854674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225775959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98486185,0.0043445723,0.000035818313,0.00027518318,0.0003777076,0.0006506483,0.00022584992,0.00006642252,0.009161932],"genre_scores_gemma":[0.9976857,0.0000737956,0.00037423943,0.00013244516,0.00007398078,0.0003865571,0.0001300848,0.000026576132,0.0011166299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857074,0.000044396787,0.00031493584,0.0002995144,0.00050489564,0.00026550228],"domain_scores_gemma":[0.9990432,0.00038036794,0.00013541336,0.00022970788,0.000090070636,0.000121215155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007470597,0.00019229132,0.0004338854,0.00005920826,0.00024225285,0.000020243757,0.00010908887,0.000037178586,0.0050558527],"category_scores_gemma":[0.00005873667,0.00017820488,0.000184774,0.0002662855,0.000078006604,0.000053818632,0.00018777515,0.000103749255,0.000032448104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016985471,0.0019529819,0.9723302,0.00023506128,0.00051885954,0.00042608,0.00074298284,0.0001327245,0.0009366957,0.0052513145,0.011055435,0.0062477826],"study_design_scores_gemma":[0.011249347,0.0015117457,0.9337176,0.00038332955,0.00055787823,0.0003815371,0.0008858311,0.0005405526,0.011484896,0.0004899709,0.03840484,0.00039243983],"about_ca_topic_score_codex":0.00045436245,"about_ca_topic_score_gemma":0.000076998615,"teacher_disagreement_score":0.038612597,"about_ca_system_score_codex":0.00058630056,"about_ca_system_score_gemma":0.00030621584,"threshold_uncertainty_score":0.99585366},"labels":[],"label_agreement":null},{"id":"W4226075892","doi":"10.3389/fnume.2022.829138","title":"Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles &lt;71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Frontiers in Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Université de Bretagne Occidentale","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; Prednisone; Diffuse large B-cell lymphoma; Cyclophosphamide; Oncology; Etoposide; Progression-free survival; Survival analysis; Lymphoma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.01759440043442422,"score_gpt":0.28829007480590924,"score_spread":0.270695674371485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226075892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927865,0.0026042624,0.000039155628,0.0016406308,0.0008975957,0.0014457931,0.00010078464,0.00006379717,0.00042146025],"genre_scores_gemma":[0.9954015,0.00048733313,0.0030333924,0.00011819453,0.000119689874,0.0005912733,0.00008929163,0.00007350957,0.000085792235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966516,0.0002762029,0.0008261886,0.00075981533,0.00095850235,0.0005277143],"domain_scores_gemma":[0.99852717,0.00021989355,0.00025981138,0.0005558111,0.000054884174,0.0003824159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006153713,0.000428431,0.0010825327,0.00042407194,0.00014501256,0.00002680191,0.00015168349,0.00011318198,0.000053113286],"category_scores_gemma":[0.00024352038,0.00034116022,0.000088469154,0.00024487756,0.00019370925,0.00016427085,0.0005606645,0.00016261244,0.0000019719505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028179238,0.026310079,0.8737063,0.0015861712,0.0005031165,0.005432796,0.017973114,0.000011675549,0.02094349,0.00045598735,0.017711408,0.0071866196],"study_design_scores_gemma":[0.23271583,0.012991515,0.67313564,0.008249148,0.0010465505,0.0016034291,0.046048842,0.006079452,0.0078115747,0.00013143326,0.008959533,0.0012270372],"about_ca_topic_score_codex":0.0005124089,"about_ca_topic_score_gemma":0.000029320345,"teacher_disagreement_score":0.20453659,"about_ca_system_score_codex":0.0014870013,"about_ca_system_score_gemma":0.00014984101,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W4226189987","doi":"","title":"Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma","year":2021,"lang":"en","type":"editorial","venue":"The Journal of the American Medical Association (JAMA) Network (American Medical Association)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Toronto","funders":"St. Baldrick's Foundation","keywords":"Radiation oncology; Hodgkin lymphoma; Medicine; Stage (stratigraphy); Oncology; Lymphoma; Internal medicine; Radiation therapy; Proton therapy; Medical physics; Biology","score_opus":0.023083579198251932,"score_gpt":0.3506722800612397,"score_spread":0.32758870086298775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226189987","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7767102,0.0035855102,0.00012894494,0.08258981,0.1292536,0.007148738,0.00033864158,0.00007665358,0.00016787648],"genre_scores_gemma":[0.26070634,0.04155341,0.0014418948,0.028079648,0.66210526,0.0026614987,0.0013830959,0.00036885584,0.0016999966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97356534,0.0089046545,0.003903183,0.000741751,0.011506631,0.0013784573],"domain_scores_gemma":[0.94237894,0.03983,0.014639968,0.00069362164,0.0017153095,0.00074214966],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0276369,0.0008188985,0.003834404,0.00035103844,0.00038385144,0.00027071583,0.0013222969,0.0017411185,0.00018558546],"category_scores_gemma":[0.11114643,0.0005327841,0.0011836163,0.0023274678,0.0005634319,0.0005181795,0.00030500072,0.004095768,0.000007960219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.021659296,0.002541189,0.26280177,0.000050564886,0.001946944,0.000115542105,0.00037426778,0.00014122164,0.0000022532943,0.00001668448,0.5245661,0.18578416],"study_design_scores_gemma":[0.18617262,0.010156185,0.37817553,0.0027479075,0.0010422653,0.000047792568,0.0008424781,0.0012859976,0.000019148118,0.00016789582,0.41843843,0.0009037381],"about_ca_topic_score_codex":0.0041314834,"about_ca_topic_score_gemma":0.0014062505,"teacher_disagreement_score":0.5328517,"about_ca_system_score_codex":0.013717822,"about_ca_system_score_gemma":0.012033579,"threshold_uncertainty_score":0.99971235},"labels":[],"label_agreement":null},{"id":"W4229005543","doi":"10.1080/10428194.2022.2060505","title":"Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review","year":2022,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine","score_opus":0.029441916850048464,"score_gpt":0.30669290550330847,"score_spread":0.27725098865326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229005543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011354898,0.98174673,0.00004442344,0.00021041626,0.0013586853,0.009281763,0.0012817617,0.0005807792,0.0043599284],"genre_scores_gemma":[0.0002578679,0.97367775,0.0011620534,0.0024938213,0.0012452801,0.010536963,0.0037023046,0.0007841472,0.006139806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881962,0.0005922899,0.0033659306,0.0036315494,0.0018308776,0.0023831676],"domain_scores_gemma":[0.9921995,0.0013755006,0.0020827046,0.0028390458,0.00033662273,0.0011666574],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013032256,0.0033372792,0.010240975,0.00096629397,0.0013043345,0.00031606556,0.0010485254,0.0014608973,0.0012293467],"category_scores_gemma":[0.00036997735,0.0028075243,0.0042829076,0.0018969608,0.00063705444,0.00041790056,0.0006326068,0.00039697668,0.00022825568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00073820556,0.0010959981,0.00009425787,0.046075154,0.0034515553,0.0019916492,0.00016097548,3.12168e-7,0.0000019325785,0.0011105434,0.02925861,0.9160208],"study_design_scores_gemma":[0.028450152,0.0019383891,0.0012331945,0.03702183,0.011114213,0.017110469,0.00008390046,0.000055482575,0.000011863746,0.00010193508,0.90046895,0.0024096107],"about_ca_topic_score_codex":0.001122851,"about_ca_topic_score_gemma":0.000023427572,"teacher_disagreement_score":0.9136112,"about_ca_system_score_codex":0.05380495,"about_ca_system_score_gemma":0.016650455,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W4229083035","doi":"10.3324/haematol.2021.278438","title":"Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; Takeda Oncology","keywords":"Classical Hodgkin lymphoma; Medicine; Hodgkin lymphoma; Stage (stratigraphy); Lymphoma; Internal medicine; Oncology; Gerontology; Biology","score_opus":0.016657081744397482,"score_gpt":0.28360123698800677,"score_spread":0.26694415524360926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229083035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661183,0.00070775376,0.00006786747,0.00045726384,0.000047303958,0.0015326709,0.00009133028,0.00014149248,0.0003424606],"genre_scores_gemma":[0.9971008,0.00007351346,0.00070862053,0.00053812563,0.000027331209,0.0004464882,0.00058696495,0.000029144134,0.0004890463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973286,0.00035559805,0.0005006087,0.0008218614,0.00054950087,0.00044387192],"domain_scores_gemma":[0.9979399,0.0004212526,0.00023878881,0.0009789912,0.00019646238,0.0002246195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012937307,0.0003814462,0.0012010527,0.00008718037,0.00020166281,0.00007478349,0.0001818085,0.00014023867,0.0009238556],"category_scores_gemma":[0.0001545954,0.00020383945,0.00031492172,0.0010492228,0.00012456272,0.000073301475,0.00012905488,0.00012840495,0.00008234717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569107,0.01731892,0.9509521,0.000015218391,0.0045637367,0.013653165,0.0017771771,0.000011738359,0.000029047353,0.00003798182,0.00063460704,0.009449389],"study_design_scores_gemma":[0.046478517,0.0015222688,0.94245917,0.00009134437,0.005738031,0.000041830906,0.0016589145,0.00011823653,0.0010044372,0.00000944379,0.00062289013,0.00025491568],"about_ca_topic_score_codex":0.00019394413,"about_ca_topic_score_gemma":0.001299557,"teacher_disagreement_score":0.044921607,"about_ca_system_score_codex":0.00020047821,"about_ca_system_score_gemma":0.00018297885,"threshold_uncertainty_score":0.99998945},"labels":[],"label_agreement":null},{"id":"W4229460053","doi":"10.3390/curroncol29050278","title":"STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Genome instability; Lymphoma; Genome; Microsatellite instability; Computational biology; Pathology; Cancer research; Genetics; Gene; Biology; DNA; Microsatellite","score_opus":0.06510713494232942,"score_gpt":0.3450845879054133,"score_spread":0.27997745296308385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229460053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714995,0.0042429976,0.000004133411,0.00054721517,0.0009081811,0.0010394753,0.0000734746,0.000051216277,0.0059833247],"genre_scores_gemma":[0.9974717,0.00011323564,0.0005130026,0.0004276863,0.00018414318,0.00092707464,0.0002849802,0.000019722487,0.000058448564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788934,0.00028920555,0.0005320352,0.00050306343,0.00034556512,0.00044081552],"domain_scores_gemma":[0.99902284,0.00022940444,0.00017755147,0.00032616322,0.000060480266,0.00018358494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005961011,0.0002021628,0.0005823069,0.00017753537,0.00012350343,0.0000067104893,0.00015015503,0.000049267197,0.00043575882],"category_scores_gemma":[0.00009401611,0.00018448239,0.00012093714,0.00030290912,0.00007403467,0.00004571002,0.00030737475,0.00024120476,0.000040665887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063893455,0.016806815,0.90573364,0.00038055607,0.00003174466,0.00090611953,0.0006230484,0.000015894391,0.002303448,0.0002014562,0.0005920658,0.071766295],"study_design_scores_gemma":[0.014024855,0.0019675968,0.9052246,0.000038726586,0.00010685311,0.00032842893,0.00050162553,0.000081226615,0.0005684307,0.00014450606,0.07680116,0.00021198236],"about_ca_topic_score_codex":0.00002657694,"about_ca_topic_score_gemma":0.0000106683065,"teacher_disagreement_score":0.07620909,"about_ca_system_score_codex":0.004170278,"about_ca_system_score_gemma":0.0011721328,"threshold_uncertainty_score":0.99965256},"labels":[],"label_agreement":null},{"id":"W4229720161","doi":"10.3410/f.732930117.793577562","title":"Faculty Opinions recommendation of The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Outcome (game theory); Medicine; Lymphoma; Peripheral; Internal medicine; Oncology; Family medicine","score_opus":0.0384795683761278,"score_gpt":0.34552903255688244,"score_spread":0.3070494641807546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229720161","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009768514,0.0008423338,0.0000062843224,0.15607871,0.0011441915,0.0033980361,0.8383053,0.000023925579,0.00010355392],"genre_scores_gemma":[0.001488177,0.0007446903,0.00037875035,0.004475044,0.00037903583,0.0005460906,0.9913803,0.00003552638,0.00057241693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944162,0.00034100603,0.002208153,0.00077616534,0.0019829005,0.00027558923],"domain_scores_gemma":[0.99021894,0.00024463853,0.0028270737,0.0016779014,0.004858804,0.00017261712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006604099,0.00058653974,0.0011288457,0.00014021814,0.00025433305,0.00009825761,0.0015115719,0.0004597495,0.00021484421],"category_scores_gemma":[0.0040621753,0.00027307274,0.0010922942,0.0013707698,0.00033612998,0.000194563,0.00061237544,0.0005929671,0.000015157861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009288282,0.0030093063,0.008298078,0.0020175648,0.0004181825,0.0000013239871,0.00036068694,1.4204939e-7,0.000002247657,0.000016275677,0.98390865,0.0018746828],"study_design_scores_gemma":[0.0042858473,0.0002622566,0.07567326,0.0046557807,0.00037941424,0.000024126895,0.00005202565,0.000010455909,0.00012174496,0.000009275219,0.9143086,0.0002172142],"about_ca_topic_score_codex":0.00038346837,"about_ca_topic_score_gemma":0.00001662429,"teacher_disagreement_score":0.153075,"about_ca_system_score_codex":0.00036281854,"about_ca_system_score_gemma":0.00082021294,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W4230158136","doi":"10.3410/f.734986287.793577569","title":"Faculty Opinions recommendation of Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Refractory (planetary science); Randomized controlled trial; Peripheral; Medicine; Lymphoma; Peripheral T-cell lymphoma; Family medicine; Oncology; Internal medicine; T cell; Immunology; Biology","score_opus":0.03419327442181177,"score_gpt":0.33695724488223566,"score_spread":0.3027639704604239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230158136","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011063848,0.00046022894,0.0000026361718,0.02693354,0.0003448575,0.0074026543,0.9636967,0.00003657161,0.000016430466],"genre_scores_gemma":[0.0019026041,0.00021229821,0.00035335057,0.0026602254,0.000109977555,0.0008552192,0.993567,0.00004509429,0.00029423472],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992989,0.0011587505,0.0028195898,0.00084035326,0.0018373616,0.00035492855],"domain_scores_gemma":[0.98940784,0.00047706015,0.0028822978,0.0012865484,0.0053783813,0.0005678738],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085513387,0.000717236,0.0028743811,0.0004431359,0.0001272288,0.00006608138,0.0007653322,0.00053020276,0.00032049228],"category_scores_gemma":[0.014543418,0.0003621269,0.00050700345,0.003325196,0.00037338363,0.0002907941,0.0002500713,0.0005352214,0.000008182032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013797747,0.025200311,0.00028378065,0.0057367138,0.0007955388,0.0000033957308,0.0006472455,8.461263e-8,0.0000027064386,0.0000030374867,0.95232356,0.0012058546],"study_design_scores_gemma":[0.21491264,0.003539954,0.0066833296,0.009461739,0.0012100645,0.000006518535,0.00008113153,0.000005430948,0.00003088953,5.3429557e-7,0.76378787,0.00027990772],"about_ca_topic_score_codex":0.00032295912,"about_ca_topic_score_gemma":0.00005726503,"teacher_disagreement_score":0.2011149,"about_ca_system_score_codex":0.00046270946,"about_ca_system_score_gemma":0.0018833101,"threshold_uncertainty_score":0.99988306},"labels":[],"label_agreement":null},{"id":"W4230189396","doi":"10.1002/9780471420194.tnmc54.pub3","title":"Hodgkin Lymphoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Medicine; Biopsy; Internal medicine; Radiology; Oncology; Biology","score_opus":0.02642259021051842,"score_gpt":0.3238355317268078,"score_spread":0.2974129415162894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230189396","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041644624,0.0041642534,0.00000219193,0.0009005638,0.0004234438,0.00042715206,0.0028846695,0.00028304264,0.99049824],"genre_scores_gemma":[0.0009097699,0.0016526043,0.0017355632,0.00058474066,0.0017439437,0.00004524118,0.0036830138,0.00037324158,0.9892719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907637,0.000011516166,0.00012942147,0.00033052661,0.00022316849,0.000229011],"domain_scores_gemma":[0.9986742,0.000021640612,0.00019388528,0.0009284339,0.00002359869,0.00015822056],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000027006376,0.0002915966,0.00055612496,0.00013890656,0.000040961684,0.00001889173,0.00014003647,0.0002903696,0.013905866],"category_scores_gemma":[0.000053003707,0.00021542632,0.0001732369,0.000031910444,0.00006744106,0.000011654753,0.00005791502,0.00005571826,0.001384752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019953803,0.00086743396,0.000960898,0.000067016656,0.00025691072,0.0005262993,0.000006341813,5.8980882e-9,0.0000032576158,0.00003872758,0.85266554,0.1445876],"study_design_scores_gemma":[0.0030766942,0.00016938071,0.015479225,0.0010678379,0.0003079128,0.00008890264,0.000002960507,0.0000043162736,0.000040083218,0.000011287309,0.9795628,0.00018855504],"about_ca_topic_score_codex":0.0005627886,"about_ca_topic_score_gemma":0.00039570942,"teacher_disagreement_score":0.14439906,"about_ca_system_score_codex":0.0001287669,"about_ca_system_score_gemma":0.00020146013,"threshold_uncertainty_score":0.9993928},"labels":[],"label_agreement":null},{"id":"W4230270945","doi":"10.1182/blood-2019-124116","title":"Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Internal medicine; Vinblastine; Progression-free survival; Chemotherapy regimen; Clinical endpoint; Population; Oncology; Surgery; Procarbazine; Chemotherapy; Vincristine; Lymphoma; Randomized controlled trial; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.008803946367613627,"score_gpt":0.24582186709172427,"score_spread":0.23701792072411065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230270945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578667,0.00009313627,0.000008539403,0.0009841777,0.000079909136,0.0021701804,0.000046663194,0.000032822383,0.0007979287],"genre_scores_gemma":[0.99770576,0.000019376634,0.0006191904,0.0003166072,0.000066806984,0.00013584166,0.00001388545,0.000038317583,0.0010842193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886495,0.000037889607,0.00022596435,0.0003124837,0.0003226109,0.00023612283],"domain_scores_gemma":[0.9990476,0.00007543998,0.0001292521,0.0006001337,0.0000752398,0.00007235121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012605038,0.00018733856,0.00039898412,0.000037675105,0.000045482124,0.000016198355,0.00014492284,0.00006269949,0.000106961634],"category_scores_gemma":[0.000014454678,0.00010198852,0.00014811661,0.00014398627,0.000052866988,0.00003333207,0.000042340256,0.000044815944,0.000037247257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010152254,0.018457595,0.97171885,0.00009284229,0.00090596854,0.000019186678,0.00040147017,0.0000015120497,0.0014298509,0.000507393,0.00049902545,0.0049510994],"study_design_scores_gemma":[0.08720129,0.004455752,0.82341075,0.00012124195,0.00068546465,0.000026709618,0.00053232716,0.000030748968,0.077080145,0.000025952708,0.006249673,0.00017995795],"about_ca_topic_score_codex":0.0000430886,"about_ca_topic_score_gemma":0.000025638685,"teacher_disagreement_score":0.1483081,"about_ca_system_score_codex":0.000058300287,"about_ca_system_score_gemma":0.00017204383,"threshold_uncertainty_score":0.4158971},"labels":[],"label_agreement":null},{"id":"W4230576967","doi":"10.1182/blood.v116.21.2006.2006","title":"Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Stromal cell; Germinal center; Biology; Survival analysis; Tumor microenvironment; Oncology; Lymphoma; Cancer research; Medicine; Immune system; Computational biology; Internal medicine; B cell; Immunology; Antibody","score_opus":0.01764671600249155,"score_gpt":0.2466483515204561,"score_spread":0.22900163551796457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230576967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895334,0.00016193092,0.0000034284728,0.000112135494,0.00005430336,0.00024552536,0.00002716466,0.000007094879,0.00043507136],"genre_scores_gemma":[0.9994548,0.00004223965,0.00034708253,0.000057315876,0.000034353194,0.000030466683,0.000008272823,0.000009864284,0.000015607728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993562,0.000043058437,0.00018433116,0.00014893213,0.00015723678,0.000110259454],"domain_scores_gemma":[0.99949783,0.00013503569,0.000095017094,0.0002226807,0.000011249164,0.000038156944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017349546,0.00008818002,0.00016863964,0.000046677993,0.000033026685,0.0000033833642,0.000033888005,0.000031532654,0.000022345248],"category_scores_gemma":[0.00002818427,0.00005415056,0.00003993152,0.000045410103,0.00003315586,0.000012353663,0.000027019605,0.000044018543,0.0000012870701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000682284,0.012184697,0.46446073,0.00003897473,0.000009770868,0.000012844495,0.00010630067,9.045652e-7,0.5226173,0.000016972901,0.000009985626,0.0004733505],"study_design_scores_gemma":[0.020985976,0.00023554818,0.3062351,0.00010143497,0.000066437664,0.000005685226,0.000059626207,0.00009682896,0.6720742,0.0000049292075,0.00010640709,0.000027819167],"about_ca_topic_score_codex":0.00006305779,"about_ca_topic_score_gemma":0.00002479559,"teacher_disagreement_score":0.15822563,"about_ca_system_score_codex":0.000017594104,"about_ca_system_score_gemma":0.000020295467,"threshold_uncertainty_score":0.22081958},"labels":[],"label_agreement":null},{"id":"W4231085890","doi":"10.1182/blood.v110.11.360.360","title":"Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Follicular lymphoma; Fluorescence in situ hybridization; Biology; Comparative genomic hybridization; Molecular biology; Lymphoma; clone (Java method); In situ hybridization; Immunohistochemistry; Gene; Gene expression; Genetics; Chromosome; Immunology","score_opus":0.010667655400651685,"score_gpt":0.2430981211410825,"score_spread":0.23243046574043083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231085890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951367,0.0036544318,0.00036807085,0.00015494543,0.000011256352,0.0005197321,0.000003070217,0.00001971919,0.00013212346],"genre_scores_gemma":[0.9913016,0.00043264285,0.007976363,0.00008351612,0.000042964835,0.00008729784,0.000024059062,0.000013942277,0.00003759476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932486,0.000016609141,0.00015551831,0.0002276249,0.0001340623,0.00014131409],"domain_scores_gemma":[0.9996924,0.000020526802,0.000031483825,0.0001338763,0.000027836999,0.00009390322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058299185,0.00011932875,0.00016870418,0.000075814874,0.000050831008,0.000019236175,0.000015716876,0.000054051667,0.000009345413],"category_scores_gemma":[0.0000065728827,0.00008027167,0.00001539716,0.00007597088,0.00003698434,0.00004561051,0.000008023724,0.000026921862,0.0000012126134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010409177,0.00080855243,0.9339536,0.000041378258,0.000046223737,0.00011351592,0.00041226746,0.0000015118753,0.05912257,0.00002234531,0.0000102354625,0.0053637307],"study_design_scores_gemma":[0.007715412,0.00020441241,0.64016014,0.00013639287,0.000113299546,0.00023445139,0.000028907187,0.00002995569,0.3512595,0.000014988599,0.00003528732,0.000067239416],"about_ca_topic_score_codex":0.00003688507,"about_ca_topic_score_gemma":0.000040561292,"teacher_disagreement_score":0.29379344,"about_ca_system_score_codex":0.000023483592,"about_ca_system_score_gemma":0.000032666074,"threshold_uncertainty_score":0.32733834},"labels":[],"label_agreement":null},{"id":"W4231147894","doi":"10.1002/(sici)1097-0142(20000215)88:4<894::aid-cncr21>3.3.co;2-f","title":"Bone marrow staging of patients with non‐Hodgkin lymphoma by flow cytometry","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Bone marrow; Lymphoma; Pathology; Flow cytometry; Immunology","score_opus":0.005160308511322926,"score_gpt":0.23412362032351106,"score_spread":0.22896331181218813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231147894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513155,0.00130008,0.00000992049,0.00020250541,0.000059078116,0.00025793666,0.00016230442,0.000020289186,0.0028563295],"genre_scores_gemma":[0.99701875,0.0002789753,0.00036004515,0.00049408764,0.000049740007,0.00008030019,0.000080513855,0.000022801629,0.0016147902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991655,0.000008941146,0.00016013204,0.00020234534,0.0002628507,0.00020026696],"domain_scores_gemma":[0.99952674,0.00001854026,0.000055429606,0.00022003186,0.000069205154,0.0001100827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000029048686,0.00013324138,0.00027249724,0.0000553295,0.000031727443,0.000007245429,0.00003997163,0.000042882766,0.0022490176],"category_scores_gemma":[0.0000041058597,0.000093759,0.000050520484,0.00020591421,0.00004550304,0.00005268695,0.000009270908,0.000025067577,0.00003378668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033983623,0.00060896575,0.7066468,0.00005213066,0.00013080884,0.000022758857,0.0001175845,0.000012234416,0.0001812062,0.0000012462964,0.010695148,0.28119126],"study_design_scores_gemma":[0.010063741,0.00041296106,0.9508933,0.00025184025,0.0001791332,0.0000026768396,0.000020821983,0.00009274529,0.013848349,0.0000025751183,0.024089834,0.00014206424],"about_ca_topic_score_codex":0.00023123146,"about_ca_topic_score_gemma":0.000008406152,"teacher_disagreement_score":0.2810492,"about_ca_system_score_codex":0.00027428905,"about_ca_system_score_gemma":0.00010396648,"threshold_uncertainty_score":0.99866307},"labels":[],"label_agreement":null},{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","score_opus":0.007872528325920655,"score_gpt":0.2359594050837431,"score_spread":0.22808687675782247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231537586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776929,0.0012475887,0.0002686256,0.016223807,0.00027212445,0.0032251568,0.00019280161,0.00008597828,0.00079100457],"genre_scores_gemma":[0.9888663,0.00009615144,0.0016503447,0.0071987314,0.00021707798,0.0008183417,0.0003996986,0.00007621392,0.00067712],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976558,0.00003696792,0.0004352336,0.0005739241,0.0005631758,0.0007349076],"domain_scores_gemma":[0.9986409,0.000086082015,0.00023757177,0.0004297884,0.00029530757,0.00031036633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011807585,0.00040335738,0.0007010312,0.00007512703,0.0002764747,0.00006329269,0.00015048079,0.000076849276,0.000032633983],"category_scores_gemma":[0.00001939046,0.00028693778,0.00016010573,0.00022320921,0.00007462569,0.00010239899,0.000025597816,0.000067910645,0.00001866608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006756706,0.018285364,0.26528198,0.0003825162,0.001082298,0.0005940069,0.0003360211,0.000029783308,0.0003340501,0.00036735658,0.576034,0.1305159],"study_design_scores_gemma":[0.11443194,0.003714197,0.45903984,0.00029736405,0.00015290071,0.00008453343,0.00008984589,0.00031375926,0.0053789737,0.00012563812,0.41579756,0.0005734484],"about_ca_topic_score_codex":0.41436642,"about_ca_topic_score_gemma":0.07081407,"teacher_disagreement_score":0.34355235,"about_ca_system_score_codex":0.0011240466,"about_ca_system_score_gemma":0.002384058,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W4231664599","doi":"10.1093/jncimonographs/lgu007","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Mantle Cell Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC; University of California, San Francisco; National Institutes of Health; Yale University; Institut Bergonié; Institut de Veille Sanitaire; Agence Française de Sécurité Sanitaire de l'Environnement et du Travail; American Association for Cancer Research; Bundesamt für Strahlenschutz; José Carreras Leukämie-Stiftung; Agència de Gestió d'Ajuts Universitaris i de Recerca; Institut National Du Cancer; National Institute on Deafness and Other Communication Disorders; Università degli Studi di Cagliari; Institut National de la Santé et de la Recherche Médicale; European Commission; Ministero dell’Istruzione, dell’Università e della Ricerca; Région Normandie; Université de Bourgogne; Health Research Board; Fondation de France; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; University of Rochester","keywords":"Medicine; Family history; Odds ratio; Mantle cell lymphoma; Internal medicine; Lymphoma; Hay fever; Risk factor; Confidence interval; Atopy; Asthma","score_opus":0.02052069905608796,"score_gpt":0.2564203533360708,"score_spread":0.23589965427998286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231664599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893387,0.0043396703,0.00039911238,0.00025696785,0.0010722225,0.0011213678,0.000071046736,0.00011410855,0.0032868185],"genre_scores_gemma":[0.9955957,0.000734051,0.00079085777,0.0011183689,0.00032444726,0.00048285062,0.00016358057,0.00006273104,0.00072743883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762124,0.00013805962,0.0004966951,0.00062115013,0.0006471809,0.0004756985],"domain_scores_gemma":[0.9979757,0.0007095849,0.00029349668,0.00055570045,0.0001388496,0.0003266725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055120396,0.0004304803,0.000554993,0.00030235425,0.00020327422,0.00002862097,0.00025512945,0.00026894637,0.00008030405],"category_scores_gemma":[0.00026182318,0.00027716215,0.0004022611,0.00014834496,0.00037510725,0.000109860826,0.000081362494,0.000083572035,0.000025622448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006443376,0.00228506,0.7001507,0.00017652467,0.0004159793,0.0000339121,0.0027298955,6.7936253e-7,0.00008668748,0.00051994453,0.24028605,0.05267018],"study_design_scores_gemma":[0.007693337,0.0008964164,0.63801086,0.00007013525,0.00039066584,0.000036852005,0.00030047965,0.0013740596,0.00024354814,0.000056281635,0.35064918,0.0002781715],"about_ca_topic_score_codex":0.0025636172,"about_ca_topic_score_gemma":0.00013691135,"teacher_disagreement_score":0.11036313,"about_ca_system_score_codex":0.0011542483,"about_ca_system_score_gemma":0.0008898304,"threshold_uncertainty_score":0.99996805},"labels":[],"label_agreement":null},{"id":"W4231688435","doi":"10.1038/labinvest.2014.37","title":"Quality Assurance","year":2014,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Quality assurance; Medicine; Pathology; External quality assessment","score_opus":0.021212840944995086,"score_gpt":0.2859914725498682,"score_spread":0.2647786316048731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231688435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927006,0.00009136583,0.00009752213,0.002301947,0.00011612395,0.00013067112,0.000008420783,0.00009025185,0.0044630934],"genre_scores_gemma":[0.99431175,0.0000087630115,0.001887316,0.003459751,0.00013597879,0.000035104415,0.00004007748,0.00000777537,0.00011350842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934524,0.00008791858,0.00015536057,0.00015074605,0.0001667065,0.000094043986],"domain_scores_gemma":[0.99938744,0.00007578178,0.00006593613,0.0002199196,0.00012665516,0.00012428807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023355098,0.00007569206,0.00013477574,0.000026365498,0.000048079935,0.000013800135,0.000024430836,0.000049844377,0.000034456374],"category_scores_gemma":[0.00028670928,0.000063069754,0.000026410704,0.00016960959,0.00005335337,0.000081788465,0.0000057846723,0.00003796603,0.00017225402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000129883665,0.00007600112,0.95428526,0.000058486945,0.000024001836,0.0000031546874,0.00012543467,0.0000041777935,0.016563136,0.020753907,0.004969311,0.0031241465],"study_design_scores_gemma":[0.00091731,0.00007865973,0.91863495,0.00004012748,0.000022889835,0.0000015566758,0.000012564186,0.00006493073,0.049976934,0.0011255234,0.029053327,0.00007122884],"about_ca_topic_score_codex":0.000025831421,"about_ca_topic_score_gemma":0.000013622776,"teacher_disagreement_score":0.03565031,"about_ca_system_score_codex":0.00006947148,"about_ca_system_score_gemma":0.000113553906,"threshold_uncertainty_score":0.25719097},"labels":[],"label_agreement":null},{"id":"W4231713150","doi":"10.1182/blood.v124.21.3095.3095","title":"Four-Year Survival Data from an Ongoing Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Anaplastic large-cell lymphoma; Population; Refractory (planetary science); Oncology; Phases of clinical research; Chemotherapy regimen; CD30; Lymphoma; Surgery; Clinical trial; Cancer","score_opus":0.021746382804301072,"score_gpt":0.26774050288155915,"score_spread":0.24599412007725807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231713150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839973,0.000066180866,0.0000096266895,0.000004831777,0.0001377472,0.0008343226,0.00038387446,0.000038424067,0.0001252316],"genre_scores_gemma":[0.9987924,0.0000064738965,0.00014250929,0.000017996143,0.00008786465,0.000029284203,0.00086215656,0.000044253014,0.0000170786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978947,0.00022047514,0.00046635274,0.0005939725,0.00051872944,0.0003057932],"domain_scores_gemma":[0.998098,0.00026651454,0.0002428208,0.0011445677,0.00007893767,0.00016914168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024865443,0.00024846668,0.000614971,0.00012613309,0.00005273546,0.000020849036,0.0002399236,0.00007806705,0.000041566378],"category_scores_gemma":[0.00012095165,0.00017353383,0.000032425723,0.00018769475,0.000022602684,0.00016892467,0.00012946488,0.000077210374,0.000022519915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028055615,0.12112636,0.87396014,0.00008681204,0.00023914271,0.00017864688,0.00053197384,0.0000014733757,0.00009342612,0.0000022545369,0.00003079464,0.00094341236],"study_design_scores_gemma":[0.24576642,0.015297512,0.7362332,0.0003721214,0.00077675306,0.0000064552805,0.0008489545,0.00025527755,0.00023228597,6.489125e-7,0.000035856887,0.00017455009],"about_ca_topic_score_codex":0.00070142874,"about_ca_topic_score_gemma":0.001179953,"teacher_disagreement_score":0.24296086,"about_ca_system_score_codex":0.00009537389,"about_ca_system_score_gemma":0.00015248859,"threshold_uncertainty_score":0.7076504},"labels":[],"label_agreement":null},{"id":"W4231714547","doi":"10.1097/pap.0b013e318268ef97","title":"In Reply","year":2012,"lang":"en","type":"article","venue":"Advances in Anatomic Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Family medicine; Library science; Medical laboratory; Pathology; Computer science","score_opus":0.00988529417841797,"score_gpt":0.32255937509691024,"score_spread":0.31267408091849225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231714547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656568,0.021175602,0.000008865255,0.00089265796,0.00036437667,0.00014552141,0.0000018315619,0.000015376401,0.011738947],"genre_scores_gemma":[0.99288476,0.0033254435,0.00079697504,0.002749846,0.000066995024,0.000059802845,0.0000050801973,0.0000070868446,0.0001040125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992799,0.00003980546,0.00018197254,0.00015979295,0.00005259651,0.000285915],"domain_scores_gemma":[0.9996559,0.00006174363,0.000035280693,0.00018172497,0.0000073536985,0.000057996396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015709567,0.000081356935,0.00022455816,0.00013473687,0.000009049687,0.0000011137519,0.00003682238,0.000050973264,0.00006686475],"category_scores_gemma":[0.000063233856,0.00006725075,0.000030079425,0.00013886808,0.00005323739,0.00019094828,0.00002183222,0.00007485112,0.000103276514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004407993,0.0004040718,0.9728862,0.00001139028,0.0000033073547,0.0008395325,0.0002454294,0.0000021450253,0.00017971925,0.004570878,0.00017980507,0.020633444],"study_design_scores_gemma":[0.0033256505,0.00011574643,0.8827055,0.00004655182,0.000013705942,0.00073883584,0.00012787139,0.000019964842,0.002582386,0.0018555559,0.108361095,0.000107122934],"about_ca_topic_score_codex":0.000029564699,"about_ca_topic_score_gemma":0.000054514938,"teacher_disagreement_score":0.10818129,"about_ca_system_score_codex":0.00017343245,"about_ca_system_score_gemma":0.000023302926,"threshold_uncertainty_score":0.27424058},"labels":[],"label_agreement":null},{"id":"W4231804874","doi":"10.3410/f.735372083.793577565","title":"Faculty Opinions recommendation of Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Peripheral T-cell lymphoma; Oncology; Internal medicine; Refractory (planetary science); Chemotherapy; Peripheral; T cell; Immunology; Immune system; Biology","score_opus":0.06327456038452195,"score_gpt":0.3449508267115681,"score_spread":0.2816762663270462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231804874","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020779783,0.0020525043,0.000006703458,0.20674215,0.00048626258,0.0031852345,0.7872268,0.000026935899,0.00006561066],"genre_scores_gemma":[0.001339747,0.002480558,0.0007585846,0.007371141,0.00027894822,0.0006834661,0.9866315,0.000045820587,0.0004102483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99503577,0.00071058556,0.0018511955,0.0010066603,0.0010073051,0.00038851338],"domain_scores_gemma":[0.9931987,0.0006599541,0.0019758863,0.0012652216,0.0025797253,0.0003204934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005496656,0.0007255653,0.0015880576,0.00017514516,0.00027318634,0.000115860705,0.00068905705,0.0007645912,0.000049674007],"category_scores_gemma":[0.0016775323,0.00043294005,0.0006698403,0.00081961637,0.0004026992,0.00014873297,0.00019210826,0.00031681842,0.0000079675165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088562275,0.0071520987,0.00004553565,0.0019080997,0.00034049747,0.0000029373236,0.00095632835,2.2630927e-7,0.000036686415,0.000016754146,0.97520435,0.013450893],"study_design_scores_gemma":[0.030017124,0.0022433205,0.014105687,0.0039012057,0.00048347705,0.00003113985,0.0001852507,0.000045621215,0.00009652048,0.0000136911185,0.94854844,0.00032849875],"about_ca_topic_score_codex":0.00067845505,"about_ca_topic_score_gemma":0.00007367383,"teacher_disagreement_score":0.19940469,"about_ca_system_score_codex":0.0014348299,"about_ca_system_score_gemma":0.0009941071,"threshold_uncertainty_score":0.99981225},"labels":[],"label_agreement":null},{"id":"W4232498758","doi":"10.3410/f.733679087.793577564","title":"Faculty Opinions recommendation of Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peripheral; Lymphoma; Medicine; Peripheral T-cell lymphoma; Medical physics; Nuclear medicine; Radiology; Internal medicine; Computer science; T cell; Immunology","score_opus":0.039139098673010284,"score_gpt":0.3542303836162397,"score_spread":0.3150912849432294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232498758","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106733496,0.0007034885,0.000013102236,0.03449086,0.00032855035,0.004344066,0.95994484,0.000014252689,0.000054088163],"genre_scores_gemma":[0.0025452068,0.00016263274,0.00094595255,0.0009052024,0.00008888879,0.000555172,0.9946943,0.000025717542,0.00007694801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946643,0.0004049936,0.0017900321,0.0006141116,0.00228054,0.00024603133],"domain_scores_gemma":[0.9831833,0.00017059023,0.0024047953,0.0011638446,0.012825498,0.00025193585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012571303,0.00047644734,0.0013957325,0.00021801496,0.00010016952,0.000026385953,0.0005943048,0.0001940058,0.00032743244],"category_scores_gemma":[0.0041376646,0.0002811218,0.0007352834,0.001206061,0.00030808608,0.00018027065,0.00018197625,0.00023849378,0.0000055356995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018468035,0.003575263,0.0004747612,0.01587408,0.00038978364,2.043739e-7,0.00008218655,1.1965692e-7,7.0110474e-7,0.000029841489,0.9735198,0.0058685644],"study_design_scores_gemma":[0.008664376,0.00081698963,0.045379575,0.007977546,0.0016316549,0.000011943129,0.000031476582,0.000054780492,0.000115445415,0.0000090526055,0.9351017,0.00020549168],"about_ca_topic_score_codex":0.00006296318,"about_ca_topic_score_gemma":0.0000046062332,"teacher_disagreement_score":0.044904817,"about_ca_system_score_codex":0.00022282025,"about_ca_system_score_gemma":0.0014107398,"threshold_uncertainty_score":0.9999641},"labels":[],"label_agreement":null},{"id":"W4232538195","doi":"10.1200/jco.2004.22.14_suppl.6521","title":"Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Follicular lymphoma; Radiation therapy; Internal medicine; Gastroenterology; Incidence (geometry); Surgery; Cumulative incidence; Lymphoma; Cohort","score_opus":0.09243860262198297,"score_gpt":0.42922491079748964,"score_spread":0.3367863081755067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232538195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890438,0.0028262176,0.00003602218,0.007304806,0.00030091556,0.0003288527,9.1782516e-7,0.000006826001,0.00015166463],"genre_scores_gemma":[0.9916319,0.0047928398,0.000994464,0.002231314,0.00024052117,0.000014346543,0.0000037815473,0.000012605603,0.000078224555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979858,0.00012245474,0.0012841241,0.00018544048,0.00023279851,0.00018939632],"domain_scores_gemma":[0.9981772,0.00071478897,0.00064535317,0.00015016405,0.00006048849,0.00025203367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007118253,0.00016234045,0.0012532055,0.00011839346,0.00004770564,0.000010620255,0.000053380358,0.00024450518,0.00002103408],"category_scores_gemma":[0.00022597102,0.00009244961,0.00036092856,0.000096869306,0.000047273257,0.00011081716,0.00001767896,0.00014023135,0.000002293812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021198501,0.0043744263,0.76070195,0.0000060128996,0.000556024,0.004613291,0.00016751893,0.000009664113,0.000027956703,0.000027174752,0.0000097464645,0.2273864],"study_design_scores_gemma":[0.07479484,0.046093486,0.875443,0.00010203848,0.00027927032,0.00016476713,0.000044824697,0.0000045979127,0.0006043441,0.00004829738,0.0023393768,0.00008120259],"about_ca_topic_score_codex":0.00017852792,"about_ca_topic_score_gemma":0.0003472666,"teacher_disagreement_score":0.2273052,"about_ca_system_score_codex":0.00063752214,"about_ca_system_score_gemma":0.00081430277,"threshold_uncertainty_score":0.37699857},"labels":[],"label_agreement":null},{"id":"W4232553190","doi":"10.1200/jco.2004.22.90140.6526","title":"CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma (DLBCL)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Stage (stratigraphy); Biology","score_opus":0.053011621939452344,"score_gpt":0.40569978897706094,"score_spread":0.3526881670376086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232553190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933491,0.0019183612,0.0000079386655,0.0035502098,0.00031819945,0.0003692672,0.0000033459135,0.000005826222,0.00047777506],"genre_scores_gemma":[0.9918164,0.0050408253,0.00060894946,0.0022333676,0.00023170956,0.000014316388,0.0000010299213,0.000012937532,0.0000404813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690807,0.00032286078,0.0019369511,0.00017243081,0.00040537486,0.00025431017],"domain_scores_gemma":[0.9953539,0.0024936649,0.001429491,0.00027396705,0.00022683376,0.00022217874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016151316,0.00015844665,0.0011323602,0.00010961145,0.000037601683,0.0000045853812,0.00021508617,0.0002850798,0.00002611621],"category_scores_gemma":[0.0018079606,0.00007920429,0.0004716337,0.00016871252,0.00018111487,0.00012781669,0.0000583242,0.00032897305,0.000014991039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036477274,0.086351134,0.8731461,0.00003458794,0.0001744607,0.0013224476,0.00051408756,0.000105451494,0.00085857906,0.00012219018,0.0003942691,0.03332894],"study_design_scores_gemma":[0.11555936,0.0063386187,0.8629396,0.0003422294,0.00011509977,0.00013717913,0.00015612523,0.0000063422804,0.0014793478,0.000299119,0.012560745,0.000066208166],"about_ca_topic_score_codex":0.00004335996,"about_ca_topic_score_gemma":0.000034133518,"teacher_disagreement_score":0.11191163,"about_ca_system_score_codex":0.0002669558,"about_ca_system_score_gemma":0.0014584194,"threshold_uncertainty_score":0.32298574},"labels":[],"label_agreement":null},{"id":"W4232712038","doi":"10.1002/1097-0142(20001025)90:5<322::aid-cncr10>3.0.co;2-z","title":"Author reply","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytopathology; Lymphoma; Pathology; General surgery; Cytology","score_opus":0.025228150153742065,"score_gpt":0.32765301382443407,"score_spread":0.302424863670692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232712038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92643833,0.0023838175,5.4601315e-7,0.011128972,0.00011100983,0.000114373564,0.0000061583514,0.000043616677,0.0597732],"genre_scores_gemma":[0.9243095,0.00031362867,0.00010076976,0.004661303,0.00019872302,0.000089506604,0.0000044513436,0.000006795523,0.07031533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996909,0.000003346247,0.000055566223,0.00010045931,0.00006399669,0.00008576318],"domain_scores_gemma":[0.99977326,0.000006575514,0.000007878812,0.0001347321,0.00001294213,0.00006463674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00001559268,0.000042992902,0.00007920635,0.000009529739,0.000020481591,0.0000043661257,0.000014627454,0.000016850345,0.012012768],"category_scores_gemma":[0.000003742458,0.000030329089,0.000036067344,0.000043278054,0.000012422298,0.000014637545,0.0000024391804,0.00001816922,0.00047171858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007651517,0.00015736085,0.09021891,0.000013568695,0.00006941036,0.000102772334,0.0001481357,0.0000038132864,0.00012281642,0.00016555031,0.22375672,0.68516445],"study_design_scores_gemma":[0.0007706376,0.0000530216,0.22989766,0.000035419587,0.000046258287,0.000012341135,0.000004836856,0.0000120826435,0.0023477683,0.000026020321,0.7667612,0.00003276021],"about_ca_topic_score_codex":0.00017050692,"about_ca_topic_score_gemma":0.0000062984286,"teacher_disagreement_score":0.68513167,"about_ca_system_score_codex":0.00009697536,"about_ca_system_score_gemma":0.000053476666,"threshold_uncertainty_score":0.9888904},"labels":[],"label_agreement":null},{"id":"W4233201458","doi":"10.1038/modpathol.2014.28","title":"Quality Assurance","year":2014,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; MALT lymphoma; Pathology; KRAS; Adenocarcinoma; Lymphoma; Mucosa-associated lymphoid tissue; Lung; Lymphoproliferative disorders; Internal medicine; Cancer; Colorectal cancer","score_opus":0.026698776825020417,"score_gpt":0.31164243357591714,"score_spread":0.2849436567508967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233201458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655274,0.00023238648,0.007485243,0.001976463,0.00012001622,0.00010620966,0.0000042265387,0.00006366618,0.024484383],"genre_scores_gemma":[0.9958838,0.000022052842,0.0015705454,0.0017669229,0.00007993744,0.000035094035,0.000012575004,0.000008521394,0.0006205087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993209,0.000082114275,0.00013471243,0.00021468813,0.00008821062,0.00015936147],"domain_scores_gemma":[0.9994696,0.000088945235,0.00003684707,0.00030834432,0.000031385258,0.00006488851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018464588,0.000079126046,0.00023025964,0.0000235637,0.000031873347,0.000003896504,0.000034615758,0.000069851,0.000049731952],"category_scores_gemma":[0.00010346756,0.00006038158,0.00006165533,0.000028351138,0.00004103721,0.000016526621,0.00001860304,0.00004240724,0.00021661313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088469154,0.00062025525,0.80437285,0.00004665898,0.000042827327,0.00026922853,0.0003218719,0.000012923443,0.007916241,0.007885371,0.0015999494,0.17682336],"study_design_scores_gemma":[0.0018881004,0.00021050214,0.98205554,0.000010729068,0.00002780752,0.00019711319,0.000004200867,0.0004887034,0.0020909326,0.003829808,0.009121376,0.00007519254],"about_ca_topic_score_codex":0.000018190516,"about_ca_topic_score_gemma":0.000016850863,"teacher_disagreement_score":0.1776827,"about_ca_system_score_codex":0.000034983153,"about_ca_system_score_gemma":0.000022454653,"threshold_uncertainty_score":0.27841958},"labels":[],"label_agreement":null},{"id":"W4233560067","doi":"10.1515/iupac.84.1065","title":"Primary Lymphoid Organ","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Immunology; Medicine; Immune system; Philosophy; Linguistics","score_opus":0.01146993014644207,"score_gpt":0.37983141007324034,"score_spread":0.36836147992679824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233560067","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007137615,0.0023193187,0.0000054610196,0.002010268,0.00069834327,0.0006162184,0.9930244,0.00011283774,0.0004993779],"genre_scores_gemma":[0.00006740386,0.00413108,0.00007635461,0.0021392752,0.0015337334,0.00005164573,0.9906506,0.000057579637,0.0012923136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967784,0.000051356983,0.0005512882,0.00069902185,0.0013816393,0.0005382872],"domain_scores_gemma":[0.9974803,0.00011647157,0.00025151824,0.0012833723,0.00045453745,0.0004138109],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025420118,0.00061969354,0.0011788796,0.00024455157,0.00010275606,0.000042558513,0.00023715151,0.0004777607,0.0055548684],"category_scores_gemma":[0.000260372,0.00039494413,0.00034025067,0.00018743394,0.00014517503,0.000062208324,0.00017839749,0.0002169002,0.000028201948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004499194,0.0015760182,0.0007481514,0.00035013354,0.0005380083,0.0011327903,0.000005452007,2.9985582e-8,0.00002102206,0.000008326283,0.9823902,0.012779936],"study_design_scores_gemma":[0.0071407342,0.0007623878,0.0018091217,0.0012038406,0.00091787643,0.00045247344,0.000005893465,1.7431542e-7,0.00016748921,0.000026526182,0.98709846,0.00041501297],"about_ca_topic_score_codex":0.00022869557,"about_ca_topic_score_gemma":0.0001574254,"teacher_disagreement_score":0.012364923,"about_ca_system_score_codex":0.0027894927,"about_ca_system_score_gemma":0.002987506,"threshold_uncertainty_score":0.9998503},"labels":[],"label_agreement":null},{"id":"W4234790254","doi":"10.3410/f.13476981.14857085","title":"Faculty Opinions recommendation of Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.","year":2012,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Phenotype; Lymphoma; Pathology; Medicine; Oncology; Internal medicine; Biology; Genetics; Gene; Lung cancer","score_opus":0.02018252070317733,"score_gpt":0.3354661525545379,"score_spread":0.31528363185136055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234790254","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079512957,0.0044114217,0.0000017572179,0.015881052,0.00031449998,0.0036585946,0.9748555,0.000012190796,0.00006988868],"genre_scores_gemma":[0.045868136,0.00047895935,0.00017092245,0.00034215575,0.000098252916,0.00017286051,0.9527158,0.000022849199,0.0001300599],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99519277,0.0006363946,0.0019389153,0.00058395613,0.0012873246,0.00036065927],"domain_scores_gemma":[0.99096125,0.0005114816,0.0030644313,0.0014453653,0.0037567846,0.00026068208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001118031,0.00058335584,0.0016383154,0.0003362848,0.0001380666,0.000025994575,0.0007815435,0.000525789,0.00008603613],"category_scores_gemma":[0.0060773036,0.00028761185,0.0008723019,0.0016390588,0.0004699296,0.00015360079,0.00051741174,0.00044086232,0.000003967417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018566792,0.011886468,0.0015059079,0.0050767823,0.0009069289,6.517162e-7,0.0006273022,1.5356754e-7,0.0000056515178,0.000056002613,0.97768974,0.002058739],"study_design_scores_gemma":[0.007208564,0.001847774,0.58818376,0.011222217,0.0017996473,0.00007199036,0.00010017351,0.0000020770365,0.00012293448,0.0000095109135,0.38921618,0.00021518032],"about_ca_topic_score_codex":0.00021956823,"about_ca_topic_score_gemma":0.000010398629,"teacher_disagreement_score":0.58847356,"about_ca_system_score_codex":0.00016408782,"about_ca_system_score_gemma":0.00073440763,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W4235288901","doi":"10.1016/j.jaad.2018.05.546","title":"Epidemiology of diffuse large B-cell lymphoma in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Lymphoma; Dermatology; Diffuse large B-cell lymphoma; Pathology","score_opus":0.018282922450906507,"score_gpt":0.30332098257356827,"score_spread":0.28503806012266175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235288901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979983,0.001296285,0.0000074720565,0.018274274,0.00012337572,0.00009353223,0.000010816667,0.000001470402,0.0002098277],"genre_scores_gemma":[0.9939888,0.00039146666,0.00044685253,0.005082944,0.0000610816,0.000001988334,3.629637e-7,0.0000094016195,0.000017078175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980545,0.00033156513,0.0010110681,0.00010956871,0.00018669725,0.00030660845],"domain_scores_gemma":[0.99711806,0.00060907396,0.0019294552,0.0001531958,0.000071948176,0.00011824568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002195273,0.00012637988,0.0012016211,0.00014676807,0.000023347582,3.0758093e-7,0.00028431907,0.00006617583,0.000017397626],"category_scores_gemma":[0.0002885621,0.00007583829,0.00019034721,0.00026850624,0.0005060186,0.000029481822,0.00008009867,0.0001622796,0.0000024070175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030369026,0.0010435005,0.9915002,0.000034922414,0.00013505905,0.00008341732,0.00010523609,0.0000012057824,0.0004825119,0.00022856344,0.0046461,0.0014355936],"study_design_scores_gemma":[0.0074775848,0.00028191897,0.96085614,0.00009630952,0.0001370084,0.0035357822,0.00029051813,0.000058636415,0.023346452,0.00020867967,0.0036494185,0.0000615281],"about_ca_topic_score_codex":0.07162339,"about_ca_topic_score_gemma":0.0143933445,"teacher_disagreement_score":0.057230048,"about_ca_system_score_codex":0.0003157321,"about_ca_system_score_gemma":0.0008624476,"threshold_uncertainty_score":0.93455875},"labels":[],"label_agreement":null},{"id":"W4235339542","doi":"10.1016/j.jaad.2018.05.735","title":"Long-term incidence and geographic trends of follicular lymphoma in Canada: A population-based study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Follicular lymphoma; Incidence (geometry); Term (time); Population; Follicular phase; Demography; Lymphoma; Environmental health; Internal medicine","score_opus":0.011264561706176745,"score_gpt":0.29121312827931845,"score_spread":0.2799485665731417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235339542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945805,0.0005522726,0.000002047857,0.0046954257,0.000039822407,0.00011676171,0.0000032018897,0.0000014271737,0.000008533085],"genre_scores_gemma":[0.99914056,0.00005469424,0.00009476926,0.00067541003,0.000021952756,0.0000035308226,4.7015e-7,0.0000067649516,0.0000018347986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986352,0.0001574376,0.00063586776,0.000107825115,0.0003110546,0.00015263703],"domain_scores_gemma":[0.9984712,0.0001497651,0.0011115653,0.000120262666,0.00006277109,0.00008442867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106237116,0.00011184719,0.00071650627,0.0003254205,0.00002981466,0.0000020677471,0.00016561277,0.000034848523,0.00000849843],"category_scores_gemma":[0.000057147096,0.00007065465,0.00010971124,0.0004846384,0.00024417293,0.000037897753,0.00004058861,0.00009151905,1.3303821e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022235363,0.00036117542,0.9917248,0.000020077277,0.00018214494,0.00014867284,0.0000922632,0.000005389513,0.00011788927,0.000008746376,0.000049571157,0.0070669213],"study_design_scores_gemma":[0.0029376512,0.00044353228,0.99296135,0.00012978096,0.0002441806,0.0013719,0.00014307607,0.00004863944,0.00163779,0.00001661556,0.00001265152,0.000052830655],"about_ca_topic_score_codex":0.14984831,"about_ca_topic_score_gemma":0.06524646,"teacher_disagreement_score":0.08460186,"about_ca_system_score_codex":0.00018972665,"about_ca_system_score_gemma":0.00041514396,"threshold_uncertainty_score":0.95181036},"labels":[],"label_agreement":null},{"id":"W4235726509","doi":"10.1002/1097-0142(20001025)90:5<322::aid-cncr10>3.3.co;2-q","title":"Author reply","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytopathology; Lymphoma; Pathology; General surgery; Cytology","score_opus":0.025228150153742065,"score_gpt":0.32765301382443407,"score_spread":0.302424863670692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235726509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92643833,0.0023838175,5.4601315e-7,0.011128972,0.00011100983,0.000114373564,0.0000061583514,0.000043616677,0.0597732],"genre_scores_gemma":[0.9243095,0.00031362867,0.00010076976,0.004661303,0.00019872302,0.000089506604,0.0000044513436,0.000006795523,0.07031533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996909,0.000003346247,0.000055566223,0.00010045931,0.00006399669,0.00008576318],"domain_scores_gemma":[0.99977326,0.000006575514,0.000007878812,0.0001347321,0.00001294213,0.00006463674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00001559268,0.000042992902,0.00007920635,0.000009529739,0.000020481591,0.0000043661257,0.000014627454,0.000016850345,0.012012768],"category_scores_gemma":[0.000003742458,0.000030329089,0.000036067344,0.000043278054,0.000012422298,0.000014637545,0.0000024391804,0.00001816922,0.00047171858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007651517,0.00015736085,0.09021891,0.000013568695,0.00006941036,0.000102772334,0.0001481357,0.0000038132864,0.00012281642,0.00016555031,0.22375672,0.68516445],"study_design_scores_gemma":[0.0007706376,0.0000530216,0.22989766,0.000035419587,0.000046258287,0.000012341135,0.000004836856,0.0000120826435,0.0023477683,0.000026020321,0.7667612,0.00003276021],"about_ca_topic_score_codex":0.00017050692,"about_ca_topic_score_gemma":0.0000062984286,"teacher_disagreement_score":0.68513167,"about_ca_system_score_codex":0.00009697536,"about_ca_system_score_gemma":0.000053476666,"threshold_uncertainty_score":0.9888904},"labels":[],"label_agreement":null},{"id":"W4236681238","doi":"10.1634/theoncologist.2014-0232","title":"In Reply","year":2014,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Anthracycline; Radiation therapy; Lymphoma; Oncology; Chemotherapy; Internal medicine; Diffuse large B-cell lymphoma; Intensive care medicine; Cancer; Breast cancer","score_opus":0.041495251654115176,"score_gpt":0.3193977156798092,"score_spread":0.277902464025694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236681238","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013630472,0.00030246054,7.6240053e-7,0.9308006,0.00032476487,0.00041704124,0.000004674504,0.00003308722,0.06675353],"genre_scores_gemma":[0.011011043,0.00012056299,0.0000636461,0.9665466,0.003258687,0.00017736392,0.00008342246,0.000021756618,0.018716924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989942,0.00010343464,0.00021636496,0.0002524495,0.000187518,0.00024604448],"domain_scores_gemma":[0.9988475,0.00036176012,0.00010927861,0.00063356827,0.00002270137,0.00002517968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023710715,0.00017725946,0.00043692457,0.000053572705,0.000037262485,0.000014908413,0.00015460512,0.0003318393,0.00026348993],"category_scores_gemma":[0.00009529759,0.00009018664,0.000121522986,0.000077073906,0.00015240586,0.000011194498,0.000046605663,0.00060896215,0.00072781043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024746112,0.00010039005,0.0021172632,0.000037661153,0.000045342927,0.0035230985,0.000033123324,2.9006836e-7,0.0000013862652,0.000050708542,0.9927806,0.0012853841],"study_design_scores_gemma":[0.0011856646,0.00038030327,0.0069501065,0.00008746312,0.00014098677,0.00024956398,0.0000055147325,0.0000032154492,0.000033697535,0.00024016055,0.9906311,0.00009224655],"about_ca_topic_score_codex":0.00084397016,"about_ca_topic_score_gemma":0.000046117624,"teacher_disagreement_score":0.048036605,"about_ca_system_score_codex":0.0005134575,"about_ca_system_score_gemma":0.00013599705,"threshold_uncertainty_score":0.9354774},"labels":[],"label_agreement":null},{"id":"W4236840402","doi":"10.3410/f.734560442.793577561","title":"Faculty Opinions recommendation of Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Brentuximab vedotin; CD30; Medicine; Oncology; Chemotherapy; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Peripheral; Not Otherwise Specified; Immunology; T cell; Immune system","score_opus":0.041313739267319446,"score_gpt":0.37873486864520467,"score_spread":0.3374211293778852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236840402","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010713107,0.0012411652,0.000076292694,0.18755506,0.0005426239,0.010321702,0.8001322,0.000047448717,0.000072766736],"genre_scores_gemma":[0.0000584932,0.00080125354,0.0015404527,0.007945795,0.00054280146,0.0031056793,0.98559666,0.00005422941,0.00035464036],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944688,0.00034315488,0.0020547914,0.0010878076,0.0015509521,0.0004944819],"domain_scores_gemma":[0.99043006,0.0002498862,0.0022047106,0.0013336906,0.005193311,0.0005883158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008958123,0.0009141226,0.0022148383,0.00021810115,0.00026206538,0.0001741485,0.0009199682,0.00077225646,0.00023552826],"category_scores_gemma":[0.0014656537,0.00054004317,0.0014325908,0.001887159,0.0003590625,0.00024944582,0.00019600458,0.00044693577,0.000028270599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0679226,0.007904313,0.0000041001645,0.006992593,0.0010010394,0.0000020086964,0.00013702015,5.3729178e-8,0.0000017285505,0.000064582644,0.9090242,0.006945795],"study_design_scores_gemma":[0.35056713,0.0021652137,0.000104179584,0.006464312,0.001068652,0.00005846475,0.000028647672,0.000008158474,0.00009842908,0.000004365709,0.6391191,0.00031333452],"about_ca_topic_score_codex":0.00008303578,"about_ca_topic_score_gemma":0.0000055097207,"teacher_disagreement_score":0.28264454,"about_ca_system_score_codex":0.00056094234,"about_ca_system_score_gemma":0.0018829461,"threshold_uncertainty_score":0.99970514},"labels":[],"label_agreement":null},{"id":"W4237054892","doi":"10.5858/133.8.1262","title":"A TNM-Based Clinical Staging System of Ocular Adnexal Lymphomas","year":2009,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Staging system; Context (archaeology); TNM staging system; Eye neoplasm; Lymphoma; Radiology; Pathology; Cancer; Internal medicine","score_opus":0.019005776890880698,"score_gpt":0.3172941949285088,"score_spread":0.2982884180376281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237054892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890935,0.0030994636,0.00037833193,0.0016100638,0.0002718349,0.00042188304,0.00004617231,0.00007755472,0.0050012367],"genre_scores_gemma":[0.99481237,0.0001784383,0.0032241305,0.0014485412,0.00021965083,0.000016480813,0.000054711156,0.000019389998,0.000026276826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974476,0.00039064453,0.0010625736,0.00043483207,0.00034618782,0.00031816665],"domain_scores_gemma":[0.9977603,0.0006554523,0.00045184573,0.00069524377,0.00016741645,0.00026974487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064804027,0.0002587493,0.0012384881,0.00030273417,0.00004743956,0.0000015824,0.0001613747,0.0001353854,0.0000395432],"category_scores_gemma":[0.00040676,0.00018717506,0.00020718655,0.000297814,0.0009754013,0.000034528173,0.000029888704,0.00015335076,0.0000070302467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015573435,0.0026716245,0.88818455,0.000642456,0.00041074568,0.0061879805,0.0012456044,0.000014842655,0.057181217,0.010224889,0.0007930216,0.030885743],"study_design_scores_gemma":[0.017747063,0.006865261,0.9494146,0.0019650457,0.0008659491,0.00016317627,0.0008210834,0.00032846077,0.020012524,0.00017770797,0.0014467054,0.00019238627],"about_ca_topic_score_codex":0.000018690514,"about_ca_topic_score_gemma":0.0000023173593,"teacher_disagreement_score":0.06123011,"about_ca_system_score_codex":0.000057458463,"about_ca_system_score_gemma":0.0005425189,"threshold_uncertainty_score":0.7632777},"labels":[],"label_agreement":null},{"id":"W4237908349","doi":"10.3410/f.12659958.13910056","title":"Faculty Opinions recommendation of Analysis of the coding genome of diffuse large B-cell lymphoma.","year":2011,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Coding (social sciences); Diffuse large B-cell lymphoma; Genome; Lymphoma; Computational biology; Computer science; Biology; Medicine; Internal medicine; Genetics; Gene; Statistics; Mathematics","score_opus":0.03449071235534922,"score_gpt":0.3359422797984883,"score_spread":0.30145156744313906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237908349","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044155753,0.0020784042,0.000012627851,0.03393504,0.0004120765,0.0015358751,0.96184516,0.000015237148,0.00012140945],"genre_scores_gemma":[0.0010483379,0.0013772399,0.0002621602,0.0017113637,0.00009026286,0.00017172203,0.99480253,0.000023713968,0.0005126811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950124,0.00041900616,0.0021620637,0.0005904208,0.0014817957,0.00033431713],"domain_scores_gemma":[0.9897293,0.00019442858,0.0030397275,0.0022335318,0.004546386,0.0002566647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011008009,0.0005144758,0.0018843345,0.00066149514,0.00015709815,0.000030522875,0.0012584485,0.00059285475,0.0005073477],"category_scores_gemma":[0.0025109737,0.00027291008,0.0018214158,0.0039808257,0.00036684613,0.0001457642,0.00056859344,0.00037326096,0.0000123930295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030302928,0.0062828464,0.00027420025,0.0078077763,0.0018202043,3.4457392e-7,0.00026218314,5.8177818e-8,0.000008610087,0.00028493704,0.98258746,0.000641083],"study_design_scores_gemma":[0.0034486002,0.00017156133,0.045214552,0.006712268,0.004893623,0.0000119114075,0.000043864224,0.000009129941,0.00015486611,0.0000054309376,0.93913037,0.00020379788],"about_ca_topic_score_codex":0.00017529029,"about_ca_topic_score_gemma":0.000013891828,"teacher_disagreement_score":0.044940352,"about_ca_system_score_codex":0.00020092576,"about_ca_system_score_gemma":0.0006193228,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W4237955961","doi":"10.1182/blood.v122.21.635.635","title":"Genomic Rearrangements Involving Programmed Death Ligands Are Recurrent In Primary Mediastinal Large B-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Fluorescence in situ hybridization; Biology; Lymphoma; Cancer research; Comparative genomic hybridization; Diffuse large B-cell lymphoma; Follicular lymphoma; Gene; Genetics; Chromosome; Immunology","score_opus":0.015670916103664292,"score_gpt":0.23278064174697613,"score_spread":0.21710972564331182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237955961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913831,0.0045466856,0.0000011997832,0.00029955374,0.00013278768,0.0011748524,0.000012993262,0.00007337829,0.0023754996],"genre_scores_gemma":[0.9970693,0.0005345728,0.0008204462,0.00040357801,0.00016878404,0.0006552532,0.00012758082,0.000035082867,0.0001853925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833566,0.000030175283,0.0003644207,0.000399797,0.000322151,0.00054782524],"domain_scores_gemma":[0.9991706,0.000047868733,0.00013602624,0.00032027898,0.000074562864,0.00025069134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016020208,0.0002453433,0.0003946468,0.00014693386,0.000064303575,0.000047496145,0.00010961459,0.00009934594,0.0001033962],"category_scores_gemma":[0.000040417464,0.00019949207,0.00010941905,0.00017497558,0.000022439295,0.000091785616,0.00010503353,0.00008173504,0.0002480201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005588603,0.015924275,0.9628702,0.00019656259,0.00010775988,0.0003294689,0.00035300205,6.9200404e-8,0.002399757,0.000014260957,0.00071574963,0.017033003],"study_design_scores_gemma":[0.030289123,0.0004690905,0.9609555,0.00038183355,0.00022848503,0.000051565807,0.00016302145,0.000026629212,0.0060643884,0.000027154847,0.0011547682,0.00018841369],"about_ca_topic_score_codex":0.00018198209,"about_ca_topic_score_gemma":0.0000587285,"teacher_disagreement_score":0.030233236,"about_ca_system_score_codex":0.00031552007,"about_ca_system_score_gemma":0.00015209228,"threshold_uncertainty_score":0.8135051},"labels":[],"label_agreement":null},{"id":"W4238104384","doi":"10.1007/s11523-020-00772-4","title":"Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product","year":2020,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Paragraph; Rituximab; Follicular lymphoma; Lymphoma; Internal medicine; Medical physics; Oncology; World Wide Web","score_opus":0.022459294506606785,"score_gpt":0.2756866625027647,"score_spread":0.2532273679961579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238104384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940767,0.00017673231,0.000008038482,0.0030476456,0.00014433522,0.0021583133,0.000047800182,0.000017503602,0.00032288025],"genre_scores_gemma":[0.99855304,0.000021577847,0.00060970016,0.00036424366,0.000069240785,0.00008569688,0.00027554223,0.000011795365,0.000009141576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985637,0.0001646543,0.00046243976,0.0004167795,0.00020584624,0.00018656731],"domain_scores_gemma":[0.99894917,0.00044957642,0.00018658585,0.00022586512,0.000087920795,0.00010088613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015142222,0.00016040815,0.00063631526,0.000057918984,0.000031903997,0.000005220001,0.00006859991,0.00007141687,0.000011907995],"category_scores_gemma":[0.000424709,0.00009109738,0.000019673083,0.00038807862,0.00007146352,0.000034012224,0.000037933747,0.000096142925,0.000006045025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4457036,0.005711347,0.50992745,0.000012072032,0.0001362133,0.000060687067,0.0028812082,0.00014152183,0.00008669858,0.000009677274,0.0018216063,0.033507902],"study_design_scores_gemma":[0.24655788,0.010783771,0.7387747,0.00012479571,0.00009699731,0.0000021588114,0.00012713255,0.00014892411,0.0006846313,0.0000015344955,0.0026182646,0.000079190904],"about_ca_topic_score_codex":0.002205532,"about_ca_topic_score_gemma":0.0017749587,"teacher_disagreement_score":0.22884725,"about_ca_system_score_codex":0.0002639568,"about_ca_system_score_gemma":0.00022786549,"threshold_uncertainty_score":0.37148434},"labels":[],"label_agreement":null},{"id":"W4238281055","doi":"10.1002/cytob.21115","title":"Computational analysis optimizes the flow cytometric evaluation for lymphoma","year":2013,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD38; Germinal center; Immunophenotyping; CD5; CD19; Population; Flow cytometry; Lymphoma; Cytometry; B cell; Pathology; Computational biology; Biology; Immunology; Medicine; Genetics; Antibody","score_opus":0.089644743984458,"score_gpt":0.4084936653387295,"score_spread":0.3188489213542715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238281055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490964,0.002559346,0.035270005,0.004136745,0.0012045306,0.004797932,0.00022256766,0.00025713828,0.0024553456],"genre_scores_gemma":[0.97477114,0.00021225573,0.018310916,0.0026330873,0.0009272901,0.0015773162,0.00093543413,0.000055993794,0.00057654013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943626,0.0004328614,0.0017354789,0.0010563504,0.0016858306,0.00072686444],"domain_scores_gemma":[0.9883589,0.007812452,0.0005299299,0.001114671,0.0015708217,0.0006132382],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0038624387,0.000484167,0.001400632,0.0023782249,0.0004258291,0.000247505,0.00041226138,0.00040293712,0.0026579944],"category_scores_gemma":[0.0053846827,0.0003170428,0.0017845877,0.010983988,0.00035084624,0.00027631858,0.0001571619,0.00023154773,0.0010195335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034318733,0.003308159,0.7006154,0.000070301925,0.0071947435,0.00001457417,0.000040398194,0.0046416423,0.000009422453,0.000119346085,0.03196704,0.25167578],"study_design_scores_gemma":[0.008683851,0.0007735492,0.77035123,0.0000329356,0.005997205,0.000028213666,0.00009540091,0.2079852,0.00009968149,0.00040245085,0.0052240356,0.00032625513],"about_ca_topic_score_codex":0.000043547443,"about_ca_topic_score_gemma":0.0000030679553,"teacher_disagreement_score":0.2513495,"about_ca_system_score_codex":0.0005279716,"about_ca_system_score_gemma":0.00043594706,"threshold_uncertainty_score":0.9999282},"labels":[],"label_agreement":null},{"id":"W4238391527","doi":"10.3410/f.1092382.546811","title":"Faculty Opinions recommendation of Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.","year":2007,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Pathogenesis; Computational biology; Cancer research; Lymphoma; Biology; Bioinformatics; Genetics; Medicine; Immunology","score_opus":0.027771506846527048,"score_gpt":0.3433171096169564,"score_spread":0.3155456027704293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238391527","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021652057,0.018129753,0.00012206284,0.06217218,0.00022811738,0.002105875,0.91718125,0.000015357007,0.00002377389],"genre_scores_gemma":[0.000114324124,0.002791576,0.0046908553,0.0020774722,0.00013767203,0.00018476324,0.98968047,0.000030760733,0.0002920968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687713,0.00016128832,0.0012394233,0.00058356725,0.0008584869,0.00028012885],"domain_scores_gemma":[0.99371034,0.0001616583,0.0011841673,0.0009593993,0.0037032107,0.00028122775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053004536,0.00045225557,0.0010477285,0.00033371858,0.0001020204,0.000035990975,0.00045228878,0.0005292534,0.00010706315],"category_scores_gemma":[0.0010599066,0.00028738586,0.0006510344,0.00094603904,0.0002539593,0.00008463649,0.00017231704,0.00018870443,0.000004527298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005331912,0.0015073026,0.00004011814,0.0075890827,0.00040414606,8.003695e-7,0.00021543486,3.967925e-8,0.0000465672,0.00010505236,0.98079556,0.009242573],"study_design_scores_gemma":[0.0031359964,0.00043282186,0.0137383,0.0046035275,0.001089726,0.00003957281,0.00009824363,0.0000056019408,0.0006525689,0.000021250791,0.9759529,0.0002294652],"about_ca_topic_score_codex":0.000082049024,"about_ca_topic_score_gemma":0.0000025945787,"teacher_disagreement_score":0.072499245,"about_ca_system_score_codex":0.00014566485,"about_ca_system_score_gemma":0.00068926846,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4238817388","doi":"10.1182/blood.v118.21.436.436","title":"Whole Transcriptome Sequencing Reveals Recurrent NOTCH1 Mutations in Mantle Cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Sanger sequencing; Transcriptome; Biology; Cancer research; Cyclin D1; Lymphoma; Molecular biology; Genetics; Exon; DNA sequencing; Gene; Cell cycle; Immunology; Gene expression","score_opus":0.03791925599566054,"score_gpt":0.25330303484173555,"score_spread":0.215383778846075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238817388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803346,0.0010780257,0.000008354876,0.00015744464,0.00011264335,0.0003671418,0.000027252256,0.00004922362,0.017865362],"genre_scores_gemma":[0.9975098,0.00008866695,0.0015107244,0.0001873837,0.000047332444,0.00011566846,0.00004140427,0.000019810273,0.00047922597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902725,0.00003100734,0.0002733307,0.00025159222,0.00015897423,0.00025784023],"domain_scores_gemma":[0.9995137,0.000028631754,0.000052549265,0.00024293942,0.0000372832,0.00012491636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000935871,0.00014360248,0.0002421002,0.00012408533,0.000043994103,0.0000100751595,0.000062160325,0.00006677469,0.00014126729],"category_scores_gemma":[0.000014872793,0.00012265024,0.00009789836,0.00018747663,0.000027519805,0.00006904498,0.000012333077,0.000046539586,0.00021999533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003074352,0.038637772,0.72518414,0.0007216564,0.0004864442,0.004734502,0.030321823,0.000003629134,0.16716233,0.0012015516,0.0018215072,0.029417207],"study_design_scores_gemma":[0.022261124,0.00079859456,0.7818498,0.000447693,0.00065981824,0.00020180039,0.0009378713,0.000025725214,0.19026278,0.00054856826,0.0016992412,0.00030699314],"about_ca_topic_score_codex":0.00027063707,"about_ca_topic_score_gemma":0.00005938622,"teacher_disagreement_score":0.056665644,"about_ca_system_score_codex":0.00016106939,"about_ca_system_score_gemma":0.00012186173,"threshold_uncertainty_score":0.5001532},"labels":[],"label_agreement":null},{"id":"W4238849000","doi":"10.1038/sj.modpathol.3801039","title":"Infections","year":2008,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pathology; Medicine","score_opus":0.028832754905011818,"score_gpt":0.2693312317826026,"score_spread":0.2404984768775908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238849000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811568,0.00027692402,0.00084591727,0.0007450233,0.000094921525,0.00009491417,0.0000026865064,0.00006924631,0.016713526],"genre_scores_gemma":[0.99737173,0.00013088093,0.00042846837,0.0007214074,0.000055893957,0.000045721084,0.000011168888,0.000007050792,0.0012276644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961627,0.000014040891,0.00007313454,0.00013208731,0.000048680435,0.00011579984],"domain_scores_gemma":[0.99972564,0.000017576005,0.000014173989,0.00016647366,0.000022926199,0.00005320372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019431562,0.00005692083,0.00012353703,0.000043100536,0.00007180248,0.0000011825393,0.000015018906,0.000052908817,0.000094763614],"category_scores_gemma":[0.000016947291,0.000044760953,0.000052020638,0.000041107556,0.00005367803,0.00001576865,0.000014079322,0.00003805799,0.0002782692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022813469,0.0011581144,0.9758257,0.0000063667003,0.000043747892,0.004082734,0.00062727474,0.000013573438,0.0021907475,0.0007693664,0.002984508,0.012275026],"study_design_scores_gemma":[0.0018115148,0.00046303985,0.97636455,0.0000058380238,0.000052795673,0.010040166,0.000005572349,0.00022241948,0.0019060359,0.0007613126,0.008298503,0.00006822343],"about_ca_topic_score_codex":0.000017358736,"about_ca_topic_score_gemma":0.0000061482497,"teacher_disagreement_score":0.016214903,"about_ca_system_score_codex":0.000040770672,"about_ca_system_score_gemma":0.00003888589,"threshold_uncertainty_score":0.35766804},"labels":[],"label_agreement":null},{"id":"W4238888358","doi":"10.1016/j.bjps.2017.05.059","title":"Reply to: ‘Patients with low-risk cutaneous squamous cell carcinoma do not require extended out-patient follow-up’","year":2017,"lang":"en","type":"letter","venue":"Journal of Plastic Reconstructive & Aesthetic Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Forehead; Scalp; Medicine; Dermatology; Basal cell; Lymphoma; Nose; Differential diagnosis; Cancer research; Nuclear medicine; Pathology; Surgery","score_opus":0.012284594628442285,"score_gpt":0.22320241455152426,"score_spread":0.21091781992308198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238888358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97786677,0.00036456934,0.00002443738,0.0109494105,0.008550828,0.0010057626,0.00046610503,0.000029725561,0.0007423809],"genre_scores_gemma":[0.9775585,0.000086263986,0.0005447368,0.019928517,0.001058473,0.00006032241,0.000101353384,0.00020717355,0.00045467354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934996,0.0003606286,0.0021210506,0.0010459032,0.0019604333,0.0010124207],"domain_scores_gemma":[0.9881433,0.0028095427,0.0050169155,0.0013858358,0.0019459636,0.0006984251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038265306,0.001140466,0.0029520362,0.0010475898,0.00034226407,0.00021915355,0.000417829,0.00067943294,0.00020730941],"category_scores_gemma":[0.0016558327,0.00079761894,0.0014397795,0.0001899793,0.00043869743,0.00028755845,0.000110041736,0.0018160734,0.00013253228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059081484,0.0011487226,0.4444677,0.0003206138,0.00069769775,0.05090989,0.0006342296,0.00001839968,0.000004389712,0.0000010671508,0.3960128,0.09987635],"study_design_scores_gemma":[0.03178712,0.02411789,0.5290711,0.011932952,0.011931618,0.14543709,0.00052065164,0.000026075018,0.0013503336,0.00017769936,0.23929137,0.004356103],"about_ca_topic_score_codex":0.00022904981,"about_ca_topic_score_gemma":0.000010193718,"teacher_disagreement_score":0.15672143,"about_ca_system_score_codex":0.0013079476,"about_ca_system_score_gemma":0.0020466202,"threshold_uncertainty_score":0.99944746},"labels":[],"label_agreement":null},{"id":"W4239172580","doi":"10.1182/blood.v120.21.798.798","title":"Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; ABVD; Medicine; Dacarbazine; Vinblastine; Internal medicine; Oncology; Regimen; Bleomycin; Hodgkin's lymphoma; Lymphoma; Chemotherapy; Vincristine; CD30","score_opus":0.009071070798672023,"score_gpt":0.22776056938644199,"score_spread":0.21868949858776995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239172580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681157,0.00066850544,0.000032653763,0.00015827247,0.00006158097,0.0018271381,0.000048175956,0.00009779806,0.00029430992],"genre_scores_gemma":[0.9947956,0.00011579303,0.0034634415,0.0004472029,0.00006127769,0.00040950504,0.00020791932,0.0000925898,0.0004066345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979255,0.00006431983,0.0003219066,0.0004530556,0.000563428,0.0006717813],"domain_scores_gemma":[0.99867773,0.00013617377,0.00019843948,0.00055654213,0.00012642286,0.00030469912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009510749,0.00045971895,0.0006800469,0.0001371834,0.00007488112,0.00003869973,0.00011626288,0.00009136017,0.00010780421],"category_scores_gemma":[0.000026995467,0.00023974804,0.000053104624,0.00037218962,0.00007445501,0.00033587744,0.000028410115,0.00009015199,0.000024093717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019340586,0.032127768,0.93417597,0.000041137617,0.00048332164,0.00036332448,0.00056911964,0.000011706483,0.000028511384,0.00004617588,0.000082431034,0.012729944],"study_design_scores_gemma":[0.22181256,0.012444622,0.7616195,0.00032946074,0.00022714696,0.000020950569,0.00014619023,0.000005035345,0.0026263325,0.0000022555619,0.0004614856,0.00030445482],"about_ca_topic_score_codex":0.0002488016,"about_ca_topic_score_gemma":0.0004039327,"teacher_disagreement_score":0.20247199,"about_ca_system_score_codex":0.00017301054,"about_ca_system_score_gemma":0.00023804964,"threshold_uncertainty_score":0.9776641},"labels":[],"label_agreement":null},{"id":"W4239785860","doi":"10.3410/f.735407983.793577568","title":"Faculty Opinions recommendation of Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Refractory (planetary science); Medicine; Lymphoma; Multicenter study; Oncology; Peripheral T-cell lymphoma; Internal medicine; Dermatology; Medical physics; T cell; Immunology; Randomized controlled trial; Materials science","score_opus":0.02397853880284322,"score_gpt":0.3242911669809553,"score_spread":0.30031262817811205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239785860","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041379215,0.0003928336,0.0000013294934,0.059337594,0.00047335084,0.004425962,0.93487996,0.000037019134,0.000038182014],"genre_scores_gemma":[0.0027218605,0.0001801108,0.0004941861,0.00331362,0.00015537407,0.00056775275,0.9921231,0.000049171296,0.00039480787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946157,0.00053149776,0.0018608031,0.0009204394,0.0016768073,0.00039476552],"domain_scores_gemma":[0.99292296,0.00017342246,0.0017288921,0.0013292514,0.003430216,0.00041524644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005099621,0.00076483993,0.0015618617,0.0003690115,0.00013552031,0.00009414721,0.00074223726,0.0005113925,0.0003280624],"category_scores_gemma":[0.0033487317,0.00038716313,0.0004970083,0.0021723828,0.00020971423,0.0003398096,0.00036244933,0.00064657524,0.00003832395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055116497,0.02573846,0.0047960416,0.006116092,0.00034104046,0.000006748934,0.0004968075,8.2441346e-8,5.514492e-7,0.0000017388079,0.9597824,0.002168844],"study_design_scores_gemma":[0.014335456,0.0027452323,0.13599151,0.009477286,0.00047602016,0.0000116213005,0.000070570335,0.000005771006,0.000003460535,6.1594835e-7,0.83656836,0.00031407693],"about_ca_topic_score_codex":0.00012972478,"about_ca_topic_score_gemma":0.00004329997,"teacher_disagreement_score":0.13119549,"about_ca_system_score_codex":0.0005361988,"about_ca_system_score_gemma":0.0007561379,"threshold_uncertainty_score":0.999858},"labels":[],"label_agreement":null},{"id":"W4240810606","doi":"10.1182/blood.v120.21.679.679","title":"Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Anaplastic lymphoma kinase; Medicine; T-cell lymphoma; Not Otherwise Specified; Pathology; Leukemia; Oncology; Cancer research; Internal medicine; T cell; Immunology; Lung cancer","score_opus":0.017754767901032247,"score_gpt":0.24122807573663735,"score_spread":0.2234733078356051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240810606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722423,0.021793762,0.00000455371,0.000089911926,0.00007520616,0.00037336885,0.000006792275,0.000040722574,0.0003914327],"genre_scores_gemma":[0.9972148,0.0005967247,0.0015923457,0.00021616738,0.00015252826,0.00009944736,0.000045515746,0.000015733483,0.000066750144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914646,0.00004454187,0.00014502597,0.00022013333,0.00011978513,0.00032402348],"domain_scores_gemma":[0.9995532,0.00006729847,0.00004497272,0.00015914222,0.000018437131,0.00015692247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009592092,0.00016937003,0.00022971851,0.00005863686,0.000044506305,0.00001538838,0.00003999209,0.0001250195,0.00003652525],"category_scores_gemma":[0.00003060512,0.000110297755,0.000049083155,0.00007234307,0.000034825935,0.00007264069,0.00004855281,0.000046145095,0.000012164767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006101081,0.0036286514,0.94578165,0.000036792408,0.00002516612,0.00011238537,0.00022009149,7.1774394e-7,0.047278658,0.000008105889,0.00006501781,0.0027817464],"study_design_scores_gemma":[0.007971995,0.00025701197,0.6910276,0.000073595635,0.00012019046,0.00009481587,0.00006369698,0.00001484158,0.30001688,0.0000116577985,0.00023512529,0.00011259667],"about_ca_topic_score_codex":0.000039361923,"about_ca_topic_score_gemma":0.0000052498426,"teacher_disagreement_score":0.25475407,"about_ca_system_score_codex":0.000041243795,"about_ca_system_score_gemma":0.000026106234,"threshold_uncertainty_score":0.4497812},"labels":[],"label_agreement":null},{"id":"W4240889406","doi":"10.1002/(sici)1096-8652(200005)64:1<82::aid-ajh20>3.3.co;2-u","title":"Decreased expression of p33ING1 mRNA in lymphoid malignancies","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.007835042333373116,"score_gpt":0.26017268592153003,"score_spread":0.2523376435881569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240889406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967517,0.0014795766,0.000010424677,0.0006287418,0.000036879268,0.00006801664,0.000001533607,0.000004584937,0.0010185428],"genre_scores_gemma":[0.99669623,0.0006902018,0.0022341416,0.00030447496,0.000024964873,0.000004319013,0.0000012457041,0.000009375514,0.000035071356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892044,0.00007586409,0.0005445743,0.0001015608,0.00017440255,0.0001831616],"domain_scores_gemma":[0.99911416,0.00015420609,0.00038062836,0.00014886753,0.00007674055,0.0001253963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001220586,0.000106945365,0.00073181005,0.00017356413,0.000015350079,0.000002512388,0.00007935366,0.00003546566,0.00040599643],"category_scores_gemma":[0.000059334154,0.00007463806,0.00013592825,0.00018788673,0.00019798498,0.00004629226,0.000010045195,0.00006191388,0.000011450628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001083246,0.0011307661,0.93959916,0.00003607526,0.00008204069,0.0016538879,0.00045923772,0.000013806385,0.0091037685,0.00018207009,0.00064530224,0.046010636],"study_design_scores_gemma":[0.012037305,0.005298033,0.52873814,0.0018038913,0.00024793687,0.03171228,0.0014644358,0.000026921662,0.41510874,0.00036791808,0.0029552416,0.00023916073],"about_ca_topic_score_codex":0.0001645929,"about_ca_topic_score_gemma":0.000005595232,"teacher_disagreement_score":0.41086102,"about_ca_system_score_codex":0.000075411255,"about_ca_system_score_gemma":0.00019109108,"threshold_uncertainty_score":0.44453764},"labels":[],"label_agreement":null},{"id":"W4241027748","doi":"10.1182/blood.v118.21.lba-6.bld0076_p3_lba-6","title":"Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Interim analysis; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Oncology; Chemotherapy; Progression-free survival; Surgery; Gastroenterology; Lymphoma; Confidence interval","score_opus":0.043929145144591966,"score_gpt":0.33856769130066294,"score_spread":0.294638546156071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241027748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88346416,0.00009452567,0.0002519327,0.000023832728,0.000058853668,0.114573106,0.000029292387,0.00006284918,0.0014414238],"genre_scores_gemma":[0.8829209,0.000002808902,0.00081266573,0.000031659172,0.00012763194,0.11599534,0.000039771174,0.000035543413,0.000033637567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972117,0.00034273206,0.0011212406,0.00057341816,0.00033670707,0.00041418523],"domain_scores_gemma":[0.99822354,0.0003559423,0.0005266183,0.0004639949,0.00024497014,0.00018494195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004946891,0.00042620144,0.0021498594,0.00014176169,0.00012569758,0.000047394686,0.00016235492,0.000075948876,0.000024990606],"category_scores_gemma":[0.000105182895,0.00028496914,0.00037160245,0.00012431202,0.00016876466,0.00011948652,0.00009814675,0.00007364306,0.0000064323144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71074593,0.23568496,0.010112623,0.0005233127,0.006688223,0.0015170556,0.022054868,0.000017837701,0.0025820762,0.0008980828,0.000065684304,0.009109318],"study_design_scores_gemma":[0.9585574,0.011580756,0.0016611434,0.0004618854,0.0025445397,0.000077046796,0.0037910182,0.001600176,0.019286603,0.00008488329,0.00009111241,0.00026342206],"about_ca_topic_score_codex":0.001566608,"about_ca_topic_score_gemma":0.00040516947,"teacher_disagreement_score":0.24781147,"about_ca_system_score_codex":0.00013897404,"about_ca_system_score_gemma":0.0003033743,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4242251781","doi":"10.3410/f.738489571.793577576","title":"Faculty Opinions recommendation of Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anaplastic large-cell lymphoma; Identification (biology); Lymphoma; Oncology; Medicine; Internal medicine; Cancer research; Biology","score_opus":0.021248863861179926,"score_gpt":0.3217563352083038,"score_spread":0.3005074713471239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242251781","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019709354,0.0009533763,0.000050913135,0.08216255,0.00073254155,0.0022704415,0.9137268,0.000038297556,0.00004535841],"genre_scores_gemma":[0.0015948084,0.001404836,0.00057719904,0.0017729849,0.00024528455,0.00038522697,0.9936171,0.000038825387,0.00036374416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938389,0.0006167846,0.0025046493,0.0008872384,0.001775004,0.00037739196],"domain_scores_gemma":[0.9881265,0.00039286047,0.0036759246,0.0016383051,0.0057454426,0.00042095067],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011216487,0.00064391823,0.0016603832,0.00043247864,0.00022173843,0.00007247052,0.00093314156,0.00070531113,0.0003040766],"category_scores_gemma":[0.008987922,0.00042051685,0.0008910333,0.0023776526,0.0003299633,0.000264329,0.00036809949,0.0005869282,0.0001214463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095519135,0.0031444915,0.00005670961,0.010701816,0.0005328887,0.0000011402591,0.00022959894,1.3873921e-7,0.0000075847106,0.00015890211,0.9823548,0.0027163797],"study_design_scores_gemma":[0.00524804,0.00053523516,0.019842831,0.008743678,0.0014624353,0.000023363715,0.00007034841,0.00001992229,0.0005247417,0.000028048045,0.96319467,0.00030670222],"about_ca_topic_score_codex":0.00024489374,"about_ca_topic_score_gemma":0.000017469287,"teacher_disagreement_score":0.08038957,"about_ca_system_score_codex":0.00028065513,"about_ca_system_score_gemma":0.00084566674,"threshold_uncertainty_score":0.99982464},"labels":[],"label_agreement":null},{"id":"W4243068057","doi":"10.3410/f.1091205.544604","title":"Faculty Opinions recommendation of Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.","year":2007,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Conditioning regimen; Transplantation; Regimen; Hematopoietic stem cell transplantation; Immunology; Stem cell; Medicine; Haematopoiesis; Internal medicine; Biology; Genetics","score_opus":0.01571783422292425,"score_gpt":0.3164559357064486,"score_spread":0.3007381014835243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243068057","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111218375,0.0070455046,0.00010795454,0.013140638,0.0002718888,0.00283495,0.9764362,0.000024016883,0.000027610738],"genre_scores_gemma":[0.0012052085,0.00042005564,0.0017413414,0.00048635036,0.00004982013,0.00095250487,0.9948349,0.000032736738,0.00027705525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954366,0.00018253134,0.0024392698,0.0005222066,0.0011148187,0.00030455008],"domain_scores_gemma":[0.99326295,0.00024673017,0.0021808508,0.00096354686,0.0031500494,0.00019590175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007951119,0.0004917785,0.001391619,0.00042886825,0.00015095301,0.00003206565,0.0005075574,0.00049339625,0.0003244563],"category_scores_gemma":[0.0003312957,0.00033487816,0.0007456259,0.0009600468,0.00025722766,0.00021806141,0.0001354539,0.00035644442,0.0000071249697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017408327,0.0022362107,0.000118222924,0.041822523,0.00053122797,6.903041e-7,0.0013164942,2.6193075e-7,0.000024251714,0.000093119816,0.945477,0.008205894],"study_design_scores_gemma":[0.00309081,0.00028008805,0.03166444,0.02177077,0.0010363733,0.000022471426,0.00021785896,0.000005910041,0.00073715724,0.000012647472,0.9408972,0.0002642438],"about_ca_topic_score_codex":0.000036497055,"about_ca_topic_score_gemma":0.000004974773,"teacher_disagreement_score":0.031546216,"about_ca_system_score_codex":0.00018691768,"about_ca_system_score_gemma":0.001224918,"threshold_uncertainty_score":0.99991035},"labels":[],"label_agreement":null},{"id":"W4243387969","doi":"10.1182/blood-2020-137089","title":"Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Chemotherapy; Medicine; Internal medicine; Chemotherapy regimen; Oncology; Lymphoma; Classical Hodgkin lymphoma; Stage (stratigraphy); Hodgkin lymphoma; Biology","score_opus":0.008877696365832067,"score_gpt":0.22346718816336134,"score_spread":0.21458949179752926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243387969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949886,0.00008319029,0.000020507156,0.0013772186,0.0000234509,0.0031859404,0.00008358756,0.00005287635,0.00018459963],"genre_scores_gemma":[0.9983018,0.00002352097,0.0006345437,0.0005328318,0.00006250487,0.00022135426,0.000052130174,0.000054350476,0.000116939744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848956,0.000050382587,0.0002853468,0.00042374487,0.00043283697,0.00031812416],"domain_scores_gemma":[0.9989952,0.000059920927,0.00019573199,0.00043766765,0.0001480601,0.00016344439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006978751,0.00027479534,0.0005163827,0.00002890172,0.00008536221,0.00002218305,0.00015933892,0.0000616896,0.000040712708],"category_scores_gemma":[0.00002429111,0.0001398849,0.00011595262,0.00025291825,0.000083848594,0.00004650481,0.000052216175,0.00005810503,0.000008130078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037943483,0.02207512,0.9678473,0.00010084799,0.0012259716,0.00003376969,0.0011055089,0.000002326284,0.00004026104,0.00006209794,0.00042414424,0.0032883028],"study_design_scores_gemma":[0.19660698,0.014763306,0.7729291,0.00018514294,0.0018738789,0.000008703186,0.00048013477,0.000033251697,0.0109109795,0.0000045539277,0.0019460103,0.00025796934],"about_ca_topic_score_codex":0.000054511864,"about_ca_topic_score_gemma":0.000034132125,"teacher_disagreement_score":0.1949182,"about_ca_system_score_codex":0.000066316315,"about_ca_system_score_gemma":0.0002075289,"threshold_uncertainty_score":0.57043403},"labels":[],"label_agreement":null},{"id":"W4243540262","doi":"10.1309/tye7-k2cq-mq70-7frt","title":"Antibody Selection in Immunohistochemical Detection of Cyclin D1 in Mantle Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Polyclonal antibodies; Mantle cell lymphoma; Immunohistochemistry; Cyclin D1; Staining; Monoclonal antibody; Molecular biology; Antibody; Lymphoma; Biology; Chemistry; Pathology; Medicine; Immunology; Cell; Cell cycle; Biochemistry","score_opus":0.015361396106123535,"score_gpt":0.3759344113304613,"score_spread":0.36057301522433777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243540262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825084,0.0003931338,0.00019750706,0.00048365,0.00018833693,0.00010491095,0.0000011540028,0.0000049419423,0.0003754968],"genre_scores_gemma":[0.9965661,0.00065868633,0.0022281252,0.0002993466,0.00020973194,0.0000038498492,0.0000027475048,0.000011978021,0.000019439918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752295,0.00029283809,0.0016245056,0.00018798198,0.00016958198,0.00020211867],"domain_scores_gemma":[0.9983042,0.0004578772,0.00090766477,0.00011820924,0.00010587998,0.000106152285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009034434,0.00011843534,0.00095498574,0.00027065832,0.000011499902,0.000002269075,0.00007964297,0.00013073237,0.0000231552],"category_scores_gemma":[0.00038344678,0.00009659276,0.00025786538,0.00032852942,0.00027833565,0.00005768407,0.000020705449,0.00027730965,0.000012645577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016504647,0.0038906287,0.60022104,0.000010620394,0.000031886797,0.00039442838,0.00012598558,0.000025549392,0.121205054,0.0000038046985,0.000017152328,0.27242336],"study_design_scores_gemma":[0.0087501975,0.004724432,0.96021885,0.00008474031,0.00007554953,0.0010775572,0.00014394331,0.00014553468,0.02411974,0.000036041365,0.0005413014,0.00008208681],"about_ca_topic_score_codex":0.00010610354,"about_ca_topic_score_gemma":0.00004964331,"teacher_disagreement_score":0.3599978,"about_ca_system_score_codex":0.00021360743,"about_ca_system_score_gemma":0.00018264732,"threshold_uncertainty_score":0.39389387},"labels":[],"label_agreement":null},{"id":"W4244239070","doi":"10.1148/cases.20202465","title":"Primary Breast Lymphoma","year":2020,"lang":"en","type":"standard","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Primary (astronomy); Medicine; Lymphoma; Oncology; Internal medicine; Physics; Astronomy","score_opus":0.012832116298181356,"score_gpt":0.24649693577323864,"score_spread":0.2336648194750573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244239070","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006510843,0.004761649,0.000018962262,0.01601688,0.0010440182,0.0008069282,0.0017680502,0.00033864207,0.97459376],"genre_scores_gemma":[0.10585643,0.026535464,0.009211692,0.104438506,0.018431693,0.0008561806,0.040607374,0.0008923768,0.69317025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983699,0.000016933585,0.00028458517,0.00050026196,0.0005512754,0.00027709632],"domain_scores_gemma":[0.9990065,0.000047535745,0.00008668403,0.00041617398,0.000095877724,0.00034720375],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000037966623,0.00037567626,0.0008528262,0.0000833006,0.00005019799,0.00003549026,0.0000960038,0.00029293785,0.0023016722],"category_scores_gemma":[0.000015173595,0.00026108982,0.00036433895,0.0001317977,0.000049838953,0.000028473009,0.00009872595,0.00009713014,0.0010501592],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019304779,0.00040919948,0.001887841,0.00041730577,0.00052336307,0.0012910655,0.000031679898,1.8979534e-8,0.000004846303,0.00031704747,0.83456826,0.16035633],"study_design_scores_gemma":[0.0044776895,0.00036212231,0.036960695,0.00036899658,0.0006893301,0.0009885872,0.000020985739,0.0000020131436,0.000092268194,0.000028596625,0.9557558,0.0002529629],"about_ca_topic_score_codex":0.00008954729,"about_ca_topic_score_gemma":0.000006879831,"teacher_disagreement_score":0.2814235,"about_ca_system_score_codex":0.0008376133,"about_ca_system_score_gemma":0.0011197028,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4244325348","doi":"10.3899/jrheum.100360","title":"Canadian Rheumatology Association (CRA) Meeting, Quebec City, Quebec, February 3-6, 2010","year":2010,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine","score_opus":0.008359141954515913,"score_gpt":0.24039813356559916,"score_spread":0.23203899161108324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244325348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94737905,0.0005493779,0.00000798122,0.048166655,0.0022747423,0.00018801949,0.0000059522085,0.000020938442,0.001407276],"genre_scores_gemma":[0.9961257,0.0009576077,0.00021694732,0.00067843584,0.000034006334,0.000006185627,0.000009093238,0.000024136192,0.0019479132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792355,0.0002577859,0.0007862522,0.0001502084,0.00034200348,0.00054017565],"domain_scores_gemma":[0.99703556,0.0008342551,0.00094595656,0.00036482184,0.00039836037,0.00042104247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011956542,0.00022255603,0.0007970038,0.00031223625,0.00022588394,0.000031390387,0.00030942418,0.0004051323,0.0006242092],"category_scores_gemma":[0.0009232107,0.00014340825,0.00021506722,0.00016199479,0.00013402547,0.00011886802,0.000050628907,0.00073256914,0.0001597936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010379348,0.00015622049,0.9199837,0.000020595866,0.00041659139,0.00007159813,0.0005057328,0.0000020105012,0.00022981182,0.0015384052,0.075157076,0.001814503],"study_design_scores_gemma":[0.0039079236,0.00030407333,0.94728607,0.0002109937,0.00051895314,0.026201868,0.0003281351,0.000040109444,0.0007609642,0.00085460633,0.019364152,0.00022212279],"about_ca_topic_score_codex":0.9429966,"about_ca_topic_score_gemma":0.98834234,"teacher_disagreement_score":0.055792924,"about_ca_system_score_codex":0.00088445726,"about_ca_system_score_gemma":0.002066325,"threshold_uncertainty_score":0.6834653},"labels":[],"label_agreement":null},{"id":"W4244549863","doi":"10.1097/hs9.0000000000000081","title":"Relapsed/Refractory Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Download; Medicine; Glioblastoma; Refractory (planetary science); Internal medicine; Oncology; Library science; Cancer research; Computer science; World Wide Web; Biology","score_opus":0.017253013479712986,"score_gpt":0.2710261903154046,"score_spread":0.2537731768356916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244549863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83278906,0.0012658841,0.000019446152,0.0007767714,0.00032249448,0.00023078741,0.000004748051,0.00014413035,0.16444667],"genre_scores_gemma":[0.98739415,0.00008910244,0.0014933995,0.0012272617,0.0006060594,0.000040231324,0.00001527267,0.00002956596,0.00910494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990309,0.000019707804,0.00017798772,0.00028176693,0.00022220188,0.00026746697],"domain_scores_gemma":[0.99919015,0.000045986435,0.000053292133,0.00043485276,0.00009050691,0.00018523952],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059926475,0.00016203217,0.00023861924,0.000026501992,0.00009350975,0.000016570499,0.000060542778,0.000109309854,0.0036755665],"category_scores_gemma":[0.000042877662,0.00012287118,0.000113917675,0.00013407125,0.000105221065,0.000062028725,0.000036300375,0.000038469865,0.0030555846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062370836,0.0038906296,0.22399852,0.00014000761,0.0004955263,0.00092295423,0.00087370735,2.603313e-7,0.0043380037,0.0052988837,0.31619337,0.44322443],"study_design_scores_gemma":[0.00678353,0.0016072756,0.3148683,0.00018523748,0.00016789632,0.0002786121,0.00018767167,0.000030672978,0.025539909,0.0002597548,0.6498573,0.00023384411],"about_ca_topic_score_codex":0.0000825005,"about_ca_topic_score_gemma":0.00003519951,"teacher_disagreement_score":0.4429906,"about_ca_system_score_codex":0.0001926768,"about_ca_system_score_gemma":0.00013376623,"threshold_uncertainty_score":0.99772066},"labels":[],"label_agreement":null},{"id":"W4245015319","doi":"10.1002/9780471420194.tnmc54.pub2","title":"Hodgkin Lymphoma","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Pathology","score_opus":0.013909747709782374,"score_gpt":0.29025139845146825,"score_spread":0.2763416507416859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245015319","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022039644,0.0021694633,0.0000028063416,0.0012461599,0.0006871566,0.0005540638,0.0031482591,0.0004662555,0.98952186],"genre_scores_gemma":[0.0009590293,0.0006485193,0.004893058,0.0011120882,0.0021398999,0.00005409828,0.0047070542,0.0005021012,0.98498416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902135,0.000011082378,0.00017217657,0.00033063922,0.00023043588,0.00023433036],"domain_scores_gemma":[0.9990569,0.00002997188,0.00011694226,0.00059393933,0.000025160272,0.00017713597],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00002648244,0.0002977162,0.0005093801,0.00017366135,0.000018588195,0.0000104013325,0.00009131959,0.0004556637,0.044247705],"category_scores_gemma":[0.000036459067,0.00021861916,0.00016372814,0.00008977835,0.00005614127,0.000007819445,0.000042699983,0.00011541467,0.0016245344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019692072,0.0013353257,0.00091202947,0.00005874865,0.00019629658,0.00032828804,0.000008764289,5.1349796e-9,0.000030439689,0.00007886445,0.8707183,0.12631321],"study_design_scores_gemma":[0.00275809,0.00016390132,0.010890559,0.00037693002,0.000268898,0.000114075636,0.0000048986276,0.0000044495537,0.00011896655,0.000014073919,0.9850921,0.00019307746],"about_ca_topic_score_codex":0.00040503565,"about_ca_topic_score_gemma":0.00068315864,"teacher_disagreement_score":0.12612014,"about_ca_system_score_codex":0.00008282852,"about_ca_system_score_gemma":0.0001859625,"threshold_uncertainty_score":0.99915284},"labels":[],"label_agreement":null},{"id":"W4245051263","doi":"10.1182/blood-2020-134622","title":"Does Upfront Autologous Stem Cell Transplant at First Relapse Improve Outcome in Transplant Eligible Follicular Lymphoma Patients Who Relapse within 24 Months","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Rituximab; Chemoimmunotherapy; Oncology; Hematopoietic stem cell transplantation; Transplantation; Lymphoma","score_opus":0.01020112181199483,"score_gpt":0.20894424549641993,"score_spread":0.1987431236844251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245051263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937196,0.0013122583,0.000005598367,0.001736197,0.0004830341,0.0015237088,0.0004314945,0.00016660539,0.0006215484],"genre_scores_gemma":[0.99698424,0.000623666,0.00021591218,0.00082354946,0.00007802809,0.00027136618,0.00019882405,0.00007651053,0.0007278819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685204,0.00007980487,0.0009794032,0.00089185755,0.0005573594,0.0006395209],"domain_scores_gemma":[0.99857825,0.00010442464,0.00021985215,0.0005261361,0.000053483614,0.00051784975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013072097,0.00054856867,0.0010083466,0.000115477764,0.00014989659,0.000033716773,0.00021247244,0.00031244234,0.000042717198],"category_scores_gemma":[0.0000134217635,0.0003394037,0.00035611558,0.00023151435,0.0000574866,0.00011834009,0.00005392542,0.00017587605,0.00014686288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010637493,0.0048703733,0.9790736,0.00057507976,0.00033740888,0.0040516597,0.008224312,0.000039354883,0.0006358551,0.000043450884,0.0004302089,0.000654962],"study_design_scores_gemma":[0.0871564,0.004115111,0.7364018,0.00095673365,0.0029788015,0.00014941691,0.00038020167,0.00078221265,0.16223665,0.000030261283,0.0036596262,0.0011528098],"about_ca_topic_score_codex":0.00058016623,"about_ca_topic_score_gemma":0.00058066344,"teacher_disagreement_score":0.2426718,"about_ca_system_score_codex":0.0003583672,"about_ca_system_score_gemma":0.00012457545,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W4245100347","doi":"10.3410/f.717973237.793469927","title":"Faculty Opinions recommendation of Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.","year":2013,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Positron emission tomography; Medicine; Lymphoma; Tomography; Bone marrow; Positron Emission Tomography-Computed Tomography; Radiology; Biopsy; Computed tomography; Nuclear medicine; Hodgkin lymphoma; Positron emission; Medical physics; Pathology","score_opus":0.03560153569550638,"score_gpt":0.3233305126709559,"score_spread":0.2877289769754495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245100347","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088480265,0.00162043,0.000038481678,0.062060043,0.0005205661,0.0059912563,0.9295984,0.000067165915,0.000015155358],"genre_scores_gemma":[0.00047042445,0.00035836155,0.002748888,0.0022473936,0.00018942829,0.0015085059,0.991663,0.0000548587,0.0007591856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504304,0.00041041366,0.0016693231,0.0010177239,0.001309595,0.0005499019],"domain_scores_gemma":[0.98820966,0.00035450872,0.0019327909,0.0015809105,0.0074062897,0.0005158063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005102381,0.0009353474,0.0016814872,0.0006033461,0.00039043708,0.00018312629,0.0006888392,0.0007084492,0.00035825648],"category_scores_gemma":[0.001304558,0.00047578986,0.0010245797,0.0021947513,0.00055533525,0.00029953683,0.00017568431,0.00032710165,0.000025282678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005109365,0.004068486,0.0007254399,0.005073648,0.0011050305,0.000002377937,0.000093200375,4.9201613e-8,0.00000879402,0.000029039758,0.9803096,0.008073413],"study_design_scores_gemma":[0.008629226,0.0030783266,0.03292954,0.0149214445,0.0013088118,0.00009605746,0.0000209436,0.000012401923,0.00014262387,0.0000075185967,0.93839383,0.00045924948],"about_ca_topic_score_codex":0.00023875588,"about_ca_topic_score_gemma":0.0000062261197,"teacher_disagreement_score":0.062064532,"about_ca_system_score_codex":0.00040501176,"about_ca_system_score_gemma":0.0010253494,"threshold_uncertainty_score":0.9997694},"labels":[],"label_agreement":null},{"id":"W4245247676","doi":"10.1182/asheducation.v2012.1.313.3797303","title":"Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy","year":2012,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hematologist; Radiation oncologist; Radiation therapy; Clinical trial; Hodgkin lymphoma; Stage (stratigraphy); Lymphoma; Protocol (science); Counterpoint; Oncology; Medical physics; Intensive care medicine; Internal medicine; Pathology; Disease; Psychology; Alternative medicine; Biology","score_opus":0.008745288096373016,"score_gpt":0.25135073081611004,"score_spread":0.24260544271973702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245247676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97824156,0.017395345,0.000010277262,0.0011054319,0.00007970501,0.00031688614,0.0000039160277,0.000017430988,0.002829415],"genre_scores_gemma":[0.99818516,0.0010585941,0.00007479231,0.00046991408,0.000051203115,0.000061037135,0.000006281322,0.000010350768,0.00008269472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993707,0.00006961872,0.00018250957,0.00010390113,0.000091651855,0.00018161396],"domain_scores_gemma":[0.9994454,0.00016442557,0.00009706887,0.0002062006,0.00002334309,0.00006355675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017437962,0.00009698332,0.00031323778,0.00004526572,0.000037592963,0.00000505321,0.00003542629,0.000067758694,0.000091131944],"category_scores_gemma":[0.00003134759,0.00005496878,0.00006740474,0.000053303866,0.00012250987,0.00005763672,0.00002065443,0.000024713618,0.000032389074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000482776,0.00040280496,0.8511284,0.000020856334,0.00015118807,0.000008595269,0.0018781874,4.5544233e-8,0.00016960612,0.10022482,0.00019868862,0.04533406],"study_design_scores_gemma":[0.015084339,0.0002844004,0.8928057,0.00003381124,0.00010146063,0.0007254379,0.0005205373,0.000076095974,0.0692847,0.0012674036,0.019717257,0.00009885982],"about_ca_topic_score_codex":0.00023279873,"about_ca_topic_score_gemma":0.00000543141,"teacher_disagreement_score":0.09895742,"about_ca_system_score_codex":0.00002830149,"about_ca_system_score_gemma":0.00002398562,"threshold_uncertainty_score":0.22415617},"labels":[],"label_agreement":null},{"id":"W4245855097","doi":"10.1182/blood.v108.11.811.811","title":"Structural Profiles of p53 Gene Mutations Predict Clinical Outcome in Diffuse Large B-Cell Lymphoma: An International Collaborative Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Missense mutation; Mutation; Diffuse large B-cell lymphoma; Cancer research; Biology; Nonsense mutation; Lymphoma; Gene mutation; Gene; Molecular biology; Genetics; Internal medicine; Medicine; Immunology","score_opus":0.02295707299003613,"score_gpt":0.33455964198884625,"score_spread":0.3116025689988101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245855097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763286,0.0001243994,0.0000019505965,0.00009035618,0.00016740753,0.0008438071,0.0003695476,0.000030625262,0.000739066],"genre_scores_gemma":[0.9982239,0.000013674461,0.0009156339,0.000039406557,0.00017852982,0.00011425022,0.00038306435,0.000014889375,0.000116677846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848413,0.00010095301,0.00066210167,0.00028657806,0.00029783207,0.00016838076],"domain_scores_gemma":[0.99923366,0.000104133964,0.0001731441,0.00024063203,0.00016981902,0.00007860738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016526607,0.00014604254,0.0003642896,0.00011548652,0.00003993204,0.000016846754,0.00010051121,0.00007179475,0.000033510503],"category_scores_gemma":[0.00007171465,0.00011249566,0.00008266213,0.00019582719,0.00005490942,0.00011039282,0.000043247124,0.00005022007,0.00000714681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000965622,0.06844634,0.9302057,0.000011322393,0.00014692708,0.00019141086,0.0003496183,0.0000036237295,0.00012232641,0.00017114404,0.000030891526,0.00022414782],"study_design_scores_gemma":[0.07473999,0.0009418151,0.91991615,0.000015092524,0.00027084225,0.000014284919,0.0005756442,0.00014019471,0.0032179893,0.000038418817,0.000043290132,0.000086293905],"about_ca_topic_score_codex":0.00022801833,"about_ca_topic_score_gemma":0.00027739382,"teacher_disagreement_score":0.07464343,"about_ca_system_score_codex":0.000070588365,"about_ca_system_score_gemma":0.00015790475,"threshold_uncertainty_score":0.458744},"labels":[],"label_agreement":null},{"id":"W4246621148","doi":"10.1200/jco.2002.20.3.647","title":"Primary Cutaneous Follicular Lymphoma: An Assessment of Clinical, Histopathologic, Immunophenotypic, and Molecular Features","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Immunohistochemistry; Pathology; CD20; Follicular phase; Trunk; Radiation therapy; Internal medicine; Biology","score_opus":0.08091390790361995,"score_gpt":0.454774142752142,"score_spread":0.37386023484852204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246621148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97880435,0.008953134,0.00005548475,0.0032024276,0.0009845779,0.00026565383,0.0000047723693,0.000013285871,0.0077163056],"genre_scores_gemma":[0.96426713,0.008117893,0.022956925,0.0039651385,0.00048458463,0.000006282909,0.0000050580647,0.000021434658,0.00017553086],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99439996,0.00093522854,0.0035506904,0.00035090666,0.0005029094,0.00026028682],"domain_scores_gemma":[0.9940862,0.0019335835,0.0025866553,0.00044119157,0.00042444706,0.0005279075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027195318,0.00023098892,0.0027676697,0.00011424563,0.00005361057,0.000012582293,0.00020540401,0.0006333052,0.00014683139],"category_scores_gemma":[0.001719912,0.00015312739,0.0008744321,0.00009914433,0.0004539258,0.00010170892,0.00009464485,0.000530496,0.0000062739578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018720208,0.020949004,0.29180503,0.00007136349,0.0010263693,0.018797606,0.00007737776,0.00001092046,0.0008527111,0.0006906821,0.0039603133,0.6598866],"study_design_scores_gemma":[0.015921015,0.032153737,0.90894157,0.00009520132,0.0012614221,0.0057472833,0.000049565213,0.00009039523,0.00011556121,0.000381238,0.03509235,0.00015068332],"about_ca_topic_score_codex":0.000020116975,"about_ca_topic_score_gemma":0.0000042978454,"teacher_disagreement_score":0.6597359,"about_ca_system_score_codex":0.00026020626,"about_ca_system_score_gemma":0.0008170455,"threshold_uncertainty_score":0.62443537},"labels":[],"label_agreement":null},{"id":"W4246681679","doi":"10.1080/10428190210192","title":"Results of a Randomized Phase III Trial in Children and Adolescents with Advanced Stage Diffuse Large Cell Non-Hodgkin's Lymphoma: A Pediatric Oncology Group Study","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Vincristine; Prednisone; Cyclophosphamide; Internal medicine; Working Formulation; Lymphoma; Diffuse large B-cell lymphoma; Stage (stratigraphy); Methotrexate; Randomized controlled trial; Oncology; Lymphoblastic lymphoma; Chemotherapy; Gastroenterology; Surgery; Non-Hodgkin's lymphoma; Immunology; T cell","score_opus":0.007457312578628314,"score_gpt":0.2532243498802955,"score_spread":0.2457670373016672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246681679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550266,0.003965742,0.000024176832,0.000054322092,0.0002391441,0.008741999,0.00023872306,0.00015039652,0.0010828251],"genre_scores_gemma":[0.9916195,0.0054262327,0.00036768755,0.00032786836,0.00034050312,0.0011414835,0.00017859576,0.00015644757,0.0004416792],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922825,0.00069474336,0.002510054,0.001969328,0.0011031063,0.0014402671],"domain_scores_gemma":[0.9957203,0.0006599651,0.0013458673,0.0012153228,0.00019510726,0.0008634307],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012962384,0.0013080245,0.0040917303,0.0009616191,0.00031236312,0.000108215885,0.00038240736,0.00063830375,0.000031567288],"category_scores_gemma":[0.00023141001,0.0010072613,0.00048544002,0.0011264357,0.00048932876,0.0004140631,0.00034376624,0.000190234,0.000018431369],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7697125,0.061982654,0.079057515,0.00039161133,0.000816987,0.0020864687,0.0050496114,0.000010064005,0.00016428807,0.000043105643,0.00042007776,0.080265105],"study_design_scores_gemma":[0.8257941,0.010525545,0.15691862,0.00035114377,0.001887669,0.00040543487,0.0008913709,0.0016942973,0.00037024406,0.000009399922,0.00032885754,0.00082332117],"about_ca_topic_score_codex":0.0030062464,"about_ca_topic_score_gemma":0.0002893041,"teacher_disagreement_score":0.079441786,"about_ca_system_score_codex":0.0048327753,"about_ca_system_score_gemma":0.0014800205,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W4247016860","doi":"10.1200/jco.2004.99.312","title":"In Reply:","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine","score_opus":0.14731839661788587,"score_gpt":0.5162364027535872,"score_spread":0.3689180061357013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247016860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92562264,0.0003838521,0.000010679706,0.06456424,0.0008442795,0.00006871504,2.5789427e-7,0.0000026081443,0.008502712],"genre_scores_gemma":[0.97978675,0.00066910026,0.003521489,0.015124423,0.0007479104,0.0000016148605,2.5412447e-7,0.0000046005116,0.00014385955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814934,0.000080829785,0.0014181901,0.000084184954,0.00015681474,0.00011063864],"domain_scores_gemma":[0.9983745,0.00063260645,0.00057829544,0.00010390531,0.000108762906,0.00020193761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013776694,0.00005456311,0.00081389403,0.000074976524,0.00000780577,0.000002180898,0.00005129339,0.00014660075,0.000101485704],"category_scores_gemma":[0.0019327191,0.000033904114,0.0002886902,0.00007771198,0.000060047172,0.000058197995,0.00001509831,0.00030843331,0.000053604475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036661027,0.015110266,0.7465234,0.000016229618,0.00036681592,0.024349378,0.00015943272,0.000050464845,0.000058927384,0.0027882934,0.016022692,0.19088802],"study_design_scores_gemma":[0.021784903,0.010775248,0.7429633,0.00008165376,0.00011451048,0.0011289011,0.000031681997,0.0000013464016,0.00018833282,0.002871065,0.22002533,0.000033706347],"about_ca_topic_score_codex":0.000046491426,"about_ca_topic_score_gemma":0.000030955038,"teacher_disagreement_score":0.20400263,"about_ca_system_score_codex":0.00030079755,"about_ca_system_score_gemma":0.0014511246,"threshold_uncertainty_score":0.25742328},"labels":[],"label_agreement":null},{"id":"W4247051977","doi":"10.1200/jco.2013.31.15_suppl.tps8612","title":"Phase III study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Oncology; Vinblastine; Chemotherapy regimen; Regimen; Bleomycin; Chemotherapy; Vincristine; CD30; Lymphoma; Cyclophosphamide","score_opus":0.09144301180543674,"score_gpt":0.4451930388676109,"score_spread":0.3537500270621742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247051977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867119,0.0026472292,0.00015112133,0.005421203,0.0014648525,0.0027953098,0.00004984601,0.000035422512,0.0007230725],"genre_scores_gemma":[0.9907259,0.0024744112,0.0037154343,0.0007272876,0.0014215304,0.00022738207,0.000046195586,0.00007616217,0.00058570766],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925458,0.00045821234,0.004591031,0.0009071284,0.00074857,0.0007492827],"domain_scores_gemma":[0.98745984,0.0063447445,0.0030128695,0.0005844104,0.0014132235,0.0011849061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012898364,0.00076032925,0.00474378,0.00036518584,0.00015571008,0.00005211313,0.00026405603,0.00060469145,0.00019109635],"category_scores_gemma":[0.0032695504,0.0005091321,0.0006828017,0.00025136134,0.00052693405,0.00038332865,0.00020435585,0.00046338548,0.000018682378],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16326317,0.10508201,0.033814177,0.00021585793,0.006793075,0.0015962608,0.0011594762,0.0000900504,0.0077822725,0.00023627978,0.009847754,0.67011964],"study_design_scores_gemma":[0.53342605,0.32919654,0.10752041,0.00033369218,0.0046766438,0.00065265084,0.0015399125,0.002425263,0.0020606474,0.00013117513,0.017571323,0.00046567732],"about_ca_topic_score_codex":0.00042621835,"about_ca_topic_score_gemma":0.00043625102,"teacher_disagreement_score":0.66965395,"about_ca_system_score_codex":0.00073369045,"about_ca_system_score_gemma":0.0016627152,"threshold_uncertainty_score":0.999736},"labels":[],"label_agreement":null},{"id":"W4247401149","doi":"10.4021/jmc345w","title":"Primary Hepatic Lymphoma: A Diagnosis to Remember","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Liver biopsy; Jaundice; Liver function; Lymphoma; Liver function tests; Biopsy; Radiology; Internal medicine; Surgery","score_opus":0.03267632500026138,"score_gpt":0.3188295173991295,"score_spread":0.28615319239886816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247401149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755455,0.0072424826,0.000022971895,0.015058223,0.0005988783,0.00015090725,0.0000034658078,0.000012530399,0.0013650449],"genre_scores_gemma":[0.9882711,0.0013567918,0.0009283692,0.007793694,0.0014958784,0.00002816105,0.0000027757296,0.000016379216,0.00010682531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974206,0.0000631211,0.00052924245,0.00009543872,0.001568849,0.00032274355],"domain_scores_gemma":[0.9974224,0.00067291915,0.0001686194,0.00016999169,0.00013479822,0.0014312927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076474407,0.00014156218,0.00049216894,0.00014252737,0.000042506963,0.000014617008,0.00011454913,0.00011518826,0.001441527],"category_scores_gemma":[0.0022059751,0.00008794692,0.00023280615,0.00017415531,0.0000457747,0.00012681632,0.00006431073,0.00010609099,0.00013103684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029025626,0.004333049,0.6959403,0.00011301819,0.0002612399,0.0075257034,0.00030524575,3.005184e-7,0.000027453834,0.0001080088,0.11423,0.1768654],"study_design_scores_gemma":[0.00545118,0.0016799633,0.73946816,0.0010488312,0.00065620575,0.021400023,0.00013725802,0.0000038398553,0.0020622627,0.000017784569,0.22792497,0.0001495162],"about_ca_topic_score_codex":0.00006320686,"about_ca_topic_score_gemma":0.000007719702,"teacher_disagreement_score":0.17671588,"about_ca_system_score_codex":0.00035888838,"about_ca_system_score_gemma":0.00039356036,"threshold_uncertainty_score":0.9994713},"labels":[],"label_agreement":null},{"id":"W4247555751","doi":"10.1038/sj.labinvest.3700735","title":"Infections","year":2008,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine","score_opus":0.024004764444153868,"score_gpt":0.24637858569629048,"score_spread":0.22237382125213662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247555751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955177,0.00012214524,0.0000117726,0.0009798863,0.00010167968,0.0001328663,0.000006578993,0.00010923749,0.0030181687],"genre_scores_gemma":[0.99739146,0.000051806204,0.00058008335,0.0015480471,0.000102792896,0.00004858228,0.000038954135,0.0000071842446,0.00023109118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996019,0.000018127801,0.00009517752,0.000103354796,0.00010585486,0.00007557243],"domain_scores_gemma":[0.9996022,0.000017295011,0.000029610008,0.00013316487,0.00010469128,0.000113016366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030714076,0.00006063701,0.00008138311,0.00004951839,0.00011327312,0.0000047825556,0.000012485185,0.000041420997,0.00006849301],"category_scores_gemma":[0.00005398052,0.000052095715,0.00002450379,0.00026185476,0.000078007135,0.00008781923,0.0000048982674,0.000037590293,0.00023637064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040916193,0.00014031796,0.9827701,0.00000958872,0.000025908372,0.00004666733,0.00025503308,0.0000040557907,0.0050139716,0.0021726985,0.009358857,0.00019874697],"study_design_scores_gemma":[0.0008424697,0.00015815337,0.92791,0.000022304526,0.000040625524,0.00006438142,0.000016855123,0.000027742582,0.04668889,0.00020942384,0.02395405,0.000065110566],"about_ca_topic_score_codex":0.000027134998,"about_ca_topic_score_gemma":0.0000050603567,"teacher_disagreement_score":0.05486007,"about_ca_system_score_codex":0.00008642174,"about_ca_system_score_gemma":0.00021379585,"threshold_uncertainty_score":0.30381453},"labels":[],"label_agreement":null},{"id":"W4247580066","doi":"10.1158/1538-7445.sabcs18-3480","title":"Abstract 3480:<i>TMEM30A</i>loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Molecular and Cellular Biology / Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Vulnerability (computing); Lymphoma; Function (biology); Cancer research; Computer science; Computational biology; Biology; Genetics; Immunology; Computer security","score_opus":0.01130891725487708,"score_gpt":0.24674553257605755,"score_spread":0.2354366153211805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247580066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869845,0.010713978,0.0005420641,0.00012683832,0.00009072409,0.00052882923,0.00001771612,0.000016162097,0.0009791753],"genre_scores_gemma":[0.99788094,0.0009377664,0.000622425,0.0003118529,0.000014572343,0.000045591976,0.000109382214,0.000022270868,0.000055174838],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987285,0.00009103557,0.00034656076,0.00045639326,0.00011058209,0.00026693786],"domain_scores_gemma":[0.99927324,0.00008872095,0.00008466943,0.00033957217,0.00009450198,0.00011931787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015907889,0.00022208,0.00039726516,0.00010252167,0.000047361416,0.000015326206,0.00005388875,0.00022854347,0.000069602764],"category_scores_gemma":[0.000013378785,0.00018906643,0.00009146944,0.00011909772,0.00021666486,0.000025711357,0.00005506131,0.000055652,0.0000160652],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120453566,0.00083782815,0.50468546,0.00008567739,0.00012156065,0.000050612285,0.0001342365,0.000020168387,0.48360234,0.000460217,0.0000033000508,0.009878176],"study_design_scores_gemma":[0.006683888,0.0008960735,0.48499817,0.000031969947,0.00025570043,0.000029889738,0.00015253761,0.0002020008,0.5048386,0.0009087056,0.000783672,0.00021879858],"about_ca_topic_score_codex":0.00008515911,"about_ca_topic_score_gemma":0.000008435671,"teacher_disagreement_score":0.021236269,"about_ca_system_score_codex":0.000053205626,"about_ca_system_score_gemma":0.000117681026,"threshold_uncertainty_score":0.7709905},"labels":[],"label_agreement":null},{"id":"W4248166007","doi":"10.4021/jmc87w","title":"A Case of Mucosa-Associated Lymphoid Tissue Lymphoma (MALToma) That Developed From Lungs and Stomach","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Jikei University School of Medicine","keywords":"Medicine; Pathology; Lymphoma; Bronchiectasis; MALT lymphoma; Stomach; Lymphatic system; Lung; Pleural effusion; Differential diagnosis; Radiology; Gastroenterology; Internal medicine","score_opus":0.06769790500666006,"score_gpt":0.31468455046671107,"score_spread":0.246986645460051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248166007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935161,0.0049102018,0.000020750833,0.00074637315,0.00023930747,0.00014932887,0.000045978984,0.000016162365,0.00035580574],"genre_scores_gemma":[0.9969779,0.0010511423,0.0011857862,0.0005418264,0.00015863434,0.000005703872,0.000010492328,0.000021531067,0.00004695878],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99769706,0.00012079902,0.0007100449,0.00019179596,0.0010270132,0.0002532815],"domain_scores_gemma":[0.99762976,0.0006247086,0.00057158223,0.00018092843,0.00025677995,0.00073624455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006016748,0.000213451,0.0007898687,0.00016422295,0.00006607426,0.000014574257,0.00013311405,0.00024635246,0.0010378709],"category_scores_gemma":[0.0014773855,0.00014339853,0.00015289431,0.00015696023,0.00018354763,0.00011492474,0.00008195632,0.00011699097,0.0000070100887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011734052,0.004006168,0.39717844,0.000106757856,0.0014522164,0.42326236,0.0027286424,4.05244e-8,0.00029028198,0.0000903801,0.0062196124,0.1634917],"study_design_scores_gemma":[0.02519327,0.0035904131,0.569743,0.0014603927,0.0018856194,0.35334817,0.0018213376,0.00007564368,0.03973844,0.00017439538,0.0026514386,0.00031791243],"about_ca_topic_score_codex":0.0035786657,"about_ca_topic_score_gemma":0.00029424415,"teacher_disagreement_score":0.17256455,"about_ca_system_score_codex":0.00023102085,"about_ca_system_score_gemma":0.00081308663,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W4248240157","doi":"10.1158/1538-7445.am2019-3765","title":"Abstract 3765: Somatic JAK-STAT mutations in subtypes of aggressive B-cell lymphomas with DLBCL morphology","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC","funders":"","keywords":"BCL6; Cancer research; Diffuse large B-cell lymphoma; Lymphoma; Biology; Neuroblastoma RAS viral oncogene homolog; Phenotype; Gene; B cell; Immunology; Mutation; KRAS; Genetics; Germinal center; Antibody","score_opus":0.03930099950478923,"score_gpt":0.371593883685706,"score_spread":0.3322928841809168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248240157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898393,0.0022178842,6.492588e-7,0.0006769811,0.000051035047,0.0007717453,0.000030301153,0.000011715632,0.0064003714],"genre_scores_gemma":[0.99792993,0.00051571184,0.00011130497,0.00005016434,0.000029353405,0.0002979562,0.00003267646,0.0000232526,0.0010096733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.00006569626,0.0002303189,0.00028777073,0.00047017055,0.00038898273],"domain_scores_gemma":[0.99879843,0.00034025856,0.00014409644,0.00034226174,0.00025690466,0.00011803365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022094543,0.00011770372,0.00032515623,0.0002962963,0.00004027535,0.000012272195,0.00010620147,0.00007541687,0.0010615054],"category_scores_gemma":[0.000069876245,0.00008325933,0.00004718465,0.00042793064,0.00018958784,0.00006223864,0.00004034255,0.00015265221,0.00024542314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045933892,0.0015940473,0.9671379,0.00056577905,0.000119034274,0.0008793312,0.0011331146,0.00012765826,0.023336636,0.00020755723,0.0007268935,0.003712756],"study_design_scores_gemma":[0.0100328745,0.00066097797,0.88405067,0.0008173767,0.000042325577,0.000050154333,0.00093008124,0.000047368994,0.10277387,0.00016730049,0.0003137306,0.000113296934],"about_ca_topic_score_codex":0.0024118293,"about_ca_topic_score_gemma":0.0003150372,"teacher_disagreement_score":0.08308721,"about_ca_system_score_codex":0.00047599038,"about_ca_system_score_gemma":0.00089647085,"threshold_uncertainty_score":0.99985164},"labels":[],"label_agreement":null},{"id":"W4248934310","doi":"10.3410/f.13757.505956","title":"Faculty Opinions recommendation of Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.","year":2006,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Randomized controlled trial; Oncology; Clinical trial; Hodgkin lymphoma; Radiation therapy; Medical physics; Internal medicine; Lymphoma; Chemotherapy; Family medicine; Vincristine; Biology; Cyclophosphamide","score_opus":0.07434982123185249,"score_gpt":0.4197232132420384,"score_spread":0.3453733920101859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248934310","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011296299,0.0027304543,0.000022727161,0.039055344,0.00030098166,0.0055367397,0.95118886,0.000006943724,0.00002832529],"genre_scores_gemma":[0.011011509,0.0023132511,0.00022432877,0.0017275013,0.00011123715,0.00078831334,0.9837315,0.00001888872,0.000073474854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99260557,0.0022210141,0.0028575,0.00050419307,0.0015913771,0.00022033784],"domain_scores_gemma":[0.9895675,0.0013514847,0.004484218,0.00053373695,0.003917521,0.00014551912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041923956,0.00047806045,0.0033834635,0.00026431264,0.00011524549,0.000048445778,0.00041432647,0.0004514356,0.000039445964],"category_scores_gemma":[0.0030520025,0.0002146937,0.00041402457,0.00097506336,0.00093792175,0.00026450303,0.00008946212,0.00039185162,2.1216685e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014819658,0.00384949,0.005469626,0.0016500974,0.0015467798,4.204723e-7,0.00024349405,0.000003472043,2.0966044e-7,0.00030428043,0.95890963,0.013202823],"study_design_scores_gemma":[0.13817339,0.0011771694,0.072784446,0.0052370797,0.00045623718,0.000003970393,0.00005237106,0.00005588629,0.000012852233,0.0000061395017,0.78185725,0.00018319472],"about_ca_topic_score_codex":0.019258808,"about_ca_topic_score_gemma":0.010098806,"teacher_disagreement_score":0.17705238,"about_ca_system_score_codex":0.00040289582,"about_ca_system_score_gemma":0.0029858768,"threshold_uncertainty_score":0.987272},"labels":[],"label_agreement":null},{"id":"W4249167763","doi":"10.1002/9780471420194.tnmc55.pub2","title":"Non‐Hodgkin Lymphomas","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.012045373086325632,"score_gpt":0.2877559204112793,"score_spread":0.27571054732495365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249167763","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020559002,0.0013577456,0.0000028953652,0.0010939821,0.00073369395,0.00065572833,0.0024104153,0.00035838527,0.9913313],"genre_scores_gemma":[0.0018200338,0.0006108305,0.004576116,0.0011704498,0.0023682963,0.00007188148,0.0049427524,0.0005563057,0.9838833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886084,0.000008176369,0.0002083636,0.00038299305,0.00026260252,0.0002770052],"domain_scores_gemma":[0.99890953,0.000027996475,0.00013921654,0.00068341946,0.000031214753,0.0002086468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000032747797,0.00035222716,0.0006041402,0.00020096287,0.000022913773,0.000012173138,0.00011010967,0.00052169163,0.051009815],"category_scores_gemma":[0.000028492188,0.0002604056,0.00019181627,0.000107777865,0.00006338917,0.000009820556,0.00005165156,0.00018981913,0.0018984475],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024489376,0.0013494529,0.0024111,0.00008931624,0.00024888624,0.00040679175,0.000015760714,1.1574981e-8,0.00007183004,0.000060582763,0.9572899,0.038031895],"study_design_scores_gemma":[0.0029878104,0.00019261737,0.012798953,0.00048370138,0.00032874104,0.0001113543,0.000006655514,0.00001032882,0.00022689687,0.000014454714,0.9826072,0.00023128124],"about_ca_topic_score_codex":0.00044874148,"about_ca_topic_score_gemma":0.0006055947,"teacher_disagreement_score":0.049111366,"about_ca_system_score_codex":0.00010283779,"about_ca_system_score_gemma":0.00023829787,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W4249384979","doi":"10.1200/jco.2019.37.15_suppl.7532","title":"Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Brentuximab vedotin; Population; Dacarbazine; Internal medicine; Nuclear medicine; Oncology; Chemotherapy; Lymphoma; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.06538313009105307,"score_gpt":0.41756307624279165,"score_spread":0.3521799461517386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249384979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851011,0.00011815492,0.000073314135,0.012070716,0.00075005094,0.0010460374,0.000010184331,0.0000064161536,0.0008240289],"genre_scores_gemma":[0.99477404,0.00011827836,0.0025654808,0.0016189287,0.00045195964,0.000015528341,0.0000015731576,0.000026286467,0.00042794418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971829,0.00024127087,0.0016195195,0.0002354857,0.00048156813,0.00023927297],"domain_scores_gemma":[0.9955855,0.0016899044,0.0017366435,0.00040172625,0.00038702574,0.00019917314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018466321,0.00017846275,0.0016473818,0.000060408907,0.000034939072,0.000008988153,0.00026317875,0.000245868,0.0001545363],"category_scores_gemma":[0.00046172726,0.00008518229,0.00065648503,0.00013486609,0.00019270033,0.000060467475,0.000057932753,0.00028804445,0.000019648436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013245069,0.017318344,0.877114,0.00003824743,0.0012818822,0.00010123543,0.000093693154,0.00000815977,0.00006416069,0.00044188992,0.0024924616,0.08780088],"study_design_scores_gemma":[0.0714379,0.03745113,0.83723557,0.00010156332,0.0005985936,0.00009087496,0.00023016984,0.00007036858,0.00049097766,0.00014545028,0.0520578,0.000089623856],"about_ca_topic_score_codex":0.00001740626,"about_ca_topic_score_gemma":0.00008153171,"teacher_disagreement_score":0.08771126,"about_ca_system_score_codex":0.00021776457,"about_ca_system_score_gemma":0.001757542,"threshold_uncertainty_score":0.3473633},"labels":[],"label_agreement":null},{"id":"W4251021353","doi":"10.3410/f.733831909.793577560","title":"Faculty Opinions recommendation of High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transplantation; Medicine; Chemotherapy; Cancer; Oncology; Enteropathy; Stem cell; Autologous stem-cell transplantation; Internal medicine; Disease; Biology","score_opus":0.046239742050222084,"score_gpt":0.39117435914232085,"score_spread":0.34493461709209877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251021353","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033289813,0.0035597,0.000001422803,0.06946078,0.00022593576,0.003408322,0.919977,0.0000225142,0.000015320908],"genre_scores_gemma":[0.011588384,0.005469166,0.00008244017,0.0026599807,0.000095161944,0.0008117897,0.97904575,0.000032732092,0.00021461512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954412,0.0008141518,0.001323612,0.000841162,0.0012134148,0.0003664533],"domain_scores_gemma":[0.99549776,0.00022649045,0.0013092211,0.00066832476,0.0019757545,0.00032245155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011481148,0.00051166187,0.0012457741,0.00046197715,0.00023825682,0.000089888366,0.00044545546,0.00052764674,0.00019116946],"category_scores_gemma":[0.00061173755,0.00033180727,0.00024023042,0.0014967428,0.00029733416,0.00012815563,0.00021944467,0.0006699306,0.000007723194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029769147,0.005021194,0.0005402208,0.0056751734,0.00026161765,0.000010242559,0.0020972544,3.8352926e-8,0.000012172869,0.000013830958,0.9770718,0.008998757],"study_design_scores_gemma":[0.016606491,0.0024000907,0.02112652,0.013452469,0.00051206874,0.000048846232,0.00028000597,0.000009695772,0.00015118039,0.0000087198,0.94511384,0.00029009816],"about_ca_topic_score_codex":0.0005136641,"about_ca_topic_score_gemma":0.000049332022,"teacher_disagreement_score":0.0668008,"about_ca_system_score_codex":0.00030480302,"about_ca_system_score_gemma":0.0005241834,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4251363279","doi":"10.1093/jncimonographs/lgu011","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Marginal Zone Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Internal medicine; Marginal zone B-cell lymphoma; Lymphoma; Splenic marginal zone lymphoma; Family history; Follicular lymphoma; Gastroenterology; Marginal zone; Immunology; Spleen; B cell; Splenectomy","score_opus":0.022316562757564225,"score_gpt":0.2637918898201732,"score_spread":0.241475327062609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251363279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024516,0.0042680325,0.0010279051,0.00045676416,0.001119694,0.0011816727,0.0000764675,0.00012805576,0.0014962701],"genre_scores_gemma":[0.9949737,0.0006842395,0.001200156,0.0012373556,0.00043807056,0.000603455,0.00019840876,0.00006486812,0.00059972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973138,0.00016277282,0.0005483079,0.00067275524,0.00077305036,0.0005292884],"domain_scores_gemma":[0.99779755,0.00076762517,0.0003153482,0.00057062076,0.00017384607,0.0003749838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006852829,0.00047677007,0.0006369884,0.00035894854,0.00022845669,0.000032499585,0.00026789043,0.00028409515,0.00009750257],"category_scores_gemma":[0.00039117452,0.00030911347,0.00042770518,0.00017989775,0.0005025559,0.00013152183,0.00008538357,0.00009782114,0.000020092632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010342238,0.0015431165,0.73948926,0.00012557817,0.000617097,0.000040367853,0.0020020623,6.4200583e-7,0.00004404837,0.0010245353,0.158621,0.095458046],"study_design_scores_gemma":[0.006744908,0.0009500242,0.6596604,0.00008511016,0.00039053545,0.00007216962,0.00022583004,0.001372804,0.000055958033,0.000044102584,0.33013994,0.00025822496],"about_ca_topic_score_codex":0.0031839437,"about_ca_topic_score_gemma":0.00020479466,"teacher_disagreement_score":0.17151894,"about_ca_system_score_codex":0.0014519866,"about_ca_system_score_gemma":0.0010917933,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W4251887365","doi":"10.1002/9781119263906.ch9","title":"HODGKIN LYMPHOMA","year":2021,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Disease; Pathology; Test (biology); Liver cancer; Liver function tests; Cancer; Internal medicine; Biology","score_opus":0.01724277570541881,"score_gpt":0.27859968115449435,"score_spread":0.2613569054490755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251887365","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008759408,0.0078468295,0.000006463537,0.00046633687,0.00023431616,0.00020773521,0.000009800012,0.00015847002,0.9909825],"genre_scores_gemma":[0.0010113511,0.0010277514,0.0016770111,0.001118148,0.0004085064,0.000043975204,0.00022767234,0.00025135642,0.9942342],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934745,0.000009700829,0.00009208054,0.0002538944,0.00015786765,0.0001390089],"domain_scores_gemma":[0.9994677,0.000013254862,0.0000389073,0.00036243777,0.000014400729,0.000103308535],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000014260133,0.00017607916,0.00035282614,0.000086608736,0.000009176316,0.000010987184,0.000031882508,0.00019345083,0.07786874],"category_scores_gemma":[0.000008863912,0.00012267113,0.00014195638,0.00007103578,0.000017833427,0.0000027972592,0.00002845704,0.00002018849,0.0007937747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004206864,0.00040936013,0.00282654,0.00007544088,0.00031858255,0.0007642138,0.0000042991533,2.9525875e-9,0.0000061168353,0.00072190625,0.9544134,0.040455934],"study_design_scores_gemma":[0.0019077997,0.00006449857,0.007946811,0.0004267669,0.00016768655,0.00011665261,0.000010295351,7.9203204e-7,0.00037969882,0.000006275785,0.98885465,0.00011806269],"about_ca_topic_score_codex":0.00062267657,"about_ca_topic_score_gemma":0.00012374444,"teacher_disagreement_score":0.07707497,"about_ca_system_score_codex":0.000097902885,"about_ca_system_score_gemma":0.00015370206,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W4252034974","doi":"10.1002/9780471420194.tnmc82","title":"Malignant Lymphoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Malignant lymphoma; Lymphoma; Medicine; Oncology; Cancer research; Internal medicine","score_opus":0.025773682823806182,"score_gpt":0.3117782941354491,"score_spread":0.2860046113116429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252034974","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004373785,0.005050481,0.0000018988388,0.00090940803,0.0004516364,0.0004751149,0.0035231651,0.00027500908,0.9888759],"genre_scores_gemma":[0.00093982206,0.0020321861,0.0013249969,0.00055219687,0.0014503032,0.000047806137,0.0034541413,0.0003674811,0.9898311],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990352,0.000010385075,0.00013908536,0.00034371033,0.00022804472,0.00024358291],"domain_scores_gemma":[0.99864906,0.00001725824,0.00020105005,0.00094216893,0.000024783745,0.00016569627],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00002704954,0.00029716737,0.0005663988,0.0001309392,0.00004245404,0.000018529403,0.0001380646,0.00027284928,0.012383395],"category_scores_gemma":[0.00003930787,0.00020890133,0.00017744783,0.000029171466,0.00006520633,0.000011132017,0.000060485916,0.00004712901,0.0013144192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002067355,0.0009705798,0.0009407193,0.00008934788,0.0002795042,0.00092235074,0.000006780899,5.8201772e-9,0.0000063495663,0.000060451774,0.90111095,0.09559227],"study_design_scores_gemma":[0.002789163,0.00016264901,0.011570312,0.0015650354,0.00033521198,0.0001293936,0.0000035591272,0.0000044304575,0.00006608895,0.000010670098,0.98316836,0.00019510262],"about_ca_topic_score_codex":0.0005671751,"about_ca_topic_score_gemma":0.00031033243,"teacher_disagreement_score":0.09539717,"about_ca_system_score_codex":0.00012686725,"about_ca_system_score_gemma":0.00021285574,"threshold_uncertainty_score":0.9994632},"labels":[],"label_agreement":null},{"id":"W4252290951","doi":"10.3410/f.718135672.793493701","title":"Faculty Opinions recommendation of The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"German; Hodgkin lymphoma; Lymphoma; Histology; Lymphocyte; Medicine; Internal medicine; Pathology; Oncology; History","score_opus":0.02446721701871737,"score_gpt":0.3636199373421915,"score_spread":0.33915272032347415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252290951","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008700991,0.002432285,0.000011735135,0.066698804,0.0009423683,0.005251656,0.923753,0.000022503316,0.000017501658],"genre_scores_gemma":[0.007819346,0.00033877057,0.00021020834,0.0016629439,0.00026010192,0.0009775425,0.9885789,0.000040642644,0.000111550835],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99209136,0.0016749301,0.0029754548,0.0010184873,0.0017575459,0.0004822022],"domain_scores_gemma":[0.9892096,0.0007614279,0.003428599,0.0034697575,0.0028589084,0.00027171272],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002537878,0.00078224816,0.0020874892,0.00033366107,0.00023471765,0.00007247559,0.0017635066,0.0007275684,0.00026703178],"category_scores_gemma":[0.010367689,0.00035413628,0.0013410401,0.0020393871,0.0005645486,0.00015530024,0.00076004653,0.00063675304,0.00001994409],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113292605,0.004817409,0.003034071,0.0016900199,0.0008455951,0.000019337243,0.0005099278,2.1960756e-7,0.000003969611,0.00005795441,0.9859355,0.0029727218],"study_design_scores_gemma":[0.0037143999,0.0005530247,0.29023892,0.0078018527,0.0010051464,0.000403033,0.000043386455,0.000015804582,0.00000797381,0.000019583002,0.69597316,0.00022368919],"about_ca_topic_score_codex":0.0033433025,"about_ca_topic_score_gemma":0.00014924051,"teacher_disagreement_score":0.2899623,"about_ca_system_score_codex":0.00092406344,"about_ca_system_score_gemma":0.0017031833,"threshold_uncertainty_score":0.99989104},"labels":[],"label_agreement":null},{"id":"W4252305908","doi":"10.3410/f.732122473.793577574","title":"Faculty Opinions recommendation of A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Romidepsin; Refractory (planetary science); Lymphoma; Medicine; Internal medicine; Oncology; Family medicine; Chemistry; Physics","score_opus":0.0342406760216572,"score_gpt":0.360904822158515,"score_spread":0.3266641461368578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252305908","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029174616,0.0015336293,6.732862e-7,0.061098028,0.0001797835,0.0030942177,0.93113583,0.000016448084,0.00002392872],"genre_scores_gemma":[0.006365472,0.0013898042,0.00021860603,0.0010239106,0.00006472046,0.00028691586,0.99047005,0.000023692526,0.00015682312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576753,0.0007142278,0.0015648229,0.000748824,0.00095745694,0.00024713774],"domain_scores_gemma":[0.99501747,0.00028826302,0.00180041,0.0009995735,0.0015543338,0.0003399599],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001089165,0.000500211,0.0015901179,0.00038448052,0.00009385329,0.000046287165,0.00038212645,0.0004885571,0.00006409517],"category_scores_gemma":[0.0035643848,0.00032357624,0.00028201658,0.0013414515,0.00023490928,0.0001984521,0.0003740675,0.00048825177,0.000004814541],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025440985,0.008924547,0.00034693655,0.010824836,0.00026542446,0.000003255385,0.00037292362,1.1049108e-8,0.000022056023,0.00000798088,0.97125036,0.007727268],"study_design_scores_gemma":[0.012811443,0.0015653459,0.05852407,0.010697089,0.00063656404,0.000033424127,0.00009580662,0.0000085538895,0.000039117807,0.0000047470935,0.9153549,0.00022895385],"about_ca_topic_score_codex":0.00020937745,"about_ca_topic_score_gemma":0.000015013426,"teacher_disagreement_score":0.060074117,"about_ca_system_score_codex":0.00017502846,"about_ca_system_score_gemma":0.00044547682,"threshold_uncertainty_score":0.9999216},"labels":[],"label_agreement":null},{"id":"W4252571225","doi":"10.1182/blood.v110.11.49.49","title":"Paraffin-Based 6-Gene Model Predicts Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Medicine; Prednisone; CHOP; Oncology; Lymphoma; Rituximab; Anthracycline; Cyclophosphamide; International Prognostic Index; Gastroenterology; Cancer; Chemotherapy; Breast cancer","score_opus":0.011909332328848167,"score_gpt":0.2339422522528658,"score_spread":0.22203291992401764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252571225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692297,0.00021175553,0.00014456705,0.000031196716,0.000025420679,0.0006050939,0.00014780492,0.00007640186,0.0018348125],"genre_scores_gemma":[0.99772954,0.00001759231,0.0013610628,0.0002871603,0.00002829516,0.00004429052,0.00017763599,0.00004294829,0.00031148596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836135,0.00001681065,0.00042690727,0.00032762752,0.000444572,0.00042270464],"domain_scores_gemma":[0.9988737,0.00007443272,0.00017614076,0.0004609646,0.0001561432,0.00025860203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010859308,0.00026654382,0.0004582262,0.0001324789,0.000053311123,0.000008182238,0.000084108615,0.0001177749,0.000015456013],"category_scores_gemma":[0.000025336336,0.00018260034,0.00013513018,0.0001685549,0.000043942193,0.000039978695,0.000024075869,0.000040155697,0.000024253695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060219434,0.071236834,0.9263298,0.00007880838,0.00018841348,0.00022807397,0.00007821627,0.000029281131,0.00051660906,0.000012813269,0.000055366672,0.0006436192],"study_design_scores_gemma":[0.1430062,0.0013976534,0.6589347,0.00008335494,0.0009476864,0.0000076118654,0.000011955844,0.0009243916,0.19441983,0.000002346584,0.00008399346,0.00018028758],"about_ca_topic_score_codex":0.00006595056,"about_ca_topic_score_gemma":0.00003594623,"teacher_disagreement_score":0.26739508,"about_ca_system_score_codex":0.00009436188,"about_ca_system_score_gemma":0.000108270695,"threshold_uncertainty_score":0.7446226},"labels":[],"label_agreement":null},{"id":"W4252728565","doi":"10.1016/j.beha.2018.08.002","title":"Editor's introduction","year":2018,"lang":"en","type":"editorial","venue":"Best Practice & Research Clinical Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; T-cell lymphoma; Radiation therapy; Chemotherapy; Peripheral T-cell lymphoma; Oncology; Disease; Immunology; Immune system; T cell","score_opus":0.10419735969455782,"score_gpt":0.546708306170629,"score_spread":0.44251094647607125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252728565","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070168957,0.0018748145,0.000007801325,0.043662634,0.9423392,0.0013253676,0.000058738184,0.00011581933,0.009913985],"genre_scores_gemma":[0.0002469503,0.009775902,0.0014975632,0.00026013088,0.9791118,0.0004392926,0.00080068543,0.00011937518,0.0077483044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98728716,0.0040019425,0.0018498594,0.0020120454,0.0035278026,0.0013211973],"domain_scores_gemma":[0.93432605,0.05310918,0.0009016307,0.002541452,0.008104714,0.0010169621],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.012437762,0.0005308127,0.0021984857,0.000493633,0.00040265778,0.00016939949,0.0005695987,0.0039981077,0.0010417853],"category_scores_gemma":[0.24323139,0.0004269402,0.00053336547,0.0005912202,0.0020908017,0.00039790192,0.0006865964,0.005662501,0.014052559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029805766,0.0087901065,0.00050239655,0.00030137575,0.00093777216,0.0039359555,0.000042541833,2.5597348e-8,0.0000012948784,0.00038448212,0.9756666,0.0064568613],"study_design_scores_gemma":[0.0037667146,0.010445586,0.000048027643,0.0003259719,0.0011129474,0.001016366,0.00017623417,0.0000052840683,0.000028612872,0.00024894436,0.9825232,0.00030212483],"about_ca_topic_score_codex":0.0005755646,"about_ca_topic_score_gemma":0.00009243506,"teacher_disagreement_score":0.23079363,"about_ca_system_score_codex":0.0009459472,"about_ca_system_score_gemma":0.007465766,"threshold_uncertainty_score":0.9998714},"labels":[],"label_agreement":null},{"id":"W4252749574","doi":"10.1200/jco.2004.22.14_suppl.6080","title":"Malignant pleural effusions in lymphoproliferative disorders: A clinico-pathologic study","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dartmouth General Hospital","funders":"","keywords":"Medicine; Thoracentesis; Pleural effusion; Internal medicine; Malignancy; Malignant pleural effusion; Lymphoproliferative disorders; Gastroenterology; Multiple myeloma; Lymphoma; Pleural disease; Odds ratio; Pleurisy; Pathology; Respiratory disease; Lung","score_opus":0.14496618618163537,"score_gpt":0.4967297756653875,"score_spread":0.35176358948375214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252749574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850666,0.00040806492,0.000019526951,0.011462423,0.00089703134,0.00064042455,0.0000026426899,0.000010841768,0.0014924603],"genre_scores_gemma":[0.9941899,0.0011027409,0.0016878593,0.002420847,0.00049651385,0.000029762183,0.000001631767,0.000013307102,0.00005744363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545044,0.0006327899,0.0029692838,0.0002860666,0.00036328565,0.00029815076],"domain_scores_gemma":[0.9961959,0.0017813521,0.0012174312,0.00023386025,0.00020733093,0.00036412996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030395726,0.00019263935,0.0018566694,0.00019273786,0.000052149182,0.000010264574,0.00015820525,0.00031845053,0.00007924273],"category_scores_gemma":[0.0033663444,0.000114476956,0.00060031225,0.00022447553,0.00017734789,0.00009857918,0.000083126346,0.0005907018,0.000050485483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029194038,0.035141576,0.90134525,0.0000063955185,0.00026606154,0.009832218,0.00081789354,0.00006539491,0.000014814894,0.0001890272,0.00017538972,0.0492266],"study_design_scores_gemma":[0.046212316,0.048657145,0.89890665,0.000121699944,0.00035516865,0.00082547654,0.001319177,0.0000111059535,0.000020243688,0.0016296259,0.0018403492,0.000101063066],"about_ca_topic_score_codex":0.00010965471,"about_ca_topic_score_gemma":0.00072783686,"teacher_disagreement_score":0.049125537,"about_ca_system_score_codex":0.0004907675,"about_ca_system_score_gemma":0.0021867377,"threshold_uncertainty_score":0.46682346},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4252862210","doi":"10.1182/blood-2019-124217","title":"Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Mantle cell lymphoma; Internal medicine; Regimen; Oncology; Transplantation; Chemotherapy regimen; Maintenance therapy; Surgery; Cancer; Lymphoma; Chemotherapy","score_opus":0.004943166813335075,"score_gpt":0.20229945854946726,"score_spread":0.1973562917361322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252862210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640447,0.0012410788,4.0026524e-7,0.0001208427,0.000033610722,0.0005503566,0.000013498382,0.000021884023,0.0016138862],"genre_scores_gemma":[0.9978777,0.0015292757,0.00017653267,0.00015156556,0.000023321252,0.000031376298,0.000048701426,0.000017982791,0.00014353394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992485,0.000013340541,0.00013697287,0.00026882233,0.00015547348,0.00017689283],"domain_scores_gemma":[0.9996874,0.000021048867,0.000040515704,0.00014244435,0.000025170415,0.000083456194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004294079,0.00014968979,0.00024711748,0.00010173289,0.00003012773,0.000019342866,0.00002316245,0.00006403597,0.000032318774],"category_scores_gemma":[0.0000017447614,0.00010160387,0.000018631627,0.000109423854,0.000024076686,0.00007956059,0.000010564028,0.00003883114,0.000021601605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041471224,0.0062451023,0.98652184,0.00006956468,0.00005709958,0.000046069094,0.00034084666,4.4420275e-7,0.00083049823,0.000028763428,0.000027063006,0.0054180096],"study_design_scores_gemma":[0.07891661,0.001783999,0.89778715,0.00014451718,0.00010329088,0.00007411153,0.000053599437,0.0000061161754,0.020415237,0.00002724604,0.0005593827,0.0001287219],"about_ca_topic_score_codex":0.00041888587,"about_ca_topic_score_gemma":0.000025439671,"teacher_disagreement_score":0.08873466,"about_ca_system_score_codex":0.000025210766,"about_ca_system_score_gemma":0.000047203248,"threshold_uncertainty_score":0.41432858},"labels":[],"label_agreement":null},{"id":"W4253128972","doi":"10.1002/9780471420194.tnmc55.pub3","title":"Non‐Hodgkin Lymphomas","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Internal medicine","score_opus":0.022085005140127175,"score_gpt":0.3192980448404833,"score_spread":0.2972130397003561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253128972","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004309713,0.0026414741,0.0000023705934,0.00083163596,0.000478505,0.00053130765,0.0023065796,0.00023069115,0.99254644],"genre_scores_gemma":[0.0017287467,0.0014967436,0.0016835725,0.00062778353,0.0019393184,0.000060319697,0.003890555,0.00041686298,0.9881561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989246,0.000008484514,0.00015846179,0.00038288484,0.00025459842,0.0002709486],"domain_scores_gemma":[0.99848646,0.00002046807,0.00022637619,0.0010501902,0.000029332288,0.00018717132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000033372162,0.0003452556,0.0006573814,0.00016213211,0.00004900406,0.000021618445,0.00016612814,0.0003381698,0.016837878],"category_scores_gemma":[0.00004082357,0.00025674177,0.0002025235,0.000039846593,0.00007557172,0.000014407896,0.000069218746,0.00009418665,0.0016295789],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024940757,0.0008958553,0.0025507768,0.00010193974,0.00032403207,0.00064467057,0.000011626791,1.3310358e-8,0.000008421673,0.00003076545,0.9506911,0.04471588],"study_design_scores_gemma":[0.0033089116,0.00019814684,0.017902099,0.001311039,0.00037332828,0.00008748426,0.000004093011,0.000010003822,0.000079417754,0.000011669256,0.9764884,0.00022538923],"about_ca_topic_score_codex":0.0006141769,"about_ca_topic_score_gemma":0.0003572794,"teacher_disagreement_score":0.044490494,"about_ca_system_score_codex":0.00015708196,"about_ca_system_score_gemma":0.00025745243,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W4254390104","doi":"10.1200/jco.2005.05.302","title":"In Reply:","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine","score_opus":0.14842619539725949,"score_gpt":0.5229542709720655,"score_spread":0.374528075574806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254390104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88202167,0.0005850121,0.000004132093,0.10046267,0.0005743682,0.0000627645,2.611924e-7,0.0000026185767,0.016286526],"genre_scores_gemma":[0.9693107,0.000823986,0.004665093,0.022836955,0.0017782698,0.0000016065513,2.38743e-7,0.000004600361,0.0005785535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799305,0.000120834855,0.0015367043,0.00008246267,0.00015447168,0.00011245446],"domain_scores_gemma":[0.9979718,0.0010140891,0.0006004345,0.00010506421,0.00010723117,0.00020143104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001660752,0.00005402447,0.0008075021,0.00007557115,0.000007257883,0.0000021915125,0.00005257822,0.0001436176,0.00030827476],"category_scores_gemma":[0.0017496949,0.000033637236,0.00028177418,0.000064014,0.000049813152,0.00007390865,0.000015566638,0.00030727216,0.00009158006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014925816,0.005684648,0.4495443,0.0000047028784,0.00014396787,0.0028960465,0.000054715616,0.000008307297,0.000018099021,0.00033753316,0.057865344,0.48194975],"study_design_scores_gemma":[0.0076923044,0.004073635,0.44135776,0.000027443522,0.00007014714,0.0004931017,0.000013332922,0.000015144906,0.000080156315,0.00014071756,0.5460154,0.000020876822],"about_ca_topic_score_codex":0.000013328886,"about_ca_topic_score_gemma":0.00003449971,"teacher_disagreement_score":0.48815003,"about_ca_system_score_codex":0.00022266047,"about_ca_system_score_gemma":0.00078652793,"threshold_uncertainty_score":0.33753926},"labels":[],"label_agreement":null},{"id":"W4254511029","doi":"10.1200/jco.2002.20.1.197","title":"Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Stage (stratigraphy); Internal medicine; Lymphoma; International Prognostic Index; Surgery; Cancer; Radiation therapy; Large-cell lymphoma; Working Formulation; B symptoms; Oncology; Cyclophosphamide; Non-Hodgkin's lymphoma","score_opus":0.11869513060941014,"score_gpt":0.3949859720411679,"score_spread":0.27629084143175775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254511029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911683,0.00369598,0.000046845173,0.0037188025,0.0006112621,0.00039034596,0.000038918748,0.000011332631,0.0003181793],"genre_scores_gemma":[0.9680889,0.020735022,0.0007741176,0.008078792,0.0012619388,0.00004704559,0.000009542601,0.000021991562,0.0009826286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802315,0.00020082986,0.0010586809,0.00025899918,0.0002270562,0.00023126049],"domain_scores_gemma":[0.9969536,0.0013927182,0.0009043839,0.00021085078,0.00021628979,0.00032212693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054165005,0.0001124566,0.00075459346,0.000018245843,0.00020484922,0.00013287719,0.00013807359,0.00028397993,0.0003808652],"category_scores_gemma":[0.0005487325,0.00009675882,0.0002747628,0.00007937807,0.00015719619,0.00017809976,0.000023142615,0.00016912456,0.0000028043023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051369966,0.01159511,0.6810754,0.000011795256,0.00016696306,0.00026273602,0.0008491554,4.861389e-7,0.00003081109,0.000008835572,0.050444365,0.25504065],"study_design_scores_gemma":[0.041217122,0.0039597214,0.7693754,0.0000695777,0.00021289842,0.000056239576,0.00032627583,0.00044928875,0.00001898718,0.00009484436,0.18412912,0.000090542526],"about_ca_topic_score_codex":0.0044233333,"about_ca_topic_score_gemma":0.009584079,"teacher_disagreement_score":0.2549501,"about_ca_system_score_codex":0.00020019792,"about_ca_system_score_gemma":0.00029679906,"threshold_uncertainty_score":0.66867864},"labels":[],"label_agreement":null},{"id":"W4254559332","doi":"10.1182/blood.v112.11.268.268","title":"Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Diffuse Large-B-Cell Lymphoma: Results of An International Study (NHL-003)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Progressive disease; Oncology; Refractory (planetary science); Lymphoma; Surgery; Phases of clinical research; Febrile neutropenia; Chemotherapy regimen; Gastroenterology; Neutropenia; Chemotherapy; Multiple myeloma","score_opus":0.01276798037817791,"score_gpt":0.24683295234209737,"score_spread":0.23406497196391945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254559332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887085,0.000039713683,0.0000010020416,0.00003231414,0.000033180022,0.0007720966,0.00008070774,0.000005667568,0.00016448335],"genre_scores_gemma":[0.99963343,0.00007659053,0.00015171086,0.000024447641,0.000009571737,0.000012759542,0.000045420013,0.000010603039,0.000035472836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891305,0.00009080006,0.0004407648,0.00015732516,0.0003146124,0.00008342236],"domain_scores_gemma":[0.999139,0.0001107423,0.0003151136,0.0002792233,0.0001196936,0.000036213285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013732641,0.00010432874,0.00028742192,0.00007587866,0.00002606891,0.0000022712552,0.00007779237,0.000041443236,0.0000070067904],"category_scores_gemma":[0.00007048329,0.000058069632,0.000030818283,0.00012109674,0.00006257802,0.00008045699,0.000022498081,0.00003137713,2.7310836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0149980765,0.08410133,0.896644,0.00002165014,0.00019733679,0.000014143951,0.0028617838,0.0000035432329,0.0002499267,0.000007774949,0.000013592085,0.00088687334],"study_design_scores_gemma":[0.24996665,0.002257429,0.73958296,0.000080329606,0.00009678154,0.0000035300864,0.00016807168,0.000012786508,0.007744202,7.9045424e-7,0.000044688062,0.000041798634],"about_ca_topic_score_codex":0.00023359095,"about_ca_topic_score_gemma":0.00008759987,"teacher_disagreement_score":0.23496857,"about_ca_system_score_codex":0.00003478528,"about_ca_system_score_gemma":0.00009547984,"threshold_uncertainty_score":0.23680109},"labels":[],"label_agreement":null},{"id":"W4255276779","doi":"10.3410/f.732292396.793577570","title":"Faculty Opinions recommendation of Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Cancer research; Internal medicine; Oncology; Pharmacology","score_opus":0.0646205427403994,"score_gpt":0.39044017756529026,"score_spread":0.32581963482489085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255276779","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029120696,0.0009787943,0.0000063398147,0.09358743,0.0005186386,0.0031801893,0.901396,0.000010800294,0.00003061699],"genre_scores_gemma":[0.0027794994,0.0011099773,0.00031065004,0.0012617616,0.00019837612,0.00030539188,0.9939275,0.000020748806,0.00008609922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492574,0.0006331688,0.0022229769,0.0006426693,0.0013304151,0.00024502585],"domain_scores_gemma":[0.9934727,0.00040775354,0.0023448544,0.0012548338,0.0022412452,0.00027861586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001150817,0.00046547945,0.0017421457,0.00025040255,0.0000806637,0.000031600626,0.00072037586,0.0006829381,0.00006296725],"category_scores_gemma":[0.0057014707,0.0002561681,0.0008329902,0.0015879424,0.000468767,0.00022578146,0.0005321465,0.000559307,0.000003769177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001334979,0.006711248,0.000021307726,0.008498389,0.0002001278,4.952062e-7,0.00016547983,1.09722535e-7,0.000015424968,0.00007213722,0.9777832,0.0051971115],"study_design_scores_gemma":[0.034191884,0.0010484946,0.002037935,0.012447124,0.0005787438,0.000016629672,0.000022645492,0.000049482103,0.0004670106,0.000021328964,0.94892645,0.00019227056],"about_ca_topic_score_codex":0.00013154118,"about_ca_topic_score_gemma":0.000008326362,"teacher_disagreement_score":0.09253151,"about_ca_system_score_codex":0.00015237731,"about_ca_system_score_gemma":0.0011752426,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W4256099973","doi":"10.3410/f.1098053.552960","title":"Faculty Opinions recommendation of Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.","year":2007,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Pathogenesis; Allele; Genetics; Chromosome; Lymphoma; Biology; Computational biology; Medicine; Gene; Internal medicine","score_opus":0.04869973433041665,"score_gpt":0.37434318539526895,"score_spread":0.3256434510648523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256099973","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008017352,0.0049153296,0.000025793186,0.012638789,0.00030142654,0.0016755627,0.97959715,0.000026622485,0.000017568342],"genre_scores_gemma":[0.001932443,0.0028518746,0.00074939954,0.0016221511,0.00007152142,0.00019701464,0.99243766,0.00002816878,0.00010978865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513906,0.00036794847,0.0018295815,0.00075388706,0.0014950025,0.0004144939],"domain_scores_gemma":[0.99065304,0.00043885104,0.001844035,0.0012986404,0.0053568757,0.000408586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007091008,0.00058653695,0.0019882247,0.0006920199,0.00019963032,0.000077831646,0.0004653784,0.0006349957,0.00026640313],"category_scores_gemma":[0.0021598418,0.000386768,0.0011620566,0.003164437,0.00040315633,0.0002086059,0.00034757674,0.00028938087,0.000013709961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048037804,0.0012379346,0.0023502721,0.008452717,0.0031449804,0.0000030503663,0.00014869668,4.6847464e-7,0.000024206893,0.000063865686,0.98230386,0.002221889],"study_design_scores_gemma":[0.0021621748,0.00015280527,0.15141378,0.0053851055,0.0039874013,0.000042953656,0.00009026102,0.000017420176,0.00013790862,0.0000044981207,0.83634615,0.00025951452],"about_ca_topic_score_codex":0.00037469092,"about_ca_topic_score_gemma":0.000041091753,"teacher_disagreement_score":0.14906351,"about_ca_system_score_codex":0.00025517002,"about_ca_system_score_gemma":0.00046826465,"threshold_uncertainty_score":0.99985844},"labels":[],"label_agreement":null},{"id":"W4280534972","doi":"10.3899/jrheum.220120","title":"Dr. Griffiths et al reply","year":2022,"lang":"fr","type":"letter","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Censoring (clinical trials); Observational study; Randomized controlled trial; Golimumab; Internal medicine; Physical therapy; Rheumatoid arthritis; Adalimumab; Pathology","score_opus":0.018761018636340138,"score_gpt":0.28362582589763846,"score_spread":0.26486480726129835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280534972","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12683702,0.026069056,0.000025569445,0.8371919,0.008011559,0.0002948527,0.000040917203,0.000013671028,0.0015154838],"genre_scores_gemma":[0.0591512,0.055975817,0.00017290127,0.8798595,0.00033711529,0.000026809374,0.000063026135,0.000101725884,0.00431187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945704,0.0019327671,0.0015926304,0.00028267078,0.0008703788,0.00075117504],"domain_scores_gemma":[0.9935006,0.0031928201,0.0020854685,0.00077923713,0.0002379388,0.00020396843],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002170802,0.0005181291,0.0017724335,0.00029978392,0.0002853303,0.000029256376,0.0007450716,0.00027729795,0.0076911952],"category_scores_gemma":[0.00046001116,0.00030894484,0.0006632451,0.00022009133,0.00041676316,0.00009552278,0.000282724,0.0029554262,0.00038412976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007370663,0.0004955933,0.07918627,0.00013167877,0.0022463135,0.003599251,0.0011315608,0.000037965117,0.00001033533,0.00093663076,0.90919816,0.0022891434],"study_design_scores_gemma":[0.0036752755,0.0021803367,0.0051044086,0.0007495653,0.0013576357,0.16385204,0.00039295526,0.000015844305,0.00002514443,0.00026285148,0.82218,0.0002039842],"about_ca_topic_score_codex":0.0011042313,"about_ca_topic_score_gemma":0.00003804239,"teacher_disagreement_score":0.16025278,"about_ca_system_score_codex":0.00075127004,"about_ca_system_score_gemma":0.0010910344,"threshold_uncertainty_score":0.9999363},"labels":[],"label_agreement":null},{"id":"W4281250923","doi":"10.1200/edbk_349307","title":"Revising the Treatment Pathways in Lymphoma: New Standards of Care—How Do We Choose?","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Cancer Research UK; European Hematology Association","keywords":"Rituximab; Medicine; Follicular lymphoma; Prednisone; Lymphoma; Vincristine; Oncology; CHOP; Internal medicine; Cyclophosphamide; Diffuse large B-cell lymphoma; Refractory (planetary science); Chemotherapy; Biology","score_opus":0.14322419516008214,"score_gpt":0.487645114634505,"score_spread":0.3444209194744229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281250923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024898088,0.9761122,0.0000017502088,0.018879307,0.0003913398,0.0014051831,0.00022795788,0.000010382846,0.0027229288],"genre_scores_gemma":[0.0002692001,0.9931386,0.0018867467,0.0013599951,0.00073448214,0.0005004857,0.00025524234,0.000042165673,0.0018130518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957678,0.0006895438,0.0019329523,0.00062015,0.0006883217,0.0003012435],"domain_scores_gemma":[0.98724914,0.009261582,0.0023414083,0.00067486597,0.00022547819,0.00024754196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000970406,0.00042794965,0.0045059123,0.00007326632,0.000100294754,0.000009571075,0.00029443967,0.0002828481,0.0009853131],"category_scores_gemma":[0.00056761154,0.00026651198,0.0030357079,0.00046648047,0.0011323442,0.000037776474,0.00009751235,0.00033750955,0.000007176213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007682472,0.0035179951,0.0013745875,0.0011829707,0.0011109895,0.000006742718,0.0016534507,5.89536e-7,3.0363182e-8,0.00026724325,0.034499884,0.9563087],"study_design_scores_gemma":[0.002608652,0.0041256826,0.0034308452,0.0024687052,0.0019212717,0.000029932275,0.0025391066,6.699417e-7,5.85858e-7,0.00006683057,0.98262876,0.00017897332],"about_ca_topic_score_codex":0.00038621822,"about_ca_topic_score_gemma":0.000014803229,"teacher_disagreement_score":0.9561297,"about_ca_system_score_codex":0.005297261,"about_ca_system_score_gemma":0.038755633,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W4281486289","doi":"10.1002/hon.3033","title":"Exome sequencing identifies <i>PD‐L2</i> as a potential predisposition gene for lymphoma","year":2022,"lang":"en","type":"letter","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"American Cancer Society","keywords":"Exome sequencing; Lymphoma; Cancer research; Germline; Biology; Follicular lymphoma; Gene; Genetics; Medicine; Immunology; Mutation","score_opus":0.036548349414169644,"score_gpt":0.3103958639145961,"score_spread":0.2738475145004265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281486289","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22237442,0.004212302,0.00039709418,0.7544308,0.0038580052,0.0053718067,0.00065936305,0.0006236114,0.008072655],"genre_scores_gemma":[0.1449502,0.00062497606,0.0031358653,0.8258564,0.0043787127,0.0074971924,0.008328556,0.00015477388,0.0050733206],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627334,0.00028383356,0.0008592088,0.0011068329,0.0006072592,0.0008695277],"domain_scores_gemma":[0.99787337,0.00074165507,0.00047799305,0.00054603466,0.00016970916,0.00019122419],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026691883,0.000587664,0.0017938138,0.00023218547,0.0003641009,0.000054608143,0.0002763174,0.0017636676,0.0022504365],"category_scores_gemma":[0.00020946616,0.00046169446,0.00082179316,0.00018011377,0.00022674794,0.000073590585,0.00027166578,0.0006241979,0.00022583168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010757067,0.0010872333,0.00019770209,0.00064838154,0.0007357879,0.06315497,0.000106268526,0.000005373631,0.001063433,0.0005686701,0.92871726,0.0026392015],"study_design_scores_gemma":[0.007255333,0.0060595553,0.0004952187,0.00012911094,0.0018537702,0.037813745,0.00012572874,0.000072529765,0.004105552,0.0029763095,0.93855065,0.0005625166],"about_ca_topic_score_codex":0.00008403266,"about_ca_topic_score_gemma":0.0000049515206,"teacher_disagreement_score":0.07742423,"about_ca_system_score_codex":0.002609458,"about_ca_system_score_gemma":0.00095177884,"threshold_uncertainty_score":0.99978346},"labels":[],"label_agreement":null},{"id":"W4281625438","doi":"10.1182/blood.2022015851","title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Barts Charity","keywords":"Terminology; Medicine; Consensus conference; Internal medicine","score_opus":0.03787384926230386,"score_gpt":0.30971631521710863,"score_spread":0.27184246595480477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281625438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694252,0.0012453593,0.0000019195534,0.024190163,0.00065015536,0.0002955876,0.000118888776,0.000024141598,0.004048593],"genre_scores_gemma":[0.99762326,0.00015861425,0.00026038624,0.00087601476,0.00022214123,0.000121728204,0.00018644516,0.000009836552,0.00054154673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987471,0.00013032318,0.00044215177,0.00019349717,0.00039305747,0.00009387946],"domain_scores_gemma":[0.9978274,0.0012427296,0.00027766876,0.0005310866,0.000080396574,0.000040711937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048656823,0.00008067619,0.00016347501,0.000014542954,0.0002056719,0.000016091786,0.00019825644,0.000042579348,0.00012547034],"category_scores_gemma":[0.00031989787,0.000044110162,0.00014951747,0.000072839284,0.00011629425,0.000008774732,0.000120304845,0.0001427574,0.000011478435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026725174,0.0020110293,0.90396744,0.0000028432778,0.00059764774,0.0002939389,0.00017517954,0.000001478034,0.00043563257,0.00077188323,0.08438229,0.007093381],"study_design_scores_gemma":[0.0047442773,0.000151692,0.7878614,0.000017604401,0.00037383402,0.0009014523,0.00093296333,0.00008238467,0.0006302422,0.00026880633,0.2039843,0.00005104071],"about_ca_topic_score_codex":0.00016001347,"about_ca_topic_score_gemma":0.000041583768,"teacher_disagreement_score":0.119602025,"about_ca_system_score_codex":0.00006282339,"about_ca_system_score_gemma":0.00025158952,"threshold_uncertainty_score":0.17987603},"labels":[],"label_agreement":null},{"id":"W4281627747","doi":"10.1200/jco.2022.40.16_suppl.7516","title":"Favezelimab (anti–LAG-3) plus pembrolizumab in patients with anti–PD-1–naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An open-label phase 1/2 study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Internal medicine; Neutropenia; Cohort; Oncology; Cancer; Toxicity; Gastroenterology; Immunotherapy","score_opus":0.13589889030561272,"score_gpt":0.470248609626649,"score_spread":0.3343497193210363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281627747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937603,0.0001491179,0.0000057345915,0.0022772918,0.0012430247,0.0016593008,0.000042618813,0.000021456131,0.00084115454],"genre_scores_gemma":[0.99551827,0.00015627491,0.0009738628,0.0024541873,0.000419886,0.00010300058,0.000045243654,0.00006632391,0.0002629595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99172866,0.0021659178,0.0034904985,0.00070841215,0.0013219756,0.0005845576],"domain_scores_gemma":[0.9932142,0.002143671,0.0026376292,0.0006491945,0.00053435354,0.00082097994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031619642,0.00041460607,0.0033254984,0.00038214884,0.00023830424,0.00005297895,0.0007647435,0.00035710237,0.00053531775],"category_scores_gemma":[0.0015925455,0.00026234673,0.00024947803,0.00053400616,0.00026873723,0.00045992684,0.0005554631,0.0012629033,0.000021759406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13519944,0.23970008,0.4618699,0.000015907828,0.0009297924,0.013957777,0.0005149735,0.000026664926,0.000013832951,0.000041176092,0.003541926,0.14418852],"study_design_scores_gemma":[0.26342598,0.20423476,0.5174322,0.00006263401,0.00057236716,0.00033677224,0.00063697627,0.000119325276,0.0000055922815,0.000017982275,0.012972165,0.00018325738],"about_ca_topic_score_codex":0.0001326464,"about_ca_topic_score_gemma":0.00014229685,"teacher_disagreement_score":0.14400527,"about_ca_system_score_codex":0.0023304198,"about_ca_system_score_gemma":0.0067108157,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W4281628094","doi":"10.3389/fonc.2022.880144","title":"Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma","year":2022,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Shanxi Medical University","keywords":"Medicine; Internal medicine; Relative risk; Incidence (geometry); Lymphoma; CHOP; Risk factor; Prednisone; Vincristine; Cumulative incidence; Confidence interval; Cyclophosphamide; Chemotherapy; Transplantation","score_opus":0.07485278393170099,"score_gpt":0.35462436242632556,"score_spread":0.2797715784946246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281628094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004940524,0.99123544,0.0003686522,0.000035398316,0.00047019563,0.0017451693,0.0010322743,0.000009907225,0.00016244753],"genre_scores_gemma":[0.0043723118,0.9875606,0.0065992265,0.000037415102,0.000025113519,0.000902404,0.00037091796,0.00004331297,0.000088754685],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99745625,0.00033266254,0.0010136245,0.0006295442,0.00028019852,0.0002877134],"domain_scores_gemma":[0.9965827,0.0013217567,0.0013830438,0.00052637194,0.000071797214,0.00011431789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047670535,0.00046605073,0.008063721,0.0012017433,0.00004843155,0.0000051807965,0.00021713288,0.00032278505,0.00012028354],"category_scores_gemma":[0.00014262072,0.00029522492,0.0018226038,0.0008482036,0.00028439844,0.000038290727,0.00013288243,0.00016929714,3.141168e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000711617,0.0014644611,0.03753771,0.0040446557,0.40691695,0.00024828053,0.001331522,0.000018037472,2.7150034e-7,0.000029345467,0.002682647,0.5450145],"study_design_scores_gemma":[0.0018959058,0.002368532,0.002653412,0.00025750272,0.53556573,0.00003351108,0.00034714967,0.000051900417,0.0000032484888,0.000012062231,0.45661452,0.00019653414],"about_ca_topic_score_codex":0.0010605974,"about_ca_topic_score_gemma":0.0005068346,"teacher_disagreement_score":0.544818,"about_ca_system_score_codex":0.001157683,"about_ca_system_score_gemma":0.0007959852,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W4281629140","doi":"10.1200/jco.2022.40.16_suppl.tps7588","title":"CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who have received ≥ 1 line of systemic therapy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Lenalidomide; Medicine; Rituximab; Follicular lymphoma; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Neutropenia; Gastroenterology; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.13090223204693324,"score_gpt":0.4447035934095154,"score_spread":0.31380136136258213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281629140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387234,0.00231812,0.000014740863,0.0008300374,0.000769179,0.0020695925,0.000029949411,0.0000063205625,0.00008971556],"genre_scores_gemma":[0.9972441,0.0014413401,0.00052934425,0.00027062633,0.00032250863,0.00007585485,0.000019301382,0.000033776494,0.0000631568],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99147666,0.002426903,0.004312272,0.00036543686,0.0011070234,0.00031170435],"domain_scores_gemma":[0.9830231,0.0107038645,0.0049688686,0.00043616196,0.0006248883,0.00024313504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061798533,0.00029736818,0.0033773002,0.00020735922,0.00013556702,0.000009493975,0.00027853882,0.00026341187,0.000098696524],"category_scores_gemma":[0.004812642,0.00016030933,0.0004918891,0.0002852501,0.00030158198,0.00009721658,0.00012964233,0.0006571238,6.6737744e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87960887,0.013709534,0.005433188,0.000049448117,0.0015619248,0.00046057225,0.0008791411,0.0011630706,0.00007000665,0.000009061683,0.00018776904,0.09686739],"study_design_scores_gemma":[0.78202176,0.18357545,0.029345913,0.00059218996,0.0011627766,0.00014931415,0.0006807318,0.0013757307,0.000078194505,0.000009731726,0.0008753776,0.00013284879],"about_ca_topic_score_codex":0.00021057104,"about_ca_topic_score_gemma":0.00005644531,"teacher_disagreement_score":0.1698659,"about_ca_system_score_codex":0.0015294425,"about_ca_system_score_gemma":0.0053779436,"threshold_uncertainty_score":0.9540241},"labels":[],"label_agreement":null},{"id":"W4281654053","doi":"10.3390/curroncol29060328","title":"Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Venetoclax; Bortezomib; Medicine; Splenic marginal zone lymphoma; Lymphoma; Refractory (planetary science); Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Leukemia; Chronic lymphocytic leukemia; Spleen; Splenectomy","score_opus":0.07733332209479953,"score_gpt":0.3864639387577372,"score_spread":0.3091306166629377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281654053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517257,0.007962412,0.0000151006325,0.0041054483,0.0010553863,0.0009170438,0.00004095508,0.000050217473,0.0006808758],"genre_scores_gemma":[0.9956011,0.0017491435,0.00011863974,0.0011251502,0.00016033849,0.00070269493,0.00014283367,0.000023595518,0.0003764837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984472,0.00026463103,0.00027241596,0.00041250212,0.0003010583,0.00030222235],"domain_scores_gemma":[0.9990642,0.0002302585,0.0001257701,0.0002667087,0.000095626216,0.00021740788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028958457,0.00018764973,0.0003952973,0.00022907494,0.00022035283,0.000012064853,0.000094851035,0.00007314132,0.0004137004],"category_scores_gemma":[0.00005956208,0.00017160123,0.00008075644,0.00022919933,0.00006933757,0.000045073084,0.00015430094,0.0001541269,0.000048841426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004389904,0.0043908474,0.059892636,0.000036009453,0.00018225021,0.00038410362,0.001603742,0.000007208905,0.0014048018,0.00167288,0.028116202,0.8979194],"study_design_scores_gemma":[0.008590084,0.004876648,0.36396667,0.000019971309,0.000065953944,0.0002257594,0.00023020916,0.000054955308,0.00029563223,0.000085846725,0.6214694,0.00011890406],"about_ca_topic_score_codex":0.00004540823,"about_ca_topic_score_gemma":0.000010939234,"teacher_disagreement_score":0.8978005,"about_ca_system_score_codex":0.0025479426,"about_ca_system_score_gemma":0.0007375217,"threshold_uncertainty_score":0.6997695},"labels":[],"label_agreement":null},{"id":"W4281670144","doi":"10.1200/jco.2022.40.16_suppl.7545","title":"Favezelimab (anti–LAG-3) plus pembrolizumab in patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after anti–PD-1 treatment: An open-label phase 1/2 study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Internal medicine; Cohort; Oncology; Clinical endpoint; Neutropenia; Gastroenterology; Cancer; Clinical trial; Toxicity; Immunotherapy","score_opus":0.12424472767676215,"score_gpt":0.46060701607648763,"score_spread":0.3363622883997255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281670144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473184,0.00023796069,0.000002594966,0.0016777787,0.00093444396,0.0017651282,0.000060093233,0.000020422112,0.00056970876],"genre_scores_gemma":[0.9961337,0.00023548378,0.00072852673,0.0017360584,0.00039647275,0.0002483794,0.00004770483,0.00007029594,0.00040336416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99265414,0.0018529703,0.0031443303,0.000716764,0.0010533752,0.00057839154],"domain_scores_gemma":[0.9947141,0.001484858,0.0019784877,0.0006722144,0.00035855576,0.00079180626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001853636,0.00046273135,0.003275373,0.00036876954,0.00018938194,0.00005530693,0.000531946,0.00033374425,0.0006954086],"category_scores_gemma":[0.0006344774,0.0002748677,0.00028653178,0.00044379267,0.0002235061,0.0004411342,0.00035686517,0.0007672394,0.000024061022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16121833,0.23341116,0.43296936,0.000009763897,0.0009107697,0.01630728,0.0004615621,0.000011340685,0.000005835073,0.0000108650975,0.0007030222,0.1539807],"study_design_scores_gemma":[0.26159364,0.23631585,0.48351407,0.000048342536,0.0007278193,0.00028107187,0.00033614424,0.00006491215,0.0000050372882,0.000008760542,0.016938785,0.00016558798],"about_ca_topic_score_codex":0.00015281461,"about_ca_topic_score_gemma":0.0002664794,"teacher_disagreement_score":0.15381512,"about_ca_system_score_codex":0.0032858434,"about_ca_system_score_gemma":0.005454133,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W4281678979","doi":"10.1200/jco.2022.40.16_suppl.tps7583","title":"inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Lenalidomide; Follicular lymphoma; Internal medicine; Phases of clinical research; Oncology; CD20; Lymphoma; Clinical trial; Gastroenterology; Multiple myeloma","score_opus":0.12665443699702822,"score_gpt":0.451538070324499,"score_spread":0.3248836333274708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281678979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077755,0.0033654,0.00010371101,0.0025089385,0.0012890688,0.0016970495,0.000069996146,0.00001448682,0.00017378374],"genre_scores_gemma":[0.9946902,0.0009919512,0.002428567,0.00069351826,0.00064049085,0.0002113724,0.000014938882,0.000048717942,0.00028027935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940551,0.0009693212,0.003114023,0.00056129217,0.00082973705,0.00047053694],"domain_scores_gemma":[0.9884694,0.0075386935,0.0025584735,0.0003868595,0.00041180907,0.000634756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004122395,0.00039044296,0.0035724847,0.0003401447,0.00026387212,0.000026501117,0.00025032985,0.00032490562,0.00016496044],"category_scores_gemma":[0.0027206922,0.0002822549,0.0006067315,0.00022185122,0.00033361628,0.00019361397,0.00029598898,0.0006468651,0.0000036000592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73904353,0.09532422,0.0069226846,0.00019066577,0.0045093093,0.008921503,0.0013828789,0.000044696237,0.00010430378,0.00012896533,0.0052182544,0.13820896],"study_design_scores_gemma":[0.7881477,0.13396315,0.011191539,0.00011263136,0.004011034,0.0023080562,0.004758919,0.00046807944,0.000091508104,0.00006453762,0.054617375,0.0002654757],"about_ca_topic_score_codex":0.0001624941,"about_ca_topic_score_gemma":0.00015151608,"teacher_disagreement_score":0.13794349,"about_ca_system_score_codex":0.0012482966,"about_ca_system_score_gemma":0.0034640336,"threshold_uncertainty_score":0.999963},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4281683029","doi":"10.1200/jco.2022.40.16_suppl.7503","title":"First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Internal medicine; Oncology; Bleomycin; Population; Progression-free survival; Chemotherapy regimen; Chemotherapy; Surgery; Lymphoma; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.04392624238914087,"score_gpt":0.38510317768361135,"score_spread":0.34117693529447046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281683029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943663,0.000040662275,0.00008433847,0.004243502,0.0005227707,0.00046634936,0.00008521804,0.000009576403,0.00018128297],"genre_scores_gemma":[0.99603504,0.00006197559,0.0012850739,0.0020979606,0.00019814231,0.000020664344,0.00011208868,0.000028531065,0.0001605234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951143,0.0005986026,0.0026249408,0.00041445048,0.0008905009,0.00035718744],"domain_scores_gemma":[0.99592793,0.0009143236,0.0018176241,0.00040041763,0.0004178779,0.0005218405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021362645,0.00025040927,0.0028669967,0.0005275401,0.00006016917,0.000010607167,0.0002812107,0.00023094221,0.0006024842],"category_scores_gemma":[0.0003364309,0.00017534746,0.00062211097,0.00084446993,0.000115243594,0.000103405895,0.00013408937,0.00048783177,0.000003105695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04788165,0.035173897,0.8506618,0.000012947986,0.0039444086,0.00059951807,0.0003001263,0.0030477524,0.000025088018,0.00006429555,0.0007163117,0.057572205],"study_design_scores_gemma":[0.08206553,0.043766875,0.8592883,0.00002023841,0.001526554,0.000009202281,0.000106676984,0.0022206556,0.000046152814,0.000017788649,0.010783359,0.00014867802],"about_ca_topic_score_codex":0.00031552592,"about_ca_topic_score_gemma":0.0006999584,"teacher_disagreement_score":0.05742353,"about_ca_system_score_codex":0.0013576623,"about_ca_system_score_gemma":0.0016677476,"threshold_uncertainty_score":0.7150462},"labels":[],"label_agreement":null},{"id":"W4281709044","doi":"10.1200/jco.2022.40.16_suppl.7517","title":"Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"BCL6; Medicine; Hazard ratio; Internal medicine; Immunohistochemistry; Oncology; Lymphoma; Diffuse large B-cell lymphoma; Proportional hazards model; Univariate analysis; Confidence interval; International Prognostic Index; Cancer research; Multivariate analysis; Immunology; B cell; Antibody; Germinal center","score_opus":0.06113772831689156,"score_gpt":0.4070163829463697,"score_spread":0.34587865462947814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281709044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196906,0.0034540242,0.000001402997,0.013276494,0.0005387347,0.0003617356,0.000064107706,0.0000050745675,0.00032936622],"genre_scores_gemma":[0.992892,0.0015917339,0.00017664133,0.004845244,0.00015891549,0.000021018917,0.000019773459,0.000012559766,0.00028206903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711186,0.0008282377,0.0013069649,0.00021358297,0.00034031417,0.00019905357],"domain_scores_gemma":[0.9953466,0.0033777435,0.00081607513,0.0001827181,0.000048097867,0.00022878169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017793437,0.00013968747,0.0010628628,0.00006188175,0.00011611703,0.000015181438,0.00011672184,0.00016298157,0.00014049078],"category_scores_gemma":[0.00073212123,0.00007570196,0.00018923714,0.00008275721,0.00008059574,0.000061637664,0.0001934956,0.00034790213,0.000003498684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024193147,0.029686345,0.8903452,0.000004614003,0.00025100197,0.0006891434,0.00027838515,1.3784012e-7,0.00017611255,0.000011443715,0.023983251,0.030381188],"study_design_scores_gemma":[0.3360518,0.005291633,0.5543581,0.000026415853,0.0002480049,0.00003937926,0.0003294727,0.000011525495,0.0000518424,0.00008300638,0.10345382,0.000054965134],"about_ca_topic_score_codex":0.0003156312,"about_ca_topic_score_gemma":0.000047143647,"teacher_disagreement_score":0.3359871,"about_ca_system_score_codex":0.00019132085,"about_ca_system_score_gemma":0.0002880988,"threshold_uncertainty_score":0.30870363},"labels":[],"label_agreement":null},{"id":"W4281732590","doi":"10.1200/jco.2022.40.16_suppl.tps7590","title":"frontMIND: A phase III, randomized, double-blind study of tafasitamab + lenalidomide + R-CHOP versus R-CHOP alone for newly diagnosed high-intermediate and high-risk diffuse large B-cell lymphoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"MorphoSys","keywords":"Medicine; Lenalidomide; Internal medicine; CHOP; Diffuse large B-cell lymphoma; Vincristine; Oncology; Phases of clinical research; Clinical endpoint; Rituximab; Gastroenterology; Lymphoma; Randomized controlled trial; Clinical trial; Chemotherapy; Multiple myeloma; Cyclophosphamide","score_opus":0.07088796854688545,"score_gpt":0.4139830785513839,"score_spread":0.34309511000449844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281732590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98935723,0.0015970565,0.00016168332,0.0013714544,0.0036724184,0.0035314122,0.00016628281,0.000017529288,0.00012492758],"genre_scores_gemma":[0.9942379,0.0022067258,0.00094051956,0.0006286521,0.0011152261,0.0005846262,0.00003796212,0.00005559301,0.00019281376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99180865,0.001546437,0.0046603847,0.00058069185,0.0008513232,0.00055250444],"domain_scores_gemma":[0.97661144,0.016669475,0.0050358498,0.0004877582,0.00048161254,0.00071388204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0067182123,0.00043490823,0.0056610233,0.0003741737,0.000245124,0.000028073091,0.00034727165,0.00033406893,0.0002181094],"category_scores_gemma":[0.002969601,0.00031013583,0.0012592291,0.00020664801,0.00029390032,0.00016332157,0.0003035961,0.00069225417,0.000005429411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80735385,0.1374836,0.007640126,0.000037623264,0.0038963498,0.0021312248,0.00096780754,0.000021433301,0.00002260794,0.000067444795,0.0034571784,0.03692078],"study_design_scores_gemma":[0.90414053,0.06973053,0.009727037,0.000048378384,0.008113103,0.000117698044,0.0020789471,0.00022830295,0.00013495874,0.00013664545,0.005311173,0.0002327121],"about_ca_topic_score_codex":0.00084285304,"about_ca_topic_score_gemma":0.0003830644,"teacher_disagreement_score":0.096786685,"about_ca_system_score_codex":0.00054620614,"about_ca_system_score_gemma":0.001275072,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W4281741466","doi":"10.1200/jco.2022.40.16_suppl.7510","title":"Zanubrutinib plus obinutuzumab (ZO) versus obinutuzumab (O) monotherapy in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the phase 2 randomized ROSEWOOD trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Obinutuzumab; Phases of clinical research; Follicular lymphoma; Gastroenterology; Surrogate endpoint; Refractory (planetary science); Randomized controlled trial; Surgery; Clinical trial; Lymphoma; Rituximab","score_opus":0.06847802474352627,"score_gpt":0.4077650418084169,"score_spread":0.3392870170648906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281741466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373543,0.00066222844,0.000012056085,0.00082296436,0.0019053672,0.0019187855,0.00003584019,0.000011061091,0.0008962643],"genre_scores_gemma":[0.99659103,0.0007988941,0.00047163613,0.0014516725,0.00023494166,0.0001670666,0.000043483695,0.000037280934,0.00020400772],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9902874,0.0031132852,0.004481662,0.00043078812,0.0013164071,0.0003704298],"domain_scores_gemma":[0.9866905,0.0066601345,0.005238106,0.00069108483,0.00041834617,0.00030182741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005145922,0.00034006988,0.0054519116,0.0005354465,0.0001345006,0.0000126222885,0.0004565405,0.000333204,0.00047607737],"category_scores_gemma":[0.0030018312,0.00017491837,0.0025293163,0.0012985189,0.0003659806,0.000118590346,0.00014623012,0.0007179406,0.0000022941779],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.91945255,0.014817398,0.0054697725,0.000015616375,0.011339274,0.00069312233,0.00036192138,0.000895341,0.000008147012,0.00004311178,0.0006866216,0.046217136],"study_design_scores_gemma":[0.86139876,0.06771837,0.04925729,0.00006176868,0.009742784,0.00003467089,0.00018239734,0.000563917,0.000026621692,0.000022972059,0.010827853,0.00016261048],"about_ca_topic_score_codex":0.00019467989,"about_ca_topic_score_gemma":0.000093464696,"teacher_disagreement_score":0.058053795,"about_ca_system_score_codex":0.008476495,"about_ca_system_score_gemma":0.013114641,"threshold_uncertainty_score":0.9953298},"labels":[],"label_agreement":null},{"id":"W4281771147","doi":"10.1200/jco.2022.40.16_suppl.7504","title":"Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Vincristine; Etoposide; Hazard ratio; Regimen; Prednisone; Gastroenterology; Oncology; Surgery; Lymphoma; Cyclophosphamide; Chemotherapy; CD30; Confidence interval","score_opus":0.0271985694545777,"score_gpt":0.36863847134308475,"score_spread":0.34143990188850704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281771147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885817,0.0006144094,0.000033669927,0.008137283,0.00080579007,0.0015911302,0.0001220403,0.000021464208,0.00009249518],"genre_scores_gemma":[0.9955215,0.000611828,0.0011319927,0.0012312775,0.0011514745,0.00014954734,0.00011858288,0.000046983307,0.000036838264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990844,0.0038205076,0.0028444661,0.0006640648,0.0013399811,0.0004869892],"domain_scores_gemma":[0.98622316,0.0075139953,0.0049162526,0.0006740341,0.00027784187,0.00039474232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008095501,0.00038451652,0.0025327823,0.00017870388,0.00027331628,0.000039743245,0.00045470134,0.00032289908,0.00014158648],"category_scores_gemma":[0.003675176,0.00022278292,0.00033865488,0.00042435343,0.00019742848,0.00015420612,0.00032921036,0.0013019998,0.000003888667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011331347,0.03722138,0.8336911,0.0000016696224,0.0036277296,0.007120751,0.0004194203,0.000058163165,0.0000019110198,0.000013661312,0.0025967031,0.10391613],"study_design_scores_gemma":[0.15753491,0.07013766,0.7644752,0.00003789737,0.002398933,0.002402947,0.00076662767,0.00002003759,0.0000041926755,0.00010172852,0.0019381215,0.00018169603],"about_ca_topic_score_codex":0.0072437236,"about_ca_topic_score_gemma":0.005957398,"teacher_disagreement_score":0.14620356,"about_ca_system_score_codex":0.0018306412,"about_ca_system_score_gemma":0.0026056683,"threshold_uncertainty_score":0.9993671},"labels":[],"label_agreement":null},{"id":"W4281818131","doi":"10.1200/jco.2022.40.16_suppl.e19553","title":"Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"MorphoSys","keywords":"Medicine; CHOP; Neutropenia; Internal medicine; Lenalidomide; Clinical endpoint; Gastroenterology; Pharmacodynamics; Diffuse large B-cell lymphoma; Pharmacokinetics; Lymphoma; Clinical trial; Toxicity; Multiple myeloma","score_opus":0.054692984075220816,"score_gpt":0.42278285337690696,"score_spread":0.36808986930168613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281818131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413025,0.00024613857,0.000012274066,0.0014151318,0.00042289085,0.003505125,0.00009826101,0.000004247598,0.00016564755],"genre_scores_gemma":[0.9960184,0.00085012516,0.000887645,0.0016397951,0.00010042061,0.00040905928,0.000033769393,0.000036346188,0.000024400284],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99276435,0.001968433,0.0036554348,0.00046965465,0.00070966093,0.0004324702],"domain_scores_gemma":[0.9921347,0.004941698,0.0019821022,0.00024525897,0.0002557222,0.0004405222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044962983,0.0003244017,0.0032404836,0.00064879225,0.00006617769,0.000021762895,0.00034786435,0.00016266108,0.0001427438],"category_scores_gemma":[0.0014816874,0.00024532145,0.00017833944,0.00060353946,0.00010679179,0.00021351916,0.0003736687,0.0006569084,0.0000028057516],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3804439,0.3873913,0.18892217,0.000038316717,0.00038664887,0.004244237,0.0014808717,0.00022161087,0.00002767981,0.0000066121825,0.0005739564,0.0362627],"study_design_scores_gemma":[0.85417193,0.043252464,0.09640925,0.00018121765,0.0007636129,0.00005764387,0.000899145,0.0018511639,0.00004112195,0.000021724813,0.0021565887,0.00019416098],"about_ca_topic_score_codex":0.00035406632,"about_ca_topic_score_gemma":0.0015650915,"teacher_disagreement_score":0.473728,"about_ca_system_score_codex":0.0009818784,"about_ca_system_score_gemma":0.00084094267,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W4281912254","doi":"10.1016/j.radonc.2022.05.034","title":"Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000–2015)","year":2022,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Proportional hazards model; Lymphoma; Stage (stratigraphy); Epidemiology; Oncology; Chemotherapy; Incidence (geometry); Survival analysis; Hazard ratio; Gastroenterology; Confidence interval; Biology","score_opus":0.01793568874818988,"score_gpt":0.3060663074657073,"score_spread":0.2881306187175174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281912254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994721,0.0027426933,0.00021320928,0.000556656,0.000049570393,0.0010360918,0.0004893467,0.000043491476,0.00014795807],"genre_scores_gemma":[0.9931859,0.0017153453,0.0012344416,0.0013420654,0.00009024718,0.00046650245,0.00040592795,0.000050365896,0.0015092283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982304,0.00014740613,0.00037198394,0.0005559967,0.0003018963,0.0003923202],"domain_scores_gemma":[0.9986064,0.00036760967,0.00023968611,0.0005193884,0.000070818314,0.00019610483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003019629,0.0003081545,0.0010424636,0.0003661989,0.00019306481,0.000017680788,0.00013624558,0.00011190718,0.00053422316],"category_scores_gemma":[0.0000085632455,0.00023426571,0.00019960119,0.00058538985,0.00017112044,0.00007146295,0.000026417914,0.000110136556,7.5971593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010708354,0.002278884,0.9626951,0.00008325723,0.0049923095,0.0009191783,0.0010876004,0.003647372,0.002306144,0.00053008995,0.00015817457,0.010593495],"study_design_scores_gemma":[0.021300383,0.01426933,0.94381744,0.000033886754,0.0013278959,0.0001321498,0.000057820118,0.00060328515,0.0010763446,0.0000057430657,0.017092813,0.00028289636],"about_ca_topic_score_codex":0.0009835184,"about_ca_topic_score_gemma":0.00056236936,"teacher_disagreement_score":0.018877685,"about_ca_system_score_codex":0.0012516148,"about_ca_system_score_gemma":0.00027834746,"threshold_uncertainty_score":0.95530784},"labels":[],"label_agreement":null},{"id":"W4281947220","doi":"10.1200/jco.2022.40.16_suppl.7560","title":"Subgroup analysis in RE-MIND2, an observational, retrospective cohort study of tafasitamab plus lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"MorphoSys","keywords":"Medicine; Lenalidomide; Internal medicine; Hazard ratio; Rituximab; Diffuse large B-cell lymphoma; Bendamustine; Oncology; Clinical endpoint; Neutropenia; Cohort; Refractory (planetary science); Surgery; Lymphoma; Confidence interval; Clinical trial; Multiple myeloma; Toxicity","score_opus":0.08161183968352281,"score_gpt":0.3866761694353465,"score_spread":0.3050643297518237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281947220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979237,0.00033558937,0.0000026340506,0.00021317683,0.00047843036,0.0008599891,0.000030330086,0.000006278072,0.00014991288],"genre_scores_gemma":[0.9991998,0.00017751046,0.00012410434,0.00021636947,0.000104348794,0.00007669425,0.000046505273,0.000023420595,0.000031245097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99376136,0.0015722511,0.002831802,0.00040976025,0.0011404033,0.0002844518],"domain_scores_gemma":[0.99408334,0.0020320616,0.0027411869,0.00041791447,0.0005186614,0.00020681946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036950568,0.00022866929,0.0026837601,0.0006075985,0.00007540937,0.000008698933,0.00024585356,0.00019831685,0.00009912151],"category_scores_gemma":[0.0007100617,0.0001637379,0.00040574002,0.0009313567,0.0000856143,0.00022466324,0.0000980139,0.00057926594,0.0000014822226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035770547,0.13555375,0.82281756,0.000014091993,0.0027408937,0.0007193581,0.0015444394,0.00019880034,0.0000026799905,0.000024362364,0.00006811395,0.00054541073],"study_design_scores_gemma":[0.21455133,0.04214853,0.7367379,0.000037388632,0.0017665323,0.000008984602,0.0044454164,0.000077453595,0.0000017788632,0.000007942561,0.000112455244,0.00010429132],"about_ca_topic_score_codex":0.0004519485,"about_ca_topic_score_gemma":0.0019511407,"teacher_disagreement_score":0.1787808,"about_ca_system_score_codex":0.003279153,"about_ca_system_score_gemma":0.0013131333,"threshold_uncertainty_score":0.8574871},"labels":[],"label_agreement":null},{"id":"W4281984015","doi":"10.1200/jco.2022.40.16_suppl.7526","title":"Characterization of CD20 expression loss as a mechanism of resistance to mosunetuzumab in patients with relapsed/refractory B-cell non-Hodgkin lymphomas.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"CD20; Medicine; PAX5; Immunohistochemistry; Lymphoma; clone (Java method); B cell; Antibody; Cancer research; Pathology; Immunology; Biology; Gene","score_opus":0.02265403805456371,"score_gpt":0.3389661542117521,"score_spread":0.31631211615718835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281984015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976437,0.00005237652,0.000059326503,0.00070814864,0.0004693434,0.00040587812,0.000020727408,0.000002999263,0.0006375192],"genre_scores_gemma":[0.9975438,0.00011865502,0.0013318247,0.0006398346,0.00010330386,0.00002316463,0.000017770431,0.000018836216,0.0002027992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965711,0.0003764163,0.0020229605,0.00020916692,0.00065139495,0.00016895437],"domain_scores_gemma":[0.99615073,0.00056603574,0.0024785816,0.00023640292,0.00035697804,0.00021129116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011258974,0.0001352546,0.0012504664,0.00021342804,0.00003337562,0.0000023577718,0.00016015365,0.00016475368,0.00014436664],"category_scores_gemma":[0.00041414145,0.00009650179,0.00020601763,0.00024873824,0.00005992922,0.000088634464,0.00009975475,0.00031421334,0.0000033494275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06760066,0.037497297,0.85252565,0.00015936448,0.0002746614,0.0010688478,0.0011610751,0.00006225901,0.02237584,0.0001786315,0.0009116824,0.016184054],"study_design_scores_gemma":[0.03599525,0.042078868,0.8958303,0.00036639092,0.00017569467,0.000023041024,0.00013500603,0.000008870971,0.018652102,0.00012217321,0.0065077133,0.00010459341],"about_ca_topic_score_codex":0.000018241808,"about_ca_topic_score_gemma":0.000013391976,"teacher_disagreement_score":0.043304678,"about_ca_system_score_codex":0.0005248193,"about_ca_system_score_gemma":0.0012727987,"threshold_uncertainty_score":0.39352286},"labels":[],"label_agreement":null},{"id":"W4282010314","doi":"10.1101/2022.06.10.495605","title":"Global Profiling of c-Jun and JunB transcription factor binding sites in an ALK+ ALCL cell line","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"JUNB; Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; c-jun; Cancer research; Transcription factor; Molecular biology; Cell growth; Biology; Chromatin immunoprecipitation; Chemistry; Gene expression; Gene; Genetics; Lymphoma; Promoter; Medicine; Immunology","score_opus":0.025399341709421062,"score_gpt":0.26037557440096254,"score_spread":0.23497623269154147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282010314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450487,0.0027037333,0.000039578103,0.000111021436,0.00039738647,0.0011847296,0.00090860995,0.0001342329,0.00001582531],"genre_scores_gemma":[0.99452883,0.0006170938,0.004328642,0.0000715358,0.00014617149,0.00022861379,0.000007982676,0.00006842902,0.0000027253543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746615,0.00012666742,0.0006425329,0.00092125137,0.0004249371,0.00041845985],"domain_scores_gemma":[0.998462,0.000043401255,0.00033590823,0.0007051207,0.00017881741,0.00027471394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031573547,0.0004877617,0.00081169006,0.0003307724,0.000089996814,0.000070775335,0.00018872313,0.0003479587,0.00008924485],"category_scores_gemma":[0.000052702417,0.00048850506,0.00015618872,0.0005106277,0.00007421442,0.00014122114,0.0002104079,0.00035736806,0.000004531874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102324106,0.00084895204,0.51382965,0.00072713965,0.0000804201,0.000113979615,0.000029101639,0.000040624782,0.4841212,0.00008676496,0.000009473702,0.000010371461],"study_design_scores_gemma":[0.0024907826,0.00035469397,0.6299963,0.00044011307,0.0002732063,6.105448e-8,0.000021946305,0.00041411773,0.3654019,0.0000012816708,0.0002051936,0.00040038588],"about_ca_topic_score_codex":0.00015975941,"about_ca_topic_score_gemma":0.00001658914,"teacher_disagreement_score":0.118719295,"about_ca_system_score_codex":0.00073377887,"about_ca_system_score_gemma":0.00044865964,"threshold_uncertainty_score":0.99975663},"labels":[],"label_agreement":null},{"id":"W4282937035","doi":"10.1158/1078-0432.ccr-21-3648","title":"Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"National Cancer Institute","keywords":"Lenalidomide; Medicine; Internal medicine; Rituximab; Hazard ratio; Clinical endpoint; Propensity score matching; Diffuse large B-cell lymphoma; Oncology; Cohort; Surgery; Lymphoma; Multiple myeloma; Clinical trial; Confidence interval","score_opus":0.3554271189949901,"score_gpt":0.5253473410827839,"score_spread":0.16992022208779384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096596,0.0013234626,0.0000050698013,0.0011062401,0.0007520624,0.0054097464,0.00022560213,0.00004549831,0.00016633404],"genre_scores_gemma":[0.9927821,0.0003222973,0.000113205875,0.00010121697,0.00052447856,0.005373432,0.0001405282,0.000055418604,0.00058729335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99514794,0.0009907102,0.0010231513,0.0008588265,0.0014835994,0.00049578067],"domain_scores_gemma":[0.99345756,0.00411504,0.0003058615,0.0008568737,0.0010019582,0.00026272796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054589943,0.00021345,0.0009782689,0.00015973636,0.0004120277,0.000031203723,0.00036104568,0.00013040396,0.0004914759],"category_scores_gemma":[0.0017522849,0.00017532977,0.00033192348,0.0004698551,0.0002834873,0.000116492774,0.00024224831,0.00072185183,0.0000064956735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04293278,0.009583791,0.93823403,0.00010859475,0.0017948445,0.00005013164,0.0016501365,0.000030459121,0.0005874795,0.00024692208,0.0020618602,0.0027189644],"study_design_scores_gemma":[0.059344236,0.016564954,0.916034,0.000074811265,0.00032858827,0.0000037132133,0.0061656656,0.00026162542,0.00019622152,0.000062680236,0.0008045196,0.00015899588],"about_ca_topic_score_codex":0.001472124,"about_ca_topic_score_gemma":0.00026491037,"teacher_disagreement_score":0.02220005,"about_ca_system_score_codex":0.00283812,"about_ca_system_score_gemma":0.0019329552,"threshold_uncertainty_score":0.74215853},"labels":[],"label_agreement":null},{"id":"W4283014330","doi":"10.6004/jnccn.2022.7014","title":"Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hazard ratio; Interquartile range; Proportional hazards model; Population; Diffuse large B-cell lymphoma; Internal medicine; Comorbidity; Retrospective cohort study; Lymphoma; Rituximab; Confidence interval","score_opus":0.030460634555253694,"score_gpt":0.2936127694747425,"score_spread":0.2631521349194888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283014330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576944,0.0013323207,0.0000083922505,0.0012836889,0.0005401412,0.0009729743,0.00004384061,0.000007525129,0.000041663916],"genre_scores_gemma":[0.99552655,0.000035023462,0.000118475626,0.0038364297,0.00025263955,0.00014594824,0.000022598328,0.00002410671,0.000038240585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737686,0.00034441167,0.0004957309,0.00019955402,0.0013486673,0.00023477688],"domain_scores_gemma":[0.99766594,0.0004557147,0.00066436775,0.00014534962,0.0009829708,0.00008565282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018786552,0.0001992984,0.00041071378,0.0001358888,0.0003313312,0.000025449861,0.00019352684,0.000028518167,0.00012244855],"category_scores_gemma":[0.000054897668,0.00012216353,0.00018021425,0.00055330945,0.000017509365,0.00008773423,0.00007862457,0.00023408716,7.9022436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002097264,0.0113700805,0.92864007,0.0000060555703,0.00026178564,0.000030655046,0.0003851117,0.05344093,0.0000034109923,0.000013472989,0.0027769345,0.00097423635],"study_design_scores_gemma":[0.058243774,0.0013214234,0.9361234,0.0001547437,0.0000831569,0.00000481914,0.00027751687,0.000650871,0.000009403149,0.00005323629,0.0029583452,0.00011932417],"about_ca_topic_score_codex":0.00013620146,"about_ca_topic_score_gemma":0.00010119774,"teacher_disagreement_score":0.05614651,"about_ca_system_score_codex":0.001847751,"about_ca_system_score_gemma":0.00048438396,"threshold_uncertainty_score":0.49816844},"labels":[],"label_agreement":null},{"id":"W4283065589","doi":"10.1148/rg.210162","title":"Non-Hodgkin Lymphoma Imaging Spectrum in Children, Adolescents, and Young Adults","year":2022,"lang":"en","type":"article","venue":"Radiographics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Lymphoma; Medical imaging; Clinical trial; Clinical Practice; Modalities; Hodgkin lymphoma; Radiology; Medical physics; Health care; Family medicine; Pathology","score_opus":0.003577923648828313,"score_gpt":0.2108485751862687,"score_spread":0.2072706515374404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283065589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939638,0.004146377,0.000004919496,0.00073389476,0.00018638745,0.0005515404,0.000027532737,0.000052698975,0.00033286362],"genre_scores_gemma":[0.99768573,0.0013964361,0.00009346379,0.00052231085,0.00008558165,0.000102091675,0.0000645987,0.000030074129,0.000019731102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866706,0.000038367398,0.0002336084,0.00039639568,0.00031741153,0.00034718047],"domain_scores_gemma":[0.99947697,0.000014176771,0.00006469977,0.00028516148,0.00001413309,0.0001448341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015770085,0.00019336591,0.00028076035,0.00052269,0.00017774358,0.000026139756,0.000086518085,0.00003411245,0.000028996505],"category_scores_gemma":[0.0000072595217,0.0001877461,0.00013233392,0.00076655636,0.000070172246,0.00005914636,0.00010395508,0.00013673997,0.0000027664198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014729652,0.0007940516,0.98559177,0.000028816301,0.000073601776,0.00028643574,0.00027956732,0.0000027241404,0.000013530957,0.0001542145,0.00052266207,0.012105345],"study_design_scores_gemma":[0.008115879,0.00020508413,0.988632,0.00014010747,0.00009172257,0.0011561095,0.000182656,0.00059136905,0.000079122685,0.000073065305,0.00055625866,0.00017660647],"about_ca_topic_score_codex":0.0012246496,"about_ca_topic_score_gemma":0.00009008325,"teacher_disagreement_score":0.011928739,"about_ca_system_score_codex":0.00019890231,"about_ca_system_score_gemma":0.000058664293,"threshold_uncertainty_score":0.76560634},"labels":[],"label_agreement":null},{"id":"W4283217918","doi":"10.1097/hs9.0000000000000745","title":"A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Retrospective cohort study; Rituximab; Confidence interval; Cohort; Oncology; Lymphoma; Surgery; Biology","score_opus":0.009417120956188822,"score_gpt":0.24231788140318222,"score_spread":0.2329007604469934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283217918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589425,0.00009467978,8.6617274e-7,0.000038939175,0.00010292536,0.002520008,0.000089106754,0.000038530077,0.0012207071],"genre_scores_gemma":[0.9973127,0.00003500453,0.0002608695,0.00006093648,0.000013226884,0.0009051147,0.00006449624,0.000042606192,0.0013050099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980478,0.000091747985,0.00046726636,0.00044266117,0.0007311104,0.0002193936],"domain_scores_gemma":[0.99851733,0.00007516349,0.00037170903,0.00065374235,0.00027420322,0.00010783968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006130889,0.00028522202,0.0009850217,0.000063620464,0.000112376445,0.000004041151,0.000086292224,0.000047358444,0.00095561583],"category_scores_gemma":[0.0000490241,0.00017040843,0.00017789811,0.0003074039,0.00004251523,0.00004740678,0.00006993016,0.000053388605,0.00000552991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021391883,0.0259385,0.9642947,0.000036733752,0.0022989921,0.00019155242,0.0012557934,0.000008883231,0.000009725144,0.000038504077,0.0002835366,0.0035038963],"study_design_scores_gemma":[0.030080175,0.032146856,0.93291175,0.00004974055,0.0010041991,0.000009203765,0.002839899,0.000007876529,0.00028551198,0.0000056363483,0.00050600356,0.0001531531],"about_ca_topic_score_codex":0.0024839747,"about_ca_topic_score_gemma":0.0005286744,"teacher_disagreement_score":0.03138295,"about_ca_system_score_codex":0.0017241047,"about_ca_system_score_gemma":0.000251923,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W4283328755","doi":"10.1097/01.hs9.0000847280.69256.81","title":"P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Rituximab; Lenalidomide; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Phases of clinical research; Oncology; CD20; Gastroenterology; Clinical trial; Multiple myeloma","score_opus":0.031827012363458154,"score_gpt":0.3023487328686932,"score_spread":0.27052172050523504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283328755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845473,0.009047923,0.00010411663,0.00043265978,0.00042982885,0.0045174183,0.00034518866,0.00012160571,0.00045393128],"genre_scores_gemma":[0.9934293,0.00034050073,0.0015040438,0.0002559332,0.00021755876,0.0024711674,0.00016710737,0.00015198419,0.0014624313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953779,0.00030191138,0.001082716,0.0012981391,0.0010648852,0.0008744643],"domain_scores_gemma":[0.9967301,0.0010146593,0.0005629463,0.0009437788,0.00021214012,0.0005363575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006383764,0.00082201464,0.0019906661,0.0002486434,0.00070708035,0.00008919885,0.00027708587,0.00022875615,0.0005844633],"category_scores_gemma":[0.00024460338,0.0007005427,0.0003502058,0.00046455016,0.00023815173,0.00027392307,0.0004752844,0.00019916074,0.000017277534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65580904,0.11938917,0.007490213,0.0025979741,0.0077181505,0.011913036,0.012536647,0.00012754381,0.0019319962,0.0010214549,0.012976242,0.16648851],"study_design_scores_gemma":[0.9180947,0.020705907,0.003651556,0.00032696457,0.0031941067,0.0016750281,0.019717716,0.0016505701,0.0029621266,0.00005561401,0.027006418,0.0009592703],"about_ca_topic_score_codex":0.0012442764,"about_ca_topic_score_gemma":0.00048999675,"teacher_disagreement_score":0.26228565,"about_ca_system_score_codex":0.0018316875,"about_ca_system_score_gemma":0.0011153854,"threshold_uncertainty_score":0.99954456},"labels":[],"label_agreement":null},{"id":"W4283384745","doi":"10.1097/01.hs9.0000851224.51567.a8","title":"PB2098: ‘REAL-WORLD’ TREATMENT PATTERNS AND PATHWAYS OF SECOND LINE DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN UK, CANADA, FRANCE, GERMANY, ITALY AND SPAIN USING A PROSPECTIVE SURVEY OF PHYSICIANS","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Internal medicine; Refractory (planetary science); Pediatrics; Oncology","score_opus":0.012443807399632972,"score_gpt":0.23042647623620943,"score_spread":0.21798266883657647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283384745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995876,0.0004768658,0.0000018533505,0.0000160634,0.000050040566,0.00075268047,0.0023974015,0.0000072253088,0.00042184882],"genre_scores_gemma":[0.9991067,0.000109501234,0.000046530346,0.00009068867,0.000014760753,0.00009037726,0.00018918198,0.000028802462,0.00032346486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986172,0.000103331404,0.00037331,0.00034917644,0.0002834168,0.00027360287],"domain_scores_gemma":[0.9992565,0.0001242026,0.00023085604,0.0002381142,0.00006668002,0.00008367009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010496953,0.00023569043,0.00061765494,0.00006718913,0.0000798888,0.000006079938,0.000044015535,0.00003448101,0.000103828614],"category_scores_gemma":[0.000007947041,0.00020728761,0.000054540105,0.00025345376,0.000037735743,0.00003731048,0.000091456255,0.000050647624,2.1979342e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017475747,0.008370383,0.9872462,0.0001712394,0.00014305176,0.00012826687,0.0010385884,0.0000045689294,0.00015812769,0.000019811809,0.000061320374,0.0024836625],"study_design_scores_gemma":[0.02092522,0.00090539845,0.9728941,0.000118397315,0.000105500716,0.0000055222044,0.00043161164,0.00038197372,0.0039746203,0.000006553085,0.000095856456,0.00015526006],"about_ca_topic_score_codex":0.5796244,"about_ca_topic_score_gemma":0.846426,"teacher_disagreement_score":0.2668016,"about_ca_system_score_codex":0.0006965383,"about_ca_system_score_gemma":0.00033750437,"threshold_uncertainty_score":0.84529436},"labels":[],"label_agreement":null},{"id":"W4283640058","doi":"10.1002/cnr2.1661","title":"A longitudinal analysis of early lung function trajectory in survivors of childhood Hodgkin lymphoma","year":2022,"lang":"en","type":"article","venue":"Cancer Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary function testing; Bleomycin; Asymptomatic; Lung; Lung cancer; Vital capacity; Lymphoma; Cohort; Pediatrics; Radiation therapy; Lung volumes; Internal medicine; Diffusing capacity; Surgery; Lung function; Chemotherapy","score_opus":0.013866180936044569,"score_gpt":0.27007664770412276,"score_spread":0.2562104667680782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283640058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958403,0.0030458304,0.00000822772,0.00004592513,0.00025111172,0.000267948,0.000028248372,0.000013718116,0.0004986903],"genre_scores_gemma":[0.9994708,0.000071942326,0.000014367286,0.000034218436,0.000026163023,0.00023509644,0.00005240516,0.000011964022,0.00008307665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861056,0.000045872373,0.0005141561,0.00029589594,0.00038880087,0.0001447302],"domain_scores_gemma":[0.99914634,0.000031010695,0.00037817578,0.00032734952,0.0000603322,0.00005677382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023304182,0.000110829526,0.0005258382,0.00045327906,0.000035884786,0.00000281479,0.000031747655,0.000032350734,0.00061012316],"category_scores_gemma":[0.000016694526,0.000101945785,0.000254191,0.0011554752,0.0000307909,0.000036824888,0.000034581866,0.000045795852,1.7979727e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017816882,0.0009877628,0.9867648,0.000038660975,0.0017080808,0.00061658194,0.0005722231,0.001222611,0.00019849323,0.000012153774,0.00011497193,0.0075855283],"study_design_scores_gemma":[0.0010707076,0.0003430885,0.99457777,0.00004159698,0.0023706525,0.00006618288,0.00012256281,0.00007812512,0.0010100205,0.000009121966,0.00023297702,0.000077179866],"about_ca_topic_score_codex":0.010889047,"about_ca_topic_score_gemma":0.0013614971,"teacher_disagreement_score":0.009527549,"about_ca_system_score_codex":0.00053401,"about_ca_system_score_gemma":0.0003385184,"threshold_uncertainty_score":0.99569756},"labels":[],"label_agreement":null},{"id":"W4283698841","doi":"10.1200/jco.21.02698","title":"Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Autologous stem-cell transplantation; Hazard ratio; Cohort; Bendamustine; Chemoimmunotherapy; Oncology; Cytarabine; Retrospective cohort study; Transplantation; Surgery; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.025955125559323392,"score_gpt":0.34530363848414874,"score_spread":0.31934851292482536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283698841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974103,0.00031966076,0.0000016393693,0.0010237372,0.00010092075,0.00035224986,0.00020285575,0.000003824057,0.000584825],"genre_scores_gemma":[0.9959578,0.0030956608,0.0005178241,0.00018730517,0.000028410313,0.000013593931,0.000073343625,0.000010030432,0.000116068506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772847,0.00027867846,0.0013644866,0.00021386465,0.00024946537,0.00016503429],"domain_scores_gemma":[0.997375,0.0012144524,0.0010398519,0.00012109096,0.00009983439,0.00014976782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000554321,0.00013781297,0.0012809362,0.0001191676,0.000039879236,0.000004247776,0.000043096556,0.00007651195,0.00001854588],"category_scores_gemma":[0.0000946123,0.00008218385,0.00011242961,0.00009205881,0.0000745182,0.000053549877,0.000023880128,0.00011552558,5.354895e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01834176,0.016185675,0.93865263,0.000017962724,0.00028821934,0.0010281894,0.00047154227,0.0000056206454,0.0000016266779,0.000018789602,0.00009113391,0.024896832],"study_design_scores_gemma":[0.1516279,0.013996667,0.8321147,0.00007686498,0.00063039665,0.000038008206,0.00011663801,0.000023481118,0.000040879535,0.000032792672,0.0012435452,0.000058123886],"about_ca_topic_score_codex":0.0007423665,"about_ca_topic_score_gemma":0.0016183213,"teacher_disagreement_score":0.13328615,"about_ca_system_score_codex":0.0003212966,"about_ca_system_score_gemma":0.00035400045,"threshold_uncertainty_score":0.335136},"labels":[],"label_agreement":null},{"id":"W4283701656","doi":"10.1182/blood.2022016098","title":"Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Children’s Oncology Group; National Cancer Institute; Princess Margaret Cancer Foundation; St. Baldrick's Foundation","keywords":"Cog; Medicine; Oncology; Hodgkin lymphoma; Internal medicine; Stage (stratigraphy); Radiation therapy; Lymphoma; Biology","score_opus":0.010960613258775238,"score_gpt":0.25436897807985154,"score_spread":0.2434083648210763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283701656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167114,0.0052869082,0.00027638188,0.00031268367,0.00016556367,0.0012989771,0.0006230289,0.00016230559,0.000203013],"genre_scores_gemma":[0.9919893,0.00065189967,0.0028733138,0.00045093437,0.0003687178,0.0010515495,0.00024041493,0.00007785192,0.0022959805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973685,0.00023738458,0.0004770998,0.00070076296,0.0006400131,0.00057623617],"domain_scores_gemma":[0.9982026,0.00038555852,0.00029099238,0.0007190639,0.00012255188,0.00027920047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004622232,0.00034647758,0.00075229094,0.0007694419,0.00043702516,0.000076622724,0.00022079819,0.000111392816,0.0006781284],"category_scores_gemma":[0.000117430835,0.0003136286,0.00078968593,0.001864965,0.00004226403,0.00009650844,0.0000728464,0.00012332837,0.000023173428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015962662,0.005873745,0.977511,0.00005919399,0.007222968,0.0004230422,0.0012424567,0.0001303503,0.00030367676,0.00007484883,0.0023400409,0.0032224117],"study_design_scores_gemma":[0.035376597,0.003414909,0.936101,0.000008855565,0.013655294,0.000033290533,0.00022773964,0.00050013623,0.0022444658,0.000047784506,0.007960423,0.00042946465],"about_ca_topic_score_codex":0.0008579284,"about_ca_topic_score_gemma":0.000027338669,"teacher_disagreement_score":0.041409962,"about_ca_system_score_codex":0.00030415106,"about_ca_system_score_gemma":0.00031006936,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W4283749401","doi":"10.1016/j.jcjo.2022.06.004","title":"Follicular lymphoma isolated to the superior oblique muscle","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Surgery; Thrombosis; Clopidogrel; Radiology; Internal medicine; Aspirin","score_opus":0.02047168032786226,"score_gpt":0.25654324098705206,"score_spread":0.2360715606591898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283749401","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30480427,0.003064325,0.0000018500891,0.68424624,0.0019549187,0.0005292304,0.00014602169,0.0000049534547,0.0052481885],"genre_scores_gemma":[0.65422755,0.0000218905,0.000106789266,0.33731616,0.0025388347,0.000088787216,0.00013754296,0.00009568987,0.0054667545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777395,0.00027572096,0.0006017237,0.00031288786,0.00033541018,0.000700317],"domain_scores_gemma":[0.9979298,0.00016755913,0.00028407515,0.0005854483,0.00026511613,0.0007680195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029752465,0.0003529651,0.00084772316,0.0006562662,0.00027828716,0.000056540404,0.00053523236,0.0005314356,0.010467791],"category_scores_gemma":[0.00017449842,0.00024294214,0.00052075577,0.0003813345,0.00010572991,0.000041837164,0.00004732753,0.00090054615,0.00011604284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004096998,0.00003260527,0.0025659944,0.000019554043,0.00038519216,0.4121694,0.00018905311,0.0000090017165,0.000005486121,0.000008680173,0.584078,0.00049606775],"study_design_scores_gemma":[0.00084171916,0.0016196526,0.011330249,0.0000614761,0.0002673639,0.3440863,0.00005009724,0.0000018892886,0.000011853142,0.000022373093,0.64156365,0.0001433652],"about_ca_topic_score_codex":0.011277321,"about_ca_topic_score_gemma":0.00027274032,"teacher_disagreement_score":0.3494233,"about_ca_system_score_codex":0.0015891218,"about_ca_system_score_gemma":0.005110312,"threshold_uncertainty_score":0.9953067},"labels":[],"label_agreement":null},{"id":"W4284878948","doi":"10.1038/s41586-022-04906-8","title":"Super-enhancer hypermutation alters oncogene expression in B cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Simon Fraser University","funders":"National Cancer Institute","keywords":"Enhancer; Cytidine deaminase; Biology; Somatic hypermutation; Gene; Genetics; Cancer research; Activation-induced (cytidine) deaminase; Regulation of gene expression; Gene expression; B cell","score_opus":0.007654626356781204,"score_gpt":0.2622476736721439,"score_spread":0.2545930473153627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284878948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925525,0.0047544735,0.000001919401,0.0011842488,0.00032231124,0.00027320514,0.00002075822,0.000029985853,0.0041578184],"genre_scores_gemma":[0.9964847,0.000102998056,0.00030835834,0.0019052802,0.000084324805,0.00017293871,0.0001563532,0.000016184134,0.0007688665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999105,0.00004365812,0.00012753515,0.00023906243,0.00032419295,0.00016054609],"domain_scores_gemma":[0.9996601,0.000043119977,0.00003572154,0.00017455213,0.00002473652,0.000061814324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072677925,0.00010568596,0.00015531229,0.00010061024,0.00008508484,0.0000076107185,0.000058297475,0.00022388801,0.00043845453],"category_scores_gemma":[0.000015613854,0.000086629916,0.00006514119,0.00020588473,0.00000972531,0.00004800473,0.00005325117,0.0003413707,0.000024081228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015617152,0.0089783985,0.16641252,0.00020031427,0.00009469597,0.0025392203,0.0047141355,0.00051891594,0.6180141,0.00017935436,0.07107381,0.12571284],"study_design_scores_gemma":[0.014377273,0.000560589,0.17622577,0.00009145774,0.00008055217,0.00012532546,0.0010702108,0.00020477669,0.7135117,0.000089141286,0.09341525,0.000247917],"about_ca_topic_score_codex":0.00003388212,"about_ca_topic_score_gemma":0.00000834964,"teacher_disagreement_score":0.12546493,"about_ca_system_score_codex":0.0005672609,"about_ca_system_score_gemma":0.000105179955,"threshold_uncertainty_score":0.48007697},"labels":[],"label_agreement":null},{"id":"W4285027377","doi":"10.1080/10428194.2022.2095624","title":"PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design","year":2022,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Janssen Biotech; Chugai Pharmaceutical; H. Lundbeck A/S; Servier; Incyte; AbbVie; Takeda Pharmaceutical Company; Teva Pharmaceutical Industries; Sandoz; MorphoSys; Celgene; Seattle Genetics; Karyopharm Therapeutics; Gilead Sciences; Merck; TG Therapeutics; Amgen","keywords":"Chemoimmunotherapy; Hazard ratio; Medicine; Internal medicine; Clinical trial; Diffuse large B-cell lymphoma; Clinical endpoint; Oncology; Meta-analysis; Progression-free survival; Sample size determination; Surrogate endpoint; Proportional hazards model; Overall survival; Confidence interval; Lymphoma; Nuclear medicine; Rituximab; Statistics","score_opus":0.206374533336237,"score_gpt":0.4167294272308164,"score_spread":0.2103548938945794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285027377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069160843,0.98120445,0.0002154979,0.00034167067,0.00042171642,0.009104155,0.0011670633,0.0002386095,0.00039073176],"genre_scores_gemma":[0.0054498105,0.977465,0.0014771759,0.00063241983,0.00042992848,0.009994638,0.003216277,0.00027743948,0.0010573233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98912936,0.0016205,0.0039055084,0.003159716,0.00077858265,0.0014063139],"domain_scores_gemma":[0.9908828,0.004254511,0.0016442001,0.0019795774,0.00016172924,0.0010771566],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0023886207,0.0019964906,0.011149818,0.0016800417,0.00066146615,0.0003287458,0.00060048816,0.0010614011,0.00049847364],"category_scores_gemma":[0.000568691,0.0015532022,0.0073459996,0.0022562663,0.0004552779,0.00021590554,0.00051948807,0.00036723778,0.000046284247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010749167,0.0021581517,0.00022733172,0.0023853572,0.122129105,0.001517271,0.00010505419,0.000012917673,5.071612e-7,0.0008038025,0.0013740698,0.85853726],"study_design_scores_gemma":[0.10097227,0.002055677,0.0024676395,0.00027214797,0.40343457,0.0021597254,0.000056393983,0.00031459637,0.000004023398,0.00037003573,0.48671302,0.0011799055],"about_ca_topic_score_codex":0.0024211777,"about_ca_topic_score_gemma":0.00015812449,"teacher_disagreement_score":0.8573574,"about_ca_system_score_codex":0.009634995,"about_ca_system_score_gemma":0.010492253,"threshold_uncertainty_score":0.9992778},"labels":[],"label_agreement":null},{"id":"W4285077583","doi":"10.1182/bloodadvances.2022008355","title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Blood Cancer UK; National Cancer Institute; Cancer Research UK; Genentech; Celgene; KWF Kankerbestrijding; Teva Pharmaceutical Industries; GlaxoSmithKline; Barts Charity; Pfizer","keywords":"Biology; Stage (stratigraphy); Follicular lymphoma; Molecular biology; Chromosomal translocation; Genetics; Cancer research; Lymphoma; Gene; Immunology","score_opus":0.006569340776565185,"score_gpt":0.2154114171436622,"score_spread":0.208842076367097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285077583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817772,0.016823798,0.0000038922194,0.000072695075,0.000029626959,0.000377669,0.00019197335,0.000019444422,0.0007037318],"genre_scores_gemma":[0.99733,0.0007023554,0.00082757015,0.00011659248,0.000019859011,0.00009547335,0.000087086446,0.000017572182,0.0008034838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991229,0.000025725738,0.00017803199,0.00026583116,0.00023222536,0.00017527722],"domain_scores_gemma":[0.99955183,0.00003104397,0.00011979476,0.00020471856,0.000007650231,0.000084956046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004938238,0.00014912726,0.0003256438,0.000051171,0.00012487844,0.000008039166,0.000060622267,0.000014215536,0.00027351806],"category_scores_gemma":[0.0000015548916,0.00011358546,0.00005225084,0.00007318936,0.00008121725,0.000056298057,0.00009119327,0.000032604563,0.0000029906312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358742,0.0018247322,0.98064107,0.0000901245,0.00037084296,0.00039362206,0.00035819886,0.00024125948,0.013079223,0.0000752528,0.000067394925,0.0023223998],"study_design_scores_gemma":[0.026392726,0.001989978,0.85726756,0.000047201123,0.00055070966,0.00028557578,0.0035878115,0.000079157166,0.03208336,0.000008235846,0.07745557,0.0002521181],"about_ca_topic_score_codex":0.0000792827,"about_ca_topic_score_gemma":0.000021753944,"teacher_disagreement_score":0.123373516,"about_ca_system_score_codex":0.000062208856,"about_ca_system_score_gemma":0.000042541913,"threshold_uncertainty_score":0.46318808},"labels":[],"label_agreement":null},{"id":"W4285385793","doi":"10.1172/jci161979","title":"Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply.","year":2022,"lang":"en","type":"letter","venue":"Journal of Clinical Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Mechanism (biology); Biology; Cancer research; Lymphoma; Computational biology; Genetics; Immunology; Epistemology; Philosophy","score_opus":0.07895625948709005,"score_gpt":0.35606782101422313,"score_spread":0.27711156152713307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285385793","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22904432,0.0013247973,0.00012827937,0.7661876,0.0019063896,0.0011853358,0.000040686038,0.000007596178,0.00017496319],"genre_scores_gemma":[0.13512999,0.0023454833,0.007901282,0.8474922,0.005919925,0.00014926212,0.00008728944,0.00007556762,0.000898998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960082,0.00031688254,0.0025373688,0.00023728165,0.00071060687,0.00018966648],"domain_scores_gemma":[0.99286115,0.0033955413,0.00286635,0.00039229405,0.00039009834,0.0000945435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001663461,0.00019874929,0.0009931647,0.00016976669,0.00004682287,0.00001732825,0.00023471887,0.00041551972,0.00011273071],"category_scores_gemma":[0.0018957952,0.00012383047,0.0007096512,0.00016838385,0.00016793942,0.000052039006,0.00004815641,0.0009937352,0.0000030716367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059562834,0.00080595823,0.06854069,0.00064830895,0.00058531796,0.0012415387,0.0002079245,0.00007502973,0.00006150351,0.00038680478,0.92263204,0.0042192717],"study_design_scores_gemma":[0.01891877,0.008739047,0.13166116,0.0012594104,0.003495879,0.00072861154,0.00011138499,0.0009301206,0.003075727,0.031580374,0.7991186,0.00038094478],"about_ca_topic_score_codex":0.000062089675,"about_ca_topic_score_gemma":0.0000037007508,"teacher_disagreement_score":0.12351345,"about_ca_system_score_codex":0.00023002308,"about_ca_system_score_gemma":0.0010726933,"threshold_uncertainty_score":0.50496596},"labels":[],"label_agreement":null},{"id":"W4285491618","doi":"10.1200/jco.21.02707","title":"Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Gene signature; Gene expression profiling; Peripheral T-cell lymphoma; Cohort; Pathology; Lymphoma; Transcriptome; Oncology; Internal medicine; Gene expression; Bioinformatics; Computational biology; Gene; T cell; Immunology; Biology","score_opus":0.11950702309088221,"score_gpt":0.47054557871177616,"score_spread":0.3510385556208939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285491618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95380217,0.0071264375,0.000052508276,0.03543752,0.001991067,0.00067685975,0.00002276651,0.0000042306133,0.0008864316],"genre_scores_gemma":[0.9816327,0.0051977322,0.00306944,0.008626283,0.001158123,0.0001834281,0.0000058350392,0.000014393452,0.000112026915],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402744,0.002107073,0.002820388,0.00020391124,0.000614526,0.00022669033],"domain_scores_gemma":[0.9576197,0.03880797,0.002757263,0.00031977476,0.00037042986,0.00012481722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010313718,0.00014630455,0.0011480522,0.00006639638,0.00015861631,0.000016001002,0.0004234854,0.00021159793,0.00017713911],"category_scores_gemma":[0.008827566,0.000069395326,0.0009043798,0.00015302247,0.00022119065,0.000116489544,0.00015109256,0.00067799434,0.0000014100774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032359116,0.06006174,0.53974766,0.000081027254,0.0013258138,0.0021269973,0.0021530217,0.0008275309,0.00019796488,0.00048741268,0.11157976,0.24905199],"study_design_scores_gemma":[0.034692913,0.02684439,0.44295263,0.000067533445,0.0014134598,0.00048164077,0.0049660476,0.0002243283,0.001067473,0.0002516657,0.48691916,0.00011874112],"about_ca_topic_score_codex":0.00005087472,"about_ca_topic_score_gemma":0.000017046195,"teacher_disagreement_score":0.37533942,"about_ca_system_score_codex":0.00019829675,"about_ca_system_score_gemma":0.0012549824,"threshold_uncertainty_score":0.9995215},"labels":[],"label_agreement":null},{"id":"W4289745867","doi":"10.1016/j.cancergen.2022.07.006","title":"Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group","year":2022,"lang":"en","type":"review","venue":"Cancer Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Genetic testing; Precision medicine; Oncology; Hematopathology; Medicine; Genomics; Internal medicine; Bioinformatics; Biology; Pathology; Cytogenetics; Genetics; Genome; Gene","score_opus":0.1388611146140194,"score_gpt":0.34856159036249645,"score_spread":0.20970047574847706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289745867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005158355,0.98752695,0.000013822846,0.0004750259,0.0012194058,0.0038206615,0.0013831665,0.00003739601,0.00036521984],"genre_scores_gemma":[0.0021680193,0.98836577,0.00036814393,0.0031165972,0.00080127857,0.003963012,0.0007986971,0.00020971619,0.00020875623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945087,0.0004465871,0.002375188,0.0012472108,0.0007472583,0.00067506445],"domain_scores_gemma":[0.99419636,0.0011606786,0.0020211837,0.0022446944,0.00013259292,0.0002444868],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006973011,0.00088402926,0.0030155287,0.0001917531,0.00020508443,0.000056833633,0.00078044954,0.00032975123,0.0014921584],"category_scores_gemma":[0.00012931046,0.0006614086,0.0010631793,0.0007477006,0.00016951066,0.00004206165,0.0003072476,0.00027281232,0.000028896868],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014915812,0.0048539825,0.008116595,0.030400492,0.00095951185,0.00080230477,0.00031039744,0.000023628118,0.000024896946,0.00002410893,0.00700466,0.94733024],"study_design_scores_gemma":[0.0062452853,0.000080722624,0.008096946,0.07578945,0.0052082487,0.000044491608,0.000042936477,0.000036588473,0.00008256728,0.0000031120846,0.9038164,0.00055323855],"about_ca_topic_score_codex":0.0026581655,"about_ca_topic_score_gemma":0.0024455648,"teacher_disagreement_score":0.94677705,"about_ca_system_score_codex":0.005799311,"about_ca_system_score_gemma":0.0065880045,"threshold_uncertainty_score":0.9995837},"labels":[],"label_agreement":null},{"id":"W4290943589","doi":"10.1093/acprof:oso/9780195101812.002.41007","title":"References","year":2006,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidemiology; Psychiatric epidemiology; Psychosocial; Psychiatry; Mental health; Public health; Publishing; Medicine; Gerontology; Library science; Psychology; Political science","score_opus":0.01503235252781808,"score_gpt":0.26703996771117655,"score_spread":0.25200761518335846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290943589","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026678788,0.001549894,0.000002002261,0.00021956238,0.000075756965,0.0001265274,0.000008344387,0.00014667974,0.9978446],"genre_scores_gemma":[0.00166062,0.00021001245,0.0006935234,0.00021239712,0.00024242866,0.000018001665,0.000099854704,0.00008964855,0.99677354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968266,0.0000025863098,0.000049553695,0.000113710106,0.00008475574,0.000066706896],"domain_scores_gemma":[0.99979764,0.000005023692,0.000024255958,0.00013743556,0.0000046206,0.000031005122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000062623526,0.00008806633,0.00016416195,0.00005615584,0.0000045184465,0.000004228287,0.000017084103,0.0000986259,0.008118073],"category_scores_gemma":[0.0000013915314,0.000051103692,0.00004443964,0.000023755938,0.0000116851415,0.0000019499691,0.000006087629,0.000018472454,0.00076560804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013913083,0.00011675698,0.0067963093,0.000019377883,0.00005694967,0.00004265141,6.856543e-7,1.8497155e-9,3.5994222e-7,0.0009125931,0.9854665,0.00658642],"study_design_scores_gemma":[0.0004748924,0.000053469495,0.007647547,0.00011970282,0.000083797975,0.0000074211503,0.0000018300618,1.6972963e-7,0.00004500619,0.000018964667,0.99149424,0.000052977353],"about_ca_topic_score_codex":0.0024603636,"about_ca_topic_score_gemma":0.00067694596,"teacher_disagreement_score":0.0073524653,"about_ca_system_score_codex":0.00002358554,"about_ca_system_score_gemma":0.000030943153,"threshold_uncertainty_score":0.9927886},"labels":[],"label_agreement":null},{"id":"W4290988282","doi":"10.3389/fmed.2022.955373","title":"High percentages of peripheral blood T-cell activation in childhood Hodgkin's lymphoma are associated with inferior outcome","year":2022,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD8; CD3; Medicine; T cell; Flow cytometry; Internal medicine; Human leukocyte antigen; Gastroenterology; Immunology; Immune system; Antigen","score_opus":0.009153134147413453,"score_gpt":0.23464862152778604,"score_spread":0.2254954873803726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290988282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958845,0.00060501805,0.000032346197,0.0020173404,0.00035434487,0.0006569095,0.00002193279,0.000032695534,0.00039494262],"genre_scores_gemma":[0.99759305,0.000086874206,0.0008070252,0.0007529375,0.000069975016,0.00017527558,0.00020892943,0.000033643253,0.00027231523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980622,0.00013528994,0.00052817026,0.0003403736,0.0006256961,0.00030828803],"domain_scores_gemma":[0.99920833,0.00006588305,0.0003028499,0.00027645275,0.00005104121,0.000095414165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031944335,0.00024107612,0.00094375946,0.00041839364,0.00007157359,0.000004386911,0.000121112585,0.00007826616,0.0002689027],"category_scores_gemma":[0.00015350513,0.0001831822,0.00006232567,0.00061494,0.00011333763,0.000070782604,0.000056480538,0.00019184765,4.915252e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035661279,0.0034128223,0.9890645,0.000053530806,0.00018651904,0.00024777424,0.0020407324,0.00009206881,0.00028748103,0.0000127700605,0.0019023239,0.0023428225],"study_design_scores_gemma":[0.029546097,0.0018301475,0.9610811,0.00040866135,0.00025906382,0.00001805483,0.005551465,0.000054877477,0.0008631181,0.000028108952,0.00020176155,0.00015756788],"about_ca_topic_score_codex":0.00075675396,"about_ca_topic_score_gemma":0.000070345035,"teacher_disagreement_score":0.029189484,"about_ca_system_score_codex":0.0009789937,"about_ca_system_score_gemma":0.00013602893,"threshold_uncertainty_score":0.74699533},"labels":[],"label_agreement":null},{"id":"W4291019548","doi":"10.1200/jco.22.00843","title":"Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R<sup>2</sup>) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Provincial Health Services Authority; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Lenalidomide; Follicular lymphoma; Internal medicine; Hazard ratio; Clinical endpoint; Progression-free survival; Oncology; Chemotherapy; Lymphoma; Clinical trial; Gastroenterology; Confidence interval; Multiple myeloma","score_opus":0.04292526790811107,"score_gpt":0.3750719490034204,"score_spread":0.3321466810953093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291019548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751423,0.0040048747,0.00003549867,0.016077803,0.0017293498,0.00080963154,0.00034774074,0.000053032556,0.0017997897],"genre_scores_gemma":[0.982417,0.00550872,0.0062760324,0.004118389,0.00070506264,0.00010007605,0.00019006696,0.00008994887,0.00059472217],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9910872,0.0012762609,0.0046152486,0.00093831326,0.0012204557,0.00086251687],"domain_scores_gemma":[0.988595,0.0068174843,0.0026671747,0.0007873636,0.00045661617,0.00067633693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031649747,0.00055796746,0.0041019763,0.00028385795,0.00020289481,0.000031255615,0.00058771466,0.00057954725,0.00043569636],"category_scores_gemma":[0.0055445177,0.0004522667,0.0013273166,0.0006347516,0.00030767906,0.00025878428,0.00020834546,0.0012400516,0.00010258019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52506405,0.06554961,0.027289916,0.000045636283,0.0037278617,0.022310112,0.0009881516,0.002090654,0.0004282963,0.00027262024,0.13728587,0.21494724],"study_design_scores_gemma":[0.59912586,0.016332284,0.015850611,0.00024821408,0.0007145063,0.00032665805,0.0009351415,0.0013921524,0.00042903295,0.00034945854,0.36386475,0.00043135765],"about_ca_topic_score_codex":0.0007347241,"about_ca_topic_score_gemma":0.00012568058,"teacher_disagreement_score":0.22657886,"about_ca_system_score_codex":0.0036123057,"about_ca_system_score_gemma":0.0027369778,"threshold_uncertainty_score":0.99979293},"labels":[],"label_agreement":null},{"id":"W4291173185","doi":"10.1182/bloodadvances.2022007536","title":"Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Blood Cancer UK; Academy of Medical Sciences; Cancer Research UK; Barts Charity; European Hematology Association","keywords":"Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Population; Medicine; Ibrutinib; Clinical trial; Germinal center; Gene signature; Biology; Immunology; B cell; Gene; Chronic lymphocytic leukemia; Leukemia; Gene expression; Genetics","score_opus":0.007225127182962229,"score_gpt":0.23365595563583555,"score_spread":0.22643082845287332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291173185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939885,0.004646611,0.0000068271615,0.000020647629,0.00017596918,0.000507817,0.00038699544,0.00004161684,0.00022501808],"genre_scores_gemma":[0.9980094,0.00033968058,0.0009458372,0.000036192585,0.000037033507,0.00013837586,0.00028298065,0.000023496992,0.00018702792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855095,0.00005953574,0.0002598957,0.00034416525,0.0005267252,0.0002587428],"domain_scores_gemma":[0.99916995,0.000073314455,0.00027623176,0.00027664797,0.000116750176,0.00008712286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009301021,0.00018297398,0.00032207125,0.00008671754,0.00026832902,0.000013366392,0.00010060605,0.000025914524,0.00010419416],"category_scores_gemma":[0.000037081285,0.00012749498,0.00008039916,0.00022777602,0.000046546727,0.00015457321,0.00009541617,0.000063448264,0.0000072583184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008805278,0.018250786,0.9781665,0.00013440484,0.000109329834,0.00007980759,0.00020296613,0.00001331051,0.0011601052,0.000017976334,0.00013308991,0.00085120276],"study_design_scores_gemma":[0.03421092,0.0019562782,0.75901973,0.00012500472,0.0005765208,0.000012862488,0.00051924447,0.00001182555,0.2006727,0.00003984263,0.0026649986,0.00019006598],"about_ca_topic_score_codex":0.000029783734,"about_ca_topic_score_gemma":0.000013189524,"teacher_disagreement_score":0.21914676,"about_ca_system_score_codex":0.000054531487,"about_ca_system_score_gemma":0.00007251874,"threshold_uncertainty_score":0.5199094},"labels":[],"label_agreement":null},{"id":"W4291233545","doi":"","title":"The 10th Annual Winter Workshop and Meeting of the Canadian Rheumatology Association. Mont Tremblant, Quebec, Canada. February 26-March 1, 2003. Abstracts.","year":2003,"lang":"en","type":"other","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine","score_opus":0.00788576336222402,"score_gpt":0.20137157704797887,"score_spread":0.19348581368575485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291233545","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034293193,0.035897467,2.5523948e-7,0.053161893,0.0037105836,0.0062637115,0.0010031426,0.00009868499,0.8655711],"genre_scores_gemma":[0.31583622,0.0013726255,0.000020738911,0.0011315327,0.00013031763,0.0008813287,0.000044963017,0.00021724308,0.680365],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981789,0.00013074657,0.000372483,0.0002832848,0.00039344482,0.0006411276],"domain_scores_gemma":[0.998485,0.00025895477,0.0004275597,0.00038349512,0.00014242137,0.00030251592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601686,0.0002592107,0.00049006246,0.000099550176,0.00017943255,0.000035539746,0.00015959564,0.00032121319,0.00007394797],"category_scores_gemma":[0.00081496895,0.00014871077,0.00007145776,0.0001779361,0.000093512,0.000016253949,0.000037058944,0.00023292273,0.000003719753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011413517,0.000036927642,0.1532179,0.00003423413,0.0005166934,0.000035176334,0.000066268156,7.4094623e-7,2.8396622e-8,0.000059338643,0.8376341,0.008387176],"study_design_scores_gemma":[0.0005434844,0.0000032684725,0.55392206,0.000110781046,0.00012796135,0.000020044967,0.000114363786,7.805758e-7,0.000007756784,0.0000026053988,0.44505548,0.00009139083],"about_ca_topic_score_codex":0.99641407,"about_ca_topic_score_gemma":0.9999354,"teacher_disagreement_score":0.40070418,"about_ca_system_score_codex":0.0020289524,"about_ca_system_score_gemma":0.0027275337,"threshold_uncertainty_score":0.60642487},"labels":[],"label_agreement":null},{"id":"W4291932245","doi":"","title":"Abstracts of the Canadian Rheumatology Association meeting, February 25-28, 2004, Lake Louise, Canada.","year":2004,"lang":"en","type":"other","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Family medicine; Internal medicine","score_opus":0.007666575964616813,"score_gpt":0.19108573299827647,"score_spread":0.18341915703365966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291932245","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075310734,0.0037656967,4.6226614e-8,0.008603811,0.0016709801,0.0020770924,0.00062441005,0.00005140158,0.97567546],"genre_scores_gemma":[0.6535571,0.00023425666,0.00001702816,0.0009921495,0.00014149748,0.00065426185,0.00019914703,0.0001707399,0.3440338],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983924,0.00004064682,0.00032617454,0.00024927888,0.00044902458,0.00054244464],"domain_scores_gemma":[0.99863064,0.000052191856,0.0005474369,0.0003671015,0.00007218638,0.00033046093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017246786,0.00023159459,0.000505694,0.00014132414,0.00006720679,0.0000123787995,0.0001416726,0.0004125947,0.00037700133],"category_scores_gemma":[0.0003412537,0.00016668401,0.00011297573,0.00014263674,0.000038590737,0.0000102378835,0.000021233664,0.00016109738,0.000019405346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003329351,0.000068294146,0.28436103,0.000084002735,0.00037117198,0.00005732809,0.000014041354,0.0000038907638,3.5901778e-8,0.00006460376,0.7132441,0.0017281702],"study_design_scores_gemma":[0.00073519384,0.000003830236,0.57068986,0.00014644241,0.00014817856,0.000015956679,0.0000039950737,9.252753e-8,0.000028837972,0.000007754385,0.4281383,0.00008156386],"about_ca_topic_score_codex":0.9980657,"about_ca_topic_score_gemma":0.9999608,"teacher_disagreement_score":0.646026,"about_ca_system_score_codex":0.0037089922,"about_ca_system_score_gemma":0.004782403,"threshold_uncertainty_score":0.9698885},"labels":[],"label_agreement":null},{"id":"W4292533762","doi":"10.1016/j.clml.2022.08.008","title":"An Epidemiological Model to Estimate the Prevalence of Diffuse Large B-Cell Lymphoma in the United States","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Broadcom (Canada); Vancouver Coastal Health","funders":"","keywords":"Epidemiology; Medicine; Diffuse large B-cell lymphoma; Incidence (geometry); Disease; Population; Lymphoma; Relative survival; Mortality rate; Internal medicine; Environmental health; Cancer registry","score_opus":0.05327180857641299,"score_gpt":0.3865145714777316,"score_spread":0.3332427629013186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292533762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936113,0.00045745738,0.00014352924,0.0035316052,0.00015642305,0.0012894992,0.00026719627,0.0000908065,0.00045220717],"genre_scores_gemma":[0.98365784,0.00042457067,0.0010094312,0.013548755,0.00010471187,0.00069331034,0.00022762577,0.00004567033,0.00028810493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99405265,0.0017823883,0.0016464893,0.00090776506,0.0007917457,0.0008189355],"domain_scores_gemma":[0.9935093,0.0038607386,0.00041394343,0.0016852269,0.00013036637,0.00040043073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041605295,0.00044627796,0.001003647,0.00017624894,0.0004163476,0.00003740051,0.0012008672,0.0002023981,0.00011151307],"category_scores_gemma":[0.0011104296,0.00024345328,0.00046450004,0.00094608846,0.00035926286,0.00009046406,0.0005360382,0.0002916287,0.000050506882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043220865,0.047561556,0.7695375,0.0004440476,0.00027311427,0.0013624273,0.0044554793,0.02363556,0.00019675225,0.008413502,0.013434821,0.12636314],"study_design_scores_gemma":[0.012923836,0.0021129618,0.83960253,0.0000661913,0.0002458512,0.00011669813,0.00053190085,0.13743247,0.00011738169,0.0010613162,0.0055343723,0.00025449603],"about_ca_topic_score_codex":0.0003831503,"about_ca_topic_score_gemma":0.000029978379,"teacher_disagreement_score":0.12610865,"about_ca_system_score_codex":0.0010397602,"about_ca_system_score_gemma":0.00078529044,"threshold_uncertainty_score":0.99277365},"labels":[],"label_agreement":null},{"id":"W4292977925","doi":"10.1182/blood.2022015854","title":"Genomic profiling for clinical decision making in lymphoid neoplasms","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Cancer Research UK; Barts Charity","keywords":"Computational biology; Disease; Genomics; Immunophenotyping; Epigenetics; Biology; Genome; Bioinformatics; Medicine; Pathology; Genetics; Gene","score_opus":0.041210583576327633,"score_gpt":0.3566992800359085,"score_spread":0.3154886964595809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292977925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973667,0.0010107078,0.00006350918,0.00013392002,0.00024832643,0.0007068346,0.00001954524,0.000028471311,0.0004219872],"genre_scores_gemma":[0.98567295,0.00008068656,0.013156738,0.00044265756,0.00013196366,0.0004247362,0.000026743292,0.000018915453,0.000044607874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990018,0.00003433149,0.00034527178,0.00027221968,0.00015372118,0.00019262536],"domain_scores_gemma":[0.9992551,0.0004167883,0.00006482095,0.00019433483,0.000016739517,0.0000521925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037848676,0.00008808574,0.00024276962,0.00007725527,0.000096012496,0.000009811501,0.00006621679,0.000038414717,0.0000654881],"category_scores_gemma":[0.000115121366,0.000077217774,0.0001374222,0.00010060123,0.000011562084,0.000017475995,0.000095877374,0.000067644796,0.000013863113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037086193,0.0024242296,0.9572601,0.000016939815,0.00005162772,0.00015965172,0.0000636543,0.00002697594,0.0002199112,0.00016135091,0.0002557791,0.03898895],"study_design_scores_gemma":[0.052994177,0.002460264,0.92204267,0.00017424341,0.0005287062,0.00072395435,0.00031363982,0.0014806608,0.0045361356,0.0008828542,0.013586401,0.0002762701],"about_ca_topic_score_codex":0.000009731548,"about_ca_topic_score_gemma":0.0000075536145,"teacher_disagreement_score":0.052623317,"about_ca_system_score_codex":0.0001629988,"about_ca_system_score_gemma":0.00016706518,"threshold_uncertainty_score":0.31488496},"labels":[],"label_agreement":null},{"id":"W4293101897","doi":"10.1158/0008-5472.can-22-1215","title":"Notch Signaling Promotes Mature T-Cell Lymphomagenesis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Notch signaling pathway; Cancer research; Biology; T cell; Cell growth; Lymphoma; Signal transduction; Immunology; Cell biology; Genetics; Immune system","score_opus":0.07120128710731898,"score_gpt":0.38355342241072005,"score_spread":0.31235213530340106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293101897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834316,0.0072791744,0.0000011694611,0.0039020171,0.00013433788,0.0006513149,0.000051577987,0.00004976858,0.0044990517],"genre_scores_gemma":[0.99013627,0.00029576072,0.00015094441,0.000345578,0.00022165482,0.0016464846,0.000033615295,0.000034817087,0.0071349056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978662,0.00016155146,0.00014255336,0.00037022168,0.0009817091,0.00047772247],"domain_scores_gemma":[0.9991391,0.000134522,0.000028579385,0.00034583692,0.00017184862,0.00018015417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005317592,0.00011482261,0.00020066861,0.00018127264,0.0005105819,0.0000393969,0.00016578464,0.000043841937,0.0038349594],"category_scores_gemma":[0.000031645148,0.00009536361,0.000092867114,0.0006122222,0.00006248614,0.000034397443,0.00023468211,0.0002616607,0.0000974108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009882861,0.0029159149,0.0837267,0.00057202805,0.00029967655,0.0018220032,0.0020492466,0.00021869666,0.7684149,0.00032684582,0.09359711,0.045068614],"study_design_scores_gemma":[0.0050024805,0.001019137,0.021281267,0.00011205255,0.00010161268,0.000096265445,0.0012036348,0.00009853248,0.84424865,0.00017635079,0.12641352,0.00024648893],"about_ca_topic_score_codex":0.00070347264,"about_ca_topic_score_gemma":0.000010663319,"teacher_disagreement_score":0.07583377,"about_ca_system_score_codex":0.0011530229,"about_ca_system_score_gemma":0.0007366928,"threshold_uncertainty_score":0.9970757},"labels":[],"label_agreement":null},{"id":"W4293103727","doi":"10.3390/curroncol29090480","title":"Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Germinal center; Transplantation; Oncology; Internal medicine; Autologous stem-cell transplantation; Pathology; Cancer research; B cell; Immunology; Antibody","score_opus":0.037326170408160206,"score_gpt":0.3216155852868793,"score_spread":0.28428941487871906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293103727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942304,0.0010320124,0.0000179531,0.00017398292,0.0007160542,0.0007493427,0.00005798266,0.00006230219,0.0029599539],"genre_scores_gemma":[0.99865353,0.000034347642,0.00023327053,0.00024397268,0.00009096097,0.00034872172,0.0002739874,0.000035934692,0.00008524686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979623,0.00019404973,0.0003813074,0.0004907807,0.00040848163,0.0005631003],"domain_scores_gemma":[0.9990667,0.00015714226,0.00020940925,0.00033139464,0.000068925016,0.00016642445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022218878,0.00024840276,0.0005011416,0.00022346666,0.00023506422,0.000015574782,0.00013458937,0.000069570706,0.00015020302],"category_scores_gemma":[0.00004472862,0.00020734608,0.0000890558,0.00034927877,0.000050580733,0.000061196624,0.0002641668,0.00012988433,0.000029816652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064974907,0.043968152,0.81194025,0.000055721797,0.000036610618,0.00020728084,0.00065828324,0.00000561454,0.000004741944,0.00009440229,0.0008982986,0.14148091],"study_design_scores_gemma":[0.07448355,0.0027568624,0.81973106,0.00007048174,0.00012810198,0.000033762408,0.00029618104,0.00019778969,0.00008304729,0.00002521196,0.10198133,0.00021264912],"about_ca_topic_score_codex":0.0000631261,"about_ca_topic_score_gemma":0.000043809017,"teacher_disagreement_score":0.14126825,"about_ca_system_score_codex":0.0024101941,"about_ca_system_score_gemma":0.0004145641,"threshold_uncertainty_score":0.8455327},"labels":[],"label_agreement":null},{"id":"W4293113254","doi":"10.14740/wjon1504","title":"Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Hodgkin lymphoma; Lymphoma; Population; Oncology; Population based study; Internal medicine; Pediatrics; Family medicine; Environmental health","score_opus":0.047887336714797016,"score_gpt":0.37159959734785597,"score_spread":0.32371226063305897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293113254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972209,0.0004825265,0.00008759065,0.0010517567,0.00044227453,0.00052300416,0.000011803675,0.0000039179977,0.00017626797],"genre_scores_gemma":[0.9945372,0.000008905115,0.004587032,0.0005621288,0.00012047895,0.000075011325,0.000009033492,0.00001291306,0.00008734302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820167,0.0003857172,0.000883447,0.00016067448,0.00016678117,0.00020174106],"domain_scores_gemma":[0.99621433,0.002521815,0.00086916005,0.00012563639,0.00015132382,0.000117707044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016777912,0.00012302224,0.0010535391,0.0003227453,0.00010539297,0.000001530838,0.000090944035,0.000033578413,0.000054984343],"category_scores_gemma":[0.00044794352,0.00009671012,0.00015699715,0.00015637757,0.000050828683,0.000027381713,0.00006648029,0.00010269041,3.413729e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021373134,0.004023275,0.9276885,0.000046320776,0.00012805412,0.00036778228,0.00011736269,0.000075251904,0.000040088784,0.00003519602,0.0002859446,0.06505493],"study_design_scores_gemma":[0.014465613,0.015523351,0.965987,0.00004319222,0.0003960501,0.0007392102,0.00022986915,0.00022999402,0.00004516514,0.00015848424,0.0021140047,0.00006801773],"about_ca_topic_score_codex":0.00014985893,"about_ca_topic_score_gemma":0.0002686563,"teacher_disagreement_score":0.064986914,"about_ca_system_score_codex":0.0006360519,"about_ca_system_score_gemma":0.0006132558,"threshold_uncertainty_score":0.39437243},"labels":[],"label_agreement":null},{"id":"W4293274664","doi":"10.1097/pas.0000000000001956","title":"Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas","year":2022,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Somatic evolution in cancer; Pathology; Biology; Cancer research; Disease; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.02347288646106581,"score_gpt":0.280870378603039,"score_spread":0.25739749214197316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293274664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584824,0.0020386642,0.000044423286,0.0015894084,0.000084895764,0.00015171751,0.000080859805,0.0000044036697,0.00015738605],"genre_scores_gemma":[0.99800193,0.00017683957,0.0015436318,0.00014893175,0.000059156704,0.000023045408,0.000027115542,0.000007381448,0.000011949225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976232,0.0009541298,0.00064310717,0.0001621671,0.00039105193,0.00022635117],"domain_scores_gemma":[0.99763745,0.001242763,0.00078289147,0.00011884307,0.00010767087,0.0001104004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016225395,0.00012264689,0.00060011836,0.00020066673,0.00012794194,0.0000042587226,0.000115369556,0.000025104644,0.00010989792],"category_scores_gemma":[0.00015461327,0.00008158098,0.00012801244,0.0004025384,0.00034721274,0.000043507254,0.00008297763,0.00041023758,0.0000018529075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002905488,0.00285099,0.9703918,0.000038309783,0.00015182713,0.008061667,0.001566171,0.0003940014,0.0024632358,0.0027171758,0.00019375863,0.008265548],"study_design_scores_gemma":[0.009680576,0.003704537,0.9604657,0.000046029978,0.00026214117,0.020786496,0.0024785881,0.0003031847,0.00054204854,0.000984707,0.00060544955,0.00014049449],"about_ca_topic_score_codex":0.00000920064,"about_ca_topic_score_gemma":0.0000013278519,"teacher_disagreement_score":0.01272483,"about_ca_system_score_codex":0.0001505392,"about_ca_system_score_gemma":0.00031118817,"threshold_uncertainty_score":0.3326776},"labels":[],"label_agreement":null},{"id":"W4293312807","doi":"10.14740/jocmr4802","title":"Urothelial Carcinoma With Pulmonary Tumor Thrombotic Microangiopathy After Chemotherapy for Hodgkin Lymphoma","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Autopsy; Chemotherapy; Respiratory failure; Lung; Lymphoma; Cause of death; Non-Hodgkin's lymphoma; Internal medicine; Gastroenterology; Disease","score_opus":0.1156003369256854,"score_gpt":0.4542157632889859,"score_spread":0.3386154263633005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293312807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96712404,0.003537488,0.000047164827,0.026791252,0.0005280572,0.0010959075,0.000023075812,0.000011168215,0.00084183103],"genre_scores_gemma":[0.99191207,0.0003798051,0.0011166944,0.002549264,0.0031297163,0.00024397975,0.000008884445,0.00006267208,0.00059689255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948169,0.00062512845,0.0014880938,0.00039440533,0.0020727736,0.0006026925],"domain_scores_gemma":[0.9949022,0.0026856472,0.0004628339,0.00044828575,0.0008876661,0.000613395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006665324,0.00023167516,0.0012870784,0.00044227138,0.00023231147,0.000017461687,0.00033546082,0.00007895109,0.0009948981],"category_scores_gemma":[0.0010612789,0.00013531085,0.00048999366,0.0005117788,0.00056246197,0.00007302518,0.000115402974,0.0006929102,0.00001100072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052317,0.0076310057,0.78987426,0.0002719284,0.00086418417,0.013520244,0.0005702082,0.000004869208,0.0010553326,0.00010391822,0.024184866,0.10960219],"study_design_scores_gemma":[0.03848527,0.046301246,0.8143235,0.0005415635,0.00043071536,0.0064379727,0.001088998,0.00015548737,0.0009892541,0.00043964578,0.09061384,0.00019253379],"about_ca_topic_score_codex":0.00006762403,"about_ca_topic_score_gemma":0.0000036774152,"teacher_disagreement_score":0.10940965,"about_ca_system_score_codex":0.0003303462,"about_ca_system_score_gemma":0.0015835322,"threshold_uncertainty_score":0.99991834},"labels":[],"label_agreement":null},{"id":"W4293354701","doi":"10.1002/ijc.34266","title":"Physical activity and the risk of <scp>non‐Hodgkin</scp> lymphoma subtypes: A pooled analysis","year":2022,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; BC Cancer Agency","funders":"National Cancer Institute; European Regional Development Fund; Instituto de Salud Carlos III; Medical Research Council; Centers for Disease Control and Prevention; National Health and Medical Research Council; Israel Science Foundation; Ministerio de Economía y Competitividad; Generalitat de Catalunya; University of South Australia; Michael Smith Health Research BC; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; American Institute for Cancer Research; California Department of Public Health; United States Agency for International Development; Henry J. Predolin Foundation for Research in Leukemia; Centres de Recerca de Catalunya","keywords":"Medicine; Lymphoma; Odds ratio; Internal medicine; Confounding; Follicular lymphoma; Oncology; Case-control study; Hodgkin lymphoma; Logistic regression; Etiology; Epidemiology; Immunology","score_opus":0.00789290978432512,"score_gpt":0.2966272202759695,"score_spread":0.2887343104916444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293354701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605125,0.0014787317,0.00007452069,0.0015749327,0.00025117252,0.00008935844,0.00007327719,0.0000026105065,0.00040413905],"genre_scores_gemma":[0.9984628,0.0008319683,0.000034285353,0.00021270654,0.00027519677,0.000027438155,0.0000026001821,0.0000065862873,0.00014644675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877983,0.00010115056,0.00021269804,0.00010071838,0.00072174927,0.00008385415],"domain_scores_gemma":[0.9985546,0.0004429565,0.0005445787,0.00010247403,0.00029542978,0.00005997162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002772951,0.000088455214,0.0003738382,0.00018325674,0.000058776124,0.000018033605,0.00015560156,0.00001642993,0.00008615725],"category_scores_gemma":[0.000112433016,0.00005236851,0.00040230626,0.00021323128,0.000089568464,0.0000640824,0.00007914991,0.00010550017,8.18128e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024497553,0.0023179073,0.8326678,0.000014059626,0.043061834,0.00023552262,0.0029447826,0.0027586725,0.0015926388,0.0006827217,0.0016447749,0.10962952],"study_design_scores_gemma":[0.009813751,0.00025766416,0.9704973,0.0000288209,0.0066138734,0.00011087323,0.00032104584,0.0033019097,0.0058805714,0.00038522726,0.0027598965,0.00002904091],"about_ca_topic_score_codex":0.0009089297,"about_ca_topic_score_gemma":0.000056726003,"teacher_disagreement_score":0.13782951,"about_ca_system_score_codex":0.0003041933,"about_ca_system_score_gemma":0.0002101985,"threshold_uncertainty_score":0.21355258},"labels":[],"label_agreement":null},{"id":"W4293553347","doi":"10.14740/jh1035","title":"Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin","year":2022,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dacarbazine; Brentuximab vedotin; Vinblastine; ABVD; Nivolumab; Bleomycin; Internal medicine; Cyclophosphamide; Procarbazine; Lymphoma; Oncology; Vincristine; Chemotherapy; Radiology; Hodgkin lymphoma; Cancer","score_opus":0.008509687977466355,"score_gpt":0.24265469619571017,"score_spread":0.23414500821824383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293553347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945436,0.004171055,0.000004908668,0.00081626885,0.00002658138,0.00015742556,0.0000076142715,0.0000043358077,0.0002681992],"genre_scores_gemma":[0.9986499,0.00040690321,0.0008283532,0.000043746793,0.0000136081035,0.000007194552,0.0000045323773,0.000013270523,0.00003251228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987185,0.00009746046,0.0006155639,0.00015433386,0.00024868533,0.00016546395],"domain_scores_gemma":[0.9988798,0.00017561932,0.00056919776,0.00013308959,0.00014188609,0.00010042659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020964156,0.0001335536,0.00086110685,0.00027877715,0.000043557895,0.0000035957273,0.00005582358,0.000043985972,0.000083395695],"category_scores_gemma":[0.000074820375,0.00009612089,0.000051201314,0.00022977444,0.000102884514,0.00005464296,0.00006586629,0.000097303426,2.1235563e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003926796,0.0030393724,0.96056366,0.0002821914,0.00030137142,0.001197561,0.000322562,0.00005124845,0.024978984,0.00022843773,0.0003166641,0.004791157],"study_design_scores_gemma":[0.053968977,0.00846108,0.78527254,0.0011253835,0.0005953416,0.026034806,0.00082334655,0.00045083195,0.12259171,0.00022050494,0.00027972469,0.00017577638],"about_ca_topic_score_codex":0.0002550721,"about_ca_topic_score_gemma":0.000037056,"teacher_disagreement_score":0.17529114,"about_ca_system_score_codex":0.00009776652,"about_ca_system_score_gemma":0.00016397987,"threshold_uncertainty_score":0.39196962},"labels":[],"label_agreement":null},{"id":"W4293755562","doi":"10.1186/s12943-022-01640-7","title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Cancer research; Anaplastic large-cell lymphoma; Biology; STAT3; Platelet-derived growth factor receptor; STAT5; Growth factor receptor; Signal transduction; Growth factor; Lymphoma; Immunology; Receptor; Cell biology","score_opus":0.008495873797131988,"score_gpt":0.2833116882356187,"score_spread":0.2748158144384867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293755562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455076,0.0029909825,0.00018617579,0.0006872158,0.00016900615,0.0008058002,0.0000493281,0.000042962234,0.00051773863],"genre_scores_gemma":[0.99725026,0.00007884317,0.00031036578,0.000661985,0.00003443711,0.0012657607,0.00015840057,0.00003791683,0.00020203492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852616,0.00009092859,0.00022520038,0.00036624438,0.0004545821,0.0003368793],"domain_scores_gemma":[0.9994846,0.000032225966,0.00010196687,0.00023402736,0.000045808833,0.000101344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011025835,0.00017489669,0.0002399151,0.00014429893,0.00012495198,0.000015315947,0.00006673837,0.000042240754,0.0005198782],"category_scores_gemma":[0.000018517858,0.0001551516,0.000090396665,0.00037008917,0.000016624283,0.000065416745,0.00009068576,0.0000968198,0.000018123095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002604581,0.022961622,0.3095679,0.0004508273,0.00044433586,0.007774705,0.0023649787,0.0010114935,0.3485703,0.00022296753,0.0031183946,0.3009079],"study_design_scores_gemma":[0.043910947,0.003921168,0.25584316,0.00037270968,0.0004971412,0.00022391904,0.0005733055,0.0068944795,0.6195846,0.0002235293,0.06710459,0.000850404],"about_ca_topic_score_codex":0.00028793357,"about_ca_topic_score_gemma":0.00005951299,"teacher_disagreement_score":0.3000575,"about_ca_system_score_codex":0.0012860929,"about_ca_system_score_gemma":0.00039105766,"threshold_uncertainty_score":0.63268983},"labels":[],"label_agreement":null},{"id":"W4294051557","doi":"10.1016/j.jtct.2022.08.030","title":"Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Alberta Health Services","funders":"Gilead Sciences; Merck; AstraZeneca; Novartis; Eisai Canada; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Autologous stem-cell transplantation; CHOP; Induction chemotherapy; Internal medicine; Oncology; International Prognostic Index; Transplantation; Lymphoma; Diffuse large B-cell lymphoma; Surgery; Chemotherapy","score_opus":0.02328548444801918,"score_gpt":0.25200732098411066,"score_spread":0.2287218365360915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294051557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942244,0.0010626188,0.0023114833,0.00051755185,0.00007522562,0.0011775048,0.00012173402,0.00006026742,0.00044918392],"genre_scores_gemma":[0.9947221,0.0031091443,0.0003422824,0.00034436097,0.000015293903,0.00048158903,0.0004942304,0.000023638891,0.0004673521],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990766,0.000059441372,0.00019363825,0.00030325222,0.00019427943,0.00017280881],"domain_scores_gemma":[0.9996043,0.000085431864,0.00008772203,0.0000974094,0.00004084063,0.0000842839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011530442,0.00018870391,0.00027191098,0.00009919385,0.00034303198,0.000031514417,0.000030391348,0.000052158844,0.00004752621],"category_scores_gemma":[1.7736158e-7,0.0001445496,0.000052087442,0.00009859432,0.000055928947,0.00009985894,0.0000024189853,0.00005433128,0.0000014257962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07192906,0.0047659553,0.2823983,0.002375246,0.0022201221,0.0011900634,0.078634515,0.00043696907,0.069812864,0.007821672,0.00019094508,0.47822428],"study_design_scores_gemma":[0.14823622,0.007716352,0.3642518,0.00012284695,0.0017767554,0.0018580162,0.008131786,0.0004974238,0.45985097,0.00029422747,0.0063252575,0.00093835907],"about_ca_topic_score_codex":0.0000966981,"about_ca_topic_score_gemma":0.000014016341,"teacher_disagreement_score":0.47728592,"about_ca_system_score_codex":0.000059765414,"about_ca_system_score_gemma":0.00007335174,"threshold_uncertainty_score":0.5894562},"labels":[],"label_agreement":null},{"id":"W4294527101","doi":"10.1007/s00428-022-03404-6","title":"Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma","year":2022,"lang":"en","type":"review","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; BCL6; Burkitt's lymphoma; Diffuse large B-cell lymphoma; B cell; Cancer research; Pathology; Medicine; Biology; Immunology; Antibody","score_opus":0.060287314886263,"score_gpt":0.3424474962878011,"score_spread":0.2821601814015381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294527101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027236883,0.9644621,0.0000075619505,0.00087672257,0.0007554511,0.0029050536,0.00033336997,0.00026902862,0.0031538464],"genre_scores_gemma":[0.019222092,0.97362906,0.0014375246,0.000569248,0.0010790983,0.0018416917,0.0018287083,0.00019093635,0.00020162955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922799,0.0015214225,0.0016880878,0.0024828587,0.0006799427,0.0013478121],"domain_scores_gemma":[0.99005425,0.0068790196,0.00081857026,0.0015025157,0.00004007821,0.00070553645],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010750628,0.0017457117,0.0047641923,0.0010298112,0.0005574095,0.00009022559,0.0006234919,0.000995062,0.00010909575],"category_scores_gemma":[0.0010008002,0.0012317799,0.0007651118,0.0011630885,0.0013750382,0.00015392459,0.0010812944,0.0011532224,0.000043598175],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012290115,0.0034915993,0.0013768648,0.0050060265,0.00090217625,0.002443799,0.0005600997,0.0000016927108,0.0000052697037,0.0018913476,0.000631026,0.9835672],"study_design_scores_gemma":[0.008819514,0.0016513314,0.022192322,0.0026951453,0.005561762,0.00065507594,0.0009210706,0.000050643317,0.000020461888,0.001171517,0.95502496,0.0012361952],"about_ca_topic_score_codex":0.00053171406,"about_ca_topic_score_gemma":0.00006141099,"teacher_disagreement_score":0.982331,"about_ca_system_score_codex":0.00048603385,"about_ca_system_score_gemma":0.0010358384,"threshold_uncertainty_score":0.9995289},"labels":[],"label_agreement":null},{"id":"W4294771021","doi":"10.1158/2643-3249.lymphoma22-a12","title":"Abstract A12: Pervasive hypermutation of super-enhancer regions dysregulates oncogene expression in diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Somatic hypermutation; Enhancer; Genetics; Gene; Cancer research; Germinal center; B cell; Gene expression","score_opus":0.012631251303586995,"score_gpt":0.2578647238791112,"score_spread":0.2452334725755242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842144,0.00911673,0.0000052879996,0.00048052624,0.00020744567,0.0005128223,0.00040980885,0.000026569402,0.0008193987],"genre_scores_gemma":[0.9960436,0.0017271889,0.00006085945,0.0002381717,0.00010133112,0.00080531766,0.00022057918,0.000038062317,0.00076487125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834853,0.000054039836,0.00039367686,0.00041951553,0.00045723066,0.00032699594],"domain_scores_gemma":[0.9992058,0.00009544473,0.00018444157,0.00036904792,0.0000529641,0.00009224888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009827584,0.00022131357,0.00041774477,0.00015797942,0.00013723322,0.000020938103,0.00011459978,0.00006575184,0.0003360909],"category_scores_gemma":[0.000015313139,0.00019075042,0.00019290097,0.00027804487,0.000044156943,0.00025295222,0.00012508473,0.000087732835,0.0000064518426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015463845,0.07944908,0.3312343,0.00068402727,0.00050881424,0.00087983254,0.0047146264,0.00056039635,0.569994,0.00031959254,0.0034516524,0.006657308],"study_design_scores_gemma":[0.036326908,0.000452517,0.33733973,0.0004192802,0.0004125886,0.00003980805,0.0019195745,0.00003547087,0.62082994,0.000102669546,0.00184632,0.00027520646],"about_ca_topic_score_codex":0.0008315486,"about_ca_topic_score_gemma":0.0002420039,"teacher_disagreement_score":0.07899657,"about_ca_system_score_codex":0.00047603468,"about_ca_system_score_gemma":0.0004654878,"threshold_uncertainty_score":0.7778576},"labels":[],"label_agreement":null},{"id":"W4294771401","doi":"10.1158/2643-3249.lymphoma22-a19","title":"Abstract A19: Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Follicular lymphoma; Transcriptome; Lymphoma; Somatic evolution in cancer; Tumor microenvironment; Cancer research; Phenotype; Cancer; Genetics; Gene; Immunology; Tumor cells; Gene expression","score_opus":0.0067827158771484415,"score_gpt":0.21553513545212058,"score_spread":0.20875241957497215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881808,0.009864158,0.000018484381,0.00037664617,0.000052130432,0.0007321584,0.00048091996,0.000008262414,0.0002864156],"genre_scores_gemma":[0.9976767,0.0013283844,0.000031483483,0.00019317998,0.000017829427,0.00045672787,0.00008395711,0.000016883689,0.00019488337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853295,0.00009586278,0.00043984925,0.00033635562,0.00034859483,0.00024640502],"domain_scores_gemma":[0.99936587,0.000079702324,0.00019550069,0.00028076884,0.000013831391,0.00006434227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000254765,0.00019433266,0.0005639098,0.00017392832,0.00009134941,0.000022368986,0.00008992218,0.000031296397,0.00018115071],"category_scores_gemma":[0.0000039896477,0.00012787055,0.00028401674,0.0004537273,0.00012723786,0.00008263525,0.00003745358,0.00006844933,0.0000013149205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003242755,0.011345806,0.4286745,0.00047615866,0.004171807,0.00052199134,0.0018840289,0.0032415134,0.5423043,0.00015995152,0.0006267668,0.0033504535],"study_design_scores_gemma":[0.019302564,0.00044034014,0.56163615,0.00014171629,0.0047349995,0.000026386406,0.001758875,0.000102923186,0.4106449,0.00003957395,0.00095496216,0.00021659936],"about_ca_topic_score_codex":0.0049642427,"about_ca_topic_score_gemma":0.00029324394,"teacher_disagreement_score":0.13296168,"about_ca_system_score_codex":0.00078259176,"about_ca_system_score_gemma":0.00019125575,"threshold_uncertainty_score":0.7504483},"labels":[],"label_agreement":null},{"id":"W4294975927","doi":"10.1182/bloodadvances.2022008258","title":"The outcome of older adults with classic Hodgkin lymphoma in British Columbia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Bleomycin; Internal medicine; Hodgkin lymphoma; Population; Lymphoma; Chemotherapy; Pediatrics","score_opus":0.005573712684059084,"score_gpt":0.22951469428269247,"score_spread":0.22394098159863338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294975927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888709,0.009339441,5.0180284e-7,0.00030067106,0.00009351193,0.0004648153,0.000032208598,0.00002073562,0.0008772222],"genre_scores_gemma":[0.99777794,0.00051310903,0.00019431548,0.0001733272,0.000025387308,0.000388812,0.0000129460705,0.000013995676,0.0009001788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989733,0.000042048996,0.00025492185,0.00021651045,0.0003127709,0.00020042667],"domain_scores_gemma":[0.9994663,0.00012557307,0.00011367404,0.00021270275,0.00003342078,0.000048333746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000981737,0.000076429606,0.00025362743,0.000022137838,0.00016988277,0.000032975502,0.00009885885,0.00001719511,0.000107093794],"category_scores_gemma":[0.000024468098,0.00007073898,0.000058150796,0.00022579244,0.00008259465,0.00005717248,0.000054111275,0.000049716244,0.0000018210836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008876634,0.0012949272,0.8913852,0.00004245016,0.00005780929,0.0003396102,0.0001234733,0.0000070251936,0.0000044308113,0.00001855069,0.00027177526,0.10636599],"study_design_scores_gemma":[0.010253108,0.00074759434,0.9728468,0.00017393372,0.000093513416,0.00026720474,0.0012981821,0.000007306527,0.00016288631,0.00003664506,0.01402505,0.00008776116],"about_ca_topic_score_codex":0.005440265,"about_ca_topic_score_gemma":0.060037795,"teacher_disagreement_score":0.10627823,"about_ca_system_score_codex":0.00007503624,"about_ca_system_score_gemma":0.0000743664,"threshold_uncertainty_score":0.95711404},"labels":[],"label_agreement":null},{"id":"W4295815436","doi":"10.1093/jncimonographs/lgu012","title":"Medical History, Lifestyle, Family History, and Occupational Risk Factors for Peripheral T-Cell Lymphomas: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","year":2014,"lang":"en","type":"article","venue":"JNCI Monographs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; Cancer Council NSW; Medical Research Council; National Institutes of Health; H. Lundbeck A/S; Institut de Veille Sanitaire; Agence Française de Sécurité Sanitaire de l'Environnement et du Travail; American Association for Cancer Research; Bundesamt für Strahlenschutz; José Carreras Leukämie-Stiftung; Dansk Kræftforsknings Fond; Stockholms Läns Landsting; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Health and Medical Research Council; Institut National Du Cancer; Lundbeckfonden; National Institute on Deafness and Other Communication Disorders; Università degli Studi di Cagliari; Institut National de la Santé et de la Recherche Médicale; European Commission; Fondation de France; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; University of California, San Francisco; Michael Smith Health Research BC; Université de Bourgogne; Health Research Board; Alleanza Contro il Cancro; Région Normandie; Ministero dell’Istruzione, dell’Università e della Ricerca; University of Rochester; Comprehensive Cancer Center, City of Hope; Institut Bergonié; Yale University; Canadian Institutes of Health Research; Cancerfonden","keywords":"Family history; Lymphoma; Hodgkin lymphoma; Medicine; Medical history; Non-Hodgkin's lymphoma; Past medical history; Peripheral T-cell lymphoma; Internal medicine; Oncology; Immunology; T cell","score_opus":0.01999308591671171,"score_gpt":0.25729713416662703,"score_spread":0.23730404824991533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295815436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889396,0.0047007184,0.0004284387,0.00027053797,0.0010983258,0.001168545,0.00006022648,0.00012630309,0.0032073185],"genre_scores_gemma":[0.99505126,0.00067576545,0.0009940026,0.0013772397,0.00038056108,0.0005725212,0.00016206603,0.000066675944,0.0007198743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974865,0.00016108817,0.0005235627,0.00064970687,0.00067826273,0.00050088513],"domain_scores_gemma":[0.99804986,0.00060089113,0.0002906702,0.0005496714,0.00015376325,0.00035516015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005511637,0.0004656448,0.0005874587,0.0002657689,0.0002186142,0.000035447058,0.00026117358,0.00028103148,0.00013337389],"category_scores_gemma":[0.00029807386,0.00029965068,0.00045168414,0.00014758547,0.00043300743,0.00012609572,0.00007444697,0.00010926597,0.000012896271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066729,0.001361284,0.83169085,0.0001321742,0.00038891236,0.000023142917,0.0035147008,0.0000012388535,0.00010863402,0.00044245349,0.12722279,0.034446537],"study_design_scores_gemma":[0.0074910964,0.0012355671,0.64443064,0.00007800665,0.0003857592,0.000045496356,0.0004440433,0.0025530763,0.00014992223,0.00005521998,0.3428031,0.00032807357],"about_ca_topic_score_codex":0.0025855652,"about_ca_topic_score_gemma":0.00015693011,"teacher_disagreement_score":0.2155803,"about_ca_system_score_codex":0.0015504741,"about_ca_system_score_gemma":0.0011046816,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W4296529229","doi":"10.1016/s2152-2650(22)01498-7","title":"ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Vincristine; Internal medicine; Prednisone; Gastroenterology; CHOP; Hazard ratio; Cyclophosphamide; Clinical endpoint; International Prognostic Index; Surgery; Confidence interval; Lymphoma; Chemotherapy; Randomized controlled trial","score_opus":0.016170071289462105,"score_gpt":0.2827769139615351,"score_spread":0.26660684267207296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296529229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749622,0.012672566,0.000009114409,0.0007665054,0.00096467586,0.0075729713,0.002274357,0.00041337986,0.00036422597],"genre_scores_gemma":[0.99050105,0.0031024325,0.00045435858,0.0017648926,0.00043279596,0.0008822467,0.0020825306,0.00033496643,0.00044471308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98645204,0.0015394575,0.003935031,0.003666619,0.0022024813,0.0022043486],"domain_scores_gemma":[0.98921406,0.0043167956,0.0016750781,0.0029559163,0.0004700821,0.001368045],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002021089,0.0019838463,0.0037114827,0.00040219547,0.0016319164,0.00036007958,0.0010748373,0.0006847157,0.00015025501],"category_scores_gemma":[0.0010208912,0.0014652812,0.00055136683,0.0016530928,0.0008587014,0.0005149066,0.001511246,0.0010214762,0.000061527615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18650578,0.11556724,0.54302853,0.00007467736,0.0018942411,0.0022036552,0.0042942856,0.000014008124,0.000073761665,0.000054913042,0.0023389808,0.14394994],"study_design_scores_gemma":[0.44162685,0.01262207,0.5381161,0.0002052253,0.0008978588,0.000051583673,0.0011740777,0.00054655096,0.00014919264,0.000039919545,0.0037014051,0.00086916244],"about_ca_topic_score_codex":0.017601097,"about_ca_topic_score_gemma":0.0015176507,"teacher_disagreement_score":0.25512108,"about_ca_system_score_codex":0.0054783206,"about_ca_system_score_gemma":0.0024628998,"threshold_uncertainty_score":0.9996678},"labels":[],"label_agreement":null},{"id":"W4296529430","doi":"10.1016/s2152-2650(22)00990-9","title":"Poster: HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Oncology; Stage (stratigraphy); Internal medicine; Medicine; Classical Hodgkin lymphoma; Chemotherapy; Hodgkin lymphoma; Lymphoma; Biology","score_opus":0.019777399116568974,"score_gpt":0.29484443637337776,"score_spread":0.2750670372568088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296529430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615157,0.00015246945,0.000022720444,0.00068800297,0.00041047725,0.0013935906,0.00054209126,0.00017222064,0.00046683702],"genre_scores_gemma":[0.9933378,0.00010411874,0.0003647953,0.0014545899,0.00017335404,0.00020766379,0.0036873876,0.00014268019,0.00052757945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99251723,0.0006233197,0.002536746,0.001726308,0.0015650505,0.0010313682],"domain_scores_gemma":[0.9954794,0.00070652255,0.0010499791,0.0017186768,0.00034038007,0.0007050127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011056485,0.0008625796,0.0029792702,0.0007526937,0.00028188832,0.00007316115,0.00068306853,0.00045055762,0.00070363755],"category_scores_gemma":[0.00014725213,0.0007151365,0.0009760449,0.0020718025,0.0004593824,0.00028486433,0.00047654574,0.00036689322,0.00002319787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018363563,0.012780829,0.798163,0.000054592594,0.0034860068,0.00044986804,0.00036851698,0.0003484632,0.00006494004,0.00013583885,0.00047307066,0.16531132],"study_design_scores_gemma":[0.08047811,0.006880336,0.89970875,0.00006433445,0.001793371,0.000013620909,0.00013313956,0.006880114,0.00030974727,0.000026857253,0.003046782,0.0006648607],"about_ca_topic_score_codex":0.0017736065,"about_ca_topic_score_gemma":0.00076872966,"teacher_disagreement_score":0.16464646,"about_ca_system_score_codex":0.004843094,"about_ca_system_score_gemma":0.002053859,"threshold_uncertainty_score":0.99952996},"labels":[],"label_agreement":null},{"id":"W4296529454","doi":"10.1016/s2152-2650(22)00699-1","title":"Oral Abstract: ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Vincristine; Medicine; Doxorubicin; Rituximab; Cyclophosphamide; CHOP; Internal medicine; Oncology; Chemotherapy; Gastroenterology; Lymphoma","score_opus":0.01905922969332775,"score_gpt":0.29031897160643977,"score_spread":0.27125974191311203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296529454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781217,0.009975769,0.0000053244835,0.0006254126,0.00095135334,0.0071019833,0.0024059706,0.00039644804,0.00041601935],"genre_scores_gemma":[0.99153507,0.0024626483,0.0004344323,0.0015476139,0.00039204233,0.0007497293,0.0022145412,0.00032513292,0.0003388161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9870138,0.0010943394,0.003994293,0.0035229255,0.0021837284,0.0021909014],"domain_scores_gemma":[0.98971707,0.0039720177,0.0017377953,0.0027508985,0.00046170093,0.0013605354],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002097206,0.0019644804,0.0036711928,0.00038448154,0.0015512223,0.00037819616,0.001037897,0.0007028861,0.00019040258],"category_scores_gemma":[0.00095652335,0.001454708,0.0005454646,0.001469667,0.0009335237,0.00056490226,0.0013095255,0.0010841477,0.000066110595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18350068,0.12060816,0.5066136,0.000078394136,0.0017997171,0.0025622302,0.0037927143,0.000015582486,0.00008158962,0.00004521926,0.0023096278,0.17859249],"study_design_scores_gemma":[0.43099856,0.010626554,0.55128145,0.00019413176,0.0008279946,0.000048164206,0.0010723658,0.00038852,0.0001436025,0.000035385234,0.0035279717,0.0008552725],"about_ca_topic_score_codex":0.018114846,"about_ca_topic_score_gemma":0.0016500098,"teacher_disagreement_score":0.24749789,"about_ca_system_score_codex":0.004440675,"about_ca_system_score_gemma":0.0023038115,"threshold_uncertainty_score":0.99974865},"labels":[],"label_agreement":null},{"id":"W4296529960","doi":"10.1016/s2152-2650(22)01087-4","title":"Poster: TCL-323 Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) With Intention for Curative Therapy Incorporating High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Chemotherapy; Internal medicine; Lymphoma; Stem cell; Peripheral T-cell lymphoma; Hematopoietic stem cell transplantation; Transplantation; T cell; Immunology; Biology; Immune system","score_opus":0.028208172304721193,"score_gpt":0.28940357171932724,"score_spread":0.26119539941460607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296529960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432164,0.0021249277,0.00008524845,0.0007023161,0.0002731458,0.0019149997,0.00014506925,0.00009766514,0.0003349791],"genre_scores_gemma":[0.99511045,0.00093517004,0.001183093,0.0012779875,0.00010337059,0.00049434014,0.00017829509,0.00012105123,0.00059623853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959543,0.0003436237,0.0016180761,0.0010271043,0.0005610941,0.0004958127],"domain_scores_gemma":[0.99690396,0.00095579657,0.00095482793,0.0006064703,0.00020239086,0.00037653124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074736227,0.00061242364,0.0014735002,0.00015320694,0.0003836023,0.00005970346,0.00021039521,0.00027402284,0.00005844087],"category_scores_gemma":[0.000023747167,0.00046860543,0.00038736273,0.00026670343,0.00046988946,0.00020591229,0.000107875494,0.00020921062,0.000003647154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021849252,0.0058064624,0.45661795,0.00078889617,0.00076811947,0.0005380149,0.0045520253,0.000008746628,0.0069444026,0.0004927873,0.00030422508,0.5013291],"study_design_scores_gemma":[0.089107886,0.016041026,0.8733849,0.00034708402,0.00050157367,0.0005676094,0.0022894635,0.0005801561,0.013711632,0.00027851822,0.0024211952,0.0007689685],"about_ca_topic_score_codex":0.00020986218,"about_ca_topic_score_gemma":0.0000197216,"teacher_disagreement_score":0.50056016,"about_ca_system_score_codex":0.0010395481,"about_ca_system_score_gemma":0.0007005716,"threshold_uncertainty_score":0.99977654},"labels":[],"label_agreement":null},{"id":"W4296529971","doi":"10.1016/s2152-2650(22)01483-5","title":"HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Internal medicine; Vinblastine; Hazard ratio; Oncology; Bleomycin; Progression-free survival; Chemotherapy; Chemotherapy regimen; Confidence interval; Lymphoma; Surgery; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.02059907530529329,"score_gpt":0.29731698021762476,"score_spread":0.27671790491233145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296529971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964046,0.00014809768,0.00004150884,0.00058124564,0.0004007041,0.0013333167,0.00046741875,0.00017560598,0.0004475288],"genre_scores_gemma":[0.9936369,0.00011488995,0.0005611134,0.001203802,0.0001825644,0.00023151228,0.0033619897,0.0001392555,0.0005679448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925706,0.0006031456,0.0024936295,0.0017182912,0.0015889948,0.0010253744],"domain_scores_gemma":[0.99550474,0.00073078164,0.0010326754,0.0016991141,0.00032866225,0.00070404273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001165254,0.0008451743,0.0029847156,0.0007395976,0.0002893802,0.000066734676,0.0006719561,0.00044765882,0.0007834861],"category_scores_gemma":[0.00016748263,0.0007012927,0.00096902845,0.0022382857,0.0004816441,0.00026865356,0.00043618778,0.00037197443,0.000022748813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016789172,0.013910213,0.77585804,0.000054042564,0.0036631122,0.00042740026,0.0003351102,0.0006940702,0.000058468908,0.00023114459,0.0006210423,0.1873582],"study_design_scores_gemma":[0.08009349,0.00586605,0.89476895,0.000057906505,0.001774982,0.000009964797,0.0001508894,0.012278521,0.00026065882,0.000035611203,0.0040525757,0.00065042294],"about_ca_topic_score_codex":0.0018441093,"about_ca_topic_score_gemma":0.0007835152,"teacher_disagreement_score":0.18670776,"about_ca_system_score_codex":0.0050355354,"about_ca_system_score_gemma":0.0022017225,"threshold_uncertainty_score":0.99954385},"labels":[],"label_agreement":null},{"id":"W4296532704","doi":"10.1016/s2152-2650(22)01552-x","title":"IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Internal medicine; Follicular lymphoma; Phases of clinical research; Gastroenterology; Lymphoma; Oncology; Clinical trial; Multiple myeloma","score_opus":0.051951077989837335,"score_gpt":0.3526723269500253,"score_spread":0.300721248960188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296532704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852535,0.005256513,0.00010657576,0.0006466633,0.0012996938,0.0061368975,0.0006489302,0.00027431312,0.00037690377],"genre_scores_gemma":[0.9908484,0.0009548774,0.0018238267,0.00090608426,0.00075156335,0.002993488,0.0003672025,0.00030711986,0.0010474302],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98861325,0.0011567074,0.0037063377,0.0028987597,0.0018977767,0.0017271461],"domain_scores_gemma":[0.9888414,0.0057409965,0.0016338492,0.0018375991,0.0004914051,0.0014547135],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026956133,0.0016002613,0.004540067,0.00070640683,0.001267562,0.00020200359,0.00082289113,0.0006761407,0.00025580174],"category_scores_gemma":[0.0017532767,0.0014006296,0.0011350805,0.0009424334,0.0010801445,0.00050423533,0.0013292085,0.00043759454,0.0000652862],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38616696,0.050523005,0.0069350167,0.00074307993,0.0047583827,0.008613889,0.0022370564,0.000040045292,0.00035949168,0.00046940328,0.005162466,0.5339912],"study_design_scores_gemma":[0.7921175,0.030551976,0.12654933,0.00040367234,0.004512838,0.002601694,0.005626377,0.0035095073,0.00082584366,0.00013218536,0.03160765,0.001561439],"about_ca_topic_score_codex":0.0014089132,"about_ca_topic_score_gemma":0.00029457608,"teacher_disagreement_score":0.53242975,"about_ca_system_score_codex":0.007237346,"about_ca_system_score_gemma":0.0055290097,"threshold_uncertainty_score":0.9996745},"labels":[],"label_agreement":null},{"id":"W4296533011","doi":"10.1016/s2152-2650(22)01578-6","title":"TCL-323 Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) With Intention for Curative Therapy Incorporating High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Oncology; Chemotherapy; Anaplastic large-cell lymphoma; Gemcitabine; Progression-free survival; Lymphoma; Hematopoietic stem cell transplantation; Regimen; Refractory (planetary science); Peripheral T-cell lymphoma; Salvage therapy; Chemotherapy regimen; Gastroenterology; Romidepsin; Transplantation; Immunology; T cell; CD30","score_opus":0.029522456149170376,"score_gpt":0.29152269695165867,"score_spread":0.2620002408024883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296533011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994471,0.002124645,0.00015275361,0.00059599575,0.00026544233,0.001837708,0.00012457739,0.00009888979,0.00032899602],"genre_scores_gemma":[0.994485,0.0010490672,0.0018009827,0.0010642904,0.00010806198,0.0005521279,0.00015817065,0.00011790626,0.00066435616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960158,0.00033067874,0.0015837767,0.0010171476,0.0005632394,0.00048936723],"domain_scores_gemma":[0.99690884,0.000991222,0.00093810237,0.00059339893,0.00019454739,0.00037386306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007823703,0.0005983357,0.0014649122,0.00014798381,0.0003940656,0.000054574768,0.00020461589,0.00027106045,0.00006301147],"category_scores_gemma":[0.000026478703,0.00045783882,0.0003808645,0.0002810195,0.00049231754,0.00019341703,0.00009799017,0.00021060047,0.0000035158664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019790318,0.0062378244,0.3886693,0.00079905847,0.0007897358,0.0005109946,0.0042397743,0.000016109901,0.006564464,0.00084858056,0.0003877783,0.5711461],"study_design_scores_gemma":[0.095504105,0.01507437,0.86626315,0.00034528787,0.0005312837,0.0004737133,0.0028731583,0.0010734735,0.013154247,0.00040397907,0.0034857409,0.00081752083],"about_ca_topic_score_codex":0.00021168037,"about_ca_topic_score_gemma":0.000019305544,"teacher_disagreement_score":0.57032853,"about_ca_system_score_codex":0.0010615392,"about_ca_system_score_gemma":0.00074036996,"threshold_uncertainty_score":0.99978733},"labels":[],"label_agreement":null},{"id":"W4296533650","doi":"10.1016/s2152-2650(22)01554-3","title":"IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Dosing; Gastroenterology; Follicular lymphoma; Clinical endpoint; Surgery; Lymphoma; Clinical trial","score_opus":0.02636925942745788,"score_gpt":0.32061302432645694,"score_spread":0.29424376489899906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296533650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880267,0.0010418175,0.000014962082,0.0001881401,0.0002928332,0.008633067,0.001600468,0.00013826309,0.000063767184],"genre_scores_gemma":[0.99223644,0.00080756657,0.0006455135,0.00049049506,0.000298393,0.0027543886,0.0022876011,0.0001616451,0.00031798793],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940055,0.00082883646,0.001876261,0.0018559066,0.0008319331,0.0006015776],"domain_scores_gemma":[0.9950831,0.0014770954,0.0011186292,0.0012780947,0.00051577704,0.0005273178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063517195,0.0008917533,0.0019952424,0.00022621831,0.0007633313,0.000068215144,0.0002676647,0.00035166898,0.000077662495],"category_scores_gemma":[0.00016795468,0.00065475225,0.00051393453,0.0003546846,0.00028753266,0.00026948247,0.00014166873,0.00015254409,0.000006336467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10112676,0.047591597,0.12110365,0.000021138412,0.0029723127,0.00019875918,0.0054028,0.000036427762,0.00020962804,0.000006118686,0.0003660567,0.7209647],"study_design_scores_gemma":[0.22718781,0.119417764,0.64186054,0.00011892742,0.0007925599,0.000014995935,0.0008032712,0.0027954804,0.001535605,0.00003680181,0.004964659,0.000471543],"about_ca_topic_score_codex":0.0018166439,"about_ca_topic_score_gemma":0.000085795175,"teacher_disagreement_score":0.7204932,"about_ca_system_score_codex":0.002885222,"about_ca_system_score_gemma":0.0009619862,"threshold_uncertainty_score":0.9995904},"labels":[],"label_agreement":null},{"id":"W4296613255","doi":"10.1016/s2152-2650(22)01064-3","title":"Poster: IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Refractory (planetary science); Follicular lymphoma; Medicine; Oncology; Internal medicine; Follicular phase; Lymphoma; Biology","score_opus":0.025252225964605732,"score_gpt":0.3178122279718731,"score_spread":0.29256000200726734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296613255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875559,0.0010441488,0.000007717478,0.0002207134,0.00029880813,0.008869531,0.001800279,0.00013530633,0.00006756246],"genre_scores_gemma":[0.992617,0.00071821106,0.00042080905,0.00058629503,0.00028071925,0.0024395147,0.0024885645,0.0001641773,0.0002846795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9939692,0.0008489749,0.0019017024,0.0018543852,0.0008212204,0.0006045383],"domain_scores_gemma":[0.9951299,0.001414596,0.0011299403,0.0012892323,0.00050990836,0.00052646274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006048766,0.00090389146,0.0019911388,0.0002317335,0.00073467655,0.00007375134,0.00027230644,0.00035247544,0.00007126139],"category_scores_gemma":[0.00014767706,0.00066366704,0.00051802216,0.0003346352,0.00027444537,0.000283296,0.00015411142,0.00015086672,0.000006468477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11188491,0.044865333,0.14796335,0.000022049077,0.0029333173,0.00021613775,0.0057657864,0.0000214017,0.00023384042,0.0000040198365,0.00028853808,0.6858013],"study_design_scores_gemma":[0.22148325,0.12871934,0.64049697,0.0001265628,0.0007852083,0.000019354937,0.0006792935,0.0018023466,0.0017019375,0.000027401913,0.0036898076,0.00046851815],"about_ca_topic_score_codex":0.0017666557,"about_ca_topic_score_gemma":0.00008656241,"teacher_disagreement_score":0.6853328,"about_ca_system_score_codex":0.002789571,"about_ca_system_score_gemma":0.0009046647,"threshold_uncertainty_score":0.99958146},"labels":[],"label_agreement":null},{"id":"W4296613368","doi":"10.1016/s2152-2650(22)01062-x","title":"Poster: IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Refractory (planetary science); Oncology; Placebo; Pathology; Multiple myeloma; Biology","score_opus":0.049127865764089895,"score_gpt":0.3488319352136375,"score_spread":0.2997040694495476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296613368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850038,0.0051947245,0.000055756605,0.0007438562,0.0013068876,0.006301783,0.0007320253,0.00026687558,0.0003942758],"genre_scores_gemma":[0.99187124,0.0008495996,0.0012019261,0.001066592,0.0007040128,0.0026606116,0.00040331885,0.00030951668,0.0009331954],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9886226,0.0011778675,0.00373175,0.0028849903,0.001862329,0.0017204374],"domain_scores_gemma":[0.98912746,0.0054544085,0.0016431161,0.0018481257,0.0004857439,0.001441159],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00254561,0.0016123552,0.0045010406,0.0007158203,0.0012178936,0.00021541116,0.00082935666,0.00067374244,0.00023403093],"category_scores_gemma":[0.001525581,0.0014094856,0.0011364055,0.0008841825,0.0010233276,0.0005259748,0.0014151378,0.00042920184,0.00006535004],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4255727,0.049195565,0.0091397865,0.0007729792,0.0048153824,0.009327207,0.0024586022,0.000024793391,0.00040649233,0.00031430137,0.0041701337,0.49380207],"study_design_scores_gemma":[0.7766777,0.03391991,0.14776196,0.00042588645,0.0044434466,0.0032004856,0.0047458042,0.0023173832,0.0009211205,0.00009977326,0.023938695,0.0015477994],"about_ca_topic_score_codex":0.0013744687,"about_ca_topic_score_gemma":0.00029360363,"teacher_disagreement_score":0.49225426,"about_ca_system_score_codex":0.006958313,"about_ca_system_score_gemma":0.00515052,"threshold_uncertainty_score":0.9996624},"labels":[],"label_agreement":null},{"id":"W4296969016","doi":"10.1016/s2152-2650(22)01000-x","title":"Poster: ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Rituximab; Cyclophosphamide; Vincristine; Medicine; Doxorubicin; CHOP; Internal medicine; Oncology; Chemotherapy; Lymphoma","score_opus":0.015765062508904634,"score_gpt":0.2811204971392092,"score_spread":0.2653554346303046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296969016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745974,0.012538669,0.0000057002912,0.0007857241,0.0009821432,0.0077611604,0.0025206008,0.00040310447,0.0004055321],"genre_scores_gemma":[0.99065065,0.0027868554,0.00032304073,0.0020663517,0.0004159121,0.0007996718,0.0022479035,0.00033806084,0.00037153854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864542,0.001565182,0.0039677117,0.0036494883,0.0021674202,0.0021959895],"domain_scores_gemma":[0.9893718,0.0041375556,0.001687552,0.002963991,0.00048203656,0.0013570687],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019310097,0.0019968566,0.0036936167,0.0004098772,0.0015859181,0.00037705502,0.0010761416,0.00068330276,0.00013882125],"category_scores_gemma":[0.00093101076,0.0014749988,0.00055543653,0.0015585461,0.00090898393,0.00053623173,0.001584148,0.0010017755,0.000061209044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19513601,0.1068613,0.55659443,0.00007429537,0.001818307,0.0022464907,0.0045650476,0.000008320749,0.00007907325,0.000038414873,0.0018564749,0.13072185],"study_design_scores_gemma":[0.43779802,0.014068488,0.5413945,0.0002170453,0.00089746667,0.000064095046,0.0010237325,0.00034528307,0.00016889833,0.000029802304,0.0031249702,0.0008677265],"about_ca_topic_score_codex":0.014147044,"about_ca_topic_score_gemma":0.0012537831,"teacher_disagreement_score":0.24266203,"about_ca_system_score_codex":0.0045634997,"about_ca_system_score_gemma":0.0022152902,"threshold_uncertainty_score":0.9997139},"labels":[],"label_agreement":null},{"id":"W4297178676","doi":"10.1016/j.clinimag.2022.09.004","title":"18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma","year":2022,"lang":"en","type":"article","venue":"Clinical Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Salvage therapy; Refractory (planetary science); Stage (stratigraphy); Standardized uptake value; Retrospective cohort study; Positron emission tomography; Nuclear medicine; Lymphoma; Radiology; Internal medicine; Chemotherapy","score_opus":0.029055771156362445,"score_gpt":0.3475229291753411,"score_spread":0.3184671580189787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297178676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915697,0.0013753586,0.0000027524334,0.004663406,0.00042363856,0.0010481174,0.00001444011,0.00011544556,0.0007871148],"genre_scores_gemma":[0.9944754,0.000109396235,0.00042395008,0.004041595,0.00013946618,0.0005425854,0.000021206279,0.00005824868,0.00018811545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640554,0.0008758438,0.000992059,0.00073102827,0.00044329002,0.00055223994],"domain_scores_gemma":[0.9960554,0.0029168117,0.00016552748,0.0005365946,0.00004361255,0.00028202723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027644003,0.00025542895,0.00059715135,0.00035523524,0.00014436209,0.000039807,0.00021271792,0.000014558699,0.00017076771],"category_scores_gemma":[0.0025401758,0.00023482254,0.00021408638,0.00058835215,0.000083042425,0.00009427558,0.00027524022,0.00043185396,0.000065475535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027503627,0.0031337787,0.8866369,0.000009425264,0.000037997965,0.010543552,0.0003612951,0.000046971418,0.00038495942,0.000007642182,0.00043102264,0.09565608],"study_design_scores_gemma":[0.012359611,0.0014094934,0.9666433,0.00021197753,0.00003806491,0.0005782872,0.00093472004,0.0015820512,0.00011351162,0.00006830183,0.015839504,0.00022120011],"about_ca_topic_score_codex":0.00027077532,"about_ca_topic_score_gemma":0.000031230484,"teacher_disagreement_score":0.09543488,"about_ca_system_score_codex":0.00077234,"about_ca_system_score_gemma":0.00042800276,"threshold_uncertainty_score":0.95757854},"labels":[],"label_agreement":null},{"id":"W4297266032","doi":"10.1097/mph.0000000000002547","title":"Metronomic Chemotherapy for Burkitt Lymphoma in a Patient With HIV: Case Report","year":2022,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Chemotherapy; Lymphoma; Human immunodeficiency virus (HIV); Oncology; Burkitt's lymphoma; Combination chemotherapy; Internal medicine; Hodgkin lymphoma; Immunology","score_opus":0.014689790938682912,"score_gpt":0.2957702401109371,"score_spread":0.2810804491722542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297266032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910075,0.0022508244,0.00013627273,0.005036167,0.00043160593,0.0006920678,0.000013494811,0.000012551379,0.0004194969],"genre_scores_gemma":[0.99245083,0.00018670685,0.005814187,0.00079121697,0.00035424213,0.0002950365,0.000012144024,0.000031923595,0.00006372895],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99776256,0.00016166312,0.0011518494,0.00028495095,0.00025262855,0.00038635934],"domain_scores_gemma":[0.9975807,0.0005524202,0.0012408295,0.00023981066,0.00017791553,0.00020832784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007358965,0.00021051563,0.0010941961,0.0006278127,0.00011507244,0.0000063896746,0.00010805192,0.00013896781,0.00014832779],"category_scores_gemma":[0.00012851534,0.00015684932,0.00025575378,0.0003665564,0.000050970702,0.00006079777,0.00005814713,0.00021361926,0.0000040971468],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038676828,0.005708469,0.22286832,0.000072554314,0.00047745282,0.72920036,0.0011283776,0.0000960041,0.000018179257,0.00020647566,0.01955826,0.016797876],"study_design_scores_gemma":[0.023337722,0.011181981,0.0044658566,0.0000092382425,0.0006549649,0.9043,0.0018160423,0.00008018302,0.0002482349,0.00010026708,0.05364258,0.00016296373],"about_ca_topic_score_codex":0.0000483439,"about_ca_topic_score_gemma":0.000028872884,"teacher_disagreement_score":0.21840248,"about_ca_system_score_codex":0.0021224762,"about_ca_system_score_gemma":0.0020907328,"threshold_uncertainty_score":0.639613},"labels":[],"label_agreement":null},{"id":"W4297338547","doi":"10.1080/10428194.2022.2123226","title":"Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation","keywords":"Chemoimmunotherapy; Medicine; Asymptomatic; Follicular lymphoma; Biopsy; Radiology; Malignancy; Lymphoma; Interim; Internal medicine; Surgery; Oncology; Rituximab","score_opus":0.026550311206926063,"score_gpt":0.2996931429276785,"score_spread":0.27314283172075243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297338547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923527,0.0033236607,0.00003450901,0.00015231967,0.0005541158,0.0023550682,0.00041748703,0.000080853344,0.0007292556],"genre_scores_gemma":[0.99444115,0.002625048,0.00063242385,0.000292395,0.00014002537,0.0010146223,0.00052024965,0.00011856122,0.00021551957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944507,0.0002852964,0.0023437105,0.0012639653,0.00078337453,0.0008729361],"domain_scores_gemma":[0.99638015,0.00082113314,0.0009144626,0.0012311817,0.0002666302,0.00038642663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007658095,0.0008185649,0.0023291488,0.00044866392,0.0003560852,0.000032159405,0.00038937276,0.00026206858,0.0001480308],"category_scores_gemma":[0.00018397745,0.0007296614,0.0009568932,0.00077714166,0.00041562124,0.00016776775,0.00028047326,0.00007685848,0.000004011892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004495335,0.007100646,0.5235316,0.00029719184,0.00066165114,0.000107797074,0.0007884352,0.000043619602,0.00012785752,0.00008542443,0.0004063501,0.46235406],"study_design_scores_gemma":[0.095554076,0.0066851596,0.8630911,0.00037424144,0.00053853117,0.00015966283,0.0004342905,0.0040609725,0.0077397004,0.00012509206,0.02066648,0.0005706531],"about_ca_topic_score_codex":0.0033985002,"about_ca_topic_score_gemma":0.00022741071,"teacher_disagreement_score":0.4617834,"about_ca_system_score_codex":0.0092316335,"about_ca_system_score_gemma":0.0028303498,"threshold_uncertainty_score":0.9995155},"labels":[],"label_agreement":null},{"id":"W4297473430","doi":"10.14740/jmc3973","title":"Immunocompetent Patient With Primary Bone Marrow Hodgkin Lymphoma","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cytopenia; Generalized lymphadenopathy; Bone marrow; Lymphoma; Malignancy; Cervical lymphadenopathy; Biopsy; Chemotherapy; Physical examination; Bone marrow examination; B symptoms; Radiology; Surgery; Internal medicine","score_opus":0.013448555738170838,"score_gpt":0.2482268268587791,"score_spread":0.23477827112060826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297473430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981619,0.0074572302,0.000009413623,0.009633362,0.0003318682,0.00018216303,0.000012021564,0.000012949489,0.0007419965],"genre_scores_gemma":[0.9950365,0.00044491977,0.00056335,0.003579601,0.00022295087,0.000034476623,0.000014199105,0.000018416398,0.000085610394],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9963586,0.000117284035,0.000551461,0.00013724652,0.0026109456,0.00022450829],"domain_scores_gemma":[0.9986542,0.0002519037,0.0003496413,0.00018673344,0.000117030584,0.0004405018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048097974,0.00014923532,0.0004917184,0.00014118484,0.00013547609,0.000015957738,0.00013345781,0.00004648198,0.002211],"category_scores_gemma":[0.00016185016,0.00009047594,0.000212213,0.00016484733,0.0000809133,0.000053537,0.0001357448,0.0002245306,0.000007441589],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056615444,0.010834121,0.053050082,0.0001443441,0.0010449546,0.34422964,0.00060252636,0.000030509009,0.0003573394,0.0002247194,0.05250069,0.53131956],"study_design_scores_gemma":[0.025504632,0.02736922,0.17592055,0.0007629381,0.0008330828,0.4607694,0.0020128372,0.000042301042,0.0015621457,0.00004145919,0.30486608,0.00031539137],"about_ca_topic_score_codex":0.000083597886,"about_ca_topic_score_gemma":0.000004736064,"teacher_disagreement_score":0.53100413,"about_ca_system_score_codex":0.00065328454,"about_ca_system_score_gemma":0.001032337,"threshold_uncertainty_score":0.9987011},"labels":[],"label_agreement":null},{"id":"W4297973475","doi":"10.3390/curroncol29100566","title":"Extra-Nodal Lymphomas of the Head and Neck and Oral Cavity: A Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Head and neck; Retrospective cohort study; Exact test; Statistical significance; Oral cavity; Radiological weapon; Radiology; Internal medicine; Surgery; Dentistry","score_opus":0.07223359703200063,"score_gpt":0.3813831039720231,"score_spread":0.3091495069400224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297973475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413687,0.002969869,4.2549817e-7,0.0008989453,0.0005308401,0.00075029454,0.000029282668,0.000012198138,0.0006712583],"genre_scores_gemma":[0.99948823,0.00010230873,0.000022397333,0.00009349883,0.000043729455,0.00016955244,0.0000048754628,0.000007797091,0.00006760095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906474,0.00016720105,0.00017406793,0.000252612,0.00019182324,0.0001495411],"domain_scores_gemma":[0.99954695,0.00005696695,0.00009152517,0.00019325536,0.000039944083,0.00007134009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016609913,0.00010841379,0.00035671034,0.000044976092,0.00016380099,0.0000049994237,0.000053883305,0.000027860751,0.00008012316],"category_scores_gemma":[0.000042204836,0.00007237465,0.000050387935,0.00013464449,0.00013302559,0.000019158459,0.00026471817,0.000121210716,9.445142e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023818442,0.004339278,0.9468259,0.000018180366,0.00009164189,0.00005079415,0.001908856,3.1151768e-7,0.00003737045,0.00038485724,0.00069541344,0.045409188],"study_design_scores_gemma":[0.008256518,0.0042861444,0.96703565,0.000016408907,0.00023804161,0.00021867154,0.0012639677,0.000030230334,0.000045522404,0.00017754322,0.018370977,0.000060331964],"about_ca_topic_score_codex":0.00016929257,"about_ca_topic_score_gemma":0.0001580106,"teacher_disagreement_score":0.045348857,"about_ca_system_score_codex":0.00049906975,"about_ca_system_score_gemma":0.00018088639,"threshold_uncertainty_score":0.29513526},"labels":[],"label_agreement":null},{"id":"W4298208107","doi":"","title":"Canadian Rheumatology Association annual meeting. Mont Tremblant, Quebec, Canada. February 21-24, 2001. Abstracts.","year":2001,"lang":"en","type":"other","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine","score_opus":0.008442070601415061,"score_gpt":0.1980185716993713,"score_spread":0.18957650109795623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298208107","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014675371,0.007403988,2.2700486e-7,0.0158425,0.0024470608,0.0025181214,0.0014616634,0.00023091288,0.95542014],"genre_scores_gemma":[0.055630695,0.0020102325,0.00003177942,0.0015498439,0.0004429241,0.001417964,0.0011286456,0.00032561048,0.93746233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721724,0.000069649905,0.00046248003,0.00051240716,0.00050178636,0.0012364634],"domain_scores_gemma":[0.9979208,0.00010133822,0.00048026975,0.00039424957,0.000087372966,0.0010159619],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022203689,0.00043967325,0.00085689145,0.000370713,0.00007608682,0.00003110066,0.00014315022,0.0006713763,0.0011706653],"category_scores_gemma":[0.000269618,0.00039924285,0.00012913988,0.00015122966,0.000022073287,0.0000321777,0.000022200065,0.00023695636,0.00010104246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000123405935,0.0001144775,0.1934207,0.00004743008,0.00054940773,0.00089331134,0.000024734623,0.0000012632848,4.1287343e-8,0.000008927846,0.7898665,0.015060876],"study_design_scores_gemma":[0.0009503575,0.00000778637,0.4614151,0.00007815398,0.00019164696,0.000057703724,0.000040267685,9.1105255e-7,0.000005612624,0.0000016266536,0.5370518,0.00019906303],"about_ca_topic_score_codex":0.999931,"about_ca_topic_score_gemma":0.99998844,"teacher_disagreement_score":0.2679944,"about_ca_system_score_codex":0.009525445,"about_ca_system_score_gemma":0.003545939,"threshold_uncertainty_score":0.9998459},"labels":[],"label_agreement":null},{"id":"W4302742543","doi":"10.1182/blood.2022016534","title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Lymphoma; Somatic hypermutation; Burkitt's lymphoma; Biology; Cancer research; Immunology; Genetics; Medicine; B cell; Antibody","score_opus":0.00705122267271078,"score_gpt":0.2161619672365638,"score_spread":0.20911074456385303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302742543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968839,0.0011420571,1.710299e-7,0.0002418091,0.00007829465,0.00027913653,0.000017538403,0.000024563911,0.0013324749],"genre_scores_gemma":[0.9980092,0.0006147185,0.000102907296,0.0008527328,0.00010242011,0.00021834133,0.000025538648,0.000011232087,0.00006293252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924,0.000029175764,0.0001793553,0.00021338895,0.00013699103,0.00020112206],"domain_scores_gemma":[0.99962634,0.000060826445,0.00004359625,0.0001749491,0.000017039982,0.00007724045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005938751,0.00011242401,0.00019232249,0.00014470452,0.00006539965,0.0000062023632,0.000045193374,0.000043311877,0.000072266295],"category_scores_gemma":[0.000027876247,0.0000937604,0.000040135477,0.00017401858,0.00001680556,0.000014424486,0.00007696552,0.00005391948,0.000022284861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079689504,0.0019971994,0.9846041,0.00002486676,0.000027724558,0.000611376,0.00023317507,0.0000027059093,0.00004558683,0.00028611644,0.00015064483,0.011936785],"study_design_scores_gemma":[0.011679172,0.0015638998,0.98461235,0.0000068170475,0.00014310308,0.00039832172,0.00010439941,0.000014884022,0.0002718889,0.00005565632,0.001054141,0.00009534835],"about_ca_topic_score_codex":0.00014823921,"about_ca_topic_score_gemma":0.000024304929,"teacher_disagreement_score":0.011841437,"about_ca_system_score_codex":0.00008882624,"about_ca_system_score_gemma":0.00007307794,"threshold_uncertainty_score":0.38234383},"labels":[],"label_agreement":null},{"id":"W4303649582","doi":"10.1016/j.ctro.2022.10.001","title":"Radiation therapy for primary orbital and ocular adnexal lymphoma","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; External beam radiotherapy; Lymphoma; Follicular lymphoma; Radiology; Nuclear medicine; Internal medicine; Brachytherapy","score_opus":0.038453950130419835,"score_gpt":0.36662012757979845,"score_spread":0.3281661774493786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303649582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799083,0.0058648814,0.0001991923,0.012011223,0.00030782464,0.0008205001,0.00011667567,0.000027607795,0.00074380677],"genre_scores_gemma":[0.99313027,0.001566335,0.0009619855,0.0028677771,0.0003197215,0.00032994416,0.00072062336,0.000011852945,0.0000914859],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988515,0.00013005003,0.00042312135,0.00029669626,0.00017017403,0.000128494],"domain_scores_gemma":[0.99864674,0.0009973695,0.00010572893,0.0000745973,0.000044246382,0.00013133696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044708143,0.000104503066,0.00031098325,0.00006631327,0.00023840873,0.000010364014,0.000027595599,0.00010388207,0.00012818458],"category_scores_gemma":[0.000054940585,0.00009259536,0.0001232263,0.00007512964,0.000110030116,0.000068562826,0.000012370055,0.00007050005,0.0000027083802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001611043,0.00096707133,0.3183501,0.000012539842,0.00014817767,0.000014643235,0.00012602158,0.000015399643,0.000018047791,0.0038730209,0.0006114756,0.67425245],"study_design_scores_gemma":[0.015500757,0.0019725459,0.77920926,0.000002051497,0.00008643945,0.00009055633,0.000017846052,0.0008900577,0.000013056065,0.0017389533,0.20040192,0.00007657789],"about_ca_topic_score_codex":0.000010412535,"about_ca_topic_score_gemma":0.0000019703275,"teacher_disagreement_score":0.67417586,"about_ca_system_score_codex":0.00007459459,"about_ca_system_score_gemma":0.00035541196,"threshold_uncertainty_score":0.3775929},"labels":[],"label_agreement":null},{"id":"W4303983518","doi":"10.1097/01.hs9.0000890604.66330.a0","title":"P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Dacarbazine; ABVD; Medicine; Hazard ratio; Internal medicine; Vinblastine; Oncology; Population; Progression-free survival; Vincristine; Lymphoma; Confidence interval; Surgery; Chemotherapy; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.008250420486286589,"score_gpt":0.23995847702341683,"score_spread":0.23170805653713022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303983518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778885,0.00012431637,0.000087362365,0.0003382935,0.000052468702,0.001004549,0.00021496548,0.000071916125,0.00031726962],"genre_scores_gemma":[0.9958649,0.000030587325,0.0011987969,0.0002554833,0.000022722887,0.00020030573,0.0018085394,0.00006979409,0.0005488271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974366,0.00010621283,0.0005367771,0.0007105872,0.00074314175,0.00046670475],"domain_scores_gemma":[0.9984877,0.00007874364,0.00033821556,0.00071984774,0.0001574866,0.00021798925],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014976106,0.0004100843,0.0011635267,0.00019222815,0.000121056866,0.000019649377,0.0001771553,0.000091874535,0.0016086912],"category_scores_gemma":[0.000011247517,0.0003025925,0.00017869056,0.0012680809,0.00008623344,0.0001412972,0.00008681092,0.00015505776,0.0000021844646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025556095,0.017531153,0.9301711,0.00010377254,0.0034464602,0.00023587172,0.001113016,0.0059759268,0.0002628025,0.00013112025,0.00022575363,0.015246944],"study_design_scores_gemma":[0.09646687,0.0068714777,0.88101953,0.00007072486,0.0011608488,0.0000047552885,0.0005707352,0.01054123,0.0012500267,0.00000680096,0.001589361,0.0004476233],"about_ca_topic_score_codex":0.0009143157,"about_ca_topic_score_gemma":0.0030941127,"teacher_disagreement_score":0.070910774,"about_ca_system_score_codex":0.00095728104,"about_ca_system_score_gemma":0.0004033351,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W4304480113","doi":"10.1007/s00428-022-03420-6","title":"Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series","year":2022,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Julius-Maximilians-Universität Würzburg","keywords":"BCL6; Germinal center; Lymphoma; Diffuse large B-cell lymphoma; Fluorescence in situ hybridization; In situ hybridization; Immunohistochemistry; Medicine; Cancer research; Pathology; Biology; B cell; Gene expression; Immunology; Gene; Antibody; Genetics","score_opus":0.02336059218416619,"score_gpt":0.33787330289902506,"score_spread":0.31451271071485887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304480113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780206,0.003815831,0.0015965236,0.004143152,0.0003845095,0.004750935,0.0004230285,0.00008110119,0.0067842836],"genre_scores_gemma":[0.99476016,0.00088219205,0.001700607,0.00021133469,0.0001238508,0.0014749086,0.00032478393,0.00003852811,0.00048362944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644715,0.00054035056,0.0012526776,0.0006985099,0.00066386955,0.00039745888],"domain_scores_gemma":[0.99252415,0.0022436015,0.0031924513,0.0015819258,0.0003689278,0.00008895798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017144597,0.0003721676,0.0010075457,0.00017818488,0.0003805346,0.0000064517935,0.0006496979,0.000114626484,0.000018607096],"category_scores_gemma":[0.0014709957,0.00020387977,0.0005170827,0.00082157337,0.0013788615,0.00006628005,0.00045682242,0.00025117685,0.0000016452096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073774685,0.012306772,0.64114696,0.0012938723,0.0029178422,0.00024331424,0.0052120434,0.0010506801,0.1933487,0.0789196,0.003820612,0.052362125],"study_design_scores_gemma":[0.008889977,0.002384787,0.77426755,0.00018788771,0.0020549048,0.00012296783,0.002852583,0.0014933802,0.19622788,0.007319679,0.003884106,0.00031428857],"about_ca_topic_score_codex":0.0006493454,"about_ca_topic_score_gemma":0.00005751785,"teacher_disagreement_score":0.1331206,"about_ca_system_score_codex":0.00021139286,"about_ca_system_score_gemma":0.00074336067,"threshold_uncertainty_score":0.8313976},"labels":[],"label_agreement":null},{"id":"W4304690353","doi":"10.1016/j.jtct.2022.10.003","title":"Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Bendamustine; Regimen; Carmustine; Mucositis; Transplantation; Autologous stem-cell transplantation; Oncology; Lymphoma; Internal medicine; Surgery; Chemotherapy; Rituximab; Cyclophosphamide","score_opus":0.024390318959001678,"score_gpt":0.2759682069388299,"score_spread":0.2515778879798282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304690353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971659,0.00071702583,0.00061638496,0.00010761097,0.000039433362,0.000599907,0.00043307344,0.000027997086,0.00029264882],"genre_scores_gemma":[0.99809873,0.00053091923,0.00017720566,0.00009263522,0.000008090115,0.00010865672,0.000917024,0.00002540468,0.000041345644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854577,0.00011564415,0.0005105364,0.0002661114,0.00033026558,0.00023168848],"domain_scores_gemma":[0.99933755,0.00013916472,0.0002630671,0.0001606339,0.000043107924,0.00005646116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024686812,0.00022263416,0.00043948888,0.0002776249,0.00013588756,0.000009035655,0.000064358464,0.00005127698,0.0002736143],"category_scores_gemma":[6.2214235e-7,0.0001853876,0.00020054218,0.00021413337,0.000043152155,0.000056124547,0.000003924764,0.00007039198,7.2152653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038061708,0.0036128685,0.5415313,0.00050232204,0.00052421674,0.00019836542,0.013018264,0.002460537,0.4204412,0.00045051237,0.000012772839,0.013441411],"study_design_scores_gemma":[0.021688506,0.0020728158,0.60864353,0.000091822505,0.00020554093,0.000020422101,0.0010328045,0.00082826155,0.36515424,0.000015487769,0.000052296586,0.00019429521],"about_ca_topic_score_codex":0.00043581135,"about_ca_topic_score_gemma":0.000016605274,"teacher_disagreement_score":0.06711216,"about_ca_system_score_codex":0.00009775705,"about_ca_system_score_gemma":0.0001118002,"threshold_uncertainty_score":0.7559887},"labels":[],"label_agreement":null},{"id":"W4306149913","doi":"10.3390/curroncol29100603","title":"Plasmacytic Pleural Effusion as a Major Presentation of Angioimmunoblastic T-Cell Lymphoma: A Case Report","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities","keywords":"Medicine; Presentation (obstetrics); Angioimmunoblastic T-cell lymphoma; Pleural effusion; Pathology; Lymphoma; Primary effusion lymphoma; Case presentation; Immunology; Internal medicine; T cell; Radiology; Surgery; Immune system","score_opus":0.05019010042758231,"score_gpt":0.3746330168962608,"score_spread":0.32444291646867846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306149913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381876,0.0018055751,0.000012676563,0.00028777056,0.0012573034,0.0007187396,0.000025897927,0.000038900183,0.0020343962],"genre_scores_gemma":[0.9986087,0.00005218025,0.0000919041,0.000048507212,0.00008124958,0.0004254124,0.0002288546,0.000017878567,0.00044529792],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99851114,0.00014576968,0.00047612714,0.0003173474,0.00031048237,0.00023916388],"domain_scores_gemma":[0.99893004,0.00024854945,0.00031153983,0.00030289195,0.00009242042,0.000114551185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017706132,0.00015686298,0.00039527495,0.00016820244,0.00016345578,0.000005477747,0.000070615475,0.000048795104,0.0004988409],"category_scores_gemma":[0.00010921691,0.00013848854,0.00016950992,0.00022825832,0.00006962231,0.00003641491,0.00019208886,0.000097972064,0.000043892363],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053531057,0.053323593,0.21938568,0.0010562696,0.00068042835,0.5211085,0.005118953,0.00020607247,0.008910301,0.0007682908,0.024667557,0.15942127],"study_design_scores_gemma":[0.07807906,0.015825504,0.06446933,0.00015993664,0.0029582996,0.67220503,0.004333663,0.0054649063,0.017767753,0.00034521145,0.13775149,0.00063981855],"about_ca_topic_score_codex":0.0004200221,"about_ca_topic_score_gemma":0.000024880996,"teacher_disagreement_score":0.15878145,"about_ca_system_score_codex":0.0009543247,"about_ca_system_score_gemma":0.00060308375,"threshold_uncertainty_score":0.5647398},"labels":[],"label_agreement":null},{"id":"W4306249959","doi":"10.1182/bloodadvances.2022007360","title":"Transformation of FL into DLBCL with a PMBL gene expression signature","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"BCL6; Biology; Germinal center; Cancer research; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Genetics; B cell; Immunology","score_opus":0.005289266285482754,"score_gpt":0.23605219897205865,"score_spread":0.23076293268657588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306249959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756117,0.009457608,0.00010899575,0.00046670044,0.000054295644,0.00034931532,0.000021795402,0.00003227389,0.0019478541],"genre_scores_gemma":[0.9950224,0.00027742644,0.0042559016,0.00011698657,0.000029691188,0.0001494698,0.00006404805,0.000008084288,0.00007596729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993681,0.000019632342,0.00013036806,0.00012513099,0.00026741644,0.00008935215],"domain_scores_gemma":[0.99971485,0.000022978464,0.000069562004,0.000120575634,0.000030154933,0.000041872947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041365878,0.00008302031,0.00016176468,0.00004684921,0.000092895745,0.0000031509242,0.00004252287,0.000018996121,0.000088202214],"category_scores_gemma":[0.0000042908796,0.00005441807,0.00004300518,0.00012441083,0.00002058991,0.00011170546,0.000014834263,0.000055911536,0.0000014097931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034923465,0.014656836,0.19732212,0.0012148273,0.0007206096,0.0005104282,0.01604118,0.0021948963,0.57801855,0.001727843,0.0008941754,0.18320622],"study_design_scores_gemma":[0.0073639336,0.0018581799,0.01208583,0.00012823973,0.00024048217,0.00009639532,0.00095777854,0.000020733074,0.95467335,0.00015331295,0.022315335,0.000106425134],"about_ca_topic_score_codex":0.000016021928,"about_ca_topic_score_gemma":0.000006513478,"teacher_disagreement_score":0.37665483,"about_ca_system_score_codex":0.000030119467,"about_ca_system_score_gemma":0.00004362735,"threshold_uncertainty_score":0.22191045},"labels":[],"label_agreement":null},{"id":"W4306411219","doi":"10.1002/ajh.26767","title":"Utilization of <scp>real‐world</scp> data in assessing treatment effectiveness for diffuse large <scp>B‐cell</scp> lymphoma","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"MorphoSys; Verastem Oncology; Teva Pharmaceutical Industries; Genentech; Celgene; Adaptive Biotechnologies; Gilead Sciences; TG Therapeutics; Pfizer; Bristol-Myers Squibb","keywords":"Observational study; Medicine; Covariate; Clinical trial; Randomized controlled trial; Oncology; Propensity score matching; Diffuse large B-cell lymphoma; Sample size determination; Comparative effectiveness research; Clinical study design; Internal medicine; Lymphoma; Computer science; Statistics; Machine learning; Pathology; Alternative medicine","score_opus":0.08210967973667803,"score_gpt":0.396500964877894,"score_spread":0.31439128514121595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306411219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05873776,0.93776286,0.00034216838,0.000024005043,0.00044743257,0.0017672001,0.00037106243,0.000022343607,0.0005251806],"genre_scores_gemma":[0.030520208,0.9668202,0.0010501521,0.00004802938,0.00012097306,0.00032786906,0.0009088337,0.00012532713,0.000078441844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951757,0.0011501596,0.0018783956,0.0006779065,0.00045908365,0.0006587276],"domain_scores_gemma":[0.9852165,0.009708739,0.0036651944,0.0009869221,0.00016302527,0.00025965102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010213571,0.00068700494,0.0060001495,0.0011557745,0.00011715121,0.00003110784,0.0005559476,0.00017661908,0.000016581165],"category_scores_gemma":[0.000943909,0.000500703,0.0008678871,0.001071897,0.00022178693,0.00017782165,0.00024218089,0.00022458824,0.0000044207554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048637,0.011315733,0.027975554,0.010141035,0.0020315165,0.0015008387,0.00035008125,0.0000023349291,0.0000029213563,0.00043090343,0.0006635048,0.9455369],"study_design_scores_gemma":[0.013761772,0.004432075,0.0053331,0.008409262,0.0067250254,0.0040117344,0.0013871483,0.000057638365,0.00021716804,0.000045863762,0.95548964,0.00012958754],"about_ca_topic_score_codex":0.00021677538,"about_ca_topic_score_gemma":0.00006333073,"teacher_disagreement_score":0.9548261,"about_ca_system_score_codex":0.0014652007,"about_ca_system_score_gemma":0.0019997028,"threshold_uncertainty_score":0.9997445},"labels":[],"label_agreement":null},{"id":"W4306743619","doi":"10.1111/bjh.18519","title":"<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada)","funders":"National Cancer Institute; Allergan; Incyte; Genentech; Sunesis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; Gilead Sciences; Sanofi; Amgen; Pfizer; MorphoSys; Celgene; BeiGene; Patient-Centered Outcomes Research Institute","keywords":"Mantle cell lymphoma; Medicine; Bruton's tyrosine kinase; Refractory (planetary science); Chart; Cancer research; Ibrutinib; Tyrosine kinase; Internal medicine; Lymphoma; Oncology; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.006174186714432873,"score_gpt":0.22688186975725133,"score_spread":0.22070768304281846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306743619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737216,0.023489697,8.7864055e-7,0.00021204706,0.00045811906,0.0014240324,0.00005352334,0.000025338626,0.0006147543],"genre_scores_gemma":[0.9939524,0.003882888,0.00007101538,0.0008316036,0.000110983055,0.00040742618,0.000027526996,0.00007336701,0.0006427711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958832,0.0008499392,0.0011105353,0.0005606734,0.0010065443,0.00058908673],"domain_scores_gemma":[0.9972907,0.00040348247,0.00096226885,0.00047320465,0.0005940057,0.00027637728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007928484,0.00038232215,0.0013167089,0.00028457286,0.00037181613,0.00008463518,0.00037981576,0.000082785315,0.00012134029],"category_scores_gemma":[0.0008307354,0.00029685962,0.00019659147,0.0010196762,0.0002208438,0.00040588863,0.0002750156,0.00082995003,0.00002123408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008047604,0.0069525787,0.9021914,0.0001889914,0.00014483406,0.06868185,0.0021054104,0.0000018524773,0.000016624892,0.000008803067,0.018844062,0.00078314386],"study_design_scores_gemma":[0.011184326,0.002671718,0.9438116,0.0020254666,0.00036162502,0.01308276,0.002398943,0.0000016427135,0.00025465203,0.000006281215,0.024120588,0.00008039992],"about_ca_topic_score_codex":0.0003162796,"about_ca_topic_score_gemma":0.00060149847,"teacher_disagreement_score":0.05559909,"about_ca_system_score_codex":0.0007243969,"about_ca_system_score_gemma":0.00037751495,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W4306761162","doi":"10.1016/j.critrevonc.2022.103860","title":"A systematic review of contemporary phase I trials in patients with lymphoma","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Adverse effect; Clinical trial; Internal medicine; Oncology","score_opus":0.153472054092088,"score_gpt":0.47553061678527725,"score_spread":0.3220585626931892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306761162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010005863,0.9774598,0.000003128102,0.0003527467,0.0003051828,0.01963659,0.00011767477,0.000023224706,0.0020916592],"genre_scores_gemma":[0.00006383739,0.9826511,0.0003114255,0.0015919124,0.00003015904,0.014688173,0.0005653776,0.00007573925,0.000022233002],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9765432,0.011462313,0.009817248,0.0010011389,0.00053011504,0.0006459754],"domain_scores_gemma":[0.9757665,0.019169692,0.0031194384,0.0014310178,0.00018291698,0.00033043814],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009094412,0.00093527895,0.036931336,0.0007170892,0.000042965843,0.000008005822,0.00046116472,0.00068237423,0.00085881294],"category_scores_gemma":[0.051530804,0.0005532131,0.0018562992,0.0011254128,0.0004077138,0.000072779105,0.00022413621,0.0005598662,0.00011214678],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014502207,0.008219857,0.00020131055,0.7902773,0.00035093128,0.0014854966,0.000020087571,8.5392643e-10,2.4797748e-9,0.0030468476,0.0018820255,0.19437113],"study_design_scores_gemma":[0.0060531893,0.0020123401,0.0000063854,0.5593463,0.0048238575,0.0005165972,0.000010336342,1.7120284e-7,1.3288052e-7,0.0000262478,0.42696747,0.00023694264],"about_ca_topic_score_codex":0.0000137789875,"about_ca_topic_score_gemma":0.000005680185,"teacher_disagreement_score":0.42508543,"about_ca_system_score_codex":0.0018422436,"about_ca_system_score_gemma":0.0026458267,"threshold_uncertainty_score":0.99969196},"labels":[],"label_agreement":null},{"id":"W4306911627","doi":"10.1158/2159-8290.cd-22-0561","title":"An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas","year":2022,"lang":"en","type":"editorial","venue":"Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; BC Cancer Foundation; National Institute of Allergy and Infectious Diseases; Gilead Sciences; Knut och Alice Wallenbergs Stiftelse; National Cancer Institute; Center for Innovative Medicine; National Institutes of Health; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; Radiumhemmets Forskningsfonder; Canadian Institutes of Health Research; Cancerfonden; Pershing Square Sohn Cancer Research Alliance; Leukemia and Lymphoma Society; National Institute of Mental Health; Vetenskapsrådet; WorldQuant Foundation; American Society of Hematology; Memorial Sloan-Kettering Cancer Center; Vallee Foundation; Michael Smith Health Research BC; AstraZeneca; Else Kröner-Fresenius-Stiftung","keywords":"Transformation (genetics); Cancer research; Computational biology; Immunology; Medicine; Biology; Genetics; Gene","score_opus":0.010681958515993618,"score_gpt":0.2841240747523021,"score_spread":0.2734421162363085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306911627","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4023988,0.024715884,0.000012341453,0.00039715905,0.5623413,0.0037319784,0.0019700087,0.00015952006,0.0042730286],"genre_scores_gemma":[0.675948,0.011807572,0.00006648701,0.00011228115,0.29725084,0.0069980416,0.0048145326,0.00016153502,0.002840677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743176,0.00011766618,0.0006204076,0.00042481572,0.0010708782,0.00033446527],"domain_scores_gemma":[0.99844956,0.00025324273,0.00037727677,0.000710878,0.00012581586,0.000083240964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024096743,0.00041348246,0.0008495844,0.00011082437,0.00018669486,0.00012145052,0.00031876971,0.00032266814,0.00031362844],"category_scores_gemma":[0.000026949643,0.00026258756,0.00050970016,0.00023928727,0.00014629554,0.00039188832,0.00004016702,0.0003556311,0.000005506402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005137947,0.008831855,0.0070649707,0.002638268,0.0016843381,0.00013445938,0.006478721,0.00013665773,0.0009549772,0.00026830324,0.87330467,0.09336482],"study_design_scores_gemma":[0.016241597,0.0025245657,0.028171942,0.00051575387,0.0023076446,0.0000075237303,0.0004600382,0.000024964076,0.0021195218,0.00004234481,0.94713676,0.0004473222],"about_ca_topic_score_codex":0.0026918242,"about_ca_topic_score_gemma":0.00011366401,"teacher_disagreement_score":0.27354926,"about_ca_system_score_codex":0.00068015826,"about_ca_system_score_gemma":0.0014487823,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W4307114719","doi":"10.1038/s41375-022-01711-0","title":"Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"Cilag; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research Council; Celgene; Janssen Pharmaceuticals; Gilead Sciences; Servier; Amgen; Pfizer; GlaxoSmithKline; World Health Organization; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Genome-wide association study; Biology; Heritability; Genetics; Genetic association; Genetic architecture; Germline; Missing heritability problem; Locus (genetics); Quantitative trait locus; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.015973320079582,"score_gpt":0.2779399029163564,"score_spread":0.2619665828367744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307114719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960847,0.0005639624,0.00007262684,0.0004339229,0.0003586128,0.001385542,0.00020841444,0.000098402066,0.0007938295],"genre_scores_gemma":[0.99473226,0.000014943264,0.0010162238,0.00038097656,0.0002279487,0.0012245227,0.0005472072,0.00004151507,0.001814403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.00006643967,0.00039825996,0.0005027848,0.00034025346,0.0003628962],"domain_scores_gemma":[0.9988558,0.00019497998,0.0001321436,0.0005996614,0.00007073708,0.00014664541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000240011,0.00022700174,0.0004331926,0.00007463062,0.000343881,0.000032611628,0.00016270246,0.00006343286,0.00049973326],"category_scores_gemma":[0.00006202726,0.00019607591,0.00023751959,0.00018120093,0.00007180991,0.000037671725,0.0001609487,0.00007887759,0.00004750042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012627589,0.0016049703,0.88002455,0.00037655313,0.0002781791,0.0003269799,0.00042487396,0.00005379474,0.0037819548,0.00026143604,0.023910576,0.08769335],"study_design_scores_gemma":[0.0064313705,0.00086575455,0.9677108,0.00003120916,0.00026994024,0.00009619749,0.000122029785,0.0016108239,0.009985226,0.0004261962,0.012231583,0.00021886858],"about_ca_topic_score_codex":0.00074278103,"about_ca_topic_score_gemma":0.00022866919,"teacher_disagreement_score":0.087686226,"about_ca_system_score_codex":0.0018084539,"about_ca_system_score_gemma":0.00043664424,"threshold_uncertainty_score":0.7995744},"labels":[],"label_agreement":null},{"id":"W4307294294","doi":"10.1016/j.ijrobp.2022.07.435","title":"Impact of Myc-Altered Pathology on Radiotherapy Efficacy among Patients with Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Retrospective Study","year":2022,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; BCL6; Univariate analysis; Retrospective cohort study; Refractory (planetary science); Cohort; Gastroenterology; Oncology; Chemotherapy; Lymphoma; Palliative care; B cell; Multivariate analysis; Immunology","score_opus":0.009291714192632658,"score_gpt":0.3105688070213747,"score_spread":0.30127709282874204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307294294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966345,0.000276366,0.00018130644,0.00020684669,0.0011116241,0.00086613104,0.00043175972,0.000020739017,0.0002707552],"genre_scores_gemma":[0.9983617,0.00016146096,0.00035901202,0.00025908416,0.0005386838,0.00006475948,0.00019045059,0.000040345727,0.000024469484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737805,0.0006663746,0.000764569,0.00035165827,0.00057609327,0.00026323216],"domain_scores_gemma":[0.99601865,0.0004028017,0.0019732283,0.0002429353,0.0012249121,0.00013746123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044399645,0.00029359225,0.00083734666,0.000314424,0.00014531732,0.0000147731425,0.0002986725,0.00013210542,0.00015771757],"category_scores_gemma":[0.00013912741,0.0002175095,0.00031589126,0.0003604667,0.0001629242,0.0001708105,0.00006964106,0.00037336047,0.000004709119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064411326,0.035417166,0.93955815,0.0000026195096,0.0023069645,0.00019457476,0.0029726462,0.00070734764,0.0002223861,0.0002777052,0.000748547,0.011150781],"study_design_scores_gemma":[0.06993489,0.04642985,0.88149375,0.000020807394,0.00022531024,0.000045846085,0.0003710611,0.00008239059,0.00020747806,0.00013756742,0.0008984658,0.00015259144],"about_ca_topic_score_codex":0.000035654793,"about_ca_topic_score_gemma":0.000004659634,"teacher_disagreement_score":0.06349376,"about_ca_system_score_codex":0.004620199,"about_ca_system_score_gemma":0.0010927871,"threshold_uncertainty_score":0.9992009},"labels":[],"label_agreement":null},{"id":"W4307440076","doi":"10.1182/blood.2022018248","title":"Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; Kelowna General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Population; Germinal center; Oncology; Internal medicine; Fluorescence in situ hybridization; Biology; Cancer research; Medicine; B cell; Immunology; Antibody; Gene; Genetics","score_opus":0.02772950040507347,"score_gpt":0.3427468016348526,"score_spread":0.3150173012297791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307440076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983889,0.000121085155,3.5115545e-7,0.000068971596,0.00009732658,0.0003270894,0.00003670616,0.000021241503,0.0009383623],"genre_scores_gemma":[0.99917436,0.000043439006,0.00015412863,0.00021117565,0.000018534356,0.00009503799,0.0000452419,0.000017430728,0.00024067273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861085,0.00010987988,0.00057509635,0.00023391366,0.00028080784,0.00018942545],"domain_scores_gemma":[0.9993142,0.000106331485,0.00017060946,0.00031333332,0.000017480319,0.000078077246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024994568,0.00011277177,0.00050350546,0.00013733751,0.00003930273,0.0000038067953,0.000068877576,0.0000386964,0.000045405923],"category_scores_gemma":[0.00005865043,0.00009538561,0.00020123237,0.00018953395,0.000012613055,0.000023248498,0.000101731915,0.00005328563,0.0000060706257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007638186,0.03941488,0.9571873,0.000028783998,0.000055274475,0.00072346383,0.000059350637,0.0000010347117,0.000055701774,0.000107549145,0.000020682048,0.0022696306],"study_design_scores_gemma":[0.04283171,0.00039069695,0.95362,0.000023196439,0.00022217637,0.000014586958,0.00003483772,0.00007107844,0.0024718018,0.000034924033,0.00020524075,0.000079714],"about_ca_topic_score_codex":0.0012136857,"about_ca_topic_score_gemma":0.00046445185,"teacher_disagreement_score":0.04275533,"about_ca_system_score_codex":0.00007042632,"about_ca_system_score_gemma":0.00006883176,"threshold_uncertainty_score":0.3889712},"labels":[],"label_agreement":null},{"id":"W4307880957","doi":"10.14740/jh1054","title":"Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; International Prognostic Index; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Anthracycline; Surgery; Cyclophosphamide; Prednisone; Rituximab; Chemotherapy regimen; Regimen; CHOP; Progression-free survival; Chemotherapy; Lymphoma; Cancer","score_opus":0.005867450219788346,"score_gpt":0.25644675874754835,"score_spread":0.25057930852776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307880957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987682,0.00016588705,0.00012062341,0.0004816147,0.00003120616,0.00028383816,0.000009664597,0.000004597305,0.00013433435],"genre_scores_gemma":[0.9992012,0.00003329114,0.00038476527,0.00025038718,0.000015302714,0.000054643646,0.000028228023,0.000013089977,0.000019115838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998748,0.00012894117,0.00041031206,0.00020427935,0.00031316155,0.00019532333],"domain_scores_gemma":[0.999114,0.000041720923,0.00046055336,0.00018834257,0.00011852844,0.00007689113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023194042,0.00012303772,0.0006452486,0.00055224606,0.00004204302,0.0000063705825,0.00010386978,0.000043526237,0.000046632533],"category_scores_gemma":[0.000010976766,0.000091376125,0.0000991286,0.00063763023,0.000024538529,0.00009483638,0.00002494111,0.00013317472,0.0000014022139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010438166,0.019306866,0.9762475,0.0000068967847,0.00038023878,0.00039032113,0.0010762574,0.000031798354,0.000013474207,0.00035362827,0.000056312118,0.0010928873],"study_design_scores_gemma":[0.04921901,0.0030662103,0.9453437,0.000013492686,0.00026100312,0.00014873945,0.00050112803,0.00039712232,0.00045953988,0.00027918292,0.00022215929,0.00008872998],"about_ca_topic_score_codex":0.00018060618,"about_ca_topic_score_gemma":0.0003650081,"teacher_disagreement_score":0.048175193,"about_ca_system_score_codex":0.0007825384,"about_ca_system_score_gemma":0.00009526533,"threshold_uncertainty_score":0.37262103},"labels":[],"label_agreement":null},{"id":"W4308211464","doi":"10.1038/s41588-022-01213-w","title":"Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis","year":2022,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Human Genome Research Institute; Moonshot Research and Development Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIHR Maudsley Biomedical Research Centre; National Institutes of Health; Kementerian Kesihatan Malaysia; Versus Arthritis; Kanae Foundation for the Promotion of Medical Science; Instituto de Salud Carlos III; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Vetenskapsrådet; Foundation for the National Institutes of Health; Fonds National de la Recherche Luxembourg; Wellcome Trust; European League Against Rheumatism; King's College London; Tokyo Medical and Dental University; National Institute for Health and Care Research; Ministerio de Ciencia e Innovación; Japan Agency for Medical Research and Development; Qatar National Research Fund; Qatar Foundation; National Center for Advancing Translational Sciences; Department of Health and Social Care; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research","keywords":"Genome-wide association study; Biology; Genetic genealogy; Genetic association; Genetics; Genetic architecture; Rheumatoid arthritis; 1000 Genomes Project; Evolutionary biology; Computational biology; Single-nucleotide polymorphism; Gene; Genotype; Quantitative trait locus; Population; Medicine; Immunology","score_opus":0.06789304924686873,"score_gpt":0.37702505468534914,"score_spread":0.3091320054384804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308211464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019490046,0.9951831,0.00010299824,0.000055055494,0.00088676676,0.0013542166,0.00030621185,0.000054460703,0.000108196116],"genre_scores_gemma":[0.001703186,0.9838118,0.011934356,0.00039118202,0.0001592252,0.0005130993,0.0011318115,0.000113942624,0.00024142163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964725,0.000156984,0.0010549836,0.0008487159,0.0009283976,0.0005384407],"domain_scores_gemma":[0.9978096,0.00043913687,0.00077958533,0.00068647653,0.0001033704,0.00018181413],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003054712,0.00063864794,0.0021651357,0.00048150824,0.00011812445,0.00007587713,0.00031562016,0.0013448421,0.00043793645],"category_scores_gemma":[0.00045068536,0.0005731479,0.0007680232,0.0008335825,0.000021474712,0.000030634772,0.00019759343,0.0013085188,0.00007102028],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000101904325,0.001732875,0.0208944,0.004218141,0.0019131704,0.00076950534,0.00011383592,0.000055961882,0.000015098588,0.000006556845,0.0007594173,0.96951085],"study_design_scores_gemma":[0.0024660658,0.00015051995,0.06712763,0.0037659379,0.0013425694,0.00015835176,0.000034366778,0.000024177725,0.00003290169,0.000034451932,0.9243121,0.00055089133],"about_ca_topic_score_codex":0.000047972157,"about_ca_topic_score_gemma":0.00014180463,"teacher_disagreement_score":0.9689599,"about_ca_system_score_codex":0.002259326,"about_ca_system_score_gemma":0.0006972399,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W4308365535","doi":"10.1080/10428194.2022.2136968","title":"Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy","year":2022,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine; Leukemia and Lymphoma Society of Canada","keywords":"Diffuse large B-cell lymphoma; CHOP; Gene; Lymphoma; Biology; Cancer research; Transcription factor; Oncology; Internal medicine; Bioinformatics; Genetics; Medicine; Immunology","score_opus":0.018983383939383654,"score_gpt":0.27462303849781894,"score_spread":0.2556396545584353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308365535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717619,0.02489293,0.00011119173,0.00012356302,0.00065531075,0.0014581583,0.00070179673,0.00011270614,0.00018246555],"genre_scores_gemma":[0.9903823,0.005094404,0.001724292,0.000620399,0.00019070214,0.00046515433,0.0006937106,0.00016157085,0.0006674585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930751,0.00061061914,0.0028017017,0.001300896,0.0013026333,0.000909063],"domain_scores_gemma":[0.99566424,0.0008075347,0.0017402836,0.0010212202,0.00024844578,0.00051829545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00112585,0.00097137387,0.002739509,0.00046899854,0.00046988646,0.00005214959,0.00043361224,0.0004687948,0.00014135826],"category_scores_gemma":[0.00011178127,0.00082817185,0.0009249466,0.00062524097,0.00039713073,0.00040684186,0.0005570438,0.0001193734,0.000004253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006441415,0.008647768,0.5316555,0.0008255956,0.00076936034,0.00011812023,0.0008666618,0.000014508982,0.3859475,0.00018083083,0.0011235367,0.06340924],"study_design_scores_gemma":[0.16427858,0.0028228683,0.41712674,0.00032559552,0.0007394942,0.00028229045,0.0008799909,0.0017040909,0.38252544,0.0001888054,0.028092608,0.0010334824],"about_ca_topic_score_codex":0.0007665242,"about_ca_topic_score_gemma":0.0000073438837,"teacher_disagreement_score":0.15783717,"about_ca_system_score_codex":0.001771585,"about_ca_system_score_gemma":0.0016334296,"threshold_uncertainty_score":0.9994169},"labels":[],"label_agreement":null},{"id":"W4308736832","doi":"10.1038/s41467-022-34408-0","title":"Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Terry Fox Research Institute; National Cancer Institute; BC Cancer Foundation; Government of Canada; Genome British Columbia; Canadian Institutes of Health Research; Cancer Research Society; Genome Canada","keywords":"Phenotype; Germinal center; Mass cytometry; Follicular lymphoma; Biology; Flow cytometry; Lymphoma; Cell of origin; Pathology; Cancer research; B cell; Gene expression profiling; Cell; Immunology; Medicine; Genetics; Gene; Gene expression; Antibody","score_opus":0.014198996278995327,"score_gpt":0.2494442235580457,"score_spread":0.2352452272790504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308736832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749619,0.01099187,0.00003134088,0.000989237,0.000049569757,0.0010603284,0.00015168698,0.00006944534,0.011694649],"genre_scores_gemma":[0.99038047,0.00044753,0.00755321,0.00035716148,0.000013082472,0.00034976596,0.0007852507,0.000025154182,0.000088388246],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870604,0.00027204008,0.00032047374,0.00017429677,0.00037027692,0.00015687602],"domain_scores_gemma":[0.9977906,0.00024526613,0.00027883364,0.0014160788,0.00018385402,0.0000854064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030974692,0.0001509029,0.0002788384,0.00014401338,0.000423759,0.000013412738,0.00035383267,0.000113925984,0.00003920284],"category_scores_gemma":[0.000035900346,0.0001241499,0.00012787417,0.0004917679,0.00006222326,0.00007760227,0.00011380075,0.00035397505,0.0000053853414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035457024,0.055895712,0.6863312,0.0014219176,0.0020694542,0.00014585363,0.016041439,0.00072283566,0.17668253,0.013167093,0.010126773,0.03384949],"study_design_scores_gemma":[0.052348517,0.0065085776,0.2967519,0.0005574769,0.006305113,0.0005227771,0.010609791,0.004494929,0.4980568,0.00043057068,0.121910624,0.0015029429],"about_ca_topic_score_codex":0.00022130719,"about_ca_topic_score_gemma":0.00005950755,"teacher_disagreement_score":0.38957933,"about_ca_system_score_codex":0.00030993373,"about_ca_system_score_gemma":0.00023559008,"threshold_uncertainty_score":0.5062686},"labels":[],"label_agreement":null},{"id":"W4309287965","doi":"10.1080/10428194.2022.2136956","title":"Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study","year":2022,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Cohort; Internal medicine; Lenalidomide; Oncology; Lymphoma; Refractory (planetary science); Clinical endpoint; Adverse effect; Multiple myeloma; Cancer; Clinical trial; Immunotherapy","score_opus":0.008453224238700503,"score_gpt":0.2541884000132351,"score_spread":0.2457351757745346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309287965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868465,0.0008991163,0.000096529526,0.00020705389,0.00071654393,0.00624734,0.00058298133,0.00041398275,0.002151809],"genre_scores_gemma":[0.98851156,0.00012529545,0.0008296372,0.0016931887,0.0004281008,0.0052137687,0.0011035777,0.00034061607,0.0017542371],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99221927,0.00027200842,0.0014186045,0.0023490114,0.0018960712,0.0018450483],"domain_scores_gemma":[0.9954736,0.0005547212,0.0006845805,0.0017417818,0.00045887905,0.0010864028],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005520104,0.0015223792,0.002022562,0.00068355247,0.0019502204,0.00026708364,0.00067080924,0.00034815184,0.0002489588],"category_scores_gemma":[0.00011187809,0.0012886879,0.0005999869,0.0011236981,0.0003493114,0.00046250963,0.00065819436,0.00016826176,0.00006714742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039040405,0.060486723,0.27972218,0.0006019686,0.003431686,0.0026650294,0.005527374,0.00016152274,0.00023781699,0.000638051,0.020317659,0.5871696],"study_design_scores_gemma":[0.42460704,0.025184799,0.48443255,0.00017967992,0.0022699973,0.0010346142,0.0026026266,0.0034148446,0.000807045,0.00013462754,0.053541537,0.0017906536],"about_ca_topic_score_codex":0.0019083332,"about_ca_topic_score_gemma":0.00007689207,"teacher_disagreement_score":0.58537894,"about_ca_system_score_codex":0.017193504,"about_ca_system_score_gemma":0.005176039,"threshold_uncertainty_score":0.9997525},"labels":[],"label_agreement":null},{"id":"W4309326277","doi":"10.1101/2022.11.17.516951","title":"Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of Victoria; University of British Columbia; Spinal Cord Injury BC","funders":"Terry Fox Research Institute; Genome British Columbia; BC Cancer Foundation; Paul G. Allen Frontiers Group; Canadian Institutes of Health Research; Genome Canada","keywords":"Follicular lymphoma; Biology; Tumor microenvironment; Phenotype; Lymphoma; Transformation (genetics); Malignant transformation; CD8; Transcriptome; Somatic evolution in cancer; Cancer research; Cell; Mantle cell lymphoma; Computational biology; Gene; Immunology; Genetics; Tumor cells; Immune system; Gene expression","score_opus":0.008296112741222546,"score_gpt":0.20074940355340432,"score_spread":0.19245329081218177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309326277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912248,0.005683321,0.00018226677,0.00024188404,0.00014721722,0.0019002042,0.0005494531,0.00005007112,0.000020786052],"genre_scores_gemma":[0.9968596,0.0013264747,0.00092598406,0.00013851344,0.00003452684,0.00063579314,0.0000047230374,0.000064936175,0.000009408959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968751,0.00034947201,0.0009153246,0.00088834326,0.0005233931,0.00044835082],"domain_scores_gemma":[0.9979821,0.00013102232,0.0005420804,0.0010502387,0.000102300575,0.00019229573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084487454,0.00054065726,0.0013776695,0.00057089387,0.0001150208,0.000051862324,0.0002547564,0.0002196441,0.00013442435],"category_scores_gemma":[0.0000369185,0.00040371987,0.0004929386,0.0009577315,0.00026960307,0.0000484207,0.000190695,0.0002686296,0.000006657126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006229593,0.0026251285,0.12439717,0.00072597596,0.0018380872,0.00037452436,0.00009100844,0.00026851922,0.8688048,0.00014782019,0.00009666374,0.000007337462],"study_design_scores_gemma":[0.0068225395,0.00019427991,0.43861672,0.0003322555,0.0032804434,9.897092e-8,0.00005539856,0.00038230457,0.5487422,0.0000015261085,0.0011955771,0.0003766839],"about_ca_topic_score_codex":0.0008492802,"about_ca_topic_score_gemma":0.000013140135,"teacher_disagreement_score":0.32006264,"about_ca_system_score_codex":0.0020531756,"about_ca_system_score_gemma":0.00045298575,"threshold_uncertainty_score":0.99984145},"labels":[],"label_agreement":null},{"id":"W4309655877","doi":"10.1093/bfgp/elac038","title":"Deep learning-based classifier of diffuse large B-cell lymphoma cell-of-origin with clinical outcome","year":2022,"lang":"en","type":"article","venue":"Briefings in Functional Genomics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Ministry of Education, India; Council of Scientific and Industrial Research, India","keywords":"Diffuse large B-cell lymphoma; Classifier (UML); Artificial intelligence; Machine learning; CHOP; Multilayer perceptron; Lymphoma; Oncology; Perceptron; Overall survival; Internal medicine; Computer science; Medicine; Artificial neural network","score_opus":0.03483489723150836,"score_gpt":0.2775315387444447,"score_spread":0.24269664151293635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309655877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682254,0.0003450437,0.0005608459,0.0004067437,0.0002192003,0.00027624183,0.000033498978,0.000022747066,0.0013131488],"genre_scores_gemma":[0.99608165,0.000042654065,0.0011645546,0.0014677526,0.000066169836,0.0000750227,0.00014560996,0.00003726844,0.0009193437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981501,0.0000934402,0.00071209914,0.00036239086,0.00042451563,0.00025744172],"domain_scores_gemma":[0.9987979,0.00037596415,0.00037067974,0.00025959456,0.0000893977,0.00010647292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042957105,0.00018546233,0.00050595036,0.00015329025,0.00010956424,0.0000070766923,0.000094248986,0.00008516785,0.00028271176],"category_scores_gemma":[0.00005483634,0.00016403366,0.00022267828,0.00023557077,0.000096497504,0.000027179996,0.000090644,0.0002150808,0.000013176286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019500031,0.014049661,0.97543246,0.00009573075,0.0000893335,0.00008913093,0.00011064505,0.0054300767,0.00019776306,0.00040458416,0.0006785433,0.0014720454],"study_design_scores_gemma":[0.050264057,0.0018790893,0.82009244,0.000026953265,0.00024534142,0.00004352874,0.00026627627,0.005959757,0.0010584068,0.00003708666,0.119879305,0.0002477533],"about_ca_topic_score_codex":0.00016439597,"about_ca_topic_score_gemma":0.00002128589,"teacher_disagreement_score":0.15534003,"about_ca_system_score_codex":0.0004509988,"about_ca_system_score_gemma":0.00048990943,"threshold_uncertainty_score":0.6689098},"labels":[],"label_agreement":null},{"id":"W4309698627","doi":"10.21203/rs.3.rs-2280012/v1","title":"The effects of PD-1/PD-L1 expression on the prognosis of lymphoma: A protocol for systematic review and meta-analysis","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"China Academy of Chinese Medical Sciences; State Administration of Traditional Chinese Medicine of the People's Republic of China; National Natural Science Foundation of China","keywords":"Protocol (science); Meta-analysis; Expression (computer science); Lymphoma; Internal medicine; Computer science; Computational biology; Oncology; Medicine; Cancer research; Biology; Pathology; Programming language; Alternative medicine","score_opus":0.1372609310836284,"score_gpt":0.46619646679996407,"score_spread":0.32893553571633566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309698627","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027990758,0.050610367,0.0000074980253,0.0058269184,0.00001903992,0.94007194,0.0002914664,0.000026313737,0.00034738955],"genre_scores_gemma":[0.10846147,0.0014441655,0.00006490009,0.00008822985,0.0000156913,0.8893805,0.000040057123,0.000031928186,0.00047305773],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936836,0.0024866608,0.0009313022,0.0005998752,0.001917247,0.00038130913],"domain_scores_gemma":[0.98721766,0.00934979,0.00069896807,0.0018309209,0.00077450916,0.00012813306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004831386,0.00034608008,0.0029394804,0.0002948314,0.00038183213,0.00005743501,0.00048887375,0.00012964182,0.00017134994],"category_scores_gemma":[0.0040160073,0.00013386038,0.002027721,0.00072808296,0.00019676461,0.000019964655,0.0008827021,0.00029684338,0.0000022780844],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032563988,0.0016007074,0.00048996235,0.9268088,0.0665368,0.00001770604,0.00022651302,0.0000031472318,0.000029576244,0.0004907342,0.0033646917,0.00010577333],"study_design_scores_gemma":[0.005500376,0.0065247687,0.0055096145,0.18641213,0.7698503,0.000011213904,0.0008008948,0.00016557277,0.022241946,0.0007223249,0.0018116944,0.00044917423],"about_ca_topic_score_codex":0.000120160985,"about_ca_topic_score_gemma":0.000008620386,"teacher_disagreement_score":0.7403966,"about_ca_system_score_codex":0.00029243837,"about_ca_system_score_gemma":0.00037599148,"threshold_uncertainty_score":0.5458668},"labels":[],"label_agreement":null},{"id":"W4309827664","doi":"10.2217/cer-2022-0146","title":"Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Refractory (planetary science); Clinical trial; Internal medicine; Lymphoma; Oncology; Diffuse large B-cell lymphoma","score_opus":0.1483897253639382,"score_gpt":0.4705964074388625,"score_spread":0.3222066820749243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309827664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045879573,0.94838095,0.0000016921445,0.000014535885,0.00012106722,0.0054077553,0.00005560576,0.000004245611,0.00013459656],"genre_scores_gemma":[0.032183155,0.966737,0.000023591327,0.000025962092,0.000020186038,0.0009241397,0.000016348133,0.000039646613,0.000030021767],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9844272,0.010640598,0.0023071598,0.00040601162,0.0017850415,0.00043400162],"domain_scores_gemma":[0.98519796,0.01144401,0.001865899,0.00057690137,0.00065271166,0.00026251562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005658727,0.00050896377,0.008540761,0.0010648927,0.0001203356,0.000026448673,0.0003166249,0.00016726872,0.000074147145],"category_scores_gemma":[0.0014588152,0.00027545373,0.0010089772,0.0009879409,0.00014332417,0.00009109769,0.0003076506,0.0008044659,0.000008781545],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065457926,0.0138460575,0.00083147053,0.9644575,0.0015902141,0.0011935958,0.0002735728,1.86381e-7,0.0000014561319,0.000019936771,0.00009890384,0.01703249],"study_design_scores_gemma":[0.012612276,0.0059521887,0.0030651249,0.928801,0.0023790828,0.0006430223,0.00022850087,0.0000030896358,0.00006739049,0.00000677736,0.045982677,0.00025889522],"about_ca_topic_score_codex":0.000020523714,"about_ca_topic_score_gemma":0.000007979699,"teacher_disagreement_score":0.045883775,"about_ca_system_score_codex":0.0021538713,"about_ca_system_score_gemma":0.0015623479,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W4310090075","doi":"10.1182/blood-2022-165440","title":"Treatment Patterns and Outcomes in Adolescent and Young Adults with Nodular Lymphocyte Predominant Hodgkin Lymphoma: An Impact Cohort Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Cohort; Young adult; Hodgkin lymphoma; Lymphocyte; Population; Cohort study; Immunology; Internal medicine; Oncology; Gerontology; Environmental health","score_opus":0.011001187158341735,"score_gpt":0.26756732155693325,"score_spread":0.2565661343985915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310090075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969535,0.0004055217,0.0000013343422,0.00007550465,0.000037132704,0.002351215,0.00012826554,0.000039112707,0.000008429019],"genre_scores_gemma":[0.9987183,0.000057844707,0.0000729012,0.00006832669,0.000021237272,0.00081225025,0.00019507052,0.00003515531,0.000018898421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838364,0.0001254313,0.00028753967,0.000552039,0.00036594676,0.0002854153],"domain_scores_gemma":[0.9992425,0.000039915933,0.00009961889,0.00039087134,0.000025975814,0.00020114741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112756104,0.00031837702,0.0005613221,0.00016178412,0.00016051841,0.000036668258,0.00004830217,0.000034457298,0.00003292689],"category_scores_gemma":[0.000008053349,0.00020867547,0.000065148946,0.00012217903,0.00001718043,0.000061835686,0.000048516475,0.000037316328,7.9253385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011207677,0.0239648,0.96624345,0.000033995864,0.00044579033,0.0013106479,0.0009913935,0.000041309704,0.000007783795,0.0000013370383,9.99501e-7,0.005837729],"study_design_scores_gemma":[0.07041763,0.008711673,0.9180143,0.00007214805,0.00082881923,0.00025387167,0.0009269389,0.00039894116,0.00016723413,7.787521e-7,0.000005568963,0.0002021189],"about_ca_topic_score_codex":0.018717257,"about_ca_topic_score_gemma":0.0029663076,"teacher_disagreement_score":0.06929686,"about_ca_system_score_codex":0.0008654418,"about_ca_system_score_gemma":0.00017287127,"threshold_uncertainty_score":0.98781717},"labels":[],"label_agreement":null},{"id":"W4310092952","doi":"10.1182/blood-2022-157256","title":"Analysis of Immune Pharmacodynamic and Baseline Biomarkers in Patients with Relapsed or Refractory Follicular Lymphoma Treated with Mosunetuzumab in Combination with Lenalidomide","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Follicular lymphoma; Internal medicine; Lymphoma; Gastroenterology; Pharmacodynamics; CD20; Rituximab; Oncology; Immunology; Pharmacokinetics; Multiple myeloma","score_opus":0.005207669908985609,"score_gpt":0.21806182011278613,"score_spread":0.21285415020380052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310092952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862653,0.0003973636,0.000004539126,0.00006806675,0.000006574544,0.0007666389,0.000061630926,0.000019241359,0.000049439495],"genre_scores_gemma":[0.99869394,0.00005887207,0.00020282113,0.000041928182,0.0000020630284,0.00020186203,0.00073930493,0.000026573507,0.00003260336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984938,0.00015473283,0.00038270053,0.00035114423,0.00042291515,0.00019471323],"domain_scores_gemma":[0.9992562,0.000098330034,0.00023192294,0.00026047468,0.00008402529,0.0000690567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022087958,0.0002092773,0.0005932387,0.0007214716,0.00005393988,0.000007504056,0.00005509496,0.000035905472,0.00006631202],"category_scores_gemma":[0.000015666532,0.00013010348,0.000055231412,0.001895874,0.000060108527,0.0000779756,0.000030283696,0.00006304762,2.537055e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014288136,0.011438432,0.96551853,0.00004171325,0.004731571,0.00053453824,0.00019292887,0.00035746142,0.00029044342,0.0000032828627,0.0000030332023,0.0025999288],"study_design_scores_gemma":[0.11679718,0.0046163737,0.86986196,0.00012321312,0.0046151225,0.000020077941,0.00018755015,0.0023133832,0.0012947473,4.764799e-7,0.000016350356,0.00015357225],"about_ca_topic_score_codex":0.0016946528,"about_ca_topic_score_gemma":0.00057261885,"teacher_disagreement_score":0.102509044,"about_ca_system_score_codex":0.00034926724,"about_ca_system_score_gemma":0.0001544824,"threshold_uncertainty_score":0.5305466},"labels":[],"label_agreement":null},{"id":"W4310093222","doi":"10.1182/blood-2022-157679","title":"Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Lymphoma; Chemotherapy; Materials science","score_opus":0.021954608644807205,"score_gpt":0.2717345479628102,"score_spread":0.24977993931800302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310093222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087423,0.0048787156,7.5507774e-7,0.000131365,0.00011188899,0.0035942362,0.00016570224,0.000053044103,0.00019005101],"genre_scores_gemma":[0.9989193,0.00012681501,0.00011238215,0.000084675834,0.000051123876,0.00037180292,0.00008277402,0.000047098823,0.00020404122],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965283,0.0005975611,0.0010021621,0.0008172567,0.00063915754,0.00041553297],"domain_scores_gemma":[0.998119,0.00060881936,0.00039243896,0.000580352,0.00008859714,0.00021076968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011273581,0.00040061187,0.0015143774,0.0003804773,0.00032847348,0.000024669962,0.000111191825,0.000077487595,0.000026789536],"category_scores_gemma":[0.00042641786,0.00033014888,0.00014361138,0.00035001276,0.000101859936,0.000069130634,0.00049620686,0.0002148664,0.0000018784704],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14596207,0.82184,0.011979582,0.00007991358,0.0004416288,0.0027411547,0.011690248,0.0000011452877,0.0013435583,0.000008862989,0.00009297149,0.0038188573],"study_design_scores_gemma":[0.9377586,0.024920229,0.027259413,0.0000988967,0.0018953452,0.00018280806,0.0063059493,0.0003799569,0.00069086935,0.000012324896,0.00023004104,0.00026555208],"about_ca_topic_score_codex":0.00072584784,"about_ca_topic_score_gemma":0.00016515798,"teacher_disagreement_score":0.79691976,"about_ca_system_score_codex":0.0002481987,"about_ca_system_score_gemma":0.00021589526,"threshold_uncertainty_score":0.99991506},"labels":[],"label_agreement":null},{"id":"W4310096378","doi":"10.1182/blood-2022-157194","title":"FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Follicular lymphoma; Bendamustine; Oncology; Internal medicine; Proportional hazards model; Cohort; Rituximab; Lymphoma","score_opus":0.01932055398222882,"score_gpt":0.2626529377360294,"score_spread":0.24333238375380056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779946,0.000059542737,0.000012603782,0.0004034259,0.00016259645,0.00055511534,0.000025472851,0.000044499204,0.00093731505],"genre_scores_gemma":[0.99758846,0.000009836287,0.0007484225,0.00041599968,0.000057125726,0.00065954356,0.00013446511,0.000023465362,0.00036268754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988639,0.000040910174,0.00020721919,0.00031062934,0.00037333343,0.00020400867],"domain_scores_gemma":[0.9995606,0.00002810391,0.000052883162,0.00022016447,0.000037929047,0.00010030145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011349401,0.00013777746,0.00018282914,0.00013102654,0.00007492456,0.000010455809,0.00013164945,0.000035367102,0.00006317483],"category_scores_gemma":[0.00004381022,0.00012294375,0.0000679823,0.00014237556,0.000008492535,0.00006252449,0.000090237496,0.00006144411,0.000021122916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038198888,0.017232655,0.9710703,0.0000142127055,0.0003531902,0.00048293418,0.00066848675,0.00032598432,0.0011972735,0.00059372233,0.000047966165,0.0076313037],"study_design_scores_gemma":[0.022520285,0.0012590152,0.96235245,0.00004851569,0.00017257727,0.00007407631,0.00007143089,0.010579823,0.0020709096,0.00021258647,0.00044542016,0.00019292525],"about_ca_topic_score_codex":0.0001331263,"about_ca_topic_score_gemma":0.000027962999,"teacher_disagreement_score":0.022138296,"about_ca_system_score_codex":0.0002659772,"about_ca_system_score_gemma":0.00021371494,"threshold_uncertainty_score":0.50135005},"labels":[],"label_agreement":null},{"id":"W4310106202","doi":"10.1182/blood-2022-159620","title":"Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Oncology; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Cancer; Disease; Biology; Medicine; Bioinformatics","score_opus":0.014591015969556604,"score_gpt":0.25844537089205044,"score_spread":0.24385435492249383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926085,0.0055926912,0.000003237737,0.00063554203,0.00017998017,0.00061915384,0.00020519365,0.00005133947,0.00010438128],"genre_scores_gemma":[0.9976856,0.0009509914,0.0004582208,0.00030317635,0.00011972279,0.00022556407,0.00009262515,0.000025629442,0.00013846158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984974,0.00023257533,0.00032838422,0.00042206713,0.00027429883,0.0002452183],"domain_scores_gemma":[0.99916226,0.00023288134,0.00014196392,0.00027851664,0.000039169354,0.00014523185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030649148,0.00020495337,0.00052178535,0.00013511801,0.00013015901,0.000040759496,0.000101026635,0.00012081421,0.00006259344],"category_scores_gemma":[0.00014143184,0.0001536164,0.00013158505,0.00021550315,0.00007891898,0.00007805031,0.00017507748,0.00046462248,0.0000085516385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017816786,0.002693873,0.9900021,0.000015204892,0.00074313674,0.00049843075,0.0019007055,0.000001947364,0.0002668106,0.00034159116,0.00096325437,0.002394787],"study_design_scores_gemma":[0.014837364,0.0007562936,0.9758032,0.000039530958,0.0010272397,0.00008469324,0.0010111342,0.000023229579,0.0026013704,0.0004112231,0.0032618064,0.00014290086],"about_ca_topic_score_codex":0.00054072286,"about_ca_topic_score_gemma":0.00050445565,"teacher_disagreement_score":0.014659196,"about_ca_system_score_codex":0.00006093904,"about_ca_system_score_gemma":0.00012578574,"threshold_uncertainty_score":0.6264295},"labels":[],"label_agreement":null},{"id":"W4310106214","doi":"10.1182/blood-2022-164610","title":"Identification of Genetic Subtypes in Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Kingston General Hospital; Jewish General Hospital; Spinal Cord Injury BC; Queen's University; University Health Network","funders":"","keywords":"Follicular lymphoma; Identification (biology); Lymphoma; Biology; Medicine; Computational biology; Genetics; Pathology; Immunology","score_opus":0.008740443350802804,"score_gpt":0.23381972092916037,"score_spread":0.22507927757835755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763745,0.001685143,0.0000024646931,0.00014249227,0.0000396733,0.00018914994,0.000007929338,0.00000999571,0.0002856788],"genre_scores_gemma":[0.9995306,0.000052650175,0.00009296438,0.00004925928,0.00001452097,0.00012395174,0.000014499094,0.0000064136552,0.000115129005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943906,0.000024751627,0.00018450737,0.00011674105,0.00015984708,0.00007511035],"domain_scores_gemma":[0.9997142,0.000015248186,0.00005490596,0.00017605706,0.000015786032,0.000023789531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070297,0.000045725992,0.00011485435,0.00007107852,0.000026635487,0.0000027788126,0.000039313007,0.000013741249,0.000080814134],"category_scores_gemma":[0.000013330179,0.000042285,0.000047940543,0.00015552527,0.000010422985,0.000010610249,0.000028166973,0.000014058377,0.000010272955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031058273,0.0040628705,0.9764713,0.000030639774,0.00008577512,0.00019511185,0.00020806241,0.00002947548,0.013417183,0.00025246316,0.00008658136,0.0051294756],"study_design_scores_gemma":[0.004363051,0.00016672819,0.93139285,0.000008718033,0.00013844244,0.00006646247,0.00007135983,0.000038851715,0.06301053,0.000081319005,0.00062482845,0.00003688765],"about_ca_topic_score_codex":0.00009779445,"about_ca_topic_score_gemma":0.0000070237215,"teacher_disagreement_score":0.049593344,"about_ca_system_score_codex":0.00005465775,"about_ca_system_score_gemma":0.000052476167,"threshold_uncertainty_score":0.17243321},"labels":[],"label_agreement":null},{"id":"W4310107925","doi":"10.1182/blood-2022-168586","title":"Long-Term Outcomes of Patients Aged 65 Years or Older with Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) and T-Follicular Helper T-Cell Lymphoma (TFHTCL) Treated with Curative Intent CHOP(like) Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; Follicular lymphoma; Internal medicine; Not Otherwise Specified; Oncology; Gastroenterology","score_opus":0.012141398437224277,"score_gpt":0.22782259915125588,"score_spread":0.2156812007140316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967959,0.00063887466,0.0000061006435,0.0001868223,0.00006169493,0.0017641125,0.00012529512,0.000074804084,0.00034637633],"genre_scores_gemma":[0.99475205,0.00027248616,0.00040669026,0.00093655975,0.000037645448,0.00040472476,0.00014933755,0.00012822101,0.00291229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974022,0.00012341127,0.00047135164,0.00073760515,0.0007849549,0.00048046568],"domain_scores_gemma":[0.9985777,0.000072976785,0.00032561834,0.00061765825,0.0001500654,0.00025593844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009155995,0.0005746488,0.0009456314,0.00016778403,0.00017732289,0.00004930319,0.00018107508,0.00009998422,0.000621942],"category_scores_gemma":[0.000007018959,0.00036247596,0.00019471964,0.00037299737,0.00018151905,0.00011603809,0.00009622914,0.00009252018,0.000009079413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056855776,0.025180938,0.95839995,0.000110775,0.0013027798,0.0009896723,0.003139735,0.000004535781,0.0012197328,0.0000045857378,0.00019094998,0.0037707896],"study_design_scores_gemma":[0.11251079,0.004303677,0.8515114,0.000097070486,0.00074416783,0.00009780293,0.0006179924,0.000008365053,0.029332323,6.5079263e-7,0.0003676412,0.00040810806],"about_ca_topic_score_codex":0.00034740925,"about_ca_topic_score_gemma":0.00010498204,"teacher_disagreement_score":0.106888525,"about_ca_system_score_codex":0.00036497123,"about_ca_system_score_gemma":0.00021860377,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W4310108249","doi":"10.1182/blood-2022-160070","title":"Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Splenic marginal zone lymphoma; Epidemiology; Marginal zone; Medicine; Incidence (geometry); Checklist; Lymphoma; Systematic review; MEDLINE; Internal medicine; Biology; Immunology; Splenectomy","score_opus":0.0659910679463812,"score_gpt":0.394142646086409,"score_spread":0.32815157814002777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310108249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063733314,0.9911777,1.3609595e-7,0.00022557502,0.000089800196,0.0014597786,0.00050815806,0.0000067435362,0.00015878248],"genre_scores_gemma":[0.0012168231,0.99778855,0.000039497594,0.00013385092,0.000112306014,0.00036951466,0.00025209895,0.000030047366,0.00005729077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774075,0.00072235323,0.0008535785,0.0003554474,0.000100117744,0.00022772874],"domain_scores_gemma":[0.997046,0.0010299439,0.0010100178,0.0008177427,0.00002210018,0.00007422145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005961878,0.00042097908,0.0027260566,0.000063231695,0.000084818756,0.000014459535,0.00018257818,0.00013611921,0.00020263427],"category_scores_gemma":[0.000113015754,0.00016271241,0.0015264193,0.00014527315,0.00009835476,0.00003588126,0.00013887898,0.00012385526,0.000002235814],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063719945,0.0009699865,0.022648277,0.060129046,0.0029493533,0.000041370295,0.000050203784,1.3243945e-7,6.5378266e-8,0.000040841267,0.00034199943,0.91282237],"study_design_scores_gemma":[0.0035692342,0.00097673,0.052458797,0.22931212,0.021139871,0.0028324088,0.000019825598,0.0000011077611,0.000003047865,0.000008774619,0.68945754,0.00022052671],"about_ca_topic_score_codex":0.00053122785,"about_ca_topic_score_gemma":0.0000069766866,"teacher_disagreement_score":0.9126018,"about_ca_system_score_codex":0.00070137816,"about_ca_system_score_gemma":0.0010412688,"threshold_uncertainty_score":0.663522},"labels":[],"label_agreement":null},{"id":"W4310112231","doi":"10.1182/blood-2022-165616","title":"Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Exome; Biology; Transcriptome; Population; Hematopathology; Genetics; Gene; Exome sequencing; Cancer research; Medicine; Mutation; Gene expression; Chromosome; Cytogenetics","score_opus":0.0188363791763551,"score_gpt":0.25124439853159547,"score_spread":0.23240801935524036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899796,0.008430905,0.000006402472,0.00022155326,0.00008604654,0.00074578275,0.00038086527,0.00006600524,0.00008283022],"genre_scores_gemma":[0.9982973,0.00027584407,0.00040234692,0.00007727789,0.000055953926,0.00054727774,0.0002499774,0.000030038953,0.00006402265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998148,0.00019402477,0.00048612745,0.00043935952,0.00041993352,0.0003125097],"domain_scores_gemma":[0.99919903,0.00014736304,0.0002310978,0.0001822768,0.00011786665,0.0001223521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003271859,0.00022726828,0.00051322166,0.000259279,0.000203987,0.000017182505,0.00006440922,0.00006682231,0.00009809136],"category_scores_gemma":[0.000041852185,0.00022007816,0.00013949811,0.00049764686,0.000060119182,0.000065274886,0.00007170506,0.00014277143,0.0000010077417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006505212,0.007343011,0.8906646,0.00023877161,0.0009459284,0.00093943975,0.0059182565,0.0007149396,0.08585403,0.000398963,0.000067703026,0.0062638344],"study_design_scores_gemma":[0.057897694,0.0034982208,0.524708,0.0015553386,0.0032011096,0.0004437416,0.0039863153,0.0057320353,0.3970696,0.00022122766,0.0006476906,0.0010390829],"about_ca_topic_score_codex":0.00050245866,"about_ca_topic_score_gemma":0.00031914224,"teacher_disagreement_score":0.36595666,"about_ca_system_score_codex":0.0005113786,"about_ca_system_score_gemma":0.00052472594,"threshold_uncertainty_score":0.89745265},"labels":[],"label_agreement":null},{"id":"W4310112801","doi":"10.1182/blood-2022-160405","title":"Integrated Single Cell Analysis Reveals Co-Evolution of Malignant B Cells and the Tumor Microenvironment in Transformed Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Follicular lymphoma; Biology; Somatic evolution in cancer; clone (Java method); Phenotype; Diffuse large B-cell lymphoma; Lymphoma; Genetics; Genetic heterogeneity; Transcriptome; Cancer research; Computational biology; Immunology; Cancer; Gene","score_opus":0.00631071562594156,"score_gpt":0.19596600671591646,"score_spread":0.1896552910899749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579346,0.0028447085,0.000023647372,0.00024649862,0.000017035965,0.00062758767,0.000094463394,0.00000850496,0.0003440638],"genre_scores_gemma":[0.9991857,0.00019446094,0.00015819371,0.000110928806,0.0000066809616,0.00017327712,0.000058635786,0.000010529228,0.00010161023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886215,0.00014702363,0.0003353496,0.00023128829,0.00024613432,0.00017803378],"domain_scores_gemma":[0.9995203,0.000070447524,0.00011119898,0.00023057914,0.000012209387,0.000055245542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027892066,0.00013250837,0.00043597602,0.00016629236,0.00007571347,0.00000714084,0.00006372599,0.00002404925,0.000112977184],"category_scores_gemma":[0.000005752163,0.000085340806,0.00019574308,0.00043787787,0.00008765374,0.000018484334,0.000028731243,0.000042798307,0.0000025272666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011443153,0.018888421,0.37687045,0.00017071997,0.002389466,0.0005780972,0.0023127927,0.00024789185,0.59518105,0.00018921895,0.00023497669,0.0017925922],"study_design_scores_gemma":[0.037824713,0.0008710017,0.29475275,0.000054179596,0.0057311216,0.00008865296,0.0019121555,0.0002654353,0.6570246,0.000050974613,0.0012511403,0.0001732521],"about_ca_topic_score_codex":0.00061552203,"about_ca_topic_score_gemma":0.000033307842,"teacher_disagreement_score":0.0821177,"about_ca_system_score_codex":0.00030899516,"about_ca_system_score_gemma":0.000054866578,"threshold_uncertainty_score":0.3480097},"labels":[],"label_agreement":null},{"id":"W4310127708","doi":"10.1182/blood-2022-159594","title":"Mosunetuzumab with Polatuzumab Vedotin Is Effective and Has a Manageable Safety Profile in Patients Aged &amp;lt;65 and ≥65 Years with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) and ≥1 Prior Therapy: Subgroup Analysis of a Phase Ib/II Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Saskatchewan Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Lymphoma; Oncology; Refractory (planetary science); Biology","score_opus":0.007074890573360376,"score_gpt":0.22455263845268628,"score_spread":0.2174777478793259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946718,0.0020465667,0.000002218061,0.000028760793,0.000013504222,0.002872631,0.00025719055,0.000030012608,0.00007729592],"genre_scores_gemma":[0.998707,0.0001807762,0.0001869996,0.000094618044,0.000008145449,0.00046942462,0.0001488739,0.000048233167,0.00015594115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978891,0.00022754387,0.00035222762,0.0006937177,0.00049451366,0.00034291035],"domain_scores_gemma":[0.9989201,0.00014618531,0.00024988002,0.00046088453,0.00005659696,0.00016634238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025580113,0.00033854414,0.000853035,0.0004538624,0.00031155362,0.000037501624,0.00007656443,0.00006436465,0.00004924519],"category_scores_gemma":[0.000016283622,0.0002535568,0.000073039984,0.00086112495,0.000112090274,0.000111558795,0.00018166166,0.0001435956,6.845264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071724253,0.10379732,0.8644929,0.00007893076,0.0035950174,0.00025872525,0.013184648,0.0000014390587,0.00014109729,0.0000034625482,0.000032565436,0.007241452],"study_design_scores_gemma":[0.22612453,0.014216304,0.75456816,0.0000534401,0.0032257647,0.000013219238,0.0009935197,0.000057452202,0.00024332864,0.0000016676332,0.00029199707,0.00021061554],"about_ca_topic_score_codex":0.0007970475,"about_ca_topic_score_gemma":0.00061109796,"teacher_disagreement_score":0.2189521,"about_ca_system_score_codex":0.0002024447,"about_ca_system_score_gemma":0.00011613302,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W4310163212","doi":"10.1182/blood-2022-158650","title":"A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Pharmacodynamics; Pharmacokinetics; Medicine; Pharmacology; Chemistry","score_opus":0.018552294918837694,"score_gpt":0.28789978770429453,"score_spread":0.26934749278545683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310163212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507016,0.0010771931,0.0000037427628,0.00036613012,0.000070169284,0.003178461,0.00010868933,0.000017933564,0.00010752261],"genre_scores_gemma":[0.99878085,0.00032346498,0.00031151832,0.000066297,0.000014417061,0.00034743067,0.00004718523,0.000056009634,0.000052811953],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974741,0.00037553854,0.0005793723,0.0006101203,0.00059472135,0.0003661676],"domain_scores_gemma":[0.99869955,0.0001938282,0.00040595,0.0004191618,0.00013282087,0.00014869735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004985069,0.00039994472,0.0009121281,0.0002650831,0.00014827191,0.000024223958,0.0002583026,0.0000567938,0.000023784745],"category_scores_gemma":[0.000035828816,0.00028258716,0.00003687236,0.00071935845,0.00018908922,0.00023805787,0.0005375341,0.0002500067,1.4784698e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046647858,0.3486503,0.55745184,0.000345306,0.00062980474,0.0011089614,0.0035833148,0.00021782647,0.028616302,0.000034317676,0.00005006536,0.01266405],"study_design_scores_gemma":[0.48835617,0.03784264,0.43667415,0.000230385,0.0011800836,0.00039197647,0.001305254,0.0034717347,0.03012509,0.000012580003,0.0000496055,0.00036031412],"about_ca_topic_score_codex":0.001676679,"about_ca_topic_score_gemma":0.00088657514,"teacher_disagreement_score":0.44170833,"about_ca_system_score_codex":0.0002889429,"about_ca_system_score_gemma":0.00034870848,"threshold_uncertainty_score":0.9999626},"labels":[],"label_agreement":null},{"id":"W4310564872","doi":"10.3324/haematol.2022.282025","title":"&lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Disease; Medicine; Anaplastic lymphoma kinase; Cancer research; Oncology; Internal medicine; Lung cancer","score_opus":0.0348352812346705,"score_gpt":0.28881175528688846,"score_spread":0.25397647405221796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310564872","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35343012,0.009661493,0.00043384172,0.52897537,0.0045958543,0.011545671,0.035259046,0.0015624188,0.054536175],"genre_scores_gemma":[0.6184163,0.0005994424,0.002327224,0.3561937,0.0016548443,0.0018986849,0.0055033555,0.0003274499,0.01307899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99052554,0.0011316782,0.002226871,0.0025558437,0.0016663197,0.0018937408],"domain_scores_gemma":[0.9923048,0.0030418113,0.0009781612,0.0021542122,0.00032437642,0.0011966259],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00068762514,0.0015344324,0.0036072661,0.00031579126,0.00067437615,0.00014494141,0.0007910662,0.0014801618,0.008017145],"category_scores_gemma":[0.0018516972,0.0011635295,0.001494013,0.00043455142,0.000543127,0.000059832175,0.0007889293,0.0012915283,0.0006598489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015677939,0.00707042,0.07532438,0.0011178695,0.0011740802,0.08277472,0.00020395746,0.0000016323834,0.000025347346,0.0005202823,0.82953167,0.0006878632],"study_design_scores_gemma":[0.015588215,0.0025599,0.10799899,0.0003970239,0.0044907616,0.0007993421,0.000055092616,0.00024735287,0.00005358269,0.0006286886,0.86569405,0.0014870181],"about_ca_topic_score_codex":0.00009319261,"about_ca_topic_score_gemma":0.00010665995,"teacher_disagreement_score":0.2649862,"about_ca_system_score_codex":0.0008645343,"about_ca_system_score_gemma":0.0013056236,"threshold_uncertainty_score":0.9998161},"labels":[],"label_agreement":null},{"id":"W4311115665","doi":"10.1200/jco.22.02473","title":"The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Associazione Italiana per la Ricerca sul Cancro; University College London; Cancer Research UK","keywords":"Medicine; International Prognostic Index; Internal medicine; Stage (stratigraphy); Proportional hazards model; Hazard ratio; Oncology; Prognostic variable; Multivariate analysis; Lymphoma; Rituximab; Confidence interval","score_opus":0.15409362817916955,"score_gpt":0.454837998927281,"score_spread":0.30074437074811144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311115665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957527,0.0005076234,0.00055310025,0.0067227487,0.0019259143,0.00031580296,0.00004546765,0.000006264669,0.00034780157],"genre_scores_gemma":[0.9955131,0.000821527,0.0020217716,0.0009631713,0.00046484367,0.000047598263,0.000022679813,0.000009526143,0.00013577913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565417,0.00060779735,0.0028026036,0.00019355818,0.00060607214,0.00013578181],"domain_scores_gemma":[0.98968303,0.0074110827,0.002239283,0.00017546923,0.00033317597,0.00015796455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00424362,0.0001091209,0.0007133704,0.000044326367,0.00017675561,0.000014943559,0.000210074,0.00012896635,0.000042712374],"category_scores_gemma":[0.0055910894,0.000058782858,0.0002504477,0.000074948715,0.00024011933,0.00007169762,0.00017036282,0.00040994643,0.0000017625576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034973263,0.0021134443,0.6603601,0.000004652833,0.00064165564,0.000092479146,0.00019151396,0.0010460991,0.000006534601,0.00032356093,0.0011370768,0.33058554],"study_design_scores_gemma":[0.0107165715,0.0030848489,0.9143857,0.00004657177,0.00036593174,0.00010995748,0.0005148962,0.007697246,0.000054336066,0.00053657906,0.062435143,0.00005223834],"about_ca_topic_score_codex":0.000016515942,"about_ca_topic_score_gemma":0.000017912216,"teacher_disagreement_score":0.3305333,"about_ca_system_score_codex":0.00024956753,"about_ca_system_score_gemma":0.0024001144,"threshold_uncertainty_score":0.66934603},"labels":[],"label_agreement":null},{"id":"W4311145947","doi":"10.1016/j.jevs.2022.104193","title":"Lymphomatosis as a Cause of Abdominal Pain and Distension in Two Adult Horses","year":2022,"lang":"en","type":"article","venue":"Journal of Equine Veterinary Science","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Medicine; Lethargy; Abdominal distension; Lymphoma; Cecum; Peritoneal fluid; Pathology; Ascites; Histology; Jejunum; Abdominal pain; Anorexia; B-cell lymphoma; Mesentery; Gastroenterology; Internal medicine","score_opus":0.025178650136258068,"score_gpt":0.3312816957732756,"score_spread":0.3061030456370175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311145947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835384,0.000530485,0.000005744814,0.0007546061,0.0001295413,0.0001076688,0.0000043939694,0.0000029830494,0.00011075109],"genre_scores_gemma":[0.99856377,0.0001311671,0.0009790063,0.00026621326,0.000025092282,0.000005910456,5.780557e-7,0.000005239157,0.00002302624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99856424,0.00009505817,0.00040563563,0.00015862002,0.00059465325,0.00018180812],"domain_scores_gemma":[0.9991519,0.00012316856,0.00026970584,0.0001444428,0.00016078021,0.00015002325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997772,0.000096246964,0.00030249436,0.0004739908,0.00009773146,0.000015721924,0.0001399194,0.000009983429,0.000045030643],"category_scores_gemma":[0.000312229,0.00007079231,0.00007044984,0.0006257793,0.00023449662,0.00020817152,0.00019347122,0.00007662102,7.598617e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027751175,0.0017470561,0.35954964,0.0000863967,0.00005270658,0.009150648,0.001157011,0.00005531574,0.59948725,0.00022821828,0.00014114384,0.025569515],"study_design_scores_gemma":[0.01709334,0.20461124,0.67495716,0.0011115568,0.00023927973,0.08201275,0.0043598847,0.0029497396,0.01107683,0.0002328035,0.0010297238,0.00032570303],"about_ca_topic_score_codex":0.000120141405,"about_ca_topic_score_gemma":0.0000034876573,"teacher_disagreement_score":0.5884104,"about_ca_system_score_codex":0.00024725977,"about_ca_system_score_gemma":0.00040573566,"threshold_uncertainty_score":0.28868264},"labels":[],"label_agreement":null},{"id":"W4311377226","doi":"10.3390/cells11244039","title":"RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Cells","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; University of Ottawa","funders":"Southeast University; National Natural Science Foundation of China","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Pathology","score_opus":0.006234166115530777,"score_gpt":0.21856441985212016,"score_spread":0.2123302537365894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311377226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418354,0.0022194516,0.0001067946,0.0005038432,0.00039426598,0.0015320417,0.00022644688,0.000054516247,0.00077911414],"genre_scores_gemma":[0.994705,0.00019740869,0.0004016517,0.00076614134,0.00011831819,0.0010870245,0.00013537979,0.000038136066,0.0025509293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879986,0.000047141082,0.00019745306,0.00035606243,0.0002276481,0.00037181095],"domain_scores_gemma":[0.99891347,0.0005554302,0.00006803123,0.00024101186,0.000037125348,0.00018490986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014083358,0.0001797589,0.0002674151,0.000070409056,0.00027028314,0.000031359476,0.00006638968,0.00004392034,0.00032795526],"category_scores_gemma":[0.000087819484,0.0001555877,0.00013191531,0.00009466821,0.000032694585,0.000033978602,0.00014891707,0.00004836302,0.000040902454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003353242,0.11737141,0.57646817,0.0022486388,0.0011446839,0.007338826,0.0028017024,0.00004764076,0.020808985,0.0011943801,0.19267112,0.074551225],"study_design_scores_gemma":[0.117923215,0.0038085037,0.5389976,0.00013250885,0.0023208307,0.0005451352,0.0008704554,0.0030157177,0.024891518,0.0004074844,0.30623397,0.0008530989],"about_ca_topic_score_codex":0.000017680428,"about_ca_topic_score_gemma":0.0000019214826,"teacher_disagreement_score":0.11456998,"about_ca_system_score_codex":0.00013513926,"about_ca_system_score_gemma":0.00009425835,"threshold_uncertainty_score":0.6344682},"labels":[],"label_agreement":null},{"id":"W4311916201","doi":"10.1200/jco.22.00272","title":"Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Crizotinib; Chemotherapy; Oncology; Internal medicine; Pediatric oncology; Anaplastic lymphoma kinase; Lymphoma; Anaplastic large-cell lymphoma; Cancer; Lung cancer","score_opus":0.030733638649790996,"score_gpt":0.36043339663175894,"score_spread":0.32969975798196793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311916201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321204,0.00013551037,0.000045851142,0.0039400277,0.00071452884,0.0015387316,0.000055744753,0.0000050580575,0.00035251325],"genre_scores_gemma":[0.99697924,0.00017386358,0.0010837773,0.0010393946,0.0005164465,0.00009281313,0.000060887513,0.000022721293,0.000030871797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618155,0.000659383,0.0020858946,0.00025322373,0.00054623466,0.00027372647],"domain_scores_gemma":[0.9913009,0.005054638,0.0029131402,0.00020335683,0.00037504162,0.00015294206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030514766,0.00017149348,0.0013569476,0.00020242065,0.000099615194,0.0000055500127,0.00020122941,0.00018619606,0.000027472724],"category_scores_gemma":[0.00093802344,0.00009179877,0.00029289845,0.00033638757,0.00011883182,0.00006552598,0.000049086473,0.000381568,9.032822e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43590605,0.07001601,0.45733097,0.000019178171,0.00033016058,0.00010496531,0.00019732682,0.000038847516,6.67513e-7,0.0000929878,0.0029446175,0.033018194],"study_design_scores_gemma":[0.39640304,0.15572986,0.44044515,0.000011205958,0.0004040628,0.000034335324,0.00008236352,0.000026304184,0.000005761657,0.000033870318,0.006768518,0.00005553881],"about_ca_topic_score_codex":0.000027671287,"about_ca_topic_score_gemma":0.00008253569,"teacher_disagreement_score":0.08571385,"about_ca_system_score_codex":0.0004911024,"about_ca_system_score_gemma":0.0017790308,"threshold_uncertainty_score":0.37434453},"labels":[],"label_agreement":null},{"id":"W4312210538","doi":"10.1002/cncy.22676","title":"Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto‐Heme Interinstitutional Collaborative study","year":2022,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Biopsy; Retrospective cohort study; Follicular lymphoma; Radiology; Lymphoma; Surgery; Internal medicine","score_opus":0.041194764477306606,"score_gpt":0.3054421268222656,"score_spread":0.26424736234495905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312210538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992109,0.0015197399,0.0000619689,0.0008059951,0.0016387629,0.0017440458,0.0010933394,0.000052369272,0.0009747881],"genre_scores_gemma":[0.99266756,0.0003773027,0.00009724591,0.00015331106,0.00015507142,0.006273851,0.00019898229,0.0000216826,0.000055023098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798566,0.00020032715,0.00052450993,0.00054080033,0.00040929008,0.0003394401],"domain_scores_gemma":[0.99864304,0.00031676417,0.00026538683,0.00032871348,0.00031936608,0.00012673852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023278392,0.00028518928,0.0006561694,0.00021464114,0.0003421035,0.000012002999,0.00016090635,0.00009559256,0.0010224045],"category_scores_gemma":[0.0004111363,0.00027375226,0.00017228084,0.00063286454,0.00024979364,0.000099801626,0.00022250469,0.00014605057,0.000024205014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035355599,0.0038631742,0.9764485,0.00006309727,0.00045248936,0.0019231816,0.0062575717,0.00012894206,0.00043309745,0.0009438382,0.00071046286,0.0052401023],"study_design_scores_gemma":[0.01731683,0.009472936,0.9579192,0.000120364755,0.00085476856,0.0004616439,0.0029353942,0.000046670346,0.005572404,0.000065068656,0.00487072,0.00036399357],"about_ca_topic_score_codex":0.00043936018,"about_ca_topic_score_gemma":0.00045264192,"teacher_disagreement_score":0.018529277,"about_ca_system_score_codex":0.0026863413,"about_ca_system_score_gemma":0.00062406523,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W4312452366","doi":"10.48036/apims.v18i3.648","title":"Diagnostic Accuracy of Positron Emission Tomography-Computed Tomography (PET-CT Scan) In Detecting Bone Marrow Involvement in Patients with Diffuse Large B cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Medicine; Bone marrow; Biopsy; Radiology; Lymphoma; Positron emission tomography; Gold standard (test); Nuclear medicine; Lymph node; Hematology; Pathology; Internal medicine","score_opus":0.01037762076923679,"score_gpt":0.22608051696994658,"score_spread":0.2157028962007098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312452366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973297,0.0005292455,0.000017555963,0.00063902064,0.00009778002,0.0009588676,0.00016261262,0.000043506665,0.00022169454],"genre_scores_gemma":[0.99879986,0.00020526152,0.00016606171,0.0004926642,0.000018860044,0.000014849058,0.00025032187,0.000029241042,0.000022870632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960228,0.00039416787,0.00069906015,0.00062960637,0.0015907186,0.0006636443],"domain_scores_gemma":[0.997342,0.00090254756,0.0005035815,0.0004963072,0.00022227307,0.00053332705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007374847,0.0003707543,0.0008802443,0.0011841892,0.00019215746,0.000010190893,0.00040921042,0.000072407565,0.00023723116],"category_scores_gemma":[0.00038955756,0.00034102236,0.00033060735,0.001966756,0.00017272547,0.00019500876,0.0005344484,0.0003047728,0.0000015553393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002022182,0.02474463,0.9635357,0.00027721663,0.00022462927,0.0026194449,0.0005557031,0.000017753939,0.00019012018,0.000045875866,0.00061371113,0.005152979],"study_design_scores_gemma":[0.0396088,0.0023397182,0.9472591,0.001030682,0.00019067274,0.000022764292,0.0013700557,0.00024890044,0.006726766,0.000034235996,0.0008187473,0.00034955895],"about_ca_topic_score_codex":0.0023511525,"about_ca_topic_score_gemma":0.00039993122,"teacher_disagreement_score":0.037586614,"about_ca_system_score_codex":0.00032451397,"about_ca_system_score_gemma":0.00036102303,"threshold_uncertainty_score":0.99990416},"labels":[],"label_agreement":null},{"id":"W4313339648","doi":"10.1002/ijc.34412","title":"Bendamustine and rituximab is well‐tolerated and efficient in the treatment of indolent non‐Hodgkin<scp>'</scp>s lymphoma and mantle cell lymphoma in elderly: A single center observational study","year":2022,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University; Sunnybrook Health Science Centre; University of Toronto; Barrie Urology Group; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Bendamustine; Mantle cell lymphoma; Neutropenia; Rituximab; Internal medicine; Febrile neutropenia; Lymphoma; Adverse effect; Follicular lymphoma; Gastroenterology; Surgery; Chemotherapy","score_opus":0.03382648075684918,"score_gpt":0.3089850100804504,"score_spread":0.2751585293236012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313339648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334574,0.004246179,0.000002174393,0.0015233858,0.00021040757,0.0004034519,0.000077348006,0.0000020179705,0.00018930329],"genre_scores_gemma":[0.99824756,0.0009968454,0.000052888,0.00045586316,0.00007985896,0.00007699332,0.000011757545,0.0000107583655,0.00006746625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846303,0.000077042416,0.0005001224,0.00019346329,0.00062562525,0.00014073984],"domain_scores_gemma":[0.9991945,0.0002015532,0.00028802315,0.00008527992,0.00016812241,0.000062504376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000204025,0.00015620308,0.00033574627,0.00026106113,0.000050305178,0.000038348815,0.000102273654,0.000028211567,0.0000605457],"category_scores_gemma":[0.000014391228,0.0001080225,0.000059252965,0.00014151765,0.00004897905,0.00005045639,0.000058192458,0.00005481518,4.4447555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071559154,0.026961965,0.9200367,0.000022881235,0.00038950203,0.0007170787,0.011510535,0.00024721303,0.00033180197,0.000017951385,0.00037945708,0.03866935],"study_design_scores_gemma":[0.048734248,0.003136119,0.93422735,0.00011213543,0.00013743718,0.00044007332,0.0035875225,0.000994592,0.0014756605,0.000022056516,0.007077459,0.00005534922],"about_ca_topic_score_codex":0.0005679624,"about_ca_topic_score_gemma":0.00022029609,"teacher_disagreement_score":0.048018657,"about_ca_system_score_codex":0.0006184017,"about_ca_system_score_gemma":0.00016486093,"threshold_uncertainty_score":0.44050297},"labels":[],"label_agreement":null},{"id":"W4313348357","doi":"10.1101/2022.12.29.522203","title":"A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; Natural Sciences and Engineering Research Council of Canada; Deutsche Krebshilfe; Wilhelm Sander-Stiftung; European Commission; Cancer Research UK","keywords":"IRF4; Transcription factor; Biology; Mutation; Genetics; Gene; Cancer research; Cell biology","score_opus":0.02259669978653841,"score_gpt":0.26447935812189255,"score_spread":0.24188265833535413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313348357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943598,0.0034878592,0.00017294363,0.00022779616,0.00053630647,0.0008924802,0.00015957971,0.00014344741,0.000019813875],"genre_scores_gemma":[0.9918064,0.0002605264,0.0072914045,0.00012725037,0.00015130085,0.00025637727,0.000011178133,0.0000813145,0.000014254131],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975827,0.000108414795,0.00060698873,0.00083772925,0.00052634417,0.00033783354],"domain_scores_gemma":[0.99831814,0.000039895003,0.00030383415,0.00083930936,0.00021749664,0.00028129978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003614642,0.00036949324,0.00064429524,0.00030298316,0.000062416264,0.00004881102,0.00020290275,0.00028604735,0.00030158088],"category_scores_gemma":[0.00008518686,0.00039686228,0.00016194195,0.0005810158,0.00004561204,0.00011114252,0.00010663439,0.00024116156,0.000010528363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011319647,0.006569302,0.40628442,0.0012992441,0.0008963319,0.0011902668,0.00023357097,0.00023854172,0.5776998,0.0019848815,0.0015784402,0.0008932871],"study_design_scores_gemma":[0.004940637,0.00072448445,0.89725506,0.00049415947,0.0003797365,2.0920069e-7,0.000021145746,0.00024603377,0.08333641,0.0000053652075,0.012066902,0.00052986667],"about_ca_topic_score_codex":0.001136,"about_ca_topic_score_gemma":0.000012105003,"teacher_disagreement_score":0.49436334,"about_ca_system_score_codex":0.00091120944,"about_ca_system_score_gemma":0.0014919126,"threshold_uncertainty_score":0.9998483},"labels":[],"label_agreement":null},{"id":"W4313349720","doi":"10.4049/jimmunol.186.supp.104.11","title":"Elevated IL-7 availability does not account for T cell proliferation in moderate lymphopenia. (104.11)","year":2011,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"T-cell receptor; T cell; Biology; Immunology; Cell growth; Cell biology; Molecular biology; Immune system; Biochemistry","score_opus":0.02749166541421887,"score_gpt":0.25646015891028673,"score_spread":0.22896849349606785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313349720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968248,0.00053636817,0.000088022105,0.0015364529,0.00025699983,0.0005584434,0.00000928628,0.000007882951,0.00018171851],"genre_scores_gemma":[0.9982916,0.00039491826,0.0005340836,0.0003964591,0.00006465154,0.000033711272,0.000004178703,0.000012757809,0.0002676201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884534,0.00015164651,0.00055797474,0.00010730363,0.00012074077,0.00021700055],"domain_scores_gemma":[0.9988951,0.00017341322,0.0003362374,0.00025483238,0.00030335566,0.000037067693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008013231,0.00013295352,0.000378386,0.00010884038,0.00006797533,0.000010584976,0.00014544302,0.00010405792,0.00011864892],"category_scores_gemma":[0.000098070734,0.000064907894,0.00009801011,0.000083178245,0.00008259972,0.00012243807,0.000031558517,0.00011804419,0.000018977082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062285367,0.010320976,0.32447398,0.00022748395,0.0014287076,0.00023944108,0.015490521,0.00006713546,0.56346816,0.0011184235,0.001395368,0.019484475],"study_design_scores_gemma":[0.011839343,0.0021882812,0.2698167,0.0000703794,0.00031133372,0.0003822983,0.00046563466,0.00035294608,0.71247387,0.0011060475,0.0008716963,0.000121459874],"about_ca_topic_score_codex":0.00027154703,"about_ca_topic_score_gemma":0.00011848788,"teacher_disagreement_score":0.14900574,"about_ca_system_score_codex":0.0002686401,"about_ca_system_score_gemma":0.00025105992,"threshold_uncertainty_score":0.2646867},"labels":[],"label_agreement":null},{"id":"W4313438681","doi":"10.3389/fonc.2022.1080988","title":"The application of machine learning to imaging in hematological oncology: A scoping review","year":2022,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Grantová Agentura České Republiky","keywords":"Medicine; Medical physics; Oncology; Internal medicine; Computer science","score_opus":0.043937343458052475,"score_gpt":0.41320873303291655,"score_spread":0.36927138957486405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313438681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000048771935,0.9913686,0.00013267765,0.0016902747,0.00039292648,0.0043490203,0.000005230797,0.000020877002,0.002035529],"genre_scores_gemma":[0.000018185934,0.9916623,0.0026731961,0.0006450743,0.000037610087,0.004776328,0.000115637544,0.000027844368,0.00004380856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967986,0.0009417575,0.0012128804,0.0004908471,0.00019353908,0.0003623958],"domain_scores_gemma":[0.9977864,0.0011153138,0.0006114592,0.0003709465,0.000026092672,0.00008977768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014468877,0.00028329834,0.0032299263,0.00032633537,0.0000881392,0.000004639936,0.00027889392,0.0002109289,0.00005865691],"category_scores_gemma":[0.000767479,0.00018509019,0.0003014049,0.0006995978,0.00010358764,0.00001809898,0.00025287096,0.00064373686,0.000012659501],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039158567,0.0003748625,0.005784584,0.018492892,0.000055493594,0.00028230072,0.00006119623,0.0000019638208,4.1715328e-8,0.00006948979,0.0022249182,0.9726131],"study_design_scores_gemma":[0.0007700598,0.00043015036,0.00005548369,0.061931495,0.00043180067,0.00028868899,0.00008394749,0.0000477212,1.8700659e-7,0.000026833115,0.93580645,0.00012718579],"about_ca_topic_score_codex":0.00009052341,"about_ca_topic_score_gemma":0.00012954861,"teacher_disagreement_score":0.9724859,"about_ca_system_score_codex":0.0030313854,"about_ca_system_score_gemma":0.0011870236,"threshold_uncertainty_score":0.7926967},"labels":[],"label_agreement":null},{"id":"W4313453663","doi":"10.1002/ajh.26809","title":"Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Microsemi (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Venetoclax; Medicine; Lymphoma; Brentuximab vedotin; Obinutuzumab; Follicular lymphoma; Rituximab; Oncology; Internal medicine; Antibody-drug conjugate; Cancer research; Antibody; Immunology; Chronic lymphocytic leukemia; Leukemia; Monoclonal antibody; CD30","score_opus":0.02619885197197588,"score_gpt":0.33404745906188976,"score_spread":0.3078486070899139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943776,0.003940978,0.0000147328565,0.0011615563,0.00003410307,0.00038742466,0.00002651082,0.000013647894,0.000043433007],"genre_scores_gemma":[0.9955731,0.0020552487,0.0021683036,0.00008841596,0.000041061,0.000025251331,0.000010467776,0.000020883213,0.000017291197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827486,0.00017148045,0.00070438784,0.0003816121,0.00019047575,0.00027716783],"domain_scores_gemma":[0.9980942,0.0009829312,0.0004583203,0.00018723191,0.000057376055,0.0002199335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027077962,0.00022769933,0.001104112,0.00021116216,0.00006373045,0.00002054824,0.00005108116,0.000051783365,0.000001905714],"category_scores_gemma":[0.00012852534,0.00015295018,0.0000468744,0.0002478581,0.00028095886,0.0000913055,0.000047310765,0.00009597011,0.0000010056332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021296343,0.003924951,0.890343,0.000049691283,0.0013532183,0.0097531825,0.015362108,0.00009510329,0.000175394,0.00013738546,0.00029546302,0.057214133],"study_design_scores_gemma":[0.11592716,0.029861944,0.8314572,0.0008043074,0.0008784275,0.0021334735,0.013883447,0.0031364402,0.0002947505,0.00084208034,0.00038184956,0.00039892003],"about_ca_topic_score_codex":0.00079848646,"about_ca_topic_score_gemma":0.00033269092,"teacher_disagreement_score":0.094630815,"about_ca_system_score_codex":0.00021348252,"about_ca_system_score_gemma":0.0002328792,"threshold_uncertainty_score":0.6237127},"labels":[],"label_agreement":null},{"id":"W4313495477","doi":"10.1139/bcb-2022-0288","title":"Effects of the omega-3 fatty acid DHA on histone and p53 acetylation in diffuse large B cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Acetylation; Histone; Biology; Epigenetics; Cancer research; Histone Acetyltransferases; Histone acetyltransferase; PCAF; Diffuse large B-cell lymphoma; Molecular biology; Biochemistry; Gene; Lymphoma; Immunology","score_opus":0.005855082689565333,"score_gpt":0.2345661919319996,"score_spread":0.22871110924243426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313495477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960617,0.0021764722,5.4671136e-7,0.00032823972,0.000065471,0.0001768295,0.00001802637,0.000015322436,0.0011573833],"genre_scores_gemma":[0.99840474,0.00080978376,0.000010227582,0.00016764135,0.000033459837,0.000028838125,0.000052718762,0.0000060678612,0.00048652285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994142,0.000031990377,0.00012545798,0.00022257723,0.00004755151,0.0001582065],"domain_scores_gemma":[0.9996112,0.00010614629,0.00005914619,0.00015758995,0.000013858726,0.000052087562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006774873,0.000113042515,0.00018810549,0.00002958491,0.000041381827,0.0000027749718,0.000037889557,0.00015539363,0.0000042883803],"category_scores_gemma":[0.00003520021,0.00007324738,0.00004045672,0.00011037768,0.00008971348,0.000007263016,0.00005964277,0.000039988234,0.0000055917867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011940463,0.0016125791,0.052981436,0.00037798283,0.000014845102,0.00001943648,0.00011602636,6.934172e-8,0.9405453,0.00003081347,0.00027779865,0.0039043091],"study_design_scores_gemma":[0.0084014805,0.0001388325,0.16549897,0.00004628172,0.000033400403,0.0000044309104,0.00004256827,0.000015658828,0.8246129,0.000020027503,0.0011283973,0.00005704989],"about_ca_topic_score_codex":0.00001896573,"about_ca_topic_score_gemma":0.000001504209,"teacher_disagreement_score":0.115932405,"about_ca_system_score_codex":0.000049508926,"about_ca_system_score_gemma":0.000027549822,"threshold_uncertainty_score":0.29869413},"labels":[],"label_agreement":null},{"id":"W4313888610","doi":"10.3390/curroncol30010062","title":"CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential Diagnostic Pitfall","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mantle cell lymphoma; Malignancy; Lymphoma; CD5; Pathology; Marginal zone; Blastoid; MALT lymphoma; B cell; Immunology; Antibody","score_opus":0.04008076730404771,"score_gpt":0.32251325114408663,"score_spread":0.28243248384003894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313888610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892236,0.0005867638,0.000073121075,0.001046482,0.0012176003,0.0010758189,0.000041173967,0.00023985562,0.0064955996],"genre_scores_gemma":[0.99678266,0.0005154135,0.00042789456,0.00020104971,0.00048257803,0.0004571908,0.00026405766,0.000048533853,0.00082062423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978865,0.00013972484,0.00036033487,0.00058492954,0.0003770547,0.0006514662],"domain_scores_gemma":[0.998363,0.0007399198,0.00018345671,0.00031224487,0.00014424432,0.00025711828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015390619,0.0003231829,0.00061050407,0.00022771274,0.00014586582,0.000035573965,0.00012363293,0.0001384574,0.00013795128],"category_scores_gemma":[0.00014020556,0.00023316871,0.00016606106,0.00038382525,0.00018556061,0.000102604135,0.00014944261,0.00015154509,0.0005848186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022575685,0.011426676,0.8420079,0.0010085587,0.00093160383,0.011666402,0.0029773589,0.00010417408,0.0024810876,0.00022930118,0.036050394,0.088859014],"study_design_scores_gemma":[0.030007811,0.0033405873,0.91606635,0.00034238282,0.0009945248,0.00046247873,0.000587716,0.0011549641,0.004149463,0.00039368653,0.04199032,0.0005097463],"about_ca_topic_score_codex":0.00005421227,"about_ca_topic_score_gemma":0.000010521123,"teacher_disagreement_score":0.08834927,"about_ca_system_score_codex":0.0006552417,"about_ca_system_score_gemma":0.00053594296,"threshold_uncertainty_score":0.95083445},"labels":[],"label_agreement":null},{"id":"W4313910225","doi":"10.1097/pai.0000000000001095","title":"Reinventing Nuclear Histo-score Utilizing Inherent Morphologic Cutoffs: Blue-brown Color H-score (BBC-HS)","year":2023,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Ottawa; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Stain; Staining; Immunohistochemistry; H&E stain; Cutoff; Intraclass correlation; Pathology; Medicine; Kappa; Nuclear medicine; Internal medicine; Mathematics; Physics; Clinical psychology","score_opus":0.026283343699684582,"score_gpt":0.2713069837313913,"score_spread":0.2450236400317067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313910225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97771907,0.0019575006,0.000044271725,0.00082148565,0.00038368013,0.0011017416,0.000029828321,0.00076630345,0.017176112],"genre_scores_gemma":[0.99336964,0.00020445268,0.0010549417,0.001881632,0.00012553885,0.0007542262,0.0009089426,0.00018571637,0.0015148894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958303,0.00006548536,0.00093112857,0.0013995982,0.00055726536,0.0012162259],"domain_scores_gemma":[0.9974071,0.000099646335,0.00044616533,0.0015549724,0.00014821718,0.0003439473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030519982,0.0007685896,0.0010915449,0.00024161869,0.00039841994,0.000053585576,0.0005256935,0.0006280078,0.0009328566],"category_scores_gemma":[0.00014388969,0.00076980365,0.0005277379,0.00075098546,0.00054086355,0.000051986724,0.00053515495,0.0006339428,0.0013328235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038314133,0.00054973067,0.00077357015,0.00019578105,0.00042535362,0.0054263724,0.0002497041,0.000042454853,0.97672,0.0013298331,0.011535482,0.0023685764],"study_design_scores_gemma":[0.0108271325,0.00087082945,0.010873393,0.0004196217,0.0013321065,0.0038399084,0.0015056436,0.00026217225,0.94811404,0.00048026338,0.019800961,0.001673938],"about_ca_topic_score_codex":0.00011606869,"about_ca_topic_score_gemma":2.279363e-7,"teacher_disagreement_score":0.028605971,"about_ca_system_score_codex":0.0011465745,"about_ca_system_score_gemma":0.00024012451,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W4315436222","doi":"10.1111/bjh.18640","title":"Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Internal medicine; Oncology; Surgery; Transplantation; Confidence interval; Progression-free survival; Lymphoma; Overall survival","score_opus":0.01479505417405778,"score_gpt":0.2630927141485054,"score_spread":0.2482976599744476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315436222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384874,0.0030362858,0.0014569575,0.00045087686,0.00056115934,0.00046108826,0.00008005409,0.000029508308,0.000075299984],"genre_scores_gemma":[0.9971328,0.0018379167,0.00063105015,0.0000557398,0.00005137505,0.000033832974,0.00007872455,0.000023772614,0.00015482542],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9983754,0.00010698166,0.00079210923,0.00019190203,0.00024147195,0.00029212784],"domain_scores_gemma":[0.9986625,0.00022640762,0.0005460445,0.00010429853,0.00032947716,0.00013128138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022234293,0.00015902566,0.00086269097,0.00019849041,0.00009348677,0.00002145637,0.00010606955,0.00018232413,0.000021958142],"category_scores_gemma":[0.000032632564,0.00015191847,0.0004427219,0.0001837515,0.000109006716,0.00011808427,0.00001211523,0.00007658393,0.000009555126],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044931443,0.0032287152,0.16764933,0.002996076,0.003426696,0.5187113,0.0026638224,0.0001530821,0.014573522,0.0009174715,0.009380988,0.27180582],"study_design_scores_gemma":[0.027765019,0.0019429923,0.50990194,0.001216323,0.0017982236,0.3687993,0.00059002545,0.0001723346,0.087019876,0.00046171312,0.00009814756,0.00023411476],"about_ca_topic_score_codex":0.00003253266,"about_ca_topic_score_gemma":0.000032754517,"teacher_disagreement_score":0.3422526,"about_ca_system_score_codex":0.000078743986,"about_ca_system_score_gemma":0.00034660107,"threshold_uncertainty_score":0.6195055},"labels":[],"label_agreement":null},{"id":"W4315473447","doi":"10.1182/blood.2022017734","title":"Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Prednisone; Vincristine; Population; CHOP; Gastroenterology; Adverse effect; Confidence interval; Cyclophosphamide; Surgery; Oncology; Lymphoma; Chemotherapy","score_opus":0.030816614180201356,"score_gpt":0.3290154114159041,"score_spread":0.29819879723570275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315473447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976051,0.00044201652,0.0000026958,0.0006903685,0.00007666113,0.0008386252,0.000068537614,0.00012862482,0.00014735771],"genre_scores_gemma":[0.9969907,0.000062829764,0.000050336097,0.00009194464,0.00024709204,0.00008694922,0.0023719028,0.000019499601,0.000078737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864674,0.0001511158,0.00033805548,0.00034274146,0.00026562714,0.00025570794],"domain_scores_gemma":[0.9991052,0.00015192435,0.000095499796,0.00049432367,0.000034676184,0.000118365766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019304518,0.00016511593,0.00039067998,0.00023307357,0.00008166997,0.000046242618,0.00009331137,0.00010416138,0.00010662442],"category_scores_gemma":[0.00011877766,0.00010853786,0.00019554293,0.0014704528,0.00002124244,0.00007590561,0.000025588199,0.00008834527,0.00008410558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003718722,0.0065917443,0.98084927,0.0000048610827,0.0015371933,0.00027849563,0.0009216193,0.000019121255,0.00043865736,0.000054022934,0.00015966,0.0054266336],"study_design_scores_gemma":[0.14999957,0.0008363811,0.84230554,0.000029035886,0.0042746314,0.0000035621679,0.00014539197,0.0010002964,0.0010283907,0.000068599424,0.00020679981,0.00010181141],"about_ca_topic_score_codex":0.011328822,"about_ca_topic_score_gemma":0.004162921,"teacher_disagreement_score":0.14628084,"about_ca_system_score_codex":0.00009792207,"about_ca_system_score_gemma":0.0000980174,"threshold_uncertainty_score":0.9952548},"labels":[],"label_agreement":null},{"id":"W4315753261","doi":"10.3324/haematol.2022.282265","title":"Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Tumor microenvironment; Diffuse large B-cell lymphoma; Immune system; CD8; T cell; Lymphoma; Cancer research; Biology; Immunology; Medicine","score_opus":0.011364487942087954,"score_gpt":0.22063610256699678,"score_spread":0.20927161462490884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315753261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961053,0.00050747127,8.797103e-7,0.0018015722,0.000029500696,0.0008654789,0.000019955878,0.000051246443,0.0006186111],"genre_scores_gemma":[0.99833775,0.000413271,0.000028945053,0.00062848197,0.0000073088822,0.0002321162,0.00009654715,0.000017781551,0.00023781198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998479,0.00013684209,0.00033348048,0.0003520538,0.00029321725,0.00040537992],"domain_scores_gemma":[0.9993862,0.0001426994,0.0001407163,0.00025647093,0.000013982211,0.000059934235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039568054,0.00021130044,0.0004779471,0.0001032353,0.00007668195,0.000024394662,0.00008787896,0.00008682845,0.000042022613],"category_scores_gemma":[0.000040946932,0.00011605801,0.00006018365,0.00035201586,0.00006959343,0.00003812977,0.00006594654,0.00008234705,0.00009400422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003860275,0.03006709,0.9522235,0.00019405436,0.000066148255,0.010985504,0.0019230758,0.0000013385877,0.0022017704,0.00009549113,0.0011540211,0.00070197845],"study_design_scores_gemma":[0.023731556,0.00053955347,0.9596375,0.00019634303,0.00007509338,0.00017434091,0.0013293435,0.00017863075,0.0136022065,0.000035805373,0.00033625637,0.00016337722],"about_ca_topic_score_codex":0.000101331745,"about_ca_topic_score_gemma":0.00012506603,"teacher_disagreement_score":0.029527536,"about_ca_system_score_codex":0.00014820376,"about_ca_system_score_gemma":0.00004010895,"threshold_uncertainty_score":0.47327083},"labels":[],"label_agreement":null},{"id":"W4315780383","doi":"10.1021/acsmedchemlett.2c00502","title":"Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor","year":2023,"lang":"en","type":"article","venue":"ACS Medicinal Chemistry Letters","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; Ontario Institute for Cancer Research; University of Toronto; Ontario Ministry of Research and Innovation; Ontario Ministry of Research, Innovation and Science","keywords":"BCL6; Lymphoma; Virtual screening; Repressor; Cancer research; Diffuse large B-cell lymphoma; Bioavailability; Chemistry; Pharmacology; Medicine; Transcription factor; B cell; Internal medicine; Drug discovery; Immunology; Gene; Biochemistry; Germinal center","score_opus":0.012822958598365764,"score_gpt":0.24186456128942602,"score_spread":0.22904160269106025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315780383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942226,0.0003504912,0.0000125150345,0.008789183,0.000091899645,0.00019834671,0.00003268831,0.00007426101,0.00102838],"genre_scores_gemma":[0.9969562,0.00021355273,0.00015368554,0.0013634351,0.00033272244,0.00003655929,0.0001175274,0.000026022604,0.0008002566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853987,0.000009932244,0.0002978184,0.00039748542,0.00041418694,0.0003406832],"domain_scores_gemma":[0.9991864,0.00010699678,0.00020046868,0.00028022865,0.00006541002,0.00016047957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014836542,0.00022875403,0.00041524222,0.00007166255,0.000059729275,0.000019503139,0.000087520406,0.000094875,0.00002197799],"category_scores_gemma":[0.00014632381,0.00017862495,0.00008213043,0.00040468472,0.00023231904,0.00010222989,0.00007762884,0.0001442745,0.000019148045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015329626,0.0002227297,0.05948394,0.0004068391,0.0001991527,0.00028200904,0.00016825472,0.0000012400337,0.91528517,0.0000063402053,0.023021745,0.00076930906],"study_design_scores_gemma":[0.0045103948,0.00020146013,0.056339227,0.0005203813,0.00031335233,0.00028942837,0.00033970678,0.000024616058,0.9353869,0.000010337312,0.001861208,0.00020301463],"about_ca_topic_score_codex":0.00021593292,"about_ca_topic_score_gemma":0.0000029276264,"teacher_disagreement_score":0.021160536,"about_ca_system_score_codex":0.00013439957,"about_ca_system_score_gemma":0.00012405649,"threshold_uncertainty_score":0.7284114},"labels":[],"label_agreement":null},{"id":"W4316663311","doi":"10.3390/immuno3010002","title":"Plasma Cytokine Levels and Cytokine Genetic Polymorphisms in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy","year":2023,"lang":"en","type":"article","venue":"Immuno","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University; Health Sciences North","funders":"","keywords":"Single-nucleotide polymorphism; Oncology; Cyclophosphamide; Medicine; Internal medicine; Breast cancer; SNP; Genotype; Chemotherapy; Metastatic breast cancer; Cytokine; Cancer; Gastroenterology; Immunology; Biology; Gene","score_opus":0.012804620689693338,"score_gpt":0.2493928402572254,"score_spread":0.23658821956753207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316663311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709374,0.00040543638,0.000002183865,0.0015638565,0.000098871154,0.0005290393,0.00020477071,0.00006292857,0.000039170314],"genre_scores_gemma":[0.9982476,0.00042251768,0.00047004,0.0002947158,0.000039435592,0.0001469593,0.000067723864,0.000049412625,0.00026156678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987896,0.00003068117,0.00025711666,0.00031611428,0.00026982924,0.00033663472],"domain_scores_gemma":[0.99942267,0.00006633404,0.000084407024,0.00027755412,0.00005679617,0.000092223025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007602002,0.00023081768,0.00039425172,0.00018293833,0.000059339185,0.00002722351,0.00006237594,0.000042480246,0.00023851584],"category_scores_gemma":[0.000009905227,0.00016479194,0.000037698646,0.00043300746,0.000060103288,0.00007694889,0.00003845861,0.000076784716,0.000039839422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008143674,0.0005714344,0.91278243,0.000039202,0.00034568005,0.00015852337,0.00035878655,0.000029223496,0.0022224975,0.000010422067,0.00016315744,0.08250429],"study_design_scores_gemma":[0.018100027,0.00039421255,0.9780763,0.00032778137,0.0001235995,0.000050047878,0.000022808055,0.00007678946,0.0024544138,0.000018358036,0.00018174238,0.0001739583],"about_ca_topic_score_codex":0.0015342608,"about_ca_topic_score_gemma":0.00009746719,"teacher_disagreement_score":0.08233033,"about_ca_system_score_codex":0.00022433989,"about_ca_system_score_gemma":0.00008884918,"threshold_uncertainty_score":0.672002},"labels":[],"label_agreement":null},{"id":"W4317209122","doi":"10.3390/curroncol30020102","title":"Prognostic Significance of p53 and p63 in Diffuse Large B-Cell Lymphoma: A Single-Institution Experience","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Medicine; Germinal center; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Ki-67; Retrospective cohort study; International Prognostic Index; Internal medicine; Tissue microarray; Single Center; Overall survival; Pathology; B cell; Antibody; Immunology","score_opus":0.08474836527699617,"score_gpt":0.3725807059172227,"score_spread":0.28783234064022656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317209122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960723,0.0018884406,0.00003014798,0.00022967209,0.0004311608,0.0005657974,0.00001382556,0.000047656944,0.0007209789],"genre_scores_gemma":[0.9987468,0.0007095683,0.000069500384,0.00003762343,0.00005043422,0.00030985096,0.000031609467,0.000007734082,0.000036866717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901086,0.000050731403,0.0002646539,0.00027564637,0.00012931449,0.00026881782],"domain_scores_gemma":[0.9994309,0.00018896925,0.00009075123,0.00014916033,0.000045557535,0.000094648705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109570654,0.000119476965,0.000318149,0.00014714702,0.00003581925,0.0000051778147,0.000048244576,0.00007552157,0.0000096464255],"category_scores_gemma":[0.00015810478,0.00009943262,0.00004144743,0.00033284075,0.00014155518,0.000048431222,0.00005967035,0.000046492132,0.000028792658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017174151,0.031093132,0.86964285,0.0003413439,0.000017253538,0.00033169013,0.0030405796,0.000001318442,0.003385945,0.00064110575,0.0004877745,0.09084525],"study_design_scores_gemma":[0.04288869,0.0018849793,0.89179623,0.00043949916,0.0001275956,0.00006266681,0.0011577841,0.00082301674,0.010376536,0.00010855826,0.050118558,0.00021588328],"about_ca_topic_score_codex":0.000025429637,"about_ca_topic_score_gemma":0.000041922427,"teacher_disagreement_score":0.09062936,"about_ca_system_score_codex":0.0003131383,"about_ca_system_score_gemma":0.00018947273,"threshold_uncertainty_score":0.40547445},"labels":[],"label_agreement":null},{"id":"W4317734394","doi":"10.1186/s12885-023-10546-6","title":"Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada); Raincoast Conservation Foundation","funders":"Gilead Sciences","keywords":"Medicine; Follicular lymphoma; Surgical oncology; Refractory (planetary science); Oncology; Meta-analysis; Internal medicine; Lymphoma","score_opus":0.12117419768373015,"score_gpt":0.4282934673655019,"score_spread":0.3071192696817717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317734394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028264234,0.9896227,0.0000012043646,0.00006089121,0.000117678996,0.0091127595,0.00078010693,0.000018956389,0.0000030535882],"genre_scores_gemma":[0.000063810796,0.981188,0.0002069519,0.0004761379,0.0000541317,0.016627017,0.0002193925,0.00007030578,0.0010942788],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99602723,0.00041479486,0.0022905276,0.00067298394,0.00036335867,0.00023109393],"domain_scores_gemma":[0.9965387,0.0011455993,0.0011401636,0.0007961956,0.00025890823,0.000120463956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007313774,0.0005854242,0.012813584,0.0003736335,0.000020889694,0.00002393821,0.00012718314,0.0003812539,0.000059710783],"category_scores_gemma":[0.00040091763,0.00028993993,0.0066411337,0.0008780216,0.00003906156,0.000048466067,0.000050340706,0.0001059467,0.0000062194695],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063392705,0.00097532186,0.028158601,0.77034837,0.17783044,0.000022415845,0.00004002359,8.282148e-8,5.171577e-10,0.000002543156,0.00031363053,0.022245206],"study_design_scores_gemma":[0.0031898525,0.0002505727,0.022601236,0.12522158,0.784471,0.00000225461,0.0000018066204,9.539493e-7,3.416822e-8,0.0000016328316,0.06400566,0.00025342265],"about_ca_topic_score_codex":0.000040694347,"about_ca_topic_score_gemma":0.00014197186,"teacher_disagreement_score":0.64512676,"about_ca_system_score_codex":0.00022726772,"about_ca_system_score_gemma":0.0003559601,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W4317908165","doi":"10.1186/s40644-023-00520-7","title":"Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma","year":2023,"lang":"en","type":"article","venue":"Cancer Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queensland Health; McGill University","keywords":"Medicine; Concordance; Nuclear medicine; Positron emission tomography; PET-CT; Radiology; Prospective cohort study; Lymphoma; Internal medicine","score_opus":0.012243937636606795,"score_gpt":0.31421191698262224,"score_spread":0.30196797934601544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317908165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426395,0.00253791,0.000004717906,0.0018468784,0.00009662073,0.0007030908,0.00004036141,0.000031736516,0.00047475443],"genre_scores_gemma":[0.99571306,0.0033995907,0.00019115748,0.00021913704,0.00004084786,0.0003300453,0.0000072769717,0.000025593308,0.000073297466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984816,0.00014490966,0.00034445056,0.00036781788,0.00034037916,0.00032088748],"domain_scores_gemma":[0.9981509,0.0012484419,0.00015858012,0.0002703298,0.00009420049,0.000077537676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088528695,0.00020880665,0.000420592,0.00022113652,0.00010125421,0.000034133373,0.00009399791,0.0000047451763,0.000020149317],"category_scores_gemma":[0.00022684154,0.00015065678,0.0000548905,0.00044766942,0.00022149518,0.00015751197,0.00009947755,0.000091781665,0.0000018535147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020595186,0.00017514706,0.98376596,0.0002818969,0.00007644331,0.0014451148,0.0017284839,0.000061565,0.00055207126,0.00011190017,0.00018777921,0.011407694],"study_design_scores_gemma":[0.00368466,0.00019752205,0.9829762,0.0010239003,0.0001530081,0.00045437063,0.0026115864,0.0057646045,0.0027201234,0.000055561944,0.00021742168,0.00014106734],"about_ca_topic_score_codex":0.00068486814,"about_ca_topic_score_gemma":0.000032579836,"teacher_disagreement_score":0.011266626,"about_ca_system_score_codex":0.00042473842,"about_ca_system_score_gemma":0.00036740748,"threshold_uncertainty_score":0.6143605},"labels":[],"label_agreement":null},{"id":"W4317936530","doi":"10.1016/j.urolonc.2022.10.032","title":"Age related differences in primary testicular lymphoma: A population based cohort study","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Incidence (geometry); Malignancy; Lymphoma; Internal medicine; Cohort; Seminoma; Population; Diffuse large B-cell lymphoma; Pathological; Chemotherapy","score_opus":0.027681491698843493,"score_gpt":0.2947032491944229,"score_spread":0.26702175749557944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945411,0.00022021211,0.0000015777302,0.0027830433,0.000109944885,0.001054268,0.0000069393323,0.00015653568,0.0011263893],"genre_scores_gemma":[0.9954075,0.00011734173,0.002531635,0.0008127185,0.000026125508,0.00045245295,0.00034117902,0.000011036952,0.00029997886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985487,0.0001830744,0.0003700025,0.0004278579,0.00019810803,0.00027225775],"domain_scores_gemma":[0.99903715,0.00045413294,0.000110423854,0.00019829095,0.00003013487,0.00016988533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041905712,0.00019020004,0.0004786425,0.00031052055,0.00016806214,0.00001989571,0.000059983468,0.00019230481,0.000035115605],"category_scores_gemma":[0.00022737836,0.00014696129,0.000048373357,0.0007056296,0.00021505446,0.00006240776,0.000039218,0.000120342986,0.000037909504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004520451,0.0012691115,0.99404037,0.000017634286,0.00006368935,0.001985592,0.00023958132,0.000049544615,0.000026225236,0.0006168979,0.00035162194,0.0012945324],"study_design_scores_gemma":[0.0030957533,0.0020868,0.98611844,0.000049570037,0.0003252943,0.00009363092,0.00015298578,0.0014007586,0.000008489224,0.0019893595,0.004546911,0.0001319856],"about_ca_topic_score_codex":0.00047145598,"about_ca_topic_score_gemma":0.00008694036,"teacher_disagreement_score":0.007921903,"about_ca_system_score_codex":0.0003665517,"about_ca_system_score_gemma":0.0002646163,"threshold_uncertainty_score":0.5992908},"labels":[],"label_agreement":null},{"id":"W4318499470","doi":"10.1097/mph.0000000000002625","title":"Hodgkin Lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up","year":2023,"lang":"en","type":"review","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Nodular sclerosis; Lymphoma; Cohort; Internal medicine; Hodgkin lymphoma; Disease; Cancer; Pediatrics; Breast cancer; Surgery","score_opus":0.033610503384941,"score_gpt":0.3446698915185262,"score_spread":0.3110593881335852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318499470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30305123,0.6955216,7.9440605e-7,0.0001325433,0.00041726278,0.00075095444,0.0000667873,0.000012286131,0.000046550547],"genre_scores_gemma":[0.028636856,0.9702937,0.00017233379,0.000036516754,0.00066116115,0.00002820206,0.000055459484,0.00006842513,0.000047340927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955203,0.0004624798,0.0026188744,0.00052045414,0.000383844,0.0004940297],"domain_scores_gemma":[0.99551743,0.00073427305,0.0028052467,0.0003448266,0.00022328709,0.0003749611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001003437,0.00054298923,0.004817886,0.0013306302,0.000045871064,0.000013128578,0.00025262535,0.001088273,0.000008434962],"category_scores_gemma":[0.000595283,0.00039168663,0.0005558621,0.0006446108,0.00018263594,0.000072635135,0.00022577432,0.0005058849,0.000029435352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003810878,0.00090203923,0.6178839,0.00605562,0.0007472041,0.0031237516,0.00013630594,3.7472255e-8,8.4354724e-8,0.000012850579,0.0008004331,0.36995667],"study_design_scores_gemma":[0.04243888,0.004404267,0.86618185,0.012435228,0.012426667,0.041887563,0.00007503129,7.2795336e-7,0.0000020559055,0.000051070576,0.019496338,0.00060031237],"about_ca_topic_score_codex":0.000058387668,"about_ca_topic_score_gemma":0.0002090781,"teacher_disagreement_score":0.36935636,"about_ca_system_score_codex":0.0005980456,"about_ca_system_score_gemma":0.0018882134,"threshold_uncertainty_score":0.9998535},"labels":[],"label_agreement":null},{"id":"W4318826914","doi":"10.3390/curroncol30020135","title":"Management of Marginal Zone Lymphoma: A Canadian Perspective","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Impact; University of Alberta; Queen Elizabeth II Health Sciences Centre; Fluidigm (Canada); Dalhousie University; McGill University Health Centre","funders":"","keywords":"Medicine; Lymphoma; Disease; Clinical trial; Lymphoplasmacytic Lymphoma; Splenic marginal zone lymphoma; Presentation (obstetrics); Pathology; Internal medicine; Surgery; Splenectomy; Spleen; Waldenstrom macroglobulinemia","score_opus":0.20152181554769782,"score_gpt":0.469430519779732,"score_spread":0.26790870423203417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318826914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022987182,0.98047936,0.0000021593673,0.00023377502,0.001339502,0.0016717501,0.00019505384,0.00004730968,0.0160081],"genre_scores_gemma":[0.00006525236,0.997415,0.00012041972,0.000016978145,0.00024509526,0.00077688886,0.00034277872,0.00005730868,0.0009602836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797493,0.000111724185,0.00059254625,0.0005525863,0.00024147585,0.0005267466],"domain_scores_gemma":[0.9985483,0.00012924918,0.00031104646,0.00044842783,0.00015287111,0.00041008537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018115334,0.0004160107,0.0022862905,0.0006058456,0.000056872366,0.000007457699,0.00018481871,0.0002922896,0.0001853619],"category_scores_gemma":[0.000021213054,0.00032273983,0.00063987565,0.00054228475,0.000117415475,0.000016766422,0.00011440802,0.00015258482,0.000771581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017553359,0.0010523325,0.00007184063,0.01632442,0.001674782,0.0022837403,0.00009267967,2.902231e-8,1.9690103e-9,0.007255021,0.0058721,0.9653555],"study_design_scores_gemma":[0.0020584937,0.00044228384,0.0006453768,0.01752875,0.005806395,0.00026927853,0.00029392968,0.0000011298952,1.0934498e-7,0.000060429946,0.9726839,0.00020994671],"about_ca_topic_score_codex":0.01189394,"about_ca_topic_score_gemma":0.006918847,"teacher_disagreement_score":0.9668118,"about_ca_system_score_codex":0.0074834614,"about_ca_system_score_gemma":0.0029805014,"threshold_uncertainty_score":0.99992245},"labels":[],"label_agreement":null},{"id":"W4318940213","doi":"10.1016/j.ccell.2023.01.003","title":"IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Weill Cornell Medical College; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Fondation ARC pour la Recherche sur le Cancer; Cancer Research Institute","keywords":"IDH2; Angioimmunoblastic T-cell lymphoma; Cancer research; Germinal center; Biology; Plasma cell; Epigenetics; Tumor microenvironment; Carcinogenesis; Mutation; B cell; Immunology; T cell; Cancer; Genetics; Gene; IDH1; Antibody; Immune system","score_opus":0.012309495828722403,"score_gpt":0.23600646424023472,"score_spread":0.22369696841151232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318940213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924942,0.0009468439,0.00009646556,0.004628787,0.00014932611,0.00039216547,0.000018393406,0.000032058746,0.0012417501],"genre_scores_gemma":[0.9922507,0.00054047775,0.000087806635,0.0008715331,0.00009849322,0.00038435453,0.00004869811,0.000018286462,0.005699644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993824,0.000013529624,0.00008619577,0.0002228863,0.00014806808,0.00014695108],"domain_scores_gemma":[0.999656,0.000038558937,0.000032391057,0.00015620257,0.00002121556,0.00009562629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000351362,0.00011113674,0.00010776715,0.000032703032,0.00010750803,0.000020545967,0.000024586194,0.000025563573,0.0003077853],"category_scores_gemma":[0.0000014867395,0.00006648,0.000041060255,0.00011394125,0.000030383402,0.00004471237,0.000026857704,0.000044165066,0.00019026342],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001690966,0.0026264498,0.13030946,0.0004798985,0.0014392552,0.0006878122,0.011051265,0.06933085,0.5733723,0.0001394434,0.15994768,0.04892463],"study_design_scores_gemma":[0.005904809,0.0007370061,0.47373807,0.00017598117,0.00080093386,0.00005236413,0.002913079,0.0014836926,0.28235617,0.00002722889,0.23145387,0.00035680187],"about_ca_topic_score_codex":0.0002627702,"about_ca_topic_score_gemma":0.00008405253,"teacher_disagreement_score":0.3434286,"about_ca_system_score_codex":0.0002649196,"about_ca_system_score_gemma":0.000037067268,"threshold_uncertainty_score":0.3370033},"labels":[],"label_agreement":null},{"id":"W4321598875","doi":"10.3324/haematol.2022.281375","title":"Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"Royal Australasian College of Physicians; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; International Prognostic Index; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Prospective cohort study; Cohort; Oncology; Gastroenterology","score_opus":0.037713355729774856,"score_gpt":0.32978408898951506,"score_spread":0.2920707332597402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321598875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896921,0.0001525331,0.000001406855,0.007907785,0.0002372786,0.0009895484,0.00002491611,0.00020530228,0.00078912225],"genre_scores_gemma":[0.99808,0.0001253873,0.00005865063,0.0005128633,0.000028855935,0.0005619984,0.00008918976,0.000016410697,0.0005266354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980657,0.00012966616,0.00038996138,0.00048076612,0.0005453914,0.00038849885],"domain_scores_gemma":[0.9990584,0.00012803302,0.000100835125,0.00053269346,0.00005210654,0.00012791595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030565888,0.00026081863,0.0005412809,0.00008951575,0.00012329427,0.000057210305,0.00034083935,0.00010642829,0.00009367778],"category_scores_gemma":[0.00013845571,0.00014756208,0.00014737032,0.0003780128,0.00008016932,0.000114185656,0.000097594224,0.000051663174,0.00034814767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007384063,0.005499851,0.97962326,0.000011101666,0.0002684491,0.0032924225,0.00052792515,0.000004453828,0.000039949067,0.000559175,0.004998438,0.0051011643],"study_design_scores_gemma":[0.0072125196,0.00041732047,0.9843591,0.00003447142,0.0000797549,0.00026565057,0.001453406,0.000117866526,0.00042637726,0.00015645166,0.005322127,0.00015496598],"about_ca_topic_score_codex":0.00030016399,"about_ca_topic_score_gemma":0.00018178725,"teacher_disagreement_score":0.008387901,"about_ca_system_score_codex":0.0002519884,"about_ca_system_score_gemma":0.00006206209,"threshold_uncertainty_score":0.6017407},"labels":[],"label_agreement":null},{"id":"W4321850936","doi":"10.14740/jh1081","title":"Soft-Tissue Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Child Unmasked by COVID-19","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Anaplastic lymphoma kinase; Lymphoma; Pathology; Differential diagnosis; Biopsy; Large-cell lymphoma; Large cell; Lymph node; Not Otherwise Specified; Rhabdomyosarcoma; Sarcoma; Internal medicine; Adenocarcinoma; Cancer","score_opus":0.010426927049554679,"score_gpt":0.28069354843735794,"score_spread":0.2702666213878033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886518,0.0033492888,0.00032157602,0.0060274866,0.00052221015,0.00039386033,0.00009686324,0.00006651477,0.00057037844],"genre_scores_gemma":[0.9972881,0.0004141784,0.00015891291,0.0016630753,0.000111922505,0.000030710227,0.00007789679,0.000045073073,0.00021010137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973249,0.00018849166,0.0009495596,0.0003732513,0.00044275352,0.0007210417],"domain_scores_gemma":[0.99730873,0.0011259482,0.0005210461,0.0002682365,0.00013290449,0.00064313627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038482752,0.0003496986,0.0011659459,0.0007844876,0.00014835424,0.000026107977,0.00019615098,0.00026731662,0.00015480698],"category_scores_gemma":[0.0007298082,0.00028171684,0.0002321679,0.0008112107,0.00011592681,0.00011431531,0.000084196625,0.00015111329,0.00026046467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011787271,0.032885246,0.37700805,0.0023032068,0.002209968,0.25288248,0.0052992497,0.0003399362,0.0028752259,0.0056091794,0.28950027,0.017299928],"study_design_scores_gemma":[0.25142503,0.022620654,0.38162026,0.002958814,0.0024266385,0.12791625,0.0049024923,0.0030246377,0.062705375,0.0019110971,0.13651551,0.001973265],"about_ca_topic_score_codex":0.00008465484,"about_ca_topic_score_gemma":0.000116332616,"teacher_disagreement_score":0.23963775,"about_ca_system_score_codex":0.00083351927,"about_ca_system_score_gemma":0.00075169525,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W4321850953","doi":"10.14740/jh1037","title":"Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hepatosplenomegaly; Medicine; Leukocytosis; Lymphoma; Malignancy; Pathology; Leukemia; Germ cell tumors; Disease; Immunology; Internal medicine; Chemotherapy","score_opus":0.008060955677331245,"score_gpt":0.22760000723210924,"score_spread":0.219539051554778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977481,0.0005425324,0.000027481832,0.00038775057,0.0003390341,0.00056924316,0.000008661243,0.00007056944,0.00030666625],"genre_scores_gemma":[0.9993308,0.00015359388,0.00017151379,0.00008383988,0.00005847637,0.000041860654,0.00002535781,0.000052720356,0.00008181166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976752,0.00013993036,0.0007784262,0.00035435733,0.00034945825,0.0007026393],"domain_scores_gemma":[0.99846834,0.00018782848,0.00059222925,0.00031166789,0.00016629192,0.00027366003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067911315,0.00038613105,0.0011731066,0.0004808502,0.000071808034,0.000028894363,0.000102737606,0.00021459909,0.000019652343],"category_scores_gemma":[0.000014917917,0.00023006697,0.00013726472,0.00045963915,0.00007604075,0.000078413286,0.000033632954,0.00014604232,0.000050454022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006404519,0.0024141425,0.7898068,0.00088413054,0.0009858779,0.19275647,0.0017847092,0.00063821924,0.00043023162,0.00019102488,0.00038191082,0.0033219545],"study_design_scores_gemma":[0.020581914,0.020165307,0.7335525,0.0028924642,0.0006033278,0.21296278,0.0009296395,0.0014730857,0.0064050206,0.0000037222333,0.00010566907,0.00032457148],"about_ca_topic_score_codex":0.000046656038,"about_ca_topic_score_gemma":0.00011226045,"teacher_disagreement_score":0.0562543,"about_ca_system_score_codex":0.0012083574,"about_ca_system_score_gemma":0.00056812,"threshold_uncertainty_score":0.9381859},"labels":[],"label_agreement":null},{"id":"W4322486907","doi":"10.1111/his.14896","title":"Lack of reproducibility of histopathological features in <i>MYC</i>‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium","year":2023,"lang":"en","type":"article","venue":"Histopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Barts Charity","keywords":"Lymphoma; Pathology; B-cell lymphoma; Fluorescence in situ hybridization; Medicine; Hematopathology; Diffuse large B-cell lymphoma; H&E stain; Biomarker; Histopathology; Cohort; Oncology; Biology; Immunohistochemistry; Cytogenetics","score_opus":0.05583996186750207,"score_gpt":0.3174975318966446,"score_spread":0.2616575700291425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322486907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935219,0.0028016833,0.0000098745595,0.0005114407,0.0003527639,0.0010926931,0.00046717995,0.00009639638,0.0011460606],"genre_scores_gemma":[0.9986913,0.000060667473,0.00017263662,0.00024043089,0.000063235064,0.00009339793,0.00016179602,0.000038472514,0.00047804156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613696,0.000514074,0.0010043029,0.0014112927,0.00040412124,0.0005292461],"domain_scores_gemma":[0.9965825,0.00054524717,0.00042666006,0.002199578,0.00013524569,0.00011073343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016789662,0.00035712335,0.0011505574,0.00024412097,0.00010997289,0.000015787238,0.00028095362,0.00022973858,0.00004322981],"category_scores_gemma":[0.001140053,0.00025038313,0.0003099256,0.00069582096,0.0005653914,0.00009370292,0.00029551418,0.00011202594,0.000041741398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009003216,0.009012693,0.9265142,0.00005913679,0.00002993457,0.0032314856,0.0031921784,0.0000027670728,0.05093158,0.000011782573,0.0031983391,0.0029155582],"study_design_scores_gemma":[0.010935488,0.0006122568,0.97882515,0.00007271599,0.00025775476,0.00023883666,0.0018104487,0.000032900643,0.0046173427,0.00011792102,0.0022790155,0.00020014215],"about_ca_topic_score_codex":0.00096252444,"about_ca_topic_score_gemma":0.00013003148,"teacher_disagreement_score":0.052310955,"about_ca_system_score_codex":0.00045821152,"about_ca_system_score_gemma":0.00025811017,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W4322772072","doi":"10.1016/j.ijrobp.2023.02.020","title":"Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy","year":2023,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Concordance; Positron emission tomography; Lymphoma; Nuclear medicine; Internal medicine; Oncology","score_opus":0.0538272388678093,"score_gpt":0.3960109439835586,"score_spread":0.3421837051157493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060982782,0.9344894,0.00008274505,0.0005333236,0.0021612858,0.0015742423,0.00011907714,0.00003304818,0.000024090232],"genre_scores_gemma":[0.009549954,0.9867734,0.00044682738,0.00032115146,0.0023776041,0.000068649555,0.00038088372,0.00007341503,0.000008151731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946755,0.0012565135,0.002677132,0.00044545197,0.0005617736,0.00038359052],"domain_scores_gemma":[0.9927123,0.0013124081,0.004927286,0.00028835575,0.00057182694,0.00018783013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017606376,0.00049933285,0.0025006584,0.0009757086,0.000052107465,0.000023186874,0.00043708103,0.00038936865,0.000026935686],"category_scores_gemma":[0.00081606314,0.00039633916,0.0013000082,0.0010053156,0.00008890807,0.00023473761,0.000064723485,0.00041154653,0.0000065281392],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008128312,0.0012670832,0.063712016,0.0010272432,0.000987542,0.00025030208,0.00009691208,0.000013920104,0.000023813865,0.00007589596,0.0006346508,0.9237823],"study_design_scores_gemma":[0.1942318,0.007489709,0.08640175,0.049360536,0.00874622,0.0018244233,0.000046168363,0.0009030673,0.00016635907,0.0010748757,0.6482001,0.001554974],"about_ca_topic_score_codex":0.000029400204,"about_ca_topic_score_gemma":0.0000017556202,"teacher_disagreement_score":0.9222273,"about_ca_system_score_codex":0.0028097248,"about_ca_system_score_gemma":0.0032951848,"threshold_uncertainty_score":0.99984884},"labels":[],"label_agreement":null},{"id":"W4323350812","doi":"10.1093/jcag/gwac036.162","title":"A162 RARE PRESENTATION OF EXTRANODAL NK/T-CELL LYMPHOMA INVOLVING STOMACH AND EYE: CASE REPORT AND LITERATURE REVIEW","year":2023,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pathology; Stomach; T-cell lymphoma; Lymphoma; Esophagogastroduodenoscopy; Gastroenterology; Internal medicine; Endoscopy","score_opus":0.009178402578444966,"score_gpt":0.257914118580827,"score_spread":0.24873571600238206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323350812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845871,0.004059163,7.1420664e-7,0.010898055,0.00016351261,0.00019670882,0.000044906574,0.0000026116268,0.000047228154],"genre_scores_gemma":[0.99357355,0.005268144,0.00008584557,0.00068875944,0.000054891327,0.0000034639377,0.000016366752,0.000007902234,0.00030108832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988226,0.00018311283,0.00051084836,0.00009542944,0.00022144694,0.00016650946],"domain_scores_gemma":[0.998258,0.00007569815,0.0010161668,0.000118397315,0.00036022472,0.00017149339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066607265,0.00008763432,0.00037974073,0.00019767699,0.00006398511,0.000012515652,0.000049660182,0.00008377418,0.000007900732],"category_scores_gemma":[0.00035453253,0.00006364806,0.00011501404,0.00016629776,0.00003696225,0.000075164484,0.00002099831,0.00008838257,3.2375587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088406814,0.00006779185,0.98025995,0.0005104437,0.00019683795,0.009182575,0.00038783211,0.0000024902101,0.0002495748,0.000008361821,0.008573218,0.00047249952],"study_design_scores_gemma":[0.004177215,0.00059349707,0.95838445,0.001595169,0.00046173626,0.033790294,0.00013154438,0.00003784277,0.00018537173,0.000026729054,0.0005791603,0.000036965397],"about_ca_topic_score_codex":0.0016198137,"about_ca_topic_score_gemma":0.031939812,"teacher_disagreement_score":0.03032,"about_ca_system_score_codex":0.00041574475,"about_ca_system_score_gemma":0.00023141991,"threshold_uncertainty_score":0.98572475},"labels":[],"label_agreement":null},{"id":"W4323537794","doi":"10.1101/2023.03.06.23286584","title":"Relapse timing is associated with distinct evolutionary dynamics in DLBCL","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Terry Fox Research Institute; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen's University; Spinal Cord Injury BC; Princess Margaret Cancer Centre; Simon Fraser University","funders":"National Cancer Institute; Terry Fox Research Institute; Provincial Health Services Authority; Genome British Columbia; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Concordance; Biology; Lymphoma; Exome sequencing; Oncology; Disease; Exome; Mutation; Internal medicine; Gene; Genetics; Medicine; Immunology","score_opus":0.03637405617765748,"score_gpt":0.280804741061227,"score_spread":0.2444306848835695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323537794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925106,0.0003628574,0.000022093136,0.0032509966,0.00036107755,0.00060206384,0.00021577356,0.00020920666,0.002465308],"genre_scores_gemma":[0.9941822,0.00015273214,0.00028752183,0.00016479718,0.00008104286,0.00025575428,0.0013539724,0.00007594295,0.003446022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981332,0.00006734253,0.00038053343,0.000620091,0.00044907568,0.00034975374],"domain_scores_gemma":[0.9987783,0.00022665135,0.00019723424,0.00056061335,0.00010074525,0.0001364864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025626298,0.00033136323,0.0006134809,0.00022438352,0.00006222228,0.000021818692,0.00013220335,0.0003232109,0.00006942126],"category_scores_gemma":[0.00032449947,0.00025877508,0.00015650592,0.0003128583,0.00006965024,0.000027745948,0.00028647616,0.00045413987,0.00014258633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007304496,0.00082447473,0.9938656,0.00011622642,0.00035246086,0.002036439,0.00019220666,0.00003837567,0.0000011367504,0.00009849079,0.001897443,0.00050409156],"study_design_scores_gemma":[0.0024854264,0.00013406287,0.9847034,0.0020695853,0.0003249596,0.000030259556,0.00006973894,0.009322005,0.00001882491,0.00040681197,0.0001893949,0.0002454909],"about_ca_topic_score_codex":0.00086315547,"about_ca_topic_score_gemma":0.0014642011,"teacher_disagreement_score":0.00928363,"about_ca_system_score_codex":0.0025167996,"about_ca_system_score_gemma":0.00034565738,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W4323810083","doi":"10.1182/bloodadvances.2022009323","title":"Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Autologous stem-cell transplantation; Refractory (planetary science); Antibody-drug conjugate; Transplantation; Lymphoma; Regimen; Hodgkin lymphoma; Immunology; Antibody; Monoclonal antibody","score_opus":0.005045077618291691,"score_gpt":0.22553880673670618,"score_spread":0.22049372911841447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323810083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963746,0.002207844,0.0000029262392,0.00012345576,0.00015886888,0.000419855,0.00003939776,0.00013350797,0.0005395081],"genre_scores_gemma":[0.99637,0.0025803838,0.00030887788,0.000103218634,0.00007979632,0.00023771798,0.00019316484,0.00002491173,0.00010191433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877805,0.00003573394,0.0002447916,0.00034046092,0.00029860102,0.0003023835],"domain_scores_gemma":[0.99950886,0.00010410228,0.00008451776,0.00017315545,0.00004254663,0.00008679665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057094876,0.00018878444,0.0002691382,0.00023826346,0.000040964205,0.000012709047,0.00005263453,0.00006845756,0.000028014183],"category_scores_gemma":[0.000019098232,0.0001376357,0.000054619508,0.00048841216,0.000032006366,0.00019109357,0.000011615647,0.000052453655,0.000109247274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006409096,0.0019327778,0.9647961,0.00015764269,0.000036902366,0.00080536574,0.00028919516,0.000017123672,0.0000059244685,0.000009196219,0.00005028381,0.031258542],"study_design_scores_gemma":[0.01587117,0.00092157716,0.9811509,0.000112912894,0.00032103123,0.000019572024,0.0000329434,0.0000075259404,0.00035833643,0.000029366678,0.0010171598,0.00015747572],"about_ca_topic_score_codex":0.000027275972,"about_ca_topic_score_gemma":0.00010661538,"teacher_disagreement_score":0.031101065,"about_ca_system_score_codex":0.000069107984,"about_ca_system_score_gemma":0.00008360461,"threshold_uncertainty_score":0.5612621},"labels":[],"label_agreement":null},{"id":"W4323821448","doi":"10.1182/blood.2022017951","title":"Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"Seagen; Bristol-Myers Squibb","keywords":"Nivolumab; Library science; Web site; Medicine; Art history; Art; World Wide Web; Cancer; Internal medicine; Computer science","score_opus":0.014395435835163306,"score_gpt":0.24272774717149329,"score_spread":0.22833231133632997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323821448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959199,0.0003782312,0.000048045855,0.0009583302,0.00023584752,0.0009179467,0.0000618744,0.0003512536,0.0011285724],"genre_scores_gemma":[0.9955013,0.00010241393,0.0011268066,0.00022187439,0.0002554176,0.00051868067,0.00037274338,0.00006628973,0.0018345166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983896,0.000027201942,0.00027959148,0.00042821627,0.00039440586,0.00048095992],"domain_scores_gemma":[0.99885964,0.00025801206,0.000112361115,0.00040419103,0.00012386696,0.00024194345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014522608,0.0002667073,0.00045736588,0.00015713878,0.00014216432,0.000026932634,0.00010342212,0.000103723076,0.000063338855],"category_scores_gemma":[0.00008921086,0.00019551555,0.00015575693,0.00036589697,0.000081827326,0.00006645367,0.000043012722,0.00005963044,0.00024756507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013245443,0.05970708,0.65808016,0.0013669637,0.0051258295,0.0062766424,0.0022465233,0.000013600071,0.0066393255,0.0028513442,0.08007621,0.16437086],"study_design_scores_gemma":[0.20875956,0.017588126,0.71602994,0.0006465187,0.00261011,0.00064319366,0.00041684668,0.00023535466,0.023670632,0.00017236134,0.028562587,0.000664781],"about_ca_topic_score_codex":0.000073849325,"about_ca_topic_score_gemma":0.00005360324,"teacher_disagreement_score":0.19551411,"about_ca_system_score_codex":0.000108459026,"about_ca_system_score_gemma":0.00026625162,"threshold_uncertainty_score":0.79728925},"labels":[],"label_agreement":null},{"id":"W4323822038","doi":"10.1097/mph.0000000000002656","title":"Precursor B-cell Lymphoblastic Lymphoma in Children: Hacettepe Experience","year":2023,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lymphoblastic lymphoma; Lymphoma; Stage (stratigraphy); Internal medicine; Incidence (geometry); B symptoms; Neutropenia; Disease; Bone marrow; Febrile neutropenia; Gastroenterology; Surgery; Pediatrics; Chemotherapy; Immunology; T cell","score_opus":0.016739877945308526,"score_gpt":0.3033988684156728,"score_spread":0.2866589904703643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323822038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182814,0.003322191,0.000018778492,0.0020347803,0.00077464315,0.0003941672,0.000005524838,0.00005396782,0.0015678328],"genre_scores_gemma":[0.99444246,0.003144868,0.0008463341,0.00053344766,0.00073899113,0.00006619676,0.0000085383635,0.00003209359,0.00018708402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997145,0.00020848929,0.0012242628,0.00035304527,0.00041005097,0.00065915816],"domain_scores_gemma":[0.9976421,0.000750418,0.0007626461,0.00028263667,0.00018925987,0.0003729691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005821306,0.0002920181,0.0011893003,0.0010580114,0.00006940883,0.000014125785,0.0002668879,0.00042706318,0.000121808625],"category_scores_gemma":[0.0004439812,0.00022892104,0.00030285155,0.0011734646,0.00012591487,0.00014078079,0.00010792265,0.00022932306,0.00043829766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004060658,0.0028492121,0.9601708,0.00007345843,0.00012095506,0.0064101834,0.0012038056,0.000024015055,0.00012053809,0.00012507293,0.021697901,0.006797976],"study_design_scores_gemma":[0.028453495,0.0045935125,0.9291081,0.00007770864,0.00075926335,0.024218425,0.00095382944,0.00015306918,0.002638264,0.0002369979,0.008424268,0.00038309558],"about_ca_topic_score_codex":0.000023293904,"about_ca_topic_score_gemma":0.000008323414,"teacher_disagreement_score":0.031062746,"about_ca_system_score_codex":0.0008934719,"about_ca_system_score_gemma":0.0015428955,"threshold_uncertainty_score":0.93351287},"labels":[],"label_agreement":null},{"id":"W4324318067","doi":"10.1111/bjh.18734","title":"Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Risk stratification; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Baseline (sea); Biology","score_opus":0.012649448597859235,"score_gpt":0.28815157069404135,"score_spread":0.27550212209618213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324318067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292856,0.0046904935,0.00002820398,0.0011692906,0.00038389774,0.0006522602,0.000024576311,0.000040464056,0.00008223818],"genre_scores_gemma":[0.99572754,0.003215227,0.0005051783,0.00008687917,0.00028359794,0.000071314826,0.00004568939,0.000027728423,0.00003684365],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972811,0.0006312745,0.0010882268,0.00031548121,0.00030928673,0.00037466214],"domain_scores_gemma":[0.9984076,0.00036985878,0.00065239344,0.00020083431,0.00018733184,0.00018198582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001378456,0.00019217645,0.0011660232,0.00048797883,0.00009203989,0.000038950486,0.00017230958,0.0001554088,0.00004902279],"category_scores_gemma":[0.00075033825,0.0001828838,0.00019754695,0.00052382145,0.00008444417,0.00013261686,0.00005588823,0.00024462296,0.00005186163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475777,0.007213274,0.4184612,0.00004044459,0.00094557443,0.11624759,0.0010776747,0.000023866158,0.00084840297,0.0002790706,0.0030451156,0.451342],"study_design_scores_gemma":[0.012001034,0.0017588602,0.8771497,0.00012243967,0.00051618996,0.10590622,0.0011810035,0.000117072814,0.00030363092,0.00025179563,0.0005636279,0.00012842241],"about_ca_topic_score_codex":0.002110511,"about_ca_topic_score_gemma":0.0012572029,"teacher_disagreement_score":0.4586885,"about_ca_system_score_codex":0.0001944356,"about_ca_system_score_gemma":0.0004259431,"threshold_uncertainty_score":0.7457785},"labels":[],"label_agreement":null},{"id":"W4324332302","doi":"10.1016/j.path.2023.01.010","title":"Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms","year":2023,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; DNA sequencing; Disease; Computational biology; Bioinformatics; Pathology; Gene; Genetics; Biology","score_opus":0.09583156318015153,"score_gpt":0.35439656428277544,"score_spread":0.2585650011026239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324332302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03249847,0.9647128,0.000001976407,0.000043106505,0.00037565373,0.0017485146,0.0002928339,0.000060665767,0.00026596987],"genre_scores_gemma":[0.00412634,0.9934901,0.00024679836,0.000042816788,0.0003420971,0.00053247076,0.0010775273,0.00006693614,0.00007488635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686164,0.00042575033,0.0013251308,0.00075631676,0.0002484683,0.0003827008],"domain_scores_gemma":[0.99366754,0.005167311,0.0004959378,0.00038523186,0.00010096031,0.00018302652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006490229,0.0004610422,0.0026691405,0.00027594858,0.000046443703,0.000017894454,0.00010138805,0.0011623611,0.000021938438],"category_scores_gemma":[0.0020802738,0.0003386574,0.00040689617,0.00040569095,0.00021890277,0.000055246866,0.00014593198,0.00048405767,0.000056246085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010828048,0.0007100948,0.04228965,0.008195929,0.0003937155,0.013485897,0.00030889997,0.00001369447,0.0000035271082,0.0005016898,0.00013976269,0.93384886],"study_design_scores_gemma":[0.016956413,0.006717397,0.017479219,0.07762717,0.01641844,0.019327024,0.00064410816,0.002734537,0.000056430457,0.0016703561,0.8381873,0.0021816392],"about_ca_topic_score_codex":0.000021641657,"about_ca_topic_score_gemma":0.000028647106,"teacher_disagreement_score":0.9316672,"about_ca_system_score_codex":0.00037685386,"about_ca_system_score_gemma":0.0008381572,"threshold_uncertainty_score":0.99990654},"labels":[],"label_agreement":null},{"id":"W4327913905","doi":"10.1097/01.cot.0000923892.22715.ff","title":"Mosunetuzumab-Axgb Approved for R/R Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; Lymphoma","score_opus":0.025297535335653407,"score_gpt":0.3171134566673111,"score_spread":0.2918159213316577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327913905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85868424,0.0012293292,0.000096087715,0.02069613,0.0008121495,0.0022970133,0.0000643953,0.00073746365,0.1153832],"genre_scores_gemma":[0.91262776,0.00032852186,0.0048305616,0.0027103398,0.0004923318,0.0019862824,0.00053677533,0.00006850752,0.076418914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897677,0.000028033988,0.00020377967,0.0003116954,0.0001232624,0.00035646718],"domain_scores_gemma":[0.9991782,0.0002838184,0.00006297139,0.00027424726,0.00006778906,0.00013298896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016063503,0.00015648747,0.0004072541,0.00010679505,0.000103620936,0.000010605853,0.00007356569,0.0001828486,0.00019412416],"category_scores_gemma":[0.0000963998,0.00012120805,0.00020232082,0.00021440686,0.00006550774,0.00003287255,0.00004509293,0.0000282168,0.0009167581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000488427,0.0014530623,0.010481411,0.00009256065,0.0007530664,0.00067403424,0.00035604712,0.00001484826,0.0015199903,0.005177972,0.7370864,0.24190214],"study_design_scores_gemma":[0.010306926,0.0017475871,0.03983354,0.000031663363,0.00035014338,0.00011379103,0.00016191721,0.0013497166,0.0056942375,0.0009562486,0.9392964,0.0001577845],"about_ca_topic_score_codex":0.00004129622,"about_ca_topic_score_gemma":0.00001097037,"teacher_disagreement_score":0.24174437,"about_ca_system_score_codex":0.00034317077,"about_ca_system_score_gemma":0.00030286895,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W4328008237","doi":"10.1007/174_2022_375","title":"Benign Lymphoid Disorders","year":2023,"lang":"en","type":"book-chapter","venue":"Medical radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski","funders":"","keywords":"Lymphoid hyperplasia; Pathology; Immunophenotyping; Pseudolymphoma; Lymphoma; Lymphatic system; Hyperplasia; Lymphoproliferative disorders; Orbit (dynamics); Medicine; Polyclonal antibodies; Immunology; Antibody; Antigen","score_opus":0.017012045963117655,"score_gpt":0.26609113229350567,"score_spread":0.24907908633038803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328008237","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085068156,0.0037521713,0.000032725864,0.01643843,0.0019199324,0.00061458343,0.000055133693,0.0003636067,0.9759727],"genre_scores_gemma":[0.017151436,0.023064082,0.00009357046,0.0052746166,0.0018457777,0.00014838556,0.00097026076,0.00019155009,0.9512603],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.997852,0.000029312752,0.00044893773,0.00061109796,0.0006247681,0.0004338279],"domain_scores_gemma":[0.99826396,0.0005066059,0.00010892904,0.0004905546,0.00003491706,0.00059502746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023090013,0.00039333873,0.0010147231,0.00018469196,0.000059919177,0.000005160589,0.00018331214,0.0012084341,0.006313378],"category_scores_gemma":[0.0003968968,0.00029197897,0.0003773258,0.00003576373,0.00044318754,0.000010873141,0.00010473605,0.00037436452,0.0034520763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023207067,0.00034341295,0.008990342,0.000205574,0.0020379347,0.0076837675,0.00010936863,7.9690443e-7,0.0000036551594,0.3343444,0.31953287,0.32651585],"study_design_scores_gemma":[0.003654954,0.00083341065,0.0035232168,0.00037627944,0.00047307607,0.0016914418,0.0000067699298,0.00003519054,0.0000049290343,0.01918544,0.96989053,0.00032476662],"about_ca_topic_score_codex":0.000056320903,"about_ca_topic_score_gemma":0.00009348683,"teacher_disagreement_score":0.65035766,"about_ca_system_score_codex":0.0002834217,"about_ca_system_score_gemma":0.00059638574,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W433802874","doi":"10.1182/blood.v124.21.4410.4410","title":"A Phase II Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone (R-CyBor-D) in Relapsed Low Grade and Mantle Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Bortezomib; Rituximab; Internal medicine; Follicular lymphoma; Cyclophosphamide; Gastroenterology; Tolerability; Marginal zone B-cell lymphoma; Multiple myeloma; Oncology; Surgery; Lymphoma; Immunology; Chemotherapy; Adverse effect; B cell","score_opus":0.021446768741428156,"score_gpt":0.3095067927312773,"score_spread":0.28806002398984915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W433802874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566394,0.0022073248,0.0000057259117,0.00028178786,0.0001402319,0.0007771837,0.000015663543,0.000026403754,0.00088174414],"genre_scores_gemma":[0.9966618,0.0013829892,0.0014286593,0.00019251154,0.00013765779,0.00006111636,0.000016665757,0.000024857936,0.00009374078],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998254,0.00012740017,0.0006840396,0.00044709828,0.00021965512,0.00026778245],"domain_scores_gemma":[0.99871707,0.00045076528,0.00019138413,0.00036277733,0.00003590298,0.00024207114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058423413,0.000215553,0.0008127246,0.00010471521,0.000054524317,0.000012552832,0.000060821334,0.00018875141,0.000019408584],"category_scores_gemma":[0.00027807438,0.00017617302,0.00012187673,0.00015059205,0.00016546689,0.000040861505,0.00008083218,0.00009186147,0.000005789131],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039114647,0.30965662,0.3517255,0.0005132288,0.0005597331,0.0007681794,0.00069085613,3.9682922e-7,0.0024988225,0.00050164683,0.0005974913,0.2933729],"study_design_scores_gemma":[0.8440609,0.012317955,0.12317921,0.00014897312,0.00062047114,0.00006584973,0.000036963298,0.0001435217,0.018107131,0.00018229791,0.000946709,0.00019004277],"about_ca_topic_score_codex":0.00017126848,"about_ca_topic_score_gemma":0.000023657862,"teacher_disagreement_score":0.80494624,"about_ca_system_score_codex":0.000024926756,"about_ca_system_score_gemma":0.000096355965,"threshold_uncertainty_score":0.71841276},"labels":[],"label_agreement":null},{"id":"W4360600617","doi":"10.1111/bjh.18730","title":"Extensive histiocytosis masking anaplastic large‐cell lymphoma (<scp>ALCL</scp>)","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Malignancy; Lymphoma; Anaplastic large-cell lymphoma; Medicine; Pathology; Etiology; Pathological; Malignant histiocytosis; Immunology; Histiocyte","score_opus":0.013828634285665772,"score_gpt":0.2544446971270109,"score_spread":0.24061606284134512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881556,0.008047297,0.00026331813,0.0005325823,0.0007811863,0.00018611208,0.000032292457,0.000067829315,0.0019337753],"genre_scores_gemma":[0.99527013,0.002373359,0.0005921657,0.0006682931,0.00022628826,0.000016767463,0.00002739238,0.000043290347,0.00078229816],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99787927,0.000110641915,0.0007388608,0.00027526138,0.00039746508,0.00059849484],"domain_scores_gemma":[0.9979123,0.0006798468,0.00047314007,0.00018743824,0.00043037304,0.00031691353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003064174,0.00021157597,0.0009869533,0.00037034214,0.0001735183,0.00005472809,0.00015293274,0.000184359,0.00006572053],"category_scores_gemma":[0.00089027634,0.00021465271,0.00034824113,0.00040562078,0.00009712406,0.00011294707,0.000085769854,0.00016593172,0.000307053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014517613,0.0027355272,0.03261072,0.0003763355,0.0007614557,0.7452101,0.0006695402,0.000046839228,0.0005380529,0.0006628565,0.18633735,0.029906051],"study_design_scores_gemma":[0.021295715,0.0013944556,0.16806327,0.001644714,0.0009991328,0.7485802,0.0013948352,0.00029671434,0.008339238,0.00077015324,0.0470392,0.00018235316],"about_ca_topic_score_codex":0.000042589934,"about_ca_topic_score_gemma":0.00003615775,"teacher_disagreement_score":0.13929816,"about_ca_system_score_codex":0.0002670088,"about_ca_system_score_gemma":0.0003717419,"threshold_uncertainty_score":0.87532836},"labels":[],"label_agreement":null},{"id":"W4360973954","doi":"10.1007/978-3-319-28845-1_5620-1","title":"Germ-Cell, Lymphoid and Myeloid Tumors, Pathology of the Cervix","year":2022,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Pathology; Germ cell tumors; Medicine; Cervix; Myeloid; Biology; Cancer research; Cancer; Internal medicine","score_opus":0.008948123701323862,"score_gpt":0.22045155989741522,"score_spread":0.21150343619609135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360973954","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20433192,0.011522512,0.0000014263476,0.0007333023,0.0008544122,0.0008647068,0.00040769184,0.000031453426,0.78125256],"genre_scores_gemma":[0.45750245,0.06890523,0.0010497388,0.0016721055,0.0006937584,0.000337257,0.00045396775,0.00029511427,0.46909037],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978261,0.00012371717,0.00078282424,0.00060046,0.00035717172,0.0003097471],"domain_scores_gemma":[0.9978313,0.0002651415,0.00079983595,0.000892981,0.00009695428,0.000113823815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025558998,0.0004434401,0.0012495473,0.00020417875,0.0000892692,0.0000026372327,0.00025284852,0.00042126994,0.0016972881],"category_scores_gemma":[0.00008045134,0.00031759022,0.00036701138,0.000058073594,0.00058641605,0.00002697975,0.00051217206,0.00033349774,0.000022659458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001424432,0.004772549,0.44283286,0.00449354,0.001585357,0.04168507,0.0088434275,0.000012027508,0.008448166,0.3159015,0.033110958,0.13689013],"study_design_scores_gemma":[0.006250055,0.0027086025,0.119204625,0.00034213348,0.00179871,0.010460002,0.00013531999,0.0000020813486,0.0018801312,0.0071168034,0.8494032,0.0006983403],"about_ca_topic_score_codex":0.000049712773,"about_ca_topic_score_gemma":0.00001577642,"teacher_disagreement_score":0.8162922,"about_ca_system_score_codex":0.00014114122,"about_ca_system_score_gemma":0.00044075947,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W4361812092","doi":"10.1158/1078-0432.c.6532418.v1","title":"Data from Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lymphoma; Neutropenia; Internal medicine; Gastroenterology; Diffuse large B-cell lymphoma; Rituximab; Adverse effect; Pharmacokinetics; Phases of clinical research; Chemotherapy","score_opus":0.04658525768970542,"score_gpt":0.34445852919109365,"score_spread":0.2978732715013882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361812092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898841,0.000135197,0.00008122274,0.00031437748,0.00066435226,0.0049828608,0.0028643291,0.00023159408,0.0008420148],"genre_scores_gemma":[0.95845056,0.00016384383,0.00074798433,0.00018419638,0.00018756646,0.0002054022,0.039399505,0.00013662607,0.0005243244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513096,0.00016598051,0.0010368881,0.002060822,0.0010533137,0.00055202475],"domain_scores_gemma":[0.9957877,0.00024471697,0.00047353256,0.0029870793,0.00021746867,0.00028951312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004314447,0.0008115774,0.001469405,0.00041243978,0.00009719208,0.00015803232,0.00062858657,0.0002732969,0.00020402683],"category_scores_gemma":[0.000052332256,0.0005912681,0.00013381454,0.00039764217,0.00007291181,0.00023612533,0.0016810028,0.00031356694,0.0004821827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010891025,0.041190118,0.9490877,0.00013855385,0.00079492247,0.0006746017,0.0005071446,0.00006035832,0.000042118376,0.0000018147796,0.0034329984,0.0029806183],"study_design_scores_gemma":[0.07826163,0.001113746,0.9145729,0.00071256526,0.0010984619,0.0000011894496,0.00034548467,0.0026918638,0.00037830393,0.000026088699,0.0002373987,0.0005604006],"about_ca_topic_score_codex":0.013352144,"about_ca_topic_score_gemma":0.0014585651,"teacher_disagreement_score":0.077172525,"about_ca_system_score_codex":0.00045752327,"about_ca_system_score_gemma":0.00052157487,"threshold_uncertainty_score":0.9996539},"labels":[],"label_agreement":null},{"id":"W4361812409","doi":"10.1158/1078-0432.c.6532418","title":"Data from Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lymphoma; Neutropenia; Internal medicine; Gastroenterology; Diffuse large B-cell lymphoma; Rituximab; Adverse effect; Pharmacokinetics; Phases of clinical research; Chemotherapy","score_opus":0.04658525768970542,"score_gpt":0.34445852919109365,"score_spread":0.2978732715013882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361812409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898841,0.000135197,0.00008122274,0.00031437748,0.00066435226,0.0049828608,0.0028643291,0.00023159408,0.0008420148],"genre_scores_gemma":[0.95845056,0.00016384383,0.00074798433,0.00018419638,0.00018756646,0.0002054022,0.039399505,0.00013662607,0.0005243244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513096,0.00016598051,0.0010368881,0.002060822,0.0010533137,0.00055202475],"domain_scores_gemma":[0.9957877,0.00024471697,0.00047353256,0.0029870793,0.00021746867,0.00028951312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004314447,0.0008115774,0.001469405,0.00041243978,0.00009719208,0.00015803232,0.00062858657,0.0002732969,0.00020402683],"category_scores_gemma":[0.000052332256,0.0005912681,0.00013381454,0.00039764217,0.00007291181,0.00023612533,0.0016810028,0.00031356694,0.0004821827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010891025,0.041190118,0.9490877,0.00013855385,0.00079492247,0.0006746017,0.0005071446,0.00006035832,0.000042118376,0.0000018147796,0.0034329984,0.0029806183],"study_design_scores_gemma":[0.07826163,0.001113746,0.9145729,0.00071256526,0.0010984619,0.0000011894496,0.00034548467,0.0026918638,0.00037830393,0.000026088699,0.0002373987,0.0005604006],"about_ca_topic_score_codex":0.013352144,"about_ca_topic_score_gemma":0.0014585651,"teacher_disagreement_score":0.077172525,"about_ca_system_score_codex":0.00045752327,"about_ca_system_score_gemma":0.00052157487,"threshold_uncertainty_score":0.9996539},"labels":[],"label_agreement":null},{"id":"W4361812605","doi":"10.1158/1078-0432.c.6532319.v1","title":"Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; University of Waterloo; Simon Fraser University; Michael Smith Health Research BC","keywords":"Mantle cell lymphoma; Chemistry; Nuclear medicine; Medicine; Molecular biology; Lymphoma; Internal medicine; Biology","score_opus":0.10866958391441366,"score_gpt":0.34040121532736817,"score_spread":0.2317316314129545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361812605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692268,0.023950566,0.00031018036,0.0010439256,0.0016411184,0.0013175153,0.0015878587,0.00026886372,0.00065319816],"genre_scores_gemma":[0.88789403,0.028796121,0.053536355,0.0009696733,0.002716903,0.00013248008,0.023598868,0.0003157093,0.002039831],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978509,0.000029450019,0.00043235472,0.0010904251,0.00023607748,0.00036081616],"domain_scores_gemma":[0.9980037,0.00030529665,0.00023603329,0.0011543508,0.00012886542,0.00017172332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030377816,0.00042267318,0.00070999906,0.000117999545,0.0001217772,0.00010290875,0.00027359647,0.00022491992,0.00022439199],"category_scores_gemma":[0.00009806735,0.00033301383,0.00011675442,0.00009196706,0.000051084575,0.000094981115,0.00081370014,0.00013284391,0.000035411576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030628887,0.0041606696,0.20358953,0.001876674,0.0035196517,0.00042985528,0.0012617104,0.00003927929,0.13852559,0.000032187272,0.45672253,0.18677944],"study_design_scores_gemma":[0.05371573,0.0007844725,0.05886259,0.0032820657,0.0028440505,0.00007290165,0.001582115,0.093274795,0.2455779,0.0011565157,0.5358245,0.003022374],"about_ca_topic_score_codex":0.0013506316,"about_ca_topic_score_gemma":0.0000080176405,"teacher_disagreement_score":0.18375707,"about_ca_system_score_codex":0.0002711252,"about_ca_system_score_gemma":0.00033575122,"threshold_uncertainty_score":0.9999122},"labels":[],"label_agreement":null},{"id":"W4361812893","doi":"10.1158/1078-0432.c.6532319","title":"Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; University of Waterloo; Simon Fraser University; Michael Smith Health Research BC","keywords":"Mantle cell lymphoma; Chemistry; Nuclear medicine; Molecular biology; Medicine; Lymphoma; Internal medicine; Biology","score_opus":0.10866958391441366,"score_gpt":0.34040121532736817,"score_spread":0.2317316314129545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361812893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692268,0.023950566,0.00031018036,0.0010439256,0.0016411184,0.0013175153,0.0015878587,0.00026886372,0.00065319816],"genre_scores_gemma":[0.88789403,0.028796121,0.053536355,0.0009696733,0.002716903,0.00013248008,0.023598868,0.0003157093,0.002039831],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978509,0.000029450019,0.00043235472,0.0010904251,0.00023607748,0.00036081616],"domain_scores_gemma":[0.9980037,0.00030529665,0.00023603329,0.0011543508,0.00012886542,0.00017172332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030377816,0.00042267318,0.00070999906,0.000117999545,0.0001217772,0.00010290875,0.00027359647,0.00022491992,0.00022439199],"category_scores_gemma":[0.00009806735,0.00033301383,0.00011675442,0.00009196706,0.000051084575,0.000094981115,0.00081370014,0.00013284391,0.000035411576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030628887,0.0041606696,0.20358953,0.001876674,0.0035196517,0.00042985528,0.0012617104,0.00003927929,0.13852559,0.000032187272,0.45672253,0.18677944],"study_design_scores_gemma":[0.05371573,0.0007844725,0.05886259,0.0032820657,0.0028440505,0.00007290165,0.001582115,0.093274795,0.2455779,0.0011565157,0.5358245,0.003022374],"about_ca_topic_score_codex":0.0013506316,"about_ca_topic_score_gemma":0.0000080176405,"teacher_disagreement_score":0.18375707,"about_ca_system_score_codex":0.0002711252,"about_ca_system_score_gemma":0.00033575122,"threshold_uncertainty_score":0.9999122},"labels":[],"label_agreement":null},{"id":"W4361834863","doi":"10.1158/1078-0432.c.6532508.v1","title":"Data from Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"MorphoSys","keywords":"Medicine; Lenalidomide; Internal medicine; Propensity score matching; Rituximab; Clinical endpoint; Diffuse large B-cell lymphoma; Oncology; Cohort; Bendamustine; Gemcitabine; Lymphoma; Cancer; Multiple myeloma; Clinical trial","score_opus":0.21464139744619248,"score_gpt":0.38411671487009413,"score_spread":0.16947531742390165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361834863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812037,0.00071741955,0.00017944355,0.0004442879,0.0018694788,0.009176936,0.0059398487,0.00030490765,0.00016398613],"genre_scores_gemma":[0.97448397,0.00027772837,0.0023367743,0.00005767131,0.00062650524,0.0017342803,0.019641906,0.00014797227,0.0006931846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99535245,0.00019470189,0.0012625462,0.0019065692,0.0008891386,0.0003945867],"domain_scores_gemma":[0.9928654,0.0018016449,0.0009011639,0.0035968183,0.00063125073,0.00020371434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000995037,0.000676339,0.0020128498,0.00018970801,0.0001226424,0.00008352576,0.0008263684,0.0004968252,0.00015805048],"category_scores_gemma":[0.0007989719,0.0005345766,0.000354036,0.00017331283,0.000098900535,0.00023050542,0.000936825,0.0004101588,0.000032994434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01860196,0.01007976,0.94151604,0.0005497922,0.018956577,0.000103351354,0.0037997372,0.00006825769,0.0012456649,0.00020007152,0.0044050803,0.0004737222],"study_design_scores_gemma":[0.052285414,0.0021733444,0.93256,0.00058062555,0.003597429,0.0000027202038,0.006130295,0.0016363241,0.00032551982,0.00018944302,0.000070295115,0.0004485905],"about_ca_topic_score_codex":0.006883828,"about_ca_topic_score_gemma":0.0016743856,"teacher_disagreement_score":0.033683453,"about_ca_system_score_codex":0.0018284664,"about_ca_system_score_gemma":0.0011807521,"threshold_uncertainty_score":0.9997294},"labels":[],"label_agreement":null},{"id":"W4361866689","doi":"10.1182/asheducation.v2012.1.402.3798516","title":"Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; Vincristine; Oncology; Clinical trial; Lymphoma; Prednisone; Internal medicine; Personalized medicine; Precision medicine; Targeted therapy; Cyclophosphamide; Bioinformatics; Pathology; Chemotherapy; Biology; Cancer","score_opus":0.029848461155324746,"score_gpt":0.2972972393264521,"score_spread":0.26744877817112733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361866689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783994,0.006417363,0.000031295018,0.00029061988,0.00021625128,0.0004920903,0.0000064368114,0.000076575416,0.0046294476],"genre_scores_gemma":[0.99884874,0.00016014924,0.00012047495,0.00042803638,0.000032391516,0.00015371236,0.000042393618,0.000027450358,0.00018665753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854493,0.0000749436,0.00028696435,0.00024247792,0.000164231,0.0006864345],"domain_scores_gemma":[0.9991234,0.00027743026,0.00008667604,0.00031555092,0.000023998127,0.00017293524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108036365,0.00024557288,0.0005066592,0.00012006963,0.00005063266,0.000019413252,0.000076834614,0.00017241269,0.00011686676],"category_scores_gemma":[0.00003170147,0.00017095954,0.00010313934,0.00011800376,0.000063085485,0.00013481436,0.00004152692,0.00006359855,0.00019669156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035997477,0.011269616,0.96936184,0.00009692794,0.00006470926,0.00017614815,0.00091651466,1.0233316e-7,0.00006619168,0.017346563,0.00031543765,0.00034996672],"study_design_scores_gemma":[0.013852771,0.0001996852,0.9631519,0.00007123051,0.00015927768,0.00042656914,0.0024228848,0.000022087712,0.009551885,0.00031578433,0.009620052,0.00020587165],"about_ca_topic_score_codex":0.00016505596,"about_ca_topic_score_gemma":0.00009520132,"teacher_disagreement_score":0.017030777,"about_ca_system_score_codex":0.00016684248,"about_ca_system_score_gemma":0.00013006905,"threshold_uncertainty_score":0.6971528},"labels":[],"label_agreement":null},{"id":"W4361947202","doi":"10.1158/1078-0432.c.6530333","title":"Data from A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Regional Development Fund; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya; Centres de Recerca de Catalunya; Institució Catalana de Recerca i Estudis Avançats; Instituto de Salud Carlos III; Leukemia and Lymphoma Society","keywords":"Cyclin D1; Mantle cell lymphoma; Cancer research; Biology; Cyclin D; Cyclin; Cell cycle; Chromatin; Cyclin A2; Cyclin B; Transcriptional regulation; Cyclin D2; Gene expression; Molecular biology; Gene; Lymphoma; Genetics; Immunology","score_opus":0.2729269484406759,"score_gpt":0.436182784845837,"score_spread":0.16325583640516111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361947202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725664,0.001295873,0.00012678855,0.004381013,0.0042809756,0.004196825,0.0074495557,0.0008089176,0.004893605],"genre_scores_gemma":[0.952872,0.0018597472,0.008583192,0.00077415234,0.0009828089,0.0010894104,0.025522,0.000120934405,0.008195758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99450153,0.00017719642,0.001875604,0.001953728,0.000944953,0.00054700626],"domain_scores_gemma":[0.9962862,0.00046418997,0.00026960188,0.0024833274,0.00007317516,0.0004234804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085801637,0.0005750584,0.0013718056,0.00022362158,0.000042561238,0.00010325265,0.0008165608,0.0008476941,0.000764549],"category_scores_gemma":[0.00015089568,0.00045291235,0.000474765,0.00014618094,0.000106513544,0.000086510554,0.0014633023,0.00055488275,0.0013771036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040943088,0.016993895,0.937605,0.0003189844,0.00063904445,0.002075046,0.0000761871,0.000021184314,0.000009417518,0.000040532403,0.017268404,0.024542827],"study_design_scores_gemma":[0.015355475,0.00036583134,0.9656984,0.000498092,0.00078164064,0.000015253175,0.00008491941,0.0035008749,0.000061939885,0.0005390608,0.012702379,0.0003961152],"about_ca_topic_score_codex":0.0041905143,"about_ca_topic_score_gemma":0.0025669092,"teacher_disagreement_score":0.02809337,"about_ca_system_score_codex":0.00043702056,"about_ca_system_score_gemma":0.0007536124,"threshold_uncertainty_score":0.9997923},"labels":[],"label_agreement":null},{"id":"W4361949338","doi":"10.1158/1078-0432.c.6518128.v1","title":"Data from Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; International Prognostic Index; Lymphoma; Follicular phase; Internal medicine; Medicine; Oncology; Gene; Gene expression profiling; Gene expression; Diffuse large B-cell lymphoma; Biology; Genetics","score_opus":0.13715790706680334,"score_gpt":0.36619289632352814,"score_spread":0.2290349892567248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361949338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913424,0.0010701598,0.0004940577,0.00079197827,0.0009913688,0.0010447329,0.003447399,0.00026391062,0.00055398594],"genre_scores_gemma":[0.98093224,0.00025816017,0.0052411202,0.000397029,0.0003138091,0.0001273866,0.012173661,0.00010191889,0.000454694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968751,0.000094544834,0.00081990275,0.0013515704,0.00045925195,0.00039959562],"domain_scores_gemma":[0.9971973,0.00038202657,0.00028755446,0.0018846493,0.00006117577,0.00018729511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003091259,0.00047712226,0.000982945,0.00021140443,0.000053099844,0.00008638552,0.00045713765,0.00037533022,0.00019269022],"category_scores_gemma":[0.00029419526,0.0003921575,0.00020321418,0.00016630074,0.000035184577,0.00013586337,0.002737389,0.00027507506,0.00012795324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010675555,0.00095971936,0.9860256,0.00010094661,0.0013175504,0.00129469,0.0002710549,0.00013681671,0.00042182952,0.000002731029,0.0050818375,0.004280513],"study_design_scores_gemma":[0.012794102,0.00016520907,0.8218741,0.003143192,0.0022987847,0.0000735378,0.0015002998,0.14612128,0.007866887,0.0003392015,0.0027221183,0.0011012916],"about_ca_topic_score_codex":0.03439245,"about_ca_topic_score_gemma":0.0007710444,"teacher_disagreement_score":0.16415146,"about_ca_system_score_codex":0.0013140581,"about_ca_system_score_gemma":0.00029993308,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W4361958911","doi":"10.1158/1078-0432.c.6518098.v1","title":"Data from MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Foundation","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; microRNA; Proportional hazards model; Internal medicine; Oncology; Lymphoma; Univariate analysis; Medicine; Survival analysis; Multivariate analysis; Biology; Gene; Genetics","score_opus":0.04810481516563529,"score_gpt":0.284161640820278,"score_spread":0.2360568256546427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361958911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343784,0.00024780497,0.000007824218,0.0001412641,0.00035797487,0.0016344372,0.013414675,0.00016069267,0.00059746654],"genre_scores_gemma":[0.98014003,0.00027996642,0.00020771356,0.00014340781,0.00007537932,0.0001643465,0.0174746,0.00011021232,0.0014043708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625427,0.0000851079,0.0010408948,0.0013325263,0.0008073331,0.00047990138],"domain_scores_gemma":[0.9961967,0.00017476726,0.0006391613,0.002564597,0.00016331962,0.0002614496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016448984,0.00063590327,0.0014142486,0.0003746531,0.000033106026,0.00003884452,0.0006245632,0.0004983179,0.0001289319],"category_scores_gemma":[0.000086422064,0.0004313101,0.00017414958,0.00024603753,0.000056571178,0.000080739555,0.0019084598,0.00025897773,0.00012569486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004857424,0.029059917,0.96583015,0.00029375852,0.00076993485,0.00054958113,0.00017327495,0.0000027873518,0.000012390172,0.0000018535528,0.0026377009,0.0001829236],"study_design_scores_gemma":[0.05885892,0.00027589753,0.93688774,0.0010027115,0.00081419153,0.0000019929164,0.00018163268,0.00011954859,0.0010443688,0.000009760131,0.00046392146,0.00033931076],"about_ca_topic_score_codex":0.0115195345,"about_ca_topic_score_gemma":0.0059218914,"teacher_disagreement_score":0.05837318,"about_ca_system_score_codex":0.00064622855,"about_ca_system_score_gemma":0.0002368581,"threshold_uncertainty_score":0.99981385},"labels":[],"label_agreement":null},{"id":"W4362415619","doi":"10.1158/0008-5472.22376628.v1","title":"Supplementary Materials from Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Leukemia and Lymphoma Society; Cancer Research Institute","keywords":"Transcription factor; Diffuse large B-cell lymphoma; Cancer research; Factor (programming language); Transcription (linguistics); Computational biology; Lymphoma; Biology; Computer science; Medicine; Genetics; Internal medicine; Gene","score_opus":0.048816902101213665,"score_gpt":0.3011939613682096,"score_spread":0.25237705926699594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362415619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232203,0.00026003597,0.00101553,0.0013059165,0.0031601153,0.0028607326,0.06778634,0.00028357017,0.00010751121],"genre_scores_gemma":[0.90093076,0.00044032253,0.0050276145,0.00048451786,0.0011725267,0.0011980396,0.08905425,0.00013264071,0.0015593191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721617,0.00007306401,0.0007877733,0.00093474693,0.00039371316,0.0005945607],"domain_scores_gemma":[0.9987963,0.00014082233,0.00023131608,0.0005244823,0.00009302464,0.00021408196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019308907,0.000553192,0.0009104557,0.00014418064,0.00012972661,0.00013649627,0.00016488563,0.00041332486,0.008290321],"category_scores_gemma":[0.000024818752,0.00045278654,0.0005267521,0.00004879472,0.000023162367,0.000052586198,0.00025145814,0.000115412455,0.00012545328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024367715,0.019315444,0.045608677,0.0040127398,0.0043064132,0.00056016323,0.0031225511,0.00000815226,0.7598825,0.0005607652,0.15825798,0.0019278193],"study_design_scores_gemma":[0.043396354,0.00037865058,0.020090759,0.0004473327,0.002053224,0.0000039802794,0.0005001015,0.00018010793,0.89928925,0.0010852155,0.03180223,0.0007727762],"about_ca_topic_score_codex":0.0070324377,"about_ca_topic_score_gemma":0.00034454136,"teacher_disagreement_score":0.13940674,"about_ca_system_score_codex":0.0006048512,"about_ca_system_score_gemma":0.00019943566,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W4362426166","doi":"10.1158/1078-0432.22440865.v1","title":"Supplementary Data 2 from Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Outcome (game theory); Follicular phase; Lymphoma; Computer science; Computational biology; Oncology; Medicine; Internal medicine; Biology; Mathematics","score_opus":0.11030337871211747,"score_gpt":0.36155541735459656,"score_spread":0.2512520386424791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362426166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975141,0.00060583226,0.0002591788,0.001473711,0.000980541,0.0013667978,0.019847244,0.00015403247,0.00017169626],"genre_scores_gemma":[0.9109516,0.00027202588,0.0073131467,0.0006642616,0.00033745822,0.00017085123,0.07995851,0.00010520494,0.00022691723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650127,0.000108458815,0.00095613115,0.001438397,0.00052688987,0.0004688849],"domain_scores_gemma":[0.9972504,0.0003556355,0.00028863124,0.0018542986,0.000051237887,0.00019979224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003376523,0.00052805117,0.0009884523,0.00023557113,0.00006345092,0.00008167001,0.0004984272,0.00029435343,0.0011933566],"category_scores_gemma":[0.00013095015,0.0004478961,0.00021271074,0.00015815163,0.000036359237,0.00012693023,0.003405501,0.00027577335,0.000058445275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012270198,0.0009952722,0.97765785,0.000098852375,0.0015536749,0.0012625373,0.00029519826,0.000078444784,0.0003534776,0.0000015663495,0.014868884,0.0027115208],"study_design_scores_gemma":[0.026018785,0.00035122372,0.81096745,0.0035458354,0.0045944867,0.000108758184,0.0043851817,0.11990622,0.018849954,0.00041528913,0.009064041,0.0017927672],"about_ca_topic_score_codex":0.117834836,"about_ca_topic_score_gemma":0.0025011043,"teacher_disagreement_score":0.16669041,"about_ca_system_score_codex":0.001635219,"about_ca_system_score_gemma":0.00029519707,"threshold_uncertainty_score":0.9997973},"labels":[],"label_agreement":null},{"id":"W4362527258","doi":"10.1111/bjh.18757","title":"Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte‐predominant Hodgkin lymphoma: an <scp>IMPACT</scp> cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Institute for Work & Health; St. Michael's Hospital; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research; C17 Children's Cancer and Blood Disorders; Pediatric Oncology Group of Ontario","keywords":"Medicine; Cohort; Lymphoma; Hodgkin lymphoma; Lymphocyte; Young adult; Cohort study; Immunology; Oncology; Internal medicine","score_opus":0.009237723298726562,"score_gpt":0.269366761292752,"score_spread":0.2601290379940254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362527258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968012,0.0019405545,0.0000035412668,0.00008294111,0.00015636021,0.00094036467,0.000034449928,0.000026633006,0.000013933165],"genre_scores_gemma":[0.99649775,0.003193263,0.00006280426,0.000046847716,0.000040136114,0.00007041558,0.000016904694,0.00003881395,0.00003309272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794036,0.00019119047,0.0006466334,0.0004109175,0.00035182966,0.00045908513],"domain_scores_gemma":[0.99885565,0.00012801742,0.00030420747,0.00022223982,0.00012538867,0.00036450877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027243872,0.0003121317,0.0014058677,0.00033695414,0.00009247996,0.00007387851,0.00008859235,0.00011783843,0.0000055526475],"category_scores_gemma":[0.00012059292,0.00022935978,0.00011137591,0.00018309752,0.00010093357,0.00017597851,0.000058515172,0.00008388172,0.000005243063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000280629,0.003464012,0.8133014,0.00007416184,0.00054365426,0.16191688,0.0013667333,0.0000024274448,0.0000045597358,0.0000015435145,0.00003702728,0.019006973],"study_design_scores_gemma":[0.031228188,0.0045038005,0.7721414,0.00088189886,0.00039151087,0.18810391,0.0025061506,0.00006330553,0.000082054365,0.000005467546,0.000013838595,0.000078462734],"about_ca_topic_score_codex":0.0050589615,"about_ca_topic_score_gemma":0.004283949,"teacher_disagreement_score":0.041159976,"about_ca_system_score_codex":0.00046324855,"about_ca_system_score_gemma":0.000248002,"threshold_uncertainty_score":0.9353021},"labels":[],"label_agreement":null},{"id":"W4362540012","doi":"10.1158/2159-8290.22535401.v1","title":"Supplementary Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Transcriptome; Tumor microenvironment; Lymphoma; Disease; Cancer research; Computational biology; Hodgkin lymphoma; Biology; T-cell lymphoma; Medicine; Tumor cells; Pathology; Immunology; Genetics; Gene; Gene expression","score_opus":0.06460473783767265,"score_gpt":0.28371140373133363,"score_spread":0.21910666589366098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96074593,0.00349314,0.00006928777,0.0032715101,0.00021607905,0.0015865252,0.03011205,0.00005289207,0.0004525957],"genre_scores_gemma":[0.93140846,0.0010685752,0.00216044,0.0011090449,0.000084840205,0.00029707656,0.06339043,0.000085336396,0.00039581506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949979,0.00037206602,0.0013676117,0.001650419,0.0010220596,0.00058991165],"domain_scores_gemma":[0.9948604,0.0006133684,0.0005101705,0.003711511,0.000027626222,0.0002769312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006688178,0.0006959227,0.0015307328,0.0005585007,0.00006964186,0.00007822589,0.0011934338,0.00017072294,0.0019620014],"category_scores_gemma":[0.00002860246,0.0004935405,0.0007209107,0.00059884484,0.00013625712,0.000064160566,0.0010176614,0.0002566548,0.000119993514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048294643,0.01073387,0.9442028,0.00079487934,0.0033253185,0.0019982478,0.0010719864,0.00022400444,0.007128285,0.000011872372,0.028981442,0.0010443415],"study_design_scores_gemma":[0.008595359,0.00026281335,0.9574358,0.00068253215,0.019491509,0.000005612498,0.0017001169,0.0014187895,0.006210664,0.00023679735,0.0032903946,0.0006696256],"about_ca_topic_score_codex":0.009489521,"about_ca_topic_score_gemma":0.0018776159,"teacher_disagreement_score":0.033278376,"about_ca_system_score_codex":0.00066502945,"about_ca_system_score_gemma":0.00027112509,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W4362542218","doi":"10.1158/1538-7445.am2023-939","title":"Abstract 939: Genomic characterization of PMBCL, cHL and DLBCL utilizing tissue and liquid biopsies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Lymphoma; Cancer research; Liquid biopsy; Cancer; Gene; Pathology; Population; Medicine; Biology; Internal medicine; Genetics","score_opus":0.10647327242046294,"score_gpt":0.4201807178689819,"score_spread":0.313707445448519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957637,0.001944458,2.6228253e-7,0.0014688371,0.00004616823,0.00032714874,0.00004339981,0.000025183303,0.0003808284],"genre_scores_gemma":[0.98603463,0.013313368,0.000008709629,0.000029445759,0.0000978025,0.00009693241,0.000046823097,0.000015215172,0.0003570655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991893,0.00002176846,0.0001343174,0.00020443521,0.00022208391,0.00022807019],"domain_scores_gemma":[0.99954855,0.00008072457,0.000030110228,0.0001378802,0.000097137425,0.000105567546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027054414,0.00007269013,0.00017132079,0.00019143982,0.00008495269,0.00002370141,0.000035864225,0.000050201874,0.00010200879],"category_scores_gemma":[0.000040510826,0.00005942141,0.000015411952,0.00025293484,0.00013917412,0.00005696705,0.000079141275,0.00007550299,0.000027467077],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018885618,0.00007050262,0.034329724,0.00031450798,0.00005071406,0.00004874808,0.0005680393,2.5565157e-7,0.9362252,0.00008709641,0.00022484465,0.027891554],"study_design_scores_gemma":[0.0008645018,0.00023131279,0.74475116,0.00018338069,0.000014708393,0.0000070917586,0.00015512532,0.000017006803,0.24906757,0.000011072909,0.0046525095,0.000044553108],"about_ca_topic_score_codex":0.00043354373,"about_ca_topic_score_gemma":0.00001961645,"teacher_disagreement_score":0.71042144,"about_ca_system_score_codex":0.000094043484,"about_ca_system_score_gemma":0.00012149852,"threshold_uncertainty_score":0.24231347},"labels":[],"label_agreement":null},{"id":"W4362618120","doi":"10.1158/2159-8290.22535401","title":"Supplementary Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Transcriptome; Tumor microenvironment; Lymphoma; Computational biology; Cancer research; Disease; Biology; Tumor cells; Genetics; Medicine; Gene; Immunology; Internal medicine; Gene expression","score_opus":0.06460473783767265,"score_gpt":0.28371140373133363,"score_spread":0.21910666589366098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362618120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96074593,0.00349314,0.00006928777,0.0032715101,0.00021607905,0.0015865252,0.03011205,0.00005289207,0.0004525957],"genre_scores_gemma":[0.93140846,0.0010685752,0.00216044,0.0011090449,0.000084840205,0.00029707656,0.06339043,0.000085336396,0.00039581506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949979,0.00037206602,0.0013676117,0.001650419,0.0010220596,0.00058991165],"domain_scores_gemma":[0.9948604,0.0006133684,0.0005101705,0.003711511,0.000027626222,0.0002769312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006688178,0.0006959227,0.0015307328,0.0005585007,0.00006964186,0.00007822589,0.0011934338,0.00017072294,0.0019620014],"category_scores_gemma":[0.00002860246,0.0004935405,0.0007209107,0.00059884484,0.00013625712,0.000064160566,0.0010176614,0.0002566548,0.000119993514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048294643,0.01073387,0.9442028,0.00079487934,0.0033253185,0.0019982478,0.0010719864,0.00022400444,0.007128285,0.000011872372,0.028981442,0.0010443415],"study_design_scores_gemma":[0.008595359,0.00026281335,0.9574358,0.00068253215,0.019491509,0.000005612498,0.0017001169,0.0014187895,0.006210664,0.00023679735,0.0032903946,0.0006696256],"about_ca_topic_score_codex":0.009489521,"about_ca_topic_score_gemma":0.0018776159,"teacher_disagreement_score":0.033278376,"about_ca_system_score_codex":0.00066502945,"about_ca_system_score_gemma":0.00027112509,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W4362668845","doi":"10.1097/hs9.0000000000000863","title":"Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Oncology; Blood Cancer UK; Genentech; Celgene; KWF Kankerbestrijding; Teva Pharmaceutical Industries; National Cancer Institute; Cancer Research UK; GlaxoSmithKline; Pfizer","keywords":"Medicine; Follicular lymphoma; Asymptomatic; Rituximab; Lymphoma; Stage (stratigraphy); Biopsy; International Prognostic Index; Internal medicine; Surgery; Oncology","score_opus":0.018462729907170905,"score_gpt":0.25210918094393764,"score_spread":0.23364645103676673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362668845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957122,0.0021785,0.0000014848769,0.0003318324,0.00015992715,0.00074608077,0.00004561359,0.000118908596,0.00070545456],"genre_scores_gemma":[0.99415296,0.0019191672,0.00071703095,0.00021931365,0.00014960715,0.0002568202,0.00012371562,0.00005344671,0.0024079112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998417,0.000030324169,0.00028045854,0.0005253278,0.0003059862,0.0004408626],"domain_scores_gemma":[0.99914366,0.00008679807,0.00008820226,0.0003890435,0.000026017406,0.0002662794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042647116,0.00032351547,0.00040868024,0.00004768739,0.00015204238,0.00005120846,0.000055828532,0.00010059289,0.00014164219],"category_scores_gemma":[0.000056309713,0.00021720718,0.0001383444,0.00016019466,0.0000632338,0.00003471619,0.00009552005,0.000031659543,0.0001835777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051778567,0.0013738842,0.8041718,0.00017104916,0.00049702585,0.001939945,0.0008426822,0.0000142262825,0.0008897038,0.000027886557,0.0044024456,0.18515158],"study_design_scores_gemma":[0.009326715,0.00087216543,0.97247696,0.0001952437,0.00034453877,0.000087887456,0.00019091097,0.000030371017,0.0063146497,0.000026377451,0.009902475,0.00023169644],"about_ca_topic_score_codex":0.00012687838,"about_ca_topic_score_gemma":0.000055443998,"teacher_disagreement_score":0.18491988,"about_ca_system_score_codex":0.00043939508,"about_ca_system_score_gemma":0.000054041953,"threshold_uncertainty_score":0.88574517},"labels":[],"label_agreement":null},{"id":"W4365134805","doi":"10.1007/s00520-023-07717-3","title":"Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6","year":2023,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"ABVD; Medicine; Quality of life (healthcare); Dacarbazine; Randomized controlled trial; Stage (stratigraphy); Disease; Longitudinal study; Clinical trial; Pediatrics; Physical therapy; Internal medicine; Surgery; Chemotherapy; Vincristine; Pathology","score_opus":0.04750010836059008,"score_gpt":0.37607033327692524,"score_spread":0.32857022491633514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365134805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888857,0.0029035062,7.1636697e-7,0.0024592055,0.00025186263,0.0050152265,0.00020097608,0.000010796376,0.00027199436],"genre_scores_gemma":[0.9967421,0.0007057532,0.0000028969628,0.00023511137,0.00002942713,0.0021163884,0.00006440535,0.00001224532,0.000091670074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994843,0.0016731585,0.0021587028,0.0003535729,0.00063063164,0.00034093158],"domain_scores_gemma":[0.99643284,0.0018217212,0.0010550312,0.00042470903,0.0001996801,0.00006603452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00346243,0.00021624129,0.003407275,0.0005730206,0.000031641335,0.000010001927,0.00016602545,0.000117615025,0.00010766864],"category_scores_gemma":[0.0015404824,0.00011236913,0.0010027917,0.002839768,0.00018552216,0.000053836902,0.000048600225,0.00013666214,0.000001652728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3742579,0.0006977475,0.6123895,0.00008552064,0.0014315116,0.000047914287,0.01013748,0.00022490257,0.000003802891,0.00013959873,0.00005179198,0.0005323319],"study_design_scores_gemma":[0.4692259,0.0001785729,0.52693254,0.00012733178,0.00049717503,2.1230215e-7,0.0028383408,0.00008457801,0.000037942427,0.000018802617,0.000005505057,0.000053127977],"about_ca_topic_score_codex":0.06606112,"about_ca_topic_score_gemma":0.053927585,"teacher_disagreement_score":0.09496802,"about_ca_system_score_codex":0.0008002563,"about_ca_system_score_gemma":0.0013167005,"threshold_uncertainty_score":0.96333575},"labels":[],"label_agreement":null},{"id":"W4366064163","doi":"10.3747/co.v16i5.385","title":"131I–Tositumomab in Lymphoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; Cancer Care Ontario; Grand River Hospital; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radioimmunotherapy; Refractory (planetary science); Lymphoma; Oncology; Rituximab; Follicular lymphoma; Internal medicine; Non-Hodgkin's lymphoma; Monoclonal antibody; Clinical trial; Immunology; Antibody","score_opus":0.08046375294017716,"score_gpt":0.4106432427563107,"score_spread":0.33017948981613354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366064163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97108465,0.0038748484,0.000008625107,0.0041609323,0.000576827,0.00031304374,0.0000025756165,0.00005236936,0.019926108],"genre_scores_gemma":[0.9983228,0.0004706278,0.00015511308,0.00070202444,0.0001780291,0.000043457978,0.000028118777,0.0000062144372,0.000093626775],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990773,0.00004179538,0.00023491235,0.0002452676,0.00011934982,0.00028133663],"domain_scores_gemma":[0.99953264,0.000053989916,0.00005064487,0.00019826955,0.000034288085,0.0001301803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008506282,0.00013067755,0.00034506764,0.00013066443,0.000031062744,0.0000062409426,0.000060036255,0.00008959352,0.000098950135],"category_scores_gemma":[0.000038793634,0.00010506957,0.00008289535,0.00016745049,0.00003413511,0.00003618711,0.000019188627,0.000065882836,0.00020968635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013954593,0.0051760096,0.18420632,0.000013771021,0.0000149496245,0.00044803615,0.00018595379,5.6374387e-7,0.00016371602,0.0015997624,0.0057823416,0.80226904],"study_design_scores_gemma":[0.007350101,0.0012723572,0.7910515,0.00007311885,0.000052866035,0.00018511705,0.000033263477,0.000055750803,0.0006448842,0.00043076265,0.19875905,0.00009119868],"about_ca_topic_score_codex":0.000014662042,"about_ca_topic_score_gemma":0.000020918656,"teacher_disagreement_score":0.80217785,"about_ca_system_score_codex":0.00072321534,"about_ca_system_score_gemma":0.0002184301,"threshold_uncertainty_score":0.42846128},"labels":[],"label_agreement":null},{"id":"W4366251092","doi":"10.1016/j.jcjo.2023.03.015","title":"Feasibility of partial-orbit irradiation as a treatment strategy for patients with orbital mucosa-associated lymphoid tissue lymphoma","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Orbit (dynamics); Medicine; Lacrimal gland; Lymphoma; Radiation therapy; MALT lymphoma; Lymphatic system; Eyelid; Stage (stratigraphy); Nuclear medicine; Surgery; Radiology; Internal medicine; Pathology","score_opus":0.04373048570280448,"score_gpt":0.3155712979600792,"score_spread":0.27184081225727474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366251092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697953,0.00021174256,0.0000013742729,0.00027648066,0.00027073684,0.0007850239,0.00025713546,0.000007992131,0.0012100047],"genre_scores_gemma":[0.99913114,0.0000071289296,0.00007948831,0.000018251914,0.00007211924,0.000048592097,0.00023776616,0.00002853122,0.00037700485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839604,0.00008504817,0.00057598535,0.00023345793,0.00020801992,0.00050145615],"domain_scores_gemma":[0.9979389,0.00019230398,0.0004694957,0.00022036054,0.0005262263,0.0006527546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022347647,0.00021942265,0.000658064,0.00034355235,0.00011181394,0.000017506967,0.000094605886,0.0001625654,0.00028618853],"category_scores_gemma":[0.00023864809,0.00016381551,0.00018258319,0.00034190936,0.00011558813,0.00009161872,0.000006518649,0.00003714873,0.000021786169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007666934,0.0010889062,0.98499346,0.0000329546,0.00063687924,0.008494564,0.0003415804,0.00006940551,0.000030855295,0.00015283014,0.000380229,0.0030116723],"study_design_scores_gemma":[0.014368354,0.015647896,0.9570575,0.00007819846,0.0003894597,0.010778087,0.00014176096,0.000033262353,0.00084556965,0.00025869638,0.00025722687,0.00014400852],"about_ca_topic_score_codex":0.009163468,"about_ca_topic_score_gemma":0.0006403764,"teacher_disagreement_score":0.02793595,"about_ca_system_score_codex":0.001693921,"about_ca_system_score_gemma":0.0034478824,"threshold_uncertainty_score":0.9974346},"labels":[],"label_agreement":null},{"id":"W4366607155","doi":"10.1016/s2352-3026(23)00062-5","title":"Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Cancer Research UK; National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Internal medicine; Population; Lymphoma; Oncology; Chemotherapy; Immunology; Immune system","score_opus":0.010968648447637177,"score_gpt":0.27560009410366065,"score_spread":0.2646314456560235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366607155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955188,0.00045540082,0.0000016381452,0.0010921309,0.00019006117,0.001467596,0.00012001699,0.00003241647,0.0011219507],"genre_scores_gemma":[0.99919623,0.00013722495,0.000023506907,0.000120189405,0.000063047475,0.00017676917,0.00009851067,0.00002216337,0.00016234719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810547,0.00045846254,0.0004730111,0.0003096582,0.0002505,0.00040292213],"domain_scores_gemma":[0.997858,0.0006978183,0.00032519805,0.0010361177,0.00003745573,0.00004541453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056575524,0.00024499212,0.0020658944,0.00031742427,0.000047068257,0.00000813007,0.00031501177,0.00016131974,0.000072148425],"category_scores_gemma":[0.000075997275,0.00011214173,0.00032002944,0.0011284656,0.00022566483,0.00002420631,0.0001333605,0.00021792318,0.000026013362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13245943,0.004385311,0.83754444,0.0005626609,0.006629628,0.00034722275,0.0023360958,0.000110181994,0.0007248777,0.0005204817,0.0051445793,0.009235095],"study_design_scores_gemma":[0.14204985,0.0023502049,0.8331971,0.00017706002,0.0021138198,0.00010026675,0.000062092695,0.000117246425,0.019576717,0.000029931474,0.00011764052,0.00010805442],"about_ca_topic_score_codex":0.00061672734,"about_ca_topic_score_gemma":0.0002812736,"teacher_disagreement_score":0.018851839,"about_ca_system_score_codex":0.00008729172,"about_ca_system_score_gemma":0.00015725155,"threshold_uncertainty_score":0.4573007},"labels":[],"label_agreement":null},{"id":"W4366609228","doi":"10.1182/blood.2022018719","title":"Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"Michael Smith Health Research BC; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre; National Cancer Institute; Genome Canada","keywords":"Somatic hypermutation; Biology; Follicular lymphoma; Diffuse large B-cell lymphoma; Malignancy; Lymphoma; BCL6; Germinal center; Oncology; Genetics; Computational biology; Cancer research; Medicine; B cell; Immunology","score_opus":0.0138347985585874,"score_gpt":0.2504044069735727,"score_spread":0.23656960841498528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366609228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875087,0.0004506595,0.000094816794,0.00018714466,0.00003702024,0.00019330169,0.000060120332,0.00005379346,0.00017226028],"genre_scores_gemma":[0.9991878,0.0002522264,0.00028941897,0.000032935062,0.000028549204,0.000038222526,0.00011013713,0.000014517832,0.000046152054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993136,0.00001726356,0.00018125739,0.00017954428,0.00015968073,0.00014868271],"domain_scores_gemma":[0.999563,0.00012764355,0.00005950104,0.00013669707,0.000029384157,0.00008380681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059241076,0.000097698714,0.00019301004,0.0000705844,0.000063557396,0.0000126441655,0.000027412016,0.00003946834,0.000016851076],"category_scores_gemma":[0.00006333206,0.000080495236,0.000057193694,0.00015922847,0.000020086853,0.000022620789,0.000034366072,0.000014872727,0.000015195021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009926392,0.0006777124,0.98044944,0.000103593076,0.00014949337,0.0002976839,0.00019410718,0.000001192714,0.006022452,0.00007606152,0.00028344934,0.011734905],"study_design_scores_gemma":[0.0054052044,0.00021566018,0.96934503,0.00015512783,0.00040682437,0.00008611097,0.00008048663,0.0002954106,0.02378418,0.00003542168,0.00011266076,0.00007788857],"about_ca_topic_score_codex":0.00013984571,"about_ca_topic_score_gemma":0.000012375029,"teacher_disagreement_score":0.017761728,"about_ca_system_score_codex":0.000024266685,"about_ca_system_score_gemma":0.000024545312,"threshold_uncertainty_score":0.32825005},"labels":[],"label_agreement":null},{"id":"W4367042961","doi":"10.1016/j.ijrobp.2023.04.022","title":"Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Radiation oncology; Refractory (planetary science); Radiation therapy; Lymphoma; Hodgkin lymphoma; Oncology; Pediatric oncology; Internal medicine; Pediatrics; Cancer","score_opus":0.021292107879104787,"score_gpt":0.3126337855775956,"score_spread":0.2913416776984908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367042961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898865,0.001649512,0.00014479438,0.0063477587,0.0014205538,0.00039102035,0.00006146772,0.000035328565,0.000063067455],"genre_scores_gemma":[0.9768522,0.019162988,0.00042621448,0.0018527543,0.0012414078,0.000032838765,0.0003880446,0.000024530216,0.00001904065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980535,0.00035796955,0.0007802855,0.00032269728,0.00027073815,0.00021480893],"domain_scores_gemma":[0.99744254,0.0009609519,0.0009693063,0.00018242869,0.00032532227,0.000119430675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006236682,0.00021230288,0.00048877706,0.0001896081,0.00008407536,0.000043880107,0.00016294209,0.00028307698,0.00001356866],"category_scores_gemma":[0.0005676854,0.00015188337,0.0001337725,0.00020265266,0.0001863178,0.00029060597,0.00006482934,0.0002889734,0.0000101275355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053458,0.0006246426,0.69279635,0.0000014426422,0.00039994819,0.0003252868,0.00052545476,0.000010557853,0.00044451375,0.00061785284,0.0014908414,0.3022285],"study_design_scores_gemma":[0.015194423,0.0010805615,0.96784604,0.00006868262,0.00010491855,0.00088901864,0.00010583197,0.00045860765,0.00021536814,0.0014268366,0.01248458,0.00012516382],"about_ca_topic_score_codex":0.0006683147,"about_ca_topic_score_gemma":0.00009150627,"teacher_disagreement_score":0.30210334,"about_ca_system_score_codex":0.0010900325,"about_ca_system_score_gemma":0.00040320298,"threshold_uncertainty_score":0.6193624},"labels":[],"label_agreement":null},{"id":"W4367551202","doi":"10.1007/s00109-023-02313-8","title":"PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Journal of Molecular Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Natural Science Foundation of Shandong Province; China Postdoctoral Science Foundation; Key Technology Research and Development Program of Shandong; National Natural Science Foundation of China","keywords":"Mantle cell lymphoma; Molecular medicine; Value (mathematics); Cancer research; Cell; Lymphoma; Chemistry; Internal medicine; Biology; Medicine; Oncology; Pathology; Genetics; Cell cycle; Mathematics; Statistics","score_opus":0.012934337891377184,"score_gpt":0.24975669209539417,"score_spread":0.23682235420401698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367551202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381506,0.0032330237,0.00010682096,0.0006898428,0.00043515148,0.00040676387,0.000009839217,0.000032128108,0.0012713815],"genre_scores_gemma":[0.9978698,0.001295816,0.00031603719,0.00015377252,0.00022173217,0.0000239799,0.00002843172,0.000040136823,0.000050321654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972002,0.0002803941,0.0010325557,0.0002871633,0.0008272664,0.0003724041],"domain_scores_gemma":[0.99836427,0.0002059541,0.00068291876,0.0002734756,0.00019034915,0.0002830486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010668203,0.00026996207,0.0008709708,0.00093455426,0.00004421417,0.000009795376,0.000133464,0.00014363402,0.000027609572],"category_scores_gemma":[0.00028808834,0.00018427715,0.00014805008,0.0010179956,0.000061678686,0.00009442641,0.000060249633,0.0002633327,0.000034560795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021313964,0.0024910246,0.29669213,0.0009953618,0.00039074683,0.14388134,0.0037410036,0.0025374086,0.51643515,0.00013931347,0.0058102394,0.024754858],"study_design_scores_gemma":[0.041367043,0.0020405755,0.64539784,0.018687095,0.00042388318,0.0012436849,0.0036593361,0.0022693202,0.28396827,0.000098575365,0.0005499722,0.00029443187],"about_ca_topic_score_codex":0.00035333118,"about_ca_topic_score_gemma":0.000015681242,"teacher_disagreement_score":0.34870568,"about_ca_system_score_codex":0.0007122532,"about_ca_system_score_gemma":0.00024353758,"threshold_uncertainty_score":0.75146043},"labels":[],"label_agreement":null},{"id":"W4367603471","doi":"10.1016/j.leukres.2023.107239","title":"Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Kingston Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Arch; Lymphoma; Medicine; Business; Intensive care medicine; Engineering; Structural engineering; Pathology","score_opus":0.02424807262812283,"score_gpt":0.3532056420237922,"score_spread":0.32895756939566934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367603471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951426,0.00015080866,3.1353198e-7,0.0011053111,0.00006692153,0.00080174574,0.000036431404,0.000035051264,0.0026608468],"genre_scores_gemma":[0.99735373,0.00038848422,0.000014489636,0.00010379709,0.000032891076,0.000066114764,0.00015314679,0.000033380988,0.0018539603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765843,0.00019033055,0.00035064243,0.0003515675,0.00088216877,0.0005668811],"domain_scores_gemma":[0.99858105,0.0005858635,0.00006611692,0.00046705935,0.00016102567,0.00013886424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067356904,0.00020644041,0.0003949922,0.00043375642,0.00013175812,0.000041425956,0.00017946385,0.00016127696,0.000104115075],"category_scores_gemma":[0.00021608033,0.0001205312,0.00017710337,0.0007722174,0.00024327371,0.000057975634,0.00012839175,0.0002651687,0.000053890708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028440735,0.0006748103,0.96538514,0.00005458352,0.00026469023,0.00009419984,0.0009259834,0.000019336112,0.000045226017,0.000994949,0.0012969564,0.029959736],"study_design_scores_gemma":[0.009281145,0.0006749361,0.9854921,0.00018561527,0.00001937598,0.0000071642085,0.0002321488,0.002762605,0.00054283364,0.00058994716,0.00010904355,0.000103078135],"about_ca_topic_score_codex":0.005476427,"about_ca_topic_score_gemma":0.00019777156,"teacher_disagreement_score":0.02985666,"about_ca_system_score_codex":0.0035256562,"about_ca_system_score_gemma":0.0005872326,"threshold_uncertainty_score":0.9219468},"labels":[],"label_agreement":null},{"id":"W4367673623","doi":"10.1016/s2352-3026(23)00030-3","title":"European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours","year":2023,"lang":"en","type":"review","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Ministero della Salute; Regeneron Pharmaceuticals; Associazione Italiana per la Ricerca sul Cancro; Celgene; Society of Nuclear Medicine and Molecular Imaging; Gilead Sciences; Sanofi; Siemens Healthineers; Bristol-Myers Squibb; Amgen","keywords":"Appropriate Use Criteria; Medicine; Delphi method; Medical physics; Evidence-based medicine; MEDLINE; Interim; Expert opinion; Consensus conference; Family medicine; Alternative medicine; Artificial intelligence; Computer science; Pathology; Political science; Intensive care medicine; Internal medicine","score_opus":0.09752737482974728,"score_gpt":0.374843280926998,"score_spread":0.2773159060972507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367673623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025971697,0.94707197,0.0000010473035,0.047235064,0.00014933568,0.00093405065,0.000027544032,0.000084762745,0.0018990772],"genre_scores_gemma":[0.005933754,0.9927461,0.000109585744,0.00089562667,0.00008932977,0.00006702162,0.00007339819,0.000057600715,0.000027541633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710953,0.001185134,0.0008263306,0.00035772394,0.00018131486,0.0003399344],"domain_scores_gemma":[0.9973322,0.0014284936,0.0006779006,0.00043689637,0.00006314522,0.00006137743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011825889,0.00030810133,0.0034855148,0.00021010077,0.00005551362,0.0000100948155,0.00018262528,0.00015503235,0.000050862887],"category_scores_gemma":[0.00062181376,0.00017227518,0.0001709921,0.00031303233,0.00022157675,0.000012675513,0.00010738107,0.0003189879,0.00007082567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013512542,0.000440263,0.016618408,0.008667587,0.0011782043,0.008534837,0.0009810342,3.2204508e-7,0.0000045523225,0.021388918,0.05231503,0.8897357],"study_design_scores_gemma":[0.006350443,0.0003434959,0.0026830202,0.019879619,0.0017749381,0.0061228815,0.00029106482,0.000017352524,0.0000068874824,0.0024440351,0.9597183,0.0003679741],"about_ca_topic_score_codex":0.00008928248,"about_ca_topic_score_gemma":0.000015328791,"teacher_disagreement_score":0.90740323,"about_ca_system_score_codex":0.00016806518,"about_ca_system_score_gemma":0.000093634204,"threshold_uncertainty_score":0.7025178},"labels":[],"label_agreement":null},{"id":"W4367852933","doi":"10.3390/curroncol30050352","title":"Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Ontario","keywords":"Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Oncology; Cancer","score_opus":0.03782033243266207,"score_gpt":0.3141249817923656,"score_spread":0.2763046493597035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367852933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963089,0.0010368288,0.000008141527,0.0012254041,0.0006476855,0.00036725804,0.000011850785,0.000012024544,0.00038190366],"genre_scores_gemma":[0.9993939,0.00006936873,0.00019320851,0.000030803723,0.00006409823,0.00008404915,0.00004364917,0.000010639847,0.00011030976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988124,0.00007537745,0.0004042316,0.00021857352,0.00024071276,0.0002487221],"domain_scores_gemma":[0.9991317,0.00030253857,0.0001805677,0.00023149952,0.000073517855,0.00008018022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002413465,0.00014041516,0.00050234195,0.00010405606,0.000051973602,0.000003344105,0.00009130511,0.00007173616,0.000047883514],"category_scores_gemma":[0.000092289265,0.00009718996,0.0000588418,0.0002763165,0.00012235431,0.000022791552,0.000089771296,0.000056171953,0.0000025829129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026941934,0.0009073341,0.6021065,0.00030821713,0.00020141873,0.00059942907,0.0048744422,0.00038773558,0.00020823663,0.00041916757,0.0042772815,0.3854408],"study_design_scores_gemma":[0.01015458,0.0004223652,0.9421852,0.0003838712,0.00020101373,0.0001455842,0.0012060998,0.004866536,0.0006528975,0.00008171343,0.03957037,0.00012975329],"about_ca_topic_score_codex":0.84527254,"about_ca_topic_score_gemma":0.77049357,"teacher_disagreement_score":0.38531104,"about_ca_system_score_codex":0.0011295296,"about_ca_system_score_gemma":0.0020271572,"threshold_uncertainty_score":0.39632913},"labels":[],"label_agreement":null},{"id":"W4368617660","doi":"10.14740/jh1087","title":"Primary Diffuse Large B-Cell Lymphoma of the Bone","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoimmunotherapy; Vincristine; Prednisone; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Cyclophosphamide; Radiation therapy; CHOP; Oncology; Internal medicine; Pathology; Chemotherapy","score_opus":0.011144186136802155,"score_gpt":0.2529127904437643,"score_spread":0.24176860430696215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368617660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992355,0.0019616059,0.0000045379315,0.0036422291,0.0003141238,0.00009780244,0.000003929217,0.000009503966,0.001611251],"genre_scores_gemma":[0.99839175,0.00036661423,0.0001276357,0.0005709252,0.000058167832,0.000003122095,0.0000020055588,0.0000106269035,0.0004691678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990232,0.00004779219,0.0004422533,0.00007269817,0.00023215266,0.00018190047],"domain_scores_gemma":[0.99908817,0.00015429057,0.0003749756,0.00021063912,0.00009756461,0.00007437449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001979397,0.00008547178,0.00049285666,0.000118664044,0.000036336834,0.0000029248913,0.00009602577,0.00007290844,0.00003423185],"category_scores_gemma":[0.00007365214,0.000045698704,0.00025543806,0.00019770779,0.000051392133,0.00002896859,0.000066359265,0.000060917828,0.000041493735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007053052,0.021792239,0.816291,0.00075969094,0.00069828803,0.006492098,0.0009926329,0.0000017023746,0.015002662,0.0062341704,0.12578645,0.005243789],"study_design_scores_gemma":[0.045901805,0.0009291348,0.8039153,0.00039333806,0.0005669244,0.015132758,0.00034712994,0.000025624251,0.10131103,0.0007899703,0.030562334,0.00012463906],"about_ca_topic_score_codex":0.0000037041848,"about_ca_topic_score_gemma":0.0000020418295,"teacher_disagreement_score":0.09522412,"about_ca_system_score_codex":0.00007096373,"about_ca_system_score_gemma":0.00018790577,"threshold_uncertainty_score":0.1863539},"labels":[],"label_agreement":null},{"id":"W4376224490","doi":"10.2196/45455","title":"Epidemiology and a Predictive Model of Prognosis Index Based on Machine Learning in Primary Breast Lymphoma: Population-Based Study","year":2023,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Epidemiology; Medicine; Lymphoma; Population; Index (typography); Oncology; Medical physics; Computer science; Internal medicine; Environmental health; World Wide Web","score_opus":0.03958970828950156,"score_gpt":0.3183480668817851,"score_spread":0.2787583585922835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376224490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900765,0.00029800017,0.00007518256,0.008900003,0.000021361895,0.0014267534,0.00011616687,0.000082636594,0.00007226339],"genre_scores_gemma":[0.99714154,0.00007203609,0.0000875462,0.0016411515,0.000018076062,0.00052588957,0.00047671713,0.000017274875,0.000019787165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978614,0.00054777303,0.00052238104,0.00042385535,0.00021663921,0.00042797255],"domain_scores_gemma":[0.9983289,0.00085091544,0.0002049569,0.00017979827,0.00006936813,0.00036601746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017307927,0.00017692718,0.00070479803,0.000369044,0.000102324666,0.00000707191,0.00003897322,0.00008654479,0.0000032866678],"category_scores_gemma":[0.00035986217,0.00014035418,0.00004153778,0.00047896348,0.000042757016,0.00004573071,0.00002975055,0.0001086452,8.8804387e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048128207,0.0014381105,0.9715067,0.00028200078,0.000024376437,0.000009357527,0.00023094546,0.002147382,3.330641e-7,0.000019287632,0.000036278372,0.023823926],"study_design_scores_gemma":[0.0045005167,0.00096451613,0.6511831,0.000037305144,0.0000012963085,0.0000030047986,0.00006401014,0.3431544,5.730889e-8,0.000008400889,0.00002435867,0.00005898572],"about_ca_topic_score_codex":0.00071953103,"about_ca_topic_score_gemma":0.00021977352,"teacher_disagreement_score":0.34100702,"about_ca_system_score_codex":0.00026955627,"about_ca_system_score_gemma":0.0007581556,"threshold_uncertainty_score":0.57234776},"labels":[],"label_agreement":null},{"id":"W4377233023","doi":"10.1101/2023.05.19.541331","title":"The spatially resolved tumor microenvironment predicts treatment outcome in relapsed/refractory Hodgkin lymphoma","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; University Health Network","funders":"","keywords":"Tumor microenvironment; Lymphoma; Oncology; Refractory (planetary science); Cancer research; Medicine; Internal medicine; Pathology; Biology; Cancer","score_opus":0.024867297953105,"score_gpt":0.24325438463941504,"score_spread":0.21838708668631004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377233023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877927,0.004409151,0.000020321151,0.0020106921,0.001792965,0.0030913227,0.00035709198,0.00050274015,0.000023048746],"genre_scores_gemma":[0.9920194,0.0033433842,0.0009525725,0.0003930451,0.00053934846,0.0023198794,0.000003856149,0.00029771763,0.00013079347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946329,0.00027628677,0.0014136791,0.0016706197,0.00085921935,0.0011473154],"domain_scores_gemma":[0.9954971,0.00040629884,0.0006802688,0.0027199,0.00014372598,0.000552721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007752273,0.0011284966,0.0013451069,0.0003990004,0.0003172633,0.00021244104,0.000545158,0.00056966685,0.000037139587],"category_scores_gemma":[0.0003168208,0.000834484,0.0005127885,0.00042145778,0.00025757775,0.00006572929,0.0006216617,0.00048558592,0.00047245857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076751976,0.0051010116,0.94065696,0.00052063057,0.0016002735,0.00568734,0.0000724889,0.00016386936,0.043778066,0.00016237993,0.0013216723,0.00016781437],"study_design_scores_gemma":[0.007447313,0.0007523417,0.92841136,0.00088442356,0.00057691283,2.131654e-7,0.000008766565,0.0001498071,0.03869866,0.0000022038885,0.022377996,0.00069001503],"about_ca_topic_score_codex":0.00087330077,"about_ca_topic_score_gemma":0.00012243037,"teacher_disagreement_score":0.021056322,"about_ca_system_score_codex":0.0053653717,"about_ca_system_score_gemma":0.0013529211,"threshold_uncertainty_score":0.99941057},"labels":[],"label_agreement":null},{"id":"W4377966778","doi":"10.21203/rs.3.rs-2897256/v1","title":"Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pathological; Cytology; Medicine; Pathology","score_opus":0.2468369160165553,"score_gpt":0.47855463832287937,"score_spread":0.23171772230632406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377966778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506766,0.0031932748,0.00015111979,0.03667594,0.00041078735,0.0071989023,0.0011735389,0.0001034863,0.0004163125],"genre_scores_gemma":[0.9781093,0.009113812,0.00041207776,0.00023423597,0.00033392728,0.011022106,0.00021647968,0.000054214604,0.00050383137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964966,0.00040246008,0.0005406209,0.00088721403,0.000920322,0.000752765],"domain_scores_gemma":[0.9924914,0.0048334897,0.0001306861,0.0011741143,0.0011543183,0.00021599734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001261955,0.00033287646,0.00087934476,0.00028254912,0.00024531246,0.000062917556,0.00045405483,0.0005667264,0.0004318922],"category_scores_gemma":[0.0018701869,0.00018822955,0.00052030146,0.00032294335,0.00053606345,0.00002256736,0.0014185964,0.00093306805,0.0001311473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012169488,0.003780593,0.84332424,0.0034331062,0.0022239096,0.0011388698,0.0055151596,0.0001117842,0.00027137704,0.0051411455,0.08341474,0.050428126],"study_design_scores_gemma":[0.0034328408,0.00430817,0.9377522,0.0014938227,0.00038640088,0.000046785237,0.0018287277,0.00068098004,0.031006705,0.0052922345,0.01343084,0.00034033234],"about_ca_topic_score_codex":0.0006922179,"about_ca_topic_score_gemma":0.00011711877,"teacher_disagreement_score":0.09442792,"about_ca_system_score_codex":0.00046233914,"about_ca_system_score_gemma":0.00066341605,"threshold_uncertainty_score":0.7675778},"labels":[],"label_agreement":null},{"id":"W4378212038","doi":"10.1101/2023.05.24.542195","title":"Single Cell Spatial Analysis and Biomarker Discovery in Hodgkin Lymphoma","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Tumor microenvironment; Immune system; CD8; Mass cytometry; Cancer research; T cell; Biology; Lymphoma; Immunotherapy; Immunology; Phenotype","score_opus":0.020334262766285457,"score_gpt":0.23478062928214358,"score_spread":0.21444636651585813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378212038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957705,0.0014732359,0.00041304083,0.00039909602,0.000547945,0.00080310315,0.00031763804,0.00025339643,0.000022004768],"genre_scores_gemma":[0.9972968,0.00071024144,0.0011699315,0.00015475549,0.00020251414,0.00029783163,0.0000042573765,0.00013192865,0.00003175542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996771,0.00012394448,0.00066777033,0.0013676471,0.0004703117,0.00059937104],"domain_scores_gemma":[0.9977936,0.00015161156,0.0003273848,0.0012396477,0.00015694303,0.00033080703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004022584,0.00064764835,0.0011877487,0.0011947113,0.00008195385,0.0002776563,0.0002007547,0.00054306583,0.00003124942],"category_scores_gemma":[0.00012730173,0.0006129657,0.00037513606,0.0014327462,0.0001268241,0.00013538399,0.00054095744,0.00022390332,0.000062597406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017089733,0.00179976,0.8789996,0.0005462648,0.0018060408,0.0013639291,0.000017852302,0.000021643238,0.11496244,0.00003308905,0.00022496186,0.000053506606],"study_design_scores_gemma":[0.0024951363,0.00010769477,0.8832482,0.0003745079,0.001948155,3.158248e-8,0.00000384482,0.00051528204,0.11029684,0.0000011792079,0.00049469766,0.0005143953],"about_ca_topic_score_codex":0.002528241,"about_ca_topic_score_gemma":0.00019033493,"teacher_disagreement_score":0.00466561,"about_ca_system_score_codex":0.0008401049,"about_ca_system_score_gemma":0.0005171656,"threshold_uncertainty_score":0.9996322},"labels":[],"label_agreement":null},{"id":"W4378530625","doi":"10.1002/pbc.30452","title":"Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831","year":2023,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"Provincial Health Services Authority; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Nuclear medicine; Mediastinal mass; Radiology; Hazard ratio; Hodgkin lymphoma; Mediastinum; Lymphoma; Confidence interval; Internal medicine","score_opus":0.010441758712580882,"score_gpt":0.26723106263755225,"score_spread":0.25678930392497135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378530625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98166317,0.0141683435,0.0000028035374,0.0007652223,0.00056049484,0.0022122597,0.0004609914,0.00012517514,0.000041570387],"genre_scores_gemma":[0.9816357,0.013928066,0.00023356458,0.00012232744,0.002485858,0.0012625371,0.00024113178,0.00006469852,0.00002614294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622345,0.00034773565,0.0010318154,0.000944913,0.00074267027,0.0007094277],"domain_scores_gemma":[0.9966513,0.0016496308,0.0007076067,0.00061942375,0.00011630632,0.00025574592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010571717,0.00045422322,0.0010361717,0.00037630263,0.00016445246,0.000027636217,0.00023735431,0.00015259776,0.00009688115],"category_scores_gemma":[0.0009417503,0.0003193687,0.0001568888,0.0016969881,0.0000803627,0.00008330643,0.00027909948,0.00028909848,0.00003426067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018799477,0.0058695525,0.9829179,0.00008874235,0.00038844717,0.0031920339,0.0013071803,0.00001131635,0.000004467068,0.000020245863,0.0012399005,0.0047721853],"study_design_scores_gemma":[0.018338501,0.0017813081,0.97119397,0.00004188408,0.007448137,0.00022417205,0.00043566927,0.000032139636,0.00001729295,0.00007227179,0.00013434365,0.00028033982],"about_ca_topic_score_codex":0.015201629,"about_ca_topic_score_gemma":0.0015264287,"teacher_disagreement_score":0.018150507,"about_ca_system_score_codex":0.00019092936,"about_ca_system_score_gemma":0.00083668117,"threshold_uncertainty_score":0.99992585},"labels":[],"label_agreement":null},{"id":"W4378675662","doi":"10.1016/j.clml.2023.05.013","title":"External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Janssen Canada; Janssen Pharmaceuticals; Canadian Institutes of Health Research","keywords":"Medicine; Follicular lymphoma; Internal medicine; Oncology; Follicular phase; Lymphoma","score_opus":0.029738740034475547,"score_gpt":0.2829057458374034,"score_spread":0.25316700580292784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378675662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582595,0.0012907885,0.0000025136665,0.0007021986,0.00024711865,0.0014131127,0.00019190852,0.00008865728,0.00023777838],"genre_scores_gemma":[0.9967163,0.001333873,0.000120628654,0.0002991078,0.00016857035,0.00032323127,0.00009339136,0.00007463511,0.0008702314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523693,0.0006869347,0.0014464705,0.000799704,0.0013107003,0.00051926565],"domain_scores_gemma":[0.9947771,0.0020170587,0.001190618,0.0014044391,0.00027193132,0.00033889632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018233763,0.00047201148,0.0010923508,0.00012931325,0.00040276087,0.000040267623,0.00041940657,0.00037957652,0.00014143044],"category_scores_gemma":[0.0011436485,0.00025039958,0.0006638174,0.0007932143,0.0012683048,0.00012824762,0.00062961056,0.00013524097,0.00015835397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059715693,0.00041396578,0.93752366,0.00007656942,0.00079220656,0.00011836,0.00035596592,0.00004523896,0.00039179542,0.000047417332,0.002652769,0.056984875],"study_design_scores_gemma":[0.008920367,0.0007740443,0.94219154,0.00084243575,0.0014981992,0.00015906691,0.00006193535,0.00017808733,0.04375709,0.00016140776,0.0012020065,0.0002538427],"about_ca_topic_score_codex":0.0004963045,"about_ca_topic_score_gemma":0.00010594597,"teacher_disagreement_score":0.05673103,"about_ca_system_score_codex":0.0013480914,"about_ca_system_score_gemma":0.00063623255,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W4378953570","doi":"10.1080/10428194.2023.2216819","title":"Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score","year":2023,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Novo Nordisk Fonden; Greater Copenhagen Health Science Partners; Lundbeckfonden; Kræftens Bekæmpelse","keywords":"Mantle cell lymphoma; Internal medicine; Oncology; Medicine; Lymphoma; Geology","score_opus":0.055044144537478974,"score_gpt":0.2632539157212679,"score_spread":0.20820977118378892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378953570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873681,0.0064501,0.0000052577575,0.0010969425,0.00053486077,0.0018611475,0.000029935583,0.00019575839,0.0024578793],"genre_scores_gemma":[0.99519897,0.0026551073,0.00012733058,0.00048081085,0.00020340928,0.0004848882,0.0000513365,0.00011168334,0.0006864896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954587,0.0002606597,0.0012220786,0.001079337,0.00089052244,0.0010886947],"domain_scores_gemma":[0.99666363,0.0011079704,0.0004752926,0.0011652687,0.00010598857,0.00048184168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006377799,0.0007924865,0.0014251479,0.0004682898,0.00047353364,0.00013950602,0.0005147144,0.0003275747,0.000019604176],"category_scores_gemma":[0.00028571833,0.00049398595,0.00042279964,0.001898665,0.00096125284,0.0003109043,0.0005890199,0.00013175233,0.000054857264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020067282,0.00082843454,0.71654326,0.00087007,0.00064285385,0.00047484037,0.00723246,0.00007446999,0.0012001179,0.0018791441,0.0051328675,0.26311478],"study_design_scores_gemma":[0.06041758,0.00031602875,0.9129665,0.0012288067,0.0007052843,0.00048985577,0.0031332267,0.005217808,0.010812858,0.00048488262,0.0036554527,0.00057170715],"about_ca_topic_score_codex":0.0056383223,"about_ca_topic_score_gemma":0.00032146744,"teacher_disagreement_score":0.26254308,"about_ca_system_score_codex":0.0030124453,"about_ca_system_score_gemma":0.0028853384,"threshold_uncertainty_score":0.99975115},"labels":[],"label_agreement":null},{"id":"W4378953885","doi":"10.1182/blood.2023020396","title":"Targeted therapy in mediastinal gray zone lymphoma","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Ibrutinib; Gray (unit); Internal medicine; Radiology; Surgery; Chronic lymphocytic leukemia; Leukemia","score_opus":0.022466062525544585,"score_gpt":0.25448360834420963,"score_spread":0.23201754581866504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378953885","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4928947,0.005282181,0.000001499663,0.4967926,0.0010760821,0.0013882547,0.00017208532,0.00041770568,0.001974879],"genre_scores_gemma":[0.13530302,0.005586144,0.0006386021,0.8294326,0.012853902,0.0015490869,0.0050348197,0.0004480523,0.009153779],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978391,0.00007188591,0.00039922085,0.0005637635,0.0005679294,0.0005581144],"domain_scores_gemma":[0.99897367,0.00022793746,0.00012572158,0.0005090432,0.00005993731,0.000103674116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011647214,0.000434547,0.0007614196,0.0003605231,0.000039096823,0.000026191572,0.00015147973,0.0006450498,0.00024380292],"category_scores_gemma":[0.00005721388,0.0003275848,0.00025047798,0.00039402736,0.00005818349,0.000027863829,0.000044090673,0.00037862136,0.0006554072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007469345,0.0021384351,0.06013787,0.00013863368,0.0007345871,0.032604687,0.00018821952,1.650185e-7,0.000100486446,0.00000451361,0.88903064,0.01484708],"study_design_scores_gemma":[0.030344386,0.0011505284,0.33875674,0.00066964043,0.0005471791,0.00050562265,0.00002338723,0.0000037589773,0.0032193733,0.000058714068,0.6242104,0.000510242],"about_ca_topic_score_codex":0.0005209455,"about_ca_topic_score_gemma":0.000052094645,"teacher_disagreement_score":0.3575917,"about_ca_system_score_codex":0.00015908414,"about_ca_system_score_gemma":0.00029046036,"threshold_uncertainty_score":0.9999176},"labels":[],"label_agreement":null},{"id":"W4378979009","doi":"10.1016/s2352-3026(23)00094-7","title":"Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study","year":2023,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; University of California, San Francisco; Centers for Disease Control and Prevention; Dana-Farber/Harvard Cancer Center; University of Southern California; California Department of Public Health; American Society of Hematology","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Mental health; Gerontology; Internal medicine; Pediatrics; Oncology; Psychiatry","score_opus":0.015844687599885176,"score_gpt":0.28512575649984684,"score_spread":0.2692810688999617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378979009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914953,0.00006493435,0.0000016219694,0.0068106037,0.00007430429,0.0014111691,0.000027200154,0.000034858145,0.00008001454],"genre_scores_gemma":[0.9984586,0.000034199173,0.0000095663445,0.0011102929,0.000019833462,0.00018051,0.00015069087,0.000014681111,0.000021612599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987399,0.00028218393,0.00018784268,0.00022035446,0.00022148919,0.00034823723],"domain_scores_gemma":[0.9993043,0.0002241813,0.000086592445,0.0003261491,0.000012076998,0.000046724817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031367847,0.00014174634,0.0005099406,0.0000660046,0.00017404823,0.000014904186,0.00009889783,0.000033521414,0.000009647823],"category_scores_gemma":[0.000015520249,0.00006718525,0.00002811621,0.00024150028,0.000051673473,0.000027171855,0.000039160535,0.000057518962,0.000015009036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014152052,0.005220438,0.9906481,0.00004531812,0.000033679335,0.00004623514,0.002982296,0.0000018283458,5.1241717e-8,0.00015273865,0.0003777641,0.00035006017],"study_design_scores_gemma":[0.03417934,0.00042008742,0.96390235,0.0000340234,0.00003743266,0.0000063577786,0.0011179465,0.0001142998,9.1318947e-7,0.000026010026,0.00009376622,0.00006749352],"about_ca_topic_score_codex":0.0019422871,"about_ca_topic_score_gemma":0.018347347,"teacher_disagreement_score":0.03403782,"about_ca_system_score_codex":0.000075641175,"about_ca_system_score_gemma":0.000055011904,"threshold_uncertainty_score":0.99956524},"labels":[],"label_agreement":null},{"id":"W4378980099","doi":"10.1200/edbk_390334","title":"Frontline Management of Nodal Peripheral T-Cell Lymphomas","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Brentuximab vedotin; Vincristine; Medicine; Lymphoma; Oncology; BCL6; Internal medicine; CD30; Anthracycline; Peripheral T-cell lymphoma; CHOP; Cyclophosphamide; Cancer research; Chemotherapy; Immunology; T cell; B cell; Cancer; Breast cancer; Immune system","score_opus":0.061678216736186245,"score_gpt":0.43936448155116903,"score_spread":0.3776862648149828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378980099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9002753,0.00058349624,0.00002601838,0.053772297,0.00043139947,0.00044259147,0.000027660282,0.00004258422,0.04439866],"genre_scores_gemma":[0.92140317,0.0037516428,0.03015912,0.0074229892,0.00041622625,0.00012824521,0.0001638646,0.000021861237,0.03653288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981244,0.00007943507,0.0009438576,0.00031470085,0.0003192484,0.00021831354],"domain_scores_gemma":[0.99763924,0.001146619,0.00056314294,0.0002812548,0.00018525534,0.00018447985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045455282,0.0001387332,0.00083053875,0.000031314547,0.00004430314,0.00000206487,0.00012059347,0.00010483052,0.00091253244],"category_scores_gemma":[0.000052141306,0.0001174094,0.0006935151,0.0002692673,0.000980488,0.000034947352,0.0000767739,0.00010366713,0.000106032094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045046123,0.009361713,0.4902997,0.0002120725,0.00144593,0.000018196593,0.00075095036,0.000027642318,0.00013924128,0.0021554567,0.3080083,0.18713032],"study_design_scores_gemma":[0.0039629783,0.0016370325,0.7755665,0.000045811947,0.0003013442,0.0000058060155,0.001685936,0.00014215862,0.00015841323,0.00019621653,0.2162048,0.00009300047],"about_ca_topic_score_codex":0.00013097005,"about_ca_topic_score_gemma":0.000001932356,"teacher_disagreement_score":0.2852668,"about_ca_system_score_codex":0.00025993408,"about_ca_system_score_gemma":0.0012973787,"threshold_uncertainty_score":0.99915904},"labels":[],"label_agreement":null},{"id":"W4379281872","doi":"10.1200/jco.2023.41.16_suppl.7555","title":"Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Adverse effect; Follicular lymphoma; Regimen; Phases of clinical research; Refractory (planetary science); Surgery; Lymphoma; Gastroenterology; Clinical trial","score_opus":0.0552513847129782,"score_gpt":0.3780557654255918,"score_spread":0.32280438071261364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947213,0.00010539795,2.122627e-7,0.0036678235,0.000598026,0.00071628095,0.000027959919,0.0000065393206,0.00015643897],"genre_scores_gemma":[0.9986059,0.00036118075,0.000077113706,0.0005021306,0.0003602885,0.0000053093263,0.00000850631,0.000015533959,0.00006405077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961609,0.0007865987,0.0020867714,0.00024053908,0.00054353924,0.00018164814],"domain_scores_gemma":[0.9902402,0.0074554808,0.0015132698,0.00040271,0.00023000767,0.00015829176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020224191,0.00014936882,0.0011393318,0.00006400798,0.000067023735,0.000007876409,0.00018992556,0.00020818715,0.000017278297],"category_scores_gemma":[0.00496481,0.000058392256,0.00019331268,0.00033028013,0.00020130911,0.00005922082,0.00012337982,0.0003634481,0.0000075957832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04877756,0.01180946,0.8976751,0.00000550568,0.0005676467,0.00036717247,0.00082871254,0.00002218074,0.0000031925015,0.000004794068,0.0030372115,0.036901437],"study_design_scores_gemma":[0.11141225,0.026856255,0.85010517,0.00022484874,0.00042091627,0.0000076157453,0.00068808335,0.000008011417,0.0000116503925,0.0000069851826,0.010203004,0.00005518964],"about_ca_topic_score_codex":0.00020106477,"about_ca_topic_score_gemma":0.0004112528,"teacher_disagreement_score":0.062634684,"about_ca_system_score_codex":0.00024412025,"about_ca_system_score_gemma":0.0009876301,"threshold_uncertainty_score":0.59436995},"labels":[],"label_agreement":null},{"id":"W4379339089","doi":"10.1200/jco.2023.41.16_suppl.7545","title":"Zanubrutinib plus obinutuzumab versus obinutuzumab in patients with relapsed/refractory follicular lymphoma: Updated analysis of the ROSEWOOD study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"BeiGene","keywords":"Medicine; Obinutuzumab; Internal medicine; Follicular lymphoma; Rituximab; Clinical endpoint; International Prognostic Index; Oncology; Refractory (planetary science); Progression-free survival; Neutropenia; Salvage therapy; Surgery; Gastroenterology; Chemotherapy; Lymphoma; Randomized controlled trial","score_opus":0.0636855480645238,"score_gpt":0.3946122477324434,"score_spread":0.3309266996679196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379339089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688065,0.000108413245,0.0000011468376,0.0004934058,0.0012622452,0.00061914115,0.00001656526,0.000016207105,0.0006022146],"genre_scores_gemma":[0.99919415,0.00012079042,0.0000995009,0.00026324778,0.00013693946,0.000015520107,0.000032380198,0.000023997973,0.00011346986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477845,0.0007590953,0.002792217,0.00034383524,0.0009741746,0.00035224005],"domain_scores_gemma":[0.99407345,0.0020737625,0.0023953116,0.00059571647,0.0005863843,0.000275376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00203205,0.0002497632,0.0025812567,0.00056118105,0.00006369601,0.000010198,0.00033880025,0.0003645284,0.000087193635],"category_scores_gemma":[0.0017144593,0.00013421685,0.0010322544,0.002302494,0.00020588501,0.00010812234,0.00014587522,0.00046500986,0.000019320869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02270824,0.0072537083,0.9439244,0.0000103854845,0.009535316,0.0009609842,0.00038233088,0.0013783386,0.0000024203882,0.000025460744,0.0015907218,0.012227653],"study_design_scores_gemma":[0.09931315,0.024707545,0.864498,0.00006398183,0.0070642564,0.000008098338,0.00047756892,0.00033755507,0.000013585441,0.0000096788635,0.003397169,0.000109414774],"about_ca_topic_score_codex":0.00023021591,"about_ca_topic_score_gemma":0.00045342793,"teacher_disagreement_score":0.079426445,"about_ca_system_score_codex":0.003494008,"about_ca_system_score_gemma":0.0056034285,"threshold_uncertainty_score":0.9940241},"labels":[],"label_agreement":null},{"id":"W4379339971","doi":"10.1200/jco.2023.41.16_suppl.7515","title":"Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Cohort; Salvage therapy; Anthracycline; Chemotherapy; Cancer; Breast cancer","score_opus":0.021160036168766737,"score_gpt":0.32007736944883763,"score_spread":0.2989173332800709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379339971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955983,0.0013272351,0.00006650908,0.0013947963,0.00039602278,0.0009892747,0.000024467154,0.000090192785,0.00011316138],"genre_scores_gemma":[0.9861614,0.012145285,0.000714816,0.0005178376,0.00019474079,0.00004146722,0.000027975335,0.0000847879,0.00011165637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943981,0.0013050599,0.0022649122,0.00064902054,0.00076094846,0.0006219552],"domain_scores_gemma":[0.9954393,0.001138506,0.0022116958,0.00039507577,0.00030328624,0.0005121632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023082378,0.00049743336,0.0022249524,0.00047760623,0.00013060527,0.00003542362,0.00022463751,0.0006418701,0.000024108025],"category_scores_gemma":[0.00030419225,0.00032405625,0.00031765515,0.0005351915,0.00042525667,0.00021218532,0.000037643065,0.0008967143,0.000030040275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14567123,0.005210621,0.78174543,0.00012238463,0.00051652995,0.0039192946,0.0009926399,0.00006415914,0.00016455112,0.0000039529486,0.00022977601,0.061359394],"study_design_scores_gemma":[0.121760495,0.025052369,0.84528995,0.0017145262,0.0006372665,0.003707096,0.00030095238,0.00054213544,0.00036209653,0.000017456941,0.00031773385,0.00029791502],"about_ca_topic_score_codex":0.0002512901,"about_ca_topic_score_gemma":0.00044507722,"teacher_disagreement_score":0.0635445,"about_ca_system_score_codex":0.000663143,"about_ca_system_score_gemma":0.0025027767,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W4379341253","doi":"10.1200/jco.2023.41.16_suppl.7518","title":"Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC","funders":"","keywords":"Medicine; Vincristine; Internal medicine; Rituximab; Prednisone; Hazard ratio; CHOP; International Prognostic Index; Cyclophosphamide; Gastroenterology; Diffuse large B-cell lymphoma; Confidence interval; Lymphoma; Surgery; Oncology; Chemotherapy","score_opus":0.07306567624849852,"score_gpt":0.44908758379917674,"score_spread":0.3760219075506782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973834,0.000111589085,0.000007779849,0.0013935221,0.00021710599,0.00039669932,0.000020348525,0.000006738709,0.00046280003],"genre_scores_gemma":[0.9985762,0.00022162465,0.00009788329,0.0008618295,0.00013538434,0.000012754703,0.00002126285,0.000012574646,0.000060491628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959635,0.00072900526,0.0021263957,0.00021531575,0.00068027136,0.00028548858],"domain_scores_gemma":[0.9947515,0.0028768736,0.0014864905,0.00034189806,0.0003284071,0.00021480175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003328962,0.0001614867,0.0018169228,0.00051932206,0.000042404172,0.000010663383,0.00023747933,0.00019215763,0.000042130952],"category_scores_gemma":[0.00087740936,0.00008037981,0.0006421092,0.001371328,0.000095048425,0.00007683923,0.000049825852,0.00028983256,0.000015741043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002992659,0.19158822,0.7599975,0.0000100255,0.0020629752,0.0017483557,0.0007658801,0.000003528528,0.000003563828,0.000017240567,0.0007294947,0.040080573],"study_design_scores_gemma":[0.14315797,0.04674938,0.80029076,0.000027315642,0.004510616,0.000015498697,0.0011594968,0.00010310983,0.000008858056,0.000012353489,0.0039035885,0.00006106027],"about_ca_topic_score_codex":0.00014136282,"about_ca_topic_score_gemma":0.00065505935,"teacher_disagreement_score":0.14483884,"about_ca_system_score_codex":0.00017166756,"about_ca_system_score_gemma":0.0005797332,"threshold_uncertainty_score":0.32777935},"labels":[],"label_agreement":null},{"id":"W4379470548","doi":"10.1182/bloodadvances.2022009575","title":"Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Servier; Italfarmaco; Celltrion; Incyte; BeiGene; Pharmacyclics; MEI Pharma; Regeneron Pharmaceuticals; FibroGen; Gilead Sciences; Bayer HealthCare; Sanofi; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Cilag; Astellas Pharma; TG Therapeutics; Amgen; Pfizer; GlaxoSmithKline","keywords":"Refractory (planetary science); Medicine; Multicenter study; Open label; Oncology; Internal medicine; Cancer research; Clinical trial; Biology; Randomized controlled trial","score_opus":0.020355212790046588,"score_gpt":0.32105314748437636,"score_spread":0.30069793469432976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379470548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154824,0.0038559437,0.0000015974794,0.0002170138,0.000086010325,0.0013701888,0.000030183552,0.00012918284,0.0027616331],"genre_scores_gemma":[0.9944898,0.001022621,0.0018073578,0.00016475636,0.000070240676,0.00028546902,0.00004901421,0.000038985552,0.0020717373],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872553,0.00003980777,0.0002197785,0.00047787465,0.00024658695,0.000290406],"domain_scores_gemma":[0.9992154,0.00015958086,0.00011624375,0.0002993304,0.000049348866,0.00016008837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008846931,0.00024849214,0.00038907453,0.00008710528,0.00017045058,0.00008487222,0.00010340935,0.000050698804,0.000032149554],"category_scores_gemma":[0.000031355947,0.0001609215,0.00002431305,0.00025296744,0.00004743371,0.00029932297,0.00010868428,0.000110571695,0.000052367886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038529763,0.060172636,0.7966349,0.00046117217,0.0009907117,0.0062832246,0.005036929,0.000012770766,0.0037449175,0.000039481292,0.0015558132,0.12121443],"study_design_scores_gemma":[0.6178358,0.05334522,0.2316843,0.0020098572,0.004811826,0.00055475696,0.017823787,0.0006028881,0.026083918,0.00006116104,0.043802097,0.0013843612],"about_ca_topic_score_codex":0.0000844552,"about_ca_topic_score_gemma":0.00011260477,"teacher_disagreement_score":0.61398286,"about_ca_system_score_codex":0.000033842178,"about_ca_system_score_gemma":0.000054110285,"threshold_uncertainty_score":0.6562188},"labels":[],"label_agreement":null},{"id":"W4379645970","doi":"10.1200/jco.2023.41.17_suppl.lba4","title":"SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Brentuximab vedotin; Clinical endpoint; Oncology; Nivolumab; Randomized controlled trial; Chemotherapy; Cancer; Lymphoma; Hodgkin lymphoma; Immunotherapy","score_opus":0.12644087717551697,"score_gpt":0.4876273556058542,"score_spread":0.36118647843033724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379645970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900252,0.00067769317,0.000005784942,0.0026161154,0.0028445616,0.0012992636,0.000008021078,0.000035805937,0.0024875274],"genre_scores_gemma":[0.9954596,0.0024857935,0.00040086696,0.00043441582,0.00048654433,0.00008024386,0.000008281112,0.00004225946,0.0006019538],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99143773,0.0017597405,0.0049055186,0.00045923877,0.00090903795,0.00052875263],"domain_scores_gemma":[0.98386914,0.011623905,0.003080279,0.00047577062,0.00046885654,0.00048202617],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0058819847,0.00034054488,0.0049627223,0.00054771185,0.00005556142,0.000014771767,0.00032675997,0.00044990168,0.00022994904],"category_scores_gemma":[0.009458716,0.00024040465,0.0011882868,0.00070434285,0.00033385004,0.00016089292,0.0001671799,0.00057966,0.00013050772],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5509346,0.03039364,0.12168983,0.00007778219,0.0025393653,0.008231326,0.0011573404,0.00016323637,0.000067285546,0.0002002928,0.0023958744,0.28214937],"study_design_scores_gemma":[0.6954478,0.03642843,0.25613275,0.00020896281,0.0010574458,0.00009324559,0.0024785858,0.00029111354,0.00008390184,0.00016286467,0.0074482523,0.00016665622],"about_ca_topic_score_codex":0.0003126217,"about_ca_topic_score_gemma":0.00052956847,"teacher_disagreement_score":0.28198272,"about_ca_system_score_codex":0.0006720052,"about_ca_system_score_gemma":0.0023147357,"threshold_uncertainty_score":0.99888504},"labels":[],"label_agreement":null},{"id":"W4379662235","doi":"10.1200/jco.2023.41.17_suppl.lba7505","title":"Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Medicine; Clinical endpoint; Rituximab; Hazard ratio; Internal medicine; Randomization; Randomized controlled trial; Regimen; Radiation therapy; Lymphoma; Nuclear medicine; Oncology; Radiology; Confidence interval","score_opus":0.06727258392776242,"score_gpt":0.3905714880302037,"score_spread":0.3232989041024413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379662235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648318,0.00026305357,0.00007354546,0.03213914,0.00079823914,0.0016824092,0.000009386376,0.000014974648,0.000187434],"genre_scores_gemma":[0.9766867,0.0017448654,0.0055978196,0.01481547,0.00070283894,0.00011528714,0.000021912578,0.000041132906,0.0002739781],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945678,0.0018548404,0.0023714092,0.00021453704,0.0007186117,0.00027278453],"domain_scores_gemma":[0.9835011,0.014171395,0.0013816828,0.0002723464,0.00043458954,0.00023892704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01084334,0.00019174692,0.002343519,0.00022551548,0.00005654345,0.000018706216,0.00020027348,0.00020124005,0.00005518128],"category_scores_gemma":[0.0034527634,0.00009518368,0.00049319,0.00044849853,0.0002096824,0.00007744513,0.000030467254,0.00028242337,0.000015826228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8667347,0.0032947955,0.04703211,0.000009783073,0.00038481326,0.00025221467,0.0003160894,0.000018763045,0.000063920226,0.000007404783,0.00321897,0.07866644],"study_design_scores_gemma":[0.52894276,0.020043472,0.42307556,0.00007884339,0.0001300579,0.000014546391,0.000025603576,0.000025401278,0.00001987236,0.000027166026,0.027560143,0.000056582656],"about_ca_topic_score_codex":0.000023015526,"about_ca_topic_score_gemma":0.000010594842,"teacher_disagreement_score":0.37604344,"about_ca_system_score_codex":0.0007258345,"about_ca_system_score_gemma":0.002190587,"threshold_uncertainty_score":0.413353},"labels":[],"label_agreement":null},{"id":"W4379979648","doi":"10.1002/hon.3164_263","title":"An open‐label phase 1/2 study of favezelimab plus pembrolizumab in patients with relapsed/refractory classical Hodgkin lymphoma with/without previous anti‐PD‐1 treatment","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; CancerCare Manitoba; Jewish General Hospital","funders":"Gilead Sciences","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Cohort; Internal medicine; Lymphoma; Oncology; Gastroenterology; Cancer; Surgery; Immunotherapy","score_opus":0.05988519933506927,"score_gpt":0.378718182469252,"score_spread":0.31883298313418273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379979648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993894,0.000099635996,0.0000050948515,0.00033216688,0.000076211334,0.004202335,0.00002672192,0.00015588012,0.0012079824],"genre_scores_gemma":[0.9976928,0.00009719541,0.0005305519,0.00017335227,0.000026816298,0.0011356239,0.00018739146,0.0000526965,0.00010353038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964947,0.00047400274,0.00083392585,0.0009912546,0.00052523334,0.00068087777],"domain_scores_gemma":[0.99787176,0.0004105787,0.00038230952,0.00078186864,0.00017113928,0.00038232858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021093602,0.00051976857,0.002228568,0.0002776353,0.0001135377,0.000030385812,0.00032384813,0.00036164653,0.0000768706],"category_scores_gemma":[0.00007643673,0.0002856331,0.00006925504,0.0006617161,0.00027541502,0.00016380867,0.00018115033,0.00016408357,0.000067187895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02354375,0.18125673,0.7489075,0.000054503074,0.00046411846,0.0056393207,0.0010169233,0.0000158838,0.00004941428,0.00022133792,0.00017907211,0.038651425],"study_design_scores_gemma":[0.2131124,0.17762275,0.6064234,0.00011596856,0.00043748686,0.00021849717,0.000609425,0.00022927455,0.00017386685,0.00001757199,0.00078014756,0.00025924848],"about_ca_topic_score_codex":0.00020387892,"about_ca_topic_score_gemma":0.00034087725,"teacher_disagreement_score":0.18956864,"about_ca_system_score_codex":0.0013321674,"about_ca_system_score_gemma":0.000703732,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W4379979997","doi":"10.1002/hon.3163_19","title":"A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Cancer Research UK; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Clinical endpoint; Hazard ratio; Regimen; Randomized controlled trial; Randomization; Internal medicine; Rituximab; Oncology; Lymphoma; Nuclear medicine; Radiology; Confidence interval","score_opus":0.03295171682899981,"score_gpt":0.30465833751503085,"score_spread":0.271706620686031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379979997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504656,0.00083209266,0.00005199345,0.0011876705,0.00022162276,0.0023103629,0.00002745552,0.00006566523,0.0002565658],"genre_scores_gemma":[0.9947117,0.0005130705,0.0031274664,0.00048681436,0.000040489173,0.0009630804,0.00010011443,0.00002317798,0.00003410979],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973116,0.0008433456,0.0007323389,0.00034754968,0.00042361816,0.0003415742],"domain_scores_gemma":[0.99603546,0.00315764,0.0002983563,0.00026891814,0.00013704917,0.0001025848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009712194,0.00024625755,0.0019419339,0.00023159485,0.000031282918,0.000006999551,0.0000933388,0.00022728514,0.00013698335],"category_scores_gemma":[0.0003555893,0.00014962994,0.00023048284,0.00049648306,0.0003079219,0.000046768037,0.000032651875,0.00008679211,0.000016110596],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9518155,0.0031708942,0.039522678,0.000041296033,0.00024173973,0.0003464676,0.00028763228,0.0000022239374,0.00022464512,0.0002114749,0.00008527253,0.004050194],"study_design_scores_gemma":[0.68654317,0.006805874,0.3041308,0.000043299704,0.000119062766,0.000013064229,0.000027347847,0.000027768441,0.00032716303,0.00005398412,0.0018068746,0.00010163378],"about_ca_topic_score_codex":0.00002530619,"about_ca_topic_score_gemma":0.0000072786456,"teacher_disagreement_score":0.26527232,"about_ca_system_score_codex":0.00051179633,"about_ca_system_score_gemma":0.0004622309,"threshold_uncertainty_score":0.61017317},"labels":[],"label_agreement":null},{"id":"W4379981126","doi":"10.1002/hon.3164_453","title":"Analyses of a patient with 3 sequential Post Transplant Lymphoprolierative Disease (PTLD) biopsies reveal persistence of Histone 1 gene mutation, suspected to mediate PTLD","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Histopathology; Lymphoma; Biology; Pathology; Tonsil; Rituximab; Lymphomatoid granulomatosis; Cancer research; Medicine","score_opus":0.05473514137890682,"score_gpt":0.36372947059617367,"score_spread":0.3089943292172668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540895,0.00038293345,0.000039422266,0.0029402324,0.00006288335,0.00067286345,0.00019910949,0.000064408785,0.00022917388],"genre_scores_gemma":[0.99741507,0.00010404502,0.0015632646,0.00036056747,0.000019238632,0.00020386904,0.0002828303,0.0000114483255,0.000039668543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983063,0.00013811239,0.0005493498,0.00037878047,0.00033994854,0.00028754087],"domain_scores_gemma":[0.99854386,0.00031601428,0.00024024898,0.00021119312,0.00037939666,0.0003093019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090500434,0.00020518964,0.0008817479,0.00021960885,0.000060999108,0.0000035218784,0.000080080514,0.00011510462,0.00013700276],"category_scores_gemma":[0.00020903711,0.00012619636,0.0001660515,0.00058797275,0.00033213585,0.00003122589,0.00003913043,0.000056643585,0.000026230273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044358984,0.018046778,0.47227323,0.002171979,0.0046862112,0.08336407,0.02666733,0.001556597,0.3336073,0.0049549965,0.0027952439,0.005517285],"study_design_scores_gemma":[0.010059758,0.017462824,0.5600557,0.0005088751,0.0024026334,0.0025606614,0.0030189443,0.00030537107,0.40271944,0.0002188257,0.00022057022,0.00046640093],"about_ca_topic_score_codex":0.0001524773,"about_ca_topic_score_gemma":0.00006807595,"teacher_disagreement_score":0.08778247,"about_ca_system_score_codex":0.00027961924,"about_ca_system_score_gemma":0.000488199,"threshold_uncertainty_score":0.51461387},"labels":[],"label_agreement":null},{"id":"W4379981156","doi":"10.1002/hon.3164_270","title":"Analysis of Real‐World Treatment Patterns and Outcomes Among Patients With Relapsed/Refractory Follicular Lymphoma Including POD24 Patients","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; Refractory (planetary science); Follicular phase; Demographics; Chemoimmunotherapy; Lymphoma; Oncology; Rituximab; Biology","score_opus":0.030421045072058867,"score_gpt":0.31378527222432356,"score_spread":0.2833642271522647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978578,0.000032202373,0.000003100808,0.00020336486,0.00007259136,0.00065242336,0.00006498985,0.00010185598,0.0010116894],"genre_scores_gemma":[0.9985416,0.0002776863,0.00013280411,0.00017810932,0.000009711785,0.00019364744,0.00049457035,0.000020216417,0.00015166888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803936,0.0001274561,0.0005652844,0.0005229923,0.00035038762,0.000394507],"domain_scores_gemma":[0.9983029,0.00064410345,0.0003291765,0.0003484783,0.00013293148,0.00024242022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104457795,0.0003158298,0.0015666123,0.00056712865,0.00010335832,0.000009387068,0.00007355991,0.00021137718,0.00009971637],"category_scores_gemma":[0.00008600525,0.00017831396,0.00028741988,0.00089053554,0.00016298571,0.000061108,0.000121339355,0.0000565849,0.000017752229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029039837,0.0048166406,0.98178333,0.000039522893,0.002868087,0.00042243645,0.0002068837,0.000005881797,0.0000014830877,0.00018547082,0.00007952695,0.009300355],"study_design_scores_gemma":[0.010567848,0.0038581258,0.98145795,0.00005480582,0.0030128858,0.000003540378,0.000079964564,0.00008057754,0.000074240445,0.000018734387,0.00062428415,0.00016702565],"about_ca_topic_score_codex":0.0009112738,"about_ca_topic_score_gemma":0.0011155243,"teacher_disagreement_score":0.010277449,"about_ca_system_score_codex":0.00060114113,"about_ca_system_score_gemma":0.00006814577,"threshold_uncertainty_score":0.7271432},"labels":[],"label_agreement":null},{"id":"W4379981685","doi":"10.1002/hon.3164_210","title":"Biological and clinical relevance of CD79 protein and gene expression in diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Rituximab; Immunohistochemistry; Oncology; Germinal center; Hematology; Pathology; Antibody; B cell; Immunology","score_opus":0.05289518463836473,"score_gpt":0.35816274357793804,"score_spread":0.3052675589395733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635077,0.0013521771,0.000012791372,0.0010484222,0.00004889233,0.0005945648,0.000009137616,0.00005055943,0.0005327127],"genre_scores_gemma":[0.99357176,0.0032850737,0.0026479878,0.00024000467,0.00002834483,0.0001261973,0.000017598433,0.000008101389,0.00007491445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824226,0.00024923103,0.00059293583,0.00046678595,0.000113536415,0.0003352301],"domain_scores_gemma":[0.99841416,0.0010344675,0.00014603669,0.00018905422,0.000031165724,0.00018509873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045617882,0.00016298413,0.00087912986,0.00008383171,0.00004026912,0.0000039085676,0.000057756286,0.0004732773,0.000038309292],"category_scores_gemma":[0.00066023105,0.000098325225,0.00008195216,0.00018727826,0.00029376044,0.000024613932,0.00022311894,0.00011469093,0.000035671892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009403012,0.015092996,0.95251656,0.000121466925,0.000028102688,0.00285101,0.000095753596,7.115608e-8,0.012979418,0.0011687976,0.00041379084,0.013791716],"study_design_scores_gemma":[0.030701064,0.0037451065,0.9336785,0.00016582706,0.000040307834,0.00039903758,0.00013997963,0.00013367794,0.024023,0.0011468414,0.0056652557,0.00016137316],"about_ca_topic_score_codex":0.0000053828203,"about_ca_topic_score_gemma":0.000008081422,"teacher_disagreement_score":0.029760763,"about_ca_system_score_codex":0.00005634469,"about_ca_system_score_gemma":0.000061272964,"threshold_uncertainty_score":0.40095863},"labels":[],"label_agreement":null},{"id":"W4379981722","doi":"10.1002/hon.3163_43","title":"GOLIDOCITINIB IN TREATING REFRACTORY OR RELAPSED PERIPHERAL T‐CELL LYMPHOMA: PRIMARY ANALYSIS OF THE MULTINATIONAL PIVOTAL STUDY RESULTS (JACKPOT8)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Discontinuation; Refractory (planetary science); Clinical endpoint; Gastroenterology; Oncology; Surgery; Clinical trial","score_opus":0.04208158833851896,"score_gpt":0.342433251329565,"score_spread":0.30035166299104604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706967,0.000078054625,0.0000011396464,0.0010592176,0.00010923011,0.0007840895,0.000042854743,0.00007413834,0.010781583],"genre_scores_gemma":[0.9977142,0.000042673695,0.0004233604,0.00031730844,0.000035056455,0.00023666675,0.00013367509,0.000012741828,0.0010842953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973844,0.00044325506,0.00091381354,0.0004985609,0.00040359428,0.00035634273],"domain_scores_gemma":[0.99712044,0.0019413631,0.0003637553,0.00037063455,0.00010500241,0.00009879463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005313468,0.0002169416,0.0011255285,0.0003126808,0.00010254888,0.000007652574,0.0001629419,0.00025209354,0.00016812599],"category_scores_gemma":[0.00087381346,0.00011676017,0.00032973054,0.0018896519,0.0001726681,0.000039548573,0.00017559214,0.000148378,0.000026618885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032179756,0.0210813,0.95913863,0.00006714219,0.0008546892,0.0030013197,0.002410245,0.00014381531,0.00042585077,0.00021083404,0.0009715866,0.008476606],"study_design_scores_gemma":[0.019741533,0.0022244349,0.9728632,0.0000358446,0.0007865958,0.0000843215,0.0018612529,0.000926559,0.00025017752,0.000018597424,0.0010883769,0.00011911497],"about_ca_topic_score_codex":0.00014235498,"about_ca_topic_score_gemma":0.00034616547,"teacher_disagreement_score":0.018856866,"about_ca_system_score_codex":0.0007638904,"about_ca_system_score_gemma":0.0003854748,"threshold_uncertainty_score":0.47613418},"labels":[],"label_agreement":null},{"id":"W4379981760","doi":"10.1002/hon.3165_523","title":"THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INADEQUATE RESPONSE TO CHEMOTHERAPY. THE PRELIMINARY EXPERIENCE FROM THE RAFTING TRIAL","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Radiation therapy; Internal medicine; Dacarbazine; Chemotherapy; Oncology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.023930521339907054,"score_gpt":0.3082493475796885,"score_spread":0.2843188262397815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972957,0.00013947861,0.000017518916,0.024159607,0.00026492568,0.0021550697,0.000021669182,0.00012445461,0.00016026292],"genre_scores_gemma":[0.994832,0.00014478712,0.00015505416,0.0030604377,0.00012374042,0.0013619198,0.000015470494,0.00002456827,0.0002820649],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971172,0.0009613713,0.00044904827,0.00048092194,0.00043412216,0.0005573153],"domain_scores_gemma":[0.99063116,0.008184016,0.00024034231,0.0006963718,0.0000831072,0.00016501588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088519056,0.00026373597,0.0005101681,0.000034561617,0.0007304034,0.000058188303,0.00040696227,0.0001957209,0.00007172683],"category_scores_gemma":[0.0015841876,0.000093596616,0.00014345603,0.00045752604,0.00036764675,0.00003903957,0.00023176044,0.00018621501,0.00026469328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45438707,0.002673867,0.36135945,0.000010003837,0.0004090996,0.0013092438,0.013279456,0.000017907052,0.000071951494,0.00044668897,0.007074204,0.15896107],"study_design_scores_gemma":[0.038559545,0.008298671,0.91808665,0.000052046227,0.00008931912,0.000029272933,0.0019380945,0.000069350965,0.00063384796,0.00010012123,0.03199731,0.0001457823],"about_ca_topic_score_codex":0.00028512362,"about_ca_topic_score_gemma":0.000048866514,"teacher_disagreement_score":0.5567272,"about_ca_system_score_codex":0.0002380746,"about_ca_system_score_gemma":0.00019468376,"threshold_uncertainty_score":0.5617747},"labels":[],"label_agreement":null},{"id":"W4379981833","doi":"10.1002/hon.3163_37","title":"LUNG STAGING IN PEDIATRIC HODGKIN LYMPHOMA: STAGING EVALUATION &amp; RESPONSE CRITERIA HARMONIZATION FOR CHILDHOOD, ADOLESCENT &amp; YOUNG ADULT HL (SEARCH FOR CAYAHL) CONSENSUS","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Population; Cohort; Lung; Pediatrics; Pathology","score_opus":0.08851257481726457,"score_gpt":0.41003496185568383,"score_spread":0.3215223870384193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98423564,0.00056428433,0.0016982878,0.007907701,0.0004545123,0.0047069024,0.00009940751,0.00021096223,0.00012227133],"genre_scores_gemma":[0.98953027,0.00034794564,0.0060410104,0.0006620984,0.0002063417,0.0022332745,0.0008131835,0.000048143476,0.00011772726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640673,0.0007136538,0.0008265783,0.00076951145,0.0004585487,0.0008249445],"domain_scores_gemma":[0.9960318,0.0025197687,0.00021832407,0.00034313172,0.00066386507,0.00022309653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025564611,0.0003177601,0.0008332005,0.00055550406,0.00023285706,0.00004277586,0.00012236628,0.00036648678,0.00007631542],"category_scores_gemma":[0.0034662073,0.00026753548,0.00020241599,0.0007377295,0.000090473026,0.000055348246,0.00010134772,0.00013812643,0.000073226656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087390775,0.003676978,0.94895643,0.0008706266,0.00013212186,0.0003154292,0.002219227,0.00019474282,0.001184164,0.0012160847,0.018218046,0.014277062],"study_design_scores_gemma":[0.025892058,0.00093965227,0.95584655,0.00020900629,0.00053410535,0.0002715456,0.00058574014,0.0110938875,0.0011139426,0.000406941,0.0027216915,0.00038490197],"about_ca_topic_score_codex":0.00007106609,"about_ca_topic_score_gemma":0.00014886339,"teacher_disagreement_score":0.017152982,"about_ca_system_score_codex":0.0015992728,"about_ca_system_score_gemma":0.00091015664,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W4379981853","doi":"10.1002/hon.3164_189","title":"Prognostic impact of HLA‐I neoantigen‐specific CD8+ T cells in limited‐stage follicular lymphoma","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Medical Research Council; National Health and Medical Research Council; Mater Foundation","keywords":"Stage (stratigraphy); Medicine; CD8; Follicular lymphoma; Internal medicine; Lymphoma; Cohort; Oncology; Human leukocyte antigen; Immunology; Biology; Antigen","score_opus":0.04746191264766503,"score_gpt":0.33938508126465805,"score_spread":0.291923168616993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933848,0.00085418037,0.000009067142,0.00063368864,0.00015233888,0.0008840534,0.000026706679,0.00014879038,0.003906403],"genre_scores_gemma":[0.9978373,0.0009786325,0.00042730558,0.00015902682,0.00004010328,0.0001894954,0.00007777191,0.000022755248,0.00026763143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978183,0.00016257419,0.00065791595,0.00048130698,0.00025765577,0.0006222738],"domain_scores_gemma":[0.9982427,0.000869641,0.00018667767,0.00037898653,0.00008031892,0.00024171463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002676234,0.00027957532,0.0011715507,0.00030821122,0.00004365306,0.000009335453,0.00013967992,0.0004076773,0.0006084347],"category_scores_gemma":[0.00020590151,0.00018262582,0.00042993255,0.00090671005,0.00018216982,0.00003765291,0.000112189824,0.0001157708,0.0008348275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005884474,0.0056643873,0.94284225,0.00016782699,0.0002779575,0.018705297,0.00027467078,0.000085478954,0.009519501,0.003195835,0.008133063,0.01054527],"study_design_scores_gemma":[0.0066002035,0.0039508957,0.96301013,0.00013749338,0.000100324825,0.0006110476,0.00016901888,0.00037709955,0.0095142,0.0002860931,0.0150225535,0.00022093524],"about_ca_topic_score_codex":0.00008174516,"about_ca_topic_score_gemma":0.000014693899,"teacher_disagreement_score":0.02016787,"about_ca_system_score_codex":0.0004909494,"about_ca_system_score_gemma":0.00030494548,"threshold_uncertainty_score":0.99994314},"labels":[],"label_agreement":null},{"id":"W4379981896","doi":"10.1002/hon.3164_365","title":"Role of upfront autologous stem cell transplantation (ASCT) in adults with T‐NHL in first complete remission (CR1): A systematic literature review and meta‐analysis","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; Oncology; Randomized controlled trial; Hazard ratio; Meta-analysis; Observational study; Transplantation; Confidence interval","score_opus":0.02524563465409945,"score_gpt":0.28523598792378485,"score_spread":0.2599903532696854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7726947,0.22071993,0.000011387589,0.0029604845,0.000012668876,0.0027426914,0.000050010432,0.0000734727,0.00073462666],"genre_scores_gemma":[0.9619522,0.036707193,0.00038996205,0.00027297187,0.000002261788,0.00052843837,0.000101838225,0.0000075601047,0.000037548518],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9981999,0.00032562355,0.0007009675,0.00037474858,0.00016660277,0.00023217843],"domain_scores_gemma":[0.9987929,0.0005956747,0.00024349055,0.00021214261,0.000056316665,0.00009950808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032576398,0.00020461231,0.0026721826,0.00028161157,0.000028874998,0.0000051824527,0.00006458574,0.000219091,0.00004787145],"category_scores_gemma":[0.00002680703,0.000109911605,0.00021154853,0.0010418198,0.000057205674,0.00003422977,0.000023713217,0.00013388184,0.000009833042],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002939982,0.004887386,0.20985669,0.7251196,0.021659456,0.022714894,0.009633394,0.00021009785,0.00024237474,0.0016778223,0.00035331032,0.00070500374],"study_design_scores_gemma":[0.018734954,0.0070165605,0.53284186,0.06961289,0.3574106,0.005854331,0.0022658724,0.003817617,0.00096466445,0.000255977,0.00037832747,0.0008463114],"about_ca_topic_score_codex":0.00005113622,"about_ca_topic_score_gemma":0.00056268944,"teacher_disagreement_score":0.6555067,"about_ca_system_score_codex":0.00010376079,"about_ca_system_score_gemma":0.00004337608,"threshold_uncertainty_score":0.4482065},"labels":[],"label_agreement":null},{"id":"W4379981918","doi":"10.1002/hon.3163_140","title":"RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Regimen; Oncology; Radiation therapy; Stage (stratigraphy); Lymphoma; Progression-free survival; Gastroenterology; Surgery; Overall survival","score_opus":0.0890290924963258,"score_gpt":0.32970095318427256,"score_spread":0.24067186068794677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107486,0.0006382134,0.000029783683,0.0058713187,0.00017671462,0.001981111,0.000034873286,0.00009110622,0.00010202188],"genre_scores_gemma":[0.99760723,0.00026117172,0.00051072217,0.00079503236,0.000049020033,0.00054081227,0.00019852676,0.000014902548,0.00002260982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824303,0.00023412691,0.000558275,0.0004093908,0.00023448905,0.0003206716],"domain_scores_gemma":[0.997287,0.0020352064,0.00022852622,0.00027850692,0.00007641602,0.00009439738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040758806,0.00022346796,0.0010314297,0.00008305664,0.00008081064,0.000016460406,0.00010926067,0.00038901594,0.000038331986],"category_scores_gemma":[0.0008370873,0.00012730532,0.00015901397,0.00043700964,0.00017106383,0.00004424551,0.00008548857,0.00013770991,0.000008081886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06433644,0.0109703485,0.89501023,0.00009171505,0.0005494621,0.0012293564,0.0016543603,0.000009015186,0.0017799325,0.012095432,0.00036161096,0.011912068],"study_design_scores_gemma":[0.24498518,0.00533642,0.7446284,0.00013893297,0.0001430915,0.000061046136,0.00052479026,0.0013059526,0.00079544703,0.0012559679,0.0006780627,0.0001466837],"about_ca_topic_score_codex":0.00028929667,"about_ca_topic_score_gemma":0.00011724127,"teacher_disagreement_score":0.18064874,"about_ca_system_score_codex":0.0001534976,"about_ca_system_score_gemma":0.00018449803,"threshold_uncertainty_score":0.519136},"labels":[],"label_agreement":null},{"id":"W4379982010","doi":"10.1002/hon.3163_34","title":"PATTERNS OF PRESENTATION AND OUTCOMES IN STAGE IV HODGKIN LYMPHOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) AHOD1331 TRIAL","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Vincristine; Etoposide; Oncology; B symptoms; Cyclophosphamide; Lymphoma; Vinblastine; Hazard ratio; ABVD; Chemotherapy; Surgery; Confidence interval","score_opus":0.05011501305050776,"score_gpt":0.36634257648300383,"score_spread":0.3162275634324961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379982010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089515,0.00021768766,0.000018555198,0.0063832705,0.0002770666,0.0015930366,0.000060476978,0.0000724648,0.00048226165],"genre_scores_gemma":[0.99769807,0.00031207904,0.00029868644,0.0006385596,0.000090276546,0.00056149944,0.00025592337,0.000013214336,0.00013167803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774635,0.0004074417,0.00080773205,0.00047175764,0.000239377,0.00032736387],"domain_scores_gemma":[0.99635434,0.0028045138,0.00035471105,0.00033759244,0.000037851798,0.00011097243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005006915,0.0002049579,0.0011223255,0.00010513649,0.000055320015,0.000009154053,0.00011512854,0.00037211954,0.00016973501],"category_scores_gemma":[0.0007086786,0.00011539851,0.00015488271,0.00019858115,0.00015481336,0.000041709296,0.00017572778,0.00012828984,0.000027813549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004254466,0.0025499533,0.9748144,0.000019009049,0.00022090646,0.0044494686,0.00035723025,0.0000010597114,0.00005589105,0.0010351666,0.0007547684,0.011487644],"study_design_scores_gemma":[0.053205572,0.0024696253,0.94001865,0.000029421077,0.00017410846,0.00058571884,0.00042038946,0.000036480593,0.00017446326,0.0004711563,0.002315575,0.000098856784],"about_ca_topic_score_codex":0.0019188933,"about_ca_topic_score_gemma":0.0009989722,"teacher_disagreement_score":0.048951104,"about_ca_system_score_codex":0.00022580933,"about_ca_system_score_gemma":0.00016714534,"threshold_uncertainty_score":0.47058144},"labels":[],"label_agreement":null},{"id":"W4380051958","doi":"10.3390/curroncol30060418","title":"Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell Lymphoma (MCL) in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Southlake Regional Health Center","funders":"Canadian Institutes of Health Research; Government of Ontario","keywords":"Medicine; Mantle cell lymphoma; Bendamustine; Health care; Rituximab; Internal medicine; Retrospective cohort study; Population; Lymphoma; Pediatrics; Environmental health","score_opus":0.04932841562565584,"score_gpt":0.31947867805618485,"score_spread":0.27015026243052903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380051958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982262,0.00036742882,0.0000022708125,0.00033430316,0.00035007315,0.00055767695,0.00003226433,0.000010863276,0.000118866265],"genre_scores_gemma":[0.99947315,0.000060492253,0.0000336022,0.000037571048,0.000011918491,0.000071877395,0.0002694573,0.00001014181,0.00003180123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898726,0.000109245135,0.0003141946,0.0001740891,0.00021944578,0.00019576319],"domain_scores_gemma":[0.99912745,0.00030160422,0.00025213748,0.0001326121,0.00013116168,0.000055061064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013727613,0.00011169699,0.0003611288,0.000072260635,0.000060609378,0.0000029743285,0.000053930333,0.00006095524,0.000017884775],"category_scores_gemma":[0.000108088054,0.000074511525,0.000022684935,0.0002708064,0.000055369608,0.000021728325,0.00004166708,0.000068665555,6.038949e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008835127,0.0007222375,0.9339012,0.00015451318,0.000034105997,0.000036725396,0.0037368936,0.00013762891,0.000006936211,0.000008823483,0.00069526926,0.06047735],"study_design_scores_gemma":[0.008937893,0.0005943527,0.9865751,0.0003149894,0.000078436315,0.0000022097488,0.00086013146,0.0014033082,0.00020419799,0.000012760332,0.0009479767,0.000068627465],"about_ca_topic_score_codex":0.829552,"about_ca_topic_score_gemma":0.956254,"teacher_disagreement_score":0.126702,"about_ca_system_score_codex":0.0010778116,"about_ca_system_score_gemma":0.0013531061,"threshold_uncertainty_score":0.3038492},"labels":[],"label_agreement":null},{"id":"W4380078644","doi":"10.1002/hon.3163_5","title":"NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; McGill University Health Centre","funders":"National Cancer Institute; Agenzia Italiana del Farmaco, Ministero della Salute; National Institutes of Health; Seagen; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Neutropenia; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Randomized controlled trial; Chemotherapy; Lymphoma; Hodgkin lymphoma","score_opus":0.041521264897604895,"score_gpt":0.36706873840055537,"score_spread":0.3255474735029505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380078644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818264,0.00037895585,0.000010498467,0.006767494,0.000565527,0.0018099712,0.00012385454,0.00032354135,0.008193735],"genre_scores_gemma":[0.99510235,0.00018805603,0.0022352233,0.0005950976,0.00007596634,0.0006482776,0.00020493823,0.00004325894,0.00090684125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954899,0.00038494475,0.0014009165,0.0010428646,0.0006729266,0.0010084548],"domain_scores_gemma":[0.9964503,0.0014562006,0.00047131447,0.0009292169,0.00019907113,0.0004939109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006656519,0.00048243586,0.0020430018,0.00040132838,0.00010869489,0.000019758852,0.0004535768,0.0005197356,0.00014867776],"category_scores_gemma":[0.0017803424,0.00035191898,0.0002796036,0.0011506194,0.00033296723,0.0000871521,0.0005809276,0.00023043166,0.0004464971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0489295,0.041196365,0.3990979,0.0015344812,0.00092496816,0.0275306,0.003086466,0.00014611153,0.032321393,0.01893683,0.046745863,0.37954953],"study_design_scores_gemma":[0.08250049,0.014421772,0.8225558,0.00090424524,0.00020977079,0.0005242618,0.0020711324,0.00096981943,0.019541496,0.0014748155,0.053983912,0.00084247976],"about_ca_topic_score_codex":0.00026957647,"about_ca_topic_score_gemma":0.00058379915,"teacher_disagreement_score":0.42345792,"about_ca_system_score_codex":0.00068709056,"about_ca_system_score_gemma":0.000557246,"threshold_uncertainty_score":0.9998933},"labels":[],"label_agreement":null},{"id":"W4380079804","doi":"10.1002/hon.3164_441","title":"CCTG LY18‐A phase I master protocol of novel combination therapy for patients with relapsed or refractory lymphoma ‐ the RGDP‐Venetoclax substudy","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Queen's University; Spinal Cord Injury BC; University of British Columbia; McGill University; Jewish General Hospital","funders":"Loxo Oncology; AbbVie Canada; National Institutes of Health; Pharmacyclics; National Comprehensive Cancer Network; Breast Cancer Research Foundation; TG Therapeutics; Regeneron Pharmaceuticals; Genentech; Celgene; Gilead Sciences","keywords":"Medicine; Salvage therapy; Internal medicine; Gemcitabine; Rituximab; Oncology; Follicular lymphoma; Lymphoma; Refractory (planetary science); Gastroenterology; Cancer; Chemotherapy","score_opus":0.09117545114869888,"score_gpt":0.3840070893897315,"score_spread":0.29283163824103264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380079804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92626846,0.000011584171,0.00004502198,0.0011540822,0.000093550465,0.071965724,0.000024829238,0.000084279876,0.00035245062],"genre_scores_gemma":[0.8650145,0.000013311121,0.0005032845,0.0004937515,0.000030750543,0.13359943,0.0000952295,0.00002249814,0.00022722379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984535,0.00010725626,0.000487762,0.00034801793,0.00028696453,0.00031648116],"domain_scores_gemma":[0.997917,0.0010812299,0.00032160783,0.00033403802,0.0002518255,0.000094316805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025575666,0.00021757341,0.0006614926,0.00008531513,0.00011505682,0.000008738235,0.00013272774,0.00022685906,0.00011348049],"category_scores_gemma":[0.00018669464,0.00009403728,0.00012416122,0.00031198305,0.00019686575,0.000046263634,0.000046941157,0.00006928749,0.000023927816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11751214,0.16852736,0.55521065,0.0007056231,0.0014469026,0.00063826505,0.0017029364,0.000010933809,0.0011659103,0.009660741,0.01763749,0.12578103],"study_design_scores_gemma":[0.26074916,0.08724437,0.5593471,0.00015900802,0.00022230878,0.00012064463,0.00030525358,0.0004693683,0.0034491827,0.00029048132,0.08735108,0.00029204498],"about_ca_topic_score_codex":0.000009563202,"about_ca_topic_score_gemma":0.0000086877835,"teacher_disagreement_score":0.14323704,"about_ca_system_score_codex":0.0003134023,"about_ca_system_score_gemma":0.0003359419,"threshold_uncertainty_score":0.3834729},"labels":[],"label_agreement":null},{"id":"W4380079942","doi":"10.1002/hon.3164_200","title":"A low lymphocyte‐to‐monocyte ratio (LMR) predicts PFS, POD24 and OS in previously untreated, high tumor burden follicular lymphoma (FL): an analysis from the RELEVANCE trial","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Follicular lymphoma; Logistic regression; Cohort; Proportional hazards model; Lymphoma","score_opus":0.023737172665012036,"score_gpt":0.30324733167869805,"score_spread":0.27951015901368603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380079942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994875,0.0014066808,0.00004734729,0.0055448404,0.00019280551,0.0024073855,0.000062241874,0.00024040327,0.00014955422],"genre_scores_gemma":[0.9943122,0.0010391012,0.0006569355,0.0019475793,0.00028548908,0.0012615067,0.000347494,0.000030348943,0.00011933436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637264,0.0005979705,0.00084940554,0.0010503888,0.00041086433,0.0007187416],"domain_scores_gemma":[0.99660856,0.0018388598,0.0002369099,0.00075168686,0.00009187395,0.00047212615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005277057,0.00042582667,0.0017101825,0.00028230093,0.00016805866,0.000060124716,0.0002777274,0.000392209,0.00017135001],"category_scores_gemma":[0.0008920221,0.00025586123,0.00027708273,0.0015247412,0.0002066295,0.00009527382,0.0002153792,0.0001384822,0.00022050271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14187936,0.015168119,0.57977,0.00029449174,0.008922584,0.07494272,0.0081829475,0.0028305438,0.0012333086,0.0075496924,0.010134013,0.14909218],"study_design_scores_gemma":[0.21311541,0.012785973,0.72989535,0.00037107372,0.005119764,0.0009682502,0.0011494176,0.014452139,0.0033345364,0.0016274496,0.016295686,0.00088495086],"about_ca_topic_score_codex":0.0025451458,"about_ca_topic_score_gemma":0.0014720666,"teacher_disagreement_score":0.15012532,"about_ca_system_score_codex":0.000895435,"about_ca_system_score_gemma":0.0004399209,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W4380080193","doi":"10.1002/hon.3163_108","title":"AVELUMAB MONOTHERAPY FOLLOWED BY A PET ADAPTED CHEMOTHERAPY APPROACH IN THE FIRST LINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA: INITIAL RESULTS FROM THE AVENUE WINDOW STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Avelumab; Internal medicine; Oncology; Clinical endpoint; Chemotherapy; Classical Hodgkin lymphoma; Lymphoma; Cancer; Hodgkin lymphoma; Nivolumab; Immunotherapy; Clinical trial","score_opus":0.06510614357631912,"score_gpt":0.34308420220909897,"score_spread":0.27797805863277986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380080193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97281134,0.0004195993,0.000013351157,0.023126926,0.00009274013,0.0022899255,0.00016402567,0.000077720426,0.001004382],"genre_scores_gemma":[0.9959887,0.00052960584,0.00019502215,0.0016152522,0.00015227117,0.0011030402,0.0003320965,0.000025023826,0.000058961155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726635,0.0005525432,0.0007691773,0.00059910724,0.0003846304,0.00042816924],"domain_scores_gemma":[0.9961402,0.0028513467,0.0002491044,0.0006244718,0.000044017084,0.00009086616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043829135,0.00034527454,0.0011804657,0.00007370938,0.00013697037,0.00001795298,0.0002857126,0.00025318225,0.000046469202],"category_scores_gemma":[0.00015061772,0.00016005259,0.00027109796,0.0005479365,0.00025205634,0.000023857656,0.000047453617,0.00013639903,0.00004410537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047735665,0.21965577,0.49339572,0.000053096413,0.0032916996,0.016985016,0.046403706,0.000061311934,0.00050665607,0.0012242805,0.057670735,0.113016345],"study_design_scores_gemma":[0.13124463,0.023561822,0.78530586,0.00006415836,0.00042743856,0.0005454559,0.004533684,0.0011561181,0.0010284608,0.00036154894,0.051421404,0.00034943462],"about_ca_topic_score_codex":0.0005083522,"about_ca_topic_score_gemma":0.00042786504,"teacher_disagreement_score":0.2919101,"about_ca_system_score_codex":0.00037311163,"about_ca_system_score_gemma":0.00018280478,"threshold_uncertainty_score":0.6526755},"labels":[],"label_agreement":null},{"id":"W4380082565","doi":"10.1002/hon.3164_306","title":"Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"Genentech; F. Hoffmann-La Roche; American Society of Clinical Oncology","keywords":"Medicine; Vincristine; Internal medicine; Rituximab; Prednisone; Hazard ratio; CHOP; Diffuse large B-cell lymphoma; International Prognostic Index; Gastroenterology; Cyclophosphamide; Confidence interval; Lymphoma; Surgery; Oncology; Chemotherapy","score_opus":0.026968334041344685,"score_gpt":0.3401676760293203,"score_spread":0.3131993419879756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380082565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970633,0.00009616486,0.000008779576,0.0005616883,0.000039164202,0.0010363807,0.00003550637,0.00005391428,0.0011051494],"genre_scores_gemma":[0.9988978,0.00003779463,0.00006242956,0.00050463417,0.000011568381,0.0002648646,0.0001654811,0.000011151901,0.00004426305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978736,0.00035203827,0.0005266449,0.00041464114,0.0003959678,0.00043708322],"domain_scores_gemma":[0.9983632,0.0007917997,0.00019774286,0.00044538142,0.00008654153,0.000115365765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004181903,0.0002174065,0.00111857,0.0003857453,0.00007441183,0.000010251908,0.00018485473,0.00018118085,0.000096839234],"category_scores_gemma":[0.000115725496,0.00010756823,0.00020381734,0.0019740805,0.00010169798,0.000034500543,0.00008129722,0.00010500551,0.000061086284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006704429,0.15783663,0.8332287,0.000024737206,0.00062195136,0.0024090188,0.0014569127,0.000001117415,0.000012699522,0.0004202474,0.00033923195,0.0029783219],"study_design_scores_gemma":[0.07192912,0.014707785,0.9069766,0.000014169801,0.0019904182,0.000033320073,0.002524414,0.00018069144,0.00007994521,0.000029726378,0.0014164743,0.00011736982],"about_ca_topic_score_codex":0.00017572292,"about_ca_topic_score_gemma":0.00061241916,"teacher_disagreement_score":0.14312884,"about_ca_system_score_codex":0.00017448245,"about_ca_system_score_gemma":0.00009060473,"threshold_uncertainty_score":0.4386505},"labels":[],"label_agreement":null},{"id":"W4380082876","doi":"10.1002/hon.3164_308","title":"Pola‐R‐CHP versus R‐CHOEP in young patients with high‐risk diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Hazard ratio; Rituximab; Progression-free survival; Lymphoma; Proportional hazards model; Log-rank test; Oncology; Gastroenterology; Overall survival; Confidence interval","score_opus":0.015922070545087295,"score_gpt":0.2785733071257824,"score_spread":0.26265123658069506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380082876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914332,0.00011806627,0.0000046201317,0.00077180803,0.00042428175,0.00063438684,0.000045856123,0.00021148444,0.00635628],"genre_scores_gemma":[0.99832505,0.00024709903,0.00039953852,0.0003352755,0.00005272025,0.00023006056,0.00020364964,0.000027034372,0.00017957803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978525,0.00016613162,0.00041076922,0.00054007786,0.00030612445,0.00072441756],"domain_scores_gemma":[0.99848366,0.0006661861,0.00016396958,0.00035153033,0.00007342138,0.00026124733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017088855,0.0002847962,0.0008339458,0.00018835833,0.000104385705,0.000012743114,0.00012320429,0.0003633546,0.0001902096],"category_scores_gemma":[0.00021706503,0.00017910491,0.000115293624,0.0005392219,0.00011212367,0.000054374115,0.00013757485,0.00016113855,0.00087625656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020692893,0.016240515,0.9727021,0.00003624553,0.0000897925,0.0024068942,0.00016047308,0.0000012018291,0.000006822565,0.001819845,0.0018259236,0.0026409226],"study_design_scores_gemma":[0.087191366,0.0039843423,0.9027502,0.000038703398,0.0001548922,0.00005838151,0.00016186925,0.000047039877,0.00021784831,0.00013179237,0.005081812,0.00018175246],"about_ca_topic_score_codex":0.0002767067,"about_ca_topic_score_gemma":0.000515676,"teacher_disagreement_score":0.08512207,"about_ca_system_score_codex":0.0005666579,"about_ca_system_score_gemma":0.0001475567,"threshold_uncertainty_score":0.99990165},"labels":[],"label_agreement":null},{"id":"W4380084899","doi":"10.1002/hon.3164_420","title":"Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6‐year follow‐up of CHRONOS‐1","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Gilead Sciences; Eisai; Sanofi; Servier; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Adverse effect; Rituximab; Follicular lymphoma; Clinical endpoint; Phases of clinical research; Lymphoma; Refractory (planetary science); Gastroenterology; Surgery; Oncology; Chemotherapy; Clinical trial","score_opus":0.039572228225482425,"score_gpt":0.31659483745637307,"score_spread":0.2770226092308906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380084899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974395,0.00010395713,0.0000024030217,0.00076637615,0.00006022693,0.0005819802,0.000031941272,0.00003417601,0.000979414],"genre_scores_gemma":[0.99873066,0.00036288737,0.00051777705,0.00011933591,0.000010398968,0.000030784377,0.00007516728,0.000011598183,0.0001413648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855065,0.00011265198,0.00059300516,0.00030456853,0.00020666755,0.00023244078],"domain_scores_gemma":[0.99844813,0.0009111238,0.00024344733,0.0002225908,0.00008098648,0.00009370605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002277639,0.0001514468,0.0008885954,0.0001307852,0.00002397733,0.0000019106467,0.00006603517,0.00023252383,0.00007656794],"category_scores_gemma":[0.0003581723,0.00008584401,0.00006048588,0.00032860367,0.00021864595,0.000028502533,0.00005083752,0.000118158816,0.0000140432885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09973941,0.0049666506,0.8743674,0.00012763898,0.00017870273,0.00053580425,0.00059806637,0.000007357823,0.00008375962,0.00070098933,0.0020797402,0.016614439],"study_design_scores_gemma":[0.07337371,0.014335924,0.90665305,0.00016876408,0.000054597855,0.000022337037,0.00008869358,0.000013872473,0.0005529391,0.000029917883,0.004619287,0.00008687597],"about_ca_topic_score_codex":0.00004635374,"about_ca_topic_score_gemma":0.00005641372,"teacher_disagreement_score":0.032285634,"about_ca_system_score_codex":0.00014035292,"about_ca_system_score_gemma":0.00019209231,"threshold_uncertainty_score":0.3500617},"labels":[],"label_agreement":null},{"id":"W4380084965","doi":"10.1002/hon.3163_62","title":"THE PROGNOSTIC IMPACT OF CLINICAL FACTORS AND IMMUNOARCHITECTURAL PATTERNS FOR NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA: AN INTERNATIONAL STUDY BY GLOW","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; B symptoms; Hodgkin lymphoma; Lymphoma; Stage (stratigraphy); Proportional hazards model; Quartile; Classical Hodgkin lymphoma; Oncology; Gastroenterology; Pathology; Confidence interval","score_opus":0.07101162091048586,"score_gpt":0.44677877395406196,"score_spread":0.3757671530435761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380084965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969453,0.0002600253,0.000021774134,0.0006420961,0.00033211816,0.0015675147,0.000115401715,0.000068714864,0.000047047382],"genre_scores_gemma":[0.99882877,0.00034142242,0.00012364317,0.00006282321,0.00006615844,0.00036986455,0.00016363397,0.000016988637,0.000026680536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783975,0.00030398267,0.00078429625,0.0004484389,0.00023298088,0.0003905547],"domain_scores_gemma":[0.9956905,0.0034195248,0.0002630377,0.00031011438,0.000114871626,0.0002019413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006803934,0.0002429198,0.0009096083,0.000065506734,0.0001457413,0.000025135103,0.0002166787,0.00021017577,0.000043776126],"category_scores_gemma":[0.0011085469,0.00011327918,0.0003467313,0.00011623383,0.0002851371,0.000043260567,0.00015959439,0.00008178649,0.000009171701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014689574,0.0037592815,0.94451493,0.00001829284,0.0005863526,0.00022494426,0.0002641162,0.0000015235343,0.00008101941,0.0001046056,0.00042130903,0.04855469],"study_design_scores_gemma":[0.011317444,0.013276009,0.9720345,0.000024643256,0.00020363182,0.00028264476,0.0007170273,0.00071571494,0.00022902516,0.0001025525,0.000982033,0.0001147713],"about_ca_topic_score_codex":0.00022417714,"about_ca_topic_score_gemma":0.000047204314,"teacher_disagreement_score":0.048439916,"about_ca_system_score_codex":0.00024178122,"about_ca_system_score_gemma":0.0002463044,"threshold_uncertainty_score":0.4619391},"labels":[],"label_agreement":null},{"id":"W4380148889","doi":"10.1101/2023.06.07.23290748","title":"Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Signature (topology); Computational biology; Computer science; Biology; Mathematics","score_opus":0.037855941220907734,"score_gpt":0.31296891239979374,"score_spread":0.275112971178886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148303,0.0045319553,0.000040075778,0.0013701521,0.00074941985,0.0011538108,0.0004057935,0.00024900463,0.000016745667],"genre_scores_gemma":[0.991675,0.005869631,0.0005994192,0.00013268177,0.0003073906,0.00039255546,0.00061282876,0.00008022844,0.00033024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600905,0.00046586135,0.00097646855,0.0014190652,0.0006405429,0.0004889881],"domain_scores_gemma":[0.9972062,0.00066423067,0.00050641265,0.0011423557,0.00012676479,0.0003540277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001010722,0.0005886606,0.0020418656,0.0010826968,0.00008613073,0.00014473806,0.0002738111,0.0009927567,0.000050116472],"category_scores_gemma":[0.0006532101,0.00045571965,0.00080320105,0.0009083732,0.00017664123,0.00008532338,0.00061108556,0.0011724734,0.00008300631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012969808,0.000613678,0.98902696,0.00014297433,0.0065835114,0.0007395548,0.0004743158,0.00006501001,0.0000403444,0.000026221427,0.00054137025,0.0016163497],"study_design_scores_gemma":[0.005366533,0.00011003449,0.9811358,0.00033216627,0.010638606,0.0000073198353,0.00008476243,0.0009580228,0.00034421435,0.00038909176,0.00030254433,0.00033092528],"about_ca_topic_score_codex":0.0042668525,"about_ca_topic_score_gemma":0.0055531454,"teacher_disagreement_score":0.007891192,"about_ca_system_score_codex":0.00011158344,"about_ca_system_score_gemma":0.0001714859,"threshold_uncertainty_score":0.9997895},"labels":[],"label_agreement":null},{"id":"W4380357995","doi":"10.1182/bloodadvances.2023009804","title":"Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Ohio State University","keywords":"Mantle cell lymphoma; Oncology; Internal medicine; Cohort; Medicine; Nomogram; Rituximab; Population; Transplantation; Immunology; Lymphoma","score_opus":0.006465866825415123,"score_gpt":0.2592110797599587,"score_spread":0.2527452129345436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380357995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950242,0.003151804,1.1762208e-7,0.0005215854,0.000037785896,0.0004703357,0.00003304341,0.000051578845,0.0007095162],"genre_scores_gemma":[0.99714524,0.00024566328,0.00032153272,0.000109383516,0.000033092085,0.000097643715,0.00002946532,0.000019148609,0.0019988583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991184,0.000017583558,0.00020620847,0.00026252985,0.00020960401,0.00018571063],"domain_scores_gemma":[0.9994368,0.0000907938,0.00007703362,0.00018065862,0.000026536,0.00018819358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006270611,0.00014879362,0.0003015017,0.00015014588,0.000028931008,0.000006416164,0.000038738403,0.000031795433,0.00006306091],"category_scores_gemma":[0.000028795284,0.000094178955,0.000038748618,0.0002535572,0.00005549982,0.00008016744,0.000045413515,0.00002726031,0.00006790468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060177525,0.0027310632,0.96179587,0.00035019006,0.000063948486,0.0005067657,0.00023653361,0.000022737053,0.001663286,0.00000716167,0.00042289597,0.03159776],"study_design_scores_gemma":[0.010628072,0.0017934704,0.9382961,0.0007151044,0.00018468173,0.000007719787,0.00015034343,0.000026071568,0.040228434,0.000030533763,0.0077651767,0.00017429725],"about_ca_topic_score_codex":0.0000072199678,"about_ca_topic_score_gemma":0.000021030612,"teacher_disagreement_score":0.03856515,"about_ca_system_score_codex":0.000027120048,"about_ca_system_score_gemma":0.00006784312,"threshold_uncertainty_score":0.3840506},"labels":[],"label_agreement":null},{"id":"W4380423065","doi":"10.1002/hon.3191","title":"Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T‐cell lymphoma","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Peripheral T-cell lymphoma; Disease; Oncology; Epidemiology; Internal medicine; Omics; Bioinformatics; Pathology; Biology; Immunology; T cell; Immune system","score_opus":0.06318122779493782,"score_gpt":0.376297969735976,"score_spread":0.3131167419410382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380423065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04131665,0.91829354,9.679515e-7,0.002555284,0.0024858613,0.003137845,0.000065322594,0.00030982867,0.031834718],"genre_scores_gemma":[0.0029814872,0.9889127,0.0006653114,0.0009348102,0.0027532796,0.0018624199,0.00025262396,0.00016352968,0.0014738516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888161,0.0018647525,0.003917441,0.0017818878,0.0007080586,0.0029117765],"domain_scores_gemma":[0.99337965,0.0031633899,0.0013634864,0.0007218395,0.00015433122,0.001217318],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0017845989,0.0015841973,0.011941142,0.0011673674,0.00020807909,0.00010499459,0.0008757255,0.004322655,0.0051146094],"category_scores_gemma":[0.0010450964,0.0010654582,0.0013764075,0.0016174637,0.00071738724,0.00013815465,0.0006979869,0.001330077,0.0034083584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096762105,0.01988289,0.0074987276,0.006286723,0.0005300286,0.17898422,0.0007082804,0.0000018601075,6.964718e-7,0.0009886833,0.023837492,0.7603128],"study_design_scores_gemma":[0.014769572,0.0042465692,0.0023548126,0.0035991445,0.0005490399,0.043972522,0.00058936875,0.000014152969,0.0000039463102,0.0006912686,0.9283174,0.00089218613],"about_ca_topic_score_codex":0.00007473127,"about_ca_topic_score_gemma":0.00023337881,"teacher_disagreement_score":0.9044799,"about_ca_system_score_codex":0.013956159,"about_ca_system_score_gemma":0.004629009,"threshold_uncertainty_score":0.9996906},"labels":[],"label_agreement":null},{"id":"W4380740721","doi":"10.1200/jco.23.00570","title":"Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Vancouver General Hospital; Terry Fox Research Institute; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen's University; Spinal Cord Injury BC; Princess Margaret Cancer Centre; Simon Fraser University","funders":"National Cancer Institute","keywords":"Medicine; Concordance; Oncology; Cohort; Diffuse large B-cell lymphoma; Exome sequencing; Internal medicine; Somatic evolution in cancer; Autologous stem-cell transplantation; Exome; Population; Lymphoma; Biopsy; Cancer; Mutation; Gene; Biology","score_opus":0.07014261780382237,"score_gpt":0.39890226877294815,"score_spread":0.3287596509691258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380740721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887727,0.00020507618,0.0000125327015,0.0067212414,0.00046704427,0.00014581301,0.0000241348,0.00002289819,0.0036285433],"genre_scores_gemma":[0.9964005,0.0004913042,0.00040107017,0.0013292491,0.00023545054,0.0000073305214,0.0000370487,0.000021284528,0.0010767751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972465,0.000281278,0.0015503467,0.00019976066,0.0003916214,0.00033046142],"domain_scores_gemma":[0.9952308,0.0029980172,0.0010756654,0.00016786001,0.00023132504,0.00029636646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182916,0.0001467846,0.0011707857,0.00019458846,0.000052115243,0.0000067010897,0.000107976906,0.0003615049,0.00005119873],"category_scores_gemma":[0.0025168771,0.0000962196,0.0003399073,0.0004063323,0.00009973541,0.00007982328,0.000064431755,0.0003685489,0.00007034498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017196012,0.029729022,0.9300631,0.000015473912,0.00032947995,0.00975825,0.00010615176,0.0000037082575,0.0000014160939,0.00011718045,0.0121105695,0.016046006],"study_design_scores_gemma":[0.06668158,0.0059875916,0.9143802,0.00023157505,0.0003544066,0.00026539582,0.00020993639,0.003931996,0.0000050671892,0.00017618574,0.007681052,0.00009500046],"about_ca_topic_score_codex":0.000036072586,"about_ca_topic_score_gemma":0.00032284265,"teacher_disagreement_score":0.06496198,"about_ca_system_score_codex":0.0015494501,"about_ca_system_score_gemma":0.0013406421,"threshold_uncertainty_score":0.4051758},"labels":[],"label_agreement":null},{"id":"W4380854067","doi":"10.1182/blood.2022019386","title":"Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Genentech","keywords":"Medicine; Pembrolizumab; Internal medicine; Discontinuation; Cohort; Adverse effect; Brentuximab vedotin; Surgery; Salvage therapy; Chemotherapy; Lymphoma; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.02062562091102287,"score_gpt":0.2741899358055085,"score_spread":0.2535643148944856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380854067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559736,0.0005301003,0.000023242246,0.0009918171,0.00031521093,0.0007863718,0.00010273575,0.00017712744,0.0014760557],"genre_scores_gemma":[0.9935442,0.00046148122,0.00058877404,0.00023666643,0.0002756715,0.00031326388,0.00012801097,0.00006897997,0.004382954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984132,0.000040640924,0.00037942958,0.00041117275,0.00034937952,0.0004061436],"domain_scores_gemma":[0.9987543,0.00032137256,0.0001354747,0.00049714587,0.00010973009,0.00018196713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014016304,0.0002468993,0.00055424555,0.00017292373,0.00008125905,0.000016193488,0.00012838139,0.00019975539,0.00009049182],"category_scores_gemma":[0.00012609901,0.00020050834,0.00040132817,0.00028866218,0.00007592389,0.000060143117,0.000040799863,0.000059987076,0.00016375151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026924472,0.03734601,0.43102404,0.0014170269,0.008360894,0.0014402461,0.0053030686,0.000023141174,0.044093147,0.013306785,0.20589355,0.22486763],"study_design_scores_gemma":[0.2615455,0.0072669024,0.5611618,0.00041304438,0.0016297362,0.000095221,0.0003513229,0.00030377787,0.08577444,0.0010181693,0.07983315,0.0006068858],"about_ca_topic_score_codex":0.00006669227,"about_ca_topic_score_gemma":0.000015101465,"teacher_disagreement_score":0.23462105,"about_ca_system_score_codex":0.00010882902,"about_ca_system_score_gemma":0.0002452284,"threshold_uncertainty_score":0.8176493},"labels":[],"label_agreement":null},{"id":"W4381838960","doi":"10.1182/bloodadvances.2023010254","title":"Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Seagen; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Nivolumab; Neutropenia; Oncology; Adverse effect; Transplantation; Clinical endpoint; Confidence interval; Lymphoma; Surgery; Chemotherapy; CD30; Clinical trial; Immunotherapy; Cancer","score_opus":0.0092442261172573,"score_gpt":0.24120245862217496,"score_spread":0.23195823250491765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381838960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899323,0.002746178,0.00007355433,0.00069642847,0.00043376273,0.0012670052,0.00017216841,0.00036247008,0.004316124],"genre_scores_gemma":[0.99051464,0.0005748619,0.0034096553,0.00037164296,0.00025848288,0.0007025612,0.0005333752,0.00006908751,0.003565677],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981134,0.000024081892,0.0002838629,0.0004938202,0.00042525126,0.00065956346],"domain_scores_gemma":[0.99896073,0.0002462181,0.00013480909,0.0003277892,0.00012627975,0.00020418323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001558014,0.00029278212,0.00053769525,0.00012910274,0.00019403081,0.000029840437,0.00012430786,0.000070684095,0.000035169855],"category_scores_gemma":[0.00006187079,0.00021534834,0.00017895945,0.00039252042,0.00006645191,0.00015212293,0.000068580404,0.000050179027,0.00012997306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022086745,0.0524713,0.75169826,0.00417045,0.002388713,0.0028760643,0.0018817069,0.00002069706,0.0032416843,0.003589029,0.03268051,0.122894816],"study_design_scores_gemma":[0.4840712,0.015842265,0.3254312,0.0009621298,0.0028321506,0.000274413,0.0016161768,0.00019603738,0.03174592,0.0005465681,0.13538718,0.0010947686],"about_ca_topic_score_codex":0.000016195285,"about_ca_topic_score_gemma":0.000060860748,"teacher_disagreement_score":0.46198446,"about_ca_system_score_codex":0.0000920037,"about_ca_system_score_gemma":0.00026397116,"threshold_uncertainty_score":0.87816507},"labels":[],"label_agreement":null},{"id":"W4382467972","doi":"10.1371/journal.pone.0287602","title":"Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes","year":2023,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; BC Cancer Foundation; University of British Columbia; Simon Fraser University; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Gene; Genetics; Biology; Immune system; Cancer; Computational biology","score_opus":0.09298075399716177,"score_gpt":0.3023727093301753,"score_spread":0.20939195533301352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382467972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896782,0.008653148,4.962366e-7,0.0006762542,0.000048645546,0.00053828,0.00020883935,0.00006794565,0.00012821563],"genre_scores_gemma":[0.99512714,0.0033946482,0.00026762846,0.00019739842,0.0001496109,0.0004378636,0.00018342338,0.000032305463,0.0002099551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984225,0.000074910495,0.00039113822,0.0004114354,0.00033954068,0.00036048345],"domain_scores_gemma":[0.9992511,0.00017796653,0.00007160343,0.0003132486,0.000058877824,0.00012714673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014930277,0.00022011693,0.00061302324,0.00036024215,0.000050536903,0.00002243344,0.00006973741,0.00010661473,0.00012680033],"category_scores_gemma":[0.00011691476,0.00018407824,0.00006843399,0.0007048158,0.00004086299,0.000067221845,0.00006160001,0.000068236965,0.00004030488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035281392,0.0027775057,0.6439533,0.0002750445,0.00044199824,0.005939594,0.000626956,0.00013102044,0.32787186,0.0000064009114,0.000027292794,0.017596222],"study_design_scores_gemma":[0.00833988,0.00028291292,0.71270543,0.00082115637,0.00022458703,0.000021696815,0.0002830155,0.003094593,0.27395535,0.0000140463535,0.00004455505,0.00021279843],"about_ca_topic_score_codex":0.010187203,"about_ca_topic_score_gemma":0.0013241915,"teacher_disagreement_score":0.06875211,"about_ca_system_score_codex":0.00032594864,"about_ca_system_score_gemma":0.00035123248,"threshold_uncertainty_score":0.99640405},"labels":[],"label_agreement":null},{"id":"W4382653168","doi":"10.3390/diagnostics13132237","title":"Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance","year":2023,"lang":"en","type":"article","venue":"Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Medicine; Hazard ratio; Follicular lymphoma; Rituximab; Internal medicine; Lymphoma; Kurtosis; Progression-free survival; Oncology; Nuclear medicine; Confidence interval; Overall survival; Mathematics","score_opus":0.008685873162156134,"score_gpt":0.25740356255969654,"score_spread":0.2487176893975404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382653168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466264,0.0023934538,0.0000104956425,0.0007426573,0.000060675517,0.0014534553,0.00015574237,0.00009747752,0.00042342284],"genre_scores_gemma":[0.9920494,0.0062225,0.00088818773,0.00010306669,0.000015094846,0.00041293676,0.00019421686,0.000046654193,0.00006792147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983094,0.00006930724,0.00032801068,0.00045405695,0.00044030198,0.0003989304],"domain_scores_gemma":[0.9983078,0.00073926133,0.0001472444,0.0005402861,0.00010820986,0.00015719188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015277819,0.00033386436,0.00061155757,0.00021080297,0.000054998847,0.0000214921,0.00011085809,0.00009450658,0.000010697878],"category_scores_gemma":[0.00042779805,0.00022040824,0.00010130786,0.00066691655,0.00023309812,0.00005806767,0.00006488296,0.00005974529,0.00001147318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001977748,0.0033133577,0.95111,0.00011096392,0.001192324,0.0031993687,0.00041138282,0.000016938831,0.00008673861,0.00011566694,0.0009740652,0.037491467],"study_design_scores_gemma":[0.03459922,0.0038079016,0.94321537,0.0015661265,0.000426655,0.0001623934,0.0006052974,0.00059073255,0.014243869,0.0002062316,0.00031757314,0.0002586123],"about_ca_topic_score_codex":0.00062070787,"about_ca_topic_score_gemma":0.00004987416,"teacher_disagreement_score":0.037232853,"about_ca_system_score_codex":0.00026592793,"about_ca_system_score_gemma":0.00014814103,"threshold_uncertainty_score":0.8987987},"labels":[],"label_agreement":null},{"id":"W4383164304","doi":"10.1016/j.jmoldx.2023.06.007","title":"Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors","year":2023,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Brigham and Women's Hospital; Boston Children's Hospital; Dana-Farber Cancer Institute; St. Baldrick's Foundation; National Cancer Institute; National Institutes of Health; Vertex Pharmaceuticals; Charles H. Hood Foundation","keywords":"Biology; Exon; Gene isoform; Genetics; Gene; genomic DNA; Breakpoint; Molecular biology; Chromosomal translocation","score_opus":0.017437033489863956,"score_gpt":0.2820679287384496,"score_spread":0.26463089524858563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383164304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975884,0.0009788855,0.0003888404,0.00027203502,0.00029905036,0.0003345983,0.00004510339,0.000018264589,0.00007482004],"genre_scores_gemma":[0.99648494,0.0018491187,0.0012352753,0.00018134784,0.00006492048,0.000020393294,0.000027907716,0.000042515727,0.00009356955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971236,0.0000937592,0.0015472295,0.00023243236,0.00064715726,0.00035581508],"domain_scores_gemma":[0.9976793,0.0007501585,0.000800915,0.00028711432,0.00023345811,0.0002490859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066824903,0.00023493145,0.00081597053,0.00033621155,0.00004156154,0.000031063715,0.00017601647,0.00014573048,0.000087080625],"category_scores_gemma":[0.002443597,0.00016078645,0.0002850501,0.00040694515,0.0000743344,0.0001077736,0.00009896591,0.00021024933,0.000030412806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007276037,0.001199023,0.11581744,0.00020394896,0.00027390476,0.015760442,0.0005951562,0.0005477901,0.85514694,0.000030046473,0.008373168,0.0013245221],"study_design_scores_gemma":[0.0072607184,0.0016007316,0.14471166,0.0021925054,0.00034436124,0.00062855927,0.0007181026,0.00027571787,0.8416583,0.00027975367,0.00006398454,0.0002656341],"about_ca_topic_score_codex":0.000031341275,"about_ca_topic_score_gemma":0.0000014826014,"teacher_disagreement_score":0.028894214,"about_ca_system_score_codex":0.00031912245,"about_ca_system_score_gemma":0.0006417589,"threshold_uncertainty_score":0.65566814},"labels":[],"label_agreement":null},{"id":"W4383872161","doi":"10.1093/oncolo/oyad204","title":"Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Dermatology","score_opus":0.04636142410425152,"score_gpt":0.3169775137070694,"score_spread":0.27061608960281786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383872161","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3945966,0.0024718822,0.0000020015455,0.5766804,0.00039196477,0.0031571253,0.0010921924,0.000079450736,0.021528358],"genre_scores_gemma":[0.9121947,0.005414867,0.000031324114,0.07578962,0.0006819178,0.0012219198,0.001136254,0.00006720439,0.0034621786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981254,0.00029041598,0.0005952042,0.00032625606,0.00031411933,0.0003486486],"domain_scores_gemma":[0.9959835,0.002032679,0.00052339135,0.0013538462,0.000072364724,0.000034232587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030394172,0.00031634243,0.0008469446,0.00012905717,0.00008671616,0.000010681387,0.00037221273,0.0004372084,0.000043090567],"category_scores_gemma":[0.00006622815,0.0001467947,0.00037351952,0.0002853483,0.00020640476,0.000017727114,0.00004361688,0.00022071022,0.00007318756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026328609,0.034068566,0.01430265,0.00021240787,0.00049913564,0.00090564194,0.002327581,5.1030855e-7,0.0003059108,0.0003881697,0.9404682,0.006257968],"study_design_scores_gemma":[0.018213939,0.003823496,0.21690895,0.00012433912,0.0008813451,0.000030207233,0.0003594157,0.0000029188445,0.00043332076,0.00014107359,0.7589435,0.00013752302],"about_ca_topic_score_codex":0.0014344635,"about_ca_topic_score_gemma":0.00031438057,"teacher_disagreement_score":0.5175981,"about_ca_system_score_codex":0.0010693431,"about_ca_system_score_gemma":0.00036154428,"threshold_uncertainty_score":0.5986114},"labels":[],"label_agreement":null},{"id":"W4383873053","doi":"10.1007/s00277-023-05321-3","title":"Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma","year":2023,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Bendamustine; Internal medicine; Oncology; Hematology; Multiple myeloma; Lymphoma","score_opus":0.05545757967693467,"score_gpt":0.33499105010752045,"score_spread":0.2795334704305858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383873053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800156,0.003184967,0.000016076237,0.000490132,0.00743281,0.0031112912,0.0023374197,0.00012230471,0.0032894202],"genre_scores_gemma":[0.9907197,0.0008110167,0.00012773422,0.00023983546,0.00015428854,0.00023520767,0.0067666466,0.00017936625,0.0007662459],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99393874,0.0010043827,0.0013952879,0.0016988477,0.0009995089,0.0009632043],"domain_scores_gemma":[0.99130803,0.004308554,0.0014200914,0.0020343654,0.0005885333,0.00034041677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007650525,0.0011152445,0.004389238,0.001562804,0.00015341789,0.000033327316,0.00055852754,0.0005977608,0.000024778596],"category_scores_gemma":[0.0006366259,0.0009219206,0.0002863836,0.0011012029,0.0004137776,0.00020269759,0.00037867166,0.0007406138,0.000032846056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26902974,0.08701034,0.1782565,0.008569762,0.005092001,0.0014928259,0.002909118,0.00008368838,0.00010472273,0.00054059236,0.44442385,0.0024868292],"study_design_scores_gemma":[0.3850943,0.020375675,0.55440056,0.015963085,0.001913029,0.000042416756,0.0012827162,0.0017382976,0.0067918412,0.00003900139,0.010551169,0.0018079047],"about_ca_topic_score_codex":0.0047304537,"about_ca_topic_score_gemma":0.006658025,"teacher_disagreement_score":0.4338727,"about_ca_system_score_codex":0.00056290586,"about_ca_system_score_gemma":0.0014384255,"threshold_uncertainty_score":0.9993231},"labels":[],"label_agreement":null},{"id":"W4384199478","doi":"10.58931/cht.2023.2123","title":"Management of limited stage Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Medicine; Hodgkin lymphoma; Oncology; Internal medicine; Disease; Neoplasm; Lymphatic system; Pathology; Biology","score_opus":0.02175130596745079,"score_gpt":0.26964230744770595,"score_spread":0.24789100148025517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384199478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96043926,0.0005379897,0.000002866034,0.0050464817,0.0002238512,0.0004320437,0.00007012957,0.0000983613,0.033149004],"genre_scores_gemma":[0.99130374,0.00019906029,0.00024318075,0.00060865056,0.000016005228,0.00008856217,0.00011973923,0.000021153135,0.007399899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892175,0.00002548901,0.00024160862,0.00025065427,0.00012429847,0.00043616944],"domain_scores_gemma":[0.99903417,0.00004998941,0.000054576445,0.00040091408,0.000044632354,0.00041573733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009454975,0.00013937744,0.00036144807,0.0003931536,0.000059178048,0.000005204076,0.00008991112,0.000117996395,0.00037917052],"category_scores_gemma":[0.000019412977,0.00012541075,0.000096202544,0.0004907582,0.00006267727,0.000021818667,0.000030258629,0.000030359166,0.00063283223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010726711,0.00045736253,0.60142857,0.0009469715,0.0016205037,0.038430672,0.00054812385,0.00001132958,0.00007125473,0.15426506,0.14279291,0.05931996],"study_design_scores_gemma":[0.0044356226,0.00023083483,0.8175526,0.00030872726,0.00025767536,0.00038352044,0.0008058355,0.00011510634,0.0051705264,0.0002613675,0.17024577,0.00023238051],"about_ca_topic_score_codex":0.010785511,"about_ca_topic_score_gemma":0.010610286,"teacher_disagreement_score":0.21612406,"about_ca_system_score_codex":0.00026673096,"about_ca_system_score_gemma":0.00027864892,"threshold_uncertainty_score":0.99580175},"labels":[],"label_agreement":null},{"id":"W4384274089","doi":"10.58931/cht.2022.1316","title":"Moving beyond chemotherapy in the management of follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Regimen; Follicular lymphoma; Bendamustine; Internal medicine; Oncology; Chemotherapy; Lymphoma; Chemotherapy regimen; Induction chemotherapy; Surgery","score_opus":0.00916739963115653,"score_gpt":0.23730394450874662,"score_spread":0.22813654487759008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384274089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96846205,0.0019594526,0.0000017876225,0.011010148,0.000102539794,0.0005322826,0.000016092956,0.000009139181,0.017906526],"genre_scores_gemma":[0.99401987,0.000062343875,0.000181163,0.0051465584,0.000009855159,0.00029108327,0.000025864028,0.000012089966,0.0002511744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910367,0.00006285461,0.00019880572,0.00018864613,0.00016108944,0.0002849623],"domain_scores_gemma":[0.99943554,0.000043077816,0.000047925052,0.00034952152,0.000012967717,0.00011098528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019399083,0.00010359388,0.00025761398,0.00017647655,0.000115113064,0.000004348014,0.00015695988,0.000040247258,0.000514764],"category_scores_gemma":[0.0000037746713,0.000080028694,0.00008299919,0.0002827581,0.00004389533,0.000014485714,0.000027749042,0.00005244468,0.000011036258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014269132,0.00142976,0.64483595,0.00032474546,0.0010896265,0.0199782,0.00468551,0.0000464297,0.000041257437,0.24770203,0.0290977,0.050626107],"study_design_scores_gemma":[0.011015924,0.0004461852,0.7280894,0.000120938705,0.00028198885,0.003150385,0.00632196,0.00011610214,0.001610551,0.002069877,0.24646975,0.00030692006],"about_ca_topic_score_codex":0.014227322,"about_ca_topic_score_gemma":0.008634108,"teacher_disagreement_score":0.24563216,"about_ca_system_score_codex":0.0004481352,"about_ca_system_score_gemma":0.00022090813,"threshold_uncertainty_score":0.99233705},"labels":[],"label_agreement":null},{"id":"W4384461365","doi":"10.58931/cht.2022.1s1029","title":"Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre Hospitalier de l’Université de Montréal; Cégep de l'Abitibi Témiscamingue; Juravinski Cancer Centre; Université du Québec en Abitibi-Témiscamingue","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Oncology; Refractory (planetary science); Adverse effect; Internal medicine; Intensive care medicine","score_opus":0.012985825229573462,"score_gpt":0.24204650729152016,"score_spread":0.2290606820619467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384461365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866862,0.0017688096,0.0000072946923,0.003031792,0.00072261965,0.0015433171,0.0015147412,0.000069127724,0.0046560667],"genre_scores_gemma":[0.9899364,0.000084667015,0.00021668387,0.0019625567,0.000052787396,0.0021971893,0.0012961014,0.0000490938,0.004204531],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830157,0.00007438819,0.00030395066,0.00045126243,0.00015472798,0.00071411865],"domain_scores_gemma":[0.99844456,0.00015870489,0.000098476325,0.000492501,0.00007709818,0.0007286815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067099456,0.0002607668,0.00047519413,0.0002949763,0.00067891454,0.000012396726,0.00011623261,0.00012780656,0.00057797367],"category_scores_gemma":[0.000045523862,0.00023686964,0.00024799324,0.00015770464,0.0000475703,0.00004341398,0.000039756153,0.00006771492,0.00013168104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047097253,0.0635427,0.73090357,0.00014077935,0.0008001549,0.00217232,0.0017539749,0.0000047865537,0.000025853908,0.03267676,0.15359521,0.013912914],"study_design_scores_gemma":[0.063222885,0.0024955159,0.044529557,0.000014308851,0.0003636614,0.00030119755,0.00032593118,0.00007262355,0.0003920005,0.00013040903,0.88785857,0.00029331053],"about_ca_topic_score_codex":0.007985282,"about_ca_topic_score_gemma":0.017047409,"teacher_disagreement_score":0.73426336,"about_ca_system_score_codex":0.0030905127,"about_ca_system_score_gemma":0.001162691,"threshold_uncertainty_score":0.9986206},"labels":[],"label_agreement":null},{"id":"W4384461377","doi":"10.58931/cht.2022.1s1227","title":"Updates in the treatment of mantle cell lymphoma: A Canadian expert framework","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BeiGene; Royal College of Physicians and Surgeons of Canada; Bristol-Myers Squibb; Canadian Hematology Society; AstraZeneca; Celgene; Gilead Sciences","keywords":"Mantle cell lymphoma; Blastoid; IGHV@; Lymphoma; Bone marrow; Cancer research; Lymph node; Medicine; Follicular lymphoma; Biology; Oncology; Internal medicine; Chronic lymphocytic leukemia; Leukemia","score_opus":0.01419186452329993,"score_gpt":0.2532317796375717,"score_spread":0.23903991511427178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384461377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608284,0.00919284,5.593304e-7,0.01708501,0.00027988563,0.00071246806,0.00016755916,0.000011840405,0.011721442],"genre_scores_gemma":[0.9937687,0.00024895387,0.00014788986,0.0048081893,0.000034458844,0.0005842534,0.000104119805,0.000018806015,0.0002846523],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868596,0.000110653746,0.00024855658,0.0002698624,0.00013906174,0.00054592144],"domain_scores_gemma":[0.9988082,0.00017268701,0.00005178859,0.00049110345,0.00002237854,0.00045384248],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000094569645,0.00017770726,0.00040479036,0.0003873737,0.00022301025,0.000008306756,0.0001747887,0.00011024652,0.0014149098],"category_scores_gemma":[0.000019265552,0.00013064261,0.00011450193,0.0003307713,0.00007551953,0.000017510605,0.000010989947,0.00006826921,0.00005374391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010695298,0.0038917142,0.8318637,0.000057196892,0.00029131834,0.01804751,0.022486974,0.000017261491,0.000020447274,0.03485952,0.076753736,0.011603655],"study_design_scores_gemma":[0.005199982,0.0013669466,0.08989092,0.00004943459,0.0001319033,0.0017982711,0.006588014,0.00004336351,0.002435113,0.0008198734,0.8913794,0.00029678043],"about_ca_topic_score_codex":0.86703837,"about_ca_topic_score_gemma":0.9057528,"teacher_disagreement_score":0.8146257,"about_ca_system_score_codex":0.0020407988,"about_ca_system_score_gemma":0.002019606,"threshold_uncertainty_score":0.99949795},"labels":[],"label_agreement":null},{"id":"W4384463905","doi":"10.58931/cht.2022.116","title":"Management of follicular lymphoma at first relapse","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Oncology; Internal medicine; Follicular phase; Disease","score_opus":0.009802149988350896,"score_gpt":0.22303070448951995,"score_spread":0.21322855450116907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384463905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619398,0.0033925003,0.0000013283254,0.0069725164,0.0002990725,0.0005173341,0.00007192227,0.000029053228,0.026776448],"genre_scores_gemma":[0.9943018,0.000094300114,0.0002001226,0.0009874385,0.000011175012,0.0003100193,0.00009012311,0.000019991374,0.003985063],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890894,0.00003506255,0.0002414448,0.00027747283,0.00017712674,0.00035995585],"domain_scores_gemma":[0.99904305,0.00003856556,0.00006991994,0.00044931695,0.00002529438,0.0003738561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008996265,0.00013607104,0.00035280985,0.00018715442,0.00029045393,0.0000026862513,0.00011519876,0.00006149711,0.002435681],"category_scores_gemma":[0.000008395352,0.00013186451,0.000136324,0.00021218926,0.00006323281,0.000015246967,0.000108825996,0.000041304385,0.00012330036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019756345,0.0008973339,0.66031563,0.0004740964,0.0015925044,0.04162961,0.00070824596,0.000049007554,0.000015767873,0.11562723,0.1716355,0.0068575377],"study_design_scores_gemma":[0.0055667814,0.0003660827,0.1687612,0.00010191169,0.0004328735,0.0040133707,0.00045985545,0.00003928382,0.0018048346,0.00025058532,0.81796634,0.00023684948],"about_ca_topic_score_codex":0.013867665,"about_ca_topic_score_gemma":0.021488626,"teacher_disagreement_score":0.6463309,"about_ca_system_score_codex":0.0014396519,"about_ca_system_score_gemma":0.00023641901,"threshold_uncertainty_score":0.9984762},"labels":[],"label_agreement":null},{"id":"W4384463912","doi":"10.58931/cht.2022.1211","title":"Immunotherapy in Hodgkin lymphoma","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Oncology; Internal medicine; Lymphoma; Clinical trial; Malignancy; Immunotherapy; Chemotherapy; Cancer; Hodgkin lymphoma","score_opus":0.011063780678619472,"score_gpt":0.2438885588094986,"score_spread":0.23282477813087915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384463912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698677,0.0035089517,8.992862e-7,0.009778589,0.00028760778,0.00035751803,0.00003203624,0.000029446974,0.016137242],"genre_scores_gemma":[0.9924644,0.000046763882,0.000088429566,0.0061375354,0.00001945541,0.0003378862,0.000049497357,0.00001997919,0.0008360424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989672,0.000071787166,0.00019913592,0.00024177594,0.000108236236,0.00041187138],"domain_scores_gemma":[0.9993341,0.000054886237,0.00003401841,0.00030207945,0.000015010045,0.00025989037],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011783494,0.000121902915,0.00031865758,0.0003521606,0.00014873267,0.0000060280836,0.00009971095,0.00006616106,0.0029656773],"category_scores_gemma":[0.00001902494,0.00012070651,0.00007493633,0.00026663544,0.00004441816,0.000020755719,0.000023766795,0.00008144538,0.00010952965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010261741,0.0004297274,0.9123965,0.000016246042,0.00012201188,0.008289328,0.0006760323,0.000008785804,0.000061768376,0.02270601,0.027782558,0.0274084],"study_design_scores_gemma":[0.006479434,0.00034294248,0.50903326,0.00002379509,0.000026106243,0.004017363,0.00039075778,0.00004419092,0.00079410843,0.00055018975,0.47808373,0.00021415074],"about_ca_topic_score_codex":0.074351475,"about_ca_topic_score_gemma":0.08417714,"teacher_disagreement_score":0.45030117,"about_ca_system_score_codex":0.0013233152,"about_ca_system_score_gemma":0.0010159356,"threshold_uncertainty_score":0.9979457},"labels":[],"label_agreement":null},{"id":"W4384523005","doi":"10.21203/rs.3.rs-3161156/v1","title":"Bone Marrow Tumor Microenvironment of Obese Hodgkin Lymphoma Patients: implications of insulin axis","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Universidade do Porto","keywords":"Medicine; Adipokine; Leptin; Internal medicine; Bone marrow; Body mass index; Endocrinology; Osteoprotegerin; Chemokine; Oncology; Adiponectin; Obesity; Overweight; Insulin resistance; Inflammation; Receptor","score_opus":0.05473015344539702,"score_gpt":0.3576377091030091,"score_spread":0.3029075556576121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384523005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989241,0.0029940836,0.00000781935,0.0021873838,0.000102283964,0.0028671094,0.0019108535,0.000048316084,0.0006411667],"genre_scores_gemma":[0.9919695,0.003991922,0.00059882796,0.000036414538,0.00008266393,0.0013210309,0.0013511538,0.00007950485,0.0005689651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609315,0.00027447395,0.0008812245,0.00076751754,0.0013913827,0.0005922343],"domain_scores_gemma":[0.99651295,0.00044752282,0.00034080414,0.0016715932,0.0007096899,0.00031747003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007194628,0.00032540216,0.00087990094,0.00068558403,0.00009570086,0.000021651249,0.0003440928,0.00024186092,0.00025809486],"category_scores_gemma":[0.00057048135,0.0002794799,0.00040989046,0.0005296676,0.00035661898,0.000033820623,0.0013396437,0.00033301194,0.00022444906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056109816,0.0121428,0.92269456,0.00659404,0.0007130243,0.000157813,0.00070340134,0.000040067967,0.0030058397,0.00034427026,0.013813606,0.039229486],"study_design_scores_gemma":[0.0035985808,0.0011148404,0.97596085,0.0026100557,0.000121095894,0.0000070336873,0.00022903904,0.000023325161,0.012881162,0.000651914,0.0026241192,0.00017797112],"about_ca_topic_score_codex":0.0016351709,"about_ca_topic_score_gemma":0.000077670426,"teacher_disagreement_score":0.05326631,"about_ca_system_score_codex":0.0012406618,"about_ca_system_score_gemma":0.0006858981,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W4384820346","doi":"10.3324/haematol.2022.282469","title":"Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Servier; AstraZeneca","keywords":"Mantle cell lymphoma; Internal medicine; Medicine; Refractory (planetary science); Oncology; Lymphoma; Overall survival; Materials science; Metallurgy","score_opus":0.1030738814372394,"score_gpt":0.31948936529747396,"score_spread":0.21641548386023457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384820346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904676,0.00025963195,0.000001155199,0.0041235653,0.000117035466,0.0026403798,0.002187338,0.00009198985,0.000111285444],"genre_scores_gemma":[0.9880859,0.00014732848,0.00022391826,0.0035521179,0.00010135519,0.00015330019,0.007474733,0.000100391815,0.00016092122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625015,0.00025143792,0.0008043847,0.00134205,0.0008382332,0.0005137443],"domain_scores_gemma":[0.9967366,0.0011107533,0.0007130565,0.0012122252,0.000106104795,0.00012129717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019640721,0.0006955544,0.0016866775,0.00027550236,0.00014703379,0.00003781005,0.0003890791,0.0004989854,0.000037284215],"category_scores_gemma":[0.00015985801,0.0004044694,0.000061206876,0.00027439217,0.00014020807,0.00013602577,0.0004530578,0.0004974283,0.000009385285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012408082,0.024541615,0.9016736,0.00029822375,0.00085431535,0.007825036,0.0021654204,0.0000011596271,0.0000046223718,0.0000010296487,0.049176972,0.0010498977],"study_design_scores_gemma":[0.13125579,0.027202941,0.8301363,0.0017169712,0.0009824075,0.000019598452,0.00063852855,0.00003638693,0.00008248487,0.000013093501,0.007258661,0.00065684645],"about_ca_topic_score_codex":0.001726439,"about_ca_topic_score_gemma":0.0002849795,"teacher_disagreement_score":0.1188477,"about_ca_system_score_codex":0.00015326563,"about_ca_system_score_gemma":0.00020942042,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W4384923042","doi":"10.1111/bjh.18972","title":"Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus <scp>CVP</scp> or <scp>CHOP</scp> chemoimmunotherapy in Ontario","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"American Society of Hematology","keywords":"Rituximab; Chemoimmunotherapy; Medicine; Bendamustine; CHOP; Internal medicine; Oncology; Lymphoma","score_opus":0.01750002979747422,"score_gpt":0.25031042060235265,"score_spread":0.23281039080487842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715847,0.00078912376,0.000018258335,0.0002267382,0.00018306544,0.0011494488,0.00009020885,0.00006257457,0.000322097],"genre_scores_gemma":[0.9968623,0.0002231087,0.0013035036,0.00046448648,0.000032060605,0.00009651136,0.00013617748,0.00009055961,0.0007912928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961193,0.0001426255,0.001500671,0.0005096232,0.00088096166,0.0008467776],"domain_scores_gemma":[0.9969304,0.0006688714,0.0009126132,0.00040957972,0.000676519,0.00040201453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002946199,0.0005318349,0.0031770307,0.000760494,0.00011707053,0.00006356529,0.00034637155,0.00024025654,0.00006030502],"category_scores_gemma":[0.0003384565,0.00039706499,0.00026100382,0.00088627846,0.00021663624,0.00020054841,0.00010017868,0.00034237196,0.0000408225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017744054,0.0065777665,0.9368645,0.00015984332,0.0014811081,0.04356881,0.0026855413,0.00013714116,0.000025129768,0.000016354212,0.0027831024,0.003926276],"study_design_scores_gemma":[0.109976776,0.0029616673,0.8614391,0.0016061226,0.00039546302,0.019584002,0.0008252031,0.000032392712,0.0008882537,0.000009871497,0.0021762939,0.000104837425],"about_ca_topic_score_codex":0.016331336,"about_ca_topic_score_gemma":0.045731064,"teacher_disagreement_score":0.108202375,"about_ca_system_score_codex":0.0014942351,"about_ca_system_score_gemma":0.0017307877,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W4385065994","doi":"10.5348/100073z11ke2023cr","title":"Primary follicular lymphoma of the colon presenting as an incidental finding on endoscopy","year":2023,"lang":"en","type":"article","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Organomegaly; Differential diagnosis; Follicular lymphoma; Lymphoma; Endoscopy; Pathology; Follicular phase; Gastroenterology; Internal medicine","score_opus":0.02187131190509855,"score_gpt":0.2999730674231031,"score_spread":0.27810175551800453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385065994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97301245,0.00003386747,4.1399383e-7,0.00046601502,0.00014905946,0.0004272958,0.0000044211997,0.00007595787,0.02583055],"genre_scores_gemma":[0.9974518,0.000026385918,0.00009325326,0.0005181616,0.000060473107,0.000047175436,0.00003447183,0.000015700354,0.0017526243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990178,0.000043031458,0.00017892789,0.00019863922,0.00036791034,0.00019370849],"domain_scores_gemma":[0.9993967,0.000117101736,0.00007109495,0.00031755355,0.000024796935,0.00007275614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012813069,0.00010758498,0.00019987047,0.000074392454,0.00010280056,0.000014877087,0.00009470081,0.00005042119,0.00009496865],"category_scores_gemma":[0.00006613863,0.00006390853,0.00013782915,0.0002693751,0.00003466046,0.000055129996,0.00010329607,0.00002881468,0.00012509113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016012005,0.0011433986,0.9641478,0.00007945636,0.00022408534,0.0003621821,0.0006160667,0.000009911215,0.020761093,0.0042158016,0.0025634654,0.0057166046],"study_design_scores_gemma":[0.0025047879,0.00034621026,0.78126544,0.000114368464,0.00008681907,0.000041701896,0.00036458453,0.000118570155,0.2145075,0.0001340322,0.00045603493,0.000059934675],"about_ca_topic_score_codex":0.00033080677,"about_ca_topic_score_gemma":0.00001885746,"teacher_disagreement_score":0.19374642,"about_ca_system_score_codex":0.00018816187,"about_ca_system_score_gemma":0.000100518024,"threshold_uncertainty_score":0.26061141},"labels":[],"label_agreement":null},{"id":"W4385144282","doi":"10.1002/hon.3205","title":"Personalised therapy in follicular lymphoma – is the dial turning?","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Terry Fox Foundation; ViewRay; Cancer Research UK; Incyte; Eisai; BeiGene; National Cancer Research Institute; AstraZeneca; Celgene; Blood Cancer UK; Gilead Sciences","keywords":"Follicular lymphoma; Medicine; Dial; Oncology; Lymphoma; Internal medicine; Engineering","score_opus":0.13647644419123028,"score_gpt":0.40956122111084264,"score_spread":0.27308477691961236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385144282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033237182,0.989339,4.7530085e-7,0.0027311603,0.00029994137,0.0021240227,0.000026571613,0.00012273328,0.0020324106],"genre_scores_gemma":[0.0006259709,0.9943112,0.00006543013,0.0021694968,0.00023424848,0.0019759485,0.00010407898,0.000056830384,0.00045678302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969336,0.0005721845,0.0008626753,0.00071164174,0.00033395446,0.00058593496],"domain_scores_gemma":[0.996648,0.002268492,0.000347917,0.00051315356,0.000046239216,0.00017618579],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043470878,0.0005641525,0.003752075,0.00017377941,0.000102631246,0.000024086128,0.00030874604,0.00112176,0.000526352],"category_scores_gemma":[0.0002819244,0.0002551893,0.0012671725,0.0005777761,0.00023175665,0.000018552237,0.00013805156,0.00035294087,0.0009988692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010817175,0.0015574876,0.00078522245,0.0019219614,0.00073627324,0.010193919,0.00024222166,4.1072187e-8,1.707068e-7,0.001501353,0.006903268,0.9760499],"study_design_scores_gemma":[0.003629094,0.0009811749,0.00079385354,0.002618395,0.0006740574,0.0029094447,0.00005413764,0.0000045165953,0.0000026539385,0.00017710193,0.9879058,0.0002497923],"about_ca_topic_score_codex":0.00006419675,"about_ca_topic_score_gemma":0.000017133378,"teacher_disagreement_score":0.9810025,"about_ca_system_score_codex":0.00076678133,"about_ca_system_score_gemma":0.000794568,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W4385282791","doi":"10.1097/mph.0000000000002699","title":"Prognostic Factors and Treatment Outcome of Relapsing and Refractory Pediatric Mature B-cell Non-Hodgkin Lymphoma, Children’s Cancer Hospital Egypt Experience","year":2023,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Etoposide; Chemotherapy; Ifosfamide; Lymphoma; Internal medicine; Hematopoietic stem cell transplantation; Carboplatin; Retrospective cohort study; Rituximab; Refractory (planetary science); Stage (stratigraphy); Surgery; Transplantation; Cisplatin","score_opus":0.02044286871319923,"score_gpt":0.32015461727640687,"score_spread":0.29971174856320765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385282791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835008,0.014085424,0.000004517852,0.0008336364,0.000860487,0.00056722364,0.00002961239,0.000032331085,0.00008597385],"genre_scores_gemma":[0.97022986,0.028395627,0.0005214274,0.0000637877,0.0006230914,0.00005690923,0.000011029201,0.00003631993,0.0000619568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747515,0.00012266554,0.0011635314,0.00040635493,0.00033905287,0.00049325003],"domain_scores_gemma":[0.9970046,0.0009014935,0.0012643451,0.00022342218,0.0001997423,0.0004063906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002752399,0.00040227937,0.0014862252,0.00071355177,0.0001174573,0.000016576472,0.00012801753,0.00048195338,0.000034061184],"category_scores_gemma":[0.00028198608,0.00027001652,0.00024556989,0.0005370655,0.00016362469,0.00015894185,0.000101509155,0.00023860233,0.000007962115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017862751,0.0017551102,0.9880884,0.00016663759,0.00019591056,0.0012011006,0.0031149702,0.0000018898735,0.00006250858,0.000013139125,0.0015078065,0.0037138758],"study_design_scores_gemma":[0.008167003,0.0057022404,0.98056376,0.000039979906,0.0018481445,0.0013687743,0.0010924035,0.000014290816,0.0004518834,0.00002055317,0.00050483126,0.00022616149],"about_ca_topic_score_codex":0.00013332236,"about_ca_topic_score_gemma":0.000015961938,"teacher_disagreement_score":0.0143102035,"about_ca_system_score_codex":0.0006174097,"about_ca_system_score_gemma":0.0007574044,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W4385295040","doi":"10.1017/cjn.2023.258","title":"Clinical Neuropathology Conference: “It’s Getting on My Nerves”","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Neuropathology; Content (measure theory); Action (physics); Medicine; Neuroscience; Computer science; Psychology; Pathology; Physics; Mathematics","score_opus":0.10403878061680756,"score_gpt":0.35492902516275887,"score_spread":0.2508902445459513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385295040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651233,0.0002769706,0.0000044967155,0.0338286,0.0017558516,0.00019811645,0.000010393348,0.00004535989,0.007367891],"genre_scores_gemma":[0.9808674,0.0010078943,0.0006886127,0.016708815,0.00058987,0.000004555585,7.830651e-7,0.000015673219,0.000116408904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99381953,0.001441025,0.0013725479,0.00075507787,0.00095462665,0.0016571778],"domain_scores_gemma":[0.9941578,0.0014206766,0.0008359456,0.0002329182,0.00052086,0.0028318306],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0067399777,0.00039300573,0.00082764664,0.0013123476,0.0023212812,0.00054673105,0.0013709543,0.00028055627,0.00025660257],"category_scores_gemma":[0.004870817,0.00024515422,0.00049731124,0.0017261412,0.0067128907,0.0004820653,0.00009227135,0.0014197847,0.000056066663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011016082,0.00008898999,0.9385896,0.0000064739074,0.00002351095,0.041633453,0.00020382143,0.00061509106,0.000019329487,0.0014047587,0.005947366,0.011357485],"study_design_scores_gemma":[0.0008805773,0.10104809,0.84450024,0.00008940134,0.00008082342,0.037192654,0.00026600208,0.0010597392,0.000047010246,0.00417983,0.010384691,0.00027091854],"about_ca_topic_score_codex":0.00041977642,"about_ca_topic_score_gemma":0.009281179,"teacher_disagreement_score":0.1009591,"about_ca_system_score_codex":0.0002200116,"about_ca_system_score_gemma":0.004713352,"threshold_uncertainty_score":0.99970984},"labels":[],"label_agreement":null},{"id":"W4385330648","doi":"10.1038/s41598-023-39271-7","title":"microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; Eusko Jaurlaritza","keywords":"microRNA; Diffuse large B-cell lymphoma; Biomarker; Disease; Context (archaeology); Lymphoma; Bioinformatics; Pathogenesis; Cancer; Oncology; Medicine; Biology; Computational biology; Internal medicine; Gene; Genetics","score_opus":0.04519468028332955,"score_gpt":0.29086291209614673,"score_spread":0.2456682318128172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385330648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970825,0.00032612815,0.000021699185,0.00048335418,0.0006853297,0.0012181347,0.000010190358,0.000038071936,0.00013464442],"genre_scores_gemma":[0.9985801,0.00008197741,0.000109553126,0.000036498444,0.000021570919,0.0009077636,0.00009704377,0.0000117266945,0.0001537573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.000042369342,0.00041316074,0.00046587744,0.00028193445,0.00023962058],"domain_scores_gemma":[0.9990421,0.00015662554,0.00023157532,0.00041060473,0.00010489312,0.00005418477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014341275,0.00010846562,0.00018058649,0.0002575196,0.00018197684,0.00007612103,0.000046044377,0.00006336777,0.00000394028],"category_scores_gemma":[0.00016942566,0.00007238377,0.00009144389,0.0007657318,0.00009748034,0.00007743881,0.000027728944,0.00002355565,0.000004422862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054638655,0.0028445888,0.7577557,0.00035668552,0.000045729885,0.00031246842,0.0020421043,6.241412e-7,0.18794756,0.000041922758,0.0065476834,0.042050302],"study_design_scores_gemma":[0.002579272,0.00009831381,0.7176754,0.00011261855,0.000109023546,0.00013895519,0.0009726659,0.000777186,0.26664156,0.0003728312,0.010430137,0.00009206846],"about_ca_topic_score_codex":0.000065871725,"about_ca_topic_score_gemma":0.000087943794,"teacher_disagreement_score":0.07869399,"about_ca_system_score_codex":0.0001388553,"about_ca_system_score_gemma":0.000108221866,"threshold_uncertainty_score":0.29517245},"labels":[],"label_agreement":null},{"id":"W4385383441","doi":"10.1016/j.humpath.2023.07.009","title":"Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications","year":2023,"lang":"en","type":"article","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Calgary","funders":"Alberta Cancer Foundation; Alberta Precision Laboratories","keywords":"MAPK/ERK pathway; Cancer research; PI3K/AKT/mTOR pathway; Lymphoma; Idelalisib; Biology; Diffuse large B-cell lymphoma; Signal transduction; Protein kinase B; PTEN; Plasmablastic lymphoma; Kinase; Targeted therapy; Immunology; Cancer; Cell biology; Genetics; Ibrutinib; Leukemia; Chronic lymphocytic leukemia","score_opus":0.030972108966167426,"score_gpt":0.2842195070566972,"score_spread":0.25324739809052976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385383441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979969,0.0010378822,0.00017175781,0.00013043573,0.000008163552,0.00031898127,0.00004696847,0.000032087224,0.0002568122],"genre_scores_gemma":[0.9993505,0.000116936026,0.00008915371,0.00018386997,0.000007938323,0.00012433622,0.00009543547,0.000013740321,0.000018109959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989298,0.00010927951,0.0002855421,0.00030051914,0.00011299216,0.0002618404],"domain_scores_gemma":[0.9991877,0.00028920022,0.00012662566,0.00027980836,0.000051247138,0.00006542709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018627092,0.00017455682,0.0005112851,0.0003969064,0.00013878717,0.000017575647,0.00006298339,0.000070625625,0.000009172578],"category_scores_gemma":[0.000008361388,0.000111934714,0.00006572104,0.0007172815,0.00014542798,0.000022721477,0.000059582915,0.0000420084,0.000004112886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026343114,0.0037625027,0.8938608,0.00012125134,0.0015768025,0.0008910526,0.017273068,0.00035199363,0.06575814,0.014088666,0.000019289133,0.0020330176],"study_design_scores_gemma":[0.011198361,0.00045110966,0.9768212,0.00004758014,0.0014958879,0.00009687803,0.0021851994,0.0036000893,0.0036483903,0.00029752002,0.000030290757,0.00012750652],"about_ca_topic_score_codex":0.00002722613,"about_ca_topic_score_gemma":0.00016829306,"teacher_disagreement_score":0.0829604,"about_ca_system_score_codex":0.000038793944,"about_ca_system_score_gemma":0.00004550524,"threshold_uncertainty_score":0.4564565},"labels":[],"label_agreement":null},{"id":"W4385432225","doi":"10.1016/j.clml.2023.07.012","title":"Very late relapse in Hodgkin lymphoma: Characterizing an understudied population","year":2023,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Population; Oncology; Univariate analysis; Proportional hazards model; Hodgkin lymphoma; Multivariate analysis","score_opus":0.14835162407570415,"score_gpt":0.41677099581923704,"score_spread":0.2684193717435329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385432225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21270066,0.78015155,0.0000012089502,0.00019846695,0.0023651656,0.002940267,0.0001262047,0.0007417083,0.0007747737],"genre_scores_gemma":[0.01282103,0.9793992,0.00022018484,0.0006464842,0.0015076306,0.0007042543,0.0032515042,0.00042856607,0.0010211186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98993784,0.0010639853,0.0044763875,0.002359789,0.0008545017,0.0013075134],"domain_scores_gemma":[0.99332,0.0021804997,0.0015181707,0.0019680366,0.00012991289,0.00088337396],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019034523,0.0015091572,0.006697508,0.0008679142,0.00025752818,0.00015938094,0.00059025735,0.0021508555,0.000058484864],"category_scores_gemma":[0.0010919803,0.0012555837,0.0022110534,0.0015628558,0.00026493703,0.00038063573,0.0004620758,0.00053799956,0.0019766984],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024863475,0.0012169927,0.0072277924,0.004751354,0.0009685494,0.0034185029,0.00006413144,8.4575976e-7,5.38749e-7,0.00021495142,0.00063431705,0.9812534],"study_design_scores_gemma":[0.00719891,0.0007061766,0.6777496,0.020873437,0.0025830856,0.00028895566,0.0000337872,0.000075628705,8.8778694e-7,0.00016321114,0.28931746,0.0010088647],"about_ca_topic_score_codex":0.00079627475,"about_ca_topic_score_gemma":0.00021933755,"teacher_disagreement_score":0.9802445,"about_ca_system_score_codex":0.009226388,"about_ca_system_score_gemma":0.0031201048,"threshold_uncertainty_score":0.99976575},"labels":[],"label_agreement":null},{"id":"W4385472696","doi":"10.14740/jmc4121","title":"Mucosa-Associated Lymphoid Tissue Lymphoma of the Ascending Colon Successfully Removed With Endoscopic Submucosal Dissection","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; MALT lymphoma; Lymphoma; Endoscopic submucosal dissection; Lymphatic system; Pathology; Immunohistochemistry; Ascending colon; Gastrointestinal tract; Mucosa-associated lymphoid tissue; Stomach; Gastroenterology; Internal medicine; Radiology","score_opus":0.019456077435979942,"score_gpt":0.30300023431977624,"score_spread":0.2835441568837963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385472696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928966,0.0005367708,0.000008634762,0.005487481,0.0006405535,0.00020691866,0.000011866778,0.000031463132,0.00017967567],"genre_scores_gemma":[0.9987378,0.0004912104,0.000036380374,0.00023950079,0.0002839125,0.000008736593,0.000011730863,0.000021633625,0.00016910379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970307,0.00015101682,0.000607786,0.00015172211,0.0017782765,0.00028052973],"domain_scores_gemma":[0.9980347,0.0006554019,0.00056920864,0.00019047779,0.00024285291,0.00030736148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000721388,0.00016954578,0.0005473478,0.0001749987,0.00011967064,0.00002257641,0.00020163856,0.00016494466,0.00020200456],"category_scores_gemma":[0.0020698484,0.000089349574,0.0001843703,0.00068362494,0.00014653112,0.00008844422,0.000060162056,0.00014489473,0.000008009488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014747558,0.0021242087,0.939182,0.00019692698,0.00084341073,0.014660116,0.00041924202,0.000009820581,0.0033545443,0.00014328845,0.008883435,0.028708251],"study_design_scores_gemma":[0.011538272,0.0023012392,0.92730093,0.0019407454,0.0006066735,0.009613518,0.00051236624,0.000114412505,0.043971516,0.00003359476,0.0019558955,0.00011086154],"about_ca_topic_score_codex":0.00031417495,"about_ca_topic_score_gemma":0.0002055233,"teacher_disagreement_score":0.04061697,"about_ca_system_score_codex":0.0004614488,"about_ca_system_score_gemma":0.00091310986,"threshold_uncertainty_score":0.364357},"labels":[],"label_agreement":null},{"id":"W4385476260","doi":"10.1182/bloodadvances.2023010334","title":"Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Merck Sharp and Dohme; Celgene; MorphoSys; Innovent Biologics; Regeneron Pharmaceuticals; Seagen; Pfizer; Hexal AG; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Cohort; Internal medicine; Refractory (planetary science); Brentuximab vedotin; Lymphoma; Confidence interval; Progression-free survival; Gastroenterology; Surgery; Oncology; Overall survival; Hodgkin lymphoma; Immunotherapy; Cancer","score_opus":0.02890083118372735,"score_gpt":0.32613031287046934,"score_spread":0.297229481686742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926845,0.0025206613,0.000011433483,0.0013008772,0.000779835,0.0013640035,0.00031661932,0.00024534288,0.0007767392],"genre_scores_gemma":[0.9962618,0.000548034,0.00030403197,0.00015600328,0.0008280373,0.00056595105,0.00023109574,0.000050477982,0.0010546152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980653,0.000091210255,0.00035725487,0.00054618553,0.00045942736,0.00048065596],"domain_scores_gemma":[0.998311,0.00080622535,0.00013006618,0.00051595597,0.000076480974,0.00016029573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801014,0.0002836043,0.00049690047,0.000057362642,0.0002868674,0.000051699142,0.00019245967,0.00008266349,0.000081778606],"category_scores_gemma":[0.00021626211,0.00017928833,0.0002234101,0.00028597802,0.000108829074,0.00016218459,0.00009507031,0.000086035514,0.00017496313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005087939,0.05766614,0.64193106,0.00013710636,0.0034658313,0.001547303,0.0029298186,0.00001732172,0.0027740854,0.0011478725,0.026096722,0.2571988],"study_design_scores_gemma":[0.118729085,0.009027906,0.62200236,0.00017000837,0.0021851698,0.000026721078,0.006707868,0.00017249736,0.005639198,0.00063180295,0.23413897,0.0005684205],"about_ca_topic_score_codex":0.00016255607,"about_ca_topic_score_gemma":0.00019570993,"teacher_disagreement_score":0.2566304,"about_ca_system_score_codex":0.00008665807,"about_ca_system_score_gemma":0.00013260868,"threshold_uncertainty_score":0.7311166},"labels":[],"label_agreement":null},{"id":"W4385514309","doi":"10.1093/jnci/djad149","title":"Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"Institute for Clinical Evaluative Sciences","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Population; Internal medicine; Environmental health","score_opus":0.021736315031789327,"score_gpt":0.3061303879091255,"score_spread":0.2843940728773362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813646,0.00006471272,0.000002121471,0.0006108944,0.00047283008,0.00049090845,0.00011183162,0.000010433948,0.00009979316],"genre_scores_gemma":[0.9993774,0.000025436017,0.000023424978,0.0002956882,0.00012919011,0.00003562757,0.000037538204,0.000009638672,0.00006602924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998537,0.000031722157,0.00026177615,0.00011980563,0.0009300293,0.000119657445],"domain_scores_gemma":[0.99930763,0.00003613123,0.00025971822,0.000082858096,0.00023010225,0.000083534054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016821003,0.00011415023,0.00018448484,0.000110613844,0.00017727898,0.000025452016,0.00007786279,0.000027453281,0.000013068686],"category_scores_gemma":[0.000047755802,0.0000637398,0.000083471474,0.00026221626,0.00003730228,0.00019559238,0.000032570373,0.000057082132,0.0000015882049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018054167,0.0048106634,0.9931841,0.000017951941,0.00021955791,0.000009317758,0.00016458934,0.00020492473,0.0000023411872,0.000021399503,0.0006211327,0.00056348945],"study_design_scores_gemma":[0.025464848,0.00025660088,0.97281384,0.00008622129,0.00018723487,0.0000023291993,0.000049653536,0.00020521616,0.000029284383,0.00004275091,0.00079316663,0.00006882904],"about_ca_topic_score_codex":0.00037932128,"about_ca_topic_score_gemma":0.0016905061,"teacher_disagreement_score":0.025284305,"about_ca_system_score_codex":0.0005002043,"about_ca_system_score_gemma":0.00029051543,"threshold_uncertainty_score":0.25992334},"labels":[],"label_agreement":null},{"id":"W4385622696","doi":"10.32635/2176-9745.rbc.1986v32n2.3249","title":"Lung Cancer – 1986","year":2023,"lang":"en","type":"article","venue":"Revista Brasileira de Cancerologia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Cancer; Medicine; Asbestos; Incidence (geometry); Cause of death; Disease; Breast cancer; Oncology; Internal medicine","score_opus":0.027760154970756477,"score_gpt":0.3389197168465354,"score_spread":0.3111595618757789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385622696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897143,0.006041593,0.00001736203,0.0011392159,0.00019409238,0.00047471366,0.0000562427,0.00037765564,0.0019848086],"genre_scores_gemma":[0.99311835,0.0020527297,0.00010945135,0.0023064893,0.0003414213,0.000502653,0.00005876503,0.000031775005,0.0014783511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986767,0.00004179262,0.00022849727,0.0003609446,0.00020345846,0.0004885853],"domain_scores_gemma":[0.9991787,0.0000973702,0.000079965605,0.000372527,0.00006472927,0.00020668918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018112593,0.00019659061,0.0003901697,0.00010697101,0.000092024864,0.000041511088,0.00010865063,0.00012026814,0.0006251623],"category_scores_gemma":[0.000084845284,0.00015517787,0.00015363948,0.00051972043,0.00006254156,0.000047016507,0.00005306809,0.00011959985,0.00021757881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007636326,0.00005925049,0.91516745,0.00019609525,0.00016049146,0.00030757344,0.000063168365,0.00003868756,0.0006179776,0.0008314627,0.0761969,0.0062845973],"study_design_scores_gemma":[0.0013379882,0.00013583244,0.9789079,0.00021371305,0.00023049615,0.00004032763,0.000019906136,0.0006178774,0.0006209,0.000007939131,0.01772227,0.00014484883],"about_ca_topic_score_codex":0.00040818902,"about_ca_topic_score_gemma":0.000035279973,"teacher_disagreement_score":0.06374047,"about_ca_system_score_codex":0.0007775338,"about_ca_system_score_gemma":0.0003871584,"threshold_uncertainty_score":0.6845089},"labels":[],"label_agreement":null},{"id":"W4385655633","doi":"10.1097/01.hs9.0000975804.42824.bf","title":"PB2268: PAX5 ABERRANT EXPRESSION INCORPORATED IN MIPI-SP RISK SCORING SYSTEM EXHIBITS ADDITIVE VALUE IN MANTLE CELL LYMPHOMA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Proportional hazards model; Receiver operating characteristic; Lymphoma; Oncology; PAX5; International Prognostic Index; Immunohistochemistry; Cancer research; Diffuse large B-cell lymphoma; B cell; Immunology; Antibody","score_opus":0.014580188775644943,"score_gpt":0.23519362272452113,"score_spread":0.2206134339488762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385655633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826814,0.0010604406,0.000008996168,0.00007600081,0.0002588852,0.00085073966,0.00007121523,0.00023272008,0.0091728745],"genre_scores_gemma":[0.99779844,0.00042512777,0.0003459228,0.000041748364,0.000106441206,0.00034156887,0.00014970265,0.000060209917,0.00073081226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977672,0.00017031698,0.0005398739,0.000599248,0.00039440347,0.000528967],"domain_scores_gemma":[0.9988985,0.00020826157,0.00020913991,0.00043060642,0.00006175968,0.00019172138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002884466,0.0003245701,0.000588584,0.00019969342,0.000089050875,0.000026423291,0.00010207229,0.00020403342,0.00012414796],"category_scores_gemma":[0.00005706827,0.00026490967,0.00011835062,0.00096616097,0.000035098215,0.00012108201,0.000114252536,0.00014333072,0.0006947614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006553381,0.002296501,0.93987644,0.0012872695,0.00010239865,0.011703549,0.002406971,0.0010640277,0.011645656,0.00026935732,0.00840463,0.020287866],"study_design_scores_gemma":[0.018134924,0.00033300705,0.7833373,0.007343671,0.00011032511,0.00009191788,0.0053413366,0.006240764,0.17752706,0.00007362318,0.0009887202,0.00047739007],"about_ca_topic_score_codex":0.0016500944,"about_ca_topic_score_gemma":0.00032200615,"teacher_disagreement_score":0.1658814,"about_ca_system_score_codex":0.00082760374,"about_ca_system_score_gemma":0.00018804398,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W4385666790","doi":"10.1182/bloodadvances.2023010402","title":"Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Lymphoma; Cohort; Internal medicine; Rituximab; Oncology; Medicine; Cancer research; Biology; B cell; Immunology; Antibody","score_opus":0.012117921329800859,"score_gpt":0.3426426693604537,"score_spread":0.3305247480306528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385666790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978884,0.0013905488,9.250102e-7,0.000057401154,0.000016099779,0.00043252404,0.000054707565,0.000017723793,0.00014165626],"genre_scores_gemma":[0.9990262,0.00074380304,0.000075837015,0.0000053152667,0.000015101118,0.000021869871,0.000072683295,0.000007862253,0.00003133243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991725,0.00005066016,0.00027412784,0.00019991712,0.00017864112,0.00012415265],"domain_scores_gemma":[0.9994456,0.00015155053,0.00011553595,0.00017058649,0.000055451244,0.00006127904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016662266,0.000107232336,0.00040269212,0.000073851144,0.000012688006,0.0000031419472,0.000033888078,0.000035065612,0.0000035066973],"category_scores_gemma":[0.0000613604,0.00006561421,0.00006700762,0.00047136887,0.000075905555,0.00005074416,0.000023023358,0.00006130756,7.7130375e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049076,0.0036738017,0.99156326,0.00005894844,0.00030222503,0.00031358562,0.0002183599,0.000023678069,0.00045444779,0.000022092865,0.00002018623,0.0028586318],"study_design_scores_gemma":[0.0068628364,0.0036095975,0.9863449,0.00017809312,0.00033104807,0.000007680957,0.00044206285,0.000010073163,0.0021123553,0.000025462099,0.000015637863,0.000060267605],"about_ca_topic_score_codex":0.0006849524,"about_ca_topic_score_gemma":0.00066991866,"teacher_disagreement_score":0.0063720765,"about_ca_system_score_codex":0.000023441686,"about_ca_system_score_gemma":0.000059895934,"threshold_uncertainty_score":0.26756698},"labels":[],"label_agreement":null},{"id":"W4385698344","doi":"10.1097/01.hs9.0000971164.88567.72","title":"P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Internal medicine; Oncology; Lymphoma; Phases of clinical research; Clinical trial; Immunotherapy; Cancer","score_opus":0.014650674941796147,"score_gpt":0.2512173056998726,"score_spread":0.23656663075807646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385698344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693567,0.000054883974,0.000046787387,0.000606185,0.000037880458,0.00096547726,0.0000066290067,0.000051687453,0.0012947753],"genre_scores_gemma":[0.9981614,0.0000039479937,0.001366586,0.000052351617,0.000017728493,0.00012272636,0.0000859376,0.00003493659,0.00015438502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844736,0.00010335668,0.00034736848,0.0003089536,0.0005114019,0.0002815696],"domain_scores_gemma":[0.9988084,0.0005247335,0.00018648258,0.00031783571,0.00009544919,0.00006709748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014702881,0.0002100876,0.00041321025,0.000104830935,0.00005486384,0.000014593965,0.000084843625,0.000096050026,0.000051336705],"category_scores_gemma":[0.00013317756,0.00012014368,0.000055596196,0.00056261016,0.00011352885,0.00013802356,0.000043142827,0.00013051253,0.00003122265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016833408,0.0031807537,0.9732407,0.00008476531,0.000110367895,0.00012079759,0.0030918352,0.00023434279,0.000011857465,0.0006399844,0.00022431846,0.017376952],"study_design_scores_gemma":[0.03698033,0.0015755619,0.957252,0.0007958818,0.00008066595,0.0000054245415,0.00035039545,0.0023988995,0.00018708337,0.00016536575,0.00007677887,0.00013156235],"about_ca_topic_score_codex":0.00019537013,"about_ca_topic_score_gemma":0.00022886915,"teacher_disagreement_score":0.035296988,"about_ca_system_score_codex":0.0004176003,"about_ca_system_score_gemma":0.00019110745,"threshold_uncertainty_score":0.48993173},"labels":[],"label_agreement":null},{"id":"W4385706381","doi":"10.1097/01.hs9.0000971268.84093.15","title":"P1093: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF ZANUBRUTINIB (ZANU) VERSUS IBRUTINIB (IBRU) IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Percentile; Internal medicine; Progression-free survival; Oncology; Overall survival; Statistics; Mathematics","score_opus":0.05043493318807855,"score_gpt":0.3075699623141653,"score_spread":0.2571350291260867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385706381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792633,0.0018504567,0.0000067125916,0.00047295485,0.00071956904,0.0007403372,0.000052510324,0.00032244972,0.016571684],"genre_scores_gemma":[0.99605304,0.00035033765,0.00075494754,0.00011275296,0.00016588262,0.00012290655,0.00027492497,0.00008668087,0.0020785355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966735,0.00014584893,0.00095904904,0.0006824224,0.0007613405,0.0007778015],"domain_scores_gemma":[0.9978346,0.0006191708,0.0003793872,0.0007580596,0.000105584215,0.00030320388],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038784408,0.00048365345,0.0012434368,0.0003065918,0.00010972065,0.0000283192,0.00023002419,0.00034294344,0.0009578569],"category_scores_gemma":[0.00014723661,0.00043662766,0.00030568367,0.0012570105,0.00014575163,0.00011072446,0.00016463018,0.0002487268,0.0007722483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009480462,0.007911374,0.82398957,0.0011037367,0.0011594568,0.0030600324,0.0057989303,0.00022203318,0.00278416,0.0015482093,0.036575764,0.10636628],"study_design_scores_gemma":[0.03987514,0.0018584824,0.9172044,0.001131828,0.00034312886,0.000089211164,0.003969275,0.00046429297,0.012990349,0.00009932795,0.02138383,0.00059077353],"about_ca_topic_score_codex":0.0010318349,"about_ca_topic_score_gemma":0.00051958585,"teacher_disagreement_score":0.1057755,"about_ca_system_score_codex":0.00055224367,"about_ca_system_score_gemma":0.00039166943,"threshold_uncertainty_score":0.9999554},"labels":[],"label_agreement":null},{"id":"W4385706419","doi":"10.1097/01.hs9.0000967312.24545.68","title":"S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Hazard ratio; Regimen; Interim analysis; Rituximab; Diffuse large B-cell lymphoma; Randomized controlled trial; Oncology; Lymphoma; Confidence interval","score_opus":0.014219195408720247,"score_gpt":0.2630733071617222,"score_spread":0.24885411175300198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385706419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402225,0.0012319575,0.000014888925,0.0007671437,0.00041314852,0.0026996892,0.00011774586,0.000041038256,0.00069213455],"genre_scores_gemma":[0.99777776,0.00018403215,0.0009700894,0.00024592187,0.00007347188,0.00014906345,0.00004850818,0.000050713796,0.0005004378],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970222,0.0004270548,0.0009827778,0.0003817014,0.0008312722,0.00035501155],"domain_scores_gemma":[0.9978651,0.00086111034,0.0003470505,0.0006614943,0.000117303425,0.00014795183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011306785,0.00028497362,0.0010877622,0.00016493023,0.00007070497,0.000011142248,0.00022093442,0.00012395596,0.00006049854],"category_scores_gemma":[0.00050731696,0.0001854149,0.00051639875,0.0008891753,0.00006401903,0.000049564318,0.00007474735,0.00007862976,0.000009087284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8807487,0.002032806,0.01598032,0.00011723761,0.00030661872,0.000050336403,0.0021766946,0.000032662898,0.075382076,0.000008470046,0.0024425024,0.02072158],"study_design_scores_gemma":[0.7029637,0.0018984501,0.22866397,0.00059486984,0.00013799187,0.0000027398796,0.00020052455,0.000032353037,0.058905233,0.000018859399,0.006407038,0.00017425776],"about_ca_topic_score_codex":0.00013511362,"about_ca_topic_score_gemma":0.000010128502,"teacher_disagreement_score":0.21268365,"about_ca_system_score_codex":0.00037404927,"about_ca_system_score_gemma":0.0005763746,"threshold_uncertainty_score":0.75610006},"labels":[],"label_agreement":null},{"id":"W4385850624","doi":"10.1111/bjh.19018","title":"<scp>ETS1</scp> phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Swiss Cancer Research Foundation; Rotary Foundation","keywords":"Diffuse large B-cell lymphoma; ETS1; Cancer research; Phosphorylation; Lymphoma; Cell growth; Threonine; Biology; Immunology; Cell biology; Transcription factor; Genetics; Gene","score_opus":0.008459143445706712,"score_gpt":0.22323029198025593,"score_spread":0.2147711485345492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385850624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338734,0.005023769,0.000010998873,0.0006992806,0.00007759049,0.00030915503,0.00010214351,0.000009399893,0.00038031672],"genre_scores_gemma":[0.99649936,0.0026855615,0.00003941117,0.00011961744,0.000023395985,0.000006806196,0.000016040985,0.000025904386,0.000583893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982704,0.00016583929,0.00067324797,0.00016038292,0.00041780248,0.00031230628],"domain_scores_gemma":[0.997061,0.00088388415,0.0011721313,0.00017293468,0.0006147943,0.00009526999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054787676,0.0001679456,0.00086212024,0.00012245649,0.00011094745,0.000012947618,0.00016574695,0.00012045771,0.000024820152],"category_scores_gemma":[0.00018948289,0.00010477418,0.00016807442,0.0004290712,0.00025550718,0.00006198365,0.000084999345,0.000120793855,0.0000033251342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007715313,0.01529478,0.78071946,0.0017151416,0.0024347429,0.031830244,0.012849998,0.00002763058,0.023740254,0.001175136,0.12827203,0.001169032],"study_design_scores_gemma":[0.028238198,0.0015918083,0.5215973,0.0007753737,0.0010864778,0.013527822,0.0032064968,0.00014205757,0.42839,0.00024105092,0.0010976535,0.00010575318],"about_ca_topic_score_codex":0.00022567685,"about_ca_topic_score_gemma":0.00015504884,"teacher_disagreement_score":0.40464973,"about_ca_system_score_codex":0.00012659261,"about_ca_system_score_gemma":0.0002796144,"threshold_uncertainty_score":0.4272567},"labels":[],"label_agreement":null},{"id":"W4385971020","doi":"10.32635/2176-9745.rbc.1968v24n36.4143","title":"Factors Influencing Prognosis of Hodgkin’s Disease: Round Table Luncheon","year":2023,"lang":"pt","type":"article","venue":"Revista Brasileira de Cancerologia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College; Ontario Institute for Cancer Research","funders":"","keywords":"Disease; Medicine; Demography; Gerontology; Political science; Geography; Environmental health; Internal medicine; Sociology","score_opus":0.05289860495992416,"score_gpt":0.3139487049739191,"score_spread":0.2610501000139949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385971020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789627,0.0177626,0.000018470226,0.00023542851,0.00044562266,0.0014206432,0.00064656866,0.00027431658,0.00023361338],"genre_scores_gemma":[0.9951249,0.0020528878,0.000031087453,0.0003882201,0.00030853937,0.00041112246,0.00031617048,0.00009541373,0.0012716714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591154,0.00025422123,0.0009806838,0.00093567953,0.00068744115,0.0012304395],"domain_scores_gemma":[0.99683744,0.00058299664,0.00063926465,0.00093481835,0.00027085608,0.00073464983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006129612,0.0007050601,0.0013776,0.00034217437,0.00021833113,0.00014448557,0.00033139557,0.00035426609,0.000609548],"category_scores_gemma":[0.0007795853,0.0005753259,0.0004725664,0.0015948906,0.00025482,0.0002134987,0.00022384828,0.00031334712,0.00016062403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000283356,0.00046140526,0.9788916,0.0023916669,0.00072262675,0.0003533537,0.0007530926,0.00019086743,0.00058254146,0.0005720308,0.013231377,0.001566042],"study_design_scores_gemma":[0.001890161,0.00071009697,0.98853016,0.0019796472,0.001518749,0.0000064756796,0.0006048277,0.00039060868,0.0014697962,0.000010875056,0.0024519858,0.00043658906],"about_ca_topic_score_codex":0.0011084913,"about_ca_topic_score_gemma":0.000058470752,"teacher_disagreement_score":0.01616215,"about_ca_system_score_codex":0.0021282597,"about_ca_system_score_gemma":0.0017104291,"threshold_uncertainty_score":0.9996698},"labels":[],"label_agreement":null},{"id":"W4385971683","doi":"10.1182/bloodadvances.2023010673","title":"Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Cilag; Terry Fox Research Institute; Medical Research Council; Blood Cancer UK; Cancer Research UK; Michael Smith Health Research BC","keywords":"Core (optical fiber); Internal medicine; Biology; Group (periodic table); Oncology; Medicine; Cancer research; Computational biology; Computer science; Chemistry; Telecommunications","score_opus":0.035797141671741854,"score_gpt":0.3546549687342862,"score_spread":0.31885782706254434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385971683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927938,0.006300888,8.120629e-7,0.00023803252,0.000020714613,0.0004233218,0.000032491535,0.0000325735,0.00015736687],"genre_scores_gemma":[0.9978519,0.000991679,0.0008762494,0.000044968005,0.000019589732,0.0001390852,0.000046229772,0.000009170723,0.000021100854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930155,0.000017005057,0.00020734199,0.00023129239,0.00008227548,0.00016051544],"domain_scores_gemma":[0.999589,0.00013607391,0.00009226233,0.000091195965,0.00002863885,0.00006282459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006307473,0.000115821575,0.00042645042,0.00009892441,0.000026492198,0.000008101524,0.000027258951,0.000045843353,0.000006662636],"category_scores_gemma":[0.00004663277,0.00007793138,0.000019308342,0.00022431859,0.0001041603,0.000075406715,0.000036864178,0.000038789014,0.0000017188756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001209605,0.00065014564,0.98955196,0.00022096615,0.00007361654,0.000045000514,0.00032670223,7.127845e-7,0.0012768024,0.00025665067,0.000039459916,0.0074370033],"study_design_scores_gemma":[0.004587925,0.0015406115,0.9900482,0.00039030856,0.00014647917,0.000025719151,0.00032469802,0.000025904985,0.002049561,0.00010060594,0.00067871023,0.00008127368],"about_ca_topic_score_codex":0.0000626341,"about_ca_topic_score_gemma":0.00015427977,"teacher_disagreement_score":0.0073557296,"about_ca_system_score_codex":0.000010572267,"about_ca_system_score_gemma":0.000018657305,"threshold_uncertainty_score":0.31779492},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4386100396","doi":"10.3389/fonc.2023.1210945","title":"The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Positron emission tomography; Stage (stratigraphy); Retrospective cohort study; Chemoradiotherapy; Population; Radiology; PET-CT; Nuclear medicine; Biopsy; Radiation therapy; Internal medicine","score_opus":0.04659924429157465,"score_gpt":0.3655041302443387,"score_spread":0.31890488595276406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386100396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648494,0.000094371375,0.00006528049,0.00033139248,0.00029679883,0.00055115024,0.0020261835,0.000010508173,0.00013936905],"genre_scores_gemma":[0.99041194,0.00003876307,0.0009735458,0.000058219543,0.000020908992,0.000078397774,0.008152948,0.0000121306675,0.00025313298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987912,0.00008227666,0.000390651,0.00031463578,0.0001779639,0.00024327984],"domain_scores_gemma":[0.99818754,0.00068756746,0.00021955687,0.0007763389,0.00004112901,0.000087855566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021162246,0.00015222566,0.0007403377,0.00027478533,0.00006710016,0.000005619275,0.0001738817,0.000020952728,0.000082123755],"category_scores_gemma":[0.00006931586,0.000093747905,0.00016213417,0.00038712818,0.0000365891,0.0000341672,0.000026386811,0.000044267083,2.8921977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009719863,0.00063146756,0.9663532,0.0000047957897,0.0027232366,0.00019532104,0.00017326804,0.010760714,0.000006935544,0.000014481702,0.008297276,0.009867321],"study_design_scores_gemma":[0.005193738,0.001563267,0.921489,0.000019952298,0.0012384239,5.2584573e-7,0.00066822884,0.06703568,0.00009996526,0.000028583034,0.002590148,0.00007247377],"about_ca_topic_score_codex":0.9907022,"about_ca_topic_score_gemma":0.98961306,"teacher_disagreement_score":0.056274965,"about_ca_system_score_codex":0.0060358522,"about_ca_system_score_gemma":0.002455811,"threshold_uncertainty_score":0.9977798},"labels":[],"label_agreement":null},{"id":"W4386120672","doi":"10.31219/osf.io/evj59","title":"Therapeutic vaccines for follicular lymphoma: a systematic review protocol","year":2023,"lang":"en","type":"review","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Russian Science Foundation; University of Toronto","keywords":"Medicine; Follicular lymphoma; Clinical trial; Protocol (science); MEDLINE; Randomized controlled trial; CINAHL; Oncology; Family medicine; Internal medicine; Lymphoma; Alternative medicine; Psychological intervention; Pathology","score_opus":0.09460338037646608,"score_gpt":0.4248876175390804,"score_spread":0.3302842371626143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386120672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.4788664e-9,0.5758041,0.000010345854,0.00009914106,0.00004704627,0.4235887,0.000018159039,0.00016808025,0.0002644084],"genre_scores_gemma":[7.740622e-9,0.50660014,0.000076104676,0.0004055485,0.00007792037,0.48926997,0.00009711498,0.000088491564,0.0033847108],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968352,0.00016513807,0.0016011896,0.0006238947,0.00036948634,0.0004051085],"domain_scores_gemma":[0.99732065,0.0006097969,0.00063752447,0.0010925119,0.00016491291,0.00017462013],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005200869,0.0007547584,0.006899853,0.00017919361,0.0000771202,0.000043223514,0.00022582061,0.00027007685,0.000097481054],"category_scores_gemma":[0.00025936274,0.00037278855,0.0025000067,0.00053122255,0.000012660621,0.000032980177,0.00005897343,0.000053712578,0.00094619073],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052339415,0.0003459785,6.6460314e-7,0.86540735,0.0023951114,0.00006663213,0.000002381693,1.7641507e-9,3.856389e-9,0.0003433747,0.0048145987,0.12661865],"study_design_scores_gemma":[0.0012377971,0.00016779946,5.165525e-7,0.4956233,0.021836003,0.00019672212,0.0000018772663,0.0000013196258,2.4945757e-7,0.000018497081,0.48072982,0.00018609913],"about_ca_topic_score_codex":0.000012310764,"about_ca_topic_score_gemma":0.0000030672563,"teacher_disagreement_score":0.47591522,"about_ca_system_score_codex":0.0004625121,"about_ca_system_score_gemma":0.0006194707,"threshold_uncertainty_score":0.9998724},"labels":[],"label_agreement":null},{"id":"W4386270540","doi":"10.14740/jh1144","title":"Reduced-Intensity Anthracycline-Free Chemoimmunotherapy in Elderly Patients With Newly Diagnosed or Relapsed Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoimmunotherapy; Anthracycline; Diffuse large B-cell lymphoma; Internal medicine; Regimen; Vincristine; Prednisone; Oncology; Rituximab; Surgery; Cyclophosphamide; Lymphoma; Chemotherapy; Cancer; Breast cancer","score_opus":0.01223500388008925,"score_gpt":0.2639123058281492,"score_spread":0.25167730194805993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540055,0.0005058725,0.000011558535,0.0031465106,0.0003588647,0.00038065686,0.0000119745055,0.000042700714,0.00014131138],"genre_scores_gemma":[0.99742657,0.00076728757,0.0006993422,0.0007310099,0.00006776638,0.000019423225,0.000022536693,0.000043856468,0.00022220064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797106,0.000073451716,0.00082430313,0.00025654014,0.00039426668,0.0004803989],"domain_scores_gemma":[0.9980862,0.00036870755,0.0005571001,0.00048577,0.000319428,0.000182779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025924735,0.00026514448,0.0010803225,0.0004132923,0.000069121874,0.000017142263,0.00021733527,0.00018715792,0.00006924027],"category_scores_gemma":[0.0003396522,0.00016096263,0.00019276608,0.00049570826,0.00007660073,0.00012838765,0.0000610561,0.00019073085,0.000047363552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010732626,0.02641663,0.921121,0.00012135798,0.00040238316,0.0149555905,0.0009182828,0.0000026060268,0.0005001178,0.00008203966,0.019705197,0.0050421706],"study_design_scores_gemma":[0.1949564,0.0046561286,0.7871561,0.00050478027,0.00017935479,0.0017277444,0.0004283219,0.000046245405,0.0076520797,0.00012308113,0.0023474402,0.00022230612],"about_ca_topic_score_codex":0.000050899278,"about_ca_topic_score_gemma":0.00009204258,"teacher_disagreement_score":0.18422377,"about_ca_system_score_codex":0.00021496297,"about_ca_system_score_gemma":0.00031878558,"threshold_uncertainty_score":0.6563866},"labels":[],"label_agreement":null},{"id":"W4386270746","doi":"10.1016/s2152-2650(23)00683-3","title":"POSTER: HL-393 5-year Overall Survival Rate of Patients With Classical Hodgkin Lymphoma in Armenia","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Classical Hodgkin lymphoma; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine; Medicine; Demography; Sociology","score_opus":0.02585206691894636,"score_gpt":0.30184431209628065,"score_spread":0.2759922451773343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385256,0.00007140743,0.0000026870516,0.00091078784,0.0006519604,0.0009787438,0.0001338384,0.00022362177,0.0031743862],"genre_scores_gemma":[0.9968363,0.00020741965,0.0002707634,0.00087422406,0.0003099954,0.00011835663,0.0004708403,0.00011709771,0.0007950146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946996,0.00046626333,0.0018427235,0.0011605567,0.00083642657,0.00099445],"domain_scores_gemma":[0.9959408,0.0015500388,0.00049396633,0.0010794101,0.00030307582,0.0006327022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010096858,0.0006265014,0.001728408,0.00036857242,0.000096917116,0.00005077598,0.0003659545,0.00054124516,0.0001463336],"category_scores_gemma":[0.0006353398,0.00047715,0.0005433043,0.0010157286,0.0004993154,0.00019735662,0.0003037313,0.0001993366,0.00073537836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004789536,0.0022482225,0.85845035,0.00009229776,0.0003412363,0.0008634745,0.000097970275,0.0000071113695,0.000041599276,0.00056262314,0.0031218878,0.12938365],"study_design_scores_gemma":[0.039620444,0.0026120732,0.9505392,0.00039851663,0.00024075739,0.000018481218,0.000052950494,0.00016198219,0.00047620345,0.00026300387,0.0051435255,0.0004728884],"about_ca_topic_score_codex":0.00027270912,"about_ca_topic_score_gemma":0.00010027584,"teacher_disagreement_score":0.12891077,"about_ca_system_score_codex":0.0015050776,"about_ca_system_score_gemma":0.0015089364,"threshold_uncertainty_score":0.999768},"labels":[],"label_agreement":null},{"id":"W4386270767","doi":"10.1016/s2152-2650(23)01361-7","title":"IBCL-458 Mosunetuzumab Monotherapy Demonstrates Durable Efficacy With a Manageable Safety Profile in Patients With Relapsed/Refractory Follicular Lymphoma who Received ≥2 Prior Therapies: Updated Results From a Pivotal Phase II Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"Jewish General Hospital; Royal Adelaide Hospital; McGill University; American Society of Hematology","keywords":"Refractory (planetary science); Follicular lymphoma; Medicine; Safety profile; Follicular phase; Internal medicine; Phases of clinical research; Oncology; Surgery; Lymphoma; Clinical trial; Adverse effect; Materials science","score_opus":0.018487413939307234,"score_gpt":0.29245203938368375,"score_spread":0.2739646254443765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908148,0.00033169423,0.0000075547305,0.000499785,0.00023684122,0.0058515053,0.00058044435,0.00064540963,0.0010319619],"genre_scores_gemma":[0.9921527,0.000525347,0.0010145609,0.000482101,0.00019790318,0.0006629747,0.0027550538,0.00025334695,0.001956002],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9915299,0.00068773434,0.0026387027,0.002445793,0.0013134464,0.0013844608],"domain_scores_gemma":[0.9942872,0.001546604,0.00095297664,0.0020794098,0.00039641355,0.00073742616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010665212,0.0011950032,0.0023668753,0.0004528,0.00063994585,0.00016887444,0.0005835717,0.00062435656,0.00019276237],"category_scores_gemma":[0.00040114232,0.00083709724,0.00043872625,0.0021002742,0.00048038652,0.0005076835,0.00022671859,0.00038357798,0.00029947885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114545226,0.03328529,0.40639406,0.000043715158,0.0035748417,0.0036200972,0.002750906,0.00013478044,0.00006593117,0.000015938527,0.0036067849,0.43196243],"study_design_scores_gemma":[0.23395382,0.020715227,0.7373135,0.0007152851,0.0005405998,0.000017218192,0.00086038123,0.0011513827,0.00023531707,0.000023111565,0.003710807,0.0007633255],"about_ca_topic_score_codex":0.0021614542,"about_ca_topic_score_gemma":0.0004207447,"teacher_disagreement_score":0.4311991,"about_ca_system_score_codex":0.0025884928,"about_ca_system_score_gemma":0.0020990106,"threshold_uncertainty_score":0.999408},"labels":[],"label_agreement":null},{"id":"W4386270785","doi":"10.1016/s2152-2650(23)00684-5","title":"POSTER: HL-456 A Retrospective Analysis of Impact of EBV Status on Outcomes in Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Internal medicine; Oncology","score_opus":0.03763797479878597,"score_gpt":0.3871336197560925,"score_spread":0.34949564495730656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952041,0.00015703206,0.00000143932,0.00024298255,0.00026079296,0.0006992788,0.0005099479,0.00013610747,0.0027883132],"genre_scores_gemma":[0.9981809,0.00053052075,0.00010610984,0.00029691771,0.00008683671,0.00008251051,0.00030655906,0.000068562746,0.00034108275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943579,0.00032949256,0.0023978858,0.0010463201,0.00094517437,0.00092325854],"domain_scores_gemma":[0.994609,0.0022605192,0.0008496134,0.0014162103,0.00031909632,0.0005455879],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009746397,0.00059834897,0.0033377549,0.0016258102,0.000061005638,0.000024921876,0.00031616475,0.0004991465,0.0002177852],"category_scores_gemma":[0.0017828051,0.00044453054,0.002734039,0.0040446133,0.00040477578,0.000117773,0.00021240159,0.00015484828,0.00018025587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016191793,0.0020950974,0.8548443,0.00004334092,0.0057104193,0.0005845663,0.00029933738,0.00008966628,0.00012556277,0.00023608029,0.00060233363,0.13375017],"study_design_scores_gemma":[0.013617418,0.004168988,0.97728163,0.00024359126,0.002156577,0.000014829183,0.000109540386,0.00091631775,0.0008677317,0.0001867521,0.00008897025,0.00034765436],"about_ca_topic_score_codex":0.0032248392,"about_ca_topic_score_gemma":0.000303329,"teacher_disagreement_score":0.13340251,"about_ca_system_score_codex":0.0045413543,"about_ca_system_score_gemma":0.0017879574,"threshold_uncertainty_score":0.9998006},"labels":[],"label_agreement":null},{"id":"W4386270903","doi":"10.1016/s2152-2650(23)00730-9","title":"POSTER: ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; CHOP; Rituximab; Lymphoma; Internal medicine; Phases of clinical research; Oncology; Clinical trial","score_opus":0.02425523765960327,"score_gpt":0.3135336478314217,"score_spread":0.28927841017181843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901943,0.000370152,0.0000055213345,0.00032094054,0.0024549458,0.00382813,0.00050999003,0.00044470094,0.0018712836],"genre_scores_gemma":[0.994887,0.00080734695,0.00021932606,0.00064242433,0.00077098556,0.00047243084,0.0013016984,0.00026111907,0.0006376667],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9901584,0.0004956817,0.0035777767,0.0020440887,0.0017910134,0.0019330473],"domain_scores_gemma":[0.99089116,0.0038103568,0.0012521686,0.0022649416,0.00050697505,0.0012743983],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010713766,0.0012779292,0.0032664745,0.00071056857,0.00027348413,0.00010864539,0.00076208304,0.0010542079,0.00012249293],"category_scores_gemma":[0.0012926152,0.0010449587,0.0011682819,0.0018583548,0.0005654812,0.00035463832,0.00047641463,0.00039420614,0.00071210216],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4447537,0.104807526,0.15048596,0.00024041162,0.0009897979,0.013034489,0.0005449582,0.000004743871,0.00004299347,0.000118972544,0.0041119955,0.28086445],"study_design_scores_gemma":[0.5429736,0.014656792,0.43795216,0.00035629576,0.00063121034,0.00005493128,0.00015209054,0.00016690927,0.00020550145,0.000023800747,0.0022024643,0.00062425964],"about_ca_topic_score_codex":0.0006332692,"about_ca_topic_score_gemma":0.00020403588,"teacher_disagreement_score":0.2874662,"about_ca_system_score_codex":0.0026301183,"about_ca_system_score_gemma":0.0022831531,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W4386270917","doi":"10.1016/s2152-2650(23)00762-0","title":"POSTER: IBCL-458 Mosunetuzumab Monotherapy Demonstrates Durable Efficacy With a Manageable Safety Profile in Patients With Relapsed/Refractory Follicular Lymphoma who Received ≥2 Prior Therapies: Updated Results From a Pivotal Phase II Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"Universitat de Barcelona; Rigshospitalet; Universitair Medisch Centrum Groningen; Universiteit Leiden; Leids Universitair Medisch Centrum; University of California, Los Angeles; Memorial Sloan-Kettering Cancer Center; Karolinska Institutet; Gentofte Hospital; Rijksuniversiteit Groningen; Odense Universitetshospital; Helsingin Yliopisto","keywords":"Refractory (planetary science); Follicular lymphoma; Medicine; Safety profile; Follicular phase; Oncology; Internal medicine; Lymphoma; Intensive care medicine; Adverse effect; Biology","score_opus":0.017855556000897835,"score_gpt":0.2902768768952964,"score_spread":0.2724213208943986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043846,0.00033727082,0.0000038762023,0.0005822758,0.00024239768,0.0060399636,0.00066145207,0.0006230727,0.0010712299],"genre_scores_gemma":[0.99255115,0.00046908535,0.0006536592,0.0005776126,0.00018660811,0.00059487193,0.0029900947,0.00025635934,0.0017205382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915091,0.0007063215,0.0026700408,0.0024398721,0.0012921613,0.0013825035],"domain_scores_gemma":[0.994333,0.0014818272,0.0009659626,0.0020914087,0.0003928112,0.0007349746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010120359,0.0012092378,0.0023604096,0.00046090892,0.00061821553,0.0001814294,0.0005912327,0.00062300294,0.00017600987],"category_scores_gemma":[0.00035046937,0.00084772176,0.0004432627,0.0019493297,0.00045734277,0.0005315023,0.0002464527,0.0003768667,0.00029518583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12364606,0.030649543,0.45939118,0.000044346947,0.0034370702,0.0037333036,0.0028817963,0.00007577956,0.00007261426,0.000010122145,0.0027184803,0.3733397],"study_design_scores_gemma":[0.2317172,0.023472706,0.7381056,0.0007626185,0.0005471715,0.000022678849,0.0007380754,0.0007567848,0.00027120698,0.00001761467,0.0028188673,0.00076948653],"about_ca_topic_score_codex":0.0021030174,"about_ca_topic_score_gemma":0.00041805074,"teacher_disagreement_score":0.37257022,"about_ca_system_score_codex":0.002503256,"about_ca_system_score_gemma":0.0019636685,"threshold_uncertainty_score":0.99939734},"labels":[],"label_agreement":null},{"id":"W4386270971","doi":"10.1016/s2152-2650(23)00760-7","title":"POSTER: IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; School of Medicine, Stanford University; Centre hospitalier régional universitaire de Lille; Washington University School of Medicine in St. Louis; University College London Hospitals NHS Foundation Trust; Universität zu Köln; Massachusetts General Hospital; Hokkaido University; Bristol-Myers Squibb; Centro de Investigación Biomédica en Red de Cáncer; Medizinische Universität Wien; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; Universität Wien; University College London","keywords":"Follicular lymphoma; Follicular phase; Oncology; Medicine; Internal medicine; Biology; Lymphoma","score_opus":0.02781592921887291,"score_gpt":0.3251656614464571,"score_spread":0.2973497322275842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935011,0.00032524482,0.000001948575,0.00062175986,0.00052556995,0.00314838,0.00039582828,0.0003036355,0.0011765083],"genre_scores_gemma":[0.99655175,0.0002680057,0.00018359414,0.00057648495,0.00026656358,0.0003096838,0.00094070984,0.0001660919,0.00073709234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918836,0.00049703434,0.003176037,0.0017779968,0.0014652802,0.0012000675],"domain_scores_gemma":[0.9952952,0.0008946759,0.0007486769,0.0018726854,0.00039999562,0.0007887457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013606576,0.00091981876,0.002321865,0.0005955857,0.00026215607,0.000058198795,0.00056860293,0.0005828682,0.0000653275],"category_scores_gemma":[0.00056578754,0.0007170573,0.0007908995,0.0018444234,0.00042417267,0.00027743072,0.0003108993,0.0002289291,0.00024225401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017728157,0.029418007,0.5917895,0.0001247983,0.0009722182,0.0024642672,0.0010389724,0.000015730297,0.000080680824,0.000023360784,0.0024526163,0.35389167],"study_design_scores_gemma":[0.17205125,0.021892928,0.7998889,0.00048116638,0.0007210537,0.000028099412,0.00028321764,0.00017896881,0.0009179838,0.00002339466,0.002955379,0.00057765306],"about_ca_topic_score_codex":0.00065605936,"about_ca_topic_score_gemma":0.00020828843,"teacher_disagreement_score":0.353314,"about_ca_system_score_codex":0.001508419,"about_ca_system_score_gemma":0.001352222,"threshold_uncertainty_score":0.99952805},"labels":[],"label_agreement":null},{"id":"W4386271023","doi":"10.1016/s2152-2650(23)00732-2","title":"POSTER: ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ibrutinib; Temozolomide; Rituximab; Medicine; Etoposide; Dexamethasone; Lymphoma; Doxorubicin; Pharmacology; Oncology; Internal medicine; Chemotherapy; Leukemia","score_opus":0.04750053828667632,"score_gpt":0.3651694180102589,"score_spread":0.31766887972358254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386271023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940873,0.0005730341,0.000030835516,0.0016144032,0.0007664908,0.0051489184,0.0004985145,0.0007891994,0.0011698896],"genre_scores_gemma":[0.9929958,0.00019042955,0.0018139402,0.001400258,0.0005366752,0.0010561995,0.00055834634,0.00029147015,0.0011568624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99038076,0.0009921533,0.0034659994,0.0022220372,0.0013324773,0.0016065435],"domain_scores_gemma":[0.98673064,0.007739214,0.0012183985,0.0023379761,0.00083954586,0.0011342029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002716173,0.001217942,0.0033482122,0.0007924184,0.00048894953,0.000117061834,0.0007490162,0.0008712104,0.0002024649],"category_scores_gemma":[0.002112949,0.00096987723,0.0010805655,0.0017946109,0.0007569629,0.00036184952,0.00044281592,0.0003458039,0.00038540942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112574086,0.027408525,0.14128032,0.00039221862,0.0035921955,0.0046301493,0.0013494523,0.000012235349,0.0027023787,0.00019651883,0.014600549,0.69126135],"study_design_scores_gemma":[0.1609208,0.032262467,0.7820662,0.0004992869,0.001694567,0.0006609548,0.0013155859,0.0006115953,0.008798148,0.00008898767,0.010231149,0.00085020455],"about_ca_topic_score_codex":0.00049093226,"about_ca_topic_score_gemma":0.00020318705,"teacher_disagreement_score":0.69041115,"about_ca_system_score_codex":0.0015362506,"about_ca_system_score_gemma":0.004522646,"threshold_uncertainty_score":0.99927515},"labels":[],"label_agreement":null},{"id":"W4386277421","doi":"10.1016/s2152-2650(23)01364-2","title":"IBCL-489 Mosunetuzumab Retreatment Is Effective and Well-Tolerated in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Refractory (planetary science); Lymphoma; Medicine; Oncology; Internal medicine; Cancer research; Biology","score_opus":0.012945079043927426,"score_gpt":0.28596927122502575,"score_spread":0.2730241921810983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286,0.0002936855,0.000002681028,0.0003739253,0.00043717818,0.0027587868,0.00006839501,0.00031892568,0.0028864238],"genre_scores_gemma":[0.99345195,0.0008023998,0.00039982967,0.0014403093,0.0001975114,0.0005686029,0.00043125133,0.0001671059,0.002541058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943861,0.00036646932,0.0015429107,0.0017560886,0.0008697866,0.0010786706],"domain_scores_gemma":[0.99553025,0.0016890435,0.00048643915,0.0012051217,0.00028510878,0.0008040135],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006501539,0.0009112782,0.0017803956,0.0004281414,0.0002423989,0.00009424183,0.00025097484,0.0007703861,0.00019056513],"category_scores_gemma":[0.00032420896,0.0006271913,0.00035134182,0.0014756765,0.00042612964,0.0002480474,0.0002529142,0.00026128508,0.0010517213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009349749,0.0035789579,0.58121973,0.00013286997,0.00049228844,0.0023816042,0.00043968274,0.0000051982634,0.00002471392,0.000010519336,0.0073841223,0.39498055],"study_design_scores_gemma":[0.07510286,0.010457078,0.9047421,0.00070147193,0.0004751666,0.000051431947,0.0001325662,0.0007263298,0.0011840805,0.000034917735,0.005746006,0.00064597087],"about_ca_topic_score_codex":0.0005058854,"about_ca_topic_score_gemma":0.00007752265,"teacher_disagreement_score":0.39433458,"about_ca_system_score_codex":0.0038843842,"about_ca_system_score_gemma":0.001552797,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W4386277871","doi":"10.1016/s2152-2650(23)01273-9","title":"HL-353 Long-Term Outcomes of Bulky Classic Hodgkin Lymphoma Managed With a Positron Emission Tomography (PET)-Adapted Approach Demonstrate Excellent Outcomes in PET-Negative Cases","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Positron emission tomography; Hodgkin lymphoma; Lymphoma; Nuclear medicine; Term (time); Medicine; Pet imaging; Positron emission; PET-CT; Physics; Internal medicine","score_opus":0.04336737510032816,"score_gpt":0.3250377707127791,"score_spread":0.28167039561245094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945296,0.00035204695,0.000023848172,0.00071370316,0.00029585307,0.0020010753,0.00010240967,0.00042987926,0.0015515857],"genre_scores_gemma":[0.99499786,0.00060179987,0.001649484,0.00045629844,0.00011169827,0.0004340422,0.00033300195,0.00015439471,0.0012614469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99282813,0.00045126057,0.002491248,0.0017214046,0.0012492439,0.0012587244],"domain_scores_gemma":[0.9934188,0.0030948524,0.00092989247,0.0014674243,0.000258635,0.0008303722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009680815,0.0011302482,0.0029790518,0.00097528554,0.0002490713,0.0000962836,0.0005713482,0.00040367193,0.00006513856],"category_scores_gemma":[0.0006649004,0.0007922534,0.0012238509,0.0019685703,0.000847241,0.0002747846,0.0003714049,0.0003229432,0.00010572042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024324534,0.003582664,0.86280936,0.0002929,0.0014703852,0.011947713,0.0001841221,0.000015719002,0.00017657851,0.000108100845,0.00046096387,0.11651902],"study_design_scores_gemma":[0.024918329,0.0022124413,0.96564275,0.00086855027,0.0009336194,0.000981559,0.0005063845,0.0006918727,0.0022986098,0.000113691,0.000050588314,0.00078162475],"about_ca_topic_score_codex":0.00091697264,"about_ca_topic_score_gemma":0.00030007187,"teacher_disagreement_score":0.11573739,"about_ca_system_score_codex":0.0015301136,"about_ca_system_score_gemma":0.0012852569,"threshold_uncertainty_score":0.9994528},"labels":[],"label_agreement":null},{"id":"W4386281911","doi":"10.1016/s2152-2650(23)00354-3","title":"Oral Abstract: IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Follicular phase; Medicine; Phase (matter); Internal medicine; Gastroenterology; Lymphoma; Chemistry; Organic chemistry","score_opus":0.03522214240249506,"score_gpt":0.3376478688833309,"score_spread":0.3024257264808359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386281911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400014,0.000252964,0.0000021187216,0.00047007634,0.00051842385,0.0028596807,0.00038621624,0.00030385767,0.0012065376],"genre_scores_gemma":[0.99671173,0.00023827063,0.00028827298,0.00040623968,0.00025471198,0.00029481685,0.0009497655,0.00016317601,0.0006930023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919133,0.00031993413,0.0032736394,0.0017440745,0.001517994,0.0012310272],"domain_scores_gemma":[0.99536496,0.0008770775,0.0008025369,0.0017376622,0.0004034132,0.0008143605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015573541,0.00092883245,0.0023471254,0.00055843254,0.0002658871,0.00006144051,0.000559862,0.0006210894,0.000103411476],"category_scores_gemma":[0.0006019558,0.0007273432,0.00078450114,0.0017372328,0.00045372566,0.00030736497,0.0002515834,0.0002656699,0.000273251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015027455,0.032438286,0.49352443,0.00012547876,0.0009028101,0.0027338122,0.00078964804,0.000032590728,0.00007910216,0.000027241444,0.0030984594,0.4512207],"study_design_scores_gemma":[0.16582768,0.015306243,0.8122141,0.00042731478,0.00067249424,0.000020333588,0.0003209072,0.00019152666,0.0007551388,0.000030829513,0.0036409814,0.00059246557],"about_ca_topic_score_codex":0.000941556,"about_ca_topic_score_gemma":0.0003090417,"teacher_disagreement_score":0.45062822,"about_ca_system_score_codex":0.0015010233,"about_ca_system_score_gemma":0.0014614074,"threshold_uncertainty_score":0.99951774},"labels":[],"label_agreement":null},{"id":"W4386281987","doi":"10.1016/s2152-2650(23)01333-2","title":"ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; CHOP; Internal medicine; Lymphoma; Oncology; Rituximab; Phases of clinical research; Clinical trial","score_opus":0.025283672554976166,"score_gpt":0.31651602205791074,"score_spread":0.2912323495029346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386281987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906751,0.00036110624,0.000009867949,0.0003055025,0.0024035564,0.0036807328,0.00043915343,0.00045818524,0.0016668035],"genre_scores_gemma":[0.9946771,0.0009090672,0.00033334768,0.00051808887,0.00080805126,0.00052897655,0.0011720231,0.00025638056,0.00079690904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990208,0.0004776885,0.0035265984,0.0020371212,0.0018175651,0.0019330191],"domain_scores_gemma":[0.990765,0.003988288,0.0012324128,0.002243903,0.00049038423,0.0012800397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011247718,0.0012571777,0.0032725371,0.00069647684,0.00027728727,0.000100706086,0.0007547841,0.0010566018,0.00013397839],"category_scores_gemma":[0.0014443197,0.001028582,0.0011604287,0.0020025144,0.0005232521,0.0003347192,0.00044153866,0.00039827373,0.00072790135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42440054,0.11329945,0.13403091,0.00023845474,0.0010084582,0.012554404,0.0004815987,0.000008764747,0.000038083268,0.00018301909,0.0053494605,0.30840686],"study_design_scores_gemma":[0.5652073,0.013179039,0.41648012,0.0003423161,0.0006446033,0.00004260059,0.00018096826,0.00030063328,0.00018133284,0.000034964338,0.0027669722,0.00063910795],"about_ca_topic_score_codex":0.0008033162,"about_ca_topic_score_gemma":0.00025172599,"teacher_disagreement_score":0.30776775,"about_ca_system_score_codex":0.0032623755,"about_ca_system_score_gemma":0.0025938067,"threshold_uncertainty_score":0.99921644},"labels":[],"label_agreement":null},{"id":"W4386282071","doi":"10.1016/s2152-2650(23)00779-6","title":"POSTER: MCL-467 Glofitamab Monotherapy Induces High Complete Response Rates in Patients With Heavily Pretreated Relapsed or Refractory Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Refractory (planetary science); Mantle (geology); Medicine; Cancer research; Lymphoma; Oncology; Internal medicine; Geochemistry; Geology; Materials science; Metallurgy","score_opus":0.03224054143366972,"score_gpt":0.3083022262537733,"score_spread":0.27606168482010357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501735,0.0002717613,0.0000010484308,0.0010258199,0.00053527387,0.0017942269,0.00023021358,0.0005129117,0.0006114013],"genre_scores_gemma":[0.99390215,0.00045374988,0.00037682324,0.0019000877,0.00019880857,0.0002758201,0.0007589979,0.00021285842,0.0019207158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99337655,0.0009235775,0.0019404752,0.0015808955,0.00097255176,0.0012059689],"domain_scores_gemma":[0.9938414,0.003012829,0.00060753967,0.0014928099,0.00033916303,0.0007062766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010507902,0.0009088404,0.0017866115,0.00058982475,0.00025425115,0.00012205209,0.00047477885,0.00075754593,0.00021221885],"category_scores_gemma":[0.0005729412,0.00063634146,0.00040237248,0.0016400425,0.00043894275,0.00033002338,0.00020529045,0.00027327836,0.0012030044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08764255,0.005179227,0.7237093,0.00011429888,0.0004997394,0.0027074916,0.0003521199,0.000007034019,0.00062874734,0.000024618479,0.0043234103,0.17481147],"study_design_scores_gemma":[0.07271788,0.009121159,0.90866935,0.00061548897,0.00022090197,0.000046003643,0.00011077923,0.0000937337,0.0026901297,0.000043069682,0.004969111,0.00070236984],"about_ca_topic_score_codex":0.00064824295,"about_ca_topic_score_gemma":0.000066083776,"teacher_disagreement_score":0.18496007,"about_ca_system_score_codex":0.0028409695,"about_ca_system_score_gemma":0.002170402,"threshold_uncertainty_score":0.9996088},"labels":[],"label_agreement":null},{"id":"W4386282097","doi":"10.1016/s2152-2650(23)00681-x","title":"POSTER: HL-353 Long-Term Outcomes of Bulky Classic Hodgkin Lymphoma Managed With a Positron Emission Tomography (PET)-Adapted Approach Demonstrate Excellent Outcomes in PET-Negative Cases","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Positron emission tomography; Term (time); Medicine; Lymphoma; Nuclear medicine; Positron emission; Hodgkin lymphoma; Medical physics; Radiology; Internal medicine; Physics","score_opus":0.04161993237991492,"score_gpt":0.3221626072723113,"score_spread":0.28054267489239637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420017,0.00036290922,0.000013534364,0.0008456092,0.00030759993,0.0021058584,0.000121730794,0.00042314676,0.00161946],"genre_scores_gemma":[0.99559855,0.00054085493,0.0010831194,0.00055979646,0.00010789279,0.00039366275,0.00037772805,0.0001602497,0.00117817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926971,0.00047309452,0.0025580225,0.0017471423,0.0012472133,0.0012774239],"domain_scores_gemma":[0.9934606,0.0029692287,0.0009568397,0.001502078,0.00027181083,0.00083943637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009316329,0.0011628402,0.0030017453,0.0010044443,0.00024660397,0.00010639395,0.0005890136,0.00041105732,0.00006096689],"category_scores_gemma":[0.00058132573,0.00081670436,0.0012428768,0.0018498877,0.00081344496,0.0002951303,0.0004108512,0.00032349737,0.00010723883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002855492,0.0035055007,0.8709402,0.00030625958,0.0014878802,0.012701609,0.0002141768,0.000008884771,0.00020275642,0.00006883829,0.0003722231,0.10733618],"study_design_scores_gemma":[0.025296388,0.00262135,0.96448344,0.0009387489,0.0009559764,0.0012805654,0.00044635328,0.00040225877,0.0026455407,0.000085828724,0.00004046065,0.000803109],"about_ca_topic_score_codex":0.0008928646,"about_ca_topic_score_gemma":0.00029989556,"teacher_disagreement_score":0.106533065,"about_ca_system_score_codex":0.0015022234,"about_ca_system_score_gemma":0.0012177735,"threshold_uncertainty_score":0.9994284},"labels":[],"label_agreement":null},{"id":"W4386282163","doi":"10.1016/s2152-2650(23)01365-4","title":"IBCL-492 A Cost-Effectiveness Analysis of Mosunetuzumab for Treatment of Thirdor Higher-Line Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Follicular phase; Oncology; Line (geometry); Lymphoma; Medicine; First line treatment; Internal medicine; Cancer research; Medical physics; Mathematics; Biology; Chemotherapy","score_opus":0.09003371517577248,"score_gpt":0.3918500559816391,"score_spread":0.3018163408058666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941267,0.0007061651,0.00004005719,0.00058755995,0.00032769688,0.0034374224,0.0004883139,0.00014571677,0.0001404092],"genre_scores_gemma":[0.9907525,0.0028465353,0.0003066237,0.0005484191,0.0001732477,0.0018812984,0.0029413288,0.00008912634,0.00046087426],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994112,0.0009333598,0.0023422083,0.0010503731,0.00078491523,0.0007771296],"domain_scores_gemma":[0.98629993,0.010490186,0.00087021006,0.001555412,0.00047123933,0.00031301036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018131454,0.00067353115,0.002891729,0.001102741,0.00014662849,0.000032946606,0.00044017803,0.00056805596,0.00008046937],"category_scores_gemma":[0.00092684844,0.00040405235,0.0017745892,0.0051966524,0.0004579877,0.00010543931,0.00010009338,0.00008166221,0.000035451838],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02619018,0.0149593,0.39467174,0.0007063404,0.016063202,0.0021378133,0.0016882851,0.0032682864,0.00050359586,0.0010195697,0.0018172114,0.5369745],"study_design_scores_gemma":[0.036026616,0.007844825,0.90731645,0.00033296674,0.0062500527,0.000028258888,0.0003726575,0.011920223,0.0021063362,0.00017621618,0.027263336,0.0003620583],"about_ca_topic_score_codex":0.0032184413,"about_ca_topic_score_gemma":0.00039399587,"teacher_disagreement_score":0.53661245,"about_ca_system_score_codex":0.002855299,"about_ca_system_score_gemma":0.001271881,"threshold_uncertainty_score":0.99984115},"labels":[],"label_agreement":null},{"id":"W4386282282","doi":"10.1016/s2152-2650(23)01349-6","title":"IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Follicular phase; Medicine; Internal medicine; Lymphoma","score_opus":0.029069847383775885,"score_gpt":0.3288922633345039,"score_spread":0.299822415950728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938868,0.00031569667,0.0000040806685,0.0005178326,0.0005100753,0.0030007926,0.00033496114,0.00031112303,0.0011185906],"genre_scores_gemma":[0.99648285,0.00029924655,0.00029693387,0.0004630385,0.00028142892,0.00034449206,0.00083620584,0.00016112202,0.0008346813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919697,0.00047647773,0.0031189795,0.0017626958,0.0014823024,0.0011898667],"domain_scores_gemma":[0.99531335,0.00092667696,0.0007301653,0.0018441483,0.00040132532,0.000784318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014392853,0.00089676835,0.0023120584,0.0005812228,0.00026757744,0.000052346702,0.000554538,0.0005784618,0.000070816706],"category_scores_gemma":[0.0006573737,0.00069884706,0.0007792616,0.0019952953,0.00044445085,0.0002594116,0.00028060644,0.00022993238,0.00024246295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015455311,0.03161439,0.5407746,0.00012078114,0.000978317,0.0023006913,0.0009511988,0.000029019198,0.00007062531,0.00003843249,0.0032725676,0.4043941],"study_design_scores_gemma":[0.17346969,0.01896493,0.80041075,0.00044193014,0.00070585025,0.000020329342,0.000331909,0.00028300245,0.0007866208,0.000031703592,0.0039880113,0.00056529045],"about_ca_topic_score_codex":0.000661426,"about_ca_topic_score_gemma":0.00020518206,"teacher_disagreement_score":0.4038288,"about_ca_system_score_codex":0.0015450967,"about_ca_system_score_gemma":0.0014432858,"threshold_uncertainty_score":0.9995463},"labels":[],"label_agreement":null},{"id":"W4386282286","doi":"10.1016/s2152-2650(23)00763-2","title":"POSTER: IBCL-489 Mosunetuzumab Retreatment Is Effective and Well-Tolerated in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"Universitat de Barcelona; Rigshospitalet; Universitair Medisch Centrum Groningen; Universiteit Leiden; Leids Universitair Medisch Centrum; University of California, Los Angeles; Memorial Sloan-Kettering Cancer Center; Karolinska Institutet; Gentofte Hospital; Rijksuniversiteit Groningen; Odense Universitetshospital; Helsingin Yliopisto","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Hodgkin lymphoma; Cancer research; Biology","score_opus":0.012633692421430935,"score_gpt":0.2837801952237903,"score_spread":0.27114650280235936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924871,0.0003023068,0.0000012884234,0.0004460184,0.0004521868,0.00289575,0.00008212805,0.00031134943,0.0030218961],"genre_scores_gemma":[0.9937308,0.0007087184,0.0002452807,0.0017455453,0.00018785012,0.0005091343,0.0004882871,0.00017189808,0.002212479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99430436,0.00038453253,0.0015849383,0.0017717478,0.00086566363,0.001088775],"domain_scores_gemma":[0.99554676,0.0016272323,0.0005024456,0.001230383,0.0002854873,0.00080766634],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006218383,0.0009345462,0.0017952736,0.00044008048,0.0002380537,0.00010359767,0.00025954616,0.00077453715,0.0001741869],"category_scores_gemma":[0.00028364785,0.00064443704,0.00035999043,0.0013725223,0.0004075479,0.00026478583,0.00028021386,0.0002601133,0.0010334982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010885706,0.0034642373,0.62620455,0.00013819801,0.0004998097,0.002569306,0.0004879558,0.000002940417,0.000028712348,0.000006603869,0.005573812,0.35013816],"study_design_scores_gemma":[0.07547749,0.01221622,0.9040898,0.0007612445,0.00048927165,0.000069772235,0.00011413229,0.0004580971,0.0013833063,0.000025950805,0.0042543993,0.000660307],"about_ca_topic_score_codex":0.00050686294,"about_ca_topic_score_gemma":0.00007977115,"teacher_disagreement_score":0.34947783,"about_ca_system_score_codex":0.0037760113,"about_ca_system_score_gemma":0.0014595333,"threshold_uncertainty_score":0.9997443},"labels":[],"label_agreement":null},{"id":"W4386282297","doi":"10.1016/s2152-2650(23)01378-2","title":"MCL-467 Glofitamab Monotherapy Induces High Complete Response Rates in Patients With Heavily Pretreated Relapsed or Refractory Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Refractory (planetary science); Internal medicine; Lymphoma; Medicine; Cancer research; Mantle (geology); Oncology; Biology; Geology; Geochemistry","score_opus":0.033724029113427985,"score_gpt":0.3111347993158181,"score_spread":0.27741077020239013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386282297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953359,0.00026283448,0.0000019057667,0.0008653219,0.00052055955,0.0017125438,0.00019471669,0.00052908325,0.0005771313],"genre_scores_gemma":[0.9938492,0.00050917617,0.0005945879,0.0015523591,0.00020804578,0.00030769105,0.0006765338,0.00020773365,0.002094681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934664,0.00089176215,0.0018952703,0.0015678691,0.0009803402,0.0011983948],"domain_scores_gemma":[0.9937554,0.0031561048,0.0005907969,0.001468283,0.0003259354,0.0007034545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011066621,0.000887874,0.0017751172,0.00057599996,0.00025952817,0.00011138614,0.0004630827,0.00075483444,0.00023312206],"category_scores_gemma":[0.0006506467,0.0006206613,0.00039445705,0.0017698234,0.0004590622,0.00031022567,0.00018507581,0.0002751643,0.0012309109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08156968,0.0056339954,0.7000755,0.00011453317,0.00051533245,0.002630109,0.00031748952,0.0000138363885,0.00058047863,0.00004201308,0.005885558,0.20262146],"study_design_scores_gemma":[0.07218253,0.007787916,0.90916353,0.00056685874,0.00021348633,0.000033824148,0.00013463158,0.00016650555,0.0022971157,0.00005811682,0.00670669,0.0006887651],"about_ca_topic_score_codex":0.00066390476,"about_ca_topic_score_gemma":0.0000652225,"teacher_disagreement_score":0.20908804,"about_ca_system_score_codex":0.002894449,"about_ca_system_score_gemma":0.0023260394,"threshold_uncertainty_score":0.9996245},"labels":[],"label_agreement":null},{"id":"W4386301304","doi":"10.1016/s2152-2650(23)00685-7","title":"POSTER: HL-603 Hodgkin Lymphoma in Tripoli University Hospital Libya","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Ancient history; General surgery; Pediatrics; History; Internal medicine","score_opus":0.028993087539450898,"score_gpt":0.3081496081471979,"score_spread":0.279156520607747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386301304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810335,0.00025479446,0.00000270926,0.0033022822,0.0011867074,0.00090991514,0.000080540136,0.0006206571,0.012608874],"genre_scores_gemma":[0.9917969,0.0012131049,0.00021378695,0.001264268,0.00058964203,0.000036906964,0.00023927515,0.00009584949,0.0045502833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952343,0.00035096586,0.0012883054,0.0013102193,0.00066159584,0.0011545977],"domain_scores_gemma":[0.996278,0.0012146967,0.0003226575,0.001165019,0.00015725265,0.00086240063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008480497,0.0006075129,0.0013700292,0.0005631077,0.00020830808,0.00006930158,0.0005095584,0.0007280109,0.00019372506],"category_scores_gemma":[0.0006809075,0.0005682619,0.000875546,0.0017325922,0.00045212943,0.00028083028,0.00045703637,0.00021449346,0.0032499698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009325988,0.0014616679,0.49103126,0.00005595243,0.00026748434,0.008074039,0.00023408995,0.0000031288055,0.000026166732,0.0008087182,0.015983107,0.4811218],"study_design_scores_gemma":[0.020464424,0.0014657198,0.91587067,0.00027304134,0.00023685014,0.0001603305,0.0002853917,0.0002841311,0.00033833866,0.00025942829,0.059815176,0.00054647186],"about_ca_topic_score_codex":0.0007935609,"about_ca_topic_score_gemma":0.000105477855,"teacher_disagreement_score":0.48057532,"about_ca_system_score_codex":0.0034707151,"about_ca_system_score_gemma":0.0020124544,"threshold_uncertainty_score":0.9996769},"labels":[],"label_agreement":null},{"id":"W4386346949","doi":"10.1002/jmv.29070","title":"Assessing the prognostic scoring models to predict patient outcomes in AIDS‐related diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"letter","venue":"Journal of Medical Virology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Citation; Library science; Medicine; Human immunodeficiency virus (HIV); Lymphoma; Family medicine; Immunology; Computer science","score_opus":0.031598462369579035,"score_gpt":0.30765528120388635,"score_spread":0.2760568188343073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5726462,0.0006317754,0.00006979664,0.42468256,0.0013388966,0.00047866485,0.0000115155235,0.000027043583,0.00011353643],"genre_scores_gemma":[0.68423665,0.00047745722,0.00012980352,0.31364223,0.0011198095,0.000090779155,0.000035729598,0.00008898999,0.00017855047],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99410915,0.0005418822,0.0017052594,0.00042797052,0.0023632066,0.0008525542],"domain_scores_gemma":[0.9958818,0.0023278394,0.000756564,0.00043742155,0.00013945301,0.00045695447],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014622194,0.00046130214,0.0015708891,0.00066715485,0.000094895135,0.0000665393,0.0005411979,0.0014011328,0.00011144272],"category_scores_gemma":[0.0014568922,0.00025203463,0.0004874488,0.00038255466,0.00013283284,0.00013390364,0.0003174454,0.0021425795,0.000076895165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026533767,0.012052238,0.31195894,0.00043681616,0.0020070341,0.12762284,0.0022265338,0.00015930971,0.000020633903,0.000073869545,0.51171756,0.031458903],"study_design_scores_gemma":[0.0895675,0.012163898,0.6330592,0.008517038,0.0040335767,0.008143015,0.0010994213,0.007189649,0.000075273696,0.0019469626,0.23299623,0.001208216],"about_ca_topic_score_codex":0.00007180207,"about_ca_topic_score_gemma":0.000016458273,"teacher_disagreement_score":0.3211003,"about_ca_system_score_codex":0.00054581213,"about_ca_system_score_gemma":0.0008751801,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W4386407017","doi":"10.2217/fon-2023-0358","title":"Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"Seagen","keywords":"Medicine; Stage (stratigraphy); Family medicine; Regimen; Alternative medicine; Lymphoma; Internal medicine; Pathology","score_opus":0.04817714389186973,"score_gpt":0.3564879811656919,"score_spread":0.3083108372738222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386407017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730016,0.000418292,0.000003466706,0.008113804,0.0013238847,0.0037353374,0.00015185785,0.00023535188,0.013016384],"genre_scores_gemma":[0.981413,0.00060010765,0.00013499864,0.0011175922,0.0023170607,0.0028031878,0.00032698637,0.00004380193,0.011243247],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980625,0.00020550004,0.0003913367,0.0005708332,0.00024086927,0.00052896695],"domain_scores_gemma":[0.99823916,0.00073767506,0.00020398507,0.0005772566,0.00009549981,0.00014641197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002641175,0.00036547726,0.00085295335,0.00015560891,0.00029818589,0.000029347884,0.00017265033,0.0001481665,0.00011111858],"category_scores_gemma":[0.00002405544,0.00019716057,0.00025535497,0.00043800633,0.00009927374,0.00004488507,0.00006402975,0.00007575273,0.00014013344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043576974,0.021936016,0.27616906,0.00009847883,0.00396568,0.0014430142,0.0070831664,0.00003399324,0.00023782285,0.0045622685,0.10663248,0.5734803],"study_design_scores_gemma":[0.019561304,0.010188617,0.52703464,0.000022095719,0.0008052983,0.000008186969,0.005114613,0.0001239435,0.0002924391,0.0001245115,0.43654838,0.00017596038],"about_ca_topic_score_codex":0.0013450959,"about_ca_topic_score_gemma":0.016859736,"teacher_disagreement_score":0.57330436,"about_ca_system_score_codex":0.0011433661,"about_ca_system_score_gemma":0.000526969,"threshold_uncertainty_score":0.9408128},"labels":[],"label_agreement":null},{"id":"W4386423632","doi":"10.1038/s41375-023-01978-x","title":"Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","year":2023,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; World Health Organization","keywords":"Germline; Hodgkin lymphoma; Lymphoma; Biology; Genetics; Medicine; Computational biology; Immunology; Gene","score_opus":0.019204196609360447,"score_gpt":0.29091253425279445,"score_spread":0.271708337643434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386423632","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6879294,0.008515387,0.00034766074,0.0017757482,0.24446984,0.013032752,0.0025764734,0.0021394875,0.039213244],"genre_scores_gemma":[0.3056113,0.0007997478,0.0005032468,0.00033802344,0.008401518,0.002347918,0.013554271,0.0003476593,0.6680963],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996555,0.00007788508,0.00089676765,0.0012005892,0.000583841,0.00068596087],"domain_scores_gemma":[0.99721575,0.000496924,0.00044140138,0.0012511882,0.0003045162,0.00029025026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028730085,0.0007306774,0.0013864723,0.0002299586,0.00028902083,0.000117486255,0.00028148733,0.00089011947,0.00022882078],"category_scores_gemma":[0.00035832007,0.00061739655,0.00068367546,0.00039064532,0.00017023354,0.000055752444,0.00015821653,0.00036004712,0.0005239119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039351705,0.00040510713,0.032048035,0.001181995,0.00043272885,0.00031020725,0.00009177677,0.0000041458165,0.000036132504,0.000008201779,0.92788094,0.037207194],"study_design_scores_gemma":[0.004905265,0.0008584641,0.7666039,0.001278519,0.0013214772,0.00012711284,0.000060094844,0.0024498631,0.0012084945,0.00017958097,0.22039251,0.0006147241],"about_ca_topic_score_codex":0.0021277433,"about_ca_topic_score_gemma":0.00315486,"teacher_disagreement_score":0.73455584,"about_ca_system_score_codex":0.0034079028,"about_ca_system_score_gemma":0.0019334032,"threshold_uncertainty_score":0.9996277},"labels":[],"label_agreement":null},{"id":"W4386609802","doi":"10.1016/j.jtct.2023.09.005","title":"Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; International Prognostic Index; Salvage therapy; Diffuse large B-cell lymphoma; Transplantation; Retrospective cohort study; Oncology; Lymphoma; Chemotherapy","score_opus":0.011949575277734369,"score_gpt":0.25717679271407673,"score_spread":0.24522721743634235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386609802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969459,0.00081965374,0.0002709419,0.0003839066,0.000086318214,0.00052601576,0.0002430749,0.00012323275,0.00060096115],"genre_scores_gemma":[0.9562746,0.041296992,0.0001227047,0.00023075612,0.00003254719,0.00007763955,0.0016229096,0.000022351607,0.00031948127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988865,0.00011475542,0.00025506548,0.0002981716,0.00018674262,0.00025875418],"domain_scores_gemma":[0.9995603,0.00012219284,0.00007419063,0.00011852248,0.000030508918,0.000094287076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017652301,0.00020228139,0.0002590949,0.00019521402,0.00011832282,0.000018471845,0.00003911027,0.000104668274,0.00010021239],"category_scores_gemma":[0.0000016963198,0.00016543189,0.00007205454,0.00030152418,0.000043479795,0.000113073766,0.000002564458,0.00007065831,0.000116858784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00615396,0.0043565617,0.84921616,0.0008628733,0.0005464697,0.0029153528,0.033939816,0.00015710211,0.06484881,0.0041947165,0.00042356487,0.032384608],"study_design_scores_gemma":[0.03534864,0.0004108269,0.7449419,0.00014046587,0.00018534147,0.00003475033,0.00096975174,0.00063314714,0.21549016,0.00026018795,0.0013320429,0.0002527705],"about_ca_topic_score_codex":0.0001841131,"about_ca_topic_score_gemma":0.00006562594,"teacher_disagreement_score":0.15064135,"about_ca_system_score_codex":0.00003637293,"about_ca_system_score_gemma":0.000054047745,"threshold_uncertainty_score":0.6746117},"labels":[],"label_agreement":null},{"id":"W4386946364","doi":"10.1097/pcr.0000000000000329","title":"Large B-Cell Lymphoma With IRF4 Rearrangement: From Theory to Practice","year":2019,"lang":"en","type":"article","venue":"AJSP Review and Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus; Hôpital du Saint-Sacrement","funders":"","keywords":"IRF4; Lymphoma; Biology; Interferon regulatory factors; Gene rearrangement; Cancer research; Transcription factor; BCL6; B cell; Gene; Genetics; Immunology; Antibody","score_opus":0.005076117697789626,"score_gpt":0.2562525458653575,"score_spread":0.25117642816756786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386946364","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18366215,0.76039267,0.000055160246,0.0059542153,0.00027968248,0.0026633781,0.00001395226,0.000066260596,0.046912566],"genre_scores_gemma":[0.9003839,0.048075944,0.0036875287,0.035333056,0.00012744733,0.00023896909,0.00012893758,0.000050921622,0.011973325],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881536,0.00005935244,0.00029801842,0.00040027412,0.00023239822,0.00019459006],"domain_scores_gemma":[0.9988634,0.00010093094,0.0001935197,0.00056457054,0.00008833082,0.00018927535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044219213,0.00016778553,0.00047061546,0.000027338865,0.000044656765,0.000017970362,0.000026719881,0.00004241823,0.0003826618],"category_scores_gemma":[0.00008094855,0.00009695611,0.00006828944,0.00011215541,0.000013428273,0.00008545882,0.00004066379,0.00003635074,0.00023407486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002335856,0.009216675,0.78035825,0.0062524113,0.0017514908,0.01899114,0.0015165561,3.715898e-7,0.0005815687,0.001608817,0.07395712,0.105532005],"study_design_scores_gemma":[0.0024831586,0.0004725297,0.11202285,0.0023759727,0.0017105405,0.0013236417,0.0001331927,7.480486e-8,0.00033137298,0.00005960921,0.8789192,0.00016788211],"about_ca_topic_score_codex":0.00009178656,"about_ca_topic_score_gemma":0.000005397366,"teacher_disagreement_score":0.80496204,"about_ca_system_score_codex":0.000049755705,"about_ca_system_score_gemma":0.00007711794,"threshold_uncertainty_score":0.41898784},"labels":[],"label_agreement":null},{"id":"W4387036012","doi":"10.14405/kjvr.20230027","title":"Peritoneal lymphomatosis with pleural and peritoneal effusions in a dog: a case report","year":2023,"lang":"en","type":"article","venue":"Korean Journal of Veterinary Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Research Foundation of Korea; National Research Foundation","keywords":"Medicine; Pathology; Pleural effusion; Peritoneal Effusion; Peritoneal fluid; Lymph; Abdomen; Lymphatic system; Lymphoma; Mesentery; Effusion; Radiology","score_opus":0.12742505634220883,"score_gpt":0.429084119102413,"score_spread":0.30165906276020416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387036012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963204,0.00039389206,7.9044713e-7,0.0022286498,0.00006584114,0.00030329247,0.000009942624,0.000020298634,0.0006568816],"genre_scores_gemma":[0.99857986,0.00040213403,0.0005111276,0.000022798606,0.0001628231,0.000039477272,0.000009805121,0.000029386485,0.00024257883],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99770856,0.0002192739,0.00050198,0.00026809075,0.00079927646,0.00050281815],"domain_scores_gemma":[0.99856526,0.0002988403,0.000111923735,0.00028722928,0.00029687476,0.00043984863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013986018,0.00016679702,0.00045101286,0.0008033305,0.00021080073,0.00006681205,0.00009432849,0.00007234825,0.000047282396],"category_scores_gemma":[0.00016002728,0.0001122624,0.00010131358,0.0007964797,0.000265476,0.00014664186,0.00016765835,0.00033822242,0.00001246242],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013397137,0.00047241064,0.19724183,0.00009280298,0.000102549944,0.791737,0.0013961983,0.0000027624785,0.002203679,0.000013539257,0.00067182945,0.004725678],"study_design_scores_gemma":[0.0039249663,0.0064887796,0.3050318,0.00042288261,0.000035856257,0.680482,0.0022850265,0.00019103942,0.0003273107,0.000015027517,0.0007083566,0.000086993045],"about_ca_topic_score_codex":0.00045212207,"about_ca_topic_score_gemma":0.00004478628,"teacher_disagreement_score":0.111255065,"about_ca_system_score_codex":0.0002685156,"about_ca_system_score_gemma":0.00044086168,"threshold_uncertainty_score":0.4577928},"labels":[],"label_agreement":null},{"id":"W4387114848","doi":"10.3324/haematol.2023.283557","title":"Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"National Cancer Institute; Pharmacyclics; Genentech; F. Hoffmann-La Roche; Incyte; H. Lundbeck A/S; BeiGene; CSL Behring; AstraZeneca; MorphoSys; Celgene; Gilead Sciences; Teva Pharmaceutical Industries; Servier; TG Therapeutics; Amgen","keywords":"Bendamustine; Medicine; Obinutuzumab; Follicular lymphoma; Internal medicine; Tolerability; Rituximab; Adverse effect; Phases of clinical research; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.042731580876233986,"score_gpt":0.328386806788105,"score_spread":0.28565522591187104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387114848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994399,0.0018845455,0.0000018359733,0.0007312044,0.00016394716,0.0017237043,0.00002730377,0.0003876049,0.000680834],"genre_scores_gemma":[0.9977515,0.00035707737,0.00023722237,0.00026407294,0.00005684344,0.0005084445,0.00008236545,0.00004488902,0.0006976355],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973322,0.00014306145,0.0006495504,0.00081561157,0.0004281496,0.0006314248],"domain_scores_gemma":[0.99858344,0.00030509595,0.00016496837,0.0006016797,0.0000663,0.0002785027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028653504,0.00044157758,0.0012387951,0.0003951081,0.0002831887,0.00003886772,0.00015148266,0.00022963675,0.00020342537],"category_scores_gemma":[0.0003985805,0.00029527716,0.00014773534,0.00090395607,0.000120746925,0.00008475776,0.00029280415,0.00016525363,0.00024199214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03130996,0.14500242,0.2552278,0.0016893294,0.0029151614,0.36959764,0.027658263,0.00007823033,0.0012942812,0.0036883445,0.03126434,0.13027424],"study_design_scores_gemma":[0.46369672,0.033938497,0.4445263,0.0011121491,0.0015415057,0.006813007,0.013200072,0.0051577133,0.0013981243,0.0005107884,0.02646418,0.0016409351],"about_ca_topic_score_codex":0.00042801347,"about_ca_topic_score_gemma":0.0002144468,"teacher_disagreement_score":0.43238676,"about_ca_system_score_codex":0.00079925073,"about_ca_system_score_gemma":0.00046882522,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W4387124851","doi":"10.1016/j.clml.2023.09.007","title":"Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Oncology; Internal medicine; Follicular phase; Rituximab; Lymphoma; Cancer research","score_opus":0.05146645465287799,"score_gpt":0.3362929252474394,"score_spread":0.28482647059456145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387124851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939867,0.0014160066,0.000029908393,0.0005515954,0.00030148236,0.0020555598,0.00025538902,0.00035313368,0.0010502255],"genre_scores_gemma":[0.9908988,0.002261342,0.002364877,0.00028320967,0.0002717144,0.0007517386,0.00067433936,0.0001280612,0.0023659477],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958731,0.00016875865,0.0014511102,0.0011669517,0.0005276871,0.0008124139],"domain_scores_gemma":[0.99591786,0.0016210807,0.0005680844,0.0010217904,0.00021961163,0.00065159536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043626383,0.0007473281,0.002074536,0.00029103627,0.00025555197,0.000047930134,0.00019381435,0.00050881057,0.000028513083],"category_scores_gemma":[0.00020584514,0.00050924515,0.0007145626,0.00060484785,0.00047826022,0.00014299333,0.0001167214,0.000079895304,0.00011932351],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005263088,0.004217955,0.33467087,0.00016869386,0.0044980557,0.00096657424,0.00033321595,0.000029249273,0.00029402447,0.00023297816,0.00492012,0.6444052],"study_design_scores_gemma":[0.045303024,0.013080963,0.90657043,0.00036966347,0.0025047078,0.00021352421,0.00014019526,0.0012712498,0.0067133773,0.00012679228,0.02324789,0.0004581692],"about_ca_topic_score_codex":0.00029037677,"about_ca_topic_score_gemma":0.00007793828,"teacher_disagreement_score":0.643947,"about_ca_system_score_codex":0.001891739,"about_ca_system_score_gemma":0.0013613497,"threshold_uncertainty_score":0.9997359},"labels":[],"label_agreement":null},{"id":"W4387207740","doi":"10.1016/j.ijrobp.2023.06.206","title":"Consolidative Radio therapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab Vedotin: CheckMate 744","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Brentuximab vedotin; Oncology; Internal medicine; Nivolumab; Autologous stem-cell transplantation; Bendamustine; Chemotherapy; Refractory (planetary science); Lymphoma; Surgery; Hodgkin lymphoma; Cancer; Immunotherapy; Rituximab","score_opus":0.011070411867796705,"score_gpt":0.2622991500452562,"score_spread":0.2512287381774595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978246,0.00033927432,0.000113958886,0.0003368701,0.00036339846,0.00060082466,0.0002204119,0.00004044812,0.00016018054],"genre_scores_gemma":[0.9971281,0.001979832,0.00020035314,0.00011982347,0.00013630184,0.000043879216,0.000311884,0.00004272638,0.00003704887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975012,0.00041829713,0.00096233375,0.0003532939,0.0004218583,0.00034302488],"domain_scores_gemma":[0.99705034,0.0006033039,0.0015443546,0.00018945066,0.0004900235,0.00012252112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037806458,0.0003367767,0.0009512608,0.00048994564,0.00004702546,0.000015378437,0.00026444887,0.00027165562,0.000021351687],"category_scores_gemma":[0.000029207167,0.00024164586,0.00015774298,0.00048371093,0.00025025435,0.00022739178,0.000024238741,0.00034550167,0.000015703967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010184168,0.0034991908,0.90790683,0.00002007765,0.0008191335,0.00036893657,0.0019781364,0.0020267947,0.00025196184,0.00011221204,0.00014136817,0.072691165],"study_design_scores_gemma":[0.08597683,0.008401004,0.8972154,0.0003504715,0.00016923065,0.00008676501,0.00023601635,0.002004319,0.004809988,0.00008666184,0.00042836706,0.00023493716],"about_ca_topic_score_codex":0.00017113979,"about_ca_topic_score_gemma":0.000055652366,"teacher_disagreement_score":0.07579266,"about_ca_system_score_codex":0.0021926598,"about_ca_system_score_gemma":0.0011592442,"threshold_uncertainty_score":0.98540324},"labels":[],"label_agreement":null},{"id":"W4387208068","doi":"10.1016/j.ijrobp.2023.06.362","title":"Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma Study","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"Innovent Biologics; Deutsche Krebshilfe; Hexal AG; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Vincristine; Radiation therapy; Clinical endpoint; Prednisone; Internal medicine; Randomized controlled trial; Regimen; Oncology; Nuclear medicine; Cyclophosphamide; Chemotherapy","score_opus":0.055544867326888236,"score_gpt":0.38186062354509065,"score_spread":0.3263157562182024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387208068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907463,0.0005270993,0.00097117113,0.0036076794,0.0027035028,0.0012113272,0.00012075798,0.00005889734,0.00005322946],"genre_scores_gemma":[0.9930425,0.0026286726,0.00054758915,0.0007201234,0.0027126817,0.00011123911,0.00015587971,0.000031767886,0.000049494844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982599,0.00025343974,0.00073583616,0.00027190836,0.00030077746,0.00017814148],"domain_scores_gemma":[0.9970412,0.0012943664,0.0010025068,0.0001404442,0.00040489156,0.000116591524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007148617,0.00021579582,0.00061857194,0.00034160892,0.00009971095,0.00003423293,0.00016335765,0.00017291075,0.000014492722],"category_scores_gemma":[0.00048784664,0.00016440963,0.00023774516,0.00021755265,0.000060188573,0.000152938,0.000028714681,0.00012150043,0.000012228697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010858175,0.002550025,0.7959286,0.0000056752524,0.0011612091,0.000053274234,0.00041567063,0.000072250325,0.000019752059,0.0024342006,0.0025143009,0.18398689],"study_design_scores_gemma":[0.22976005,0.0153966565,0.73936903,0.00001783274,0.00039349726,0.000034198085,0.0001707553,0.0010345787,0.00016043286,0.0040171742,0.009475923,0.00016983735],"about_ca_topic_score_codex":0.000039436203,"about_ca_topic_score_gemma":0.0000030126655,"teacher_disagreement_score":0.21890187,"about_ca_system_score_codex":0.0005810366,"about_ca_system_score_gemma":0.0005054365,"threshold_uncertainty_score":0.670443},"labels":[],"label_agreement":null},{"id":"W4387220460","doi":"10.1002/jha2.785","title":"The pathobiology of select adolescent young adult lymphomas","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Spinal Cord Injury BC; BC Cancer Agency","funders":"Servier","keywords":"Lymphoma; Follicular lymphoma; Medicine; Hodgkin lymphoma; Epidemiology; Population; Young adult; Lymphoproliferative disorders; Cancer; Oncology; Internal medicine; Environmental health","score_opus":0.061307852934027456,"score_gpt":0.36014847227096225,"score_spread":0.2988406193369348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113268434,0.9965428,6.769559e-7,0.00010815824,0.0005738095,0.0010989538,0.000056638022,0.000078123085,0.0014275614],"genre_scores_gemma":[0.00029075847,0.99739265,0.000024819792,0.000062860665,0.0002956224,0.00033998725,0.00016317809,0.000066135246,0.0013639794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820405,0.0001582512,0.0006677632,0.0003761604,0.00022196023,0.0003718059],"domain_scores_gemma":[0.99842423,0.00036903398,0.00035720796,0.00061459205,0.00013053187,0.000104427636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002103627,0.00037070276,0.0016612922,0.00009390577,0.000099319266,0.000013148702,0.00019801402,0.00027730566,0.000022763463],"category_scores_gemma":[0.00017705507,0.00018744475,0.00073309615,0.00034498188,0.00008203038,0.000010112058,0.00010036128,0.0001565023,0.0004700488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017281716,0.00024367604,0.0009228071,0.008074858,0.0007451877,0.00023265065,0.000047540863,2.1348669e-8,3.84896e-7,0.0007914339,0.00790556,0.9810186],"study_design_scores_gemma":[0.000800597,0.00025545314,0.0013097438,0.016308334,0.0020223404,0.00042112923,0.000029880108,0.0000013460224,0.000018130222,0.000020990286,0.97863394,0.0001781181],"about_ca_topic_score_codex":0.000116314506,"about_ca_topic_score_gemma":0.000074469244,"teacher_disagreement_score":0.9808405,"about_ca_system_score_codex":0.000379912,"about_ca_system_score_gemma":0.0005838865,"threshold_uncertainty_score":0.76437753},"labels":[],"label_agreement":null},{"id":"W4387220835","doi":"10.1002/jha2.786","title":"Scientific techniques in adolescent and young adult classic Hodgkin lymphoma","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Leukemia and Lymphoma Society; Lymphoma Research Foundation","keywords":"Lymphoma; Hodgkin lymphoma; Genomics; Medicine; Medical physics; Computational biology; Genome; Biology; Internal medicine; Genetics","score_opus":0.0733396494760577,"score_gpt":0.35720715747159715,"score_spread":0.28386750799553945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069264515,0.9956683,0.0000013014538,0.00011471469,0.00051020685,0.0017108198,0.000040601448,0.00023427627,0.0010271538],"genre_scores_gemma":[0.00044442734,0.99603415,0.00019385146,0.000066701585,0.00019761258,0.0006606407,0.00017988699,0.00008537384,0.0021373408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977591,0.000090481146,0.0006066053,0.0007739624,0.00036060918,0.00040926307],"domain_scores_gemma":[0.9989093,0.00007784498,0.00019068096,0.00056274,0.00007892144,0.00018053853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029235875,0.0004568706,0.0015868802,0.00059731974,0.00009253017,0.00012767609,0.00013697936,0.00032115204,0.000018395178],"category_scores_gemma":[0.00009532906,0.00032942893,0.00031920627,0.00076012814,0.0001279705,0.00005352945,0.00015546175,0.0001632643,0.00029492195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006853454,0.00037127125,0.0015836974,0.010319864,0.00009964661,0.00075506524,0.000067921355,1.9150967e-9,5.887584e-7,0.00015777159,0.006333803,0.9803035],"study_design_scores_gemma":[0.0009241326,0.00011840496,0.004495176,0.05935644,0.0007538032,0.00033878832,0.000033679637,0.0000033855442,0.000036435387,0.000028349325,0.9335924,0.00031904108],"about_ca_topic_score_codex":0.00016927223,"about_ca_topic_score_gemma":0.00025062164,"teacher_disagreement_score":0.97998446,"about_ca_system_score_codex":0.00081078196,"about_ca_system_score_gemma":0.00048249055,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W4387356945","doi":"10.1002/hon.3225","title":"Expression of “DNA damage response” pathway genes in diffuse large B‐cell lymphoma: The potential for exploiting synthetic lethality","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Diffuse large B-cell lymphoma; Biology; Gene; Cancer research; Lymphoma; FANCA; DNA repair; Gene expression profiling; Follicular lymphoma; Cancer; Gene expression; Genetics; Immunology","score_opus":0.038836643700257974,"score_gpt":0.3187934555673111,"score_spread":0.2799568118670531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387356945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952615,0.00037904517,0.00010753441,0.002782104,0.00014016539,0.0008084807,0.00003968377,0.00008298939,0.00039852],"genre_scores_gemma":[0.9983175,0.0001167819,0.0004989235,0.00028771313,0.00004503962,0.0005723244,0.00003288478,0.000016993064,0.00011184934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978849,0.0005440806,0.0005305869,0.00037740896,0.00019881142,0.00046420546],"domain_scores_gemma":[0.9966746,0.0026174565,0.00019214481,0.00035553088,0.00006088884,0.00009936426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010795272,0.00018219945,0.00069313304,0.00010632798,0.00012447992,0.0000073078722,0.00014916284,0.0002815226,0.000048005888],"category_scores_gemma":[0.0007360573,0.0001021419,0.00022080822,0.00023102104,0.00015661358,0.00003051069,0.00018374674,0.00008006441,0.000036350775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021921637,0.08457811,0.0957994,0.0014880452,0.00019432964,0.012794242,0.0036624044,0.0000374225,0.73337847,0.012958447,0.004666757,0.02852073],"study_design_scores_gemma":[0.05717775,0.0033021686,0.27661726,0.00038649884,0.00022230271,0.000589463,0.004789671,0.0014757351,0.6363983,0.0023774884,0.016266841,0.00039651064],"about_ca_topic_score_codex":0.000013926235,"about_ca_topic_score_gemma":0.000009856197,"teacher_disagreement_score":0.18081786,"about_ca_system_score_codex":0.00015536572,"about_ca_system_score_gemma":0.0001585893,"threshold_uncertainty_score":0.4165226},"labels":[],"label_agreement":null},{"id":"W4387357326","doi":"10.3324/haematol.2023.283303","title":"Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Seagen","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Chemotherapy; Medicine; Stage (stratigraphy); Hodgkin lymphoma; Oncology; Internal medicine; Lymphoma; Pediatrics; Biology","score_opus":0.019321271487194744,"score_gpt":0.25608773366937543,"score_spread":0.23676646218218067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387357326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8889869,0.00043574753,0.0000050983363,0.1076416,0.000117537464,0.0021259915,0.000051417752,0.00019966881,0.0004360361],"genre_scores_gemma":[0.92929506,0.00090480293,0.00044327878,0.066099614,0.00023096197,0.00070794876,0.00028927892,0.00015631465,0.0018727395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667025,0.00013630693,0.00059303566,0.001151276,0.0006176053,0.0008315532],"domain_scores_gemma":[0.99878854,0.00014646514,0.00027948525,0.00057492545,0.00006016544,0.00015044004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013892312,0.00075560826,0.0017521456,0.000391944,0.000060202452,0.00006186725,0.00019569084,0.00090166327,0.00007013787],"category_scores_gemma":[0.000041903517,0.0004205865,0.00009731798,0.00056197646,0.0002513666,0.00006555157,0.000092596005,0.0006952087,0.00006355918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012857729,0.0028762226,0.7269962,0.0024122195,0.00033463613,0.15107505,0.0009459682,9.023137e-7,0.000003965162,0.000021695538,0.09169456,0.010780886],"study_design_scores_gemma":[0.07762616,0.00412899,0.8600975,0.01731816,0.0002512322,0.004582033,0.00055707345,0.00016173728,0.00022865992,0.000020437861,0.033874802,0.001153161],"about_ca_topic_score_codex":0.00077333354,"about_ca_topic_score_gemma":0.002459817,"teacher_disagreement_score":0.14649302,"about_ca_system_score_codex":0.00045214884,"about_ca_system_score_gemma":0.00032561805,"threshold_uncertainty_score":0.9998246},"labels":[],"label_agreement":null},{"id":"W4387519805","doi":"10.1002/jha2.796","title":"A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Hazard ratio; Concordance; Medicine; Internal medicine; Confidence interval; Follicular lymphoma; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Nuclear medicine","score_opus":0.0548538705679847,"score_gpt":0.3546498356595077,"score_spread":0.299795965091523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387519805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968914,0.0005191588,1.6428837e-7,0.0012820199,0.000114311806,0.0010681382,0.000069662885,0.0000068069326,0.000048361468],"genre_scores_gemma":[0.9996407,0.00009715752,0.00001793634,0.00006786286,0.000024767982,0.000054833974,0.0000114782515,0.000008114787,0.0000771589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882376,0.0003337407,0.00033577098,0.00015164865,0.00023671628,0.00011837575],"domain_scores_gemma":[0.9983239,0.001011984,0.00022206019,0.00035545108,0.000053724623,0.00003285857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007171082,0.0001077602,0.00040951298,0.000027450318,0.000080093465,0.00001226535,0.000096248645,0.00003764181,0.000021101781],"category_scores_gemma":[0.0004938257,0.00004150644,0.0000421377,0.00015323843,0.00013764719,0.000033798628,0.00008249403,0.000063983,0.0000028778713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055326736,0.0004769196,0.9846682,0.000027857332,0.0000684834,0.000002543199,0.0024624607,0.0000013933959,0.00074991724,0.000002899974,0.00413346,0.0018731941],"study_design_scores_gemma":[0.012166416,0.00082204706,0.9794482,0.00048958487,0.00018494346,0.0000014708035,0.00020998657,0.00017713515,0.0060153618,0.00000707164,0.00043187753,0.000045919547],"about_ca_topic_score_codex":0.00017143127,"about_ca_topic_score_gemma":0.00004933743,"teacher_disagreement_score":0.006633743,"about_ca_system_score_codex":0.000026310468,"about_ca_system_score_gemma":0.0000749761,"threshold_uncertainty_score":0.16925834},"labels":[],"label_agreement":null},{"id":"W4387665269","doi":"10.1038/s41375-023-02064-y","title":"Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Takeda Medical Research Foundation; Gilead Sciences; Roche; AstraZeneca; Miltenyi Biotec; Novartis; Deutsche Krebshilfe; Amgen; Pfizer; AbbVie; Staatssekretariat für Bildung, Forschung und Innovation; Merck","keywords":"Medicine; ABVD; Stage (stratigraphy); Internal medicine; Progression-free survival; Nuclear medicine; Hodgkin lymphoma; Hodgkin's lymphoma; Lymphoma; Randomized controlled trial; Overall survival; Oncology; Gastroenterology; Chemotherapy; Vincristine","score_opus":0.035273216745741055,"score_gpt":0.29185858039651585,"score_spread":0.2565853636507748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387665269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335825,0.000103844555,5.943542e-7,0.0002982966,0.00043515817,0.0011755164,0.000046953835,0.000044455002,0.004536924],"genre_scores_gemma":[0.98927736,0.00019590324,0.00006245359,0.00006268009,0.0000749594,0.0001958081,0.000027786145,0.000026480571,0.010076564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984051,0.000087113556,0.00052454777,0.00028406916,0.00038440988,0.00031473287],"domain_scores_gemma":[0.99884504,0.00018472433,0.00019359613,0.0006422695,0.00005095576,0.00008340049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020138125,0.00021077746,0.0005945409,0.00015419754,0.000044853787,0.000009200678,0.00014194133,0.00008732714,0.00007003772],"category_scores_gemma":[0.00010894462,0.00012933718,0.00033993146,0.0006207146,0.000075979224,0.000043734843,0.000069649795,0.000043084703,0.00006320878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030165007,0.0052753002,0.87154084,0.0005047103,0.0016262663,0.0017414654,0.008169248,0.00040545815,0.010625883,0.003725193,0.012901997,0.05331865],"study_design_scores_gemma":[0.25240177,0.0022336715,0.64666957,0.00031354805,0.0003195378,0.000022706387,0.00039706958,0.00036231277,0.08974765,0.00015902167,0.0071829697,0.00019015765],"about_ca_topic_score_codex":0.008508043,"about_ca_topic_score_gemma":0.00043676686,"teacher_disagreement_score":0.22487125,"about_ca_system_score_codex":0.0014401647,"about_ca_system_score_gemma":0.0008395747,"threshold_uncertainty_score":0.9980944},"labels":[],"label_agreement":null},{"id":"W4387750733","doi":"10.14309/01.ajg.0000958284.22632.2d","title":"S2161 Metastatic Pancreatic Marginal Zone Lymphoma: Case Report of a Rare Diagnosis","year":2023,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Marginal zone B-cell lymphoma; Endoscopic ultrasound; Lymphoma; Radiology; Splenic marginal zone lymphoma; Marginal zone; Pathology; Internal medicine; Splenectomy; B cell","score_opus":0.018717305816512233,"score_gpt":0.28599495612673265,"score_spread":0.26727765031022044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387750733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932684,0.00025161356,0.00013576119,0.005946362,0.0001357309,0.000193688,0.000020248173,0.000017013459,0.000031230957],"genre_scores_gemma":[0.9973692,0.00050337525,0.0012173138,0.00065567484,0.000108537846,0.00004473494,0.000008782517,0.000023600458,0.00006875602],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9979483,0.00031964554,0.00083800853,0.00017249213,0.0003346373,0.00038689858],"domain_scores_gemma":[0.99741375,0.0004194149,0.0013513692,0.0004082522,0.00021146583,0.00019574272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066010706,0.00019606578,0.001172879,0.00029689,0.0000643686,0.000008216287,0.00015983563,0.00001687014,0.00006575963],"category_scores_gemma":[0.00017135874,0.000116873554,0.00035587698,0.00041708545,0.0004983032,0.000051626466,0.0000712017,0.000106956686,0.000017322689],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00617479,0.0008467683,0.6642068,0.000045715635,0.0017377372,0.31336257,0.00035227052,0.000041894018,0.00009901252,0.000012570338,0.0033474113,0.009772457],"study_design_scores_gemma":[0.0045849336,0.016845351,0.34856716,0.00013788886,0.0016619312,0.62584156,0.0014762022,0.000066729415,0.0002756796,0.00004242142,0.00044210418,0.0000580546],"about_ca_topic_score_codex":0.00032045352,"about_ca_topic_score_gemma":0.000038797367,"teacher_disagreement_score":0.31563962,"about_ca_system_score_codex":0.000120014556,"about_ca_system_score_gemma":0.00012917005,"threshold_uncertainty_score":0.47659653},"labels":[],"label_agreement":null},{"id":"W4387846911","doi":"10.1016/j.pediatrneurol.2023.10.009","title":"Letter to the Editor: The Application of Interleukin-1 Antagonists in Patients With Megalencephalic Leukoencephalopathy With Subcortical Cysts: Caution Warranted","year":2023,"lang":"en","type":"letter","venue":"Pediatric Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Leukoencephalopathy; Medicine; Psychology; Neuroscience; Pediatrics; Pathology","score_opus":0.005908868018603716,"score_gpt":0.22055121209117148,"score_spread":0.21464234407256777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387846911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5409546,0.00007631114,0.00007688995,0.45547765,0.001345705,0.0019176247,0.00007193237,0.000055990393,0.000023273964],"genre_scores_gemma":[0.75045574,0.00006868406,0.000015949474,0.23616165,0.012079432,0.00082284823,0.00030436603,0.00006388261,0.000027481938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738204,0.00023982581,0.00052245334,0.0006828635,0.0006719753,0.00050081895],"domain_scores_gemma":[0.9982217,0.0004584028,0.00030851588,0.0007762881,0.00016759189,0.0000675203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001846281,0.00037577157,0.0005723487,0.00030079985,0.00008021774,0.000018098865,0.0003377734,0.0003745142,0.000008887155],"category_scores_gemma":[0.0000585047,0.00017834593,0.00009445433,0.00076668774,0.00019415286,0.0000423558,0.00009264176,0.001004191,0.000085629865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000798701,0.00023050072,0.5035404,0.000097277974,0.000055866058,0.00035196164,0.00018784782,0.000014607911,0.000002156805,0.000005144517,0.49433145,0.00038409524],"study_design_scores_gemma":[0.003031153,0.003617229,0.77312356,0.000031616906,0.00065841834,0.00007104978,0.00000767357,0.000044794833,0.000018807807,0.000008729979,0.21915455,0.00023240523],"about_ca_topic_score_codex":0.00042562862,"about_ca_topic_score_gemma":0.00019485579,"teacher_disagreement_score":0.27517688,"about_ca_system_score_codex":0.00014761393,"about_ca_system_score_gemma":0.00017562883,"threshold_uncertainty_score":0.7272736},"labels":[],"label_agreement":null},{"id":"W4387856171","doi":"10.20944/preprints202310.1317.v1","title":"Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Non-Hodgkin Lymphoma","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; CHOP; Internal medicine; Lymphoma; Chemotherapy; Oncology; Diffuse large B-cell lymphoma; Context (archaeology); Retrospective cohort study; Biology","score_opus":0.1103030112972399,"score_gpt":0.3781330748393544,"score_spread":0.26783006354211447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387856171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929344,0.00012219387,0.000004835871,0.0012563977,0.00071957114,0.0038747443,0.000090117224,0.00018152378,0.00081623474],"genre_scores_gemma":[0.99572605,0.00036915162,0.00009755314,0.00041343577,0.00015996248,0.0016336084,0.00008475654,0.00014047115,0.001374994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970383,0.00008732801,0.00070085184,0.0012634014,0.00047100367,0.0004391336],"domain_scores_gemma":[0.99704945,0.0008200774,0.00042318017,0.0013076136,0.00016226868,0.00023740882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059899234,0.0006653402,0.0016269432,0.0002728155,0.00007447848,0.00001732054,0.0002820809,0.0005349712,0.00008060808],"category_scores_gemma":[0.00047645255,0.00052787614,0.0005789377,0.000118332835,0.000047483663,0.00003918867,0.0005824174,0.00022758216,0.00032704766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020062819,0.0009393274,0.95511425,0.0014679487,0.0017626929,0.00004392647,0.00045850122,0.000011160221,0.025191061,0.000053472908,0.000096095064,0.012855298],"study_design_scores_gemma":[0.010087448,0.00074740703,0.70174223,0.0006397966,0.0003179294,0.0000090338735,0.000015961377,0.0000938542,0.2857609,0.000105363724,0.00020525661,0.00027484342],"about_ca_topic_score_codex":0.0001886283,"about_ca_topic_score_gemma":0.000010177544,"teacher_disagreement_score":0.26056984,"about_ca_system_score_codex":0.0003794439,"about_ca_system_score_gemma":0.00020648427,"threshold_uncertainty_score":0.9997173},"labels":[],"label_agreement":null},{"id":"W4387950790","doi":"10.1111/bjh.19153","title":"Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving <scp>bendamustine–rituximab</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Mantle cell lymphoma; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma","score_opus":0.043650211586456954,"score_gpt":0.33396383853634376,"score_spread":0.2903136269498868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957967,0.0026221778,0.0000020479251,0.0001494314,0.0003677147,0.00037615414,0.000016338414,0.000012101121,0.000657343],"genre_scores_gemma":[0.9973459,0.0020279386,0.00045380834,0.000066949135,0.00002273975,0.000011601037,0.000034542332,0.000018590705,0.00001792546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997273,0.00048136388,0.00119057,0.00023379372,0.0005185431,0.00030268982],"domain_scores_gemma":[0.99771947,0.00078963174,0.00058321684,0.000121874575,0.0005757776,0.00021003747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022182649,0.00013727741,0.0008993053,0.00043539674,0.000044123117,0.000020146123,0.000080213365,0.00019314009,0.000022490767],"category_scores_gemma":[0.0025659006,0.00013549055,0.00016381124,0.00035945594,0.00012729265,0.00009684646,0.000040271036,0.00011228369,0.000015837475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006226168,0.0020038295,0.79492885,0.00011500262,0.00033574074,0.007842464,0.00017193737,0.000009669348,0.000017708737,0.00000332001,0.0042504612,0.19025874],"study_design_scores_gemma":[0.029807262,0.00051440217,0.95627624,0.0009319169,0.00059897354,0.009759457,0.00031266842,0.00082902797,0.00068590697,0.00011469065,0.00011827714,0.000051160638],"about_ca_topic_score_codex":0.0011551839,"about_ca_topic_score_gemma":0.0006933743,"teacher_disagreement_score":0.19020759,"about_ca_system_score_codex":0.00016609694,"about_ca_system_score_gemma":0.00052094733,"threshold_uncertainty_score":0.55251443},"labels":[],"label_agreement":null},{"id":"W4387954600","doi":"10.1055/s-0041-1723315","title":"Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial","year":2021,"lang":"en","type":"article","venue":"Pneumologie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Nintedanib; Medicine; Placebo; Clinical trial; Internal medicine; Phenotype; Idiopathic pulmonary fibrosis; Pathology; Alternative medicine; Lung; Biology","score_opus":0.01914762384932684,"score_gpt":0.3187347174448566,"score_spread":0.29958709359552976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387954600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978322,0.0010601851,6.07518e-7,0.00015287072,0.00004854266,0.0008162774,0.00000512466,0.000005531189,0.00007865419],"genre_scores_gemma":[0.99961996,0.00002297683,0.00025617296,0.000029241011,0.000010521867,0.000042019605,0.000007487584,0.000006600568,0.000005007823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917036,0.00009814111,0.00022140743,0.00017133263,0.00023108858,0.00010765316],"domain_scores_gemma":[0.9992041,0.00023414863,0.00022703088,0.00019541245,0.00011408605,0.000025217938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055177017,0.000105966516,0.00036267456,0.000053293996,0.000015159965,0.0000029746234,0.000043405187,0.00005884247,0.0000056245476],"category_scores_gemma":[0.00031249612,0.000051827552,0.000061555125,0.00022380475,0.0001251001,0.000020067604,0.000059000115,0.00005775172,1.1238802e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011598579,0.0037205913,0.9543057,0.00034134986,0.00019863316,0.00004906142,0.0003590287,0.000006789446,0.011608168,0.000029127268,0.000010032287,0.017772948],"study_design_scores_gemma":[0.019057553,0.0033222665,0.64567804,0.0013351397,0.00016025826,0.0000014530445,0.000034204648,0.0000031598681,0.3303495,0.000020795365,0.0000022369793,0.000035359735],"about_ca_topic_score_codex":0.000023720188,"about_ca_topic_score_gemma":0.0000031898444,"teacher_disagreement_score":0.31874135,"about_ca_system_score_codex":0.000037006033,"about_ca_system_score_gemma":0.000089252775,"threshold_uncertainty_score":0.21134663},"labels":[],"label_agreement":null},{"id":"W4387959658","doi":"10.14740/jh1138","title":"When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Lymphoma; Pathology; Internal medicine","score_opus":0.011403410851258245,"score_gpt":0.26084817098239815,"score_spread":0.24944476013113992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387959658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940674,0.0041409484,0.00005723616,0.00027865372,0.00030253438,0.00074089324,0.0001109804,0.000027034273,0.0002743777],"genre_scores_gemma":[0.99921334,0.00037274326,0.000077190896,0.00009442003,0.000050105547,0.00008109436,0.00003923834,0.000036121874,0.000035759826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965013,0.0004772906,0.0014797599,0.00033237823,0.0006483848,0.0005608441],"domain_scores_gemma":[0.99625295,0.0014799818,0.0013215272,0.00036176,0.00043646622,0.0001473262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042674644,0.0003516456,0.0011648057,0.0007381114,0.00018804362,0.000029808782,0.00026439346,0.00018609734,0.000044092027],"category_scores_gemma":[0.00042430614,0.00023405369,0.000331934,0.0007641144,0.00018434561,0.00018205734,0.00011897139,0.000101485995,0.00002681862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024967333,0.055081,0.6267669,0.005065954,0.0056919525,0.04278591,0.11171534,0.0012629585,0.050888486,0.014884334,0.013402344,0.04748744],"study_design_scores_gemma":[0.06513566,0.012621895,0.72927713,0.0057990164,0.0015253964,0.013890122,0.040020432,0.0020350977,0.12707566,0.0017559454,0.0001989337,0.00066471484],"about_ca_topic_score_codex":0.00040539366,"about_ca_topic_score_gemma":0.00015751725,"teacher_disagreement_score":0.102510184,"about_ca_system_score_codex":0.0006562831,"about_ca_system_score_gemma":0.00056394335,"threshold_uncertainty_score":0.9544432},"labels":[],"label_agreement":null},{"id":"W4388141279","doi":"10.21873/anticanres.16677","title":"Exploring<i>TBL1XR1</i>and<i>NCOR1</i>Expression in B-cell Lymphoma Subtypes: Interaction With DNA Damage Repair Genes","year":2023,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"Alberta Cancer Foundation; Alberta Precision Laboratories","keywords":"Biology; Cancer research; Lymphoma; Follicular lymphoma; DNA damage; Germinal center; Diffuse large B-cell lymphoma; Gene; B cell; Genetics; Immunology; DNA; Antibody","score_opus":0.17279191438188843,"score_gpt":0.38233342130607745,"score_spread":0.20954150692418902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388141279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436235,0.0004918605,0.0000018079572,0.0011303378,0.000101711135,0.0005269274,0.0000045863576,0.0001585518,0.0032218602],"genre_scores_gemma":[0.9913203,0.006799021,0.00020211661,0.00008741647,0.00013549601,0.00052425225,0.000026378731,0.000039306677,0.0008657119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978395,0.00013575476,0.00022901931,0.00053516455,0.00068824517,0.0005723352],"domain_scores_gemma":[0.99882334,0.00034548223,0.000036324032,0.0004578388,0.00014576361,0.00019123046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063561334,0.00016699766,0.00028818537,0.0004929587,0.00015379975,0.000048212845,0.00009005464,0.000060245944,0.000059397433],"category_scores_gemma":[0.00007549281,0.00011964754,0.000060026163,0.0010444609,0.00015251296,0.00028371098,0.00015593856,0.00017268982,0.00024827057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002471555,0.001976001,0.9079577,0.00060127553,0.00011019028,0.0026517333,0.0022557622,0.000020325015,0.032842938,0.0001890787,0.005454494,0.043468982],"study_design_scores_gemma":[0.0068808557,0.0011378207,0.80025333,0.001096877,0.000040661802,0.000044880195,0.0022487699,0.00073849194,0.16501904,0.00004582854,0.022277668,0.00021575652],"about_ca_topic_score_codex":0.001217353,"about_ca_topic_score_gemma":0.000283323,"teacher_disagreement_score":0.1321761,"about_ca_system_score_codex":0.0003322556,"about_ca_system_score_gemma":0.00023507408,"threshold_uncertainty_score":0.4879085},"labels":[],"label_agreement":null},{"id":"W4388198364","doi":"10.14740/jh1169","title":"Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Oncology; Gemcitabine; Internal medicine; Chemotherapy; Meta-analysis; Lymphoma","score_opus":0.07517470672761221,"score_gpt":0.37052971228799286,"score_spread":0.29535500556038063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388198364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010073797,0.9958579,0.00006494086,0.0006410471,0.00024147709,0.0031360597,0.000022697455,0.000012221978,0.000013611932],"genre_scores_gemma":[0.00009120142,0.99696094,0.0016399726,0.00033936716,0.00012700698,0.00025768438,0.000052711897,0.00006759628,0.00046350373],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99525875,0.00036063785,0.0033653772,0.00033649214,0.00034446773,0.00033427405],"domain_scores_gemma":[0.99272144,0.002215179,0.0040824413,0.00051242905,0.00029254664,0.00017596692],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011655431,0.00056754955,0.023152746,0.00045053096,0.000043634835,0.000012710244,0.0002348947,0.00030377661,0.00006423437],"category_scores_gemma":[0.0003163131,0.00029714868,0.008343581,0.0006818768,0.000070868686,0.00003452164,0.00003745133,0.00017150232,0.0000079504925],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059882503,0.00056363014,0.000005322109,0.70695966,0.28628206,0.00020037727,0.00001695531,6.105157e-7,2.6126184e-8,0.00009895528,0.0037735424,0.0020389513],"study_design_scores_gemma":[0.0039326847,0.0003685032,0.0000060091475,0.089090124,0.8728973,0.0038781427,0.000005798963,0.000007113368,0.00000126058,0.000025069374,0.029602265,0.00018568886],"about_ca_topic_score_codex":0.0000044602193,"about_ca_topic_score_gemma":0.0000041493254,"teacher_disagreement_score":0.61786956,"about_ca_system_score_codex":0.00013009414,"about_ca_system_score_gemma":0.00034615202,"threshold_uncertainty_score":0.9999481},"labels":[],"label_agreement":null},{"id":"W4388456067","doi":"10.1038/s41467-023-41954-8","title":"Transcriptional reprogramming by mutated IRF4 in lymphoma","year":2023,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Medical Research Council; Canadian Institutes of Health Research; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; Natural Sciences and Engineering Research Council of Canada; Deutsche Krebshilfe; Wilhelm Sander-Stiftung; European Commission; Government of Canada; Kay Kendall Leukaemia Fund","keywords":"Reprogramming; IRF4; Lymphoma; Cancer research; Genetics; Transcription factor; Biology; Computational biology; Gene; Immunology","score_opus":0.027139132606472858,"score_gpt":0.3328859233356521,"score_spread":0.3057467907291792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388456067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9214504,0.021758635,0.000006407393,0.04408853,0.00016616967,0.0007677991,0.00009840819,0.00049945014,0.011164238],"genre_scores_gemma":[0.9938943,0.0017360834,0.0013356102,0.00060239306,0.0000168242,0.00024330911,0.0016423732,0.0000150908245,0.0005140161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921656,0.000054232638,0.00020017981,0.00018112239,0.00016810294,0.00017977848],"domain_scores_gemma":[0.9986847,0.00016807576,0.00003441604,0.0009754341,0.0000649522,0.00007241444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015769766,0.00009707489,0.00015990417,0.0001530188,0.00012184899,0.000017900946,0.00023795466,0.00018315835,0.000026558811],"category_scores_gemma":[0.00008996248,0.0000868703,0.00007947154,0.00084319536,0.00006790458,0.000051481533,0.000062692656,0.00022165489,0.000113455295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015822318,0.0058936737,0.55635834,0.000062653366,0.00039206241,0.00018292735,0.0019603276,0.000010720176,0.009861334,0.03191323,0.1283563,0.26485023],"study_design_scores_gemma":[0.002409064,0.00004732425,0.65937835,0.00006927518,0.000050945582,0.00003286587,0.00017920905,0.00048058957,0.0006404487,0.00016574329,0.3364488,0.00009741716],"about_ca_topic_score_codex":0.0001223985,"about_ca_topic_score_gemma":0.00028962496,"teacher_disagreement_score":0.26475284,"about_ca_system_score_codex":0.00020187364,"about_ca_system_score_gemma":0.00008082566,"threshold_uncertainty_score":0.35424682},"labels":[],"label_agreement":null},{"id":"W4388470240","doi":"10.1016/b978-0-443-15717-2.00005-6","title":"Hodgkin's Lymphoma","year":2023,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Alberta","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Pathology; Lymph; Groin; Hodgkin lymphoma; Dermatology; Internal medicine; Surgery","score_opus":0.024765529389659105,"score_gpt":0.25978229485099463,"score_spread":0.23501676546133554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388470240","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002020562,0.0012669044,1.5346961e-7,0.00033603056,0.000625543,0.00083624606,0.000067405155,0.0003301906,0.99633545],"genre_scores_gemma":[0.0015501996,0.00062145555,0.00013861379,0.0009949926,0.0007051614,0.00014119927,0.00015152172,0.00022044664,0.9954764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804807,0.0000111426725,0.00043530378,0.00061045715,0.00051923766,0.00037578572],"domain_scores_gemma":[0.99850166,0.00009459755,0.00018025511,0.0008328134,0.000101889964,0.00028877263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011371354,0.00055267627,0.00088615314,0.00022523236,0.00009114722,0.000035457637,0.00013605061,0.00045304533,0.0004894055],"category_scores_gemma":[0.00001917761,0.000448138,0.00056433014,0.000016587275,0.00011485515,0.000016758215,0.0001306815,0.00015277717,0.005954494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041822303,0.00004725011,0.000092719805,0.00012691585,0.00060559245,0.0017314281,0.00006384195,3.5489993e-8,0.0000043587606,0.010819119,0.0030426898,0.98342425],"study_design_scores_gemma":[0.0020791641,0.00027926988,0.0015846329,0.0011074675,0.0008544335,0.00018819774,0.0000044098247,0.0000012926499,0.0001021709,0.0051099905,0.9882989,0.0003900923],"about_ca_topic_score_codex":0.0000017487934,"about_ca_topic_score_gemma":0.00001367774,"teacher_disagreement_score":0.9852562,"about_ca_system_score_codex":0.0003801895,"about_ca_system_score_gemma":0.0003210151,"threshold_uncertainty_score":0.99979705},"labels":[],"label_agreement":null},{"id":"W4388517342","doi":"10.1055/s-0043-1765291","title":"Diagnostic Accuracy and Safety of Endoscopic Ultrasound-Guided End-Cutting Fine-Needle Biopsy (FNB) Needles For Tissue Sampling of Abdominal and Mediastinal Lymphadenopathies: A Prospective Multicentre Series","year":2023,"lang":"en","type":"article","venue":"Endoscopy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Endoscopic ultrasound; Radiology; Biopsy; Sampling (signal processing); Fine needle biopsy; Endoscopy; Prospective cohort study; Adverse effect; Surgery; Fine-needle aspiration; Internal medicine","score_opus":0.022669769185137193,"score_gpt":0.3121013214691662,"score_spread":0.289431552284029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388517342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445593,0.0025383432,0.00023597517,0.00028438104,0.0001847668,0.001775556,0.00030705016,0.000078930854,0.00013905983],"genre_scores_gemma":[0.9783288,0.0013457147,0.019601922,0.000022293269,0.00016387051,0.00032425715,0.00009930956,0.0000396363,0.00007415641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816144,0.000046883033,0.0006336653,0.00044793924,0.0002863714,0.00042372555],"domain_scores_gemma":[0.99262255,0.006465718,0.00032107378,0.00023776769,0.00017902267,0.0001738488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026575176,0.00031746746,0.0007373685,0.00021130717,0.00016943013,0.00002886386,0.000081871665,0.00009815995,0.00004724351],"category_scores_gemma":[0.0050598634,0.00026896977,0.0000843729,0.0003290289,0.00029378047,0.00016790151,0.00008544864,0.0000746184,0.000004470176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013337136,0.00045559864,0.86805654,0.0020703261,0.00041948856,0.00011731523,0.0121805165,0.00002068733,0.10412828,0.0007166253,0.00018119362,0.01031973],"study_design_scores_gemma":[0.012881589,0.0013661046,0.5525214,0.0018337568,0.000650768,0.00034654792,0.006563907,0.00012878762,0.42292866,0.0003514642,0.00017566983,0.00025133396],"about_ca_topic_score_codex":0.00028677908,"about_ca_topic_score_gemma":0.000022895485,"teacher_disagreement_score":0.3188004,"about_ca_system_score_codex":0.00009741892,"about_ca_system_score_gemma":0.00016685053,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W4388799903","doi":"10.14740/wjon1610","title":"Catch the Calcium: T-Cell Histiocyte-Rich B-Cell Lymphoma Presenting as Hypercalcemia","year":2023,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Hackensack Meridian Health","keywords":"Medicine; Vincristine; Prednisone; CHOP; Lymphoma; Rituximab; Cyclophosphamide; Malignancy; Gastroenterology; Internal medicine; Pathology; Chemotherapy","score_opus":0.033995741678832236,"score_gpt":0.32770453128513705,"score_spread":0.2937087896063048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388799903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88455814,0.001672389,0.000004694244,0.0137057975,0.0009291046,0.00023882106,0.0000024453595,0.0000338934,0.09885471],"genre_scores_gemma":[0.9706372,0.0005344456,0.0002813762,0.0014230829,0.0007309498,0.000021475695,0.0000064847222,0.00002940904,0.0263356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981457,0.00016366958,0.00063668017,0.00019816188,0.0004237421,0.00043202707],"domain_scores_gemma":[0.9980153,0.00077134615,0.0004480682,0.00028657058,0.00023709414,0.00024163611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006007546,0.0001918743,0.00055732066,0.00032080195,0.00017792893,0.00002636344,0.00023856593,0.00011222638,0.00026127018],"category_scores_gemma":[0.00012990976,0.00011711334,0.00027189104,0.00066134956,0.00011151264,0.0000630273,0.000107692416,0.00024395985,0.0006004164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010747204,0.0062299096,0.22486971,0.00016154243,0.00062310114,0.017839197,0.002056021,0.00016297167,0.00888339,0.00067035307,0.60561204,0.13181704],"study_design_scores_gemma":[0.014063001,0.0016116684,0.13322677,0.000084444655,0.0007900539,0.0033295176,0.00065239804,0.00014948171,0.014306862,0.00027150553,0.83132994,0.00018437073],"about_ca_topic_score_codex":0.00014960415,"about_ca_topic_score_gemma":0.00005504148,"teacher_disagreement_score":0.2257179,"about_ca_system_score_codex":0.0010119266,"about_ca_system_score_gemma":0.0010173551,"threshold_uncertainty_score":0.7717338},"labels":[],"label_agreement":null},{"id":"W4388826613","doi":"10.1097/pas.0000000000002156","title":"Extranodal NK/T-Cell Lymphoma Predominantly Composed of Anaplastic Cells","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Anaplastic lymphoma kinase; CD30; Anaplastic large-cell lymphoma; Pathology; Lymphoma; Large cell; T-cell lymphoma; Medicine; Biology; Internal medicine; Cancer; Adenocarcinoma","score_opus":0.012574889963202747,"score_gpt":0.2608988026701231,"score_spread":0.24832391270692036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388826613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725956,0.0003850937,0.000025740288,0.0012791351,0.00022175172,0.00012835342,0.000014804346,0.000015979052,0.0006695649],"genre_scores_gemma":[0.99802905,0.0012486111,0.00029508892,0.00013590047,0.00013328143,0.0000040427008,0.00000351775,0.00001790924,0.0001326215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834687,0.00027100556,0.00061042653,0.00015083537,0.000318002,0.00030285082],"domain_scores_gemma":[0.9978175,0.0009662078,0.0006540338,0.00025042953,0.00013748642,0.00017434236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004917144,0.0001613808,0.00091209053,0.00018264948,0.000051349223,0.000005852877,0.0001930552,0.00004288516,0.00005788448],"category_scores_gemma":[0.000030428393,0.00009001696,0.0003287301,0.00048548818,0.00073398574,0.000028480566,0.000050336817,0.000115797295,0.00006768924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040390566,0.014079937,0.09993036,0.0003819467,0.0016264638,0.14320166,0.004510681,0.0011312611,0.37518045,0.000974981,0.011635121,0.3069566],"study_design_scores_gemma":[0.049553018,0.037645828,0.72717285,0.00046448622,0.0017329442,0.03719249,0.0027159508,0.0006276243,0.12796603,0.0004985849,0.013875327,0.0005548372],"about_ca_topic_score_codex":0.00001752848,"about_ca_topic_score_gemma":7.9573874e-7,"teacher_disagreement_score":0.6272425,"about_ca_system_score_codex":0.000060362134,"about_ca_system_score_gemma":0.00014876349,"threshold_uncertainty_score":0.3670785},"labels":[],"label_agreement":null},{"id":"W4388916426","doi":"10.52768/2379-1039/2101","title":"Autologous stem cell transplant for relapsed peripheral T-cell lymphoma in a dialysis-dependent patient","year":2023,"lang":"en","type":"article","venue":"Open Journal of Clinical and Medical Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Lymphoma; Multiple myeloma; Autologous stem-cell transplantation; Oncology; Context (archaeology); Internal medicine; Stem cell; Hemodialysis; Dialysis; Chemotherapy; End stage renal disease; Stage (stratigraphy); Surgery; Biology","score_opus":0.047314808442598534,"score_gpt":0.3584169604453455,"score_spread":0.31110215200274693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388916426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462605,0.0008350572,0.000030684176,0.002158489,0.00074246613,0.0006875274,0.00001158269,0.000011666091,0.00089647726],"genre_scores_gemma":[0.99688476,0.0015377643,0.00022646115,0.0005159838,0.00019473798,0.000058027337,0.000014236006,0.000019081393,0.00054893957],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9957734,0.00019775584,0.0025960137,0.00037836132,0.0007273216,0.0003271499],"domain_scores_gemma":[0.9969232,0.0008977572,0.0007898833,0.00023674723,0.00014004117,0.0010123882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003393599,0.0001936543,0.0012430993,0.00011302972,0.0000767725,0.000044684268,0.00008601741,0.00027513254,0.000112462796],"category_scores_gemma":[0.00041672122,0.000121825506,0.0004373368,0.0001666047,0.000113621725,0.000091459646,0.00009218304,0.00024585918,0.000003715955],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014487782,0.0029215878,0.0732652,0.00010881047,0.00014122899,0.65771925,0.00046763915,0.000004441237,0.000014531707,0.0000064842866,0.0013598559,0.2625422],"study_design_scores_gemma":[0.08735208,0.0162028,0.12110872,0.0022040447,0.0023160607,0.7047905,0.0021073024,0.0012832195,0.0021487223,0.00045999073,0.059307933,0.0007186757],"about_ca_topic_score_codex":0.0001248435,"about_ca_topic_score_gemma":0.000085317646,"teacher_disagreement_score":0.2618235,"about_ca_system_score_codex":0.000072930416,"about_ca_system_score_gemma":0.0010402683,"threshold_uncertainty_score":0.49679},"labels":[],"label_agreement":null},{"id":"W4388924168","doi":"10.1101/2023.11.21.567983","title":"Revisiting Reddy: A DLBCL Do-over","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Exome sequencing; Biology; Genetics; Computational biology; Exome; Gene; Mutation","score_opus":0.024048819919108518,"score_gpt":0.25813947458287645,"score_spread":0.23409065466376794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388924168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952305,0.0037042082,0.00007795171,0.00177727,0.0016640639,0.0014766194,0.00032591211,0.001345175,0.000105719286],"genre_scores_gemma":[0.9922388,0.0012948813,0.003198514,0.00060466543,0.0017993157,0.0005317257,0.0000016418351,0.00027545265,0.00005496511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626267,0.00010007066,0.0007444996,0.0014333689,0.0006914163,0.00076797284],"domain_scores_gemma":[0.9964771,0.00014731377,0.00045692807,0.0019907253,0.00041190544,0.00051597157],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006230588,0.00074529334,0.0011040198,0.0003756945,0.00017678933,0.00026399715,0.00032896848,0.00065313344,0.00015994275],"category_scores_gemma":[0.00046354686,0.000705878,0.00044689918,0.00059385167,0.00009187413,0.000095481795,0.00067867886,0.00067812204,0.0008328814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030260233,0.0020139604,0.8060036,0.0052729887,0.0036218695,0.007395313,0.000056914774,0.000037829337,0.14965379,0.004005437,0.02153971,0.000096043084],"study_design_scores_gemma":[0.0032017971,0.000109741624,0.9263598,0.004484345,0.0009790449,1.1751304e-7,0.0000044014178,0.00016324609,0.04279183,0.0000047029043,0.02095692,0.0009440591],"about_ca_topic_score_codex":0.00015225237,"about_ca_topic_score_gemma":0.0000010522576,"teacher_disagreement_score":0.120356254,"about_ca_system_score_codex":0.0009073008,"about_ca_system_score_gemma":0.0008470452,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W4389047718","doi":"10.1038/s41375-023-02093-7","title":"Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Daiichi Sankyo Europe; Moonshot Research and Development Program; Kobayashi Foundation for Cancer Research; Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; SGH Foundation; SENSHIN Medical Research Foundation; University of Tsukuba; Yasuda Memorial Medical Foundation; Japan Agency for Medical Research and Development","keywords":"Biology; Immune system; CD8; Phenotype; Tumor microenvironment; Follicular lymphoma; T cell; Single-cell analysis; Cell; Immunology; Cancer research; Lymphoma; Gene; Genetics","score_opus":0.016589786416554578,"score_gpt":0.23540848384223204,"score_spread":0.21881869742567744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389047718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915095,0.0033844525,0.0000050049944,0.00022248605,0.00014796742,0.0003780192,0.000020294923,0.00016934199,0.0041629397],"genre_scores_gemma":[0.99723005,0.00025931402,0.00023715581,0.0003355842,0.000105928346,0.00006674236,0.00012765832,0.00003549201,0.0016020979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986966,0.000043228523,0.00023781235,0.000405715,0.00025020738,0.00036641708],"domain_scores_gemma":[0.99921614,0.00009052625,0.00009539382,0.00037704958,0.00004954885,0.00017136162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010327576,0.00022020367,0.00031830167,0.00009135427,0.00017846402,0.000027542686,0.000063285515,0.00009782911,0.000030781215],"category_scores_gemma":[0.000029370833,0.00018416444,0.00014743474,0.0002224596,0.00006569177,0.000055911223,0.00014176984,0.000044096338,0.00061488367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016354322,0.0033437884,0.27681226,0.001386364,0.00071171543,0.0066021136,0.0020353496,0.00032402345,0.64467365,0.00037571878,0.03239833,0.029701285],"study_design_scores_gemma":[0.009089284,0.0005115088,0.31546843,0.000104316336,0.00028577144,0.00014919793,0.00009430324,0.0007622234,0.6611367,0.000069086214,0.01207183,0.00025738293],"about_ca_topic_score_codex":0.00027895742,"about_ca_topic_score_gemma":0.00004521334,"teacher_disagreement_score":0.03865617,"about_ca_system_score_codex":0.0014834543,"about_ca_system_score_gemma":0.00014073859,"threshold_uncertainty_score":0.79032904},"labels":[],"label_agreement":null},{"id":"W4389084499","doi":"10.3390/curroncol30120738","title":"Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Chemotherapy; Context (archaeology); Oncology","score_opus":0.06621186883668831,"score_gpt":0.3907269848803933,"score_spread":0.324515116043705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389084499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959436,0.0007724716,0.0000022601541,0.0009215707,0.00077767565,0.0011273345,0.00005295261,0.00007201899,0.00033011538],"genre_scores_gemma":[0.9983335,0.0005622946,0.000017072052,0.0003177038,0.000098376615,0.00035577634,0.000059571736,0.000029342189,0.00022634908],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887145,0.00006114845,0.00026714697,0.00032080032,0.00015163973,0.00032782104],"domain_scores_gemma":[0.99865353,0.0008174414,0.000121304634,0.00021861694,0.00005702286,0.00013209342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019514117,0.00021455731,0.00069171574,0.00014725841,0.000054726817,0.0000056798526,0.000065556895,0.00013821921,0.00001548113],"category_scores_gemma":[0.000118955846,0.00015026292,0.00016933226,0.0001307273,0.000023289602,0.000024208688,0.00004209096,0.00005247329,0.00005821729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034908368,0.023921259,0.4685019,0.0010509699,0.00049303763,0.000069204245,0.0008183386,2.8488756e-7,0.017824499,0.00052698195,0.0070076897,0.476295],"study_design_scores_gemma":[0.18041135,0.0138802305,0.6762073,0.00015513739,0.00035681648,0.000017139242,0.000074738455,0.00036948262,0.06863268,0.00004695915,0.059584346,0.00026378618],"about_ca_topic_score_codex":0.0000033830336,"about_ca_topic_score_gemma":0.000004245318,"teacher_disagreement_score":0.4760312,"about_ca_system_score_codex":0.00020986127,"about_ca_system_score_gemma":0.00008587124,"threshold_uncertainty_score":0.61275434},"labels":[],"label_agreement":null},{"id":"W4389220387","doi":"10.1182/blood-2023-178097","title":"Long-Term Remissions after First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Mantle cell lymphoma; Internal medicine; Population; Oncology; Rituximab; Transplantation; Surgery; International Prognostic Index; Progression-free survival; Bendamustine; Hazard ratio; Cytarabine; Median follow-up; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.017305788770932248,"score_gpt":0.258110924069722,"score_spread":0.24080513529878977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963992,0.0007091519,0.00010556621,0.0005473895,0.00014938081,0.0007137874,0.00015494891,0.00018648691,0.0010340668],"genre_scores_gemma":[0.9934707,0.0009324365,0.0002955413,0.00013730701,0.00011913593,0.00046464964,0.0003499921,0.000035062887,0.004195123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901336,0.000014154625,0.00022516007,0.00029830486,0.00015607526,0.00029296387],"domain_scores_gemma":[0.99936813,0.00013255716,0.000055063305,0.00025327897,0.000040680905,0.00015030423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006036096,0.00016881626,0.00023635564,0.0000920519,0.00010111667,0.000016629328,0.000057093606,0.00011168711,0.000072961295],"category_scores_gemma":[0.0000036547067,0.00013263205,0.00015453309,0.00014962045,0.000018299823,0.00003688552,0.000015557565,0.000027916576,0.00024054166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001548033,0.014891182,0.9018154,0.0044050477,0.00037633104,0.008533951,0.002424269,0.00003428264,0.0068355473,0.000038292917,0.005652491,0.053445175],"study_design_scores_gemma":[0.017389055,0.00060581224,0.8259149,0.00022358084,0.0011140527,0.00015703535,0.000034421937,0.000060803995,0.1532124,0.000024389425,0.0010845171,0.00017901247],"about_ca_topic_score_codex":0.000011163705,"about_ca_topic_score_gemma":0.000027469745,"teacher_disagreement_score":0.14637685,"about_ca_system_score_codex":0.000048575253,"about_ca_system_score_gemma":0.00007013204,"threshold_uncertainty_score":0.5408578},"labels":[],"label_agreement":null},{"id":"W4389220730","doi":"10.1182/blood-2023-182019","title":"Favezelimab in Combination with Pembrolizumab in Patients with Heavily Pretreated Anti-PD-1-Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Refractory (planetary science); Oncology; Cohort; Salvage therapy; Neutropenia; Chemotherapy regimen; Chemotherapy; Gastroenterology; Cancer; Immunotherapy","score_opus":0.020525088306902833,"score_gpt":0.307566127537709,"score_spread":0.28704103923080615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758786,0.000022059317,0.0000010116859,0.00006188729,0.00001623738,0.0019906943,0.00009774795,0.00006948375,0.0001530061],"genre_scores_gemma":[0.9975154,0.000009453745,0.000082453385,0.00003314697,0.0000054369534,0.00020218026,0.002084634,0.000038997252,0.000028340271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977334,0.00020187063,0.0005225636,0.00060369575,0.0005927264,0.00034570612],"domain_scores_gemma":[0.9988132,0.00006772624,0.00021236908,0.0005554752,0.00019992332,0.00015131451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021053903,0.00029203517,0.0009611271,0.001103107,0.000050085182,0.000043459826,0.00018626326,0.00010039244,0.000025354097],"category_scores_gemma":[0.000030140533,0.00020675112,0.000037423404,0.0039795474,0.00006458934,0.0002738043,0.00008350074,0.00008825163,0.000007309444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038636895,0.19926758,0.790856,0.000016543325,0.0017320951,0.0005770857,0.0005229185,0.00002317357,0.00009545282,0.000010299221,0.000016564123,0.0030186162],"study_design_scores_gemma":[0.24154447,0.017208906,0.73649424,0.00008789177,0.0025597857,0.0000028363766,0.0002484131,0.0010572696,0.0006252323,0.0000018125187,0.000004581035,0.00016454252],"about_ca_topic_score_codex":0.0009771439,"about_ca_topic_score_gemma":0.0010511378,"teacher_disagreement_score":0.23768078,"about_ca_system_score_codex":0.00024289427,"about_ca_system_score_gemma":0.0002216908,"threshold_uncertainty_score":0.8431066},"labels":[],"label_agreement":null},{"id":"W4389221050","doi":"10.1182/blood-2023-184531","title":"Results from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; Ipilimumab; Internal medicine; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Gastroenterology; Clinical trial; CD30; Immunotherapy; Cancer","score_opus":0.02715352419553314,"score_gpt":0.3111144662650398,"score_spread":0.28396094206950667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513847,0.000080933736,2.2219876e-7,0.00018360573,0.00017579462,0.004081636,0.0002028964,0.00001692625,0.00011954832],"genre_scores_gemma":[0.99945253,0.00004443801,0.000016482507,0.000009275205,0.000027930884,0.00027994817,0.00009346957,0.000024832234,0.000051108575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633646,0.0012450226,0.0008972908,0.0004043328,0.0008712276,0.00024563665],"domain_scores_gemma":[0.99723786,0.0011504763,0.00045015058,0.0008558692,0.0002326007,0.00007303931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012562013,0.00019231389,0.000845967,0.00026494992,0.00014610963,0.0000124958,0.00026626687,0.00008652936,0.000007423792],"category_scores_gemma":[0.00079366216,0.00010371984,0.00014662769,0.0008371238,0.00039497798,0.00008815324,0.0003012203,0.00016490133,9.1250837e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6236203,0.26886147,0.08584488,0.000053637596,0.00095708086,0.000018586295,0.011119719,0.0000020771076,0.00032437642,0.000099736986,0.00016331661,0.00893483],"study_design_scores_gemma":[0.6578576,0.012538294,0.3268446,0.00027181886,0.00041488625,6.4972784e-7,0.0011454484,0.000053656342,0.0007288709,0.000074628195,0.000008996559,0.000060526905],"about_ca_topic_score_codex":0.0020089184,"about_ca_topic_score_gemma":0.0011151166,"teacher_disagreement_score":0.2563232,"about_ca_system_score_codex":0.000103110404,"about_ca_system_score_gemma":0.00018531246,"threshold_uncertainty_score":0.42295724},"labels":[],"label_agreement":null},{"id":"W4389221065","doi":"10.1182/blood-2023-184933","title":"PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Oncology; Internal medicine; Progression-free survival; Diffuse large B-cell lymphoma; CHOP; Positron emission tomography; Surrogate endpoint; Prospective cohort study; Chemotherapy regimen; Chemotherapy; Nuclear medicine; Lymphoma; CD30","score_opus":0.023539901021196817,"score_gpt":0.3126062720174304,"score_spread":0.2890663709962336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977954,0.00016790227,1.6236578e-7,0.0009608531,0.00010326041,0.00057757925,0.0000311907,0.000082489336,0.00028113625],"genre_scores_gemma":[0.99880254,0.00014192896,0.00004232332,0.00016342236,0.000041611143,0.00014714642,0.000046854584,0.000027886768,0.0005862873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998352,0.00013200886,0.0004314667,0.00035333142,0.00040756667,0.0003236218],"domain_scores_gemma":[0.99902815,0.00022807115,0.00008587355,0.00045929686,0.000037480964,0.00016115689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047827317,0.00019215274,0.00049265154,0.0004317107,0.000020148926,0.000013474999,0.00012932427,0.00014134847,0.00011512564],"category_scores_gemma":[0.00027163568,0.0001541436,0.00010590912,0.0003999408,0.00003165337,0.000085311345,0.00008318523,0.00012439089,0.00012425109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010192841,0.004788721,0.9874771,0.000069537615,0.00012416183,0.0032307385,0.0009171196,0.0000019570923,0.0012732644,0.00003141359,0.000045462733,0.0010211931],"study_design_scores_gemma":[0.0160975,0.0010623425,0.96697485,0.00022646418,0.0001237865,0.00006241313,0.00012358543,0.00000903232,0.015121128,0.000039490456,0.000037975322,0.00012143245],"about_ca_topic_score_codex":0.00040493772,"about_ca_topic_score_gemma":0.0006398622,"teacher_disagreement_score":0.0205023,"about_ca_system_score_codex":0.00014292396,"about_ca_system_score_gemma":0.00022356573,"threshold_uncertainty_score":0.6285794},"labels":[],"label_agreement":null},{"id":"W4389221098","doi":"10.1182/blood-2023-178623","title":"Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Roche (Canada)","funders":"","keywords":"Internal medicine; Oncology; Rituximab; Prednisone; Medicine; Diffuse large B-cell lymphoma; Vincristine; CHOP; Hazard ratio; Cyclophosphamide; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.04947849914337601,"score_gpt":0.3414480010660991,"score_spread":0.29196950192272314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778354,0.0007235075,1.6782903e-7,0.00024931954,0.000142411,0.00063358975,0.00000867639,0.000009689016,0.0004491077],"genre_scores_gemma":[0.999528,0.00023781019,0.00003280191,0.000036162226,0.00006913268,0.000051349412,0.0000043456644,0.000011935534,0.000028467162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987247,0.00010912385,0.0004778221,0.0001996302,0.00029374863,0.00019499368],"domain_scores_gemma":[0.9986112,0.0008014114,0.000096889155,0.0004259147,0.000025097374,0.000039451774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038259858,0.00012658177,0.00035319896,0.00007887243,0.000025081332,0.000007875317,0.00017902158,0.000055244902,0.00001800261],"category_scores_gemma":[0.000076944896,0.00006382736,0.00011094825,0.00036237066,0.000048717156,0.000013227861,0.000074606316,0.000117224474,0.000009964676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017573668,0.0060201283,0.9901835,0.000024023628,0.000117682626,0.0000934,0.0013937436,0.0000137758325,0.00023946702,0.000057592282,0.000021726191,0.0016592805],"study_design_scores_gemma":[0.013291527,0.0012837468,0.9820996,0.000043946966,0.00030820887,0.0000026979208,0.0015450025,0.000020349264,0.0012453151,0.000050263636,0.000055325163,0.00005402824],"about_ca_topic_score_codex":0.0008894132,"about_ca_topic_score_gemma":0.0013073405,"teacher_disagreement_score":0.01311579,"about_ca_system_score_codex":0.000028305474,"about_ca_system_score_gemma":0.000054329535,"threshold_uncertainty_score":0.26028043},"labels":[],"label_agreement":null},{"id":"W4389221945","doi":"10.1182/blood-2023-182942","title":"Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Rituximab; Mantle cell lymphoma; Medicine; Internal medicine; Progression-free survival; Maintenance therapy; Ibrutinib; Secondary hyperparathyroidism; Population; Oncology; Surgery; Chemotherapy; Lymphoma; Chronic lymphocytic leukemia; Leukemia","score_opus":0.020995166741289987,"score_gpt":0.2729382086107077,"score_spread":0.25194304186941774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632335,0.0014858808,9.0337744e-7,0.0005258329,0.00025008872,0.0010698291,0.00006913898,0.00012742238,0.0001475324],"genre_scores_gemma":[0.99817413,0.00024523106,0.00018136184,0.00020375133,0.00011592758,0.000112945934,0.00007557094,0.000053717464,0.00083735934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983527,0.00003658707,0.00047234792,0.0004474982,0.0003477958,0.00034306585],"domain_scores_gemma":[0.99901706,0.00018447191,0.00013071908,0.0004319848,0.00007172578,0.00016401948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015571492,0.00031734008,0.0006959874,0.00019298859,0.00011738075,0.000025421423,0.000087077184,0.00008715909,0.0000951209],"category_scores_gemma":[0.00004661547,0.00023450381,0.00019726629,0.0002889806,0.000035336998,0.00007933117,0.000115342096,0.00005874633,0.00004509223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021754701,0.03719722,0.9517386,0.00018025356,0.00071698125,0.001079271,0.0012388029,0.000002932135,0.0033975304,0.0000040295317,0.00030403605,0.0039228103],"study_design_scores_gemma":[0.12827286,0.0026374997,0.784932,0.00014547119,0.00074319565,0.000012534477,0.0007043926,0.000079579506,0.0813111,0.000006096887,0.00091695855,0.00023829595],"about_ca_topic_score_codex":0.00022255209,"about_ca_topic_score_gemma":0.00016026974,"teacher_disagreement_score":0.16680658,"about_ca_system_score_codex":0.00003875754,"about_ca_system_score_gemma":0.000044951594,"threshold_uncertainty_score":0.9562788},"labels":[],"label_agreement":null},{"id":"W4389222044","doi":"10.1182/blood-2023-174139","title":"Multi-Dimensional Molecular and Tumor-Microenvironment Analysis of Classic Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria; Princess Margaret Cancer Centre; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Biology; Neuroblastoma RAS viral oncogene homolog; Cancer research; Tumor microenvironment; CDKN2A; Lymphoma; ATRX; Comparative genomic hybridization; Gene expression profiling; Cancer; KRAS; Gene; Immunology; Mutation; Gene expression; Genetics; Chromosome","score_opus":0.012070556515798003,"score_gpt":0.24300556486920458,"score_spread":0.23093500835340658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984342,0.0009873882,0.0000060429647,0.00024310726,0.00001868316,0.0001612363,0.000034146284,0.00003280942,0.00008237104],"genre_scores_gemma":[0.9981373,0.00010802899,0.0012621572,0.00022017823,0.000009895481,0.00003097019,0.00008945711,0.000012900572,0.00012910011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913114,0.000023228673,0.0001952994,0.00025829687,0.00022329413,0.00016873101],"domain_scores_gemma":[0.99952155,0.000046592093,0.00006305483,0.00024316076,0.000016531772,0.00010912602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007184285,0.00012268445,0.00034680945,0.00024513598,0.000031062726,0.0000057748057,0.00003289013,0.000036790272,0.000056955192],"category_scores_gemma":[0.000016470152,0.00009888072,0.00016188175,0.00045788765,0.00006173027,0.000015321097,0.00006499332,0.00001917424,0.0000404963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005999585,0.00469218,0.82390904,0.00005893696,0.0068228156,0.001641036,0.00015118251,0.00013903553,0.15733439,0.00009432189,0.00030100538,0.004796073],"study_design_scores_gemma":[0.0061801025,0.00017121901,0.9028482,0.000032045085,0.0047113686,0.000035300625,0.000032056778,0.001105321,0.08454694,0.000006413308,0.00024860929,0.00008246091],"about_ca_topic_score_codex":0.00004885672,"about_ca_topic_score_gemma":0.0000062271106,"teacher_disagreement_score":0.07893914,"about_ca_system_score_codex":0.00003818998,"about_ca_system_score_gemma":0.000031958145,"threshold_uncertainty_score":0.40322387},"labels":[],"label_agreement":null},{"id":"W4389222186","doi":"10.1182/blood-2023-186810","title":"Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Biology; Epigenetics; Gene expression profiling; Genetics; Genotype; Copy number analysis; Genotyping; Cancer research; Copy-number variation; Gene; Oncology; Computational biology; Genome; Medicine; Gene expression","score_opus":0.03157524680023135,"score_gpt":0.313715626803719,"score_spread":0.2821403800034877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948748,0.0037888607,0.0004666765,0.0003175162,0.00002460246,0.00025241158,0.000033152133,0.000026203712,0.00021577171],"genre_scores_gemma":[0.98884827,0.00048690516,0.010482504,0.0000366492,0.000011800135,0.000024260793,0.00008381121,0.0000109551165,0.0000148694535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992671,0.00009032358,0.00021326324,0.00019985304,0.000119603246,0.00010985819],"domain_scores_gemma":[0.999479,0.00020547844,0.00008430621,0.00014009404,0.000053690725,0.000037407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001360454,0.000111024354,0.0003051996,0.000059240865,0.000030215473,0.0000065744607,0.000032187865,0.0000756766,0.00002253986],"category_scores_gemma":[0.000060021448,0.00008630457,0.00005901119,0.00013405933,0.00014124806,0.000027071235,0.000020588517,0.000022269152,0.0000028465217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017868205,0.0012758202,0.1115221,0.00023598295,0.00041944406,0.00013191822,0.00034204934,0.0000068087884,0.8696896,0.0017339922,0.000015475765,0.014448168],"study_design_scores_gemma":[0.0037573448,0.00045726838,0.44635907,0.000046824796,0.00035489912,0.000028001297,0.0000354983,0.000017046916,0.54847085,0.00028331575,0.00014229117,0.00004761973],"about_ca_topic_score_codex":0.000046653677,"about_ca_topic_score_gemma":0.0000013099458,"teacher_disagreement_score":0.33483696,"about_ca_system_score_codex":0.000018680621,"about_ca_system_score_gemma":0.000065307635,"threshold_uncertainty_score":0.35193983},"labels":[],"label_agreement":null},{"id":"W4389229884","doi":"10.1182/blood-2023-183021","title":"Prognosis of Progressive Follicular Lymphoma within 24 Months of First-Line Therapy Is Not Influenced By the Initial Regimen Intensity","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Jazz Pharmaceuticals; BeiGene; Seagen; Gilead Sciences; AstraZeneca","keywords":"Rituximab; Medicine; Follicular lymphoma; Bendamustine; Internal medicine; Progression-free survival; Regimen; Oncology; Vincristine; Prednisone; Chemoimmunotherapy; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.029280450191425174,"score_gpt":0.2885598334666918,"score_spread":0.2592793832752666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937624,0.0013999263,6.5407244e-7,0.003271335,0.00007619177,0.001199694,0.000088683206,0.00006554418,0.00013558229],"genre_scores_gemma":[0.9983106,0.00040631052,0.0001252769,0.0005864631,0.00006281729,0.00036475007,0.000049279184,0.000024551018,0.00006989774],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856764,0.000041786054,0.00042549134,0.00028573303,0.00045006868,0.000229253],"domain_scores_gemma":[0.99874073,0.00012438392,0.00030625385,0.00045107264,0.00029383798,0.00008370793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001830759,0.00020354397,0.00048581552,0.000074620235,0.00008074924,0.000011991172,0.00015196837,0.00010743659,0.000027022197],"category_scores_gemma":[0.000112348156,0.000119796474,0.00019855428,0.0004363868,0.00019376482,0.00005017891,0.00007674053,0.00005446602,0.00001250769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025996983,0.01306777,0.91557175,0.00032638316,0.0047573755,0.0006337891,0.010666344,0.0000097579705,0.014961926,0.00013420964,0.012170368,0.025100628],"study_design_scores_gemma":[0.012256712,0.0015619898,0.14790322,0.00030349224,0.0004799851,0.0000485898,0.0003062713,0.00008813655,0.8361856,0.00006672843,0.0006777823,0.00012150357],"about_ca_topic_score_codex":0.00033059792,"about_ca_topic_score_gemma":0.000009658471,"teacher_disagreement_score":0.8212237,"about_ca_system_score_codex":0.0000320125,"about_ca_system_score_gemma":0.00011346888,"threshold_uncertainty_score":0.48851585},"labels":[],"label_agreement":null},{"id":"W4389230555","doi":"10.1182/blood-2023-189296","title":"Mixture Model to Predict the Cumulative Incidence of Relapses in Follicular Lymphoma : Need for Longer Follow-up or Alternative Outcomes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Concordia University; Health Sciences Centre; McGill University","funders":"","keywords":"Follicular lymphoma; Medicine; Rituximab; Cumulative incidence; Internal medicine; Lymphoma; Lenalidomide; Proportional hazards model; Oncology; Follicular phase; Cohort; Multiple myeloma","score_opus":0.0364898041094287,"score_gpt":0.3124659496955246,"score_spread":0.2759761455860959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955735,0.0001783312,0.00015263537,0.0020255845,0.000121198755,0.0016248462,0.00011067141,0.000049380007,0.00016384093],"genre_scores_gemma":[0.99588805,0.00006107304,0.0009105583,0.0005136047,0.000046469904,0.0007261886,0.000030073452,0.000026802927,0.001797152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871886,0.000035728917,0.00032696954,0.00030039568,0.00034679438,0.00027122468],"domain_scores_gemma":[0.99874926,0.000568185,0.00010168688,0.00035568257,0.00013032363,0.00009485597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020065838,0.00019656686,0.00044859014,0.00015498535,0.000055981072,0.000011510115,0.00015505179,0.00008042707,0.000009232208],"category_scores_gemma":[0.0006073326,0.00010534262,0.00019950242,0.0004716361,0.000040213123,0.00006767619,0.00009132097,0.000040656283,0.000015040829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022797831,0.0036325203,0.9513253,0.0002257094,0.0024492508,0.0006587968,0.019376075,0.005088149,0.0012799988,0.0017279165,0.00616211,0.0057943696],"study_design_scores_gemma":[0.046409886,0.0018122179,0.87633204,0.0007796643,0.0014120957,0.000038581547,0.0016876637,0.024526527,0.044058442,0.0021107912,0.00045859066,0.00037346882],"about_ca_topic_score_codex":0.00025448768,"about_ca_topic_score_gemma":0.00022585104,"teacher_disagreement_score":0.07499325,"about_ca_system_score_codex":0.000088648274,"about_ca_system_score_gemma":0.00016957698,"threshold_uncertainty_score":0.42957473},"labels":[],"label_agreement":null},{"id":"W4389231298","doi":"10.1182/blood-2023-178658","title":"A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Refractory (planetary science); Clinical trial; Oncology; Pediatrics; Internal medicine; Environmental health","score_opus":0.023666609501856208,"score_gpt":0.2794719716501671,"score_spread":0.25580536214831084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975686,0.0010660243,6.192786e-7,0.00008538829,0.00007438074,0.000750189,0.00003011921,0.000033609584,0.00039106945],"genre_scores_gemma":[0.9989183,0.00070837804,0.00007901224,0.00008988311,0.000049192477,0.000052562908,0.00001274249,0.000015303676,0.00007461154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880993,0.000033336848,0.00030564095,0.0003492351,0.0002684393,0.00023338734],"domain_scores_gemma":[0.9994294,0.00005759934,0.00009448828,0.0002416606,0.000031678297,0.00014516698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015175335,0.00017192528,0.00035714512,0.00015089176,0.00003344125,0.000011742488,0.000050385454,0.00008286161,0.000004530563],"category_scores_gemma":[0.000038703784,0.0001440968,0.000042983782,0.00051512814,0.000029924178,0.00003802921,0.00011732366,0.000040050876,0.00000900719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013589657,0.025626065,0.9668638,0.00015559376,0.000099509445,0.0004367927,0.00054994324,0.0000018311175,0.00026469753,0.0000033648494,0.0007441669,0.005118331],"study_design_scores_gemma":[0.053260863,0.0012777928,0.94371235,0.000110399684,0.00035527337,0.000030497,0.0006454862,0.00008297641,0.00025394495,0.0000046175837,0.00015664355,0.00010913383],"about_ca_topic_score_codex":0.0002416237,"about_ca_topic_score_gemma":0.00008698258,"teacher_disagreement_score":0.053124968,"about_ca_system_score_codex":0.00009186155,"about_ca_system_score_gemma":0.00007834037,"threshold_uncertainty_score":0.5876097},"labels":[],"label_agreement":null},{"id":"W4389231435","doi":"10.1182/blood-2023-173247","title":"Favorable Outcomes of Splenic Marginal Zone Lymphoma in an International Study of 934 Patients with Long Follow-up","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Cumulative incidence; Internal medicine; Population; Splenic marginal zone lymphoma; Splenectomy; Pediatrics; Lymphoma; Cohort","score_opus":0.016339767721603404,"score_gpt":0.27110303631320976,"score_spread":0.25476326859160636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991005,0.000022430704,8.131791e-7,0.000037908772,0.00009336201,0.0004619934,0.000027152326,0.000021266414,0.00023456929],"genre_scores_gemma":[0.99951994,0.000014260941,0.000069652924,0.000014779439,0.000013312798,0.00005168496,0.00009122511,0.00001425759,0.00021090839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895984,0.000024965602,0.00026822704,0.00019464036,0.00040837034,0.00014395996],"domain_scores_gemma":[0.99944586,0.00004351118,0.00010481718,0.00024482733,0.000106007654,0.000055007207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008111373,0.00011214424,0.00033095691,0.00019849336,0.000015372874,0.000006010223,0.000092595015,0.000029441368,0.000043516327],"category_scores_gemma":[0.00001939824,0.000079834965,0.000047760663,0.00026023964,0.00002045823,0.00008839947,0.000035513596,0.000022195776,0.000010336071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002882902,0.018566953,0.97763264,0.000026422316,0.00048560198,0.00012794256,0.0006278839,0.0000063983057,0.000020661651,0.000024800778,0.000014265798,0.0021781544],"study_design_scores_gemma":[0.045381244,0.0023408444,0.95067865,0.00007867749,0.00025357012,0.0000030148506,0.00042278648,0.000014984102,0.0007461744,0.000005369215,0.000009388441,0.00006528602],"about_ca_topic_score_codex":0.0004714762,"about_ca_topic_score_gemma":0.000643676,"teacher_disagreement_score":0.045092955,"about_ca_system_score_codex":0.000046701196,"about_ca_system_score_gemma":0.000058401878,"threshold_uncertainty_score":0.32555753},"labels":[],"label_agreement":null},{"id":"W4389232111","doi":"10.1182/blood-2023-182906","title":"Evaluation of a Prognostic 23-Gene Expression Panel in a Set of 390 Multiethnic Hodgkin Lymphoma Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lymphoma; Epidemiology; Diffuse large B-cell lymphoma; Nodular sclerosis; Pathology; Hodgkin lymphoma","score_opus":0.07360362703588208,"score_gpt":0.3180780086692459,"score_spread":0.24447438163336382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983514,0.00039324243,6.8642214e-7,0.000033987013,0.000057066478,0.0009776378,0.000044076543,0.000025506666,0.000116413394],"genre_scores_gemma":[0.99910355,0.000075020725,0.00022760945,0.000010944061,0.000021872564,0.00027327734,0.0002559253,0.000014515061,0.000017268614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842876,0.00012717507,0.00034546657,0.00020822296,0.000727327,0.00016302512],"domain_scores_gemma":[0.9991676,0.00012420453,0.00014713447,0.00024637041,0.00025981263,0.000054872864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048396143,0.00011105895,0.00027523155,0.00018077999,0.0000144339565,0.0000023459058,0.000050221344,0.00007410502,0.000018901237],"category_scores_gemma":[0.0005210322,0.000087356275,0.00007408127,0.0003789547,0.000024628198,0.000034141605,0.00004546999,0.000021847,0.000021768134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000803059,0.0045396523,0.93999934,0.00012547054,0.00010454173,0.000020940306,0.0010137515,0.000029845882,0.018003844,0.0000016532744,0.0001029894,0.035977647],"study_design_scores_gemma":[0.019070392,0.00047944556,0.7941792,0.000424198,0.0005081768,0.0000029016628,0.00011485607,0.00045491324,0.18466383,0.000039503055,0.0000057873235,0.00005678525],"about_ca_topic_score_codex":0.00008805225,"about_ca_topic_score_gemma":0.00001898883,"teacher_disagreement_score":0.16665998,"about_ca_system_score_codex":0.00007862272,"about_ca_system_score_gemma":0.00017076444,"threshold_uncertainty_score":0.35622856},"labels":[],"label_agreement":null},{"id":"W4389232200","doi":"10.1182/blood-2023-190983","title":"Management and Outcomes for Primary Mediastinal B-Cell Lymphoma Patients with Partial Metabolic Response","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Single Center; Stage (stratigraphy); Refractory (planetary science); Lymphoma; Internal medicine; Retrospective cohort study; Chemotherapy; Medical record; Cancer; Population; Surgery; Gastroenterology","score_opus":0.009196977561909209,"score_gpt":0.23401155205805632,"score_spread":0.2248145744961471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784803,0.0002575422,0.000006333091,0.0004269324,0.000065085944,0.00086592877,0.000046764235,0.00008316917,0.0004001857],"genre_scores_gemma":[0.9961173,0.00009605717,0.001828717,0.00032495605,0.0000441108,0.0004594391,0.00011336491,0.00002580777,0.0009902744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905026,0.000026998161,0.0001536585,0.0002594278,0.00025765382,0.00025201673],"domain_scores_gemma":[0.9994111,0.00017324842,0.000048563186,0.00019742835,0.000038608396,0.00013101677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013369613,0.00015207744,0.0002748676,0.000108664004,0.00007072734,0.000017042257,0.000039506962,0.00003282832,0.000007788855],"category_scores_gemma":[0.000027062351,0.000099855766,0.00006225311,0.00013736406,0.00003386211,0.000036823436,0.00005288313,0.000015055889,0.000031588203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019061138,0.0035161588,0.9775901,0.00011553959,0.0004563328,0.00021551189,0.000116648174,3.1533432e-7,0.000023586103,0.00008677627,0.00053110253,0.0154418135],"study_design_scores_gemma":[0.041967154,0.0007143644,0.9453333,0.000035634148,0.0010808904,0.000007272058,0.0000363047,0.0000040023783,0.0015957981,0.000012400182,0.009107,0.00010586588],"about_ca_topic_score_codex":0.0000055142664,"about_ca_topic_score_gemma":0.0000011482914,"teacher_disagreement_score":0.04006104,"about_ca_system_score_codex":0.000024639628,"about_ca_system_score_gemma":0.000044680222,"threshold_uncertainty_score":0.4072},"labels":[],"label_agreement":null},{"id":"W4389232244","doi":"10.1182/blood-2023-180518","title":"Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Follicular lymphoma; Biology; Cytotoxic T cell; Follicular phase; Tumor microenvironment; CD8; Immunology; Mass cytometry; Cancer research; Lymphoma; Immune system; In vitro; Phenotype; Genetics; Gene","score_opus":0.020512897902196812,"score_gpt":0.23826838035942524,"score_spread":0.21775548245722842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239296,0.0004813341,0.00011518873,0.0003150492,0.0003829154,0.00032724836,0.000045606448,0.000221093,0.005718633],"genre_scores_gemma":[0.99632305,0.00016681384,0.00015410954,0.00015942188,0.00045344746,0.00010394307,0.0008820551,0.000032553355,0.0017245836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878067,0.00002548219,0.00023182732,0.0003268125,0.00034445064,0.00029076732],"domain_scores_gemma":[0.99940234,0.00012585962,0.00007128654,0.00022222991,0.00006625913,0.000112000154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000518103,0.00019495784,0.00024604262,0.00007678687,0.00013594085,0.00003535499,0.000048246864,0.000073439194,0.00030744856],"category_scores_gemma":[0.00006529258,0.00015601287,0.00014144927,0.00040138458,0.000040161092,0.00007484378,0.00003834387,0.00002637226,0.0012643464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020242829,0.0058096326,0.9589903,0.00022001915,0.0006309547,0.0018573073,0.00052410905,0.000046995425,0.0030628128,0.0011822183,0.024109412,0.0033638394],"study_design_scores_gemma":[0.012009245,0.00027350785,0.95054215,0.000077820725,0.000831507,0.00011833038,0.00006589896,0.00017711287,0.022161698,0.00030574706,0.013237333,0.00019962016],"about_ca_topic_score_codex":0.000075706615,"about_ca_topic_score_gemma":0.000022387709,"teacher_disagreement_score":0.019098885,"about_ca_system_score_codex":0.00007281378,"about_ca_system_score_gemma":0.00009934125,"threshold_uncertainty_score":0.99951327},"labels":[],"label_agreement":null},{"id":"W4389234009","doi":"10.1182/blood-2023-186530","title":"Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; DNA methylation; Epigenetics; Cancer research; RHOA; Molecular biology; Genetics; Gene; Signal transduction; Gene expression","score_opus":0.009178195687767161,"score_gpt":0.23238213633178698,"score_spread":0.22320394064401983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430364,0.0037641223,0.000008758102,0.00018271068,0.000042110478,0.0003330442,0.00004324535,0.00007363801,0.0012487354],"genre_scores_gemma":[0.99718696,0.0006662135,0.00022027461,0.00008268128,0.000026748736,0.00013537733,0.00008911375,0.000018838691,0.0015738083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885166,0.00006548003,0.00030048055,0.0003443925,0.00013283592,0.00030518183],"domain_scores_gemma":[0.9994024,0.0001755218,0.000046931204,0.0002481526,0.000033727545,0.000093260816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018576506,0.00019650834,0.0005508052,0.00047798041,0.000061662286,0.000028749719,0.000057021516,0.00007124979,0.00007725891],"category_scores_gemma":[0.000039234237,0.00015075953,0.00018683814,0.00090781134,0.00006345281,0.000060356662,0.000026207454,0.000052646592,0.000067382025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011678824,0.0024465455,0.9631288,0.0001396715,0.0017364797,0.0002833619,0.0036591054,0.000057934732,0.026578601,0.00017853577,0.00036133573,0.0013128484],"study_design_scores_gemma":[0.009505483,0.0003109132,0.9716693,0.00007145894,0.00236977,0.000019317991,0.0011572456,0.00032597687,0.013937573,0.00025826026,0.000207841,0.0001668254],"about_ca_topic_score_codex":0.0004904545,"about_ca_topic_score_gemma":0.00019391283,"teacher_disagreement_score":0.012641029,"about_ca_system_score_codex":0.00012030998,"about_ca_system_score_gemma":0.00008121632,"threshold_uncertainty_score":0.6147795},"labels":[],"label_agreement":null},{"id":"W4389234861","doi":"10.1182/blood-2023-175079","title":"Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Clinical trial; Internal medicine; Oncology; Stage (stratigraphy); Lymphoma; Medical physics; Diffuse large B-cell lymphoma","score_opus":0.029666469429999193,"score_gpt":0.3083927011317674,"score_spread":0.27872623170176825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98657817,0.00040198956,0.0016546508,0.00054294633,0.00037635455,0.0014916195,0.008839926,0.00007988621,0.00003445475],"genre_scores_gemma":[0.99362063,0.000111294794,0.00030731136,0.000080550555,0.00024376529,0.0010767232,0.0044657364,0.000029233677,0.00006477799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976949,0.00012896354,0.00065909605,0.00051115593,0.00078937,0.00021652383],"domain_scores_gemma":[0.9968172,0.0015475837,0.0005090142,0.0005963152,0.000464131,0.00006577746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035632803,0.00023959567,0.00040400145,0.00018322798,0.00020281422,0.00013366994,0.0005367113,0.000081427694,0.000049506052],"category_scores_gemma":[0.0011072798,0.00015051717,0.00028964342,0.0005492584,0.00010724982,0.000111425885,0.00018106936,0.000089119276,0.000014373847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027301535,0.0013732117,0.9744462,0.000007726366,0.0075373244,0.00002002414,0.008691281,0.0023210119,0.000103301034,0.00019442591,0.00014396568,0.00488856],"study_design_scores_gemma":[0.008748454,0.00012301166,0.95175725,0.000029867866,0.008485482,0.0000011726294,0.015454359,0.01308321,0.0014304053,0.0006531184,0.00009486968,0.00013878396],"about_ca_topic_score_codex":0.0013537556,"about_ca_topic_score_gemma":0.0027948578,"teacher_disagreement_score":0.022688886,"about_ca_system_score_codex":0.00011559254,"about_ca_system_score_gemma":0.00019273291,"threshold_uncertainty_score":0.61379117},"labels":[],"label_agreement":null},{"id":"W4389234876","doi":"10.1182/blood-2023-180107","title":"Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Oncology; Clinical endpoint; Chemotherapy regimen; Progression-free survival; Nivolumab; Randomized controlled trial; Chemotherapy; Cancer; Lymphoma; Hodgkin lymphoma; Immunotherapy","score_opus":0.015254296584439435,"score_gpt":0.277822775644979,"score_spread":0.26256847906053954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534154,0.00059369794,0.000003259663,0.0008184123,0.0001322529,0.0012810878,0.00023357433,0.00016456148,0.0014316046],"genre_scores_gemma":[0.9976018,0.00039497472,0.0010504453,0.00008169691,0.00012099614,0.0001972685,0.0001220288,0.000051718063,0.00037905335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719965,0.00010646136,0.00062507135,0.0007189358,0.0007808893,0.0005689871],"domain_scores_gemma":[0.99816716,0.0003216035,0.00025076838,0.0007731524,0.00013646473,0.00035083108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035510564,0.0003599216,0.00079658587,0.00039310526,0.000089275825,0.000032072367,0.00021923502,0.00012296179,0.000017438202],"category_scores_gemma":[0.00034239743,0.00027884846,0.00009006563,0.0012255135,0.00008845857,0.00010522585,0.00025349995,0.00009968318,0.000046843412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005055043,0.00884899,0.9608594,0.00048639224,0.0002348744,0.0012930367,0.0010757193,0.00004245042,0.002524982,0.00010010633,0.0014154966,0.018063493],"study_design_scores_gemma":[0.07209186,0.0027272834,0.90584314,0.00048525404,0.00032460492,0.000043902735,0.00041089498,0.00011081122,0.017111551,0.000036651705,0.000483565,0.0003304621],"about_ca_topic_score_codex":0.0003733764,"about_ca_topic_score_gemma":0.0008550507,"teacher_disagreement_score":0.067036815,"about_ca_system_score_codex":0.00013599143,"about_ca_system_score_gemma":0.00032305662,"threshold_uncertainty_score":0.9999664},"labels":[],"label_agreement":null},{"id":"W4389234885","doi":"10.1182/blood-2023-180114","title":"Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Neutropenia; Progression-free survival; Regimen; Chemotherapy regimen; Phases of clinical research; Surrogate endpoint; Oncology; Surgery; Clinical trial; Chemotherapy","score_opus":0.009811042039027357,"score_gpt":0.25776014205619513,"score_spread":0.24794910001716777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668866,0.00008538471,7.933218e-7,0.00077142654,0.000117129646,0.0017744692,0.00011169996,0.00015088687,0.00029956902],"genre_scores_gemma":[0.997386,0.00003024784,0.0005309282,0.0007782045,0.000052860072,0.00042827232,0.00016668058,0.00006241748,0.000564398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783844,0.00009723829,0.00035634986,0.00063246285,0.0005821856,0.0004933038],"domain_scores_gemma":[0.99885446,0.00011491546,0.00011044485,0.0005713359,0.000092053975,0.00025676348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015532374,0.00033494504,0.00060507463,0.00024954413,0.000088124434,0.00005847151,0.0001361828,0.00010861955,0.000060873743],"category_scores_gemma":[0.000071693656,0.0002502302,0.00006557109,0.0005392281,0.000044004915,0.000076609744,0.00013806923,0.00009164489,0.000077950375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018889926,0.0062936875,0.94578767,0.00011141198,0.0003419426,0.0012666441,0.0018893577,0.000008562624,0.0023311167,0.0000046046016,0.0025568197,0.037519213],"study_design_scores_gemma":[0.063637964,0.0019197385,0.923796,0.0004849442,0.000111649184,0.000003984592,0.0002059817,0.00004718616,0.0091142915,0.0000060153097,0.00040201927,0.00027019644],"about_ca_topic_score_codex":0.00015363753,"about_ca_topic_score_gemma":0.00017559048,"teacher_disagreement_score":0.061748974,"about_ca_system_score_codex":0.000107758286,"about_ca_system_score_gemma":0.00008562521,"threshold_uncertainty_score":0.999995},"labels":[],"label_agreement":null},{"id":"W4389235331","doi":"10.1182/blood-2023-190409","title":"<i>Hnrnpu</i> mutations Are Haploinsufficient and Alter the Transcriptome of MYC-Driven Lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"","keywords":"Biology; Cancer research; Molecular biology; Exome sequencing; Transcriptome; Lymphoma; Gene expression profiling; Gene; Genetics; Mutation; Gene expression; Immunology","score_opus":0.017293452637522185,"score_gpt":0.2510827985554384,"score_spread":0.23378934591791622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947166,0.0007124332,0.000003863067,0.0029765684,0.00006480481,0.00031281408,0.00005755642,0.00006279983,0.0010925564],"genre_scores_gemma":[0.99892956,0.0002231943,0.0000776422,0.0003688225,0.000040686646,0.00007757438,0.000029476814,0.000013622203,0.00023940037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993262,0.0000204463,0.00016944858,0.00016420514,0.00016343482,0.0001562136],"domain_scores_gemma":[0.9995278,0.00008397786,0.00005319901,0.00021602467,0.000046596193,0.00007236273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006372186,0.00009854441,0.00018684652,0.000069460344,0.0000834177,0.000011717793,0.00004882139,0.00003501462,0.000027320819],"category_scores_gemma":[0.000020724026,0.000060293587,0.00008543243,0.00025413494,0.000087930304,0.000024130486,0.000021059666,0.00003060993,0.00004504828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001143239,0.008872832,0.9249525,0.0004099908,0.0014377905,0.0007135482,0.009835649,0.0000868379,0.03552271,0.0045053074,0.007045894,0.0065026097],"study_design_scores_gemma":[0.008621756,0.00040368488,0.95464605,0.000144802,0.00089549815,0.00014467599,0.0010332653,0.00021604753,0.029997773,0.00014615219,0.003635656,0.00011461597],"about_ca_topic_score_codex":0.000046808374,"about_ca_topic_score_gemma":0.000014625844,"teacher_disagreement_score":0.029693568,"about_ca_system_score_codex":0.000016687723,"about_ca_system_score_gemma":0.000045480127,"threshold_uncertainty_score":0.24587011},"labels":[],"label_agreement":null},{"id":"W4389235359","doi":"10.1182/blood-2023-179375","title":"Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Health Sciences Centre; McMaster University; Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Ibrutinib; Medicine; Rituximab; Internal medicine; Transplantation; Oncology; Autologous stem-cell transplantation; Chemotherapy regimen; Diffuse large B-cell lymphoma; Surgery; Chemotherapy; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.011184035330873247,"score_gpt":0.23683911131216084,"score_spread":0.2256550759812876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954491,0.00019750379,0.000003360896,0.0016633554,0.00006256839,0.0014291821,0.00001581423,0.000085324325,0.001093756],"genre_scores_gemma":[0.99833703,0.00033315513,0.00020572623,0.00030636878,0.00004527857,0.00022414555,0.00002669443,0.000023476096,0.0004981386],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910223,0.000047127272,0.00018595438,0.00026096407,0.00017517639,0.00022854812],"domain_scores_gemma":[0.99951786,0.00014375728,0.000046574834,0.00019290247,0.000018910669,0.000080011756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014150496,0.00014686816,0.00028537688,0.00008285152,0.00006912531,0.000022643135,0.000058463134,0.00007097669,0.000011531941],"category_scores_gemma":[0.0000031150814,0.00008848664,0.000039181235,0.00031729526,0.000027955663,0.000026173939,0.000011432579,0.000042978845,0.00005417599],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27834556,0.08501907,0.2501197,0.0018174438,0.0010200882,0.008630513,0.040838595,0.0000248428,0.017272562,0.00039587702,0.005415366,0.3111004],"study_design_scores_gemma":[0.56217265,0.005549348,0.31720594,0.00013287221,0.00042995394,0.0001296706,0.0005302412,0.000040486255,0.112340935,0.000019215866,0.0012319593,0.00021675612],"about_ca_topic_score_codex":0.00007400438,"about_ca_topic_score_gemma":0.0000621385,"teacher_disagreement_score":0.31088364,"about_ca_system_score_codex":0.000041689218,"about_ca_system_score_gemma":0.00008091537,"threshold_uncertainty_score":0.36083803},"labels":[],"label_agreement":null},{"id":"W4389236480","doi":"10.3324/haematol.2021.280275","title":"Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Vincristine; Oncology; CHOP; Peripheral T-cell lymphoma; Medicine; Prednisone; Lymphoma; Internal medicine; T cell; Immunology; Cancer research; CD30; Chemotherapy; Cyclophosphamide; Immune system","score_opus":0.05974935561026039,"score_gpt":0.2606493981969898,"score_spread":0.2009000425867294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389236480","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04247128,0.0099050775,0.0000014556979,0.93491954,0.0004444653,0.0013922509,0.000037477395,0.00023520617,0.0105932355],"genre_scores_gemma":[0.39684954,0.005323311,0.0010654632,0.5534596,0.024006333,0.0029924302,0.0017602576,0.0003912691,0.014151814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977201,0.00013822316,0.0003975448,0.0007760061,0.0003832224,0.0005848528],"domain_scores_gemma":[0.9990489,0.00017677026,0.0001435133,0.00050375663,0.000026511025,0.00010055928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009784088,0.00053137646,0.0011068684,0.00017465229,0.00007947098,0.000060666396,0.00015054992,0.0010223321,0.00017737164],"category_scores_gemma":[0.0000040923132,0.00034666035,0.00022003376,0.00020441443,0.00014134712,0.00003533981,0.00012366282,0.00058144,0.00011325296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012538752,0.0006624236,0.047524128,0.0011233923,0.00028539624,0.02145248,0.0004967676,0.0000010897361,0.000005672017,0.00013485349,0.9164239,0.011764485],"study_design_scores_gemma":[0.003336282,0.00040517646,0.05854479,0.0001802732,0.00028815056,0.0014871884,0.00029209306,0.000065727676,0.00009906912,0.00029267865,0.93457675,0.0004318392],"about_ca_topic_score_codex":0.000077131386,"about_ca_topic_score_gemma":0.0000069623206,"teacher_disagreement_score":0.38145998,"about_ca_system_score_codex":0.00019859377,"about_ca_system_score_gemma":0.00010203579,"threshold_uncertainty_score":0.99989855},"labels":[],"label_agreement":null},{"id":"W4389242340","doi":"10.1053/j.seminhematol.2023.11.006","title":"Biological heterogeneity in diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Michael Smith Health Research BC","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; Precision medicine; Computational biology; Oncology; Medicine; Bioinformatics; Immunology; Genetics","score_opus":0.02726806348528607,"score_gpt":0.3029398652008562,"score_spread":0.27567180171557015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955719,0.0019037082,0.000001372973,0.00068538805,0.00015013757,0.00031812003,0.000012117394,0.00009641811,0.0012608292],"genre_scores_gemma":[0.99764687,0.0013818418,0.00015002354,0.0004041178,0.000019631681,0.00017638711,0.000073818315,0.000015022179,0.00013231653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985124,0.00009237891,0.0003427488,0.00040078952,0.00010724361,0.00054444757],"domain_scores_gemma":[0.99925125,0.00027909988,0.00004910686,0.00030557203,0.0000141282335,0.0001008636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023186389,0.00017568858,0.0005347377,0.00027903382,0.000029325463,0.000004688129,0.00009424923,0.00025385706,0.00004253279],"category_scores_gemma":[0.00012016079,0.00013753693,0.00009588382,0.0004992124,0.00007086175,0.000022691895,0.00012763373,0.000077360055,0.00040622623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106235704,0.0071933116,0.98186904,0.000055854445,0.000014909683,0.0055464664,0.0002282697,5.659646e-7,0.00024853682,0.0011078444,0.0014711813,0.0021577766],"study_design_scores_gemma":[0.03433281,0.00056763954,0.93038833,0.00030604922,0.000026997432,0.0010830137,0.00044194094,0.00038358432,0.02569455,0.0007947284,0.0057011056,0.0002792336],"about_ca_topic_score_codex":0.000050268136,"about_ca_topic_score_gemma":0.00014551863,"teacher_disagreement_score":0.0514807,"about_ca_system_score_codex":0.00016813242,"about_ca_system_score_gemma":0.00004927005,"threshold_uncertainty_score":0.5608593},"labels":[],"label_agreement":null},{"id":"W4389243209","doi":"10.1182/blood-2023-186969","title":"Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Biology; Gene expression profiling; Cancer research; Subtyping; Fluorescence in situ hybridization; Lymphoma; Genetics; Gene; Gene expression; Immunology","score_opus":0.016163835044492196,"score_gpt":0.2848491811892356,"score_spread":0.2686853461447434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998183,0.0003836908,0.000038529597,0.000012858285,0.000055373803,0.0006669813,0.000074437135,0.00011014355,0.00047497236],"genre_scores_gemma":[0.99704283,0.000022279199,0.0023510177,0.000019339075,0.000094617884,0.000098727316,0.00020728812,0.000031149342,0.00013272585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873376,0.000094324285,0.00025790636,0.00037567155,0.00020146862,0.00033686293],"domain_scores_gemma":[0.9992043,0.00012297096,0.000120680976,0.00036280125,0.00005931352,0.00012994044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023960478,0.00018350569,0.0003973403,0.00012498436,0.00011874017,0.000013683802,0.00008400828,0.00004375939,0.000027065342],"category_scores_gemma":[0.000049258044,0.00011906439,0.000051135634,0.00029038958,0.00002243556,0.000069700436,0.00007914881,0.000045235254,0.000026680615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023331505,0.010037701,0.9223138,0.00009729748,0.00016669252,0.00025383697,0.00042068414,0.000016921469,0.06604756,0.00004463897,0.000029811394,0.0003377402],"study_design_scores_gemma":[0.030708369,0.004481868,0.5107274,0.00021752942,0.0006786429,0.000030413908,0.00045900137,0.00020435962,0.45213893,0.00008868471,0.00005441309,0.00021036132],"about_ca_topic_score_codex":0.000083314495,"about_ca_topic_score_gemma":0.000025466587,"teacher_disagreement_score":0.41158637,"about_ca_system_score_codex":0.00002875862,"about_ca_system_score_gemma":0.00009675615,"threshold_uncertainty_score":0.48553047},"labels":[],"label_agreement":null},{"id":"W4389243549","doi":"10.1182/blood-2023-180926","title":"Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Refractory (planetary science); Antibody; Radioimmunotherapy; Lymphoma; Classical Hodgkin lymphoma; Monoclonal antibody; Internal medicine; Cancer research; Oncology; Immunology; Biology; Hodgkin lymphoma","score_opus":0.014312390929512147,"score_gpt":0.2590484232701427,"score_spread":0.24473603234063057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996506,0.00094878295,0.0000014579516,0.0001894227,0.000037352085,0.0019450588,0.0000767661,0.0001737354,0.00012142835],"genre_scores_gemma":[0.99414,0.004729475,0.00029696428,0.00006156674,0.000051460127,0.000051912873,0.00047446296,0.000106160485,0.00008796836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997125,0.00019732545,0.0006406439,0.00094722846,0.00049056025,0.0005992338],"domain_scores_gemma":[0.9981717,0.00032809237,0.0002904126,0.0007293235,0.00013857012,0.00034189573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024019672,0.0005573837,0.0012099079,0.00043257177,0.0001413305,0.000047205074,0.0001373052,0.00025189223,0.000026189678],"category_scores_gemma":[0.00005438785,0.00034182778,0.00007923296,0.0009394002,0.00038014003,0.00024953941,0.00007882939,0.00015341242,0.000008313735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111922445,0.013903148,0.95520824,0.00014772628,0.00053431257,0.0008009811,0.00067483645,0.000005772129,0.0012186798,0.000014051162,0.00007374531,0.016226232],"study_design_scores_gemma":[0.07848544,0.014986376,0.9013875,0.00086800184,0.00049377204,0.00012881168,0.00013156045,0.000051925155,0.0027640217,0.0000015538628,0.00031296143,0.0003880653],"about_ca_topic_score_codex":0.00016265333,"about_ca_topic_score_gemma":0.000033508357,"teacher_disagreement_score":0.06729319,"about_ca_system_score_codex":0.000094281364,"about_ca_system_score_gemma":0.00025325792,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W4389244392","doi":"10.3324/haematol.2023.282719","title":"Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Computational biology; Characterization (materials science); Lymphoma; Peripheral T-cell lymphoma; Medicine; Computer science; Biology; Pathology; Immunology; T cell; Materials science; Nanotechnology; Immune system","score_opus":0.016698499312848013,"score_gpt":0.26887717057554317,"score_spread":0.25217867126269516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68534416,0.017670397,0.0012760856,0.29005495,0.0002875285,0.0039307727,0.000022583894,0.00025945826,0.0011541011],"genre_scores_gemma":[0.685762,0.30051437,0.0034405496,0.0039743977,0.00023484166,0.0032964442,0.0014467968,0.000034389293,0.0012962084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999072,0.00006619021,0.00026417707,0.0003153475,0.000131707,0.00015059169],"domain_scores_gemma":[0.9995276,0.000014706706,0.000084251216,0.00026096648,0.000056318164,0.000056184912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115848685,0.00013961531,0.00027163763,0.000069589,0.000082905484,0.000020077807,0.000038189053,0.00004024946,0.000085420405],"category_scores_gemma":[0.000055339584,0.00008235031,0.00003698719,0.00046586728,0.000025265559,0.00009306078,0.000022284828,0.000016991695,0.00005086674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016741827,0.0076370295,0.10627835,0.00469082,0.00035702184,0.0012841218,0.0041974997,0.0063570966,0.021150805,0.01324093,0.02562273,0.8075094],"study_design_scores_gemma":[0.0042587607,0.0018660338,0.19904001,0.0009407931,0.00028110063,0.00039536593,0.00061393296,0.0033075784,0.0059608286,0.000039241047,0.7829285,0.0003678123],"about_ca_topic_score_codex":0.0000076114457,"about_ca_topic_score_gemma":0.000009621545,"teacher_disagreement_score":0.8071416,"about_ca_system_score_codex":0.00018971837,"about_ca_system_score_gemma":0.000032430733,"threshold_uncertainty_score":0.3358148},"labels":[],"label_agreement":null},{"id":"W4389244542","doi":"10.3324/haematol.2023.282716","title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Biology; T cell; CD8; NODAL; Epigenetics; Anaplastic lymphoma kinase; Cell of origin; Cancer research; Immunology; Pathology; Medicine; Cell; Genetics; Immune system; Gene","score_opus":0.13516869267368736,"score_gpt":0.36153845979951,"score_spread":0.22636976712582263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002680004,0.99614066,0.0000055246724,0.00010597113,0.000679528,0.00081196416,0.00010465111,0.00012336604,0.0017603191],"genre_scores_gemma":[0.0006064884,0.99845946,0.00012752431,0.000014882791,0.00021467257,0.00024639166,0.0001896024,0.0000374402,0.000103541825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837196,0.00013544108,0.0005735921,0.00048640466,0.00013516164,0.0002974432],"domain_scores_gemma":[0.99893624,0.00025236752,0.0003365576,0.00030744425,0.00003466408,0.00013271207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010680536,0.00040657714,0.0023798407,0.00018517682,0.00011884241,0.000014693079,0.00008361873,0.00040243057,0.00011365628],"category_scores_gemma":[0.000030475418,0.00024883624,0.0004925944,0.0003067821,0.00015109224,0.000019157067,0.0001032167,0.00017424248,0.000042964537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029480594,0.0008421775,0.0009447041,0.03948841,0.00053993176,0.0007258767,0.00021110252,2.4365178e-8,4.2142807e-7,0.0075606974,0.0016041754,0.948053],"study_design_scores_gemma":[0.00079887087,0.00028871515,0.0001465522,0.0059273336,0.0016549914,0.0015372228,0.00020799453,0.0000014541752,0.0000017189687,0.00019772981,0.98901486,0.00022255487],"about_ca_topic_score_codex":0.000012950469,"about_ca_topic_score_gemma":0.000007593218,"teacher_disagreement_score":0.98741066,"about_ca_system_score_codex":0.00036738897,"about_ca_system_score_gemma":0.00023012827,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W4389246769","doi":"10.1182/blood-2023-182128","title":"Favezelimab in Combination with Pembrolizumab in Patients with Anti-PD-1-Naive Relapsed or Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; CancerCare Manitoba; Jewish General Hospital","funders":"Genentech; Swedish Orphan Biovitrum; Astellas Pharma; Incyte; BeiGene; Regeneron Pharmaceuticals; Adaptive Biotechnologies; Karyopharm Therapeutics; Gilead Sciences; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Takeda Oncology; Amgen","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Cohort; Phases of clinical research; Chemotherapy regimen; Cancer; Chemotherapy; Immunotherapy","score_opus":0.025602268471923734,"score_gpt":0.31626125814749706,"score_spread":0.29065898967557335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977523,0.000014494318,0.0000012251965,0.00008053046,0.000021418831,0.0018554223,0.00007865398,0.00005489515,0.00014102533],"genre_scores_gemma":[0.9980905,0.000012368705,0.00015436043,0.000045035697,0.000006791618,0.00020333217,0.0013949837,0.00003757584,0.000055055792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977658,0.00020835847,0.00052832736,0.0005875459,0.00059062015,0.00031934367],"domain_scores_gemma":[0.99876213,0.0001071631,0.00024510844,0.00055403664,0.00019253326,0.00013901664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024417954,0.0002695327,0.00093832845,0.0010092634,0.000052478088,0.000037454032,0.00019198665,0.000101201214,0.000036734375],"category_scores_gemma":[0.000059527058,0.00017548612,0.000034993496,0.0036231317,0.00006613813,0.00026861735,0.00009199686,0.00009593315,0.000008337213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008834432,0.19377378,0.7900093,0.000018298462,0.001757091,0.0011099554,0.0008669735,0.000015790356,0.00006638616,0.000017035203,0.00003463654,0.0034963093],"study_design_scores_gemma":[0.26747712,0.021501005,0.70674396,0.00008978804,0.0024038646,0.0000034413213,0.00051266706,0.000773301,0.00032926953,0.0000024642259,0.0000086010305,0.00015451008],"about_ca_topic_score_codex":0.0005741203,"about_ca_topic_score_gemma":0.0011405858,"teacher_disagreement_score":0.2586427,"about_ca_system_score_codex":0.00025204377,"about_ca_system_score_gemma":0.0002974655,"threshold_uncertainty_score":0.71561164},"labels":[],"label_agreement":null},{"id":"W4389246922","doi":"10.1182/blood-2023-182449","title":"Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Immune thrombocytopenia; Medicine; Quality of life (healthcare); Pediatrics; Family medicine; Nursing; Immunology","score_opus":0.038612421930202194,"score_gpt":0.3072146374003306,"score_spread":0.2686022154701284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517685,0.0011940704,2.5154142e-7,0.0009624667,0.00005070699,0.0005250948,0.00002199158,0.000020763207,0.0020477965],"genre_scores_gemma":[0.999207,0.0004437822,0.000058768306,0.00011090144,0.000032568445,0.00001444312,0.000018136023,0.000010353931,0.00010404514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.0000891861,0.0005208686,0.00016153842,0.00028300018,0.00015735268],"domain_scores_gemma":[0.9990467,0.00017686583,0.00017029303,0.00050818047,0.00005084899,0.00004715599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041421686,0.00009770689,0.00055765297,0.000053825923,0.00002847861,0.0000056911567,0.00012089883,0.00006268446,0.00006711977],"category_scores_gemma":[0.0005634269,0.00005998762,0.00017980511,0.00040151464,0.000045685272,0.000044198798,0.00013151219,0.00006670402,0.00003427659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006606504,0.0041700257,0.9796463,0.00031439602,0.00025327076,0.000023374861,0.00091303734,0.0000026316732,0.007107748,0.0016405648,0.00050802104,0.0053545525],"study_design_scores_gemma":[0.006579877,0.00015462707,0.9487467,0.00035652984,0.00010293538,0.0000036893036,0.00018401377,0.0000010442672,0.04351753,0.00007654418,0.00022274759,0.000053773423],"about_ca_topic_score_codex":0.0003831789,"about_ca_topic_score_gemma":0.00001584834,"teacher_disagreement_score":0.03640978,"about_ca_system_score_codex":0.000024563667,"about_ca_system_score_gemma":0.00014007076,"threshold_uncertainty_score":0.24462241},"labels":[],"label_agreement":null},{"id":"W4389246942","doi":"10.1182/blood-2023-182119","title":"Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Chemotherapy regimen; Neutropenia; Chemotherapy; Phases of clinical research; Immunotherapy; Cancer; Biology","score_opus":0.03583989734029489,"score_gpt":0.32327395640727447,"score_spread":0.28743405906697955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938389,0.00019417722,6.1478187e-7,0.00021163144,0.000113273614,0.0052200803,0.00004194637,0.00009292646,0.00028645043],"genre_scores_gemma":[0.9981541,0.0006868978,0.00012451169,0.00021597948,0.000035183464,0.0004310794,0.00012480604,0.00007987158,0.00014757036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99733144,0.00021410856,0.00071683334,0.0006542721,0.00061347784,0.0004698902],"domain_scores_gemma":[0.9981724,0.000495278,0.00027362467,0.0006262689,0.00016674111,0.00026566026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004275113,0.00042650514,0.001471777,0.00038452365,0.00010302179,0.000054508495,0.00023534441,0.00016895236,0.00005946269],"category_scores_gemma":[0.00016643255,0.00026482632,0.000068379406,0.00081389165,0.0001123733,0.00021067579,0.0001447325,0.00012668237,0.000020845471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7756444,0.10390031,0.08091195,0.000048933805,0.0018840869,0.00043674125,0.0027431834,0.0000014881376,0.0004728026,0.000011501866,0.00036099175,0.033583585],"study_design_scores_gemma":[0.70428103,0.027797628,0.26546046,0.00014925127,0.00033434897,0.000006853674,0.00028817696,0.000037298734,0.0009402441,0.0000027539622,0.00047025707,0.00023167806],"about_ca_topic_score_codex":0.0002694063,"about_ca_topic_score_gemma":0.000064721666,"teacher_disagreement_score":0.18454851,"about_ca_system_score_codex":0.00018978848,"about_ca_system_score_gemma":0.00029614838,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W4389247375","doi":"10.1182/blood-2023-172972","title":"CD79 Expression Is Associated with Cell-of-Origin and Outcome in Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Rituximab; Oncology; Cohort; Lymphoma; Immunohistochemistry; Pathology","score_opus":0.017784000998983536,"score_gpt":0.26151111943951993,"score_spread":0.2437271184405364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997948,0.0003684092,5.586431e-7,0.00014083253,0.00002940915,0.00024547696,0.000044747427,0.00005735981,0.001165208],"genre_scores_gemma":[0.99847525,0.00015410816,0.000072764706,0.00014101402,0.00001626438,0.000040813367,0.000047330555,0.000020954505,0.0010315111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990841,0.000026153344,0.00020918617,0.00022521341,0.00021166002,0.00024369234],"domain_scores_gemma":[0.9994901,0.000105495725,0.000083221596,0.00019975875,0.00002602415,0.00009542196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103967934,0.00013799584,0.00032221747,0.000115683804,0.000033766762,0.000009080493,0.000040112463,0.00008369119,0.000020900536],"category_scores_gemma":[0.000027161332,0.00009451612,0.00004676456,0.00027238394,0.000020164653,0.000035136338,0.00004580131,0.000036897705,0.000028959917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044302873,0.014523646,0.9802083,0.00007138223,0.000046578258,0.00046139065,0.00056150556,1.1100999e-7,0.0033352075,0.000009513534,0.0005525472,0.0001855514],"study_design_scores_gemma":[0.079578966,0.0003564487,0.81612587,0.00024991334,0.0002125082,0.00000917477,0.00016661009,0.00003111957,0.102620125,0.000012711934,0.0005141682,0.00012240784],"about_ca_topic_score_codex":0.000068466026,"about_ca_topic_score_gemma":0.000018580815,"teacher_disagreement_score":0.16408242,"about_ca_system_score_codex":0.0000448917,"about_ca_system_score_gemma":0.00004545808,"threshold_uncertainty_score":0.38542557},"labels":[],"label_agreement":null},{"id":"W4389247633","doi":"10.1182/blood-2023-173320","title":"Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Stage (stratigraphy); International Prognostic Index; Cohort; Clinical trial; Oncology; Lymphoma; Diffuse large B-cell lymphoma","score_opus":0.04584341434878424,"score_gpt":0.3080739144749554,"score_spread":0.26223050012617116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958799,0.00008480657,0.000056672387,0.000847903,0.00053898833,0.0018917973,0.00038408616,0.000059675236,0.00025620055],"genre_scores_gemma":[0.9966648,0.000017387409,0.0007847205,0.00009566839,0.00021706142,0.0008322474,0.0011957188,0.000025000407,0.00016740238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979905,0.00006705753,0.00057477294,0.00041733653,0.0007615695,0.00018876536],"domain_scores_gemma":[0.9984655,0.0003656817,0.00037170245,0.00038637713,0.0003437208,0.0000670464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000382158,0.00019742954,0.00023772687,0.00011039822,0.00017543185,0.00009456718,0.00028685623,0.00008281772,0.00001939695],"category_scores_gemma":[0.0006402457,0.00012776596,0.0000915671,0.00021604457,0.0000814608,0.00008462769,0.0002441566,0.000042046016,0.000007865726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013256808,0.0016020732,0.97123575,0.0000216353,0.0010466982,0.00007326668,0.006821393,0.0000042913875,0.00010655849,0.0001678144,0.00023819221,0.018549778],"study_design_scores_gemma":[0.009442604,0.00014431293,0.9680547,0.00010298428,0.00055382546,0.000051531344,0.0042619673,0.00006095692,0.013874607,0.000058680856,0.0032690554,0.00012475961],"about_ca_topic_score_codex":0.00039121855,"about_ca_topic_score_gemma":0.00011489962,"teacher_disagreement_score":0.018425018,"about_ca_system_score_codex":0.00015370065,"about_ca_system_score_gemma":0.000378047,"threshold_uncertainty_score":0.52101445},"labels":[],"label_agreement":null},{"id":"W4389247977","doi":"10.1182/blood-2023-180088","title":"Real-World Response Rates across Lines of Therapy Among Patients with Relapsed/Refractory Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Obinutuzumab; Medicine; Bendamustine; Rituximab; Internal medicine; Follicular lymphoma; Chemoimmunotherapy; Oncology; Salvage therapy; Vincristine; Chlorambucil; Lenalidomide; Maintenance therapy; Surgery; Lymphoma; Cyclophosphamide; Chemotherapy; Multiple myeloma","score_opus":0.014775043117736685,"score_gpt":0.2817246509657994,"score_spread":0.2669496078480627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985339,0.0002939485,1.9628449e-7,0.00013589863,0.00007430492,0.00054111506,0.000053196018,0.00012779822,0.00023966306],"genre_scores_gemma":[0.99783415,0.00057112466,0.0000862502,0.000075126685,0.000059096266,0.00011864722,0.000116984025,0.000044327426,0.0010942952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866736,0.00008351024,0.00028662995,0.0002963323,0.00036174816,0.00030441565],"domain_scores_gemma":[0.9988312,0.0002652051,0.00015273113,0.0004574821,0.00016861045,0.00012474737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022009101,0.00020654405,0.0003793926,0.00013442746,0.000088087414,0.000017178281,0.000081834085,0.000077588295,0.000026441097],"category_scores_gemma":[0.000073496834,0.00013385534,0.00012617119,0.000574207,0.000104333245,0.00007730722,0.000037125268,0.000039408576,0.000042134383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002733263,0.0037461477,0.98749995,0.000028566801,0.00048577983,0.00024281465,0.000501977,0.0000024126648,0.0011133893,0.000009736879,0.00046857953,0.0031673794],"study_design_scores_gemma":[0.024831774,0.0014657145,0.92236984,0.00018349668,0.00014442005,0.0000028213167,0.000085686974,0.0000044532794,0.04898629,0.000008515889,0.0017865846,0.00013038224],"about_ca_topic_score_codex":0.00038512843,"about_ca_topic_score_gemma":0.00009338488,"teacher_disagreement_score":0.06513009,"about_ca_system_score_codex":0.000057335354,"about_ca_system_score_gemma":0.00011835674,"threshold_uncertainty_score":0.5458462},"labels":[],"label_agreement":null},{"id":"W4389248060","doi":"10.1182/blood-2023-174093","title":"Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interquartile range; Rituximab; Internal medicine; Randomized controlled trial; Lymphoma; Randomization; Positron emission tomography; Oncology; Surgery; Nuclear medicine","score_opus":0.025186645666516735,"score_gpt":0.2696481536327393,"score_spread":0.24446150796622257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969625,0.000023062643,0.0000010632571,0.00043598193,0.0000954892,0.0018987381,0.00009027952,0.000029779147,0.00046312268],"genre_scores_gemma":[0.9987897,0.000028004148,0.0000142221925,0.0005245376,0.000030420562,0.00035859036,0.00018247917,0.000027251115,0.000044796852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975888,0.00028456916,0.0006403672,0.0003264174,0.0008171716,0.0003426459],"domain_scores_gemma":[0.998329,0.00096970465,0.00022977937,0.00030326494,0.00009959522,0.000068701076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093735533,0.00024159535,0.0009834314,0.00022740183,0.000040738476,0.000016324835,0.00017485338,0.00008207891,0.000021812912],"category_scores_gemma":[0.00033908745,0.00013795396,0.00013295755,0.00061989354,0.00006316948,0.000054580065,0.000074016745,0.00009343199,0.00001342583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045954213,0.011798796,0.9781112,0.00005570255,0.0003972117,0.0004807184,0.003443322,0.0000016547724,0.000009883372,0.0000033709528,0.000040119827,0.0010626152],"study_design_scores_gemma":[0.2844939,0.0006839553,0.7132232,0.00021277199,0.00039810335,0.0000029688645,0.0006980872,0.00002187206,0.0001616188,0.0000032988862,0.0000022210627,0.000097975724],"about_ca_topic_score_codex":0.0023754863,"about_ca_topic_score_gemma":0.0013029911,"teacher_disagreement_score":0.2798985,"about_ca_system_score_codex":0.00012438602,"about_ca_system_score_gemma":0.0001427701,"threshold_uncertainty_score":0.5625599},"labels":[],"label_agreement":null},{"id":"W4389248313","doi":"10.1182/blood-2023-177788","title":"Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Chemoimmunotherapy; Medicine; Mantle cell lymphoma; Rituximab; Bendamustine; Regimen; Internal medicine; Population; Chemotherapy regimen; Transplantation; CHOP; Oncology; Surgery; Lymphoma; Chemotherapy","score_opus":0.006566587970460126,"score_gpt":0.18956007484853263,"score_spread":0.18299348687807251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977427,0.0001095169,3.1692417e-7,0.000119246135,0.000039877028,0.0003069656,0.00011205462,0.00002169385,0.0015476071],"genre_scores_gemma":[0.9990681,0.00012006839,0.00006199883,0.00008619068,0.000004647042,0.000031170228,0.00016005417,0.000015591344,0.0004522191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904996,0.000009641742,0.00021583804,0.00021159394,0.00026299246,0.00024994757],"domain_scores_gemma":[0.9996165,0.000055178793,0.000041382315,0.00015617299,0.000025423466,0.00010533893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035491485,0.0001560358,0.00035883702,0.00010761474,0.000026843565,0.000005462839,0.00004505418,0.00004533269,0.000034703273],"category_scores_gemma":[0.0000016460575,0.0001087451,0.000034301727,0.0001628071,0.000019827043,0.000032346026,0.000007914378,0.000035874746,0.000004615681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012733389,0.0014516537,0.9968647,0.00010976728,0.000118645235,0.0004046432,0.000463025,0.000003195509,0.000056227233,0.000010588547,0.00021421019,0.00017602001],"study_design_scores_gemma":[0.02240554,0.000258415,0.96634763,0.00014420121,0.00027772918,0.0000144576015,0.000041707117,0.000003173028,0.010063847,0.0000059964536,0.00032336492,0.00011394759],"about_ca_topic_score_codex":0.8842207,"about_ca_topic_score_gemma":0.9622327,"teacher_disagreement_score":0.07801203,"about_ca_system_score_codex":0.00009416879,"about_ca_system_score_gemma":0.0004783131,"threshold_uncertainty_score":0.44344965},"labels":[],"label_agreement":null},{"id":"W4389248455","doi":"10.1182/blood-2023-182747","title":"An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Mantle cell lymphoma; Population; Internal medicine; Retrospective cohort study; Cohort; Follicular lymphoma; Diffuse large B-cell lymphoma; Clinical endpoint; Cancer registry; Cumulative incidence; Oncology; Cohort study; Lymphoma; Cancer; Clinical trial","score_opus":0.013088101312105305,"score_gpt":0.2569232533274708,"score_spread":0.24383515201536549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998938,0.000034139528,6.432456e-7,0.000019586645,0.00009242124,0.0005129352,0.0002342846,0.000014420708,0.00015357304],"genre_scores_gemma":[0.9994914,0.000019137617,0.00007208954,0.0000074356226,0.000024243102,0.00007242581,0.0002457425,0.000017311133,0.000050243998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988202,0.000049774157,0.00026620372,0.00024453268,0.00048015403,0.00013915444],"domain_scores_gemma":[0.99938256,0.00008132071,0.00009146418,0.00027658313,0.000091926086,0.00007612375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011037898,0.0001300637,0.00027634218,0.00013714888,0.000023580254,0.0000068539043,0.00008405143,0.00003765739,0.000035845875],"category_scores_gemma":[0.000023773247,0.00010169086,0.00003234435,0.000105296094,0.000031690943,0.00008160345,0.00010950622,0.00002629682,0.000003445078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006400906,0.016616909,0.98145926,0.00003598297,0.00032835035,0.00017230537,0.00048814082,0.000017293352,0.00008350997,0.000015216943,0.0000079396,0.0001349775],"study_design_scores_gemma":[0.03624413,0.0013910581,0.96056956,0.00006305687,0.00026481794,0.0000031947793,0.00034034316,0.0000529082,0.0009753346,0.0000054036586,0.0000044507424,0.000085739724],"about_ca_topic_score_codex":0.0003371858,"about_ca_topic_score_gemma":0.0006285522,"teacher_disagreement_score":0.03560404,"about_ca_system_score_codex":0.00006352909,"about_ca_system_score_gemma":0.000039567087,"threshold_uncertainty_score":0.41468328},"labels":[],"label_agreement":null},{"id":"W4389248470","doi":"10.1182/blood-2023-173527","title":"Leukostasis Twist in Mantle Cell Lymphoma: Systematic Review and Case Report","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Leukostasis; Leukapheresis; Medicine; Mantle cell lymphoma; Tumor lysis syndrome; Leukocytosis; Lymphoma; Internal medicine; Surgery; Gastroenterology; Leukemia; Chemotherapy","score_opus":0.015389342711114381,"score_gpt":0.2672834175380476,"score_spread":0.2518940748269332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413883,0.054342736,1.7173153e-7,0.0005849499,0.000033362532,0.0011343763,0.00001179718,0.000068642876,0.0024356348],"genre_scores_gemma":[0.9914282,0.00658516,0.000055959994,0.0003617865,0.000018363906,0.00028457108,0.000033008626,0.000016495067,0.0012164373],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990549,0.00003569411,0.0003784915,0.00023072548,0.0001310468,0.00016914961],"domain_scores_gemma":[0.99935126,0.000074905845,0.00009196247,0.0003591064,0.0000264564,0.00009630049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027351972,0.00011960729,0.00053744146,0.00008085218,0.000033264412,0.000012588419,0.000025529982,0.00003886761,0.000018616383],"category_scores_gemma":[0.00012427242,0.00008701391,0.000063802436,0.00027401367,0.000016824417,0.000025628677,0.000037102924,0.00002237506,0.00014388541],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004604021,0.0018733408,0.029365113,0.25606966,0.00017882482,0.70970803,0.00015821813,6.3413154e-8,0.000023723744,0.000029119132,0.0024075261,0.00018174133],"study_design_scores_gemma":[0.031404965,0.00059520715,0.06537859,0.12716979,0.018971466,0.74645615,0.00095086196,0.000031581574,0.007301211,0.000060084407,0.0009847007,0.0006953817],"about_ca_topic_score_codex":0.0002250055,"about_ca_topic_score_gemma":0.00004002624,"teacher_disagreement_score":0.12889987,"about_ca_system_score_codex":0.000057544472,"about_ca_system_score_gemma":0.000056414403,"threshold_uncertainty_score":0.35483244},"labels":[],"label_agreement":null},{"id":"W4389295786","doi":"10.1182/blood.2023022348","title":"Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Refractory (planetary science); Cancer research; Mechanism (biology); Medicine; Lymphoma; Biology; Immunology; Physics","score_opus":0.01112497727708489,"score_gpt":0.24913952812169748,"score_spread":0.2380145508446126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389295786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263936,0.00063861837,0.0000026405366,0.00020961472,0.00007053259,0.0004001138,0.000024545281,0.000044231427,0.0059703235],"genre_scores_gemma":[0.99713975,0.00021252445,0.00054732873,0.000082184815,0.000027300764,0.00008507468,0.000017006425,0.000024697341,0.0018641155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872446,0.00003830441,0.0003765648,0.0002824873,0.00035146004,0.00022669374],"domain_scores_gemma":[0.99914634,0.00011091789,0.0001284312,0.00042901677,0.00006365524,0.00012163897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014384706,0.00014457107,0.00039279455,0.00021595966,0.00002111306,0.000003234559,0.000098779565,0.00010386706,0.0000612819],"category_scores_gemma":[0.00008938157,0.00012124465,0.00009758427,0.0004676665,0.000026285243,0.00002806104,0.00007422615,0.00004808373,0.00009708631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022706282,0.02079813,0.1503576,0.0015464979,0.00028355076,0.003396684,0.005673236,0.000032206728,0.8012105,0.006364403,0.0063802833,0.0016862409],"study_design_scores_gemma":[0.013856479,0.00080442894,0.054232772,0.00087365054,0.00011515003,0.0000124387425,0.00027434505,0.000005252439,0.9279695,0.0007437774,0.0009915761,0.000120639554],"about_ca_topic_score_codex":0.00013551318,"about_ca_topic_score_gemma":0.000039909013,"teacher_disagreement_score":0.12675896,"about_ca_system_score_codex":0.00009131874,"about_ca_system_score_gemma":0.0001674194,"threshold_uncertainty_score":0.49442133},"labels":[],"label_agreement":null},{"id":"W4389393806","doi":"10.53876/001c.90841","title":"A CD5 gene signature identifies diffuse large B-cell lymphomas sensitive to Brutonʼs tyrosine kinase inhibition","year":2023,"lang":"en","type":"article","venue":"International Journal of Cancer Care and Delivery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Bruton's tyrosine kinase; Tyrosine kinase; Cancer research; Gene; Signature (topology); B cell; Biology; Genetics; Signal transduction; Antibody; Mathematics","score_opus":0.009863278905774308,"score_gpt":0.281026768618629,"score_spread":0.2711634897128547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389393806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99058205,0.0060959016,0.000036421043,0.0017098141,0.0008282913,0.0001240954,0.00031097283,0.000019854515,0.0002925709],"genre_scores_gemma":[0.9919097,0.0048455545,0.00010388277,0.0020726093,0.0006700523,0.000012219258,0.00010067113,0.000014390927,0.00027094735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989025,0.000020432852,0.00026479608,0.00015854763,0.0005063203,0.0001474182],"domain_scores_gemma":[0.99851686,0.00006013944,0.00014230185,0.00007191779,0.0010533831,0.0001554298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007411297,0.00013020338,0.00022201665,0.0003074027,0.00005161131,0.0000664247,0.000054096403,0.00006504146,0.000037982063],"category_scores_gemma":[0.000028276483,0.00010429122,0.00014873566,0.00014727535,0.000022001084,0.0001542314,0.000072995725,0.00008124361,0.000021278684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009623481,0.005313074,0.14687881,0.0004938631,0.0044017388,0.059020597,0.023746911,0.0006316073,0.40360105,0.0005367586,0.18007079,0.16568135],"study_design_scores_gemma":[0.031234007,0.0013307926,0.24176665,0.0019144886,0.0007005294,0.0011730391,0.0047179824,0.00016818848,0.6930117,0.0001284346,0.023415579,0.0004385926],"about_ca_topic_score_codex":0.0001676329,"about_ca_topic_score_gemma":0.000101091835,"teacher_disagreement_score":0.28941068,"about_ca_system_score_codex":0.00037731064,"about_ca_system_score_gemma":0.00018826628,"threshold_uncertainty_score":0.42528725},"labels":[],"label_agreement":null},{"id":"W4389444625","doi":"10.1212/wnl.88.16_supplement.p6.361","title":"Impact of Long-term Teriflunomide Treatment on Severe Relapses: Analysis of TEMSO and TOWER Extensions (P6.361)","year":2017,"lang":"en","type":"article","venue":"Neurology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Tower; Term (time); Medicine; Psychiatry; Engineering; Physics; Multiple sclerosis","score_opus":0.027213032414733253,"score_gpt":0.3375023957841389,"score_spread":0.3102893633694056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389444625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975177,0.00015633722,7.627744e-7,0.0007504365,0.00007096385,0.00023433568,0.000052262658,0.000009743904,0.0012074439],"genre_scores_gemma":[0.99913853,0.00042378297,0.000016402288,0.00019207784,0.000021079248,0.000018889956,0.000026704702,0.000011154973,0.00015135764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991502,0.000038749626,0.00024389832,0.00030134773,0.00009494519,0.0001708145],"domain_scores_gemma":[0.99865335,0.00014255391,0.00023499811,0.00080427673,0.000053196953,0.000111649424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038854923,0.00016652733,0.0006787557,0.000205289,0.00007667552,0.000008467337,0.00006998794,0.00010487334,0.00017299032],"category_scores_gemma":[0.000061427825,0.00010615792,0.0003139083,0.00006723865,0.00015243929,0.0000338596,0.000047398273,0.000049257575,0.0000049209148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012726657,0.0010893075,0.98461443,0.000008185922,0.001965357,0.000442917,0.00008528877,0.000029618603,0.0018215154,0.00002449871,0.00010836028,0.00853785],"study_design_scores_gemma":[0.0030529676,0.010373785,0.98282737,0.000017730219,0.0026194886,0.00011408531,0.000001556158,0.000055063712,0.0008155256,0.0000062356326,0.000055335793,0.00006084787],"about_ca_topic_score_codex":0.001063727,"about_ca_topic_score_gemma":0.0001872239,"teacher_disagreement_score":0.009284478,"about_ca_system_score_codex":0.000049855185,"about_ca_system_score_gemma":0.00006220674,"threshold_uncertainty_score":0.43289942},"labels":[],"label_agreement":null},{"id":"W4389542099","doi":"10.1200/jco.23.01574","title":"CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"CD5; Diffuse large B-cell lymphoma; Cancer research; Biology; B cell; breakpoint cluster region; Lymphoma; Gene; Genetics; Immunology; Antibody","score_opus":0.0603212062346504,"score_gpt":0.4085103311707689,"score_spread":0.34818912493611853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389542099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813718,0.00034914265,0.000061841245,0.014990147,0.0016407386,0.0003032968,0.000051110965,0.000041404135,0.0011905084],"genre_scores_gemma":[0.9875025,0.0010197846,0.0008385834,0.0076449965,0.0015629871,0.000010454002,0.000052520198,0.000027747677,0.0013403986],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967898,0.00033857062,0.0017057678,0.00029604675,0.00049006747,0.00037976247],"domain_scores_gemma":[0.9959517,0.0016944597,0.0008930493,0.00023474763,0.00059364206,0.00063240266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019800935,0.00020643328,0.0013457156,0.00028683283,0.000082550265,0.00002431011,0.000085437125,0.0004783778,0.00009053095],"category_scores_gemma":[0.0020845497,0.00014617041,0.0006267005,0.00042114392,0.00008856621,0.00011777243,0.00012259884,0.0004442055,0.0004244619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015781242,0.07655659,0.09350098,0.0002341388,0.0021410522,0.11690944,0.0018255484,0.00009701058,0.06718972,0.0008425397,0.5437498,0.08117192],"study_design_scores_gemma":[0.07019264,0.016158124,0.74523646,0.00040422767,0.0011201784,0.0013569896,0.00056958315,0.0001318217,0.068772204,0.0003958882,0.09533557,0.000326324],"about_ca_topic_score_codex":0.000017860322,"about_ca_topic_score_gemma":0.000039515,"teacher_disagreement_score":0.6517355,"about_ca_system_score_codex":0.00035748567,"about_ca_system_score_gemma":0.00084355986,"threshold_uncertainty_score":0.59606564},"labels":[],"label_agreement":null},{"id":"W4389549604","doi":"10.1038/s41586-023-06903-x","title":"Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling","year":2023,"lang":"en","type":"article","venue":"Nature","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; Regeneron Pharmaceuticals; National Institutes of Health; Pharmacyclics; Genentech; Deutsche Krebshilfe; Chugai Pharmaceutical; Seagen; Pfizer; Incyte; Emerson Collective; BeiGene; Varian Medical Systems; Celgene; Bristol-Myers Squibb; AstraZeneca; TG Therapeutics; Canadian Institutes of Health Research; Adaptive Biotechnologies; Damon Runyon Cancer Research Foundation; Virginia and D.K. Ludwig Fund for Cancer Research; Kite Pharma; National Cancer Institute; Gilead Sciences; U.S. Department of Defense","keywords":"Hodgkin lymphoma; Lymphoma; Computational biology; Profiling (computer programming); Biology; Cancer research; Medicine; Pathology; Computer science","score_opus":0.010024892291609421,"score_gpt":0.26158266051279716,"score_spread":0.25155776822118775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389549604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898535,0.0033109444,0.000001615876,0.0023776111,0.00030077292,0.00037003923,0.00010623399,0.00023259335,0.0034466947],"genre_scores_gemma":[0.99558735,0.00018111872,0.0004310007,0.0008947972,0.00019734124,0.00007774215,0.0007192991,0.00003416361,0.0018772064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989516,0.000020508722,0.00015213857,0.0003327976,0.00023933152,0.0003036259],"domain_scores_gemma":[0.9993497,0.0001428009,0.000056151097,0.00026372282,0.00006420226,0.00012339666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008741052,0.00018297812,0.00025961877,0.00008587808,0.000096125754,0.00002468404,0.00008418801,0.00057879137,0.00006711916],"category_scores_gemma":[0.00015100064,0.00013660021,0.00011806938,0.00033014308,0.00003094601,0.000033658398,0.00005192133,0.00028084553,0.0005867794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034169972,0.0009528243,0.696826,0.00021017474,0.0005425376,0.0019889327,0.00031497105,0.0000033492597,0.025138965,0.002133658,0.2372371,0.034309793],"study_design_scores_gemma":[0.0047493265,0.00028973282,0.8627456,0.00011309708,0.000232271,0.0001509668,0.00010384422,0.00010799335,0.08023632,0.00024061001,0.050764672,0.0002655739],"about_ca_topic_score_codex":0.00003637587,"about_ca_topic_score_gemma":0.000014628048,"teacher_disagreement_score":0.18647242,"about_ca_system_score_codex":0.00023037744,"about_ca_system_score_gemma":0.0001483384,"threshold_uncertainty_score":0.75420576},"labels":[],"label_agreement":null},{"id":"W4389607743","doi":"10.1016/j.jcjo.2023.11.006","title":"Clinicopathologic features of conjunctival MALT lymphomas refractory to radiation therapy","year":2023,"lang":"en","type":"review","venue":"Canadian Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"MSH6; MSH2; Radiation therapy; Lymphoma; MALT lymphoma; Medicine; Refractory (planetary science); MLH1; Gastroenterology; Cancer research; Internal medicine; Pathology; Cancer; Biology; DNA mismatch repair","score_opus":0.11955428740435095,"score_gpt":0.3951759816198021,"score_spread":0.27562169421545113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389607743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012491558,0.9808951,2.6639944e-7,0.0001896964,0.0016798784,0.00069509464,0.00011742705,0.0000059342074,0.003925045],"genre_scores_gemma":[0.023264665,0.9745545,0.00011714653,0.00011153229,0.0005761413,0.000040211176,0.000068452915,0.00007489871,0.0011924895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748504,0.00034899893,0.0012197299,0.0003035377,0.000220044,0.00042264804],"domain_scores_gemma":[0.9967286,0.00052047364,0.0011550111,0.0003961865,0.00028741296,0.0009123153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059463765,0.00038539167,0.0026790514,0.0011568442,0.00006133308,0.000016544727,0.0002861653,0.0005748121,0.00059559173],"category_scores_gemma":[0.00062208687,0.00026897018,0.0008611698,0.0004476243,0.00013349447,0.00004248191,0.000018764225,0.0003580508,0.000100267556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015776504,0.00022587519,0.0057616206,0.0018872633,0.0011736993,0.10118186,0.0001439855,0.0000013179372,0.0000011157574,0.00015164213,0.007620823,0.88169307],"study_design_scores_gemma":[0.0019025017,0.0050487146,0.038918637,0.0052462555,0.0010023454,0.24635108,0.000034970497,5.320876e-8,0.000008239101,0.00008289054,0.70113957,0.0002647184],"about_ca_topic_score_codex":0.0011657077,"about_ca_topic_score_gemma":0.000040600644,"teacher_disagreement_score":0.8814283,"about_ca_system_score_codex":0.00090298726,"about_ca_system_score_gemma":0.007160229,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W4389763605","doi":"10.1200/jco.23.00838","title":"Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Bendamustine; Obinutuzumab; Vincristine; Hazard ratio; Follicular lymphoma; Rituximab; CHOP; Cyclophosphamide; Prednisone; Chemotherapy; Oncology; Induction chemotherapy; Gastroenterology; Minimal residual disease; Surgery; Lymphoma; Confidence interval; Leukemia","score_opus":0.05636821618870117,"score_gpt":0.42493185501344843,"score_spread":0.36856363882474724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389763605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734235,0.00010340357,0.0000012678848,0.00078514696,0.0002103677,0.0014131954,0.000053113563,0.000012385958,0.00007877706],"genre_scores_gemma":[0.9993948,0.00007054894,0.00006658839,0.00019335772,0.00010303613,0.000044730266,0.000028638187,0.00001678015,0.000081522565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516135,0.0006589453,0.0026298743,0.0003179542,0.00087495934,0.0003569309],"domain_scores_gemma":[0.9955065,0.001172819,0.001846036,0.00038879644,0.0005906815,0.00049511896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00157253,0.0002092258,0.0022225883,0.0004285481,0.000045814377,0.000008938758,0.00017512779,0.00014839844,0.000028710236],"category_scores_gemma":[0.0023796025,0.000104643186,0.00067222817,0.0015673516,0.00018883456,0.000082242266,0.00009837378,0.0002449216,0.000004066838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029798135,0.040523835,0.91659904,0.000017122078,0.006788339,0.0017302622,0.0005534686,0.00014227463,5.7021583e-7,0.000006665796,0.00025549522,0.003584825],"study_design_scores_gemma":[0.109607294,0.02695748,0.8504422,0.00008150078,0.012260936,0.0000034089485,0.0002898431,0.0001282534,0.0000042354986,0.000010284715,0.00013677013,0.00007779224],"about_ca_topic_score_codex":0.000130617,"about_ca_topic_score_gemma":0.00032963778,"teacher_disagreement_score":0.07980916,"about_ca_system_score_codex":0.0005380556,"about_ca_system_score_gemma":0.0018430249,"threshold_uncertainty_score":0.42672253},"labels":[],"label_agreement":null},{"id":"W4389831827","doi":"10.1186/s13045-023-01520-7","title":"Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium","year":2023,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Oncology; Cohort; Retrospective cohort study; Hematology; Hematopoietic stem cell transplantation; Transplantation; Lymphoma","score_opus":0.032297133307245776,"score_gpt":0.3348060902558893,"score_spread":0.30250895694864355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389831827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973244,0.0023847502,0.00039342727,0.005997925,0.00022086407,0.0007401526,0.000092969516,0.000016415617,0.0004210647],"genre_scores_gemma":[0.99342656,0.0012641037,0.0032067439,0.0016420645,0.000087038876,0.00017021655,0.00011173581,0.000022857861,0.0000687048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700636,0.00039239792,0.0014909899,0.0003825815,0.00031021822,0.00041744727],"domain_scores_gemma":[0.9911431,0.006029686,0.0018651027,0.00048505477,0.00039274877,0.0000842722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009989792,0.00031145223,0.0020408926,0.00040842535,0.000106300206,0.000015549387,0.00040924703,0.00022180068,0.00001555233],"category_scores_gemma":[0.0004974997,0.00015101787,0.000793229,0.0011695212,0.0005842411,0.000055315722,0.00006975946,0.00022767007,0.000004869758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030040988,0.009704208,0.9580492,0.000048035992,0.0023781867,0.006888155,0.00402172,0.00023114202,0.00081500347,0.00049845874,0.0071511446,0.0072106565],"study_design_scores_gemma":[0.010380259,0.0031289642,0.96854264,0.000060919698,0.0035899198,0.00478412,0.004754226,0.00087361946,0.0020422265,0.00048491123,0.0012001507,0.0001580448],"about_ca_topic_score_codex":0.00037593197,"about_ca_topic_score_gemma":0.0010736883,"teacher_disagreement_score":0.010493449,"about_ca_system_score_codex":0.00020670365,"about_ca_system_score_gemma":0.00072411995,"threshold_uncertainty_score":0.615833},"labels":[],"label_agreement":null},{"id":"W4389925750","doi":"10.3390/curroncol30120764","title":"Ibrutinib Plus RCHOP versus RCHOP Only in Young Patients with Activated B-Cell-like Diffuse Large B-Cell Lymphoma (ABC-DLBCL): A Cost-Effectiveness Analysis","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"American Society of Hematology","keywords":"Ibrutinib; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Oncology; Population; CHOP; Lymphoma; Leukemia; Chronic lymphocytic leukemia; Environmental health","score_opus":0.05304657159249052,"score_gpt":0.36458477167312264,"score_spread":0.3115382000806321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389925750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338984,0.00034800946,0.00002894887,0.000101010584,0.0015077164,0.0022305236,0.0001821333,0.00019964548,0.0020121706],"genre_scores_gemma":[0.9962648,0.00038333077,0.00003358189,0.00005303141,0.0000934036,0.00090768165,0.0020315303,0.0000622251,0.00017038416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964389,0.0004702223,0.0005436362,0.00095520954,0.00056868553,0.0010233258],"domain_scores_gemma":[0.9974602,0.00095641566,0.00029290773,0.00063764106,0.00025363607,0.0003991985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038777365,0.000524156,0.0012692342,0.0009860132,0.0001717372,0.000035969533,0.00021653254,0.00029052046,0.00008886043],"category_scores_gemma":[0.0001234817,0.00041429346,0.00033499105,0.0028995965,0.00013215953,0.00013448387,0.00020818856,0.00027257524,0.00026440102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007008421,0.048458233,0.9189802,0.00018551318,0.0009902657,0.00032898007,0.0009179833,0.000036195233,0.000074239215,0.000029072919,0.0007354921,0.022255434],"study_design_scores_gemma":[0.20315626,0.0020817153,0.7766946,0.00012451205,0.0017320014,0.0000065954205,0.00030073692,0.0006945049,0.0005529447,0.0000036676631,0.014319043,0.00033343403],"about_ca_topic_score_codex":0.00031724924,"about_ca_topic_score_gemma":0.0009031037,"teacher_disagreement_score":0.19614784,"about_ca_system_score_codex":0.0032922784,"about_ca_system_score_gemma":0.00092177064,"threshold_uncertainty_score":0.9998309},"labels":[],"label_agreement":null},{"id":"W4389942753","doi":"10.1200/jco.23.01115","title":"Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; University Health Network","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Seagen; BC Cancer Foundation; Genome British Columbia; BeiGene; Regeneron Pharmaceuticals; Genome Canada; Kanae Foundation for the Promotion of Medical Science; National Cancer Institute; Strong; Genentech; AstraZeneca; Pfizer","keywords":"Tumor microenvironment; Medicine; Lymphoma; Oncology; Internal medicine; Cancer research; Pathology; Cancer","score_opus":0.0919978999920369,"score_gpt":0.4107195557820578,"score_spread":0.31872165579002093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389942753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859003,0.0005086127,0.0000037350528,0.01057097,0.001300686,0.000421797,0.00001148049,0.00002664796,0.0012557679],"genre_scores_gemma":[0.9923399,0.0028681485,0.0011422185,0.001972841,0.00057623244,0.000036662954,0.0000112299795,0.000030388814,0.0010223486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955406,0.00045390974,0.0027865868,0.00031930444,0.0004905787,0.0004090184],"domain_scores_gemma":[0.9949879,0.0027565248,0.0013339814,0.00033784733,0.00008101097,0.0005027448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017727617,0.0002604012,0.0021123432,0.00030407612,0.000040194394,0.000009515265,0.00015585985,0.00032094857,0.00014368206],"category_scores_gemma":[0.0015560059,0.00016435368,0.0007843576,0.00018743327,0.00016388598,0.000063401654,0.000073881296,0.00028007606,0.00023561654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023706143,0.012192531,0.77637416,0.000013030402,0.0006493324,0.012139862,0.00014769573,0.000040130013,0.00013060133,0.00001729305,0.0031275651,0.19279721],"study_design_scores_gemma":[0.034853008,0.025842523,0.8411765,0.0001149404,0.0003886287,0.00024118008,0.00008056518,0.000052590323,0.00021760003,0.00007574414,0.09685316,0.00010354072],"about_ca_topic_score_codex":0.00011452459,"about_ca_topic_score_gemma":0.00017865875,"teacher_disagreement_score":0.19269367,"about_ca_system_score_codex":0.0015875977,"about_ca_system_score_gemma":0.0016814083,"threshold_uncertainty_score":0.6702149},"labels":[],"label_agreement":null},{"id":"W4389994778","doi":"10.1245/s10434-023-14733-4","title":"ASO Visual Abstract: Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach","year":2023,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Surgical oncology; Medicine; Multidisciplinary approach; Term (time); General surgery; Intensive care medicine; Surgery; Social science","score_opus":0.11286052515892585,"score_gpt":0.4272443857206916,"score_spread":0.31438386056176576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389994778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736746,0.00068200415,9.671367e-7,0.0047162767,0.000079570666,0.00046071748,0.000020959642,0.00005079876,0.020314101],"genre_scores_gemma":[0.9902863,0.008324575,0.00016203313,0.000072336064,0.000054698445,0.0000739531,0.00009970048,0.000017772876,0.00090861606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982318,0.000064879394,0.0006079317,0.00037883176,0.00034311877,0.00037343262],"domain_scores_gemma":[0.9986446,0.0006101143,0.00019158244,0.00022712827,0.00009170545,0.0002348847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044740443,0.00021059465,0.0009870438,0.00023583492,0.00004627765,0.0000057165958,0.0000880758,0.00020679852,0.00013894505],"category_scores_gemma":[0.00001054221,0.0001474306,0.00029390407,0.00028620526,0.0002863019,0.00004806623,0.00025050758,0.00010489067,0.000040215167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010632889,0.0064059333,0.89418995,0.00046436905,0.0008902888,0.009083642,0.00017322108,0.000009198335,0.000020786263,0.0019035431,0.0015003389,0.08429542],"study_design_scores_gemma":[0.0059390776,0.0014416875,0.9836593,0.00008354388,0.00017652364,0.00024018876,0.0001161211,0.000060853745,0.00038905608,0.00008227144,0.0076836594,0.0001276752],"about_ca_topic_score_codex":0.000025655168,"about_ca_topic_score_gemma":0.0000029145847,"teacher_disagreement_score":0.08946937,"about_ca_system_score_codex":0.000032265685,"about_ca_system_score_gemma":0.000050782135,"threshold_uncertainty_score":0.6012046},"labels":[],"label_agreement":null},{"id":"W4390124903","doi":"10.1016/j.jval.2023.09.2673","title":"PCR236 Treatment Preferences Among Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Lymphoma; Demography; Internal medicine; Sociology; Biology","score_opus":0.027145006543339806,"score_gpt":0.26055075679010387,"score_spread":0.23340575024676405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944174,0.0008818209,0.0000012364321,0.002067902,0.00011906604,0.0022178139,0.000094555064,0.00008879152,0.0001113899],"genre_scores_gemma":[0.9916941,0.005601937,0.000019089628,0.0012488101,0.00003649544,0.00038839874,0.0007148258,0.00004449352,0.0002518458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970752,0.00067882857,0.00060629175,0.000473024,0.00047049593,0.0006961759],"domain_scores_gemma":[0.9977155,0.0011351007,0.00028622375,0.0005627059,0.00008204689,0.00021845283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007715102,0.00036236868,0.0005806647,0.00055922556,0.0002669983,0.000048796075,0.0001541151,0.00011050469,0.0000094686375],"category_scores_gemma":[0.0000607,0.00017343387,0.00006798054,0.0016610306,0.00024971704,0.0000871117,0.00007663679,0.0001816465,0.00002096623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002073,0.0072690975,0.9830524,0.00014631989,0.00011320899,0.0000685703,0.0059162336,0.0003803585,2.8007094e-7,0.0003611499,0.00028778677,0.0019044105],"study_design_scores_gemma":[0.0703916,0.0013009409,0.90971655,0.00052890467,0.000078297315,0.0000035109463,0.0009133295,0.0073142266,0.000008052967,0.000093418974,0.009481265,0.00016990087],"about_ca_topic_score_codex":0.084031984,"about_ca_topic_score_gemma":0.001843853,"teacher_disagreement_score":0.08218814,"about_ca_system_score_codex":0.0006575251,"about_ca_system_score_gemma":0.00029174055,"threshold_uncertainty_score":0.9220675},"labels":[],"label_agreement":null},{"id":"W4390484306","doi":"10.3324/haematol.2023.284289","title":"&lt;i&gt;Erratum&lt;/i&gt; to: &lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Anaplastic large-cell lymphoma; Cancer research; Internal medicine","score_opus":0.02840536132505914,"score_gpt":0.298310698904237,"score_spread":0.26990533757917784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390484306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93689287,0.009800225,0.0011456308,0.007209648,0.0022669951,0.003952361,0.0041173194,0.0010767409,0.033538226],"genre_scores_gemma":[0.9824249,0.00058432895,0.0037897632,0.003373277,0.00048416888,0.00089175696,0.00051459024,0.00020686547,0.007730315],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99061006,0.0007129476,0.0023319044,0.0027443862,0.0014571531,0.002143518],"domain_scores_gemma":[0.9917884,0.0025807994,0.000421078,0.0019347721,0.00047348134,0.002801454],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0010610251,0.0014571332,0.0028122272,0.00040801123,0.00062017824,0.00035413032,0.00073130033,0.0008254468,0.0017765292],"category_scores_gemma":[0.0027704241,0.0010861076,0.0012222823,0.001008573,0.0005882536,0.00016572722,0.00065108214,0.0004530064,0.002158707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010273713,0.04636834,0.2311123,0.005032626,0.0059196465,0.1154865,0.0043639587,0.000062575185,0.020033728,0.09550215,0.44690073,0.018943723],"study_design_scores_gemma":[0.023552341,0.0055436594,0.5758166,0.0023023714,0.006142716,0.0012951735,0.00018448448,0.0050371434,0.0016923307,0.004110963,0.37121406,0.0031081764],"about_ca_topic_score_codex":0.000045150642,"about_ca_topic_score_gemma":0.00055756647,"teacher_disagreement_score":0.34470427,"about_ca_system_score_codex":0.0007871697,"about_ca_system_score_gemma":0.0014524453,"threshold_uncertainty_score":0.99981785},"labels":[],"label_agreement":null},{"id":"W4390821849","doi":"10.1007/978-3-030-97378-0_5620","title":"Germ Cell, Lymphoid and Myeloid Tumors, Pathology of the Cervix","year":2023,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathology; Medicine; Myeloid; Cervix; Germ cell tumors; Biology; Cancer research; Internal medicine; Cancer","score_opus":0.012048185871899025,"score_gpt":0.22896495984509277,"score_spread":0.21691677397319375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390821849","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22374372,0.0059215906,0.0000024035032,0.0008240583,0.0012562744,0.0010053898,0.00042332674,0.000070648246,0.7667526],"genre_scores_gemma":[0.24301991,0.051788755,0.00065975194,0.00077374594,0.0007066497,0.00016181398,0.0002632837,0.00028360618,0.7023425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979094,0.00007901367,0.00078591134,0.00058784394,0.00030633825,0.00033144964],"domain_scores_gemma":[0.9978591,0.0003282063,0.00071105943,0.0008496142,0.00013016773,0.000121830664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024304904,0.00044838522,0.0012641912,0.00022347448,0.00005755254,0.0000030854192,0.00021878294,0.0006158548,0.00023377844],"category_scores_gemma":[0.000110476896,0.0003082131,0.00035118498,0.000068405,0.00063206896,0.000021683203,0.00035633286,0.00025692102,0.00008798769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010754396,0.0030390266,0.4875337,0.00688631,0.0017494737,0.048369855,0.008717531,0.000008137215,0.010458919,0.23025969,0.04598108,0.15592088],"study_design_scores_gemma":[0.011814674,0.0040922565,0.59713805,0.0018787929,0.003785035,0.011327507,0.00025520648,0.0000060901834,0.0074000093,0.029739346,0.33105922,0.0015038196],"about_ca_topic_score_codex":0.000038066042,"about_ca_topic_score_gemma":0.00002932452,"teacher_disagreement_score":0.28507814,"about_ca_system_score_codex":0.000084030406,"about_ca_system_score_gemma":0.00036452623,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W4390829938","doi":"10.12688/f1000research.128907.1","title":"Case Report: Primary follicular lymphoma of the colon presenting as an incidental finding on endoscopy","year":2024,"lang":"en","type":"preprint","venue":"F1000Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Differential diagnosis; Follicular lymphoma; Pathology; Lymphoma; Endoscopy; Organomegaly; Follicular phase; Gastroenterology; Internal medicine","score_opus":0.05137385967161309,"score_gpt":0.37749054293796813,"score_spread":0.326116683266355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390829938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452027,0.00116515,5.67744e-7,0.00090904406,0.00076035666,0.0025473887,0.000117771626,0.000094041,0.019885419],"genre_scores_gemma":[0.99450403,0.00011149228,0.00019611696,0.00012787715,0.00041609118,0.0005352167,0.00027137995,0.000099982215,0.0037378024],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955563,0.00035340092,0.00069717213,0.0009894031,0.00183286,0.0005708411],"domain_scores_gemma":[0.99701715,0.00039409916,0.0002806094,0.0017781164,0.00022815686,0.0003018679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011088006,0.0003912219,0.0006936685,0.00038234246,0.0002418313,0.00016087355,0.00043280917,0.00037097736,0.00019129492],"category_scores_gemma":[0.0005808328,0.00026428883,0.0005558588,0.00038238804,0.00021472672,0.000049581777,0.0030581634,0.0007246183,0.00013054012],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006581322,0.0031904185,0.11226855,0.003163623,0.0015389883,0.8576733,0.0017465934,0.00004628385,0.00410464,0.0018750092,0.0055059087,0.008228547],"study_design_scores_gemma":[0.010197455,0.003157578,0.26236108,0.010787257,0.0026525615,0.28973868,0.002182187,0.0019711927,0.40139592,0.010165395,0.004101204,0.0012894907],"about_ca_topic_score_codex":0.0034915344,"about_ca_topic_score_gemma":0.000087697015,"teacher_disagreement_score":0.56793463,"about_ca_system_score_codex":0.001408239,"about_ca_system_score_gemma":0.0018568663,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W4391100668","doi":"10.1158/1078-0432.ccr-23-3504","title":"KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Pharmacyclics; Syöpäsäätiö; Mersana Therapeutics; Fonds Wetenschappelijk Onderzoek; Seagen; Incyte; Massachusetts General Hospital; Vlaamse regering; Leukemia and Lymphoma Society; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Lymphoma; Cancer research; Cell; Medicine; Biology; Immunology; Genetics","score_opus":0.09780909894217026,"score_gpt":0.44468662170203926,"score_spread":0.346877522759869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391100668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860363,0.0060430826,0.0000035797177,0.0014644259,0.00016049092,0.0008188272,0.000032483727,0.00004344239,0.005397391],"genre_scores_gemma":[0.99597704,0.0011733485,0.000031183317,0.00040423605,0.00020081048,0.00023567925,0.000049781895,0.00004230877,0.0018856359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976407,0.00015244643,0.00036925357,0.0005829587,0.0007865423,0.00046805793],"domain_scores_gemma":[0.9985931,0.00057090214,0.00003450353,0.0003439427,0.00023059464,0.00022697943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007106927,0.0001670909,0.00032229236,0.00017586334,0.000061464874,0.00008933558,0.00012700612,0.00021240664,0.00036269924],"category_scores_gemma":[0.00004753282,0.0001064341,0.000107828135,0.0005874733,0.00016707141,0.00007328865,0.000056291534,0.00044463703,0.0002647947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030444178,0.006971503,0.91887623,0.0004148457,0.00013329198,0.00027611354,0.000119700046,0.0000112467715,0.00011748933,0.00035370328,0.0032486785,0.06643279],"study_design_scores_gemma":[0.011544302,0.003135104,0.97189337,0.00046851145,0.00007822834,0.0000035240628,0.00007425687,0.00015691629,0.0008427596,0.0001669036,0.011494882,0.0001412539],"about_ca_topic_score_codex":0.0013573102,"about_ca_topic_score_gemma":0.00027753387,"teacher_disagreement_score":0.06629154,"about_ca_system_score_codex":0.0004998523,"about_ca_system_score_gemma":0.0011764539,"threshold_uncertainty_score":0.43402565},"labels":[],"label_agreement":null},{"id":"W4391104484","doi":"10.1111/bjh.19295","title":"New standards of care for treatment of diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Victorian Cancer Agency","keywords":"Guideline; Medicine; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Hematology; Internal medicine; Clinical trial; CHOP; Oncology; Intensive care medicine; Pediatrics; Pathology","score_opus":0.009537349733890525,"score_gpt":0.2938472672033778,"score_spread":0.28430991746948725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391104484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8619391,0.1356218,0.00060912303,0.000296724,0.00037349595,0.00030387606,0.00044554612,0.000009895421,0.000400477],"genre_scores_gemma":[0.9925111,0.0049715564,0.0020747585,0.000028292963,0.000116433985,0.00001099083,0.000019394845,0.000022974395,0.00024449074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987469,0.000032301396,0.00062086346,0.00013922628,0.00025669302,0.00020405877],"domain_scores_gemma":[0.9989355,0.00016537473,0.00023298146,0.00012257496,0.00039475196,0.00014880067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001008732,0.00012817969,0.0010146976,0.00013965732,0.000029590698,0.0000149952575,0.00006307834,0.000100655845,0.000087157045],"category_scores_gemma":[0.000054278964,0.00010717441,0.00046724005,0.000087403176,0.000044478715,0.000048976548,0.000013784119,0.000024232246,0.0000017066267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024244392,0.018457418,0.020316293,0.0065958244,0.0032684621,0.123244405,0.006648988,0.0000038440403,0.0009789397,0.0036520737,0.047304112,0.7671052],"study_design_scores_gemma":[0.13341305,0.020369053,0.013237786,0.0070089907,0.0045030178,0.29794273,0.002645392,0.00006210482,0.1779097,0.0009943155,0.34152615,0.00038772557],"about_ca_topic_score_codex":0.00015888887,"about_ca_topic_score_gemma":0.00012133157,"teacher_disagreement_score":0.7667175,"about_ca_system_score_codex":0.00036082324,"about_ca_system_score_gemma":0.0013283477,"threshold_uncertainty_score":0.43704456},"labels":[],"label_agreement":null},{"id":"W4391111985","doi":"10.1053/j.seminhematol.2024.01.008","title":"Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities","year":2023,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Genentech; Roche","keywords":"Rituximab; Prednisone; Medicine; Cyclophosphamide; Vincristine; Internal medicine; Lymphoma; Oncology; Diffuse large B-cell lymphoma; Malignancy; Intensive care medicine; Chemotherapy","score_opus":0.014019188564911892,"score_gpt":0.2852982883684454,"score_spread":0.2712790998035335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391111985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157983,0.00048693625,0.0000051912043,0.0063029868,0.000086305896,0.0010675472,0.00004265496,0.00004240218,0.00038612014],"genre_scores_gemma":[0.9962959,0.00023352857,0.00016912662,0.0012794716,0.00004985726,0.0006670607,0.0000728085,0.000030746116,0.0012014636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990943,0.00001902951,0.0001828427,0.00027290266,0.00012659337,0.00030432193],"domain_scores_gemma":[0.99907047,0.00052842667,0.00006957934,0.00022185901,0.000043952274,0.00006569464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009585307,0.00016039563,0.0004086594,0.00011101178,0.00012109551,0.000015995045,0.00007150393,0.00009022495,0.000024521742],"category_scores_gemma":[0.00007860721,0.00009006354,0.000037544043,0.00019310521,0.00009292916,0.000033572676,0.00005405073,0.00006418517,0.000052353218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061005855,0.00034081566,0.92676455,0.0002548015,0.00009578491,0.0003025527,0.0027166712,0.0000063095194,0.0000015239289,0.00046824175,0.06657919,0.0018595036],"study_design_scores_gemma":[0.017371742,0.0053358315,0.88751245,0.0070904884,0.00036790085,0.0010451487,0.006870399,0.00069639104,0.0021301252,0.00077574427,0.07017422,0.000629575],"about_ca_topic_score_codex":0.000025193602,"about_ca_topic_score_gemma":0.00014427453,"teacher_disagreement_score":0.039252106,"about_ca_system_score_codex":0.0000814017,"about_ca_system_score_gemma":0.000035948637,"threshold_uncertainty_score":0.36726847},"labels":[],"label_agreement":null},{"id":"W4391166587","doi":"10.21203/rs.3.rs-3851546/v1","title":"Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to first line ABVD Therapy","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Jewish General Hospital","funders":"Diagnostic Services Manitoba","keywords":"ABVD; Oncology; Internal medicine; Medicine; Disease; Multivariate analysis; Lymphoma; Dacarbazine; Biomarker; Cancer; Chemotherapy; Biology; Cyclophosphamide","score_opus":0.04973913105036446,"score_gpt":0.4041266393118358,"score_spread":0.3543875082614713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391166587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88418484,0.038479324,0.000024916486,0.07230489,0.00014321723,0.0032801311,0.0009053437,0.00016058979,0.00051677023],"genre_scores_gemma":[0.98276275,0.011308115,0.00012559787,0.00018666068,0.00019550353,0.0021140624,0.00024790323,0.000073576724,0.0029858383],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950745,0.0006273237,0.00066908327,0.0011117562,0.00174479,0.0007725321],"domain_scores_gemma":[0.9949613,0.0012106099,0.00013679982,0.002440905,0.0009296385,0.00032075157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002780497,0.00044852737,0.0011363054,0.0025451756,0.00020616362,0.00013615123,0.00076203124,0.0006509106,0.0002017383],"category_scores_gemma":[0.0012498137,0.00026642127,0.0006800581,0.0043272697,0.00039864966,0.000024203628,0.001888022,0.0007955293,0.00020864986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020453027,0.010580437,0.2630303,0.0054057664,0.032501936,0.0029925706,0.00619073,0.00064382487,0.002932638,0.00092676247,0.24469717,0.40964484],"study_design_scores_gemma":[0.007890141,0.011235539,0.55703866,0.0077575287,0.003610326,0.000119817014,0.0014483123,0.0011699272,0.05992436,0.0027576739,0.34608033,0.00096736796],"about_ca_topic_score_codex":0.0010263349,"about_ca_topic_score_gemma":0.00022367964,"teacher_disagreement_score":0.4086775,"about_ca_system_score_codex":0.0010142555,"about_ca_system_score_gemma":0.0012463613,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W4391167737","doi":"10.1080/10428194.2024.2306463","title":"The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"Ministry of Long-Term Care; Ministry of Health, Ontario","keywords":"Diffuse large B-cell lymphoma; Retrospective cohort study; Medicine; Lymphoma; Overall survival; Cohort; Oncology; Internal medicine","score_opus":0.008793164795337854,"score_gpt":0.2719263780576062,"score_spread":0.26313321326226835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391167737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803779,0.004404756,0.00003492216,0.00012726401,0.000742597,0.0025653474,0.00020774758,0.00039747215,0.0111419875],"genre_scores_gemma":[0.9925981,0.002904734,0.00003561861,0.00021123025,0.00039762646,0.000484548,0.00019505165,0.00020839133,0.002964704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940546,0.00036501265,0.0012021731,0.0016155055,0.0015067259,0.0012559851],"domain_scores_gemma":[0.99625,0.00085929665,0.00040081455,0.001544781,0.00035304867,0.0005921051],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010468968,0.0011435252,0.0015718202,0.00046466754,0.0006942773,0.00044735434,0.00042090568,0.00044437108,0.000087850996],"category_scores_gemma":[0.00018367932,0.00074189215,0.0008851688,0.0010423849,0.0003314706,0.00033884484,0.0002686949,0.00014876413,0.0001368832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031540592,0.013489907,0.9141366,0.0003700984,0.0034781098,0.0018742846,0.0023951987,0.000045347882,0.0005263359,0.0074069593,0.010487882,0.042635243],"study_design_scores_gemma":[0.049548708,0.0035434163,0.9308901,0.00046508468,0.001040631,0.00036965407,0.000592755,0.0061862227,0.0012639178,0.00046653269,0.004925335,0.00070767076],"about_ca_topic_score_codex":0.005340574,"about_ca_topic_score_gemma":0.00015188204,"teacher_disagreement_score":0.04639465,"about_ca_system_score_codex":0.01969127,"about_ca_system_score_gemma":0.0037870884,"threshold_uncertainty_score":0.9995032},"labels":[],"label_agreement":null},{"id":"W4391282252","doi":"10.1111/bjh.19308","title":"Variant <scp>ALK</scp>‐fusion positive anaplastic large cell lymphoma (<scp>ALCL</scp>): A population‐based paediatric study of the <scp>NHL‐BFM</scp> study group","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"Deutsche Kinderkrebsstiftung","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; NPM1; Lymphoma; Fusion gene; Population; Medicine; Cancer research; Oncology; Biology; Internal medicine; Gene; Genetics","score_opus":0.008075213031464162,"score_gpt":0.24370080411177006,"score_spread":0.2356255910803059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391282252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263174,0.012321479,0.00017614875,0.000114079674,0.001672208,0.0021073015,0.00017680705,0.00007949962,0.00072071824],"genre_scores_gemma":[0.99815744,0.00038799262,0.00022899664,0.00028631295,0.00039886349,0.000099545265,0.000059284925,0.000112016896,0.0002695325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993816,0.0011408123,0.0019636352,0.0007862119,0.0013656564,0.0009276714],"domain_scores_gemma":[0.993255,0.003956051,0.0011815851,0.0005816817,0.0005670473,0.00045863635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011812415,0.0006037046,0.0018947455,0.00082021643,0.00045808873,0.00019609224,0.00053833,0.0003462857,0.000027301227],"category_scores_gemma":[0.0017867747,0.0004845919,0.0007149382,0.0013429576,0.000118382144,0.00027933088,0.0003158416,0.000578425,0.00005053923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008660064,0.05338889,0.7265334,0.00081518845,0.0024128214,0.18538435,0.0072004814,0.00015040081,0.00020321031,0.00043349806,0.019036837,0.004354341],"study_design_scores_gemma":[0.026004693,0.007861614,0.88711905,0.0015436966,0.0036921555,0.06309754,0.00826248,0.00063371327,0.0005247698,0.00025470305,0.0009175802,0.000088026085],"about_ca_topic_score_codex":0.0008147919,"about_ca_topic_score_gemma":0.0006267656,"teacher_disagreement_score":0.16058564,"about_ca_system_score_codex":0.0005331502,"about_ca_system_score_gemma":0.00071196596,"threshold_uncertainty_score":0.99976057},"labels":[],"label_agreement":null},{"id":"W4391311482","doi":"10.1007/s12185-023-03692-x","title":"STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment","year":2024,"lang":"en","type":"article","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Cole Foundation; Michael Smith Health Research BC; Canadian Cancer Society; Cancer Research Society","keywords":"STAT6; Tumor microenvironment; Diffuse large B-cell lymphoma; Cancer research; Biology; Lymphoma; Interleukin 4; Immunology; Cytokine","score_opus":0.009095023416842294,"score_gpt":0.27290583503698485,"score_spread":0.2638108116201425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391311482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714977,0.008166853,0.00011762902,0.018088892,0.0011083417,0.0001431501,0.000039580504,0.000017419428,0.00082040526],"genre_scores_gemma":[0.99656737,0.00055642746,0.00037798568,0.0012355724,0.00018579999,0.000018568893,0.000029016068,0.000019672956,0.0010095733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986463,0.00006111867,0.00051490124,0.00016168506,0.00042898135,0.00018697458],"domain_scores_gemma":[0.9990362,0.00037474377,0.00020902962,0.00015131148,0.00012427762,0.000104452556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018366394,0.00013768463,0.00025946216,0.00017876942,0.00006855008,0.000041029,0.00020226088,0.00004886111,0.0004278412],"category_scores_gemma":[0.000072953146,0.00008257604,0.00023740996,0.00006801497,0.00008464352,0.00007974093,0.00009881029,0.00011372505,0.00030605434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054138303,0.06281968,0.15877439,0.0005712907,0.014016407,0.19596966,0.017464416,0.00010313084,0.04604877,0.12655203,0.35299703,0.019269383],"study_design_scores_gemma":[0.04618714,0.0015364852,0.069721244,0.0007544474,0.0014312322,0.12893137,0.0018096465,0.001451861,0.04293122,0.0034981302,0.70130384,0.00044335527],"about_ca_topic_score_codex":0.000011039867,"about_ca_topic_score_gemma":0.0000108696895,"teacher_disagreement_score":0.34830683,"about_ca_system_score_codex":0.0005706372,"about_ca_system_score_gemma":0.00015225659,"threshold_uncertainty_score":0.46845612},"labels":[],"label_agreement":null},{"id":"W4391338127","doi":"10.1182/bloodadvances.2023012109","title":"Large B-cell lymphoma-<i>IRF4</i>+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent; Japan Agency for Medical Research and Development; Cancer Research Institute","keywords":"IRF4; Neoplasm; Lymphoma; Chemotherapy; B cell; Malignant lymphoma; Cancer research; Medicine; Oncology; Internal medicine; Immunology; Biology; Pathology; Transcription factor; Antibody; Genetics; Gene","score_opus":0.002666590924800702,"score_gpt":0.22399379010229203,"score_spread":0.22132719917749133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391338127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95415515,0.03934572,0.0000013526118,0.0011945616,0.0001028003,0.0007834402,0.000089047084,0.000082150575,0.004245764],"genre_scores_gemma":[0.9915959,0.003738592,0.0006797167,0.0005388489,0.000119783945,0.00015099099,0.00007580748,0.00004927809,0.0030510877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841356,0.000033414104,0.00028774823,0.00060416147,0.00022352693,0.00043757557],"domain_scores_gemma":[0.99945945,0.00006205843,0.000041888292,0.0002531984,0.000019092053,0.00016433065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012931877,0.0002896294,0.00043103742,0.00022123802,0.00003646875,0.00006821569,0.00009473568,0.00011497418,0.00013743287],"category_scores_gemma":[0.000013137624,0.00023123855,0.0000765995,0.00054064195,0.000021501286,0.00017028561,0.000054990167,0.00009602868,0.00015745345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006311095,0.013552875,0.9077228,0.00091783295,0.00026506235,0.00205966,0.006729542,0.000015897243,0.013544176,0.00014113718,0.0070151915,0.047404718],"study_design_scores_gemma":[0.030188201,0.00063829793,0.8642256,0.0014394296,0.00022750116,0.0011328112,0.00034780108,0.000095607065,0.07708725,0.00007392618,0.02396058,0.00058294577],"about_ca_topic_score_codex":0.000112985705,"about_ca_topic_score_gemma":0.00018874624,"teacher_disagreement_score":0.06354308,"about_ca_system_score_codex":0.000091719354,"about_ca_system_score_gemma":0.00011900937,"threshold_uncertainty_score":0.9429634},"labels":[],"label_agreement":null},{"id":"W4391409524","doi":"10.2196/54882","title":"The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial","year":2024,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Clinical endpoint; Common Terminology Criteria for Adverse Events; Adverse effect; Obinutuzumab; Internal medicine; Clinical trial","score_opus":0.1143196482836305,"score_gpt":0.49351260142056547,"score_spread":0.37919295313693496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391409524","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23886886,0.0000019211543,0.00006948961,0.00090222555,0.000008953294,0.76004374,0.000047020654,0.00002130645,0.00003647189],"genre_scores_gemma":[0.21600902,2.6874443e-7,0.00059627206,0.000009549979,0.000088359804,0.7830547,0.00004411009,0.000042685166,0.00015505092],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99667716,0.00024634524,0.0010823824,0.00049712055,0.0009054159,0.00059160055],"domain_scores_gemma":[0.9955577,0.002545445,0.0003363087,0.0006167993,0.0007978945,0.00014581157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002966079,0.0002879947,0.000865314,0.0003228766,0.0004736238,0.00011305391,0.00027499566,0.000080757054,0.000013632432],"category_scores_gemma":[0.00043810974,0.00012638958,0.00025875113,0.000792953,0.00026557755,0.00012870603,0.00017425053,0.00018804065,0.0000030777612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95620036,0.030346459,0.00078378344,0.0018766756,0.00033413933,0.000007248618,0.000858819,0.00003845238,0.000107419,0.000034061417,0.00080074585,0.008611841],"study_design_scores_gemma":[0.91763693,0.023374086,0.0011983901,0.010243475,0.00007981249,0.0000018250887,0.000033732646,0.0027967766,0.003682121,0.000013288915,0.04081286,0.00012669976],"about_ca_topic_score_codex":0.00012298788,"about_ca_topic_score_gemma":0.00014131416,"teacher_disagreement_score":0.040012114,"about_ca_system_score_codex":0.00023120792,"about_ca_system_score_gemma":0.00048128687,"threshold_uncertainty_score":0.5154018},"labels":[],"label_agreement":null},{"id":"W4391438115","doi":"10.3324/haematol.2024.285005","title":"&lt;i&gt;Erratum to&lt;/i&gt;: Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2024,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Characterization (materials science); Computational biology; Medicine; Peripheral T-cell lymphoma; Lymphoma; Biology; Internal medicine; Immunology; Nanotechnology; T cell; Materials science","score_opus":0.012532389194545813,"score_gpt":0.2569160452565248,"score_spread":0.24438365606197898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391438115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008667425,0.51838267,0.0021481204,0.40112796,0.018822614,0.017943712,0.00039703012,0.00063270674,0.03187776],"genre_scores_gemma":[0.011889724,0.8378772,0.005834497,0.008460363,0.0026593674,0.011464388,0.013079772,0.00023324159,0.108501405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968893,0.00019100076,0.0008573086,0.0011864714,0.00046473392,0.00041120526],"domain_scores_gemma":[0.9983689,0.000024302039,0.00031429174,0.0008527487,0.00022297546,0.0002167789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023752335,0.00065361697,0.0011422576,0.00026643314,0.00016385077,0.00012267203,0.00016671352,0.00033776686,0.00020285287],"category_scores_gemma":[0.00014472927,0.00041072431,0.00017262432,0.00080270873,0.000067127316,0.00015144607,0.00010543084,0.00014273345,0.000115792274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038846882,0.0020300297,0.00015755254,0.004691971,0.00029238677,0.00059221155,0.0008755635,0.00026811237,0.0024328637,0.0027355526,0.9386304,0.046904914],"study_design_scores_gemma":[0.0009295483,0.0012047185,0.0018122541,0.0029722052,0.0005925006,0.0002974345,0.00005101395,0.00034141602,0.00025992715,0.000023228335,0.9911328,0.00038294197],"about_ca_topic_score_codex":0.000008208464,"about_ca_topic_score_gemma":0.00008396696,"teacher_disagreement_score":0.39266762,"about_ca_system_score_codex":0.0011306283,"about_ca_system_score_gemma":0.00031704077,"threshold_uncertainty_score":0.9998345},"labels":[],"label_agreement":null},{"id":"W4391648206","doi":"10.1007/s00259-024-06616-x","title":"TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images — a multi-center generalizability analysis","year":2024,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; GE Healthcare","keywords":"Segmentation; Medicine; Voxel; Nuclear medicine; Computer science; Artificial intelligence; Radiology","score_opus":0.010159231511542082,"score_gpt":0.2727730223656349,"score_spread":0.2626137908540928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391648206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810496,0.011419866,0.0003220519,0.0061718156,0.00017598378,0.0001669767,0.00000854707,0.00008386743,0.0006012998],"genre_scores_gemma":[0.9941086,0.0005597058,0.0027160111,0.00239764,0.00011560424,0.0000015244002,0.000021644062,0.000053826152,0.000025408166],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9980688,0.00035773672,0.0006676212,0.0003090779,0.00035430441,0.00024244953],"domain_scores_gemma":[0.9992594,0.000026873431,0.00017286197,0.00019107749,0.000120311015,0.00022945544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007824568,0.00023306714,0.0005635639,0.0006671526,0.00005058229,0.00008343089,0.00007940466,0.000004259088,0.00010570321],"category_scores_gemma":[0.00009864073,0.00016840329,0.0002575083,0.0005320847,0.00012019785,0.00021127214,0.000055932782,0.00012877616,0.000020293113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049194274,0.0030043332,0.25105602,0.00053770014,0.0062731947,0.45081595,0.004875015,0.00028956393,0.16008523,0.00007226612,0.022404712,0.10009408],"study_design_scores_gemma":[0.022104753,0.0008524352,0.83445203,0.0012940313,0.0064228517,0.02695278,0.0020080705,0.06813997,0.002497679,0.000006612764,0.03480398,0.00046482438],"about_ca_topic_score_codex":0.000077561315,"about_ca_topic_score_gemma":0.0000013446006,"teacher_disagreement_score":0.583396,"about_ca_system_score_codex":0.00012186753,"about_ca_system_score_gemma":0.000058124,"threshold_uncertainty_score":0.68672866},"labels":[],"label_agreement":null},{"id":"W4391720393","doi":"10.7759/cureus.53972","title":"Burkitt Lymphoma With Aberrant Expression of Cytoplasmic Terminal Deoxynucleotidyl Transferase: A Case Report","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada)","funders":"","keywords":"Terminal deoxynucleotidyl transferase; Lymphoma; Immunophenotyping; Cytoplasm; Immunohistochemistry; Pathology; Biology; Lymphoblastic lymphoma; Burkitt's lymphoma; Flow cytometry; Cancer research; BCL10; Molecular biology; Medicine; TUNEL assay; Immunology; Cell biology; T cell","score_opus":0.013805479627869119,"score_gpt":0.271292559975996,"score_spread":0.2574870803481269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391720393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306834,0.003303137,0.00013150749,0.00032677336,0.00018549456,0.00037494776,0.00003531008,0.000106700994,0.0024677995],"genre_scores_gemma":[0.99811006,0.00012826032,0.0008742262,0.000054844055,0.000108575776,0.00007747084,0.00003675,0.00003593982,0.00057388394],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987544,0.000019655878,0.00033675018,0.00038394955,0.00028285073,0.00022241364],"domain_scores_gemma":[0.99922985,0.00006709625,0.000047582223,0.00042780218,0.00005974004,0.00016790352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096770986,0.0002105721,0.00035228996,0.000076238786,0.000055587996,0.000025689098,0.000048673035,0.00008683935,0.00022242732],"category_scores_gemma":[0.000015581938,0.00013277464,0.0001434159,0.00015474402,0.00007780802,0.00009679537,0.000017116232,0.000057034566,0.000024290348],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004339867,0.0012043662,0.01013433,0.0005178295,0.00030885995,0.9466802,0.0010684582,0.0000040747177,0.016618086,0.00021574087,0.002534457,0.02027963],"study_design_scores_gemma":[0.0049284,0.0017189761,0.015409611,0.0022146674,0.0011061166,0.71803606,0.00037785436,0.0002933119,0.24277309,0.000048724156,0.012784927,0.0003082708],"about_ca_topic_score_codex":0.00030049818,"about_ca_topic_score_gemma":0.00006435655,"teacher_disagreement_score":0.22864412,"about_ca_system_score_codex":0.00016883553,"about_ca_system_score_gemma":0.00026626556,"threshold_uncertainty_score":0.54143924},"labels":[],"label_agreement":null},{"id":"W4391994614","doi":"10.3390/ph17030272","title":"Therapeutic Vaccines for Follicular Lymphoma: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Estech","keywords":"Follicular lymphoma; Medicine; Lymphoma; Medical physics; Computational biology; Bioinformatics; Internal medicine; Biology","score_opus":0.13684682648835328,"score_gpt":0.4744746082156228,"score_spread":0.33762778172726954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391994614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.0382645e-7,0.98019505,0.000021097796,0.0009331185,0.0004663137,0.01764052,0.00013986087,0.00021567757,0.0003882502],"genre_scores_gemma":[0.000005828831,0.97875136,0.00010241156,0.0033950817,0.00034755556,0.0155812325,0.00023297375,0.00018138636,0.0014021563],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964189,0.00024003857,0.0015524857,0.0007949743,0.00042895513,0.0005646553],"domain_scores_gemma":[0.99749875,0.000810468,0.00032813847,0.0008451795,0.00013923904,0.00037821973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007123247,0.00090830337,0.006581455,0.00020403447,0.000072908166,0.00007932663,0.0002589221,0.000271597,0.0001521003],"category_scores_gemma":[0.00027235216,0.0004928032,0.003030545,0.00050723954,0.000033532684,0.000042255408,0.00008874512,0.00015814816,0.0015958011],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062744057,0.00035528318,3.3111462e-7,0.7740233,0.00421744,0.00016855747,0.000005593817,2.3933513e-9,9.970463e-8,0.0005710213,0.0063569895,0.21429513],"study_design_scores_gemma":[0.0006255515,0.000056730747,7.8936445e-8,0.4179245,0.11794003,0.0004910546,0.000001178032,0.000008555485,0.000002456308,0.000041952677,0.4626975,0.00021041078],"about_ca_topic_score_codex":0.0000016261375,"about_ca_topic_score_gemma":1.7740156e-7,"teacher_disagreement_score":0.45634052,"about_ca_system_score_codex":0.0005318839,"about_ca_system_score_gemma":0.00048327938,"threshold_uncertainty_score":0.99975234},"labels":[],"label_agreement":null},{"id":"W4392121666","doi":"10.15173/m.v1i35.2200","title":"Hodgkin's Lymphoma","year":2019,"lang":"en","type":"article","venue":"The Meducator","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lymphoma; Medicine; Immunology","score_opus":0.00821799385143913,"score_gpt":0.25316115004745093,"score_spread":0.2449431561960118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392121666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96222365,0.00055296964,4.7339958e-7,0.007848025,0.0005837594,0.0003508806,0.0000020552484,0.000039197752,0.028398968],"genre_scores_gemma":[0.9888815,0.000041277654,0.00011233859,0.0021298262,0.00021028945,0.000052882508,0.000006162423,0.000013854833,0.008551849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994128,0.000020308204,0.00009165721,0.00014233436,0.00016091202,0.00017201006],"domain_scores_gemma":[0.9993116,0.00007984502,0.000029198565,0.0004591862,0.000023066981,0.00009707946],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000911092,0.00009283086,0.00015422994,0.000027189748,0.00004111412,0.0000127987805,0.000085314416,0.000029950459,0.0011803388],"category_scores_gemma":[0.000022111,0.000047713103,0.00008578416,0.00008976103,0.00003254014,0.000022188118,0.000026673864,0.000026235854,0.0045002117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025821195,0.0024442843,0.76893014,0.00009263887,0.0005097708,0.00007063973,0.0027324767,7.7481025e-7,0.0033623185,0.008931849,0.08421093,0.12845597],"study_design_scores_gemma":[0.0023711035,0.00023561025,0.76326346,0.00004842766,0.00013801416,0.00015436223,0.0004994383,0.000008618054,0.011674282,0.00018086663,0.22132674,0.00009906583],"about_ca_topic_score_codex":0.000066647415,"about_ca_topic_score_gemma":0.0000017007876,"teacher_disagreement_score":0.1371158,"about_ca_system_score_codex":0.000117507356,"about_ca_system_score_gemma":0.00018464071,"threshold_uncertainty_score":0.99973273},"labels":[],"label_agreement":null},{"id":"W4392168815","doi":"10.1111/bjh.19299","title":"Correlation of T‐cell receptor constant beta‐chain 1 by flow cytometry with molecular T‐cell receptor clonality for the investigation of T‐cell lymphoproliferation","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Foundation (evidence); Medicine; Editorial board; Library science; Family medicine; Law; Political science; Computer science","score_opus":0.010241620617665053,"score_gpt":0.23256297959925865,"score_spread":0.22232135898159358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392168815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7259267,0.066474885,0.013393409,0.18453775,0.0024008597,0.003995292,0.0025885692,0.000049063732,0.0006335],"genre_scores_gemma":[0.9166019,0.004907661,0.020210922,0.051498428,0.0012806602,0.0002760071,0.0037793573,0.00025937962,0.0011857043],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964933,0.0003436896,0.0016362976,0.00040929002,0.0007787224,0.0003387496],"domain_scores_gemma":[0.9956498,0.000845771,0.0020558315,0.00031414488,0.0010058429,0.00012857688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006961422,0.00038760682,0.0015224107,0.0003034891,0.000089969966,0.00005152152,0.00021860682,0.0007728082,0.00012267074],"category_scores_gemma":[0.00013038245,0.00030316427,0.0004958952,0.00032550146,0.0004096408,0.000104538645,0.00003874511,0.00075278385,0.000010770987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006711643,0.00054649304,0.0032316037,0.0041281083,0.0010600366,0.0038552356,0.0003132461,0.00006614983,0.02414389,0.00005870152,0.9603746,0.0015507493],"study_design_scores_gemma":[0.018916272,0.0052815024,0.0003757362,0.0077077853,0.0078831175,0.044116586,0.00043823058,0.0013947958,0.78997624,0.0007063082,0.122236036,0.0009673966],"about_ca_topic_score_codex":0.000098663615,"about_ca_topic_score_gemma":0.000009166365,"teacher_disagreement_score":0.8381386,"about_ca_system_score_codex":0.00036089314,"about_ca_system_score_gemma":0.0011650891,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4392229909","doi":"10.21203/rs.3.rs-3955819/v1","title":"BR or R-CHOP induction followed by rituximab maintenance in transplant-ineligible patients with mantle cell lymphoma","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Rituximab; Medicine; Lymphoma; CHOP; Internal medicine; Induction therapy; Oncology; Cancer research; Chemotherapy","score_opus":0.027932852376303118,"score_gpt":0.3340341859810545,"score_spread":0.3061013336047514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392229909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987742,0.0028038728,0.00000766583,0.0013297619,0.0002950423,0.0028762852,0.0008120576,0.0001055487,0.004027742],"genre_scores_gemma":[0.9901523,0.0019227599,0.00016610822,0.00005667804,0.00012895503,0.0011009845,0.0012354138,0.000103691185,0.005133087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579793,0.0001858162,0.00045620365,0.0011124071,0.00151329,0.00093433773],"domain_scores_gemma":[0.9982894,0.00016835527,0.00008067059,0.00075116585,0.0003959285,0.00031448362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047874544,0.000457199,0.00073488575,0.0006715492,0.0001092822,0.0001436659,0.00024191246,0.00044413473,0.00019207633],"category_scores_gemma":[0.000059886377,0.0002944949,0.00018280624,0.00075057265,0.000121205616,0.00007019947,0.00032710153,0.0008866245,0.00038448712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01691182,0.038996294,0.64773065,0.02112764,0.0010239407,0.009258109,0.003214907,0.00004761239,0.0007293779,0.00019835077,0.22323589,0.03752539],"study_design_scores_gemma":[0.14543836,0.009052683,0.7083643,0.049711462,0.0009943729,0.00019626594,0.001802573,0.00078186224,0.020134602,0.001604563,0.05942159,0.00249736],"about_ca_topic_score_codex":0.0025443775,"about_ca_topic_score_gemma":0.00045677758,"teacher_disagreement_score":0.16381429,"about_ca_system_score_codex":0.0016954673,"about_ca_system_score_gemma":0.0011125583,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W4392239323","doi":"10.51731/cjht.2024.842","title":"Polatuzumab Vedotin (Polivy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Rituximab; Prednisone; Lymphoma; Internal medicine; Doxorubicin; Cyclophosphamide; Oncology; Chemotherapy; Political science","score_opus":0.023820182957066567,"score_gpt":0.3022941830101228,"score_spread":0.2784740000530562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392239323","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27950025,0.5773185,0.000045685,0.14020436,0.00096344127,0.0002411555,0.000017883107,0.00023875771,0.0014699666],"genre_scores_gemma":[0.99716806,0.0016274118,0.0004478894,0.00058958115,0.000026770183,0.0000044415037,0.0000019899846,0.000013620147,0.000120241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901485,0.000017080178,0.0003816801,0.00011160178,0.00012266266,0.00035214398],"domain_scores_gemma":[0.9994644,0.000046569436,0.00009645413,0.00017742552,0.000070513786,0.00014465509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020526157,0.00010638534,0.00031138118,0.00073326856,0.00010850273,0.00004725513,0.00011835213,0.00010754399,0.00004293264],"category_scores_gemma":[0.00018570908,0.00007559657,0.000112027396,0.000319978,0.00010876991,0.00006786708,0.000009269942,0.00026987304,0.00004474751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000847146,0.000030560448,0.010872192,0.0002159642,0.00013551104,0.0026852933,0.00028632302,0.0000013215423,0.000017639211,0.008541512,0.029555604,0.9476496],"study_design_scores_gemma":[0.0007177127,0.0012483064,0.039469745,0.0015533824,0.000067602654,0.0032624053,0.0018189424,0.000023890534,0.0009399374,0.0037742541,0.9470058,0.00011798288],"about_ca_topic_score_codex":0.004523864,"about_ca_topic_score_gemma":0.0013560784,"teacher_disagreement_score":0.94753164,"about_ca_system_score_codex":0.0011354515,"about_ca_system_score_gemma":0.005859298,"threshold_uncertainty_score":0.99977654},"labels":[],"label_agreement":null},{"id":"W4392240560","doi":"10.14309/crj.0000000000001280","title":"A Rare Case of Gastric Extranodal NK/T-Cell Lymphoma With Orbital Involvement","year":2024,"lang":"en","type":"article","venue":"ACG Case Reports Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Vomiting; Nausea; Epigastric pain; T-cell lymphoma; Lymphoma; Rare disease; Presentation (obstetrics); Biopsy; Gastric lymphoma; Disease; Gastroenterology; Internal medicine; Dermatology; Surgery","score_opus":0.014301785730972969,"score_gpt":0.25896397175211344,"score_spread":0.24466218602114048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392240560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879619,0.009498317,0.000092964925,0.0002000674,0.00038472543,0.0003372047,0.000015798778,0.00004580443,0.001463204],"genre_scores_gemma":[0.9977338,0.00023717563,0.0011334078,0.00006308513,0.00030358523,0.00002677185,0.000014984952,0.000041848558,0.0004453663],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980181,0.00003820531,0.0007875867,0.00034494078,0.00047104733,0.00034011566],"domain_scores_gemma":[0.9986265,0.00007464854,0.00030564875,0.00035412147,0.00020830113,0.0004308279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036312794,0.00026475496,0.00042722173,0.00028124856,0.00014593225,0.00010351459,0.000025243546,0.00007863667,0.00031212968],"category_scores_gemma":[0.000029055114,0.00016942326,0.00026679187,0.00033611315,0.00007087368,0.00017699295,0.000033209624,0.00015670563,0.000009478933],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013168911,0.0012162033,0.019135542,0.00029405154,0.0004263813,0.95888096,0.0004908146,0.0000082520155,0.0005800307,0.000019339126,0.002282581,0.016534157],"study_design_scores_gemma":[0.002940417,0.0013777555,0.0013798906,0.0006754616,0.0009647514,0.9827329,0.00083807396,0.00007219348,0.0068760887,0.000034484856,0.0019465677,0.00016143247],"about_ca_topic_score_codex":0.00037464694,"about_ca_topic_score_gemma":0.000055190354,"teacher_disagreement_score":0.023851926,"about_ca_system_score_codex":0.00042301536,"about_ca_system_score_gemma":0.00092241954,"threshold_uncertainty_score":0.69088805},"labels":[],"label_agreement":null},{"id":"W4392289092","doi":"10.7759/cureus.55183","title":"Radial Endobronchial Ultrasound to Diagnose a Case of Non-Hodgkin’s Lymphoma in the Lung: A Case Report and Literature Review","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Radiology; Lymphoma; Etiology; Lung; Ultrasound; Pneumonia; Bronchoscopy; Pathology; Internal medicine","score_opus":0.010850148033856769,"score_gpt":0.31820205568935095,"score_spread":0.3073519076554942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392289092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7465171,0.24944443,0.0000033907563,0.0016399284,0.0002588255,0.001161925,0.00007871194,0.00002037829,0.00087530806],"genre_scores_gemma":[0.9772797,0.02059219,0.00020369855,0.0011147299,0.0003030529,0.00035460838,0.000045131477,0.000019332376,0.00008753398],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987352,0.000076748445,0.0004041933,0.00038579357,0.00018070846,0.0002173962],"domain_scores_gemma":[0.9987375,0.00048703788,0.000056700435,0.0005009683,0.000052435887,0.00016531476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041623684,0.00021009635,0.00041510642,0.00008263507,0.00005057104,0.00006799038,0.00006083617,0.00008638981,0.000054480646],"category_scores_gemma":[0.00044279505,0.00012627504,0.00013829432,0.00042808248,0.00004782566,0.00008278619,0.000037289756,0.00009642173,0.0000062972717],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046514182,0.0004550861,0.004788814,0.001474986,0.00011902285,0.94183093,0.004119436,1.7449614e-7,0.000047130638,0.00021523304,0.03462053,0.01228216],"study_design_scores_gemma":[0.0015219301,0.0003993827,0.0066115665,0.0055192797,0.000552011,0.9657341,0.000217516,0.00002462928,0.00017676716,0.000034430177,0.019071685,0.0001366765],"about_ca_topic_score_codex":0.0011183063,"about_ca_topic_score_gemma":0.0005178201,"teacher_disagreement_score":0.23076262,"about_ca_system_score_codex":0.00017778427,"about_ca_system_score_gemma":0.00016877998,"threshold_uncertainty_score":0.51493466},"labels":[],"label_agreement":null},{"id":"W4392294824","doi":"10.7759/cureus.55210","title":"Primary Calvarial Lymphoma: A Case Report","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Skull; Differential diagnosis; Lesion; Radiology; Surgery; Pathology","score_opus":0.01763117324650107,"score_gpt":0.29265427924603704,"score_spread":0.27502310599953594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392294824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238058,0.010272016,0.000046085996,0.0017678358,0.0018489799,0.00037521892,0.0000233873,0.0003243022,0.061536398],"genre_scores_gemma":[0.995184,0.000087570006,0.00048752667,0.0003835501,0.0008073245,0.000071204355,0.00007259486,0.000022971273,0.0028832364],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991649,0.000011551644,0.0001961955,0.00028771922,0.00016726619,0.00017241667],"domain_scores_gemma":[0.99941933,0.000057507168,0.000021162743,0.00033158076,0.000031561252,0.00013885736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009765858,0.0001221227,0.00019394913,0.000036483292,0.000047003945,0.00004199984,0.000026887987,0.00007641316,0.00026450877],"category_scores_gemma":[0.00004464308,0.00008832628,0.0001302526,0.00010927207,0.000029339077,0.000060973365,0.000035118097,0.00003646653,0.00024100766],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038809438,0.0004839568,0.0029784217,0.00009469652,0.00026510845,0.928161,0.00013968936,1.9737034e-7,0.00013334292,0.0016027075,0.038774878,0.027327178],"study_design_scores_gemma":[0.002375431,0.00027185516,0.014746295,0.000154137,0.0006023316,0.6736523,0.0000417928,0.00014481932,0.0009509704,0.00022902373,0.3066637,0.00016737776],"about_ca_topic_score_codex":0.0006398368,"about_ca_topic_score_gemma":0.000034124205,"teacher_disagreement_score":0.2678888,"about_ca_system_score_codex":0.0004501974,"about_ca_system_score_gemma":0.00034204987,"threshold_uncertainty_score":0.3601841},"labels":[],"label_agreement":null},{"id":"W4392386270","doi":"10.1007/s10549-024-07258-1","title":"Primary MALT lymphoma of the breast: pathological and radiological characteristics","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lymphoma; Radiology; Radiological weapon; Breast cancer; Biopsy; Radiation therapy; Etiology; Pathology; Pathological; MALT lymphoma; Mammography; Cancer; Internal medicine","score_opus":0.048446132025886365,"score_gpt":0.3457668137984467,"score_spread":0.2973206817725603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392386270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815593,0.010164186,7.828699e-7,0.006441871,0.000073973046,0.00055438903,0.00061182387,0.00002941008,0.0005642641],"genre_scores_gemma":[0.9894453,0.009407645,0.00003966673,0.000089616646,0.00017042375,0.00029870126,0.000027998372,0.000012808739,0.0005078267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863863,0.000101806676,0.00018959928,0.00039409104,0.00033357783,0.00034228386],"domain_scores_gemma":[0.99924994,0.00018005095,0.000025511297,0.00023496019,0.0000863664,0.00022320461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017570447,0.00017658924,0.00034678448,0.00005854589,0.0001370505,0.000053144413,0.000056960664,0.000090592,0.00010972893],"category_scores_gemma":[0.000010237551,0.000080879334,0.00009158888,0.00018664883,0.00049226545,0.000037221598,0.00012257475,0.00008520696,0.0000082284605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071943115,0.0010662498,0.4493011,0.00014585101,0.00027459257,0.00075169187,0.0001262315,5.022389e-8,0.000568963,0.0012542991,0.00029873516,0.5454928],"study_design_scores_gemma":[0.0019162921,0.0009576593,0.98852557,0.0003006246,0.000119323304,0.0053164978,0.000037342485,0.000024051998,0.00031731278,0.00017760684,0.0022365826,0.00007111292],"about_ca_topic_score_codex":0.00037309632,"about_ca_topic_score_gemma":0.000011682264,"teacher_disagreement_score":0.5454217,"about_ca_system_score_codex":0.00050391356,"about_ca_system_score_gemma":0.00032110547,"threshold_uncertainty_score":0.32981637},"labels":[],"label_agreement":null},{"id":"W4392595924","doi":"10.3390/cancers16061090","title":"Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Children's Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Medicine; Radiomics; Nuclear medicine; Standardized uptake value; Feature selection; Radiology; Progression-free survival; Positron emission tomography; Chemotherapy; Artificial intelligence; Internal medicine; Computer science","score_opus":0.03576613156520476,"score_gpt":0.3268786021849472,"score_spread":0.29111247061974244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392595924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901866,0.0066498416,0.00014547369,0.000113231996,0.000423474,0.0004246607,0.0005657427,0.000050539085,0.0014404658],"genre_scores_gemma":[0.9965459,0.0014841417,0.0012383489,0.00010893052,0.00015435168,0.00007444735,0.00019295189,0.000027706852,0.00017319631],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988446,0.00004474272,0.00036793735,0.0003165955,0.00022522509,0.00020086375],"domain_scores_gemma":[0.99920714,0.0003070597,0.00010366873,0.00020778214,0.00005953938,0.00011481853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026699653,0.00019378739,0.00039270072,0.00013472397,0.000042515305,0.000010760171,0.000037954356,0.000022291755,0.000059312497],"category_scores_gemma":[0.00005476723,0.00014671964,0.00012760487,0.00014039104,0.000077757584,0.00006158096,0.000021136822,0.000040298553,0.000004907303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011161714,0.0015178708,0.33446488,0.0025914717,0.00114185,0.0010022471,0.0008563664,0.00048278872,0.019609276,0.0001997895,0.0026503461,0.6343669],"study_design_scores_gemma":[0.08812915,0.021255406,0.33657724,0.0044364105,0.008125254,0.002339179,0.00096489605,0.18603557,0.33531484,0.00016132455,0.015548596,0.0011121242],"about_ca_topic_score_codex":0.00049242016,"about_ca_topic_score_gemma":0.000019827925,"teacher_disagreement_score":0.6332548,"about_ca_system_score_codex":0.0026560868,"about_ca_system_score_gemma":0.00096474454,"threshold_uncertainty_score":0.6945575},"labels":[],"label_agreement":null},{"id":"W4392598142","doi":"10.1182/blood.2023021184","title":"MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Lymphoma","score_opus":0.010493719434570004,"score_gpt":0.2502497193253536,"score_spread":0.2397559998907836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392598142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078476,0.005824869,0.0000010770832,0.0005798978,0.0003482615,0.0006397002,0.000018311881,0.000025403704,0.0017777303],"genre_scores_gemma":[0.99858075,0.00060671376,0.00004346507,0.0000758591,0.00025903957,0.00011562513,0.000030474135,0.00001629235,0.00027176333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905074,0.00006440876,0.0002730615,0.0002759063,0.00016201119,0.00017390183],"domain_scores_gemma":[0.99942505,0.0002542426,0.00005526947,0.00018549942,0.000014098851,0.00006584993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017554122,0.00013657907,0.0002873344,0.00011165893,0.000041798306,0.000015105668,0.00004496643,0.0001216386,0.00007488016],"category_scores_gemma":[0.000035120032,0.00008529976,0.00008110383,0.0001681645,0.00011865546,0.000037757083,0.000060638955,0.000050274364,0.000030822022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02842584,0.056079354,0.438412,0.0010455584,0.0031453182,0.0025525857,0.006689616,0.000010421713,0.04166269,0.0041177175,0.006936015,0.41092286],"study_design_scores_gemma":[0.27899462,0.006280704,0.6560626,0.00034953133,0.001963356,0.0016025908,0.00018255232,0.00004542399,0.04747388,0.0002274214,0.006559823,0.00025747577],"about_ca_topic_score_codex":0.0004773751,"about_ca_topic_score_gemma":0.00026980077,"teacher_disagreement_score":0.4106654,"about_ca_system_score_codex":0.00028332608,"about_ca_system_score_gemma":0.00018178091,"threshold_uncertainty_score":0.34784234},"labels":[],"label_agreement":null},{"id":"W4392923906","doi":"10.1007/s12325-024-02822-z","title":"Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada)","funders":"National Cancer Institute; Kite Pharma","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Hazard ratio; Population; Oncology; Progression-free survival; Confidence interval; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.01086648479791213,"score_gpt":0.2654537285972432,"score_spread":0.25458724379933106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392923906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442793,0.053898577,0.000007823918,0.000046082627,0.00010197729,0.0011884464,0.0000387004,0.00008245108,0.00035662565],"genre_scores_gemma":[0.993356,0.005603722,0.00047430268,0.00007708412,0.00002944561,0.0001377688,0.00013481735,0.000066050176,0.000120801225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980534,0.000094286916,0.0005320675,0.0005663973,0.00039205851,0.00036182106],"domain_scores_gemma":[0.99913853,0.00015432296,0.00019857787,0.00032709213,0.000065713866,0.00011578253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012781833,0.00038813084,0.0007858702,0.0003221038,0.0000434086,0.000029164848,0.00008507823,0.00011276543,0.000027170303],"category_scores_gemma":[0.0000058263263,0.00025585137,0.000053082986,0.0006014942,0.00013661993,0.0002821391,0.000026711392,0.00014212856,0.000004446732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005108126,0.005926873,0.8595737,0.0004757833,0.00013165403,0.00023546033,0.0022922363,0.000095422896,0.0006761087,0.000029923516,0.000034551616,0.12542015],"study_design_scores_gemma":[0.03858412,0.008433924,0.8983271,0.0031001945,0.00015013352,0.000022139271,0.0003290262,0.00015906156,0.046307612,0.000031982374,0.0041366,0.0004181021],"about_ca_topic_score_codex":0.0004268269,"about_ca_topic_score_gemma":0.00037845763,"teacher_disagreement_score":0.12500206,"about_ca_system_score_codex":0.00037536738,"about_ca_system_score_gemma":0.00015648657,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W4393201929","doi":"10.1200/jco.23.01655","title":"International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Oncology; Radiation therapy; Lymphoma; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Hodgkin lymphoma; Gastroenterology","score_opus":0.1277191329791658,"score_gpt":0.47341353432658,"score_spread":0.34569440134741425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393201929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546299,0.005144503,0.0010625378,0.023532057,0.010176682,0.0006583487,0.000027273045,0.000037549,0.004731151],"genre_scores_gemma":[0.98352337,0.0020866306,0.008276241,0.0017397519,0.0037144376,0.00004503039,0.000014378446,0.000028250864,0.00057192583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711066,0.00011446232,0.0018954908,0.00026214612,0.00038157342,0.00023566971],"domain_scores_gemma":[0.9950233,0.0034218526,0.00059958984,0.00015786297,0.00046566967,0.0003317076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018845065,0.00016251659,0.0010963646,0.00017879426,0.000034818127,0.000037800986,0.00018214654,0.00031099978,0.00023759025],"category_scores_gemma":[0.0034600012,0.00010287162,0.0009654672,0.00011040937,0.00013266288,0.000114465474,0.00005261455,0.00017733709,0.00008011982],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037118478,0.003446661,0.0541389,0.00009732488,0.0016314589,0.0049127145,0.00007092516,0.0000066769003,0.00009193011,0.0013081438,0.025811817,0.9047716],"study_design_scores_gemma":[0.018254047,0.011979832,0.1376323,0.0006200863,0.0011701498,0.0029461877,0.00004377109,0.0015105953,0.0003760139,0.00069730636,0.82465637,0.00011335024],"about_ca_topic_score_codex":0.0000090495805,"about_ca_topic_score_gemma":0.000004566191,"teacher_disagreement_score":0.90465826,"about_ca_system_score_codex":0.0006934452,"about_ca_system_score_gemma":0.003031215,"threshold_uncertainty_score":0.5377245},"labels":[],"label_agreement":null},{"id":"W4393220438","doi":"10.1038/s41375-024-02231-9","title":"Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Internal medicine; Chemotherapy; Gastroenterology; Rituximab; Aggressive lymphoma; Oncology; Surgery","score_opus":0.009715735242453978,"score_gpt":0.2747426015366222,"score_spread":0.2650268662941682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393220438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034107,0.005896592,0.000009121762,0.0006484444,0.00058308296,0.0013919652,0.00023746124,0.000081388986,0.00081085885],"genre_scores_gemma":[0.9966655,0.00064041157,0.00020324493,0.0007144268,0.0004518933,0.00022369227,0.00062866596,0.00004839401,0.00042376638],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833155,0.00006724064,0.0003727413,0.0005351253,0.0003868706,0.00030645213],"domain_scores_gemma":[0.99876434,0.00040371338,0.00014482344,0.0005219405,0.000047353966,0.000117855925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095800475,0.00027725523,0.00036432734,0.000075457196,0.000064254265,0.000082928265,0.00013117195,0.00011122258,0.00006954937],"category_scores_gemma":[0.00005719012,0.00014942496,0.00012313717,0.0002599772,0.00007020399,0.00016549378,0.000023313756,0.0001270202,0.000055998553],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25481436,0.00778465,0.08535954,0.00008660205,0.0009306892,0.004992228,0.0040971865,0.000053142976,0.0004751688,0.00007246102,0.005901663,0.6354323],"study_design_scores_gemma":[0.71093136,0.0029238279,0.27507713,0.001288673,0.0002944238,0.000014615271,0.000042302465,0.00023810228,0.0024447008,0.00002983097,0.0064107818,0.0003042225],"about_ca_topic_score_codex":0.0003841162,"about_ca_topic_score_gemma":0.000056375895,"teacher_disagreement_score":0.6351281,"about_ca_system_score_codex":0.001619628,"about_ca_system_score_gemma":0.00048428756,"threshold_uncertainty_score":0.6093373},"labels":[],"label_agreement":null},{"id":"W4393385075","doi":"10.1182/blood.2023021620","title":"Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; bluebird bio; Seagen; Gilead Sciences; Leukemia and Lymphoma Society; Celgene; AstraZeneca; TG Therapeutics; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Oncology; Cytokine release syndrome; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Immunotherapy; Rituximab; Cancer; Chimeric antigen receptor","score_opus":0.0058238696159880485,"score_gpt":0.24535100752126743,"score_spread":0.23952713790527938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393385075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93123025,0.06400504,0.0000047148656,0.00050397514,0.0001743534,0.00038888585,0.0013736321,0.00007775267,0.0022413738],"genre_scores_gemma":[0.9962453,0.00042717103,0.0002371643,0.00039559754,0.00006258037,0.00008837905,0.00017851936,0.0000440823,0.0023211949],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844134,0.000036646732,0.00043372047,0.00039028964,0.00034131776,0.0003566959],"domain_scores_gemma":[0.9992893,0.000059404156,0.00006382971,0.00036444585,0.000074876516,0.00014817239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013639645,0.000255687,0.00078205724,0.00016746324,0.000031611304,0.000026359014,0.00009624925,0.00008313617,0.0004634503],"category_scores_gemma":[0.000027638527,0.00019482934,0.00024936438,0.00027269698,0.000033182587,0.000063671,0.00006280356,0.00007321155,0.000093829134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077185174,0.023048373,0.92431015,0.0027198482,0.0016671942,0.0037590684,0.0028608828,0.0000017973924,0.008102902,0.0010171167,0.019117957,0.012622852],"study_design_scores_gemma":[0.058026955,0.0023381854,0.16559283,0.00040173045,0.0017106647,0.00008774163,0.00064959377,0.0000480588,0.46730223,0.000038211758,0.3033715,0.00043230047],"about_ca_topic_score_codex":0.00009741266,"about_ca_topic_score_gemma":0.00015549969,"teacher_disagreement_score":0.7587173,"about_ca_system_score_codex":0.000116500676,"about_ca_system_score_gemma":0.00029293526,"threshold_uncertainty_score":0.794491},"labels":[],"label_agreement":null},{"id":"W4393678539","doi":"10.5281/zenodo.7013885","title":"Gene-level read counts from bulk RNA-seq data for 38 follicular lymphoma diagnostic biopsies","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"RNA-Seq; Follicular lymphoma; Lymphoma; Gene; Computational biology; Biology; Virology; Genetics; Gene expression; Transcriptome; Immunology","score_opus":0.08577851135798885,"score_gpt":0.2894450713728534,"score_spread":0.20366656001486455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393678539","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004231787,0.0011514283,0.00005253315,0.0005859186,0.00036984513,0.0011246804,0.99353474,0.00025728557,0.0025004132],"genre_scores_gemma":[0.00031664033,0.0027121543,0.0002409412,0.00034261134,0.000442987,0.0000013879365,0.9936857,0.0010726039,0.0011849271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974616,0.00017146464,0.0003743534,0.00089328474,0.00067944353,0.00041985564],"domain_scores_gemma":[0.99699134,0.00022075637,0.00020557723,0.0020014574,0.00033646752,0.00024441685],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038519115,0.0003256998,0.0004383425,0.00023940559,0.0012634797,0.0004184072,0.0015101373,0.00016606602,0.13389891],"category_scores_gemma":[0.0021082587,0.00031323446,0.000119220356,0.00031915357,0.000121102275,0.00012208128,0.0024867002,0.00018435759,0.008018493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106993655,0.0005756327,0.0000021827977,0.0001369115,0.00042939972,0.00025742603,0.00004781714,0.0000021826952,0.000034215933,0.000039098497,0.9654648,0.032903362],"study_design_scores_gemma":[0.0021152068,0.0003670685,0.000326386,0.000103503924,0.0004394708,0.00016201922,0.000056120858,0.000036188372,0.00007807797,0.00003964898,0.9959848,0.0002914979],"about_ca_topic_score_codex":0.00032961348,"about_ca_topic_score_gemma":0.0000022447437,"teacher_disagreement_score":0.12588042,"about_ca_system_score_codex":0.00053213065,"about_ca_system_score_gemma":0.000041766685,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W4393739368","doi":"10.5281/zenodo.7013884","title":"Gene-level read counts from bulk RNA-seq data for 38 follicular lymphoma diagnostic biopsies","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; RNA-Seq; Lymphoma; Gene; Follicular phase; Biology; Computational biology; Gene expression; Genetics; Transcriptome; Immunology","score_opus":0.08577851135798885,"score_gpt":0.2894450713728534,"score_spread":0.20366656001486455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393739368","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004231787,0.0011514283,0.00005253315,0.0005859186,0.00036984513,0.0011246804,0.99353474,0.00025728557,0.0025004132],"genre_scores_gemma":[0.00031664033,0.0027121543,0.0002409412,0.00034261134,0.000442987,0.0000013879365,0.9936857,0.0010726039,0.0011849271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974616,0.00017146464,0.0003743534,0.00089328474,0.00067944353,0.00041985564],"domain_scores_gemma":[0.99699134,0.00022075637,0.00020557723,0.0020014574,0.00033646752,0.00024441685],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038519115,0.0003256998,0.0004383425,0.00023940559,0.0012634797,0.0004184072,0.0015101373,0.00016606602,0.13389891],"category_scores_gemma":[0.0021082587,0.00031323446,0.000119220356,0.00031915357,0.000121102275,0.00012208128,0.0024867002,0.00018435759,0.008018493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106993655,0.0005756327,0.0000021827977,0.0001369115,0.00042939972,0.00025742603,0.00004781714,0.0000021826952,0.000034215933,0.000039098497,0.9654648,0.032903362],"study_design_scores_gemma":[0.0021152068,0.0003670685,0.000326386,0.000103503924,0.0004394708,0.00016201922,0.000056120858,0.000036188372,0.00007807797,0.00003964898,0.9959848,0.0002914979],"about_ca_topic_score_codex":0.00032961348,"about_ca_topic_score_gemma":0.0000022447437,"teacher_disagreement_score":0.12588042,"about_ca_system_score_codex":0.00053213065,"about_ca_system_score_gemma":0.000041766685,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W4393948046","doi":"10.1038/s41375-024-02239-1","title":"High-plex imaging and cellular neighborhood spatial analysis reveals multiple immune escape and suppression patterns in diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Terry Fox Research Institute","funders":"BC Cancer Foundation; Terry Fox Research Institute","keywords":"Lymphoma; Immune system; Biology; Diffuse large B-cell lymphoma; Immune escape; Immunology; Cancer research","score_opus":0.00595107593452828,"score_gpt":0.21825239909151986,"score_spread":0.21230132315699157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393948046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479028,0.01145907,0.0000990442,0.03845148,0.00042697394,0.0007925369,0.00061020703,0.000104594874,0.00015326425],"genre_scores_gemma":[0.95878446,0.0010994211,0.00011975385,0.0343584,0.0010198844,0.00014306995,0.00339353,0.00012507127,0.00095638126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670076,0.00014927729,0.0007464037,0.0011850693,0.0004909062,0.00072758034],"domain_scores_gemma":[0.9984397,0.0002835251,0.00024157896,0.00080180616,0.00004850535,0.00018482812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018214257,0.00072199514,0.0014556949,0.0007490196,0.00010123623,0.00017878982,0.00014992425,0.00063455326,0.00015639268],"category_scores_gemma":[0.000037120764,0.00057733,0.00035703936,0.00038934092,0.000060996386,0.0001031372,0.00034424404,0.0006458608,0.000039236304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017075417,0.0019318813,0.8394223,0.0024698188,0.0018098385,0.02098487,0.0008020734,0.000002988651,0.003504777,0.000009999091,0.118493944,0.010396753],"study_design_scores_gemma":[0.080708034,0.00033435784,0.8094883,0.0034061067,0.014438467,0.00020438022,0.00020348457,0.018045759,0.012537642,0.00019709143,0.058500152,0.0019362437],"about_ca_topic_score_codex":0.0062246094,"about_ca_topic_score_gemma":0.0002026257,"teacher_disagreement_score":0.08053728,"about_ca_system_score_codex":0.0009852047,"about_ca_system_score_gemma":0.00015934499,"threshold_uncertainty_score":0.9996678},"labels":[],"label_agreement":null},{"id":"W4393989179","doi":"10.1158/1538-7445.am2024-lb102","title":"Abstract LB102: Triaging oral premalignant lesions: Plasma ultrashort cell-free DNA-based liquid biopsy approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Biopsy; Medicine; Liquid biopsy; Pathology; Plasma cell; Dermatology; Cancer; Internal medicine","score_opus":0.11506196709690761,"score_gpt":0.4039929315496844,"score_spread":0.2889309644527768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741999,0.008619441,0.000040149054,0.0031416817,0.00031448907,0.0013556044,0.00012739372,0.00019932167,0.012002056],"genre_scores_gemma":[0.9949362,0.0009276198,0.0005609584,0.00009515629,0.00039834817,0.0013251473,0.000098096156,0.0000727928,0.0015856707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996731,0.000119397686,0.00037073606,0.000781402,0.0011661478,0.0008313227],"domain_scores_gemma":[0.99805707,0.0004900749,0.00003264905,0.0008075816,0.0002061844,0.00040646835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011512449,0.00026565744,0.00040444036,0.000460094,0.00022817196,0.0001778244,0.00032044656,0.00016124679,0.0006148541],"category_scores_gemma":[0.00016159215,0.00018879326,0.00022102454,0.00079546944,0.00019564206,0.00011448574,0.000111310204,0.00048298753,0.00021435319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00994632,0.010913341,0.029485425,0.011300541,0.0020160435,0.01237938,0.0027309086,0.0006598375,0.545581,0.0030624976,0.25286087,0.11906386],"study_design_scores_gemma":[0.009864075,0.0015755183,0.01996243,0.0032626032,0.00033272846,0.00014227716,0.0007045728,0.0022452052,0.91526276,0.00009743948,0.045960296,0.00059012446],"about_ca_topic_score_codex":0.00080791,"about_ca_topic_score_gemma":0.000029989602,"teacher_disagreement_score":0.36968175,"about_ca_system_score_codex":0.0009963462,"about_ca_system_score_gemma":0.0017997521,"threshold_uncertainty_score":0.76987654},"labels":[],"label_agreement":null},{"id":"W4393989657","doi":"10.1158/1538-7445.am2024-ct146","title":"Abstract CT146: AZD0466 in patients with advanced non-Hodgkin lymphoma: Efficacy and safety in an open-label phase 1 trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Open label; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine; Phases of clinical research; Clinical trial; Intensive care medicine","score_opus":0.08726353258399154,"score_gpt":0.47005823842994365,"score_spread":0.3827947058459521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377865,0.0014400933,5.726004e-7,0.0005195502,0.00013033289,0.0032924972,0.00006157773,0.000020617646,0.00075611786],"genre_scores_gemma":[0.9980147,0.00058651995,0.000089407375,0.000054609663,0.000104591934,0.00090700976,0.00008535432,0.000039808492,0.00011802708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978865,0.00009122009,0.0003160981,0.00063041196,0.0005659914,0.0005098071],"domain_scores_gemma":[0.99898654,0.00026136616,0.000027402542,0.00034688946,0.000120421784,0.00025736672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006405022,0.0001810228,0.00038507173,0.00034714243,0.000078733785,0.00015837819,0.00018126589,0.00008668889,0.00014769884],"category_scores_gemma":[0.000071627976,0.00012928928,0.000015638825,0.00071202725,0.00011692995,0.00033763115,0.00013335166,0.00023626852,0.000023365146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19035228,0.016132299,0.056555256,0.00022530153,0.00010241409,0.00092046,0.00083902566,0.000010373276,0.00081515854,0.0000807641,0.00059580035,0.7333709],"study_design_scores_gemma":[0.43538037,0.0074811243,0.55264944,0.0011802912,0.000021532733,0.0000019551806,0.00007276215,0.000077523575,0.0007331742,0.000020613177,0.0022295206,0.00015169483],"about_ca_topic_score_codex":0.001406077,"about_ca_topic_score_gemma":0.00083997886,"teacher_disagreement_score":0.7332192,"about_ca_system_score_codex":0.0011102745,"about_ca_system_score_gemma":0.00091587374,"threshold_uncertainty_score":0.5272264},"labels":[],"label_agreement":null},{"id":"W4394300159","doi":"10.6084/m9.figshare.22618420","title":"Additional file 2 of Clinicopathological characteristics, local treatment, and prognostic factors in IE/IIE primary breast lymphoma: a retrospective study of 67 patients","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Oncology; Retrospective cohort study; Lymphoma","score_opus":0.03300870902959186,"score_gpt":0.3016141171671272,"score_spread":0.26860540813753536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394300159","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3484074,0.000005714389,6.9912693e-9,0.000003504533,0.00004566586,0.0015099759,0.6499809,0.0000012587948,0.000045565295],"genre_scores_gemma":[0.05618251,0.00004054896,0.000050360843,0.000008007823,0.000042312902,0.00079014763,0.9427552,0.000019701161,0.00011118701],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99785703,0.00011841631,0.00077151746,0.00068211695,0.00033909807,0.00023182748],"domain_scores_gemma":[0.99758726,0.0011301367,0.00060314697,0.00039425772,0.00015190725,0.00013330608],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008375098,0.00038347318,0.0013428332,0.00019036856,0.000041434,0.000025812295,0.00017629823,0.00025307824,0.07418277],"category_scores_gemma":[0.00059496856,0.00027436027,0.00010988523,0.00020006018,0.00019467586,0.0000620443,0.0003218724,0.00010481922,0.00022452937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038644517,0.019963963,0.28530085,0.000047891597,0.00020249664,0.00038443645,0.00009273209,2.3328658e-8,1.0598282e-7,3.2447687e-8,0.6815705,0.012050564],"study_design_scores_gemma":[0.006897437,0.00696512,0.9210665,0.0008621038,0.00047824666,0.000027550612,0.00027611703,7.8416736e-7,0.0000023969912,0.0000013219587,0.06324264,0.00017974773],"about_ca_topic_score_codex":0.0006058486,"about_ca_topic_score_gemma":0.0004224911,"teacher_disagreement_score":0.6357657,"about_ca_system_score_codex":0.0005676948,"about_ca_system_score_gemma":0.0004326704,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W4394395294","doi":"10.6084/m9.figshare.21559447","title":"Additional file 1 of The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study","year":2022,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Retrospective cohort study; Medicine; Internal medicine; Value (mathematics); Oncology; Multicenter study; Lymphoma; Statistics; Mathematics","score_opus":0.008416353380512071,"score_gpt":0.24047980705398814,"score_spread":0.23206345367347606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394395294","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06778822,0.0000056454846,1.6753952e-9,0.000012444449,0.000039823088,0.0033802723,0.92846775,3.654435e-7,0.00030545017],"genre_scores_gemma":[0.010461983,9.80598e-7,0.00013325742,0.00003195976,0.000016714857,0.0015511315,0.9876183,0.000014561799,0.00017107658],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99827784,0.000121860816,0.00036472804,0.00039668594,0.0006889056,0.00014994724],"domain_scores_gemma":[0.99846196,0.00035119455,0.0004457973,0.00055726874,0.0001355896,0.00004820251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007352445,0.00022156003,0.00057780714,0.0000935154,0.000050259623,0.000015308078,0.00034897705,0.00006269556,0.8219653],"category_scores_gemma":[0.00016651527,0.00013389756,0.00008521376,0.00024746955,0.00008263047,0.000056254292,0.0005306218,0.00011509476,0.000034760353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006834577,0.015722755,0.2097559,0.000034616212,0.00035172983,0.000044623823,0.00008572608,5.380439e-7,2.287428e-8,5.1464166e-8,0.7721501,0.001170508],"study_design_scores_gemma":[0.0068494217,0.0012209363,0.7334853,0.0007691086,0.00033680364,0.00000832054,0.00011788999,4.8099844e-7,0.0000010813661,2.8398736e-7,0.25712162,0.00008877601],"about_ca_topic_score_codex":0.00043889237,"about_ca_topic_score_gemma":0.0002493403,"teacher_disagreement_score":0.82193047,"about_ca_system_score_codex":0.0005793421,"about_ca_system_score_gemma":0.00066058565,"threshold_uncertainty_score":0.5460184},"labels":[],"label_agreement":null},{"id":"W4394572135","doi":"10.1002/2056-4538.12370","title":"Prediction of immunochemotherapy response for diffuse large <scp>B</scp>‐cell lymphoma using artificial intelligence digital pathology","year":2024,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Research Foundation of Korea; Korea Health Industry Development Institute; Chonnam National University Hwasun Hospital; National IT Industry Promotion Agency; National Research Foundation","keywords":"Diffuse large B-cell lymphoma; Digital pathology; International Prognostic Index; Lymphoma; Medicine; Rituximab; Vincristine; Artificial intelligence; Pathology; Oncology; Internal medicine; Computer science; Cyclophosphamide; Chemotherapy","score_opus":0.24479458890027883,"score_gpt":0.4799469988756251,"score_spread":0.23515240997534625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394572135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872323,0.0043492615,0.0057999888,0.0012436198,0.0006232704,0.0004967242,0.0001594831,0.000015426975,0.00007992105],"genre_scores_gemma":[0.99565876,0.0028723893,0.0006755379,0.000116422,0.00046689418,0.000012672704,0.000009175439,0.000028204786,0.0001599659],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957227,0.0014837562,0.0014425024,0.00027121787,0.0005671054,0.00051268755],"domain_scores_gemma":[0.9783043,0.020054583,0.00030071838,0.00042571698,0.0007350388,0.00017959204],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014929279,0.00016192014,0.00061589695,0.0003792482,0.00015046615,0.000046702524,0.0003080125,0.00031924885,0.000017853601],"category_scores_gemma":[0.009267646,0.00009699103,0.00047158584,0.00038291092,0.000795967,0.00011424405,0.00012649132,0.0005868391,0.000031783144],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064233795,0.058218636,0.05383082,0.0008341072,0.0023884275,0.019073635,0.012399798,0.000053149317,0.3155813,0.0053207963,0.010118109,0.45794743],"study_design_scores_gemma":[0.051024448,0.13359368,0.26066408,0.0040897704,0.0034207103,0.040841002,0.021611478,0.020560453,0.3288027,0.09301587,0.041805927,0.0005698665],"about_ca_topic_score_codex":0.0000026603216,"about_ca_topic_score_gemma":8.5053307e-7,"teacher_disagreement_score":0.45737755,"about_ca_system_score_codex":0.00018937694,"about_ca_system_score_gemma":0.000884461,"threshold_uncertainty_score":0.99907774},"labels":[],"label_agreement":null},{"id":"W4394620469","doi":"10.14740/jh1242","title":"Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis","year":2024,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hemophagocytic lymphohistiocytosis; Lymphoma; Antibody; Immunology; Natural killer cell; Natural death; Pathology; Cytotoxicity; Biology; Disease","score_opus":0.02048483558660016,"score_gpt":0.33607417096704983,"score_spread":0.3155893353804497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394620469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715295,0.026787117,0.000024750994,0.00037371076,0.0005451459,0.00045568717,0.0000046064156,0.000014986257,0.00026453935],"genre_scores_gemma":[0.99517214,0.0020608038,0.002451717,0.000032632055,0.000096433876,0.000010771693,0.000011614129,0.000032607986,0.00013125993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738383,0.00011435336,0.0015045323,0.0003029276,0.00035738366,0.0003369802],"domain_scores_gemma":[0.9980822,0.0007266635,0.00056012033,0.00026630965,0.00016352696,0.00020113683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000256354,0.00029902818,0.0016317534,0.00040383125,0.000022672866,0.000013213707,0.00011637294,0.00019387029,0.000020509045],"category_scores_gemma":[0.000047105572,0.00017955218,0.0005419287,0.00032053227,0.00019444675,0.00006993117,0.000019911551,0.00011006194,0.0000071736094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006214263,0.028994843,0.90614194,0.0014048202,0.0014141811,0.015776059,0.0009630362,0.000017450217,0.004629215,0.00044244033,0.00022094791,0.033780828],"study_design_scores_gemma":[0.10901555,0.030923914,0.5062106,0.0031045962,0.0034668327,0.023218805,0.0003950649,0.0007796348,0.31993705,0.0000802316,0.0024005338,0.00046719093],"about_ca_topic_score_codex":0.00007149502,"about_ca_topic_score_gemma":0.000012427449,"teacher_disagreement_score":0.3999313,"about_ca_system_score_codex":0.00042844404,"about_ca_system_score_gemma":0.0010432362,"threshold_uncertainty_score":0.7321925},"labels":[],"label_agreement":null},{"id":"W4394770131","doi":"10.1200/cci.23.00255","title":"Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"JCO Clinical Cancer Informatics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"National Cancer Institute; Genentech; Bristol-Myers Squibb","keywords":"Stage (stratigraphy); Lymphoma; Overall survival; Progression-free survival; Oncology; Hodgkin lymphoma; Internal medicine; Artificial intelligence; Medicine; Computer science; Biology","score_opus":0.06404453194239833,"score_gpt":0.3941105043026188,"score_spread":0.33006597236022045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394770131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670596,0.007993396,0.008452784,0.0035359962,0.0032905554,0.0035241065,0.0016635056,0.0005465871,0.0039334362],"genre_scores_gemma":[0.9864163,0.0040966496,0.006621586,0.0007429006,0.00036343813,0.0007192574,0.00037270732,0.00005399843,0.0006131527],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976581,0.00006598009,0.0011751701,0.00027699498,0.00047186806,0.0003519065],"domain_scores_gemma":[0.99819696,0.00094369485,0.00018975977,0.00033353773,0.00010671039,0.00022933022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773514,0.0002626578,0.00060658366,0.00013302275,0.000078875,0.000086614404,0.000112095055,0.000223725,0.00003620911],"category_scores_gemma":[0.0004279004,0.00019443706,0.00020750398,0.00018281343,0.00008282162,0.00037846575,0.00009767042,0.00024670773,0.000005978967],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026685894,0.0011920177,0.46501234,0.0026872533,0.00029892154,0.0000686024,0.00080247095,0.014856147,0.0000033831584,0.0033596233,0.001964209,0.50708646],"study_design_scores_gemma":[0.016466506,0.0016379457,0.06476943,0.001095041,0.00020710238,0.0000057490956,0.0001565526,0.86416274,0.000049034945,0.0007024794,0.050504476,0.00024292969],"about_ca_topic_score_codex":0.00012953428,"about_ca_topic_score_gemma":0.0001630159,"teacher_disagreement_score":0.8493066,"about_ca_system_score_codex":0.00032075148,"about_ca_system_score_gemma":0.0004752848,"threshold_uncertainty_score":0.7928913},"labels":[],"label_agreement":null},{"id":"W4394853075","doi":"10.1002/psp4.13141","title":"Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated <scp>DLBCL</scp> from the <scp>POLARIX</scp> study","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Rituximab; Adverse effect; Pharmacokinetics; Oncology; Population; Cyclophosphamide; Dosing; Pharmacology; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.026281336400886365,"score_gpt":0.3321197062955578,"score_spread":0.30583836989467145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394853075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538441,0.039840046,0.000023589131,0.00007528499,0.0015439423,0.0041490234,0.00028632733,0.00015963732,0.000078079705],"genre_scores_gemma":[0.9972437,0.0012250013,0.000047329086,0.00026230203,0.0003263163,0.00035073998,0.00028580189,0.000108376145,0.0001504235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99439335,0.00155159,0.0013430659,0.0009834138,0.0009703661,0.0007582276],"domain_scores_gemma":[0.99169904,0.0065143206,0.0005217338,0.00044613087,0.00040518312,0.00041359622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011429422,0.0006894602,0.0013293561,0.0019273872,0.0001658867,0.00015277197,0.00035314835,0.00021034094,0.000031703563],"category_scores_gemma":[0.00055104017,0.00046574764,0.00018392927,0.0046217525,0.0001507571,0.00025835118,0.00019507424,0.00057011395,0.000025286012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055167335,0.004535275,0.97371954,0.00029484078,0.0031782845,0.00046515348,0.002537883,0.0003743781,0.008713637,0.000006494863,0.0036104023,0.0020124114],"study_design_scores_gemma":[0.028277047,0.0027345903,0.9485396,0.00025880287,0.004442752,0.000037306858,0.00090473035,0.0029874109,0.007242082,0.0000036855502,0.004453976,0.00011802102],"about_ca_topic_score_codex":0.0021888134,"about_ca_topic_score_gemma":0.000017883056,"teacher_disagreement_score":0.04339964,"about_ca_system_score_codex":0.0006777337,"about_ca_system_score_gemma":0.00027388657,"threshold_uncertainty_score":0.9997794},"labels":[],"label_agreement":null},{"id":"W4394855090","doi":"10.1101/2024.04.12.585865","title":"Mutations in the IgG B cell receptor associated with class-switched B cell lymphomas","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Francis Crick Institute; Cancer Research UK; Wellcome Trust","keywords":"breakpoint cluster region; B-cell receptor; Immunoglobulin class switching; Germinal center; B cell; Cancer research; Biology; Immunoglobulin G; Antibody; Molecular biology; Immunology; Receptor; Genetics","score_opus":0.012926649074845233,"score_gpt":0.22212488319607315,"score_spread":0.20919823412122793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394855090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915717,0.002623277,0.000010095152,0.0019010273,0.000738888,0.0018642846,0.0003850423,0.00037441822,0.00053126784],"genre_scores_gemma":[0.9965706,0.00025598006,0.0008263136,0.000679357,0.00027157855,0.001130057,0.000008640107,0.00018054544,0.000076947916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966108,0.0002222794,0.00063836796,0.0011372294,0.0007322264,0.00065905903],"domain_scores_gemma":[0.99737513,0.00026980066,0.0003719522,0.0013473162,0.0003726384,0.00026315765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063452363,0.0007368707,0.0008173469,0.00037957192,0.00014369926,0.0002865806,0.00040305252,0.0006241693,0.000099126424],"category_scores_gemma":[0.00015123836,0.0005161653,0.0002633219,0.0011030713,0.00013417088,0.000065655826,0.0002705485,0.0008876556,0.00036701505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007410735,0.021131277,0.439617,0.0055698226,0.0037846656,0.008409284,0.0014359333,0.00031031508,0.48329008,0.0030996264,0.032587014,0.000023907058],"study_design_scores_gemma":[0.009981333,0.0007725302,0.62623125,0.0038314895,0.003042411,2.609669e-7,0.00013721593,0.0005587231,0.34175426,0.000016920465,0.011890321,0.0017833059],"about_ca_topic_score_codex":0.00019367882,"about_ca_topic_score_gemma":0.000027544786,"teacher_disagreement_score":0.18661422,"about_ca_system_score_codex":0.0015440416,"about_ca_system_score_gemma":0.0019569232,"threshold_uncertainty_score":0.999729},"labels":[],"label_agreement":null},{"id":"W4394920724","doi":"10.2196/55601","title":"Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design","year":2024,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Leids Universitair Medisch Centrum; Ministerie van Volksgezondheid, Welzijn en Sport; Universitair Medisch Centrum Groningen; ZonMw; Erasmus Medisch Centrum; Universiteit Leiden; Haaglanden Medisch Centrum","keywords":"Survivorship curve; Medicine; Incidence (geometry); Retrospective cohort study; Adverse effect; Cohort; Health care; Cohort study; Quality of life (healthcare); Family medicine; Cancer; Gerontology; Internal medicine; Nursing","score_opus":0.15077164364276402,"score_gpt":0.5196606697240252,"score_spread":0.36888902608126123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394920724","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3010098,0.000014818018,0.00038797446,0.000005000192,0.000008683266,0.69841105,0.00007082585,0.00004706047,0.000044784243],"genre_scores_gemma":[0.48684594,9.809452e-8,0.000176421,7.3336156e-7,0.000022548886,0.5128751,0.00000815684,0.000059313625,0.000011739282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99345326,0.0029159635,0.00056682684,0.001171317,0.0012548122,0.0006377893],"domain_scores_gemma":[0.99335164,0.0040160893,0.00014984157,0.0006446644,0.0016120783,0.00022568874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005416825,0.00046538073,0.001298321,0.00045905105,0.00022738698,0.000118867865,0.00021432171,0.00014439781,0.000013376382],"category_scores_gemma":[0.00027713628,0.00031228043,0.00020021353,0.00070455903,0.00033943547,0.00019052513,0.00016126741,0.00017613947,0.000001598258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09208014,0.04343457,0.8331969,0.019452542,0.0012713012,0.00011394719,0.0053933025,0.000004107442,0.0028579521,0.0001406366,0.000024389255,0.0020302075],"study_design_scores_gemma":[0.05345594,0.13520938,0.66610795,0.008586344,0.00009473068,0.000009011883,0.003344086,0.00013429634,0.13237341,0.000026658554,0.00041337614,0.00024483007],"about_ca_topic_score_codex":0.0011176341,"about_ca_topic_score_gemma":0.00028496294,"teacher_disagreement_score":0.18583614,"about_ca_system_score_codex":0.0012519992,"about_ca_system_score_gemma":0.00069006765,"threshold_uncertainty_score":0.99993294},"labels":[],"label_agreement":null},{"id":"W4394921808","doi":"10.1111/bjh.19470","title":"Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"BeiGene; Regeneron Pharmaceuticals; CSL Behring; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; CHOP; Diffuse large B-cell lymphoma; Oncology; Prednisolone; Radiation therapy; Chemoimmunotherapy; Gastroenterology; Retrospective cohort study; Cyclophosphamide; Lymphoma; Surgery; Chemotherapy","score_opus":0.007356814304960758,"score_gpt":0.2515189810320495,"score_spread":0.24416216672708874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394921808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706169,0.026710764,0.000058246085,0.0003688537,0.0007340847,0.00040860657,0.000026551446,0.000045543125,0.0010304708],"genre_scores_gemma":[0.99758494,0.0011464758,0.0004917632,0.00019946806,0.00019949862,0.000016453325,0.00000777981,0.000032784865,0.00032083842],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99824387,0.00012716452,0.00061013317,0.00028027673,0.00037109654,0.00036744436],"domain_scores_gemma":[0.9990669,0.00015420651,0.00019098884,0.000162176,0.00020721013,0.00021853157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002705651,0.00018041117,0.0008583952,0.00023198011,0.00008455252,0.000085915824,0.00011160193,0.000100197256,0.000121827245],"category_scores_gemma":[0.00014558267,0.00016163585,0.0002843933,0.00026667828,0.000049953866,0.00013648844,0.000066834065,0.00020943294,0.00007527725],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027125087,0.035004586,0.23445764,0.00028818366,0.00088146696,0.69941795,0.0011653462,2.8359466e-7,0.00006661428,0.00013924691,0.012584408,0.015723014],"study_design_scores_gemma":[0.032453492,0.0015955451,0.5018247,0.000744766,0.0010023892,0.45794383,0.0009916271,0.000037959257,0.00015149181,0.000077227116,0.0030253362,0.00015167933],"about_ca_topic_score_codex":0.00006250273,"about_ca_topic_score_gemma":0.00005560687,"teacher_disagreement_score":0.26736704,"about_ca_system_score_codex":0.00059402693,"about_ca_system_score_gemma":0.00044199245,"threshold_uncertainty_score":0.6591319},"labels":[],"label_agreement":null},{"id":"W4394932930","doi":"10.1080/10428194.2024.2338851","title":"Management of relapsed/refractory mantle cell lymphoma","year":2024,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Mantle cell lymphoma; Chimeric antigen receptor; Refractory (planetary science); Medicine; Ibrutinib; Lymphoma; Oncology; Internal medicine; Immunotherapy; Biology; Chronic lymphocytic leukemia; Cancer; Leukemia","score_opus":0.020328474560353502,"score_gpt":0.28568424620108385,"score_spread":0.2653557716407303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394932930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010657661,0.94913787,0.0000074616114,0.000040579856,0.0015099556,0.0029003473,0.00043405936,0.0005196525,0.0347924],"genre_scores_gemma":[0.009282634,0.97133195,0.00090909365,0.00021754767,0.00063372526,0.0010782123,0.00095789664,0.0006302876,0.0149586275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901734,0.000295893,0.0031385233,0.0029756634,0.0016145986,0.0018019156],"domain_scores_gemma":[0.99403304,0.00046443805,0.0013811514,0.00274267,0.00021504912,0.0011636768],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00057219807,0.002888885,0.0064451983,0.0013169884,0.00035268546,0.0002644872,0.00093862275,0.0020281882,0.0002067198],"category_scores_gemma":[0.000030589767,0.0022487454,0.0028348763,0.0016351541,0.0006342015,0.00031004983,0.0010562739,0.0003180711,0.0015588632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023684818,0.0015479745,0.00004838081,0.07842087,0.0034609917,0.007710719,0.00021704171,7.3247094e-7,0.0000052186533,0.0016240054,0.011461529,0.8952657],"study_design_scores_gemma":[0.01742071,0.00070665387,0.0008581328,0.043757416,0.021926777,0.003530403,0.000261539,0.00007172686,0.00017314243,0.00016803197,0.9092758,0.0018496524],"about_ca_topic_score_codex":0.00065552944,"about_ca_topic_score_gemma":0.00001086208,"teacher_disagreement_score":0.8978143,"about_ca_system_score_codex":0.018941093,"about_ca_system_score_gemma":0.0072762915,"threshold_uncertainty_score":0.9992674},"labels":[],"label_agreement":null},{"id":"W4395466827","doi":"10.1002/ajh.27345","title":"Management of post‐autologous transplant relapse in patients with T‐cell lymphomas","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lymphoma","score_opus":0.003466785784256579,"score_gpt":0.22099655403061624,"score_spread":0.21752976824635967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395466827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961563,0.0018601479,0.000029528666,0.00078873,0.00010846887,0.00015340233,0.000007278741,0.00000925423,0.00088690117],"genre_scores_gemma":[0.9977496,0.0002874733,0.0017646773,0.00013862093,0.000008240674,0.0000055838946,0.0000059476065,0.000015605232,0.000024215586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989225,0.00004563471,0.000479555,0.00014465541,0.00021672218,0.00019088303],"domain_scores_gemma":[0.99937826,0.000086999644,0.00022341586,0.00013834884,0.000083302446,0.00008965775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008616879,0.00013237786,0.0006261063,0.000269375,0.000010741999,0.000004289527,0.00007452371,0.00003221581,0.000037992515],"category_scores_gemma":[0.0000032715304,0.000083153194,0.00011087398,0.00026024997,0.00015919351,0.000043026448,0.000011943431,0.00009226393,0.000009898889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019258659,0.0019972452,0.93328077,0.00043266237,0.00080739247,0.016581716,0.00077100866,0.000010339426,0.000027984852,0.00216583,0.00020846975,0.04179072],"study_design_scores_gemma":[0.008907031,0.010901999,0.96966827,0.0019459483,0.0008320221,0.003995749,0.00090645475,0.000016606,0.0020854631,0.00010999713,0.00046982968,0.00016061509],"about_ca_topic_score_codex":0.000046793288,"about_ca_topic_score_gemma":0.0000045566712,"teacher_disagreement_score":0.041630108,"about_ca_system_score_codex":0.000106950276,"about_ca_system_score_gemma":0.00011605522,"threshold_uncertainty_score":0.3390889},"labels":[],"label_agreement":null},{"id":"W4395689019","doi":"10.1038/s41375-024-02254-2","title":"The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MSD K.K.; Bristol-Myers Squibb Canada; Sanofi-Aventis Korea Company; Servier; Miltenyi Biotec; Takeda Pharmaceutical Company; AbbVie; Janssen Pharmaceuticals; Gilead Sciences; Roche; Novartis; Merck; GlaxoSmithKline; Celgene; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Falk Foundation","keywords":"Mantle cell lymphoma; Medicine; Bortezomib; Leukocytopenia; Internal medicine; Cytarabine; Rituximab; Autologous stem-cell transplantation; Neutropenia; Oncology; Gastroenterology; Surgery; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.018981698256178164,"score_gpt":0.28300044277037933,"score_spread":0.26401874451420115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395689019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458356,0.0037511021,0.00002525338,0.0005500569,0.000796254,0.0034573714,0.00011219312,0.000038759023,0.006685424],"genre_scores_gemma":[0.9933756,0.001768723,0.0006886835,0.00030593094,0.00035497535,0.00029211614,0.00007187969,0.000070317146,0.0030717778],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968788,0.0007623877,0.0010068149,0.00053117773,0.00041471748,0.00040609136],"domain_scores_gemma":[0.99700475,0.0016311574,0.00033938437,0.0007809355,0.00007695063,0.00016684821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018936911,0.00034435815,0.0010921246,0.00011528853,0.00015739998,0.00008602094,0.000377935,0.00012964288,0.00009145386],"category_scores_gemma":[0.00021677866,0.00018311595,0.00018150423,0.00056762865,0.00023890329,0.000106795414,0.00031962682,0.00013261488,0.000044229273],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7881023,0.010293923,0.0000739894,0.00037295918,0.00043850526,0.00075397047,0.00092234317,0.000048563827,0.0040776157,0.00056376244,0.036444847,0.15790717],"study_design_scores_gemma":[0.97059804,0.0016975654,0.0012412827,0.00082534354,0.0006650741,0.000036534693,0.00011416099,0.00093015406,0.01034968,0.00018513318,0.013135093,0.00022190744],"about_ca_topic_score_codex":0.0012413552,"about_ca_topic_score_gemma":0.00016070234,"teacher_disagreement_score":0.18249571,"about_ca_system_score_codex":0.0007236865,"about_ca_system_score_gemma":0.00069922424,"threshold_uncertainty_score":0.7467252},"labels":[],"label_agreement":null},{"id":"W4396616315","doi":"10.3390/curroncol31050195","title":"Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Seagen","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Internal medicine; Lymphoma; Classical Hodgkin lymphoma; Refractory (planetary science); Mycosis fungoides; CD30; Retrospective cohort study; Oncology; Gastroenterology; T cell; Immunology; Hodgkin lymphoma","score_opus":0.030587962952484286,"score_gpt":0.3317075844834219,"score_spread":0.30111962153093763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396616315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944374,0.0017377966,0.000039999373,0.0007988754,0.00082967634,0.001205286,0.0001981566,0.00020393931,0.000548899],"genre_scores_gemma":[0.9946187,0.0010273533,0.00034824607,0.00017927117,0.00015698501,0.00044118776,0.00214269,0.00007575535,0.0010097747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962806,0.00034425827,0.0007758253,0.0011786171,0.00065154844,0.0007691288],"domain_scores_gemma":[0.9980933,0.00044640922,0.00022491312,0.00058601185,0.0002640496,0.00038530206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021406944,0.00062262284,0.0013789649,0.0010878397,0.00011977291,0.00008107912,0.00016382246,0.00032557105,0.00059786625],"category_scores_gemma":[0.000079985104,0.00036641647,0.00033984132,0.0029699733,0.00025445444,0.00014930534,0.00010530268,0.00026326804,0.00008429202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01330453,0.03834957,0.8112315,0.00020722387,0.002590877,0.0027258138,0.0018667292,0.000027467773,0.0000060627626,0.00009245958,0.005127252,0.12447055],"study_design_scores_gemma":[0.05034464,0.01661526,0.83972174,0.00041351534,0.0036281294,0.00004635446,0.00044916134,0.0034706728,0.00008306347,0.00003588691,0.08470611,0.00048546374],"about_ca_topic_score_codex":0.00023004063,"about_ca_topic_score_gemma":0.0007909726,"teacher_disagreement_score":0.12398508,"about_ca_system_score_codex":0.009814165,"about_ca_system_score_gemma":0.0013691346,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W4396626528","doi":"10.1182/blood.2024024251","title":"Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Toronto; University Health Network; Terry Fox Research Institute; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Somatic hypermutation; BCL6; Gene rearrangement; Biology; Lymphoma; Follicular lymphoma; Cancer research; Diffuse large B-cell lymphoma; B cell; Genetics; Germinal center; Gene; Antibody; Immunology","score_opus":0.016528980564083445,"score_gpt":0.25229560774036597,"score_spread":0.23576662717628252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396626528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900955,0.0034562266,0.0000019386105,0.0005510959,0.00011469513,0.0015862021,0.00006805016,0.0001474109,0.003978866],"genre_scores_gemma":[0.9963178,0.0013465298,0.00039477876,0.0007278417,0.00010386398,0.00028418997,0.0000876098,0.000075675714,0.0006616894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976454,0.00012068407,0.00037935906,0.0008794278,0.00051188166,0.0004632714],"domain_scores_gemma":[0.9988099,0.00008455803,0.000073354415,0.00048569436,0.000055557663,0.00049096433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030480314,0.0004281376,0.00056716043,0.0002629441,0.0001144553,0.00015683055,0.00009842036,0.000110768546,0.000037494003],"category_scores_gemma":[0.000016715707,0.00032402645,0.00005091146,0.00038688292,0.000110473644,0.00028493063,0.00012245004,0.0001359918,0.000021790369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044980212,0.02768115,0.9347031,0.0004720464,0.0011839581,0.007718252,0.003432857,5.7062203e-7,0.0014830297,0.00014589855,0.0014040724,0.021325227],"study_design_scores_gemma":[0.10974586,0.011737498,0.8456588,0.0014282252,0.0045993384,0.0008660102,0.004618825,0.000059669914,0.008909391,0.00021686421,0.011099073,0.0010604616],"about_ca_topic_score_codex":0.0010845991,"about_ca_topic_score_gemma":0.00040429953,"teacher_disagreement_score":0.10929606,"about_ca_system_score_codex":0.00010563361,"about_ca_system_score_gemma":0.00016493382,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4396716955","doi":"10.14740/wjon1846","title":"Definitive Radiotherapy for Stage I Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Cohort of Unique-Dose Administration of 30 Gy in 15 Fractions and Analysis of Remission Duration","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mucosa-associated lymphoid tissue; Radiation therapy; MALT lymphoma; Stage (stratigraphy); Lymphoma; Retrospective cohort study; Cohort; Internal medicine; Gastroenterology; Gastric lymphoma; Surgery","score_opus":0.018782291479207115,"score_gpt":0.34505651908234297,"score_spread":0.32627422760313585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396716955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953916,0.0020165516,0.0007575225,0.0006678029,0.00011135584,0.00043289352,0.000113152775,0.0000056814215,0.00050344487],"genre_scores_gemma":[0.99602854,0.0018336154,0.0018478055,0.00003296961,0.00003556195,0.000021709686,0.000057436,0.000011386295,0.00013098645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840575,0.0001547763,0.0009352809,0.00016150087,0.00022411245,0.00011854781],"domain_scores_gemma":[0.99772155,0.0006779867,0.00096148835,0.00009536606,0.00046776922,0.00007584555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006470283,0.000120357035,0.0009142021,0.0011745783,0.000027388358,0.000006576218,0.000037700447,0.00011474722,0.00010654329],"category_scores_gemma":[0.00030342903,0.00009847083,0.0001945711,0.0011958678,0.00007895718,0.00009677469,0.000008047739,0.00007908805,1.4406739e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036183025,0.0042055896,0.9105494,0.0001509205,0.0062226458,0.0003577804,0.0014203504,0.00008175001,0.034788314,0.001574504,0.0005081982,0.03652225],"study_design_scores_gemma":[0.0064235376,0.0059032748,0.9629388,0.00030299518,0.002873943,0.00017168917,0.00026939297,0.001198459,0.018542953,0.00017025677,0.0011335624,0.0000711344],"about_ca_topic_score_codex":0.00014712563,"about_ca_topic_score_gemma":0.00054166623,"teacher_disagreement_score":0.05238941,"about_ca_system_score_codex":0.0016051265,"about_ca_system_score_gemma":0.0009552915,"threshold_uncertainty_score":0.419735},"labels":[],"label_agreement":null},{"id":"W4396993814","doi":"10.1681/asn.20213210s1595d","title":"Patients with Active Mantle Cell Lymphoma May Present with Monoclonal, Polyclonal, or C3-Dominant Glomerulonephritides, Which Respond to Lymphoma-Directed Therapy","year":2021,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mantle cell lymphoma; Monoclonal; Lymphoma; Mantle (geology); Medicine; Monoclonal antibody; Cancer research; Polyclonal antibodies; Immunology; Internal medicine; Geology; Geochemistry; Antibody","score_opus":0.01327185811378285,"score_gpt":0.2646752656552743,"score_spread":0.2514034075414915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396993814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846433,0.0007860992,0.000019736002,0.013773391,0.00007454426,0.0005085101,0.00005982488,0.000013902964,0.00012072847],"genre_scores_gemma":[0.97719496,0.0017225915,0.01120687,0.009010197,0.00018635481,0.00003356853,0.000011547115,0.000057079218,0.00057684584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973897,0.00029434124,0.0005967391,0.00037941698,0.00084975583,0.0004900956],"domain_scores_gemma":[0.9962923,0.00043105183,0.0012140229,0.000563537,0.0012006459,0.000298433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018683885,0.0003647496,0.0011564741,0.000096848584,0.00015688888,0.000022556154,0.00030864117,0.0000927921,0.000082473925],"category_scores_gemma":[0.00004345171,0.00018569887,0.00043669555,0.0011440747,0.0005066765,0.000106856474,0.00013392327,0.00014901602,0.000004623249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18482196,0.026888119,0.35101297,0.0001950218,0.012305237,0.0014185525,0.0060867905,0.00016776416,0.09209585,0.000019392573,0.17570794,0.14928038],"study_design_scores_gemma":[0.019606587,0.008772919,0.86318594,0.00018506667,0.00045733227,0.0010438211,0.001459079,0.000019585634,0.050728183,0.000008585372,0.054312307,0.00022061862],"about_ca_topic_score_codex":0.00045126333,"about_ca_topic_score_gemma":0.00007711984,"teacher_disagreement_score":0.51217294,"about_ca_system_score_codex":0.00046950323,"about_ca_system_score_gemma":0.0015881356,"threshold_uncertainty_score":0.757258},"labels":[],"label_agreement":null},{"id":"W4399045402","doi":"10.1111/bjh.19555","title":"Canadian cancer trials group <scp>LY</scp>.17: A randomized phase <scp>II</scp> study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐<scp>DICEP</scp>) versus R‐<scp>GDP</scp>","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; University of Calgary; Princess Margaret Cancer Centre; Queen's University; Moncton Hospital; University Health Network; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Canadian Cancer Society; Roche Canada","keywords":"Medicine; Rituximab; Gemcitabine; Autologous stem-cell transplantation; Internal medicine; Etoposide; Salvage therapy; Oncology; Diffuse large B-cell lymphoma; Interim analysis; Cyclophosphamide; Melphalan; Surgery; Lymphoma; Chemotherapy; Urology; Clinical trial","score_opus":0.04200162874759488,"score_gpt":0.33967622265958025,"score_spread":0.29767459391198536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399045402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8864257,0.10165707,0.000090425274,0.00022452793,0.0030917025,0.0061390717,0.0013798675,0.00013652802,0.0008551049],"genre_scores_gemma":[0.9821315,0.013165721,0.00054387684,0.00097168906,0.00039705983,0.0009986666,0.00018108763,0.00031901713,0.0012913855],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9840537,0.0031667766,0.0066994503,0.0016729401,0.0019031146,0.0025040533],"domain_scores_gemma":[0.9665518,0.026031846,0.0036342298,0.0008863967,0.0014020151,0.0014937061],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007180327,0.0015719495,0.009004703,0.0018301881,0.00055472757,0.00033323545,0.00096509815,0.0011837308,0.000049662925],"category_scores_gemma":[0.0069821067,0.001423238,0.0021907506,0.001218134,0.00050824735,0.00057535066,0.00019089159,0.0016784136,0.00004369418],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021961445,0.13749649,0.09786208,0.0050392393,0.025743693,0.49164805,0.09733715,0.0003843268,0.023720466,0.000561709,0.057868253,0.040377103],"study_design_scores_gemma":[0.8925292,0.009130056,0.023795761,0.0044107996,0.006745865,0.028675256,0.016982393,0.0012360028,0.012189466,0.00020115537,0.0037988585,0.00030521723],"about_ca_topic_score_codex":0.0458193,"about_ca_topic_score_gemma":0.041981064,"teacher_disagreement_score":0.87056774,"about_ca_system_score_codex":0.002165506,"about_ca_system_score_gemma":0.004160906,"threshold_uncertainty_score":0.9997029},"labels":[],"label_agreement":null},{"id":"W4399202399","doi":"10.1182/blood.2024023962","title":"Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Bendamustine; Lenalidomide; Bortezomib; Rituximab; Medicine; Oncology; Multiple myeloma; Internal medicine; Lymphoma","score_opus":0.013759621593156638,"score_gpt":0.2607973280820516,"score_spread":0.24703770648889495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421906,0.0019492828,0.00015975854,0.0005262931,0.000060056358,0.0026698096,0.000026199392,0.00006777853,0.00032173106],"genre_scores_gemma":[0.99691814,0.00012099839,0.0018442388,0.000046672143,0.00009999128,0.0007243705,0.000019832945,0.000034217523,0.00019152183],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988541,0.00004111452,0.00029744348,0.0003804865,0.00022550336,0.00020135319],"domain_scores_gemma":[0.99924695,0.00022786317,0.00008727263,0.00021937938,0.00013556745,0.00008298414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026689228,0.00020704519,0.00080945384,0.000112917754,0.000056529138,0.000034414188,0.000035173358,0.000048192167,0.0000095673895],"category_scores_gemma":[0.000056883204,0.00011339568,0.000081805265,0.00016739311,0.00011437134,0.00008438247,0.000017001108,0.00007451224,0.000002284994],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70212597,0.1150393,0.09578585,0.0048046666,0.023887362,0.0026474458,0.01299706,0.000027012191,0.0022660475,0.008186006,0.0021175423,0.030115763],"study_design_scores_gemma":[0.9740491,0.004703353,0.0059431805,0.0008687614,0.0058011715,0.00064184563,0.0016024667,0.000120116696,0.0055632344,0.00007777328,0.0004450046,0.00018397847],"about_ca_topic_score_codex":0.00024502893,"about_ca_topic_score_gemma":0.00008647606,"teacher_disagreement_score":0.27192315,"about_ca_system_score_codex":0.00003332506,"about_ca_system_score_gemma":0.00011600495,"threshold_uncertainty_score":0.46241418},"labels":[],"label_agreement":null},{"id":"W4399208036","doi":"10.1053/j.seminhematol.2024.05.005","title":"Molecular biomarkers in classic Hodgkin lymphoma","year":2024,"lang":"en","type":"review","venue":"Seminars in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"BC Cancer Foundation; Gilead Research Scholars; Gilead Sciences","keywords":"Medicine; Lymphoma; Biomarker; Malignancy; Clinical trial; Disease; Immunotherapy; Population; Oncology; Cancer; Internal medicine; Biology","score_opus":0.02873641042350275,"score_gpt":0.35066815653789835,"score_spread":0.32193174611439557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399208036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011151445,0.9929945,8.5658957e-7,0.00029030495,0.0005353162,0.0012861841,0.000020637284,0.00006513816,0.0036919375],"genre_scores_gemma":[0.0008323461,0.99728876,0.00032221604,0.000119397526,0.000034463428,0.00096032897,0.00017684173,0.00010423586,0.00016139592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699545,0.00021990089,0.001047339,0.00091109826,0.00021954002,0.0006066933],"domain_scores_gemma":[0.9986604,0.00032799278,0.00018388976,0.0006666617,0.00001837905,0.00014268902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026062352,0.0006538004,0.003286052,0.001217256,0.000015578082,0.000018114943,0.00020817858,0.00091607275,0.00006163048],"category_scores_gemma":[0.00012174756,0.00049524306,0.00063553586,0.0010856037,0.00014894293,0.000024431536,0.00016930848,0.0002844829,0.0005150823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002474708,0.00063124805,0.001254527,0.024647845,0.0007118479,0.04404727,0.00006639748,1.1602333e-7,3.7243692e-7,0.00283491,0.0048545892,0.92092615],"study_design_scores_gemma":[0.0015595147,0.00020678395,0.00006333601,0.09810277,0.0021546322,0.009674558,0.000046873094,0.000019759364,0.000026708274,0.00037414682,0.8873254,0.0004454965],"about_ca_topic_score_codex":0.00007542445,"about_ca_topic_score_gemma":0.00005338869,"teacher_disagreement_score":0.9204806,"about_ca_system_score_codex":0.0011801174,"about_ca_system_score_gemma":0.0007161064,"threshold_uncertainty_score":0.9997499},"labels":[],"label_agreement":null},{"id":"W4399305286","doi":"10.1200/jco.2024.42.16_suppl.e23165","title":"Patients’ voices matter: Translating pretreatment patient-reported outcomes into high and low health-related quality of life provides a new clinical aspect on prognosis and survival in patients with previously untreated diffuse large B‐cell lymphoma.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Intensive care medicine; Overall survival; Internal medicine; Nursing","score_opus":0.052483682107085095,"score_gpt":0.3913854228204668,"score_spread":0.3389017407133817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399305286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921956,0.0016098134,0.000002670363,0.0040657534,0.00046957273,0.0015281484,0.000026962522,0.000024670706,0.000076823366],"genre_scores_gemma":[0.9976572,0.00058669306,0.00083070225,0.00073615025,0.00006647583,0.000023283026,0.00003688938,0.000037847618,0.000024752571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99107814,0.0013266497,0.005961742,0.00058086694,0.0006621278,0.0003904983],"domain_scores_gemma":[0.99156684,0.0039941296,0.0031140004,0.0002477566,0.00030072336,0.00077657925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002370161,0.00037932262,0.0031797532,0.00023466986,0.000056298388,0.0000339899,0.000086492335,0.00038695798,0.000022565559],"category_scores_gemma":[0.001661298,0.00022092984,0.00040706788,0.0002563216,0.00020372929,0.00017350701,0.000056769735,0.00042986328,0.0000037585694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076405955,0.039602224,0.8350819,0.0003928072,0.0015140992,0.0001644819,0.0010096607,0.0000012163897,3.0146072e-7,0.00001726111,0.00019672977,0.11437877],"study_design_scores_gemma":[0.08700089,0.041417304,0.86936885,0.0010563046,0.000664347,0.0000076005626,0.000093520284,0.000029289788,0.000009341328,0.000058928654,0.00013623029,0.00015738298],"about_ca_topic_score_codex":0.0015182212,"about_ca_topic_score_gemma":0.0007341562,"teacher_disagreement_score":0.11422139,"about_ca_system_score_codex":0.00037163327,"about_ca_system_score_gemma":0.0019282376,"threshold_uncertainty_score":0.90092576},"labels":[],"label_agreement":null},{"id":"W4399481113","doi":"10.1200/jco.2024.42.16_suppl.7061","title":"Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Roche (Canada)","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; CHOP; Pathology; Cancer research; Oncology; Internal medicine","score_opus":0.06469420735463101,"score_gpt":0.41847921984842756,"score_spread":0.35378501249379657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971609,0.0016013104,0.000008964848,0.00032976302,0.000200711,0.0005577969,0.00003360335,0.0000029879236,0.00010392203],"genre_scores_gemma":[0.9988342,0.00050462264,0.00035676622,0.00017401893,0.00008543065,0.0000139662125,0.00001347281,0.000011385452,0.0000061481733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996311,0.00059176906,0.0021200418,0.0002587374,0.0004897171,0.00022872018],"domain_scores_gemma":[0.9956393,0.0030418765,0.0007986972,0.00021274929,0.00016569601,0.00014164462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031370893,0.00017596295,0.0015379762,0.00056376227,0.00002122975,0.000013798823,0.00015097865,0.00017831213,0.00001848739],"category_scores_gemma":[0.00042181328,0.00009718891,0.00036717285,0.00065977505,0.00011791196,0.00009674166,0.00005851617,0.00033209962,9.641365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009529179,0.10582783,0.86798954,0.000080288824,0.0020174736,0.00086799276,0.0021784,0.0000070541464,0.00016357156,0.00005802321,0.000014563957,0.011266069],"study_design_scores_gemma":[0.12939283,0.027627792,0.83614355,0.000093914896,0.003701035,0.000008680014,0.0019569376,0.0005950899,0.000078534686,0.000010040662,0.00031988235,0.00007171249],"about_ca_topic_score_codex":0.00020344746,"about_ca_topic_score_gemma":0.0014404539,"teacher_disagreement_score":0.11986365,"about_ca_system_score_codex":0.00033396605,"about_ca_system_score_gemma":0.0006985153,"threshold_uncertainty_score":0.39632487},"labels":[],"label_agreement":null},{"id":"W4399481144","doi":"10.1200/jco.2024.42.16_suppl.7068","title":"Impact of bridging therapy (BT) on lisocabtagene maraleucel (liso-cel) treatment in patients (pt) with R/R follicular lymphoma (FL).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Oncology; Internal medicine; Lymphoma","score_opus":0.07392619698520736,"score_gpt":0.44311054637387054,"score_spread":0.3691843493886632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486107,0.0020101583,0.000007452564,0.0013534654,0.0004918471,0.00043341375,0.000011635513,0.000011523136,0.00081945874],"genre_scores_gemma":[0.9952448,0.0032866534,0.00035153684,0.00045577702,0.00045768573,0.000016364904,0.000010005099,0.000031504595,0.00014568267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969161,0.0002870552,0.0017742342,0.00028228603,0.00044860024,0.00029172288],"domain_scores_gemma":[0.9972263,0.0012121531,0.0007736019,0.0002536515,0.00021351049,0.00032076248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007923886,0.00026822355,0.0017386349,0.00028968416,0.000023789327,0.00001710554,0.00010610763,0.00026902062,0.00009786852],"category_scores_gemma":[0.00022876944,0.00013623986,0.0010344185,0.00023233975,0.00009251313,0.00009876423,0.000019332781,0.00022499601,0.000019724397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007324594,0.013490297,0.60867524,0.000015418333,0.0016124882,0.0022190947,0.000112949856,0.000063079715,0.000025191188,0.000029385552,0.0006775827,0.3657547],"study_design_scores_gemma":[0.03608106,0.10455911,0.8515389,0.00042062206,0.0003604468,0.00012813127,0.000017840031,0.000103199636,0.0003841802,0.00002864607,0.00627603,0.00010181564],"about_ca_topic_score_codex":0.00026681897,"about_ca_topic_score_gemma":0.000034165638,"teacher_disagreement_score":0.3656529,"about_ca_system_score_codex":0.0015555213,"about_ca_system_score_gemma":0.0022171976,"threshold_uncertainty_score":0.55557},"labels":[],"label_agreement":null},{"id":"W4399481193","doi":"10.1200/jco.2024.42.16_suppl.7020","title":"Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Oncology; Hodgkin lymphoma; Phases of clinical research; Chemotherapy","score_opus":0.057857997307203125,"score_gpt":0.43845667029719165,"score_spread":0.3805986729899885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938809,0.00071244326,0.0000067021942,0.0025365634,0.0009315745,0.0013270596,0.000108918386,0.000038940227,0.00045689504],"genre_scores_gemma":[0.9959351,0.0007563212,0.0014207535,0.0007245896,0.00053772377,0.000052101597,0.00007257456,0.000054720404,0.0004461522],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99417496,0.000588425,0.0034843609,0.0006395407,0.0007334835,0.00037925658],"domain_scores_gemma":[0.9943089,0.0030529557,0.0012759531,0.00051505317,0.00034514422,0.0005019973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015570258,0.00039667438,0.0022643257,0.00031579786,0.00006874614,0.000034250235,0.00018642438,0.00047783117,0.00014211617],"category_scores_gemma":[0.0008920511,0.00021105137,0.00044794913,0.0004460338,0.0001291077,0.00021498861,0.00005821399,0.0005331731,0.000029684561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.184366,0.08866411,0.32857946,0.000012056466,0.0023861425,0.011777925,0.0010303367,0.000005004085,0.000011308277,0.0000018837163,0.0033934305,0.37977234],"study_design_scores_gemma":[0.17533952,0.21635677,0.59333175,0.0005525276,0.00083098724,0.0000434369,0.00012816416,0.00007756002,0.00005047067,0.000017541617,0.013134195,0.00013706708],"about_ca_topic_score_codex":0.000691251,"about_ca_topic_score_gemma":0.00038740758,"teacher_disagreement_score":0.37963527,"about_ca_system_score_codex":0.0016498324,"about_ca_system_score_gemma":0.0025609976,"threshold_uncertainty_score":0.8606425},"labels":[],"label_agreement":null},{"id":"W4399481260","doi":"10.1200/jco.2024.42.16_suppl.7021","title":"Mosunetuzumab with polatuzumab vedotin: Subgroup analyses in patients (pts) with primary refractory or early relapsed large B-cell lymphoma (LBCL).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Internal medicine; Lymphoma; Subgroup analysis; B-cell lymphoma","score_opus":0.06794785047623743,"score_gpt":0.41044518608994285,"score_spread":0.34249733561370543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914012,0.002542432,0.000021617312,0.00094350794,0.00064536865,0.00036411572,0.000011096522,0.000029785595,0.004040904],"genre_scores_gemma":[0.9946319,0.0007988772,0.0018745268,0.0014155217,0.0004866242,0.00001387145,0.000022288617,0.000055503344,0.00070091296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564064,0.00041720277,0.002245128,0.00044982668,0.00078786805,0.0004593531],"domain_scores_gemma":[0.99543285,0.0022293222,0.001105789,0.00034763906,0.0003824546,0.0005019368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010639849,0.00032821845,0.0020131283,0.0003833683,0.00005105523,0.000040423078,0.00019197281,0.0004701181,0.00012368678],"category_scores_gemma":[0.00046397094,0.00016778933,0.0004297156,0.0005393935,0.00017761358,0.0003116355,0.000061350045,0.00076446694,0.000055065106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047416586,0.037454013,0.7982725,0.00020022917,0.0016902133,0.018574702,0.00043235923,0.000009663702,0.000029471239,0.000056310255,0.004089446,0.09177454],"study_design_scores_gemma":[0.07027134,0.06883621,0.8208739,0.00069308624,0.0011268049,0.00031561355,0.00011381437,0.000046300953,0.00004604113,0.000019310519,0.037468936,0.00018863949],"about_ca_topic_score_codex":0.00011261758,"about_ca_topic_score_gemma":0.00020720175,"teacher_disagreement_score":0.0915859,"about_ca_system_score_codex":0.0015100854,"about_ca_system_score_gemma":0.005021257,"threshold_uncertainty_score":0.8907494},"labels":[],"label_agreement":null},{"id":"W4399481268","doi":"10.1200/jco.2024.42.16_suppl.7055","title":"A phase 1/2 study of favezelimab in combination with pembrolizumab for anti–PD-1–naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An updated analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Classical Hodgkin lymphoma; Oncology; Lymphoma; Internal medicine; Cancer research; Immunotherapy; Hodgkin lymphoma; Cancer","score_opus":0.10065436574981813,"score_gpt":0.4814330227714067,"score_spread":0.3807786570215886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960918,0.0002325115,0.00021339773,0.0019836957,0.000420018,0.000849138,0.000019453417,0.000019459643,0.00017052481],"genre_scores_gemma":[0.9979548,0.00017064216,0.0011078271,0.00030291325,0.00024310104,0.000037901056,0.000058865047,0.000028081915,0.00009590621],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952435,0.00071273476,0.0028376132,0.0004099174,0.00053202576,0.00026421473],"domain_scores_gemma":[0.9948871,0.0025211757,0.0013429549,0.0003044196,0.0006089498,0.0003353882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022735477,0.00023045306,0.0026117878,0.0007529549,0.000037540194,0.000022862001,0.0001626841,0.00038283868,0.00008707744],"category_scores_gemma":[0.00089952076,0.00013337616,0.0005512422,0.0009149009,0.00016476637,0.00023476858,0.000032041222,0.00041017757,0.0000034376471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13116337,0.2995635,0.18392003,0.00011452212,0.012324333,0.01145695,0.0014480335,0.00009184428,0.00019276285,0.00040952358,0.002999331,0.35631582],"study_design_scores_gemma":[0.1792412,0.28491294,0.51325333,0.00017045315,0.008065432,0.0002985368,0.0010098268,0.005883385,0.00009961582,0.000092226284,0.0068188366,0.00015423102],"about_ca_topic_score_codex":0.000069186004,"about_ca_topic_score_gemma":0.00041186606,"teacher_disagreement_score":0.3561616,"about_ca_system_score_codex":0.00058683736,"about_ca_system_score_gemma":0.0025730082,"threshold_uncertainty_score":0.5438922},"labels":[],"label_agreement":null},{"id":"W4399481598","doi":"10.1200/jco.2024.42.16_suppl.7053","title":"Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; ABVD; Stage (stratigraphy); Lymphoma; Dacarbazine; Overall survival; Oncology; Nuclear medicine; Chemotherapy; Surgery; Internal medicine; Vincristine","score_opus":0.07000405330839714,"score_gpt":0.4136482641684603,"score_spread":0.34364421086006314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972412,0.00026712587,0.000015390198,0.000555311,0.0008551159,0.00047959006,0.000037079142,0.000015899162,0.00053325994],"genre_scores_gemma":[0.99874264,0.00021405879,0.000380372,0.00010176317,0.00029457593,0.000009407406,0.00003754977,0.000025923968,0.0001936986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950582,0.0007908912,0.002578635,0.00043761716,0.0008259613,0.00030868952],"domain_scores_gemma":[0.9940113,0.0038269015,0.0010762429,0.00035562954,0.00036749576,0.0003624502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014695893,0.00026587394,0.0027248843,0.0004189793,0.000023970693,0.000028539482,0.00018711599,0.00037414223,0.00019368043],"category_scores_gemma":[0.00072235835,0.00016508857,0.0006448625,0.0006996067,0.00012750398,0.00016324066,0.000078504294,0.00046903244,0.000013899737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03257533,0.02031311,0.9079681,0.000020505395,0.01073622,0.0024771984,0.0005831686,0.00009606917,0.0000018028435,0.000044141045,0.00031469093,0.024869645],"study_design_scores_gemma":[0.08283528,0.039261293,0.8693434,0.00015500833,0.0062249885,0.000003554667,0.00044580802,0.0002041515,0.0000096206195,0.000018712328,0.0013716498,0.00012651506],"about_ca_topic_score_codex":0.0008978543,"about_ca_topic_score_gemma":0.0019742937,"teacher_disagreement_score":0.050259944,"about_ca_system_score_codex":0.00074146956,"about_ca_system_score_gemma":0.001483801,"threshold_uncertainty_score":0.67321163},"labels":[],"label_agreement":null},{"id":"W4399481603","doi":"10.1200/jco.2024.42.16_suppl.7056","title":"A phase 1/2 study of favezelimab in combination with pembrolizumab for heavily pretreated anti–PD-1–refractory classical Hodgkin lymphoma (cHL): An updated analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Classical Hodgkin lymphoma; Oncology; Lymphoma; Internal medicine; Brentuximab vedotin; Cancer research; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.08561850792821196,"score_gpt":0.4751666784907593,"score_spread":0.3895481705625473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996623,0.00032957585,0.00015414324,0.0014535292,0.00032257623,0.0008637505,0.000022873088,0.00002293305,0.0002076531],"genre_scores_gemma":[0.9986762,0.00012096184,0.00060013455,0.00021533633,0.00019515325,0.000035042343,0.00008357385,0.000027559028,0.000046053778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547464,0.000665033,0.0026757545,0.00040207867,0.0005133859,0.00026910278],"domain_scores_gemma":[0.9960149,0.001613751,0.0011270528,0.00029068082,0.0006089722,0.0003446545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018897665,0.00023586137,0.002553408,0.0007791983,0.000033968798,0.000025512461,0.00014882995,0.00036036686,0.00006792417],"category_scores_gemma":[0.00046973472,0.00014832953,0.0005625226,0.0009497798,0.0001520819,0.00023187131,0.00002750307,0.00035882817,0.0000028596596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048739582,0.26487303,0.40276805,0.00008762704,0.010416803,0.0052315076,0.00081219646,0.000106096246,0.00020106655,0.00025189744,0.0013098834,0.26520225],"study_design_scores_gemma":[0.12729432,0.20307298,0.6516269,0.00013246112,0.0070165107,0.00020124858,0.00044081008,0.006811714,0.00014961418,0.00006881149,0.0030536603,0.00013100082],"about_ca_topic_score_codex":0.00010584104,"about_ca_topic_score_gemma":0.00033920925,"teacher_disagreement_score":0.26507124,"about_ca_system_score_codex":0.0005447311,"about_ca_system_score_gemma":0.0018736403,"threshold_uncertainty_score":0.6048703},"labels":[],"label_agreement":null},{"id":"W4399491087","doi":"10.1016/j.ccell.2024.05.011","title":"Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; University of Victoria; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network; Spinal Cord Injury BC","funders":"Natural Sciences and Engineering Research Council of Canada; BC Cancer Foundation; Genome British Columbia; Canadian Institutes of Health Research; Genome Canada; Teva Pharmaceutical Industries; Michael Smith Health Research BC; Lymphatic Research Foundation; Bayer; Terry Fox Research Institute; AbbVie; V Foundation for Cancer Research","keywords":"Follicular lymphoma; Biology; Malignant transformation; Phenotype; Transcriptome; Tumor microenvironment; Transformation (genetics); Lymphoma; Single-cell analysis; Somatic evolution in cancer; Cell; Cancer research; Computational biology; Immunology; Gene; Genetics; Tumor cells; Gene expression","score_opus":0.009647670930777518,"score_gpt":0.23149520175491564,"score_spread":0.22184753082413813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399491087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96239793,0.03542811,0.00016833153,0.00013701014,0.000076188255,0.000470652,0.00017294894,0.000022085807,0.0011267423],"genre_scores_gemma":[0.9942346,0.0044905925,0.00032525865,0.00006835585,0.000023789897,0.00010770403,0.00006656244,0.000022573757,0.0006605204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987445,0.000040065715,0.0003783579,0.00040044315,0.00018912273,0.00024749705],"domain_scores_gemma":[0.9995386,0.000044017783,0.000067436085,0.0002087361,0.000021639798,0.00011959101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011759275,0.00020604003,0.00048936135,0.0002068328,0.00002349539,0.000019103634,0.000047525733,0.000075352524,0.00027204162],"category_scores_gemma":[0.0000014766423,0.00015833552,0.00020598424,0.0004197396,0.00006524888,0.000058862162,0.00001216595,0.00004287907,0.000017598433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013927465,0.0012978315,0.05303098,0.00077968376,0.00050815335,0.0003499973,0.00076231157,0.00014053109,0.93640655,0.000017541546,0.00072264666,0.0058444743],"study_design_scores_gemma":[0.0027477536,0.0003155463,0.039985836,0.00035988344,0.0019691924,0.000008465267,0.0004621133,0.0007371129,0.94610554,0.0000211696,0.0071012117,0.00018617677],"about_ca_topic_score_codex":0.0020270506,"about_ca_topic_score_gemma":0.00013474956,"teacher_disagreement_score":0.03183671,"about_ca_system_score_codex":0.0015793879,"about_ca_system_score_gemma":0.00015953825,"threshold_uncertainty_score":0.6456735},"labels":[],"label_agreement":null},{"id":"W4399505149","doi":"10.1158/1538-8514.synthleth24-a024","title":"Abstract A024: SOX11: An <i>Achilles heel</i> of mantle cell lymphoma enhancing sensitivity to DNA damaging agents by impairing DNA repair","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chromatin; DNA damage; Homologous recombination; Transcription factor; Cell biology; DNA repair; Biology; Histone; DNA-binding domain; Molecular biology; Cancer research; Chemistry; DNA; Genetics; Gene","score_opus":0.017109744278648097,"score_gpt":0.2964902886175709,"score_spread":0.2793805443389228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399505149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878945,0.008818675,0.0007205859,0.0006883901,0.00029153153,0.0004538899,0.000092839255,0.0002222615,0.00081736577],"genre_scores_gemma":[0.99576163,0.00049135665,0.0005703544,0.0027740465,0.00009802676,0.00004952662,0.000050753984,0.00009512937,0.00010916398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810815,0.00007858433,0.00037709938,0.00056245754,0.00043294323,0.0004407587],"domain_scores_gemma":[0.9989981,0.000064144275,0.000081526596,0.0005435375,0.00008107819,0.0002316236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002822273,0.00033429085,0.0004246141,0.00013094685,0.00008835906,0.00007313684,0.00009138331,0.00010603745,0.000046437293],"category_scores_gemma":[0.0000055293863,0.00029978377,0.00028422681,0.0002630145,0.0000481394,0.00012202678,0.000069777096,0.000102526414,0.000025388887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000860981,0.00080781727,0.0038070385,0.00041693109,0.00065101736,0.0009811554,0.0013277518,0.00011962513,0.95355797,0.000032241358,0.0006146808,0.03759769],"study_design_scores_gemma":[0.0013629175,0.00025623362,0.016347598,0.00063615467,0.00056230545,0.000050972863,0.00028301825,0.0016657489,0.9645076,0.000019891531,0.013982635,0.00032495867],"about_ca_topic_score_codex":0.00058072776,"about_ca_topic_score_gemma":0.00011089113,"teacher_disagreement_score":0.037272733,"about_ca_system_score_codex":0.00046779047,"about_ca_system_score_gemma":0.00023802863,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W4399600471","doi":"10.3324/haematol.2024.284968","title":"PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire","year":2024,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Hematopoietic stem cell transplantation; Blockade; Lymphoma; Transplantation; Hematopoietic cell; Stem cell; Hodgkin lymphoma; Bone marrow transplantation; Oncology; Haematopoiesis; Immunology; Internal medicine; Biology; Receptor","score_opus":0.013621294772128315,"score_gpt":0.26700380028615983,"score_spread":0.2533825055140315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399600471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697185,0.0060665244,0.000023505185,0.020303426,0.0002598709,0.0017258278,0.00026338574,0.00002654069,0.0016124251],"genre_scores_gemma":[0.9866002,0.00066370645,0.00023070155,0.010904945,0.00013544247,0.0005277465,0.00007482944,0.00006802726,0.00079438713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626744,0.00080153754,0.00092757243,0.0006753508,0.00071256387,0.00061552564],"domain_scores_gemma":[0.99790835,0.0010513791,0.00043447106,0.00041310338,0.00007857122,0.000114126466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007217831,0.00059354183,0.0012860439,0.00026166587,0.00009603845,0.000028409564,0.00029383737,0.00074138265,0.00040187527],"category_scores_gemma":[0.00001793462,0.00040870934,0.0003683464,0.00037024243,0.00027501895,0.000034858862,0.00009861838,0.00044500694,0.00014609263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010059428,0.014946121,0.85703033,0.015166573,0.0018067004,0.012129694,0.04632317,0.0004526329,0.01145006,0.00039376097,0.037680823,0.001614198],"study_design_scores_gemma":[0.014958039,0.0020184268,0.86675435,0.007174418,0.002768964,0.00397586,0.003149372,0.0004478061,0.09543129,0.0013883486,0.0011045411,0.000828559],"about_ca_topic_score_codex":0.0004225371,"about_ca_topic_score_gemma":0.000070021444,"teacher_disagreement_score":0.08398123,"about_ca_system_score_codex":0.0006926156,"about_ca_system_score_gemma":0.0008194094,"threshold_uncertainty_score":0.9998365},"labels":[],"label_agreement":null},{"id":"W4399617067","doi":"10.1016/j.ijpt.2024.100032","title":"Radiotherapy utilization and outcomes from a contemporary study of brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin lymphoma","year":2024,"lang":"en","type":"article","venue":"International Journal of Particle Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal","funders":"","keywords":"Brentuximab vedotin; Hodgkin lymphoma; Oncology; Medicine; Chemotherapy; Radiation therapy; Lymphoma; Internal medicine","score_opus":0.03215129974594797,"score_gpt":0.31701475499200577,"score_spread":0.2848634552460578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399617067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880085,0.009403296,0.00009803075,0.001931268,0.00022561238,0.0002934649,0.000013456813,0.0000142581075,0.000012109377],"genre_scores_gemma":[0.9920875,0.0072185267,0.00028869338,0.00018115847,0.00017451936,0.000011591616,0.000004183,0.000021945038,0.00001192261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986523,0.00009355236,0.00050972553,0.00016715056,0.00048062459,0.000096656266],"domain_scores_gemma":[0.9992,0.00021658168,0.0002508545,0.0001097613,0.0001547913,0.00006802275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023680333,0.00014252633,0.0003671012,0.0002137202,0.000014454439,0.000051204326,0.00010185804,0.000035763183,0.000062235966],"category_scores_gemma":[0.00001624204,0.00009095349,0.00007362291,0.00018149192,0.000033772292,0.0001781189,0.000009080699,0.00006675164,0.0000012160474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028323715,0.0035708004,0.8809942,0.0000057267707,0.0011223333,0.00033988018,0.0029110946,0.000023160637,0.0005788904,0.00007970462,0.00004706736,0.10749477],"study_design_scores_gemma":[0.0313237,0.0028239605,0.9602688,0.00009627062,0.000076631244,0.000053713866,0.0003811126,0.00063771824,0.003957617,0.00015905424,0.00014243845,0.00007898166],"about_ca_topic_score_codex":0.0006343148,"about_ca_topic_score_gemma":0.000038116454,"teacher_disagreement_score":0.10741579,"about_ca_system_score_codex":0.00012938875,"about_ca_system_score_gemma":0.00015339503,"threshold_uncertainty_score":0.37089756},"labels":[],"label_agreement":null},{"id":"W4399680528","doi":"10.23937/2469-5807/1510150","title":"Primary Testicular Lymphoma in Newfoundland and Labrador, Canada: A 10-Year Evaluation","year":2024,"lang":"en","type":"article","venue":"International Journal of Pathology and Clinical Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary (astronomy); Medicine; Geography","score_opus":0.09084197456603607,"score_gpt":0.4702885843492954,"score_spread":0.3794466097832593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399680528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98563755,0.005158878,0.000005950757,0.0076700645,0.000362514,0.000111082256,0.000006382441,0.000002245548,0.0010453579],"genre_scores_gemma":[0.9966122,0.0024199395,0.00018552593,0.00028189516,0.0002802885,0.0000059288413,0.000007762099,0.000005116126,0.00020134014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998236,0.00029493464,0.00042045143,0.00016746837,0.00075351325,0.00012765192],"domain_scores_gemma":[0.99754524,0.0016243499,0.000048803213,0.0000622884,0.0005882189,0.00013108726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034130432,0.000058833506,0.00020185186,0.00020485284,0.000024541165,0.000040516796,0.000072370756,0.00008802913,0.00011998651],"category_scores_gemma":[0.0021738473,0.000041525567,0.000045987785,0.00009360992,0.00016124778,0.0000652049,0.00006326925,0.00023875141,0.000006428328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006146413,0.00041639913,0.69398326,0.000026217967,0.00023197559,0.02053765,0.00007145401,0.0000011564352,0.000060221293,0.0009611431,0.0020255025,0.28107035],"study_design_scores_gemma":[0.0036524383,0.0006383986,0.98507553,0.0002818787,0.00006329009,0.0030477266,0.00005661184,0.00042508089,0.000008954836,0.001342553,0.005372194,0.000035318135],"about_ca_topic_score_codex":0.009855328,"about_ca_topic_score_gemma":0.028811606,"teacher_disagreement_score":0.29109228,"about_ca_system_score_codex":0.0005755796,"about_ca_system_score_gemma":0.0019293984,"threshold_uncertainty_score":0.99673814},"labels":[],"label_agreement":null},{"id":"W4399706553","doi":"10.1016/j.jval.2024.03.2238","title":"EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Hôpital Maisonneuve-Rosemont; ABB (Canada)","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Lymphoma; Health care; Intensive care medicine; Oncology; Internal medicine; Political science; Materials science","score_opus":0.014958049802229171,"score_gpt":0.24436470290524887,"score_spread":0.2294066531030197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988351,0.007972906,8.843668e-7,0.0017217887,0.00011114045,0.001418624,0.0001233756,0.0000136273275,0.0002866433],"genre_scores_gemma":[0.9964213,0.00095267454,0.00015111266,0.0021598542,0.000014933454,0.00009688618,0.00012786254,0.000028767472,0.000046641275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976493,0.00031010032,0.00060644577,0.00036908578,0.0005519673,0.00051307585],"domain_scores_gemma":[0.9990272,0.0002314313,0.00012499218,0.00044945165,0.0000223777,0.0001445604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043315918,0.00018946773,0.00040648266,0.00022179962,0.000044437613,0.000015046462,0.00011441982,0.000041072366,0.0000055602245],"category_scores_gemma":[0.000009223439,0.00012328166,0.00003844444,0.00057028845,0.000018259218,0.00005749688,0.00004074475,0.00015372153,0.000002806739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027397706,0.005558794,0.9645312,0.0037561646,0.000041959727,0.00081663986,0.009525913,0.00017216217,5.8833553e-8,0.00046926222,0.0023172877,0.012536609],"study_design_scores_gemma":[0.015360684,0.00071877555,0.9521714,0.0026979775,0.000018296734,0.000003231219,0.0051489254,0.00019336813,0.0000036795986,0.000005634505,0.02357243,0.000105602936],"about_ca_topic_score_codex":0.8717494,"about_ca_topic_score_gemma":0.69521785,"teacher_disagreement_score":0.17653157,"about_ca_system_score_codex":0.0056317016,"about_ca_system_score_gemma":0.002598318,"threshold_uncertainty_score":0.9981855},"labels":[],"label_agreement":null},{"id":"W4399993470","doi":"10.1016/s2352-3026(24)00143-1","title":"Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Novartis; Sierra Oncology; GlaxoSmithKline","keywords":"Medicine; Follicular lymphoma; Radiation therapy; Rituximab; Oncology; Stage (stratigraphy); Lymphoma; Internal medicine; Immunotherapy; CD20; Follicular phase; Cancer","score_opus":0.021878447465958302,"score_gpt":0.28960860053651144,"score_spread":0.26773015307055315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399993470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920648,0.0042300127,0.000043168,0.0014232995,0.00009992395,0.0018218898,0.00014539064,0.00005066187,0.000120878045],"genre_scores_gemma":[0.9986977,0.00041368793,0.00030440866,0.00013552292,0.000072721385,0.00018465528,0.000046618436,0.00003152797,0.00011313655],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99837375,0.00019733909,0.00038457525,0.0004003147,0.00029529276,0.00034872798],"domain_scores_gemma":[0.99906814,0.00022775804,0.00011138587,0.00043807394,0.00006201375,0.00009262429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022272284,0.00022898476,0.0008961404,0.000105563944,0.000056729372,0.000026604308,0.000110179106,0.000083018385,0.0000216308],"category_scores_gemma":[0.00004359346,0.00013041597,0.00008076942,0.0002059374,0.00028273166,0.00007228805,0.00002346704,0.000098445606,0.0000051802335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52450824,0.004918811,0.45220864,0.00031191317,0.0010460386,0.0023652664,0.00292183,0.000047347457,0.00007844074,0.0017838799,0.0006942323,0.009115391],"study_design_scores_gemma":[0.437101,0.003197758,0.55552286,0.00045763428,0.00022478592,0.000072712304,0.00006222997,0.00070869556,0.0007290045,0.00011622221,0.0016248149,0.00018228813],"about_ca_topic_score_codex":0.0003518111,"about_ca_topic_score_gemma":0.000092210066,"teacher_disagreement_score":0.10331421,"about_ca_system_score_codex":0.00022441855,"about_ca_system_score_gemma":0.00023816129,"threshold_uncertainty_score":0.5318209},"labels":[],"label_agreement":null},{"id":"W4400005506","doi":"10.1080/17474086.2024.2372325","title":"Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hodgkin lymphoma; Salvage therapy; Lymphoma; Intensive care medicine; Oncology; Medical physics; Internal medicine; Chemotherapy","score_opus":0.05508825183610309,"score_gpt":0.40248809726720497,"score_spread":0.34739984543110186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400005506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.0646556e-7,0.9901065,0.0000026937146,0.0047663385,0.0005186934,0.004180481,0.00003750202,0.00006592164,0.00032121822],"genre_scores_gemma":[7.668012e-7,0.98830587,0.0057662856,0.00055657496,0.0006389453,0.004422004,0.00017099312,0.00010338059,0.000035193476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976438,0.0001446366,0.00097398285,0.0007166548,0.00017992331,0.00034098103],"domain_scores_gemma":[0.99851054,0.00024213997,0.0004216388,0.000605344,0.000090899164,0.00012943201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002768215,0.0006606827,0.005310561,0.00016459679,0.000042581323,0.000012439487,0.00015898944,0.00043107505,0.000046004414],"category_scores_gemma":[0.000034738052,0.0003687807,0.0010835067,0.0001484729,0.00013813037,0.00003090123,0.00006555594,0.00010515653,0.000018948089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009620104,0.0002043346,6.490732e-7,0.31748027,0.0007101293,0.00012643442,0.000096277385,8.984259e-11,4.177013e-8,0.003104178,0.006695634,0.67157245],"study_design_scores_gemma":[0.0008059968,0.00037846674,7.690056e-7,0.21627979,0.0016031365,0.0018653957,0.000031173953,3.1067725e-7,0.000007940472,0.000024741475,0.77878624,0.0002160678],"about_ca_topic_score_codex":0.0000016178103,"about_ca_topic_score_gemma":4.185763e-7,"teacher_disagreement_score":0.77209055,"about_ca_system_score_codex":0.00009853848,"about_ca_system_score_gemma":0.0002937065,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W4400320270","doi":"10.3390/curroncol31070287","title":"Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Medicaid; Cohort; Retrospective cohort study; Lymphoma; Hodgkin lymphoma; Health care; Confidence interval","score_opus":0.021476121235594284,"score_gpt":0.3235582077613787,"score_spread":0.30208208652578444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400320270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982805,0.0019066164,0.00001637801,0.00048245452,0.0012747858,0.0055550532,0.00082954793,0.000050841652,0.000056251516],"genre_scores_gemma":[0.99415106,0.00010618782,0.000095064854,0.00009878515,0.00016969169,0.004893225,0.0003538079,0.00005041671,0.000081738224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824625,0.00006283464,0.00027978726,0.0007332189,0.00022992553,0.00044797844],"domain_scores_gemma":[0.99866515,0.0003259877,0.00007047648,0.00022982869,0.00017795448,0.00053060707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020401494,0.00032050483,0.0006981684,0.00019186261,0.00013262816,0.000055386306,0.00005330821,0.00010104841,0.000014769528],"category_scores_gemma":[0.00016716149,0.0002237692,0.00010985051,0.00010741229,0.00013706068,0.00008546985,0.00004445555,0.000089605266,0.0000029966686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001137971,0.003456687,0.9299965,0.00023655644,0.0005619838,0.00020489005,0.0007809233,7.6570075e-8,1.1984972e-7,0.00011659766,0.0006954608,0.06281226],"study_design_scores_gemma":[0.01877025,0.0070451414,0.94914234,0.00013612777,0.001309382,0.000008979933,0.00019442331,0.00010030922,8.0389077e-7,0.000071946066,0.023012912,0.00020739419],"about_ca_topic_score_codex":0.0020459567,"about_ca_topic_score_gemma":0.052560415,"teacher_disagreement_score":0.06260487,"about_ca_system_score_codex":0.001450734,"about_ca_system_score_gemma":0.00075438333,"threshold_uncertainty_score":0.9647279},"labels":[],"label_agreement":null},{"id":"W4400358109","doi":"10.1080/10428194.2024.2373323","title":"Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Transplantation; Stem cell; Autologous stem-cell transplantation; Term (time); Lymphoma; Medicine; Oncology; Internal medicine; Biology; Cell biology; Astronomy; Physics","score_opus":0.01213021060018144,"score_gpt":0.24807137991661388,"score_spread":0.23594116931643244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400358109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791878,0.013970055,0.00044837984,0.000090187685,0.0008757653,0.0015582122,0.0004978805,0.0002608459,0.0031109028],"genre_scores_gemma":[0.9910398,0.004008711,0.00082739047,0.00021719834,0.00020844363,0.00036884964,0.00048666802,0.00016891604,0.002674039],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954735,0.00008928356,0.0015284315,0.0012739907,0.00071791356,0.0009168744],"domain_scores_gemma":[0.99724126,0.0006278276,0.0005368031,0.00088839274,0.00025703324,0.0004486771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035988208,0.00086575956,0.0015424455,0.00048113518,0.00019611273,0.000091205526,0.00033855438,0.0005619298,0.00005771611],"category_scores_gemma":[0.000016995673,0.0007535684,0.00080954627,0.0006105417,0.00034514946,0.0003304668,0.00008779718,0.00007147586,0.00003709899],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00522226,0.0021156985,0.14504592,0.020301966,0.0013152871,0.0034799655,0.004450531,0.000042730866,0.033710387,0.0019496664,0.0036450713,0.7787205],"study_design_scores_gemma":[0.04587828,0.001556137,0.54628134,0.0017299243,0.0026407042,0.001957075,0.0004003157,0.0025194255,0.3939624,0.00020452445,0.001913796,0.0009560666],"about_ca_topic_score_codex":0.0004887653,"about_ca_topic_score_gemma":0.00008321425,"teacher_disagreement_score":0.77776444,"about_ca_system_score_codex":0.0035935184,"about_ca_system_score_gemma":0.0034904324,"threshold_uncertainty_score":0.9994915},"labels":[],"label_agreement":null},{"id":"W4400390802","doi":"10.1016/j.jtct.2024.06.025","title":"Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Transplantation; Chimeric antigen receptor; Lymphoma; Hematopoietic cell; Hematopoietic stem cell transplantation; Cell therapy; Oncology; Intensive care medicine; Immunology; Internal medicine; Stem cell; Haematopoiesis; T cell; Biology; Immune system","score_opus":0.02285975617575238,"score_gpt":0.3010973140132257,"score_spread":0.27823755783747334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400390802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095455,0.016482038,0.01228291,0.004995322,0.00010854985,0.0044042226,0.00067338056,0.000041862808,0.000057173886],"genre_scores_gemma":[0.8072185,0.1866235,0.003953213,0.0008225914,0.00006953724,0.0005645845,0.0006598383,0.000057613008,0.00003064054],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977288,0.00036794483,0.0007150499,0.00065106276,0.00025844597,0.0002786991],"domain_scores_gemma":[0.99737847,0.0019041977,0.00028807242,0.00018550313,0.00013731548,0.000106421634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014547136,0.00040890943,0.00059878075,0.00008557908,0.0004212679,0.00013496126,0.00007667659,0.00014466561,0.0000028559605],"category_scores_gemma":[0.000007327409,0.00026966786,0.00040272492,0.00025476638,0.00049844914,0.0002289983,0.000004009709,0.00013907313,1.8661923e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053005014,0.0050997343,0.022951597,0.017403705,0.007712387,0.00019543248,0.345907,0.000053518394,0.25684798,0.017105116,0.00042196646,0.27329654],"study_design_scores_gemma":[0.26411602,0.011655712,0.09096674,0.0032326323,0.018403832,0.0008622653,0.027045673,0.00668006,0.557115,0.0039573875,0.013689865,0.0022747703],"about_ca_topic_score_codex":0.00007934985,"about_ca_topic_score_gemma":0.000036127876,"teacher_disagreement_score":0.31886134,"about_ca_system_score_codex":0.000027462835,"about_ca_system_score_gemma":0.00009380038,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W4400457441","doi":"10.1038/s41591-024-03175-4","title":"Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study","year":2024,"lang":"en","type":"erratum","venue":"Nature Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Follicular phase; Lymphoma; Medicine; Internal medicine; Computational biology; Cancer research; Biology","score_opus":0.01716661525465423,"score_gpt":0.34758894078243563,"score_spread":0.3304223255277814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400457441","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07175783,0.4485457,0.000012832203,0.11030382,0.2891676,0.010257945,0.00020817267,0.0006161548,0.06912994],"genre_scores_gemma":[0.51354367,0.0031853612,0.000018920851,0.0035255023,0.013981727,0.00086637755,0.0016033353,0.00021203423,0.46306306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516934,0.00023945374,0.0009825684,0.0012637657,0.0016800163,0.0006648302],"domain_scores_gemma":[0.99769914,0.0002714834,0.000224044,0.001264945,0.00020282989,0.0003375404],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009289132,0.0009933492,0.0018563042,0.0007064759,0.00018096599,0.000053039937,0.00039773036,0.0017719425,0.00067762454],"category_scores_gemma":[0.00035198897,0.00053035363,0.00047494832,0.0014223888,0.00023693804,0.00005687109,0.00007720783,0.0032097164,0.00013764287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047261163,0.0047353823,0.0011914268,0.00040561846,0.0011922851,0.009600507,0.0021366847,6.806149e-7,0.000027031143,0.00003560659,0.95011985,0.030082304],"study_design_scores_gemma":[0.023322724,0.003959052,0.02339846,0.003451709,0.0048046703,0.00073173054,0.0016966568,0.00020874637,0.000097013,0.000043018925,0.9378401,0.00044608934],"about_ca_topic_score_codex":0.0006379985,"about_ca_topic_score_gemma":0.00088205526,"teacher_disagreement_score":0.44536033,"about_ca_system_score_codex":0.0011080591,"about_ca_system_score_gemma":0.0007683937,"threshold_uncertainty_score":0.9997148},"labels":[],"label_agreement":null},{"id":"W4401045493","doi":"10.1111/bjh.19655","title":"Rolling the <scp>DICEP</scp> on lymphoma salvage treatments? Choose wisely","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Etoposide; Medicine; Salvage therapy; Lymphoma; Internal medicine; Cyclophosphamide; Oncology; Surgery; Transplantation; Autologous stem-cell transplantation; Chemotherapy","score_opus":0.013722826710478291,"score_gpt":0.2684085778397481,"score_spread":0.2546857511292698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429345,0.048774406,0.000024403931,0.0023984958,0.0008300382,0.0002680006,0.000018261408,0.000051100793,0.004700774],"genre_scores_gemma":[0.99301636,0.0042342134,0.00020255179,0.00096030795,0.0003873116,0.000026569805,0.000009231209,0.000042623342,0.0011208433],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982288,0.00013694521,0.0006108635,0.00025990757,0.00038480034,0.00037869986],"domain_scores_gemma":[0.99844354,0.00078478863,0.0002110945,0.00021434067,0.00013002717,0.00021623247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032235926,0.0002205248,0.0007101145,0.00018008126,0.00016245777,0.0001529752,0.00016978363,0.00014338273,0.00007822161],"category_scores_gemma":[0.0002950574,0.0001522382,0.00042417814,0.0002129125,0.00012523128,0.00012667538,0.000034009947,0.00022243042,0.00021102025],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010879412,0.0024928937,0.010194588,0.00021439535,0.0031953873,0.60010535,0.001055451,0.000024629355,0.00018777675,0.0029549943,0.08151888,0.29794684],"study_design_scores_gemma":[0.0076815565,0.0016475144,0.098330334,0.0028438095,0.0015978738,0.79875,0.00051344314,0.000121964,0.003920778,0.001645535,0.08285234,0.000094849085],"about_ca_topic_score_codex":0.000080964724,"about_ca_topic_score_gemma":0.0000138174855,"teacher_disagreement_score":0.29785198,"about_ca_system_score_codex":0.00030631231,"about_ca_system_score_gemma":0.00038781986,"threshold_uncertainty_score":0.6208094},"labels":[],"label_agreement":null},{"id":"W4401314113","doi":"10.7759/cureus.66124","title":"Efficacy and Safety of Bendamustine-Rituximab as Frontline Therapy for Indolent Non-Hodgkin Lymphoma: A Real-World, Single-Center, Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; McGill University","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Internal medicine; Neutropenia; Adverse effect; Follicular lymphoma; Common Terminology Criteria for Adverse Events; Retrospective cohort study; Lymphoma; Nausea; Febrile neutropenia; Surgery; Oncology; Chemotherapy","score_opus":0.025863549080198164,"score_gpt":0.3234013393008758,"score_spread":0.2975377902206776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401314113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877766,0.0054847794,0.000045181736,0.0005757972,0.00042866374,0.0032797628,0.00015467627,0.00009933612,0.0021552073],"genre_scores_gemma":[0.99686235,0.0013943409,0.0004991929,0.00010382507,0.0002916498,0.00029536764,0.00008131036,0.000053756616,0.00041821867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983711,0.00003729927,0.00045414217,0.00056286866,0.0002906373,0.00028394576],"domain_scores_gemma":[0.9990382,0.0001877468,0.00010182843,0.00038350947,0.00014266145,0.0001460293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021060345,0.0002939739,0.00066845835,0.00014060992,0.00008254103,0.00004266316,0.00008484186,0.00007651355,0.00006831978],"category_scores_gemma":[0.000069817834,0.00021810236,0.00016436444,0.00024589244,0.000073744355,0.00007373738,0.000064864296,0.00006640797,0.000012116627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019501725,0.10532009,0.53831977,0.00062569184,0.005948591,0.0009007845,0.0126200905,0.0000037838572,0.00344051,0.0024494037,0.009248621,0.30162093],"study_design_scores_gemma":[0.10014075,0.014965882,0.86232084,0.0008440003,0.0007599028,0.00008366507,0.00067034026,0.00020660364,0.004692185,0.00018919367,0.014782454,0.00034419517],"about_ca_topic_score_codex":0.00063586596,"about_ca_topic_score_gemma":0.00030800357,"teacher_disagreement_score":0.32400104,"about_ca_system_score_codex":0.0006110537,"about_ca_system_score_gemma":0.00016378028,"threshold_uncertainty_score":0.8893956},"labels":[],"label_agreement":null},{"id":"W4401392108","doi":"10.1038/s41408-024-01111-w","title":"Identification of genetic subtypes in follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; Vector Institute; Princess Margaret Cancer Centre; Queen's University; University of Toronto; University Health Network","funders":"National Cancer Institute; Terry Fox Research Institute; Government of Canada; Deutsche Forschungsgemeinschaft; National Institutes of Health; Princess Margaret Cancer Foundation; Leukemia and Lymphoma Society of Canada; F. Hoffmann-La Roche; Génome Québec; Canadian Institutes of Health Research; Else Kröner-Fresenius-Stiftung; Leukemia and Lymphoma Society","keywords":"Identification (biology); Follicular lymphoma; Lymphoma; Medicine; Computational biology; Hematology; Internal medicine; Biology; Bioinformatics; Immunology; Oncology; Genetics; Pathology","score_opus":0.010477757073206589,"score_gpt":0.2798505639844227,"score_spread":0.2693728069112161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401392108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415396,0.057205006,0.000026410427,0.00067777885,0.00029828187,0.00009995464,0.0000057219713,0.000010282511,0.00013696337],"genre_scores_gemma":[0.9938968,0.005510137,0.000113304915,0.000051272094,0.00021656955,0.000029428582,0.0000014426143,0.000010879831,0.00017016828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992436,0.000019039337,0.00031141288,0.00011743158,0.00019385513,0.00011463963],"domain_scores_gemma":[0.9997029,0.000018359024,0.00006332678,0.00010090639,0.000050956758,0.000063555264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001177222,0.00007065979,0.0001534706,0.00013804394,0.00002167634,0.000034731034,0.000041785475,0.000036089077,0.00011341292],"category_scores_gemma":[0.000011906738,0.00005291435,0.00009621488,0.00018845459,0.000017485869,0.00004755921,0.000007821416,0.000044853725,0.0000132323075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008119151,0.0011002945,0.7776253,0.0003035848,0.00080729346,0.002128099,0.00060563546,0.000096981756,0.027040947,0.00034350686,0.0013631957,0.18850398],"study_design_scores_gemma":[0.0026048224,0.00014263878,0.9163316,0.00064132386,0.00057328545,0.0010770198,0.0000432879,0.00024549695,0.07537966,0.00027449496,0.0026182842,0.00006809015],"about_ca_topic_score_codex":0.00011553024,"about_ca_topic_score_gemma":0.000031669933,"teacher_disagreement_score":0.18843588,"about_ca_system_score_codex":0.0001415835,"about_ca_system_score_gemma":0.00029574113,"threshold_uncertainty_score":0.21577847},"labels":[],"label_agreement":null},{"id":"W4401420883","doi":"10.3324/haematol.2024.285973","title":"A &lt;i&gt;nu&lt;/i&gt; mouse model of diffuse large B-cell lymphoma in constitutional &lt;i&gt;Atm&lt;/i&gt; loss","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Chemistry; Medicine; Internal medicine","score_opus":0.019798043463003054,"score_gpt":0.25487065980390505,"score_spread":0.23507261634090199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401420883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95659095,0.015364284,0.0007571866,0.0013723896,0.0004087137,0.001369613,0.00087616115,0.00047389526,0.022786802],"genre_scores_gemma":[0.99065703,0.0023955423,0.0017879119,0.00062528247,0.000116420124,0.0005435034,0.00031371074,0.00007883378,0.0034817602],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99493676,0.00018679112,0.0013464064,0.0013023647,0.0010249623,0.0012026922],"domain_scores_gemma":[0.9973031,0.00056314655,0.00030033724,0.0010693871,0.00024388812,0.0005201276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005049766,0.0008520006,0.0017750784,0.0005472137,0.0002472279,0.000098441575,0.00044660302,0.0006399423,0.00050225743],"category_scores_gemma":[0.0002656422,0.00065430667,0.0006753111,0.0006910154,0.0010209555,0.00026707223,0.0003510692,0.00022855871,0.00080219714],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088305655,0.030593337,0.008344796,0.0016203737,0.0008119714,0.010754372,0.0012210624,0.0003254694,0.06360793,0.85108674,0.02928398,0.0014669355],"study_design_scores_gemma":[0.15486154,0.004268244,0.03431909,0.0067607313,0.0044049127,0.009921715,0.00031100554,0.12805465,0.12975846,0.01897997,0.50232494,0.006034733],"about_ca_topic_score_codex":0.000014413274,"about_ca_topic_score_gemma":0.00014756416,"teacher_disagreement_score":0.83210677,"about_ca_system_score_codex":0.000683247,"about_ca_system_score_gemma":0.0010559228,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W4401437309","doi":"10.1111/bjh.19698","title":"Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Follicular lymphoma; Radiation therapy; Oncology; Medicine; Stage (stratigraphy); Internal medicine; Lymphoma; Cohort; Gene; Bioinformatics; Biology; Genetics","score_opus":0.015915330690542677,"score_gpt":0.25425456712591393,"score_spread":0.23833923643537125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401437309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564863,0.042016152,0.000028745433,0.0010179282,0.000051414994,0.00025159653,0.000009447381,0.000020552441,0.00011786437],"genre_scores_gemma":[0.9945357,0.00450028,0.00068481395,0.00011115774,0.000039390885,0.000030709976,0.000022116035,0.000018874147,0.000056951896],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99916184,0.000064043605,0.00033383412,0.00015194104,0.00013653706,0.00015182648],"domain_scores_gemma":[0.99956644,0.00010111348,0.00010162624,0.000052744137,0.000088100256,0.00008995316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106183885,0.0001033632,0.0003875678,0.00023215418,0.000039107243,0.000072478295,0.000029666971,0.000077651704,0.00002764446],"category_scores_gemma":[0.000033068023,0.00008466659,0.00007217201,0.00024495836,0.000063274834,0.00012608436,0.000006225612,0.00006337316,0.000002739899],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029296346,0.0018161809,0.30915236,0.00011896304,0.00076228834,0.28866914,0.00054644304,0.000013949806,0.0012280177,0.0002028139,0.0003744433,0.39682245],"study_design_scores_gemma":[0.010062907,0.002300593,0.45161498,0.0011654434,0.00030868425,0.50541824,0.00015341683,0.00025357664,0.02450974,0.000085163054,0.0039720046,0.00015523043],"about_ca_topic_score_codex":0.00014178672,"about_ca_topic_score_gemma":0.00006994554,"teacher_disagreement_score":0.3966672,"about_ca_system_score_codex":0.00014261785,"about_ca_system_score_gemma":0.00017245908,"threshold_uncertainty_score":0.34526035},"labels":[],"label_agreement":null},{"id":"W4401498692","doi":"10.1101/2024.08.09.24311704","title":"Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in early-stage follicular lymphoma: TROG99.03","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Hazard ratio; Cyclophosphamide; Vincristine; Progression-free survival; Oncology; Surgery; Lymphoma; Overall survival; Chemotherapy; Confidence interval","score_opus":0.007033545226867226,"score_gpt":0.23611348046363703,"score_spread":0.2290799352367698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401498692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782672,0.016652886,0.000022673408,0.001855701,0.00022279822,0.0023442612,0.00039796898,0.00021476964,0.000021731357],"genre_scores_gemma":[0.99637,0.000631638,0.000074183554,0.00041455863,0.00015770741,0.0014637323,0.00025733426,0.00014447444,0.00048632792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660033,0.0002910301,0.0006164277,0.0011721251,0.0006346261,0.0006854749],"domain_scores_gemma":[0.99809533,0.00014627917,0.00029947117,0.00072403456,0.00017501581,0.00055988773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003256128,0.0008032417,0.001493993,0.0003572257,0.00006920552,0.00017907648,0.00015246235,0.00041061296,0.0000716747],"category_scores_gemma":[0.00016458191,0.0005460009,0.00030110954,0.00029968433,0.0001461834,0.0000753229,0.00020050042,0.00048043704,0.000013805082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052626096,0.002565018,0.96527743,0.00069485366,0.0010438145,0.023487108,0.0005321819,0.00002951377,0.0006369548,0.000051883304,0.0001297312,0.0002888682],"study_design_scores_gemma":[0.035180725,0.00042363998,0.9544003,0.0046344274,0.0010626081,0.000023210418,0.00011066248,0.002025629,0.0011255962,0.0002391897,0.00018837731,0.0005856532],"about_ca_topic_score_codex":0.00018272958,"about_ca_topic_score_gemma":0.00009716922,"teacher_disagreement_score":0.029918116,"about_ca_system_score_codex":0.0010848232,"about_ca_system_score_gemma":0.00051264866,"threshold_uncertainty_score":0.9996992},"labels":[],"label_agreement":null},{"id":"W4401504256","doi":"10.1182/blood.2024025603","title":"Unbalanced <i>MYC</i> break-apart FISH patterns indicate the presence of a <i>MYC</i> rearrangement in HGBCL-DH-<i>BCL2</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Biology; Gene rearrangement; Fluorescence in situ hybridization; Context (archaeology); Fish <Actinopterygii>; Immunohistochemistry; Lymphoma; Gene; Molecular biology; Chromosome; Cancer research; Genetics; Immunology","score_opus":0.011007390692018592,"score_gpt":0.24916259809207478,"score_spread":0.2381552074000562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401504256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861848,0.0020278865,0.0000067641668,0.0054531875,0.0002703908,0.000880493,0.00018305799,0.000095691445,0.0048977616],"genre_scores_gemma":[0.9958697,0.0015502,0.00008691408,0.0015733504,0.00016561091,0.00033136565,0.000062745545,0.00003337806,0.000326721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819905,0.00006340371,0.00044493296,0.00045104124,0.00046385813,0.00037774636],"domain_scores_gemma":[0.99889755,0.00022323671,0.000090231995,0.0006192529,0.00004758455,0.00012211187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029011795,0.00023853511,0.00039021412,0.00011125481,0.000049017195,0.000049893995,0.00021883335,0.000113897106,0.000110128574],"category_scores_gemma":[0.000050421335,0.00015293948,0.00016847925,0.00042658029,0.000100481666,0.00008025493,0.0001085708,0.00025917098,0.00005838467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018877727,0.0058744336,0.92947453,0.00078897725,0.0008916884,0.0014233898,0.0027234282,0.0000075557186,0.023786107,0.0006430165,0.019797288,0.014400778],"study_design_scores_gemma":[0.017359117,0.001124551,0.6109979,0.0032762748,0.0017521182,0.0006240667,0.00046324963,0.00017932706,0.23622853,0.00028369034,0.12710033,0.00061080826],"about_ca_topic_score_codex":0.0005325997,"about_ca_topic_score_gemma":0.00044250293,"teacher_disagreement_score":0.31847662,"about_ca_system_score_codex":0.00005163232,"about_ca_system_score_gemma":0.00014578167,"threshold_uncertainty_score":0.6236691},"labels":[],"label_agreement":null},{"id":"W4401513963","doi":"10.3390/cancers16162816","title":"Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to First-Line ABVD Therapy","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"Diagnostic Services Manitoba","keywords":"ABVD; Dacarbazine; Medicine; Oncology; Internal medicine; Vinblastine; Disease; Cohort; Multivariate analysis; Bleomycin; Logistic regression; Lymphoma; Cancer; Chemotherapy","score_opus":0.014070206063686589,"score_gpt":0.29087025100662095,"score_spread":0.27680004494293436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401513963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94974905,0.026802212,0.00009987146,0.022154797,0.00018463774,0.00050019834,0.00012919596,0.00010510802,0.00027490332],"genre_scores_gemma":[0.9932862,0.003641551,0.00007226809,0.0010315487,0.00006733451,0.00028881806,0.000017986586,0.000019420011,0.0015749004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989761,0.000039047336,0.00023354367,0.0003176391,0.00021893492,0.0002147489],"domain_scores_gemma":[0.99910456,0.00018595508,0.000045910532,0.0005029699,0.00006678213,0.00009381583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021771177,0.00015564635,0.00035853838,0.00035363907,0.00005570238,0.00002033686,0.00014173044,0.00009303918,0.00012609006],"category_scores_gemma":[0.00008168529,0.00009089202,0.00019296778,0.0017711404,0.00011472973,0.000033661217,0.000032204105,0.00004560034,0.000029298286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006178376,0.0005032124,0.1139503,0.00022657608,0.012849766,0.0005142495,0.003344263,0.0014343472,0.0067749335,0.0005085306,0.18729104,0.6664244],"study_design_scores_gemma":[0.0033188818,0.0021134068,0.11335126,0.00035116784,0.0016937746,0.000047263755,0.00030752763,0.0010962841,0.06399577,0.00006530382,0.8134372,0.00022210853],"about_ca_topic_score_codex":0.00047847736,"about_ca_topic_score_gemma":0.00011430793,"teacher_disagreement_score":0.6662023,"about_ca_system_score_codex":0.0012139544,"about_ca_system_score_gemma":0.00054788013,"threshold_uncertainty_score":0.3706469},"labels":[],"label_agreement":null},{"id":"W4401529517","doi":"10.1016/j.ijrobp.2024.04.021","title":"At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Radiation therapy; Lymphoma; Enhanced Data Rates for GSM Evolution; Hodgkin lymphoma; Medicine; Radiology; Computer science; Pathology; Artificial intelligence","score_opus":0.01688798446765984,"score_gpt":0.3305488111037373,"score_spread":0.31366082663607747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401529517","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40408465,0.05720429,0.00019707391,0.009734692,0.52526313,0.0014470445,0.0005078675,0.00004163696,0.0015196296],"genre_scores_gemma":[0.7099407,0.022608567,0.00020911206,0.00057179487,0.26596102,0.00007520184,0.00041249604,0.00006628684,0.00015486359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736434,0.0003396493,0.0011091154,0.0003158899,0.0006417153,0.00022929847],"domain_scores_gemma":[0.9938869,0.0033399472,0.0017970537,0.00021872715,0.00068427966,0.00007308461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013933459,0.00031995086,0.00081435713,0.0002322385,0.00009971282,0.00006178924,0.0004232688,0.000561221,0.00004268291],"category_scores_gemma":[0.0011463409,0.0001860616,0.0003817293,0.0001981171,0.00034707715,0.00015523283,0.00015415395,0.00056387746,0.000013525954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002152529,0.0011433423,0.10545081,0.000042115942,0.003292211,0.000062320105,0.0028219076,0.00018096835,0.0006430507,0.0032435646,0.21512328,0.6658439],"study_design_scores_gemma":[0.03788194,0.0011385032,0.05126796,0.00054107205,0.0007061518,0.00019911009,0.00021303455,0.0035982602,0.0017930648,0.0060481005,0.8963206,0.00029223957],"about_ca_topic_score_codex":0.00018589065,"about_ca_topic_score_gemma":0.00002372408,"teacher_disagreement_score":0.6811973,"about_ca_system_score_codex":0.0021787365,"about_ca_system_score_gemma":0.0011645018,"threshold_uncertainty_score":0.75873715},"labels":[],"label_agreement":null},{"id":"W4401588211","doi":"10.20944/preprints202408.0366.v1","title":"3D-Q-FISH/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/ Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma","year":2024,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics; McGill University; Jewish General Hospital","funders":"","keywords":"Telomere; Shelterin; Germinal center; Biology; Lymphoma; Cancer research; Mantle cell lymphoma; B cell; Immunology; Genetics; DNA; Antibody","score_opus":0.05595600720738127,"score_gpt":0.3444466549147986,"score_spread":0.28849064770741734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401588211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849428,0.0013150439,0.000021939763,0.0071251756,0.00088071206,0.0030978909,0.00032485166,0.00037009848,0.0019215193],"genre_scores_gemma":[0.9957403,0.00029163214,0.000285749,0.00039758,0.00019300693,0.0021145863,0.00032812395,0.0001521907,0.00049684185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945822,0.00046705976,0.0013987459,0.0018803558,0.00090941583,0.0007622492],"domain_scores_gemma":[0.9954998,0.00031716278,0.000814492,0.0027997014,0.0002957666,0.00027310278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006523916,0.0009829861,0.0017960693,0.00036611644,0.00017857685,0.0000969906,0.0012062776,0.001012633,0.00046222287],"category_scores_gemma":[0.00050570007,0.0007276885,0.00091826124,0.00032652408,0.0010322587,0.000046575195,0.0066497787,0.000949475,0.0008962927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030612412,0.008229988,0.5890194,0.004280673,0.008250402,0.007525625,0.0036835712,0.000035154964,0.23366813,0.006422761,0.0009176439,0.1349054],"study_design_scores_gemma":[0.0024830562,0.0003042053,0.65735173,0.0011135944,0.0015882595,0.0005016385,0.00017842188,0.00024537116,0.32837287,0.003560858,0.0036938784,0.0006061239],"about_ca_topic_score_codex":0.0009517338,"about_ca_topic_score_gemma":0.00021598967,"teacher_disagreement_score":0.13429928,"about_ca_system_score_codex":0.0007982873,"about_ca_system_score_gemma":0.00078337884,"threshold_uncertainty_score":0.9998816},"labels":[],"label_agreement":null},{"id":"W4401656522","doi":"10.1002/ajh.27459","title":"Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; Astellas Pharma; Irish Research Council; University of Queensland; National Cancer Institute; National Research Foundation; Cancer Australia; Leukaemia Foundation; EUSA Pharma; Mater Foundation; National Research Foundation Singapore; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; BeiGene; Daiichi Sankyo Europe; Sanofi; Amgen; American Association for Cancer Research; Bristol-Myers Squibb; National Health and Medical Research Council; American Society of Hematology","keywords":"TIGIT; CD8; Immune system; Cancer research; Lymphoma; Immunophenotyping; Biology; Hodgkin's lymphoma; T cell; Lymphocyte; Immunology; Tumor microenvironment; Flow cytometry","score_opus":0.005422366018276542,"score_gpt":0.24567511970297534,"score_spread":0.2402527536846988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401656522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467827,0.0511663,0.000029025367,0.00097004196,0.0002953134,0.00028498203,0.000008579638,0.000035307676,0.00042771798],"genre_scores_gemma":[0.99256486,0.005079652,0.0016381501,0.00041857103,0.00010734988,0.000028880435,0.0000065462095,0.000058002657,0.00009801296],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99733955,0.00020972858,0.0009679537,0.00050023844,0.00033272913,0.0006498147],"domain_scores_gemma":[0.9978696,0.0008545339,0.0004559624,0.0002815718,0.00010854864,0.00042980016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043799193,0.00043070753,0.0014717089,0.0005243808,0.000087459746,0.00009928485,0.0001626771,0.0001354985,0.000020434245],"category_scores_gemma":[0.00041717943,0.0003303883,0.0002328504,0.00048924016,0.0009181902,0.00019737703,0.0001157202,0.0002000626,0.000015569267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007406985,0.0030449918,0.6616057,0.0008367371,0.0068513323,0.081979364,0.0089214565,0.000011833223,0.011625328,0.003425735,0.0039631464,0.21699364],"study_design_scores_gemma":[0.0340635,0.016056508,0.4188029,0.0032764615,0.0029102527,0.42701447,0.015177213,0.0011628979,0.056864966,0.0011921094,0.02311434,0.00036437457],"about_ca_topic_score_codex":0.0004727124,"about_ca_topic_score_gemma":0.000019384244,"teacher_disagreement_score":0.3450351,"about_ca_system_score_codex":0.0002966668,"about_ca_system_score_gemma":0.0006468138,"threshold_uncertainty_score":0.9999148},"labels":[],"label_agreement":null},{"id":"W4401688491","doi":"10.1200/jco-24-01373","title":"Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Radiation therapy; Lymphoma; Radiology; Oncology; Internal medicine","score_opus":0.10203807123778129,"score_gpt":0.46138059044866436,"score_spread":0.35934251921088306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401688491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730279,0.006196938,0.000029635834,0.008509531,0.0030995437,0.00029605982,0.0000062100407,0.000009199597,0.008824975],"genre_scores_gemma":[0.9858367,0.0058831526,0.004481287,0.00084861566,0.0025323564,0.0000056306944,0.000005238117,0.000017107519,0.0003899224],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955425,0.0003876275,0.003239612,0.00021241243,0.00043150326,0.00018634816],"domain_scores_gemma":[0.9934181,0.0049648965,0.0010104572,0.0001644105,0.00014477162,0.00029734877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037910745,0.00013740413,0.0016096246,0.00023468253,0.000012133344,0.0000075456583,0.00011862522,0.00038419472,0.0000740769],"category_scores_gemma":[0.0017502179,0.00008402024,0.00063563086,0.00019535932,0.0001301852,0.00007849818,0.000026890133,0.00036919123,0.000009916864],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26680583,0.017059462,0.009291489,0.00013073457,0.00037054814,0.006146706,0.00024656777,0.000007062281,0.00050220435,0.00006727128,0.018823953,0.6805482],"study_design_scores_gemma":[0.5324138,0.05566458,0.21637037,0.000888916,0.0005024185,0.0007393095,0.0000550529,0.00019567717,0.00071204704,0.00020805906,0.19212665,0.00012311868],"about_ca_topic_score_codex":0.000023107868,"about_ca_topic_score_gemma":0.0000056294543,"teacher_disagreement_score":0.68042505,"about_ca_system_score_codex":0.00052620715,"about_ca_system_score_gemma":0.003925583,"threshold_uncertainty_score":0.6963815},"labels":[],"label_agreement":null},{"id":"W4401728184","doi":"10.1038/s41409-024-02399-9","title":"Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era","year":2024,"lang":"en","type":"letter","venue":"Bone Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Bendamustine; Medicine; Transplantation; Stem cell; Lymphoma; Autologous stem-cell transplantation; Oncology; Internal medicine; Rituximab","score_opus":0.017772619363866763,"score_gpt":0.264297254571095,"score_spread":0.24652463520722823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401728184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57658285,0.0038164922,0.0021640912,0.3894134,0.0016163783,0.010806599,0.0075501855,0.00029861918,0.0077513834],"genre_scores_gemma":[0.9471138,0.003075607,0.000499327,0.032908734,0.0005958095,0.0014554362,0.013810625,0.00011301539,0.00042763428],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705154,0.0001579358,0.0010158642,0.0006203068,0.00068106677,0.00047325963],"domain_scores_gemma":[0.99859536,0.0006878003,0.00024020705,0.00033143704,0.0000902138,0.000054958065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003771721,0.00053421455,0.00084974,0.0004710411,0.000067841705,0.000041812516,0.00016584854,0.00072668266,0.000027183358],"category_scores_gemma":[0.000003908446,0.0003821515,0.0004706814,0.00032855678,0.00008168124,0.00009599742,0.0000028193006,0.0004597258,0.000015194745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017220167,0.004663512,0.0038696527,0.15290546,0.0018816259,0.035064004,0.062327232,0.00018343625,0.00886458,0.0015799823,0.43967447,0.27176586],"study_design_scores_gemma":[0.106804244,0.012791994,0.2927087,0.01605253,0.039413843,0.014906424,0.0021781304,0.0013129151,0.12814802,0.0008340753,0.38079658,0.004052525],"about_ca_topic_score_codex":0.00024945938,"about_ca_topic_score_gemma":0.00017822823,"teacher_disagreement_score":0.37053093,"about_ca_system_score_codex":0.00014478235,"about_ca_system_score_gemma":0.00036705646,"threshold_uncertainty_score":0.999863},"labels":[],"label_agreement":null},{"id":"W4401785292","doi":"10.1002/jha2.992","title":"Low‐grade follicular lymphoma with interferon regulatory factor‐4 rearrangement: Expanding the spectrum of interferon regulatory factor‐4‐rearranged lymphomas","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"IRF4; Interferon regulatory factors; Lymphoma; Follicular lymphoma; Cancer research; Biology; Transcription factor; BCL6; Gene rearrangement; B cell; Immunology; Genetics; Gene; Antibody; Germinal center","score_opus":0.018431809353097475,"score_gpt":0.2595265361951416,"score_spread":0.24109472684204414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401785292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98746604,0.0066440017,0.00008585988,0.0013865756,0.00072400953,0.0010526589,0.000055000673,0.00031158671,0.0022742664],"genre_scores_gemma":[0.99753565,0.00027369018,0.0000820618,0.00018290829,0.00038462508,0.00013843429,0.000050227172,0.00013679653,0.001215628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996744,0.00014376066,0.00068264594,0.0008397641,0.0009171176,0.00067275035],"domain_scores_gemma":[0.9980126,0.00019195784,0.0002044896,0.0012367547,0.00007632943,0.0002778739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002671081,0.00062318856,0.0008189443,0.000340646,0.00018729153,0.00012839519,0.00032578598,0.00021629749,0.000547036],"category_scores_gemma":[0.000026074431,0.0003783962,0.00048241863,0.00049620896,0.0002771194,0.0002501145,0.00015069298,0.00019373723,0.00010731558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009920145,0.008475153,0.22279492,0.0062929494,0.018461315,0.006798399,0.054335013,0.000068832305,0.3691553,0.01474312,0.024630256,0.2643246],"study_design_scores_gemma":[0.008364302,0.0036983704,0.34400043,0.0048057917,0.0009931148,0.00056302716,0.0019549779,0.00022050845,0.6209404,0.00025425508,0.013363346,0.0008414756],"about_ca_topic_score_codex":0.00024066762,"about_ca_topic_score_gemma":0.00010997876,"teacher_disagreement_score":0.26348314,"about_ca_system_score_codex":0.0012199702,"about_ca_system_score_gemma":0.00030267017,"threshold_uncertainty_score":0.9998668},"labels":[],"label_agreement":null},{"id":"W4401805922","doi":"10.1007/s12185-024-03834-9","title":"Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study","year":2024,"lang":"en","type":"article","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Medicine; Internal medicine; Adverse effect; Cohort; Refractory (planetary science); Gastroenterology; Lymphoma; Oncology","score_opus":0.01632198740253884,"score_gpt":0.3324388202306839,"score_spread":0.31611683282814507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401805922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263287,0.00074675825,0.0020895416,0.0020601659,0.0013239946,0.00093195646,0.00004242671,0.00001422229,0.00015808245],"genre_scores_gemma":[0.9965048,0.00004105227,0.0024499802,0.00019088466,0.00021619556,0.00019489622,0.000046382378,0.000031849428,0.0003239963],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856335,0.00003063396,0.0006286687,0.00023112292,0.0003552549,0.00019098735],"domain_scores_gemma":[0.99856776,0.00047918884,0.000260602,0.00010367014,0.0005010792,0.0000876878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307926,0.00016936922,0.00046270527,0.0005191377,0.00004095913,0.000036285906,0.0001407456,0.000080034566,0.000041596948],"category_scores_gemma":[0.0001289795,0.00012132293,0.00020827333,0.00011134184,0.000034160712,0.00017714482,0.000025667883,0.00008721405,0.000008300902],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10188953,0.09191912,0.20335527,0.0013038417,0.013811985,0.03233359,0.028775545,0.00018221023,0.006420777,0.015938368,0.050198045,0.45387173],"study_design_scores_gemma":[0.5633557,0.2576353,0.023360698,0.0033123565,0.003048752,0.022873748,0.01359716,0.0060715326,0.03980789,0.003871153,0.062097926,0.00096777256],"about_ca_topic_score_codex":0.000027281607,"about_ca_topic_score_gemma":0.000066373796,"teacher_disagreement_score":0.4614662,"about_ca_system_score_codex":0.00036577636,"about_ca_system_score_gemma":0.00041208556,"threshold_uncertainty_score":0.49474058},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4401821206","doi":"10.1002/cam4.70032","title":"Association of race/ethnicity and insurance with survival in patients with diffuse large B‐cell lymphoma in a large real‐world cohort","year":2024,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Hazard ratio; Medicaid; Confidence interval; Internal medicine; Ethnic group; Demography; Cohort; Diffuse large B-cell lymphoma; Pacific islanders; Population; Lymphoma; Health care; Environmental health","score_opus":0.00694280115001146,"score_gpt":0.259106073101652,"score_spread":0.25216327195164057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401821206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934888,0.00308229,0.000004641413,0.0011483175,0.00015652763,0.0006933512,0.000108203356,0.000027869764,0.0012899953],"genre_scores_gemma":[0.9966393,0.0021007487,0.00001956685,0.00021456559,0.000080088466,0.00013732663,0.00007712039,0.000026570498,0.00070467504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841976,0.00005911337,0.00033609004,0.0003567633,0.00051509985,0.00031315454],"domain_scores_gemma":[0.99928737,0.00017081182,0.0001281877,0.00019298782,0.00011069754,0.000109938825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040815378,0.00019670243,0.0006306706,0.0002334015,0.000021917873,0.000006104502,0.000041481224,0.00006988826,0.000052820542],"category_scores_gemma":[0.00004400952,0.00012058021,0.000022889604,0.00069779,0.00005806813,0.00008404639,0.000022515724,0.00011180867,0.0000016080609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007570825,0.0022184085,0.99297464,0.0003501652,0.00015383287,0.00011554605,0.00097040593,0.0000012538184,0.00001696157,0.00006925097,0.00048727277,0.0018852012],"study_design_scores_gemma":[0.045612875,0.0006371659,0.9496645,0.0021809512,0.00020578317,0.0000010489922,0.000091721624,0.000080406375,0.00015338568,0.000005975771,0.0012511346,0.00011507785],"about_ca_topic_score_codex":0.0030817622,"about_ca_topic_score_gemma":0.01597104,"teacher_disagreement_score":0.044855792,"about_ca_system_score_codex":0.0009189486,"about_ca_system_score_gemma":0.00019015804,"threshold_uncertainty_score":0.8912216},"labels":[],"label_agreement":null},{"id":"W4401835065","doi":"10.1097/mph.0000000000002943","title":"PET/CT Response Assessment in Pediatric Hodgkin Lymphoma: Does Deauville Score 3 Reflect Negativity?","year":2024,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Orthopaedic Innovation Centre","funders":"","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Interim; Oncology; Nuclear medicine; Negativity effect; Internal medicine; Radiology; Psychology","score_opus":0.024416809068017464,"score_gpt":0.36321084848803975,"score_spread":0.3387940394200223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401835065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712558,0.01270054,0.00005837565,0.010985917,0.0022579348,0.00051319745,0.000013831536,0.00007262652,0.0021417795],"genre_scores_gemma":[0.98521924,0.008340303,0.0039931946,0.00040292888,0.0016900393,0.000077293575,0.0000064530514,0.000057472585,0.00021305318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951591,0.00112447,0.0017600446,0.00057323807,0.00063156994,0.0007516049],"domain_scores_gemma":[0.9943123,0.0038171473,0.0007536986,0.00038413558,0.00027604713,0.0004567059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002968914,0.00045643054,0.0017073198,0.0020806477,0.00010230024,0.000055840104,0.0002807825,0.00017367554,0.00022919437],"category_scores_gemma":[0.001020545,0.00029958077,0.0005341521,0.0014727036,0.000118658434,0.00028701752,0.00014047853,0.00076758163,0.0001170007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002700267,0.0043907035,0.7180675,0.00065411814,0.00042555935,0.24039344,0.00043935468,0.0000133504955,0.00017568725,0.0014151912,0.020825487,0.010499309],"study_design_scores_gemma":[0.025051055,0.013033605,0.71403676,0.00033558824,0.0044628447,0.17931886,0.0009789031,0.00030561528,0.0010944137,0.0024777702,0.05801015,0.00089444796],"about_ca_topic_score_codex":0.000052447187,"about_ca_topic_score_gemma":0.00008768511,"teacher_disagreement_score":0.06107459,"about_ca_system_score_codex":0.0027502622,"about_ca_system_score_gemma":0.0070870724,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W4401876257","doi":"10.1016/s2152-2650(24)01494-0","title":"ABCL-185 Mosunetuzumab with Polatuzumab Vedotin: Subgroup Analyses in Patients (pts) With Primary Refractory or Early Relapsed Large B-Cell Lymphoma (LBCL)","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Refractory (planetary science); Internal medicine; Lymphoma","score_opus":0.028299857927520617,"score_gpt":0.31862729576335885,"score_spread":0.29032743783583825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401876257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869937,0.0036237496,0.000027694046,0.00026214847,0.0006060858,0.0015319015,0.000117370524,0.0005414795,0.0062959176],"genre_scores_gemma":[0.99156046,0.0006554485,0.0013049323,0.001493102,0.00050130195,0.00027607096,0.00064141926,0.00030672102,0.0032605554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919706,0.00042319056,0.0022218055,0.00228908,0.0015606907,0.0015346304],"domain_scores_gemma":[0.99471855,0.0016108509,0.0005327185,0.0017669472,0.00035491877,0.0010160386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063989824,0.0012234712,0.0022534165,0.0006385192,0.00025819245,0.0002864333,0.0005450731,0.00088057684,0.00021020552],"category_scores_gemma":[0.00026917324,0.00078134605,0.0006810519,0.0018542765,0.00045891886,0.00066000276,0.00027829834,0.000554144,0.0006867273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.021752667,0.015105699,0.63666,0.00074475334,0.0016255961,0.01202871,0.0006867229,0.000010337283,0.00009018508,0.0002190503,0.004366768,0.3067095],"study_design_scores_gemma":[0.06645372,0.01105108,0.90077734,0.001803195,0.0011523842,0.00021442806,0.00015477824,0.00037448647,0.00032789534,0.000037637765,0.016680304,0.0009727705],"about_ca_topic_score_codex":0.0010105035,"about_ca_topic_score_gemma":0.0004031476,"teacher_disagreement_score":0.30573675,"about_ca_system_score_codex":0.0089911055,"about_ca_system_score_gemma":0.0063730674,"threshold_uncertainty_score":0.99946374},"labels":[],"label_agreement":null},{"id":"W4401876847","doi":"10.1016/s2152-2650(24)00857-7","title":"Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients With Relapsed and/or Refractory Follicular Lymphoma After ≥2 Prior Therapies: 3-Year Follow-Up From a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Follicular phase; Oncology; Internal medicine; Lymphoma","score_opus":0.018964239231852156,"score_gpt":0.31255429481854125,"score_spread":0.2935900555866891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401876847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927053,0.0025663052,0.000010393218,0.00048751617,0.00054650364,0.003085372,0.00020644927,0.00027927372,0.00011292573],"genre_scores_gemma":[0.9945572,0.00040593854,0.0009905259,0.0010649539,0.00025155634,0.00089669524,0.000086904365,0.000169977,0.0015762185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99464077,0.0005125156,0.0015732972,0.001706318,0.00078234577,0.0007847328],"domain_scores_gemma":[0.9963765,0.0014621657,0.00022702148,0.0010734492,0.00018980846,0.00067106256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006931168,0.00081042416,0.0015788124,0.0003555029,0.00022671997,0.00024342172,0.00026290183,0.00043428392,0.00021101533],"category_scores_gemma":[0.0004154611,0.0005450689,0.0003870024,0.00068579544,0.00028108462,0.00036637223,0.00017286476,0.00022794717,0.00012366273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08036345,0.006634571,0.43071043,0.000035831,0.0012920361,0.0031432193,0.0025714166,5.254432e-7,0.0000821351,0.000010955057,0.00062469876,0.47453073],"study_design_scores_gemma":[0.099884726,0.026616663,0.86221254,0.0010223684,0.0005510411,0.000028469958,0.00075011404,0.00011268293,0.00022041688,0.000049069426,0.007949651,0.00060223666],"about_ca_topic_score_codex":0.0007221695,"about_ca_topic_score_gemma":0.00042565976,"teacher_disagreement_score":0.47392848,"about_ca_system_score_codex":0.0016154634,"about_ca_system_score_gemma":0.0017405935,"threshold_uncertainty_score":0.99970007},"labels":[],"label_agreement":null},{"id":"W4401878537","doi":"10.1016/s2152-2650(24)00372-0","title":"What Is Dark Zone Lymphoma and Is It Clinically Relevant?","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Oncology; Internal medicine","score_opus":0.037758515209233665,"score_gpt":0.3579115738942809,"score_spread":0.32015305868504723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401878537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93530583,0.020538291,0.000045307446,0.030791963,0.0037039693,0.00096097053,0.0001001361,0.00052544236,0.008028071],"genre_scores_gemma":[0.9014242,0.044080347,0.001775038,0.037666444,0.0016902462,0.00015386977,0.0001072313,0.00018710693,0.012915503],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99249107,0.00025853454,0.002861573,0.0023184544,0.0009958586,0.0010745152],"domain_scores_gemma":[0.99315816,0.0031872622,0.00033394608,0.0016842305,0.0002711333,0.0013652695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015751617,0.0008927022,0.0018416352,0.00025456655,0.00027794053,0.0007892746,0.0004131472,0.001080485,0.0009132071],"category_scores_gemma":[0.0006499059,0.0007120416,0.0012251186,0.0006642697,0.0009056615,0.0007800526,0.00046863346,0.0003519418,0.0036691483],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007891329,0.0008557205,0.035151627,0.0002793038,0.0009756272,0.0030570545,0.0006499283,1.5558355e-7,0.000046560894,0.00064316293,0.14782389,0.80972785],"study_design_scores_gemma":[0.0091981655,0.0022999225,0.60818636,0.0023359768,0.0011426723,0.0013118061,0.0004238662,0.0010782141,0.00055493833,0.0012846709,0.37144062,0.00074278034],"about_ca_topic_score_codex":0.00013848692,"about_ca_topic_score_gemma":0.00001704362,"teacher_disagreement_score":0.80898505,"about_ca_system_score_codex":0.0014464336,"about_ca_system_score_gemma":0.0025298207,"threshold_uncertainty_score":0.9998978},"labels":[],"label_agreement":null},{"id":"W4401896808","doi":"10.1016/s2152-2650(24)01551-9","title":"ABCL-711 Brentuximab Vedotin (BV) in Combination With Lenalidomide (Len) and Rituximab (R) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Results From the Phase 3 ECHELON-3 Study","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Brentuximab vedotin; Lenalidomide; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Multiple myeloma; Hodgkin lymphoma","score_opus":0.016213739826199818,"score_gpt":0.29246344216781545,"score_spread":0.2762497023416156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401896808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934598,0.0015970736,0.00001148918,0.00088324153,0.00040211913,0.0026472688,0.00036315984,0.00018553832,0.00045026012],"genre_scores_gemma":[0.9969905,0.0003673268,0.00022769018,0.00072462036,0.00020678487,0.00029762334,0.0008221611,0.0001382197,0.00022506337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934667,0.0007367327,0.0020318215,0.0018306295,0.0010567355,0.0008773777],"domain_scores_gemma":[0.99432206,0.0032963676,0.0004535089,0.0012856706,0.00019794005,0.0004444313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015348194,0.0008222203,0.0014979559,0.00032479604,0.00020498059,0.000236207,0.00038216345,0.00044519195,0.000022984466],"category_scores_gemma":[0.0005360754,0.00051049545,0.00023895658,0.00088698854,0.00033785202,0.00046147243,0.00025542954,0.0005055107,0.00013420683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019349078,0.15115258,0.58230644,0.00007668541,0.00043471562,0.0024185188,0.0016794818,0.00000120844,0.0000059984345,0.000068894864,0.0008855425,0.24162084],"study_design_scores_gemma":[0.3750206,0.0049316813,0.6152381,0.00082354015,0.00041857787,0.00001881395,0.00046868832,0.0005633719,0.0000594862,0.00006750923,0.0020002432,0.00038943713],"about_ca_topic_score_codex":0.0020878213,"about_ca_topic_score_gemma":0.0015399732,"teacher_disagreement_score":0.35567153,"about_ca_system_score_codex":0.0027712865,"about_ca_system_score_gemma":0.0014634678,"threshold_uncertainty_score":0.99973464},"labels":[],"label_agreement":null},{"id":"W4401897141","doi":"10.1016/s2152-2650(24)01563-5","title":"IBCL-335 Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients With Relapsed and/or Refractory Follicular Lymphoma After ≥2 Prior Therapies: 3-Year Follow-Up From a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Internal medicine; Follicular phase; Oncology; Phases of clinical research; Lymphoma; Clinical trial","score_opus":0.018944815220853627,"score_gpt":0.31241898043882904,"score_spread":0.2934741652179754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401897141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992245,0.0027387089,0.000011297064,0.00051689707,0.00059195946,0.0032338032,0.00024009775,0.00029963997,0.00012260703],"genre_scores_gemma":[0.99418634,0.0004570774,0.0010220063,0.0011386209,0.00027500882,0.0009530374,0.0000976299,0.00018550477,0.001684777],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942496,0.0005566684,0.0016863036,0.0018180604,0.00084190903,0.0008475026],"domain_scores_gemma":[0.99610853,0.0015607807,0.0002515519,0.0011530505,0.00020612201,0.0007199582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074529357,0.0008752966,0.0016887725,0.00038046553,0.0002469542,0.00026373155,0.00028887356,0.00047201742,0.00022282037],"category_scores_gemma":[0.00044905962,0.00059314264,0.00042148487,0.00073181605,0.000305433,0.0003945509,0.00018932568,0.00024992652,0.00013497456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081550755,0.007308134,0.4315049,0.000040487295,0.0014164515,0.003381314,0.0027321607,6.1401425e-7,0.00009312108,0.000012222174,0.0007222298,0.4712376],"study_design_scores_gemma":[0.10357957,0.026513247,0.8575848,0.0010844284,0.000593338,0.00003145787,0.0007952142,0.000121683624,0.00023691884,0.00005299284,0.008755263,0.0006511296],"about_ca_topic_score_codex":0.00077308837,"about_ca_topic_score_gemma":0.00045294358,"teacher_disagreement_score":0.47058648,"about_ca_system_score_codex":0.0017324913,"about_ca_system_score_gemma":0.0018494651,"threshold_uncertainty_score":0.99965197},"labels":[],"label_agreement":null},{"id":"W4401959513","doi":"10.1016/j.bneo.2024.100039","title":"Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation","year":2024,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Solid organ; Pathological; Organ transplantation; Transplantation; Medicine; Lymphoma; Pathology; Internal medicine","score_opus":0.010411507844044439,"score_gpt":0.28176754517615193,"score_spread":0.2713560373321075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401959513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958635,0.008613286,0.000007897499,0.000250299,0.00019975731,0.00022083413,0.000036476733,0.00006654323,0.0010185476],"genre_scores_gemma":[0.99379337,0.004636408,0.0007207818,0.00016080249,0.00035795465,0.00003754493,0.000029910278,0.000018618854,0.00024458504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896586,0.00004221334,0.00031090793,0.00032690982,0.00016899504,0.00018510703],"domain_scores_gemma":[0.9995559,0.000115758274,0.000034930406,0.00013504416,0.00002842194,0.00012994409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011316299,0.00015789681,0.00031270267,0.00007081608,0.000028392664,0.00002794401,0.00003369617,0.00016422836,0.00008446513],"category_scores_gemma":[0.000013605336,0.00010897133,0.00014163108,0.0001295893,0.000073030504,0.00004581966,0.000017889075,0.00007633167,0.000018794399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046319855,0.0019364539,0.9730943,0.0005655814,0.00014177179,0.004383794,0.000712658,1.9745382e-7,0.00067370717,0.00011062676,0.0005952813,0.017322443],"study_design_scores_gemma":[0.0053016823,0.0010103836,0.98468953,0.00007339234,0.0015335137,0.0012425723,0.000036943737,0.000011605266,0.005652853,0.000043042786,0.00029306652,0.00011142323],"about_ca_topic_score_codex":0.000010157174,"about_ca_topic_score_gemma":0.0000084995645,"teacher_disagreement_score":0.017211022,"about_ca_system_score_codex":0.000014007483,"about_ca_system_score_gemma":0.00010497809,"threshold_uncertainty_score":0.4443722},"labels":[],"label_agreement":null},{"id":"W4401994938","doi":"10.1182/blood.2024025248","title":"Circulating composite B- and T-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Cancer research; Internal medicine; Immunology","score_opus":0.009958353825372837,"score_gpt":0.23855696701245074,"score_spread":0.22859861318707791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401994938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736932,0.011261849,0.000004885512,0.0002979873,0.00006266626,0.00010854944,0.000003969348,0.000092389586,0.014474534],"genre_scores_gemma":[0.99877703,0.0001317615,0.00051436655,0.00016306588,0.00009442331,0.00001316952,0.0000104168,0.000012344835,0.00028341467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999556,0.0000066228404,0.00008444224,0.00016363924,0.0000847805,0.000104491985],"domain_scores_gemma":[0.9997649,0.000044610006,0.00000921431,0.00009704542,0.000009927568,0.000074258845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030717125,0.00007548539,0.00010983309,0.00003701075,0.00003628321,0.000041874857,0.0000137761635,0.00003061845,0.00002131065],"category_scores_gemma":[0.0000037905088,0.00005761067,0.00004391216,0.00006603289,0.00001574376,0.00002676933,0.000019408166,0.000018873243,0.000065871856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003666398,0.0063122506,0.691009,0.0012928125,0.00096454896,0.011993138,0.0013189261,0.0000013735344,0.09140411,0.0027521518,0.0016091154,0.1913059],"study_design_scores_gemma":[0.022623384,0.0006427189,0.78453,0.0012320644,0.0023323242,0.005284646,0.00012132824,0.0011327695,0.16414918,0.00034057762,0.01722902,0.0003820041],"about_ca_topic_score_codex":0.000029666611,"about_ca_topic_score_gemma":7.56568e-7,"teacher_disagreement_score":0.1909239,"about_ca_system_score_codex":0.000022282851,"about_ca_system_score_gemma":0.000032746084,"threshold_uncertainty_score":0.23492949},"labels":[],"label_agreement":null},{"id":"W4402103808","doi":"10.1016/j.jaad.2024.07.027","title":"54010 DISCRN: (D)ifferentiating (I)mmune (S)ignatures in (C)utaneous T-Cell Lymphoma and Atopic D(e)rmatitis Through Integrative Single-Cell (RN)A Sequencing Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Lymphoma; Internal medicine","score_opus":0.013947217648198753,"score_gpt":0.28524804908997664,"score_spread":0.2713008314417779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97982705,0.01128313,0.00012522117,0.0077861813,0.00012050368,0.00014383004,0.000013694314,0.000012850705,0.000687516],"genre_scores_gemma":[0.9961636,0.0014150828,0.0013486652,0.00093377236,0.000060561964,0.000004257234,0.000002094986,0.00001851909,0.00005344847],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810994,0.0002626025,0.000848588,0.00021657342,0.0002904183,0.00027190178],"domain_scores_gemma":[0.9983133,0.0005174866,0.00089071406,0.00013765928,0.00005639411,0.000084418425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010296096,0.00024046312,0.0011513854,0.00041659756,0.00006723414,0.000030046453,0.00021825255,0.00011956914,0.000018748922],"category_scores_gemma":[0.00007342746,0.00014164417,0.00040411775,0.00095224107,0.00049329037,0.00013206514,0.00010566748,0.00044961207,0.0000018593664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070025196,0.0024079673,0.74653536,0.001358008,0.008836368,0.005551838,0.0327317,0.00017177762,0.11735404,0.0026449366,0.0024661887,0.07924154],"study_design_scores_gemma":[0.007982559,0.0017394919,0.3912044,0.002920312,0.009839479,0.037675064,0.013860615,0.004720219,0.52269334,0.0038998008,0.002700219,0.00076454226],"about_ca_topic_score_codex":0.00024694653,"about_ca_topic_score_gemma":0.00004723899,"teacher_disagreement_score":0.40533927,"about_ca_system_score_codex":0.00032157282,"about_ca_system_score_gemma":0.00014437232,"threshold_uncertainty_score":0.57760817},"labels":[],"label_agreement":null},{"id":"W4402454102","doi":"10.1097/rlu.0000000000005426","title":"CXCR4-Targeted PET Imaging in Hematologic Malignancies","year":2024,"lang":"en","type":"review","venue":"Clinical Nuclear Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Lymphoma; Contingency table; Multiple myeloma; Nuclear medicine; CXCR4; Positron emission tomography; Internal medicine; Machine learning","score_opus":0.12118329153444185,"score_gpt":0.4569028428940068,"score_spread":0.33571955135956494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402454102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002511256,0.98780125,2.3667894e-7,0.004932088,0.001439106,0.001068313,0.000019464087,0.00023391933,0.004254472],"genre_scores_gemma":[0.00068264036,0.99455327,0.0001842304,0.0025485847,0.0009658524,0.00008095386,0.00018496762,0.000146296,0.0006531988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539053,0.00025829102,0.0023568138,0.0010276445,0.00043454804,0.00053217594],"domain_scores_gemma":[0.9974114,0.0009525321,0.0003613739,0.00079700456,0.00006639556,0.00041132068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010463459,0.0006885108,0.0049474286,0.00041530028,0.00004601788,0.000023678185,0.0002638736,0.00034158153,0.0011369188],"category_scores_gemma":[0.0015246668,0.00038217148,0.0010472776,0.00060678204,0.0005407623,0.0000403557,0.00021585329,0.00096378505,0.0029688259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004313751,0.00086473476,0.0014316288,0.021369997,0.0004717074,0.022575637,0.0000884678,1.272196e-8,3.390911e-7,0.0011141613,0.15451896,0.79752123],"study_design_scores_gemma":[0.0018450595,0.0004661543,0.0007506342,0.08014827,0.0046396703,0.0019325076,0.00008886272,0.00001652583,4.6908657e-8,0.0001334809,0.90969235,0.00028646123],"about_ca_topic_score_codex":0.000050906518,"about_ca_topic_score_gemma":0.0000054886686,"teacher_disagreement_score":0.7972348,"about_ca_system_score_codex":0.0003289241,"about_ca_system_score_gemma":0.00030985576,"threshold_uncertainty_score":0.999863},"labels":[],"label_agreement":null},{"id":"W4402455324","doi":"10.1080/14712598.2024.2404079","title":"Mosunetuzumab for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Follicular lymphoma; Medicine; Cancer research; Lymphoma; Oncology; Internal medicine; Rituximab; Biology; Immunology","score_opus":0.23548741695875694,"score_gpt":0.44401641511800954,"score_spread":0.2085289981592526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402455324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033508157,0.99432176,0.0000089560535,0.0005868409,0.0010375889,0.0036579901,0.00011792699,0.00007386684,0.00016157245],"genre_scores_gemma":[0.000064488515,0.9933098,0.00012812029,0.00035043803,0.00094021315,0.004591667,0.0004563301,0.000049282608,0.00010966027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982956,0.00010456744,0.0005490226,0.0005884113,0.00018721393,0.00027520265],"domain_scores_gemma":[0.998272,0.0008046484,0.00017608136,0.0006097034,0.000040930016,0.00009664456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000980179,0.0005940909,0.0018751805,0.00008481512,0.000086464206,0.000022952321,0.00017286031,0.0004330326,0.000109751934],"category_scores_gemma":[0.00001877847,0.00020287234,0.002135418,0.00018348593,0.000111779766,0.000008329013,0.000016962937,0.000047941438,0.00007925367],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002537787,0.0022006948,0.0000028951815,0.00014579041,0.0017530442,0.000013692352,0.000072202034,7.81602e-8,0.0000012945735,0.0012161627,0.0035957885,0.9907446],"study_design_scores_gemma":[0.0027065969,0.010690396,0.000023927207,0.0025037928,0.000056906792,0.000038405593,0.000015880563,0.0000052421165,0.00007384996,0.000063546475,0.98361814,0.00020331623],"about_ca_topic_score_codex":0.000022377504,"about_ca_topic_score_gemma":1.5289437e-7,"teacher_disagreement_score":0.9905413,"about_ca_system_score_codex":0.0004585982,"about_ca_system_score_gemma":0.00015598012,"threshold_uncertainty_score":0.8272894},"labels":[],"label_agreement":null},{"id":"W4402528918","doi":"10.1111/bjh.19764","title":"A randomized trial of ibrutinib and R‐<scp>GDP</scp> prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Spinal Cord Injury BC; Jewish General Hospital; University of Manitoba; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Alberta Health Services; Hôpital Notre-Dame; Moncton Hospital; University of British Columbia; Université Laval; Université de Montréal; University of Saskatchewan; University of Calgary; Princess Margaret Cancer Centre; Kingston General Hospital; Simon Fraser University","funders":"Janssen Research and Development; Canadian Cancer Society; Roche Canada","keywords":"Ibrutinib; Lymphoma; Medicine; Stem cell; Oncology; Internal medicine; Cancer research; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.011479990470827229,"score_gpt":0.24372286820860742,"score_spread":0.23224287773778018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402528918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398042,0.02565251,0.00001437723,0.03024577,0.0011871975,0.0021847829,0.00030412775,0.00002014191,0.00058691436],"genre_scores_gemma":[0.9242158,0.011659657,0.0005470296,0.058146104,0.0014170236,0.00027791646,0.00012432161,0.00020858279,0.0034035635],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99506056,0.00073303614,0.002389003,0.00053241465,0.00061889214,0.0006661189],"domain_scores_gemma":[0.99618834,0.0020406472,0.0010387052,0.0002865691,0.00017134033,0.0002744147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011164244,0.00049995945,0.0047706333,0.0007411811,0.00004967871,0.00007446522,0.0002495648,0.0010299586,0.000025241741],"category_scores_gemma":[0.00019721898,0.0004343463,0.0009419421,0.0002320894,0.00016790128,0.000053091604,0.00007600219,0.0009489364,0.000025146115],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11482792,0.005328505,0.00020289535,0.0029851259,0.0008744866,0.5003769,0.0017718286,2.991174e-7,0.00003538768,0.000022864859,0.37142426,0.002149516],"study_design_scores_gemma":[0.80631685,0.001135395,0.00010232836,0.0044639586,0.0020410542,0.12350718,0.000113059585,0.000007728271,0.0009298434,0.00007382152,0.061160643,0.0001481602],"about_ca_topic_score_codex":0.0001673485,"about_ca_topic_score_gemma":0.00006830263,"teacher_disagreement_score":0.6914889,"about_ca_system_score_codex":0.00021131815,"about_ca_system_score_gemma":0.00073781435,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W4402534146","doi":"10.1177/24741264241276602","title":"Isolated Recurrence of Diffuse Large B-Cell Lymphoma Predominantly in the Iris and Ciliary Body","year":2024,"lang":"en","type":"article","venue":"Journal of VitreoRetinal Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Ciliary body; IRIS (biosensor); Diffuse large B-cell lymphoma; Lymphoma; Medicine; Pathology; Ophthalmology; Computer science; Artificial intelligence","score_opus":0.006163760635973437,"score_gpt":0.2607549556149843,"score_spread":0.25459119497901084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402534146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654826,0.03285458,0.000018611712,0.0009718727,0.00011382818,0.00018231678,0.00008350452,0.0000073622277,0.00028530697],"genre_scores_gemma":[0.99618816,0.0034333083,0.00007099226,0.00013602362,0.00009802442,0.000008456232,0.000008595646,0.000011219891,0.00004519004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873006,0.00011176921,0.00046225404,0.00015249461,0.0003590056,0.00018443486],"domain_scores_gemma":[0.9990565,0.00036718,0.00017129106,0.00015504533,0.00010362151,0.00014632428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002566282,0.00015195087,0.00035526016,0.00017214795,0.00003502415,0.000044150715,0.000109323715,0.000043542295,0.000031100102],"category_scores_gemma":[0.00015683944,0.00008379632,0.00020901098,0.0002390959,0.000106308056,0.00012576136,0.000033886623,0.00009718503,0.000003830413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056858636,0.039843675,0.8665771,0.002027389,0.0004981468,0.015578068,0.0026479596,9.560076e-7,0.0029423207,0.0018400953,0.0149532,0.047405228],"study_design_scores_gemma":[0.013537227,0.0025102773,0.9709296,0.0027802442,0.001282547,0.0014121288,0.0007183968,0.0008347277,0.0012401697,0.0005944495,0.0040078647,0.00015233044],"about_ca_topic_score_codex":0.000015837131,"about_ca_topic_score_gemma":0.00000185928,"teacher_disagreement_score":0.104352534,"about_ca_system_score_codex":0.00006997159,"about_ca_system_score_gemma":0.00022579041,"threshold_uncertainty_score":0.3417115},"labels":[],"label_agreement":null},{"id":"W4402827770","doi":"10.1038/s41375-024-02420-6","title":"Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Swedish Orphan Biovitrum; F. Hoffmann-La Roche; Incyte; BeiGene; Gilead Sciences; MorphoSys; Celgene; Eli Lilly and Company; AstraZeneca; Agios Pharmaceuticals; Roche; Amgen","keywords":"Lymphoma; Medicine; Retrospective cohort study; Oncology; Internal medicine; Randomized controlled trial; Pediatrics","score_opus":0.02574011826774529,"score_gpt":0.3359160215656327,"score_spread":0.3101759032978874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402827770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896776,0.0034225183,0.00095958414,0.00012609876,0.00033820182,0.004001813,0.0012855034,0.00006916038,0.0001195088],"genre_scores_gemma":[0.99655694,0.0009792446,0.0009647943,0.00009276257,0.00018730035,0.00055168266,0.00033967313,0.00006332273,0.00026426796],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741036,0.0002066558,0.0011053947,0.00046570227,0.0004794098,0.0003324657],"domain_scores_gemma":[0.99649566,0.001993293,0.0006465658,0.00042439293,0.00030376227,0.00013634769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008614624,0.0003651617,0.0025256441,0.00017806538,0.00008149023,0.000028211554,0.000102786296,0.00012988661,0.00011405445],"category_scores_gemma":[0.0005038402,0.00019247505,0.0005825289,0.00031518395,0.00012469557,0.00010626377,0.000027499913,0.000089743146,0.000007702724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7697752,0.055708636,0.13542262,0.00071640575,0.0059227785,0.00006943992,0.003737684,0.000016652757,0.0006541003,0.0020946339,0.004721983,0.021159884],"study_design_scores_gemma":[0.94608474,0.0053169783,0.012653656,0.00044201515,0.0021268162,0.0000025317886,0.000058047386,0.001754191,0.029600065,0.00024683005,0.0014965825,0.00021752973],"about_ca_topic_score_codex":0.0009540169,"about_ca_topic_score_gemma":0.000105637504,"teacher_disagreement_score":0.17630957,"about_ca_system_score_codex":0.0008030202,"about_ca_system_score_gemma":0.00044789538,"threshold_uncertainty_score":0.7848905},"labels":[],"label_agreement":null},{"id":"W4402863797","doi":"10.3390/cancers16193278","title":"Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karen Elise Jensens Fond; Aarhus Universitet","keywords":"Follicular lymphoma; Stage (stratigraphy); Profiling (computer programming); Medicine; Follicular phase; Oncology; Lymphoma; Computational biology; Internal medicine; Bioinformatics; Computer science; Biology","score_opus":0.005972184959994875,"score_gpt":0.2694780328920639,"score_spread":0.26350584793206905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402863797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901963,0.005012514,0.00009129462,0.000048106835,0.00026392346,0.0039814254,0.00018495528,0.00009871152,0.00012275352],"genre_scores_gemma":[0.99504614,0.00018152408,0.0013645112,0.00003579425,0.000057317142,0.00300395,0.00013988807,0.000036987694,0.00013388855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988817,0.000019741814,0.00017621777,0.0004189173,0.00024794918,0.00025550518],"domain_scores_gemma":[0.9995537,0.00004326588,0.00007100661,0.00017093515,0.000082516446,0.00007857431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008098933,0.00018282083,0.00023495808,0.00011594331,0.00007094837,0.000040295457,0.00004824149,0.00007711493,0.00000816769],"category_scores_gemma":[0.000042631098,0.00011903274,0.00008383704,0.00019554936,0.000053237847,0.00015246226,0.000017973822,0.000071475595,0.000003277297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005170288,0.0003876473,0.8596244,0.0012929416,0.0007685974,0.00017691936,0.0010416403,0.0041206987,0.00050734763,0.00023096908,0.0006602709,0.12601827],"study_design_scores_gemma":[0.023698172,0.0048033125,0.8422707,0.005988206,0.00076019444,0.0000024129865,0.0004146843,0.0083141485,0.10873326,0.00023590344,0.0042773914,0.00050164736],"about_ca_topic_score_codex":0.00007202237,"about_ca_topic_score_gemma":0.000018423814,"teacher_disagreement_score":0.12551662,"about_ca_system_score_codex":0.0020589656,"about_ca_system_score_gemma":0.0005718856,"threshold_uncertainty_score":0.53841233},"labels":[],"label_agreement":null},{"id":"W4402927660","doi":"10.1080/10428194.2024.2403668","title":"Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; University Health Network; University of Toronto","funders":"Merck Canada","keywords":"Diffuse large B-cell lymphoma; Survivin; Refractory (planetary science); Lymphoma; Cancer research; Medicine; Intensity (physics); Aggressive lymphoma; Oncology; Internal medicine; Rituximab; Biology; Cancer; Physics; Optics","score_opus":0.00902916657617432,"score_gpt":0.24642681576975697,"score_spread":0.23739764919358267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402927660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759298,0.016097086,0.000062382314,0.0002451775,0.001056073,0.0011809672,0.0003597182,0.00033884283,0.0047299634],"genre_scores_gemma":[0.992296,0.002904557,0.0009139113,0.0007994159,0.0003763281,0.00018390737,0.00024385928,0.00019315493,0.0020888976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942531,0.00022697763,0.0015006788,0.0016187317,0.0012205697,0.0011799484],"domain_scores_gemma":[0.99527687,0.00083001395,0.0008878278,0.0015026578,0.0005142209,0.0009883937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055427174,0.0011211177,0.002089614,0.00086143875,0.00027175818,0.00012848801,0.00049071206,0.00088698807,0.00009031904],"category_scores_gemma":[0.0004501106,0.00090059993,0.0007779849,0.0010602274,0.00041389058,0.00037419176,0.00061694434,0.0001885933,0.00010378467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012785742,0.02187633,0.05680489,0.0077993125,0.0026547213,0.0076617547,0.015502156,0.000033108263,0.2976526,0.0038338988,0.068402596,0.50499284],"study_design_scores_gemma":[0.06881771,0.002314848,0.57548195,0.0070663546,0.0013912267,0.0017284908,0.0016017385,0.000877422,0.30899873,0.00040785654,0.029796934,0.0015167203],"about_ca_topic_score_codex":0.0019294295,"about_ca_topic_score_gemma":0.00009276624,"teacher_disagreement_score":0.51867706,"about_ca_system_score_codex":0.0051875114,"about_ca_system_score_gemma":0.003461948,"threshold_uncertainty_score":0.99934447},"labels":[],"label_agreement":null},{"id":"W4402999653","doi":"10.1016/j.ctro.2024.100869","title":"Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Genentech; F. Hoffmann-La Roche; Incyte; BeiGene; TG Therapeutics; Bristol-Myers Squibb; AstraZeneca; Celgene; BC Cancer Foundation; Seagen; Kite Pharma; Gilead Sciences; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Follicular lymphoma; Medicine; Radiation therapy; Stage (stratigraphy); Lymphoma; Disease; Follicular phase; Internal medicine; Oncology; Biology","score_opus":0.034160292813871646,"score_gpt":0.3511407458965813,"score_spread":0.3169804530827096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402999653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145187,0.0027109853,0.00009821031,0.014488656,0.000080891965,0.0006849405,0.00015324319,0.000067205125,0.00026398542],"genre_scores_gemma":[0.99532986,0.0014431897,0.00017999506,0.0017543822,0.00007798966,0.0001540871,0.0006141875,0.000023902578,0.0004224384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984595,0.00014890743,0.00048765904,0.00044221221,0.00026534242,0.00019637238],"domain_scores_gemma":[0.9985424,0.00095777615,0.000090155365,0.00012586001,0.00006072468,0.00022304719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026785134,0.00020515088,0.00051504816,0.00015981813,0.00008463101,0.00002836477,0.000031786545,0.0001818785,0.0001741231],"category_scores_gemma":[0.00005902603,0.00012824632,0.00013615601,0.00028249683,0.00014572527,0.00014558702,0.00000515268,0.00010078299,0.000011329328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012405877,0.0018095968,0.84355676,0.000013711808,0.0006538598,0.00035997064,0.00021834637,0.000030246123,0.000002439283,0.0003901587,0.00008687484,0.15163742],"study_design_scores_gemma":[0.019244231,0.0020053245,0.96110165,0.00006944502,0.00028658798,0.000011446448,0.000008915103,0.0024622963,0.000025008572,0.00035356567,0.014279444,0.00015208908],"about_ca_topic_score_codex":0.00005171719,"about_ca_topic_score_gemma":0.00007744736,"teacher_disagreement_score":0.15148534,"about_ca_system_score_codex":0.00012729793,"about_ca_system_score_gemma":0.00046742347,"threshold_uncertainty_score":0.5229733},"labels":[],"label_agreement":null},{"id":"W4403014078","doi":"10.1016/s2352-3026(24)00276-x","title":"Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups","year":2024,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control","funders":"National Institutes of Health; National Comprehensive Cancer Network; National Cancer Institute; American Association of Physicists in Medicine","keywords":"Medicine; Clinical trial; Nomenclature; Lymphoma; Medical physics; Intensive care medicine; Internal medicine; Taxonomy (biology)","score_opus":0.2870654028184923,"score_gpt":0.48311623671278964,"score_spread":0.19605083389429734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403014078","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13917731,0.031258382,0.0027503776,0.8088201,0.009111188,0.004598767,0.0019400335,0.00031403312,0.0020297782],"genre_scores_gemma":[0.9483481,0.0022543678,0.0086333025,0.020011166,0.017408542,0.0012676752,0.0017693735,0.000044789747,0.00026267546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99548215,0.0024620413,0.0012240398,0.00034234452,0.00018953781,0.0002998674],"domain_scores_gemma":[0.9538224,0.045346636,0.00035750857,0.00030443902,0.000102205224,0.00006681854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011622675,0.00017928035,0.0017171034,0.00003509896,0.00023807454,0.00006770411,0.00016475581,0.00023071941,0.0002822081],"category_scores_gemma":[0.007950005,0.000084333224,0.00049123063,0.00017652733,0.00011135244,0.000030422661,0.000038661987,0.00016222411,0.00010457752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084685156,0.00016804856,0.008090861,0.000029679619,0.0012727912,0.000032592274,0.0003008796,0.000013588562,0.0000072520747,0.114823386,0.84689593,0.027518155],"study_design_scores_gemma":[0.010018677,0.00020791977,0.026824748,0.00017776605,0.0013333915,0.0003228516,0.00008494611,0.0031068628,0.0000777547,0.13017212,0.8275245,0.00014850465],"about_ca_topic_score_codex":0.000032537868,"about_ca_topic_score_gemma":0.000027831451,"teacher_disagreement_score":0.8091708,"about_ca_system_score_codex":0.0001524114,"about_ca_system_score_gemma":0.00046112377,"threshold_uncertainty_score":0.95174736},"labels":[],"label_agreement":null},{"id":"W4403057894","doi":"10.1055/s-0044-1789701","title":"Assessment and impact of age on the efficacy and safety among patients in the etrasimod ELEVATE UC clinvical programme","year":2024,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Computer science; Medicine","score_opus":0.02945311598421272,"score_gpt":0.3430448589814592,"score_spread":0.31359174299724646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403057894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958631,0.00015825765,0.000009445784,0.0021555766,0.000062430605,0.0011219189,0.000040994208,0.00003378714,0.0005545287],"genre_scores_gemma":[0.998941,0.00031450886,0.00008918047,0.0004455615,0.000037214155,0.00010103995,0.00005106987,0.000015726313,0.0000047192143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984088,0.0001991338,0.00034133156,0.00034466002,0.00029545723,0.0004106356],"domain_scores_gemma":[0.9989257,0.00057022995,0.00006433183,0.0003084981,0.000027198179,0.00010405915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005342345,0.00022837133,0.00033206245,0.000085409054,0.00005869877,0.00007377729,0.000114564835,0.00007615188,0.000018188251],"category_scores_gemma":[0.0001091932,0.00009903249,0.000134212,0.0001312384,0.0002253921,0.00005358352,0.00008371564,0.00029053565,0.000003887012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000435533,0.00125256,0.98387194,0.000042396434,0.00020060792,0.00015332882,0.00020006548,0.000005506935,0.000027451006,0.0005302653,0.00034858086,0.012931769],"study_design_scores_gemma":[0.0036365641,0.0059973034,0.98930174,0.00022997308,0.00012668285,0.000015476247,0.000070077615,0.00020185926,0.000022915681,0.000014430956,0.00033178943,0.00005119005],"about_ca_topic_score_codex":0.00016034931,"about_ca_topic_score_gemma":0.00005068633,"teacher_disagreement_score":0.012880579,"about_ca_system_score_codex":0.000044480697,"about_ca_system_score_gemma":0.00004730615,"threshold_uncertainty_score":0.40384278},"labels":[],"label_agreement":null},{"id":"W4403147307","doi":"10.1200/jco.23.02470","title":"Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Gastroenterology; Refractory (planetary science); Dosing; Neutropenia; Rash; Tolerability; Surgery; Adverse effect; Lymphoma; Toxicity","score_opus":0.10317170409455788,"score_gpt":0.4670318790647525,"score_spread":0.3638601749701946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403147307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817311,0.0034770044,0.0000032682724,0.005330698,0.0025605934,0.00033119344,0.00004279659,0.000020164905,0.0065031555],"genre_scores_gemma":[0.9956506,0.0008477162,0.0006316592,0.0007873622,0.0013420703,0.000009792737,0.000011640384,0.000022614075,0.00069654937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953959,0.00045675426,0.003091969,0.0003717985,0.00043112083,0.00025247716],"domain_scores_gemma":[0.99408287,0.0043039634,0.00078661693,0.00030236327,0.00014512791,0.00037904206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027020476,0.00019095585,0.0015168918,0.00022410614,0.00003825591,0.000019057003,0.0001576499,0.0003691534,0.00016502],"category_scores_gemma":[0.0016849021,0.00012527543,0.00052558153,0.00022023273,0.00008639912,0.000102415404,0.000089110166,0.0005878786,0.0001400765],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023993688,0.17095488,0.04175361,0.000030908894,0.0010505642,0.064070396,0.0016740101,0.000005499887,0.00013824251,0.000033834913,0.03495072,0.66134363],"study_design_scores_gemma":[0.22170395,0.1281735,0.3541813,0.00042073216,0.0013400036,0.00031549993,0.0010491146,0.00020313733,0.00018242777,0.00032297298,0.2919226,0.00018478067],"about_ca_topic_score_codex":0.00024219853,"about_ca_topic_score_gemma":0.00013606093,"teacher_disagreement_score":0.66115886,"about_ca_system_score_codex":0.0006292542,"about_ca_system_score_gemma":0.0021648044,"threshold_uncertainty_score":0.51085836},"labels":[],"label_agreement":null},{"id":"W4403173763","doi":"10.1038/s41408-024-01153-0","title":"MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"Agencia Estatal de Investigación; European Regional Development Fund; Instituto de Salud Carlos III; Ministerio de Economía y Competitividad; Generalitat de Catalunya; European Commission; Michael Smith Health Research BC","keywords":"Lymphoma; Burkitt's lymphoma; Medicine; Cancer research; Hematology; B cell; Oncology; Internal medicine; Immunology; Antibody","score_opus":0.004214530295685977,"score_gpt":0.22791742188011657,"score_spread":0.2237028915844306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403173763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86470777,0.13242334,0.0000036525994,0.001164273,0.0003768011,0.00030806448,0.000047413185,0.000050979033,0.0009177313],"genre_scores_gemma":[0.98797166,0.0102499835,0.00020280552,0.00043125643,0.0006270106,0.0000669974,0.000017339215,0.000053083084,0.0003798544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983912,0.00005137899,0.00033538858,0.00040967556,0.00040565798,0.00040666948],"domain_scores_gemma":[0.99930257,0.00002284617,0.00010002628,0.00020461732,0.000059143607,0.00031080487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001426174,0.00028932965,0.0003977024,0.00024498557,0.000106786276,0.00023307107,0.00009824888,0.00016490238,0.00010970043],"category_scores_gemma":[0.000015360196,0.00022088092,0.00017072877,0.00029931747,0.000044003405,0.00015655626,0.000039509956,0.00023141931,0.000018334647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036033793,0.0015430864,0.93606836,0.0001958905,0.00091235875,0.006369069,0.0011890839,0.0000029192581,0.0013510814,0.00003832382,0.0035488799,0.048420623],"study_design_scores_gemma":[0.017839363,0.00038262844,0.9577294,0.0023736064,0.000856024,0.012735169,0.00022009091,0.00006502732,0.005945149,0.00006123731,0.0015121032,0.00028017495],"about_ca_topic_score_codex":0.00069213856,"about_ca_topic_score_gemma":0.0001490603,"teacher_disagreement_score":0.123263925,"about_ca_system_score_codex":0.00034038862,"about_ca_system_score_gemma":0.0003922831,"threshold_uncertainty_score":0.90072626},"labels":[],"label_agreement":null},{"id":"W4403214873","doi":"10.1080/2162402x.2024.2412869","title":"The landscape of T-cell engagers for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; National Institutes of Health; Fundación Española de Hematología y Hemoterapia","keywords":"Medicine; Follicular lymphoma; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.03959889579960756,"score_gpt":0.3349351575010171,"score_spread":0.29533626170140953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403214873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002815667,0.9953292,0.0000018020676,0.00023183793,0.00062216015,0.0020645498,0.00011192218,0.000016615038,0.0013403618],"genre_scores_gemma":[0.0006812824,0.9955825,0.0000577825,0.000012684491,0.000108351094,0.0014917696,0.0001605024,0.000048980688,0.001856141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854475,0.0001296479,0.0006359833,0.0002919185,0.00013011678,0.00026755553],"domain_scores_gemma":[0.9965975,0.0020853989,0.00037298768,0.0008454078,0.00006851291,0.000030146597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020321051,0.00037044648,0.001775506,0.000097591284,0.00012251629,0.000011027411,0.00022325684,0.0002866999,0.00003370716],"category_scores_gemma":[0.000039520204,0.0001405089,0.0015053574,0.00019305594,0.00020955557,0.000007733656,0.000040821193,0.00007324963,0.00003829805],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007310103,0.0009520501,0.000014545104,0.0035330402,0.004217359,0.000035583413,0.0001937464,1.0399745e-7,0.000004597535,0.00059446326,0.0019214815,0.98845994],"study_design_scores_gemma":[0.002283383,0.0025710554,0.000040080395,0.0018183944,0.013244381,0.00010020705,0.00016697978,0.0000038504495,0.0001379694,0.000023690898,0.97950965,0.00010033805],"about_ca_topic_score_codex":0.000081758786,"about_ca_topic_score_gemma":0.00001107074,"teacher_disagreement_score":0.9883596,"about_ca_system_score_codex":0.00031502717,"about_ca_system_score_gemma":0.0006243713,"threshold_uncertainty_score":0.5729787},"labels":[],"label_agreement":null},{"id":"W4403310535","doi":"10.14740/jmc4288","title":"Tonsillar Diffuse Large B-Cell Lymphoma of Non-Germinal Center Type With Cluster of Differentiation 5 Positive in a Pediatric Girl","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Germinal center; Girl; Center (category theory); Cluster (spacecraft); Pediatrics; B cell; Immunology; Genetics; Antibody","score_opus":0.008909399677339686,"score_gpt":0.2770265611649099,"score_spread":0.26811716148757025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403310535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586654,0.0025558092,0.000060189992,0.0009798673,0.00021629753,0.00012905194,0.000023993593,0.0000035008366,0.00016475967],"genre_scores_gemma":[0.9980057,0.001417422,0.0001066963,0.00015492947,0.00024988604,0.0000022781385,0.000011364983,0.000013048736,0.00003866149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823076,0.000056577184,0.0005387966,0.0001150244,0.00090141303,0.00015743476],"domain_scores_gemma":[0.9989841,0.0003292132,0.0002174791,0.00009430817,0.0001839759,0.00019093508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709142,0.00012369691,0.000437733,0.00028947473,0.000012123511,0.000009695084,0.000066916466,0.00010685847,0.00012055307],"category_scores_gemma":[0.00017000936,0.000071566916,0.000140995,0.0002645186,0.00004417835,0.00007116621,0.000033962075,0.00012168836,0.000003931553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00417757,0.035853665,0.90760434,0.002011997,0.0005169348,0.028754078,0.0019017915,0.0000027670949,0.0003718752,0.00009121481,0.00524474,0.013469012],"study_design_scores_gemma":[0.043230712,0.0075636823,0.92776185,0.0035353892,0.001407901,0.0068576266,0.00035869927,0.0011637019,0.0074039027,0.000014329872,0.0005305472,0.00017168128],"about_ca_topic_score_codex":0.000039021255,"about_ca_topic_score_gemma":0.000026382466,"teacher_disagreement_score":0.039053146,"about_ca_system_score_codex":0.000121361394,"about_ca_system_score_gemma":0.00047391938,"threshold_uncertainty_score":0.29184142},"labels":[],"label_agreement":null},{"id":"W4403369008","doi":"10.1111/bjh.19823","title":"The value of semiquantitative <scp>PET</scp> features and end‐of‐therapy <scp>PET</scp> in grade <scp>3B</scp> follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"University of Melbourne","keywords":"Medicine; Lymphoma; Follicular lymphoma; Positron emission tomography; Standardized uptake value; Diffuse large B-cell lymphoma; CHOP; Nuclear medicine; Aggressive lymphoma; Chemotherapy; Internal medicine; Oncology; Rituximab","score_opus":0.012043750600632674,"score_gpt":0.2742954154243849,"score_spread":0.26225166482375223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403369008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8120514,0.18529424,0.000027559814,0.0006094995,0.0005731217,0.00051416113,0.00006541507,0.000030271709,0.00083430717],"genre_scores_gemma":[0.95309246,0.04468659,0.001059409,0.0003012251,0.00016282513,0.000052319687,0.000019458983,0.000078273246,0.00054743304],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9959891,0.0005459604,0.0014801897,0.0005110194,0.0007310488,0.00074268796],"domain_scores_gemma":[0.99256045,0.005561434,0.0008095219,0.00034945892,0.00039546343,0.00032369705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010568603,0.0004653289,0.0018097294,0.00050743215,0.00017621084,0.00014061178,0.00037553994,0.00026684263,0.0000073778965],"category_scores_gemma":[0.0020906432,0.0003642495,0.00061259285,0.0006122848,0.0006274899,0.00025481358,0.00011552932,0.0004903356,0.000009918719],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001600145,0.0073215063,0.12962197,0.0025909573,0.01081131,0.529366,0.014774356,0.00012896856,0.009546721,0.050610475,0.15224749,0.09282018],"study_design_scores_gemma":[0.013151816,0.0024814492,0.26088193,0.0050004036,0.0009165828,0.5905834,0.0064655296,0.00021957516,0.060906783,0.0081498,0.051134504,0.00010825915],"about_ca_topic_score_codex":0.00056947966,"about_ca_topic_score_gemma":0.0003101401,"teacher_disagreement_score":0.14104104,"about_ca_system_score_codex":0.00021624878,"about_ca_system_score_gemma":0.0007127246,"threshold_uncertainty_score":0.99988097},"labels":[],"label_agreement":null},{"id":"W4403420022","doi":"10.1016/j.jtho.2024.09.075","title":"OA14.06 Divarasib Single-Agent Long-Term Follow-up and Atezolizumab Combination Treatment in Patients with KRAS G12C-Positive NSCLC","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"Samsung; Genentech; Humanitas Research Hospital; Universitair Ziekenhuis Antwerpen; Jewish General Hospital; Maastricht Universitair Medisch Centrum; Peter MacCallum Cancer Centre; Sungkyunkwan University; University of Manchester; Victoria University; University of Melbourne; Ottawa Hospital Research Institute; Monash University; Università degli Studi di Milano; Hospital de Câncer de Barretos; Seoul National University; Seoul National University Bundang Hospital; McGill University; Yale Cancer Center; Yale University","keywords":"Medicine; Atezolizumab; Term (time); Oncology; KRAS; Internal medicine; Pembrolizumab; Cancer; Immunotherapy; Colorectal cancer","score_opus":0.019908694389413197,"score_gpt":0.3534978687197636,"score_spread":0.3335891743303504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403420022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943557,0.001696519,0.0000400232,0.0020255793,0.0005606524,0.00056635716,0.000011523813,0.000015262356,0.0007284325],"genre_scores_gemma":[0.9988295,0.00025261016,0.0002732427,0.00013049481,0.000102796235,0.000020489293,0.000043620705,0.000023781511,0.00032348055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858886,0.00014867018,0.00047860632,0.0002378986,0.00030567724,0.00024029966],"domain_scores_gemma":[0.99904364,0.00020911796,0.00024726236,0.00012515421,0.0001921291,0.00018270052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018039982,0.00022843007,0.00062096195,0.0003456124,0.000051146013,0.00004871748,0.00005258232,0.00013362242,0.00003774727],"category_scores_gemma":[0.000029948078,0.00014169102,0.00013335,0.0001914694,0.00007184759,0.00018081482,0.000029619196,0.00015254934,0.00001872344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00334883,0.005360389,0.61012197,0.00008030771,0.00072935247,0.0035042835,0.0012825009,0.0000026034097,0.000085356805,0.000058949638,0.00022314997,0.37520233],"study_design_scores_gemma":[0.010609184,0.022158159,0.9623788,0.0009019437,0.0010359364,0.00068703276,0.000096409836,0.000021277845,0.0013445317,0.000064284024,0.00057574065,0.00012669222],"about_ca_topic_score_codex":0.000032747652,"about_ca_topic_score_gemma":0.000077738165,"teacher_disagreement_score":0.37507564,"about_ca_system_score_codex":0.00263291,"about_ca_system_score_gemma":0.00034952635,"threshold_uncertainty_score":0.68849677},"labels":[],"label_agreement":null},{"id":"W4403484404","doi":"10.3390/ijms252011179","title":"Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review","year":2024,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karen Elise Jensens Fond; Institut for Klinisk Medicin, Aarhus Universitet; Aarhus Universitet","keywords":"Follicular lymphoma; Outcome (game theory); Lymphoma; Transformation (genetics); Computational biology; Oncology; Medicine; Internal medicine; Bioinformatics; Immunology; Biology; Genetics; Gene","score_opus":0.025794416455384855,"score_gpt":0.3198393269418272,"score_spread":0.2940449104864423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403484404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13847342,0.8602484,0.00004215497,0.0001965279,0.00023096052,0.0007419266,0.000041149917,0.0000036049048,0.0000218569],"genre_scores_gemma":[0.25087762,0.7487887,0.00018650308,0.00006820607,0.000010623978,0.000023342383,0.000033790846,0.000010717025,4.7203486e-7],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99705154,0.00014102756,0.0013040635,0.00024673739,0.0011236011,0.00013305721],"domain_scores_gemma":[0.9987677,0.000052644365,0.000704782,0.00010514492,0.00029873705,0.00007102202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042683576,0.0002519404,0.0011988292,0.0009788461,0.000012530412,0.0000363991,0.00023596916,0.00009514543,0.0000021815968],"category_scores_gemma":[0.00004099727,0.00015308644,0.00030921143,0.0005789014,0.00012097693,0.00016657605,0.000034103938,0.000116462674,0.0000013165402],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025296886,0.002161529,0.034878597,0.0710631,0.0061300895,0.0053337016,0.00037925143,0.00015016785,0.00004429942,0.0013124401,0.00007146659,0.8782224],"study_design_scores_gemma":[0.018371714,0.0033561683,0.03973465,0.89783424,0.009896257,0.006006588,0.0002107864,0.00014894527,0.00016939853,0.0002032215,0.023331197,0.0007368239],"about_ca_topic_score_codex":0.00005612301,"about_ca_topic_score_gemma":0.000002434379,"teacher_disagreement_score":0.8774856,"about_ca_system_score_codex":0.00043678426,"about_ca_system_score_gemma":0.00037117788,"threshold_uncertainty_score":0.6242684},"labels":[],"label_agreement":null},{"id":"W4403523964","doi":"10.1002/9781394244843.ch6","title":"LYMPHOPROLIFERATIVE DISORDERS","year":2024,"lang":"en","type":"other","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Lymphoproliferative disorders; Medicine; Computational biology; Computer science; Biology; Immunology; Lymphoma","score_opus":0.0074118400031621765,"score_gpt":0.27570027753761983,"score_spread":0.26828843753445764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403523964","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000084701105,0.0075097005,0.0000065865324,0.0015751122,0.00029877262,0.000397314,0.000024452904,0.00037047174,0.9898091],"genre_scores_gemma":[0.0018196424,0.0012835077,0.00031724057,0.0006227038,0.00029950822,0.00010745992,0.0000524126,0.0004033983,0.9950941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994186,0.000005048198,0.00007722715,0.00025744122,0.00012515193,0.000116528274],"domain_scores_gemma":[0.99968994,0.0000066224547,0.000020519628,0.00020253185,0.000005409006,0.000074975644],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000118758735,0.0001841027,0.00025765997,0.00012571743,0.0000060469692,0.000014399898,0.000023572818,0.00014284284,0.014163268],"category_scores_gemma":[0.00000418745,0.000112967,0.00012509455,0.00006512871,0.000026961085,0.000004581922,0.0000206904,0.00004006814,0.010820881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005792412,0.00016060192,0.0009901113,0.00012562449,0.0004773079,0.00008100473,0.000027939388,6.3293326e-9,4.6332153e-7,0.0029927508,0.98796946,0.007168927],"study_design_scores_gemma":[0.00078004424,0.00010315443,0.00024992786,0.00036815234,0.00029534436,0.000019589213,0.000021748789,0.0000028148036,0.000033933215,0.00027647114,0.99773616,0.000112685724],"about_ca_topic_score_codex":0.00040825392,"about_ca_topic_score_gemma":0.00025774902,"teacher_disagreement_score":0.009766663,"about_ca_system_score_codex":0.00009019258,"about_ca_system_score_gemma":0.0000764724,"threshold_uncertainty_score":0.9899493},"labels":[],"label_agreement":null},{"id":"W4403538079","doi":"10.1038/s41375-024-02431-3","title":"Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Institutes of Health; National Cancer Institute; Fondazione Città della Speranza; Lymphoma Research Foundation; U.S. Department of Health and Human Services","keywords":"Lymphoma; Transcriptome; Biology; Cancer research; Tropomyosin; Cell cycle; Actin; Cell; Targeted therapy; Immunology; Gene; Gene expression; Genetics; Cancer","score_opus":0.01701707335172056,"score_gpt":0.2442203755642656,"score_spread":0.22720330221254503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403538079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96455824,0.033061087,0.000014026534,0.00017398887,0.00015078894,0.0003307226,0.000052785676,0.00003849418,0.0016198547],"genre_scores_gemma":[0.9944135,0.0041969777,0.00076816423,0.00017176985,0.00011037527,0.00002294445,0.000011075763,0.000028571672,0.00027661977],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998853,0.000040023726,0.00039651647,0.00030417778,0.00021434091,0.00019192585],"domain_scores_gemma":[0.99932915,0.00013834937,0.00009700212,0.0002780949,0.000052520572,0.000104875646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015564871,0.00018144144,0.00040845393,0.00011442086,0.00002433501,0.000015900507,0.000067731664,0.00008222368,0.000020621648],"category_scores_gemma":[0.000016739024,0.0001440528,0.00015334316,0.00024924692,0.00008573282,0.000054181106,0.000013495888,0.000048897953,0.0000035147286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005832114,0.0028709143,0.44069737,0.009339282,0.0013852001,0.0012055597,0.0022643635,0.000009789209,0.41027018,0.0013702703,0.022859903,0.10189506],"study_design_scores_gemma":[0.011906386,0.0017288848,0.3200468,0.0007012201,0.0008740125,0.00010570044,0.00013848503,0.00014124652,0.65015745,0.0004645194,0.013314446,0.00042080306],"about_ca_topic_score_codex":0.00007343475,"about_ca_topic_score_gemma":0.000014537825,"teacher_disagreement_score":0.2398873,"about_ca_system_score_codex":0.00038444778,"about_ca_system_score_gemma":0.0002710594,"threshold_uncertainty_score":0.5874303},"labels":[],"label_agreement":null},{"id":"W4403572969","doi":"10.14740/jh1333","title":"Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Immunohistochemistry; Mantle cell lymphoma; Medicine; Pathology; Risk stratification; Lymphoma; Staining; Internal medicine","score_opus":0.016668838778053384,"score_gpt":0.30543056391769285,"score_spread":0.2887617251396395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403572969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922664,0.008406231,0.0009796428,0.0003130068,0.00017015486,0.0001605456,0.000021852919,0.0000053108133,0.00071662775],"genre_scores_gemma":[0.9967431,0.0001921545,0.002964999,0.000010074138,0.0000336489,0.0000057224424,0.0000066468256,0.000008046543,0.000035632096],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899673,0.000031215972,0.0006432498,0.00009566632,0.00013125486,0.00010185495],"domain_scores_gemma":[0.99885297,0.0003366174,0.0004151342,0.00014141819,0.00020672419,0.00004716047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026012424,0.00007680028,0.0004528559,0.000101781516,0.00001700746,0.0000036429615,0.00005668917,0.000083293846,0.000054031156],"category_scores_gemma":[0.00011350021,0.00005554694,0.00021748322,0.00006916342,0.000070122034,0.000037911974,0.000010778949,0.000057405712,0.0000019366078],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074450052,0.014644533,0.36479202,0.011898256,0.00402895,0.0010820257,0.0055949376,0.000013478622,0.36008886,0.04712444,0.036632907,0.1466546],"study_design_scores_gemma":[0.005019216,0.001511421,0.031436227,0.0005029971,0.00087567826,0.0015854298,0.0006746119,0.0010550114,0.9520089,0.00303685,0.0022085954,0.000085030544],"about_ca_topic_score_codex":0.000014966383,"about_ca_topic_score_gemma":0.0000010151831,"teacher_disagreement_score":0.5919201,"about_ca_system_score_codex":0.000053943506,"about_ca_system_score_gemma":0.00029262772,"threshold_uncertainty_score":0.22651385},"labels":[],"label_agreement":null},{"id":"W4403572970","doi":"10.14740/jh1284","title":"Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation","year":2024,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Allegheny Health Network","keywords":"Medicine; Lymphoma; Epstein–Barr virus; Virus; Mutation; Virology; Immunology; Biology; Genetics; Gene","score_opus":0.006017521349183284,"score_gpt":0.23825598040687068,"score_spread":0.2322384590576874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403572970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684007,0.010488582,0.00010084883,0.00069726806,0.0002760045,0.00026001153,0.000023319612,0.00002560591,0.0012883103],"genre_scores_gemma":[0.99927163,0.00017061943,0.00019641186,0.0001381485,0.00007265792,0.0000100631005,0.0000170836,0.000029210845,0.000094186915],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984615,0.00010593847,0.000705255,0.00017235547,0.00034177367,0.00021319142],"domain_scores_gemma":[0.99848056,0.0003950142,0.00055233145,0.00013734457,0.0003099824,0.0001247807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023607217,0.00018676124,0.00081364927,0.0002801072,0.000037335176,0.000017430537,0.00007623398,0.0001500602,0.0000495162],"category_scores_gemma":[0.000097910764,0.00012165941,0.00022503705,0.000234393,0.00007079256,0.00009460334,0.000015926873,0.00011819081,0.000028661547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009052778,0.051708467,0.43772838,0.008623192,0.042870548,0.21087822,0.04502162,0.00048889406,0.07967266,0.028734073,0.028962996,0.056258187],"study_design_scores_gemma":[0.040876113,0.014242392,0.24931172,0.01787912,0.0064582117,0.18590842,0.0025168746,0.0004905962,0.48034796,0.00075828674,0.00057906075,0.0006312482],"about_ca_topic_score_codex":0.000025717081,"about_ca_topic_score_gemma":0.000008554826,"teacher_disagreement_score":0.4006753,"about_ca_system_score_codex":0.00033641365,"about_ca_system_score_gemma":0.000518164,"threshold_uncertainty_score":0.49611267},"labels":[],"label_agreement":null},{"id":"W4403572979","doi":"10.14740/jh1303","title":"Primary Refractory Discordant Diffuse Large B-Cell and Classical Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Windsor Regional Hospital; Western University","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Primary (astronomy); Refractory (planetary science); Classical Hodgkin lymphoma; Pathology; Hodgkin lymphoma; Biology","score_opus":0.01001491768719936,"score_gpt":0.26744276989502047,"score_spread":0.2574278522078211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403572979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668708,0.026279451,0.00010085957,0.0045793955,0.00046964726,0.00009288383,0.000006392512,0.000020107678,0.0015804833],"genre_scores_gemma":[0.99636376,0.0017324397,0.0006928527,0.00057942205,0.00018593899,0.000004719105,0.0000041037565,0.00001965588,0.00041713024],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892664,0.000053179043,0.00042718637,0.0001652147,0.00020238802,0.00022541134],"domain_scores_gemma":[0.99922055,0.0002646201,0.00012951902,0.0001392627,0.00004581922,0.0002002311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001660253,0.00014405917,0.0005560057,0.00016393626,0.000036927613,0.000027697984,0.000053900436,0.00008633739,0.000048260034],"category_scores_gemma":[0.00003981513,0.0000886119,0.00017207205,0.00007563284,0.00007476594,0.00009754871,0.000050406456,0.00014740766,0.000033092812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032324055,0.05768276,0.27730507,0.0043498403,0.0029671174,0.21575946,0.0022949916,3.4027047e-7,0.022315657,0.059556212,0.22583164,0.12870452],"study_design_scores_gemma":[0.0456768,0.0059313383,0.22079384,0.0018994563,0.0018704269,0.16266564,0.00050540565,0.0002357811,0.017446388,0.0019928007,0.5404814,0.00050072727],"about_ca_topic_score_codex":0.0000025622658,"about_ca_topic_score_gemma":0.000002474352,"teacher_disagreement_score":0.31464976,"about_ca_system_score_codex":0.00016474773,"about_ca_system_score_gemma":0.00026781144,"threshold_uncertainty_score":0.36134884},"labels":[],"label_agreement":null},{"id":"W4403602456","doi":"10.58931/cht.2023.2339","title":"The role of FDG-PET scanning and PET-adapted therapy in the primary treatment of Hodgkin lymphoma: A primer for clinicians","year":2023,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Primer (cosmetics); Pet imaging; PET-CT; Medicine; Hodgkin lymphoma; Lymphoma; Medical physics; Nuclear medicine; Positron emission tomography; Radiology; Internal medicine; Chemistry","score_opus":0.024063330741172503,"score_gpt":0.2874105923960588,"score_spread":0.2633472616548863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403602456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848122,0.007343651,4.7570478e-7,0.0052671726,0.000069986265,0.0010677062,0.000059008093,0.000012743575,0.0013670814],"genre_scores_gemma":[0.99733555,0.0014825329,0.000096280666,0.00048513524,0.000024227622,0.00038327384,0.000049251383,0.000018075152,0.00012566507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889696,0.00008688193,0.00034809086,0.000212841,0.00009889956,0.00035635906],"domain_scores_gemma":[0.9984872,0.0008810444,0.00011496413,0.00033836628,0.000054756172,0.0001237031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002577119,0.00015206588,0.00048096103,0.00017039226,0.00012321757,0.000007057434,0.0001012026,0.000062584026,0.000008904849],"category_scores_gemma":[0.00006609501,0.000084425905,0.00011597243,0.00024376163,0.00017911804,0.000018060677,0.000009205261,0.000028192682,0.0000037967293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047494113,0.00067984726,0.7806927,0.00007085985,0.0006271646,0.00079167815,0.0042069014,0.0000027690699,0.00020672886,0.012049057,0.002628291,0.19756907],"study_design_scores_gemma":[0.012355792,0.0024001002,0.874924,0.00017650332,0.00024474756,0.00095387996,0.004117941,0.00027719294,0.005430261,0.001620415,0.097292714,0.00020645357],"about_ca_topic_score_codex":0.020393234,"about_ca_topic_score_gemma":0.039550822,"teacher_disagreement_score":0.19736262,"about_ca_system_score_codex":0.0002031968,"about_ca_system_score_gemma":0.00075898244,"threshold_uncertainty_score":0.98613006},"labels":[],"label_agreement":null},{"id":"W4403622122","doi":"10.58931/cht.2024.3146","title":"Front-line Management of Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Front line; Follicular lymphoma; Line (geometry); Front (military); Lymphoma; Medicine; Computer science; Geology; Internal medicine; History; Mathematics; Oceanography; Geometry","score_opus":0.012860254862607789,"score_gpt":0.25845115870483865,"score_spread":0.24559090384223087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403622122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8507868,0.044456515,0.00010272902,0.012655337,0.0010920707,0.0009464667,0.00010281568,0.00015616714,0.08970107],"genre_scores_gemma":[0.9947723,0.00027448562,0.00070257427,0.00062275695,0.000039174516,0.00007817225,0.00005711373,0.000022006672,0.0034314026],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990272,0.000016573891,0.00023839124,0.00027894348,0.00011091328,0.00032800573],"domain_scores_gemma":[0.99920964,0.00003494681,0.000023380919,0.00032654987,0.000032673892,0.00037283316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007077429,0.00014559912,0.00035330455,0.00023078597,0.00003847591,0.000010084062,0.000071752685,0.000116761716,0.000962887],"category_scores_gemma":[0.0000075029634,0.00011972978,0.00014217684,0.00015288999,0.00006366064,0.000027698174,0.000018400082,0.000034931534,0.0006260965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009081869,0.00068796985,0.09497675,0.0031344888,0.004988549,0.077561624,0.00069191155,0.000008938298,0.00008380711,0.47263545,0.18720222,0.15793747],"study_design_scores_gemma":[0.0054899706,0.00053784135,0.10136441,0.0024535994,0.0018022717,0.0043896134,0.00041433497,0.0006663102,0.015668793,0.002197158,0.8644872,0.0005285307],"about_ca_topic_score_codex":0.01118469,"about_ca_topic_score_gemma":0.010179515,"teacher_disagreement_score":0.67728496,"about_ca_system_score_codex":0.00037164558,"about_ca_system_score_gemma":0.00037800823,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W4403622134","doi":"10.58931/cht.2023.2341","title":"Frontline treatment of aggressive B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Lymphoma; Aggressive lymphoma; B-cell lymphoma; Medicine; Cancer research; Internal medicine; Rituximab","score_opus":0.01861575547947897,"score_gpt":0.2644674569887634,"score_spread":0.24585170150928443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403622134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219085,0.00338694,7.487124e-7,0.0034475713,0.00024851912,0.00039495883,0.00010777487,0.00006682134,0.01015584],"genre_scores_gemma":[0.99513316,0.0005293134,0.0001258481,0.0003652703,0.000053136704,0.00012067986,0.00019516259,0.000023668706,0.003453766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890447,0.000027588416,0.00025615466,0.00027044708,0.00009860708,0.00044275998],"domain_scores_gemma":[0.99876887,0.000104978055,0.0001599649,0.00037603613,0.000065899694,0.000524262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035498088,0.00018245526,0.00053900026,0.00034077163,0.00006852587,0.00000420391,0.000061431296,0.0001554342,0.0003371853],"category_scores_gemma":[0.000054915734,0.00014383906,0.0001514471,0.00027074447,0.000092024085,0.000019432167,0.000010498055,0.000018698875,0.0007643567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000137321,0.0021164373,0.83499795,0.00016772523,0.0006558704,0.020715289,0.0013377937,0.000006378293,0.00022252118,0.0045096464,0.0924064,0.042726673],"study_design_scores_gemma":[0.029074635,0.002883864,0.6247322,0.0003305587,0.0007945613,0.002500533,0.00068005954,0.0002948173,0.09601786,0.00048178108,0.24164851,0.0005606333],"about_ca_topic_score_codex":0.030497376,"about_ca_topic_score_gemma":0.03270668,"teacher_disagreement_score":0.21026576,"about_ca_system_score_codex":0.0005541624,"about_ca_system_score_gemma":0.00087275845,"threshold_uncertainty_score":0.9849439},"labels":[],"label_agreement":null},{"id":"W4403622135","doi":"10.58931/cht.2024.3148","title":"Follicular Non-Hodgkin Lymphoma: First Relapse and Beyond","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority","funders":"Acadia University","keywords":"Follicular lymphoma; Follicular phase; Lymphoma; Medicine; Oncology; Hodgkin lymphoma; Internal medicine","score_opus":0.007170227836454627,"score_gpt":0.2335209303813079,"score_spread":0.22635070254485326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403622135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9173093,0.025854563,0.000012608348,0.03064872,0.000760698,0.0005456808,0.000056811332,0.00011363843,0.024697982],"genre_scores_gemma":[0.99540037,0.0003308043,0.00025479202,0.0022406974,0.00007941256,0.000108536056,0.000047843685,0.00003315086,0.0015044018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988316,0.000017606437,0.00020200414,0.00041691275,0.00009407349,0.0004377754],"domain_scores_gemma":[0.9988013,0.00012102027,0.000019161338,0.00030725787,0.000029679872,0.0007215676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000878618,0.00020058853,0.0003801511,0.00027381149,0.00014435656,0.00004171014,0.000057757137,0.00022143572,0.0003023925],"category_scores_gemma":[0.00004623691,0.00016703106,0.00010098202,0.00020373834,0.00011458849,0.00005764514,0.000022648193,0.00007260138,0.0003352771],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005711947,0.00030343825,0.32704175,0.0008761856,0.0012328384,0.06352015,0.0019902128,0.0000015824057,0.00006126355,0.10112389,0.46898547,0.03480611],"study_design_scores_gemma":[0.00335914,0.0003329635,0.09511098,0.00049165566,0.0005276494,0.011236564,0.00018175866,0.0004454548,0.001369994,0.0011757596,0.8853663,0.00040175297],"about_ca_topic_score_codex":0.016944366,"about_ca_topic_score_gemma":0.06323067,"teacher_disagreement_score":0.41638085,"about_ca_system_score_codex":0.00041317265,"about_ca_system_score_gemma":0.0006986166,"threshold_uncertainty_score":0.9896019},"labels":[],"label_agreement":null},{"id":"W4403622155","doi":"10.58931/cht.2024.3251","title":"Mantle Cell Lymphoma: Evolving Frontline Treatment Strategies","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Toronto","keywords":"Mantle cell lymphoma; Mantle (geology); Geology; Lymphoma; Earth science; Geochemistry; Medicine; Internal medicine","score_opus":0.012498502379326561,"score_gpt":0.25695230629642807,"score_spread":0.2444538039171015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403622155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77606344,0.06727509,0.000033686774,0.009592581,0.0012901846,0.00078505697,0.00014275553,0.00033064932,0.14448658],"genre_scores_gemma":[0.99304897,0.00030430764,0.00036010786,0.0004722299,0.00013760991,0.00012365494,0.000109281194,0.000038036924,0.0054058027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986941,0.000026619746,0.00023428274,0.00041581894,0.000096974596,0.0005321603],"domain_scores_gemma":[0.99893093,0.000097366865,0.000023754545,0.0003394608,0.00004067947,0.0005677833],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000049523962,0.000255472,0.00042498004,0.00028016797,0.00011518168,0.00008235517,0.00006723278,0.00017788702,0.0012115572],"category_scores_gemma":[0.000012335251,0.00019601789,0.00015766571,0.00015742645,0.00007215864,0.00009916883,0.000011812237,0.00005048732,0.0011490075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015505892,0.0036357588,0.22054099,0.0016210385,0.0028309068,0.115227096,0.0050032684,0.000027380782,0.0008203597,0.15414065,0.39144793,0.10454956],"study_design_scores_gemma":[0.008820158,0.0014052724,0.06439762,0.0006698292,0.0012082295,0.0061284644,0.0018537556,0.0019254322,0.018803693,0.0016817196,0.8922723,0.00083355565],"about_ca_topic_score_codex":0.05034985,"about_ca_topic_score_gemma":0.08479568,"teacher_disagreement_score":0.50082433,"about_ca_system_score_codex":0.0014199152,"about_ca_system_score_gemma":0.0023192328,"threshold_uncertainty_score":0.9997015},"labels":[],"label_agreement":null},{"id":"W4403622159","doi":"10.58931/cht.2024.3150","title":"Maintenance Therapy for CD20+ Indolent Lymphoma: Who Should Receive Maintenance?","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Maintenance therapy; Medicine; Lymphoma; CD20; Oncology; Intensive care medicine; Internal medicine; Medical physics; Chemotherapy","score_opus":0.02888856460784047,"score_gpt":0.2892735946245331,"score_spread":0.26038503001669266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403622159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6199703,0.077047706,0.00068413245,0.23058559,0.006278289,0.007603039,0.0013903182,0.0007458625,0.055694737],"genre_scores_gemma":[0.98089904,0.0015466217,0.00039401845,0.00994234,0.00021295315,0.0009186067,0.0001266522,0.00007225678,0.005887543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793077,0.000037491824,0.00035190702,0.0006346976,0.00014165753,0.0009034672],"domain_scores_gemma":[0.998412,0.00025234002,0.000050087227,0.00045839598,0.00014406702,0.0006831225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894138,0.00032367522,0.00063516025,0.00031109102,0.00015099437,0.000049288585,0.00014951554,0.00030949278,0.000328022],"category_scores_gemma":[0.00012547318,0.00024314143,0.00027755456,0.00025971464,0.00016656658,0.000071479044,0.000016795664,0.000119475204,0.00024093402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030736244,0.00026336565,0.024042089,0.00032758934,0.00081603444,0.005241606,0.0011424005,0.0000017427046,0.00005787605,0.1406881,0.7161226,0.110989206],"study_design_scores_gemma":[0.0053417133,0.0005218618,0.020298319,0.00091165723,0.00013488543,0.00227458,0.00022088905,0.0002626379,0.002526565,0.0025093306,0.9646401,0.00035749044],"about_ca_topic_score_codex":0.009887455,"about_ca_topic_score_gemma":0.028628785,"teacher_disagreement_score":0.36092868,"about_ca_system_score_codex":0.0011884845,"about_ca_system_score_gemma":0.0017477063,"threshold_uncertainty_score":0.9967058},"labels":[],"label_agreement":null},{"id":"W4403787695","doi":"10.1080/13696998.2024.2422227","title":"Matching-adjusted indirect comparison of acalabrutinib versus ibrutinib in relapsed/refractory mantle cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Ibrutinib; Mantle cell lymphoma; Medicine; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Chronic lymphocytic leukemia; Leukemia; Metallurgy","score_opus":0.0384226166842584,"score_gpt":0.3214999179717034,"score_spread":0.283077301287445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403787695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869236,0.0051386165,0.000010960655,0.0023254068,0.0018398362,0.00012549985,0.0000105781,0.000015879208,0.0036096438],"genre_scores_gemma":[0.99654865,0.0024213656,0.00034489218,0.00017715398,0.00037894788,0.0000032771366,0.000009322267,0.000027701408,0.000088690664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977288,0.000066857705,0.0012919236,0.00020426133,0.00045278625,0.00025532607],"domain_scores_gemma":[0.99815875,0.00079141965,0.00042974149,0.00018789188,0.00005066417,0.00038150998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009383192,0.00018772233,0.00092102785,0.00034155304,0.000022642025,0.000027845352,0.00022184582,0.00031850062,0.00053816475],"category_scores_gemma":[0.0001738117,0.00014628477,0.00029407637,0.00015957053,0.000097337645,0.00009761645,0.000067026725,0.00043155483,0.00006466568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010167628,0.020521527,0.16226473,0.0022594703,0.0029822493,0.007236383,0.009815274,0.00053294725,0.00043520477,0.0048803426,0.032611385,0.7462929],"study_design_scores_gemma":[0.20344037,0.01722749,0.36713105,0.012176966,0.0033597508,0.0028940428,0.011451735,0.028168164,0.03881934,0.0019837106,0.3116824,0.0016649609],"about_ca_topic_score_codex":0.00008038613,"about_ca_topic_score_gemma":0.000053049658,"teacher_disagreement_score":0.7446279,"about_ca_system_score_codex":0.00060655305,"about_ca_system_score_gemma":0.0011855281,"threshold_uncertainty_score":0.596532},"labels":[],"label_agreement":null},{"id":"W4403997357","doi":"10.1016/j.modpat.2024.100646","title":"Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach","year":2024,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; National Cancer Center; Leukemia and Lymphoma Society","keywords":"Pathology; Lymphoma; Peripheral; Medicine; Internal medicine","score_opus":0.03028611225024352,"score_gpt":0.28041942240977585,"score_spread":0.25013331015953233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403997357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985848,0.0066254227,0.0044103907,0.000077055505,0.00020387053,0.0001742109,0.000018094786,0.00008112679,0.0025618337],"genre_scores_gemma":[0.98340315,0.00006335893,0.015868424,0.00014888497,0.00007543501,0.0000627925,0.000031874628,0.000038599694,0.0003075068],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99881464,0.000064529464,0.0002729493,0.00042523674,0.00014269089,0.00027993857],"domain_scores_gemma":[0.99927145,0.00025999398,0.0000499486,0.00029882693,0.000040577364,0.0000791748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012045501,0.00018534357,0.00040510585,0.00012610025,0.000039121485,0.000018565242,0.000059072376,0.00014637037,0.000031581094],"category_scores_gemma":[0.000083666746,0.00014458424,0.00015767304,0.0001190546,0.000103983235,0.000049326223,0.000053357136,0.000067511806,0.000023493403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006104231,0.008181167,0.5311477,0.0023312573,0.00076932414,0.013664139,0.011305085,0.0028933517,0.14685442,0.0013268824,0.0004223614,0.2804939],"study_design_scores_gemma":[0.017315209,0.0026188889,0.22726148,0.0010932204,0.002424761,0.008759304,0.00040400442,0.6770769,0.057973605,0.0011863083,0.0027880238,0.0010982885],"about_ca_topic_score_codex":0.00009961782,"about_ca_topic_score_gemma":0.0000040632513,"teacher_disagreement_score":0.67418355,"about_ca_system_score_codex":0.0001535986,"about_ca_system_score_gemma":0.00012342252,"threshold_uncertainty_score":0.5895974},"labels":[],"label_agreement":null},{"id":"W4404196418","doi":"10.1111/bjh.19859","title":"Long‐term follow‐up of bulky classic Hodgkin lymphoma managed with ABVD and PET‐guided RT demonstrates excellent outcomes in PET‐negative cases","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Loxo Oncology; Seagen; Veracyte; BeiGene; Regeneron Pharmaceuticals; AstraZeneca","keywords":"ABVD; Hodgkin lymphoma; Medicine; Lymphoma; Term (time); Nuclear medicine; Oncology; Internal medicine; Chemotherapy; Vincristine; Physics; Cyclophosphamide","score_opus":0.019706015738161328,"score_gpt":0.2827852178886166,"score_spread":0.26307920215045527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404196418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850432,0.012980414,0.000022869002,0.0011143122,0.00024395854,0.00031024878,0.00002266041,0.000017728356,0.00024455925],"genre_scores_gemma":[0.9962486,0.0026077884,0.000626172,0.000099285084,0.000032666125,0.000021319098,0.000006649133,0.000028765924,0.00032876924],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982118,0.00009925264,0.0008090399,0.00028340163,0.00029301483,0.00030347655],"domain_scores_gemma":[0.9986578,0.00059130194,0.0002995126,0.00013655105,0.0001525058,0.000162331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023395552,0.00023741765,0.0012126017,0.00033539083,0.00005335948,0.000078402554,0.00009753225,0.00006900685,0.000054620585],"category_scores_gemma":[0.00015457279,0.0001876379,0.00019595418,0.00019199782,0.00028828756,0.0001936911,0.00004638145,0.00015855565,0.000004316248],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032745872,0.00063420285,0.43024322,0.00042155696,0.00083853025,0.5539167,0.00026117614,0.0000015155048,0.0000703064,0.00024553182,0.00071351655,0.012326301],"study_design_scores_gemma":[0.007183524,0.00079226954,0.46600437,0.0024735513,0.00040161354,0.52054167,0.0003386185,0.000017735112,0.0019252022,0.00017546839,0.000027343107,0.000118644006],"about_ca_topic_score_codex":0.0004445501,"about_ca_topic_score_gemma":0.0014293261,"teacher_disagreement_score":0.035761137,"about_ca_system_score_codex":0.00017458247,"about_ca_system_score_gemma":0.00039416904,"threshold_uncertainty_score":0.76516515},"labels":[],"label_agreement":null},{"id":"W4404237602","doi":"10.1093/neuonc/noae165.0081","title":"BIOM-08. LEVERAGING CSF PROTEOMICS TO OPTIMIZE CNS LYMPHOMA MANAGEMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteomics; Lymphoma; Computational biology; Computer science; Medicine; Immunology; Biology; Gene; Genetics","score_opus":0.026041957325661006,"score_gpt":0.30502791185521955,"score_spread":0.27898595452955854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8388227,0.0011291349,0.0016964275,0.066147275,0.0038258205,0.0041313516,0.000039118157,0.00079106237,0.08341711],"genre_scores_gemma":[0.95881575,0.00065433333,0.023478817,0.014115545,0.0005161692,0.001075226,0.000039461996,0.0000917027,0.0012129644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982113,0.000071892966,0.00033523052,0.0006650155,0.00023981016,0.00047670314],"domain_scores_gemma":[0.9989697,0.00022278006,0.00004355733,0.0004237422,0.000046138288,0.0002940827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001595898,0.00026474404,0.0004339508,0.00029695427,0.00009037452,0.00007075426,0.00013947446,0.00013460313,0.00023029259],"category_scores_gemma":[0.000051208408,0.0002192077,0.00016393693,0.00037123018,0.00004995805,0.00006830451,0.00020957604,0.00010142645,0.0012503795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007044338,0.0021149917,0.0026644247,0.0004234633,0.0008274385,0.024609271,0.0013865378,0.00020600563,0.04811941,0.0043097613,0.102688976,0.81194526],"study_design_scores_gemma":[0.0046592243,0.001750901,0.0049564796,0.00016169458,0.00043831536,0.0009914002,0.00015625314,0.0010981729,0.022800466,0.00014943989,0.96259105,0.00024658456],"about_ca_topic_score_codex":0.00004367817,"about_ca_topic_score_gemma":0.0000058728997,"teacher_disagreement_score":0.8599021,"about_ca_system_score_codex":0.0011095834,"about_ca_system_score_gemma":0.00027404074,"threshold_uncertainty_score":0.9995273},"labels":[],"label_agreement":null},{"id":"W4404305892","doi":"10.1158/1557-3265.liqbiop24-b050","title":"Abstract B050: Frequent monitoring of NSCLC immunotherapy using an mDETECT liquid biopsy reveals unexpected complexity and opportunities","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Immunotherapy; Liquid biopsy; Medicine; Biopsy; Oncology; Internal medicine; Cancer","score_opus":0.6264189750004209,"score_gpt":0.5694848793649353,"score_spread":0.05693409563548557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753769,0.02228221,0.0000049381088,0.0010429817,0.00033032108,0.00044038467,0.00006230513,0.00005851895,0.0004014598],"genre_scores_gemma":[0.9858611,0.012895582,0.00041899015,0.00004314869,0.0005703783,0.00007680581,0.000011470357,0.00003520748,0.00008727019],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976281,0.0002782566,0.0006696929,0.0004512758,0.0005900165,0.0003826607],"domain_scores_gemma":[0.99804497,0.00082748407,0.00007153821,0.00042293925,0.00032216098,0.00031091116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018322258,0.00015894568,0.0005048349,0.00020250326,0.00013177107,0.000077291,0.0001237238,0.00014691526,0.00033546038],"category_scores_gemma":[0.00014307178,0.000121271325,0.00015239243,0.0002501811,0.00068430277,0.000120016426,0.000078229634,0.00042874494,0.000005749487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072053196,0.0038111904,0.34501,0.0021152243,0.0022331188,0.0029338072,0.001801699,0.000008900184,0.27869397,0.0022897231,0.0006114725,0.35328555],"study_design_scores_gemma":[0.0039469227,0.0044477517,0.9434574,0.004298371,0.00015228214,0.00009465515,0.0012356559,0.0003314412,0.038643878,0.00086349907,0.0021968498,0.00033128873],"about_ca_topic_score_codex":0.0034250868,"about_ca_topic_score_gemma":0.00002442485,"teacher_disagreement_score":0.5984474,"about_ca_system_score_codex":0.00033825487,"about_ca_system_score_gemma":0.00065421493,"threshold_uncertainty_score":0.517773},"labels":[],"label_agreement":null},{"id":"W4404353984","doi":"10.1016/s0140-6736(24)01774-4","title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Oxaliplatin; Rituximab; Medicine; Refractory (planetary science); Gemcitabine; Open label; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Phases of clinical research; Clinical trial; Chemotherapy; Cancer; Colorectal cancer; Materials science","score_opus":0.07879406084213593,"score_gpt":0.37819790433514383,"score_spread":0.2994038434930079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404353984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717225,0.0073140925,0.00013121477,0.0067690257,0.0017710881,0.0060863737,0.00170225,0.0002467944,0.004256666],"genre_scores_gemma":[0.9894,0.0012857065,0.0017873504,0.0012903062,0.0020762184,0.0012017576,0.0003761396,0.00007465721,0.0025078063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975658,0.00014640571,0.00054198405,0.00066889916,0.00037577428,0.0007011396],"domain_scores_gemma":[0.99748504,0.0012036373,0.00014631242,0.00083964283,0.00007359849,0.00025177212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078876736,0.0004367411,0.0013030645,0.000056397555,0.00028026078,0.000347537,0.00039329505,0.00017888674,0.00012804393],"category_scores_gemma":[0.000419505,0.00025109312,0.00018128149,0.00029384036,0.00011615793,0.00021573482,0.00024983913,0.00013478863,0.00010139143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8569392,0.0153043475,0.000046069123,0.00038124458,0.0007625219,0.0005645595,0.00038574243,2.6091374e-7,0.00015141781,0.0020880913,0.094329044,0.029047528],"study_design_scores_gemma":[0.8393526,0.00457646,0.00011323441,0.00022082162,0.0011121065,0.00006839375,0.00013151615,0.0020351836,0.00023238869,0.00022680037,0.15166384,0.00026664234],"about_ca_topic_score_codex":0.00013435395,"about_ca_topic_score_gemma":0.0000971487,"teacher_disagreement_score":0.0573348,"about_ca_system_score_codex":0.0006574246,"about_ca_system_score_gemma":0.00051315903,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W4404413319","doi":"10.1016/j.ijrobp.2024.11.072","title":"Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta University of the Arts; University of British Columbia Hospital; BC Cancer Agency","funders":"University of Maryland; Mayo Clinic","keywords":"Radiation therapy; Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Cancer research; Pathology; Biology","score_opus":0.010595741428999017,"score_gpt":0.3209092740199974,"score_spread":0.3103135325909984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404413319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950229,0.0015732944,0.00021629337,0.00027176787,0.0013867678,0.00083492923,0.0004110319,0.00003710045,0.00024592082],"genre_scores_gemma":[0.99735135,0.0010582278,0.00012936773,0.00021023363,0.00070073124,0.000042063497,0.00043433675,0.000045316818,0.00002837555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976483,0.00043717158,0.0008267163,0.00036812542,0.00045577268,0.00026394136],"domain_scores_gemma":[0.9967429,0.00072431,0.0011454117,0.00020898154,0.001024082,0.00015434022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039061005,0.00032907655,0.00070471514,0.00031511678,0.00006925748,0.00003864773,0.00022825653,0.00024036328,0.00006436837],"category_scores_gemma":[0.00013244865,0.00022337887,0.0003087455,0.0003435269,0.00014898315,0.0003037085,0.000030899108,0.00028569443,0.000021495713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030553385,0.020907624,0.86003435,0.0000068999557,0.0023063188,0.00013560796,0.0021241582,0.00013494483,0.00041755076,0.00021048148,0.0028379613,0.107828766],"study_design_scores_gemma":[0.051786862,0.02828406,0.91369104,0.000085708314,0.00027854217,0.00002766177,0.00014696064,0.00020777503,0.0011570475,0.00014624794,0.003998424,0.00018963986],"about_ca_topic_score_codex":0.000032583877,"about_ca_topic_score_gemma":0.0000032437588,"teacher_disagreement_score":0.10763913,"about_ca_system_score_codex":0.0018665064,"about_ca_system_score_gemma":0.0010524165,"threshold_uncertainty_score":0.9109126},"labels":[],"label_agreement":null},{"id":"W4404494605","doi":"10.1101/2024.11.15.623868","title":"CCL19⁺ fibroblasts define a proliferative niche in chronic lymphocytic leukemia","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BIO (Canada)","funders":"","keywords":"Chronic lymphocytic leukemia; Follicular lymphoma; Cancer research; Lymphoma; Follicular phase; Leukemia; Medicine; Immunology; Internal medicine","score_opus":0.013560778047405889,"score_gpt":0.24237708560595222,"score_spread":0.22881630755854634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404494605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797818,0.015865207,0.000016054235,0.00046271898,0.0008160143,0.002205625,0.00019998284,0.00056276977,0.00008982481],"genre_scores_gemma":[0.9946149,0.0013348169,0.0010463598,0.0003424604,0.0007764114,0.0016169265,0.0000019225579,0.00022483052,0.00004136196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958624,0.00012372862,0.000874228,0.0016639018,0.0005821265,0.00089360995],"domain_scores_gemma":[0.9973645,0.00011908894,0.00028159868,0.0014890068,0.0002967972,0.00044898587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038226886,0.0009763877,0.0012850008,0.000601766,0.00008699428,0.00021950259,0.0003168541,0.00080028456,0.00009811278],"category_scores_gemma":[0.00019754823,0.00087740726,0.00036261385,0.0008511097,0.00014462414,0.00008224521,0.00083458103,0.0010091682,0.00072894705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001975,0.002739932,0.1970247,0.041534923,0.0082953945,0.025501978,0.0004571653,0.0065426505,0.6920174,0.009210347,0.014600425,0.00010007844],"study_design_scores_gemma":[0.012173041,0.0011517684,0.33342066,0.016746188,0.0017826621,0.0000012458712,0.0000074283134,0.012673847,0.612086,0.0000344882,0.007637006,0.0022856733],"about_ca_topic_score_codex":0.00040520853,"about_ca_topic_score_gemma":0.00004206139,"teacher_disagreement_score":0.13639598,"about_ca_system_score_codex":0.03674611,"about_ca_system_score_gemma":0.020790337,"threshold_uncertainty_score":0.99936765},"labels":[],"label_agreement":null},{"id":"W4404673017","doi":"10.1097/01.cot.0001095592.92818.5c","title":"Landmark Clinical Trial Shows Value of Immunotherapy for Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Lymphoma; Hodgkin lymphoma; Value (mathematics); Clinical trial; Landmark; Oncology; Internal medicine; Statistics; Mathematics; Computer science; Artificial intelligence; Cancer","score_opus":0.05033925146743528,"score_gpt":0.412808112025622,"score_spread":0.3624688605581867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404673017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528056,0.0087794885,0.00012649626,0.0048483526,0.0025778923,0.0017205924,0.00008385001,0.000116296294,0.028941436],"genre_scores_gemma":[0.97518563,0.0015990481,0.00593194,0.0012499596,0.0014444733,0.0005376708,0.00010097615,0.00004728821,0.013903008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888456,0.000099340905,0.0004686068,0.00026259216,0.00010446561,0.00018045992],"domain_scores_gemma":[0.99823487,0.0013578576,0.00007441906,0.00021862212,0.000044932993,0.000069284215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578508,0.00012534621,0.00057758385,0.00007092415,0.00003091013,0.000010162738,0.00006807135,0.00023254311,0.0005465458],"category_scores_gemma":[0.00011092182,0.00008624524,0.00039302005,0.00007522329,0.00011013181,0.000026582156,0.000019424568,0.000048611713,0.0000709427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041440573,0.0035923158,0.008659709,0.000089788395,0.0015257047,0.00018463687,0.00020606142,8.262619e-7,0.00031258815,0.010087986,0.13388063,0.8000192],"study_design_scores_gemma":[0.11397984,0.013494352,0.011915347,0.00013413289,0.000479803,0.00007409285,0.00003449521,0.00036983407,0.0016051184,0.0013285507,0.85647225,0.00011219523],"about_ca_topic_score_codex":0.000032665626,"about_ca_topic_score_gemma":0.0000061519554,"teacher_disagreement_score":0.79990697,"about_ca_system_score_codex":0.00016061644,"about_ca_system_score_gemma":0.000631669,"threshold_uncertainty_score":0.5984293},"labels":[],"label_agreement":null},{"id":"W4404945177","doi":"10.1016/j.ebiom.2024.105468","title":"Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Queen's University; Princess Margaret Cancer Centre","funders":"Cancer Council Victoria; Medical Research Council; University of Texas MD Anderson Cancer Center; National Health and Medical Research Council; National Cancer Institute; Mater Foundation","keywords":"Medicine; Follicular lymphoma; Rituximab; Radiation therapy; Adjuvant; Stage (stratigraphy); Lymphoma; Oncology; Disease; Internal medicine; CD8; Follicular phase; Pathology; Immunology; Immune system; Biology","score_opus":0.006063168085090828,"score_gpt":0.23952100477469612,"score_spread":0.2334578366896053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404945177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97334,0.021605803,0.000037959144,0.0010576452,0.00014358062,0.00367725,0.000066233035,0.00006587048,0.000005658501],"genre_scores_gemma":[0.9973147,0.0013321678,0.000014497893,0.00019825381,0.00013519434,0.00077139505,0.00008126103,0.00004688721,0.0001056486],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99778116,0.00025108692,0.0006699306,0.00045884904,0.0004651023,0.0003738726],"domain_scores_gemma":[0.99890256,0.0003146252,0.00017433315,0.00027823236,0.00008833649,0.00024193738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052003004,0.0003435286,0.001229437,0.0005081661,0.000023871198,0.000028561548,0.00006255773,0.0001337677,0.000041871815],"category_scores_gemma":[0.00014035651,0.00020253648,0.00012600608,0.0006190374,0.00014637804,0.000095455594,0.000011758576,0.000113828486,0.0000010136705],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69995403,0.004249968,0.25690553,0.00060071517,0.0008380517,0.013839832,0.0022670717,0.0000057054212,0.018447366,0.000027467258,0.00009610262,0.0027681447],"study_design_scores_gemma":[0.67457706,0.0026133778,0.31343138,0.006333479,0.0002029491,0.000027257838,0.00029082925,0.0012581963,0.0010322377,0.000013120571,0.00004386368,0.00017621818],"about_ca_topic_score_codex":0.00018602627,"about_ca_topic_score_gemma":0.000025531506,"teacher_disagreement_score":0.056525853,"about_ca_system_score_codex":0.00048495285,"about_ca_system_score_gemma":0.00028362413,"threshold_uncertainty_score":0.8259198},"labels":[],"label_agreement":null},{"id":"W4404956337","doi":"10.14740/jh1341","title":"Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Refractory (planetary science); CD20; Retrospective cohort study; Oncology; Pathology; Cancer research; Biology","score_opus":0.014366707001165066,"score_gpt":0.3029357246956277,"score_spread":0.28856901769446264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404956337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955498,0.0026301679,0.000010313115,0.00034443717,0.00046174123,0.00029483903,0.0000023247476,0.000010436823,0.00069591944],"genre_scores_gemma":[0.9991105,0.00023112465,0.00030971805,0.000047934365,0.0000835835,0.000012853147,9.0032205e-7,0.000021433178,0.00018190374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836487,0.00010673531,0.0008093129,0.0002078377,0.00032315677,0.00018808126],"domain_scores_gemma":[0.9989924,0.00019848542,0.00034920676,0.00022053583,0.00013815623,0.00010124426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030152034,0.0001596873,0.00085796794,0.00040451932,0.00002219645,0.000008309279,0.0000974635,0.00014199385,0.00012569252],"category_scores_gemma":[0.000115609626,0.00009626603,0.00014858258,0.00026942542,0.000047977137,0.00007711854,0.000043343778,0.00019181297,0.000016342547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004276459,0.018496102,0.90128565,0.00050822744,0.000479372,0.049086764,0.0063787587,0.0000071863733,0.009109089,0.00019086277,0.0069021867,0.0032793614],"study_design_scores_gemma":[0.04168742,0.025854256,0.81758964,0.0034141615,0.000645236,0.013146764,0.0052166707,0.00011272822,0.08982729,0.00042765116,0.0018010237,0.0002771513],"about_ca_topic_score_codex":0.00004149806,"about_ca_topic_score_gemma":0.00003232825,"teacher_disagreement_score":0.083695985,"about_ca_system_score_codex":0.00038161746,"about_ca_system_score_gemma":0.0003429731,"threshold_uncertainty_score":0.39256147},"labels":[],"label_agreement":null},{"id":"W4405034695","doi":"10.1182/blood-2024-204618","title":"Anthracycline Exposure and Breast Cancer Risk in Female Hodgkin Lymphoma Survivors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Anthracycline; Medicine; Breast cancer; Cumulative incidence; Internal medicine; Oncology; Hazard ratio; Population; Chemotherapy; Cohort; Cancer; Incidence (geometry); Surgery; Confidence interval","score_opus":0.00951813058039922,"score_gpt":0.267181504793005,"score_spread":0.25766337421260577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763087,0.021420287,0.0000012761859,0.0010541916,0.00017554045,0.00022052879,0.00017409647,0.00007133625,0.0005740187],"genre_scores_gemma":[0.9928846,0.0063426895,0.00010403597,0.000099654215,0.00020366037,0.00008857623,0.000016793765,0.000023859686,0.00023617416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990993,0.00003473199,0.00019095457,0.00032255464,0.00014451605,0.000207915],"domain_scores_gemma":[0.9995654,0.000092474984,0.00002795535,0.00018106017,0.000021293054,0.00011179054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121120596,0.00015250778,0.00025284634,0.00010684278,0.000037186583,0.000037310958,0.00003281871,0.000076052165,0.00015334034],"category_scores_gemma":[0.000016662472,0.00011258969,0.000061372906,0.00021576173,0.00004359793,0.000062567684,0.00003187253,0.00005882244,0.000029962526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004626861,0.0012925623,0.9160885,0.00010972752,0.0001881073,0.00087309646,0.00033258664,0.0000011059366,0.00018217812,0.000056084522,0.00014202276,0.08068772],"study_design_scores_gemma":[0.006077803,0.00016466685,0.9881853,0.00042015623,0.0003951175,0.00040249652,0.000108576605,0.00007590222,0.0025974403,0.00003413986,0.001418766,0.000119626515],"about_ca_topic_score_codex":0.004400978,"about_ca_topic_score_gemma":0.0018170971,"teacher_disagreement_score":0.08056809,"about_ca_system_score_codex":0.00006408687,"about_ca_system_score_gemma":0.00010449228,"threshold_uncertainty_score":0.6652992},"labels":[],"label_agreement":null},{"id":"W4405034714","doi":"10.1182/blood-2024-197897","title":"Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Hematologic Neoplasms; Cancer; Biology","score_opus":0.019346873056893303,"score_gpt":0.28652010574810005,"score_spread":0.26717323269120674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964961,0.0017030026,0.000002067672,0.00006101406,0.000084233325,0.0014473313,0.000031823223,0.000045142708,0.0001292914],"genre_scores_gemma":[0.9981189,0.000038636328,0.0011033015,0.000070676884,0.000017054843,0.00021533376,0.00000806847,0.000041968928,0.000386104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814075,0.00008772176,0.00063285895,0.0004559566,0.00045099115,0.00023170954],"domain_scores_gemma":[0.9990146,0.00019186146,0.00018456926,0.00034472483,0.00013154627,0.00013266208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025192142,0.00029095073,0.00083416066,0.00022055839,0.00003295334,0.000014441183,0.000078475685,0.000080302685,0.000020150947],"category_scores_gemma":[0.00009746444,0.00016912086,0.00011219633,0.00019958572,0.00010776378,0.0001159175,0.00008481785,0.000082965846,0.0000014833647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013359819,0.019985644,0.94024813,0.00013905414,0.0017740914,0.00064356724,0.013825268,2.0437741e-7,0.00019145517,0.000009577416,0.000031564923,0.009791643],"study_design_scores_gemma":[0.100594826,0.045557585,0.84871894,0.001392574,0.0015297834,0.000012909838,0.001328162,0.000006339632,0.00036624845,0.0000042230486,0.00024966727,0.00023872755],"about_ca_topic_score_codex":0.00014925389,"about_ca_topic_score_gemma":0.00022212202,"teacher_disagreement_score":0.09152915,"about_ca_system_score_codex":0.00022353232,"about_ca_system_score_gemma":0.00044355833,"threshold_uncertainty_score":0.6896549},"labels":[],"label_agreement":null},{"id":"W4405038077","doi":"10.1182/blood-2024-200914","title":"Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Internal medicine; Lymphoma; Oncology; Ibrutinib; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.006753079207637134,"score_gpt":0.2281801692373907,"score_spread":0.22142709002975358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854176,0.012387218,3.7766912e-7,0.00036233175,0.00013768476,0.001199791,0.00022956925,0.000097589356,0.00016780556],"genre_scores_gemma":[0.99789256,0.0009083709,0.000058061913,0.00042871,0.00003562766,0.0001502485,0.00013899938,0.00005873506,0.0003286626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982173,0.00013610932,0.00031325794,0.0005318737,0.000418757,0.0003826878],"domain_scores_gemma":[0.99868023,0.0005386468,0.00008344339,0.00050751906,0.000044481603,0.00014570108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001472039,0.0003287307,0.00043893937,0.00008070934,0.000110101086,0.00008901053,0.00010096395,0.00010406677,0.00003918306],"category_scores_gemma":[0.00004758817,0.00017278062,0.00006951961,0.0001636779,0.000059760125,0.00013822655,0.00007069623,0.000161678,0.000029117644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030377306,0.062838405,0.9208187,0.000024658159,0.00070530386,0.0001339084,0.0056559206,1.2996177e-8,0.000043201628,0.0000038265957,0.0006317556,0.008840551],"study_design_scores_gemma":[0.08603846,0.0016194901,0.90038043,0.00014276335,0.0005472997,0.0000011147308,0.0014754884,0.0000016393266,0.00019253051,0.00001249358,0.009398462,0.00018983692],"about_ca_topic_score_codex":0.00072105374,"about_ca_topic_score_gemma":0.0002769357,"teacher_disagreement_score":0.08573469,"about_ca_system_score_codex":0.00016628916,"about_ca_system_score_gemma":0.00013612468,"threshold_uncertainty_score":0.70457894},"labels":[],"label_agreement":null},{"id":"W4405038337","doi":"10.1182/blood-2024-200836","title":"Outcomes in Older Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Victoria Hospital; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; Santé Montérégie; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Refractory (planetary science); Ibrutinib; Hematologic Neoplasms; Large-cell lymphoma; Oncology; Internal medicine; Cancer; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.007211173418807461,"score_gpt":0.2324425596235811,"score_spread":0.22523138620477365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957976,0.0016917356,0.0000010631541,0.0003513712,0.00020198304,0.0011367397,0.00010404748,0.000098221106,0.0006172432],"genre_scores_gemma":[0.9985511,0.000050794635,0.000046486533,0.00046487444,0.00007126246,0.00018990006,0.00008912896,0.000047270725,0.00048923306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985118,0.00007056999,0.000266372,0.00043597491,0.00041500863,0.00030027376],"domain_scores_gemma":[0.99893343,0.00033826285,0.000047292597,0.00054386974,0.000035521574,0.00010160691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010793335,0.0002583365,0.00035651212,0.00007659655,0.00006896182,0.000058642596,0.00012156179,0.000079652134,0.000070343565],"category_scores_gemma":[0.000031802243,0.00012999542,0.00010136865,0.00020273327,0.00002585658,0.00008444333,0.00007430415,0.000116231895,0.0001730083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006779056,0.12931599,0.8654595,0.000019820685,0.00043542212,0.00058311236,0.002067244,4.646221e-8,0.0000051437896,0.0000131744555,0.00048927474,0.0015434579],"study_design_scores_gemma":[0.096136466,0.0007722934,0.8995908,0.00015465003,0.0007189435,0.0000026298796,0.0005553043,0.0000045657016,0.0002062523,0.000011253271,0.0017029002,0.00014395975],"about_ca_topic_score_codex":0.00048195664,"about_ca_topic_score_gemma":0.00031751205,"teacher_disagreement_score":0.12854369,"about_ca_system_score_codex":0.00012785222,"about_ca_system_score_gemma":0.0001129408,"threshold_uncertainty_score":0.53010595},"labels":[],"label_agreement":null},{"id":"W4405038597","doi":"10.1182/blood-2024-198424","title":"Primary Results of Patient-Reported Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) Versus Rituximab Plus GemOx (R-GemOx) from the Phase III Starglo Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Rituximab; Oxaliplatin; Gemcitabine; Diffuse large B-cell lymphoma; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.009550830445306644,"score_gpt":0.23689357618990545,"score_spread":0.2273427457445988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264085,0.0016945068,0.000002152694,0.00015408943,0.00018393862,0.0034418395,0.001223383,0.00017352348,0.00048570952],"genre_scores_gemma":[0.9977162,0.00007797829,0.00023711426,0.00011596216,0.000049933198,0.00022645581,0.0012904328,0.000109739856,0.00017617349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569416,0.00019324162,0.0012075866,0.0011321673,0.0011332388,0.0006396195],"domain_scores_gemma":[0.9970667,0.0007813303,0.00049612566,0.0011643101,0.00022249123,0.00026905627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024773038,0.00074453355,0.0014385158,0.00026199533,0.00016319213,0.00009337558,0.00019016399,0.0001872702,0.000025359497],"category_scores_gemma":[0.00011823802,0.00042319254,0.00015043492,0.00065041776,0.00016903454,0.00027134648,0.00018889926,0.00024790136,0.000010598375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04434546,0.1251641,0.8151049,0.00013175557,0.0033200516,0.0028719837,0.0045599295,0.0000037287255,0.00006676072,0.0000062131944,0.0002544982,0.004170625],"study_design_scores_gemma":[0.47067925,0.009294099,0.5151201,0.0003337592,0.0025469218,0.000012108003,0.0010051192,0.00005967887,0.00039300078,0.000002036124,0.00023144479,0.00032248226],"about_ca_topic_score_codex":0.0026186912,"about_ca_topic_score_gemma":0.00073467585,"teacher_disagreement_score":0.4263338,"about_ca_system_score_codex":0.00061175006,"about_ca_system_score_gemma":0.00052309514,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W4405038899","doi":"10.1182/blood-2024-202071","title":"Timing of End-of-Treatment PET Scans and Impact on Subsequent Testing in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Nuclear medicine; Radiology; Pathology","score_opus":0.02708134883324766,"score_gpt":0.29160277034892296,"score_spread":0.2645214215156753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946314,0.0028411478,0.0000010150768,0.000058821617,0.000033931523,0.00027902756,0.000080522725,0.000026081645,0.0020480219],"genre_scores_gemma":[0.9992778,0.00023481304,0.00030940594,0.00001744573,0.000030674073,0.000033673572,0.000019629655,0.00001946725,0.000057132387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991829,0.000020490932,0.00023272223,0.00022268703,0.00013143219,0.0002097791],"domain_scores_gemma":[0.99940854,0.00025005807,0.00004915611,0.00018074593,0.00002156427,0.00008991035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008250248,0.00016515596,0.00031830434,0.00015046782,0.000018751813,0.000011873291,0.000026942955,0.00003282394,0.000022201983],"category_scores_gemma":[0.00002855034,0.00010819034,0.000098341414,0.00017333665,0.000026840908,0.000028394252,0.000022084783,0.000025606645,0.0000058290543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119067234,0.040587146,0.91687673,0.00053515064,0.0004923169,0.0024092405,0.0012978405,0.000008870429,0.010306017,0.00025605087,0.000040297964,0.027071299],"study_design_scores_gemma":[0.0684462,0.0073743127,0.67834824,0.002649636,0.0013444639,0.0005668446,0.00026483618,0.0021836252,0.2382562,0.00006676078,0.00022656893,0.00027231494],"about_ca_topic_score_codex":0.0008949035,"about_ca_topic_score_gemma":0.000049374456,"teacher_disagreement_score":0.23852846,"about_ca_system_score_codex":0.00026129445,"about_ca_system_score_gemma":0.00021282626,"threshold_uncertainty_score":0.4411874},"labels":[],"label_agreement":null},{"id":"W4405039051","doi":"10.1182/blood-2024-204328","title":"Clinical Characteristics and Outcomes of Aggressive Transformation in Splenic Marginal Zone Lymphoma: An International Study of 111 Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Splenic marginal zone lymphoma; Medicine; Lymphoma; Aggressive lymphoma; Internal medicine; Oncology; Splenectomy; Spleen; Rituximab","score_opus":0.018754896625669693,"score_gpt":0.32644066873014,"score_spread":0.3076857721044703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917907,0.00010843783,0.000002352355,0.00005480224,0.00016045195,0.00033263027,0.00006780686,0.00000883008,0.00008561405],"genre_scores_gemma":[0.99956125,0.00020453912,0.0000706134,0.000015158562,0.000028419843,0.000020158901,0.00008436017,0.000006489653,0.000008982737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991092,0.000033298234,0.00046014247,0.000136453,0.00019537476,0.0000655412],"domain_scores_gemma":[0.9995792,0.00007261097,0.00014618777,0.00009899237,0.000059890503,0.000043105043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010972158,0.000078787045,0.00028225168,0.00010776907,0.0000078505445,0.00000796311,0.000038292776,0.0000390796,0.000016009939],"category_scores_gemma":[0.000047890935,0.000058479774,0.00004685962,0.000061738254,0.000027340828,0.00009808053,0.000015590214,0.000031714393,0.0000017943513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013771991,0.0144417565,0.9360591,0.000069975475,0.00028438284,0.00007469624,0.0013491495,7.622401e-8,0.000009381858,0.00006708295,0.0000021319886,0.047504507],"study_design_scores_gemma":[0.013806466,0.0019906347,0.98313457,0.0001814622,0.0003192644,0.000011114096,0.00023813063,0.0000885643,0.0001501653,0.0000069673324,0.000028850558,0.000043800417],"about_ca_topic_score_codex":0.00006355316,"about_ca_topic_score_gemma":0.00002751907,"teacher_disagreement_score":0.04746071,"about_ca_system_score_codex":0.000024385488,"about_ca_system_score_gemma":0.00003983806,"threshold_uncertainty_score":0.2384736},"labels":[],"label_agreement":null},{"id":"W4405039206","doi":"10.1182/blood-2024-212184","title":"Outcomes of Patients with Refractory and Relapsed Primary Mediastinal B Cell Lymphoma: A Canadian Single-Center Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Ipsen; Eisai; Gilead Sciences; AstraZeneca; Incyte; Amgen","keywords":"Medicine; Refractory (planetary science); Single Center; Lymphoma; Center (category theory); Internal medicine; Diffuse large B-cell lymphoma; Oncology","score_opus":0.006428186327959113,"score_gpt":0.196676574980264,"score_spread":0.1902483886523049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995434,0.0009655938,0.0000013419248,0.00017082233,0.000051255043,0.00020727662,0.00012695881,0.000023909413,0.0030188377],"genre_scores_gemma":[0.9990236,0.00002898836,0.00033299887,0.00018727673,0.000019773997,0.000018882158,0.00019201763,0.000016930566,0.00017950444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991286,0.000016792188,0.00018605313,0.00024533688,0.00023739014,0.00018586664],"domain_scores_gemma":[0.9993853,0.000078874495,0.000045761444,0.00019014395,0.000059646798,0.00024025002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004246653,0.00014187612,0.0003481465,0.00031433004,0.00002980484,0.000018567756,0.000033360095,0.00005451484,0.000049683807],"category_scores_gemma":[0.000013892023,0.000092983406,0.000099108205,0.00029800736,0.000046924186,0.000050593888,0.000016537826,0.000033750075,0.000007076781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049885148,0.0035997494,0.9913147,0.00011548898,0.001643033,0.00025797045,0.00019232443,1.3401214e-7,0.000029467932,0.0000056572676,0.00015486233,0.0026367079],"study_design_scores_gemma":[0.009009374,0.0006076609,0.98436964,0.00008306294,0.004258969,0.000009961848,0.000026103879,0.0000044487565,0.00036894088,0.0000014725935,0.0011692318,0.00009114895],"about_ca_topic_score_codex":0.005599618,"about_ca_topic_score_gemma":0.0066917217,"teacher_disagreement_score":0.008959489,"about_ca_system_score_codex":0.00016913249,"about_ca_system_score_gemma":0.00028822193,"threshold_uncertainty_score":0.8464985},"labels":[],"label_agreement":null},{"id":"W4405040001","doi":"10.1182/blood-2024-205985","title":"Zilovertamab Vedotin in Combination with Nemtabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Refractory (planetary science); Open label; Oncology; Phases of clinical research; Cohort; Lymphoma; Clinical trial; Materials science","score_opus":0.017048808674541633,"score_gpt":0.2905989565411042,"score_spread":0.27355014786656257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401313,0.00017972958,0.0000048776496,0.00012860504,0.00011539135,0.0046338034,0.00007706835,0.000025962852,0.000821448],"genre_scores_gemma":[0.99815005,0.000016958587,0.00037518362,0.00007157286,0.000023290733,0.00044772553,0.00011408976,0.00004290258,0.0007582054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865836,0.000054290944,0.00034335122,0.00037729758,0.00036649755,0.00020020542],"domain_scores_gemma":[0.9990885,0.00018326125,0.00013337671,0.0003948047,0.00013985577,0.00006015532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018997748,0.00020087796,0.00037531892,0.00008389758,0.000061726445,0.00004109284,0.00015567325,0.00005706928,0.00002254153],"category_scores_gemma":[0.000047432863,0.000100199075,0.000033741646,0.0003405721,0.000039183687,0.00011021184,0.000068388,0.000060925133,0.0000052094283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049271393,0.19232741,0.79511034,0.00025766497,0.0005645054,0.00015749157,0.0006871425,9.0419593e-7,0.00017991997,0.00007781917,0.0008822968,0.004827394],"study_design_scores_gemma":[0.34498346,0.02583886,0.61666036,0.00073339685,0.0018198922,0.00001409574,0.00034557751,0.00016811717,0.007762656,0.000013511197,0.0014404473,0.00021960044],"about_ca_topic_score_codex":0.00021741043,"about_ca_topic_score_gemma":0.0001709405,"teacher_disagreement_score":0.34005633,"about_ca_system_score_codex":0.0001347757,"about_ca_system_score_gemma":0.0003750574,"threshold_uncertainty_score":0.40859997},"labels":[],"label_agreement":null},{"id":"W4405040604","doi":"10.1182/blood-2024-199227","title":"Multiomic Profiling Reveals Pleiotropic Effects of Somatic IRF4-C99R Mutations in Primary Mediastinal Large B-Cell Lymphomas","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Somatic cell; Biology; B cell; Cancer research; Profiling (computer programming); IRF4; Genetics; Immunology; Antibody; Gene; Transcription factor","score_opus":0.006549509104057437,"score_gpt":0.24393117999976213,"score_spread":0.2373816708957047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910369,0.0066395723,0.000030249115,0.000116637675,0.00017668423,0.0008569528,0.00002378101,0.00007945462,0.0010397475],"genre_scores_gemma":[0.99605334,0.00012153603,0.0031263253,0.000070674214,0.000093835115,0.00023199974,0.00010182099,0.000028474828,0.00017198568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877197,0.000055197943,0.00038697512,0.00027456248,0.00024195787,0.00026936966],"domain_scores_gemma":[0.9991437,0.0004470928,0.00006756695,0.00021423178,0.00003319304,0.00009420625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012002998,0.00016742012,0.00037858944,0.00022781563,0.000032399046,0.000016310125,0.00005761009,0.00007786038,0.000025590136],"category_scores_gemma":[0.00011820372,0.00013528536,0.00012019075,0.00028483418,0.000026414264,0.00006465983,0.000035814297,0.00007830218,0.00007353564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063648426,0.016315648,0.74618834,0.015232289,0.00054883363,0.0033690333,0.0022869622,0.000007586246,0.21037261,0.0013024389,0.00020148346,0.0041110935],"study_design_scores_gemma":[0.021268206,0.00048416565,0.7182012,0.0026942368,0.0010902173,0.0001478161,0.00010195834,0.0006038235,0.2549476,0.00023629982,0.000043410146,0.00018101552],"about_ca_topic_score_codex":0.00003559623,"about_ca_topic_score_gemma":0.000008143929,"teacher_disagreement_score":0.044575,"about_ca_system_score_codex":0.0001677172,"about_ca_system_score_gemma":0.00026809887,"threshold_uncertainty_score":0.5516777},"labels":[],"label_agreement":null},{"id":"W4405040849","doi":"10.1182/blood-2024-198979","title":"Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Refractory (planetary science); Lymphoma; Nuclear medicine; Hodgkin lymphoma; Oncology; Internal medicine; Immunotherapy; Cancer; Biology","score_opus":0.012153910540274026,"score_gpt":0.2723099036470323,"score_spread":0.26015599310675824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890561,0.009376954,0.000028945486,0.00020324445,0.00014353245,0.0005332863,0.000055352564,0.000050717303,0.00055187655],"genre_scores_gemma":[0.9975539,0.0005551669,0.0016270482,0.000023868552,0.00007392125,0.000045887668,0.00004454755,0.000032570468,0.00004307478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839926,0.00005887623,0.0006312974,0.00035049213,0.00035471187,0.00020534464],"domain_scores_gemma":[0.99921584,0.00012756181,0.00015553915,0.0002966274,0.000088921144,0.000115510215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022778467,0.00021113124,0.0006167698,0.00027456734,0.000025581106,0.000024617277,0.000054071465,0.00015342644,0.00005830277],"category_scores_gemma":[0.00008414565,0.0001763037,0.000115605275,0.0003514358,0.0001057639,0.000102448,0.00005974935,0.00008716119,0.0000050106582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00482119,0.04035762,0.7422025,0.0054381327,0.0018315169,0.0015062231,0.015320774,0.0019850025,0.022887422,0.0007418701,0.0038461112,0.15906164],"study_design_scores_gemma":[0.112231046,0.010427724,0.55943364,0.009861022,0.002234372,0.0002318626,0.0021551084,0.015261147,0.28555104,0.00020347383,0.0015740402,0.00083552086],"about_ca_topic_score_codex":0.00024697697,"about_ca_topic_score_gemma":0.00004812316,"teacher_disagreement_score":0.2626636,"about_ca_system_score_codex":0.00019015692,"about_ca_system_score_gemma":0.0003078924,"threshold_uncertainty_score":0.7189456},"labels":[],"label_agreement":null},{"id":"W4405040925","doi":"10.1182/blood-2024-211926","title":"Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Oncology; Lymphoma","score_opus":0.0070960583230896485,"score_gpt":0.20959559229100455,"score_spread":0.2024995339679149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899233,0.006924217,0.000011760064,0.00033604898,0.0001827581,0.0008897147,0.00004663754,0.00011104428,0.0015745012],"genre_scores_gemma":[0.99705374,0.0007060112,0.0010274823,0.00037355023,0.00013391642,0.00018017164,0.00021521865,0.00006197948,0.00024790553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822676,0.00003591266,0.0003729261,0.0005093743,0.00044677942,0.00040826143],"domain_scores_gemma":[0.9992911,0.00007013294,0.00006851815,0.00035428448,0.00007885713,0.00013705628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001421969,0.00032219573,0.00048577128,0.00020520871,0.00005071377,0.0000579376,0.00009304061,0.00009965965,0.00008451245],"category_scores_gemma":[0.000007952148,0.00021962212,0.00010832833,0.00031305032,0.000045131477,0.00011519892,0.000049728296,0.00009747548,0.00006483647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059024815,0.017429287,0.9388585,0.000326662,0.00029459057,0.000957342,0.00077596225,0.000004814884,0.0008906949,0.000020589048,0.0005241589,0.03932712],"study_design_scores_gemma":[0.0410891,0.0016619262,0.9323186,0.0010668355,0.00021492469,0.000026405767,0.000037058562,0.000020896008,0.021670878,0.000007680285,0.0016384032,0.0002472889],"about_ca_topic_score_codex":0.00022542197,"about_ca_topic_score_gemma":0.00003696223,"teacher_disagreement_score":0.04049885,"about_ca_system_score_codex":0.00034477463,"about_ca_system_score_gemma":0.00028384844,"threshold_uncertainty_score":0.89559305},"labels":[],"label_agreement":null},{"id":"W4405041011","doi":"10.1182/blood-2024-210922","title":"Rate of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated with First-Line Bendamustine Rituximab and Rituximab Maintenance","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Bendamustine; Follicular lymphoma; Medicine; Oncology; Lymphoma; Internal medicine; Immunology","score_opus":0.005882372212843601,"score_gpt":0.20399034437020896,"score_spread":0.19810797215736536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417096,0.0043298756,0.000017117352,0.00047296664,0.000019092291,0.0005025616,0.00011915915,0.000038055565,0.0003302162],"genre_scores_gemma":[0.99809754,0.0012934235,0.00027092418,0.000071188915,0.000013599583,0.00006886391,0.00011963828,0.00001823189,0.000046574103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914867,0.000019365245,0.00028054352,0.00025142592,0.000116385796,0.00018361222],"domain_scores_gemma":[0.99963766,0.00006172681,0.000045592467,0.00011788398,0.00006442953,0.00007267943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008592535,0.00018066732,0.00037357726,0.00013571508,0.00003709011,0.000024558602,0.000023495586,0.00006147745,0.000014308078],"category_scores_gemma":[0.000017535533,0.00012270715,0.000040255734,0.00020936567,0.000072826595,0.0001487378,0.000013782968,0.000040746025,0.0000030017604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015678843,0.01957357,0.88305527,0.0052083605,0.0010742215,0.001724293,0.003358006,0.00000512303,0.00087080867,0.0016775397,0.00022437933,0.08166053],"study_design_scores_gemma":[0.09048728,0.0018986182,0.88084656,0.0024218706,0.00077206036,0.00025422339,0.00010716814,0.0004087608,0.021197956,0.00010287668,0.0012836359,0.00021897102],"about_ca_topic_score_codex":0.0002100115,"about_ca_topic_score_gemma":0.000184439,"teacher_disagreement_score":0.08891939,"about_ca_system_score_codex":0.000043909822,"about_ca_system_score_gemma":0.00007134966,"threshold_uncertainty_score":0.5003852},"labels":[],"label_agreement":null},{"id":"W4405041154","doi":"10.1182/blood-2024-206056","title":"Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Refractory (planetary science); Population; Internal medicine; Oncology; Survival analysis; Biology","score_opus":0.007412395196389881,"score_gpt":0.24189963578463985,"score_spread":0.23448724058824996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795836,0.00034335174,0.000078263816,0.000057681616,0.00009605532,0.00056261505,0.0007854538,0.00006114956,0.00005705466],"genre_scores_gemma":[0.9983815,0.000018406743,0.00035056693,0.000052800217,0.00002921467,0.00009291004,0.0007899496,0.00002883411,0.00025583152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988948,0.000027757676,0.00027317205,0.00030419513,0.00028727457,0.00021281646],"domain_scores_gemma":[0.9991027,0.0003576374,0.000089156776,0.0002560866,0.00008149906,0.00011288151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010334366,0.00017799955,0.0004873182,0.00022237308,0.000056525445,0.00001955912,0.000036314024,0.00007740088,0.000029617875],"category_scores_gemma":[0.000067153014,0.00010409361,0.00018245926,0.00033801253,0.000015756938,0.000053684802,0.000016606458,0.000027191596,0.0000016167204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033059833,0.022186711,0.9748602,0.00028313356,0.0019377281,0.000026996453,0.00013015927,8.139599e-7,0.0000041959734,0.000040581628,0.000054995402,0.00014391301],"study_design_scores_gemma":[0.052740987,0.0010095245,0.93816346,0.00007803832,0.0068581416,4.6122713e-7,0.000031833355,0.00023003887,0.00021592001,0.000003319112,0.0005588481,0.000109451765],"about_ca_topic_score_codex":0.00009470443,"about_ca_topic_score_gemma":0.00017280702,"teacher_disagreement_score":0.05241039,"about_ca_system_score_codex":0.000058914644,"about_ca_system_score_gemma":0.00011052957,"threshold_uncertainty_score":0.42448142},"labels":[],"label_agreement":null},{"id":"W4405041516","doi":"10.1182/blood-2024-198509","title":"Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Internal medicine; Oncology; Lymphoma; Gastroenterology; Cancer research; Biology","score_opus":0.010397018450015252,"score_gpt":0.22791181545587202,"score_spread":0.21751479700585677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302906,0.0028278197,0.000005542245,0.00038638443,0.00039196663,0.00097060646,0.00006722635,0.00018695027,0.0021344358],"genre_scores_gemma":[0.9953067,0.00052926934,0.0004913541,0.00028611944,0.00015624388,0.00022589248,0.00020099619,0.000105295716,0.002698182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976399,0.00007015275,0.0004523999,0.00071348797,0.0005988533,0.00052521337],"domain_scores_gemma":[0.9989265,0.00010164792,0.00006749089,0.0005627127,0.00007684179,0.00026480752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014186415,0.0004145755,0.0005854383,0.00025472965,0.00007773344,0.00007330221,0.00013763641,0.00022463067,0.00029003652],"category_scores_gemma":[0.00004162198,0.00027754254,0.00024989306,0.0005517006,0.00006112254,0.00017675612,0.00003155816,0.00014724123,0.00019866184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058913045,0.02551925,0.8925323,0.0010151727,0.0028802697,0.010243731,0.0023885884,0.0000044286007,0.0016515056,0.000315991,0.007007139,0.05055031],"study_design_scores_gemma":[0.14091408,0.0075442097,0.7844171,0.0022047344,0.0027700802,0.00015513695,0.00025984147,0.00005040267,0.011869291,0.000041393785,0.048929147,0.00084461155],"about_ca_topic_score_codex":0.00019948548,"about_ca_topic_score_gemma":0.00019415807,"teacher_disagreement_score":0.13502277,"about_ca_system_score_codex":0.00033012743,"about_ca_system_score_gemma":0.00036633894,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W4405041646","doi":"10.1182/blood-2024-199677","title":"Shallow Whole Genome Sequencing of Circulating Tumor DNA Is Predictive of Outcome in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Eisai; AstraZeneca","keywords":"Diffuse large B-cell lymphoma; Circulating tumor DNA; Lymphoma; DNA; Biology; Genome; Whole genome sequencing; Computational biology; Medicine; Cancer research; Genetics; Cancer; Immunology; Gene","score_opus":0.018836650703115066,"score_gpt":0.25801323572019697,"score_spread":0.2391765850170819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457055,0.0024914788,0.000011428062,0.000092316266,0.00006141678,0.00035231217,0.00023311314,0.00004383275,0.0021435423],"genre_scores_gemma":[0.99933386,0.00002695086,0.00023617291,0.000113621565,0.000054405657,0.000040822466,0.000032926793,0.000029566918,0.00013166864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986449,0.000025681557,0.00050332147,0.00030061448,0.0002699966,0.00025549243],"domain_scores_gemma":[0.9993987,0.00009474203,0.00010490078,0.0002695474,0.000048989437,0.00008312622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016352591,0.00016543259,0.000459733,0.00017802628,0.00002080573,0.000011027428,0.00007086504,0.00006328269,0.000040290714],"category_scores_gemma":[0.000043279968,0.00013640581,0.00017766829,0.00026663483,0.00003147512,0.000067650886,0.000059571692,0.000057416502,0.000020875234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036884157,0.011912376,0.8876788,0.0013264433,0.0003899605,0.0015813897,0.0050731073,0.0000060800962,0.09136951,0.00017397293,0.000015704401,0.00043577788],"study_design_scores_gemma":[0.039292883,0.0007351523,0.8291927,0.0013365039,0.0010139975,0.00017954392,0.0011254983,0.0019157033,0.12456981,0.00011430938,0.00027472663,0.00024919596],"about_ca_topic_score_codex":0.00019244596,"about_ca_topic_score_gemma":0.00001758565,"teacher_disagreement_score":0.05848612,"about_ca_system_score_codex":0.00022484506,"about_ca_system_score_gemma":0.0001860337,"threshold_uncertainty_score":0.55624676},"labels":[],"label_agreement":null},{"id":"W4405042174","doi":"10.1182/blood-2024-200018","title":"Glofitamab Induces High Response Rates and Durable Remissions in Patients (Pts) with Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL), Including Those with a Poor Prognosis: Subgroup Results from a Phase I/II Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Medicine; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Gastroenterology; Biology","score_opus":0.017680364791631657,"score_gpt":0.2715621329628678,"score_spread":0.25388176817123614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367094,0.0027036802,3.0035898e-7,0.0004926568,0.000064512016,0.0023097852,0.00037917015,0.00019983646,0.00017912248],"genre_scores_gemma":[0.9981557,0.00015968886,0.00038810034,0.000063186555,0.000038835333,0.0005200699,0.0002826665,0.00008444831,0.00030726395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706197,0.00028077944,0.0005777529,0.0010551449,0.0005485371,0.0004758057],"domain_scores_gemma":[0.9984197,0.00053368806,0.00017232937,0.00046937118,0.00012432324,0.00028061453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038433756,0.00049363344,0.0006344561,0.00035599424,0.00027870963,0.00013892972,0.00011628954,0.00016497438,0.000020293232],"category_scores_gemma":[0.00016309955,0.00031259772,0.000056144418,0.0007806377,0.000082776576,0.0003043311,0.00013632256,0.00019877472,0.000012384999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08338982,0.15614295,0.7124619,0.00024843257,0.0017649118,0.0075256885,0.014870809,0.0000023243067,0.012122472,0.000006056658,0.0006774969,0.010787131],"study_design_scores_gemma":[0.18453744,0.037122842,0.7098955,0.0042967224,0.0018538511,0.000058656944,0.0024708665,0.0000440107,0.058859773,0.00001150494,0.00033537246,0.00051344174],"about_ca_topic_score_codex":0.0019619584,"about_ca_topic_score_gemma":0.00015006568,"teacher_disagreement_score":0.119020104,"about_ca_system_score_codex":0.00030212427,"about_ca_system_score_gemma":0.00045058105,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W4405042392","doi":"10.1182/blood-2024-202410","title":"The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Lymphoma; Cancer research; Internal medicine","score_opus":0.008573535445317285,"score_gpt":0.2539957262234783,"score_spread":0.24542219077816105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915184,0.0050288974,0.0000024581707,0.0001055501,0.0001749338,0.00034861444,0.000017356448,0.00005844573,0.0027453469],"genre_scores_gemma":[0.99918413,0.00018681247,0.00002498877,0.000025570991,0.00010706958,0.000040369785,0.000016318176,0.00001555094,0.000399177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920857,0.00003541447,0.00016950737,0.0001970676,0.00021765014,0.00017179847],"domain_scores_gemma":[0.9994236,0.0001415161,0.000026744876,0.0002944191,0.00003338614,0.00008029816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015255286,0.00010480458,0.0001624423,0.000049309994,0.000091910224,0.000033749577,0.00006494136,0.000034477638,0.000049271177],"category_scores_gemma":[0.000016669948,0.00005606355,0.00006995469,0.00016060633,0.000015974027,0.000034646062,0.000040212977,0.000029965955,0.000059668328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043776282,0.10430877,0.8494589,0.00038980122,0.0011158739,0.0023966327,0.0039279666,0.0000019182928,0.0019405341,0.0012844651,0.004552444,0.030184938],"study_design_scores_gemma":[0.043582104,0.009783764,0.9039567,0.0002465306,0.0028416165,0.00015720598,0.0038133992,0.0007313492,0.017354367,0.00008470838,0.017200507,0.00024771996],"about_ca_topic_score_codex":0.000032981523,"about_ca_topic_score_gemma":0.00007846745,"teacher_disagreement_score":0.09452501,"about_ca_system_score_codex":0.000017989138,"about_ca_system_score_gemma":0.00008964591,"threshold_uncertainty_score":0.22862051},"labels":[],"label_agreement":null},{"id":"W4405042679","doi":"10.1182/blood-2024-199981","title":"<i>CSF2RB</i> Mutations Result in Cytokine-Dependent Gain-of-Function Phenotypes in Classic Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Princess Margaret Cancer Centre; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Biology; Cancer research; Exome sequencing; Cytokine; Mutation; Genetics; Gene","score_opus":0.01419930214028463,"score_gpt":0.26067772837866476,"score_spread":0.24647842623838012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896796,0.0027285682,0.000034929613,0.00076655403,0.00025088203,0.00037579602,0.000033768385,0.000075705444,0.0060541998],"genre_scores_gemma":[0.99883443,0.00017611956,0.0002439075,0.00014388426,0.00009809121,0.00012615041,0.000065063556,0.000023237788,0.000289106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988195,0.00004620204,0.0003767807,0.0003093208,0.00024254137,0.0002056823],"domain_scores_gemma":[0.99947894,0.00015688986,0.00004469905,0.00022141938,0.000036013746,0.000062053514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016241212,0.00014602355,0.0002621593,0.0003151378,0.000021150629,0.00002287277,0.00004857177,0.00009298302,0.00004799628],"category_scores_gemma":[0.000063501764,0.000121495636,0.00008572182,0.0004928144,0.000034452674,0.00007691116,0.000024832736,0.00007406729,0.00009203725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011133463,0.022415023,0.741338,0.001059486,0.0011380193,0.0059248977,0.0042596143,0.0005507948,0.031606045,0.015821954,0.0028248155,0.17194797],"study_design_scores_gemma":[0.02173266,0.0009553541,0.9053361,0.0012841185,0.0007870604,0.00016597589,0.0004448804,0.00075722113,0.062564716,0.0017950773,0.0038849937,0.00029185537],"about_ca_topic_score_codex":0.00048451638,"about_ca_topic_score_gemma":0.0005213694,"teacher_disagreement_score":0.17165612,"about_ca_system_score_codex":0.00018845074,"about_ca_system_score_gemma":0.00021558517,"threshold_uncertainty_score":0.4954448},"labels":[],"label_agreement":null},{"id":"W4405043806","doi":"10.1182/blood-2024-209760","title":"Tumor Microenvironment Differences between Diagnostic and Relapsed Classic Hodgkin Lymphoma Revealed By Single Cell Transcriptome Sequencing","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Transcriptome; Lymphoma; Biology; Tumor microenvironment; Cancer research; Medicine; Pathology; Genetics; Tumor cells; Gene","score_opus":0.015546759578168241,"score_gpt":0.214408723331779,"score_spread":0.19886196375361076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976182,0.021600036,0.000020326324,0.0008055783,0.0001166128,0.00050505507,0.00012443667,0.00012616877,0.000519801],"genre_scores_gemma":[0.9975241,0.0009156605,0.00031641478,0.0002215107,0.00014376598,0.00011459883,0.00007503035,0.00004524059,0.0006436938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841434,0.000060523078,0.00033712908,0.00054680347,0.0002728218,0.00036840982],"domain_scores_gemma":[0.9989403,0.0005035584,0.000053191496,0.0002451043,0.000010178731,0.0002476578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000970355,0.00029854235,0.00045622428,0.0000936083,0.000092106566,0.00009264862,0.00007472506,0.000091369664,0.000059774648],"category_scores_gemma":[0.00003658981,0.00023160152,0.00012429192,0.00013807577,0.00010643372,0.00007835973,0.00003187702,0.00008856265,0.00007062787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040650422,0.0031450323,0.6728971,0.0009382755,0.00068999105,0.0022515475,0.0012214653,2.1816382e-7,0.2974895,0.00003306016,0.003538334,0.01775482],"study_design_scores_gemma":[0.011725539,0.002099315,0.72830033,0.0014843586,0.0033562405,0.00034753047,0.00025999566,0.000023356868,0.24541539,0.0001287151,0.0063437824,0.000515458],"about_ca_topic_score_codex":0.00007687966,"about_ca_topic_score_gemma":0.0000045360616,"teacher_disagreement_score":0.05540322,"about_ca_system_score_codex":0.00027966316,"about_ca_system_score_gemma":0.000088915236,"threshold_uncertainty_score":0.9444436},"labels":[],"label_agreement":null},{"id":"W4405044058","doi":"10.1182/blood-2024-201819","title":"Retreatment with R-CHOP-like Therapy in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma (DLBCL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Rituximab; Oncology; CHOP; Internal medicine","score_opus":0.004987517875997582,"score_gpt":0.2040393088167558,"score_spread":0.19905179094075823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952948,0.00251438,0.0000010945886,0.00011622675,0.000059099817,0.0007393107,0.00005093042,0.000064643085,0.0011595134],"genre_scores_gemma":[0.99820817,0.00051862566,0.00026595072,0.00013386291,0.000022251008,0.0001042201,0.00007123969,0.000048236485,0.0006274675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987357,0.000028343986,0.00023417817,0.000367091,0.00034994373,0.00028470575],"domain_scores_gemma":[0.9993241,0.000051485764,0.00006202796,0.00039225307,0.000056945853,0.00011319779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006130444,0.00024483915,0.000360269,0.00013717033,0.000029151595,0.000020280144,0.00005449144,0.00007449899,0.000032530963],"category_scores_gemma":[0.0000036103856,0.00013676216,0.00007833618,0.0003057173,0.000037172187,0.000068966554,0.000021206262,0.00005437787,0.000032091757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009851132,0.0713582,0.9203873,0.0001057037,0.00061070896,0.0008596537,0.00065657566,5.771683e-7,0.000059768823,0.00006117327,0.00013801162,0.0047772224],"study_design_scores_gemma":[0.15920414,0.005751737,0.825679,0.0006168962,0.0004627245,0.000017687693,0.0000395107,0.000011471112,0.005986491,0.000010044719,0.0020465555,0.00017371561],"about_ca_topic_score_codex":0.00011060635,"about_ca_topic_score_gemma":0.00004495734,"teacher_disagreement_score":0.15821904,"about_ca_system_score_codex":0.00013156133,"about_ca_system_score_gemma":0.00013697566,"threshold_uncertainty_score":0.55769986},"labels":[],"label_agreement":null},{"id":"W4405044205","doi":"10.1182/blood-2024-204219","title":"A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Follicular lymphoma; Bendamustine; Rituximab; Oncology; Medicine; Internal medicine; Regimen; Lymphoma; Somatic hypermutation; Cohort; Immunology; B cell","score_opus":0.01586826079335281,"score_gpt":0.27276425969778473,"score_spread":0.25689599890443193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98071754,0.016856758,0.00062980864,0.00041691322,0.00026293693,0.00074553525,0.00002911125,0.00015346192,0.00018790635],"genre_scores_gemma":[0.99442524,0.00017553987,0.004720734,0.00007886262,0.00008073359,0.00023945923,0.00014025444,0.000052188236,0.0000870147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853235,0.000019667128,0.0004093431,0.00041637075,0.00036948992,0.000252793],"domain_scores_gemma":[0.999162,0.00014691052,0.0000892913,0.00042304685,0.00009480194,0.000083909596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012609934,0.0002328931,0.00038936725,0.0001661598,0.00006380305,0.00005957216,0.000099124925,0.000100728306,0.00002750732],"category_scores_gemma":[0.00006610937,0.00019690041,0.00036375655,0.00035177654,0.000051820356,0.000075276155,0.000020018753,0.00004710406,0.00002703614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015164523,0.009589502,0.055007562,0.0007584078,0.0015420364,0.0003233086,0.00037707298,0.000018183862,0.8902942,0.00044342037,0.00007353558,0.041421108],"study_design_scores_gemma":[0.025737042,0.00068567443,0.39587364,0.0013920764,0.0021668307,0.00010476831,0.00016524791,0.0018873909,0.570433,0.00007523277,0.0011851031,0.0002939738],"about_ca_topic_score_codex":0.000036443973,"about_ca_topic_score_gemma":0.0000072618263,"teacher_disagreement_score":0.34086606,"about_ca_system_score_codex":0.00009558894,"about_ca_system_score_gemma":0.00025193617,"threshold_uncertainty_score":0.8029366},"labels":[],"label_agreement":null},{"id":"W4405044297","doi":"10.1182/blood-2024-198794","title":"Utility of the Central Nervous System International Prognostic Index (CNS-IPI) in Patients with Primary Mediastinal B-Cell Lymphoma Treated with Rituximab-Containing Chemoimmunotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Lymphoma","score_opus":0.004827238272667484,"score_gpt":0.19048472047735954,"score_spread":0.18565748220469205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626577,0.0005250001,0.000007609013,0.00007848041,0.0001141665,0.0008646281,0.000041102572,0.00006750925,0.0020357596],"genre_scores_gemma":[0.99953383,0.000010030737,0.00011389047,0.000046396173,0.00004998411,0.0000870786,0.00008687141,0.000030626597,0.0000412647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985558,0.000044950866,0.00031413927,0.00031732034,0.00049736677,0.00027045273],"domain_scores_gemma":[0.99937034,0.00008480352,0.000107106185,0.00026050324,0.00010682279,0.00007045312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008018121,0.00021870236,0.00035015208,0.0000932877,0.000036587076,0.000032595763,0.00013225735,0.00006593004,0.00002206606],"category_scores_gemma":[0.000012567298,0.00011822061,0.00008037915,0.000278942,0.00008693814,0.0000755164,0.000036155943,0.00008481558,0.0000033230494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015187016,0.007365395,0.98215425,0.00031463173,0.00043439167,0.00020623888,0.0003767328,0.0000020998732,0.000035729783,0.00002463902,0.0000095752985,0.007557617],"study_design_scores_gemma":[0.035617433,0.0008443009,0.9584722,0.0016967177,0.00035570288,0.000076654025,0.000117411335,0.0002922445,0.0023756742,0.0000011190134,0.00003674631,0.0001138124],"about_ca_topic_score_codex":0.0003523276,"about_ca_topic_score_gemma":0.000041903957,"teacher_disagreement_score":0.03409873,"about_ca_system_score_codex":0.00023259419,"about_ca_system_score_gemma":0.00037029677,"threshold_uncertainty_score":0.48208967},"labels":[],"label_agreement":null},{"id":"W4405044300","doi":"10.1182/blood-2024-194858","title":"Omission of Bleomycin in Limited Stage Classic Hodgkin Lymphoma Patients with a Negative PET Scan Following 2 Cycles of ABVD Is Associated with Comparable Outcomes and Reduced Pulmonary Toxicity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ABVD; Bleomycin; Medicine; Pulmonary toxicity; Lymphoma; Dacarbazine; Vinblastine; Hodgkin lymphoma; Toxicity; Nuclear medicine; Stage (stratigraphy); Internal medicine; Oncology; Radiology; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.012877484421636625,"score_gpt":0.25103095137538667,"score_spread":0.23815346695375003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981745,0.00036833136,7.6016374e-7,0.00016364768,0.000023765733,0.00058641244,0.00010302078,0.000034979155,0.000544614],"genre_scores_gemma":[0.9992446,0.0000265824,0.00035630574,0.000047498448,0.0000049604887,0.000034363846,0.00006195182,0.000025931045,0.0001978496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986821,0.0000680574,0.00033621048,0.00033132022,0.00036490202,0.00021743753],"domain_scores_gemma":[0.99921185,0.00025630233,0.00015701597,0.00018785859,0.00008840335,0.00009856714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010999864,0.0002225094,0.00066269765,0.00019721812,0.00003880255,0.00002175512,0.000049235456,0.000060566705,0.000010714711],"category_scores_gemma":[0.00007286174,0.00014133428,0.00008346188,0.0004290661,0.00006905545,0.00013762683,0.00003495782,0.000060626997,6.0401896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004391111,0.004772166,0.9885107,0.00016568259,0.0009902783,0.00046775787,0.00070312264,0.0000025218915,0.0029184676,0.00001635617,0.000024345292,0.0009894836],"study_design_scores_gemma":[0.014308973,0.0009847587,0.92528105,0.0026205613,0.00058866513,0.000010498699,0.00035668013,0.0001868822,0.05550232,0.000016468259,0.0000046501823,0.00013850146],"about_ca_topic_score_codex":0.0005350476,"about_ca_topic_score_gemma":0.00013227359,"teacher_disagreement_score":0.063229665,"about_ca_system_score_codex":0.00017200397,"about_ca_system_score_gemma":0.00018913436,"threshold_uncertainty_score":0.57634443},"labels":[],"label_agreement":null},{"id":"W4405044335","doi":"10.1182/blood-2024-197938","title":"Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Rituximab; Medicine; Cyclophosphamide; Internal medicine; Doxorubicin; Oncology; Chemotherapy; Lymphoma","score_opus":0.009204980291732019,"score_gpt":0.28513701449659884,"score_spread":0.27593203420486684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943978,0.0028453215,0.0000013380912,0.00032840064,0.000132674,0.0013541258,0.00041094385,0.000043650263,0.00048570076],"genre_scores_gemma":[0.9993478,0.00008237667,0.000043835258,0.00006516116,0.000028819919,0.000043334596,0.000041267947,0.000030905412,0.00031648428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814415,0.00011096564,0.00048114432,0.00047267607,0.0005074153,0.0002836547],"domain_scores_gemma":[0.99863267,0.00033753412,0.00018246441,0.0005835167,0.00012933835,0.0001344528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019141696,0.00032406702,0.0011058645,0.00033068354,0.000088662186,0.000037938324,0.00013650196,0.00011610079,0.00005421476],"category_scores_gemma":[0.00013457653,0.0001822553,0.00071462494,0.0009206586,0.00013702226,0.00006329773,0.00010399799,0.00016902285,0.0000069744915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070504117,0.0050413697,0.96771264,0.00006770873,0.02026879,0.00011225477,0.0036729798,0.00001646289,0.00159751,0.00023271759,0.00006505257,0.00050747825],"study_design_scores_gemma":[0.018006373,0.003019115,0.9567388,0.00022598385,0.01241853,0.000014250764,0.0005564743,0.00017257873,0.008668027,0.000024115707,0.0000085795955,0.0001471177],"about_ca_topic_score_codex":0.005022827,"about_ca_topic_score_gemma":0.00027616828,"teacher_disagreement_score":0.017301332,"about_ca_system_score_codex":0.0001966582,"about_ca_system_score_gemma":0.00031490016,"threshold_uncertainty_score":0.7593046},"labels":[],"label_agreement":null},{"id":"W4405044602","doi":"10.1182/blood-2024-207439","title":"Creation of a Multistate Model to Improve Prognostication across the Disease Course in Advanced Stage Classic Hodgkin Lymphoma (cHL): A Report from the Holistic Consortium","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Classical Hodgkin lymphoma; Hodgkin lymphoma; Disease; Medicine; Internal medicine; Biology","score_opus":0.022539320628567727,"score_gpt":0.33646711895915277,"score_spread":0.31392779833058504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267185,0.0017083166,0.0005931529,0.0022374464,0.00010435226,0.0016733834,0.00085003284,0.00005279161,0.00010864857],"genre_scores_gemma":[0.99764436,0.000075483105,0.00049575063,0.00024203508,0.00006484569,0.0009159261,0.00019001061,0.000023933546,0.00034765608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867815,0.000044658533,0.00040136697,0.00038333246,0.0002767705,0.00021571579],"domain_scores_gemma":[0.99870366,0.00039109093,0.000119809454,0.00056735595,0.00009594751,0.00012212012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021131222,0.00015718065,0.00021657553,0.000027609654,0.00006438574,0.000055848333,0.00009122282,0.000041002706,0.000007616435],"category_scores_gemma":[0.00049883936,0.00008867575,0.00008651489,0.00020911069,0.00010504137,0.000068934176,0.000048534468,0.000055829558,0.000014191263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025099642,0.013556449,0.77508944,0.00057262386,0.0012049979,0.0056071617,0.011298888,0.0027429147,0.01414639,0.003110212,0.0009220703,0.1692389],"study_design_scores_gemma":[0.005630578,0.00017609012,0.946409,0.00049541256,0.000994843,0.000028959643,0.00048045334,0.039800085,0.0049293744,0.000348308,0.0005694581,0.00013743267],"about_ca_topic_score_codex":0.0005486199,"about_ca_topic_score_gemma":0.0002133946,"teacher_disagreement_score":0.17131957,"about_ca_system_score_codex":0.000113328286,"about_ca_system_score_gemma":0.00043917092,"threshold_uncertainty_score":0.36160922},"labels":[],"label_agreement":null},{"id":"W4405044960","doi":"10.1182/blood-2024-194581","title":"A Randomized Phase II Study of Mosunetuzumab SC Plus Polatuzumab Vedotin Demonstrates Improved Outcomes Versus Rituximab Plus Polatuzumab Vedotin in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Juravinski Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Brentuximab vedotin; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Clinical trial; Hodgkin lymphoma","score_opus":0.013819270255672847,"score_gpt":0.2782877504936997,"score_spread":0.2644684802380268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884768,0.004378025,0.000007273765,0.00009583051,0.00059386017,0.005317982,0.00016948293,0.00027710118,0.00068365195],"genre_scores_gemma":[0.9975994,0.00016018352,0.0004575079,0.00007487841,0.000091014255,0.00068627583,0.00025952808,0.00017170102,0.00049946917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99456173,0.0004116178,0.0016816983,0.0013011702,0.0010382765,0.0010055108],"domain_scores_gemma":[0.99657726,0.0011510261,0.00052574446,0.0010841868,0.00025550261,0.00040629684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052218436,0.00097297726,0.0030027572,0.00072681945,0.0002507974,0.000109541485,0.0003469836,0.0003664985,0.000099612604],"category_scores_gemma":[0.0004468157,0.00066278956,0.00052512955,0.0010021033,0.00020704202,0.00032802997,0.00024311902,0.00041690806,0.00004848215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64876264,0.2938466,0.027325686,0.00078572426,0.006527565,0.0029157065,0.010695148,0.000013568612,0.00045978758,0.00013712901,0.000186289,0.008344155],"study_design_scores_gemma":[0.9467576,0.029655479,0.011576778,0.0006894818,0.004422015,0.000033987533,0.002284877,0.002061864,0.001644733,0.000011192125,0.0001885234,0.00067344896],"about_ca_topic_score_codex":0.0015944799,"about_ca_topic_score_gemma":0.00076623686,"teacher_disagreement_score":0.297995,"about_ca_system_score_codex":0.0014574379,"about_ca_system_score_gemma":0.0022694145,"threshold_uncertainty_score":0.99958235},"labels":[],"label_agreement":null},{"id":"W4405045778","doi":"10.1182/blood-2024-201624","title":"Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma Enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Refractory (planetary science); Hodgkin lymphoma; Randomized controlled trial; Adverse effect; Phases of clinical research; Lymphoma; Clinical trial; Cancer; Immunotherapy","score_opus":0.006462541439846968,"score_gpt":0.2460965308151292,"score_spread":0.2396339893752822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964099,0.0009922658,0.0000013693434,0.00008136212,0.00010279049,0.0021781637,0.000029354936,0.000024944891,0.00017982801],"genre_scores_gemma":[0.9995247,0.00023204563,0.000018346254,0.000017379254,0.000022498007,0.00009283991,0.000026923017,0.000024620647,0.000040617542],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982679,0.00034335346,0.0005391427,0.00035714317,0.00034049415,0.00015197521],"domain_scores_gemma":[0.9987544,0.00057324953,0.00018325388,0.00033417062,0.00007214912,0.00008278641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033066518,0.00021514502,0.00073045405,0.0002635903,0.00009133775,0.000017468616,0.00007844232,0.000064118765,0.00000994908],"category_scores_gemma":[0.000127906,0.00012540584,0.0000895305,0.00035952323,0.00012092852,0.00008189396,0.00008007271,0.00009951272,7.145435e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093497254,0.42843166,0.40754992,0.00031011744,0.0013863258,0.000081840015,0.009703205,0.000005268422,0.000068137604,0.00036362463,0.000042391566,0.05856028],"study_design_scores_gemma":[0.55926573,0.009728337,0.42917135,0.00020317512,0.0011585369,0.0000040627924,0.00017049476,0.000093702736,0.0001071289,0.000011393733,0.000009370717,0.00007670016],"about_ca_topic_score_codex":0.00008854607,"about_ca_topic_score_gemma":0.000080367536,"teacher_disagreement_score":0.4657685,"about_ca_system_score_codex":0.000076063174,"about_ca_system_score_gemma":0.00011433635,"threshold_uncertainty_score":0.51139015},"labels":[],"label_agreement":null},{"id":"W4405046554","doi":"10.1182/blood-2024-194612","title":"Subcutaneous Mosunetuzumab Leads to High Rates of Durable Responses, Low Rates of Cytokine Release Syndrome, and Non-Inferior Exposure Compared with Intravenous Administration in Patients with Relapsed/Refractory Follicular Lymphoma: Primary Analysis of a Pivotal Phase II","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Cytokine release syndrome; Refractory (planetary science); Cytokine; Internal medicine; Lymphoma; Gastroenterology; Surgery; Immunotherapy; Cancer; Chimeric antigen receptor","score_opus":0.005541275097004713,"score_gpt":0.23355324115830206,"score_spread":0.22801196606129734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977197,0.00091602135,0.0000096541,0.000059388443,0.000017443144,0.00089087465,0.0003490025,0.000020969768,0.000016957838],"genre_scores_gemma":[0.9986651,0.00007034346,0.0005527239,0.00002126562,0.000007437285,0.000075776756,0.0005326337,0.00003268231,0.00004205174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820155,0.0000684348,0.00065245153,0.0004243019,0.00042601707,0.00022724748],"domain_scores_gemma":[0.9988366,0.00017289112,0.00024050422,0.00038438998,0.0002129504,0.0001526807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011920296,0.00028503567,0.0010565725,0.0005505435,0.00004291913,0.000017747954,0.00006711878,0.00009667799,0.00001976569],"category_scores_gemma":[0.000041010473,0.00020629932,0.000101226105,0.0011163114,0.00011185799,0.00010118977,0.00003057416,0.00006548499,7.766278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03376172,0.034934256,0.8943073,0.001262051,0.0052073887,0.0052279057,0.0011178078,0.00022258087,0.02223396,0.000017911818,0.000021888238,0.0016852099],"study_design_scores_gemma":[0.028722068,0.04270324,0.84619576,0.0011255405,0.004803434,0.00026525417,0.00008200758,0.00012734075,0.07575415,0.0000015666127,0.000007716207,0.00021193732],"about_ca_topic_score_codex":0.00038471966,"about_ca_topic_score_gemma":0.00018879295,"teacher_disagreement_score":0.053520195,"about_ca_system_score_codex":0.00014925754,"about_ca_system_score_gemma":0.00057261274,"threshold_uncertainty_score":0.8412642},"labels":[],"label_agreement":null},{"id":"W4405047616","doi":"10.1182/blood-2024-207584","title":"Clinical Approach to “Pathologically Ambiguous Follicular Lymphoma”: A Real-World Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Referral; Cohort; Incidence (geometry); Internal medicine; Pediatrics; Pathology; Family medicine","score_opus":0.044821113352813996,"score_gpt":0.3485662788225161,"score_spread":0.3037451654697021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96140206,0.00077409163,0.000034154546,0.00039897877,0.00022853786,0.0013786452,0.00001007152,0.00035484857,0.035418626],"genre_scores_gemma":[0.9929671,0.00012484448,0.0032005557,0.00073543016,0.00040494543,0.00047752573,0.0000229406,0.00003731295,0.0020292923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979059,0.00012314082,0.0004958772,0.00076491106,0.00037616352,0.0003340253],"domain_scores_gemma":[0.99888486,0.000094826486,0.00003338507,0.0005839248,0.00005101369,0.0003520152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005036279,0.00024120869,0.00055953296,0.00015249554,0.00007309807,0.00008188913,0.00012838833,0.00010053126,0.000038159807],"category_scores_gemma":[0.00008659061,0.0001612215,0.000315326,0.00050164526,0.00003902406,0.00003366316,0.00011604121,0.00009581678,0.00048781963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021684587,0.08567211,0.7849907,0.00013771797,0.0019957246,0.016038349,0.0012295652,0.0000034371412,0.00015458843,0.0017780516,0.0044376296,0.10334526],"study_design_scores_gemma":[0.007912488,0.003005957,0.97740567,0.00010891702,0.0016117404,0.0002805637,0.00019263267,0.00003649174,0.00019187947,0.000057815334,0.008982646,0.00021320953],"about_ca_topic_score_codex":0.000265362,"about_ca_topic_score_gemma":0.00003380889,"teacher_disagreement_score":0.19241494,"about_ca_system_score_codex":0.00009011069,"about_ca_system_score_gemma":0.00014586665,"threshold_uncertainty_score":0.6574422},"labels":[],"label_agreement":null},{"id":"W4405048325","doi":"10.1182/blood-2024-200265","title":"Open-Label Phase 1 Study to Evaluate the Safety of SGN-35T in Patients with Relapsed/Refractory CD30-Expressing Lymphoid Malignancies (SGN35T-001; trial in progress)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Galderma; Eisai; Regeneron Pharmaceuticals; Alexion Pharmaceuticals","keywords":"Medicine; Refractory (planetary science); Open label; Internal medicine; Oncology; Phases of clinical research; Hematologic Neoplasms; Clinical trial; Cancer; Biology","score_opus":0.033274451831716796,"score_gpt":0.3390484901438522,"score_spread":0.3057740383121354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991719,0.0015867329,4.917243e-7,0.00028675154,0.00019025913,0.0057475464,0.00004833441,0.000031633692,0.00038924583],"genre_scores_gemma":[0.9986612,0.000029963496,0.00019660131,0.00009315537,0.00006573875,0.00076683314,0.000037461657,0.00003866939,0.00011033067],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977248,0.0002177882,0.0006124095,0.0005027495,0.0006175368,0.0003247219],"domain_scores_gemma":[0.9989973,0.00017823411,0.00009496464,0.00051966705,0.00010574566,0.00010414723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007512343,0.00025989825,0.0005481548,0.00019684085,0.00006978516,0.000101552694,0.0002592049,0.000055954002,0.000043864587],"category_scores_gemma":[0.00010303456,0.00014680486,0.000043855493,0.0005410387,0.00007225581,0.00018811191,0.00020210083,0.00011941685,0.000019259767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059440896,0.18938705,0.70531267,0.00015299873,0.00071991474,0.00066183246,0.006081232,0.000007369008,0.00028558102,0.000059174017,0.0004326791,0.037458614],"study_design_scores_gemma":[0.6971803,0.020515414,0.27534744,0.0020801253,0.0009219153,0.000010925027,0.00069900154,0.000038909184,0.0020222766,0.000015963533,0.00090721535,0.00026054267],"about_ca_topic_score_codex":0.0002716258,"about_ca_topic_score_gemma":0.000106599364,"teacher_disagreement_score":0.63773936,"about_ca_system_score_codex":0.00022395013,"about_ca_system_score_gemma":0.00041511602,"threshold_uncertainty_score":0.59865284},"labels":[],"label_agreement":null},{"id":"W4405052776","doi":"10.1182/blood-2024-210718","title":"Allogeneic Hematopoietic Stem Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Oncology; Follicular lymphoma; Lymphoma; Mantle cell lymphoma; Hematopoietic stem cell transplantation; Diffuse large B-cell lymphoma; Plerixafor; Salvage therapy; Transplantation; Chemotherapy; CXCR4","score_opus":0.01444469021835099,"score_gpt":0.22761697860543728,"score_spread":0.2131722883870863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499274,0.012563277,0.00006367565,0.00076526724,0.00011109079,0.0007234372,0.00036289668,0.000018009609,0.00039958768],"genre_scores_gemma":[0.9982908,0.0002433633,0.0002755714,0.0006425375,0.000055768945,0.00032700866,0.00008408928,0.000025542176,0.000055329936],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989441,0.00002511766,0.00026915953,0.00029996855,0.00017572624,0.00028592447],"domain_scores_gemma":[0.9993787,0.00014816373,0.00003040401,0.0003108782,0.000017292115,0.0001145562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008234211,0.00017840766,0.000244398,0.00007204805,0.000040109277,0.0000269855,0.00015213093,0.00007952954,0.00005028465],"category_scores_gemma":[0.0000010276623,0.00011169045,0.00016159548,0.00011406615,0.0000466082,0.000035186524,0.00000787868,0.00006279362,0.000008625481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002500382,0.023995625,0.40449682,0.0019761282,0.0009908624,0.003688379,0.29404098,0.000008727545,0.2653353,0.00056485145,0.0006891112,0.0039631943],"study_design_scores_gemma":[0.026913263,0.0006935381,0.034689955,0.0015849657,0.0010567101,0.00020783038,0.009965292,0.0003760482,0.91598594,0.000067761524,0.007995266,0.00046343615],"about_ca_topic_score_codex":0.015328858,"about_ca_topic_score_gemma":0.0045985933,"teacher_disagreement_score":0.6506507,"about_ca_system_score_codex":0.00007538257,"about_ca_system_score_gemma":0.00026045344,"threshold_uncertainty_score":0.99122816},"labels":[],"label_agreement":null},{"id":"W4405096023","doi":"10.1182/blood-2024-203181","title":"Golseek-2: A Phase 2 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination with Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Open label; Oncology; Internal medicine; Phases of clinical research; Lymphoma; Randomized controlled trial; Clinical trial","score_opus":0.02673293755314466,"score_gpt":0.3393171476816203,"score_spread":0.31258421012847565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882049,0.0015811712,0.0000402334,0.0006294562,0.000026506168,0.009355617,0.000019781592,0.000025857184,0.00011649077],"genre_scores_gemma":[0.9972965,0.00015445735,0.00046065814,0.00011945522,0.000008101152,0.001865522,0.000015693504,0.000032452208,0.000047130008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791807,0.0003535175,0.00052904437,0.00047833193,0.00040616855,0.00031486285],"domain_scores_gemma":[0.9982549,0.0010716098,0.00008043275,0.00038438372,0.000074541465,0.00013414523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997869,0.00025802173,0.0009707779,0.00016682238,0.000050840023,0.00007709269,0.00013428114,0.000034656674,0.0000108748245],"category_scores_gemma":[0.00032147064,0.00013662278,0.000035418365,0.00062355073,0.000090980284,0.00015147313,0.000095485804,0.00007432857,0.000005746349],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5225693,0.3218743,0.071171455,0.00034939966,0.003064722,0.006848347,0.018358033,0.00033733898,0.0007406518,0.0018992153,0.00002952043,0.0527577],"study_design_scores_gemma":[0.9315233,0.0059259306,0.05620587,0.001172021,0.0014475774,0.00002649062,0.0010189499,0.0009616596,0.0014698876,0.000051211973,0.000029252384,0.00016785544],"about_ca_topic_score_codex":0.00073168933,"about_ca_topic_score_gemma":0.0011104612,"teacher_disagreement_score":0.40895396,"about_ca_system_score_codex":0.00012668225,"about_ca_system_score_gemma":0.00025105508,"threshold_uncertainty_score":0.5571315},"labels":[],"label_agreement":null},{"id":"W4405096057","doi":"10.1182/blood-2024-202516","title":"CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Randomized controlled trial; Internal medicine; Oncology","score_opus":0.010354968366270884,"score_gpt":0.26413868819023817,"score_spread":0.2537837198239673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020636,0.0031458065,0.000010881756,0.00020523272,0.00027181912,0.004808675,0.00010825875,0.00021738192,0.0010256121],"genre_scores_gemma":[0.995034,0.00043129103,0.00043007467,0.00015427578,0.00023793317,0.001806553,0.00026652368,0.00010917745,0.0015302044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968506,0.00022730106,0.00086556835,0.00083601155,0.00060849363,0.0006120391],"domain_scores_gemma":[0.9985731,0.00031606294,0.00016031261,0.0005799592,0.00011667136,0.00025385883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003876201,0.0005814079,0.0017645078,0.00038090814,0.000121089375,0.00009891612,0.00014105237,0.00021546775,0.00046161012],"category_scores_gemma":[0.00018068471,0.00032702024,0.0004098497,0.00069594034,0.0001496711,0.00015942726,0.000076432334,0.0000918473,0.00014455919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87408334,0.0627343,0.0023662061,0.00017378673,0.002206216,0.005134848,0.0009567408,0.000001941207,0.00010763804,0.00005533137,0.0004210582,0.051758576],"study_design_scores_gemma":[0.96845776,0.012156836,0.00093148265,0.0010200886,0.0033097796,0.00024440762,0.000033036053,0.0007994271,0.009271874,0.000015267431,0.0033552751,0.00040476493],"about_ca_topic_score_codex":0.0010665202,"about_ca_topic_score_gemma":0.00015838337,"teacher_disagreement_score":0.0943744,"about_ca_system_score_codex":0.0005827499,"about_ca_system_score_gemma":0.00071764976,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W4405096067","doi":"10.1182/blood-2024-207223","title":"A Comparison of the Timing of Treatment Initiation for Older Versus Younger Patients with Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Internal medicine; Oncology","score_opus":0.03317416899513719,"score_gpt":0.30665910596451434,"score_spread":0.27348493696937715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978065,0.00082567317,0.000014648884,0.00008337218,0.00011872987,0.00071205775,0.00003905557,0.000013214297,0.00038675376],"genre_scores_gemma":[0.9994207,0.000010133154,0.00030805336,0.000013313412,0.000027144231,0.00012459035,0.00005313811,0.000012352375,0.000030577525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994768,0.0000102087115,0.00016056836,0.00012256338,0.00014522282,0.000084675565],"domain_scores_gemma":[0.999595,0.00008755281,0.000064715336,0.00015910793,0.0000690432,0.000024623176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021375712,0.00008953954,0.00020317586,0.000034279306,0.000026764657,0.000006250119,0.000025641215,0.00003245114,0.000011416817],"category_scores_gemma":[0.000011856342,0.000046092715,0.00011514341,0.0000956176,0.000020767206,0.00003215229,0.000008947523,0.000008814719,0.000001677998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063697714,0.009109822,0.9640501,0.00032077936,0.0021291745,0.000007172229,0.00202493,0.000011433143,0.000326528,0.00042682013,0.0002319658,0.020724261],"study_design_scores_gemma":[0.035425074,0.0038733634,0.8477429,0.0005483348,0.003660781,0.0000030432084,0.00013315163,0.00029539023,0.107134506,0.000008777671,0.0010920546,0.00008258625],"about_ca_topic_score_codex":0.000043141594,"about_ca_topic_score_gemma":0.000007658641,"teacher_disagreement_score":0.11630721,"about_ca_system_score_codex":0.00010941583,"about_ca_system_score_gemma":0.00010081318,"threshold_uncertainty_score":0.18796064},"labels":[],"label_agreement":null},{"id":"W4405096087","doi":"10.1182/blood-2024-197902","title":"Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"Pharmacyclics; Genentech; F. Hoffmann-La Roche; Incyte; Constellation Pharmaceuticals; BeiGene; Eli Lilly and Company; AstraZeneca; MorphoSys; Celgene; Gilead Sciences; Agios Pharmaceuticals; Astellas Pharma; TG Therapeutics; Takeda Oncology; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Amgen","keywords":"Mantle cell lymphoma; Refractory (planetary science); Medicine; Safety profile; Lymphoma; Internal medicine; Oncology; Cancer research; Adverse effect; Biology","score_opus":0.005187459901947161,"score_gpt":0.21742126831108918,"score_spread":0.21223380840914202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535024,0.0013510349,0.000006764308,0.000113733724,0.000037347854,0.0009775163,0.00004779725,0.00012403402,0.0019915225],"genre_scores_gemma":[0.9974421,0.00040551426,0.0005888766,0.000047968977,0.000023388775,0.00013255182,0.00005166206,0.000045158595,0.0012627454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987512,0.000046513298,0.00020935822,0.00046984848,0.0002187858,0.0003042938],"domain_scores_gemma":[0.9994342,0.00010500631,0.000056208788,0.00025768284,0.000031992844,0.000114923154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080741695,0.0002537383,0.00033750298,0.00014140487,0.00007359061,0.000063497464,0.00004776098,0.00009793371,0.00006938465],"category_scores_gemma":[0.000006821629,0.00016369997,0.000044786106,0.00029227784,0.000046732697,0.00019529367,0.000025217503,0.00008843082,0.000015556909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036099444,0.008820885,0.9382145,0.00043423238,0.0004316685,0.0011116959,0.0005294097,0.000004458076,0.0010836704,0.000014142645,0.00020015644,0.045545273],"study_design_scores_gemma":[0.025128884,0.0018972238,0.94647217,0.0007050413,0.0003322609,0.00003881735,0.00006915946,0.00045109366,0.024136158,0.000010412169,0.0005304748,0.00022833173],"about_ca_topic_score_codex":0.00062516873,"about_ca_topic_score_gemma":0.00010989531,"teacher_disagreement_score":0.04531694,"about_ca_system_score_codex":0.00021701597,"about_ca_system_score_gemma":0.00019004573,"threshold_uncertainty_score":0.6675491},"labels":[],"label_agreement":null},{"id":"W4405107401","doi":"10.1182/blood-2024-212973","title":"Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Medicine; Minimal residual disease; Hematopoietic stem cell transplantation; Transplantation; Hematopoietic cell; Lymphoma; Internal medicine; Complete remission; Oncology; Surgery; Gastroenterology; Cancer research; Haematopoiesis; Stem cell; Chemotherapy; Leukemia; Biology","score_opus":0.02012098563730711,"score_gpt":0.27635723759576747,"score_spread":0.25623625195846034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953637,0.001242765,0.000010856667,0.00018524304,0.00013396115,0.0020273477,0.000508224,0.000033705426,0.00049420184],"genre_scores_gemma":[0.9985346,0.0002096622,0.0002082876,0.0000286094,0.000056436907,0.0002109474,0.0006663291,0.00003498647,0.000050131082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975987,0.00016210487,0.0010375541,0.0004678269,0.0004659695,0.00026781714],"domain_scores_gemma":[0.99833804,0.00081911235,0.00029652458,0.00037411108,0.000060533035,0.000111652866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031684968,0.00027187192,0.0009061529,0.00015476035,0.000046727255,0.000022792332,0.000110394096,0.00010802716,0.00010279716],"category_scores_gemma":[0.00008157303,0.00017459888,0.00019196472,0.0002607171,0.00011946157,0.00007772328,0.000031335887,0.00009264013,0.000006134816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9216839,0.025708001,0.035171583,0.0017367286,0.00037667836,0.0074183578,0.0035477595,0.00007213247,0.0024074,0.000030525985,0.00012684302,0.0017200668],"study_design_scores_gemma":[0.9012567,0.0015106668,0.034593992,0.0014668077,0.0017539904,0.00006291082,0.00014532688,0.00036016258,0.05843949,0.00012618517,0.00007967501,0.00020412868],"about_ca_topic_score_codex":0.0014646733,"about_ca_topic_score_gemma":0.00028342975,"teacher_disagreement_score":0.056032088,"about_ca_system_score_codex":0.000102182734,"about_ca_system_score_gemma":0.00034225686,"threshold_uncertainty_score":0.7119936},"labels":[],"label_agreement":null},{"id":"W4405107409","doi":"10.1182/blood-2024-212970","title":"Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Lymphoma; Clinical trial; Multiple myeloma; Biology","score_opus":0.02853263491178453,"score_gpt":0.3116804466416099,"score_spread":0.28314781172982534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784965,0.007904722,0.000027421886,0.00069759425,0.00026077675,0.0019801245,0.0008119501,0.00017586719,0.00029191395],"genre_scores_gemma":[0.99626255,0.00021849627,0.0010921522,0.00016578013,0.00040100864,0.0005257145,0.00032577445,0.000058204718,0.00095034426],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804986,0.000056940826,0.0004841772,0.0007711308,0.00031610212,0.00032178476],"domain_scores_gemma":[0.9984646,0.0006465389,0.00008004917,0.00051267893,0.00006945474,0.00022670797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002590441,0.00030917773,0.00061440817,0.00013185706,0.00012469679,0.00011315387,0.00008199651,0.00013440762,0.00003925469],"category_scores_gemma":[0.0002951046,0.00021070852,0.00018727824,0.00018220615,0.000044989152,0.00011743492,0.00005640775,0.00007369474,0.000053644482],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11759083,0.3771654,0.011457626,0.0015197555,0.027154187,0.073288694,0.028541774,0.0000027971919,0.010525257,0.0006162856,0.048515376,0.30362204],"study_design_scores_gemma":[0.8891872,0.012598484,0.0125034675,0.0009626861,0.009532977,0.00043259986,0.0019782002,0.0005406212,0.016862113,0.0002026581,0.05459074,0.0006082607],"about_ca_topic_score_codex":0.0004183304,"about_ca_topic_score_gemma":0.000081343496,"teacher_disagreement_score":0.7715964,"about_ca_system_score_codex":0.00020192,"about_ca_system_score_gemma":0.0003809215,"threshold_uncertainty_score":0.8592444},"labels":[],"label_agreement":null},{"id":"W4405126143","doi":"10.1182/blood-2024-200290","title":"High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; Pharmacyclics; Swedish Orphan Biovitrum; F. Hoffmann-La Roche; Incyte; BeiGene; Regeneron Pharmaceuticals; Gilead Sciences; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline; Amgen","keywords":"Bendamustine; Mantle cell lymphoma; Medicine; Internal medicine; Rituximab; Oncology; Phases of clinical research; Lymphoma; Clinical trial","score_opus":0.007631377048258434,"score_gpt":0.2546233731632256,"score_spread":0.24699199611496714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759555,0.0009374748,0.000002775269,0.00008230878,0.0000482636,0.0008022585,0.00027935058,0.000038922506,0.0002130747],"genre_scores_gemma":[0.99904865,0.00025680085,0.00020794109,0.000020061812,0.000038496197,0.00004114118,0.00029546808,0.00002360358,0.000067838984],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985438,0.000115489835,0.00045989492,0.00038729727,0.0002770761,0.00021646821],"domain_scores_gemma":[0.99909043,0.0000994413,0.0001714329,0.00046838913,0.000066679706,0.00010364378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020396129,0.00021335714,0.0007162765,0.00031470307,0.000035542023,0.000022729211,0.000096780685,0.00010303693,0.000075547396],"category_scores_gemma":[0.000022914935,0.000121749275,0.00015334402,0.001366021,0.00009874687,0.000064589694,0.000041796437,0.000074043186,0.0000023241216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042761516,0.14083709,0.7465192,0.0007271971,0.015533099,0.001382349,0.004231038,0.00008590054,0.0058923787,0.00043947893,0.00028058843,0.04131015],"study_design_scores_gemma":[0.6040331,0.0071342257,0.2212021,0.00037527573,0.039050397,0.000051586678,0.00026416575,0.0018529227,0.12552968,0.00002563762,0.00020308391,0.00027782586],"about_ca_topic_score_codex":0.0020840194,"about_ca_topic_score_gemma":0.00055918976,"teacher_disagreement_score":0.5612716,"about_ca_system_score_codex":0.000049404163,"about_ca_system_score_gemma":0.00016484411,"threshold_uncertainty_score":0.49647912},"labels":[],"label_agreement":null},{"id":"W4405276065","doi":"10.1200/jco-24-01278","title":"Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Dacarbazine; Medicine; Vinblastine; Nivolumab; Hodgkin lymphoma; Brentuximab vedotin; Oncology; Lymphoma; Doxorubicin; Bleomycin; Internal medicine; Chemotherapy; Cancer; Immunotherapy","score_opus":0.054305279392703645,"score_gpt":0.43882162680534387,"score_spread":0.38451634741264024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405276065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851882,0.0039464533,0.000038255308,0.00687729,0.0016056125,0.00075180095,0.000010776325,0.000017639004,0.001563989],"genre_scores_gemma":[0.99202263,0.003485375,0.001207844,0.001009866,0.0018632475,0.00002664464,0.000011401174,0.0000341552,0.00033882653],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99549586,0.00031317418,0.0029805407,0.00034175414,0.00057208637,0.00029658386],"domain_scores_gemma":[0.9957872,0.0020721778,0.0011383747,0.0002682821,0.00038114592,0.00035283528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017859758,0.00026051688,0.0023171545,0.00030489525,0.000029515479,0.000011269651,0.00016653314,0.00041386666,0.0003659459],"category_scores_gemma":[0.0010509922,0.00014949421,0.00059632823,0.00032952506,0.00021247017,0.00012423264,0.00004965547,0.00046371907,0.000017308792],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39667448,0.039148252,0.0037669835,0.00005348727,0.0009429597,0.005632947,0.00043774187,0.000010258733,0.00008754527,0.00008033823,0.0051228194,0.5480422],"study_design_scores_gemma":[0.648594,0.27869388,0.03650437,0.0012457843,0.00050921954,0.0007904771,0.0001350464,0.0005298911,0.00057501503,0.000069328824,0.032214805,0.00013814241],"about_ca_topic_score_codex":0.00020314346,"about_ca_topic_score_gemma":0.00013752733,"teacher_disagreement_score":0.547904,"about_ca_system_score_codex":0.0004404881,"about_ca_system_score_gemma":0.0039113117,"threshold_uncertainty_score":0.69384986},"labels":[],"label_agreement":null},{"id":"W4405500642","doi":"10.51731/cjht.2024.1047","title":"Brentuximab Vedotin (Adcetris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Reimbursement; Dacarbazine; Vinblastine; Medicine; Hodgkin lymphoma; Doxorubicin; Oncology; Internal medicine; Pharmacology; Lymphoma; Chemotherapy; Political science","score_opus":0.0252575892802914,"score_gpt":0.30406359354986845,"score_spread":0.278806004269577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405500642","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22696514,0.598601,0.00007596877,0.17123884,0.001233143,0.0002945966,0.000027466687,0.00027120652,0.00129262],"genre_scores_gemma":[0.9968226,0.002112341,0.00041968506,0.00048638115,0.00002425214,0.000005257044,0.0000025929533,0.000012987275,0.00011392256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989655,0.00001786092,0.000405285,0.000118714685,0.00013773802,0.00035489566],"domain_scores_gemma":[0.9994528,0.0000533339,0.00010384657,0.0001752896,0.000080014725,0.00013466632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003012521,0.000106972824,0.00033301336,0.00076279946,0.00010170843,0.000050763418,0.00012192081,0.00010173377,0.00005369751],"category_scores_gemma":[0.0002140897,0.00007616156,0.000117490476,0.00038019856,0.0001028453,0.00007070617,0.000009612131,0.00026459762,0.00005024188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067832552,0.00003640761,0.011917964,0.00017456815,0.00009924311,0.0021059432,0.00012767325,9.0857e-7,0.000009256744,0.0025108384,0.03330064,0.9497098],"study_design_scores_gemma":[0.0009849928,0.0011694074,0.033796124,0.0014267659,0.000068176785,0.0030592731,0.0011879379,0.000019377621,0.0010669803,0.0020799069,0.9550322,0.00010881214],"about_ca_topic_score_codex":0.002558972,"about_ca_topic_score_gemma":0.0008220603,"teacher_disagreement_score":0.94960093,"about_ca_system_score_codex":0.0008975765,"about_ca_system_score_gemma":0.0045413957,"threshold_uncertainty_score":0.8056241},"labels":[],"label_agreement":null},{"id":"W4405638522","doi":"10.1101/2024.12.13.628396","title":"The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B Cell Lymphoma","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Cancer Research Society; Leukemia and Lymphoma Society","keywords":"Cancer research; Refractory (planetary science); Mutant; CCR4; Medicine; Internal medicine; Chemokine; Chemistry; Materials science; Receptor; Chemokine receptor","score_opus":0.011995760705631015,"score_gpt":0.23519995034539962,"score_spread":0.2232041896397686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405638522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94336784,0.050690815,0.00008379324,0.0019698774,0.00058646576,0.0017442831,0.0013820024,0.00015764212,0.000017279419],"genre_scores_gemma":[0.9899407,0.0067551513,0.0014124556,0.00071514206,0.00020697774,0.00071328174,0.0000026218038,0.00021461914,0.00003904094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962168,0.00013310816,0.0008112755,0.0014106864,0.00048047348,0.000947669],"domain_scores_gemma":[0.99733317,0.0007560299,0.0002209592,0.0011791915,0.00013523245,0.00037539878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063056505,0.0007472774,0.00080500415,0.0002148175,0.00031217485,0.00024496228,0.00027423727,0.00056238146,0.000015414786],"category_scores_gemma":[0.0001515898,0.000589231,0.00026532877,0.00025525186,0.00029847136,0.000048763326,0.00041659272,0.00058074755,0.000051700288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058205216,0.0357622,0.055207636,0.014336748,0.003302428,0.00494397,0.0013454045,0.000014080523,0.8654813,0.0095445765,0.0040829787,0.00015811296],"study_design_scores_gemma":[0.06653542,0.0015309671,0.27938172,0.0090088425,0.0043807793,0.0000012401474,0.00031551145,0.011301204,0.45523787,0.00044296464,0.16712809,0.004735375],"about_ca_topic_score_codex":0.000041225492,"about_ca_topic_score_gemma":0.000018499086,"teacher_disagreement_score":0.41024348,"about_ca_system_score_codex":0.0013108223,"about_ca_system_score_gemma":0.0005790888,"threshold_uncertainty_score":0.9996559},"labels":[],"label_agreement":null},{"id":"W4405728279","doi":"10.1177/12034754241308238","title":"Small Lymphocytic Lymphoma","year":2024,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lymphoma; Dermatology; Pathology","score_opus":0.041740433528341274,"score_gpt":0.27393459510831086,"score_spread":0.23219416157996958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405728279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9322456,0.054856885,0.00003319415,0.008500936,0.001176402,0.00009095754,0.0000020194964,0.000036864054,0.003057141],"genre_scores_gemma":[0.9837451,0.012272039,0.0001287801,0.0018567607,0.0011812432,0.0000022938434,0.0000043547443,0.00002386911,0.00078556914],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99857366,0.00003526496,0.00064255274,0.0001597928,0.00036906253,0.00021969156],"domain_scores_gemma":[0.99796396,0.0012928502,0.00013467699,0.00013584844,0.00013729202,0.00033534723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041021296,0.00018083803,0.0007367678,0.00043778535,0.00004307856,0.000030268919,0.000039808754,0.000079720165,0.00017642963],"category_scores_gemma":[0.0002920396,0.00010582856,0.00024713445,0.00021815853,0.000115126684,0.00006125834,0.000013609801,0.00008455754,0.000020393232],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007663388,0.00036390978,0.02573167,0.0009302777,0.0012935504,0.2077216,0.0011642748,0.0000036312724,0.0011305931,0.0005595431,0.14298269,0.6173519],"study_design_scores_gemma":[0.0031324918,0.0019902172,0.008627542,0.0067961947,0.0018410971,0.53723204,0.0005982469,0.000453635,0.000805252,0.00076955656,0.43748227,0.0002714285],"about_ca_topic_score_codex":0.00004469136,"about_ca_topic_score_gemma":0.000002516677,"teacher_disagreement_score":0.6170805,"about_ca_system_score_codex":0.00031335268,"about_ca_system_score_gemma":0.000800373,"threshold_uncertainty_score":0.43155637},"labels":[],"label_agreement":null},{"id":"W4405989572","doi":"10.1001/jamaoncol.2024.5627","title":"Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Brentuximab vedotin; Bendamustine; Internal medicine; Nivolumab; Oncology; Young adult; Cohort; Pediatrics; Hodgkin lymphoma; Cancer; Lymphoma; Rituximab","score_opus":0.008159520686991968,"score_gpt":0.2401589212079284,"score_spread":0.23199940052093643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61526245,0.003326127,0.000004550674,0.36755872,0.0006002194,0.0028000849,0.0003242449,0.000083491046,0.010040105],"genre_scores_gemma":[0.60180044,0.002951472,0.0006732302,0.38899532,0.0014378377,0.0008157123,0.0023091608,0.00008160596,0.00093520456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970163,0.00032404225,0.00069958635,0.000980858,0.00030613012,0.0006730993],"domain_scores_gemma":[0.99878013,0.00017314813,0.00018077056,0.0007180588,0.000044025128,0.00010389102],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00024169213,0.0005311778,0.0013701894,0.0007330934,0.000039398197,0.00002587292,0.0003079472,0.0023292883,0.000022225471],"category_scores_gemma":[0.000085236396,0.00046419897,0.0001715657,0.00034321364,0.00013100375,0.000045191788,0.00012995466,0.0011247786,0.000013948599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090026954,0.0015386273,0.61087936,0.0006290045,0.00017132792,0.0046012737,0.0004241737,5.180689e-7,0.0000016041201,0.000021862237,0.34066474,0.040167216],"study_design_scores_gemma":[0.047140118,0.00066344684,0.8827585,0.002443523,0.0003389298,0.0014367538,0.000041462506,0.00004398361,0.000014762127,0.00004806324,0.06472673,0.00034372092],"about_ca_topic_score_codex":0.0026189021,"about_ca_topic_score_gemma":0.00077895797,"teacher_disagreement_score":0.275938,"about_ca_system_score_codex":0.0013673665,"about_ca_system_score_gemma":0.0005945488,"threshold_uncertainty_score":0.99978095},"labels":[],"label_agreement":null},{"id":"W4405989592","doi":"10.1001/jamaoncol.2024.5648","title":"Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Salvage therapy; Hodgkin lymphoma; Lymphoma; Radiation therapy; Chemotherapy; Oncology; Clinical trial; Internal medicine; Surgery","score_opus":0.015207195881695454,"score_gpt":0.2821397839153472,"score_spread":0.2669325880336518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989592","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04027279,0.0061916243,0.00013918903,0.9323642,0.0031766216,0.0041813646,0.0026376515,0.00029145592,0.010745082],"genre_scores_gemma":[0.006812207,0.025087249,0.0022688687,0.9344185,0.015835414,0.0028952616,0.0038930601,0.0001778129,0.008611624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652684,0.00033839222,0.00079664116,0.0010329594,0.0004198698,0.0008853292],"domain_scores_gemma":[0.99505776,0.0027945675,0.0004931595,0.0013263223,0.00017208762,0.00015610713],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003727212,0.0007243455,0.0017078925,0.0005440645,0.0001806858,0.000047406815,0.0005556561,0.0031887968,0.00029054203],"category_scores_gemma":[0.00026091057,0.00056950585,0.0009162277,0.0002746241,0.000102922335,0.000058916867,0.00007522925,0.00089644676,0.0001267693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015503212,0.0011295,0.01002516,0.0005763691,0.00086016883,0.0038246352,0.00017964917,5.181908e-7,0.00000857098,0.000045905144,0.8792785,0.10252071],"study_design_scores_gemma":[0.042919934,0.0037592524,0.025993478,0.00016078082,0.002359956,0.00020950052,0.000011178006,0.000015007265,0.00020965094,0.0005007689,0.9234176,0.00044284546],"about_ca_topic_score_codex":0.00026599097,"about_ca_topic_score_gemma":0.00004876422,"teacher_disagreement_score":0.10207787,"about_ca_system_score_codex":0.0012314991,"about_ca_system_score_gemma":0.0018755859,"threshold_uncertainty_score":0.99967563},"labels":[],"label_agreement":null},{"id":"W4406022048","doi":"10.1007/978-3-031-67722-9_5","title":"Follicular Lymphoma","year":2024,"lang":"en","type":"book-chapter","venue":"Practical guides in radiation oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Pathology","score_opus":0.04476210486563933,"score_gpt":0.38736197825819607,"score_spread":0.34259987339255676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406022048","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019860754,0.005900284,0.000017041439,0.03157775,0.00092005404,0.0006768618,0.000020223755,0.00009796745,0.9605912],"genre_scores_gemma":[0.042778686,0.014692311,0.0049150176,0.011895577,0.002040617,0.00044856564,0.00058171473,0.00022795683,0.92241955],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981429,0.000039144394,0.0006708848,0.0005475729,0.000327762,0.0002717347],"domain_scores_gemma":[0.99826115,0.0008920334,0.00020795691,0.00035413177,0.00008716266,0.00019755168],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003241639,0.00032070186,0.0007405917,0.00033481757,0.00003160777,0.000030620322,0.000060195827,0.0008430464,0.0016673446],"category_scores_gemma":[0.0005342029,0.0002736776,0.00025597314,0.00006352207,0.00010743578,0.000080097656,0.00007350431,0.0003017823,0.0029208027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021347051,0.00061380275,0.0004890726,0.00010146029,0.00055407744,0.009032004,0.00006332868,0.0000037965808,0.000006099732,0.7151741,0.0811382,0.1926106],"study_design_scores_gemma":[0.0023813818,0.00071632385,0.0013502671,0.00018614244,0.0007472527,0.0010603415,0.000007977299,0.0002040746,0.00004803798,0.023018422,0.9700667,0.00021307546],"about_ca_topic_score_codex":0.00003582559,"about_ca_topic_score_gemma":0.000025124153,"teacher_disagreement_score":0.8889285,"about_ca_system_score_codex":0.0028260322,"about_ca_system_score_gemma":0.0010243462,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W4406044421","doi":"10.3389/fphar.2024.1426772","title":"Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review","year":2025,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"International Network of Agencies for Health Technology Assessment; National Natural Science Foundation of China","keywords":"Obinutuzumab; Follicular lymphoma; Medicine; Lymphoma; Oncology; Intensive care medicine; Rituximab; Internal medicine","score_opus":0.01574002584105422,"score_gpt":0.32438097165096236,"score_spread":0.30864094580990814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406044421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039324767,0.98822516,0.00002038288,0.000025458525,0.0006928806,0.01019472,0.000098346274,0.000014608799,0.00033522223],"genre_scores_gemma":[0.00019395998,0.99716556,0.00030716544,0.00019642993,0.00002185579,0.0015851427,0.00045862794,0.000035321817,0.000035931334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969681,0.00095005456,0.00086194224,0.0006434957,0.00020437577,0.00037206514],"domain_scores_gemma":[0.99860233,0.0005367041,0.0003532505,0.00030741259,0.000083539286,0.00011674576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051082636,0.00051708304,0.004409792,0.00054868805,0.00002631004,0.0000036397637,0.0001576038,0.00029954634,0.000036904396],"category_scores_gemma":[0.000075180804,0.00036830545,0.0002919367,0.0008146758,0.00015415828,0.00003997522,0.00011018703,0.00020262791,0.0000022917436],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015130526,0.0014524236,0.011199867,0.11708004,0.0011193589,0.00021163248,0.0000114936065,0.0000012351115,3.6198102e-8,0.0000083827,0.0039005252,0.86350197],"study_design_scores_gemma":[0.03500989,0.0006837902,0.022299796,0.14704707,0.0065550716,0.000022579126,0.0000026584812,0.000003430209,0.000005145169,0.000003101886,0.7880608,0.000306653],"about_ca_topic_score_codex":0.00003476944,"about_ca_topic_score_gemma":0.0000020673008,"teacher_disagreement_score":0.8631953,"about_ca_system_score_codex":0.0023225755,"about_ca_system_score_gemma":0.0012253894,"threshold_uncertainty_score":0.9998769},"labels":[],"label_agreement":null},{"id":"W4406091184","doi":"10.58931/cht.2024.3358","title":"Front-line Treatment of Older Patients with Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Front line; Hodgkin lymphoma; Medicine; Lymphoma; Oncology; Internal medicine; History; Archaeology","score_opus":0.009216902251404107,"score_gpt":0.23852874471188265,"score_spread":0.22931184246047853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406091184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732847,0.005161038,0.000010651284,0.0019567413,0.0002697971,0.0005793543,0.00013910896,0.000049339662,0.004505521],"genre_scores_gemma":[0.9976329,0.000073898795,0.0002620476,0.000323735,0.00004340336,0.00010877733,0.00018702133,0.000030382516,0.001337809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895895,0.000021411568,0.00022597524,0.0003186507,0.00011937953,0.0003556164],"domain_scores_gemma":[0.99907255,0.00007105223,0.000035423334,0.0003138773,0.00007148151,0.00043564086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024061539,0.00020763902,0.0004738585,0.00025285047,0.000044756078,0.000010815145,0.000045380006,0.0001281227,0.00087111327],"category_scores_gemma":[0.000011210937,0.00013617621,0.00010240398,0.00013474813,0.00009055252,0.000036287158,0.00000575921,0.000023695038,0.00025515445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001008289,0.0010475714,0.9228743,0.00015622424,0.0008638325,0.0026622666,0.0007618843,0.0000014358296,0.000004201791,0.0033227932,0.010591913,0.05761276],"study_design_scores_gemma":[0.01034661,0.0031701347,0.8620602,0.0006093918,0.00079936447,0.00056952663,0.00008493541,0.000087919405,0.004932631,0.00008952895,0.11693315,0.00031664112],"about_ca_topic_score_codex":0.022969248,"about_ca_topic_score_gemma":0.04466843,"teacher_disagreement_score":0.106341235,"about_ca_system_score_codex":0.0007586776,"about_ca_system_score_gemma":0.00092347054,"threshold_uncertainty_score":0.9835369},"labels":[],"label_agreement":null},{"id":"W4406091245","doi":"10.58931/cht.2024.3356","title":"Relapsed or Refractory Mantle Cell Lymphoma: Available and Emerging Therapies","year":2024,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Refractory (planetary science); Mantle (geology); Medicine; Cancer research; Lymphoma; Oncology; Geology; Internal medicine; Geochemistry; Astrobiology; Biology","score_opus":0.015324093857137127,"score_gpt":0.24940447350731826,"score_spread":0.23408037965018114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406091245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8588983,0.0794838,0.0000030121453,0.009533832,0.00074810704,0.0004086919,0.00003992724,0.00016486109,0.050719474],"genre_scores_gemma":[0.9743509,0.0013467134,0.0002231891,0.0012968541,0.000063204294,0.00005931773,0.000025111143,0.000035350236,0.02259933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894285,0.000029856708,0.00018542616,0.00035916868,0.000081092956,0.00040157733],"domain_scores_gemma":[0.9991221,0.00014483147,0.000023846102,0.00026230805,0.000026715295,0.0004202033],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008848512,0.00017740413,0.0003201258,0.00024814633,0.00012922018,0.00003778807,0.000051874817,0.00016187127,0.0023533755],"category_scores_gemma":[0.00002804042,0.00012871421,0.000059041882,0.00015856567,0.00009071942,0.00006959127,0.000016281667,0.000074795695,0.00085178635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018486904,0.00050914864,0.09987985,0.0012600464,0.00083826337,0.027607257,0.003763683,3.2062002e-7,0.00075416337,0.015961926,0.80372643,0.045514036],"study_design_scores_gemma":[0.002272991,0.0002548366,0.007203358,0.00027646005,0.00018684055,0.0022210672,0.00041426992,0.00010269837,0.002840376,0.0001709769,0.98383176,0.00022438254],"about_ca_topic_score_codex":0.012674903,"about_ca_topic_score_gemma":0.022010703,"teacher_disagreement_score":0.18010531,"about_ca_system_score_codex":0.00032406306,"about_ca_system_score_gemma":0.0009564366,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null},{"id":"W4406119971","doi":"10.1200/jco-24-02242","title":"Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Seagen; Pfizer","keywords":"Medicine; Placebo; Internal medicine; Hazard ratio; Lenalidomide; Diffuse large B-cell lymphoma; Clinical endpoint; Gastroenterology; Brentuximab vedotin; Rituximab; Surgery; Oncology; Confidence interval; Lymphoma; Clinical trial; Multiple myeloma; Pathology; CD30","score_opus":0.062473665567266086,"score_gpt":0.4445531832436627,"score_spread":0.38207951767639664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406119971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96814996,0.00088747055,0.00071062014,0.017971138,0.0026199438,0.00044145322,0.000008608251,0.000013959093,0.009196868],"genre_scores_gemma":[0.9902319,0.0005515416,0.0021909825,0.004724304,0.0003659564,0.000019417736,0.000011091288,0.000010960183,0.001893882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974301,0.00019781374,0.0017766167,0.00016920049,0.00020773211,0.00021857207],"domain_scores_gemma":[0.9950046,0.0030884605,0.0010601681,0.0001747535,0.00046713324,0.00020491387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018270906,0.00012165707,0.001165217,0.0001428991,0.000059549693,0.0000106379985,0.000115945266,0.00033946737,0.000031085016],"category_scores_gemma":[0.0025363695,0.00008503222,0.00067722506,0.0001225794,0.000064426175,0.00006309868,0.00003953676,0.00019217536,0.000018530842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010955479,0.19998656,0.17933436,0.00017267236,0.0011006019,0.00058493594,0.00010052015,0.0000011326174,0.00013553786,0.009851209,0.119702265,0.47807473],"study_design_scores_gemma":[0.2467901,0.013718449,0.33944827,0.00015061628,0.0010039898,0.00006789897,0.00007422838,0.0002442455,0.00064137735,0.001844853,0.39593598,0.00007999503],"about_ca_topic_score_codex":0.0000056003355,"about_ca_topic_score_gemma":0.000009094696,"teacher_disagreement_score":0.47799474,"about_ca_system_score_codex":0.0003582573,"about_ca_system_score_gemma":0.0015865333,"threshold_uncertainty_score":0.34675133},"labels":[],"label_agreement":null},{"id":"W4406158641","doi":"10.1182/bloodadvances.2024014689","title":"The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Identification (biology); Stage (stratigraphy); Hodgkin lymphoma; Lymphoma; Computer science; Risk model; Oncology; Internal medicine; Computational biology; Medicine; Risk analysis (engineering); Biology","score_opus":0.008848177751884546,"score_gpt":0.2788198384813748,"score_spread":0.26997166072949025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406158641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928517,0.005799231,0.00044151273,0.000100079196,0.00006373779,0.00038498922,0.00018929211,0.000018026194,0.00015148244],"genre_scores_gemma":[0.99040794,0.007768635,0.0015028542,0.00001364401,0.00001838409,0.000066667424,0.000091597365,0.0000059748363,0.00012429834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99906194,0.000042858606,0.0004365765,0.0002082724,0.00015370782,0.00009666941],"domain_scores_gemma":[0.99926144,0.00013639733,0.00024191957,0.00024975155,0.00008679996,0.000023714556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019804928,0.00009635687,0.00020542488,0.0000985167,0.00006567361,0.0000093675535,0.000052701165,0.000043465083,8.490843e-7],"category_scores_gemma":[0.00016363242,0.00006823761,0.00003689701,0.00019907198,0.00007270678,0.00024187531,0.000019111798,0.00003084514,1.6807428e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051089743,0.0028010905,0.44404286,0.00019560158,0.000098150434,0.000003230229,0.00039122652,0.004990216,0.0071341223,0.0039199064,0.0000052215837,0.5359075],"study_design_scores_gemma":[0.004859275,0.00025633452,0.92175424,0.00018740195,0.0002644819,0.000002695579,0.00071206276,0.026312366,0.043105334,0.0023138751,0.00017543533,0.000056493005],"about_ca_topic_score_codex":0.00007589696,"about_ca_topic_score_gemma":0.00029615298,"teacher_disagreement_score":0.535851,"about_ca_system_score_codex":0.00004498637,"about_ca_system_score_gemma":0.00006286514,"threshold_uncertainty_score":0.2782649},"labels":[],"label_agreement":null},{"id":"W4406165921","doi":"10.1016/j.humpath.2025.105715","title":"Indolent clonal lymphoid disorders","year":2025,"lang":"en","type":"review","venue":"Human Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Lymphoma; Lymphoid hyperplasia; Disease; Somatic evolution in cancer; Hematopathology; Pathology; Medicine; Lymphoproliferative disorders; Lymphatic system; Immunology; Biology; Cancer; Internal medicine; Cytogenetics; Genetics","score_opus":0.03812767733117936,"score_gpt":0.38420060480950263,"score_spread":0.3460729274783233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406165921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010060662,0.97771347,0.0000029886473,0.0000757645,0.00038541193,0.0009838836,0.00006345781,0.0000767218,0.020597726],"genre_scores_gemma":[0.00011860988,0.9939723,0.00006735347,0.00032934494,0.00020820517,0.000684972,0.00086015847,0.000038738246,0.0037202886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817073,0.00016154934,0.00054295367,0.0006046145,0.0001597541,0.00036037204],"domain_scores_gemma":[0.99892026,0.0001493214,0.00019625243,0.000589523,0.00002957061,0.00011506117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001089535,0.0004598808,0.0020439394,0.00033128366,0.00011198225,0.000012749972,0.00015520806,0.00046793875,0.00035504546],"category_scores_gemma":[0.000039750328,0.00033777763,0.000782732,0.00016905839,0.00012824245,0.000014014535,0.00014190398,0.00017441639,0.00026849026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006301097,0.00066911016,0.00087866804,0.011017425,0.00027117302,0.0009184475,0.000038232858,2.0752779e-8,1.6545111e-7,0.0024275973,0.004796953,0.9789759],"study_design_scores_gemma":[0.0014046667,0.00030737213,0.0007918938,0.00839092,0.002218004,0.0009037841,0.0000048452766,5.582993e-8,6.666157e-7,0.00018227084,0.98556596,0.00022957106],"about_ca_topic_score_codex":0.000013523815,"about_ca_topic_score_gemma":0.000029284885,"teacher_disagreement_score":0.980769,"about_ca_system_score_codex":0.00037466656,"about_ca_system_score_gemma":0.0005489621,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W4406415128","doi":"10.1016/s1541-9800(11)70466-5","title":"10.1016/s1541-9800(11)70466-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Belimumab; Medicine; Business; Immunology; Antibody; B-cell activating factor","score_opus":0.006167521874476419,"score_gpt":0.1907808129486419,"score_spread":0.1846132910741655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406415128","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011255367,0.00018843984,8.300964e-8,0.0013862896,0.000001690812,0.00031968224,0.000014808582,0.000118804805,0.98671484],"genre_scores_gemma":[0.0030296284,0.0000014801668,0.00015170404,0.00021420915,0.00017532022,0.00006538218,0.00004028213,0.000025069085,0.99629694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911106,0.000017336652,0.0001629897,0.00024415043,0.00020339637,0.0002610924],"domain_scores_gemma":[0.9992924,0.000051399336,0.000019408753,0.00035030706,0.00003556797,0.000250918],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059986618,0.00015409559,0.00024305675,0.000058065874,0.00005476483,0.000020743677,0.00007408094,0.0000607435,0.99774706],"category_scores_gemma":[0.000024269148,0.0001224124,0.00009727565,0.0001424111,0.000023674997,0.0000399965,0.000021982214,0.00004269338,0.9963932],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010051558,0.0003421429,0.000014165146,0.000006974217,0.000047718662,0.00007602832,0.000016167507,0.000003976482,0.000015134938,0.0000011307978,0.5020323,0.49734378],"study_design_scores_gemma":[0.0015535683,0.00043509764,0.0023560042,0.00005100032,0.0001116301,0.000057170542,0.0000011464117,0.0000296954,0.000497546,0.0000028050877,0.99477583,0.00012849773],"about_ca_topic_score_codex":0.00007629987,"about_ca_topic_score_gemma":4.6123537e-7,"teacher_disagreement_score":0.49721527,"about_ca_system_score_codex":0.00012554457,"about_ca_system_score_gemma":0.00005140625,"threshold_uncertainty_score":0.49918327},"labels":[],"label_agreement":null},{"id":"W4406447700","doi":"10.1016/j.yonc.2013.05.021","title":"10.1016/j.yonc.2013.05.021","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine; Association (psychology)","score_opus":0.006823570424036658,"score_gpt":0.19518450783815686,"score_spread":0.1883609374141202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406447700","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007177313,0.00027795136,7.196589e-8,0.0021038677,0.0000018378137,0.00028966693,0.00001285204,0.000095943986,0.9900405],"genre_scores_gemma":[0.0017199822,0.000002584439,0.00013099176,0.0002494883,0.00017552788,0.000055774817,0.000039187507,0.000022275846,0.9976042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991991,0.000015482896,0.00014567822,0.00022074259,0.0001816776,0.00023731761],"domain_scores_gemma":[0.99935627,0.000035884703,0.000017932167,0.00032032692,0.000035092504,0.00023448268],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050033676,0.00013981355,0.00022647572,0.000049151957,0.00004816922,0.00001905789,0.00006358586,0.000054553962,0.99717206],"category_scores_gemma":[0.000013815976,0.000109922315,0.000088170775,0.000121654295,0.000021279984,0.00003990753,0.000019605191,0.00004335498,0.99641496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081580845,0.00025244558,0.0000040847576,0.0000046895016,0.00004487915,0.00006814418,0.000011436144,0.0000028376696,0.00001302829,6.948362e-7,0.49113616,0.50838],"study_design_scores_gemma":[0.0014396587,0.0005265562,0.0013483699,0.000048244932,0.00010142204,0.000063287465,8.550779e-7,0.000029583869,0.00044847818,0.0000021884064,0.99587524,0.00011608675],"about_ca_topic_score_codex":0.000100999256,"about_ca_topic_score_gemma":3.4490415e-7,"teacher_disagreement_score":0.50826395,"about_ca_system_score_codex":0.00009801463,"about_ca_system_score_gemma":0.000044141958,"threshold_uncertainty_score":0.4482502},"labels":[],"label_agreement":null},{"id":"W4406464796","doi":"10.1016/j.yoph.2013.02.009","title":"10.1016/j.yoph.2013.02.009","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunohistochemistry; Lymphoma; Orbit (dynamics); Pathology","score_opus":0.006168058956045263,"score_gpt":0.1907965025527445,"score_spread":0.18462844359669922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406464796","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01032189,0.0002872553,4.9982173e-8,0.0019717792,0.0000016184674,0.00030177904,0.000012567795,0.0001067661,0.9869963],"genre_scores_gemma":[0.0032316006,0.0000028826853,0.000116696945,0.00023077584,0.00017307811,0.000032059,0.00003470906,0.000022073504,0.9961561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918926,0.000015728834,0.00015003783,0.0002230388,0.00018283191,0.00023910082],"domain_scores_gemma":[0.9993536,0.000034352448,0.000017855871,0.00032233546,0.000034311815,0.00023756328],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005289814,0.00014172886,0.0002252179,0.000051649913,0.00004873514,0.000018648278,0.00006682694,0.00005606248,0.9974136],"category_scores_gemma":[0.0000144552605,0.00011123713,0.00008814448,0.0001200137,0.000019864421,0.000039407998,0.000019014644,0.000043382646,0.99710983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010280892,0.0002804823,0.0000049952687,0.0000050473623,0.000045132074,0.00005664739,0.000011281349,0.000005625469,0.0000141366645,5.8725055e-7,0.4684817,0.53099155],"study_design_scores_gemma":[0.0013707224,0.00055253285,0.0016120628,0.00004530466,0.000097305296,0.000051009225,7.908659e-7,0.00004045469,0.00040180414,0.0000027505084,0.9957083,0.00011699992],"about_ca_topic_score_codex":0.00009746411,"about_ca_topic_score_gemma":2.6285744e-7,"teacher_disagreement_score":0.53087455,"about_ca_system_score_codex":0.0000972016,"about_ca_system_score_gemma":0.000041608644,"threshold_uncertainty_score":0.45361185},"labels":[],"label_agreement":null},{"id":"W4406468488","doi":"10.4212/cjhp.3614","title":"Multiple Successful Desensitizations to Brentuximab Vedotin in the Setting of Relapsed Peripheral T-Cell Lymphoma: Case Report","year":2025,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Brentuximab vedotin; Peripheral T-cell lymphoma; Oncology; Medicine; Lymphoma; Internal medicine; Hodgkin lymphoma; T cell; Immunology","score_opus":0.011104167587915726,"score_gpt":0.28205089270981365,"score_spread":0.27094672512189794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406468488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736484,0.000660302,0.000013014972,0.019587148,0.00040969133,0.00045866007,0.000025808326,0.0000036239533,0.0014768882],"genre_scores_gemma":[0.99862653,0.000015098278,0.0001432367,0.0009957418,0.000085524945,0.000012157079,0.000009152371,0.000009938041,0.000102638776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876124,0.00010842086,0.00054511026,0.00012122925,0.00020306882,0.0002609052],"domain_scores_gemma":[0.99879104,0.0001998368,0.00023565578,0.0002465983,0.00027455742,0.0002522917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053133385,0.00013301797,0.0002696859,0.00022203865,0.00022298885,0.00005339627,0.0001829437,0.000026780297,0.00003024652],"category_scores_gemma":[0.0003113973,0.00008126944,0.00014674531,0.00049986684,0.00007238731,0.00008511906,0.000018248964,0.00013979172,0.0000034670065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012527694,0.00088144833,0.8667422,0.000051589763,0.00020433686,0.10836109,0.0065796985,0.00042713978,0.00022253775,0.000076713084,0.010954319,0.0053736554],"study_design_scores_gemma":[0.052382294,0.0017180617,0.76642597,0.001145008,0.0018965243,0.11083609,0.016483523,0.0021710196,0.022963073,0.00029078,0.023008825,0.0006788245],"about_ca_topic_score_codex":0.048127104,"about_ca_topic_score_gemma":0.054561235,"teacher_disagreement_score":0.10031621,"about_ca_system_score_codex":0.0004759128,"about_ca_system_score_gemma":0.0018266339,"threshold_uncertainty_score":0.96269053},"labels":[],"label_agreement":null},{"id":"W4406468542","doi":"10.1016/s0246-0610(03)00050-1","title":"10.1016/s0246-0610(03)00050-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.007103944971569513,"score_gpt":0.19768657163010125,"score_spread":0.19058262665853173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406468542","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003272874,0.00023267946,5.8765885e-8,0.0014353851,0.0000015089295,0.00032181226,0.00001565686,0.0001209516,0.99459904],"genre_scores_gemma":[0.0022092627,0.0000019925187,0.00013034327,0.00021563315,0.00017533147,0.000067190624,0.000044175038,0.000025518224,0.9971306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999088,0.000017724571,0.00016357093,0.00024752037,0.000211819,0.0002713544],"domain_scores_gemma":[0.9992878,0.000042401436,0.000018597108,0.00034611963,0.000037210364,0.00026788114],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000648663,0.00015407165,0.00024262289,0.000061524865,0.000054896078,0.000021965927,0.00007380879,0.000060874976,0.99804765],"category_scores_gemma":[0.000021067619,0.00012212894,0.00009680418,0.0001501254,0.000023800825,0.00004214944,0.000021713555,0.00005172661,0.99820215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012127119,0.0002994233,0.000005887524,0.000006326328,0.000053180618,0.00006820097,0.000013024468,0.0000031633012,0.000016784294,4.1771125e-7,0.6248622,0.37455013],"study_design_scores_gemma":[0.001472269,0.0005371471,0.0017156666,0.000055690416,0.00011098129,0.00005485035,9.860851e-7,0.000029894873,0.00048075605,0.0000031094432,0.9954103,0.00012831221],"about_ca_topic_score_codex":0.000058743994,"about_ca_topic_score_gemma":2.3632339e-7,"teacher_disagreement_score":0.3744218,"about_ca_system_score_codex":0.00012245668,"about_ca_system_score_gemma":0.000052862204,"threshold_uncertainty_score":0.49802735},"labels":[],"label_agreement":null},{"id":"W4406508844","doi":"10.1016/s0246-0319(19)30004-4","title":"10.1016/s0246-0319(19)30004-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.008074932165094978,"score_gpt":0.20344936890932344,"score_spread":0.19537443674422847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406508844","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016027743,0.00027447354,9.291227e-8,0.0015957328,0.0000014650601,0.00033503256,0.000015906953,0.00013093997,0.99604356],"genre_scores_gemma":[0.0019047161,0.000002070245,0.0001377345,0.0002836655,0.00016379301,0.00007050157,0.000043401673,0.000025012981,0.9973691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908733,0.00001833565,0.00016358613,0.00025024853,0.00021198836,0.0002684789],"domain_scores_gemma":[0.99922276,0.000046228426,0.000018829285,0.0003467207,0.000034308345,0.0003311813],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006696891,0.00015413448,0.00024050164,0.00006351336,0.00005929016,0.000021970418,0.00007444787,0.00006115328,0.99808633],"category_scores_gemma":[0.000028335411,0.00012210531,0.00009928987,0.00015551076,0.00002423712,0.000040489227,0.000022028635,0.00005132749,0.99724084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001237418,0.00030578603,0.000007258547,0.0000075130174,0.00005477517,0.000081380516,0.000014781441,0.000004239972,0.000013573074,2.4527768e-7,0.73203486,0.26735184],"study_design_scores_gemma":[0.0016053225,0.0005015952,0.0014529893,0.00004838149,0.0001099255,0.00006651894,0.0000010604364,0.000028283075,0.0003406093,0.000004262601,0.9957128,0.00012825875],"about_ca_topic_score_codex":0.00008160525,"about_ca_topic_score_gemma":2.2592917e-7,"teacher_disagreement_score":0.26722357,"about_ca_system_score_codex":0.00014403614,"about_ca_system_score_gemma":0.000066877416,"threshold_uncertainty_score":0.497931},"labels":[],"label_agreement":null},{"id":"W4406537425","doi":"10.1016/s1155-1984(98)13206-5","title":"10.1016/s1155-1984(98)13206-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Biology","score_opus":0.006185086438571807,"score_gpt":0.190861134136275,"score_spread":0.1846760476977032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406537425","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008025437,0.00020034733,7.331523e-8,0.0012135177,0.0000015581631,0.0003098616,0.0000140255215,0.000116975934,0.9901182],"genre_scores_gemma":[0.0027830282,0.0000015230719,0.00013187194,0.00022999049,0.00016645435,0.0000614818,0.00004228286,0.000024224608,0.99655914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991435,0.000016520711,0.0001581995,0.00023636958,0.00019199596,0.0002534207],"domain_scores_gemma":[0.99933285,0.000039205246,0.000018772735,0.00033022885,0.000033963588,0.0002449618],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000056957986,0.00014884483,0.00024579788,0.000058094192,0.000051655483,0.000020010182,0.0000697656,0.00005896715,0.9979977],"category_scores_gemma":[0.000018857667,0.00011860475,0.00009508439,0.00014180846,0.000022210746,0.000039715065,0.000020716663,0.000048156126,0.9973405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012512054,0.00031542082,0.000006888282,0.0000066031866,0.000058226753,0.000071006645,0.000014103371,0.000004050429,0.000017154724,9.1063185e-7,0.47397786,0.52540267],"study_design_scores_gemma":[0.0014408994,0.00049575727,0.0025143183,0.0000492571,0.00011311352,0.000048504757,8.685802e-7,0.000027589453,0.0004748026,0.000002919382,0.9947069,0.00012501427],"about_ca_topic_score_codex":0.00007018388,"about_ca_topic_score_gemma":2.528385e-7,"teacher_disagreement_score":0.5252776,"about_ca_system_score_codex":0.000115275194,"about_ca_system_score_gemma":0.000050132134,"threshold_uncertainty_score":0.48365614},"labels":[],"label_agreement":null},{"id":"W4406547871","doi":"10.1016/s1541-9800(05)70162-9","title":"10.1016/s1541-9800(05)70162-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Value (mathematics); Antibody; Test (biology); Medicine; Immunology; Biology; Mathematics; Statistics; Ecology","score_opus":0.0063856234960555525,"score_gpt":0.1922143427944069,"score_spread":0.18582871929835135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406547871","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006399323,0.00019929113,8.484261e-8,0.0014942106,0.0000018537648,0.00032280688,0.000015592026,0.00012107427,0.9914458],"genre_scores_gemma":[0.0023686653,0.0000017003679,0.00013643989,0.000263151,0.00017692108,0.00006566134,0.00004093676,0.000025391473,0.9969211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910027,0.000017433005,0.00016506766,0.00024597096,0.0002039802,0.00026727736],"domain_scores_gemma":[0.99929756,0.000040682557,0.000020047228,0.00034599032,0.00003605498,0.000259668],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000593463,0.00015647395,0.0002467832,0.000060054306,0.000055107594,0.00002088474,0.00007320421,0.000060897622,0.9978166],"category_scores_gemma":[0.000019968393,0.00012307228,0.0000994202,0.00014418973,0.000023396953,0.000042313946,0.00002168593,0.000049251805,0.99729764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011897319,0.00031131855,0.0000042904653,0.0000061322303,0.000052864645,0.00008725948,0.000013712783,0.0000030116564,0.000018357192,8.009438e-7,0.51693004,0.48245323],"study_design_scores_gemma":[0.0016144799,0.0005880201,0.001732684,0.000052901403,0.000112579626,0.0000748302,9.507229e-7,0.000027368782,0.0005656621,0.0000033080687,0.99509716,0.00013002669],"about_ca_topic_score_codex":0.000058021393,"about_ca_topic_score_gemma":2.2109464e-7,"teacher_disagreement_score":0.4823232,"about_ca_system_score_codex":0.0001214972,"about_ca_system_score_gemma":0.00005293908,"threshold_uncertainty_score":0.5018742},"labels":[],"label_agreement":null},{"id":"W4406548411","doi":"10.1016/s1155-195x(15)72083-9","title":"10.1016/s1155-195x(15)72083-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0060575505041381905,"score_gpt":0.19038662186733507,"score_spread":0.18432907136319687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406548411","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008349744,0.00023533218,8.547899e-8,0.0013441517,0.000001577396,0.00032331236,0.00001570595,0.00012171614,0.98960835],"genre_scores_gemma":[0.0028937573,0.0000016014511,0.00013841224,0.00025193137,0.00017139676,0.00006491817,0.000042599262,0.000025013227,0.99641037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991115,0.000017022714,0.00016395202,0.00024466097,0.00020079543,0.00026211102],"domain_scores_gemma":[0.99930316,0.000041597137,0.00001953804,0.00034528133,0.000036081696,0.000254367],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059223556,0.00015370105,0.00024574806,0.000059754842,0.00005649575,0.000020592586,0.000073291405,0.000060589904,0.99787706],"category_scores_gemma":[0.000020215413,0.00012299244,0.000098427,0.00014792048,0.000023103705,0.000041652966,0.000022752012,0.000049599625,0.99698174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013010176,0.0003256148,0.000007479015,0.0000067489223,0.000056176497,0.00007366091,0.00001527742,0.0000036724787,0.000019964253,7.957354e-7,0.45204654,0.547314],"study_design_scores_gemma":[0.0015387031,0.00052632904,0.0021612893,0.000051450203,0.00011291824,0.00005859637,9.787256e-7,0.000027924098,0.0005480156,0.0000029120715,0.9948417,0.00012916],"about_ca_topic_score_codex":0.0000576947,"about_ca_topic_score_gemma":2.6787697e-7,"teacher_disagreement_score":0.5471848,"about_ca_system_score_codex":0.00011414912,"about_ca_system_score_gemma":0.000051932187,"threshold_uncertainty_score":0.50154865},"labels":[],"label_agreement":null},{"id":"W4406548699","doi":"10.1016/s1155-1984(14)62555-3","title":"10.1016/s1155-1984(14)62555-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.006120262116168079,"score_gpt":0.19105263327018052,"score_spread":0.18493237115401243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406548699","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005462058,0.00021556753,8.094814e-8,0.001220602,0.0000017810187,0.00032567966,0.000015839625,0.00012311024,0.9926353],"genre_scores_gemma":[0.0027673012,0.0000016817388,0.00013741296,0.00022929956,0.00016681578,0.000065971144,0.000042110514,0.00002536739,0.99656403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991003,0.00001747755,0.00016510903,0.00024749353,0.0002045972,0.00026499768],"domain_scores_gemma":[0.9992931,0.000041656935,0.000019643214,0.00034786577,0.00004027755,0.00025747734],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060653416,0.00015616139,0.00024858204,0.000060107377,0.000056109548,0.000020958914,0.00007336947,0.000062873405,0.9974432],"category_scores_gemma":[0.000022261012,0.00012447053,0.0000994804,0.00014756432,0.000023572675,0.00004055592,0.00002170292,0.000051486608,0.9968112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014601897,0.0003558444,0.000007827762,0.0000073907368,0.00006173532,0.0000790607,0.000015343432,0.0000040956124,0.000017678905,0.0000013679862,0.46976683,0.5295368],"study_design_scores_gemma":[0.0016093141,0.00052866014,0.0017786339,0.000052788542,0.00011456377,0.000057793364,8.372511e-7,0.000024417603,0.00049307465,0.0000029239807,0.9952063,0.00013071342],"about_ca_topic_score_codex":0.000043587926,"about_ca_topic_score_gemma":2.5827222e-7,"teacher_disagreement_score":0.5294061,"about_ca_system_score_codex":0.00011978866,"about_ca_system_score_gemma":0.00005231105,"threshold_uncertainty_score":0.5075761},"labels":[],"label_agreement":null},{"id":"W4406548723","doi":"10.1016/s1155-1984(21)83453-6","title":"10.1016/s1155-1984(21)83453-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.006114087776466288,"score_gpt":0.19083605005159357,"score_spread":0.18472196227512727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406548723","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008666967,0.00021722383,8.0094146e-8,0.0014688865,0.0000016976737,0.00033109513,0.00001568507,0.00012190606,0.98917645],"genre_scores_gemma":[0.0025026521,0.0000017260315,0.00013255831,0.00023723957,0.00017435096,0.00006915213,0.000044294604,0.000025255054,0.99681276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990977,0.000017315435,0.00016557657,0.00024578287,0.00020570884,0.00026791127],"domain_scores_gemma":[0.9992847,0.000043659325,0.000019723397,0.00034731362,0.00003609441,0.00026852652],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060277143,0.00015551983,0.00024796245,0.00006107811,0.00005361362,0.000020668907,0.000073225325,0.000061605395,0.99726564],"category_scores_gemma":[0.000022189057,0.00012336457,0.00009768232,0.000150467,0.000024491375,0.000041543215,0.000021574666,0.000050917748,0.996771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013387513,0.0003429121,0.000007877576,0.000007011664,0.000058795056,0.00008180879,0.000018175439,0.0000033885192,0.000018819896,8.183386e-7,0.43182182,0.5675047],"study_design_scores_gemma":[0.0015405765,0.00052123953,0.002282999,0.000052722615,0.00011101113,0.000061138504,9.662873e-7,0.000025953883,0.00054850895,0.0000029757834,0.9947223,0.00012960729],"about_ca_topic_score_codex":0.00005510611,"about_ca_topic_score_gemma":2.2236685e-7,"teacher_disagreement_score":0.56737506,"about_ca_system_score_codex":0.0001202515,"about_ca_system_score_gemma":0.0000540449,"threshold_uncertainty_score":0.5030661},"labels":[],"label_agreement":null},{"id":"W4406551049","doi":"10.1016/s1541-9800(09)70193-0","title":"10.1016/s1541-9800(09)70193-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma","score_opus":0.006335774542526313,"score_gpt":0.19177023361999507,"score_spread":0.18543445907746875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406551049","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007550731,0.00022145234,8.474062e-8,0.0012459127,0.000001603692,0.00032319358,0.000015003781,0.000118570504,0.99052346],"genre_scores_gemma":[0.0019300272,0.0000017454342,0.00013063785,0.00017041541,0.00017274612,0.00006322057,0.00004026011,0.000025160523,0.9974658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991094,0.000017182318,0.00016330593,0.00024455466,0.00020345401,0.00026213785],"domain_scores_gemma":[0.9993078,0.000041748368,0.000019480807,0.00034228296,0.000035888665,0.00025276534],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000057929523,0.00015485506,0.0002456915,0.00005932727,0.000053937492,0.00002083746,0.00007194567,0.0000605677,0.99764836],"category_scores_gemma":[0.000020065438,0.0001229608,0.00009835179,0.0001475636,0.00002266309,0.000041479438,0.000021490816,0.000049707454,0.99756914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012909962,0.0003253396,0.0000070215315,0.000006713237,0.000056763496,0.00007147598,0.000015236503,0.0000037413017,0.00001925105,8.851902e-7,0.40028036,0.5990841],"study_design_scores_gemma":[0.0015678618,0.0005435833,0.002077986,0.00005255504,0.00011165603,0.000056399433,0.000001000709,0.000029211205,0.0005484306,0.000002995577,0.99487907,0.000129265],"about_ca_topic_score_codex":0.000056246896,"about_ca_topic_score_gemma":2.2580866e-7,"teacher_disagreement_score":0.59895486,"about_ca_system_score_codex":0.00011568814,"about_ca_system_score_gemma":0.000051573727,"threshold_uncertainty_score":0.5014196},"labels":[],"label_agreement":null},{"id":"W4406555636","doi":"10.1016/s1634-6939(21)87413-x","title":"10.1016/s1634-6939(21)87413-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Internal medicine","score_opus":0.00607817733318208,"score_gpt":0.19008908933671034,"score_spread":0.18401091200352826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555636","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007204267,0.00022883597,8.909722e-8,0.0014161974,0.0000016044844,0.0003226382,0.000015272164,0.00012166097,0.99068946],"genre_scores_gemma":[0.0027249896,0.0000017538558,0.00013739374,0.00023367118,0.00017613811,0.000064567066,0.000052625997,0.00002515258,0.9965837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910456,0.000017300243,0.00016637462,0.00024464063,0.000203641,0.00026348414],"domain_scores_gemma":[0.99929637,0.000040306022,0.000019501016,0.00034991608,0.0000364876,0.00025744602],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060028357,0.00015520492,0.00024590176,0.00005942315,0.00005424763,0.000020938722,0.00007271633,0.000060795013,0.99688464],"category_scores_gemma":[0.00002020976,0.00012316319,0.000098478784,0.0001477619,0.000023585175,0.00004123673,0.000021521968,0.000049891787,0.9974756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013774974,0.00033283356,0.000007644652,0.0000068403515,0.000059027116,0.000077527526,0.000014541472,0.0000036975061,0.000018754954,8.935485e-7,0.4459649,0.5533756],"study_design_scores_gemma":[0.0015360507,0.0005253548,0.002082979,0.000051671304,0.000115190596,0.000058749385,9.3670417e-7,0.00002966935,0.00046300044,0.0000028970571,0.9950042,0.00012932756],"about_ca_topic_score_codex":0.000051616622,"about_ca_topic_score_gemma":2.0475099e-7,"teacher_disagreement_score":0.55324626,"about_ca_system_score_codex":0.00012640003,"about_ca_system_score_gemma":0.000054708107,"threshold_uncertainty_score":0.5022449},"labels":[],"label_agreement":null},{"id":"W4406556248","doi":"10.1016/s1637-5017(22)44860-5","title":"10.1016/s1637-5017(22)44860-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine","score_opus":0.006043564834417532,"score_gpt":0.19230253723879823,"score_spread":0.1862589724043807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406556248","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073527806,0.00020135612,7.099142e-8,0.0011659187,0.0000016451551,0.0003166225,0.000014978043,0.000120047465,0.9908266],"genre_scores_gemma":[0.002302451,0.0000017957382,0.00013096377,0.00022814026,0.00016876486,0.00006325055,0.00003959555,0.00002504677,0.99704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991149,0.000016707554,0.00016138364,0.00024314629,0.0002034711,0.0002603987],"domain_scores_gemma":[0.99929875,0.000038598406,0.000019734913,0.00035182296,0.000036286252,0.00025481946],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059051177,0.00015389085,0.00024454383,0.00005899602,0.0000554789,0.000022055105,0.00007444283,0.000059280133,0.9980527],"category_scores_gemma":[0.000020174873,0.00012235725,0.00009719278,0.00014049206,0.000022815542,0.00004202466,0.000021901285,0.000048615035,0.99701995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121618075,0.0003084456,0.0000071494005,0.0000060978577,0.00005268638,0.00007041683,0.000010951129,0.0000032178884,0.0000151567,8.0617644e-7,0.4621123,0.53729117],"study_design_scores_gemma":[0.0015138588,0.00054901175,0.0020341845,0.000050960487,0.00011302912,0.000057386376,8.8378744e-7,0.00002845717,0.0004571672,0.0000030026736,0.9950638,0.00012827484],"about_ca_topic_score_codex":0.000056398218,"about_ca_topic_score_gemma":1.7562358e-7,"teacher_disagreement_score":0.5371629,"about_ca_system_score_codex":0.00011332935,"about_ca_system_score_gemma":0.00004955084,"threshold_uncertainty_score":0.49895838},"labels":[],"label_agreement":null},{"id":"W4406573007","doi":"10.1016/s1879-8551(19)30198-8","title":"10.1016/s1879-8551(19)30198-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0071391452187940015,"score_gpt":0.19757318512087316,"score_spread":0.19043403990207916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406573007","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005640231,0.00030541726,1.0580376e-7,0.0015753956,0.0000015423494,0.00033806032,0.000015545174,0.00012507023,0.9919986],"genre_scores_gemma":[0.0020141962,0.0000019936938,0.00014058541,0.00031026895,0.00016133933,0.00006748455,0.000041549054,0.000024406985,0.99723816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991126,0.000018388155,0.00016206867,0.0002455128,0.00020184246,0.00025957634],"domain_scores_gemma":[0.9992425,0.000044757544,0.000019522096,0.00034328978,0.00003312993,0.00031684033],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006179839,0.00015343394,0.00024199556,0.00006184453,0.00005875846,0.000020448646,0.000072647104,0.00006045611,0.99764585],"category_scores_gemma":[0.000025833693,0.00012194781,0.00012537213,0.00014928811,0.00002368842,0.000040334977,0.000021506477,0.000049410835,0.99695516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013008174,0.00030650976,0.000008142145,0.0000073214032,0.0000673792,0.00008392334,0.000015467172,0.0000045229103,0.000011495151,9.377206e-7,0.48213023,0.51723397],"study_design_scores_gemma":[0.0015607548,0.0005216911,0.0016766249,0.000044134744,0.00012963325,0.00007236638,0.000001018901,0.000024068922,0.00023190679,0.0000033754645,0.9956062,0.0001282632],"about_ca_topic_score_codex":0.00007383981,"about_ca_topic_score_gemma":2.137714e-7,"teacher_disagreement_score":0.5171057,"about_ca_system_score_codex":0.0001358128,"about_ca_system_score_gemma":0.00006421234,"threshold_uncertainty_score":0.4972887},"labels":[],"label_agreement":null},{"id":"W4406573043","doi":"10.1016/s1877-7864(14)57050-4","title":"10.1016/s1877-7864(14)57050-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.00609436063322524,"score_gpt":0.19071241680354376,"score_spread":0.1846180561703185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406573043","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068484833,0.00023234542,8.054035e-8,0.0013369543,0.0000017290042,0.00032759056,0.000014441817,0.00012130642,0.99111706],"genre_scores_gemma":[0.0022950405,0.0000017740557,0.00014751434,0.00024607359,0.00016739781,0.00006850827,0.000040756044,0.000025057758,0.9970079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910617,0.000017467593,0.00016316219,0.00024438015,0.00020723495,0.00026160764],"domain_scores_gemma":[0.9992971,0.000040517272,0.000019118126,0.00034829837,0.00004087871,0.00025412918],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000596466,0.00015477194,0.00024536185,0.00005911169,0.000054744894,0.000020798983,0.00007155233,0.0000622137,0.99741614],"category_scores_gemma":[0.00002016513,0.00012287193,0.0000977005,0.00014818508,0.0000223199,0.000042265638,0.000021947099,0.000049746508,0.99694407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001403673,0.000341968,0.0000074795826,0.000007181246,0.000057690162,0.00007422276,0.0000149154,0.0000035247,0.000018745393,9.179565e-7,0.43028587,0.5690471],"study_design_scores_gemma":[0.0015772323,0.0005374016,0.002085815,0.000050764305,0.00010890305,0.000045637462,8.6389423e-7,0.000026831729,0.00049851154,0.0000030898027,0.99493605,0.00012889518],"about_ca_topic_score_codex":0.000050972703,"about_ca_topic_score_gemma":2.3182116e-7,"teacher_disagreement_score":0.5689182,"about_ca_system_score_codex":0.00011145845,"about_ca_system_score_gemma":0.00004788069,"threshold_uncertainty_score":0.5010572},"labels":[],"label_agreement":null},{"id":"W4406573924","doi":"10.1016/s1637-5017(19)30136-x","title":"10.1016/s1637-5017(19)30136-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0073854140687659945,"score_gpt":0.19847829932069813,"score_spread":0.19109288525193213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406573924","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006162005,0.00024305584,8.880528e-8,0.0017708641,0.0000015877583,0.00033320242,0.0000150121095,0.00012773547,0.9913464],"genre_scores_gemma":[0.0021703131,0.0000020826474,0.00013844357,0.00030540166,0.00017033138,0.000069899004,0.000042949338,0.000024513178,0.9970761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991009,0.000018278079,0.00016291486,0.00024879174,0.00020474533,0.00026435705],"domain_scores_gemma":[0.9992219,0.000044528264,0.000020124713,0.00035517948,0.00003428826,0.000323933],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000064058935,0.00015509597,0.00024383343,0.000062169885,0.00006105617,0.000022914937,0.0000756521,0.000060119382,0.99777526],"category_scores_gemma":[0.000027944787,0.00012326214,0.00009750081,0.00014547342,0.000024338528,0.000041667212,0.00002177938,0.000049667095,0.99694765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012258858,0.00029901892,0.000008528628,0.000006968163,0.000052643572,0.000078878395,0.000014011799,0.000004307779,0.000013407118,8.8557846e-7,0.48458913,0.51480967],"study_design_scores_gemma":[0.0015829602,0.00052034995,0.0019151832,0.00004451674,0.000110721776,0.00006534256,0.0000010059997,0.000026978667,0.00035111245,0.0000033576832,0.995249,0.00012948278],"about_ca_topic_score_codex":0.00008102137,"about_ca_topic_score_gemma":2.3582149e-7,"teacher_disagreement_score":0.51468015,"about_ca_system_score_codex":0.00013282151,"about_ca_system_score_gemma":0.00006264155,"threshold_uncertainty_score":0.5026484},"labels":[],"label_agreement":null},{"id":"W4406574322","doi":"10.1016/s1637-5017(19)30165-6","title":"10.1016/s1637-5017(19)30165-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.00734380093420637,"score_gpt":0.19858107751486548,"score_spread":0.19123727658065912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406574322","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006437814,0.0002384512,8.907822e-8,0.0016942301,0.0000015928135,0.0003329911,0.000016126833,0.00012959343,0.9911491],"genre_scores_gemma":[0.0018746807,0.0000020280593,0.00013841195,0.0003046951,0.00016919983,0.00006907024,0.00004169268,0.000024833678,0.99737537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909264,0.0000181873,0.00016523068,0.000251476,0.0002068388,0.0002656203],"domain_scores_gemma":[0.99921584,0.00004448607,0.00002046953,0.000357085,0.00003444525,0.00032767706],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000064623266,0.0001568046,0.00024700767,0.0000629888,0.00006186365,0.000022757316,0.000076521595,0.000060702478,0.9978033],"category_scores_gemma":[0.00002825191,0.00012378063,0.0000990757,0.00014536748,0.000025251353,0.00004203617,0.000022417546,0.000048913982,0.9970317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013071638,0.00030485546,0.000008085017,0.0000069868765,0.000053631353,0.0000813277,0.000013863768,0.000005440693,0.000012396481,7.716307e-7,0.48799887,0.51138306],"study_design_scores_gemma":[0.0016301688,0.0005158455,0.0016385209,0.000046438923,0.00011051802,0.000066841516,9.827983e-7,0.000030043353,0.0002826985,0.0000031924892,0.9955436,0.00013113224],"about_ca_topic_score_codex":0.00007662492,"about_ca_topic_score_gemma":2.242694e-7,"teacher_disagreement_score":0.5112519,"about_ca_system_score_codex":0.00013239872,"about_ca_system_score_gemma":0.00006389548,"threshold_uncertainty_score":0.5047627},"labels":[],"label_agreement":null},{"id":"W4406583231","doi":"10.1016/s1155-1984(98)13207-7","title":"10.1016/s1155-1984(98)13207-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.006156340537222707,"score_gpt":0.1907451365276688,"score_spread":0.1845887959904461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583231","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008661185,0.00017847551,7.178732e-8,0.0014683477,0.0000015206449,0.00031443534,0.000014668276,0.00011670773,0.9892446],"genre_scores_gemma":[0.0030110204,0.00000159702,0.00012841911,0.00021402894,0.00016633095,0.000062984975,0.00004853569,0.000024160056,0.9963429],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991463,0.000016671098,0.00015817916,0.00023532397,0.00019259508,0.00025094548],"domain_scores_gemma":[0.9993401,0.000039279093,0.000018899802,0.00032717688,0.000033918306,0.00024061879],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000057299745,0.00014833311,0.000247335,0.000057344547,0.000051712417,0.0000202891,0.00006940548,0.000058392856,0.9978349],"category_scores_gemma":[0.000015866905,0.000118262105,0.00009441571,0.00013983047,0.000021932949,0.00004047801,0.000020714111,0.000047850655,0.99730843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013158242,0.00031198436,0.00000949194,0.000006623593,0.000059985312,0.00007082295,0.0000141003575,0.000004137862,0.000014536418,6.877473e-7,0.52322984,0.4761462],"study_design_scores_gemma":[0.001504761,0.00046783392,0.003451961,0.000048847705,0.0001151815,0.00004759428,8.6923666e-7,0.000027870678,0.0004408632,0.0000023218088,0.9937675,0.00012440795],"about_ca_topic_score_codex":0.00006194794,"about_ca_topic_score_gemma":1.7551e-7,"teacher_disagreement_score":0.4760218,"about_ca_system_score_codex":0.000113193186,"about_ca_system_score_gemma":0.000047704096,"threshold_uncertainty_score":0.4822589},"labels":[],"label_agreement":null},{"id":"W4406583346","doi":"10.1016/s1155-1968(20)30226-1","title":"10.1016/s1155-1968(20)30226-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.0060244036055472835,"score_gpt":0.1903891506423161,"score_spread":0.1843647470367688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583346","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071081836,0.0002182308,7.2835e-8,0.0014269714,0.0000015918879,0.00032210595,0.000020159256,0.00011953494,0.99078315],"genre_scores_gemma":[0.0019913313,0.0000013959593,0.00012588449,0.00024083903,0.00017048689,0.0000673201,0.000055184482,0.000024904084,0.9973227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911386,0.00001744586,0.0001623559,0.00024394176,0.00019937684,0.00026302162],"domain_scores_gemma":[0.99930334,0.00003992862,0.000019448891,0.00034465472,0.000035314555,0.00025733846],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005922414,0.00015340273,0.00024322244,0.000060223727,0.000055638408,0.000020136724,0.000072938,0.000059256392,0.99783254],"category_scores_gemma":[0.00001796628,0.00012248523,0.000095854084,0.00014794088,0.000023311151,0.00004046648,0.000021454587,0.00004989132,0.9965882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001389012,0.00033446384,0.0000071519253,0.000006715859,0.000058058817,0.00007754335,0.000014755691,0.0000048767997,0.000029024799,7.6772676e-7,0.46038717,0.53894055],"study_design_scores_gemma":[0.0015354913,0.0005503868,0.0012740142,0.00004786145,0.00011156518,0.0000604941,8.9311754e-7,0.000029432964,0.00055111654,0.0000027009278,0.99570733,0.00012871015],"about_ca_topic_score_codex":0.000046863537,"about_ca_topic_score_gemma":2.8053816e-7,"teacher_disagreement_score":0.53881186,"about_ca_system_score_codex":0.000120162294,"about_ca_system_score_gemma":0.00005563643,"threshold_uncertainty_score":0.49948025},"labels":[],"label_agreement":null},{"id":"W4406643034","doi":"10.1016/b978-2-294-76306-9.50356-2","title":"10.1016/b978-2-294-76306-9.50356-2","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Environmental science","score_opus":0.010331496650430502,"score_gpt":0.1928365493571415,"score_spread":0.182505052706711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643034","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000047922567,0.0010883531,6.4115824e-8,0.0006925581,0.0000056280724,0.0008338549,0.00015490055,0.00019125578,0.9970286],"genre_scores_gemma":[0.000007926605,0.000009393922,0.000082045175,0.00024160766,0.0006581516,0.00007917381,0.0004425906,0.00014609897,0.99833304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981201,0.000010993472,0.00040393134,0.0006087951,0.00046819405,0.00038795607],"domain_scores_gemma":[0.9984889,0.00007521994,0.00010964766,0.00078828,0.000091788854,0.000446156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000714636,0.0005701662,0.0008489154,0.00024068986,0.00007381926,0.00003722907,0.0001635047,0.0004011499,0.9977769],"category_scores_gemma":[0.00001590222,0.00048486673,0.00037382194,0.000043721488,0.000062998886,0.00003786743,0.00007888459,0.00021661623,0.99787384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018367,0.00015170583,2.0718593e-7,0.000028216979,0.0003220239,0.00039109268,0.000008135064,8.900901e-7,0.0000015047467,0.000062936066,0.42543,0.57341963],"study_design_scores_gemma":[0.0015358669,0.00079252286,0.000035967212,0.0005136117,0.0007131481,0.00014089022,2.2186963e-7,0.0000033000488,0.00003715192,0.00008930955,0.99569523,0.00044274848],"about_ca_topic_score_codex":0.000036654375,"about_ca_topic_score_gemma":4.5405466e-7,"teacher_disagreement_score":0.5729769,"about_ca_system_score_codex":0.0003698088,"about_ca_system_score_gemma":0.00018266833,"threshold_uncertainty_score":0.99976027},"labels":[],"label_agreement":null},{"id":"W4406849797","doi":"10.20944/preprints202501.1882.v1","title":"Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-cell Lymphoma in Canada","year":2025,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Bispecific antibody; Diffuse large B-cell lymphoma; Lymphoma; Antibody; Cancer research; Medicine; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.10714410953811691,"score_gpt":0.3312089363708466,"score_spread":0.22406482683272966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406849797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274695,0.0022640042,0.000018763101,0.00037373079,0.00042954768,0.0025258872,0.001102463,0.000018175286,0.0005204874],"genre_scores_gemma":[0.9893274,0.0076736026,0.00039642391,0.000056198,0.000048043497,0.00074620167,0.00015076381,0.000026150778,0.0015752738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772507,0.000066311644,0.0008046675,0.00068784965,0.0003314232,0.00038466539],"domain_scores_gemma":[0.9970523,0.00075768447,0.00040408561,0.0014912457,0.00019783022,0.00009681839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015584812,0.00042607536,0.001097389,0.00017959916,0.000055213775,0.000008183198,0.00026310823,0.00017430054,0.00008282651],"category_scores_gemma":[0.00009731621,0.0002901236,0.00043657792,0.00014196866,0.00008011804,0.000029231496,0.00040351687,0.00009196603,0.0000066080424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059415994,0.012856083,0.98068887,0.00071890873,0.00082873274,0.000057037145,0.00094299763,0.00056810066,0.00023973992,0.00012156325,0.00018164152,0.002202193],"study_design_scores_gemma":[0.013555926,0.00015908039,0.8641429,0.0005221186,0.0006831374,0.0000037010545,0.00033626953,0.00065073324,0.10296012,0.00001646431,0.016769724,0.00019984513],"about_ca_topic_score_codex":0.6046226,"about_ca_topic_score_gemma":0.27277517,"teacher_disagreement_score":0.33184746,"about_ca_system_score_codex":0.0018449535,"about_ca_system_score_gemma":0.0025881575,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W4406956815","doi":"10.1097/qad.0000000000004051","title":"Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS","year":2025,"lang":"en","type":"article","venue":"AIDS","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Guangxi Medical University; National Institute on Drug Abuse; Natural Science Foundation of Guangxi Province; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Virus; Epstein–Barr virus; Medicine; Virology; Human immunodeficiency virus (HIV); Pathology; Viral disease; Gammaherpesvirinae; Herpesviridae; Immunology","score_opus":0.009488581123437792,"score_gpt":0.2386351143124116,"score_spread":0.22914653318897382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406956815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946616,0.00025076445,0.000021658458,0.00035564997,0.000053107415,0.0006195064,0.000029037194,0.00007509335,0.003933556],"genre_scores_gemma":[0.9970929,0.00002286333,0.0011067959,0.0010405235,0.000011939904,0.00026491378,0.000047095495,0.000023403363,0.00038957302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881434,0.00005490587,0.00023674052,0.00032624492,0.00025330263,0.000314442],"domain_scores_gemma":[0.99923104,0.00015460976,0.000069685935,0.0003450493,0.000083497354,0.000116139505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008355318,0.0002061209,0.0003755182,0.00018846757,0.0000892389,0.000019654934,0.000064491906,0.0000503366,0.0000617562],"category_scores_gemma":[0.00009161856,0.0001309729,0.000063852065,0.0006414928,0.00006018338,0.00006172552,0.00004463283,0.00011275016,0.00002643907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042375326,0.0028140177,0.9540296,0.000034475503,0.00023414561,0.0011721175,0.00052271417,0.000034105266,0.00061735744,0.00034061613,0.00075291144,0.03902418],"study_design_scores_gemma":[0.011277713,0.0041744565,0.9714114,0.0009181517,0.0002562362,0.000016585711,0.00070604915,0.00011375231,0.005645371,0.000034031527,0.0052534,0.00019284831],"about_ca_topic_score_codex":0.0021500273,"about_ca_topic_score_gemma":0.0019268646,"teacher_disagreement_score":0.038831335,"about_ca_system_score_codex":0.0003684529,"about_ca_system_score_gemma":0.00025437822,"threshold_uncertainty_score":0.534092},"labels":[],"label_agreement":null},{"id":"W4407079796","doi":"10.5858/arpa.2024-0366-oa","title":"The Impact of Scoring Method on Accuracy and Reproducibility of Hans Cell-of-Origin Prediction in Excisional Biopsies of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified","year":2025,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Reproducibility; Lymphoma; Medicine; Pathology; Diffuse large B-cell lymphoma; Cell of origin; Internal medicine; Statistics; Cancer; Mathematics","score_opus":0.021166589893935925,"score_gpt":0.3411323636841402,"score_spread":0.31996577379020424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407079796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945207,0.0033682953,0.00011505981,0.00026972924,0.00016296782,0.0004935053,0.00031166562,0.000007835972,0.00075023243],"genre_scores_gemma":[0.99733555,0.00135778,0.0011281511,0.00003509321,0.000039640843,0.000019994126,0.000016620665,0.0000114194545,0.000055739212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976177,0.0004226382,0.00097642606,0.00054037356,0.00024494712,0.00019791973],"domain_scores_gemma":[0.9949123,0.0031142752,0.0005971483,0.0011502833,0.00016000324,0.00006597579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017128781,0.00020058623,0.0009121647,0.0003846126,0.000037329206,0.0000010059335,0.00014399887,0.000083164276,0.000014050157],"category_scores_gemma":[0.0017107151,0.00011918214,0.0001266327,0.00043155387,0.00092421315,0.00003851473,0.00008512093,0.00010419972,2.2061825e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031812135,0.0051265866,0.5577668,0.0004992729,0.00014934981,0.000041852676,0.0031614343,0.000017575207,0.42307004,0.00074576936,0.00011025258,0.0061298516],"study_design_scores_gemma":[0.010677003,0.0014772228,0.6964022,0.000563021,0.00013204398,0.000004582361,0.0005817669,0.00008357576,0.28970283,0.00029294332,0.000040591312,0.000042226835],"about_ca_topic_score_codex":0.00022899751,"about_ca_topic_score_gemma":0.00002088524,"teacher_disagreement_score":0.1386354,"about_ca_system_score_codex":0.000052939962,"about_ca_system_score_gemma":0.00038537107,"threshold_uncertainty_score":0.48601067},"labels":[],"label_agreement":null},{"id":"W4407368596","doi":"10.1093/bjr/tqaf028","title":"18F-FDG PET or PET/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Follicular lymphoma; Receiver operating characteristic; Nuclear medicine; Lymphoma; Biopsy; Meta-analysis; Positron emission tomography; Area under the curve; Radiology; Diagnostic accuracy; Pathology; Internal medicine","score_opus":0.03686764000243213,"score_gpt":0.32084739506317295,"score_spread":0.2839797550607408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407368596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018039764,0.9959247,0.0000165447,0.0000736222,0.000059189184,0.0020112705,0.00008586118,0.0000072294797,0.00001759378],"genre_scores_gemma":[0.019719573,0.97959757,0.00018060666,0.00012412546,0.000031745687,0.00023927007,0.000042312015,0.000023561503,0.00004124347],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947507,0.0011291722,0.003156084,0.00036237156,0.0002921528,0.00030954482],"domain_scores_gemma":[0.9960118,0.0012411464,0.0021572309,0.00028054166,0.0001481327,0.00016115603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001540326,0.00046658743,0.013134991,0.0008938625,0.00005866725,0.00003710091,0.00018137322,0.00006577605,0.000066415625],"category_scores_gemma":[0.000702827,0.0003205201,0.0019316708,0.00082525815,0.00010878474,0.0001170775,0.000040254043,0.00029941963,0.0000010159112],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021978783,0.00013481113,0.00001373896,0.87159693,0.084195584,0.0120429145,0.000030210513,0.000006088532,9.936205e-8,0.000016524693,0.000070296104,0.03187082],"study_design_scores_gemma":[0.001911554,0.0003455395,0.000034743258,0.15273462,0.47663867,0.36770037,0.000024598321,0.000013858771,0.0000011549608,0.000006078089,0.0004481364,0.0001406911],"about_ca_topic_score_codex":0.00034695616,"about_ca_topic_score_gemma":0.00031439323,"teacher_disagreement_score":0.7188623,"about_ca_system_score_codex":0.0022520598,"about_ca_system_score_gemma":0.0020318178,"threshold_uncertainty_score":0.99992466},"labels":[],"label_agreement":null},{"id":"W4407694204","doi":"10.3390/curroncol32020118","title":"Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Refractory (planetary science); Stem cell; Lymphoma; Oncology; Transplantation; Internal medicine; Cancer research; Biology","score_opus":0.029052898813682667,"score_gpt":0.31605329315105335,"score_spread":0.2870003943373707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407694204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477416,0.0017673671,0.000012774007,0.00022834071,0.00056061504,0.0005619651,0.00003358905,0.000019608058,0.0020415685],"genre_scores_gemma":[0.99915105,0.00031046875,0.00006459781,0.00012975738,0.000011492891,0.000088263354,0.00006929666,0.000010991643,0.00016407503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988346,0.00008280419,0.00038790848,0.00028050682,0.00017314969,0.00024099664],"domain_scores_gemma":[0.9992935,0.00017283941,0.00012780887,0.00025651485,0.0000731677,0.000076145734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008594047,0.00018546505,0.00061301515,0.00021146752,0.000022308901,0.0000026086616,0.00008832466,0.0001221353,0.00003756482],"category_scores_gemma":[0.00000591059,0.00012551257,0.00009457722,0.00016917984,0.0000735496,0.000030126605,0.000025798901,0.00007967996,0.00001732557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000675202,0.008499185,0.8715253,0.00015128015,0.000116083145,0.00003877876,0.00027593534,0.0000022027311,0.00001942933,0.00010897098,0.00035685755,0.11823077],"study_design_scores_gemma":[0.021816295,0.0016930619,0.9588675,0.00021391014,0.00025732972,0.0000018599876,0.000055961278,0.0000047798126,0.0008932684,0.00001086176,0.01608797,0.000097191165],"about_ca_topic_score_codex":0.00002907769,"about_ca_topic_score_gemma":0.00004889348,"teacher_disagreement_score":0.11813358,"about_ca_system_score_codex":0.0005407473,"about_ca_system_score_gemma":0.0003818439,"threshold_uncertainty_score":0.5118254},"labels":[],"label_agreement":null},{"id":"W4407743712","doi":"10.6004/jnccn.2024.7082","title":"Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Anxiety; Depression (economics); Geriatric Depression Scale; Population; Clinical trial; Internal medicine; Physical therapy; Lymphoma; Rituximab; Psychiatry","score_opus":0.017783172372039358,"score_gpt":0.30242581169189714,"score_spread":0.2846426393198578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407743712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98160565,0.0119775385,0.000010313296,0.0046379073,0.00079037994,0.00044332954,0.0000046629957,0.0000072138932,0.000522985],"genre_scores_gemma":[0.9952325,0.0006739162,0.00032798885,0.003308416,0.00021616383,0.000043013177,0.000002548949,0.0000131660245,0.00018228378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834096,0.000064057596,0.0005652852,0.00017416671,0.00065078796,0.00020475668],"domain_scores_gemma":[0.99704397,0.00031896489,0.00096334063,0.00013789712,0.0014838369,0.000052022413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081663624,0.00018902677,0.0004814338,0.00014186482,0.0001106374,0.000023049288,0.0001322799,0.000063947264,0.00005931707],"category_scores_gemma":[0.00010087907,0.00010512016,0.00021014539,0.00052471895,0.00006743654,0.000084351195,0.00004334345,0.00019593345,7.468483e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002023272,0.00045796097,0.9749958,0.000032606276,0.0013146804,0.00013731312,0.0002924935,0.006135931,0.000031629676,0.00008203466,0.0070019695,0.0074943355],"study_design_scores_gemma":[0.009827224,0.00017495398,0.9826005,0.0042546676,0.00016780179,0.00025191263,0.00011008588,0.000107611995,0.00034218899,0.00021853742,0.0018464525,0.00009803229],"about_ca_topic_score_codex":0.000058365804,"about_ca_topic_score_gemma":0.00003899345,"teacher_disagreement_score":0.013626833,"about_ca_system_score_codex":0.0009687417,"about_ca_system_score_gemma":0.0006878023,"threshold_uncertainty_score":0.42866758},"labels":[],"label_agreement":null},{"id":"W4407761773","doi":"10.1182/blood.2024027182","title":"Blastoid variant of double-hit lymphoma masquerading as acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Blastoid; Medicine; Lymphoblastic Leukemia; Lymphoblastic lymphoma; Lymphoma; Leukemia; Oncology; Internal medicine; Immunology; Mantle cell lymphoma","score_opus":0.008223069084560474,"score_gpt":0.2527310163647831,"score_spread":0.24450794728022265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407761773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559675,0.0008620673,0.00009884367,0.00045294798,0.0002514405,0.00043884345,0.000014040425,0.000088203335,0.041826125],"genre_scores_gemma":[0.99580824,0.00020833708,0.00070447725,0.00044155432,0.00008161468,0.000091763446,0.00002396234,0.000024159779,0.0026158672],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985727,0.00002353779,0.0004106026,0.00037665054,0.00028254904,0.00033393828],"domain_scores_gemma":[0.9990319,0.00012940766,0.00011783023,0.000474928,0.000097277465,0.00014866784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009672983,0.00024778213,0.0005469532,0.00021699195,0.000087778026,0.000025696985,0.0001322404,0.00013425363,0.00014121289],"category_scores_gemma":[0.00004227624,0.00020405545,0.00020296428,0.00038807304,0.00007015673,0.00005976782,0.00009023624,0.000045315777,0.00011632327],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009477635,0.040171746,0.3840525,0.0028024286,0.036138397,0.02005728,0.0032786727,0.00016611406,0.117669515,0.27333203,0.014387995,0.09846571],"study_design_scores_gemma":[0.1397856,0.0021877661,0.17621697,0.0022294899,0.010996137,0.0027073028,0.00024042962,0.0004538559,0.65112597,0.0014500819,0.011934088,0.00067228614],"about_ca_topic_score_codex":0.0003070368,"about_ca_topic_score_gemma":0.000009120356,"teacher_disagreement_score":0.53345644,"about_ca_system_score_codex":0.0004634334,"about_ca_system_score_gemma":0.0009914803,"threshold_uncertainty_score":0.832114},"labels":[],"label_agreement":null},{"id":"W4407818636","doi":"10.1016/j.adro.2025.101744","title":"Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"Advances in Radiation Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University Health Network","keywords":"Medicine; Center (category theory); Retrospective cohort study; Lymphoma; Primary (astronomy); Radiology; Internal medicine; Oncology","score_opus":0.004564458303895093,"score_gpt":0.2986384374931664,"score_spread":0.2940739791892713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407818636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470526,0.0019741599,0.0001833574,0.0004928185,0.00018473889,0.00046039943,0.00003042876,0.000015696201,0.001953157],"genre_scores_gemma":[0.9968255,0.0005619366,0.0017650779,0.0004936191,0.000016884951,0.00014433819,0.00007931382,0.000006713484,0.00010661024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870986,0.00018226478,0.00040556287,0.0002872061,0.00022739106,0.00018768948],"domain_scores_gemma":[0.9987717,0.00056221784,0.00025698994,0.00021134526,0.00014233487,0.000055368535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019060796,0.00014294106,0.0007446532,0.0005101372,0.000030996223,0.0000036030517,0.00006177686,0.000079884114,0.000038445192],"category_scores_gemma":[0.00022991245,0.00010463769,0.00011284452,0.0008377255,0.00010080644,0.0001389596,0.00002547574,0.0000500112,0.0000039211723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038972467,0.003194186,0.9531098,0.000020301724,0.00056155433,0.000020772046,0.00024205568,0.00017202568,0.000015850363,0.00018160492,0.000022943073,0.038561657],"study_design_scores_gemma":[0.020920862,0.0007734657,0.9660497,0.000018236884,0.0011535505,5.773794e-7,0.00005025099,0.00015514487,0.0008830152,0.000020489488,0.009899351,0.00007539325],"about_ca_topic_score_codex":0.000042308333,"about_ca_topic_score_gemma":0.00013198653,"teacher_disagreement_score":0.038486265,"about_ca_system_score_codex":0.0008405818,"about_ca_system_score_gemma":0.00032093964,"threshold_uncertainty_score":0.42670015},"labels":[],"label_agreement":null},{"id":"W4407823594","doi":"10.3904/kjim.2024.279","title":"Follicular lymphoma: contemporary clinical management with a focus on recent therapeutic advances","year":2025,"lang":"en","type":"review","venue":"The Korean Journal of Internal Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Intensive care medicine; Oncology; Internal medicine","score_opus":0.06555684152399355,"score_gpt":0.39073900335474854,"score_spread":0.325182161830755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407823594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003175431,0.9694978,0.00014965438,0.0045183315,0.0011495241,0.0012710572,0.000008205453,0.000017665596,0.023356033],"genre_scores_gemma":[0.001987573,0.9933722,0.00012882959,0.0020413925,0.0012847198,0.000057849225,0.000012161011,0.00005303617,0.0010622279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954875,0.00053770177,0.0022403805,0.00039300387,0.0010319368,0.00030945602],"domain_scores_gemma":[0.995336,0.0013352993,0.0019871753,0.00072403083,0.0003008627,0.00031664225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015272831,0.0006755569,0.003620929,0.0004579724,0.000075263786,0.00002277064,0.00064461055,0.00015921121,0.0000807245],"category_scores_gemma":[0.00016399793,0.0002516941,0.001002644,0.00040315234,0.0003720233,0.00006099575,0.00008910563,0.0005879058,0.000023871373],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018359575,0.0009488563,0.00020533231,0.0035069832,0.006738549,0.00601925,0.00005428619,2.2808116e-7,1.8433868e-8,0.00080533646,0.006355296,0.97352993],"study_design_scores_gemma":[0.008507367,0.007325148,0.0002026072,0.16845311,0.008462034,0.002996516,0.00014207399,5.1888685e-7,0.0000035382868,0.0003721742,0.8033641,0.00017081105],"about_ca_topic_score_codex":0.000018640028,"about_ca_topic_score_gemma":0.0000026223224,"teacher_disagreement_score":0.9733591,"about_ca_system_score_codex":0.0004838671,"about_ca_system_score_gemma":0.00065992033,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W4407829487","doi":"10.1182/bloodadvances.2024015292","title":"BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Rituximab; Medicine; Lymphoma; CHOP; Internal medicine; Oncology; Cancer research","score_opus":0.004071240537659484,"score_gpt":0.21840127292166742,"score_spread":0.21433003238400794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407829487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914145,0.0018014541,0.000039003575,0.0002960023,0.0000816568,0.000626583,0.00003665117,0.00006049582,0.0056436867],"genre_scores_gemma":[0.995376,0.0013478602,0.0011732125,0.00022775623,0.00002563269,0.00014667501,0.00006351442,0.00001895677,0.0016204295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988326,0.000019050347,0.00021982801,0.00039626786,0.00021643967,0.0003158018],"domain_scores_gemma":[0.9994899,0.00004674536,0.000076695156,0.0002304072,0.00008362751,0.00007264139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033094973,0.00023631817,0.0003694331,0.00016198777,0.00006729285,0.00002006285,0.000068055015,0.0000620341,0.000026917318],"category_scores_gemma":[0.0000070655597,0.0001316964,0.000034679146,0.00049026654,0.0000625518,0.00019920908,0.000010540032,0.000056488007,0.000016686581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034706704,0.007038248,0.96909183,0.00023757461,0.00013335834,0.0004186471,0.00012616103,0.000030307023,0.000057358775,0.00008563635,0.00014135322,0.019168854],"study_design_scores_gemma":[0.09480845,0.0019739533,0.8645209,0.002075627,0.000650989,0.000095698684,0.000268841,0.000016104996,0.023464998,0.000065726235,0.0117303245,0.00032840413],"about_ca_topic_score_codex":0.00026732098,"about_ca_topic_score_gemma":0.0007025422,"teacher_disagreement_score":0.10457095,"about_ca_system_score_codex":0.000111809866,"about_ca_system_score_gemma":0.00016635914,"threshold_uncertainty_score":0.5370423},"labels":[],"label_agreement":null},{"id":"W4407859877","doi":"10.1080/10428194.2025.2467801","title":"Clinical characteristics and disease outcomes of primary bone lymphoma in the rituximab era: a retrospective study from the Princess Margaret Cancer Center, Toronto, Canada","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Rituximab; Center (category theory); Retrospective cohort study; Disease; Cancer; Gerontology; Lymphoma; Internal medicine","score_opus":0.011134680906223465,"score_gpt":0.27865381948408596,"score_spread":0.26751913857786247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407859877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98384166,0.009093555,0.0000044055755,0.0023870098,0.0006979278,0.001994615,0.0009127354,0.000048418402,0.0010196485],"genre_scores_gemma":[0.98568285,0.0045816004,0.00007317566,0.00832742,0.00023570831,0.0005491444,0.000183145,0.000052127718,0.0003148218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504256,0.0005146878,0.001530338,0.0012070311,0.0009749166,0.0007304388],"domain_scores_gemma":[0.9963205,0.0011848102,0.0005199824,0.0013169026,0.00020410794,0.0004536934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006851552,0.0007772398,0.0019288608,0.00009267327,0.00038891958,0.00012833066,0.0005181355,0.0002561815,0.000039123002],"category_scores_gemma":[0.00039467437,0.00047556614,0.00028176527,0.00041159923,0.0005034017,0.00021760415,0.0004489923,0.00016047197,0.0000018784675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014279301,0.0027990877,0.88688517,0.0001363189,0.00084990566,0.00083234865,0.0010194822,5.076039e-7,0.0000064654546,0.00044612115,0.003902506,0.10169417],"study_design_scores_gemma":[0.04073015,0.0002805725,0.9485812,0.0005211346,0.0010987729,0.00006248427,0.0015663384,0.00019831164,0.000018069415,0.00013144886,0.0063984757,0.00041302358],"about_ca_topic_score_codex":0.6514654,"about_ca_topic_score_gemma":0.41783804,"teacher_disagreement_score":0.23362738,"about_ca_system_score_codex":0.01425547,"about_ca_system_score_gemma":0.01196508,"threshold_uncertainty_score":0.9997696},"labels":[],"label_agreement":null},{"id":"W4407975585","doi":"10.1016/j.jtct.2025.01.662","title":"The Role of Second-HSCT for Children with Relapsed Hematological Malignancies: A Single Center Experience","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Single Center; Medicine; Center (category theory); Pediatrics; Internal medicine","score_opus":0.010220891432548507,"score_gpt":0.23716373792628598,"score_spread":0.22694284649373747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500585,0.0029673036,0.0005988634,0.00019558368,0.000016594362,0.00048602582,0.000018213743,0.000013668878,0.00069792016],"genre_scores_gemma":[0.99804056,0.0012384168,0.00019463978,0.00019971255,0.000005430804,0.000107632455,0.000051874926,0.0000044189087,0.00015732353],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958843,0.000015366937,0.000120658384,0.00011866336,0.00006603145,0.00009082958],"domain_scores_gemma":[0.9997665,0.00006095637,0.000033353757,0.00008737532,0.0000271736,0.000024590112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037440022,0.00007574225,0.00012753776,0.000018793318,0.00008411922,0.000011660377,0.000030825733,0.00003209803,0.000016428565],"category_scores_gemma":[0.0000011409752,0.000039401657,0.00004364822,0.00004736105,0.00006772737,0.000020653573,0.0000012506447,0.000019058116,4.1116306e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062285075,0.0016113532,0.7199804,0.00017428366,0.000640108,0.000022050817,0.0074670734,0.0000013862166,0.20170735,0.019678444,0.00007160592,0.042417414],"study_design_scores_gemma":[0.009096341,0.0007694113,0.106981896,0.0001288025,0.00007552216,0.00007064864,0.0006305925,0.000017348604,0.87859136,0.0002976276,0.0032667252,0.00007375545],"about_ca_topic_score_codex":0.0000068180707,"about_ca_topic_score_gemma":0.000009549041,"teacher_disagreement_score":0.676884,"about_ca_system_score_codex":0.000008395355,"about_ca_system_score_gemma":0.000018854478,"threshold_uncertainty_score":0.16067529},"labels":[],"label_agreement":null},{"id":"W4408128725","doi":"10.1097/nm9.0000000000000023","title":"Diffuse Hypermetabolic Soft Tissue Nodules on FDG PET in Follicular Lymphoma","year":2025,"lang":"en","type":"article","venue":"Clinical nuclear medicine open.","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Soft tissue; Follicular lymphoma; Pathology; Medicine; Lymphoma; Nuclear medicine","score_opus":0.04149911377809925,"score_gpt":0.3945450803545788,"score_spread":0.3530459665764796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408128725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082193,0.0012306601,0.0000028654083,0.036265012,0.00090911606,0.0012931293,0.0000117393165,0.00009111225,0.051977083],"genre_scores_gemma":[0.9642438,0.001626576,0.00044176565,0.03028166,0.00045229142,0.00006566664,0.00006371122,0.000055857563,0.0027686574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714184,0.00020036651,0.0010695556,0.0007792609,0.00038195966,0.00042701102],"domain_scores_gemma":[0.99765795,0.0007942344,0.0001406356,0.00096640474,0.000070142996,0.00037063842],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00079531036,0.00033892138,0.0013709924,0.0002312994,0.00011211452,0.000043990633,0.00046796293,0.00018436629,0.0010174868],"category_scores_gemma":[0.0015397053,0.00023108702,0.00015845,0.00045696978,0.0003642821,0.00008575401,0.00032148528,0.0002502935,0.0009410803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021941462,0.01503096,0.1013696,0.00016566466,0.00060040894,0.0042145457,0.00022944447,0.0000029365535,0.00028740152,0.022075858,0.22533537,0.62849367],"study_design_scores_gemma":[0.021797368,0.0012438555,0.42234105,0.0008207461,0.0002733374,0.000042325017,0.00016073718,0.000107871194,0.000050663108,0.00025770662,0.5527537,0.00015067538],"about_ca_topic_score_codex":0.0006246917,"about_ca_topic_score_gemma":0.000052209147,"teacher_disagreement_score":0.628343,"about_ca_system_score_codex":0.00016555631,"about_ca_system_score_gemma":0.00017209211,"threshold_uncertainty_score":0.9998957},"labels":[],"label_agreement":null},{"id":"W4408162287","doi":"10.1111/bjh.20038","title":"A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Celgene","keywords":"Follicular lymphoma; Lymphoma; Medicine; Follicular phase; Lymphocyte; Immunology; Monocyte; Oncology; Internal medicine","score_opus":0.006197750062904729,"score_gpt":0.23811405283016207,"score_spread":0.23191630276725733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408162287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896726,0.0055595,0.00028217214,0.0035952986,0.00018352109,0.0004585193,0.000021906117,0.00002705996,0.00019940655],"genre_scores_gemma":[0.99610066,0.0009887554,0.0006948428,0.0012742969,0.000056644465,0.00006110345,0.00001601793,0.000036276622,0.0007713742],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99697006,0.00025136428,0.0011833598,0.0004667927,0.0005870368,0.00054141454],"domain_scores_gemma":[0.9978899,0.00030301136,0.0006338473,0.0003105216,0.0005836681,0.00027910242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048801966,0.00031190994,0.0017013713,0.00072092086,0.00012079883,0.00010551182,0.00027479714,0.00027879325,0.000059880957],"category_scores_gemma":[0.00073652744,0.00029653718,0.0003337689,0.0011810523,0.00009822996,0.00021237967,0.00007848676,0.0002476744,0.000029051685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039169714,0.0047731996,0.3272388,0.00026326117,0.006985614,0.6068297,0.0015773488,0.00055116526,0.00067322614,0.00096344465,0.0073379995,0.038889244],"study_design_scores_gemma":[0.053150125,0.0018915103,0.81104094,0.008236833,0.002656568,0.10548423,0.00042543374,0.0003223944,0.014304735,0.0008001024,0.0010648647,0.0006222425],"about_ca_topic_score_codex":0.0025028053,"about_ca_topic_score_gemma":0.0018162439,"teacher_disagreement_score":0.5013455,"about_ca_system_score_codex":0.0016195227,"about_ca_system_score_gemma":0.001378107,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W4408420587","doi":"10.1101/2025.03.11.642396","title":"The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Pathology","score_opus":0.01402737962560652,"score_gpt":0.24534745094329405,"score_spread":0.23132007131768753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408420587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97235227,0.0232439,0.000009837123,0.00078423787,0.0010028718,0.0018837864,0.00042796487,0.00021948805,0.000075638636],"genre_scores_gemma":[0.9767644,0.02060158,0.0008099076,0.00034370326,0.0002306536,0.0011203897,0.0000014089594,0.00008182277,0.000046180932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968595,0.00013382782,0.00076734426,0.0010196847,0.0005209322,0.000698749],"domain_scores_gemma":[0.99644864,0.00039355,0.00050450553,0.001569292,0.00072573865,0.00035826187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046286726,0.0007110027,0.0010213347,0.00025340082,0.00031013455,0.00016550148,0.00041498384,0.00054490275,0.000015028837],"category_scores_gemma":[0.00028734116,0.0005321051,0.00028007088,0.0005873353,0.00023804072,0.00007353266,0.0007470707,0.00030854536,0.000024591185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003290775,0.014586293,0.9592493,0.0032009194,0.0016124562,0.00029188907,0.00004550977,0.0000013015473,0.009900724,0.0039755376,0.006714252,0.00009273048],"study_design_scores_gemma":[0.009970095,0.00035585256,0.6281887,0.0018483249,0.001486015,8.042669e-8,0.000009536077,0.00008376513,0.26536423,0.000003982106,0.09203596,0.0006534508],"about_ca_topic_score_codex":0.000139874,"about_ca_topic_score_gemma":0.0000078769635,"teacher_disagreement_score":0.3310606,"about_ca_system_score_codex":0.00039716795,"about_ca_system_score_gemma":0.001178316,"threshold_uncertainty_score":0.99971306},"labels":[],"label_agreement":null},{"id":"W4408444351","doi":"10.1016/j.ijrobp.2025.03.011","title":"An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Radiation oncology; Lymphoma; Oncology; Radiology; Internal medicine","score_opus":0.021680709389471958,"score_gpt":0.36162387281614805,"score_spread":0.3399431634266761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408444351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860065,0.0007486845,0.002906503,0.0020541574,0.006073741,0.0012960426,0.00015157489,0.000051882842,0.0007109248],"genre_scores_gemma":[0.99274725,0.0014493538,0.0013522324,0.0010877101,0.0024002986,0.00017627772,0.0007065764,0.0000400467,0.000040261246],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965224,0.00043549365,0.00168598,0.0004976818,0.0005243204,0.0003341262],"domain_scores_gemma":[0.99552596,0.00073102466,0.0019755,0.00031493674,0.0012676115,0.00018495043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008827747,0.00038213955,0.00095698185,0.00068025955,0.00012994942,0.000062022904,0.0006226559,0.00043058733,0.000074920245],"category_scores_gemma":[0.0003043195,0.0003311965,0.0004408129,0.0002949774,0.00016182465,0.0006728536,0.0000720806,0.00021425493,0.000008133844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003446087,0.009286098,0.45821536,0.000008957183,0.00208003,0.00004517849,0.001115324,0.00032957207,0.0019344524,0.0072107557,0.00048979034,0.5158384],"study_design_scores_gemma":[0.086168565,0.021917468,0.8202411,0.000104725026,0.0006119331,0.000271622,0.0007342661,0.005284711,0.010036983,0.0049220547,0.049307358,0.00039923177],"about_ca_topic_score_codex":0.0001466104,"about_ca_topic_score_gemma":0.00001782861,"teacher_disagreement_score":0.51543915,"about_ca_system_score_codex":0.003296377,"about_ca_system_score_gemma":0.0014161676,"threshold_uncertainty_score":0.999914},"labels":[],"label_agreement":null},{"id":"W4408475496","doi":"10.1182/bloodadvances.2024014707","title":"Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Rituximab; Vincristine; Hazard ratio; CHOP; Gastroenterology; Cyclophosphamide; Diffuse large B-cell lymphoma; Neutropenia; Lymphoma; Febrile neutropenia; Adverse effect; Confidence interval; Subgroup analysis; Surgery; Chemotherapy","score_opus":0.004697327659869831,"score_gpt":0.2778089905230055,"score_spread":0.27311166286313565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408475496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967454,0.00178223,0.0000068043523,0.000055022727,0.000030713534,0.0006659356,0.000047097736,0.00001181842,0.0006549544],"genre_scores_gemma":[0.99933004,0.00010293872,0.000076618024,0.00022767895,0.000008810475,0.00009003066,0.000054823013,0.0000069653534,0.00010208589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989632,0.00006380501,0.0002457975,0.0002492688,0.000293048,0.0001849062],"domain_scores_gemma":[0.9993479,0.000109595276,0.000097573204,0.00035704058,0.000051828236,0.000036016914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110599496,0.00013606918,0.00039421118,0.00027192247,0.000040307805,0.000013794015,0.00011264138,0.000027737531,0.000014211586],"category_scores_gemma":[0.000018732142,0.00007808318,0.00009961723,0.0011184884,0.00003239941,0.0000747115,0.00002846726,0.000034749788,0.0000020605487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017248538,0.112227395,0.8802234,0.000027371441,0.0009598482,0.00016828006,0.0013484763,0.0000026690243,0.000013083358,0.000037458853,0.00002097924,0.0047985357],"study_design_scores_gemma":[0.06350763,0.0011203727,0.9283563,0.000052257015,0.0041245604,6.1856844e-7,0.0015531856,0.000016163764,0.0004624587,0.000005459197,0.0007305885,0.00007043451],"about_ca_topic_score_codex":0.00021577325,"about_ca_topic_score_gemma":0.00063164975,"teacher_disagreement_score":0.11110702,"about_ca_system_score_codex":0.000033846198,"about_ca_system_score_gemma":0.000045207005,"threshold_uncertainty_score":0.31841397},"labels":[],"label_agreement":null},{"id":"W4408475501","doi":"10.1101/2025.03.11.25323696","title":"High-grade B-cell lymphoma, not otherwise specified: an LLMPP study","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Toronto; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Terry Fox Research Institute; Provincial Health Services Authority; Genome British Columbia; Michael Smith Health Research BC; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"Lymphoma; Computer science; Medicine; Internal medicine","score_opus":0.037668656769116696,"score_gpt":0.3028845164536961,"score_spread":0.2652158596845794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408475501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855648,0.0009435534,0.000014695117,0.0011180375,0.0017431504,0.0025038507,0.00017314166,0.00029561244,0.0076431367],"genre_scores_gemma":[0.9874462,0.00040916383,0.0009756742,0.00092204224,0.000758466,0.00063881115,0.00019920654,0.00007995104,0.008570469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634624,0.00023566601,0.000722926,0.00140743,0.000757667,0.00053005543],"domain_scores_gemma":[0.99668264,0.00015418872,0.00027034382,0.0023372567,0.00014021796,0.00041534274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039126107,0.0007582462,0.0012966808,0.00034671326,0.00012704356,0.00010619791,0.0005236837,0.0004144175,0.00042533054],"category_scores_gemma":[0.00004823405,0.0006095489,0.00040141118,0.0002585224,0.000078928984,0.00005414325,0.00058541994,0.00032669216,0.000330493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009908982,0.06896793,0.8872787,0.0009067702,0.0018310614,0.0037821436,0.0030822111,0.00008534129,0.0005002006,0.00072753354,0.0058138794,0.026033325],"study_design_scores_gemma":[0.0188931,0.0013519715,0.94233114,0.00039567,0.00180072,0.000022033324,0.0006251082,0.000080646976,0.018394088,0.00023959833,0.015127955,0.00073794776],"about_ca_topic_score_codex":0.0018994351,"about_ca_topic_score_gemma":0.00034007107,"teacher_disagreement_score":0.067615956,"about_ca_system_score_codex":0.0006204663,"about_ca_system_score_gemma":0.0005707277,"threshold_uncertainty_score":0.9996356},"labels":[],"label_agreement":null},{"id":"W4408738577","doi":"10.1002/pbc.31687","title":"Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B‐Cell Non‐Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions","year":2025,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Cog; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Family medicine","score_opus":0.015116845789944974,"score_gpt":0.318748492705669,"score_spread":0.30363164691572403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408738577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9011101,0.09695889,0.0000010754774,0.000098164026,0.000063729785,0.0011115684,0.00046566868,0.0000072327816,0.00018356416],"genre_scores_gemma":[0.97354203,0.025861518,0.000045291792,0.00003429554,0.00007052571,0.00021890635,0.0002165435,0.000008758323,0.0000021053024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988412,0.00012696456,0.0002935885,0.0003504267,0.00018888981,0.00019890175],"domain_scores_gemma":[0.99904525,0.00010292108,0.0003947346,0.00022258874,0.0001731375,0.00006133774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086972235,0.00023146432,0.00047641082,0.00017394267,0.00006986176,0.000022844815,0.0000804806,0.00010221133,0.0000029991943],"category_scores_gemma":[0.000022199052,0.0001376612,0.000048702892,0.00045103751,0.00013101292,0.000105405,0.000043109398,0.000096918266,1.9774316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037069665,0.0024613363,0.98030764,0.0005640444,0.00022516609,0.00001909851,0.0039435383,0.000007884564,0.000004571697,0.000030018853,0.000041392734,0.012024631],"study_design_scores_gemma":[0.011191049,0.0015211249,0.9810504,0.00028145526,0.002782968,0.000026254093,0.0027357198,7.276236e-7,0.0002668204,0.0000018342581,0.000034755165,0.00010692834],"about_ca_topic_score_codex":0.022104304,"about_ca_topic_score_gemma":0.014817162,"teacher_disagreement_score":0.072431944,"about_ca_system_score_codex":0.00019246721,"about_ca_system_score_gemma":0.0017332536,"threshold_uncertainty_score":0.9844076},"labels":[],"label_agreement":null},{"id":"W4408751629","doi":"10.63485/v26bd-pbv25","title":"Latest additions to DOAJ: 35 new entries (part 2)","year":2008,"lang":"en","type":"preprint","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.05553895516374124,"score_gpt":0.3229849493733408,"score_spread":0.2674459942095996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408751629","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26169547,0.004658941,0.00045345136,0.092907585,0.0035815183,0.0052700187,0.0017748998,0.0013399886,0.62831813],"genre_scores_gemma":[0.7253832,0.017016008,0.019406954,0.014876305,0.004272849,0.0012701773,0.0053687147,0.00014102593,0.21226478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987171,0.000012315306,0.0002899531,0.00045124465,0.00026844916,0.0002608887],"domain_scores_gemma":[0.998686,0.000086801345,0.000060762486,0.0005920706,0.00007590527,0.000498429],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000025618927,0.00028666662,0.00046744628,0.000139653,0.00007833664,0.000039429095,0.00009119226,0.00019973928,0.0084155025],"category_scores_gemma":[0.000063298605,0.00021804521,0.0002286704,0.00010716962,0.00003400758,0.000022015949,0.00025034318,0.0001559177,0.0022394664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002880312,0.0005250371,0.011615649,0.000033712146,0.00026617676,0.00028517388,0.00017533914,0.000032076743,0.0000064400497,0.00062145904,0.98156047,0.00484968],"study_design_scores_gemma":[0.0013553735,0.0001616171,0.05313311,0.00051646476,0.00033564356,0.00011974293,0.00003028412,0.0000074954423,0.0026399253,0.00041430167,0.9410128,0.0002732477],"about_ca_topic_score_codex":0.0010636616,"about_ca_topic_score_gemma":0.000121242636,"teacher_disagreement_score":0.46368772,"about_ca_system_score_codex":0.0002795138,"about_ca_system_score_gemma":0.00065133284,"threshold_uncertainty_score":0.9985374},"labels":[],"label_agreement":null},{"id":"W4408777282","doi":"10.1016/j.labinv.2024.102579","title":"352 Cytopathology and Hematopathology Review of Head and Neck Biopsy Specimens with a Diagnosis of Lymphoma","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hematopathology; Cytopathology; Head and neck; Pathology; Medicine; Lymphoma; Biopsy; Cytology; Biology; Surgery; Cytogenetics","score_opus":0.010259548819636158,"score_gpt":0.2638638331821389,"score_spread":0.25360428436250276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408777282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96496975,0.032043893,0.000005042756,0.0021965266,0.000033432956,0.00039599065,0.000037849164,0.000016644544,0.00030086996],"genre_scores_gemma":[0.9835822,0.011261385,0.002694652,0.002261443,0.000014265815,0.00012716102,0.000029416697,0.000009344417,0.000020139973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991568,0.00008259944,0.00032304053,0.00023253495,0.00010120117,0.000103842816],"domain_scores_gemma":[0.9992113,0.00008835102,0.00018067751,0.0002290971,0.00021173971,0.000078814905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015520307,0.00013098479,0.0004861338,0.00011295747,0.000029020393,0.0000036780718,0.00002697534,0.00007794814,0.00001214333],"category_scores_gemma":[0.00013992046,0.000100023135,0.000022486696,0.00039211893,0.00037769382,0.000054292697,0.00002846069,0.000030500814,0.000001206807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048200276,0.0001848324,0.98073196,0.004598165,0.00005441665,0.0000804921,0.00017294752,9.3530375e-8,0.005097216,0.0069996463,0.0003560418,0.0016759664],"study_design_scores_gemma":[0.0023607276,0.0005501314,0.9226936,0.008483241,0.00034934466,0.00015343326,0.000051518968,0.0000036318725,0.06392688,0.00035882217,0.0009877018,0.00008093328],"about_ca_topic_score_codex":0.00002562345,"about_ca_topic_score_gemma":0.000010824683,"teacher_disagreement_score":0.05882967,"about_ca_system_score_codex":0.000041727057,"about_ca_system_score_gemma":0.00021932667,"threshold_uncertainty_score":0.4078825},"labels":[],"label_agreement":null},{"id":"W4408796326","doi":"10.1016/j.labinv.2024.103456","title":"1220 The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Phenotype; Lymphoma; Pathology; Anaplastic lymphoma kinase; Biology; Computational biology; Evolutionary biology; Medicine; Genetics; Gene","score_opus":0.012291921041415523,"score_gpt":0.26380651541489114,"score_spread":0.2515145943734756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408796326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620765,0.0005423425,0.00011374294,0.0011452942,0.000159468,0.0007661309,0.000026149026,0.000056230154,0.0009830107],"genre_scores_gemma":[0.9980499,0.000011661997,0.0002289975,0.0012036257,0.00006294676,0.00008800383,0.00014000935,0.000014656262,0.00020020697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876165,0.00015230307,0.0003411991,0.0002981202,0.00027788652,0.00016886038],"domain_scores_gemma":[0.9988149,0.00007007327,0.00016193694,0.00057119137,0.00022229373,0.00015963717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021862933,0.0001641136,0.00023850643,0.00011603918,0.00010455876,0.000031783416,0.00010752771,0.0000793382,0.0000609055],"category_scores_gemma":[0.00008346352,0.00011858481,0.000044673216,0.00074542663,0.00006357493,0.00011432916,0.000026619122,0.00005366069,0.000021496531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015141538,0.003961902,0.96229523,0.00013327043,0.00021835434,0.00006413148,0.0025299368,0.000024883742,0.010986923,0.009706692,0.0077425465,0.0021847019],"study_design_scores_gemma":[0.0071732393,0.0007729155,0.95047444,0.000078908015,0.00053730846,0.0000021064518,0.0020556096,0.000602433,0.034776915,0.0006381135,0.002758729,0.00012926954],"about_ca_topic_score_codex":0.000056960394,"about_ca_topic_score_gemma":0.000087548724,"teacher_disagreement_score":0.02378999,"about_ca_system_score_codex":0.000096505966,"about_ca_system_score_gemma":0.0010129152,"threshold_uncertainty_score":0.4835748},"labels":[],"label_agreement":null},{"id":"W4408796352","doi":"10.1016/j.labinv.2024.103528","title":"1292 Real-Life Comparison of Overall and Event-Free Survival Among Peripheral T Cell Lymphomas with T Follicular Helper Immunophenotype and PTCL Not Otherwise Specified","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital","funders":"","keywords":"Immunophenotyping; Follicular phase; Peripheral; Event (particle physics); Medicine; Peripheral T-cell lymphoma; T cell; Immunology; Internal medicine; Flow cytometry; Immune system","score_opus":0.01264021852347211,"score_gpt":0.2524911229797006,"score_spread":0.2398509044562285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408796352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959312,0.0017670584,0.000027560578,0.0005740795,0.00010528282,0.00046519324,0.000037162656,0.00004268525,0.001049793],"genre_scores_gemma":[0.9981666,0.00018835152,0.0007815077,0.0004792758,0.00004700303,0.000041448962,0.000050422732,0.00002363226,0.00022171484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987613,0.000104703526,0.00035527247,0.00032524203,0.0002810028,0.0001725043],"domain_scores_gemma":[0.9989554,0.00007088203,0.00018384063,0.000422496,0.00018991255,0.00017745176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015143646,0.00022496349,0.00045883268,0.000085270156,0.000099326615,0.000041302064,0.000066989625,0.000121223646,0.000027759337],"category_scores_gemma":[0.00005788121,0.00018161962,0.000035589055,0.0002735508,0.00027697184,0.00014756425,0.00004882896,0.00007555104,0.0000017913601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046846503,0.00027938574,0.96523654,0.00021927877,0.000194537,0.000018740424,0.0011468463,0.00004067448,0.026896752,0.0047509014,0.0005657408,0.00018213081],"study_design_scores_gemma":[0.006693745,0.00036556585,0.914046,0.00021884969,0.0002567477,0.0000012533794,0.00044155953,0.00043704722,0.076718934,0.00019919587,0.000453175,0.00016794713],"about_ca_topic_score_codex":0.0005580338,"about_ca_topic_score_gemma":0.00021659277,"teacher_disagreement_score":0.05119057,"about_ca_system_score_codex":0.00014782917,"about_ca_system_score_gemma":0.00035775852,"threshold_uncertainty_score":0.7406233},"labels":[],"label_agreement":null},{"id":"W4408796376","doi":"10.1016/j.labinv.2024.103492","title":"1256 Unveiling the Molecular Distinction Between DLBCL-NOS and Large B-cell Lymphoma of Immune Privileged Sites (LBCL-IPS): Decoding the TLR4-MYD88 Axis","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Cancer research; Lymphoma; Medicine; Immunology","score_opus":0.00934248179826877,"score_gpt":0.24617800732784675,"score_spread":0.23683552552957798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408796376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292356,0.0032508625,0.00028599004,0.0021604437,0.00012429485,0.0006574453,0.00004609365,0.000056417917,0.000494915],"genre_scores_gemma":[0.9984493,0.00008923939,0.00031409203,0.0007814454,0.00007946723,0.00008851214,0.0001247911,0.00001860637,0.00005449954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985539,0.00020790924,0.00046763514,0.00028978984,0.00026259446,0.00021821569],"domain_scores_gemma":[0.998605,0.00038205282,0.0002499721,0.00045288313,0.00022415453,0.00008592267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057926314,0.00020643737,0.00029819,0.000095130265,0.00034197306,0.000053109037,0.000113636386,0.00011556168,0.000009944896],"category_scores_gemma":[0.00032074112,0.00013057038,0.00008381537,0.0006193003,0.00022772777,0.00012523985,0.00007759759,0.000106525025,0.000007360945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042294585,0.00044067376,0.9223504,0.0002680619,0.00025084196,0.000011238978,0.0011053267,0.0000060484886,0.06251585,0.008406389,0.00033528227,0.004267601],"study_design_scores_gemma":[0.0043455656,0.00010961423,0.6350059,0.00025994205,0.0005178371,0.0000023541734,0.0005848177,0.0004285086,0.35573816,0.0008209998,0.0020591656,0.00012712278],"about_ca_topic_score_codex":0.0000721319,"about_ca_topic_score_gemma":0.000024845964,"teacher_disagreement_score":0.2932223,"about_ca_system_score_codex":0.00015242235,"about_ca_system_score_gemma":0.00028688603,"threshold_uncertainty_score":0.53245056},"labels":[],"label_agreement":null},{"id":"W4408914453","doi":"10.1080/10428194.2025.2482890","title":"Analysis of a cancer-care based diagnosis program for lymphoma","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Lymphoma; Cancer; Medicine; Medical physics; Intensive care medicine; Oncology; Internal medicine","score_opus":0.01046438545395141,"score_gpt":0.30284193546222354,"score_spread":0.29237755000827215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97384506,0.01663977,0.00020356955,0.00063624897,0.00044348804,0.0032702738,0.0006709553,0.00042585752,0.0038647635],"genre_scores_gemma":[0.982867,0.0021882849,0.0033439533,0.0019351525,0.00016554884,0.007899335,0.0008475226,0.00010768654,0.0006455233],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99488544,0.00012123049,0.0014200966,0.0016280932,0.0007511076,0.0011940071],"domain_scores_gemma":[0.99575275,0.00096677686,0.00056420907,0.0013771419,0.0007544092,0.0005846953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028655442,0.00103745,0.0024463397,0.0016631971,0.0004719318,0.00016043335,0.00045466374,0.00069820986,0.00012142037],"category_scores_gemma":[0.00020999815,0.00091560575,0.001583111,0.0033684343,0.00048470596,0.00020057485,0.00019665074,0.000064886925,0.000009125963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001364913,0.0014173327,0.35491222,0.0012169578,0.0056972657,0.00009444877,0.00042065085,0.0002210135,0.0001995864,0.000840132,0.0028877303,0.63072777],"study_design_scores_gemma":[0.042614937,0.0010530807,0.81275326,0.0011644982,0.020354273,0.000025612422,0.0007516034,0.024126826,0.025084142,0.00011480207,0.07103457,0.0009223676],"about_ca_topic_score_codex":0.0054275566,"about_ca_topic_score_gemma":0.0008480853,"teacher_disagreement_score":0.6298054,"about_ca_system_score_codex":0.010756712,"about_ca_system_score_gemma":0.007311396,"threshold_uncertainty_score":0.99932945},"labels":[],"label_agreement":null},{"id":"W4408990065","doi":"10.1038/s41375-025-02563-0","title":"Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Moonshot Research and Development Program; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; Gilead Sciences; Kobayashi Foundation for Cancer Research; Japan Science and Technology Agency; Leukemia and Lymphoma Society","keywords":"Tumor microenvironment; Biology; Lymphoma; Chromosome instability; Follicular lymphoma; Exome sequencing; Genome instability; Immune system; Exome; Cancer research; Peripheral T-cell lymphoma; T cell; Immunology; Oncology; Medicine; Chromosome; Gene; Mutation; Genetics","score_opus":0.003155162568191225,"score_gpt":0.20795986439047304,"score_spread":0.2048047018222818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408990065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133873,0.0045168954,0.000036569825,0.00063577306,0.00008685528,0.00036240037,0.00000873652,0.00003969508,0.0029743607],"genre_scores_gemma":[0.99045837,0.0002607591,0.001277238,0.001673041,0.000022456104,0.000061103776,0.000015297775,0.000019865385,0.006211871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990829,0.000019984132,0.00016668039,0.00033786942,0.00015047227,0.0002420727],"domain_scores_gemma":[0.9995078,0.000049937677,0.000050597162,0.0002711595,0.000012185435,0.00010835699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002571357,0.00022809167,0.00031410003,0.000053509983,0.00008887288,0.000033320186,0.000056350676,0.00006460485,0.0000548293],"category_scores_gemma":[0.000005898751,0.00014505531,0.00006794795,0.000071499824,0.00010789543,0.000030075795,0.000052705007,0.00006447063,0.00002054089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031445269,0.0002713453,0.9878594,0.0001110883,0.00027032857,0.0005812137,0.00018744929,0.00010144884,0.001869735,0.00011052406,0.001401286,0.0069217146],"study_design_scores_gemma":[0.0074433624,0.0003081542,0.9806606,0.0001261552,0.00034979518,0.000060082897,0.00007784874,0.00022937711,0.0051887864,0.000038392023,0.0053634066,0.00015403621],"about_ca_topic_score_codex":0.00018594894,"about_ca_topic_score_gemma":0.000028427745,"teacher_disagreement_score":0.00719881,"about_ca_system_score_codex":0.0006038056,"about_ca_system_score_gemma":0.00017222398,"threshold_uncertainty_score":0.59151834},"labels":[],"label_agreement":null},{"id":"W4409140497","doi":"10.1182/blood.2024027782","title":"The immunotherapy real estate of Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Immunotherapy; Immunology; Internal medicine; Immune system","score_opus":0.006475643344723708,"score_gpt":0.26360044880184796,"score_spread":0.25712480545712424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409140497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292016,0.0011905471,0.0000026872956,0.00093850016,0.00008269224,0.00019058074,0.0000045218685,0.000023429671,0.06836546],"genre_scores_gemma":[0.9880076,0.010250611,0.0001844882,0.00014429179,0.000023404411,0.00004312038,0.0000047566314,0.00000702122,0.0013347077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994943,0.000020953805,0.00016012182,0.000100587626,0.00010218647,0.00012181779],"domain_scores_gemma":[0.9994681,0.00012500217,0.00004404208,0.00029834322,0.000040383184,0.000024152936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008327675,0.000074251824,0.0001512715,0.000030765037,0.00006725598,0.000010170851,0.00006372122,0.000031039417,0.000012781474],"category_scores_gemma":[0.000016420789,0.000042534426,0.000084559426,0.00011581091,0.00005372483,0.000011794124,0.000017727885,0.00001591973,0.000009865739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031925674,0.0029764185,0.20780136,0.000039960923,0.0010871866,0.000071938455,0.00030904738,3.7655832e-7,0.0055059157,0.00471721,0.001541419,0.77562994],"study_design_scores_gemma":[0.013424695,0.00035138568,0.8354858,0.00009439758,0.0002773779,0.000022287313,0.00009256751,0.0000064684455,0.11603296,0.0003321827,0.033821262,0.00005860229],"about_ca_topic_score_codex":0.0004164346,"about_ca_topic_score_gemma":0.000026778398,"teacher_disagreement_score":0.7755713,"about_ca_system_score_codex":0.000030443163,"about_ca_system_score_gemma":0.00013098927,"threshold_uncertainty_score":0.17345035},"labels":[],"label_agreement":null},{"id":"W4409146559","doi":"10.33137/utmj.v102i1.42092","title":"A Huge Primary Retroperitoneal Diffuse Large B-cell Lymphoma: A Case Report","year":2025,"lang":"en","type":"article","venue":"University of Toronto Medical Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Primary (astronomy); Pathology; Radiology; Physics","score_opus":0.005261506697505758,"score_gpt":0.2300229159150718,"score_spread":0.22476140921756604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409146559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9003005,0.0029364235,0.00040527096,0.0018472718,0.0003589882,0.00016580807,0.000014278613,0.000032778113,0.09393867],"genre_scores_gemma":[0.9877899,0.0014340414,0.0011609698,0.00051043014,0.00014661544,2.730828e-7,0.000016622804,0.00000805779,0.00893308],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985167,0.000072285125,0.00029541945,0.00021645824,0.0006236114,0.0002755556],"domain_scores_gemma":[0.99876297,0.00007091118,0.00016786142,0.00027200405,0.00016898179,0.0005573002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037420014,0.00014025506,0.00042833947,0.000056861936,0.00024417337,0.000012208227,0.00015635673,0.00017820694,0.0014010096],"category_scores_gemma":[0.00012952083,0.00011992895,0.00026754473,0.000057644742,0.00013105688,0.0001358447,0.00015352911,0.00014825752,0.000008152424],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007726842,0.013288254,0.0220835,0.00014907589,0.00048844307,0.8741554,0.00067030964,6.6159856e-8,0.00008302572,0.00024185913,0.042299,0.04576838],"study_design_scores_gemma":[0.10339472,0.0011466888,0.12276116,0.0011358365,0.0016628953,0.34553492,0.005546389,0.000280316,0.0003310787,0.000027375558,0.41781002,0.00036858808],"about_ca_topic_score_codex":0.0061110514,"about_ca_topic_score_gemma":0.0018895774,"teacher_disagreement_score":0.5286205,"about_ca_system_score_codex":0.0013549787,"about_ca_system_score_gemma":0.0012059745,"threshold_uncertainty_score":0.99951184},"labels":[],"label_agreement":null},{"id":"W4409504327","doi":"10.1038/s43018-025-00967-6","title":"Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial","year":2025,"lang":"en","type":"erratum","venue":"Nature Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; Clinical trial; Phases of clinical research; Lymphoma; Materials science","score_opus":0.005353447077030111,"score_gpt":0.2809839314133019,"score_spread":0.2756304843362718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409504327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88922215,0.06960869,0.000012889609,0.0010058238,0.026355304,0.0053430786,0.0013952971,0.00011634845,0.006940447],"genre_scores_gemma":[0.81318283,0.01618939,0.000106926,0.00296093,0.0020857297,0.0011833257,0.009844874,0.0001864608,0.15425955],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692255,0.00015811519,0.00069335505,0.0010711019,0.0006569637,0.00049788645],"domain_scores_gemma":[0.9983735,0.0002152197,0.0004048642,0.0006494778,0.00016532217,0.0001916042],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00020047119,0.000666853,0.0017446443,0.0010922521,0.00009572465,0.0000427545,0.00014122047,0.0017710909,0.00016140513],"category_scores_gemma":[0.00006612993,0.0005003451,0.0002733524,0.0015948429,0.000058013044,0.00010625646,0.00005523773,0.0014577941,0.000002281129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23282374,0.063403934,0.10356894,0.00044419794,0.0030464083,0.00034530988,0.0005682543,0.000011307644,0.0000017959378,0.000006923617,0.52950084,0.06627835],"study_design_scores_gemma":[0.4137879,0.0011734664,0.319652,0.00067308906,0.0018589125,7.2920267e-7,0.000013652462,0.00005167282,0.000008881855,9.740726e-7,0.2624594,0.00031933215],"about_ca_topic_score_codex":0.00037386167,"about_ca_topic_score_gemma":0.0013370828,"teacher_disagreement_score":0.26704141,"about_ca_system_score_codex":0.003483813,"about_ca_system_score_gemma":0.0015354275,"threshold_uncertainty_score":0.99974483},"labels":[],"label_agreement":null},{"id":"W4409557260","doi":"10.3390/siuj6020028","title":"Features and Management of Incidental Prostatic Lymphoma Obtained in Lower Urinary Tract Symptoms Surgery: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Société Internationale d’Urologie Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Urinary system; Lower urinary tract symptoms; Urology; Lymphoma; General surgery; Surgery; Prostate; Internal medicine; Cancer","score_opus":0.030761574576359713,"score_gpt":0.35539830120763466,"score_spread":0.32463672663127496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409557260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089486706,0.99384457,0.0000021226815,0.00040037208,0.00045956977,0.0031358283,0.000057317888,0.000021708496,0.0011836307],"genre_scores_gemma":[0.002900775,0.9942031,0.00009342962,0.00043889196,0.000065807915,0.0007679594,0.00016478886,0.000025559688,0.0013397055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963844,0.00040245423,0.0018374312,0.00039389462,0.00067858683,0.0003032779],"domain_scores_gemma":[0.99655044,0.0014513083,0.0013867877,0.00031990837,0.00017155588,0.00011998668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010429582,0.0004984627,0.0035042344,0.0006056408,0.00006108618,0.000054061868,0.00026802032,0.00022314394,0.00007990307],"category_scores_gemma":[0.00053549494,0.00033648856,0.0011087172,0.00033560797,0.00008102496,0.00011108648,0.00018160329,0.00031124352,0.000006522154],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054946835,0.0018580621,0.0014386497,0.8402464,0.0026785575,0.0053181793,0.000028274142,1.3302868e-7,1.45066e-8,0.00017260939,0.0014862877,0.14671794],"study_design_scores_gemma":[0.0017861999,0.00041374323,0.0108095575,0.95353967,0.008483743,0.01484222,0.000073693795,0.0000019426677,2.3393781e-7,0.000114510425,0.009660803,0.0002737116],"about_ca_topic_score_codex":0.000009250049,"about_ca_topic_score_gemma":0.0000012179592,"teacher_disagreement_score":0.14644422,"about_ca_system_score_codex":0.0010726297,"about_ca_system_score_gemma":0.0006466742,"threshold_uncertainty_score":0.9999087},"labels":[],"label_agreement":null},{"id":"W4409606510","doi":"10.3390/genes16040467","title":"Splenic Diffuse Red Pulp Small B-Cell Lymphoma with Overlapping Clinical and Immunophenotypic Features with Hairy Cell Leukaemia: A Case Report and a Review of the Literature","year":2025,"lang":"en","type":"review","venue":"Genes","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; McMaster University; University of Toronto","funders":"","keywords":"Red pulp; Splenic marginal zone lymphoma; Immunophenotyping; Pathology; Pancytopenia; Hairy cell leukemia; Hairy Cell; Medicine; Bone marrow; Lymphoma; Lymphocytosis; Large-cell lymphoma; B cell; Leukemia; Splenectomy; Spleen; Immunology; Antigen","score_opus":0.02089754210430024,"score_gpt":0.2935370185562373,"score_spread":0.2726394764519371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409606510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017765187,0.9790862,6.7159215e-7,0.00012130293,0.00012851392,0.002382145,0.0000724415,0.00002666543,0.00041684907],"genre_scores_gemma":[0.00062161137,0.9954808,0.00062514626,0.00032324233,0.00011948795,0.0002817756,0.00013634778,0.000054155265,0.0023574336],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99733543,0.00027363058,0.0010093458,0.0008336978,0.00026287985,0.0002850264],"domain_scores_gemma":[0.99712384,0.00038861667,0.00088234904,0.0012730287,0.00017444478,0.00015772515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036555275,0.00066344766,0.0027793578,0.000108848886,0.00013505526,0.00005679485,0.00014658208,0.0004190951,0.000004925473],"category_scores_gemma":[0.00010645969,0.00030814865,0.00049382413,0.00048687728,0.00021928977,0.000037721544,0.00021414502,0.00031418298,7.102335e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016444632,0.00095757295,0.0037874775,0.37090898,0.00092835503,0.040349428,0.000097410244,2.8059295e-8,0.0000012318866,0.000009527904,0.001028513,0.581767],"study_design_scores_gemma":[0.0065954966,0.0006531436,0.003700743,0.5135787,0.01451738,0.13864318,0.000042956308,3.3192342e-7,0.000022165825,0.000003764995,0.32175952,0.00048264163],"about_ca_topic_score_codex":0.000085616244,"about_ca_topic_score_gemma":0.00005862339,"teacher_disagreement_score":0.5812844,"about_ca_system_score_codex":0.00010782238,"about_ca_system_score_gemma":0.0013311185,"threshold_uncertainty_score":0.99993706},"labels":[],"label_agreement":null},{"id":"W4409684616","doi":"10.1080/10428194.2025.2495112","title":"The paradox of the spleen: is it a nodal or extranodal site of lymphoma?","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"NODAL; Spleen; Lymphoma; Medicine; Pathology; Internal medicine","score_opus":0.012184667552049428,"score_gpt":0.26549384872640247,"score_spread":0.253309181174353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409684616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764958,0.00640062,0.00003397801,0.0035416433,0.0007492476,0.0013502886,0.00017723443,0.00009116638,0.011160008],"genre_scores_gemma":[0.98355556,0.0030182756,0.00030603548,0.0034391147,0.00018465405,0.0002229728,0.000032567958,0.000080993115,0.009159843],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948004,0.0002380147,0.0017024912,0.001060298,0.0011259125,0.0010728929],"domain_scores_gemma":[0.9952235,0.0012140174,0.0007315982,0.002084118,0.00037973202,0.00036699336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005680625,0.00090870855,0.0015097492,0.00028365495,0.0007904043,0.0001244621,0.00079294853,0.00056809117,0.0001370318],"category_scores_gemma":[0.00028468805,0.0005050969,0.0008996543,0.0014171702,0.0013202071,0.00020422623,0.00052861206,0.00011891644,0.000042549007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010662076,0.0026164928,0.21862602,0.0019435382,0.0037816302,0.00059803104,0.0055851317,0.00004150155,0.00920983,0.0148630375,0.074196845,0.65787584],"study_design_scores_gemma":[0.042805254,0.00071800494,0.7131546,0.0018353587,0.0018784617,0.0011523683,0.0015438254,0.0022489678,0.081881166,0.00076265325,0.15121965,0.0007996745],"about_ca_topic_score_codex":0.0030326128,"about_ca_topic_score_gemma":0.00037693663,"teacher_disagreement_score":0.6570762,"about_ca_system_score_codex":0.004141754,"about_ca_system_score_gemma":0.007820871,"threshold_uncertainty_score":0.99974006},"labels":[],"label_agreement":null},{"id":"W4409831628","doi":"10.14740/jh2043","title":"Phosphatidylinositol 3-Kinase Inhibition and Allogeneic Stem Cell Transplantation Can Overcome Chemotherapy Resistance in Refractory Burkitt Lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Transplantation; Stem cell; Cancer research; Refractory (planetary science); Chemotherapy; Phosphatidylinositol; Kinase; Immunology; Biology; Internal medicine; Cell biology","score_opus":0.007153250394514924,"score_gpt":0.249830780784306,"score_spread":0.2426775303897911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409831628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98272634,0.013338103,0.000057532834,0.0029916826,0.00012883547,0.00017951858,0.000004864031,0.0000067422466,0.00056638627],"genre_scores_gemma":[0.9940014,0.0043703597,0.0005841538,0.0008258494,0.000024310562,0.000009426494,0.0000054904813,0.00000879239,0.00017024558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901325,0.00006187904,0.00049587915,0.00014530736,0.00013311142,0.0001505552],"domain_scores_gemma":[0.99939346,0.00010660364,0.00024472974,0.00010649008,0.00007712105,0.00007160633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013731464,0.00012771429,0.00045138833,0.00024183425,0.000034884757,0.000009682241,0.000035497273,0.00012180596,0.000011362214],"category_scores_gemma":[0.0000067949377,0.00010412072,0.00007455222,0.00014306561,0.000043149495,0.00006838218,0.0000057347447,0.000078224075,0.0000010530362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00455987,0.0036404426,0.90625066,0.0019439664,0.00037000657,0.009895622,0.0028432105,0.000006767841,0.031159012,0.005762369,0.002664044,0.030904049],"study_design_scores_gemma":[0.017972331,0.000504959,0.64292324,0.0011491223,0.00022490075,0.0014954282,0.0002676435,0.0000063978287,0.33155337,0.000675217,0.0030919577,0.0001354576],"about_ca_topic_score_codex":0.000030803214,"about_ca_topic_score_gemma":0.0001344345,"teacher_disagreement_score":0.30039436,"about_ca_system_score_codex":0.00025019678,"about_ca_system_score_gemma":0.00020957764,"threshold_uncertainty_score":0.42459196},"labels":[],"label_agreement":null},{"id":"W4409878627","doi":"10.1097/md.0000000000042251","title":"Hematologic malignancies masquerading as rheumatologic diseases: A case series and review","year":2025,"lang":"en","type":"review","venue":"Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Multiple myeloma; Lymphoma; Pancytopenia; Medical diagnosis; Dermatology; Rituximab; Hematologic malignancy; Bone marrow; Internal medicine; Pathology","score_opus":0.036777118857325417,"score_gpt":0.36111017233119524,"score_spread":0.3243330534738698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409878627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037540492,0.99077785,0.0000016195528,0.0040548,0.00025944598,0.0025352333,0.00005079846,0.00014935469,0.0021333655],"genre_scores_gemma":[0.00006967144,0.9946611,0.0000923069,0.0018380769,0.00009347016,0.0010377174,0.00028745522,0.00003424693,0.0018859556],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973717,0.00019176248,0.0010172002,0.0007290912,0.00029933435,0.00039092745],"domain_scores_gemma":[0.9978366,0.00066986587,0.00037862247,0.00068404013,0.0000906214,0.00034025733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000260288,0.00074965076,0.0054604965,0.0002968404,0.00015792863,0.000017093125,0.00012046284,0.000251617,0.000477224],"category_scores_gemma":[0.00140608,0.00040595935,0.00040194724,0.00055969565,0.0003260192,0.00005910326,0.00014906157,0.00021957005,0.000067799425],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001409015,0.00015187707,0.00034466098,0.4613954,0.0004925496,0.05727047,0.000036403784,1.7751637e-9,2.5812497e-8,0.0022669616,0.023182074,0.4548455],"study_design_scores_gemma":[0.0005638325,0.0003552815,0.000006696244,0.3400683,0.0073094745,0.1323963,0.000049339353,1.129664e-7,1.7922714e-7,0.00008795422,0.51898724,0.00017526795],"about_ca_topic_score_codex":0.00008635585,"about_ca_topic_score_gemma":0.0000062234367,"teacher_disagreement_score":0.49580517,"about_ca_system_score_codex":0.00024878024,"about_ca_system_score_gemma":0.0005203774,"threshold_uncertainty_score":0.99983925},"labels":[],"label_agreement":null},{"id":"W4409963174","doi":"10.1056/nejmc2501018","title":"Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma","year":2025,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); Medicine; Lymphoma; Internal medicine; Brentuximab vedotin; Oncology; Cancer research; Hodgkin lymphoma; Materials science; Metallurgy","score_opus":0.013497889061452498,"score_gpt":0.25944331030761963,"score_spread":0.24594542124616714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409963174","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043145016,0.016880922,0.00003058012,0.92840385,0.0015591126,0.00047781333,0.000010930204,0.000026433858,0.009465317],"genre_scores_gemma":[0.26676244,0.0058575817,0.0011382397,0.6635137,0.048989847,0.000018789233,0.0002652986,0.00014006004,0.013314006],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965785,0.0001685493,0.0011572086,0.00037815698,0.0012394758,0.00047807104],"domain_scores_gemma":[0.9974961,0.0005418757,0.00081347616,0.0005020589,0.00032190557,0.0003245715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046689642,0.00056588306,0.0019041025,0.0010740141,0.000041678264,0.000019025338,0.00026483875,0.00058503007,0.00026973558],"category_scores_gemma":[0.00035746017,0.00032058472,0.00020966542,0.00044725486,0.00014939721,0.000092614784,0.000037297435,0.0014540381,0.000011104864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014742363,0.000283233,0.008486427,0.00028378825,0.0006500653,0.03569718,0.00042488394,0.0000023961798,0.000026055499,0.000016664304,0.826511,0.12614402],"study_design_scores_gemma":[0.13200276,0.0049047885,0.024893755,0.00849569,0.0012490485,0.0058174855,0.00008407916,0.0000037970303,0.000053223284,0.00011646949,0.822153,0.00022593777],"about_ca_topic_score_codex":0.00087034353,"about_ca_topic_score_gemma":0.00009487758,"teacher_disagreement_score":0.26489013,"about_ca_system_score_codex":0.001104335,"about_ca_system_score_gemma":0.0024143883,"threshold_uncertainty_score":0.9999246},"labels":[],"label_agreement":null},{"id":"W4409964068","doi":"10.1002/ajh.27688","title":"Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Workflow; Identification (biology); Computational biology; Computer science; Bioinformatics; Biology; Database","score_opus":0.05738899509302728,"score_gpt":0.343285930744665,"score_spread":0.28589693565163776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409964068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060216643,0.92231566,0.00784641,0.008038455,0.00025041748,0.001108202,0.00008868402,0.000005212778,0.00013033385],"genre_scores_gemma":[0.106739186,0.87195504,0.020012591,0.0008180548,0.000089796056,0.00020692364,0.00014885512,0.00002219677,0.0000073473966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973997,0.00025059472,0.0016420268,0.00026333975,0.00022105203,0.0002232836],"domain_scores_gemma":[0.99492633,0.003260606,0.0012611137,0.00028112915,0.00020214457,0.000068646696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005810602,0.00027562896,0.0022881194,0.0002988802,0.000046177123,0.000019180437,0.00041183914,0.00014531909,0.00003184321],"category_scores_gemma":[0.00058158895,0.00014822204,0.0005210225,0.00032591255,0.00054721296,0.000033686312,0.00010795171,0.0003014728,0.0000010910322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074013486,0.0024529947,0.0045076148,0.0042795683,0.0075781825,0.0010083333,0.007403783,0.0000065581494,0.0024000641,0.055105068,0.0011230308,0.9133947],"study_design_scores_gemma":[0.014635893,0.0050130156,0.014268379,0.09125959,0.0097510815,0.031364225,0.054290403,0.000080336635,0.0017358239,0.0030525855,0.7727515,0.00179716],"about_ca_topic_score_codex":0.000022617134,"about_ca_topic_score_gemma":0.0000030115352,"teacher_disagreement_score":0.9115975,"about_ca_system_score_codex":0.00017698333,"about_ca_system_score_gemma":0.00041539394,"threshold_uncertainty_score":0.6044319},"labels":[],"label_agreement":null},{"id":"W4410002553","doi":"10.1200/jco-25-00690","title":"Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Juno Therapeutics; Swedish Orphan Biovitrum; Karyopharm Therapeutics; Gilead Sciences; BeiGene; Sanofi; Pharmacyclics; Genentech; Galápagos; Cilag; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Rituximab; Oncology; Lymphoma; Internal medicine; Cancer research","score_opus":0.07492511335142048,"score_gpt":0.4563691692280959,"score_spread":0.3814440558766754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410002553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9430899,0.0013317578,0.000021816373,0.012177782,0.001218709,0.0002250949,0.0000042385377,0.000012820517,0.04191789],"genre_scores_gemma":[0.99132437,0.0010989357,0.0015843798,0.0036697323,0.00037391987,0.000007090317,0.000005162875,0.000011622826,0.0019247637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964943,0.00028192438,0.0024398668,0.00023253953,0.0002543349,0.00029702586],"domain_scores_gemma":[0.9961668,0.0021721632,0.00087881525,0.0002216465,0.00027941764,0.00028110444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014727442,0.0001737653,0.0018174996,0.0002798583,0.000032334476,0.000010251718,0.00016245,0.00047932114,0.00019401211],"category_scores_gemma":[0.0015844539,0.00011931858,0.0004859147,0.00033438348,0.00013510376,0.000064146974,0.00007416056,0.0004060741,0.00008169311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008717207,0.03356099,0.48104703,0.00010541624,0.00058484427,0.00940608,0.00010242519,0.000022458413,0.00007152908,0.00068162335,0.03135806,0.43434232],"study_design_scores_gemma":[0.11399055,0.005441071,0.72677135,0.00030253423,0.00062817754,0.00030091387,0.00013404168,0.00021369988,0.00070517004,0.0003183139,0.1510893,0.00010486617],"about_ca_topic_score_codex":0.00009984477,"about_ca_topic_score_gemma":0.000077912126,"teacher_disagreement_score":0.43423745,"about_ca_system_score_codex":0.0007028277,"about_ca_system_score_gemma":0.0034655964,"threshold_uncertainty_score":0.6147819},"labels":[],"label_agreement":null},{"id":"W4410004394","doi":"10.3390/curroncol32050265","title":"Patient-Reported Outcome Measures (PROMS) in Lymphoma","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Patient-reported outcome; Medicine; Clinical trial; Clinical significance; Lymphoma; Medical physics; Pathology; Quality of life (healthcare); Nursing","score_opus":0.24605203525068625,"score_gpt":0.47085223853032987,"score_spread":0.22480020327964362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410004394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024669463,0.9881606,0.0000019559752,0.00011915468,0.0029863673,0.0024019028,0.000041184532,0.00007650932,0.005965628],"genre_scores_gemma":[0.00026042145,0.9970979,0.00004820598,0.00009689913,0.00016526016,0.0016010674,0.0004322748,0.00003614537,0.0002618096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964563,0.00031597735,0.0016501697,0.00075357466,0.00033198352,0.00049198413],"domain_scores_gemma":[0.997961,0.00045027115,0.0006072902,0.00065868726,0.00012477083,0.00019802105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025677937,0.00059730985,0.003779541,0.00066431414,0.000044770695,0.000014819839,0.00015936294,0.0005788761,0.000102239406],"category_scores_gemma":[0.00051365275,0.00042396176,0.0008157497,0.00057365536,0.000077680816,0.000029315335,0.0001682601,0.00030043317,0.00015757591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002829289,0.0034665172,0.0139141595,0.013619361,0.00037234748,0.00096254476,0.000048877464,4.1236405e-8,1.5144868e-8,0.00008155934,0.0033935797,0.9641127],"study_design_scores_gemma":[0.003143417,0.00045393629,0.002592122,0.018751172,0.0029844125,0.00030588193,0.000013311215,8.2329973e-7,5.5147234e-7,0.000018584933,0.9714556,0.00028020513],"about_ca_topic_score_codex":0.00004706876,"about_ca_topic_score_gemma":0.000053099175,"teacher_disagreement_score":0.968062,"about_ca_system_score_codex":0.0032495141,"about_ca_system_score_gemma":0.0027749548,"threshold_uncertainty_score":0.99982125},"labels":[],"label_agreement":null},{"id":"W4410015692","doi":"10.3389/fonc.2025.1515250","title":"Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults","year":2025,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Spinal Cord Injury BC; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Tumor microenvironment; Hodgkin lymphoma; Classical Hodgkin lymphoma; Biomarker; Young adult; Immune system; Stromal cell; Biology; Lymphoma; Disease; Medicine; Immunology; Cancer research; Internal medicine; Genetics","score_opus":0.006772475240372933,"score_gpt":0.28254369614268937,"score_spread":0.2757712209023164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410015692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02307007,0.97444165,0.000031636395,0.00007079555,0.0004110956,0.0017030641,0.00006693221,0.000008849191,0.00019589842],"genre_scores_gemma":[0.009624239,0.9880003,0.0016799206,0.00017152463,0.000029674924,0.0002752575,0.00015708347,0.000027619046,0.000034413075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977212,0.00032573708,0.00078393036,0.0007015466,0.000090002,0.0003776177],"domain_scores_gemma":[0.99916625,0.000064791246,0.00032320217,0.00032430212,0.00001239773,0.000109059096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017092272,0.00043230996,0.002764462,0.00067196885,0.000019221454,0.000004640201,0.00012508755,0.00053229346,0.000005378944],"category_scores_gemma":[0.000058964462,0.0003627178,0.00017297936,0.00024203378,0.00032468833,0.000018497425,0.00020383259,0.00020470445,0.0000017408454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008188352,0.0006674277,0.3198689,0.0038915423,0.00020717841,0.00023384336,0.000035302408,4.88783e-8,6.529951e-7,0.00003675651,0.0005145573,0.6744619],"study_design_scores_gemma":[0.022785075,0.0023026776,0.36992246,0.05583424,0.0028350768,0.001276163,0.00014464934,0.000014474129,0.000031448766,0.00020196998,0.54389364,0.0007581428],"about_ca_topic_score_codex":0.00019124956,"about_ca_topic_score_gemma":0.00004292455,"teacher_disagreement_score":0.6737038,"about_ca_system_score_codex":0.0012126402,"about_ca_system_score_gemma":0.00045444825,"threshold_uncertainty_score":0.99988246},"labels":[],"label_agreement":null},{"id":"W4410192422","doi":"10.1158/2643-3230.bcd-24-0240","title":"DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"NHLBI Division of Intramural Research; National Cancer Institute; Canadian Institutes of Health Research; Pharmacyclics; EUSA Pharma; National Institute of Allergy and Infectious Diseases; MorphoSys; Terry Fox Research Institute; Michael Smith Health Research BC; Ministerio de Ciencia e Innovación; Canada's Michael Smith Genome Sciences Centre; Fundación Cellex; St. Jude Children's Research Hospital; Gilead Sciences; TG Therapeutics; Pfizer; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Amgen; Incyte; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"DNA methylation; Lymphoma; DNA; Burkitt's lymphoma; Methylation; Cancer research; Computational biology; Biology; Medicine; Genetics; Immunology; Gene; Gene expression","score_opus":0.009172808857633568,"score_gpt":0.3035139083737359,"score_spread":0.2943410995161023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410192422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937225,0.0070915422,0.0000717751,0.001156842,0.000094537296,0.0002682077,0.00004132851,0.000016969052,0.0018865152],"genre_scores_gemma":[0.997862,0.00089036935,0.00017666243,0.0004283114,0.000051955896,0.000053173346,0.000023534058,0.0000100742145,0.0005039116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918723,0.00003786492,0.00022519326,0.0002665012,0.0001612029,0.00012197901],"domain_scores_gemma":[0.999459,0.00011570825,0.00009158246,0.00022401707,0.000053235202,0.000056441302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008235104,0.00013217403,0.00034871287,0.00005597655,0.000033013544,0.000023167691,0.00003956512,0.000069314934,0.000008455368],"category_scores_gemma":[0.000041637697,0.000088204,0.00009313864,0.00014673926,0.000116788804,0.00007856635,0.000037356032,0.00003803485,4.4872377e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070339866,0.0013004385,0.9233827,0.00023258712,0.0016629109,0.0000952035,0.000043396787,0.000005258886,0.0016205602,0.0024479176,0.0005180342,0.06798762],"study_design_scores_gemma":[0.0052156765,0.00041338467,0.8888389,0.00039434692,0.0017250264,0.000011481097,0.000028306868,0.0000042203715,0.10242764,0.0001821332,0.00067478925,0.00008408402],"about_ca_topic_score_codex":0.0005737898,"about_ca_topic_score_gemma":0.00022502386,"teacher_disagreement_score":0.10080708,"about_ca_system_score_codex":0.000048582668,"about_ca_system_score_gemma":0.00028346377,"threshold_uncertainty_score":0.35968545},"labels":[],"label_agreement":null},{"id":"W4410390992","doi":"10.2196/70129","title":"Incidence, Prognostic Factors, and Treatment Impact on Survival in Natural Killer/T-Cell Lymphoma: Population-Based Study in the United States","year":2025,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Population; Lymphoma; Epidemiology; Survival rate; Radiation therapy; Survival analysis; Cohort; Internal medicine; Demography; Environmental health","score_opus":0.04295628436695104,"score_gpt":0.40772393296796106,"score_spread":0.36476764860101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410390992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577314,0.00014037013,3.475891e-7,0.0006297146,0.00005087334,0.0030792372,0.000017374587,0.00001545017,0.00029349292],"genre_scores_gemma":[0.9987156,0.000047843896,0.0000037249476,0.0000556594,0.000009316791,0.0007241359,0.0003691423,0.000008818036,0.00006577709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766314,0.0007379359,0.00030145157,0.00025051332,0.00062844716,0.00041853124],"domain_scores_gemma":[0.9968679,0.002639097,0.000046006422,0.00026187356,0.000108840904,0.00007631002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000685591,0.00022763453,0.00034050603,0.0010966233,0.0001663451,0.00008062716,0.000109740446,0.000055563607,0.000010786626],"category_scores_gemma":[0.00012223283,0.00010843877,0.000063657964,0.0015361527,0.000059758535,0.000104965984,0.00004525658,0.00019159612,0.000007737307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056284503,0.008226902,0.98004776,0.000041338775,0.00006471642,0.00009412076,0.009057424,0.000067778485,0.0000016056621,0.00007589577,0.00012157084,0.0016380268],"study_design_scores_gemma":[0.01001569,0.003606864,0.9745197,0.00019467482,0.00001800642,0.00000107062,0.009023855,0.0023375368,0.00008381769,0.000062015955,0.000053721506,0.00008300583],"about_ca_topic_score_codex":0.011814117,"about_ca_topic_score_gemma":0.0020579963,"teacher_disagreement_score":0.009756122,"about_ca_system_score_codex":0.0017171693,"about_ca_system_score_gemma":0.00029703393,"threshold_uncertainty_score":0.9947663},"labels":[],"label_agreement":null},{"id":"W4410411765","doi":"10.1016/j.ijrobp.2025.02.017","title":"Transplant-Free Salvage of Relapsed/Refractory Classic Hodgkin Lymphoma in Children, Adolescents, and Young Adults: An Emerging Role for Radiation Therapy","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Salvage therapy; Hodgkin lymphoma; Medicine; Refractory (planetary science); Radiation therapy; Lymphoma; Young adult; Oncology; Pediatrics; Internal medicine; Chemotherapy","score_opus":0.008586432005434913,"score_gpt":0.29822581962697453,"score_spread":0.2896393876215396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410411765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7404131,0.013002989,0.00092770136,0.0009438065,0.24058504,0.0015464554,0.0024105979,0.000048895876,0.00012139408],"genre_scores_gemma":[0.8154732,0.03188068,0.00076074427,0.00024983007,0.1484984,0.00008661924,0.0029576488,0.000065104374,0.000027774457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971521,0.00028909364,0.0013071633,0.00045497366,0.0005088731,0.00028782804],"domain_scores_gemma":[0.9960976,0.00072685734,0.0018969007,0.00029247403,0.00085016974,0.000135966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005969852,0.0004115323,0.0010614904,0.00053662393,0.00006578836,0.000030553485,0.00051431503,0.0009687258,0.000010467644],"category_scores_gemma":[0.00052310264,0.00036975983,0.00036661598,0.00016402408,0.00013751592,0.0003240047,0.00004644587,0.0005085168,0.00000110277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041502225,0.0024758002,0.50691754,0.00007325597,0.0014345535,0.000024260498,0.0007724918,0.000032397762,0.00028159888,0.00039670733,0.03244226,0.45099893],"study_design_scores_gemma":[0.1297444,0.009133143,0.6271587,0.0027714246,0.0012107822,0.0001473712,0.00020008956,0.0012686126,0.0017523693,0.004001262,0.22181801,0.00079383474],"about_ca_topic_score_codex":0.00019349168,"about_ca_topic_score_gemma":0.0000499005,"teacher_disagreement_score":0.4502051,"about_ca_system_score_codex":0.0014811736,"about_ca_system_score_gemma":0.0015368211,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W4410414256","doi":"10.3324/haematol.2024.287141","title":"Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Cohort; Population; Progression-free survival; Retrospective cohort study; Surgery; Overall survival; Multiple myeloma","score_opus":0.10806593627858142,"score_gpt":0.3951758313215723,"score_spread":0.2871098950429909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410414256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341,0.0011384521,0.0000036153524,0.0012891535,0.00023143094,0.0013187333,0.0002293369,0.000054707816,0.0023245565],"genre_scores_gemma":[0.9965003,0.0007194826,0.00037946203,0.00069132174,0.000059239723,0.00010977545,0.0001830591,0.000019147874,0.0013381772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684024,0.00038407888,0.0012029118,0.0008265411,0.00036166032,0.00038455048],"domain_scores_gemma":[0.99398005,0.0031717967,0.00037584812,0.0022810712,0.000078659854,0.00011257652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009433183,0.00030038675,0.0014118245,0.00014094255,0.000105267405,0.000025115138,0.0006902224,0.00016692329,0.00021127508],"category_scores_gemma":[0.0008704516,0.00015794182,0.00016691115,0.0005600296,0.00019312993,0.00006653299,0.0007021858,0.00020596031,0.00007843519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039427495,0.01940353,0.96034074,0.000038950733,0.00050774426,0.0020242454,0.0003938399,4.1516137e-7,0.000008683669,0.00059383345,0.005829655,0.0069156364],"study_design_scores_gemma":[0.036475305,0.00077834015,0.95654464,0.00035279963,0.000607462,0.000014893735,0.0014304313,0.00010014852,0.00013556604,0.0001857382,0.0032283529,0.00014634701],"about_ca_topic_score_codex":0.005050417,"about_ca_topic_score_gemma":0.021324279,"teacher_disagreement_score":0.032532554,"about_ca_system_score_codex":0.00021933788,"about_ca_system_score_gemma":0.00037621846,"threshold_uncertainty_score":0.996534},"labels":[],"label_agreement":null},{"id":"W4410457970","doi":"10.1016/j.ophtha.2025.04.015","title":"Meticulous Examination Leads to Prompt Excision of a Low-Grade Follicular Lymphoma Located in the Conjunctival Fornix","year":2025,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Fornix; Medicine; Follicular lymphoma; Follicular phase; Lymphoma; Pathology; Internal medicine; Hippocampus","score_opus":0.018666447751763345,"score_gpt":0.3106700899478089,"score_spread":0.2920036421960456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410457970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327826,0.00032403594,0.00006645305,0.0016626572,0.00013087918,0.0010564812,0.0000046075443,0.000013316621,0.0034633197],"genre_scores_gemma":[0.99880946,0.000011054604,0.00018712325,0.0002695661,0.000019992844,0.00028637724,0.0000372144,0.000009500272,0.00036973204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877596,0.00020000542,0.000309802,0.0002901375,0.00020064131,0.00022345895],"domain_scores_gemma":[0.9991833,0.00025177613,0.00006661306,0.0003556683,0.000097242075,0.000045402972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437598,0.0001511516,0.00037680182,0.00025025845,0.0000391044,0.000007542282,0.00012668307,0.0001289587,0.000052691663],"category_scores_gemma":[0.00019304597,0.00009690438,0.00009163557,0.0005458685,0.000059339865,0.000025975667,0.000051725612,0.000047766924,0.000024301087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016433417,0.012632888,0.8616179,0.0007177979,0.0005418241,0.0069401455,0.0029267883,0.00015507113,0.029218882,0.00924976,0.0014382303,0.07291735],"study_design_scores_gemma":[0.0040591513,0.0012073417,0.9625419,0.00022474937,0.00011294595,0.000989796,0.0002583141,0.00011466964,0.029840477,0.00028588413,0.0002807508,0.00008401429],"about_ca_topic_score_codex":0.00021646278,"about_ca_topic_score_gemma":0.00000695879,"teacher_disagreement_score":0.100923985,"about_ca_system_score_codex":0.00018490657,"about_ca_system_score_gemma":0.00011412914,"threshold_uncertainty_score":0.3951646},"labels":[],"label_agreement":null},{"id":"W4410488748","doi":"10.1016/j.bneo.2025.100117","title":"Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"Institut canadien d'information sur la santé; Princess Margaret Cancer Foundation; Ministry of Long-Term Care; Institute for Clinical Evaluative Sciences; Ministry of Health, Uganda; Ontario Ministry of Health and Long-Term Care","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Population; Survival analysis; Medicine; Oncology; Internal medicine; Environmental health","score_opus":0.004499670534224287,"score_gpt":0.2224345223380903,"score_spread":0.21793485180386601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410488748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917734,0.00007635126,0.000007424331,0.000076972785,0.000036863596,0.00033941143,0.000035315654,0.000036439604,0.00021389124],"genre_scores_gemma":[0.99934876,0.0000036118054,0.00012594118,0.00020513221,0.000004077964,0.000027478593,0.00019775542,0.000011804431,0.00007541533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892443,0.000036534206,0.00025555413,0.00030968012,0.00023670019,0.00023707666],"domain_scores_gemma":[0.9993453,0.000179501,0.00007698995,0.00025643274,0.000046498484,0.00009528185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054794047,0.00020781824,0.0005093975,0.0004464221,0.0000696318,0.000028186636,0.000041203613,0.00007405206,0.000010904477],"category_scores_gemma":[0.00004192524,0.00014240906,0.000101124424,0.0006974538,0.000014007929,0.000055186378,0.000025829222,0.000039478804,0.0000017787166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001077639,0.007427507,0.9913293,0.00004536222,0.0006722827,0.000023344077,0.00012861229,0.000015647543,0.0000019175961,0.00004226246,0.0000040764235,0.00020192393],"study_design_scores_gemma":[0.046361204,0.00014284678,0.9507953,0.00005466649,0.002117076,1.899967e-7,0.00007707774,0.00010775681,0.00020579976,0.000003867565,0.00001622485,0.00011800054],"about_ca_topic_score_codex":0.0013373602,"about_ca_topic_score_gemma":0.0016562775,"teacher_disagreement_score":0.04625344,"about_ca_system_score_codex":0.00012358012,"about_ca_system_score_gemma":0.000099059536,"threshold_uncertainty_score":0.5807273},"labels":[],"label_agreement":null},{"id":"W4410512966","doi":"10.3899/jrheum.2025-0390.pv266","title":"RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT","year":2025,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Immunology; Antibody","score_opus":0.009095638048537559,"score_gpt":0.2567065797732695,"score_spread":0.24761094172473194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410512966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975155,0.00015847124,0.00002920674,0.001913557,0.00008893027,0.00023218777,0.000027169648,0.0000035944709,0.00003140007],"genre_scores_gemma":[0.99943864,0.00009993702,0.00028849475,0.000090690235,0.0000023147131,0.0000037786021,0.0000034689622,0.000009014436,0.0000636453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899805,0.00015606814,0.0004643642,0.00007431443,0.00016943565,0.00013778175],"domain_scores_gemma":[0.99871075,0.00043036038,0.00031462358,0.00024557608,0.00023063815,0.0000680656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021378764,0.000113133196,0.00064791547,0.00021896671,0.000024151306,0.0000032449734,0.00010376021,0.000049859627,0.00002270957],"category_scores_gemma":[0.0001646148,0.00006168039,0.00009573413,0.00016725155,0.000114111615,0.000027739732,0.00002866465,0.000050958464,0.0000033769768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029870499,0.0032568357,0.9569855,0.000046296977,0.00066675077,0.00003286013,0.0027711166,0.00000809756,0.0008717429,0.00006155645,0.00022488674,0.0052038566],"study_design_scores_gemma":[0.010011918,0.0071306922,0.9775434,0.000493843,0.00043260885,0.00024273105,0.0005880465,0.0000056500894,0.0028440724,0.000026107333,0.0006297946,0.00005111601],"about_ca_topic_score_codex":0.0001608768,"about_ca_topic_score_gemma":0.000019510378,"teacher_disagreement_score":0.02055792,"about_ca_system_score_codex":0.00019770653,"about_ca_system_score_gemma":0.00028676158,"threshold_uncertainty_score":0.25152534},"labels":[],"label_agreement":null},{"id":"W4410521987","doi":"10.3390/curroncol32050285","title":"Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Hematopoietic cell; Lymphoma; Refractory (planetary science); Single Center; Transplantation; Progression-free survival; Incidence (geometry); Oncology; Gastroenterology; Surgery; Overall survival; Haematopoiesis; Stem cell; Chemotherapy","score_opus":0.041541472574432296,"score_gpt":0.3281859019232341,"score_spread":0.2866444293488018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410521987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430747,0.010088786,0.00033277986,0.0024202897,0.00058177504,0.0010374261,0.0001963184,0.000009074162,0.001026102],"genre_scores_gemma":[0.9970496,0.00059100945,0.0002974945,0.0012385792,0.000047781905,0.00056967966,0.00016507394,0.000010771483,0.000029980953],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988095,0.00006390658,0.00036302453,0.00030943775,0.00011515081,0.0003389629],"domain_scores_gemma":[0.99917203,0.00028877403,0.00007511621,0.00031802474,0.000043007058,0.000103040635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011415746,0.00018338328,0.00038753063,0.00011363753,0.000057216304,0.000007817563,0.00021192158,0.00011985849,0.000066359295],"category_scores_gemma":[0.000008387864,0.0001225314,0.00015554711,0.00013638943,0.000115016075,0.000022953482,0.000016225691,0.00010416396,0.0000045668453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044210805,0.017608939,0.89013904,0.00057456444,0.00017906647,0.0001993792,0.05149003,0.0000061659807,0.018014992,0.0006097848,0.0025579454,0.018178007],"study_design_scores_gemma":[0.0778682,0.0020952988,0.34360164,0.0018585031,0.0011349405,0.000082550454,0.01507471,0.00088047644,0.16649029,0.00052631675,0.3895977,0.0007893423],"about_ca_topic_score_codex":0.007981772,"about_ca_topic_score_gemma":0.009284343,"teacher_disagreement_score":0.54653734,"about_ca_system_score_codex":0.0003868129,"about_ca_system_score_gemma":0.0006934222,"threshold_uncertainty_score":0.99862415},"labels":[],"label_agreement":null},{"id":"W4410706115","doi":"10.1200/go-24-00538","title":"Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"JCO Global Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Queen's University","funders":"","keywords":"Refractory (planetary science); Medicine; Hodgkin lymphoma; Lymphoma; Nivolumab; Immune checkpoint; Cancer research; Oncology; Immune system; Immunotherapy; Internal medicine; Immunology; Materials science","score_opus":0.021328019612400426,"score_gpt":0.35390638083162085,"score_spread":0.3325783612192204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410706115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088549015,0.9760581,5.8758314e-7,0.0005720133,0.0015739839,0.009450742,0.00013480565,0.00012471159,0.011996491],"genre_scores_gemma":[0.00022946167,0.9940877,0.00010098492,0.0010435089,0.00021750439,0.0031794654,0.00036951876,0.00006198432,0.00070984894],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9919521,0.0013222336,0.0041002124,0.0011811616,0.00056083826,0.0008834487],"domain_scores_gemma":[0.9952276,0.0008360567,0.0018720294,0.0015382053,0.00017845315,0.00034770247],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013031894,0.0012116791,0.012730801,0.00040551447,0.00007795083,0.000029746881,0.0005079811,0.00141602,0.00010485848],"category_scores_gemma":[0.0015926136,0.0008531583,0.0023462803,0.0016798414,0.00015959602,0.000064925756,0.00040197276,0.0004556734,0.0008453155],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000029493229,0.0031865817,0.000042058608,0.69008994,0.00078299036,0.0030861443,0.000013212549,6.2574856e-8,2.1735065e-7,0.00015015062,0.0033180139,0.29930115],"study_design_scores_gemma":[0.0034606957,0.00064927834,0.00017932427,0.5938198,0.008914148,0.0010704992,0.0000137657935,5.00972e-7,0.0000014844147,0.000012827289,0.3914937,0.00038396125],"about_ca_topic_score_codex":0.00033454405,"about_ca_topic_score_gemma":0.00008572709,"teacher_disagreement_score":0.3881757,"about_ca_system_score_codex":0.012498735,"about_ca_system_score_gemma":0.0059164506,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4410803018","doi":"10.1200/jco.2025.43.16_suppl.tps7097","title":"A phase 1 trial of BTM-3566 in relapsed/refractory mature B cell lymphomas.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Cancer research; Internal medicine","score_opus":0.07507945975374432,"score_gpt":0.4758546823248268,"score_spread":0.4007752225710825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410803018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97019327,0.0017883204,0.000007868199,0.005486853,0.002525079,0.00033810604,0.00000485723,0.0000051086913,0.019650517],"genre_scores_gemma":[0.99406916,0.0014758911,0.00097594265,0.0018772914,0.00078686024,0.000008718016,0.00000273227,0.000009350095,0.0007940414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959958,0.00040780308,0.0029246863,0.0001812279,0.00029462535,0.0001958181],"domain_scores_gemma":[0.99479055,0.0028732563,0.0016219366,0.00024333573,0.00025042816,0.00022050992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021880898,0.000142959,0.0018992082,0.00027416254,0.000016591412,0.0000043212945,0.00014879189,0.00060543313,0.00012409643],"category_scores_gemma":[0.002472148,0.00009547845,0.0007036093,0.00023676519,0.00013979599,0.0000491751,0.000045197197,0.00061415357,0.000011105152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39011618,0.12818056,0.060661405,0.00015541789,0.00079981907,0.0041652936,0.00017607052,0.000006772982,0.0005548106,0.00043461623,0.04182775,0.3729213],"study_design_scores_gemma":[0.66718274,0.05521249,0.07418281,0.00034700677,0.0007659821,0.00009322171,0.0001145331,0.000023020768,0.0011849899,0.0005629561,0.20024517,0.0000850907],"about_ca_topic_score_codex":0.000021163409,"about_ca_topic_score_gemma":0.000021925805,"teacher_disagreement_score":0.3728362,"about_ca_system_score_codex":0.00037959852,"about_ca_system_score_gemma":0.003467324,"threshold_uncertainty_score":0.61508834},"labels":[],"label_agreement":null},{"id":"W4410803346","doi":"10.1200/jco.2025.43.16_suppl.tps7092","title":"waveLINE-010: Zilovertamab vedotin plus R-CHP versus R-CHOP in untreated diffuse large B-cell lymphoma.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CHOP; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Nuclear medicine","score_opus":0.07439077906988986,"score_gpt":0.4476976849947862,"score_spread":0.37330690592489635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410803346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643211,0.0014192822,0.000031872576,0.008256332,0.0030390595,0.0003031313,0.000010340332,0.000018790495,0.022600127],"genre_scores_gemma":[0.99076504,0.0021248288,0.0008703426,0.0038493795,0.0005796295,0.00001010245,0.000010814154,0.00002074867,0.0017691253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99549085,0.00042744292,0.0028967133,0.0003367608,0.00038009018,0.00046813017],"domain_scores_gemma":[0.99346316,0.0042976597,0.0011079089,0.00035200478,0.00035841294,0.0004208608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017827816,0.00026845394,0.0021236497,0.0003395729,0.00004918232,0.000016981743,0.00022613454,0.00064788305,0.00015787846],"category_scores_gemma":[0.0036625126,0.00018950082,0.0007153404,0.00040563874,0.00012220831,0.00009488923,0.00011301538,0.0005660573,0.00010438645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08595608,0.14096299,0.42757735,0.00017313012,0.002477305,0.017165687,0.00034970406,0.00003860882,0.00017462394,0.002103406,0.048614867,0.27440625],"study_design_scores_gemma":[0.36010227,0.009030381,0.48001447,0.000294814,0.0010196199,0.00011182236,0.00022243409,0.0005852897,0.00036137868,0.00016732642,0.14791726,0.00017293476],"about_ca_topic_score_codex":0.00014716982,"about_ca_topic_score_gemma":0.0003174397,"teacher_disagreement_score":0.2742333,"about_ca_system_score_codex":0.0012792383,"about_ca_system_score_gemma":0.0039607817,"threshold_uncertainty_score":0.7727619},"labels":[],"label_agreement":null},{"id":"W4410812202","doi":"10.1200/jco.2025.43.16_suppl.11109","title":"Treatment preferences of patients, caregivers, and physicians in follicular lymphoma (FL): A global discrete-choice experiment (DCE) study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Follicular lymphoma; Oncology; Lymphoma; Internal medicine","score_opus":0.052886751790550156,"score_gpt":0.43958523803503885,"score_spread":0.3866984862444887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410812202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452436,0.0016899914,0.0000040485834,0.001291852,0.0004252204,0.00054022885,0.000012034626,0.0000036747178,0.0015085834],"genre_scores_gemma":[0.9985004,0.00088597345,0.0002674227,0.00016321335,0.00009993106,0.00002201055,0.0000035466128,0.0000043379005,0.00005317616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975462,0.0003231725,0.001453624,0.00023017678,0.0002763099,0.00017050405],"domain_scores_gemma":[0.99779516,0.0008777856,0.000809047,0.00017586682,0.00019917017,0.0001429683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031845263,0.00016772824,0.0014868726,0.0000854661,0.000027062728,0.000007225931,0.000095264266,0.00015758841,0.000012069007],"category_scores_gemma":[0.0004142297,0.00010551192,0.00032554968,0.00016283481,0.00013378552,0.00006347584,0.00006118537,0.000082959305,9.766762e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016905755,0.018634893,0.7786749,0.000014516788,0.00086108665,0.0002366786,0.00056123425,0.0000038211733,0.00000369145,0.00008682387,0.00024790826,0.19898383],"study_design_scores_gemma":[0.03511358,0.030019954,0.9248652,0.00015482705,0.000803662,0.000008114773,0.0024131467,0.00001198401,0.000101975114,0.00009101863,0.006351608,0.00006495518],"about_ca_topic_score_codex":0.00078169286,"about_ca_topic_score_gemma":0.0005642479,"teacher_disagreement_score":0.19891888,"about_ca_system_score_codex":0.0008071043,"about_ca_system_score_gemma":0.0008769664,"threshold_uncertainty_score":0.43026513},"labels":[],"label_agreement":null},{"id":"W4410818934","doi":"10.1200/jco.2025.43.16_suppl.7015","title":"Glofitamab plus gemcitabine and oxaliplatin (Glofit-GemOx) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 2-year (yr) follow-up of STARGLO.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Gemcitabine; Diffuse large B-cell lymphoma; Oxaliplatin; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.027591271327323627,"score_gpt":0.35002051646402144,"score_spread":0.3224292451366978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410818934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272245,0.0010204139,0.000022303877,0.0015167152,0.0009022023,0.00046035726,0.000032051117,0.0000100933585,0.0033134297],"genre_scores_gemma":[0.9950153,0.0012544226,0.0017145127,0.0011815677,0.00015421059,0.000010438731,0.000016702807,0.000025463081,0.00062736723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563557,0.0003834636,0.0026779466,0.00035825948,0.0005431333,0.00040163263],"domain_scores_gemma":[0.9950543,0.0019896966,0.0016939546,0.00035009885,0.00053215295,0.0003798013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015419547,0.00028741898,0.002229318,0.0003558746,0.000049502396,0.000012305618,0.00018015933,0.0005047172,0.000057760113],"category_scores_gemma":[0.0015461952,0.00019226741,0.00038461812,0.0003468986,0.00022436182,0.00016214671,0.00013418759,0.00047699563,0.000008431468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018727696,0.039108958,0.8932375,0.00011995107,0.0005616344,0.0005556353,0.00018907274,0.0000022933637,0.000017620017,0.00024352103,0.0040787663,0.0431574],"study_design_scores_gemma":[0.2591313,0.015505314,0.70316607,0.00037523214,0.0005714378,0.000023641902,0.0002037181,0.000036468806,0.00006997341,0.00010078551,0.020694552,0.00012150802],"about_ca_topic_score_codex":0.000087059365,"about_ca_topic_score_gemma":0.0001910796,"teacher_disagreement_score":0.24040362,"about_ca_system_score_codex":0.00068285473,"about_ca_system_score_gemma":0.001961359,"threshold_uncertainty_score":0.7840438},"labels":[],"label_agreement":null},{"id":"W4410893329","doi":"10.1097/01.cot.0000000000000067","title":"Tafasitamab Cuts Progression-Free Survival in Follicular Lymphoma","year":2025,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Progression-free survival; Follicular phase; Oncology; Lymphoma; Internal medicine; Medicine; Overall survival","score_opus":0.011581287322477155,"score_gpt":0.3207634338455437,"score_spread":0.3091821465230665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410893329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6273553,0.0031079198,0.000009221189,0.017563824,0.0005417685,0.0006825695,0.000007642664,0.00009883081,0.35063294],"genre_scores_gemma":[0.97989535,0.00019234669,0.0017070468,0.0012543186,0.000082047336,0.00030132773,0.000037015976,0.000015063477,0.016515508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887204,0.000092377355,0.00025564164,0.00031235488,0.00017476817,0.00029280473],"domain_scores_gemma":[0.9991521,0.00022418334,0.000055581266,0.000429046,0.00005201854,0.000087065484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000199415,0.00016246128,0.0004696765,0.00017811764,0.0000597123,0.000010623272,0.00013534563,0.0002129696,0.0002434644],"category_scores_gemma":[0.0001619654,0.000121873665,0.00011060166,0.00028682488,0.00008536109,0.00003955045,0.00013243164,0.000062622865,0.0001294651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045520664,0.0042452826,0.6474692,0.000055935,0.0003354904,0.0022684694,0.0001591867,0.0000019940485,0.00020774492,0.008086458,0.092857406,0.2438576],"study_design_scores_gemma":[0.017539186,0.0008459552,0.7168679,0.00029968252,0.00023023956,0.00007793973,0.00015314555,0.00008025108,0.0032682046,0.0015656791,0.25892356,0.00014823933],"about_ca_topic_score_codex":0.00010091165,"about_ca_topic_score_gemma":0.00011015043,"teacher_disagreement_score":0.35254005,"about_ca_system_score_codex":0.0005956338,"about_ca_system_score_gemma":0.0006136612,"threshold_uncertainty_score":0.4969864},"labels":[],"label_agreement":null},{"id":"W4410932907","doi":"10.1111/ejh.14443","title":"Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Bendamustine; Medicine; Internal medicine; Tolerability; Neutropenia; Rituximab; Rash; Gastroenterology; Adverse effect; Population; Lymphoma; Surgery; Chemotherapy","score_opus":0.011521212179555798,"score_gpt":0.2727653484747512,"score_spread":0.2612441362951954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410932907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861826,0.006604571,0.0019879686,0.002094131,0.00033999147,0.00043844437,0.000016453614,0.000011982952,0.0023239106],"genre_scores_gemma":[0.9930596,0.00063589675,0.005685135,0.00031632383,0.00007333418,0.0000037335074,0.000005968474,0.000023743049,0.00019628975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983337,0.00021130612,0.000895225,0.00019717193,0.00013499089,0.00022763184],"domain_scores_gemma":[0.998534,0.00036954958,0.00047713448,0.00023911291,0.00025656514,0.00012361899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060464826,0.00018351502,0.00095544657,0.0002444656,0.000069201305,0.000010311491,0.00013339886,0.00004580272,0.00002764791],"category_scores_gemma":[0.0003777225,0.00013317484,0.00020863747,0.00012224093,0.0001611855,0.000042262975,0.000076939934,0.000055013355,0.000007850005],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047310513,0.0113099,0.05031737,0.0033885788,0.0059088324,0.03510626,0.0024747723,0.000064652006,0.008324077,0.024091434,0.021730011,0.7899736],"study_design_scores_gemma":[0.26466,0.008299785,0.40104458,0.004485536,0.0039500766,0.05489281,0.00044158855,0.00036291403,0.05752199,0.0003860942,0.20344871,0.00050592533],"about_ca_topic_score_codex":0.000003590627,"about_ca_topic_score_gemma":9.587727e-7,"teacher_disagreement_score":0.7894677,"about_ca_system_score_codex":0.00011553398,"about_ca_system_score_gemma":0.00035352787,"threshold_uncertainty_score":0.5430712},"labels":[],"label_agreement":null},{"id":"W4410956128","doi":"10.1007/s40336-025-00707-x","title":"SUVR (SUVmax Lymphoma/SUVmax Liver) vs. Deauville score for predicting PFS in Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Imaging","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Nuclear medicine; Radiology; Internal medicine; Oncology","score_opus":0.035816638737477695,"score_gpt":0.345147206302465,"score_spread":0.3093305675649873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410956128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750744,0.006308803,0.002733956,0.010316075,0.00041667215,0.0010374632,0.00007641871,0.00009870803,0.00393752],"genre_scores_gemma":[0.99319124,0.00048387307,0.00375996,0.0018714408,0.00021832532,0.000122257,0.00012230406,0.000020524143,0.00021009435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998106,0.000058959708,0.00077049213,0.00054446387,0.00019170216,0.0003283936],"domain_scores_gemma":[0.9981685,0.0012954436,0.000084599546,0.00017876463,0.00011368422,0.00015898069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908296,0.00022244628,0.0004995063,0.00016959824,0.00016798766,0.00004922077,0.00007835087,0.00011529136,0.000030017212],"category_scores_gemma":[0.00021003911,0.00019184894,0.0002522131,0.00022296385,0.00020770138,0.0001495592,0.00003340854,0.00007823561,0.0000078940175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041845848,0.0006483326,0.6931404,0.00010759801,0.00009728589,0.000058438214,0.00008314842,0.000007655986,0.000008630055,0.0024578813,0.0003170968,0.3026551],"study_design_scores_gemma":[0.015897017,0.00012770551,0.9547748,0.0005596028,0.00024600746,0.000042609754,0.000055363023,0.015641492,0.000124623,0.0029036712,0.00945979,0.00016730952],"about_ca_topic_score_codex":0.00014420235,"about_ca_topic_score_gemma":0.00007198781,"teacher_disagreement_score":0.3024878,"about_ca_system_score_codex":0.000057562094,"about_ca_system_score_gemma":0.00033594426,"threshold_uncertainty_score":0.7823373},"labels":[],"label_agreement":null},{"id":"W4411041980","doi":"10.3389/fviro.2025.1583648","title":"CD30 associates with EBER-EBV but not HCV-NS3 in T-cell non-Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Frontiers in Virology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pázmány Péter Katolikus Egyetem; Universitas Gadjah Mada; Frontiers Foundation","keywords":"CD30; Virology; Lymphoma; NS3; Medicine; Cancer research; Biology; Virus; Immunology; Hepatitis C virus","score_opus":0.004167056380415072,"score_gpt":0.22595189393624895,"score_spread":0.2217848375558339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411041980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97591776,0.0012612328,0.00021195137,0.0030668287,0.00072946656,0.0005459145,0.000015221275,0.000038663205,0.018212989],"genre_scores_gemma":[0.9901949,0.00028583812,0.003323396,0.0031313153,0.000051567957,0.00021992321,0.00003725316,0.000025026075,0.0027307675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998292,0.00010564597,0.0003813152,0.00050401245,0.00016996863,0.00054703275],"domain_scores_gemma":[0.99927855,0.00013128303,0.000102509366,0.00036219883,0.000035435096,0.00009000113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021851454,0.00026881168,0.00076743425,0.000490188,0.00004879943,0.000013807109,0.00015059566,0.00032282493,0.000035100165],"category_scores_gemma":[0.000056875644,0.00022013548,0.0000924946,0.00042090152,0.00014184057,0.000054607834,0.00007064893,0.00015801356,0.000036771246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010097652,0.0013429427,0.95808774,0.000046829184,0.00018190574,0.00068664004,0.00027323194,0.000031218096,0.0002663251,0.00012109216,0.02065601,0.017296314],"study_design_scores_gemma":[0.01757697,0.00078227016,0.96217114,0.00012605448,0.00017219473,0.000014705355,0.00035128888,0.00057680934,0.0065409443,0.00041250943,0.011061855,0.0002132492],"about_ca_topic_score_codex":0.0008453463,"about_ca_topic_score_gemma":0.0004941146,"teacher_disagreement_score":0.017083066,"about_ca_system_score_codex":0.0007750317,"about_ca_system_score_gemma":0.00027753253,"threshold_uncertainty_score":0.8976864},"labels":[],"label_agreement":null},{"id":"W4411236837","doi":"10.1016/j.htct.2025.103847","title":"Multi-cohort gene expression model enhances prognostic stratification in diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"letter","venue":"Hematology Transfusion and Cell Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stratification (seeds); Lymphoma; Risk stratification; Diffuse large B-cell lymphoma; Cohort; Prognostic model; Oncology; Expression (computer science); Internal medicine; Computational biology; Cancer research; Overall survival; Biology; Computer science","score_opus":0.017259435767511176,"score_gpt":0.26237200953283735,"score_spread":0.24511257376532616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411236837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387282,0.01303533,0.0017094242,0.041949198,0.00024274267,0.0028722966,0.000071337585,0.000116456,0.0012749926],"genre_scores_gemma":[0.77049714,0.096638836,0.0040503447,0.12105272,0.00017629792,0.0017225296,0.0014965136,0.00009744679,0.004268145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759674,0.00015668463,0.0005859222,0.00091270707,0.00027616322,0.00047178066],"domain_scores_gemma":[0.9990312,0.00016896005,0.0001484858,0.00049174397,0.00006431586,0.00009529919],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013509888,0.0005223933,0.00095559435,0.00028610817,0.00014164716,0.000029036724,0.00013062563,0.0011129581,0.00007501087],"category_scores_gemma":[0.0000057457937,0.0003956651,0.00018771809,0.00015498229,0.00008012922,0.000054957425,0.00002043019,0.00040927125,0.000012937623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002877326,0.12665544,0.21452346,0.006706663,0.00069157314,0.0054126945,0.0057908646,0.000010936553,0.4200727,0.00019871454,0.19907315,0.017986467],"study_design_scores_gemma":[0.09337476,0.0006484308,0.011253781,0.0013529204,0.00049147283,0.0002015398,0.00018183865,0.004333666,0.8565064,0.00018017602,0.030447232,0.0010278019],"about_ca_topic_score_codex":0.000049767397,"about_ca_topic_score_gemma":0.000034927703,"teacher_disagreement_score":0.4364337,"about_ca_system_score_codex":0.00008010626,"about_ca_system_score_gemma":0.00023569276,"threshold_uncertainty_score":0.9998495},"labels":[],"label_agreement":null},{"id":"W4411255343","doi":"10.1002/ajh.27736","title":"Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; Norges Forskningsråd; Leukemia and Lymphoma Society","keywords":"Angioimmunoblastic T-cell lymphoma; Transcriptome; Lymphoma; Medicine; Cancer research; Computational biology; Oncology; Internal medicine; Biology; Immunology; T cell; Gene; Genetics; Gene expression","score_opus":0.004244613251270105,"score_gpt":0.24985277281071286,"score_spread":0.24560815955944276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411255343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876095,0.010018728,0.00044862935,0.0010803635,0.00007303787,0.00012360893,0.000004658498,0.000005752591,0.0006357017],"genre_scores_gemma":[0.99722373,0.00062016386,0.001527601,0.00039652627,0.000010407406,0.0000124084845,0.0000029928,0.00000769636,0.00019844998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869585,0.00016448279,0.00063506054,0.0001830543,0.00009240693,0.00022915035],"domain_scores_gemma":[0.99896115,0.00039737657,0.00029263328,0.00016043498,0.00010578796,0.00008258859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002154726,0.00016955701,0.0012998891,0.00080687384,0.00003787812,0.000012359978,0.000083467494,0.000044186785,0.000042283835],"category_scores_gemma":[0.00007166442,0.00012048961,0.00025491032,0.0007059844,0.00031995677,0.000056494024,0.000018484687,0.000105351595,0.0000027038272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007203935,0.00095612643,0.9796906,0.00008114275,0.0023550729,0.00038612445,0.0019125907,0.00004871332,0.0026848302,0.0015312497,0.0003614612,0.009271692],"study_design_scores_gemma":[0.0073675276,0.0021255678,0.96733224,0.00030221048,0.0032152624,0.0011635234,0.008456117,0.00021671284,0.0078099295,0.0012686512,0.00054974214,0.00019254217],"about_ca_topic_score_codex":0.00030794548,"about_ca_topic_score_gemma":0.00008670207,"teacher_disagreement_score":0.012358389,"about_ca_system_score_codex":0.00024646663,"about_ca_system_score_gemma":0.0002473201,"threshold_uncertainty_score":0.49134237},"labels":[],"label_agreement":null},{"id":"W4411298500","doi":"10.1002/pbc.31856","title":"Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331","year":2025,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Hodgkin lymphoma; Pediatric oncology; Lymphoma; Oncology; Internal medicine; Pediatrics; Cancer","score_opus":0.010779296094988011,"score_gpt":0.27613593879525006,"score_spread":0.26535664270026205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411298500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915505,0.0032288663,0.0000014043119,0.0005451107,0.001135439,0.0025048915,0.00028528325,0.000044933015,0.00070359634],"genre_scores_gemma":[0.99411947,0.0035039275,0.000058033664,0.00029543342,0.0008597426,0.00087147293,0.0002236418,0.000032777814,0.000035478988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653405,0.00047535793,0.0007175955,0.00064067973,0.0012448434,0.00038747597],"domain_scores_gemma":[0.99804455,0.0003495854,0.0005551838,0.00046475948,0.00048299762,0.000102929735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061737007,0.00036035717,0.0005503031,0.0006578332,0.000111794696,0.000021260106,0.00030676703,0.00023598883,0.00014084484],"category_scores_gemma":[0.00075264915,0.00025582447,0.00022346704,0.0014249053,0.00005267219,0.00008134859,0.00012920404,0.00022284508,0.000012713011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016931185,0.007863957,0.91285896,0.000037976864,0.00044510828,0.0000059527265,0.00016465304,0.00015580747,0.0000013597544,0.00007895998,0.0007481264,0.07746985],"study_design_scores_gemma":[0.025266817,0.0009263798,0.9647351,0.00012968587,0.008194946,0.000004525068,0.000010930748,0.00009103095,0.00023875106,0.0001756177,0.000035833826,0.0001903704],"about_ca_topic_score_codex":0.0023937924,"about_ca_topic_score_gemma":0.00045984908,"teacher_disagreement_score":0.07727948,"about_ca_system_score_codex":0.001060944,"about_ca_system_score_gemma":0.0012687239,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W4411330578","doi":"10.1200/jco-25-00204","title":"Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Neutropenia; Febrile neutropenia; Nivolumab; Adverse effect; Lymphoma; Gastroenterology; Surgery; Cancer; Chemotherapy; Hodgkin lymphoma; Immunotherapy","score_opus":0.04522248505722954,"score_gpt":0.4201453365192767,"score_spread":0.3749228514620472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411330578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812539,0.00036795923,0.000019631716,0.0037624768,0.0023982527,0.00052869815,0.000007253613,0.000014762664,0.011647029],"genre_scores_gemma":[0.9950565,0.0004624463,0.0008391384,0.0024409944,0.00028203122,0.000026106063,0.000010032002,0.000023453342,0.000859265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960519,0.00047172065,0.002164449,0.00037771647,0.00053710974,0.00039712462],"domain_scores_gemma":[0.9944102,0.0032008898,0.0013352105,0.00034261824,0.00038399317,0.00032706687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010782154,0.00027812977,0.0019381895,0.00033734797,0.00005618262,0.000015470721,0.00020112295,0.00040678613,0.00015956309],"category_scores_gemma":[0.0017569875,0.00018080152,0.00048010368,0.00034948112,0.0001785925,0.00012308806,0.00006745482,0.0005390113,0.000043271328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036652006,0.016082488,0.5024099,0.000031784457,0.00062908116,0.0010608404,0.00005752014,0.00004430312,0.0000026276534,0.00024886566,0.0029774744,0.43980312],"study_design_scores_gemma":[0.17584226,0.027716786,0.7561102,0.0004500369,0.00035630146,0.000012084504,0.000095345225,0.00003607175,0.00004453855,0.000043701886,0.03917443,0.00011826475],"about_ca_topic_score_codex":0.000028808827,"about_ca_topic_score_gemma":0.000138798,"teacher_disagreement_score":0.43968487,"about_ca_system_score_codex":0.0011623669,"about_ca_system_score_gemma":0.0023669705,"threshold_uncertainty_score":0.7372872},"labels":[],"label_agreement":null},{"id":"W4411333827","doi":"10.1002/hon.70094_184","title":"184 | GENOMIC PROFILING OF EXTRANODAL DISEASE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA: A COMBINED ANALYSIS OF POLARIX AND GOYA","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Roche (Canada)","funders":"National Cancer Institute; Gilead Sciences; Seagen; Pfizer","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Profiling (computer programming); Disease; Pathology; Computer science","score_opus":0.007201085497103421,"score_gpt":0.26195510284320767,"score_spread":0.25475401734610426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411333827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786127,0.00084946945,0.000033587152,0.00020598508,0.000019855252,0.00053484953,0.000049825,0.000012713957,0.00043247617],"genre_scores_gemma":[0.9988967,0.000053704567,0.000713846,0.00016757364,0.000002002281,0.00005201101,0.00008530983,0.000005359937,0.000023488801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988144,0.00009021772,0.00044591632,0.00028688388,0.00012176514,0.00024081358],"domain_scores_gemma":[0.9991722,0.00026766813,0.00015984668,0.0002055871,0.00007345362,0.00012124394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010611995,0.00014682923,0.0010370258,0.00029374077,0.00002753713,0.000002818336,0.000059275382,0.00013500958,0.000030447405],"category_scores_gemma":[0.000070979404,0.00009460715,0.00011863653,0.00050085445,0.00014293948,0.000019644533,0.00008042073,0.000050943454,0.0000013913553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028398558,0.025469014,0.96597886,0.00019807882,0.0005103481,0.00015819498,0.00006665685,0.000002948549,0.00012351165,0.0043377215,0.000010937143,0.0003038777],"study_design_scores_gemma":[0.032659393,0.0009208706,0.9632881,0.000054856057,0.0018591306,0.0000016474594,0.000045070126,0.0003601661,0.0006013636,0.00009668547,0.000039460512,0.00007320897],"about_ca_topic_score_codex":0.00005538491,"about_ca_topic_score_gemma":0.000043515018,"teacher_disagreement_score":0.029819537,"about_ca_system_score_codex":0.00015056336,"about_ca_system_score_gemma":0.00019543798,"threshold_uncertainty_score":0.38579676},"labels":[],"label_agreement":null},{"id":"W4411333831","doi":"10.1002/hon.70093_50","title":"50 | FIXED‐DURATION OUTPATIENT SUBCUTANEOUS MOSUNETUZUMAB + POLATUZUMAB VEDOTIN SHOWS ROBUST EFFICACY IN A PHASE II STUDY OF RELAPSED/REFRACTORY POST‐BTKi MANTLE CELL LYMPHOMA","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital","funders":"Science and Engineering Research Board; BeiGene; F. Hoffmann-La Roche; Genentech; AstraZeneca; Celgene; Gilead Sciences; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Refractory (planetary science); Mantle cell lymphoma; Internal medicine; Lymphoma; Oncology; Materials science; Composite material","score_opus":0.024737485077325528,"score_gpt":0.31162199020163306,"score_spread":0.2868845051243075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411333831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909042,0.0012058493,0.000021312342,0.00072623446,0.000346496,0.0021026237,0.000019096093,0.000089565096,0.0045846393],"genre_scores_gemma":[0.99802125,0.00009314763,0.00053960516,0.0005050706,0.000028888006,0.0002537441,0.0000975675,0.000021782918,0.00043892823],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9967846,0.0003573214,0.0013030915,0.00071713334,0.00033605215,0.00050176284],"domain_scores_gemma":[0.99781203,0.00087722443,0.00041288242,0.00054851075,0.00017102544,0.0001783373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021463535,0.00038833692,0.0014193557,0.00035031373,0.0001486296,0.000011993709,0.00019947745,0.00054063706,0.0002574386],"category_scores_gemma":[0.00038038575,0.00029335005,0.00020343767,0.00042995095,0.00014137042,0.000060617007,0.00022266053,0.00026563441,0.000045983943],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029760825,0.738319,0.103201516,0.00069821044,0.0008308748,0.018007122,0.009288543,0.00038955663,0.012753229,0.0032232518,0.0043189987,0.0792089],"study_design_scores_gemma":[0.30683535,0.35187793,0.2692854,0.00088457216,0.0022195326,0.002910197,0.01381008,0.0025208306,0.020722378,0.00030083902,0.027129326,0.0015035511],"about_ca_topic_score_codex":0.00035310458,"about_ca_topic_score_gemma":0.00040344518,"teacher_disagreement_score":0.38644105,"about_ca_system_score_codex":0.0012981166,"about_ca_system_score_gemma":0.0005699532,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W4411336441","doi":"10.1002/hon.70094_234","title":"234 | POST HOC ANALYSIS OF OUTCOMES BY POD24 STATUS FROM THE inMIND STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Post-hoc analysis; Oncology; Internal medicine; Refractory (planetary science); Follicular phase; Lymphoma; Biology; Multiple myeloma","score_opus":0.02154364929248844,"score_gpt":0.3335280764054523,"score_spread":0.31198442711296387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411336441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312633,0.003296231,0.0000045028582,0.0022269366,0.00006037726,0.00081424706,0.000109366796,0.000016128932,0.00034587987],"genre_scores_gemma":[0.998187,0.0003329949,0.0002330159,0.0009713571,0.0000045472857,0.00012098099,0.00007380052,0.000007807867,0.00006850276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768007,0.00041684855,0.00089086307,0.0004551216,0.00025776564,0.00029933374],"domain_scores_gemma":[0.995847,0.0031586648,0.0003257882,0.00045730805,0.00011084672,0.00010040773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027473937,0.00024223099,0.0021693748,0.00026283896,0.00005382479,0.00000771616,0.00014662051,0.00029645674,0.00014932334],"category_scores_gemma":[0.000675779,0.00012306307,0.00021782084,0.00078446226,0.00023418305,0.000027617874,0.0001603632,0.00012223174,0.000003159569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063043013,0.021861097,0.95698506,0.00003752224,0.00436531,0.00097127934,0.0011996138,0.000003898397,0.00025359524,0.00035957413,0.00069836277,0.0069603734],"study_design_scores_gemma":[0.055090282,0.004229462,0.9292915,0.000061973005,0.0037035288,0.000019439158,0.0056317127,0.0000851713,0.00041038886,0.00006651907,0.0012955628,0.00011446491],"about_ca_topic_score_codex":0.0025982242,"about_ca_topic_score_gemma":0.0024076703,"teacher_disagreement_score":0.04878598,"about_ca_system_score_codex":0.00041930564,"about_ca_system_score_gemma":0.00035365362,"threshold_uncertainty_score":0.50183666},"labels":[],"label_agreement":null},{"id":"W4411343772","doi":"10.3390/curroncol32060356","title":"Prognostic Value of Multiple Manual Segmentation Methods for Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Positron emission tomography; Nuclear medicine; Positron Emission Tomography-Computed Tomography; Radiology; Segmentation; PET-CT; Pathology; Artificial intelligence; Computer science","score_opus":0.0469910933012218,"score_gpt":0.43689359919967463,"score_spread":0.3899025058984528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411343772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782927,0.002164643,0.015265574,0.00037506118,0.0007807874,0.0021728263,0.00007263286,0.00004885712,0.0008269013],"genre_scores_gemma":[0.95758015,0.00019118085,0.040437035,0.00015215192,0.000058068563,0.0010496787,0.0002589225,0.000019129995,0.00025366218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987023,0.000164876,0.00035758383,0.00034414677,0.000121458856,0.00030963353],"domain_scores_gemma":[0.99828655,0.0010416715,0.00018241178,0.00023467667,0.0001591615,0.00009553904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645621,0.00019887547,0.0005185891,0.00015165124,0.00007682866,0.00000798326,0.00007982483,0.000021254618,0.000018595192],"category_scores_gemma":[0.00019290728,0.00014610567,0.00013641691,0.00017920123,0.0000752796,0.000041138683,0.000054115706,0.000053994336,0.000007798999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014407871,0.04891822,0.5232803,0.0013658179,0.00047986483,0.00018982081,0.0003944084,0.0000056210065,0.0010711667,0.002405235,0.0027216736,0.41772705],"study_design_scores_gemma":[0.24019556,0.0103582665,0.35820892,0.0010059567,0.0049262857,0.00056605914,0.0017474124,0.011429659,0.105960004,0.00058497005,0.26442194,0.00059499365],"about_ca_topic_score_codex":0.000020847036,"about_ca_topic_score_gemma":0.000021881424,"teacher_disagreement_score":0.41713208,"about_ca_system_score_codex":0.00045310578,"about_ca_system_score_gemma":0.0004374121,"threshold_uncertainty_score":0.5958016},"labels":[],"label_agreement":null},{"id":"W4411346424","doi":"10.1002/hon.70094_296","title":"296 | LIMITED STAGE DIFFUSE LARGE B CELL LYMPHOMA IN THE MODERN ERA: REAL‐WORLD OUTCOMES IN AN INTERNATIONAL STUDY OF OVER ONE THOUSAND PATIENTS","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Alberta Health Services","funders":"TG Therapeutics; AstraZeneca; Bristol-Myers Squibb","keywords":"Stage (stratigraphy); Diffuse large B-cell lymphoma; Medicine; Lymphoma; Internal medicine; Oncology; Geology","score_opus":0.03325769351432889,"score_gpt":0.3525467663493674,"score_spread":0.3192890728350385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411346424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885579,0.000040737512,0.0000033985887,0.0007177749,0.00011514071,0.0010286462,0.000023012399,0.000022057106,0.009491331],"genre_scores_gemma":[0.99800265,0.00006813624,0.000102777005,0.0012253245,0.0000096609765,0.00022856466,0.00004937451,0.0000075092885,0.0003059827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818516,0.00033096748,0.0005894348,0.00034878394,0.00027754312,0.0002680842],"domain_scores_gemma":[0.99870116,0.00069153507,0.00015106401,0.00033550902,0.00006513392,0.000055580873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024265684,0.00017630933,0.00077306764,0.00027477613,0.000033745942,0.000010973056,0.00021762583,0.00015348109,0.000073111434],"category_scores_gemma":[0.000117790325,0.00010272132,0.000075192904,0.00030191932,0.000053839616,0.000060131533,0.00013659187,0.00013461665,0.000004647791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055623776,0.14768696,0.84641546,0.000025427345,0.00007368628,0.00041163393,0.0012474306,0.0000024469264,0.000013222856,0.0020980325,0.00009443517,0.0013750301],"study_design_scores_gemma":[0.04056103,0.0018905817,0.9556623,0.00003438241,0.0000694525,0.0000023722844,0.0005915479,0.00028063598,0.00006862582,0.00027821408,0.00048281543,0.00007801129],"about_ca_topic_score_codex":0.00038232675,"about_ca_topic_score_gemma":0.0044056606,"teacher_disagreement_score":0.14579637,"about_ca_system_score_codex":0.00034847128,"about_ca_system_score_gemma":0.000088255736,"threshold_uncertainty_score":0.41888538},"labels":[],"label_agreement":null},{"id":"W4411349405","doi":"10.1002/hon.70093_56","title":"56 | GENOMIC ANALYSIS OF MATURE B‐CELL LYMPHOMAS","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Spinal Cord Injury BC; Simon Fraser University; Genome British Columbia","funders":"Celgene; Gilead Sciences","keywords":"B cell; Cancer research; Computational biology; Biology; Genetics; Medicine; Antibody","score_opus":0.0158113372617889,"score_gpt":0.3204125927343742,"score_spread":0.3046012554725853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411349405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89909434,0.0032290637,0.000063359155,0.0024238422,0.00011118027,0.0002599393,0.000011491986,0.00004940394,0.094757356],"genre_scores_gemma":[0.99517995,0.00023170744,0.0016491,0.0018022492,0.000015644579,0.00005546099,0.000043851367,0.0000046202313,0.0010174003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889,0.00007171842,0.0004020575,0.0003046219,0.00010439698,0.00022720906],"domain_scores_gemma":[0.99901855,0.00037653642,0.00012919337,0.00031184973,0.000070062,0.00009379522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010214295,0.00014686557,0.001121306,0.00030009294,0.000037546193,0.000004057732,0.00009715423,0.00034334284,0.00073899096],"category_scores_gemma":[0.00006808123,0.000096549644,0.000621427,0.000773383,0.00012652733,0.000011666691,0.000082823826,0.000082452716,0.000054314438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076241797,0.0065472755,0.88744044,0.000257238,0.0071220067,0.0014390664,0.0001454515,0.00003441007,0.0037609332,0.06866255,0.015657041,0.008171147],"study_design_scores_gemma":[0.00566329,0.0010375194,0.9045409,0.000048400605,0.012056708,0.00014130968,0.00017130088,0.0003138856,0.010294034,0.0011307565,0.064432524,0.00016937975],"about_ca_topic_score_codex":0.000031652206,"about_ca_topic_score_gemma":0.000018572977,"teacher_disagreement_score":0.0960856,"about_ca_system_score_codex":0.00028641967,"about_ca_system_score_gemma":0.00022767326,"threshold_uncertainty_score":0.80914325},"labels":[],"label_agreement":null},{"id":"W4411450234","doi":"10.1056/evidoa2500115","title":"An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma","year":2025,"lang":"en","type":"article","venue":"NEJM Evidence","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Stage (stratigraphy); Cohort; Internal medicine; Clinical trial; Confidence interval; Statistic; Proportional hazards model; Oncology; Statistics; Mathematics","score_opus":0.05666676248189542,"score_gpt":0.3540777375617735,"score_spread":0.2974109750798781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411450234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806197,0.001085617,0.013285404,0.0017703029,0.00028541664,0.0012904331,0.0001014132,0.00020836343,0.0013533465],"genre_scores_gemma":[0.98888725,0.00041499484,0.004755811,0.0012187856,0.000096530865,0.00067242014,0.000048786045,0.000019103594,0.0038862932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862987,0.00004250144,0.00030029847,0.0004542118,0.00028625148,0.00028684724],"domain_scores_gemma":[0.9988201,0.0002808029,0.000084433595,0.0005292677,0.00013494118,0.00015043194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023487667,0.00018933628,0.0003038742,0.00014267543,0.00014602882,0.00006905893,0.00014395609,0.0001366322,0.00003161064],"category_scores_gemma":[0.00023447635,0.00015840419,0.00014082716,0.00021128586,0.00005613285,0.00036120872,0.000038365426,0.00004603639,0.000022264383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019572098,0.0021540285,0.8291724,0.0007041909,0.0004940448,0.00008512894,0.0018533536,0.0006839393,0.003366631,0.008933652,0.018883763,0.1317117],"study_design_scores_gemma":[0.008586733,0.0010981892,0.82504225,0.001455506,0.0006758472,0.000010934513,0.00010617134,0.15097634,0.0050932905,0.0010772569,0.005661285,0.0002161749],"about_ca_topic_score_codex":0.0001322432,"about_ca_topic_score_gemma":0.000042212338,"teacher_disagreement_score":0.15029241,"about_ca_system_score_codex":0.00035431507,"about_ca_system_score_gemma":0.00051386765,"threshold_uncertainty_score":0.64595354},"labels":[],"label_agreement":null},{"id":"W4411453748","doi":"10.1080/14796694.2025.2513219","title":"Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"BeiGene; Sanofi; AstraZeneca; Pfizer","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Medical physics; Hodgkin lymphoma","score_opus":0.0047277561266267035,"score_gpt":0.26764125658082977,"score_spread":0.2629135004542031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411453748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632693,0.0009172781,0.0000019976092,0.0030899872,0.00029740468,0.0014173803,0.000026339276,0.00002435049,0.00789834],"genre_scores_gemma":[0.99728197,0.00009789517,0.000057384346,0.00040886737,0.000060492308,0.00027592923,0.000065422544,0.0000130980625,0.0017389159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988989,0.00019404254,0.00025481876,0.0002642498,0.00015950015,0.00022847154],"domain_scores_gemma":[0.999249,0.00016273781,0.00011932539,0.00038149982,0.00004361139,0.00004386708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000133488,0.00018532161,0.0004973185,0.00013591819,0.00006411738,0.000006001591,0.00010245464,0.00013383836,0.000023660057],"category_scores_gemma":[0.000015460299,0.000103953855,0.00008611921,0.00039257391,0.000035123074,0.000024480447,0.00006445669,0.00006896035,0.0000060758653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009104252,0.102112345,0.86727184,0.0000788909,0.0002386726,0.0002974874,0.006986972,9.129651e-7,0.00022674404,0.0006842356,0.0016376579,0.019553794],"study_design_scores_gemma":[0.090658344,0.0036326167,0.88172305,0.000089379886,0.00034670206,0.000019452373,0.007952477,0.000029633595,0.0036200823,0.000012517029,0.011826844,0.00008891594],"about_ca_topic_score_codex":0.0008551398,"about_ca_topic_score_gemma":0.012704482,"teacher_disagreement_score":0.09847973,"about_ca_system_score_codex":0.0011502577,"about_ca_system_score_gemma":0.00053260115,"threshold_uncertainty_score":0.7089399},"labels":[],"label_agreement":null},{"id":"W4411474622","doi":"10.1182/blood.2025028412","title":"Somatic <i>IRF4</i> mutations and thymic tropism in primary mediastinal large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Eisai; Michael Smith Health Research BC; Veracyte; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Genome Canada; Seagen; Gilead Sciences; AstraZeneca; Deutsche Forschungsgemeinschaft; Bristol-Myers Squibb","keywords":"IRF4; Biology; Phenotype; Cancer research; Lymphoma; Transcription factor; Genetics; Immunology; Gene","score_opus":0.004425606108904823,"score_gpt":0.22436540302452654,"score_spread":0.2199397969156217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411474622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128027,0.0029628768,0.000018224528,0.0008148435,0.000064682434,0.00033769698,0.000014597432,0.000039232753,0.014467563],"genre_scores_gemma":[0.99739444,0.00021992532,0.0008135417,0.00087404076,0.000033422577,0.00010718726,0.000053660886,0.000009877051,0.00049392803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.000027164147,0.00021928656,0.00020968058,0.00012818916,0.00021183275],"domain_scores_gemma":[0.9995593,0.00013307355,0.000038711984,0.0001718056,0.000021416474,0.00007573715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006727319,0.0001255076,0.00024902239,0.00013894703,0.000055631546,0.000016490376,0.000040411625,0.00005793009,0.000018561966],"category_scores_gemma":[0.0000329103,0.00010411141,0.000049445236,0.00018947324,0.000033807723,0.000042754455,0.000041515596,0.00004092671,0.00002603192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006751003,0.019394951,0.96038836,0.0006484053,0.00020490494,0.0007341571,0.00077263755,5.888332e-7,0.003703491,0.0011385231,0.0006289531,0.012317521],"study_design_scores_gemma":[0.037056506,0.00015597118,0.953002,0.00028636883,0.0004484439,0.000084048595,0.00013352458,0.00004440463,0.0074887495,0.00035163382,0.00085103593,0.00009732769],"about_ca_topic_score_codex":0.000034748176,"about_ca_topic_score_gemma":0.000027141894,"teacher_disagreement_score":0.036988996,"about_ca_system_score_codex":0.000084631545,"about_ca_system_score_gemma":0.00020980001,"threshold_uncertainty_score":0.424554},"labels":[],"label_agreement":null},{"id":"W4411523929","doi":"10.1002/hon.70111","title":"Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Staatssekretariat für Bildung, Forschung und Innovation; Swiss Cancer Research Foundation","keywords":"Medicine; Lymphoma; Follicular lymphoma; Retrospective cohort study; Internal medicine; Gastroenterology; Gastrointestinal tract; Presentation (obstetrics); Follicular phase; Pathology; Radiology","score_opus":0.0258332540265981,"score_gpt":0.31135873062543884,"score_spread":0.28552547659884076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411523929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974332,0.0007183792,0.00011091962,0.0019719114,0.00081656314,0.0013065363,0.000035748733,0.00006657785,0.020641373],"genre_scores_gemma":[0.9974944,0.00006551322,0.00038866972,0.0012990605,0.000042746015,0.00026341254,0.00004353838,0.000013596455,0.00038903888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973094,0.00047831767,0.0007318101,0.0006097876,0.00051620486,0.0003545222],"domain_scores_gemma":[0.9980873,0.0007401298,0.00024263364,0.0005352486,0.00028601076,0.00010866167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006660553,0.00029451572,0.001135498,0.00012396589,0.00013185182,0.00001737371,0.00042842,0.00033186242,0.000200695],"category_scores_gemma":[0.00054426934,0.00017431306,0.00034679397,0.00052699074,0.00032890783,0.000049945156,0.00031873825,0.00011545964,0.000019588553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012330544,0.016050037,0.96338695,0.00003956649,0.000794767,0.00070494326,0.00014672686,0.000001032227,0.00038317003,0.007019694,0.0016713941,0.0085686715],"study_design_scores_gemma":[0.013865154,0.0015855231,0.9792711,0.00007024265,0.00031220386,0.0004123467,0.00016443293,0.000041192277,0.0008092591,0.00054281903,0.0027895367,0.00013617604],"about_ca_topic_score_codex":0.00055084325,"about_ca_topic_score_gemma":0.0004432352,"teacher_disagreement_score":0.023162434,"about_ca_system_score_codex":0.0012559341,"about_ca_system_score_gemma":0.0005998163,"threshold_uncertainty_score":0.71082807},"labels":[],"label_agreement":null},{"id":"W4411558199","doi":"10.1080/10428194.2025.2502805","title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Post-hoc analysis; Refractory (planetary science); Medicine; Post hoc; Oncology; Lymphoma; Internal medicine; Cancer; Materials science; Immunotherapy","score_opus":0.009830960614451054,"score_gpt":0.2684047589855079,"score_spread":0.2585737983710569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411558199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97752464,0.017914912,0.000024103178,0.00034787075,0.0002776483,0.0012538837,0.00032994448,0.00014660304,0.0021804236],"genre_scores_gemma":[0.9850734,0.009773966,0.0005657837,0.0013427845,0.00008603345,0.00028023578,0.00041763677,0.00010733693,0.0023528237],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9938223,0.00031011034,0.0023139475,0.0015156305,0.0009758456,0.0010622088],"domain_scores_gemma":[0.9953439,0.0010963691,0.00095813,0.001620545,0.0005360924,0.00044496672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005611453,0.0011141468,0.0031936576,0.0022570593,0.00021899666,0.00007486937,0.0005685468,0.00092574814,0.00016969179],"category_scores_gemma":[0.00029816598,0.00087571185,0.0009812602,0.0042038606,0.00063180504,0.000257144,0.00025484036,0.00013170956,0.000012581978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03834166,0.006388776,0.13354374,0.0010295757,0.008692789,0.00086845655,0.0025473007,0.00011307106,0.023231171,0.0009198325,0.0044144257,0.7799092],"study_design_scores_gemma":[0.11111158,0.003677611,0.82090557,0.0012216403,0.004196758,0.00020088333,0.00096421025,0.0038578403,0.034411483,0.00011293625,0.018281726,0.0010577488],"about_ca_topic_score_codex":0.007824774,"about_ca_topic_score_gemma":0.0007098201,"teacher_disagreement_score":0.77885145,"about_ca_system_score_codex":0.00762137,"about_ca_system_score_gemma":0.007467495,"threshold_uncertainty_score":0.9993694},"labels":[],"label_agreement":null},{"id":"W4411577994","doi":"10.1016/j.ijom.2025.04.586","title":"High-Grade Maxillary Sinus B-cell Lymphoma: A Case Report and Review of the Literature","year":2025,"lang":"en","type":"article","venue":"International Journal of Oral and Maxillofacial Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Maxillary sinus; Lymphoma; B-cell lymphoma; Dentistry; Internal medicine","score_opus":0.011560719800234716,"score_gpt":0.2718015633827822,"score_spread":0.2602408435825475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411577994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92973447,0.05976139,0.0000030870344,0.008802683,0.0011932362,0.00012096157,0.000032615986,0.0000039895517,0.00034757116],"genre_scores_gemma":[0.95123243,0.04617309,0.0001524391,0.0019600969,0.000056918096,0.0000037235934,0.000013762579,0.0000058435003,0.00040167916],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988835,0.000028660002,0.000562816,0.000116724856,0.00032017566,0.000088130604],"domain_scores_gemma":[0.9989844,0.000048351492,0.00037810378,0.00010509381,0.00040962137,0.000074440875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029394525,0.0001199211,0.0004048488,0.00014055152,0.000043261105,0.00003151775,0.00006157684,0.000058569403,0.00001775464],"category_scores_gemma":[0.0002111027,0.00006869314,0.00024995944,0.00015617641,0.000076135715,0.00010075549,0.0000723422,0.000069870155,3.3479782e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004030555,0.0012063526,0.15037693,0.0013993761,0.0008446869,0.50274974,0.00010236529,4.0396102e-7,0.0003913757,0.00074960606,0.0061390465,0.3356371],"study_design_scores_gemma":[0.003100698,0.000100381985,0.114810325,0.010167969,0.0005313818,0.72634715,0.000045054032,0.0000025232573,0.0035826033,0.0006349864,0.14054039,0.00013652716],"about_ca_topic_score_codex":0.00021062013,"about_ca_topic_score_gemma":0.0000034275895,"teacher_disagreement_score":0.33550057,"about_ca_system_score_codex":0.0000765117,"about_ca_system_score_gemma":0.0002328817,"threshold_uncertainty_score":0.2801225},"labels":[],"label_agreement":null},{"id":"W4411660266","doi":"10.51847/vr6k36tr0l884","title":"10.51847/vr6k36tr0l884","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cauda equina syndrome; Cauda equina; Hodgkin lymphoma; Lymphoma; Pathology; Surgery; Spinal cord","score_opus":0.007118108594788451,"score_gpt":0.20255473829253842,"score_spread":0.19543662969774997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411660266","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019978914,0.00014035685,4.682054e-8,0.001172682,0.0000018249633,0.00023894466,0.000008984753,0.00009242854,0.97836584],"genre_scores_gemma":[0.006950552,0.0000017486543,0.00013361454,0.0003460516,0.00011406993,0.000045215143,0.000028013545,0.00001606997,0.99236465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936426,0.000010629498,0.000113758084,0.00017581436,0.00014620759,0.0001893287],"domain_scores_gemma":[0.99948645,0.000027371212,0.000011461292,0.00025417338,0.000025045018,0.00019547359],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000039851733,0.000106617015,0.00017516213,0.000042127514,0.00003791285,0.0000137629495,0.000047928494,0.000040440762,0.9942429],"category_scores_gemma":[0.000013421381,0.00008380513,0.00006908618,0.000112852875,0.000014793639,0.000028007067,0.000013289174,0.000029189252,0.9896503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012129419,0.00029715695,0.000021172365,0.000004744424,0.00004629562,0.000074581345,0.00001118395,0.0000034266825,0.000025932473,0.0000016245699,0.1010148,0.8983778],"study_design_scores_gemma":[0.0011295931,0.0004212749,0.0044871457,0.000033172415,0.000074736796,0.000046540485,4.8238616e-7,0.000022028109,0.00018960821,8.094096e-7,0.9935068,0.000087794586],"about_ca_topic_score_codex":0.000033355493,"about_ca_topic_score_gemma":8.687346e-8,"teacher_disagreement_score":0.89829,"about_ca_system_score_codex":0.000077513665,"about_ca_system_score_gemma":0.00003442169,"threshold_uncertainty_score":0.3417474},"labels":[],"label_agreement":null},{"id":"W4411730356","doi":"10.1101/2025.06.25.661613","title":"Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Genomics; Lymphoma; Tumor microenvironment; Computational biology; Functional genomics; Mantle (geology); Biology; Cancer research; Tumor cells; Immunology; Genetics; Gene; Genome","score_opus":0.013134582081458832,"score_gpt":0.20659856548177366,"score_spread":0.19346398340031484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411730356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334455,0.0046291472,0.00006633826,0.00027438643,0.0002874605,0.00097351085,0.00032179907,0.000083179046,0.000019636112],"genre_scores_gemma":[0.9950758,0.0013089017,0.0026320433,0.00036046654,0.00017083941,0.0003855263,0.0000060684965,0.000032593496,0.000027717026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751407,0.00010066121,0.0005556315,0.0011394062,0.00024362872,0.00044657846],"domain_scores_gemma":[0.9985944,0.00012534988,0.00024028757,0.00070759386,0.00008818896,0.00024419354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027984488,0.00051251356,0.0009151067,0.0005167987,0.000088510664,0.00007304394,0.00015119827,0.0003563762,0.000063294305],"category_scores_gemma":[0.00006933871,0.00045719245,0.00025372795,0.00050358975,0.0001319176,0.00003404683,0.00043923422,0.00024143358,0.000040005474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015949922,0.0016333148,0.9596178,0.0003674841,0.00090345496,0.00032713878,0.000007081017,0.00006721478,0.036601145,0.00006296308,0.00024535114,0.000007546353],"study_design_scores_gemma":[0.0021172282,0.00011312716,0.9567411,0.00022841968,0.001576382,1.0988754e-7,0.0000037584498,0.00019026834,0.037207764,0.0000014021196,0.0014499234,0.00037051536],"about_ca_topic_score_codex":0.00011389314,"about_ca_topic_score_gemma":0.000007077796,"teacher_disagreement_score":0.0033202455,"about_ca_system_score_codex":0.0010088484,"about_ca_system_score_gemma":0.0005323374,"threshold_uncertainty_score":0.999788},"labels":[],"label_agreement":null},{"id":"W4411743715","doi":"10.1002/ctm2.70380","title":"T‐cell differentiation stage block bias confers hypermethylation and mediastinal preference in T‐cell lymphoblastic lymphoma","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Cancer research; Biology; Flow cytometry; T cell; Demethylating agent; Molecular biology; Immunology; DNA methylation; Genetics; Gene expression; Gene; Immune system","score_opus":0.0785733804514466,"score_gpt":0.33232219009261127,"score_spread":0.25374880964116464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411743715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878142,0.002942037,0.0003390009,0.004423358,0.00022405526,0.00046389145,0.000018148976,0.00002700914,0.003748324],"genre_scores_gemma":[0.9967829,0.0014687845,0.00030513832,0.00057853735,0.00012472246,0.00003499884,0.00012088755,0.000009390582,0.00057462335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981919,0.000111207686,0.0007675352,0.0004430195,0.00029542152,0.0001909295],"domain_scores_gemma":[0.99780536,0.0016535219,0.00011245696,0.00013530535,0.00009403284,0.00019933263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037160915,0.0002118655,0.0005176619,0.00020980851,0.0000709959,0.000013241584,0.00004295648,0.00016320002,0.00008937586],"category_scores_gemma":[0.00025562238,0.00015416891,0.000060819137,0.00021961535,0.00035323785,0.00006785936,0.000019413888,0.00011445935,0.0000052272335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005092968,0.0008434218,0.96080256,0.0002749753,0.000055037242,0.000025810199,0.00021683684,0.00001099786,0.0002732784,0.0016449037,0.00009868895,0.035244197],"study_design_scores_gemma":[0.018826269,0.0005426636,0.9736294,0.0004665327,0.00030229194,0.000010252016,0.00009287252,0.0038094649,0.00027555702,0.0011157424,0.00081045495,0.000118503885],"about_ca_topic_score_codex":0.0000789548,"about_ca_topic_score_gemma":0.000040969127,"teacher_disagreement_score":0.03512569,"about_ca_system_score_codex":0.000028288636,"about_ca_system_score_gemma":0.00020446868,"threshold_uncertainty_score":0.6286826},"labels":[],"label_agreement":null},{"id":"W4411770344","doi":"10.14740/jmc5086","title":"B-Cell Lymphoma Presenting as a Pancreatic Mass","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Arrowhead Regional Medical Center","keywords":"Medicine; Pancreatic mass; Lymphoma; Internal medicine; Pancreas","score_opus":0.016852326396857537,"score_gpt":0.31475789374144336,"score_spread":0.29790556734458584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411770344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700668,0.0065833502,0.00006214381,0.0105377305,0.00033623664,0.00010914153,0.0000013002024,0.000012427665,0.012290905],"genre_scores_gemma":[0.99480075,0.0011131098,0.0004120917,0.0017184415,0.0003275671,0.000005986272,0.0000016325303,0.000007845017,0.0016125807],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812245,0.000059397233,0.00049561064,0.000108130036,0.0010216804,0.00019272736],"domain_scores_gemma":[0.9985034,0.0006835651,0.00018844823,0.000144488,0.00012771277,0.00035239867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041732477,0.000115036964,0.00042033088,0.00015352912,0.00005274874,0.000027523733,0.0001253336,0.00011225039,0.00058736646],"category_scores_gemma":[0.0017999236,0.00007327448,0.0002273546,0.00015515725,0.00006117523,0.000053597483,0.000041684794,0.00011916414,0.000032778054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011860385,0.009221287,0.47144064,0.0010357957,0.0015738436,0.15493998,0.00039553276,0.000002943944,0.00070650363,0.001909315,0.22608896,0.13149916],"study_design_scores_gemma":[0.10176811,0.0068772454,0.34390524,0.013310442,0.007620072,0.07809749,0.0050337883,0.0010482231,0.073266394,0.0038702039,0.36446595,0.000736831],"about_ca_topic_score_codex":0.00008840542,"about_ca_topic_score_gemma":0.0000018104982,"teacher_disagreement_score":0.13837701,"about_ca_system_score_codex":0.00015375759,"about_ca_system_score_gemma":0.000904849,"threshold_uncertainty_score":0.64312506},"labels":[],"label_agreement":null},{"id":"W4411919562","doi":"10.1016/j.ijrobp.2025.06.3876","title":"Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Hodgkin lymphoma; Medicine; Radiation therapy; Modality (human–computer interaction); Lymphoma; Treatment modality; Radiology; Medical physics; Internal medicine; Computer science; Artificial intelligence","score_opus":0.06816975993043761,"score_gpt":0.37331877342916664,"score_spread":0.305149013498729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411919562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241054,0.001845464,0.00040704123,0.002465911,0.0013290641,0.0009261852,0.00007359469,0.000026210442,0.00051600527],"genre_scores_gemma":[0.9968072,0.0016852901,0.00029078807,0.0002639353,0.0006550418,0.00008242998,0.00016848378,0.000020009473,0.000026793683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970061,0.00072247966,0.0013657798,0.00034296775,0.00036025955,0.00020237274],"domain_scores_gemma":[0.99655974,0.0009550724,0.0017761255,0.00025493724,0.00035831286,0.00009582092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064256997,0.00030980204,0.0010956815,0.0005202061,0.000068585476,0.000022346858,0.00026946954,0.00025512025,0.000015110468],"category_scores_gemma":[0.00017361576,0.00024160508,0.00030598795,0.00037477782,0.00010703375,0.00016258271,0.000035699242,0.00022553683,0.000007091716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022596656,0.014265156,0.7162606,0.0000068982263,0.0011363184,0.000025695028,0.0007349964,0.00073457113,0.000050885086,0.0036143647,0.00033814317,0.2605727],"study_design_scores_gemma":[0.044970904,0.010835865,0.93300974,0.0000409029,0.0003027012,0.000007336851,0.00030224887,0.0021150121,0.0033877187,0.003786197,0.0010893128,0.0001520819],"about_ca_topic_score_codex":0.0003338307,"about_ca_topic_score_gemma":0.000020726065,"teacher_disagreement_score":0.26042062,"about_ca_system_score_codex":0.0023773743,"about_ca_system_score_gemma":0.0012280839,"threshold_uncertainty_score":0.98523694},"labels":[],"label_agreement":null},{"id":"W4411966677","doi":"10.1111/bjh.20239","title":"Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Incyte; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Eli Lilly and Company","keywords":"Mantle cell lymphoma; Lymphoma; Medicine; Mantle (geology); Cancer research; Oncology; Internal medicine; Intensive care medicine; Geology; Geochemistry","score_opus":0.010890812951829193,"score_gpt":0.2748953398795863,"score_spread":0.2640045269277571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411966677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94930625,0.04873625,0.000017522168,0.00082728616,0.0002453556,0.00017331637,0.00000312061,0.0000041695735,0.0006867133],"genre_scores_gemma":[0.9902739,0.008803041,0.00018290541,0.00057872373,0.000024795403,0.000011400661,0.000001537471,0.000008521563,0.00011517307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884737,0.00007649954,0.00051732606,0.0001676259,0.00015161526,0.00023958337],"domain_scores_gemma":[0.9994994,0.00015606152,0.00015349787,0.00007690445,0.000048775517,0.00006537753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021914685,0.00011979248,0.0006033166,0.0002240231,0.00002783704,0.00002582222,0.00006984427,0.00008637997,0.000023454055],"category_scores_gemma":[0.00003412501,0.00011250183,0.000078053454,0.00011528305,0.00006439031,0.00011086568,0.000037697584,0.00010919476,0.0000012915168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046499117,0.0019795122,0.69803435,0.0003576829,0.0001541075,0.05289936,0.00015390218,0.0000048898673,0.00035463163,0.0011671801,0.00045546264,0.24397394],"study_design_scores_gemma":[0.020353368,0.00053352735,0.9430735,0.00092946785,0.000106782274,0.024226472,0.0002491008,0.000034157452,0.00268687,0.0040490986,0.0036278267,0.00012979103],"about_ca_topic_score_codex":0.000375555,"about_ca_topic_score_gemma":0.0009665422,"teacher_disagreement_score":0.24503921,"about_ca_system_score_codex":0.00017519825,"about_ca_system_score_gemma":0.00021589751,"threshold_uncertainty_score":0.45876914},"labels":[],"label_agreement":null},{"id":"W4412105729","doi":"10.1093/bjr/tqaf145","title":"Author response to Letter manuscript BJR-D-25-00310 “Aligning systematic reviews: the role of PET in detecting histological transformation in follicular lymphoma”","year":2025,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Transformation (genetics); Pathology; Follicular phase; Medical physics; Internal medicine; Biology","score_opus":0.02033430670282667,"score_gpt":0.2809494961575199,"score_spread":0.26061518945469325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412105729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627273,0.031232864,0.00022092805,0.0045946916,0.00017884203,0.00089307775,0.0000019344143,0.000004922015,0.00014544257],"genre_scores_gemma":[0.99760914,0.00050824485,0.0005872165,0.0011097203,0.000038636306,0.00009331457,0.0000011623595,0.000006445615,0.000046110647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99652183,0.0016579463,0.0013112569,0.0001367496,0.0001522132,0.00022002115],"domain_scores_gemma":[0.99866617,0.00069283356,0.00036518666,0.00013972282,0.00007729737,0.000058774025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003801442,0.00012132751,0.0010052301,0.0003324309,0.00005493175,0.000015907703,0.00014377754,0.00009092876,0.000008637204],"category_scores_gemma":[0.0021531084,0.00008691925,0.00020911443,0.00031368996,0.00004642873,0.000070161455,0.000017444965,0.00018335906,0.0000027797757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014098048,0.004812351,0.3116147,0.02499162,0.0021715898,0.05184668,0.020275947,0.00067736726,0.08142337,0.0021781924,0.035716485,0.45019364],"study_design_scores_gemma":[0.015062783,0.0021048998,0.7270174,0.057395227,0.00087108026,0.16950144,0.0049824403,0.0005230652,0.005132212,0.0007285825,0.016327467,0.0003533967],"about_ca_topic_score_codex":0.00013697417,"about_ca_topic_score_gemma":0.00010470789,"teacher_disagreement_score":0.44984025,"about_ca_system_score_codex":0.00048377996,"about_ca_system_score_gemma":0.00010525368,"threshold_uncertainty_score":0.35444644},"labels":[],"label_agreement":null},{"id":"W4412125701","doi":"10.1200/po-25-00200","title":"Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"DNA; Genome; Cell-free fetal DNA; DNA sequencing; Computational biology; Whole genome sequencing; Biology; Genetics; Gene","score_opus":0.012237026845153052,"score_gpt":0.30584458902256906,"score_spread":0.293607562177416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412125701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94420266,0.0006075813,0.006373481,0.0015133127,0.00044329453,0.0021289042,0.0004985777,0.00007061206,0.044161588],"genre_scores_gemma":[0.97724646,0.00031606588,0.018457841,0.00072024297,0.00008584618,0.00048496673,0.00015999567,0.00003341449,0.0024951857],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781185,0.000156703,0.0006407716,0.0005740166,0.0003450544,0.000471623],"domain_scores_gemma":[0.996986,0.001265497,0.00039883435,0.0008414841,0.0003408171,0.00016741706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006435597,0.00029031,0.000858714,0.00025373773,0.00016114251,0.000019588795,0.00026541343,0.00028767716,0.00008154924],"category_scores_gemma":[0.00017616429,0.0002079395,0.00023260845,0.0002940141,0.0000657943,0.000073660485,0.000120704295,0.00011691549,0.000023181992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009675591,0.056367163,0.16648331,0.0022691118,0.0022580677,0.0009905122,0.0026210924,0.00029863234,0.5369334,0.004956412,0.04852946,0.16861723],"study_design_scores_gemma":[0.14327085,0.015120341,0.19984142,0.00074724626,0.0023018424,0.00009358642,0.0015868521,0.0009181378,0.3133813,0.0019504834,0.32015705,0.0006308909],"about_ca_topic_score_codex":0.00009091435,"about_ca_topic_score_gemma":0.0000980962,"teacher_disagreement_score":0.27162758,"about_ca_system_score_codex":0.0017629619,"about_ca_system_score_gemma":0.0016375105,"threshold_uncertainty_score":0.8479527},"labels":[],"label_agreement":null},{"id":"W4412166613","doi":"10.1017/cjn.2025.10201","title":"P.017 EBNA1 titres are elevated in radiologically isolated syndrome and correlate with plasma GFAP","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Pathology; Medicine","score_opus":0.01676084656389305,"score_gpt":0.24751971407390763,"score_spread":0.2307588675100146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412166613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774076,0.0022582482,0.000006215803,0.007626077,0.00030720205,0.00025892167,0.000006680095,0.000017877655,0.0017780447],"genre_scores_gemma":[0.9949086,0.0011801558,0.0006044768,0.003199615,0.000035515077,0.0000054569323,3.7340982e-7,0.0000071885083,0.000058634465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662,0.0005081297,0.0007724917,0.0005611667,0.00046100043,0.0010772365],"domain_scores_gemma":[0.997127,0.00057924754,0.000543823,0.00013455401,0.00029708163,0.0013183109],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00151806,0.00034159984,0.0007552802,0.001245547,0.0012166224,0.00040260935,0.00073749403,0.00023327897,0.000076918164],"category_scores_gemma":[0.0010897468,0.00019258377,0.00013272122,0.0016449967,0.004707917,0.0004645025,0.000053486958,0.00095543935,0.0000019808435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039259612,0.00007020205,0.9571181,0.000010004522,0.00003668959,0.039366312,0.000092629656,0.00060823467,0.000018658477,0.00041932744,0.00029443388,0.0015728319],"study_design_scores_gemma":[0.0012067822,0.058191556,0.86867857,0.0002239993,0.00007452166,0.06727256,0.00014445589,0.0012083271,0.00002170446,0.0020447616,0.0007493451,0.00018341707],"about_ca_topic_score_codex":0.0014044397,"about_ca_topic_score_gemma":0.05271971,"teacher_disagreement_score":0.08843951,"about_ca_system_score_codex":0.0003210846,"about_ca_system_score_gemma":0.0027967603,"threshold_uncertainty_score":0.9980007},"labels":[],"label_agreement":null},{"id":"W4412488898","doi":"10.1182/bloodadvances.2024014654","title":"Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Internal medicine; Clinical trial; Lesion; Oncology; Gastroenterology; Surgery; Cancer; Immunotherapy","score_opus":0.010172272588648537,"score_gpt":0.3021202913284249,"score_spread":0.2919480187397763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412488898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777762,0.0073689716,0.00023580596,0.00051450735,0.00030560888,0.0009264036,0.000023983157,0.00008430117,0.012764177],"genre_scores_gemma":[0.98960173,0.00028042728,0.00917139,0.00028040164,0.00008115914,0.00013805061,0.000023975328,0.000028240598,0.00039464573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978252,0.000078666475,0.0006863309,0.00058830454,0.00036965415,0.0004518501],"domain_scores_gemma":[0.99847037,0.0005408164,0.00022232719,0.00048444135,0.00013081322,0.00015121706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012254663,0.0003441402,0.0008789354,0.00045481688,0.00009337469,0.000021227032,0.00018131269,0.00012233469,0.000034154236],"category_scores_gemma":[0.0005556681,0.00029280782,0.00018328229,0.00076516747,0.00010191632,0.0002650011,0.000121377394,0.000115402436,0.000032813685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060521215,0.0153621575,0.47867104,0.0017027715,0.0015315493,0.0013575844,0.004666514,0.0063887653,0.006627612,0.008970662,0.0005642811,0.46810493],"study_design_scores_gemma":[0.04431865,0.0012448098,0.92256737,0.002468609,0.00057563226,0.00007543817,0.0003057833,0.0007694991,0.022599906,0.0005304389,0.004167174,0.00037670415],"about_ca_topic_score_codex":0.00021303752,"about_ca_topic_score_gemma":0.000052976702,"teacher_disagreement_score":0.46772823,"about_ca_system_score_codex":0.00039100499,"about_ca_system_score_gemma":0.0004901673,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W4412493495","doi":"10.1182/bloodadvances.2025016651","title":"High-grade B-cell lymphoma, not otherwise specified: an LLMPP study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; University of Toronto; University Health Network; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome British Columbia; National Cancer Institute; Genome Canada","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Not Otherwise Specified; Cell of origin; Biology; Germinal center; Population; Cancer research; Oncology; Pathology; Medicine; B cell; Internal medicine; Cancer; Immunology; Antibody","score_opus":0.01410312446159241,"score_gpt":0.28861591362199057,"score_spread":0.2745127891603982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412493495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292166,0.0054277163,0.000008680364,0.00061982335,0.00040126502,0.00082101446,0.000018623257,0.00014058009,0.009640635],"genre_scores_gemma":[0.9930157,0.0006106018,0.0014822553,0.0008533538,0.00022463541,0.00016335705,0.000018890643,0.000023699513,0.0036075064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855584,0.00005408333,0.0002998509,0.0005064096,0.00028761846,0.00029618465],"domain_scores_gemma":[0.9990423,0.00009710329,0.000082604165,0.00057834014,0.000052019095,0.00014768809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000936763,0.00025701168,0.0004405919,0.00012681728,0.00012404,0.00004114639,0.00015216807,0.000057933237,0.00010081861],"category_scores_gemma":[0.000020027905,0.0001938007,0.00010200346,0.0002816988,0.000054310694,0.00016837152,0.000046860747,0.000048418133,0.00008518625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009062964,0.10307568,0.7328844,0.00023949145,0.0009431432,0.0014178567,0.001081233,0.000034405944,0.0032372177,0.004154979,0.0017083368,0.15031692],"study_design_scores_gemma":[0.04146462,0.0029685595,0.7219707,0.00013887286,0.0013624014,0.00002789392,0.0023088946,0.000010358714,0.1535996,0.00045907023,0.07529644,0.0003925903],"about_ca_topic_score_codex":0.00025821084,"about_ca_topic_score_gemma":0.00024247388,"teacher_disagreement_score":0.15036239,"about_ca_system_score_codex":0.00008387579,"about_ca_system_score_gemma":0.0001108594,"threshold_uncertainty_score":0.7902963},"labels":[],"label_agreement":null},{"id":"W4412820579","doi":"10.1038/s41408-025-01329-2","title":"Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Pharmacyclics; Genentech; Regeneron Pharmaceuticals; National Institutes of Health; Swedish Orphan Biovitrum; Sanofi; Kyowa Hakko Kirin; Cilag; Italfarmaco; Seagen; Celltrion; Pfizer; Incyte; BeiGene; Astex Pharmaceuticals; Kite Pharma; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Takeda Pharmaceuticals U.S.A.; Leukemia and Lymphoma Society; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Takeda Oncology; Amgen","keywords":"Brentuximab vedotin; Oncology; Medicine; Internal medicine; Chemotherapy; Subgroup analysis; Anaplastic large-cell lymphoma; Lymphoma; Front line; Clinical trial; Hodgkin lymphoma; Meta-analysis","score_opus":0.013720827726550729,"score_gpt":0.28571803154387887,"score_spread":0.2719972038173281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412820579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744626,0.022877395,0.0001301809,0.00032858702,0.0006444952,0.0013181872,0.00018710637,0.000008845018,0.000042602],"genre_scores_gemma":[0.99401927,0.003791101,0.000037735317,0.000107693,0.00014362848,0.0002535743,0.0000106116895,0.00002121988,0.0016151539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983424,0.00008950158,0.00062036596,0.00025903032,0.00039092827,0.0002977801],"domain_scores_gemma":[0.99845946,0.00029749487,0.00047967955,0.00050000625,0.00018406099,0.00007932648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025640114,0.00024006117,0.0008840117,0.0001962687,0.00020611974,0.000022049364,0.00022026827,0.00007010104,0.00009985446],"category_scores_gemma":[0.00001892235,0.00012391013,0.0008276845,0.00054499257,0.000045927307,0.000024123088,0.000036895453,0.000053115302,0.0000012191389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035030488,0.022820365,0.91323686,0.00023142078,0.036671493,0.0000486221,0.005460597,0.0005913805,0.0012324759,0.000019118945,0.0012650611,0.014919552],"study_design_scores_gemma":[0.15424907,0.0037660722,0.75648713,0.000515225,0.05612423,0.000052344218,0.0020446328,0.002112469,0.022720195,0.000009803382,0.0017327141,0.00018614462],"about_ca_topic_score_codex":0.0005925732,"about_ca_topic_score_gemma":0.0018689055,"teacher_disagreement_score":0.15674976,"about_ca_system_score_codex":0.0010761791,"about_ca_system_score_gemma":0.00056346034,"threshold_uncertainty_score":0.50529087},"labels":[],"label_agreement":null},{"id":"W4412851597","doi":"10.1016/j.ajt.2025.07.1643","title":"Calling All DSA Positive Allows Existing Banff Guidelines to Diagnose Many More Cases of Histologic ABMR Currently Missed Only Because They Are DSA-Negative","year":2025,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College; BP (Canada)","funders":"","keywords":"Medicine; Radiology","score_opus":0.05664906445063591,"score_gpt":0.371821325104591,"score_spread":0.3151722606539551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412851597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910141,0.00078103,0.0016797958,0.005693025,0.00016279136,0.00034827422,0.00014896937,0.000015762264,0.00015625579],"genre_scores_gemma":[0.98781365,0.0016470833,0.008327175,0.0020101466,0.00007862504,0.00001630367,0.00005511106,0.00001535946,0.000036552792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824256,0.00012069499,0.0008557119,0.00022631866,0.00033748578,0.00021724273],"domain_scores_gemma":[0.9972453,0.0009288028,0.0007990029,0.0001360846,0.0007222841,0.00016852113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020477317,0.00023269962,0.0006810206,0.0003023081,0.00007111656,0.000016142007,0.000118915705,0.00004290581,0.0000137340585],"category_scores_gemma":[0.00039099748,0.00017786419,0.00022659876,0.00025586737,0.00010598588,0.00010761382,0.0000089237765,0.0001363041,0.0000021277858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010734104,0.0035982742,0.7072819,0.00087214523,0.003915833,0.013397796,0.032333,0.0036367765,0.017452398,0.00048060608,0.0026415817,0.20365559],"study_design_scores_gemma":[0.0087442985,0.0051318803,0.9187327,0.009435025,0.004528546,0.0023516887,0.010929006,0.00035806425,0.038448546,0.00014021005,0.0007156237,0.0004844318],"about_ca_topic_score_codex":0.0016245968,"about_ca_topic_score_gemma":0.00025064292,"teacher_disagreement_score":0.21145077,"about_ca_system_score_codex":0.00025666298,"about_ca_system_score_gemma":0.00023819579,"threshold_uncertainty_score":0.72530913},"labels":[],"label_agreement":null},{"id":"W4412867041","doi":"10.1093/ajcp/aqaf074","title":"An immunohistochemical germinal center B-cell dark zone signature identifies Burkitt lymphoma and molecular high-grade B-cell lymphomas","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Germinal center; B cell; Lymphoma; Immunohistochemistry; Burkitt's lymphoma; Pathology; Biology; B-cell lymphoma; Medicine; Antibody; Immunology","score_opus":0.008986164073463612,"score_gpt":0.3299716642525583,"score_spread":0.3209855001790947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412867041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914089,0.0035712558,0.00082386256,0.002212341,0.0010389545,0.00019790395,0.000016000642,0.000024359324,0.00070645683],"genre_scores_gemma":[0.9861348,0.0007946201,0.008345909,0.0041341097,0.00033495936,0.000010831591,0.000023867262,0.000032128668,0.0001887388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964817,0.0005397223,0.0016270031,0.00055090623,0.00036810435,0.00043255425],"domain_scores_gemma":[0.9970752,0.0006239054,0.0009882001,0.000561609,0.00028666406,0.0004644471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075712276,0.0003525439,0.0016184683,0.00025582622,0.00008650303,0.000039005943,0.00030728534,0.000293518,0.000033186458],"category_scores_gemma":[0.00023382324,0.00027515375,0.00053022325,0.00027963647,0.0012415192,0.000092997296,0.00011562073,0.0004370498,0.000011083317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009053475,0.029726565,0.33740908,0.00028290332,0.0015030734,0.039131444,0.0006461776,0.000018870684,0.23950037,0.00092433003,0.012865841,0.32893786],"study_design_scores_gemma":[0.07784124,0.02500043,0.78593004,0.00078118127,0.0036140066,0.01190967,0.0015472552,0.00014339085,0.07620413,0.002612385,0.013249025,0.001167228],"about_ca_topic_score_codex":0.000047876732,"about_ca_topic_score_gemma":0.0000019315194,"teacher_disagreement_score":0.448521,"about_ca_system_score_codex":0.0001517195,"about_ca_system_score_gemma":0.000478916,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W4413052189","doi":"10.1080/10428194.2025.2531154","title":"The evolution of treatment for pediatric advanced stage classic Hodgkin lymphoma – a narrative literature review","year":2025,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Randomized controlled trial; Intensive care medicine; Lymphoma; Hodgkin lymphoma; Pediatrics; Internal medicine; Nursing","score_opus":0.015566333508557956,"score_gpt":0.3100154015530648,"score_spread":0.2944490680445068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413052189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015927578,0.98423827,0.000031341893,0.0001793764,0.00091592007,0.009823101,0.0013718001,0.00021731715,0.0016301008],"genre_scores_gemma":[0.00060711254,0.9764302,0.0005182385,0.00036786502,0.00068859884,0.0074122953,0.0015447498,0.00023175032,0.012199207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99166584,0.0006290978,0.0029961509,0.0022842037,0.00087896036,0.0015457686],"domain_scores_gemma":[0.9910301,0.0029557818,0.002295593,0.0023200123,0.0007328662,0.00066562457],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00071396923,0.002500589,0.0066271424,0.0008355932,0.0010683966,0.00023410142,0.00076677115,0.001460383,0.000023995935],"category_scores_gemma":[0.0006112396,0.0015607091,0.0031480896,0.0025247796,0.00046374416,0.00031374223,0.00031091063,0.00018535406,0.000027124419],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005565701,0.00056510424,0.00007333395,0.09673084,0.0016518838,0.00021968766,0.0003858994,0.0000016960485,0.0000016694542,0.0018524379,0.0061138603,0.891847],"study_design_scores_gemma":[0.01925296,0.0021680202,0.00047450128,0.10607105,0.012129444,0.0008207685,0.000335668,0.00007213593,0.000025921465,0.00011506074,0.8573527,0.0011817843],"about_ca_topic_score_codex":0.0003738849,"about_ca_topic_score_gemma":0.00008732141,"teacher_disagreement_score":0.89066523,"about_ca_system_score_codex":0.05150756,"about_ca_system_score_gemma":0.03119342,"threshold_uncertainty_score":0.9998359},"labels":[],"label_agreement":null},{"id":"W4413138673","doi":"10.1182/blood.2024026018","title":"Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Chimeric antigen receptor; Lymphoma; Medicine; Immunotherapy; Tumor microenvironment; Immunology; Oncology; Immune system; Cancer research; Bioinformatics; Biology","score_opus":0.018947519111163633,"score_gpt":0.28078744849761056,"score_spread":0.2618399293864469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413138673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829696,0.011302373,0.00004529026,0.0011107102,0.00013010354,0.0035715448,0.00025825584,0.000032469383,0.0005796604],"genre_scores_gemma":[0.99016774,0.005100709,0.0020186938,0.000056766796,0.00006542524,0.0018869068,0.00023557506,0.000034380835,0.00043380196],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984339,0.00003894229,0.0005826329,0.00046866594,0.00018615079,0.0002897365],"domain_scores_gemma":[0.998094,0.0003891192,0.00023789889,0.00053398864,0.0006296852,0.00011529819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007705582,0.00034415978,0.0008872001,0.00016139774,0.000088127024,0.000010250783,0.00005367381,0.00017674491,0.000008328942],"category_scores_gemma":[0.00009376058,0.00023159762,0.000262428,0.00034560738,0.00003310856,0.000038463157,0.000017746343,0.000016275244,8.019124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012262133,0.17235863,0.23210691,0.0015650316,0.01875363,0.00005205107,0.004615666,0.000032969332,0.03333466,0.003243886,0.0010693441,0.5206051],"study_design_scores_gemma":[0.17107233,0.056249037,0.0647122,0.00048033768,0.00503718,0.00003075059,0.00035269567,0.00025944956,0.6627602,0.00026825131,0.038424455,0.00035310106],"about_ca_topic_score_codex":0.00025385208,"about_ca_topic_score_gemma":0.00017277611,"teacher_disagreement_score":0.6294255,"about_ca_system_score_codex":0.00027476277,"about_ca_system_score_gemma":0.00046822373,"threshold_uncertainty_score":0.94442767},"labels":[],"label_agreement":null},{"id":"W4413141479","doi":"10.1182/bloodadvances.2024015600","title":"Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; Ottawa Hospital; University of Ottawa; Health Canada","funders":"Pharmacyclics; Genentech; Astellas Pharma; EUSA Pharma; Seagen; Regeneron Pharmaceuticals; Incyte; F. Hoffmann-La Roche; Kite Pharma; Gilead Sciences; Ipsen; BeiGene; Daiichi Sankyo Europe; University College London Hospitals NHS Foundation Trust; Sanofi; Swedish Orphan Biovitrum; Omeros Corporation; Spectrum Pharmaceuticals; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Refractory (planetary science); Clinical endpoint; Adverse effect; Lymphoma; Surgery; Gastroenterology; Oncology; Clinical trial; Hodgkin lymphoma","score_opus":0.021684557376753625,"score_gpt":0.35288138836029603,"score_spread":0.3311968309835424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413141479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98413724,0.00847925,0.00008027724,0.0007662387,0.00040998746,0.002430623,0.00004993616,0.00016992226,0.0034765017],"genre_scores_gemma":[0.9887374,0.0004808193,0.0017480744,0.00048013811,0.00016496766,0.0011575987,0.00004305114,0.000027105363,0.0071608624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984999,0.000042246407,0.00039496087,0.00050919474,0.00022350911,0.0003301925],"domain_scores_gemma":[0.99876803,0.00040757316,0.00012705367,0.00046420688,0.000115691146,0.00011745022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013234362,0.0002697705,0.00054882176,0.00016104586,0.00016570545,0.000028799195,0.00011643509,0.00006982349,0.000052795192],"category_scores_gemma":[0.00028040132,0.00018227099,0.0001471506,0.0003335342,0.00006200251,0.00014489838,0.000044974968,0.00005107248,0.000015678183],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007848652,0.090766065,0.1774907,0.00061351474,0.0020897172,0.001227331,0.0005203647,0.0000039428546,0.0016587911,0.00084957725,0.006833083,0.71009827],"study_design_scores_gemma":[0.2681644,0.027750595,0.1423629,0.0007691424,0.004790532,0.00011207375,0.0024560879,0.00012245942,0.02590116,0.00052053964,0.52639997,0.00065013836],"about_ca_topic_score_codex":0.000037567457,"about_ca_topic_score_gemma":0.00010266894,"teacher_disagreement_score":0.70944816,"about_ca_system_score_codex":0.00016907956,"about_ca_system_score_gemma":0.00036438456,"threshold_uncertainty_score":0.7432795},"labels":[],"label_agreement":null},{"id":"W4413272991","doi":"10.1080/10428194.2025.2542943","title":"Understanding the clinical approach to “pathologically ambiguous follicular lymphoma” through a Real-World cohort","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Israel Cancer Research Fund","keywords":"Follicular lymphoma; Cohort; Lymphoma; Follicular phase; Medicine; Oncology; Internal medicine","score_opus":0.06678686074280356,"score_gpt":0.32518067801713424,"score_spread":0.2583938172743307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413272991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81993777,0.0018324743,0.004443166,0.0017599924,0.0009067364,0.0030961742,0.000047733734,0.0006069276,0.16736901],"genre_scores_gemma":[0.9698502,0.0031751378,0.0044362186,0.014914682,0.0005347117,0.0010465794,0.00015776178,0.0001395944,0.00574515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99200624,0.0005717304,0.0020253921,0.00247706,0.0011996159,0.001719988],"domain_scores_gemma":[0.99524623,0.00089907413,0.0004581221,0.002247464,0.0002588499,0.0008902369],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015850909,0.001325182,0.0022617583,0.0005058091,0.00138729,0.0004442469,0.00086134276,0.0008751534,0.000046381014],"category_scores_gemma":[0.0003887524,0.00091448595,0.0010378896,0.002225152,0.000988965,0.00030941094,0.000754585,0.00024173778,0.0001561357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046253996,0.005839038,0.46993423,0.0007467795,0.0052645663,0.0035942076,0.0032199307,0.00029953677,0.00048447147,0.15251465,0.076087184,0.27739],"study_design_scores_gemma":[0.027100304,0.0007953324,0.90164036,0.00064612523,0.0021042987,0.0011559261,0.0014399457,0.0019576459,0.00067341345,0.004784445,0.05652591,0.0011762817],"about_ca_topic_score_codex":0.004605574,"about_ca_topic_score_gemma":0.00021359355,"teacher_disagreement_score":0.43170616,"about_ca_system_score_codex":0.017910263,"about_ca_system_score_gemma":0.004820495,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W4413783982","doi":"10.1016/s2152-2650(25)00381-7","title":"ORAL ABSTRACT: CT-230 Lisocabtagene Maraleucel (liso-cel) in Patients With Relapsed or Refractory (R/R) Marginal Zone Lymphoma (MZL) in the Phase 2 TRANSCEND FL Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Gastroenterology; Oncology; Cancer research; Metallurgy","score_opus":0.030105559221708125,"score_gpt":0.3463035311878021,"score_spread":0.316197971966094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413783982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917109,0.0005127219,0.0000074945115,0.0009689329,0.0005726693,0.0035499453,0.00008293511,0.00012730376,0.0024671233],"genre_scores_gemma":[0.99458784,0.0002513753,0.0002985027,0.0024910565,0.0002015834,0.00059743226,0.00028617002,0.00009861315,0.0011874287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927053,0.00068345125,0.0026097703,0.0016180265,0.0012122266,0.0011712246],"domain_scores_gemma":[0.99537724,0.0017535379,0.0004954242,0.0017186744,0.00021609776,0.00043900197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017882824,0.00095157535,0.0019536933,0.00054844964,0.00025312032,0.00014295045,0.0007932531,0.00043848838,0.00028786302],"category_scores_gemma":[0.00047537065,0.00059633143,0.00048762074,0.0015746364,0.0004972969,0.0003557287,0.00014177067,0.00055384013,0.00015195597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015494357,0.03159684,0.5432981,0.00009485558,0.00037262944,0.005149505,0.00043954683,0.000004648884,0.000011128017,0.000046093264,0.001962279,0.40152997],"study_design_scores_gemma":[0.13806498,0.0068769413,0.84188396,0.00060771336,0.0006060167,0.000059884063,0.00081161404,0.00007369917,0.0000744669,0.000030777577,0.010372225,0.00053774717],"about_ca_topic_score_codex":0.0010780008,"about_ca_topic_score_gemma":0.0015348808,"teacher_disagreement_score":0.4009922,"about_ca_system_score_codex":0.003076177,"about_ca_system_score_gemma":0.0027993002,"threshold_uncertainty_score":0.9996488},"labels":[],"label_agreement":null},{"id":"W4413791289","doi":"10.1016/s2152-2650(25)02310-9","title":"ABCL-818: Utility of Khorana, ThroLy, and “Roma” Scores in Predicting VTE in DLBCL and Follicular Lymphoma","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Oncology; Lymphoma","score_opus":0.021686881864033926,"score_gpt":0.3286328388341788,"score_spread":0.3069459569701449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413791289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889594,0.006143082,0.000012634049,0.0009530717,0.0002436709,0.0008976794,0.000029412635,0.00006906297,0.0026919947],"genre_scores_gemma":[0.99656916,0.0018165499,0.0005501747,0.0006799429,0.0000898117,0.00010076494,0.000025526786,0.000033408363,0.00013468137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957137,0.0003030062,0.0018993634,0.0010924088,0.00038309177,0.0006084412],"domain_scores_gemma":[0.9971291,0.0013550549,0.00030825584,0.0007647357,0.000111214045,0.0003316583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013256295,0.00046352076,0.001592046,0.0003753779,0.00009814553,0.000045591194,0.00020270461,0.00054081675,0.000022692666],"category_scores_gemma":[0.0011845877,0.00040098847,0.0002878079,0.00072118937,0.0005461211,0.00017470522,0.00034775113,0.00017824858,0.000007870991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064098905,0.0008999857,0.6527495,0.00022783517,0.00015385858,0.00037387878,0.00014243259,8.3537e-7,0.0000786377,0.00035210277,0.00021438082,0.3441656],"study_design_scores_gemma":[0.022372024,0.00046171996,0.9687621,0.0014713015,0.00025758648,0.00008275432,0.00022109336,0.0033363954,0.0010063403,0.0010599853,0.0007035942,0.00026513],"about_ca_topic_score_codex":0.0027689862,"about_ca_topic_score_gemma":0.0008588605,"teacher_disagreement_score":0.34390044,"about_ca_system_score_codex":0.00082266517,"about_ca_system_score_gemma":0.0012056436,"threshold_uncertainty_score":0.9998442},"labels":[],"label_agreement":null},{"id":"W4413791306","doi":"10.1016/s2152-2650(25)02276-1","title":"ABCL-544: Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Oxaliplatin; Diffuse large B-cell lymphoma; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Phases of clinical research; Clinical trial; Chemotherapy; Cancer","score_opus":0.013681318148002447,"score_gpt":0.28937860924308473,"score_spread":0.2756972910950823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413791306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922937,0.0007546087,0.000012863763,0.00042733017,0.001355673,0.0027005353,0.00029561942,0.000094929535,0.002064726],"genre_scores_gemma":[0.9958038,0.0002713562,0.00036629965,0.0009725871,0.00021644217,0.00017916133,0.0002152636,0.00008965322,0.0018854454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942944,0.00044711083,0.002171993,0.0012282551,0.00095087197,0.0009073533],"domain_scores_gemma":[0.99561405,0.001251396,0.00077298586,0.0015899201,0.00031063196,0.00046104132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000838965,0.0007490615,0.0018510965,0.00029331702,0.0002448239,0.00006842352,0.00049657957,0.0006688777,0.00007316289],"category_scores_gemma":[0.00094170065,0.0005031394,0.0006320683,0.0009028498,0.00053056015,0.00023149462,0.0004786925,0.00031481404,0.00003927124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1351837,0.039682068,0.6458906,0.00028170733,0.0007095347,0.00021670939,0.00036029052,0.0000018148863,0.000051140094,0.00068888365,0.0043974807,0.17253606],"study_design_scores_gemma":[0.45406103,0.0026768495,0.53592557,0.00040882264,0.000461817,0.0000047260924,0.000103521656,0.000100156154,0.00021944755,0.00007944584,0.0056774993,0.00028113986],"about_ca_topic_score_codex":0.0003415719,"about_ca_topic_score_gemma":0.00018900602,"teacher_disagreement_score":0.31887734,"about_ca_system_score_codex":0.0026453596,"about_ca_system_score_gemma":0.0027655666,"threshold_uncertainty_score":0.99974203},"labels":[],"label_agreement":null},{"id":"W4413791504","doi":"10.1016/s2152-2650(25)01391-6","title":"POSTER: CT-230 Lisocabtagene Maraleucel (liso-cel) in Patients With Relapsed or Refractory (R/R) Marginal Zone Lymphoma (MZL) in the Phase 2 TRANSCEND FL Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Lymphoma; Gastroenterology; Clinical trial","score_opus":0.023934277908603474,"score_gpt":0.3349150465922123,"score_spread":0.3109807686836088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413791504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910637,0.000656145,0.000007787188,0.0012762705,0.0005739846,0.0038592196,0.00008207503,0.00012342651,0.0023573602],"genre_scores_gemma":[0.9934573,0.0002791147,0.00019578477,0.0035584432,0.00020697569,0.00062263705,0.00027532424,0.00009786383,0.0013065346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925575,0.0010424089,0.0024967042,0.0016253414,0.0011528572,0.0011251374],"domain_scores_gemma":[0.9953033,0.0017856397,0.0004532485,0.0018239291,0.000217638,0.00041630073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015510914,0.0009290694,0.0019051447,0.0005725132,0.00024568167,0.00013481741,0.0007965534,0.00040483772,0.00018416732],"category_scores_gemma":[0.00044094535,0.00057731516,0.00048164657,0.0016379686,0.00045917885,0.00031719054,0.00016993827,0.00047566826,0.00013212682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018224189,0.028876202,0.59931475,0.00009362042,0.00039534114,0.0047175176,0.0005871532,0.0000021044705,0.000011056194,0.000038916154,0.0015653027,0.34617385],"study_design_scores_gemma":[0.1441083,0.009652493,0.83488256,0.0006815822,0.0006432929,0.00008190035,0.00073158636,0.000059496586,0.00008772449,0.000023262264,0.008530157,0.00051768136],"about_ca_topic_score_codex":0.0007431479,"about_ca_topic_score_gemma":0.001047902,"teacher_disagreement_score":0.3456562,"about_ca_system_score_codex":0.0030967551,"about_ca_system_score_gemma":0.0025917424,"threshold_uncertainty_score":0.9996678},"labels":[],"label_agreement":null},{"id":"W4413810210","doi":"10.1016/s2152-2650(25)01007-9","title":"POSTER: ABCL-544 Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Diffuse large B-cell lymphoma; Oxaliplatin; Refractory (planetary science); Internal medicine; Phases of clinical research; Lymphoma; Oncology; Chemotherapy; Cancer; Colorectal cancer; Metallurgy; Materials science","score_opus":0.013464250707773583,"score_gpt":0.2872150006567484,"score_spread":0.2737507499489748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413810210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184436,0.000754643,0.000006955885,0.00044212257,0.0013820565,0.002787884,0.0003393515,0.000092824936,0.0023498018],"genre_scores_gemma":[0.99613416,0.00023903004,0.00023482769,0.0011832621,0.00020821884,0.00015988167,0.00024007977,0.00009138047,0.001509156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426806,0.0004609432,0.0021968957,0.0012293804,0.0009376487,0.0009070902],"domain_scores_gemma":[0.99563414,0.0012077972,0.00078204565,0.0015984336,0.00031732797,0.00046025205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007975235,0.0007586966,0.0018440556,0.0002987256,0.00023940814,0.00007324589,0.0004988029,0.00066529535,0.00006660858],"category_scores_gemma":[0.00083762314,0.00050999253,0.00063529843,0.00084279425,0.0005672228,0.0002442653,0.0005117117,0.00030933303,0.00003886467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13843095,0.0350338,0.6722871,0.00027065264,0.00067268213,0.00022655395,0.00039469101,9.618095e-7,0.0000547642,0.0004327408,0.0032913273,0.14890376],"study_design_scores_gemma":[0.44681805,0.0030547145,0.5438901,0.00043281453,0.00046338857,0.0000063124244,0.00009008109,0.00005807105,0.00025002877,0.00005616631,0.004597499,0.00028276132],"about_ca_topic_score_codex":0.00027931627,"about_ca_topic_score_gemma":0.00015556382,"teacher_disagreement_score":0.3083871,"about_ca_system_score_codex":0.0021334,"about_ca_system_score_gemma":0.0024354996,"threshold_uncertainty_score":0.9997352},"labels":[],"label_agreement":null},{"id":"W4413836841","doi":"10.3390/cancers17172845","title":"Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"HORIZON EUROPE Framework Programme; European Commission","keywords":"Medicine; Radiation therapy; Lymphoma; Radiology; Medical physics; Pathology","score_opus":0.03926208189073094,"score_gpt":0.3970430156669144,"score_spread":0.3577809337761835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049055725,0.9890927,0.000022168264,0.000095744545,0.00038772734,0.009918836,0.00025699486,0.00002482834,0.00019608579],"genre_scores_gemma":[0.000006683559,0.9951475,0.00033002006,0.0011067957,0.00008627611,0.0025733206,0.00013424916,0.00004333211,0.00057177554],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968996,0.00023238787,0.0018677984,0.0005217053,0.00023147676,0.00024703034],"domain_scores_gemma":[0.99645966,0.001731783,0.00078611,0.0007294413,0.000108874585,0.00018415513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066946447,0.00048837694,0.007653128,0.00010593439,0.000044568904,0.00001021659,0.00015621263,0.0002764735,0.000022894774],"category_scores_gemma":[0.00072994345,0.0002975503,0.0019663435,0.00021856454,0.000114856695,0.000024059043,0.000018054028,0.00007829025,0.000003070301],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003339271,0.000079318124,0.00014803205,0.7529237,0.0029077139,0.000017284841,0.0000094323195,5.070562e-8,9.139758e-9,0.00006942567,0.0013617035,0.24244992],"study_design_scores_gemma":[0.0036760967,0.00019958659,0.00006535172,0.6970558,0.017285202,0.00003868123,0.0000058305195,0.0000014507369,2.7615724e-7,0.0000021052156,0.2814911,0.00017848078],"about_ca_topic_score_codex":0.000042926982,"about_ca_topic_score_gemma":0.0000039134306,"teacher_disagreement_score":0.2801294,"about_ca_system_score_codex":0.0019644871,"about_ca_system_score_gemma":0.003181181,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W4413862932","doi":"10.4103/pajo.pajo_103_24","title":"The prevalence and characteristics of ocular adnexal lymphomas of the conjunctiva and orbit","year":2025,"lang":"en","type":"article","venue":"The Pan-American Journal of Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Conjunctiva; Orbit (dynamics); Medicine; Dermatology; Ophthalmology; Optometry; Pathology; Engineering","score_opus":0.007449520584528477,"score_gpt":0.26806587189030945,"score_spread":0.260616351305781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413862932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251926,0.0031975096,0.0000049933356,0.0031239288,0.00017826314,0.00017934656,0.0000115055445,0.0000013152277,0.00078386103],"genre_scores_gemma":[0.9983881,0.0010951768,0.000060579667,0.00011140008,0.000036866662,0.0000047888293,2.651938e-7,0.000006296445,0.00029653538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989099,0.00023308273,0.00043818902,0.000102010825,0.00017105349,0.00014578878],"domain_scores_gemma":[0.9980423,0.00078050426,0.00065029185,0.0003012457,0.00017524579,0.000050426825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000403845,0.00011780133,0.00048381515,0.000045138535,0.000106328705,0.000008259388,0.00019923804,0.0000338202,0.0000197441],"category_scores_gemma":[0.00028709482,0.000049234757,0.00010838161,0.00016934186,0.0014440574,0.000021526232,0.00011091074,0.00011727121,3.3808416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087515905,0.00025982942,0.9764457,0.00012019248,0.00063446816,0.00017750972,0.00042400628,5.9995835e-7,0.0016412152,0.0011223209,0.00007553739,0.01822351],"study_design_scores_gemma":[0.001096825,0.0013429429,0.9835382,0.0002161786,0.0005267566,0.00999858,0.00036925517,0.000010678831,0.0021865447,0.0003941878,0.00027979078,0.000040067906],"about_ca_topic_score_codex":0.0000625488,"about_ca_topic_score_gemma":2.835588e-7,"teacher_disagreement_score":0.018183442,"about_ca_system_score_codex":0.000040142524,"about_ca_system_score_gemma":0.00022176866,"threshold_uncertainty_score":0.53206897},"labels":[],"label_agreement":null},{"id":"W4413908705","doi":"10.3390/curroncol32090488","title":"Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Shanghai Science and Technology Development Foundation","keywords":"Immunohistochemistry; Medicine; Expression (computer science); Correlation; Pathology; Bioinformatics; Cancer research; Oncology; Biology; Computer science","score_opus":0.028653059056835236,"score_gpt":0.3443561305139172,"score_spread":0.315703071457082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413908705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167776,0.0053093066,0.0013301165,0.00034042858,0.00015623821,0.0005939784,0.0000047199683,0.000008847726,0.0005786226],"genre_scores_gemma":[0.99882364,0.00022666673,0.0006124769,0.000027072421,0.000018071321,0.00023069301,0.000030105148,0.0000039950905,0.000027261536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994343,0.00004212583,0.00020526745,0.0001708958,0.000049903112,0.00009754052],"domain_scores_gemma":[0.99952716,0.00019848102,0.00006728063,0.00011812116,0.000055738274,0.00003321295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040684085,0.00008616082,0.00022372426,0.00008422647,0.00002652557,0.0000032227263,0.000027172795,0.000057145775,0.000011200102],"category_scores_gemma":[0.000053073083,0.00005796399,0.000021268468,0.00011948874,0.0000933904,0.000015662772,0.000021927084,0.000078419216,0.0000014539822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002578211,0.002244657,0.9094817,0.00013570394,0.00002990026,0.000010418205,0.00059784093,0.000032597953,0.026603725,0.00026716766,0.00038833273,0.05995015],"study_design_scores_gemma":[0.006477887,0.0009351609,0.9658018,0.0009850938,0.00013078014,0.000027948621,0.00014761947,0.0019194912,0.018784149,0.00021399342,0.00448455,0.00009152891],"about_ca_topic_score_codex":0.000011045502,"about_ca_topic_score_gemma":0.000011052895,"teacher_disagreement_score":0.05985862,"about_ca_system_score_codex":0.0001799713,"about_ca_system_score_gemma":0.00020738706,"threshold_uncertainty_score":0.23637028},"labels":[],"label_agreement":null},{"id":"W4413971415","doi":"10.1016/j.modpat.2025.100875","title":"Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications","year":2025,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; Université du Québec à Rimouski","funders":"National Institutes of Health; Université de Paris; Université Paris-Est Créteil Val-de-Marne; Institut National de la Santé et de la Recherche Médicale","keywords":"Pathology; Follicular phase; Hematopathology; Medicine; Epstein–Barr virus; B cell; Follicular lymphoma; Biology; Lymphoma; Immunology; Virus; Internal medicine; Cytogenetics; Antibody","score_opus":0.006273001952489797,"score_gpt":0.22287717096907378,"score_spread":0.21660416901658397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413971415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974099,0.0023712139,0.012768453,0.0022510577,0.00010800342,0.0013793878,0.000120634264,0.00019131912,0.0067109345],"genre_scores_gemma":[0.99325585,0.00015894911,0.0021228087,0.001990933,0.00004299879,0.0008510293,0.00014598052,0.00005034381,0.0013811155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813503,0.00009603144,0.00029092867,0.0007702292,0.00019699469,0.00051079225],"domain_scores_gemma":[0.998218,0.00054036325,0.00010906583,0.0007330765,0.00020003525,0.00019945654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006726866,0.00038977337,0.0005815533,0.00019680065,0.00022486744,0.000036302914,0.00013383417,0.00018940149,0.000050837407],"category_scores_gemma":[0.000054442447,0.00026812227,0.00011647485,0.00032871144,0.0002114625,0.00006166997,0.00007415645,0.00014126279,0.00012343573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003352907,0.012518927,0.8620181,0.00066826283,0.0021077155,0.023396282,0.005767111,0.0036776422,0.05432557,0.0050897566,0.0063809734,0.02069673],"study_design_scores_gemma":[0.036665842,0.006734409,0.80723697,0.0015551484,0.005271444,0.00427829,0.0005181469,0.0028231659,0.12787743,0.0016201831,0.0040626493,0.0013563382],"about_ca_topic_score_codex":0.00019005866,"about_ca_topic_score_gemma":0.00033056174,"teacher_disagreement_score":0.073551856,"about_ca_system_score_codex":0.00035371463,"about_ca_system_score_gemma":0.0005364611,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W4414003172","doi":"10.14740/jh2103","title":"Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone Lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Duke-NUS Medical School","keywords":"Medicine; Lymphoma; Pathology; Dermatology","score_opus":0.016023753173953093,"score_gpt":0.3329830061747263,"score_spread":0.3169592530007732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414003172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909098,0.0019943183,0.0002928482,0.0058978773,0.000312461,0.00015405173,0.0000038220064,0.0000053350864,0.00042944425],"genre_scores_gemma":[0.9977425,0.00030309064,0.0013334581,0.0004690851,0.000043174856,0.000004315782,0.000001854924,0.000006928777,0.00009563912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858165,0.0000879761,0.000862993,0.0001335904,0.00017052698,0.0001632477],"domain_scores_gemma":[0.9988267,0.00036295006,0.00037464066,0.00015848203,0.00014953574,0.00012768047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028310058,0.00012561184,0.0009787193,0.00018202096,0.000024912095,0.0000064632054,0.00007234493,0.00012802517,0.000045267596],"category_scores_gemma":[0.00029542897,0.00008288853,0.00024279187,0.00007565392,0.000114877555,0.000038212973,0.000046103865,0.00009579657,0.0000036095282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023853296,0.0012532643,0.9714069,0.00017493803,0.0008033224,0.0016812152,0.000041073094,1.0372452e-7,0.000011616326,0.0023743352,0.00067197176,0.021342745],"study_design_scores_gemma":[0.0070920307,0.0010217143,0.9840272,0.00040816137,0.00067847956,0.0044599483,0.00013154196,0.000010756628,0.0005367651,0.0002484941,0.0013319066,0.000052993408],"about_ca_topic_score_codex":0.000015806532,"about_ca_topic_score_gemma":0.00001022073,"teacher_disagreement_score":0.021289751,"about_ca_system_score_codex":0.00004194767,"about_ca_system_score_gemma":0.00023847951,"threshold_uncertainty_score":0.33800963},"labels":[],"label_agreement":null},{"id":"W4414161460","doi":"10.1182/blood.2025028823","title":"Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Logistic regression; Lymphoma; Radiation therapy; Chemotherapy regimen; Performance status; Clinical trial; Salvage therapy","score_opus":0.0073887445773075915,"score_gpt":0.26097553912508514,"score_spread":0.25358679454777755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492973,0.00019839077,4.911037e-7,0.00016090237,0.000041161824,0.0007638887,0.000021354488,0.0000061722303,0.0038779113],"genre_scores_gemma":[0.9994793,0.000039853403,0.00009653269,0.00021869622,0.000015360043,0.000044007462,0.000029792121,0.000008155291,0.00006833139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991294,0.000047330435,0.0002685585,0.0001391628,0.0002826412,0.0001329],"domain_scores_gemma":[0.9991907,0.00025214118,0.00013580605,0.00034249263,0.000054691423,0.000024164388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010388763,0.00013787551,0.00039843208,0.000107046115,0.000015950167,0.0000039086044,0.000094580224,0.00004714144,0.000015825344],"category_scores_gemma":[0.00003084906,0.00006623864,0.00015442968,0.00018667003,0.00004956353,0.0000178998,0.000012517726,0.00003671563,0.0000013495148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01626303,0.029897382,0.9489802,0.000041652966,0.00050236675,0.000014823272,0.000342304,6.930861e-7,0.00013051619,0.00003587285,0.00016457943,0.0036265648],"study_design_scores_gemma":[0.21191256,0.00438113,0.77888733,0.00010476109,0.0002207563,0.0000010890922,0.000026999565,3.1382464e-7,0.0043941387,0.000010664712,0.000019330138,0.000040908573],"about_ca_topic_score_codex":0.0001480577,"about_ca_topic_score_gemma":0.000003904139,"teacher_disagreement_score":0.19564953,"about_ca_system_score_codex":0.00008058896,"about_ca_system_score_gemma":0.00025236837,"threshold_uncertainty_score":0.27011335},"labels":[],"label_agreement":null},{"id":"W4414279952","doi":"10.1016/j.jasc.2025.07.051","title":"Time from Clinical Suspicion to Diagnosis of Lymphoma Across Biopsy Types: A Multi-Center Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Society of Cytopathology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Lymphoma; Biopsy; Malignant lymphoma; Needle biopsy; MEDLINE","score_opus":0.02931308109350126,"score_gpt":0.3853421214164297,"score_spread":0.3560290403229284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414279952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945682,0.00026271775,0.00007066332,0.0044057397,0.0002887878,0.00031917304,0.000051108324,0.0000060494544,0.000027557213],"genre_scores_gemma":[0.9924206,0.0002813643,0.004488437,0.0025602747,0.00010768392,0.00001257881,0.0000015228134,0.000011735544,0.00011578792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998115,0.00028074384,0.0009402559,0.0002021349,0.00026104902,0.00020081193],"domain_scores_gemma":[0.9976655,0.00045389603,0.0010575254,0.000425041,0.00030057036,0.00009742971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064327446,0.0001534662,0.0011252715,0.00004703482,0.0000526749,0.00000557506,0.00029671058,0.00007321655,0.000020951426],"category_scores_gemma":[0.00025291755,0.00009453523,0.00089495414,0.00036116462,0.00057685934,0.00002941924,0.00021720136,0.00012771122,0.000008672852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006081414,0.008308113,0.96053034,0.000014424867,0.0007605952,0.000054227923,0.0021636516,0.0000037601849,0.001975744,0.0000012356943,0.0056656823,0.019914076],"study_design_scores_gemma":[0.007923188,0.0026926703,0.98176473,0.00020134544,0.000495888,0.000083822444,0.003568256,0.00002682294,0.002134622,0.000011718707,0.001032213,0.00006474862],"about_ca_topic_score_codex":0.00018219277,"about_ca_topic_score_gemma":0.000008653019,"teacher_disagreement_score":0.021234358,"about_ca_system_score_codex":0.00015034345,"about_ca_system_score_gemma":0.00018801239,"threshold_uncertainty_score":0.38550347},"labels":[],"label_agreement":null},{"id":"W4414320880","doi":"10.1182/bloodadvances.2025016827","title":"Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Hope Foundation","keywords":"Follicular lymphoma; Logistic regression; Gene expression profiling; Cohort; Clinical trial; Lymphoma; Gene expression; Retrospective cohort study; Confidence interval","score_opus":0.004189811290160337,"score_gpt":0.2238877554359425,"score_spread":0.21969794414578217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414320880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980374,0.0011365387,0.000046082394,0.000042523836,0.0000304087,0.0005669359,0.0000056411595,0.000009832854,0.00012465504],"genre_scores_gemma":[0.9883952,0.000029747232,0.011326147,0.00005521379,0.0000064216906,0.00010014909,0.000031528416,0.0000051567376,0.000050429582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993053,0.000014226056,0.00017124874,0.00019959366,0.00020542297,0.00010422974],"domain_scores_gemma":[0.99970984,0.000019687603,0.000053894226,0.000109594715,0.000055195993,0.000051781593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003915755,0.00010172152,0.00018641235,0.00010556583,0.000027143244,0.0000034293669,0.0000323085,0.000038750033,0.0000022627703],"category_scores_gemma":[0.000018609628,0.000068779766,0.00001579315,0.00017482013,0.000009428779,0.00008151334,0.000023770703,0.000016923275,8.048979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029153517,0.0011004036,0.98134595,0.00006808879,0.0000688173,0.0000073034043,0.0002807613,0.000015527477,0.0012498264,0.000010387764,0.000006888825,0.015554503],"study_design_scores_gemma":[0.0054665306,0.00026010058,0.7019389,0.00061118184,0.00005458201,4.992901e-7,0.000019087372,5.020111e-7,0.29111484,0.000010552253,0.00047752034,0.000045689394],"about_ca_topic_score_codex":0.000011650147,"about_ca_topic_score_gemma":0.0000067050123,"teacher_disagreement_score":0.28986502,"about_ca_system_score_codex":0.000044071105,"about_ca_system_score_gemma":0.000063758496,"threshold_uncertainty_score":0.28047577},"labels":[],"label_agreement":null},{"id":"W4414344389","doi":"10.1158/1538-7755.disp25-a091","title":"Abstract A091: Clinical and demographic differences between children and young adult US-born and non-US-born Latinos diagnosed with classical Hodgkin Lymphoma in the MESH Study Cohort","year":2025,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Young adult; Logistic regression; Hodgkin lymphoma; Incidence (geometry); Cohort; Classical Hodgkin lymphoma; Cohort study; Demographics","score_opus":0.027632382980433863,"score_gpt":0.36079382862607734,"score_spread":0.3331614456456435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414344389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896461,0.0041330275,0.000048483165,0.003413636,0.00013558635,0.0024866979,0.000029162497,0.00003005743,0.000077261],"genre_scores_gemma":[0.99214876,0.0060009947,0.00031403458,0.0006198452,0.000111898844,0.0006735464,0.000086566615,0.000015227301,0.000029122675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650127,0.001071872,0.0009525579,0.0009136196,0.00015300215,0.000407653],"domain_scores_gemma":[0.99671763,0.0023631584,0.00032791006,0.00035320726,0.00006687918,0.00017122297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022745978,0.0003629007,0.0011136148,0.0002428229,0.00018357053,0.000030064914,0.00012626428,0.00032990688,0.000009448446],"category_scores_gemma":[0.00042860952,0.00022137388,0.00013309988,0.00036276982,0.00081144087,0.000096322896,0.0000861932,0.00022634605,7.505592e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005163302,0.000794012,0.93545103,0.000044336008,0.001872175,0.000030070338,0.00012305219,1.3803033e-7,0.0000035478813,0.000049823626,0.00049722363,0.06061826],"study_design_scores_gemma":[0.009295632,0.0011878195,0.9864836,0.00056985713,0.0015394118,0.000022311811,0.00021378961,0.000085001586,0.0000046024966,0.0003756909,0.000022382621,0.00019992264],"about_ca_topic_score_codex":0.0032109753,"about_ca_topic_score_gemma":0.006335137,"teacher_disagreement_score":0.060418334,"about_ca_system_score_codex":0.00007964777,"about_ca_system_score_gemma":0.00014593251,"threshold_uncertainty_score":0.9027365},"labels":[],"label_agreement":null},{"id":"W4414422124","doi":"10.1080/10428194.2025.2553863","title":"From dimensions through dynamics to outcomes – lymph nodes and skin assessments predict CTCL outcomes","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Retrospective cohort study; Lymph; Predictive value of tests; Lymph node; Cut-off; Cutoff; Clinical trial","score_opus":0.010649052137224705,"score_gpt":0.2962868721994522,"score_spread":0.2856378200622275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414422124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823794,0.0020656676,0.00041408438,0.002538673,0.0009563544,0.0013116854,0.00049632025,0.0004339283,0.009403903],"genre_scores_gemma":[0.9771934,0.0012278565,0.00597884,0.009478005,0.00016717374,0.00045887055,0.0004826525,0.00013056422,0.004882609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945826,0.00016183732,0.0012365083,0.001873371,0.0009141812,0.0012315148],"domain_scores_gemma":[0.99610406,0.0010562746,0.00029186418,0.001486875,0.00021681502,0.00084411434],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002581696,0.0012869948,0.0020779923,0.00048988697,0.00069475506,0.00033855235,0.00041916405,0.00067491265,0.00007248935],"category_scores_gemma":[0.00024800096,0.0010249295,0.00048476094,0.0007713398,0.00038908338,0.0004907742,0.00078228733,0.00013804875,0.000100279765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048147253,0.0008093887,0.8439731,0.0001727092,0.0019309615,0.00046377984,0.00075594673,0.000022521142,0.0002009009,0.006858091,0.004275128,0.14005598],"study_design_scores_gemma":[0.026520329,0.000277598,0.95209676,0.00069974316,0.001455909,0.00017842275,0.0011178154,0.0031819285,0.001269663,0.0026760073,0.009621092,0.0009047246],"about_ca_topic_score_codex":0.0136203095,"about_ca_topic_score_gemma":0.00033097653,"teacher_disagreement_score":0.13915126,"about_ca_system_score_codex":0.010674001,"about_ca_system_score_gemma":0.0029726701,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W4414430512","doi":"10.1055/s-0045-1811168","title":"Identifying Somatic Lymph Nodes for VLNT Using Technetium-99m Sulfur Colloid","year":2025,"lang":"en","type":"article","venue":"Indian Journal of Plastic Surgery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Lymph; Lymph node; Lymphedema; Lymphatic system; Sentinel lymph node; Indocyanine green","score_opus":0.036757307128874955,"score_gpt":0.30602939940375956,"score_spread":0.2692720922748846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414430512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916564,0.0014489264,0.0041156565,0.00021175048,0.0022366685,0.0002138951,0.000021211683,0.000018420777,0.000077059085],"genre_scores_gemma":[0.9976364,0.00009734227,0.0017294403,0.00013879001,0.0002604956,0.000018080855,0.000006854669,0.000022344497,0.00009030106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998311,0.00004157518,0.0008330861,0.00016296147,0.00031845743,0.00033295003],"domain_scores_gemma":[0.99483865,0.0041017295,0.00046463474,0.00016382783,0.000245651,0.0001855247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005405566,0.00019585322,0.00070176367,0.00084174995,0.0001423223,0.00007558524,0.00009002267,0.00010455033,0.00005415457],"category_scores_gemma":[0.0018998709,0.00015708397,0.0005274371,0.0003685622,0.000058244226,0.00012660807,0.00002496178,0.000094512725,0.0000073405886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005578519,0.0008701978,0.9708279,0.0012517911,0.0016183514,0.0030326417,0.0002987961,0.00029561878,0.009538708,0.000115588446,0.0033247548,0.008267813],"study_design_scores_gemma":[0.010671157,0.00032405928,0.90826845,0.019939726,0.0034696648,0.004803196,0.0019629276,0.001349423,0.045408837,0.0012824786,0.0019182741,0.00060180883],"about_ca_topic_score_codex":0.000016978258,"about_ca_topic_score_gemma":0.0000022613096,"teacher_disagreement_score":0.06255944,"about_ca_system_score_codex":0.0004901203,"about_ca_system_score_gemma":0.0012050272,"threshold_uncertainty_score":0.64056987},"labels":[],"label_agreement":null},{"id":"W4414433856","doi":"10.3390/ijms26199306","title":"Proteomic Profiling of Limited-Stage Follicular Lymphoma Reveals Differentially Expressed Proteins Linked to Disease Progression Post-Radiation Therapy","year":2025,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal; Karen Elise Jensens Fond; Aarhus Universitet","keywords":"Follicular lymphoma; Lymphoma; Pathogenesis; Disease; Proteomics; Differential diagnosis; Gene expression profiling; Immune system","score_opus":0.015590481443333902,"score_gpt":0.31914436691360665,"score_spread":0.30355388547027273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414433856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990358,0.001410793,0.001846501,0.004850605,0.00030039306,0.0010674313,0.000016937138,0.000010911076,0.0001384035],"genre_scores_gemma":[0.99207735,0.00021067605,0.0068806186,0.00060975115,0.00007136031,0.00007895642,0.000010738221,0.000007520582,0.00005303343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795187,0.00008871921,0.00053390604,0.00022536547,0.001050228,0.0001499254],"domain_scores_gemma":[0.9984007,0.0000402214,0.00044249714,0.00015136844,0.0008110894,0.00015413966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037949302,0.00014060109,0.00025879062,0.00048655318,0.00006440342,0.000089450215,0.00038890244,0.00004615386,0.000013512199],"category_scores_gemma":[0.00033733193,0.000095011004,0.00022461344,0.0002819664,0.00008262383,0.000159697,0.00006429424,0.000051117888,0.0000016418103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001288002,0.0013200903,0.081139795,0.000045255034,0.00040718098,0.000341331,0.00017226813,0.00026059762,0.84173155,0.0012825974,0.000031298652,0.071980014],"study_design_scores_gemma":[0.0035102502,0.00101478,0.36122346,0.0011561841,0.00008212654,0.000013700925,0.000040106766,0.00030593926,0.6318392,0.0004252809,0.0002909787,0.000097966906],"about_ca_topic_score_codex":0.000016010224,"about_ca_topic_score_gemma":3.3127606e-7,"teacher_disagreement_score":0.28008366,"about_ca_system_score_codex":0.00015260052,"about_ca_system_score_gemma":0.0006409974,"threshold_uncertainty_score":0.38744363},"labels":[],"label_agreement":null},{"id":"W4414497874","doi":"10.1182/blood.2025028848","title":"PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Roche (Canada)","funders":"Wake Forest School of Medicine; University of Texas MD Anderson Cancer Center; Samsung; Genentech; Tianjin Medical University; Daiichi-Sankyo; University of Rochester; Sungkyunkwan University; University of Alberta; Université de Lille; Regeneron Pharmaceuticals; Yuhan; Univerzita Karlova v Praze; Memorial Sloan-Kettering Cancer Center; AstraZeneca; F. Hoffmann-La Roche; lékařská fakulta Univerzity Karlovy; Amgen","keywords":"Adverse effect; Tolerability; Quality of life (healthcare); Hematology; Incidence (geometry); Prednisone; Clinical trial","score_opus":0.06259727055660541,"score_gpt":0.4278840482358637,"score_spread":0.36528677767925827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414497874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937842,0.00022045764,0.0000020155587,0.0012891233,0.0005300535,0.0038161867,0.00005284607,0.000050581406,0.00025452557],"genre_scores_gemma":[0.9974683,0.000045152105,0.00005517603,0.0014008619,0.00019760417,0.0003450533,0.000077064746,0.000014879137,0.0003959003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767137,0.00025404862,0.001042215,0.00047680637,0.00027797342,0.00027759586],"domain_scores_gemma":[0.9983844,0.0006472846,0.00017432598,0.0006414162,0.00005610158,0.000096427226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997462,0.00018492276,0.00058993313,0.00007625328,0.0000884251,0.000008475132,0.00014211793,0.00014122305,0.00007860505],"category_scores_gemma":[0.001303538,0.00011672586,0.0002625145,0.00031922615,0.00002935999,0.000043661923,0.00010410373,0.00024217596,0.0000615057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010057556,0.077058956,0.90942156,0.0000056703143,0.00093150965,0.00051385787,0.00034234516,3.0987405e-8,0.000009546707,0.000021457176,0.00058037223,0.0010571592],"study_design_scores_gemma":[0.33627734,0.0020787835,0.65811276,0.00013772953,0.0013907219,0.0000026105733,0.00033415738,0.000006788259,0.00009734186,0.000048547696,0.0014461937,0.00006699818],"about_ca_topic_score_codex":0.00052702246,"about_ca_topic_score_gemma":0.00041347882,"teacher_disagreement_score":0.3262198,"about_ca_system_score_codex":0.0000582493,"about_ca_system_score_gemma":0.00032060244,"threshold_uncertainty_score":0.47599426},"labels":[],"label_agreement":null},{"id":"W4414714697","doi":"10.1016/j.cjca.2025.08.185","title":"P274 SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS ASSOCIATED WITH RECEIPT OF LP(A) TESTING IN ONTARIO: A POPULATION-BASED CROSS-SECTIONAL ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Receipt; MEDLINE; Cross-sectional study; Logistic regression","score_opus":0.032431652147781403,"score_gpt":0.30634120983449536,"score_spread":0.273909557686714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990534,0.000110992136,0.000072908464,0.00019726627,0.00013756413,0.000080105056,0.000022231932,0.0000019200736,0.00032360616],"genre_scores_gemma":[0.9995104,0.000007697738,0.0002180479,0.00013895062,0.00005026243,0.0000024399394,0.000044110853,0.0000041830203,0.00002388619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988729,0.00012931493,0.00061674946,0.00012861536,0.000090875146,0.00016157019],"domain_scores_gemma":[0.99842995,0.0005798811,0.00032137017,0.000090526744,0.00037976747,0.00019850739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006133503,0.00008759379,0.00072582165,0.0006621299,0.000055910932,0.000013294364,0.00004157598,0.00016033657,0.000009483894],"category_scores_gemma":[0.0009021691,0.00007097936,0.00022584235,0.0005011213,0.00012177346,0.00002283202,0.0000037891587,0.00022124017,1.066124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096808944,0.000016439637,0.9965553,0.0000064632663,0.0019850647,0.00017568788,0.000012937418,0.0005241726,0.0000018588155,0.000018075372,0.000028622562,0.00057852775],"study_design_scores_gemma":[0.0022815978,0.00035274096,0.9958037,0.00010241883,0.0011042479,0.00003607956,0.0000080132495,0.000114885996,0.000001139243,0.000049865757,0.00009545729,0.000049844766],"about_ca_topic_score_codex":0.066318095,"about_ca_topic_score_gemma":0.41881645,"teacher_disagreement_score":0.35249835,"about_ca_system_score_codex":0.0005554077,"about_ca_system_score_gemma":0.0032074666,"threshold_uncertainty_score":0.9398994},"labels":[],"label_agreement":null},{"id":"W4414761454","doi":"10.1200/jco-25-01957","title":"Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Phases of clinical research; Clinical trial; Adverse effect; Primary (astronomy); Clinical endpoint; Safety profile","score_opus":0.05260119380452237,"score_gpt":0.419853000832879,"score_spread":0.36725180702835664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414761454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97556037,0.0017975771,0.000020635041,0.0047617783,0.0026304622,0.0007399788,0.000047171143,0.000009664371,0.01443238],"genre_scores_gemma":[0.9944402,0.0018159227,0.00028336997,0.0017976826,0.0005246252,0.0000131557035,0.000019480012,0.000016240818,0.0010893496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99345016,0.00074858876,0.0045844684,0.0003169725,0.0005186893,0.00038113355],"domain_scores_gemma":[0.99307364,0.0036458934,0.0022976382,0.00046449213,0.0002741243,0.00024421778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031030118,0.00024469147,0.0024450263,0.00026856514,0.00006188961,0.000009006939,0.00035941566,0.00064175104,0.00003339851],"category_scores_gemma":[0.0016614617,0.00014583445,0.0009950453,0.00043724748,0.0001837241,0.00009405029,0.000080882106,0.0007036834,0.000006560688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81742924,0.0905357,0.013697501,0.0001726169,0.0009301499,0.0020131194,0.00062160747,0.00002736436,0.00057589804,0.00033499204,0.021591429,0.05207039],"study_design_scores_gemma":[0.8394177,0.015965344,0.056535877,0.00050226063,0.0009558005,0.00008923349,0.00010676851,0.000109006105,0.0010328825,0.00014713651,0.085021414,0.00011655199],"about_ca_topic_score_codex":0.00018150936,"about_ca_topic_score_gemma":0.00016533295,"teacher_disagreement_score":0.07457035,"about_ca_system_score_codex":0.001174799,"about_ca_system_score_gemma":0.00852244,"threshold_uncertainty_score":0.9970983},"labels":[],"label_agreement":null},{"id":"W4414975841","doi":"10.3324/haematol.2025.288058","title":"Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Foundation; Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; BC Cancer Agency; BC Children's Hospital","funders":"Seagen; Pfizer","keywords":"ABVD; Young adult; Incidence (geometry); Disease; Risk factor; Cumulative incidence; Hodgkin lymphoma; Radiation therapy; Heart failure","score_opus":0.018417311775531665,"score_gpt":0.27541564926819495,"score_spread":0.25699833749266326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951641,0.0021161481,0.000006982124,0.0005348082,0.000224355,0.00057800784,0.00001469243,0.000030581763,0.0013303075],"genre_scores_gemma":[0.9978061,0.0013445494,0.000052432188,0.00025830764,0.000015314401,0.00018425222,0.0000087565295,0.00000617688,0.00032412005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987727,0.00011773034,0.00033041424,0.00033887636,0.00019735745,0.00024292812],"domain_scores_gemma":[0.9993289,0.00013265393,0.000078067445,0.00031010472,0.00007656211,0.00007372452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012322968,0.00012095298,0.00056378264,0.000026388561,0.00015107005,0.000110585606,0.0001088643,0.00012029805,0.00003206845],"category_scores_gemma":[0.00016395745,0.00010506278,0.00011184041,0.00022394261,0.00033521085,0.000035420333,0.00012023779,0.000072580595,0.0000030625913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047232294,0.0007823912,0.98452,0.00014161403,0.00004593751,0.00058375066,0.00018278527,8.8152326e-8,0.000029350716,0.00018893965,0.002340939,0.01113698],"study_design_scores_gemma":[0.0016103121,0.00009128095,0.99612206,0.0005901954,0.00007399764,0.00022727124,0.00032226392,0.000017952912,0.00063807744,0.000049588623,0.00016708484,0.00008989646],"about_ca_topic_score_codex":0.026665013,"about_ca_topic_score_gemma":0.0537369,"teacher_disagreement_score":0.027071886,"about_ca_system_score_codex":0.000101714875,"about_ca_system_score_gemma":0.00008061556,"threshold_uncertainty_score":0.9798165},"labels":[],"label_agreement":null},{"id":"W4415053014","doi":"10.1182/bloodadvances.2025017282","title":"Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with <i>MYC</i> / <i>BCL2</i> rearrangements, DLBCL morphology","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Hôpital du Sacré-Cœur de Montréal; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Chemoimmunotherapy; Follicular lymphoma; Lymphoma; Rituximab; Cohort; Guideline; Retrospective cohort study; Diffuse large B-cell lymphoma","score_opus":0.006088559667140422,"score_gpt":0.23686720687315738,"score_spread":0.23077864720601696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415053014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915744,0.005703454,0.000024961251,0.0027354748,0.00028971076,0.000600341,0.000016998909,0.000056135686,0.0014155122],"genre_scores_gemma":[0.9943884,0.0011450303,0.0027783923,0.000533041,0.00012392305,0.00013053903,0.00021616556,0.000019231142,0.00066527695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984963,0.00006207447,0.00045952568,0.00046041547,0.0002441118,0.00027757214],"domain_scores_gemma":[0.9991415,0.000107695036,0.00020249505,0.00039984452,0.000085282954,0.00006314585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010498845,0.00022650987,0.0005380702,0.00025455694,0.00004697105,0.0000098919645,0.00008917288,0.00009058112,0.000031212654],"category_scores_gemma":[0.000054641063,0.00017592989,0.00006867363,0.00060095754,0.00008480514,0.00016204316,0.00003385679,0.00006356332,0.000008316226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057678664,0.00624869,0.9771239,0.00028210183,0.00021053526,0.0001341936,0.00007752294,0.0001348184,0.0035345613,0.0012814928,0.0015659994,0.008829387],"study_design_scores_gemma":[0.03063903,0.00074376527,0.87105674,0.0002669994,0.00065138005,0.00006399781,0.00018146333,0.000008728832,0.07934517,0.00048829877,0.016353734,0.00020067811],"about_ca_topic_score_codex":0.0010108242,"about_ca_topic_score_gemma":0.00036879373,"teacher_disagreement_score":0.10606715,"about_ca_system_score_codex":0.00011995749,"about_ca_system_score_gemma":0.00008525064,"threshold_uncertainty_score":0.7174213},"labels":[],"label_agreement":null},{"id":"W4415097697","doi":"10.1016/j.jmoldx.2025.09.004","title":"Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping Lymphomas","year":2025,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; University of British Columbia; University Health Network; Canada's Michael Smith Genome Sciences Centre","funders":"BC Cancer Agency; Terry Fox Research Institute; Genome British Columbia; Provincial Health Services Authority; Ontario Research Foundation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Subtyping; Lymphoma; Concordance; Housekeeping gene; Follicular lymphoma; Gene expression; Gene expression profiling; Fluorescence in situ hybridization","score_opus":0.00974582437544816,"score_gpt":0.2715332189998574,"score_spread":0.2617873946244092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415097697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8994286,0.0046207653,0.09504697,0.00036209845,0.000117138305,0.0003270403,0.00001522539,0.0000042401653,0.00007793795],"genre_scores_gemma":[0.97489023,0.0026700303,0.02226908,0.00007280103,0.00004174065,0.000015642861,0.000020728156,0.000009512754,0.00001023712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906766,0.00006977757,0.00044723874,0.000115104776,0.00020664188,0.00009358497],"domain_scores_gemma":[0.9984134,0.00048649425,0.00045574986,0.0001617641,0.00041379797,0.000068781286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039014712,0.00010014633,0.00027734978,0.000154967,0.000047366546,0.000018938714,0.000047701433,0.00008049242,0.000003216175],"category_scores_gemma":[0.0016177088,0.00008078648,0.00012435846,0.000105400024,0.000028457853,0.00005563648,0.000017176651,0.000056131626,3.005926e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041584249,0.0013413148,0.20471798,0.00036339954,0.00061786576,0.00011590997,0.00020976255,0.0011726299,0.75459105,0.002668773,0.0010297572,0.03275575],"study_design_scores_gemma":[0.0030360157,0.00038922418,0.06513339,0.000546146,0.00081354997,0.000034917204,0.000045326422,0.0005251179,0.9269192,0.0022647835,0.00023329936,0.00005903533],"about_ca_topic_score_codex":0.000006389367,"about_ca_topic_score_gemma":3.0786885e-7,"teacher_disagreement_score":0.17232817,"about_ca_system_score_codex":0.000087606815,"about_ca_system_score_gemma":0.00016499183,"threshold_uncertainty_score":0.3294377},"labels":[],"label_agreement":null},{"id":"W4415256607","doi":"10.1146/annurev-pathmechdis-111523-023413","title":"Genomic Taxonomy of Aggressive B-Cell Lymphoid Neoplasms","year":2025,"lang":"en","type":"review","venue":"Annual Review of Pathology Mechanisms of Disease","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Taxonomy (biology); Genomics; Molecular taxonomy; Biological classification; Systems biology; Key (lock); Genome","score_opus":0.019290088253618973,"score_gpt":0.30921792411697335,"score_spread":0.28992783586335436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415256607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051810912,0.99123186,0.00011231758,0.00005005788,0.00025086105,0.003845976,0.0035909577,0.000018009783,0.00084813614],"genre_scores_gemma":[0.000157315,0.995432,0.001764641,0.0004051747,0.000039993727,0.0011284582,0.00076518167,0.000047265843,0.00025993],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99622554,0.0004032783,0.001969672,0.00069300126,0.000356086,0.0003524289],"domain_scores_gemma":[0.9933747,0.00043178882,0.0041639325,0.0012256808,0.0004587187,0.00034517952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004032345,0.0006891918,0.005741109,0.00036972287,0.000031187516,0.00000222728,0.0004312783,0.00032653674,0.00024281321],"category_scores_gemma":[0.00070558384,0.0005088249,0.0022668273,0.00037844983,0.0002053854,0.000045607845,0.00029454884,0.0001513239,0.000046547157],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006692061,0.0015450529,0.00003495977,0.54534787,0.00037445585,0.000806407,0.000016589875,6.848784e-8,0.0000089410005,0.0012198465,0.0014417794,0.4491371],"study_design_scores_gemma":[0.0026236828,0.0014265175,0.0000545226,0.66061944,0.032295518,0.00029646014,0.00007341128,3.3498776e-7,0.0005840031,0.00033691485,0.3011501,0.0005390738],"about_ca_topic_score_codex":0.00001158027,"about_ca_topic_score_gemma":5.658106e-7,"teacher_disagreement_score":0.44859803,"about_ca_system_score_codex":0.0001524771,"about_ca_system_score_gemma":0.0028295985,"threshold_uncertainty_score":0.9997363},"labels":[],"label_agreement":null},{"id":"W4415469095","doi":"10.1136/bmjopen-2025-106180","title":"Pragmatic paradigm for patient-reported outcome measure selection in lymphoma clinical trials: a rapid review study","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Québec International","funders":"","keywords":"Lymphoma; Clinical trial; Prom; Selection (genetic algorithm); Quality of life (healthcare); Measure (data warehouse); MEDLINE; Outcome (game theory)","score_opus":0.32728221649199235,"score_gpt":0.537820968604835,"score_spread":0.21053875211284262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415469095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5904412,0.015168157,0.00021801832,0.027006095,0.0016645376,0.3548904,0.000040361945,0.00017528464,0.01039593],"genre_scores_gemma":[0.9520502,0.000710507,0.0008797989,0.005754473,0.00011624742,0.039681245,0.00007178815,0.000029765737,0.0007059861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99488294,0.0014446691,0.0026897094,0.00046450572,0.00029927777,0.00021892325],"domain_scores_gemma":[0.9973935,0.0012257788,0.0006732486,0.00047513473,0.00012982095,0.00010254032],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012378908,0.00020301239,0.0018084085,0.00011300699,0.00006866446,0.000057465488,0.00015732832,0.00009705434,0.00007882769],"category_scores_gemma":[0.010953127,0.00013845728,0.00033359663,0.00045356565,0.000016119759,0.00009689756,0.000109689965,0.000066666784,0.000021191212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015367324,0.006500057,0.6784962,0.0010442584,0.00091678434,0.00008977891,0.000110544825,5.034111e-7,0.0000017272914,0.000110835754,0.021304168,0.28988844],"study_design_scores_gemma":[0.047220733,0.0030678306,0.91137415,0.008035941,0.0029934952,0.00006027867,0.00024378569,0.00014457828,0.00003190418,0.0002411327,0.026344867,0.0002413116],"about_ca_topic_score_codex":0.0002466873,"about_ca_topic_score_gemma":0.00022773942,"teacher_disagreement_score":0.36160898,"about_ca_system_score_codex":0.00030720193,"about_ca_system_score_gemma":0.00079464674,"threshold_uncertainty_score":0.99737805},"labels":[],"label_agreement":null},{"id":"W4415665454","doi":"10.51731/cjht.2025.1273","title":"Polatuzumab Vedotin (Polivy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Clinical trial; Anticancer drug; Drug approval","score_opus":0.0167420741400342,"score_gpt":0.3023423456240574,"score_spread":0.28560027148402317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665454","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07977595,0.72689694,0.00007417066,0.18625985,0.0029328368,0.00058630237,0.00004309778,0.00008149147,0.0033493566],"genre_scores_gemma":[0.9805372,0.015777959,0.00036101034,0.0026347928,0.00004014939,0.00001126593,0.0000033125968,0.00002286231,0.00061146927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962976,0.00013298387,0.0017031971,0.00032059647,0.000280399,0.0012652181],"domain_scores_gemma":[0.9973578,0.00019854802,0.0009779151,0.00067872216,0.00042569422,0.00036132624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000740817,0.0003983651,0.0012976774,0.002688708,0.00065264676,0.00010468655,0.0006399433,0.0005145932,0.00011750883],"category_scores_gemma":[0.0014766869,0.00033475782,0.00033505235,0.0012337085,0.0006056205,0.00013520377,0.000059662725,0.00089068303,0.000054138247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000047388734,0.00017510646,0.056263242,0.0005000511,0.0005662067,0.0011730767,0.00040689867,0.0000056798413,0.000006847949,0.015069354,0.041085444,0.8847007],"study_design_scores_gemma":[0.004702856,0.002645872,0.1350895,0.0073097516,0.00040616945,0.00063727616,0.012462526,0.000022848984,0.0013292016,0.007820668,0.8272441,0.00032925562],"about_ca_topic_score_codex":0.026124,"about_ca_topic_score_gemma":0.008424911,"teacher_disagreement_score":0.90076125,"about_ca_system_score_codex":0.005393479,"about_ca_system_score_gemma":0.038975894,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W4415668968","doi":"10.1016/j.htct.2025.104823","title":"DARATUMUMAB + BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (DVRD) VS VRD IN TRANSPLANT-INELIGIBLE (TIE)/TRANSPLANT-DEFERRED (TD) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): PHASE 3 CEPHEUS TRIAL CYTOGENETIC SUBGROUP ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Daratumumab; Post-hoc analysis; Subgroup analysis; Overall survival; Multiple myeloma; Dexamethasone; Randomized controlled trial; Post hoc","score_opus":0.016632488741825695,"score_gpt":0.28689884151977596,"score_spread":0.27026635277795025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415668968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97579634,0.018731803,0.0014041879,0.0011310353,0.00022202106,0.0019761634,0.000101997066,0.00009719579,0.0005392407],"genre_scores_gemma":[0.92751646,0.07037503,0.00033936667,0.00096547324,0.0000360126,0.00035690452,0.00024322077,0.000037606867,0.00012991864],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967656,0.00031765684,0.00096185115,0.0010223675,0.0002828604,0.00064966275],"domain_scores_gemma":[0.99825144,0.00075082073,0.0001238969,0.0004962556,0.000060803533,0.000316799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003452523,0.0006072124,0.001810134,0.00082707574,0.00024403959,0.00005430282,0.00014718925,0.00042699373,0.0002159739],"category_scores_gemma":[0.000015780686,0.00049190095,0.00042258966,0.0009802388,0.00022311902,0.00008745978,0.000014675452,0.00028962316,0.0000052571622],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2620743,0.010732184,0.6387741,0.0005539484,0.0028044751,0.00252031,0.0043654116,0.00002018813,0.034674738,0.00032567044,0.00032022066,0.042834453],"study_design_scores_gemma":[0.72161996,0.0039539146,0.10542676,0.0005042526,0.0039110836,0.00039488016,0.00054279726,0.0015270839,0.15681781,0.00020082104,0.0041862046,0.00091442786],"about_ca_topic_score_codex":0.00092159765,"about_ca_topic_score_gemma":0.0019096003,"teacher_disagreement_score":0.5333473,"about_ca_system_score_codex":0.00006383273,"about_ca_system_score_gemma":0.00015555309,"threshold_uncertainty_score":0.99975324},"labels":[],"label_agreement":null},{"id":"W4415675833","doi":"10.1182/blood.2025031086","title":"High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic predisposition; Lymphoma; Prospective cohort study; Survival rate; MEDLINE; Young adult","score_opus":0.0050455531586384925,"score_gpt":0.21703668836330425,"score_spread":0.21199113520466575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415675833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949718,0.0020125823,0.000008822744,0.0007330536,0.00008926845,0.0011310503,0.000063877385,0.00008459345,0.0009049115],"genre_scores_gemma":[0.99822545,0.00025882298,0.00043976077,0.00015089204,0.00007033712,0.00039651923,0.00018553874,0.000021186142,0.00025149758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987418,0.00004256747,0.0002645566,0.00042732788,0.00019676879,0.00032700077],"domain_scores_gemma":[0.9995239,0.000034966262,0.00006380971,0.00023590095,0.000034586643,0.00010687114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010238589,0.00022409426,0.00039616047,0.00019142653,0.00011157754,0.00006821862,0.000062097075,0.0001281548,0.000011379924],"category_scores_gemma":[0.000019267505,0.00019195539,0.0000860669,0.00033132994,0.000036441466,0.000094473944,0.00007152212,0.0000622129,0.000012950167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010500458,0.014473936,0.9829918,0.000092507486,0.00027588572,0.000041455063,0.00036483648,2.0924428e-7,0.0003116405,0.00027356352,0.00032375174,0.00074537913],"study_design_scores_gemma":[0.03951584,0.00038393663,0.94266415,0.00031027952,0.0009511929,0.00015054591,0.00006492489,0.00002842543,0.015659954,0.000061091174,0.000060573548,0.00014908047],"about_ca_topic_score_codex":0.0009341172,"about_ca_topic_score_gemma":0.00046407618,"teacher_disagreement_score":0.040327676,"about_ca_system_score_codex":0.000110792236,"about_ca_system_score_gemma":0.00016375926,"threshold_uncertainty_score":0.7827714},"labels":[],"label_agreement":null},{"id":"W4415734847","doi":"10.1182/bloodadvances.2025017620","title":"Retreatment with R-CHOP–like therapy in patients with late relapse of diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Hôpital du Sacré-Cœur de Montréal; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Incyte; BeiGene; Seagen; Gilead Sciences; Veracyte; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"International Prognostic Index; Regimen; Lymphoma; Stage (stratigraphy); Overall survival; Performance status; Chemotherapy; Confidence interval","score_opus":0.0031681085524921113,"score_gpt":0.21466799324006597,"score_spread":0.21149988468757386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415734847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910962,0.005395144,0.0000027832868,0.00012223389,0.00005238145,0.0007383507,0.00002718677,0.00003067818,0.0025350228],"genre_scores_gemma":[0.99600965,0.0019165414,0.00075610855,0.0002591793,0.000008750339,0.000119692326,0.00003695459,0.000018402547,0.000874711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889714,0.000027004773,0.00024026523,0.00032339175,0.00025838372,0.00025383773],"domain_scores_gemma":[0.99931234,0.00006125294,0.00012270082,0.0003545331,0.00008254754,0.00006663288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004257113,0.00022395268,0.00040851397,0.00012691657,0.000043697015,0.000008556067,0.000064941334,0.000049934573,0.000012623812],"category_scores_gemma":[0.000006533853,0.00012725098,0.000054303546,0.00032787857,0.00005381818,0.00010645589,0.000021118722,0.00003801409,0.000004139697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018879882,0.033520553,0.9517625,0.00007174438,0.0002756534,0.00009715957,0.00017263071,0.000004418749,0.000032301414,0.00008200883,0.000035052686,0.012057973],"study_design_scores_gemma":[0.118614,0.0034862007,0.8636528,0.0004680674,0.00022966474,0.0000020036084,0.000066150395,0.0000026258163,0.008737655,0.000027777389,0.0045860526,0.0001269465],"about_ca_topic_score_codex":0.00006414956,"about_ca_topic_score_gemma":0.00010570944,"teacher_disagreement_score":0.11672602,"about_ca_system_score_codex":0.00009032002,"about_ca_system_score_gemma":0.00010726377,"threshold_uncertainty_score":0.51891446},"labels":[],"label_agreement":null},{"id":"W4415923281","doi":"10.1038/s41467-025-64666-7","title":"Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; University of Nebraska Medical Center; American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Mantle cell lymphoma; Transcriptome; Epigenetics; Mass cytometry; Myeloid leukemia; Tumor microenvironment; Regulator; Gene expression profiling; Population","score_opus":0.015550676611155721,"score_gpt":0.26228245264359484,"score_spread":0.24673177603243912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415923281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709858,0.021484146,0.000014703729,0.0049668886,0.00004258288,0.00034050352,0.000027791926,0.000019718038,0.0021179174],"genre_scores_gemma":[0.9930062,0.0023386907,0.0029731137,0.00093214586,0.000013834445,0.00010995142,0.00030752373,0.000004635142,0.00031388752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993425,0.00006455568,0.00019288644,0.00020881635,0.000068897694,0.00012236428],"domain_scores_gemma":[0.9989427,0.0002651828,0.00004751935,0.00066796114,0.000027619164,0.000049028436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009865989,0.00010561493,0.00021992184,0.0002024134,0.000114628834,0.000015022929,0.00014778106,0.00012834894,0.000022484779],"category_scores_gemma":[0.000049546605,0.000083655585,0.000083112085,0.0004117099,0.000110474306,0.000019173047,0.00020098746,0.00016843282,0.0000140768525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042669697,0.0013572996,0.9933725,0.00001209365,0.00023650938,0.0000068970994,0.00003744089,0.000006012847,0.00077372097,0.0013126283,0.0014577783,0.0013844664],"study_design_scores_gemma":[0.0012360361,0.000040604955,0.9792358,0.00002269463,0.0005075665,0.000009411767,0.00006267701,0.0001773523,0.00056534575,0.00009497704,0.017983334,0.000064178676],"about_ca_topic_score_codex":0.000038769253,"about_ca_topic_score_gemma":0.00019504389,"teacher_disagreement_score":0.022020468,"about_ca_system_score_codex":0.00026171736,"about_ca_system_score_gemma":0.00007492658,"threshold_uncertainty_score":0.34113756},"labels":[],"label_agreement":null},{"id":"W4415949455","doi":"10.1080/10428194.2025.2579721","title":"Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lymphoma; Radiation therapy; Disease; MEDLINE; Clinical trial","score_opus":0.00894682280453036,"score_gpt":0.25578112319509644,"score_spread":0.24683430039056609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415949455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871813,0.0017004274,0.00003499539,0.0002638444,0.00035228074,0.001962101,0.000041916344,0.00027512902,0.008188024],"genre_scores_gemma":[0.99004185,0.0007369112,0.0013050633,0.0054047923,0.00009921071,0.00043425837,0.00024237,0.00015487138,0.0015806999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943248,0.00028086157,0.0014076983,0.0017510095,0.0010031521,0.0012324679],"domain_scores_gemma":[0.9961243,0.00086760474,0.000486723,0.001548082,0.00032442666,0.0006488236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045568324,0.0012268192,0.001967147,0.00071491214,0.00033347172,0.0001557029,0.000412174,0.00075781666,0.000070321395],"category_scores_gemma":[0.00008666534,0.00083562784,0.00043244602,0.0011133527,0.0006426797,0.00032503923,0.00013223992,0.00023741699,0.000057219753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0076138917,0.0030716744,0.85140085,0.0001609771,0.0005588811,0.00042264682,0.00012991774,0.000085883315,0.000012806704,0.00022670496,0.0010868738,0.13522887],"study_design_scores_gemma":[0.14967187,0.0038427028,0.82955533,0.00072154746,0.00041110188,0.000034192624,0.000100232355,0.00034596218,0.000726482,0.000053321095,0.013750205,0.0007870785],"about_ca_topic_score_codex":0.001727846,"about_ca_topic_score_gemma":0.0002046672,"teacher_disagreement_score":0.14205797,"about_ca_system_score_codex":0.011868971,"about_ca_system_score_gemma":0.011025172,"threshold_uncertainty_score":0.99940944},"labels":[],"label_agreement":null},{"id":"W4415966100","doi":"10.1182/blood.2025029949","title":"Classic Hodgkin lymphoma with signet ring cell morphology mimicking adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Signet ring cell; Adenocarcinoma; Hodgkin lymphoma; Morphology (biology); Lymphoma; Signet ring cell carcinoma","score_opus":0.009167817723630267,"score_gpt":0.2274746615911367,"score_spread":0.21830684386750643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415966100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722034,0.0030030853,0.000070134876,0.0006443724,0.000098214936,0.00033435467,0.000005178044,0.00009447005,0.023546807],"genre_scores_gemma":[0.99582636,0.00006082025,0.0014522643,0.0008646198,0.00008330247,0.00008786949,0.000020514011,0.000023696724,0.0015805726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988788,0.000034856843,0.00020283108,0.0003912091,0.00015322925,0.00033908396],"domain_scores_gemma":[0.99930984,0.00009255773,0.000065353976,0.00038302483,0.000045825407,0.00010339289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006082667,0.00020821558,0.0003430535,0.00015062727,0.00009119755,0.00002507893,0.00009107761,0.00010792144,0.00006639809],"category_scores_gemma":[0.000013160496,0.00015719933,0.000084801315,0.00023742167,0.00006332584,0.000037775786,0.000058829602,0.00006163193,0.00006594398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001802861,0.0031333086,0.97619987,0.00013910186,0.00043815494,0.0021108778,0.00017024226,0.000005588555,0.008010768,0.0005881561,0.0012710548,0.0077525824],"study_design_scores_gemma":[0.022008764,0.00092653465,0.79165024,0.00027145646,0.0012731506,0.00046640256,0.00012554698,0.000034088785,0.1805998,0.000058090904,0.0023837215,0.0002022099],"about_ca_topic_score_codex":0.00010694023,"about_ca_topic_score_gemma":0.000018480589,"teacher_disagreement_score":0.18454964,"about_ca_system_score_codex":0.000113874776,"about_ca_system_score_gemma":0.00021479835,"threshold_uncertainty_score":0.6410403},"labels":[],"label_agreement":null},{"id":"W4416019328","doi":"10.1016/j.ijgc.2025.102535","title":"IS A SENTINEL LYMPH NODE BIOPSY OF BENEFIT IN VULVAR TUMORS ≥4CM?","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Sentinel lymph node; Biopsy; Vulvar cancer; Lymph node; Vulvar neoplasm","score_opus":0.019968942683277945,"score_gpt":0.33649508752268864,"score_spread":0.3165261448394107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98316514,0.0008029142,0.000021870766,0.011933732,0.0004777429,0.00007145564,0.000020241636,0.000004474731,0.0035024195],"genre_scores_gemma":[0.99587286,0.00048371442,0.00033949543,0.0027655016,0.000109594475,0.000015736785,0.0000027990284,0.00000442591,0.00040590682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987606,0.000016959826,0.0005797193,0.00012931996,0.00038284523,0.0001305715],"domain_scores_gemma":[0.9988934,0.00019160472,0.0002882493,0.0000776169,0.00048412036,0.000065018554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013801883,0.00010619991,0.00036267706,0.0002531594,0.000013397626,0.000012360097,0.00018458246,0.00007563968,0.0010234301],"category_scores_gemma":[0.0001846032,0.0000719938,0.00019775613,0.00020940605,0.00005786317,0.000055678884,0.000056807636,0.00010080064,0.000006077168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043090718,0.00093919825,0.9863449,0.00001870055,0.00039112664,0.00067444117,0.000058667763,0.000104561645,0.00083260896,0.0011834587,0.00065205724,0.008369413],"study_design_scores_gemma":[0.004330641,0.000074084135,0.98985666,0.00043883294,0.00007766159,0.00012059807,0.000050192237,0.00010437202,0.0029408415,0.0010534953,0.0008983127,0.000054322336],"about_ca_topic_score_codex":0.0003144079,"about_ca_topic_score_gemma":0.000017470275,"teacher_disagreement_score":0.012707677,"about_ca_system_score_codex":0.0006038893,"about_ca_system_score_gemma":0.00028303877,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W4416026301","doi":"10.1080/13543784.2025.2587276","title":"Diffuse large B-cell lymphoma: what clinical progress have we seen in the last 5 years?","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); Primary tumor; Clinical trial; Targeted therapy; First line treatment; Brentuximab vedotin","score_opus":0.03428570444146658,"score_gpt":0.3572830119342453,"score_spread":0.3229973074927787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416026301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8819282,0.014259107,0.000009836661,0.09537145,0.0016725102,0.001321453,0.000032436314,0.00008864168,0.0053163697],"genre_scores_gemma":[0.9690723,0.0054728254,0.00055212365,0.022953155,0.00050256535,0.00053977827,0.00032922978,0.000020810907,0.0005572558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981014,0.00022758586,0.00047194396,0.00041160863,0.00052004925,0.00026741598],"domain_scores_gemma":[0.99873626,0.00057292846,0.00009563654,0.00039278285,0.00006126515,0.00014112731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043587576,0.00020115853,0.00028805347,0.00015041213,0.00010681482,0.00010977281,0.00018455049,0.00014773928,0.000031850395],"category_scores_gemma":[0.00010694686,0.00013812906,0.00015982363,0.00025663714,0.00022476433,0.000168109,0.000069873844,0.00014132465,0.00013396409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004529952,0.03964679,0.48568302,0.000120601464,0.0002533905,0.00014853915,0.012597626,0.000005060803,0.000019189998,0.10411419,0.25100076,0.10595785],"study_design_scores_gemma":[0.01970587,0.0002470545,0.5089105,0.0009804544,0.000011262183,0.000008419383,0.0023539553,0.00024328913,0.00042722235,0.0015086043,0.46543565,0.00016772018],"about_ca_topic_score_codex":0.000026973836,"about_ca_topic_score_gemma":0.000007732224,"teacher_disagreement_score":0.2144349,"about_ca_system_score_codex":0.00019057782,"about_ca_system_score_gemma":0.00036963736,"threshold_uncertainty_score":0.56327397},"labels":[],"label_agreement":null},{"id":"W4416295879","doi":"10.1016/j.bmcl.2025.130471","title":"Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors","year":2025,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario","keywords":"Transcription factor; Bromodomain; Drug discovery; Sulfonamide; Lymphoma; BCL6; Virtual screening; Structure–activity relationship; Transcription (linguistics); Drug","score_opus":0.004269112887691976,"score_gpt":0.21632286151044147,"score_spread":0.2120537486227495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416295879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809992,0.0035693808,0.00004162891,0.013581435,0.00033377844,0.0005127703,0.000088749264,0.00010200763,0.00077108026],"genre_scores_gemma":[0.9938748,0.0002928199,0.00017921862,0.0045606894,0.00035553647,0.00003439189,0.00022494122,0.000058913265,0.0004187251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671274,0.000056150955,0.00088502397,0.00090359105,0.00080261007,0.0006398651],"domain_scores_gemma":[0.9980974,0.00030648056,0.00036524257,0.0007536064,0.00013013197,0.0003471128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023283671,0.000681888,0.001052458,0.0002069167,0.00015435377,0.00006071503,0.00027380465,0.0003219684,0.00013637365],"category_scores_gemma":[0.00027771122,0.00054764835,0.00028306263,0.00054977636,0.00071318314,0.00014232507,0.00015356859,0.0002483536,0.000007764243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006392303,0.0008735845,0.024991456,0.0013792438,0.00035469912,0.000403857,0.000100992256,0.0000073798465,0.9655115,0.00003302125,0.0031129906,0.0025920728],"study_design_scores_gemma":[0.010963886,0.00025539068,0.036561422,0.0009577491,0.00088016014,0.0001664116,0.0003086772,0.000047628277,0.94837844,0.00007213464,0.0010132722,0.00039481826],"about_ca_topic_score_codex":0.00054415246,"about_ca_topic_score_gemma":0.00000961065,"teacher_disagreement_score":0.017133022,"about_ca_system_score_codex":0.00064870727,"about_ca_system_score_gemma":0.0007044181,"threshold_uncertainty_score":0.9996975},"labels":[],"label_agreement":null},{"id":"W4416386731","doi":"10.1016/j.bneo.2025.100184","title":"Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Medical Council of Canada; Institute for Clinical Evaluative Sciences","keywords":"Mantle cell lymphoma; Chemoimmunotherapy; Rituximab; Retrospective cohort study; Lymphoma; Overall survival","score_opus":0.004504251309844768,"score_gpt":0.20126007053874237,"score_spread":0.1967558192288976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416386731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103415,0.00034841345,0.0000049344635,0.00015536557,0.000055819703,0.0005109113,0.000044812077,0.000023639386,0.007821942],"genre_scores_gemma":[0.9980838,0.00016765489,0.00035753546,0.000162525,0.000003872033,0.00004468205,0.00007144303,0.000014100372,0.0010944341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890447,0.00001573605,0.00031389395,0.00030289782,0.0002034715,0.00025952564],"domain_scores_gemma":[0.9995146,0.00007941482,0.000057497822,0.00022243433,0.000036759775,0.00008931991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004342847,0.00022491987,0.000525872,0.00021720318,0.000035038356,0.000011413934,0.00006278818,0.00009376337,0.000034426324],"category_scores_gemma":[0.0000023423154,0.00015896122,0.00006853799,0.00017742811,0.00004218611,0.000056109875,0.000012015224,0.0000607476,0.0000056836425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055715855,0.0034945689,0.9936597,0.0002053396,0.00023273802,0.00014866858,0.00069108506,0.0000021793605,0.0001152478,0.00012915838,0.00008176607,0.00068241777],"study_design_scores_gemma":[0.029254625,0.00046449684,0.94813544,0.00041369876,0.00068174023,0.000022818149,0.00003227722,0.0000033752647,0.020391017,0.000028551936,0.0004407866,0.0001311763],"about_ca_topic_score_codex":0.015767636,"about_ca_topic_score_gemma":0.046032533,"teacher_disagreement_score":0.045524236,"about_ca_system_score_codex":0.000078481346,"about_ca_system_score_gemma":0.0002738547,"threshold_uncertainty_score":0.99078643},"labels":[],"label_agreement":null},{"id":"W4416529234","doi":"10.14740/jmc5192","title":"Cecal Involvement of Diffuse Large B-Cell Lymphoma: A Rare Extra-Nodal Presentation","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Presentation (obstetrics); Lymphoma; Gastrointestinal tract; Chemotherapy; Refractory (planetary science); Cancer; Right hemicolectomy","score_opus":0.022894853022114536,"score_gpt":0.3166470547238733,"score_spread":0.29375220170175875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416529234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882639,0.0050778757,0.00023523218,0.0050512226,0.0003740037,0.00018092121,0.00001680555,0.000008060993,0.00079194887],"genre_scores_gemma":[0.9971859,0.001036343,0.00024015155,0.0009770399,0.00022593846,0.000008975581,0.0000125690685,0.0000078470575,0.0003052422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766666,0.0000775444,0.0006934249,0.0001215256,0.0012489274,0.00019194429],"domain_scores_gemma":[0.99863285,0.0004138352,0.00028161742,0.00015299885,0.00020881616,0.0003099008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043437202,0.00012863,0.00045246055,0.00018587435,0.00004221502,0.000013171713,0.00012677326,0.00012826352,0.00035702606],"category_scores_gemma":[0.00065292505,0.00008487642,0.0002507687,0.00017299311,0.00007388064,0.00007219097,0.00006178253,0.00011420534,0.0000045962124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040312517,0.12902723,0.48279327,0.002336766,0.0017392434,0.035155404,0.0017325231,0.000003513944,0.0017807995,0.003598279,0.21453616,0.12326556],"study_design_scores_gemma":[0.29127368,0.008130862,0.46674177,0.006849035,0.003619019,0.0059207585,0.0068963473,0.00081832055,0.10238455,0.0006488179,0.10621716,0.0004996666],"about_ca_topic_score_codex":0.00008367585,"about_ca_topic_score_gemma":0.00002492607,"teacher_disagreement_score":0.28724244,"about_ca_system_score_codex":0.00018439653,"about_ca_system_score_gemma":0.000740643,"threshold_uncertainty_score":0.3909185},"labels":[],"label_agreement":null},{"id":"W4416926257","doi":"10.1182/blood.2024027700","title":"Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Subtyping; Gene expression profiling; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; EZH2; Epigenetics","score_opus":0.014035150953222714,"score_gpt":0.29543626886569024,"score_spread":0.2814011179124675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416926257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963762,0.00091493275,0.00005422725,0.000038686325,0.00003506624,0.00059552805,0.000014758895,0.00003432057,0.0019362355],"genre_scores_gemma":[0.99367756,0.000015269175,0.0059201326,0.00003894862,0.000042177937,0.00007222431,0.000048513095,0.000009657631,0.00017554007],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927,0.000060551673,0.00018211242,0.00024433355,0.00009711133,0.00014587755],"domain_scores_gemma":[0.999485,0.000056732708,0.000067555055,0.0002884898,0.000050357696,0.00005184365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013245222,0.00011135114,0.0002922193,0.00006798508,0.000066657296,0.000008228102,0.000056593908,0.000036119054,0.000019715388],"category_scores_gemma":[0.000042558637,0.000068234556,0.000033136734,0.00011969731,0.000020638805,0.00004141741,0.000045710745,0.000047077516,0.0000023280006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001308131,0.004570063,0.9168826,0.000058110945,0.00022810795,0.00003576056,0.00016580017,0.0000031976485,0.07691511,0.00018434227,0.000021054735,0.000805066],"study_design_scores_gemma":[0.006434057,0.0015328113,0.4556387,0.00030112738,0.00055482326,0.000008160059,0.00014357315,0.000011692754,0.5350595,0.00018348201,0.00005199041,0.00008005797],"about_ca_topic_score_codex":0.000082737955,"about_ca_topic_score_gemma":0.000008201601,"teacher_disagreement_score":0.46124384,"about_ca_system_score_codex":0.000018002429,"about_ca_system_score_gemma":0.00007431058,"threshold_uncertainty_score":0.27825242},"labels":[],"label_agreement":null},{"id":"W4416928707","doi":"10.1200/jco-25-00892","title":"FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Cancerfonden; Mater Foundation","keywords":"Follicular lymphoma; Clinical trial; Lymphoma; Prognostic model; Proportional hazards model; Cause of death; Disease; Follicular phase","score_opus":0.10786766392590452,"score_gpt":0.4663264441712946,"score_spread":0.3584587802453901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416928707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97801703,0.0015398022,0.0049737296,0.010232283,0.002562597,0.0019465444,0.000009203554,0.000018612021,0.00070021895],"genre_scores_gemma":[0.97380584,0.002651708,0.015940787,0.0052514384,0.0016537256,0.00016814636,0.0000067685432,0.000021834412,0.0004997619],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99438184,0.00040198868,0.004043451,0.00043176964,0.00038491664,0.0003560326],"domain_scores_gemma":[0.9864329,0.010840966,0.001423707,0.00031375277,0.0005134976,0.00047514643],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004105727,0.00025356095,0.0025248704,0.00014927436,0.00008220311,0.000030071275,0.00017382995,0.0006670088,0.000011536046],"category_scores_gemma":[0.011957472,0.00017094048,0.0014089976,0.0001233332,0.00021046423,0.00009816723,0.000101444675,0.0003415004,0.0000047427025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10539012,0.01918629,0.16292648,0.000077627774,0.0025830765,0.00078168826,0.000058228325,0.00011639584,0.000008966056,0.0013912319,0.009979708,0.69750017],"study_design_scores_gemma":[0.5625829,0.045492638,0.30929422,0.00033024227,0.0055047907,0.00012469183,0.000049646827,0.023399608,0.00001552797,0.0065240795,0.046448417,0.00023319488],"about_ca_topic_score_codex":0.000007801316,"about_ca_topic_score_gemma":0.000015345395,"teacher_disagreement_score":0.697267,"about_ca_system_score_codex":0.0003118121,"about_ca_system_score_gemma":0.0039874716,"threshold_uncertainty_score":0.99636525},"labels":[],"label_agreement":null},{"id":"W4416930849","doi":"10.1055/s-0045-1812988","title":"Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Hodgkin lymphoma; Nivolumab; Lymphoma; Phases of clinical research; Randomized controlled trial","score_opus":0.006988153577421633,"score_gpt":0.2628725201907544,"score_spread":0.2558843666133328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868304,0.004071412,0.000011315745,0.00039626515,0.0006122156,0.0073357383,0.00013099177,0.000027135911,0.0005845119],"genre_scores_gemma":[0.99661076,0.0026399791,0.000043611988,0.00009189196,0.00007662019,0.00022483029,0.00007145809,0.000057562876,0.00018326021],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99287057,0.002231777,0.0024119564,0.0010832384,0.00086381345,0.0005386443],"domain_scores_gemma":[0.9933075,0.0034426306,0.0014366064,0.0011653589,0.00037809633,0.00026982438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016986388,0.00077763054,0.0026908799,0.0008745807,0.00048528102,0.000050353767,0.00037175918,0.00033069172,0.000038827864],"category_scores_gemma":[0.0011846693,0.00051832676,0.00032759292,0.0014047297,0.0006198018,0.00022897239,0.00045461126,0.0004312719,0.0000021417952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22539966,0.23436654,0.4711432,0.0003259597,0.0013295333,0.0000216195,0.005929216,0.000025325422,0.000007681621,0.00049933104,0.00008216447,0.060869783],"study_design_scores_gemma":[0.5523507,0.01607115,0.42642373,0.0003834861,0.0033359705,9.545153e-7,0.00069932395,0.00033975285,0.00007141923,0.000031521497,0.00005302196,0.00023896765],"about_ca_topic_score_codex":0.00028647174,"about_ca_topic_score_gemma":0.00021111488,"teacher_disagreement_score":0.32695106,"about_ca_system_score_codex":0.00031044742,"about_ca_system_score_gemma":0.00089618936,"threshold_uncertainty_score":0.99972683},"labels":[],"label_agreement":null},{"id":"W4416930886","doi":"10.1055/s-0045-1812958","title":"Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Quality assurance; Process (computing); Radiation therapy; Quality (philosophy)","score_opus":0.012318789444405972,"score_gpt":0.33897847010388277,"score_spread":0.3266596806594768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59395254,0.38553163,0.000058648628,0.008202662,0.00087606866,0.004045709,0.00008749481,0.00011482072,0.0071304403],"genre_scores_gemma":[0.65204734,0.3427776,0.00069952436,0.0024737061,0.00039676295,0.0005453329,0.00006781192,0.00006760883,0.0009242919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99052805,0.001311814,0.0035343221,0.0017726225,0.000909265,0.0019439303],"domain_scores_gemma":[0.9952227,0.001820269,0.00083809334,0.0013826869,0.00025157354,0.00048469208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035450282,0.0010693225,0.0032722983,0.000526139,0.00017929634,0.00010156784,0.0005620581,0.0006421011,0.00064361613],"category_scores_gemma":[0.0017119882,0.0009950252,0.00062114873,0.0028679778,0.0002016643,0.0003490876,0.00011349342,0.0004924569,0.0001937993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019424043,0.011044373,0.88362014,0.025202116,0.00086458033,0.0017618311,0.0025289003,0.00009124697,0.0008465409,0.00087491574,0.0046054847,0.06661746],"study_design_scores_gemma":[0.044071224,0.00069536286,0.8791195,0.04837899,0.0013676553,0.000047258512,0.0003817246,0.00042720317,0.007921849,0.00038461114,0.015544719,0.0016598932],"about_ca_topic_score_codex":0.0029986356,"about_ca_topic_score_gemma":0.0010130319,"teacher_disagreement_score":0.06495757,"about_ca_system_score_codex":0.002169226,"about_ca_system_score_gemma":0.005373953,"threshold_uncertainty_score":0.99925},"labels":[],"label_agreement":null},{"id":"W4416930890","doi":"10.1055/s-0045-1812957","title":"Multi-modality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; BC Cancer Agency","funders":"","keywords":"Hodgkin lymphoma; Volume (thermodynamics); Radiation therapy; Lymphoma","score_opus":0.05045135664699682,"score_gpt":0.3555162644689606,"score_spread":0.3050649078219638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86492777,0.027110957,0.09108348,0.0049471986,0.0052970303,0.0054623056,0.0009633077,0.00015688034,0.000051058396],"genre_scores_gemma":[0.92622316,0.05108718,0.014593332,0.001081908,0.004431935,0.0009127669,0.0012254451,0.00010060897,0.00034368213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895301,0.0014274854,0.0048376555,0.0021395602,0.00073359074,0.0013315975],"domain_scores_gemma":[0.9924278,0.0033195699,0.0015896157,0.0013346015,0.0007822295,0.0005461702],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0059502027,0.0010573446,0.0019761045,0.0009858746,0.0005456512,0.0002599425,0.0005102755,0.0014722439,0.00021615907],"category_scores_gemma":[0.0048980652,0.0010218098,0.0011496971,0.0021612162,0.0002632093,0.00044329575,0.00020945052,0.0006594667,0.00044445883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023785986,0.006836255,0.6746642,0.00020103568,0.00038727862,0.000027678241,0.0003386114,0.0008742218,0.000009979178,0.0012722121,0.0013818673,0.31162807],"study_design_scores_gemma":[0.016782422,0.0018745981,0.83637106,0.00012981822,0.0020910853,0.000001374464,0.00022617354,0.124724835,0.0015522923,0.0029484215,0.0124103725,0.0008875675],"about_ca_topic_score_codex":0.0025059502,"about_ca_topic_score_gemma":0.00053903495,"teacher_disagreement_score":0.3107405,"about_ca_system_score_codex":0.000929748,"about_ca_system_score_gemma":0.004158579,"threshold_uncertainty_score":0.99982405},"labels":[],"label_agreement":null},{"id":"W4416930920","doi":"10.1055/s-0045-1812961","title":"Predicted Breast Cancer Risk after Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Analysis of a Multi-Institutional Children’s Oncology Group Trial","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; SickKids Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Radiation therapy; Breast cancer; Clinical trial; Cancer; Radiation oncology; Pediatric oncology","score_opus":0.012324377837068802,"score_gpt":0.3141025340791938,"score_spread":0.301778156242125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8845911,0.062537715,0.008585565,0.0016775795,0.004406225,0.0064620613,0.031542264,0.00010843711,0.000089073794],"genre_scores_gemma":[0.939955,0.042290125,0.005461204,0.00055697456,0.0054055797,0.0046148514,0.0014347824,0.00007674256,0.00020475374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925407,0.0007064747,0.0027825052,0.00175157,0.00096511724,0.0012535889],"domain_scores_gemma":[0.99331945,0.0025570642,0.0016964655,0.0010081532,0.0007609357,0.00065790757],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014519247,0.0011631217,0.0034286645,0.0023137738,0.000495534,0.00007544098,0.00052530103,0.0011642732,0.0013914384],"category_scores_gemma":[0.00077722926,0.00095094653,0.0028148794,0.0040503815,0.0006351969,0.0002134585,0.0001823391,0.0004131884,0.000012325443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114325315,0.015577976,0.7731938,0.00027360723,0.032023404,0.0000716667,0.00048752007,0.00039251862,0.000011886117,0.00024586183,0.002155996,0.061240472],"study_design_scores_gemma":[0.22560148,0.002500719,0.67627084,0.00011030796,0.085429005,0.000018572808,0.000036502675,0.0065161735,0.000057046982,0.000014779869,0.0029521242,0.00049241626],"about_ca_topic_score_codex":0.0024803742,"about_ca_topic_score_gemma":0.0008378561,"teacher_disagreement_score":0.11127617,"about_ca_system_score_codex":0.0019198748,"about_ca_system_score_gemma":0.0071771457,"threshold_uncertainty_score":0.99952143},"labels":[],"label_agreement":null},{"id":"W4416930931","doi":"10.1055/s-0045-1812922","title":"Prognostic value of 18F-FDG PET/CT volumetric parameters in childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL): a systematic review from the international SEARCH group (Staging, Evaluation and Response Criteria Harmonization)","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital","funders":"","keywords":"Hodgkin lymphoma; Young adult; Value (mathematics); Lymphoma","score_opus":0.016478047421087428,"score_gpt":0.3032299690275915,"score_spread":0.28675192160650403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79269624,0.19492786,0.00011067265,0.0037152565,0.0007089152,0.007533975,0.00022044603,0.000026021333,0.000060608974],"genre_scores_gemma":[0.92659885,0.06989465,0.0006611218,0.0015974622,0.00009710729,0.0007866937,0.00026381345,0.000047832906,0.000052484003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99143445,0.0033178742,0.0021587783,0.0010906394,0.0014621692,0.00053605967],"domain_scores_gemma":[0.9929945,0.004248048,0.00080122554,0.0009182926,0.00080884073,0.00022913287],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061453925,0.0006183794,0.0015185275,0.00073463045,0.00023990351,0.00031044296,0.00047286286,0.000069135414,0.000075097385],"category_scores_gemma":[0.017414909,0.00047628756,0.0002589581,0.0018283739,0.000283199,0.00029068044,0.00039444963,0.0002995786,0.000020880318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008077927,0.0021094463,0.9469939,0.04090555,0.0015232804,0.00027665158,0.0010446648,0.000013156519,0.000033342218,0.00029767407,0.0007672579,0.005227306],"study_design_scores_gemma":[0.010684229,0.00037514116,0.84290767,0.11781172,0.0088663,0.00014345051,0.00082940684,0.017707752,0.00020007005,0.00009543867,0.000028802786,0.00035003282],"about_ca_topic_score_codex":0.0015914879,"about_ca_topic_score_gemma":0.00008952265,"teacher_disagreement_score":0.13390258,"about_ca_system_score_codex":0.00067394355,"about_ca_system_score_gemma":0.0013378656,"threshold_uncertainty_score":0.99976885},"labels":[],"label_agreement":null},{"id":"W4416930951","doi":"10.1055/s-0045-1812908","title":"AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy to Immuno-oncology for Children &amp; Adults with Newly Diagnosed Stage I and II Hodgkin Lymphoma","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; London Health Sciences Centre; Western University","funders":"","keywords":"Stage (stratigraphy); Hodgkin lymphoma; Randomized controlled trial; Radiation therapy; Lymphoma; Clinical trial","score_opus":0.022915334330003458,"score_gpt":0.33648549651795323,"score_spread":0.31357016218794975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935334,0.022541923,0.0032975338,0.0067118355,0.0012833682,0.028997127,0.0012388042,0.00019947981,0.0003959178],"genre_scores_gemma":[0.9714281,0.009427787,0.008267632,0.0018919025,0.00088970334,0.005914709,0.0005513616,0.00016894599,0.0014598917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9905685,0.0023055135,0.002640852,0.0020250282,0.0008663422,0.0015937636],"domain_scores_gemma":[0.9843366,0.01146943,0.0010861295,0.0015170401,0.00063845055,0.0009523348],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0053918962,0.0014837225,0.005463858,0.0009135242,0.0012395185,0.0003178398,0.0005304393,0.0007852577,0.00024838344],"category_scores_gemma":[0.0038432132,0.0011300958,0.0010112688,0.0010370552,0.00064906554,0.0002272956,0.00040727315,0.00036075083,0.00002523037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8686063,0.008630095,0.0058693727,0.00013718083,0.006019929,0.00015559423,0.0045074597,0.000043065334,0.00021008257,0.00040259166,0.0045217606,0.100896545],"study_design_scores_gemma":[0.8484537,0.03466804,0.005118312,0.0008844585,0.0036964219,0.000026502305,0.0005359788,0.00022732069,0.0024060593,0.000044135693,0.10301288,0.0009262161],"about_ca_topic_score_codex":0.0009239536,"about_ca_topic_score_gemma":0.00043379026,"teacher_disagreement_score":0.09997033,"about_ca_system_score_codex":0.00094905007,"about_ca_system_score_gemma":0.0052435477,"threshold_uncertainty_score":0.9997912},"labels":[],"label_agreement":null},{"id":"W4416930955","doi":"10.1055/s-0045-1812900","title":"Lung Involvement in Pediatric Hodgkin Lymphoma: Imaging challenges in adequate staging","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Lung; Medical imaging; MEDLINE; Disease; Computed tomography","score_opus":0.02864972943831271,"score_gpt":0.29734070843538696,"score_spread":0.2686909789970742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52344376,0.44147423,0.000045911853,0.015500906,0.0024149534,0.0021758128,0.00003616501,0.000106747204,0.014801507],"genre_scores_gemma":[0.8386004,0.1582657,0.00025338746,0.00076702586,0.0008182459,0.00060849474,0.000049187358,0.00008668929,0.0005508672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99200326,0.0005855702,0.002452563,0.002018893,0.0008691673,0.0020705627],"domain_scores_gemma":[0.9963433,0.0011856521,0.00052974635,0.001312509,0.00016721674,0.00046153966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024083175,0.0011268347,0.0016968007,0.0025517626,0.00021503706,0.00017554696,0.0005536808,0.00044684616,0.00024956086],"category_scores_gemma":[0.0004011277,0.0011460136,0.00046840412,0.002470783,0.00013757935,0.00043744175,0.0006546478,0.0006149054,0.0002314009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003403333,0.004532116,0.83610094,0.0015442836,0.00026636326,0.002065854,0.003351294,0.00009019356,0.00000627759,0.004491693,0.0012981861,0.14591248],"study_design_scores_gemma":[0.031231383,0.00025505622,0.9479879,0.0016803386,0.0016569303,0.0000089482555,0.005156957,0.0032015587,0.00044527822,0.0006103548,0.00673133,0.0010339512],"about_ca_topic_score_codex":0.001288351,"about_ca_topic_score_gemma":0.0005127734,"teacher_disagreement_score":0.31515664,"about_ca_system_score_codex":0.0022836586,"about_ca_system_score_gemma":0.0024374905,"threshold_uncertainty_score":0.999099},"labels":[],"label_agreement":null},{"id":"W4416930956","doi":"10.1055/s-0045-1812902","title":"Imaging Pitfalls in Pediatric, Adolescent, and Young Adult Hodgkin Lymphoma: A SEARCH for CAYAHL Initiative to Bridge Multidisciplinary Patient Care","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Multidisciplinary approach; Bridge (graph theory); Young adult; Patient care; MEDLINE","score_opus":0.018633078758229272,"score_gpt":0.3096165855821062,"score_spread":0.2909835068238769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416930956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357399,0.047341105,0.00029190938,0.0040233186,0.0017278645,0.007494978,0.0014237827,0.00008575943,0.0018714264],"genre_scores_gemma":[0.9860611,0.008078112,0.0013131225,0.0017305797,0.00088942546,0.0013731461,0.00032784225,0.000120013174,0.00010665321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99344987,0.0003937209,0.0017079824,0.0019937386,0.00072937587,0.0017253314],"domain_scores_gemma":[0.99574053,0.0010348973,0.00033959284,0.00087138725,0.0011518248,0.0008617636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005957668,0.0010604935,0.001459558,0.0012295445,0.00058548764,0.00022446696,0.00035177168,0.00040937093,0.000023058334],"category_scores_gemma":[0.0006409592,0.001042229,0.000437631,0.0014127879,0.00018652805,0.00029978808,0.0010098483,0.000432543,0.00008716355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020183935,0.0031274746,0.88929355,0.0023809795,0.00023801603,0.00059791165,0.020377167,0.000034544268,0.000026750671,0.00037900894,0.0032172857,0.078308895],"study_design_scores_gemma":[0.02809543,0.0019024643,0.94963956,0.0015075237,0.0016909352,0.000026749645,0.011695362,0.0007901805,0.00250853,0.000043935685,0.0011196724,0.0009796607],"about_ca_topic_score_codex":0.0018877587,"about_ca_topic_score_gemma":0.0006420386,"teacher_disagreement_score":0.07732923,"about_ca_system_score_codex":0.00147197,"about_ca_system_score_gemma":0.0027113182,"threshold_uncertainty_score":0.9992028},"labels":[],"label_agreement":null},{"id":"W4416968887","doi":"10.1182/bloodadvances.2025018079","title":"Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pharmacyclics; Genentech; National Institutes of Health; Incyte; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; Ipsen; BeiGene; Daiichi Sankyo Europe; Sanofi; Pfizer; National Institute of Allergy and Infectious Diseases; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Follicular lymphoma; Lymphoma; Context (archaeology); Clinical trial; Disease; Chemotherapy; Follicular phase","score_opus":0.01563828593378401,"score_gpt":0.3053785913689192,"score_spread":0.2897403054351352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416968887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8306094,0.030811854,0.00008439617,0.10374064,0.006030916,0.00060418446,0.000221475,0.000101749494,0.02779543],"genre_scores_gemma":[0.9781297,0.00094193075,0.0027627153,0.0017848866,0.00023692499,0.00013523758,0.00026824552,0.000008715646,0.015731633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991912,0.000027482052,0.00018704406,0.00028203253,0.00017926388,0.0001329384],"domain_scores_gemma":[0.99906373,0.00044189047,0.000054271906,0.0003059267,0.000089881985,0.00004427987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091095084,0.000105354186,0.00013730272,0.00006050916,0.00023967243,0.00010933382,0.0001363647,0.000029148867,0.00028428048],"category_scores_gemma":[0.00016290483,0.000066568755,0.000095810916,0.00026794322,0.00012140475,0.000055085515,0.000060813225,0.000038334718,0.000064146276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108129854,0.0021080521,0.2618988,0.00002062309,0.0015169916,0.00013413957,0.00028341232,0.000018645085,0.0004949369,0.006251741,0.1696183,0.55754626],"study_design_scores_gemma":[0.002947068,0.000023002282,0.086144015,0.00029840172,0.00040526045,0.000015727728,0.00045089037,0.00006586391,0.0044037416,0.0018761074,0.9032895,0.00008043285],"about_ca_topic_score_codex":0.000050107457,"about_ca_topic_score_gemma":0.00014304896,"teacher_disagreement_score":0.7336712,"about_ca_system_score_codex":0.000060470586,"about_ca_system_score_gemma":0.00013520097,"threshold_uncertainty_score":0.31126717},"labels":[],"label_agreement":null},{"id":"W4417001966","doi":"10.1182/blood-2025-2738","title":"The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McGill University","funders":"","keywords":"Brentuximab vedotin; Randomization; Dacarbazine; Quality of life (healthcare); Clinical endpoint; Surrogate endpoint; Hodgkin lymphoma; Chemotherapy regimen; Phases of clinical research; Clinical trial","score_opus":0.01630886923820037,"score_gpt":0.3165869747371246,"score_spread":0.30027810549892425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993582,0.0002732835,0.0000010531733,0.0004953924,0.00034859835,0.0017605542,0.000041331477,0.00003542567,0.0034623516],"genre_scores_gemma":[0.9977999,0.0001543257,0.000040626277,0.00063965673,0.000056845798,0.00032577716,0.000016379467,0.000017885775,0.0009486098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978542,0.00010798667,0.0008494033,0.0003446754,0.0005172284,0.000326515],"domain_scores_gemma":[0.9970908,0.0011560892,0.0005620294,0.0009811039,0.00013723336,0.00007269783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033081495,0.0002651391,0.00058417354,0.00006775446,0.00021787624,0.000030070658,0.00020491991,0.00009840471,0.000021536513],"category_scores_gemma":[0.0006774046,0.00013363131,0.00028380103,0.00033700297,0.0002544684,0.000042823107,0.000079561505,0.00009800404,0.0000075803746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19306864,0.08092823,0.42856422,0.00037078888,0.00836331,0.0015538459,0.0014769526,0.0019503483,0.0067109996,0.029467527,0.004115146,0.24342999],"study_design_scores_gemma":[0.37637255,0.006562297,0.50109017,0.00084319414,0.00091089937,0.000008668254,0.00016168592,0.000015161209,0.105630875,0.00052101625,0.0076586395,0.0002248262],"about_ca_topic_score_codex":0.00006763237,"about_ca_topic_score_gemma":0.000024356172,"teacher_disagreement_score":0.24320516,"about_ca_system_score_codex":0.00008972651,"about_ca_system_score_gemma":0.00023156508,"threshold_uncertainty_score":0.5449327},"labels":[],"label_agreement":null},{"id":"W4417002052","doi":"10.1182/blood-2025-1845","title":"External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; Canadian Cancer Society; University of Toronto","funders":"","keywords":"ABVD; Clinical trial; Hodgkin lymphoma; Brentuximab vedotin; International Prognostic Index; Lymphoma; Cohort; Chemotherapy regimen","score_opus":0.06479326219693014,"score_gpt":0.4040638090016049,"score_spread":0.3392705468046747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942425,0.0001523926,0.00012304138,0.0013182048,0.0004787502,0.0024070172,0.000021741245,0.000024207564,0.0012321535],"genre_scores_gemma":[0.9985657,0.00006780671,0.000109805114,0.0003095358,0.00021447685,0.00041048718,0.00003204812,0.000013037009,0.0002771204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623865,0.0013680926,0.0011982756,0.000375729,0.00062213646,0.00019712244],"domain_scores_gemma":[0.9973866,0.0013490665,0.00048731733,0.00060390437,0.00012506863,0.00004807405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037010182,0.00018791015,0.0005078891,0.0001680947,0.00008736712,0.00007858815,0.000401575,0.00012799528,0.000051255938],"category_scores_gemma":[0.0014027725,0.00010614726,0.00025915666,0.000435837,0.0000956242,0.00010510405,0.000115276634,0.00015587121,0.000014079787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002757352,0.012577929,0.9714917,0.000023757872,0.00039920953,0.000028688828,0.0006358675,0.000003206284,0.00033707469,0.0017872994,0.00015503439,0.012284526],"study_design_scores_gemma":[0.01627881,0.00053866266,0.9765489,0.00023317545,0.0006920901,0.000009806199,0.00035817438,0.000106954285,0.004072298,0.0005033122,0.0005730314,0.00008478453],"about_ca_topic_score_codex":0.00037559675,"about_ca_topic_score_gemma":0.00010011418,"teacher_disagreement_score":0.016003076,"about_ca_system_score_codex":0.00011324789,"about_ca_system_score_gemma":0.00023029494,"threshold_uncertainty_score":0.43285596},"labels":[],"label_agreement":null},{"id":"W4417002464","doi":"10.1182/blood-2025-8027","title":"Test characteristics of end-of-treatment PET scans in diffuse large b-cell lymphoma in a population-level cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Chemoimmunotherapy; Diffuse large B-cell lymphoma; Biopsy; Cohort; Lymphoma; False positive paradox; Retrospective cohort study","score_opus":0.011718566527138896,"score_gpt":0.2585494978111685,"score_spread":0.24683093128402958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974023,0.00024691486,0.000002513971,0.00009358163,0.00004874618,0.00053505664,0.00030535556,0.000010725904,0.0013548138],"genre_scores_gemma":[0.99877137,0.00026151934,0.00024197476,0.00005075708,0.000015371674,0.00011425809,0.00021749912,0.000011119765,0.00031611955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899286,0.000022725008,0.00045642682,0.00020758316,0.00012737274,0.00019305466],"domain_scores_gemma":[0.99935097,0.00016544673,0.00011338096,0.00027986223,0.000041502062,0.00004886633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007790263,0.00015050112,0.0004887833,0.00022193372,0.000015671376,0.0000045246993,0.000049745977,0.000053963668,0.00002131693],"category_scores_gemma":[0.00007744674,0.00012497931,0.00008221503,0.00026432326,0.000022242026,0.00002364082,0.00002940565,0.000024281146,0.0000041649914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004495561,0.05605414,0.9404172,0.00011480423,0.000098710996,0.00017111706,0.00013961972,2.5899794e-7,0.00036660294,0.00023083684,0.000012831812,0.002348933],"study_design_scores_gemma":[0.0420367,0.00036721348,0.94902676,0.00032112695,0.00032861557,0.000011895254,0.000035823945,0.000058898,0.0075842845,0.000023385863,0.00013066934,0.00007462941],"about_ca_topic_score_codex":0.0025626132,"about_ca_topic_score_gemma":0.0009254041,"teacher_disagreement_score":0.05568693,"about_ca_system_score_codex":0.00029076054,"about_ca_system_score_gemma":0.00023405103,"threshold_uncertainty_score":0.5096508},"labels":[],"label_agreement":null},{"id":"W4417004071","doi":"10.1182/blood-2025-1800","title":"Promising response rates and manageable safety with mosunetuzumab plus lenalidomide (Mosun-Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): US extension cohort from the Phase III CELESTIMO study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Lenalidomide; Follicular lymphoma; Cohort; Adverse effect; Rituximab; Common Terminology Criteria for Adverse Events; Cytokine release syndrome; Phases of clinical research","score_opus":0.006508503620268719,"score_gpt":0.241098801781042,"score_spread":0.2345902981607733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942157,0.0016144754,0.000023734505,0.0002933168,0.000052691088,0.003559151,0.000031574986,0.000059496717,0.00014982288],"genre_scores_gemma":[0.9984251,0.00009675519,0.00040718575,0.00032543796,0.00002474194,0.00025270082,0.0001047771,0.000041476877,0.00032180655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763715,0.0003081316,0.0004659818,0.0007442606,0.00047667735,0.00036782344],"domain_scores_gemma":[0.99827164,0.00050947716,0.00017353964,0.00077477645,0.0001377432,0.00013284468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048900064,0.0003915401,0.0007017374,0.00013895117,0.00029085917,0.00007865665,0.00012269654,0.000100064164,0.00001526921],"category_scores_gemma":[0.00011421617,0.00022237109,0.00005816291,0.00041357032,0.00011855891,0.00015774505,0.00010452345,0.00013123927,0.0000043169625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050918855,0.012355743,0.9292165,0.000029200119,0.0012124605,0.0012714145,0.0006610646,0.000046421108,0.00012711226,0.0000086516575,0.00012741466,0.0040251575],"study_design_scores_gemma":[0.18280922,0.0029739393,0.8091445,0.00079208094,0.0017970826,0.000017513908,0.00048630993,0.00010741944,0.001233422,0.000008722096,0.00042205706,0.00020771529],"about_ca_topic_score_codex":0.0023444619,"about_ca_topic_score_gemma":0.00038752804,"teacher_disagreement_score":0.13189036,"about_ca_system_score_codex":0.0003961586,"about_ca_system_score_gemma":0.0004278731,"threshold_uncertainty_score":0.90680295},"labels":[],"label_agreement":null},{"id":"W4417004073","doi":"10.1182/blood-2025-1801","title":"Phase 2 bellwave-003 cohort f: Updated clinical outcomes of nemtabrutinib in participants with relapsed or refractory marginal zone lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Mantle cell lymphoma; Cohort; Bruton's tyrosine kinase; Idelalisib; Refractory (planetary science); Phases of clinical research; Bendamustine; Follicular lymphoma","score_opus":0.036017164921138274,"score_gpt":0.3636572974253188,"score_spread":0.32764013250418056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961944,0.00031117478,0.0000085589045,0.0004998148,0.00013585975,0.0007455088,0.000034928693,0.000050964438,0.0020187541],"genre_scores_gemma":[0.9968127,0.00020887393,0.0006885018,0.0005208919,0.00003230381,0.000104309715,0.000090064765,0.000021776515,0.0015205962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978287,0.00012169675,0.00088216877,0.0004427513,0.00031182656,0.00041280666],"domain_scores_gemma":[0.99859023,0.0003558617,0.00020892639,0.00056254707,0.00008969633,0.00019273252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042776432,0.00024908638,0.0009762894,0.00017201647,0.000042825737,0.000010427479,0.00010384074,0.00016414227,0.00018840651],"category_scores_gemma":[0.0002466068,0.00015742838,0.00014180891,0.00044469652,0.00015187073,0.00005809133,0.00005379973,0.00011191397,0.000024778548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035331564,0.03685952,0.9479028,0.00005353287,0.0014107575,0.0011640262,0.00006319599,4.2321935e-7,0.00013170038,0.00010412748,0.000851362,0.00792542],"study_design_scores_gemma":[0.10013978,0.0028423064,0.88667154,0.0002890221,0.0017410853,0.000032197677,0.00007636312,0.00002273535,0.0051090284,0.0000077450595,0.0029259517,0.00014223429],"about_ca_topic_score_codex":0.00025225006,"about_ca_topic_score_gemma":0.00020979157,"teacher_disagreement_score":0.09660663,"about_ca_system_score_codex":0.00009252902,"about_ca_system_score_gemma":0.00068027887,"threshold_uncertainty_score":0.6419743},"labels":[],"label_agreement":null},{"id":"W4417004318","doi":"10.1182/blood-2025-5410","title":"Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Population; Chemotherapy; Chemotherapy regimen; Retrospective cohort study; Lymphoma; Survival analysis; Gene rearrangement; Progression-free survival; Disease; Stage (stratigraphy)","score_opus":0.004704925180450714,"score_gpt":0.24157327475217577,"score_spread":0.23686834957172506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959486,0.00018148306,0.0000017004319,0.000073148,0.0000067303727,0.00064946595,0.000049715967,0.000015297454,0.0030738576],"genre_scores_gemma":[0.9992184,0.000035286306,0.00036350248,0.00004226642,0.000006728831,0.000046767276,0.000067409004,0.000012248541,0.00020740555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923956,0.000024034533,0.00017535269,0.00023019865,0.00016615997,0.00016469196],"domain_scores_gemma":[0.9995121,0.000040704217,0.000074990654,0.00020335276,0.00009975362,0.00006913626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036223766,0.00016474664,0.00035228935,0.00013664142,0.00002286578,0.0000075632474,0.000030709198,0.000044764143,0.0000337259],"category_scores_gemma":[0.000021468144,0.00009370827,0.000037366055,0.00025060383,0.000053591626,0.000048605976,0.000020665693,0.000044906516,0.0000019078027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013848079,0.005005022,0.98984903,0.00003333673,0.0010287893,0.000048180907,0.00017815611,0.0000019703502,0.00004947556,0.000009761998,0.00013338147,0.0022780758],"study_design_scores_gemma":[0.042820286,0.003533155,0.9498562,0.00048198714,0.00059844926,0.0000026067962,0.00003337903,0.000006646114,0.0025604258,0.000011005694,0.00001555009,0.00008027768],"about_ca_topic_score_codex":0.0011289549,"about_ca_topic_score_gemma":0.00014389121,"teacher_disagreement_score":0.041435476,"about_ca_system_score_codex":0.000084214465,"about_ca_system_score_gemma":0.00007466561,"threshold_uncertainty_score":0.38213125},"labels":[],"label_agreement":null},{"id":"W4417004453","doi":"10.1182/blood-2025-6299","title":"PET imaging biomarkers predict survival in peripheral T-cell lymphoma: A systematic review and meta-analysis.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Hazard ratio; Interim; Meta-analysis; Prospective cohort study; Positron emission tomography; Lymphoma; Pet imaging; Clinical trial; Imaging biomarker","score_opus":0.014393939488430254,"score_gpt":0.26696360743330244,"score_spread":0.2525696679448722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004453","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17649707,0.80484223,0.000022457109,0.004609121,0.00006201405,0.003199018,0.000060395007,0.0000910727,0.010616602],"genre_scores_gemma":[0.9944869,0.0027740165,0.0002310374,0.0012021761,0.00000650708,0.0004531843,0.000028497247,0.000011331927,0.00080629456],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985269,0.00017824695,0.0005161542,0.00035940556,0.00020735967,0.00021196298],"domain_scores_gemma":[0.9991935,0.00012534439,0.000108368244,0.00043297966,0.00004968455,0.00009012981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046590937,0.0002199679,0.0019934056,0.00022385606,0.000040019593,0.000033714354,0.00007400866,0.000025594647,0.00008164042],"category_scores_gemma":[0.00008742121,0.00014473163,0.0006007652,0.00067710783,0.000036547408,0.00004760805,0.000049896717,0.000032538926,0.000005876445],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004250568,0.007042478,0.31533322,0.27340636,0.40117523,0.0017236385,0.0001536173,0.0000012676165,0.000060293853,0.0001962096,0.0008099435,0.000055236516],"study_design_scores_gemma":[0.0063445102,0.000042149073,0.030356908,0.001925594,0.96075773,0.00008806386,0.00009241084,0.000092004295,0.00012660668,0.0000115498,0.000030524316,0.00013194245],"about_ca_topic_score_codex":0.00022717504,"about_ca_topic_score_gemma":0.00006036977,"teacher_disagreement_score":0.8179899,"about_ca_system_score_codex":0.000086411965,"about_ca_system_score_gemma":0.000096274845,"threshold_uncertainty_score":0.59019846},"labels":[],"label_agreement":null},{"id":"W4417004874","doi":"10.1182/blood-2025-1016","title":"Pembrolizumab (Pembro) plus R-CHOP is efficacious as first-line therapy for primary mediastinal B-cell lymphoma (PMBL) with high rates of ctdna negativity – interim efficacy analysis of the ALLG-Pacific (NHL35) trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Pembrolizumab; Interim analysis; Discontinuation; Clinical endpoint; Clinical trial; Lung cancer; Chemoimmunotherapy; Regimen; Lymphoma; Surrogate endpoint","score_opus":0.01613233198756853,"score_gpt":0.28237400725371653,"score_spread":0.266241675266148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937182,0.0010882071,0.00007936345,0.0012055289,0.00019827813,0.002494804,0.00018960836,0.000042624015,0.0009833847],"genre_scores_gemma":[0.99772346,0.00043774323,0.00043464662,0.0003148317,0.00010793791,0.0003315548,0.000115875766,0.00003642292,0.0004975395],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976022,0.00012938373,0.0007668029,0.0005923366,0.0005408262,0.00036843185],"domain_scores_gemma":[0.99688554,0.0012249941,0.0005304705,0.00091774965,0.00031655474,0.00012468628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002546388,0.0004300772,0.0014413161,0.00035548297,0.00014184111,0.000027425363,0.00031947342,0.00015591783,0.000069311514],"category_scores_gemma":[0.00018826214,0.0002556281,0.0007908319,0.0012150962,0.000262019,0.000053658125,0.00009980012,0.00009725849,0.0000032453622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5760361,0.14570321,0.106898606,0.002283364,0.057851166,0.00019024918,0.0063493657,0.0004238961,0.016787218,0.00070362963,0.0022799773,0.08449321],"study_design_scores_gemma":[0.45413372,0.0072264853,0.3168891,0.00042632685,0.012532807,0.000019178331,0.00012523866,0.00024155335,0.20729776,0.00006584378,0.00074767694,0.00029431467],"about_ca_topic_score_codex":0.00038460418,"about_ca_topic_score_gemma":0.000082377235,"teacher_disagreement_score":0.2099905,"about_ca_system_score_codex":0.0001970025,"about_ca_system_score_gemma":0.00081302394,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W4417004880","doi":"10.1182/blood-2025-661","title":"Integrated clinico-biological profiling identifies a high-risk epigenetic signature in Mantle Cell Lymphoma: A lysa study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Mantle cell lymphoma; Epigenetics; DNA methylation; Transcriptome; Multivariate analysis; Gene expression profiling; Survival analysis; CDKN2A","score_opus":0.014292622670228959,"score_gpt":0.2740520551911256,"score_spread":0.2597594325208966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943446,0.0031393017,0.000008561561,0.00011506029,0.00021277073,0.0013118369,0.000024335339,0.00008858016,0.0007549709],"genre_scores_gemma":[0.9980812,0.00039204516,0.00042570438,0.00013983165,0.000050803123,0.0002873118,0.000057480105,0.000014572843,0.00055103307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983424,0.0001819259,0.00047769162,0.0005263624,0.00017075452,0.0003008712],"domain_scores_gemma":[0.9991338,0.00023748791,0.00010031167,0.00037605382,0.000076127,0.00007617786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028388,0.00024151745,0.0005239094,0.00019262805,0.00007595408,0.000036909965,0.0001294911,0.00020519996,0.00004170996],"category_scores_gemma":[0.00018345835,0.00016414869,0.00012823413,0.00047073493,0.000048986025,0.000027984448,0.00009588809,0.00016967408,0.000051336854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018992601,0.022729592,0.96940815,0.000052463205,0.0003047964,0.00071698637,0.0002637611,0.0000032188277,0.002142909,0.000054646185,0.00013659892,0.0039969534],"study_design_scores_gemma":[0.026331283,0.0012295182,0.8915151,0.00018390312,0.0008386853,0.000009727285,0.0016125325,0.00002718948,0.07763953,0.0003212148,0.00012159758,0.00016977389],"about_ca_topic_score_codex":0.0005400989,"about_ca_topic_score_gemma":0.00020815083,"teacher_disagreement_score":0.0778931,"about_ca_system_score_codex":0.00009978186,"about_ca_system_score_gemma":0.00018881123,"threshold_uncertainty_score":0.66937894},"labels":[],"label_agreement":null},{"id":"W4417004940","doi":"10.1182/blood-2025-1020","title":"Long-term follow-up with sustained progression-free survival (PFS) benefit after subcutaneous (SC) mosunetuzumab in combination with polatuzumab vedotin compared with rituximab plus polatuzumab vedotin in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"","keywords":"Rituximab; Follicular lymphoma; Refractory (planetary science); Clinical endpoint; Phases of clinical research; Cytokine release syndrome; Lymphoma; Cohort","score_opus":0.004965107923882109,"score_gpt":0.22528995639170812,"score_spread":0.22032484846782602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326974,0.00074951904,0.00003486764,0.00022691528,0.00015953975,0.0045108586,0.000068328154,0.00018327808,0.0007969739],"genre_scores_gemma":[0.99572575,0.000039889972,0.001443299,0.00014476322,0.000043008407,0.0008722851,0.0006765649,0.00019648304,0.00085793453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945153,0.00018992959,0.001019785,0.0014934237,0.0015568477,0.001224739],"domain_scores_gemma":[0.9965486,0.00033993038,0.0005554934,0.0015668297,0.0006083508,0.00038082458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002100149,0.0011416752,0.0017966073,0.00094424,0.00021789428,0.00015761465,0.00048773925,0.00039573072,0.000050963816],"category_scores_gemma":[0.00006910628,0.0007207279,0.0001317588,0.0018415253,0.0002807792,0.00037894447,0.00021118898,0.0004754089,0.000013512578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11418805,0.026243273,0.8467384,0.00053284096,0.00065573305,0.00752126,0.001169128,0.000050075538,0.000021129463,0.00004325946,0.00003617847,0.0028006837],"study_design_scores_gemma":[0.2792925,0.016258704,0.69765073,0.0036422163,0.00091389177,0.00014527312,0.00045896386,0.00014944446,0.0007076303,0.000014647063,0.000025826954,0.0007401809],"about_ca_topic_score_codex":0.001037675,"about_ca_topic_score_gemma":0.011320151,"teacher_disagreement_score":0.16510445,"about_ca_system_score_codex":0.002458933,"about_ca_system_score_gemma":0.0024165628,"threshold_uncertainty_score":0.99952435},"labels":[],"label_agreement":null},{"id":"W4417005015","doi":"10.1182/blood-2025-1819","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of patients receiving second-line treatment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Chemoimmunotherapy; Follicular lymphoma; Refractory (planetary science); Population; Phases of clinical research; Neutropenia; Placebo; Maintenance therapy","score_opus":0.03145136658565763,"score_gpt":0.3478430245550208,"score_spread":0.3163916579693632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996837,0.0006582714,0.0000105508,0.00009084224,0.00014212207,0.0018975683,0.00030176603,0.000016569638,0.00004529049],"genre_scores_gemma":[0.99822783,0.0003481443,0.00064907875,0.00007853754,0.000036072423,0.00017719339,0.00009734325,0.0000203529,0.00036545718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982147,0.0000828252,0.0009407327,0.00039958823,0.0001717852,0.00019031849],"domain_scores_gemma":[0.998218,0.00076571415,0.00036174228,0.0003622928,0.00017315564,0.00011910164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025931408,0.00025716948,0.0012839468,0.00012549506,0.00006488522,0.000012474538,0.000053265347,0.00012158125,0.000013705313],"category_scores_gemma":[0.0004788317,0.00017102748,0.00018192484,0.00009705924,0.00008613999,0.000051285715,0.000058043148,0.000038946797,5.8550455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004264364,0.09624566,0.84219307,0.00027012383,0.0023925619,0.00006616371,0.00041076695,2.311342e-8,0.00009173918,0.000015157978,0.000042222484,0.054008164],"study_design_scores_gemma":[0.2815731,0.012592491,0.6987502,0.00015915066,0.0031085347,0.0000047406247,0.00020755624,0.00001937125,0.0031055682,0.000009178185,0.00036507688,0.00010504196],"about_ca_topic_score_codex":0.0000405224,"about_ca_topic_score_gemma":0.00004253275,"teacher_disagreement_score":0.27730873,"about_ca_system_score_codex":0.000108140084,"about_ca_system_score_gemma":0.00023663549,"threshold_uncertainty_score":0.69742984},"labels":[],"label_agreement":null},{"id":"W4417008302","doi":"10.1182/blood-2025-1851","title":"Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Dacarbazine; ABVD; Stage (stratigraphy); Regimen; Interim analysis; Phases of clinical research; Brentuximab vedotin; Chemotherapy regimen; Progression-free survival","score_opus":0.016185490822117392,"score_gpt":0.3174914110932512,"score_spread":0.3013059202711338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995872,0.00084508373,0.000026076868,0.00018156851,0.000034968092,0.0024746773,0.00041221073,0.000031631036,0.00012178068],"genre_scores_gemma":[0.9978916,0.0002707502,0.0012312008,0.000007505809,0.0000093694725,0.00044004526,0.00009980564,0.000020046908,0.000029669667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977877,0.00013657103,0.0008171326,0.0006233485,0.00034271556,0.00029252892],"domain_scores_gemma":[0.99817497,0.00028136556,0.00029528094,0.0008981255,0.00019140058,0.00015887828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021327175,0.00037568648,0.0014031817,0.00058860925,0.00004654324,0.0000127156845,0.00011593004,0.00004234135,0.000020205372],"category_scores_gemma":[0.00009378959,0.00025550203,0.00021107089,0.0011125337,0.00014226115,0.00006591365,0.000091306196,0.000029965533,3.3827288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032087013,0.061505932,0.87662405,0.00014991993,0.004789836,0.00028447894,0.0009525903,0.00009704898,0.0019928862,0.000009173816,0.0000018534923,0.050383527],"study_design_scores_gemma":[0.092915885,0.020927444,0.800842,0.0004771605,0.010228187,0.000008170831,0.0018802416,0.0005019695,0.07201067,0.0000070043043,0.000021216549,0.00018008378],"about_ca_topic_score_codex":0.0016604563,"about_ca_topic_score_gemma":0.0035301733,"teacher_disagreement_score":0.08970718,"about_ca_system_score_codex":0.00043634285,"about_ca_system_score_gemma":0.0003258442,"threshold_uncertainty_score":0.99998975},"labels":[],"label_agreement":null},{"id":"W4417008388","doi":"10.1182/blood-2025-884","title":"Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Chemoimmunotherapy; Mantle cell lymphoma; Rituximab; Phases of clinical research; Progressive disease; Clinical endpoint; Minimal residual disease; Lymphoma; Ibrutinib","score_opus":0.009038424887865857,"score_gpt":0.2500816424486637,"score_spread":0.24104321756079786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529135,0.00052956503,4.827626e-7,0.00017486591,0.000057706224,0.0018153335,0.0003358616,0.000028177483,0.0017666795],"genre_scores_gemma":[0.9989093,0.000081217506,0.0000701391,0.00016983468,0.000030813568,0.00015621156,0.00021936392,0.00001663884,0.00034649408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986884,0.00007724913,0.00029243663,0.00047449494,0.00021532098,0.00025207453],"domain_scores_gemma":[0.9990934,0.00023554468,0.00008391717,0.00046521524,0.00004197515,0.000079921716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006792053,0.00025479493,0.0004124168,0.000070943075,0.00010485644,0.000033779692,0.000081068014,0.000069436705,0.000015282636],"category_scores_gemma":[0.000025117226,0.0001458093,0.0000538212,0.0002002579,0.00006154038,0.0000448252,0.0000455672,0.000050380786,0.000022488573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076842783,0.10533146,0.8560788,0.000017994353,0.0009611272,0.0005174851,0.0046237735,0.000002567787,0.000015314517,0.000014163435,0.00032567015,0.024427371],"study_design_scores_gemma":[0.38537252,0.0033121589,0.6062618,0.00010350388,0.0010491833,0.0000019685167,0.0009348543,0.00002126647,0.0019030132,0.000008406649,0.0009269606,0.00010439266],"about_ca_topic_score_codex":0.0022090042,"about_ca_topic_score_gemma":0.00029854858,"teacher_disagreement_score":0.37768823,"about_ca_system_score_codex":0.00035303962,"about_ca_system_score_gemma":0.00027722373,"threshold_uncertainty_score":0.5945931},"labels":[],"label_agreement":null},{"id":"W4417008450","doi":"10.1182/blood-2025-885","title":"Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Bendamustine; Hazard ratio; Clinical endpoint; Discontinuation; Rituximab; Randomization; Confidence interval; Phases of clinical research; Mantle cell lymphoma","score_opus":0.006260741455784101,"score_gpt":0.24771047819589428,"score_spread":0.2414497367401102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953303,0.00018831168,0.0000038980825,0.0001219702,0.000036514113,0.0034026382,0.00041521297,0.00003225196,0.0004689387],"genre_scores_gemma":[0.9959122,0.000015469814,0.00036014535,0.000140858,0.000018214194,0.0006663258,0.0002662594,0.00003419822,0.0025863545],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978361,0.000101616,0.00069441897,0.00055131665,0.00044534437,0.00037118982],"domain_scores_gemma":[0.99846655,0.00007757767,0.0002635474,0.00081737345,0.00023066837,0.00014427204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009746631,0.00043129743,0.0013505885,0.00045974564,0.00003811443,0.000016050491,0.00014220522,0.00012845451,0.0003619568],"category_scores_gemma":[0.00002856272,0.00020768202,0.00027566316,0.0018059191,0.00009213946,0.00005588416,0.00007061188,0.000053598145,0.000016145787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22792321,0.05846908,0.7049768,0.00007958115,0.005678543,0.000116374424,0.0006667744,0.000030214956,0.00007137393,6.178495e-7,0.000095041985,0.0018923801],"study_design_scores_gemma":[0.60270923,0.011953185,0.33817193,0.00053502806,0.025332725,0.0000023997625,0.000059230624,0.00015127477,0.020607589,6.212642e-7,0.00023501378,0.00024173758],"about_ca_topic_score_codex":0.00049201923,"about_ca_topic_score_gemma":0.0009219943,"teacher_disagreement_score":0.37478605,"about_ca_system_score_codex":0.00022599798,"about_ca_system_score_gemma":0.0003923565,"threshold_uncertainty_score":0.8469027},"labels":[],"label_agreement":null},{"id":"W4417008866","doi":"10.1182/blood-2025-3582","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes by age","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Refractory (planetary science); Population; Phases of clinical research; Placebo; Post-hoc analysis; Neutropenia; Progression-free survival","score_opus":0.028369455627643467,"score_gpt":0.355005242533406,"score_spread":0.3266357869057625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618006,0.001510933,0.000028859331,0.00035711593,0.00013330892,0.0014957311,0.0001897169,0.00002857218,0.00007567747],"genre_scores_gemma":[0.99759597,0.00038052368,0.00056436344,0.00036695975,0.00004253907,0.00018301561,0.000077297074,0.000020940322,0.0007684123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984404,0.00007329373,0.0006891257,0.00041480514,0.00017396953,0.00020840066],"domain_scores_gemma":[0.9985502,0.0006825523,0.00019347026,0.00035543053,0.00007484566,0.00014354734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033533937,0.00023215606,0.0010474023,0.00008542918,0.000083025974,0.000027035414,0.00006532497,0.00013870774,0.000007615127],"category_scores_gemma":[0.00049369654,0.0001603658,0.00014963775,0.00008993229,0.000110861816,0.000047754853,0.00006962612,0.000059471324,0.0000013809108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064832317,0.12483262,0.8117068,0.0004522553,0.0036146685,0.0010362085,0.00051093585,8.792721e-9,0.00072233204,0.00012015773,0.0027161401,0.04780466],"study_design_scores_gemma":[0.48054373,0.007654055,0.49709436,0.00022330694,0.004964482,0.000038975613,0.0004643358,0.00002239982,0.0027663663,0.000035198478,0.0059675816,0.00022518844],"about_ca_topic_score_codex":0.000045832363,"about_ca_topic_score_gemma":0.000012710032,"teacher_disagreement_score":0.4740605,"about_ca_system_score_codex":0.000054406257,"about_ca_system_score_gemma":0.00018833908,"threshold_uncertainty_score":0.6539528},"labels":[],"label_agreement":null},{"id":"W4417008940","doi":"10.1182/blood-2025-3581","title":"Prognostic impact of Mantle Cell Lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Lenalidomide; Mantle cell lymphoma; Rituximab; Bortezomib; Chemoimmunotherapy; Maintenance therapy; Diffuse large B-cell lymphoma; Induction chemotherapy; Phases of clinical research; Follicular lymphoma","score_opus":0.012168514822884483,"score_gpt":0.30387745695810225,"score_spread":0.29170894213521775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971866,0.00056166365,0.000012238363,0.0002233667,0.000035903264,0.001574187,0.000044538323,0.000015582718,0.00034591425],"genre_scores_gemma":[0.9991074,0.000067300774,0.00043486225,0.000047507077,0.000019085568,0.00018280161,0.000017680515,0.000017824883,0.00010551255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983335,0.00023540479,0.00049779454,0.00035904394,0.00030927465,0.0002649495],"domain_scores_gemma":[0.99882436,0.0003039293,0.00022819053,0.00044677593,0.00013834196,0.000058409732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050682307,0.00024683692,0.000630329,0.00023412073,0.00005272314,0.00001985924,0.00011986825,0.000068696376,0.000014322499],"category_scores_gemma":[0.00012806534,0.00014450293,0.00008498286,0.00042050052,0.00008642999,0.00008420668,0.000057367743,0.0000944924,0.0000018327612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007927745,0.064520635,0.92043585,0.00020973323,0.00062130566,0.00040765153,0.0009971781,0.000011305882,0.0021143383,0.00001938543,0.0002041191,0.0025307387],"study_design_scores_gemma":[0.087438986,0.0057429904,0.89703465,0.0004273189,0.0010238668,0.000114884606,0.0023538815,0.0000581609,0.0056522936,0.00001956111,0.00002342569,0.00010997255],"about_ca_topic_score_codex":0.0013532358,"about_ca_topic_score_gemma":0.00023775546,"teacher_disagreement_score":0.07951124,"about_ca_system_score_codex":0.00013279915,"about_ca_system_score_gemma":0.00037358757,"threshold_uncertainty_score":0.5892658},"labels":[],"label_agreement":null},{"id":"W4417008991","doi":"10.1182/blood-2025-3601","title":"Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Cohort; Clinical endpoint; Confidence interval; Lymphoma; Clinical trial; Epidemiology; Proportional hazards model; Cohort study","score_opus":0.011164805391691509,"score_gpt":0.28778310082296477,"score_spread":0.27661829543127325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765384,0.00021838408,0.000020578427,0.0001244407,0.000032955304,0.0017540195,0.0000641953,0.000031916312,0.00009965895],"genre_scores_gemma":[0.99796987,0.00020582347,0.00042872687,0.000055798813,0.000019610245,0.00086811517,0.00040811868,0.000022042133,0.00002186999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985801,0.00006334936,0.0003345263,0.00044517798,0.00038076963,0.00019609612],"domain_scores_gemma":[0.99900997,0.00012440028,0.00013195955,0.00040240178,0.00022121794,0.00011004387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006851338,0.00027022985,0.0004311689,0.00024759167,0.000027184902,0.000038735263,0.00012975973,0.00007107746,0.000057375746],"category_scores_gemma":[0.000053649244,0.00016716587,0.00010546471,0.00033062883,0.00003239139,0.0001868835,0.000029224382,0.000033179105,0.000005508755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016666608,0.013542185,0.9718362,0.000013189475,0.0025368205,0.00010890518,0.00036944705,0.000055088352,0.00033841273,0.000003919676,0.0000048646352,0.009524322],"study_design_scores_gemma":[0.017659897,0.006755447,0.9171069,0.0016286374,0.0008760793,0.000008322245,0.000028882614,0.00004068979,0.055745445,0.000004248216,0.000010548117,0.00013487495],"about_ca_topic_score_codex":0.006400493,"about_ca_topic_score_gemma":0.00031995127,"teacher_disagreement_score":0.055407032,"about_ca_system_score_codex":0.0007958949,"about_ca_system_score_gemma":0.00027662938,"threshold_uncertainty_score":0.9675674},"labels":[],"label_agreement":null},{"id":"W4417009115","doi":"10.1182/blood-2025-3578","title":"Analysis of predictive factors for POD24 in patients with previously untreated mantle cell lymphoma receiving bendamustine-rituximab with or without acalabrutinib in the phase 3 ECHO trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Mantle cell lymphoma; Logistic regression; Hazard ratio; Confidence interval; Placebo; Rituximab; Proportional hazards model; Phases of clinical research; Odds ratio","score_opus":0.012089763459884453,"score_gpt":0.2813415108521616,"score_spread":0.26925174739227714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956974,0.00007492702,0.000026500502,0.00005184755,0.000026769332,0.0033925134,0.00020946254,0.000023329154,0.00049727893],"genre_scores_gemma":[0.9987617,0.000018778364,0.00026585738,0.000055905737,0.000016772397,0.00040052275,0.00035981482,0.000019627943,0.00010101864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840605,0.00009306709,0.00046443348,0.00041110662,0.0003161974,0.00030916423],"domain_scores_gemma":[0.99875706,0.0004514049,0.00021558571,0.0003751655,0.00013983076,0.000060931467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019110742,0.00026573948,0.0008537716,0.000488388,0.000052617357,0.000020766793,0.00012889771,0.000098687335,0.000021444916],"category_scores_gemma":[0.00013449631,0.00013072879,0.00012651307,0.0015711237,0.00005931679,0.0000659403,0.000023788232,0.000068901114,4.5453783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05128425,0.030808477,0.9129177,0.000102380654,0.0017163394,0.00002934828,0.0016819352,0.000017965733,0.000006183274,0.000004331111,0.000021028247,0.001410105],"study_design_scores_gemma":[0.4034396,0.0069441716,0.5785276,0.00036923442,0.0076715895,0.0000010389867,0.0006883042,0.000261329,0.001960069,0.0000020946077,0.000022583186,0.00011234024],"about_ca_topic_score_codex":0.0004107068,"about_ca_topic_score_gemma":0.00085539813,"teacher_disagreement_score":0.35215536,"about_ca_system_score_codex":0.00014406512,"about_ca_system_score_gemma":0.0003129508,"threshold_uncertainty_score":0.53309655},"labels":[],"label_agreement":null},{"id":"W4417009636","doi":"10.1182/blood-2025-5330","title":"Non-invasive classification &amp; molecular subtyping of mature lymphoid neoplasms by cell-free DNA profiling","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Subtyping; Liquid biopsy; Gene expression profiling; DNA methylation; Cell-free fetal DNA; Biopsy; Immunohistochemistry; Circulating tumor cell; Gene","score_opus":0.007938541094122937,"score_gpt":0.23966449549946628,"score_spread":0.23172595440534335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764837,0.0021777393,0.00024460614,0.00074726326,0.00009256896,0.00053504884,0.00004373508,0.000041809217,0.00846884],"genre_scores_gemma":[0.9952833,0.00020064799,0.0032587673,0.00031755044,0.00002711107,0.00009792167,0.00023475039,0.000017136668,0.0005627989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990554,0.000019198225,0.000258703,0.00028793135,0.00019072657,0.00018803176],"domain_scores_gemma":[0.999076,0.0000716902,0.00011885215,0.0005570754,0.00010738381,0.00006899711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068601155,0.00015813259,0.00027535376,0.00009454511,0.00005017313,0.000014977686,0.000119383556,0.00013610187,0.000013717105],"category_scores_gemma":[0.000086923545,0.00013637227,0.00011688553,0.00023943406,0.000034644247,0.000034244546,0.000052981555,0.000063736574,0.000018325592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071657996,0.002167794,0.1352501,0.0004952893,0.00026165627,0.00003808262,0.00013490481,0.0000029420476,0.85504514,0.0006942142,0.00527332,0.0005648724],"study_design_scores_gemma":[0.006670048,0.00009245326,0.0137682175,0.0003223794,0.0006031091,0.000020993353,0.00009401511,0.000023041073,0.9773658,0.00012906308,0.0008088851,0.00010199612],"about_ca_topic_score_codex":0.000043897722,"about_ca_topic_score_gemma":0.000009073179,"teacher_disagreement_score":0.122320645,"about_ca_system_score_codex":0.000081403974,"about_ca_system_score_gemma":0.00026381214,"threshold_uncertainty_score":0.55610996},"labels":[],"label_agreement":null},{"id":"W4417009708","doi":"10.1182/blood-2025-5367","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of high-risk patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Lenalidomide; Follicular lymphoma; Refractory (planetary science); Phases of clinical research; Neutropenia; Placebo; Post-hoc analysis; Dosing; Progression-free survival","score_opus":0.019422702537377132,"score_gpt":0.3272506070412496,"score_spread":0.30782790450387243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973699,0.0004581769,0.000018455812,0.000074324336,0.0001616508,0.001544564,0.00033977098,0.000015153173,0.000018042452],"genre_scores_gemma":[0.9985041,0.00035369888,0.00073058734,0.00007852018,0.00003151747,0.00011248374,0.00006272791,0.000017545002,0.000108801185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983319,0.00009177675,0.0008451726,0.00035698322,0.00020513388,0.00016903834],"domain_scores_gemma":[0.99820244,0.00074080174,0.0003981586,0.0003590702,0.00019116604,0.000108362154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030524394,0.00020847122,0.0011460567,0.0001113893,0.00006366251,0.000010742827,0.00006205414,0.00012462473,0.0000050385897],"category_scores_gemma":[0.00086047774,0.00014214139,0.00014673814,0.00009747699,0.000106025516,0.000045480017,0.000075534765,0.000053359337,7.2842965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037608892,0.07013372,0.8919483,0.00021455146,0.0018066027,0.000048923117,0.00020877617,1.6527826e-8,0.00002380617,0.000046433255,0.00008925318,0.031718723],"study_design_scores_gemma":[0.27535537,0.0065581156,0.71277463,0.00011817121,0.0036252555,0.0000029003816,0.00013976365,0.000010308503,0.0011613024,0.000026648944,0.00014087498,0.00008669211],"about_ca_topic_score_codex":0.00014087785,"about_ca_topic_score_gemma":0.000017148559,"teacher_disagreement_score":0.27159446,"about_ca_system_score_codex":0.000045106186,"about_ca_system_score_gemma":0.00018144342,"threshold_uncertainty_score":0.5796358},"labels":[],"label_agreement":null},{"id":"W4417009769","doi":"10.1182/blood-2025-2772","title":"Reassessing bone marrow staging practices in limited-stage follicular lymphoma in the PET era","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Follicular lymphoma; Positron emission tomography; Bone marrow; Biopsy; Lymphoma; Retrospective cohort study; Fine-needle aspiration","score_opus":0.021897750399162138,"score_gpt":0.30707894741033204,"score_spread":0.2851811970111699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97542286,0.0029183384,0.0000030062056,0.0061528133,0.000058758884,0.00042577644,0.0000044265944,0.00003208115,0.014981914],"genre_scores_gemma":[0.9969652,0.0002937878,0.000687178,0.0013848521,0.000042792315,0.0001225465,0.000021666378,0.0000120587865,0.00046991138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876666,0.00014488006,0.000282436,0.00029227123,0.00024325892,0.0002704733],"domain_scores_gemma":[0.9990241,0.0003522769,0.00015373797,0.00039882737,0.000029872996,0.000041194984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004807592,0.00015458722,0.0002755942,0.00022160851,0.000071058115,0.000094968775,0.00010080184,0.000049715392,0.000020037653],"category_scores_gemma":[0.0003313289,0.00010550144,0.00007480128,0.00054851174,0.000026263586,0.0001468886,0.000045692104,0.00010927872,0.000009477674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007963924,0.005086258,0.9742531,0.00014786566,0.00014561477,0.007409551,0.0006518737,0.0000049090845,0.00095713534,0.0013691371,0.0003386186,0.009556273],"study_design_scores_gemma":[0.012266565,0.00010127296,0.97223747,0.0007257405,0.00036871954,0.00019379717,0.0017288573,0.00015675944,0.003114151,0.0001026051,0.008874122,0.00012992977],"about_ca_topic_score_codex":0.0009355881,"about_ca_topic_score_gemma":0.000299618,"teacher_disagreement_score":0.021542322,"about_ca_system_score_codex":0.00013724259,"about_ca_system_score_gemma":0.00025130154,"threshold_uncertainty_score":0.4302224},"labels":[],"label_agreement":null},{"id":"W4417009797","doi":"10.1182/blood-2025-2761","title":"Outcomes of autologous stem cell transplantation using busulfan-melphalan conditioning with pharmacokinetic monitoring for relapsed diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Busulfan; Melphalan; Rituximab; Autologous stem-cell transplantation; Carmustine; Diffuse large B-cell lymphoma; Transplantation; Lymphoma","score_opus":0.01424451056297561,"score_gpt":0.27704321430655765,"score_spread":0.26279870374358205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696505,0.00066271645,0.0007801984,0.000056841815,0.00014304832,0.0006958284,0.00012557382,0.000062317464,0.0005084185],"genre_scores_gemma":[0.9972272,0.000102490005,0.0021284872,0.000052286796,0.000034213044,0.00011078731,0.00008404624,0.0000233797,0.00023711014],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903446,0.000026219417,0.00029324697,0.00024196223,0.0001603334,0.00024376974],"domain_scores_gemma":[0.9993535,0.00018577688,0.00013886769,0.00017186113,0.00008569541,0.000064275984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006593293,0.0001837406,0.00038036174,0.00013378476,0.000109666915,0.000014753152,0.00005524525,0.00007095658,0.000004472768],"category_scores_gemma":[0.0000042710635,0.00014416274,0.000107070664,0.00014760537,0.000025495174,0.000054856235,0.000009520044,0.00003547463,0.0000013573691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046590864,0.013041338,0.9404372,0.001313741,0.0006488344,0.00021700603,0.00073186535,0.000050164468,0.04052198,0.00010099668,0.00002411512,0.0024468345],"study_design_scores_gemma":[0.07450683,0.00033359448,0.36511993,0.00033735717,0.0027739163,0.000035507463,0.00023072503,0.00020031101,0.55628717,0.0000075933967,0.000049331033,0.00011774809],"about_ca_topic_score_codex":0.00005105825,"about_ca_topic_score_gemma":0.000003262882,"teacher_disagreement_score":0.57531726,"about_ca_system_score_codex":0.00007200107,"about_ca_system_score_gemma":0.00011164296,"threshold_uncertainty_score":0.5878786},"labels":[],"label_agreement":null},{"id":"W4417009812","doi":"10.1182/blood-2025-2769","title":"Limited-stage Mantle Cell Lymphoma: Real-world outcomes according to nodal vs. extranodal presentation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Stage (stratigraphy); Radiation therapy; Chemotherapy; Proportional hazards model; Retrospective cohort study; Chemotherapy regimen; Survival analysis; Transplantation; Disease","score_opus":0.015790387473181844,"score_gpt":0.29953035294808844,"score_spread":0.2837399654749066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928968,0.0001627735,0.00004470454,0.002106708,0.00027070797,0.00065063674,0.000028294115,0.0001285077,0.06763966],"genre_scores_gemma":[0.9702047,0.00008219171,0.0011103079,0.0011092403,0.00009195072,0.00013955327,0.000055351993,0.000024088178,0.027182614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987175,0.00003029926,0.00030069592,0.00037628593,0.00025593606,0.00031928023],"domain_scores_gemma":[0.9991757,0.00015375856,0.0000600075,0.00039148523,0.000060192437,0.00015883587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008156558,0.00021483397,0.0003699326,0.00029149986,0.00010709104,0.000054791682,0.000105049316,0.000066881774,0.000082099315],"category_scores_gemma":[0.00003979394,0.00017736809,0.00016052379,0.00040933752,0.000019809793,0.00008202416,0.00007973418,0.00004562361,0.00015463203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014592637,0.0034937842,0.98577684,0.00012651089,0.00022920634,0.00024304456,0.00015964407,0.000005597497,0.0019541185,0.00085242226,0.002618432,0.0043944595],"study_design_scores_gemma":[0.013320626,0.00018910291,0.90222245,0.000114829236,0.0005843265,0.000007122831,0.00024087449,0.000026837877,0.075174324,0.000028013243,0.007930601,0.00016086093],"about_ca_topic_score_codex":0.00088918005,"about_ca_topic_score_gemma":0.00020069092,"teacher_disagreement_score":0.08355437,"about_ca_system_score_codex":0.00015362854,"about_ca_system_score_gemma":0.00013511609,"threshold_uncertainty_score":0.72328603},"labels":[],"label_agreement":null},{"id":"W4417011174","doi":"10.1182/blood-2025-1905","title":"Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 &amp;lt;1% expression","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Brentuximab vedotin; CD30; Lymphoma; Diffuse large B-cell lymphoma; Immunohistochemistry; Rituximab; Refractory (planetary science); Clinical endpoint","score_opus":0.007496286780307536,"score_gpt":0.23599997250196073,"score_spread":0.2285036857216532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997331,0.00028833593,0.000008815859,0.00006742369,0.000046335306,0.0011740528,0.000029148907,0.0000431153,0.0010117381],"genre_scores_gemma":[0.998011,0.00006497411,0.00049213145,0.00005624703,0.000010780168,0.00015433606,0.0002857176,0.000026259906,0.00089857075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986397,0.00006714672,0.0003300292,0.00037180466,0.000331807,0.00025948335],"domain_scores_gemma":[0.998995,0.0001522863,0.00018097089,0.00047852122,0.00010354286,0.0000896652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056586196,0.00025954033,0.0004649712,0.0002065198,0.000059059388,0.000012442585,0.000067406676,0.00009904427,0.000025843812],"category_scores_gemma":[0.00003577038,0.00014648857,0.00006659957,0.00031298603,0.00003896062,0.00007067291,0.00003297488,0.00004569547,0.000010312991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057878816,0.25482166,0.73336554,0.000117714575,0.00024684178,0.00006593319,0.0004497321,9.3126505e-7,0.0005331856,0.000042563872,0.00012859463,0.004439445],"study_design_scores_gemma":[0.29300034,0.00414741,0.68102324,0.0007193731,0.00051466987,0.0000022985325,0.000034989698,0.0000036895058,0.01937293,0.0000028769055,0.0010641292,0.00011404104],"about_ca_topic_score_codex":0.00009069045,"about_ca_topic_score_gemma":0.00011120951,"teacher_disagreement_score":0.28721246,"about_ca_system_score_codex":0.0003099714,"about_ca_system_score_gemma":0.00026038932,"threshold_uncertainty_score":0.59736305},"labels":[],"label_agreement":null},{"id":"W4417012091","doi":"10.1182/blood-2025-5479","title":"Zilovertamab vedotin plus R-CHP versus R-CHOP for first-line treatment of diffuse large B-cell lymphoma: The phase 3 waveline-010 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Brentuximab vedotin; Prednisone; Diffuse large B-cell lymphoma; International Prognostic Index; Phases of clinical research; Lymphoma; Neutropenia; Bendamustine","score_opus":0.027065021891596163,"score_gpt":0.3250178730099192,"score_spread":0.29795285111832304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912663,0.0024797902,0.000055133765,0.000996185,0.0004384344,0.003170985,0.00027219308,0.00005793689,0.0012630245],"genre_scores_gemma":[0.9963439,0.00045766166,0.00016577092,0.00016270432,0.00019442008,0.0008054211,0.00011479684,0.000033403205,0.0017218997],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830633,0.000045295288,0.00051230704,0.00045699903,0.0002739872,0.00040508236],"domain_scores_gemma":[0.9981236,0.0006580215,0.0001554147,0.00080144155,0.00014002714,0.00012148188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013672895,0.00035629945,0.00067921693,0.000110825276,0.00020458606,0.000024534997,0.00015156933,0.00009937538,0.000035697896],"category_scores_gemma":[0.00011817169,0.00021571926,0.0003621388,0.00025300315,0.00004783573,0.000034478682,0.000063293424,0.000037577658,0.000021203887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014070981,0.9132392,0.030443722,0.00036789704,0.0055159847,0.00042630447,0.003444339,0.000010523431,0.0006529899,0.0008357436,0.002693733,0.028298588],"study_design_scores_gemma":[0.890568,0.018149776,0.013330039,0.00011031614,0.0074452767,0.000011544947,0.0013068437,0.0006596217,0.03999556,0.000038596656,0.028121991,0.0002624117],"about_ca_topic_score_codex":0.00023465228,"about_ca_topic_score_gemma":0.00032317638,"teacher_disagreement_score":0.8950894,"about_ca_system_score_codex":0.00030670903,"about_ca_system_score_gemma":0.00032097384,"threshold_uncertainty_score":0.8796776},"labels":[],"label_agreement":null},{"id":"W4417013127","doi":"10.1182/blood-2025-6265","title":"Patient characteristics and treatment outcomes with Pola-R-CHP: A real-world study of patients with previously untreated diffuse large B-cell lymphoma (DLBCL) in the United States (US)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Prednisone; Rituximab; Vincristine; Lymphoma; Cancer; Clinical trial; Disease; Diffuse large B-cell lymphoma; Bendamustine","score_opus":0.006293172537444891,"score_gpt":0.2309704447356517,"score_spread":0.22467727219820682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968638,0.000075415,3.7713374e-7,0.000121553356,0.000016762013,0.0025162692,0.0001558747,0.0000328909,0.00021707348],"genre_scores_gemma":[0.99858004,0.00021411362,0.000036368107,0.0002712006,0.0000051915076,0.00029838432,0.00043536935,0.000023698356,0.00013562292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850255,0.00012484725,0.0003982635,0.00034558543,0.0003149691,0.00031375256],"domain_scores_gemma":[0.99890476,0.00019433058,0.00019477325,0.0004872085,0.00012972522,0.00008917686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065308006,0.00033418622,0.0006078427,0.00030561408,0.0000878192,0.000032146007,0.00007126644,0.000040571183,0.000004148401],"category_scores_gemma":[0.000013789936,0.00015817521,0.000043780707,0.0006428311,0.00005198821,0.000036825128,0.000042151933,0.000043994314,0.000001190939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007472927,0.15707667,0.83509177,0.000056212873,0.000678992,0.00019027037,0.005043458,6.108269e-7,0.0000011603826,0.00002145007,0.000013252393,0.0010788324],"study_design_scores_gemma":[0.117789835,0.008350823,0.8700543,0.0001853667,0.0016023956,0.0000028601457,0.0014252868,0.000013721572,0.00015210251,0.0000017100473,0.00029277566,0.00012881226],"about_ca_topic_score_codex":0.0050504305,"about_ca_topic_score_gemma":0.0037488875,"teacher_disagreement_score":0.14872585,"about_ca_system_score_codex":0.00016062785,"about_ca_system_score_gemma":0.00010281433,"threshold_uncertainty_score":0.7634774},"labels":[],"label_agreement":null},{"id":"W4417016546","doi":"10.1182/blood-2025-5523","title":"Odronextamab treatment for patients with rare subtypes of relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL): Updated efficacy and safety analyses from a dedicated cohort of the ELM-2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Aggressive lymphoma; Follicular lymphoma; Lymphoma; Cohort; Dosing; Mantle cell lymphoma; Prospective cohort study; Adverse effect","score_opus":0.01020518810993391,"score_gpt":0.2701855490575468,"score_spread":0.2599803609476129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947073,0.0013121967,0.0000064848914,0.000060569793,0.000053585973,0.0032328416,0.00038471722,0.000021952641,0.00022036546],"genre_scores_gemma":[0.9987851,0.0001877765,0.00022608972,0.000036451103,0.000015703397,0.0002078062,0.00038671753,0.000023446106,0.00013092464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848235,0.00008879588,0.0004889325,0.0004358464,0.0003054228,0.0001986438],"domain_scores_gemma":[0.9982077,0.00034580924,0.00051372027,0.0005953596,0.00024995988,0.00008749098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006520823,0.00028967252,0.00075255526,0.00011979605,0.000108361106,0.000009928471,0.00012173625,0.00010094953,0.000020411067],"category_scores_gemma":[0.00007159964,0.00015787268,0.00013997368,0.00033052274,0.00012362075,0.000039140923,0.00006626847,0.00003910867,0.0000011071016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033052058,0.03848477,0.94827396,0.000055017746,0.0043527526,0.00002655376,0.00047658477,0.0000037948666,0.00068628776,0.0000026665246,0.00014757953,0.004184848],"study_design_scores_gemma":[0.089969955,0.0046307337,0.8488796,0.00038052964,0.007065408,0.0000014378758,0.00021744093,0.0000147206265,0.048610754,0.0000048012876,0.00011266739,0.0001119588],"about_ca_topic_score_codex":0.00086851517,"about_ca_topic_score_gemma":0.000092384944,"teacher_disagreement_score":0.099394344,"about_ca_system_score_codex":0.00013260181,"about_ca_system_score_gemma":0.00031585293,"threshold_uncertainty_score":0.64378613},"labels":[],"label_agreement":null},{"id":"W4417016669","doi":"10.1182/blood-2025-8082","title":"Real-world use of Pola-R-CHP for untreated diffuse large B-cell lymphoma (DLBCL): A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Systematic review; MEDLINE; Prednisone; Lymphoma; Meta-analysis; Clinical trial; Cochrane Library; Adverse effect","score_opus":0.0130026048439279,"score_gpt":0.2741083363861438,"score_spread":0.2611057315422159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6239722,0.3562328,0.000034125856,0.0019435632,0.00032413178,0.010950995,0.0009487742,0.00026253593,0.0053309184],"genre_scores_gemma":[0.91861486,0.062248636,0.0011678374,0.0025898474,0.000081692255,0.0011987858,0.0005054012,0.00005763494,0.013535311],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984281,0.00008664518,0.0006348913,0.00033472423,0.00020636822,0.0003092727],"domain_scores_gemma":[0.99831194,0.00037729865,0.00022877417,0.00071680284,0.00024144021,0.00012372958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000179312,0.00026348088,0.0010591534,0.00021309666,0.00006381496,0.000040762796,0.00009992182,0.00010232833,0.000011243752],"category_scores_gemma":[0.00023562467,0.00018532903,0.00036937502,0.000707354,0.000022099664,0.000073898096,0.000045411347,0.000041956257,0.0000131925535],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030550582,0.09022738,0.06201429,0.8077908,0.0028915482,0.00064976944,0.0003647285,9.777508e-8,0.001146518,0.008022381,0.025720263,0.00086669764],"study_design_scores_gemma":[0.173564,0.001101479,0.03950526,0.71380675,0.023640402,0.00018234523,0.000054335822,0.00010183541,0.02886748,0.000096900796,0.018461013,0.00061817665],"about_ca_topic_score_codex":0.00007991182,"about_ca_topic_score_gemma":0.000046673213,"teacher_disagreement_score":0.2946427,"about_ca_system_score_codex":0.00010681005,"about_ca_system_score_gemma":0.0001606329,"threshold_uncertainty_score":0.7557499},"labels":[],"label_agreement":null},{"id":"W4417016716","doi":"10.1182/blood-2025-52","title":"EZH2 and CREBBP mutation status identify a subset of patients who benefit from bendamustine- over CHOP/CVP-based immunochemotherapies in follicular lymphoma: Findings from the GALLIUM trial and validation in a large international cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bendamustine; Obinutuzumab; Cohort; Rituximab; Follicular lymphoma; Chemoimmunotherapy; Clinical trial; Proportional hazards model","score_opus":0.005904439077180711,"score_gpt":0.25681821949520606,"score_spread":0.25091378041802537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735546,0.0009065378,0.000010738447,0.00024059278,0.00012320389,0.0008040278,0.00052630366,0.000008555913,0.000024555626],"genre_scores_gemma":[0.99789673,0.0002755551,0.00011994751,0.00016107033,0.00003087099,0.00011077555,0.0013833418,0.00001004947,0.000011635203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989158,0.000043856853,0.00036738097,0.0002715702,0.0002581703,0.00014324431],"domain_scores_gemma":[0.9993602,0.0002676681,0.00011663766,0.00015591443,0.000069113536,0.000030456917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015177547,0.00014036169,0.00028289718,0.00014561138,0.000035920322,0.000047142406,0.000056603876,0.00008620731,0.00004985784],"category_scores_gemma":[0.0001389791,0.00011018292,0.00005346253,0.00015910366,0.00003284165,0.000091550435,0.000039638388,0.00004592515,6.3353264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025847265,0.0018808271,0.9931964,0.000015976519,0.0003356256,0.000011824428,0.0006537648,0.000002489348,0.0004178936,0.000041880325,0.000036515255,0.00082201895],"study_design_scores_gemma":[0.13118249,0.00011750016,0.8609036,0.00025458747,0.0002544797,2.9856838e-7,0.000097234515,0.00020283433,0.006686273,0.00015403345,0.000075847085,0.000070768714],"about_ca_topic_score_codex":0.0044797393,"about_ca_topic_score_gemma":0.0005832737,"teacher_disagreement_score":0.1322928,"about_ca_system_score_codex":0.000113440816,"about_ca_system_score_gemma":0.00007397856,"threshold_uncertainty_score":0.67720556},"labels":[],"label_agreement":null},{"id":"W4417016745","doi":"10.1182/blood-2025-7188","title":"Radiotherapy consolidation post-autologous stem cell transplant in Relapsed/Refractory aggressive non-Hodgkin lymphoma improves progression-free and overall survival in patients with partial but not complete metabolic response pre-transplant","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Aggressive lymphoma; Radiation therapy; Proportional hazards model; Lymphoma; Autologous stem-cell transplantation; Chemotherapy; Salvage therapy; Stem cell; Cohort; Prognostic variable","score_opus":0.006319775147884242,"score_gpt":0.2346033067782472,"score_spread":0.22828353163036297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505913,0.002072553,0.000018321853,0.00044082513,0.00013496178,0.0017571935,0.00043257096,0.00004658998,0.000037854777],"genre_scores_gemma":[0.9984987,0.00042576581,0.0002867263,0.00027992117,0.000025340512,0.0002682491,0.0001389658,0.00003286619,0.000043487787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977024,0.00034994353,0.0005420862,0.0005816835,0.00038788616,0.00043596982],"domain_scores_gemma":[0.9986451,0.00042699504,0.00025411687,0.00044906788,0.00008430583,0.00014041422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002777838,0.00037653735,0.00074987044,0.00033069626,0.0000804909,0.000038418522,0.00014462684,0.00019599524,0.0000066846496],"category_scores_gemma":[0.000024433908,0.00027344597,0.00007884231,0.00020300475,0.00012485548,0.00010484266,0.000029612294,0.00014381848,0.0000016284843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045097563,0.007857392,0.9107889,0.000217188,0.0004038492,0.0011990183,0.0023729128,0.000008365231,0.020463651,0.00007198369,0.000010527222,0.011508668],"study_design_scores_gemma":[0.074028194,0.0024379452,0.8887418,0.0009671295,0.00037970446,0.000032086824,0.00006327535,0.00009712336,0.032917317,0.000009839381,0.00007528002,0.00025029847],"about_ca_topic_score_codex":0.00043927584,"about_ca_topic_score_gemma":0.00017113925,"teacher_disagreement_score":0.028930634,"about_ca_system_score_codex":0.00014801424,"about_ca_system_score_gemma":0.0004104559,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4417017803","doi":"10.1182/blood-2025-129","title":"PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"ABVD; Hodgkin lymphoma; Clinical trial; Disease; Proportional hazards model; Stage (stratigraphy); Lymphoma; International Prognostic Index; Interim analysis","score_opus":0.04745001400502891,"score_gpt":0.3630787663845383,"score_spread":0.3156287523795094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846215,0.0059634396,0.0027486815,0.0008205152,0.00008827139,0.001188792,0.0006403865,0.00004332961,0.000044461915],"genre_scores_gemma":[0.99828833,0.00023777259,0.00083086506,0.00010251966,0.000025589114,0.0002714924,0.00004194917,0.000029665913,0.00017183177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985681,0.00009685702,0.00030026335,0.00038582276,0.00022518895,0.0004237633],"domain_scores_gemma":[0.99808615,0.0009177796,0.00019194276,0.0005031463,0.00015613306,0.00014482821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026366184,0.00032135533,0.00048936903,0.000061946084,0.0004308846,0.00008947241,0.00017448018,0.0000342744,0.0000033016618],"category_scores_gemma":[0.00010458854,0.00017395029,0.00035531254,0.00021286105,0.00032757394,0.000106526924,0.00007444812,0.00008307309,7.9561084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017337648,0.009303574,0.8981662,0.00029487142,0.0071836333,0.00015844124,0.004403758,0.04150233,0.0016959228,0.0011722905,0.0003401592,0.018441182],"study_design_scores_gemma":[0.051932726,0.00074459385,0.76711655,0.00040686544,0.0018862226,0.0000043004084,0.0024568802,0.17226972,0.0027267633,0.00014909015,0.000043406544,0.00026288934],"about_ca_topic_score_codex":0.0005716173,"about_ca_topic_score_gemma":0.00032628104,"teacher_disagreement_score":0.13104963,"about_ca_system_score_codex":0.00014715706,"about_ca_system_score_gemma":0.0007425196,"threshold_uncertainty_score":0.7093487},"labels":[],"label_agreement":null},{"id":"W4417017817","doi":"10.1182/blood-2025-140","title":"Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Somatic hypermutation; Pathogenesis; BCL6; B cell; Mutation; Phenocopy","score_opus":0.012964988583459906,"score_gpt":0.237054735305634,"score_spread":0.2240897467221741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98006123,0.0133348955,0.00006455667,0.00053309364,0.00006852624,0.00064639683,0.0000438329,0.000086242726,0.0051611983],"genre_scores_gemma":[0.99669105,0.00091880717,0.00040616433,0.0004051827,0.00007296271,0.00013075401,0.000030866086,0.000027119373,0.0013171041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845177,0.00010145601,0.0002652276,0.0005333865,0.00025990602,0.00038822563],"domain_scores_gemma":[0.99893725,0.00017837196,0.0000679628,0.00060186395,0.00006743849,0.00014713581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016732689,0.00030906024,0.0004816455,0.000086677115,0.00019303715,0.000074278185,0.00009563581,0.00011251582,0.000066751076],"category_scores_gemma":[0.000011271018,0.0002090987,0.000120860495,0.00017572423,0.00017755861,0.00007728327,0.000062451385,0.00007672244,0.00001940138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026560313,0.023278184,0.95794374,0.00037709225,0.0006712655,0.000821281,0.0015302174,3.395727e-7,0.0026126239,0.006105798,0.000085380074,0.0063085053],"study_design_scores_gemma":[0.051336925,0.00069211726,0.8363877,0.00028736747,0.00074726675,0.00014885413,0.0011491657,0.00000843083,0.091014214,0.00047323602,0.017407121,0.0003475864],"about_ca_topic_score_codex":0.000054134176,"about_ca_topic_score_gemma":0.000037195066,"teacher_disagreement_score":0.121556,"about_ca_system_score_codex":0.000080772756,"about_ca_system_score_gemma":0.00014149737,"threshold_uncertainty_score":0.8526797},"labels":[],"label_agreement":null},{"id":"W4417018408","doi":"10.1182/blood-2025-4550","title":"Outcomes and treatment strategies following CD20/CD3 bispecific antibody failure in non-Hodgkin's lymphoma: A retrospective single-center study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Retrospective cohort study; Refractory (planetary science); Clinical trial; Rituximab; Lymphoma; Cancer; Antibody; Progressive disease","score_opus":0.012643894072925854,"score_gpt":0.2913683519374613,"score_spread":0.2787244578645354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316704,0.00047376324,0.0000046452565,0.00051908166,0.00017666844,0.001588193,0.000015515698,0.00007018562,0.0039849174],"genre_scores_gemma":[0.9989484,0.00007265046,0.00021622427,0.0000778278,0.000042114956,0.00023713407,0.000028361892,0.000024163914,0.0003531274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983848,0.000053419142,0.0003584267,0.00060132437,0.00024157095,0.00036049503],"domain_scores_gemma":[0.9993002,0.00009171055,0.00006784097,0.00040267612,0.000043131888,0.00009445755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009571172,0.00036664127,0.0007706713,0.0003008421,0.00011514487,0.00013363548,0.000070045266,0.000099308454,0.00001336682],"category_scores_gemma":[0.000025243417,0.00026441575,0.00019831255,0.0003693293,0.000043631913,0.0001441773,0.000067367495,0.00005679981,0.000009788587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009325017,0.024888085,0.9675925,0.000022823117,0.0013950899,0.0013986945,0.0013500861,3.9781676e-7,0.0007643318,0.00016735349,0.000038782706,0.0022886086],"study_design_scores_gemma":[0.04691411,0.0021858292,0.9432124,0.00021394072,0.00079332327,0.000028627917,0.0052254642,0.0000040620494,0.00090405287,0.00006251548,0.00027293805,0.0001827407],"about_ca_topic_score_codex":0.00046520482,"about_ca_topic_score_gemma":0.0012722132,"teacher_disagreement_score":0.04682086,"about_ca_system_score_codex":0.0005111786,"about_ca_system_score_gemma":0.00015330446,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W4417018967","doi":"10.1182/blood-2025-1860","title":"Favorable safety and efficacy in a phase II trial using duvelisib maintenance after autologous stem cell transplant in T-cell and B-cell non-Hodgkin lymphomas","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Maintenance therapy; Lymphoma; Phases of clinical research; Clinical trial; Adverse effect; Dosing; Stem cell; Safety profile","score_opus":0.009838374246912229,"score_gpt":0.2522366914532227,"score_spread":0.24239831720631047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250674,0.0039733225,0.00002996501,0.00016859261,0.00011305901,0.001295194,0.00004919906,0.000024489014,0.0018394153],"genre_scores_gemma":[0.99771583,0.0009547027,0.00042265933,0.0001943619,0.000031787775,0.00008269054,0.00001312531,0.000020660613,0.00056420354],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983272,0.000073271796,0.0005177042,0.00052034867,0.00013985981,0.0004216037],"domain_scores_gemma":[0.9993609,0.00015049544,0.00008324447,0.0002553685,0.000022560444,0.00012743408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002352514,0.0002809254,0.00064979075,0.00023043266,0.00007730203,0.000029033967,0.000061483566,0.00016576855,0.0000133994845],"category_scores_gemma":[0.0000074171294,0.00023118481,0.00007735539,0.0002748631,0.000063063795,0.00006369416,0.000057219422,0.00012394416,0.000002803493],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23507127,0.23576409,0.3591297,0.003904401,0.00062239886,0.024449965,0.017573886,0.00014701094,0.057472177,0.00018484924,0.00040136767,0.06527889],"study_design_scores_gemma":[0.8710412,0.0033558055,0.05470221,0.0013510633,0.0008704751,0.00015005631,0.000313497,0.0013705052,0.06536159,0.00001954007,0.0010359456,0.00042812835],"about_ca_topic_score_codex":0.00045219227,"about_ca_topic_score_gemma":0.00012275706,"teacher_disagreement_score":0.63596994,"about_ca_system_score_codex":0.0001576106,"about_ca_system_score_gemma":0.00027065683,"threshold_uncertainty_score":0.94274426},"labels":[],"label_agreement":null},{"id":"W4417019203","doi":"10.1182/blood-2025-351","title":"Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Somatic hypermutation; Circulating tumor DNA; Germline; Circulating tumor cell; Stage (stratigraphy); Digital polymerase chain reaction; Lymphoma; Nivolumab; Hodgkin lymphoma","score_opus":0.0136591892245383,"score_gpt":0.28789300236431237,"score_spread":0.2742338131397741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979577,0.00016581692,0.000003741381,0.0001782521,0.00002716673,0.0010572356,0.00008977392,0.000058246627,0.0004620415],"genre_scores_gemma":[0.9986442,0.000004306981,0.0006036253,0.00032285287,0.0000124307,0.00019268534,0.000057923422,0.000038683353,0.00012332258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980636,0.00013234731,0.00048075223,0.0005413891,0.00042736626,0.0003545166],"domain_scores_gemma":[0.99872315,0.00020081713,0.00019297247,0.0005501576,0.00018998446,0.00014293952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000087597975,0.00033252838,0.0007527973,0.0005228967,0.000059399346,0.00002753485,0.00011657641,0.000040125113,0.000027138938],"category_scores_gemma":[0.00033547965,0.00025406125,0.00012808817,0.0009210613,0.000044183475,0.00006387518,0.000050124083,0.00005998323,0.000007237565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028537195,0.005089839,0.9148373,0.00018333641,0.0005168024,0.003437042,0.00014601406,0.00021147208,0.070515305,0.000027432183,0.0000086004975,0.0021731546],"study_design_scores_gemma":[0.019584186,0.0014911362,0.71716,0.0012259412,0.00042810527,0.000009868486,0.000266635,0.000020845575,0.25961444,0.0000020260575,0.000028742572,0.00016806085],"about_ca_topic_score_codex":0.00031681717,"about_ca_topic_score_gemma":0.00005018793,"teacher_disagreement_score":0.19767727,"about_ca_system_score_codex":0.00027339198,"about_ca_system_score_gemma":0.0003102665,"threshold_uncertainty_score":0.9999912},"labels":[],"label_agreement":null},{"id":"W4417019216","doi":"10.1182/blood-2025-352","title":"Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mantle cell lymphoma; Gene signature; Proportional hazards model; Hazard ratio; Lymphoma; Gene; Cancer; Gene expression profiling; DNA sequencing","score_opus":0.007545335341883648,"score_gpt":0.24144168625415277,"score_spread":0.23389635091226912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887604,0.006154192,0.00006847157,0.00013740185,0.00019139975,0.00040860893,0.00014515729,0.000044638466,0.004089737],"genre_scores_gemma":[0.99469656,0.0006162472,0.0028346577,0.00009290397,0.000028275617,0.000053382282,0.000066773464,0.000016189295,0.0015949996],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873656,0.000028462679,0.0003717674,0.00029253575,0.00030419236,0.00026645485],"domain_scores_gemma":[0.9990548,0.00011625956,0.00018560431,0.0004674993,0.00008417957,0.000091660404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008266422,0.00021516094,0.00045219186,0.00012236107,0.00007786351,0.000017455934,0.00010044745,0.00016753715,0.00006914389],"category_scores_gemma":[0.00004849824,0.00015180698,0.00018998688,0.00014196146,0.000040949075,0.000046775673,0.0000910084,0.00008748882,0.000013405563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013045006,0.010140345,0.5883404,0.00017809449,0.00047367535,0.00007957037,0.00026855688,0.0000064346164,0.3972715,0.00012340526,0.00040238677,0.0025851803],"study_design_scores_gemma":[0.010163578,0.000121467216,0.44093224,0.00010504523,0.00042445093,0.000006531757,0.00012870955,0.000003234256,0.5477501,0.000033632725,0.00025990064,0.00007110821],"about_ca_topic_score_codex":0.0003228073,"about_ca_topic_score_gemma":0.00001858707,"teacher_disagreement_score":0.15047859,"about_ca_system_score_codex":0.00006613463,"about_ca_system_score_gemma":0.00020308905,"threshold_uncertainty_score":0.61905086},"labels":[],"label_agreement":null},{"id":"W4417019334","doi":"10.1182/blood-2025-784","title":"Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Clinical endpoint; Diffuse large B-cell lymphoma; Clinical trial; Retrospective cohort study; Geriatric oncology; Surrogate endpoint; Activities of daily living; Survival analysis; Subgroup analysis","score_opus":0.006616230252781837,"score_gpt":0.27263158721558056,"score_spread":0.2660153569627987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955024,0.0012774493,0.0000022189772,0.00011264828,0.00001864346,0.00044304435,0.000082984734,0.000017159982,0.0025434413],"genre_scores_gemma":[0.9986896,0.0002884261,0.00032854613,0.000060536368,0.000010195089,0.000026084466,0.000032506887,0.0000148504105,0.00054923724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990478,0.000025366386,0.00032325287,0.00023293817,0.00016030717,0.00021032],"domain_scores_gemma":[0.9992837,0.00011986464,0.00011596076,0.0003337638,0.000060014525,0.00008673722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058291964,0.00018583718,0.0006033899,0.000240098,0.000018212617,0.0000048815027,0.00005405513,0.00006540913,0.000024392479],"category_scores_gemma":[0.000027642429,0.00011563113,0.00011540642,0.00026384168,0.00004626936,0.000038334172,0.000047121852,0.000043198128,0.0000012017646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047558185,0.023058947,0.9736276,0.00019730125,0.00040867363,0.00006467973,0.0004941974,2.9192435e-7,0.00020578963,0.00011031315,0.00012271905,0.0012338797],"study_design_scores_gemma":[0.09519089,0.000546766,0.89575636,0.00051317684,0.00038646595,0.0000042905904,0.00012409086,0.000027667653,0.0073302267,0.000014960755,0.000023964449,0.00008112681],"about_ca_topic_score_codex":0.0048770313,"about_ca_topic_score_gemma":0.0016836092,"teacher_disagreement_score":0.094715305,"about_ca_system_score_codex":0.00009325302,"about_ca_system_score_gemma":0.00019959852,"threshold_uncertainty_score":0.7372645},"labels":[],"label_agreement":null},{"id":"W4417019424","doi":"10.1182/blood-2025-353","title":"Integrated multi-omic profiling reveals two biologically distinct subgroups of splenic marginal zone lymphoma with prognostic relevance","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Splenic marginal zone lymphoma; Malignancy; Epigenetics; DNA methylation; CDKN2A; CpG site; Proportional hazards model; Cohort; Survival analysis","score_opus":0.015311901334553112,"score_gpt":0.26673766939455806,"score_spread":0.25142576806000494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956948,0.0016682791,0.0005124759,0.0002465604,0.000054259315,0.0010962556,0.00004846881,0.00010110083,0.00057776505],"genre_scores_gemma":[0.9790595,0.00011144752,0.019818462,0.00011259903,0.00003480339,0.00022935451,0.000129511,0.000018661567,0.00048563658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985508,0.00006826825,0.00043141254,0.00044787154,0.00017728982,0.0003243941],"domain_scores_gemma":[0.9988704,0.00029959064,0.00016868138,0.0003663258,0.00019830588,0.000096711185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001604852,0.00026435076,0.0005700316,0.000108476255,0.00006366792,0.000015225975,0.00012087772,0.00008866471,0.000026430627],"category_scores_gemma":[0.00037156444,0.00016224952,0.000107898544,0.00042797517,0.00012589582,0.00003588462,0.00005330208,0.00008314349,0.000016825144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006620682,0.004781377,0.9716629,0.00026186506,0.00046212407,0.00030167302,0.000028175979,0.0000018709012,0.012997997,0.0008332308,0.000039064613,0.007967669],"study_design_scores_gemma":[0.021521455,0.0014231371,0.9243156,0.0014995026,0.0010457512,0.00016353943,0.000052336116,0.00017525758,0.049377564,0.00006594608,0.00017288172,0.00018705733],"about_ca_topic_score_codex":0.00013276712,"about_ca_topic_score_gemma":0.00006532643,"teacher_disagreement_score":0.04734731,"about_ca_system_score_codex":0.00011324907,"about_ca_system_score_gemma":0.00028913186,"threshold_uncertainty_score":0.6616343},"labels":[],"label_agreement":null},{"id":"W4417065537","doi":"10.1016/s0140-6736(25)01778-7","title":"Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"Incyte","keywords":"Rituximab; Follicular lymphoma; Refractory (planetary science); Randomized controlled trial; Follicular phase; Lymphoma","score_opus":0.022994172911965826,"score_gpt":0.3258974189189807,"score_spread":0.3029032460070149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417065537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779023,0.003945178,0.000011912716,0.008211105,0.00027967108,0.0044502965,0.000030167832,0.00005715443,0.0051122173],"genre_scores_gemma":[0.9945665,0.0007446074,0.00012367273,0.0023424376,0.00034824573,0.0010241074,0.00001871323,0.000011794211,0.0008199377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983038,0.00027322635,0.00050661544,0.00033128934,0.00023295017,0.00035217553],"domain_scores_gemma":[0.9984316,0.00071059336,0.00013943673,0.00057897076,0.000047677844,0.00009172519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072902226,0.00024735977,0.0015881908,0.00007816676,0.00010316651,0.000053806154,0.00015059295,0.00012529845,0.00006416612],"category_scores_gemma":[0.0007208424,0.00012808567,0.00021361992,0.00030078748,0.00010107653,0.00004406587,0.00005035413,0.00008723897,0.000020357913],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9629037,0.005350549,0.0013898491,0.000052551717,0.00064041873,0.0004574923,0.000112983515,6.944972e-7,0.00009348407,0.00062007806,0.01179001,0.016588235],"study_design_scores_gemma":[0.98074,0.0008712246,0.0039696093,0.00025366433,0.0007119087,0.000039463852,0.00007332564,0.00021194678,0.00030672346,0.00033564988,0.012361217,0.00012527434],"about_ca_topic_score_codex":0.00015815493,"about_ca_topic_score_gemma":0.000082223894,"teacher_disagreement_score":0.01783634,"about_ca_system_score_codex":0.00031614653,"about_ca_system_score_gemma":0.00033514976,"threshold_uncertainty_score":0.5223182},"labels":[],"label_agreement":null},{"id":"W4417065789","doi":"10.1016/s0140-6736(25)01965-8","title":"A new standard for relapsed or refractory follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Rituximab; Refractory (planetary science); Lenalidomide; Lymphoma; Follicular phase","score_opus":0.02928612709321546,"score_gpt":0.3167678987511604,"score_spread":0.2874817716579449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417065789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7620902,0.012162643,0.0058061597,0.15650225,0.0015009834,0.004338433,0.00026537746,0.0005144733,0.056819454],"genre_scores_gemma":[0.9389187,0.0008425502,0.008898087,0.011361326,0.001321996,0.00033045927,0.00005430439,0.00003078677,0.038241755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935657,0.000020355257,0.0001331679,0.00015762432,0.0001267373,0.00020552159],"domain_scores_gemma":[0.99916625,0.0001921278,0.00003800686,0.00050514686,0.000040621053,0.00005781912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014712753,0.00010422555,0.0003740877,0.000029659199,0.000084797284,0.000022759988,0.00011228706,0.000051498617,0.00009722757],"category_scores_gemma":[0.00013102211,0.000051618747,0.00010702959,0.00012387858,0.000021097303,0.000022492379,0.000026433412,0.000030648895,0.000024939458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054717646,0.00016996449,0.007243296,0.00009852371,0.00043038992,0.00005660948,0.00017537922,0.000001098198,0.00019511502,0.008294108,0.81608415,0.16177963],"study_design_scores_gemma":[0.01848653,0.0005201884,0.03713107,0.00019978358,0.00030242256,0.000013418155,0.000048004455,0.000023086775,0.0034399515,0.0017197538,0.93804747,0.00006830453],"about_ca_topic_score_codex":0.00007116779,"about_ca_topic_score_gemma":0.000031590236,"teacher_disagreement_score":0.1768285,"about_ca_system_score_codex":0.00019258707,"about_ca_system_score_gemma":0.00039281315,"threshold_uncertainty_score":0.21049514},"labels":[],"label_agreement":null},{"id":"W4417129959","doi":"10.58931/cht.2025.4377","title":"New Developments in the Front‑line Treatment of Advanced Stage Classic Hodgkin Lymphoma: A Canadian Perspective","year":2025,"lang":"","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Perspective (graphical); Stage (stratigraphy); Clinical trial; Hodgkin lymphoma; MEDLINE; Paradigm shift","score_opus":0.015418309164467054,"score_gpt":0.2833311281488873,"score_spread":0.2679128189844202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417129959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6521031,0.10262193,0.000035776106,0.08063466,0.0032721173,0.0076618805,0.0012157724,0.000046981168,0.15240774],"genre_scores_gemma":[0.98321503,0.0015562185,0.00055163814,0.0031528098,0.000078106954,0.00041017323,0.00012404534,0.00004401872,0.010867961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954802,0.0003440482,0.0010744433,0.0010379811,0.0002900205,0.0017733462],"domain_scores_gemma":[0.99625146,0.00047935874,0.00025716808,0.0010768516,0.00025070691,0.0016844742],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025229933,0.00079150905,0.0016571523,0.0018029764,0.00036246536,0.00004466143,0.0005104703,0.00060903275,0.0010435425],"category_scores_gemma":[0.00026495146,0.0006226293,0.00030435566,0.0011400045,0.00030419944,0.00010272564,0.000033014556,0.00017267052,0.00019057044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005997862,0.002628491,0.5762137,0.00026000777,0.0035238634,0.014792834,0.037886444,0.000053188756,0.000017644048,0.17708193,0.02906573,0.15787636],"study_design_scores_gemma":[0.03235428,0.00187919,0.58465636,0.0014381827,0.0012172565,0.00036096698,0.032041837,0.000081878265,0.0024288883,0.0014277601,0.3411889,0.00092449004],"about_ca_topic_score_codex":0.9751334,"about_ca_topic_score_gemma":0.99780995,"teacher_disagreement_score":0.33111188,"about_ca_system_score_codex":0.021313071,"about_ca_system_score_gemma":0.049823444,"threshold_uncertainty_score":0.99986964},"labels":[],"label_agreement":null},{"id":"W4417187153","doi":"10.1080/14796694.2025.2599082","title":"Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; Jewish General Hospital","funders":"Seagen; Bristol-Myers Squibb","keywords":"Nivolumab; Brentuximab vedotin; Lymphoma; Ipilimumab; Chemoimmunotherapy; Immunotherapy","score_opus":0.009151288919165883,"score_gpt":0.2901132775739707,"score_spread":0.2809619886548048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417187153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8652391,0.011658593,0.00037920312,0.019221934,0.0065623447,0.0026379016,0.00020141651,0.0003203398,0.0937792],"genre_scores_gemma":[0.97321844,0.0006131826,0.0014108851,0.0057729017,0.0012121194,0.00059118797,0.0002931165,0.00004447296,0.016843684],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834156,0.000075519085,0.0003736603,0.00050530536,0.00015673893,0.000547238],"domain_scores_gemma":[0.9987587,0.00030818803,0.0001416526,0.00049195066,0.00012809214,0.0001714538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001589285,0.00028460973,0.00070283015,0.0001746407,0.00018427156,0.000017447337,0.00015021191,0.0004681401,0.00013737133],"category_scores_gemma":[0.00006792293,0.00023160568,0.0002939237,0.00020066636,0.000060790768,0.00005150207,0.0000907816,0.00013065146,0.0001368743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005410805,0.06318782,0.01234014,0.0006779583,0.00081664504,0.00075681147,0.0010526433,7.0793214e-7,0.0011363443,0.015798166,0.6813858,0.21743613],"study_design_scores_gemma":[0.11391326,0.001987825,0.017022148,0.000067026165,0.00046616167,0.00004819122,0.00040698095,0.00008168562,0.0013280578,0.0001374021,0.86437315,0.00016811515],"about_ca_topic_score_codex":0.00004546941,"about_ca_topic_score_gemma":0.00014266407,"teacher_disagreement_score":0.21726802,"about_ca_system_score_codex":0.001685316,"about_ca_system_score_gemma":0.0011619017,"threshold_uncertainty_score":0.9444605},"labels":[],"label_agreement":null},{"id":"W4417256274","doi":"10.1182/bloodadvances.2025018527","title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"Pharmacyclics; Genentech; Incyte; Ipsen; BeiGene; Regeneron Pharmaceuticals; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rituximab; Mantle cell lymphoma; Retrospective cohort study; Lymphoma; Maintenance therapy; Clinical trial; Overall survival","score_opus":0.0024159603800341634,"score_gpt":0.2047243923878011,"score_spread":0.20230843200776694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417256274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894468,0.0059323134,0.000022202146,0.00037470597,0.000100798585,0.0005487345,0.00008788818,0.000028725479,0.0034577881],"genre_scores_gemma":[0.99573445,0.00057644997,0.0024234368,0.00026174771,0.000026095806,0.00015954675,0.000044219676,0.000018594981,0.00075543625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864876,0.000010110316,0.00037719018,0.00038607803,0.00025627523,0.00032160585],"domain_scores_gemma":[0.99923867,0.00007195742,0.00012712863,0.00034630802,0.00014525506,0.00007068551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045837816,0.00024173585,0.0005412969,0.00016126543,0.000040016363,0.000010003243,0.0000994965,0.00006313594,0.0000530573],"category_scores_gemma":[0.000024716157,0.00017120858,0.00008347295,0.0003419929,0.00008238197,0.00013401946,0.000056501707,0.000050167455,0.000016184615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012327688,0.018265758,0.9621172,0.00042369362,0.00007670835,0.000116180665,0.000058847112,0.000022738754,0.000005485266,0.00019460743,0.00006924057,0.017416758],"study_design_scores_gemma":[0.068560116,0.00089152186,0.91612285,0.0011459138,0.0003004931,0.0000047298613,0.000042450636,0.000018522624,0.006277842,0.00021184002,0.0062478962,0.00017579908],"about_ca_topic_score_codex":0.00009077272,"about_ca_topic_score_gemma":0.00042688695,"teacher_disagreement_score":0.06732735,"about_ca_system_score_codex":0.00008766668,"about_ca_system_score_gemma":0.00007647561,"threshold_uncertainty_score":0.69816834},"labels":[],"label_agreement":null},{"id":"W4417290288","doi":"10.1016/j.ijrobp.2025.12.005","title":"Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; BC Cancer Agency","funders":"National Institute of Biomedical Imaging and Bioengineering; GE Healthcare; National Cancer Institute; National Institutes of Health; American Radium Society; U.S. Department of Defense; Society of Nuclear Medicine and Molecular Imaging; St. Baldrick's Foundation; American Society of Hematology; Children’s Oncology Group; Lymphoma Research Foundation","keywords":"Radiation therapy; Hodgkin lymphoma; Radiation treatment planning; Volume (thermodynamics); Computed tomography; Multimodality","score_opus":0.03906739976952554,"score_gpt":0.3802946831017202,"score_spread":0.34122728333219465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417290288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8744831,0.0011869291,0.11667541,0.0033207093,0.0034437615,0.00066504703,0.00015073756,0.00003307739,0.00004121764],"genre_scores_gemma":[0.9781733,0.00604914,0.010464426,0.0012140741,0.0035186058,0.00007784193,0.00045547483,0.000022352006,0.000024794133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966948,0.0004886817,0.0018670432,0.00039658934,0.00027970952,0.0002731468],"domain_scores_gemma":[0.9957049,0.0013032175,0.0015478837,0.00020350823,0.0011161002,0.00012438993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017796172,0.00025891003,0.0007166428,0.00042600223,0.00009621191,0.00004396947,0.00028663524,0.00042967778,0.000038269758],"category_scores_gemma":[0.0014401028,0.00022872507,0.000426225,0.00038508337,0.0001211545,0.00028393228,0.00004709469,0.0003070996,0.000027292717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009549566,0.0014153647,0.5616596,0.000006305921,0.00028640803,0.000009411398,0.00010567427,0.0010624364,0.000040643143,0.004656669,0.0004179754,0.42938456],"study_design_scores_gemma":[0.011332962,0.0019384224,0.8882687,0.000044086933,0.00030955073,0.000012713461,0.00005798792,0.050776865,0.0016660212,0.034110125,0.011261845,0.00022072712],"about_ca_topic_score_codex":0.00021188274,"about_ca_topic_score_gemma":0.000035131277,"teacher_disagreement_score":0.42916384,"about_ca_system_score_codex":0.0014669718,"about_ca_system_score_gemma":0.0013212726,"threshold_uncertainty_score":0.93271375},"labels":[],"label_agreement":null},{"id":"W48324117","doi":"10.4049/jimmunol.186.supp.153.9","title":"A simple and fast method for the enrichment of lymphoid progenitors from mouse bone marrow (153.9)","year":2011,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Progenitor cell; Cell sorting; Biology; Flow cytometry; Population; Bone marrow; Immunomagnetic separation; Immunology; Lymphopoiesis; Molecular biology; Progenitor; Cell biology; Stem cell; Medicine","score_opus":0.024912172224916013,"score_gpt":0.28054009837978205,"score_spread":0.25562792615486607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48324117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98360765,0.013793095,0.0010097427,0.0009707208,0.00015530438,0.0003743162,0.000018143455,0.000004334432,0.00006672005],"genre_scores_gemma":[0.992755,0.0018279945,0.005043768,0.00017140586,0.000086879605,0.000021880089,0.000002238098,0.000012337816,0.000078520316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991521,0.00013118514,0.00038005135,0.00007114228,0.000112912945,0.00015258239],"domain_scores_gemma":[0.99856824,0.0006282106,0.0003886282,0.00024069044,0.00013486897,0.000039368504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050428335,0.00010944794,0.00036190182,0.000054995828,0.00007370231,0.0000039340803,0.00013467333,0.000058570324,0.00006530276],"category_scores_gemma":[0.00007887676,0.000048775997,0.00012697485,0.000051592906,0.00012749105,0.000031972784,0.000054740325,0.00007901121,0.0000020137932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015648445,0.0035300255,0.12173655,0.00007721166,0.012449995,0.00012112397,0.019524645,0.000008848236,0.5535851,0.001132467,0.0034727072,0.26871285],"study_design_scores_gemma":[0.014979655,0.006176419,0.23430909,0.000085045314,0.0032851526,0.0028937066,0.005631361,0.0001148965,0.72324866,0.0022359667,0.0068789087,0.00016112701],"about_ca_topic_score_codex":0.00056905753,"about_ca_topic_score_gemma":0.000014651864,"teacher_disagreement_score":0.2685517,"about_ca_system_score_codex":0.00006687242,"about_ca_system_score_gemma":0.00008804279,"threshold_uncertainty_score":0.19890274},"labels":[],"label_agreement":null},{"id":"W569817895","doi":"","title":"British Columbia Cancer Agency/Centre for Lymphoid Cancer (抗がん剤治療の最前線 : 分子標的薬剤の使用による進歩(前篇)) -- (世界のがん診療施設の紹介と今後の展望)","year":2012,"lang":"ja","type":"article","venue":"最新医学","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Agency (philosophy); International agency; Medicine; Sociology; Internal medicine; Social science","score_opus":0.020563560729093308,"score_gpt":0.28765327228346566,"score_spread":0.26708971155437233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W569817895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8387553,0.13951315,0.000010466515,0.0027099573,0.008270143,0.0031058593,0.0027808757,0.0001832723,0.0046709776],"genre_scores_gemma":[0.8683207,0.02221058,0.00027183793,0.002656033,0.005847987,0.0021413385,0.00032118996,0.00020357191,0.09802673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99481547,0.00012177415,0.0009278508,0.0010441571,0.0007563874,0.0023343603],"domain_scores_gemma":[0.9967631,0.00029254967,0.0004244749,0.00083725207,0.00041394538,0.0012686949],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037947725,0.00064737734,0.0012536886,0.00008572971,0.0005089734,0.00043649494,0.000351107,0.0005272699,0.03859473],"category_scores_gemma":[0.00014779496,0.0008575775,0.0007124728,0.00043817316,0.00021371637,0.000418678,0.00016832673,0.00021346626,0.00052630546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009643462,0.0019355799,0.5665152,0.0004897411,0.0009776946,0.00009903418,0.0013338162,0.000003866783,0.00016413892,0.00003238107,0.29819223,0.1301599],"study_design_scores_gemma":[0.009729409,0.00024798998,0.49659327,0.0017409901,0.002435934,0.00009342219,0.00042329408,0.000113074275,0.0012155339,0.000040951763,0.48655733,0.0008088057],"about_ca_topic_score_codex":0.26409507,"about_ca_topic_score_gemma":0.15256485,"teacher_disagreement_score":0.18836509,"about_ca_system_score_codex":0.0022003208,"about_ca_system_score_gemma":0.0011606729,"threshold_uncertainty_score":0.9993875},"labels":[],"label_agreement":null},{"id":"W58957722","doi":"10.1155/2011/605928","title":"Primary Pancreatic Lymphoma: A Rare Cause of Massive Upper Gastrointestinal Hemorrhage","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Duodenum; Fine-needle aspiration; Abdominal pain; Perforation; Surgery; Radiology; Biopsy","score_opus":0.018472743595523696,"score_gpt":0.21701671061921124,"score_spread":0.19854396702368754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W58957722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691206,0.00029689894,0.0001640226,0.0006132422,0.00017986064,0.00015600413,0.000040020925,0.0000047916883,0.0016330732],"genre_scores_gemma":[0.9896317,0.000015901143,0.009231427,0.0008854836,0.000099657365,0.000006706308,0.000011505058,0.000022087279,0.00009552995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851865,0.00008547259,0.00057938823,0.00016109113,0.00014956025,0.00050585426],"domain_scores_gemma":[0.99809617,0.00003790559,0.00042330963,0.00024194711,0.00029663424,0.0009040593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013286047,0.00019977303,0.000676447,0.00039901418,0.000045560686,0.0000070704473,0.00015795273,0.00005730275,0.00053824706],"category_scores_gemma":[0.00009426988,0.00016083076,0.00024963258,0.000083712766,0.00023080404,0.00008404628,0.000017921455,0.000118157,0.000014862584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001176835,0.0002810285,0.9794471,0.00006605685,0.00025930043,0.016105257,0.00029633509,8.194304e-7,0.00020363806,0.000057046163,0.0011537719,0.0009527615],"study_design_scores_gemma":[0.0053839628,0.0065382104,0.9394314,0.00030195812,0.0005347896,0.046899024,0.00016810768,0.0000070984165,0.00050329976,0.000049854352,0.000121778736,0.00006047392],"about_ca_topic_score_codex":0.0018980167,"about_ca_topic_score_gemma":0.0023395116,"teacher_disagreement_score":0.04001571,"about_ca_system_score_codex":0.0004332736,"about_ca_system_score_gemma":0.0011516883,"threshold_uncertainty_score":0.6558488},"labels":[],"label_agreement":null},{"id":"W592038723","doi":"10.1097/moh.0000000000000155","title":"Genomic alterations underlying immune privilege in malignant lymphomas","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Biology; Tumor microenvironment; Immune checkpoint; CIITA; Reprogramming; Ibrutinib; Lymphoma; Antigen presentation; Immune privilege; Cancer research; Immunology; Context (archaeology); Immunotherapy; T cell; Leukemia; Genetics; Chronic lymphocytic leukemia; Gene","score_opus":0.23908150373590129,"score_gpt":0.4466250735577052,"score_spread":0.2075435698218039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W592038723","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016787395,0.99297154,0.000013384031,0.00011723678,0.0044774828,0.0019936839,0.000033945227,0.000041293297,0.0001835519],"genre_scores_gemma":[0.0009224953,0.9962003,0.00010714182,0.000008214793,0.00016917528,0.0013595197,0.0011583051,0.00005582309,0.00001902341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680245,0.00027580617,0.0015180468,0.0006793576,0.00020673028,0.00051758275],"domain_scores_gemma":[0.9985146,0.000234508,0.00040865282,0.0006149008,0.000057219066,0.00017011732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031628585,0.0005282704,0.0028845149,0.0007697352,0.00004401138,0.000023821298,0.00019698845,0.00038990856,0.00007707555],"category_scores_gemma":[0.000070689166,0.00042285307,0.00037698928,0.00044740533,0.0000755076,0.00005884568,0.00015943295,0.0003219597,0.00029970094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020097294,0.0019529779,0.015945228,0.031997938,0.00016488507,0.0001557994,0.00024397986,0.0000017883336,2.5696505e-7,0.020373106,0.0013380293,0.9278059],"study_design_scores_gemma":[0.0026405044,0.00011767765,0.0016053338,0.04515492,0.0002161282,0.0015701762,0.000022673414,0.00003206926,9.2075544e-7,0.0002151011,0.9480732,0.0003513083],"about_ca_topic_score_codex":0.00004964407,"about_ca_topic_score_gemma":0.000018543205,"teacher_disagreement_score":0.94673514,"about_ca_system_score_codex":0.0015160913,"about_ca_system_score_gemma":0.0014438003,"threshold_uncertainty_score":0.9998223},"labels":[],"label_agreement":null},{"id":"W596154374","doi":"10.1371/journal.pone.0127589","title":"Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Follicular lymphoma; International Prognostic Index; Hazard ratio; Performance status; Surgery; Progression-free survival; Nuclear medicine; Oncology; Gastroenterology; Lymphoma; Cancer; Diffuse large B-cell lymphoma; Overall survival; Rituximab; Confidence interval","score_opus":0.03218934973685546,"score_gpt":0.24449094061636997,"score_spread":0.2123015908795145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W596154374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982515,0.00054123445,0.0000011210169,0.0005054443,0.000007203534,0.0005800979,0.000023787557,0.000039678038,0.000049935585],"genre_scores_gemma":[0.99883467,0.0000966613,0.0005854232,0.00016167936,0.000015877713,0.000054759334,0.00002156503,0.000025328143,0.00020400695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987395,0.000087426946,0.0002350706,0.00028076075,0.0004714457,0.00018578625],"domain_scores_gemma":[0.9991646,0.000058514175,0.00008296083,0.00038820723,0.00011109135,0.00019462474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002350985,0.00018281263,0.0005710007,0.00012047072,0.000022727432,0.00001234708,0.000054659093,0.00009343894,0.000024350991],"category_scores_gemma":[0.000048832284,0.00012820706,0.00004833299,0.00013892031,0.00007668622,0.00009321032,0.000022529955,0.000042385313,0.000004702871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032372263,0.0098890085,0.96989244,0.00004154972,0.0007593781,0.00023008049,0.0015131109,2.970927e-7,0.01306175,0.0000056268823,0.000013179854,0.0013563575],"study_design_scores_gemma":[0.019279966,0.0024508266,0.90480626,0.00015668772,0.000264706,0.000023454048,0.00017135686,0.00008027514,0.072612874,0.000010203426,0.000028061202,0.00011533935],"about_ca_topic_score_codex":0.0006670312,"about_ca_topic_score_gemma":0.00004603201,"teacher_disagreement_score":0.065086186,"about_ca_system_score_codex":0.00024052215,"about_ca_system_score_gemma":0.00014135095,"threshold_uncertainty_score":0.5228132},"labels":[],"label_agreement":null},{"id":"W6889906283","doi":"10.3389/fonc.2023.1210945.s001","title":"Presentation_1_The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada.pptx","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Retrospective cohort study; Chemoradiotherapy; Biopsy; Cohort; Overall survival; Radiation therapy","score_opus":0.13454496440737806,"score_gpt":0.38552479002157364,"score_spread":0.2509798256141956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889906283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55946,0.000014053753,4.0135765e-7,0.0000405455,0.000012015196,0.0003891501,0.44000995,0.000016075635,0.00005782527],"genre_scores_gemma":[0.538075,6.5725004e-7,0.00003172807,0.000025448984,0.000012401004,0.000088825815,0.46154958,0.000009614937,0.00020676541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885017,0.000029050818,0.0003050935,0.0003290022,0.0003147251,0.00017197515],"domain_scores_gemma":[0.9982331,0.0004845476,0.0002196045,0.00083971955,0.00009658732,0.00012644292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000036371744,0.00016792901,0.00046761663,0.00021812557,0.00005230441,0.000014426801,0.0001369263,0.000011490223,0.045674648],"category_scores_gemma":[0.00014497929,0.000120339144,0.0002049494,0.00038046748,0.000003047329,0.0000781549,0.000029659259,0.000024736199,0.000010093784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005537044,0.0010570501,0.8943633,0.00009805194,0.0057136994,0.00024759118,0.00030445948,0.029103952,0.000040161754,0.000005196734,0.06657014,0.0019426957],"study_design_scores_gemma":[0.003243908,0.00043643476,0.95301884,0.00030233842,0.0011652615,3.6125493e-7,0.00012353974,0.039275642,0.0010345286,0.000001911237,0.0012985187,0.00009873609],"about_ca_topic_score_codex":0.9703554,"about_ca_topic_score_gemma":0.942227,"teacher_disagreement_score":0.06527162,"about_ca_system_score_codex":0.0012514085,"about_ca_system_score_gemma":0.0011830005,"threshold_uncertainty_score":0.95519775},"labels":[],"label_agreement":null},{"id":"W6902237666","doi":"10.6084/m9.figshare.24847099","title":"Additional file 1 of Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Ibrutinib; Lymphoma; Bendamustine","score_opus":0.039058989535826864,"score_gpt":0.28518833891603346,"score_spread":0.24612934938020659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902237666","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15977809,0.00021659209,0.0000022979013,0.00016924908,0.000012628657,0.00074772665,0.8384361,0.00002519149,0.00061208446],"genre_scores_gemma":[0.43570295,0.00002466784,0.00057809247,0.00029448653,0.000037378337,0.0025030952,0.560667,0.000015078628,0.00017730478],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99836576,0.000075563556,0.0005622124,0.00040581185,0.00034140187,0.0002492322],"domain_scores_gemma":[0.9908867,0.0077199996,0.00058318325,0.00050122093,0.00026271536,0.000046211157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008292863,0.00024980295,0.0006888759,0.00014900233,0.0000751129,0.000020176589,0.00025669322,0.00008215263,0.10978164],"category_scores_gemma":[0.0014598832,0.00012843727,0.00050202856,0.0011862126,0.00008798071,0.000042407544,0.00006636831,0.0000704122,0.000051931835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021978817,0.0021103048,0.008273011,0.00005298048,0.0003958136,0.00018020332,0.0005972474,0.00007240057,0.000026068092,0.0000039847696,0.9852672,0.0028009606],"study_design_scores_gemma":[0.0022634985,0.00038082924,0.9776205,0.00053221086,0.00049565855,0.000032372922,0.0010114381,0.0022224204,0.00060135056,0.00003765296,0.014653729,0.00014833668],"about_ca_topic_score_codex":0.00025131842,"about_ca_topic_score_gemma":0.00040986895,"teacher_disagreement_score":0.9706135,"about_ca_system_score_codex":0.00006713441,"about_ca_system_score_gemma":0.00029311032,"threshold_uncertainty_score":0.89103216},"labels":[],"label_agreement":null},{"id":"W6907595279","doi":"10.25316/ir-10476","title":"Nanaimo Free Press [Tuesday, April 5, 1898]","year":2019,"lang":"en","type":"other","venue":"VIURRSpace (Vancouver Island University)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.010556192980785582,"score_gpt":0.20960919692516833,"score_spread":0.19905300394438274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6907595279","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001099295,0.0014078036,0.00006571737,0.0003473701,0.0015720988,0.0009058347,0.0003952153,0.00030084595,0.9949941],"genre_scores_gemma":[0.00084180554,0.0020802717,0.00030774984,0.00016331847,0.00040702015,0.000003405016,0.000006076185,0.00030730027,0.99588305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981802,0.00005430793,0.0001334837,0.00071870105,0.0004490405,0.0004642449],"domain_scores_gemma":[0.9980826,0.00005911088,0.00023516035,0.0012963312,0.00007219724,0.00025459574],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003943745,0.0005357536,0.0008159188,0.00056157477,0.000075506636,0.00002900157,0.00038278822,0.00054238527,0.0010298737],"category_scores_gemma":[0.000021634696,0.00047360733,0.0003280396,0.00030234718,0.00010039781,0.00008275984,0.00027471708,0.00024304043,0.0005571321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001577006,0.0003838787,0.00009899865,0.00024524366,0.00072233775,0.0010901863,0.00008872065,0.0000032463515,0.000004531793,0.0008254251,0.9956762,0.0007034989],"study_design_scores_gemma":[0.0075481026,0.00027679838,0.00006886188,0.0006183108,0.0008951673,0.000013924587,0.00018805788,0.000011260067,0.00007492794,0.000010925584,0.98981553,0.0004781068],"about_ca_topic_score_codex":0.0027187336,"about_ca_topic_score_gemma":0.0026738455,"teacher_disagreement_score":0.007390402,"about_ca_system_score_codex":0.00044683114,"about_ca_system_score_gemma":0.00028613457,"threshold_uncertainty_score":0.9998833},"labels":[],"label_agreement":null},{"id":"W6907751610","doi":"10.25316/ir-14256","title":"Nanaimo Free Press [Saturday, June 19, 1880]","year":2020,"lang":"en","type":"other","venue":"VIUSpace (Vancouver Island University Library)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.00862020974875157,"score_gpt":0.19269737087364466,"score_spread":0.18407716112489309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6907751610","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002130618,0.0021022572,0.000034493645,0.0050948304,0.0011554754,0.00078224944,0.00091575854,0.0007483193,0.98914534],"genre_scores_gemma":[0.00044902504,0.003697218,0.0014145656,0.0009187949,0.00062396703,0.0000032668927,0.0000991339,0.00037145324,0.9924226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812955,0.00007191585,0.00016012846,0.0007727744,0.0004292957,0.0004363357],"domain_scores_gemma":[0.9981839,0.000061360624,0.00022684225,0.0009379589,0.00001735805,0.00057259505],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000015080812,0.0005766487,0.00084303395,0.0003089814,0.00011339952,0.000050713486,0.00048936845,0.0005237587,0.003946947],"category_scores_gemma":[0.000021003903,0.0005094787,0.0003608597,0.00037368646,0.00012472442,0.0002633096,0.0005075573,0.0003274749,0.00020535909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029310744,0.00032763492,0.0004303575,0.0002802063,0.0007584434,0.0028831,0.00018880791,0.0000011900519,0.0000026345658,0.0006489451,0.9938249,0.00036068057],"study_design_scores_gemma":[0.0063118367,0.0002320152,0.00022141209,0.00041371214,0.000738583,0.000010351496,0.00017462853,0.000011054079,0.00015966133,0.000032701948,0.99118704,0.00050701824],"about_ca_topic_score_codex":0.0018597724,"about_ca_topic_score_gemma":0.108363815,"teacher_disagreement_score":0.10650404,"about_ca_system_score_codex":0.0001554263,"about_ca_system_score_gemma":0.00035891926,"threshold_uncertainty_score":0.99973565},"labels":[],"label_agreement":null},{"id":"W6920451771","doi":"10.6084/m9.figshare.13088019.v1","title":"Additional file 1 of Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Probabilistic logic; Brentuximab vedotin; Stage (stratigraphy); Survival analysis; Statistical analysis","score_opus":0.03844652954051604,"score_gpt":0.28324236773277,"score_spread":0.24479583819225398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920451771","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069197887,0.00007380168,3.5561564e-7,0.000029751987,0.0000041859453,0.00076370087,0.9914048,0.000018702844,0.00078494946],"genre_scores_gemma":[0.42116338,6.951664e-7,0.00012368675,0.000035414596,0.000010488399,0.002201449,0.576423,0.000008080131,0.000033801603],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99898106,0.00006969274,0.00028010484,0.00027884007,0.00024267982,0.00014760283],"domain_scores_gemma":[0.9978286,0.0015366885,0.00017820515,0.00018657927,0.00016627948,0.00010366413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023391562,0.00013768571,0.00053696585,0.00012073706,0.000013477066,0.0000042856514,0.000074943106,0.000056690275,0.9337217],"category_scores_gemma":[0.0031126465,0.00012101213,0.00021798443,0.00076839817,0.000011279625,0.00004909295,0.000052127638,0.000037776124,0.00019735814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067116227,0.0022582607,0.0026354513,0.002758292,0.0007433349,0.00016820231,0.0001269323,0.0007535038,0.00006670637,0.000011227265,0.9814289,0.00837801],"study_design_scores_gemma":[0.005464654,0.0005837697,0.8721298,0.0048415456,0.00024173544,0.000003849952,0.00006713899,0.0015938161,0.0014889056,0.000008194073,0.11341797,0.00015864609],"about_ca_topic_score_codex":0.000018741877,"about_ca_topic_score_gemma":0.000033556535,"teacher_disagreement_score":0.93352437,"about_ca_system_score_codex":0.0001772827,"about_ca_system_score_gemma":0.0002566982,"threshold_uncertainty_score":0.49347317},"labels":[],"label_agreement":null},{"id":"W6920521673","doi":"10.6084/m9.figshare.16584291","title":"Additional file 1 of Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Open MIND","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); B-cell lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Clinical trial","score_opus":0.07129483290947411,"score_gpt":0.33469090271041735,"score_spread":0.2633960698009432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920521673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84051055,0.00030503073,2.9604587e-7,0.00007503977,0.00010955431,0.0005604937,0.12695515,0.000003168619,0.031480707],"genre_scores_gemma":[0.92228276,0.000054619613,0.006163958,0.00003274124,0.000050330567,0.00035682216,0.059973277,0.000031209227,0.011054305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841046,0.000098726814,0.0005488147,0.00038638452,0.00030391337,0.0002517223],"domain_scores_gemma":[0.99766356,0.0013861671,0.00031653178,0.00039974364,0.00011148345,0.00012253545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000073904164,0.00022049808,0.0007693537,0.000118221564,0.000049899154,0.00002064794,0.00013379399,0.00014336141,0.54172945],"category_scores_gemma":[0.00018315071,0.00017236684,0.00014813831,0.00030750674,0.000042736454,0.000075340235,0.00011816881,0.00006252779,0.000306714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007526731,0.073488005,0.0075474726,0.0001516237,0.0008831319,0.0016527568,0.0045534084,0.000012948998,0.0010629452,0.00001119005,0.74277794,0.16033188],"study_design_scores_gemma":[0.0664121,0.004445367,0.10044379,0.0012818646,0.00044761557,0.00003770363,0.004265723,0.00015424006,0.09417519,0.00000613025,0.7279895,0.00034077602],"about_ca_topic_score_codex":0.00030007685,"about_ca_topic_score_gemma":0.0015662722,"teacher_disagreement_score":0.5414227,"about_ca_system_score_codex":0.00050416146,"about_ca_system_score_gemma":0.0010936128,"threshold_uncertainty_score":0.7028916},"labels":[],"label_agreement":null},{"id":"W6920797507","doi":"10.6084/m9.figshare.28545024.v1","title":"Additional file 1 of Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma","year":2025,"lang":"","type":"article","venue":"Open MIND","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Lymphoma; Clinical trial; Radiation therapy","score_opus":0.04982240803473014,"score_gpt":0.3302717735961898,"score_spread":0.28044936556145966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920797507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7865337,0.0057429406,0.000009901983,0.00025513206,0.00011503119,0.0041386783,0.20249513,0.0000019741512,0.0007075049],"genre_scores_gemma":[0.9660178,0.003388501,0.0069202944,0.00003608954,0.00006124321,0.0007343243,0.013499683,0.000042275784,0.009299836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712944,0.00016211854,0.0015176862,0.0005532451,0.0003463835,0.00029115193],"domain_scores_gemma":[0.9898703,0.00801925,0.001108135,0.00061687606,0.00026753265,0.00011789543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024002399,0.00044062332,0.0019015449,0.00017693572,0.00017637345,0.000028326154,0.00025416358,0.0002645566,0.10236457],"category_scores_gemma":[0.00035273115,0.00025125346,0.00024951014,0.00035534395,0.00042506433,0.00010399706,0.00018437929,0.000060242663,0.0000048597526],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060430836,0.023806855,0.004962171,0.0012788787,0.009763745,0.000061131206,0.007122792,0.000093301234,0.0011632985,0.000023758139,0.11886914,0.7724241],"study_design_scores_gemma":[0.083474874,0.024789046,0.37414402,0.0086790575,0.007824911,0.000037909584,0.0035909556,0.002380393,0.107497275,0.000029302424,0.38702428,0.00052795885],"about_ca_topic_score_codex":0.00032601814,"about_ca_topic_score_gemma":0.0003132809,"teacher_disagreement_score":0.7718961,"about_ca_system_score_codex":0.00025002562,"about_ca_system_score_gemma":0.00097104744,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W6927562224","doi":"10.30476/mejc.2022.93676.1703","title":"Outcomes of Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma Patients at a Tertiary Referral Centre","year":2023,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Autologous stem-cell transplantation; Incidence (geometry); Follicular lymphoma; Retrospective cohort study; Lymphoma; Progression-free survival; Ibritumomab tiuxetan; Overall survival","score_opus":0.14176356352842498,"score_gpt":0.4844214192180953,"score_spread":0.34265785568967033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6927562224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955195,0.0010521206,0.000018272329,0.0002673328,0.00047609786,0.0013997047,0.00037615746,0.00005029739,0.00084050366],"genre_scores_gemma":[0.9946953,0.0034315938,0.00013896306,0.00023889783,0.000043628275,0.00012988283,0.0002903642,0.000056045665,0.0009753153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974805,0.00010870031,0.0009511833,0.00041973952,0.0006192444,0.00042062066],"domain_scores_gemma":[0.99791646,0.00045087078,0.00072453666,0.00038019614,0.00028218122,0.00024576142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036584944,0.00033303988,0.0010149864,0.0005921789,0.00016215758,0.000114144736,0.0006104397,0.00014100049,0.000730785],"category_scores_gemma":[0.00003922757,0.00025635867,0.00038305344,0.0004971068,0.0000640215,0.00053747406,0.00022137059,0.00007091222,0.00003082679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009638911,0.0012084026,0.93045914,0.00051665434,0.0004161528,0.00011176199,0.0005545765,0.000019919704,0.0059276433,0.000005754376,0.019803127,0.040012993],"study_design_scores_gemma":[0.006335809,0.00007084157,0.916978,0.0004304511,0.00047030128,0.000011215403,0.000079696605,0.00007668463,0.0744033,0.0000966022,0.0008284233,0.0002186635],"about_ca_topic_score_codex":0.00039182795,"about_ca_topic_score_gemma":0.000053642125,"teacher_disagreement_score":0.068475656,"about_ca_system_score_codex":0.00029971555,"about_ca_system_score_gemma":0.00014021604,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W6930310087","doi":"10.5281/zenodo.11059220","title":"Effect Of Pulsed Electromagnetic Field And Microwave Therapy On Pain And Physical Function In Older Adults With Knee Osteoarthritis: A Randomized Clinical Trial.","year":2024,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Electrotherapy; Osteoarthritis; Randomized controlled trial; Visual analogue scale; Modalities; Clinical trial","score_opus":0.011110308378908414,"score_gpt":0.2696446708937633,"score_spread":0.2585343625148549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930310087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89806247,0.0028391096,0.000013171175,0.00057799224,0.0001678635,0.0100473305,0.08684473,0.00019568305,0.0012516428],"genre_scores_gemma":[0.5580882,0.0025464408,0.00001145971,0.0003399662,0.00030800098,0.000004837936,0.43795446,0.0006632184,0.0000834331],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969608,0.0017159848,0.0003576276,0.0005003666,0.00026553182,0.0001996679],"domain_scores_gemma":[0.9985329,0.0008247637,0.00012220103,0.00030613347,0.000099633966,0.00011435329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015738884,0.00023129176,0.00073839846,0.00023079065,0.00013350554,0.00014521432,0.000099139375,0.00014348362,0.0005279094],"category_scores_gemma":[0.0010747415,0.00015818683,0.00010646768,0.00021671808,0.00016766132,0.000034008037,0.00013300097,0.0003651286,0.00026496698],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3496423,0.0006353983,0.000002567726,0.00038590512,0.0001719861,0.000074045805,0.00012438293,7.153745e-8,0.000030733583,0.0000053738713,0.28415665,0.3647706],"study_design_scores_gemma":[0.58438927,0.118924946,0.00019688312,0.0015414787,0.0004110833,0.00009074011,0.000031796975,0.000054916396,0.0002265348,0.000015086504,0.29392633,0.00019092853],"about_ca_topic_score_codex":0.000033056138,"about_ca_topic_score_gemma":0.0000019793163,"teacher_disagreement_score":0.36457965,"about_ca_system_score_codex":0.000049861945,"about_ca_system_score_gemma":0.000008595144,"threshold_uncertainty_score":0.64506716},"labels":[],"label_agreement":null},{"id":"W6938973396","doi":"10.60692/xshm0-gnw32","title":"Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase","year":2008,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Autophosphorylation; Anaplastic lymphoma kinase; Protein kinase domain; Tyrosine kinase; Anaplastic large-cell lymphoma; Receptor tyrosine kinase; Phosphorylation; GRB2; Kinase","score_opus":0.013857371483337986,"score_gpt":0.18338213511909807,"score_spread":0.16952476363576008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6938973396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391127,0.0000029174553,0.004991475,0.000047801655,0.00015919273,0.00054808595,0.00013084112,0.00001765122,0.00019074656],"genre_scores_gemma":[0.9997678,3.6072424e-7,0.00006632521,0.000056795743,0.000011295066,0.000032054748,0.000035598834,0.0000071413824,0.00002266933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987466,0.000050623177,0.00058375386,0.00007670353,0.00044260395,0.00009975747],"domain_scores_gemma":[0.99860895,0.000009797286,0.00083809596,0.00037148086,0.00014095519,0.000030708783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011143238,0.000116927906,0.00025637445,0.000090925,0.00007437218,0.000006556611,0.00009777579,0.00006577671,0.0000043446944],"category_scores_gemma":[0.000027281689,0.00006536113,0.00013150656,0.00022865672,0.0000500065,0.00023897183,0.000045505207,0.000024312241,0.000011446318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008648945,0.00027795485,0.7243293,0.0056064194,0.0010309654,0.00002258235,0.14851865,0.00064337155,0.0989003,0.017419087,0.000017372897,0.002369131],"study_design_scores_gemma":[0.0017513167,0.000078270285,0.6175025,0.00048652658,0.000093265684,0.000055383396,0.0010546033,0.0006546877,0.3782608,0.0000031262107,0.000008278949,0.000051229537],"about_ca_topic_score_codex":0.000023138768,"about_ca_topic_score_gemma":1.0135518e-7,"teacher_disagreement_score":0.2793605,"about_ca_system_score_codex":0.00020167568,"about_ca_system_score_gemma":0.000118794786,"threshold_uncertainty_score":0.26653492},"labels":[],"label_agreement":null},{"id":"W6939437915","doi":"10.6084/m9.figshare.13088019","title":"Additional file 1 of Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Probabilistic logic; Brentuximab vedotin; Stage (stratigraphy); Survival analysis; Statistical analysis","score_opus":0.03844652954051604,"score_gpt":0.28324236773277,"score_spread":0.24479583819225398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939437915","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069197887,0.00007380168,3.5561564e-7,0.000029751987,0.0000041859453,0.00076370087,0.9914048,0.000018702844,0.00078494946],"genre_scores_gemma":[0.42116338,6.951664e-7,0.00012368675,0.000035414596,0.000010488399,0.002201449,0.576423,0.000008080131,0.000033801603],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99898106,0.00006969274,0.00028010484,0.00027884007,0.00024267982,0.00014760283],"domain_scores_gemma":[0.9978286,0.0015366885,0.00017820515,0.00018657927,0.00016627948,0.00010366413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023391562,0.00013768571,0.00053696585,0.00012073706,0.000013477066,0.0000042856514,0.000074943106,0.000056690275,0.9337217],"category_scores_gemma":[0.0031126465,0.00012101213,0.00021798443,0.00076839817,0.000011279625,0.00004909295,0.000052127638,0.000037776124,0.00019735814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067116227,0.0022582607,0.0026354513,0.002758292,0.0007433349,0.00016820231,0.0001269323,0.0007535038,0.00006670637,0.000011227265,0.9814289,0.00837801],"study_design_scores_gemma":[0.005464654,0.0005837697,0.8721298,0.0048415456,0.00024173544,0.000003849952,0.00006713899,0.0015938161,0.0014889056,0.000008194073,0.11341797,0.00015864609],"about_ca_topic_score_codex":0.000018741877,"about_ca_topic_score_gemma":0.000033556535,"teacher_disagreement_score":0.93352437,"about_ca_system_score_codex":0.0001772827,"about_ca_system_score_gemma":0.0002566982,"threshold_uncertainty_score":0.49347317},"labels":[],"label_agreement":null},{"id":"W6939666973","doi":"10.6084/m9.figshare.14999010.v1","title":"Additional file 1 of Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Survival analysis; MEDLINE; Radiation therapy; Chemotherapy","score_opus":0.017293204794059484,"score_gpt":0.21388323497388845,"score_spread":0.19659003017982896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939666973","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40051818,0.000023937453,1.1839093e-8,0.000009433495,0.0000060246066,0.0004250746,0.5978515,0.000014316357,0.0011514965],"genre_scores_gemma":[0.5194312,3.7685595e-7,0.000023642606,0.0000597395,0.000024360063,0.0006814516,0.47944936,0.000016606475,0.00031329534],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985112,0.00012041508,0.00023785958,0.00032284067,0.00057070307,0.00023696109],"domain_scores_gemma":[0.99823684,0.00084131485,0.00016056623,0.00037501004,0.00029660854,0.00008964361],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023491968,0.00021462263,0.00031294135,0.000058190577,0.00006491143,0.000023740322,0.000091949914,0.000062782274,0.74352497],"category_scores_gemma":[0.00033508133,0.00012076438,0.000069104564,0.00032033227,0.0000128994325,0.00007516473,0.000047234727,0.0000777197,0.00017581657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002529926,0.05139528,0.13213608,0.000065868495,0.00013680484,0.00093921536,0.00041625786,0.000001167608,0.0000010747793,1.510846e-7,0.8140416,0.00061347394],"study_design_scores_gemma":[0.01851573,0.0017003943,0.91422117,0.0014700735,0.00008496564,0.000008484254,0.00078874105,0.000010526443,0.000113580005,1.4299931e-7,0.062949486,0.00013669154],"about_ca_topic_score_codex":0.000031622545,"about_ca_topic_score_gemma":0.00048248295,"teacher_disagreement_score":0.7820851,"about_ca_system_score_codex":0.00016457967,"about_ca_system_score_gemma":0.0002603349,"threshold_uncertainty_score":0.49246284},"labels":[],"label_agreement":null},{"id":"W6949398150","doi":"10.5281/zenodo.13618083","title":"Antibody Characterization Report for PATL2","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Antibody; Recombinant DNA; Immunofluorescence; Immunoprecipitation; Western blot; Blot; Nomination; Construct (python library)","score_opus":0.033671241265400415,"score_gpt":0.3001358246465977,"score_spread":0.2664645833811973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949398150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46039578,0.0012063415,0.24658974,0.019032368,0.0018080125,0.006793455,0.0022751745,0.007695797,0.25420332],"genre_scores_gemma":[0.87778443,0.00024198013,0.0003634644,0.0002521503,0.00047328425,3.818411e-7,0.115642525,0.0013112597,0.00393054],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998869,0.0000495021,0.00023095388,0.00038173553,0.00023720822,0.00023159095],"domain_scores_gemma":[0.9991238,0.00002138661,0.000050249055,0.00031415818,0.00035443998,0.0001359654],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032945146,0.000114625676,0.0001469171,0.00017032323,0.00066677673,0.0005003986,0.00014672164,0.00005352613,0.0033647947],"category_scores_gemma":[0.0002899227,0.00010177307,0.00008568012,0.0003137802,0.000047889025,0.00016317019,0.00016995824,0.00008004338,0.0028061005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030345764,0.0009886828,0.0002869667,0.0009087628,0.00047522108,0.0014183335,0.0014588226,0.0000035415376,0.46349746,0.012765733,0.060671445,0.45722157],"study_design_scores_gemma":[0.00063855184,0.00037114613,0.008673413,0.00011923792,0.00007299075,0.0010719681,0.000041519615,0.0005199583,0.0017394022,0.00005832002,0.98659176,0.00010172367],"about_ca_topic_score_codex":0.0000052951546,"about_ca_topic_score_gemma":3.578997e-8,"teacher_disagreement_score":0.9259203,"about_ca_system_score_codex":0.00018231066,"about_ca_system_score_gemma":0.000009050656,"threshold_uncertainty_score":0.99797034},"labels":[],"label_agreement":null},{"id":"W6950194502","doi":"10.5281/zenodo.4885179","title":"MDA-OnlineRegisters","year":2021,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Scripting language; The Internet; Web site; Online presence management; Headline","score_opus":0.04443419586714656,"score_gpt":0.276078608890945,"score_spread":0.23164441302379843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950194502","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014449627,0.0014640643,0.00008111765,0.0010913701,0.0001506679,0.00049537345,0.00029034595,0.00085108913,0.9954315],"genre_scores_gemma":[0.0064008846,0.0018872843,0.00080761866,0.0007583109,0.0009400824,1.180879e-7,0.021950651,0.014887889,0.9523672],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852896,0.0001237018,0.00019052115,0.0004939047,0.000367565,0.00029534328],"domain_scores_gemma":[0.9987557,0.000010417327,0.00011921356,0.000668507,0.00021193689,0.00023425772],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012799393,0.00021776745,0.00031359252,0.00026645724,0.0004245186,0.00027487194,0.00032694207,0.00015555511,0.13483785],"category_scores_gemma":[0.00018825853,0.00020280939,0.00012214841,0.00029834863,0.000109111985,0.000024394645,0.0005313395,0.00018236728,0.009307774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024547826,0.0003482986,0.000008845753,0.00020356078,0.0002254245,0.00023797991,0.00008034444,3.5495128e-7,0.00012332857,0.00062158983,0.93588597,0.062239766],"study_design_scores_gemma":[0.0012170415,0.00020385426,0.0003653323,0.00040453766,0.000100308054,0.00037483388,0.0000726306,0.0000091813445,0.00009193194,0.0000067538704,0.99697727,0.00017632343],"about_ca_topic_score_codex":0.00005683858,"about_ca_topic_score_gemma":0.0000010088726,"teacher_disagreement_score":0.12553008,"about_ca_system_score_codex":0.00023943793,"about_ca_system_score_gemma":0.000009968671,"threshold_uncertainty_score":0.9914636},"labels":[],"label_agreement":null},{"id":"W6957971593","doi":"10.6084/m9.figshare.26563327.v1","title":"Additional file 1 of Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Table (database); Meta-analysis; Systematic review; MEDLINE; Selection (genetic algorithm); Clinical trial","score_opus":0.0550872213619992,"score_gpt":0.3415465526461346,"score_spread":0.28645933128413537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957971593","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005178706,0.14751464,2.6408019e-8,0.00008566543,0.000008605863,0.0013280009,0.8505188,0.000008792978,0.000017563558],"genre_scores_gemma":[0.028677098,0.0013105706,0.00044558223,0.00082408235,0.00003141245,0.015203388,0.95242095,0.00002485284,0.001062038],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985307,0.00008071422,0.0008086985,0.00026283236,0.00022553028,0.00009155973],"domain_scores_gemma":[0.9965086,0.0026773945,0.00024288558,0.00026156855,0.00025251138,0.000057030604],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008465319,0.00016646176,0.0018478706,0.00014503721,0.00000985135,0.000013951946,0.000048695216,0.000107174725,0.66488606],"category_scores_gemma":[0.00256179,0.00009105002,0.0015313942,0.0003295997,0.000007692023,0.00006645679,0.000022994198,0.00004241897,0.00003308592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050395476,0.0008984652,0.0010607877,0.077814765,0.03880485,0.00003435321,0.000047530568,8.726354e-8,1.7279643e-8,8.319623e-7,0.88090247,0.00038542712],"study_design_scores_gemma":[0.0037934547,0.0009588994,0.49773934,0.13668627,0.1505946,0.000007348446,0.000008168984,0.00006483931,0.000007600743,0.000008501656,0.20987153,0.00025944164],"about_ca_topic_score_codex":0.0000010465889,"about_ca_topic_score_gemma":0.0000033199992,"teacher_disagreement_score":0.67103094,"about_ca_system_score_codex":0.000026082243,"about_ca_system_score_gemma":0.000084115316,"threshold_uncertainty_score":0.3712912},"labels":[],"label_agreement":null},{"id":"W6958361893","doi":"10.6084/m9.figshare.24847099.v1","title":"Additional file 1 of Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Ibrutinib; Lymphoma; Bendamustine","score_opus":0.039058989535826864,"score_gpt":0.28518833891603346,"score_spread":0.24612934938020659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958361893","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15977809,0.00021659209,0.0000022979013,0.00016924908,0.000012628657,0.00074772665,0.8384361,0.00002519149,0.00061208446],"genre_scores_gemma":[0.43570295,0.00002466784,0.00057809247,0.00029448653,0.000037378337,0.0025030952,0.560667,0.000015078628,0.00017730478],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99836576,0.000075563556,0.0005622124,0.00040581185,0.00034140187,0.0002492322],"domain_scores_gemma":[0.9908867,0.0077199996,0.00058318325,0.00050122093,0.00026271536,0.000046211157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008292863,0.00024980295,0.0006888759,0.00014900233,0.0000751129,0.000020176589,0.00025669322,0.00008215263,0.10978164],"category_scores_gemma":[0.0014598832,0.00012843727,0.00050202856,0.0011862126,0.00008798071,0.000042407544,0.00006636831,0.0000704122,0.000051931835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021978817,0.0021103048,0.008273011,0.00005298048,0.0003958136,0.00018020332,0.0005972474,0.00007240057,0.000026068092,0.0000039847696,0.9852672,0.0028009606],"study_design_scores_gemma":[0.0022634985,0.00038082924,0.9776205,0.00053221086,0.00049565855,0.000032372922,0.0010114381,0.0022224204,0.00060135056,0.00003765296,0.014653729,0.00014833668],"about_ca_topic_score_codex":0.00025131842,"about_ca_topic_score_gemma":0.00040986895,"teacher_disagreement_score":0.9706135,"about_ca_system_score_codex":0.00006713441,"about_ca_system_score_gemma":0.00029311032,"threshold_uncertainty_score":0.89103216},"labels":[],"label_agreement":null},{"id":"W6976906023","doi":"10.6084/m9.figshare.16584291.v1","title":"Additional file 1 of Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); B-cell lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Clinical trial","score_opus":0.06748993954256262,"score_gpt":0.3035584589654617,"score_spread":0.23606851942289908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976906023","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04110359,0.00059144426,1.9852486e-8,0.00003019582,0.000050907376,0.00030189927,0.95043766,0.000032279324,0.00745197],"genre_scores_gemma":[0.30458325,0.000012951779,0.0002779643,0.000038997572,0.000048245933,0.0006660805,0.692552,0.000023974118,0.0017965761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850553,0.00007181321,0.00047500595,0.0003354437,0.00034280182,0.00026943057],"domain_scores_gemma":[0.9970262,0.0020084209,0.00029915592,0.00036659738,0.00017530052,0.00012431764],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000018461564,0.00023662066,0.00066158694,0.00013457189,0.00004378749,0.000009221913,0.00008145793,0.00017513901,0.94809294],"category_scores_gemma":[0.00092139875,0.00018977474,0.00021104106,0.0003355448,0.000011215363,0.00004997642,0.00006870341,0.000073875766,0.0008039958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007480035,0.011428752,0.00036237927,0.0003056549,0.00017007359,0.00038139708,0.00050659967,0.0000039527504,0.00004908788,0.0000017380814,0.981694,0.0043483865],"study_design_scores_gemma":[0.03349477,0.002618098,0.10313139,0.006597093,0.00016807424,0.00002744741,0.0011393469,0.00017367315,0.023875477,0.0000037126647,0.82847774,0.00029319638],"about_ca_topic_score_codex":0.000059041682,"about_ca_topic_score_gemma":0.00041510415,"teacher_disagreement_score":0.94728893,"about_ca_system_score_codex":0.0005197187,"about_ca_system_score_gemma":0.0008421689,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W6976987026","doi":"10.6084/m9.figshare.12569699","title":"Additional file 1 of A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Obinutuzumab; Rituximab; Adverse effect; CHOP; Phases of clinical research; Progression-free survival","score_opus":0.04060774016850836,"score_gpt":0.28654289855779874,"score_spread":0.24593515838929036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976987026","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33864623,0.000056004377,8.78129e-8,0.00000765351,0.0000023543278,0.0021531272,0.6588887,0.000010348786,0.00023551214],"genre_scores_gemma":[0.5353612,0.000002251387,0.00007421251,0.000050383944,0.0000073031797,0.0018809349,0.462489,0.000014725444,0.00011998931],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785817,0.00013796434,0.0008264497,0.0004137231,0.00052479137,0.00023889022],"domain_scores_gemma":[0.9972965,0.0010854718,0.00069549936,0.00035632032,0.00040510186,0.00016106683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047405527,0.00027275228,0.0021517545,0.00024299251,0.000035869398,0.000015213416,0.00022763805,0.00007680927,0.71703696],"category_scores_gemma":[0.0013075116,0.0001799192,0.00018497565,0.001258228,0.000022696973,0.000110053275,0.00017769395,0.00005816866,0.00006225274],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18000261,0.12904708,0.00088517315,0.00039999947,0.003727059,0.00019243301,0.0014068244,0.000016490621,7.507513e-7,6.226384e-7,0.68375313,0.0005678352],"study_design_scores_gemma":[0.9708697,0.005687595,0.012731462,0.0021497007,0.0027740311,0.0000013213487,0.00023980236,0.0022351926,0.00006180779,2.2876333e-7,0.00307419,0.00017494048],"about_ca_topic_score_codex":0.00022391022,"about_ca_topic_score_gemma":0.0001957134,"teacher_disagreement_score":0.79086715,"about_ca_system_score_codex":0.00028200616,"about_ca_system_score_gemma":0.00067587977,"threshold_uncertainty_score":0.7336892},"labels":[],"label_agreement":null},{"id":"W6977658391","doi":"10.6084/m9.figshare.14999010","title":"Additional file 1 of Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Survival analysis; MEDLINE; Radiation therapy; Chemotherapy","score_opus":0.017293204794059484,"score_gpt":0.21388323497388845,"score_spread":0.19659003017982896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977658391","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40051818,0.000023937453,1.1839093e-8,0.000009433495,0.0000060246066,0.0004250746,0.5978515,0.000014316357,0.0011514965],"genre_scores_gemma":[0.5194312,3.7685595e-7,0.000023642606,0.0000597395,0.000024360063,0.0006814516,0.47944936,0.000016606475,0.00031329534],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985112,0.00012041508,0.00023785958,0.00032284067,0.00057070307,0.00023696109],"domain_scores_gemma":[0.99823684,0.00084131485,0.00016056623,0.00037501004,0.00029660854,0.00008964361],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023491968,0.00021462263,0.00031294135,0.000058190577,0.00006491143,0.000023740322,0.000091949914,0.000062782274,0.74352497],"category_scores_gemma":[0.00033508133,0.00012076438,0.000069104564,0.00032033227,0.0000128994325,0.00007516473,0.000047234727,0.0000777197,0.00017581657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002529926,0.05139528,0.13213608,0.000065868495,0.00013680484,0.00093921536,0.00041625786,0.000001167608,0.0000010747793,1.510846e-7,0.8140416,0.00061347394],"study_design_scores_gemma":[0.01851573,0.0017003943,0.91422117,0.0014700735,0.00008496564,0.000008484254,0.00078874105,0.000010526443,0.000113580005,1.4299931e-7,0.062949486,0.00013669154],"about_ca_topic_score_codex":0.000031622545,"about_ca_topic_score_gemma":0.00048248295,"teacher_disagreement_score":0.7820851,"about_ca_system_score_codex":0.00016457967,"about_ca_system_score_gemma":0.0002603349,"threshold_uncertainty_score":0.49246284},"labels":[],"label_agreement":null},{"id":"W6981046237","doi":"","title":"Development and shaping of lamellar soft magnetic composite","year":2009,"lang":"en","type":"article","venue":"NPARC","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lamellar structure; Powder metallurgy; Composite number; Compaction; Process (computing); Development (topology)","score_opus":0.020417912670712253,"score_gpt":0.25072417608420233,"score_spread":0.2303062634134901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981046237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984139,0.0008167189,0.000015236443,0.0008066943,0.000013180142,0.00011213687,7.7303e-7,0.0000150834,0.014081147],"genre_scores_gemma":[0.9810064,0.000068790854,0.018324146,0.00043573283,0.000014347983,0.0000036391605,0.0000045495626,0.0000034197096,0.00013897699],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99957985,0.000004920902,0.00011999033,0.00009760451,0.000104564744,0.000093074654],"domain_scores_gemma":[0.9997974,0.00001635922,0.000024097299,0.00008026303,0.000020937945,0.000060958635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035956302,0.00006278831,0.00014393246,0.00003094574,0.000025149051,0.0000051068373,0.000018212879,0.000023925531,0.000083709245],"category_scores_gemma":[0.0000052140645,0.000049508915,0.000019655487,0.00003841174,0.000018490355,0.000012204969,0.000010964114,0.00001981233,0.000011876577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007582966,0.0005935226,0.080938935,0.00007878097,0.000056600893,0.000102878395,0.0010643984,7.975379e-7,0.13695547,0.0015640964,0.0006403973,0.7779283],"study_design_scores_gemma":[0.002191628,0.00044111622,0.85955924,0.00019381025,0.00007755538,0.00005526968,0.000042228872,0.00009785208,0.12522347,0.00038487717,0.011644106,0.0000888216],"about_ca_topic_score_codex":0.000002216208,"about_ca_topic_score_gemma":8.550459e-7,"teacher_disagreement_score":0.7786203,"about_ca_system_score_codex":0.000029161904,"about_ca_system_score_gemma":0.000031260843,"threshold_uncertainty_score":0.2018915},"labels":[],"label_agreement":null},{"id":"W6990092037","doi":"","title":"The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use","year":2002,"lang":"en","type":"article","venue":"Iris Unimore (University of Modena and Reggio Emilia)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Fludarabine; Resource use; Indirect costs; Cost–benefit analysis; Lymphoma; CHOP","score_opus":0.02077104761910328,"score_gpt":0.24025118022722516,"score_spread":0.21948013260812188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990092037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973596,0.00014708741,0.00005666102,0.00062233326,0.000018341947,0.00021989588,0.00005607601,0.000008852287,0.0015111779],"genre_scores_gemma":[0.99826354,0.00079733355,0.000418769,0.000019975158,0.000010041573,7.750687e-7,0.000039769475,0.0000072289226,0.0004425891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898684,0.00007166183,0.00022307342,0.00026285287,0.00031206937,0.00014348018],"domain_scores_gemma":[0.9989108,0.00018746774,0.0002890826,0.00034173304,0.0001848686,0.00008606733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017494659,0.00012224035,0.0004438292,0.00039061919,0.00010673235,0.000008876072,0.00015655224,0.00009678926,0.000021195148],"category_scores_gemma":[0.000060489794,0.000102622114,0.00017965758,0.0005452323,0.00027558501,0.00015581536,0.00008012453,0.0000654771,3.559038e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042352654,0.00066910917,0.96871376,0.000021248026,0.0009842272,0.00007790301,0.0068203444,0.00038369477,0.0005269459,0.0001893683,0.00032100515,0.020868856],"study_design_scores_gemma":[0.00385608,0.00033297017,0.9440444,0.00016691978,0.0008042313,0.000005947914,0.0044399174,0.045516036,0.00042564142,0.000013723268,0.00030950218,0.00008459956],"about_ca_topic_score_codex":0.0012530586,"about_ca_topic_score_gemma":0.00065459666,"teacher_disagreement_score":0.04513234,"about_ca_system_score_codex":0.00022443621,"about_ca_system_score_gemma":0.000029646688,"threshold_uncertainty_score":0.41848084},"labels":[],"label_agreement":null},{"id":"W6995268711","doi":"","title":"Journey 2050","year":2019,"lang":"en","type":"article","venue":"UNI ScholarWorks (University of Northern Iowa)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Best practice; Work (physics); Key (lock); Productivity","score_opus":0.010053140142498066,"score_gpt":0.20178741776491554,"score_spread":0.1917342776224175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995268711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728512,0.00030071413,0.000041586063,0.0012128621,0.00008697295,0.00024841388,0.00000869732,0.000044854445,0.025204659],"genre_scores_gemma":[0.9902396,0.00014256677,0.0008598356,0.00014703591,0.000032789067,1.4664332e-7,0.000035885638,0.000013590313,0.008528552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917066,0.00003387198,0.00009617932,0.0002305473,0.0002696615,0.00019910761],"domain_scores_gemma":[0.9991202,0.00004096415,0.00010278309,0.0004011031,0.00015780072,0.00017714723],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011074136,0.00012491726,0.00028703458,0.00013557285,0.0001097114,0.000014229153,0.0001612974,0.00012592395,0.001368352],"category_scores_gemma":[0.000015615422,0.00012632573,0.0001884223,0.00022915607,0.00006018794,0.00021298723,0.00007697235,0.00019903408,0.0008522488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017375423,0.00040586753,0.98326147,0.00003413981,0.00021865492,0.00017646793,0.00054595683,0.00003665861,0.0003804494,0.00042891334,0.0008625273,0.013475162],"study_design_scores_gemma":[0.0051482,0.0003918065,0.93099594,0.0002993024,0.00022072511,0.000052733383,0.0022178874,0.00014415503,0.00018923926,0.00007092487,0.06008336,0.0001857553],"about_ca_topic_score_codex":0.00045194398,"about_ca_topic_score_gemma":0.0003951802,"teacher_disagreement_score":0.05922083,"about_ca_system_score_codex":0.00015971038,"about_ca_system_score_gemma":0.000087731605,"threshold_uncertainty_score":0.99992573},"labels":[],"label_agreement":null},{"id":"W6995530821","doi":"","title":"Pedagogies in English for Academic Purposes: Teaching and Learning in International Contexts","year":2021,"lang":"en","type":"other","venue":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"English for academic purposes; Diversity (politics); Principal (computer security); English language; Work (physics); Focus (optics); Higher education","score_opus":0.02159745235127066,"score_gpt":0.31607307790267347,"score_spread":0.29447562555140283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995530821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83864444,0.03563554,0.00007488541,0.0025804744,0.0022040952,0.0020958309,0.00007394457,0.00046296307,0.118227854],"genre_scores_gemma":[0.82786393,0.009233316,0.0049866983,0.0006957613,0.0023570457,0.00034352345,0.0006343293,0.00061462796,0.15327074],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975983,0.00025351357,0.00064863457,0.0007091822,0.00032351344,0.00046684445],"domain_scores_gemma":[0.99853283,0.00070773356,0.0003310098,0.00021883793,0.000083992956,0.00012558502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000924746,0.00045571523,0.00085375726,0.00091723824,0.00012495568,0.00010707723,0.00020069105,0.0004975962,0.000081287704],"category_scores_gemma":[0.0019846638,0.00041614272,0.00018589459,0.00014509962,0.00006500639,0.00007808598,0.00012663938,0.0018052611,0.0000038518683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009659596,0.002125913,0.56952405,0.002031955,0.0024592578,0.004954656,0.07351436,0.000106990854,0.0035686435,0.0037199215,0.067282006,0.26974627],"study_design_scores_gemma":[0.015098994,0.00058458635,0.023171537,0.020540686,0.00038365767,0.0004651605,0.011293,0.0005367696,0.0007424268,0.00023729946,0.9257763,0.001169564],"about_ca_topic_score_codex":0.00037924372,"about_ca_topic_score_gemma":0.00039304947,"teacher_disagreement_score":0.85849434,"about_ca_system_score_codex":0.00034259586,"about_ca_system_score_gemma":0.00026472006,"threshold_uncertainty_score":0.99982905},"labels":[],"label_agreement":null},{"id":"W7001068443","doi":"","title":"The Importance of Policy for Community Economic Development: A Case Study of the Manitoba Context","year":2011,"lang":"en","type":"article","venue":"WinnSpace (University of Winnipeg)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Social Sciences and Humanities Research Council of Canada","keywords":"General partnership; Context (archaeology); Participatory action research; Action (physics); Order (exchange); Social policy; Citizen journalism; Policy analysis","score_opus":0.04990574552156106,"score_gpt":0.2492653303821651,"score_spread":0.19935958486060407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001068443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724656,0.00009219723,0.0000074666327,0.0006322934,0.000044077664,0.00085592753,0.000026991365,0.0000085031215,0.0010860069],"genre_scores_gemma":[0.99931043,0.000016669406,0.00028251443,0.000038490623,0.000012345561,0.0000026106648,0.0000022829706,0.000007770213,0.00032690295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993811,0.00008613262,0.0001767301,0.00011092748,0.00010282361,0.00014224426],"domain_scores_gemma":[0.99872035,0.00018790289,0.00033544376,0.0005810333,0.00012089344,0.00005438045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023919293,0.00010892951,0.00030155014,0.00006330754,0.0004310771,0.0000024171063,0.00027140224,0.000044533597,0.000016705435],"category_scores_gemma":[0.000033054224,0.00007847027,0.00012794096,0.00011723549,0.00025651776,0.000060890485,0.00015969765,0.000076971635,0.0000022946454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005654707,0.0023088318,0.9009452,0.000114465285,0.0008293267,0.00010980127,0.085198015,0.000001922582,0.000058218164,0.0014954563,0.00079993746,0.007573396],"study_design_scores_gemma":[0.005135659,0.00076716207,0.6324115,0.00006961212,0.00027998886,0.00010462997,0.3580529,0.000014111859,0.0014518625,0.00006355319,0.0015642885,0.00008477769],"about_ca_topic_score_codex":0.045607436,"about_ca_topic_score_gemma":0.13594809,"teacher_disagreement_score":0.2728549,"about_ca_system_score_codex":0.00020871397,"about_ca_system_score_gemma":0.0003328396,"threshold_uncertainty_score":0.96074796},"labels":[],"label_agreement":null},{"id":"W7001404267","doi":"","title":"Infrastructures essentielles en béton : prolonger la durée de vie des ponts au Canada","year":2013,"lang":"fr","type":"article","venue":"NPARC","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Latin Americans; Chinatown; Rail transportation","score_opus":0.004503915990585925,"score_gpt":0.22163963200836634,"score_spread":0.21713571601778042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001404267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92936367,0.004979427,0.000010917078,0.012600538,0.00093463255,0.0005060735,0.000039969153,0.000024253093,0.05154052],"genre_scores_gemma":[0.9905906,0.00090878096,0.0019063308,0.00062460074,0.000760845,0.00016287486,0.00002375821,0.000033169697,0.004989062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982782,0.0001610647,0.00025225297,0.0002817709,0.00030501373,0.0007217189],"domain_scores_gemma":[0.99863917,0.00042526284,0.00007555737,0.0003835094,0.00007525854,0.0004012705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001315712,0.00027494677,0.0003263784,0.00004877024,0.00014577775,0.00005431414,0.00017072567,0.00019107478,0.006184999],"category_scores_gemma":[0.00028806974,0.00022102785,0.00008401413,0.00010605949,0.00020362115,0.00010897588,0.000099797246,0.00015230411,0.00015888855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044967805,0.00044603756,0.627368,0.00040244195,0.00049152627,0.000744007,0.0019970634,0.000037739468,0.0048348503,0.0035931212,0.16729431,0.19274598],"study_design_scores_gemma":[0.0016339129,0.00014421964,0.9016689,0.00046413214,0.0002806899,0.00016325532,0.00031138732,0.00020347681,0.014182502,0.0073129055,0.07342283,0.0002117984],"about_ca_topic_score_codex":0.74315137,"about_ca_topic_score_gemma":0.55627495,"teacher_disagreement_score":0.27430093,"about_ca_system_score_codex":0.0016373026,"about_ca_system_score_gemma":0.0028527388,"threshold_uncertainty_score":0.9947235},"labels":[],"label_agreement":null},{"id":"W7001531857","doi":"","title":"La prise de contrôle inversée en droit canadien","year":2008,"lang":"fr","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Public capital; Public policy; Context (archaeology); Capital (architecture)","score_opus":0.0020449902554264057,"score_gpt":0.136423584566062,"score_spread":0.1343785943106356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001531857","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038925633,0.0058299615,0.000009760217,0.005469201,0.00042051228,0.00051587494,0.0007673597,0.00001452831,0.94804716],"genre_scores_gemma":[0.58193326,0.0040003727,0.0005236536,0.0021572679,0.00030149496,0.000037226444,0.00003522997,0.0001244942,0.41088697],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664396,0.000220706,0.00043352862,0.00047599073,0.0014701501,0.00075566076],"domain_scores_gemma":[0.9974363,0.00078933564,0.00027844383,0.00038085447,8.320921e-7,0.0011142679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000018649589,0.0005009545,0.0007830691,0.00005587074,0.00018876874,0.000020243262,0.0002645781,0.000168495,0.0008432067],"category_scores_gemma":[0.000014827541,0.00049716793,0.00009406582,0.00008426353,0.0002781785,0.00013845653,0.0001508149,0.00027310607,5.3382646e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012060493,0.00069922983,0.38482106,0.0018680157,0.0029407118,0.02059836,0.0013470551,0.000059841717,0.0016117811,0.38799462,0.09175528,0.10509801],"study_design_scores_gemma":[0.0027940741,0.00021876735,0.17523852,0.0011916003,0.00027384405,0.00028178253,0.0021912057,0.00042775032,0.009038335,0.00028773595,0.8075528,0.000503562],"about_ca_topic_score_codex":0.3234637,"about_ca_topic_score_gemma":0.56140757,"teacher_disagreement_score":0.71579754,"about_ca_system_score_codex":0.00021328953,"about_ca_system_score_gemma":0.0169497,"threshold_uncertainty_score":0.999748},"labels":[],"label_agreement":null},{"id":"W7001647539","doi":"","title":"130 landen en jurisdicties committeren zich aan 2-pijlerherziening van het internationale winstbelastingsysteem","year":2021,"lang":"nl","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pilgrim; Prime minister; European union","score_opus":0.02114110344886426,"score_gpt":0.2630461524845371,"score_spread":0.24190504903567284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001647539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96153355,0.01136808,0.00037894075,0.0010054908,0.0009607691,0.00041042615,0.0015482984,0.0001594165,0.022635018],"genre_scores_gemma":[0.9778998,0.00494189,0.001038915,0.00076031114,0.0017695129,0.000035299076,0.009049253,0.00007945138,0.0044255913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960787,0.0005486449,0.0007668084,0.0012253721,0.0006145511,0.00076587085],"domain_scores_gemma":[0.9962096,0.0013722767,0.00033923707,0.0015657857,0.0001065166,0.00040657504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070559914,0.0005990893,0.00084622885,0.00015372582,0.0005834274,0.00045129439,0.0010465101,0.00017065591,0.00036396607],"category_scores_gemma":[0.000052187723,0.0005220067,0.00012605473,0.00032175568,0.00012683925,0.00047380832,0.0023001535,0.00045271177,0.00023086324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023651619,0.00073698297,0.93922246,0.0015225117,0.002089851,0.0011085098,0.0152829,0.00037484244,0.0002828341,0.00023869045,0.0053002164,0.033603698],"study_design_scores_gemma":[0.005218827,0.0003532403,0.7454273,0.010005128,0.0015699429,0.00069209177,0.007480702,0.09430277,0.00029496974,0.00018695224,0.1335798,0.00088824244],"about_ca_topic_score_codex":0.0017202921,"about_ca_topic_score_gemma":0.004150644,"teacher_disagreement_score":0.19379513,"about_ca_system_score_codex":0.00015052919,"about_ca_system_score_gemma":0.00018555108,"threshold_uncertainty_score":0.99972314},"labels":[],"label_agreement":null},{"id":"W7015558324","doi":"","title":"Symmetry and broken symmetry in molecules","year":2005,"lang":"en","type":"article","venue":"NPARC","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"","score_opus":0.009636681593273477,"score_gpt":0.2544125247887404,"score_spread":0.2447758431954669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7015558324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171924,0.0009898045,0.00000416448,0.0033669805,0.000022702729,0.00012717175,0.0000030482486,0.0000225395,0.07827121],"genre_scores_gemma":[0.9946383,0.00026478156,0.0034245122,0.001069425,0.00007848454,0.000019385725,0.0000059064187,0.000009303411,0.00048988924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994523,0.00001234967,0.000114508424,0.00015886003,0.00011210797,0.00014986658],"domain_scores_gemma":[0.99970526,0.000042583364,0.000017348182,0.00013198623,0.00001233203,0.00009051388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005375948,0.00008376362,0.00015770986,0.00009234892,0.000018177856,0.000010432455,0.000025217021,0.000049162227,0.00014665561],"category_scores_gemma":[0.000029463632,0.0000662607,0.00003112718,0.000103102706,0.000026539894,0.000035660556,0.000025198427,0.00005012855,0.00007027253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055769215,0.0006737662,0.71704686,0.000045075943,0.000060663653,0.00020247416,0.00013937295,6.4355436e-7,0.0044124103,0.01029765,0.005206285,0.26185906],"study_design_scores_gemma":[0.00416331,0.00019489959,0.9601803,0.000120936034,0.0000686942,0.00011207602,0.000082834486,0.00029637016,0.01573949,0.00091543235,0.017993834,0.00013186633],"about_ca_topic_score_codex":0.000029259978,"about_ca_topic_score_gemma":0.000021920665,"teacher_disagreement_score":0.26172718,"about_ca_system_score_codex":0.00008988111,"about_ca_system_score_gemma":0.000024779963,"threshold_uncertainty_score":0.2702033},"labels":[],"label_agreement":null},{"id":"W7020632091","doi":"","title":"Linfoma de Burkitt : revisão sistemática da eficácia e segurança dos tratamentos quimioterápicos e estudo epidemiológico dos fatores prognósticos, de risco e sobrevida global","year":2020,"lang":"pt","type":"article","venue":"Repositório Digital Institucional da UFPR (Universidade Federal do Paraná)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Cancer; Burkitt's lymphoma; Romidepsin; Immunotherapy","score_opus":0.037831122300105956,"score_gpt":0.28860887275714425,"score_spread":0.2507777504570383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7020632091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92102635,0.019591318,0.0021557887,0.024356874,0.0007551236,0.004676817,0.0022127891,0.0006543711,0.024570575],"genre_scores_gemma":[0.9917574,0.0010249623,0.00087104423,0.0031759348,0.0010690177,0.00013881752,0.00081333786,0.00014809662,0.0010014224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908731,0.000417104,0.00208185,0.0024899961,0.0017988342,0.0023391407],"domain_scores_gemma":[0.9934959,0.0006213964,0.0010325467,0.0012014355,0.00041711962,0.0032315953],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00047360858,0.0018896065,0.0025899773,0.00025850226,0.0013103238,0.0027100507,0.0010767804,0.00095675065,0.0003908807],"category_scores_gemma":[0.0008665724,0.0018426386,0.0016693621,0.0010896648,0.00065938814,0.0020357517,0.0006719614,0.000973857,0.0010754182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012693378,0.0119740935,0.7092686,0.007824242,0.012861921,0.051572498,0.008878867,0.002728425,0.0025470871,0.0753348,0.042341307,0.061974768],"study_design_scores_gemma":[0.06273362,0.014657944,0.6159651,0.02327254,0.013337888,0.01707225,0.012548366,0.019665405,0.0037660976,0.0013977197,0.20468913,0.010893918],"about_ca_topic_score_codex":0.0007694024,"about_ca_topic_score_gemma":0.00008483917,"teacher_disagreement_score":0.16234782,"about_ca_system_score_codex":0.0036993017,"about_ca_system_score_gemma":0.0024713739,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W7027359939","doi":"","title":"Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies","year":2021,"lang":"en","type":"other","venue":"Open Repository of the University of Porto (University of Porto)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Lymphoma; Burkitt's lymphoma; Confidence interval; Quality of life (healthcare); MEDLINE; Public health","score_opus":0.026792342575016493,"score_gpt":0.27867107523916124,"score_spread":0.25187873266414473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7027359939","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07472726,0.41885713,0.00026200383,0.004068447,0.002228063,0.030064523,0.00232936,0.00013242073,0.46733078],"genre_scores_gemma":[0.022182535,0.021772318,0.004251466,0.00006321286,0.00003461979,0.0000020633959,0.00024719763,0.00009697775,0.9513496],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99842465,0.00012869966,0.0004619801,0.0003796369,0.00046128986,0.0001437353],"domain_scores_gemma":[0.9958786,0.00007849347,0.0026002908,0.0008716523,0.00048812365,0.00008286272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024209156,0.00028119705,0.00216939,0.00016690076,0.0001380339,0.0000031422785,0.0007490854,0.00017923352,0.0008157512],"category_scores_gemma":[0.00003160803,0.00025389477,0.0012657846,0.00019501994,0.0004619083,0.00006772489,0.00043145844,0.000045616463,0.0000016818253],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078451727,0.006114406,0.011616368,0.675534,0.034637876,0.0006354279,0.0018603168,7.167837e-7,0.0004732969,0.00054159027,0.2673144,0.00048707039],"study_design_scores_gemma":[0.017944152,0.0016406367,0.029819993,0.87063676,0.034569632,0.00022616771,0.012979427,0.000007159635,0.0028992188,0.000049080736,0.028579112,0.00064864045],"about_ca_topic_score_codex":0.0028175008,"about_ca_topic_score_gemma":0.00016877062,"teacher_disagreement_score":0.48401883,"about_ca_system_score_codex":0.00032639614,"about_ca_system_score_gemma":0.00046403197,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W7033539258","doi":"","title":"Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Chemotherapy; Disease; Hodgkin lymphoma; Autologous stem-cell transplantation; Stage (stratigraphy); Cancer","score_opus":0.09355104931014305,"score_gpt":0.4500661133937765,"score_spread":0.3565150640836334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7033539258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750883,0.02193841,0.00004670378,0.0005178019,0.0004816978,0.0009380628,0.000033950677,0.00004197964,0.0009131006],"genre_scores_gemma":[0.9738441,0.025261361,0.00005457609,0.00050285814,0.00012105879,0.00008249218,0.000012825882,0.000062034305,0.000058696056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970964,0.0003044603,0.0008636211,0.00062898424,0.00062596257,0.00048054903],"domain_scores_gemma":[0.9982317,0.0002202956,0.00052246056,0.0005290167,0.00009998579,0.00039655715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006782182,0.00046834166,0.0011826955,0.0006823587,0.0001224538,0.00029537236,0.0006933229,0.00016197341,0.00047506377],"category_scores_gemma":[0.000027066722,0.00036345882,0.00019037194,0.00045653377,0.000105525294,0.00043710013,0.0001380931,0.0002589116,0.000021868604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016335901,0.0031485914,0.60113233,0.0002614184,0.00010070434,0.00016774432,0.00027419,0.000012878743,0.005933699,0.00008274549,0.0021574742,0.3850946],"study_design_scores_gemma":[0.013260442,0.00016953688,0.936246,0.0030281392,0.00016408827,0.000052340827,0.000025242107,0.000081554965,0.04365212,0.0006660459,0.0022997404,0.00035480259],"about_ca_topic_score_codex":0.0008663539,"about_ca_topic_score_gemma":0.0000632818,"teacher_disagreement_score":0.38473982,"about_ca_system_score_codex":0.00033698988,"about_ca_system_score_gemma":0.00014621991,"threshold_uncertainty_score":0.99988174},"labels":[],"label_agreement":null},{"id":"W7054304868","doi":"","title":"Alerus Entrepreneurship Challenge 2011","year":2011,"lang":"en","type":"article","venue":"UND Scholarly Commons (University of North Dakota)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; TSG101; Pretext; Gestational period; Diafiltration; Sclerodactyly","score_opus":0.05982019877107003,"score_gpt":0.22776774822318194,"score_spread":0.1679475494521119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7054304868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94979405,0.0009110068,0.000032499098,0.00081068743,0.00007648292,0.00025532948,0.000047149344,0.00007436812,0.047998395],"genre_scores_gemma":[0.9969523,0.00041675568,0.0011572634,0.000076388984,0.000022964414,7.404822e-7,0.00004874453,0.0000135875025,0.0013112781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989179,0.000070838585,0.00013972756,0.00032332612,0.0002846682,0.00026355527],"domain_scores_gemma":[0.9986802,0.000057976613,0.00012344753,0.00066750357,0.00017302524,0.00029788128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000103068334,0.00017576868,0.00034994812,0.00021170733,0.00021145525,0.000019203944,0.00029471464,0.00009997866,0.0014709433],"category_scores_gemma":[0.000021115697,0.00018876312,0.00021323416,0.00017358572,0.00015299584,0.0005931024,0.000160206,0.00021782143,0.000564498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021455233,0.0013881336,0.9768273,0.000028555087,0.00034257243,0.00055742415,0.0011937738,2.571289e-7,0.000012038291,0.0011037493,0.0012977602,0.017033862],"study_design_scores_gemma":[0.0023728544,0.0005789254,0.9830662,0.000047674657,0.0004643175,0.000024403214,0.00022289202,0.0000064457863,0.00010662951,0.000119829805,0.012833696,0.00015611332],"about_ca_topic_score_codex":0.0016463915,"about_ca_topic_score_gemma":0.0030361377,"teacher_disagreement_score":0.047158197,"about_ca_system_score_codex":0.0001018059,"about_ca_system_score_gemma":0.000097923075,"threshold_uncertainty_score":0.99944186},"labels":[],"label_agreement":null},{"id":"W7084496860","doi":"10.1007/978-3-031-93022-5_4","title":"Evaluating AI Assistive Technologies for Older Adults Living with Dementia Using a Disability Justice Framework","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dementia; Economic Justice; Assistive technology; Independent living; Order (exchange); Activities of daily living; Social model of disability; Social justice","score_opus":0.037550032990755385,"score_gpt":0.35180470733557534,"score_spread":0.31425467434481996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084496860","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06516474,0.028949985,0.21625163,0.0126931975,0.0025832662,0.038949523,0.00094591524,0.005007549,0.6294542],"genre_scores_gemma":[0.6256911,0.00016432951,0.33202028,0.00096839253,0.00028420897,0.0008915533,0.000113521724,0.00013460455,0.039731972],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.997989,0.000014896245,0.0004315649,0.0008318977,0.00039741438,0.00033523922],"domain_scores_gemma":[0.9971237,0.0015095527,0.0002464822,0.0006492326,0.00040775305,0.00006325257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002255885,0.0004985391,0.00074711203,0.00010338867,0.0002342248,0.00005161768,0.00009394182,0.0005616356,0.00028710274],"category_scores_gemma":[0.0009044563,0.00034179958,0.00023797205,0.000063405736,0.00020661141,0.00005873786,0.0001750287,0.000316446,0.00000537729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013354222,0.0022517585,0.07663408,0.011209201,0.0098983655,0.00012388079,0.00063655403,0.0000442568,0.000009504399,0.13320553,0.0026853129,0.7619661],"study_design_scores_gemma":[0.030366395,0.012222194,0.22606456,0.42162427,0.20501444,0.0002820774,0.010905476,0.040821772,0.0018176306,0.033328936,0.010816889,0.00673537],"about_ca_topic_score_codex":0.00005655556,"about_ca_topic_score_gemma":0.00004590852,"teacher_disagreement_score":0.7552308,"about_ca_system_score_codex":0.0006730138,"about_ca_system_score_gemma":0.00034995115,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W7084497545","doi":"10.1007/978-3-031-95288-3_25","title":"Seismic Performance of Ductile Links for Wall-to-Wall Connections in Precast Concrete Structures","year":2025,"lang":"en","type":"book-chapter","venue":"Lecture notes in civil engineering","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Precast concrete; Shear wall; Seismic loading; Seismic analysis; Reinforcement; Reinforced concrete; Structural system","score_opus":0.010964003171511687,"score_gpt":0.23198919577372332,"score_spread":0.22102519260221162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084497545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8331317,0.026249306,0.04947649,0.0088885985,0.006317203,0.018575126,0.0012137656,0.00089385366,0.05525398],"genre_scores_gemma":[0.99479157,0.00028602214,0.0022698438,0.00028730967,0.0001740046,0.0001836474,0.00010637499,0.00006860266,0.001832599],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99868625,0.0000045266343,0.00044668163,0.00040682268,0.00015945687,0.00029624545],"domain_scores_gemma":[0.9989413,0.0004705763,0.00009021564,0.00033774567,0.0000829591,0.00007722774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007566491,0.00040059237,0.0007479859,0.0005724837,0.000024623261,0.000011082583,0.00010464237,0.00059462874,0.00007779329],"category_scores_gemma":[0.00019400078,0.00037315508,0.00016837353,0.0001209526,0.000022935974,0.000030443054,0.000043836066,0.00053256407,0.000002499738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058503303,0.00007148889,0.007433867,0.006056374,0.0009859924,0.00010797748,0.0015018542,0.9490814,0.0018213561,0.0054992945,0.00059406064,0.026261266],"study_design_scores_gemma":[0.019795643,0.004498205,0.027836652,0.03273677,0.0020377368,0.00044733525,0.000016155578,0.5874492,0.07646786,0.003914331,0.24117774,0.0036223596],"about_ca_topic_score_codex":0.00010133985,"about_ca_topic_score_gemma":0.00037254978,"teacher_disagreement_score":0.36163223,"about_ca_system_score_codex":0.00041141448,"about_ca_system_score_gemma":0.00015211084,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W7088228805","doi":"10.5281/zenodo.17325626","title":"Erinnyis alope","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Larva; Distribution (mathematics); Population; Host (biology); Common species","score_opus":0.025632570401309222,"score_gpt":0.26921738032993897,"score_spread":0.24358480992862974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7088228805","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08948451,0.0003610911,0.00066186115,0.0059078834,0.00013979607,0.0006398225,0.000076499535,0.00087500486,0.9018535],"genre_scores_gemma":[0.9905509,0.00019093684,0.00027965105,0.00081421033,0.00007293354,6.538845e-8,0.00078197307,0.00048631427,0.006823039],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990945,0.00007324813,0.00015440452,0.00026764983,0.00018872187,0.00022150877],"domain_scores_gemma":[0.9991895,0.000014712822,0.000031792733,0.00036342844,0.00027943173,0.00012112371],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018207204,0.00009690741,0.00013840132,0.00017642943,0.0008728337,0.00022255324,0.0002426568,0.000043149,0.009159685],"category_scores_gemma":[0.0002515283,0.000088078144,0.000056288794,0.00043758983,0.00007483586,0.00007084172,0.00042863126,0.00009486528,0.006879203],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014060149,0.00058695953,0.00023965251,0.0001003555,0.00018768746,0.000082523526,0.00029446682,0.000004343384,0.0019360387,0.015817596,0.5877292,0.3928806],"study_design_scores_gemma":[0.0012590803,0.0002060596,0.017066954,0.000061101244,0.000045875357,0.00008486649,0.00008490715,0.00004600074,0.0017436405,0.000116185875,0.9792135,0.000071847855],"about_ca_topic_score_codex":0.000015570784,"about_ca_topic_score_gemma":1.3165044e-7,"teacher_disagreement_score":0.90106636,"about_ca_system_score_codex":0.00021153978,"about_ca_system_score_gemma":0.0000063286284,"threshold_uncertainty_score":0.99389404},"labels":[],"label_agreement":null},{"id":"W7090367903","doi":"10.2196/63920","title":"The Coordination on Mobile Pandemic Apps Best Practice and Solution Sharing (COMPASS) Framework: Holistic Approach to Pandemic mHealth Apps","year":2025,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pandemic; Compass; Coronavirus disease 2019 (COVID-19); Health care; mHealth; Public health","score_opus":0.12543428627921244,"score_gpt":0.4772078565941094,"score_spread":0.351773570314897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7090367903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93936414,0.0022005804,0.0062414734,0.0059837108,0.00019496346,0.005348012,0.000024209674,0.00012370394,0.040519215],"genre_scores_gemma":[0.9942521,0.0013463149,0.00033769608,0.0003198889,0.00008422085,0.0027221807,0.000036022207,0.000014563794,0.00088701624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976532,0.00029723722,0.00034054194,0.00039701603,0.00071047386,0.0006015707],"domain_scores_gemma":[0.9965618,0.0022903667,0.000094333365,0.00041915872,0.00042063344,0.0002136829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002214706,0.00017667632,0.00027249506,0.0003353406,0.0009528795,0.00016910498,0.00018252281,0.00015096097,0.000005315752],"category_scores_gemma":[0.0008701736,0.000115748066,0.000051536455,0.0007754006,0.0001700834,0.0002425455,0.0002465307,0.00074242114,0.0001143685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037284445,0.009267907,0.097480424,0.0016321975,0.0007363583,0.00002158174,0.02066728,0.0002140664,0.00025913134,0.20169349,0.03147022,0.6328289],"study_design_scores_gemma":[0.014580292,0.011711381,0.61621284,0.006610432,0.0004883922,0.00029945612,0.05191984,0.06344691,0.0007660688,0.017545769,0.21540692,0.0010116614],"about_ca_topic_score_codex":0.0001871466,"about_ca_topic_score_gemma":0.00001347771,"teacher_disagreement_score":0.6318172,"about_ca_system_score_codex":0.0012269092,"about_ca_system_score_gemma":0.00023268026,"threshold_uncertainty_score":0.7328875},"labels":[],"label_agreement":null},{"id":"W7093121247","doi":"","title":"C034 | THE ROLE OF STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH CHECKPOINT INHIBITORS: ITALIAN MULTICENTER EXPERIENCE","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Autologous stem-cell transplantation; Transplantation; Classical Hodgkin lymphoma; Brentuximab vedotin; Nivolumab; Pembrolizumab; Salvage therapy; Hodgkin lymphoma","score_opus":0.04719699277587143,"score_gpt":0.41104289712328596,"score_spread":0.36384590434741454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093121247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387544,0.002564581,0.0000135615155,0.00009428949,0.00009237906,0.0011753173,0.00004073383,0.000017847613,0.0021258339],"genre_scores_gemma":[0.9983364,0.0010771776,0.0000730766,0.00012285764,0.00002490587,0.00016242047,0.000037091795,0.000033660424,0.00013242144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974996,0.0002083194,0.0008519062,0.00043454362,0.0006926358,0.00031300995],"domain_scores_gemma":[0.9982819,0.00020373252,0.0006240934,0.00044937836,0.00027664416,0.00016426432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026802512,0.0003465168,0.0007349026,0.00047909096,0.000112650654,0.00018669576,0.0005856316,0.00011444342,0.0003033148],"category_scores_gemma":[0.000017900795,0.00019941594,0.00013474905,0.0008307779,0.0002094412,0.00082684425,0.00011155389,0.00017729698,0.0000030471715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045441873,0.0036348416,0.95971715,0.00013451446,0.00023300436,0.00007453299,0.0013326083,0.00002480758,0.0073587494,0.000008936091,0.00025408657,0.022682592],"study_design_scores_gemma":[0.009127172,0.00017198146,0.82341516,0.0016758521,0.00025849853,0.000004454168,0.0005534715,0.0000303859,0.16402885,0.00001546562,0.0005441216,0.0001745916],"about_ca_topic_score_codex":0.0013148447,"about_ca_topic_score_gemma":0.00012777497,"teacher_disagreement_score":0.15667011,"about_ca_system_score_codex":0.0003482411,"about_ca_system_score_gemma":0.00022060014,"threshold_uncertainty_score":0.8131946},"labels":[],"label_agreement":null},{"id":"W7108441632","doi":"10.1182/blood-2025-1761","title":"Genomic and transcriptomic landscape of extranodal marginal zone lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transcriptome; Lymphoma; Exome sequencing; BCL10; Copy number analysis; Missense mutation; Mutation; Exome","score_opus":0.006672173479129042,"score_gpt":0.22576154697001088,"score_spread":0.21908937349088184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108441632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98701215,0.0066815875,0.000023961717,0.00042473825,0.00005566752,0.00018789252,0.000016761074,0.000021346053,0.0055758827],"genre_scores_gemma":[0.9983758,0.0004033016,0.00043640158,0.00014108892,0.000030457108,0.000019029369,0.000011391761,0.000007503468,0.00057504425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945617,0.000011587906,0.00016082317,0.00016463088,0.00007862944,0.00012816848],"domain_scores_gemma":[0.9997166,0.00002839207,0.000026049453,0.0001507496,0.000021115075,0.00005708951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044226374,0.00009986921,0.00024819796,0.000086753396,0.000027474209,0.0000071793856,0.000035335026,0.000050682986,0.000065631386],"category_scores_gemma":[0.0000043598898,0.000080922386,0.000069347414,0.00008258231,0.00004199399,0.000018039935,0.000012312908,0.0000202747,0.0000065378945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032667277,0.0025032926,0.91890574,0.00024581532,0.00055694307,0.00012508382,0.00019254486,3.0956542e-7,0.05345322,0.0014120404,0.00047449258,0.021803848],"study_design_scores_gemma":[0.017767178,0.00022823,0.9414542,0.00011069319,0.0007419903,0.00011426896,0.000051454477,0.000018403038,0.037152987,0.0000491103,0.002247678,0.000063826956],"about_ca_topic_score_codex":0.000054350603,"about_ca_topic_score_gemma":0.00001313105,"teacher_disagreement_score":0.022548443,"about_ca_system_score_codex":0.000019766288,"about_ca_system_score_gemma":0.00010231209,"threshold_uncertainty_score":0.32999194},"labels":[],"label_agreement":null},{"id":"W7108463524","doi":"10.1182/blood-2025-4507","title":"The impact of marginalization on outcomes in patients with Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Oakville-Trafalgar Memorial Hospital; University of Toronto","funders":"","keywords":"Socioeconomic status; Hodgkin lymphoma; Census; Immigration; Retrospective cohort study; Proportional hazards model; Health care; Population; Ethnic group","score_opus":0.004784470550882652,"score_gpt":0.25990299224498525,"score_spread":0.2551185216941026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108463524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971427,0.00007626496,0.0000013812955,0.00016541028,0.000018295177,0.0002804571,0.0000058683377,0.000007002227,0.0023026688],"genre_scores_gemma":[0.99969375,0.000018174505,0.00002275437,0.000053194726,0.0000035680184,0.00002360778,0.000013911032,0.0000044088733,0.00016663327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958456,0.000016942962,0.00011080021,0.000083945015,0.00011504973,0.00008872952],"domain_scores_gemma":[0.99965584,0.00007426956,0.000040568313,0.00017068363,0.000039510374,0.000019111658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003594353,0.00007211141,0.00014498421,0.000060839062,0.000024846213,0.000006457997,0.00003141577,0.000022210128,0.0000069097346],"category_scores_gemma":[0.000033795877,0.00003259403,0.00004882325,0.00014410626,0.000018110048,0.000014075843,0.0000090875055,0.000012159274,0.0000031231837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025259415,0.0036748154,0.99004084,0.000008240946,0.00022372378,0.0000050750473,0.00002967013,0.0000065508116,0.000002813817,0.00037161843,0.00011353734,0.005270535],"study_design_scores_gemma":[0.014056128,0.0009305768,0.9837794,0.00010700861,0.000093015165,4.1543268e-7,0.000008704659,0.0000054097704,0.00091026333,0.00003686118,0.00004404494,0.000028218876],"about_ca_topic_score_codex":0.00017445786,"about_ca_topic_score_gemma":0.000019158475,"teacher_disagreement_score":0.013803534,"about_ca_system_score_codex":0.00008552965,"about_ca_system_score_gemma":0.000080649355,"threshold_uncertainty_score":0.13291459},"labels":[],"label_agreement":null},{"id":"W7108678797","doi":"10.1182/blood-2025-154","title":"Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University Health Centre; Institute of Cancer Research","funders":"","keywords":"Brentuximab vedotin; Dacarbazine; Randomized controlled trial; Nivolumab; International Prognostic Index; Hodgkin lymphoma; Clinical trial; ABVD; Nomogram","score_opus":0.031878883213405707,"score_gpt":0.3669264143961367,"score_spread":0.335047531182731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108678797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906074,0.00036690698,0.000023806364,0.0011540793,0.0016888307,0.0036791482,0.000022081063,0.00002053584,0.0024372258],"genre_scores_gemma":[0.9976501,0.00085207925,0.00026631806,0.00017817182,0.00023018042,0.0005849289,0.000039304865,0.000013020391,0.00018593467],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615663,0.0008153376,0.0017799722,0.0004023971,0.00061158836,0.00023405634],"domain_scores_gemma":[0.9936103,0.00478199,0.00065359665,0.0006635669,0.00023417886,0.000056336816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026762486,0.00021486124,0.00093559053,0.00012858,0.000060742717,0.00001968885,0.00047436016,0.00018913891,0.000026422831],"category_scores_gemma":[0.006310817,0.00012217123,0.00057672407,0.00041780475,0.0004438074,0.00008252169,0.00014342356,0.000215105,0.000008263198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2845056,0.012302998,0.64913666,0.000098993456,0.00073777116,0.000010718922,0.00016090713,0.000009059616,0.000008781684,0.0010267352,0.000113441296,0.051888335],"study_design_scores_gemma":[0.5833533,0.0011792891,0.4124195,0.00037019944,0.000823194,0.000004411916,0.00012313975,0.00077144074,0.00039687357,0.000038079947,0.00044864241,0.00007196581],"about_ca_topic_score_codex":0.000048819853,"about_ca_topic_score_gemma":0.000030776217,"teacher_disagreement_score":0.29884768,"about_ca_system_score_codex":0.00007416128,"about_ca_system_score_gemma":0.0005497094,"threshold_uncertainty_score":0.7555093},"labels":[],"label_agreement":null},{"id":"W7108732077","doi":"10.1182/blood-2025-151","title":"3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; University of Toronto; Cargill (Canada)","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Hodgkin lymphoma; Dacarbazine; Clinical endpoint; Stage (stratigraphy); Randomized controlled trial; Lymphoma","score_opus":0.011486390225167467,"score_gpt":0.2751201723404266,"score_spread":0.2636337821152592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108732077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930576,0.0002837078,0.000007894459,0.0006313522,0.00039038662,0.0035756328,0.00006780681,0.00006989826,0.0019157239],"genre_scores_gemma":[0.9975014,0.000010574611,0.0005197083,0.00014586818,0.000034023098,0.000509175,0.000019175555,0.000038214053,0.0012219006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976198,0.00015857806,0.00056057365,0.0005982806,0.000609964,0.0004527885],"domain_scores_gemma":[0.9980111,0.0001699735,0.0002152509,0.0012640415,0.00018648458,0.00015310787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025328484,0.0003546055,0.0008388661,0.00017538492,0.00011213344,0.000035900495,0.0004246621,0.00008934172,0.00003290572],"category_scores_gemma":[0.00017539147,0.00021871457,0.00015458297,0.00078838976,0.00010765886,0.000060874205,0.00030877182,0.000117241296,0.000008245461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026200358,0.016487075,0.966211,0.00013333876,0.00064930087,0.00011171988,0.00092761277,0.000007806263,0.0023591125,0.00019218163,0.00027465442,0.010026139],"study_design_scores_gemma":[0.12220391,0.0025490576,0.85169303,0.000812103,0.0005675208,0.0000066415987,0.0027521881,0.000045654167,0.018438928,0.000021071664,0.0006842445,0.00022566524],"about_ca_topic_score_codex":0.0006686449,"about_ca_topic_score_gemma":0.0031927659,"teacher_disagreement_score":0.119583875,"about_ca_system_score_codex":0.00020500315,"about_ca_system_score_gemma":0.000551759,"threshold_uncertainty_score":0.8918922},"labels":[],"label_agreement":null},{"id":"W7112193051","doi":"","title":"Burkitt Lymphoma International Prognostic Index","year":2021,"lang":"en","type":"article","venue":"VBN Forskningsportal (Aalborg Universitet)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"","score_opus":0.007582976453948645,"score_gpt":0.22641014946086635,"score_spread":0.2188271730069177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7112193051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9307591,0.00028392713,0.00006219879,0.0012021457,0.00040826603,0.00021704471,0.000026582751,0.0001396788,0.06690109],"genre_scores_gemma":[0.9837766,0.00010616547,0.0005512354,0.00059590064,0.00017687076,0.0000073779047,0.00049019203,0.000028806746,0.014266802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852306,0.000014849821,0.00023545731,0.0004497473,0.00044787826,0.00032904],"domain_scores_gemma":[0.9989578,0.000055563687,0.00011974468,0.00030352507,0.0002953325,0.00026799462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005508131,0.00023037908,0.00030266077,0.00019657191,0.00012362386,0.000045230558,0.00013789703,0.00012917914,0.001731188],"category_scores_gemma":[0.00008171439,0.00022322506,0.00022855923,0.0004065863,0.00007607167,0.00021868912,0.00012923409,0.00008265161,0.00025428706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015880214,0.00090801186,0.9683115,0.000028239623,0.00050759345,0.009098643,0.0003231896,0.000009106168,0.00030203201,0.004750393,0.0060743573,0.009528159],"study_design_scores_gemma":[0.0062619993,0.00020972862,0.7624805,0.00019694868,0.00037154282,0.0008522242,0.0013291327,0.00025849388,0.004111665,0.00012306767,0.22349171,0.00031297794],"about_ca_topic_score_codex":0.00014763647,"about_ca_topic_score_gemma":0.000033417222,"teacher_disagreement_score":0.21741736,"about_ca_system_score_codex":0.00039640255,"about_ca_system_score_gemma":0.00041707623,"threshold_uncertainty_score":0.9991814},"labels":[],"label_agreement":null},{"id":"W7114834996","doi":"","title":"Pulmonary Nodular Lymphoid Hyperplasia: Reviewing a Lung Cancer Mimicker","year":2025,"lang":"en","type":"article","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Lymphoma; Biopsy; Lung; Lymph; Mediastinoscopy; Lymphoproliferative disorders; Immunophenotyping; Lymphatic system","score_opus":0.0106661544740096,"score_gpt":0.29305955036413944,"score_spread":0.28239339589012985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7114834996","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10485173,0.7845438,0.03830981,0.014928906,0.0032741616,0.0030468097,0.00014920486,0.00037646058,0.05051912],"genre_scores_gemma":[0.990576,0.0013787248,0.0001721498,0.0068900357,0.00036734823,0.0004667428,0.000054555305,0.000027132915,0.00006730416],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99776524,0.00007169085,0.0004904022,0.0006171375,0.00059889926,0.00045665092],"domain_scores_gemma":[0.99875546,0.00021510503,0.000073497715,0.00042003256,0.000076654185,0.00045925897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032342775,0.00032714178,0.00074647064,0.00009261345,0.0001586203,0.000039389502,0.00016119539,0.00026899544,0.0006139791],"category_scores_gemma":[0.00026870857,0.0002337781,0.00021351191,0.00022466913,0.00018749574,0.00010614229,0.00016339603,0.00024617536,0.00001463164],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001757153,0.0006522029,0.22954364,0.0010023315,0.00044236542,0.00086954917,0.0001586286,8.02947e-7,0.00022177616,0.00079987955,0.00070797093,0.76542515],"study_design_scores_gemma":[0.029739851,0.00056455407,0.20914084,0.0017042431,0.006501331,0.00315068,0.0003523941,0.52692133,0.003560808,0.00076689245,0.21578708,0.0018099827],"about_ca_topic_score_codex":0.00066781085,"about_ca_topic_score_gemma":0.000018306235,"teacher_disagreement_score":0.8857243,"about_ca_system_score_codex":0.00016343023,"about_ca_system_score_gemma":0.000013092361,"threshold_uncertainty_score":0.95331943},"labels":[],"label_agreement":null},{"id":"W7115029889","doi":"","title":"Pulmonary Nodular Lymphoid Hyperplasia: Reviewing a Lung Cancer Mimicker","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Lymphoma; Biopsy; Lung; Lymph; Mediastinoscopy; Lymphoproliferative disorders; Immunophenotyping; Lymphatic system","score_opus":0.16377969261511938,"score_gpt":0.5635187155504215,"score_spread":0.39973902293530217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115029889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6137767,0.3625544,0.00003861604,0.0015853961,0.00084601896,0.0011284081,0.000044315915,0.00004853564,0.01997765],"genre_scores_gemma":[0.8451398,0.14952879,0.00023294149,0.0027460807,0.0002282573,0.0003339459,0.000026752376,0.000055254208,0.0017081604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969797,0.00017918217,0.0010322703,0.00064164074,0.0006585888,0.000508615],"domain_scores_gemma":[0.99777097,0.00026575243,0.0005380135,0.0007280426,0.00037008052,0.00032716623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070979574,0.00045506563,0.0013990604,0.00074251567,0.00028730527,0.0004812539,0.0011243474,0.00015764571,0.006981947],"category_scores_gemma":[0.00023490452,0.00036236984,0.00045162803,0.0012425268,0.00010538947,0.0010245236,0.0007165237,0.00026441898,0.000025410432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024115066,0.00083383196,0.85171777,0.00062582,0.0010232435,0.0006000031,0.00006591427,0.000022563281,0.01741621,0.00006054097,0.07193608,0.055456866],"study_design_scores_gemma":[0.0022904975,0.000012906223,0.88203704,0.0077553974,0.0015408926,0.00035690967,0.000058725847,0.00024477826,0.027615469,0.00039457346,0.07726871,0.00042408865],"about_ca_topic_score_codex":0.0017844946,"about_ca_topic_score_gemma":0.000022653858,"teacher_disagreement_score":0.23136315,"about_ca_system_score_codex":0.0007490929,"about_ca_system_score_gemma":0.0006613948,"threshold_uncertainty_score":0.9998828},"labels":[],"label_agreement":null},{"id":"W7116633529","doi":"10.2139/ssrn.5933255","title":"Discovery of Pyrrolopyrimidinone Inhibitors of the BCL6-SMRT Corepressor Interaction","year":2025,"lang":"","type":"preprint","venue":"SSRN Electronic Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"BCL6; Corepressor; Germinal center; Repressor; Drug discovery; Virtual screening; Protein–protein interaction; Small molecule; Lymphoma","score_opus":0.011264898955258423,"score_gpt":0.2741960931166049,"score_spread":0.26293119416134647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116633529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585555,0.02871985,0.00044438793,0.0022927565,0.0053366055,0.0013863497,0.00010850065,0.000014927937,0.0031410824],"genre_scores_gemma":[0.9164079,0.078152366,0.000021685735,0.00008283964,0.00072565547,0.000056385383,0.000024891826,0.000040874023,0.0044874325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99287796,0.00051066466,0.0023114115,0.00074851344,0.0011375981,0.002413881],"domain_scores_gemma":[0.9942409,0.00046115593,0.0032682521,0.001296244,0.00060434,0.00012911194],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021618097,0.000773734,0.0016868481,0.00045853996,0.00027603476,0.000074750125,0.00088424876,0.00056852587,0.00006981217],"category_scores_gemma":[0.00044123927,0.0005037096,0.0018575487,0.0005154803,0.00040688523,0.0003055509,0.00090481946,0.0051219678,0.00000877026],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015216791,0.023899263,0.37899184,0.004551446,0.051896255,0.00010117436,0.0065690917,0.0057696598,0.034987733,0.17187683,0.002530113,0.3036098],"study_design_scores_gemma":[0.024652978,0.0073891734,0.11976844,0.033733446,0.019121338,0.0027238468,0.016534217,0.00087966654,0.664901,0.10625381,0.002299855,0.0017422094],"about_ca_topic_score_codex":0.0014438855,"about_ca_topic_score_gemma":0.00061412633,"teacher_disagreement_score":0.6299133,"about_ca_system_score_codex":0.005667675,"about_ca_system_score_gemma":0.016639877,"threshold_uncertainty_score":0.99974144},"labels":[],"label_agreement":null},{"id":"W7117104920","doi":"10.1016/j.ijrobp.2025.12.011","title":"Enhancing Radiation Therapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Children's Hospital of Western Ontario; University Health Network; BC Children's Hospital; Princess Margaret Cancer Centre; University of British Columbia","funders":"National Center for Health Statistics; St. Baldrick's Foundation","keywords":"Radiation therapy; Contouring; Quality assurance; Lymphoma; Hodgkin lymphoma; Clinical trial; Radiation treatment planning; Positron emission tomography","score_opus":0.018272806229332177,"score_gpt":0.372227282509611,"score_spread":0.3539544762802788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117104920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97802526,0.011853292,0.00042365497,0.0067577083,0.0010467825,0.00061882654,0.000025406145,0.000028420647,0.0012206249],"genre_scores_gemma":[0.94167686,0.05476934,0.0005577125,0.0022703463,0.00051865476,0.000059270045,0.00009357709,0.000015197628,0.000039044466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732715,0.00045469,0.0013256478,0.00029221526,0.00030498498,0.00029529977],"domain_scores_gemma":[0.9975306,0.000671138,0.0010358613,0.00016460985,0.0005082828,0.00008955024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001104027,0.00022499305,0.0008274677,0.0002694832,0.00003872863,0.000019650732,0.0002629782,0.00020992995,0.00005159521],"category_scores_gemma":[0.00064150407,0.00019195612,0.00021966212,0.000436087,0.00007474273,0.00027839333,0.000024847786,0.00022166931,0.000015667423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005748499,0.0017666022,0.7058138,0.00010076015,0.00033408156,0.0000866433,0.00043480232,0.00017723159,0.0015920677,0.0018432661,0.00053773064,0.28673816],"study_design_scores_gemma":[0.018600171,0.0005905701,0.9612571,0.001718253,0.000095335876,0.00008808851,0.000049397288,0.0004686919,0.005660711,0.004098496,0.0071697193,0.00020347668],"about_ca_topic_score_codex":0.00018320665,"about_ca_topic_score_gemma":0.000052943997,"teacher_disagreement_score":0.28653467,"about_ca_system_score_codex":0.0026227913,"about_ca_system_score_gemma":0.0016546692,"threshold_uncertainty_score":0.7827743},"labels":[],"label_agreement":null},{"id":"W7117449343","doi":"10.1158/2326-6066.cir-25-0583","title":"The CCL17–CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"Cole Foundation; Canadian Cancer Society; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Lymphoma; Infiltration (HVAC); Chemokine; STAT protein; Ex vivo; In vivo; Chemokine receptor; Mutant; Doxorubicin; STAT3","score_opus":0.033104659551749814,"score_gpt":0.3643765976180743,"score_spread":0.3312719380663245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117449343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84953827,0.13718304,0.000014940997,0.011593949,0.00014885433,0.00088774617,0.00012709382,0.000019089737,0.0004870473],"genre_scores_gemma":[0.9709211,0.024963828,0.000084327454,0.00078566215,0.000032464854,0.0008961572,0.00002046145,0.00002955076,0.0022664769],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763626,0.00026039864,0.00037603494,0.00055450056,0.0002681977,0.00090461876],"domain_scores_gemma":[0.99708337,0.0021268222,0.000041016865,0.0005219756,0.00013626527,0.0000905599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007416373,0.00020214437,0.00035541426,0.00020594486,0.00054775865,0.00004478127,0.00020288126,0.00021473468,0.000038631275],"category_scores_gemma":[0.00027240574,0.00014510532,0.00008185477,0.00029393518,0.00082394126,0.000038808677,0.000174001,0.00035153443,0.000016830998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04383132,0.040268965,0.25828862,0.0018861761,0.0029928624,0.0009725266,0.010414519,0.0000024989822,0.39351735,0.017808614,0.018509792,0.21150677],"study_design_scores_gemma":[0.116868965,0.001997611,0.35564452,0.0012743734,0.00033227404,0.00004144604,0.0076942327,0.0016382746,0.0617357,0.0051924386,0.44691405,0.0006660977],"about_ca_topic_score_codex":0.00019808745,"about_ca_topic_score_gemma":0.00029708052,"teacher_disagreement_score":0.42840424,"about_ca_system_score_codex":0.0012418109,"about_ca_system_score_gemma":0.0005093826,"threshold_uncertainty_score":0.5917223},"labels":[],"label_agreement":null},{"id":"W7117532524","doi":"10.1080/10428194.2025.2598663","title":"Time to diagnosis and treatment in lymphoma and implications for health-related outcomes: a systematic review","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hatch (Canada)","funders":"","keywords":"Checklist; Presentation (obstetrics); Lymphoma; Confidence interval; Interval (graph theory); MEDLINE; Consistency (knowledge bases); Medical diagnosis","score_opus":0.014372511580656168,"score_gpt":0.2987673864370383,"score_spread":0.28439487485638215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117532524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8532812,0.11396512,0.000019300745,0.019844595,0.00011780552,0.011316495,0.0002412082,0.00023322858,0.0009810608],"genre_scores_gemma":[0.87372756,0.070342116,0.0011878499,0.026193488,0.00006477716,0.021444136,0.00033785668,0.0001680823,0.0065341145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99538904,0.0002102245,0.0017940146,0.0013800919,0.00027799554,0.000948655],"domain_scores_gemma":[0.9963604,0.0012654449,0.0004004437,0.0010315499,0.000147805,0.0007943087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057988265,0.0009240095,0.003015356,0.00062765187,0.0004343302,0.00013347549,0.00020038137,0.00035018552,0.000025180847],"category_scores_gemma":[0.00046045834,0.00071993645,0.00034089733,0.0009167153,0.00021443151,0.00018076188,0.00018785271,0.000045267512,0.000059432554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009588468,0.003626706,0.22361633,0.15657082,0.0037736036,0.00030554386,0.002783223,0.0000104533465,0.00013348476,0.0055716555,0.021927824,0.5807215],"study_design_scores_gemma":[0.042311113,0.0018245957,0.8652553,0.07034526,0.003114467,0.0010492988,0.0002766921,0.00077021326,0.0001962635,0.00055456825,0.013239159,0.0010630661],"about_ca_topic_score_codex":0.0018406139,"about_ca_topic_score_gemma":0.00026143386,"teacher_disagreement_score":0.641639,"about_ca_system_score_codex":0.011796023,"about_ca_system_score_gemma":0.002740228,"threshold_uncertainty_score":0.9995252},"labels":[],"label_agreement":null},{"id":"W7117579440","doi":"10.14740/jh2157","title":"Primary Gastrointestinal B-Cell Lymphomas: A Clinicopathological Review","year":2025,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Gastrointestinal tract; Pathological; Lymphoproliferative disorders; Lymphoma; Gastrointestinal system","score_opus":0.015191769488432632,"score_gpt":0.31357148915389815,"score_spread":0.2983797196654655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117579440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6306473,0.28711727,0.0007382353,0.031871744,0.0006724333,0.00066591625,0.0000048738084,0.000041180672,0.048241045],"genre_scores_gemma":[0.91971105,0.024923978,0.027245088,0.026847638,0.0001610274,0.0000245598,0.000009340646,0.000017000175,0.001060296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858,0.000099143974,0.00082164624,0.00014075852,0.00016236662,0.00019610125],"domain_scores_gemma":[0.9987861,0.00029416804,0.00039771758,0.00019125294,0.00021350342,0.000117282485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040463047,0.00013344569,0.00093134976,0.00012430911,0.000030397468,0.000005444304,0.00010591712,0.00006334384,0.00015227967],"category_scores_gemma":[0.00039729563,0.00008429424,0.00033090834,0.00014484093,0.0000785296,0.00003464967,0.000048284903,0.00016786969,0.000044595352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064349145,0.004436418,0.825238,0.0037462683,0.000118867814,0.017924745,0.000015119761,3.8446302e-7,0.00049931736,0.0029299492,0.13048835,0.013959069],"study_design_scores_gemma":[0.021857364,0.0072078183,0.44411936,0.034545913,0.0025965406,0.4102993,0.00008615439,0.000011715156,0.0037385374,0.0022307844,0.073010646,0.0002958712],"about_ca_topic_score_codex":9.235307e-7,"about_ca_topic_score_gemma":2.2724984e-7,"teacher_disagreement_score":0.39237455,"about_ca_system_score_codex":0.00014174984,"about_ca_system_score_gemma":0.00050588005,"threshold_uncertainty_score":0.34374192},"labels":[],"label_agreement":null},{"id":"W7130679891","doi":"10.6084/m9.figshare.28545024","title":"Additional file 1 of Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma","year":2025,"lang":"","type":"article","venue":"Figshare","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Lymphoma; Clinical trial; Radiation therapy","score_opus":0.04818356817931566,"score_gpt":0.30414676647665606,"score_spread":0.2559631982973404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7130679891","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05366287,0.010127616,8.92141e-7,0.000112389745,0.000057055753,0.0023305747,0.93351007,0.000014084163,0.00018445602],"genre_scores_gemma":[0.49635413,0.0013119985,0.0006044256,0.000055056895,0.000078113364,0.0016561368,0.49739096,0.000043839656,0.0025053646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739593,0.00012068517,0.0013194975,0.0004824731,0.00037806318,0.00030334896],"domain_scores_gemma":[0.9869015,0.010980793,0.0010461635,0.0005627316,0.00039186605,0.00011692732],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000070436465,0.00046216891,0.0016466256,0.00019480006,0.00015640212,0.00001386957,0.00016404607,0.00031145726,0.5461969],"category_scores_gemma":[0.0014267401,0.0002689506,0.00033327486,0.00037569748,0.00013077864,0.000071565555,0.000114436654,0.00006853457,0.000010827476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013922891,0.007915162,0.00060603843,0.004087093,0.0040125703,0.000028332559,0.0018210143,0.000055885692,0.00013154172,0.000007878894,0.89179885,0.075612746],"study_design_scores_gemma":[0.045789346,0.015746728,0.38318905,0.036584888,0.0033684638,0.000027684959,0.0011345928,0.0026668615,0.031701453,0.000018730549,0.47931352,0.00045869776],"about_ca_topic_score_codex":0.0000793912,"about_ca_topic_score_gemma":0.000097562806,"teacher_disagreement_score":0.54618603,"about_ca_system_score_codex":0.0002544513,"about_ca_system_score_gemma":0.00075862225,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W7132910660","doi":"","title":"Immunobiologic prognostic factors in aggressive non-Hodgkin&apos;s lymphoma: The role of proliferative index, host-immune response, and continuous lactate dehydrogenase level in predicting survival in 148 consecutive subjects","year":2000,"lang":"en","type":"dissertation","venue":"TSpace","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Care Ontario","keywords":"Lactate dehydrogenase; Survival analysis; Proportional hazards model; Antibody; Disease; L-Lactate dehydrogenase","score_opus":0.01938686307736085,"score_gpt":0.31194558818164364,"score_spread":0.29255872510428277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132910660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877146,0.00768983,9.46053e-8,0.00009076964,0.00012030649,0.0034002496,0.00012908362,0.00002620785,0.0008288955],"genre_scores_gemma":[0.99744564,0.00079466036,0.000013654187,0.000020725322,0.000019966854,0.0006144134,0.00058072485,0.000057567853,0.0004526486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968255,0.000739526,0.0008550118,0.0006562404,0.00034041694,0.00058331044],"domain_scores_gemma":[0.99662495,0.0019125137,0.0008454978,0.0003544311,0.00016551236,0.000097083495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006347028,0.00063027715,0.0013865323,0.00055520085,0.000090027475,0.000034949557,0.00017436051,0.0005016617,0.00002179241],"category_scores_gemma":[0.0012341947,0.00043984715,0.00013785688,0.0006008362,0.00020888027,0.000080093734,0.00005580717,0.00045217716,0.0000036728136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01825027,0.0011789729,0.8777302,0.00013987717,0.0002810931,0.0008912792,0.09062352,0.000011999478,0.009311984,0.00000961472,0.000003167587,0.0015680364],"study_design_scores_gemma":[0.008103472,0.0010169675,0.8722039,0.0026040599,0.0001393941,0.000046498997,0.0573806,0.00009503572,0.05805098,0.00003454566,0.000009779862,0.00031474786],"about_ca_topic_score_codex":0.010253384,"about_ca_topic_score_gemma":0.008952216,"teacher_disagreement_score":0.048738997,"about_ca_system_score_codex":0.00053924025,"about_ca_system_score_gemma":0.001097031,"threshold_uncertainty_score":0.99980533},"labels":[],"label_agreement":null},{"id":"W7133087698","doi":"","title":"p53 mutations in non-Hodgkin&apos;s lymphoma, correlation with prognosis","year":2000,"lang":"en","type":"dissertation","venue":"TSpace","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Correlation; Mutation; Cancer; Disease; Gene","score_opus":0.016201677339972038,"score_gpt":0.3359165226376833,"score_spread":0.31971484529771127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133087698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310908,0.00059483486,0.000006216554,0.00040577806,0.00017572303,0.0014604134,0.000010608254,0.00008334286,0.06617232],"genre_scores_gemma":[0.95791614,0.00028487534,0.0007592102,0.000104383806,0.000095588635,0.0008462092,0.0044301874,0.00007901658,0.035484385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984424,0.00003139384,0.00032817843,0.00048361707,0.0004047416,0.0003096573],"domain_scores_gemma":[0.9991546,0.00008334787,0.00019387138,0.0003108026,0.00011995622,0.00013740773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006304573,0.0003799386,0.0005279311,0.00035040439,0.00008922276,0.000041299554,0.00006866155,0.00032252126,0.0005100335],"category_scores_gemma":[0.00002213519,0.00030728677,0.00012063644,0.0004824778,0.000031042906,0.00008196015,0.0000054586626,0.00013957993,0.0003039856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008631962,0.010427735,0.49401805,0.0015042585,0.0016352655,0.0024562853,0.06999932,0.00084766425,0.0004919365,0.0005016698,0.010985595,0.39850026],"study_design_scores_gemma":[0.007087461,0.00081319147,0.9780372,0.0018000791,0.0009268851,0.000072767034,0.004401765,0.000399379,0.0022011327,0.00003533292,0.003780478,0.00044433604],"about_ca_topic_score_codex":0.0015175251,"about_ca_topic_score_gemma":0.0023140146,"teacher_disagreement_score":0.48401916,"about_ca_system_score_codex":0.00052875606,"about_ca_system_score_gemma":0.0005106864,"threshold_uncertainty_score":0.99993795},"labels":[],"label_agreement":null},{"id":"W7160244399","doi":"10.52768/2766-7820/3868","title":"Delayed post treatment inflammation mimics relapsed disease in primary mediastinal large B-cell lymphoma on 18F-FDG PET","year":2025,"lang":"","type":"article","venue":"Journal of Clinical Images and Medical Case Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lymphoma; Inflammation; Disease; Stage (stratigraphy); Mediastinum; Positron emission tomography; Medical imaging","score_opus":0.018004083514141154,"score_gpt":0.35358738347118207,"score_spread":0.3355832999570409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7160244399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698198,0.011377911,0.00005417662,0.0135818375,0.0027685727,0.00086110376,0.00007745872,0.000016477823,0.0014426861],"genre_scores_gemma":[0.95875233,0.036095306,0.00032573543,0.002619962,0.0014189249,0.00003149869,0.00009615245,0.000038871178,0.00062121416],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.98896164,0.00076278136,0.006824756,0.00085484766,0.0018331927,0.0007628145],"domain_scores_gemma":[0.98853636,0.00412363,0.0029392035,0.0006708985,0.0007091874,0.003020724],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054467954,0.00068984705,0.0025786478,0.0005298076,0.00020656917,0.00010501329,0.000113210524,0.00043286642,0.00026127617],"category_scores_gemma":[0.011325512,0.00047419872,0.0011353876,0.0003719361,0.00045723357,0.00027650467,0.00017624513,0.0008315558,0.000010052318],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067995726,0.019767683,0.08275131,0.00040217323,0.0006177199,0.693438,0.000113819486,0.0000050358276,0.000014296003,0.000027852822,0.0014933099,0.19456922],"study_design_scores_gemma":[0.10434808,0.015599364,0.63099223,0.009326877,0.0073904847,0.20317678,0.00063316186,0.0013330266,0.0004750471,0.00030071588,0.025670283,0.00075392047],"about_ca_topic_score_codex":0.00019265788,"about_ca_topic_score_gemma":0.000083017476,"teacher_disagreement_score":0.54824096,"about_ca_system_score_codex":0.000969294,"about_ca_system_score_gemma":0.0074249497,"threshold_uncertainty_score":0.999771},"labels":[],"label_agreement":null},{"id":"W76243008","doi":"10.1182/blood.v124.21.5447.5447","title":"Safety and Efficacy of Dose Attentuated R-CHOP Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in the Very Elderly: A Cohort Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Tolerability; CHOP; Chemotherapy regimen; Oncology; Regimen; Lymphoma; Cancer; Adverse effect","score_opus":0.010482693665450514,"score_gpt":0.2578473889440864,"score_spread":0.24736469527863586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W76243008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965371,0.00044382256,0.000005645778,0.0001686852,0.000021294823,0.0025298386,0.000028509761,0.00001118393,0.0002539394],"genre_scores_gemma":[0.9990449,0.0004819209,0.00006687817,0.000078790574,0.000032082145,0.00020430781,0.000027460608,0.000017007866,0.00004668283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990195,0.00007230126,0.00031843313,0.0002355017,0.00017493241,0.0001793312],"domain_scores_gemma":[0.9990488,0.00036367046,0.000114197406,0.0003831625,0.000040073886,0.00005009569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002240073,0.00016604528,0.0005161189,0.000060577575,0.00003676652,0.000006530168,0.000058290538,0.00005065434,0.000007359521],"category_scores_gemma":[0.000025909776,0.00009619978,0.00011147896,0.00011022381,0.000033031207,0.000017351862,0.000011574521,0.0000118715925,0.0000012352244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011686544,0.13745956,0.8432525,0.000052223248,0.00048737472,0.000015808513,0.0022911353,2.4368782e-7,0.0005863567,0.000032438053,0.000024011753,0.014629722],"study_design_scores_gemma":[0.19321632,0.0065301307,0.7926333,0.000033502027,0.000734721,0.0000071520562,0.00029016924,0.000028304932,0.0058357096,0.0000058932555,0.00061991275,0.00006487359],"about_ca_topic_score_codex":0.00018839746,"about_ca_topic_score_gemma":0.000047486945,"teacher_disagreement_score":0.19204767,"about_ca_system_score_codex":0.00004713816,"about_ca_system_score_gemma":0.000038844475,"threshold_uncertainty_score":0.3922913},"labels":[],"label_agreement":null},{"id":"W805386214","doi":"10.1182/blood.v124.21.2976.2976","title":"Single Cell Mass Cytometry for Phenotypic Analysis of Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Population; Mass cytometry; Cancer research; Immunology; Lymphoma; Molecular biology; Pathology; Medicine; Phenotype; Genetics","score_opus":0.010772123293533314,"score_gpt":0.23540012164552687,"score_spread":0.22462799835199357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W805386214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915074,0.0006422573,0.0017987938,0.000060982577,0.000055465043,0.00029051377,0.00010143639,0.000038405175,0.0055047274],"genre_scores_gemma":[0.99601674,0.000029003784,0.0028319438,0.00020601315,0.00008428926,0.000053463442,0.00013545337,0.000024681753,0.00061838626],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998933,0.00002670894,0.00027419542,0.00027797502,0.00020730935,0.00028081812],"domain_scores_gemma":[0.9989915,0.00020699305,0.00013926122,0.00044210235,0.0000874979,0.00013263567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013379438,0.00016096521,0.00053938664,0.00030594133,0.000048241396,0.00001275624,0.00008291419,0.00008928277,0.00005936379],"category_scores_gemma":[0.000052124844,0.00012870817,0.00038426142,0.00054958946,0.000022454784,0.00002784816,0.000026058971,0.00001984985,0.000024711935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028505304,0.1551593,0.7109794,0.0006261206,0.0046585747,0.000036588943,0.00040077884,0.000005082313,0.11915234,0.0006333564,0.00085231505,0.0072110924],"study_design_scores_gemma":[0.08850197,0.0015454098,0.17845498,0.000043948,0.021183128,0.0000037201958,0.00010450724,0.0010160068,0.7005221,0.00008433928,0.008270477,0.00026937498],"about_ca_topic_score_codex":0.00002486843,"about_ca_topic_score_gemma":0.000010073242,"teacher_disagreement_score":0.5813698,"about_ca_system_score_codex":0.000054416836,"about_ca_system_score_gemma":0.000035254696,"threshold_uncertainty_score":0.5248567},"labels":[],"label_agreement":null},{"id":"W824520190","doi":"10.1182/blood.v122.21.2948.2948","title":"Lupus Increases The Incidence Ratio Of Hematologic Malignancies: A Meta-Analysis Of Cohort Studies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Lymphoma; Incidence (geometry); Population; Confidence interval; Meta-analysis; Etiology; Cohort study; Oncology; Immunology; Environmental health","score_opus":0.06219536481522704,"score_gpt":0.3072800703527492,"score_spread":0.24508470553752215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W824520190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531915,0.02348258,0.000003342558,0.00048064982,0.000013033408,0.00048352798,0.00001599216,0.000011364313,0.00019037373],"genre_scores_gemma":[0.99820966,0.00073282834,0.00029430824,0.0001825829,0.0000067166616,0.00039436048,0.000007535111,0.000004128968,0.00016785724],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9990199,0.00006635735,0.000374398,0.00016122338,0.00027036536,0.000107733584],"domain_scores_gemma":[0.9985146,0.00051075435,0.00022396394,0.0004188098,0.0002943033,0.00003756735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018599725,0.000119603814,0.0011399481,0.00008861538,0.000037239563,0.0000060860466,0.00008580026,0.000030465786,0.00029243593],"category_scores_gemma":[0.00033591615,0.000053957083,0.0005844706,0.00039920682,0.00014803531,0.000043037297,0.000056227964,0.000021971005,0.00001272607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064360343,0.0012149647,0.6749687,0.00006055404,0.32155243,0.000022704522,0.0003336416,0.0000067921883,0.00074579124,0.00045818381,0.0006117609,0.00001803516],"study_design_scores_gemma":[0.000815748,0.00020016158,0.35161412,0.000018495699,0.6055542,0.00005623308,0.00076379045,0.000025593034,0.04074096,0.0001342587,0.00001531045,0.00006109891],"about_ca_topic_score_codex":0.001361377,"about_ca_topic_score_gemma":0.0000908466,"teacher_disagreement_score":0.32335457,"about_ca_system_score_codex":0.000015715968,"about_ca_system_score_gemma":0.000046345063,"threshold_uncertainty_score":0.32019684},"labels":[],"label_agreement":null},{"id":"W84242093","doi":"10.7175/fe.v6i4.845","title":"Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato","year":2005,"lang":"en","type":"article","venue":"Farmeconomia Health economics and therapeutic pathways","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Formulary; Ibritumomab tiuxetan; Health care; Clinical trial; Resource consumption; Pediatrics; Internal medicine; Radioimmunotherapy; Family medicine","score_opus":0.03793197532515781,"score_gpt":0.2879080719108901,"score_spread":0.24997609658573228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84242093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97461885,0.007786975,0.00006179928,0.012235904,0.0006802213,0.0022171475,0.000476493,0.00012984607,0.0017927756],"genre_scores_gemma":[0.97622436,0.008441754,0.0008103359,0.012581302,0.00056792423,0.00031702657,0.0004382749,0.00013054445,0.0004884704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516654,0.00014150454,0.0017655158,0.0014629848,0.00017213941,0.0012913378],"domain_scores_gemma":[0.9966743,0.00026222854,0.0007513969,0.0011302148,0.00007832996,0.0011035391],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083526375,0.0008630631,0.0016467128,0.00030363892,0.00057081523,0.00034493528,0.00031082358,0.0003397274,0.00023673705],"category_scores_gemma":[0.0000145116755,0.0008183988,0.00042546508,0.00016192913,0.0002085094,0.00031821543,0.00013813008,0.00037740654,0.0002321652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004490282,0.007898647,0.22485015,0.00096535846,0.0041390453,0.00017064229,0.0061819525,0.0006264045,0.0007876555,0.019631276,0.010818735,0.71943986],"study_design_scores_gemma":[0.022167116,0.0034688432,0.3323832,0.00039912903,0.00046470156,0.0002871701,0.0004859025,0.012147316,0.0015799395,0.0004632129,0.62470186,0.0014516654],"about_ca_topic_score_codex":0.0006731968,"about_ca_topic_score_gemma":0.0012059245,"teacher_disagreement_score":0.7179882,"about_ca_system_score_codex":0.0019386972,"about_ca_system_score_gemma":0.0011392877,"threshold_uncertainty_score":0.99942666},"labels":[],"label_agreement":null},{"id":"W877133176","doi":"10.1155/2013/195690","title":"Endoscopic Ultrasonographic Features of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with a ‘Pseudocircumvolutory’ Appearance","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Esophagogastroduodenoscopy; Gastroenterology; Internal medicine; Pathology; Hepatitis B; Lymphoma; Endoscopy","score_opus":0.005985146019970185,"score_gpt":0.20396660891002735,"score_spread":0.19798146289005716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W877133176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960735,0.0017383111,0.000055945824,0.0012012635,0.00022961068,0.00034584818,0.000025873549,0.000009467855,0.0003201662],"genre_scores_gemma":[0.99835384,0.00010173995,0.0005303394,0.0007675378,0.000096311625,0.000024440233,0.000010940642,0.000029172723,0.00008565466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981811,0.00012327306,0.0005452677,0.00021607002,0.0002459651,0.00068829005],"domain_scores_gemma":[0.9977926,0.000044820797,0.00054984575,0.00025647465,0.00045041597,0.0009058653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014039098,0.00026085635,0.0007869689,0.00065873633,0.000080585865,0.000027837119,0.00021244962,0.00012605319,0.00018448159],"category_scores_gemma":[0.0000854432,0.00019821618,0.00018766048,0.00030659992,0.00030930698,0.00013378044,0.0000085346355,0.00014054005,0.000014581033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002366816,0.00027311867,0.9908712,0.00003749687,0.00062982657,0.0006487512,0.00016694801,0.000009350104,0.001044576,0.00002634567,0.0027070178,0.0033487228],"study_design_scores_gemma":[0.008455221,0.0068621184,0.9757581,0.00037620377,0.00029296763,0.0067070276,0.00011649159,0.0000036964896,0.0008103358,0.000024909117,0.00052020315,0.000072772826],"about_ca_topic_score_codex":0.008605889,"about_ca_topic_score_gemma":0.013193088,"teacher_disagreement_score":0.015113111,"about_ca_system_score_codex":0.0004706329,"about_ca_system_score_gemma":0.001061466,"threshold_uncertainty_score":0.9979959},"labels":[],"label_agreement":null},{"id":"W91601700","doi":"","title":"Primary low-grade B-cell lymphoma of the urinary bladder: case report and literature review.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Lymphoma; Urinary bladder; MALT lymphoma; Urinary system; Pathology; Marginal zone; Malignant lymphoma; Mucosa-associated lymphoid tissue; Internal medicine; B cell; Immunology; Antibody","score_opus":0.013858858999987518,"score_gpt":0.21456840939450494,"score_spread":0.20070955039451743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W91601700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7846413,0.19817093,1.2363037e-7,0.003153438,0.00011695985,0.0013169774,0.000016998118,0.000024114124,0.012559129],"genre_scores_gemma":[0.9623381,0.030557694,0.00006632972,0.0020445243,0.00008689253,0.0006697822,0.000017042474,0.000016045287,0.004203619],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99896413,0.000043684286,0.00030529458,0.00025255667,0.00021494659,0.00021940134],"domain_scores_gemma":[0.9990554,0.00004374409,0.00015388738,0.0005481114,0.00005025005,0.00014864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015450624,0.00015018207,0.00031576885,0.00003711555,0.00005717628,0.000013400207,0.000055034252,0.00006950854,0.000022139015],"category_scores_gemma":[0.00007075215,0.0000875584,0.00014294614,0.00021000215,0.00007004271,0.00005461582,0.00007008644,0.000056452038,0.0000036445251],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006548243,0.008343082,0.10019735,0.006284571,0.00037013608,0.5240385,0.00052213646,1.13461695e-7,0.000038300386,0.00005592562,0.112263955,0.24782048],"study_design_scores_gemma":[0.0037128632,0.00008224037,0.6425189,0.0010249402,0.00050740957,0.32988456,0.0000143552525,0.0000054160582,0.0016450931,0.0000125657025,0.020457558,0.0001341035],"about_ca_topic_score_codex":0.000012521148,"about_ca_topic_score_gemma":9.3603967e-7,"teacher_disagreement_score":0.5423215,"about_ca_system_score_codex":0.00008895716,"about_ca_system_score_gemma":0.000021213866,"threshold_uncertainty_score":0.3570528},"labels":[],"label_agreement":null},{"id":"W945635311","doi":"10.1182/blood.v122.21.4382.4382","title":"Three-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Population; Oncology; Refractory (planetary science); Chemotherapy regimen; Phases of clinical research; CD30; Lymphoma; Surgery; Chemotherapy","score_opus":0.023484202020987745,"score_gpt":0.27857208762072533,"score_spread":0.2550878855997376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W945635311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856836,0.000035133544,0.0000051903476,0.000021007261,0.000041493542,0.0011184069,0.00018306576,0.00001590826,0.000011464768],"genre_scores_gemma":[0.99817646,0.000025433297,0.00020286813,0.000015727452,0.000026076383,0.000039383758,0.0014791997,0.00002409397,0.000010780958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987787,0.000051545496,0.00037603773,0.000377683,0.0002771257,0.00013891481],"domain_scores_gemma":[0.9987301,0.000061176186,0.00024779045,0.00075162476,0.00009155115,0.00011775238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000711646,0.00015719935,0.00039684962,0.00010213177,0.00003366356,0.000015239476,0.00012335503,0.00006203961,0.00008656032],"category_scores_gemma":[0.000055567787,0.00010605797,0.000017800414,0.00014612249,0.000030866275,0.0002746416,0.00009888335,0.000041213,0.0000023808182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001092313,0.036696978,0.93050444,0.000035337976,0.00020269952,0.00003436322,0.0007655808,2.2365517e-8,0.0048213038,4.231778e-7,0.0000076530305,0.025838895],"study_design_scores_gemma":[0.09362195,0.005087467,0.8979053,0.00040102497,0.00044241495,0.0000020728428,0.00014717305,0.00003326942,0.0022592586,0.00000125514,0.0000029671164,0.00009585854],"about_ca_topic_score_codex":0.0007638972,"about_ca_topic_score_gemma":0.00040366215,"teacher_disagreement_score":0.09252963,"about_ca_system_score_codex":0.000033140353,"about_ca_system_score_gemma":0.00009555745,"threshold_uncertainty_score":0.43249184},"labels":[],"label_agreement":null},{"id":"W953396656","doi":"10.1155/2016/7056035","title":"Early Bronchus-Associated Lymphoid Tissue Lymphoma Diagnosed with Immunoglobulin Heavy Chain Molecular Testing","year":2016,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lymphoma; Pathology; MALT lymphoma; Mucosa-associated lymphoid tissue; Immunoglobulin heavy chain; Immunoglobulin light chain; Lymphatic system; Immunohistochemistry; Marginal zone B-cell lymphoma; B cell; Antibody; Marginal zone; Immunology","score_opus":0.01659561847828256,"score_gpt":0.23702407210416146,"score_spread":0.2204284536258789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W953396656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925222,0.003180157,0.00004902777,0.001254534,0.00019711106,0.00043605032,0.00005831909,0.00006547612,0.0022371605],"genre_scores_gemma":[0.99513364,0.000045368633,0.00030579075,0.0037638787,0.00027557797,0.000052614272,0.0000058540786,0.000084466024,0.00033279706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731547,0.00018441785,0.00052982126,0.0004148648,0.0005361873,0.0010192542],"domain_scores_gemma":[0.9966526,0.00021518953,0.00028520598,0.00047719618,0.00044393403,0.0019258916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044162205,0.00039840429,0.00052231015,0.0004137477,0.0004582053,0.00014517053,0.00023317989,0.00021841706,0.00027447235],"category_scores_gemma":[0.0005761945,0.00026169507,0.00014100072,0.0004700249,0.00015320275,0.00018748453,0.000024344863,0.00014718168,0.00019291845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023911758,0.00035416958,0.72239226,0.00001577311,0.0005783068,0.031506587,0.00021117834,0.000005839947,0.012066118,0.00012639807,0.0030613784,0.2294429],"study_design_scores_gemma":[0.017572967,0.0027502778,0.91403055,0.0013198991,0.0002551897,0.0031248338,0.0000889831,0.000004192595,0.013396364,0.000060061117,0.046846576,0.0005501216],"about_ca_topic_score_codex":0.017900653,"about_ca_topic_score_gemma":0.01383206,"teacher_disagreement_score":0.22889277,"about_ca_system_score_codex":0.0042840666,"about_ca_system_score_gemma":0.0047695283,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W96606994","doi":"10.1016/j.ophtha.2005.10.042","title":"Conjunctival T-cell Lymphoma","year":2006,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Lymphoma; Dermatology; Pathology","score_opus":0.011177497761037793,"score_gpt":0.25234444809139295,"score_spread":0.24116695033035515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W96606994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72274196,0.00035782924,0.000003058306,0.0004211436,0.00017334417,0.00012935718,0.0000036238948,0.000031636948,0.276138],"genre_scores_gemma":[0.9878249,0.0000053245503,0.000455897,0.00019398086,0.00019641392,0.000042813343,0.00004836164,0.000015992748,0.011216307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922866,0.000026322286,0.00015544286,0.00023823573,0.00010542758,0.00024591753],"domain_scores_gemma":[0.9995519,0.000059709342,0.000042396045,0.00023405632,0.000038224534,0.00007374201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041437946,0.00012927371,0.00024424444,0.000055856282,0.00004729917,0.0000068579848,0.000043766137,0.00010258465,0.00080262223],"category_scores_gemma":[0.000008841885,0.00010172044,0.000096608936,0.00007984561,0.00006843435,0.000022647342,0.000026412203,0.000027641114,0.0006734447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029136383,0.004983639,0.9524671,0.00004007608,0.00008059471,0.0110038,0.00002245764,0.0000039213496,0.0048268144,0.0050141513,0.017261544,0.004004549],"study_design_scores_gemma":[0.0077342424,0.0008208747,0.9408577,0.000012051255,0.0001020504,0.012745693,0.000017078126,0.000016069347,0.020162942,0.000922733,0.016467681,0.00014085366],"about_ca_topic_score_codex":0.00046146044,"about_ca_topic_score_gemma":9.577639e-7,"teacher_disagreement_score":0.26508293,"about_ca_system_score_codex":0.00010930785,"about_ca_system_score_gemma":0.00007922779,"threshold_uncertainty_score":0.87881505},"labels":[],"label_agreement":null},{"id":"W98406833","doi":"10.1007/978-3-7091-6016-9_4","title":"Advances in understanding and use of autoantibodies as markers of diseases","year":2003,"lang":"en","type":"book-chapter","venue":"","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Autoantibody; Ribonucleoprotein; snRNP; Immunology; Biology; Centromere; Medicine; Genetics; Antibody; RNA; Chromosome","score_opus":0.0411124627609014,"score_gpt":0.27918772638301814,"score_spread":0.23807526362211673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W98406833","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073798615,0.0429593,0.000025221527,0.00028612168,0.00009958436,0.0006830239,0.00011933829,0.000022451775,0.9484251],"genre_scores_gemma":[0.7077969,0.16268465,0.0006969618,0.00026803892,0.000020186637,0.000011499101,0.000069159156,0.00005222639,0.12840042],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933237,0.0000062437575,0.00024801667,0.00017080712,0.00015731707,0.00008523904],"domain_scores_gemma":[0.9994722,0.00018412744,0.00012541279,0.00013426822,0.000025602783,0.00005841212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025024496,0.00016152886,0.0004923748,0.00015751676,0.000010929099,0.000004342255,0.000015916448,0.00007787384,0.0002156177],"category_scores_gemma":[0.000033738674,0.00011674413,0.000085522624,0.000016009326,0.00014756601,0.000070898626,0.000018115785,0.000033070126,0.0000012752035],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006645819,0.00033903873,0.2993798,0.0014225803,0.00052621606,0.00027185844,0.00009346516,0.0000029585362,0.000009754712,0.68299043,0.001978928,0.0123204095],"study_design_scores_gemma":[0.025119279,0.006957762,0.29219624,0.031485174,0.006873084,0.00024971753,0.0022664794,0.000066947825,0.0016748151,0.2194174,0.4115563,0.0021367911],"about_ca_topic_score_codex":0.00006904441,"about_ca_topic_score_gemma":0.000050526036,"teacher_disagreement_score":0.82002467,"about_ca_system_score_codex":0.00012513912,"about_ca_system_score_gemma":0.000056758625,"threshold_uncertainty_score":0.47606874},"labels":[],"label_agreement":null}]}